,Word,T,P
0,Pre-operative,1,1
1,short-term,1,0
2,pulmonary,1,0
3,rehabilitation,1,1
4,for,1,0
5,patients,0,0
6,of,0,0
7,chronic,0,0
8,obstructive,0,0
9,pulmonary,0,0
10,disease,0,0
11,undergoing,0,0
12,coronary,1,0
13,artery,1,1
14,bypass,1,1
15,graft,1,1
16,surgery,1,1
17,.,1,0
18,The,0,0
19,role,0,0
20,of,0,0
21,pre-operative,1,0
22,short-term,1,0
23,pulmonary,1,0
24,rehabilitation,1,1
25,in,0,0
26,patients,0,0
27,with,0,0
28,chronic,0,0
29,obstructive,0,0
30,pulmonary,0,0
31,disease,0,0
32,who,0,0
33,undergo,0,0
34,coronary,0,0
35,artery,0,0
36,bypass,0,1
37,graft,0,1
38,surgery,0,1
39,has,0,0
40,been,0,0
41,assessed,0,0
42,for,0,0
43,the,0,0
44,first,0,0
45,time,0,0
46,prospectively,0,0
47,.,0,0
48,Forty-five,0,0
49,patients,0,0
50,posted,0,0
51,for,0,0
52,coronary,1,0
53,artery,1,0
54,bypass,0,1
55,graft,0,1
56,surgery,0,1
57,were,0,0
58,randomised,0,0
59,to,0,0
60,receive,0,0
61,either,0,0
62,short-term,1,0
63,pulmonary,1,0
64,rehabilitation,1,1
65,(,0,1
66,group,0,1
67,I,0,0
68,),0,0
69,or,1,1
70,no,1,0
71,such,1,0
72,programme,1,1
73,(,0,1
74,group,0,1
75,II,0,1
76,),0,0
77,.,0,0
78,Patients,0,0
79,of,0,0
80,both,0,0
81,the,0,0
82,groups,0,0
83,were,0,0
84,evenly,0,0
85,matched,0,0
86,with,0,0
87,respect,0,0
88,to,0,0
89,age,0,0
90,",",0,0
91,sex,0,0
92,",",0,0
93,body,0,0
94,surface,0,1
95,area,0,0
96,",",0,0
97,duration,0,0
98,and,0,0
99,severity,0,0
100,of,0,0
101,chronic,0,0
102,obstructive,0,0
103,pulmonary,0,0
104,disease,0,0
105,and,0,0
106,coronary,0,0
107,artery,0,0
108,disease,0,0
109,.,0,0
110,Normal,0,0
111,individuals,0,0
112,who,0,0
113,evenly,0,0
114,matched,0,0
115,with,0,0
116,the,0,0
117,study,0,0
118,group,0,0
119,were,0,0
120,assessed,0,0
121,for,0,0
122,normal,0,0
123,respiratory,0,0
124,function,0,0
125,parameters,0,0
126,.,0,0
127,Pre-operative,0,0
128,and,0,0
129,post-operative,0,0
130,peak,0,0
131,expiratory,0,0
132,flow,0,0
133,rate,0,0
134,",",0,0
135,inspiratory,0,0
136,capacity,0,0
137,",",0,0
138,post-operative,0,0
139,ventilation,0,1
140,time,0,0
141,",",0,0
142,post-operative,0,0
143,pulmonary,0,0
144,complication,0,0
145,and,0,0
146,hospital,0,0
147,stay,0,0
148,were,0,0
149,determined,0,0
150,in,0,0
151,both,0,0
152,the,0,0
153,groups,0,0
154,.,0,0
155,Peak,0,0
156,expiratory,0,0
157,flow,0,0
158,rate,0,0
159,(,0,0
160,220.0,0,0
161,+/-,0,0
162,12.9,0,0
163,and,0,0
164,324.3,0,0
165,+/-,0,0
166,84.3,0,0
167,in,0,0
168,group,0,0
169,I,0,0
170,",",0,0
171,218.0,0,0
172,+/-,0,0
173,16.4,0,0
174,and,0,0
175,260.5,0,0
176,+/-,0,0
177,35.2,0,0
178,in,0,0
179,group,0,0
180,II,0,1
181,),0,1
182,and,0,0
183,inspiratory,0,1
184,capacity,0,0
185,(,0,0
186,844.0,0,0
187,+/-,0,0
188,147.4,0,0
189,and,0,0
190,1100.0,0,0
191,+/-,0,0
192,158.1,0,0
193,in,0,0
194,group,0,0
195,I,0,0
196,",",0,0
197,830.0,0,0
198,+/-,0,0
199,117.4,0,0
200,and,0,0
201,1090,0,0
202,+/-,0,0
203,137,0,1
204,in,0,0
205,group,0,0
206,II,0,0
207,),0,0
208,were,0,0
209,significantly,0,0
210,lower,0,0
211,before,0,0
212,and,0,0
213,after,0,0
214,surgery,0,1
215,respectively,0,0
216,in,0,0
217,both,0,0
218,groups,0,0
219,compared,0,0
220,to,0,0
221,normal,0,0
222,values,0,0
223,.,0,0
224,Even,0,0
225,though,0,0
226,both,0,0
227,groups,0,0
228,showed,0,0
229,a,0,0
230,significant,0,0
231,rise,0,0
232,in,0,0
233,post-operative,0,0
234,peak,0,0
235,expiratory,0,0
236,flow,0,0
237,rate,0,0
238,and,0,0
239,inspiratory,0,1
240,capacity,0,0
241,after,0,0
242,surgery,0,0
243,",",0,0
244,the,0,0
245,post-operative,0,0
246,peak,0,0
247,expiratory,0,0
248,flow,0,0
249,rate,0,0
250,and,0,0
251,inspiratory,0,1
252,capacity,0,0
253,in,0,0
254,group,0,0
255,I,0,0
256,was,0,0
257,significantly,0,0
258,higher,0,0
259,than,0,0
260,in,0,0
261,group,0,0
262,II,0,0
263,.,0,0
264,In,0,0
265,group,0,0
266,I,0,0
267,",",0,0
268,the,0,0
269,post-operative,0,0
270,ventilation,0,1
271,time,0,0
272,(,0,0
273,24.5,0,0
274,+/-,0,0
275,6.00,0,0
276,hours,0,0
277,),0,0
278,",",0,0
279,post-operative,0,0
280,complications,0,0
281,(,0,0
282,n,0,0
283,=,0,0
284,4,0,1
285,),0,0
286,and,0,0
287,hospital,0,0
288,stay,0,0
289,(,0,0
290,12.4,0,0
291,+/-,0,0
292,3.6,0,0
293,days,0,0
294,),0,0
295,were,0,0
296,significantly,0,0
297,lower,0,0
298,than,0,0
299,in,0,0
300,group,0,0
301,II,0,1
302,(,0,0
303,35.2,0,0
304,+/-,0,0
305,22.3,0,0
306,hours,0,0
307,",",0,0
308,n,0,0
309,=,0,0
310,11,0,0
311,",",0,0
312,18.8,0,0
313,+/-,0,0
314,6.6,0,0
315,days,0,0
316,respectively,0,0
317,),0,0
318,.,0,0
319,These,0,0
320,data,0,0
321,suggest,0,0
322,that,0,0
323,short-term,0,0
324,pulmonary,0,0
325,rehabilitation,0,1
326,is,0,0
327,feasible,0,0
328,and,0,0
329,effective,0,0
330,in,0,0
331,improving,0,0
332,pulmonary,0,0
333,functions,0,0
334,before,0,0
335,and,0,0
336,after,0,0
337,surgery,0,1
338,and,0,0
339,in,0,0
340,reducing,0,0
341,surgical,0,1
342,morbidity,0,0
343,and,0,0
344,cost,0,0
345,of,0,0
346,medical,0,0
347,care,0,1
348,significantly,0,0
349,.,0,0
350,Anesthesia,0,1
351,for,0,0
352,in,0,0
353,vitro,0,0
354,fertilization,0,0
355,:,0,0
356,the,0,0
357,addition,0,0
358,of,0,0
359,fentanyl,1,1
360,to,0,0
361,1.5,0,0
362,%,0,0
363,lidocaine,1,1
364,.,1,0
365,UNLABELLED,0,0
366,Ultrasonically,0,1
367,guided,0,1
368,transvaginal,0,1
369,oocyte,0,0
370,retrieval,0,1
371,is,0,0
372,relatively,0,0
373,short,0,0
374,procedure,0,0
375,that,0,0
376,is,0,0
377,performed,0,0
378,on,0,0
379,an,0,0
380,out-patient,0,1
381,basis,0,0
382,.,0,0
383,The,0,0
384,optimal,0,0
385,anesthetic,0,1
386,technique,0,1
387,should,0,0
388,allow,0,0
389,good,0,0
390,surgical,0,1
391,anesthesia,0,1
392,with,0,0
393,minimal,0,0
394,side,0,0
395,effects,0,0
396,",",0,0
397,a,0,0
398,short,0,1
399,recovery,0,0
400,time,0,0
401,",",0,0
402,and,0,0
403,",",0,0
404,if,0,0
405,possible,0,0
406,",",0,0
407,a,0,0
408,high,0,0
409,rate,0,0
410,of,0,0
411,successful,0,0
412,pregnancy,0,0
413,.,0,0
414,Spinal,1,0
415,anesthesia,1,1
416,is,0,0
417,often,0,0
418,used,0,0
419,in,0,0
420,this,0,0
421,institution,0,0
422,",",0,0
423,as,0,0
424,well,0,0
425,as,0,0
426,many,0,0
427,others,0,0
428,",",0,0
429,for,0,0
430,this,0,0
431,procedure,0,0
432,.,0,0
433,The,0,0
434,addition,0,0
435,of,0,0
436,fentanyl,0,1
437,may,0,0
438,be,0,0
439,effective,0,0
440,for,0,0
441,both,0,0
442,intraoperative,0,1
443,and,0,0
444,postoperative,0,0
445,pain,0,0
446,relief,0,0
447,.,0,0
448,We,0,0
449,assessed,0,0
450,the,0,0
451,effect,0,0
452,of,0,0
453,adding,0,1
454,fentanyl,0,1
455,to,0,0
456,1.5,0,0
457,%,0,0
458,lidocaine,0,1
459,in,0,0
460,women,0,0
461,undergoing,0,0
462,ultrasonically,0,1
463,guided,0,1
464,oocyte,0,0
465,retrieval,0,1
466,.,0,0
467,Seventy-eight,0,0
468,women,0,0
469,were,0,0
470,randomized,0,0
471,to,0,0
472,receive,0,0
473,45,1,0
474,mg,1,1
475,of,1,0
476,hyperbaric,1,1
477,1.5,1,0
478,%,1,0
479,lidocaine,1,1
480,with,1,0
481,or,1,0
482,without,1,0
483,10,1,0
484,microg,1,0
485,of,1,0
486,fentanyl,1,1
487,.,1,0
488,Visual,0,0
489,analog,0,1
490,scale,0,0
491,(,0,1
492,VAS,0,1
493,),0,1
494,pain,0,0
495,scores,0,0
496,were,0,0
497,lower,0,0
498,in,0,0
499,the,0,0
500,operating,0,1
501,room,0,1
502,(,0,1
503,OR,0,0
504,),0,1
505,(,0,0
506,P,0,0
507,<,0,0
508,0.05,0,0
509,),0,0
510,and,0,0
511,postanesthesia,0,1
512,care,0,1
513,unit,0,1
514,(,0,1
515,PACU,0,1
516,),0,1
517,(,0,0
518,P,0,0
519,<,0,0
520,0.0005,0,0
521,),0,0
522,for,0,0
523,the,0,0
524,group,0,0
525,that,0,0
526,received,0,0
527,fentanyl,0,1
528,.,0,0
529,In,0,0
530,addition,0,0
531,",",0,0
532,the,0,0
533,amount,0,0
534,of,0,0
535,narcotic,0,0
536,required,0,0
537,in,0,0
538,the,0,0
539,PACU,0,1
540,was,0,0
541,less,0,0
542,in,0,0
543,the,0,0
544,fentanyl,0,1
545,group,0,0
546,(,0,0
547,P,0,0
548,<,0,0
549,0.005,0,0
550,),0,0
551,.,0,0
552,There,0,0
553,was,0,0
554,no,0,0
555,difference,0,0
556,in,0,0
557,VAS,0,1
558,scores,0,0
559,the,0,0
560,evening,0,0
561,of,0,0
562,or,0,1
563,24,0,0
564,h,0,0
565,after,0,0
566,the,0,0
567,procedure,0,0
568,.,0,0
569,The,0,0
570,amount,0,0
571,of,0,0
572,analgesics,0,0
573,and,0,0
574,narcotics,0,1
575,required,0,0
576,after,0,0
577,discharge,0,0
578,was,0,0
579,the,0,0
580,same,0,0
581,for,0,0
582,both,0,0
583,groups,0,0
584,.,0,0
585,Timed,0,0
586,variables,0,0
587,",",0,0
588,such,0,0
589,as,0,0
590,time,0,0
591,to,0,0
592,urination,0,0
593,",",0,0
594,ambulation,0,0
595,",",0,0
596,and,0,0
597,discharge,0,1
598,",",0,0
599,were,0,0
600,the,0,0
601,same,0,0
602,for,0,0
603,both,0,0
604,groups,0,0
605,of,0,0
606,women,0,0
607,.,0,0
608,The,0,0
609,addition,0,0
610,of,0,0
611,fentanyl,0,1
612,to,0,0
613,lidocaine,0,1
614,for,0,0
615,transvaginal,0,1
616,oocyte,0,0
617,retrieval,0,1
618,results,0,0
619,in,0,0
620,a,0,0
621,more,0,0
622,comfortable,0,0
623,patient,0,0
624,in,0,0
625,the,0,0
626,OR,0,0
627,and,0,0
628,PACU,0,1
629,.,0,0
630,IMPLICATIONS,0,0
631,This,0,0
632,study,0,0
633,demonstrates,0,0
634,that,0,0
635,when,0,0
636,fentanyl,0,1
637,is,0,0
638,added,0,0
639,to,0,0
640,a,0,0
641,local,0,1
642,anesthetic,0,1
643,",",0,0
644,lidocaine,0,1
645,",",0,0
646,with,0,0
647,spinal,0,0
648,anesthesia,0,1
649,for,0,0
650,egg,0,1
651,retrieval,0,1
652,procedures,0,0
653,",",0,0
654,patients,0,0
655,are,0,0
656,more,0,0
657,comfortable,0,0
658,during,0,0
659,the,0,0
660,procedure,0,0
661,compared,0,0
662,with,0,0
663,those,0,0
664,who,0,0
665,receive,0,0
666,lidocaine,0,1
667,alone,0,1
668,.,0,0
669,In,0,0
670,addition,0,0
671,",",0,0
672,the,0,0
673,narcotic,0,0
674,requirements,0,0
675,of,0,0
676,patients,0,0
677,are,0,0
678,less,0,0
679,in,0,0
680,the,0,0
681,postanesthesia,0,1
682,care,0,1
683,unit,0,0
684,.,0,0
685,Piperacillin/tazobactam,1,1
686,plus,1,1
687,tobramycin,1,1
688,versus,1,1
689,ceftazidime,1,1
690,plus,1,1
691,tobramycin,1,1
692,as,0,0
693,empiric,0,0
694,therapy,0,1
695,for,0,0
696,fever,0,0
697,in,0,0
698,severely,0,0
699,neutropenic,0,0
700,patients,0,0
701,.,0,0
702,The,0,0
703,objective,0,0
704,of,0,0
705,this,0,0
706,trial,0,0
707,was,0,0
708,to,0,0
709,evaluate,0,0
710,the,0,0
711,potential,0,0
712,advantages,0,0
713,of,0,0
714,the,0,0
715,combination,0,1
716,of,0,0
717,piperacillin,1,1
718,and,1,0
719,tazobactam,1,1
720,in,0,0
721,the,0,0
722,control,0,0
723,of,0,0
724,fever,0,0
725,in,0,0
726,neutropenic,0,0
727,patients,0,0
728,.,0,0
729,In,0,0
730,this,0,0
731,single-center,0,0
732,study,0,0
733,",",0,0
734,patients,0,0
735,who,0,0
736,experienced,0,0
737,a,0,0
738,total,0,0
739,of,0,0
740,247,0,0
741,febrile,0,0
742,episodes,0,0
743,were,0,0
744,prospectively,0,0
745,randomized,0,0
746,to,0,0
747,receive,0,0
748,either,0,0
749,our,0,0
750,standard,0,1
751,regimen,0,1
752,",",0,0
753,ceftazidime,1,1
754,3,0,0
755,g/day,0,0
756,(,0,0
757,1,0,1
758,g,0,1
759,t.i.d,0,1
760,.,0,1
761,),0,0
762,plus,0,1
763,tobramycin,1,1
764,3,0,0
765,mg/kg,0,1
766,per,0,1
767,day,0,1
768,(,0,0
769,1.5,0,1
770,mg/kg,0,1
771,b.i.d,0,1
772,.,0,0
773,),0,0
774,",",0,0
775,or,0,1
776,piperacillin,1,1
777,12,0,0
778,g/day,0,0
779,plus,0,1
780,tazobactam,1,1
781,1.5,0,1
782,g/day,0,0
783,(,0,0
784,4,0,1
785,g+0.5,0,0
786,g,0,1
787,t.i.d,0,1
788,.,0,1
789,),0,0
790,plus,0,1
791,tobramycin,1,1
792,3,0,0
793,mg/kg,0,1
794,per,0,1
795,day,0,1
796,(,0,0
797,1.5,0,0
798,mg/kg,0,1
799,b.i.d.,0,1
800,),0,0
801,.,0,0
802,Vancomycin,1,1
803,was,0,0
804,added,0,0
805,in,0,0
806,all,0,0
807,cases,0,0
808,of,0,0
809,persistent,0,0
810,fever,0,0
811,in,0,0
812,the,0,0
813,ceftazidime,1,1
814,arm,0,0
815,",",0,0
816,but,0,0
817,only,0,0
818,when,0,0
819,there,0,0
820,was,0,0
821,microbiologically,0,0
822,documented,0,0
823,resistance,0,0
824,in,0,0
825,the,0,0
826,piperacillin/tazobactam,1,1
827,arm,0,0
828,.,0,0
829,All,0,0
830,247,0,0
831,episodes,0,0
832,were,0,0
833,evaluable,0,0
834,by,0,0
835,intent-to-treat,0,0
836,analysis,0,0
837,.,0,0
838,The,0,0
839,two,0,0
840,populations,0,0
841,were,0,0
842,well,0,0
843,matched,0,0
844,in,0,0
845,terms,0,0
846,of,0,0
847,age,0,0
848,",",0,0
849,gender,0,0
850,",",0,0
851,underlying,0,0
852,disease,0,0
853,",",0,0
854,chemotherapy,0,1
855,received,0,0
856,",",0,0
857,oral,0,1
858,decontamination,0,1
859,",",0,0
860,clinical,0,0
861,and,0,0
862,bacterial,0,0
863,documentation,0,0
864,",",0,0
865,and,0,0
866,severity,0,0
867,and,0,0
868,duration,0,0
869,of,0,0
870,neutropenia,0,0
871,.,0,0
872,Initial,0,0
873,antibacterial,1,0
874,therapy,1,1
875,was,0,0
876,successful,0,0
877,(,0,0
878,apyrexia,0,0
879,at,0,0
880,72,0,0
881,h,0,0
882,",",0,0
883,without,0,0
884,antibiotic,0,1
885,change,0,0
886,),0,0
887,more,0,0
888,frequently,0,0
889,(,0,0
890,P,0,0
891,=,0,0
892,0.008,0,0
893,),0,0
894,with,0,0
895,the,0,0
896,regimen,0,1
897,containing,0,1
898,piperacillin/tazobactam,1,1
899,(,0,1
900,54.4,0,0
901,%,0,0
902,),0,0
903,than,0,0
904,with,0,0
905,the,0,0
906,one,0,0
907,including,0,0
908,ceftazidime,1,1
909,(,0,1
910,37.6,0,0
911,%,0,0
912,),0,0
913,.,0,0
914,Fewer,0,0
915,(,0,0
916,P,0,0
917,=,0,0
918,0.02,0,0
919,),0,0
920,major,0,0
921,infectious,0,0
922,events,0,0
923,(,0,0
924,infectious,0,0
925,death,0,0
926,or,0,1
927,delay,0,0
928,in,0,0
929,treatment,0,0
930,of,0,0
931,underlying,0,0
932,disease,0,0
933,due,0,0
934,to,0,0
935,infection,0,0
936,),0,0
937,were,0,0
938,observed,0,0
939,during,0,0
940,piperacillin/,1,1
941,tazobactam,1,1
942,treatment,0,1
943,(,0,0
944,2.6,0,0
945,%,0,0
946,),0,0
947,than,0,0
948,with,0,0
949,the,0,0
950,ceftazidime,1,1
951,regimen,0,1
952,(,0,0
953,11.3,0,0
954,%,0,0
955,),0,0
956,",",0,0
957,despite,0,0
958,a,0,0
959,lower,0,0
960,frequency,0,0
961,of,0,0
962,glycopeptide,1,1
963,addition,0,0
964,when,0,0
965,piperacillin/tazobactam,1,1
966,was,0,0
967,used,0,0
968,(,0,0
969,54.4,0,0
970,%,0,0
971,versus,0,1
972,77.4,0,0
973,%,0,0
974,),0,0
975,according,0,0
976,to,0,0
977,the,0,0
978,rules,0,0
979,adopted,0,0
980,.,0,0
981,This,0,0
982,trial,0,0
983,confirmed,0,0
984,the,0,0
985,efficacy,0,0
986,of,0,0
987,the,0,0
988,piperacillin/tazobactam,1,1
989,combination,0,1
990,for,0,0
991,empirical,0,0
992,treatment,0,0
993,of,0,0
994,febrile,0,0
995,neutropenic,0,0
996,patients,0,0
997,.,0,0
998,This,0,0
999,antibiotic,0,1
1000,combination,0,1
1001,permitted,0,0
1002,a,0,0
1003,dramatic,0,0
1004,decrease,0,0
1005,in,0,0
1006,empiric,1,0
1007,glycopeptide,1,1
1008,antibiotic,1,1
1009,administration,0,0
1010,in,0,0
1011,such,0,0
1012,patients,0,0
1013,.,0,0
1014,Comparison,0,0
1015,of,0,0
1016,patient-controlled,1,1
1017,and,1,0
1018,nurse-administered,1,1
1019,analgesia,1,1
1020,using,0,0
1021,intravenous,0,1
1022,fentanyl,0,1
1023,during,0,0
1024,labor,0,0
1025,.,0,0
1026,Preliminary,0,0
1027,observations,0,0
1028,have,0,0
1029,shown,0,0
1030,that,0,0
1031,fentanyl,1,1
1032,citrate,1,1
1033,",",0,0
1034,a,0,0
1035,potent,0,0
1036,narcotic,0,0
1037,",",0,0
1038,is,0,0
1039,helpful,0,0
1040,during,0,0
1041,labor,0,0
1042,without,0,1
1043,undue,0,0
1044,side,0,0
1045,effects,0,0
1046,.,0,0
1047,This,0,0
1048,randomized,0,0
1049,prospective,0,0
1050,investigation,0,0
1051,compared,0,0
1052,the,0,0
1053,patient-controlled,1,1
1054,administration,1,0
1055,of,1,0
1056,fentanyl,1,1
1057,with,0,0
1058,that,0,0
1059,of,0,0
1060,administration,1,0
1061,by,1,0
1062,nurses,1,0
1063,on,1,0
1064,request,1,0
1065,.,1,0
1066,Eighty,0,0
1067,healthy,0,0
1068,women,0,0
1069,beginning,0,0
1070,active,0,1
1071,labor,0,0
1072,(,0,1
1073,cervical,0,1
1074,dilation,0,1
1075,4,0,1
1076,cm,0,0
1077,),0,0
1078,at,0,0
1079,term,0,0
1080,were,0,0
1081,assigned,0,0
1082,to,0,0
1083,receive,0,0
1084,fentanyl,1,1
1085,intravenously,1,1
1086,by,1,0
1087,either,1,0
1088,patient-controlled,1,1
1089,administration,1,1
1090,(,1,1
1091,n=37,1,1
1092,),1,1
1093,or,1,1
1094,nurse,1,1
1095,administration,1,0
1096,on,1,0
1097,demand,1,0
1098,(,0,1
1099,n=43,0,0
1100,),0,0
1101,.,0,0
1102,Pain,0,0
1103,intensity,0,0
1104,measurements,0,0
1105,during,0,0
1106,early,0,0
1107,and,0,0
1108,late,0,0
1109,labor,0,0
1110,revealed,0,0
1111,the,0,0
1112,degree,0,0
1113,of,0,0
1114,analgesia,0,0
1115,to,0,0
1116,be,0,0
1117,the,0,0
1118,same,0,0
1119,in,0,0
1120,both,0,0
1121,groups,0,0
1122,.,0,0
1123,The,0,0
1124,delay,0,0
1125,in,0,0
1126,setting,0,0
1127,up,0,0
1128,the,0,0
1129,infusion,0,1
1130,system,0,1
1131,and,0,0
1132,the,0,0
1133,short,0,1
1134,time,0,0
1135,between,0,0
1136,requesting,0,0
1137,analgesia,0,1
1138,and,0,0
1139,vaginal,0,1
1140,delivery,0,0
1141,were,0,0
1142,limitations,0,0
1143,with,0,0
1144,self-administration,0,1
1145,.,0,0
1146,Maternal,0,0
1147,oversedation,0,0
1148,and,0,0
1149,vomiting,0,0
1150,did,0,0
1151,not,0,0
1152,occur,0,0
1153,.,0,0
1154,Neonatal,0,0
1155,naloxone,0,1
1156,therapy,0,1
1157,was,0,0
1158,used,0,0
1159,infrequently,0,0
1160,",",0,0
1161,umbilical,0,0
1162,serum,0,0
1163,levels,0,0
1164,of,0,0
1165,fentanyl,0,1
1166,were,0,0
1167,the,0,0
1168,same,0,0
1169,in,0,0
1170,both,0,0
1171,groups,0,0
1172,",",0,0
1173,and,0,0
1174,postnatal,0,0
1175,neuroadaptive,0,0
1176,testing,0,0
1177,revealed,0,0
1178,comparable,0,0
1179,results,0,0
1180,in,0,0
1181,both,0,0
1182,groups,0,0
1183,.,0,0
1184,Despite,0,0
1185,the,0,0
1186,usefulness,0,0
1187,of,0,0
1188,fentanyl,0,1
1189,during,0,0
1190,labor,0,0
1191,",",0,0
1192,administration,1,0
1193,by,1,0
1194,the,1,0
1195,patient,1,0
1196,had,0,0
1197,no,0,0
1198,advantages,0,0
1199,over,0,0
1200,administration,1,0
1201,by,1,0
1202,the,1,0
1203,nurses,1,0
1204,in,0,0
1205,significantly,0,0
1206,reducing,0,0
1207,drug,0,1
1208,use,0,0
1209,",",0,0
1210,improving,0,0
1211,pain,0,0
1212,relief,0,0
1213,",",0,0
1214,or,0,1
1215,avoiding,0,0
1216,drowsiness,0,0
1217,.,0,0
1218,Local,0,0
1219,injection,0,1
1220,of,0,0
1221,bupivacaine,1,1
1222,after,0,0
1223,rubber,0,1
1224,band,0,1
1225,ligation,0,1
1226,of,0,0
1227,hemorrhoids,0,0
1228,:,0,0
1229,prospective,0,0
1230,",",0,0
1231,randomized,0,0
1232,study,0,0
1233,.,0,0
1234,PURPOSE,0,0
1235,The,0,0
1236,aim,0,0
1237,of,0,0
1238,this,0,0
1239,study,0,0
1240,was,0,0
1241,to,0,0
1242,determine,0,0
1243,if,0,0
1244,local,0,1
1245,injection,0,1
1246,of,0,0
1247,bupivacaine,1,1
1248,after,0,0
1249,hemorrhoidal,0,0
1250,banding,0,1
1251,causes,0,0
1252,a,0,0
1253,decrease,0,0
1254,in,0,0
1255,pain,0,0
1256,and,0,0
1257,in,0,0
1258,the,0,0
1259,incidence,0,0
1260,of,0,0
1261,associated,0,0
1262,symptoms,0,0
1263,.,0,0
1264,METHODS,0,0
1265,After,0,0
1266,hemorrhoidal,0,0
1267,banding,0,0
1268,",",0,0
1269,patients,0,0
1270,were,0,0
1271,randomly,1,0
1272,assigned,1,0
1273,to,1,0
1274,receive,1,0
1275,a,1,0
1276,local,1,1
1277,injection,1,1
1278,of,1,0
1279,bupivacaine,1,1
1280,with,1,0
1281,"1:200,000",1,1
1282,epinephrine,1,1
1283,",",1,0
1284,an,1,0
1285,injection,1,1
1286,of,1,0
1287,normal,1,0
1288,saline,1,1
1289,",",1,0
1290,or,1,1
1291,no,1,0
1292,injection,1,1
1293,",",1,0
1294,just,1,0
1295,superior,1,0
1296,to,1,0
1297,each,1,0
1298,band,1,1
1299,.,1,0
1300,Pain,1,0
1301,was,1,0
1302,graded,1,0
1303,by,1,0
1304,the,1,0
1305,patient,1,0
1306,and,1,0
1307,by,1,0
1308,the,1,0
1309,study,1,0
1310,nurse,1,1
1311,within,1,0
1312,30,1,0
1313,minutes,1,0
1314,",",1,0
1315,and,1,0
1316,any,1,0
1317,associated,1,0
1318,symptoms,1,0
1319,were,1,0
1320,recorded,1,0
1321,.,1,0
1322,At,1,0
1323,intervals,1,0
1324,6,1,0
1325,",",1,0
1326,24,1,0
1327,",",1,0
1328,and,1,0
1329,48,1,0
1330,hours,1,0
1331,postbanding,1,0
1332,",",1,0
1333,the,1,0
1334,patient,1,0
1335,recorded,1,0
1336,pain,1,0
1337,",",1,0
1338,limitation,1,0
1339,of,1,0
1340,activities,1,0
1341,",",1,0
1342,and,1,0
1343,analgesic,1,0
1344,requirements,1,0
1345,.,1,0
1346,Associated,0,0
1347,symptoms,0,0
1348,while,0,0
1349,at,0,0
1350,home,0,1
1351,were,0,0
1352,recorded,0,0
1353,.,0,0
1354,RESULTS,0,0
1355,Of,0,0
1356,115,0,0
1357,patients,0,0
1358,studied,0,0
1359,",",0,0
1360,42,0,0
1361,received,0,0
1362,bupivacaine,1,1
1363,injection,0,1
1364,",",0,0
1365,42,0,0
1366,received,0,0
1367,normal,1,0
1368,saline,1,1
1369,injection,0,1
1370,",",0,0
1371,and,0,0
1372,31,0,0
1373,received,0,0
1374,no,1,0
1375,injection,1,1
1376,.,1,0
1377,In,0,0
1378,patients,0,0
1379,receiving,0,0
1380,bupivacaine,1,1
1381,compared,0,0
1382,with,0,0
1383,no,0,0
1384,injection,0,1
1385,",",0,0
1386,within,0,0
1387,30,0,0
1388,minutes,0,0
1389,postbanding,0,0
1390,there,0,0
1391,was,0,0
1392,a,0,0
1393,significant,0,0
1394,reduction,0,0
1395,in,0,0
1396,pain,0,0
1397,graded,0,0
1398,by,0,0
1399,the,0,0
1400,patient,0,0
1401,(,0,0
1402,P,0,0
1403,=,0,0
1404,0.000002,0,0
1405,),0,0
1406,and,0,0
1407,by,0,0
1408,the,0,0
1409,nurse,0,1
1410,(,0,0
1411,P,0,0
1412,=,0,0
1413,0.000005,0,0
1414,),0,0
1415,and,0,0
1416,a,0,0
1417,significant,0,0
1418,reduction,0,0
1419,in,0,0
1420,incidence,0,0
1421,of,0,0
1422,nausea,0,0
1423,(,0,0
1424,P,0,0
1425,=,0,0
1426,0.01,0,0
1427,),0,0
1428,and,0,0
1429,shaking,0,1
1430,(,0,1
1431,P,0,0
1432,=,0,0
1433,0.008,0,0
1434,),0,0
1435,.,0,0
1436,However,0,0
1437,",",0,0
1438,in,0,0
1439,the,0,0
1440,bupivacaine,1,1
1441,group,0,0
1442,compared,0,0
1443,with,0,0
1444,the,0,0
1445,other,0,0
1446,two,0,0
1447,groups,0,0
1448,",",0,0
1449,at,0,0
1450,the,0,0
1451,intervals,0,0
1452,of,0,0
1453,6,0,0
1454,",",0,0
1455,24,0,0
1456,",",0,0
1457,and,0,0
1458,48,0,0
1459,hours,0,0
1460,postbanding,0,0
1461,there,0,0
1462,was,0,0
1463,no,0,0
1464,sustained,0,0
1465,reduction,0,0
1466,in,0,0
1467,the,0,0
1468,severity,0,0
1469,of,0,0
1470,pain,0,0
1471,and,0,0
1472,no,0,0
1473,reduction,0,0
1474,in,0,0
1475,analgesic,0,1
1476,requirements,0,0
1477,or,0,1
1478,limitation,0,0
1479,of,0,0
1480,normal,0,0
1481,activities,0,0
1482,.,0,0
1483,In,0,0
1484,the,0,0
1485,week,0,0
1486,after,0,0
1487,banding,0,0
1488,",",0,0
1489,there,0,0
1490,was,0,0
1491,no,0,0
1492,difference,0,0
1493,between,0,0
1494,groups,0,0
1495,in,0,0
1496,symptoms,0,0
1497,of,0,0
1498,nausea,0,0
1499,",",0,0
1500,shaking,0,0
1501,",",0,0
1502,lightheadedness,0,0
1503,",",0,0
1504,urinary,0,0
1505,retention,0,0
1506,",",0,0
1507,or,0,1
1508,bleeding,0,0
1509,.,0,0
1510,CONCLUSIONS,0,0
1511,Bupivacaine,1,1
1512,injection,0,1
1513,may,0,0
1514,be,0,0
1515,useful,0,0
1516,for,0,0
1517,reducing,0,0
1518,pain,0,0
1519,and,0,0
1520,associated,0,0
1521,symptoms,0,0
1522,long,0,0
1523,enough,0,0
1524,to,0,0
1525,tolerate,0,0
1526,a,0,0
1527,trip,0,1
1528,home,0,1
1529,from,0,0
1530,the,0,0
1531,outpatient,0,0
1532,department,0,0
1533,but,0,0
1534,does,0,0
1535,not,0,0
1536,show,0,0
1537,a,0,0
1538,sustained,0,0
1539,effect,0,0
1540,.,0,0
1541,Isradipine,1,1
1542,",",0,0
1543,raised,0,0
1544,glycosylated,0,0
1545,haemoglobin,0,0
1546,",",0,0
1547,and,0,0
1548,risk,0,0
1549,of,0,0
1550,cardiovascular,0,0
1551,events,0,0
1552,.,0,0
1553,Long,0,0
1554,term,0,1
1555,response,0,0
1556,to,0,0
1557,therapy,0,1
1558,of,0,0
1559,chronic,0,0
1560,anti-HBe-positive,0,0
1561,hepatitis,0,1
1562,B,0,1
1563,is,0,0
1564,poor,0,0
1565,independent,0,0
1566,of,0,0
1567,type,0,0
1568,and,0,0
1569,schedule,0,1
1570,of,0,0
1571,interferon,0,1
1572,.,0,0
1573,OBJECTIVE,0,0
1574,The,0,0
1575,response,0,0
1576,rate,0,0
1577,to,0,0
1578,alpha,1,1
1579,interferon,1,1
1580,(,1,1
1581,IFN,1,0
1582,),1,1
1583,of,0,0
1584,chronic,0,0
1585,anti-HBe-positive,0,0
1586,hepatitis,0,1
1587,B,0,1
1588,is,0,0
1589,variable,0,0
1590,.,0,0
1591,We,0,0
1592,studied,0,0
1593,whether,0,0
1594,type,0,0
1595,",",0,0
1596,dose,0,0
1597,",",0,0
1598,and,0,0
1599,schedule,0,1
1600,of,0,0
1601,IFN,1,0
1602,",",0,0
1603,and,0,0
1604,type,0,0
1605,and,0,0
1606,frequency,0,0
1607,of,0,0
1608,posttreatment,0,0
1609,monitoring,0,0
1610,",",0,0
1611,influence,0,0
1612,the,0,0
1613,response,0,0
1614,rate,0,0
1615,.,0,0
1616,METHODS,0,0
1617,Seventy-two,0,0
1618,consecutive,0,0
1619,anti-HBe-positive,0,0
1620,chronic,0,0
1621,hepatitis,0,1
1622,B,0,1
1623,patients,0,0
1624,(,0,0
1625,59,0,0
1626,male,0,0
1627,and,0,0
1628,13,0,0
1629,female,0,0
1630,",",0,0
1631,median,0,0
1632,age,0,0
1633,41,0,0
1634,yr,0,0
1635,),0,0
1636,stratified,0,0
1637,by,0,0
1638,sex,0,0
1639,and,0,0
1640,histology,0,0
1641,were,0,0
1642,randomly,0,0
1643,allocated,0,0
1644,to,0,0
1645,three,0,0
1646,treatment,0,0
1647,arms,0,0
1648,.,0,0
1649,Twenty-seven,0,0
1650,patients,0,0
1651,(,0,0
1652,A,0,0
1653,),0,0
1654,received,0,0
1655,10,0,0
1656,million,0,0
1657,units,0,0
1658,alpha-N1,1,1
1659,IFN,1,0
1660,i.m,1,1
1661,.,1,0
1662,t.w,0,1
1663,.,0,0
1664,for,0,0
1665,24,0,0
1666,wk,0,0
1667,(,0,0
1668,total,0,0
1669,dose,0,0
1670,:,0,0
1671,720,0,0
1672,million,0,0
1673,units,0,0
1674,),0,0
1675,;,0,0
1676,21,0,0
1677,(,0,0
1678,B,0,1
1679,),0,1
1680,received,0,0
1681,9,0,0
1682,million,0,0
1683,units,0,0
1684,alpha-2a,1,1
1685,IFN,1,0
1686,i.m,1,1
1687,.,1,0
1688,t.w,0,1
1689,.,0,0
1690,for,0,0
1691,4,0,0
1692,wk,0,0
1693,",",0,0
1694,followed,0,1
1695,by,0,0
1696,18,0,0
1697,million,0,0
1698,units,0,0
1699,for,0,0
1700,12,0,0
1701,wk,0,0
1702,and,0,0
1703,9,0,0
1704,million,0,0
1705,units,0,0
1706,for,0,0
1707,8,0,0
1708,wk,0,0
1709,(,0,0
1710,972,0,0
1711,million,0,0
1712,units,0,0
1713,),0,0
1714,;,0,0
1715,24,0,0
1716,(,0,0
1717,C,0,1
1718,),0,1
1719,received,0,0
1720,2,1,0
1721,alpha-2a,1,1
1722,IFN,1,0
1723,courses,1,1
1724,(,0,0
1725,9,0,0
1726,million,0,0
1727,units,0,0
1728,i.m,0,1
1729,.,0,0
1730,t.w,0,1
1731,.,0,0
1732,for,0,0
1733,16,0,0
1734,and,0,0
1735,12,0,0
1736,wk,0,0
1737,separated,0,0
1738,by,0,0
1739,a,0,0
1740,6-month,0,0
1741,interval,0,0
1742,[,0,0
1743,756,0,0
1744,million,0,0
1745,units,0,0
1746,],0,0
1747,),0,0
1748,.,0,0
1749,Primary,0,0
1750,response,0,0
1751,was,0,0
1752,defined,0,0
1753,by,0,0
1754,normal,0,0
1755,ALT,0,1
1756,and,0,0
1757,serum,0,0
1758,HBV-DNA,0,1
1759,levels,0,0
1760,below,0,0
1761,10,0,0
1762,pg/ml,0,0
1763,at,0,0
1764,the,0,0
1765,end,0,0
1766,of,0,0
1767,therapy,0,1
1768,and,0,0
1769,sustained,0,0
1770,response,0,0
1771,by,0,0
1772,normal,0,0
1773,ALT,0,1
1774,(,0,0
1775,tested,0,0
1776,monthly,0,1
1777,),0,0
1778,",",0,0
1779,undetectable,0,0
1780,HBV-DNA,0,1
1781,and,0,0
1782,IgM,0,1
1783,anti-HBc,0,1
1784,(,0,0
1785,<,0,0
1786,7,0,0
1787,I.U,0,0
1788,.,0,0
1789,Paul,0,0
1790,Ehrlich,0,1
1791,Institute,0,0
1792,),0,1
1793,(,0,0
1794,tested,0,0
1795,every,0,1
1796,3,0,0
1797,months,0,0
1798,),0,0
1799,during,0,0
1800,the,0,0
1801,posttreatment,0,0
1802,follow-up,0,0
1803,.,0,0
1804,RESULTS,0,0
1805,At,0,0
1806,the,0,0
1807,end,0,0
1808,of,0,0
1809,treatment,0,0
1810,",",0,0
1811,12,0,0
1812,",",0,0
1813,8,0,0
1814,",",0,0
1815,and,0,0
1816,13,0,0
1817,patients,0,0
1818,from,0,0
1819,groups,0,0
1820,A,0,0
1821,",",0,0
1822,B,0,0
1823,",",0,0
1824,and,0,0
1825,C,0,1
1826,",",0,0
1827,respectively,0,0
1828,",",0,0
1829,were,0,0
1830,responders,0,0
1831,.,0,0
1832,At,0,0
1833,the,0,0
1834,18-month,0,0
1835,follow-up,0,0
1836,",",0,0
1837,two,0,0
1838,patients,0,0
1839,in,0,0
1840,group,0,0
1841,A,0,0
1842,and,0,0
1843,only,0,0
1844,one,0,0
1845,in,0,0
1846,groups,0,0
1847,B,0,0
1848,and,0,0
1849,C,0,1
1850,maintained,0,0
1851,the,0,0
1852,response,0,0
1853,.,0,0
1854,Overall,0,0
1855,",",0,0
1856,after,0,0
1857,34,0,0
1858,months,0,0
1859,(,0,0
1860,median,0,0
1861,posttreatment,0,1
1862,follow-up,0,0
1863,),0,0
1864,",",0,0
1865,three,0,0
1866,patients,0,0
1867,were,0,0
1868,long,0,0
1869,term,0,0
1870,responders,0,0
1871,",",0,0
1872,whereas,0,0
1873,three,0,0
1874,showed,0,0
1875,a,0,0
1876,sustained,0,0
1877,remission,0,0
1878,after,0,0
1879,relapse,0,0
1880,.,0,0
1881,CONCLUSIONS,0,0
1882,The,0,0
1883,rate,0,0
1884,of,0,0
1885,long,0,0
1886,term,0,1
1887,response,0,0
1888,to,0,0
1889,interferon,0,1
1890,of,0,0
1891,anti-HBe-positive,0,0
1892,chronic,0,0
1893,hepatitis,0,1
1894,B,0,1
1895,is,0,0
1896,poor,0,0
1897,",",0,0
1898,independent,0,0
1899,of,0,0
1900,IFN,0,0
1901,type,0,0
1902,",",0,0
1903,dose,0,0
1904,",",0,0
1905,or,0,1
1906,schedule,0,1
1907,;,0,0
1908,the,0,0
1909,more,0,0
1910,stringent,0,0
1911,the,0,0
1912,monitoring,0,0
1913,",",0,0
1914,the,0,0
1915,higher,0,0
1916,the,0,0
1917,relapse,0,0
1918,rate,0,0
1919,.,0,0
1920,A,0,0
1921,randomized,0,0
1922,phase,0,0
1923,II,0,1
1924,trial,0,0
1925,of,0,0
1926,5-fluorouracil,1,1
1927,",",0,0
1928,with,0,0
1929,or,0,1
1930,without,0,1
1931,human,1,1
1932,interferon-beta,1,1
1933,",",0,0
1934,for,0,0
1935,advanced,0,0
1936,colorectal,0,0
1937,cancer,0,0
1938,.,0,0
1939,This,0,0
1940,study,0,0
1941,compared,0,0
1942,the,0,0
1943,efficacy,0,0
1944,and,0,0
1945,safety,0,0
1946,of,0,0
1947,5-fluorouracil,1,1
1948,(,1,1
1949,5-FU,1,1
1950,),1,1
1951,monotherapy,1,1
1952,to,0,0
1953,that,0,0
1954,of,0,0
1955,5-FU,1,1
1956,combined,1,1
1957,with,1,0
1958,natural,1,0
1959,human,1,1
1960,interferon-beta,1,1
1961,(,1,1
1962,IFN-beta,1,1
1963,),1,1
1964,in,0,0
1965,patients,0,0
1966,with,0,0
1967,unresectable,0,0
1968,",",0,0
1969,advanced,0,0
1970,colorectal,0,0
1971,carcinoma,0,0
1972,.,0,0
1973,Forty-nine,0,0
1974,chemotherapy-naive,0,0
1975,patients,0,0
1976,were,0,0
1977,randomized,0,0
1978,to,0,0
1979,5-FU,0,1
1980,alone,0,1
1981,or,0,0
1982,to,0,0
1983,the,0,0
1984,combination,0,1
1985,.,0,0
1986,All,0,0
1987,patients,0,0
1988,received,0,0
1989,750,0,1
1990,mg,0,1
1991,m,0,0
1992,(,0,0
1993,-2,0,0
1994,),0,1
1995,day,0,1
1996,(,0,1
1997,-1,0,0
1998,),0,1
1999,5-FU,0,1
2000,for,0,0
2001,5,0,0
2002,days,0,0
2003,by,0,0
2004,continuous,0,1
2005,intravenous,0,1
2006,(,0,0
2007,i.v,0,1
2008,.,0,1
2009,),0,0
2010,infusion,0,0
2011,",",0,0
2012,followed,0,1
2013,after,0,0
2014,day,0,0
2015,15,0,0
2016,by,0,0
2017,a,0,0
2018,weekly,0,1
2019,i.v,0,1
2020,.,0,0
2021,bolus,0,0
2022,of,0,0
2023,750,0,1
2024,mg,0,1
2025,m,0,0
2026,(,0,1
2027,-2,0,0
2028,),0,0
2029,.,0,0
2030,IFN-beta,1,1
2031,was,0,0
2032,injected,0,0
2033,intramuscularly,0,1
2034,three,0,0
2035,times,0,0
2036,weekly,0,0
2037,at,0,0
2038,9,0,0
2039,M,0,0
2040,IU,0,1
2041,.,0,0
2042,Treatment,0,0
2043,continued,0,0
2044,for,0,0
2045,52,0,0
2046,weeks,0,0
2047,",",0,0
2048,or,0,0
2049,until,0,0
2050,disease,0,0
2051,progression,0,0
2052,or,0,1
2053,intolerable,0,0
2054,toxicity,0,0
2055,.,0,0
2056,Clinical,0,0
2057,endpoints,0,0
2058,were,0,0
2059,tumor,0,0
2060,response,0,0
2061,",",0,0
2062,time,0,0
2063,to,0,0
2064,progression,0,0
2065,",",0,0
2066,survival,0,0
2067,and,0,0
2068,toxicity,0,0
2069,.,0,0
2070,The,0,0
2071,addition,0,0
2072,of,0,0
2073,IFN-3,1,1
2074,to,1,0
2075,5-FU,1,1
2076,significantly,0,0
2077,improved,0,0
2078,response,0,0
2079,rate,0,0
2080,(,0,0
2081,33.3,0,0
2082,%,0,0
2083,vs,0,0
2084,4.5,0,0
2085,%,0,0
2086,for,0,0
2087,evaluable,0,0
2088,patients,0,0
2089,;,0,0
2090,P,0,0
2091,=,0,0
2092,0.021,0,0
2093,),0,0
2094,",",0,0
2095,time,0,0
2096,to,0,0
2097,progression,0,0
2098,(,0,0
2099,median,0,0
2100,7.2,0,0
2101,vs,0,0
2102,4.2,0,0
2103,months,0,0
2104,;,0,0
2105,P,0,0
2106,=,0,0
2107,0.0435,0,0
2108,),0,0
2109,",",0,0
2110,and,0,0
2111,survival,0,0
2112,time,0,0
2113,(,0,0
2114,median,0,0
2115,15.9,0,0
2116,vs,0,0
2117,7.2,0,0
2118,months,0,0
2119,;,0,0
2120,P,0,0
2121,=,0,0
2122,0.038,0,0
2123,),0,0
2124,without,0,0
2125,significantly,0,0
2126,increasing,0,0
2127,toxicity,0,0
2128,compared,0,0
2129,to,0,0
2130,5-FU,0,1
2131,alone,0,1
2132,.,0,0
2133,Cumulative,0,0
2134,5-FU,1,1
2135,dose,0,0
2136,was,0,0
2137,higher,0,0
2138,with,0,0
2139,combined,0,1
2140,therapy,0,1
2141,(,0,0
2142,P,0,0
2143,<,0,0
2144,0.001,0,0
2145,),0,0
2146,:,0,0
2147,more,0,0
2148,patients,0,0
2149,receiving,0,0
2150,monotherapy,0,1
2151,discontinued,0,0
2152,treatment,0,0
2153,because,0,0
2154,of,0,0
2155,disease,0,0
2156,progression,0,0
2157,.,0,0
2158,Fever,0,0
2159,was,0,0
2160,more,0,0
2161,frequent,0,0
2162,with,0,0
2163,combined,0,1
2164,therapy,0,1
2165,(,0,0
2166,P,0,0
2167,=,0,0
2168,0.008,0,0
2169,),0,0
2170,;,0,0
2171,there,0,0
2172,were,0,0
2173,no,0,0
2174,other,0,0
2175,differences,0,0
2176,in,0,0
2177,toxicity,0,0
2178,.,0,0
2179,The,0,0
2180,only,0,0
2181,grade,0,0
2182,IV,0,0
2183,toxicity,0,0
2184,observed,0,0
2185,was,0,0
2186,neutropenia,0,0
2187,(,0,0
2188,two,0,0
2189,patients,0,0
2190,per,0,0
2191,group,0,0
2192,),0,0
2193,.,0,0
2194,A,0,0
2195,randomized,0,0
2196,phase,0,0
2197,III,0,1
2198,trial,0,0
2199,has,0,0
2200,been,0,0
2201,initiated,0,0
2202,to,0,0
2203,confirm,0,0
2204,the,0,0
2205,synergy,0,1
2206,between,0,0
2207,5-FU,1,1
2208,and,0,0
2209,IFN-beta,1,1
2210,.,1,0
2211,Primary,1,0
2212,capsulectomy,1,1
2213,",",1,0
2214,anterior,1,0
2215,vitrectomy,1,1
2216,",",1,0
2217,lensectomy,1,1
2218,",",1,0
2219,and,1,0
2220,posterior,1,1
2221,chamber,1,1
2222,lens,1,1
2223,implantation,1,0
2224,in,0,0
2225,children,0,0
2226,:,0,0
2227,limbal,0,1
2228,versus,0,0
2229,pars,0,1
2230,plana,0,1
2231,.,0,0
2232,PURPOSE,0,0
2233,To,0,0
2234,compare,0,0
2235,the,0,0
2236,results,0,0
2237,of,0,0
2238,a,0,0
2239,limbal,1,1
2240,versus,0,0
2241,a,0,0
2242,pars,1,1
2243,plana,1,1
2244,approach,1,1
2245,for,0,0
2246,primary,1,0
2247,posterior,1,1
2248,capsulectomy,1,1
2249,and,1,0
2250,anterior,1,1
2251,vitrectomy,1,1
2252,in,0,0
2253,the,0,0
2254,management,0,1
2255,of,0,0
2256,childhood,0,0
2257,cataract,0,0
2258,.,0,0
2259,SETTING,0,0
2260,Department,0,0
2261,of,0,0
2262,Ophthalmology,0,1
2263,",",0,0
2264,Labbafinejad,0,1
2265,Medical,0,1
2266,Center,0,0
2267,",",0,0
2268,Tehran,0,0
2269,",",0,0
2270,Iran,0,1
2271,.,0,0
2272,METHODS,0,0
2273,A,0,0
2274,randomized,0,0
2275,",",0,0
2276,controlled,0,0
2277,",",0,0
2278,double-masked,0,0
2279,clinical,0,0
2280,trial,0,0
2281,of,0,0
2282,45,0,0
2283,eyes,0,0
2284,was,0,0
2285,conducted,0,0
2286,.,0,0
2287,After,0,0
2288,being,0,0
2289,matched,0,0
2290,",",0,0
2291,38,0,0
2292,eyes,0,0
2293,were,0,0
2294,included,0,0
2295,in,0,0
2296,the,0,0
2297,study,0,0
2298,and,0,0
2299,were,0,0
2300,divided,0,0
2301,into,0,0
2302,2,0,0
2303,equal,0,0
2304,groups,0,0
2305,for,0,0
2306,data,0,0
2307,analysis,0,0
2308,.,0,0
2309,All,0,0
2310,eyes,0,0
2311,had,0,0
2312,lensectomy,1,1
2313,and,1,0
2314,posterior,1,1
2315,chamber,1,1
2316,intraocular,1,1
2317,lens,1,1
2318,(,1,0
2319,PC,1,1
2320,IOL,1,1
2321,),1,0
2322,implantation,1,0
2323,.,1,0
2324,Primary,1,0
2325,posterior,1,0
2326,capsulectomy,1,1
2327,and,1,0
2328,anterior,1,1
2329,vitrectomy,1,1
2330,were,0,0
2331,performed,0,0
2332,through,0,0
2333,the,0,0
2334,limbus,0,0
2335,in,0,0
2336,half,0,0
2337,of,0,0
2338,the,0,0
2339,eyes,0,0
2340,and,0,0
2341,the,0,0
2342,pars,0,1
2343,plana,0,1
2344,in,0,0
2345,the,0,0
2346,other,0,0
2347,half,0,0
2348,.,0,0
2349,Main,0,0
2350,outcome,0,0
2351,measures,0,0
2352,included,0,0
2353,visual,0,0
2354,acuity,0,0
2355,",",0,0
2356,estimated,0,0
2357,red,0,0
2358,reflex,0,0
2359,",",0,0
2360,postsurgical,0,0
2361,inflammatory,0,0
2362,reaction,0,1
2363,",",0,0
2364,corneal,0,0
2365,clarity,0,0
2366,",",0,0
2367,posterior,0,0
2368,synechias,0,1
2369,",",0,0
2370,iris,0,0
2371,capture,0,0
2372,",",0,0
2373,IOL,0,1
2374,position,0,0
2375,",",0,0
2376,capsulectomy,0,1
2377,size,0,0
2378,",",0,0
2379,glaucoma,0,0
2380,",",0,0
2381,cystoid,0,1
2382,macular,0,0
2383,edema,0,0
2384,",",0,0
2385,retinal,0,0
2386,tear,0,0
2387,",",0,0
2388,and,0,0
2389,postoperative,0,0
2390,refraction,0,0
2391,.,0,0
2392,RESULTS,0,0
2393,No,0,0
2394,statistically,0,0
2395,significant,0,0
2396,differences,0,0
2397,were,0,0
2398,found,0,0
2399,between,0,0
2400,the,0,0
2401,2,0,0
2402,approaches,0,0
2403,in,0,0
2404,the,0,0
2405,outcome,0,0
2406,measures,0,0
2407,.,0,0
2408,CONCLUSION,0,0
2409,The,0,0
2410,anatomic,0,0
2411,and,0,0
2412,visual,0,0
2413,results,0,0
2414,were,0,0
2415,encouraging,0,0
2416,when,0,0
2417,posterior,1,1
2418,capsulectomy,1,1
2419,and,1,0
2420,anterior,1,1
2421,vitrectomy,1,1
2422,",",0,0
2423,using,0,0
2424,a,0,0
2425,limbal,0,1
2426,or,0,1
2427,pars,0,1
2428,plana,0,1
2429,approach,0,0
2430,",",0,0
2431,were,0,0
2432,combined,0,1
2433,with,0,0
2434,lensectomy,1,1
2435,and,1,0
2436,PC,1,1
2437,IOL,1,1
2438,implantation,1,0
2439,in,0,0
2440,children,0,0
2441,.,0,0
2442,The,0,0
2443,application,0,0
2444,of,0,0
2445,these,0,0
2446,techniques,0,1
2447,depends,0,0
2448,on,0,0
2449,surgeon,0,1
2450,experience,0,0
2451,and,0,0
2452,skill,0,0
2453,.,0,0
2454,Calcitriol,1,1
2455,for,0,0
2456,bone,0,0
2457,disease,0,0
2458,in,0,0
2459,patients,0,0
2460,with,0,0
2461,cirrhosis,0,0
2462,of,0,0
2463,the,0,0
2464,liver,0,0
2465,.,0,0
2466,BACKGROUND,0,0
2467,Osteoporosis,0,0
2468,is,0,0
2469,associated,0,0
2470,with,0,0
2471,cirrhosis,0,0
2472,of,0,0
2473,the,0,0
2474,liver,0,0
2475,",",0,0
2476,but,0,0
2477,the,0,0
2478,effects,0,0
2479,of,0,0
2480,therapy,0,1
2481,for,0,0
2482,osteoporosis,0,0
2483,associated,0,0
2484,with,0,0
2485,cirrhosis,0,0
2486,are,0,0
2487,still,0,0
2488,controversial,0,0
2489,.,0,0
2490,METHODS,0,0
2491,We,0,0
2492,evaluated,0,0
2493,the,0,0
2494,effects,0,0
2495,of,0,0
2496,calcitriol,1,1
2497,(,1,0
2498,"1alpha,25-dihydroxyvitamin",1,1
2499,D3,1,1
2500,),1,1
2501,on,0,0
2502,bone,0,0
2503,mineral,0,1
2504,density,0,0
2505,(,0,1
2506,BMD,0,0
2507,),0,1
2508,in,0,0
2509,76,0,0
2510,patients,0,0
2511,(,0,0
2512,26,0,0
2513,men,0,0
2514,and,0,0
2515,50,0,1
2516,women,0,0
2517,),0,0
2518,with,0,0
2519,cirrhosis,0,0
2520,who,0,0
2521,were,0,0
2522,assigned,0,0
2523,randomly,1,0
2524,to,1,0
2525,receive,1,1
2526,calcitriol,1,1
2527,(,1,0
2528,0.5,1,1
2529,mg,1,1
2530,twice,1,1
2531,per,1,1
2532,day,1,1
2533,),1,1
2534,or,1,1
2535,not,1,0
2536,.,1,0
2537,The,0,0
2538,BMD,0,0
2539,of,0,0
2540,the,0,0
2541,lumbar,0,1
2542,vertebrae,0,1
2543,was,0,0
2544,measured,1,0
2545,by,1,0
2546,dual-energy,1,1
2547,X-ray,1,0
2548,absorptiometry,1,0
2549,at,1,0
2550,least,1,0
2551,twice,1,0
2552,",",1,0
2553,12-57,1,0
2554,months,1,0
2555,apart,1,0
2556,.,1,0
2557,RESULTS,0,0
2558,For,0,0
2559,men,0,0
2560,",",0,0
2561,the,0,0
2562,mean,0,0
2563,annual,0,0
2564,change,0,0
2565,in,0,0
2566,BMD,0,0
2567,was,0,0
2568,1.1,0,0
2569,%,0,0
2570,in,0,0
2571,the,0,0
2572,treated,0,0
2573,group,0,0
2574,and,0,0
2575,-0.4,0,0
2576,%,0,0
2577,in,0,0
2578,the,0,0
2579,control,0,0
2580,group,0,0
2581,.,0,0
2582,The,0,0
2583,median,0,0
2584,(,0,0
2585,25th,0,0
2586,and,0,0
2587,75th,0,0
2588,percentiles,0,0
2589,),0,0
2590,annual,0,0
2591,change,0,0
2592,in,0,0
2593,BMD,0,0
2594,was,0,0
2595,0.6,0,1
2596,(,0,0
2597,-0.1,0,0
2598,",",0,0
2599,2.1,0,0
2600,%,0,0
2601,),0,0
2602,in,0,0
2603,the,0,0
2604,treated,0,0
2605,group,0,0
2606,and,0,1
2607,-1.4,0,1
2608,(,0,1
2609,-1.9,0,0
2610,",",0,0
2611,1.6,0,0
2612,%,0,0
2613,),0,0
2614,in,0,0
2615,the,0,0
2616,control,0,0
2617,group,0,0
2618,.,0,0
2619,The,0,0
2620,difference,0,0
2621,in,0,0
2622,the,0,0
2623,median,0,0
2624,annual,0,0
2625,change,0,0
2626,between,0,0
2627,the,0,0
2628,two,0,0
2629,groups,0,0
2630,was,0,0
2631,significant,0,0
2632,(,0,0
2633,P,0,0
2634,=,0,0
2635,0.013,0,0
2636,),0,0
2637,.,0,0
2638,For,0,0
2639,women,0,0
2640,",",0,0
2641,the,0,0
2642,mean,0,0
2643,annual,0,0
2644,change,0,0
2645,in,0,0
2646,BMD,0,0
2647,was,0,0
2648,-0.5,0,0
2649,%,0,0
2650,in,0,0
2651,the,0,0
2652,treated,0,0
2653,group,0,0
2654,and,0,0
2655,-2.3,0,0
2656,%,0,0
2657,in,0,0
2658,the,0,0
2659,control,0,0
2660,group,0,0
2661,.,0,0
2662,The,0,0
2663,median,0,0
2664,(,0,0
2665,25th,0,0
2666,and,0,0
2667,75th,0,0
2668,percentiles,0,0
2669,),0,0
2670,annual,0,0
2671,change,0,0
2672,in,0,0
2673,BMD,0,0
2674,was,0,0
2675,-0.5,0,0
2676,(,0,0
2677,-1.8,0,0
2678,",",0,0
2679,1.3,0,0
2680,%,0,0
2681,),0,0
2682,in,0,0
2683,the,0,0
2684,treated,0,0
2685,group,0,0
2686,and,0,1
2687,-1.5,0,1
2688,(,0,1
2689,-3.8,0,0
2690,",",0,0
2691,-0.7,0,0
2692,%,0,0
2693,),0,0
2694,in,0,0
2695,the,0,0
2696,control,0,0
2697,group,0,0
2698,.,0,0
2699,This,0,0
2700,difference,0,0
2701,was,0,0
2702,significant,0,0
2703,(,0,0
2704,P,0,0
2705,=,0,0
2706,0.011,0,0
2707,),0,0
2708,.,0,0
2709,CONCLUSIONS,0,0
2710,Our,0,0
2711,results,0,0
2712,suggest,0,0
2713,that,0,0
2714,calcitriol,0,1
2715,can,0,0
2716,prevent,0,0
2717,bone,0,0
2718,loss,0,0
2719,and,0,0
2720,",",0,0
2721,therefore,0,0
2722,",",0,0
2723,may,0,0
2724,be,0,0
2725,useful,0,0
2726,for,0,0
2727,the,0,0
2728,treatment,0,0
2729,of,0,0
2730,bone,0,0
2731,disease,0,0
2732,in,0,0
2733,patients,0,0
2734,with,0,0
2735,cirrhosis,0,0
2736,of,0,0
2737,the,0,0
2738,liver,0,0
2739,.,0,0
2740,Clinical,0,0
2741,observation,0,1
2742,on,0,0
2743,treatment,0,0
2744,of,0,0
2745,obstinate,0,0
2746,heart,0,0
2747,failure,0,0
2748,by,0,0
2749,supplementing,1,1
2750,qi,1,0
2751,and,1,1
2752,activating,1,1
2753,blood,1,0
2754,flow,1,0
2755,.,1,0
2756,Gabexate,1,1
2757,mesilate,1,1
2758,and,0,0
2759,antithrombin,1,1
2760,III,1,1
2761,for,0,0
2762,intraoperative,0,1
2763,anticoagulation,0,1
2764,in,0,0
2765,heparin,0,1
2766,pretreated,0,0
2767,patients,0,0
2768,.,0,0
2769,Thirty,0,0
2770,patients,0,0
2771,scheduled,0,0
2772,for,0,0
2773,elective,0,0
2774,myocardial,0,0
2775,revascularization,0,0
2776,and,0,0
2777,having,0,0
2778,undergone,0,0
2779,preoperative,0,1
2780,heparin,0,1
2781,treatment,0,0
2782,have,0,0
2783,been,0,0
2784,admitted,0,0
2785,to,0,0
2786,this,0,0
2787,prospective,0,0
2788,",",0,0
2789,randomized,0,0
2790,study,0,0
2791,.,0,0
2792,The,0,0
2793,aim,0,0
2794,of,0,0
2795,the,0,0
2796,study,0,0
2797,was,0,0
2798,to,0,0
2799,test,0,0
2800,two,0,0
2801,different,0,0
2802,strategies,0,0
2803,for,0,0
2804,preserving,0,0
2805,circulating,0,0
2806,antithrombin,0,1
2807,III,0,1
2808,(,0,1
2809,AT-III,0,1
2810,),0,1
2811,during,0,0
2812,cardiopulmonary,0,0
2813,bypass,0,1
2814,.,0,0
2815,Patients,0,0
2816,in,0,0
2817,the,0,0
2818,control,0,1
2819,group,0,1
2820,(,0,1
2821,group,0,0
2822,C,0,1
2823,",",0,0
2824,n,0,0
2825,=,0,0
2826,10,0,0
2827,),0,0
2828,were,0,0
2829,treated,0,0
2830,with,0,0
2831,a,0,0
2832,standard,1,1
2833,heparinization,1,1
2834,(,0,0
2835,300,0,1
2836,IU/kg,0,1
2837,),0,0
2838,.,0,0
2839,Patients,0,0
2840,in,0,0
2841,group,0,0
2842,A,0,1
2843,(,0,0
2844,n,0,0
2845,=,0,0
2846,10,0,0
2847,),0,0
2848,received,0,0
2849,the,0,0
2850,same,0,0
2851,management,0,1
2852,plus,0,1
2853,two,1,0
2854,doses,1,0
2855,of,1,0
2856,purified,1,0
2857,antithrombin,1,1
2858,III,1,1
2859,(,0,0
2860,1000,0,0
2861,IU,0,1
2862,each,0,0
2863,),0,0
2864,.,0,0
2865,Patients,0,0
2866,in,0,0
2867,group,0,0
2868,GA,0,1
2869,received,0,0
2870,200,1,1
2871,IU/kg,1,1
2872,heparin,1,1
2873,and,1,0
2874,a,1,0
2875,continuous,1,1
2876,infusion,1,1
2877,of,1,0
2878,heparin,1,1
2879,(,1,0
2880,100,1,1
2881,IU/kg/h,1,1
2882,),1,0
2883,and,1,0
2884,gabexate,1,1
2885,mesilate,1,1
2886,(,0,0
2887,2,0,1
2888,mg/kg/h,0,0
2889,),0,0
2890,plus,0,1
2891,the,0,0
2892,same,0,0
2893,dose,0,0
2894,of,0,0
2895,antithrombin,1,0
2896,III,1,0
2897,as,0,0
2898,group,0,0
2899,A,0,0
2900,.,0,0
2901,Both,0,1
2902,group,0,0
2903,A,0,0
2904,and,0,0
2905,group,0,0
2906,GA,0,1
2907,demonstrated,0,0
2908,a,0,0
2909,preservation,0,0
2910,of,0,0
2911,circulating,0,0
2912,AT-III,0,0
2913,when,0,0
2914,compared,0,0
2915,to,0,0
2916,group,0,0
2917,C,0,1
2918,;,0,0
2919,this,0,0
2920,effect,0,0
2921,was,0,0
2922,more,0,0
2923,pronounced,0,0
2924,in,0,0
2925,group,0,0
2926,GA,0,1
2927,.,0,0
2928,The,0,0
2929,total,0,0
2930,heparin,0,1
2931,dosage,0,0
2932,was,0,0
2933,less,0,0
2934,in,0,0
2935,group,0,0
2936,GA,0,1
2937,than,0,0
2938,in,0,0
2939,groups,0,0
2940,A,0,0
2941,and,0,0
2942,C.,0,1
2943,Purified,0,1
2944,AT-III,0,1
2945,administration,0,0
2946,is,0,0
2947,recommended,0,0
2948,in,0,0
2949,heparin,0,1
2950,pretreated,0,0
2951,patients,0,0
2952,;,0,0
2953,the,0,0
2954,addition,0,0
2955,of,0,0
2956,gabexate,0,1
2957,mesilate,0,1
2958,to,0,0
2959,this,0,0
2960,protocol,0,1
2961,decreases,0,0
2962,the,0,0
2963,heparin,0,1
2964,requirement,0,0
2965,and,0,0
2966,increases,0,0
2967,the,0,0
2968,AT-III,0,0
2969,preservation,0,0
2970,.,0,0
2971,The,0,0
2972,impact,0,0
2973,of,0,0
2974,schizophrenic,0,0
2975,patient,0,0
2976,functionality,0,0
2977,on,0,0
2978,service,0,1
2979,utilization,0,0
2980,and,0,0
2981,cost,0,0
2982,.,0,0
2983,Based,0,0
2984,on,0,0
2985,a,0,0
2986,presentation,0,0
2987,by,0,0
2988,Sandra,0,1
2989,L.,0,1
2990,Tunis,0,1
2991,",",0,0
2992,PhD,0,1
2993,.,0,0
2994,With,0,0
2995,the,0,0
2996,advent,0,0
2997,of,0,0
2998,atypical,0,0
2999,agents,0,0
3000,in,0,0
3001,the,0,0
3002,treatment,0,0
3003,of,0,0
3004,schizophrenia,0,0
3005,",",0,0
3006,physicians,0,1
3007,and,0,0
3008,policy,0,0
3009,makers,0,0
3010,must,0,0
3011,consider,0,0
3012,the,0,0
3013,costs,0,0
3014,that,0,0
3015,may,0,0
3016,accompany,0,0
3017,greater,0,0
3018,clinical,0,0
3019,efficacy,0,0
3020,.,0,1
3021,Analyses,0,0
3022,reveal,0,0
3023,that,0,0
3024,olanzapine,1,1
3025,shows,0,0
3026,a,0,0
3027,greater,0,0
3028,clinical,0,0
3029,cost,0,0
3030,effectiveness,0,0
3031,",",0,0
3032,as,0,0
3033,well,0,0
3034,as,0,0
3035,a,0,0
3036,greater,0,0
3037,functional,0,0
3038,cost,0,0
3039,effectiveness,0,0
3040,",",0,0
3041,than,0,0
3042,haloperidol,1,1
3043,",",0,0
3044,and,0,0
3045,that,0,0
3046,functional,0,0
3047,outcomes,0,0
3048,",",0,0
3049,in,0,0
3050,particular,0,0
3051,",",0,0
3052,show,0,0
3053,promise,0,0
3054,as,0,0
3055,important,0,0
3056,measures,0,0
3057,of,0,0
3058,effectiveness,0,0
3059,.,0,0
3060,Functional,0,0
3061,outcomes,0,0
3062,can,0,0
3063,help,0,0
3064,differentiate,0,0
3065,medications,0,1
3066,and,0,0
3067,can,0,0
3068,be,0,0
3069,used,0,0
3070,to,0,0
3071,help,0,0
3072,demonstrate,0,0
3073,the,0,0
3074,cost,0,0
3075,effectiveness,0,0
3076,of,0,0
3077,atypical,0,0
3078,agents,0,0
3079,.,0,0
3080,Mental,0,0
3081,health,0,0
3082,and,0,0
3083,physical,0,1
3084,health,0,0
3085,functioning,0,0
3086,",",0,0
3087,as,0,0
3088,well,0,0
3089,as,0,0
3090,work,0,0
3091,status,0,0
3092,",",0,0
3093,are,0,0
3094,all,0,0
3095,measures,0,0
3096,of,0,0
3097,functioning,0,0
3098,that,0,0
3099,have,0,0
3100,been,0,0
3101,used,0,0
3102,to,0,0
3103,evaluate,0,0
3104,treatment,0,0
3105,strategies,0,0
3106,.,0,0
3107,When,0,0
3108,comparing,0,0
3109,olanzapine,1,1
3110,with,0,0
3111,haloperidol,1,1
3112,",",0,0
3113,cost,0,0
3114,savings,0,0
3115,are,0,0
3116,seen,0,0
3117,throughout,0,0
3118,the,0,0
3119,treatment,0,1
3120,period,0,0
3121,(,0,0
3122,1,0,1
3123,year,0,0
3124,),0,0
3125,",",0,0
3126,with,0,0
3127,physical,0,1
3128,functioning,0,0
3129,most,0,0
3130,highly,0,0
3131,affected,0,0
3132,over,0,0
3133,time,0,0
3134,.,0,0
3135,Functional,0,0
3136,outcomes,0,0
3137,can,0,0
3138,therefore,0,0
3139,serve,0,0
3140,2,0,0
3141,purposes,0,0
3142,:,0,0
3143,to,0,0
3144,enhance,0,0
3145,compliance,0,0
3146,by,0,0
3147,improving,0,0
3148,health-related,0,0
3149,quality,0,0
3150,of,0,0
3151,life,0,0
3152,and,0,0
3153,to,0,0
3154,assist,0,0
3155,in,0,0
3156,making,0,0
3157,both,0,0
3158,treatment,0,1
3159,and,0,0
3160,formulary,0,1
3161,decisions,0,0
3162,.,0,0
3163,Barriers,0,0
3164,to,0,0
3165,hypertension,0,0
3166,care,0,1
3167,and,0,0
3168,control,0,1
3169,in,0,0
3170,young,0,0
3171,urban,0,0
3172,black,0,0
3173,men,0,0
3174,.,0,0
3175,Barriers,0,0
3176,to,0,0
3177,high,0,0
3178,blood,0,1
3179,pressure,0,0
3180,(,0,1
3181,HBP,0,0
3182,),0,1
3183,care,0,1
3184,and,0,0
3185,control,0,1
3186,have,0,0
3187,been,0,0
3188,reported,0,0
3189,in,0,0
3190,the,0,0
3191,literature,0,0
3192,for,0,0
3193,>,0,0
3194,30,0,0
3195,years,0,0
3196,.,0,0
3197,Few,0,0
3198,reports,0,0
3199,on,0,0
3200,barriers,0,0
3201,",",0,0
3202,however,0,0
3203,",",0,0
3204,have,0,0
3205,focused,0,0
3206,on,0,0
3207,the,0,0
3208,young,0,0
3209,black,0,0
3210,man,0,0
3211,with,0,0
3212,HBP,0,0
3213,",",0,0
3214,the,0,0
3215,age/sex/race,0,0
3216,group,0,0
3217,with,0,0
3218,the,0,0
3219,highest,0,0
3220,rates,0,0
3221,of,0,0
3222,early,0,0
3223,severe,0,0
3224,and,0,0
3225,complicated,0,0
3226,HBP,0,0
3227,and,0,0
3228,the,0,0
3229,lowest,0,0
3230,rates,0,0
3231,of,0,0
3232,awareness,0,0
3233,",",0,0
3234,treatment,0,0
3235,",",0,0
3236,and,0,0
3237,control,0,0
3238,.,0,0
3239,In,0,0
3240,a,0,0
3241,randomized,0,0
3242,clinical,0,0
3243,trial,0,0
3244,of,0,0
3245,comprehensive,0,0
3246,care,0,1
3247,for,0,0
3248,hypertensive,0,0
3249,young,0,0
3250,urban,0,0
3251,black,0,0
3252,men,0,0
3253,",",0,0
3254,factors,0,0
3255,potentially,0,0
3256,associated,0,0
3257,with,0,0
3258,care,0,1
3259,and,0,0
3260,control,0,1
3261,were,0,0
3262,assessed,0,0
3263,at,0,0
3264,baseline,0,0
3265,for,0,0
3266,the,0,0
3267,309,0,0
3268,enrolled,0,0
3269,men,0,0
3270,.,0,0
3271,A,0,0
3272,majority,0,0
3273,of,0,0
3274,the,0,0
3275,men,0,0
3276,encountered,0,0
3277,a,0,0
3278,variety,0,0
3279,of,0,0
3280,barriers,0,0
3281,including,0,0
3282,economic,0,0
3283,",",0,0
3284,social,0,0
3285,",",0,0
3286,and,0,0
3287,lifestyle,0,1
3288,obstacles,0,0
3289,to,0,0
3290,adequate,0,0
3291,BP,0,0
3292,care,0,1
3293,and,0,0
3294,control,0,1
3295,",",0,0
3296,including,0,0
3297,no,0,0
3298,current,0,1
3299,HBP,0,0
3300,care,0,1
3301,(,0,0
3302,49,0,0
3303,%,0,0
3304,),0,0
3305,",",0,0
3306,risk,0,0
3307,of,0,0
3308,alcoholism,0,0
3309,(,0,0
3310,62,0,0
3311,%,0,0
3312,),0,0
3313,",",0,0
3314,use,0,0
3315,of,0,0
3316,illicit,0,0
3317,drugs,0,1
3318,(,0,0
3319,45,0,0
3320,%,0,0
3321,),0,0
3322,",",0,0
3323,social,0,1
3324,isolation,0,1
3325,(,0,0
3326,47,0,0
3327,%,0,0
3328,),0,0
3329,",",0,0
3330,unemployment,0,0
3331,(,0,0
3332,40,0,1
3333,%,0,0
3334,),0,0
3335,",",0,0
3336,and,0,0
3337,lack,0,0
3338,of,0,0
3339,health,0,0
3340,insurance,0,1
3341,(,0,0
3342,51,0,0
3343,%,0,0
3344,),0,0
3345,.,0,0
3346,Having,0,0
3347,health,0,0
3348,insurance,0,1
3349,(,0,0
3350,odds,0,0
3351,ratio,0,0
3352,=,0,0
3353,7.20,0,0
3354,",",0,0
3355,P,0,0
3356,=,0,0
3357,.00,0,0
3358,),0,1
3359,and,0,0
3360,a,0,0
3361,negative,0,0
3362,urine,0,0
3363,drug,0,1
3364,screen,0,0
3365,(,0,0
3366,odds,0,0
3367,ratio,0,0
3368,=,0,0
3369,.56,0,0
3370,",",0,0
3371,P,0,0
3372,=,0,0
3373,.04,0,0
3374,),0,0
3375,were,0,0
3376,significant,0,0
3377,predictors,0,0
3378,of,0,0
3379,being,0,0
3380,in,0,0
3381,HBP,0,0
3382,care,0,1
3383,.,0,0
3384,Low,0,0
3385,alcoholism,0,0
3386,risk,0,0
3387,and,0,0
3388,employment,0,0
3389,were,0,0
3390,identified,0,0
3391,as,0,0
3392,significant,0,0
3393,predictors,0,0
3394,of,0,0
3395,compliance,0,0
3396,with,0,0
3397,HBP,0,0
3398,medication-taking,0,1
3399,behavior,0,0
3400,.,0,0
3401,Men,0,0
3402,currently,0,0
3403,using,0,0
3404,illicit,0,0
3405,drugs,0,1
3406,were,0,0
3407,2.64,0,0
3408,times,0,0
3409,less,0,0
3410,likely,0,0
3411,to,0,0
3412,have,0,0
3413,controlled,0,0
3414,BP,0,0
3415,compared,0,0
3416,with,0,0
3417,their,0,0
3418,counterparts,0,0
3419,who,0,0
3420,did,0,0
3421,not,0,0
3422,use,0,0
3423,illicit,0,0
3424,drugs,0,1
3425,",",0,0
3426,and,0,0
3427,men,0,0
3428,currently,0,0
3429,taking,0,0
3430,HBP,0,0
3431,medication,0,1
3432,were,0,0
3433,63,0,0
3434,times,0,0
3435,more,0,0
3436,likely,0,0
3437,have,0,0
3438,controlled,0,0
3439,BP,0,0
3440,compared,0,0
3441,with,0,0
3442,men,0,0
3443,not,0,0
3444,taking,0,0
3445,HBP,0,0
3446,medication,0,1
3447,.,0,0
3448,Comprehensive,1,0
3449,interventions,1,0
3450,are,0,0
3451,needed,0,0
3452,to,0,0
3453,address,0,0
3454,socioeconomic,0,0
3455,and,0,0
3456,lifestyle,0,1
3457,issues,0,0
3458,as,0,0
3459,well,0,0
3460,as,0,0
3461,other,0,0
3462,barriers,0,0
3463,to,0,0
3464,care,0,1
3465,and,0,0
3466,treatment,0,0
3467,",",0,0
3468,if,0,0
3469,HBP,0,0
3470,care,0,1
3471,is,0,0
3472,to,0,0
3473,be,0,0
3474,salient,0,0
3475,and,0,0
3476,effective,0,0
3477,in,0,0
3478,this,0,0
3479,high,0,0
3480,risk,0,0
3481,group,0,0
3482,.,0,0
3483,Lack,0,1
3484,of,0,0
3485,benefit,0,0
3486,of,0,0
3487,a,0,0
3488,single,0,0
3489,dose,0,0
3490,of,0,0
3491,synthetic,1,1
3492,human,1,1
3493,secretin,1,1
3494,in,0,0
3495,the,0,0
3496,treatment,0,0
3497,of,0,0
3498,autism,0,0
3499,and,0,0
3500,pervasive,0,0
3501,developmental,0,0
3502,disorder,0,0
3503,.,0,0
3504,BACKGROUND,0,0
3505,Secretin,1,1
3506,is,0,0
3507,a,0,0
3508,peptide,0,0
3509,hormone,0,1
3510,that,0,0
3511,stimulates,0,0
3512,pancreatic,0,0
3513,secretion,0,0
3514,.,0,0
3515,After,0,0
3516,recent,0,0
3517,publicity,0,0
3518,about,0,0
3519,a,0,0
3520,child,0,0
3521,with,0,0
3522,autism,0,0
3523,whose,0,0
3524,condition,0,0
3525,markedly,0,0
3526,improved,0,0
3527,after,0,0
3528,a,0,0
3529,single,0,0
3530,dose,0,0
3531,of,0,0
3532,secretin,1,1
3533,",",0,0
3534,thousands,0,0
3535,of,0,0
3536,children,0,0
3537,with,0,0
3538,autistic,0,0
3539,disorders,0,0
3540,may,0,0
3541,have,0,0
3542,received,0,0
3543,secretin,1,1
3544,injections,1,1
3545,.,1,0
3546,METHODS,0,0
3547,We,0,0
3548,conducted,0,0
3549,a,0,0
3550,double-blind,0,0
3551,",",0,0
3552,placebo-controlled,1,1
3553,trial,0,0
3554,of,0,0
3555,a,0,0
3556,single,0,0
3557,intravenous,0,1
3558,dose,0,0
3559,of,0,0
3560,synthetic,1,1
3561,human,1,1
3562,secretin,1,1
3563,in,0,0
3564,60,0,0
3565,children,0,0
3566,(,0,0
3567,age,0,0
3568,",",0,0
3569,3,0,0
3570,to,0,0
3571,14,0,0
3572,years,0,0
3573,),0,0
3574,with,0,0
3575,autism,0,0
3576,or,0,1
3577,pervasive,0,0
3578,developmental,0,0
3579,disorder,0,0
3580,.,0,0
3581,The,0,0
3582,children,0,0
3583,were,0,0
3584,randomly,0,0
3585,assigned,0,0
3586,to,0,0
3587,treatment,0,0
3588,with,0,0
3589,an,0,0
3590,intravenous,0,1
3591,infusion,0,1
3592,of,0,0
3593,synthetic,1,1
3594,human,1,1
3595,secretin,1,1
3596,(,0,0
3597,0.4,0,1
3598,microg,0,1
3599,per,0,0
3600,kilogram,0,1
3601,of,0,0
3602,body,0,0
3603,weight,0,0
3604,),0,1
3605,or,0,1
3606,saline,1,1
3607,placebo,1,1
3608,.,1,0
3609,We,0,0
3610,used,0,0
3611,standardized,0,0
3612,behavioral,0,1
3613,measures,0,0
3614,of,0,0
3615,the,0,0
3616,primary,0,0
3617,and,0,0
3618,secondary,0,0
3619,features,0,0
3620,of,0,0
3621,autism,0,0
3622,",",0,0
3623,including,0,0
3624,the,0,0
3625,Autism,0,0
3626,Behavior,0,0
3627,Checklist,0,0
3628,",",0,0
3629,to,0,0
3630,assess,0,0
3631,the,0,0
3632,degree,0,0
3633,of,0,0
3634,impairment,0,0
3635,at,0,0
3636,base,0,0
3637,line,0,0
3638,and,0,0
3639,over,0,0
3640,the,0,0
3641,course,0,0
3642,of,0,0
3643,a,0,0
3644,four-week,0,1
3645,period,0,0
3646,after,0,0
3647,treatment,0,0
3648,.,0,0
3649,RESULTS,0,0
3650,Of,0,0
3651,the,0,0
3652,60,0,0
3653,children,0,0
3654,",",0,0
3655,4,0,0
3656,could,0,0
3657,not,0,0
3658,be,0,0
3659,evaluated,0,0
3660,-,0,0
3661,2,0,0
3662,received,0,0
3663,secretin,1,1
3664,outside,0,1
3665,the,0,0
3666,study,0,0
3667,",",0,0
3668,and,0,0
3669,2,0,0
3670,did,0,0
3671,not,0,0
3672,return,0,0
3673,for,0,0
3674,follow-up,0,0
3675,.,0,0
3676,Thus,0,0
3677,",",0,0
3678,56,0,0
3679,children,0,0
3680,(,0,0
3681,28,0,0
3682,in,0,0
3683,each,0,0
3684,group,0,0
3685,),0,0
3686,completed,0,0
3687,the,0,0
3688,study,0,0
3689,.,0,0
3690,As,0,0
3691,compared,0,0
3692,with,0,0
3693,placebo,1,1
3694,",",1,0
3695,secretin,1,1
3696,treatment,0,0
3697,was,0,0
3698,not,0,0
3699,associated,0,0
3700,with,0,0
3701,significant,0,0
3702,improvements,0,0
3703,in,0,0
3704,any,0,0
3705,of,0,0
3706,the,0,0
3707,outcome,0,0
3708,measures,0,0
3709,.,0,0
3710,Among,0,0
3711,the,0,0
3712,children,0,0
3713,in,0,0
3714,the,0,0
3715,secretin,1,1
3716,group,0,0
3717,",",0,0
3718,the,0,0
3719,mean,0,0
3720,total,0,0
3721,score,0,0
3722,on,0,0
3723,the,0,0
3724,Autism,0,0
3725,Behavior,0,0
3726,Checklist,0,1
3727,at,0,0
3728,base,0,0
3729,line,0,0
3730,was,0,0
3731,59.0,0,0
3732,(,0,0
3733,range,0,0
3734,of,0,0
3735,possible,0,0
3736,values,0,0
3737,",",0,0
3738,0,0,0
3739,to,0,0
3740,158,0,0
3741,",",0,0
3742,with,0,0
3743,a,0,0
3744,larger,0,0
3745,value,0,0
3746,corresponding,0,0
3747,to,0,0
3748,greater,0,0
3749,impairment,0,0
3750,),0,0
3751,",",0,0
3752,and,0,0
3753,among,0,0
3754,those,0,0
3755,in,0,0
3756,the,0,0
3757,placebo,1,1
3758,group,0,0
3759,it,0,0
3760,was,0,0
3761,63.2,0,0
3762,.,0,0
3763,The,0,0
3764,mean,0,0
3765,decreases,0,0
3766,in,0,0
3767,scores,0,0
3768,over,0,0
3769,the,0,0
3770,four-week,0,1
3771,period,0,0
3772,were,0,0
3773,8.9,0,0
3774,in,0,0
3775,the,0,0
3776,secretin,1,1
3777,group,0,0
3778,and,0,0
3779,17.8,0,0
3780,in,0,0
3781,the,0,0
3782,placebo,1,1
3783,group,0,0
3784,(,0,1
3785,mean,0,0
3786,difference,0,0
3787,",",0,0
3788,-8.9,0,0
3789,;,0,0
3790,95,0,0
3791,percent,0,0
3792,confidence,0,0
3793,interval,0,0
3794,",",0,0
3795,-19.4,0,0
3796,to,0,0
3797,1.6,0,0
3798,;,0,0
3799,P=0.11,0,0
3800,),0,0
3801,.,0,0
3802,None,0,0
3803,of,0,0
3804,the,0,0
3805,children,0,0
3806,had,0,0
3807,treatment-limiting,0,0
3808,adverse,0,0
3809,effects,0,0
3810,.,0,0
3811,After,0,0
3812,they,0,0
3813,were,0,0
3814,told,0,0
3815,the,0,0
3816,results,0,0
3817,",",0,0
3818,69,0,0
3819,percent,0,0
3820,of,0,0
3821,the,0,0
3822,parents,0,0
3823,of,0,0
3824,the,0,0
3825,children,0,0
3826,in,0,0
3827,this,0,0
3828,study,0,0
3829,said,0,0
3830,they,0,0
3831,remained,0,0
3832,interested,0,0
3833,in,0,0
3834,secretin,1,1
3835,as,0,0
3836,a,0,0
3837,treatment,0,0
3838,for,0,0
3839,their,0,0
3840,children,0,0
3841,.,0,0
3842,CONCLUSIONS,0,0
3843,A,0,0
3844,single,0,0
3845,dose,0,0
3846,of,0,0
3847,synthetic,0,1
3848,human,1,1
3849,secretin,1,1
3850,is,0,0
3851,not,0,0
3852,an,0,0
3853,effective,0,0
3854,treatment,0,0
3855,for,0,0
3856,autism,0,0
3857,or,0,1
3858,pervasive,0,0
3859,developmental,0,0
3860,disorder,0,0
3861,.,0,0
3862,Gastric,0,0
3863,carcinoma,0,0
3864,:,0,0
3865,expression,0,0
3866,of,0,0
3867,c-erbB-2/neu,0,1
3868,oncoprotein,0,0
3869,",",0,0
3870,epidermal,0,1
3871,growth,0,0
3872,factor,0,1
3873,receptor,0,0
3874,",",0,0
3875,cathepsin,0,0
3876,D,0,1
3877,",",0,0
3878,progesterone,0,1
3879,receptor,0,0
3880,and,0,0
3881,tumor,0,0
3882,associated,0,0
3883,glycoprotein-72,0,1
3884,in,0,0
3885,different,0,0
3886,histological,0,0
3887,types,0,0
3888,.,0,0
3889,OBJECTIVE,0,0
3890,Gastric,0,0
3891,carcinoma,0,0
3892,can,0,0
3893,be,0,0
3894,divided,0,0
3895,into,0,0
3896,two,0,0
3897,main,0,0
3898,histological,0,0
3899,and,0,0
3900,clinical,0,0
3901,types,0,0
3902,:,0,0
3903,diffuse,0,0
3904,and,0,0
3905,intestinal,0,0
3906,.,0,0
3907,The,0,0
3908,aim,0,0
3909,of,0,0
3910,this,0,0
3911,study,0,0
3912,was,0,0
3913,to,0,0
3914,investigate,0,0
3915,the,0,0
3916,expression,0,0
3917,of,0,0
3918,neu/c-erbB-2,1,1
3919,oncoprotein,1,0
3920,",",0,0
3921,epidermal,0,1
3922,growth,0,0
3923,factor,0,1
3924,receptor,0,0
3925,(,0,1
3926,EGFR,0,1
3927,),0,1
3928,",",0,0
3929,cathepsin,0,1
3930,D,0,1
3931,(,0,1
3932,catD,0,1
3933,),0,1
3934,",",0,0
3935,progesterone,0,1
3936,receptor,0,0
3937,(,0,1
3938,PR,0,1
3939,),0,1
3940,and,0,0
3941,tumor-associated,0,0
3942,glycoprotein-72,0,1
3943,(,0,1
3944,TAG-72,0,0
3945,),0,1
3946,in,0,0
3947,gastric,0,0
3948,carcinoma,0,0
3949,of,0,0
3950,these,0,0
3951,histological,0,0
3952,types,0,0
3953,.,0,0
3954,METHOD,0,0
3955,In,0,0
3956,this,0,0
3957,randomized,0,0
3958,",",0,0
3959,prospective,0,0
3960,study,0,0
3961,we,0,0
3962,analyzed,0,0
3963,85,0,0
3964,biopsy,1,0
3965,samples,1,0
3966,from,0,0
3967,patients,0,0
3968,with,0,0
3969,gastric,0,0
3970,adenocarcinoma,0,0
3971,.,0,0
3972,The,0,0
3973,control,0,0
3974,group,0,0
3975,consisted,0,0
3976,of,0,0
3977,40,0,0
3978,specimens,0,0
3979,from,0,0
3980,normal,1,0
3981,gastric,1,0
3982,mucosa,1,0
3983,.,1,0
3984,Neu,0,0
3985,oncoprotein,0,0
3986,and,0,0
3987,PR,0,1
3988,were,0,0
3989,determined,0,0
3990,by,0,0
3991,ELISA,1,0
3992,.,1,0
3993,CatD,0,0
3994,and,0,0
3995,TAG-72,0,0
3996,were,0,0
3997,quantified,0,0
3998,with,0,0
3999,immunoradiometric,0,0
4000,(,0,1
4001,IRMA,0,1
4002,),0,1
4003,methods,0,0
4004,",",0,0
4005,and,0,0
4006,EGFR,0,0
4007,were,0,0
4008,studied,0,0
4009,by,0,0
4010,radioimmunoassay,1,1
4011,(,0,1
4012,RIA,0,1
4013,),0,0
4014,.,0,0
4015,RESULTS,0,0
4016,Neu,0,0
4017,",",0,0
4018,EGFR,0,0
4019,",",0,0
4020,catD,0,0
4021,and,0,0
4022,TAG-72,0,0
4023,concentrations,0,0
4024,were,0,0
4025,higher,0,0
4026,in,0,0
4027,the,0,0
4028,tumoral,0,0
4029,group,0,0
4030,(,0,1
4031,p,0,0
4032,=,0,0
4033,0.02,0,0
4034,",",0,0
4035,p,0,0
4036,=,0,0
4037,0.00001,0,0
4038,",",0,0
4039,p,0,0
4040,=,0,0
4041,0.002,0,0
4042,and,0,0
4043,p,0,0
4044,=,0,0
4045,0.007,0,0
4046,",",0,0
4047,respectively,0,0
4048,),0,0
4049,.,0,0
4050,In,0,0
4051,diffuse,0,0
4052,adenocarcinomas,0,0
4053,",",0,0
4054,catD,0,0
4055,and,0,0
4056,PR,0,1
4057,expression,0,0
4058,was,0,0
4059,increased,0,0
4060,(,0,0
4061,p,0,0
4062,=,0,0
4063,0.01,0,0
4064,and,0,0
4065,p,0,0
4066,=,0,0
4067,0.04,0,0
4068,respectively,0,0
4069,),0,0
4070,",",0,0
4071,whereas,0,0
4072,TAG-72,0,0
4073,concentration,0,0
4074,",",0,0
4075,which,0,0
4076,correlated,0,0
4077,with,0,0
4078,neu,0,0
4079,(,0,0
4080,r,0,0
4081,=,0,0
4082,0.57,0,0
4083,),0,0
4084,",",0,0
4085,was,0,0
4086,higher,0,0
4087,in,0,0
4088,the,0,0
4089,intestinal,0,0
4090,type,0,0
4091,(,0,0
4092,p,0,0
4093,=,0,0
4094,0.04,0,0
4095,),0,0
4096,.,0,0
4097,No,0,0
4098,significant,0,0
4099,differences,0,0
4100,in,0,0
4101,EGFR,0,0
4102,and,0,0
4103,neu,0,0
4104,concentrations,0,0
4105,were,0,0
4106,seen,0,0
4107,between,0,0
4108,the,0,0
4109,two,0,0
4110,histological,0,0
4111,types,0,0
4112,.,0,0
4113,CONCLUSIONS,0,0
4114,The,0,0
4115,higher,0,0
4116,PR,0,0
4117,and,0,0
4118,catD,0,0
4119,concentrations,0,0
4120,in,0,0
4121,diffuse,0,0
4122,adenocarcinomas,0,0
4123,",",0,0
4124,and,0,0
4125,the,0,0
4126,overexpression,0,0
4127,of,0,0
4128,TAG-72,0,0
4129,in,0,0
4130,the,0,0
4131,intestinal,0,0
4132,type,0,0
4133,",",0,0
4134,support,0,0
4135,the,0,0
4136,existence,0,0
4137,of,0,0
4138,two,0,0
4139,modes,0,0
4140,of,0,0
4141,gastric,0,0
4142,carcinogenesis,0,0
4143,.,0,0
4144,Randomised,0,1
4145,controlled,0,0
4146,study,0,0
4147,of,0,0
4148,clinical,0,0
4149,outcome,0,0
4150,following,0,0
4151,trophic,1,1
4152,feeding,1,1
4153,.,1,0
4154,AIMS,0,0
4155,To,0,0
4156,determine,0,0
4157,the,0,0
4158,effect,0,0
4159,of,0,0
4160,trophic,1,1
4161,feeding,1,1
4162,on,0,0
4163,clinical,0,0
4164,outcome,0,0
4165,in,0,0
4166,ill,0,0
4167,preterm,0,0
4168,infants,0,0
4169,.,0,0
4170,METHODS,0,0
4171,A,0,0
4172,randomised,0,0
4173,",",0,0
4174,controlled,0,0
4175,",",0,0
4176,prospective,0,0
4177,study,0,0
4178,of,0,0
4179,100,0,0
4180,preterm,0,0
4181,infants,0,0
4182,",",0,0
4183,weighing,0,0
4184,less,0,0
4185,than,0,0
4186,1750,0,0
4187,g,0,1
4188,at,0,0
4189,birth,0,0
4190,and,0,0
4191,requiring,0,0
4192,ventilatory,0,1
4193,support,0,1
4194,and,0,0
4195,parenteral,0,1
4196,nutrition,0,1
4197,",",0,0
4198,was,0,0
4199,performed,0,0
4200,.,0,0
4201,Group,0,0
4202,TF,0,1
4203,(,0,0
4204,48,0,0
4205,infants,0,0
4206,),0,0
4207,received,0,0
4208,trophic,1,1
4209,feeding,1,1
4210,from,1,0
4211,day,1,1
4212,3,1,0
4213,(,1,0
4214,0.5-1,1,0
4215,ml/h,1,1
4216,),1,0
4217,along,1,0
4218,with,1,0
4219,parenteral,1,1
4220,nutrition,1,1
4221,until,0,0
4222,ventilatory,1,1
4223,support,1,0
4224,finished,0,0
4225,.,0,0
4226,Group,0,0
4227,C,0,1
4228,(,0,0
4229,52,0,0
4230,infants,0,0
4231,),0,0
4232,received,0,0
4233,parenteral,1,1
4234,nutrition,1,1
4235,alone,1,1
4236,.,1,0
4237,Nutritive,1,0
4238,milk,1,1
4239,feeding,1,1
4240,was,0,0
4241,then,0,0
4242,introduced,0,0
4243,to,0,0
4244,both,0,0
4245,groups,0,0
4246,.,0,0
4247,Clinical,0,0
4248,outcomes,0,0
4249,measured,0,0
4250,included,0,0
4251,total,0,0
4252,energy,0,1
4253,intake,0,1
4254,and,0,0
4255,growth,0,0
4256,over,0,0
4257,the,0,0
4258,first,0,0
4259,six,0,0
4260,postnatal,0,0
4261,weeks,0,0
4262,",",0,0
4263,sepsis,0,0
4264,incidence,0,0
4265,",",0,0
4266,liver,0,0
4267,function,0,0
4268,",",0,0
4269,milk,0,1
4270,tolerance,0,0
4271,",",0,0
4272,duration,0,0
4273,of,0,0
4274,respiratory,0,0
4275,support,0,0
4276,",",0,0
4277,duration,0,0
4278,of,0,0
4279,hospital,0,0
4280,stay,0,0
4281,and,0,0
4282,complication,0,0
4283,incidence,0,0
4284,.,0,0
4285,RESULTS,0,0
4286,Groups,0,0
4287,were,0,0
4288,well,0,0
4289,matched,0,0
4290,for,0,0
4291,birthweight,0,0
4292,",",0,0
4293,gestation,0,0
4294,and,0,0
4295,CRIB,0,1
4296,scores,0,0
4297,.,0,0
4298,Infants,0,0
4299,in,0,0
4300,group,0,0
4301,TF,0,1
4302,had,0,0
4303,significantly,0,0
4304,greater,0,0
4305,energy,0,0
4306,intake,0,0
4307,",",0,0
4308,mean,0,0
4309,difference,0,0
4310,41.4,0,0
4311,(,0,0
4312,95,0,0
4313,%,0,0
4314,confidence,0,0
4315,interval,0,0
4316,9,0,0
4317,",",0,0
4318,73.7,0,0
4319,),0,0
4320,kcal/kg,0,0
4321,p=0.02,0,0
4322,;,0,0
4323,weight,0,0
4324,gain,0,0
4325,",",0,0
4326,130,0,0
4327,(,0,0
4328,CI,0,0
4329,1,0,0
4330,",",0,0
4331,250,0,1
4332,),0,0
4333,g,0,1
4334,p,0,0
4335,=,0,0
4336,0.02,0,0
4337,;,0,0
4338,head,0,0
4339,circumference,0,0
4340,gain,0,0
4341,",",0,0
4342,mean,0,0
4343,difference,0,0
4344,0.7,0,0
4345,(,0,0
4346,CI,0,0
4347,0.1,0,1
4348,",",0,0
4349,1.3,0,0
4350,),0,0
4351,cm,0,0
4352,",",0,0
4353,p,0,0
4354,=,0,0
4355,0.04,0,0
4356,;,0,0
4357,fewer,0,0
4358,episodes,0,0
4359,of,0,0
4360,culture,0,0
4361,confirmed,0,0
4362,sepsis,0,0
4363,",",0,0
4364,mean,0,0
4365,difference,0,0
4366,-0.7,0,0
4367,(,0,0
4368,-1.3,0,0
4369,",",0,0
4370,-0.2,0,0
4371,),0,1
4372,episodes,0,0
4373,",",0,0
4374,p,0,0
4375,=,0,0
4376,0.04,0,0
4377,;,0,0
4378,less,0,0
4379,parenteral,0,1
4380,nutrition,0,0
4381,",",0,0
4382,mean,0,0
4383,difference,0,0
4384,-11.5,0,0
4385,(,0,0
4386,CI,0,0
4387,-20,0,0
4388,",",0,0
4389,-3,0,1
4390,),0,0
4391,days,0,0
4392,",",0,0
4393,p,0,0
4394,=,0,0
4395,0,0,0
4396,.,0,0
4397,03,0,0
4398,;,0,0
4399,tolerated,0,0
4400,full,0,0
4401,milk,0,1
4402,feeds,0,1
4403,(,0,0
4404,165,0,0
4405,ml/kg/day,0,1
4406,),0,0
4407,earlier,0,0
4408,",",0,0
4409,mean,0,0
4410,difference,0,0
4411,-11.2,0,1
4412,(,0,0
4413,CI,0,0
4414,-19,0,1
4415,",",0,0
4416,-3,0,1
4417,),0,0
4418,days,0,0
4419,",",0,0
4420,p,0,0
4421,=,0,0
4422,0.03,0,0
4423,;,0,0
4424,reduced,0,0
4425,requirement,0,0
4426,for,0,0
4427,supplemental,0,1
4428,oxygen,0,1
4429,",",0,0
4430,mean,0,0
4431,difference,0,0
4432,-22.4,0,0
4433,(,0,0
4434,CI-41.5,0,0
4435,",",0,0
4436,-3.3,0,0
4437,),0,0
4438,days,0,0
4439,",",0,0
4440,p,0,0
4441,=,0,0
4442,0.02,0,0
4443,;,0,0
4444,and,0,0
4445,were,0,0
4446,discharged,0,1
4447,home,0,1
4448,earlier,0,0
4449,",",0,0
4450,mean,0,0
4451,difference,0,0
4452,-22.1,0,0
4453,(,0,0
4454,CI,0,0
4455,-42.1,0,0
4456,",",0,0
4457,-2.2,0,0
4458,),0,0
4459,days,0,0
4460,",",0,0
4461,p,0,0
4462,=,0,0
4463,0.04,0,0
4464,.,0,0
4465,There,0,0
4466,was,0,0
4467,no,0,0
4468,significant,0,0
4469,difference,0,0
4470,in,0,0
4471,the,0,0
4472,relative,0,0
4473,risk,0,0
4474,of,0,0
4475,any,0,0
4476,complication,0,0
4477,.,0,0
4478,CONCLUSIONS,0,0
4479,Trophic,1,0
4480,feeding,1,1
4481,improves,0,0
4482,clinical,0,0
4483,outcome,0,0
4484,in,0,0
4485,ill,0,0
4486,preterm,0,0
4487,infants,0,0
4488,requiring,0,0
4489,parenteral,1,1
4490,nutrition,1,1
4491,.,1,0
4492,Comparison,0,0
4493,of,0,0
4494,chemotherapy,1,1
4495,with,1,0
4496,chemohormonal,1,1
4497,therapy,1,1
4498,as,0,0
4499,first-line,0,1
4500,therapy,0,1
4501,for,0,0
4502,metastatic,0,0
4503,",",0,0
4504,hormone-sensitive,0,0
4505,breast,0,0
4506,cancer,0,0
4507,:,0,0
4508,An,0,0
4509,Eastern,0,0
4510,Cooperative,0,0
4511,Oncology,0,0
4512,Group,0,0
4513,study,0,0
4514,.,0,0
4515,PURPOSE,0,0
4516,Although,0,0
4517,hormonal,0,0
4518,therapy,0,1
4519,represents,0,0
4520,standard,0,1
4521,therapy,0,1
4522,for,0,0
4523,metastatic,0,0
4524,hormone-sensitive,0,0
4525,disease,0,0
4526,",",0,0
4527,many,0,0
4528,patients,0,0
4529,receive,0,0
4530,initial,0,0
4531,chemotherapy,1,1
4532,because,0,0
4533,of,0,0
4534,the,0,0
4535,location,0,0
4536,",",0,0
4537,bulk,0,0
4538,",",0,0
4539,or,0,1
4540,aggressiveness,0,0
4541,of,0,0
4542,their,0,0
4543,disease,0,0
4544,.,0,0
4545,It,0,0
4546,is,0,0
4547,uncertain,0,0
4548,whether,0,0
4549,simultaneous,1,0
4550,hormonal,1,0
4551,therapy,1,1
4552,provides,0,0
4553,additional,0,0
4554,benefit,0,0
4555,compared,0,0
4556,with,0,0
4557,chemotherapy,0,1
4558,alone,0,1
4559,.,0,0
4560,Eastern,0,0
4561,Cooperative,0,0
4562,Oncology,0,0
4563,Group,0,0
4564,trial,0,0
4565,E3186,0,0
4566,was,0,0
4567,initiated,0,0
4568,to,0,0
4569,explore,0,0
4570,this,0,0
4571,question,0,0
4572,.,0,0
4573,PATIENTS,0,0
4574,AND,0,0
4575,METHODS,0,0
4576,Between,0,0
4577,January,0,0
4578,1988,0,0
4579,and,0,0
4580,December,0,0
4581,1992,0,0
4582,",",0,0
4583,231,0,0
4584,patients,0,0
4585,with,0,0
4586,estrogen,0,1
4587,receptor,0,0
4588,(,0,1
4589,ER,0,1
4590,),0,1
4591,-positive,0,0
4592,or,0,1
4593,ER-unknown,0,0
4594,metastatic,0,0
4595,breast,0,0
4596,cancer,0,0
4597,were,0,0
4598,randomized,0,0
4599,to,0,0
4600,receive,0,0
4601,either,0,1
4602,chemotherapy,1,1
4603,(,1,0
4604,cyclophosphamide,1,1
4605,",",1,0
4606,doxorubicin,1,1
4607,",",1,0
4608,and,1,0
4609,fluorouracil,1,1
4610,?CAF,1,1
4611,),1,1
4612,or,1,1
4613,chemohormonal,1,1
4614,therapy,1,1
4615,(,1,1
4616,CAF,1,1
4617,plus,1,1
4618,tamoxifen,1,1
4619,and,1,1
4620,Halotestin,1,1
4621,?fluoxymesterone,1,1
4622,;,1,0
4623,Pharmacia-Upjohn,1,1
4624,",",1,0
4625,Kalamazoo,1,0
4626,",",1,0
4627,MI,1,1
4628,?CAFTH,1,0
4629,),1,0
4630,as,1,0
4631,front-line,1,1
4632,therapy,1,1
4633,for,1,0
4634,metastatic,0,0
4635,breast,0,0
4636,cancer,0,0
4637,.,0,0
4638,Patients,0,0
4639,who,0,0
4640,experienced,0,0
4641,a,0,0
4642,complete,0,0
4643,response,0,0
4644,to,0,0
4645,induction,0,1
4646,therapy,0,1
4647,either,0,1
4648,received,0,1
4649,or,0,1
4650,did,0,0
4651,not,0,0
4652,receive,0,1
4653,maintenance,0,0
4654,cyclophosphamide,0,1
4655,",",0,0
4656,methotrexate,0,1
4657,",",0,0
4658,fluorouracil,0,1
4659,",",0,0
4660,prednisone,0,1
4661,",",0,0
4662,and,0,0
4663,TH,0,0
4664,as,0,0
4665,a,0,0
4666,secondary,0,0
4667,randomization,0,0
4668,.,0,0
4669,RESULTS,0,0
4670,The,0,0
4671,response,0,0
4672,rates,0,0
4673,(,0,0
4674,complete,0,0
4675,response,0,0
4676,and,0,0
4677,partial,0,0
4678,response,0,0
4679,),0,0
4680,of,0,0
4681,patients,0,0
4682,who,0,0
4683,received,0,0
4684,CAF,0,1
4685,and,0,0
4686,CAFTH,0,1
4687,were,0,0
4688,similar,0,0
4689,(,0,0
4690,69.2,0,0
4691,%,0,0
4692,v,0,1
4693,68.9,0,0
4694,%,0,0
4695,",",0,0
4696,respectively,0,0
4697,;,0,0
4698,P,0,0
4699,=.99,0,0
4700,),0,0
4701,.,0,0
4702,Time,0,0
4703,to,0,0
4704,treatment,0,1
4705,failure,0,0
4706,(,0,1
4707,TTF,0,1
4708,),0,1
4709,was,0,0
4710,slightly,0,0
4711,longer,0,0
4712,for,0,0
4713,patients,0,0
4714,who,0,0
4715,received,0,0
4716,chemohormonal,0,1
4717,therapy,0,1
4718,compared,0,0
4719,with,0,0
4720,chemotherapy,0,1
4721,alone,0,1
4722,patients,0,0
4723,(,0,0
4724,13.4,0,0
4725,months,0,0
4726,v,0,0
4727,10.3,0,0
4728,months,0,0
4729,",",0,0
4730,respectively,0,0
4731,;,0,0
4732,P,0,0
4733,=.087,0,0
4734,),0,0
4735,",",0,0
4736,and,0,0
4737,TTF,0,1
4738,was,0,0
4739,significantly,0,0
4740,longer,0,0
4741,in,0,0
4742,ER-positive,0,0
4743,compared,0,0
4744,with,0,0
4745,ER-negative,0,0
4746,patients,0,0
4747,(,0,0
4748,17.4,0,0
4749,months,0,0
4750,v,0,0
4751,10.3,0,0
4752,months,0,0
4753,",",0,0
4754,respectively,0,0
4755,;,0,0
4756,P,0,0
4757,=.048,0,0
4758,),0,0
4759,.,0,0
4760,However,0,0
4761,",",0,0
4762,ER,0,1
4763,status,0,0
4764,had,0,0
4765,no,0,0
4766,effect,0,0
4767,on,0,0
4768,overall,0,0
4769,survival,0,0
4770,(,0,0
4771,30.0,0,0
4772,months,0,0
4773,for,0,0
4774,CAF,0,1
4775,v,0,1
4776,29.3,0,0
4777,months,0,0
4778,for,0,0
4779,CAFTH,0,0
4780,),0,0
4781,.,0,0
4782,CONCLUSION,0,0
4783,In,0,0
4784,patients,0,0
4785,with,0,0
4786,potentially,0,0
4787,hormone-sensitive,0,0
4788,metastatic,0,0
4789,breast,0,0
4790,cancer,1,0
4791,",",1,0
4792,chemohormonal,1,1
4793,therapy,1,1
4794,prolongs,1,1
4795,TTF,0,0
4796,for,0,0
4797,ER-positive,0,0
4798,patients,0,0
4799,without,0,0
4800,improving,0,0
4801,overall,0,0
4802,survival,0,0
4803,.,0,0
4804,The,0,0
4805,effect,0,0
4806,of,0,0
4807,body,0,0
4808,weight,0,0
4809,changes,0,0
4810,and,0,0
4811,endurance,0,0
4812,training,0,1
4813,on,0,0
4814,24h,0,0
4815,substrate,0,0
4816,oxidation,0,0
4817,.,0,0
4818,OBJECTIVE,0,0
4819,To,0,0
4820,investigate,0,0
4821,the,0,0
4822,effect,0,0
4823,of,0,0
4824,exercise,1,1
4825,training,1,1
4826,and,1,0
4827,dietary,1,1
4828,macronutrient,1,1
4829,composition,1,0
4830,on,0,0
4831,24,0,0
4832,h,0,0
4833,substrate,0,0
4834,oxidation,0,1
4835,in,0,0
4836,male,0,0
4837,",",0,0
4838,obese,0,0
4839,subjects,0,0
4840,.,0,0
4841,DESIGN,0,0
4842,A,0,0
4843,16,0,0
4844,month,0,0
4845,exercise,1,1
4846,intervention,1,1
4847,study,0,0
4848,was,0,0
4849,executed,0,0
4850,",",0,0
4851,including,0,0
4852,a,0,0
4853,weight,0,0
4854,loss,0,0
4855,period,0,0
4856,with,0,0
4857,a,0,0
4858,very,1,0
4859,low,1,0
4860,energy,1,1
4861,diet,1,1
4862,(,1,1
4863,VLED,1,1
4864,),1,1
4865,for,0,0
4866,2,0,0
4867,months,0,0
4868,at,0,0
4869,the,0,0
4870,start,0,0
4871,of,0,0
4872,the,0,0
4873,study,0,0
4874,.,0,0
4875,SUBJECTS,0,0
4876,Twelve,0,0
4877,male,0,0
4878,",",0,0
4879,obese,0,0
4880,subjects,0,0
4881,(,0,0
4882,age,0,0
4883,36.3+/-5.1,0,0
4884,y,0,0
4885,;,0,0
4886,body,0,0
4887,weight,0,0
4888,94.6+/-13.9,0,0
4889,kg,0,0
4890,;,0,0
4891,body,0,0
4892,mass,0,0
4893,index,0,0
4894,",",0,0
4895,BMI,0,1
4896,30.8+/-3.0,0,0
4897,kg/m2,0,0
4898,),0,1
4899,and,0,0
4900,in,0,0
4901,an,0,0
4902,additional,0,0
4903,study,0,0
4904,15,0,0
4905,lean,0,0
4906,",",0,0
4907,well-trained,0,1
4908,subjects,0,0
4909,(,0,0
4910,age,0,0
4911,36.2+/-7.2,0,0
4912,y,0,0
4913,;,0,0
4914,body,0,0
4915,weight,0,0
4916,72.2+/-5.9,0,0
4917,kg,0,0
4918,;,0,0
4919,BMI,0,1
4920,22.3+/-1.7,0,0
4921,kg/m2,0,0
4922,),0,0
4923,participated,0,0
4924,.,0,0
4925,MEASUREMENTS,0,0
4926,Substrate,0,0
4927,oxidation,0,1
4928,was,0,0
4929,measured,0,0
4930,during,0,0
4931,a,0,0
4932,standardized,0,0
4933,36,0,0
4934,h,0,0
4935,stay,0,0
4936,in,0,0
4937,the,0,0
4938,respiration,0,1
4939,chamber,0,1
4940,at,0,0
4941,the,0,0
4942,start,0,0
4943,of,0,0
4944,the,0,0
4945,study,0,0
4946,(,0,0
4947,0,0,0
4948,months,0,0
4949,),0,0
4950,",",0,0
4951,and,0,0
4952,at,0,0
4953,4,0,0
4954,",",0,0
4955,10,0,0
4956,and,0,0
4957,16,0,0
4958,months,0,0
4959,.,0,0
4960,In,0,0
4961,the,0,0
4962,respiration,0,1
4963,chamber,0,1
4964,subjects,0,0
4965,were,0,0
4966,randomly,0,0
4967,assigned,0,0
4968,to,0,0
4969,a,0,0
4970,high-fat,1,1
4971,(,1,1
4972,Hi.F,1,1
4973,),1,1
4974,diet,1,1
4975,(,1,1
4976,60,1,0
4977,%,1,0
4978,of,1,0
4979,energy,1,1
4980,(,1,1
4981,En,1,1
4982,%,1,0
4983,),1,1
4984,fat,1,1
4985,),1,1
4986,or,1,1
4987,a,1,0
4988,reduced-fat,1,1
4989,(,1,0
4990,Red.F,1,0
4991,),1,1
4992,diet,1,1
4993,(,1,0
4994,30,1,1
4995,En,1,1
4996,%,1,0
4997,fat,1,0
4998,),1,0
4999,.,1,0
5000,The,0,0
5001,well-trained,0,0
5002,group,0,0
5003,was,0,0
5004,measured,0,0
5005,once,0,0
5006,in,0,0
5007,the,0,0
5008,respiration,0,1
5009,chamber,0,1
5010,for,0,0
5011,36,0,0
5012,h,0,0
5013,according,0,0
5014,to,0,0
5015,the,0,0
5016,same,0,0
5017,protocol,0,0
5018,.,0,0
5019,RESULTS,0,0
5020,At,0,0
5021,any,0,0
5022,time,0,0
5023,point,0,0
5024,",",0,0
5025,independent,0,0
5026,of,0,0
5027,the,0,0
5028,diet,0,1
5029,consumed,0,0
5030,",",0,0
5031,the,0,0
5032,24,0,0
5033,h,0,0
5034,carbohydrate,0,1
5035,(,0,1
5036,CHO,0,1
5037,),0,1
5038,balances,0,0
5039,in,0,0
5040,the,0,0
5041,chamber,0,1
5042,were,0,0
5043,mostly,0,0
5044,negative,0,0
5045,(,0,0
5046,means,0,0
5047,ranging,0,0
5048,from,0,0
5049,+31,0,1
5050,to,0,0
5051,-98,0,0
5052,g/d,0,1
5053,),0,1
5054,and,0,0
5055,the,0,0
5056,fat,0,0
5057,balances,0,0
5058,mostly,0,0
5059,positive,0,0
5060,(,0,0
5061,means,0,0
5062,ranging,0,0
5063,from,0,0
5064,-26,0,1
5065,to,0,0
5066,+38,0,0
5067,g/d,0,1
5068,),0,0
5069,for,0,0
5070,the,0,0
5071,obese,0,0
5072,a,0,0
5073,well,0,0
5074,as,0,0
5075,for,0,0
5076,the,0,0
5077,lean,0,0
5078,",",0,0
5079,well-trained,0,0
5080,group,0,0
5081,.,0,0
5082,For,0,0
5083,both,0,0
5084,diets,0,1
5085,an,0,0
5086,increased,0,0
5087,shortage,0,0
5088,of,0,0
5089,70,0,0
5090,g,0,1
5091,of,0,0
5092,CHO,0,1
5093,was,0,0
5094,found,0,0
5095,at,0,0
5096,16,0,0
5097,months,0,0
5098,compared,0,0
5099,with,0,0
5100,4,0,0
5101,months,0,0
5102,",",0,0
5103,and,0,0
5104,an,0,0
5105,increase,0,0
5106,in,0,0
5107,fat,0,0
5108,balance,0,0
5109,of,0,0
5110,33,0,0
5111,g,0,1
5112,during,0,0
5113,the,0,0
5114,same,0,0
5115,time,0,0
5116,period,0,0
5117,in,0,0
5118,the,0,0
5119,obese,0,0
5120,subjects,0,0
5121,",",0,0
5122,indicating,0,0
5123,that,0,0
5124,CHO,0,1
5125,oxidation,0,1
5126,had,0,0
5127,increased,0,0
5128,with,0,0
5129,12,0,0
5130,months,0,0
5131,endurance,0,0
5132,training,0,1
5133,.,0,0
5134,In,0,0
5135,the,0,0
5136,well-trained,0,0
5137,group,0,0
5138,the,0,0
5139,24h,0,0
5140,CHO,0,1
5141,balance,0,0
5142,was,0,0
5143,even,0,0
5144,more,0,0
5145,negative,0,0
5146,for,0,0
5147,both,0,0
5148,types,0,0
5149,of,0,0
5150,diet,0,1
5151,(,0,0
5152,-103,0,1
5153,to,0,0
5154,-185,0,1
5155,g/d,0,1
5156,for,0,0
5157,the,0,0
5158,Red.F,0,0
5159,and,0,0
5160,Hi.F,0,1
5161,diet,0,1
5162,",",0,0
5163,respectively,0,0
5164,),0,0
5165,under,0,0
5166,similar,0,0
5167,conditions,0,0
5168,compared,0,0
5169,with,0,0
5170,the,0,0
5171,trained,0,1
5172,obese,0,0
5173,group,0,0
5174,.,0,0
5175,CONCLUSION,0,0
5176,The,0,0
5177,changes,0,0
5178,in,0,0
5179,24,0,0
5180,h,0,0
5181,substrate,0,0
5182,utilization,0,0
5183,in,0,0
5184,the,0,0
5185,obese,0,0
5186,",",0,0
5187,as,0,0
5188,well,0,0
5189,as,0,0
5190,in,0,0
5191,the,0,0
5192,well-trained,0,0
5193,group,0,0
5194,",",0,0
5195,suggest,0,0
5196,that,0,0
5197,endurance,0,0
5198,training,0,1
5199,increased,0,0
5200,the,0,0
5201,reliance,0,0
5202,on,0,0
5203,carbohydrate,0,1
5204,oxidation,0,1
5205,and,0,0
5206,therefore,0,0
5207,did,0,0
5208,not,0,0
5209,increase,0,0
5210,24,0,0
5211,fat,0,0
5212,oxidation,0,0
5213,.,0,0
5214,Regression,0,0
5215,of,0,0
5216,left,0,0
5217,ventricular,0,0
5218,hypertrophy,0,0
5219,after,0,0
5220,stentless,1,1
5221,versus,0,1
5222,conventional,1,1
5223,aortic,1,0
5224,valve,1,0
5225,replacement,1,1
5226,.,1,0
5227,The,0,0
5228,goal,0,0
5229,of,0,0
5230,this,0,0
5231,study,0,0
5232,was,0,0
5233,to,0,0
5234,analyze,0,0
5235,regression,0,0
5236,of,0,0
5237,left,0,0
5238,ventricular,0,0
5239,hypertrophy,0,0
5240,after,0,0
5241,randomization,0,0
5242,to,0,0
5243,conventional,1,1
5244,biological,1,0
5245,versus,1,1
5246,stentless,1,1
5247,aortic,1,0
5248,valve,1,0
5249,replacement,1,1
5250,.,1,1
5251,Stentless,1,0
5252,(,0,0
5253,Freestyle,0,0
5254,",",0,0
5255,Toronto,0,0
5256,",",0,0
5257,n,0,0
5258,=,0,0
5259,106,0,0
5260,),0,0
5261,or,0,1
5262,conventional,1,1
5263,biological,1,0
5264,aortic,1,0
5265,valves,1,1
5266,(,0,0
5267,Carpentier-Edwards,0,1
5268,",",0,0
5269,n,0,0
5270,=,0,0
5271,74,0,0
5272,),0,0
5273,were,0,0
5274,evaluated,0,0
5275,prospectively,0,0
5276,.,0,0
5277,Preoperatively,0,0
5278,there,0,0
5279,were,0,0
5280,no,0,0
5281,differences,0,0
5282,with,0,0
5283,regard,0,0
5284,to,0,0
5285,aortic,0,0
5286,valve,0,0
5287,pathology,0,0
5288,",",0,0
5289,left,0,0
5290,ventricular,0,0
5291,function,0,0
5292,",",0,0
5293,and,0,0
5294,pressure,0,0
5295,gradients,0,0
5296,between,0,0
5297,the,0,0
5298,two,0,0
5299,patient,0,0
5300,groups,0,0
5301,.,0,0
5302,The,0,0
5303,patient,0,0
5304,annulus,0,1
5305,index,0,0
5306,(,0,0
5307,13.55,0,0
5308,vs.,0,0
5309,13.46,0,0
5310,mm,0,0
5311,;,0,0
5312,NS,0,0
5313,),0,0
5314,measured,0,0
5315,intraoperatively,0,1
5316,was,0,0
5317,used,0,0
5318,as,0,0
5319,baseline,0,0
5320,for,0,0
5321,further,0,0
5322,comparison,0,0
5323,.,0,0
5324,Postoperatively,0,0
5325,",",0,0
5326,left,0,0
5327,ventricular,0,0
5328,mass,0,0
5329,index,0,0
5330,was,0,0
5331,213+/-77,0,0
5332,g/m2,0,0
5333,(,0,1
5334,stentless,0,1
5335,),0,1
5336,compared,0,0
5337,with,0,0
5338,202+/-72,0,0
5339,(,0,0
5340,conventional,0,1
5341,group,0,1
5342,),0,1
5343,g/m2,0,0
5344,(,0,1
5345,NS,0,0
5346,),0,0
5347,",",0,0
5348,whereas,0,0
5349,after,0,0
5350,6,0,0
5351,months,0,0
5352,it,0,0
5353,was,0,0
5354,141+/-41,0,0
5355,g/m2,0,0
5356,in,0,0
5357,the,0,0
5358,stentless,0,1
5359,and,0,0
5360,170+/-43,0,0
5361,g/m2,0,0
5362,in,0,0
5363,the,0,0
5364,conventional,0,1
5365,group,0,0
5366,(,0,0
5367,P,0,0
5368,<,0,0
5369,.05,0,0
5370,),0,0
5371,.,0,0
5372,Regression,0,0
5373,of,0,0
5374,left,0,0
5375,ventricular,0,0
5376,hypertrophy,0,0
5377,occurs,0,0
5378,in,0,0
5379,all,0,0
5380,patients,0,0
5381,after,0,0
5382,aortic,0,0
5383,valve,0,0
5384,replacement,0,1
5385,.,0,0
5386,Nevertheless,0,0
5387,",",0,0
5388,the,0,0
5389,use,0,0
5390,of,0,0
5391,stentless,1,1
5392,bioprostheses,1,1
5393,leads,0,0
5394,to,0,0
5395,a,0,0
5396,significant,0,0
5397,enhancement,0,0
5398,",",0,0
5399,which,0,0
5400,may,0,0
5401,result,0,0
5402,in,0,0
5403,a,0,0
5404,reduction,0,0
5405,of,0,0
5406,the,0,0
5407,cardiac,0,0
5408,risk,0,0
5409,profile,0,0
5410,for,0,0
5411,the,0,0
5412,patient,0,0
5413,.,0,0
5414,Changes,0,0
5415,in,0,0
5416,cardiac,0,0
5417,muscle,0,1
5418,mass,0,0
5419,and,0,0
5420,function,0,0
5421,in,0,0
5422,hemodialysis,0,0
5423,patients,0,0
5424,during,0,0
5425,growth,1,0
5426,hormone,1,1
5427,treatment,1,0
5428,.,1,0
5429,BACKGROUND,0,0
5430,Adult,0,0
5431,patients,0,0
5432,with,0,0
5433,chronic,0,0
5434,renal,0,0
5435,failure,0,0
5436,(,0,1
5437,CRF,0,1
5438,),0,1
5439,often,0,0
5440,show,0,0
5441,symptoms,0,0
5442,as,0,0
5443,fatigue,0,0
5444,",",0,0
5445,wasting,0,0
5446,",",0,0
5447,and,0,0
5448,reduced,0,0
5449,working,0,0
5450,capacity,0,0
5451,with,0,0
5452,concomitant,0,0
5453,findings,0,0
5454,of,0,0
5455,reduced,0,0
5456,cardiac,0,0
5457,performance,0,0
5458,and,0,0
5459,muscle,0,0
5460,mass,0,0
5461,.,0,0
5462,This,0,0
5463,state,0,0
5464,may,0,0
5465,in,0,0
5466,part,0,0
5467,be,0,0
5468,caused,0,0
5469,by,0,0
5470,an,0,0
5471,imbalance,0,0
5472,in,0,0
5473,the,0,0
5474,somatostatin/somatomedine,0,1
5475,axis,0,0
5476,resulting,0,0
5477,in,0,0
5478,increased,0,0
5479,catabolism,0,0
5480,.,0,0
5481,During,0,0
5482,an,0,0
5483,attempt,0,0
5484,to,0,0
5485,correct,0,0
5486,this,0,0
5487,catabolic,0,0
5488,state,0,0
5489,by,0,0
5490,administration,1,0
5491,of,1,0
5492,exogenous,1,1
5493,growth,1,0
5494,hormone,1,1
5495,",",0,0
5496,cardiac,0,0
5497,muscle,0,1
5498,mass,0,0
5499,and,0,0
5500,performance,0,0
5501,were,0,0
5502,studied,0,0
5503,.,0,0
5504,METHODS,0,0
5505,In,0,0
5506,a,0,0
5507,double-blind,0,0
5508,",",0,0
5509,placebo-controlled,1,1
5510,6-month,0,0
5511,study,0,0
5512,comprising,0,1
5513,20,0,0
5514,adult,0,0
5515,enfeebled,1,0
5516,hemodialysis,1,0
5517,patients,1,0
5518,",",0,0
5519,9,0,0
5520,patients,0,0
5521,were,0,0
5522,treated,0,0
5523,with,0,0
5524,a,0,0
5525,single,0,0
5526,daily,0,1
5527,subcutaneous,0,1
5528,injection,0,1
5529,of,0,0
5530,recombinant,1,1
5531,human,1,1
5532,growth,1,1
5533,hormone,1,1
5534,(,1,1
5535,rhGH,1,1
5536,),1,1
5537,4,0,1
5538,IU/m2,0,1
5539,and,0,0
5540,11,0,0
5541,with,0,0
5542,placebo,1,1
5543,injections,0,1
5544,.,0,0
5545,Left,0,0
5546,ventricular,0,0
5547,muscle,0,1
5548,mass,0,0
5549,(,0,1
5550,LVM,0,1
5551,),0,1
5552,and,0,0
5553,ejection,0,1
5554,fraction,0,1
5555,(,0,1
5556,EF,0,1
5557,),0,1
5558,were,0,0
5559,evaluated,0,0
5560,by,0,0
5561,echocardiography,0,0
5562,and,0,0
5563,the,0,0
5564,maximal,0,0
5565,working,0,0
5566,capacity,0,0
5567,(,0,1
5568,MWC,0,1
5569,),0,1
5570,was,0,0
5571,measured,0,0
5572,by,0,0
5573,a,0,0
5574,bicycle,1,1
5575,exercise,1,1
5576,test,1,0
5577,performed,0,0
5578,before,0,0
5579,and,0,0
5580,after,0,0
5581,the,0,0
5582,treatment,0,0
5583,period,0,0
5584,.,0,0
5585,Supplementary,0,1
5586,electrocardiography,0,0
5587,(,0,1
5588,ECG,0,1
5589,),0,1
5590,was,0,0
5591,performed,0,0
5592,before,0,0
5593,and,0,0
5594,after,0,0
5595,6-month,0,0
5596,treatment,0,0
5597,.,0,0
5598,RESULTS,0,0
5599,Median,0,0
5600,LVM,0,1
5601,increased,0,0
5602,significantly,0,0
5603,from,0,0
5604,172,0,0
5605,to,0,0
5606,220,0,0
5607,g,0,1
5608,(,0,0
5609,p,0,0
5610,=,0,0
5611,0.03,0,0
5612,),0,0
5613,in,0,0
5614,the,0,0
5615,rhGH-treated,0,0
5616,group,0,0
5617,",",0,0
5618,while,0,0
5619,an,0,0
5620,insignificant,0,0
5621,decrease,0,0
5622,was,0,0
5623,observed,0,0
5624,in,0,0
5625,the,0,0
5626,placebo,0,1
5627,group,0,0
5628,from,0,0
5629,281,0,0
5630,to,0,0
5631,200,0,1
5632,g,0,1
5633,(,0,0
5634,p,0,0
5635,=,0,0
5636,0.3,0,0
5637,),0,0
5638,.,0,0
5639,The,0,0
5640,EF,0,0
5641,showed,0,0
5642,no,0,0
5643,significant,0,0
5644,changes,0,0
5645,in,0,0
5646,the,0,0
5647,two,0,0
5648,groups,0,0
5649,.,0,0
5650,MWC,0,0
5651,showed,0,0
5652,a,0,0
5653,slight,0,0
5654,",",0,0
5655,insignificant,0,0
5656,decrease,0,0
5657,in,0,0
5658,both,0,0
5659,groups,0,0
5660,.,0,0
5661,From,0,0
5662,ECG,0,0
5663,no,0,0
5664,significant,0,0
5665,ST,0,0
5666,deviations,0,0
5667,were,0,0
5668,found,0,0
5669,and,0,0
5670,no,0,0
5671,significant,0,0
5672,changes,0,0
5673,regarding,0,0
5674,B-Hb,0,0
5675,",",0,0
5676,blood,0,0
5677,pressure,0,0
5678,or,0,1
5679,pulse,0,1
5680,were,0,0
5681,observed,0,0
5682,in,0,0
5683,the,0,0
5684,two,0,0
5685,groups,0,0
5686,.,0,0
5687,Irregular,0,0
5688,heart,0,0
5689,rhythm,0,1
5690,aggravated,0,0
5691,in,0,0
5692,one,0,0
5693,patient,0,0
5694,during,0,0
5695,the,0,0
5696,first,0,0
5697,month,0,0
5698,of,0,0
5699,treatment,0,0
5700,with,0,0
5701,rhGH,0,1
5702,",",0,0
5703,but,0,0
5704,was,0,0
5705,overcome,0,0
5706,by,0,0
5707,a,0,0
5708,-blocking,0,1
5709,agent,0,0
5710,.,0,0
5711,CONCLUSION,0,0
5712,The,0,0
5713,treatment,0,0
5714,with,0,0
5715,rhGH,0,1
5716,of,0,0
5717,adult,0,0
5718,chronic,0,0
5719,hemodialysis,0,1
5720,patients,0,0
5721,for,0,0
5722,6,0,0
5723,months,0,0
5724,increased,0,0
5725,the,0,0
5726,left,0,0
5727,ventricular,0,0
5728,mass,0,0
5729,significantly,0,0
5730,",",0,0
5731,but,0,0
5732,without,0,0
5733,any,0,0
5734,effect,0,0
5735,on,0,0
5736,ejection,0,0
5737,fraction,0,1
5738,or,0,1
5739,maximal,0,0
5740,working,0,0
5741,capacity,0,0
5742,.,0,0
5743,No,0,0
5744,electrocardiographic,0,0
5745,signs,0,0
5746,of,0,0
5747,ischemia,0,0
5748,were,0,0
5749,associated,0,0
5750,with,0,0
5751,the,0,0
5752,increasing,0,0
5753,muscle,0,1
5754,mass,0,0
5755,and,0,0
5756,only,0,0
5757,one,0,0
5758,patient,0,0
5759,developed,0,0
5760,symptoms,0,0
5761,that,0,0
5762,might,0,0
5763,relate,0,0
5764,to,0,0
5765,ischemia,0,0
5766,.,0,0
5767,No,0,0
5768,changes,0,0
5769,in,0,0
5770,B-Hb,0,0
5771,",",0,0
5772,blood,0,0
5773,pressure,0,0
5774,or,0,1
5775,pulse,0,1
5776,were,0,0
5777,observed,0,0
5778,during,0,0
5779,the,0,0
5780,treatment,0,0
5781,period,0,0
5782,.,0,0
5783,Safety,0,0
5784,of,0,0
5785,the,0,0
5786,combination,1,1
5787,of,1,0
5788,valsartan,1,1
5789,and,1,0
5790,benazepril,1,1
5791,in,0,0
5792,patients,0,0
5793,with,0,0
5794,chronic,0,0
5795,renal,0,0
5796,disease,0,0
5797,.,0,0
5798,European,0,0
5799,Group,0,0
5800,for,0,0
5801,the,0,0
5802,Investigation,0,0
5803,of,0,0
5804,Valsartan,1,1
5805,in,0,0
5806,Chronic,0,0
5807,Renal,0,0
5808,Disease,0,0
5809,.,0,0
5810,OBJECTIVE,0,0
5811,Several,0,0
5812,experimental,0,0
5813,and,0,0
5814,clinical,0,0
5815,studies,0,0
5816,indicate,0,0
5817,that,0,0
5818,the,0,0
5819,renin,0,0
5820,system,0,0
5821,may,0,0
5822,play,0,0
5823,a,0,0
5824,pivotal,0,0
5825,role,0,0
5826,in,0,0
5827,progressing,0,0
5828,renal,0,0
5829,disease,0,0
5830,.,0,0
5831,The,0,0
5832,combination,0,0
5833,of,0,0
5834,an,0,0
5835,angiotensin-converting,0,1
5836,enzyme,0,1
5837,inhibitor,0,1
5838,and,0,0
5839,an,0,0
5840,angiotensin,0,1
5841,receptor,0,0
5842,blocker,0,1
5843,could,0,0
5844,provide,0,0
5845,a,0,0
5846,higher,0,0
5847,degree,0,0
5848,of,0,0
5849,blockade,0,0
5850,of,0,0
5851,the,0,0
5852,renin-angiotensin,0,1
5853,system,0,0
5854,than,0,0
5855,either,0,0
5856,agent,0,0
5857,alone,0,1
5858,.,0,0
5859,Such,0,0
5860,enhanced,0,0
5861,suppression,0,0
5862,might,0,0
5863,be,0,0
5864,of,0,0
5865,benefit,0,0
5866,for,0,0
5867,patients,0,0
5868,exhibiting,0,0
5869,a,0,0
5870,progressive,0,0
5871,decline,0,0
5872,in,0,0
5873,renal,0,0
5874,function,0,0
5875,because,0,0
5876,of,0,0
5877,chronic,0,0
5878,renal,0,0
5879,disease,0,0
5880,.,0,0
5881,METHODS,0,0
5882,A,0,0
5883,pilot,0,0
5884,multinational,0,0
5885,",",0,0
5886,multicentre,0,0
5887,",",0,0
5888,randomized,0,0
5889,",",0,0
5890,active-controlled,0,1
5891,",",0,0
5892,parallel,0,0
5893,group,0,0
5894,open-label,0,0
5895,study,0,0
5896,has,0,0
5897,been,0,0
5898,conducted,0,0
5899,in,0,0
5900,a,0,0
5901,group,0,0
5902,of,0,0
5903,patients,0,0
5904,with,0,0
5905,progressive,0,0
5906,chronic,0,0
5907,renal,0,0
5908,failure,0,0
5909,(,0,1
5910,creatinine,0,0
5911,clearance,0,0
5912,20-45,0,1
5913,ml/min,0,0
5914,),0,1
5915,either,0,1
5916,with,0,0
5917,or,0,1
5918,without,0,0
5919,proteinuria,0,0
5920,and,0,0
5921,hypertension,0,0
5922,.,0,0
5923,The,0,0
5924,primary,0,0
5925,aim,0,0
5926,of,0,0
5927,the,0,0
5928,study,0,0
5929,was,0,0
5930,to,0,0
5931,investigate,0,0
5932,the,0,0
5933,safety,0,0
5934,and,0,0
5935,tolerability,0,0
5936,of,0,0
5937,the,0,0
5938,combination,1,1
5939,of,1,0
5940,valsartan,1,1
5941,and,1,0
5942,benazepril,1,1
5943,.,1,0
5944,Patients,0,0
5945,were,0,0
5946,randomly,0,0
5947,assigned,0,0
5948,to,0,0
5949,one,0,0
5950,of,0,0
5951,three,0,0
5952,groups,0,0
5953,:,0,0
5954,group,0,0
5955,1,0,0
5956,received,0,0
5957,valsartan,1,1
5958,160,1,0
5959,mg,1,1
5960,once,0,1
5961,daily,0,1
5962,(,0,0
5963,n,0,0
5964,=,0,0
5965,22,0,0
5966,),0,0
5967,;,0,0
5968,group,0,0
5969,2,0,0
5970,received,0,0
5971,valsartan,1,1
5972,80,1,0
5973,mg,1,1
5974,once,1,1
5975,daily,1,1
5976,plus,1,1
5977,benazepril,1,1
5978,5,1,1
5979,or,1,0
5980,10,1,0
5981,mg,1,1
5982,once,1,0
5983,daily,1,1
5984,(,0,0
5985,n,0,0
5986,=,0,0
5987,42,0,0
5988,),0,0
5989,;,0,0
5990,group,0,0
5991,3,0,0
5992,received,0,0
5993,valsartan,1,1
5994,160,1,0
5995,mg,1,1
5996,once,0,1
5997,daily,0,1
5998,plus,1,1
5999,benazepril,1,1
6000,5,1,1
6001,or,1,0
6002,10,1,0
6003,mg,1,1
6004,once,0,0
6005,daily,0,1
6006,(,0,0
6007,n,0,0
6008,=,0,0
6009,44,0,0
6010,),0,0
6011,.,0,0
6012,The,0,0
6013,study,0,0
6014,lasted,0,0
6015,for,0,0
6016,5,0,0
6017,weeks,0,0
6018,",",0,0
6019,and,0,0
6020,in,0,0
6021,groups,0,0
6022,2,0,0
6023,and,0,0
6024,3,0,0
6025,benazepril,0,1
6026,was,0,0
6027,added,0,0
6028,on,0,0
6029,top,0,0
6030,of,0,0
6031,valsartan,0,1
6032,after,0,0
6033,the,0,0
6034,first,0,0
6035,week,0,0
6036,of,0,0
6037,therapy,0,1
6038,with,0,0
6039,the,0,0
6040,angiotensin,0,1
6041,receptor,0,0
6042,blocker,0,1
6043,.,0,0
6044,RESULTS,0,0
6045,Serum,0,0
6046,creatinine,0,0
6047,increased,0,0
6048,in,0,0
6049,all,0,0
6050,three,0,0
6051,groups,0,0
6052,(,0,0
6053,mean,0,0
6054,change,0,0
6055,within,0,0
6056,a,0,0
6057,group,0,0
6058,:,0,0
6059,11,0,0
6060,micromol/l,0,0
6061,in,0,0
6062,group,0,0
6063,1,0,0
6064,",",0,0
6065,P=,0,1
6066,0.045,0,0
6067,;,0,0
6068,9,0,0
6069,micromol/l,0,0
6070,in,0,0
6071,group,0,0
6072,2,0,0
6073,",",0,0
6074,P=,0,1
6075,0.030,0,0
6076,;,0,0
6077,15,0,0
6078,micromol/l,0,0
6079,in,0,0
6080,group,0,0
6081,3,0,0
6082,",",0,0
6083,P=,0,1
6084,0.0006,0,0
6085,),0,0
6086,.,0,0
6087,Serum,0,0
6088,potassium,0,0
6089,also,0,0
6090,increased,0,0
6091,in,0,0
6092,all,0,0
6093,three,0,0
6094,groups,0,0
6095,of,0,0
6096,patients,0,0
6097,(,0,0
6098,mean,0,0
6099,change,0,0
6100,within,0,0
6101,a,0,0
6102,group,0,0
6103,:,0,0
6104,0.28,0,0
6105,mmol/l,0,0
6106,in,0,0
6107,group,0,0
6108,1,0,0
6109,",",0,0
6110,P=,0,1
6111,0.28,0,0
6112,;,0,0
6113,0.48,0,0
6114,mmol/l,0,0
6115,in,0,0
6116,group,0,0
6117,2,0,0
6118,",",0,0
6119,P=,0,1
6120,0.0008,0,0
6121,;,0,0
6122,0.36,0,0
6123,mmol/l,0,0
6124,in,0,0
6125,group,0,0
6126,3,0,0
6127,",",0,0
6128,P=,0,1
6129,0.02,0,0
6130,),0,0
6131,.,0,0
6132,After,0,0
6133,5,0,0
6134,weeks,0,0
6135,of,0,0
6136,treatment,0,0
6137,",",0,0
6138,the,0,0
6139,largest,0,0
6140,decrease,0,0
6141,in,0,0
6142,blood,0,0
6143,pressure,0,0
6144,was,0,0
6145,observed,0,0
6146,in,0,0
6147,group,0,0
6148,3,0,0
6149,(,0,0
6150,the,0,0
6151,mean,0,0
6152,change,0,0
6153,from,0,0
6154,baseline,0,0
6155,in,0,0
6156,seated,0,0
6157,diastolic,0,0
6158,blood,0,0
6159,pressure,0,0
6160,(,0,1
6161,SDBP,0,0
6162,),0,1
6163,and,0,0
6164,seated,0,0
6165,systolic,0,0
6166,blood,0,0
6167,pressure,0,0
6168,(,0,1
6169,SSBP,0,1
6170,),0,0
6171,",",0,0
6172,respectively,0,0
6173,",",0,0
6174,were,0,0
6175,:,0,0
6176,-2.0,0,0
6177,and,0,0
6178,-11.5,0,0
6179,mmHg,0,1
6180,in,0,0
6181,group,0,0
6182,1,0,0
6183,;,0,0
6184,-7.6,0,0
6185,and,0,0
6186,-15.4,0,0
6187,mmHg,0,1
6188,in,0,0
6189,group,0,0
6190,2,0,0
6191,;,0,0
6192,-12.6,0,0
6193,and,0,0
6194,-21.6,0,0
6195,mmHg,0,1
6196,in,0,0
6197,group,0,0
6198,3,0,0
6199,),0,0
6200,.,0,0
6201,In,0,0
6202,addition,0,0
6203,",",0,0
6204,both,0,0
6205,combination,0,1
6206,treatments,0,0
6207,resulted,0,0
6208,in,0,0
6209,the,0,0
6210,reduction,0,0
6211,of,0,0
6212,proteinuria,0,0
6213,.,0,0
6214,The,0,0
6215,total,0,0
6216,number,0,0
6217,of,0,0
6218,patients,0,0
6219,with,0,0
6220,adverse,0,0
6221,experiences,0,0
6222,were,0,0
6223,10,0,0
6224,(,0,0
6225,45.5,0,0
6226,%,0,0
6227,),0,0
6228,",",0,0
6229,14,0,0
6230,(,0,0
6231,33.3,0,0
6232,%,0,0
6233,),0,0
6234,and,0,0
6235,11,0,0
6236,(,0,0
6237,25,0,0
6238,%,0,0
6239,),0,0
6240,in,0,0
6241,groups,0,0
6242,"1,2",0,1
6243,and,0,0
6244,3,0,0
6245,",",0,0
6246,respectively,0,0
6247,.,0,0
6248,In,0,0
6249,six,0,0
6250,patients,0,0
6251,(,0,0
6252,5.6,0,0
6253,%,0,0
6254,),0,0
6255,therapy,0,1
6256,was,0,0
6257,discontinued,0,0
6258,as,0,0
6259,a,0,0
6260,result,0,0
6261,of,0,0
6262,adverse,0,0
6263,experiences,0,0
6264,.,0,0
6265,Only,0,0
6266,one,0,0
6267,patient,0,0
6268,in,0,0
6269,each,0,0
6270,of,0,0
6271,the,0,0
6272,combined,0,1
6273,therapy,0,1
6274,groups,0,0
6275,withdrew,0,0
6276,from,0,0
6277,the,0,0
6278,study,0,0
6279,because,0,0
6280,of,0,0
6281,hyperkalaemia,0,0
6282,and,0,0
6283,no,0,0
6284,patients,0,0
6285,were,0,0
6286,forced,0,0
6287,to,0,0
6288,withdraw,0,0
6289,because,0,0
6290,of,0,0
6291,an,0,0
6292,increase,0,0
6293,in,0,0
6294,serum,0,0
6295,creatinine,0,0
6296,",",0,0
6297,acute,0,0
6298,renal,0,0
6299,failure,0,0
6300,or,0,1
6301,hospitalization,0,0
6302,.,0,0
6303,CONCLUSIONS,0,0
6304,These,0,0
6305,results,0,0
6306,indicate,0,0
6307,that,0,0
6308,short-term,0,0
6309,combination,0,1
6310,of,0,0
6311,an,0,0
6312,angiotensin-converting,0,1
6313,enzyme,0,1
6314,inhibitor,0,1
6315,and,0,0
6316,an,0,0
6317,angiotensin,0,1
6318,receptor,0,0
6319,blocker,0,1
6320,is,0,0
6321,safe,0,0
6322,and,0,0
6323,well,0,0
6324,tolerated,0,0
6325,in,0,0
6326,patients,0,0
6327,with,0,0
6328,moderate,0,0
6329,chronic,0,0
6330,renal,0,0
6331,failure,0,0
6332,.,0,0
6333,[,0,0
6334,Administration,0,0
6335,of,0,0
6336,tobramycin,1,1
6337,aerosols,1,0
6338,in,0,0
6339,patients,0,0
6340,with,0,0
6341,nosocomial,0,0
6342,pneumonia,0,0
6343,:,0,0
6344,a,0,0
6345,preliminary,0,0
6346,study,0,0
6347,],0,1
6348,.,0,0
6349,OBJECTIVE,0,0
6350,The,0,0
6351,aim,0,0
6352,of,0,0
6353,this,0,0
6354,study,0,0
6355,was,0,0
6356,to,0,0
6357,assess,0,0
6358,renal,0,0
6359,and,0,0
6360,respiratory,0,0
6361,tolerance,0,0
6362,of,0,0
6363,aerosolized,0,1
6364,tobramycin,1,1
6365,in,0,0
6366,intubated,0,0
6367,and,0,0
6368,mechanically,0,1
6369,ventilated,0,1
6370,patients,0,0
6371,with,0,0
6372,nosocomial,0,0
6373,pneumonia,0,0
6374,.,0,1
6375,PATIENTS,0,0
6376,AND,0,0
6377,METHODS,0,0
6378,This,0,0
6379,was,0,0
6380,a,0,0
6381,multicenter,0,0
6382,",",0,0
6383,randomized,0,0
6384,",",0,0
6385,double-blind,0,0
6386,",",0,0
6387,placebo,0,1
6388,controlled,0,0
6389,study,0,0
6390,.,0,0
6391,Thirty-eight,0,0
6392,mechanically,0,0
6393,ventilated,0,1
6394,patients,0,0
6395,with,0,0
6396,documented,0,0
6397,nosocomial,0,1
6398,pneumonia,0,0
6399,were,0,0
6400,included,0,0
6401,.,0,0
6402,Patients,0,0
6403,treated,0,0
6404,with,0,0
6405,intravenous,1,1
6406,betalactam,1,1
6407,and,1,0
6408,tobramycin,1,1
6409,were,1,0
6410,randomly,1,0
6411,allocated,1,0
6412,to,1,0
6413,receive,1,1
6414,aerosolized,1,1
6415,tobramycin,1,1
6416,(,1,0
6417,6,1,0
6418,mg/kg/day,1,1
6419,",",1,0
6420,n,1,0
6421,=,1,0
6422,21,1,0
6423,),1,0
6424,or,1,1
6425,placebo,1,1
6426,(,1,1
6427,n,1,0
6428,=,1,0
6429,17,1,0
6430,),1,0
6431,.,1,0
6432,The,1,0
6433,aerosol,1,1
6434,was,1,0
6435,administered,1,0
6436,via,1,0
6437,a,1,0
6438,pneumatic,1,1
6439,nebulizer,1,1
6440,once,1,1
6441,a,1,0
6442,day,1,0
6443,for,1,0
6444,5,1,0
6445,days,1,0
6446,.,1,0
6447,RESULTS,0,0
6448,Respiratory,0,0
6449,tolerance,0,0
6450,was,0,0
6451,good,0,0
6452,in,0,0
6453,all,0,0
6454,but,0,0
6455,two,0,0
6456,patients,0,0
6457,.,0,0
6458,No,0,0
6459,acute,0,0
6460,renal,0,0
6461,failure,0,0
6462,occurred,0,0
6463,.,0,0
6464,By,0,0
6465,day,0,0
6466,10,0,0
6467,",",0,0
6468,7,0,0
6469,patients,0,0
6470,in,0,0
6471,the,0,0
6472,tobramycin,0,1
6473,group,0,0
6474,(,0,0
6475,35,0,0
6476,%,0,0
6477,),0,0
6478,had,0,0
6479,been,0,0
6480,extubated,0,0
6481,versus,0,0
6482,3,0,0
6483,in,0,0
6484,the,0,0
6485,placebo,0,1
6486,group,0,0
6487,(,0,0
6488,18.5,0,0
6489,%,0,0
6490,",",0,0
6491,p,0,0
6492,=,0,0
6493,0.18,0,0
6494,),0,0
6495,.,0,0
6496,By,0,0
6497,day,0,0
6498,28,0,0
6499,",",0,0
6500,6,0,0
6501,patients,0,0
6502,had,0,0
6503,died,0,0
6504,(,0,0
6505,2,0,0
6506,in,0,0
6507,the,0,0
6508,tobramycin,0,1
6509,group,0,0
6510,and,0,0
6511,4,0,0
6512,in,0,0
6513,the,0,0
6514,placebo,0,1
6515,group,0,0
6516,",",0,0
6517,p,0,0
6518,=,0,0
6519,0.23,0,0
6520,),0,0
6521,.,0,0
6522,CONCLUSION,0,0
6523,Aerosolized,0,1
6524,tobramycin,0,1
6525,was,0,0
6526,well,0,0
6527,tolerated,0,0
6528,in,0,0
6529,ventilated,0,1
6530,patients,0,0
6531,with,0,0
6532,documented,0,0
6533,nosocomial,0,0
6534,pneumonia,0,0
6535,.,0,0
6536,Efficacy,0,0
6537,of,0,0
6538,a,0,0
6539,barrier,1,1
6540,cream,1,1
6541,and,1,0
6542,its,1,0
6543,vehicle,1,1
6544,as,0,0
6545,protective,0,0
6546,measures,0,0
6547,against,0,0
6548,occupational,0,1
6549,irritant,0,1
6550,contact,0,1
6551,dermatitis,0,0
6552,.,0,0
6553,The,0,0
6554,actual,0,0
6555,advantage,0,0
6556,of,0,0
6557,barrier,1,0
6558,creams,1,1
6559,over,0,0
6560,bland,0,0
6561,emollients,0,1
6562,for,0,0
6563,skin,0,0
6564,protection,0,1
6565,is,0,0
6566,still,0,0
6567,hotly,0,0
6568,debated,0,0
6569,.,0,0
6570,In,0,0
6571,a,0,0
6572,randomized,0,0
6573,",",0,0
6574,double-blinded,0,0
6575,study,0,0
6576,",",0,0
6577,a,0,0
6578,newly-introduced,0,1
6579,barrier,1,1
6580,cream,1,1
6581,and,0,0
6582,its,0,0
6583,moisturizing,1,1
6584,vehicle,1,1
6585,were,0,0
6586,compared,0,0
6587,regarding,0,0
6588,their,0,0
6589,skin,0,0
6590,compatibility,0,0
6591,",",0,0
6592,efficacy,0,0
6593,and,0,0
6594,resulting,0,0
6595,acceptance,0,0
6596,.,0,0
6597,Thus,0,0
6598,",",0,0
6599,2,0,0
6600,panels,0,0
6601,of,0,0
6602,25,0,0
6603,hospital,0,0
6604,nurses,0,0
6605,with,0,0
6606,mild,0,0
6607,signs,0,0
6608,of,0,0
6609,skin,0,0
6610,irritation,0,0
6611,were,0,0
6612,asked,0,0
6613,to,0,0
6614,use,0,0
6615,1,0,0
6616,of,0,0
6617,the,0,0
6618,test,0,0
6619,products,0,1
6620,provided,0,0
6621,(,1,0
6622,verum,1,1
6623,or,1,1
6624,vehicle,1,1
6625,),1,1
6626,over,1,0
6627,a,1,0
6628,period,1,0
6629,of,1,0
6630,4,1,0
6631,weeks,1,0
6632,.,1,0
6633,Effects,0,0
6634,of,0,0
6635,both,0,0
6636,types,0,0
6637,of,0,0
6638,preparations,0,0
6639,were,0,0
6640,studied,0,0
6641,weekly,0,1
6642,by,0,0
6643,clinical,0,0
6644,examination,0,0
6645,and,0,0
6646,the,0,0
6647,instrumental,0,0
6648,assessment,0,0
6649,of,0,0
6650,bioengineering,0,0
6651,parameters,0,0
6652,.,0,0
6653,Results,0,0
6654,showed,0,0
6655,no,0,0
6656,significant,0,0
6657,differences,0,0
6658,between,0,0
6659,barrier,1,0
6660,cream,1,1
6661,and,0,0
6662,vehicle,1,1
6663,.,1,0
6664,In,0,0
6665,both,0,0
6666,groups,0,0
6667,",",0,0
6668,clinical,0,0
6669,skin,0,0
6670,status,0,0
6671,improved,0,0
6672,and,0,0
6673,stratum,0,1
6674,corneum,0,0
6675,hydration,0,1
6676,increased,0,0
6677,significantly,0,0
6678,during,0,0
6679,the,0,0
6680,study,0,0
6681,period,0,0
6682,.,0,0
6683,Both,0,0
6684,preparations,0,0
6685,were,0,0
6686,tolerated,0,0
6687,and,0,0
6688,accepted,0,0
6689,well,0,0
6690,",",0,0
6691,thus,0,0
6692,showing,0,0
6693,both,0,0
6694,skin,0,0
6695,protection,0,0
6696,and,0,0
6697,skin,0,0
6698,care,0,1
6699,.,0,0
6700,These,0,0
6701,results,0,0
6702,contribute,0,0
6703,to,0,0
6704,the,0,0
6705,debate,0,0
6706,as,0,0
6707,to,0,0
6708,whether,0,0
6709,a,0,0
6710,strict,0,0
6711,distinction,0,0
6712,between,0,0
6713,skin,0,0
6714,care,0,1
6715,and,0,0
6716,skin,0,0
6717,protection,0,0
6718,products,0,1
6719,is,0,0
6720,justified,0,0
6721,.,0,0
6722,The,0,0
6723,vehicle,1,0
6724,alone,0,1
6725,is,0,0
6726,capable,0,0
6727,of,0,0
6728,positively,0,0
6729,influencing,0,0
6730,skin,0,0
6731,status,0,0
6732,.,0,0
6733,Emphasis,0,0
6734,must,0,0
6735,be,0,0
6736,laid,0,0
6737,on,0,0
6738,regular,0,0
6739,",",0,0
6740,frequent,0,0
6741,",",0,0
6742,and,0,0
6743,correct,0,0
6744,application,0,1
6745,of,0,0
6746,a,0,0
6747,product,0,0
6748,for,0,0
6749,it,0,0
6750,to,0,0
6751,be,0,0
6752,effective,0,0
6753,.,0,0
6754,Treatment,0,1
6755,with,0,0
6756,metformin,1,1
6757,of,0,0
6758,non-diabetic,0,0
6759,men,0,0
6760,with,0,0
6761,hypertension,0,0
6762,",",0,0
6763,hypertriglyceridaemia,0,0
6764,and,0,0
6765,central,0,0
6766,fat,0,1
6767,distribution,0,0
6768,:,0,0
6769,the,0,0
6770,BIGPRO,0,0
6771,1.2,0,0
6772,trial,0,0
6773,.,0,0
6774,BACKGROUND,0,0
6775,In,0,0
6776,the,0,0
6777,BIGPRO,0,0
6778,1,0,0
6779,trial,0,0
6780,",",0,0
6781,one,0,0
6782,year,0,0
6783,of,0,0
6784,treatment,0,0
6785,with,0,0
6786,metformin,1,1
6787,in,0,0
6788,non-diabetic,0,0
6789,obese,0,0
6790,subjects,0,0
6791,with,0,0
6792,a,0,0
6793,central,0,0
6794,fat,0,0
6795,distribution,0,0
6796,had,0,0
6797,no,0,0
6798,significant,0,0
6799,effect,0,0
6800,on,0,0
6801,fasting,0,0
6802,plasma,0,0
6803,triglyceride,0,0
6804,concentration,0,0
6805,or,0,1
6806,on,0,0
6807,blood,0,0
6808,pressure,0,0
6809,despite,0,0
6810,a,0,0
6811,decrease,0,0
6812,in,0,0
6813,weight,0,0
6814,",",0,0
6815,fasting,0,0
6816,plasma,0,0
6817,insulin,0,1
6818,and,0,0
6819,glucose,0,0
6820,concentrations,0,0
6821,.,0,0
6822,To,0,0
6823,re-evaluate,0,0
6824,the,0,0
6825,effect,0,0
6826,of,0,0
6827,metformin,1,1
6828,on,0,0
6829,fasting,0,0
6830,triglyceride,0,0
6831,concentration,0,0
6832,and,0,0
6833,on,0,0
6834,blood,0,0
6835,pressure,0,0
6836,",",0,0
6837,the,0,0
6838,BIGPRO,0,0
6839,1.2,0,0
6840,trial,0,0
6841,included,0,0
6842,non-diabetic,0,0
6843,men,0,0
6844,(,0,0
6845,n=168,0,0
6846,),0,1
6847,with,0,0
6848,a,0,0
6849,fasting,0,0
6850,plasma,0,0
6851,triglyceride,0,0
6852,concentration,0,0
6853,>,0,0
6854,or,0,1
6855,=1.7,0,0
6856,and,0,1
6857,<,0,0
6858,or,0,1
6859,=6.5,0,0
6860,mmol/l,0,0
6861,",",0,0
6862,high,0,0
6863,blood,0,0
6864,pressure,0,0
6865,(,0,1
6866,systolic,0,0
6867,>,0,0
6868,or,0,1
6869,=140,0,0
6870,and,0,1
6871,<,0,0
6872,or,0,1
6873,=180,0,0
6874,and/or,0,0
6875,diastolic,0,0
6876,>,0,0
6877,or,0,1
6878,=90,0,0
6879,and,0,1
6880,<,0,0
6881,or,0,1
6882,=105,0,0
6883,mmHg,0,1
6884,",",0,0
6885,or,0,1
6886,treatment,0,0
6887,for,0,0
6888,hypertension,0,0
6889,),0,1
6890,and,0,0
6891,a,0,0
6892,waist-to-hip,0,0
6893,ratio,0,0
6894,>,0,0
6895,or,0,1
6896,=0.95,0,0
6897,.,0,0
6898,METHODS,0,0
6899,A,0,0
6900,randomised,0,0
6901,double-blind,0,0
6902,trial,0,0
6903,comparing,0,0
6904,metformin,1,1
6905,treatment,1,1
6906,(,1,0
6907,850,1,1
6908,mg,1,1
6909,bid,1,1
6910,),1,0
6911,with,1,0
6912,placebo,1,1
6913,.,1,0
6914,RESULTS,0,0
6915,Metformin,1,1
6916,had,0,0
6917,no,0,0
6918,significant,0,0
6919,effect,0,0
6920,either,0,1
6921,on,0,0
6922,blood,0,0
6923,pressure,0,0
6924,or,0,1
6925,plasma,0,0
6926,triglyceride,0,0
6927,concentration,0,0
6928,.,0,0
6929,In,0,0
6930,comparison,0,0
6931,with,0,0
6932,the,0,0
6933,placebo,1,1
6934,group,0,0
6935,",",0,0
6936,fasting,0,0
6937,plasma,0,0
6938,insulin,0,1
6939,(,0,0
6940,p,0,0
6941,<,0,0
6942,0.04,0,0
6943,),0,0
6944,",",0,0
6945,total,0,0
6946,cholesterol,0,1
6947,(,0,0
6948,p,0,0
6949,<,0,0
6950,0.05,0,0
6951,),0,0
6952,and,0,0
6953,Apo,0,1
6954,B,0,1
6955,(,0,0
6956,p,0,0
6957,<,0,0
6958,0.008,0,0
6959,),0,0
6960,concentrations,0,0
6961,decreased,0,0
6962,more,0,0
6963,in,0,0
6964,the,0,0
6965,metformin,0,1
6966,group,0,0
6967,in,0,0
6968,the,0,0
6969,BIGPRO,0,0
6970,1,0,0
6971,.,0,0
6972,2,0,0
6973,trial,0,0
6974,",",0,0
6975,confirming,0,0
6976,most,0,0
6977,of,0,0
6978,the,0,0
6979,previous,0,0
6980,results,0,0
6981,of,0,0
6982,the,0,0
6983,BIGPRO,0,0
6984,1,0,0
6985,trial,0,0
6986,.,0,0
6987,Tissue,0,0
6988,plasminogen,0,1
6989,activator,0,1
6990,antigen,0,0
6991,concentration,0,0
6992,decreased,0,0
6993,significantly,0,0
6994,(,0,0
6995,p,0,0
6996,<,0,0
6997,0.01,0,0
6998,),0,0
6999,only,0,0
7000,in,0,0
7001,the,0,0
7002,metformin,1,1
7003,group,0,0
7004,",",0,0
7005,but,0,0
7006,this,0,0
7007,was,0,0
7008,not,0,0
7009,significantly,0,0
7010,different,0,0
7011,from,0,0
7012,the,0,0
7013,placebo,1,1
7014,group,0,0
7015,(,0,0
7016,p,0,0
7017,<,0,0
7018,0.12,0,0
7019,),0,0
7020,;,0,0
7021,further,0,0
7022,",",0,0
7023,there,0,0
7024,were,0,0
7025,no,0,0
7026,significant,0,0
7027,differences,0,0
7028,in,0,0
7029,the,0,0
7030,change,0,0
7031,in,0,0
7032,plasminogen,0,1
7033,activator,0,1
7034,inhibitor,0,1
7035,1,0,0
7036,.,0,0
7037,CONCLUSIONS,0,0
7038,The,0,0
7039,consistency,0,0
7040,of,0,0
7041,the,0,0
7042,two,0,0
7043,BIGPRO,0,0
7044,trials,0,0
7045,supports,0,0
7046,the,0,0
7047,conclusion,0,0
7048,that,0,0
7049,metformin,1,1
7050,affects,0,0
7051,several,0,0
7052,cardiovascular,0,0
7053,risk,0,0
7054,factors,0,0
7055,favourably,0,0
7056,in,0,0
7057,non-diabetic,0,0
7058,subjects,0,0
7059,with,0,0
7060,a,0,0
7061,central,0,0
7062,fat,0,0
7063,distribution,0,0
7064,.,0,0
7065,Combination,0,1
7066,cyclopentolate,1,1
7067,and,0,0
7068,phenylephrine,1,1
7069,for,0,0
7070,mydriasis,0,0
7071,in,0,0
7072,premature,0,0
7073,infants,0,0
7074,with,0,0
7075,heavily,0,0
7076,pigmented,0,0
7077,irides,0,0
7078,.,0,0
7079,PURPOSE,0,0
7080,This,0,0
7081,study,0,0
7082,examined,0,0
7083,whether,0,0
7084,safe,0,0
7085,and,0,0
7086,effective,0,0
7087,mydriasis,0,1
7088,can,0,0
7089,be,0,0
7090,achieved,0,0
7091,in,0,0
7092,premature,0,0
7093,infants,0,0
7094,with,0,0
7095,heavily,0,0
7096,pigmented,0,0
7097,irides,0,0
7098,using,0,0
7099,combination,0,1
7100,cyclopentolate,1,1
7101,0.2,0,1
7102,%,0,0
7103,and,0,0
7104,phenylephrine,1,1
7105,1,0,0
7106,%,0,0
7107,eyedrops,0,1
7108,.,0,0
7109,METHODS,0,0
7110,A,0,0
7111,prospective,0,0
7112,",",0,0
7113,randomized,0,0
7114,double-blind,0,0
7115,study,0,0
7116,was,0,0
7117,performed,0,0
7118,to,0,0
7119,compare,0,0
7120,combination,0,1
7121,cyclopentolate,1,1
7122,0.2,0,1
7123,%,0,0
7124,and,0,0
7125,phenylephrine,1,1
7126,1,0,0
7127,%,0,0
7128,eye-drops,0,1
7129,with,0,0
7130,triple,0,1
7131,instillation,0,1
7132,of,0,0
7133,tropicamide,1,1
7134,0.5,0,1
7135,%,0,0
7136,and,0,0
7137,phenylephrine,1,1
7138,2.5,0,0
7139,%,0,0
7140,.,0,0
7141,Twenty-eight,0,0
7142,consecutive,0,0
7143,babies,0,0
7144,with,0,0
7145,dark,0,1
7146,irides,0,0
7147,and,0,0
7148,birthweight,0,0
7149,<,0,0
7150,1600,0,1
7151,g,0,1
7152,referred,0,0
7153,for,0,0
7154,screening,0,0
7155,for,0,0
7156,retinopathy,0,0
7157,of,0,0
7158,prematurity,0,0
7159,comprised,0,0
7160,the,0,0
7161,study,0,0
7162,population,0,0
7163,.,0,0
7164,Infants,0,0
7165,',0,0
7166,eyes,0,0
7167,were,0,0
7168,randomly,0,0
7169,dilated,0,0
7170,twice,0,0
7171,with,0,0
7172,both,0,0
7173,regimens,0,1
7174,within,0,0
7175,a,0,0
7176,2-week,0,0
7177,period,0,0
7178,.,0,0
7179,Blood,0,0
7180,pressure,0,0
7181,",",0,0
7182,heart,0,0
7183,rate,0,0
7184,",",0,0
7185,and,0,0
7186,pupil,0,1
7187,size,0,0
7188,were,0,0
7189,measured,0,0
7190,.,0,0
7191,RESULTS,0,0
7192,Good,0,0
7193,mydriasis,0,0
7194,was,0,0
7195,achieved,0,0
7196,in,0,0
7197,both,0,0
7198,groups,0,0
7199,with,0,0
7200,no,0,0
7201,significant,0,0
7202,differences,0,0
7203,in,0,0
7204,pupil,0,1
7205,size,0,0
7206,or,0,1
7207,blood,0,1
7208,pressure,0,1
7209,(,0,0
7210,systolic,0,0
7211,",",0,0
7212,diastolic,0,0
7213,",",0,0
7214,or,0,1
7215,mean,0,0
7216,arterial,0,0
7217,pressures,0,0
7218,),0,0
7219,over,0,0
7220,starting,0,0
7221,baseline,0,0
7222,values,0,0
7223,.,0,0
7224,Pulse,0,0
7225,rates,0,0
7226,decelerated,0,0
7227,below,0,0
7228,the,0,0
7229,baseline,0,0
7230,values,0,0
7231,in,0,0
7232,both,0,0
7233,groups,0,0
7234,",",0,0
7235,but,0,0
7236,these,0,0
7237,differences,0,0
7238,were,0,0
7239,not,0,0
7240,large,0,0
7241,.,0,0
7242,CONCLUSION,0,0
7243,The,0,0
7244,single,0,1
7245,combination,0,1
7246,eyedrop,0,1
7247,of,0,0
7248,cyclopentolate,0,1
7249,0.2,0,1
7250,%,0,0
7251,and,0,0
7252,phenylephrine,0,1
7253,1,0,0
7254,%,0,0
7255,is,0,0
7256,as,0,0
7257,effective,0,0
7258,and,0,0
7259,safe,0,0
7260,a,0,0
7261,mydriatic,0,1
7262,for,0,0
7263,infants,0,0
7264,with,0,0
7265,dark,0,0
7266,irides,0,0
7267,as,0,0
7268,both,0,0
7269,tropicamide,0,1
7270,0.5,0,1
7271,%,0,0
7272,and,0,0
7273,phenylephrine,0,1
7274,2.5,0,0
7275,%,0,0
7276,.,0,0
7277,Study,0,0
7278,of,0,0
7279,the,0,0
7280,vaginal,0,1
7281,tolerance,0,0
7282,to,0,0
7283,Acidform,1,0
7284,",",1,0
7285,an,1,0
7286,acid-buffering,1,1
7287,",",1,0
7288,bioadhesive,1,1
7289,gel,1,1
7290,.,1,0
7291,Vaginal,0,0
7292,tolerance,0,0
7293,tests,0,0
7294,were,0,0
7295,performed,0,0
7296,with,0,0
7297,a,0,0
7298,new,0,0
7299,potential,0,0
7300,microbicidal,0,1
7301,and,0,0
7302,spermicidal,0,1
7303,product,0,1
7304,",",0,0
7305,an,0,0
7306,acid-buffering,1,1
7307,vaginal,1,1
7308,gel,1,1
7309,(,1,1
7310,Acidform,1,1
7311,),1,1
7312,without,1,0
7313,or,1,1
7314,with,1,0
7315,nonoxynol-9,1,1
7316,(,1,1
7317,N-9,1,1
7318,),1,0
7319,.,1,0
7320,The,0,0
7321,potential,0,0
7322,advantages,0,0
7323,over,0,0
7324,other,0,0
7325,vaginal,0,1
7326,products,0,1
7327,include,0,0
7328,keeping,0,0
7329,a,0,0
7330,low,0,0
7331,pH,0,1
7332,",",0,0
7333,decrease,0,0
7334,of,0,0
7335,the,0,0
7336,irritating,0,0
7337,effect,0,0
7338,of,0,0
7339,N-9,1,0
7340,on,0,0
7341,the,0,0
7342,cervix,0,1
7343,or,0,1
7344,vaginal,0,1
7345,mucosa,0,0
7346,associated,0,0
7347,with,0,0
7348,greater,0,0
7349,retention,0,0
7350,of,0,0
7351,the,0,0
7352,product,0,0
7353,after,0,0
7354,application,0,0
7355,",",0,0
7356,and,0,0
7357,decreasing,0,0
7358,messiness,0,0
7359,as,0,0
7360,compared,0,0
7361,to,0,0
7362,other,0,0
7363,vaginal,0,1
7364,products,0,0
7365,.,0,0
7366,Three,0,0
7367,groups,0,0
7368,of,0,0
7369,six,0,0
7370,women,0,0
7371,were,0,0
7372,admitted,0,0
7373,and,0,0
7374,randomly,0,0
7375,assigned,0,0
7376,to,0,0
7377,use,0,0
7378,Acidform,1,0
7379,with,0,0
7380,0,0,0
7381,%,0,0
7382,",",0,0
7383,2.5,0,0
7384,%,0,0
7385,",",0,0
7386,and,0,0
7387,5,0,1
7388,%,0,0
7389,N-9,1,0
7390,.,1,0
7391,Colposcopic,0,0
7392,evaluation,0,0
7393,for,0,0
7394,vulvar,0,0
7395,",",0,0
7396,vaginal,0,1
7397,",",0,0
7398,and,0,0
7399,cervical,0,0
7400,signs,0,0
7401,of,0,0
7402,irritation,0,0
7403,was,0,0
7404,performed,0,0
7405,and,0,0
7406,photographs,0,0
7407,were,0,0
7408,taken,0,0
7409,",",0,0
7410,following,0,0
7411,a,0,0
7412,specific,0,0
7413,World,0,1
7414,Health,0,1
7415,Organization,0,1
7416,protocol,0,0
7417,",",0,0
7418,at,0,0
7419,time,0,0
7420,0,0,0
7421,",",0,0
7422,and,0,0
7423,after,0,0
7424,24,0,0
7425,h,0,0
7426,and,0,0
7427,6,0,0
7428,days,0,0
7429,of,0,0
7430,application,0,0
7431,of,0,0
7432,the,0,0
7433,gel,0,1
7434,.,0,0
7435,No,0,0
7436,irritation,0,0
7437,or,0,1
7438,symptom,0,0
7439,was,0,0
7440,reported,0,0
7441,by,0,0
7442,users,0,0
7443,of,0,0
7444,Acidform,1,0
7445,without,1,0
7446,N-9,1,0
7447,.,1,0
7448,A,0,0
7449,generalized,0,0
7450,and,0,0
7451,intense,0,0
7452,erythema,0,0
7453,in,0,0
7454,cervix,0,0
7455,was,0,0
7456,observed,0,0
7457,in,0,0
7458,10,0,0
7459,of,0,0
7460,12,0,0
7461,Acidform/N-9,1,1
7462,users,0,0
7463,and,0,0
7464,abrasion,0,1
7465,occurred,0,0
7466,in,0,0
7467,nine,0,0
7468,of,0,0
7469,them,0,0
7470,.,0,0
7471,Vulvar,0,0
7472,irritation,0,0
7473,was,0,0
7474,seen,0,0
7475,in,0,0
7476,seven,0,0
7477,of,0,0
7478,these,0,0
7479,10,0,0
7480,volunteers,0,0
7481,.,0,0
7482,N-9,0,0
7483,concentration,0,0
7484,in,0,0
7485,the,0,0
7486,gel,0,1
7487,(,0,0
7488,2.5,0,1
7489,%,0,0
7490,or,0,1
7491,5.0,0,1
7492,%,0,0
7493,),0,0
7494,was,0,0
7495,not,0,0
7496,related,0,0
7497,to,0,0
7498,the,0,0
7499,findings,0,0
7500,.,0,0
7501,No,0,0
7502,ulcer,0,0
7503,",",0,0
7504,exulceration,0,0
7505,",",0,0
7506,or,0,1
7507,de-epithelialization,0,1
7508,was,0,0
7509,observed,0,0
7510,.,0,0
7511,Acidform,1,0
7512,without,1,0
7513,N-9,1,0
7514,was,0,0
7515,well,0,0
7516,tolerated,0,0
7517,by,0,0
7518,volunteers,0,0
7519,",",0,0
7520,but,0,0
7521,it,0,0
7522,was,0,0
7523,unable,0,0
7524,to,0,0
7525,protect,0,0
7526,the,0,0
7527,cervix,0,0
7528,",",0,0
7529,vagina,0,0
7530,",",0,0
7531,and,0,0
7532,vulva,0,0
7533,from,0,0
7534,the,0,0
7535,N-9,0,0
7536,effects,0,0
7537,.,0,0
7538,Growth,0,1
7539,hormone,0,1
7540,(,0,1
7541,GH,0,1
7542,),0,1
7543,responses,0,0
7544,to,0,0
7545,GH-releasing,1,1
7546,hormone,1,1
7547,alone,1,1
7548,or,0,1
7549,combined,1,1
7550,with,1,0
7551,arginine,1,1
7552,in,0,0
7553,patients,0,0
7554,with,0,0
7555,adrenal,0,0
7556,incidentaloma,0,0
7557,:,0,0
7558,evidence,0,0
7559,for,0,0
7560,enhanced,0,0
7561,somatostatinergic,0,1
7562,tone,0,0
7563,.,0,0
7564,Spontaneous,0,0
7565,and,0,0
7566,stimulated,0,0
7567,GH,0,1
7568,secretion,0,0
7569,is,0,0
7570,blunted,0,0
7571,in,0,0
7572,hypercortisolemic,0,0
7573,states,0,0
7574,due,0,0
7575,to,0,0
7576,increased,0,0
7577,hypothalamic,0,0
7578,somatostatinergic,0,1
7579,tone,0,0
7580,.,0,0
7581,However,0,0
7582,",",0,0
7583,no,0,0
7584,data,0,0
7585,are,0,0
7586,available,0,0
7587,on,0,0
7588,the,0,0
7589,characteristics,0,0
7590,of,0,0
7591,GH,0,1
7592,secretion,0,0
7593,in,0,0
7594,patients,0,0
7595,with,0,0
7596,incidentally,0,0
7597,discovered,0,0
7598,adrenal,0,0
7599,adenomas,0,0
7600,.,0,0
7601,They,0,0
7602,represent,0,0
7603,an,0,0
7604,interesting,0,0
7605,model,0,0
7606,for,0,0
7607,studying,0,0
7608,GH,0,1
7609,secretion,0,0
7610,",",0,0
7611,as,0,0
7612,a,0,0
7613,slight,0,0
7614,degree,0,0
7615,of,0,0
7616,cortisol,0,0
7617,excess,0,0
7618,may,0,0
7619,frequently,0,0
7620,be,0,0
7621,observed,0,0
7622,in,0,0
7623,such,0,0
7624,patients,0,0
7625,who,0,0
7626,do,0,0
7627,not,0,0
7628,present,0,0
7629,with,0,0
7630,any,0,0
7631,clear,0,1
7632,Cushingoid,0,0
7633,sign,0,0
7634,.,0,0
7635,In,0,0
7636,the,0,0
7637,present,0,0
7638,study,0,0
7639,",",0,0
7640,10,0,0
7641,patients,0,0
7642,(,0,0
7643,3,0,0
7644,men,0,0
7645,and,0,0
7646,7,0,0
7647,women,0,0
7648,",",0,0
7649,aged,0,0
7650,48-63,0,0
7651,yr,0,0
7652,),0,0
7653,with,0,0
7654,an,0,0
7655,adrenal,0,0
7656,mass,0,0
7657,discovered,0,0
7658,serendipitously,0,0
7659,underwent,0,0
7660,",",0,0
7661,on,0,0
7662,separate,0,0
7663,occasions,0,0
7664,",",0,0
7665,a,0,0
7666,GHRH,1,0
7667,injection,1,1
7668,alone,1,1
7669,or,0,1
7670,combined,1,1
7671,with,1,0
7672,an,1,0
7673,infusion,1,1
7674,of,1,0
7675,the,1,0
7676,functional,1,0
7677,somatostatin,1,1
7678,antagonist,1,1
7679,",",1,0
7680,arginine,1,1
7681,.,1,0
7682,Thirteen,0,0
7683,age-matched,0,0
7684,healthy,0,0
7685,volunteers,0,0
7686,served,0,0
7687,as,0,0
7688,controls,1,0
7689,.,1,0
7690,Briefly,0,0
7691,",",0,0
7692,arginine,1,1
7693,(,1,0
7694,30,1,1
7695,g,1,1
7696,),1,0
7697,was,1,0
7698,infused,1,0
7699,from,1,0
7700,-30,1,0
7701,to,1,0
7702,0,1,0
7703,min,1,0
7704,",",1,0
7705,and,1,0
7706,GHRH,1,1
7707,(,1,1
7708,100,1,1
7709,microg,1,1
7710,),1,0
7711,was,1,0
7712,injected,1,1
7713,as,1,0
7714,a,1,0
7715,bolus,1,1
7716,at,1,0
7717,0,1,0
7718,min,1,0
7719,",",0,0
7720,with,0,0
7721,measurement,0,0
7722,of,0,0
7723,serum,1,0
7724,GH,1,1
7725,[,1,1
7726,immunoradiometric,1,1
7727,assay,1,1
7728,(,1,1
7729,IRMA,1,1
7730,),1,1
7731,],1,0
7732,every,0,1
7733,15,0,0
7734,min,0,0
7735,for,0,0
7736,150,0,0
7737,min,0,0
7738,.,0,0
7739,Plasma,1,0
7740,IGF-I,1,1
7741,(,1,0
7742,RIA,1,1
7743,after,1,0
7744,acid-ethanol,1,1
7745,extraction,1,0
7746,),1,0
7747,was,0,0
7748,measured,0,0
7749,in,0,0
7750,a,0,0
7751,morning,0,0
7752,sample,0,0
7753,.,0,0
7754,The,0,0
7755,diagnosis,0,0
7756,of,0,0
7757,cortical,0,0
7758,adenoma,0,0
7759,was,0,0
7760,based,0,0
7761,on,0,0
7762,computed,0,0
7763,tomography,0,1
7764,features,0,0
7765,and,0,0
7766,pattern,0,0
7767,of,0,0
7768,uptake,0,0
7769,on,0,0
7770,adrenal,0,0
7771,scintigraphy,0,1
7772,.,0,0
7773,Patients,0,0
7774,with,0,0
7775,obesity,0,0
7776,and/or,0,0
7777,diabetes,0,0
7778,were,0,0
7779,excluded,0,0
7780,.,0,0
7781,The,0,0
7782,study,0,0
7783,design,0,0
7784,included,0,0
7785,also,0,0
7786,an,0,0
7787,endocrine,0,0
7788,work-up,0,1
7789,aimed,0,0
7790,to,0,0
7791,study,0,0
7792,the,0,0
7793,hypothalamic-pituitary-adrenal,0,0
7794,axis,0,0
7795,[,0,0
7796,urinary,0,0
7797,free,0,0
7798,cortisol,0,0
7799,(,0,1
7800,UFC,0,1
7801,),0,1
7802,excretion,0,0
7803,",",0,0
7804,serum,0,0
7805,cortisol,0,0
7806,at,0,0
7807,0800,0,0
7808,h,0,0
7809,",",0,0
7810,plasma,0,0
7811,ACTH,0,0
7812,at,0,0
7813,0800,0,0
7814,h,0,0
7815,",",0,0
7816,morning,0,0
7817,cortisol,0,0
7818,after,0,0
7819,overnight,0,0
7820,1,0,0
7821,mg,0,1
7822,dexamethasone,0,1
7823,],0,0
7824,.,0,0
7825,Five,0,0
7826,of,0,0
7827,10,0,0
7828,patients,0,0
7829,showed,0,0
7830,abnormalities,0,0
7831,of,0,0
7832,the,0,0
7833,hypothalamic-pituitary-adrenal,0,0
7834,axis,0,0
7835,",",0,0
7836,including,0,0
7837,borderline,0,0
7838,or,0,1
7839,increased,0,0
7840,UFC,0,1
7841,excretion,0,0
7842,in,0,0
7843,4,0,0
7844,of,0,0
7845,them,0,0
7846,accompanied,0,0
7847,by,0,0
7848,blunted,0,0
7849,ACTH,0,0
7850,in,0,0
7851,2,0,0
7852,cases,0,0
7853,and,0,0
7854,failure,0,0
7855,of,0,0
7856,cortisol,0,0
7857,to,0,0
7858,suppress,0,0
7859,after,0,0
7860,dexamethasone,0,1
7861,in,0,0
7862,1,0,0
7863,;,0,0
7864,the,0,0
7865,fifth,0,0
7866,patient,0,0
7867,displayed,0,0
7868,low,0,0
7869,ACTH,0,0
7870,and,0,0
7871,resistance,0,0
7872,to,0,0
7873,dexamethasone,0,1
7874,suppression,0,0
7875,.,0,0
7876,However,0,0
7877,",",0,0
7878,all,0,0
7879,patients,0,0
7880,had,0,0
7881,a,0,0
7882,unilateral,0,0
7883,uptake,0,0
7884,of,0,0
7885,the,0,0
7886,tracer,0,1
7887,on,0,0
7888,the,0,0
7889,side,0,0
7890,of,0,0
7891,the,0,0
7892,mass,0,0
7893,with,0,0
7894,suppression,0,0
7895,of,0,0
7896,the,0,0
7897,contralateral,0,0
7898,normal,0,0
7899,adrenal,0,0
7900,gland,0,0
7901,.,0,0
7902,As,0,0
7903,a,0,0
7904,group,0,0
7905,",",0,0
7906,the,0,0
7907,patients,0,0
7908,displayed,0,0
7909,greater,0,0
7910,UFC,0,1
7911,excretion,0,0
7912,and,0,0
7913,lower,0,0
7914,ACTH,0,0
7915,concentrations,0,0
7916,than,0,0
7917,the,0,0
7918,controls,0,0
7919,.,0,0
7920,GH,0,0
7921,release,0,0
7922,after,0,0
7923,GHRH,1,1
7924,treatment,1,0
7925,was,0,0
7926,blunted,0,0
7927,in,0,0
7928,patients,0,0
7929,bearing,0,0
7930,adrenal,0,0
7931,incidentaloma,0,0
7932,compared,0,0
7933,with,0,0
7934,controls,0,0
7935,(,0,0
7936,GH,0,1
7937,peak,0,0
7938,",",0,0
7939,5.7,0,0
7940,+/-,0,0
7941,5.2,0,0
7942,vs.,0,0
7943,18.0,0,0
7944,+/-,0,0
7945,7.0,0,0
7946,microg/L,0,0
7947,;,0,0
7948,P,0,0
7949,<,0,0
7950,0.0001,0,0
7951,),0,0
7952,",",0,0
7953,whereas,0,0
7954,GHRH,1,1
7955,plus,1,1
7956,arginine,1,1
7957,was,0,0
7958,able,0,0
7959,to,0,0
7960,elicit,0,0
7961,a,0,0
7962,comparable,0,0
7963,response,0,0
7964,in,0,0
7965,the,0,0
7966,2,0,0
7967,groups,0,0
7968,(,0,0
7969,GH,0,1
7970,peak,0,0
7971,",",0,0
7972,33.5,0,0
7973,+/-,0,0
7974,20.3,0,0
7975,vs.,0,0
7976,33.7,0,0
7977,+/-,0,0
7978,17.5,0,0
7979,microg/L,0,0
7980,;,0,0
7981,P,0,0
7982,=,0,0
7983,NS,0,0
7984,),0,0
7985,.,0,0
7986,The,0,0
7987,ratio,0,0
7988,between,0,0
7989,GH,0,1
7990,peaks,0,0
7991,after,0,0
7992,GHRH,1,0
7993,plus,1,1
7994,arginine,1,1
7995,and,0,0
7996,after,0,0
7997,GHRH,1,1
7998,plus,1,1
7999,saline,1,1
8000,was,0,0
8001,significantly,0,0
8002,greater,0,0
8003,in,0,0
8004,patients,0,0
8005,than,0,0
8006,in,0,0
8007,controls,0,0
8008,(,0,0
8009,751,0,1
8010,+/-,0,0
8011,531,0,0
8012,%,0,0
8013,vs.,0,0
8014,81,0,0
8015,+/-,0,0
8016,45,0,0
8017,%,0,0
8018,;,0,0
8019,P,0,0
8020,=,0,0
8021,0.0001,0,0
8022,),0,0
8023,.,0,0
8024,Similar,0,0
8025,data,0,0
8026,were,0,0
8027,obtained,0,0
8028,when,0,0
8029,comparing,0,0
8030,GH,0,1
8031,area,0,0
8032,under,0,0
8033,the,0,0
8034,curve,0,0
8035,after,0,0
8036,GHRH,0,1
8037,plus,0,1
8038,saline,0,1
8039,or,0,1
8040,GHRH,0,1
8041,plus,0,1
8042,arginine,0,1
8043,between,0,0
8044,the,0,0
8045,2,0,0
8046,groups,0,0
8047,.,0,0
8048,In,0,0
8049,summary,0,0
8050,",",0,0
8051,the,0,0
8052,present,0,0
8053,data,0,0
8054,suggest,0,0
8055,that,0,0
8056,in,0,0
8057,patients,0,0
8058,with,0,0
8059,incidental,0,0
8060,adrenal,0,0
8061,adenomas,0,0
8062,the,0,0
8063,GH,0,1
8064,response,0,0
8065,to,0,0
8066,GHRH,0,1
8067,is,0,0
8068,blunted,0,0
8069,due,0,0
8070,to,0,0
8071,increased,0,0
8072,somatostatinergic,0,1
8073,tone,0,0
8074,",",0,0
8075,as,0,0
8076,it,0,0
8077,can,0,0
8078,be,0,0
8079,restored,0,0
8080,to,0,0
8081,normal,0,0
8082,by,0,0
8083,pretreatment,0,0
8084,with,0,0
8085,the,0,0
8086,functional,0,0
8087,somatostatin,0,1
8088,antagonist,0,1
8089,arginine,0,1
8090,.,0,0
8091,The,0,0
8092,blunted,0,0
8093,GH,0,1
8094,release,0,0
8095,to,0,0
8096,GHRH,0,0
8097,may,0,0
8098,be,0,0
8099,an,0,0
8100,early,0,0
8101,and,0,0
8102,long,0,0
8103,lasting,0,0
8104,sign,0,0
8105,of,0,0
8106,autonomous,0,0
8107,cortisol,0,0
8108,secretion,0,0
8109,by,0,0
8110,the,0,0
8111,adrenal,0,0
8112,adenoma,0,0
8113,.,0,0
8114,Human,0,1
8115,motor,0,0
8116,responses,0,0
8117,to,0,0
8118,simultaneous,0,0
8119,aversive,1,0
8120,stimulation,1,1
8121,and,1,0
8122,failure,1,0
8123,on,0,0
8124,a,0,0
8125,valued,0,0
8126,task,0,1
8127,.,0,0
8128,The,0,0
8129,effects,0,0
8130,of,0,0
8131,presentation,0,0
8132,of,0,0
8133,an,0,0
8134,aversive,1,0
8135,stimulus,1,1
8136,and,1,0
8137,simultaneous,1,1
8138,failure,1,0
8139,on,1,0
8140,a,1,0
8141,bogus,1,1
8142,intelligence,1,0
8143,test,1,0
8144,upon,0,0
8145,a,0,0
8146,subject,0,0
8147,'s,0,0
8148,aggressive,0,0
8149,reactions,0,0
8150,were,0,0
8151,studied,0,0
8152,.,0,0
8153,The,0,0
8154,subject,0,0
8155,'s,0,0
8156,fist,0,1
8157,clenching,0,0
8158,was,0,0
8159,used,0,0
8160,as,0,0
8161,an,0,0
8162,indicator,0,0
8163,of,0,0
8164,aggression,0,0
8165,.,0,0
8166,Four,0,0
8167,conditions,0,0
8168,",",0,0
8169,generated,0,0
8170,by,0,0
8171,the,0,0
8172,combinations,0,0
8173,of,0,0
8174,two,0,0
8175,kinds,0,0
8176,of,0,0
8177,stimulus,0,0
8178,delivered,0,1
8179,to,0,0
8180,the,0,0
8181,subjects,0,0
8182,(,1,0
8183,aversive,1,0
8184,or,1,1
8185,nonaversive,1,1
8186,),1,1
8187,and,0,0
8188,two,0,0
8189,outcomes,0,0
8190,of,0,0
8191,the,0,0
8192,task,0,1
8193,(,0,1
8194,failure,0,0
8195,or,0,1
8196,success,0,0
8197,),0,0
8198,",",0,0
8199,were,0,0
8200,investigated,0,0
8201,.,0,0
8202,20,0,0
8203,female,0,0
8204,and,0,0
8205,20,0,0
8206,male,0,0
8207,students,0,0
8208,(,0,0
8209,ages,0,0
8210,:,0,0
8211,17-34,0,0
8212,years,0,0
8213,),0,0
8214,were,0,0
8215,instructed,0,0
8216,",",0,0
8217,upon,0,0
8218,the,0,0
8219,reception,0,0
8220,of,0,0
8221,an,0,0
8222,aversive,1,0
8223,or,1,1
8224,nonaversive,1,1
8225,acoustic,1,1
8226,signal,1,0
8227,",",0,0
8228,to,0,0
8229,press,0,0
8230,with,0,0
8231,the,0,0
8232,right,0,0
8233,hand,0,1
8234,a,0,0
8235,device,0,1
8236,that,0,0
8237,displayed,0,0
8238,a,0,0
8239,slide,0,0
8240,.,0,0
8241,Each,0,0
8242,slide,0,0
8243,presented,0,0
8244,an,0,0
8245,item,0,0
8246,from,0,0
8247,an,0,0
8248,intelligence,0,0
8249,test,0,0
8250,",",0,0
8251,to,0,0
8252,which,0,0
8253,the,0,0
8254,subjects,0,0
8255,were,0,0
8256,either,0,0
8257,allowed,0,0
8258,to,0,0
8259,answer,0,0
8260,successfully,0,1
8261,(,0,1
8262,success,0,0
8263,),0,1
8264,or,0,1
8265,not,0,0
8266,(,0,1
8267,failure,0,0
8268,),0,1
8269,.,0,0
8270,Failure,0,0
8271,increased,0,0
8272,the,0,0
8273,subject,0,0
8274,'s,0,0
8275,autonomic,0,0
8276,arousal,0,0
8277,",",0,0
8278,as,0,0
8279,measured,0,0
8280,by,0,0
8281,photoplethysmographic,0,0
8282,sensors,0,0
8283,",",0,0
8284,in,0,0
8285,all,0,0
8286,stimulation,0,1
8287,conditions,0,0
8288,",",0,0
8289,but,0,0
8290,only,0,0
8291,the,0,0
8292,condition,0,0
8293,with,0,0
8294,aversive,0,0
8295,stimulation,0,1
8296,increased,0,0
8297,the,0,0
8298,speed,0,0
8299,of,0,0
8300,clenching,0,0
8301,.,0,0
8302,This,0,0
8303,was,0,0
8304,interpreted,0,0
8305,as,0,0
8306,indicating,0,0
8307,subject,0,0
8308,'s,0,0
8309,tendencies,0,0
8310,to,0,0
8311,aggression,0,0
8312,.,0,0
8313,These,0,0
8314,results,0,0
8315,are,0,0
8316,discussed,0,0
8317,in,0,0
8318,relation,0,0
8319,to,0,0
8320,the,0,0
8321,effects,0,0
8322,of,0,0
8323,frustration,0,0
8324,.,0,0
8325,Does,0,0
8326,waiting,0,0
8327,matter,0,0
8328,?,0,0
8329,A,0,0
8330,randomized,0,0
8331,controlled,0,0
8332,trial,0,0
8333,of,0,0
8334,new,0,0
8335,non-urgent,0,1
8336,rheumatology,0,0
8337,out-patient,0,1
8338,referrals,0,0
8339,.,0,0
8340,OBJECTIVE,0,0
8341,To,0,0
8342,examine,0,0
8343,the,0,0
8344,effect,0,0
8345,of,0,0
8346,waiting,0,0
8347,times,0,0
8348,on,0,0
8349,the,0,0
8350,health,0,0
8351,status,0,0
8352,of,0,0
8353,patients,0,0
8354,referred,0,0
8355,for,0,0
8356,a,0,0
8357,non-urgent,0,1
8358,rheumatology,0,0
8359,opinion,0,1
8360,.,0,0
8361,METHODS,0,0
8362,The,0,0
8363,study,0,0
8364,was,0,0
8365,a,0,0
8366,randomized,0,0
8367,controlled,0,0
8368,clinical,0,0
8369,study,0,0
8370,evaluating,1,0
8371,a,1,0
8372,'fast,1,1
8373,track,1,1
8374,',1,1
8375,appointment,1,1
8376,with,1,0
8377,a,1,0
8378,6-week,1,0
8379,target,1,0
8380,waiting,1,0
8381,time,1,0
8382,against,1,0
8383,an,1,0
8384,'ordinary,1,0
8385,',1,0
8386,appointment,1,1
8387,in,0,0
8388,the,0,0
8389,main,0,0
8390,city,0,0
8391,out-patient,0,1
8392,clinic,0,0
8393,of,0,0
8394,the,0,0
8395,rheumatology,0,0
8396,service,0,1
8397,for,0,0
8398,the,0,0
8399,Lothian,0,1
8400,and,0,0
8401,Borders,0,1
8402,region,0,1
8403,(,0,0
8404,population,0,0
8405,approximately,0,0
8406,1,0,0
8407,million,0,0
8408,),0,0
8409,.,0,0
8410,Health,0,0
8411,status,0,0
8412,was,0,0
8413,measured,0,0
8414,using,0,0
8415,the,0,0
8416,SF12,0,1
8417,physical,0,1
8418,and,0,0
8419,mental,0,0
8420,summary,0,0
8421,component,0,0
8422,T-scores,0,0
8423,and,0,0
8424,pain,0,0
8425,was,0,0
8426,measured,0,0
8427,with,0,0
8428,a,0,0
8429,100,0,0
8430,mm,0,0
8431,visual,0,0
8432,analogue,0,0
8433,pain,0,0
8434,scale,0,0
8435,.,0,0
8436,Secondary,0,0
8437,outcomes,0,0
8438,were,0,0
8439,health,0,0
8440,utility,0,0
8441,and,0,0
8442,perceived,0,0
8443,health,0,0
8444,both,0,0
8445,measured,0,0
8446,with,0,0
8447,the,0,0
8448,EuroQol,0,1
8449,instrument,0,1
8450,",",0,0
8451,mental,0,0
8452,health,0,0
8453,measured,0,0
8454,with,0,0
8455,the,0,0
8456,Hospital,0,0
8457,Anxiety,0,0
8458,and,0,0
8459,Depression,0,0
8460,scale,0,0
8461,",",0,0
8462,disability,0,0
8463,with,0,0
8464,the,0,0
8465,modified,0,0
8466,Health,0,0
8467,Assessment,0,1
8468,Questionnaire,0,1
8469,and,0,0
8470,economic,0,0
8471,costs,0,0
8472,measured,0,0
8473,from,0,0
8474,a,0,0
8475,societal,0,1
8476,perspective,0,0
8477,.,0,0
8478,RESULTS,0,0
8479,Mean,0,0
8480,waiting,0,0
8481,times,0,0
8482,were,0,0
8483,43,0,0
8484,days,0,0
8485,(,0,0
8486,sigma,0,0
8487,=,0,0
8488,+/-16,0,0
8489,),0,1
8490,and,0,0
8491,105,0,0
8492,days,0,0
8493,(,0,0
8494,sigma,0,0
8495,=,0,0
8496,+/-51,0,0
8497,),0,0
8498,for,0,0
8499,'fast,0,1
8500,track,0,1
8501,',0,1
8502,and,0,0
8503,'ordinary,0,0
8504,',0,1
8505,appointments,0,0
8506,",",0,0
8507,respectively,0,0
8508,.,0,0
8509,Both,0,0
8510,groups,0,0
8511,showed,0,0
8512,significant,0,0
8513,improvements,0,0
8514,in,0,0
8515,mean,0,0
8516,[,0,0
8517,95,0,0
8518,%,0,0
8519,confidence,0,0
8520,interval,0,0
8521,(,0,1
8522,CI,0,0
8523,),0,1
8524,],0,0
8525,scores,0,0
8526,for,0,0
8527,pain,0,0
8528,:,0,1
8529,11,0,0
8530,(,0,0
8531,7,0,0
8532,",",0,0
8533,16,0,0
8534,),0,0
8535,(,0,0
8536,P,0,0
8537,<,0,0
8538,0.001,0,0
8539,),0,0
8540,;,0,0
8541,physical,0,1
8542,health,0,0
8543,status,0,0
8544,:,0,1
8545,4,0,0
8546,(,0,0
8547,2,0,0
8548,",",0,0
8549,5,0,1
8550,),0,0
8551,(,0,0
8552,P,0,0
8553,<,0,0
8554,0.001,0,0
8555,),0,0
8556,;,0,0
8557,mental,0,0
8558,health,0,0
8559,status,0,0
8560,:,0,1
8561,2,0,0
8562,(,0,0
8563,0.1,0,0
8564,",",0,0
8565,4,0,0
8566,),0,0
8567,(,0,0
8568,P,0,0
8569,<,0,0
8570,0.02,0,0
8571,),0,0
8572,;,0,0
8573,and,0,0
8574,health,0,0
8575,utility,0,0
8576,:,0,1
8577,0.11,0,0
8578,(,0,0
8579,0.07,0,0
8580,",",0,0
8581,0.16,0,0
8582,),0,0
8583,(,0,0
8584,P,0,0
8585,<,0,0
8586,0.001,0,0
8587,),0,0
8588,by,0,0
8589,the,0,0
8590,end,0,0
8591,of,0,0
8592,the,0,0
8593,15-month,0,0
8594,period,0,0
8595,of,0,0
8596,the,0,0
8597,study,0,0
8598,",",0,0
8599,but,0,0
8600,there,0,0
8601,was,0,0
8602,no,0,0
8603,significant,0,0
8604,difference,0,0
8605,between,0,0
8606,either,0,1
8607,arm,0,0
8608,of,0,0
8609,the,0,0
8610,study,0,0
8611,.,0,0
8612,CONCLUSIONS,0,0
8613,Rationing,0,0
8614,by,0,0
8615,delay,0,0
8616,was,0,0
8617,not,0,0
8618,detrimental,0,0
8619,to,0,0
8620,either,0,1
8621,mental,0,0
8622,or,0,1
8623,physical,0,1
8624,health,0,0
8625,and,0,0
8626,patients,0,0
8627,in,0,0
8628,both,0,0
8629,arms,0,0
8630,of,0,0
8631,the,0,0
8632,study,0,0
8633,showed,0,0
8634,significant,0,0
8635,and,0,0
8636,similar,0,0
8637,improvement,0,0
8638,in,0,0
8639,health,0,0
8640,by,0,0
8641,15,0,0
8642,months,0,0
8643,.,0,0
8644,Expenditure,0,0
8645,of,0,0
8646,resources,0,0
8647,on,0,0
8648,waiting,0,0
8649,times,0,0
8650,without,0,0
8651,regard,0,0
8652,to,0,0
8653,clinical,0,0
8654,outcomes,0,0
8655,is,0,0
8656,likely,0,0
8657,to,0,0
8658,be,0,0
8659,wasteful,0,0
8660,and,0,0
8661,additional,0,0
8662,resources,0,0
8663,should,0,0
8664,be,0,0
8665,directed,0,0
8666,at,0,0
8667,achieving,0,0
8668,the,0,0
8669,greatest,0,0
8670,clinical,0,0
8671,benefit,0,0
8672,.,0,0
8673,More,0,0
8674,research,0,0
8675,into,0,0
8676,effective,0,0
8677,methods,0,0
8678,of,0,0
8679,controlling,0,0
8680,demand,0,0
8681,and,0,0
8682,better,0,0
8683,identification,0,0
8684,of,0,0
8685,those,0,0
8686,who,0,0
8687,would,0,0
8688,benefit,0,0
8689,from,0,0
8690,access,0,0
8691,to,0,0
8692,specialist,0,1
8693,care,0,1
8694,is,0,0
8695,needed,0,0
8696,.,0,0
8697,A,0,0
8698,laser-powered,1,1
8699,hydrokinetic,1,0
8700,system,1,0
8701,for,0,0
8702,caries,0,0
8703,removal,0,0
8704,and,0,0
8705,cavity,0,1
8706,preparation,0,1
8707,.,0,0
8708,BACKGROUND,0,0
8709,Laser,1,1
8710,systems,1,0
8711,have,0,0
8712,been,0,0
8713,developed,0,0
8714,for,0,0
8715,the,0,0
8716,cutting,0,1
8717,of,0,0
8718,dental,0,0
8719,hard,0,0
8720,tissues,0,0
8721,.,0,0
8722,The,0,0
8723,erbium,0,1
8724,",",0,0
8725,chromium,0,1
8726,:,0,0
8727,yttrium-scandium-gallium-garnet,0,1
8728,",",0,0
8729,or,0,1
8730,Er,1,1
8731,",",1,0
8732,Cr,1,0
8733,:,1,0
8734,YSGG,1,0
8735,",",1,0
8736,laser,1,1
8737,system,1,1
8738,used,0,0
8739,in,0,0
8740,conjunction,0,1
8741,with,0,0
8742,an,0,0
8743,air-water,0,1
8744,spray,0,1
8745,has,0,0
8746,been,0,0
8747,shown,0,0
8748,to,0,0
8749,be,0,0
8750,efficacious,0,0
8751,in,0,0
8752,vitro,0,0
8753,for,0,0
8754,cavity,0,1
8755,preparation,0,1
8756,.,0,0
8757,METHODS,0,0
8758,The,0,0
8759,authors,0,0
8760,randomly,0,0
8761,selected,0,0
8762,subjects,0,0
8763,for,0,0
8764,cavity,0,1
8765,preparation,0,1
8766,with,0,0
8767,conventional,1,1
8768,air,1,0
8769,turbine/bur,1,1
8770,dental,1,1
8771,surgery,1,1
8772,or,1,1
8773,an,1,0
8774,Er,1,1
8775,",",1,0
8776,Cr,1,0
8777,:,1,0
8778,YSGG,1,0
8779,laser-powered,1,1
8780,system,1,0
8781,using,0,0
8782,a,0,0
8783,split-mouth,0,1
8784,design,0,0
8785,.,0,0
8786,They,0,0
8787,prepared,0,1
8788,Class,0,0
8789,I,0,0
8790,",",0,0
8791,III,0,0
8792,and,0,0
8793,V,0,1
8794,cavities,0,1
8795,",",0,0
8796,placed,0,0
8797,resin,1,1
8798,restorations,1,1
8799,and,0,0
8800,evaluated,0,0
8801,subjects,0,0
8802,on,0,0
8803,the,0,0
8804,day,0,0
8805,of,0,0
8806,the,0,0
8807,procedure,0,0
8808,and,0,0
8809,30,0,1
8810,days,0,0
8811,and,0,0
8812,six,0,0
8813,months,0,0
8814,postoperatively,0,0
8815,for,0,0
8816,pulp,0,0
8817,vitality,0,0
8818,",",0,0
8819,recurrent,0,0
8820,caries,0,0
8821,",",0,0
8822,pain,0,0
8823,and,0,0
8824,discomfort,0,0
8825,",",0,0
8826,and,0,0
8827,restoration,0,0
8828,retention,0,0
8829,.,0,0
8830,Sixty-seven,0,0
8831,subjects,0,0
8832,completed,0,0
8833,the,0,0
8834,study,0,0
8835,.,0,0
8836,RESULTS,0,0
8837,There,0,0
8838,were,0,0
8839,no,0,0
8840,statistical,0,0
8841,differences,0,0
8842,between,0,0
8843,the,0,0
8844,two,0,0
8845,treatment,0,0
8846,groups,0,0
8847,for,0,0
8848,the,0,0
8849,parameters,0,0
8850,measured,0,0
8851,with,0,0
8852,one,0,0
8853,exception,0,0
8854,;,0,0
8855,there,0,0
8856,was,0,0
8857,a,0,0
8858,statistically,0,0
8859,significant,0,0
8860,decrease,0,0
8861,in,0,0
8862,discomfort,0,0
8863,levels,0,0
8864,for,0,0
8865,the,0,0
8866,laser,0,1
8867,system,0,0
8868,at,0,0
8869,the,0,0
8870,time,0,0
8871,of,0,0
8872,cavity,0,1
8873,preparation,0,1
8874,for,0,0
8875,subjects,0,0
8876,who,0,0
8877,declined,0,0
8878,to,0,0
8879,receive,0,0
8880,local,0,1
8881,anesthetic,0,1
8882,.,0,0
8883,CONCLUSIONS,0,0
8884,The,0,0
8885,Er,1,1
8886,",",1,0
8887,Cr,1,0
8888,:,1,0
8889,YSGG,1,0
8890,laser,1,1
8891,system,1,1
8892,is,0,0
8893,effective,0,0
8894,for,0,0
8895,preparation,0,1
8896,of,0,0
8897,Class,0,0
8898,I,0,0
8899,",",0,0
8900,III,0,0
8901,and,0,0
8902,V,0,1
8903,cavities,0,1
8904,and,0,0
8905,resin,0,1
8906,restorations,0,1
8907,are,0,0
8908,retained,0,0
8909,by,0,0
8910,lased,0,1
8911,tooth,0,0
8912,surfaces,0,1
8913,.,0,0
8914,CLINICAL,0,0
8915,IMPLICATIONS,0,1
8916,Hard-tissue,0,1
8917,cutting,0,1
8918,lasers,0,1
8919,are,0,0
8920,being,0,0
8921,introduced,0,0
8922,for,0,0
8923,use,0,0
8924,in,0,0
8925,operative,0,0
8926,dentistry,0,0
8927,.,0,0
8928,In,0,0
8929,this,0,0
8930,study,0,0
8931,",",0,0
8932,an,0,0
8933,Er,1,1
8934,",",1,0
8935,Cr,1,0
8936,:,1,0
8937,YSGG,1,0
8938,laser,1,1
8939,has,0,0
8940,been,0,0
8941,shown,0,0
8942,to,0,0
8943,be,0,0
8944,effective,0,0
8945,for,0,0
8946,cavity,0,1
8947,preparation,0,1
8948,and,0,0
8949,restoration,0,0
8950,replacement,0,1
8951,.,0,0
8952,The,0,0
8953,Finnish,0,0
8954,Diabetes,0,0
8955,Prevention,0,1
8956,Study,0,0
8957,.,0,0
8958,The,0,0
8959,aim,0,0
8960,of,0,0
8961,the,0,0
8962,Finnish,0,0
8963,Diabetes,0,0
8964,Prevention,0,1
8965,Study,0,0
8966,is,0,0
8967,to,0,0
8968,assess,0,0
8969,the,0,0
8970,efficacy,0,0
8971,of,0,0
8972,an,0,0
8973,intensive,1,1
8974,diet-exercise,1,0
8975,programme,1,1
8976,in,0,0
8977,preventing,0,0
8978,or,0,1
8979,delaying,0,0
8980,type,0,0
8981,2,0,0
8982,diabetes,0,0
8983,in,0,0
8984,individuals,0,0
8985,with,0,0
8986,impaired,0,0
8987,glucose,0,1
8988,tolerance,0,0
8989,(,0,1
8990,IGT,0,1
8991,),0,1
8992,and,0,0
8993,to,0,0
8994,evaluate,0,0
8995,the,0,0
8996,effect,0,0
8997,of,0,0
8998,the,0,0
8999,programme,0,1
9000,on,0,0
9001,the,0,0
9002,risk,0,0
9003,factors,0,0
9004,of,0,0
9005,atherosclerotic,0,0
9006,vascular,0,0
9007,diseases,0,0
9008,and,0,0
9009,the,0,0
9010,incidence,0,0
9011,of,0,0
9012,cardiovascular,0,0
9013,events,0,0
9014,.,0,0
9015,In,0,0
9016,this,0,0
9017,ongoing,0,0
9018,study,0,0
9019,",",0,0
9020,a,0,0
9021,total,0,0
9022,of,0,0
9023,523,0,0
9024,overweight,0,0
9025,subjects,0,0
9026,with,0,0
9027,IGT,0,0
9028,based,0,0
9029,on,0,0
9030,two,0,0
9031,oral,0,1
9032,glucose,0,0
9033,tolerance,0,0
9034,tests,0,0
9035,were,0,0
9036,randomized,0,0
9037,to,0,0
9038,either,0,0
9039,an,0,0
9040,intervention,0,1
9041,group,0,0
9042,or,0,1
9043,a,0,0
9044,control,0,1
9045,group,0,0
9046,.,0,0
9047,The,0,0
9048,main,0,0
9049,measure,0,0
9050,in,0,0
9051,the,0,0
9052,intervention,0,1
9053,group,0,0
9054,is,0,0
9055,individual,1,0
9056,dietary,1,0
9057,advice,1,1
9058,aimed,0,0
9059,at,0,0
9060,reducing,1,0
9061,weight,1,0
9062,and,1,0
9063,intake,1,0
9064,of,1,0
9065,saturated,1,1
9066,fat,1,0
9067,and,1,0
9068,increasing,1,0
9069,intake,1,0
9070,of,1,0
9071,dietary,1,1
9072,fibre,1,1
9073,.,1,0
9074,The,0,0
9075,intervention,0,1
9076,subjects,0,0
9077,are,0,0
9078,individually,0,0
9079,guided,0,1
9080,to,0,0
9081,increase,1,0
9082,their,1,0
9083,level,1,0
9084,of,1,0
9085,physical,1,1
9086,activity,1,0
9087,.,1,0
9088,The,0,0
9089,control,1,0
9090,group,1,0
9091,receives,1,0
9092,general,1,0
9093,information,1,0
9094,about,1,0
9095,the,1,0
9096,benefits,1,0
9097,of,1,0
9098,weight,1,0
9099,reduction,1,0
9100,",",1,0
9101,physical,1,1
9102,activity,1,0
9103,and,1,0
9104,healthy,1,0
9105,diet,1,1
9106,in,1,0
9107,the,1,0
9108,prevention,1,0
9109,of,1,0
9110,diabetes,1,0
9111,.,1,0
9112,A,0,0
9113,pilot,0,0
9114,study,0,0
9115,began,0,0
9116,in,0,0
9117,1993,0,0
9118,",",0,0
9119,and,0,0
9120,recruitment,0,0
9121,ended,0,0
9122,in,0,0
9123,1998,0,0
9124,.,0,0
9125,By,0,0
9126,the,0,0
9127,end,0,0
9128,of,0,0
9129,April,0,1
9130,1999,0,0
9131,there,0,0
9132,were,0,0
9133,65,0,0
9134,new,0,0
9135,cases,0,0
9136,of,0,0
9137,diabetes,0,0
9138,",",0,0
9139,34,0,0
9140,drop-outs,0,0
9141,and,0,0
9142,one,0,0
9143,death,0,0
9144,.,0,0
9145,The,0,0
9146,weight,0,0
9147,reduction,0,0
9148,was,0,0
9149,greater,0,0
9150,(,0,0
9151,-4.6,0,0
9152,kg,0,1
9153,),0,0
9154,at,0,0
9155,1,0,0
9156,year,0,0
9157,in,0,0
9158,the,0,0
9159,intervention,0,1
9160,group,0,0
9161,(,0,0
9162,n,0,0
9163,=,0,0
9164,152,0,0
9165,),0,0
9166,than,0,0
9167,in,0,0
9168,the,0,0
9169,control,0,1
9170,group,0,0
9171,(,0,1
9172,n,0,0
9173,=,0,0
9174,143,0,0
9175,",",0,0
9176,-0.9,0,0
9177,kg,0,1
9178,",",0,0
9179,P,0,0
9180,<,0,0
9181,0.0001,0,0
9182,),0,0
9183,",",0,0
9184,and,0,0
9185,this,0,0
9186,difference,0,0
9187,was,0,0
9188,sustained,0,0
9189,in,0,0
9190,the,0,0
9191,second,0,0
9192,year,0,0
9193,of,0,0
9194,follow-up,0,0
9195,.,0,0
9196,At,0,0
9197,1,0,0
9198,year,0,0
9199,43.4,0,0
9200,%,0,0
9201,and,0,0
9202,at,0,0
9203,2,0,0
9204,years,0,0
9205,41.8,0,0
9206,%,0,0
9207,of,0,0
9208,the,0,0
9209,intervention,0,1
9210,subjects,0,0
9211,had,0,0
9212,achieved,0,0
9213,a,0,0
9214,weight,0,0
9215,reduction,0,0
9216,of,0,0
9217,at,0,0
9218,least,0,0
9219,5,0,0
9220,kg,0,0
9221,",",0,0
9222,while,0,0
9223,the,0,0
9224,corresponding,0,0
9225,figures,0,0
9226,for,0,0
9227,the,0,0
9228,control,0,1
9229,subjects,0,0
9230,were,0,0
9231,14.0,0,0
9232,and,0,0
9233,12.0,0,0
9234,%,0,0
9235,(,0,0
9236,P,0,0
9237,<,0,0
9238,0.001,0,0
9239,between,0,0
9240,the,0,0
9241,groups,0,0
9242,),0,0
9243,.,0,0
9244,At,0,0
9245,1,0,0
9246,year,0,0
9247,the,0,0
9248,intervention,0,1
9249,group,0,0
9250,showed,0,0
9251,significantly,0,0
9252,greater,0,0
9253,reductions,0,0
9254,in,0,0
9255,2,0,0
9256,h,0,0
9257,glucose,0,0
9258,",",0,0
9259,fasting,0,0
9260,and,0,0
9261,2,0,1
9262,h,0,0
9263,insulin,0,1
9264,",",0,0
9265,systolic,0,0
9266,and,0,0
9267,diastolic,0,0
9268,blood,0,0
9269,pressure,0,0
9270,",",0,0
9271,and,0,0
9272,serum,0,0
9273,triglycerides,0,0
9274,.,0,0
9275,Most,0,0
9276,of,0,0
9277,the,0,0
9278,beneficial,0,0
9279,changes,0,0
9280,in,0,0
9281,cardiovascular,0,0
9282,risk,0,0
9283,factors,0,0
9284,were,0,0
9285,sustained,0,0
9286,for,0,0
9287,2,0,0
9288,years,0,0
9289,.,0,0
9290,These,0,0
9291,interim,0,0
9292,results,0,0
9293,of,0,0
9294,the,0,0
9295,ongoing,0,0
9296,Finnish,0,0
9297,Diabetes,0,0
9298,Prevention,0,1
9299,Study,0,0
9300,demonstrate,0,0
9301,the,0,0
9302,efficacy,0,0
9303,and,0,0
9304,feasibility,0,0
9305,of,0,0
9306,the,0,0
9307,lifestyle,0,1
9308,intervention,0,1
9309,programme,0,1
9310,.,0,0
9311,Is,0,0
9312,a,0,0
9313,calculated,0,0
9314,total,0,0
9315,hip,0,0
9316,BMD,0,0
9317,of,0,0
9318,clinical,0,0
9319,use,0,0
9320,?,0,0
9321,The,0,0
9322,diagnosis,0,0
9323,of,0,0
9324,osteoporosis,0,0
9325,is,0,0
9326,based,0,0
9327,on,0,0
9328,bone,0,0
9329,mass,0,0
9330,measurement,0,0
9331,.,0,0
9332,To,0,0
9333,avoid,0,0
9334,the,0,0
9335,errors,0,0
9336,associated,0,0
9337,with,0,0
9338,the,0,0
9339,measurement,0,0
9340,of,0,0
9341,spinal,0,0
9342,bone,0,0
9343,density,0,0
9344,the,0,0
9345,total,0,0
9346,hip,0,0
9347,has,0,0
9348,been,0,0
9349,accepted,0,0
9350,as,0,0
9351,the,0,0
9352,standard,0,1
9353,measurement,0,0
9354,site,0,0
9355,.,0,0
9356,This,0,0
9357,information,0,0
9358,is,0,0
9359,not,0,0
9360,available,0,0
9361,for,0,0
9362,many,0,0
9363,early,0,0
9364,measurements,0,0
9365,.,0,0
9366,We,0,0
9367,have,0,0
9368,assessed,0,0
9369,whether,0,0
9370,it,0,0
9371,is,0,0
9372,possible,0,0
9373,to,0,0
9374,derive,0,0
9375,clinically,0,0
9376,useful,0,0
9377,information,0,0
9378,about,0,0
9379,total,1,0
9380,hip,1,0
9381,bone,1,0
9382,mineral,1,1
9383,density,1,0
9384,(,0,1
9385,BMD,0,0
9386,),0,1
9387,from,0,0
9388,measurements,0,0
9389,at,0,0
9390,other,0,0
9391,hip,0,0
9392,sites,0,0
9393,.,0,0
9394,The,0,0
9395,bone,0,0
9396,mass,0,0
9397,measurements,0,0
9398,of,0,0
9399,46,0,0
9400,patients,0,0
9401,participating,0,0
9402,in,0,0
9403,a,0,0
9404,current,0,0
9405,trial,0,0
9406,of,0,0
9407,therapy,0,1
9408,for,0,0
9409,osteoporosis,0,0
9410,were,0,0
9411,reviewed,0,0
9412,.,0,0
9413,The,0,0
9414,total,0,0
9415,hip,0,0
9416,BMD,0,0
9417,as,0,0
9418,directly,0,0
9419,measured,0,0
9420,was,0,0
9421,compared,0,0
9422,with,0,0
9423,that,0,0
9424,obtained,0,0
9425,from,0,0
9426,the,0,0
9427,formula,0,1
9428,:,0,0
9429,Total,0,0
9430,hip,0,0
9431,BMD,0,0
9432,=,0,0
9433,0.48,0,0
9434,x,0,0
9435,Neck,0,0
9436,BMD,0,0
9437,+,0,1
9438,0.62,0,0
9439,x,0,0
9440,Trochanteric,0,1
9441,BMD,0,0
9442,+,0,1
9443,0.03,0,0
9444,.,0,0
9445,In,0,0
9446,30,0,0
9447,patients,0,0
9448,with,0,0
9449,follow-up,0,0
9450,data,0,0
9451,the,0,0
9452,rate,0,0
9453,of,0,0
9454,change,0,0
9455,in,0,0
9456,hip,0,0
9457,BMD,0,0
9458,over,0,0
9459,a,0,0
9460,year,0,0
9461,was,0,0
9462,also,0,0
9463,determined,0,0
9464,by,0,0
9465,both,0,0
9466,methods,0,0
9467,.,0,0
9468,In,0,0
9469,the,0,0
9470,pretreatment,0,0
9471,state,0,0
9472,there,0,0
9473,was,0,0
9474,good,0,0
9475,agreement,0,0
9476,between,0,0
9477,the,0,0
9478,two,0,0
9479,measures,0,0
9480,(,0,0
9481,r2,0,0
9482,=,0,0
9483,0.96,0,0
9484,",",0,0
9485,SEE,0,0
9486,0.012,0,0
9487,g/cm2,0,0
9488,),0,0
9489,.,0,0
9490,If,0,0
9491,the,0,0
9492,formula,0,1
9493,was,0,0
9494,used,0,0
9495,to,0,0
9496,compute,0,0
9497,a,0,0
9498,change,0,0
9499,in,0,0
9500,total,0,0
9501,hip,0,0
9502,BMD,0,0
9503,",",0,0
9504,the,0,0
9505,agreement,0,0
9506,between,0,0
9507,both,0,0
9508,methods,0,0
9509,remained,0,0
9510,good,0,0
9511,.,0,0
9512,However,0,0
9513,",",0,0
9514,the,0,0
9515,standard,0,1
9516,error,0,0
9517,of,0,0
9518,the,0,0
9519,estimate,0,0
9520,of,0,0
9521,the,0,0
9522,change,0,0
9523,represented,0,0
9524,59,0,0
9525,%,0,0
9526,of,0,0
9527,the,0,0
9528,observed,0,0
9529,change,0,0
9530,.,0,0
9531,This,0,0
9532,indicates,0,0
9533,that,0,0
9534,the,0,0
9535,error,0,0
9536,associated,0,0
9537,with,0,0
9538,this,0,0
9539,estimate,0,0
9540,is,0,0
9541,too,0,0
9542,great,0,0
9543,to,0,0
9544,allow,0,0
9545,clinically,0,0
9546,meaningful,0,0
9547,conclusions,0,0
9548,to,0,0
9549,be,0,0
9550,drawn,0,0
9551,from,0,0
9552,calculated,0,0
9553,total,0,0
9554,hip,0,0
9555,BMD,0,0
9556,.,0,0
9557,We,0,0
9558,conclude,0,0
9559,that,0,0
9560,",",0,0
9561,whilst,0,0
9562,it,0,0
9563,may,0,0
9564,be,0,0
9565,possible,0,0
9566,to,0,0
9567,obtain,0,0
9568,reasonable,0,0
9569,point,0,0
9570,estimates,0,0
9571,of,0,0
9572,total,0,0
9573,hip,0,0
9574,BMD,0,0
9575,from,0,0
9576,other,0,0
9577,measures,0,0
9578,in,0,0
9579,the,0,0
9580,hip,0,0
9581,",",0,0
9582,these,0,0
9583,estimates,0,0
9584,are,0,0
9585,too,0,0
9586,imprecise,0,0
9587,to,0,0
9588,allow,0,0
9589,conclusions,0,0
9590,about,0,0
9591,change,0,0
9592,in,0,0
9593,BMD,0,0
9594,to,0,0
9595,be,0,0
9596,made,0,0
9597,.,0,0
9598,On,0,0
9599,the,0,0
9600,search,0,0
9601,for,0,0
9602,the,0,0
9603,neurophysiological,0,0
9604,manifestation,0,0
9605,of,0,0
9606,recollective,0,0
9607,experience,0,0
9608,.,0,0
9609,M.E,0,0
9610,.,0,0
9611,Smith,0,0
9612,(,0,0
9613,1993,0,0
9614,),0,0
9615,obtained,0,0
9616,event-related,0,0
9617,brain,0,0
9618,potentials,0,1
9619,(,0,0
9620,ERPs,0,1
9621,),0,1
9622,from,0,0
9623,subjects,0,0
9624,performing,0,0
9625,a,0,0
9626,recognition,1,0
9627,memory,1,0
9628,task,1,1
9629,using,0,1
9630,remember,0,0
9631,(,0,1
9632,R,0,1
9633,),0,1
9634,and,0,0
9635,know,0,0
9636,(,0,1
9637,K,0,1
9638,),0,1
9639,judgments,0,0
9640,",",0,0
9641,and,0,0
9642,reported,0,0
9643,observing,0,0
9644,in,0,0
9645,the,0,0
9646,ERP,0,1
9647,a,0,0
9648,neurophysiological,0,0
9649,manifestation,0,0
9650,of,0,0
9651,recollective,0,0
9652,experience,0,0
9653,as,0,0
9654,a,0,0
9655,difference,0,0
9656,between,0,0
9657,the,0,0
9658,positive,0,0
9659,waveforms,0,0
9660,elicited,0,0
9661,by,0,0
9662,stimuli,0,1
9663,that,0,0
9664,yielded,0,0
9665,R,0,1
9666,and,0,0
9667,K,0,0
9668,judgments,0,0
9669,.,0,0
9670,We,0,0
9671,replicated,0,0
9672,his,0,0
9673,experiment,0,0
9674,and,0,0
9675,examined,0,0
9676,the,0,0
9677,componential,0,0
9678,structure,0,0
9679,of,0,0
9680,the,0,0
9681,R,0,1
9682,>,0,0
9683,K,0,1
9684,effect,0,0
9685,in,0,0
9686,two,0,0
9687,ways,0,0
9688,.,0,0
9689,First,0,0
9690,",",0,0
9691,we,0,0
9692,found,0,0
9693,that,0,0
9694,correction,0,0
9695,for,0,0
9696,P300,0,1
9697,latency,0,0
9698,jitter,0,0
9699,eliminated,0,0
9700,the,0,0
9701,effect,0,0
9702,reported,0,0
9703,by,0,0
9704,Smith,0,0
9705,.,0,0
9706,Second,0,0
9707,",",0,0
9708,the,0,0
9709,application,0,0
9710,of,0,0
9711,principal,0,0
9712,component,0,0
9713,analysis,0,0
9714,indicated,0,0
9715,that,0,0
9716,the,0,0
9717,positive,0,0
9718,waveform,0,1
9719,elicited,0,0
9720,by,0,0
9721,the,0,0
9722,words,0,1
9723,in,0,0
9724,the,0,0
9725,test,0,0
9726,list,0,0
9727,was,0,0
9728,a,0,0
9729,P300,0,1
9730,.,0,0
9731,These,0,0
9732,analyses,0,0
9733,do,0,0
9734,not,0,0
9735,support,0,0
9736,the,0,0
9737,hypothesis,0,0
9738,that,0,0
9739,there,0,0
9740,is,0,0
9741,a,0,0
9742,new,0,0
9743,component,0,0
9744,(,0,0
9745,the,0,0
9746,memory-evoked,0,0
9747,shift,0,0
9748,),0,0
9749,that,0,0
9750,is,0,0
9751,a,0,0
9752,specific,0,0
9753,manifestation,0,0
9754,of,0,0
9755,recollection,0,0
9756,.,0,0
9757,Depressive,0,1
9758,mood,0,0
9759,symptoms,0,0
9760,associated,0,0
9761,with,0,0
9762,ovarian,0,0
9763,suppression,0,0
9764,.,0,0
9765,OBJECTIVE,0,0
9766,To,0,0
9767,determine,0,0
9768,if,0,0
9769,sertraline,1,1
9770,is,0,0
9771,helpful,0,0
9772,in,0,0
9773,the,0,0
9774,management,0,1
9775,of,0,0
9776,depressive,0,0
9777,symptoms,0,0
9778,associated,0,0
9779,with,0,0
9780,ovarian,0,0
9781,suppression,0,0
9782,during,0,0
9783,GnRH,1,1
9784,agonist,1,1
9785,therapy,1,1
9786,as,0,0
9787,compared,0,0
9788,with,0,0
9789,a,0,0
9790,placebo-controlled,1,1
9791,group,0,0
9792,.,0,0
9793,DESIGN,0,0
9794,Double-blind,0,0
9795,placebo-controlled,1,1
9796,prospective,0,0
9797,study,0,0
9798,design,0,0
9799,.,0,0
9800,SETTING,0,0
9801,An,0,0
9802,obstetrics/gynecological,0,1
9803,office,0,1
9804,specializing,0,1
9805,in,0,0
9806,infertility,0,0
9807,in,0,0
9808,an,0,0
9809,academic,0,0
9810,environment,0,0
9811,.,0,1
9812,PATIENT,0,0
9813,(,0,0
9814,S,0,1
9815,),0,1
9816,Premenstrual,0,1
9817,women,0,0
9818,with,0,0
9819,laparoscopically,0,1
9820,diagnosed,0,0
9821,endometriosis,0,0
9822,who,0,0
9823,required,0,0
9824,GnRH,1,1
9825,agonist,1,1
9826,therapy,1,1
9827,for,0,0
9828,treatment,0,0
9829,and,0,0
9830,did,0,0
9831,not,0,0
9832,have,0,0
9833,significant,0,0
9834,depressive,0,0
9835,or,0,1
9836,premenstrual,0,0
9837,mood,0,0
9838,symptoms,0,0
9839,at,0,0
9840,baseline,0,0
9841,.,0,1
9842,INTERVENTION,0,0
9843,(,0,0
9844,S,0,1
9845,),0,1
9846,Participants,0,0
9847,were,0,0
9848,randomly,0,0
9849,assigned,0,0
9850,to,0,0
9851,either,0,0
9852,the,0,0
9853,sertraline,1,1
9854,treatment,1,1
9855,group,0,0
9856,or,0,1
9857,to,0,0
9858,the,0,0
9859,placebo,1,1
9860,group,0,0
9861,for,0,0
9862,the,0,0
9863,3-month,0,0
9864,duration,0,0
9865,of,0,0
9866,the,0,0
9867,GnRH,1,1
9868,agonist,1,1
9869,therapy,1,1
9870,.,1,0
9871,MAIN,0,0
9872,OUTCOME,0,0
9873,MEASURE,0,1
9874,(,0,1
9875,S,0,1
9876,),0,1
9877,The,0,0
9878,21-item,0,0
9879,Hamilton,0,0
9880,Rating,0,0
9881,Scale,0,0
9882,for,0,0
9883,Depression,0,0
9884,(,0,1
9885,HRSD,0,1
9886,),0,0
9887,",",0,0
9888,which,0,0
9889,is,0,0
9890,an,0,0
9891,instrument,0,0
9892,designed,0,0
9893,to,0,0
9894,assess,0,0
9895,depressive,0,0
9896,symptomatology,0,0
9897,.,0,1
9898,RESULT,0,0
9899,(,0,0
9900,S,0,1
9901,),0,1
9902,A,0,0
9903,Hotellings,0,1
9904,T,0,0
9905,(,0,1
9906,2,0,0
9907,),0,0
9908,test,0,0
9909,for,0,0
9910,repeated,0,0
9911,measure,0,0
9912,analysis,0,0
9913,indicated,0,0
9914,a,0,0
9915,statistically,0,0
9916,significant,0,0
9917,(,0,0
9918,P,0,0
9919,<,0,0
9920,.05,0,0
9921,),0,1
9922,between-group,0,0
9923,difference,0,0
9924,across,0,0
9925,time,0,0
9926,for,0,0
9927,the,0,0
9928,HRSD,0,1
9929,(,0,1
9930,T,0,0
9931,(,0,1
9932,2,0,0
9933,),0,0
9934,=,0,0
9935,13.3,0,0
9936,;,0,0
9937,F,0,0
9938,[,0,0
9939,3,0,0
9940,",",0,0
9941,28,0,0
9942,],0,0
9943,=,0,0
9944,4.1,0,0
9945,;,0,0
9946,P=.02,0,0
9947,),0,0
9948,with,0,0
9949,the,0,0
9950,sertraline,1,1
9951,treatment,0,1
9952,group,0,0
9953,manifesting,0,0
9954,significantly,0,0
9955,fewer,0,0
9956,depressive,0,0
9957,symptoms,0,0
9958,than,0,0
9959,the,0,0
9960,control,0,0
9961,group,0,0
9962,.,0,1
9963,CONCLUSION,0,0
9964,(,0,0
9965,S,0,1
9966,),0,1
9967,The,0,0
9968,results,0,0
9969,indicate,0,0
9970,that,0,0
9971,sertraline,1,1
9972,is,0,0
9973,an,0,0
9974,effective,0,0
9975,option,0,0
9976,in,0,0
9977,the,0,0
9978,management,0,1
9979,of,0,0
9980,depressive,0,0
9981,mood,0,0
9982,symptoms,0,0
9983,associated,0,0
9984,with,0,0
9985,ovarian,0,0
9986,suppression,0,0
9987,during,0,0
9988,GnRH,1,1
9989,agonist,1,1
9990,therapy,1,1
9991,.,1,0
9992,Update,0,0
9993,on,0,0
9994,tamoxifen,1,1
9995,to,0,0
9996,prevent,0,0
9997,breast,0,0
9998,cancer,0,0
9999,.,0,0
10000,The,0,0
10001,Italian,0,0
10002,Tamoxifen,1,1
10003,Prevention,0,1
10004,Study,0,0
10005,.,0,0
10006,Efficacy,0,0
10007,and,0,0
10008,safety,0,0
10009,of,0,0
10010,recombinant,1,1
10011,human,1,1
10012,nerve,1,1
10013,growth,1,0
10014,factor,1,0
10015,in,0,0
10016,patients,0,0
10017,with,0,0
10018,diabetic,0,0
10019,polyneuropathy,0,0
10020,:,0,0
10021,A,0,0
10022,randomized,0,0
10023,controlled,0,0
10024,trial,0,0
10025,.,0,0
10026,rhNGF,0,0
10027,Clinical,0,0
10028,Investigator,0,0
10029,Group,0,0
10030,.,0,0
10031,CONTEXT,0,0
10032,Nerve,0,1
10033,growth,0,0
10034,factor,0,1
10035,is,0,0
10036,a,0,0
10037,neurotrophic,0,0
10038,factor,0,0
10039,that,0,0
10040,promotes,0,0
10041,the,0,0
10042,survival,0,0
10043,of,0,0
10044,small,0,0
10045,fiber,0,1
10046,sensory,0,1
10047,neurons,0,0
10048,and,0,0
10049,sympathetic,0,0
10050,neurons,0,0
10051,in,0,0
10052,the,0,0
10053,peripheral,0,0
10054,nervous,0,0
10055,system,0,0
10056,.,0,0
10057,Recombinant,1,0
10058,human,1,1
10059,nerve,1,1
10060,growth,1,1
10061,factor,1,1
10062,(,1,1
10063,rhNGF,1,1
10064,),1,1
10065,has,0,0
10066,demonstrated,0,0
10067,efficacy,0,0
10068,as,0,0
10069,treatment,0,0
10070,for,0,0
10071,peripheral,0,0
10072,neuropathy,0,0
10073,in,0,0
10074,experimental,0,0
10075,models,0,0
10076,and,0,0
10077,phase,0,0
10078,2,0,0
10079,clinical,0,0
10080,trials,0,0
10081,.,0,0
10082,OBJECTIVE,0,0
10083,To,0,0
10084,evaluate,0,0
10085,the,0,0
10086,efficacy,0,0
10087,and,0,0
10088,safety,0,0
10089,of,0,0
10090,a,0,0
10091,12-month,0,0
10092,regimen,0,1
10093,of,0,0
10094,rhNGF,0,0
10095,in,0,0
10096,patients,0,0
10097,with,0,0
10098,diabetic,0,0
10099,polyneuropathy,0,0
10100,.,0,0
10101,DESIGN,0,0
10102,Randomized,0,0
10103,",",0,0
10104,double-blind,0,0
10105,",",0,0
10106,placebo-controlled,1,1
10107,phase,0,0
10108,3,0,0
10109,trial,0,0
10110,conducted,0,0
10111,from,0,0
10112,July,0,0
10113,1997,0,0
10114,through,0,0
10115,May,0,1
10116,1999,0,0
10117,.,0,0
10118,SETTING,0,0
10119,Eighty-four,0,0
10120,outpatient,0,0
10121,centers,0,0
10122,throughout,0,0
10123,the,0,0
10124,United,0,0
10125,States,0,0
10126,.,0,0
10127,PATIENTS,0,0
10128,A,0,0
10129,total,0,0
10130,of,0,0
10131,1019,0,0
10132,men,0,0
10133,and,0,0
10134,women,0,0
10135,aged,0,0
10136,18,0,0
10137,to,0,0
10138,74,0,0
10139,years,0,0
10140,with,0,0
10141,either,0,0
10142,type,0,0
10143,1,0,0
10144,or,0,0
10145,type,0,0
10146,2,0,0
10147,diabetes,0,0
10148,and,0,0
10149,a,0,0
10150,sensory,0,1
10151,polyneuropathy,0,0
10152,attributable,0,0
10153,to,0,0
10154,diabetes,0,0
10155,.,0,0
10156,INTERVENTIONS,0,0
10157,Patients,0,0
10158,were,0,0
10159,randomly,0,0
10160,assigned,0,0
10161,to,0,0
10162,receive,0,0
10163,either,0,1
10164,rhNGF,1,0
10165,",",0,0
10166,0.1,0,1
10167,microg/kg,0,1
10168,(,0,0
10169,n,0,0
10170,=,0,0
10171,504,0,0
10172,),0,0
10173,",",0,0
10174,or,0,1
10175,placebo,1,1
10176,(,0,1
10177,n,0,0
10178,=,0,0
10179,515,0,0
10180,),0,0
10181,by,0,0
10182,subcutaneous,0,1
10183,injection,0,1
10184,3,0,0
10185,times,0,0
10186,per,0,0
10187,week,0,0
10188,for,0,0
10189,48,0,0
10190,weeks,0,0
10191,.,0,0
10192,Patients,0,0
10193,were,0,0
10194,assessed,0,0
10195,at,0,0
10196,baseline,0,0
10197,",",0,0
10198,12,0,0
10199,weeks,0,0
10200,",",0,0
10201,24,0,0
10202,weeks,0,0
10203,",",0,0
10204,and,0,0
10205,48,0,0
10206,weeks,0,0
10207,.,0,0
10208,MAIN,0,0
10209,OUTCOME,0,0
10210,MEASURES,0,0
10211,The,0,0
10212,primary,0,0
10213,outcome,0,0
10214,measure,0,0
10215,was,0,0
10216,a,0,0
10217,change,0,0
10218,in,0,0
10219,neuropathy,0,0
10220,between,0,0
10221,baseline,0,0
10222,and,0,0
10223,week,0,0
10224,48,0,0
10225,",",0,0
10226,demonstrated,0,0
10227,by,0,0
10228,the,0,0
10229,Neuropathy,0,0
10230,Impairment,0,0
10231,Score,0,0
10232,for,0,0
10233,the,0,0
10234,Lower,0,1
10235,Limbs,0,0
10236,",",0,0
10237,compared,0,0
10238,between,0,0
10239,the,0,0
10240,2,0,0
10241,groups,0,0
10242,.,0,0
10243,Secondary,0,0
10244,outcome,0,0
10245,measures,0,0
10246,included,0,0
10247,quantitative,0,0
10248,sensory,0,1
10249,tests,0,0
10250,using,0,0
10251,the,0,0
10252,CASE,0,1
10253,IV,0,0
10254,System,0,1
10255,",",0,0
10256,the,0,0
10257,Neuropathy,0,0
10258,Symptom,0,1
10259,and,0,0
10260,Change,0,1
10261,questionnaire,0,0
10262,",",0,0
10263,the,0,0
10264,Patient,0,1
10265,Benefit,0,0
10266,Questionnaire,0,1
10267,(,0,1
10268,PBQ,0,1
10269,),0,1
10270,",",0,0
10271,and,0,0
10272,a,0,0
10273,global,0,0
10274,symptom,0,0
10275,assessment,0,0
10276,",",0,0
10277,as,0,0
10278,well,0,0
10279,as,0,0
10280,nerve,0,0
10281,conduction,0,0
10282,studies,0,0
10283,and,0,0
10284,occurrence,0,0
10285,of,0,0
10286,new,0,0
10287,plantar,0,0
10288,foot,0,0
10289,ulcers,0,0
10290,.,0,0
10291,Patients,0,0
10292,also,0,0
10293,were,0,0
10294,evaluated,0,0
10295,for,0,0
10296,presence,0,0
10297,of,0,0
10298,adverse,0,0
10299,events,0,0
10300,.,0,0
10301,RESULTS,0,0
10302,Among,0,0
10303,patients,0,0
10304,who,0,0
10305,received,0,0
10306,rhNGF,1,0
10307,",",0,0
10308,418,0,0
10309,(,0,0
10310,83,0,0
10311,%,0,0
10312,),0,0
10313,completed,0,0
10314,the,0,0
10315,regimen,0,1
10316,compared,0,0
10317,with,0,0
10318,461,0,0
10319,(,0,0
10320,90,0,1
10321,%,0,0
10322,),0,0
10323,who,0,0
10324,received,0,0
10325,placebo,1,1
10326,.,1,0
10327,Administration,0,0
10328,of,0,0
10329,rhNGF,1,0
10330,was,0,0
10331,safe,0,0
10332,",",0,0
10333,with,0,0
10334,few,0,0
10335,adverse,0,0
10336,events,0,0
10337,attributed,0,0
10338,to,0,0
10339,treatment,0,0
10340,apart,0,0
10341,from,0,0
10342,injection,0,1
10343,site,0,0
10344,pain/hyperalgesia,0,0
10345,and,0,0
10346,other,0,0
10347,pain,0,0
10348,syndromes,0,0
10349,.,0,0
10350,However,0,0
10351,",",0,0
10352,neither,0,0
10353,the,0,0
10354,primary,0,0
10355,end,0,0
10356,point,0,0
10357,(,0,0
10358,P,0,0
10359,=.25,0,0
10360,),0,1
10361,nor,0,0
10362,most,0,0
10363,of,0,0
10364,the,0,0
10365,secondary,0,0
10366,end,0,0
10367,points,0,0
10368,demonstrated,0,0
10369,a,0,0
10370,significant,0,0
10371,benefit,0,0
10372,of,0,0
10373,rhNGF,1,0
10374,.,1,0
10375,Exceptions,0,0
10376,were,0,0
10377,the,0,0
10378,global,0,0
10379,symptom,0,0
10380,assessment,0,0
10381,(,0,0
10382,P,0,0
10383,=.03,0,0
10384,),0,1
10385,and,0,0
10386,2,0,0
10387,of,0,0
10388,32,0,0
10389,comparisons,0,0
10390,within,0,0
10391,the,0,0
10392,PBQ,0,0
10393,",",0,0
10394,which,0,0
10395,showed,0,0
10396,a,0,0
10397,modest,0,0
10398,but,0,0
10399,significant,0,0
10400,benefit,0,0
10401,of,0,0
10402,rhNGF,1,1
10403,(,0,0
10404,P,0,0
10405,=.05,0,0
10406,for,0,0
10407,severity,0,0
10408,of,0,0
10409,pain,0,0
10410,in,0,0
10411,the,0,0
10412,legs,0,0
10413,and,0,0
10414,P,0,0
10415,=.003,0,0
10416,for,0,0
10417,6-month,0,0
10418,symptoms,0,0
10419,in,0,0
10420,the,0,0
10421,feet,0,0
10422,and,0,0
10423,legs,0,0
10424,),0,0
10425,.,0,0
10426,CONCLUSION,0,0
10427,Unlike,0,0
10428,previous,0,0
10429,phase,0,0
10430,2,0,0
10431,trials,0,0
10432,",",0,0
10433,this,0,0
10434,phase,0,0
10435,3,0,0
10436,clinical,0,0
10437,trial,0,0
10438,failed,0,0
10439,to,0,0
10440,demonstrate,0,0
10441,a,0,0
10442,significant,0,0
10443,beneficial,0,0
10444,effect,0,0
10445,of,0,0
10446,rhNGF,0,0
10447,on,0,0
10448,diabetic,0,0
10449,polyneuropathy,0,0
10450,.,0,0
10451,JAMA,0,1
10452,.,0,0
10453,2000,0,0
10454,;,0,0
10455,284:2215-2221,0,0
10456,.,0,0
10457,Commentary,0,0
10458,on,0,0
10459,cytoreduction,1,1
10460,nephrectomy,1,1
10461,in,0,0
10462,metastatic,0,0
10463,renal,0,0
10464,cancer,0,0
10465,:,0,0
10466,the,0,0
10467,results,0,0
10468,of,0,0
10469,Southwest,0,0
10470,Oncology,0,0
10471,Group,0,0
10472,Trial,0,0
10473,8949,0,0
10474,.,0,0
10475,Probiotics,1,1
10476,in,0,0
10477,the,0,0
10478,management,0,1
10479,of,0,0
10480,atopic,0,0
10481,eczema,0,0
10482,.,0,0
10483,BACKGROUND,0,0
10484,Over,0,0
10485,the,0,0
10486,last,0,0
10487,two,0,0
10488,decades,0,0
10489,the,0,0
10490,incidence,0,0
10491,of,0,0
10492,allergic,0,0
10493,diseases,0,0
10494,has,0,0
10495,increased,0,0
10496,in,0,0
10497,industrialized,0,0
10498,countries,0,0
10499,",",0,0
10500,and,0,0
10501,consequently,0,0
10502,new,0,0
10503,approaches,0,0
10504,have,0,0
10505,to,0,0
10506,be,0,0
10507,explored,0,0
10508,.,0,0
10509,OBJECTIVE,0,0
10510,The,0,0
10511,potential,0,0
10512,of,0,0
10513,probiotics,0,1
10514,to,0,0
10515,control,0,0
10516,allergic,0,0
10517,inflammation,0,0
10518,at,0,0
10519,an,0,0
10520,early,0,0
10521,age,0,0
10522,was,0,0
10523,assessed,0,0
10524,in,0,0
10525,a,0,0
10526,randomized,0,0
10527,double-blind,0,0
10528,placebo-controlled,0,1
10529,study,0,0
10530,.,0,0
10531,METHODS,0,0
10532,A,0,0
10533,total,0,0
10534,of,0,0
10535,27,0,0
10536,infants,0,0
10537,",",0,0
10538,mean,0,0
10539,age,0,0
10540,4.6,0,0
10541,months,0,0
10542,",",0,0
10543,who,0,0
10544,manifested,0,0
10545,atopic,0,0
10546,eczema,0,0
10547,during,0,0
10548,exclusive,0,1
10549,breast-feeding,0,0
10550,and,0,0
10551,who,0,0
10552,have,0,0
10553,had,0,0
10554,no,0,0
10555,exposure,0,0
10556,to,0,0
10557,any,0,0
10558,infant,0,0
10559,or,0,1
10560,substitute,0,0
10561,formula,0,1
10562,were,0,0
10563,weaned,0,0
10564,to,0,0
10565,probiotic-supplemented,1,1
10566,",",1,0
10567,Bifidobacterium,1,1
10568,lactis,1,1
10569,Bb-12,1,1
10570,or,1,0
10571,Lactobacillus,1,1
10572,strain,1,1
10573,GG,1,1
10574,(,1,0
10575,ATCC,1,0
10576,53103,1,1
10577,),1,0
10578,",",1,0
10579,extensively,1,0
10580,hydrolysed,1,0
10581,whey,1,1
10582,formulas,1,1
10583,or,1,0
10584,to,1,0
10585,the,1,0
10586,same,1,0
10587,formula,1,1
10588,without,1,0
10589,probiotics,1,1
10590,.,1,0
10591,The,0,0
10592,extent,0,0
10593,and,0,0
10594,severity,0,0
10595,of,0,0
10596,atopic,0,0
10597,eczema,0,0
10598,",",0,0
10599,the,0,0
10600,growth,0,0
10601,and,0,0
10602,nutrition,0,1
10603,of,0,0
10604,infants,0,0
10605,",",0,0
10606,and,0,0
10607,concentrations,0,0
10608,of,0,0
10609,circulating,0,0
10610,cytokines/chemokines,0,0
10611,and,0,0
10612,soluble,0,1
10613,cell,0,0
10614,surface,0,1
10615,adhesion,0,0
10616,molecules,0,0
10617,in,0,0
10618,serum,0,0
10619,and,0,0
10620,methyl-histamine,0,1
10621,and,0,0
10622,eosinophilic,0,0
10623,protein,0,1
10624,X,0,1
10625,in,0,0
10626,urine,0,0
10627,were,0,0
10628,determined,0,0
10629,.,0,0
10630,RESULTS,0,0
10631,The,0,0
10632,SCORAD,0,0
10633,score,0,0
10634,reflecting,0,0
10635,the,0,0
10636,extent,0,0
10637,and,0,0
10638,severity,0,0
10639,of,0,0
10640,atopic,0,0
10641,eczema,0,0
10642,was,0,0
10643,16,0,0
10644,(,0,0
10645,7-25,0,0
10646,),0,1
10647,during,0,0
10648,breast-feeding,0,0
10649,",",0,0
10650,median,0,0
10651,(,0,0
10652,interquartile,0,0
10653,range,0,0
10654,),0,0
10655,.,0,0
10656,After,0,0
10657,2,0,0
10658,months,0,0
10659,",",0,0
10660,a,0,0
10661,significant,0,0
10662,improvement,0,0
10663,in,0,0
10664,skin,0,0
10665,condition,0,0
10666,occurred,0,0
10667,in,0,0
10668,patients,0,0
10669,given,0,0
10670,probiotic-supplemented,0,1
10671,formulas,0,1
10672,",",0,0
10673,as,0,0
10674,compared,0,0
10675,to,0,0
10676,the,0,0
10677,unsupplemented,0,1
10678,group,0,0
10679,;,0,0
10680,chi,0,0
10681,(,0,0
10682,2,0,0
10683,),0,0
10684,=,0,0
10685,12.27,0,0
10686,",",0,0
10687,P,0,0
10688,=,0,0
10689,0.002,0,0
10690,.,0,0
10691,SCORAD,0,0
10692,decreased,0,0
10693,in,0,0
10694,the,0,0
10695,Bifidobacterium,0,0
10696,lactis,0,1
10697,Bb-12,0,1
10698,group,0,0
10699,to,0,0
10700,0,0,0
10701,(,0,0
10702,0-3.8,0,0
10703,),0,1
10704,",",0,0
10705,and,0,0
10706,in,0,0
10707,the,0,0
10708,Lactobacillus,0,1
10709,GG,0,1
10710,group,0,0
10711,to,0,0
10712,1,0,0
10713,(,0,0
10714,0.1-8.7,0,0
10715,),0,0
10716,",",0,0
10717,vs,0,0
10718,unsupplemented,0,1
10719,13.4,0,0
10720,(,0,0
10721,4.5-18.2,0,1
10722,),0,0
10723,",",0,0
10724,median,0,0
10725,(,0,0
10726,interquartile,0,0
10727,range,0,0
10728,),0,0
10729,",",0,0
10730,in,0,0
10731,parallel,0,0
10732,with,0,0
10733,a,0,0
10734,reduction,0,0
10735,in,0,0
10736,the,0,0
10737,concentration,0,0
10738,of,0,0
10739,soluble,0,1
10740,CD4,0,0
10741,in,0,0
10742,serum,0,0
10743,and,0,0
10744,eosinophilic,0,0
10745,protein,0,1
10746,X,0,1
10747,in,0,0
10748,urine,0,0
10749,.,0,0
10750,CONCLUSION,0,0
10751,The,0,0
10752,results,0,0
10753,provide,0,0
10754,the,0,0
10755,first,0,0
10756,clinical,0,0
10757,demonstration,0,0
10758,of,0,0
10759,specific,0,0
10760,probiotic,0,1
10761,strains,0,0
10762,modifying,0,0
10763,the,0,0
10764,changes,0,0
10765,related,0,0
10766,to,0,0
10767,allergic,0,0
10768,inflammation,0,0
10769,.,0,0
10770,The,0,0
10771,data,0,0
10772,further,0,0
10773,indicate,0,0
10774,that,0,0
10775,probiotics,0,1
10776,may,0,0
10777,counteract,0,0
10778,inflammatory,0,0
10779,responses,0,0
10780,beyond,0,0
10781,the,0,0
10782,intestinal,0,0
10783,milieu,0,1
10784,.,0,0
10785,The,0,0
10786,combined,0,0
10787,effects,0,0
10788,of,0,0
10789,these,0,0
10790,probiotic,0,1
10791,strains,0,0
10792,will,0,0
10793,guide,0,0
10794,infants,0,0
10795,through,0,0
10796,the,0,0
10797,weaning,0,0
10798,period,0,0
10799,",",0,0
10800,when,0,0
10801,sensitization,0,0
10802,to,0,0
10803,newly,0,0
10804,encountered,0,0
10805,antigens,0,0
10806,is,0,0
10807,initiated,0,0
10808,.,0,0
10809,The,0,0
10810,probiotic,0,1
10811,approach,0,1
10812,may,0,0
10813,thus,0,0
10814,offer,0,0
10815,a,0,0
10816,new,0,0
10817,direction,0,0
10818,in,0,0
10819,the,0,0
10820,search,0,0
10821,for,0,0
10822,future,0,0
10823,foods,0,1
10824,for,0,0
10825,allergy,0,0
10826,treatment,0,1
10827,and,0,0
10828,prevention,0,0
10829,strategies,0,0
10830,.,0,0
10831,Use,0,1
10832,of,0,0
10833,World,1,1
10834,Wide,1,1
10835,Web-based,1,1
10836,directories,1,0
10837,for,0,0
10838,tracing,0,0
10839,subjects,0,0
10840,in,0,0
10841,epidemiologic,0,0
10842,studies,0,0
10843,.,0,0
10844,The,0,0
10845,recent,0,0
10846,availability,0,0
10847,of,0,0
10848,World,0,1
10849,Wide,0,1
10850,Web-based,0,1
10851,directories,0,0
10852,has,0,0
10853,opened,0,0
10854,up,0,0
10855,a,0,0
10856,new,0,0
10857,approach,0,1
10858,for,0,0
10859,tracing,0,0
10860,subjects,0,0
10861,in,0,0
10862,epidemiologic,0,0
10863,studies,0,0
10864,.,0,0
10865,The,0,0
10866,completeness,0,0
10867,of,0,0
10868,two,0,0
10869,World,1,1
10870,Wide,1,1
10871,Web-based,1,1
10872,directories,1,0
10873,(,1,0
10874,Canada411,1,1
10875,and,1,0
10876,InfoSpace,1,1
10877,Canada,1,1
10878,),1,0
10879,for,0,0
10880,subject,0,0
10881,tracing,0,0
10882,was,0,0
10883,evaluated,0,0
10884,by,0,0
10885,using,0,0
10886,a,0,0
10887,randomized,0,0
10888,crossover,0,0
10889,design,0,0
10890,for,0,0
10891,346,0,0
10892,adults,0,0
10893,randomly,0,0
10894,selected,0,0
10895,from,0,0
10896,respondents,0,0
10897,in,0,0
10898,an,0,0
10899,ongoing,0,0
10900,cohort,0,0
10901,study,0,0
10902,.,0,0
10903,About,0,0
10904,half,0,0
10905,(,0,0
10906,56.4,0,0
10907,%,0,0
10908,),0,0
10909,of,0,0
10910,the,0,0
10911,subjects,0,0
10912,were,0,0
10913,successfully,0,0
10914,located,0,0
10915,by,0,0
10916,using,0,0
10917,either,0,1
10918,Canada411,1,1
10919,or,1,1
10920,InfoSpace,1,0
10921,.,1,0
10922,Of,0,0
10923,the,0,0
10924,43.6,0,0
10925,%,0,0
10926,of,0,0
10927,the,0,0
10928,subjects,0,0
10929,who,0,0
10930,could,0,0
10931,not,0,0
10932,be,0,0
10933,located,0,0
10934,using,0,0
10935,either,0,1
10936,directory,0,0
10937,",",0,0
10938,the,0,0
10939,majority,0,0
10940,(,0,0
10941,73.5,0,0
10942,%,0,0
10943,),0,0
10944,were,0,0
10945,female,0,0
10946,.,0,0
10947,Overall,0,0
10948,",",0,0
10949,there,0,0
10950,was,0,0
10951,no,0,0
10952,clear,0,1
10953,advantage,0,0
10954,of,0,0
10955,one,0,0
10956,directory,0,0
10957,over,0,0
10958,the,0,0
10959,other,0,0
10960,.,0,0
10961,Although,0,0
10962,Canada411,0,1
10963,could,0,0
10964,find,0,0
10965,significantly,0,0
10966,more,0,0
10967,subjects,0,0
10968,than,0,0
10969,InfoSpace,0,0
10970,",",0,0
10971,the,0,0
10972,number,0,0
10973,of,0,0
10974,potential,0,0
10975,matches,0,0
10976,returned,0,0
10977,by,0,0
10978,Canada411,0,1
10979,was,0,0
10980,also,0,0
10981,higher,0,0
10982,",",0,0
10983,which,0,0
10984,meant,0,0
10985,that,0,0
10986,a,0,0
10987,longer,0,0
10988,list,0,0
10989,of,0,0
10990,potential,0,0
10991,matches,0,0
10992,had,0,0
10993,to,0,0
10994,be,0,0
10995,examined,0,0
10996,before,0,0
10997,a,0,0
10998,true,0,0
10999,match,0,0
11000,could,0,0
11001,be,0,0
11002,found,0,0
11003,.,0,0
11004,One,0,0
11005,strategy,0,0
11006,to,0,0
11007,minimize,0,0
11008,the,0,0
11009,number,0,0
11010,of,0,0
11011,potential,0,0
11012,matches,0,0
11013,per,0,0
11014,true,0,0
11015,match,0,0
11016,is,0,0
11017,to,0,0
11018,first,0,0
11019,search,0,0
11020,by,0,0
11021,InfoSpace,0,0
11022,with,0,0
11023,the,0,0
11024,last,0,0
11025,name,0,0
11026,and,0,0
11027,first,0,0
11028,name,0,0
11029,",",0,0
11030,then,0,0
11031,by,0,0
11032,Canada411,0,1
11033,with,0,0
11034,the,0,0
11035,last,0,0
11036,name,0,0
11037,and,0,0
11038,first,0,0
11039,name,0,0
11040,",",0,0
11041,and,0,0
11042,finally,0,0
11043,by,0,0
11044,InfoSpace,0,0
11045,with,0,0
11046,the,0,0
11047,last,0,0
11048,name,0,0
11049,and,0,0
11050,first,0,0
11051,initial,0,0
11052,.,0,0
11053,Internet-based,0,0
11054,searches,0,0
11055,represent,0,0
11056,a,0,0
11057,potentially,0,0
11058,useful,0,0
11059,approach,0,1
11060,to,0,0
11061,tracing,0,0
11062,subjects,0,0
11063,in,0,0
11064,epidemiologic,0,0
11065,studies,0,0
11066,.,0,0
11067,Somatostatin,1,1
11068,and,1,0
11069,ranitidine,1,1
11070,in,0,0
11071,the,0,0
11072,treatment,0,0
11073,of,0,0
11074,non-variceal,0,0
11075,upper,0,0
11076,gastrointestinal,0,0
11077,bleeding,0,0
11078,:,0,0
11079,a,0,0
11080,prospective,0,0
11081,",",0,0
11082,randomized,0,0
11083,",",0,0
11084,double-blind,0,0
11085,",",0,0
11086,controlled,0,0
11087,study,0,0
11088,.,0,0
11089,BACKGROUND/AIMS,0,0
11090,The,0,0
11091,aim,0,0
11092,of,0,0
11093,this,0,0
11094,study,0,0
11095,was,0,0
11096,to,0,0
11097,compare,0,0
11098,the,0,0
11099,efficacy,0,0
11100,of,0,0
11101,somatostatin,1,1
11102,vs.,1,0
11103,ranitidine,1,1
11104,in,0,0
11105,controlling,0,0
11106,acute,0,0
11107,non-variceal,0,0
11108,gastrointestinal,0,0
11109,bleeding,0,0
11110,.,0,0
11111,METHODOLOGY,0,0
11112,A,0,0
11113,total,0,0
11114,of,0,0
11115,48,0,0
11116,patients,0,0
11117,with,0,0
11118,acute,0,0
11119,upper,0,0
11120,gastrointestinal,0,0
11121,bleeding,0,0
11122,due,0,0
11123,to,0,0
11124,duodenal,0,0
11125,or,0,1
11126,gastric,0,0
11127,ulcer,0,0
11128,were,0,0
11129,divided,0,0
11130,into,0,0
11131,2,0,0
11132,groups,0,0
11133,.,0,0
11134,Group,0,0
11135,I,0,0
11136,consisted,0,0
11137,of,0,0
11138,15,0,0
11139,patients,0,0
11140,with,0,0
11141,Forrest,0,0
11142,IB,0,1
11143,and,0,0
11144,Group,0,0
11145,II,0,1
11146,consisted,0,0
11147,of,0,0
11148,30,0,0
11149,patients,0,0
11150,with,0,0
11151,Forrest,0,0
11152,II,0,0
11153,.,0,0
11154,Two,0,0
11155,regimens,0,0
11156,were,0,0
11157,randomly,0,0
11158,allocated,0,0
11159,to,0,0
11160,all,0,0
11161,patients,0,0
11162,within,0,0
11163,half,0,0
11164,an,0,0
11165,hour,0,0
11166,after,0,0
11167,the,0,0
11168,endoscopic,0,1
11169,procedure,0,0
11170,:,0,0
11171,1,0,0
11172,),0,0
11173,somatostatin-UCB,1,1
11174,250,0,1
11175,mcg,0,1
11176,i.v,0,1
11177,.,0,0
11178,bolus,0,0
11179,followed,0,0
11180,by,0,0
11181,continuous,0,0
11182,i.v,0,1
11183,.,0,0
11184,infusion,0,0
11185,at,0,0
11186,a,0,0
11187,rate,0,0
11188,of,0,0
11189,6,0,0
11190,mg/d,0,0
11191,for,0,0
11192,72,0,0
11193,h,0,0
11194,",",0,0
11195,or,0,1
11196,2,0,0
11197,),0,0
11198,ranitidine,1,1
11199,300,0,1
11200,mg/d,0,1
11201,by,0,0
11202,continuous,0,0
11203,i.v,0,1
11204,.,0,0
11205,infusion,0,0
11206,for,0,0
11207,72,0,0
11208,h.,0,0
11209,RESULTS,0,0
11210,In,0,0
11211,Group,0,0
11212,I,0,0
11213,",",0,0
11214,although,0,0
11215,mean,0,0
11216,blood,0,0
11217,transfusion,0,1
11218,requirements,0,0
11219,(,0,0
11220,no,0,0
11221,.,0,0
11222,of,0,0
11223,units,0,0
11224,),0,0
11225,were,0,0
11226,lower,0,0
11227,in,0,0
11228,patients,0,0
11229,treated,0,0
11230,with,0,0
11231,somatostatin,1,1
11232,than,0,0
11233,in,0,0
11234,those,0,0
11235,treated,0,0
11236,with,0,0
11237,ranitidine,1,1
11238,",",0,0
11239,this,0,0
11240,was,0,0
11241,not,0,0
11242,statistically,0,0
11243,significant,0,0
11244,(,0,0
11245,mean,0,0
11246,+/-,0,0
11247,SD,0,0
11248,:,0,0
11249,2.56,0,0
11250,+/-,0,0
11251,3.05,0,0
11252,vs.,0,0
11253,5.17,0,0
11254,+/-,0,0
11255,4.96,0,0
11256,",",0,0
11257,respectively,0,0
11258,;,0,0
11259,P,0,0
11260,>,0,0
11261,0.05,0,0
11262,),0,0
11263,;,0,0
11264,the,0,0
11265,time,0,0
11266,of,0,0
11267,bleeding,0,0
11268,stop,0,0
11269,was,0,0
11270,shorter,0,0
11271,in,0,0
11272,the,0,0
11273,somatostatin,1,1
11274,group,0,0
11275,than,0,0
11276,in,0,0
11277,the,0,0
11278,ranitidine,0,1
11279,group,0,0
11280,(,0,0
11281,mean,0,0
11282,+/-,0,0
11283,SD,0,0
11284,:,0,0
11285,3.24,0,0
11286,+/-,0,0
11287,2.45,0,0
11288,vs.,0,0
11289,11.25,0,0
11290,+/-,0,0
11291,11.63,0,0
11292,",",0,0
11293,respectively,0,0
11294,;,0,0
11295,P,0,0
11296,=,0,0
11297,0.0383,0,0
11298,),0,0
11299,.,0,0
11300,The,0,0
11301,rebleeding,0,0
11302,and,0,0
11303,the,0,0
11304,mortality,0,0
11305,rates,0,0
11306,did,0,0
11307,not,0,0
11308,differ,0,0
11309,between,0,0
11310,the,0,0
11311,treatment,0,0
11312,groups,0,0
11313,in,0,0
11314,both,0,0
11315,Group,0,0
11316,I,0,0
11317,and,0,0
11318,Group,0,0
11319,II,0,0
11320,.,0,0
11321,CONCLUSIONS,0,0
11322,Somatostatin,1,1
11323,is,0,0
11324,more,0,0
11325,effective,0,0
11326,than,0,0
11327,ranitidine,0,1
11328,in,0,0
11329,controlling,0,0
11330,acute,0,0
11331,non-variceal,0,0
11332,gastrointestinal,0,0
11333,bleeding,0,0
11334,in,0,0
11335,patients,0,0
11336,with,0,0
11337,Forrest,0,0
11338,IB,0,1
11339,bleeding,0,0
11340,activity,0,0
11341,.,0,0
11342,Somatostatin,1,1
11343,has,0,0
11344,no,0,0
11345,additional,0,0
11346,benefit,0,0
11347,in,0,0
11348,those,0,0
11349,with,0,0
11350,Forrest,0,0
11351,II,0,1
11352,bleeding,0,0
11353,activity,0,0
11354,.,0,0
11355,Do,0,0
11356,heavier,0,0
11357,women,0,0
11358,benefit,0,0
11359,from,0,0
11360,a,0,0
11361,higher,0,0
11362,dose,0,0
11363,of,0,0
11364,leuprolide,1,1
11365,acetate,1,1
11366,for,0,0
11367,suppression,0,0
11368,of,0,0
11369,serum,0,0
11370,estradiol,0,1
11371,?,0,0
11372,OBJECTIVE,0,0
11373,To,0,0
11374,determine,0,0
11375,if,0,0
11376,heavier,0,0
11377,women,0,0
11378,benefit,0,0
11379,from,0,0
11380,a,0,0
11381,higher,0,0
11382,dose,0,0
11383,of,0,0
11384,the,0,0
11385,gonadotropin-releasing,1,1
11386,hormone,1,1
11387,analogue,1,1
11388,leuprolide,1,1
11389,acetate,1,1
11390,(,1,1
11391,LA,1,1
11392,),1,1
11393,depot,0,1
11394,in,0,0
11395,terms,0,0
11396,of,0,0
11397,suppression,0,0
11398,of,0,0
11399,serum,0,0
11400,estradiol,0,1
11401,.,0,0
11402,METHODS,0,0
11403,This,0,0
11404,was,0,0
11405,a,0,0
11406,retrospective,0,0
11407,analysis,0,0
11408,of,0,0
11409,the,0,0
11410,effect,0,0
11411,of,0,0
11412,LA,1,1
11413,depot,1,1
11414,3.75,0,0
11415,mg,0,1
11416,and,0,0
11417,7.5,0,1
11418,mg,0,1
11419,on,0,0
11420,serum,1,0
11421,estradiol,1,1
11422,from,0,0
11423,a,0,0
11424,multicenter,0,0
11425,",",0,0
11426,double-blind,0,0
11427,",",0,0
11428,parallel-group,0,0
11429,",",0,0
11430,12-week,0,0
11431,study,0,0
11432,of,0,0
11433,women,0,0
11434,with,0,0
11435,anemia,0,0
11436,due,0,0
11437,to,0,0
11438,bleeding,0,0
11439,from,0,0
11440,uterine,0,0
11441,leiomyomata,0,0
11442,.,0,0
11443,Serum,0,0
11444,estradiol,0,1
11445,levels,0,0
11446,were,0,0
11447,obtained,0,0
11448,at,0,0
11449,baseline,0,0
11450,and,0,0
11451,at,0,0
11452,week,0,0
11453,12,0,0
11454,.,0,0
11455,Patients,0,0
11456,were,0,0
11457,divided,0,0
11458,into,0,0
11459,weight,0,0
11460,quartiles,0,0
11461,according,0,0
11462,to,0,0
11463,their,0,0
11464,baseline,0,0
11465,weight,0,0
11466,in,0,0
11467,kilograms,0,0
11468,:,0,0
11469,46-,0,0
11470,<,0,0
11471,64,0,0
11472,",",0,0
11473,64-,0,0
11474,<,0,0
11475,72,0,0
11476,",",0,0
11477,72-,0,0
11478,<,0,0
11479,89,0,0
11480,",",0,0
11481,89-159,0,0
11482,(,0,0
11483,pounds-102-,0,0
11484,<,0,0
11485,140,0,0
11486,",",0,0
11487,140-,0,0
11488,<,0,0
11489,159,0,0
11490,",",0,0
11491,159-,0,0
11492,<,0,0
11493,196,0,0
11494,",",0,0
11495,196-350,0,0
11496,),0,0
11497,.,0,0
11498,RESULTS,0,0
11499,At,0,0
11500,baseline,0,0
11501,there,0,0
11502,was,0,0
11503,no,0,0
11504,statistically,0,0
11505,significant,0,0
11506,difference,0,0
11507,in,0,0
11508,estradiol,0,1
11509,level,0,0
11510,between,0,0
11511,groups,0,0
11512,as,0,0
11513,a,0,0
11514,whole,0,0
11515,or,0,1
11516,within,0,0
11517,weight,0,0
11518,quartiles,0,0
11519,.,0,0
11520,Within,0,0
11521,each,0,0
11522,group,0,0
11523,there,0,0
11524,was,0,0
11525,no,0,0
11526,relationship,0,0
11527,between,0,0
11528,weight,0,0
11529,and,0,0
11530,baseline,0,0
11531,estradiol,0,1
11532,.,0,0
11533,At,0,0
11534,week,0,0
11535,12,0,0
11536,",",0,0
11537,whereas,0,0
11538,estradiol,0,1
11539,levels,0,0
11540,were,0,0
11541,significantly,0,0
11542,greater,0,0
11543,in,0,0
11544,the,0,0
11545,heavier,0,0
11546,patients,0,0
11547,in,0,0
11548,each,0,0
11549,of,0,0
11550,the,0,0
11551,groups,0,0
11552,(,0,0
11553,LA,0,1
11554,3.75,0,0
11555,mg,0,1
11556,",",0,0
11557,p,0,0
11558,=,0,0
11559,0.044,0,0
11560,;,0,0
11561,LA,0,1
11562,7.5,0,1
11563,mg,0,1
11564,",",0,0
11565,p,0,0
11566,=,0,0
11567,0.002,0,0
11568,),0,0
11569,",",0,0
11570,there,0,0
11571,was,0,0
11572,no,0,0
11573,significant,0,0
11574,difference,0,0
11575,in,0,0
11576,estradiol,0,1
11577,between,0,0
11578,groups,0,0
11579,as,0,0
11580,a,0,0
11581,whole,0,0
11582,or,0,1
11583,within,0,0
11584,any,0,0
11585,of,0,0
11586,the,0,0
11587,weight,0,0
11588,quartiles,0,0
11589,.,0,0
11590,Moreover,0,0
11591,",",0,0
11592,at,0,0
11593,week,0,0
11594,12,0,0
11595,there,0,0
11596,was,0,0
11597,no,0,0
11598,significant,0,0
11599,difference,0,0
11600,between,0,0
11601,groups,0,0
11602,in,0,0
11603,the,0,0
11604,percentage,0,0
11605,of,0,0
11606,patients,0,0
11607,with,0,0
11608,estradiol,0,1
11609,suppressed,0,0
11610,to,0,0
11611,the,0,0
11612,menopausal,0,0
11613,range,0,0
11614,.,0,0
11615,CONCLUSION,0,0
11616,Heavier,0,0
11617,women,0,0
11618,do,0,0
11619,not,0,0
11620,benefit,0,0
11621,from,0,0
11622,a,0,0
11623,higher,0,0
11624,dose,0,0
11625,of,0,0
11626,LA,1,1
11627,depot,0,1
11628,(,0,0
11629,7.5,0,1
11630,vs.,0,0
11631,3.75,0,0
11632,mg,0,1
11633,),0,0
11634,for,0,0
11635,suppression,0,0
11636,of,0,0
11637,serum,0,0
11638,levels,0,0
11639,of,0,0
11640,estradiol,0,1
11641,.,0,0
11642,Sertraline,1,1
11643,treatment,0,0
11644,of,0,0
11645,generalized,0,0
11646,social,0,0
11647,phobia,0,0
11648,:,0,0
11649,a,0,0
11650,20-week,0,0
11651,",",0,0
11652,double-blind,0,0
11653,",",0,0
11654,placebo-controlled,0,1
11655,study,0,0
11656,.,0,0
11657,OBJECTIVE,0,0
11658,The,0,0
11659,authors,0,0
11660,evaluated,0,0
11661,the,0,0
11662,efficacy,0,0
11663,",",0,0
11664,safety,0,0
11665,",",0,0
11666,and,0,0
11667,tolerability,0,0
11668,of,0,0
11669,sertraline,1,1
11670,",",0,0
11671,a,0,0
11672,selective,0,0
11673,serotonin,0,1
11674,reuptake,0,1
11675,inhibitor,0,1
11676,",",0,0
11677,in,0,0
11678,the,0,0
11679,treatment,0,0
11680,of,0,0
11681,generalized,0,0
11682,social,0,0
11683,phobia,0,0
11684,.,0,0
11685,METHOD,0,0
11686,Adult,0,0
11687,outpatients,0,0
11688,with,0,0
11689,generalized,0,0
11690,social,0,1
11691,phobia,0,0
11692,(,0,1
11693,N=204,0,1
11694,),0,1
11695,from,0,0
11696,10,0,0
11697,Canadian,0,0
11698,centers,0,0
11699,were,0,0
11700,randomly,0,0
11701,assigned,0,0
11702,to,0,0
11703,receive,0,1
11704,sertraline,1,1
11705,or,1,1
11706,placebo,1,1
11707,in,0,0
11708,a,0,0
11709,2:1,0,0
11710,ratio,0,0
11711,for,0,0
11712,a,0,0
11713,20-week,0,1
11714,double-blind,0,0
11715,study,0,0
11716,following,0,0
11717,a,0,0
11718,1-week,0,0
11719,",",0,0
11720,single-blind,0,0
11721,",",0,0
11722,placebo,0,1
11723,run-in,0,0
11724,.,0,0
11725,The,0,0
11726,initial,0,0
11727,dose,0,0
11728,of,0,0
11729,sertraline,1,1
11730,was,0,0
11731,50,0,0
11732,mg/day,0,1
11733,with,0,0
11734,increases,0,0
11735,of,0,0
11736,50,0,0
11737,mg/day,0,1
11738,every,0,0
11739,3,0,0
11740,weeks,0,0
11741,permitted,0,0
11742,after,0,0
11743,the,0,0
11744,fourth,0,0
11745,week,0,0
11746,of,0,0
11747,treatment,0,1
11748,(,0,0
11749,dosing,0,0
11750,was,0,0
11751,flexible,0,1
11752,up,0,0
11753,to,0,0
11754,a,0,0
11755,maximum,0,0
11756,of,0,0
11757,200,0,1
11758,mg/day,0,1
11759,),0,0
11760,.,0,0
11761,Primary,0,0
11762,efficacy,0,0
11763,assessments,0,0
11764,were,0,0
11765,the,0,0
11766,percentage,0,0
11767,of,0,0
11768,patients,0,0
11769,rated,0,0
11770,much,0,0
11771,or,0,1
11772,very,0,0
11773,much,0,0
11774,improved,0,0
11775,on,0,0
11776,the,0,0
11777,Clinical,0,0
11778,Global,0,0
11779,Impression,0,0
11780,(,0,1
11781,CGI,0,0
11782,),0,1
11783,improvement,0,0
11784,item,0,1
11785,and,0,0
11786,the,0,0
11787,mean,0,0
11788,changes,0,0
11789,from,0,0
11790,baseline,0,0
11791,to,0,0
11792,study,0,0
11793,endpoint,0,0
11794,in,0,0
11795,total,0,0
11796,score,0,0
11797,on,0,0
11798,the,0,0
11799,social,0,0
11800,phobia,0,0
11801,subscale,0,0
11802,of,0,0
11803,the,0,0
11804,Marks,0,1
11805,Fear,0,1
11806,Questionnaire,0,1
11807,and,0,0
11808,total,0,0
11809,score,0,0
11810,on,0,0
11811,the,0,0
11812,Brief,0,1
11813,Social,0,0
11814,Phobia,0,0
11815,Scale,0,0
11816,.,0,0
11817,RESULTS,0,0
11818,In,0,0
11819,intent-to-treat,0,0
11820,endpoint,0,0
11821,analyses,0,0
11822,of,0,0
11823,203,0,0
11824,of,0,0
11825,the,0,0
11826,patients,0,0
11827,",",0,0
11828,significantly,0,0
11829,more,0,0
11830,of,0,0
11831,the,0,0
11832,134,0,0
11833,patients,0,0
11834,given,0,0
11835,sertraline,1,1
11836,(,0,0
11837,N=71,0,1
11838,[,0,1
11839,53,0,0
11840,%,0,0
11841,],0,0
11842,),0,0
11843,than,0,0
11844,of,0,0
11845,the,0,0
11846,69,0,0
11847,patients,0,0
11848,receiving,0,0
11849,placebo,1,1
11850,(,0,1
11851,N=20,0,1
11852,[,0,1
11853,29,0,0
11854,%,0,0
11855,],0,0
11856,),0,0
11857,were,0,0
11858,considered,0,0
11859,responders,0,0
11860,according,0,0
11861,to,0,0
11862,their,0,0
11863,CGI,0,0
11864,improvement,0,0
11865,scores,0,0
11866,at,0,0
11867,the,0,0
11868,end,0,0
11869,of,0,0
11870,treatment,0,0
11871,.,0,0
11872,The,0,0
11873,mean,0,0
11874,reductions,0,0
11875,in,0,0
11876,the,0,0
11877,social,0,0
11878,phobia,0,0
11879,subscale,0,0
11880,of,0,0
11881,the,0,0
11882,Marks,0,1
11883,Fear,0,1
11884,Questionnaire,0,1
11885,and,0,0
11886,in,0,0
11887,the,0,0
11888,total,0,0
11889,score,0,0
11890,on,0,0
11891,the,0,0
11892,Brief,0,1
11893,Social,0,0
11894,Phobia,0,0
11895,Scale,0,0
11896,were,0,0
11897,32.6,0,0
11898,%,0,0
11899,and,0,0
11900,34.3,0,0
11901,%,0,0
11902,in,0,0
11903,the,0,0
11904,sertraline,1,1
11905,group,0,0
11906,and,0,0
11907,10.8,0,0
11908,%,0,0
11909,and,0,0
11910,18.6,0,0
11911,%,0,0
11912,in,0,0
11913,the,0,0
11914,placebo,1,1
11915,group,0,0
11916,",",0,0
11917,respectively,0,0
11918,.,0,0
11919,Analysis,0,0
11920,of,0,0
11921,covariance,0,0
11922,showed,0,0
11923,superiority,0,0
11924,of,0,0
11925,sertraline,1,1
11926,over,0,0
11927,placebo,1,1
11928,on,0,0
11929,all,0,0
11930,primary,0,0
11931,and,0,0
11932,secondary,0,0
11933,efficacy,0,0
11934,measures,0,0
11935,.,0,0
11936,Sertraline,1,1
11937,was,0,0
11938,well,0,0
11939,tolerated,0,0
11940,:,0,0
11941,103,0,0
11942,(,0,0
11943,76,0,0
11944,%,0,0
11945,),0,0
11946,of,0,0
11947,the,0,0
11948,135,0,0
11949,sertraline-treated,1,0
11950,patients,0,0
11951,and,0,0
11952,54,0,0
11953,(,0,0
11954,78,0,0
11955,%,0,0
11956,),0,0
11957,of,0,0
11958,the,0,0
11959,69,0,0
11960,placebo-treated,1,0
11961,patients,0,0
11962,completed,0,0
11963,the,0,0
11964,study,0,0
11965,.,0,0
11966,CONCLUSIONS,0,0
11967,Sertraline,1,1
11968,is,0,0
11969,an,0,0
11970,effective,0,0
11971,treatment,0,0
11972,for,0,0
11973,patients,0,0
11974,with,0,0
11975,generalized,0,0
11976,social,0,0
11977,phobia,0,0
11978,.,0,0
11979,Counselor,0,1
11980,and,0,0
11981,stimulus,0,1
11982,control,0,1
11983,enhancements,0,0
11984,of,0,0
11985,a,0,0
11986,stage-matched,1,1
11987,expert,1,0
11988,system,1,1
11989,intervention,1,1
11990,for,0,0
11991,smokers,0,0
11992,in,0,0
11993,a,0,0
11994,managed,0,0
11995,care,0,0
11996,setting,0,0
11997,.,0,0
11998,BACKGROUND,0,0
11999,Previous,0,0
12000,research,0,0
12001,has,0,0
12002,demonstrated,0,0
12003,the,0,0
12004,efficacy,0,0
12005,of,0,0
12006,an,0,0
12007,interactive,1,1
12008,expert,1,0
12009,system,1,1
12010,intervention,1,1
12011,for,0,0
12012,smoking,0,0
12013,cessation,0,1
12014,for,0,0
12015,a,0,0
12016,general,0,0
12017,population,0,0
12018,.,0,0
12019,The,0,0
12020,intervention,0,1
12021,provides,0,0
12022,individualized,0,0
12023,feedback,0,1
12024,that,0,0
12025,guides,0,1
12026,participants,0,0
12027,through,0,0
12028,the,0,0
12029,stages,0,0
12030,of,0,0
12031,change,0,0
12032,for,0,0
12033,cessation,0,1
12034,.,0,0
12035,Enhancing,0,0
12036,the,0,0
12037,expert,0,0
12038,system,0,0
12039,by,0,0
12040,adding,0,1
12041,proactive,0,1
12042,telephone,0,1
12043,counseling,0,1
12044,or,0,1
12045,a,0,0
12046,stimulus,0,1
12047,control,0,1
12048,computer,0,1
12049,designed,0,0
12050,to,0,0
12051,produce,0,0
12052,nicotine,0,1
12053,fading,0,0
12054,could,0,0
12055,produce,0,0
12056,preventive,0,0
12057,programs,0,0
12058,with,0,0
12059,greater,0,0
12060,population,0,0
12061,impacts,0,0
12062,.,0,0
12063,METHODS,0,0
12064,Four,0,0
12065,interventions,0,0
12066,were,0,0
12067,compared,0,0
12068,:,0,0
12069,(,0,0
12070,a,0,0
12071,),0,0
12072,the,1,0
12073,interactive,1,1
12074,expert,1,0
12075,system,1,1
12076,intervention,1,1
12077,;,1,0
12078,(,0,1
12079,b,0,0
12080,),0,1
12081,the,0,0
12082,expert,1,1
12083,system,1,1
12084,intervention,1,1
12085,plus,1,1
12086,counselor,1,1
12087,calls,1,1
12088,;,1,0
12089,(,0,0
12090,c,0,0
12091,),0,1
12092,the,1,0
12093,expert,1,1
12094,system,1,1
12095,intervention,1,1
12096,plus,1,1
12097,the,1,0
12098,stimulus,1,1
12099,control,1,1
12100,computer,1,1
12101,;,1,1
12102,and,0,0
12103,(,0,1
12104,d,0,1
12105,),0,1
12106,an,0,0
12107,assessment,1,0
12108,only,1,0
12109,condition,1,0
12110,.,1,0
12111,A,0,0
12112,4,0,0
12113,(,0,0
12114,intervention,0,1
12115,),0,1
12116,x,0,0
12117,4,0,0
12118,(,0,0
12119,occasions,0,0
12120,),0,1
12121,(,0,0
12122,"0,6,12",0,1
12123,",",0,0
12124,and,0,0
12125,18,0,0
12126,months,0,0
12127,),0,0
12128,design,0,0
12129,was,0,0
12130,used,0,0
12131,.,0,0
12132,Smokers,0,0
12133,were,0,0
12134,contacted,0,0
12135,at,0,0
12136,home,0,1
12137,via,0,1
12138,telephone,0,1
12139,or,0,1
12140,mail,0,1
12141,.,0,0
12142,The,0,0
12143,initial,0,0
12144,subject,0,0
12145,pool,0,0
12146,was,0,0
12147,the,0,0
12148,"24,178",0,0
12149,members,0,0
12150,of,0,0
12151,a,0,0
12152,managed,0,0
12153,care,0,1
12154,company,0,0
12155,.,0,0
12156,Screening,0,0
12157,was,0,0
12158,completed,0,0
12159,for,0,0
12160,"19,236",0,1
12161,members,0,0
12162,(,0,0
12163,79.6,0,0
12164,%,0,0
12165,),0,0
12166,",",0,0
12167,of,0,0
12168,whom,0,0
12169,"4,653",0,0
12170,were,0,0
12171,smokers,0,0
12172,;,0,0
12173,85.3,0,0
12174,%,0,0
12175,of,0,0
12176,the,0,0
12177,smokers,0,0
12178,were,0,0
12179,enrolled,0,0
12180,.,0,0
12181,RESULTS,0,0
12182,Thirty-eight,0,0
12183,percent,0,0
12184,were,0,0
12185,in,0,0
12186,the,0,0
12187,precontemplation,0,1
12188,stage,0,0
12189,",",0,0
12190,45,0,0
12191,%,0,0
12192,in,0,0
12193,the,0,0
12194,contemplation,0,0
12195,stage,0,0
12196,",",0,0
12197,and,0,0
12198,only,0,0
12199,17,0,0
12200,%,0,0
12201,in,0,0
12202,the,0,0
12203,preparation,0,1
12204,stage,0,0
12205,.,0,0
12206,At,0,0
12207,18,0,0
12208,months,0,0
12209,",",0,0
12210,the,0,0
12211,expert,0,0
12212,system,0,0
12213,resulted,0,0
12214,in,0,0
12215,23.2,0,0
12216,%,0,0
12217,point,0,0
12218,prevalence,0,0
12219,abstinence,0,0
12220,",",0,0
12221,which,0,0
12222,was,0,0
12223,33,0,0
12224,%,0,0
12225,greater,0,0
12226,than,0,0
12227,that,0,0
12228,of,0,0
12229,assessment,0,0
12230,only,0,0
12231,.,0,0
12232,The,0,0
12233,counselor,0,1
12234,enhancement,0,0
12235,produced,0,0
12236,increased,0,0
12237,cessation,0,1
12238,at,0,0
12239,12,0,0
12240,months,0,0
12241,but,0,0
12242,not,0,0
12243,at,0,0
12244,18,0,0
12245,months,0,0
12246,.,0,0
12247,The,0,0
12248,stimulus,0,0
12249,control,0,1
12250,computer,0,1
12251,produced,0,0
12252,no,0,0
12253,improvement,0,0
12254,",",0,0
12255,resulting,0,0
12256,in,0,0
12257,20,0,0
12258,%,0,0
12259,worse,0,0
12260,cessation,0,0
12261,rates,0,0
12262,than,0,0
12263,the,0,0
12264,assessment,0,0
12265,only,0,0
12266,condition,0,0
12267,.,0,0
12268,CONCLUSIONS,0,0
12269,The,0,0
12270,enhanced,0,0
12271,conditions,0,0
12272,failed,0,0
12273,to,0,0
12274,outperform,0,0
12275,the,0,0
12276,expert,0,0
12277,system,0,0
12278,alone,0,1
12279,.,0,0
12280,The,0,0
12281,study,0,0
12282,also,0,0
12283,demonstrated,0,0
12284,the,0,0
12285,ability,0,0
12286,of,0,0
12287,the,0,0
12288,interactive,1,1
12289,expert,1,0
12290,system,1,0
12291,to,0,0
12292,produce,0,0
12293,significantly,0,0
12294,greater,0,0
12295,cessation,0,0
12296,in,0,0
12297,a,0,0
12298,population,0,0
12299,of,0,0
12300,smokers,0,0
12301,than,0,0
12302,assessment,0,0
12303,alone,0,1
12304,.,0,0
12305,[,0,0
12306,Diphtheria,0,1
12307,antitoxin,0,1
12308,level,0,0
12309,2,0,0
12310,years,0,0
12311,after,0,0
12312,booster,1,1
12313,vaccination,1,1
12314,],1,0
12315,.,0,0
12316,In,0,0
12317,a,0,0
12318,prospective,0,0
12319,",",0,0
12320,controlled,0,0
12321,",",0,0
12322,randomized,0,0
12323,",",0,0
12324,multicenter,0,0
12325,study,0,0
12326,the,0,0
12327,immunogenicity,0,0
12328,of,0,0
12329,a,0,0
12330,single,0,1
12331,(,0,0
12332,day,0,1
12333,0,0,0
12334,),0,0
12335,and,0,0
12336,two,0,1
12337,(,0,0
12338,day,0,0
12339,0,0,0
12340,",",0,0
12341,28,0,0
12342,),0,0
12343,booster,1,1
12344,vaccination,1,1
12345,against,1,0
12346,diphtheria,1,1
12347,were,0,0
12348,compared,0,0
12349,in,0,0
12350,subjects,0,0
12351,who,0,0
12352,had,0,0
12353,received,0,0
12354,their,0,0
12355,last,0,0
12356,diphtheria,1,1
12357,vaccination,1,1
12358,more,0,0
12359,than,0,0
12360,10,0,0
12361,years,0,0
12362,ago,0,0
12363,.,0,0
12364,Both,0,1
12365,short-term,0,0
12366,and,0,0
12367,long-term,0,0
12368,immunogenicity,0,0
12369,was,0,0
12370,assessed,0,0
12371,by,0,0
12372,determining,0,0
12373,diphtheria,1,1
12374,antitoxin,1,1
12375,levels,0,0
12376,four,0,0
12377,weeks,0,0
12378,after,0,0
12379,vaccination,1,1
12380,and,0,0
12381,after,0,0
12382,one,0,0
12383,and,0,0
12384,two,0,0
12385,years,0,0
12386,.,0,0
12387,102,0,0
12388,subjects,0,0
12389,received,0,0
12390,the,0,0
12391,first,1,0
12392,booster,1,1
12393,vaccination,1,1
12394,",",1,0
12395,and,1,0
12396,83,1,0
12397,were,1,0
12398,vaccinated,1,0
12399,twice,1,0
12400,.,1,0
12401,Prior,0,0
12402,to,0,0
12403,the,0,0
12404,first,0,0
12405,vaccination,0,1
12406,27,0,0
12407,%,0,0
12408,of,0,0
12409,the,0,0
12410,subjects,0,0
12411,had,0,0
12412,a,0,0
12413,diphtheria,0,1
12414,antitoxin,0,1
12415,level,0,0
12416,below,0,0
12417,0.01,0,0
12418,I.U./ml,0,0
12419,;,0,0
12420,after,0,0
12421,the,0,0
12422,first,0,0
12423,booster,0,1
12424,only,0,0
12425,5,0,0
12426,%,0,0
12427,were,0,0
12428,unprotected,0,0
12429,.,0,0
12430,The,0,0
12431,second,0,0
12432,booster,1,1
12433,did,0,0
12434,not,0,0
12435,show,0,0
12436,a,0,0
12437,significant,0,0
12438,effect,0,0
12439,",",0,0
12440,however,0,0
12441,",",0,0
12442,in,0,0
12443,1,0,0
12444,of,0,0
12445,the,0,0
12446,5,0,0
12447,subjects,0,0
12448,who,0,0
12449,were,0,0
12450,still,0,0
12451,unprotected,0,0
12452,after,0,0
12453,the,0,0
12454,first,0,0
12455,booster,0,1
12456,the,0,0
12457,second,0,0
12458,elicited,0,0
12459,an,0,0
12460,antitoxin,0,1
12461,level,0,0
12462,of,0,0
12463,more,0,0
12464,than,0,0
12465,0.01,0,0
12466,I.U./ml,0,0
12467,.,0,0
12468,After,0,0
12469,one,0,0
12470,and,0,0
12471,two,0,0
12472,years,0,0
12473,7,0,0
12474,%,0,0
12475,and,0,0
12476,8,0,0
12477,%,0,0
12478,of,0,0
12479,the,0,0
12480,subjects,0,0
12481,had,0,0
12482,diphtheria,0,1
12483,antitoxin,0,1
12484,level,0,0
12485,below,0,0
12486,0.01,0,0
12487,I.U./ml,0,0
12488,.,0,0
12489,A,0,0
12490,serological,0,0
12491,effect,0,0
12492,of,0,0
12493,a,0,0
12494,second,0,0
12495,booster,1,1
12496,vaccination,1,1
12497,four,0,0
12498,weeks,0,0
12499,after,0,0
12500,the,0,0
12501,first,0,0
12502,one,0,0
12503,could,0,0
12504,not,0,0
12505,be,0,0
12506,demonstrated,0,0
12507,neither,0,0
12508,after,0,0
12509,one,0,0
12510,nor,0,0
12511,after,0,0
12512,two,0,0
12513,years,0,0
12514,.,0,0
12515,Cognitive,0,1
12516,performance,0,0
12517,and,0,0
12518,serotonergic,0,1
12519,function,0,0
12520,in,0,0
12521,users,0,0
12522,of,0,0
12523,ecstasy,0,0
12524,.,0,1
12525,RATIONALE,0,0
12526,(,0,0
12527,+/-,0,0
12528,),0,1
12529,"3,4-Methylenedioxymethamphetamine",1,1
12530,(,1,0
12531,MDMA,1,1
12532,or,1,1
12533,ecstasy,1,1
12534,),1,1
12535,has,0,0
12536,been,0,0
12537,shown,0,0
12538,to,0,0
12539,cause,0,0
12540,long,0,0
12541,term,0,1
12542,damage,0,0
12543,to,0,0
12544,serotonergic,0,0
12545,cerebral,0,0
12546,neurons,0,0
12547,in,0,0
12548,animals,0,0
12549,.,0,0
12550,The,0,0
12551,neurotoxic,0,0
12552,effects,0,0
12553,in,0,0
12554,humans,0,0
12555,are,0,0
12556,less,0,0
12557,clear,0,0
12558,and,0,0
12559,little,0,0
12560,is,0,0
12561,known,0,0
12562,about,0,0
12563,the,0,0
12564,functional,0,0
12565,consequences,0,0
12566,",",0,0
12567,although,0,0
12568,some,0,0
12569,studies,0,0
12570,suggest,0,0
12571,memory,0,0
12572,impairment,0,0
12573,.,0,0
12574,Given,0,0
12575,the,0,0
12576,widespread,0,0
12577,use,0,0
12578,of,0,0
12579,MDMA,1,0
12580,",",0,0
12581,our,0,0
12582,lack,0,0
12583,of,0,0
12584,knowledge,0,0
12585,raises,0,0
12586,concerns,0,0
12587,.,0,0
12588,OBJECTIVE,0,0
12589,We,0,0
12590,investigated,0,0
12591,",",0,0
12592,in,0,0
12593,humans,0,0
12594,",",0,0
12595,the,0,0
12596,relation,0,0
12597,between,0,0
12598,past,0,0
12599,use,0,0
12600,of,0,0
12601,ecstasy,0,1
12602,and,0,0
12603,cognitive,0,1
12604,performance,0,0
12605,as,0,0
12606,well,0,0
12607,as,0,0
12608,serotonergic,0,0
12609,function,0,0
12610,.,0,0
12611,METHODS,0,0
12612,Two,0,0
12613,groups,0,0
12614,of,0,0
12615,21,0,0
12616,males,0,0
12617,with,0,0
12618,moderate,0,0
12619,and,0,0
12620,heavy,0,1
12621,recreational,0,0
12622,use,0,0
12623,of,0,0
12624,MDMA,1,0
12625,",",0,0
12626,respectively,0,0
12627,",",0,0
12628,and,0,0
12629,a,0,0
12630,control,0,1
12631,group,0,0
12632,of,0,0
12633,20,0,0
12634,males,0,0
12635,without,0,0
12636,use,0,0
12637,of,0,0
12638,MDMA,1,0
12639,were,0,0
12640,compared,0,0
12641,.,0,0
12642,All,0,0
12643,were,0,0
12644,from,0,0
12645,the,0,0
12646,same,0,0
12647,subculture,0,0
12648,.,0,1
12649,Reaction,0,0
12650,time,0,0
12651,",",0,0
12652,direct,0,0
12653,recall,0,1
12654,",",0,0
12655,and,0,0
12656,recognition,0,0
12657,were,0,0
12658,assessed,0,0
12659,.,0,0
12660,Serotonergic,0,0
12661,function,0,0
12662,was,0,0
12663,measured,0,0
12664,by,0,0
12665,the,0,0
12666,neuro-endocrine,0,0
12667,response,0,0
12668,to,0,0
12669,a,0,0
12670,placebo-controlled,1,1
12671,",",0,0
12672,crossover,0,0
12673,challenge,0,0
12674,with,0,0
12675,dexfenfluramine,1,1
12676,.,1,0
12677,RESULTS,0,0
12678,Ecstasy,0,1
12679,users,0,0
12680,showed,0,0
12681,a,0,0
12682,broad,0,0
12683,pattern,0,0
12684,of,0,0
12685,statistically,0,0
12686,significant,0,0
12687,",",0,0
12688,but,0,0
12689,clinically,0,0
12690,small,0,0
12691,",",0,0
12692,impairment,0,0
12693,of,0,0
12694,memory,0,0
12695,and,0,0
12696,prolonged,0,0
12697,reaction,0,1
12698,times,0,0
12699,.,0,0
12700,Heavy,0,0
12701,users,0,0
12702,were,0,0
12703,affected,0,0
12704,stronger,0,0
12705,than,0,0
12706,moderate,0,0
12707,users,0,0
12708,.,0,0
12709,Release,0,0
12710,of,0,0
12711,cortisol,0,0
12712,but,0,0
12713,not,0,0
12714,of,0,0
12715,prolactin,0,0
12716,after,0,0
12717,dexfenfluramine,1,1
12718,administration,0,0
12719,was,0,0
12720,significantly,0,0
12721,reduced,0,0
12722,in,0,0
12723,both,0,0
12724,groups,0,0
12725,of,0,0
12726,ecstasy,0,1
12727,users,0,0
12728,compared,0,0
12729,with,0,0
12730,the,0,0
12731,controls,0,0
12732,.,0,0
12733,Analyses,0,0
12734,of,0,0
12735,covariance,0,0
12736,showed,0,0
12737,that,0,0
12738,likely,0,0
12739,confounding,0,0
12740,variables,0,0
12741,including,0,0
12742,recent,0,0
12743,exposure,0,0
12744,to,0,0
12745,ecstasy,0,1
12746,",",0,0
12747,psychosocial,0,0
12748,profiles,0,0
12749,and,0,0
12750,use,0,0
12751,of,0,0
12752,other,0,0
12753,drugs,0,1
12754,did,0,0
12755,not,0,0
12756,explain,0,0
12757,the,0,0
12758,differences,0,0
12759,found,0,0
12760,between,0,0
12761,the,0,0
12762,groups,0,0
12763,.,0,0
12764,CONCLUSIONS,0,0
12765,These,0,0
12766,results,0,0
12767,provide,0,0
12768,further,0,0
12769,evidence,0,0
12770,that,0,0
12771,use,0,0
12772,of,0,0
12773,ecstasy,0,1
12774,may,0,0
12775,be,0,0
12776,associated,0,0
12777,with,0,0
12778,impairment,0,0
12779,of,0,0
12780,memory,0,0
12781,and,0,0
12782,of,0,0
12783,serotonergic,0,0
12784,function,0,0
12785,.,0,0
12786,These,0,0
12787,findings,0,0
12788,are,0,0
12789,compatible,0,0
12790,with,0,0
12791,neurotoxicity,0,0
12792,of,0,0
12793,ecstasy,0,1
12794,as,0,0
12795,shown,0,0
12796,in,0,0
12797,animals,0,0
12798,.,0,0
12799,Beneficial,0,0
12800,effects,0,0
12801,of,0,0
12802,a,0,0
12803,soy-based,1,1
12804,dietary,1,1
12805,supplement,1,1
12806,on,0,0
12807,lipid,0,0
12808,levels,0,0
12809,and,0,0
12810,cardiovascular,0,0
12811,risk,0,0
12812,markers,0,0
12813,in,0,0
12814,type,0,0
12815,2,0,0
12816,diabetic,0,0
12817,subjects,0,0
12818,.,0,0
12819,OBJECTIVE,0,0
12820,Consumption,0,0
12821,of,0,0
12822,soy,0,1
12823,protein,0,1
12824,has,0,0
12825,recently,0,0
12826,been,0,0
12827,shown,0,0
12828,to,0,0
12829,improve,0,0
12830,the,0,0
12831,blood,0,0
12832,lipid,0,0
12833,levels,0,0
12834,in,0,0
12835,nondiabetic,0,0
12836,subjects,0,0
12837,.,0,0
12838,The,0,0
12839,purpose,0,0
12840,of,0,0
12841,this,0,0
12842,study,0,0
12843,was,0,0
12844,to,0,0
12845,evaluate,0,0
12846,if,0,0
12847,a,0,0
12848,dietary,0,1
12849,supplement,0,1
12850,of,0,0
12851,soy,1,1
12852,protein,1,1
12853,",",1,0
12854,isoflavones,1,1
12855,",",1,0
12856,and,1,0
12857,cotyledon,1,1
12858,fiber,1,1
12859,(,1,1
12860,Abalon,1,1
12861,),1,1
12862,affects,0,0
12863,cardiovascular,0,0
12864,risk,0,0
12865,markers,0,0
12866,",",0,0
12867,blood,0,0
12868,glucose,0,0
12869,",",0,0
12870,and,0,0
12871,insulin,0,1
12872,levels,0,0
12873,in,0,0
12874,type,0,0
12875,2,0,0
12876,diabetic,0,0
12877,subjects,0,0
12878,.,0,0
12879,RESEARCH,0,0
12880,DESIGN,0,0
12881,AND,0,0
12882,METHODS,0,0
12883,Twenty,0,1
12884,type,0,0
12885,2,0,0
12886,diabetic,0,0
12887,subjects,0,0
12888,participated,0,0
12889,in,0,0
12890,a,0,0
12891,crossover,0,0
12892,trial,0,0
12893,.,0,0
12894,They,0,0
12895,were,0,0
12896,randomized,0,0
12897,to,0,0
12898,double-blind,0,0
12899,supplementation,0,1
12900,for,0,0
12901,6,1,0
12902,weeks,1,0
12903,with,1,0
12904,Abalon,1,1
12905,(,1,0
12906,soy,1,1
12907,protein,1,1
12908,[,0,0
12909,50,0,0
12910,g/day,0,0
12911,],0,0
12912,with,0,0
12913,high,0,0
12914,levels,0,0
12915,of,0,0
12916,isoflavones,1,1
12917,[,0,0
12918,minimum,0,0
12919,165,0,0
12920,mg/day,0,1
12921,],0,0
12922,and,0,0
12923,cotyledon,1,1
12924,fiber,1,1
12925,[,0,0
12926,20,0,0
12927,g/day,0,0
12928,],0,0
12929,),0,0
12930,or,0,1
12931,placebo,1,1
12932,(,0,1
12933,casein,0,1
12934,[,0,0
12935,50,0,0
12936,g/day,0,0
12937,],0,0
12938,and,0,0
12939,cellulose,0,1
12940,[,0,0
12941,20,0,0
12942,g/day,0,0
12943,],0,0
12944,),0,0
12945,",",0,0
12946,separated,0,0
12947,by,0,0
12948,a,0,0
12949,3-week,0,0
12950,wash-out,0,1
12951,period,0,0
12952,.,0,0
12953,RESULTS,0,0
12954,The,0,0
12955,results,0,0
12956,are,0,0
12957,expressed,0,0
12958,as,0,0
12959,means,0,0
12960,+/-,0,0
12961,SD,0,0
12962,.,0,0
12963,The,0,0
12964,percentage,0,0
12965,mean,0,0
12966,treatment,0,0
12967,difference,0,0
12968,between,0,0
12969,Abalon,1,1
12970,and,0,0
12971,placebo,1,1
12972,demonstrated,0,0
12973,significantly,0,0
12974,lower,0,0
12975,mean,0,0
12976,values,0,0
12977,after,0,0
12978,Abalon,1,1
12979,for,0,0
12980,LDL,0,1
12981,cholesterol,0,1
12982,(,0,0
12983,10,0,0
12984,+/-,0,0
12985,15,0,0
12986,%,0,0
12987,",",0,0
12988,P,0,0
12989,<,0,0
12990,0.05,0,0
12991,),0,0
12992,",",0,0
12993,LDL/UHDL,0,1
12994,ratio,0,0
12995,(,0,0
12996,12,0,0
12997,+/-,0,0
12998,18,0,0
12999,%,0,0
13000,",",0,0
13001,P,0,0
13002,<,0,0
13003,0.05,0,0
13004,),0,0
13005,",",0,0
13006,apolipoprotein,0,0
13007,(,0,1
13008,apo,0,0
13009,),0,1
13010,B100,0,1
13011,(,0,0
13012,30,0,0
13013,+/-,0,0
13014,38,0,0
13015,%,0,0
13016,",",0,0
13017,P,0,0
13018,<,0,0
13019,0.01,0,0
13020,),0,0
13021,",",0,0
13022,triglycerides,0,0
13023,(,0,0
13024,22,0,0
13025,+/-,0,0
13026,10,0,0
13027,%,0,0
13028,",",0,0
13029,P,0,0
13030,<,0,0
13031,0.05,0,0
13032,),0,0
13033,",",0,0
13034,and,0,1
13035,homocysteine,0,1
13036,(,0,0
13037,14,0,0
13038,+/-,0,0
13039,21,0,0
13040,%,0,0
13041,",",0,0
13042,P,0,0
13043,<,0,0
13044,0.01,0,0
13045,),0,0
13046,",",0,0
13047,whereas,0,0
13048,the,0,0
13049,total,0,0
13050,cholesterol,0,0
13051,value,0,0
13052,tended,0,0
13053,to,0,0
13054,be,0,0
13055,less,0,0
13056,significant,0,0
13057,but,0,0
13058,still,0,0
13059,lower,0,0
13060,(,0,0
13061,8,0,0
13062,+/-,0,0
13063,15,0,0
13064,%,0,0
13065,",",0,0
13066,P,0,0
13067,<,0,0
13068,0.08,0,0
13069,),0,0
13070,.,0,0
13071,No,0,0
13072,change,0,0
13073,occurred,0,0
13074,in,0,0
13075,HDL,0,1
13076,cholesterol,0,0
13077,",",0,0
13078,apo,0,0
13079,B100/apo,0,1
13080,A1,0,1
13081,ratio,0,0
13082,",",0,0
13083,plasminogen,0,1
13084,activator,0,1
13085,inhibitor,0,1
13086,1,0,0
13087,",",0,0
13088,factor,0,0
13089,VIIc,0,1
13090,",",0,0
13091,von,0,0
13092,Willebrand,0,0
13093,factor,0,0
13094,",",0,0
13095,fibrinogen,0,0
13096,",",0,0
13097,lipoprotein,0,0
13098,(,0,1
13099,a,0,0
13100,),0,0
13101,",",0,0
13102,glucose,0,0
13103,",",0,0
13104,HbA1c,0,1
13105,",",0,0
13106,or,0,1
13107,24-h,0,1
13108,blood,0,0
13109,pressure,0,0
13110,.,0,0
13111,CONCLUSIONS,0,0
13112,These,0,0
13113,results,0,0
13114,indicate,0,0
13115,beneficial,0,0
13116,effects,0,0
13117,of,0,0
13118,dietary,0,1
13119,supplementation,0,1
13120,with,0,0
13121,Abalon,1,1
13122,on,0,0
13123,cardiovascular,0,0
13124,risk,0,0
13125,markers,0,0
13126,in,0,0
13127,type,0,0
13128,2,0,0
13129,diabetic,0,0
13130,subjects,0,0
13131,.,0,0
13132,This,0,0
13133,improvement,0,0
13134,is,0,0
13135,seen,0,0
13136,even,0,0
13137,in,0,0
13138,individuals,0,0
13139,with,0,0
13140,near-normal,0,0
13141,lipid,0,0
13142,values,0,0
13143,.,0,0
13144,Effect,0,0
13145,of,0,0
13146,protein,1,1
13147,ingestion,1,0
13148,on,0,0
13149,the,0,0
13150,glucose,0,0
13151,appearance,0,0
13152,rate,0,0
13153,in,0,0
13154,people,0,0
13155,with,0,0
13156,type,0,0
13157,2,0,0
13158,diabetes,0,0
13159,.,0,0
13160,Amino,0,0
13161,acids,0,0
13162,derived,0,0
13163,from,0,0
13164,ingested,0,0
13165,protein,0,1
13166,are,0,0
13167,potential,0,0
13168,substrates,0,1
13169,for,0,0
13170,gluconeogenesis,0,0
13171,.,0,0
13172,However,0,0
13173,",",0,0
13174,several,0,0
13175,laboratories,0,0
13176,have,0,0
13177,reported,0,0
13178,that,0,0
13179,protein,0,1
13180,ingestion,0,0
13181,does,0,0
13182,not,0,0
13183,result,0,0
13184,in,0,0
13185,an,0,0
13186,increase,0,0
13187,in,0,0
13188,the,0,0
13189,circulating,0,0
13190,glucose,0,0
13191,concentration,0,0
13192,in,0,0
13193,people,0,0
13194,with,0,0
13195,or,0,0
13196,without,0,0
13197,type,0,0
13198,2,0,0
13199,diabetes,0,0
13200,.,0,0
13201,The,0,0
13202,reason,0,0
13203,for,0,0
13204,this,0,0
13205,has,0,0
13206,remained,0,0
13207,unclear,0,0
13208,.,0,0
13209,In,0,0
13210,people,0,0
13211,without,0,0
13212,diabetes,0,0
13213,it,0,0
13214,seems,0,0
13215,to,0,0
13216,be,0,0
13217,due,0,0
13218,to,0,0
13219,less,0,0
13220,glucose,0,0
13221,being,0,0
13222,produced,0,0
13223,and,0,0
13224,entering,0,0
13225,the,0,0
13226,circulation,0,0
13227,than,0,0
13228,the,0,0
13229,calculated,0,0
13230,theoretical,0,0
13231,amount,0,0
13232,.,0,0
13233,Therefore,0,0
13234,",",0,0
13235,we,0,0
13236,were,0,0
13237,interested,0,0
13238,in,0,0
13239,determining,0,0
13240,whether,0,0
13241,this,0,0
13242,also,0,0
13243,was,0,0
13244,the,0,0
13245,case,0,0
13246,in,0,0
13247,people,0,0
13248,with,0,0
13249,type,0,0
13250,2,0,0
13251,diabetes,0,0
13252,.,0,0
13253,Ten,0,0
13254,male,0,0
13255,subjects,0,0
13256,with,0,0
13257,untreated,0,0
13258,type,0,0
13259,2,0,0
13260,diabetes,0,0
13261,were,0,0
13262,given,0,0
13263,",",0,0
13264,in,0,0
13265,random,0,0
13266,sequence,0,0
13267,",",0,0
13268,50,1,1
13269,g,1,1
13270,protein,1,1
13271,in,1,0
13272,the,1,0
13273,form,1,0
13274,of,1,0
13275,very,1,0
13276,lean,1,0
13277,beef,1,1
13278,or,1,1
13279,only,1,0
13280,water,1,1
13281,at,1,0
13282,0800,1,0
13283,h,1,0
13284,and,1,0
13285,studied,1,0
13286,over,1,0
13287,the,1,0
13288,subsequent,1,0
13289,8,1,0
13290,h.,1,0
13291,Protein,1,1
13292,ingestion,0,0
13293,resulted,0,0
13294,in,0,0
13295,an,0,0
13296,increase,0,0
13297,in,0,0
13298,circulating,0,0
13299,insulin,0,1
13300,",",0,0
13301,C-peptide,0,1
13302,",",0,0
13303,glucagon,0,1
13304,",",0,0
13305,alpha,0,1
13306,amino,0,1
13307,and,0,0
13308,urea,0,1
13309,nitrogen,0,0
13310,",",0,0
13311,and,0,0
13312,triglycerides,0,0
13313,;,0,0
13314,a,0,0
13315,decrease,0,0
13316,in,0,0
13317,nonesterified,0,0
13318,fatty,0,1
13319,acids,0,1
13320,;,0,0
13321,and,0,0
13322,a,0,0
13323,modest,0,0
13324,increase,0,0
13325,in,0,0
13326,respiratory,0,0
13327,quotient,0,0
13328,.,0,0
13329,The,0,0
13330,total,0,0
13331,amount,0,0
13332,of,0,0
13333,protein,0,1
13334,deaminated,0,0
13335,and,0,0
13336,the,0,0
13337,amino,0,1
13338,groups,0,0
13339,incorporated,0,0
13340,into,0,0
13341,urea,0,0
13342,was,0,0
13343,calculated,0,0
13344,to,0,0
13345,be,0,0
13346,approximately,0,0
13347,20-23,0,0
13348,g.,0,1
13349,The,0,0
13350,net,0,0
13351,amount,0,0
13352,of,0,0
13353,glucose,0,0
13354,estimated,0,0
13355,to,0,0
13356,be,0,0
13357,produced,0,0
13358,",",0,0
13359,based,0,0
13360,on,0,0
13361,the,0,0
13362,quantity,0,0
13363,of,0,0
13364,amino,0,1
13365,acids,0,1
13366,deaminated,0,0
13367,",",0,0
13368,was,0,0
13369,approximately,0,0
13370,11-13,0,0
13371,g.,0,1
13372,However,0,0
13373,",",0,0
13374,the,0,0
13375,amount,0,0
13376,of,0,0
13377,glucose,0,0
13378,appearing,0,0
13379,in,0,0
13380,the,0,0
13381,circulation,0,0
13382,was,0,0
13383,only,0,0
13384,approximately,0,0
13385,2,0,0
13386,g.,0,0
13387,The,0,0
13388,peripheral,0,0
13389,plasma,0,0
13390,glucose,0,0
13391,concentration,0,0
13392,decreased,0,0
13393,by,0,0
13394,approximately,0,0
13395,1,0,0
13396,mM,0,1
13397,after,0,0
13398,ingestion,0,0
13399,of,0,0
13400,either,0,1
13401,protein,0,1
13402,or,0,1
13403,water,0,1
13404,",",0,0
13405,confirming,0,0
13406,that,0,0
13407,ingested,0,0
13408,protein,0,1
13409,does,0,0
13410,not,0,0
13411,result,0,0
13412,in,0,0
13413,a,0,0
13414,net,0,0
13415,increase,0,0
13416,in,0,0
13417,glucose,0,0
13418,concentration,0,0
13419,",",0,0
13420,and,0,0
13421,results,0,0
13422,in,0,0
13423,only,0,0
13424,a,0,0
13425,modest,0,0
13426,increase,0,0
13427,in,0,0
13428,the,0,0
13429,rate,0,0
13430,of,0,0
13431,glucose,0,0
13432,disappearance,0,0
13433,.,0,0
13434,Clinical,0,0
13435,implications,0,0
13436,of,0,0
13437,a,0,0
13438,reduction,0,0
13439,in,0,0
13440,psychological,0,0
13441,distress,0,0
13442,on,0,0
13443,cardiac,0,0
13444,prognosis,0,0
13445,in,0,0
13446,patients,0,0
13447,participating,0,0
13448,in,0,0
13449,a,0,0
13450,psychosocial,1,0
13451,intervention,1,1
13452,program,1,1
13453,.,1,0
13454,OBJECTIVE,0,0
13455,The,0,0
13456,objective,0,0
13457,of,0,0
13458,this,0,0
13459,secondary,0,0
13460,analysis,0,0
13461,was,0,0
13462,to,0,0
13463,examine,0,0
13464,the,0,0
13465,relationships,0,0
13466,between,0,0
13467,a,0,0
13468,reduction,0,0
13469,in,0,0
13470,psychological,0,0
13471,distress,0,0
13472,and,0,0
13473,long-term,0,0
13474,cardiac,0,0
13475,and,0,0
13476,psychological,0,0
13477,outcomes,0,0
13478,in,0,0
13479,post-myocardial,0,0
13480,infarction,0,0
13481,patients,0,0
13482,who,0,0
13483,participated,0,0
13484,in,0,0
13485,a,0,0
13486,randomized,0,0
13487,trial,0,0
13488,of,0,0
13489,home-based,0,1
13490,psychosocial,0,0
13491,nursing,0,1
13492,interventions,0,1
13493,(,0,0
13494,the,0,0
13495,Montreal,0,0
13496,Heart,0,1
13497,Attack,0,1
13498,Readjustment,0,0
13499,Trial,0,1
13500,[,0,0
13501,M-HART,0,1
13502,],0,0
13503,),0,0
13504,.,0,0
13505,Gender,0,0
13506,differences,0,0
13507,were,0,0
13508,considered,0,0
13509,.,0,0
13510,METHODS,0,0
13511,We,0,0
13512,studied,1,0
13513,433,1,0
13514,patients,1,0
13515,(,1,0
13516,36.0,1,0
13517,%,1,0
13518,women,1,0
13519,),1,0
13520,from,1,0
13521,the,1,0
13522,M-HART,1,1
13523,treatment,1,0
13524,group,1,0
13525,who,1,0
13526,received,1,0
13527,two,1,0
13528,home,1,1
13529,visits,1,0
13530,after,1,0
13531,achieving,1,0
13532,a,1,0
13533,high,1,0
13534,psychological,1,0
13535,distress,1,0
13536,score,1,0
13537,(,1,0
13538,ie,1,0
13539,",",1,0
13540,>,1,0
13541,or,1,1
13542,=5,1,0
13543,),1,1
13544,on,1,0
13545,the,1,0
13546,General,1,0
13547,Health,1,1
13548,Questionnaire,1,1
13549,(,1,1
13550,GHQ,1,0
13551,),1,1
13552,.,1,0
13553,Short-term,0,0
13554,GHQ,0,0
13555,success,0,0
13556,was,0,0
13557,determined,0,0
13558,by,0,0
13559,a,0,0
13560,return,0,0
13561,to,0,0
13562,a,0,0
13563,normal,0,0
13564,GHQ,0,0
13565,score,0,0
13566,(,0,0
13567,<,0,0
13568,5,0,1
13569,),0,0
13570,or,0,1
13571,a,0,0
13572,reduction,0,0
13573,of,0,0
13574,>,0,0
13575,or,0,1
13576,=50,0,0
13577,%,0,0
13578,after,0,0
13579,the,0,0
13580,two,0,0
13581,visits,0,0
13582,.,0,0
13583,Patients,0,0
13584,with,0,0
13585,short-term,0,0
13586,successful,0,0
13587,and,0,0
13588,unsuccessful,0,0
13589,GHQ,0,0
13590,outcomes,0,0
13591,were,0,0
13592,compared,0,0
13593,for,0,0
13594,mid-term,0,0
13595,maintenance,0,0
13596,of,0,0
13597,success,0,0
13598,",",0,0
13599,1-year,0,0
13600,death,0,0
13601,and,0,0
13602,readmission,0,0
13603,rates,0,0
13604,",",0,0
13605,and,0,0
13606,1-year,0,0
13607,depression,0,1
13608,and,0,0
13609,anxiety,0,0
13610,symptoms,0,0
13611,.,0,0
13612,RESULTS,0,0
13613,Patients,0,0
13614,with,0,0
13615,short-term,0,0
13616,GHQ,0,0
13617,success,0,0
13618,were,0,0
13619,more,0,0
13620,likely,0,0
13621,to,0,0
13622,show,0,0
13623,mid-term,0,0
13624,GHQ,0,1
13625,success,0,0
13626,(,0,0
13627,p,0,0
13628,<,0,0
13629,.001,0,0
13630,),0,0
13631,",",0,0
13632,marginally,0,0
13633,less,0,0
13634,likely,0,0
13635,to,0,0
13636,die,0,0
13637,of,0,0
13638,any,0,0
13639,causes,0,0
13640,(,0,0
13641,p,0,0
13642,=,0,0
13643,.087,0,0
13644,),0,0
13645,",",0,0
13646,less,0,0
13647,likely,0,0
13648,to,0,0
13649,die,0,1
13650,of,0,0
13651,cardiac,0,0
13652,causes,0,0
13653,(,0,0
13654,p,0,0
13655,=,0,0
13656,.043,0,0
13657,),0,0
13658,",",0,0
13659,less,0,0
13660,likely,0,0
13661,to,0,0
13662,be,0,0
13663,readmitted,0,0
13664,for,0,0
13665,any,0,0
13666,reason,0,0
13667,(,0,0
13668,p,0,0
13669,<,0,0
13670,.001,0,0
13671,),0,1
13672,and,0,0
13673,for,0,0
13674,cardiac,0,0
13675,reasons,0,0
13676,(,0,0
13677,p,0,0
13678,<,0,0
13679,.001,0,0
13680,),0,0
13681,",",0,0
13682,and,0,0
13683,less,0,0
13684,likely,0,0
13685,to,0,0
13686,have,0,0
13687,high,0,0
13688,depression,0,1
13689,(,0,0
13690,p,0,0
13691,<,0,0
13692,.001,0,0
13693,),0,1
13694,and,0,1
13695,anxiety,0,0
13696,(,0,1
13697,p,0,0
13698,<,0,0
13699,.001,0,0
13700,),0,0
13701,at,0,0
13702,1-year,0,0
13703,than,0,0
13704,patients,0,0
13705,with,0,0
13706,short-term,0,0
13707,unsuccessful,0,0
13708,GHQ,0,0
13709,outcomes,0,0
13710,.,0,0
13711,Results,0,0
13712,held,0,0
13713,for,0,0
13714,men,0,0
13715,and,0,0
13716,women,0,0
13717,and,0,0
13718,were,0,0
13719,not,0,0
13720,altered,0,0
13721,by,0,0
13722,controlling,0,0
13723,for,0,0
13724,potential,0,0
13725,confounders,0,0
13726,.,0,0
13727,However,0,0
13728,",",0,0
13729,the,0,0
13730,number,0,0
13731,of,0,0
13732,deaths,0,0
13733,prevented,0,0
13734,analysis,0,0
13735,with,0,0
13736,statistical,0,0
13737,controls,0,0
13738,.,0,0
13739,CONCLUSIONS,0,0
13740,Post-myocardial,0,0
13741,infarction,0,0
13742,interventions,0,1
13743,that,0,0
13744,reduce,0,0
13745,psychological,0,0
13746,distress,0,0
13747,have,0,0
13748,the,0,0
13749,potential,0,0
13750,to,0,0
13751,improve,0,0
13752,long-term,0,0
13753,prognosis,0,0
13754,and,0,0
13755,psychological,0,0
13756,status,0,0
13757,for,0,0
13758,both,0,0
13759,men,0,0
13760,and,0,0
13761,women,0,0
13762,.,0,0
13763,Effectiveness,0,0
13764,of,0,0
13765,the,0,0
13766,school,1,0
13767,dental,1,1
13768,screening,1,1
13769,programme,1,1
13770,in,0,0
13771,stimulating,0,0
13772,dental,0,1
13773,attendance,0,0
13774,for,0,0
13775,children,0,0
13776,in,0,0
13777,need,0,0
13778,of,0,0
13779,treatment,0,0
13780,in,0,0
13781,Northern,0,1
13782,Ireland,0,0
13783,.,0,0
13784,UNLABELLED,0,0
13785,The,0,0
13786,school,1,0
13787,dental,1,1
13788,screening,1,1
13789,programme,1,1
13790,has,0,0
13791,been,0,0
13792,in,0,0
13793,existence,0,0
13794,from,0,0
13795,the,0,0
13796,beginning,0,0
13797,of,0,0
13798,the,0,0
13799,20th,0,0
13800,century,0,0
13801,yet,0,0
13802,its,0,0
13803,value,0,0
13804,in,0,0
13805,encouraging,0,0
13806,attendance,0,0
13807,among,0,0
13808,children,0,0
13809,with,0,0
13810,a,0,0
13811,dental,0,1
13812,health,0,0
13813,need,0,0
13814,is,0,0
13815,not,0,0
13816,fully,0,0
13817,established,0,0
13818,.,0,0
13819,OBJECTIVE,0,0
13820,To,0,0
13821,evaluate,0,0
13822,the,0,0
13823,effectiveness,0,0
13824,of,0,0
13825,school,1,0
13826,dental,1,1
13827,screening,1,1
13828,in,0,0
13829,promoting,0,0
13830,dental,0,1
13831,attendance,0,0
13832,among,0,0
13833,children,0,0
13834,with,0,0
13835,a,0,0
13836,treatment,0,1
13837,need,0,0
13838,and,0,0
13839,to,0,0
13840,examine,0,0
13841,the,0,0
13842,relative,0,0
13843,importance,0,0
13844,of,0,0
13845,screening,0,0
13846,",",0,0
13847,social,0,1
13848,class,0,0
13849,and,0,0
13850,other,0,0
13851,factors,0,0
13852,in,0,0
13853,dental,0,0
13854,attendance,0,0
13855,.,0,0
13856,METHODS,0,0
13857,Sixty-four,0,0
13858,participating,0,0
13859,schools,0,0
13860,were,0,0
13861,assigned,0,0
13862,to,0,0
13863,study,0,0
13864,and,0,0
13865,control,0,1
13866,groups,0,0
13867,using,0,0
13868,a,0,0
13869,stratified,0,0
13870,",",0,0
13871,blocked,0,1
13872,randomisation,0,0
13873,technique,0,1
13874,.,0,0
13875,The,0,0
13876,study,0,0
13877,group,0,0
13878,children,0,0
13879,received,0,0
13880,the,0,0
13881,standard,1,1
13882,school,1,0
13883,dental,1,1
13884,screening,1,1
13885,and,0,0
13886,the,0,0
13887,dental,0,1
13888,attendance,0,0
13889,of,0,0
13890,those,0,0
13891,with,0,0
13892,a,0,0
13893,positive,0,0
13894,screening,0,0
13895,result,0,0
13896,was,0,0
13897,assessed,0,0
13898,after,0,0
13899,2,0,0
13900,months,0,0
13901,by,0,0
13902,means,0,0
13903,of,0,0
13904,a,0,0
13905,questionnaire,0,0
13906,issued,0,0
13907,to,0,0
13908,the,0,0
13909,children,0,0
13910,'s,0,0
13911,parents,0,0
13912,.,0,0
13913,The,0,0
13914,control,0,0
13915,group,1,0
13916,children,1,0
13917,were,1,0
13918,not,1,0
13919,",",1,0
13920,at,1,0
13921,this,1,0
13922,stage,1,0
13923,",",1,0
13924,screened,1,0
13925,",",0,0
13926,yet,0,0
13927,their,0,0
13928,parents,0,0
13929,received,0,0
13930,the,0,0
13931,same,1,0
13932,questionnaire,1,0
13933,assessing,1,0
13934,dental,1,1
13935,attendance,1,0
13936,over,1,0
13937,the,1,0
13938,2-month,1,0
13939,period,1,0
13940,.,1,0
13941,However,0,0
13942,",",0,0
13943,only,0,0
13944,questionnaires,0,0
13945,from,0,0
13946,control,1,0
13947,group,0,0
13948,children,0,0
13949,who,0,0
13950,had,0,0
13951,a,0,0
13952,positive,0,0
13953,result,0,0
13954,at,0,0
13955,a,0,0
13956,subsequent,0,0
13957,screening,0,0
13958,were,0,0
13959,retained,0,0
13960,for,0,0
13961,analysis,0,0
13962,.,0,0
13963,RESULTS,0,0
13964,A,0,0
13965,total,0,0
13966,of,0,0
13967,"2,321",0,0
13968,children,0,0
13969,were,0,0
13970,screened,0,0
13971,",",0,0
13972,with,0,0
13973,980,0,0
13974,having,0,0
13975,a,0,0
13976,positive,0,0
13977,result,0,0
13978,.,0,0
13979,The,0,0
13980,mean,0,0
13981,dmft,0,0
13982,of,0,0
13983,those,0,0
13984,screening,0,0
13985,positive,0,0
13986,was,0,0
13987,4.85,0,0
13988,.,0,0
13989,In,0,0
13990,all,0,0
13991,",",0,0
13992,664,0,0
13993,completed,0,0
13994,questionnaires,0,0
13995,were,0,0
13996,returned,0,0
13997,",",0,0
13998,giving,0,0
13999,a,0,0
14000,response,0,0
14001,rate,0,0
14002,of,0,0
14003,67.8,0,0
14004,%,0,0
14005,.,0,0
14006,Dental,0,0
14007,attendance,0,0
14008,was,0,0
14009,reported,0,0
14010,among,0,0
14011,45.5,0,0
14012,%,0,0
14013,of,0,0
14014,the,0,0
14015,study,0,0
14016,group,0,1
14017,(,0,1
14018,n=352,0,0
14019,),0,1
14020,in,0,0
14021,the,0,0
14022,2,0,0
14023,months,0,0
14024,following,0,0
14025,screening,0,0
14026,.,0,0
14027,In,0,0
14028,the,0,0
14029,same,0,0
14030,period,0,0
14031,",",0,0
14032,27.6,0,0
14033,%,0,0
14034,of,0,0
14035,the,0,0
14036,control,0,1
14037,group,0,0
14038,(,0,1
14039,n=312,0,1
14040,),0,0
14041,claimed,0,0
14042,attendance,0,0
14043,.,0,0
14044,The,0,0
14045,effect,0,0
14046,was,0,0
14047,found,0,0
14048,to,0,0
14049,be,0,0
14050,significant,0,0
14051,among,0,0
14052,the,0,0
14053,high,0,0
14054,employed,0,0
14055,group,0,0
14056,(,0,0
14057,P,0,0
14058,<,0,0
14059,0.01,0,0
14060,),0,0
14061,and,0,0
14062,the,0,0
14063,unemployed,0,1
14064,group,0,0
14065,(,0,0
14066,P,0,0
14067,<,0,0
14068,0.05,0,0
14069,),0,0
14070,.,0,0
14071,CONCLUSION,0,0
14072,School,0,0
14073,dental,0,1
14074,screening,0,0
14075,was,0,0
14076,capable,0,0
14077,of,0,0
14078,stimulating,0,0
14079,dental,0,0
14080,attendance,0,0
14081,.,0,0
14082,The,0,0
14083,strong,0,0
14084,effect,0,0
14085,among,0,0
14086,the,0,0
14087,lowest,0,0
14088,socio-economic,0,0
14089,group,0,0
14090,shows,0,0
14091,that,0,0
14092,school,0,0
14093,dental,0,1
14094,screening,0,0
14095,may,0,0
14096,be,0,0
14097,used,0,0
14098,to,0,0
14099,decrease,0,0
14100,dental,0,0
14101,health,0,0
14102,inequalities,0,0
14103,.,0,0
14104,Comments,0,0
14105,on,0,0
14106,Comparison,0,0
14107,of,0,0
14108,gastrointestinal,0,0
14109,tolerance,1,0
14110,feeding,1,1
14111,proctocols,1,0
14112,in,0,0
14113,critically,0,0
14114,ill,0,0
14115,patients,0,0
14116,:,0,0
14117,a,0,0
14118,prospective,0,0
14119,",",0,0
14120,randomized,0,0
14121,controlled,0,0
14122,clinical,0,0
14123,trial,0,0
14124,.,0,0
14125,Clinical,0,0
14126,and,0,0
14127,microbial,0,0
14128,evaluation,0,0
14129,of,0,0
14130,a,0,0
14131,histatin-containing,1,1
14132,mouthrinse,1,1
14133,in,0,0
14134,humans,0,0
14135,with,0,0
14136,experimental,0,0
14137,gingivitis,0,0
14138,.,0,0
14139,OBJECTIVE,0,0
14140,P-113,1,0
14141,",",1,0
14142,a,1,0
14143,12,1,0
14144,amino,1,1
14145,acid,1,1
14146,histatin-based,1,1
14147,peptide,1,0
14148,",",0,0
14149,was,0,0
14150,evaluated,0,0
14151,in,0,0
14152,a,0,0
14153,mouthrinse,1,1
14154,formulation,1,1
14155,for,0,0
14156,safety,0,0
14157,",",0,0
14158,prevention,0,0
14159,of,0,0
14160,the,0,0
14161,development,0,0
14162,of,0,0
14163,experimental,0,0
14164,gingivitis,0,0
14165,",",0,0
14166,and,0,0
14167,for,0,0
14168,its,0,0
14169,effects,0,0
14170,on,0,0
14171,periodontal,0,0
14172,flora,0,0
14173,.,0,0
14174,METHOD,0,0
14175,159,0,0
14176,periodontally,0,0
14177,healthy,0,0
14178,subjects,0,0
14179,abstained,0,0
14180,from,0,0
14181,oral,0,1
14182,hygiene,0,0
14183,procedures,0,1
14184,and,0,0
14185,self-administered,1,1
14186,either,1,1
14187,0.005,1,0
14188,%,1,0
14189,",",1,0
14190,0.01,1,0
14191,%,1,0
14192,",",1,0
14193,0.05,1,0
14194,%,1,0
14195,P-113,1,1
14196,or,1,1
14197,placebo,1,1
14198,mouthrinse,1,1
14199,formulations,1,1
14200,twice,1,0
14201,daily,1,0
14202,over,1,0
14203,a,1,0
14204,four,1,0
14205,week,1,0
14206,treatment,1,0
14207,period,1,0
14208,.,1,0
14209,During,0,0
14210,this,0,0
14211,time,0,0
14212,",",0,0
14213,the,0,0
14214,safety,0,0
14215,",",0,0
14216,anti-plaque,0,0
14217,",",0,0
14218,and,0,0
14219,anti-gingivitis,0,1
14220,effects,0,0
14221,of,0,0
14222,P-113,0,0
14223,were,0,0
14224,evaluated,0,0
14225,.,0,0
14226,RESULTS,0,0
14227,There,0,0
14228,was,0,0
14229,a,0,0
14230,significant,0,0
14231,reduction,0,0
14232,in,0,0
14233,plaque,0,0
14234,(,0,1
14235,p=0.046,0,0
14236,),0,1
14237,and,0,0
14238,a,0,0
14239,reduction,0,0
14240,in,0,0
14241,gingivitis,0,1
14242,(,0,1
14243,p=0.086,0,0
14244,),0,1
14245,for,0,0
14246,subjects,0,0
14247,using,0,0
14248,0.01,0,0
14249,%,0,0
14250,P-113,1,1
14251,mouthrinse,1,1
14252,.,1,0
14253,Significantly,0,0
14254,more,0,0
14255,subjects,0,0
14256,in,0,0
14257,the,0,0
14258,0.01,0,0
14259,%,0,0
14260,and,0,0
14261,0.05,0,0
14262,%,0,0
14263,treatment,0,0
14264,groups,0,0
14265,showed,0,0
14266,a,0,0
14267,small,0,0
14268,increase,0,0
14269,in,0,0
14270,plaque,0,0
14271,index,0,0
14272,of,0,0
14273,<,0,0
14274,0.25,0,0
14275,as,0,0
14276,compared,0,0
14277,to,0,0
14278,the,0,0
14279,placebo,0,1
14280,group,0,0
14281,(,0,0
14282,p,0,0
14283,<,0,0
14284,0.05,0,0
14285,),0,0
14286,.,0,0
14287,Similar,0,0
14288,trends,0,0
14289,were,0,0
14290,noted,0,0
14291,for,0,0
14292,changes,0,0
14293,in,0,0
14294,the,0,0
14295,%,0,0
14296,of,0,0
14297,sites,0,0
14298,with,0,0
14299,bleeding,0,0
14300,on,0,0
14301,probing,0,0
14302,in,0,0
14303,the,0,0
14304,0.01,0,0
14305,%,0,0
14306,P-113,1,1
14307,group,0,0
14308,.,0,0
14309,There,0,0
14310,were,0,0
14311,no,0,0
14312,treatment-related,0,0
14313,adverse,0,0
14314,events,0,0
14315,",",0,0
14316,and,0,0
14317,there,0,0
14318,were,0,0
14319,no,0,0
14320,adverse,0,0
14321,shifts,0,0
14322,in,0,0
14323,supragingival,0,1
14324,microflora,0,0
14325,during,0,0
14326,the,0,0
14327,study,0,0
14328,.,0,0
14329,CONCLUSION,0,0
14330,These,0,0
14331,data,0,0
14332,suggest,0,0
14333,that,0,0
14334,P-113,1,1
14335,mouthrinse,1,1
14336,is,0,0
14337,safe,0,0
14338,and,0,0
14339,reduces,0,0
14340,plaque,0,0
14341,",",0,0
14342,gingivitis,0,0
14343,and,0,0
14344,gingival,0,0
14345,bleeding,0,0
14346,in,0,0
14347,the,0,0
14348,human,0,1
14349,experimental,0,0
14350,gingivitis,0,0
14351,model,0,0
14352,.,0,0
14353,[,0,0
14354,Advantages,0,1
14355,of,0,0
14356,video,1,1
14357,assisted,1,1
14358,thoracic,1,1
14359,surgery,1,1
14360,in,0,0
14361,the,0,0
14362,treatment,0,0
14363,of,0,0
14364,spontaneous,0,0
14365,pneumothorax,0,0
14366,],0,0
14367,.,0,0
14368,Spontaneous,0,0
14369,pneumothorax,0,0
14370,(,0,1
14371,SP,0,1
14372,),0,1
14373,is,0,0
14374,a,0,0
14375,disabling,0,0
14376,condition,0,0
14377,mostly,0,0
14378,affecting,0,0
14379,young,0,0
14380,",",0,0
14381,thin,0,1
14382,and,0,0
14383,otherwise,0,0
14384,healthy,0,0
14385,males,0,0
14386,.,0,0
14387,It,0,0
14388,is,0,0
14389,usually,0,0
14390,caused,0,0
14391,by,0,0
14392,ruptured,0,0
14393,pleural,0,0
14394,blebs,0,1
14395,.,0,0
14396,The,0,0
14397,first,0,0
14398,treatment,0,0
14399,is,0,0
14400,the,0,0
14401,insertion,1,0
14402,of,1,0
14403,a,1,0
14404,chest,1,1
14405,tube,1,1
14406,(,1,1
14407,ICT,1,1
14408,),1,1
14409,but,0,0
14410,in,0,0
14411,a,0,0
14412,great,0,0
14413,number,0,0
14414,of,0,0
14415,patients,0,0
14416,there,0,0
14417,is,0,0
14418,recurrence,0,0
14419,of,0,0
14420,the,0,0
14421,disease,0,0
14422,.,0,0
14423,We,0,0
14424,believe,0,0
14425,that,0,0
14426,the,0,0
14427,video,1,1
14428,assisted,1,1
14429,thoracoscopy,1,1
14430,(,1,1
14431,VATS,1,1
14432,),1,1
14433,is,0,0
14434,the,0,0
14435,best,0,0
14436,treatment,0,0
14437,possible,0,0
14438,because,0,0
14439,it,0,0
14440,allows,0,0
14441,us,0,0
14442,to,0,0
14443,treat,0,0
14444,the,0,0
14445,ruptured,0,0
14446,bleb,0,1
14447,radically,0,0
14448,avoiding,0,0
14449,any,0,0
14450,recurrence,0,0
14451,.,0,0
14452,In,0,0
14453,order,0,0
14454,to,0,0
14455,prove,0,0
14456,it,0,0
14457,",",0,0
14458,40,0,0
14459,patients,0,0
14460,admitted,0,0
14461,in,0,0
14462,a,0,0
14463,five-year,0,0
14464,period,0,0
14465,",",0,0
14466,with,0,0
14467,a,0,0
14468,SP,0,0
14469,",",0,0
14470,were,0,0
14471,randomly,0,0
14472,assigned,0,0
14473,to,0,0
14474,be,0,0
14475,treated,0,0
14476,by,0,0
14477,ICT,1,0
14478,or,1,1
14479,VATS,1,0
14480,.,1,0
14481,The,0,0
14482,ICT,1,0
14483,patients,0,0
14484,were,0,0
14485,in,0,0
14486,the,0,0
14487,hospital,0,0
14488,a,0,0
14489,mean,0,0
14490,time,0,0
14491,of,0,0
14492,7.5,0,1
14493,(,0,0
14494,4,0,0
14495,to,0,0
14496,15,0,0
14497,),0,0
14498,days,0,0
14499,and,0,0
14500,the,0,0
14501,VATS,1,0
14502,patients,0,0
14503,",",0,0
14504,5.3,0,0
14505,(,0,0
14506,2,0,0
14507,to,0,0
14508,7,0,0
14509,),0,0
14510,days,0,0
14511,(,0,0
14512,P,0,0
14513,<,0,0
14514,.05,0,0
14515,),0,0
14516,.,0,0
14517,ICT,1,0
14518,patients,0,0
14519,required,0,0
14520,analgesic,0,0
14521,drugs,0,1
14522,during,0,0
14523,76.8,0,0
14524,+/-,0,0
14525,31,0,0
14526,hours,0,0
14527,and,0,0
14528,VATS,1,0
14529,patients,0,0
14530,38.4,0,0
14531,+/-,0,0
14532,13,0,0
14533,hours,0,0
14534,(,0,0
14535,p,0,0
14536,<,0,0
14537,.05,0,0
14538,),0,0
14539,.,0,0
14540,From,0,0
14541,the,0,0
14542,ICT,1,0
14543,group,0,0
14544,",",0,0
14545,8,0,0
14546,(,0,0
14547,53,0,0
14548,%,0,0
14549,),0,0
14550,patients,0,0
14551,had,0,0
14552,recurrence,0,0
14553,of,0,0
14554,the,0,0
14555,disease,0,0
14556,and,0,0
14557,6,0,1
14558,(,0,0
14559,40,0,1
14560,%,0,0
14561,),0,0
14562,had,0,0
14563,a,0,0
14564,prolonged,0,0
14565,air,0,0
14566,leak,0,0
14567,",",0,0
14568,while,0,0
14569,none,0,0
14570,of,0,0
14571,the,0,0
14572,patients,0,0
14573,of,0,0
14574,the,0,0
14575,VATS,1,0
14576,group,0,0
14577,had,0,0
14578,any,0,0
14579,complication,0,0
14580,(,0,0
14581,<,0,0
14582,.001,0,0
14583,),0,0
14584,.,0,0
14585,Cost,0,0
14586,of,0,0
14587,ICT,1,0
14588,and,0,0
14589,VATS,1,0
14590,were,0,0
14591,$,0,0
14592,850,0,1
14593,and,0,0
14594,$,0,0
14595,1730,0,0
14596,",",0,0
14597,respectively,0,0
14598,.,0,0
14599,According,0,0
14600,to,0,0
14601,these,0,0
14602,results,0,0
14603,",",0,0
14604,VATS,1,0
14605,should,0,0
14606,be,0,0
14607,the,0,0
14608,treatment,0,0
14609,of,0,0
14610,choice,0,0
14611,in,0,0
14612,SP,0,0
14613,patients,0,0
14614,.,0,0
14615,It,0,0
14616,treats,0,0
14617,the,0,0
14618,cause,0,0
14619,of,0,0
14620,the,0,0
14621,disease,0,0
14622,.,0,0
14623,It,0,0
14624,also,0,0
14625,reduces,0,0
14626,the,0,0
14627,hospitalization,0,0
14628,time,0,0
14629,",",0,0
14630,the,0,0
14631,use,0,0
14632,of,0,0
14633,analgesic,0,1
14634,drugs,0,1
14635,post,0,0
14636,surgery,0,0
14637,",",0,0
14638,decreases,0,0
14639,recurrence,0,0
14640,of,0,0
14641,the,0,0
14642,disease,0,0
14643,and,0,0
14644,the,0,0
14645,cost,0,0
14646,of,0,0
14647,the,0,0
14648,treatment,0,0
14649,.,0,0
14650,Moreover,0,0
14651,",",0,0
14652,the,0,0
14653,patients,0,0
14654,were,0,0
14655,back,0,0
14656,to,0,0
14657,work,0,0
14658,in,0,0
14659,less,0,0
14660,than,0,0
14661,10,0,0
14662,days,0,0
14663,.,0,0
14664,Dose,0,1
14665,response,0,0
14666,effect,0,0
14667,of,0,0
14668,cyclical,1,1
14669,medroxyprogesterone,1,1
14670,on,0,0
14671,blood,0,0
14672,pressure,0,0
14673,in,0,0
14674,postmenopausal,0,0
14675,women,0,0
14676,.,0,0
14677,OBJECTIVE,0,0
14678,This,0,0
14679,study,0,0
14680,was,0,0
14681,designed,0,0
14682,to,0,0
14683,compare,0,0
14684,with,0,0
14685,placebo,1,1
14686,the,0,0
14687,dose-response,0,0
14688,effect,0,0
14689,of,0,0
14690,cyclical,0,1
14691,doses,0,0
14692,of,0,0
14693,the,0,0
14694,C21,1,0
14695,progestogen,1,1
14696,",",1,0
14697,medroxyprogesterone,1,1
14698,acetate,1,1
14699,(,0,1
14700,MPA,0,1
14701,),0,1
14702,on,0,0
14703,blood,0,0
14704,pressure,0,0
14705,(,0,1
14706,BP,0,0
14707,),0,1
14708,when,0,0
14709,administered,0,0
14710,to,0,0
14711,normotensive,0,0
14712,postmenopausal,0,0
14713,women,0,0
14714,receiving,0,0
14715,a,0,0
14716,fixed,0,1
14717,mid-range,0,0
14718,daily,0,1
14719,dose,0,0
14720,of,0,0
14721,conjugated,1,1
14722,equine,1,1
14723,oestrogen,1,1
14724,(,1,1
14725,CEE,1,1
14726,),1,0
14727,.,1,0
14728,MATERIALS,0,0
14729,AND,0,0
14730,METHODS,0,0
14731,Twenty,0,1
14732,normotensive,0,0
14733,postmenopausal,0,0
14734,women,0,0
14735,(,0,0
14736,median,0,0
14737,age,0,0
14738,53,0,0
14739,years,0,0
14740,),0,0
14741,participated,0,0
14742,in,0,0
14743,the,0,0
14744,study,0,0
14745,which,0,0
14746,used,0,0
14747,a,0,0
14748,double-blind,0,0
14749,crossover,0,0
14750,design,0,0
14751,.,0,0
14752,There,0,0
14753,were,0,0
14754,four,1,0
14755,randomised,1,0
14756,treatment,1,0
14757,phases,1,0
14758,",",0,0
14759,each,0,0
14760,of,0,0
14761,4,0,0
14762,weeks,0,0
14763,duration,0,0
14764,.,0,0
14765,The,0,0
14766,four,0,0
14767,blinded,0,0
14768,treatments,0,0
14769,were,0,0
14770,MPA,1,1
14771,2.5,1,1
14772,mg,1,1
14773,",",1,0
14774,MPA,1,1
14775,5,1,1
14776,mg,1,1
14777,",",1,0
14778,MPA,1,1
14779,10,1,1
14780,mg,1,1
14781,and,1,0
14782,matching,1,1
14783,placebo,1,1
14784,",",1,0
14785,taken,1,0
14786,for,1,0
14787,the,1,0
14788,last,1,0
14789,14,1,0
14790,days,1,0
14791,of,1,0
14792,each,1,0
14793,28,1,0
14794,day,1,0
14795,treatment,1,0
14796,cycle,1,0
14797,.,1,0
14798,CEE,0,0
14799,0.625,0,1
14800,mg,0,1
14801,was,0,0
14802,also,0,0
14803,administered,0,0
14804,once,0,0
14805,daily,0,1
14806,as,0,0
14807,open,0,1
14808,labelled,0,0
14809,tablets,0,1
14810,to,0,0
14811,all,0,0
14812,subjects,0,0
14813,throughout,0,0
14814,the,0,0
14815,study,0,0
14816,.,0,0
14817,Clinic,0,0
14818,BP,0,0
14819,was,0,0
14820,measured,0,0
14821,weekly,0,1
14822,with,0,0
14823,the,0,0
14824,mean,0,0
14825,values,0,0
14826,of,0,0
14827,weeks,0,0
14828,3,0,0
14829,and,0,0
14830,4,0,0
14831,of,0,0
14832,each,0,0
14833,phase,0,0
14834,used,0,0
14835,for,0,0
14836,analysis,0,0
14837,.,0,0
14838,Ambulatory,0,0
14839,BP,0,0
14840,was,0,0
14841,performed,0,0
14842,in,0,0
14843,the,0,0
14844,final,0,0
14845,week,0,0
14846,of,0,0
14847,each,0,0
14848,phase,0,0
14849,.,0,0
14850,RESULTS,0,0
14851,Compared,0,0
14852,with,0,0
14853,the,0,0
14854,placebo,0,1
14855,phase,0,0
14856,",",0,0
14857,end,0,0
14858,of,0,0
14859,phase,0,0
14860,clinic,0,0
14861,BP,0,0
14862,was,0,0
14863,unchanged,0,0
14864,by,0,0
14865,any,0,0
14866,of,0,0
14867,the,0,0
14868,progestogen,0,1
14869,treatments,0,0
14870,.,0,0
14871,There,0,0
14872,was,0,0
14873,a,0,0
14874,dose-dependent,0,0
14875,decrease,0,0
14876,in,0,0
14877,ambulatory,0,0
14878,daytime,0,0
14879,diastolic,0,0
14880,and,0,0
14881,mean,0,0
14882,arterial,0,0
14883,BP,0,0
14884,with,0,0
14885,the,0,0
14886,progestogen,0,1
14887,treatments,0,1
14888,compared,0,0
14889,with,0,0
14890,placebo,0,1
14891,(,0,0
14892,P,0,0
14893,<,0,0
14894,0.05,0,0
14895,),0,0
14896,.,0,0
14897,CONCLUSION,0,0
14898,In,0,0
14899,a,0,0
14900,regimen,0,1
14901,of,0,0
14902,postmenopausal,0,0
14903,hormone,0,1
14904,replacement,0,1
14905,therapy,0,1
14906,with,0,0
14907,a,0,0
14908,fixed,0,0
14909,mid-range,0,0
14910,daily,0,1
14911,dose,0,0
14912,of,0,0
14913,CEE,1,1
14914,combined,0,1
14915,with,0,0
14916,a,0,0
14917,cyclical,0,1
14918,regimen,0,1
14919,of,0,0
14920,a,0,0
14921,C21,0,0
14922,progestogen,0,1
14923,spanning,0,0
14924,the,0,0
14925,current,0,0
14926,clinical,0,0
14927,dose,0,0
14928,range,0,0
14929,",",0,0
14930,the,0,0
14931,progestogen,1,1
14932,has,0,0
14933,either,0,0
14934,no,0,0
14935,effect,0,0
14936,or,0,1
14937,a,0,0
14938,small,0,0
14939,dose-dependent,0,0
14940,reduction,0,0
14941,in,0,0
14942,clinic,0,0
14943,and,0,0
14944,ambulatory,0,0
14945,BPs,0,1
14946,over,0,0
14947,one,0,0
14948,treatment,0,0
14949,cycle,0,0
14950,.,0,0
14951,Why,0,0
14952,were,0,0
14953,the,0,0
14954,results,0,0
14955,of,0,0
14956,the,0,0
14957,Heart,0,1
14958,Outcomes,0,0
14959,Prevention,0,1
14960,Evaluation,0,1
14961,(,0,1
14962,HOPE,0,1
14963,),0,1
14964,trial,0,0
14965,so,0,0
14966,astounding,0,0
14967,?,0,0
14968,The,0,0
14969,Heart,0,0
14970,Outcomes,0,0
14971,Prevention,0,1
14972,Evaluation,0,1
14973,(,0,1
14974,HOPE,0,1
14975,),0,1
14976,study,0,0
14977,was,0,0
14978,important,0,0
14979,because,0,0
14980,it,0,0
14981,showed,0,0
14982,the,0,0
14983,benefits,0,0
14984,of,0,0
14985,ramipril,1,1
14986,-,0,0
14987,an,0,0
14988,angiotensin-converting,1,1
14989,enzyme,1,0
14990,(,1,1
14991,ACE,1,0
14992,),1,1
14993,inhibitor,1,1
14994,-,0,0
14995,in,0,0
14996,patients,0,0
14997,at,0,0
14998,high,0,0
14999,risk,0,0
15000,for,0,0
15001,cardiovascular,0,0
15002,events,0,0
15003,.,0,0
15004,Treatment,0,0
15005,with,0,0
15006,ramipril,1,1
15007,significantly,0,0
15008,reduced,0,0
15009,the,0,0
15010,rates,0,0
15011,of,0,0
15012,death,0,0
15013,",",0,0
15014,myocardial,0,0
15015,infarction,0,0
15016,",",0,0
15017,stroke,0,0
15018,",",0,0
15019,coronary,0,0
15020,revascularization,0,0
15021,",",0,0
15022,cardiac,0,0
15023,arrest,0,0
15024,and,0,0
15025,heart,0,0
15026,failure,0,0
15027,",",0,0
15028,as,0,0
15029,well,0,0
15030,as,0,0
15031,the,0,0
15032,risk,0,0
15033,of,0,0
15034,diabetes-related,0,0
15035,complications,0,0
15036,and,0,0
15037,of,0,0
15038,diabetes,0,0
15039,itself,0,0
15040,.,0,0
15041,The,0,0
15042,effects,0,0
15043,of,0,0
15044,therapy,0,1
15045,with,0,0
15046,vitamin,1,1
15047,E,1,1
15048,were,0,0
15049,also,0,0
15050,evaluated,0,0
15051,",",0,0
15052,but,0,0
15053,no,0,0
15054,statistical,0,0
15055,benefits,0,0
15056,were,0,0
15057,shown,0,0
15058,.,0,0
15059,The,0,0
15060,benefits,0,0
15061,of,0,0
15062,ACE,1,0
15063,inhibitor,1,1
15064,therapy,1,1
15065,that,0,0
15066,were,0,0
15067,observed,0,0
15068,were,0,0
15069,likely,0,0
15070,due,0,0
15071,to,0,0
15072,a,0,0
15073,variety,0,0
15074,of,0,0
15075,mechanisms,0,0
15076,",",0,0
15077,not,0,0
15078,just,0,0
15079,a,0,0
15080,reduction,0,0
15081,in,0,0
15082,blood,0,0
15083,pressure,0,0
15084,.,0,0
15085,A,0,0
15086,comparative,0,0
15087,study,0,0
15088,of,0,0
15089,caudal,1,1
15090,bupivacaine,1,1
15091,and,1,0
15092,midazolam-bupivacaine,1,1
15093,mixture,1,1
15094,for,0,0
15095,post-operative,0,0
15096,analgesia,0,0
15097,in,0,0
15098,children,0,0
15099,undergoing,0,0
15100,genitourinary,0,0
15101,surgery,0,1
15102,.,0,0
15103,OBJECTIVE,0,0
15104,This,0,0
15105,study,0,0
15106,was,0,0
15107,designed,0,0
15108,to,0,0
15109,evaluate,0,0
15110,the,0,0
15111,analgesic,0,1
15112,efficacy,0,0
15113,of,0,0
15114,caudal,1,1
15115,midazolam-bupivacaine,1,1
15116,combination,1,1
15117,in,0,0
15118,providing,0,0
15119,post-operative,0,0
15120,pain,0,0
15121,relief,0,0
15122,in,0,0
15123,children,0,0
15124,undergoing,0,0
15125,genitourinary,0,0
15126,surgery,0,1
15127,and,0,0
15128,to,0,0
15129,study,0,0
15130,the,0,0
15131,occurrence,0,0
15132,of,0,0
15133,adverse,0,0
15134,effects,0,0
15135,.,0,0
15136,SUBJECTS,0,0
15137,AND,0,0
15138,METHODS,0,0
15139,Thirty,0,0
15140,children,0,0
15141,",",0,0
15142,aged,0,0
15143,2,0,0
15144,to,0,0
15145,8,0,0
15146,years,0,0
15147,",",0,0
15148,scheduled,0,0
15149,for,0,0
15150,genitourinary,0,0
15151,surgery,0,1
15152,were,0,0
15153,allocated,0,0
15154,randomly,0,0
15155,to,0,0
15156,receive,0,0
15157,either,0,0
15158,0.25,0,1
15159,%,0,0
15160,bupivacaine,1,1
15161,0.5,0,1
15162,ml/kg,0,0
15163,(,0,0
15164,group,0,0
15165,B,0,1
15166,;,0,0
15167,n,0,0
15168,=,0,0
15169,15,0,0
15170,),0,0
15171,or,0,1
15172,0.25,0,1
15173,%,0,0
15174,bupivacaine,1,1
15175,0.5,1,1
15176,ml/kg,1,0
15177,with,1,0
15178,50,1,0
15179,microg/kg,1,1
15180,midazolam,1,1
15181,(,0,0
15182,group,0,0
15183,BM,0,1
15184,;,0,0
15185,n,0,0
15186,=,0,0
15187,15,0,0
15188,),0,0
15189,by,0,0
15190,the,0,0
15191,caudal,0,1
15192,route,0,1
15193,immediately,0,0
15194,after,0,0
15195,induction,0,0
15196,of,0,0
15197,general,0,0
15198,anesthesia,0,1
15199,.,0,0
15200,Heart,0,0
15201,rate,0,0
15202,",",0,0
15203,arterial,0,0
15204,blood,0,0
15205,pressure,0,0
15206,and,0,0
15207,oxygen,0,1
15208,saturation,0,0
15209,were,0,0
15210,monitored,0,0
15211,throughout,0,0
15212,the,0,0
15213,study,0,0
15214,period,0,0
15215,.,0,0
15216,Postoperative,0,0
15217,pain,0,0
15218,was,0,0
15219,assessed,0,0
15220,at,0,0
15221,regular,0,0
15222,intervals,0,0
15223,for,0,0
15224,12,0,0
15225,hours,0,0
15226,using,0,0
15227,an,0,0
15228,objective,0,0
15229,pain,0,0
15230,score,0,0
15231,.,0,0
15232,Analgesia,0,0
15233,was,0,0
15234,supplemented,0,1
15235,whenever,0,0
15236,the,0,0
15237,pain,0,0
15238,score,0,0
15239,was,0,0
15240,>,0,0
15241,or,0,1
15242,=,0,0
15243,4,0,0
15244,.,0,0
15245,Duration,0,0
15246,of,0,0
15247,analgesia,0,0
15248,",",0,0
15249,as,0,0
15250,well,0,0
15251,as,0,0
15252,the,0,0
15253,requirement,0,0
15254,of,0,0
15255,additional,0,0
15256,analgesics,0,0
15257,",",0,0
15258,were,0,0
15259,noted,0,0
15260,.,0,0
15261,RESULTS,0,0
15262,Lowest,0,0
15263,pain,0,0
15264,scores,0,0
15265,were,0,0
15266,observed,0,0
15267,with,0,0
15268,the,0,0
15269,addition,0,0
15270,of,0,0
15271,midazolam,1,1
15272,to,1,0
15273,caudal,1,1
15274,bupivacaine,1,1
15275,(,0,0
15276,p,0,0
15277,<,0,0
15278,0.01,0,0
15279,),0,0
15280,.,0,0
15281,Duration,0,0
15282,of,0,0
15283,analgesia,0,0
15284,was,0,0
15285,longer,0,0
15286,in,0,0
15287,group,0,0
15288,BM,0,1
15289,(,0,0
15290,11,0,0
15291,+/-,0,0
15292,0.5,0,1
15293,h,0,0
15294,),0,0
15295,as,0,0
15296,compared,0,0
15297,to,0,0
15298,group,0,0
15299,B,0,1
15300,(,0,0
15301,7.4,0,0
15302,+/-,0,0
15303,2.1,0,0
15304,hours,0,0
15305,),0,0
15306,(,0,0
15307,p,0,0
15308,<,0,0
15309,0.05,0,0
15310,),0,0
15311,.,0,0
15312,Fewer,0,0
15313,children,0,0
15314,(,0,0
15315,26.6,0,0
15316,%,0,0
15317,),0,0
15318,required,0,0
15319,additional,0,0
15320,analgesia,0,0
15321,in,0,0
15322,the,0,0
15323,combination,0,1
15324,group,0,0
15325,whereas,0,0
15326,in,0,0
15327,group,0,0
15328,B,0,0
15329,",",0,0
15330,60,0,0
15331,%,0,0
15332,of,0,0
15333,the,0,0
15334,children,0,0
15335,received,0,0
15336,analgesic,0,0
15337,supplements,0,1
15338,within,0,0
15339,6,0,0
15340,hours,0,0
15341,after,0,0
15342,surgery,0,1
15343,(,0,0
15344,p,0,0
15345,<,0,0
15346,0.05,0,0
15347,),0,0
15348,.,0,0
15349,There,0,0
15350,were,0,0
15351,no,0,0
15352,significant,0,0
15353,changes,0,0
15354,in,0,0
15355,heart,0,0
15356,rate,0,0
15357,",",0,0
15358,blood,0,0
15359,pressure,0,0
15360,and,0,0
15361,oxygen,0,1
15362,saturation,0,0
15363,in,0,0
15364,both,0,0
15365,groups,0,0
15366,.,0,0
15367,We,0,0
15368,observed,0,0
15369,no,0,0
15370,untoward,0,0
15371,event,0,0
15372,in,0,0
15373,either,0,0
15374,of,0,0
15375,the,0,0
15376,groups,0,0
15377,.,0,0
15378,CONCLUSION,0,0
15379,Caudal,1,0
15380,administration,1,0
15381,of,1,0
15382,bupivacaine-midazolam,1,1
15383,mixture,1,1
15384,prolongs,0,1
15385,post-operative,0,0
15386,analgesia,0,0
15387,compared,0,0
15388,to,0,0
15389,bupivacaine,1,1
15390,alone,0,1
15391,without,0,0
15392,causing,0,0
15393,any,0,0
15394,adverse,0,0
15395,effects,0,0
15396,.,0,0
15397,There,0,0
15398,are,0,0
15399,some,0,0
15400,benefits,0,0
15401,for,0,0
15402,eradicating,0,0
15403,Helicobacter,0,0
15404,pylori,0,0
15405,in,0,0
15406,patients,0,0
15407,with,0,0
15408,non-ulcer,0,0
15409,dyspepsia,0,0
15410,.,0,0
15411,BACKGROUND,0,0
15412,The,0,0
15413,relationship,0,0
15414,between,0,0
15415,Helicobacter,0,0
15416,pylori,0,0
15417,infection,0,0
15418,and,0,0
15419,non-ulcer,0,0
15420,dyspepsia,0,0
15421,is,0,0
15422,not,0,0
15423,established,0,0
15424,.,0,0
15425,AIM,0,0
15426,To,0,0
15427,determine,0,0
15428,whether,0,0
15429,eradication,0,0
15430,of,0,0
15431,H.,0,0
15432,pylori,0,0
15433,might,0,0
15434,be,0,0
15435,of,0,0
15436,benefit,0,0
15437,in,0,0
15438,non-ulcer,0,0
15439,dyspepsia,0,0
15440,patients,0,0
15441,.,0,0
15442,METHODS,0,0
15443,We,0,0
15444,randomly,0,0
15445,assigned,0,0
15446,129,0,0
15447,H.,0,0
15448,pylori,0,0
15449,infected,0,0
15450,patients,0,0
15451,with,0,0
15452,severe,0,0
15453,epigastric,0,0
15454,pain,0,0
15455,",",0,0
15456,without,0,0
15457,gastro-oesophageal,0,0
15458,reflux,0,0
15459,symptoms,0,0
15460,",",0,0
15461,to,0,0
15462,receive,0,0
15463,twice,0,1
15464,daily,0,1
15465,treatment,0,0
15466,with,0,0
15467,300,0,1
15468,mg,0,1
15469,of,0,0
15470,ranitidine,1,1
15471,",",0,0
15472,1000,0,0
15473,mg,0,1
15474,of,0,0
15475,amoxicillin,1,1
15476,",",0,0
15477,and,0,0
15478,500,0,1
15479,mg,0,1
15480,of,0,0
15481,clarithromycin,1,1
15482,for,0,0
15483,7,0,0
15484,days,0,0
15485,and,0,0
15486,124,0,0
15487,such,0,0
15488,patients,0,0
15489,to,0,0
15490,receive,0,0
15491,identical-appearing,0,0
15492,placebos,1,1
15493,.,1,0
15494,RESULTS,0,0
15495,Treatment,0,0
15496,was,0,0
15497,successful,0,0
15498,(,0,0
15499,decrease,0,0
15500,of,0,0
15501,symptoms,0,0
15502,at,0,0
15503,12,0,0
15504,months,0,0
15505,),0,0
15506,in,0,0
15507,62,0,0
15508,%,0,0
15509,of,0,0
15510,patients,0,0
15511,in,0,0
15512,the,0,0
15513,active-treatment,0,1
15514,group,0,0
15515,and,0,0
15516,in,0,0
15517,60,0,0
15518,%,0,0
15519,of,0,0
15520,the,0,0
15521,placebo,0,1
15522,group,0,0
15523,(,0,1
15524,N.S.,0,1
15525,),0,0
15526,.,0,0
15527,At,0,0
15528,12,0,0
15529,months,0,0
15530,",",0,0
15531,the,0,0
15532,rate,0,0
15533,of,0,0
15534,eradication,0,0
15535,of,0,0
15536,H.,0,0
15537,pylori,0,0
15538,was,0,0
15539,69,0,0
15540,%,0,0
15541,in,0,0
15542,the,0,0
15543,active-treatment,0,1
15544,group,0,0
15545,and,0,0
15546,18,0,0
15547,%,0,0
15548,in,0,0
15549,the,0,0
15550,placebo,1,1
15551,group,0,0
15552,(,0,0
15553,P,0,0
15554,<,0,0
15555,0.001,0,0
15556,),0,0
15557,.,0,0
15558,Complete,0,0
15559,relief,0,0
15560,of,0,0
15561,symptoms,0,0
15562,occurred,0,0
15563,significantly,0,0
15564,more,0,0
15565,frequently,0,0
15566,in,0,0
15567,patients,0,0
15568,on,0,0
15569,the,0,0
15570,active,0,1
15571,treatment,0,0
15572,(,0,0
15573,43,0,0
15574,%,0,0
15575,),0,0
15576,than,0,0
15577,in,0,0
15578,placebo-treated,1,0
15579,patients,0,0
15580,(,0,0
15581,31,0,0
15582,%,0,0
15583,",",0,0
15584,P=0.048,0,0
15585,),0,0
15586,.,0,0
15587,Within,0,0
15588,the,0,0
15589,active-treatment,0,1
15590,group,0,0
15591,",",0,0
15592,therapeutic,0,0
15593,success,0,0
15594,was,0,0
15595,significantly,0,0
15596,more,0,0
15597,frequent,0,0
15598,in,0,0
15599,the,0,0
15600,non-infected,0,0
15601,patients,0,0
15602,(,0,0
15603,84,0,0
15604,%,0,0
15605,vs.,0,0
15606,64,0,0
15607,%,0,0
15608,",",0,0
15609,P=0.04,0,0
15610,),0,0
15611,.,0,0
15612,CONCLUSIONS,0,0
15613,Although,0,0
15614,eradicating,0,0
15615,H.,0,0
15616,pylori,0,0
15617,is,0,0
15618,not,0,0
15619,likely,0,0
15620,to,0,0
15621,relieve,0,0
15622,symptoms,0,0
15623,in,0,0
15624,the,0,0
15625,majority,0,0
15626,of,0,0
15627,patients,0,0
15628,with,0,0
15629,non-ulcer,0,0
15630,dyspepsia,0,0
15631,",",0,0
15632,a,0,0
15633,small,0,0
15634,proportion,0,0
15635,of,0,0
15636,H.,0,0
15637,pylori-infected,0,0
15638,patients,0,0
15639,may,0,0
15640,benefit,0,0
15641,from,0,0
15642,eradication,0,0
15643,treatment,0,0
15644,.,0,0
15645,Olanzapine,1,1
15646,versus,1,1
15647,haloperidol,1,1
15648,in,0,0
15649,children,0,0
15650,with,0,0
15651,autistic,0,0
15652,disorder,0,0
15653,:,0,0
15654,an,0,0
15655,open,0,1
15656,pilot,0,0
15657,study,0,0
15658,.,0,0
15659,OBJECTIVES,0,0
15660,Conventional,0,1
15661,neuroleptics,1,1
15662,ameliorate,0,0
15663,symptoms,0,0
15664,in,0,0
15665,children,0,0
15666,with,0,0
15667,autistic,0,0
15668,disorder,0,0
15669,;,0,0
15670,however,0,0
15671,",",0,0
15672,they,0,0
15673,are,0,0
15674,known,0,0
15675,to,0,0
15676,cause,0,0
15677,dyskinesias,0,0
15678,.,0,0
15679,Atypical,1,0
15680,neuroleptics,1,1
15681,",",0,0
15682,including,0,0
15683,olanzapine,0,1
15684,",",0,0
15685,may,0,0
15686,have,0,0
15687,less,0,0
15688,risk,0,0
15689,for,0,0
15690,dyskinesia,0,0
15691,",",0,0
15692,but,0,0
15693,their,0,0
15694,efficacy,0,0
15695,in,0,0
15696,autistic,0,0
15697,disorder,0,0
15698,is,0,0
15699,not,0,0
15700,established,0,0
15701,.,0,0
15702,This,0,0
15703,study,0,0
15704,was,0,0
15705,designed,0,0
15706,to,0,0
15707,investigate,0,0
15708,the,0,0
15709,safety,0,0
15710,and,0,0
15711,effectiveness,0,0
15712,of,0,0
15713,open-label,0,0
15714,olanzapine,1,1
15715,as,0,0
15716,a,0,0
15717,treatment,0,0
15718,for,0,0
15719,children,0,0
15720,with,0,0
15721,autistic,0,0
15722,disorder,0,0
15723,by,0,0
15724,using,0,0
15725,haloperidol,1,1
15726,as,0,0
15727,a,0,0
15728,standard,0,1
15729,comparator,0,1
15730,treatment,0,0
15731,.,0,0
15732,METHOD,0,0
15733,In,0,0
15734,a,0,0
15735,parallel,0,0
15736,groups,0,0
15737,design,0,0
15738,",",0,0
15739,12,0,0
15740,children,0,0
15741,with,0,0
15742,DSM-IV,0,0
15743,autistic,0,0
15744,disorder,0,0
15745,(,0,1
15746,mean,0,0
15747,age,0,0
15748,7.8+/-2.1,0,1
15749,years,0,0
15750,),0,0
15751,were,0,0
15752,randomized,0,0
15753,to,0,0
15754,6,0,0
15755,weeks,0,0
15756,of,0,0
15757,open,1,1
15758,treatment,1,0
15759,with,1,0
15760,olanzapine,1,1
15761,or,1,1
15762,haloperidol,1,1
15763,.,1,1
15764,Mean,0,0
15765,final,0,0
15766,dosages,0,0
15767,were,0,0
15768,7.9+/-2.5,0,0
15769,mg/day,0,1
15770,for,0,0
15771,olanzapine,1,1
15772,and,0,0
15773,1.4+/-0.7,0,0
15774,mg/day,0,1
15775,for,0,0
15776,haloperidol,1,1
15777,.,1,0
15778,Outcome,0,0
15779,measures,0,0
15780,included,0,0
15781,the,0,0
15782,Clinical,0,0
15783,Global,0,0
15784,Impressions,0,1
15785,(,0,1
15786,CGI,0,0
15787,),0,1
15788,and,0,0
15789,the,0,0
15790,Children,0,0
15791,'s,0,0
15792,Psychiatric,0,0
15793,Rating,0,0
15794,Scale,0,1
15795,(,0,1
15796,CPRS,0,1
15797,),0,0
15798,.,0,0
15799,RESULTS,0,0
15800,Both,0,1
15801,groups,0,0
15802,had,0,0
15803,symptom,0,0
15804,reduction,0,0
15805,.,0,0
15806,Five,0,0
15807,of,0,0
15808,six,0,0
15809,in,0,0
15810,the,0,0
15811,olanzapine,1,1
15812,group,0,0
15813,and,0,0
15814,three,0,0
15815,of,0,0
15816,six,0,0
15817,in,0,0
15818,the,0,0
15819,haloperidol,1,1
15820,group,0,0
15821,were,0,0
15822,rated,0,0
15823,as,0,0
15824,responders,0,0
15825,according,0,0
15826,to,0,0
15827,the,0,0
15828,CGI,0,0
15829,Improvement,0,0
15830,item,0,0
15831,.,0,0
15832,Subjects,0,0
15833,showed,0,0
15834,improvement,0,0
15835,on,0,0
15836,the,0,0
15837,CPRS,0,1
15838,Autism,0,0
15839,Factor,0,1
15840,(,0,0
15841,"F1,9",0,0
15842,=,0,0
15843,24.4,0,0
15844,",",0,0
15845,p,0,0
15846,=,0,0
15847,.0008,0,0
15848,),0,0
15849,.,0,0
15850,Side,0,0
15851,effects,0,0
15852,included,0,0
15853,drowsiness,0,0
15854,and,0,0
15855,weight,0,0
15856,gain,0,0
15857,.,0,0
15858,CONCLUSIONS,0,0
15859,The,0,0
15860,findings,0,0
15861,suggest,0,0
15862,that,0,0
15863,olanzapine,1,1
15864,is,0,0
15865,a,0,0
15866,promising,0,0
15867,treatment,0,0
15868,for,0,0
15869,children,0,0
15870,with,0,0
15871,autistic,0,0
15872,disorder,0,0
15873,.,0,0
15874,Further,0,0
15875,placebo-controlled,0,1
15876,and,0,0
15877,long-term,0,0
15878,studies,0,0
15879,of,0,0
15880,olanzapine,1,1
15881,in,0,0
15882,autistic,0,0
15883,disorder,0,0
15884,are,0,0
15885,required,0,0
15886,.,0,0
15887,Comparison,0,0
15888,of,0,0
15889,thiopentone/guaifenesin,1,1
15890,",",1,0
15891,ketamine/guaifenesin,1,1
15892,and,1,0
15893,ketamine/midazolam,1,1
15894,for,0,0
15895,the,0,0
15896,induction,0,0
15897,of,0,0
15898,horses,0,0
15899,to,0,0
15900,be,0,0
15901,anaesthetised,0,1
15902,with,0,0
15903,isoflurane,0,1
15904,.,0,0
15905,Forty-eight,0,0
15906,horses,0,0
15907,subjected,0,0
15908,to,0,0
15909,elective,0,0
15910,surgery,0,0
15911,were,0,0
15912,randomly,0,0
15913,assigned,0,0
15914,to,0,0
15915,three,0,0
15916,groups,0,0
15917,of,0,0
15918,16,0,0
15919,horses,0,0
15920,.,0,0
15921,After,0,0
15922,premedication,0,0
15923,with,0,0
15924,0.1,0,0
15925,mg/kg,0,1
15926,acepromazine,1,1
15927,intramuscularly,0,1
15928,and,0,0
15929,0.6,0,0
15930,mg/kg,0,1
15931,xylazine,1,1
15932,intravenously,0,1
15933,",",0,0
15934,anaesthesia,0,1
15935,was,0,0
15936,induced,0,0
15937,either,0,0
15938,with,0,0
15939,2,0,0
15940,g,0,1
15941,thiopentone,1,1
15942,in,0,0
15943,500,0,1
15944,ml,0,0
15945,of,0,0
15946,a,0,0
15947,10,0,0
15948,per,0,0
15949,cent,0,0
15950,guaifenesin,1,1
15951,solution,0,1
15952,",",0,0
15953,given,0,0
15954,intravenously,0,1
15955,at,0,0
15956,a,0,0
15957,dose,0,0
15958,of,0,0
15959,1,0,0
15960,ml/kg,0,0
15961,(,0,0
15962,group,0,1
15963,TG,0,1
15964,),0,0
15965,",",0,0
15966,or,0,1
15967,with,0,0
15968,100,0,0
15969,mg/kg,0,1
15970,guaifenesin,1,1
15971,and,1,0
15972,2.2,1,0
15973,mg/kg,1,1
15974,ketamine,1,1
15975,given,0,0
15976,intravenously,0,1
15977,(,0,0
15978,group,0,1
15979,KG,0,1
15980,),0,0
15981,",",0,0
15982,or,0,1
15983,with,0,0
15984,0.06,0,0
15985,mg/kg,0,1
15986,midazolam,1,1
15987,",",0,0
15988,and,0,0
15989,2.2,0,0
15990,mg/kg,0,1
15991,ketamine,1,1
15992,given,0,0
15993,intravenously,0,1
15994,(,0,0
15995,group,0,1
15996,KM,0,1
15997,),0,0
15998,.,0,0
15999,Anaesthesia,0,0
16000,was,0,0
16001,maintained,0,0
16002,with,0,0
16003,isoflurane,1,1
16004,.,1,0
16005,The,0,0
16006,mean,0,0
16007,(,0,1
16008,sd,0,0
16009,),0,1
16010,end,0,0
16011,tidal,0,1
16012,isoflurane,1,1
16013,concentration,0,0
16014,(,0,0
16015,per,0,1
16016,cent,0,0
16017,),0,0
16018,needed,0,0
16019,to,0,0
16020,maintain,0,0
16021,a,0,0
16022,light,0,1
16023,surgical,0,1
16024,anaesthesia,0,1
16025,(,0,1
16026,stage,0,0
16027,III,0,1
16028,",",0,0
16029,plane,0,1
16030,2,0,0
16031,),0,0
16032,was,0,0
16033,significantly,0,0
16034,lower,0,0
16035,in,0,0
16036,group,0,0
16037,KM,0,1
16038,(,0,0
16039,0.91,0,0
16040,[,0,0
16041,0.03,0,0
16042,],0,0
16043,),0,0
16044,than,0,0
16045,in,0,0
16046,groups,0,0
16047,TG,0,0
16048,(,0,0
16049,1.11,0,0
16050,[,0,0
16051,0.03,0,0
16052,],0,0
16053,),0,0
16054,and,0,1
16055,KG,0,1
16056,(,0,0
16057,1.14,0,0
16058,[,0,0
16059,0.03,0,0
16060,],0,0
16061,),0,0
16062,.,0,0
16063,The,0,0
16064,mean,0,0
16065,(,0,1
16066,sd,0,0
16067,),0,1
16068,arterial,0,1
16069,pressure,0,1
16070,(,0,1
16071,mmHg,0,1
16072,),0,1
16073,was,0,0
16074,significantly,0,0
16075,lower,0,0
16076,in,0,0
16077,group,0,0
16078,KG,0,1
16079,(,0,0
16080,67.4,0,0
16081,[,0,0
16082,2.07,0,0
16083,],0,0
16084,),0,0
16085,than,0,0
16086,in,0,0
16087,groups,0,0
16088,TC,0,1
16089,(,0,0
16090,75.6,0,0
16091,[,0,0
16092,2.23,0,0
16093,],0,0
16094,),0,0
16095,and,0,1
16096,KM,0,1
16097,(,0,0
16098,81.0,0,0
16099,[,0,0
16100,2.16,0,0
16101,],0,0
16102,),0,0
16103,.,0,0
16104,There,0,0
16105,were,0,0
16106,no,0,0
16107,significant,0,0
16108,differences,0,0
16109,in,0,0
16110,the,0,0
16111,logarithm,0,0
16112,of,0,0
16113,the,0,0
16114,heart,0,0
16115,rate,0,0
16116,",",0,0
16117,recovery,0,0
16118,time,0,0
16119,or,0,1
16120,quality,0,0
16121,of,0,0
16122,recovery,0,0
16123,between,0,0
16124,the,0,0
16125,three,0,0
16126,induction,0,0
16127,groups,0,0
16128,.,0,0
16129,However,0,0
16130,",",0,0
16131,pronounced,0,0
16132,ataxia,0,0
16133,was,0,0
16134,observed,0,0
16135,in,0,0
16136,the,0,0
16137,horses,0,0
16138,of,0,0
16139,group,0,0
16140,KM,0,1
16141,",",0,0
16142,especially,0,0
16143,after,0,0
16144,periods,0,0
16145,of,0,0
16146,anaesthesia,0,1
16147,lasting,0,0
16148,less,0,0
16149,than,0,0
16150,75,0,0
16151,minutes,0,0
16152,.,0,0
16153,[,0,0
16154,Comparison,0,0
16155,between,0,0
16156,anterior,1,0
16157,rhinomanometry,1,0
16158,and,0,0
16159,impulse-oscillometric,1,1
16160,rhinometry,1,1
16161,found,0,0
16162,within,0,0
16163,nasal,0,0
16164,allergen,0,1
16165,provocation,0,0
16166,],0,0
16167,.,0,0
16168,UNLABELLED,0,0
16169,Besides,0,0
16170,the,0,0
16171,standard,0,1
16172,method,0,0
16173,of,0,0
16174,anterior,1,1
16175,rhinomanometry,1,1
16176,(,1,1
16177,aR,1,0
16178,),1,0
16179,",",1,0
16180,the,1,0
16181,impulse-oscillometric,1,1
16182,rhinometry,1,1
16183,(,1,1
16184,IOS,1,1
16185,),1,1
16186,is,0,0
16187,available,0,0
16188,for,0,0
16189,measurements,0,0
16190,of,0,0
16191,the,0,0
16192,nasal,0,0
16193,resistance,0,0
16194,.,0,0
16195,The,0,0
16196,aR,0,0
16197,is,0,0
16198,a,0,0
16199,procedure,0,0
16200,dependent,0,0
16201,on,0,0
16202,the,0,0
16203,cooperation,0,0
16204,of,0,0
16205,the,0,0
16206,patient,0,0
16207,",",0,0
16208,whereas,0,0
16209,IOS,0,1
16210,is,0,0
16211,measured,0,0
16212,regardless,0,0
16213,from,0,0
16214,the,0,0
16215,breathing,0,1
16216,activities,0,0
16217,of,0,0
16218,the,0,0
16219,patient,0,0
16220,.,0,0
16221,We,0,0
16222,examined,0,0
16223,weather,0,0
16224,the,0,0
16225,resistance-measurement,0,0
16226,by,0,0
16227,means,0,0
16228,of,0,0
16229,IOS,0,1
16230,in,0,0
16231,comparison,0,0
16232,to,0,0
16233,the,0,0
16234,aR,0,0
16235,is,0,0
16236,a,0,0
16237,more,0,0
16238,suitable,0,0
16239,method,0,1
16240,for,0,0
16241,nasal,0,0
16242,allergic,0,0
16243,provocation,0,0
16244,.,0,0
16245,METHOD,0,0
16246,17,0,0
16247,patients,0,0
16248,with,0,0
16249,anamnestic,0,0
16250,known,0,0
16251,rhinokonjunktivitis,0,0
16252,(,0,0
16253,6,0,0
16254,f,0,0
16255,",",0,0
16256,11,0,0
16257,m,0,0
16258,),0,0
16259,had,0,0
16260,a,0,0
16261,pricktest,1,0
16262,and,0,0
16263,then,0,1
16264,a,0,0
16265,nasal,1,0
16266,provocation,1,0
16267,testing,1,0
16268,with,0,0
16269,an,0,0
16270,allergen,0,1
16271,which,0,0
16272,provoked,0,0
16273,a,0,0
16274,reaction,0,1
16275,on,0,0
16276,the,0,0
16277,skin,0,0
16278,.,0,0
16279,The,0,0
16280,complete,0,0
16281,resistance,0,0
16282,of,0,0
16283,the,0,0
16284,nose,0,0
16285,was,0,0
16286,measured,0,0
16287,in,0,0
16288,a,0,0
16289,randomized,0,0
16290,order,0,0
16291,by,0,0
16292,means,0,0
16293,of,0,0
16294,aR,1,0
16295,and,1,0
16296,IOS,1,1
16297,.,1,0
16298,RESULTS,0,0
16299,The,0,0
16300,complete,0,0
16301,resistance,0,0
16302,showed,0,0
16303,neither,0,0
16304,in,0,0
16305,the,0,0
16306,basic,0,1
16307,measurement,0,1
16308,(,0,0
16309,aR,0,0
16310,"0,38",0,0
16311,+/-,0,0
16312,"0,14",0,0
16313,kPa/l/s,0,1
16314,;,0,0
16315,IOS,0,1
16316,"0,38",0,0
16317,+/-,0,0
16318,"0,11",0,0
16319,kPa/l/s,0,1
16320,),0,0
16321,nor,0,0
16322,in,0,0
16323,the,0,0
16324,control,0,1
16325,solution,0,1
16326,(,0,0
16327,aR,0,0
16328,"0,38",0,0
16329,+/-,0,0
16330,"0,14",0,0
16331,;,0,0
16332,IOS,0,1
16333,"0,39",0,0
16334,+/-,0,0
16335,"0,14",0,0
16336,),0,0
16337,nor,0,0
16338,after,0,0
16339,application,0,1
16340,of,0,0
16341,the,0,0
16342,allergenic,0,1
16343,solution,0,1
16344,(,0,0
16345,15,0,0
16346,min,0,0
16347,:,0,0
16348,aR,0,0
16349,"0,69",0,0
16350,+/-,0,0
16351,"0,27",0,0
16352,;,0,0
16353,IOS,0,1
16354,"0,77",0,0
16355,+/-,0,0
16356,"0,42",0,0
16357,;,0,0
16358,30,0,0
16359,min,0,0
16360,:,0,0
16361,aR,0,0
16362,"0,65",0,0
16363,+/-,0,0
16364,"0,29",0,0
16365,;,0,0
16366,IOS,0,1
16367,"0,6",0,0
16368,+/-,0,0
16369,"0,38",0,0
16370,),0,0
16371,a,0,0
16372,significant,0,0
16373,difference,0,0
16374,between,0,0
16375,the,0,0
16376,two,0,0
16377,methods,0,0
16378,.,0,0
16379,The,0,0
16380,results,0,0
16381,of,0,0
16382,the,0,0
16383,measurement,0,0
16384,of,0,0
16385,aR,0,0
16386,and,0,0
16387,IOS,0,1
16388,after,0,0
16389,the,0,0
16390,allergenic,0,0
16391,solution,0,1
16392,showed,0,0
16393,a,0,0
16394,positive,0,0
16395,correlation,0,0
16396,(,0,0
16397,15,0,0
16398,min,0,0
16399,:,0,0
16400,r,0,0
16401,=,0,0
16402,"0,63",0,0
16403,",",0,0
16404,p,0,0
16405,<,0,0
16406,"0,01",0,0
16407,;,0,0
16408,30,0,0
16409,min,0,0
16410,:,0,0
16411,r,0,0
16412,=,0,0
16413,"0,67",0,0
16414,",",0,0
16415,p,0,0
16416,<,0,0
16417,"0,01",0,0
16418,),0,0
16419,.,0,0
16420,We,0,0
16421,found,0,0
16422,by,0,0
16423,means,0,0
16424,of,0,0
16425,clinic,0,0
16426,and,0,0
16427,measurement,0,0
16428,methods,0,0
16429,in,0,0
16430,the,0,0
16431,aR,0,0
16432,of,0,0
16433,7,0,0
16434,patients,0,0
16435,a,0,0
16436,positive,0,0
16437,reaction,0,1
16438,",",0,0
16439,within,0,0
16440,7,0,0
16441,patient,0,0
16442,a,0,0
16443,negative,0,0
16444,reaction,0,1
16445,",",0,0
16446,3,0,0
16447,patients,0,0
16448,had,0,0
16449,a,0,0
16450,unspecific,0,0
16451,nasal,0,0
16452,hyperreactivity,0,0
16453,.,0,0
16454,There,0,0
16455,was,0,0
16456,a,0,0
16457,correspondence,0,0
16458,in,0,0
16459,6,0,0
16460,of,0,0
16461,the,0,0
16462,7,0,0
16463,patients,0,0
16464,with,0,0
16465,positive,0,0
16466,reaction,0,1
16467,in,0,0
16468,aR,0,0
16469,between,0,0
16470,both,0,0
16471,methods,0,0
16472,.,0,0
16473,4,0,0
16474,of,0,0
16475,the,0,0
16476,7,0,0
16477,results,0,0
16478,with,0,0
16479,negative,0,0
16480,reaction,0,1
16481,in,0,0
16482,the,0,0
16483,aR,0,0
16484,would,0,0
16485,have,0,0
16486,been,0,0
16487,positive,0,0
16488,then,0,1
16489,underlying,0,0
16490,the,0,0
16491,same,0,0
16492,criteria,0,0
16493,in,0,0
16494,the,0,0
16495,IOS,0,1
16496,without,0,0
16497,announcing,0,0
16498,the,0,0
16499,symptomscore,0,0
16500,a,0,0
16501,relevant,0,0
16502,clinical,0,0
16503,symptomatic,0,0
16504,while,0,0
16505,testing,0,0
16506,.,0,0
16507,CONCLUSION,0,0
16508,IOS,1,1
16509,is,0,0
16510,a,0,0
16511,suitable,0,0
16512,procedure,0,0
16513,for,0,0
16514,nasal,0,1
16515,provocation,0,0
16516,testing,0,1
16517,and,0,0
16518,provides,0,0
16519,results,0,0
16520,similar,0,0
16521,to,0,0
16522,the,0,0
16523,aR,0,0
16524,.,0,0
16525,In,0,0
16526,comparison,0,0
16527,to,0,0
16528,aR,0,0
16529,IOS,0,1
16530,is,0,0
16531,not,0,0
16532,dependent,0,0
16533,on,0,0
16534,the,0,0
16535,patients,0,0
16536,cooperation,0,0
16537,.,0,0
16538,Due,0,1
16539,to,0,0
16540,its,0,0
16541,higher,0,0
16542,sensitivity,0,0
16543,the,0,0
16544,valid,0,0
16545,limits,0,0
16546,of,0,0
16547,the,0,0
16548,aR,0,0
16549,at,0,0
16550,provocation,0,0
16551,testings,0,1
16552,can,0,0
16553,not,0,0
16554,be,0,0
16555,transferred,0,0
16556,to,0,0
16557,IOS,0,1
16558,to,0,0
16559,avoid,0,0
16560,a,0,0
16561,false,0,0
16562,positive,0,0
16563,reaction,0,1
16564,.,0,0
16565,Penetration,0,1
16566,of,0,0
16567,ofloxacin,1,1
16568,and,1,0
16569,ciprofloxacin,1,1
16570,into,0,0
16571,the,0,0
16572,aqueous,0,1
16573,humor,0,0
16574,of,0,0
16575,eyes,0,0
16576,with,0,0
16577,functioning,0,0
16578,filtering,0,0
16579,blebs,0,1
16580,:,0,0
16581,a,0,0
16582,randomized,0,0
16583,trial,0,0
16584,.,0,0
16585,OBJECTIVE,0,0
16586,To,0,0
16587,determine,0,0
16588,concentrations,0,0
16589,of,0,0
16590,ofloxacin,0,1
16591,and,0,0
16592,ciprofloxacin,0,1
16593,hydrochloride,0,1
16594,in,0,0
16595,aqueous,0,1
16596,humor,0,0
16597,after,0,0
16598,topical,0,1
16599,or,0,1
16600,combined,0,1
16601,topical,0,1
16602,and,0,0
16603,oral,0,1
16604,administration,0,0
16605,in,0,0
16606,eyes,0,0
16607,with,0,0
16608,filtering,0,0
16609,blebs,0,1
16610,.,0,0
16611,DESIGN,0,0
16612,A,0,0
16613,prospective,0,0
16614,",",0,0
16615,investigator-masked,0,0
16616,",",0,0
16617,randomized,0,0
16618,",",0,0
16619,controlled,0,0
16620,comparative,0,0
16621,study,0,0
16622,involving,0,0
16623,36,0,0
16624,eyes,0,0
16625,of,0,0
16626,34,0,0
16627,patients,0,0
16628,with,0,0
16629,functioning,0,0
16630,filtering,0,0
16631,blebs,0,1
16632,who,0,0
16633,were,0,0
16634,to,0,0
16635,undergo,0,0
16636,cataract,0,0
16637,surgery,0,1
16638,.,0,0
16639,Treatment,0,0
16640,groups,0,0
16641,received,0,0
16642,either,0,0
16643,topical,1,1
16644,ofloxacin,1,1
16645,or,1,1
16646,topical,1,1
16647,ciprofloxacin,1,1
16648,(,0,1
16649,instillation,0,1
16650,of,0,0
16651,0.3,0,0
16652,%,0,0
16653,ophthalmic,0,1
16654,solution,0,1
16655,every,0,1
16656,30,0,0
16657,minutes,0,0
16658,for,0,0
16659,4,0,0
16660,hours,0,0
16661,before,0,0
16662,surgery,1,0
16663,),1,0
16664,",",0,0
16665,or,0,1
16666,a,0,0
16667,combined,0,1
16668,topical,0,1
16669,plus,0,1
16670,oral,0,1
16671,regimen,0,1
16672,(,1,0
16673,ciprofloxacin,1,1
16674,hydrochloride,1,1
16675,",",1,0
16676,four,1,0
16677,100-mg,1,1
16678,tablets,1,1
16679,",",1,0
16680,or,1,0
16681,ofloxacin,1,1
16682,",",1,0
16683,one,1,0
16684,400-mg,1,1
16685,tablet,1,1
16686,",",0,0
16687,administered,0,0
16688,24-26,0,0
16689,",",0,0
16690,12-14,0,0
16691,",",0,0
16692,and,0,0
16693,2,0,0
16694,hours,0,0
16695,preceding,0,0
16696,surgery,1,0
16697,),1,0
16698,.,0,0
16699,The,0,0
16700,main,0,0
16701,outcome,0,0
16702,measure,0,0
16703,was,0,0
16704,antibiotic,0,1
16705,concentration,0,0
16706,measured,0,0
16707,by,0,0
16708,chromatographic,0,1
16709,separation,0,0
16710,and,0,0
16711,mass,0,0
16712,spectrometry,0,1
16713,of,0,0
16714,aqueous,0,1
16715,samples,0,0
16716,obtained,0,0
16717,during,0,0
16718,surgery,0,0
16719,.,0,0
16720,RESULTS,0,0
16721,Topical,0,0
16722,antibiotic,0,1
16723,treatment,0,0
16724,yielded,0,0
16725,mean,0,0
16726,concentrations,0,0
16727,of,0,0
16728,ofloxacin,1,1
16729,",",0,0
16730,0.75,0,0
16731,microg/mL,0,0
16732,",",0,0
16733,and,0,0
16734,ciprofloxacin,1,1
16735,",",0,0
16736,0.21,0,0
16737,microg/mL,0,0
16738,",",0,0
16739,in,0,0
16740,aqueous,0,1
16741,.,0,0
16742,With,0,0
16743,combined,0,1
16744,topical,0,1
16745,and,0,0
16746,oral,0,1
16747,therapy,0,1
16748,",",0,0
16749,significantly,0,0
16750,more,0,0
16751,ofloxacin,0,1
16752,was,0,0
16753,measured,0,0
16754,than,0,0
16755,ciprofloxacin,0,1
16756,(,0,0
16757,3.84,0,0
16758,microg/mL,0,1
16759,vs,0,0
16760,0.35,0,0
16761,microg/mL,0,0
16762,[,0,0
16763,P,0,0
16764,<,0,0
16765,.001,0,0
16766,],0,0
16767,),0,0
16768,.,0,0
16769,The,0,0
16770,combination,0,0
16771,regimen,0,1
16772,produced,0,0
16773,significantly,0,0
16774,greater,0,0
16775,ofloxacin,0,1
16776,levels,0,0
16777,than,0,0
16778,did,0,0
16779,topical,0,1
16780,therapy,0,1
16781,alone,0,1
16782,(,0,0
16783,P,0,0
16784,=.007,0,0
16785,),0,0
16786,.,0,0
16787,CONCLUSIONS,0,0
16788,Ofloxacin,0,1
16789,penetrates,0,0
16790,better,0,0
16791,than,0,0
16792,ciprofloxacin,0,1
16793,into,0,0
16794,the,0,0
16795,aqueous,0,1
16796,of,0,0
16797,eyes,0,0
16798,with,0,0
16799,filtering,0,0
16800,blebs,0,1
16801,",",0,0
16802,particularly,0,0
16803,after,0,0
16804,combined,0,1
16805,topical,0,1
16806,and,0,0
16807,oral,0,1
16808,administration,0,0
16809,",",0,0
16810,by,0,0
16811,which,0,0
16812,ofloxacin,0,1
16813,reaches,0,0
16814,more,0,0
16815,than,0,0
16816,a,0,0
16817,10-fold,0,0
16818,greater,0,0
16819,concentration,0,0
16820,than,0,0
16821,does,0,0
16822,ciprofloxacin,0,1
16823,.,0,0
16824,Combined,0,0
16825,topical,1,1
16826,and,1,0
16827,oral,1,1
16828,therapy,1,1
16829,with,1,0
16830,ofloxacin,1,1
16831,may,0,0
16832,be,0,0
16833,beneficial,0,0
16834,in,0,0
16835,the,0,0
16836,treatment,0,0
16837,of,0,0
16838,bleb-associated,0,0
16839,infections,0,0
16840,.,0,0
16841,A,0,0
16842,randomized,0,0
16843,intervention,0,1
16844,to,0,0
16845,improve,0,0
16846,ongoing,0,0
16847,participation,0,0
16848,in,0,0
16849,mammography,0,1
16850,.,0,0
16851,OBJECTIVE,0,0
16852,To,0,0
16853,test,0,0
16854,the,0,0
16855,effectiveness,0,0
16856,of,0,0
16857,interventions,1,1
16858,intended,1,0
16859,to,0,0
16860,increase,0,0
16861,rates,0,0
16862,of,0,0
16863,regular,0,1
16864,breast,0,0
16865,cancer,0,0
16866,screening,0,1
16867,",",0,0
16868,according,0,0
16869,to,0,0
16870,recommended,0,0
16871,guidelines,0,0
16872,.,0,0
16873,STUDY,0,0
16874,DESIGN,0,0
16875,A,0,0
16876,randomized,0,0
16877,controlled,0,0
16878,trial,0,0
16879,of,0,0
16880,2,0,0
16881,outreach,1,1
16882,interventions,1,1
16883,(,1,0
16884,a,1,0
16885,mail,1,1
16886,reminder,1,1
16887,and,1,0
16888,a,1,0
16889,telephone,1,1
16890,reminder,1,1
16891,plus,1,1
16892,appointment,1,1
16893,scheduling,1,0
16894,),1,1
16895,compared,0,0
16896,with,0,0
16897,a,0,0
16898,routine,1,1
16899,publicity,1,0
16900,campaign,1,1
16901,to,0,0
16902,encourage,0,0
16903,continued,0,0
16904,participation,0,0
16905,in,0,0
16906,mammography,1,1
16907,screening,0,0
16908,.,0,0
16909,PARTICIPANTS,0,0
16910,AND,0,0
16911,METHODS,0,0
16912,Participants,0,0
16913,were,0,0
16914,1908,0,0
16915,women,0,0
16916,aged,0,0
16917,50,0,0
16918,to,0,0
16919,75,0,0
16920,years,0,0
16921,continuously,0,0
16922,enrolled,0,0
16923,in,0,0
16924,a,0,0
16925,large,0,0
16926,group-model,0,0
16927,HMO,0,1
16928,during,0,0
16929,the,0,0
16930,study,0,0
16931,who,0,0
16932,underwent,0,0
16933,a,0,0
16934,bilateral,0,1
16935,mammogram,0,0
16936,during,0,0
16937,the,0,0
16938,first,0,0
16939,quarter,0,0
16940,of,0,0
16941,1994,0,0
16942,and,0,0
16943,no,0,0
16944,subsequent,0,0
16945,mammogram,0,0
16946,during,0,0
16947,the,0,0
16948,next,0,0
16949,18,0,0
16950,to,0,0
16951,21,0,0
16952,months,0,0
16953,.,0,0
16954,Data,0,0
16955,were,0,0
16956,obtained,0,0
16957,from,0,0
16958,health,0,0
16959,plan,0,0
16960,administrative,0,0
16961,data,0,0
16962,files,0,0
16963,supplemented,0,1
16964,by,0,0
16965,medical,0,0
16966,chart,0,1
16967,review,0,0
16968,.,0,0
16969,Women,0,0
16970,were,0,0
16971,randomly,0,0
16972,assigned,0,0
16973,to,0,0
16974,receive,0,1
16975,(,0,0
16976,1,0,0
16977,),0,0
16978,a,1,0
16979,mail,1,1
16980,reminder,1,1
16981,",",1,0
16982,(,1,0
16983,2,1,0
16984,),1,0
16985,a,1,0
16986,telephone,1,1
16987,reminder,1,1
16988,",",1,0
16989,or,1,1
16990,(,1,0
16991,3,1,1
16992,),1,0
16993,routine,1,0
16994,publicity,1,0
16995,on,1,0
16996,mammography,1,1
16997,for,1,0
16998,all,1,0
16999,women,1,0
17000,.,1,0
17001,The,0,0
17002,outcome,0,0
17003,measure,0,0
17004,was,0,0
17005,a,0,0
17006,mammogram,0,0
17007,received,0,0
17008,after,0,0
17009,the,0,0
17010,intervention,0,1
17011,period,0,0
17012,and,0,0
17013,within,0,0
17014,2,0,0
17015,years,0,0
17016,of,0,0
17017,the,0,0
17018,initial,0,0
17019,mammogram,0,0
17020,date,0,0
17021,.,0,0
17022,RESULTS,0,0
17023,Bivariate,0,0
17024,and,0,0
17025,multivariate,0,0
17026,statistical,0,0
17027,analyses,0,0
17028,showed,0,0
17029,that,0,0
17030,participation,0,0
17031,was,0,0
17032,significantly,0,0
17033,higher,0,0
17034,for,0,0
17035,women,0,0
17036,contacted,0,0
17037,by,0,0
17038,telephone,0,1
17039,than,0,0
17040,through,0,0
17041,routine,0,0
17042,publicity,0,0
17043,.,0,0
17044,Mail,0,0
17045,reminders,0,1
17046,were,0,0
17047,no,0,0
17048,more,0,0
17049,effective,0,0
17050,than,0,0
17051,a,0,0
17052,routine,1,1
17053,publicity,1,0
17054,campaign,1,1
17055,.,1,0
17056,Primary,0,0
17057,care,0,1
17058,physician,0,1
17059,and,0,0
17060,gynecologist,0,0
17061,visits,0,0
17062,increased,0,0
17063,the,0,0
17064,likelihood,0,0
17065,of,0,0
17066,a,0,0
17067,subsequent,0,0
17068,mammogram,0,0
17069,for,0,0
17070,women,0,0
17071,in,0,0
17072,all,0,0
17073,intervention,0,1
17074,groups,0,0
17075,.,0,0
17076,CONCLUSIONS,0,0
17077,Telephone,1,1
17078,contact,1,1
17079,by,0,0
17080,regular,0,1
17081,health,0,0
17082,plan,0,0
17083,staff,0,0
17084,was,0,0
17085,more,0,0
17086,successful,0,0
17087,than,0,0
17088,publicity,0,0
17089,in,0,0
17090,encouraging,0,0
17091,continued,0,0
17092,participation,0,0
17093,in,0,0
17094,mammography,0,1
17095,screening,0,0
17096,in,0,0
17097,women,0,0
17098,enrolled,0,0
17099,in,0,0
17100,a,0,0
17101,group-model,0,1
17102,managed,0,0
17103,health,0,1
17104,care,0,1
17105,plan,0,0
17106,.,0,0
17107,Because,0,0
17108,mailings,0,1
17109,did,0,0
17110,not,0,0
17111,influence,0,0
17112,participation,0,0
17113,in,0,0
17114,mammography,0,1
17115,screening,0,0
17116,",",0,0
17117,health,0,0
17118,plans,0,1
17119,should,0,0
17120,be,0,0
17121,cautious,0,0
17122,about,0,0
17123,investing,0,0
17124,in,0,0
17125,member,0,0
17126,mailings,0,1
17127,without,0,0
17128,first,0,0
17129,evaluating,0,0
17130,their,0,0
17131,effectiveness,0,0
17132,in,0,0
17133,the,0,0
17134,context,0,0
17135,of,0,0
17136,existing,0,0
17137,outreach,0,0
17138,efforts,0,0
17139,.,0,0
17140,Induction,1,1
17141,versus,0,1
17142,noninduction,1,1
17143,in,0,0
17144,renal,0,0
17145,transplant,0,0
17146,recipients,0,0
17147,with,0,0
17148,tacrolimus-based,0,1
17149,immunosuppression,0,1
17150,.,0,0
17151,BACKGROUND,0,0
17152,The,0,0
17153,aim,0,0
17154,of,0,0
17155,this,0,0
17156,study,0,0
17157,was,0,0
17158,to,0,0
17159,compare,0,0
17160,the,0,0
17161,efficacy,0,0
17162,and,0,0
17163,safety,0,0
17164,of,0,0
17165,induction,0,0
17166,treatment,0,0
17167,with,0,0
17168,antithymocyte,1,1
17169,globulins,1,1
17170,(,1,0
17171,ATG,1,1
17172,),1,1
17173,followed,0,1
17174,by,0,0
17175,tacrolimus,1,1
17176,therapy,0,1
17177,with,0,0
17178,immediate,0,0
17179,tacrolimus,0,1
17180,therapy,0,1
17181,in,0,0
17182,renal,0,0
17183,transplant,0,0
17184,recipients,0,0
17185,.,0,0
17186,METHODS,0,0
17187,This,0,0
17188,12-month,0,0
17189,",",0,0
17190,open,0,1
17191,",",0,0
17192,prospective,0,0
17193,study,0,0
17194,was,0,0
17195,conducted,0,0
17196,in,0,0
17197,15,0,0
17198,centers,0,0
17199,in,0,0
17200,France,0,0
17201,and,0,0
17202,1,0,0
17203,center,0,0
17204,in,0,0
17205,Belgium,0,0
17206,;,0,0
17207,309,0,0
17208,patients,0,0
17209,were,0,0
17210,randomized,0,0
17211,to,0,0
17212,receive,0,0
17213,either,0,1
17214,induction,1,0
17215,therapy,1,1
17216,with,1,1
17217,ATG,1,1
17218,(,0,1
17219,n=151,0,0
17220,),0,1
17221,followed,0,1
17222,by,0,0
17223,initiation,0,0
17224,of,0,0
17225,tacrolimus,1,1
17226,on,0,0
17227,day,0,0
17228,9,0,0
17229,or,0,0
17230,immediate,0,0
17231,tacrolimus-based,1,1
17232,triple,1,1
17233,therapy,1,1
17234,(,0,1
17235,n=158,0,0
17236,),0,0
17237,.,0,0
17238,In,0,0
17239,both,0,0
17240,study,0,0
17241,arms,0,0
17242,",",0,0
17243,the,0,0
17244,initial,0,0
17245,daily,0,1
17246,tacrolimus,1,1
17247,dose,0,0
17248,was,0,0
17249,0.2,0,0
17250,mg/kg,0,1
17251,.,0,0
17252,Steroid,1,0
17253,boluses,1,0
17254,were,0,0
17255,given,0,0
17256,in,0,0
17257,the,0,0
17258,first,0,0
17259,2,0,0
17260,days,0,0
17261,and,0,0
17262,tapered,0,1
17263,thereafter,0,0
17264,from,0,0
17265,20,0,0
17266,mg/day,0,1
17267,to,0,0
17268,5,0,0
17269,mg/day,0,1
17270,.,0,0
17271,Azathioprine,1,1
17272,was,0,0
17273,administered,0,0
17274,at,0,0
17275,1-2,0,0
17276,mg/kg,0,1
17277,per,0,0
17278,day,0,0
17279,.,0,0
17280,RESULTS,0,0
17281,At,0,0
17282,month,0,0
17283,12,0,0
17284,",",0,0
17285,biopsy-confirmed,0,0
17286,acute,0,0
17287,rejections,0,0
17288,were,0,0
17289,reported,0,0
17290,for,0,0
17291,15.2,0,0
17292,%,0,0
17293,(,0,1
17294,induction,0,1
17295,),0,1
17296,and,0,0
17297,30.4,0,0
17298,%,0,0
17299,(,0,1
17300,noninduction,0,1
17301,),0,1
17302,of,0,0
17303,patients,0,0
17304,(,0,0
17305,P=0.001,0,0
17306,),0,0
17307,.,0,0
17308,The,0,0
17309,incidence,0,0
17310,of,0,0
17311,steroid-sensitive,0,0
17312,acute,0,0
17313,rejections,0,0
17314,was,0,0
17315,7.9,0,0
17316,%,0,0
17317,(,0,1
17318,induction,0,1
17319,),0,1
17320,and,0,0
17321,22.2,0,0
17322,%,0,0
17323,(,0,1
17324,noninduction,0,1
17325,),0,1
17326,(,0,1
17327,P=0.001,0,0
17328,),0,1
17329,.,0,0
17330,Steroid-resistant,0,0
17331,acute,0,0
17332,rejections,0,0
17333,were,0,0
17334,reported,0,0
17335,for,0,0
17336,8.6,0,0
17337,%,0,0
17338,(,0,1
17339,induction,0,1
17340,),0,1
17341,and,0,0
17342,8.9,0,0
17343,%,0,0
17344,(,0,1
17345,noninduction,0,1
17346,),0,1
17347,of,0,0
17348,patients,0,0
17349,.,0,0
17350,A,0,0
17351,total,0,0
17352,of,0,0
17353,nine,0,0
17354,patients,0,0
17355,died,0,0
17356,.,0,0
17357,Patient,0,0
17358,survival,0,0
17359,and,0,0
17360,graft,0,1
17361,survival,0,0
17362,at,0,0
17363,month,0,0
17364,12,0,0
17365,was,0,0
17366,similar,0,0
17367,in,0,0
17368,both,0,0
17369,treatment,0,0
17370,groups,0,0
17371,(,0,0
17372,97.4,0,0
17373,%,0,0
17374,vs.,0,0
17375,96.8,0,0
17376,%,0,0
17377,and,0,0
17378,92.1,0,0
17379,%,0,0
17380,vs.,0,0
17381,91.1,0,0
17382,%,0,0
17383,",",0,0
17384,respectively,0,0
17385,),0,0
17386,.,0,0
17387,Statistically,0,0
17388,significant,0,0
17389,differences,0,0
17390,in,0,0
17391,the,0,0
17392,incidence,0,0
17393,of,0,0
17394,adverse,0,0
17395,events,0,0
17396,were,0,0
17397,found,0,0
17398,for,0,0
17399,cytomegalovirus,0,0
17400,(,0,1
17401,CMV,0,1
17402,),0,1
17403,infection,0,0
17404,(,0,1
17405,induction,0,0
17406,",",0,0
17407,32.5,0,0
17408,%,0,0
17409,vs.,0,0
17410,noninduction,0,0
17411,",",0,0
17412,19.0,0,0
17413,%,0,0
17414,",",0,0
17415,P=0.009,0,0
17416,),0,0
17417,",",0,0
17418,leukopenia,0,0
17419,(,0,0
17420,37.3,0,0
17421,%,0,0
17422,vs.,0,0
17423,9.5,0,0
17424,%,0,0
17425,",",0,0
17426,P,0,0
17427,<,0,0
17428,0.001,0,0
17429,),0,0
17430,",",0,0
17431,fever,0,0
17432,(,0,0
17433,25.2,0,0
17434,%,0,0
17435,vs.,0,0
17436,10.1,0,0
17437,%,0,0
17438,",",0,0
17439,P=0.001,0,0
17440,),0,0
17441,",",0,0
17442,herpes,0,0
17443,simplex,0,0
17444,(,0,0
17445,17.9,0,0
17446,%,0,0
17447,vs.,0,0
17448,5.7,0,0
17449,%,0,0
17450,",",0,0
17451,P=0.001,0,0
17452,),0,0
17453,",",0,0
17454,and,0,1
17455,thrombocytopenia,0,0
17456,(,0,1
17457,11.3,0,0
17458,%,0,0
17459,vs.,0,0
17460,3.2,0,0
17461,%,0,0
17462,",",0,0
17463,P=0.007,0,0
17464,),0,0
17465,.,0,0
17466,In,0,0
17467,the,0,0
17468,induction,0,0
17469,group,0,0
17470,",",0,0
17471,serum,0,0
17472,sickness,0,0
17473,was,0,0
17474,observed,0,0
17475,in,0,0
17476,10.6,0,0
17477,%,0,0
17478,of,0,0
17479,patients,0,0
17480,.,0,0
17481,The,0,0
17482,incidence,0,0
17483,of,0,0
17484,new,0,0
17485,onset,0,0
17486,diabetes,0,0
17487,mellitus,0,0
17488,was,0,0
17489,3.4,0,0
17490,%,0,0
17491,(,0,1
17492,induction,0,1
17493,),0,1
17494,and,0,0
17495,4.5,0,1
17496,%,0,0
17497,(,0,1
17498,noninduction,0,1
17499,),0,0
17500,.,0,0
17501,CONCLUSION,0,0
17502,Low,0,0
17503,incidences,0,0
17504,of,0,0
17505,acute,0,0
17506,rejection,0,0
17507,were,0,0
17508,found,0,0
17509,in,0,0
17510,both,0,0
17511,treatment,0,0
17512,arms,0,0
17513,.,0,0
17514,Induction,0,0
17515,treatment,0,0
17516,with,0,0
17517,ATG,1,1
17518,has,0,0
17519,the,0,0
17520,advantage,0,0
17521,of,0,0
17522,a,0,0
17523,lower,0,0
17524,incidence,0,0
17525,of,0,0
17526,acute,0,0
17527,rejection,0,0
17528,",",0,0
17529,but,0,0
17530,it,0,0
17531,significantly,0,0
17532,increases,0,0
17533,adverse,0,0
17534,events,0,0
17535,",",0,0
17536,particularly,0,0
17537,CMV,0,1
17538,infection,0,0
17539,.,0,0
17540,Safety,0,1
17541,and,0,0
17542,efficacy,0,0
17543,of,0,0
17544,PNU-142633,1,1
17545,",",1,0
17546,a,1,0
17547,selective,1,0
17548,5-HT1D,1,0
17549,agonist,1,1
17550,",",0,0
17551,in,0,0
17552,patients,0,0
17553,with,0,0
17554,acute,0,0
17555,migraine,0,0
17556,.,0,0
17557,In,0,0
17558,this,0,0
17559,randomized,0,0
17560,",",0,0
17561,double-blind,0,0
17562,",",0,0
17563,placebo-controlled,0,1
17564,",",0,0
17565,parallel-group,0,0
17566,study,0,0
17567,",",0,0
17568,patients,0,0
17569,received,0,0
17570,a,0,0
17571,single,0,0
17572,50-mg,1,1
17573,oral,1,1
17574,dose,1,0
17575,of,1,0
17576,a,1,0
17577,5-HT,1,1
17578,(,1,0
17579,1D,1,1
17580,),1,0
17581,agonist,1,1
17582,",",1,0
17583,PNU-142633,1,1
17584,(,1,0
17585,n,1,0
17586,=,1,0
17587,34,1,0
17588,),1,0
17589,",",1,0
17590,or,1,1
17591,matching,1,1
17592,placebo,1,1
17593,(,0,1
17594,n,0,0
17595,=,0,0
17596,35,0,0
17597,),0,0
17598,during,0,0
17599,an,0,0
17600,acute,0,0
17601,migraine,0,0
17602,attack,0,0
17603,.,0,0
17604,No,0,0
17605,statistically,0,0
17606,significant,0,0
17607,treatment,0,0
17608,effects,0,0
17609,were,0,0
17610,observed,0,0
17611,at,0,0
17612,1,0,0
17613,and,0,0
17614,2,0,0
17615,h,0,0
17616,after,0,0
17617,dosing,0,0
17618,",",0,0
17619,even,0,0
17620,after,0,0
17621,stratifying,0,0
17622,by,0,0
17623,baseline,0,0
17624,headache,0,0
17625,intensity,0,0
17626,.,0,0
17627,At,0,0
17628,1,0,0
17629,and,0,0
17630,2,0,0
17631,h,0,0
17632,post-dose,0,0
17633,",",0,0
17634,8.8,0,0
17635,%,0,0
17636,and,0,0
17637,29.4,0,0
17638,%,0,0
17639,of,0,0
17640,the,0,0
17641,PNU-142633,1,1
17642,group,0,0
17643,",",0,0
17644,respectively,0,0
17645,",",0,0
17646,and,0,0
17647,8.6,0,0
17648,%,0,0
17649,and,0,0
17650,40.0,0,0
17651,%,0,0
17652,of,0,0
17653,the,0,0
17654,placebo,1,1
17655,group,0,0
17656,",",0,0
17657,respectively,0,0
17658,",",0,0
17659,experienced,0,0
17660,headache,0,0
17661,relief,0,0
17662,;,0,0
17663,2.9,0,0
17664,%,0,0
17665,and,0,0
17666,8.8,0,0
17667,%,0,0
17668,of,0,0
17669,the,0,0
17670,PNU-142633,1,1
17671,group,0,0
17672,and,0,0
17673,0,0,0
17674,%,0,0
17675,and,0,0
17676,5.7,0,0
17677,%,0,0
17678,of,0,0
17679,the,0,0
17680,placebo,1,1
17681,group,0,0
17682,were,0,0
17683,free,0,0
17684,of,0,0
17685,headache,0,0
17686,pain,0,0
17687,.,0,0
17688,Adverse,0,0
17689,events,0,0
17690,associated,0,0
17691,with,0,0
17692,PNU-142633,1,1
17693,treatment,0,0
17694,included,0,0
17695,chest,0,1
17696,pain,0,0
17697,(,0,0
17698,two,0,0
17699,patients,0,0
17700,),0,0
17701,and,0,0
17702,QTc,0,1
17703,prolongation,0,0
17704,(,0,0
17705,three,0,1
17706,patients,0,0
17707,),0,0
17708,.,0,0
17709,Results,0,0
17710,from,0,0
17711,this,0,0
17712,study,0,0
17713,suggest,0,0
17714,that,0,0
17715,anti-migraine,0,1
17716,efficacy,0,0
17717,is,0,0
17718,not,0,0
17719,mediated,0,0
17720,solely,0,0
17721,through,0,0
17722,the,0,0
17723,5-HT,1,1
17724,(,1,0
17725,1D,1,1
17726,),1,1
17727,receptor,0,0
17728,subtype,0,0
17729,",",0,0
17730,although,0,0
17731,this,0,0
17732,receptor,0,0
17733,may,0,0
17734,contribute,0,0
17735,",",0,0
17736,at,0,0
17737,least,0,0
17738,in,0,0
17739,part,0,0
17740,",",0,0
17741,to,0,0
17742,the,0,0
17743,adverse,0,0
17744,cardiovascular,0,0
17745,effects,0,0
17746,observed,0,0
17747,with,0,0
17748,5-HT,1,1
17749,agonist,1,1
17750,medications,0,0
17751,.,0,0
17752,Caffeine,1,1
17753,eliminates,0,0
17754,psychomotor,0,0
17755,vigilance,0,0
17756,deficits,0,0
17757,from,0,0
17758,sleep,0,0
17759,inertia,0,0
17760,.,0,0
17761,STUDY,0,0
17762,OBJECTIVES,0,0
17763,This,0,0
17764,study,0,0
17765,sought,0,0
17766,to,0,0
17767,establish,0,0
17768,the,0,0
17769,effects,0,0
17770,of,0,0
17771,caffeine,1,1
17772,on,0,0
17773,sleep,0,0
17774,inertia,0,0
17775,",",0,0
17776,which,0,0
17777,is,0,0
17778,the,0,0
17779,ubiquitous,0,0
17780,phenomenon,0,0
17781,of,0,0
17782,cognitive,0,0
17783,performance,0,0
17784,impairment,0,0
17785,",",0,0
17786,grogginess,0,0
17787,and,0,0
17788,tendency,0,0
17789,to,0,0
17790,return,0,0
17791,to,0,0
17792,sleep,0,0
17793,immediately,0,0
17794,after,0,0
17795,awakening,0,0
17796,.,0,0
17797,DESIGN,0,0
17798,28,0,0
17799,normal,0,0
17800,adult,0,0
17801,volunteers,0,0
17802,were,0,0
17803,administered,0,0
17804,sustained,0,0
17805,low-dose,1,1
17806,caffeine,1,1
17807,or,1,1
17808,placebo,1,1
17809,(,0,1
17810,randomized,0,0
17811,double-blind,0,0
17812,),0,0
17813,during,0,0
17814,the,0,0
17815,last,0,0
17816,66,0,0
17817,hours,0,0
17818,of,0,0
17819,an,0,0
17820,88-hour,0,1
17821,period,0,0
17822,of,0,0
17823,extended,0,1
17824,wakefulness,0,0
17825,that,0,0
17826,included,0,0
17827,seven,0,0
17828,2-hour,0,0
17829,naps,0,0
17830,during,0,0
17831,which,0,0
17832,polysomnographical,0,0
17833,recordings,0,1
17834,were,0,0
17835,made,0,0
17836,.,0,0
17837,Every,0,0
17838,2,0,0
17839,hours,0,0
17840,of,0,0
17841,wakefulness,0,0
17842,",",0,0
17843,and,0,0
17844,immediately,0,0
17845,after,0,0
17846,abrupt,0,0
17847,awakening,0,0
17848,from,0,0
17849,the,0,0
17850,naps,0,0
17851,",",0,0
17852,psychomotor,0,0
17853,vigilance,0,0
17854,performance,0,0
17855,was,0,0
17856,tested,0,0
17857,.,0,0
17858,SETTING,0,0
17859,N/A,0,0
17860,.,0,0
17861,PARTICIPANTS,0,0
17862,N/A,0,0
17863,.,0,0
17864,INTERVENTIONS,0,0
17865,N/A,0,0
17866,.,0,0
17867,MEASUREMENTS,0,0
17868,AND,0,0
17869,RESULTS,0,0
17870,In,0,0
17871,the,0,0
17872,placebo,1,1
17873,condition,0,0
17874,",",0,0
17875,sleep,0,0
17876,inertia,0,0
17877,was,0,0
17878,manifested,0,0
17879,as,0,0
17880,significantly,0,0
17881,impaired,0,0
17882,psychomotor,0,0
17883,vigilance,0,0
17884,upon,0,0
17885,awakening,0,0
17886,from,0,0
17887,the,0,0
17888,naps,0,0
17889,.,0,0
17890,This,0,0
17891,impairment,0,0
17892,was,0,0
17893,absent,0,0
17894,in,0,0
17895,the,0,0
17896,caffeine,0,1
17897,condition,0,0
17898,.,0,0
17899,Caffeine,0,1
17900,had,0,0
17901,only,0,0
17902,modest,0,0
17903,effects,0,0
17904,on,0,0
17905,nap,0,0
17906,sleep,0,0
17907,.,0,0
17908,CONCLUSIONS,0,0
17909,Caffeine,1,1
17910,was,0,0
17911,efficacious,0,0
17912,in,0,0
17913,overcoming,0,0
17914,sleep,0,0
17915,inertia,0,0
17916,.,0,0
17917,This,0,0
17918,suggests,0,0
17919,a,0,0
17920,reason,0,0
17921,for,0,0
17922,the,0,0
17923,popularity,0,0
17924,of,0,0
17925,caffeine-containing,0,1
17926,beverages,0,1
17927,after,0,0
17928,awakening,0,0
17929,.,0,0
17930,Caffeine,0,1
17931,'s,0,0
17932,main,0,0
17933,mechanism,0,0
17934,of,0,0
17935,action,0,0
17936,on,0,0
17937,the,0,0
17938,central,0,0
17939,nervous,0,0
17940,system,0,1
17941,is,0,0
17942,antagonism,0,0
17943,of,0,0
17944,adenosine,0,0
17945,receptors,0,0
17946,.,0,0
17947,Thus,0,0
17948,",",0,0
17949,increased,0,0
17950,adenosine,0,1
17951,in,0,0
17952,the,0,0
17953,brain,0,0
17954,upon,0,0
17955,awakening,0,0
17956,may,0,0
17957,be,0,0
17958,the,0,0
17959,cause,0,0
17960,of,0,0
17961,sleep,0,0
17962,inertia,0,0
17963,.,0,0
17964,Carotid,0,0
17965,sinus,0,0
17966,syndrome,0,0
17967,:,0,0
17968,a,0,0
17969,modifiable,0,0
17970,risk,0,0
17971,factor,0,0
17972,for,0,0
17973,nonaccidental,0,0
17974,falls,0,0
17975,in,0,0
17976,older,0,0
17977,adults,0,0
17978,(,0,0
17979,SAFE,0,1
17980,PACE,0,1
17981,),0,0
17982,.,0,0
17983,OBJECTIVES,0,0
17984,The,0,0
17985,aim,0,0
17986,of,0,0
17987,the,0,0
17988,study,0,0
17989,was,0,0
17990,to,0,0
17991,determine,0,0
17992,whether,0,0
17993,cardiac,1,0
17994,pacing,1,1
17995,reduces,0,0
17996,falls,0,0
17997,in,0,0
17998,older,0,0
17999,adults,0,0
18000,with,0,0
18001,cardioinhibitory,0,0
18002,carotid,0,0
18003,sinus,0,0
18004,hypersensitivity,0,0
18005,(,0,1
18006,CSH,0,0
18007,),0,0
18008,.,0,0
18009,BACKGROUND,0,0
18010,Cardioinhibitory,0,0
18011,carotid,0,0
18012,sinus,0,0
18013,syndrome,0,0
18014,causes,0,0
18015,syncope,0,0
18016,",",0,0
18017,and,0,0
18018,symptoms,0,0
18019,respond,0,0
18020,to,0,0
18021,cardiac,1,0
18022,pacing,1,1
18023,.,1,0
18024,There,0,0
18025,is,0,0
18026,circumstantial,0,0
18027,evidence,0,0
18028,for,0,0
18029,an,0,0
18030,association,0,0
18031,between,0,0
18032,falls,0,0
18033,and,0,0
18034,the,0,0
18035,syndrome,0,0
18036,.,0,0
18037,METHODS,0,0
18038,A,0,0
18039,randomized,0,0
18040,controlled,0,0
18041,trial,0,0
18042,was,0,0
18043,done,0,0
18044,of,0,0
18045,consecutive,0,0
18046,older,0,0
18047,patients,0,0
18048,(,0,0
18049,>,0,0
18050,50,0,1
18051,years,0,0
18052,),0,0
18053,attending,0,0
18054,an,0,0
18055,accident,0,0
18056,and,0,0
18057,emergency,0,1
18058,facility,0,1
18059,because,0,0
18060,of,0,0
18061,a,0,0
18062,non-accidental,0,0
18063,fall,0,0
18064,.,0,0
18065,Patients,0,0
18066,were,0,0
18067,randomized,0,0
18068,to,0,0
18069,dual-chamber,1,1
18070,pacemaker,1,1
18071,implant,1,1
18072,(,1,0
18073,paced,1,1
18074,patients,1,0
18075,),1,0
18076,or,0,1
18077,standard,1,1
18078,treatment,1,1
18079,(,1,1
18080,controls,1,0
18081,),1,0
18082,.,1,0
18083,The,0,0
18084,primary,0,0
18085,outcome,0,0
18086,was,0,0
18087,the,0,0
18088,number,0,0
18089,of,0,0
18090,falls,0,0
18091,during,0,0
18092,one,0,0
18093,year,0,0
18094,of,0,0
18095,follow-up,0,0
18096,.,0,0
18097,RESULTS,0,0
18098,One,0,0
18099,hundred,0,0
18100,seventy-five,0,0
18101,eligible,0,0
18102,patients,0,0
18103,(,0,0
18104,mean,0,0
18105,age,0,0
18106,73,0,0
18107,+/-,0,0
18108,10,0,0
18109,years,0,0
18110,;,0,0
18111,60,0,0
18112,%,0,0
18113,women,0,0
18114,),0,0
18115,were,0,0
18116,randomized,0,0
18117,to,0,0
18118,the,0,0
18119,trial,0,0
18120,:,0,0
18121,pacemaker,1,0
18122,87,0,0
18123,;,0,0
18124,controls,1,0
18125,88,0,0
18126,.,0,0
18127,Falls,0,0
18128,(,0,0
18129,without,0,1
18130,loss,0,0
18131,of,0,0
18132,consciousness,0,0
18133,),0,0
18134,were,0,0
18135,reduced,0,0
18136,by,0,0
18137,two-thirds,0,0
18138,:,0,0
18139,controls,0,0
18140,reported,0,0
18141,669,0,0
18142,falls,0,0
18143,(,0,0
18144,mean,0,0
18145,9.3,0,0
18146,;,0,0
18147,range,0,0
18148,0,0,0
18149,to,0,0
18150,89,0,0
18151,),0,0
18152,",",0,0
18153,and,0,0
18154,paced,0,1
18155,patients,0,0
18156,216,0,0
18157,falls,0,0
18158,(,0,0
18159,mean,0,0
18160,4.1,0,0
18161,;,0,0
18162,range,0,0
18163,0,0,0
18164,to,0,0
18165,29,0,0
18166,),0,0
18167,.,0,0
18168,Thus,0,0
18169,",",0,0
18170,paced,0,1
18171,patients,0,0
18172,were,0,0
18173,significantly,0,0
18174,less,0,0
18175,likely,0,0
18176,to,0,0
18177,fall,0,0
18178,(,0,0
18179,odds,0,0
18180,ratio,0,0
18181,0.42,0,0
18182,;,0,0
18183,95,0,0
18184,%,0,0
18185,confidence,0,0
18186,interval,0,0
18187,:,0,0
18188,0.23,0,0
18189,",",0,0
18190,0.75,0,0
18191,),0,0
18192,than,0,0
18193,were,0,0
18194,controls,0,0
18195,.,0,0
18196,Syncopal,0,0
18197,events,0,0
18198,were,0,0
18199,also,0,0
18200,reduced,0,0
18201,during,0,0
18202,the,0,0
18203,follow-up,0,0
18204,period,0,0
18205,",",0,0
18206,but,0,0
18207,there,0,0
18208,were,0,0
18209,much,0,0
18210,fewer,0,0
18211,syncopal,0,0
18212,events,0,0
18213,than,0,0
18214,falls-28,0,0
18215,episodes,0,0
18216,in,0,0
18217,paced,0,1
18218,patients,0,0
18219,and,0,0
18220,47,0,0
18221,in,0,0
18222,controls,0,0
18223,.,0,0
18224,Injurious,0,0
18225,events,0,0
18226,were,0,0
18227,reduced,0,0
18228,by,0,0
18229,70,0,0
18230,%,0,0
18231,(,0,0
18232,202,0,0
18233,in,0,0
18234,controls,0,0
18235,compared,0,0
18236,to,0,0
18237,61,0,0
18238,in,0,0
18239,paced,0,1
18240,patients,0,0
18241,),0,0
18242,.,0,0
18243,CONCLUSIONS,0,0
18244,There,0,0
18245,is,0,0
18246,a,0,0
18247,strong,0,0
18248,association,0,0
18249,between,0,0
18250,non-accidental,0,0
18251,falls,0,0
18252,and,0,0
18253,cardioinhibitory,0,0
18254,CSH,0,0
18255,.,0,0
18256,These,0,0
18257,patients,0,0
18258,would,0,0
18259,not,0,0
18260,usually,0,0
18261,be,0,0
18262,referred,0,0
18263,for,0,0
18264,cardiovascular,0,0
18265,assessment,0,0
18266,.,0,0
18267,Carotid,0,0
18268,sinus,0,0
18269,hypersensitivity,0,0
18270,should,0,0
18271,be,0,0
18272,considered,0,0
18273,in,0,0
18274,all,0,0
18275,older,0,0
18276,adults,0,0
18277,who,0,0
18278,have,0,0
18279,non-accidental,0,0
18280,falls,0,0
18281,.,0,0
18282,Evaluating,0,0
18283,the,0,0
18284,impact,0,0
18285,of,0,0
18286,peer,1,1
18287,",",1,0
18288,nurse,1,1
18289,case-managed,1,1
18290,",",1,0
18291,and,1,0
18292,standard,1,1
18293,HIV,1,1
18294,risk-reduction,1,1
18295,programs,1,1
18296,on,0,0
18297,psychosocial,0,0
18298,and,0,0
18299,health-promoting,0,1
18300,behavioral,0,1
18301,outcomes,0,0
18302,among,0,0
18303,homeless,0,0
18304,women,0,0
18305,.,0,0
18306,Investigators,0,0
18307,examined,0,0
18308,the,0,0
18309,6-month,0,0
18310,impact,0,0
18311,of,0,0
18312,three,0,0
18313,cognitive-behavioral,1,1
18314,HIV,1,1
18315,risk-reduction,1,1
18316,programs,1,1
18317,on,0,0
18318,behavioral,0,1
18319,factors,0,0
18320,(,0,0
18321,substance,0,0
18322,use,0,0
18323,and,0,0
18324,sexual,0,0
18325,risk,0,0
18326,behaviors,0,0
18327,),0,0
18328,and,0,0
18329,cognitive,0,1
18330,and,0,0
18331,psychological,0,0
18332,resources,0,0
18333,of,0,0
18334,325,0,0
18335,women,0,0
18336,who,0,0
18337,resided,0,0
18338,in,0,0
18339,emergency,0,1
18340,or,0,1
18341,sober-living,0,0
18342,shelters,0,0
18343,and,0,0
18344,their,0,0
18345,308,0,0
18346,intimate,0,0
18347,sexual,0,0
18348,partners,0,0
18349,.,0,0
18350,Participants,0,0
18351,were,0,0
18352,randomized,0,0
18353,by,0,0
18354,shelter,0,0
18355,to,0,0
18356,a,0,0
18357,peer-mentored,1,0
18358,",",1,0
18359,a,1,0
18360,nurse,1,1
18361,case-managed,1,1
18362,",",1,0
18363,or,1,1
18364,a,1,0
18365,standard,1,1
18366,care,1,1
18367,HIV,1,1
18368,risk-reduction,1,1
18369,program,1,1
18370,.,1,0
18371,Significant,0,0
18372,improvements,0,0
18373,were,0,0
18374,observed,0,0
18375,in,0,0
18376,all,0,0
18377,groups,0,0
18378,in,0,0
18379,all,0,0
18380,behavioral,0,1
18381,factors,0,0
18382,and,0,0
18383,cognitive,0,0
18384,and,0,0
18385,psychological,0,0
18386,resources,0,0
18387,except,0,0
18388,for,0,0
18389,self-esteem,0,0
18390,.,0,0
18391,Participants,0,0
18392,in,0,0
18393,the,0,0
18394,peer-mentored,1,1
18395,and,1,0
18396,nurse,1,1
18397,case-managed,1,1
18398,groups,0,0
18399,did,0,0
18400,not,0,0
18401,differ,0,0
18402,significantly,0,0
18403,from,0,0
18404,the,0,0
18405,standard,1,1
18406,group,1,0
18407,in,0,0
18408,self-esteem,0,0
18409,",",0,0
18410,life,0,0
18411,satisfaction,0,0
18412,",",0,0
18413,psychological,0,0
18414,well-being,0,0
18415,",",0,0
18416,use,0,0
18417,of,0,0
18418,noninjection,0,1
18419,drugs,0,1
18420,",",0,0
18421,sex,0,0
18422,with,0,0
18423,multiple,0,0
18424,partners,0,0
18425,",",0,0
18426,and,0,0
18427,unprotected,0,0
18428,sex,0,0
18429,at,0,0
18430,6,0,0
18431,months,0,0
18432,(,0,0
18433,n,0,0
18434,=,0,0
18435,633,0,0
18436,),0,0
18437,.,0,0
18438,It,0,0
18439,was,0,0
18440,concluded,0,0
18441,that,0,0
18442,a,0,0
18443,standard,0,1
18444,approach,0,1
18445,by,0,0
18446,health,0,0
18447,care,0,1
18448,professionals,0,0
18449,appears,0,0
18450,to,0,0
18451,effectively,0,0
18452,modify,0,0
18453,HIV,0,1
18454,risk,0,0
18455,behaviors,0,0
18456,for,0,0
18457,a,0,0
18458,majority,0,0
18459,of,0,0
18460,homeless,0,0
18461,participants,0,0
18462,and,0,0
18463,may,0,0
18464,have,0,0
18465,important,0,0
18466,economic,0,1
18467,and,0,0
18468,policy,0,0
18469,implications,0,0
18470,.,0,0
18471,Further,0,0
18472,",",0,0
18473,the,0,0
18474,impact,0,0
18475,of,0,0
18476,short-term,0,0
18477,programs,0,1
18478,that,0,0
18479,address,0,0
18480,psychological,0,0
18481,vulnerabilities,0,0
18482,of,0,0
18483,impoverished,0,0
18484,populations,0,0
18485,needs,0,0
18486,to,0,0
18487,be,0,0
18488,studied,0,0
18489,further,0,0
18490,.,0,0
18491,[,1,0
18492,Statins,1,1
18493,in,0,0
18494,the,0,0
18495,treatment,0,0
18496,of,0,0
18497,patients,0,0
18498,with,0,0
18499,arterial,0,0
18500,occlusive,0,1
18501,disease,0,0
18502,of,0,0
18503,the,0,0
18504,lower,0,0
18505,extremities,0,0
18506,],0,0
18507,.,0,0
18508,In,0,0
18509,patients,0,0
18510,with,0,0
18511,advanced,0,0
18512,atherosclerosis,0,0
18513,manifested,0,0
18514,by,0,0
18515,arterial,0,0
18516,occlusion,0,0
18517,in,0,0
18518,the,0,0
18519,lower,0,0
18520,extremities,0,0
18521,without,0,0
18522,a,0,0
18523,baseline,0,0
18524,blood,0,0
18525,lipid,0,1
18526,disorder,0,0
18527,statin,1,1
18528,treatment,1,0
18529,caused,0,0
18530,improvement,0,0
18531,of,0,0
18532,the,0,0
18533,efficiency,0,0
18534,",",0,0
18535,i.e,0,1
18536,.,0,0
18537,prolongation,0,0
18538,of,0,0
18539,the,0,0
18540,claudication,0,1
18541,interval,0,0
18542,",",0,0
18543,while,0,0
18544,in,0,0
18545,a,0,0
18546,comparable,0,0
18547,control,0,1
18548,group,0,0
18549,without,0,1
18550,statins,0,1
18551,the,0,0
18552,efficiency,0,0
18553,deteriorated,0,0
18554,further,0,0
18555,.,0,0
18556,In,0,0
18557,patients,0,0
18558,with,0,0
18559,arterial,0,0
18560,occlusion,0,0
18561,of,0,0
18562,the,0,0
18563,lower,0,0
18564,extremities,0,0
18565,with,0,0
18566,baseline,0,0
18567,dyslipidaemia,0,1
18568,statin,1,1
18569,treatment,1,0
18570,proved,0,0
18571,protective,0,0
18572,",",0,0
18573,i.e,0,1
18574,.,0,0
18575,at,0,0
18576,least,0,0
18577,it,0,0
18578,retarded,0,0
18579,the,0,0
18580,patients,0,0
18581,',0,0
18582,complaints,0,0
18583,.,0,0
18584,The,0,0
18585,authors,0,0
18586,recorded,0,0
18587,improvement,0,0
18588,of,0,0
18589,the,0,0
18590,prooxidation,0,0
18591,state,0,0
18592,which,0,0
18593,followed,0,1
18594,after,0,0
18595,the,0,0
18596,dynamics,0,0
18597,of,0,0
18598,improvement,0,0
18599,of,0,0
18600,the,0,0
18601,impaired,0,0
18602,blood,0,0
18603,lipid,0,0
18604,spectrum,0,0
18605,.,0,0
18606,The,0,0
18607,results,0,0
18608,admit,0,0
18609,a,0,0
18610,possible,0,0
18611,part,0,0
18612,played,0,0
18613,by,0,0
18614,the,0,0
18615,pleiotropic,0,0
18616,effect,0,0
18617,of,0,0
18618,statins,0,1
18619,.,0,0
18620,Prophylactic,0,1
18621,use,0,0
18622,of,0,0
18623,amifostine,1,1
18624,to,0,0
18625,prevent,0,0
18626,radiochemotherapy-induced,0,1
18627,mucositis,0,0
18628,and,0,0
18629,xerostomia,0,0
18630,in,0,0
18631,head-and-neck,0,1
18632,cancer,0,0
18633,.,0,0
18634,PURPOSE,0,0
18635,To,0,0
18636,determine,0,0
18637,the,0,0
18638,prophylactic,0,1
18639,properties,0,0
18640,of,0,0
18641,amifostine,1,1
18642,against,0,0
18643,acute,0,0
18644,and,0,0
18645,late,0,0
18646,toxicities,0,0
18647,from,0,0
18648,radiochemotherapy,0,1
18649,in,0,0
18650,patients,0,0
18651,with,0,0
18652,head-and-neck,0,1
18653,cancer,0,0
18654,.,0,1
18655,METHODS,0,0
18656,AND,0,0
18657,MATERIALS,0,1
18658,Fifty,0,0
18659,patients,0,0
18660,were,0,0
18661,randomized,0,0
18662,to,0,0
18663,receive,0,0
18664,conventional,1,1
18665,radiotherapy,1,1
18666,(,0,1
18667,RT,0,1
18668,),0,1
18669,(,0,0
18670,2-Gy,0,1
18671,fractions,0,1
18672,",",0,0
18673,5,0,0
18674,days,0,0
18675,weekly,0,0
18676,",",0,0
18677,to,0,0
18678,a,0,0
18679,total,0,0
18680,of,0,0
18681,60-74,0,0
18682,Gy,0,1
18683,",",0,0
18684,depending,0,0
18685,on,0,0
18686,the,0,0
18687,tumor,0,0
18688,localization,0,0
18689,and,0,0
18690,TNM,0,1
18691,classification,0,0
18692,),0,1
18693,and,0,1
18694,carboplatin,1,1
18695,(,0,1
18696,90,0,1
18697,mg/m,0,1
18698,(,0,0
18699,2,0,0
18700,),0,0
18701,infusion,0,1
18702,once,0,1
18703,per,0,0
18704,week,0,0
18705,before,0,0
18706,RT,0,0
18707,),0,0
18708,.,0,1
18709,Amifostine,1,1
18710,(,0,0
18711,300,0,1
18712,mg/m,0,1
18713,(,0,0
18714,2,0,1
18715,),0,0
18716,),0,0
18717,was,0,0
18718,administered,0,0
18719,in,0,0
18720,the,0,0
18721,study,0,0
18722,group,0,0
18723,only,0,0
18724,15-30,0,0
18725,min,0,0
18726,before,0,0
18727,RT,0,0
18728,for,0,0
18729,6-7.5,0,0
18730,weeks,0,0
18731,.,0,0
18732,The,0,0
18733,primary,0,0
18734,study,0,0
18735,end,0,0
18736,point,0,0
18737,was,0,0
18738,the,0,0
18739,grading,0,0
18740,of,0,0
18741,acute,0,0
18742,and,0,0
18743,late,0,0
18744,nonhematologic,0,0
18745,toxicities,0,0
18746,(,0,0
18747,mucositis,0,0
18748,",",0,0
18749,dysphagia,0,0
18750,",",0,0
18751,xerostomia,0,0
18752,),0,0
18753,induced,0,0
18754,by,0,0
18755,radiochemotherapy,1,1
18756,.,1,0
18757,Secondary,0,0
18758,end,0,0
18759,points,0,0
18760,included,0,0
18761,treatment,0,0
18762,duration,0,0
18763,",",0,0
18764,hematologic,0,0
18765,toxicity,0,0
18766,",",0,0
18767,and,0,0
18768,clinical,0,0
18769,outcome,0,0
18770,.,0,0
18771,RESULTS,0,0
18772,The,0,0
18773,treatment,0,0
18774,duration,0,0
18775,was,0,0
18776,significantly,0,0
18777,shorter,0,0
18778,in,0,0
18779,the,0,0
18780,amifostine-treated,0,1
18781,group,0,0
18782,(,0,0
18783,p,0,0
18784,=,0,0
18785,0.013,0,0
18786,),0,0
18787,",",0,0
18788,because,0,0
18789,treatment,0,0
18790,interruptions,0,0
18791,were,0,0
18792,more,0,0
18793,frequent,0,0
18794,in,0,0
18795,the,0,0
18796,control,0,0
18797,group,0,0
18798,.,0,0
18799,Acute,0,0
18800,toxicities,0,0
18801,(,0,0
18802,mucositis,0,0
18803,and,0,1
18804,dysphagia,0,1
18805,),0,0
18806,were,0,0
18807,less,0,0
18808,severe,0,0
18809,in,0,0
18810,the,0,0
18811,amifostine-treated,0,1
18812,group,0,0
18813,.,0,0
18814,By,0,0
18815,Week,0,0
18816,3,0,0
18817,",",0,0
18818,all,0,0
18819,in,0,0
18820,the,0,0
18821,control,0,1
18822,group,0,0
18823,experienced,0,0
18824,Grade,0,1
18825,2,0,0
18826,mucositis,0,0
18827,compared,0,0
18828,with,0,0
18829,only,0,0
18830,9,0,0
18831,%,0,0
18832,in,0,0
18833,the,0,0
18834,amifostine-treated,0,1
18835,group,0,0
18836,(,0,0
18837,p,0,0
18838,<,0,0
18839,0.0001,0,0
18840,),0,0
18841,.,0,0
18842,By,0,0
18843,Week,0,0
18844,5,0,0
18845,",",0,0
18846,52.2,0,0
18847,%,0,0
18848,of,0,0
18849,the,0,0
18850,patients,0,0
18851,in,0,0
18852,the,0,0
18853,control,0,1
18854,group,0,0
18855,experienced,0,0
18856,Grade,0,1
18857,4,0,0
18858,mucositis,0,0
18859,compared,0,0
18860,with,0,0
18861,4.5,0,0
18862,%,0,0
18863,in,0,0
18864,the,0,0
18865,amifostine-treated,0,1
18866,group,0,0
18867,(,0,0
18868,p,0,0
18869,=,0,0
18870,0.0006,0,0
18871,),0,0
18872,.,0,0
18873,Similar,0,0
18874,results,0,0
18875,were,0,0
18876,obtained,0,0
18877,for,0,0
18878,dysphagia,0,0
18879,.,0,0
18880,At,0,0
18881,3,0,0
18882,months,0,0
18883,of,0,0
18884,follow-up,0,0
18885,",",0,0
18886,only,0,0
18887,27,0,0
18888,%,0,0
18889,of,0,0
18890,patients,0,0
18891,in,0,0
18892,the,0,0
18893,study,0,0
18894,group,0,0
18895,experienced,0,0
18896,Grade,0,1
18897,2,0,0
18898,xerostomia,0,0
18899,compared,0,0
18900,with,0,0
18901,73.9,0,0
18902,%,0,0
18903,in,0,0
18904,the,0,0
18905,control,0,1
18906,group,0,0
18907,(,0,0
18908,p,0,0
18909,=,0,0
18910,0.0001,0,0
18911,),0,0
18912,.,0,0
18913,Eighteen,0,0
18914,months,0,0
18915,after,0,0
18916,cessation,0,1
18917,of,0,0
18918,therapy,0,1
18919,",",0,0
18920,the,0,0
18921,proportion,0,0
18922,of,0,0
18923,patients,0,0
18924,with,0,0
18925,Grade,0,1
18926,2,0,0
18927,xerostomia,0,0
18928,was,0,0
18929,4.5,0,0
18930,%,0,0
18931,vs.,0,0
18932,30.4,0,0
18933,%,0,0
18934,for,0,0
18935,each,0,0
18936,respective,0,0
18937,treatment,0,1
18938,group,0,1
18939,(,0,0
18940,p,0,0
18941,=,0,0
18942,0.047,0,0
18943,),0,0
18944,.,0,0
18945,Cytoprotection,1,0
18946,with,0,0
18947,amifostine,1,1
18948,did,0,0
18949,not,0,0
18950,affect,0,0
18951,treatment,0,0
18952,outcome,0,0
18953,",",0,0
18954,with,0,0
18955,90.9,0,0
18956,%,0,0
18957,complete,0,0
18958,responses,0,0
18959,in,0,0
18960,the,0,0
18961,amifostine-treated,0,1
18962,group,0,0
18963,compared,0,0
18964,with,0,0
18965,78.3,0,0
18966,%,0,0
18967,in,0,0
18968,the,0,0
18969,control,0,1
18970,group,0,0
18971,(,0,0
18972,p,0,0
18973,=,0,0
18974,0.414,0,0
18975,),0,0
18976,.,0,0
18977,CONCLUSION,0,0
18978,Amifostine,1,1
18979,was,0,0
18980,effective,0,0
18981,in,0,0
18982,reducing,0,0
18983,mucositis,0,0
18984,and,0,1
18985,dysphagia,0,1
18986,resulting,0,0
18987,from,0,0
18988,radiochemotherapy,0,1
18989,in,0,0
18990,patients,0,0
18991,with,0,0
18992,head-and-neck,0,1
18993,cancer,0,0
18994,.,0,0
18995,Furthermore,0,0
18996,",",0,0
18997,amifostine,1,1
18998,reduced,0,0
18999,the,0,0
19000,severity,0,0
19001,of,0,0
19002,late,0,0
19003,xerostomia,0,0
19004,",",0,0
19005,a,0,0
19006,side,0,0
19007,effect,0,0
19008,of,0,0
19009,RT,0,0
19010,with,0,0
19011,long-lasting,0,0
19012,consequences,0,0
19013,.,0,0
19014,Amifostine,1,1
19015,treatment,0,0
19016,did,0,0
19017,not,0,0
19018,affect,0,0
19019,the,0,0
19020,clinical,0,0
19021,outcome,0,0
19022,.,0,0
19023,[,0,0
19024,Efficacy,0,0
19025,and,0,0
19026,immune,0,0
19027,memory,0,0
19028,of,0,0
19029,plasma-derived,1,1
19030,hepatitis,1,1
19031,B,1,1
19032,vaccine,1,1
19033,11,0,0
19034,years,0,0
19035,after,0,0
19036,primary,0,0
19037,immunization,0,1
19038,],0,0
19039,.,0,0
19040,OBJECTIVE,0,0
19041,To,0,0
19042,evaluate,0,0
19043,the,0,0
19044,long-term,0,0
19045,efficacy,0,0
19046,of,0,0
19047,hepatitis,1,1
19048,B,1,1
19049,vaccine,1,1
19050,10,0,0
19051,years,0,0
19052,after,0,0
19053,primary,0,0
19054,immunization,0,1
19055,to,0,0
19056,provide,0,0
19057,scientific,0,0
19058,basis,0,0
19059,for,0,0
19060,the,0,0
19061,time,0,0
19062,of,0,0
19063,revaccination,0,1
19064,.,0,0
19065,METHODS,0,0
19066,The,0,0
19067,study,0,0
19068,was,0,0
19069,strictly,0,1
19070,designed,0,0
19071,with,0,0
19072,randomization,0,0
19073,",",0,0
19074,double-blinding,0,0
19075,",",0,0
19076,and,0,0
19077,placebo-controlled,1,1
19078,method,0,1
19079,to,0,0
19080,observe,0,0
19081,the,0,0
19082,efficacy,0,0
19083,and,0,0
19084,immune,0,0
19085,memory,0,0
19086,11,0,0
19087,years,0,0
19088,following,0,0
19089,hepatitis,1,1
19090,B,1,1
19091,vaccination,1,1
19092,.,1,0
19093,RESULTS,0,0
19094,Immunogenicity,0,0
19095,and,0,0
19096,protective,0,0
19097,rate,0,0
19098,of,0,0
19099,vaccine,0,1
19100,were,0,0
19101,still,0,0
19102,kept,0,0
19103,well,0,0
19104,11,0,0
19105,years,0,0
19106,after,0,0
19107,immunization,0,1
19108,with,0,0
19109,a,0,0
19110,protective,0,0
19111,rate,0,0
19112,against,0,0
19113,HBV,0,1
19114,infection,0,0
19115,of,0,0
19116,73.5,0,0
19117,%,0,0
19118,.,0,0
19119,But,0,0
19120,",",0,0
19121,there,0,0
19122,was,0,0
19123,no,0,0
19124,significant,0,0
19125,difference,0,0
19126,in,0,0
19127,HBV,0,1
19128,infection,0,0
19129,rates,0,0
19130,between,0,0
19131,vaccine,0,1
19132,group,0,0
19133,and,0,0
19134,placebo-controlled,0,1
19135,group,0,1
19136,(,0,0
19137,7.89,0,0
19138,%,0,0
19139,vs.,0,0
19140,13.25,0,0
19141,%,0,0
19142,",",0,0
19143,P,0,0
19144,>,0,0
19145,0.1,0,1
19146,),0,0
19147,nine,0,0
19148,to,0,0
19149,11,0,0
19150,years,0,0
19151,following,0,0
19152,immunization,0,1
19153,.,0,0
19154,There,0,0
19155,still,0,0
19156,existed,0,0
19157,immune,0,0
19158,memory,0,0
19159,11,0,0
19160,years,0,0
19161,after,0,0
19162,immunization,0,1
19163,",",0,0
19164,but,0,0
19165,it,0,0
19166,was,0,0
19167,significantly,0,0
19168,weaker,0,0
19169,than,0,0
19170,that,0,0
19171,within,0,0
19172,the,0,0
19173,first,0,0
19174,10,0,0
19175,years,0,0
19176,after,0,0
19177,immunization,0,1
19178,.,0,0
19179,CONCLUSION,0,0
19180,The,0,0
19181,efficacy,0,0
19182,of,0,0
19183,the,0,0
19184,vaccine,0,1
19185,had,0,0
19186,begun,0,0
19187,to,0,0
19188,drop,0,0
19189,11,0,0
19190,years,0,0
19191,after,0,0
19192,immunization,0,1
19193,",",0,0
19194,which,0,0
19195,should,0,0
19196,be,0,0
19197,followed,0,0
19198,up,0,0
19199,further,0,0
19200,to,0,0
19201,reach,0,0
19202,a,0,0
19203,clear,0,0
19204,conclusion,0,0
19205,.,0,0
19206,Effect,0,0
19207,of,0,0
19208,oxolamine,1,1
19209,on,0,0
19210,cough,0,0
19211,sensitivity,0,0
19212,in,0,0
19213,COPD,0,0
19214,patients,0,0
19215,.,0,0
19216,Effect,0,0
19217,of,0,0
19218,delayed,1,0
19219,cord,1,0
19220,clamping,1,1
19221,on,0,0
19222,iron,0,1
19223,stores,0,1
19224,in,0,0
19225,infants,0,0
19226,born,0,0
19227,to,0,0
19228,anemic,0,0
19229,mothers,0,0
19230,:,0,0
19231,a,0,0
19232,randomized,0,0
19233,controlled,0,0
19234,trial,0,0
19235,.,0,0
19236,OBJECTIVE,0,0
19237,To,0,0
19238,study,0,0
19239,the,0,0
19240,effects,0,0
19241,of,0,0
19242,cord,0,0
19243,clamping,0,1
19244,on,0,0
19245,iron,0,1
19246,stores,0,1
19247,of,0,0
19248,infants,0,0
19249,born,0,0
19250,to,0,0
19251,anemic,0,0
19252,mothers,0,0
19253,at,0,0
19254,3,0,0
19255,months,0,0
19256,of,0,0
19257,age,0,0
19258,.,0,0
19259,DESIGN,0,0
19260,Randomized,0,0
19261,controlled,0,0
19262,trial,0,0
19263,.,0,0
19264,SETTING,0,0
19265,Teaching,0,0
19266,hospital,0,0
19267,.,0,0
19268,METHODS,0,0
19269,Infants,0,0
19270,born,0,0
19271,to,0,0
19272,mothers,0,0
19273,with,0,0
19274,hemoglobin,0,0
19275,(,0,1
19276,Hb,0,1
19277,),0,1
19278,<,0,0
19279,100,0,0
19280,g/L,0,0
19281,were,0,0
19282,randomized,0,0
19283,at,0,0
19284,delivery,0,0
19285,to,0,0
19286,either,0,1
19287,immediate,1,1
19288,cord,1,1
19289,clamping,1,1
19290,(,0,1
19291,early,0,0
19292,group,0,1
19293,),0,1
19294,or,0,1
19295,cord,1,0
19296,clamping,1,1
19297,delayed,1,0
19298,till,1,0
19299,descent,1,0
19300,of,1,0
19301,placenta,1,0
19302,into,1,1
19303,vagina,1,0
19304,(,0,1
19305,delayed,0,1
19306,group,0,0
19307,),0,0
19308,.,0,0
19309,The,0,0
19310,outcome,0,0
19311,measures,0,0
19312,were,0,0
19313,infant,0,0
19314,'s,0,0
19315,hemoglobin,0,0
19316,and,0,0
19317,serum,0,0
19318,ferritin,0,1
19319,3,0,0
19320,months,0,0
19321,after,0,0
19322,delivery,0,0
19323,.,0,0
19324,RESULTS,0,0
19325,There,0,0
19326,were,0,0
19327,102,0,0
19328,neonates,0,0
19329,randomized,0,0
19330,to,0,0
19331,early,0,0
19332,(,0,0
19333,n,0,0
19334,=,0,0
19335,43,0,0
19336,),0,0
19337,or,0,1
19338,delayed,0,1
19339,cord,0,1
19340,clamping,0,1
19341,(,0,0
19342,n,0,0
19343,=,0,0
19344,59,0,0
19345,),0,0
19346,.,0,0
19347,The,0,0
19348,groups,0,0
19349,were,0,0
19350,comparable,0,0
19351,for,0,0
19352,maternal,0,0
19353,age,0,0
19354,",",0,0
19355,parity,0,0
19356,",",0,0
19357,weight,0,0
19358,and,0,0
19359,supplemental,0,1
19360,iron,0,1
19361,intake,0,0
19362,",",0,0
19363,infant,0,0
19364,s,0,1
19365,birth,0,0
19366,weight,0,0
19367,",",0,0
19368,gestation,0,0
19369,and,0,0
19370,sex,0,0
19371,.,0,0
19372,The,0,0
19373,mean,0,0
19374,infant,0,0
19375,ferritin,0,1
19376,and,0,0
19377,Hb,0,1
19378,at,0,0
19379,3,0,0
19380,months,0,0
19381,were,0,0
19382,significantly,0,0
19383,higher,0,0
19384,in,0,0
19385,the,0,0
19386,delayed,1,0
19387,clamping,1,1
19388,group,0,1
19389,(,0,0
19390,118.4,0,0
19391,microg/L,0,1
19392,and,0,0
19393,99,0,0
19394,g/L,0,1
19395,),0,0
19396,than,0,0
19397,in,0,0
19398,the,0,0
19399,early,1,0
19400,clamping,1,1
19401,group,0,1
19402,(,0,0
19403,73,0,0
19404,microg/L,0,1
19405,and,0,0
19406,88,0,0
19407,g/L,0,1
19408,),0,0
19409,.,0,0
19410,The,0,0
19411,mean,0,0
19412,decrease,0,0
19413,in,0,0
19414,Hb,0,1
19415,(,0,1
19416,g/L,0,1
19417,),0,1
19418,at,0,0
19419,3,0,0
19420,months,0,0
19421,adjusted,0,0
19422,for,0,0
19423,co-variates,0,0
19424,was,0,0
19425,significantly,0,0
19426,less,0,0
19427,in,0,0
19428,the,0,0
19429,delayed,1,0
19430,clamping,1,1
19431,group,0,0
19432,compared,0,0
19433,to,0,0
19434,the,0,0
19435,early,1,0
19436,clamping,1,1
19437,group,0,1
19438,(,0,0
19439,-1.09,0,0
19440,",",0,0
19441,95,0,0
19442,%,0,0
19443,CI-1.58,0,0
19444,to,0,0
19445,-0.62,0,0
19446,",",0,0
19447,p,0,0
19448,>,0,0
19449,0.001,0,0
19450,),0,0
19451,.,0,0
19452,The,0,0
19453,odds,0,0
19454,for,0,0
19455,anemia,0,0
19456,(,0,0
19457,<,0,0
19458,100,0,1
19459,g/L,0,1
19460,),0,0
19461,at,0,0
19462,3,0,0
19463,months,0,0
19464,was,0,0
19465,7.7,0,0
19466,(,0,0
19467,95,0,0
19468,%,0,0
19469,CI,0,0
19470,1.84-34.9,0,0
19471,),0,0
19472,times,0,0
19473,higher,0,0
19474,in,0,0
19475,the,0,0
19476,early,0,0
19477,compared,0,0
19478,to,0,0
19479,the,0,0
19480,delayed,1,0
19481,clamping,1,1
19482,group,0,0
19483,.,0,0
19484,CONCLUSION,0,0
19485,Iron,0,1
19486,stores,0,1
19487,and,0,0
19488,Hb,0,1
19489,in,0,0
19490,infancy,0,0
19491,can,0,0
19492,be,0,0
19493,improved,0,0
19494,in,0,0
19495,neonates,0,0
19496,born,0,0
19497,to,0,0
19498,anemic,0,0
19499,mothers,0,0
19500,by,0,0
19501,delaying,1,0
19502,cord,1,0
19503,clamping,1,1
19504,at,0,0
19505,birth,0,0
19506,.,0,0
19507,The,0,0
19508,impact,0,0
19509,of,0,0
19510,different,0,0
19511,doses,0,0
19512,of,0,0
19513,medroxyprogesterone,1,1
19514,acetate,1,1
19515,on,0,0
19516,mood,0,0
19517,symptoms,0,0
19518,in,0,0
19519,sequential,1,0
19520,hormonal,1,0
19521,therapy,1,1
19522,.,1,0
19523,The,0,0
19524,aim,0,0
19525,of,0,0
19526,this,0,0
19527,study,0,0
19528,was,0,0
19529,to,0,0
19530,compare,0,0
19531,adverse,0,0
19532,mood,0,0
19533,effects,0,0
19534,of,0,0
19535,two,0,0
19536,different,0,0
19537,doses,0,0
19538,of,0,0
19539,medroxyprogesterone,1,1
19540,acetate,1,1
19541,(,1,1
19542,MPA,1,1
19543,),1,1
19544,during,0,0
19545,postmenopausal,0,0
19546,hormone,0,1
19547,replacement,0,1
19548,therapy,0,1
19549,(,0,1
19550,HRT,0,1
19551,),0,1
19552,in,0,0
19553,women,0,0
19554,with,0,0
19555,and,0,0
19556,without,0,0
19557,a,0,0
19558,history,0,0
19559,of,0,0
19560,premenstrual,0,0
19561,syndrome,0,0
19562,(,0,1
19563,PMS,0,1
19564,),0,0
19565,.,0,0
19566,The,0,0
19567,study,0,0
19568,was,0,0
19569,designed,0,0
19570,as,0,0
19571,a,0,0
19572,randomized,0,0
19573,double-blind,0,0
19574,cross-over,0,0
19575,study,0,0
19576,and,0,0
19577,included,0,0
19578,36,0,0
19579,postmenopausal,0,0
19580,women,0,0
19581,at,0,0
19582,three,0,0
19583,health,0,0
19584,care,0,1
19585,areas,0,0
19586,in,0,0
19587,northern,0,0
19588,Sweden,0,0
19589,.,0,0
19590,The,0,0
19591,women,0,0
19592,received,0,0
19593,2,1,0
19594,mg,1,0
19595,estradiol,1,1
19596,continuously,0,0
19597,during,0,0
19598,five,0,0
19599,28-day,0,0
19600,cycles,0,0
19601,and,0,0
19602,10,0,1
19603,mg,0,1
19604,or,0,1
19605,20,0,0
19606,mg,0,1
19607,MPA,0,1
19608,sequentially,0,1
19609,for,0,0
19610,12,0,0
19611,days,0,0
19612,during,0,0
19613,each,0,0
19614,cycle,0,0
19615,.,0,0
19616,The,0,0
19617,main,0,0
19618,outcome,0,0
19619,measures,0,0
19620,were,0,0
19621,mood,0,0
19622,and,0,0
19623,physical,0,1
19624,symptoms,0,0
19625,noted,0,0
19626,on,0,0
19627,a,0,0
19628,daily,0,1
19629,rating,0,0
19630,scale,0,0
19631,.,0,0
19632,We,0,0
19633,found,0,0
19634,that,0,0
19635,physical,0,1
19636,symptoms,0,0
19637,did,0,0
19638,not,0,0
19639,differ,0,0
19640,between,0,0
19641,10,0,0
19642,and,0,0
19643,20,0,0
19644,mg,0,1
19645,MPA,0,1
19646,.,0,0
19647,Both,0,0
19648,women,0,0
19649,with,0,0
19650,a,0,0
19651,history,0,0
19652,of,0,0
19653,PMS,0,1
19654,and,0,0
19655,women,0,0
19656,without,0,0
19657,responded,0,0
19658,with,0,0
19659,more,0,0
19660,negative,0,0
19661,mood,0,0
19662,symptoms,0,0
19663,with,0,0
19664,the,0,0
19665,lower,0,0
19666,dose,0,0
19667,of,0,0
19668,MPA,0,1
19669,.,0,0
19670,In,0,0
19671,women,0,0
19672,with,0,0
19673,previous,0,0
19674,PMS,0,0
19675,the,0,0
19676,higher,0,0
19677,dose,0,0
19678,of,0,0
19679,MPA,0,1
19680,enhanced,0,0
19681,positive,0,0
19682,mood,0,0
19683,symptoms,0,0
19684,.,0,0
19685,With,0,0
19686,respect,0,0
19687,to,0,0
19688,mood,0,0
19689,and,0,0
19690,physical,0,1
19691,symptoms,0,0
19692,",",0,0
19693,the,0,0
19694,aim,0,0
19695,to,0,0
19696,lower,0,0
19697,MPA,0,1
19698,doses,0,0
19699,in,0,0
19700,HRT,0,1
19701,is,0,0
19702,unwarranted,0,0
19703,.,0,0
19704,Parenteral,0,1
19705,troxerutin,1,1
19706,and,1,0
19707,carbazochrome,1,1
19708,combination,1,1
19709,in,0,0
19710,the,0,0
19711,treatment,0,0
19712,of,0,0
19713,post-hemorrhoidectomy,0,1
19714,status,0,0
19715,:,0,0
19716,a,0,0
19717,randomized,0,0
19718,",",0,0
19719,double-blind,0,0
19720,",",0,0
19721,placebo-controlled,0,1
19722,",",0,0
19723,phase,0,0
19724,IV,0,0
19725,study,0,0
19726,.,0,0
19727,Flavonoids,0,1
19728,",",0,0
19729,such,0,0
19730,as,0,0
19731,troxerutin,1,1
19732,",",0,0
19733,have,0,0
19734,been,0,0
19735,shown,0,0
19736,to,0,0
19737,be,0,0
19738,safe,0,0
19739,and,0,0
19740,effective,0,0
19741,agents,0,1
19742,for,0,0
19743,the,0,0
19744,treatment,0,0
19745,of,0,0
19746,chronic,0,0
19747,venous,0,0
19748,insufficiency,0,0
19749,.,0,0
19750,The,0,0
19751,fixed,0,0
19752,combination,0,1
19753,between,0,0
19754,troxerutin,1,1
19755,150,0,0
19756,mg,0,1
19757,and,0,0
19758,carbazochrome,1,1
19759,1.5,0,1
19760,mg,0,1
19761,(,0,0
19762,Fleboside,0,1
19763,ampoules,0,1
19764,),0,0
19765,was,0,0
19766,previously,0,0
19767,shown,0,0
19768,to,0,0
19769,have,0,0
19770,a,0,0
19771,good,0,0
19772,efficacy,0,0
19773,and,0,0
19774,safety,0,0
19775,profile,0,0
19776,in,0,0
19777,non-surgical,0,1
19778,patients,0,0
19779,with,0,0
19780,acute,0,0
19781,uncomplicated,0,0
19782,hemorrhoids,0,0
19783,.,0,0
19784,The,0,0
19785,purpose,0,0
19786,of,0,0
19787,this,0,0
19788,randomized,0,0
19789,",",0,0
19790,double-blind,0,0
19791,",",0,0
19792,placebo-controlled,0,1
19793,study,0,0
19794,was,0,0
19795,to,0,0
19796,investigate,0,0
19797,the,0,0
19798,efficacy,0,0
19799,and,0,0
19800,tolerability,0,0
19801,of,0,0
19802,the,0,0
19803,active,0,1
19804,combination,0,1
19805,in,0,0
19806,the,0,0
19807,treatment,0,0
19808,of,0,0
19809,post-hemorrhoidectomy,0,1
19810,patients,0,0
19811,.,0,0
19812,30,0,0
19813,patients,0,0
19814,were,0,0
19815,randomized,0,0
19816,to,0,0
19817,receive,0,0
19818,one,0,0
19819,of,0,0
19820,two,0,0
19821,treatments,0,0
19822,:,0,0
19823,troxerutin,1,1
19824,150,1,0
19825,mg,1,1
19826,and,1,0
19827,carbazochrome,1,1
19828,1.5,1,0
19829,mg,1,1
19830,",",0,0
19831,or,0,1
19832,placebo,1,1
19833,",",0,0
19834,i.m,0,1
19835,.,0,0
19836,3,0,0
19837,ml,0,0
19838,ampoules,0,1
19839,twice,0,0
19840,a,0,0
19841,day,0,0
19842,for,0,0
19843,five,0,0
19844,consecutive,0,0
19845,days,0,0
19846,after,0,0
19847,the,0,0
19848,surgical,0,1
19849,procedure,0,0
19850,",",0,0
19851,starting,0,0
19852,from,0,0
19853,the,0,0
19854,day,0,0
19855,of,0,0
19856,surgery,0,0
19857,.,0,0
19858,Efficacy,0,0
19859,parameters,0,0
19860,were,0,0
19861,assessed,0,0
19862,as,0,0
19863,follows,0,0
19864,:,0,0
19865,at,0,0
19866,baseline,0,0
19867,(,0,1
19868,T1,0,1
19869,),0,0
19870,",",0,0
19871,after,0,0
19872,the,0,0
19873,first,0,0
19874,administration,0,0
19875,(,0,0
19876,T2,0,1
19877,;,0,0
19878,day,0,0
19879,of,0,0
19880,surgery,0,1
19881,),0,0
19882,",",0,0
19883,the,0,0
19884,second,0,0
19885,day,0,0
19886,after,0,0
19887,the,0,0
19888,surgical,0,1
19889,procedure,0,1
19890,(,0,1
19891,T3,0,1
19892,),0,1
19893,",",0,0
19894,and,0,0
19895,the,0,0
19896,fifth,0,0
19897,day,0,0
19898,after,0,0
19899,the,0,0
19900,surgical,0,1
19901,procedure,0,1
19902,(,0,1
19903,T4,0,0
19904,),0,1
19905,;,0,0
19906,hemorrhoidal,0,0
19907,symptoms,0,0
19908,based,0,0
19909,on,0,0
19910,a,0,0
19911,visual,0,0
19912,analogue,0,1
19913,scale,0,0
19914,(,0,1
19915,VAS,0,1
19916,),0,1
19917,:,0,0
19918,pain,0,0
19919,",",0,0
19920,discharge,0,1
19921,",",0,0
19922,bleeding,0,0
19923,",",0,0
19924,inflammation,0,0
19925,",",0,0
19926,and,0,0
19927,pruritus,0,0
19928,;,0,0
19929,analgesic,0,1
19930,intake,0,0
19931,",",0,0
19932,if,0,0
19933,any,0,0
19934,;,0,0
19935,time,0,0
19936,to,0,0
19937,restore,0,0
19938,a,0,0
19939,physiological,0,0
19940,defecation,0,0
19941,;,0,0
19942,edema,0,0
19943,evaluation,0,0
19944,(,0,1
19945,based,0,0
19946,on,0,0
19947,a,0,0
19948,four-point,0,0
19949,scale,0,0
19950,:,0,0
19951,0,0,0
19952,=,0,0
19953,absent,0,0
19954,;,0,0
19955,1,0,0
19956,=,0,0
19957,mild,0,0
19958,;,0,0
19959,2,0,0
19960,=,0,0
19961,moderate,0,0
19962,;,0,0
19963,3,0,0
19964,=,0,0
19965,severe,0,0
19966,),0,0
19967,;,0,0
19968,camera,0,1
19969,pictures,0,1
19970,taken,0,0
19971,at,0,0
19972,T1,0,1
19973,and,0,1
19974,T4,0,0
19975,(,0,0
19976,in,0,0
19977,selected,0,0
19978,patients,0,0
19979,),0,0
19980,;,0,0
19981,and,0,0
19982,blood,0,0
19983,coagulation,0,1
19984,tests,0,0
19985,.,0,0
19986,Analysis,0,0
19987,between,0,0
19988,treatment,0,0
19989,groups,0,0
19990,revealed,0,0
19991,a,0,0
19992,highly,0,0
19993,significant,0,0
19994,difference,0,0
19995,at,0,0
19996,T3,0,1
19997,and,0,0
19998,T4,0,0
19999,for,0,0
20000,the,0,0
20001,total,0,0
20002,VAS,0,1
20003,score,0,0
20004,(,0,0
20005,p,0,0
20006,=,0,0
20007,0.007,0,0
20008,and,0,0
20009,p,0,0
20010,=,0,0
20011,0.001,0,0
20012,",",0,0
20013,respectively,0,0
20014,),0,0
20015,in,0,0
20016,favor,0,0
20017,of,0,0
20018,the,0,0
20019,active,0,1
20020,combination,0,1
20021,treatment,0,0
20022,.,0,0
20023,A,0,0
20024,statistically,0,0
20025,significant,0,0
20026,difference,0,0
20027,was,0,0
20028,also,0,0
20029,observed,0,0
20030,for,0,0
20031,bleeding,0,0
20032,and,0,0
20033,pruritus,0,0
20034,at,0,0
20035,T3,0,1
20036,and,0,0
20037,for,0,0
20038,these,0,0
20039,two,0,0
20040,parameters,0,0
20041,and,0,0
20042,both,0,0
20043,inflammation,0,0
20044,and,0,0
20045,edema,0,0
20046,at,0,1
20047,T4,0,0
20048,(,0,0
20049,p,0,0
20050,<,0,0
20051,0.001,0,0
20052,),0,0
20053,in,0,0
20054,favor,0,0
20055,of,0,0
20056,the,0,0
20057,active,0,1
20058,combination,0,1
20059,group,0,0
20060,.,0,0
20061,No,0,0
20062,adverse,0,0
20063,events,0,0
20064,were,0,0
20065,reported,0,0
20066,.,0,0
20067,Neither,0,0
20068,the,0,0
20069,active,0,1
20070,combination,0,1
20071,nor,0,0
20072,placebo,0,1
20073,affected,0,0
20074,blood,0,0
20075,coagulation,0,0
20076,tests,0,0
20077,.,0,0
20078,We,0,0
20079,conclude,0,0
20080,that,0,0
20081,intramuscular,0,1
20082,administration,0,0
20083,of,0,0
20084,the,0,0
20085,fixed,0,1
20086,combination,1,1
20087,of,1,0
20088,troxerutin,1,1
20089,150,0,0
20090,mg,0,1
20091,and,1,0
20092,carbazochrome,1,1
20093,1.5,0,0
20094,mg,0,1
20095,is,0,0
20096,effective,0,0
20097,",",0,0
20098,well,0,0
20099,tolerated,0,0
20100,and,0,0
20101,superior,0,0
20102,to,0,0
20103,placebo,1,1
20104,in,0,0
20105,improving,0,0
20106,hemorrhoidal,0,0
20107,and,0,0
20108,post-surgical,0,0
20109,symptoms,0,0
20110,during,0,0
20111,the,0,0
20112,five,0,0
20113,days,0,0
20114,following,0,0
20115,surgery,0,0
20116,.,0,0
20117,Safety,0,1
20118,of,0,0
20119,intravitreous,0,1
20120,fomivirsen,1,1
20121,for,0,0
20122,treatment,0,0
20123,of,0,0
20124,cytomegalovirus,0,0
20125,retinitis,0,0
20126,in,0,0
20127,patients,0,0
20128,with,0,0
20129,AIDS,0,0
20130,.,0,0
20131,PURPOSE,0,0
20132,To,0,0
20133,report,0,0
20134,data,0,0
20135,regarding,0,0
20136,the,0,0
20137,safety,0,0
20138,of,0,0
20139,intravitreous,0,1
20140,fomivirsen,1,1
20141,for,0,0
20142,treatment,0,0
20143,of,0,0
20144,cytomegalovirus,0,0
20145,(,0,1
20146,CMV,0,1
20147,),0,1
20148,retinitis,0,0
20149,in,0,0
20150,patients,0,0
20151,with,0,0
20152,acquired,0,0
20153,immunodeficiency,0,0
20154,syndrome,0,0
20155,(,0,1
20156,AIDS,0,0
20157,),0,0
20158,.,0,0
20159,DESIGN,0,0
20160,Critical,0,0
20161,review,0,0
20162,of,0,0
20163,safety,0,0
20164,data,0,0
20165,from,0,0
20166,three,0,0
20167,randomized,0,0
20168,controlled,0,0
20169,clinical,0,0
20170,trials,0,0
20171,with,0,0
20172,supplemental,0,1
20173,information,0,0
20174,from,0,0
20175,an,0,0
20176,expanded,0,0
20177,drug,0,1
20178,access,0,0
20179,program,0,1
20180,.,0,0
20181,METHODS,0,0
20182,Adverse,0,0
20183,ocular,0,0
20184,events,0,0
20185,reported,0,0
20186,by,0,0
20187,clinician,0,0
20188,investigators,0,0
20189,were,0,0
20190,listed,0,0
20191,using,0,0
20192,terms,0,0
20193,modified,0,0
20194,from,0,0
20195,the,0,0
20196,COSTART,0,0
20197,dictionary,0,1
20198,.,0,0
20199,Data,0,0
20200,for,0,0
20201,two,0,0
20202,doses,0,0
20203,(,0,0
20204,165-microg/injection,0,1
20205,[,0,0
20206,35,0,0
20207,eyes,0,0
20208,",",0,0
20209,30,0,0
20210,patients,0,0
20211,],0,0
20212,and,0,0
20213,330-microg/injection,0,1
20214,[,0,0
20215,153,0,0
20216,eyes,0,0
20217,",",0,0
20218,120,0,0
20219,patients,0,0
20220,],0,0
20221,),0,0
20222,and,0,0
20223,two,0,0
20224,330-microg/injection,0,1
20225,dose,0,0
20226,schedules,0,1
20227,of,0,0
20228,different,0,0
20229,intensity,0,0
20230,were,0,0
20231,pooled,0,0
20232,to,0,0
20233,calculate,0,0
20234,incidence,0,0
20235,rates,0,0
20236,for,0,0
20237,each,0,0
20238,event,0,0
20239,.,0,0
20240,Rates,0,0
20241,were,0,0
20242,calculated,0,0
20243,as,0,0
20244,events/patient-year,0,0
20245,(,0,0
20246,based,0,0
20247,on,0,0
20248,total,0,0
20249,cumulative,0,0
20250,reported,0,0
20251,events,0,0
20252,and,0,0
20253,duration,0,0
20254,of,0,0
20255,treatment,0,0
20256,),0,0
20257,for,0,0
20258,events,0,0
20259,that,0,0
20260,could,0,0
20261,recur,0,0
20262,during,0,0
20263,treatment,0,0
20264,.,0,0
20265,Rates,0,0
20266,were,0,0
20267,calculated,0,0
20268,as,0,0
20269,patients,0,0
20270,with,0,0
20271,events/person-year,0,0
20272,for,0,0
20273,the,0,0
20274,following,0,0
20275,events,0,0
20276,:,0,0
20277,retinal,0,0
20278,detachment,0,0
20279,",",0,0
20280,cataract,0,0
20281,",",0,0
20282,visual,0,0
20283,field,0,0
20284,disturbance,0,0
20285,",",0,0
20286,and,0,0
20287,retinal,0,1
20288,pigment,0,0
20289,epitheliopathy,0,0
20290,.,0,0
20291,To,0,0
20292,assess,0,0
20293,the,0,0
20294,ability,0,0
20295,to,0,0
20296,manage,0,0
20297,events,0,0
20298,",",0,0
20299,we,0,0
20300,reviewed,0,0
20301,treatments,0,0
20302,given,0,0
20303,for,0,0
20304,two,0,0
20305,events,0,0
20306,(,0,0
20307,anterior,0,1
20308,chamber,0,1
20309,inflammation,0,0
20310,",",0,0
20311,increased,0,0
20312,intraocular,0,1
20313,pressure,0,0
20314,),0,0
20315,in,0,0
20316,one,0,0
20317,trial,0,0
20318,.,0,0
20319,We,0,0
20320,also,0,0
20321,report,0,0
20322,an,0,0
20323,analysis,0,0
20324,comparing,0,0
20325,the,0,0
20326,proportion,0,0
20327,of,0,0
20328,eyes,0,0
20329,that,0,0
20330,developed,0,0
20331,one,0,0
20332,or,0,0
20333,more,0,0
20334,key,0,0
20335,events,0,0
20336,to,0,0
20337,the,0,0
20338,cumulative,0,0
20339,number,0,0
20340,of,0,0
20341,injections,0,1
20342,.,0,0
20343,RESULTS,0,0
20344,Incidence,0,0
20345,rates,0,0
20346,were,0,0
20347,dose,0,0
20348,and,0,0
20349,schedule,0,1
20350,dependent,0,0
20351,(,0,0
20352,165,0,0
20353,microg/injection,0,0
20354,",",0,0
20355,4.06,0,0
20356,events/patient-year,0,0
20357,;,0,0
20358,330,0,0
20359,microg/injection,0,0
20360,",",0,0
20361,6.58,0,0
20362,events/patient-year,0,0
20363,[,0,0
20364,less,0,0
20365,intense,0,0
20366,regimen,0,1
20367,],0,0
20368,and,0,0
20369,8.35,0,0
20370,events/patient-year,0,0
20371,[,0,0
20372,more,0,0
20373,intense,0,0
20374,regimen,0,1
20375,],0,0
20376,),0,0
20377,.,0,0
20378,The,0,0
20379,most,0,0
20380,frequently,0,0
20381,reported,0,0
20382,events,0,0
20383,were,0,0
20384,anterior,0,0
20385,chamber,0,1
20386,inflammation,0,0
20387,and,0,0
20388,increased,0,0
20389,intraocular,0,1
20390,pressure,0,0
20391,.,0,0
20392,We,0,0
20393,found,0,0
20394,no,0,0
20395,evidence,0,0
20396,that,0,0
20397,the,0,0
20398,proportion,0,0
20399,of,0,0
20400,patients,0,0
20401,with,0,0
20402,events,0,0
20403,increased,0,0
20404,as,0,0
20405,the,0,0
20406,number,0,0
20407,of,0,0
20408,injections,0,1
20409,increased,0,0
20410,.,0,0
20411,CONCLUSIONS,0,0
20412,Intravitreous,0,1
20413,fomivirsen,0,1
20414,is,0,0
20415,well,0,0
20416,tolerated,0,0
20417,with,0,0
20418,an,0,0
20419,acceptable,0,0
20420,safety,0,0
20421,profile,0,0
20422,.,0,0
20423,Adverse,0,0
20424,ocular,0,0
20425,events,0,0
20426,associated,0,0
20427,with,0,0
20428,doses,0,0
20429,and,0,0
20430,schedules,0,1
20431,used,0,0
20432,clinically,0,0
20433,can,0,0
20434,be,0,0
20435,managed,0,0
20436,successfully,0,0
20437,with,0,0
20438,medical,0,0
20439,therapy,0,1
20440,.,0,0
20441,Regional,1,0
20442,ischemic,1,0
20443,preconditioning,1,1
20444,enhances,0,0
20445,myocardial,0,0
20446,performance,0,0
20447,in,0,0
20448,off-pump,0,1
20449,coronary,0,0
20450,artery,0,0
20451,bypass,0,1
20452,grafting,0,1
20453,.,0,0
20454,OBJECTIVES,0,0
20455,We,0,0
20456,intended,0,0
20457,to,0,0
20458,investigate,0,0
20459,whether,0,0
20460,ischemic,0,0
20461,preconditioning,0,1
20462,(,0,1
20463,IP,0,1
20464,),0,1
20465,enhances,0,0
20466,myocardial,0,0
20467,performance,0,0
20468,in,0,0
20469,patients,0,0
20470,who,0,0
20471,undergo,0,0
20472,off-pump,0,1
20473,coronary,0,0
20474,artery,0,0
20475,bypass,0,1
20476,grafting,0,1
20477,(,0,1
20478,CABG,0,0
20479,),0,0
20480,.,0,0
20481,DESIGN,0,0
20482,A,0,0
20483,controlled,0,0
20484,",",0,0
20485,randomized,0,0
20486,",",0,0
20487,prospective,0,0
20488,study,0,0
20489,.,0,0
20490,SETTING,0,0
20491,A,0,0
20492,university,0,0
20493,hospital,0,0
20494,.,0,0
20495,PATIENTS,0,0
20496,Thirty-two,0,0
20497,patients,0,0
20498,with,0,0
20499,left,0,0
20500,anterior,0,0
20501,descending,0,0
20502,coronary,0,1
20503,artery,0,0
20504,(,0,1
20505,LAD,0,0
20506,),0,1
20507,or,0,1
20508,two-vessel,0,1
20509,heart,0,0
20510,disease,0,0
20511,(,0,0
20512,including,0,1
20513,LAD,0,0
20514,),0,0
20515,who,0,0
20516,were,0,0
20517,to,0,0
20518,undergo,0,0
20519,off-pump,0,1
20520,CABG,0,0
20521,were,0,0
20522,randomized,0,0
20523,into,0,0
20524,an,0,0
20525,IP,0,1
20526,group,0,0
20527,and,0,0
20528,a,0,0
20529,control,0,1
20530,group,0,0
20531,.,0,0
20532,INTERVENTIONS,0,0
20533,IP,0,1
20534,was,0,0
20535,induced,0,0
20536,by,0,0
20537,occluding,1,0
20538,the,1,0
20539,LAD,1,0
20540,twice,1,1
20541,for,1,0
20542,a,1,0
20543,2-min,1,1
20544,period,1,0
20545,followed,1,1
20546,by,1,0
20547,3-min,1,1
20548,LAD,1,0
20549,reperfusion,1,1
20550,before,1,0
20551,bypass,1,1
20552,grafting,1,1
20553,of,1,0
20554,the,1,0
20555,first,1,0
20556,coronary,1,0
20557,vessel,1,0
20558,.,1,1
20559,MEASUREMENTS,0,0
20560,AND,0,0
20561,RESULTS,0,0
20562,Registration,0,0
20563,included,0,0
20564,hemodynamic,0,0
20565,data,0,0
20566,from,0,0
20567,the,0,0
20568,peripheral,0,0
20569,artery,0,0
20570,and,0,0
20571,the,0,0
20572,pulmonary,0,0
20573,artery,0,0
20574,",",0,0
20575,and,0,0
20576,the,0,0
20577,measurement,0,0
20578,of,0,0
20579,cardiac,0,0
20580,troponin,0,0
20581,I,0,0
20582,(,0,0
20583,CTnI,0,1
20584,),0,1
20585,and,0,0
20586,creatine,0,1
20587,kinase,0,1
20588,isoenzyme,0,1
20589,MB,0,1
20590,(,0,1
20591,CK-MB,0,0
20592,),0,0
20593,values,0,0
20594,.,0,0
20595,IP,0,1
20596,resulted,0,0
20597,in,0,0
20598,a,0,0
20599,complete,0,0
20600,recovery,0,0
20601,of,0,0
20602,the,0,0
20603,mean,0,0
20604,stroke,0,0
20605,volume,0,1
20606,index,0,0
20607,(,0,1
20608,SVI,0,1
20609,),0,1
20610,after,0,0
20611,the,0,0
20612,operation,0,0
20613,.,0,0
20614,In,0,0
20615,the,0,0
20616,control,0,1
20617,subjects,0,0
20618,",",0,0
20619,the,0,0
20620,mean,0,0
20621,SVI,0,1
20622,showed,0,0
20623,a,0,0
20624,significant,0,0
20625,reduction,0,0
20626,postoperatively,0,0
20627,(,0,0
20628,p,0,0
20629,=,0,0
20630,0.039,0,0
20631,),0,0
20632,.,0,0
20633,On,0,0
20634,the,0,0
20635,first,0,0
20636,postoperative,0,0
20637,day,0,0
20638,",",0,0
20639,the,0,0
20640,increase,0,0
20641,in,0,0
20642,the,0,0
20643,mean,0,0
20644,heart,0,0
20645,rate,0,0
20646,(,0,1
20647,HR,0,0
20648,),0,1
20649,was,0,0
20650,also,0,0
20651,significantly,0,0
20652,lower,0,0
20653,in,0,0
20654,the,0,0
20655,IP,0,1
20656,patients,0,0
20657,.,0,0
20658,The,0,0
20659,CTnI,0,0
20660,level,0,0
20661,was,0,0
20662,statistically,0,0
20663,significantly,0,0
20664,lower,0,0
20665,in,0,0
20666,the,0,0
20667,IP,0,1
20668,group,0,1
20669,(,0,0
20670,p,0,0
20671,=,0,0
20672,0.043,0,0
20673,),0,0
20674,",",0,0
20675,and,0,0
20676,IP,0,1
20677,patients,0,0
20678,tended,0,0
20679,to,0,0
20680,have,0,0
20681,a,0,0
20682,smaller,0,0
20683,CK-MB,0,0
20684,release,0,0
20685,after,0,0
20686,surgery,0,1
20687,(,0,0
20688,not,0,0
20689,significant,0,0
20690,),0,0
20691,.,0,0
20692,The,0,0
20693,duration,0,0
20694,of,0,0
20695,mechanical,0,0
20696,ventilation,0,1
20697,",",0,0
20698,the,0,0
20699,length,0,0
20700,of,0,0
20701,stay,0,0
20702,in,0,0
20703,the,0,0
20704,ICU,0,0
20705,",",0,0
20706,and,0,0
20707,the,0,0
20708,use,0,0
20709,of,0,0
20710,inotropic,0,1
20711,medication,0,1
20712,did,0,0
20713,not,0,0
20714,increase,0,0
20715,after,0,0
20716,the,0,0
20717,IP,0,1
20718,protocol,0,0
20719,.,0,0
20720,CONCLUSIONS,0,0
20721,Two,0,0
20722,cycles,0,0
20723,of,0,0
20724,regional,0,0
20725,2-min,0,1
20726,IP,0,1
20727,in,0,0
20728,the,0,0
20729,LAD,0,0
20730,",",0,0
20731,followed,0,0
20732,by,0,0
20733,3,0,0
20734,min,0,0
20735,of,0,0
20736,reperfusion,0,0
20737,",",0,0
20738,proved,0,0
20739,to,0,0
20740,be,0,0
20741,applicable,0,1
20742,and,0,0
20743,safe,0,0
20744,in,0,0
20745,patients,0,0
20746,undergoing,0,0
20747,off-pump,0,1
20748,myocardial,0,0
20749,revascularization,0,0
20750,",",0,0
20751,it,0,0
20752,tended,0,0
20753,to,0,0
20754,decrease,0,0
20755,the,0,0
20756,immediate,0,0
20757,myocardial,0,0
20758,enzyme,0,1
20759,release,0,0
20760,",",0,0
20761,it,0,0
20762,prohibited,0,0
20763,the,0,0
20764,postoperative,0,0
20765,increase,0,0
20766,in,0,0
20767,HR,0,0
20768,",",0,0
20769,and,0,0
20770,it,0,0
20771,enhanced,0,0
20772,the,0,0
20773,recovery,0,0
20774,of,0,0
20775,SVI,0,1
20776,.,0,0
20777,Prolonged,1,1
20778,GnRH,1,1
20779,agonist,1,1
20780,and,1,0
20781,add-back,1,1
20782,therapy,1,1
20783,for,0,0
20784,symptomatic,0,0
20785,endometriosis,0,0
20786,:,0,0
20787,long-term,0,0
20788,follow-up,0,0
20789,.,0,0
20790,OBJECTIVE,0,0
20791,To,0,0
20792,assess,0,0
20793,post-treatment,0,0
20794,effects,0,0
20795,in,0,0
20796,endometriosis,0,0
20797,patients,0,0
20798,of,0,0
20799,a,0,0
20800,12-month,0,0
20801,course,0,0
20802,of,0,0
20803,GnRH,1,1
20804,agonist,1,1
20805,alone,0,1
20806,or,0,0
20807,with,0,0
20808,one,0,0
20809,of,0,0
20810,three,1,0
20811,add-back,1,0
20812,regimens,1,0
20813,.,1,0
20814,METHODS,0,0
20815,This,0,0
20816,is,0,0
20817,a,0,0
20818,post-treatment,0,0
20819,follow-up,0,0
20820,analysis,0,0
20821,of,0,0
20822,a,0,0
20823,randomized,0,0
20824,",",0,0
20825,double-masked,0,0
20826,",",0,0
20827,placebo-controlled,1,1
20828,52-week,0,0
20829,trial,0,0
20830,.,0,0
20831,All,0,0
20832,patients,0,0
20833,had,0,0
20834,received,0,0
20835,monthly,0,1
20836,leuprolide,1,1
20837,acetate,1,1
20838,and,0,0
20839,were,0,0
20840,randomized,0,0
20841,to,0,0
20842,one,0,0
20843,of,0,0
20844,four,0,0
20845,groups,0,0
20846,:,0,0
20847,A-daily,0,1
20848,placebo,1,1
20849,;,1,0
20850,B-daily,0,1
20851,norethindrone,1,1
20852,acetate,1,1
20853,5,0,1
20854,mg,0,1
20855,;,0,0
20856,C-daily,1,1
20857,norethindrone,1,1
20858,acetate,1,1
20859,5,0,1
20860,mg,0,1
20861,and,0,0
20862,conjugated,1,1
20863,equine,1,1
20864,estrogens,1,1
20865,0.625,0,1
20866,mg,0,0
20867,;,0,0
20868,and,0,0
20869,D-daily,0,1
20870,norethindrone,1,1
20871,acetate,1,1
20872,5,0,1
20873,mg,0,1
20874,and,0,0
20875,conjugated,1,1
20876,equine,1,1
20877,estrogens,1,1
20878,1.25,0,0
20879,mg.,0,0
20880,Of,0,1
20881,201,0,0
20882,patients,0,0
20883,enrolled,0,0
20884,in,0,0
20885,the,0,0
20886,initial,0,0
20887,trial,0,0
20888,",",0,0
20889,123,0,0
20890,completed,0,0
20891,at,0,0
20892,least,0,0
20893,280,0,0
20894,days,0,0
20895,of,0,0
20896,therapy,0,1
20897,and,0,0
20898,entered,0,0
20899,the,0,0
20900,follow-up,0,0
20901,period,0,0
20902,.,0,0
20903,Physical,0,0
20904,findings,0,0
20905,and,0,0
20906,symptoms,0,0
20907,were,0,0
20908,quantified,0,0
20909,",",0,0
20910,and,0,0
20911,lumbar,0,1
20912,spine,0,1
20913,bone,0,0
20914,mineral,0,0
20915,density,0,0
20916,was,0,0
20917,determined,0,0
20918,at,0,0
20919,intervals,0,0
20920,for,0,0
20921,up,0,0
20922,to,0,0
20923,12,0,0
20924,and,0,0
20925,24,0,0
20926,months,0,0
20927,post-therapy,0,0
20928,.,0,0
20929,RESULTS,0,0
20930,Symptom,0,0
20931,and,0,0
20932,pelvic,0,1
20933,examination,0,0
20934,scores,0,0
20935,remained,0,0
20936,significantly,0,0
20937,below,0,0
20938,baseline,0,0
20939,for,0,0
20940,at,0,0
20941,least,0,0
20942,8,0,0
20943,months,0,0
20944,after,0,0
20945,completion,0,0
20946,of,0,0
20947,therapy,0,1
20948,for,0,0
20949,all,0,0
20950,four,0,0
20951,groups,0,0
20952,(,0,0
20953,P,0,0
20954,<,0,0
20955,.05,0,0
20956,),0,0
20957,.,0,0
20958,Findings,0,0
20959,were,0,0
20960,not,0,0
20961,affected,0,0
20962,by,0,0
20963,endometriosis,0,0
20964,scores,0,0
20965,noted,0,0
20966,on,0,0
20967,screening,0,0
20968,laparoscopy,0,1
20969,.,0,0
20970,Mean,0,0
20971,bone,0,0
20972,mineral,0,0
20973,density,0,0
20974,values,0,0
20975,remained,0,0
20976,at,0,0
20977,or,0,1
20978,above,0,0
20979,baseline,0,0
20980,in,0,0
20981,all,0,0
20982,add-back,0,1
20983,groups,0,0
20984,.,0,0
20985,The,0,0
20986,significant,0,0
20987,mean,0,0
20988,loss,0,0
20989,in,0,0
20990,bone,0,0
20991,density,0,0
20992,in,0,0
20993,group,0,0
20994,A,0,0
20995,during,0,0
20996,therapy,0,1
20997,reversed,0,1
20998,slowly,0,0
20999,and,0,0
21000,had,0,0
21001,not,0,0
21002,returned,0,0
21003,to,0,0
21004,baseline,0,0
21005,at,0,0
21006,the,0,0
21007,final,0,0
21008,follow-up,0,0
21009,visit,0,0
21010,(,0,0
21011,P,0,0
21012,<,0,0
21013,.001,0,0
21014,),0,0
21015,.,0,0
21016,CONCLUSION,0,0
21017,GnRH,1,1
21018,agonist,1,1
21019,and,0,0
21020,norethindrone,1,1
21021,acetate,1,1
21022,alone,1,1
21023,or,0,1
21024,combined,0,1
21025,with,0,0
21026,low-dose,1,1
21027,conjugated,1,1
21028,equine,1,0
21029,estrogens,1,1
21030,administered,0,0
21031,to,0,0
21032,symptomatic,0,0
21033,endometriosis,0,0
21034,patients,0,0
21035,for,0,0
21036,12,0,0
21037,months,0,0
21038,provides,0,0
21039,extended,0,0
21040,pain,0,0
21041,relief,0,0
21042,and,0,0
21043,bone,0,0
21044,mineral,0,0
21045,density,0,0
21046,preservation,0,0
21047,after,0,0
21048,completion,0,0
21049,of,0,0
21050,therapy,0,1
21051,.,0,0
21052,Effect,0,0
21053,of,0,0
21054,cerivastatin,1,1
21055,on,0,0
21056,proteinuria,0,0
21057,and,0,0
21058,urinary,0,0
21059,podocytes,0,0
21060,in,0,0
21061,patients,0,0
21062,with,0,0
21063,chronic,0,0
21064,glomerulonephritis,0,0
21065,.,0,0
21066,BACKGROUND,0,0
21067,We,0,0
21068,previously,0,0
21069,reported,0,0
21070,urinary,0,0
21071,podocytes,0,0
21072,to,0,0
21073,be,0,0
21074,a,0,0
21075,marker,0,0
21076,of,0,0
21077,glomerular,0,0
21078,injury,0,0
21079,.,0,0
21080,The,0,0
21081,aim,0,0
21082,of,0,0
21083,the,0,0
21084,present,0,0
21085,study,0,0
21086,was,0,0
21087,to,0,0
21088,determine,0,0
21089,whether,0,0
21090,cerivastatin,1,1
21091,",",0,0
21092,a,0,0
21093,newly,0,0
21094,developed,0,0
21095,",",0,0
21096,potent,0,0
21097,synthetic,0,1
21098,statin,0,1
21099,",",0,0
21100,affects,0,0
21101,proteinuria,0,0
21102,and,0,0
21103,urinary,0,0
21104,podocyte,0,1
21105,excretion,0,0
21106,in,0,0
21107,patients,0,0
21108,with,0,0
21109,chronic,0,0
21110,glomerulonephritis,0,0
21111,(,0,1
21112,CGN,0,1
21113,),0,0
21114,.,0,0
21115,METHODS,0,0
21116,We,0,0
21117,randomly,0,0
21118,assigned,0,0
21119,40,0,0
21120,normotensive,0,0
21121,hypercholesterolemic,0,0
21122,patients,0,0
21123,with,0,0
21124,CGN,0,0
21125,to,0,0
21126,receive,0,0
21127,either,0,1
21128,cerivastatin,1,1
21129,0.15,0,1
21130,mg/day,0,1
21131,(,0,0
21132,n=20,0,1
21133,),0,1
21134,or,0,1
21135,placebo,1,1
21136,(,0,1
21137,n=20,0,1
21138,),0,0
21139,.,0,0
21140,Subjects,0,0
21141,comprised,0,0
21142,24,0,0
21143,men,0,0
21144,and,0,0
21145,16,0,0
21146,women,0,0
21147,",",0,0
21148,with,0,0
21149,a,0,0
21150,mean,0,0
21151,age,0,0
21152,of,0,0
21153,40.8+/-14.4,0,0
21154,years,0,0
21155,;,0,0
21156,27,0,0
21157,had,0,0
21158,IgA,0,0
21159,nephropathy,0,0
21160,and,0,0
21161,13,0,0
21162,had,0,0
21163,non-IgA,0,0
21164,proliferative,0,0
21165,glomerulonephritis,0,0
21166,.,0,0
21167,Treatment,0,0
21168,was,0,0
21169,continued,0,0
21170,for,0,0
21171,6,0,0
21172,months,0,0
21173,.,0,0
21174,Plasma,0,0
21175,total,0,0
21176,cholesterol,0,0
21177,",",0,0
21178,HDL-cholesterol,0,1
21179,",",0,0
21180,LDL-cholesterol,0,1
21181,and,0,0
21182,triglycerides,0,0
21183,",",0,0
21184,urinary,0,0
21185,protein,0,1
21186,excretion,0,0
21187,and,0,0
21188,the,0,0
21189,number,0,0
21190,of,0,0
21191,podocytes,0,0
21192,were,0,0
21193,measured,0,0
21194,before,0,0
21195,treatment,0,0
21196,and,0,0
21197,at,0,0
21198,3,0,0
21199,and,0,0
21200,6,0,0
21201,months,0,0
21202,after,0,0
21203,treatment,0,0
21204,.,0,0
21205,RESULTS,0,0
21206,After,0,0
21207,6,0,0
21208,months,0,0
21209,",",0,0
21210,a,0,0
21211,significant,0,0
21212,reduction,0,0
21213,in,0,0
21214,total,0,0
21215,cholesterol,0,0
21216,(,0,0
21217,P,0,0
21218,<,0,0
21219,0.001,0,0
21220,),0,0
21221,",",0,0
21222,LDL-cholesterol,0,1
21223,(,0,0
21224,P,0,0
21225,<,0,0
21226,0.001,0,0
21227,),0,0
21228,and,0,0
21229,triglycerides,0,0
21230,(,0,0
21231,P,0,0
21232,<,0,0
21233,0.05,0,0
21234,),0,0
21235,",",0,0
21236,and,0,0
21237,a,0,0
21238,significant,0,0
21239,increase,0,0
21240,in,0,0
21241,HDL-cholesterol,0,1
21242,(,0,0
21243,P,0,0
21244,<,0,0
21245,0.001,0,0
21246,),0,0
21247,were,0,0
21248,observed,0,0
21249,in,0,0
21250,the,0,0
21251,group,0,0
21252,treated,0,0
21253,with,0,0
21254,cerivastatin,1,1
21255,.,1,0
21256,Urinary,0,0
21257,protein,0,1
21258,excretion,0,0
21259,decreased,0,0
21260,from,0,0
21261,1.8+/-0.6,0,0
21262,to,0,0
21263,0.8+/-0.4,0,0
21264,g/day,0,1
21265,",",0,0
21266,(,0,0
21267,P,0,0
21268,<,0,0
21269,0.01,0,0
21270,),0,0
21271,in,0,0
21272,this,0,0
21273,group,0,0
21274,",",0,0
21275,and,0,0
21276,urinary,0,0
21277,podocyte,0,1
21278,excretion,0,0
21279,decreased,0,0
21280,from,0,0
21281,1.6+/-0.6,0,0
21282,to,0,0
21283,0.9+/-0.4,0,0
21284,cells/ml,0,0
21285,(,0,0
21286,P,0,0
21287,<,0,0
21288,0.01,0,0
21289,),0,0
21290,.,0,0
21291,However,0,0
21292,",",0,0
21293,placebo,1,1
21294,showed,0,0
21295,little,0,0
21296,effect,0,0
21297,on,0,0
21298,these,0,0
21299,lipid,0,0
21300,levels,0,0
21301,",",0,0
21302,urinary,0,0
21303,protein,0,1
21304,excretion,0,0
21305,and,0,0
21306,urinary,0,0
21307,podocyte,0,1
21308,excretion,0,0
21309,.,0,0
21310,The,0,0
21311,differences,0,0
21312,between,0,0
21313,the,0,0
21314,cerivastatin,0,1
21315,group,0,0
21316,and,0,0
21317,the,0,0
21318,placebo,0,1
21319,group,0,0
21320,were,0,0
21321,significant,0,0
21322,(,0,0
21323,cholesterol,0,0
21324,",",0,0
21325,P,0,0
21326,<,0,0
21327,0.001,0,0
21328,;,0,0
21329,LDL-cholesterol,0,1
21330,",",0,0
21331,P,0,0
21332,<,0,0
21333,0.001,0,0
21334,;,0,0
21335,triglycerides,0,0
21336,",",0,0
21337,P,0,0
21338,<,0,0
21339,0.05,0,0
21340,;,0,0
21341,HDL-cholesterol,0,1
21342,",",0,0
21343,P,0,0
21344,<,0,0
21345,0.001,0,0
21346,;,0,0
21347,urinary,0,0
21348,protein,0,1
21349,",",0,0
21350,P,0,0
21351,<,0,0
21352,0.01,0,0
21353,;,0,0
21354,and,0,0
21355,urinary,0,0
21356,podocytes,0,0
21357,",",0,0
21358,P,0,0
21359,<,0,0
21360,0.01,0,0
21361,),0,0
21362,.,0,0
21363,CONCLUSION,0,0
21364,Statins,0,1
21365,such,0,0
21366,as,0,0
21367,cerivastatin,0,1
21368,may,0,0
21369,be,0,0
21370,beneficial,0,0
21371,for,0,0
21372,restoration,0,0
21373,of,0,0
21374,injured,0,0
21375,podocytes,0,0
21376,in,0,0
21377,patients,0,0
21378,with,0,0
21379,CGN,0,0
21380,and,0,0
21381,hypercholesterolaemia,0,0
21382,.,0,0
21383,Metformin,1,1
21384,does,0,0
21385,not,0,0
21386,enhance,0,0
21387,ovulation,0,0
21388,induction,0,1
21389,in,0,0
21390,clomiphene,0,1
21391,resistant,0,0
21392,polycystic,0,0
21393,ovary,0,0
21394,syndrome,0,0
21395,in,0,0
21396,clinical,0,0
21397,practice,0,0
21398,.,0,0
21399,AIMS,0,0
21400,To,0,0
21401,determine,0,0
21402,whether,0,0
21403,metformin,1,1
21404,pretreatment,1,0
21405,has,0,0
21406,beneficial,0,0
21407,effects,0,0
21408,in,0,0
21409,clomiphene,0,1
21410,resistant,0,0
21411,infertile,0,0
21412,women,0,0
21413,with,0,0
21414,polycystic,0,0
21415,ovary,0,0
21416,syndrome,0,0
21417,(,0,1
21418,PCOS,0,1
21419,),0,1
21420,in,0,0
21421,an,0,0
21422,infertility,0,0
21423,clinic,0,0
21424,.,0,0
21425,METHODS,0,0
21426,This,0,0
21427,was,0,0
21428,a,0,0
21429,randomized,0,0
21430,placebo,0,1
21431,controlled,0,0
21432,double-blind,0,0
21433,crossover,0,0
21434,study,0,0
21435,of,0,0
21436,3,0,0
21437,months,0,0
21438,metformin,1,1
21439,(,0,0
21440,1500,0,0
21441,mg,0,1
21442,day-1,1,0
21443,),1,1
21444,/placebo,1,1
21445,",",0,0
21446,followed,0,1
21447,by,0,0
21448,3,0,0
21449,months,0,0
21450,metformin/placebo,1,1
21451,together,1,0
21452,with,1,0
21453,clomiphene,1,1
21454,(,0,0
21455,50-100,0,1
21456,mg,0,1
21457,for,0,0
21458,5,0,0
21459,days,0,0
21460,),0,0
21461,for,0,0
21462,three,0,0
21463,cycles,0,0
21464,in,0,0
21465,clomiphene,0,1
21466,resistant,0,0
21467,women,0,0
21468,with,0,0
21469,PCOS,0,0
21470,.,0,0
21471,The,0,0
21472,primary,0,0
21473,outcomes,0,0
21474,were,0,0
21475,restoration,0,0
21476,of,0,0
21477,spontaneous,0,0
21478,menses,0,0
21479,",",0,0
21480,ovulation,0,0
21481,induction,0,1
21482,(,0,1
21483,spontaneous,0,0
21484,or,0,1
21485,clomiphene,0,1
21486,induced,0,0
21487,),0,0
21488,and,0,0
21489,pregnancy,0,0
21490,.,0,0
21491,Secondary,0,0
21492,endpoints,0,0
21493,were,0,0
21494,changes,0,0
21495,in,0,0
21496,biochemical,0,0
21497,parameters,0,0
21498,related,0,0
21499,to,0,0
21500,androgens,0,1
21501,and,0,0
21502,insulin,0,1
21503,.,0,0
21504,RESULTS,0,0
21505,Twelve,0,0
21506,women,0,0
21507,completed,0,0
21508,the,0,0
21509,metformin,1,1
21510,arm,0,0
21511,and,0,0
21512,14,0,0
21513,the,0,0
21514,placebo,1,1
21515,arm,0,0
21516,.,0,0
21517,Spontaneous,0,0
21518,menstruation,0,0
21519,resumed,0,0
21520,in,0,0
21521,five,0,0
21522,metformin,1,1
21523,treated,0,0
21524,patients,0,0
21525,and,0,0
21526,in,0,0
21527,six,0,0
21528,placebo,1,1
21529,treated,0,0
21530,women,0,0
21531,",",0,0
21532,P=0.63,0,0
21533,.,0,0
21534,No,0,0
21535,women,0,0
21536,given,0,0
21537,metformin,0,1
21538,spontaneously,0,0
21539,ovulated,0,0
21540,",",0,0
21541,although,0,0
21542,one,0,0
21543,patient,0,0
21544,given,0,0
21545,placebo,1,1
21546,did,0,0
21547,",",0,0
21548,P=0.30,0,0
21549,.,0,0
21550,There,0,0
21551,was,0,0
21552,no,0,0
21553,difference,0,0
21554,in,0,0
21555,the,0,0
21556,efficacy,0,0
21557,of,0,0
21558,clomiphene,0,1
21559,between,0,0
21560,the,0,0
21561,two,0,0
21562,groups,0,0
21563,with,0,0
21564,ovulation,0,0
21565,being,0,0
21566,induced,0,0
21567,in,0,0
21568,five,0,0
21569,(,0,0
21570,out,0,0
21571,of,0,0
21572,12,0,0
21573,),0,0
21574,metformin,1,1
21575,treated,0,0
21576,women,0,0
21577,and,0,0
21578,four,0,0
21579,(,0,0
21580,out,0,0
21581,of,0,0
21582,14,0,0
21583,),0,0
21584,placebo,1,1
21585,treated,0,0
21586,women,0,0
21587,",",0,0
21588,P=0.63,0,0
21589,.,0,0
21590,Pregnancy,0,0
21591,occurred,0,0
21592,in,0,0
21593,three,0,0
21594,(,0,0
21595,out,0,0
21596,of,0,0
21597,12,0,0
21598,),0,0
21599,women,0,0
21600,given,0,0
21601,metformin,1,1
21602,and,0,0
21603,two,0,0
21604,(,0,0
21605,out,0,0
21606,of,0,0
21607,14,0,0
21608,),0,0
21609,women,0,0
21610,given,0,0
21611,placebo,1,1
21612,",",0,0
21613,P=0.59,0,0
21614,.,0,0
21615,CONCLUSIONS,0,0
21616,Metformin,1,1
21617,is,0,0
21618,not,0,0
21619,always,0,0
21620,beneficial,0,0
21621,when,0,0
21622,given,0,0
21623,to,0,0
21624,clomiphene,0,1
21625,resistant,0,0
21626,infertile,0,0
21627,women,0,0
21628,with,0,0
21629,PCOS,0,0
21630,in,0,0
21631,clinical,0,0
21632,practice,0,0
21633,.,0,0
21634,A,0,0
21635,single,0,0
21636,infusion,0,1
21637,of,0,0
21638,intravenous,0,1
21639,ketamine,1,1
21640,improves,0,0
21641,pain,0,0
21642,relief,0,0
21643,in,0,0
21644,patients,0,0
21645,with,0,0
21646,critical,0,0
21647,limb,0,0
21648,ischaemia,0,1
21649,:,0,0
21650,results,0,0
21651,of,0,0
21652,a,0,0
21653,double,0,1
21654,blind,0,0
21655,randomised,0,0
21656,controlled,0,0
21657,trial,0,0
21658,.,0,0
21659,We,0,0
21660,report,0,0
21661,the,0,0
21662,first,0,0
21663,double,0,1
21664,blind,0,0
21665,randomised,0,0
21666,controlled,0,0
21667,trial,0,0
21668,of,0,0
21669,regular,0,1
21670,opioids,1,1
21671,and,0,0
21672,an,0,0
21673,infusion,0,1
21674,of,0,0
21675,low,0,0
21676,dose,0,1
21677,(,0,0
21678,0.6,0,1
21679,mg/kg,0,1
21680,),0,0
21681,intravenous,0,1
21682,ketamine,1,1
21683,compared,0,0
21684,with,0,0
21685,opioids,1,1
21686,and,0,0
21687,placebo,1,1
21688,in,0,0
21689,patients,0,0
21690,with,0,0
21691,allodynia,0,0
21692,",",0,0
21693,hyperalgesia,0,0
21694,and,0,0
21695,hyperpathia,0,0
21696,secondary,0,0
21697,to,0,0
21698,critical,0,0
21699,limb,0,0
21700,ischaemia,0,1
21701,.,0,0
21702,Thirty-five,0,0
21703,patients,0,0
21704,completed,0,0
21705,the,0,0
21706,study,0,0
21707,",",0,0
21708,18,0,0
21709,received,0,0
21710,regular,0,0
21711,opioids,1,1
21712,plus,1,1
21713,ketamine,1,1
21714,",",0,0
21715,while,0,0
21716,17,0,0
21717,received,0,0
21718,regular,1,0
21719,opioids,1,1
21720,plus,1,1
21721,placebo,1,1
21722,.,1,0
21723,Using,0,0
21724,the,0,0
21725,Brief,0,1
21726,Pain,0,0
21727,Inventory,0,0
21728,",",0,0
21729,the,0,0
21730,%,0,0
21731,pain,0,0
21732,relief,0,0
21733,that,0,0
21734,the,0,0
21735,patients,0,0
21736,in,0,0
21737,the,0,0
21738,ketamine,0,1
21739,group,0,0
21740,attributed,0,0
21741,to,0,0
21742,their,0,0
21743,medication,0,1
21744,improved,0,0
21745,significantly,0,0
21746,from,0,0
21747,50,0,0
21748,%,0,0
21749,immediately,0,0
21750,pre-infusion,0,0
21751,to,0,0
21752,65,0,0
21753,%,0,0
21754,24,0,0
21755,h,0,0
21756,post-infusion,0,0
21757,and,0,0
21758,69,0,0
21759,%,0,0
21760,5,0,0
21761,days,0,0
21762,post,0,0
21763,infusion,0,0
21764,.,0,0
21765,Over,0,0
21766,the,0,0
21767,same,0,0
21768,period,0,0
21769,",",0,0
21770,the,0,0
21771,pain,0,0
21772,relief,0,0
21773,achieved,0,0
21774,by,0,0
21775,the,0,0
21776,placebo,0,1
21777,group,0,0
21778,rose,0,0
21779,from,0,0
21780,58,0,0
21781,%,0,0
21782,pre-infusion,0,1
21783,to,0,0
21784,56,0,0
21785,%,0,0
21786,24,0,0
21787,h,0,0
21788,post,0,0
21789,infusion,0,1
21790,and,0,0
21791,then,0,1
21792,50,0,1
21793,%,0,0
21794,relief,0,0
21795,5,0,0
21796,days,0,0
21797,later,0,0
21798,.,0,0
21799,This,0,0
21800,was,0,0
21801,statistically,0,0
21802,significant,0,0
21803,(,0,0
21804,P,0,0
21805,<,0,0
21806,0.05,0,0
21807,),0,0
21808,using,0,0
21809,both,0,0
21810,the,0,0
21811,t-test,0,0
21812,and,0,0
21813,the,0,0
21814,Wilcoxon,0,0
21815,Rank,0,1
21816,Sum,0,0
21817,test,0,0
21818,.,0,0
21819,The,0,0
21820,ketamine,0,1
21821,group,0,0
21822,also,0,0
21823,showed,0,0
21824,a,0,0
21825,statistically,0,0
21826,significant,0,0
21827,difference,0,0
21828,24,0,0
21829,h,0,0
21830,post,0,0
21831,infusion,0,1
21832,of,0,0
21833,the,0,0
21834,effect,0,0
21835,of,0,0
21836,pain,0,0
21837,on,0,0
21838,their,0,0
21839,general,0,0
21840,activity,0,0
21841,(,0,1
21842,P=0.03,0,0
21843,),0,1
21844,and,0,0
21845,on,0,0
21846,their,0,0
21847,enjoyment,0,0
21848,of,0,0
21849,life,0,0
21850,(,0,1
21851,P=0.004,0,0
21852,),0,0
21853,.,0,0
21854,This,0,0
21855,study,0,0
21856,shows,0,0
21857,that,0,0
21858,combining,0,0
21859,a,0,0
21860,single,0,1
21861,infusion,0,1
21862,of,0,0
21863,low,0,0
21864,dose,0,0
21865,ketamine,0,1
21866,with,0,0
21867,regular,0,1
21868,opioid,1,1
21869,analgesia,1,0
21870,can,0,0
21871,result,0,0
21872,in,0,0
21873,a,0,0
21874,significant,0,0
21875,improvement,0,0
21876,in,0,0
21877,pain,0,0
21878,relief,0,0
21879,for,0,0
21880,this,0,0
21881,patient,0,0
21882,group,0,0
21883,.,0,0
21884,[,0,0
21885,Effect,0,0
21886,of,0,0
21887,valociclovir,1,1
21888,hydrochloride,1,1
21889,on,0,0
21890,patients,0,0
21891,with,0,0
21892,herpes,0,0
21893,zoster,0,0
21894,],0,0
21895,.,0,0
21896,Improving,0,0
21897,patient,1,0
21898,involvement,1,0
21899,in,0,0
21900,chronic,0,0
21901,disease,0,0
21902,management,0,1
21903,:,0,0
21904,the,0,0
21905,views,0,1
21906,of,0,0
21907,patients,0,0
21908,",",0,0
21909,GPs,0,0
21910,and,0,0
21911,specialists,0,0
21912,on,0,0
21913,a,0,0
21914,guidebook,0,1
21915,for,0,0
21916,ulcerative,0,0
21917,colitis,0,0
21918,.,0,0
21919,Patient,0,0
21920,information,0,0
21921,",",0,0
21922,shared,0,0
21923,care,0,1
21924,and,0,0
21925,decision-making,0,0
21926,are,0,0
21927,recognised,0,0
21928,as,0,0
21929,beneficial,0,0
21930,to,0,0
21931,chronic,0,0
21932,disease,0,0
21933,management,0,1
21934,.,0,0
21935,As,0,0
21936,part,0,0
21937,of,0,0
21938,an,0,0
21939,RCT,0,0
21940,",",0,0
21941,opinions,0,0
21942,of,0,0
21943,ulcerative,0,0
21944,colitis,0,0
21945,patients,0,0
21946,and,0,0
21947,their,0,0
21948,doctors,0,0
21949,were,0,0
21950,sought,0,0
21951,on,0,0
21952,a,0,0
21953,guidebook,0,1
21954,designed,0,0
21955,to,0,0
21956,support,1,1
21957,self-care,1,0
21958,and,0,0
21959,mediate,1,0
21960,doctor/patient,1,1
21961,interaction,1,0
21962,during,0,0
21963,consultations,0,0
21964,.,0,0
21965,Semi-structured,1,0
21966,interviews,1,0
21967,were,0,0
21968,conducted,0,0
21969,with,0,0
21970,6,0,0
21971,specialists,0,0
21972,and,0,0
21973,16,0,0
21974,GPs,0,0
21975,.,0,0
21976,Patients,0,0
21977,',0,0
21978,views,0,1
21979,were,0,0
21980,obtained,0,0
21981,from,0,0
21982,written,0,1
21983,responses,0,0
21984,to,0,0
21985,a,0,0
21986,postal,1,1
21987,questionnaire,1,1
21988,(,0,0
21989,136,0,0
21990,replies,0,0
21991,),0,0
21992,.,0,0
21993,Inclusion,0,0
21994,of,0,0
21995,lay,0,0
21996,knowledge,0,0
21997,and,0,0
21998,clarification,0,0
21999,of,0,0
22000,treatment,0,0
22001,decision,0,0
22002,processes,0,0
22003,increased,0,0
22004,patients,0,0
22005,',0,0
22006,perception,0,0
22007,of,0,0
22008,involvement,0,0
22009,in,0,0
22010,disease,0,0
22011,management,0,1
22012,through,0,0
22013,increased,0,0
22014,identification,0,0
22015,and,0,0
22016,awareness,0,0
22017,of,0,0
22018,others,0,0
22019,',0,0
22020,self-management,0,0
22021,experiences,0,0
22022,.,0,0
22023,Doctors,0,0
22024,focused,0,0
22025,on,0,0
22026,the,0,0
22027,importance,0,0
22028,of,0,0
22029,improving,0,0
22030,patients,0,0
22031,',0,1
22032,compliance,0,0
22033,and,0,0
22034,use,0,0
22035,of,0,0
22036,services,0,1
22037,.,0,0
22038,However,0,0
22039,",",0,0
22040,the,0,0
22041,guidebook,0,1
22042,was,0,0
22043,seldom,0,0
22044,used,0,0
22045,as,0,0
22046,it,0,0
22047,had,0,0
22048,been,0,0
22049,intended,0,0
22050,during,0,0
22051,consultations,0,0
22052,.,0,0
22053,Patients,0,0
22054,felt,0,0
22055,constrained,0,0
22056,by,0,0
22057,time,0,0
22058,limits,0,0
22059,and,0,0
22060,consultants,0,0
22061,did,0,0
22062,not,0,0
22063,actively,0,0
22064,encourage,0,0
22065,guidebook,0,1
22066,use,0,0
22067,.,0,0
22068,Based,0,0
22069,on,0,0
22070,the,0,0
22071,findings,0,0
22072,",",0,0
22073,we,0,0
22074,suggest,0,0
22075,an,0,0
22076,approach,0,1
22077,utilising,0,1
22078,the,0,0
22079,guidebook,0,1
22080,to,0,0
22081,improve,0,0
22082,patient,0,0
22083,participation,0,0
22084,in,0,0
22085,disease,0,0
22086,management,0,0
22087,.,0,0
22088,Double-blind,0,0
22089,placebo-controlled,0,1
22090,trial,0,0
22091,of,0,0
22092,secretin,1,1
22093,:,1,0
22094,effects,0,0
22095,on,0,0
22096,aberrant,0,0
22097,behavior,0,0
22098,in,0,0
22099,children,0,0
22100,with,0,0
22101,autism,0,0
22102,.,0,0
22103,Secretin,1,1
22104,has,0,0
22105,been,0,0
22106,proposed,0,0
22107,as,0,0
22108,a,0,0
22109,treatment,0,0
22110,alternative,0,0
22111,for,0,0
22112,autistic,0,0
22113,spectrum,0,0
22114,disorders,0,0
22115,",",0,0
22116,but,0,0
22117,empirical,0,0
22118,support,0,1
22119,is,0,0
22120,lacking,0,0
22121,.,0,0
22122,A,0,0
22123,double-blind,0,0
22124,placebo-controlled,0,1
22125,study,0,0
22126,examined,0,0
22127,the,0,0
22128,effect,0,0
22129,of,0,0
22130,a,0,0
22131,single,0,0
22132,dose,0,0
22133,of,0,0
22134,synthetic,1,1
22135,human,1,1
22136,secretin,1,1
22137,on,0,0
22138,aberrant,0,0
22139,behavior,0,0
22140,.,0,1
22141,Parent,0,0
22142,and,0,0
22143,teacher,0,1
22144,data,0,0
22145,from,0,0
22146,the,0,0
22147,Aberrant,0,0
22148,Behavior,0,0
22149,Checklist,0,0
22150,for,0,0
22151,eight,0,0
22152,male,0,0
22153,children,0,0
22154,were,0,0
22155,analyzed,0,0
22156,for,0,0
22157,reliable,0,0
22158,change,0,0
22159,in,0,0
22160,a,0,0
22161,clinical,0,0
22162,replication,0,0
22163,series,0,0
22164,.,0,0
22165,By,0,0
22166,parent,0,1
22167,and,0,0
22168,teacher,0,1
22169,report,0,0
22170,",",0,0
22171,the,0,0
22172,majority,0,0
22173,of,0,0
22174,change,0,0
22175,occurred,0,0
22176,either,0,0
22177,on,0,0
22178,the,0,0
22179,placebo,1,1
22180,trial,0,0
22181,or,0,1
22182,reflected,0,0
22183,deterioration,0,0
22184,subsequent,0,0
22185,to,0,0
22186,secretin,1,1
22187,infusion,0,1
22188,.,0,0
22189,Repeated-measures,0,0
22190,multivariate,0,0
22191,analysis,0,0
22192,of,0,0
22193,variance,0,0
22194,results,0,0
22195,were,0,0
22196,similar,0,0
22197,.,0,0
22198,Results,0,0
22199,are,0,0
22200,consistent,0,0
22201,with,0,0
22202,other,0,0
22203,studies,0,0
22204,",",0,0
22205,suggesting,0,0
22206,that,0,0
22207,secretin,1,1
22208,may,0,0
22209,not,0,0
22210,be,0,0
22211,an,0,0
22212,effective,0,0
22213,treatment,0,0
22214,option,0,0
22215,.,0,0
22216,A,0,0
22217,scanning,0,1
22218,electron,0,1
22219,microscopic,0,1
22220,study,0,0
22221,of,0,0
22222,different,0,0
22223,caries,0,0
22224,removal,0,0
22225,techniques,0,1
22226,on,0,0
22227,human,0,0
22228,dentin,0,1
22229,.,0,0
22230,Scanning,0,0
22231,electron,0,0
22232,microscopy,0,1
22233,(,0,1
22234,SEM,0,1
22235,),0,1
22236,evaluated,0,0
22237,the,0,0
22238,effect,0,0
22239,of,0,0
22240,different,0,0
22241,caries,0,0
22242,removal,0,0
22243,techniques,0,1
22244,on,0,0
22245,human,0,1
22246,dentin,0,1
22247,topography,0,0
22248,.,0,0
22249,Thirty-six,0,0
22250,extracted,0,0
22251,human,0,1
22252,carious,0,1
22253,mandibular,0,0
22254,molars,0,0
22255,were,0,0
22256,randomly,0,0
22257,assigned,0,0
22258,to,0,0
22259,six,0,0
22260,groups,0,0
22261,according,0,0
22262,to,0,0
22263,caries,0,0
22264,removal,0,0
22265,technique,0,1
22266,.,0,0
22267,Carious,0,0
22268,tissue,0,0
22269,was,0,0
22270,removed,0,0
22271,by,0,0
22272,hand,1,1
22273,excavation,1,1
22274,",",1,0
22275,bur,1,1
22276,excavation,1,1
22277,",",1,0
22278,air-abrasion,1,1
22279,",",1,0
22280,laser,1,1
22281,ablation,1,1
22282,",",1,0
22283,chemomechanical,1,1
22284,methods,1,0
22285,and,1,0
22286,sono-abrasion,1,1
22287,.,1,0
22288,The,0,0
22289,remaining,0,0
22290,dentin,0,1
22291,surfaces,0,1
22292,were,0,0
22293,replicated,1,0
22294,and,1,0
22295,gold-coated,1,1
22296,.,1,0
22297,The,0,0
22298,surfaces,0,0
22299,were,0,0
22300,examined,0,0
22301,using,0,0
22302,SEM,0,1
22303,and,0,0
22304,distinct,0,0
22305,differences,0,0
22306,in,0,0
22307,appearance,0,0
22308,were,0,0
22309,observed,0,0
22310,among,0,0
22311,specimens,0,0
22312,treated,0,0
22313,with,0,0
22314,different,0,0
22315,caries,0,0
22316,removal,0,0
22317,techniques,0,1
22318,.,0,0
22319,While,0,0
22320,hand-excavated,0,0
22321,",",0,0
22322,bur-excavated,0,1
22323,and,0,0
22324,air-abraded,0,1
22325,carious,0,1
22326,dentin,0,1
22327,surfaces,0,1
22328,were,0,0
22329,covered,0,0
22330,with,0,0
22331,a,0,0
22332,residual,0,0
22333,smear,0,1
22334,layer,0,1
22335,",",0,0
22336,sono-abrasion,0,1
22337,with,0,0
22338,patent,0,0
22339,dentinal,0,0
22340,tubules,0,0
22341,completely,0,0
22342,removed,0,0
22343,the,0,0
22344,smear,0,1
22345,layer,0,0
22346,.,0,0
22347,A,0,0
22348,few,0,0
22349,patent,0,0
22350,orifices,0,0
22351,of,0,0
22352,dentinal,0,0
22353,tubules,0,0
22354,were,0,0
22355,observed,0,0
22356,in,0,0
22357,dentin,0,1
22358,subjected,0,0
22359,to,0,0
22360,laser,0,1
22361,ablation,0,1
22362,and,0,0
22363,chemo-mechanical,0,1
22364,caries,0,0
22365,removal,0,0
22366,.,0,0
22367,Limited,0,0
22368,effects,0,0
22369,of,0,0
22370,micronutrient,1,1
22371,supplementation,1,1
22372,on,0,0
22373,strength,0,0
22374,and,0,0
22375,physical,0,1
22376,function,0,0
22377,after,0,0
22378,abdominal,0,0
22379,aortic,0,0
22380,aneurysmectomy,0,1
22381,.,0,0
22382,BACKGROUND,0,0
22383,Tissue,0,0
22384,injury,0,0
22385,following,0,0
22386,ischemia-reperfusion,0,1
22387,is,0,0
22388,mediated,0,0
22389,in,0,0
22390,part,0,0
22391,by,0,0
22392,free,0,0
22393,oxygen,0,0
22394,radicals,0,1
22395,.,0,0
22396,We,0,0
22397,hypothesized,0,0
22398,that,0,0
22399,perioperative,0,1
22400,micronutrient,1,1
22401,supplementation,1,1
22402,would,0,0
22403,augment,0,0
22404,antioxidant,0,0
22405,defenses,0,0
22406,",",0,0
22407,minimize,0,0
22408,muscle,0,0
22409,injury,0,0
22410,",",0,0
22411,and,0,0
22412,minimize,0,0
22413,postoperative,0,0
22414,decreases,0,0
22415,in,0,0
22416,muscle,0,0
22417,strength,0,0
22418,and,0,0
22419,physical,0,1
22420,function,0,0
22421,following,0,0
22422,abdominal,0,0
22423,aortic,0,0
22424,aneurysmectomy,0,1
22425,.,0,0
22426,SETTING,0,0
22427,A,0,0
22428,university-affiliated,0,0
22429,hospital,0,0
22430,and,0,0
22431,regional,0,0
22432,referral,0,1
22433,center,0,0
22434,.,0,0
22435,DESIGN,0,0
22436,A,0,0
22437,randomized,0,0
22438,",",0,0
22439,double-blind,0,0
22440,",",0,0
22441,placebo-controlled,1,1
22442,trial,0,0
22443,of,0,0
22444,supplementation,1,1
22445,with,1,0
22446,beta-carotene,1,1
22447,",",1,0
22448,vitamins,1,1
22449,C,1,0
22450,and,1,0
22451,E,1,1
22452,",",1,0
22453,zinc,1,1
22454,",",1,0
22455,and,1,0
22456,selenium,1,1
22457,for,0,0
22458,a,0,0
22459,period,0,0
22460,of,0,0
22461,2-3,0,0
22462,weeks,0,0
22463,prior,0,0
22464,to,0,0
22465,surgery,0,1
22466,and,0,0
22467,1,0,0
22468,week,0,0
22469,thereafter,0,0
22470,.,0,0
22471,STUDY,0,0
22472,POPULATION,0,0
22473,Patients,0,0
22474,undergoing,0,0
22475,elective,0,1
22476,abdominal,1,0
22477,aortic,1,0
22478,aneurysmectomy,1,1
22479,(,0,0
22480,n=18,0,0
22481,per,0,1
22482,group,0,0
22483,),0,0
22484,.,0,0
22485,PRINCIPAL,0,0
22486,MEASUREMENTS,0,0
22487,Handgrip,0,1
22488,and,0,0
22489,other,0,0
22490,measures,0,0
22491,of,0,0
22492,strength,0,0
22493,and,0,0
22494,physical,0,1
22495,function,0,0
22496,.,0,0
22497,RESULTS,0,0
22498,Handgrip,0,1
22499,and,0,0
22500,quadriceps,0,1
22501,strength,0,0
22502,decreased,0,0
22503,following,0,0
22504,surgery,0,1
22505,",",0,0
22506,but,0,0
22507,not,0,0
22508,to,0,0
22509,a,0,0
22510,significantly,0,0
22511,different,0,0
22512,extent,0,0
22513,in,0,0
22514,the,0,0
22515,placebo,0,1
22516,and,0,0
22517,supplemented,0,1
22518,groups,0,0
22519,.,0,0
22520,Self-rated,0,0
22521,physical,0,0
22522,function,0,0
22523,decreased,0,0
22524,following,0,0
22525,surgery,1,1
22526,in,0,0
22527,the,0,0
22528,placebo,0,1
22529,group,0,0
22530,and,0,0
22531,was,0,0
22532,preserved,0,0
22533,in,0,0
22534,the,0,0
22535,supplemented,0,1
22536,group,0,0
22537,.,0,0
22538,CONCLUSIONS,0,0
22539,Perioperative,1,1
22540,supplementation,1,1
22541,with,1,0
22542,micronutrients,1,1
22543,with,0,0
22544,antioxidant,0,0
22545,properties,0,0
22546,has,0,0
22547,limited,0,0
22548,effects,0,0
22549,on,0,0
22550,strength,0,0
22551,and,0,0
22552,physical,0,1
22553,function,0,0
22554,following,0,0
22555,major,0,0
22556,elective,0,1
22557,surgery,0,0
22558,.,0,0
22559,Risperidone,1,1
22560,in,0,0
22561,children,0,0
22562,with,0,0
22563,autism,0,0
22564,and,0,0
22565,serious,0,0
22566,behavioral,0,1
22567,problems,0,0
22568,.,0,0
22569,BACKGROUND,0,0
22570,Atypical,0,0
22571,antipsychotic,0,1
22572,agents,0,0
22573,",",0,0
22574,which,0,0
22575,block,0,0
22576,postsynaptic,0,0
22577,dopamine,0,1
22578,and,0,0
22579,serotonin,0,1
22580,receptors,0,0
22581,",",0,0
22582,have,0,0
22583,advantages,0,0
22584,over,0,0
22585,traditional,0,1
22586,antipsychotic,0,1
22587,medications,0,1
22588,in,0,0
22589,the,0,0
22590,treatment,0,0
22591,of,0,0
22592,adults,0,0
22593,with,0,0
22594,schizophrenia,0,0
22595,and,0,0
22596,may,0,0
22597,be,0,0
22598,beneficial,0,0
22599,in,0,0
22600,children,0,0
22601,with,0,0
22602,autistic,0,0
22603,disorder,0,0
22604,who,0,0
22605,have,0,0
22606,serious,0,0
22607,behavioral,0,1
22608,disturbances,0,0
22609,.,0,0
22610,However,0,0
22611,",",0,0
22612,data,0,0
22613,on,0,0
22614,the,0,0
22615,safety,0,0
22616,and,0,0
22617,efficacy,0,0
22618,of,0,0
22619,atypical,1,0
22620,antipsychotic,1,1
22621,agents,0,1
22622,in,0,0
22623,children,0,0
22624,are,0,0
22625,limited,0,0
22626,.,0,0
22627,METHODS,0,0
22628,We,0,0
22629,conducted,0,0
22630,a,0,0
22631,multisite,0,0
22632,",",0,0
22633,randomized,0,0
22634,",",0,0
22635,double-blind,0,0
22636,trial,0,0
22637,of,0,0
22638,risperidone,1,1
22639,as,0,0
22640,compared,0,0
22641,with,0,0
22642,placebo,1,1
22643,for,0,0
22644,the,0,0
22645,treatment,0,0
22646,of,0,0
22647,autistic,0,0
22648,disorder,0,0
22649,accompanied,0,0
22650,by,0,0
22651,severe,0,0
22652,tantrums,0,0
22653,",",0,0
22654,aggression,0,0
22655,",",0,0
22656,or,0,1
22657,self-injurious,0,0
22658,behavior,0,0
22659,in,0,0
22660,children,0,0
22661,5,0,0
22662,to,0,0
22663,17,0,0
22664,years,0,0
22665,old,0,0
22666,.,0,0
22667,The,0,0
22668,primary,0,0
22669,outcome,0,0
22670,measures,0,0
22671,were,0,0
22672,the,0,0
22673,score,0,0
22674,on,0,0
22675,the,0,0
22676,Irritability,0,0
22677,subscale,0,0
22678,of,0,0
22679,the,0,0
22680,Aberrant,0,0
22681,Behavior,0,0
22682,Checklist,0,1
22683,and,0,0
22684,the,0,0
22685,rating,0,0
22686,on,0,0
22687,the,0,0
22688,Clinical,0,0
22689,Global,0,0
22690,Impressions,0,1
22691,-,0,1
22692,Improvement,0,0
22693,(,0,1
22694,CGI-I,0,1
22695,),0,1
22696,scale,0,0
22697,at,0,0
22698,eight,0,0
22699,weeks,0,0
22700,.,0,0
22701,RESULTS,0,0
22702,A,0,0
22703,total,0,0
22704,of,0,0
22705,101,0,0
22706,children,0,0
22707,(,0,0
22708,82,0,0
22709,boys,0,0
22710,and,0,0
22711,19,0,0
22712,girls,0,0
22713,;,0,0
22714,mean,0,0
22715,[,0,0
22716,+/-SD,0,0
22717,],0,1
22718,age,0,0
22719,",",0,0
22720,8.8+/-2.7,0,0
22721,years,0,0
22722,),0,0
22723,were,0,0
22724,randomly,0,0
22725,assigned,0,0
22726,to,0,0
22727,receive,0,1
22728,risperidone,1,1
22729,(,0,0
22730,49,0,0
22731,children,0,0
22732,),0,0
22733,or,0,1
22734,placebo,1,1
22735,(,0,1
22736,52,0,0
22737,),0,0
22738,.,0,0
22739,Treatment,0,0
22740,with,0,0
22741,risperidone,1,1
22742,for,0,0
22743,eight,0,0
22744,weeks,0,0
22745,(,0,0
22746,dose,0,0
22747,range,0,0
22748,",",0,0
22749,0.5,0,0
22750,to,0,0
22751,3.5,0,0
22752,mg,0,1
22753,per,0,0
22754,day,0,0
22755,),0,0
22756,resulted,0,0
22757,in,0,0
22758,a,0,0
22759,56.9,0,0
22760,percent,0,0
22761,reduction,0,0
22762,in,0,0
22763,the,0,0
22764,Irritability,0,0
22765,score,0,0
22766,",",0,0
22767,as,0,0
22768,compared,0,0
22769,with,0,0
22770,a,0,0
22771,14.1,0,0
22772,percent,0,0
22773,decrease,0,0
22774,in,0,0
22775,the,0,0
22776,placebo,1,1
22777,group,0,0
22778,(,0,0
22779,P,0,0
22780,<,0,0
22781,0.001,0,0
22782,),0,0
22783,.,0,0
22784,The,0,0
22785,rate,0,0
22786,of,0,0
22787,a,0,0
22788,positive,0,0
22789,response,0,0
22790,",",0,0
22791,defined,0,0
22792,as,0,0
22793,at,0,0
22794,least,0,0
22795,a,0,0
22796,25,0,0
22797,percent,0,0
22798,decrease,0,0
22799,in,0,0
22800,the,0,0
22801,Irritability,0,0
22802,score,0,0
22803,and,0,0
22804,a,0,0
22805,rating,0,0
22806,of,0,0
22807,much,0,0
22808,improved,0,0
22809,or,0,1
22810,very,0,0
22811,much,0,0
22812,improved,0,0
22813,on,0,0
22814,the,0,0
22815,CGI-I,0,1
22816,scale,0,0
22817,",",0,0
22818,was,0,0
22819,69,0,0
22820,percent,0,0
22821,in,0,0
22822,the,0,0
22823,risperidone,1,1
22824,group,0,0
22825,(,0,0
22826,34,0,0
22827,of,0,0
22828,49,0,0
22829,children,0,0
22830,had,0,0
22831,a,0,0
22832,positive,0,0
22833,response,0,0
22834,),0,1
22835,and,0,0
22836,12,0,0
22837,percent,0,0
22838,in,0,0
22839,the,0,0
22840,placebo,1,1
22841,group,0,0
22842,(,0,0
22843,6,0,0
22844,of,0,0
22845,52,0,0
22846,",",0,0
22847,P,0,0
22848,<,0,0
22849,0.001,0,0
22850,),0,0
22851,.,0,0
22852,Risperidone,1,1
22853,therapy,0,1
22854,was,0,0
22855,associated,0,0
22856,with,0,0
22857,an,0,0
22858,average,0,0
22859,weight,0,0
22860,gain,0,0
22861,of,0,0
22862,2.7+/-2.9,0,0
22863,kg,0,0
22864,",",0,0
22865,as,0,0
22866,compared,0,0
22867,with,0,0
22868,0.8+/-2.2,0,0
22869,kg,0,0
22870,with,0,1
22871,placebo,1,1
22872,(,0,0
22873,P,0,0
22874,<,0,0
22875,0.001,0,0
22876,),0,0
22877,.,0,0
22878,Increased,0,0
22879,appetite,0,0
22880,",",0,0
22881,fatigue,0,0
22882,",",0,0
22883,drowsiness,0,0
22884,",",0,0
22885,dizziness,0,0
22886,",",0,0
22887,and,0,0
22888,drooling,0,0
22889,were,0,0
22890,more,0,0
22891,common,0,0
22892,in,0,0
22893,the,0,0
22894,risperidone,1,1
22895,group,0,0
22896,than,0,0
22897,in,0,0
22898,the,0,0
22899,placebo,0,1
22900,group,0,0
22901,(,0,0
22902,P,0,0
22903,<,0,0
22904,0.05,0,0
22905,for,0,0
22906,each,0,0
22907,comparison,0,0
22908,),0,0
22909,.,0,0
22910,In,0,0
22911,two,0,0
22912,thirds,0,0
22913,of,0,0
22914,the,0,0
22915,children,0,0
22916,with,0,0
22917,a,0,0
22918,positive,0,0
22919,response,0,0
22920,to,0,0
22921,risperidone,0,1
22922,at,0,0
22923,eight,0,0
22924,weeks,0,0
22925,(,0,0
22926,23,0,0
22927,of,0,0
22928,34,0,0
22929,),0,0
22930,",",0,0
22931,the,0,0
22932,benefit,0,0
22933,was,0,0
22934,maintained,0,0
22935,at,0,0
22936,six,0,0
22937,months,0,0
22938,.,0,0
22939,CONCLUSIONS,0,0
22940,Risperidone,1,1
22941,was,0,0
22942,effective,0,0
22943,and,0,0
22944,well,0,0
22945,tolerated,0,0
22946,for,0,0
22947,the,0,0
22948,treatment,0,0
22949,of,0,0
22950,tantrums,0,0
22951,",",0,0
22952,aggression,0,0
22953,",",0,0
22954,or,0,1
22955,self-injurious,0,0
22956,behavior,0,0
22957,in,0,0
22958,children,0,0
22959,with,0,0
22960,autistic,0,0
22961,disorder,0,0
22962,.,0,0
22963,The,0,0
22964,short,0,0
22965,period,0,0
22966,of,0,0
22967,this,0,0
22968,trial,0,0
22969,limits,0,0
22970,inferences,0,0
22971,about,0,0
22972,adverse,0,0
22973,effects,0,0
22974,such,0,0
22975,as,0,0
22976,tardive,0,0
22977,dyskinesia,0,0
22978,.,0,0
22979,Cyclosporine,1,1
22980,inhibition,0,0
22981,of,0,0
22982,P-glycoprotein,0,1
22983,in,0,0
22984,chronic,0,0
22985,myeloid,0,0
22986,leukemia,0,0
22987,blast,0,0
22988,phase,0,0
22989,.,0,0
22990,Chronic,0,0
22991,myeloid,0,0
22992,leukemia,0,0
22993,blast,0,0
22994,phase,0,0
22995,(,0,1
22996,CML-BP,0,0
22997,),0,1
22998,cells,0,0
22999,commonly,0,0
23000,express,0,0
23001,the,0,0
23002,multidrug,0,0
23003,transporter,0,0
23004,",",0,0
23005,P-glycoprotein,0,1
23006,(,0,1
23007,Pgp,0,1
23008,),0,0
23009,.,0,0
23010,To,0,0
23011,determine,0,0
23012,whether,0,0
23013,Pgp,0,1
23014,inhibition,0,0
23015,improves,0,0
23016,treatment,0,0
23017,outcome,0,0
23018,in,0,0
23019,CML-BP,0,0
23020,",",0,0
23021,the,0,0
23022,Southwest,0,0
23023,Oncology,0,0
23024,Group,0,0
23025,performed,0,0
23026,a,0,0
23027,randomized,1,0
23028,",",1,0
23029,controlled,1,0
23030,trial,1,0
23031,testing,1,1
23032,the,1,0
23033,benefit,1,0
23034,of,1,0
23035,the,1,0
23036,Pgp,1,1
23037,modulator,1,0
23038,",",1,0
23039,cyclosporin,1,1
23040,A,1,0
23041,(,1,1
23042,CsA,1,1
23043,),1,1
23044,.,1,0
23045,Seventy-three,0,0
23046,eligible,0,0
23047,patients,0,0
23048,were,0,0
23049,assigned,1,0
23050,to,1,0
23051,treatment,1,0
23052,with,1,1
23053,cytarabine,1,1
23054,and,1,0
23055,infusional,1,1
23056,daunorubicin,1,1
23057,with,1,0
23058,or,1,1
23059,without,1,0
23060,intravenous,1,1
23061,CsA,1,1
23062,.,1,0
23063,Treatment,0,0
23064,with,0,0
23065,CsA,0,1
23066,yielded,0,0
23067,no,0,0
23068,improvement,0,0
23069,in,0,0
23070,treatment,0,0
23071,outcome,0,0
23072,as,0,0
23073,measured,0,0
23074,by,0,0
23075,the,0,0
23076,frequency,0,0
23077,of,0,0
23078,induction,0,1
23079,resistance,0,0
23080,(,0,0
23081,68,0,0
23082,%,0,0
23083,vs,0,0
23084,53,0,0
23085,%,0,0
23086,),0,0
23087,",",0,0
23088,rate,0,0
23089,of,0,0
23090,complete,0,0
23091,remission,0,0
23092,or,0,1
23093,restored,0,1
23094,chronic,0,0
23095,phase,0,0
23096,(,0,0
23097,CR/CP,0,1
23098,",",0,0
23099,8,0,0
23100,%,0,0
23101,vs,0,0
23102,30,0,1
23103,%,0,0
23104,),0,0
23105,",",0,0
23106,and,0,1
23107,survival,0,0
23108,(,0,0
23109,3,0,0
23110,vs,0,0
23111,5,0,0
23112,months,0,0
23113,),0,0
23114,.,0,0
23115,Blast,0,0
23116,expression,0,0
23117,of,0,0
23118,Pgp,0,1
23119,(,0,0
23120,63,0,0
23121,%,0,0
23122,),0,0
23123,and,0,1
23124,LRP,0,1
23125,(,0,1
23126,71,0,0
23127,%,0,0
23128,),0,0
23129,was,0,0
23130,common,0,0
23131,",",0,0
23132,whereas,0,0
23133,only,0,0
23134,Pgp,0,1
23135,adversely,0,0
23136,impacted,0,0
23137,the,0,0
23138,rate,0,0
23139,of,0,0
23140,CR/CP,0,1
23141,(,0,0
23142,P,0,0
23143,=.025,0,0
23144,),0,0
23145,.,0,0
23146,We,0,0
23147,conclude,0,0
23148,that,0,0
23149,Pgp,0,1
23150,has,0,0
23151,prognostic,0,0
23152,relevance,0,0
23153,in,0,0
23154,CML-BP,0,0
23155,but,0,0
23156,that,0,0
23157,the,0,0
23158,modulation,0,0
23159,of,0,0
23160,Pgp,0,1
23161,function,0,0
23162,with,0,0
23163,CsA,0,1
23164,as,0,0
23165,applied,0,0
23166,in,0,0
23167,this,0,0
23168,trial,0,0
23169,is,0,0
23170,ineffective,0,0
23171,.,0,0
23172,Randomized,0,0
23173,comparative,0,0
23174,study,0,0
23175,of,0,0
23176,tegafur/uracil,1,1
23177,and,1,0
23178,oral,1,1
23179,leucovorin,1,1
23180,versus,1,1
23181,parenteral,1,1
23182,fluorouracil,1,1
23183,and,1,0
23184,leucovorin,1,1
23185,in,0,0
23186,patients,0,0
23187,with,0,0
23188,previously,0,0
23189,untreated,0,0
23190,metastatic,0,0
23191,colorectal,0,0
23192,cancer,0,0
23193,.,0,0
23194,PURPOSE,0,0
23195,This,0,0
23196,phase,0,0
23197,III,0,0
23198,study,0,0
23199,compared,0,0
23200,the,0,0
23201,time,0,0
23202,to,0,0
23203,progression,0,0
23204,(,0,1
23205,TTP,0,1
23206,),0,1
23207,of,0,0
23208,an,0,0
23209,oral,0,1
23210,regimen,0,1
23211,of,0,0
23212,dihydropyrimidine,1,1
23213,dehydrogenase,1,0
23214,inhibitory,1,0
23215,fluoropyrimidine,1,1
23216,composed,0,0
23217,of,0,0
23218,a,0,0
23219,fixed,0,1
23220,combination,0,1
23221,of,0,0
23222,tegafur,1,1
23223,and,1,0
23224,uracil,1,1
23225,in,0,0
23226,a,0,0
23227,1:4,0,0
23228,molar,0,0
23229,ratio,0,0
23230,(,0,1
23231,UFT,0,1
23232,),0,1
23233,and,0,0
23234,leucovorin,1,1
23235,(,0,1
23236,LV,0,1
23237,),0,1
23238,to,0,0
23239,intravenous,1,1
23240,(,1,1
23241,IV,1,0
23242,),1,1
23243,fluorouracil,1,1
23244,(,0,1
23245,5-FU,0,1
23246,),0,1
23247,and,1,0
23248,LV,1,1
23249,in,0,0
23250,previously,0,0
23251,untreated,0,0
23252,metastatic,0,0
23253,colorectal,0,0
23254,carcinoma,0,0
23255,(,0,1
23256,CRC,0,1
23257,),0,0
23258,patients,0,0
23259,.,0,0
23260,Secondary,0,0
23261,end,0,0
23262,points,0,0
23263,were,0,0
23264,survival,0,0
23265,",",0,0
23266,tumor,0,0
23267,response,0,0
23268,",",0,0
23269,safety,0,0
23270,",",0,0
23271,and,0,0
23272,quality,0,0
23273,of,0,0
23274,life,0,0
23275,.,0,0
23276,PATIENTS,0,0
23277,AND,0,0
23278,METHODS,0,0
23279,Between,0,0
23280,May,0,1
23281,1996,0,0
23282,and,0,0
23283,July,0,0
23284,1997,0,0
23285,",",0,0
23286,380,0,0
23287,patients,0,0
23288,were,0,0
23289,randomized,0,0
23290,to,0,0
23291,receive,0,0
23292,either,0,1
23293,UFT,1,1
23294,(,0,0
23295,300,0,1
23296,mg/m,0,1
23297,(,0,0
23298,2,0,0
23299,),0,1
23300,/d,0,1
23301,),0,1
23302,and,0,1
23303,LV,1,1
23304,(,0,1
23305,90,0,1
23306,mg/d,0,1
23307,),0,0
23308,",",0,0
23309,administered,0,0
23310,for,0,0
23311,28,0,0
23312,days,0,0
23313,every,0,0
23314,35,0,0
23315,days,0,0
23316,",",0,0
23317,or,0,1
23318,5-FU,1,1
23319,(,0,0
23320,425,0,0
23321,mg/m,0,1
23322,(,0,0
23323,2,0,0
23324,),0,1
23325,/d,0,1
23326,),0,1
23327,and,0,1
23328,LV,1,1
23329,(,0,1
23330,20,0,1
23331,mg/m,0,1
23332,(,0,0
23333,2,0,0
23334,),0,1
23335,/d,0,0
23336,),0,0
23337,",",0,0
23338,given,0,0
23339,IV,0,0
23340,for,0,0
23341,5,0,0
23342,days,0,0
23343,every,0,0
23344,35,0,0
23345,days,0,0
23346,.,0,0
23347,RESULTS,0,0
23348,No,0,0
23349,statistically,0,0
23350,significant,0,0
23351,difference,0,0
23352,in,0,0
23353,TTP,0,0
23354,was,0,0
23355,observed,0,0
23356,between,0,0
23357,treatments,0,0
23358,.,0,0
23359,With,0,0
23360,320,0,0
23361,events,0,0
23362,assessed,0,0
23363,",",0,0
23364,the,0,0
23365,median,0,0
23366,TTP,0,0
23367,was,0,0
23368,3.4,0,0
23369,months,0,0
23370,(,0,0
23371,95,0,0
23372,%,0,0
23373,Confidence,0,1
23374,interval,0,0
23375,[,0,0
23376,CI,0,0
23377,],0,0
23378,",",0,0
23379,2.6,0,0
23380,to,0,0
23381,3.8,0,0
23382,),0,0
23383,on,0,0
23384,UFT/LV,0,1
23385,and,0,0
23386,3.3,0,0
23387,months,0,0
23388,(,0,0
23389,95,0,0
23390,%,0,0
23391,CI,0,0
23392,",",0,0
23393,2.5,0,0
23394,to,0,0
23395,3.7,0,0
23396,),0,0
23397,on,0,0
23398,5-FU/LV,0,1
23399,(,0,0
23400,P,0,0
23401,=.591,0,0
23402,",",0,0
23403,stratified,0,0
23404,log-rank,0,0
23405,test,0,0
23406,),0,0
23407,.,0,0
23408,There,0,0
23409,were,0,0
23410,no,0,0
23411,statistically,0,0
23412,significant,0,0
23413,differences,0,0
23414,in,0,0
23415,survival,0,0
23416,",",0,0
23417,tumor,0,0
23418,response,0,0
23419,",",0,0
23420,duration,0,0
23421,of,0,0
23422,response,0,0
23423,",",0,0
23424,and,0,0
23425,time,0,0
23426,to,0,0
23427,response,0,0
23428,.,0,1
23429,Substantial,0,0
23430,safety,0,0
23431,benefits,0,0
23432,were,0,0
23433,observed,0,0
23434,in,0,0
23435,patients,0,0
23436,treated,0,0
23437,with,0,0
23438,UFT/LV,0,0
23439,.,0,0
23440,They,0,0
23441,experienced,0,0
23442,significantly,0,0
23443,less,0,0
23444,stomatitis/mucositis,0,0
23445,(,0,0
23446,P,0,0
23447,<,0,0
23448,.001,0,0
23449,),0,1
23450,and,0,0
23451,myelosuppression,0,1
23452,",",0,0
23453,resulting,0,0
23454,in,0,0
23455,fewer,0,0
23456,episodes,0,0
23457,of,0,0
23458,febrile,0,0
23459,neutropenia,0,0
23460,(,0,0
23461,P,0,0
23462,<,0,0
23463,.001,0,0
23464,),0,1
23465,and,0,0
23466,less,0,0
23467,documented,0,0
23468,infection,0,0
23469,(,0,0
23470,P,0,0
23471,=.04,0,0
23472,),0,0
23473,.,0,0
23474,Concomitant,0,0
23475,medication,0,0
23476,usage,0,0
23477,was,0,0
23478,significantly,0,0
23479,greater,0,0
23480,on,0,0
23481,5-FU/LV,0,0
23482,(,0,0
23483,P,0,0
23484,=.010,0,0
23485,),0,0
23486,.,0,0
23487,With,0,0
23488,respect,0,0
23489,to,0,0
23490,quality,0,0
23491,of,0,0
23492,life,0,0
23493,",",0,0
23494,after,0,0
23495,correcting,0,0
23496,for,0,0
23497,baseline,0,0
23498,imbalances,0,0
23499,",",0,0
23500,there,0,0
23501,were,0,0
23502,no,0,0
23503,significant,0,0
23504,differences,0,0
23505,between,0,0
23506,treatments,0,0
23507,for,0,0
23508,any,0,0
23509,scale,0,0
23510,",",0,0
23511,except,0,0
23512,diarrhea,0,0
23513,.,0,0
23514,CONCLUSION,0,0
23515,The,0,0
23516,oral,0,1
23517,UFT/LV,0,0
23518,regimen,0,1
23519,failed,0,0
23520,to,0,0
23521,achieve,0,0
23522,improved,0,0
23523,TTP,0,0
23524,;,0,0
23525,however,0,0
23526,",",0,0
23527,the,0,0
23528,study,0,0
23529,confirms,0,0
23530,significant,0,0
23531,safety,0,0
23532,improvements,0,0
23533,compared,0,0
23534,with,0,0
23535,bolus,0,1
23536,IV,0,0
23537,5-FU/LV,0,1
23538,for,0,0
23539,the,0,0
23540,first-line,0,1
23541,treatment,0,0
23542,of,0,0
23543,metastatic,0,0
23544,CRC,0,1
23545,.,0,0
23546,Stepwise,1,1
23547,hook,1,1
23548,extension,1,0
23549,technique,1,1
23550,for,0,0
23551,radiofrequency,0,1
23552,ablation,0,1
23553,therapy,0,1
23554,of,0,0
23555,hepatocellular,0,0
23556,carcinoma,0,0
23557,.,0,0
23558,OBJECTIVE,0,0
23559,Our,0,0
23560,study,0,0
23561,was,0,0
23562,designed,0,0
23563,to,0,0
23564,examine,0,0
23565,the,0,0
23566,efficacy,0,0
23567,of,0,0
23568,stepwise,1,0
23569,hook,1,1
23570,extension,1,0
23571,technique,1,1
23572,for,1,0
23573,radiofrequency,1,1
23574,ablation,1,1
23575,(,1,1
23576,RFA,1,1
23577,),1,1
23578,therapy,1,1
23579,of,0,0
23580,hepatocellular,0,0
23581,carcinoma,0,0
23582,in,0,0
23583,a,0,0
23584,randomized,0,0
23585,controlled,0,0
23586,study,0,0
23587,.,0,0
23588,METHOD,0,0
23589,Twenty,0,0
23590,patients,0,0
23591,with,0,0
23592,hepatocellular,0,0
23593,carcinoma,0,0
23594,measuring,0,0
23595,<,0,0
23596,25,0,0
23597,mm,0,0
23598,were,0,0
23599,divided,0,0
23600,randomly,0,0
23601,into,0,0
23602,two,0,0
23603,equal,0,0
23604,groups,0,0
23605,.,0,0
23606,RFA,1,0
23607,was,0,0
23608,applied,0,0
23609,using,0,0
23610,our,0,0
23611,new,0,0
23612,stepwise,1,0
23613,hook,1,1
23614,extension,1,0
23615,technique,1,1
23616,in,0,0
23617,patients,0,0
23618,of,0,0
23619,group,0,0
23620,1,0,0
23621,",",0,0
23622,and,0,0
23623,the,0,0
23624,full,1,0
23625,extension,1,0
23626,method,1,1
23627,in,0,0
23628,group,0,0
23629,2,0,0
23630,.,0,0
23631,The,0,0
23632,10-hook,1,1
23633,electrode,1,1
23634,of,1,0
23635,LeVeen,1,0
23636,needle,1,1
23637,was,0,0
23638,deployed,0,0
23639,in,0,0
23640,four,0,0
23641,steps,0,0
23642,to,0,0
23643,full,0,0
23644,extension,0,0
23645,during,0,0
23646,ablation,0,1
23647,in,0,0
23648,group,0,0
23649,1,0,0
23650,",",0,0
23651,and,0,0
23652,full,0,0
23653,extension,0,0
23654,at,0,0
23655,start,0,0
23656,of,0,0
23657,treatment,0,0
23658,in,0,0
23659,group,0,0
23660,2,0,0
23661,.,0,0
23662,RESULTS,0,0
23663,Roll-off,0,0
23664,was,0,0
23665,achieved,0,0
23666,in,0,0
23667,all,0,0
23668,10,0,0
23669,patients,0,0
23670,of,0,0
23671,group,0,0
23672,1,0,0
23673,",",0,0
23674,indicative,0,0
23675,of,0,0
23676,sufficient,0,0
23677,tumor,0,0
23678,coagulation,0,1
23679,",",0,0
23680,but,0,0
23681,only,0,0
23682,in,0,0
23683,3,0,0
23684,of,0,0
23685,10,0,0
23686,patients,0,0
23687,of,0,0
23688,group,0,0
23689,2,0,0
23690,.,0,0
23691,The,0,0
23692,median,0,0
23693,time,0,0
23694,to,0,0
23695,completion,0,0
23696,of,0,0
23697,treatment,0,0
23698,was,0,0
23699,6,0,0
23700,min,0,0
23701,and,0,0
23702,55,0,0
23703,s,0,0
23704,(,0,0
23705,range,0,0
23706,3,0,0
23707,min,0,0
23708,to,0,0
23709,14,0,0
23710,min,0,0
23711,and,0,0
23712,3,0,0
23713,s,0,0
23714,),0,0
23715,and,0,0
23716,15,0,1
23717,min,0,0
23718,(,0,0
23719,6-15,0,1
23720,min,0,1
23721,),0,0
23722,",",0,0
23723,respectively,0,0
23724,.,0,0
23725,The,0,0
23726,total,0,0
23727,power,0,0
23728,output,0,0
23729,used,0,0
23730,for,0,0
23731,RF,0,0
23732,was,0,0
23733,lower,0,0
23734,in,0,0
23735,group,0,0
23736,1,0,0
23737,than,0,0
23738,in,0,0
23739,group,0,0
23740,2,0,0
23741,(,0,0
23742,median,0,0
23743,271,0,0
23744,vs.,0,0
23745,"1,045",0,0
23746,W.m,0,0
23747,),0,0
23748,.,0,0
23749,The,0,0
23750,diameters,0,0
23751,of,0,0
23752,RFA-induced,0,0
23753,lesions,0,0
23754,were,0,0
23755,not,0,0
23756,significantly,0,0
23757,different,0,0
23758,between,0,0
23759,the,0,0
23760,groups,0,0
23761,(,0,0
23762,group,0,0
23763,1,0,0
23764,:,0,0
23765,27,0,0
23766,",",0,0
23767,range,0,0
23768,23-37,0,0
23769,mm,0,0
23770,;,0,0
23771,group,0,0
23772,2,0,0
23773,:,0,0
23774,23,0,0
23775,",",0,0
23776,0-42,0,0
23777,mm,0,0
23778,),0,0
23779,.,0,0
23780,CONCLUSIONS,0,0
23781,Application,0,1
23782,of,0,0
23783,RFA,0,1
23784,using,0,0
23785,stepwise,0,1
23786,hook,0,1
23787,extension,0,0
23788,technique,0,1
23789,is,0,0
23790,superior,0,0
23791,to,0,0
23792,the,0,0
23793,full,0,0
23794,extension,0,0
23795,method,0,1
23796,since,0,0
23797,it,0,0
23798,produces,0,0
23799,the,0,0
23800,same,0,0
23801,therapeutic,0,0
23802,effects,0,0
23803,within,0,0
23804,a,0,0
23805,short,0,1
23806,period,0,0
23807,using,0,0
23808,a,0,0
23809,lower,0,0
23810,energy,0,0
23811,.,0,0
23812,Clinical,0,0
23813,evaluation,0,0
23814,of,0,0
23815,two,0,0
23816,adhesive,0,1
23817,composite,1,1
23818,cements,1,1
23819,for,0,0
23820,the,0,0
23821,suppression,0,0
23822,of,0,0
23823,dentinal,0,0
23824,cold,0,1
23825,sensitivity,0,0
23826,.,0,0
23827,STATEMENT,0,0
23828,OF,0,1
23829,PROBLEMS,0,0
23830,Postoperative,0,1
23831,cold,0,1
23832,sensitivity,0,0
23833,after,0,0
23834,the,0,0
23835,cementation,0,1
23836,of,0,0
23837,indirect,0,0
23838,restorations,0,1
23839,with,0,0
23840,composite,0,1
23841,cements,0,1
23842,has,0,0
23843,been,0,0
23844,reported,0,0
23845,frequently,0,0
23846,but,0,0
23847,not,0,0
23848,scientifically,0,0
23849,documented,0,0
23850,.,0,0
23851,PURPOSE,0,0
23852,This,0,0
23853,controlled,0,0
23854,clinical,0,0
23855,study,0,0
23856,was,0,0
23857,designed,0,0
23858,to,0,0
23859,simulate,0,0
23860,the,0,0
23861,dentin/composite,0,1
23862,cement,0,1
23863,interface,0,0
23864,immediately,0,0
23865,after,0,0
23866,cementation,0,1
23867,of,0,0
23868,a,0,0
23869,cast,0,1
23870,restoration,0,0
23871,.,0,0
23872,The,0,0
23873,desensitizing,0,1
23874,capabilities,0,0
23875,of,0,0
23876,a,0,0
23877,composite,0,1
23878,cement,0,1
23879,that,0,0
23880,contains,0,0
23881,a,0,0
23882,self-etching,0,1
23883,",",0,0
23884,dual-polymerizing,0,1
23885,resin,0,1
23886,adhesive,0,1
23887,system,0,0
23888,were,0,0
23889,compared,0,0
23890,with,0,0
23891,those,0,0
23892,of,0,0
23893,a,0,0
23894,composite,0,1
23895,cement,0,1
23896,that,0,0
23897,use,0,0
23898,phosphoric,1,1
23899,acid,1,1
23900,etching,0,1
23901,followed,0,1
23902,by,0,0
23903,a,0,0
23904,single-bottle,0,1
23905,",",0,0
23906,light-activated,0,1
23907,primer/resin-based,0,1
23908,adhesive,0,1
23909,.,0,1
23910,MATERIAL,0,0
23911,AND,0,0
23912,METHODS,0,0
23913,The,0,0
23914,hypersensitive,0,0
23915,root,0,1
23916,surfaces,0,1
23917,of,0,0
23918,selected,0,0
23919,teeth,0,0
23920,were,0,0
23921,randomized,0,0
23922,to,0,0
23923,receive,0,0
23924,1,0,0
23925,of,0,0
23926,3,0,0
23927,treatments,0,0
23928,:,0,0
23929,coating,1,0
23930,with,1,0
23931,a,1,0
23932,self-etching,1,1
23933,adhesive,1,1
23934,(,1,1
23935,Linkmax,1,0
23936,),1,1
23937,and,1,0
23938,its,1,0
23939,respective,1,0
23940,cement,1,1
23941,",",1,0
23942,coating,1,1
23943,with,1,0
23944,a,1,0
23945,conventionally,1,0
23946,etched,1,1
23947,adhesive,1,1
23948,(,1,0
23949,RelyX,1,1
23950,ARC,1,1
23951,),1,1
23952,and,1,0
23953,its,1,0
23954,cement,1,1
23955,",",1,0
23956,or,1,1
23957,no,1,1
23958,treatment,1,1
23959,(,0,0
23960,negative,0,1
23961,control,0,1
23962,),0,0
23963,.,0,0
23964,The,0,0
23965,sample,0,0
23966,size,0,0
23967,was,0,0
23968,22,0,0
23969,.,0,0
23970,Dentin,0,1
23971,sensitivity,0,0
23972,was,0,0
23973,ascertained,0,0
23974,with,0,0
23975,an,0,0
23976,accurate,0,0
23977,cold,0,1
23978,testing,0,1
23979,device,0,1
23980,that,0,0
23981,slowly,0,0
23982,decreased,0,0
23983,in,0,0
23984,temperature,0,0
23985,.,0,0
23986,Tooth,0,0
23987,sensitivity,0,0
23988,was,0,0
23989,measured,0,0
23990,both,0,0
23991,immediately,0,0
23992,and,0,0
23993,at,0,0
23994,7,0,0
23995,days,0,0
23996,after,0,0
23997,placement,0,0
23998,.,0,0
23999,Two-way,0,0
24000,analysis,0,0
24001,of,0,0
24002,variance,0,0
24003,and,0,0
24004,Fisher,0,1
24005,'s,0,0
24006,least,0,0
24007,significant,0,0
24008,difference,0,0
24009,test,0,1
24010,(,0,0
24011,P,0,0
24012,<,0,0
24013,.05,0,0
24014,),0,0
24015,were,0,0
24016,used,0,0
24017,to,0,0
24018,determine,0,0
24019,whether,0,0
24020,significant,0,0
24021,differences,0,0
24022,existed,0,0
24023,as,0,0
24024,a,0,0
24025,function,0,0
24026,of,0,0
24027,treatment,0,1
24028,type,0,0
24029,or,0,1
24030,time,0,0
24031,.,0,0
24032,RESULTS,0,0
24033,Immediately,0,0
24034,after,0,0
24035,placement,0,0
24036,",",0,0
24037,the,0,0
24038,self-etching,1,1
24039,adhesive,1,1
24040,and,1,0
24041,its,1,0
24042,respective,1,0
24043,cement,1,1
24044,resulted,0,0
24045,in,0,0
24046,more,0,0
24047,suppression,0,0
24048,of,0,0
24049,cold,0,1
24050,sensitivity,0,0
24051,than,0,0
24052,no,0,0
24053,treatment,0,1
24054,(,0,1
24055,control,0,1
24056,),0,1
24057,;,0,0
24058,with,0,0
24059,Linkmax,0,0
24060,treatment,0,0
24061,",",0,0
24062,the,0,0
24063,temperature,0,0
24064,at,0,0
24065,which,0,0
24066,teeth,0,0
24067,responded,0,0
24068,was,0,0
24069,reduced,0,0
24070,by,0,0
24071,8.4,0,0
24072,degrees,0,0
24073,C.,0,0
24074,The,0,0
24075,conventionally,0,0
24076,etched,1,1
24077,adhesive,1,1
24078,and,1,0
24079,its,1,0
24080,cement,1,1
24081,reduced,0,0
24082,the,0,0
24083,temperature,0,0
24084,at,0,0
24085,which,0,0
24086,teeth,0,0
24087,responded,0,0
24088,by,0,0
24089,9.4,0,0
24090,degrees,0,0
24091,C.,0,0
24092,After,0,0
24093,1,0,0
24094,week,0,0
24095,",",0,0
24096,these,0,0
24097,temperature,0,0
24098,reductions,0,0
24099,were,0,0
24100,7.0,0,0
24101,degrees,0,0
24102,C,0,0
24103,and,0,0
24104,4.3,0,0
24105,degrees,0,0
24106,C,0,0
24107,",",0,0
24108,respectively,0,0
24109,.,0,0
24110,Untreated,0,0
24111,controls,0,0
24112,at,0,0
24113,the,0,0
24114,2,0,0
24115,intervals,0,0
24116,showed,0,0
24117,a,0,0
24118,mean,0,0
24119,decrease,0,0
24120,in,0,0
24121,sensitivity,0,0
24122,to,0,0
24123,cold,0,1
24124,of,0,0
24125,3.6,0,0
24126,degrees,0,0
24127,C,0,0
24128,and,0,0
24129,4.1,0,0
24130,degrees,0,0
24131,C.,0,1
24132,Statistical,0,0
24133,analysis,0,0
24134,showed,0,0
24135,type,0,0
24136,of,0,0
24137,composite,0,1
24138,cement,0,1
24139,to,0,0
24140,be,0,0
24141,a,0,0
24142,significant,0,0
24143,factor,0,0
24144,.,0,0
24145,CONCLUSION,0,0
24146,Within,0,0
24147,the,0,0
24148,limitations,0,0
24149,of,0,0
24150,this,0,0
24151,study,0,0
24152,and,0,0
24153,in,0,0
24154,comparison,0,0
24155,to,0,0
24156,untreated,0,0
24157,control,0,1
24158,teeth,0,0
24159,",",0,0
24160,Linkmax,1,0
24161,treatment,1,0
24162,resulted,0,0
24163,in,0,0
24164,a,0,0
24165,significant,0,0
24166,reduction,0,0
24167,in,0,0
24168,tooth,0,0
24169,root,0,1
24170,sensitivity,0,0
24171,over,0,0
24172,1,0,0
24173,week,0,0
24174,(,0,1
24175,P=.02,0,0
24176,),0,1
24177,",",0,0
24178,whereas,0,0
24179,RelyX,0,1
24180,ARC,0,1
24181,did,0,0
24182,not,0,0
24183,(,0,0
24184,P=.066,0,0
24185,),0,0
24186,.,0,0
24187,Therapeutic,0,1
24188,angiogenesis,0,0
24189,for,0,0
24190,patients,0,0
24191,with,0,0
24192,limb,0,0
24193,ischaemia,0,1
24194,by,0,0
24195,autologous,1,1
24196,transplantation,1,0
24197,of,1,0
24198,bone-marrow,1,1
24199,cells,1,0
24200,:,1,0
24201,a,0,0
24202,pilot,0,0
24203,study,0,0
24204,and,0,0
24205,a,0,0
24206,randomised,0,0
24207,controlled,0,0
24208,trial,0,0
24209,.,0,0
24210,BACKGROUND,0,0
24211,Preclinical,0,0
24212,studies,0,0
24213,have,0,0
24214,established,0,0
24215,that,0,0
24216,implantation,0,0
24217,of,0,0
24218,bone,0,0
24219,marrow-mononuclear,0,1
24220,cells,0,0
24221,",",0,0
24222,including,0,0
24223,endothelial,0,0
24224,progenitor,0,0
24225,cells,0,0
24226,",",0,0
24227,into,0,0
24228,ischaemic,0,0
24229,limbs,0,1
24230,increases,0,0
24231,collateral,0,0
24232,vessel,0,0
24233,formation,0,0
24234,.,0,0
24235,We,0,0
24236,investigated,0,0
24237,efficacy,0,0
24238,and,0,0
24239,safety,0,0
24240,of,0,0
24241,autologous,1,1
24242,implantation,1,0
24243,of,1,0
24244,bone,1,0
24245,marrow-mononuclear,1,1
24246,cells,1,0
24247,in,1,0
24248,patients,0,0
24249,with,0,0
24250,ischaemic,0,0
24251,limbs,0,0
24252,because,0,0
24253,of,0,0
24254,peripheral,0,0
24255,arterial,0,0
24256,disease,0,0
24257,.,0,0
24258,METHODS,0,0
24259,We,0,0
24260,first,0,0
24261,did,0,0
24262,a,0,0
24263,pilot,0,0
24264,study,0,0
24265,",",0,0
24266,in,0,0
24267,which,0,0
24268,25,0,0
24269,patients,0,0
24270,(,0,0
24271,group,0,0
24272,A,0,0
24273,),0,0
24274,with,0,0
24275,unilateral,0,0
24276,ischaemia,0,1
24277,of,0,0
24278,the,0,0
24279,leg,0,0
24280,were,0,0
24281,injected,1,1
24282,with,1,0
24283,bone,1,0
24284,marrow-mononuclear,1,1
24285,cells,1,0
24286,into,1,0
24287,the,1,0
24288,gastrocnemius,1,1
24289,of,1,0
24290,the,1,0
24291,ischaemic,1,1
24292,limb,1,0
24293,and,1,0
24294,with,1,0
24295,saline,1,1
24296,into,1,0
24297,the,1,0
24298,less,1,0
24299,ischaemic,1,0
24300,limb,1,0
24301,.,1,0
24302,We,0,0
24303,then,0,0
24304,recruited,0,0
24305,22,0,0
24306,patients,0,0
24307,(,0,0
24308,group,0,1
24309,B,0,1
24310,),0,0
24311,with,0,0
24312,bilateral,0,1
24313,leg,0,0
24314,ischaemia,0,1
24315,",",0,0
24316,who,0,0
24317,were,0,0
24318,randomly,0,0
24319,injected,1,1
24320,with,1,0
24321,bone,1,0
24322,marrow-mononuclear,1,1
24323,cells,1,0
24324,in,1,0
24325,one,1,0
24326,leg,1,0
24327,and,1,0
24328,peripheral,1,0
24329,blood-mononuclear,1,0
24330,cells,1,0
24331,in,1,0
24332,the,1,0
24333,other,1,0
24334,as,1,0
24335,a,1,0
24336,control,1,0
24337,.,1,0
24338,Primary,0,0
24339,outcomes,0,0
24340,were,0,0
24341,safety,0,0
24342,and,0,0
24343,feasibility,0,0
24344,of,0,0
24345,treatment,0,0
24346,",",0,0
24347,based,0,0
24348,on,0,0
24349,ankle-brachial,0,1
24350,index,0,0
24351,(,0,1
24352,ABI,0,1
24353,),0,1
24354,and,0,0
24355,rest,0,1
24356,pain,0,0
24357,",",0,0
24358,and,0,0
24359,analysis,0,0
24360,was,0,0
24361,per,0,0
24362,protocol,0,0
24363,.,0,0
24364,FINDINGS,0,0
24365,Two,0,0
24366,patients,0,0
24367,were,0,0
24368,excluded,0,0
24369,from,0,0
24370,group,0,0
24371,B,0,1
24372,after,0,0
24373,randomisation,0,0
24374,.,0,0
24375,At,0,0
24376,4,0,0
24377,weeks,0,0
24378,in,0,0
24379,group,0,0
24380,B,0,0
24381,patients,0,0
24382,",",0,0
24383,ABI,0,0
24384,was,0,0
24385,significantly,0,0
24386,improved,0,0
24387,in,0,0
24388,legs,0,0
24389,injected,0,0
24390,with,0,0
24391,bone,1,0
24392,marrow-mononuclear,1,1
24393,cells,1,0
24394,compared,0,0
24395,with,0,0
24396,those,0,0
24397,injected,0,0
24398,with,0,0
24399,peripheral,1,0
24400,blood-mononuclear,1,0
24401,cells,1,0
24402,(,0,0
24403,difference,0,0
24404,0.09,0,0
24405,[,0,0
24406,95,0,0
24407,%,0,0
24408,CI,0,0
24409,0.06-0.11,0,0
24410,],0,0
24411,;,0,0
24412,p,0,0
24413,<,0,0
24414,0.0001,0,0
24415,),0,0
24416,.,0,0
24417,Similar,0,0
24418,improvements,0,0
24419,were,0,0
24420,seen,0,0
24421,for,0,0
24422,transcutaneous,0,1
24423,oxygen,0,1
24424,pressure,0,0
24425,(,0,0
24426,13,0,0
24427,[,0,0
24428,9-17,0,0
24429,],0,0
24430,;,0,0
24431,p,0,0
24432,<,0,0
24433,0.0001,0,0
24434,),0,0
24435,",",0,0
24436,rest,0,1
24437,pain,0,0
24438,(,0,0
24439,-0.85,0,0
24440,[,0,1
24441,-1.6,0,0
24442,to,0,0
24443,-0.12,0,0
24444,],0,0
24445,;,0,0
24446,p=0.025,0,0
24447,),0,0
24448,",",0,0
24449,and,0,0
24450,pain-free,0,0
24451,walking,0,1
24452,time,0,0
24453,(,0,0
24454,1.2,0,0
24455,[,0,0
24456,0.7-1.7,0,0
24457,],0,0
24458,;,0,1
24459,p=0.0001,0,0
24460,),0,0
24461,.,0,0
24462,These,0,0
24463,improvements,0,0
24464,were,0,0
24465,sustained,0,0
24466,at,0,0
24467,24,0,0
24468,weeks,0,0
24469,.,0,0
24470,Similar,0,0
24471,improvements,0,0
24472,were,0,0
24473,seen,0,0
24474,in,0,0
24475,group,0,0
24476,A,0,0
24477,patients,0,0
24478,.,0,0
24479,Two,0,0
24480,patients,0,0
24481,in,0,0
24482,group,0,0
24483,A,0,0
24484,died,0,0
24485,after,0,0
24486,myocardial,0,0
24487,infarction,0,0
24488,unrelated,0,0
24489,to,0,0
24490,treatment,0,0
24491,.,0,0
24492,INTERPRETATION,0,0
24493,Autologous,1,1
24494,implantation,1,0
24495,of,1,0
24496,bone,1,0
24497,marrow-mononuclear,1,1
24498,cells,1,0
24499,could,0,0
24500,be,0,0
24501,safe,0,0
24502,and,0,0
24503,effective,0,0
24504,for,0,0
24505,achievement,0,0
24506,of,0,0
24507,therapeutic,0,0
24508,angiogenesis,0,0
24509,",",0,0
24510,because,0,0
24511,of,0,0
24512,the,0,0
24513,natural,0,0
24514,ability,0,0
24515,of,0,0
24516,marrow,0,0
24517,cells,0,0
24518,to,0,0
24519,supply,0,0
24520,endothelial,0,0
24521,progenitor,0,0
24522,cells,0,0
24523,and,0,0
24524,to,0,0
24525,secrete,0,0
24526,various,0,0
24527,angiogenic,0,0
24528,factors,0,0
24529,or,0,0
24530,cytokines,0,0
24531,.,0,0
24532,7-hexanoyltaxol-eluting,1,1
24533,stent,1,1
24534,for,0,0
24535,prevention,0,0
24536,of,0,0
24537,neointimal,0,0
24538,growth,0,0
24539,:,0,0
24540,an,0,0
24541,intravascular,0,0
24542,ultrasound,0,1
24543,analysis,0,0
24544,from,0,0
24545,the,0,0
24546,Study,0,0
24547,to,0,0
24548,COmpare,0,1
24549,REstenosis,0,0
24550,rate,0,0
24551,between,0,0
24552,QueST,0,1
24553,and,0,1
24554,QuaDS-QP2,0,1
24555,(,0,1
24556,SCORE,0,1
24557,),0,0
24558,.,0,0
24559,BACKGROUND,0,0
24560,Inhibition,0,0
24561,of,0,0
24562,neointimal,0,0
24563,tissue,0,0
24564,growth,0,1
24565,has,0,0
24566,been,0,0
24567,demonstrated,0,0
24568,in,0,0
24569,preliminary,0,0
24570,human,0,1
24571,feasibility,0,0
24572,studies,0,0
24573,with,0,0
24574,a,0,0
24575,stent-based,1,1
24576,polymer,1,1
24577,sleeve,1,1
24578,delivering,1,1
24579,7-hexanoyltaxol,1,1
24580,.,1,0
24581,The,0,0
24582,Study,0,0
24583,to,0,0
24584,COmpare,0,1
24585,REstenosis,0,0
24586,rate,0,0
24587,between,0,0
24588,QueST,0,1
24589,and,0,1
24590,QuaDS-QP2,0,1
24591,(,0,1
24592,SCORE,0,1
24593,),0,1
24594,trial,0,0
24595,is,0,0
24596,a,0,0
24597,human,0,0
24598,",",0,0
24599,randomized,0,0
24600,",",0,0
24601,multicenter,0,0
24602,trial,0,0
24603,comparing,0,0
24604,7-hexanoyltaxol,1,1
24605,(,1,1
24606,QP2,1,0
24607,),1,1
24608,-eluting,1,1
24609,stents,1,1
24610,(,1,1
24611,qDES,1,1
24612,),1,1
24613,with,1,0
24614,bare,1,1
24615,metal,1,0
24616,stents,1,1
24617,(,1,0
24618,BMS,1,1
24619,),1,1
24620,in,0,0
24621,the,0,0
24622,treatment,0,0
24623,of,0,0
24624,de,0,0
24625,novo,0,0
24626,coronary,0,0
24627,lesions,0,0
24628,.,0,0
24629,The,0,0
24630,purpose,0,0
24631,of,0,0
24632,this,0,0
24633,substudy,0,0
24634,was,0,0
24635,to,0,0
24636,evaluate,0,0
24637,the,0,0
24638,acute,0,0
24639,expansion,0,1
24640,property,0,0
24641,and,0,0
24642,long-term,0,0
24643,neointimal,0,0
24644,responses,0,0
24645,of,0,0
24646,qDES,1,0
24647,compared,0,0
24648,with,0,0
24649,BMS,1,0
24650,as,0,0
24651,assessed,0,0
24652,by,0,0
24653,intravascular,0,0
24654,ultrasound,0,1
24655,(,0,1
24656,IVUS,0,1
24657,),0,0
24658,.,0,0
24659,METHODS,0,0
24660,AND,0,0
24661,RESULTS,0,0
24662,A,0,0
24663,total,0,0
24664,of,0,0
24665,122,0,0
24666,(,0,0
24667,qDES,0,0
24668,66,0,0
24669,",",0,0
24670,BMS,0,0
24671,56,0,0
24672,),0,0
24673,patients,0,0
24674,were,0,0
24675,enrolled,0,0
24676,into,0,0
24677,the,0,0
24678,IVUS,0,1
24679,substudy,0,0
24680,.,0,0
24681,All,0,0
24682,IVUS,0,1
24683,images,0,1
24684,(,0,0
24685,immediately,0,0
24686,after,0,0
24687,the,0,0
24688,procedure,0,0
24689,and,0,0
24690,at,0,0
24691,6-month,0,1
24692,follow-up,0,0
24693,),0,0
24694,were,0,0
24695,analyzed,0,0
24696,at,0,0
24697,an,0,0
24698,independent,0,0
24699,core,0,0
24700,laboratory,0,0
24701,in,0,0
24702,a,0,0
24703,blind,0,0
24704,manner,0,0
24705,.,0,0
24706,At,0,0
24707,baseline,0,0
24708,",",0,0
24709,qDES,1,1
24710,achieved,0,0
24711,stent,0,1
24712,expansion,0,0
24713,similar,0,0
24714,to,0,0
24715,BMS,0,0
24716,.,0,0
24717,At,0,0
24718,follow-up,0,0
24719,",",0,0
24720,qDES,1,0
24721,showed,0,0
24722,reduced,0,0
24723,neointimal,0,0
24724,growth,0,0
24725,by,0,0
24726,70,0,0
24727,%,0,0
24728,at,0,0
24729,the,0,0
24730,tightest,0,0
24731,cross,0,0
24732,section,0,0
24733,and,0,0
24734,by,0,0
24735,68,0,0
24736,%,0,0
24737,over,0,0
24738,the,0,0
24739,stented,0,1
24740,segment,0,0
24741,(,0,0
24742,P,0,0
24743,<,0,0
24744,0.0001,0,0
24745,for,0,0
24746,both,0,0
24747,),0,0
24748,",",0,0
24749,resulting,0,0
24750,in,0,0
24751,a,0,0
24752,significantly,0,0
24753,larger,0,0
24754,lumen,0,0
24755,in,0,0
24756,qDES,0,0
24757,than,0,0
24758,in,0,0
24759,BMS,0,0
24760,.,0,0
24761,Unlike,0,0
24762,intracoronary,0,1
24763,brachytherapy,0,1
24764,",",0,0
24765,there,0,0
24766,was,0,0
24767,no,0,0
24768,evidence,0,0
24769,of,0,0
24770,negative,0,0
24771,edge,0,0
24772,effects,0,0
24773,",",0,0
24774,unhealed,0,0
24775,dissections,0,1
24776,",",0,0
24777,or,0,0
24778,late,0,0
24779,stent-vessel,0,1
24780,wall,0,0
24781,malapposition,0,0
24782,over,0,0
24783,the,0,0
24784,stented,0,0
24785,and,0,0
24786,adjacent,0,0
24787,references,0,0
24788,segments,0,0
24789,in,0,0
24790,either,0,0
24791,group,0,0
24792,.,0,0
24793,CONCLUSIONS,0,0
24794,Detailed,0,1
24795,IVUS,0,1
24796,analysis,0,0
24797,revealed,0,0
24798,that,0,0
24799,qDES,1,0
24800,had,0,0
24801,comparable,0,0
24802,acute,0,0
24803,mechanical,0,0
24804,and,0,0
24805,superior,0,0
24806,long-term,0,0
24807,biological,0,0
24808,effects,0,0
24809,to,0,0
24810,BMS,1,0
24811,.,1,0
24812,Although,0,0
24813,the,0,0
24814,long-term,0,0
24815,benefits,0,0
24816,and,0,0
24817,limitations,0,0
24818,of,0,0
24819,this,0,0
24820,technology,0,0
24821,require,0,0
24822,further,0,0
24823,investigation,0,0
24824,",",0,0
24825,the,0,0
24826,reduction,0,0
24827,in,0,0
24828,neointimal,0,0
24829,thickenings,0,0
24830,demonstrated,0,0
24831,that,0,0
24832,local,0,1
24833,delivery,0,0
24834,of,0,0
24835,7-hexanoyltaxol,1,1
24836,through,0,0
24837,polymer,0,1
24838,sleeves,0,1
24839,augments,0,0
24840,conventional,0,1
24841,mechanical,0,0
24842,treatment,0,0
24843,of,0,0
24844,atherosclerotic,0,0
24845,disease,0,0
24846,.,0,0
24847,Tegaserod,1,1
24848,",",1,0
24849,a,1,0
24850,5-hydroxytryptamine,1,1
24851,type,1,0
24852,4,1,1
24853,receptor,1,0
24854,partial,1,0
24855,agonist,1,1
24856,",",0,0
24857,is,0,0
24858,devoid,0,0
24859,of,0,0
24860,electrocardiographic,0,0
24861,effects,0,0
24862,.,0,0
24863,OBJECTIVES,0,0
24864,Certain,0,0
24865,GI,1,0
24866,prokinetic,1,1
24867,agents,1,0
24868,have,0,0
24869,been,0,0
24870,shown,0,0
24871,to,0,0
24872,affect,0,0
24873,cardiac,0,0
24874,repolarization,0,0
24875,",",0,0
24876,which,0,0
24877,may,0,0
24878,be,0,0
24879,associated,0,0
24880,with,0,0
24881,life-threatening,0,0
24882,arrhythmias,0,0
24883,.,0,0
24884,The,0,0
24885,selective,1,0
24886,5-hydroxytryptamine,1,1
24887,type,1,0
24888,4,1,1
24889,receptor,1,0
24890,partial,1,0
24891,agonist,1,1
24892,tegaserod,1,1
24893,is,0,0
24894,a,0,0
24895,novel,0,0
24896,promotile,0,1
24897,agent,0,0
24898,developed,0,0
24899,for,0,0
24900,the,0,0
24901,treatment,0,0
24902,of,0,0
24903,functional,0,0
24904,motility,0,0
24905,disorders,0,0
24906,such,0,0
24907,as,0,0
24908,irritable,0,0
24909,bowel,0,1
24910,syndrome,0,0
24911,(,0,1
24912,IBS,0,0
24913,),0,0
24914,.,0,0
24915,The,0,0
24916,aim,0,0
24917,of,0,0
24918,the,0,0
24919,study,0,0
24920,was,0,0
24921,to,0,0
24922,investigate,0,0
24923,the,0,0
24924,cardiac,0,0
24925,safety,0,0
24926,profile,0,0
24927,of,0,0
24928,tegaserod,1,1
24929,through,0,0
24930,analysis,0,0
24931,of,0,0
24932,electrocardiographic,0,0
24933,data,0,0
24934,from,0,0
24935,clinical,0,0
24936,studies,0,0
24937,conducted,0,0
24938,in,0,0
24939,patients,0,0
24940,with,0,0
24941,IBS,0,0
24942,and,0,0
24943,a,0,0
24944,study,0,0
24945,conducted,0,0
24946,in,0,0
24947,healthy,0,0
24948,male,0,0
24949,subjects,0,0
24950,.,0,0
24951,METHODS,0,0
24952,In,0,0
24953,three,0,0
24954,randomized,0,0
24955,",",0,0
24956,double,0,1
24957,blind,0,0
24958,",",0,0
24959,placebo-controlled,0,1
24960,",",0,0
24961,parallel,0,0
24962,group,0,0
24963,clinical,0,0
24964,studies,0,0
24965,",",0,0
24966,2516,0,0
24967,IBS,0,0
24968,patients,0,0
24969,with,0,0
24970,symptoms,0,0
24971,of,0,0
24972,abdominal,0,0
24973,pain,0,0
24974,and,0,0
24975,constipation,0,0
24976,received,0,1
24977,tegaserod,1,1
24978,2,0,0
24979,or,0,0
24980,6,0,0
24981,mg,0,1
24982,b.i.d,0,1
24983,.,0,1
24984,(,0,0
24985,n,0,0
24986,=,0,0
24987,1679,0,0
24988,),0,0
24989,or,0,1
24990,placebo,1,1
24991,(,0,1
24992,n,0,0
24993,=,0,0
24994,837,0,0
24995,),0,0
24996,for,0,0
24997,12,0,0
24998,wk,0,0
24999,.,0,0
25000,In,0,0
25001,an,0,0
25002,additional,0,0
25003,study,0,0
25004,",",0,0
25005,36,0,0
25006,healthy,0,0
25007,male,0,0
25008,subjects,0,0
25009,received,0,0
25010,iv,0,0
25011,.,0,0
25012,single,0,0
25013,doses,0,0
25014,of,0,0
25015,tegaserod,1,1
25016,(,0,0
25017,0.8,0,1
25018,mg,0,1
25019,to,0,0
25020,20,0,0
25021,mg,0,1
25022,),0,1
25023,or,1,1
25024,placebo,1,1
25025,.,1,1
25026,Standard,0,1
25027,12-lead,0,0
25028,electrocardiograms,0,0
25029,were,0,0
25030,recorded,0,0
25031,at,0,0
25032,baseline,0,0
25033,and,0,0
25034,during,0,0
25035,treatment,0,0
25036,.,0,0
25037,Baseline,0,0
25038,values,0,0
25039,were,0,0
25040,compared,0,0
25041,with,0,0
25042,data,0,0
25043,collected,0,0
25044,during,0,0
25045,the,0,0
25046,treatment,0,0
25047,period,0,0
25048,.,0,0
25049,RESULTS,0,0
25050,The,0,0
25051,proportion,0,0
25052,of,0,0
25053,patients,0,0
25054,with,0,0
25055,prolongation,0,0
25056,of,0,0
25057,the,0,0
25058,QTc,0,0
25059,interval,0,0
25060,was,0,0
25061,the,0,0
25062,same,0,0
25063,for,0,0
25064,placebo,0,1
25065,and,0,0
25066,tegaserod,0,1
25067,",",0,0
25068,as,0,0
25069,was,0,0
25070,the,0,0
25071,frequency,0,0
25072,of,0,0
25073,overall,0,0
25074,electrocardiographic,0,0
25075,abnormalities,0,0
25076,.,0,0
25077,No,0,0
25078,ventricular,0,0
25079,or,0,1
25080,supraventricular,0,1
25081,tachycardia,0,0
25082,was,0,0
25083,observed,0,0
25084,.,0,0
25085,Comparable,0,0
25086,electrocardiographic,0,0
25087,results,0,0
25088,were,0,0
25089,obtained,0,0
25090,during,0,0
25091,placebo,0,1
25092,and,0,0
25093,tegaserod,0,1
25094,treatment,0,0
25095,.,0,0
25096,In,0,0
25097,healthy,0,0
25098,volunteers,0,0
25099,",",0,0
25100,tegaserod,0,1
25101,at,0,0
25102,i.v,0,1
25103,.,0,0
25104,doses,0,0
25105,resulting,0,0
25106,in,0,0
25107,plasma,0,0
25108,concentrations,0,0
25109,up,0,0
25110,to,0,0
25111,100,0,0
25112,times,0,0
25113,those,0,0
25114,measured,0,0
25115,after,0,0
25116,therapeutic,0,0
25117,doses,0,1
25118,(,0,0
25119,6,0,0
25120,mg,0,1
25121,b.i.d,0,1
25122,.,0,0
25123,),0,0
25124,did,0,0
25125,not,0,0
25126,influence,0,0
25127,electrocardiographic,0,0
25128,parameters,0,0
25129,.,0,0
25130,CONCLUSIONS,0,0
25131,Tegaserod,0,1
25132,is,0,0
25133,devoid,0,0
25134,of,0,0
25135,electrocardiographic,0,0
25136,effects,0,0
25137,and,0,0
25138,is,0,0
25139,not,0,0
25140,expected,0,0
25141,to,0,0
25142,adversely,0,0
25143,influence,0,0
25144,cardiac,0,0
25145,function,0,0
25146,.,0,0
25147,These,0,0
25148,data,0,0
25149,confirm,0,0
25150,preclinical,0,0
25151,findings,0,0
25152,.,0,0
25153,Effect,0,0
25154,of,0,0
25155,macronutrient,1,1
25156,composition,0,0
25157,of,0,0
25158,the,0,0
25159,diet,0,1
25160,on,0,0
25161,the,0,0
25162,regulation,0,0
25163,of,0,0
25164,lipolysis,0,0
25165,in,0,0
25166,adipose,0,1
25167,tissue,0,0
25168,at,0,0
25169,rest,0,0
25170,and,0,0
25171,during,0,0
25172,exercise,0,1
25173,:,0,1
25174,microdialysis,0,1
25175,study,0,0
25176,.,0,0
25177,The,0,0
25178,aim,0,0
25179,of,0,0
25180,the,0,0
25181,present,0,0
25182,study,0,0
25183,was,0,0
25184,to,0,0
25185,elucidate,0,0
25186,",",0,0
25187,using,0,0
25188,a,0,0
25189,microdialysis,0,1
25190,technique,0,1
25191,",",0,0
25192,whether,0,0
25193,modifications,0,0
25194,in,0,0
25195,the,0,0
25196,proportion,0,0
25197,of,0,0
25198,fat,1,0
25199,in,1,0
25200,the,1,0
25201,diet,1,1
25202,influence,0,0
25203,lipid,0,1
25204,mobilization,0,0
25205,from,0,0
25206,adipose,0,1
25207,tissue,0,0
25208,in,0,0
25209,situ,0,1
25210,.,0,0
25211,Nine,0,1
25212,healthy,0,0
25213,volunteers,0,0
25214,(,0,0
25215,age,0,0
25216,",",0,0
25217,23.4,0,0
25218,+/-,0,0
25219,0.2,0,0
25220,years,0,0
25221,;,0,0
25222,body,0,0
25223,mas,0,0
25224,index,0,0
25225,[,0,0
25226,BMI,0,1
25227,],0,0
25228,",",0,0
25229,23.5,0,0
25230,+/-,0,0
25231,1.6,0,0
25232,kg/m,0,0
25233,(,0,0
25234,2,0,1
25235,),0,0
25236,),0,0
25237,were,0,0
25238,fed,0,1
25239,",",0,0
25240,in,0,0
25241,random,0,0
25242,order,0,0
25243,",",0,0
25244,with,0,0
25245,a,0,0
25246,high-fat,1,1
25247,diet,1,1
25248,(,1,1
25249,HFD,1,1
25250,),1,1
25251,(,1,0
25252,65,1,0
25253,%,1,0
25254,of,1,0
25255,energy,1,1
25256,content,1,0
25257,fat,1,0
25258,",",1,0
25259,15,1,0
25260,%,1,0
25261,protein,1,1
25262,",",1,0
25263,20,1,0
25264,%,1,0
25265,carbohydrate,1,1
25266,),1,1
25267,or,1,1
25268,a,1,0
25269,high-carbohydrate,1,1
25270,diet,1,1
25271,(,1,1
25272,HCD,1,1
25273,),1,1
25274,(,1,0
25275,70,1,0
25276,%,1,0
25277,carbohydrate,1,1
25278,",",1,0
25279,15,1,0
25280,%,1,0
25281,protein,1,1
25282,",",1,0
25283,15,1,0
25284,%,1,0
25285,fat,1,0
25286,),1,0
25287,for,1,0
25288,5,1,0
25289,days,1,0
25290,",",1,0
25291,with,1,0
25292,a,1,0
25293,washout,1,1
25294,period,1,0
25295,of,1,0
25296,10,1,0
25297,days,1,0
25298,between,1,0
25299,the,1,0
25300,diets,1,1
25301,.,1,0
25302,Subjects,0,0
25303,were,0,0
25304,studied,0,0
25305,in,0,0
25306,the,0,0
25307,fasting,0,0
25308,state,0,0
25309,on,0,0
25310,the,0,0
25311,morning,0,0
25312,following,0,0
25313,days,0,0
25314,4,0,0
25315,and,0,0
25316,5,0,0
25317,of,0,0
25318,each,0,0
25319,diet,0,1
25320,.,0,0
25321,We,0,0
25322,measured,0,0
25323,the,0,0
25324,concentration,0,0
25325,of,0,0
25326,extracellular,0,0
25327,glycerol,0,1
25328,(,0,1
25329,EGC,0,1
25330,),0,1
25331,in,0,0
25332,adipose,0,1
25333,tissue,0,0
25334,in,0,0
25335,response,0,0
25336,to,0,0
25337,(,0,0
25338,1,0,1
25339,),0,1
25340,pharmacologic,0,1
25341,stimulation,0,1
25342,with,0,1
25343,isoprenaline,1,1
25344,(,0,0
25345,1,0,0
25346,and,0,0
25347,10,0,1
25348,micromol/L,0,0
25349,),0,0
25350,in,0,0
25351,situ,0,1
25352,",",0,0
25353,(,0,0
25354,2,0,0
25355,),0,0
25356,stimulation,0,1
25357,with,0,0
25358,intravenous,0,1
25359,infusion,0,1
25360,of,0,0
25361,epinephrine,1,1
25362,(,0,0
25363,0.0375,0,1
25364,microg/min/kg,0,0
25365,body,0,0
25366,weight,0,0
25367,),0,0
25368,",",0,0
25369,and,0,0
25370,(,0,0
25371,3,0,1
25372,),0,0
25373,submaximal,0,0
25374,aerobic,1,1
25375,exercise,1,1
25376,(,0,0
25377,50,0,1
25378,%,0,0
25379,V*O2max,0,0
25380,",",0,0
25381,60-minute,0,1
25382,duration,0,0
25383,),0,0
25384,.,0,0
25385,No,0,0
25386,effect,0,0
25387,of,0,0
25388,the,0,0
25389,diet,0,1
25390,composition,0,0
25391,was,0,0
25392,found,0,0
25393,in,0,0
25394,the,0,0
25395,increases,0,0
25396,of,0,0
25397,EGC,0,0
25398,in,0,0
25399,response,0,0
25400,to,0,0
25401,isoprenaline,0,1
25402,(,0,0
25403,area,0,0
25404,under,0,0
25405,the,0,0
25406,curve,0,0
25407,[,0,0
25408,AUC,0,0
25409,],0,0
25410,:,0,0
25411,HFD,0,1
25412,",",0,0
25413,"1,534",0,0
25414,+/-,0,0
25415,370,0,0
25416,micromol/90,0,0
25417,min,0,0
25418,;,0,0
25419,HCD,0,1
25420,",",0,0
25421,"1,108",0,0
25422,+/-,0,0
25423,465,0,0
25424,micromol/90,0,0
25425,min,0,0
25426,;,0,0
25427,not,0,0
25428,significant,0,0
25429,[,0,0
25430,NS,0,1
25431,],0,1
25432,),0,1
25433,or,0,1
25434,epinephrine,0,1
25435,stimulations,0,1
25436,(,0,0
25437,AUC,0,0
25438,:,0,1
25439,HFD,0,1
25440,",",0,0
25441,190,0,0
25442,+/-,0,0
25443,92,0,0
25444,micromol/30,0,0
25445,min,0,0
25446,;,0,0
25447,HCD,0,1
25448,",",0,0
25449,251,0,0
25450,+/-,0,0
25451,298,0,0
25452,micromol/30,0,0
25453,min,0,0
25454,;,0,0
25455,NS,0,0
25456,),0,0
25457,.,0,0
25458,The,0,0
25459,exercise-induced,0,0
25460,increase,0,0
25461,in,0,0
25462,EGC,0,0
25463,was,0,0
25464,higher,0,0
25465,during,0,0
25466,the,0,0
25467,HFD,0,1
25468,(,0,0
25469,AUC,0,0
25470,:,0,1
25471,HFD,0,1
25472,",",0,0
25473,"1,641",0,0
25474,+/-,0,0
25475,181,0,0
25476,micromol/60,0,0
25477,min,0,0
25478,;,0,0
25479,HCD,0,1
25480,",",0,0
25481,963,0,0
25482,+/-,0,0
25483,156,0,0
25484,micromol/60,0,0
25485,min,0,0
25486,;,0,0
25487,P,0,0
25488,<,0,0
25489,.05,0,0
25490,),0,1
25491,and,0,0
25492,was,0,0
25493,associated,0,0
25494,with,0,0
25495,a,0,0
25496,higher,0,0
25497,exercise-induced,0,0
25498,response,0,0
25499,of,0,0
25500,norepinephrine,0,1
25501,(,0,0
25502,P,0,0
25503,<,0,0
25504,.05,0,0
25505,),0,1
25506,and,0,1
25507,epinephrine,0,1
25508,(,0,1
25509,P,0,0
25510,=.056,0,0
25511,),0,0
25512,and,0,0
25513,lower,0,0
25514,insulinemia,0,1
25515,during,0,0
25516,exercise,0,1
25517,.,0,0
25518,The,0,0
25519,results,0,0
25520,suggest,0,0
25521,that,0,0
25522,macronutrient,0,1
25523,composition,0,0
25524,of,0,0
25525,diet,0,1
25526,does,0,0
25527,not,0,0
25528,affect,0,0
25529,the,0,0
25530,beta-adrenergic,0,1
25531,responsiveness,0,0
25532,of,0,0
25533,adipose,0,1
25534,tissue,0,0
25535,to,0,0
25536,catecholamine,0,0
25537,action,0,0
25538,at,0,0
25539,rest,0,0
25540,.,0,0
25541,During,0,0
25542,exercise,0,0
25543,",",0,0
25544,the,0,0
25545,HFD,1,1
25546,promotes,0,0
25547,higher,0,0
25548,lipolysis,0,0
25549,in,0,0
25550,adipose,0,1
25551,tissue,0,0
25552,and,0,0
25553,this,0,0
25554,is,0,0
25555,associated,0,0
25556,with,0,0
25557,a,0,0
25558,higher,0,0
25559,catecholamine,0,0
25560,response,0,0
25561,and,0,0
25562,lower,0,0
25563,insulinemia,0,0
25564,.,0,0
25565,Transurethral,1,1
25566,prostate,1,0
25567,resection,1,1
25568,and,0,0
25569,bleeding,0,0
25570,:,0,0
25571,a,0,0
25572,randomized,0,0
25573,",",0,0
25574,placebo,1,1
25575,controlled,0,0
25576,trial,0,0
25577,of,0,0
25578,role,0,0
25579,of,0,0
25580,finasteride,1,1
25581,for,0,0
25582,decreasing,0,0
25583,operative,0,0
25584,blood,0,0
25585,loss,0,0
25586,.,0,0
25587,PURPOSE,0,0
25588,Bleeding,0,0
25589,associated,0,0
25590,with,0,0
25591,transurethral,0,1
25592,prostate,0,0
25593,resection,0,1
25594,can,0,0
25595,often,0,0
25596,be,0,0
25597,significant,0,0
25598,and,0,0
25599,lead,0,0
25600,to,0,0
25601,increased,0,0
25602,morbidity,0,0
25603,and,0,0
25604,occasionally,0,0
25605,mortality,0,0
25606,.,0,0
25607,It,0,0
25608,has,0,0
25609,been,0,0
25610,shown,0,0
25611,that,0,0
25612,finasteride,1,1
25613,decreases,0,0
25614,bleeding,0,0
25615,in,0,0
25616,patients,0,0
25617,with,0,0
25618,hematuria,0,0
25619,of,0,0
25620,prostatic,0,0
25621,origin,0,0
25622,.,0,0
25623,We,0,0
25624,hypothesized,0,0
25625,that,0,0
25626,bleeding,0,0
25627,in,0,0
25628,patients,0,0
25629,undergoing,0,0
25630,transurethral,0,1
25631,prostate,0,0
25632,resection,0,1
25633,could,0,0
25634,be,0,0
25635,decreased,0,0
25636,by,0,0
25637,giving,0,0
25638,finasteride,1,1
25639,for,0,0
25640,2,0,0
25641,weeks,0,0
25642,before,0,0
25643,surgery,0,0
25644,.,0,0
25645,MATERIALS,0,0
25646,AND,0,0
25647,METHODS,0,0
25648,A,0,0
25649,total,0,0
25650,70,0,0
25651,patients,0,0
25652,scheduled,0,0
25653,to,0,0
25654,undergo,0,0
25655,elective,0,1
25656,transurethral,0,1
25657,prostate,0,0
25658,resection,0,1
25659,were,0,0
25660,randomized,0,0
25661,to,0,0
25662,receive,0,0
25663,5,1,0
25664,mg.,1,1
25665,finasteride,1,1
25666,daily,1,1
25667,or,1,0
25668,placebo,1,1
25669,for,0,0
25670,2,0,0
25671,weeks,0,0
25672,before,0,0
25673,surgery,0,0
25674,.,0,0
25675,Serum,0,0
25676,hemoglobin,0,0
25677,was,0,0
25678,measured,0,0
25679,before,0,0
25680,and,0,0
25681,after,0,0
25682,surgery,0,1
25683,",",0,0
25684,and,0,0
25685,the,0,0
25686,following,0,0
25687,day,0,0
25688,.,0,0
25689,The,0,0
25690,volume,0,0
25691,of,0,0
25692,irrigation,0,1
25693,fluid,0,1
25694,used,0,0
25695,and,0,0
25696,its,0,0
25697,hemoglobin,0,0
25698,concentration,0,0
25699,as,0,0
25700,well,0,0
25701,as,0,0
25702,resected,0,0
25703,prostate,0,0
25704,weight,0,0
25705,were,0,0
25706,recorded,0,0
25707,.,0,0
25708,RESULTS,0,0
25709,Of,0,0
25710,the,0,0
25711,68,0,0
25712,patients,0,0
25713,who,0,0
25714,underwent,0,0
25715,transurethral,0,1
25716,prostate,0,0
25717,resection,0,1
25718,2,0,0
25719,were,0,0
25720,withdrawn,0,0
25721,before,0,0
25722,surgery,0,0
25723,",",0,0
25724,and,0,0
25725,so,0,0
25726,32,0,0
25727,received,0,0
25728,finasteride,1,1
25729,and,0,0
25730,36,0,0
25731,received,0,0
25732,placebo,1,1
25733,.,1,0
25734,There,0,0
25735,was,0,0
25736,significantly,0,0
25737,less,0,0
25738,mean,0,0
25739,blood,0,0
25740,loss,0,0
25741,in,0,0
25742,irrigation,0,1
25743,fluid,0,1
25744,in,0,0
25745,the,0,0
25746,finasteride,1,1
25747,group,0,0
25748,than,0,0
25749,in,0,0
25750,the,0,0
25751,control,0,1
25752,group,0,0
25753,(,0,0
25754,43.6,0,0
25755,versus,0,1
25756,69.3,0,0
25757,gm,0,1
25758,.,0,0
25759,hemoglobin,0,0
25760,",",0,0
25761,p,0,0
25762,=,0,0
25763,0.011,0,0
25764,),0,0
25765,.,0,0
25766,The,0,0
25767,mean,0,0
25768,difference,0,0
25769,was,0,0
25770,more,0,0
25771,significant,0,0
25772,when,0,0
25773,blood,0,0
25774,loss,0,0
25775,per,0,0
25776,gm,0,1
25777,.,0,0
25778,resected,0,0
25779,prostate,0,0
25780,was,0,0
25781,calculated,0,0
25782,(,0,0
25783,2.65,0,0
25784,versus,0,1
25785,4.65,0,0
25786,gm,0,1
25787,.,0,0
25788,hemoglobin,0,0
25789,per,0,0
25790,gm,0,1
25791,.,0,0
25792,prostate,0,0
25793,",",0,0
25794,p,0,0
25795,<,0,0
25796,0.01,0,0
25797,),0,0
25798,.,0,0
25799,CONCLUSIONS,0,0
25800,This,0,0
25801,study,0,0
25802,shows,0,0
25803,that,0,0
25804,finasteride,1,1
25805,given,0,0
25806,for,0,0
25807,2,0,0
25808,weeks,0,0
25809,preoperatively,0,0
25810,decreases,0,0
25811,bleeding,0,0
25812,in,0,0
25813,patients,0,0
25814,undergoing,0,0
25815,transurethral,0,1
25816,prostate,0,0
25817,resection,0,1
25818,.,0,0
25819,Further,0,0
25820,study,0,0
25821,is,0,0
25822,required,0,0
25823,to,0,0
25824,determine,0,0
25825,the,0,0
25826,optimal,0,0
25827,timing,0,0
25828,and,0,0
25829,dose,0,1
25830,duration,0,0
25831,to,0,0
25832,minimize,0,0
25833,blood,0,0
25834,loss,0,0
25835,and,0,0
25836,identify,0,0
25837,how,0,0
25838,relevant,0,0
25839,such,0,0
25840,a,0,0
25841,decrease,0,0
25842,in,0,0
25843,bleeding,0,0
25844,is,0,0
25845,in,0,0
25846,clinical,0,0
25847,practice,0,0
25848,.,0,0
25849,Adherence,0,0
25850,to,0,0
25851,moderate-intensity,1,1
25852,exercise,1,1
25853,during,0,0
25854,breast,1,0
25855,cancer,1,0
25856,therapy,1,1
25857,.,1,0
25858,PURPOSE,0,0
25859,The,0,0
25860,aims,0,0
25861,of,0,0
25862,this,0,0
25863,pilot,0,0
25864,study,0,0
25865,were,0,0
25866,the,0,0
25867,following,0,0
25868,:,0,0
25869,1,0,0
25870,),0,0
25871,to,0,0
25872,examine,0,0
25873,patterns,0,0
25874,of,0,0
25875,adherence,0,0
25876,to,0,0
25877,a,0,0
25878,brisk,1,0
25879,walking,1,1
25880,program,1,1
25881,in,0,0
25882,women,0,0
25883,receiving,0,0
25884,adjuvant,1,1
25885,chemotherapy,1,1
25886,or,1,1
25887,radiation,1,1
25888,therapy,1,1
25889,for,0,0
25890,newly,0,0
25891,diagnosed,0,0
25892,breast,0,0
25893,cancer,0,0
25894,using,0,0
25895,a,0,0
25896,prospective,0,0
25897,",",0,0
25898,randomized,0,0
25899,",",0,0
25900,controlled,0,0
25901,experimental,0,0
25902,design,0,0
25903,;,0,0
25904,2,0,0
25905,),0,0
25906,to,0,0
25907,examine,0,0
25908,the,0,0
25909,influence,0,0
25910,of,0,0
25911,disease,0,0
25912,symptoms,0,0
25913,and,0,0
25914,treatment,0,0
25915,side,0,0
25916,effects,0,0
25917,on,0,0
25918,exercise,1,1
25919,levels,0,0
25920,;,0,0
25921,and,0,0
25922,3,0,0
25923,),0,0
25924,to,0,0
25925,suggest,0,0
25926,methods,0,0
25927,that,0,0
25928,may,0,0
25929,improve,0,0
25930,future,0,0
25931,clinical,0,0
25932,trials,0,0
25933,of,0,0
25934,moderate-intensity,0,0
25935,exercise,0,1
25936,in,0,0
25937,similar,0,0
25938,populations,0,0
25939,.,0,0
25940,DESCRIPTION,0,0
25941,OF,0,1
25942,STUDY,0,0
25943,Fifty-two,0,0
25944,patients,0,0
25945,with,0,0
25946,newly,0,0
25947,diagnosed,0,0
25948,breast,0,0
25949,cancer,0,0
25950,were,0,0
25951,randomly,0,0
25952,assigned,0,0
25953,to,0,0
25954,one,0,0
25955,of,0,0
25956,two,0,0
25957,treatment,0,0
25958,arms,0,0
25959,:,0,0
25960,usual,1,1
25961,care,1,1
25962,or,0,1
25963,usual,1,1
25964,care,1,1
25965,plus,1,1
25966,exercise,1,1
25967,.,1,0
25968,Those,0,0
25969,assigned,0,0
25970,to,0,0
25971,the,0,0
25972,exercise,1,1
25973,group,0,0
25974,received,0,1
25975,a,0,0
25976,standardized,1,0
25977,",",1,0
25978,self-administered,1,1
25979,",",1,0
25980,home-based,1,1
25981,brisk,1,0
25982,walking,1,1
25983,intervention,1,1
25984,in,0,0
25985,addition,0,0
25986,to,0,0
25987,usual,0,1
25988,care,0,1
25989,.,0,0
25990,Each,0,0
25991,day,0,0
25992,subjects,0,0
25993,completed,0,0
25994,self-report,0,0
25995,diary,0,1
25996,forms,0,0
25997,that,0,0
25998,elicited,0,0
25999,information,0,0
26000,about,0,0
26001,activity,0,0
26002,levels,0,0
26003,",",0,0
26004,and,0,0
26005,the,0,0
26006,occurrence,0,0
26007,of,0,0
26008,symptoms,0,0
26009,and,0,0
26010,side,0,0
26011,effects,0,0
26012,during,0,0
26013,cancer,0,0
26014,treatment,0,0
26015,.,0,0
26016,RESULTS,0,0
26017,Analyses,0,0
26018,of,0,0
26019,self-reported,0,0
26020,daily,0,1
26021,activity,0,0
26022,levels,0,0
26023,revealed,0,0
26024,a,0,0
26025,diffusion,0,0
26026,of,0,0
26027,treatment,0,0
26028,effect,0,0
26029,.,0,0
26030,Fifty,0,0
26031,percent,0,0
26032,of,0,0
26033,the,0,0
26034,usual-care,0,1
26035,group,0,0
26036,reported,0,0
26037,maintaining,0,0
26038,or,0,1
26039,increasing,0,0
26040,their,0,0
26041,physical,0,1
26042,activity,0,0
26043,to,0,0
26044,a,0,0
26045,moderate-intensity,0,1
26046,level,0,0
26047,",",0,0
26048,while,0,0
26049,33,0,0
26050,%,0,0
26051,of,0,0
26052,the,0,0
26053,exercise,0,1
26054,group,0,0
26055,did,0,0
26056,not,0,0
26057,exercise,0,1
26058,at,0,0
26059,the,0,0
26060,prescribed,0,0
26061,levels,0,0
26062,.,0,0
26063,Analyses,0,0
26064,of,0,0
26065,self-reported,0,0
26066,disease,0,0
26067,symptoms,0,0
26068,and,0,0
26069,treatment,0,0
26070,side,0,0
26071,effects,0,0
26072,did,0,0
26073,not,0,0
26074,reveal,0,0
26075,clinically,0,0
26076,meaningful,0,0
26077,differences,0,0
26078,between,0,0
26079,the,0,0
26080,two,0,0
26081,groups,0,0
26082,.,0,0
26083,CLINICAL,0,0
26084,IMPLICATIONS,0,0
26085,The,0,0
26086,results,0,0
26087,of,0,0
26088,this,0,0
26089,study,0,0
26090,suggest,0,0
26091,that,0,0
26092,women,0,0
26093,who,0,0
26094,exercised,0,0
26095,regularly,0,0
26096,before,0,0
26097,receiving,0,0
26098,a,0,0
26099,breast,0,0
26100,cancer,0,0
26101,diagnosis,0,0
26102,attempted,0,0
26103,to,0,0
26104,maintain,0,0
26105,their,0,0
26106,exercise,1,1
26107,programs,1,1
26108,.,1,0
26109,Women,0,0
26110,who,0,0
26111,lead,0,0
26112,sedentary,0,0
26113,lifestyles,0,1
26114,may,0,0
26115,benefit,0,0
26116,from,0,0
26117,a,0,0
26118,structured,1,1
26119,exercise,1,1
26120,program,1,1
26121,that,0,0
26122,includes,0,0
26123,information,0,0
26124,and,0,0
26125,support,0,1
26126,related,0,0
26127,to,0,0
26128,exercise,0,1
26129,adherence,0,0
26130,strategies,0,0
26131,.,0,0
26132,Lamivudine,1,1
26133,300,0,1
26134,mg,0,1
26135,QD,0,1
26136,versus,0,1
26137,continued,0,0
26138,lamivudine,1,1
26139,150,0,0
26140,mg,0,1
26141,BID,0,1
26142,with,0,0
26143,stavudine,1,1
26144,and,0,0
26145,a,0,0
26146,protease,1,1
26147,inhibitor,1,1
26148,in,0,0
26149,suppressed,0,0
26150,patients,0,0
26151,.,0,0
26152,PURPOSE,0,0
26153,To,0,0
26154,compare,0,0
26155,the,0,0
26156,efficacy,0,0
26157,(,0,0
26158,sustained,0,0
26159,virologic,0,1
26160,suppression,0,0
26161,),0,1
26162,and,0,0
26163,safety/tolerability,0,0
26164,of,0,0
26165,a,0,0
26166,switch,0,0
26167,to,0,0
26168,lamivudine,1,1
26169,300,0,1
26170,mg,0,1
26171,once,0,0
26172,daily,0,1
26173,(,0,1
26174,QD,0,1
26175,),0,1
26176,versus,0,1
26177,continued,0,0
26178,lamivudine,1,1
26179,150,0,0
26180,mg,0,1
26181,twice,0,1
26182,daily,0,1
26183,(,0,0
26184,BID,0,1
26185,),0,1
26186,in,0,0
26187,virologically,0,0
26188,suppressed,0,0
26189,patients,0,0
26190,(,0,0
26191,HIV-1,0,0
26192,RNA,0,1
26193,<,0,0
26194,400,0,1
26195,copies/mL,0,0
26196,for,0,0
26197,>,0,0
26198,or,0,1
26199,=3,0,0
26200,months,0,0
26201,),0,0
26202,on,0,0
26203,stable,0,0
26204,(,0,0
26205,>,0,0
26206,or,0,1
26207,=6,0,0
26208,months,0,0
26209,),0,0
26210,therapy,0,1
26211,with,0,0
26212,lamivudine,1,1
26213,150,1,0
26214,mg,1,1
26215,BID,1,1
26216,plus,1,1
26217,stavudine,1,1
26218,and,1,0
26219,either,1,1
26220,indinavir,1,1
26221,or,1,1
26222,nelfinavir,1,1
26223,.,1,0
26224,METHOD,0,0
26225,Eighty-nine,0,0
26226,suppressed,0,0
26227,patients,0,0
26228,>,0,0
26229,or,0,0
26230,=18,0,0
26231,years,0,0
26232,old,0,0
26233,with,0,0
26234,CD4,0,0
26235,counts,0,0
26236,>,0,0
26237,50,0,0
26238,cells/mm,0,0
26239,(,0,0
26240,3,0,0
26241,),0,0
26242,were,0,0
26243,enrolled,0,0
26244,in,0,0
26245,this,0,0
26246,phase,0,0
26247,II,0,0
26248,",",0,0
26249,open-label,0,0
26250,",",0,0
26251,multicenter,0,0
26252,",",0,0
26253,randomized,0,0
26254,",",0,0
26255,stratified,0,0
26256,(,0,0
26257,by,0,0
26258,pretrial,1,1
26259,protease,1,1
26260,inhibitor,1,1
26261,[,0,0
26262,PI,0,1
26263,],0,1
26264,),0,0
26265,",",0,0
26266,parallel-group,0,0
26267,clinical,0,0
26268,trial,0,0
26269,.,0,0
26270,Eighty-one,0,0
26271,patients,0,0
26272,received,0,0
26273,either,0,0
26274,lamivudine,1,1
26275,300,0,1
26276,mg,0,1
26277,QD,0,1
26278,(,0,0
26279,n,0,0
26280,=,0,0
26281,39,0,0
26282,),0,0
26283,or,0,0
26284,150,0,0
26285,mg,0,1
26286,BID,0,1
26287,(,0,0
26288,n,0,0
26289,=,0,0
26290,42,0,0
26291,),0,0
26292,with,0,0
26293,their,0,0
26294,pretrial,1,1
26295,stavudine/PI,1,1
26296,regimens,1,1
26297,for,0,0
26298,24,0,0
26299,weeks,0,0
26300,.,0,0
26301,RESULTS,0,0
26302,A,0,0
26303,high,0,0
26304,rate,0,0
26305,of,0,0
26306,virologic,0,0
26307,suppression,0,0
26308,was,0,0
26309,sustained,0,0
26310,with,0,0
26311,both,0,0
26312,regimens,0,1
26313,throughout,0,0
26314,the,0,0
26315,trial,0,0
26316,.,0,0
26317,At,0,0
26318,week,0,0
26319,24,0,0
26320,",",0,0
26321,intent-to-treat,0,0
26322,:,0,1
26323,exposed,0,0
26324,(,0,0
26325,missing,0,0
26326,=,0,0
26327,failure,0,0
26328,),0,1
26329,analyses,0,0
26330,showed,0,0
26331,no,0,0
26332,statistically,0,0
26333,significant,0,0
26334,differences,0,0
26335,in,0,0
26336,the,0,0
26337,percentage,0,0
26338,of,0,0
26339,patients,0,0
26340,with,0,0
26341,HIV-1,0,0
26342,RNA,0,1
26343,<,0,0
26344,400,0,1
26345,copies/mL,0,0
26346,(,0,0
26347,95,0,0
26348,%,0,0
26349,[,0,0
26350,QD,0,1
26351,],0,0
26352,vs.,0,0
26353,90,0,0
26354,%,0,0
26355,[,0,0
26356,BID,0,1
26357,],0,1
26358,),0,1
26359,or,0,1
26360,<,0,0
26361,50,0,1
26362,copies/mL,0,0
26363,(,0,0
26364,82,0,0
26365,%,0,0
26366,[,0,0
26367,QD,0,1
26368,],0,0
26369,vs.,0,0
26370,81,0,0
26371,%,0,0
26372,[,0,0
26373,BID,0,1
26374,],0,1
26375,),0,1
26376,or,0,1
26377,in,0,0
26378,the,0,0
26379,median,0,0
26380,change,0,0
26381,from,0,0
26382,baseline,0,0
26383,in,0,0
26384,CD4,0,0
26385,counts,0,0
26386,(,0,0
26387,+42,0,1
26388,cells/mm,0,0
26389,(,0,1
26390,3,0,0
26391,),0,0
26392,[,0,0
26393,QD,0,1
26394,],0,0
26395,vs.,0,0
26396,+22,0,1
26397,cells/mm,0,0
26398,(,0,1
26399,3,0,0
26400,),0,0
26401,[,0,0
26402,BID,0,1
26403,],0,0
26404,),0,0
26405,.,0,0
26406,Both,0,1
26407,regimens,0,0
26408,were,0,0
26409,well,0,0
26410,tolerated,0,0
26411,.,0,0
26412,No,0,0
26413,patient,0,0
26414,experienced,0,0
26415,virologic,0,0
26416,failure,0,0
26417,",",0,0
26418,clinical,0,0
26419,disease,0,0
26420,progression,0,0
26421,",",0,0
26422,or,0,1
26423,a,0,0
26424,drug-related,0,0
26425,serious,0,0
26426,adverse,0,0
26427,event,0,0
26428,during,0,0
26429,the,0,0
26430,trial,0,0
26431,.,0,0
26432,Self-reported,0,0
26433,medication,0,0
26434,adherence,0,0
26435,was,0,0
26436,high,0,0
26437,in,0,0
26438,both,0,0
26439,groups,0,0
26440,.,0,0
26441,CONCLUSION,0,0
26442,Patients,0,0
26443,who,0,0
26444,experience,0,0
26445,virologic,0,0
26446,suppression,0,0
26447,with,0,0
26448,a,0,0
26449,regimen,0,1
26450,of,0,0
26451,lamivudine,1,1
26452,150,0,0
26453,mg,0,1
26454,BID,0,1
26455,in,0,0
26456,combination,1,1
26457,with,1,0
26458,stavudine/PI,1,1
26459,can,0,0
26460,maintain,0,0
26461,that,0,0
26462,suppression,0,0
26463,by,0,0
26464,continuing,0,0
26465,their,0,0
26466,regimen,0,1
26467,or,0,0
26468,switching,0,0
26469,to,0,0
26470,lamivudine,1,1
26471,300,0,1
26472,mg,0,1
26473,QD,0,1
26474,and,0,0
26475,continuing,0,0
26476,the,0,0
26477,other,0,0
26478,components,0,0
26479,.,0,0
26480,Adverse,0,0
26481,event,0,0
26482,profiles,0,0
26483,were,0,0
26484,comparable,0,0
26485,among,0,0
26486,treatment,0,0
26487,regimens,0,1
26488,",",0,0
26489,and,0,0
26490,no,0,0
26491,new,0,0
26492,safety,0,0
26493,concerns,0,0
26494,were,0,0
26495,raised,0,0
26496,.,0,0
26497,A,0,0
26498,randomized,0,0
26499,",",0,0
26500,double-blind,0,0
26501,",",0,0
26502,placebo-controlled,1,1
26503,trial,0,0
26504,of,0,0
26505,porcine,1,1
26506,versus,0,1
26507,synthetic,1,1
26508,secretin,1,1
26509,for,0,0
26510,reducing,0,0
26511,symptoms,0,0
26512,of,0,0
26513,autism,0,0
26514,.,0,0
26515,OBJECTIVE,0,0
26516,To,0,0
26517,compare,0,0
26518,the,0,0
26519,effects,0,0
26520,of,0,0
26521,a,0,0
26522,single,0,0
26523,dose,0,0
26524,of,0,0
26525,biologic,1,0
26526,and,0,0
26527,synthetic,1,1
26528,porcine,1,1
26529,secretin,1,1
26530,to,0,0
26531,placebo,1,1
26532,on,0,0
26533,a,0,0
26534,variety,0,0
26535,of,0,0
26536,autism,0,0
26537,symptoms,0,0
26538,.,0,0
26539,METHOD,0,0
26540,Eighty-five,0,0
26541,children,0,0
26542,with,0,0
26543,autism,0,0
26544,without,0,0
26545,other,0,0
26546,medical,0,0
26547,conditions,0,0
26548,and,0,0
26549,not,0,0
26550,taking,0,0
26551,other,0,0
26552,psychotropic,1,1
26553,medications,1,1
26554,participated,0,0
26555,(,0,0
26556,ages,0,0
26557,between,0,0
26558,3,0,0
26559,and,0,0
26560,12,0,0
26561,years,0,0
26562,",",0,0
26563,mean,0,0
26564,IQ,0,0
26565,=,0,0
26566,55,0,0
26567,),0,0
26568,.,0,0
26569,Children,0,0
26570,were,0,0
26571,grouped,0,0
26572,into,0,0
26573,trios,0,0
26574,matched,0,0
26575,by,0,0
26576,age,0,0
26577,and,0,0
26578,communication,0,1
26579,level,0,0
26580,and,0,0
26581,then,0,1
26582,randomly,0,0
26583,assigned,0,0
26584,to,0,0
26585,one,0,0
26586,of,0,0
26587,three,0,0
26588,treatment,0,0
26589,groups,0,0
26590,:,0,0
26591,biologic,1,0
26592,secretin,1,1
26593,(,0,0
26594,2,0,1
26595,CU/kg,0,1
26596,),0,0
26597,",",0,0
26598,synthetic,1,1
26599,secretin,1,1
26600,(,0,0
26601,0.4,0,1
26602,microg/kg,0,1
26603,),0,0
26604,",",0,0
26605,and,0,0
26606,placebo,1,1
26607,.,1,0
26608,Measures,0,0
26609,collected,0,0
26610,1,0,0
26611,week,0,0
26612,before,0,0
26613,and,0,0
26614,4,0,0
26615,weeks,0,0
26616,after,0,0
26617,infusion,0,1
26618,included,0,0
26619,autism,0,0
26620,symptoms,0,0
26621,",",0,0
26622,language,0,0
26623,skills,0,1
26624,",",0,0
26625,and,0,0
26626,problem,0,0
26627,behaviors,0,0
26628,",",0,0
26629,gathered,0,0
26630,from,0,0
26631,parents,0,0
26632,",",0,0
26633,teachers,0,0
26634,",",0,0
26635,and,0,0
26636,investigators,0,0
26637,",",0,0
26638,who,0,0
26639,were,0,0
26640,all,0,0
26641,blind,0,0
26642,to,0,0
26643,treatment,0,0
26644,.,0,0
26645,Two-factor,0,0
26646,",",0,0
26647,repeated-measures,0,0
26648,analyses,0,0
26649,of,0,0
26650,variance,0,0
26651,(,0,0
26652,3,0,0
26653,treatment,0,0
26654,levels,0,0
26655,by,0,0
26656,2,0,0
26657,repeated,0,0
26658,measures,0,0
26659,",",0,0
26660,pre-,0,0
26661,and,0,1
26662,postinfusion,0,0
26663,),0,1
26664,were,0,0
26665,used,0,0
26666,to,0,0
26667,examine,0,0
26668,efficacy,0,0
26669,.,0,0
26670,RESULTS,0,0
26671,Direct,0,0
26672,observation,0,1
26673,measures,0,0
26674,did,0,0
26675,not,0,0
26676,show,0,0
26677,change,0,0
26678,over,0,0
26679,time,0,0
26680,related,0,0
26681,to,0,0
26682,secretin,1,1
26683,.,1,0
26684,Parent,0,0
26685,reports,0,0
26686,showed,0,0
26687,an,0,0
26688,overall,0,0
26689,reduction,0,0
26690,of,0,0
26691,symptom,0,0
26692,severity,0,0
26693,for,0,0
26694,all,0,0
26695,treatment,0,0
26696,groups,0,0
26697,",",0,0
26698,including,0,0
26699,the,0,0
26700,placebo,1,1
26701,group,0,0
26702,.,0,0
26703,One,0,0
26704,teacher-report,0,0
26705,measure,0,0
26706,showed,0,0
26707,decreases,0,0
26708,in,0,0
26709,autism,0,0
26710,symptoms,0,0
26711,in,0,0
26712,the,0,0
26713,placebo,1,1
26714,and,0,0
26715,synthetic,1,1
26716,secretin,1,1
26717,groups,0,0
26718,.,0,0
26719,CONCLUSIONS,0,0
26720,No,0,0
26721,evidence,0,0
26722,that,0,0
26723,either,0,1
26724,biologic,1,0
26725,or,0,1
26726,synthetic,1,1
26727,secretin,1,1
26728,provided,0,0
26729,amelioration,0,0
26730,of,0,0
26731,symptoms,0,0
26732,beyond,0,0
26733,placebo,1,1
26734,was,0,0
26735,observed,0,0
26736,.,0,0
26737,This,0,0
26738,held,0,0
26739,true,0,0
26740,when,0,0
26741,children,0,0
26742,with,0,0
26743,and,0,0
26744,without,0,0
26745,gastrointestinal,0,0
26746,problems,0,0
26747,were,0,0
26748,examined,0,0
26749,separately,0,0
26750,.,0,0
26751,Trials,0,0
26752,and,0,0
26753,tribulations,0,0
26754,:,0,0
26755,current,0,0
26756,challenges,0,0
26757,in,0,0
26758,conducting,0,1
26759,clinical,1,0
26760,trials,1,0
26761,.,1,0
26762,Randomized,1,0
26763,controlled,1,0
26764,trials,1,0
26765,are,0,0
26766,the,0,0
26767,gold,0,1
26768,standard,0,1
26769,for,0,0
26770,the,0,0
26771,evaluation,0,0
26772,of,0,0
26773,new,0,0
26774,therapies,0,1
26775,and,0,0
26776,surgical,0,1
26777,procedures,0,1
26778,and,0,0
26779,as,0,0
26780,such,0,0
26781,require,0,0
26782,strict,0,0
26783,attention,0,0
26784,to,0,0
26785,study,0,0
26786,design,0,0
26787,and,0,0
26788,statistical,0,0
26789,analysis,0,0
26790,.,0,0
26791,There,0,0
26792,are,0,0
26793,",",0,0
26794,however,0,0
26795,",",0,0
26796,multiple,0,0
26797,challenges,0,0
26798,in,0,0
26799,conducting,0,1
26800,a,0,0
26801,well-designed,0,0
26802,clinical,0,0
26803,trial,0,0
26804,.,0,0
26805,This,0,0
26806,article,0,0
26807,describes,0,0
26808,the,0,0
26809,difficulties,0,0
26810,encountered,0,0
26811,at,0,0
26812,a,0,0
26813,single,0,1
26814,institution,0,0
26815,participating,0,0
26816,in,0,0
26817,a,0,0
26818,multicenter,0,0
26819,drug,0,1
26820,study,0,0
26821,and,0,0
26822,reviews,0,0
26823,the,0,0
26824,challenges,0,0
26825,involved,0,0
26826,in,0,0
26827,developing,0,0
26828,a,0,0
26829,high-quality,0,0
26830,randomized,0,0
26831,controlled,0,0
26832,study,0,0
26833,.,0,0
26834,The,0,0
26835,efficacy,0,0
26836,of,0,0
26837,intramammary,1,0
26838,tilmicosin,1,1
26839,at,0,0
26840,drying-off,0,1
26841,",",0,0
26842,and,0,0
26843,other,0,0
26844,risk,0,0
26845,factors,0,0
26846,for,0,0
26847,the,0,0
26848,prevention,0,0
26849,of,0,0
26850,new,0,0
26851,intramammary,0,0
26852,infections,0,0
26853,during,0,0
26854,the,0,0
26855,dry,0,0
26856,period,0,0
26857,.,0,0
26858,The,0,0
26859,objective,0,0
26860,of,0,0
26861,this,0,0
26862,study,0,0
26863,was,0,0
26864,to,0,0
26865,compare,0,0
26866,the,0,0
26867,efficacy,0,0
26868,of,0,0
26869,an,0,0
26870,intramammary,1,0
26871,infusion,1,1
26872,",",1,0
26873,containing,1,1
26874,tilmicosin,1,1
26875,phosphate,1,1
26876,",",0,0
26877,to,0,0
26878,an,0,0
26879,infusion,1,1
26880,of,1,0
26881,a,1,0
26882,negative,1,0
26883,control,1,1
26884,intramammary,1,0
26885,placebo,1,1
26886,for,0,0
26887,preventing,0,0
26888,new,0,0
26889,intramammary,0,1
26890,infections,0,0
26891,(,0,0
26892,IMI,0,0
26893,),0,1
26894,during,0,0
26895,the,0,0
26896,dry,0,0
26897,period,0,0
26898,.,0,0
26899,Cows,0,0
26900,were,0,0
26901,enrolled,0,0
26902,from,0,0
26903,24,0,0
26904,dairy,0,0
26905,herds,0,0
26906,from,0,0
26907,three,0,0
26908,geographical,0,0
26909,regions,0,0
26910,of,0,0
26911,Canada,0,0
26912,.,0,0
26913,Data,0,0
26914,from,0,0
26915,248,0,0
26916,cows,0,0
26917,and,0,0
26918,938,0,0
26919,bacteriologically,0,0
26920,negative,0,0
26921,quarters,0,0
26922,at,0,0
26923,drying-off,0,1
26924,are,0,0
26925,summarized,0,0
26926,.,0,0
26927,Overall,0,0
26928,",",0,0
26929,the,0,0
26930,rate,0,0
26931,of,0,0
26932,new,0,0
26933,IMI,0,0
26934,during,0,0
26935,the,0,0
26936,dry,0,0
26937,period,0,0
26938,was,0,0
26939,16.7,0,0
26940,%,0,0
26941,of,0,0
26942,quarters,0,0
26943,.,0,0
26944,The,0,0
26945,new,0,0
26946,infection,0,0
26947,rates,0,0
26948,for,0,0
26949,quarters,0,0
26950,that,0,0
26951,received,0,0
26952,intramammary,1,0
26953,tilmicosin,1,1
26954,compared,0,0
26955,with,0,0
26956,the,0,0
26957,intramammary,1,0
26958,placebo,1,1
26959,were,0,0
26960,14.4,0,0
26961,and,0,0
26962,19.4,0,0
26963,%,0,0
26964,",",0,0
26965,respectively,0,0
26966,.,0,0
26967,The,0,0
26968,majority,0,0
26969,of,0,0
26970,new,0,0
26971,IMI,0,0
26972,was,0,0
26973,caused,0,0
26974,by,0,0
26975,coagulase-negative,0,0
26976,staphylococci,0,1
26977,(,0,0
26978,49,0,0
26979,%,0,0
26980,),0,0
26981,and,0,0
26982,environmental,0,1
26983,streptococcal,0,1
26984,organisms,0,0
26985,(,0,0
26986,26.8,0,0
26987,%,0,0
26988,),0,0
26989,.,0,0
26990,The,0,0
26991,probability,0,0
26992,for,0,0
26993,quarters,0,0
26994,to,0,0
26995,develop,0,0
26996,new,0,0
26997,IMI,0,0
26998,in,0,0
26999,the,0,0
27000,dry,0,0
27001,period,0,0
27002,was,0,0
27003,significantly,0,0
27004,increased,0,0
27005,when,0,0
27006,cows,0,0
27007,had,0,0
27008,higher,0,0
27009,milk,0,1
27010,production,0,0
27011,before,0,1
27012,drying-off,0,1
27013,(,0,0
27014,P,0,0
27015,=,0,0
27016,0.04,0,0
27017,),0,0
27018,",",0,0
27019,when,0,0
27020,cows,0,0
27021,had,0,0
27022,longer,0,0
27023,dry,0,0
27024,periods,0,0
27025,(,0,0
27026,P,0,0
27027,=,0,0
27028,0.02,0,0
27029,),0,0
27030,",",0,0
27031,and,0,0
27032,when,0,0
27033,dry,0,0
27034,cows,0,0
27035,were,0,0
27036,housed,0,1
27037,in,0,0
27038,tie-stall,0,0
27039,barns,0,0
27040,(,0,0
27041,P,0,0
27042,=,0,0
27043,0.002,0,0
27044,),0,0
27045,.,0,0
27046,Higher,0,0
27047,parity,0,0
27048,cows,0,0
27049,and,0,0
27050,those,0,0
27051,that,0,0
27052,had,0,0
27053,a,0,0
27054,linear,0,0
27055,score,0,0
27056,somatic,0,0
27057,cell,0,0
27058,count,0,0
27059,(,0,1
27060,SCC,0,0
27061,),0,1
27062,above,0,0
27063,4,0,0
27064,on,0,0
27065,the,0,0
27066,last,0,0
27067,DHI,0,0
27068,test,0,0
27069,were,0,0
27070,also,0,0
27071,at,0,0
27072,increased,0,0
27073,risk,0,0
27074,for,0,0
27075,new,0,0
27076,IMI,0,0
27077,(,0,0
27078,P,0,0
27079,<,0,0
27080,0.10,0,0
27081,),0,0
27082,.,0,0
27083,Administration,0,0
27084,of,0,0
27085,intramammary,1,0
27086,tilmicosin,1,1
27087,appears,0,0
27088,to,0,0
27089,be,0,0
27090,an,0,0
27091,efficacious,0,0
27092,therapy,0,1
27093,for,0,0
27094,prevention,0,0
27095,of,0,0
27096,new,0,0
27097,IMI,0,0
27098,;,0,0
27099,however,0,0
27100,",",0,0
27101,there,0,0
27102,is,0,0
27103,currently,0,0
27104,no,0,0
27105,approved,0,0
27106,intramammary,0,0
27107,formulation,0,1
27108,of,0,0
27109,this,0,0
27110,product,0,0
27111,available,0,0
27112,.,0,0
27113,Use,0,0
27114,of,0,0
27115,blanket,0,1
27116,dry,0,0
27117,cow,0,1
27118,antibiotic,0,1
27119,therapy,0,1
27120,compared,0,0
27121,to,0,0
27122,selective,0,0
27123,dry,0,0
27124,cow,0,1
27125,therapy,0,1
27126,",",0,0
27127,as,0,0
27128,well,0,0
27129,as,0,0
27130,the,0,0
27131,importance,0,0
27132,of,0,0
27133,identifying,0,0
27134,risk,0,0
27135,factors,0,0
27136,and,0,0
27137,managing,0,0
27138,the,0,0
27139,environment,0,0
27140,of,0,0
27141,dry,0,0
27142,cows,0,0
27143,are,0,0
27144,discussed,0,0
27145,.,0,0
27146,Anabolic,1,0
27147,steroids,1,1
27148,in,0,0
27149,athelics,0,0
27150,:,0,0
27151,crossover,0,0
27152,double-blind,0,0
27153,trial,0,0
27154,on,0,0
27155,weightlifters,0,1
27156,.,0,0
27157,Thirteen,0,0
27158,experienced,0,0
27159,male,0,0
27160,weightlifters,0,1
27161,taking,0,0
27162,high-protein,0,1
27163,diets,0,1
27164,and,0,0
27165,regular,0,1
27166,exercise,0,1
27167,took,0,0
27168,part,0,0
27169,in,0,0
27170,a,0,0
27171,double-blind,0,0
27172,crossover,0,0
27173,trial,0,0
27174,of,0,0
27175,methandienone,1,1
27176,10,0,0
27177,or,0,0
27178,25,0,0
27179,mg/day,0,1
27180,to,0,0
27181,seeif,0,0
27182,the,0,0
27183,drug,0,0
27184,improved,0,0
27185,athletic,0,0
27186,performance,0,0
27187,.,0,0
27188,Their,0,0
27189,improvemments,0,0
27190,were,0,0
27191,significantly,0,0
27192,greater,0,0
27193,on,0,0
27194,methandienone,1,1
27195,than,0,0
27196,on,0,0
27197,placebo,1,1
27198,;,1,0
27199,their,0,0
27200,body,0,0
27201,weights,0,0
27202,rose,0,0
27203,(,0,0
27204,though,0,0
27205,this,0,0
27206,seemed,0,0
27207,to,0,0
27208,be,0,0
27209,associated,0,0
27210,with,0,0
27211,water,0,1
27212,retention,0,0
27213,),0,1
27214,;,0,0
27215,and,0,0
27216,systolic,0,0
27217,blood,0,0
27218,pressure,0,0
27219,rose,0,0
27220,significantly,0,0
27221,.,0,0
27222,Methandienone,1,1
27223,caused,0,0
27224,many,0,0
27225,side,0,0
27226,effects,0,0
27227,",",0,0
27228,and,0,0
27229,three,0,0
27230,men,0,0
27231,had,0,0
27232,to,0,0
27233,withdraw,0,0
27234,because,0,0
27235,of,0,0
27236,them,0,0
27237,.,0,0
27238,All,0,0
27239,side,0,0
27240,effects,0,0
27241,disappeared,0,0
27242,after,0,0
27243,the,0,0
27244,drug,0,0
27245,was,0,0
27246,stopped,0,0
27247,.,0,0
27248,Anabolic,1,0
27249,steroids,1,1
27250,are,0,0
27251,effective,0,0
27252,only,0,0
27253,when,0,0
27254,given,0,0
27255,combination,0,1
27256,with,0,0
27257,exercise,0,1
27258,and,0,0
27259,high-protein,0,1
27260,diet,0,1
27261,.,0,0
27262,We,0,0
27263,deprecate,0,0
27264,their,0,0
27265,use,0,0
27266,in,0,0
27267,athletics,0,0
27268,but,0,0
27269,can,0,0
27270,suggest,0,0
27271,no,0,0
27272,way,0,0
27273,of,0,0
27274,stopping,0,0
27275,it,0,0
27276,.,0,0
27277,A,0,0
27278,comparison,0,0
27279,of,0,0
27280,the,0,0
27281,upper,1,0
27282,lip,1,1
27283,bite,1,0
27284,test,1,1
27285,(,1,0
27286,a,1,0
27287,simple,1,1
27288,new,1,0
27289,technique,1,1
27290,),1,0
27291,with,1,0
27292,modified,1,0
27293,Mallampati,1,0
27294,classification,1,0
27295,in,0,0
27296,predicting,0,0
27297,difficulty,0,0
27298,in,0,0
27299,endotracheal,0,1
27300,intubation,0,1
27301,:,0,0
27302,a,0,0
27303,prospective,0,0
27304,blinded,0,0
27305,study,0,0
27306,.,0,0
27307,We,0,0
27308,explored,0,0
27309,the,0,0
27310,possibility,0,0
27311,that,0,0
27312,a,0,0
27313,simple,0,1
27314,and,0,0
27315,single,0,1
27316,test,0,0
27317,could,0,0
27318,replace,0,0
27319,the,0,0
27320,modified,0,0
27321,Mallampati,0,0
27322,score,0,0
27323,for,0,0
27324,either,0,0
27325,a,0,0
27326,difficult,0,0
27327,or,0,1
27328,an,0,0
27329,unaccomplished,0,0
27330,tracheal,0,1
27331,intubation,0,1
27332,in,0,0
27333,an,0,0
27334,impending,0,0
27335,hypoxic,0,0
27336,patient,0,0
27337,.,0,0
27338,Three,0,0
27339,hundred,0,0
27340,adult,0,0
27341,patients,0,0
27342,were,0,0
27343,enrolled,0,0
27344,in,0,0
27345,this,0,0
27346,study,0,0
27347,.,0,0
27348,They,0,0
27349,were,0,0
27350,subjected,0,0
27351,to,0,0
27352,the,0,0
27353,following,0,0
27354,assessments,0,0
27355,:,0,0
27356,1,0,0
27357,),0,0
27358,oropharyngeal,1,0
27359,class,1,0
27360,according,1,0
27361,to,1,0
27362,the,1,0
27363,modified,1,0
27364,Mallampati,1,0
27365,criteria,1,0
27366,;,1,0
27367,2,0,0
27368,),0,0
27369,the,1,0
27370,new,1,0
27371,",",1,0
27372,upper,1,0
27373,lip,1,1
27374,bite,1,0
27375,criteria-class,1,0
27376,I,1,0
27377,=,1,0
27378,lower,1,0
27379,incisors,1,0
27380,can,1,0
27381,bite,1,0
27382,the,1,0
27383,upper,1,0
27384,lip,1,0
27385,above,1,0
27386,the,1,0
27387,vermilion,1,0
27388,line,1,0
27389,",",1,0
27390,class,1,0
27391,II,1,0
27392,=,1,0
27393,lower,1,0
27394,incisors,1,0
27395,can,1,0
27396,bite,1,0
27397,the,1,0
27398,upper,1,0
27399,lip,1,0
27400,below,1,0
27401,the,1,0
27402,vermilion,1,0
27403,line,1,0
27404,",",1,0
27405,and,1,0
27406,class,1,0
27407,III,1,0
27408,=,1,0
27409,lower,1,0
27410,incisors,1,0
27411,can,1,0
27412,not,1,0
27413,bite,1,0
27414,the,1,0
27415,upper,1,0
27416,lip,1,1
27417,;,1,0
27418,and,1,0
27419,3,0,0
27420,),0,1
27421,laryngeal,1,0
27422,view,1,0
27423,grading,1,0
27424,according,1,0
27425,to,1,0
27426,Cormack,1,0
27427,'s,1,0
27428,criteria,1,0
27429,.,1,0
27430,The,0,0
27431,incidence,0,0
27432,of,0,0
27433,difficult,0,0
27434,intubation,0,1
27435,was,0,0
27436,5.7,0,0
27437,%,0,0
27438,.,0,0
27439,The,1,0
27440,upper,1,0
27441,lip,1,1
27442,bite,1,0
27443,test,1,0
27444,showed,0,0
27445,significantly,0,0
27446,higher,0,0
27447,specificity,0,0
27448,and,0,0
27449,accuracy,0,0
27450,than,0,0
27451,the,0,0
27452,modified,1,0
27453,Mallampati,1,0
27454,test,1,1
27455,(,0,0
27456,P,0,0
27457,<,0,0
27458,0.001,0,0
27459,),0,0
27460,.,0,0
27461,Comparisons,0,0
27462,of,0,0
27463,sensitivity,0,0
27464,",",0,0
27465,positive,0,0
27466,and,0,0
27467,negative,0,0
27468,predictive,0,0
27469,values,0,0
27470,",",0,0
27471,between,0,0
27472,the,0,0
27473,two,0,0
27474,tests,0,0
27475,",",0,0
27476,however,0,0
27477,",",0,0
27478,did,0,0
27479,not,0,0
27480,reveal,0,0
27481,any,0,0
27482,significant,0,0
27483,differences,0,0
27484,(,0,0
27485,P,0,0
27486,>,0,0
27487,0.05,0,0
27488,),0,0
27489,.,0,0
27490,In,0,0
27491,conclusion,0,0
27492,",",0,0
27493,the,0,0
27494,upper,0,0
27495,lip,0,1
27496,bite,0,0
27497,test,0,0
27498,is,0,0
27499,an,0,0
27500,acceptable,0,0
27501,option,0,0
27502,for,0,0
27503,predicting,0,0
27504,difficult,0,0
27505,intubation,0,1
27506,as,0,0
27507,a,0,0
27508,simple,0,0
27509,",",0,0
27510,single,0,0
27511,test,0,0
27512,.,0,0
27513,Acute,1,0
27514,intravenous,1,1
27515,L-arginine,1,1
27516,infusion,1,1
27517,decreases,0,0
27518,endothelin-1,0,0
27519,levels,0,0
27520,and,0,0
27521,improves,0,0
27522,endothelial,0,0
27523,function,0,0
27524,in,0,0
27525,patients,0,0
27526,with,0,0
27527,angina,0,0
27528,pectoris,0,0
27529,and,0,0
27530,normal,0,0
27531,coronary,0,0
27532,arteriograms,0,0
27533,:,0,0
27534,correlation,0,0
27535,with,0,0
27536,asymmetric,0,1
27537,dimethylarginine,0,0
27538,levels,0,0
27539,.,0,0
27540,BACKGROUND,0,0
27541,We,0,0
27542,tested,0,0
27543,the,0,0
27544,hypothesis,0,0
27545,that,0,0
27546,asymmetric,1,1
27547,dimethylarginine,1,0
27548,(,0,1
27549,ADMA,0,1
27550,),0,1
27551,levels,0,0
27552,could,0,0
27553,be,0,0
27554,elevated,0,0
27555,and,0,0
27556,influence,0,0
27557,endothelin-1,1,1
27558,and,1,0
27559,nitric,1,1
27560,oxide,1,1
27561,release,0,1
27562,and,0,0
27563,action,0,0
27564,in,0,0
27565,patients,0,0
27566,with,0,0
27567,cardiac,0,0
27568,syndrome,0,0
27569,X,0,1
27570,(,0,1
27571,CSX,0,0
27572,),0,0
27573,.,0,0
27574,In,0,0
27575,addition,0,0
27576,",",0,0
27577,we,0,0
27578,evaluated,0,0
27579,whether,0,0
27580,an,0,0
27581,intravenous,0,1
27582,infusion,0,1
27583,of,0,0
27584,L-arginine,1,1
27585,would,0,0
27586,improve,0,0
27587,endothelial,0,0
27588,function,0,0
27589,in,0,0
27590,these,0,0
27591,subjects,0,0
27592,.,0,0
27593,METHODS,0,0
27594,AND,0,0
27595,RESULTS,0,0
27596,Nine,0,1
27597,patients,0,0
27598,with,0,0
27599,CSX,0,0
27600,and,0,0
27601,14,0,0
27602,control,0,0
27603,subjects,0,0
27604,underwent,0,0
27605,a,0,0
27606,continuous,0,1
27607,infusion,0,1
27608,of,0,0
27609,L-arginine,1,1
27610,(,1,0
27611,0.125,1,1
27612,g/min,1,0
27613,),1,1
27614,or,1,1
27615,saline,1,1
27616,for,0,0
27617,120,0,0
27618,minutes,0,0
27619,.,0,0
27620,Sixty,0,0
27621,minutes,0,0
27622,after,0,0
27623,L-arginine,1,1
27624,or,1,1
27625,saline,1,1
27626,infusions,1,1
27627,",",0,0
27628,an,0,0
27629,intravenous,0,1
27630,insulin,1,1
27631,bolus,0,1
27632,(,0,0
27633,0.1,0,1
27634,U/kg,0,1
27635,),0,0
27636,combined,0,1
27637,with,0,0
27638,a,0,0
27639,euglycemic,1,1
27640,clamp,1,1
27641,was,0,0
27642,performed,0,0
27643,.,0,0
27644,Basal,0,0
27645,ADMA,0,1
27646,and,0,0
27647,endothelin-1,0,0
27648,levels,0,0
27649,were,0,0
27650,higher,0,0
27651,in,0,0
27652,patients,0,0
27653,with,0,0
27654,CSX,0,0
27655,than,0,0
27656,in,0,0
27657,controls,0,0
27658,.,0,0
27659,At,0,0
27660,the,0,0
27661,end,0,0
27662,of,0,0
27663,the,0,0
27664,first,0,0
27665,hour,0,0
27666,of,0,0
27667,infusion,0,0
27668,",",0,0
27669,compared,0,0
27670,with,0,0
27671,saline,1,1
27672,",",1,0
27673,L-arginine,1,1
27674,infusion,0,1
27675,increased,0,0
27676,basal,0,1
27677,forearm,0,1
27678,blood,0,0
27679,flow,0,0
27680,",",0,0
27681,nitrite,0,1
27682,and,0,0
27683,nitrate,0,1
27684,(,0,1
27685,NOx,0,0
27686,),0,1
27687,",",0,0
27688,and,0,0
27689,forearm,0,1
27690,cGMP,0,1
27691,release,0,0
27692,and,0,0
27693,decreased,0,0
27694,endothelin-1,0,0
27695,.,0,0
27696,After,0,0
27697,insulin,0,0
27698,bolus,0,1
27699,",",0,0
27700,during,0,0
27701,saline,0,1
27702,",",0,0
27703,insulin-induced,0,0
27704,NOx,0,0
27705,",",0,0
27706,endothelin-1,0,0
27707,",",0,0
27708,and,0,0
27709,forearm,0,1
27710,cGMP,0,1
27711,release,0,0
27712,was,0,0
27713,almost,0,0
27714,abolished,0,0
27715,.,0,0
27716,Conversely,0,0
27717,",",0,0
27718,L-arginine,0,1
27719,restored,0,0
27720,a,0,0
27721,physiological,0,0
27722,profile,0,0
27723,of,0,0
27724,all,0,0
27725,endothelial,0,0
27726,variables,0,0
27727,compared,0,0
27728,with,0,0
27729,control,0,0
27730,subjects,0,0
27731,.,0,0
27732,In,0,0
27733,control,0,0
27734,subjects,0,0
27735,",",0,0
27736,compared,0,0
27737,with,0,0
27738,saline,1,1
27739,infusion,1,1
27740,",",1,0
27741,L-arginine,1,1
27742,infusion,1,1
27743,did,0,0
27744,not,0,0
27745,modify,0,0
27746,any,0,0
27747,parameter,0,0
27748,.,0,0
27749,ADMA,0,0
27750,levels,0,0
27751,were,0,0
27752,positively,0,0
27753,correlated,0,0
27754,with,0,0
27755,basal,0,0
27756,endothelin-1,0,0
27757,levels,0,0
27758,and,0,0
27759,negatively,0,0
27760,correlated,0,0
27761,with,0,0
27762,insulin-induced,0,0
27763,incremental,0,0
27764,levels,0,0
27765,of,0,0
27766,NOx,0,0
27767,and,0,0
27768,forearm,0,1
27769,cGMP,0,1
27770,release,0,0
27771,.,0,0
27772,CONCLUSIONS,0,0
27773,Plasma,0,0
27774,ADMA,0,1
27775,levels,0,0
27776,are,0,0
27777,increased,0,0
27778,in,0,0
27779,patients,0,0
27780,with,0,0
27781,CSX,0,0
27782,",",0,0
27783,and,0,0
27784,they,0,0
27785,are,0,0
27786,correlated,0,0
27787,with,0,0
27788,increases,0,0
27789,in,0,0
27790,endothelin-1,0,0
27791,and,0,0
27792,reductions,0,0
27793,in,0,0
27794,insulin-induced,0,0
27795,increments,0,0
27796,in,0,0
27797,plasma,0,0
27798,NOx,0,0
27799,and,0,0
27800,cGMP,0,1
27801,",",0,0
27802,effects,0,0
27803,that,0,0
27804,are,0,0
27805,reversed,0,0
27806,by,0,0
27807,intravenous,0,1
27808,L-arginine,0,1
27809,.,0,0
27810,These,0,0
27811,data,0,0
27812,suggest,0,0
27813,that,0,0
27814,increased,0,0
27815,ADMA,0,1
27816,levels,0,0
27817,play,0,0
27818,a,0,0
27819,role,0,0
27820,in,0,0
27821,the,0,0
27822,abnormal,0,0
27823,vascular,0,0
27824,reactivity,0,0
27825,that,0,0
27826,is,0,0
27827,observed,0,0
27828,in,0,0
27829,patients,0,0
27830,with,0,0
27831,CSX,0,0
27832,.,0,0
27833,Topical,0,0
27834,imiquimod,1,1
27835,5,1,0
27836,%,1,0
27837,cream,1,1
27838,as,0,0
27839,an,0,0
27840,effective,0,0
27841,treatment,0,0
27842,for,0,0
27843,external,0,1
27844,genital,0,0
27845,and,0,0
27846,perianal,0,0
27847,warts,0,0
27848,in,0,0
27849,different,0,0
27850,patient,0,0
27851,populations,0,0
27852,.,0,0
27853,BACKGROUND,0,0
27854,Genital,0,0
27855,infection,0,0
27856,with,0,0
27857,human,0,1
27858,papillomavirus,0,1
27859,",",0,0
27860,the,0,0
27861,cause,0,0
27862,of,0,0
27863,genital,0,0
27864,warts,0,0
27865,",",0,0
27866,is,0,0
27867,one,0,0
27868,of,0,0
27869,the,0,0
27870,most,0,0
27871,common,0,0
27872,sexually,0,0
27873,transmitted,0,0
27874,diseases,0,0
27875,.,0,0
27876,GOAL,0,0
27877,The,0,0
27878,aim,0,0
27879,of,0,0
27880,this,0,0
27881,analysis,0,0
27882,was,0,0
27883,to,0,0
27884,determine,0,0
27885,whether,0,0
27886,patients,0,0
27887,',0,0
27888,demographic,0,0
27889,variables,0,0
27890,affect,0,0
27891,the,0,0
27892,efficacy,0,0
27893,of,0,0
27894,imiquimod,1,1
27895,5,1,1
27896,%,1,0
27897,cream,1,1
27898,versus,0,1
27899,vehicle,1,1
27900,cream,1,1
27901,for,0,0
27902,the,0,0
27903,treatment,0,0
27904,of,0,0
27905,external,0,1
27906,genital,0,0
27907,and,0,0
27908,perianal,0,0
27909,warts,0,0
27910,.,0,0
27911,STUDY,0,0
27912,DESIGN,0,0
27913,Male,0,1
27914,and,0,0
27915,female,0,0
27916,immunocompetent,0,0
27917,patients,0,0
27918,applied,0,0
27919,imiquimod,1,1
27920,5,1,1
27921,%,1,0
27922,cream,1,1
27923,topically,1,1
27924,to,0,0
27925,external,0,1
27926,genital,0,0
27927,warts,0,0
27928,3,0,0
27929,times,0,0
27930,a,0,0
27931,week,0,0
27932,until,0,0
27933,wart,0,0
27934,clearance,0,0
27935,or,0,1
27936,for,0,0
27937,up,0,0
27938,to,0,0
27939,16,0,0
27940,weeks,0,0
27941,.,0,0
27942,RESULTS,0,0
27943,As,0,0
27944,previously,0,0
27945,published,0,0
27946,",",0,0
27947,the,0,0
27948,intent-to-treat,0,0
27949,(,0,1
27950,ITT,0,1
27951,),0,1
27952,clearance,0,0
27953,rate,0,0
27954,was,0,0
27955,50,0,1
27956,%,0,0
27957,(,0,0
27958,54/109,0,0
27959,),0,0
27960,in,0,0
27961,the,0,0
27962,imiquimod-treated,1,1
27963,group,0,0
27964,and,0,0
27965,11,0,0
27966,%,0,0
27967,(,0,0
27968,11/100,0,0
27969,),0,0
27970,in,0,0
27971,the,0,0
27972,vehicle-treated,1,1
27973,group,0,0
27974,(,0,0
27975,P,0,0
27976,<,0,0
27977,0.0001,0,0
27978,),0,0
27979,.,0,0
27980,The,0,0
27981,ITT,0,0
27982,clearance,0,0
27983,rate,0,0
27984,in,0,0
27985,the,0,0
27986,imiquimod-treated,1,0
27987,group,0,0
27988,was,0,0
27989,higher,0,0
27990,in,0,0
27991,females,0,0
27992,(,0,0
27993,72,0,0
27994,%,0,0
27995,),0,0
27996,than,0,0
27997,in,0,0
27998,males,0,0
27999,(,0,0
28000,33,0,0
28001,%,0,0
28002,),0,0
28003,.,0,0
28004,We,0,0
28005,have,0,0
28006,examined,0,0
28007,the,0,0
28008,clearance,0,0
28009,rates,0,0
28010,for,0,0
28011,subgroups,0,0
28012,based,0,0
28013,on,0,0
28014,variables,0,0
28015,of,0,0
28016,gender,0,0
28017,",",0,0
28018,baseline,0,0
28019,wart,0,0
28020,area,0,0
28021,",",0,0
28022,duration,0,0
28023,of,0,0
28024,current,0,0
28025,outbreak,0,0
28026,of,0,0
28027,warts,0,0
28028,",",0,0
28029,previous,0,0
28030,wart,0,0
28031,treatment,0,0
28032,",",0,0
28033,and,0,0
28034,tobacco,0,1
28035,use,0,0
28036,.,0,0
28037,For,0,0
28038,each,0,0
28039,of,0,0
28040,these,0,0
28041,subgroups,0,0
28042,",",0,0
28043,imiquimod,1,1
28044,was,0,0
28045,statistically,0,0
28046,more,0,0
28047,effective,0,0
28048,than,0,0
28049,vehicle,1,1
28050,in,0,0
28051,eradicating,0,0
28052,external,0,1
28053,genital,0,0
28054,and,0,0
28055,perianal,0,0
28056,warts,0,0
28057,.,0,0
28058,CONCLUSION,0,0
28059,Imiquimod,1,1
28060,5,1,1
28061,%,1,0
28062,cream,1,1
28063,is,0,0
28064,an,0,0
28065,effective,0,0
28066,treatment,0,0
28067,for,0,0
28068,external,0,1
28069,genital,0,0
28070,and,0,0
28071,perianal,0,0
28072,warts,0,0
28073,and,0,0
28074,provides,0,0
28075,a,0,0
28076,significant,0,0
28077,benefit,0,0
28078,in,0,0
28079,comparison,0,0
28080,with,0,0
28081,vehicle,1,1
28082,cream,1,1
28083,",",0,0
28084,independent,0,0
28085,of,0,0
28086,gender,0,0
28087,",",0,0
28088,initial,0,0
28089,wart,0,0
28090,size,0,0
28091,",",0,0
28092,duration,0,0
28093,of,0,0
28094,current,0,0
28095,outbreak,0,0
28096,of,0,0
28097,warts,0,0
28098,",",0,0
28099,previous,0,0
28100,wart,0,0
28101,treatment,0,0
28102,",",0,0
28103,or,0,1
28104,tobacco,0,1
28105,use,0,0
28106,.,0,0
28107,The,0,0
28108,development,0,0
28109,and,0,0
28110,evaluation,0,0
28111,of,0,0
28112,a,0,0
28113,computer-based,1,1
28114,program,1,1
28115,to,0,0
28116,test,0,0
28117,and,0,0
28118,to,0,0
28119,teach,0,1
28120,the,0,0
28121,recognition,0,0
28122,of,0,0
28123,facial,0,0
28124,affect,0,0
28125,.,0,0
28126,Autism,0,0
28127,is,0,0
28128,a,0,0
28129,chronic,0,0
28130,pervasive,0,0
28131,neurodevelopmental,0,0
28132,disorder,0,0
28133,characterized,0,0
28134,by,0,0
28135,the,0,0
28136,early,0,0
28137,onset,0,0
28138,of,0,0
28139,social,0,0
28140,and,0,0
28141,communicative,0,0
28142,impairments,0,0
28143,as,0,0
28144,well,0,0
28145,as,0,0
28146,restricted,0,0
28147,",",0,0
28148,ritualized,0,0
28149,",",0,0
28150,stereotypic,0,0
28151,behavior,0,0
28152,.,0,0
28153,The,0,0
28154,endophenotype,0,0
28155,of,0,0
28156,autism,0,0
28157,includes,0,0
28158,neuropsychological,0,0
28159,deficits,0,0
28160,",",0,0
28161,for,0,0
28162,instance,0,0
28163,a,0,0
28164,lack,0,0
28165,of,0,0
28166,Theory,0,1
28167,of,0,0
28168,Mind,0,1
28169,and,0,0
28170,problems,0,0
28171,recognizing,0,0
28172,facial,0,0
28173,affect,0,0
28174,.,0,0
28175,In,0,0
28176,this,0,0
28177,study,0,0
28178,",",0,0
28179,we,0,0
28180,report,0,0
28181,the,0,0
28182,development,0,0
28183,and,0,0
28184,evaluation,0,0
28185,of,0,0
28186,a,0,0
28187,computer-based,1,1
28188,program,1,1
28189,to,0,0
28190,teach,0,1
28191,and,0,0
28192,test,0,0
28193,the,0,0
28194,ability,0,0
28195,to,0,0
28196,identify,0,0
28197,basic,0,0
28198,facially,0,0
28199,expressed,0,0
28200,emotions,0,0
28201,.,0,0
28202,10,0,0
28203,adolescent,0,0
28204,or,0,1
28205,adult,0,0
28206,subjects,0,0
28207,with,0,0
28208,high-functioning,0,0
28209,autism,0,0
28210,or,0,1
28211,Asperger-syndrome,0,0
28212,were,0,0
28213,included,0,0
28214,in,0,0
28215,the,0,0
28216,investigation,0,0
28217,.,0,0
28218,A,0,0
28219,priori,0,0
28220,the,0,0
28221,facial,0,1
28222,affect,0,0
28223,recognition,0,0
28224,test,0,0
28225,had,0,0
28226,shown,0,0
28227,good,0,0
28228,psychometric,0,0
28229,properties,0,0
28230,in,0,0
28231,a,0,0
28232,normative,0,0
28233,sample,0,0
28234,(,0,1
28235,internal,0,1
28236,consistency,0,0
28237,:,0,0
28238,rtt=.91-.95,0,0
28239,;,0,0
28240,retest,0,0
28241,reliability,0,0
28242,:,0,1
28243,rtt=.89-.92,0,0
28244,),0,0
28245,.,0,0
28246,In,0,0
28247,a,0,0
28248,prepost,0,1
28249,design,0,0
28250,",",0,0
28251,one,0,0
28252,half,0,0
28253,of,0,0
28254,the,0,0
28255,sample,0,0
28256,was,0,0
28257,randomly,0,0
28258,assigned,0,0
28259,to,0,0
28260,receive,0,1
28261,computer,1,1
28262,treatment,1,0
28263,while,0,0
28264,the,0,0
28265,other,0,0
28266,half,0,0
28267,of,0,0
28268,the,0,0
28269,sample,0,0
28270,served,0,0
28271,as,0,0
28272,control,0,0
28273,group,0,0
28274,.,0,0
28275,The,0,0
28276,training,0,1
28277,was,0,0
28278,conducted,0,0
28279,for,0,0
28280,five,0,0
28281,weeks,0,0
28282,",",0,0
28283,consisting,0,0
28284,of,0,0
28285,two,0,0
28286,hours,0,0
28287,training,0,1
28288,a,0,0
28289,week,0,0
28290,.,0,0
28291,The,0,0
28292,trained,0,1
28293,individuals,0,0
28294,improved,0,0
28295,significantly,0,0
28296,on,0,0
28297,the,0,0
28298,affect,0,0
28299,recognition,0,0
28300,task,0,1
28301,",",0,0
28302,but,0,0
28303,not,0,0
28304,on,0,0
28305,any,0,0
28306,other,0,0
28307,measure,0,0
28308,.,0,0
28309,Results,0,0
28310,support,0,0
28311,the,0,0
28312,usefulness,0,0
28313,of,0,0
28314,the,0,0
28315,program,0,1
28316,to,0,0
28317,teach,0,1
28318,the,0,0
28319,detection,0,0
28320,of,0,0
28321,facial,0,0
28322,affect,0,0
28323,.,0,0
28324,However,0,0
28325,",",0,0
28326,the,0,0
28327,improvement,0,0
28328,found,0,0
28329,is,0,0
28330,limited,0,0
28331,to,0,0
28332,a,0,0
28333,circumscribed,0,1
28334,area,0,0
28335,of,0,0
28336,social-communicative,0,1
28337,function,0,0
28338,and,0,0
28339,generalization,0,0
28340,is,0,0
28341,not,0,0
28342,ensured,0,0
28343,.,0,0
28344,Bioavailability,0,0
28345,of,0,0
28346,omega-3,1,1
28347,essential,1,0
28348,fatty,1,1
28349,acids,1,1
28350,from,0,0
28351,perilla,1,1
28352,seed,1,1
28353,oil,1,1
28354,.,1,0
28355,Increased,0,0
28356,dietary,0,0
28357,intake,0,0
28358,of,0,0
28359,fish,1,1
28360,oil,1,1
28361,omega-3,1,1
28362,fatty,1,1
28363,acids,1,1
28364,",",0,0
28365,eicosapentanoic,0,1
28366,acid,0,1
28367,and,0,0
28368,docosohexanoic,0,1
28369,acid,0,1
28370,",",0,0
28371,and,0,0
28372,their,0,0
28373,precursor,0,0
28374,",",0,0
28375,alpha-linolenic,1,1
28376,acid,1,1
28377,(,0,1
28378,ALA,0,1
28379,),0,0
28380,",",0,0
28381,is,0,0
28382,associated,0,0
28383,with,0,0
28384,various,0,0
28385,health,0,0
28386,benefits,0,0
28387,.,0,0
28388,Enteric-coating,0,1
28389,(,0,0
28390,Entrox,0,1
28391,),0,0
28392,",",0,0
28393,which,0,0
28394,improves,0,0
28395,stability,0,0
28396,of,0,0
28397,omega-3,0,1
28398,capsules,0,1
28399,",",0,0
28400,has,0,0
28401,been,0,0
28402,shown,0,0
28403,to,0,0
28404,facilitate,0,0
28405,fish,0,1
28406,oil,0,1
28407,absorption,0,0
28408,after,0,0
28409,chronic,0,0
28410,treatment,0,0
28411,.,0,0
28412,To,0,0
28413,assess,0,0
28414,the,0,0
28415,effect,0,0
28416,of,0,0
28417,Entrox,0,1
28418,coating,0,1
28419,on,0,0
28420,the,0,0
28421,short-term,0,0
28422,bioavailability,0,0
28423,of,0,0
28424,ALA,1,0
28425,administered,0,0
28426,in,0,0
28427,the,0,0
28428,form,0,0
28429,of,0,0
28430,ALA-rich,0,1
28431,Perilla,0,1
28432,seed,0,1
28433,oil,0,1
28434,",",0,0
28435,12,0,0
28436,healthy,0,0
28437,subjects,0,0
28438,(,0,0
28439,6,0,0
28440,males,0,0
28441,and,0,0
28442,6,0,0
28443,females,0,0
28444,),0,0
28445,received,0,0
28446,in,0,0
28447,a,0,0
28448,random,0,0
28449,order,0,0
28450,Entrox-coated,1,1
28451,and,1,0
28452,non-coated,1,1
28453,ALA,1,1
28454,formulations,1,1
28455,",",0,0
28456,each,0,0
28457,as,0,0
28458,a,0,0
28459,single,0,0
28460,6g,0,1
28461,dose,0,0
28462,separated,0,0
28463,by,0,0
28464,a,0,0
28465,3-week,0,1
28466,washout,0,1
28467,period,0,0
28468,.,0,0
28469,Measurements,0,0
28470,of,0,0
28471,plasma,0,0
28472,ALA,0,1
28473,concentrations,0,0
28474,from,0,0
28475,0,0,0
28476,to,0,0
28477,24h,0,0
28478,showed,0,0
28479,no,0,0
28480,difference,0,0
28481,in,0,0
28482,ALA,0,0
28483,pharmacokinetics,0,0
28484,between,0,0
28485,the,0,0
28486,two,0,0
28487,formulations,0,0
28488,.,0,0
28489,However,0,0
28490,",",0,0
28491,significantly,0,0
28492,greater,0,0
28493,increases,0,0
28494,in,0,0
28495,plasma,0,0
28496,ALA,0,0
28497,levels,0,0
28498,from,0,0
28499,baseline,0,0
28500,to,0,0
28501,24h,0,0
28502,were,0,0
28503,observed,0,0
28504,after,0,0
28505,ingestion,0,0
28506,of,0,0
28507,Entrox,0,1
28508,vs.,0,0
28509,non-coated,0,1
28510,product,0,1
28511,",",0,0
28512,suggesting,0,0
28513,a,0,0
28514,possible,0,0
28515,benefit,0,0
28516,of,0,0
28517,Entrox,0,1
28518,with,0,0
28519,long-term,0,0
28520,treatment,0,0
28521,.,0,0
28522,Gastrointestinal,0,0
28523,safety,0,0
28524,of,0,0
28525,NO-aspirin,1,1
28526,(,1,1
28527,NCX-4016,1,1
28528,),1,1
28529,in,0,0
28530,healthy,0,0
28531,human,0,1
28532,volunteers,0,0
28533,:,0,0
28534,a,0,0
28535,proof,0,0
28536,of,0,0
28537,concept,0,0
28538,endoscopic,0,1
28539,study,0,0
28540,.,0,0
28541,BACKGROUND,0,0
28542,AND,0,0
28543,AIMS,0,1
28544,NCX-4016,1,1
28545,is,0,0
28546,a,0,0
28547,nitric,0,1
28548,oxide-releasing,0,1
28549,derivative,0,1
28550,of,0,0
28551,aspirin,0,1
28552,with,0,0
28553,antiplatelet,0,1
28554,activity,0,0
28555,.,0,0
28556,The,0,0
28557,aim,0,0
28558,of,0,0
28559,this,0,0
28560,study,0,0
28561,was,0,0
28562,to,0,0
28563,investigate,0,0
28564,the,0,0
28565,effect,0,0
28566,of,0,0
28567,NCX-4016,1,1
28568,on,0,0
28569,gastrointestinal,0,0
28570,mucosa,0,0
28571,and,0,0
28572,platelet,0,0
28573,functions,0,0
28574,in,0,0
28575,healthy,0,0
28576,human,0,0
28577,volunteers,0,0
28578,.,0,0
28579,METHODS,0,0
28580,This,0,0
28581,was,0,0
28582,a,0,0
28583,parallel-group,0,0
28584,",",0,0
28585,double-blind,0,0
28586,",",0,0
28587,placebo-controlled,0,1
28588,study,0,0
28589,.,0,0
28590,Forty,0,0
28591,healthy,0,0
28592,subjects,0,0
28593,were,0,0
28594,randomly,0,0
28595,allocated,0,0
28596,to,0,0
28597,receive,0,0
28598,7,0,0
28599,days,0,0
28600,of,0,0
28601,treatment,0,0
28602,with,0,0
28603,NCX-4016,1,1
28604,(,1,0
28605,400,1,1
28606,and,1,0
28607,800,1,1
28608,mg,1,1
28609,twice,1,1
28610,daily,1,1
28611,),1,0
28612,",",1,0
28613,equimolar,1,0
28614,doses,1,0
28615,of,1,0
28616,aspirin,1,1
28617,(,1,0
28618,200,1,1
28619,and,1,0
28620,420,1,0
28621,mg,1,1
28622,twice,1,1
28623,daily,1,1
28624,),1,0
28625,",",1,0
28626,or,1,1
28627,placebo,1,1
28628,.,1,0
28629,Upper,0,0
28630,endoscopies,0,0
28631,were,0,0
28632,performed,0,0
28633,before,0,0
28634,and,0,0
28635,at,0,0
28636,the,0,0
28637,end,0,0
28638,of,0,0
28639,the,0,0
28640,treatment,0,0
28641,period,0,0
28642,",",0,0
28643,and,0,0
28644,gastroduodenal,0,0
28645,lesions,0,0
28646,were,0,0
28647,graded,0,0
28648,using,0,0
28649,a,0,0
28650,predefined,0,0
28651,scoring,0,0
28652,system,0,0
28653,.,0,0
28654,Basal,0,0
28655,and,0,0
28656,posttreatment,0,0
28657,platelet,0,0
28658,aggregation,0,0
28659,in,0,0
28660,response,0,0
28661,to,0,0
28662,arachidonic,0,1
28663,acid,0,1
28664,(,0,1
28665,AA,0,1
28666,),0,1
28667,and,0,0
28668,serum,0,1
28669,thromboxane,0,1
28670,(,0,1
28671,TX,0,1
28672,),0,1
28673,B,0,1
28674,(,0,1
28675,2,0,0
28676,),0,0
28677,and,0,0
28678,AA-stimulated,0,1
28679,platelet,0,0
28680,TXB,0,1
28681,(,0,1
28682,2,0,0
28683,),0,0
28684,production,0,0
28685,were,0,0
28686,investigated,0,0
28687,.,0,0
28688,RESULTS,0,0
28689,Mucosal,0,0
28690,endoscopic,0,1
28691,injury,0,0
28692,score,0,0
28693,on,0,0
28694,day,0,0
28695,7,0,0
28696,was,0,0
28697,0.63,0,0
28698,+/-,0,0
28699,0.16,0,0
28700,in,0,0
28701,the,0,0
28702,placebo,0,1
28703,group,0,0
28704,and,0,0
28705,11.0,0,0
28706,+/-,0,0
28707,3.0,0,0
28708,and,0,0
28709,16.1,0,0
28710,+/-,0,0
28711,1.6,0,0
28712,in,0,0
28713,healthy,0,0
28714,volunteers,0,0
28715,treated,0,0
28716,with,0,0
28717,200,0,1
28718,and,0,0
28719,420,0,0
28720,mg,0,1
28721,aspirin,0,1
28722,twice,0,1
28723,daily,0,1
28724,(,0,0
28725,P,0,0
28726,<,0,0
28727,0.0001,0,0
28728,vs.,0,0
28729,placebo,0,1
28730,),0,0
28731,.,0,0
28732,NCX-4016,0,0
28733,was,0,0
28734,virtually,0,0
28735,devoid,0,0
28736,of,0,0
28737,gastric,0,0
28738,and,0,0
28739,duodenal,0,0
28740,toxicity,0,0
28741,",",0,0
28742,resulting,0,0
28743,in,0,0
28744,a,0,0
28745,total,0,0
28746,gastric,0,0
28747,and,0,0
28748,duodenal,0,0
28749,endoscopic,0,1
28750,score,0,0
28751,of,0,0
28752,1.38,0,0
28753,+/-,0,0
28754,0.3,0,0
28755,and,0,0
28756,1.25,0,0
28757,+/-,0,0
28758,0.5,0,1
28759,(,0,0
28760,P,0,0
28761,<,0,0
28762,0.0001,0,0
28763,vs.,0,0
28764,aspirin,0,1
28765,",",0,0
28766,not,0,0
28767,significant,0,0
28768,vs.,0,0
28769,placebo,0,1
28770,),0,0
28771,.,0,0
28772,NCX-4016,0,0
28773,inhibited,0,0
28774,AA-induced,0,0
28775,platelet,0,0
28776,aggregation,0,0
28777,as,0,0
28778,well,0,0
28779,as,0,0
28780,serum,0,0
28781,TXB,0,1
28782,(,0,1
28783,2,0,0
28784,),0,1
28785,and,0,0
28786,platelet,0,0
28787,TXB,0,1
28788,(,0,1
28789,2,0,0
28790,),0,0
28791,generation,0,0
28792,induced,0,0
28793,by,0,0
28794,AA,0,0
28795,to,0,0
28796,the,0,0
28797,same,0,0
28798,extent,0,0
28799,as,0,0
28800,aspirin,1,1
28801,(,0,0
28802,not,0,0
28803,significant,0,0
28804,vs.,0,0
28805,aspirin,0,1
28806,),0,0
28807,.,0,0
28808,CONCLUSIONS,0,0
28809,In,0,0
28810,this,0,0
28811,study,0,0
28812,",",0,0
28813,we,0,0
28814,have,0,0
28815,proven,0,0
28816,the,0,0
28817,concept,0,0
28818,that,0,0
28819,addition,0,0
28820,of,0,0
28821,an,0,0
28822,NO-donating,0,0
28823,moiety,0,0
28824,to,0,0
28825,aspirin,0,1
28826,results,0,0
28827,in,0,0
28828,a,0,0
28829,new,0,0
28830,chemical,0,0
28831,entity,0,0
28832,that,0,0
28833,maintains,0,0
28834,cyclooxygenase-1,0,0
28835,and,0,0
28836,platelet,0,0
28837,inhibitory,0,0
28838,activity,0,0
28839,while,0,0
28840,nearly,0,0
28841,avoiding,0,0
28842,gastrointestinal,0,0
28843,damage,0,0
28844,.,0,0
28845,Pharmacokinetics,0,0
28846,and,0,0
28847,tolerance,0,0
28848,of,0,0
28849,single-,0,1
28850,and,0,0
28851,multiple-dose,0,1
28852,oral,0,1
28853,or,0,1
28854,intravenous,0,1
28855,linezolid,1,1
28856,",",0,0
28857,an,0,0
28858,oxazolidinone,0,1
28859,antibiotic,0,1
28860,",",0,0
28861,in,0,0
28862,healthy,0,0
28863,volunteers,0,0
28864,.,0,0
28865,AIMS,0,0
28866,To,0,0
28867,determine,0,0
28868,the,0,0
28869,pharmacokinetics,0,0
28870,and,0,0
28871,tolerance,0,0
28872,of,0,0
28873,oral,0,1
28874,and,0,0
28875,intravenous,0,1
28876,linezolid,1,1
28877,",",0,0
28878,an,0,0
28879,oxazolidinone,0,1
28880,antibiotic,0,1
28881,",",0,0
28882,in,0,0
28883,healthy,0,0
28884,volunteers,0,0
28885,following,0,0
28886,single-,0,1
28887,and,0,0
28888,multiple-dose,0,1
28889,administration,0,0
28890,.,0,0
28891,METHODS,0,0
28892,In,0,0
28893,two,0,0
28894,randomized,0,0
28895,",",0,0
28896,double-blind,0,0
28897,",",0,0
28898,placebo-controlled,1,1
28899,",",0,0
28900,dose-escalating,0,0
28901,trials,0,0
28902,",",0,0
28903,subjects,0,0
28904,were,0,0
28905,exposed,0,0
28906,either,0,0
28907,to,0,0
28908,oral,0,1
28909,(,0,0
28910,375,0,0
28911,",",0,0
28912,500,0,0
28913,or,0,0
28914,625,0,0
28915,mg,0,1
28916,),0,0
28917,or,0,1
28918,intravenous,0,1
28919,(,0,1
28920,500,0,1
28921,or,0,1
28922,625,0,0
28923,mg,0,1
28924,),0,0
28925,linezolid,1,1
28926,or,1,1
28927,placebo,1,1
28928,twice,0,0
28929,daily,0,1
28930,.,0,0
28931,Serial,0,0
28932,blood,0,0
28933,and,0,0
28934,urine,0,0
28935,samples,0,0
28936,were,0,0
28937,obtained,0,0
28938,after,0,0
28939,the,0,0
28940,first-,0,0
28941,and,0,0
28942,multiple-dose,0,1
28943,administrations,0,0
28944,for,0,0
28945,up,0,0
28946,to,0,0
28947,18,0,0
28948,days,0,0
28949,.,0,0
28950,Non-compartmental,0,0
28951,pharmacokinetic,0,0
28952,analyses,0,0
28953,were,0,0
28954,used,0,0
28955,to,0,0
28956,describe,0,0
28957,the,0,0
28958,disposition,0,0
28959,of,0,0
28960,linezolid,1,1
28961,.,1,0
28962,RESULTS,0,0
28963,Plasma,0,0
28964,linezolid,1,1
28965,concentrations,0,0
28966,and,0,0
28967,area,0,0
28968,under,0,0
28969,the,0,0
28970,concentration-time,0,0
28971,curves,0,0
28972,increased,0,0
28973,proportionally,0,0
28974,with,0,0
28975,dose,0,0
28976,irrespective,0,0
28977,of,0,0
28978,the,0,0
28979,route,0,1
28980,of,0,0
28981,administration,0,0
28982,.,0,0
28983,Plasma,0,0
28984,linezolid,1,1
28985,concentrations,0,0
28986,remained,0,0
28987,above,0,0
28988,the,0,0
28989,MIC90,0,0
28990,for,0,0
28991,susceptible,0,0
28992,target,0,0
28993,pathogens,0,0
28994,(,0,0
28995,4.0,0,0
28996,mg/L,0,1
28997,),0,0
28998,for,0,0
28999,the,0,0
29000,majority,0,0
29001,of,0,0
29002,the,0,0
29003,12,0,0
29004,h,0,0
29005,dosing,0,0
29006,interval,0,0
29007,.,0,1
29008,Mean,0,0
29009,clearance,0,0
29010,",",0,0
29011,half-life,0,0
29012,and,0,0
29013,volume,0,0
29014,of,0,0
29015,distribution,0,0
29016,were,0,0
29017,similar,0,0
29018,irrespective,0,0
29019,of,0,0
29020,dose,0,0
29021,for,0,0
29022,both,0,0
29023,the,0,0
29024,oral,0,1
29025,and,0,0
29026,intravenous,0,1
29027,routes,0,0
29028,.,0,0
29029,Linezolid,1,1
29030,was,0,0
29031,well,0,0
29032,tolerated,0,0
29033,and,0,0
29034,the,0,0
29035,frequency,0,0
29036,of,0,0
29037,drug-related,0,0
29038,adverse,0,0
29039,events,0,0
29040,was,0,0
29041,similar,0,0
29042,between,0,0
29043,the,0,0
29044,linezolid,1,1
29045,and,0,0
29046,placebo,0,1
29047,groups,0,0
29048,.,0,0
29049,CONCLUSIONS,0,0
29050,Oral,0,1
29051,and,0,0
29052,intravenous,0,1
29053,linezolid,1,1
29054,exhibit,0,0
29055,linear,0,0
29056,pharmacokinetics,0,0
29057,",",0,0
29058,with,0,0
29059,concentrations,0,0
29060,remaining,0,0
29061,above,0,0
29062,the,0,0
29063,target,0,0
29064,MIC90,0,0
29065,for,0,0
29066,most,0,0
29067,of,0,0
29068,the,0,0
29069,dosing,0,0
29070,interval,0,0
29071,.,0,0
29072,These,0,0
29073,results,0,0
29074,support,0,0
29075,a,0,0
29076,twice-daily,0,1
29077,schedule,0,1
29078,for,0,0
29079,linezolid,0,1
29080,and,0,0
29081,demonstrate,0,0
29082,the,0,0
29083,feasibility,0,0
29084,of,0,0
29085,converting,0,0
29086,from,0,0
29087,intravenous,0,1
29088,to,0,0
29089,oral,0,1
29090,dosing,0,0
29091,without,0,0
29092,a,0,0
29093,dose,0,0
29094,adjustment,0,0
29095,.,0,0
29096,A,0,0
29097,single,1,1
29098,nasal,1,0
29099,allergen,1,1
29100,challenge,1,0
29101,increases,0,0
29102,induced,0,0
29103,sputum,0,0
29104,inflammatory,0,0
29105,markers,0,0
29106,in,0,0
29107,non-asthmatic,0,0
29108,subjects,0,0
29109,with,0,0
29110,seasonal,0,0
29111,allergic,0,0
29112,rhinitis,0,0
29113,:,0,0
29114,correlation,0,0
29115,with,0,0
29116,plasma,0,0
29117,interleukin-5,0,1
29118,.,0,0
29119,BACKGROUND,0,0
29120,Seasonal,0,0
29121,allergic,0,0
29122,rhinitis,0,0
29123,(,0,1
29124,SAR,0,1
29125,),0,1
29126,is,0,0
29127,a,0,0
29128,risk,0,0
29129,factor,0,0
29130,for,0,0
29131,asthma,0,0
29132,in,0,0
29133,affected,0,0
29134,individuals,0,0
29135,.,0,0
29136,Nasal,0,0
29137,allergic,0,0
29138,inflammation,0,0
29139,enhances,0,0
29140,bone-marrow,0,1
29141,eosinophil,0,0
29142,production,0,0
29143,",",0,0
29144,mainly,0,0
29145,via,0,0
29146,IL-5,0,1
29147,",",0,0
29148,and,0,0
29149,rhinitis,0,0
29150,patients,0,0
29151,have,0,0
29152,increased,0,0
29153,airway,0,0
29154,inflammation,0,0
29155,during,0,0
29156,the,0,0
29157,pollen,0,0
29158,season,0,0
29159,.,0,0
29160,OBJECTIVE,0,0
29161,To,0,0
29162,assess,0,0
29163,the,0,0
29164,impact,0,0
29165,of,0,0
29166,nasal,0,0
29167,allergy,0,0
29168,on,0,0
29169,sputum,0,0
29170,inflammatory,0,0
29171,markers,0,0
29172,.,0,0
29173,METHODS,0,0
29174,In,0,0
29175,an,0,0
29176,open-labelled,0,0
29177,",",0,0
29178,randomized,0,0
29179,",",0,0
29180,placebo-controlled,1,1
29181,cross-over,0,0
29182,study,0,0
29183,with,0,0
29184,16,0,0
29185,non-asthmatic,0,0
29186,SAR,0,1
29187,patients,0,0
29188,(,0,0
29189,median,0,0
29190,age,0,0
29191,25,0,0
29192,years,0,0
29193,",",0,0
29194,56,0,0
29195,%,0,0
29196,males,0,0
29197,),0,0
29198,",",0,0
29199,the,0,0
29200,effect,0,0
29201,of,0,0
29202,a,0,0
29203,single,1,1
29204,nasal,1,0
29205,allergen,1,1
29206,challenge,1,0
29207,performed,0,0
29208,out,0,0
29209,of,0,0
29210,season,0,0
29211,on,0,0
29212,induced,0,0
29213,sputum,0,0
29214,inflammatory,0,0
29215,parameters,0,0
29216,was,0,0
29217,evaluated,0,0
29218,.,0,0
29219,SAR,0,0
29220,patients,0,0
29221,were,0,0
29222,identified,0,0
29223,by,0,0
29224,history,0,0
29225,",",0,0
29226,skin-prick,0,0
29227,test,0,0
29228,and,0,0
29229,specific,0,0
29230,IgE,0,1
29231,.,0,0
29232,All,0,0
29233,patients,0,0
29234,had,0,0
29235,normal,0,0
29236,lung,0,0
29237,function/bronchial,0,0
29238,hyper-responsiveness,0,0
29239,out,0,0
29240,of,0,0
29241,season,0,0
29242,and,0,0
29243,a,0,0
29244,negative,0,1
29245,asthma/wheezing,0,0
29246,history,0,0
29247,.,0,0
29248,Sputum,1,0
29249,cells,1,0
29250,and,1,0
29251,supernatant,1,1
29252,levels,1,0
29253,of,1,0
29254,ECP,1,0
29255,",",1,0
29256,sICAM,1,0
29257,",",1,0
29258,IL-5,1,1
29259,and,1,0
29260,IL-10,1,1
29261,",",1,0
29262,and,1,0
29263,plasma,1,0
29264,levels,1,0
29265,of,1,0
29266,IL-5,1,1
29267,and,1,0
29268,ECP,1,0
29269,",",1,0
29270,were,1,0
29271,measured,1,0
29272,before,1,0
29273,and,1,0
29274,24,1,0
29275,h,1,0
29276,after,1,0
29277,nasal,1,0
29278,allergen,1,1
29279,challenge,1,0
29280,.,1,0
29281,After,1,0
29282,a,1,0
29283,washout,1,1
29284,period,1,0
29285,of,1,0
29286,at,1,0
29287,least,1,0
29288,4,1,0
29289,weeks,1,0
29290,",",1,0
29291,the,1,0
29292,procedure,1,0
29293,was,1,0
29294,repeated,1,0
29295,with,1,0
29296,placebo,1,1
29297,challenge,1,0
29298,(,1,1
29299,diluent,1,1
29300,),1,0
29301,.,1,0
29302,RESULTS,0,0
29303,Nasal,0,1
29304,allergen,0,1
29305,challenge,0,0
29306,led,0,0
29307,to,0,0
29308,an,0,0
29309,increase,0,0
29310,in,0,0
29311,sputum,0,1
29312,ECP,0,1
29313,(,0,0
29314,pre,0,0
29315,=,0,0
29316,60,0,0
29317,+/-,0,0
29318,12,0,0
29319,",",0,0
29320,post,0,0
29321,=,0,0
29322,212,0,0
29323,+/-,0,0
29324,63,0,0
29325,micro,0,1
29326,g/L,0,1
29327,",",0,0
29328,P,0,0
29329,=,0,0
29330,0.02,0,0
29331,vs.,0,0
29332,placebo,0,1
29333,),0,0
29334,",",0,0
29335,and,0,1
29336,sICAM,0,0
29337,(,0,0
29338,4.8,0,0
29339,+/-,0,0
29340,2.7,0,0
29341,to,0,0
29342,6.5,0,0
29343,+/-,0,0
29344,2.9,0,0
29345,ng/mL,0,0
29346,",",0,0
29347,P,0,0
29348,=,0,0
29349,0.02,0,0
29350,vs.,0,0
29351,placebo,0,1
29352,),0,0
29353,",",0,0
29354,whereas,0,0
29355,IL-10,0,0
29356,decreased,0,0
29357,after,0,0
29358,provocation,0,0
29359,(,0,0
29360,44,0,0
29361,+/-,0,0
29362,11,0,0
29363,to,0,0
29364,29,0,0
29365,+/-,0,0
29366,6,0,0
29367,pg/mL,0,0
29368,",",0,0
29369,P,0,0
29370,=,0,0
29371,0.06,0,0
29372,vs.,0,0
29373,placebo,0,1
29374,),0,0
29375,.,0,0
29376,Sputum,0,0
29377,IL-5,0,1
29378,was,0,0
29379,undetectable,0,0
29380,in,0,0
29381,all,0,0
29382,patients,0,0
29383,.,0,0
29384,The,0,0
29385,absolute,0,0
29386,number,0,0
29387,of,0,0
29388,blood,0,0
29389,and,0,0
29390,sputum,0,0
29391,eosinophils,0,0
29392,did,0,0
29393,not,0,0
29394,change,0,0
29395,significantly,0,0
29396,after,0,0
29397,allergen,0,1
29398,or,0,1
29399,placebo,0,1
29400,challenge,0,1
29401,(,0,0
29402,P,0,0
29403,>,0,0
29404,0.07,0,0
29405,",",0,0
29406,both,0,0
29407,comparisons,0,0
29408,),0,0
29409,.,0,0
29410,Plasma,0,0
29411,levels,0,0
29412,of,0,0
29413,IL-5,0,1
29414,increased,0,0
29415,after,0,0
29416,allergen,0,1
29417,challenge,0,0
29418,(,0,0
29419,8.7,0,0
29420,+/-,0,0
29421,2.9,0,0
29422,to,0,0
29423,14.5,0,0
29424,+/-,0,0
29425,3.9,0,0
29426,pg/mL,0,0
29427,",",0,0
29428,P,0,0
29429,=,0,0
29430,0.001,0,0
29431,),0,0
29432,",",0,0
29433,and,0,0
29434,the,0,0
29435,increase,0,0
29436,in,0,0
29437,plasma,0,0
29438,IL-5,0,1
29439,was,0,0
29440,positively,0,0
29441,correlated,0,0
29442,with,0,0
29443,the,0,0
29444,rise,0,0
29445,in,0,0
29446,sputum,0,0
29447,ECP,0,0
29448,in,0,0
29449,a,0,0
29450,subgroup,0,0
29451,of,0,0
29452,'responders,0,0
29453,',0,0
29454,(,0,0
29455,n,0,0
29456,=,0,0
29457,12,0,0
29458,",",0,0
29459,r,0,0
29460,=,0,0
29461,0.71,0,0
29462,",",0,0
29463,P,0,0
29464,=,0,0
29465,0.01,0,0
29466,),0,0
29467,.,0,0
29468,CONCLUSIONS,0,0
29469,A,0,0
29470,single,1,1
29471,nasal,1,0
29472,allergen,1,1
29473,challenge,1,0
29474,in,0,0
29475,SAR,0,0
29476,patients,0,0
29477,increased,0,0
29478,markers,0,0
29479,of,0,0
29480,allergic,0,0
29481,inflammation,0,0
29482,in,0,0
29483,the,0,0
29484,lower,0,0
29485,respiratory,0,0
29486,tract,0,0
29487,",",0,0
29488,possibly,0,0
29489,via,0,0
29490,pronounced,0,0
29491,activation,0,0
29492,of,0,0
29493,inflammatory,0,0
29494,cells,0,0
29495,through,0,0
29496,circulating,0,0
29497,immediate-type,0,1
29498,reaction,0,1
29499,cytokines,0,0
29500,like,0,0
29501,IL-5,0,1
29502,.,0,0
29503,These,0,0
29504,findings,0,0
29505,may,0,0
29506,provide,0,0
29507,additional,0,0
29508,explanatory,0,0
29509,data,0,0
29510,for,0,0
29511,the,0,0
29512,high,0,0
29513,susceptibility,0,0
29514,of,0,0
29515,SAR,0,0
29516,patients,0,0
29517,to,0,0
29518,incident,0,0
29519,asthma,0,0
29520,.,0,0
29521,An,1,0
29522,exposure,1,0
29523,prevention,1,0
29524,rating,1,0
29525,method,1,1
29526,for,0,0
29527,intervention,0,1
29528,needs,0,0
29529,assessment,0,0
29530,and,0,0
29531,effectiveness,0,0
29532,evaluation,0,0
29533,.,0,0
29534,This,0,0
29535,article,0,0
29536,describes,0,0
29537,a,0,0
29538,new,0,0
29539,method,0,1
29540,for,0,0
29541,(,0,0
29542,1,0,0
29543,),0,0
29544,systematically,0,0
29545,prioritizing,0,0
29546,needs,0,0
29547,for,0,0
29548,intervention,0,1
29549,on,0,0
29550,hazardous,0,0
29551,substance,0,0
29552,exposures,0,0
29553,in,0,0
29554,manufacturing,0,0
29555,work,0,0
29556,sites,0,0
29557,",",0,0
29558,and,0,0
29559,(,0,0
29560,2,0,1
29561,),0,1
29562,evaluating,0,0
29563,intervention,0,1
29564,effectiveness,0,0
29565,.,0,0
29566,We,0,0
29567,developed,0,0
29568,a,0,0
29569,checklist,1,0
29570,containing,1,1
29571,six,0,0
29572,unique,0,0
29573,sets,0,0
29574,of,0,0
29575,yes/no,0,0
29576,variables,0,0
29577,organized,0,1
29578,in,0,0
29579,a,0,0
29580,2,0,0
29581,x,0,0
29582,3,0,0
29583,matrix,0,1
29584,of,0,0
29585,exposure,0,0
29586,potential,0,0
29587,versus,0,1
29588,protection,0,1
29589,(,0,0
29590,two,0,1
29591,columns,0,1
29592,),0,0
29593,at,0,0
29594,the,0,0
29595,levels,0,0
29596,of,0,0
29597,materials,0,0
29598,",",0,0
29599,processes,0,0
29600,",",0,0
29601,and,0,0
29602,human,0,1
29603,interface,0,1
29604,(,0,0
29605,three,0,1
29606,rows,0,1
29607,),0,0
29608,.,0,0
29609,The,0,0
29610,three,0,0
29611,levels,0,0
29612,correspond,0,0
29613,to,0,0
29614,a,0,0
29615,simplified,0,0
29616,hierarchy,0,0
29617,of,0,0
29618,controls,0,0
29619,.,0,0
29620,Each,0,0
29621,of,0,0
29622,the,0,0
29623,six,0,0
29624,sets,0,0
29625,of,0,0
29626,indicator,0,0
29627,variables,0,0
29628,was,0,0
29629,reduced,0,0
29630,to,0,0
29631,a,0,0
29632,high/moderate/low,0,0
29633,rating,0,0
29634,.,0,0
29635,Ratings,0,0
29636,from,0,0
29637,the,0,0
29638,matrix,0,1
29639,were,0,0
29640,then,0,0
29641,combined,0,1
29642,to,0,0
29643,generate,0,0
29644,a,0,0
29645,single,0,0
29646,overall,0,0
29647,exposure,0,1
29648,prevention,0,0
29649,rating,0,0
29650,for,0,0
29651,each,0,0
29652,area,0,0
29653,.,0,0
29654,Reflecting,0,0
29655,the,0,0
29656,hierarchy,0,0
29657,of,0,0
29658,controls,0,0
29659,",",0,0
29660,material,0,0
29661,factors,0,0
29662,were,0,0
29663,weighted,0,1
29664,highest,0,0
29665,",",0,0
29666,followed,0,1
29667,by,0,0
29668,process,0,0
29669,",",0,0
29670,and,0,0
29671,then,0,1
29672,human,0,1
29673,interface,0,0
29674,.,0,0
29675,The,0,0
29676,checklist,0,0
29677,was,0,0
29678,filled,0,0
29679,out,0,0
29680,by,0,0
29681,an,0,0
29682,industrial,0,0
29683,hygienist,0,0
29684,while,0,0
29685,conducting,0,1
29686,a,0,0
29687,walk-through,0,1
29688,inspection,0,1
29689,(,0,0
29690,N,0,1
29691,=,0,0
29692,131,0,0
29693,manufacturing,0,0
29694,processes/areas,0,0
29695,in,0,0
29696,17,0,0
29697,large,0,0
29698,work,0,0
29699,sites,0,0
29700,),0,0
29701,.,0,0
29702,One,0,0
29703,area,0,0
29704,or,0,1
29705,process,0,0
29706,per,0,1
29707,manufacturing,0,0
29708,department,0,0
29709,was,0,0
29710,assessed,0,0
29711,and,0,0
29712,rated,0,0
29713,.,0,0
29714,Based,0,0
29715,on,0,0
29716,the,0,0
29717,resulting,0,0
29718,Exposure,0,1
29719,Prevention,0,1
29720,ratings,0,0
29721,",",0,0
29722,we,0,0
29723,concluded,0,0
29724,that,0,0
29725,exposures,0,0
29726,were,0,0
29727,well,0,0
29728,controlled,0,0
29729,in,0,0
29730,the,0,0
29731,majority,0,0
29732,of,0,0
29733,areas,0,0
29734,assessed,0,0
29735,(,0,0
29736,64,0,0
29737,%,0,0
29738,with,0,0
29739,rating,0,0
29740,of,0,0
29741,1,0,0
29742,or,0,0
29743,2,0,0
29744,on,0,0
29745,a,0,0
29746,6-point,0,0
29747,scale,0,0
29748,),0,0
29749,",",0,0
29750,that,0,0
29751,there,0,0
29752,is,0,0
29753,some,0,0
29754,room,0,0
29755,for,0,0
29756,improvement,0,0
29757,in,0,0
29758,26,0,0
29759,percent,0,0
29760,of,0,0
29761,areas,0,0
29762,(,0,0
29763,rating,0,0
29764,of,0,0
29765,3,0,0
29766,or,0,1
29767,4,0,0
29768,),0,0
29769,",",0,0
29770,and,0,0
29771,that,0,0
29772,roughly,0,0
29773,10,0,0
29774,percent,0,0
29775,of,0,0
29776,the,0,0
29777,areas,0,0
29778,assessed,0,0
29779,are,0,0
29780,urgently,0,0
29781,in,0,0
29782,need,0,0
29783,of,0,0
29784,intervention,0,1
29785,(,0,0
29786,rated,0,0
29787,as,0,0
29788,5,0,0
29789,or,0,1
29790,6,0,0
29791,),0,0
29792,.,0,0
29793,A,0,0
29794,second,0,0
29795,hygienist,0,0
29796,independently,0,0
29797,assessed,0,0
29798,a,0,0
29799,subset,0,0
29800,of,0,0
29801,areas,0,0
29802,to,0,0
29803,evaluate,0,0
29804,inter-rater,0,0
29805,reliability,0,0
29806,.,0,0
29807,The,0,0
29808,reliability,0,0
29809,of,0,0
29810,the,0,0
29811,overall,0,0
29812,exposure,0,0
29813,prevention,0,0
29814,ratings,0,0
29815,was,0,0
29816,excellent,0,0
29817,(,0,0
29818,weighted,0,1
29819,kappa,0,0
29820,=,0,0
29821,0.84,0,0
29822,),0,0
29823,.,0,0
29824,The,0,0
29825,rating,0,0
29826,scheme,0,1
29827,has,0,0
29828,good,0,0
29829,discriminatory,0,0
29830,power,0,0
29831,and,0,1
29832,reliability,0,0
29833,and,0,1
29834,shows,0,0
29835,promise,0,0
29836,as,0,0
29837,a,0,0
29838,broadly,0,0
29839,applicable,0,0
29840,and,0,0
29841,inexpensive,0,0
29842,tool,0,0
29843,for,0,0
29844,intervention,0,1
29845,needs,0,0
29846,assessment,0,0
29847,and,0,0
29848,effectiveness,0,0
29849,evaluation,0,0
29850,.,0,0
29851,Validation,0,0
29852,studies,0,0
29853,are,0,0
29854,needed,0,0
29855,as,0,0
29856,a,0,0
29857,next,0,0
29858,step,0,0
29859,.,0,0
29860,This,0,0
29861,assessment,0,0
29862,method,0,0
29863,complements,0,1
29864,quantitative,0,0
29865,exposure,0,0
29866,assessment,0,0
29867,with,0,0
29868,an,0,0
29869,upstream,0,0
29870,prevention,0,0
29871,focus,0,0
29872,.,0,0
29873,Clinic,0,1
29874,visit,0,0
29875,and,0,0
29876,waiting,0,0
29877,:,0,1
29878,patient,1,0
29879,education,1,1
29880,and,0,0
29881,satisfaction,0,0
29882,.,0,0
29883,Patients,1,0
29884,who,1,0
29885,were,1,0
29886,taught,1,0
29887,about,1,0
29888,their,1,0
29889,health,1,0
29890,problems,1,0
29891,while,1,0
29892,waiting,1,0
29893,in,1,0
29894,the,1,0
29895,clinic,1,0
29896,(,0,0
29897,n,0,0
29898,=,0,0
29899,104,0,0
29900,),0,0
29901,were,0,0
29902,significantly,0,0
29903,more,0,0
29904,satisfied,0,0
29905,with,0,0
29906,the,0,0
29907,education,0,1
29908,received,0,0
29909,during,0,0
29910,that,0,0
29911,visit,0,0
29912,than,0,0
29913,the,0,0
29914,control,1,1
29915,group,1,0
29916,(,0,0
29917,n,0,0
29918,=,0,0
29919,101,0,0
29920,),0,0
29921,.,0,0
29922,The,0,0
29923,longer,0,0
29924,patients,0,0
29925,waited,0,0
29926,in,0,0
29927,the,0,0
29928,clinic,0,0
29929,to,0,0
29930,see,0,0
29931,their,0,0
29932,providers,0,0
29933,",",0,0
29934,the,0,0
29935,less,0,0
29936,satisfied,0,0
29937,they,0,0
29938,were,0,0
29939,with,0,0
29940,the,0,0
29941,clinic,0,0
29942,visit,0,0
29943,.,0,0
29944,Pethidine,1,1
29945,versus,1,1
29946,tramadol,1,1
29947,for,0,0
29948,pain,0,0
29949,relief,0,0
29950,during,0,0
29951,labor,0,0
29952,.,0,0
29953,OBJECTIVE,0,0
29954,To,0,0
29955,evaluate,0,0
29956,and,0,0
29957,compare,0,0
29958,the,0,0
29959,analgesic,0,1
29960,efficacy,0,0
29961,and,0,0
29962,adverse,0,0
29963,effects,0,0
29964,of,0,0
29965,tramadol,1,1
29966,and,0,0
29967,pethidine,1,1
29968,in,0,0
29969,labor,0,0
29970,.,0,0
29971,METHOD,0,0
29972,Fifty-nine,0,0
29973,full,0,0
29974,term,0,0
29975,parturients,0,0
29976,were,0,0
29977,randomly,0,0
29978,assigned,0,0
29979,to,0,0
29980,one,0,0
29981,of,0,0
29982,two,0,0
29983,groups,0,0
29984,in,0,0
29985,active,0,0
29986,labor,0,0
29987,.,0,0
29988,Group,0,0
29989,1,0,0
29990,received,0,0
29991,100,0,0
29992,mg,0,0
29993,pethidine,1,1
29994,;,1,0
29995,group,0,0
29996,2,0,0
29997,",",0,0
29998,100,0,0
29999,mg,0,1
30000,tramadol,1,1
30001,",",0,0
30002,intramuscularly,0,1
30003,.,0,0
30004,Analgesic,0,0
30005,efficacy,0,0
30006,",",0,0
30007,maternal,0,0
30008,side,0,0
30009,effects,0,0
30010,",",0,0
30011,changes,0,0
30012,in,0,0
30013,the,0,0
30014,blood,0,0
30015,pressure,0,0
30016,",",0,0
30017,heart,0,0
30018,rate,0,0
30019,",",0,0
30020,and,0,0
30021,duration,0,0
30022,of,0,0
30023,labor,0,0
30024,were,0,0
30025,assessed,0,0
30026,.,0,0
30027,RESULT,0,0
30028,At,0,0
30029,30,0,0
30030,and,0,0
30031,60,0,0
30032,min,0,0
30033,after,0,0
30034,drug,0,1
30035,administration,0,0
30036,",",0,0
30037,pain,0,0
30038,relief,0,0
30039,was,0,0
30040,greater,0,0
30041,in,0,0
30042,the,0,0
30043,pethidine,1,1
30044,group,0,0
30045,than,0,0
30046,in,0,0
30047,tramadol,1,1
30048,group,0,0
30049,.,0,0
30050,The,0,0
30051,incidence,0,0
30052,of,0,0
30053,nausea,0,0
30054,and,0,0
30055,fatigue,0,0
30056,was,0,0
30057,higher,0,0
30058,in,0,0
30059,the,0,0
30060,tramadol,1,1
30061,group,0,0
30062,.,0,0
30063,Following,0,0
30064,drug,0,0
30065,administration,0,0
30066,the,0,0
30067,decrease,0,0
30068,in,0,0
30069,systolic,0,0
30070,and,0,0
30071,diastolic,0,0
30072,blood,0,0
30073,pressure,0,0
30074,and,0,0
30075,the,0,0
30076,increase,0,0
30077,in,0,0
30078,heart,0,0
30079,rate,0,0
30080,were,0,0
30081,statistically,0,0
30082,significant,0,0
30083,in,0,0
30084,both,0,0
30085,groups,0,0
30086,.,0,0
30087,No,0,0
30088,significant,0,0
30089,difference,0,0
30090,was,0,0
30091,found,0,0
30092,between,0,0
30093,the,0,0
30094,groups,0,0
30095,when,0,0
30096,compared,0,0
30097,for,0,0
30098,duration,0,0
30099,of,0,0
30100,labor,0,0
30101,and,0,0
30102,Apgar,0,0
30103,scores,0,0
30104,.,0,0
30105,None,0,0
30106,of,0,0
30107,the,0,0
30108,neonates,0,0
30109,developed,0,0
30110,respiratory,0,0
30111,depression,0,0
30112,.,0,0
30113,CONCLUSION,0,0
30114,Pethidine,1,1
30115,seems,0,0
30116,to,0,0
30117,be,0,0
30118,a,0,0
30119,better,0,0
30120,alternative,0,0
30121,than,0,0
30122,tramadol,1,1
30123,in,0,0
30124,obstetric,0,0
30125,analgesia,0,0
30126,because,0,0
30127,of,0,0
30128,its,0,0
30129,superiority,0,0
30130,in,0,0
30131,analgesic,0,1
30132,efficacy,0,0
30133,and,0,0
30134,low,0,0
30135,incidence,0,0
30136,of,0,0
30137,maternal,0,0
30138,side,0,0
30139,effects,0,0
30140,.,0,0
30141,Effect,0,0
30142,of,0,0
30143,2,0,0
30144,weeks,0,0
30145,of,0,0
30146,theophylline,0,1
30147,on,0,0
30148,glucose,0,0
30149,counterregulation,0,0
30150,in,0,0
30151,patients,0,0
30152,with,0,0
30153,type,0,0
30154,1,0,0
30155,diabetes,0,0
30156,and,0,0
30157,unawareness,0,0
30158,of,0,0
30159,hypoglycemia,0,0
30160,.,0,0
30161,BACKGROUND,0,0
30162,AND,0,0
30163,OBJECTIVE,0,1
30164,A,0,0
30165,single,0,1
30166,dose,0,0
30167,of,0,0
30168,theophylline,0,1
30169,improves,0,0
30170,hypoglycemia,0,0
30171,unawareness,0,0
30172,in,0,0
30173,type,0,0
30174,1,0,0
30175,diabetic,0,0
30176,patients,0,0
30177,.,0,0
30178,Prolonged,0,0
30179,theophylline,0,1
30180,use,0,0
30181,is,0,0
30182,",",0,0
30183,however,0,0
30184,",",0,0
30185,associated,0,0
30186,with,0,0
30187,emergence,0,0
30188,of,0,0
30189,tolerance,0,0
30190,.,0,0
30191,This,0,0
30192,study,0,0
30193,investigated,0,0
30194,whether,0,0
30195,prolonged,0,0
30196,use,0,0
30197,of,0,0
30198,theophylline,0,1
30199,retains,0,0
30200,efficacy,0,0
30201,for,0,0
30202,counterregulatory,0,0
30203,defects,0,0
30204,in,0,0
30205,patients,0,0
30206,with,0,0
30207,type,0,0
30208,1,0,0
30209,diabetes,0,0
30210,and,0,0
30211,hypoglycemia,0,0
30212,unawareness,0,0
30213,.,0,0
30214,METHODS,0,0
30215,Experiments,0,0
30216,were,0,0
30217,performed,0,0
30218,with,0,0
30219,12,0,0
30220,subjects,0,0
30221,with,0,0
30222,type,0,0
30223,1,0,0
30224,diabetes,0,0
30225,and,0,0
30226,hypoglycemia,0,0
30227,unawareness,0,0
30228,.,0,0
30229,All,0,0
30230,subjects,0,0
30231,participated,0,0
30232,in,0,0
30233,a,0,0
30234,crossover,0,0
30235,study,0,0
30236,of,0,0
30237,2,0,0
30238,randomly,0,0
30239,scheduled,0,0
30240,15-day,1,0
30241,study,1,0
30242,periods,1,0
30243,during,1,0
30244,which,1,0
30245,250,1,1
30246,mg,1,1
30247,theophylline,1,1
30248,twice,1,1
30249,daily,1,1
30250,or,1,1
30251,matching,1,1
30252,placebo,1,1
30253,was,1,0
30254,used,1,0
30255,.,1,0
30256,On,1,0
30257,the,1,0
30258,final,1,0
30259,day,1,0
30260,of,1,0
30261,each,1,0
30262,period,1,0
30263,",",1,0
30264,hyperinsulinemic,1,0
30265,(,1,0
30266,360,1,1
30267,pmol,1,0
30268,x,1,1
30269,m,1,0
30270,(,1,1
30271,-2,1,0
30272,),1,1
30273,x,1,0
30274,min,1,0
30275,(,1,1
30276,-1,1,1
30277,),1,1
30278,),1,1
30279,hypoglycemic,1,1
30280,(,1,0
30281,5.0,1,0
30282,",",1,0
30283,3.5,1,0
30284,",",1,0
30285,2.5,1,0
30286,mmol,1,0
30287,x,1,0
30288,L,1,1
30289,(,1,1
30290,-1,1,1
30291,),1,1
30292,),1,0
30293,glucose,1,0
30294,clamps,1,1
30295,were,1,0
30296,used,1,0
30297,to,1,0
30298,assess,1,0
30299,counterregulatory,1,0
30300,and,1,0
30301,cardiovascular,1,0
30302,responses,1,0
30303,.,1,0
30304,RESULTS,0,0
30305,Under,0,0
30306,normoglycemic,0,0
30307,conditions,0,0
30308,",",0,0
30309,there,0,0
30310,were,0,0
30311,no,0,0
30312,differences,0,0
30313,between,0,0
30314,theophylline,0,1
30315,and,0,0
30316,placebo,0,1
30317,.,0,0
30318,Under,0,0
30319,hypoglycemic,0,0
30320,conditions,0,0
30321,",",0,0
30322,theophylline,0,1
30323,enhanced,0,0
30324,responses,0,0
30325,of,0,0
30326,growth,0,0
30327,hormone,0,1
30328,",",0,0
30329,symptoms,0,0
30330,",",0,0
30331,heart,0,0
30332,rate,0,0
30333,",",0,0
30334,and,0,0
30335,pulse,0,1
30336,pressure,0,0
30337,(,0,0
30338,all,0,0
30339,P,0,0
30340,<,0,0
30341,.05,0,0
30342,),0,0
30343,",",0,0
30344,induced,0,0
30345,sweating,0,0
30346,at,0,0
30347,higher,0,0
30348,plasma,0,0
30349,glucose,0,0
30350,levels,0,0
30351,(,0,0
30352,P,0,0
30353,=.039,0,0
30354,),0,0
30355,",",0,0
30356,and,0,0
30357,reduced,0,0
30358,exogenous,0,1
30359,glucose,0,0
30360,requirements,0,0
30361,(,0,0
30362,P,0,0
30363,=.018,0,0
30364,),0,0
30365,.,0,0
30366,Hypoglycemia-induced,0,0
30367,responses,0,0
30368,of,0,0
30369,epinephrine,0,1
30370,",",0,0
30371,norepinephrine,0,0
30372,",",0,0
30373,and,0,0
30374,cortisol,0,0
30375,were,0,0
30376,not,0,0
30377,enhanced,0,0
30378,by,0,0
30379,theophylline,0,1
30380,.,0,0
30381,CONCLUSIONS,0,0
30382,Prolonged,0,1
30383,use,0,0
30384,of,0,0
30385,theophylline,0,1
30386,has,0,0
30387,a,0,0
30388,sustained,0,0
30389,effect,0,0
30390,on,0,0
30391,cardiovascular,0,0
30392,",",0,0
30393,metabolic,0,0
30394,",",0,0
30395,and,0,0
30396,symptom,0,0
30397,responses,0,0
30398,to,0,0
30399,hypoglycemia,0,0
30400,in,0,0
30401,patients,0,0
30402,with,0,0
30403,type,0,0
30404,1,0,0
30405,diabetes,0,0
30406,and,0,0
30407,hypoglycemia,0,0
30408,unawareness,0,0
30409,.,0,0
30410,Whether,0,0
30411,these,0,0
30412,results,0,0
30413,translate,0,0
30414,into,0,0
30415,clinical,0,0
30416,benefit,0,0
30417,remains,0,0
30418,to,0,0
30419,be,0,0
30420,determined,0,0
30421,.,0,0
30422,An,0,0
30423,in,0,0
30424,vitro,0,0
30425,comparative,0,0
30426,analysis,0,0
30427,:,0,1
30428,scanning,0,1
30429,electron,0,1
30430,microscopy,0,1
30431,of,0,0
30432,dentin/restoration,0,1
30433,interfaces,0,0
30434,.,0,0
30435,One,0,0
30436,hundred,0,0
30437,maxillary,0,0
30438,premolar,0,0
30439,teeth,0,0
30440,were,0,0
30441,randomly,0,0
30442,allocated,0,0
30443,to,0,0
30444,ten,0,0
30445,groups,0,0
30446,.,0,0
30447,Each,0,0
30448,group,0,0
30449,was,0,0
30450,restored,0,0
30451,with,0,0
30452,one,0,0
30453,of,0,0
30454,ten,1,0
30455,different,1,0
30456,restorative,1,1
30457,techniques,1,1
30458,.,1,0
30459,The,0,0
30460,teeth,0,0
30461,were,0,0
30462,stored,0,0
30463,in,0,0
30464,deionized,1,1
30465,water,1,1
30466,for,1,0
30467,7d,1,1
30468,prior,1,0
30469,to,1,0
30470,longitudinal,1,0
30471,sectioning,1,1
30472,in,1,0
30473,a,1,0
30474,mesio-distal,1,0
30475,plane,1,0
30476,.,1,0
30477,Following,0,0
30478,sectioning,0,1
30479,",",0,0
30480,ten,0,0
30481,specimens,0,0
30482,from,0,0
30483,each,0,0
30484,group,0,0
30485,were,0,0
30486,chosen,0,0
30487,at,0,0
30488,random,0,0
30489,from,0,0
30490,the,0,0
30491,20,0,0
30492,available,0,0
30493,sections,0,0
30494,.,0,0
30495,The,0,0
30496,sectioned,0,0
30497,surfaces,0,1
30498,were,0,0
30499,polished,1,1
30500,using,1,0
30501,600-grit,1,1
30502,SiC,1,1
30503,abrasive,1,1
30504,paper,1,0
30505,and,1,0
30506,etched,1,1
30507,for,1,0
30508,10,1,0
30509,s,1,0
30510,with,1,0
30511,50,1,0
30512,%,1,0
30513,phosphoric,1,1
30514,acid,1,1
30515,to,0,0
30516,remove,0,0
30517,the,0,0
30518,smear,0,1
30519,layer,0,1
30520,produced,0,0
30521,by,0,0
30522,sectioning,0,1
30523,.,0,0
30524,Five,0,0
30525,tooth,0,0
30526,sections,0,0
30527,from,0,0
30528,the,0,0
30529,dentin,0,1
30530,bonding,0,1
30531,resin,0,1
30532,groups,0,0
30533,were,0,0
30534,allowed,0,0
30535,to,0,0
30536,dry,0,0
30537,at,0,0
30538,20,0,0
30539,degrees,0,0
30540,C,0,0
30541,for,0,0
30542,24h,0,0
30543,.,0,0
30544,The,0,0
30545,glass,0,1
30546,ionomer-based,0,1
30547,groups,0,0
30548,were,0,0
30549,reimmersed,0,0
30550,in,0,0
30551,deionized,0,1
30552,water,0,1
30553,during,0,0
30554,this,0,0
30555,period,0,0
30556,.,0,0
30557,The,0,0
30558,remaining,0,0
30559,five,0,0
30560,sections,0,0
30561,from,0,0
30562,each,0,0
30563,group,0,0
30564,were,0,0
30565,replicated,0,0
30566,using,0,0
30567,an,0,0
30568,addition-cure,1,1
30569,vinyl,1,1
30570,polysiloxane,1,1
30571,impression,1,0
30572,material,1,0
30573,and,1,0
30574,an,1,0
30575,epoxy,1,1
30576,resin,1,1
30577,.,1,0
30578,A,0,0
30579,comparison,0,0
30580,was,0,0
30581,made,0,0
30582,of,0,0
30583,the,0,0
30584,sections,0,0
30585,and,0,0
30586,the,0,0
30587,replicas,0,1
30588,.,0,0
30589,All,0,0
30590,tooth,0,0
30591,specimens,0,0
30592,were,0,0
30593,sputter-coated,1,1
30594,with,1,0
30595,gold,1,1
30596,for,0,0
30597,4,0,0
30598,min,0,0
30599,and,0,0
30600,examined,0,0
30601,using,0,0
30602,a,0,0
30603,scanning,0,1
30604,electron,0,0
30605,microscope,0,1
30606,.,0,0
30607,Replicas,0,0
30608,were,0,0
30609,gold-coated,0,1
30610,for,0,0
30611,3,0,0
30612,min,0,0
30613,.,0,0
30614,Different,0,0
30615,tooth/restoration,0,1
30616,interfaces,0,0
30617,",",0,0
30618,associated,0,0
30619,with,0,0
30620,different,0,0
30621,materials,0,0
30622,",",0,0
30623,were,0,0
30624,observed,0,0
30625,.,0,0
30626,A,0,0
30627,marked,0,0
30628,difference,0,0
30629,between,0,0
30630,the,0,0
30631,replicas,0,1
30632,and,0,0
30633,tooth,0,0
30634,sections,0,0
30635,was,0,0
30636,observed,0,0
30637,for,0,0
30638,glass,1,1
30639,ionomer-based,1,1
30640,restorations,1,1
30641,but,0,0
30642,not,0,0
30643,for,0,0
30644,resin-based,1,1
30645,bonding,1,0
30646,systems,0,0
30647,.,0,0
30648,Representative,0,0
30649,samples,0,0
30650,of,0,0
30651,replicas,0,1
30652,and,0,0
30653,specimens,0,0
30654,are,0,0
30655,shown,0,0
30656,",",0,0
30657,and,0,0
30658,the,0,0
30659,significance,0,0
30660,of,0,0
30661,the,0,0
30662,observed,0,0
30663,differences,0,0
30664,is,0,0
30665,discussed,0,0
30666,.,0,0
30667,Advice,0,1
30668,or,0,1
30669,exercise,0,1
30670,for,0,0
30671,chronic,0,0
30672,whiplash,0,0
30673,disorders,0,0
30674,?,0,0
30675,Design,0,0
30676,of,0,0
30677,a,0,0
30678,randomized,0,0
30679,controlled,0,0
30680,trial,0,0
30681,.,0,0
30682,BACKGROUND,0,0
30683,Whiplash-associated,0,0
30684,disorder,0,0
30685,(,0,1
30686,or,0,1
30687,whiplash,0,1
30688,),0,1
30689,is,0,0
30690,a,0,0
30691,common,0,0
30692,condition,0,0
30693,incurring,0,0
30694,considerable,0,0
30695,expense,0,0
30696,in,0,0
30697,social,0,0
30698,and,0,0
30699,economic,0,0
30700,terms,0,0
30701,.,0,0
30702,A,0,0
30703,lack,0,0
30704,of,0,0
30705,research,0,0
30706,on,0,0
30707,effective,0,0
30708,therapy,0,1
30709,for,0,0
30710,patients,0,0
30711,with,0,0
30712,chronic,0,0
30713,whiplash,0,0
30714,associated,0,0
30715,disorders,0,0
30716,prompted,0,0
30717,the,0,0
30718,design,0,0
30719,of,0,0
30720,the,0,0
30721,current,0,0
30722,study,0,0
30723,.,0,0
30724,The,0,0
30725,primary,0,0
30726,aim,0,0
30727,of,0,0
30728,this,0,0
30729,randomised,0,0
30730,controlled,0,0
30731,trial,0,0
30732,is,0,0
30733,to,0,0
30734,determine,0,0
30735,the,0,0
30736,effects,0,0
30737,of,0,0
30738,a,0,0
30739,physical,0,1
30740,activity,0,0
30741,program,0,1
30742,for,0,0
30743,people,0,0
30744,with,0,0
30745,chronic,0,0
30746,(,0,0
30747,symptoms,0,0
30748,of,0,0
30749,>,0,0
30750,3,0,0
30751,months,0,0
30752,duration,0,0
30753,),0,0
30754,whiplash,0,0
30755,.,0,0
30756,A,0,0
30757,secondary,0,0
30758,aim,0,0
30759,is,0,0
30760,to,0,0
30761,determine,0,0
30762,if,0,0
30763,pain,0,0
30764,severity,0,0
30765,",",0,0
30766,level,0,0
30767,of,0,0
30768,disability,0,0
30769,and,0,0
30770,fear,0,0
30771,of,0,0
30772,movement/,0,0
30773,(,0,1
30774,re,0,0
30775,),0,1
30776,injury,0,0
30777,predict,0,0
30778,response,0,0
30779,to,0,0
30780,a,0,0
30781,physical,0,1
30782,activity,0,0
30783,program,0,1
30784,.,0,0
30785,METHODS/DESIGN,0,0
30786,This,0,0
30787,paper,0,0
30788,presents,0,0
30789,the,0,0
30790,rationale,0,0
30791,and,0,0
30792,design,0,0
30793,of,0,0
30794,a,0,0
30795,randomised,0,0
30796,controlled,0,0
30797,trial,0,0
30798,examining,0,0
30799,the,0,0
30800,effects,0,0
30801,of,0,0
30802,advice,1,1
30803,and,1,0
30804,individualized,1,1
30805,sub-maximal,1,0
30806,exercise,1,1
30807,programs,1,1
30808,in,0,0
30809,the,0,0
30810,treatment,0,0
30811,of,0,0
30812,whiplash,0,0
30813,associated,0,0
30814,disorders,0,0
30815,.,0,0
30816,DISCUSSION,0,0
30817,This,0,0
30818,paper,0,0
30819,highlights,0,0
30820,the,0,0
30821,design,0,0
30822,",",0,0
30823,methods,0,0
30824,and,0,0
30825,operational,0,0
30826,aspects,0,0
30827,of,0,0
30828,a,0,0
30829,significant,0,0
30830,clinical,0,0
30831,trial,0,0
30832,in,0,0
30833,the,0,0
30834,area,0,0
30835,of,0,0
30836,whiplash,0,0
30837,and,0,0
30838,chronic,0,0
30839,pain,0,0
30840,.,0,0
30841,Investigation,0,0
30842,of,0,0
30843,erosion,0,0
30844,and,0,0
30845,abrasion,0,1
30846,on,0,0
30847,enamel,0,0
30848,and,0,0
30849,dentine,0,1
30850,:,0,1
30851,a,0,0
30852,model,0,0
30853,in,0,0
30854,situ,0,1
30855,using,0,0
30856,toothpastes,1,1
30857,of,0,0
30858,different,0,0
30859,abrasivity,1,1
30860,.,1,0
30861,BACKGROUND,0,0
30862,Studies,0,0
30863,in,0,0
30864,vitro,0,0
30865,suggest,0,0
30866,that,0,0
30867,abrasion,0,1
30868,and,0,0
30869,erosion,0,0
30870,may,0,0
30871,act,0,0
30872,synergistically,0,0
30873,to,0,0
30874,produce,0,0
30875,wear,0,1
30876,of,0,0
30877,enamel,0,0
30878,and,0,0
30879,dentine,0,1
30880,.,0,0
30881,Methods,0,0
30882,in,0,0
30883,situ,0,1
30884,are,0,0
30885,recently,0,0
30886,available,0,0
30887,to,0,0
30888,study,0,0
30889,separately,0,0
30890,erosion,0,0
30891,and,0,0
30892,abrasion,0,1
30893,of,0,0
30894,dental,0,0
30895,tissues,0,0
30896,.,0,0
30897,The,0,0
30898,aim,0,0
30899,of,0,0
30900,this,0,0
30901,study,0,0
30902,was,0,0
30903,to,0,0
30904,combine,0,0
30905,two,0,0
30906,in,0,0
30907,situ,0,1
30908,protocols,0,0
30909,to,0,0
30910,study,0,0
30911,the,0,0
30912,interplay,0,0
30913,between,0,0
30914,erosion,0,0
30915,and,0,0
30916,abrasion,0,1
30917,of,0,0
30918,enamel,0,0
30919,and,0,0
30920,dentine,0,1
30921,.,0,0
30922,METHOD,0,0
30923,The,0,0
30924,study,0,0
30925,was,0,0
30926,a,0,0
30927,single-blind,0,0
30928,",",0,0
30929,randomised,0,0
30930,",",0,0
30931,five-treatment,1,0
30932,cross-over,1,0
30933,design,1,0
30934,involving,0,0
30935,15,0,0
30936,healthy,0,0
30937,volunteers,0,0
30938,.,0,0
30939,During,0,0
30940,each,0,0
30941,10-day,0,1
30942,study,0,0
30943,period,0,0
30944,",",0,0
30945,subjects,0,0
30946,wore,0,0
30947,from,0,0
30948,0900,0,0
30949,to,0,0
30950,1700,0,0
30951,h,0,0
30952,an,0,0
30953,upper,1,0
30954,removable,1,1
30955,acrylic,1,1
30956,appliance,1,1
30957,holding,1,0
30958,one,1,0
30959,polished,1,1
30960,enamel,1,0
30961,and,1,0
30962,one,1,0
30963,polished,1,1
30964,dentine,1,0
30965,specimen,1,0
30966,.,1,0
30967,The,0,0
30968,specimen,0,0
30969,treatment,0,0
30970,regimens,0,1
30971,were,0,0
30972,:,0,0
30973,1,0,0
30974,.,0,0
30975,Drinking,1,0
30976,water,1,1
30977,and,0,0
30978,brushing,1,1
30979,with,0,0
30980,toothpaste,1,1
30981,A,0,0
30982,.,0,0
30983,2,0,0
30984,.,0,0
30985,Drinking,0,0
30986,water,0,1
30987,and,0,0
30988,brushing,0,1
30989,with,0,0
30990,toothpaste,0,1
30991,B,0,0
30992,.,0,0
30993,3,0,0
30994,.,0,0
30995,Drinking,1,0
30996,orange,1,1
30997,juice,1,1
30998,.,1,0
30999,4,0,0
31000,.,0,0
31001,Drinking,0,0
31002,orange,1,1
31003,juice,1,1
31004,and,1,0
31005,brushing,1,1
31006,with,1,0
31007,toothpaste,1,1
31008,A,0,0
31009,.,0,0
31010,5,0,0
31011,.,0,0
31012,Drinking,0,0
31013,orange,0,1
31014,juice,0,1
31015,and,0,0
31016,brushing,0,1
31017,with,0,0
31018,toothpaste,0,1
31019,B,0,1
31020,.,0,1
31021,Drinking,0,0
31022,and,0,0
31023,brushing,0,1
31024,times,0,0
31025,were,0,0
31026,around,0,0
31027,0900,0,0
31028,",",0,0
31029,1100,0,0
31030,",",0,0
31031,1300,0,0
31032,and,0,0
31033,1500,0,0
31034,h.,0,0
31035,Drinks,0,1
31036,were,0,0
31037,consumed,0,0
31038,as,0,0
31039,250,0,1
31040,ml,0,0
31041,over,0,0
31042,10,0,0
31043,min,0,0
31044,and,0,0
31045,brushing,0,1
31046,ex,0,1
31047,vivo,0,0
31048,for,0,0
31049,1,0,0
31050,min,0,0
31051,to,0,0
31052,each,0,0
31053,specimen,0,0
31054,.,0,0
31055,Measurement,0,0
31056,of,0,0
31057,tissue,0,0
31058,loss,0,0
31059,was,0,0
31060,made,0,0
31061,on,0,0
31062,days,0,0
31063,5,0,0
31064,and,0,0
31065,10,0,0
31066,of,0,0
31067,each,0,0
31068,period,0,0
31069,using,0,0
31070,a,0,0
31071,profilometer,0,1
31072,.,0,0
31073,RESULTS,0,0
31074,All,0,0
31075,treatments,0,1
31076,produced,0,0
31077,increasing,0,0
31078,tissue,0,0
31079,loss,0,0
31080,over,0,0
31081,time,0,0
31082,",",0,0
31083,which,0,0
31084,was,0,0
31085,considerably,0,0
31086,greater,0,0
31087,for,0,0
31088,dentine,0,0
31089,than,0,0
31090,enamel,0,0
31091,.,0,0
31092,For,0,0
31093,enamel,0,0
31094,",",0,0
31095,the,0,0
31096,data,0,0
31097,at,0,0
31098,days,0,0
31099,5,0,0
31100,and,0,0
31101,10,0,0
31102,showed,0,0
31103,a,0,0
31104,significant,0,0
31105,effect,0,0
31106,for,0,0
31107,erosion,0,0
31108,(,0,0
31109,i.e,0,1
31110,.,0,1
31111,orange,0,1
31112,juice,0,1
31113,was,0,0
31114,significantly,0,0
31115,more,0,0
31116,erosive,0,0
31117,than,0,0
31118,water,0,1
31119,),0,0
31120,",",0,0
31121,but,0,0
31122,no,0,0
31123,significant,0,0
31124,effect,0,0
31125,for,0,0
31126,abrasion,0,1
31127,(,0,0
31128,i.e,0,1
31129,.,0,0
31130,no,0,0
31131,significant,0,0
31132,difference,0,0
31133,between,0,0
31134,the,0,0
31135,two,0,0
31136,toothpaste,0,1
31137,treatments,0,0
31138,),0,0
31139,.,0,0
31140,The,0,0
31141,combined,0,1
31142,orange,0,1
31143,juice,0,1
31144,and,0,0
31145,toothpaste,0,1
31146,effects,0,0
31147,were,0,0
31148,directional,0,0
31149,for,0,0
31150,synergy,0,1
31151,but,0,0
31152,did,0,0
31153,not,0,0
31154,reach,0,0
31155,significance,0,0
31156,.,0,0
31157,For,0,0
31158,dentine,0,0
31159,at,0,0
31160,day,0,0
31161,10,0,0
31162,",",0,0
31163,many,0,0
31164,specimens,0,0
31165,exceeded,0,0
31166,the,0,0
31167,50,0,0
31168,microm,0,0
31169,set,0,0
31170,limit,0,0
31171,of,0,0
31172,the,0,0
31173,profilometer,0,1
31174,and,0,0
31175,only,0,0
31176,day,0,0
31177,5,0,0
31178,data,0,0
31179,were,0,0
31180,considered,0,0
31181,.,0,0
31182,There,0,0
31183,were,0,0
31184,significant,0,0
31185,effects,0,0
31186,for,0,0
31187,erosion,0,0
31188,(,0,0
31189,orange,0,1
31190,juice,0,1
31191,produced,0,0
31192,significantly,0,0
31193,more,0,0
31194,erosion,0,0
31195,than,0,0
31196,water,0,1
31197,),0,1
31198,and,0,0
31199,for,0,0
31200,abrasion,0,1
31201,(,0,0
31202,paste,0,1
31203,A,0,0
31204,was,0,0
31205,significantly,0,0
31206,more,0,0
31207,abrasive,0,1
31208,to,0,0
31209,dentine,0,1
31210,than,0,0
31211,paste,0,1
31212,B,0,0
31213,),0,0
31214,.,0,0
31215,The,0,0
31216,synergy,0,1
31217,effect,0,0
31218,could,0,0
31219,not,0,0
31220,be,0,0
31221,examined,0,0
31222,for,0,0
31223,dentine,0,0
31224,due,0,0
31225,to,0,0
31226,the,0,0
31227,truncation,0,0
31228,effect,0,0
31229,as,0,0
31230,the,0,0
31231,set,0,0
31232,limit,0,0
31233,of,0,0
31234,the,0,0
31235,profilometer,0,1
31236,was,0,0
31237,exceeded,0,0
31238,.,0,0
31239,CONCLUSIONS,0,0
31240,Erosion,0,0
31241,increases,0,0
31242,the,0,0
31243,susceptibility,0,0
31244,of,0,0
31245,enamel,0,0
31246,to,0,0
31247,toothpaste,0,1
31248,abrasion,0,1
31249,.,0,0
31250,Dentine,0,0
31251,is,0,0
31252,considerably,0,0
31253,more,0,0
31254,susceptible,0,0
31255,than,0,0
31256,enamel,0,0
31257,to,0,0
31258,erosion,0,0
31259,and,0,0
31260,abrasion,0,1
31261,alone,0,1
31262,or,0,0
31263,combined,0,1
31264,.,0,0
31265,Dentine,0,0
31266,loss,0,0
31267,appears,0,0
31268,to,0,0
31269,correlate,0,0
31270,with,0,0
31271,toothpaste,0,1
31272,abrasivity,0,1
31273,(,0,1
31274,RDA,0,1
31275,value,0,0
31276,),0,0
31277,.,0,0
31278,Gastric,0,0
31279,dysrhythmia,0,1
31280,in,0,0
31281,infants,0,0
31282,with,0,0
31283,gastrointestinal,0,0
31284,diseases,0,0
31285,measured,0,0
31286,by,0,0
31287,epigastric,1,0
31288,impedance,1,0
31289,.,1,0
31290,BACKGROUND,0,0
31291,Gastrointestinal,0,0
31292,symptoms,0,0
31293,have,0,0
31294,been,0,0
31295,reported,0,0
31296,in,0,0
31297,association,0,0
31298,with,0,0
31299,myoelectrical,0,0
31300,dysrhythmia,0,0
31301,",",0,0
31302,where,0,0
31303,different,0,0
31304,types,0,0
31305,of,0,0
31306,gastric,0,0
31307,electrical,0,1
31308,activity,0,0
31309,have,0,0
31310,been,0,0
31311,described,0,0
31312,.,0,0
31313,These,0,0
31314,types,0,0
31315,of,0,0
31316,gastric,0,0
31317,myoelectrical,0,0
31318,activity,0,0
31319,and,0,0
31320,dysrhythmia,0,1
31321,can,0,0
31322,be,0,0
31323,measured,0,0
31324,by,0,0
31325,electrogastrography,1,1
31326,using,0,0
31327,cutaneous,0,0
31328,electrodes,0,1
31329,.,0,0
31330,Epigastric,1,0
31331,impedance,1,0
31332,is,0,0
31333,a,0,0
31334,non-invasive,0,0
31335,method,0,1
31336,used,0,0
31337,to,0,0
31338,study,0,0
31339,gastric,0,0
31340,emptying,0,0
31341,time,0,0
31342,and,0,0
31343,gastric,0,0
31344,phasic,0,0
31345,activity,0,0
31346,.,0,0
31347,At,0,0
31348,present,0,0
31349,no,0,0
31350,study,0,0
31351,of,0,0
31352,gastric,0,0
31353,dysrhythmia,0,0
31354,",",0,0
31355,measured,0,0
31356,with,0,0
31357,epigastric,1,0
31358,impedance,1,0
31359,",",0,0
31360,has,0,0
31361,been,0,0
31362,presented,0,0
31363,",",0,0
31364,and,0,0
31365,the,0,0
31366,purpose,0,0
31367,of,0,0
31368,the,0,0
31369,present,0,0
31370,study,0,0
31371,was,0,0
31372,to,0,0
31373,investigate,0,0
31374,gastric,0,0
31375,rhythms,0,0
31376,by,0,0
31377,means,0,0
31378,of,0,0
31379,impedance,1,1
31380,gastrography,1,1
31381,in,0,0
31382,control,0,0
31383,infants,0,0
31384,",",0,0
31385,compared,0,0
31386,to,0,0
31387,infants,0,0
31388,with,0,0
31389,different,0,0
31390,gastrointestinal,0,0
31391,diseases,0,0
31392,",",0,0
31393,before,0,0
31394,and,0,0
31395,after,0,0
31396,treatment,0,0
31397,of,0,0
31398,their,0,0
31399,disease,0,0
31400,.,0,0
31401,METHOD,0,0
31402,21,0,0
31403,patients,0,0
31404,(,0,0
31405,age,0,0
31406,0-2,0,0
31407,months,0,0
31408,),0,0
31409,and,0,0
31410,40,0,1
31411,healthy,0,0
31412,infants,0,0
31413,(,0,0
31414,age,0,0
31415,0-2,0,0
31416,months,0,0
31417,),0,0
31418,were,0,0
31419,investigated,0,0
31420,.,0,0
31421,The,0,0
31422,patients,0,0
31423,suffered,0,0
31424,from,0,0
31425,partial,0,0
31426,or,0,1
31427,total,0,0
31428,intestinal,0,0
31429,obstruction,0,0
31430,",",0,0
31431,necrotizing,0,0
31432,enterocolitis,0,0
31433,or,0,1
31434,pyloric,0,1
31435,stenosis.All,0,0
31436,infants,0,0
31437,were,0,0
31438,fasting,0,0
31439,and,0,0
31440,studied,0,0
31441,during,0,0
31442,periods,0,0
31443,of,0,0
31444,at,0,0
31445,least,0,0
31446,one,0,0
31447,hour,0,0
31448,.,0,0
31449,The,0,0
31450,patients,0,0
31451,were,0,0
31452,examined,0,0
31453,in,0,0
31454,the,0,0
31455,acute,0,0
31456,state,0,0
31457,and,0,0
31458,after,0,0
31459,treatment,0,0
31460,when,0,0
31461,possible,0,0
31462,.,0,0
31463,RESULTS,0,0
31464,A,0,0
31465,pathologic,0,0
31466,result,0,0
31467,was,0,0
31468,found,0,0
31469,in,0,0
31470,90,0,0
31471,%,0,0
31472,of,0,0
31473,the,0,0
31474,patients,0,0
31475,.,0,0
31476,A,0,0
31477,persistent,0,0
31478,phasic,0,0
31479,activity,0,0
31480,pattern,0,0
31481,was,0,0
31482,found,0,0
31483,in,0,0
31484,19,0,0
31485,of,0,0
31486,the,0,0
31487,21,0,0
31488,patients,0,0
31489,",",0,0
31490,high,0,0
31491,frequency,0,0
31492,phasic,0,0
31493,activity,0,0
31494,in,0,0
31495,11,0,0
31496,of,0,0
31497,the,0,0
31498,21,0,0
31499,patients,0,0
31500,.,0,0
31501,Short-term,0,0
31502,phasic,0,0
31503,activity,0,0
31504,was,0,0
31505,only,0,0
31506,found,0,0
31507,in,0,0
31508,13,0,0
31509,out,0,0
31510,of,0,0
31511,40,0,0
31512,of,0,0
31513,the,0,0
31514,normal,0,0
31515,infants,0,0
31516,(,0,0
31517,32.5,0,0
31518,%,0,0
31519,),0,0
31520,.,0,0
31521,CONCLUSION,0,0
31522,Using,0,0
31523,epigastric,1,0
31524,impedance,1,1
31525,we,0,0
31526,found,0,0
31527,that,0,0
31528,infants,0,0
31529,with,0,0
31530,partial,0,0
31531,or,0,1
31532,total,0,0
31533,intestinal,0,0
31534,obstruction,0,0
31535,had,0,0
31536,gastric,0,0
31537,phasic,0,0
31538,activity,0,0
31539,",",0,0
31540,which,0,0
31541,was,0,0
31542,not,0,0
31543,found,0,0
31544,in,0,0
31545,the,0,0
31546,control,0,0
31547,infants,0,0
31548,.,0,0
31549,The,0,0
31550,origin,0,0
31551,of,0,0
31552,the,0,0
31553,gastric,0,0
31554,phasic,0,0
31555,activity,0,0
31556,patterns,0,1
31557,is,0,0
31558,unknown,0,0
31559,",",0,0
31560,but,0,0
31561,they,0,0
31562,may,0,0
31563,be,0,0
31564,related,0,0
31565,to,0,0
31566,electrical,0,1
31567,control,0,1
31568,activity,0,0
31569,.,0,0
31570,Cone,0,1
31571,biopsy,0,1
31572,:,0,0
31573,has,0,0
31574,endocervical,1,0
31575,sampling,1,0
31576,a,0,0
31577,role,0,0
31578,?,0,0
31579,OBJECTIVE,0,0
31580,To,0,0
31581,investigate,0,0
31582,the,0,0
31583,sensitivity,0,0
31584,",",0,0
31585,specificity,0,0
31586,and,0,0
31587,predictive,0,0
31588,value,0,0
31589,of,0,0
31590,endocervical,1,1
31591,sampling,1,0
31592,in,0,0
31593,women,0,0
31594,with,0,0
31595,abnormal,0,0
31596,cervical,0,0
31597,smears,0,0
31598,.,0,0
31599,DESIGN,0,0
31600,A,0,0
31601,randomized,0,0
31602,study,0,0
31603,of,0,0
31604,two,0,0
31605,methods,0,0
31606,of,0,0
31607,endocervical,1,0
31608,sampling,1,0
31609,.,1,0
31610,SETTING,0,0
31611,Colposcopy,0,1
31612,clinic,0,0
31613,at,0,0
31614,Aberdeen,0,0
31615,Royal,0,1
31616,Infirmary,0,0
31617,.,0,0
31618,SUBJECTS,0,0
31619,100,0,0
31620,women,0,0
31621,with,0,0
31622,abnormal,0,0
31623,cervical,0,0
31624,smears,0,0
31625,selected,0,0
31626,for,0,0
31627,cone,0,1
31628,biopsy,0,1
31629,according,0,0
31630,to,0,0
31631,current,0,0
31632,colposcopy,0,1
31633,criteria,0,0
31634,.,0,0
31635,INTERVENTIONS,0,0
31636,53,0,0
31637,women,0,0
31638,were,0,0
31639,randomized,0,0
31640,to,0,0
31641,have,0,0
31642,endocervical,1,1
31643,sampling,1,0
31644,with,1,0
31645,the,1,0
31646,Kevorkian,1,0
31647,curette,1,1
31648,and,0,0
31649,47,0,0
31650,to,0,0
31651,have,0,0
31652,sampling,1,0
31653,with,1,0
31654,the,1,0
31655,Medscand,1,1
31656,endocervical,1,1
31657,brush,1,1
31658,.,1,0
31659,MAIN,0,0
31660,OUTCOME,0,0
31661,MEASURES,0,0
31662,Cytology,0,1
31663,and,0,0
31664,histology,0,0
31665,results,0,0
31666,from,0,0
31667,endocervical,1,0
31668,sampling,1,0
31669,compared,0,0
31670,with,0,0
31671,cone,0,1
31672,biopsy,0,1
31673,histology,0,0
31674,.,0,0
31675,RESULTS,0,0
31676,The,0,0
31677,overall,0,0
31678,sensitivity,0,0
31679,of,0,0
31680,endocervical,1,1
31681,sampling,1,0
31682,was,0,0
31683,56,0,0
31684,%,0,0
31685,",",0,0
31686,with,0,0
31687,a,0,0
31688,false,0,0
31689,negative,0,0
31690,rate,0,0
31691,of,0,0
31692,44,0,0
31693,%,0,0
31694,and,0,0
31695,a,0,0
31696,negative,0,0
31697,predictive,0,0
31698,value,0,0
31699,of,0,0
31700,26,0,0
31701,%,0,0
31702,.,0,0
31703,CONCLUSIONS,0,0
31704,Endocervical,1,0
31705,sampling,1,0
31706,should,0,0
31707,not,0,0
31708,influence,0,0
31709,management,0,1
31710,when,0,0
31711,colposcopy,0,1
31712,is,0,0
31713,unsatisfactory,0,0
31714,.,0,0
31715,Perioperative,0,1
31716,immunotherapy,0,1
31717,with,0,0
31718,recombinant,1,1
31719,interleukin,1,1
31720,2,1,0
31721,in,0,0
31722,patients,0,0
31723,undergoing,0,0
31724,surgery,0,0
31725,for,0,0
31726,colorectal,0,0
31727,cancer,0,0
31728,.,0,0
31729,Major,0,0
31730,surgery,0,0
31731,impairs,0,0
31732,the,0,0
31733,cellular,0,0
31734,immune,0,0
31735,response,0,0
31736,.,0,0
31737,We,0,0
31738,have,0,0
31739,therefore,0,0
31740,studied,0,0
31741,the,0,0
31742,immunological,0,0
31743,effects,0,0
31744,of,0,0
31745,low-dose,1,1
31746,recombinant,1,1
31747,interleukin,1,1
31748,2,1,0
31749,given,0,0
31750,to,0,0
31751,patients,0,0
31752,undergoing,0,0
31753,surgery,0,1
31754,for,0,0
31755,colorectal,0,0
31756,cancer,0,0
31757,to,0,0
31758,determine,0,0
31759,whether,0,0
31760,this,0,0
31761,agent,0,0
31762,has,0,0
31763,potential,0,0
31764,in,0,0
31765,perioperative,0,0
31766,adjuvant,0,1
31767,immunotherapy,0,1
31768,.,0,0
31769,Patients,0,0
31770,were,0,0
31771,randomly,0,0
31772,allocated,0,0
31773,to,0,0
31774,control,1,1
31775,(,0,0
31776,n,0,0
31777,=,0,0
31778,13,0,0
31779,),0,0
31780,or,0,1
31781,treatment,0,1
31782,groups,0,0
31783,(,0,0
31784,n,0,0
31785,=,0,0
31786,12,0,0
31787,),0,0
31788,.,0,0
31789,Immunological,0,0
31790,studies,0,0
31791,of,0,0
31792,both,0,0
31793,lymphocyte,0,0
31794,function,0,0
31795,and,0,0
31796,subset,0,0
31797,number,0,0
31798,were,0,0
31799,performed,0,0
31800,preoperatively,0,0
31801,and,0,0
31802,on,0,0
31803,Days,0,0
31804,1,0,0
31805,",",0,0
31806,4,0,0
31807,",",0,0
31808,7,0,0
31809,",",0,0
31810,and,0,0
31811,10,0,0
31812,.,0,0
31813,Treatment,0,0
31814,with,0,0
31815,recombinant,1,1
31816,interleukin,1,1
31817,2,1,0
31818,prevented,0,0
31819,the,0,0
31820,postoperative,0,0
31821,fall,0,0
31822,in,0,0
31823,both,0,0
31824,natural,0,0
31825,killer,0,1
31826,and,0,0
31827,lymphokine-activated,0,1
31828,killer,0,1
31829,cell,0,0
31830,cytotoxicity,0,0
31831,",",0,0
31832,clearly,0,0
31833,demonstrated,0,0
31834,in,0,0
31835,the,0,0
31836,control,0,0
31837,group,0,0
31838,.,0,0
31839,The,0,0
31840,treatment,0,0
31841,group,0,0
31842,also,0,0
31843,showed,0,0
31844,in,0,0
31845,vivo,0,0
31846,T-cell,0,0
31847,activation,0,0
31848,with,0,0
31849,an,0,0
31850,initial,0,0
31851,lymphopenia,0,0
31852,followed,0,1
31853,by,0,0
31854,a,0,0
31855,rebound,0,0
31856,lymphocytosis,0,0
31857,and,0,0
31858,upregulation,0,0
31859,of,0,0
31860,the,0,0
31861,subset,0,0
31862,markers,0,0
31863,CD25,0,1
31864,(,0,0
31865,interleukin,0,1
31866,2,0,1
31867,receptor,0,0
31868,),0,0
31869,and,0,1
31870,CD45RO,0,1
31871,(,0,1
31872,T-memory,0,0
31873,cells,0,0
31874,),0,0
31875,.,0,0
31876,These,0,0
31877,combined,0,0
31878,effects,0,0
31879,may,0,0
31880,have,0,0
31881,important,0,0
31882,consequences,0,0
31883,in,0,0
31884,controlling,0,0
31885,metastatic,0,0
31886,dissemination,0,0
31887,of,0,0
31888,tumor,0,0
31889,during,0,0
31890,the,0,0
31891,vulnerable,0,0
31892,perioperative,0,0
31893,period,0,0
31894,.,0,0
31895,Isoflurane,0,1
31896,and,0,0
31897,propofol,0,1
31898,for,0,0
31899,long-term,0,0
31900,sedation,0,0
31901,in,0,0
31902,the,0,0
31903,intensive,0,1
31904,care,0,1
31905,unit,0,0
31906,.,0,0
31907,A,0,0
31908,crossover,0,0
31909,study,0,0
31910,.,0,0
31911,Propofol,1,1
31912,and,1,0
31913,isoflurane,1,1
31914,have,0,0
31915,been,0,0
31916,reported,0,0
31917,recently,0,0
31918,to,0,0
31919,offer,0,0
31920,better,0,0
31921,sedation,0,0
31922,than,0,0
31923,alternative,0,0
31924,agents,0,0
31925,in,0,0
31926,patients,0,0
31927,who,0,0
31928,require,0,0
31929,long-term,0,0
31930,ventilation,0,1
31931,in,0,0
31932,the,0,0
31933,Intensive,0,0
31934,Care,0,0
31935,Unit,0,0
31936,.,0,0
31937,This,0,0
31938,is,0,0
31939,the,0,0
31940,first,0,0
31941,report,0,0
31942,of,0,0
31943,a,0,0
31944,direct,0,0
31945,comparison,0,0
31946,between,0,0
31947,propofol,1,1
31948,and,0,0
31949,isoflurane,1,1
31950,.,1,0
31951,Twenty-four,0,0
31952,patients,0,0
31953,predicted,0,0
31954,to,0,0
31955,require,0,0
31956,artificial,0,1
31957,ventilation,0,1
31958,for,0,0
31959,at,0,0
31960,least,0,0
31961,48,0,0
31962,h,0,0
31963,were,0,0
31964,entered,0,0
31965,into,0,0
31966,a,0,0
31967,randomised,1,0
31968,crossover,1,0
31969,study,1,0
31970,to,1,0
31971,monitor,1,0
31972,sedation,1,0
31973,quality,1,0
31974,and,1,0
31975,time,1,0
31976,to,1,0
31977,recovery,1,0
31978,from,1,0
31979,sedation,1,0
31980,.,1,0
31981,There,0,0
31982,were,0,0
31983,no,0,0
31984,significant,0,0
31985,differences,0,0
31986,between,0,0
31987,the,0,0
31988,two,0,0
31989,agents,0,0
31990,in,0,0
31991,either,0,0
31992,end-point,0,0
31993,",",0,0
31994,with,0,0
31995,over,0,0
31996,95,0,0
31997,%,0,0
31998,optimal,0,0
31999,sedation,0,0
32000,achieved,0,0
32001,by,0,0
32002,the,0,0
32003,use,0,0
32004,of,0,0
32005,each,0,0
32006,drug,0,0
32007,.,0,0
32008,Few,0,0
32009,adverse,0,0
32010,events,0,0
32011,were,0,0
32012,noted,0,0
32013,.,0,0
32014,Technological,0,0
32015,advances,0,0
32016,in,0,0
32017,the,0,0
32018,administration,0,0
32019,of,0,0
32020,volatile,0,0
32021,agents,0,1
32022,as,0,0
32023,long-term,0,0
32024,sedatives,0,0
32025,in,0,0
32026,the,0,0
32027,Intensive,0,0
32028,Care,0,0
32029,Unit,0,0
32030,may,0,0
32031,facilitate,0,0
32032,their,0,0
32033,more,0,0
32034,widespread,0,0
32035,use,0,0
32036,.,0,0
32037,Prevention,0,1
32038,of,0,0
32039,acute,0,0
32040,postoperative,0,0
32041,pressure,0,0
32042,rises,0,0
32043,in,0,0
32044,glaucoma,0,0
32045,patients,0,0
32046,undergoing,0,0
32047,cataract,0,0
32048,extraction,0,0
32049,with,0,0
32050,posterior,0,0
32051,chamber,0,1
32052,lens,0,1
32053,implant,0,1
32054,.,0,0
32055,Acute,0,0
32056,elevations,0,0
32057,in,0,0
32058,intraocular,0,1
32059,pressure,0,0
32060,(,0,1
32061,IOP,0,1
32062,),0,1
32063,commonly,0,0
32064,follow,0,0
32065,extracapsular,0,0
32066,cataract,0,0
32067,extraction,0,1
32068,and,0,0
32069,lens,0,1
32070,implant,0,1
32071,in,0,0
32072,glaucoma,0,0
32073,patients,0,0
32074,.,0,0
32075,Thirty,0,0
32076,six,0,0
32077,patients,0,0
32078,with,0,0
32079,glaucoma,0,0
32080,undergoing,0,0
32081,cataract,0,0
32082,extraction,0,1
32083,and,0,0
32084,posterior,0,1
32085,chamber,0,1
32086,lens,0,1
32087,implantation,0,0
32088,received,0,0
32089,one,0,0
32090,of,0,0
32091,three,0,0
32092,treatments,0,0
32093,.,0,0
32094,Group,0,0
32095,1,0,0
32096,:,0,0
32097,500,0,0
32098,mg,0,1
32099,of,0,0
32100,Diamox,1,1
32101,Sustets,1,0
32102,(,1,1
32103,acetazolamide,1,1
32104,),1,0
32105,1,0,0
32106,hour,0,0
32107,preoperatively,0,1
32108,(,0,0
32109,10,0,1
32110,patients,0,0
32111,),0,0
32112,;,0,0
32113,Group,0,0
32114,2,0,0
32115,:,0,0
32116,peroperative,1,0
32117,intracameral,1,1
32118,Miochol,1,1
32119,(,1,1
32120,acetylcholine,1,1
32121,),1,1
32122,(,0,0
32123,11,0,0
32124,patients,0,0
32125,),0,0
32126,;,0,0
32127,Group,0,0
32128,3,0,0
32129,:,0,0
32130,the,0,0
32131,above,0,0
32132,treatments,1,1
32133,combined,1,1
32134,(,0,0
32135,15,0,0
32136,patients,0,0
32137,),0,0
32138,.,0,0
32139,IOPs,0,0
32140,were,0,0
32141,measured,0,0
32142,at,0,0
32143,3,0,0
32144,",",0,0
32145,6,0,0
32146,",",0,0
32147,9,0,0
32148,",",0,0
32149,and,0,0
32150,24,0,0
32151,hours,0,0
32152,postoperatively,0,0
32153,.,0,0
32154,The,0,0
32155,average,0,0
32156,of,0,0
32157,the,0,0
32158,maximum,0,0
32159,pressure,0,0
32160,rises,0,0
32161,above,0,0
32162,the,0,0
32163,preoperative,0,0
32164,level,0,0
32165,over,0,0
32166,the,0,0
32167,24,0,0
32168,hour,0,0
32169,period,0,0
32170,was,0,0
32171,greatest,0,0
32172,for,0,0
32173,the,0,0
32174,group,0,0
32175,receiving,0,0
32176,acetazolamide,1,1
32177,only,0,0
32178,at,0,0
32179,8.9,0,0
32180,mm,0,0
32181,Hg,0,0
32182,;,0,0
32183,for,0,0
32184,the,0,0
32185,acetylcholine,1,1
32186,group,0,0
32187,the,0,0
32188,average,0,0
32189,maximum,0,0
32190,rise,0,0
32191,was,0,0
32192,6.3,0,0
32193,mm,0,0
32194,Hg,0,0
32195,;,0,0
32196,while,0,0
32197,the,0,0
32198,combined,0,1
32199,treatment,0,0
32200,group,0,0
32201,showed,0,0
32202,a,0,0
32203,decrease,0,0
32204,of,0,0
32205,0.7,0,0
32206,mm,0,0
32207,Hg,0,0
32208,.,0,0
32209,IOP,0,0
32210,rises,0,0
32211,of,0,0
32212,>,0,0
32213,6,0,0
32214,mm,0,0
32215,Hg,0,0
32216,were,0,0
32217,seen,0,0
32218,in,0,0
32219,7,0,0
32220,%,0,0
32221,of,0,0
32222,patients,0,0
32223,(,0,0
32224,one,0,0
32225,of,0,0
32226,15,0,0
32227,),0,0
32228,in,0,0
32229,the,0,0
32230,combined,0,1
32231,treatment,0,0
32232,group,0,0
32233,",",0,0
32234,45,0,0
32235,%,0,0
32236,(,0,0
32237,five,0,0
32238,of,0,0
32239,11,0,0
32240,),0,0
32241,of,0,0
32242,the,0,0
32243,acetylcholine,1,1
32244,group,0,0
32245,",",0,0
32246,and,0,0
32247,70,0,0
32248,%,0,0
32249,(,0,0
32250,seven,0,0
32251,of,0,0
32252,10,0,0
32253,),0,0
32254,of,0,0
32255,the,0,0
32256,acetazolamide,1,1
32257,group,0,0
32258,.,0,0
32259,IOP,0,0
32260,rises,0,0
32261,of,0,0
32262,>,0,0
32263,10,0,0
32264,mm,0,0
32265,Hg,0,0
32266,were,0,0
32267,seen,0,0
32268,in,0,0
32269,7,0,0
32270,%,0,0
32271,of,0,0
32272,the,0,0
32273,combined,0,1
32274,treatment,0,0
32275,group,0,0
32276,",",0,0
32277,in,0,0
32278,18,0,0
32279,%,0,0
32280,of,0,0
32281,the,0,0
32282,acetylcholine,1,1
32283,only,0,0
32284,group,0,0
32285,",",0,0
32286,and,0,0
32287,in,0,0
32288,50,0,1
32289,%,0,0
32290,of,0,0
32291,the,0,0
32292,acetazolamide,1,1
32293,only,0,0
32294,group,0,0
32295,.,0,0
32296,A,0,0
32297,pressure,0,0
32298,rise,0,0
32299,>,0,0
32300,20,0,0
32301,mm,0,0
32302,Hg,0,0
32303,was,0,0
32304,seen,0,0
32305,in,0,0
32306,one,0,0
32307,patient,0,0
32308,receiving,0,0
32309,acetazolamide,1,1
32310,only,0,0
32311,and,0,0
32312,one,0,0
32313,patient,0,0
32314,receiving,0,0
32315,acetylcholine,1,1
32316,only,0,0
32317,.,0,0
32318,The,0,0
32319,difference,0,0
32320,between,0,0
32321,the,0,0
32322,acetylcholine,1,1
32323,group,0,0
32324,and,0,0
32325,the,0,0
32326,combined,0,1
32327,group,0,0
32328,for,0,0
32329,rises,0,0
32330,>,0,0
32331,6,0,0
32332,mm,0,0
32333,Hg,0,0
32334,was,0,0
32335,significant,0,0
32336,using,0,0
32337,the,0,0
32338,chi,0,0
32339,2,0,0
32340,test,0,0
32341,while,0,0
32342,the,0,0
32343,acetazolamide,1,1
32344,group,0,0
32345,showed,0,0
32346,a,0,0
32347,significant,0,0
32348,difference,0,0
32349,for,0,0
32350,rises,0,0
32351,>,0,0
32352,6,0,0
32353,and,0,0
32354,10,0,0
32355,mm,0,0
32356,Hg,0,0
32357,compared,0,0
32358,with,0,0
32359,the,0,0
32360,combined,0,1
32361,group,0,0
32362,.,0,0
32363,All,0,0
32364,acute,0,0
32365,pressure,0,0
32366,rises,0,0
32367,were,0,0
32368,recorded,0,0
32369,before,0,0
32370,or,0,0
32371,at,0,0
32372,9,0,0
32373,hours,0,0
32374,following,0,0
32375,operation,0,0
32376,except,0,0
32377,in,0,0
32378,the,0,0
32379,combined,1,1
32380,treatment,1,0
32381,patient,0,0
32382,where,0,0
32383,the,0,0
32384,rise,0,0
32385,occurred,0,0
32386,at,0,0
32387,24,0,0
32388,hours,0,0
32389,.,0,0
32390,To,0,0
32391,prevent,0,0
32392,the,0,0
32393,acute,0,0
32394,IOP,0,1
32395,rises,0,0
32396,seen,0,0
32397,following,0,0
32398,cataract,0,0
32399,surgery,0,1
32400,with,0,0
32401,lens,0,1
32402,implant,0,1
32403,in,0,0
32404,glaucoma,0,0
32405,patients,0,0
32406,we,0,0
32407,recommend,0,0
32408,combined,0,1
32409,ocular,0,0
32410,hypotensive,0,0
32411,therapy,0,1
32412,.,0,0
32413,Measuring,0,0
32414,adherence,0,0
32415,in,0,0
32416,a,0,0
32417,hypertension,0,0
32418,clinical,0,0
32419,trial,0,0
32420,.,0,0
32421,BACKGROUND,0,0
32422,Non-adherence,0,0
32423,in,0,0
32424,hypertension,0,0
32425,is,0,0
32426,a,0,0
32427,global,0,0
32428,problem,0,0
32429,and,0,0
32430,promoting,0,1
32431,adherence,0,1
32432,is,0,0
32433,necessary,0,0
32434,to,0,0
32435,decrease,0,0
32436,cardiovascular,0,0
32437,mortality,0,0
32438,.,0,0
32439,AIMS,0,0
32440,The,0,0
32441,purpose,0,0
32442,of,0,0
32443,this,0,0
32444,paper,0,0
32445,is,0,0
32446,to,0,0
32447,examine,0,0
32448,the,0,0
32449,measurement,0,0
32450,of,0,0
32451,adherence,0,0
32452,to,0,0
32453,medication,1,1
32454,taking,0,0
32455,in,0,0
32456,hypertensive,0,0
32457,patients,0,0
32458,.,0,0
32459,Adherence,0,0
32460,was,0,0
32461,evaluated,0,0
32462,primarily,0,0
32463,by,0,0
32464,means,0,0
32465,of,0,0
32466,MEMS,0,1
32467,(,0,0
32468,Medication,0,1
32469,Event,0,1
32470,Monitoring,0,1
32471,System,0,1
32472,",",0,0
32473,Aprex,0,1
32474,Corporation,0,0
32475,",",0,0
32476,Fremont,0,0
32477,",",0,0
32478,California,0,1
32479,),0,0
32480,an,0,0
32481,electronic,0,1
32482,system,0,0
32483,that,0,0
32484,records,0,0
32485,the,0,0
32486,date,0,0
32487,and,0,0
32488,time,0,0
32489,of,0,0
32490,opening,0,0
32491,of,0,0
32492,the,0,0
32493,study,0,0
32494,medication,0,1
32495,container,0,1
32496,.,0,0
32497,Additional,0,0
32498,measurements,0,0
32499,such,0,0
32500,as,0,0
32501,change,0,0
32502,in,0,0
32503,urinary,0,0
32504,potassium,0,1
32505,level,0,0
32506,",",0,0
32507,capsule,0,1
32508,count,0,0
32509,",",0,0
32510,client,0,0
32511,self,0,1
32512,report,0,0
32513,and,0,0
32514,physician,0,1
32515,estimate,0,0
32516,of,0,0
32517,adherence,0,0
32518,were,0,0
32519,recorded,0,0
32520,.,0,0
32521,METHODS,0,0
32522,A,0,0
32523,randomised,0,0
32524,clinical,0,0
32525,trial,0,0
32526,was,0,0
32527,used,0,0
32528,to,0,0
32529,assign,0,0
32530,patients,0,0
32531,to,0,0
32532,receive,0,0
32533,the,0,0
32534,study,1,0
32535,medication,1,1
32536,(,1,1
32537,potassium,1,1
32538,),1,1
32539,or,1,1
32540,placebo,1,1
32541,.,1,0
32542,Descriptive,0,0
32543,statistics,0,0
32544,were,0,0
32545,used,0,0
32546,to,0,0
32547,answer,0,0
32548,the,0,0
32549,research,0,0
32550,questions,0,0
32551,.,0,0
32552,Frequency,0,0
32553,and,0,0
32554,percentage,0,0
32555,of,0,0
32556,responses,0,0
32557,to,0,0
32558,different,0,0
32559,measures,0,0
32560,of,0,0
32561,adherence,0,0
32562,were,0,0
32563,carried,0,0
32564,out,0,0
32565,as,0,0
32566,well,0,0
32567,as,0,0
32568,correlation,0,0
32569,between,0,0
32570,the,0,0
32571,measures,0,0
32572,.,0,0
32573,RESULTS,0,0
32574,One,0,0
32575,hundred,0,0
32576,and,0,0
32577,seven,0,0
32578,subjects,0,0
32579,between,0,0
32580,the,0,0
32581,ages,0,0
32582,of,0,0
32583,26,0,0
32584,and,0,0
32585,80,0,0
32586,participated,0,0
32587,in,0,0
32588,the,0,0
32589,clinical,0,0
32590,trial,0,0
32591,.,0,0
32592,The,0,0
32593,results,0,0
32594,showed,0,0
32595,that,0,0
32596,adherence,0,0
32597,measures,0,0
32598,varied,0,0
32599,with,0,0
32600,lowest,0,0
32601,adherence,0,0
32602,from,0,0
32603,two,0,0
32604,items,0,1
32605,of,0,0
32606,self-report,0,0
32607,related,0,0
32608,to,0,0
32609,forgetfulness,0,0
32610,(,0,0
32611,46,0,0
32612,and,0,0
32613,55,0,0
32614,%,0,0
32615,),0,0
32616,and,0,0
32617,stringent,0,0
32618,electronic,0,1
32619,monitoring,0,0
32620,with,0,0
32621,the,0,0
32622,MEMS,0,1
32623,(,0,0
32624,58,0,0
32625,%,0,0
32626,),0,0
32627,to,0,0
32628,percentages,0,0
32629,in,0,0
32630,the,0,0
32631,80-90,0,0
32632,range,0,0
32633,for,0,0
32634,other,0,0
32635,self-report,0,0
32636,items,0,1
32637,and,0,0
32638,the,0,0
32639,general,0,0
32640,adherence,0,0
32641,scale,0,0
32642,.,0,0
32643,Electronic,0,1
32644,monitoring,0,0
32645,correlated,0,0
32646,best,0,0
32647,with,0,0
32648,capsule,0,1
32649,count,0,0
32650,at,0,0
32651,visit,0,0
32652,5,0,0
32653,.,0,0
32654,Implications,0,0
32655,for,0,0
32656,health,0,0
32657,care,0,1
32658,providers,0,0
32659,are,0,0
32660,discussed,0,0
32661,.,0,0
32662,Effects,0,0
32663,of,0,0
32664,weight,1,0
32665,reduction,1,0
32666,interventions,1,1
32667,by,0,0
32668,community,0,0
32669,pharmacists,0,0
32670,.,0,0
32671,OBJECTIVE,0,0
32672,To,0,0
32673,compare,0,0
32674,a,0,0
32675,meal,1,1
32676,replacement,1,1
32677,(,1,1
32678,MR,1,1
32679,),1,1
32680,program,1,1
32681,with,1,0
32682,a,1,0
32683,conventional,1,1
32684,reduced-calorie,1,1
32685,diet,1,1
32686,(,1,1
32687,RCD,1,1
32688,),1,1
32689,for,0,0
32690,weight,0,0
32691,management,0,1
32692,using,0,0
32693,the,0,0
32694,pharmacy,1,0
32695,as,1,0
32696,the,1,0
32697,setting,1,0
32698,and,1,0
32699,the,1,0
32700,pharmacist,1,1
32701,as,1,0
32702,the,1,0
32703,point,1,0
32704,of,1,0
32705,contact,1,1
32706,for,1,0
32707,dietary,1,1
32708,advice,1,1
32709,.,1,0
32710,DESIGN,0,0
32711,Randomized,0,0
32712,",",0,0
32713,controlled,0,0
32714,",",0,0
32715,open-label,0,0
32716,trial,0,0
32717,.,0,0
32718,SETTING,0,0
32719,Travis,0,0
32720,Pharmacy,0,1
32721,in,0,0
32722,Shenandoah,0,0
32723,",",0,0
32724,Iowa,0,1
32725,.,0,0
32726,PATIENTS,0,0
32727,Ninety-five,0,0
32728,patients,0,0
32729,from,0,0
32730,southwestern,0,0
32731,iowa,0,0
32732,and,0,0
32733,southeastern,0,0
32734,Nebraska,0,0
32735,were,0,0
32736,enrolled,0,0
32737,",",0,0
32738,of,0,0
32739,whom,0,0
32740,88,0,0
32741,were,0,0
32742,considered,0,0
32743,eligible,0,0
32744,for,0,0
32745,comparison,0,0
32746,(,0,0
32747,by,0,0
32748,continuing,0,0
32749,through,0,0
32750,week,0,0
32751,2,0,0
32752,of,0,0
32753,the,0,0
32754,study,0,0
32755,),0,0
32756,.,0,0
32757,INTERVENTION,0,0
32758,Patients,0,0
32759,were,0,0
32760,randomized,0,0
32761,to,0,0
32762,an,0,0
32763,MR,1,1
32764,plan,0,0
32765,or,0,1
32766,a,0,0
32767,traditional,0,1
32768,RCD,1,0
32769,plan,0,0
32770,.,0,0
32771,Patients,0,0
32772,were,0,0
32773,followed,0,0
32774,for,0,0
32775,a,0,0
32776,3-month,0,0
32777,period,0,0
32778,of,0,0
32779,active,0,1
32780,weight,0,0
32781,loss,0,0
32782,and,0,0
32783,a,0,0
32784,10-week,0,1
32785,period,0,0
32786,of,0,0
32787,weight,0,0
32788,maintenance,0,0
32789,.,0,0
32790,Patients,0,0
32791,returned,0,0
32792,every,0,0
32793,3,0,0
32794,weeks,0,0
32795,for,0,0
32796,follow-up,0,0
32797,with,0,0
32798,the,0,0
32799,pharmacist,0,0
32800,",",0,0
32801,for,0,0
32802,a,0,0
32803,total,0,0
32804,of,0,0
32805,13,0,0
32806,visits,0,0
32807,.,0,0
32808,MAIN,0,0
32809,OUTCOME,0,0
32810,MEASURE,0,0
32811,Weight,0,0
32812,changes,0,0
32813,.,0,0
32814,RESULTS,0,0
32815,During,0,0
32816,the,0,0
32817,active,0,1
32818,weight,0,0
32819,loss,0,0
32820,phase,0,0
32821,",",0,0
32822,the,0,0
32823,MR,0,1
32824,(,0,0
32825,n,0,0
32826,=,0,0
32827,45,0,0
32828,),0,0
32829,and,0,0
32830,RCD,0,1
32831,(,0,1
32832,n,0,0
32833,=,0,0
32834,43,0,0
32835,),0,0
32836,groups,0,0
32837,lost,0,0
32838,a,0,0
32839,significant,0,0
32840,amount,0,0
32841,of,0,0
32842,weight,0,0
32843,",",0,0
32844,although,0,0
32845,no,0,0
32846,significant,0,0
32847,difference,0,0
32848,was,0,0
32849,found,0,0
32850,between,0,0
32851,the,0,0
32852,groups,0,0
32853,(,0,0
32854,mean,0,0
32855,+/-,0,0
32856,standard,0,1
32857,error,0,0
32858,=,0,0
32859,4.90,0,0
32860,+/-,0,0
32861,0.30,0,0
32862,kg,0,0
32863,MR,0,1
32864,versus,0,1
32865,4.30,0,0
32866,+/-,0,0
32867,0.30,0,0
32868,kg,0,0
32869,RCD,0,0
32870,;,0,0
32871,P,0,0
32872,=,0,0
32873,.16,0,0
32874,),0,0
32875,.,0,0
32876,In,0,0
32877,the,0,0
32878,weight,0,0
32879,maintenance,0,0
32880,phase,0,0
32881,",",0,0
32882,the,0,0
32883,MR,0,1
32884,group,0,0
32885,lost,0,0
32886,0.70,0,0
32887,+/-,0,0
32888,0.40,0,0
32889,kg,0,0
32890,and,0,0
32891,the,0,0
32892,RCD,0,0
32893,group,0,0
32894,lost,0,0
32895,0.90,0,0
32896,+/-,0,0
32897,0.40,0,0
32898,kg,0,0
32899,(,0,0
32900,P,0,0
32901,=,0,0
32902,.60,0,0
32903,),0,0
32904,.,0,0
32905,Significant,0,0
32906,improvements,0,0
32907,were,0,0
32908,observed,0,0
32909,in,0,0
32910,waist,0,0
32911,circumference,0,0
32912,",",0,0
32913,systolic,0,0
32914,and,0,0
32915,diastolic,0,0
32916,blood,0,0
32917,pressure,0,0
32918,",",0,0
32919,and,0,0
32920,triglyceride,0,0
32921,levels,0,0
32922,.,0,0
32923,No,0,0
32924,significant,0,0
32925,changes,0,0
32926,were,0,0
32927,seen,0,0
32928,in,0,0
32929,high-density,0,0
32930,lipoprotein,0,1
32931,cholesterol,0,1
32932,or,0,1
32933,low-density,0,0
32934,lipoprotein,0,0
32935,cholesterol,0,0
32936,levels,0,0
32937,in,0,0
32938,either,0,0
32939,group,0,0
32940,.,0,0
32941,CONCLUSION,0,0
32942,Successful,0,0
32943,weight,0,0
32944,management,0,0
32945,can,0,0
32946,be,0,0
32947,achieved,0,0
32948,in,0,0
32949,a,0,0
32950,pharmacy,0,0
32951,setting,0,0
32952,.,0,0
32953,Both,0,1
32954,MR,1,1
32955,and,1,0
32956,RCD,1,0
32957,programs,0,1
32958,were,0,0
32959,effective,0,0
32960,.,0,0
32961,Extracorporeal,1,1
32962,shock,1,0
32963,wave,1,1
32964,therapy,1,1
32965,(,1,1
32966,ESWT,1,1
32967,),1,1
32968,in,0,0
32969,patients,0,0
32970,with,0,0
32971,chronic,0,0
32972,proximal,0,0
32973,plantar,0,0
32974,fasciitis,0,0
32975,:,0,0
32976,a,0,0
32977,2-year,0,0
32978,follow-up,0,0
32979,.,0,0
32980,The,0,0
32981,aim,0,0
32982,of,0,0
32983,this,0,0
32984,study,0,0
32985,was,0,0
32986,to,0,0
32987,compare,0,0
32988,the,0,0
32989,effect,0,0
32990,of,0,0
32991,extracorporeal,1,1
32992,shock,1,0
32993,wave,1,1
32994,therapy,1,1
32995,(,0,1
32996,ESWT,0,1
32997,),0,1
32998,in,0,0
32999,patients,0,0
33000,with,0,0
33001,chronically,0,0
33002,painful,0,0
33003,proximal,0,0
33004,plantar,0,0
33005,fasciitis,0,0
33006,with,0,0
33007,a,0,0
33008,further,0,0
33009,conventional,0,1
33010,conservative,0,1
33011,treatment,0,0
33012,.,0,0
33013,Forty-seven,0,0
33014,patients,0,0
33015,(,0,0
33016,49,0,0
33017,feet,0,0
33018,),0,0
33019,with,0,0
33020,a,0,0
33021,previously,0,0
33022,unsuccessful,0,0
33023,nonsurgical,0,1
33024,treatment,0,0
33025,of,0,0
33026,at,0,0
33027,least,0,0
33028,6,0,0
33029,months,0,0
33030,were,0,0
33031,randomized,0,0
33032,to,0,0
33033,two,0,0
33034,groups,0,0
33035,.,0,0
33036,Heel,1,0
33037,cups,1,0
33038,had,0,0
33039,to,0,0
33040,be,0,0
33041,worn,0,1
33042,throughout,0,0
33043,the,0,0
33044,study,0,0
33045,.,0,0
33046,Group,0,0
33047,1,0,0
33048,(,0,0
33049,25,0,0
33050,heels,0,1
33051,),0,0
33052,was,0,0
33053,treated,0,0
33054,immediately,0,0
33055,with,0,0
33056,three,0,0
33057,sessions,0,1
33058,of,0,0
33059,ESWT,1,0
33060,(,1,0
33061,3000,1,1
33062,shock,1,0
33063,waves/session,1,1
33064,of,1,0
33065,0.2,1,1
33066,mJ/mm2,1,0
33067,),1,0
33068,at,1,0
33069,weekly,1,1
33070,intervals,1,0
33071,.,1,0
33072,The,0,0
33073,patients,0,0
33074,of,0,0
33075,group,0,0
33076,2,0,0
33077,(,0,0
33078,24,0,0
33079,heels,0,1
33080,),0,0
33081,continued,0,0
33082,nonsurgical,1,1
33083,treatment,1,1
33084,(,1,1
33085,iontophoresis,1,1
33086,with,1,1
33087,diclofenac,1,1
33088,and,1,0
33089,an,1,0
33090,oral,1,1
33091,nonsteroidal,1,1
33092,anti-inflammatory,1,1
33093,drug,1,1
33094,),1,0
33095,for,0,0
33096,12,0,0
33097,weeks,0,0
33098,.,0,0
33099,After,0,0
33100,this,0,0
33101,period,0,0
33102,they,0,0
33103,were,0,0
33104,treated,0,0
33105,using,0,0
33106,the,0,0
33107,protocol,0,1
33108,of,0,0
33109,group,0,0
33110,1,0,0
33111,.,0,0
33112,No,0,0
33113,significant,0,0
33114,difference,0,0
33115,of,0,0
33116,pain,0,0
33117,and,0,0
33118,walking,0,1
33119,time,0,0
33120,after,0,0
33121,further,0,0
33122,nonsurgical,0,1
33123,treatment,0,1
33124,(,0,0
33125,3,0,0
33126,months,0,0
33127,),0,0
33128,was,0,0
33129,seen,0,0
33130,in,0,0
33131,group,0,0
33132,2,0,0
33133,.,0,0
33134,At,0,0
33135,12,0,0
33136,weeks,0,0
33137,after,0,0
33138,ESWT,0,0
33139,",",0,0
33140,the,0,0
33141,pain,0,0
33142,estimation,0,0
33143,on,0,0
33144,the,0,0
33145,visual,0,0
33146,analogue,0,1
33147,scale,0,0
33148,(,0,1
33149,VAS,0,1
33150,),0,1
33151,for,0,0
33152,activities,0,0
33153,of,0,0
33154,daily,0,1
33155,living,0,0
33156,diminished,0,0
33157,significantly,0,0
33158,by,0,0
33159,62.9,0,0
33160,%,0,0
33161,in,0,0
33162,group,0,0
33163,1,0,0
33164,and,0,0
33165,by,0,0
33166,63.0,0,0
33167,%,0,0
33168,in,0,0
33169,group,0,0
33170,2,0,0
33171,.,0,0
33172,The,0,0
33173,comfortable,0,0
33174,walking,0,1
33175,time,0,0
33176,had,0,0
33177,increased,0,0
33178,significantly,0,0
33179,in,0,0
33180,both,0,0
33181,groups,0,0
33182,.,0,0
33183,Two,0,0
33184,years,0,0
33185,after,0,0
33186,ESWT,0,0
33187,",",0,0
33188,pain,0,0
33189,during,0,0
33190,activities,0,0
33191,of,0,0
33192,daily,0,1
33193,living,0,0
33194,decreased,0,0
33195,by,0,0
33196,94,0,0
33197,%,0,0
33198,in,0,0
33199,group,0,0
33200,1,0,0
33201,and,0,0
33202,by,0,0
33203,90,0,0
33204,%,0,0
33205,in,0,0
33206,group,0,0
33207,2,0,0
33208,on,0,0
33209,the,0,0
33210,VAS,0,1
33211,and,0,0
33212,the,0,0
33213,comfortable,0,1
33214,walking,0,1
33215,time,0,0
33216,had,0,0
33217,increased,0,0
33218,significantly,0,0
33219,in,0,0
33220,both,0,0
33221,groups,0,0
33222,.,0,0
33223,Long-term,0,0
33224,survival,0,0
33225,in,0,0
33226,a,0,0
33227,phase,0,0
33228,III,0,0
33229,",",0,0
33230,randomised,0,0
33231,study,0,0
33232,of,0,0
33233,topotecan,1,1
33234,versus,0,1
33235,paclitaxel,1,1
33236,in,0,0
33237,advanced,0,0
33238,epithelial,0,0
33239,ovarian,0,0
33240,carcinoma,0,0
33241,.,0,0
33242,BACKGROUND,0,0
33243,We,0,0
33244,have,0,0
33245,continued,0,0
33246,to,0,0
33247,monitor,0,0
33248,the,0,0
33249,survival,0,0
33250,of,0,0
33251,patients,0,0
33252,randomised,0,0
33253,in,0,0
33254,a,0,0
33255,previously,0,0
33256,reported,0,0
33257,multicentre,0,0
33258,phase,0,0
33259,III,0,1
33260,study,0,0
33261,of,0,0
33262,topotecan,1,1
33263,versus,0,1
33264,paclitaxel,1,1
33265,in,0,0
33266,patients,0,0
33267,with,0,0
33268,advanced,0,0
33269,epithelial,0,0
33270,ovarian,0,0
33271,cancer,0,0
33272,who,0,0
33273,had,0,0
33274,failed,0,0
33275,one,0,0
33276,prior,0,0
33277,platinum-based,0,1
33278,regimen,0,1
33279,.,0,0
33280,PATIENTS,0,0
33281,AND,0,0
33282,METHODS,0,0
33283,Patients,0,0
33284,with,0,0
33285,bidimensionally,0,0
33286,measurable,0,0
33287,disease,0,0
33288,were,0,0
33289,randomised,0,0
33290,to,0,0
33291,topotecan,1,1
33292,(,0,0
33293,1.5,0,1
33294,mg/m,0,1
33295,(,0,0
33296,2,0,0
33297,),0,0
33298,/day,0,0
33299,for,0,0
33300,5,0,0
33301,days,0,0
33302,),0,0
33303,or,0,1
33304,paclitaxel,1,1
33305,(,0,1
33306,175,0,1
33307,mg/m,0,1
33308,(,0,0
33309,2,0,0
33310,),0,0
33311,/day,0,0
33312,as,0,0
33313,a,0,0
33314,3-h,0,1
33315,infusion,0,1
33316,),0,0
33317,every,0,1
33318,21,0,0
33319,days,0,0
33320,.,0,0
33321,Patients,0,0
33322,were,0,0
33323,eligible,0,0
33324,for,0,0
33325,treatment,0,0
33326,with,0,0
33327,the,0,0
33328,alternate,0,1
33329,therapy,0,1
33330,at,0,0
33331,third,0,0
33332,line,0,0
33333,.,0,0
33334,The,0,0
33335,European,0,0
33336,Organisation,0,1
33337,for,0,0
33338,Research,0,0
33339,and,0,0
33340,Treatment,0,1
33341,of,0,0
33342,Cancer,0,0
33343,Quality,0,0
33344,of,0,0
33345,Life,0,0
33346,(,0,0
33347,EORTC,0,1
33348,QOL,0,1
33349,),0,0
33350,-C30,0,0
33351,questionnaire,0,0
33352,was,0,0
33353,also,0,0
33354,used,0,0
33355,to,0,0
33356,measure,0,0
33357,eight,0,0
33358,symptoms,0,0
33359,at,0,0
33360,baseline,0,0
33361,and,0,0
33362,during,0,0
33363,each,0,0
33364,course,0,0
33365,(,0,0
33366,pain,0,0
33367,",",0,0
33368,anorexia,0,0
33369,",",0,0
33370,diarrhoea,0,0
33371,",",0,0
33372,fatigue,0,0
33373,",",0,0
33374,nausea,0,0
33375,and,0,0
33376,vomiting,0,0
33377,",",0,0
33378,dyspnea,0,0
33379,",",0,0
33380,constipation,0,0
33381,and,0,1
33382,insomnia,0,0
33383,),0,0
33384,.,0,0
33385,RESULTS,0,0
33386,A,0,0
33387,total,0,0
33388,of,0,0
33389,226,0,0
33390,patients,0,0
33391,were,0,0
33392,evaluable,0,0
33393,for,0,0
33394,response,0,0
33395,.,0,0
33396,Demographic,0,0
33397,characteristics,0,0
33398,were,0,0
33399,similar,0,0
33400,in,0,0
33401,both,0,0
33402,treatment,0,0
33403,groups,0,0
33404,",",0,0
33405,as,0,0
33406,were,0,0
33407,results,0,0
33408,of,0,0
33409,the,0,0
33410,EORTC,0,0
33411,QOL-30,0,0
33412,questionnaire,0,0
33413,.,0,0
33414,For,0,0
33415,the,0,0
33416,topotecan,1,1
33417,group,0,0
33418,",",0,0
33419,median,0,0
33420,time,0,0
33421,to,0,0
33422,progression,0,0
33423,was,0,0
33424,18.9,0,0
33425,weeks,0,0
33426,(,0,0
33427,range,0,0
33428,<,0,0
33429,1,0,0
33430,to,0,0
33431,92.6+,0,0
33432,weeks,0,0
33433,;,0,0
33434,25,0,0
33435,%,0,0
33436,censored,0,0
33437,),0,0
33438,",",0,0
33439,and,0,0
33440,",",0,0
33441,for,0,0
33442,paclitaxel,1,1
33443,",",0,0
33444,14.7,0,0
33445,weeks,0,0
33446,(,0,0
33447,range,0,0
33448,<,0,0
33449,1,0,0
33450,to,0,0
33451,137.3+,0,0
33452,weeks,0,0
33453,;,0,0
33454,12.3,0,0
33455,%,0,0
33456,censored,0,0
33457,),0,0
33458,;,0,0
33459,P,0,0
33460,=,0,0
33461,0.076,0,0
33462,.,0,0
33463,At,0,0
33464,4,0,0
33465,years,0,0
33466,post-randomisation,0,0
33467,",",0,0
33468,median,0,0
33469,survival,0,0
33470,in,0,0
33471,the,0,0
33472,topotecan,1,1
33473,group,0,0
33474,was,0,0
33475,63.0,0,0
33476,weeks,0,0
33477,(,0,0
33478,range,0,0
33479,<,0,0
33480,1,0,0
33481,to,0,0
33482,238.4+,0,0
33483,weeks,0,0
33484,;,0,0
33485,20.5,0,0
33486,%,0,0
33487,censored,0,0
33488,),0,0
33489,and,0,0
33490,",",0,0
33491,for,0,0
33492,paclitaxel,1,1
33493,",",0,0
33494,53.0,0,0
33495,weeks,0,0
33496,(,0,0
33497,range,0,0
33498,<,0,0
33499,1,0,0
33500,to,0,0
33501,226.3+,0,0
33502,weeks,0,0
33503,;,0,0
33504,12.3,0,0
33505,%,0,0
33506,censored,0,0
33507,),0,0
33508,;,0,0
33509,P,0,0
33510,=,0,0
33511,0.44,0,0
33512,.,0,0
33513,CONCLUSION,0,0
33514,Topotecan,1,1
33515,continues,0,0
33516,to,0,0
33517,demonstrate,0,0
33518,comparable,0,0
33519,efficacy,0,0
33520,and,0,0
33521,survival,0,0
33522,to,0,0
33523,paclitaxel,1,1
33524,with,0,0
33525,manageable,0,0
33526,and,0,0
33527,non-cumulative,0,1
33528,haematological,0,0
33529,toxicity,0,0
33530,.,0,0
33531,Non-haematological,0,0
33532,toxicity,0,0
33533,was,0,0
33534,generally,0,0
33535,mild,0,0
33536,for,0,0
33537,both,0,0
33538,groups,0,0
33539,.,0,0
33540,The,0,0
33541,long-term,0,0
33542,survival,0,0
33543,rate,0,0
33544,indicates,0,0
33545,substantial,0,0
33546,therapeutic,0,0
33547,benefit,0,0
33548,for,0,0
33549,this,0,0
33550,group,0,0
33551,of,0,0
33552,patients,0,0
33553,receiving,0,0
33554,topotecan,1,1
33555,at,0,0
33556,relapse,0,0
33557,of,0,0
33558,ovarian,0,0
33559,cancer,0,0
33560,.,0,0
33561,Prediction,0,0
33562,of,0,0
33563,the,0,0
33564,response,0,0
33565,to,0,0
33566,citalopram,1,1
33567,and,1,0
33568,reboxetine,1,1
33569,in,0,0
33570,post-stroke,0,0
33571,depressed,0,0
33572,patients,0,0
33573,.,0,0
33574,RATIONALE,0,0
33575,AND,0,0
33576,OBJECTIVE,0,1
33577,Depression,0,0
33578,is,0,0
33579,a,0,0
33580,significant,0,0
33581,complication,0,0
33582,of,0,0
33583,stroke,0,0
33584,.,0,0
33585,The,0,0
33586,effectiveness,0,0
33587,of,0,0
33588,antidepressant,0,1
33589,drugs,0,1
33590,in,0,0
33591,the,0,0
33592,management,0,1
33593,of,0,0
33594,post-stroke,0,1
33595,depression,0,0
33596,(,0,1
33597,PSD,0,1
33598,),0,1
33599,has,0,0
33600,been,0,0
33601,widely,0,0
33602,investigated,0,0
33603,.,0,0
33604,However,0,0
33605,",",0,0
33606,the,0,0
33607,choice,0,0
33608,of,0,0
33609,antidepressant,0,1
33610,drug,0,1
33611,is,0,0
33612,critically,0,0
33613,influenced,0,0
33614,by,0,0
33615,its,0,0
33616,safety,0,0
33617,and,0,0
33618,tolerability,0,0
33619,and,0,0
33620,by,0,0
33621,its,0,0
33622,effect,0,0
33623,on,0,0
33624,concurrent,0,0
33625,pathologies,0,0
33626,.,0,0
33627,Here,0,0
33628,we,0,0
33629,investigate,0,0
33630,the,0,0
33631,efficacy,0,0
33632,and,0,0
33633,safety,0,0
33634,of,0,0
33635,a,0,0
33636,selective,0,0
33637,serotonin,1,1
33638,reuptake,1,1
33639,inhibitor,1,1
33640,(,1,1
33641,SSRI,1,0
33642,),1,1
33643,",",1,0
33644,citalopram,1,1
33645,",",1,0
33646,and,1,0
33647,a,1,0
33648,noradrenaline,1,1
33649,reuptake,1,1
33650,inhibitor,1,1
33651,(,1,1
33652,NARI,1,1
33653,),1,1
33654,",",1,0
33655,reboxetine,1,1
33656,",",0,0
33657,in,0,0
33658,post-stroke,0,0
33659,patients,0,0
33660,affected,0,0
33661,by,0,0
33662,anxious,0,0
33663,depression,0,0
33664,or,0,1
33665,retarded,0,0
33666,depression,0,0
33667,.,0,0
33668,METHODS,0,0
33669,This,0,0
33670,was,0,0
33671,a,0,0
33672,randomized,0,0
33673,double-blind,0,0
33674,study,0,0
33675,.,0,0
33676,Seventy-four,0,0
33677,post-stroke,0,0
33678,depressed,0,0
33679,patients,0,0
33680,were,0,0
33681,diagnosed,0,0
33682,as,0,0
33683,affected,0,0
33684,by,0,0
33685,anxious,0,0
33686,or,0,1
33687,retarded,0,0
33688,depression,0,0
33689,by,0,0
33690,using,0,0
33691,a,0,0
33692,synoptic,0,1
33693,table,0,0
33694,.,0,0
33695,Randomisation,0,0
33696,was,0,0
33697,planned,0,0
33698,so,0,0
33699,that,0,0
33700,50,0,0
33701,%,0,0
33702,of,0,0
33703,the,0,0
33704,patients,0,0
33705,in,0,0
33706,each,0,0
33707,subgroup,0,0
33708,were,0,0
33709,assigned,0,0
33710,for,0,0
33711,16,0,0
33712,weeks,0,0
33713,to,0,0
33714,treatment,0,0
33715,with,0,1
33716,citalopram,1,1
33717,and,0,0
33718,the,0,0
33719,remaining,0,0
33720,50,0,0
33721,%,0,0
33722,were,0,0
33723,assigned,0,0
33724,to,0,0
33725,treatment,0,0
33726,with,0,0
33727,reboxetine,1,1
33728,.,1,0
33729,The,0,0
33730,Beck,0,0
33731,Depression,0,0
33732,Inventory,0,1
33733,(,0,1
33734,BDI,0,0
33735,),0,0
33736,",",0,0
33737,the,0,0
33738,Hamilton,0,0
33739,Depression,0,0
33740,Rating,0,0
33741,Scale,0,1
33742,(,0,1
33743,HDRS,0,1
33744,),0,1
33745,and,0,0
33746,a,0,0
33747,synoptic,0,1
33748,table,0,0
33749,were,0,0
33750,used,0,0
33751,to,0,0
33752,score,0,0
33753,depressive,0,0
33754,symptoms,0,0
33755,.,0,0
33756,RESULTS,0,0
33757,Both,0,1
33758,citalopram,1,1
33759,and,0,0
33760,reboxetine,1,1
33761,showed,0,0
33762,good,0,0
33763,safety,0,0
33764,and,0,0
33765,tolerability,0,0
33766,.,0,0
33767,Citalopram,0,1
33768,exhibited,0,0
33769,greater,0,0
33770,efficacy,0,0
33771,in,0,0
33772,anxious,0,0
33773,depressed,0,0
33774,patients,0,0
33775,",",0,0
33776,while,0,0
33777,reboxetine,1,1
33778,was,0,0
33779,more,0,0
33780,effective,0,0
33781,in,0,0
33782,retarded,0,0
33783,depressed,0,0
33784,patients,0,0
33785,.,0,0
33786,CONCLUSIONS,0,0
33787,Citalopram,1,1
33788,or,0,1
33789,other,0,0
33790,SSRIs,0,1
33791,and,0,0
33792,reboxetine,1,1
33793,may,0,0
33794,be,0,0
33795,of,0,0
33796,first,0,0
33797,choice,0,0
33798,treatment,0,0
33799,in,0,0
33800,PSD,0,1
33801,because,0,0
33802,of,0,0
33803,their,0,0
33804,good,0,0
33805,efficacy,0,0
33806,and,0,0
33807,lack,0,0
33808,of,0,0
33809,severe,0,0
33810,side,0,0
33811,effects,0,0
33812,.,0,0
33813,In,0,0
33814,addition,0,0
33815,",",0,0
33816,PSD,0,1
33817,patients,0,0
33818,should,0,0
33819,be,0,0
33820,classified,0,0
33821,according,0,0
33822,to,0,0
33823,their,0,0
33824,clinical,0,0
33825,profile,0,0
33826,(,0,0
33827,similarly,0,0
33828,to,0,0
33829,patients,0,0
33830,affected,0,0
33831,by,0,0
33832,primary,0,0
33833,depression,0,0
33834,),0,0
33835,for,0,0
33836,the,0,0
33837,selection,0,0
33838,of,0,0
33839,SSRIs,0,0
33840,or,0,1
33841,reboxetine,0,1
33842,as,0,0
33843,drugs,0,1
33844,of,0,0
33845,choice,0,0
33846,in,0,0
33847,particular,0,0
33848,subgroups,0,0
33849,of,0,0
33850,patients,0,0
33851,.,0,0
33852,Effects,0,0
33853,of,0,0
33854,low,0,0
33855,and,0,0
33856,high,0,0
33857,doses,0,1
33858,of,0,0
33859,atorvastatin,1,1
33860,on,0,0
33861,arterial,0,0
33862,compliance,0,0
33863,.,0,0
33864,At,0,0
33865,the,0,0
33866,beginning,0,0
33867,of,0,0
33868,atherosclerosis,0,0
33869,before,0,0
33870,evidence,0,0
33871,of,0,0
33872,morphological,0,0
33873,lesions,0,0
33874,or,0,0
33875,plaques,0,0
33876,",",0,0
33877,vascular,0,0
33878,distensibility,0,0
33879,or,0,1
33880,arterial,0,0
33881,compliance,0,0
33882,decreased,0,0
33883,gradually,0,0
33884,.,0,0
33885,This,0,0
33886,endothelial,0,0
33887,dysfunction,0,0
33888,is,0,0
33889,regarded,0,0
33890,as,0,0
33891,an,0,0
33892,early,0,0
33893,feature,0,0
33894,of,0,0
33895,atherosclerosis,0,0
33896,.,0,0
33897,In,0,0
33898,a,0,0
33899,randomized,0,0
33900,",",0,0
33901,double-blind,0,0
33902,study,0,0
33903,design,0,0
33904,",",0,0
33905,group,0,0
33906,1,0,0
33907,(,0,0
33908,12,0,0
33909,patients,0,0
33910,;,0,0
33911,7,0,0
33912,males,0,0
33913,",",0,0
33914,5,0,0
33915,females,0,0
33916,),0,0
33917,with,0,0
33918,serum,0,0
33919,LDL-C,0,0
33920,levels,0,0
33921,higher,0,0
33922,than,0,0
33923,170,0,0
33924,mg/dL,0,0
33925,and,0,0
33926,without,0,0
33927,any,0,0
33928,other,0,0
33929,risk,0,0
33930,factor,0,0
33931,for,0,0
33932,atherosclerosis,0,0
33933,received,0,0
33934,three,0,0
33935,months,0,0
33936,of,0,0
33937,20,0,0
33938,mg/day,0,1
33939,atorvastatin,1,1
33940,treatment,1,0
33941,while,0,0
33942,group,0,0
33943,11,0,0
33944,(,0,0
33945,8,0,0
33946,males,0,0
33947,",",0,0
33948,4,0,0
33949,females,0,0
33950,),0,0
33951,with,0,0
33952,the,0,0
33953,same,0,0
33954,characteristics,0,0
33955,received,0,0
33956,80,0,0
33957,mg/day,0,1
33958,.,0,0
33959,Baseline,0,0
33960,and,0,0
33961,posttreatment,0,0
33962,serum,0,0
33963,lipid,0,0
33964,fractions,0,1
33965,and,0,0
33966,arterial,0,0
33967,compliance,0,0
33968,were,0,0
33969,measured,0,0
33970,.,0,0
33971,Arterial,0,0
33972,compliance,0,0
33973,was,0,0
33974,measured,0,0
33975,noninvasively,0,0
33976,in,0,0
33977,the,0,0
33978,left,0,0
33979,common,0,0
33980,carotid,0,0
33981,artery,0,0
33982,with,0,0
33983,color,0,0
33984,Doppler,0,1
33985,ultrasound,0,1
33986,.,0,0
33987,Atorvastatin,1,1
33988,reduced,0,0
33989,total,0,0
33990,cholesterol,0,0
33991,(,0,1
33992,TC,0,1
33993,),0,0
33994,",",0,0
33995,LDL-C,0,1
33996,",",0,0
33997,and,0,0
33998,triglyceride,0,0
33999,levels,0,0
34000,by,0,0
34001,32,0,0
34002,%,0,0
34003,(,0,0
34004,P,0,0
34005,<,0,0
34006,0.001,0,0
34007,),0,0
34008,",",0,0
34009,40.8,0,0
34010,%,0,0
34011,(,0,0
34012,P,0,0
34013,<,0,0
34014,0.001,0,0
34015,),0,0
34016,",",0,0
34017,and,0,0
34018,19,0,0
34019,%,0,0
34020,(,0,0
34021,P,0,0
34022,<,0,0
34023,0.001,0,0
34024,),0,0
34025,",",0,0
34026,respectively,0,0
34027,",",0,0
34028,and,0,0
34029,increased,0,0
34030,HDL-C,0,1
34031,by,0,0
34032,6.9,0,0
34033,%,0,0
34034,",",0,0
34035,(,0,0
34036,P,0,0
34037,=,0,0
34038,0.002,0,0
34039,),0,0
34040,in,0,0
34041,the,0,0
34042,first,0,0
34043,group,0,0
34044,.,0,0
34045,In,0,0
34046,the,0,0
34047,second,0,0
34048,group,0,0
34049,these,0,0
34050,reductions,0,0
34051,were,0,0
34052,38.5,0,0
34053,%,0,0
34054,(,0,0
34055,P,0,0
34056,<,0,0
34057,0.001,0,0
34058,),0,0
34059,",",0,0
34060,46.2,0,0
34061,%,0,0
34062,(,0,0
34063,P,0,0
34064,<,0,0
34065,0.001,0,0
34066,),0,0
34067,",",0,0
34068,and,0,0
34069,26.78,0,0
34070,%,0,0
34071,(,0,0
34072,P,0,0
34073,<,0,0
34074,0.001,0,0
34075,),0,0
34076,",",0,0
34077,respectively,0,0
34078,",",0,0
34079,and,0,0
34080,the,0,0
34081,increase,0,0
34082,in,0,0
34083,HDL,0,0
34084,was,0,0
34085,7.8,0,0
34086,%,0,0
34087,(,0,0
34088,P,0,0
34089,=,0,0
34090,0.03,0,0
34091,),0,0
34092,.,0,0
34093,It,0,0
34094,was,0,0
34095,observed,0,0
34096,that,0,0
34097,the,0,0
34098,decrease,0,0
34099,in,0,0
34100,serum,0,0
34101,TC,0,1
34102,",",0,0
34103,LDL-C,0,1
34104,and,0,0
34105,triglyceride,0,0
34106,levels,0,0
34107,were,0,0
34108,significantly,0,0
34109,higher,0,0
34110,in,0,0
34111,the,0,0
34112,second,0,0
34113,group,0,0
34114,than,0,0
34115,the,0,0
34116,first,0,0
34117,group,0,0
34118,.,0,0
34119,With,0,0
34120,atorvastatin,1,1
34121,",",0,0
34122,the,0,0
34123,distensibility,0,0
34124,coefficient,0,0
34125,(,0,1
34126,DC,0,1
34127,),0,1
34128,and,0,0
34129,compliance,0,0
34130,coefficient,0,0
34131,(,0,1
34132,CC,0,1
34133,),0,1
34134,increased,0,0
34135,from,0,0
34136,18.7,0,0
34137,+/-,0,0
34138,3.4,0,0
34139,to,0,0
34140,21.3,0,0
34141,+/-,0,0
34142,2.9,0,0
34143,10,0,0
34144,(,0,0
34145,-3,0,1
34146,),0,1
34147,x,0,0
34148,kPa,0,1
34149,(,0,1
34150,-1,0,1
34151,),0,1
34152,(,0,0
34153,P,0,0
34154,<,0,0
34155,0.001,0,0
34156,),0,0
34157,and,0,0
34158,from,0,0
34159,0.69,0,0
34160,+/-,0,0
34161,0.05,0,0
34162,to,0,0
34163,0.77,0,0
34164,+/-,0,0
34165,0.03,0,0
34166,mm2,0,0
34167,x,0,0
34168,kPa,0,1
34169,(,0,1
34170,-1,0,1
34171,),0,1
34172,(,0,0
34173,P,0,0
34174,<,0,0
34175,0.001,0,0
34176,),0,0
34177,in,0,0
34178,the,0,0
34179,first,0,0
34180,group,0,0
34181,while,0,0
34182,they,0,0
34183,changed,0,0
34184,from,0,0
34185,18.3,0,0
34186,+/-,0,0
34187,3.6,0,0
34188,to,0,0
34189,21.9,0,0
34190,+/-,0,0
34191,3.0,0,0
34192,10,0,0
34193,(,0,0
34194,-3,0,1
34195,),0,1
34196,x,0,0
34197,kPa,0,1
34198,(,0,1
34199,-1,0,1
34200,),0,1
34201,(,0,0
34202,P,0,0
34203,<,0,0
34204,0.001,0,0
34205,),0,0
34206,and,0,0
34207,from,0,0
34208,0.70,0,0
34209,+/-,0,0
34210,0.04,0,0
34211,to,0,0
34212,0.81,0,0
34213,+/-,0,0
34214,0.01,0,0
34215,mm2,0,0
34216,x,0,0
34217,kPa,0,1
34218,(,0,1
34219,-1,0,1
34220,),0,1
34221,(,0,0
34222,P,0,0
34223,<,0,0
34224,0.001,0,0
34225,),0,0
34226,respectively,0,0
34227,",",0,0
34228,in,0,0
34229,the,0,0
34230,second,0,0
34231,group,0,0
34232,.,0,1
34233,DC,0,1
34234,and,0,0
34235,CC,0,0
34236,increased,0,0
34237,in,0,0
34238,both,0,0
34239,groups,0,0
34240,",",0,0
34241,but,0,0
34242,the,0,0
34243,differences,0,0
34244,between,0,0
34245,the,0,0
34246,groups,0,0
34247,were,0,0
34248,not,0,0
34249,significant,0,0
34250,.,0,0
34251,High,0,0
34252,doses,0,0
34253,of,0,0
34254,atorvastatin,1,1
34255,reduce,0,0
34256,blood,0,0
34257,lipid,0,0
34258,levels,0,0
34259,more,0,0
34260,than,0,0
34261,conventional,0,1
34262,doses,0,0
34263,",",0,0
34264,however,0,0
34265,",",0,0
34266,the,0,0
34267,change,0,0
34268,in,0,0
34269,compliance,0,0
34270,is,0,0
34271,not,0,0
34272,dose-dependent,0,0
34273,.,0,0
34274,As,0,0
34275,endothelial,0,0
34276,dysfunction,0,0
34277,is,0,0
34278,regarded,0,0
34279,as,0,0
34280,an,0,0
34281,early,0,0
34282,feature,0,0
34283,of,0,0
34284,atherosclerosis,0,0
34285,",",0,0
34286,there,0,0
34287,would,0,0
34288,be,0,0
34289,no,0,0
34290,need,0,0
34291,to,0,0
34292,administer,0,0
34293,aggressive,0,0
34294,doses,0,0
34295,in,0,0
34296,a,0,0
34297,patient,0,0
34298,without,0,0
34299,any,0,0
34300,risk,0,0
34301,factors,0,0
34302,other,0,0
34303,than,0,0
34304,hyperlipidemia,0,0
34305,.,0,0
34306,Intervention,0,1
34307,in,0,0
34308,children,0,0
34309,with,0,0
34310,Developmental,0,1
34311,Coordination,0,0
34312,Disorder,0,0
34313,:,0,0
34314,the,0,0
34315,role,0,0
34316,of,0,0
34317,parents,1,0
34318,and,1,0
34319,teachers,1,0
34320,.,1,0
34321,BACKGROUND,0,0
34322,Children,0,0
34323,with,0,0
34324,Developmental,0,1
34325,Coordination,0,1
34326,Disorder,0,0
34327,(,0,1
34328,DCD,0,1
34329,),0,1
34330,are,0,0
34331,a,0,0
34332,heterogeneous,0,0
34333,group,0,0
34334,who,0,0
34335,have,0,0
34336,a,0,0
34337,marked,0,0
34338,impairment,0,0
34339,in,0,0
34340,the,0,0
34341,performance,0,0
34342,of,0,0
34343,functional,0,0
34344,skills,0,0
34345,.,0,0
34346,Provision,0,0
34347,for,0,0
34348,these,0,0
34349,children,0,0
34350,is,0,0
34351,usually,0,0
34352,made,0,0
34353,via,0,0
34354,a,0,0
34355,paediatrician,0,0
34356,through,0,0
34357,occupational,1,1
34358,or,0,1
34359,physiotherapy,1,1
34360,though,0,0
34361,",",0,0
34362,with,0,0
34363,a,0,0
34364,prevalence,0,0
34365,rate,0,0
34366,of,0,0
34367,5,0,0
34368,%,0,0
34369,",",0,0
34370,regular,0,1
34371,provision,0,0
34372,is,0,0
34373,not,0,0
34374,possible,0,0
34375,due,0,0
34376,to,0,0
34377,limited,0,0
34378,professional,0,0
34379,resources,0,0
34380,.,0,0
34381,AIMS,0,0
34382,The,0,0
34383,study,0,0
34384,aimed,0,0
34385,to,0,0
34386,determine,0,0
34387,the,0,0
34388,extent,0,0
34389,to,0,0
34390,which,0,0
34391,parents,1,0
34392,and,1,0
34393,teachers,1,0
34394,",",0,0
34395,with,0,0
34396,guidance,0,1
34397,",",0,0
34398,can,0,0
34399,assist,0,0
34400,in,0,0
34401,the,0,0
34402,management,0,0
34403,of,0,0
34404,children,0,0
34405,with,0,0
34406,DCD,0,0
34407,;,0,0
34408,whether,0,0
34409,children,0,0
34410,with,0,0
34411,DCD,0,0
34412,are,0,0
34413,helped,0,0
34414,in,0,0
34415,this,0,0
34416,way,0,0
34417,and,0,0
34418,how,0,0
34419,this,0,0
34420,may,0,0
34421,contribute,0,0
34422,to,0,0
34423,our,0,0
34424,understanding,0,0
34425,of,0,0
34426,the,0,0
34427,condition,0,0
34428,.,0,0
34429,SAMPLE,0,0
34430,Thirty-one,0,0
34431,children,0,0
34432,with,0,0
34433,DCD,0,0
34434,aged,0,0
34435,7,0,0
34436,to,0,0
34437,9,0,0
34438,years,0,0
34439,participated,0,0
34440,in,0,0
34441,the,0,0
34442,study,0,0
34443,.,0,0
34444,METHODS,0,0
34445,Following,0,0
34446,assessment,0,0
34447,",",0,0
34448,individual,0,0
34449,profiles,0,0
34450,were,0,0
34451,developed,0,0
34452,and,0,0
34453,each,0,0
34454,week,0,0
34455,teachers,1,0
34456,and,1,0
34457,parents,1,0
34458,were,0,0
34459,given,0,0
34460,guidelines,0,0
34461,for,0,0
34462,working,0,0
34463,with,0,0
34464,the,0,0
34465,children,0,0
34466,and,0,0
34467,each,0,0
34468,child,0,0
34469,had,0,0
34470,three,0,0
34471,to,0,0
34472,four,0,0
34473,sessions,0,1
34474,a,0,0
34475,week,0,0
34476,lasting,0,0
34477,approximately,0,0
34478,for,0,0
34479,20,0,0
34480,minutes,0,0
34481,.,0,0
34482,In,0,0
34483,Phase,0,0
34484,1,0,0
34485,",",0,0
34486,one,0,0
34487,group,0,0
34488,of,0,0
34489,children,0,0
34490,worked,0,0
34491,with,0,0
34492,teachers,0,0
34493,and,0,0
34494,the,0,0
34495,other,0,0
34496,group,0,0
34497,worked,0,0
34498,with,0,0
34499,parents,0,0
34500,.,0,0
34501,In,0,0
34502,Phase,0,0
34503,2,0,0
34504,",",0,0
34505,the,0,0
34506,two,0,0
34507,groups,0,0
34508,of,0,0
34509,children,0,0
34510,swapped,0,0
34511,over,0,0
34512,.,0,0
34513,The,0,0
34514,children,0,0
34515,were,0,0
34516,assessed,0,0
34517,regularly,0,0
34518,throughout,0,0
34519,the,0,0
34520,project,0,0
34521,using,0,0
34522,the,0,0
34523,Movement,0,0
34524,ABC,0,0
34525,",",0,0
34526,together,0,0
34527,with,0,0
34528,diaries,0,1
34529,and,0,0
34530,comments,0,0
34531,from,0,0
34532,teachers,0,0
34533,and,0,0
34534,parents,0,0
34535,.,0,0
34536,RESULTS,0,0
34537,At,0,0
34538,the,0,0
34539,end,0,0
34540,of,0,0
34541,the,0,0
34542,40-week,0,0
34543,study,0,0
34544,",",0,0
34545,27,0,0
34546,children,0,0
34547,showed,0,0
34548,significant,0,0
34549,improvement,0,0
34550,in,0,0
34551,their,0,0
34552,motor,0,0
34553,skills,0,0
34554,.,0,0
34555,CONCLUSIONS,0,0
34556,Both,0,1
34557,teachers,1,0
34558,and,1,0
34559,parents,1,0
34560,were,0,0
34561,able,0,0
34562,to,0,0
34563,provide,0,0
34564,effective,0,0
34565,intervention,0,1
34566,for,0,0
34567,the,0,0
34568,majority,0,0
34569,of,0,0
34570,the,0,0
34571,children,0,0
34572,.,0,0
34573,It,0,0
34574,is,0,0
34575,possible,0,0
34576,that,0,0
34577,the,0,0
34578,children,0,0
34579,who,0,0
34580,did,0,0
34581,not,0,0
34582,improve,0,0
34583,have,0,0
34584,difficulties,0,0
34585,that,0,0
34586,are,0,0
34587,of,0,0
34588,a,0,0
34589,more,0,0
34590,complex,0,0
34591,type,0,0
34592,which,0,0
34593,require,0,0
34594,more,0,0
34595,specialist,1,1
34596,therapy,1,1
34597,to,0,0
34598,meet,0,0
34599,their,0,0
34600,need,0,0
34601,.,0,0
34602,Azimilide,1,1
34603,decreases,0,0
34604,recurrent,0,0
34605,ventricular,0,0
34606,tachyarrhythmias,0,0
34607,in,0,0
34608,patients,0,0
34609,with,0,0
34610,implantable,0,1
34611,cardioverter,0,1
34612,defibrillators,0,0
34613,.,0,0
34614,OBJECTIVES,0,0
34615,This,0,0
34616,study,0,0
34617,evaluated,0,0
34618,the,0,0
34619,effects,0,0
34620,of,0,0
34621,azimilide,1,1
34622,dihydrochloride,1,1
34623,(,1,1
34624,AZ,1,1
34625,),1,1
34626,on,0,0
34627,anti-tachycardia,0,1
34628,pacing,0,1
34629,(,0,1
34630,ATP,0,1
34631,),0,1
34632,and,0,0
34633,shock-terminated,0,1
34634,events,0,0
34635,in,0,0
34636,patients,0,0
34637,with,0,0
34638,implantable,0,1
34639,cardioverter,0,1
34640,defibrillators,0,1
34641,(,0,0
34642,ICDs,0,1
34643,),0,0
34644,.,0,0
34645,BACKGROUND,0,0
34646,Animal,0,0
34647,studies,0,0
34648,have,0,0
34649,shown,0,0
34650,the,0,0
34651,effectiveness,0,0
34652,of,0,0
34653,AZ,0,0
34654,for,0,0
34655,therapy,0,1
34656,of,0,0
34657,supraventricular,0,1
34658,and,0,0
34659,ventricular,0,0
34660,tachycardia,0,0
34661,(,0,1
34662,VT,0,1
34663,),0,0
34664,.,0,0
34665,Azimilide,1,0
34666,dihydrochloride,1,1
34667,was,0,0
34668,investigated,0,0
34669,as,0,0
34670,adjunctive,0,1
34671,treatment,0,0
34672,for,0,0
34673,reducing,0,0
34674,the,0,0
34675,frequency,0,0
34676,of,0,0
34677,VT,0,1
34678,and,0,0
34679,",",0,0
34680,thus,0,0
34681,",",0,0
34682,the,0,0
34683,need,0,0
34684,for,0,0
34685,ICD,0,1
34686,therapies,0,1
34687,",",0,0
34688,including,0,0
34689,ATP,0,1
34690,and,0,1
34691,cardioversion/defibrillation,0,1
34692,(,0,1
34693,ICD,0,1
34694,shocks,0,1
34695,),0,0
34696,in,0,0
34697,patients,0,0
34698,with,0,0
34699,inducible,0,0
34700,monomorphic,0,0
34701,VT.,0,1
34702,METHODS,0,1
34703,A,0,0
34704,total,0,0
34705,of,0,0
34706,172,0,0
34707,patients,0,0
34708,were,0,0
34709,randomized,0,0
34710,to,0,0
34711,daily,0,1
34712,treatment,0,0
34713,with,0,0
34714,placebo,1,1
34715,",",0,0
34716,35,0,0
34717,mg,0,1
34718,",",0,0
34719,75,0,0
34720,mg,0,1
34721,",",0,0
34722,or,0,1
34723,125,0,0
34724,mg,0,1
34725,of,0,0
34726,oral,1,1
34727,AZ,1,0
34728,in,0,0
34729,this,0,0
34730,dose-ranging,0,0
34731,pilot,0,0
34732,study,0,0
34733,of,0,0
34734,patients,0,0
34735,with,0,0
34736,ICDs,0,0
34737,.,0,0
34738,The,0,0
34739,majority,0,0
34740,of,0,0
34741,patients,0,0
34742,had,0,0
34743,a,0,0
34744,history,0,0
34745,of,0,0
34746,documented,0,0
34747,remote,0,1
34748,myocardial,0,0
34749,infarction,0,0
34750,and,0,0
34751,congestive,0,0
34752,heart,0,0
34753,failure,0,0
34754,New,0,1
34755,York,0,1
34756,Heart,0,1
34757,Association,0,0
34758,class,0,0
34759,II,0,1
34760,or,0,1
34761,III,0,0
34762,.,0,0
34763,RESULTS,0,0
34764,The,0,0
34765,frequency,0,0
34766,of,0,0
34767,appropriate,0,0
34768,shocks,0,1
34769,and,0,0
34770,ATP,0,0
34771,were,0,0
34772,significantly,0,0
34773,decreased,0,0
34774,among,0,0
34775,AZ-treated,0,0
34776,patients,0,0
34777,compared,0,0
34778,with,0,0
34779,placebo,0,1
34780,patients,0,0
34781,.,0,0
34782,The,0,0
34783,incidence,0,0
34784,of,0,0
34785,ICD,0,1
34786,therapies,0,1
34787,per,0,0
34788,patient-year,0,0
34789,among,0,0
34790,the,0,0
34791,placebo,0,1
34792,group,0,0
34793,was,0,0
34794,36,0,0
34795,",",0,0
34796,and,0,0
34797,it,0,0
34798,was,0,0
34799,10,0,0
34800,",",0,0
34801,12,0,0
34802,",",0,0
34803,and,0,0
34804,9,0,0
34805,among,0,0
34806,35,0,0
34807,mg,0,0
34808,",",0,0
34809,75,0,0
34810,mg,0,1
34811,",",0,0
34812,and,0,0
34813,125,0,0
34814,mg,0,1
34815,AZ,0,0
34816,patients,0,0
34817,",",0,0
34818,respectively,0,0
34819,(,0,0
34820,hazard,0,0
34821,ratio,0,0
34822,=,0,0
34823,0.31,0,0
34824,",",0,0
34825,p,0,0
34826,=,0,0
34827,0.0001,0,0
34828,),0,0
34829,.,0,0
34830,Azimilide,0,0
34831,dihydrochloride,0,1
34832,was,0,0
34833,generally,0,0
34834,well,0,0
34835,tolerated,0,0
34836,and,0,0
34837,did,0,0
34838,not,0,0
34839,affect,0,0
34840,left,0,0
34841,ventricular,0,0
34842,ejection,0,0
34843,fraction,0,1
34844,or,0,1
34845,minimal,0,0
34846,energy,0,0
34847,requirements,0,0
34848,for,0,0
34849,defibrillation,0,1
34850,or,0,1
34851,pacing,0,1
34852,.,0,0
34853,CONCLUSIONS,0,0
34854,Azimilide,1,1
34855,dihydrochloride,1,1
34856,may,0,0
34857,be,0,0
34858,a,0,0
34859,safe,0,0
34860,and,0,0
34861,effective,0,0
34862,drug,0,1
34863,for,0,0
34864,reducing,0,0
34865,the,0,0
34866,frequency,0,0
34867,of,0,0
34868,VT,0,1
34869,and,0,0
34870,ventricular,0,0
34871,fibrillation,0,0
34872,in,0,0
34873,patients,0,0
34874,with,0,0
34875,implanted,0,1
34876,ICDs,0,0
34877,.,0,0
34878,The,0,0
34879,long-term,0,0
34880,effect,0,0
34881,of,0,0
34882,oxandrolone,1,1
34883,on,0,0
34884,hepatic,0,0
34885,acute,0,0
34886,phase,0,0
34887,proteins,0,1
34888,in,0,0
34889,severely,0,0
34890,burned,0,0
34891,children,0,0
34892,.,0,0
34893,BACKGROUND,0,0
34894,Acute,0,0
34895,phase,0,0
34896,protein,0,1
34897,production,0,0
34898,is,0,0
34899,a,0,0
34900,hallmark,0,0
34901,of,0,0
34902,severe,0,0
34903,burns,0,0
34904,.,0,0
34905,We,0,0
34906,wondered,0,0
34907,whether,0,0
34908,anabolic,1,0
34909,treatment,1,0
34910,with,0,0
34911,oxandrolone,0,1
34912,would,0,0
34913,affect,0,0
34914,these,0,0
34915,proteins,0,0
34916,.,0,0
34917,METHODS,0,0
34918,Thirty-five,0,0
34919,children,0,0
34920,with,0,0
34921,>,0,0
34922,or,0,1
34923,=40,0,0
34924,%,0,0
34925,total,0,0
34926,body,0,0
34927,surface,0,1
34928,area,0,0
34929,burns,0,0
34930,were,0,0
34931,randomized,0,0
34932,to,0,0
34933,receive,0,0
34934,either,0,1
34935,placebo,1,1
34936,or,1,1
34937,oxandrolone,1,1
34938,(,0,1
34939,0.1,0,1
34940,mg/kg,0,1
34941,by,0,0
34942,mouth,0,0
34943,twice,0,1
34944,daily,0,1
34945,),0,0
34946,from,0,0
34947,postoperative,0,0
34948,day,0,0
34949,5,0,0
34950,to,0,0
34951,1,0,0
34952,year,0,0
34953,postburn,0,0
34954,.,0,0
34955,Levels,0,0
34956,of,0,0
34957,constitutive,0,0
34958,proteins,0,1
34959,and,0,0
34960,acute,0,0
34961,phase,0,0
34962,proteins,0,1
34963,were,0,0
34964,measured,0,0
34965,at,0,0
34966,admission,0,0
34967,;,0,0
34968,at,0,0
34969,discharge,0,1
34970,;,0,0
34971,and,0,0
34972,at,0,0
34973,6,0,0
34974,",",0,0
34975,9,0,0
34976,",",0,0
34977,and,0,0
34978,12,0,0
34979,months,0,0
34980,after,0,0
34981,burn,0,0
34982,.,0,0
34983,Total,0,0
34984,albumin,0,1
34985,supplementation,0,1
34986,and,0,0
34987,hepatic,0,0
34988,transaminases,0,0
34989,were,0,0
34990,also,0,0
34991,assessed,0,0
34992,.,0,0
34993,RESULTS,0,0
34994,Constitutive,0,0
34995,proteins,0,0
34996,such,0,0
34997,as,0,0
34998,albumin,0,1
34999,",",0,0
35000,prealbumin,0,0
35001,",",0,0
35002,and,0,0
35003,retinol-binding,0,1
35004,protein,0,1
35005,levels,0,0
35006,increased,0,0
35007,(,0,0
35008,p,0,0
35009,<,0,0
35010,0.05,0,0
35011,),0,0
35012,",",0,0
35013,and,0,0
35014,acute,0,0
35015,phase,0,0
35016,proteins,0,1
35017,such,0,0
35018,as,0,0
35019,alpha,0,0
35020,1-acid,0,1
35021,glycoprotein,0,1
35022,",",0,0
35023,C3,0,0
35024,complement,0,0
35025,",",0,0
35026,alpha,0,0
35027,2-macroglobulin,0,0
35028,",",0,0
35029,and,0,0
35030,fibrinogen,0,0
35031,levels,0,0
35032,significantly,0,0
35033,decreased,0,0
35034,in,0,0
35035,the,0,0
35036,oxandrolone,0,1
35037,group,0,0
35038,compared,0,0
35039,with,0,0
35040,placebo,0,1
35041,(,0,0
35042,p,0,0
35043,<,0,0
35044,0.05,0,0
35045,),0,0
35046,.,0,0
35047,Albumin,0,0
35048,supplementation,0,1
35049,during,0,0
35050,the,0,0
35051,acute,0,0
35052,hospitalization,0,0
35053,was,0,0
35054,reduced,0,0
35055,in,0,0
35056,the,0,0
35057,oxandrolone,0,1
35058,group,0,0
35059,.,0,0
35060,Hepatic,0,0
35061,transaminases,0,0
35062,remained,0,0
35063,within,0,0
35064,normal,0,0
35065,levels,0,0
35066,.,0,0
35067,CONCLUSION,0,0
35068,Treatment,0,0
35069,with,0,0
35070,oxandrolone,0,1
35071,in,0,0
35072,severe,0,0
35073,burns,0,0
35074,significantly,0,0
35075,increases,0,0
35076,constitutive,0,0
35077,protein,0,1
35078,and,0,0
35079,reduces,0,0
35080,acute,0,0
35081,phase,0,0
35082,protein,0,1
35083,levels,0,0
35084,.,0,0
35085,Prospective,0,0
35086,",",0,0
35087,randomized,0,0
35088,trial,0,0
35089,of,0,0
35090,diclofenac,1,1
35091,and,0,0
35092,ketorolac,0,1
35093,after,0,0
35094,refractive,0,0
35095,surgery,0,0
35096,.,0,0
35097,PURPOSE,0,0
35098,To,0,0
35099,compare,0,0
35100,the,0,0
35101,effectiveness,0,0
35102,of,0,0
35103,diclofenac,1,1
35104,and,1,0
35105,ketorolac,1,1
35106,in,0,0
35107,relieving,0,0
35108,corneal,0,0
35109,pain,0,0
35110,after,0,0
35111,refractive,0,0
35112,surgery,0,1
35113,",",0,0
35114,and,0,0
35115,determine,0,0
35116,if,0,0
35117,there,0,0
35118,is,0,0
35119,a,0,0
35120,difference,0,0
35121,in,0,0
35122,stinging,0,0
35123,on,0,0
35124,instillation,0,1
35125,.,0,0
35126,METHODS,0,0
35127,Thirty,0,0
35128,patients,0,0
35129,were,0,0
35130,randomized,0,0
35131,prospectively,0,0
35132,to,0,0
35133,postoperative,1,0
35134,diclofenac,1,1
35135,in,1,0
35136,one,1,0
35137,eye,1,0
35138,and,1,0
35139,ketorolac,1,1
35140,in,1,0
35141,the,1,0
35142,other,1,0
35143,.,1,0
35144,Patients,0,0
35145,and,0,0
35146,surgeon,0,1
35147,did,0,0
35148,not,0,0
35149,know,0,0
35150,which,0,0
35151,medications,0,0
35152,were,0,0
35153,used,0,0
35154,.,0,0
35155,Ocular,0,0
35156,postoperative,0,0
35157,pain,0,0
35158,and,0,0
35159,discomfort,0,0
35160,on,0,0
35161,instillation,0,1
35162,of,0,0
35163,medication,0,1
35164,were,0,0
35165,measured,0,0
35166,after,0,0
35167,radial,0,0
35168,keratotomy,0,1
35169,with,0,0
35170,a,0,0
35171,visual,0,0
35172,analog,0,1
35173,scale,0,0
35174,and,0,0
35175,a,0,0
35176,questionnaire,0,0
35177,.,0,0
35178,RESULTS,0,0
35179,Both,0,1
35180,medications,0,1
35181,were,0,0
35182,highly,0,0
35183,effective,0,0
35184,in,0,0
35185,relieving,0,0
35186,pain,0,0
35187,.,0,0
35188,There,0,0
35189,was,0,0
35190,no,0,0
35191,significant,0,0
35192,difference,0,0
35193,in,0,0
35194,pain,0,0
35195,relief,0,0
35196,",",0,0
35197,or,0,1
35198,stinging,0,0
35199,on,0,0
35200,instillation,0,1
35201,(,0,0
35202,P,0,0
35203,=,0,0
35204,.29,0,0
35205,),0,0
35206,.,0,0
35207,CONCLUSION,0,0
35208,There,0,0
35209,was,0,0
35210,no,0,0
35211,statistical,0,0
35212,difference,0,0
35213,in,0,0
35214,the,0,0
35215,effectiveness,0,0
35216,of,0,0
35217,the,0,0
35218,medications,0,1
35219,on,0,0
35220,pain,0,0
35221,relief,0,0
35222,",",0,0
35223,or,0,1
35224,in,0,0
35225,stinging,0,0
35226,on,0,0
35227,instillation,0,0
35228,.,0,0
35229,Oscillatory,0,0
35230,potentials,0,0
35231,",",0,0
35232,retinopathy,0,0
35233,",",0,0
35234,and,0,0
35235,long-term,0,0
35236,glucose,0,0
35237,control,0,1
35238,in,0,0
35239,insulin-dependent,0,0
35240,diabetes,0,0
35241,.,0,0
35242,The,0,0
35243,main,0,0
35244,objective,0,0
35245,of,0,0
35246,the,0,0
35247,study,0,0
35248,was,0,0
35249,to,0,0
35250,assess,0,0
35251,effects,0,0
35252,of,0,0
35253,long-term,1,0
35254,lowering,1,0
35255,of,1,0
35256,glucosylated,1,1
35257,hemoglobin,1,0
35258,(,1,1
35259,HbA1,1,1
35260,%,1,0
35261,),1,0
35262,on,0,0
35263,neurosensory,0,1
35264,function,0,0
35265,in,0,0
35266,insulin-dependent,0,0
35267,diabetes,0,0
35268,.,0,0
35269,Individual,1,0
35270,(,1,0
35271,OP-1,1,1
35272,",",1,0
35273,OP-2,1,0
35274,",",1,0
35275,OP-3,1,1
35276,),1,1
35277,and,1,0
35278,summed,1,0
35279,(,1,1
35280,OP-sum,1,1
35281,),1,1
35282,amplitudes,1,0
35283,of,1,0
35284,oscillatory,1,1
35285,potentials,1,1
35286,(,1,0
35287,OPs,1,0
35288,),1,1
35289,of,1,0
35290,electroretinography,1,1
35291,were,1,0
35292,recorded,1,0
35293,at,0,0
35294,study,0,0
35295,start,0,0
35296,and,0,0
35297,7-years,0,0
35298,later,0,0
35299,in,0,0
35300,45,0,0
35301,patients,0,0
35302,(,0,0
35303,the,0,0
35304,Oslo,0,1
35305,study,0,0
35306,),0,0
35307,.,0,0
35308,As,0,0
35309,an,0,0
35310,overall,0,0
35311,7-year,0,0
35312,change,0,0
35313,",",0,0
35314,amplitudes,0,0
35315,of,0,0
35316,OP-2,0,0
35317,",",0,0
35318,OP-3,0,1
35319,and,0,0
35320,OP-sum,0,1
35321,were,0,0
35322,reduced,0,0
35323,(,0,0
35324,p,0,0
35325,<,0,0
35326,0.0001-0.01,0,0
35327,),0,0
35328,",",0,0
35329,retinopathy,0,0
35330,worsened,0,0
35331,(,0,0
35332,p,0,0
35333,=,0,0
35334,0.005,0,0
35335,),0,0
35336,",",0,0
35337,intraocular,0,1
35338,pressure,0,0
35339,decreased,0,0
35340,(,0,0
35341,p,0,0
35342,<,0,0
35343,0.001,0,0
35344,),0,0
35345,",",0,0
35346,systolic,0,0
35347,blood,0,0
35348,pressure,0,0
35349,increased,0,0
35350,(,0,0
35351,p,0,0
35352,<,0,0
35353,0.0002,0,0
35354,),0,0
35355,",",0,0
35356,and,0,0
35357,glycemic,0,0
35358,control,0,1
35359,improved,0,0
35360,from,0,0
35361,HbA1,0,1
35362,of,0,0
35363,11.2,0,0
35364,+/-,0,0
35365,2.2,0,0
35366,%,0,0
35367,at,0,0
35368,study,0,0
35369,start,0,0
35370,to,0,0
35371,a,0,0
35372,7-year,0,0
35373,cumulative,0,0
35374,mean,0,0
35375,of,0,0
35376,9.5,0,0
35377,+/-,0,0
35378,1.5,0,0
35379,%,0,0
35380,(,0,0
35381,p,0,0
35382,<,0,0
35383,0.0001,0,0
35384,),0,0
35385,.,0,0
35386,Multiple,0,0
35387,regression,0,0
35388,analysis,0,0
35389,did,0,0
35390,not,0,0
35391,identify,0,0
35392,any,0,0
35393,independent,0,0
35394,relations,0,0
35395,between,0,0
35396,change,0,0
35397,in,0,0
35398,OP-1,0,1
35399,",",0,0
35400,OP-2,0,0
35401,",",0,0
35402,OP-3,0,1
35403,",",0,0
35404,OP-sum,0,1
35405,and,0,0
35406,change,0,0
35407,in,0,0
35408,glycemic,0,0
35409,control,0,1
35410,or,0,1
35411,background,0,0
35412,variables,0,0
35413,",",0,0
35414,including,0,0
35415,change,0,0
35416,in,0,0
35417,age,0,0
35418,and,0,0
35419,duration,0,0
35420,of,0,0
35421,diabetes,0,0
35422,.,0,0
35423,However,0,0
35424,",",0,0
35425,cross-sectional,0,0
35426,observations,0,0
35427,at,0,0
35428,7,0,0
35429,years,0,0
35430,showed,0,0
35431,negative,0,0
35432,correlations,0,0
35433,between,0,0
35434,all,0,0
35435,OPs,0,0
35436,and,0,1
35437,age,0,0
35438,(,0,1
35439,p,0,0
35440,<,0,0
35441,0.0001-0.003,0,0
35442,),0,0
35443,",",0,0
35444,and,0,0
35445,between,0,0
35446,OP-3,0,1
35447,and,0,1
35448,duration,0,0
35449,(,0,1
35450,p,0,0
35451,=,0,0
35452,0.003,0,0
35453,),0,0
35454,and,0,0
35455,counts,0,0
35456,of,0,0
35457,microaneurysms,0,0
35458,(,0,0
35459,p,0,0
35460,=,0,0
35461,0.02,0,0
35462,),0,0
35463,.,0,0
35464,The,0,0
35465,data,0,0
35466,suggest,0,0
35467,that,0,0
35468,various,0,0
35469,clinical,0,0
35470,background,0,0
35471,variables,0,0
35472,may,0,0
35473,influence,0,0
35474,individual,0,0
35475,and,0,0
35476,summed,0,0
35477,amplitudes,0,0
35478,of,0,0
35479,OPs,0,0
35480,differently,0,0
35481,.,0,0
35482,Reduced,0,0
35483,neurosensory,0,0
35484,retinal,0,1
35485,function,0,0
35486,(,0,1
35487,OPs,0,1
35488,),0,1
35489,seemed,0,0
35490,to,0,0
35491,appear,0,0
35492,after,0,0
35493,7-years,0,0
35494,",",0,0
35495,independently,0,0
35496,of,0,0
35497,vascular,0,0
35498,defects,0,0
35499,of,0,0
35500,retinopathy,0,0
35501,and,0,0
35502,long-term,0,0
35503,improvement,0,0
35504,in,0,0
35505,glucose,0,0
35506,control,0,0
35507,.,0,0
35508,Effects,0,0
35509,of,0,0
35510,a,0,0
35511,combination,0,1
35512,of,0,0
35513,evening,1,0
35514,primrose,1,1
35515,oil,1,1
35516,(,1,1
35517,gamma,1,1
35518,linolenic,1,1
35519,acid,1,1
35520,),1,1
35521,and,1,0
35522,fish,1,1
35523,oil,1,1
35524,(,1,0
35525,eicosapentaenoic,1,1
35526,+,1,1
35527,docahexaenoic,1,1
35528,acid,1,1
35529,),1,1
35530,versus,1,1
35531,magnesium,1,1
35532,",",1,0
35533,and,1,0
35534,versus,1,1
35535,placebo,1,1
35536,in,0,0
35537,preventing,0,0
35538,pre-eclampsia,0,0
35539,.,0,0
35540,In,0,0
35541,a,0,0
35542,placebo,1,1
35543,controlled,0,0
35544,",",0,0
35545,partially,0,0
35546,double-blinded,0,0
35547,",",0,0
35548,clinical,0,0
35549,trial,0,0
35550,",",0,0
35551,a,0,0
35552,combination,1,1
35553,of,1,0
35554,evening,1,0
35555,primrose,1,1
35556,oil,1,1
35557,and,1,0
35558,fish,1,1
35559,oil,1,1
35560,was,1,0
35561,compared,1,0
35562,to,1,0
35563,Magnesium,1,1
35564,Oxide,1,1
35565,",",1,0
35566,and,1,0
35567,to,1,0
35568,a,1,0
35569,Placebo,1,1
35570,in,0,0
35571,preventing,0,0
35572,Pre-Eclampsia,0,0
35573,of,0,0
35574,Pregnancy,0,0
35575,.,0,0
35576,All,0,0
35577,were,0,0
35578,given,0,0
35579,as,0,0
35580,nutritional,0,1
35581,supplements,0,1
35582,for,0,0
35583,six,0,0
35584,months,0,0
35585,to,0,0
35586,a,0,0
35587,group,0,0
35588,of,0,0
35589,primiparous,0,0
35590,and,0,0
35591,multiparous,0,0
35592,pregnant,0,0
35593,women,0,0
35594,.,0,0
35595,Some,0,0
35596,of,0,0
35597,these,0,0
35598,women,0,0
35599,had,0,0
35600,personal,0,1
35601,or,0,1
35602,family,0,1
35603,histories,0,0
35604,of,0,0
35605,hypertension,0,0
35606,(,0,0
35607,21,0,0
35608,%,0,0
35609,),0,0
35610,.,0,0
35611,Only,0,0
35612,those,0,0
35613,patients,0,0
35614,who,0,0
35615,received,0,0
35616,prenatal,0,0
35617,care,0,1
35618,at,0,0
35619,the,0,0
35620,Central,0,0
35621,Maternity,0,1
35622,Hospital,0,0
35623,for,0,0
35624,Luanda,0,0
35625,were,0,0
35626,included,0,0
35627,in,0,0
35628,the,0,0
35629,study,0,0
35630,.,0,0
35631,Compared,0,0
35632,to,0,0
35633,the,0,0
35634,Placebo,1,1
35635,group,0,0
35636,(,0,0
35637,29,0,0
35638,%,0,0
35639,),0,0
35640,",",0,0
35641,the,0,0
35642,group,0,0
35643,receiving,0,0
35644,the,0,0
35645,mixture,0,1
35646,of,0,0
35647,evening,1,0
35648,primrose,1,1
35649,oil,1,1
35650,and,0,0
35651,fish,1,1
35652,oil,1,1
35653,containing,0,1
35654,Gamma-linolenic,1,1
35655,acid,1,1
35656,(,1,1
35657,GLA,1,0
35658,),1,0
35659,",",1,0
35660,Eicosapentaenoic,1,1
35661,acid,1,1
35662,(,1,1
35663,EPA,1,1
35664,),1,1
35665,",",0,0
35666,and,0,0
35667,Docosahexaenoic,1,1
35668,acid,1,1
35669,(,1,1
35670,DHA,1,1
35671,),1,1
35672,had,0,0
35673,a,0,0
35674,significantly,0,0
35675,lower,0,0
35676,incidence,0,0
35677,of,0,0
35678,edema,0,0
35679,(,0,0
35680,13,0,0
35681,%,0,0
35682,",",0,0
35683,p,0,0
35684,=,0,0
35685,0.004,0,0
35686,),0,0
35687,.,0,0
35688,The,0,0
35689,group,0,0
35690,receiving,0,0
35691,Magnesium,1,1
35692,Oxide,1,1
35693,had,0,0
35694,statistically,0,0
35695,significant,0,0
35696,fewer,0,0
35697,subjects,0,0
35698,who,0,0
35699,developed,0,0
35700,hypertension,0,0
35701,of,0,0
35702,pregnancy,0,0
35703,.,0,0
35704,There,0,0
35705,were,0,0
35706,3,0,0
35707,cases,0,0
35708,of,0,0
35709,eclampsia,0,0
35710,",",0,0
35711,all,0,0
35712,in,0,0
35713,the,0,0
35714,Placebo,1,1
35715,group,0,0
35716,.,0,0
35717,Clinical,0,0
35718,effects,0,0
35719,of,0,0
35720,naltrexone,1,1
35721,on,0,0
35722,autistic,0,0
35723,behavior,0,0
35724,.,0,0
35725,Eight,0,0
35726,young,0,0
35727,adults,0,0
35728,who,0,0
35729,were,0,0
35730,diagnosed,0,0
35731,with,0,0
35732,autism,0,0
35733,were,0,0
35734,given,0,0
35735,the,0,0
35736,opiate,1,1
35737,antagonist,1,1
35738,naltrexone,1,1
35739,to,0,0
35740,control,0,1
35741,self-injurious,0,0
35742,behavior,0,0
35743,and,0,0
35744,maladaptive,0,0
35745,idiosyncratic,0,0
35746,mannerisms,0,1
35747,.,0,0
35748,The,0,0
35749,drug,0,0
35750,and,0,0
35751,placebo,1,1
35752,were,0,0
35753,administered,0,0
35754,in,0,0
35755,a,0,0
35756,double-blind,0,0
35757,crossover,0,0
35758,design,0,0
35759,over,0,0
35760,17,0,0
35761,weeks,0,0
35762,.,0,0
35763,Although,0,0
35764,one,0,0
35765,subject,0,0
35766,appeared,0,0
35767,to,0,0
35768,have,0,0
35769,partial,0,0
35770,decreases,0,0
35771,in,0,0
35772,maladaptive,0,0
35773,behaviors,0,0
35774,associated,0,0
35775,with,0,0
35776,naltrexone,1,1
35777,use,0,0
35778,",",0,0
35779,the,0,0
35780,drugs,0,0
35781,",",0,0
35782,as,0,0
35783,administered,0,0
35784,in,0,0
35785,this,0,0
35786,study,0,0
35787,",",0,0
35788,did,0,0
35789,not,0,0
35790,reduce,0,0
35791,the,0,0
35792,self-injurious,0,0
35793,and,0,0
35794,other,0,0
35795,maladaptive,0,0
35796,behaviors,0,0
35797,of,0,0
35798,the,0,0
35799,subjects,0,0
35800,.,0,0
35801,Plasma,0,0
35802,kinetics,0,0
35803,of,0,0
35804,zeaxanthin,1,1
35805,and,0,0
35806,3'-dehydro-lutein,0,0
35807,after,0,0
35808,multiple,0,0
35809,oral,0,1
35810,doses,0,0
35811,of,0,0
35812,synthetic,1,0
35813,zeaxanthin,1,1
35814,.,1,0
35815,BACKGROUND,0,0
35816,Zeaxanthin,1,1
35817,is,0,0
35818,hypothesized,0,0
35819,to,0,0
35820,reduce,0,0
35821,the,0,0
35822,risk,0,0
35823,of,0,0
35824,age-related,0,0
35825,macular,0,0
35826,degeneration,0,0
35827,;,0,0
35828,however,0,0
35829,",",0,0
35830,kinetic,0,0
35831,information,0,0
35832,is,0,0
35833,limited,0,0
35834,.,0,0
35835,OBJECTIVES,0,0
35836,The,0,0
35837,objective,0,0
35838,was,0,0
35839,to,0,0
35840,investigate,0,0
35841,the,0,0
35842,plasma,0,0
35843,kinetics,0,0
35844,of,0,0
35845,synthetic,0,0
35846,zeaxanthin,1,1
35847,after,0,0
35848,repeated,0,0
35849,oral,0,1
35850,doses,0,0
35851,and,0,0
35852,to,0,0
35853,assess,0,0
35854,the,0,0
35855,possible,0,0
35856,influence,0,0
35857,of,0,0
35858,other,0,0
35859,carotenoids,0,1
35860,on,0,0
35861,plasma,0,0
35862,zeaxanthin,1,1
35863,concentrations,0,0
35864,.,0,0
35865,DESIGN,0,0
35866,After,0,0
35867,a,0,0
35868,run-in,0,0
35869,of,0,0
35870,3,0,0
35871,d,0,0
35872,",",0,0
35873,20,0,0
35874,healthy,0,0
35875,volunteers,0,0
35876,assigned,0,0
35877,to,0,0
35878,2,0,0
35879,parallel,0,0
35880,dose,0,0
35881,groups,0,0
35882,received,0,0
35883,once,0,0
35884,daily,0,1
35885,oral,0,1
35886,doses,0,0
35887,of,0,0
35888,either,0,0
35889,1,0,0
35890,mg,0,1
35891,(,0,0
35892,1.76,0,0
35893,micro,0,1
35894,mol,0,0
35895,),0,1
35896,or,0,1
35897,10,0,1
35898,mg,0,1
35899,(,0,0
35900,17.6,0,0
35901,micro,0,1
35902,mol,0,0
35903,),0,1
35904,zeaxanthin,1,1
35905,for,0,0
35906,42,0,0
35907,d.,0,0
35908,Plasma,0,0
35909,concentration-time,0,0
35910,profiles,0,0
35911,on,0,0
35912,days,0,0
35913,1,0,0
35914,and,0,0
35915,42,0,0
35916,",",0,0
35917,concentrations,0,0
35918,immediately,0,0
35919,before,0,0
35920,zeaxanthin,1,1
35921,intake,0,0
35922,during,0,0
35923,the,0,0
35924,dosing,0,0
35925,period,0,0
35926,",",0,0
35927,and,0,0
35928,concentrations,0,0
35929,after,0,0
35930,the,0,0
35931,last,0,0
35932,dose,0,0
35933,until,0,0
35934,day,0,0
35935,76,0,0
35936,were,0,0
35937,monitored,0,0
35938,.,0,0
35939,RESULTS,0,0
35940,all-E-Zeaxanthin,1,1
35941,concentrations,0,0
35942,increased,0,0
35943,from,0,0
35944,0.048,0,0
35945,+/-,0,0
35946,0.026,0,0
35947,micro,0,1
35948,mol/L,0,0
35949,at,0,0
35950,baseline,0,0
35951,to,0,0
35952,0.20,0,0
35953,+/-,0,0
35954,0.07,0,0
35955,and,0,0
35956,0.92,0,0
35957,+/-,0,0
35958,0.28,0,0
35959,micro,0,1
35960,mol/L,0,0
35961,with,0,0
35962,1,0,0
35963,and,0,0
35964,10,0,1
35965,mg,0,1
35966,zeaxanthin,1,1
35967,",",0,0
35968,respectively,0,0
35969,.,0,0
35970,The,0,0
35971,dose-normalized,0,0
35972,bioavailability,0,0
35973,of,0,0
35974,all-E-zeaxanthin,0,1
35975,after,0,0
35976,the10-mg,0,0
35977,dose,0,0
35978,was,0,0
35979,40,0,0
35980,%,0,0
35981,lower,0,0
35982,(,0,0
35983,P,0,0
35984,<,0,0
35985,0.001,0,0
35986,),0,0
35987,than,0,0
35988,after,0,0
35989,the,0,0
35990,1-mg,0,1
35991,dose,0,0
35992,.,0,0
35993,Other,0,0
35994,kinetic,0,0
35995,parameters,0,0
35996,did,0,0
35997,not,0,0
35998,differ,0,0
35999,significantly,0,0
36000,between,0,0
36001,groups,0,0
36002,.,0,0
36003,After,0,0
36004,17,0,0
36005,d,0,1
36006,of,0,0
36007,dosing,0,0
36008,",",0,0
36009,>,0,0
36010,90,0,0
36011,%,0,0
36012,of,0,0
36013,steady,0,0
36014,state,0,0
36015,concentrations,0,0
36016,were,0,0
36017,reached,0,0
36018,",",0,0
36019,which,0,0
36020,was,0,0
36021,compatible,0,0
36022,with,0,0
36023,an,0,0
36024,effective,0,0
36025,half-life,0,0
36026,for,0,0
36027,accumulation,0,0
36028,of,0,0
36029,5,0,0
36030,d.,0,0
36031,The,0,0
36032,terminal,0,1
36033,elimination,0,0
36034,half-life,0,0
36035,was,0,0
36036,12,0,0
36037,+/-,0,0
36038,7,0,0
36039,d,0,1
36040,(,0,0
36041,n,0,0
36042,=,0,0
36043,20,0,0
36044,),0,0
36045,.,0,0
36046,The,0,0
36047,time,0,0
36048,course,0,0
36049,of,0,0
36050,plasma,0,0
36051,all-E-3-'dehydro-lutein,0,0
36052,concentrations,0,0
36053,resembled,0,0
36054,that,0,0
36055,of,0,0
36056,all-E-zeaxanthin,1,1
36057,.,1,0
36058,The,0,0
36059,data,0,0
36060,provided,0,0
36061,evidence,0,0
36062,that,0,0
36063,all-E-3-'dehydro-lutein,0,0
36064,was,0,0
36065,derived,0,0
36066,from,0,0
36067,all-E-zeaxanthin,1,1
36068,.,1,0
36069,Concentrations,0,0
36070,of,0,0
36071,other,0,0
36072,carotenoids,0,1
36073,were,0,0
36074,not,0,0
36075,affected,0,0
36076,.,0,0
36077,Zeaxanthin,1,1
36078,was,0,0
36079,well,0,0
36080,tolerated,0,0
36081,.,0,0
36082,CONCLUSION,0,0
36083,Long-term,0,0
36084,oral,0,1
36085,intake,0,0
36086,of,0,0
36087,1,0,0
36088,and,0,0
36089,10,0,1
36090,mg,0,1
36091,zeaxanthin,1,1
36092,as,0,0
36093,beadlets,0,1
36094,increases,0,0
36095,plasma,0,0
36096,zeaxanthin,0,1
36097,concentrations,0,0
36098,approximately,0,0
36099,4-,0,1
36100,and,0,0
36101,20-fold,0,0
36102,",",0,0
36103,respectively,0,0
36104,.,0,0
36105,Evidence,0,0
36106,that,0,0
36107,all-E-3-dehydro-lutein,0,0
36108,is,0,0
36109,formed,0,0
36110,from,0,0
36111,zeaxanthin,1,1
36112,was,0,0
36113,strong,0,0
36114,.,0,0
36115,The,0,0
36116,influence,0,0
36117,of,0,0
36118,pre-,1,0
36119,and,1,0
36120,intraoperative,1,1
36121,positioning,1,0
36122,of,1,0
36123,the,1,0
36124,condyle,1,0
36125,in,0,0
36126,the,0,0
36127,centre,0,0
36128,of,0,0
36129,the,0,0
36130,articular,0,0
36131,fossa,0,0
36132,on,0,0
36133,the,0,0
36134,position,0,0
36135,of,0,0
36136,the,0,0
36137,disc,0,0
36138,in,0,0
36139,orthognathic,1,1
36140,surgery,1,0
36141,.,1,0
36142,A,0,0
36143,magnetic,0,1
36144,resonance,0,0
36145,study,0,0
36146,.,0,0
36147,OBJECTIVE,0,0
36148,We,0,0
36149,investigated,0,0
36150,the,0,0
36151,changes,0,0
36152,in,0,0
36153,the,0,0
36154,temporomandibular,0,0
36155,joint,0,0
36156,(,0,1
36157,TMJ,0,1
36158,),0,1
36159,after,0,0
36160,bilateral,1,1
36161,sagittal,1,1
36162,split,1,1
36163,osteotomy,1,1
36164,of,1,0
36165,the,1,0
36166,mandible,1,0
36167,for,0,0
36168,orthognathic,0,1
36169,surgery,0,1
36170,and,0,0
36171,the,0,0
36172,influence,0,0
36173,of,0,0
36174,positioning,1,0
36175,of,1,0
36176,the,1,0
36177,condylar,1,0
36178,process,1,0
36179,in,0,0
36180,the,0,0
36181,centre,0,0
36182,of,0,0
36183,the,0,0
36184,articular,0,0
36185,fossa,0,0
36186,before,0,0
36187,and,0,0
36188,during,0,0
36189,the,0,0
36190,operation,0,0
36191,for,0,0
36192,preventing,0,0
36193,changes,0,0
36194,in,0,0
36195,the,0,0
36196,TMJ,0,1
36197,postoperatively,0,0
36198,.,0,0
36199,STUDY,0,0
36200,DESIGN,0,0
36201,A,0,0
36202,total,0,0
36203,of,0,0
36204,28,0,0
36205,patients,0,0
36206,with,0,0
36207,mandibular,0,0
36208,retrognathism,0,0
36209,had,0,0
36210,bilateral,1,1
36211,sagittal,1,1
36212,split,1,1
36213,osteotomies,1,1
36214,for,1,0
36215,mandibular,1,0
36216,advancement,1,0
36217,.,1,0
36218,In,0,0
36219,one,0,0
36220,group,0,0
36221,of,0,0
36222,14,0,0
36223,patients,0,0
36224,(,0,0
36225,28,0,0
36226,TMJ,0,1
36227,),0,0
36228,",",0,0
36229,the,0,0
36230,condyles,1,0
36231,were,1,0
36232,placed,1,0
36233,in,1,0
36234,the,1,0
36235,centre,1,0
36236,of,1,0
36237,the,1,0
36238,articular,1,0
36239,fossa,1,0
36240,before,1,0
36241,and,1,0
36242,during,1,0
36243,the,1,0
36244,operation,1,0
36245,",",1,0
36246,and,1,0
36247,in,1,0
36248,the,1,0
36249,other,1,0
36250,group,1,0
36251,they,1,0
36252,were,1,0
36253,not,1,0
36254,.,1,0
36255,Differences,0,0
36256,on,0,0
36257,magnetic,1,1
36258,resonance,1,1
36259,imaging,1,1
36260,(,1,1
36261,MRI,1,1
36262,),1,1
36263,were,0,0
36264,calculated,0,0
36265,and,0,0
36266,the,0,0
36267,results,0,0
36268,were,0,0
36269,evaluated,0,0
36270,.,0,0
36271,RESULTS,0,0
36272,The,0,0
36273,main,0,0
36274,differences,0,0
36275,were,0,0
36276,found,0,0
36277,at,0,0
36278,maximal,0,0
36279,mouth,0,0
36280,opening,0,0
36281,.,0,0
36282,15/28,0,0
36283,TMJs,0,0
36284,(,0,0
36285,54,0,0
36286,%,0,0
36287,),0,0
36288,that,0,0
36289,had,0,0
36290,not,0,0
36291,been,0,0
36292,positioned,0,1
36293,changed,0,0
36294,the,0,0
36295,position,0,0
36296,of,0,0
36297,the,0,0
36298,disc,0,0
36299,from,0,0
36300,physiological,0,0
36301,to,0,0
36302,anterior,0,0
36303,disc,0,0
36304,derangement,0,0
36305,with,0,0
36306,and,0,0
36307,without,0,1
36308,reduction,0,0
36309,postoperatively,0,0
36310,.,0,0
36311,In,0,0
36312,the,0,0
36313,28,0,0
36314,that,0,0
36315,had,0,0
36316,been,0,0
36317,positioned,0,1
36318,",",0,0
36319,changes,0,0
36320,were,0,0
36321,found,0,0
36322,in,0,0
36323,only,0,0
36324,3,0,0
36325,TMJs,0,0
36326,(,0,0
36327,11,0,0
36328,%,0,0
36329,),0,0
36330,postoperatively,0,0
36331,.,0,0
36332,CONCLUSIONS,0,0
36333,Fixing,1,0
36334,the,1,0
36335,condylar,1,0
36336,process,1,0
36337,in,1,0
36338,the,1,0
36339,centre,1,0
36340,of,1,0
36341,the,1,0
36342,articular,1,0
36343,fossa,1,0
36344,intraoperatively,1,1
36345,before,0,0
36346,bilateral,0,1
36347,sagittal,0,1
36348,split,0,1
36349,osteotomy,0,1
36350,is,0,0
36351,a,0,0
36352,factor,0,0
36353,in,0,0
36354,preventing,0,0
36355,postoperative,0,0
36356,structural,0,0
36357,changes,0,0
36358,in,0,0
36359,the,0,0
36360,temporomandibular,0,0
36361,joint,0,0
36362,.,0,0
36363,Correlates,0,0
36364,of,0,0
36365,cognitive,0,0
36366,deficits,0,0
36367,in,0,0
36368,first,0,0
36369,episode,0,0
36370,schizophrenia,0,0
36371,.,0,0
36372,OBJECTIVE,0,0
36373,The,0,0
36374,presence,0,0
36375,of,0,0
36376,cognitive,0,0
36377,dysfunction,0,0
36378,in,0,0
36379,schizophrenia,0,0
36380,has,0,0
36381,been,0,0
36382,well,0,0
36383,documented,0,0
36384,",",0,0
36385,but,0,0
36386,questions,0,0
36387,remain,0,0
36388,about,0,0
36389,whether,0,0
36390,there,0,0
36391,are,0,0
36392,relationships,0,0
36393,between,0,0
36394,this,0,0
36395,dysfunction,0,0
36396,and,0,0
36397,clinical,0,0
36398,symptomatology,0,0
36399,.,0,0
36400,If,0,0
36401,present,0,0
36402,",",0,0
36403,such,0,0
36404,relationships,0,0
36405,should,0,0
36406,be,0,0
36407,most,0,0
36408,clearly,0,0
36409,observable,0,0
36410,in,0,0
36411,patients,0,0
36412,with,0,0
36413,first,0,0
36414,episode,0,0
36415,schizophrenia,0,0
36416,;,0,0
36417,that,0,0
36418,is,0,0
36419,",",0,0
36420,before,0,0
36421,the,0,0
36422,effects,0,0
36423,of,0,0
36424,chronic,0,0
36425,illness,0,0
36426,",",0,0
36427,institutionalization,0,0
36428,",",0,0
36429,or,0,1
36430,treatment,0,0
36431,might,0,0
36432,confound,0,0
36433,them,0,0
36434,.,0,0
36435,METHOD,0,0
36436,307,0,0
36437,schizophrenia,0,0
36438,subjects,0,0
36439,in,0,0
36440,their,0,0
36441,first,0,0
36442,episode,0,0
36443,of,0,0
36444,illness,0,0
36445,were,0,0
36446,recruited,0,0
36447,to,0,0
36448,participate,0,0
36449,in,0,0
36450,a,0,0
36451,clinical,0,0
36452,trial,0,0
36453,comparing,0,0
36454,the,0,0
36455,long-term,0,0
36456,efficacy,0,0
36457,of,0,0
36458,haloperidol,1,1
36459,and,1,0
36460,risperidone,1,1
36461,.,1,0
36462,The,0,0
36463,psychopathology,0,0
36464,",",0,0
36465,cognitive,0,0
36466,functioning,0,0
36467,",",0,0
36468,early,0,0
36469,treatment,0,0
36470,history,0,0
36471,",",0,0
36472,and,0,0
36473,duration,0,0
36474,of,0,0
36475,untreated,0,0
36476,psychosis,0,0
36477,of,0,0
36478,these,0,0
36479,subjects,0,0
36480,were,0,0
36481,assessed,0,0
36482,prior,0,0
36483,to,0,0
36484,their,0,0
36485,assignment,0,0
36486,to,0,0
36487,randomized,0,0
36488,",",0,0
36489,double-blind,0,0
36490,treatment,0,0
36491,.,0,0
36492,Approximately,0,0
36493,two-thirds,0,0
36494,of,0,0
36495,the,0,0
36496,subjects,0,0
36497,were,0,0
36498,receiving,0,0
36499,antipsychotic,1,1
36500,treatment,1,0
36501,at,0,0
36502,the,0,0
36503,time,0,0
36504,of,0,0
36505,assessment,0,0
36506,;,0,0
36507,however,0,0
36508,",",0,0
36509,the,0,0
36510,duration,0,0
36511,of,0,0
36512,treatment,0,0
36513,was,0,0
36514,limited,0,0
36515,to,0,0
36516,12,0,0
36517,weeks,0,0
36518,or,0,0
36519,less,0,0
36520,.,0,0
36521,RESULTS,0,0
36522,The,0,0
36523,severity,0,0
36524,of,0,0
36525,negative,0,0
36526,symptoms,0,0
36527,at,0,0
36528,the,0,0
36529,time,0,0
36530,of,0,0
36531,assessment,0,0
36532,was,0,0
36533,associated,0,0
36534,with,0,0
36535,deficits,0,0
36536,in,0,0
36537,memory,0,0
36538,",",0,0
36539,verbal,0,1
36540,fluency,0,0
36541,",",0,0
36542,psychomotor,0,0
36543,speed,0,0
36544,and,0,0
36545,executive,0,0
36546,function,0,0
36547,.,0,0
36548,Positive,0,0
36549,symptoms,0,0
36550,were,0,0
36551,not,0,0
36552,associated,0,0
36553,with,0,0
36554,cognitive,0,0
36555,deficits,0,0
36556,.,0,0
36557,Also,0,0
36558,",",0,0
36559,the,0,0
36560,duration,0,0
36561,of,0,0
36562,untreated,0,0
36563,illness,0,0
36564,(,0,1
36565,DUI,0,1
36566,),0,1
36567,prior,0,0
36568,to,0,0
36569,assessment,0,0
36570,was,0,0
36571,not,0,0
36572,significantly,0,0
36573,associated,0,0
36574,with,0,0
36575,cognitive,0,0
36576,impairment,0,0
36577,.,0,0
36578,CONCLUSIONS,0,0
36579,The,0,0
36580,results,0,0
36581,of,0,0
36582,this,0,0
36583,study,0,0
36584,of,0,0
36585,first,0,0
36586,episode,0,0
36587,schizophrenia,0,0
36588,patients,0,0
36589,suggest,0,0
36590,that,0,0
36591,a,0,0
36592,relationship,0,0
36593,exists,0,0
36594,between,0,0
36595,negative,0,0
36596,symptoms,0,0
36597,and,0,0
36598,cognitive,0,0
36599,dysfunction,0,0
36600,.,0,0
36601,However,0,0
36602,",",0,0
36603,that,0,0
36604,relationship,0,0
36605,accounts,0,0
36606,for,0,0
36607,only,0,0
36608,a,0,0
36609,minor,0,0
36610,portion,0,0
36611,of,0,0
36612,the,0,0
36613,variance,0,0
36614,(,0,0
36615,i.e.,0,0
36616,",",0,0
36617,10-15,0,1
36618,%,0,0
36619,),0,0
36620,in,0,0
36621,the,0,0
36622,severity,0,0
36623,of,0,0
36624,cognitive,0,0
36625,dysfunction,0,0
36626,after,0,0
36627,controlling,0,0
36628,for,0,0
36629,a,0,0
36630,number,0,0
36631,of,0,0
36632,potentially,0,0
36633,confounding,0,0
36634,factors,0,0
36635,.,0,0
36636,This,0,0
36637,finding,0,0
36638,provides,0,0
36639,support,0,0
36640,for,0,0
36641,the,0,0
36642,theory,0,0
36643,that,0,0
36644,the,0,0
36645,neurobiological,0,0
36646,processes,0,0
36647,that,0,0
36648,give,0,0
36649,rise,0,0
36650,to,0,0
36651,symptomatology,0,0
36652,and,0,0
36653,cognitive,0,1
36654,dysfunction,0,0
36655,in,0,0
36656,schizophrenia,0,0
36657,are,0,0
36658,partially,0,0
36659,overlapping,0,0
36660,.,0,0
36661,Reflexive,0,1
36662,orienting,0,1
36663,in,0,0
36664,response,0,0
36665,to,0,0
36666,eye,0,1
36667,gaze,0,1
36668,and,0,0
36669,an,0,0
36670,arrow,1,0
36671,in,0,0
36672,children,0,0
36673,with,0,0
36674,and,0,0
36675,without,0,0
36676,autism,0,0
36677,.,0,0
36678,BACKGROUND,0,0
36679,This,0,0
36680,study,0,0
36681,investigated,0,0
36682,whether,0,0
36683,another,0,0
36684,person,0,0
36685,'s,0,0
36686,social,0,0
36687,attention,0,0
36688,",",0,0
36689,specifically,0,0
36690,the,0,0
36691,direction,0,0
36692,of,0,0
36693,their,0,0
36694,eye,0,1
36695,gaze,0,1
36696,",",0,0
36697,and,0,0
36698,a,0,0
36699,non-social,0,0
36700,directional,0,1
36701,cue,0,0
36702,",",0,0
36703,an,0,0
36704,arrow,0,0
36705,",",0,0
36706,triggered,0,0
36707,reflexive,0,0
36708,orienting,0,0
36709,in,0,0
36710,children,0,0
36711,with,0,0
36712,and,0,0
36713,without,0,1
36714,autism,0,0
36715,in,0,0
36716,an,0,0
36717,experimental,0,0
36718,situation,0,0
36719,.,0,0
36720,METHODS,0,0
36721,Children,0,0
36722,with,0,0
36723,autism,0,0
36724,and,0,0
36725,typically,0,0
36726,developed,0,0
36727,children,0,0
36728,participated,0,0
36729,in,0,0
36730,one,0,0
36731,of,0,0
36732,two,0,0
36733,experiments,0,0
36734,.,0,0
36735,Both,0,0
36736,experiments,0,0
36737,involved,0,0
36738,the,0,0
36739,localization,1,0
36740,of,1,0
36741,a,1,0
36742,target,1,0
36743,that,1,0
36744,appeared,1,0
36745,to,1,0
36746,the,1,0
36747,left,1,0
36748,or,1,1
36749,right,1,0
36750,of,1,0
36751,the,1,0
36752,fixation,1,1
36753,point,1,0
36754,.,1,0
36755,Before,0,0
36756,the,0,0
36757,target,0,0
36758,appeared,0,0
36759,",",0,0
36760,the,1,0
36761,participant,1,0
36762,'s,1,0
36763,attention,1,0
36764,was,1,0
36765,cued,1,0
36766,to,1,0
36767,the,1,0
36768,left,1,0
36769,or,1,1
36770,right,1,0
36771,by,1,0
36772,either,1,0
36773,an,1,0
36774,arrow,1,0
36775,or,1,1
36776,the,1,0
36777,direction,1,1
36778,of,1,0
36779,eye,1,1
36780,gaze,1,1
36781,on,1,0
36782,a,1,0
36783,computerized,1,1
36784,face,1,0
36785,.,1,0
36786,RESULTS,0,0
36787,Children,0,0
36788,with,0,0
36789,autism,0,0
36790,were,0,0
36791,slower,0,0
36792,to,0,0
36793,respond,0,0
36794,",",0,0
36795,which,0,0
36796,suggests,0,0
36797,a,0,0
36798,slight,0,0
36799,difference,0,0
36800,in,0,0
36801,the,0,0
36802,general,0,0
36803,cognitive,0,0
36804,ability,0,0
36805,of,0,0
36806,the,0,0
36807,groups,0,0
36808,.,0,0
36809,In,0,0
36810,Experiment,0,0
36811,1,0,0
36812,",",0,0
36813,although,0,0
36814,the,0,0
36815,participants,0,0
36816,were,0,0
36817,instructed,0,0
36818,to,0,0
36819,disregard,0,0
36820,the,0,0
36821,cue,0,0
36822,and,0,0
36823,the,0,0
36824,target,0,0
36825,was,0,0
36826,correctly,0,0
36827,cued,0,0
36828,in,0,0
36829,only,0,0
36830,50,0,0
36831,%,0,0
36832,of,0,0
36833,the,0,0
36834,trials,0,0
36835,",",0,0
36836,both,0,0
36837,groups,0,0
36838,of,0,0
36839,children,0,0
36840,responded,0,0
36841,significantly,0,0
36842,faster,0,0
36843,to,0,0
36844,cued,0,0
36845,targets,0,0
36846,than,0,0
36847,to,0,0
36848,uncued,0,0
36849,targets,0,0
36850,",",0,0
36851,regardless,0,0
36852,of,0,0
36853,the,0,0
36854,cue,0,0
36855,.,0,0
36856,In,0,0
36857,Experiment,0,0
36858,2,0,0
36859,",",0,0
36860,children,0,0
36861,were,0,0
36862,instructed,0,0
36863,to,0,0
36864,attend,0,0
36865,to,0,0
36866,the,0,0
36867,direction,0,0
36868,opposite,0,0
36869,that,0,0
36870,of,0,0
36871,the,0,0
36872,cues,0,0
36873,and,0,0
36874,the,0,0
36875,target,0,0
36876,was,0,0
36877,correctly,0,0
36878,cued,0,0
36879,in,0,0
36880,only,0,0
36881,20,0,0
36882,%,0,0
36883,of,0,0
36884,the,0,0
36885,trials,0,0
36886,.,0,0
36887,Typically,0,0
36888,developed,0,0
36889,children,0,0
36890,located,0,0
36891,targets,0,0
36892,cued,0,0
36893,by,0,0
36894,eye,0,0
36895,gaze,0,1
36896,more,0,0
36897,quickly,0,0
36898,",",0,0
36899,while,0,0
36900,the,0,0
36901,arrow,0,0
36902,cue,0,0
36903,did,0,0
36904,not,0,0
36905,trigger,0,0
36906,such,0,0
36907,reflexive,0,0
36908,orienting,0,0
36909,in,0,0
36910,these,0,0
36911,children,0,0
36912,.,0,0
36913,However,0,0
36914,",",0,0
36915,both,0,0
36916,social,0,0
36917,and,0,0
36918,non-social,0,0
36919,cues,0,0
36920,shifted,0,0
36921,attention,0,0
36922,to,0,0
36923,the,0,0
36924,cued,0,1
36925,location,0,0
36926,in,0,0
36927,children,0,0
36928,with,0,0
36929,autism,0,0
36930,.,0,0
36931,CONCLUSION,0,0
36932,These,0,0
36933,results,0,0
36934,indicate,0,0
36935,that,0,0
36936,eye,0,1
36937,gaze,0,1
36938,attracted,0,0
36939,attention,0,0
36940,more,0,0
36941,effectively,0,0
36942,than,0,0
36943,the,0,0
36944,arrow,0,0
36945,in,0,0
36946,typically,0,0
36947,developed,0,0
36948,children,0,0
36949,",",0,0
36950,while,0,0
36951,children,0,0
36952,with,0,0
36953,autism,0,0
36954,shifted,0,0
36955,their,0,0
36956,attention,0,0
36957,equally,0,0
36958,in,0,0
36959,response,0,0
36960,to,0,0
36961,eye,0,1
36962,gaze,0,1
36963,and,0,0
36964,arrow,0,1
36965,direction,0,1
36966,",",0,0
36967,failing,0,0
36968,to,0,0
36969,show,0,0
36970,preferential,0,0
36971,sensitivity,0,0
36972,to,0,0
36973,the,0,0
36974,social,0,0
36975,cue,0,0
36976,.,0,0
36977,Difficulty,0,0
36978,in,0,0
36979,shifting,0,0
36980,controlled,0,0
36981,attention,0,0
36982,to,0,0
36983,the,0,0
36984,instructed,0,1
36985,side,0,0
36986,was,0,0
36987,also,0,0
36988,found,0,0
36989,in,0,0
36990,children,0,0
36991,with,0,0
36992,autism,0,0
36993,.,0,0
36994,Calcium,1,1
36995,chloride,1,1
36996,before,1,0
36997,i.v,1,1
36998,.,1,0
36999,diltiazem,1,1
37000,in,0,0
37001,the,0,0
37002,management,0,1
37003,of,0,0
37004,atrial,0,0
37005,fibrillation,0,0
37006,.,0,0
37007,Diltiazem,1,1
37008,is,0,0
37009,commonly,0,0
37010,used,0,0
37011,to,0,0
37012,treat,0,0
37013,atrial,0,0
37014,fibrillation,0,0
37015,or,0,1
37016,flutter,0,1
37017,(,0,1
37018,AFF,0,1
37019,),0,1
37020,with,0,0
37021,rapid,0,0
37022,ventricular,0,0
37023,response,0,0
37024,(,0,1
37025,RVR,0,1
37026,),0,0
37027,.,0,0
37028,Although,0,0
37029,it,0,0
37030,is,0,0
37031,very,0,0
37032,effective,0,0
37033,for,0,0
37034,rate,0,0
37035,control,0,0
37036,",",0,0
37037,up,0,0
37038,to,0,0
37039,an,0,0
37040,18,0,0
37041,%,0,0
37042,prevalence,0,0
37043,of,0,0
37044,reported,0,0
37045,diltiazem-induced,1,1
37046,hypotension,0,0
37047,[,0,0
37048,defined,0,0
37049,by,0,0
37050,systolic,0,0
37051,blood,0,0
37052,pressure,0,0
37053,(,0,1
37054,SBP,0,0
37055,),0,1
37056,<,0,0
37057,90,0,0
37058,mm,0,0
37059,Hg,0,0
37060,],0,1
37061,",",0,0
37062,and,0,0
37063,a,0,0
37064,mean,0,0
37065,of,0,0
37066,9.7,0,0
37067,%,0,0
37068,hypotension,0,0
37069,have,0,0
37070,been,0,0
37071,reported,0,0
37072,from,0,0
37073,several,0,0
37074,studies,0,0
37075,totaling,0,0
37076,over,0,0
37077,450,0,0
37078,patients,0,0
37079,.,0,0
37080,This,0,0
37081,hypotension,0,0
37082,may,0,0
37083,complicate,0,0
37084,therapy,0,0
37085,.,0,0
37086,Our,0,0
37087,objective,0,0
37088,was,0,0
37089,to,0,0
37090,determine,0,0
37091,if,0,0
37092,calcium,1,1
37093,chloride,1,1
37094,(,1,1
37095,CaCl,1,1
37096,(,1,1
37097,2,1,1
37098,),1,0
37099,),1,0
37100,pre-treatment,0,0
37101,would,0,0
37102,blunt,0,0
37103,a,0,0
37104,SBP,0,0
37105,drop,0,0
37106,after,0,0
37107,i.v,0,1
37108,.,0,0
37109,diltiazem,0,1
37110,",",0,0
37111,while,0,0
37112,allowing,0,0
37113,diltiazem,1,1
37114,to,0,0
37115,maintain,0,0
37116,its,0,0
37117,efficacy,0,0
37118,.,0,0
37119,A,0,0
37120,prospective,0,0
37121,",",0,0
37122,randomized,0,0
37123,",",0,0
37124,double-blind,0,0
37125,",",0,0
37126,placebo-controlled,0,1
37127,study,0,0
37128,was,0,0
37129,conducted,0,0
37130,.,0,0
37131,Seventy-eight,0,0
37132,patients,0,0
37133,with,0,0
37134,AFF,0,1
37135,and,0,0
37136,a,0,0
37137,ventricular,0,0
37138,rate,0,0
37139,of,0,0
37140,>,0,0
37141,/=,0,0
37142,120,0,0
37143,beats,0,0
37144,per,0,0
37145,minute,0,0
37146,were,0,0
37147,enrolled,0,0
37148,.,0,0
37149,Half,0,0
37150,received,0,0
37151,i.v,0,1
37152,.,0,1
37153,CaCl,1,0
37154,(,1,0
37155,2,1,0
37156,),1,0
37157,pre-treatment,0,0
37158,;,0,0
37159,the,0,0
37160,other,0,0
37161,half,0,1
37162,received,0,1
37163,placebo,1,1
37164,.,1,0
37165,All,0,0
37166,patients,0,0
37167,then,0,0
37168,received,0,0
37169,i.v,0,1
37170,.,0,0
37171,diltiazem,1,1
37172,in,0,0
37173,a,0,0
37174,standard,0,1
37175,",",0,0
37176,weight-based,0,1
37177,dose,0,0
37178,.,0,0
37179,A,0,0
37180,second,0,0
37181,dose,0,0
37182,of,0,0
37183,CaCl,0,1
37184,(,0,1
37185,2,0,0
37186,),0,1
37187,pre-treatment,0,0
37188,or,0,1
37189,placebo,1,1
37190,and,0,0
37191,diltiazem,1,1
37192,was,0,0
37193,given,0,0
37194,if,0,0
37195,clinically,0,0
37196,indicated,0,0
37197,for,0,0
37198,additional,0,0
37199,rate,0,0
37200,control,0,1
37201,.,0,0
37202,Both,0,1
37203,CaCl,0,0
37204,(,0,0
37205,2,0,0
37206,),0,0
37207,and,0,0
37208,placebo,1,1
37209,pre-treatment,0,0
37210,groups,0,0
37211,had,0,0
37212,equal,0,0
37213,lowering,0,0
37214,of,0,0
37215,heart,0,0
37216,rate,0,0
37217,(,0,0
37218,p,0,0
37219,<,0,0
37220,0.001,0,0
37221,),0,0
37222,.,0,0
37223,There,0,0
37224,were,0,0
37225,no,0,0
37226,adverse,0,0
37227,events,0,0
37228,in,0,0
37229,the,0,0
37230,calcium,0,1
37231,pre-treatment,0,0
37232,study,0,0
37233,arm,0,0
37234,.,0,0
37235,One,0,0
37236,patient,0,0
37237,in,0,0
37238,the,0,0
37239,placebo,0,1
37240,group,0,0
37241,became,0,0
37242,paradoxically,0,0
37243,more,0,0
37244,tachycardic,0,0
37245,and,0,0
37246,apneic,0,0
37247,after,0,0
37248,the,0,0
37249,diltiazem,0,1
37250,infusion,0,0
37251,.,0,0
37252,Although,0,0
37253,i.v,0,0
37254,.,0,1
37255,CaCl,0,0
37256,(,0,0
37257,2,0,0
37258,),0,0
37259,seems,0,0
37260,to,0,0
37261,be,0,0
37262,equally,0,0
37263,safe,0,0
37264,compared,0,0
37265,to,0,0
37266,placebo,0,1
37267,as,0,0
37268,a,0,0
37269,pre-treatment,0,0
37270,in,0,0
37271,the,0,0
37272,management,0,0
37273,of,0,0
37274,AFF,0,1
37275,with,0,0
37276,RVR,0,1
37277,",",0,0
37278,we,0,0
37279,were,0,0
37280,unable,0,0
37281,to,0,0
37282,find,0,0
37283,a,0,0
37284,statistically,0,0
37285,significant,0,0
37286,blunting,0,0
37287,of,0,0
37288,SBP,0,0
37289,drop,0,0
37290,with,0,0
37291,CaCl,0,1
37292,(,0,1
37293,2,0,0
37294,),0,0
37295,i.v,0,1
37296,.,0,0
37297,pre-treatment,0,0
37298,.,0,0
37299,Until,0,1
37300,further,0,0
37301,research,0,0
37302,determines,0,0
37303,a,0,0
37304,benefit,0,0
37305,exists,0,0
37306,",",0,0
37307,we,0,0
37308,can,0,0
37309,not,0,0
37310,recommend,0,0
37311,i.v,0,1
37312,.,0,1
37313,CaCl,1,0
37314,(,1,0
37315,2,1,0
37316,),1,0
37317,pre-treatment,0,0
37318,before,0,0
37319,diltiazem,1,1
37320,in,0,0
37321,the,0,0
37322,treatment,0,0
37323,of,0,0
37324,AFF,0,1
37325,with,0,0
37326,RVR,0,1
37327,.,0,0
37328,Bitewing,0,1
37329,film,0,1
37330,quality,0,0
37331,:,0,0
37332,a,0,0
37333,clinical,0,0
37334,comparison,0,0
37335,of,0,0
37336,the,0,0
37337,loop,1,0
37338,vs.,1,0
37339,holder,1,0
37340,techniques,1,1
37341,.,1,0
37342,OBJECTIVE,0,0
37343,To,0,0
37344,compare,0,0
37345,in,0,0
37346,vivo,0,0
37347,bitewing,0,1
37348,film,0,1
37349,quality,0,0
37350,using,0,0
37351,the,0,0
37352,holder,1,1
37353,versus,1,1
37354,the,1,0
37355,paper,1,0
37356,loop,1,0
37357,technique,1,1
37358,.,1,0
37359,METHOD,0,0
37360,AND,0,0
37361,MATERIALS,0,1
37362,Four,0,1
37363,bitewing,0,1
37364,films,0,1
37365,were,0,0
37366,taken,0,0
37367,from,0,0
37368,the,0,0
37369,right,0,0
37370,and,0,0
37371,left,0,0
37372,premolar,0,0
37373,and,0,0
37374,molar,0,0
37375,regions,0,0
37376,of,0,0
37377,45,0,0
37378,dental,0,0
37379,students,0,0
37380,using,0,0
37381,both,0,0
37382,the,0,0
37383,bitewing,1,1
37384,holder,1,1
37385,and,1,0
37386,paper,1,0
37387,loop,1,0
37388,techniques,1,1
37389,.,1,0
37390,A,0,0
37391,total,0,0
37392,of,0,0
37393,360,0,0
37394,films,0,1
37395,were,0,0
37396,taken,0,0
37397,and,0,0
37398,assessed,0,0
37399,by,0,0
37400,an,0,0
37401,experienced,0,0
37402,practitioner,0,1
37403,not,0,0
37404,apprised,0,0
37405,of,0,0
37406,the,0,0
37407,bitewing,1,1
37408,technique,1,1
37409,used,0,0
37410,.,0,0
37411,Of,0,0
37412,interest,0,0
37413,were,0,0
37414,:,0,0
37415,(,0,0
37416,1,0,0
37417,),0,0
37418,the,0,0
37419,number,0,0
37420,of,0,0
37421,overlaps,0,0
37422,and,0,0
37423,the,0,0
37424,percentage,0,0
37425,of,0,0
37426,teeth,0,0
37427,showing,0,0
37428,the,0,0
37429,alveolar,0,0
37430,crest,0,0
37431,;,0,0
37432,(,0,0
37433,2,0,0
37434,),0,1
37435,proper,0,0
37436,film,0,1
37437,positioning,0,1
37438,;,0,1
37439,and,0,0
37440,(,0,0
37441,3,0,0
37442,),0,0
37443,the,0,0
37444,percentage,0,0
37445,of,0,0
37446,cone,0,0
37447,cutting,0,1
37448,.,0,0
37449,A,0,0
37450,Poisson,0,0
37451,regression,0,0
37452,using,0,0
37453,generalized,0,0
37454,estimating,0,0
37455,equations,0,0
37456,(,0,0
37457,GEEs,0,1
37458,),0,1
37459,was,0,0
37460,used,0,0
37461,to,0,0
37462,estimate,0,0
37463,the,0,0
37464,difference,0,0
37465,in,0,0
37466,overlap,0,0
37467,between,0,0
37468,the,0,0
37469,two,0,0
37470,techniques,0,1
37471,.,0,0
37472,For,0,0
37473,proper,0,0
37474,positioning,0,1
37475,and,0,0
37476,cone,0,1
37477,cutting,0,1
37478,",",0,0
37479,logistic,0,0
37480,regressions,0,0
37481,using,0,0
37482,GEEs,0,1
37483,were,0,0
37484,used,0,0
37485,.,0,0
37486,RESULTS,0,0
37487,The,0,0
37488,average,0,0
37489,number,0,0
37490,of,0,0
37491,horizontal,0,1
37492,overlaps,0,0
37493,for,0,0
37494,the,0,0
37495,loop,1,1
37496,and,0,0
37497,holder,1,1
37498,techniques,1,1
37499,at,0,0
37500,the,0,0
37501,right,0,0
37502,premolar,0,0
37503,",",0,0
37504,right,0,0
37505,molar,0,0
37506,",",0,0
37507,left,0,0
37508,premolar,0,0
37509,",",0,0
37510,and,0,0
37511,left,0,0
37512,molar,0,0
37513,were,0,0
37514,1.64,0,0
37515,",",0,0
37516,2.11,0,0
37517,",",0,0
37518,2.16,0,0
37519,",",0,0
37520,2.78,0,0
37521,",",0,0
37522,and,0,0
37523,1.64,0,0
37524,",",0,0
37525,2.00,0,0
37526,",",0,0
37527,2.00,0,0
37528,",",0,0
37529,2.18,0,0
37530,",",0,0
37531,respectively,0,0
37532,.,0,0
37533,The,0,0
37534,loop,1,0
37535,technique,1,1
37536,was,0,0
37537,1.11,0,0
37538,times,0,0
37539,more,0,0
37540,likely,0,0
37541,to,0,0
37542,cause,0,0
37543,overlapping,0,0
37544,than,0,0
37545,the,0,0
37546,holder,1,1
37547,technique,1,1
37548,.,1,0
37549,The,0,0
37550,highest,0,0
37551,percentage,0,0
37552,of,0,0
37553,teeth,0,0
37554,showing,0,0
37555,the,0,0
37556,alveolar,0,0
37557,crest,0,0
37558,by,0,0
37559,the,0,0
37560,loop,1,0
37561,technique,1,1
37562,was,0,0
37563,97.8,0,0
37564,%,0,0
37565,in,0,0
37566,the,0,0
37567,mandibular,0,0
37568,second,0,0
37569,premolar,0,0
37570,and,0,0
37571,first,0,0
37572,molar,0,0
37573,.,0,0
37574,With,0,0
37575,respect,0,0
37576,to,0,0
37577,film,0,1
37578,positioning,0,0
37579,",",0,0
37580,the,0,0
37581,loop,1,0
37582,technique,1,1
37583,was,0,0
37584,1.12,0,0
37585,times,0,0
37586,more,0,0
37587,likely,0,0
37588,to,0,0
37589,cause,0,0
37590,improper,0,0
37591,positioning,0,0
37592,than,0,0
37593,the,0,0
37594,holder,1,1
37595,technique,1,1
37596,.,1,0
37597,Both,0,0
37598,techniques,0,1
37599,demonstrated,0,0
37600,minimal,0,0
37601,cone,0,1
37602,cutting,0,1
37603,(,0,0
37604,1,0,0
37605,in,0,0
37606,the,0,0
37607,loop,0,0
37608,versus,0,0
37609,0,0,0
37610,in,0,0
37611,the,0,0
37612,holder,0,1
37613,),0,0
37614,.,0,0
37615,CONCLUSION,0,0
37616,The,0,0
37617,quality,0,0
37618,of,0,0
37619,bitewing,0,1
37620,films,0,1
37621,taken,0,0
37622,by,0,0
37623,the,0,0
37624,loop,1,1
37625,and,1,0
37626,holder,1,1
37627,techniques,1,1
37628,was,0,0
37629,not,0,0
37630,significantly,0,0
37631,different,0,0
37632,.,0,0
37633,Role,0,0
37634,of,0,0
37635,the,0,0
37636,placebo,1,1
37637,effect,1,0
37638,in,0,0
37639,evaluating,0,0
37640,antidepressant,0,1
37641,efficacy,0,0
37642,.,0,0
37643,Bevacizumab,1,1
37644,plus,1,1
37645,irinotecan,1,1
37646,",",1,0
37647,fluorouracil,1,1
37648,",",1,0
37649,and,1,0
37650,leucovorin,1,1
37651,for,0,0
37652,metastatic,0,0
37653,colorectal,0,0
37654,cancer,0,0
37655,.,0,0
37656,BACKGROUND,0,0
37657,Bevacizumab,1,1
37658,",",0,0
37659,a,0,0
37660,monoclonal,0,1
37661,antibody,0,0
37662,against,0,0
37663,vascular,0,0
37664,endothelial,0,0
37665,growth,0,0
37666,factor,0,0
37667,",",0,0
37668,has,0,0
37669,shown,0,0
37670,promising,0,0
37671,preclinical,0,0
37672,and,0,0
37673,clinical,0,0
37674,activity,0,0
37675,against,0,0
37676,metastatic,0,0
37677,colorectal,0,0
37678,cancer,0,0
37679,",",0,0
37680,particularly,0,0
37681,in,0,0
37682,combination,0,1
37683,with,0,0
37684,chemotherapy,0,1
37685,.,0,0
37686,METHODS,0,0
37687,Of,0,0
37688,813,0,0
37689,patients,0,0
37690,with,0,0
37691,previously,0,0
37692,untreated,0,0
37693,metastatic,0,0
37694,colorectal,0,0
37695,cancer,0,0
37696,",",0,0
37697,we,0,0
37698,randomly,0,0
37699,assigned,0,0
37700,402,0,0
37701,to,0,0
37702,receive,0,0
37703,irinotecan,1,1
37704,",",1,0
37705,bolus,1,1
37706,fluorouracil,1,1
37707,",",1,0
37708,and,1,0
37709,leucovorin,1,1
37710,(,1,1
37711,IFL,1,1
37712,),1,1
37713,plus,1,1
37714,bevacizumab,1,1
37715,(,0,1
37716,5,0,1
37717,mg,0,1
37718,per,0,0
37719,kilogram,0,1
37720,of,0,0
37721,body,0,0
37722,weight,0,0
37723,every,0,1
37724,two,0,0
37725,weeks,0,0
37726,),0,0
37727,and,0,0
37728,411,0,0
37729,to,0,0
37730,receive,0,0
37731,IFL,1,1
37732,plus,1,1
37733,placebo,1,1
37734,.,1,0
37735,The,0,0
37736,primary,0,0
37737,end,0,0
37738,point,0,0
37739,was,0,0
37740,overall,0,0
37741,survival,0,0
37742,.,0,0
37743,Secondary,0,0
37744,end,0,0
37745,points,0,0
37746,were,0,0
37747,progression-free,0,0
37748,survival,0,0
37749,",",0,0
37750,the,0,0
37751,response,0,0
37752,rate,0,0
37753,",",0,0
37754,the,0,0
37755,duration,0,0
37756,of,0,0
37757,the,0,0
37758,response,0,0
37759,",",0,0
37760,safety,0,0
37761,",",0,0
37762,and,0,0
37763,the,0,0
37764,quality,0,0
37765,of,0,0
37766,life,0,0
37767,.,0,0
37768,RESULTS,0,0
37769,The,0,0
37770,median,0,0
37771,duration,0,0
37772,of,0,0
37773,survival,0,0
37774,was,0,0
37775,20.3,0,0
37776,months,0,0
37777,in,0,0
37778,the,0,0
37779,group,0,0
37780,given,0,0
37781,IFL,1,1
37782,plus,1,1
37783,bevacizumab,1,1
37784,",",0,0
37785,as,0,0
37786,compared,0,0
37787,with,0,0
37788,15.6,0,0
37789,months,0,0
37790,in,0,0
37791,the,0,0
37792,group,0,0
37793,given,0,0
37794,IFL,1,1
37795,plus,1,1
37796,placebo,1,1
37797,",",0,0
37798,corresponding,0,0
37799,to,0,0
37800,a,0,0
37801,hazard,0,0
37802,ratio,0,0
37803,for,0,0
37804,death,0,0
37805,of,0,0
37806,0.66,0,0
37807,(,0,0
37808,P,0,0
37809,<,0,0
37810,0.001,0,0
37811,),0,0
37812,.,0,0
37813,The,0,0
37814,median,0,0
37815,duration,0,0
37816,of,0,0
37817,progression-free,0,0
37818,survival,0,0
37819,was,0,0
37820,10.6,0,0
37821,months,0,0
37822,in,0,0
37823,the,0,0
37824,group,0,0
37825,given,0,0
37826,IFL,1,1
37827,plus,1,1
37828,bevacizumab,1,1
37829,",",0,0
37830,as,0,0
37831,compared,0,0
37832,with,0,0
37833,6.2,0,0
37834,months,0,0
37835,in,0,0
37836,the,0,0
37837,group,0,0
37838,given,0,0
37839,IFL,1,1
37840,plus,1,1
37841,placebo,1,1
37842,(,0,1
37843,hazard,0,0
37844,ratio,0,0
37845,for,0,0
37846,disease,0,0
37847,progression,0,0
37848,",",0,0
37849,0.54,0,0
37850,;,0,0
37851,P,0,0
37852,<,0,0
37853,0.001,0,0
37854,),0,0
37855,;,0,0
37856,the,0,0
37857,corresponding,0,0
37858,rates,0,0
37859,of,0,0
37860,response,0,0
37861,were,0,0
37862,44.8,0,0
37863,percent,0,0
37864,and,0,0
37865,34.8,0,0
37866,percent,0,0
37867,(,0,1
37868,P=0.004,0,0
37869,),0,0
37870,.,0,0
37871,The,0,0
37872,median,0,0
37873,duration,0,0
37874,of,0,0
37875,the,0,0
37876,response,0,0
37877,was,0,0
37878,10.4,0,0
37879,months,0,0
37880,in,0,0
37881,the,0,0
37882,group,0,0
37883,given,0,0
37884,IFL,1,1
37885,plus,1,1
37886,bevacizumab,1,1
37887,",",0,0
37888,as,0,0
37889,compared,0,0
37890,with,0,0
37891,7.1,0,0
37892,months,0,0
37893,in,0,0
37894,the,0,0
37895,group,0,0
37896,given,0,0
37897,IFL,1,1
37898,plus,1,1
37899,placebo,1,1
37900,(,0,1
37901,hazard,0,0
37902,ratio,0,0
37903,for,0,0
37904,progression,0,0
37905,",",0,0
37906,0.62,0,0
37907,;,0,0
37908,P=0.001,0,0
37909,),0,0
37910,.,0,0
37911,Grade,0,0
37912,3,0,0
37913,hypertension,0,0
37914,was,0,0
37915,more,0,0
37916,common,0,0
37917,during,0,0
37918,treatment,0,0
37919,with,0,0
37920,IFL,1,1
37921,plus,1,1
37922,bevacizumab,1,1
37923,than,0,0
37924,with,0,0
37925,IFL,1,1
37926,plus,1,1
37927,placebo,1,1
37928,(,0,1
37929,11.0,0,0
37930,percent,0,0
37931,vs.,0,0
37932,2.3,0,0
37933,percent,0,0
37934,),0,0
37935,but,0,0
37936,was,0,0
37937,easily,0,0
37938,managed,0,0
37939,.,0,0
37940,CONCLUSIONS,0,0
37941,The,0,0
37942,addition,0,0
37943,of,0,0
37944,bevacizumab,1,1
37945,to,0,0
37946,fluorouracil-based,1,1
37947,combination,1,1
37948,chemotherapy,1,1
37949,results,0,0
37950,in,0,0
37951,statistically,0,0
37952,significant,0,0
37953,and,0,0
37954,clinically,0,0
37955,meaningful,0,0
37956,improvement,0,0
37957,in,0,0
37958,survival,0,0
37959,among,0,0
37960,patients,0,0
37961,with,0,0
37962,metastatic,0,0
37963,colorectal,0,0
37964,cancer,0,0
37965,.,0,0
37966,Clarithromycin,1,1
37967,reduces,0,0
37968,the,0,0
37969,severity,0,0
37970,of,0,0
37971,bronchial,0,0
37972,hyperresponsiveness,0,0
37973,in,0,0
37974,patients,0,0
37975,with,0,0
37976,asthma,0,0
37977,.,0,0
37978,A,0,0
37979,randomised,0,0
37980,double-blind,0,0
37981,placebo-controlled,1,1
37982,study,0,0
37983,was,0,0
37984,designed,0,0
37985,to,0,0
37986,evaluate,0,0
37987,the,0,0
37988,effects,0,0
37989,of,0,0
37990,a,0,0
37991,semisynthetic,1,1
37992,macrolide,1,1
37993,antibiotic,1,1
37994,",",1,0
37995,clarithromycin,1,1
37996,",",0,0
37997,on,0,0
37998,bronchial,1,0
37999,hyperresponsiveness,1,0
38000,to,0,0
38001,methacholine,1,0
38002,in,0,0
38003,patients,0,0
38004,with,0,0
38005,a,0,0
38006,diagnosis,0,0
38007,of,0,0
38008,asthma,0,0
38009,.,0,0
38010,Adult,0,0
38011,asthma,0,0
38012,patients,0,0
38013,undergoing,0,0
38014,treatment,0,0
38015,with,0,0
38016,budesonide,1,1
38017,400,0,1
38018,microg,0,0
38019,b.i.d,0,1
38020,.,0,0
38021,and,0,0
38022,salbutamol,1,1
38023,200,0,1
38024,microg,0,0
38025,p.r.n,0,0
38026,.,0,0
38027,less,0,0
38028,than,0,0
38029,twice,0,0
38030,weekly,0,1
38031,were,0,0
38032,studied,0,0
38033,.,0,0
38034,Arm,0,0
38035,A,0,0
38036,(,0,0
38037,16,0,0
38038,males/six,0,0
38039,females,0,0
38040,",",0,0
38041,aged,0,0
38042,48,0,0
38043,+/-,0,0
38044,16,0,0
38045,yrs,0,0
38046,),0,0
38047,received,0,0
38048,clarithromycin,1,1
38049,250,0,1
38050,mg,0,1
38051,b.i.d,0,1
38052,.,0,0
38053,for,0,0
38054,8,0,0
38055,weeks,0,0
38056,",",0,0
38057,arm,0,0
38058,B,0,1
38059,(,0,0
38060,eight,0,1
38061,males/12,0,0
38062,females,0,0
38063,",",0,0
38064,aged,0,0
38065,42,0,0
38066,+/-,0,0
38067,12,0,0
38068,yrs,0,0
38069,),0,0
38070,clarithromycin,1,1
38071,250,0,1
38072,mg,0,0
38073,t.id,0,1
38074,.,0,0
38075,and,0,0
38076,arm,0,0
38077,C,0,1
38078,(,0,0
38079,six,0,0
38080,males/15,0,0
38081,females,0,0
38082,",",0,0
38083,aged,0,0
38084,41,0,0
38085,+/-,0,0
38086,16,0,0
38087,yrs,0,0
38088,),0,0
38089,placebo,1,1
38090,dextrose,1,1
38091,tablets,0,1
38092,.,0,0
38093,Bronchial,0,0
38094,hyperresponsiveness,0,0
38095,was,0,0
38096,quantified,0,0
38097,by,0,0
38098,measurement,0,0
38099,of,0,0
38100,the,0,0
38101,provocative,0,0
38102,dose,0,0
38103,of,0,0
38104,methacholine,1,0
38105,causing,0,0
38106,a,0,0
38107,20,0,0
38108,%,0,0
38109,fall,0,0
38110,in,0,0
38111,forced,0,1
38112,expiratory,0,0
38113,volume,0,0
38114,in,0,0
38115,one,0,0
38116,second,0,0
38117,(,0,1
38118,PD20,0,1
38119,),0,1
38120,.,0,1
38121,Median,0,0
38122,(,0,0
38123,interquartile,0,0
38124,range,0,0
38125,),0,1
38126,PD20,0,0
38127,in,0,0
38128,the,0,0
38129,three,0,0
38130,groups,0,0
38131,before,0,0
38132,and,0,0
38133,after,0,0
38134,treatment,0,0
38135,with,0,0
38136,clarithromycin,1,1
38137,were,0,0
38138,:,0,0
38139,arm,0,0
38140,A,0,0
38141,:,0,1
38142,0.3,0,1
38143,(,0,0
38144,0.1-1,0,0
38145,),0,1
38146,and,0,0
38147,1.3,0,0
38148,(,0,1
38149,0.6-2,0,0
38150,),0,1
38151,mg,0,1
38152,;,0,1
38153,arm,0,0
38154,B,0,0
38155,:,0,1
38156,0.4,0,1
38157,(,0,0
38158,0.1-0.9,0,0
38159,),0,1
38160,and,0,0
38161,2,0,1
38162,(,0,0
38163,2-2,0,0
38164,),0,1
38165,mg,0,1
38166,;,0,0
38167,and,0,0
38168,arm,0,0
38169,C,0,1
38170,:,0,1
38171,0.4,0,1
38172,(,0,0
38173,0.1-0.9,0,0
38174,),0,1
38175,and,0,0
38176,0.3,0,1
38177,(,0,1
38178,0.1-0.6,0,0
38179,),0,1
38180,mg,0,1
38181,",",0,0
38182,respectively,0,0
38183,.,0,0
38184,Serum,0,0
38185,free,0,0
38186,cortisol,0,0
38187,levels,0,0
38188,were,0,0
38189,determined,0,0
38190,and,0,0
38191,remained,0,0
38192,unchanged,0,0
38193,from,0,0
38194,baseline,0,0
38195,in,0,0
38196,the,0,0
38197,clarithromycin-treated,1,1
38198,patients,0,0
38199,.,0,0
38200,It,0,0
38201,is,0,0
38202,concluded,0,0
38203,that,0,0
38204,clarithromycin,1,1
38205,reduces,0,0
38206,the,0,0
38207,degree,0,0
38208,of,0,0
38209,bronchial,0,0
38210,hyperresponsiveness,0,0
38211,in,0,0
38212,patients,0,0
38213,with,0,0
38214,asthma,0,0
38215,.,0,0
38216,An,0,0
38217,open,0,1
38218,and,0,0
38219,randomized,0,0
38220,study,0,0
38221,comparing,0,0
38222,the,0,0
38223,efficacy,0,0
38224,of,0,0
38225,standard,1,1
38226,danazol,1,1
38227,and,1,0
38228,modified,1,0
38229,triptorelin,1,1
38230,regimens,1,1
38231,for,0,0
38232,postoperative,0,0
38233,disease,0,0
38234,management,0,1
38235,of,0,0
38236,moderate,0,0
38237,to,0,0
38238,severe,0,0
38239,endometriosis,0,0
38240,.,0,0
38241,OBJECTIVE,0,0
38242,To,0,0
38243,compare,0,0
38244,the,0,0
38245,efficacy,0,0
38246,of,0,0
38247,danazol,1,1
38248,and,1,1
38249,triptorelin,1,1
38250,(,0,1
38251,Decapeptyl,0,1
38252,CR,0,1
38253,",",0,0
38254,Ferring,0,0
38255,",",0,0
38256,Kiel,0,1
38257,",",0,0
38258,Germany,0,0
38259,),0,0
38260,in,0,0
38261,the,0,0
38262,management,0,1
38263,of,0,0
38264,moderate,0,0
38265,and,0,0
38266,severe,0,0
38267,endometriosis,0,0
38268,in,0,0
38269,terms,0,0
38270,of,0,0
38271,symptom,0,0
38272,control,0,1
38273,and,0,0
38274,revised,0,0
38275,American,0,0
38276,Fertility,0,0
38277,Society,0,1
38278,(,0,1
38279,AFS,0,1
38280,),0,1
38281,score,0,0
38282,reduction,0,0
38283,",",0,0
38284,and,0,0
38285,to,0,0
38286,evaluate,0,0
38287,the,0,0
38288,hormonal,0,0
38289,profile,0,0
38290,of,0,0
38291,patients,0,0
38292,treated,0,0
38293,with,0,0
38294,triptorelin,1,1
38295,every,0,1
38296,6,0,0
38297,weeks,0,0
38298,.,0,0
38299,DESIGN,0,0
38300,Open,0,1
38301,and,0,0
38302,randomized,0,0
38303,trial,0,0
38304,.,0,0
38305,SETTING,0,0
38306,Kwong,0,0
38307,Wah,0,0
38308,Hospital,0,0
38309,",",0,0
38310,a,0,0
38311,large,0,0
38312,public,0,0
38313,hospital,0,0
38314,in,0,0
38315,an,0,0
38316,urban,0,0
38317,location,0,0
38318,(,0,0
38319,Hong,0,1
38320,Kong,0,0
38321,),0,0
38322,.,0,1
38323,PATIENT,0,0
38324,(,0,0
38325,S,0,1
38326,),0,1
38327,Forty,0,0
38328,patients,0,0
38329,after,0,0
38330,their,0,0
38331,first,0,0
38332,conservative,0,1
38333,operation,0,0
38334,for,0,0
38335,endometriosis,0,0
38336,",",0,0
38337,with,0,0
38338,surgical,0,1
38339,confirmation,0,0
38340,of,0,0
38341,revised,0,0
38342,AFS,0,1
38343,stage,0,0
38344,III,0,0
38345,or,0,1
38346,IV,0,0
38347,endometriosis,0,0
38348,.,0,1
38349,INTERVENTION,0,0
38350,(,0,0
38351,S,0,1
38352,),0,1
38353,Postoperative,0,0
38354,6,0,0
38355,months,0,0
38356,',0,0
38357,therapy,0,1
38358,of,0,0
38359,danazol,1,1
38360,or,1,1
38361,triptorelin,1,1
38362,every,0,1
38363,6,0,0
38364,weeks,0,0
38365,",",0,0
38366,postmedical,0,1
38367,therapy,0,1
38368,second-look,0,1
38369,laparoscopy,0,1
38370,.,0,0
38371,MAIN,0,0
38372,OUTCOME,0,0
38373,MEASURE,0,1
38374,(,0,1
38375,S,0,1
38376,),0,1
38377,Symptom,0,1
38378,control,0,1
38379,and,0,0
38380,patients,0,0
38381,',0,0
38382,tolerance,0,0
38383,during,0,0
38384,medical,0,0
38385,therapy,0,1
38386,",",0,0
38387,posttherapy,0,0
38388,revised,0,0
38389,AFS,0,1
38390,score,0,0
38391,",",0,0
38392,hormonal,0,0
38393,profile,0,0
38394,during,0,0
38395,triptorelin,0,1
38396,therapy,0,1
38397,.,0,1
38398,RESULT,0,0
38399,(,0,0
38400,S,0,1
38401,),0,1
38402,Pain,0,0
38403,control,0,1
38404,was,0,0
38405,similar,0,0
38406,between,0,0
38407,danazol,1,1
38408,and,0,0
38409,triptorelin,1,1
38410,therapy,0,1
38411,.,0,0
38412,There,0,0
38413,was,0,0
38414,less,0,0
38415,breakthrough,0,0
38416,bleeding,0,0
38417,with,0,0
38418,triptorelin,1,1
38419,.,1,0
38420,More,0,0
38421,patients,0,0
38422,failed,0,0
38423,to,0,0
38424,complete,0,0
38425,the,0,0
38426,whole,0,0
38427,course,0,0
38428,of,0,0
38429,danazol,1,1
38430,because,0,0
38431,of,0,0
38432,its,0,0
38433,side,0,0
38434,effects,0,0
38435,.,0,0
38436,The,0,0
38437,revised,0,0
38438,AFS,0,1
38439,score,0,0
38440,at,0,0
38441,second-look,0,1
38442,laparoscopy,0,1
38443,did,0,0
38444,not,0,0
38445,show,0,0
38446,a,0,0
38447,significant,0,0
38448,difference,0,0
38449,between,0,0
38450,the,0,0
38451,two,0,0
38452,medications,0,0
38453,.,0,0
38454,Adequate,0,0
38455,pituitary,0,0
38456,suppression,0,0
38457,was,0,0
38458,observed,0,0
38459,with,0,0
38460,injection,0,1
38461,of,0,0
38462,triptorelin,1,1
38463,every,0,1
38464,6,0,0
38465,weeks,0,0
38466,.,0,0
38467,CONCLUSION,0,0
38468,(,0,0
38469,S,0,1
38470,),0,1
38471,Lengthening,0,1
38472,of,0,0
38473,triptorelin,1,1
38474,administration,0,0
38475,intervals,0,0
38476,from,0,0
38477,4,0,0
38478,weeks,0,0
38479,to,0,0
38480,6,0,0
38481,weeks,0,0
38482,is,0,0
38483,effective,0,0
38484,in,0,0
38485,maintaining,0,0
38486,a,0,0
38487,hypoestrogenic,0,1
38488,state,0,0
38489,.,0,0
38490,Patients,0,0
38491,were,0,0
38492,more,0,0
38493,compliant,0,0
38494,with,0,0
38495,triptorelin,1,1
38496,than,0,0
38497,danazol,1,1
38498,.,1,0
38499,Thus,0,0
38500,",",0,0
38501,triptorelin,1,1
38502,injection,0,1
38503,every,0,1
38504,6,0,0
38505,weeks,0,0
38506,is,0,0
38507,more,0,0
38508,cost-effective,0,0
38509,than,0,0
38510,conventional,0,1
38511,regimens,0,0
38512,.,0,0
38513,The,0,0
38514,prophylactic,0,1
38515,effect,0,0
38516,of,0,0
38517,valproate,1,1
38518,on,0,0
38519,glyceryltrinitrate,0,1
38520,induced,0,0
38521,migraine,0,0
38522,.,0,0
38523,In,0,0
38524,this,0,0
38525,study,0,0
38526,the,0,0
38527,human,0,1
38528,glyceryltrinitrate,0,1
38529,(,0,1
38530,GTN,0,1
38531,),0,1
38532,model,0,0
38533,of,0,0
38534,migraine,0,0
38535,was,0,0
38536,for,0,0
38537,the,0,0
38538,first,0,0
38539,time,0,0
38540,used,0,0
38541,to,0,0
38542,test,0,0
38543,the,0,0
38544,effect,0,0
38545,of,0,0
38546,a,0,0
38547,prophylactic,1,1
38548,drug,1,0
38549,.,1,0
38550,We,0,0
38551,chose,0,0
38552,to,0,0
38553,test,0,0
38554,valproate,1,1
38555,due,0,0
38556,to,0,0
38557,its,0,0
38558,well,0,0
38559,documented,0,0
38560,effect,0,0
38561,as,0,0
38562,a,0,0
38563,migraine,1,0
38564,prophylactic,1,1
38565,drug,1,1
38566,.,1,0
38567,Efficacy,0,0
38568,of,0,0
38569,this,0,0
38570,compound,0,1
38571,would,0,0
38572,support,0,0
38573,the,0,0
38574,usefulness,0,0
38575,of,0,0
38576,the,0,0
38577,model,0,0
38578,in,0,0
38579,prophylactic,0,1
38580,antimigraine,0,1
38581,drug,0,1
38582,development,0,0
38583,.,0,0
38584,Twelve,0,0
38585,patients,0,0
38586,with,0,0
38587,migraine,0,0
38588,without,0,1
38589,aura,0,0
38590,were,0,0
38591,included,0,0
38592,in,0,0
38593,a,0,0
38594,randomized,0,0
38595,double,0,1
38596,blind,0,0
38597,crossover,0,0
38598,study,0,0
38599,.,0,0
38600,Valproate,1,0
38601,1000,0,0
38602,mg,0,1
38603,or,1,1
38604,placebo,1,1
38605,was,0,0
38606,given,0,0
38607,daily,0,0
38608,",",0,0
38609,each,0,0
38610,for,0,0
38611,a,0,0
38612,minimum,0,0
38613,of,0,0
38614,13,0,0
38615,days,0,0
38616,.,0,0
38617,On,0,0
38618,the,0,0
38619,last,0,0
38620,treatment,0,0
38621,day,0,1
38622,of,0,0
38623,each,0,0
38624,arm,0,0
38625,a,0,0
38626,20,0,0
38627,min,0,0
38628,intravenous,0,1
38629,infusion,0,1
38630,of,0,0
38631,GTN,1,1
38632,(,0,0
38633,0.25,0,1
38634,microg/kg/min,0,1
38635,),0,0
38636,was,0,0
38637,given,0,0
38638,.,0,0
38639,Headache,0,0
38640,was,0,0
38641,registered,0,0
38642,for,0,0
38643,12,0,0
38644,h,0,0
38645,after,0,0
38646,the,0,0
38647,infusion,0,1
38648,and,0,0
38649,headache,0,0
38650,intensity,0,0
38651,was,0,0
38652,scored,0,0
38653,on,0,0
38654,a,0,0
38655,scale,0,0
38656,from,0,0
38657,0,0,0
38658,to,0,0
38659,10,0,0
38660,.,0,0
38661,Fulfillment,0,0
38662,of,0,0
38663,IHS,0,0
38664,criteria,0,0
38665,was,0,0
38666,recorded,0,0
38667,for,0,0
38668,24,0,0
38669,h.,0,0
38670,The,0,0
38671,middle,0,0
38672,cerebral,0,0
38673,arteries,0,0
38674,were,0,0
38675,evaluated,0,0
38676,by,0,0
38677,transcranial,0,1
38678,Doppler,0,1
38679,and,0,0
38680,the,0,0
38681,diameter,0,0
38682,of,0,0
38683,the,0,0
38684,superficial,0,0
38685,temporal,0,0
38686,and,0,0
38687,radial,0,0
38688,arteries,0,0
38689,were,0,0
38690,measured,0,0
38691,with,0,0
38692,high,0,0
38693,frequency,0,0
38694,ultrasound,0,1
38695,.,0,0
38696,GTN,1,1
38697,evoked,0,0
38698,migraine,0,0
38699,fulfilling,0,0
38700,IHS,0,0
38701,criteria,0,0
38702,1.1,0,0
38703,in,0,0
38704,6,0,0
38705,patients,0,0
38706,after,0,0
38707,placebo,1,1
38708,and,0,0
38709,in,0,0
38710,2,0,0
38711,patients,0,0
38712,after,0,0
38713,valproate,1,1
38714,(,0,0
38715,P,0,0
38716,=,0,0
38717,0.125,0,1
38718,),0,0
38719,.,0,0
38720,Including,0,0
38721,additionally,0,0
38722,3,0,0
38723,patients,0,0
38724,on,0,0
38725,placebo,1,1
38726,and,0,0
38727,1,0,0
38728,patient,0,0
38729,on,0,0
38730,valproate,1,1
38731,who,0,0
38732,felt,0,0
38733,they,0,0
38734,had,0,0
38735,suffered,0,0
38736,a,0,0
38737,migraine,0,0
38738,attack,0,0
38739,",",0,0
38740,but,0,0
38741,who,0,0
38742,had,0,0
38743,as,0,0
38744,associated,0,0
38745,symptoms,0,0
38746,only,0,0
38747,photophobia,0,0
38748,or,0,0
38749,phonophobia,0,0
38750,",",0,0
38751,a,0,0
38752,significant,0,0
38753,reduction,0,0
38754,in,0,0
38755,the,0,0
38756,number,0,0
38757,of,0,0
38758,patients,0,0
38759,with,0,0
38760,induced,0,0
38761,migraine,0,0
38762,after,0,0
38763,valproate,1,1
38764,was,0,0
38765,seen,0,0
38766,(,0,0
38767,P,0,0
38768,=,0,0
38769,0.031,0,0
38770,),0,0
38771,.,0,0
38772,Median,0,0
38773,peak,0,0
38774,headache,0,0
38775,intensity,0,0
38776,was,0,0
38777,1,0,0
38778,(,0,0
38779,range,0,0
38780,0-9,0,0
38781,),0,0
38782,after,0,0
38783,valproate,1,1
38784,compared,0,0
38785,to,0,0
38786,4.5,0,0
38787,(,0,0
38788,range,0,0
38789,0-8,0,0
38790,),0,0
38791,after,0,0
38792,placebo,1,1
38793,(,0,0
38794,P,0,0
38795,=,0,0
38796,0.120,0,0
38797,),0,0
38798,.,0,0
38799,Pretreatment,0,0
38800,with,0,0
38801,valproate,1,1
38802,as,0,0
38803,compared,0,0
38804,to,0,0
38805,placebo,1,1
38806,reduced,0,0
38807,the,0,0
38808,velocity,0,0
38809,in,0,0
38810,both,0,0
38811,middle,0,0
38812,cerebral,0,0
38813,arteries,0,0
38814,after,0,0
38815,GTN,0,1
38816,(,0,0
38817,left,0,0
38818,P,0,0
38819,=,0,0
38820,0.021,0,0
38821,",",0,0
38822,right,0,0
38823,P,0,0
38824,=,0,0
38825,0.031,0,0
38826,),0,0
38827,.,0,0
38828,No,0,0
38829,effect,0,0
38830,of,0,0
38831,valproate,1,1
38832,was,0,0
38833,seen,0,0
38834,in,0,0
38835,the,0,0
38836,diameter,0,0
38837,of,0,0
38838,the,0,0
38839,superficial,0,0
38840,temporal,0,1
38841,artery,0,0
38842,(,0,0
38843,P,0,0
38844,=,0,0
38845,0.781,0,0
38846,),0,0
38847,or,0,1
38848,the,0,0
38849,radial,0,1
38850,artery,0,0
38851,(,0,0
38852,P,0,0
38853,=,0,0
38854,0.367,0,0
38855,),0,0
38856,before,0,0
38857,or,0,1
38858,after,0,0
38859,GTN,0,1
38860,.,0,0
38861,The,0,0
38862,study,0,0
38863,indicates,0,0
38864,that,0,0
38865,a,0,0
38866,prophylactic,0,1
38867,effect,0,0
38868,of,0,0
38869,valproate,1,1
38870,may,0,0
38871,be,0,0
38872,demonstrated,0,0
38873,using,0,0
38874,the,0,0
38875,GTN,1,1
38876,human,1,1
38877,migraine,1,0
38878,model,1,0
38879,.,1,0
38880,Although,0,0
38881,",",0,0
38882,all,0,0
38883,headache,0,0
38884,parameters,0,0
38885,were,0,0
38886,reduced,0,0
38887,after,0,0
38888,valproate,1,1
38889,compared,0,0
38890,to,0,0
38891,placebo,1,1
38892,",",0,0
38893,only,0,0
38894,one,0,0
38895,parameter,0,0
38896,was,0,0
38897,statistically,0,0
38898,significantly,0,0
38899,reduced,0,0
38900,probably,0,0
38901,because,0,0
38902,of,0,0
38903,the,0,0
38904,small,0,0
38905,number,0,0
38906,of,0,0
38907,patients,0,0
38908,.,0,0
38909,The,0,0
38910,size,0,0
38911,of,0,0
38912,the,0,0
38913,effect,0,0
38914,was,0,0
38915,similar,0,0
38916,to,0,0
38917,that,0,0
38918,of,0,0
38919,valproate,0,1
38920,in,0,0
38921,clinical,0,0
38922,trials,0,0
38923,.,0,0
38924,The,1,0
38925,GTN,1,1
38926,model,1,0
38927,may,0,0
38928,therefore,0,0
38929,be,0,0
38930,a,0,0
38931,valid,0,0
38932,tool,0,0
38933,for,0,0
38934,testing,0,0
38935,new,0,0
38936,prophylactic,0,1
38937,antimigraine,0,1
38938,drugs,0,1
38939,.,0,0
38940,Effects,0,0
38941,of,0,0
38942,pioglitazone,1,1
38943,and,1,0
38944,glimepiride,1,1
38945,on,0,0
38946,glycemic,0,0
38947,control,0,1
38948,and,0,0
38949,insulin,0,1
38950,sensitivity,0,0
38951,in,0,0
38952,Mexican,0,0
38953,patients,0,0
38954,with,0,0
38955,type,0,0
38956,2,0,0
38957,diabetes,0,0
38958,mellitus,0,0
38959,:,0,0
38960,A,0,0
38961,multicenter,0,0
38962,",",0,0
38963,randomized,0,0
38964,",",0,0
38965,double-blind,0,0
38966,",",0,0
38967,parallel-group,0,0
38968,trial,0,0
38969,.,0,0
38970,BACKGROUND,0,0
38971,Pioglitazone,1,1
38972,and,0,0
38973,glimepiride,1,1
38974,improve,0,0
38975,glycemic,0,0
38976,control,0,0
38977,in,0,0
38978,patients,0,0
38979,with,0,0
38980,type,0,0
38981,2,0,0
38982,diabetes,0,0
38983,mellitus,0,0
38984,by,0,0
38985,different,0,0
38986,mechanisms,0,0
38987,.,0,0
38988,Pioglitazone,1,1
38989,is,0,0
38990,a,0,0
38991,thiazolidinedione,0,1
38992,that,0,0
38993,reduces,0,0
38994,insulin,0,0
38995,resistance,0,0
38996,",",0,0
38997,and,0,0
38998,glimepiride,1,1
38999,is,0,0
39000,a,0,0
39001,sulfonylurea,0,1
39002,insulin,0,1
39003,secretagogue,0,1
39004,.,0,0
39005,OBJECTIVE,0,0
39006,The,0,0
39007,goals,0,0
39008,of,0,0
39009,this,0,0
39010,study,0,0
39011,were,0,0
39012,to,0,0
39013,compare,0,0
39014,changes,0,0
39015,in,0,0
39016,measures,0,0
39017,of,0,0
39018,glycemic,0,0
39019,control,0,1
39020,and,0,0
39021,insulin,0,1
39022,sensitivity,0,0
39023,in,0,0
39024,Mexican,0,0
39025,patients,0,0
39026,with,0,0
39027,type,0,0
39028,2,0,0
39029,diabetes,0,0
39030,who,0,0
39031,received,0,1
39032,pioglitazone,1,1
39033,or,0,1
39034,glimepiride,1,1
39035,for,0,0
39036,1,0,0
39037,year,0,0
39038,.,0,0
39039,METHODS,0,0
39040,This,0,0
39041,was,0,0
39042,a,0,0
39043,multicenter,0,0
39044,",",0,0
39045,52-week,0,0
39046,",",0,0
39047,double-blind,0,0
39048,",",0,0
39049,parallel-group,0,0
39050,trial,0,0
39051,.,0,0
39052,Patients,0,0
39053,were,0,0
39054,randomized,0,0
39055,to,0,0
39056,receive,0,0
39057,monotherapy,0,1
39058,with,0,0
39059,either,0,1
39060,glimepiride,1,1
39061,(,0,0
39062,2,0,0
39063,mg,0,1
39064,QD,0,1
39065,initially,0,0
39066,),0,0
39067,or,1,1
39068,pioglitazone,1,1
39069,(,0,1
39070,15,0,0
39071,mg,0,1
39072,QD,0,1
39073,initially,0,0
39074,),0,0
39075,.,0,0
39076,Doses,0,0
39077,were,0,0
39078,titrated,0,0
39079,(,0,0
39080,maximal,0,0
39081,doses,0,1
39082,:,0,0
39083,pioglitazone,1,1
39084,45,0,0
39085,mg,0,1
39086,",",0,0
39087,glimepiride,1,1
39088,8,0,0
39089,mg,0,1
39090,),0,0
39091,to,0,0
39092,achieve,0,0
39093,glycemic,0,0
39094,targets,0,0
39095,(,0,0
39096,fasting,0,0
39097,blood,0,0
39098,glucose,0,1
39099,<,0,0
39100,or,0,1
39101,=7,0,0
39102,mmol/L,0,0
39103,and,0,0
39104,1-hour,0,1
39105,postprandial,0,0
39106,blood,0,0
39107,glucose,0,1
39108,<,0,0
39109,or,0,1
39110,=10,0,0
39111,mmol/L,0,0
39112,),0,0
39113,.,0,0
39114,Insulin,0,1
39115,sensitivity,0,0
39116,(,0,0
39117,primary,0,0
39118,end,0,0
39119,point,0,0
39120,),0,0
39121,was,0,0
39122,evaluated,0,0
39123,in,0,0
39124,terms,0,0
39125,of,0,0
39126,the,0,0
39127,Homeostasis,0,0
39128,Model,0,0
39129,Assessment,0,1
39130,for,0,0
39131,Insulin,0,1
39132,Sensitivity,0,0
39133,(,0,1
39134,HOMA-S,0,0
39135,),0,0
39136,",",0,0
39137,the,0,0
39138,Quantitative,0,0
39139,Insulin,0,1
39140,Sensitivity,0,0
39141,Check,0,1
39142,Index,0,1
39143,(,0,1
39144,QUICKI,0,1
39145,),0,1
39146,",",0,0
39147,and,0,0
39148,fasting,0,0
39149,serum,0,1
39150,insulin,0,1
39151,(,0,1
39152,FSI,0,1
39153,),0,0
39154,concentrations,0,0
39155,.,0,0
39156,Glycemic,0,0
39157,control,0,0
39158,was,0,0
39159,evaluated,0,0
39160,in,0,0
39161,terms,0,0
39162,of,0,0
39163,glycosylated,0,0
39164,hemoglobin,0,0
39165,(,0,1
39166,HbA,0,1
39167,(,0,1
39168,1c,0,1
39169,),0,0
39170,),0,0
39171,values,0,0
39172,and,0,0
39173,fasting,0,0
39174,plasma,0,0
39175,glucose,0,1
39176,(,0,1
39177,FPG,0,1
39178,),0,0
39179,concentrations,0,0
39180,.,0,0
39181,Patients,0,0
39182,were,0,0
39183,encouraged,0,0
39184,to,0,0
39185,maintain,0,0
39186,their,0,0
39187,individual,0,0
39188,diet,0,1
39189,and,0,0
39190,exercise,0,1
39191,regimens,0,1
39192,throughout,0,0
39193,the,0,0
39194,study,0,0
39195,.,0,0
39196,RESULTS,0,0
39197,Two,0,0
39198,hundred,0,0
39199,forty-four,0,0
39200,patients,0,0
39201,(,0,0
39202,125,0,0
39203,women,0,0
39204,",",0,0
39205,119,0,0
39206,men,0,0
39207,;,0,0
39208,all,0,0
39209,but,0,0
39210,1,0,0
39211,Hispanic,0,0
39212,),0,0
39213,were,0,0
39214,randomized,0,0
39215,to,0,0
39216,receive,0,1
39217,pioglitazone,1,1
39218,(,0,0
39219,n,0,0
39220,=,0,0
39221,121,0,1
39222,),0,0
39223,or,0,1
39224,glimepiride,1,1
39225,(,0,1
39226,n,0,0
39227,=,0,0
39228,123,0,0
39229,),0,0
39230,.,0,0
39231,In,0,0
39232,the,0,0
39233,intent-to-treat,0,0
39234,sample,0,0
39235,",",0,0
39236,pioglitazone,1,1
39237,and,0,0
39238,glimepirede,1,1
39239,produced,0,0
39240,comparable,0,0
39241,reductions,0,0
39242,in,0,0
39243,HbA,0,0
39244,(,0,1
39245,1c,0,0
39246,),0,0
39247,from,0,0
39248,baseline,0,0
39249,to,0,0
39250,the,0,0
39251,end,0,0
39252,of,0,0
39253,the,0,0
39254,study,0,0
39255,(,0,0
39256,-0.78,0,0
39257,%,0,0
39258,and,0,0
39259,-0.68,0,0
39260,%,0,0
39261,",",0,0
39262,respectively,0,0
39263,),0,0
39264,.,0,0
39265,The,0,0
39266,pioglitazone,1,1
39267,group,0,0
39268,had,0,0
39269,significantly,0,0
39270,higher,0,0
39271,HbA,0,0
39272,(,0,0
39273,1c,0,0
39274,),0,0
39275,values,0,0
39276,compared,0,0
39277,with,0,0
39278,the,0,0
39279,glimepiride,1,1
39280,group,0,0
39281,after,0,0
39282,12,0,0
39283,weeks,0,0
39284,of,0,0
39285,therapy,0,1
39286,(,0,0
39287,8.66,0,0
39288,%,0,0
39289,vs,0,0
39290,7.80,0,0
39291,%,0,0
39292,;,0,0
39293,P,0,0
39294,=,0,0
39295,0.007,0,0
39296,),0,0
39297,but,0,0
39298,had,0,0
39299,significantly,0,0
39300,lower,0,0
39301,values,0,0
39302,after,0,0
39303,52,0,0
39304,weeks,0,0
39305,(,0,0
39306,7.46,0,0
39307,%,0,0
39308,vs,0,0
39309,7.77,0,0
39310,%,0,0
39311,;,0,0
39312,P,0,0
39313,=,0,0
39314,0.027,0,0
39315,),0,0
39316,.,0,0
39317,Pioglitazone,1,1
39318,significantly,0,0
39319,reduced,0,0
39320,FPG,0,0
39321,compared,0,0
39322,with,0,0
39323,glimepiride,1,1
39324,(,0,0
39325,-0.6,0,0
39326,vs,0,0
39327,0.6,0,1
39328,mmol/L,0,0
39329,;,0,0
39330,P,0,0
39331,=,0,0
39332,0.01,0,0
39333,),0,0
39334,.,0,0
39335,Pioglitazone,1,1
39336,therapy,0,1
39337,was,0,0
39338,associated,0,0
39339,with,0,0
39340,significant,0,0
39341,increases,0,0
39342,in,0,0
39343,insulin,0,1
39344,sensitivity,0,0
39345,(,0,1
39346,reduced,0,0
39347,insulin,0,1
39348,resistance,0,0
39349,),0,0
39350,",",0,0
39351,whereas,0,0
39352,glimepiride,1,1
39353,had,0,0
39354,no,0,0
39355,effect,0,0
39356,.,0,0
39357,HOMA-S,0,0
39358,values,0,0
39359,changed,0,0
39360,18.0,0,0
39361,%,0,0
39362,for,0,0
39363,pioglitazone,1,1
39364,and,0,0
39365,-7.9,0,0
39366,%,0,0
39367,for,0,0
39368,glimepiride,1,1
39369,(,0,0
39370,P,0,0
39371,<,0,0
39372,0.001,0,0
39373,),0,0
39374,",",0,0
39375,QUICKI,0,1
39376,values,0,0
39377,changed,0,0
39378,a,0,0
39379,respective,0,0
39380,0.013,0,0
39381,and,0,0
39382,-0.007,0,0
39383,(,0,1
39384,P,0,0
39385,<,0,0
39386,0.001,0,0
39387,),0,0
39388,",",0,0
39389,and,0,0
39390,FSI,0,1
39391,values,0,0
39392,were,0,0
39393,-21.1,0,0
39394,and,0,0
39395,15.1,0,0
39396,pmol/L,0,0
39397,(,0,0
39398,P,0,0
39399,<,0,0
39400,0.001,0,0
39401,),0,0
39402,.,0,0
39403,Both,0,1
39404,drugs,0,0
39405,were,0,0
39406,well,0,0
39407,tolerated,0,0
39408,",",0,0
39409,with,0,0
39410,pioglitazone,1,1
39411,associated,0,0
39412,with,0,0
39413,more,0,0
39414,peripheral,0,0
39415,edema,0,0
39416,(,0,1
39417,number,0,0
39418,of,0,0
39419,treatment-emergent,0,0
39420,cases,0,0
39421,:,0,0
39422,35/121,0,0
39423,[,0,0
39424,28.9,0,0
39425,%,0,0
39426,],0,0
39427,vs,0,0
39428,17/123,0,0
39429,[,0,0
39430,13.8,0,0
39431,%,0,0
39432,],0,0
39433,;,0,0
39434,P,0,0
39435,=,0,0
39436,0.005,0,0
39437,),0,0
39438,and,0,0
39439,fewer,0,0
39440,hypoglycemic,0,1
39441,episodes,0,0
39442,(,0,0
39443,19,0,0
39444,[,0,0
39445,15.7,0,0
39446,%,0,0
39447,],0,0
39448,vs,0,0
39449,38,0,0
39450,[,0,0
39451,30.9,0,0
39452,%,0,0
39453,],0,0
39454,;,0,0
39455,P,0,0
39456,=,0,0
39457,0.024,0,0
39458,),0,0
39459,.,0,0
39460,The,0,0
39461,incidence,0,0
39462,of,0,0
39463,weight,0,0
39464,gain,0,0
39465,was,0,0
39466,not,0,0
39467,significantly,0,0
39468,different,0,0
39469,between,0,0
39470,treatment,0,0
39471,groups,0,0
39472,.,0,0
39473,CONCLUSIONS,0,0
39474,These,0,0
39475,data,0,0
39476,suggest,0,0
39477,that,0,0
39478,long-term,0,0
39479,treatment,0,0
39480,with,0,0
39481,pioglitazone,1,1
39482,enhances,0,0
39483,insulin,0,1
39484,sensitivity,0,0
39485,relative,0,0
39486,to,0,0
39487,glimepiride,1,1
39488,in,0,0
39489,Mexican,0,0
39490,patients,0,0
39491,with,0,0
39492,type,0,0
39493,2,0,0
39494,diabetes,0,0
39495,and,0,0
39496,that,0,0
39497,pioglitazone,1,1
39498,may,0,0
39499,have,0,0
39500,a,0,0
39501,more,0,0
39502,sustained,0,0
39503,antihyperglycemic,0,1
39504,effect,0,0
39505,.,0,0
39506,The,0,0
39507,A-V,1,1
39508,Impulse,1,0
39509,System,1,1
39510,reduces,0,0
39511,deep-vein,0,0
39512,thrombosis,0,0
39513,and,0,0
39514,swelling,0,0
39515,after,0,0
39516,hemiarthroplasty,0,1
39517,for,0,0
39518,hip,0,0
39519,fracture,0,0
39520,.,0,0
39521,We,0,0
39522,performed,0,0
39523,a,0,0
39524,prospective,0,0
39525,randomised,0,0
39526,controlled,0,0
39527,trial,0,0
39528,of,0,0
39529,the,0,0
39530,A-V,1,1
39531,Impulse,1,0
39532,System,1,1
39533,in,0,0
39534,82,0,0
39535,patients,0,0
39536,treated,0,0
39537,by,0,0
39538,hemiarthroplasty,0,1
39539,for,0,0
39540,subcapital,0,0
39541,fracture,0,0
39542,of,0,0
39543,the,0,0
39544,femoral,0,1
39545,neck,0,0
39546,.,0,0
39547,The,0,0
39548,incidence,0,0
39549,of,0,0
39550,proximal,0,0
39551,deep-vein,0,0
39552,thrombosis,0,0
39553,as,0,0
39554,assessed,0,0
39555,by,0,0
39556,Doppler,1,1
39557,ultrasonography,1,1
39558,was,0,0
39559,23,0,0
39560,%,0,0
39561,in,0,0
39562,the,0,0
39563,control,0,1
39564,group,0,0
39565,and,0,0
39566,0,0,0
39567,%,0,0
39568,in,0,0
39569,those,0,0
39570,using,0,0
39571,the,0,0
39572,device,0,1
39573,(,0,0
39574,p,0,0
39575,less,0,0
39576,than,0,0
39577,0.01,0,0
39578,),0,0
39579,.,0,0
39580,Calf,0,0
39581,and,0,0
39582,thigh,0,0
39583,circumferences,0,0
39584,were,0,0
39585,measured,0,0
39586,in,0,0
39587,both,0,0
39588,groups,0,0
39589,at,0,0
39590,seven,0,0
39591,to,0,0
39592,ten,0,0
39593,days,0,0
39594,after,0,0
39595,operation,0,0
39596,.,0,0
39597,In,0,0
39598,the,0,0
39599,treatment,0,0
39600,group,0,0
39601,there,0,0
39602,was,0,0
39603,a,0,0
39604,mean,0,0
39605,relative,0,0
39606,reduction,0,0
39607,of,0,0
39608,postoperative,0,0
39609,swelling,0,0
39610,of,0,0
39611,the,0,0
39612,thigh,0,0
39613,by,0,0
39614,3.27,0,0
39615,cm,0,0
39616,(,0,0
39617,p,0,0
39618,less,0,0
39619,than,0,0
39620,0.001,0,0
39621,),0,0
39622,and,0,0
39623,of,0,0
39624,the,0,0
39625,calf,0,1
39626,by,0,0
39627,1.55,0,0
39628,cm,0,0
39629,(,0,0
39630,p,0,0
39631,less,0,0
39632,than,0,0
39633,0.001,0,0
39634,),0,0
39635,.,0,0
39636,The,0,0
39637,A-V,0,1
39638,Impulse,0,0
39639,System,0,1
39640,appears,0,0
39641,to,0,0
39642,be,0,0
39643,a,0,0
39644,safe,0,0
39645,and,0,0
39646,effective,0,0
39647,method,0,1
39648,of,0,0
39649,reducing,0,0
39650,the,0,0
39651,incidence,0,0
39652,of,0,0
39653,proximal,0,0
39654,deep-vein,0,0
39655,thrombosis,0,0
39656,",",0,0
39657,and,0,0
39658,of,0,0
39659,postoperative,0,0
39660,swelling,0,0
39661,.,0,0
39662,Concomitant,1,1
39663,radiochemotherapy,1,1
39664,vs,1,0
39665,radiotherapy,1,1
39666,alone,1,1
39667,in,0,0
39668,patients,0,0
39669,with,0,0
39670,head,0,0
39671,and,0,0
39672,neck,0,1
39673,cancer,0,0
39674,:,0,0
39675,a,0,0
39676,Hellenic,0,0
39677,Cooperative,0,0
39678,Oncology,0,0
39679,Group,0,0
39680,Phase,0,1
39681,III,0,0
39682,Study,0,0
39683,.,0,0
39684,The,0,0
39685,primary,0,0
39686,objective,0,0
39687,of,0,0
39688,the,0,0
39689,present,0,0
39690,randomized,0,0
39691,phase,0,0
39692,III,0,1
39693,trial,0,0
39694,was,0,0
39695,to,0,0
39696,compare,0,0
39697,the,0,0
39698,3-yr,0,0
39699,survival,0,0
39700,rate,0,0
39701,of,0,0
39702,patients,0,0
39703,treated,0,0
39704,with,0,0
39705,standard,1,1
39706,fractionated,1,1
39707,radiotherapy,1,1
39708,(,1,1
39709,RT,1,1
39710,),1,1
39711,alone,0,1
39712,or,0,1
39713,with,1,0
39714,the,1,0
39715,same,1,0
39716,RT,1,0
39717,concomitantly,1,0
39718,with,1,0
39719,cisplatin,1,1
39720,(,1,1
39721,DDP,1,1
39722,),1,1
39723,or,1,1
39724,carboplatin,1,1
39725,(,1,1
39726,Cb,1,1
39727,),1,0
39728,.,1,0
39729,From,0,0
39730,January,0,0
39731,1995,0,0
39732,until,0,0
39733,July,0,0
39734,1999,0,0
39735,",",0,0
39736,124,0,0
39737,patients,0,0
39738,with,0,0
39739,histologically,0,0
39740,proven,0,0
39741,locally,0,0
39742,advanced,0,0
39743,non-nasopharyngeal,0,0
39744,head,0,1
39745,and,0,0
39746,neck,0,1
39747,cancer,0,0
39748,(,0,1
39749,HNC,0,1
39750,),0,1
39751,were,0,0
39752,randomized,0,0
39753,to,0,0
39754,receive,0,0
39755,either,0,1
39756,RT,1,1
39757,monotherapy,1,1
39758,(,0,0
39759,70,0,0
39760,Gy,0,1
39761,",",0,0
39762,Group,0,0
39763,A,0,1
39764,),0,1
39765,or,0,1
39766,the,0,0
39767,same,0,0
39768,RT,1,0
39769,concomitantly,1,0
39770,with,1,0
39771,DDP,1,1
39772,(,0,0
39773,100,0,1
39774,mg/m2,0,1
39775,on,0,0
39776,d,0,1
39777,2,0,0
39778,",",0,0
39779,22,0,0
39780,",",0,0
39781,42,0,0
39782,",",0,0
39783,Group,0,0
39784,B,0,1
39785,),0,1
39786,or,1,1
39787,Cb,1,1
39788,(,0,0
39789,7,0,0
39790,AUC,0,0
39791,on,0,0
39792,d,0,1
39793,2,0,0
39794,",",0,0
39795,22,0,0
39796,",",0,0
39797,42,0,0
39798,",",0,0
39799,Group,0,0
39800,C,0,1
39801,),0,0
39802,.,0,0
39803,There,0,0
39804,were,0,0
39805,no,0,0
39806,significant,0,0
39807,differences,0,0
39808,in,0,0
39809,complete,0,0
39810,response,0,0
39811,rates,0,0
39812,between,0,0
39813,patients,0,0
39814,treated,0,0
39815,with,0,0
39816,RT,0,0
39817,alone,0,1
39818,or,0,1
39819,combined,0,1
39820,chemoradiotherapy,1,1
39821,.,1,0
39822,However,0,0
39823,",",0,0
39824,median,0,0
39825,time,0,0
39826,to,0,0
39827,progression,0,0
39828,(,0,1
39829,TTP,0,1
39830,),0,1
39831,and,0,0
39832,overall,0,0
39833,survival,0,0
39834,(,0,1
39835,OS,0,0
39836,),0,1
39837,were,0,0
39838,significantly,0,0
39839,longer,0,0
39840,in,0,0
39841,patients,0,0
39842,treated,0,0
39843,with,0,0
39844,concomitant,1,0
39845,chemoradiotherapy,1,0
39846,.,1,0
39847,Thus,0,0
39848,",",0,0
39849,median,0,0
39850,TTP,0,0
39851,was,0,0
39852,6.3,0,0
39853,",",0,0
39854,45.2,0,0
39855,",",0,0
39856,and,0,0
39857,17.7,0,0
39858,mo,0,0
39859,in,0,0
39860,groups,0,0
39861,A,0,0
39862,",",0,0
39863,B,0,0
39864,",",0,0
39865,and,0,0
39866,C,0,1
39867,respectively,0,0
39868,(,0,0
39869,p,0,0
39870,=,0,0
39871,0.0002,0,0
39872,),0,0
39873,.,0,0
39874,Similarly,0,0
39875,",",0,0
39876,median,0,0
39877,OS,0,0
39878,was,0,0
39879,12.2,0,0
39880,",",0,0
39881,48.6,0,0
39882,",",0,0
39883,and,0,0
39884,24.5,0,0
39885,mo,0,0
39886,",",0,0
39887,respectively,0,0
39888,(,0,0
39889,p,0,0
39890,=,0,0
39891,0.0003,0,0
39892,),0,0
39893,.,0,0
39894,At,0,0
39895,3,0,0
39896,yr,0,0
39897,follow-up,0,0
39898,",",0,0
39899,17.5,0,0
39900,%,0,0
39901,of,0,0
39902,patients,0,0
39903,in,0,0
39904,group,0,0
39905,A,0,0
39906,were,0,0
39907,alive,0,0
39908,compared,0,0
39909,to,0,0
39910,52,0,0
39911,%,0,0
39912,in,0,0
39913,group,0,0
39914,B,0,1
39915,and,0,0
39916,42,0,0
39917,%,0,0
39918,in,0,0
39919,group,0,1
39920,C,0,1
39921,(,0,0
39922,p,0,0
39923,<,0,0
39924,0.001,0,0
39925,),0,0
39926,.,0,0
39927,Patients,0,0
39928,treated,0,0
39929,with,0,0
39930,concomitant,1,0
39931,chemoradiotherapy,1,1
39932,experienced,0,0
39933,more,0,0
39934,frequently,0,0
39935,severe,0,0
39936,hematological,0,0
39937,toxicity,0,0
39938,.,0,0
39939,Also,0,0
39940,",",0,0
39941,severe,0,0
39942,nausea/vomiting,0,0
39943,was,0,0
39944,more,0,0
39945,pronounced,0,0
39946,in,0,0
39947,group,0,0
39948,B,0,0
39949,",",0,0
39950,as,0,0
39951,expected,0,0
39952,.,0,0
39953,The,0,0
39954,present,0,0
39955,study,0,0
39956,clearly,0,0
39957,demonstrated,0,0
39958,that,0,0
39959,concomitant,1,0
39960,chemoradiotherapy,1,1
39961,with,1,0
39962,platinum,1,1
39963,analogs,1,0
39964,significantly,0,0
39965,prolongs,0,0
39966,3-yr,0,0
39967,survival,0,0
39968,and,0,0
39969,median,0,0
39970,OS,0,0
39971,in,0,0
39972,patients,0,0
39973,with,0,0
39974,locally,0,0
39975,advanced,0,0
39976,HNC,0,1
39977,compared,0,0
39978,to,0,0
39979,conventional,0,1
39980,RT,0,0
39981,alone,0,1
39982,.,0,0
39983,Minocycline,1,1
39984,safety,0,0
39985,and,0,0
39986,tolerability,0,0
39987,in,0,0
39988,Huntington,0,0
39989,disease,0,0
39990,.,0,0
39991,Minocycline,1,1
39992,is,0,0
39993,an,0,0
39994,antibiotic,0,1
39995,with,0,0
39996,anti-inflammatory,0,1
39997,and,0,0
39998,antiapoptotic,0,1
39999,properties,0,0
40000,that,0,0
40001,prolongs,0,0
40002,survival,0,0
40003,in,0,0
40004,a,0,0
40005,transgenic,0,1
40006,Huntington,0,0
40007,disease,0,0
40008,(,0,1
40009,HD,0,1
40010,),0,1
40011,mouse,0,1
40012,model,0,0
40013,.,0,0
40014,In,0,0
40015,a,0,0
40016,double-blind,0,0
40017,",",0,0
40018,randomized,0,0
40019,",",0,0
40020,placebo-controlled,1,1
40021,study,0,0
40022,of,0,0
40023,minocycline,1,1
40024,in,0,0
40025,60,0,0
40026,HD,0,0
40027,patients,0,0
40028,",",0,0
40029,the,0,0
40030,authors,0,0
40031,determined,0,0
40032,that,0,0
40033,over,0,0
40034,8,0,0
40035,weeks,0,0
40036,",",0,0
40037,minocycline,1,1
40038,at,1,0
40039,100,1,0
40040,and,1,0
40041,200,1,1
40042,mg/day,1,1
40043,was,0,0
40044,well,0,0
40045,tolerated,0,0
40046,and,0,0
40047,safe,0,0
40048,in,0,0
40049,HD,0,0
40050,patients,0,0
40051,.,0,0
40052,Tolerability,0,0
40053,and,0,0
40054,adverse,0,0
40055,event,0,0
40056,frequency,0,0
40057,were,0,0
40058,similar,0,0
40059,between,0,0
40060,treatment,0,0
40061,and,0,0
40062,placebo,0,1
40063,groups,0,0
40064,.,0,0
40065,Peripheral,0,1
40066,arterial,0,0
40067,disease,0,0
40068,:,0,0
40069,therapeutic,0,0
40070,confidence,0,0
40071,of,0,0
40072,CT,1,1
40073,versus,1,1
40074,digital,1,1
40075,subtraction,1,1
40076,angiography,1,1
40077,and,0,0
40078,effects,0,0
40079,on,0,0
40080,additional,0,0
40081,imaging,0,0
40082,recommendations,0,0
40083,.,0,0
40084,PURPOSE,0,0
40085,To,0,0
40086,compare,0,0
40087,multi-detector,1,1
40088,row,1,1
40089,computed,1,1
40090,tomographic,1,1
40091,(,1,1
40092,CT,1,1
40093,),1,1
40094,angiography,1,1
40095,and,1,0
40096,digital,1,1
40097,subtraction,1,1
40098,angiography,1,1
40099,(,1,1
40100,DSA,1,0
40101,),1,1
40102,prior,0,0
40103,to,0,0
40104,revascularization,1,0
40105,in,0,0
40106,patients,0,0
40107,with,0,0
40108,symptomatic,0,0
40109,peripheral,0,0
40110,arterial,0,0
40111,disease,0,0
40112,for,0,0
40113,the,0,0
40114,purpose,0,0
40115,of,0,0
40116,assessing,0,0
40117,recommendations,0,0
40118,for,0,0
40119,additional,0,0
40120,imaging,0,0
40121,and,0,0
40122,physician,0,1
40123,confidence,0,0
40124,ratings,0,0
40125,for,0,0
40126,chosen,0,0
40127,therapy,0,1
40128,.,0,0
40129,MATERIALS,0,0
40130,AND,0,0
40131,METHODS,0,0
40132,In,0,0
40133,a,0,0
40134,randomized,0,0
40135,controlled,0,0
40136,trial,0,0
40137,",",0,0
40138,73,0,0
40139,patients,0,0
40140,were,0,0
40141,assigned,0,0
40142,to,0,0
40143,CT,1,1
40144,angiography,1,1
40145,",",0,0
40146,and,0,0
40147,72,0,0
40148,were,0,0
40149,assigned,0,0
40150,to,0,0
40151,DSA,1,0
40152,.,1,0
40153,Physician,0,0
40154,confidence,0,0
40155,in,0,0
40156,the,0,0
40157,treatment,0,0
40158,decision,0,0
40159,was,0,0
40160,measured,0,0
40161,as,0,0
40162,a,0,0
40163,continuous,0,1
40164,outcome,0,0
40165,on,0,0
40166,a,0,0
40167,scale,0,0
40168,of,0,0
40169,0-10,0,0
40170,(,0,0
40171,uncertain,0,0
40172,to,0,0
40173,certain,0,0
40174,),0,1
40175,and,0,0
40176,as,0,0
40177,a,0,0
40178,dichotomous,0,0
40179,outcome,0,0
40180,(,0,1
40181,further,0,0
40182,imaging,0,0
40183,recommended,0,0
40184,",",0,0
40185,yes,0,0
40186,or,0,1
40187,no,0,0
40188,),0,0
40189,.,0,0
40190,Mean,0,0
40191,confidence,0,0
40192,scores,0,0
40193,and,0,0
40194,additional,0,0
40195,imaging,0,0
40196,recommendations,0,0
40197,were,0,0
40198,compared,0,0
40199,between,0,0
40200,CT,1,0
40201,and,1,0
40202,DSA,1,0
40203,groups,0,0
40204,in,0,0
40205,an,0,0
40206,intention-to-diagnose-and-treat,0,0
40207,analysis,0,0
40208,.,0,0
40209,To,0,0
40210,detect,0,0
40211,trends,0,0
40212,in,0,0
40213,confidence,0,0
40214,",",0,0
40215,confidence,0,0
40216,scores,0,0
40217,were,0,0
40218,plotted,0,0
40219,over,0,0
40220,time,0,0
40221,",",0,0
40222,and,0,0
40223,multiple,0,0
40224,linear,0,0
40225,regression,0,0
40226,analysis,0,0
40227,was,0,0
40228,performed,0,0
40229,.,0,0
40230,To,0,0
40231,detect,0,0
40232,trends,0,0
40233,in,0,0
40234,additional,0,0
40235,imaging,0,0
40236,recommendations,0,0
40237,",",0,0
40238,logistic,0,0
40239,regression,0,0
40240,analysis,0,0
40241,was,0,0
40242,used,0,0
40243,.,0,0
40244,Data,0,0
40245,from,0,0
40246,eligible,0,0
40247,nonrandomized,0,0
40248,patients,0,0
40249,were,0,0
40250,analyzed,0,0
40251,separately,0,0
40252,.,0,0
40253,RESULTS,0,0
40254,No,0,0
40255,statistically,0,0
40256,significant,0,0
40257,difference,0,0
40258,in,0,0
40259,baseline,0,0
40260,characteristics,0,0
40261,between,0,0
40262,randomized,0,0
40263,groups,0,0
40264,was,0,0
40265,found,0,0
40266,.,0,0
40267,CT,1,0
40268,had,0,0
40269,a,0,0
40270,lower,0,0
40271,confidence,0,0
40272,score,0,0
40273,than,0,0
40274,did,0,0
40275,DSA,1,0
40276,(,0,0
40277,7.2,0,0
40278,vs,0,0
40279,8.2,0,0
40280,",",0,0
40281,P,0,0
40282,<,0,0
40283,.001,0,0
40284,),0,0
40285,.,0,0
40286,Further,0,0
40287,imaging,0,0
40288,was,0,0
40289,recommended,0,0
40290,more,0,0
40291,often,0,0
40292,after,0,0
40293,CT,1,1
40294,(,0,0
40295,25,0,0
40296,of,0,0
40297,71,0,0
40298,patients,0,0
40299,",",0,0
40300,35,0,0
40301,%,0,0
40302,),0,0
40303,than,0,0
40304,after,0,0
40305,DSA,1,0
40306,(,0,0
40307,nine,0,0
40308,of,0,0
40309,66,0,0
40310,patients,0,0
40311,",",0,0
40312,14,0,0
40313,%,0,0
40314,;,0,0
40315,P,0,0
40316,=,0,0
40317,.003,0,0
40318,),0,0
40319,.,0,0
40320,Analysis,0,0
40321,of,0,0
40322,trends,0,0
40323,demonstrated,0,0
40324,increasing,0,0
40325,(,0,0
40326,but,0,0
40327,not,0,0
40328,statistically,0,0
40329,significant,0,0
40330,),0,0
40331,confidence,0,0
40332,in,0,0
40333,CT,1,1
40334,and,0,0
40335,stable,0,0
40336,confidence,0,0
40337,in,0,0
40338,DSA,1,0
40339,.,1,0
40340,No,0,0
40341,significant,0,0
40342,difference,0,0
40343,was,0,0
40344,found,0,0
40345,in,0,0
40346,baseline,0,0
40347,characteristics,0,0
40348,between,0,0
40349,randomized,0,0
40350,and,0,0
40351,nonrandomized,0,0
40352,patients,0,0
40353,.,0,0
40354,Among,0,0
40355,nonrandomized,0,0
40356,patients,0,0
40357,",",0,0
40358,no,0,0
40359,significant,0,0
40360,difference,0,0
40361,in,0,0
40362,mean,0,0
40363,confidence,0,0
40364,score,0,0
40365,(,0,0
40366,8.2,0,0
40367,vs,0,0
40368,8.3,0,0
40369,",",0,0
40370,P,0,0
40371,=,0,0
40372,.26,0,0
40373,),0,0
40374,was,0,0
40375,found,0,0
40376,between,0,0
40377,CT,1,1
40378,(,0,0
40379,n,0,0
40380,=,0,0
40381,24,0,0
40382,),0,0
40383,and,0,0
40384,DSA,1,0
40385,(,0,1
40386,n,0,0
40387,=,0,0
40388,26,0,0
40389,),0,0
40390,.,0,0
40391,CONCLUSION,0,0
40392,With,0,0
40393,CT,1,1
40394,angiography,1,1
40395,",",0,0
40396,physician,0,1
40397,confidence,0,0
40398,decreases,0,0
40399,with,0,0
40400,an,0,0
40401,associated,0,0
40402,increase,0,0
40403,in,0,0
40404,additional,0,0
40405,imaging,0,0
40406,prior,0,0
40407,to,0,0
40408,revascularization,0,0
40409,in,0,0
40410,patients,0,0
40411,with,0,0
40412,symptomatic,0,0
40413,peripheral,0,0
40414,arterial,0,0
40415,disease,0,0
40416,.,0,0
40417,Given,0,0
40418,that,0,0
40419,CT,1,1
40420,is,0,0
40421,less,0,0
40422,invasive,0,0
40423,than,0,0
40424,DSA,1,0
40425,",",0,0
40426,results,0,0
40427,suggest,0,0
40428,that,0,0
40429,CT,1,0
40430,may,0,0
40431,replace,0,0
40432,DSA,1,0
40433,in,0,0
40434,selected,0,0
40435,cases,0,0
40436,.,0,0
40437,Atrial,1,0
40438,remodeling,1,0
40439,after,0,0
40440,mitral,1,0
40441,valve,1,0
40442,surgery,1,1
40443,in,0,0
40444,patients,0,0
40445,with,0,0
40446,permanent,0,0
40447,atrial,0,0
40448,fibrillation,0,0
40449,.,0,0
40450,BACKGROUND,0,0
40451,Mitral,0,0
40452,valve,0,1
40453,pathology,0,0
40454,is,0,0
40455,frequently,0,0
40456,associated,0,0
40457,with,0,0
40458,auricular,0,1
40459,dilatation,0,0
40460,and,0,0
40461,atrial,0,0
40462,fibrillation,0,0
40463,.,0,0
40464,Mitral,1,0
40465,surgery,1,0
40466,allows,0,0
40467,an,0,0
40468,immediate,0,0
40469,surgical,0,1
40470,auricular,0,1
40471,remodeling,0,0
40472,and,0,0
40473,besides,0,0
40474,in,0,0
40475,those,0,0
40476,cases,0,0
40477,in,0,0
40478,which,0,0
40479,sinus,0,0
40480,rhythm,0,1
40481,is,0,0
40482,reached,0,0
40483,",",0,0
40484,it,0,0
40485,is,0,0
40486,followed,0,0
40487,by,0,0
40488,a,0,0
40489,late,0,0
40490,remodeling,0,0
40491,.,0,0
40492,The,0,0
40493,aim,0,0
40494,of,0,0
40495,this,0,0
40496,study,0,0
40497,is,0,0
40498,to,0,0
40499,investigate,0,0
40500,the,0,0
40501,process,0,0
40502,of,0,0
40503,postoperative,0,0
40504,auricular,0,0
40505,remodeling,0,0
40506,in,0,0
40507,patients,0,0
40508,with,0,0
40509,permanent,0,0
40510,atrial,0,0
40511,fibrillation,0,0
40512,undergoing,0,0
40513,mitral,1,0
40514,surgery,1,1
40515,.,1,0
40516,METHODS,0,0
40517,In,0,0
40518,a,0,0
40519,prospective,0,0
40520,randomized,0,0
40521,trial,0,0
40522,",",0,0
40523,50,0,0
40524,patients,0,0
40525,with,0,0
40526,permanent,0,0
40527,atrial,0,0
40528,fibrillation,0,0
40529,and,0,0
40530,dilated,0,1
40531,left,0,0
40532,atrium,0,0
40533,",",0,0
40534,submitted,0,0
40535,to,0,0
40536,surgical,0,1
40537,mitral,0,0
40538,repair,0,1
40539,",",0,0
40540,were,0,0
40541,divided,0,0
40542,into,0,0
40543,two,0,0
40544,groups,0,0
40545,:,0,0
40546,Group,1,0
40547,I,1,0
40548,contained,1,0
40549,25,1,0
40550,patients,1,0
40551,with,1,0
40552,left,1,0
40553,auricular,1,1
40554,reduction,1,0
40555,and,1,0
40556,mitral,1,0
40557,surgery,1,1
40558,",",1,0
40559,and,1,0
40560,Group,1,0
40561,II,1,1
40562,contained,1,0
40563,25,1,0
40564,patients,1,0
40565,with,1,0
40566,isolated,1,0
40567,valve,1,0
40568,surgery,1,1
40569,.,1,0
40570,Both,0,0
40571,groups,0,0
40572,were,0,0
40573,considered,0,0
40574,homogeneous,0,0
40575,in,0,0
40576,the,0,0
40577,preoperative,0,0
40578,assessment,0,0
40579,.,0,0
40580,RESULTS,0,0
40581,After,0,0
40582,a,0,0
40583,mean,0,0
40584,follow-up,0,0
40585,of,0,0
40586,31,0,0
40587,months,0,0
40588,",",0,0
40589,46,0,0
40590,%,0,0
40591,of,0,0
40592,patients,0,0
40593,included,0,0
40594,in,0,0
40595,Group,0,0
40596,I,0,0
40597,versus,0,0
40598,18,0,0
40599,%,0,0
40600,of,0,0
40601,patients,0,0
40602,included,0,0
40603,in,0,0
40604,Group,0,0
40605,II,0,0
40606,restarted,0,0
40607,sinus,0,0
40608,rhythm,0,1
40609,(,0,0
40610,p,0,0
40611,=,0,0
40612,0.06,0,0
40613,),0,0
40614,.,0,0
40615,An,0,0
40616,auricular,0,0
40617,remodeling,0,0
40618,with,0,0
40619,size,0,0
40620,regression,0,0
40621,occurred,0,0
40622,in,0,0
40623,those,0,0
40624,patients,0,0
40625,who,0,0
40626,recovered,0,0
40627,from,0,0
40628,sinus,0,0
40629,rhythm,0,1
40630,",",0,0
40631,worthy,0,0
40632,of,0,0
40633,remark,0,0
40634,in,0,0
40635,Group,0,0
40636,II,0,1
40637,(,0,0
40638,-10.8,0,0
40639,%,0,0
40640,of,0,0
40641,left,0,0
40642,auricular,0,1
40643,volume,0,0
40644,reduction,0,0
40645,in,0,0
40646,Group,0,0
40647,I,0,0
40648,compared,0,0
40649,to,0,0
40650,-21.5,0,0
40651,%,0,0
40652,in,0,0
40653,Group,0,0
40654,II,0,1
40655,;,0,0
40656,p,0,0
40657,<,0,0
40658,0.05,0,0
40659,),0,0
40660,.,0,0
40661,A,0,0
40662,new,0,0
40663,atrial,0,0
40664,enlargement,0,0
40665,took,0,0
40666,place,0,0
40667,in,0,0
40668,those,0,0
40669,patients,0,0
40670,who,0,0
40671,remained,0,0
40672,with,0,0
40673,atrial,0,0
40674,fibrillation,0,0
40675,(,0,0
40676,+16.8,0,0
40677,%,0,0
40678,left,0,0
40679,auricular,0,0
40680,volume,0,0
40681,in,0,0
40682,Group,0,0
40683,I,0,0
40684,vs.,0,0
40685,+8.4,0,0
40686,%,0,0
40687,in,0,0
40688,Group,0,0
40689,II,0,1
40690,;,0,0
40691,p,0,0
40692,<,0,0
40693,0.05,0,0
40694,),0,0
40695,.,0,0
40696,CONCLUSIONS,0,0
40697,Mitral,0,0
40698,surgery,0,1
40699,produces,0,0
40700,an,0,0
40701,atrial,0,0
40702,postoperative,0,0
40703,volume,0,0
40704,that,0,0
40705,decrease,0,0
40706,especially,0,0
40707,when,0,0
40708,reduction,0,0
40709,techniques,0,1
40710,are,0,0
40711,employed,0,0
40712,.,0,0
40713,Late,0,0
40714,left,0,0
40715,atrial,0,0
40716,remodeling,0,0
40717,depended,0,0
40718,on,0,0
40719,the,0,0
40720,type,0,0
40721,of,0,0
40722,atrial,0,0
40723,rhythm,0,1
40724,and,0,0
40725,postoperative,0,0
40726,surgical,0,1
40727,volume,0,0
40728,.,0,0
40729,Absorption,0,0
40730,of,0,0
40731,intramuscular,0,1
40732,phenobarbitone,0,1
40733,in,0,0
40734,children,0,0
40735,with,0,0
40736,severe,0,0
40737,falciparum,0,0
40738,malaria,0,0
40739,.,0,0
40740,The,0,0
40741,absorption,0,0
40742,of,0,0
40743,intramuscular,1,1
40744,phenobarbitone,1,1
40745,7,1,0
40746,mg.kg-1,1,1
40747,was,0,0
40748,studied,0,0
40749,in,0,0
40750,11,0,0
40751,Karen,0,1
40752,children,0,0
40753,aged,0,0
40754,between,0,0
40755,1.7,0,0
40756,and,0,0
40757,11,0,0
40758,y,0,0
40759,with,0,0
40760,severe,0,0
40761,falciparum,0,0
40762,malaria,0,0
40763,.,0,0
40764,Eight,0,0
40765,of,0,0
40766,the,0,0
40767,children,0,0
40768,were,0,0
40769,comatose,0,0
40770,.,0,0
40771,Clinical,0,0
40772,findings,0,0
40773,were,0,0
40774,compared,0,0
40775,with,0,0
40776,those,0,0
40777,in,0,0
40778,9,0,0
40779,further,0,0
40780,children,0,0
40781,with,0,0
40782,severe,0,0
40783,malaria,0,0
40784,of,0,0
40785,similar,0,0
40786,age,0,0
40787,range,0,0
40788,(,0,0
40789,four,0,0
40790,of,0,0
40791,whom,0,0
40792,were,0,0
40793,unconscious,0,0
40794,),0,0
40795,",",0,0
40796,who,0,0
40797,received,0,0
40798,an,0,0
40799,identical,1,0
40800,placebo,1,1
40801,.,1,0
40802,One,0,0
40803,child,0,0
40804,",",0,0
40805,who,0,0
40806,had,0,0
40807,received,0,0
40808,placebo,0,1
40809,",",0,0
40810,had,0,0
40811,repeated,0,0
40812,convulsions,0,0
40813,and,0,0
40814,died,0,0
40815,1,0,0
40816,h,0,0
40817,after,0,0
40818,admission,0,0
40819,to,0,0
40820,hospital,0,0
40821,.,0,0
40822,The,0,0
40823,remainder,0,0
40824,made,0,0
40825,an,0,0
40826,uncomplicated,0,0
40827,recovery,0,0
40828,.,0,0
40829,There,0,0
40830,were,0,0
40831,no,0,0
40832,convulsions,0,0
40833,subsequent,0,0
40834,to,0,0
40835,treatment,0,0
40836,",",0,0
40837,although,0,0
40838,the,0,0
40839,study,0,0
40840,was,0,0
40841,too,0,0
40842,small,0,0
40843,to,0,0
40844,assess,0,0
40845,anticonvulsant,0,1
40846,efficacy,0,0
40847,.,0,0
40848,There,0,0
40849,was,0,0
40850,no,0,0
40851,observable,0,0
40852,toxicity,0,0
40853,",",0,0
40854,but,0,0
40855,phenobarbitone,0,1
40856,recipients,0,0
40857,had,0,0
40858,a,0,0
40859,significant,0,0
40860,tendency,0,0
40861,to,0,0
40862,deepen,0,0
40863,in,0,0
40864,their,0,0
40865,level,0,0
40866,of,0,0
40867,coma,0,0
40868,or,0,1
40869,to,0,0
40870,become,0,0
40871,sleepy,0,0
40872,within,0,0
40873,the,0,0
40874,4,0,0
40875,h,0,0
40876,after,0,0
40877,drug,0,1
40878,administration,0,0
40879,.,0,0
40880,Phenobarbitone,0,1
40881,was,0,0
40882,rapidly,0,0
40883,absorbed,0,0
40884,",",0,0
40885,reaching,0,0
40886,a,0,0
40887,mean,0,0
40888,(,0,1
40889,range,0,0
40890,),0,1
40891,peak,0,0
40892,concentration,0,0
40893,of,0,0
40894,34.2,0,0
40895,[,0,0
40896,29.3-42.6,0,0
40897,],0,0
40898,mumol.l-1,0,0
40899,in,0,0
40900,a,0,0
40901,median,0,0
40902,(,0,1
40903,range,0,0
40904,),0,1
40905,of,0,0
40906,4,0,0
40907,(,0,0
40908,2.5-12,0,1
40909,),0,0
40910,h.,0,0
40911,These,0,0
40912,values,0,0
40913,are,0,0
40914,comparable,0,0
40915,to,0,0
40916,those,0,0
40917,previously,0,0
40918,reported,0,0
40919,in,0,0
40920,healthy,0,0
40921,children,0,0
40922,and,0,0
40923,in,0,0
40924,children,0,0
40925,with,0,0
40926,febrile,0,0
40927,convulsions,0,0
40928,.,0,0
40929,Intramuscular,0,1
40930,phenobarbitone,0,1
40931,is,0,0
40932,well,0,0
40933,absorbed,0,0
40934,in,0,0
40935,children,0,0
40936,with,0,0
40937,severe,0,0
40938,malaria,0,0
40939,;,0,0
40940,the,0,0
40941,optimum,0,0
40942,prophylactic,0,1
40943,anticonvulsant,0,1
40944,dose,0,1
40945,remains,0,0
40946,to,0,0
40947,be,0,0
40948,determined,0,0
40949,.,0,0
40950,The,0,0
40951,effect,0,0
40952,of,0,0
40953,calcium,1,1
40954,supplementation,1,1
40955,on,0,0
40956,bone,0,0
40957,density,0,0
40958,in,0,0
40959,premenarcheal,0,0
40960,females,0,0
40961,:,0,0
40962,a,0,0
40963,co-twin,0,0
40964,approach,0,1
40965,.,0,0
40966,The,0,0
40967,age,0,0
40968,and,0,0
40969,developmental,0,0
40970,stage,0,0
40971,at,0,0
40972,which,0,0
40973,calcium,1,1
40974,supplementation,1,1
40975,produces,0,0
40976,the,0,0
40977,greatest,0,0
40978,bone,0,0
40979,effects,0,0
40980,remain,0,0
40981,controversial,0,0
40982,.,0,0
40983,We,0,0
40984,tested,0,0
40985,the,0,0
40986,hypothesis,0,0
40987,that,0,0
40988,calcium,1,1
40989,supplementation,1,1
40990,may,0,0
40991,improve,0,0
40992,bone,0,0
40993,accrual,0,0
40994,in,0,0
40995,premenarcheal,0,0
40996,females,0,0
40997,.,0,0
40998,Fifty-one,0,0
40999,pairs,0,0
41000,of,0,0
41001,premenarcheal,0,0
41002,female,0,0
41003,twins,0,0
41004,(,0,0
41005,27,0,0
41006,monozygotic,0,0
41007,and,0,0
41008,24,0,0
41009,dizygotic,0,0
41010,;,0,0
41011,mean,0,0
41012,+/-,0,0
41013,sd,0,0
41014,age,0,0
41015,",",0,0
41016,10.3,0,0
41017,+/-,0,0
41018,1.5,0,0
41019,yr,0,0
41020,),0,0
41021,participated,0,0
41022,in,0,0
41023,a,0,0
41024,randomized,0,0
41025,",",0,0
41026,single-blind,0,0
41027,",",0,0
41028,placebo-controlled,1,1
41029,trial,0,0
41030,with,0,0
41031,one,0,0
41032,twin,0,0
41033,of,0,0
41034,each,0,0
41035,pair,0,0
41036,receiving,1,0
41037,a,1,0
41038,1200-mg,1,1
41039,calcium,1,1
41040,carbonate,1,1
41041,(,1,1
41042,Caltrate,1,1
41043,),1,1
41044,supplement,1,1
41045,.,1,0
41046,Areal,0,0
41047,bone,0,0
41048,mineral,0,0
41049,density,0,0
41050,(,0,1
41051,aBMD,0,1
41052,),0,1
41053,was,0,0
41054,measured,0,0
41055,at,0,0
41056,baseline,0,0
41057,and,0,0
41058,6,0,0
41059,",",0,0
41060,12,0,0
41061,",",0,0
41062,18,0,0
41063,and,0,0
41064,24,0,0
41065,months,0,0
41066,.,0,0
41067,There,0,0
41068,were,0,0
41069,no,0,0
41070,within-pair,0,0
41071,differences,0,0
41072,in,0,0
41073,height,0,0
41074,",",0,0
41075,weight,0,0
41076,",",0,0
41077,or,0,1
41078,calcium,0,1
41079,intake,0,1
41080,at,0,0
41081,baseline,0,0
41082,.,0,0
41083,Calcium,0,1
41084,supplementation,0,1
41085,was,0,0
41086,associated,0,0
41087,(,0,0
41088,P,0,0
41089,<,0,0
41090,0.05,0,0
41091,),0,0
41092,with,0,0
41093,increased,0,0
41094,aBMD,0,1
41095,compared,0,0
41096,with,0,0
41097,placebo,0,1
41098,",",0,0
41099,adjusted,0,0
41100,for,0,0
41101,age,0,0
41102,",",0,0
41103,height,0,0
41104,",",0,0
41105,and,0,0
41106,weight,0,0
41107,at,0,0
41108,the,0,0
41109,following,0,0
41110,time,0,0
41111,points,0,0
41112,from,0,0
41113,baseline,0,0
41114,:,0,0
41115,total,0,0
41116,hip,0,0
41117,",",0,0
41118,6,0,0
41119,months,0,0
41120,(,0,0
41121,1.9,0,0
41122,%,0,0
41123,),0,0
41124,",",0,0
41125,12,0,0
41126,months,0,0
41127,(,0,0
41128,1.6,0,0
41129,%,0,0
41130,),0,0
41131,",",0,0
41132,and,0,0
41133,18,0,0
41134,months,0,0
41135,(,0,0
41136,2.4,0,0
41137,%,0,0
41138,),0,0
41139,;,0,0
41140,lumbar,0,1
41141,spine,0,1
41142,",",0,0
41143,12,0,0
41144,months,0,0
41145,(,0,0
41146,1.0,0,1
41147,%,0,0
41148,),0,0
41149,;,0,0
41150,femoral,0,1
41151,neck,0,0
41152,",",0,0
41153,6,0,0
41154,months,0,0
41155,(,0,0
41156,1.9,0,0
41157,%,0,0
41158,),0,0
41159,.,0,0
41160,Adjusted,0,0
41161,total,0,0
41162,body,0,0
41163,bone,0,0
41164,mineral,0,0
41165,content,0,0
41166,was,0,0
41167,higher,0,0
41168,in,0,0
41169,the,0,0
41170,calcium,0,1
41171,group,0,0
41172,at,0,0
41173,6,0,0
41174,months,0,0
41175,(,0,0
41176,2.0,0,1
41177,%,0,0
41178,),0,0
41179,",",0,0
41180,12,0,0
41181,months,0,0
41182,(,0,0
41183,2.5,0,1
41184,%,0,0
41185,),0,0
41186,",",0,0
41187,18,0,0
41188,months,0,0
41189,(,0,0
41190,4.6,0,0
41191,%,0,0
41192,),0,0
41193,",",0,0
41194,and,0,0
41195,24,0,0
41196,months,0,0
41197,(,0,0
41198,3.7,0,0
41199,%,0,0
41200,),0,0
41201,",",0,0
41202,respectively,0,0
41203,(,0,0
41204,all,0,0
41205,P,0,0
41206,<,0,0
41207,0.001,0,0
41208,),0,0
41209,.,0,0
41210,Calcium,1,1
41211,supplementation,1,1
41212,was,0,0
41213,effective,0,0
41214,in,0,0
41215,increasing,0,0
41216,aBMD,0,1
41217,at,0,0
41218,regional,0,0
41219,sites,0,0
41220,over,0,0
41221,the,0,0
41222,first,0,0
41223,12-18,0,0
41224,months,0,0
41225,",",0,0
41226,but,0,0
41227,these,0,0
41228,gains,0,0
41229,were,0,0
41230,not,0,0
41231,maintained,0,0
41232,to,0,0
41233,24,0,0
41234,months,0,0
41235,.,0,0
41236,Effect,0,0
41237,of,0,0
41238,ibuprofen,1,1
41239,on,0,0
41240,cyclooxygenase,0,1
41241,and,0,0
41242,nitric,0,1
41243,oxide,0,1
41244,synthase,0,0
41245,of,0,0
41246,gastric,0,0
41247,mucosa,0,0
41248,:,0,0
41249,correlation,0,0
41250,with,0,0
41251,endoscopic,0,1
41252,lesions,0,0
41253,and,0,0
41254,adverse,0,0
41255,reactions,0,0
41256,.,0,0
41257,The,0,0
41258,aim,0,0
41259,of,0,0
41260,this,0,0
41261,study,0,0
41262,was,0,0
41263,to,0,0
41264,evaluate,0,0
41265,the,0,0
41266,effect,0,0
41267,of,0,0
41268,ibuprofen,1,1
41269,on,0,0
41270,gastric,0,0
41271,mucosa,0,0
41272,and,0,0
41273,enzymes,0,1
41274,involved,0,0
41275,in,0,0
41276,gastroprotection,0,0
41277,in,0,0
41278,healthy,0,0
41279,volunteers,0,0
41280,.,0,0
41281,Twenty-four,0,0
41282,Helicobacter,0,0
41283,pylori-negative,0,0
41284,subjects,0,0
41285,were,0,0
41286,randomized,0,0
41287,to,0,0
41288,treatment,0,0
41289,with,0,1
41290,ibuprofen,1,1
41291,or,1,1
41292,ibuprofen-arginate,1,1
41293,(,0,0
41294,each,0,0
41295,600,0,1
41296,mg/6,0,1
41297,hr,0,0
41298,during,0,0
41299,3,0,0
41300,days,0,0
41301,),0,0
41302,.,0,0
41303,Endoscopies,1,0
41304,were,0,0
41305,performed,0,0
41306,1,0,0
41307,week,0,0
41308,before,0,0
41309,and,0,0
41310,after,0,0
41311,treatment,0,0
41312,.,0,0
41313,Biopsies,0,0
41314,were,0,0
41315,taken,0,0
41316,from,0,0
41317,the,0,0
41318,gastric,0,0
41319,antrum,0,0
41320,and,0,0
41321,corpus,0,1
41322,for,0,0
41323,determination,0,0
41324,of,0,0
41325,prostaglandin,0,1
41326,E2,0,1
41327,(,0,1
41328,PGE2,0,1
41329,),0,1
41330,by,0,0
41331,ELISA,1,0
41332,and,0,1
41333,cyclooxygenase,0,1
41334,(,0,1
41335,COX-1,0,1
41336,and,0,1
41337,COX-2,0,0
41338,),0,1
41339,and,0,0
41340,nitric,0,1
41341,oxide,0,1
41342,synthase,0,1
41343,(,0,1
41344,eNOS,0,1
41345,and,0,1
41346,iNOS,0,0
41347,),0,1
41348,by,0,0
41349,western,0,1
41350,blot,0,0
41351,.,0,0
41352,All,0,0
41353,subjects,0,0
41354,had,0,0
41355,at,0,0
41356,least,0,0
41357,one,0,0
41358,gastric,0,0
41359,lesion,0,0
41360,except,0,0
41361,for,0,0
41362,two,0,0
41363,individuals,0,0
41364,taking,0,0
41365,ibuprofen-arginate,0,1
41366,.,0,0
41367,Ibuprofen-arginate,0,1
41368,caused,0,0
41369,a,0,0
41370,lower,0,0
41371,rate,0,0
41372,of,0,0
41373,clinical,0,0
41374,adverse,0,0
41375,reactions,0,0
41376,than,0,0
41377,ibuprofen,0,1
41378,.,0,0
41379,Subjects,0,0
41380,with,0,0
41381,gastric,0,0
41382,lesions,0,0
41383,or,0,0
41384,adverse,0,0
41385,reactions,0,0
41386,had,0,0
41387,lower,0,0
41388,PGE2,0,0
41389,levels,0,0
41390,.,0,0
41391,COX-1,0,0
41392,",",0,0
41393,COX-2,0,0
41394,",",0,0
41395,eNOS,0,0
41396,",",0,0
41397,and,0,0
41398,iNOS,0,0
41399,were,0,0
41400,detectable,0,0
41401,in,0,0
41402,all,0,0
41403,subjects,0,0
41404,.,0,0
41405,The,0,0
41406,constitutive,0,0
41407,enzymes,0,1
41408,(,0,0
41409,COX-1,0,1
41410,and,0,1
41411,eNOS,0,1
41412,),0,1
41413,did,0,0
41414,not,0,0
41415,change,0,0
41416,after,0,0
41417,treatment,0,0
41418,.,0,0
41419,COX-2,0,0
41420,was,0,0
41421,higher,0,0
41422,in,0,0
41423,corpus,0,0
41424,than,0,0
41425,antrum,0,0
41426,and,0,0
41427,it,0,0
41428,increased,0,0
41429,after,0,0
41430,ibuprofen,0,1
41431,treatment,0,0
41432,.,0,0
41433,iNOS,0,0
41434,tended,0,0
41435,to,0,0
41436,increase,0,0
41437,mildly,0,0
41438,in,0,0
41439,the,0,0
41440,corpus,0,0
41441,in,0,0
41442,subjects,0,0
41443,with,0,0
41444,adverse,0,0
41445,reactions,0,0
41446,or,0,0
41447,endoscopic,0,1
41448,lesions,0,0
41449,.,0,0
41450,There,0,0
41451,were,0,0
41452,no,0,0
41453,significant,0,0
41454,differences,0,0
41455,between,0,0
41456,ibuprofen,0,1
41457,and,0,0
41458,ibuprofen-arginate,0,1
41459,in,0,0
41460,PGE2,0,1
41461,",",0,0
41462,or,0,0
41463,enzymes,0,0
41464,.,0,0
41465,Skin,0,0
41466,manifestations,0,0
41467,of,0,0
41468,inhaled,0,1
41469,corticosteroids,1,1
41470,in,0,0
41471,COPD,0,0
41472,patients,0,0
41473,:,0,0
41474,results,0,0
41475,from,0,0
41476,Lung,0,1
41477,Health,0,1
41478,Study,0,0
41479,II,0,0
41480,.,0,0
41481,OBJECTIVE,0,0
41482,To,0,0
41483,define,0,0
41484,the,0,0
41485,relationship,0,0
41486,between,0,0
41487,skin,0,0
41488,bruising,0,0
41489,(,0,0
41490,as,0,0
41491,well,0,0
41492,as,0,0
41493,other,0,0
41494,cutaneous,0,0
41495,manifestations,0,0
41496,),0,0
41497,and,0,0
41498,inhaled,0,1
41499,corticosteroid,1,1
41500,(,1,1
41501,ICS,1,1
41502,),1,1
41503,therapy,0,1
41504,vs,0,0
41505,placebo,0,1
41506,in,0,0
41507,subjects,0,0
41508,with,0,0
41509,COPD,0,0
41510,who,0,0
41511,were,0,0
41512,participating,0,0
41513,in,0,0
41514,a,0,0
41515,clinical,0,0
41516,trial,0,0
41517,.,0,0
41518,To,0,0
41519,explore,0,0
41520,the,0,0
41521,relationship,0,0
41522,between,0,0
41523,easy,0,0
41524,skin,0,0
41525,bruising,0,0
41526,and,0,0
41527,other,0,0
41528,systemic,0,0
41529,effects,0,0
41530,of,0,0
41531,ICS,0,1
41532,therapy,0,1
41533,",",0,0
41534,including,0,0
41535,adrenal,0,0
41536,suppression,0,0
41537,and,0,0
41538,loss,0,0
41539,of,0,0
41540,bone,0,0
41541,mineral,0,0
41542,density,0,0
41543,(,0,1
41544,BMD,0,0
41545,),0,0
41546,.,0,0
41547,DESIGN,0,0
41548,Double-blind,0,0
41549,",",0,0
41550,randomized,0,0
41551,",",0,0
41552,placebo-controlled,0,1
41553,clinical,0,0
41554,trial,0,0
41555,of,0,0
41556,triamcinolone,1,1
41557,acetonide,1,1
41558,(,0,0
41559,1200,0,1
41560,microg,0,1
41561,daily,0,1
41562,),0,0
41563,vs,0,0
41564,placebo,1,1
41565,in,0,0
41566,participants,0,0
41567,with,0,0
41568,mild-to-moderate,0,0
41569,COPD,0,0
41570,.,0,0
41571,SETTING,0,0
41572,Lung,0,1
41573,Health,0,1
41574,Study,0,0
41575,II,0,0
41576,",",0,0
41577,a,0,0
41578,clinical,0,0
41579,trial,0,0
41580,to,0,0
41581,assess,0,0
41582,the,0,0
41583,effect,0,0
41584,of,0,0
41585,ICS,1,1
41586,compared,0,0
41587,to,0,0
41588,placebo,1,1
41589,in,0,0
41590,"1,116",0,0
41591,participants,0,0
41592,in,0,0
41593,10,0,0
41594,centers,0,0
41595,over,0,0
41596,>,0,0
41597,3.5,0,0
41598,to,0,0
41599,4.5,0,0
41600,years,0,0
41601,.,0,0
41602,PARTICIPANTS,0,0
41603,A,0,0
41604,total,0,0
41605,of,0,0
41606,"1,116",0,0
41607,smokers,0,0
41608,or,0,0
41609,recent,0,0
41610,ex-smokers,0,0
41611,with,0,0
41612,mild-to-moderate,0,0
41613,COPD,0,0
41614,(,0,1
41615,age,0,0
41616,range,0,0
41617,",",0,0
41618,40,0,0
41619,to,0,0
41620,69,0,0
41621,years,0,0
41622,;,0,0
41623,mean,0,0
41624,age,0,0
41625,",",0,0
41626,56.3,0,0
41627,years,0,0
41628,;,0,0
41629,37.2,0,0
41630,%,0,0
41631,female,0,0
41632,),0,0
41633,.,0,0
41634,MEASUREMENTS,0,0
41635,AND,0,0
41636,RESULTS,0,0
41637,Every,0,0
41638,6,0,0
41639,months,0,0
41640,",",0,0
41641,a,0,0
41642,structured,0,1
41643,questionnaire,0,0
41644,was,0,0
41645,administered,0,0
41646,to,0,0
41647,elicit,0,0
41648,reports,0,0
41649,of,0,0
41650,any,0,0
41651,bruising,0,0
41652,and/or,0,0
41653,skin,0,0
41654,rashes,0,0
41655,",",0,0
41656,slow,0,0
41657,healing,0,0
41658,of,0,0
41659,cuts,0,1
41660,or,0,0
41661,sores,0,0
41662,",",0,0
41663,or,0,0
41664,other,0,0
41665,skin,0,0
41666,changes,0,0
41667,.,0,0
41668,Compliance,0,0
41669,with,0,0
41670,inhaler,0,1
41671,use,0,0
41672,was,0,0
41673,assessed,0,0
41674,by,0,0
41675,canister,0,0
41676,weighing,0,0
41677,.,0,0
41678,A,0,0
41679,significantly,0,0
41680,higher,0,0
41681,proportion,0,0
41682,of,0,0
41683,ICS,1,1
41684,than,0,0
41685,placebo,1,1
41686,participants,0,0
41687,who,0,0
41688,complied,0,0
41689,with,0,0
41690,using,0,0
41691,their,0,0
41692,inhaler,0,1
41693,reported,0,0
41694,easy,0,0
41695,bruising,0,0
41696,(,0,0
41697,11.2,0,0
41698,%,0,0
41699,vs,0,0
41700,3.5,0,0
41701,%,0,0
41702,",",0,0
41703,respectively,0,0
41704,),0,0
41705,and,0,0
41706,the,0,0
41707,slow,0,0
41708,healing,0,0
41709,of,0,0
41710,skin,0,0
41711,cuts,0,1
41712,or,0,1
41713,sores,0,0
41714,(,0,0
41715,2.4,0,0
41716,%,0,0
41717,vs,0,0
41718,0.5,0,1
41719,%,0,0
41720,",",0,0
41721,respectively,0,0
41722,),0,0
41723,.,0,0
41724,Older,0,0
41725,men,0,0
41726,in,0,0
41727,the,0,0
41728,ICS,1,1
41729,group,0,0
41730,with,0,0
41731,good,0,0
41732,inhaler,0,1
41733,compliance,0,0
41734,appeared,0,0
41735,to,0,0
41736,be,0,0
41737,at,0,0
41738,the,0,0
41739,greatest,0,0
41740,risk,0,0
41741,of,0,0
41742,bruising,0,0
41743,.,0,0
41744,In,0,0
41745,those,0,0
41746,participants,0,0
41747,undergoing,0,0
41748,serial,0,0
41749,measurements,0,0
41750,of,0,0
41751,adrenal,0,0
41752,function,0,0
41753,and,0,0
41754,BMD,0,0
41755,",",0,0
41756,no,0,0
41757,association,0,0
41758,was,0,0
41759,noted,0,0
41760,between,0,0
41761,skin,0,0
41762,bruising,0,0
41763,and,0,0
41764,either,0,1
41765,the,0,0
41766,suppression,0,0
41767,of,0,0
41768,adrenal,0,0
41769,function,0,0
41770,or,0,1
41771,the,0,0
41772,loss,0,0
41773,of,0,0
41774,BMD,0,0
41775,as,0,0
41776,systemic,0,0
41777,complications,0,0
41778,of,0,0
41779,ICS,0,1
41780,use,0,0
41781,.,0,0
41782,CONCLUSION,0,0
41783,These,0,0
41784,findings,0,0
41785,indicate,0,0
41786,that,0,0
41787,moderate-to-high,0,0
41788,doses,0,0
41789,of,0,0
41790,ICSs,0,1
41791,result,0,0
41792,in,0,0
41793,an,0,0
41794,increased,0,0
41795,incidence,0,0
41796,of,0,0
41797,easy,0,0
41798,bruising,0,0
41799,and,0,0
41800,impairment,0,0
41801,in,0,0
41802,skin,0,0
41803,healing,0,0
41804,in,0,0
41805,middle-aged,0,0
41806,to,0,0
41807,elderly,0,0
41808,persons,0,0
41809,with,0,0
41810,COPD,0,0
41811,.,0,0
41812,No,0,0
41813,association,0,0
41814,was,0,0
41815,noted,0,0
41816,between,0,0
41817,skin,0,0
41818,bruising,0,0
41819,and,0,0
41820,other,0,0
41821,markers,0,0
41822,of,0,0
41823,systemic,0,0
41824,toxicity,0,0
41825,from,0,0
41826,the,0,0
41827,use,0,0
41828,of,0,0
41829,ICSs,1,1
41830,.,0,0
41831,Single,1,1
41832,nucleotide,1,1
41833,polymorphism,1,0
41834,in,0,0
41835,the,0,0
41836,hypoxia-inducible,0,0
41837,factor-1alpha,0,1
41838,gene,0,0
41839,in,0,0
41840,colorectal,0,0
41841,carcinoma,0,0
41842,.,0,0
41843,Colorectal,0,0
41844,carcinoma,0,0
41845,is,0,0
41846,one,0,0
41847,of,0,0
41848,the,0,0
41849,most,0,0
41850,common,0,0
41851,malignancies,0,0
41852,in,0,0
41853,the,0,0
41854,world,0,0
41855,",",0,0
41856,and,0,0
41857,its,0,0
41858,incidence,0,0
41859,has,0,0
41860,increased,0,0
41861,in,0,0
41862,recent,0,0
41863,years,0,0
41864,.,0,0
41865,We,0,0
41866,have,0,0
41867,reported,0,0
41868,that,0,0
41869,expression,0,0
41870,of,0,0
41871,hypoxia-inducible,0,1
41872,factor,0,1
41873,(,0,1
41874,HIF,0,1
41875,),0,1
41876,-1alpha,0,1
41877,correlates,0,0
41878,with,0,0
41879,expression,0,0
41880,of,0,0
41881,vascular,0,0
41882,endothelial,0,0
41883,growth,0,1
41884,factor,0,1
41885,(,0,1
41886,VEGF,0,1
41887,),0,1
41888,",",0,0
41889,tumor,0,0
41890,stage,0,0
41891,",",0,0
41892,lymphatic,0,0
41893,invasion,0,0
41894,",",0,0
41895,venous,0,0
41896,invasion,0,0
41897,",",0,0
41898,and,0,0
41899,liver,0,0
41900,metastasis,0,0
41901,.,0,0
41902,It,0,0
41903,has,0,0
41904,also,0,0
41905,been,0,0
41906,reported,0,0
41907,that,0,0
41908,a,0,0
41909,single,1,1
41910,nucleotide,1,1
41911,polymorphism,1,1
41912,(,1,1
41913,SNP,1,1
41914,),1,1
41915,in,0,0
41916,exon,0,1
41917,12,0,0
41918,of,0,0
41919,HIF-1alpha,0,1
41920,gene,0,1
41921,is,0,0
41922,present,0,0
41923,in,0,0
41924,renal,0,0
41925,cell,0,0
41926,carcinoma,0,0
41927,and,0,1
41928,head,0,1
41929,and,0,1
41930,neck,0,1
41931,squamous,0,0
41932,cell,0,0
41933,carcinoma,0,0
41934,patients,0,0
41935,.,0,0
41936,We,0,0
41937,investigated,0,0
41938,the,0,0
41939,C1772T,1,1
41940,polymorphism,1,0
41941,in,0,0
41942,colorectal,0,0
41943,cancer,0,0
41944,patients,0,0
41945,and,0,0
41946,healthy,0,0
41947,control,0,1
41948,subjects,0,0
41949,to,0,0
41950,clarify,0,0
41951,the,0,0
41952,mechanism,0,0
41953,of,0,0
41954,HIF-1alpha,1,1
41955,activation,1,0
41956,in,0,0
41957,colorectal,0,0
41958,carcinoma,0,0
41959,.,0,0
41960,The,0,0
41961,exon,0,0
41962,12,0,0
41963,genotype,0,0
41964,was,0,0
41965,not,0,0
41966,associated,0,0
41967,with,0,0
41968,sex,0,0
41969,or,0,1
41970,age,0,0
41971,.,0,0
41972,The,0,0
41973,distribution,0,0
41974,of,0,0
41975,HIF-1alpha,0,1
41976,genotypes,0,0
41977,in,0,0
41978,controls,0,0
41979,was,0,0
41980,89,0,0
41981,C/C,0,0
41982,(,0,0
41983,89,0,0
41984,%,0,0
41985,),0,0
41986,",",0,0
41987,11,0,0
41988,C/T,0,1
41989,(,0,0
41990,11,0,0
41991,%,0,0
41992,),0,0
41993,",",0,0
41994,and,0,0
41995,0,0,0
41996,T/T,0,0
41997,(,0,0
41998,0,0,0
41999,%,0,0
42000,),0,0
42001,.,0,0
42002,The,0,0
42003,distribution,0,0
42004,of,0,0
42005,HIF-1alpha,0,1
42006,genotypes,0,0
42007,in,0,0
42008,colorectal,0,0
42009,cancer,0,0
42010,patients,0,0
42011,was,0,0
42012,100,0,0
42013,C/C,0,0
42014,(,0,0
42015,100,0,1
42016,%,0,0
42017,),0,0
42018,",",0,0
42019,0,0,0
42020,C/T,0,1
42021,(,0,0
42022,0,0,0
42023,%,0,0
42024,),0,0
42025,",",0,0
42026,and,0,0
42027,0,0,0
42028,T/T,0,0
42029,(,0,0
42030,0,0,0
42031,%,0,0
42032,),0,0
42033,.,0,0
42034,The,0,0
42035,difference,0,0
42036,in,0,0
42037,genotype,0,0
42038,distribution,0,0
42039,between,0,0
42040,patients,0,0
42041,and,0,0
42042,control,1,0
42043,subjects,0,0
42044,was,0,0
42045,significant,0,0
42046,(,0,0
42047,p,0,0
42048,<,0,0
42049,0.0005,0,0
42050,),0,0
42051,.,0,0
42052,These,0,0
42053,results,0,0
42054,suggest,0,0
42055,that,0,0
42056,the,0,0
42057,C1772T,1,1
42058,polymorphism,0,0
42059,in,0,0
42060,HIF-1alpha,0,1
42061,is,0,0
42062,not,0,0
42063,involved,0,0
42064,in,0,0
42065,progression,0,0
42066,or,0,1
42067,metastasis,0,0
42068,of,0,0
42069,colorectal,0,0
42070,carcinoma,0,0
42071,.,0,0
42072,A,0,0
42073,randomized,0,0
42074,multicenter,0,0
42075,trial,0,0
42076,comparing,0,0
42077,resection,1,1
42078,and,1,0
42079,radiochemotherapy,1,1
42080,for,0,0
42081,resectable,0,0
42082,locally,0,1
42083,invasive,0,0
42084,pancreatic,0,0
42085,cancer,0,0
42086,.,0,0
42087,BACKGROUND,0,0
42088,Though,0,0
42089,the,0,0
42090,outcome,0,0
42091,of,0,0
42092,resection,0,0
42093,for,0,0
42094,locally,0,1
42095,invasive,0,0
42096,pancreatic,0,0
42097,cancer,0,0
42098,is,0,0
42099,still,0,0
42100,poor,0,0
42101,",",0,0
42102,it,0,0
42103,has,0,0
42104,gradually,0,0
42105,improved,0,0
42106,in,0,0
42107,Japan,0,1
42108,",",0,0
42109,and,0,0
42110,the,0,0
42111,5-year,0,0
42112,survival,0,0
42113,is,0,0
42114,now,0,0
42115,about,0,0
42116,10,0,0
42117,%,0,0
42118,.,0,0
42119,However,0,0
42120,",",0,0
42121,the,0,0
42122,advantage,0,0
42123,of,0,0
42124,resection,1,1
42125,over,0,0
42126,radiochemotherapy,1,1
42127,has,0,0
42128,not,0,0
42129,yet,0,0
42130,been,0,0
42131,confirmed,0,0
42132,by,0,0
42133,a,0,0
42134,randomized,0,0
42135,trial,0,0
42136,.,0,0
42137,We,0,0
42138,conducted,0,0
42139,this,0,0
42140,study,0,0
42141,to,0,0
42142,compare,0,0
42143,surgical,1,1
42144,resection,1,1
42145,alone,0,1
42146,versus,0,1
42147,radiochemotherapy,1,1
42148,without,0,1
42149,resection,0,0
42150,for,0,0
42151,locally,0,1
42152,invasive,0,0
42153,pancreatic,0,0
42154,cancer,0,0
42155,using,0,0
42156,a,0,0
42157,multicenter,0,0
42158,randomized,0,0
42159,design,0,0
42160,.,0,0
42161,METHODS,0,0
42162,Patients,0,0
42163,with,0,0
42164,pancreatic,0,0
42165,cancer,0,0
42166,who,0,0
42167,met,0,0
42168,our,0,0
42169,preoperative,0,0
42170,criteria,0,0
42171,for,0,0
42172,inclusion,0,0
42173,(,0,0
42174,pancreatic,0,0
42175,cancer,0,0
42176,invading,0,0
42177,the,0,0
42178,pancreatic,0,0
42179,capsule,0,1
42180,without,0,1
42181,involvement,0,0
42182,of,0,0
42183,the,0,0
42184,superior,0,0
42185,mesenteric,0,0
42186,artery,0,0
42187,or,0,1
42188,the,0,0
42189,common,0,0
42190,hepatic,0,0
42191,artery,0,0
42192,",",0,0
42193,or,0,1
42194,without,0,1
42195,distant,0,0
42196,metastasis,0,0
42197,),0,1
42198,underwent,0,0
42199,laparotomy,0,1
42200,.,0,0
42201,Patients,0,0
42202,with,0,0
42203,operative,0,0
42204,findings,0,0
42205,consistent,0,0
42206,with,0,0
42207,our,0,0
42208,criteria,0,0
42209,were,0,0
42210,randomized,0,0
42211,into,0,0
42212,a,0,0
42213,radical,1,1
42214,resection,1,1
42215,group,1,0
42216,and,1,0
42217,a,1,0
42218,radiochemotherapy,1,1
42219,group,1,0
42220,(,0,0
42221,200,0,1
42222,mg/m,0,1
42223,(,0,0
42224,2,0,0
42225,),0,0
42226,/day,0,0
42227,of,0,0
42228,intravenous,1,1
42229,5-fluorouracil,1,1
42230,and,1,0
42231,5040,1,1
42232,cGy,1,0
42233,of,1,0
42234,radiotherapy,1,1
42235,),1,0
42236,without,0,0
42237,resection,0,0
42238,.,0,0
42239,The,0,0
42240,2,0,0
42241,groups,0,0
42242,were,0,0
42243,compared,0,0
42244,for,0,0
42245,mean,0,0
42246,survival,0,0
42247,",",0,0
42248,hazard,0,0
42249,ratio,0,0
42250,",",0,0
42251,1-year,0,0
42252,survival,0,0
42253,",",0,0
42254,quality,0,0
42255,of,0,0
42256,life,0,0
42257,scores,0,0
42258,",",0,0
42259,and,0,0
42260,hematologic,0,0
42261,and,0,1
42262,blood,0,0
42263,chemical,0,0
42264,data,0,0
42265,.,0,0
42266,RESULTS,0,0
42267,Twenty,0,0
42268,patients,0,0
42269,were,0,0
42270,assigned,0,0
42271,to,0,0
42272,the,0,0
42273,resection,0,1
42274,group,0,0
42275,and,0,0
42276,22,0,0
42277,to,0,0
42278,the,0,0
42279,radiochemotherapy,1,1
42280,group,0,0
42281,.,0,0
42282,There,0,0
42283,was,0,0
42284,1,0,0
42285,operative,0,0
42286,death,0,0
42287,.,0,0
42288,The,0,0
42289,surgical,0,0
42290,resection,0,1
42291,group,0,0
42292,had,0,0
42293,better,0,0
42294,results,0,0
42295,than,0,0
42296,the,0,0
42297,radiochemotherapy,0,1
42298,group,0,0
42299,as,0,0
42300,measured,0,0
42301,by,0,0
42302,1-year,0,0
42303,survival,0,0
42304,(,0,0
42305,62,0,0
42306,%,0,0
42307,vs,0,0
42308,32,0,0
42309,%,0,0
42310,",",0,0
42311,P=.05,0,0
42312,),0,0
42313,",",0,0
42314,mean,0,0
42315,survival,0,0
42316,time,0,0
42317,(,0,0
42318,>,0,0
42319,17,0,0
42320,vs,0,0
42321,11,0,0
42322,months,0,0
42323,",",0,0
42324,P,0,0
42325,<,0,0
42326,.03,0,0
42327,),0,0
42328,",",0,0
42329,and,0,0
42330,hazard,0,0
42331,ratio,0,0
42332,(,0,0
42333,0.46,0,0
42334,",",0,0
42335,P=.04,0,0
42336,),0,0
42337,.,0,0
42338,There,0,0
42339,were,0,0
42340,no,0,0
42341,differences,0,0
42342,in,0,0
42343,the,0,0
42344,quality,0,0
42345,of,0,0
42346,life,0,0
42347,score,0,0
42348,or,0,1
42349,laboratory,0,0
42350,data,0,0
42351,apart,0,0
42352,from,0,0
42353,increased,0,0
42354,diarrhea,0,0
42355,after,0,0
42356,surgical,0,0
42357,resection,0,0
42358,.,0,0
42359,CONCLUSIONS,0,0
42360,Locally,0,0
42361,invasive,0,0
42362,pancreatic,0,0
42363,cancer,0,0
42364,without,0,0
42365,distant,0,0
42366,metastases,0,0
42367,and,0,0
42368,major,0,0
42369,arterial,0,0
42370,invasion,0,0
42371,appears,0,0
42372,to,0,0
42373,be,0,0
42374,best,0,0
42375,treated,0,0
42376,by,0,0
42377,surgical,0,0
42378,resection,0,0
42379,.,0,0
42380,Low-intensity,1,1
42381,exercise,1,1
42382,and,0,0
42383,reduction,0,0
42384,of,0,0
42385,the,0,0
42386,risk,0,0
42387,for,0,0
42388,falls,0,0
42389,among,0,0
42390,at-risk,0,0
42391,elders,0,0
42392,.,0,0
42393,BACKGROUND,0,0
42394,Among,0,0
42395,elderly,0,0
42396,persons,0,0
42397,",",0,0
42398,falls,0,0
42399,account,0,0
42400,for,0,0
42401,87,0,0
42402,%,0,0
42403,of,0,0
42404,all,0,0
42405,fractures,0,0
42406,and,0,0
42407,are,0,0
42408,contributing,0,0
42409,factors,0,0
42410,in,0,0
42411,many,0,0
42412,nursing,0,1
42413,home,0,1
42414,admissions,0,0
42415,.,0,0
42416,This,0,0
42417,study,0,0
42418,evaluated,0,0
42419,the,0,0
42420,effect,0,0
42421,of,0,0
42422,an,0,0
42423,easily,0,0
42424,implemented,0,0
42425,",",0,0
42426,low-intensity,1,1
42427,exercise,1,1
42428,program,1,1
42429,on,0,0
42430,the,0,0
42431,incidence,0,0
42432,of,0,0
42433,falls,0,0
42434,and,0,0
42435,the,0,0
42436,time,0,0
42437,to,0,0
42438,first,0,0
42439,fall,0,0
42440,among,0,0
42441,a,0,0
42442,clinically,0,0
42443,defined,0,0
42444,population,0,0
42445,of,0,0
42446,elderly,0,0
42447,men,0,0
42448,and,0,0
42449,women,0,0
42450,.,0,0
42451,METHODS,0,0
42452,This,0,0
42453,community-based,0,0
42454,",",0,0
42455,randomized,0,0
42456,trial,0,0
42457,compared,0,0
42458,the,0,0
42459,exercise,1,1
42460,intervention,1,1
42461,with,0,0
42462,a,0,0
42463,no-intervention,1,1
42464,control,1,0
42465,.,1,0
42466,The,0,0
42467,participants,0,0
42468,were,0,0
42469,294,0,0
42470,men,0,0
42471,and,0,0
42472,women,0,0
42473,",",0,0
42474,aged,0,0
42475,60,0,0
42476,years,0,0
42477,or,0,0
42478,older,0,0
42479,",",0,0
42480,who,0,0
42481,had,0,0
42482,either,0,0
42483,a,0,0
42484,hospital,0,0
42485,admission,0,0
42486,or,0,1
42487,bed,0,1
42488,rest,0,0
42489,for,0,0
42490,2,0,0
42491,days,0,0
42492,or,0,0
42493,more,0,0
42494,within,0,0
42495,the,0,0
42496,previous,0,0
42497,month,0,0
42498,.,0,0
42499,Exercise,1,1
42500,participants,0,0
42501,were,0,0
42502,scheduled,0,0
42503,to,0,0
42504,attend,0,1
42505,exercise,1,1
42506,sessions,1,1
42507,lasting,0,0
42508,45,0,0
42509,minutes,0,0
42510,",",0,0
42511,including,0,0
42512,warm-up,0,1
42513,and,0,0
42514,cool-down,0,1
42515,",",0,0
42516,3,0,0
42517,times,0,0
42518,a,0,0
42519,week,0,0
42520,for,0,0
42521,8,0,0
42522,weeks,0,0
42523,(,0,0
42524,24,0,0
42525,sessions,0,1
42526,),0,0
42527,.,0,0
42528,Assessments,0,0
42529,included,0,0
42530,gait,0,0
42531,and,0,0
42532,balance,0,0
42533,measures,0,0
42534,",",0,0
42535,self-reported,0,0
42536,physical,0,1
42537,function,0,0
42538,",",0,0
42539,the,0,0
42540,number,0,0
42541,of,0,0
42542,medications,0,1
42543,being,0,0
42544,taking,0,0
42545,at,0,0
42546,baseline,0,0
42547,",",0,0
42548,participant,0,1
42549,age,0,0
42550,",",0,0
42551,sex,0,0
42552,",",0,0
42553,and,0,0
42554,history,0,0
42555,of,0,0
42556,falling,0,0
42557,.,0,0
42558,Falls,0,0
42559,were,0,0
42560,tracked,0,0
42561,for,0,0
42562,1,0,0
42563,year,0,0
42564,after,0,0
42565,each,0,0
42566,participant,0,0
42567,'s,0,0
42568,baseline,0,0
42569,assessment,0,0
42570,.,0,0
42571,RESULTS,0,0
42572,29,0,0
42573,%,0,0
42574,of,0,0
42575,the,0,0
42576,study,0,0
42577,participants,0,0
42578,reported,0,0
42579,a,0,0
42580,fall,0,0
42581,during,0,0
42582,the,0,0
42583,study,0,0
42584,period,0,0
42585,.,0,0
42586,The,0,0
42587,effect,0,0
42588,of,0,0
42589,exercise,1,1
42590,in,0,0
42591,preventing,0,0
42592,falls,0,0
42593,varied,0,0
42594,significantly,0,0
42595,by,0,0
42596,baseline,0,0
42597,physical,0,1
42598,function,0,0
42599,level,0,0
42600,(,0,1
42601,p,0,0
42602,<,0,0
42603,or,0,1
42604,=.002,0,0
42605,),0,0
42606,.,0,0
42607,The,0,0
42608,risk,0,0
42609,for,0,0
42610,falls,0,0
42611,decreased,0,0
42612,for,0,0
42613,exercise,0,1
42614,participants,0,0
42615,with,0,0
42616,low,0,0
42617,baseline,0,0
42618,physical,0,1
42619,functioning,0,0
42620,(,0,1
42621,hazard,0,0
42622,ratio,0,0
42623,",",0,0
42624,.51,0,0
42625,),0,1
42626,but,0,0
42627,increased,0,0
42628,for,0,0
42629,exercise,0,1
42630,participants,0,0
42631,with,0,0
42632,high,0,0
42633,baseline,0,0
42634,physical,0,1
42635,functioning,0,0
42636,(,0,1
42637,hazard,0,0
42638,ratio,0,0
42639,",",0,0
42640,3.51,0,0
42641,),0,0
42642,.,0,0
42643,CONCLUSIONS,0,0
42644,This,0,0
42645,easily,0,0
42646,implemented,0,0
42647,",",0,0
42648,low-intensity,1,1
42649,exercise,1,1
42650,program,1,1
42651,appears,0,0
42652,to,0,0
42653,reduce,0,0
42654,the,0,0
42655,risk,0,0
42656,for,0,0
42657,falls,0,0
42658,among,0,0
42659,elderly,0,0
42660,men,0,0
42661,and,0,0
42662,women,0,0
42663,recovering,0,0
42664,from,0,0
42665,recent,0,0
42666,hospitalizations,0,0
42667,",",0,0
42668,bed,0,0
42669,rest,0,0
42670,",",0,0
42671,or,0,0
42672,both,0,0
42673,who,0,0
42674,have,0,0
42675,low,0,0
42676,levels,0,0
42677,of,0,0
42678,physical,0,1
42679,functioning,0,0
42680,.,0,0
42681,Syncope,0,0
42682,Evaluation,0,1
42683,in,0,0
42684,the,0,0
42685,Emergency,0,1
42686,Department,0,1
42687,Study,0,0
42688,(,0,1
42689,SEEDS,0,1
42690,),0,1
42691,:,0,0
42692,a,0,0
42693,multidisciplinary,0,1
42694,approach,0,1
42695,to,0,0
42696,syncope,0,0
42697,management,0,0
42698,.,0,0
42699,BACKGROUND,0,0
42700,The,0,0
42701,primary,0,0
42702,aim,0,0
42703,and,0,0
42704,central,0,0
42705,hypothesis,0,0
42706,of,0,0
42707,the,0,0
42708,study,0,0
42709,are,0,0
42710,that,0,0
42711,a,0,0
42712,designated,0,0
42713,syncope,0,0
42714,unit,0,0
42715,in,0,0
42716,the,0,0
42717,emergency,0,1
42718,department,0,0
42719,improves,0,0
42720,diagnostic,0,0
42721,yield,0,0
42722,and,0,0
42723,reduces,0,0
42724,hospital,0,0
42725,admission,0,0
42726,for,0,0
42727,patients,0,0
42728,with,0,0
42729,syncope,0,0
42730,who,0,0
42731,are,0,0
42732,at,0,0
42733,intermediate,0,0
42734,risk,0,0
42735,for,0,0
42736,an,0,0
42737,adverse,0,0
42738,cardiovascular,0,0
42739,outcome,0,0
42740,.,0,1
42741,METHODS,0,0
42742,AND,0,0
42743,RESULTS,0,0
42744,In,0,0
42745,this,0,0
42746,prospective,0,0
42747,",",0,0
42748,randomized,0,0
42749,",",0,0
42750,single-center,0,0
42751,study,0,0
42752,",",0,0
42753,patients,0,0
42754,were,0,0
42755,randomly,0,0
42756,allocated,0,0
42757,to,0,0
42758,2,0,0
42759,treatment,0,0
42760,arms,0,0
42761,:,0,0
42762,syncope,1,0
42763,unit,1,1
42764,evaluation,1,0
42765,and,1,0
42766,standard,1,1
42767,care,1,1
42768,.,1,0
42769,The,0,0
42770,2,0,0
42771,groups,0,0
42772,were,0,0
42773,compared,0,0
42774,with,0,0
42775,chi2,0,0
42776,test,0,0
42777,for,0,0
42778,independence,0,0
42779,of,0,0
42780,categorical,0,0
42781,variables,0,0
42782,.,0,0
42783,Wilcoxon,0,0
42784,rank,0,0
42785,sum,0,0
42786,test,0,0
42787,was,0,0
42788,used,0,0
42789,for,0,0
42790,continuous,0,0
42791,variables,0,0
42792,.,0,0
42793,Survival,0,0
42794,was,0,0
42795,estimated,0,0
42796,with,0,0
42797,the,0,0
42798,Kaplan-Meier,0,0
42799,method,0,0
42800,.,0,0
42801,One,0,0
42802,hundred,0,0
42803,three,0,0
42804,consecutive,0,0
42805,patients,0,0
42806,(,0,0
42807,53,0,0
42808,women,0,0
42809,;,0,0
42810,mean,0,0
42811,age,0,0
42812,64+/-17,0,0
42813,years,0,0
42814,),0,0
42815,entered,0,0
42816,the,0,0
42817,study,0,0
42818,.,0,0
42819,Fifty-one,0,0
42820,patients,0,0
42821,were,0,0
42822,randomized,0,0
42823,to,0,0
42824,the,0,0
42825,syncope,0,0
42826,unit,0,0
42827,.,0,0
42828,For,0,0
42829,the,0,0
42830,syncope,0,0
42831,unit,0,0
42832,and,0,0
42833,standard,0,1
42834,care,0,1
42835,patients,0,0
42836,",",0,0
42837,the,0,0
42838,presumptive,0,0
42839,diagnosis,0,0
42840,was,0,0
42841,established,0,0
42842,in,0,0
42843,34,0,0
42844,(,0,0
42845,67,0,0
42846,%,0,0
42847,),0,0
42848,and,0,0
42849,5,0,1
42850,(,0,0
42851,10,0,1
42852,%,0,0
42853,),0,1
42854,patients,0,0
42855,(,0,0
42856,P,0,0
42857,<,0,0
42858,0.001,0,0
42859,),0,0
42860,",",0,0
42861,respectively,0,0
42862,",",0,0
42863,hospital,0,0
42864,admission,0,0
42865,was,0,0
42866,required,0,0
42867,for,0,0
42868,22,0,0
42869,(,0,0
42870,43,0,0
42871,%,0,0
42872,),0,0
42873,and,0,0
42874,51,0,0
42875,(,0,0
42876,98,0,0
42877,%,0,0
42878,),0,1
42879,patients,0,0
42880,(,0,0
42881,P,0,0
42882,<,0,0
42883,0.001,0,0
42884,),0,0
42885,",",0,0
42886,and,0,0
42887,total,0,0
42888,patient-hospital,0,0
42889,days,0,0
42890,were,0,0
42891,reduced,0,0
42892,from,0,0
42893,140,0,0
42894,to,0,0
42895,64,0,0
42896,.,0,0
42897,Actuarial,0,0
42898,survival,0,0
42899,was,0,0
42900,97,0,0
42901,%,0,0
42902,and,0,0
42903,90,0,1
42904,%,0,0
42905,(,0,1
42906,P=0.30,0,0
42907,),0,1
42908,",",0,0
42909,and,0,0
42910,survival,0,0
42911,free,0,0
42912,from,0,0
42913,recurrent,0,0
42914,syncope,0,0
42915,was,0,0
42916,88,0,0
42917,%,0,0
42918,and,0,0
42919,89,0,0
42920,%,0,0
42921,(,0,1
42922,P=0.72,0,0
42923,),0,1
42924,at,0,0
42925,2,0,0
42926,years,0,0
42927,for,0,0
42928,the,0,0
42929,syncope,0,0
42930,unit,0,0
42931,and,0,0
42932,standard,0,1
42933,care,0,1
42934,groups,0,0
42935,",",0,0
42936,respectively,0,0
42937,.,0,0
42938,CONCLUSIONS,0,0
42939,The,0,0
42940,novel,0,0
42941,syncope,0,0
42942,unit,0,1
42943,designed,0,0
42944,for,0,0
42945,this,0,0
42946,study,0,0
42947,significantly,0,0
42948,improved,0,0
42949,diagnostic,0,0
42950,yield,0,0
42951,in,0,0
42952,the,0,0
42953,emergency,0,1
42954,department,0,0
42955,and,0,0
42956,reduced,0,0
42957,hospital,0,0
42958,admission,0,0
42959,and,0,0
42960,total,0,0
42961,length,0,1
42962,of,0,0
42963,hospital,0,0
42964,stay,0,0
42965,without,0,1
42966,affecting,0,0
42967,recurrent,0,0
42968,syncope,0,0
42969,and,0,0
42970,all-cause,0,0
42971,mortality,0,0
42972,among,0,0
42973,intermediate-risk,0,0
42974,patients,0,0
42975,.,0,0
42976,Observations,0,0
42977,from,0,0
42978,the,0,0
42979,present,0,0
42980,study,0,0
42981,provide,0,0
42982,benchmark,0,0
42983,data,0,0
42984,for,0,0
42985,improving,0,0
42986,patient,0,0
42987,care,0,1
42988,and,0,0
42989,effectively,0,0
42990,utilizing,0,0
42991,healthcare,0,0
42992,resources,0,0
42993,.,0,0
42994,[,0,0
42995,Comparison,0,0
42996,of,0,0
42997,fracture,0,0
42998,resistance,0,0
42999,of,0,0
43000,pulpless,1,1
43001,teeth,1,0
43002,restored,1,0
43003,with,1,0
43004,fiber,1,1
43005,reinforced,1,1
43006,composite,1,1
43007,posts,1,1
43008,and,0,0
43009,three,1,0
43010,kinds,1,0
43011,of,1,0
43012,resin,1,1
43013,core,1,0
43014,material,1,0
43015,],1,0
43016,.,0,0
43017,OBJECTIVE,0,0
43018,To,0,0
43019,compare,0,0
43020,the,0,0
43021,fracture,0,0
43022,resistances,0,0
43023,of,0,0
43024,pulpless,0,1
43025,teeth,0,0
43026,restored,0,0
43027,with,0,0
43028,FRC,1,1
43029,(,1,0
43030,Fiber,1,0
43031,Reinforced,1,1
43032,Composite,1,1
43033,),1,1
43034,posts,1,1
43035,and,0,0
43036,three,1,0
43037,kinds,1,0
43038,of,1,0
43039,resin,1,1
43040,core,1,0
43041,material,1,0
43042,.,1,0
43043,METHODS,0,0
43044,A,0,0
43045,total,0,0
43046,of,0,0
43047,42,0,0
43048,recently,0,0
43049,extracted,0,0
43050,upper,0,0
43051,incisors,0,0
43052,were,0,0
43053,randomly,0,0
43054,divided,0,0
43055,into,0,0
43056,3,0,0
43057,groups,0,0
43058,.,0,0
43059,Group,0,0
43060,A,0,0
43061,was,0,0
43062,restored,0,0
43063,with,0,0
43064,prefabricated,1,1
43065,glass-fiber,1,1
43066,posts,1,1
43067,and,1,0
43068,Artglass,1,1
43069,polymer,1,1
43070,core,1,0
43071,;,1,0
43072,group,0,0
43073,B,0,1
43074,with,0,0
43075,prefabricated,1,1
43076,glass-fiber,1,1
43077,posts,1,1
43078,and,1,0
43079,Charisma,1,1
43080,composite,1,1
43081,resin,1,1
43082,core,1,0
43083,;,1,0
43084,and,0,0
43085,group,0,0
43086,C,0,1
43087,with,0,0
43088,prefabricated,1,1
43089,glass-fiber,1,1
43090,posts,1,1
43091,and,1,0
43092,AB,1,1
43093,composite,1,1
43094,resin,1,1
43095,core,1,0
43096,.,1,0
43097,In,0,0
43098,every,0,0
43099,group,0,0
43100,",",0,0
43101,the,0,0
43102,core,0,0
43103,material,0,0
43104,was,0,0
43105,processed,0,0
43106,by,0,0
43107,hot-press,0,1
43108,and,0,0
43109,non,0,0
43110,hot-press,0,1
43111,respectively,0,0
43112,.,0,0
43113,The,0,0
43114,posts,0,1
43115,size,0,0
43116,and,0,0
43117,shape,0,0
43118,were,0,0
43119,identical,0,0
43120,in,0,0
43121,the,0,0
43122,3,0,0
43123,groups,0,0
43124,.,0,0
43125,All,0,0
43126,teeth,0,0
43127,were,0,0
43128,fully,0,0
43129,covered,0,0
43130,with,0,0
43131,polycarbonate,0,1
43132,resin,0,1
43133,crowns,0,1
43134,.,0,0
43135,Fracture,0,0
43136,resistance,0,0
43137,was,0,0
43138,measured,0,0
43139,by,0,0
43140,applying,0,1
43141,point,0,0
43142,force,0,1
43143,at,0,0
43144,130,0,0
43145,degrees,0,0
43146,to,0,0
43147,the,0,0
43148,long,0,0
43149,axis,0,0
43150,of,0,0
43151,the,0,0
43152,teeth,0,0
43153,on,0,0
43154,an,0,0
43155,universal,0,0
43156,testing,0,0
43157,machine,0,0
43158,.,0,0
43159,RESULTS,0,0
43160,Mean,0,0
43161,fracture,0,0
43162,threshold,0,0
43163,was,0,0
43164,505.4,0,0
43165,N,0,0
43166,+/-,0,0
43167,42.0,0,0
43168,N,0,0
43169,and,0,0
43170,564.1,0,0
43171,N,0,0
43172,+/-,0,0
43173,41.7,0,0
43174,N,0,0
43175,in,0,0
43176,group,0,0
43177,A,0,0
43178,",",0,0
43179,411.3,0,0
43180,N,0,0
43181,+/-,0,0
43182,23.3,0,0
43183,N,0,0
43184,and,0,0
43185,315.3,0,0
43186,N,0,0
43187,+/-,0,0
43188,19.1,0,0
43189,N,0,0
43190,in,0,0
43191,group,0,0
43192,B,0,1
43193,and,0,0
43194,358.4,0,0
43195,N,0,0
43196,+/-,0,0
43197,36.1,0,0
43198,N,0,0
43199,and,0,0
43200,423.4,0,0
43201,N,0,0
43202,+/-,0,0
43203,47.5,0,0
43204,N,0,0
43205,in,0,0
43206,group,0,0
43207,C.,0,1
43208,In,0,0
43209,all,0,0
43210,groups,0,0
43211,",",0,0
43212,there,0,0
43213,was,0,0
43214,no,0,0
43215,posts,0,1
43216,fracture,0,0
43217,and,0,0
43218,polycarbonate,0,1
43219,resin,0,1
43220,crowns,0,1
43221,fragmentation,0,0
43222,.,0,0
43223,CONCLUSION,0,0
43224,The,0,0
43225,composite,0,1
43226,restoration,0,0
43227,of,0,0
43228,FRC,1,0
43229,posts,1,1
43230,combined,1,1
43231,with,1,0
43232,resin,1,1
43233,core,1,0
43234,and,1,0
43235,resin,1,1
43236,crown,1,1
43237,can,0,0
43238,improve,0,0
43239,the,0,0
43240,fracture,0,0
43241,resistance,0,0
43242,of,0,0
43243,the,0,0
43244,pulpless,0,1
43245,roots,0,0
43246,.,0,0
43247,The,0,0
43248,strength,0,0
43249,of,0,0
43250,resin,0,1
43251,core,0,0
43252,material,0,0
43253,can,0,0
43254,be,0,0
43255,increased,0,0
43256,by,0,0
43257,hot-press,1,1
43258,methods,1,0
43259,.,1,0
43260,Intranasal,0,1
43261,nicotine,1,1
43262,for,0,0
43263,postoperative,0,0
43264,pain,0,0
43265,treatment,0,0
43266,.,0,0
43267,BACKGROUND,0,0
43268,Despite,0,0
43269,pharmacological,0,0
43270,treatment,0,0
43271,",",0,0
43272,70-80,0,0
43273,%,0,0
43274,of,0,0
43275,patients,0,0
43276,report,0,0
43277,moderate,0,0
43278,to,0,0
43279,severe,0,0
43280,pain,0,0
43281,after,0,0
43282,surgery,0,0
43283,.,0,0
43284,Because,0,0
43285,nicotine,0,1
43286,has,0,0
43287,been,0,0
43288,reported,0,0
43289,to,0,0
43290,have,0,0
43291,analgesic,0,0
43292,properties,0,0
43293,in,0,0
43294,animal,0,0
43295,and,0,0
43296,human,0,1
43297,volunteer,0,0
43298,studies,0,0
43299,",",0,0
43300,the,0,0
43301,authors,0,0
43302,assessed,0,0
43303,the,0,0
43304,analgesic,0,1
43305,efficacy,0,0
43306,of,0,0
43307,a,0,0
43308,single,0,0
43309,3,0,0
43310,mg,0,1
43311,dose,0,0
43312,of,0,0
43313,nicotine,1,1
43314,nasal,0,0
43315,spray,0,1
43316,administered,0,0
43317,before,0,0
43318,emergence,0,0
43319,from,0,0
43320,general,0,0
43321,anesthesia,0,1
43322,.,0,0
43323,METHODS,0,0
43324,The,0,0
43325,authors,0,0
43326,conducted,0,0
43327,a,0,0
43328,randomized,0,0
43329,",",0,0
43330,double,0,1
43331,blind,0,0
43332,",",0,0
43333,placebo,1,1
43334,controlled,0,0
43335,trial,0,0
43336,of,0,0
43337,20,0,0
43338,healthy,0,0
43339,women,0,0
43340,(,0,0
43341,mean,0,0
43342,age,0,0
43343,45,0,0
43344,(,0,0
43345,SD,0,0
43346,8,0,1
43347,),0,0
43348,yr,0,0
43349,),0,0
43350,who,0,0
43351,were,0,0
43352,to,0,0
43353,undergo,0,0
43354,uterine,1,0
43355,surgery,1,1
43356,through,0,0
43357,a,0,0
43358,low,1,0
43359,transverse,1,0
43360,incision,1,1
43361,.,1,0
43362,After,0,0
43363,the,0,0
43364,conclusion,0,0
43365,of,0,0
43366,surgery,0,1
43367,but,0,0
43368,before,0,0
43369,emergence,0,0
43370,from,0,0
43371,general,0,0
43372,anesthesia,0,1
43373,",",0,0
43374,the,0,0
43375,anesthesiologist,0,1
43376,administered,0,0
43377,either,0,1
43378,nicotine,1,1
43379,nasal,1,1
43380,spray,1,1
43381,or,1,1
43382,a,1,0
43383,placebo,1,1
43384,.,1,0
43385,Numerical,0,0
43386,analog,0,1
43387,pain,0,0
43388,score,0,0
43389,and,0,0
43390,morphine,0,1
43391,utilization,0,0
43392,and,0,0
43393,hemodynamic,0,0
43394,values,0,0
43395,were,0,0
43396,measured,0,0
43397,for,0,0
43398,24,0,0
43399,h.,0,0
43400,RESULTS,0,0
43401,The,0,0
43402,patients,0,0
43403,treated,0,0
43404,with,0,0
43405,nicotine,0,1
43406,reported,0,0
43407,lower,0,0
43408,pain,0,0
43409,scores,0,0
43410,during,0,0
43411,the,0,0
43412,first,0,0
43413,hour,0,0
43414,after,0,0
43415,surgery,0,1
43416,(,0,0
43417,peak,0,0
43418,numerical,0,0
43419,analog,0,1
43420,score,0,0
43421,",",0,0
43422,7.6,0,0
43423,(,0,0
43424,SD,0,0
43425,1.4,0,0
43426,),0,0
43427,versus,0,1
43428,5.3,0,0
43429,(,0,0
43430,SD,0,0
43431,1.6,0,0
43432,),0,0
43433,;,0,0
43434,P,0,0
43435,<,0,0
43436,0.001,0,0
43437,),0,0
43438,and,0,0
43439,used,0,0
43440,half,0,1
43441,the,0,0
43442,amount,0,0
43443,of,0,0
43444,morphine,0,1
43445,as,0,0
43446,the,0,0
43447,control,0,1
43448,group,0,0
43449,(,0,1
43450,12,0,0
43451,(,0,0
43452,SD,0,0
43453,6,0,1
43454,),0,0
43455,versus,0,1
43456,6,0,1
43457,(,0,0
43458,SD,0,0
43459,5,0,1
43460,),0,0
43461,mg,0,1
43462,;,0,0
43463,P,0,0
43464,<,0,0
43465,0.05,0,0
43466,),0,0
43467,.,0,0
43468,Patients,0,0
43469,who,0,0
43470,received,0,0
43471,nicotine,0,1
43472,still,0,0
43473,reported,0,0
43474,less,0,0
43475,pain,0,0
43476,than,0,0
43477,those,0,0
43478,in,0,0
43479,the,0,0
43480,control,0,1
43481,group,0,0
43482,24,0,0
43483,h,0,0
43484,after,0,0
43485,surgery,0,1
43486,(,0,1
43487,1.5,0,0
43488,(,0,0
43489,SD,0,0
43490,0.5,0,1
43491,),0,0
43492,versus,0,1
43493,4.9,0,0
43494,(,0,0
43495,SD,0,0
43496,1.4,0,0
43497,),0,0
43498,;,0,0
43499,P,0,0
43500,<,0,0
43501,0.01,0,0
43502,),0,0
43503,.,0,0
43504,Systolic,0,0
43505,blood,0,0
43506,pressure,0,0
43507,was,0,0
43508,lower,0,0
43509,in,0,0
43510,the,0,0
43511,group,0,0
43512,that,0,0
43513,received,0,1
43514,nicotine,0,1
43515,(,0,1
43516,105,0,0
43517,(,0,0
43518,SD,0,0
43519,3,0,1
43520,),0,0
43521,versus,0,1
43522,122,0,0
43523,(,0,0
43524,SD,0,0
43525,3,0,1
43526,),0,0
43527,;,0,0
43528,P,0,0
43529,<,0,0
43530,0.001,0,0
43531,),0,0
43532,",",0,0
43533,but,0,0
43534,there,0,0
43535,was,0,0
43536,no,0,0
43537,difference,0,0
43538,in,0,0
43539,diastolic,0,0
43540,blood,0,0
43541,pressure,0,0
43542,or,0,1
43543,heart,0,0
43544,rate,0,0
43545,.,0,0
43546,CONCLUSIONS,0,0
43547,Treatment,0,0
43548,with,0,0
43549,a,0,0
43550,single,0,0
43551,dose,0,0
43552,of,0,0
43553,nicotine,0,1
43554,immediately,0,0
43555,before,0,0
43556,emergence,0,0
43557,from,0,0
43558,anesthesia,0,1
43559,was,0,0
43560,associated,0,0
43561,with,0,0
43562,significantly,0,0
43563,lower,0,0
43564,reported,0,0
43565,pain,0,0
43566,scores,0,0
43567,during,0,0
43568,the,0,0
43569,first,0,0
43570,day,0,0
43571,after,0,0
43572,surgery,0,0
43573,.,0,0
43574,The,0,0
43575,decreased,0,0
43576,pain,0,0
43577,was,0,0
43578,associated,0,0
43579,with,0,0
43580,a,0,0
43581,reduction,0,0
43582,in,0,0
43583,morphine,0,1
43584,utilization,0,0
43585,and,0,0
43586,the,0,0
43587,analgesic,0,1
43588,effect,0,0
43589,of,0,0
43590,nicotine,0,1
43591,was,0,0
43592,not,0,0
43593,associated,0,0
43594,with,0,0
43595,hypertension,0,0
43596,or,0,1
43597,tachycardia,0,0
43598,.,0,0
43599,A,0,0
43600,randomized,0,0
43601,",",0,0
43602,evaluator-blind,0,0
43603,",",0,0
43604,multicenter,0,0
43605,comparison,0,0
43606,of,0,0
43607,the,0,0
43608,efficacy,0,0
43609,and,0,0
43610,tolerability,0,0
43611,of,0,0
43612,Perlane,1,1
43613,versus,1,1
43614,Zyplast,1,1
43615,in,0,0
43616,the,0,0
43617,correction,0,0
43618,of,0,0
43619,nasolabial,0,0
43620,folds,0,0
43621,.,0,0
43622,Bovine,1,1
43623,collagen,1,0
43624,is,0,0
43625,widely,0,0
43626,used,0,0
43627,as,0,0
43628,a,0,0
43629,dermal,0,1
43630,filler,0,1
43631,for,0,0
43632,facial,0,1
43633,soft-tissue,0,0
43634,augmentation,0,0
43635,",",0,0
43636,but,0,0
43637,it,0,0
43638,provides,0,0
43639,only,0,0
43640,temporary,0,0
43641,cosmetic,0,0
43642,improvement,0,0
43643,.,0,0
43644,Nonanimal,1,0
43645,stabilized,1,0
43646,hyaluronic,1,1
43647,acid,1,1
43648,has,0,0
43649,reduced,0,0
43650,potential,0,0
43651,for,0,0
43652,immunogenicity,0,0
43653,and,0,0
43654,hypersensitivity,0,0
43655,and,0,0
43656,may,0,0
43657,provide,0,0
43658,a,0,0
43659,more,0,0
43660,durable,0,0
43661,aesthetic,0,0
43662,result,0,0
43663,.,0,0
43664,Sixty-eight,0,0
43665,patients,0,0
43666,with,0,0
43667,prominent,0,0
43668,nasolabial,0,0
43669,folds,0,0
43670,were,0,0
43671,randomized,0,0
43672,to,0,0
43673,intradermal,1,1
43674,treatment,1,0
43675,with,1,0
43676,nonanimal,1,1
43677,stabilized,1,1
43678,hyaluronic,1,1
43679,acid,1,1
43680,gel,1,1
43681,(,1,1
43682,Perlane,1,1
43683,),1,1
43684,and,1,0
43685,bovine,1,1
43686,collagen,1,1
43687,(,1,1
43688,Zyplast,1,1
43689,),1,1
43690,on,0,0
43691,contralateral,0,0
43692,sides,0,0
43693,of,0,0
43694,the,0,0
43695,face,0,0
43696,.,0,0
43697,On,0,0
43698,achievement,0,0
43699,of,0,0
43700,optimal,0,0
43701,cosmetic,0,1
43702,result,0,0
43703,(,0,1
43704,baseline,0,0
43705,),0,0
43706,",",0,0
43707,patients,0,0
43708,were,0,0
43709,followed,0,0
43710,up,0,0
43711,for,0,0
43712,6,0,0
43713,months,0,0
43714,;,0,0
43715,bilateral,0,1
43716,retreatment,0,0
43717,with,0,0
43718,Perlane,1,0
43719,was,0,0
43720,offered,0,0
43721,at,0,0
43722,6,0,0
43723,or,0,0
43724,9,0,0
43725,months,0,0
43726,after,0,0
43727,baseline,0,0
43728,.,0,0
43729,Responses,0,0
43730,were,0,0
43731,evaluated,0,0
43732,at,0,0
43733,2,0,0
43734,",",0,0
43735,4,0,0
43736,",",0,0
43737,6,0,0
43738,",",0,0
43739,9,0,0
43740,",",0,0
43741,and,0,0
43742,12,0,0
43743,months,0,0
43744,after,0,0
43745,baseline,0,0
43746,.,0,0
43747,Investigator-based,0,0
43748,and,0,0
43749,patient-based,0,0
43750,ratings,0,0
43751,indicated,0,0
43752,that,0,0
43753,Perlane,1,0
43754,was,0,0
43755,more,0,0
43756,effective,0,0
43757,than,0,0
43758,Zyplast,1,1
43759,in,0,0
43760,maintaining,0,0
43761,cosmetic,0,0
43762,correction,0,0
43763,.,0,0
43764,According,0,0
43765,to,0,0
43766,investigator-based,0,0
43767,Wrinkle,0,1
43768,Severity,0,0
43769,Rating,0,0
43770,Scale,0,0
43771,assessments,0,0
43772,at,0,0
43773,6,0,0
43774,and,0,0
43775,9,0,0
43776,months,0,0
43777,after,0,0
43778,baseline,0,0
43779,",",0,0
43780,Perlane,1,0
43781,was,0,0
43782,superior,0,0
43783,in,0,0
43784,50.0,0,0
43785,percent,0,0
43786,and,0,0
43787,48.8,0,0
43788,percent,0,0
43789,of,0,0
43790,patients,0,0
43791,",",0,0
43792,respectively,0,0
43793,",",0,0
43794,whereas,0,0
43795,Zyplast,1,1
43796,was,0,0
43797,superior,0,0
43798,in,0,0
43799,10.3,0,0
43800,percent,0,0
43801,and,0,0
43802,14.0,0,0
43803,percent,0,0
43804,of,0,0
43805,patients,0,0
43806,",",0,0
43807,respectively,0,0
43808,(,0,0
43809,p,0,0
43810,<,0,0
43811,0.0004,0,0
43812,),0,0
43813,.,0,0
43814,Investigator-based,0,0
43815,Global,0,0
43816,Aesthetic,0,1
43817,Improvement,0,0
43818,Scale,0,1
43819,assessment,0,0
43820,at,0,0
43821,9,0,0
43822,months,0,0
43823,after,0,0
43824,baseline,0,0
43825,indicated,0,0
43826,that,0,0
43827,Perlane,1,0
43828,was,0,0
43829,superior,0,0
43830,in,0,0
43831,48.8,0,0
43832,percent,0,0
43833,of,0,0
43834,patients,0,0
43835,",",0,0
43836,whereas,0,0
43837,Zyplast,1,1
43838,was,0,0
43839,superior,0,0
43840,in,0,0
43841,14.0,0,0
43842,percent,0,0
43843,of,0,0
43844,patients,0,0
43845,(,0,0
43846,p,0,0
43847,=,0,0
43848,0.0025,0,0
43849,),0,0
43850,.,0,0
43851,Optimal,0,0
43852,cosmetic,0,0
43853,result,0,0
43854,was,0,0
43855,achieved,0,0
43856,with,0,0
43857,a,0,0
43858,smaller,0,0
43859,volume,0,0
43860,of,0,0
43861,Perlane,1,0
43862,than,0,0
43863,Zyplast,1,1
43864,(,0,0
43865,mean,0,0
43866,",",0,0
43867,1.2,0,0
43868,ml,0,1
43869,versus,0,1
43870,2.1,0,0
43871,ml,0,0
43872,),0,0
43873,.,0,0
43874,Local,0,0
43875,injection-site,0,0
43876,reactions,0,0
43877,(,0,0
43878,redness,0,0
43879,",",0,0
43880,swelling,0,0
43881,",",0,0
43882,pruritus,0,0
43883,",",0,0
43884,and,0,0
43885,induration,0,0
43886,),0,1
43887,were,0,0
43888,less,0,0
43889,frequent,0,0
43890,with,0,0
43891,Perlane,1,0
43892,than,0,0
43893,with,0,0
43894,Zyplast,1,1
43895,.,1,0
43896,Delayed-onset,0,0
43897,reactions,0,0
43898,were,0,0
43899,rare,0,0
43900,and,0,0
43901,did,0,0
43902,not,0,0
43903,reoccur,0,0
43904,after,0,0
43905,Perlane,1,0
43906,retreatment,0,0
43907,.,0,0
43908,Perlane,1,0
43909,has,0,0
43910,acceptable,0,0
43911,long-term,0,0
43912,safety,0,0
43913,and,0,0
43914,offers,0,0
43915,a,0,0
43916,longer-lasting,0,0
43917,aesthetic,0,0
43918,improvement,0,0
43919,than,0,0
43920,Zyplast,1,0
43921,.,1,0
43922,Slotted,1,0
43923,versus,1,0
43924,non-slotted,1,0
43925,locked,1,1
43926,intramedullary,1,1
43927,nailing,1,1
43928,for,0,0
43929,femoral,0,1
43930,shaft,0,0
43931,fractures,0,0
43932,.,0,0
43933,Experimentally,0,0
43934,",",0,0
43935,two,1,0
43936,slotted,1,1
43937,nails,1,1
43938,",",1,0
43939,the,1,0
43940,Grosse-Kempf,1,1
43941,nail,1,0
43942,and,1,0
43943,the,1,0
43944,AO/ASIF,1,0
43945,universal,1,0
43946,femoral,1,1
43947,nail,1,0
43948,",",0,0
43949,were,0,0
43950,compared,0,0
43951,to,0,0
43952,the,0,0
43953,non-slotted,1,1
43954,Grosse-Kempf,1,1
43955,nail,1,1
43956,and,1,0
43957,control,1,1
43958,bone,1,0
43959,using,0,0
43960,a,0,0
43961,cadaver,1,0
43962,femoral,1,1
43963,osteotomy,1,1
43964,.,1,0
43965,The,0,0
43966,stiffnesses,0,0
43967,and,0,0
43968,strengths,0,0
43969,of,0,0
43970,the,0,0
43971,osteotomies,0,1
43972,fixed,0,0
43973,with,0,0
43974,slotted,1,1
43975,nails,1,1
43976,in,0,0
43977,10-30,0,0
43978,degrees,0,0
43979,torsion,0,0
43980,were,0,0
43981,6-8,0,1
43982,%,0,0
43983,and,0,0
43984,the,0,0
43985,values,0,0
43986,of,0,0
43987,non-slotted,0,0
43988,nails,0,1
43989,40,0,0
43990,%,0,0
43991,of,0,0
43992,control,0,0
43993,bone,0,0
43994,.,0,0
43995,The,0,0
43996,maximal,0,0
43997,moments,0,0
43998,were,0,0
43999,14-18,0,0
44000,%,0,0
44001,and,0,0
44002,48,0,0
44003,%,0,0
44004,",",0,0
44005,respectively,0,0
44006,.,0,0
44007,In,0,0
44008,the,0,0
44009,clinical,0,0
44010,range,0,0
44011,of,0,0
44012,torsion,0,0
44013,",",0,0
44014,the,0,0
44015,implant-bone,0,1
44016,construct,0,0
44017,never,0,0
44018,failed,0,0
44019,or,0,0
44020,was,0,0
44021,deformed,0,0
44022,.,0,0
44023,Clinically,0,0
44024,",",0,0
44025,46,0,0
44026,femoral,0,1
44027,shaft,0,0
44028,fractures,0,0
44029,were,0,0
44030,randomized,0,0
44031,to,0,0
44032,treatment,0,0
44033,with,0,0
44034,Gross-Kempf,1,1
44035,nails,1,1
44036,",",0,0
44037,24,0,0
44038,with,0,0
44039,slotted,1,1
44040,nails,1,1
44041,and,0,0
44042,22,0,0
44043,with,0,0
44044,non-slotted,1,0
44045,nails,1,1
44046,.,1,0
44047,Four,0,0
44048,complications,0,0
44049,in,0,0
44050,the,0,0
44051,slotted,0,1
44052,nail,0,1
44053,group,0,0
44054,and,0,0
44055,three,0,0
44056,in,0,0
44057,the,0,0
44058,non-slotted,0,1
44059,nail,0,0
44060,group,0,0
44061,were,0,0
44062,considered,0,0
44063,to,0,0
44064,be,0,0
44065,independent,0,0
44066,of,0,0
44067,the,0,0
44068,choice,0,0
44069,of,0,0
44070,nail,0,0
44071,and,0,0
44072,did,0,0
44073,not,0,0
44074,affect,0,0
44075,the,0,0
44076,end,0,0
44077,result,0,0
44078,.,0,0
44079,Three,0,0
44080,splinterings,0,0
44081,of,0,0
44082,the,0,0
44083,distal,0,0
44084,fragment,0,0
44085,",",0,0
44086,one,0,0
44087,resulting,0,0
44088,in,0,0
44089,a,0,0
44090,change,0,0
44091,of,0,0
44092,the,0,0
44093,osteosynthesis,0,1
44094,implant,0,1
44095,to,0,0
44096,a,0,0
44097,condylar,0,0
44098,plate,0,1
44099,",",0,0
44100,were,0,0
44101,considered,0,0
44102,to,0,0
44103,result,0,0
44104,from,0,0
44105,the,0,0
44106,high,0,0
44107,stiffness,0,0
44108,of,0,0
44109,the,0,0
44110,non-slotted,0,0
44111,nail,0,0
44112,.,0,0
44113,Osteosynthesis,0,1
44114,of,0,0
44115,femoral,0,1
44116,shaft,0,1
44117,fractures,0,0
44118,using,0,0
44119,slotted,0,1
44120,nails,0,1
44121,has,0,0
44122,not,0,0
44123,resulted,0,0
44124,in,0,0
44125,healing,0,0
44126,disturbances,0,0
44127,",",0,0
44128,which,0,0
44129,could,0,0
44130,be,0,0
44131,accounted,0,0
44132,for,0,0
44133,by,0,0
44134,the,0,0
44135,high,0,0
44136,torsional,0,1
44137,elasticity,0,0
44138,of,0,0
44139,the,0,0
44140,nail,0,0
44141,;,0,0
44142,there,0,0
44143,seems,0,0
44144,to,0,0
44145,be,0,0
44146,no,0,0
44147,indication,0,0
44148,for,0,0
44149,high-stiffness,0,0
44150,nails,0,1
44151,in,0,0
44152,femoral,0,0
44153,fractures,0,0
44154,.,0,0
44155,A,0,0
44156,home,1,1
44157,visiting,1,0
44158,asthma,1,0
44159,education,1,1
44160,program,1,1
44161,:,1,0
44162,challenges,0,0
44163,to,0,0
44164,program,0,1
44165,implementation,0,0
44166,.,0,0
44167,This,0,0
44168,study,0,0
44169,describes,0,0
44170,the,0,0
44171,implementation,0,0
44172,of,0,0
44173,a,0,0
44174,nurse,1,1
44175,home,1,1
44176,visiting,1,0
44177,asthma,1,0
44178,education,1,1
44179,program,1,1
44180,for,0,0
44181,low-income,0,0
44182,African,0,0
44183,American,0,0
44184,families,0,1
44185,of,0,0
44186,young,0,0
44187,children,0,0
44188,with,0,0
44189,asthma,0,0
44190,.,0,0
44191,Of,0,0
44192,55,0,0
44193,families,0,0
44194,",",0,0
44195,71,0,0
44196,%,0,0
44197,completed,0,0
44198,the,0,0
44199,program,0,1
44200,consisting,0,0
44201,of,0,0
44202,eight,0,0
44203,lessons,0,0
44204,.,0,0
44205,The,0,0
44206,achievement,0,0
44207,of,0,0
44208,learning,0,1
44209,objectives,0,0
44210,was,0,0
44211,predicted,0,0
44212,by,0,0
44213,caregiver,0,0
44214,factors,0,0
44215,",",0,0
44216,such,0,0
44217,as,0,0
44218,education,0,1
44219,",",0,0
44220,presence,0,0
44221,of,0,0
44222,father,0,0
44223,or,0,1
44224,surrogate,0,0
44225,father,0,0
44226,in,0,0
44227,the,0,0
44228,household,0,1
44229,",",0,0
44230,and,0,0
44231,safety,0,0
44232,of,0,0
44233,the,0,0
44234,neighborhood,0,0
44235,",",0,0
44236,but,0,0
44237,not,0,0
44238,by,0,0
44239,child,0,0
44240,factors,0,0
44241,",",0,0
44242,such,0,0
44243,as,0,0
44244,age,0,0
44245,or,0,1
44246,severity,0,0
44247,of,0,0
44248,asthma,0,0
44249,as,0,0
44250,implied,0,0
44251,by,0,0
44252,the,0,0
44253,prescribed,0,0
44254,asthma,0,0
44255,medication,0,1
44256,regimen,0,1
44257,.,0,0
44258,Incompatibility,0,0
44259,between,0,0
44260,the,0,0
44261,scheduling,0,0
44262,needs,0,0
44263,of,0,0
44264,the,0,0
44265,families,0,1
44266,and,0,0
44267,the,0,0
44268,nurse,0,1
44269,home,0,1
44270,visitors,0,0
44271,was,0,0
44272,a,0,0
44273,major,0,0
44274,obstacle,0,0
44275,in,0,0
44276,delivering,0,1
44277,the,0,0
44278,program,0,1
44279,on,0,0
44280,time,0,0
44281,",",0,0
44282,despite,0,0
44283,the,0,0
44284,flexibility,0,0
44285,of,0,0
44286,the,0,0
44287,nurse,0,1
44288,home,0,1
44289,visitors,0,0
44290,.,0,0
44291,The,0,0
44292,authors,0,0
44293,suggest,0,0
44294,that,0,0
44295,future,0,0
44296,home-based,1,1
44297,asthma,1,0
44298,education,1,1
44299,programs,1,1
44300,contain,0,0
44301,a,0,0
44302,more,0,0
44303,limited,0,0
44304,number,0,0
44305,of,0,0
44306,home,0,1
44307,visits,0,0
44308,but,0,0
44309,add,0,0
44310,telephone,0,1
44311,follow-ups,0,0
44312,and,0,0
44313,address,0,0
44314,the,0,0
44315,broader,0,0
44316,needs,0,0
44317,of,0,0
44318,low-income,0,0
44319,families,0,0
44320,that,0,0
44321,most,0,0
44322,likely,0,0
44323,function,0,0
44324,as,0,0
44325,barriers,0,0
44326,to,0,0
44327,program,0,1
44328,success,0,0
44329,.,0,0
44330,A,0,0
44331,phase,0,0
44332,III,0,0
44333,",",0,0
44334,double-blind,0,0
44335,",",0,0
44336,placebo-controlled,1,1
44337,",",0,0
44338,multicenter,0,0
44339,study,0,0
44340,on,0,0
44341,the,0,0
44342,efficacy,0,0
44343,of,0,0
44344,recombinant,1,1
44345,human,1,1
44346,antithrombin,1,0
44347,in,0,0
44348,heparin-resistant,0,0
44349,patients,0,0
44350,scheduled,0,0
44351,to,0,0
44352,undergo,0,0
44353,cardiac,0,0
44354,surgery,0,1
44355,necessitating,0,0
44356,cardiopulmonary,0,1
44357,bypass,0,1
44358,.,0,0
44359,BACKGROUND,0,0
44360,The,0,0
44361,study,0,0
44362,evaluated,0,0
44363,the,0,0
44364,efficacy,0,0
44365,of,0,0
44366,recombinant,1,1
44367,human,1,1
44368,antithrombin,1,1
44369,(,1,1
44370,rhAT,1,0
44371,),1,1
44372,for,0,0
44373,restoring,0,0
44374,heparin,0,1
44375,responsiveness,0,0
44376,in,0,0
44377,heparin,0,1
44378,resistant,0,0
44379,patients,0,0
44380,undergoing,0,0
44381,cardiac,0,0
44382,surgery,0,1
44383,.,0,0
44384,METHODS,0,0
44385,This,0,0
44386,was,0,0
44387,a,0,0
44388,multicenter,0,0
44389,",",0,0
44390,randomized,0,0
44391,",",0,0
44392,double-blind,0,0
44393,",",0,0
44394,placebo-controlled,0,1
44395,study,0,0
44396,in,0,0
44397,heparin-resistant,0,0
44398,patients,0,0
44399,undergoing,0,0
44400,cardiac,0,0
44401,surgery,0,1
44402,with,0,0
44403,cardiopulmonary,0,0
44404,bypass,0,1
44405,.,0,0
44406,Heparin,1,1
44407,resistance,0,0
44408,was,0,0
44409,diagnosed,0,0
44410,when,0,0
44411,the,0,0
44412,activated,0,1
44413,clotting,0,0
44414,time,0,0
44415,was,0,0
44416,less,0,0
44417,than,0,0
44418,480,0,0
44419,s,0,0
44420,after,0,0
44421,400,0,1
44422,U/kg,0,1
44423,heparin,1,1
44424,.,1,0
44425,Fifty-four,0,0
44426,heparin-resistant,0,0
44427,patients,0,0
44428,were,0,0
44429,randomized,0,0
44430,.,0,0
44431,One,0,0
44432,cohort,0,0
44433,received,1,0
44434,75,1,0
44435,U/kg,1,1
44436,rhAT,1,0
44437,",",1,0
44438,and,1,0
44439,the,1,0
44440,other,1,0
44441,received,1,0
44442,normal,1,0
44443,saline,1,1
44444,.,1,0
44445,If,0,0
44446,the,0,0
44447,activated,0,1
44448,clotting,0,0
44449,time,0,0
44450,remained,0,0
44451,less,0,0
44452,than,0,0
44453,480,0,0
44454,s,0,0
44455,",",0,0
44456,this,0,0
44457,was,0,0
44458,considered,0,0
44459,treatment,0,0
44460,failure,0,0
44461,",",0,0
44462,and,0,0
44463,2,0,0
44464,units,0,0
44465,fresh,0,0
44466,frozen,0,1
44467,plasma,0,0
44468,was,0,0
44469,transfused,0,0
44470,.,0,0
44471,Patients,0,0
44472,were,0,0
44473,monitored,0,0
44474,for,0,0
44475,adverse,0,0
44476,events,0,0
44477,.,0,0
44478,RESULTS,0,0
44479,Only,0,0
44480,19,0,0
44481,%,0,0
44482,of,0,0
44483,patients,0,0
44484,in,0,0
44485,the,0,0
44486,rhAT,1,0
44487,group,0,0
44488,received,0,1
44489,fresh,0,0
44490,frozen,0,1
44491,plasma,0,0
44492,",",0,0
44493,compared,0,0
44494,with,0,0
44495,81,0,0
44496,%,0,0
44497,of,0,0
44498,patients,0,0
44499,in,0,0
44500,the,0,0
44501,placebo,1,1
44502,group,0,0
44503,(,0,0
44504,P,0,0
44505,<,0,0
44506,0.001,0,0
44507,),0,0
44508,.,0,0
44509,During,0,0
44510,their,0,0
44511,hospitalization,0,0
44512,",",0,0
44513,48,0,0
44514,%,0,0
44515,of,0,0
44516,patients,0,0
44517,in,0,0
44518,the,0,0
44519,rhAT,1,0
44520,group,0,0
44521,received,0,1
44522,fresh,0,0
44523,frozen,0,1
44524,plasma,0,0
44525,",",0,0
44526,compared,0,0
44527,with,0,0
44528,85,0,0
44529,%,0,0
44530,of,0,0
44531,patients,0,0
44532,in,0,0
44533,the,0,0
44534,placebo,1,1
44535,group,0,0
44536,(,0,0
44537,P,0,0
44538,=,0,0
44539,0.009,0,0
44540,),0,0
44541,.,0,0
44542,Patients,0,0
44543,in,0,0
44544,the,0,0
44545,placebo,0,1
44546,group,0,0
44547,required,0,0
44548,higher,0,0
44549,heparin,1,1
44550,doses,0,0
44551,(,0,0
44552,P,0,0
44553,<,0,0
44554,0.005,0,0
44555,),0,0
44556,for,0,0
44557,anticoagulation,0,1
44558,.,0,0
44559,There,0,0
44560,was,0,0
44561,no,0,0
44562,increase,0,0
44563,in,0,0
44564,serious,0,0
44565,adverse,0,0
44566,events,0,0
44567,associated,0,0
44568,with,0,0
44569,rhAT,1,0
44570,.,1,0
44571,There,0,0
44572,was,0,0
44573,increased,0,0
44574,blood,0,0
44575,loss,0,0
44576,12,0,0
44577,h,0,0
44578,postoperatively,0,0
44579,(,0,0
44580,P,0,0
44581,=,0,0
44582,0.05,0,0
44583,),0,0
44584,with,0,0
44585,a,0,0
44586,trend,0,0
44587,toward,0,0
44588,increased,0,0
44589,24-h,0,0
44590,bleeding,0,0
44591,in,0,0
44592,the,0,0
44593,rhAT,1,0
44594,group,0,0
44595,(,0,0
44596,P,0,0
44597,=,0,0
44598,0.06,0,0
44599,),0,0
44600,.,0,0
44601,There,0,0
44602,was,0,0
44603,no,0,0
44604,difference,0,0
44605,between,0,0
44606,the,0,0
44607,groups,0,0
44608,in,0,0
44609,blood,0,0
44610,and,0,0
44611,platelet,0,0
44612,transfusions,0,0
44613,.,0,0
44614,CONCLUSION,0,0
44615,Treatment,0,0
44616,with,0,0
44617,75,0,0
44618,U/kg,0,1
44619,rhAT,1,0
44620,is,0,0
44621,effective,0,0
44622,in,0,0
44623,restoring,0,0
44624,heparin,0,1
44625,responsiveness,0,0
44626,and,0,0
44627,promoting,0,1
44628,therapeutic,0,1
44629,anticoagulation,0,1
44630,in,0,0
44631,the,0,0
44632,majority,0,0
44633,of,0,0
44634,heparin-resistant,0,0
44635,patients,0,0
44636,.,0,0
44637,Treating,0,0
44638,heparin-resistant,0,0
44639,patients,0,0
44640,with,0,0
44641,rhAT,1,0
44642,may,0,0
44643,decrease,0,0
44644,the,0,0
44645,requirement,0,0
44646,for,0,0
44647,heparin,0,1
44648,and,0,0
44649,fresh,0,1
44650,frozen,0,1
44651,plasma,0,0
44652,.,0,0
44653,Immunogenicity,0,1
44654,and,0,0
44655,reactogenicity,0,0
44656,of,0,0
44657,two,0,0
44658,regimens,0,0
44659,of,0,0
44660,diphtheria-tetanus-acellular,0,1
44661,pertussis-hepatitis,0,1
44662,B-inactivated,0,1
44663,polio,0,1
44664,and,0,0
44665,Haemophilus,0,1
44666,influenzae,0,1
44667,type,1,0
44668,b,1,0
44669,vaccines,1,1
44670,administered,1,0
44671,to,0,0
44672,infants,0,0
44673,primed,0,0
44674,at,0,0
44675,birth,0,0
44676,with,0,0
44677,hepatitis,0,1
44678,B,0,1
44679,vaccine,0,1
44680,.,0,0
44681,An,0,0
44682,open,0,0
44683,",",0,0
44684,randomized,0,0
44685,study,0,0
44686,evaluated,0,0
44687,the,0,0
44688,immune,0,0
44689,response,0,0
44690,and,0,0
44691,safety,0,0
44692,of,0,0
44693,two,0,0
44694,different,0,0
44695,regimens,0,1
44696,of,0,0
44697,diphtheria-tetanus-acellular,1,1
44698,pertussis-hepatitis,1,1
44699,B-inactivated,1,1
44700,poliovirus-Haemophilus,1,1
44701,influenzae,1,0
44702,type,1,0
44703,b,1,0
44704,(,1,1
44705,DTPa-HBV-IPV-Hib,1,1
44706,),1,1
44707,immunization,0,1
44708,in,0,0
44709,infants,0,0
44710,primed,0,0
44711,at,0,0
44712,birth,0,0
44713,with,0,0
44714,hepatitis,0,1
44715,B,0,1
44716,vaccine,0,1
44717,.,0,0
44718,One-half,0,0
44719,of,0,0
44720,the,0,0
44721,150,0,0
44722,healthy,0,0
44723,",",0,0
44724,full-term,0,0
44725,infants,0,0
44726,received,1,0
44727,a,1,0
44728,DTPa,1,1
44729,HBV-IPV-Hib,1,1
44730,vaccine,1,1
44731,at,1,0
44732,1,1,0
44733,1/2,1,0
44734,",",1,0
44735,3,1,0
44736,and,1,0
44737,5,1,0
44738,months,1,0
44739,of,1,0
44740,age,1,0
44741,;,1,0
44742,the,1,0
44743,other,1,0
44744,received,1,0
44745,a,1,0
44746,DTPa-IPV-Hib,1,0
44747,vaccine,1,1
44748,at,1,0
44749,1,1,0
44750,1/2,1,0
44751,",",1,0
44752,3,1,0
44753,and,1,0
44754,5,1,0
44755,months,1,0
44756,of,1,0
44757,age,1,0
44758,with,1,0
44759,separate,1,0
44760,HBV,1,1
44761,vaccine,1,1
44762,at,1,0
44763,1,1,0
44764,and,1,0
44765,5,1,0
44766,months,1,0
44767,of,1,0
44768,age,1,0
44769,.,1,0
44770,Immune,0,0
44771,response,0,0
44772,was,0,0
44773,similar,0,0
44774,following,0,0
44775,the,0,0
44776,two,0,0
44777,regimens,0,0
44778,with,0,0
44779,100,0,0
44780,%,0,0
44781,of,0,0
44782,the,0,0
44783,vaccinees,0,0
44784,seroprotected,0,0
44785,for,0,0
44786,HBV,0,1
44787,",",0,0
44788,diphtheria,0,1
44789,",",0,0
44790,tetanus,0,1
44791,",",0,0
44792,Hib,0,1
44793,and,0,0
44794,poliovirus,0,0
44795,types,0,0
44796,2,0,0
44797,and,0,0
44798,3,0,0
44799,diseases,0,0
44800,after,0,0
44801,the,0,0
44802,full,0,0
44803,vaccination,0,1
44804,course,0,0
44805,.,0,0
44806,One,0,0
44807,vaccinee,0,0
44808,in,0,0
44809,the,0,0
44810,DTPa,0,1
44811,HBV-HPV-,0,1
44812,Hib,0,1
44813,group,0,0
44814,failed,0,0
44815,to,0,0
44816,respond,0,0
44817,to,0,0
44818,the,0,0
44819,poliovirus,0,0
44820,type,0,0
44821,1,0,0
44822,antigen,0,0
44823,.,0,0
44824,Response,0,0
44825,to,0,0
44826,the,0,0
44827,three,0,0
44828,pertussis,0,0
44829,antigens,0,0
44830,ranged,0,0
44831,from,0,0
44832,92-97,0,0
44833,%,0,0
44834,in,0,0
44835,the,0,0
44836,DTPa-IPV-Hib,0,1
44837,plus,0,1
44838,separate,0,1
44839,HBV,0,1
44840,group,0,0
44841,and,0,0
44842,100,0,1
44843,%,0,0
44844,in,0,0
44845,the,0,0
44846,DTPa,0,1
44847,HBV-IPV-Hib,0,1
44848,group,0,0
44849,.,0,0
44850,The,0,0
44851,most,0,0
44852,frequently,0,0
44853,reported,0,0
44854,post-vaccination,0,0
44855,symptoms,0,0
44856,were,0,0
44857,irritability,0,0
44858,in,0,0
44859,the,0,0
44860,DTPa-IPV-Hib,0,1
44861,plus,0,1
44862,separate,0,1
44863,HBV,0,1
44864,group,0,1
44865,(,0,0
44866,49,0,0
44867,%,0,0
44868,of,0,0
44869,vaccinees,0,0
44870,),0,0
44871,and,0,0
44872,fever,0,0
44873,",",0,0
44874,defined,0,0
44875,as,0,0
44876,axillary,0,0
44877,temperature,0,0
44878,>,0,0
44879,or,0,1
44880,=37.5,0,0
44881,degrees,0,1
44882,C,0,0
44883,",",0,0
44884,in,0,0
44885,the,0,0
44886,DTPa,0,1
44887,HBV-,0,1
44888,IPV-Hib,0,1
44889,group,0,1
44890,(,0,0
44891,50,0,1
44892,%,0,0
44893,of,0,0
44894,vaccinees,0,0
44895,),0,0
44896,.,0,0
44897,Long-term,0,0
44898,follow-up,0,0
44899,of,0,0
44900,a,0,0
44901,randomized,0,0
44902,trial,0,0
44903,of,0,0
44904,fludarabine-mitoxantrone,1,1
44905,",",0,0
44906,compared,0,0
44907,with,0,0
44908,cyclophosphamide,1,1
44909,",",1,0
44910,doxorubicin,1,1
44911,",",1,0
44912,vindesine,1,1
44913,",",1,0
44914,prednisone,1,1
44915,(,1,1
44916,CHVP,1,1
44917,),1,0
44918,",",0,0
44919,as,0,0
44920,first-line,0,1
44921,treatment,0,0
44922,of,0,0
44923,elderly,0,0
44924,patients,0,0
44925,with,0,0
44926,advanced,0,0
44927,",",0,0
44928,low-grade,0,0
44929,non-Hodgkin,0,0
44930,'s,0,0
44931,lymphoma,0,0
44932,before,0,0
44933,the,0,0
44934,era,0,0
44935,of,0,0
44936,monoclonal,0,1
44937,antibodies,0,0
44938,.,0,0
44939,BACKGROUND,0,0
44940,This,0,0
44941,randomized,0,0
44942,study,0,0
44943,compared,0,0
44944,the,0,0
44945,efficacy,0,0
44946,and,0,0
44947,safety,0,0
44948,of,0,0
44949,fludarabine-mitoxantrone,1,1
44950,(,1,1
44951,FM,1,1
44952,),1,1
44953,with,1,1
44954,mini-CHVP,1,1
44955,(,1,0
44956,cyclophosphamide,1,1
44957,",",1,0
44958,doxorubicin,1,1
44959,",",1,0
44960,vindesine,1,1
44961,",",1,0
44962,prednisone,1,1
44963,),1,0
44964,in,0,0
44965,elderly,0,0
44966,patients,0,0
44967,with,0,0
44968,advanced,0,0
44969,",",0,0
44970,low-grade,0,0
44971,non-Hodgkin,0,0
44972,'s,0,0
44973,lymphoma,0,0
44974,.,0,0
44975,PATIENTS,0,0
44976,AND,0,0
44977,METHODS,0,0
44978,End,0,1
44979,points,0,0
44980,were,0,0
44981,remission,0,0
44982,rates,0,0
44983,[,0,0
44984,overall,0,0
44985,response,0,0
44986,(,0,1
44987,OR,0,0
44988,),0,1
44989,and,0,0
44990,complete,0,0
44991,response,0,0
44992,(,0,1
44993,CR,0,1
44994,),0,1
44995,],0,0
44996,",",0,0
44997,failure-free,0,0
44998,survival,0,0
44999,(,0,1
45000,FFS,0,1
45001,),0,1
45002,",",0,0
45003,survival,0,0
45004,and,0,0
45005,toxicity,0,0
45006,.,0,0
45007,One,0,0
45008,hundred,0,0
45009,and,0,0
45010,fifty-five,0,0
45011,patients,0,0
45012,were,0,0
45013,randomized,0,0
45014,",",0,0
45015,144,0,0
45016,were,0,0
45017,evaluable,0,0
45018,for,0,0
45019,safety,0,0
45020,and,0,0
45021,142,0,0
45022,for,0,0
45023,response,0,0
45024,.,0,0
45025,Each,0,0
45026,treatment,0,0
45027,arm,0,0
45028,was,0,0
45029,given,0,0
45030,as,0,0
45031,six,0,0
45032,monthly,0,0
45033,cycles,0,0
45034,",",0,0
45035,followed,0,0
45036,by,0,0
45037,three,0,0
45038,bimonthly,0,0
45039,cycles,0,0
45040,.,0,0
45041,FM,0,0
45042,comprised,0,0
45043,fludarabine,1,1
45044,(,0,0
45045,20,0,1
45046,mg/m,0,1
45047,(,0,0
45048,2,0,0
45049,),0,0
45050,i.v,0,1
45051,.,0,0
45052,),0,0
45053,",",0,0
45054,days,0,0
45055,1-5,0,0
45056,",",0,0
45057,plus,0,1
45058,mitoxantrone,1,1
45059,(,0,1
45060,10,0,1
45061,mg/m,0,1
45062,(,0,0
45063,2,0,0
45064,),0,0
45065,i.v,0,1
45066,.,0,0
45067,),0,0
45068,",",0,0
45069,day,0,0
45070,1,0,0
45071,.,0,0
45072,CHVP,0,0
45073,cycles,0,0
45074,comprised,0,0
45075,cyclophosphamide,1,1
45076,(,0,0
45077,750,0,1
45078,mg/m,0,1
45079,(,0,0
45080,2,0,0
45081,),0,0
45082,i.v,0,1
45083,.,0,1
45084,infusion,0,0
45085,),0,0
45086,",",0,0
45087,doxorubicin,1,1
45088,(,0,0
45089,25,0,1
45090,mg/m,0,1
45091,(,0,0
45092,2,0,0
45093,),0,0
45094,i.v,0,1
45095,.,0,1
45096,),0,0
45097,and,0,0
45098,vindesine,1,1
45099,(,0,1
45100,3,0,1
45101,mg/m,0,1
45102,(,0,0
45103,2,0,0
45104,),0,0
45105,i.v,0,1
45106,.,0,0
45107,),0,0
45108,on,0,0
45109,day,0,0
45110,1,0,0
45111,",",0,0
45112,and,0,0
45113,prednisone,1,1
45114,(,0,1
45115,50,0,1
45116,mg/m,0,1
45117,(,0,0
45118,2,0,1
45119,),0,0
45120,),0,0
45121,on,0,0
45122,days,0,0
45123,1-5,0,0
45124,.,0,0
45125,RESULTS,0,0
45126,FM,1,1
45127,therapy,0,1
45128,resulted,0,0
45129,in,0,0
45130,superior,0,0
45131,remission,0,0
45132,rates,0,0
45133,(,0,0
45134,OR,0,0
45135,81,0,0
45136,%,0,0
45137,versus,0,1
45138,64,0,0
45139,%,0,0
45140,",",0,0
45141,CR,0,1
45142,49,0,0
45143,%,0,0
45144,versus,0,1
45145,17,0,0
45146,%,0,0
45147,;,0,0
45148,P,0,0
45149,=,0,0
45150,0.0004,0,0
45151,),0,0
45152,.,0,0
45153,Median,0,0
45154,FFS,0,0
45155,for,0,0
45156,FM,1,0
45157,patients,0,0
45158,was,0,0
45159,36,0,0
45160,months,0,0
45161,",",0,0
45162,compared,0,0
45163,with,0,0
45164,19,0,0
45165,months,0,0
45166,for,0,0
45167,CHVP,0,0
45168,patients,0,0
45169,",",0,0
45170,and,0,0
45171,has,0,0
45172,not,0,0
45173,yet,0,0
45174,been,0,0
45175,reached,0,0
45176,for,0,0
45177,early,0,0
45178,CR,0,1
45179,patients,0,0
45180,at,0,0
45181,53,0,0
45182,months,0,0
45183,.,0,0
45184,Treatment,0,0
45185,arm,0,0
45186,was,0,0
45187,the,0,0
45188,major,0,0
45189,risk,0,0
45190,factor,0,1
45191,influencing,0,0
45192,survival,0,0
45193,.,0,0
45194,Both,0,0
45195,treatments,0,0
45196,were,0,0
45197,well,0,0
45198,tolerated,0,0
45199,",",0,0
45200,with,0,0
45201,only,0,0
45202,few,0,0
45203,infectious,0,0
45204,complications,0,0
45205,.,0,0
45206,CONCLUSION,0,0
45207,FM,1,0
45208,was,0,0
45209,more,0,0
45210,effective,0,0
45211,than,0,0
45212,CHVP,0,1
45213,in,0,0
45214,achieving,0,0
45215,OR,0,0
45216,and,0,0
45217,CR,0,1
45218,",",0,0
45219,and,0,0
45220,favorably,0,0
45221,affected,0,0
45222,the,0,0
45223,outcome,0,0
45224,.,0,0
45225,Reducing,0,0
45226,blood,0,0
45227,loss,0,0
45228,at,0,0
45229,open,1,1
45230,myomectomy,1,1
45231,using,0,0
45232,triple,1,1
45233,tourniquets,1,1
45234,:,1,0
45235,a,0,0
45236,randomised,0,0
45237,controlled,0,0
45238,trial,0,0
45239,.,0,0
45240,OBJECTIVES,0,0
45241,To,0,0
45242,evaluate,0,0
45243,triple,1,1
45244,tourniquets,1,1
45245,in,0,0
45246,controlled,0,0
45247,conditions,0,0
45248,and,0,0
45249,for,0,0
45250,the,0,0
45251,first,0,0
45252,time,0,0
45253,to,0,0
45254,investigate,0,0
45255,the,0,0
45256,hypothesis,0,0
45257,that,0,0
45258,leaving,0,0
45259,a,0,0
45260,semi-permanent,0,1
45261,tourniquet,0,1
45262,around,0,0
45263,the,0,0
45264,uterine,0,0
45265,artery,0,0
45266,reduces,0,0
45267,post-operative,0,0
45268,bleeding,0,0
45269,from,0,0
45270,the,0,0
45271,uterine,0,0
45272,incisions,0,1
45273,.,0,0
45274,DESIGN,0,0
45275,A,0,0
45276,randomised,0,0
45277,controlled,0,0
45278,trial,0,0
45279,.,0,0
45280,SETTING,0,0
45281,Two,0,0
45282,University,0,0
45283,teaching,0,1
45284,hospitals,0,0
45285,.,0,0
45286,POPULATION,0,0
45287,Twenty-eight,0,0
45288,patients,0,0
45289,with,0,0
45290,symptomatic,0,0
45291,fibroids,0,0
45292,and,0,0
45293,uterine,0,0
45294,sizes,0,0
45295,ranging,0,0
45296,from,0,0
45297,14,0,0
45298,to,0,0
45299,24,0,0
45300,weeks,0,0
45301,of,0,0
45302,gestation,0,0
45303,undergoing,0,0
45304,open,0,1
45305,myomectomy,1,1
45306,.,1,0
45307,METHODS,0,0
45308,A,0,0
45309,number,1,0
45310,1,1,0
45311,polyglactin,1,1
45312,suture,1,1
45313,was,1,0
45314,tied,1,0
45315,around,1,0
45316,the,1,0
45317,cervix,1,0
45318,to,1,0
45319,occlude,1,0
45320,the,1,0
45321,uterine,1,0
45322,arteries,1,0
45323,",",0,0
45324,and,0,0
45325,polythene,1,1
45326,tourniquets,1,1
45327,were,1,0
45328,tied,1,0
45329,around,1,0
45330,the,1,0
45331,infundibulopelvic,1,0
45332,ligament,1,1
45333,to,1,0
45334,obstruct,1,0
45335,the,1,0
45336,ovarian,1,0
45337,vessels,1,0
45338,.,1,0
45339,At,0,0
45340,the,0,0
45341,end,0,0
45342,of,0,0
45343,the,0,0
45344,procedure,0,0
45345,",",0,0
45346,the,0,0
45347,ovarian,0,0
45348,ties,0,0
45349,were,0,0
45350,released,0,0
45351,but,0,0
45352,the,0,0
45353,uterine,0,0
45354,artery,0,0
45355,suture,0,1
45356,remained,0,0
45357,in,0,0
45358,situ,0,1
45359,.,0,0
45360,MAIN,0,0
45361,OUTCOME,0,0
45362,MEASURES,0,0
45363,Intra-operative,0,1
45364,blood,0,0
45365,loss,0,0
45366,",",0,0
45367,post-operative,0,0
45368,blood,0,0
45369,loss,0,0
45370,",",0,0
45371,blood,0,0
45372,transfusion,0,1
45373,rates,0,0
45374,",",0,0
45375,operative,0,0
45376,morbidity,0,0
45377,",",0,0
45378,uterine,0,0
45379,blood,0,0
45380,flow,0,0
45381,and,0,0
45382,ovarian,0,0
45383,function,0,0
45384,.,0,0
45385,RESULTS,0,0
45386,There,0,0
45387,was,0,0
45388,significantly,0,0
45389,less,0,0
45390,blood,0,0
45391,lost,0,0
45392,in,0,0
45393,the,0,0
45394,tourniquet,0,1
45395,group,0,0
45396,than,0,0
45397,in,0,0
45398,the,0,0
45399,control,0,1
45400,group,0,1
45401,(,0,1
45402,difference,0,0
45403,between,0,0
45404,means,0,0
45405,1870,0,0
45406,mL,0,0
45407,",",0,0
45408,95,0,0
45409,%,0,0
45410,CI,0,0
45411,1159-2580,0,0
45412,mL,0,0
45413,",",0,0
45414,P,0,0
45415,<,0,0
45416,0.0001,0,0
45417,;,0,0
45418,transfusion,0,0
45419,rates,0,0
45420,of,0,0
45421,7,0,0
45422,%,0,0
45423,and,0,0
45424,79,0,0
45425,%,0,0
45426,",",0,0
45427,P=,0,1
45428,0.0003,0,0
45429,),0,0
45430,.,0,0
45431,The,0,0
45432,volume,0,0
45433,in,0,0
45434,the,0,0
45435,pelvic,0,1
45436,drain,0,1
45437,20,0,0
45438,min,0,0
45439,post-operatively,0,0
45440,and,0,0
45441,after,0,0
45442,48,0,0
45443,hours,0,0
45444,failed,0,0
45445,to,0,0
45446,reach,0,0
45447,statistical,0,0
45448,significance,0,0
45449,between,0,0
45450,the,0,0
45451,two,0,0
45452,groups,0,0
45453,(,0,0
45454,P=,0,1
45455,0.10,0,0
45456,and,0,0
45457,P=,0,1
45458,0.165,0,0
45459,),0,0
45460,.,0,0
45461,There,0,0
45462,were,0,0
45463,no,0,0
45464,differences,0,0
45465,in,0,0
45466,uterine,0,0
45467,artery,0,0
45468,Doppler,0,1
45469,resistance,0,0
45470,indices,0,0
45471,at,0,0
45472,five,0,0
45473,days,0,0
45474,(,0,0
45475,P=,0,1
45476,0.54,0,0
45477,),0,0
45478,",",0,0
45479,six,0,0
45480,weeks,0,0
45481,(,0,0
45482,P=,0,1
45483,0.47,0,0
45484,),0,0
45485,",",0,0
45486,three,0,0
45487,months,0,0
45488,(,0,0
45489,P=,0,1
45490,0.49,0,0
45491,),0,0
45492,and,0,0
45493,at,0,0
45494,six,0,0
45495,months,0,0
45496,(,0,0
45497,P=,0,1
45498,0.18,0,0
45499,),0,0
45500,.,0,0
45501,Day,0,0
45502,two,0,0
45503,serum,0,0
45504,FSH,0,0
45505,concentrations,0,0
45506,after,0,0
45507,surgery,0,0
45508,were,0,0
45509,unchanged,0,0
45510,(,0,0
45511,P=,0,1
45512,0.45,0,0
45513,),0,0
45514,",",0,0
45515,compared,0,0
45516,with,0,0
45517,baseline,0,0
45518,values,0,0
45519,.,0,0
45520,CONCLUSIONS,0,0
45521,Triple,1,1
45522,tourniquets,1,1
45523,are,0,0
45524,effective,0,0
45525,in,0,0
45526,reducing,0,0
45527,bleeding,0,0
45528,and,0,0
45529,transfusion,0,1
45530,rates,0,0
45531,.,0,0
45532,There,0,0
45533,appears,0,0
45534,no,0,0
45535,obvious,0,0
45536,adverse,0,0
45537,effect,0,0
45538,on,0,0
45539,uterine,0,0
45540,perfusion,0,1
45541,or,0,1
45542,ovarian,0,0
45543,function,0,0
45544,.,0,0
45545,[,0,0
45546,Relationship,0,0
45547,between,0,0
45548,sCD44v6,0,0
45549,expression,0,0
45550,and,0,0
45551,TCM,0,1
45552,differentiation,0,1
45553,type,0,0
45554,of,0,0
45555,gastric,0,0
45556,carcinoma,0,0
45557,patients,0,0
45558,and,0,0
45559,influence,0,0
45560,of,0,0
45561,weitai,1,0
45562,capsule,1,1
45563,on,0,0
45564,the,0,0
45565,expression,0,0
45566,],0,0
45567,.,0,0
45568,OBJECTIVE,0,0
45569,To,0,0
45570,explore,0,0
45571,the,0,0
45572,relationship,0,0
45573,of,0,0
45574,TCM,0,0
45575,type,0,0
45576,with,0,0
45577,serum,0,0
45578,level,0,0
45579,of,0,0
45580,soluble,0,1
45581,CD44v6,0,0
45582,(,0,1
45583,sCD44v6,0,0
45584,),0,1
45585,and,0,0
45586,different,0,1
45587,histologic,0,0
45588,parameters,0,0
45589,in,0,0
45590,gastric,0,0
45591,carcinoma,0,0
45592,patients,0,0
45593,and,0,0
45594,to,0,0
45595,observe,0,1
45596,the,0,0
45597,influence,0,0
45598,of,0,0
45599,Weitai,1,1
45600,capsule,1,1
45601,(,1,1
45602,WTC,1,0
45603,),1,1
45604,on,0,0
45605,the,0,0
45606,sCD44v6,0,0
45607,expression,0,0
45608,.,0,0
45609,METHODS,0,0
45610,TCM,0,0
45611,typing,0,0
45612,and,0,0
45613,sCD44v6,0,0
45614,expression,0,0
45615,were,0,0
45616,determined,0,0
45617,in,0,0
45618,all,0,0
45619,the,0,0
45620,enrolled,0,0
45621,patients,0,0
45622,(,0,0
45623,30,0,0
45624,in,0,0
45625,the,0,0
45626,control,0,1
45627,and,0,0
45628,32,0,0
45629,in,0,0
45630,the,0,0
45631,trial,0,0
45632,group,0,0
45633,),0,1
45634,before,0,0
45635,operation,0,0
45636,",",0,0
45637,and,0,0
45638,3-4,0,0
45639,courses,0,1
45640,of,0,0
45641,chemotherapy,1,1
45642,was,0,0
45643,applied,0,0
45644,to,0,0
45645,them,0,0
45646,from,0,0
45647,3-4,0,0
45648,weeks,0,0
45649,after,0,0
45650,operation,0,0
45651,.,0,0
45652,To,0,0
45653,the,0,0
45654,patients,0,0
45655,of,0,0
45656,trial,0,0
45657,group,0,0
45658,",",0,0
45659,oral,0,1
45660,administration,0,0
45661,of,0,0
45662,WTC,1,0
45663,was,0,0
45664,given,0,0
45665,additionally,0,0
45666,with,0,0
45667,4,0,0
45668,capsules,0,1
45669,",",0,0
45670,3,0,0
45671,times,0,0
45672,a,0,0
45673,day,0,0
45674,for,0,0
45675,consecutive,0,0
45676,3,0,0
45677,months,0,0
45678,.,0,0
45679,RESULTS,0,0
45680,sCD44v6,0,0
45681,was,0,0
45682,significantly,0,0
45683,positive,0,0
45684,correlated,0,0
45685,with,0,0
45686,the,0,0
45687,degree,0,0
45688,of,0,0
45689,cancer,0,0
45690,cell,0,0
45691,differentiation,0,0
45692,",",0,0
45693,infiltration,0,0
45694,and,0,0
45695,lymph,0,0
45696,node,0,0
45697,metastasis,0,0
45698,;,0,0
45699,(,0,0
45700,2,0,0
45701,),0,0
45702,Level,0,0
45703,of,0,0
45704,sCD44v6,0,0
45705,was,0,0
45706,the,0,0
45707,highest,0,0
45708,in,0,0
45709,patients,0,0
45710,of,0,0
45711,blood,0,0
45712,stasis,0,0
45713,type,0,0
45714,",",0,0
45715,as,0,0
45716,compared,0,0
45717,with,0,0
45718,that,0,0
45719,in,0,0
45720,the,0,0
45721,patients,0,0
45722,of,0,0
45723,Pi-deficiency,0,0
45724,type,0,0
45725,or,0,1
45726,of,0,0
45727,damp-heat,0,0
45728,type,0,0
45729,",",0,0
45730,the,0,0
45731,difference,0,0
45732,was,0,0
45733,significant,0,0
45734,;,0,0
45735,(,0,0
45736,3,0,0
45737,),0,0
45738,After,0,0
45739,ending,0,1
45740,treatment,0,0
45741,",",0,0
45742,level,0,0
45743,of,0,0
45744,sCD44v6,0,0
45745,in,0,0
45746,the,0,0
45747,trial,0,0
45748,group,0,0
45749,was,0,0
45750,significantly,0,0
45751,lower,0,0
45752,than,0,0
45753,that,0,0
45754,in,0,0
45755,the,0,0
45756,control,0,0
45757,group,0,0
45758,.,0,1
45759,CONCLUSION,0,0
45760,(,0,0
45761,1,0,0
45762,),0,0
45763,Serum,0,0
45764,level,0,0
45765,of,0,0
45766,sCD44v6,0,0
45767,could,0,0
45768,be,0,0
45769,taken,0,0
45770,as,0,0
45771,the,0,0
45772,criterion,0,0
45773,for,0,0
45774,evaluating,0,0
45775,the,0,0
45776,development,0,0
45777,and,0,0
45778,prognosis,0,0
45779,of,0,0
45780,gastric,0,0
45781,cancer,0,0
45782,",",0,0
45783,as,0,0
45784,well,0,0
45785,as,0,0
45786,the,0,0
45787,therapeutic,0,0
45788,target,0,0
45789,for,0,0
45790,anti-metastasis,0,0
45791,treatment,0,1
45792,;,0,0
45793,(,0,0
45794,2,0,0
45795,),0,0
45796,Serum,0,0
45797,level,0,0
45798,of,0,0
45799,sCD44v6,0,0
45800,is,0,0
45801,related,0,0
45802,to,0,0
45803,some,0,0
45804,extent,0,0
45805,with,0,0
45806,TCM,0,0
45807,type,0,0
45808,of,0,0
45809,blood,0,0
45810,stasis,0,0
45811,and,0,0
45812,Pi-deficiency,0,0
45813,;,0,1
45814,(,0,0
45815,3,0,0
45816,),0,0
45817,WTC,1,0
45818,combined,0,1
45819,with,0,0
45820,chemotherapy,1,1
45821,could,0,0
45822,further,0,0
45823,inhibit,0,0
45824,the,0,0
45825,expression,0,0
45826,of,0,0
45827,serum,0,0
45828,sCD44v6,0,0
45829,in,0,0
45830,gastric,0,0
45831,carcinoma,0,0
45832,patients,0,0
45833,.,0,0
45834,Online,1,1
45835,conductivity,1,0
45836,monitoring,1,1
45837,:,1,1
45838,validation,0,0
45839,and,0,0
45840,usefulness,0,0
45841,in,0,0
45842,a,0,0
45843,clinical,0,0
45844,trial,0,0
45845,of,0,0
45846,reduced,1,0
45847,dialysate,1,1
45848,conductivity,1,0
45849,.,1,0
45850,Relatively,1,0
45851,low,1,0
45852,dialysate,1,1
45853,conductivity,1,0
45854,(,1,1
45855,Cndi,1,0
45856,),1,1
45857,may,0,0
45858,improve,0,0
45859,outcomes,0,0
45860,by,0,0
45861,reducing,0,0
45862,the,0,0
45863,overall,0,0
45864,sodium,0,1
45865,burden,0,0
45866,in,0,0
45867,dialysis,0,1
45868,patients,0,0
45869,.,0,0
45870,Excess,0,0
45871,sodium,0,1
45872,removal,0,0
45873,",",0,0
45874,however,0,0
45875,",",0,0
45876,could,0,0
45877,lead,0,0
45878,to,0,0
45879,hemodynamic,0,0
45880,instability,0,0
45881,.,0,0
45882,We,0,0
45883,performed,0,0
45884,a,0,0
45885,randomized,0,0
45886,controlled,1,0
45887,trial,0,0
45888,of,0,0
45889,reduction,1,0
45890,of,1,0
45891,Cndi,1,0
45892,.,1,0
45893,For,0,0
45894,the,0,0
45895,study,0,0
45896,",",0,0
45897,28,0,0
45898,patients,0,0
45899,were,0,0
45900,randomized,0,0
45901,to,0,0
45902,maintenance,1,0
45903,of,1,0
45904,Cndi,1,0
45905,at,1,0
45906,13.6,1,0
45907,mS/cm,1,1
45908,(,1,0
45909,equivalent,1,0
45910,to,1,0
45911,135,1,0
45912,mmol/L,1,0
45913,of,1,0
45914,Na+,1,1
45915,),1,1
45916,or,1,1
45917,serial,1,1
45918,reduction,1,0
45919,of,1,0
45920,Cndi,1,0
45921,in,1,0
45922,steps,1,0
45923,of,1,0
45924,0.2,1,0
45925,mS/cm,1,0
45926,",",0,0
45927,guided,0,1
45928,by,0,0
45929,symptoms,0,0
45930,and,0,0
45931,blood,0,0
45932,pressure,0,0
45933,.,0,0
45934,Sodium,0,1
45935,removal,0,0
45936,estimated,0,0
45937,from,0,0
45938,pre-,0,0
45939,and,0,0
45940,postplasma,0,0
45941,concentrations,0,0
45942,correlated,0,0
45943,well,0,0
45944,with,0,0
45945,removal,0,0
45946,measured,0,0
45947,by,0,0
45948,conductivity,0,0
45949,monitoring,0,1
45950,as,0,0
45951,ionic,0,0
45952,mass,0,0
45953,balance,0,0
45954,(,0,0
45955,R2,0,1
45956,0.66,0,0
45957,",",0,0
45958,p,0,0
45959,<,0,0
45960,0.0001,0,0
45961,),0,0
45962,.,0,0
45963,Of,0,0
45964,the,0,0
45965,16,0,0
45966,patients,0,0
45967,randomized,0,0
45968,to,0,0
45969,reduction,1,0
45970,of,1,0
45971,Cndi,1,0
45972,",",0,0
45973,6,0,0
45974,achieved,0,0
45975,Cndi,0,0
45976,13.4,0,0
45977,mS/cm,0,0
45978,",",0,0
45979,6,0,0
45980,achieved,0,0
45981,13.2,0,0
45982,mS/cm,0,0
45983,",",0,0
45984,and,0,0
45985,4,0,0
45986,achieved,0,0
45987,13.0,0,0
45988,mS/cm,0,0
45989,.,0,0
45990,No,0,0
45991,episodes,0,0
45992,of,0,0
45993,disequilibrium,0,0
45994,occurred,0,0
45995,.,0,0
45996,Interdialytic,0,0
45997,weight,0,0
45998,gain,0,0
45999,was,0,0
46000,reduced,0,0
46001,from,0,0
46002,2.34,0,0
46003,+/-,0,0
46004,0.10,0,0
46005,kg,0,0
46006,to,0,0
46007,1.57,0,0
46008,+/-,0,0
46009,0.11,0,0
46010,kg,0,0
46011,(,0,0
46012,p,0,0
46013,<,0,0
46014,0.0001,0,0
46015,),0,0
46016,.,0,0
46017,Predialysis,0,0
46018,systolic,0,0
46019,blood,0,0
46020,pressure,0,0
46021,fell,0,0
46022,from,0,0
46023,144,0,0
46024,+/-,0,0
46025,3,0,0
46026,mm,0,0
46027,Hg,0,0
46028,to,0,0
46029,137,0,1
46030,+/-,0,0
46031,4,0,0
46032,mm,0,0
46033,Hg,0,0
46034,(,0,0
46035,p,0,0
46036,<,0,0
46037,0.05,0,0
46038,),0,0
46039,.,0,0
46040,The,0,0
46041,reduction,0,0
46042,in,0,0
46043,convective,1,1
46044,sodium,1,1
46045,removal,1,0
46046,was,0,0
46047,balanced,0,0
46048,by,0,0
46049,an,0,0
46050,increase,0,0
46051,in,0,0
46052,diffusive,0,1
46053,sodium,0,1
46054,removal,0,1
46055,(,0,0
46056,95,0,0
46057,+/-,0,0
46058,9,0,0
46059,mmol,0,0
46060,cf,0,0
46061,.,0,0
46062,175,0,0
46063,+/-,0,0
46064,14,0,0
46065,mmol,0,0
46066,",",0,0
46067,p,0,0
46068,<,0,0
46069,0.0001,0,0
46070,),0,0
46071,.,0,0
46072,Reduction,1,0
46073,in,1,0
46074,Cndi,1,0
46075,monitored,0,0
46076,by,0,0
46077,IMB,0,1
46078,is,0,0
46079,safe,0,0
46080,and,0,0
46081,practical,0,0
46082,and,0,0
46083,leads,0,0
46084,to,0,0
46085,improved,0,0
46086,interdialytic,0,1
46087,weight,0,0
46088,gains,0,0
46089,and,0,0
46090,blood,0,0
46091,pressure,0,0
46092,control,0,1
46093,",",0,0
46094,while,0,0
46095,avoiding,0,0
46096,excessive,0,0
46097,sodium,0,1
46098,removal,0,0
46099,.,0,0
46100,A,0,0
46101,comparison,0,0
46102,of,0,0
46103,the,0,0
46104,efficacy,0,0
46105,of,0,0
46106,heparinized,1,1
46107,and,1,0
46108,nonheparinized,1,1
46109,solutions,1,1
46110,for,0,0
46111,maintenance,0,0
46112,of,0,0
46113,perioperative,0,0
46114,radial,0,0
46115,arterial,0,0
46116,catheter,0,1
46117,patency,0,0
46118,and,0,0
46119,subsequent,0,0
46120,occlusion,0,0
46121,.,0,0
46122,In,0,0
46123,a,0,0
46124,randomized,0,0
46125,",",0,0
46126,double-blind,0,0
46127,",",0,0
46128,controlled,0,0
46129,study,0,0
46130,",",0,0
46131,we,0,0
46132,compared,0,0
46133,heparinized,1,1
46134,and,1,0
46135,nonheparinized,1,1
46136,infusions,1,1
46137,for,0,0
46138,the,0,0
46139,maintenance,0,0
46140,of,0,0
46141,perioperative,0,0
46142,arterial,0,0
46143,catheter,0,1
46144,patency,0,0
46145,and,0,0
46146,the,0,0
46147,incidence,0,0
46148,of,0,0
46149,subsequent,0,0
46150,radial,0,0
46151,arterial,0,0
46152,occlusion,0,0
46153,.,0,0
46154,Two-hundred,0,0
46155,patients,0,0
46156,were,0,0
46157,randomized,0,0
46158,into,0,0
46159,2,1,0
46160,groups,1,0
46161,to,1,0
46162,receive,1,1
46163,heparinized,1,1
46164,(,1,0
46165,group,1,0
46166,H,1,1
46167,",",1,0
46168,n,1,0
46169,=,1,0
46170,100,1,1
46171,),1,0
46172,or,1,1
46173,nonheparinized,1,1
46174,(,1,0
46175,group,1,0
46176,S,1,1
46177,",",1,0
46178,n,1,0
46179,=,1,0
46180,100,1,1
46181,),1,0
46182,flush,1,0
46183,solutions,1,1
46184,.,1,0
46185,Radial,1,0
46186,and,1,0
46187,ulnar,1,0
46188,blood,1,0
46189,flows,1,0
46190,were,1,0
46191,assessed,1,0
46192,using,1,0
46193,Doppler,1,1
46194,probe,1,1
46195,and,1,0
46196,pulse,1,1
46197,oximetry,1,1
46198,before,1,0
46199,",",1,0
46200,just,1,0
46201,after,1,0
46202,",",1,0
46203,and,1,0
46204,24,1,0
46205,h,1,0
46206,after,1,0
46207,decannulation,1,1
46208,by,1,0
46209,the,1,0
46210,same,1,0
46211,investigator,1,0
46212,.,1,0
46213,The,0,0
46214,cannulation,0,0
46215,site,0,0
46216,was,0,0
46217,examined,0,0
46218,for,0,0
46219,complications,0,0
46220,such,0,0
46221,as,0,0
46222,hematoma,0,0
46223,",",0,0
46224,nerve,0,0
46225,injury,0,0
46226,",",0,0
46227,and,0,0
46228,infection,0,0
46229,.,0,0
46230,The,0,0
46231,mean,0,0
46232,duration,0,0
46233,of,0,0
46234,cannulations,0,0
46235,was,0,0
46236,378,0,0
46237,+/-,0,0
46238,159.0,0,0
46239,min,0,0
46240,in,0,0
46241,group,0,0
46242,H,0,1
46243,and,0,0
46244,332,0,0
46245,+/-,0,0
46246,154.6,0,0
46247,min,0,0
46248,in,0,0
46249,group,0,0
46250,S.,0,1
46251,The,0,0
46252,mean,0,0
46253,number,0,0
46254,of,0,0
46255,corrective,0,1
46256,interventions,0,1
46257,caused,0,0
46258,by,0,0
46259,dampening,0,0
46260,of,0,0
46261,the,0,0
46262,pressure,0,0
46263,wave,0,1
46264,(,0,1
46265,mean,0,0
46266,number,0,0
46267,of,0,0
46268,positional,0,0
46269,changes,0,0
46270,[,0,0
46271,group,0,0
46272,S,0,1
46273,",",0,0
46274,1.5,0,0
46275,+/-,0,0
46276,2.0,0,0
46277,;,0,0
46278,group,0,0
46279,H,0,0
46280,",",0,0
46281,1.4,0,0
46282,+/-,0,0
46283,3.8,0,0
46284,],0,0
46285,and,0,0
46286,mean,0,0
46287,number,0,0
46288,of,0,0
46289,manual,0,0
46290,flushes,0,0
46291,[,0,0
46292,group,0,0
46293,S,0,1
46294,",",0,0
46295,1.3,0,0
46296,+/-,0,0
46297,1.7,0,0
46298,;,0,0
46299,group,0,0
46300,H,0,0
46301,",",0,0
46302,1.2,0,0
46303,+/-,0,0
46304,1.2,0,0
46305,],0,0
46306,),0,0
46307,was,0,0
46308,not,0,0
46309,significantly,0,0
46310,different,0,0
46311,in,0,0
46312,both,0,0
46313,groups,0,0
46314,.,0,0
46315,After,0,0
46316,decannulation,0,1
46317,",",0,0
46318,partial,0,0
46319,or,0,1
46320,total,0,0
46321,occlusion,0,0
46322,developed,0,0
46323,in,0,0
46324,20,0,0
46325,group,0,0
46326,H,0,1
46327,patients,0,0
46328,and,0,0
46329,16,0,0
46330,group,0,0
46331,S,0,1
46332,patients,0,0
46333,(,0,0
46334,not,0,0
46335,significant,0,0
46336,),0,0
46337,.,0,0
46338,The,0,0
46339,incidence,0,0
46340,of,0,0
46341,occlusion,0,0
46342,was,0,0
46343,correlated,0,0
46344,to,0,0
46345,the,0,0
46346,presence,0,0
46347,of,0,0
46348,hematoma,0,0
46349,at,0,0
46350,the,0,0
46351,puncture,0,0
46352,site,0,0
46353,after,0,0
46354,decannulation,0,1
46355,(,0,0
46356,P,0,0
46357,=,0,0
46358,0.013,0,0
46359,),0,0
46360,",",0,0
46361,long,0,0
46362,duration,0,0
46363,of,0,0
46364,cannulation,0,1
46365,(,0,0
46366,P,0,0
46367,=,0,0
46368,0.04,0,0
46369,),0,0
46370,",",0,0
46371,and,0,0
46372,age,0,0
46373,<,0,0
46374,65,0,0
46375,yr,0,0
46376,(,0,0
46377,P,0,0
46378,=,0,0
46379,0.009,0,0
46380,),0,0
46381,.,0,0
46382,In,0,0
46383,conclusion,0,0
46384,",",0,0
46385,there,0,0
46386,is,0,0
46387,no,0,0
46388,significant,0,0
46389,difference,0,0
46390,between,0,0
46391,heparinized,1,1
46392,and,1,0
46393,nonheparinized,1,1
46394,flush,1,1
46395,solutions,1,1
46396,for,0,0
46397,the,0,0
46398,maintenance,0,0
46399,of,0,0
46400,perioperative,0,0
46401,radial,0,1
46402,artery,0,0
46403,catheter,0,1
46404,patency,0,0
46405,.,0,0
46406,Stapled,1,0
46407,hemorrhoidopexy,1,1
46408,vs.,1,0
46409,Harmonic,1,1
46410,Scalpel,1,1
46411,hemorrhoidectomy,1,1
46412,:,1,0
46413,a,0,0
46414,randomized,0,0
46415,trial,0,0
46416,.,0,0
46417,PURPOSE,0,0
46418,A,0,0
46419,randomized,0,0
46420,trial,0,0
46421,was,0,0
46422,undertaken,0,0
46423,to,0,0
46424,evaluate,0,0
46425,and,0,0
46426,compare,0,0
46427,stapled,1,1
46428,hemorrhoidopexy,1,1
46429,with,1,0
46430,excisional,1,1
46431,hemorrhoidectomy,1,1
46432,in,0,0
46433,which,0,0
46434,the,0,0
46435,Harmonic,0,1
46436,Scalpel,0,1
46437,was,0,0
46438,used,0,0
46439,.,0,0
46440,METHODS,0,0
46441,Patients,0,0
46442,with,0,0
46443,Grade,0,1
46444,III,0,0
46445,hemorrhoids,0,0
46446,who,0,0
46447,were,0,0
46448,employed,0,0
46449,during,0,0
46450,the,0,0
46451,trial,0,0
46452,period,0,0
46453,were,0,0
46454,recruited,0,0
46455,and,0,0
46456,randomized,0,0
46457,into,0,0
46458,two,0,0
46459,groups,0,0
46460,:,0,0
46461,(,0,0
46462,1,0,0
46463,),0,0
46464,Harmonic,1,1
46465,Scalpel,1,1
46466,hemorrhoidectomy,1,1
46467,",",1,0
46468,and,1,0
46469,(,1,0
46470,2,1,0
46471,),1,0
46472,stapled,1,1
46473,hemorrhoidopexy,1,1
46474,.,1,0
46475,All,0,0
46476,operations,0,0
46477,were,0,0
46478,performed,0,0
46479,by,0,0
46480,a,0,0
46481,single,0,0
46482,surgeon,0,0
46483,.,0,0
46484,In,0,0
46485,the,0,0
46486,stapled,0,1
46487,group,0,0
46488,",",0,0
46489,the,0,0
46490,doughnut,0,0
46491,obtained,0,0
46492,was,0,0
46493,sent,0,0
46494,for,0,0
46495,histopathologic,0,0
46496,examination,0,0
46497,to,0,0
46498,determine,0,0
46499,whether,0,0
46500,smooth,0,0
46501,muscles,0,1
46502,were,0,0
46503,included,0,0
46504,in,0,0
46505,the,0,0
46506,specimen,0,0
46507,.,0,0
46508,Operative,0,0
46509,data,0,0
46510,and,0,0
46511,complications,0,0
46512,were,0,0
46513,recorded,0,0
46514,",",0,0
46515,and,0,0
46516,patients,0,0
46517,were,0,0
46518,followed,0,0
46519,up,0,0
46520,through,0,0
46521,a,0,0
46522,structured,0,1
46523,pro,0,1
46524,forma,0,1
46525,protocol,0,1
46526,.,0,0
46527,An,0,0
46528,independent,0,0
46529,assessor,0,0
46530,was,0,0
46531,assigned,0,0
46532,to,0,0
46533,obtain,0,0
46534,postoperative,0,0
46535,pain,0,0
46536,scores,0,0
46537,and,0,0
46538,satisfaction,0,0
46539,scores,0,0
46540,at,0,0
46541,six-month,0,0
46542,follow-up,0,0
46543,.,0,0
46544,Patients,0,0
46545,were,0,0
46546,also,0,0
46547,administered,0,0
46548,a,0,0
46549,simple,1,1
46550,questionnaire,1,0
46551,at,0,0
46552,follow-up,0,0
46553,to,0,0
46554,assess,0,0
46555,continence,0,0
46556,functions,0,0
46557,.,0,0
46558,RESULTS,0,0
46559,Over,0,0
46560,a,0,0
46561,20-month,0,0
46562,period,0,0
46563,",",0,0
46564,88,0,0
46565,patients,0,0
46566,were,0,0
46567,recruited,0,0
46568,.,0,0
46569,The,0,0
46570,two,0,0
46571,groups,0,0
46572,were,0,0
46573,matched,0,0
46574,for,0,0
46575,age,0,0
46576,and,0,0
46577,gender,0,0
46578,distribution,0,0
46579,.,0,0
46580,No,0,0
46581,significant,0,0
46582,difference,0,0
46583,was,0,0
46584,identified,0,0
46585,between,0,0
46586,the,0,0
46587,two,0,0
46588,groups,0,0
46589,in,0,0
46590,terms,0,0
46591,of,0,0
46592,operation,0,0
46593,time,0,0
46594,",",0,0
46595,blood,0,0
46596,loss,0,0
46597,",",0,0
46598,day,0,0
46599,of,0,0
46600,first,0,0
46601,bowel,0,0
46602,movement,0,1
46603,after,0,0
46604,surgery,0,1
46605,",",0,0
46606,and,0,0
46607,complication,0,0
46608,rates,0,0
46609,.,0,0
46610,Despite,0,0
46611,a,0,0
46612,similar,0,0
46613,parenteral,0,1
46614,and,0,0
46615,oral,0,1
46616,analgesic,0,1
46617,requirement,0,0
46618,",",0,0
46619,the,0,0
46620,stapled,0,1
46621,group,0,0
46622,had,0,0
46623,a,0,0
46624,significantly,0,0
46625,better,0,0
46626,pain,0,0
46627,score,0,0
46628,(,0,0
46629,P,0,0
46630,=,0,0
46631,0.002,0,0
46632,),0,0
46633,;,0,0
46634,these,0,0
46635,patients,0,0
46636,also,0,0
46637,had,0,0
46638,a,0,0
46639,significantly,0,0
46640,shorter,0,0
46641,length,0,0
46642,of,0,0
46643,stay,0,0
46644,(,0,0
46645,P,0,0
46646,=,0,0
46647,0.02,0,0
46648,),0,0
46649,",",0,0
46650,and,0,0
46651,on,0,0
46652,average,0,0
46653,resumed,0,0
46654,work,0,0
46655,nine,0,0
46656,days,0,0
46657,earlier,0,0
46658,than,0,0
46659,the,0,0
46660,group,0,0
46661,treated,0,0
46662,with,0,0
46663,the,0,0
46664,Harmonic,0,1
46665,Scalpel,0,1
46666,(,0,0
46667,6.7,0,0
46668,vs.,0,0
46669,15.6,0,0
46670,",",0,0
46671,P,0,0
46672,=,0,0
46673,0.002,0,0
46674,),0,0
46675,.,0,0
46676,Although,0,0
46677,88,0,0
46678,percent,0,0
46679,of,0,0
46680,doughnuts,0,1
46681,obtained,0,0
46682,in,0,0
46683,the,0,0
46684,stapled,0,1
46685,group,0,0
46686,contained,0,0
46687,some,0,0
46688,smooth,0,0
46689,muscle,0,0
46690,fibers,0,1
46691,",",0,0
46692,no,0,0
46693,association,0,0
46694,was,0,0
46695,found,0,0
46696,between,0,0
46697,smooth,0,0
46698,muscle,0,1
46699,incorporation,0,1
46700,and,0,0
46701,postoperative,0,0
46702,continence,0,0
46703,function,0,0
46704,",",0,0
46705,and,0,0
46706,as,0,0
46707,a,0,0
46708,whole,0,0
46709,the,0,0
46710,continence,0,0
46711,outcomes,0,0
46712,of,0,0
46713,the,0,0
46714,stapled,0,1
46715,group,0,0
46716,were,0,0
46717,similar,0,0
46718,to,0,0
46719,those,0,0
46720,after,0,0
46721,Harmonic,0,1
46722,Scalpel,0,1
46723,hemorrhoidectomy,0,1
46724,.,0,0
46725,Finally,0,0
46726,",",0,0
46727,at,0,0
46728,six-month,0,0
46729,follow-up,0,0
46730,",",0,0
46731,patients,0,0
46732,who,0,0
46733,underwent,0,0
46734,the,0,0
46735,stapled,1,1
46736,procedure,0,0
46737,had,0,0
46738,significantly,0,0
46739,better,0,0
46740,satisfaction,0,0
46741,scores,0,0
46742,(,0,0
46743,P,0,0
46744,=,0,0
46745,0.001,0,0
46746,),0,0
46747,.,0,0
46748,CONCLUSION,0,0
46749,Stapled,1,0
46750,hemorrhoidopexy,1,1
46751,is,0,0
46752,a,0,0
46753,safe,0,0
46754,and,0,0
46755,effective,0,0
46756,procedure,0,1
46757,for,0,0
46758,Grade,0,1
46759,III,0,1
46760,hemorrhoidal,0,0
46761,disease,0,0
46762,.,0,0
46763,Patients,0,0
46764,derive,0,0
46765,greater,0,0
46766,short-term,0,0
46767,benefits,0,0
46768,of,0,0
46769,reduced,0,0
46770,pain,0,0
46771,",",0,0
46772,shorter,0,0
46773,length,0,0
46774,of,0,0
46775,stay,0,0
46776,",",0,0
46777,and,0,0
46778,earlier,0,0
46779,resumption,0,0
46780,to,0,0
46781,work,0,0
46782,.,0,0
46783,Long-term,0,0
46784,follow-up,0,0
46785,is,0,0
46786,necessary,0,0
46787,to,0,0
46788,determine,0,0
46789,whether,0,0
46790,these,0,0
46791,initial,0,0
46792,results,0,0
46793,are,0,0
46794,lasting,0,0
46795,.,0,0
46796,Loss,0,1
46797,of,0,0
46798,tooth,0,0
46799,substance,0,0
46800,during,0,0
46801,root,1,1
46802,planing,1,1
46803,with,0,0
46804,various,0,0
46805,periodontal,0,0
46806,instruments,0,0
46807,:,0,0
46808,an,0,0
46809,in,0,0
46810,vitro,0,0
46811,study,0,0
46812,.,0,0
46813,Ultrasonic,1,1
46814,and,1,0
46815,power-driven,1,1
46816,instrumentation,1,1
46817,is,0,0
46818,gaining,0,0
46819,in,0,0
46820,significance,0,0
46821,as,0,0
46822,an,0,0
46823,acceptable,0,0
46824,alternative,0,0
46825,to,0,0
46826,manual,0,1
46827,periodontal,0,0
46828,root,0,1
46829,treatment,0,0
46830,.,0,0
46831,Some,0,0
46832,question,0,0
46833,whether,0,0
46834,they,0,0
46835,do,0,0
46836,not,0,0
46837,remove,0,0
46838,too,0,0
46839,much,0,0
46840,tooth,0,0
46841,substance,0,0
46842,.,0,0
46843,Various,1,0
46844,ultrasonic,1,0
46845,scalers,1,1
46846,",",1,0
46847,hand,1,0
46848,instruments,1,1
46849,and,1,0
46850,two,1,0
46851,power-driven,1,1
46852,systems,1,0
46853,were,0,0
46854,compared,0,0
46855,by,0,0
46856,assessing,0,0
46857,the,0,0
46858,loss,0,0
46859,of,0,0
46860,tooth,0,0
46861,substance,0,0
46862,due,0,0
46863,to,0,0
46864,root,0,1
46865,instrumentation,0,1
46866,.,0,0
46867,Quantitative,0,0
46868,analysis,0,0
46869,of,0,0
46870,this,0,0
46871,effect,0,0
46872,of,0,0
46873,the,0,0
46874,instruments,0,0
46875,used,0,0
46876,was,0,0
46877,performed,0,0
46878,on,0,0
46879,20,0,0
46880,freshly,0,0
46881,extracted,0,0
46882,",",0,0
46883,non-periodontally,0,0
46884,involved,0,0
46885,",",0,0
46886,large,0,0
46887,human,0,0
46888,molars,0,0
46889,.,0,0
46890,In,0,0
46891,the,0,0
46892,first,0,0
46893,study,0,0
46894,",",0,0
46895,40,0,0
46896,specimens,0,0
46897,were,0,0
46898,randomly,0,0
46899,assigned,0,0
46900,to,0,0
46901,four,0,0
46902,groups,0,0
46903,of,0,0
46904,treatment,0,0
46905,:,0,0
46906,combined,0,1
46907,use,0,0
46908,of,0,0
46909,ultrasonic,1,1
46910,scaler,1,1
46911,and,1,0
46912,Periopolisher,1,1
46913,diamond-coated,1,1
46914,inserts,1,1
46915,(,1,0
46916,US-POL,1,1
46917,),1,1
46918,",",1,0
46919,hand,1,1
46920,instruments,1,1
46921,(,1,0
46922,MANUAL,1,0
46923,),1,0
46924,",",1,0
46925,Perioplaner-Periopolisher,1,1
46926,system,1,1
46927,(,1,1
46928,PPL-POL,1,1
46929,),1,1
46930,and,1,0
46931,Periokit,1,0
46932,ultrasonic-designed,1,1
46933,scalers,1,1
46934,(,1,0
46935,PERIOKIT,1,1
46936,),1,0
46937,.,1,0
46938,The,0,0
46939,second,0,0
46940,study,0,0
46941,involved,0,0
46942,two,0,0
46943,treatment,0,0
46944,groups,0,0
46945,",",0,0
46946,ultrasonic,1,1
46947,scaler,1,1
46948,alone,1,1
46949,and,1,0
46950,hand,1,1
46951,instruments,1,0
46952,",",0,0
46953,each,0,0
46954,allocated,0,0
46955,with,0,0
46956,20,0,0
46957,teeth,0,0
46958,(,0,0
46959,small,0,0
46960,root,0,1
46961,fragments,0,0
46962,),0,0
46963,.,0,0
46964,An,0,0
46965,unpaired,0,0
46966,two-tailed,0,0
46967,t,0,0
46968,test,0,0
46969,was,0,0
46970,carried,0,0
46971,out,0,0
46972,for,0,0
46973,both,0,0
46974,studies,0,0
46975,to,0,0
46976,compare,0,0
46977,the,0,0
46978,average,0,0
46979,weight,0,0
46980,loss,0,0
46981,of,0,0
46982,root,0,1
46983,substance,0,0
46984,with,0,0
46985,the,0,0
46986,modes,0,0
46987,of,0,0
46988,instrumentation,0,0
46989,.,0,0
46990,The,0,0
46991,level,0,0
46992,of,0,0
46993,significance,0,0
46994,was,0,0
46995,set,0,0
46996,at,0,0
46997,p,0,0
46998,<,0,0
46999,or=0.05,0,0
47000,.,0,0
47001,The,0,0
47002,overall,0,0
47003,results,0,0
47004,of,0,0
47005,the,0,0
47006,first,0,0
47007,and,0,0
47008,second,0,0
47009,experimental,0,0
47010,trials,0,0
47011,did,0,0
47012,not,0,0
47013,reveal,0,0
47014,obvious,0,0
47015,differences,0,0
47016,in,0,0
47017,weight,0,0
47018,loss,0,0
47019,between,0,0
47020,the,0,0
47021,manual,0,0
47022,",",0,0
47023,ultrasonic,0,1
47024,or,0,1
47025,power-driven,0,1
47026,root,0,1
47027,treatments,0,0
47028,.,0,0
47029,Based,0,0
47030,on,0,0
47031,the,0,0
47032,results,0,0
47033,of,0,0
47034,these,0,0
47035,two,0,0
47036,comparative,0,0
47037,studies,0,0
47038,",",0,0
47039,the,0,0
47040,power-driven,0,1
47041,inserts,0,1
47042,or,0,0
47043,the,0,0
47044,various,0,0
47045,ultrasonic,0,1
47046,scalers,0,1
47047,tested,0,0
47048,did,0,0
47049,not,0,0
47050,remove,0,0
47051,more,0,0
47052,tooth,0,0
47053,substance,0,0
47054,than,0,0
47055,conventional,0,1
47056,hand,0,0
47057,instruments,0,0
47058,.,0,0
47059,They,0,0
47060,may,0,0
47061,thus,0,0
47062,be,0,0
47063,a,0,0
47064,useful,0,0
47065,alternative,0,0
47066,for,0,0
47067,the,0,0
47068,debridement,0,1
47069,of,0,0
47070,root,0,0
47071,surfaces,0,1
47072,.,0,0
47073,Combined,1,1
47074,chemotherapy,1,1
47075,and,1,0
47076,radiotherapy,1,1
47077,compared,0,0
47078,with,0,0
47079,radiotherapy,1,1
47080,alone,1,1
47081,in,0,0
47082,patients,0,0
47083,with,0,0
47084,cancer,0,0
47085,of,0,0
47086,the,0,0
47087,esophagus,0,0
47088,.,0,0
47089,BACKGROUND,0,0
47090,The,0,0
47091,efficacy,0,0
47092,of,0,0
47093,conventional,0,1
47094,treatment,0,0
47095,with,0,0
47096,surgery,0,1
47097,and,0,0
47098,radiation,0,1
47099,for,0,0
47100,cancer,0,0
47101,of,0,0
47102,the,0,0
47103,esophagus,0,0
47104,is,0,0
47105,limited,0,0
47106,.,0,0
47107,The,0,0
47108,median,0,0
47109,survival,0,0
47110,is,0,0
47111,less,0,0
47112,than,0,0
47113,10,0,0
47114,months,0,0
47115,",",0,0
47116,and,0,0
47117,less,0,0
47118,than,0,0
47119,10,0,0
47120,percent,0,0
47121,of,0,0
47122,patients,0,0
47123,survive,0,0
47124,for,0,0
47125,5,0,0
47126,years,0,0
47127,.,0,0
47128,Recent,0,0
47129,studies,0,0
47130,have,0,0
47131,suggested,0,0
47132,that,0,0
47133,combined,1,1
47134,chemotherapy,1,1
47135,and,1,0
47136,radiation,1,1
47137,therapy,1,1
47138,may,0,0
47139,result,0,0
47140,in,0,0
47141,improved,0,0
47142,survival,0,0
47143,.,0,0
47144,METHODS,0,0
47145,This,0,0
47146,phase,0,0
47147,III,0,0
47148,prospective,0,0
47149,",",0,0
47150,randomized,0,0
47151,",",0,0
47152,and,0,0
47153,stratified,0,0
47154,trial,0,0
47155,was,0,0
47156,undertaken,0,0
47157,to,0,0
47158,evaluate,0,0
47159,the,0,0
47160,efficacy,0,0
47161,of,0,0
47162,four,0,0
47163,courses,0,0
47164,of,0,0
47165,combined,0,1
47166,fluorouracil,1,1
47167,(,1,0
47168,1000,1,0
47169,mg,1,1
47170,per,1,0
47171,square,1,0
47172,meter,1,1
47173,of,1,0
47174,body-surface,1,1
47175,area,1,0
47176,daily,1,1
47177,for,1,0
47178,four,1,0
47179,days,1,0
47180,),1,0
47181,and,1,0
47182,cisplatin,1,1
47183,(,1,1
47184,75,1,0
47185,mg,1,1
47186,per,1,0
47187,square,1,0
47188,meter,1,1
47189,on,1,0
47190,the,1,0
47191,first,1,0
47192,day,1,1
47193,),1,1
47194,plus,1,1
47195,5000,1,1
47196,cGy,1,0
47197,of,1,0
47198,radiation,1,1
47199,therapy,1,1
47200,",",0,0
47201,as,0,0
47202,compared,0,0
47203,with,0,0
47204,6400,1,1
47205,cGy,1,0
47206,of,1,0
47207,radiation,1,1
47208,therapy,1,1
47209,alone,0,1
47210,",",0,0
47211,in,0,0
47212,patients,0,0
47213,with,0,0
47214,squamous-cell,0,0
47215,carcinoma,0,0
47216,or,0,1
47217,adenocarcinoma,0,0
47218,of,0,0
47219,the,0,0
47220,thoracic,0,1
47221,esophagus,0,0
47222,.,0,0
47223,The,0,0
47224,trial,0,0
47225,was,0,0
47226,stopped,0,0
47227,after,0,0
47228,the,0,0
47229,accumulated,0,0
47230,results,0,0
47231,in,0,0
47232,121,0,0
47233,patients,0,0
47234,demonstrated,0,0
47235,a,0,0
47236,significant,0,0
47237,advantage,0,0
47238,for,0,0
47239,survival,0,0
47240,in,0,0
47241,the,0,0
47242,patients,0,0
47243,who,0,0
47244,received,0,1
47245,chemotherapy,1,1
47246,and,1,0
47247,radiation,1,1
47248,therapy,1,1
47249,.,1,0
47250,RESULTS,0,0
47251,The,0,0
47252,median,0,0
47253,survival,0,0
47254,was,0,0
47255,8.9,0,0
47256,months,0,0
47257,in,0,0
47258,the,0,0
47259,radiation-treated,0,1
47260,patients,0,0
47261,",",0,0
47262,as,0,0
47263,compared,0,0
47264,with,0,0
47265,12.5,0,0
47266,months,0,0
47267,in,0,0
47268,the,0,0
47269,patients,0,0
47270,treated,0,0
47271,with,0,0
47272,chemotherapy,1,1
47273,and,1,0
47274,radiation,1,1
47275,therapy,1,1
47276,.,1,0
47277,In,0,0
47278,the,0,0
47279,former,0,0
47280,group,0,0
47281,",",0,0
47282,the,0,0
47283,survival,0,0
47284,rates,0,0
47285,at,0,0
47286,12,0,0
47287,and,0,0
47288,24,0,0
47289,months,0,0
47290,were,0,0
47291,33,0,0
47292,percent,0,0
47293,and,0,0
47294,10,0,1
47295,percent,0,0
47296,",",0,0
47297,respectively,0,0
47298,",",0,0
47299,whereas,0,0
47300,they,0,0
47301,were,0,0
47302,50,0,1
47303,percent,0,0
47304,and,0,0
47305,38,0,0
47306,percent,0,0
47307,in,0,0
47308,the,0,0
47309,patients,0,0
47310,receiving,0,0
47311,combined,1,1
47312,therapy,1,1
47313,(,0,0
47314,P,0,0
47315,less,0,0
47316,than,0,0
47317,0.001,0,0
47318,),0,0
47319,.,0,0
47320,Seven,0,0
47321,patients,0,0
47322,in,0,0
47323,the,0,0
47324,radiotherapy,1,1
47325,group,0,0
47326,and,0,0
47327,25,0,0
47328,in,0,0
47329,the,0,0
47330,combined-therapy,1,1
47331,group,0,0
47332,were,0,0
47333,alive,0,0
47334,at,0,0
47335,the,0,0
47336,time,0,0
47337,of,0,0
47338,the,0,0
47339,analysis,0,0
47340,.,0,0
47341,The,0,0
47342,patients,0,0
47343,who,0,0
47344,received,0,0
47345,combined,0,1
47346,treatment,0,0
47347,had,0,0
47348,fewer,0,0
47349,local,0,0
47350,(,0,0
47351,P,0,0
47352,less,0,0
47353,than,0,0
47354,0.02,0,0
47355,),0,0
47356,and,0,0
47357,fewer,0,0
47358,distant,0,0
47359,(,0,0
47360,P,0,0
47361,less,0,0
47362,than,0,0
47363,0.01,0,0
47364,),0,0
47365,recurrences,0,0
47366,.,0,0
47367,Severe,0,0
47368,and,0,0
47369,life-threatening,0,0
47370,side,0,0
47371,effects,0,0
47372,occurred,0,0
47373,in,0,0
47374,44,0,0
47375,percent,0,0
47376,and,0,0
47377,20,0,0
47378,percent,0,0
47379,",",0,0
47380,respectively,0,0
47381,",",0,0
47382,of,0,0
47383,the,0,0
47384,patients,0,0
47385,who,0,0
47386,received,0,0
47387,combined,0,1
47388,therapy,0,1
47389,",",0,0
47390,as,0,0
47391,compared,0,0
47392,with,0,0
47393,25,0,0
47394,percent,0,0
47395,and,0,0
47396,3,0,0
47397,percent,0,0
47398,of,0,0
47399,those,0,0
47400,treated,0,0
47401,with,0,0
47402,radiation,0,1
47403,alone,0,1
47404,.,0,0
47405,CONCLUSIONS,0,0
47406,Concurrent,1,0
47407,therapy,1,1
47408,with,1,0
47409,cisplatin,1,1
47410,and,1,0
47411,fluorouracil,1,1
47412,and,1,0
47413,radiation,1,1
47414,is,0,0
47415,superior,0,0
47416,to,0,0
47417,radiation,1,1
47418,therapy,1,1
47419,alone,0,1
47420,in,0,0
47421,patients,0,0
47422,with,0,0
47423,localized,0,0
47424,carcinoma,0,0
47425,of,0,0
47426,the,0,0
47427,esophagus,0,0
47428,",",0,0
47429,as,0,0
47430,measured,0,0
47431,by,0,0
47432,control,0,0
47433,of,0,0
47434,local,0,1
47435,tumors,0,0
47436,",",0,0
47437,distant,0,0
47438,metastases,0,0
47439,",",0,0
47440,and,0,0
47441,survival,0,0
47442,",",0,0
47443,but,0,0
47444,at,0,0
47445,the,0,0
47446,cost,0,0
47447,of,0,0
47448,increased,0,0
47449,side,0,0
47450,effects,0,0
47451,.,0,0
47452,Cophenylcaine,1,1
47453,spray,0,1
47454,vs.,0,0
47455,placebo,1,1
47456,in,0,0
47457,flexible,0,1
47458,nasendoscopy,0,1
47459,:,0,0
47460,a,0,0
47461,prospective,0,0
47462,double-blind,0,0
47463,randomised,0,0
47464,controlled,0,0
47465,trial,0,0
47466,.,0,0
47467,Practices,0,0
47468,vary,0,0
47469,across,0,0
47470,the,0,0
47471,UK,0,0
47472,on,0,0
47473,the,0,0
47474,use,0,0
47475,of,0,0
47476,topical,0,1
47477,preparation,0,1
47478,prior,0,0
47479,to,0,0
47480,flexible,0,1
47481,fibreoptic,0,1
47482,nasendoscopy,0,1
47483,.,0,0
47484,In,0,0
47485,this,0,0
47486,double-blind,0,0
47487,study,0,0
47488,",",0,0
47489,we,0,0
47490,randomised,0,0
47491,98,0,0
47492,patients,0,0
47493,to,0,0
47494,receive,0,1
47495,cophenylcaine,1,1
47496,or,1,1
47497,placebo,1,1
47498,nasal,1,1
47499,spray,1,1
47500,before,0,0
47501,flexible,0,1
47502,nasendoscopy,0,1
47503,.,0,0
47504,A,0,0
47505,visual,0,0
47506,analogue,0,1
47507,scale,0,0
47508,(,0,1
47509,1-100,0,0
47510,),0,0
47511,was,0,0
47512,used,0,0
47513,to,0,0
47514,record,0,0
47515,pain,0,0
47516,",",0,0
47517,unpleasantness,0,0
47518,of,0,0
47519,taste,0,0
47520,and,0,0
47521,overall,0,0
47522,discomfort,0,0
47523,experienced,0,0
47524,.,0,0
47525,Overall,0,0
47526,",",0,0
47527,the,0,0
47528,procedure,0,0
47529,was,0,0
47530,associated,0,0
47531,with,0,0
47532,minimal,0,0
47533,pain,0,0
47534,and,0,0
47535,discomfort,0,0
47536,in,0,0
47537,both,0,0
47538,groups,0,0
47539,.,0,0
47540,There,0,0
47541,was,0,0
47542,no,0,0
47543,significant,0,0
47544,difference,0,0
47545,in,0,0
47546,pain,0,0
47547,or,0,1
47548,overall,0,0
47549,discomfort,0,0
47550,experienced,0,0
47551,between,0,0
47552,the,0,0
47553,two,0,0
47554,groups,0,0
47555,;,0,0
47556,however,0,0
47557,",",0,0
47558,the,0,0
47559,sensation,0,0
47560,of,0,0
47561,bad,0,1
47562,taste,0,0
47563,was,0,0
47564,significantly,0,0
47565,worse,0,0
47566,in,0,0
47567,the,0,0
47568,cophenylcaine,1,1
47569,group,0,0
47570,.,0,0
47571,In,0,0
47572,linear,0,0
47573,regression,0,0
47574,",",0,0
47575,factors,0,0
47576,that,0,0
47577,predicted,0,0
47578,the,0,0
47579,overall,0,0
47580,unpleasantness,0,0
47581,of,0,0
47582,the,0,0
47583,experience,0,0
47584,were,0,0
47585,primarily,0,0
47586,pain,0,0
47587,experienced,0,0
47588,and,0,0
47589,secondarily,0,0
47590,unpleasantness,0,0
47591,of,0,0
47592,taste,0,0
47593,.,0,0
47594,We,0,0
47595,conclude,0,0
47596,that,0,0
47597,the,0,0
47598,routine,0,0
47599,use,0,0
47600,of,0,0
47601,cophenylcaine,1,1
47602,for,0,0
47603,nasal,0,0
47604,preparation,0,1
47605,is,0,0
47606,not,0,0
47607,justified,0,0
47608,before,0,0
47609,flexible,0,1
47610,nasendoscopy,0,1
47611,.,0,0
47612,Acustimulation,1,1
47613,wrist,1,1
47614,bands,1,1
47615,are,0,0
47616,not,0,0
47617,effective,0,0
47618,for,0,0
47619,the,0,0
47620,control,0,0
47621,of,0,0
47622,chemotherapy-induced,1,0
47623,nausea,0,0
47624,in,0,0
47625,women,0,0
47626,with,0,0
47627,breast,0,0
47628,cancer,0,0
47629,.,0,0
47630,This,0,0
47631,experiment,0,0
47632,examined,0,0
47633,the,0,0
47634,efficacy,0,0
47635,of,0,0
47636,an,0,0
47637,acustimulation,1,1
47638,wrist,1,1
47639,band,1,1
47640,for,0,0
47641,the,0,0
47642,relief,0,0
47643,of,0,0
47644,chemotherapy-induced,1,0
47645,nausea,0,0
47646,using,0,0
47647,a,0,0
47648,randomized,0,0
47649,three-arm,0,0
47650,clinical,0,0
47651,trial,0,0
47652,(,1,1
47653,active,1,1
47654,acustimulation,1,1
47655,",",1,0
47656,sham,1,1
47657,acustimulation,1,0
47658,",",0,0
47659,and,0,0
47660,no,1,0
47661,acustimulation,1,1
47662,),1,0
47663,in,0,0
47664,96,0,0
47665,women,0,0
47666,with,0,0
47667,breast,0,0
47668,cancer,0,0
47669,who,0,0
47670,experienced,0,0
47671,nausea,0,0
47672,at,0,0
47673,their,0,0
47674,first,0,0
47675,chemotherapy,1,1
47676,treatment,1,0
47677,.,1,0
47678,Five,0,0
47679,outcomes,0,0
47680,related,0,0
47681,to,0,0
47682,wrist,1,1
47683,band,1,1
47684,efficacy,0,0
47685,(,0,1
47686,acute,0,0
47687,nausea,0,0
47688,",",0,0
47689,delayed,0,0
47690,nausea,0,0
47691,",",0,0
47692,vomiting,0,0
47693,",",0,0
47694,QOL,0,1
47695,",",0,0
47696,and,0,0
47697,total,0,0
47698,amount,0,0
47699,of,0,0
47700,antiemetic,1,1
47701,medication,1,1
47702,used,0,0
47703,),0,0
47704,were,0,0
47705,examined,0,0
47706,.,0,0
47707,The,0,0
47708,five,0,0
47709,outcomes,0,0
47710,were,0,0
47711,examined,0,0
47712,separately,0,0
47713,using,0,0
47714,analysis,0,0
47715,of,0,0
47716,covariance,0,0
47717,controlling,0,0
47718,for,0,0
47719,age,0,0
47720,and,0,0
47721,severity,0,0
47722,of,0,0
47723,past,0,0
47724,nausea,0,0
47725,.,0,0
47726,There,0,0
47727,were,0,0
47728,no,0,0
47729,significant,0,0
47730,differences,0,0
47731,in,0,0
47732,any,0,0
47733,of,0,0
47734,these,0,0
47735,study,0,0
47736,measures,0,0
47737,among,0,0
47738,the,0,0
47739,three,0,0
47740,treatment,0,0
47741,conditions,0,0
47742,(,0,0
47743,P,0,0
47744,>,0,0
47745,0.1,0,0
47746,for,0,0
47747,all,0,0
47748,),0,0
47749,.,0,0
47750,Study,0,0
47751,results,0,0
47752,do,0,0
47753,not,0,0
47754,support,0,0
47755,the,0,0
47756,hypothesis,0,0
47757,that,0,0
47758,acustimulation,1,0
47759,bands,1,1
47760,are,0,0
47761,efficacious,0,0
47762,as,0,0
47763,an,0,0
47764,adjunct,0,0
47765,to,0,0
47766,pharmacological,0,0
47767,antiemetics,0,1
47768,for,0,0
47769,control,0,0
47770,of,0,0
47771,chemotherapy-related,0,0
47772,nausea,0,0
47773,in,0,0
47774,female,0,0
47775,breast,0,0
47776,cancer,0,0
47777,patients,0,0
47778,.,0,0
47779,Problem-based,1,1
47780,learning,1,1
47781,:,1,0
47782,is,0,0
47783,anatomy,0,0
47784,a,0,0
47785,casualty,0,0
47786,?,0,0
47787,INTRODUCTION,0,0
47788,The,0,0
47789,teaching,0,1
47790,of,0,0
47791,medical,0,0
47792,anatomy,0,0
47793,is,0,0
47794,changing,0,0
47795,.,0,0
47796,Medical,0,0
47797,schools,0,0
47798,worldwide,0,0
47799,are,0,0
47800,moving,0,0
47801,away,0,0
47802,from,0,0
47803,dissection,0,0
47804,and,0,0
47805,lectures,0,1
47806,to,0,0
47807,a,0,0
47808,more,0,0
47809,integrated,0,1
47810,course,0,0
47811,",",0,0
47812,where,0,0
47813,basic,0,1
47814,science,0,0
47815,and,0,0
47816,clinical,0,0
47817,skills,0,1
47818,are,0,0
47819,taught,0,0
47820,simultaneously,0,1
47821,.,0,0
47822,Medical,0,0
47823,students,0,0
47824,on,0,0
47825,these,0,0
47826,integrated,0,1
47827,courses,0,0
47828,have,0,0
47829,reported,0,0
47830,a,0,0
47831,lack,0,0
47832,of,0,0
47833,confidence,0,0
47834,in,0,0
47835,their,0,0
47836,basic,0,1
47837,science,0,0
47838,knowledge,0,0
47839,",",0,0
47840,especially,0,0
47841,concerning,0,0
47842,anatomy,0,0
47843,.,0,0
47844,Our,0,0
47845,aim,0,0
47846,was,0,0
47847,to,0,0
47848,perform,0,0
47849,a,0,0
47850,randomised,0,0
47851,controlled,0,0
47852,trial,0,0
47853,(,0,1
47854,RCT,0,0
47855,),0,1
47856,to,0,0
47857,compare,0,0
47858,anatomical,0,0
47859,knowledge,0,0
47860,of,0,0
47861,two,0,0
47862,groups,0,0
47863,of,0,0
47864,second-year,0,0
47865,medical,0,0
47866,students,0,0
47867,",",0,0
47868,the,1,0
47869,first,1,0
47870,group,1,0
47871,taught,1,0
47872,on,1,0
47873,a,1,0
47874,traditional,1,1
47875,course,1,0
47876,",",1,0
47877,the,1,0
47878,second,1,0
47879,on,1,0
47880,an,1,0
47881,integrated,1,1
47882,course,1,0
47883,.,1,1
47884,MATERIALS,0,0
47885,AND,0,0
47886,METHODS,0,0
47887,Testing,0,0
47888,was,0,0
47889,done,0,0
47890,using,0,0
47891,a,0,0
47892,Questionnaire,0,0
47893,in,0,0
47894,a,0,0
47895,True/False,0,0
47896,format,0,0
47897,.,0,0
47898,There,0,0
47899,were,0,0
47900,80,0,0
47901,students,0,0
47902,in,0,0
47903,each,0,0
47904,group,0,0
47905,.,0,0
47906,There,0,0
47907,was,0,0
47908,no,0,0
47909,penalty,0,0
47910,for,0,0
47911,an,0,0
47912,incorrect,0,0
47913,answer,0,0
47914,.,0,0
47915,The,0,0
47916,test,0,0
47917,was,0,0
47918,performed,0,0
47919,under,0,0
47920,examination,0,0
47921,conditions,0,0
47922,.,0,0
47923,Papers,0,0
47924,were,0,0
47925,marked,0,0
47926,under,0,0
47927,blind,0,0
47928,conditions,0,0
47929,.,0,0
47930,Results,0,0
47931,were,0,0
47932,analysed,0,0
47933,using,0,0
47934,a,0,0
47935,Student,0,1
47936,'s,0,0
47937,t,0,0
47938,test,0,0
47939,analysis,0,0
47940,.,0,0
47941,RESULTS,0,0
47942,Those,0,0
47943,students,0,0
47944,taught,0,0
47945,on,0,0
47946,a,0,0
47947,traditional,0,1
47948,course,0,0
47949,exhibited,0,0
47950,a,0,0
47951,significantly,0,0
47952,higher,0,0
47953,level,0,0
47954,of,0,0
47955,basic,0,1
47956,anatomical,0,0
47957,knowledge,0,0
47958,(,0,0
47959,p,0,0
47960,<,0,0
47961,0.001,0,0
47962,),0,0
47963,than,0,0
47964,those,0,0
47965,taught,0,0
47966,on,0,0
47967,an,0,0
47968,integrated,0,1
47969,course,0,0
47970,.,0,0
47971,The,0,0
47972,students,0,0
47973,taught,0,0
47974,on,0,0
47975,an,0,0
47976,integrated,0,1
47977,course,0,0
47978,showed,0,0
47979,a,0,0
47980,much,0,0
47981,greater,0,0
47982,range,0,0
47983,of,0,0
47984,results,0,0
47985,.,0,0
47986,CONCLUSIONS,0,0
47987,Students,0,0
47988,taught,0,0
47989,on,0,0
47990,a,0,0
47991,traditional,0,1
47992,course,0,0
47993,have,0,0
47994,a,0,0
47995,higher,0,0
47996,level,0,0
47997,of,0,0
47998,anatomical,0,0
47999,knowledge,0,0
48000,than,0,0
48001,those,0,0
48002,taught,0,0
48003,on,0,0
48004,an,0,0
48005,integrated,0,1
48006,course,0,0
48007,.,0,0
48008,Our,0,0
48009,results,0,0
48010,differ,0,0
48011,from,0,0
48012,previous,0,0
48013,studies,0,0
48014,done,0,0
48015,in,0,0
48016,Europe,0,1
48017,which,0,0
48018,show,0,0
48019,no,0,0
48020,difference,0,0
48021,between,0,0
48022,the,0,0
48023,courses,0,0
48024,.,0,0
48025,Fulvestrant,1,1
48026,versus,0,1
48027,anastrozole,1,1
48028,for,0,0
48029,the,0,0
48030,treatment,0,0
48031,of,0,0
48032,advanced,0,0
48033,breast,0,0
48034,carcinoma,0,0
48035,:,0,0
48036,a,0,0
48037,prospectively,0,0
48038,planned,0,0
48039,combined,0,1
48040,survival,0,0
48041,analysis,0,0
48042,of,0,0
48043,two,0,0
48044,multicenter,0,0
48045,trials,0,0
48046,.,0,0
48047,BACKGROUND,0,0
48048,Fulvestrant,1,1
48049,is,0,0
48050,an,0,0
48051,estrogen,0,1
48052,receptor,0,0
48053,antagonist,0,1
48054,with,0,0
48055,no,0,0
48056,agonist,0,1
48057,effects,0,0
48058,.,0,0
48059,In,0,0
48060,the,0,0
48061,second-line,0,1
48062,treatment,0,0
48063,of,0,0
48064,advanced,0,0
48065,breast,0,0
48066,carcinoma,0,0
48067,",",0,0
48068,fulvestrant,0,1
48069,was,0,0
48070,shown,0,0
48071,previously,0,0
48072,to,0,0
48073,be,0,0
48074,as,0,0
48075,effective,0,0
48076,as,0,0
48077,the,0,0
48078,third-generation,0,0
48079,aromatase,0,1
48080,inhibitor,0,1
48081,",",0,0
48082,anastrozole,0,1
48083,",",0,0
48084,in,0,0
48085,terms,0,0
48086,of,0,0
48087,time,0,0
48088,to,0,0
48089,disease,0,0
48090,progression,0,0
48091,and,0,0
48092,objective,0,0
48093,response,0,0
48094,rates,0,0
48095,.,0,0
48096,The,0,0
48097,authors,0,0
48098,reported,0,0
48099,the,0,0
48100,overall,0,0
48101,survival,0,0
48102,results,0,0
48103,from,0,0
48104,these,0,0
48105,studies,0,0
48106,.,0,0
48107,METHODS,0,0
48108,A,0,0
48109,prospectively,0,0
48110,planned,0,0
48111,",",0,0
48112,combined,0,1
48113,",",0,0
48114,overall,0,0
48115,survival,0,0
48116,analysis,0,0
48117,was,0,0
48118,performed,0,0
48119,",",0,0
48120,including,0,0
48121,data,0,0
48122,from,0,0
48123,two,0,0
48124,Phase,0,0
48125,III,0,0
48126,trials,0,0
48127,that,0,0
48128,compared,0,0
48129,the,0,0
48130,efficacy,0,0
48131,and,0,0
48132,tolerability,0,0
48133,of,0,0
48134,fulvestrant,1,1
48135,(,1,0
48136,250,1,1
48137,mg,1,1
48138,monthly,1,0
48139,;,1,0
48140,n,1,0
48141,=,1,0
48142,428,1,0
48143,),1,0
48144,with,1,0
48145,anastrozole,1,1
48146,(,1,0
48147,1,1,0
48148,mg,1,1
48149,daily,1,0
48150,;,1,0
48151,n,0,0
48152,=,0,0
48153,423,0,0
48154,),0,0
48155,in,0,0
48156,the,0,0
48157,treatment,0,0
48158,of,0,0
48159,postmenopausal,0,0
48160,women,0,0
48161,with,0,0
48162,advanced,0,0
48163,breast,0,0
48164,carcinoma,0,0
48165,who,0,0
48166,had,0,0
48167,disease,0,0
48168,progression,0,0
48169,after,0,0
48170,receipt,0,0
48171,of,0,0
48172,previous,0,0
48173,endocrine,1,0
48174,treatment,1,0
48175,.,1,0
48176,RESULTS,0,0
48177,At,0,0
48178,an,0,0
48179,extended,0,0
48180,median,0,0
48181,follow-up,0,0
48182,of,0,0
48183,27.0,0,0
48184,months,0,0
48185,(,0,0
48186,range,0,0
48187,",",0,0
48188,0-66.9,0,0
48189,months,0,0
48190,),0,0
48191,",",0,0
48192,319,0,0
48193,(,0,0
48194,74.5,0,0
48195,%,0,0
48196,),0,0
48197,patients,0,0
48198,in,0,0
48199,the,0,0
48200,fulvestrant,0,1
48201,group,0,0
48202,and,0,0
48203,322,0,0
48204,(,0,0
48205,76.1,0,0
48206,%,0,0
48207,),0,0
48208,patients,0,0
48209,in,0,0
48210,the,0,0
48211,anastrozole,0,1
48212,group,0,0
48213,had,0,0
48214,died,0,0
48215,.,0,0
48216,Prolonged,0,0
48217,survival,0,0
48218,was,0,0
48219,observed,0,0
48220,with,0,0
48221,both,0,0
48222,drugs,0,0
48223,",",0,0
48224,with,0,0
48225,10-20,0,0
48226,%,0,0
48227,of,0,0
48228,patients,0,0
48229,still,0,0
48230,alive,0,0
48231,>,0,0
48232,5,0,0
48233,years,0,0
48234,after,0,0
48235,randomization,0,0
48236,.,0,0
48237,The,0,0
48238,median,0,0
48239,overall,0,0
48240,survival,0,0
48241,was,0,0
48242,similar,0,0
48243,between,0,0
48244,treatments,0,0
48245,",",0,0
48246,being,0,0
48247,27.4,0,0
48248,months,0,0
48249,and,0,0
48250,27.7,0,0
48251,months,0,0
48252,in,0,0
48253,fulvestrant,1,1
48254,and,0,0
48255,anastrozole-treated,1,1
48256,patients,0,0
48257,",",0,0
48258,respectively,0,0
48259,(,0,0
48260,hazards,0,0
48261,ratio,0,0
48262,",",0,0
48263,0.98,0,0
48264,;,0,0
48265,95,0,0
48266,%,0,0
48267,confidence,0,0
48268,interval,0,0
48269,",",0,0
48270,0.84-1.15,0,0
48271,;,0,0
48272,P,0,0
48273,=,0,0
48274,0.809,0,0
48275,),0,0
48276,.,0,0
48277,Fulvestrant,0,1
48278,continued,0,0
48279,to,0,0
48280,be,0,0
48281,well,0,0
48282,tolerated,0,0
48283,",",0,0
48284,and,0,0
48285,was,0,0
48286,associated,0,0
48287,with,0,0
48288,a,0,0
48289,significantly,0,0
48290,lower,0,0
48291,incidence,0,0
48292,of,0,0
48293,joint,0,0
48294,disorders,0,0
48295,compared,0,0
48296,with,0,0
48297,anastrozole,0,1
48298,(,0,0
48299,P,0,0
48300,=,0,0
48301,0.0234,0,0
48302,),0,0
48303,.,0,0
48304,CONCLUSIONS,0,0
48305,The,0,0
48306,current,0,0
48307,analysis,0,0
48308,showed,0,0
48309,that,0,0
48310,fulvestrant,1,1
48311,was,0,0
48312,similar,0,0
48313,to,0,0
48314,anastrozole,0,1
48315,with,0,0
48316,respect,0,0
48317,to,0,0
48318,overall,0,0
48319,survival,0,0
48320,in,0,0
48321,the,0,0
48322,second-line,0,1
48323,treatment,0,0
48324,of,0,0
48325,postmenopausal,0,0
48326,women,0,0
48327,with,0,0
48328,advanced,0,0
48329,breast,0,0
48330,carcinoma,0,0
48331,.,0,0
48332,Lessons,0,0
48333,learnt,0,0
48334,in,0,0
48335,conducting,0,1
48336,a,0,0
48337,clinical,1,0
48338,drug,1,1
48339,trial,1,0
48340,in,0,0
48341,children,0,0
48342,with,0,0
48343,Asperger,0,0
48344,Syndrome,0,0
48345,.,0,0
48346,OBJECTIVE,0,0
48347,To,0,0
48348,describe,0,0
48349,the,0,0
48350,authors,0,0
48351,',0,0
48352,experience,0,0
48353,of,0,0
48354,conducting,0,1
48355,a,0,0
48356,clinical,0,0
48357,drug,0,1
48358,trial,0,0
48359,in,0,0
48360,children,0,0
48361,with,0,0
48362,Asperger,0,0
48363,Syndrome,0,0
48364,",",0,0
48365,including,0,0
48366,the,0,0
48367,pitfalls,0,0
48368,encountered,0,0
48369,and,0,0
48370,lessons,0,0
48371,learnt,0,0
48372,.,0,0
48373,CONCLUSIONS,0,0
48374,The,0,0
48375,main,0,0
48376,barrier,0,0
48377,encountered,0,0
48378,was,0,0
48379,in,0,0
48380,the,0,0
48381,recruitment,0,0
48382,of,0,0
48383,children,0,0
48384,:,0,0
48385,it,0,0
48386,was,0,0
48387,not,0,0
48388,possible,0,0
48389,to,0,0
48390,recruit,0,0
48391,the,0,0
48392,target,0,0
48393,of,0,0
48394,60,0,0
48395,patients,0,0
48396,.,0,0
48397,The,0,0
48398,recruitment,0,0
48399,of,0,0
48400,children,0,0
48401,is,0,0
48402,often,0,0
48403,the,0,0
48404,major,0,0
48405,barrier,0,0
48406,to,0,0
48407,the,0,0
48408,progress,0,0
48409,of,0,0
48410,a,0,0
48411,successful,0,0
48412,clinical,0,0
48413,trial,0,0
48414,.,0,0
48415,Conducting,0,0
48416,the,0,0
48417,clinical,0,0
48418,drug,0,1
48419,trial,0,0
48420,was,0,0
48421,greatly,0,0
48422,facilitated,0,0
48423,by,0,0
48424,the,0,0
48425,appropriate,0,1
48426,setting,0,0
48427,and,0,0
48428,experienced,0,0
48429,clinical,0,0
48430,pharmacology,0,0
48431,staff,0,0
48432,.,0,0
48433,Acute,0,0
48434,pressor,0,1
48435,and,0,0
48436,hormonal,0,0
48437,effects,0,0
48438,of,0,0
48439,beta-endorphin,1,0
48440,at,0,0
48441,high,0,0
48442,doses,0,0
48443,in,0,0
48444,healthy,0,0
48445,and,0,0
48446,hypertensive,0,0
48447,subjects,0,0
48448,:,0,0
48449,role,0,0
48450,of,0,0
48451,opioid,0,1
48452,receptor,0,0
48453,agonism,0,0
48454,.,0,0
48455,CONTEXT,0,0
48456,The,0,0
48457,opioid,0,1
48458,system,0,1
48459,is,0,0
48460,involved,0,0
48461,in,0,0
48462,blood,0,0
48463,pressure,0,0
48464,regulation,0,0
48465,in,0,0
48466,both,0,0
48467,normal,0,0
48468,humans,0,0
48469,and,0,0
48470,patients,0,0
48471,with,0,0
48472,essential,0,0
48473,hypertension,0,0
48474,.,0,0
48475,OBJECTIVE,0,0
48476,The,0,0
48477,objective,0,0
48478,of,0,0
48479,the,0,0
48480,study,0,0
48481,was,0,0
48482,to,0,0
48483,investigate,0,0
48484,the,0,0
48485,effects,0,0
48486,of,0,0
48487,a,0,0
48488,high-dose,0,1
48489,infusion,0,1
48490,of,0,0
48491,beta-endorphin,1,0
48492,",",0,0
48493,an,0,0
48494,opioid,0,1
48495,peptide,0,0
48496,",",0,0
48497,on,0,0
48498,blood,0,0
48499,pressure,0,0
48500,and,0,0
48501,on,0,0
48502,the,0,0
48503,hormonal,0,0
48504,profile,0,0
48505,in,0,0
48506,healthy,0,0
48507,subjects,0,0
48508,and,0,0
48509,in,0,0
48510,hypertensive,0,0
48511,patients,0,0
48512,and,0,0
48513,the,0,0
48514,mediation,0,0
48515,played,0,0
48516,by,0,0
48517,opioid,0,1
48518,receptor,0,0
48519,agonism,0,0
48520,.,0,0
48521,DESIGN,0,0
48522,",",0,0
48523,SETTING,0,0
48524,",",0,0
48525,AND,0,0
48526,PARTICIPANTS,0,0
48527,According,0,0
48528,to,0,0
48529,a,0,0
48530,randomized,0,0
48531,double-blind,0,0
48532,design,0,0
48533,",",0,0
48534,11,0,0
48535,healthy,0,0
48536,subjects,0,0
48537,(,0,0
48538,controls,0,0
48539,),0,0
48540,and,0,0
48541,12,0,0
48542,hypertensive,0,0
48543,inpatients,0,0
48544,(,0,0
48545,mean,0,0
48546,age,0,0
48547,",",0,0
48548,38.9,0,0
48549,and,0,0
48550,40.4,0,0
48551,yr,0,0
48552,",",0,0
48553,respectively,0,0
48554,),0,0
48555,received,0,1
48556,1-h,1,0
48557,iv,1,0
48558,infusion,1,1
48559,of,1,0
48560,beta-endorphin,1,1
48561,(,1,0
48562,250,1,1
48563,mug/h,1,1
48564,),1,0
48565,and,1,0
48566,",",1,0
48567,on,1,0
48568,another,1,0
48569,occasion,1,0
48570,",",1,0
48571,the,1,0
48572,same,1,0
48573,infusion,1,1
48574,protocol,1,1
48575,preceded,1,0
48576,by,1,0
48577,the,1,0
48578,opioid,1,1
48579,antagonist,1,1
48580,naloxone,1,1
48581,(,1,0
48582,8,1,1
48583,mg,1,1
48584,),1,0
48585,.,1,0
48586,MAIN,0,0
48587,OUTCOME,0,0
48588,MEASURES,0,0
48589,Hemodynamic,0,0
48590,and,0,0
48591,hormonal,0,0
48592,measurements,0,0
48593,were,0,0
48594,performed,0,0
48595,at,0,0
48596,established,0,0
48597,times,0,0
48598,during,0,0
48599,the,0,0
48600,infusion,0,0
48601,protocols,0,0
48602,.,0,0
48603,RESULTS,0,0
48604,At,0,0
48605,baseline,0,0
48606,",",0,0
48607,circulating,0,0
48608,beta-endorphin,0,0
48609,",",0,0
48610,norepinephrine,0,0
48611,",",0,0
48612,and,0,0
48613,endothelin-1,0,0
48614,in,0,0
48615,hypertensive,0,0
48616,patients,0,0
48617,were,0,0
48618,significantly,0,0
48619,(,0,0
48620,P,0,0
48621,<,0,0
48622,0.05,0,0
48623,),0,0
48624,higher,0,0
48625,than,0,0
48626,in,0,0
48627,controls,0,0
48628,.,0,0
48629,In,0,0
48630,controls,0,0
48631,",",0,0
48632,beta-endorphin,0,0
48633,reduced,0,0
48634,blood,0,0
48635,pressure,0,0
48636,(,0,0
48637,P,0,0
48638,<,0,0
48639,0.01,0,0
48640,),0,0
48641,and,0,0
48642,circulating,0,1
48643,norepinephrine,0,1
48644,(,0,1
48645,P,0,0
48646,<,0,0
48647,0.02,0,0
48648,),0,0
48649,and,0,0
48650,increased,0,0
48651,plasma,0,0
48652,atrial,0,0
48653,natriuretic,0,1
48654,factor,0,1
48655,(,0,0
48656,P,0,0
48657,<,0,0
48658,0.003,0,0
48659,),0,0
48660,and,0,0
48661,GH,0,1
48662,(,0,1
48663,P,0,0
48664,<,0,0
48665,0.0001,0,0
48666,),0,0
48667,.,0,0
48668,In,0,0
48669,hypertensive,0,0
48670,patients,0,0
48671,",",0,0
48672,beta-endorphin,1,0
48673,decreased,0,0
48674,systemic,0,0
48675,vascular,0,0
48676,resistance,0,0
48677,(,0,0
48678,P,0,0
48679,<,0,0
48680,0.0001,0,0
48681,),0,0
48682,",",0,0
48683,blood,0,0
48684,pressure,0,0
48685,(,0,0
48686,P,0,0
48687,<,0,0
48688,0.0001,0,0
48689,),0,0
48690,",",0,0
48691,and,0,0
48692,plasma,0,0
48693,norepinephrine,0,1
48694,(,0,0
48695,P,0,0
48696,<,0,0
48697,0.0001,0,0
48698,),0,0
48699,and,0,0
48700,endothelin-1,0,1
48701,(,0,0
48702,P,0,0
48703,<,0,0
48704,0.0001,0,0
48705,),0,0
48706,and,0,0
48707,raised,0,0
48708,circulating,0,0
48709,atrial,0,0
48710,natriuretic,0,1
48711,factor,0,1
48712,(,0,0
48713,P,0,0
48714,<,0,0
48715,0.0001,0,0
48716,),0,0
48717,",",0,0
48718,GH,0,1
48719,(,0,0
48720,P,0,0
48721,<,0,0
48722,0.0001,0,0
48723,),0,0
48724,",",0,0
48725,and,0,0
48726,IGF-I,0,1
48727,(,0,1
48728,P,0,0
48729,<,0,0
48730,0.0001,0,0
48731,),0,0
48732,.,0,0
48733,These,0,0
48734,hemodynamic,0,0
48735,and,0,0
48736,hormonal,0,0
48737,responses,0,0
48738,to,0,0
48739,beta-endorphin,0,0
48740,in,0,0
48741,hypertensive,0,0
48742,patients,0,0
48743,were,0,0
48744,significantly,0,0
48745,(,0,0
48746,P,0,0
48747,<,0,0
48748,0.0001,0,0
48749,),0,0
48750,greater,0,0
48751,than,0,0
48752,in,0,0
48753,controls,0,0
48754,but,0,0
48755,were,0,0
48756,annulled,0,1
48757,in,0,0
48758,all,0,0
48759,individuals,0,0
48760,when,0,0
48761,naloxone,0,1
48762,preceded,0,0
48763,beta-endorphin,0,0
48764,infusion,0,1
48765,.,0,0
48766,CONCLUSIONS,0,0
48767,High,0,0
48768,doses,0,0
48769,of,0,0
48770,beta-endorphin,1,1
48771,induce,0,0
48772,hypotensive,0,0
48773,and,0,0
48774,beneficial,0,0
48775,hormonal,0,0
48776,effects,0,0
48777,in,0,0
48778,humans,0,0
48779,",",0,0
48780,which,0,0
48781,are,0,0
48782,enhanced,0,0
48783,in,0,0
48784,essential,0,0
48785,hypertension,0,0
48786,and,0,0
48787,are,0,0
48788,mediated,0,0
48789,by,0,0
48790,opioid,0,0
48791,receptors,0,0
48792,.,0,0
48793,Just-in-time,0,0
48794,evidence-based,0,0
48795,e-mail,0,1
48796,reminders,0,1
48797,in,0,0
48798,home,0,1
48799,health,0,0
48800,care,0,1
48801,:,0,0
48802,impact,0,0
48803,on,0,0
48804,nurse,0,1
48805,practices,0,0
48806,.,0,0
48807,OBJECTIVE,0,0
48808,To,0,0
48809,test,0,0
48810,the,0,0
48811,effectiveness,0,0
48812,of,0,0
48813,two,0,0
48814,interventions,0,0
48815,designed,0,0
48816,to,0,0
48817,improve,0,0
48818,the,0,0
48819,adoption,0,0
48820,of,0,0
48821,evidence-based,0,0
48822,practices,0,0
48823,by,0,0
48824,home,0,1
48825,health,0,0
48826,nurses,0,1
48827,caring,0,0
48828,for,0,0
48829,heart,0,0
48830,failure,0,0
48831,(,0,1
48832,HF,0,0
48833,),0,0
48834,patients,0,0
48835,.,0,0
48836,DATA,0,0
48837,SOURCES/STUDY,0,0
48838,SETTING,0,1
48839,Information,0,1
48840,on,0,0
48841,nurse,0,1
48842,practices,0,0
48843,was,0,0
48844,abstracted,0,0
48845,from,0,0
48846,the,0,0
48847,clinical,0,0
48848,records,0,0
48849,of,0,0
48850,patients,0,0
48851,admitted,0,0
48852,between,0,0
48853,June,0,0
48854,2000,0,0
48855,and,0,0
48856,November,0,0
48857,2001,0,0
48858,to,0,0
48859,the,0,0
48860,care,0,1
48861,of,0,0
48862,354,0,0
48863,study,0,0
48864,nurses,0,0
48865,at,0,0
48866,a,0,0
48867,large,0,0
48868,",",0,0
48869,urban,0,0
48870,",",0,0
48871,nonprofit,0,1
48872,home,0,1
48873,care,0,1
48874,agency,0,0
48875,.,0,0
48876,STUDY,0,0
48877,DESIGN,0,0
48878,The,0,0
48879,study,0,0
48880,employed,0,0
48881,a,0,0
48882,randomized,0,0
48883,design,0,0
48884,with,0,0
48885,nurses,0,0
48886,assigned,0,0
48887,to,0,0
48888,usual,0,1
48889,care,0,1
48890,or,0,1
48891,one,0,0
48892,of,0,0
48893,two,0,0
48894,intervention,0,1
48895,groups,0,0
48896,upon,0,0
48897,identification,0,0
48898,of,0,0
48899,an,0,0
48900,eligible,0,0
48901,patient,0,0
48902,.,0,0
48903,The,0,0
48904,basic,0,0
48905,intervention,0,1
48906,was,0,0
48907,a,0,0
48908,one-time,1,1
48909,e-mail,1,1
48910,reminder,1,1
48911,highlighting,1,0
48912,six,1,0
48913,HF-specific,1,0
48914,clinical,1,0
48915,recommendations,1,0
48916,.,1,0
48917,The,0,0
48918,augmented,0,0
48919,intervention,0,1
48920,consisted,0,0
48921,of,0,0
48922,the,0,0
48923,initial,1,0
48924,e-mail,1,1
48925,reminder,1,1
48926,supplemented,1,1
48927,by,1,0
48928,provider,1,1
48929,prompts,1,1
48930,",",1,0
48931,patient,1,0
48932,education,1,1
48933,material,1,0
48934,",",1,0
48935,and,1,0
48936,clinical,1,0
48937,nurse,1,1
48938,specialist,1,1
48939,outreach,1,1
48940,.,1,0
48941,DATA,0,0
48942,COLLECTION,0,0
48943,At,0,1
48944,each,0,0
48945,home,0,1
48946,health,0,0
48947,visit,0,0
48948,provided,0,0
48949,by,0,0
48950,a,0,0
48951,study,0,0
48952,nurse,0,1
48953,to,0,0
48954,an,0,0
48955,eligible,0,0
48956,HF,0,0
48957,patient,0,0
48958,during,0,0
48959,the,0,0
48960,45-day,0,0
48961,follow-up,0,0
48962,period,0,0
48963,",",0,0
48964,a,0,0
48965,structured,0,1
48966,chart,0,1
48967,abstraction,0,1
48968,tool,0,0
48969,was,0,0
48970,used,0,0
48971,to,0,0
48972,collect,0,0
48973,information,0,0
48974,on,0,0
48975,whether,0,0
48976,the,0,0
48977,nurse,0,1
48978,provided,0,0
48979,the,0,0
48980,care,0,1
48981,practices,0,0
48982,highlighted,0,0
48983,in,0,0
48984,the,0,0
48985,e-mail,0,1
48986,reminder,0,1
48987,.,0,0
48988,PRINCIPAL,0,0
48989,FINDINGS,0,0
48990,Both,0,1
48991,the,0,0
48992,basic,0,1
48993,and,0,0
48994,the,0,0
48995,augmented,0,0
48996,interventions,0,0
48997,greatly,0,0
48998,increased,0,0
48999,the,0,0
49000,practice,0,0
49001,of,0,0
49002,evidence-based,0,0
49003,care,0,1
49004,",",0,0
49005,according,0,0
49006,to,0,0
49007,patient,0,0
49008,records,0,0
49009,",",0,0
49010,in,0,0
49011,the,0,0
49012,areas,0,0
49013,of,0,0
49014,patient,0,0
49015,assessment,0,0
49016,and,0,0
49017,instructions,0,1
49018,about,0,0
49019,HF,0,0
49020,disease,0,0
49021,management,0,1
49022,.,0,0
49023,While,0,0
49024,not,0,0
49025,all,0,0
49026,results,0,0
49027,were,0,0
49028,statistically,0,0
49029,significant,0,0
49030,at,0,0
49031,conventional,0,1
49032,levels,0,0
49033,",",0,0
49034,intervention,0,1
49035,effects,0,0
49036,were,0,0
49037,positive,0,0
49038,in,0,0
49039,virtually,0,0
49040,all,0,0
49041,cases,0,0
49042,and,0,0
49043,effect,0,0
49044,magnitudes,0,0
49045,frequently,0,0
49046,were,0,0
49047,large,0,0
49048,.,0,0
49049,CONCLUSIONS,0,0
49050,The,0,0
49051,results,0,0
49052,of,0,0
49053,this,0,0
49054,randomized,0,0
49055,trial,0,0
49056,strongly,0,0
49057,support,0,0
49058,the,0,0
49059,efficacy,0,0
49060,of,0,0
49061,just-in-time,0,0
49062,evidence-based,0,0
49063,reminders,0,1
49064,as,0,0
49065,a,0,0
49066,means,0,0
49067,of,0,0
49068,changing,0,0
49069,clinical,0,0
49070,practice,0,1
49071,among,0,0
49072,home,0,1
49073,health,0,0
49074,nurses,0,0
49075,who,0,0
49076,are,0,0
49077,geographically,0,0
49078,dispersed,0,0
49079,and,0,0
49080,spend,0,0
49081,much,0,0
49082,of,0,0
49083,their,0,0
49084,time,0,0
49085,in,0,0
49086,the,0,0
49087,field,0,0
49088,.,0,0
49089,Inhibition,0,0
49090,of,0,0
49091,awake,0,1
49092,sympathetic,0,1
49093,nerve,0,1
49094,activity,0,0
49095,of,0,0
49096,heart,0,0
49097,failure,0,0
49098,patients,0,0
49099,with,0,0
49100,obstructive,0,0
49101,sleep,0,0
49102,apnea,0,0
49103,by,0,0
49104,nocturnal,1,0
49105,continuous,1,1
49106,positive,1,0
49107,airway,1,0
49108,pressure,1,0
49109,.,1,0
49110,OBJECTIVES,0,0
49111,This,0,0
49112,study,0,0
49113,was,0,0
49114,designed,0,0
49115,to,0,0
49116,determine,0,0
49117,whether,0,0
49118,reductions,0,0
49119,in,0,0
49120,morning,0,0
49121,systolic,0,0
49122,blood,0,0
49123,pressure,0,0
49124,(,0,1
49125,BP,0,0
49126,),0,1
49127,elicited,0,0
49128,by,0,0
49129,treatment,0,0
49130,of,0,0
49131,moderate,0,0
49132,to,0,0
49133,severe,0,0
49134,obstructive,0,0
49135,sleep,0,1
49136,apnea,0,0
49137,(,0,1
49138,OSA,0,0
49139,),0,1
49140,in,0,0
49141,heart,0,0
49142,failure,0,0
49143,(,0,1
49144,HF,0,0
49145,),0,1
49146,patients,0,0
49147,are,0,0
49148,associated,0,0
49149,with,0,0
49150,a,0,0
49151,reduction,0,0
49152,in,0,0
49153,sympathetic,0,1
49154,vasoconstrictor,0,0
49155,tone,0,0
49156,.,0,0
49157,BACKGROUND,0,0
49158,Daytime,0,0
49159,muscle,0,0
49160,sympathetic,0,1
49161,nerve,0,1
49162,activity,0,0
49163,(,0,1
49164,MSNA,0,1
49165,),0,1
49166,is,0,0
49167,elevated,0,0
49168,in,0,0
49169,HF,0,0
49170,patients,0,0
49171,with,0,0
49172,coexisting,0,0
49173,OSA,0,0
49174,.,0,0
49175,In,0,0
49176,our,0,0
49177,recent,0,0
49178,randomized,0,0
49179,trial,0,0
49180,in,0,0
49181,HF,0,0
49182,",",0,0
49183,abolition,0,0
49184,of,0,0
49185,OSA,0,0
49186,by,0,0
49187,continuous,1,1
49188,positive,1,0
49189,airway,1,1
49190,pressure,1,0
49191,(,1,1
49192,CPAP,1,1
49193,),1,1
49194,increased,0,0
49195,left,0,0
49196,ventricular,0,0
49197,ejection,0,0
49198,fraction,0,1
49199,(,0,1
49200,LVEF,0,1
49201,),0,1
49202,and,0,0
49203,lowered,0,0
49204,morning,0,0
49205,systolic,0,0
49206,BP,0,0
49207,.,0,0
49208,METHODS,0,0
49209,Muscle,1,0
49210,sympathetic,1,1
49211,nerve,1,1
49212,activity,1,0
49213,",",1,0
49214,BP,1,0
49215,",",1,0
49216,and,1,0
49217,heart,1,0
49218,rate,1,0
49219,(,1,1
49220,HR,1,0
49221,),1,1
49222,of,1,0
49223,medically,1,0
49224,treated,1,0
49225,HF,1,0
49226,patients,1,0
49227,(,1,0
49228,EF,1,0
49229,<,1,0
49230,45,1,0
49231,%,1,0
49232,),1,0
49233,and,1,1
49234,OSA,1,1
49235,(,1,1
49236,apnea-hypopnea,1,0
49237,index,1,0
49238,>,1,0
49239,or,1,0
49240,=20/h,1,0
49241,of,1,0
49242,sleep,1,0
49243,),1,0
49244,were,1,0
49245,recorded,1,0
49246,on,1,0
49247,the,1,0
49248,morning,1,0
49249,after,1,0
49250,overnight,1,1
49251,polysomnography,1,1
49252,",",1,0
49253,and,1,0
49254,again,1,0
49255,one,1,0
49256,month,1,0
49257,after,1,0
49258,patients,1,0
49259,were,1,0
49260,randomly,1,0
49261,allocated,1,0
49262,nocturnal,1,0
49263,CPAP,1,1
49264,treatment,1,1
49265,or,1,1
49266,no,1,0
49267,CPAP,1,1
49268,(,1,1
49269,control,1,1
49270,),1,0
49271,.,0,0
49272,RESULTS,0,0
49273,In,0,0
49274,nine,0,0
49275,control,0,0
49276,patients,0,0
49277,",",0,0
49278,there,0,0
49279,were,0,0
49280,no,0,0
49281,significant,0,0
49282,changes,0,0
49283,in,0,0
49284,the,0,0
49285,severity,0,0
49286,of,0,0
49287,OSA,0,0
49288,",",0,0
49289,MSNA,0,0
49290,",",0,0
49291,systolic,0,0
49292,BP,0,0
49293,",",0,0
49294,or,0,0
49295,HR,0,0
49296,.,0,0
49297,In,0,0
49298,contrast,0,0
49299,",",0,0
49300,in,0,0
49301,the,0,0
49302,8,0,0
49303,CPAP-treated,1,0
49304,patients,0,0
49305,",",0,0
49306,OSA,0,0
49307,was,0,0
49308,attenuated,0,0
49309,",",0,0
49310,and,0,0
49311,there,0,0
49312,were,0,0
49313,significant,0,0
49314,reductions,0,0
49315,in,0,0
49316,daytime,0,0
49317,MSNA,0,1
49318,(,0,0
49319,from,0,0
49320,58,0,0
49321,+/-,0,0
49322,4,0,0
49323,bursts/min,0,0
49324,to,0,0
49325,48,0,0
49326,+/-,0,0
49327,5,0,0
49328,bursts/min,0,0
49329,;,0,0
49330,84,0,0
49331,+/-,0,0
49332,4,0,0
49333,bursts/100,0,0
49334,heart,0,0
49335,beats,0,1
49336,to,0,0
49337,72,0,0
49338,+/-,0,0
49339,5,0,0
49340,bursts/100,0,0
49341,heart,0,0
49342,beats,0,1
49343,;,0,0
49344,p,0,0
49345,<,0,0
49346,0.001,0,0
49347,and,0,0
49348,p,0,0
49349,=,0,0
49350,0.003,0,0
49351,",",0,0
49352,respectively,0,0
49353,),0,0
49354,",",0,0
49355,systolic,0,0
49356,BP,0,0
49357,(,0,0
49358,from,0,0
49359,135,0,0
49360,+/-,0,0
49361,5,0,0
49362,mm,0,0
49363,Hg,0,0
49364,to,0,0
49365,120,0,0
49366,+/-,0,0
49367,6,0,0
49368,mm,0,0
49369,Hg,0,0
49370,",",0,0
49371,p,0,0
49372,=,0,0
49373,0.03,0,0
49374,),0,0
49375,",",0,0
49376,and,0,0
49377,HR,0,0
49378,(,0,0
49379,from,0,0
49380,69,0,0
49381,+/-,0,0
49382,2,0,0
49383,min,0,0
49384,(,0,1
49385,-1,0,0
49386,),0,1
49387,to,0,0
49388,66,0,0
49389,+/-,0,0
49390,2,0,0
49391,min,0,0
49392,(,0,1
49393,-1,0,0
49394,),0,1
49395,;,0,0
49396,p,0,0
49397,=,0,0
49398,0.013,0,0
49399,),0,0
49400,.,0,0
49401,CONCLUSIONS,0,0
49402,Treatment,0,0
49403,of,0,0
49404,coexisting,0,0
49405,OSA,0,0
49406,by,0,0
49407,CPAP,1,0
49408,in,0,0
49409,HF,0,0
49410,patients,0,0
49411,lowers,0,0
49412,daytime,0,0
49413,MSNA,0,0
49414,",",0,0
49415,systolic,0,0
49416,BP,0,0
49417,",",0,0
49418,and,0,0
49419,HR,0,0
49420,.,0,0
49421,Inhibition,0,0
49422,of,0,0
49423,increased,0,0
49424,central,0,0
49425,sympathetic,0,1
49426,vasoconstrictor,0,0
49427,outflow,0,0
49428,is,0,0
49429,one,0,0
49430,mechanism,0,0
49431,by,0,0
49432,which,0,0
49433,nocturnal,1,0
49434,CPAP,1,1
49435,reduces,0,0
49436,awake,0,1
49437,BP,0,0
49438,in,0,0
49439,HF,0,0
49440,patients,0,0
49441,with,0,0
49442,moderate,0,0
49443,to,0,0
49444,severe,0,0
49445,OSA,0,0
49446,.,0,0
49447,Montelukast,1,1
49448,treatment,1,0
49449,of,0,0
49450,moderate,0,0
49451,to,0,0
49452,severe,0,0
49453,atopic,0,0
49454,dermatitis,0,0
49455,in,0,0
49456,adults,0,0
49457,:,0,0
49458,a,0,0
49459,randomized,0,0
49460,",",0,0
49461,double-blind,0,0
49462,",",0,0
49463,placebo-controlled,1,1
49464,trial,0,0
49465,.,0,0
49466,In,0,0
49467,a,0,0
49468,randomized,0,0
49469,",",0,0
49470,double-blind,0,0
49471,",",0,0
49472,placebo-controlled,1,1
49473,4-week,0,0
49474,trial,0,0
49475,",",0,0
49476,59,0,0
49477,patients,0,0
49478,with,0,0
49479,moderate,0,0
49480,to,0,0
49481,severe,0,0
49482,atopic,0,0
49483,dermatitis,0,0
49484,were,0,0
49485,treated,0,0
49486,orally,0,1
49487,with,0,0
49488,10,0,0
49489,mg,0,1
49490,of,0,0
49491,the,0,0
49492,leukotriene,1,1
49493,antagonist,1,1
49494,montelukast,1,1
49495,.,1,0
49496,Forty-seven,0,0
49497,patients,0,0
49498,completed,0,0
49499,the,0,0
49500,study,0,0
49501,.,0,0
49502,No,0,0
49503,difference,0,0
49504,in,0,0
49505,efficacy,0,0
49506,was,0,0
49507,seen,0,0
49508,among,0,0
49509,patients,0,0
49510,who,0,0
49511,received,0,1
49512,montelukast,1,1
49513,and,0,0
49514,the,0,0
49515,group,0,0
49516,given,0,0
49517,a,0,0
49518,placebo,1,1
49519,.,1,0
49520,Stapled,1,0
49521,hemorrhoidopexy,1,1
49522,versus,1,1
49523,milligan-morgan,1,1
49524,hemorrhoidectomy,1,1
49525,:,1,0
49526,a,0,0
49527,prospective,0,0
49528,",",0,0
49529,randomized,0,0
49530,",",0,0
49531,multicenter,0,0
49532,trial,0,0
49533,with,0,0
49534,2-year,0,0
49535,postoperative,0,0
49536,follow,0,0
49537,up,0,0
49538,.,0,0
49539,PURPOSE,0,0
49540,The,0,0
49541,purpose,0,0
49542,of,0,0
49543,this,0,0
49544,study,0,0
49545,was,0,0
49546,to,0,0
49547,compare,0,0
49548,the,0,0
49549,outcome,0,0
49550,of,0,0
49551,stapled,1,1
49552,hemorrhoidopexy,1,1
49553,(,1,1
49554,SH,1,1
49555,group,1,1
49556,),1,0
49557,performed,0,0
49558,using,0,0
49559,a,0,0
49560,circular,0,0
49561,stapler,0,1
49562,with,0,0
49563,that,0,0
49564,of,0,0
49565,the,0,0
49566,Milligan-Morgan,1,0
49567,technique,1,1
49568,(,1,1
49569,MM,1,1
49570,group,1,0
49571,),1,0
49572,.,1,0
49573,The,0,0
49574,goals,0,0
49575,of,0,0
49576,the,0,0
49577,study,0,0
49578,were,0,0
49579,to,0,0
49580,evaluate,0,0
49581,the,0,0
49582,efficacy,0,0
49583,and,0,0
49584,reproducibility,0,0
49585,of,0,0
49586,stapled,1,1
49587,hemorrhoidopexy,1,1
49588,and,0,0
49589,define,0,0
49590,its,0,0
49591,place,0,0
49592,among,0,0
49593,conventional,0,1
49594,techniques,0,1
49595,.,0,0
49596,METHODS,0,0
49597,A,0,0
49598,series,0,0
49599,of,0,0
49600,134,0,0
49601,patients,0,0
49602,were,0,0
49603,included,0,0
49604,at,0,0
49605,7,0,0
49606,hospital,0,0
49607,centers,0,0
49608,.,0,0
49609,They,0,0
49610,were,0,0
49611,randomized,0,0
49612,according,0,0
49613,to,0,0
49614,a,0,0
49615,single-masked,0,0
49616,design,0,0
49617,and,0,0
49618,stratified,0,0
49619,by,0,1
49620,center,0,0
49621,(,0,0
49622,with,0,0
49623,balancing,0,0
49624,every,0,1
49625,4,0,0
49626,patients,0,0
49627,),0,0
49628,.,0,0
49629,Patients,0,0
49630,were,0,0
49631,clinically,0,0
49632,evaluated,0,0
49633,preoperatively,0,0
49634,and,0,0
49635,at,0,0
49636,6,0,0
49637,weeks,0,0
49638,",",0,0
49639,1,0,0
49640,year,0,0
49641,",",0,0
49642,and,0,0
49643,a,0,0
49644,minimum,0,0
49645,of,0,0
49646,2,0,0
49647,years,0,0
49648,after,0,0
49649,treatment,0,0
49650,.,0,0
49651,Patients,0,0
49652,completed,0,0
49653,a,0,0
49654,questionnaire,1,0
49655,before,0,0
49656,and,0,0
49657,1,0,0
49658,year,0,0
49659,after,0,0
49660,surgery,0,0
49661,to,0,0
49662,evaluate,0,0
49663,symptoms,0,0
49664,",",0,0
49665,function,0,0
49666,",",0,0
49667,and,0,0
49668,overall,0,0
49669,satisfaction,0,0
49670,.,0,0
49671,RESULTS,0,0
49672,The,0,0
49673,mean,0,0
49674,follow-up,0,0
49675,period,0,0
49676,was,0,0
49677,2.21,0,0
49678,years,0,0
49679,+/-,0,0
49680,0.26,0,0
49681,(,0,0
49682,1.89-3.07,0,0
49683,),0,0
49684,.,0,0
49685,Nine,0,1
49686,patients,0,0
49687,(,0,0
49688,7,0,0
49689,%,0,0
49690,),0,0
49691,could,0,0
49692,not,0,0
49693,be,0,0
49694,monitored,0,0
49695,at,0,0
49696,1,0,0
49697,or,0,0
49698,2,0,0
49699,years,0,0
49700,",",0,0
49701,but,0,0
49702,4,0,0
49703,of,0,0
49704,these,0,0
49705,9,0,0
49706,nevertheless,0,0
49707,filled,0,0
49708,in,0,0
49709,the,0,0
49710,1-year,0,0
49711,questionnaire,0,0
49712,.,0,0
49713,The,0,0
49714,patients,0,0
49715,in,0,0
49716,the,0,0
49717,SH,1,1
49718,group,0,0
49719,experienced,0,0
49720,less,0,0
49721,postoperative,0,0
49722,pain/discomfort,0,0
49723,as,0,0
49724,scored,0,0
49725,by,0,0
49726,pain,0,0
49727,during,0,0
49728,bowel,0,0
49729,movement,0,1
49730,(,0,0
49731,P,0,0
49732,<,0,0
49733,0.001,0,0
49734,),0,0
49735,",",0,0
49736,total,0,0
49737,analgesic,0,1
49738,requirement,0,0
49739,over,0,0
49740,the,0,0
49741,first,0,0
49742,3,0,0
49743,days,0,0
49744,(,0,0
49745,according,0,0
49746,to,0,0
49747,the,0,0
49748,World,0,1
49749,Health,0,1
49750,Organization,0,1
49751,[,0,0
49752,WHO,0,1
49753,],0,1
49754,class,0,0
49755,II,0,0
49756,analgesics,0,1
49757,[,0,0
49758,P,0,0
49759,=,0,0
49760,0.002,0,0
49761,],0,0
49762,;,0,0
49763,class,0,0
49764,III,0,0
49765,[,0,0
49766,P,0,0
49767,=,0,0
49768,0.066,0,0
49769,],0,0
49770,),0,0
49771,",",0,0
49772,and,0,0
49773,per-patient,0,0
49774,consumption,0,1
49775,frequency,0,0
49776,of,0,0
49777,class,0,0
49778,III,0,1
49779,analgesics,0,1
49780,(,0,0
49781,P,0,0
49782,=,0,0
49783,0.089,0,0
49784,),0,0
49785,.,0,0
49786,A,0,0
49787,clear,0,0
49788,difference,0,0
49789,in,0,0
49790,morphine,0,1
49791,requirement,0,0
49792,became,0,0
49793,evident,0,0
49794,after,0,0
49795,24,0,0
49796,hours,0,0
49797,(,0,0
49798,P,0,0
49799,=,0,0
49800,0.010,0,0
49801,),0,0
49802,.,0,0
49803,Hospital,0,0
49804,stay,0,0
49805,was,0,0
49806,significantly,0,0
49807,shorter,0,0
49808,in,0,0
49809,the,0,0
49810,SH,1,1
49811,group,0,0
49812,(,0,0
49813,SH,0,1
49814,2.2,0,0
49815,+/-,0,0
49816,1.2,0,0
49817,[,0,0
49818,0,0,0
49819,;,0,0
49820,5.0,0,0
49821,],0,0
49822,versus,0,1
49823,MM,1,1
49824,3.1,0,0
49825,+/-,0,0
49826,1.7,0,0
49827,[,0,0
49828,1,0,0
49829,;,0,0
49830,8.0,0,0
49831,],0,0
49832,P,0,0
49833,<,0,0
49834,0.001,0,0
49835,),0,0
49836,.,0,0
49837,At,0,0
49838,1,0,0
49839,year,0,0
49840,",",0,0
49841,no,0,0
49842,differences,0,0
49843,in,0,0
49844,the,0,0
49845,resolution,0,0
49846,of,0,0
49847,symptoms,0,0
49848,were,0,0
49849,observed,0,0
49850,between,0,0
49851,the,0,0
49852,2,0,0
49853,groups,0,0
49854,",",0,0
49855,and,0,0
49856,over,0,0
49857,2,0,0
49858,years,0,0
49859,",",0,0
49860,the,0,0
49861,overall,0,0
49862,incidence,0,0
49863,of,0,0
49864,complications,0,0
49865,was,0,0
49866,the,0,0
49867,same,0,0
49868,",",0,0
49869,specifically,0,0
49870,fecaloma,0,0
49871,(,0,0
49872,P,0,0
49873,=,0,0
49874,0.003,0,0
49875,),0,0
49876,in,0,0
49877,the,0,0
49878,MM,1,1
49879,group,0,0
49880,and,0,0
49881,external,0,1
49882,hemorrhoidal,0,1
49883,thrombosis,0,0
49884,(,0,0
49885,P,0,0
49886,=,0,0
49887,0.006,0,0
49888,),0,0
49889,in,0,0
49890,the,0,0
49891,SH,1,1
49892,group,0,0
49893,.,0,0
49894,Impaired,0,0
49895,sphincter,0,0
49896,function,0,0
49897,was,0,0
49898,observed,0,0
49899,at,0,0
49900,1,0,0
49901,year,0,0
49902,with,0,0
49903,no,0,0
49904,significant,0,0
49905,difference,0,0
49906,between,0,0
49907,the,0,0
49908,groups,0,0
49909,for,0,0
49910,urgency,0,0
49911,(,0,0
49912,12,0,1
49913,%,0,0
49914,),0,0
49915,",",0,0
49916,continence,0,0
49917,problems,0,0
49918,(,0,0
49919,10,0,1
49920,%,0,0
49921,),0,0
49922,",",0,0
49923,or,0,1
49924,tenesmus,0,0
49925,(,0,1
49926,3,0,1
49927,%,0,0
49928,),0,0
49929,.,0,0
49930,No,0,0
49931,patient,0,0
49932,needed,0,0
49933,a,0,0
49934,second,0,0
49935,procedure,0,0
49936,for,0,0
49937,recurrence,0,0
49938,within,0,0
49939,2,0,0
49940,years,0,0
49941,",",0,0
49942,although,0,0
49943,partial,0,0
49944,residual,0,0
49945,prolapse,0,0
49946,was,0,0
49947,detected,0,0
49948,in,0,0
49949,4,0,0
49950,SH,1,1
49951,patients,0,0
49952,(,0,0
49953,7.5,0,1
49954,%,0,0
49955,),0,0
49956,versus,0,1
49957,1,0,1
49958,MM,1,1
49959,patient,0,0
49960,(,0,0
49961,1.8,0,0
49962,%,0,0
49963,),0,1
49964,(,0,0
49965,P,0,0
49966,=,0,0
49967,0.194,0,0
49968,),0,0
49969,.,0,0
49970,CONCLUSION,0,0
49971,Stapled,1,0
49972,hemorrhoidopexy,1,1
49973,causes,0,0
49974,significantly,0,0
49975,less,0,0
49976,postoperative,0,0
49977,pain,0,0
49978,.,0,0
49979,The,0,0
49980,technique,0,1
49981,is,0,0
49982,reproducible,0,0
49983,and,0,0
49984,can,0,0
49985,achieve,0,0
49986,comparable,0,0
49987,outcomes,0,0
49988,as,0,0
49989,those,0,0
49990,of,0,0
49991,the,0,0
49992,MM,1,1
49993,technique,0,1
49994,as,0,0
49995,long,0,0
49996,as,0,0
49997,the,0,0
49998,well-described,0,0
49999,steps,0,0
50000,of,0,0
50001,the,0,0
50002,technique,0,1
50003,are,0,0
50004,followed,0,0
50005,.,0,0
50006,Like,0,0
50007,with,0,0
50008,conventional,0,1
50009,surgery,1,0
50010,",",0,0
50011,anorectal,0,0
50012,dysfunction,0,0
50013,can,0,0
50014,occur,0,0
50015,after,0,0
50016,stapled,1,1
50017,hemorrhoidopexy,1,1
50018,in,0,0
50019,some,0,0
50020,patients,0,0
50021,.,0,0
50022,Its,0,0
50023,effectiveness,0,0
50024,in,0,0
50025,relieving,0,0
50026,symptoms,0,0
50027,is,0,0
50028,equivalent,0,0
50029,to,0,0
50030,conventional,0,1
50031,surgery,0,1
50032,",",0,0
50033,and,0,0
50034,the,0,0
50035,number,0,0
50036,of,0,0
50037,hemorrhoidal,0,0
50038,prolapse,0,0
50039,recurrences,0,0
50040,at,0,0
50041,2,0,0
50042,years,0,0
50043,is,0,0
50044,not,0,0
50045,significantly,0,0
50046,different,0,0
50047,.,0,0
50048,Hemorroidopexy,1,1
50049,is,0,0
50050,applicable,0,0
50051,for,0,0
50052,treating,0,0
50053,reducible,0,1
50054,hemorrhoidal,0,0
50055,prolapse,0,0
50056,.,0,0
50057,Simvastatin,1,1
50058,and,0,0
50059,preparation,0,1
50060,of,0,0
50061,polyunsaturated,1,1
50062,phospholipids,1,0
50063,produce,0,0
50064,similar,0,0
50065,changes,0,0
50066,in,0,0
50067,the,0,0
50068,phospholipid,0,0
50069,composition,0,0
50070,of,0,0
50071,high-density,0,0
50072,lipoproteins,0,0
50073,during,0,0
50074,hypercholesterolemia,0,0
50075,.,0,0
50076,We,0,0
50077,studied,0,0
50078,the,0,0
50079,phospholipid,0,0
50080,composition,0,0
50081,of,0,0
50082,high-density,0,0
50083,lipoproteins,0,0
50084,in,0,0
50085,patients,0,0
50086,with,0,0
50087,coronary,0,0
50088,heart,0,0
50089,disease,0,0
50090,and,0,0
50091,hypercholesterolemia,0,0
50092,treated,0,0
50093,with,0,0
50094,simvastatin,1,1
50095,(,1,0
50096,Zocor,1,1
50097,",",0,0
50098,inhibitor,0,1
50099,of,0,0
50100,the,0,0
50101,key,0,0
50102,enzyme,0,0
50103,of,0,0
50104,cholesterol,0,1
50105,synthesis,0,0
50106,),0,1
50107,and,0,0
50108,preparation,0,1
50109,of,0,0
50110,polyunsaturated,0,1
50111,phospholipids,1,0
50112,(,1,0
50113,lipostabil,1,1
50114,forte,1,1
50115,),1,0
50116,.,1,0
50117,Simvastatin,1,1
50118,produced,0,0
50119,a,0,0
50120,hypolipidemic,0,1
50121,effect,0,0
50122,and,0,0
50123,modulates,0,0
50124,the,0,0
50125,phospholipid,0,0
50126,composition,0,0
50127,of,0,0
50128,high-density,0,0
50129,lipoproteins,0,0
50130,(,0,0
50131,similarly,0,0
50132,to,0,0
50133,lipostabil,1,1
50134,forte,1,1
50135,),1,0
50136,.,0,0
50137,These,0,0
50138,changes,0,0
50139,contribute,0,0
50140,to,0,0
50141,functional,0,0
50142,activity,0,0
50143,of,0,0
50144,high-density,0,0
50145,lipoproteins,0,0
50146,in,0,0
50147,the,0,0
50148,reverse,0,1
50149,cholesterol,0,0
50150,transport,0,0
50151,.,0,0
50152,Open,1,1
50153,flap,1,1
50154,debridement,1,1
50155,with,1,0
50156,or,1,1
50157,without,1,1
50158,intentional,1,0
50159,cementum,1,1
50160,removal,1,0
50161,:,1,0
50162,a,0,0
50163,4-month,0,0
50164,follow-up,0,0
50165,.,0,0
50166,OBJECTIVES,0,0
50167,The,0,0
50168,aim,0,0
50169,of,0,0
50170,this,0,0
50171,study,0,0
50172,was,0,0
50173,to,0,0
50174,investigate,0,0
50175,the,0,0
50176,influence,0,0
50177,of,0,0
50178,cementum,1,1
50179,removal,1,0
50180,on,1,0
50181,periodontal,1,0
50182,repair,1,1
50183,.,1,0
50184,MATERIAL,0,0
50185,AND,0,0
50186,METHODS,0,0
50187,Forty,0,0
50188,subjects,0,0
50189,with,0,0
50190,chronic,0,0
50191,periodontitis,0,0
50192,and,0,0
50193,presenting,0,0
50194,",",0,0
50195,at,0,0
50196,least,0,0
50197,",",0,0
50198,two,0,0
50199,proximal,0,0
50200,sites,0,0
50201,in,0,0
50202,anterior,0,0
50203,teeth,0,0
50204,(,0,0
50205,upper,0,0
50206,or,0,1
50207,lower,0,0
50208,),0,0
50209,with,0,0
50210,probing,0,0
50211,depth,0,0
50212,>,0,0
50213,or,0,1
50214,=5,0,0
50215,mm,0,0
50216,were,0,0
50217,selected,0,0
50218,.,0,0
50219,After,0,0
50220,oral,0,1
50221,hygiene,0,0
50222,instructions,0,1
50223,and,0,0
50224,ultrasonic,0,1
50225,supragingival,0,1
50226,instrumentation,0,1
50227,",",0,0
50228,the,0,0
50229,subjects,0,0
50230,were,0,0
50231,randomly,0,0
50232,assigned,0,0
50233,for,0,0
50234,one,0,0
50235,of,0,0
50236,the,0,0
50237,following,0,0
50238,groups,0,0
50239,:,0,0
50240,CIC,1,0
50241,",",1,0
50242,scaled,1,0
50243,with,1,0
50244,Gracey,1,1
50245,curettes,1,1
50246,;,1,0
50247,CIUS,1,1
50248,",",1,0
50249,scaled,1,0
50250,with,1,0
50251,ultrasonic,1,1
50252,device,1,1
50253,;,1,0
50254,CDC,1,1
50255,",",1,0
50256,calculus,1,0
50257,deattachment,1,0
50258,with,1,0
50259,Gracey,1,1
50260,curettes,1,1
50261,and,1,0
50262,brushing,1,1
50263,with,1,0
50264,saline,1,1
50265,solution,1,1
50266,;,1,0
50267,and,1,0
50268,CDUS,1,1
50269,",",1,0
50270,calculus,1,0
50271,deattachment,1,0
50272,with,1,0
50273,ultrasonic,1,1
50274,device,1,1
50275,and,1,0
50276,brushing,1,1
50277,with,1,0
50278,saline,1,1
50279,solution,1,1
50280,.,1,0
50281,Full-thickness,0,0
50282,flaps,0,1
50283,were,0,0
50284,reflected,0,0
50285,and,0,0
50286,the,0,0
50287,instrumentation,0,1
50288,was,0,0
50289,performed,0,0
50290,with,0,0
50291,a,0,0
50292,clinical,0,0
50293,microscope,0,1
50294,.,0,0
50295,Probing,0,0
50296,depth,0,0
50297,(,0,1
50298,PD,0,1
50299,),0,1
50300,",",0,0
50301,relative,0,0
50302,gingival,0,0
50303,margin,0,1
50304,level,0,0
50305,(,0,1
50306,RGML,0,1
50307,),0,1
50308,and,0,0
50309,relative,0,0
50310,attachment,0,0
50311,level,0,0
50312,(,0,1
50313,RAL,0,1
50314,),0,1
50315,were,0,0
50316,registered,0,0
50317,at,0,0
50318,five,0,0
50319,experimental,0,0
50320,periods,0,0
50321,:,0,0
50322,baseline,0,0
50323,and,0,0
50324,30,0,0
50325,",",0,0
50326,60,0,0
50327,",",0,0
50328,90,0,0
50329,and,0,0
50330,120,0,0
50331,days,0,0
50332,postoperative,0,0
50333,.,0,0
50334,RESULTS,0,0
50335,All,0,0
50336,the,0,0
50337,approaches,0,0
50338,were,0,0
50339,able,0,0
50340,to,0,0
50341,markedly,0,0
50342,reduce,0,0
50343,the,0,0
50344,PD,0,0
50345,values,0,0
50346,from,0,0
50347,the,0,0
50348,baseline,0,0
50349,to,0,0
50350,the,0,0
50351,other,0,0
50352,evaluation,0,0
50353,periods,0,0
50354,(,0,0
50355,p,0,0
50356,<,0,0
50357,0.0001,0,0
50358,),0,0
50359,.,0,0
50360,The,0,0
50361,increase,0,0
50362,in,0,0
50363,RGML,0,1
50364,values,0,0
50365,was,0,0
50366,statistically,0,0
50367,significant,0,0
50368,only,0,0
50369,for,0,0
50370,the,0,0
50371,CDUS,1,1
50372,group,0,0
50373,.,0,0
50374,There,0,0
50375,were,0,0
50376,no,0,0
50377,statistically,0,0
50378,significant,0,0
50379,differences,0,0
50380,between,0,0
50381,the,0,0
50382,baseline,0,0
50383,and,0,0
50384,postoperative,0,0
50385,values,0,0
50386,in,0,0
50387,all,0,0
50388,groups,0,0
50389,for,0,0
50390,the,0,0
50391,RAL,0,0
50392,changes,0,0
50393,.,0,0
50394,The,0,0
50395,changes,0,0
50396,in,0,0
50397,RAL,0,0
50398,were,0,0
50399,statistically,0,0
50400,significant,0,0
50401,only,0,0
50402,among,0,0
50403,the,0,0
50404,groups,0,0
50405,CDC,1,1
50406,and,0,0
50407,CDUS,1,1
50408,(,0,1
50409,p,0,0
50410,<,0,0
50411,0.0001,0,0
50412,),0,0
50413,.,0,0
50414,CONCLUSION,0,0
50415,The,0,0
50416,conventional,1,1
50417,scaling,1,0
50418,and,1,0
50419,root,1,1
50420,planing,1,1
50421,and,1,0
50422,the,1,0
50423,calculus,1,0
50424,deattachment,1,0
50425,were,0,0
50426,effective,0,0
50427,in,0,0
50428,reducing,0,0
50429,the,0,0
50430,probing,0,0
50431,depth,0,0
50432,values,0,0
50433,",",0,0
50434,regardless,0,0
50435,of,0,0
50436,the,0,0
50437,instrumentation,0,1
50438,method,0,0
50439,.,0,0
50440,NHS,1,1
50441,Direct,0,0
50442,and,0,0
50443,older,0,0
50444,people,0,0
50445,.,0,0
50446,Topiramate,1,1
50447,improves,0,0
50448,health-related,0,0
50449,quality,0,0
50450,of,0,0
50451,life,0,0
50452,when,0,0
50453,used,0,0
50454,to,0,0
50455,prevent,0,0
50456,migraine,0,0
50457,.,0,0
50458,OBJECTIVE,0,0
50459,To,0,0
50460,assess,0,0
50461,changes,0,0
50462,in,0,0
50463,health-related,0,0
50464,quality,0,0
50465,of,0,0
50466,life,0,0
50467,(,0,1
50468,HRQoL,0,1
50469,),0,1
50470,measures,0,0
50471,among,0,0
50472,patients,0,0
50473,receiving,0,1
50474,topiramate,1,1
50475,(,1,1
50476,TPM,1,1
50477,),1,1
50478,100,0,0
50479,mg/d,0,1
50480,in,0,0
50481,two,0,0
50482,divided,0,0
50483,doses,0,0
50484,for,0,0
50485,migraine,0,0
50486,prevention,0,0
50487,in,0,0
50488,three,0,0
50489,randomized,0,0
50490,",",0,0
50491,double-blind,0,0
50492,",",0,0
50493,placebo-controlled,0,1
50494,",",0,0
50495,26-week,0,0
50496,trials,0,0
50497,with,0,0
50498,similar,0,0
50499,protocols,0,1
50500,and,0,0
50501,study,0,0
50502,populations,0,0
50503,.,0,0
50504,BACKGROUND,0,0
50505,Migraine,0,0
50506,substantially,0,0
50507,impairs,0,0
50508,HRQoL,0,1
50509,and,0,0
50510,work,0,0
50511,productivity,0,0
50512,before,0,0
50513,",",0,0
50514,during,0,0
50515,",",0,0
50516,and,0,0
50517,after,0,0
50518,attacks,0,0
50519,.,0,0
50520,Approximately,0,0
50521,50,0,0
50522,%,0,0
50523,of,0,0
50524,patients,0,0
50525,with,0,0
50526,migraine,0,0
50527,could,0,0
50528,be,0,0
50529,recommended,0,0
50530,for,0,0
50531,preventive,0,0
50532,therapies,0,0
50533,",",0,0
50534,yet,0,0
50535,only,0,0
50536,3,0,0
50537,%,0,0
50538,to,0,0
50539,5,0,0
50540,%,0,0
50541,of,0,0
50542,patients,0,0
50543,receive,0,0
50544,them,0,0
50545,.,0,0
50546,TPM,1,1
50547,is,0,0
50548,an,0,0
50549,effective,0,0
50550,and,0,0
50551,generally,0,0
50552,well-tolerated,0,0
50553,migraine,0,0
50554,prophylactic,0,1
50555,(,0,1
50556,preventive,0,1
50557,),0,1
50558,therapy,0,1
50559,for,0,0
50560,adults,0,0
50561,",",0,0
50562,as,0,0
50563,demonstrated,0,0
50564,in,0,0
50565,several,0,0
50566,randomized,0,0
50567,",",0,0
50568,double-blind,0,0
50569,",",0,0
50570,placebo-controlled,0,1
50571,trials,0,0
50572,.,0,0
50573,The,0,0
50574,most,0,0
50575,common,0,0
50576,adverse,0,0
50577,events,0,0
50578,in,0,0
50579,double-blind,0,0
50580,",",0,0
50581,placebo-controlled,0,1
50582,studies,0,0
50583,of,0,0
50584,TPM,1,1
50585,in,0,0
50586,migraine,0,0
50587,prevention,0,0
50588,are,0,0
50589,paresthesia,0,0
50590,",",0,0
50591,fatigue,0,0
50592,",",0,0
50593,anorexia,0,0
50594,",",0,0
50595,nausea,0,0
50596,",",0,0
50597,taste,0,0
50598,alteration,0,0
50599,",",0,0
50600,and,0,0
50601,diarrhea,0,0
50602,.,0,1
50603,DESIGN,0,0
50604,AND,0,0
50605,METHODS,0,0
50606,The,0,0
50607,Migraine-Specific,0,0
50608,Questionnaire,0,1
50609,(,0,0
50610,MSQ,0,0
50611,",",0,0
50612,version,0,0
50613,2.1,0,0
50614,),0,0
50615,was,0,0
50616,used,0,0
50617,to,0,0
50618,assess,0,0
50619,the,0,0
50620,effect,0,0
50621,of,0,0
50622,TPM,1,1
50623,100,0,0
50624,mg/d,0,0
50625,on,0,0
50626,the,0,0
50627,functionality,0,0
50628,and,0,0
50629,HRQoL,0,1
50630,of,0,0
50631,randomized,0,0
50632,intent-to-treat,0,0
50633,(,0,1
50634,ITT,0,1
50635,),0,1
50636,and,0,0
50637,study-completer,0,0
50638,populations,0,0
50639,pooled,0,0
50640,from,0,0
50641,three,0,0
50642,randomized,0,0
50643,",",0,0
50644,double-blind,0,0
50645,",",0,0
50646,placebo-controlled,0,1
50647,trials,0,0
50648,.,0,0
50649,MSQ,0,0
50650,scores,0,0
50651,(,0,0
50652,0,0,0
50653,to,0,0
50654,100,0,0
50655,",",0,0
50656,higher,0,0
50657,score,0,0
50658,indicates,0,0
50659,better,0,0
50660,functioning,0,0
50661,),0,0
50662,were,0,0
50663,assessed,0,0
50664,for,0,0
50665,the,0,0
50666,following,0,0
50667,three,0,0
50668,domains,0,0
50669,:,0,0
50670,role,0,0
50671,restriction,0,1
50672,(,0,1
50673,examines,0,0
50674,the,0,0
50675,degree,0,0
50676,to,0,0
50677,which,0,0
50678,performance,0,0
50679,of,0,0
50680,daily,0,1
50681,activities,0,0
50682,is,0,0
50683,limited,0,0
50684,by,0,0
50685,migraine,0,0
50686,),0,0
50687,",",0,0
50688,role,0,0
50689,prevention,0,0
50690,(,0,1
50691,examines,0,0
50692,the,0,0
50693,degree,0,0
50694,to,0,0
50695,which,0,0
50696,performance,0,0
50697,of,0,0
50698,daily,0,1
50699,activities,0,0
50700,is,0,0
50701,interrupted,0,1
50702,by,0,0
50703,migraine,0,0
50704,),0,0
50705,",",0,0
50706,and,0,0
50707,emotional,0,0
50708,function,0,0
50709,(,0,0
50710,examines,0,0
50711,feelings,0,0
50712,of,0,0
50713,frustration,0,0
50714,and,0,0
50715,helplessness,0,0
50716,due,0,0
50717,to,0,0
50718,migraine,0,0
50719,),0,0
50720,.,0,0
50721,Between-group,0,0
50722,differences,0,0
50723,from,0,0
50724,baseline,0,0
50725,in,0,0
50726,mean,0,0
50727,MSQ,0,0
50728,domain,0,0
50729,scores,0,0
50730,for,0,0
50731,TPM,1,1
50732,100,0,1
50733,mg/d,0,1
50734,and,0,0
50735,placebo,1,1
50736,were,0,0
50737,compared,0,0
50738,using,0,0
50739,a,0,0
50740,mixed-effects,0,0
50741,model,0,0
50742,with,0,0
50743,piecewise,0,1
50744,linear,0,0
50745,regression,0,0
50746,.,0,0
50747,Effect,0,0
50748,sizes,0,0
50749,were,0,0
50750,calculated,0,0
50751,to,0,0
50752,estimate,0,0
50753,the,0,0
50754,magnitude,0,0
50755,of,0,0
50756,change,0,0
50757,in,0,0
50758,HRQoL,0,1
50759,that,0,0
50760,can,0,0
50761,be,0,0
50762,associated,0,0
50763,with,0,0
50764,TPM,1,1
50765,therapy,1,1
50766,.,1,0
50767,RESULTS,0,0
50768,TPM,1,1
50769,100,0,0
50770,mg/d,0,0
50771,significantly,0,0
50772,improved,0,0
50773,all,0,0
50774,three,0,0
50775,MSQ,0,0
50776,domains,0,0
50777,compared,0,0
50778,with,0,0
50779,placebo,1,1
50780,for,0,0
50781,both,0,0
50782,the,0,0
50783,ITT,0,1
50784,(,1,0
50785,TPM,1,1
50786,",",0,0
50787,n,0,0
50788,=,0,0
50789,372,0,0
50790,;,0,0
50791,placebo,1,1
50792,",",0,0
50793,n,0,0
50794,=,0,0
50795,362,0,0
50796,),0,0
50797,and,0,0
50798,study-completer,0,1
50799,(,0,1
50800,TPM,0,1
50801,",",0,0
50802,n,0,0
50803,=,0,0
50804,220,0,0
50805,;,0,0
50806,placebo,0,1
50807,",",0,0
50808,n,0,0
50809,=,0,0
50810,216,0,0
50811,),0,0
50812,populations,0,0
50813,(,0,0
50814,P,0,0
50815,<,0,0
50816,.001,0,0
50817,for,0,0
50818,all,0,0
50819,three,0,0
50820,domains,0,0
50821,",",0,0
50822,both,0,0
50823,populations,0,0
50824,),0,0
50825,.,0,0
50826,Effect,0,0
50827,sizes,0,0
50828,for,0,0
50829,TPM,1,1
50830,100,0,0
50831,mg/d,0,0
50832,varied,0,0
50833,from,0,0
50834,0.40,0,0
50835,to,0,0
50836,0.78,0,0
50837,",",0,0
50838,indicating,0,0
50839,that,0,0
50840,the,0,0
50841,changes,0,0
50842,in,0,0
50843,MSQ,0,0
50844,scores,0,0
50845,for,0,0
50846,TPM,1,1
50847,100,0,0
50848,mg/d,0,1
50849,were,0,0
50850,moderate,0,0
50851,and,0,0
50852,may,0,0
50853,be,0,0
50854,clinically,0,0
50855,significant,0,0
50856,.,0,0
50857,CONCLUSION,0,0
50858,TPM,1,1
50859,100,0,0
50860,mg/d,0,1
50861,has,0,0
50862,been,0,0
50863,shown,0,0
50864,to,0,0
50865,be,0,0
50866,effective,0,0
50867,in,0,0
50868,the,0,0
50869,prevention,0,0
50870,of,0,0
50871,migraine,0,0
50872,headache,0,0
50873,in,0,0
50874,adults,0,0
50875,.,0,0
50876,As,0,0
50877,the,0,0
50878,MSQ,0,0
50879,results,0,0
50880,from,0,0
50881,the,0,0
50882,three,0,0
50883,randomized,0,0
50884,",",0,0
50885,placebo-controlled,0,1
50886,trials,0,0
50887,indicate,0,0
50888,",",0,0
50889,HRQoL,0,1
50890,is,0,0
50891,significantly,0,0
50892,improved,0,0
50893,for,0,0
50894,up,0,0
50895,to,0,0
50896,6,0,0
50897,months,0,0
50898,following,0,0
50899,initiation,0,0
50900,of,0,0
50901,treatment,0,0
50902,.,0,0
50903,Atomoxetine,1,1
50904,alone,0,1
50905,or,0,1
50906,combined,0,1
50907,with,0,0
50908,fluoxetine,1,1
50909,for,0,0
50910,treating,0,0
50911,ADHD,0,1
50912,with,0,0
50913,comorbid,0,0
50914,depressive,0,0
50915,or,0,1
50916,anxiety,0,0
50917,symptoms,0,0
50918,.,0,0
50919,OBJECTIVE,0,0
50920,Symptoms,0,0
50921,of,0,0
50922,depression,0,0
50923,and,0,0
50924,anxiety,0,0
50925,are,0,0
50926,commonly,0,0
50927,comorbid,0,0
50928,with,0,0
50929,attention-deficit/hyperactivity,0,1
50930,disorder,0,0
50931,(,0,1
50932,ADHD,0,1
50933,),0,0
50934,.,0,0
50935,The,0,0
50936,authors,0,0
50937,assessed,0,0
50938,the,0,0
50939,safety,0,0
50940,and,0,0
50941,effectiveness,0,0
50942,of,0,0
50943,atomoxetine,1,1
50944,monotherapy,0,1
50945,compared,0,0
50946,with,0,0
50947,combined,0,1
50948,atomoxetine/fluoxetine,1,1
50949,therapy,1,1
50950,in,0,0
50951,a,0,0
50952,population,0,0
50953,of,0,0
50954,children,0,0
50955,and,0,0
50956,adolescents,0,0
50957,with,0,0
50958,ADHD,0,1
50959,and,0,0
50960,concurrent,0,1
50961,symptoms,0,0
50962,of,0,0
50963,depression,0,0
50964,or,0,1
50965,anxiety,0,0
50966,.,0,0
50967,METHOD,0,0
50968,Patients,0,0
50969,were,0,0
50970,randomized,0,0
50971,to,0,0
50972,treatment,0,0
50973,with,0,1
50974,fluoxetine,1,1
50975,(,1,0
50976,n,1,0
50977,=,1,0
50978,127,1,0
50979,),1,0
50980,or,1,1
50981,placebo,1,1
50982,(,0,1
50983,n,0,0
50984,=,0,0
50985,46,0,0
50986,),0,0
50987,under,0,0
50988,double-blind,0,0
50989,conditions,0,0
50990,for,0,0
50991,8,0,0
50992,weeks,0,0
50993,",",0,0
50994,with,0,0
50995,concomitant,1,0
50996,atomoxetine,1,1
50997,use,1,0
50998,the,1,0
50999,last,1,0
51000,5,1,0
51001,weeks,1,0
51002,.,1,0
51003,RESULTS,0,0
51004,At,0,0
51005,end,0,0
51006,point,0,0
51007,",",0,0
51008,reductions,0,0
51009,in,0,0
51010,ADHD,0,1
51011,",",0,0
51012,depressive,0,0
51013,",",0,0
51014,and,0,0
51015,anxiety,0,0
51016,symptoms,0,0
51017,were,0,0
51018,marked,0,0
51019,for,0,0
51020,both,0,0
51021,treatment,0,0
51022,groups,0,0
51023,(,0,0
51024,p,0,0
51025,<,0,0
51026,.001,0,0
51027,for,0,0
51028,the,0,0
51029,relevant,0,0
51030,scale,0,0
51031,in,0,0
51032,each,0,0
51033,symptom,0,0
51034,cluster,0,0
51035,),0,0
51036,.,0,0
51037,Some,0,0
51038,differences,0,0
51039,between,0,0
51040,treatment,0,0
51041,groups,0,0
51042,for,0,0
51043,depressive,0,0
51044,symptoms,0,0
51045,were,0,0
51046,significant,0,0
51047,",",0,0
51048,but,0,0
51049,the,0,0
51050,magnitudes,0,0
51051,of,0,0
51052,the,0,0
51053,differences,0,0
51054,were,0,0
51055,small,0,0
51056,and,0,0
51057,likely,0,0
51058,of,0,0
51059,limited,0,0
51060,clinical,0,0
51061,importance,0,0
51062,.,0,0
51063,Completion,0,0
51064,rates,0,0
51065,for,0,0
51066,the,0,0
51067,two,0,0
51068,groups,0,0
51069,were,0,0
51070,similar,0,0
51071,",",0,0
51072,as,0,0
51073,were,0,0
51074,discontinuation,0,0
51075,rates,0,0
51076,for,0,0
51077,adverse,0,0
51078,events,0,0
51079,.,0,0
51080,The,0,0
51081,combination,0,1
51082,group,0,0
51083,had,0,0
51084,greater,0,0
51085,increases,0,0
51086,in,0,0
51087,blood,0,0
51088,pressure,0,0
51089,and,0,0
51090,pulse,0,1
51091,than,0,0
51092,did,0,0
51093,the,0,0
51094,monotherapy,0,1
51095,group,0,0
51096,.,0,0
51097,CONCLUSIONS,0,0
51098,In,0,0
51099,pediatric,0,0
51100,patients,0,0
51101,with,0,0
51102,ADHD,0,1
51103,and,0,0
51104,comorbid,0,0
51105,symptoms,0,0
51106,of,0,0
51107,depression,0,0
51108,or,0,1
51109,anxiety,0,0
51110,",",0,0
51111,atomoxetine,1,1
51112,monotherapy,1,1
51113,appears,0,0
51114,to,0,0
51115,be,0,0
51116,effective,0,0
51117,for,0,0
51118,treating,0,0
51119,ADHD,0,1
51120,.,0,1
51121,Anxiety,0,0
51122,and,0,0
51123,depressive,0,0
51124,symptoms,0,0
51125,also,0,0
51126,improved,0,0
51127,",",0,0
51128,but,0,0
51129,the,0,0
51130,absence,0,0
51131,of,0,0
51132,a,0,0
51133,placebo-only,0,0
51134,arm,0,0
51135,does,0,0
51136,not,0,0
51137,allow,0,0
51138,us,0,0
51139,to,0,0
51140,conclude,0,0
51141,that,0,0
51142,these,0,0
51143,effects,0,0
51144,are,0,0
51145,specifically,0,0
51146,the,0,0
51147,result,0,0
51148,of,0,0
51149,treatment,0,0
51150,with,0,0
51151,atomoxetine,1,1
51152,.,1,0
51153,Combined,1,0
51154,atomoxetine/fluoxetine,1,1
51155,therapy,0,1
51156,was,0,0
51157,well,0,0
51158,tolerated,0,0
51159,.,0,0
51160,Clinical,0,0
51161,efficacy,0,0
51162,of,0,0
51163,fluvoxamine,1,1
51164,and,0,0
51165,functional,0,0
51166,polymorphism,0,1
51167,in,0,0
51168,a,0,0
51169,serotonin,0,1
51170,transporter,0,0
51171,gene,0,1
51172,on,0,0
51173,childhood,0,0
51174,autism,0,0
51175,.,0,0
51176,We,0,0
51177,studied,0,0
51178,the,0,0
51179,correlation,0,0
51180,between,0,0
51181,response,0,0
51182,to,0,0
51183,fluvoxamine,1,1
51184,and,0,0
51185,serotonin,0,1
51186,transporter,0,0
51187,gene,0,1
51188,promoter,0,1
51189,region,0,1
51190,polymorphism,0,1
51191,(,0,1
51192,5-HTTLPR,0,0
51193,),0,0
51194,.,0,0
51195,Eighteen,0,0
51196,children,0,0
51197,with,0,0
51198,autistic,0,0
51199,disorder,0,0
51200,completed,0,0
51201,a,0,0
51202,12-week,0,0
51203,double-blind,0,0
51204,",",0,0
51205,placebo-controlled,1,1
51206,",",0,0
51207,randomized,0,0
51208,crossover,0,0
51209,study,0,0
51210,of,0,0
51211,fluvoxamine,1,1
51212,.,1,0
51213,Behavioral,0,0
51214,assessments,0,0
51215,were,0,0
51216,obtained,0,0
51217,before,0,0
51218,and,0,0
51219,at,0,0
51220,12,0,0
51221,weeks,0,0
51222,of,0,0
51223,treatment,0,0
51224,.,0,1
51225,5-HTTLPR,0,0
51226,(,0,0
51227,long,0,1
51228,(,0,1
51229,l,0,1
51230,),0,1
51231,or,0,1
51232,short,0,1
51233,(,0,1
51234,s,0,1
51235,),0,1
51236,),0,0
51237,",",0,0
51238,was,0,0
51239,analyzed,0,0
51240,by,0,0
51241,the,0,0
51242,PCR,1,0
51243,method,1,0
51244,.,1,0
51245,Ten,0,0
51246,out,0,0
51247,of,0,0
51248,18,0,0
51249,patients,0,0
51250,responded,0,0
51251,to,0,0
51252,fluvoxamine,1,1
51253,treatment,0,0
51254,;,0,0
51255,allele,0,0
51256,type,0,0
51257,analysis,0,0
51258,revealed,0,0
51259,that,0,0
51260,clinical,0,0
51261,global,0,0
51262,effectiveness,0,0
51263,was,0,0
51264,noted,0,0
51265,significantly,0,0
51266,more,0,0
51267,in,0,0
51268,the,0,0
51269,l,0,0
51270,allele,0,0
51271,than,0,0
51272,in,0,0
51273,the,0,0
51274,s,0,0
51275,allele,0,0
51276,.,0,0
51277,However,0,0
51278,",",0,0
51279,with,0,0
51280,respect,0,0
51281,to,0,0
51282,language,0,1
51283,use,0,0
51284,",",0,0
51285,a,0,0
51286,significant,0,0
51287,effectiveness,0,0
51288,was,0,0
51289,noted,0,0
51290,in,0,0
51291,the,0,0
51292,s,0,0
51293,allele,0,0
51294,.,0,0
51295,5-HTTLPR,0,0
51296,may,0,0
51297,influence,0,0
51298,the,0,0
51299,individual,0,0
51300,responses,0,0
51301,to,0,0
51302,fluvoxamine,1,1
51303,administration,0,0
51304,.,0,0
51305,Pulse,1,1
51306,versus,1,1
51307,continuous,1,1
51308,terbinafine,1,1
51309,for,0,0
51310,onychomycosis,0,0
51311,:,0,0
51312,a,0,0
51313,randomized,0,0
51314,",",0,0
51315,double-blind,0,0
51316,",",0,0
51317,controlled,0,0
51318,trial,0,0
51319,.,0,0
51320,BACKGROUND,0,0
51321,Effective,0,0
51322,treatments,0,1
51323,for,0,0
51324,onychomycosis,0,0
51325,are,0,0
51326,expensive,0,0
51327,.,0,0
51328,Previous,0,0
51329,studies,0,0
51330,suggest,0,0
51331,that,0,0
51332,less,0,0
51333,costly,0,0
51334,",",0,0
51335,pulsed,0,1
51336,doses,0,0
51337,of,0,0
51338,antifungal,1,1
51339,medications,1,0
51340,may,0,0
51341,be,0,0
51342,as,0,0
51343,effective,0,0
51344,as,0,0
51345,standard,0,1
51346,",",0,0
51347,continuous,0,0
51348,doses,0,0
51349,.,0,0
51350,Terbinafine,0,1
51351,is,0,0
51352,the,0,0
51353,current,0,0
51354,treatment,0,0
51355,of,0,0
51356,choice,0,0
51357,for,0,0
51358,toenail,0,0
51359,onychomycosis,0,0
51360,.,0,0
51361,OBJECTIVE,0,0
51362,Our,0,0
51363,purpose,0,0
51364,was,0,0
51365,to,0,0
51366,determine,0,0
51367,whether,0,0
51368,pulse-dose,1,1
51369,terbinafine,1,1
51370,is,0,0
51371,as,0,0
51372,effective,0,0
51373,as,0,0
51374,standard,1,1
51375,continuous-dose,1,1
51376,terbinafine,1,1
51377,for,0,0
51378,treatment,0,0
51379,of,0,0
51380,toenail,0,0
51381,onychomycosis,0,0
51382,.,0,0
51383,METHODS,0,0
51384,We,0,0
51385,conducted,0,0
51386,a,0,0
51387,double-blind,0,0
51388,",",0,0
51389,randomized,0,0
51390,",",0,0
51391,noninferiority,0,0
51392,",",0,0
51393,clinical,0,0
51394,intervention,0,1
51395,trial,0,0
51396,in,0,0
51397,the,0,0
51398,Minneapolis,0,0
51399,Veterans,0,0
51400,Affairs,0,0
51401,Medical,0,1
51402,Center,0,0
51403,.,0,0
51404,The,0,0
51405,main,0,0
51406,inclusion,0,0
51407,criteria,0,0
51408,for,0,0
51409,participants,0,0
51410,were,0,0
51411,a,0,0
51412,positive,0,0
51413,dermatophyte,0,0
51414,culture,0,0
51415,and,0,0
51416,at,0,0
51417,least,0,0
51418,25,0,0
51419,%,0,0
51420,distal,0,0
51421,subungual,0,0
51422,clinical,0,0
51423,involvement,0,0
51424,.,0,0
51425,Six,0,0
51426,hundred,0,0
51427,eighteen,0,0
51428,volunteers,0,0
51429,were,0,0
51430,screened,0,0
51431,;,0,0
51432,306,0,0
51433,were,0,0
51434,randomized,0,0
51435,.,0,0
51436,Terbinafine,1,1
51437,",",0,0
51438,250,0,0
51439,mg,0,0
51440,daily,0,0
51441,for,0,0
51442,3,0,0
51443,months,0,0
51444,(,0,0
51445,continuous,0,1
51446,),0,1
51447,or,0,1
51448,terbinafine,1,1
51449,",",0,0
51450,500,0,0
51451,mg,0,0
51452,daily,0,0
51453,for,0,0
51454,1,0,0
51455,week,0,0
51456,per,0,0
51457,month,0,0
51458,for,0,0
51459,3,0,0
51460,months,0,0
51461,(,0,0
51462,pulse,0,1
51463,),0,1
51464,was,0,0
51465,administered,0,0
51466,.,0,0
51467,The,0,0
51468,primary,0,0
51469,outcome,0,0
51470,measure,0,0
51471,was,0,0
51472,mycological,0,0
51473,cure,0,0
51474,of,0,0
51475,the,0,0
51476,target,0,0
51477,toenail,0,0
51478,at,0,0
51479,18,0,0
51480,months,0,0
51481,.,0,0
51482,Secondary,0,0
51483,outcome,0,0
51484,measures,0,0
51485,included,0,0
51486,clinical,0,0
51487,cure,0,0
51488,and,0,1
51489,complete,0,0
51490,(,0,1
51491,clinical,0,0
51492,plus,0,1
51493,mycological,0,0
51494,),0,1
51495,cure,0,0
51496,of,0,0
51497,the,0,0
51498,target,0,0
51499,toenail,0,0
51500,and,0,0
51501,complete,0,0
51502,cure,0,0
51503,of,0,0
51504,all,0,0
51505,10,0,0
51506,toenails,0,0
51507,.,0,0
51508,RESULTS,0,0
51509,Results,0,0
51510,of,0,0
51511,an,0,0
51512,intent-to-treat,0,0
51513,analysis,0,0
51514,did,0,0
51515,not,0,0
51516,meet,0,0
51517,the,0,0
51518,prespecified,0,0
51519,criterion,0,0
51520,for,0,0
51521,noninferiority,0,0
51522,but,0,0
51523,did,0,0
51524,demonstrate,0,0
51525,the,0,0
51526,superiority,0,0
51527,of,0,0
51528,continuous-dose,1,1
51529,terbinafine,1,1
51530,for,0,0
51531,:,0,0
51532,mycological,0,0
51533,cure,0,0
51534,of,0,0
51535,the,0,0
51536,target,0,0
51537,toenail,0,0
51538,(,0,0
51539,70.9,0,0
51540,%,0,0
51541,[,0,0
51542,105/148,0,0
51543,],0,0
51544,vs,0,0
51545,58.7,0,0
51546,%,0,0
51547,[,0,0
51548,84/143,0,0
51549,],0,0
51550,;,0,0
51551,P,0,0
51552,=.03,0,0
51553,",",0,0
51554,relative,0,0
51555,risk,0,0
51556,[,0,0
51557,RR,0,1
51558,],0,0
51559,of,0,0
51560,1.21,0,0
51561,[,0,0
51562,95,0,0
51563,%,0,0
51564,confidence,0,0
51565,interval,0,0
51566,(,0,1
51567,CI,0,0
51568,),0,1
51569,",",0,0
51570,1.02-1.43,0,0
51571,],0,0
51572,),0,0
51573,;,0,0
51574,clinical,0,0
51575,cure,0,0
51576,of,0,0
51577,the,0,0
51578,target,0,0
51579,toenail,0,0
51580,(,0,0
51581,44.6,0,0
51582,%,0,0
51583,[,0,0
51584,66/148,0,0
51585,],0,0
51586,vs,0,0
51587,29.3,0,0
51588,%,0,0
51589,[,0,0
51590,42/143,0,0
51591,],0,0
51592,;,0,0
51593,P,0,0
51594,=.007,0,0
51595,",",0,0
51596,RR,0,0
51597,=1.52,0,0
51598,[,0,0
51599,95,0,0
51600,%,0,0
51601,CI,0,0
51602,",",0,0
51603,1.11-2.07,0,0
51604,),0,0
51605,;,0,0
51606,complete,0,0
51607,cure,0,0
51608,of,0,0
51609,the,0,0
51610,target,0,0
51611,toenail,0,0
51612,(,0,0
51613,40.5,0,0
51614,%,0,0
51615,[,0,0
51616,60/148,0,0
51617,],0,0
51618,vs,0,0
51619,28.0,0,0
51620,%,0,0
51621,[,0,0
51622,40/143,0,0
51623,],0,0
51624,;,0,0
51625,P,0,0
51626,=.02,0,0
51627,",",0,0
51628,RR=1.45,0,0
51629,[,0,0
51630,95,0,0
51631,%,0,0
51632,CI,0,0
51633,",",0,0
51634,1.04-2.01,0,0
51635,),0,0
51636,;,0,0
51637,and,0,0
51638,complete,0,0
51639,cure,0,0
51640,of,0,0
51641,all,0,0
51642,10,0,0
51643,toenails,0,0
51644,(,0,0
51645,25.2,0,0
51646,%,0,0
51647,[,0,0
51648,36/143,0,0
51649,],0,0
51650,vs,0,0
51651,14.7,0,0
51652,%,0,0
51653,[,0,0
51654,21/143,0,0
51655,],0,0
51656,;,0,0
51657,P,0,0
51658,=.03,0,0
51659,",",0,0
51660,RR,0,0
51661,=1.71,0,0
51662,[,0,0
51663,95,0,0
51664,%,0,0
51665,CI,0,0
51666,",",0,0
51667,1.05-2.79,0,0
51668,),0,0
51669,.,0,0
51670,Tolerability,0,0
51671,of,0,0
51672,the,0,0
51673,regimens,0,1
51674,did,0,0
51675,not,0,0
51676,differ,0,0
51677,significantly,0,0
51678,between,0,0
51679,the,0,0
51680,groups,0,0
51681,(,0,0
51682,chi2,0,0
51683,=1.63,0,0
51684,;,0,0
51685,P,0,0
51686,=.65,0,0
51687,),0,0
51688,.,0,0
51689,LIMITATIONS,0,0
51690,The,0,0
51691,study,0,0
51692,population,0,0
51693,primarily,0,0
51694,consisted,0,0
51695,of,0,0
51696,older,0,0
51697,men,0,0
51698,with,0,0
51699,severe,0,0
51700,onychomycosis,0,0
51701,.,0,0
51702,CONCLUSIONS,0,0
51703,This,0,0
51704,study,0,0
51705,demonstrated,0,0
51706,the,0,0
51707,superiority,0,0
51708,of,0,0
51709,continuous-,0,1
51710,over,0,0
51711,pulse-dose,1,1
51712,terbinafine,1,1
51713,.,1,0
51714,We,0,0
51715,also,0,0
51716,found,0,0
51717,this,0,0
51718,expensive,0,0
51719,therapy,0,1
51720,to,0,0
51721,be,0,0
51722,much,0,0
51723,less,0,0
51724,effective,0,0
51725,than,0,0
51726,previously,0,0
51727,believed,0,0
51728,",",0,0
51729,particularly,0,0
51730,for,0,0
51731,achieving,0,0
51732,complete,0,0
51733,cure,0,0
51734,of,0,0
51735,all,0,0
51736,10,0,0
51737,toenails,0,0
51738,.,0,0
51739,Addition,0,1
51740,of,0,0
51741,fexofenadine,1,1
51742,to,0,0
51743,inhaled,1,1
51744,corticosteroid,1,1
51745,therapy,1,1
51746,to,0,0
51747,reduce,0,0
51748,inflammatory,0,0
51749,biomarkers,0,0
51750,in,0,0
51751,atopic,0,0
51752,asthma,0,0
51753,.,0,0
51754,BACKGROUND,0,0
51755,We,0,0
51756,previously,0,0
51757,showed,0,0
51758,that,0,0
51759,H1-antihistamines,0,1
51760,may,0,0
51761,shift,0,0
51762,the,0,0
51763,PC20,0,1
51764,(,0,1
51765,provocation,0,0
51766,concentration,0,0
51767,that,0,0
51768,caused,0,0
51769,a,0,0
51770,decrease,0,0
51771,in,0,0
51772,forced,0,1
51773,expiratory,0,0
51774,volume,0,0
51775,in,0,0
51776,1,0,0
51777,second,0,0
51778,of,0,0
51779,20,0,0
51780,%,0,0
51781,),0,0
51782,threshold,0,0
51783,to,0,0
51784,adenosine,0,1
51785,monophosphate,0,1
51786,(,0,1
51787,AMP,0,1
51788,),0,1
51789,challenge,0,0
51790,but,0,0
51791,may,0,0
51792,paradoxically,0,0
51793,prolong,0,0
51794,recovery,0,0
51795,.,0,0
51796,OBJECTIVES,0,0
51797,To,0,0
51798,measure,0,0
51799,AMP,0,1
51800,recovery,0,0
51801,using,0,0
51802,a,0,0
51803,constant,0,0
51804,predetermined,0,0
51805,AMP,0,1
51806,PC20,0,1
51807,and,0,0
51808,to,0,0
51809,evaluate,0,0
51810,whether,0,0
51811,fexofenadine,1,1
51812,use,0,0
51813,confers,0,0
51814,add-on,0,1
51815,effects,0,0
51816,to,0,0
51817,treatment,0,0
51818,with,0,0
51819,either,0,1
51820,fluticasone,1,1
51821,propionate,1,1
51822,alone,0,1
51823,or,0,1
51824,combined,1,1
51825,fluticasone,1,1
51826,propionate-salmeterol,1,1
51827,.,1,0
51828,METHODS,0,0
51829,Fourteen,0,0
51830,atopic,0,0
51831,patients,0,0
51832,with,0,0
51833,mild-to-moderate,0,0
51834,asthma,0,0
51835,(,0,1
51836,forced,0,1
51837,expiratory,0,0
51838,volume,0,0
51839,in,0,0
51840,1,0,0
51841,second,0,0
51842,of,0,0
51843,76,0,0
51844,%,0,0
51845,),0,0
51846,completed,0,0
51847,a,0,0
51848,double-blind,0,0
51849,",",0,0
51850,randomized,0,0
51851,",",0,0
51852,crossover,0,0
51853,study,0,0
51854,consisting,0,0
51855,of,0,0
51856,3-week,0,1
51857,treatment,0,0
51858,blocks,0,1
51859,of,0,0
51860,either,0,0
51861,fluticasone,1,1
51862,propionate-salmeterol,1,1
51863,",",0,0
51864,250,0,1
51865,microg,0,0
51866,twice,0,1
51867,daily,0,1
51868,",",0,0
51869,or,0,1
51870,fluticasone,1,1
51871,propionate,1,1
51872,alone,1,1
51873,",",0,0
51874,250,0,1
51875,microg,0,0
51876,twice,0,1
51877,daily,0,0
51878,",",0,0
51879,in,0,0
51880,conjunction,0,1
51881,with,0,0
51882,either,0,1
51883,fexofenadine,1,1
51884,",",0,0
51885,180,0,0
51886,mg,0,1
51887,once,0,1
51888,daily,0,1
51889,",",0,0
51890,or,0,1
51891,matched,0,0
51892,placebo,1,1
51893,.,1,0
51894,Recovery,0,0
51895,after,0,0
51896,a,0,0
51897,predetermined,0,0
51898,AMP,0,1
51899,PC20,0,1
51900,challenge,0,0
51901,was,0,0
51902,measured,0,0
51903,(,0,0
51904,primary,0,0
51905,outcome,0,0
51906,),0,0
51907,",",0,0
51908,along,0,0
51909,with,0,0
51910,exhaled,0,0
51911,nitric,0,1
51912,oxide,0,0
51913,levels,0,0
51914,",",0,0
51915,plasma,0,0
51916,eosinophil,0,0
51917,cationic,0,1
51918,protein,0,1
51919,levels,0,0
51920,",",0,0
51921,peripheral,0,0
51922,eosinophil,0,0
51923,counts,0,0
51924,",",0,0
51925,pulmonary,0,0
51926,function,0,0
51927,",",0,0
51928,diary,0,1
51929,card,0,1
51930,outcomes,0,0
51931,",",0,0
51932,and,0,0
51933,quality,0,0
51934,of,0,0
51935,life,0,0
51936,(,0,0
51937,all,0,0
51938,secondary,0,0
51939,outcomes,0,0
51940,),0,0
51941,.,0,0
51942,RESULTS,0,0
51943,There,0,0
51944,were,0,0
51945,no,0,0
51946,differences,0,0
51947,in,0,0
51948,any,0,0
51949,of,0,0
51950,the,0,0
51951,primary,0,0
51952,or,0,1
51953,secondary,0,0
51954,outcomes,0,0
51955,when,0,0
51956,fexofenadine,1,1
51957,was,0,0
51958,added,0,0
51959,to,0,0
51960,treatment,0,0
51961,with,0,0
51962,either,0,1
51963,fluticasone,1,1
51964,propionate-salmeterol,1,1
51965,or,1,1
51966,fluticasone,1,1
51967,propionate,1,1
51968,alone,0,1
51969,.,0,0
51970,The,0,0
51971,mean,0,0
51972,AMP,0,1
51973,recovery,0,0
51974,time,0,0
51975,was,0,0
51976,25.0,0,0
51977,vs,0,0
51978,23.4,0,0
51979,minutes,0,0
51980,for,0,0
51981,fexofenadine,1,1
51982,and,0,0
51983,placebo,1,1
51984,",",0,0
51985,respectively,0,0
51986,",",0,0
51987,as,0,0
51988,add-on,0,1
51989,to,0,0
51990,fluticasone-salmeterol,1,1
51991,and,0,0
51992,22.5,0,0
51993,vs,0,0
51994,23.9,0,0
51995,minutes,0,0
51996,",",0,0
51997,respectively,0,0
51998,",",0,0
51999,as,0,0
52000,add-on,0,1
52001,to,0,0
52002,fluticasone,1,1
52003,alone,0,1
52004,.,0,0
52005,CONCLUSION,0,0
52006,Fexofenadine,1,1
52007,did,0,0
52008,not,0,0
52009,affect,0,0
52010,recovery,0,0
52011,to,0,0
52012,a,0,0
52013,fixed,0,1
52014,dose,0,0
52015,of,0,0
52016,AMP,0,1
52017,challenge,0,0
52018,or,0,1
52019,any,0,0
52020,other,0,0
52021,surrogate,0,0
52022,inflammatory,0,0
52023,markers,0,0
52024,when,0,0
52025,given,0,0
52026,as,0,0
52027,add-on,0,1
52028,therapy,0,1
52029,to,0,0
52030,corticosteroid-treatedatopic,0,0
52031,asthmatic,0,0
52032,patients,0,0
52033,.,0,0
52034,[,0,0
52035,Study,0,0
52036,on,0,0
52037,classification,0,0
52038,and,0,0
52039,treatment,0,0
52040,of,0,0
52041,vulvovaginal,0,0
52042,candidiasis,0,0
52043,],0,0
52044,.,0,0
52045,OBJECTIVE,0,0
52046,To,0,0
52047,determine,0,0
52048,the,0,0
52049,clinical,0,0
52050,manifestations,0,0
52051,of,0,0
52052,vulvovaginal,0,0
52053,candidiasis,0,0
52054,(,0,1
52055,VVC,0,1
52056,),0,1
52057,and,0,0
52058,to,0,0
52059,study,0,0
52060,the,0,0
52061,mycologic,0,0
52062,eradication,0,0
52063,rate,0,0
52064,of,0,0
52065,different,0,0
52066,miconazole,1,1
52067,treatment,0,0
52068,courses,0,1
52069,for,0,0
52070,VVC,0,1
52071,.,0,0
52072,METHODS,0,0
52073,Three,0,0
52074,hundred,0,0
52075,cases,0,0
52076,of,0,0
52077,VVC,0,1
52078,were,0,0
52079,recruited,0,0
52080,.,0,0
52081,The,0,0
52082,Candidas,0,0
52083,were,0,0
52084,cultured,0,0
52085,.,0,0
52086,A,0,0
52087,prospective,0,0
52088,and,0,0
52089,randomized,0,0
52090,study,0,0
52091,was,0,0
52092,performed,0,0
52093,to,0,0
52094,compare,0,0
52095,the,0,0
52096,treatment,0,0
52097,effect,0,0
52098,of,0,0
52099,3,1,0
52100,day,1,1
52101,miconazole,1,1
52102,(,0,0
52103,400,0,1
52104,mg/d,0,1
52105,),0,0
52106,",",0,0
52107,6,1,0
52108,day,1,1
52109,miconazole,1,1
52110,(,0,0
52111,400,0,1
52112,mg/d,0,1
52113,),0,0
52114,",",0,0
52115,and,0,0
52116,7,1,0
52117,day,1,1
52118,miconazole,1,1
52119,(,0,0
52120,200,0,1
52121,mg/d,0,1
52122,),0,0
52123,for,0,0
52124,uncomplicated,0,0
52125,and,0,0
52126,complicated,0,0
52127,VVC,0,1
52128,.,0,0
52129,RESULTS,0,0
52130,Among,0,0
52131,300,0,1
52132,cases,0,0
52133,of,0,0
52134,VVC,0,1
52135,",",0,0
52136,uncomplicated,0,0
52137,",",0,0
52138,complicated,0,0
52139,and,0,0
52140,recurrent,0,0
52141,VVC,0,1
52142,were,0,0
52143,56.0,0,0
52144,%,0,0
52145,",",0,0
52146,44.0,0,0
52147,%,0,0
52148,and,0,0
52149,9.7,0,0
52150,%,0,0
52151,(,0,0
52152,29/300,0,0
52153,),0,0
52154,respectively,0,0
52155,.,0,0
52156,C.,0,0
52157,albicans,0,0
52158,was,0,0
52159,isolated,0,0
52160,most,0,0
52161,frequently,0,0
52162,90.3,0,0
52163,%,0,0
52164,(,0,0
52165,271/300,0,0
52166,),0,0
52167,",",0,0
52168,followed,0,1
52169,by,0,0
52170,C.,0,1
52171,glabrata,0,0
52172,(,0,0
52173,7.3,0,0
52174,%,0,0
52175,),0,0
52176,",",0,0
52177,C.,0,1
52178,tropicalis,0,0
52179,(,0,0
52180,1.3,0,0
52181,%,0,0
52182,),0,0
52183,",",0,0
52184,C.,0,1
52185,krusei,0,1
52186,(,0,0
52187,0.7,0,0
52188,%,0,0
52189,),0,0
52190,",",0,0
52191,and,0,0
52192,C.,0,1
52193,parapsilosis,0,1
52194,(,0,0
52195,0.3,0,1
52196,%,0,0
52197,),0,0
52198,.,0,0
52199,Mycologic,0,0
52200,eradication,0,0
52201,rate,0,0
52202,of,0,0
52203,3,0,0
52204,day,0,0
52205,",",0,0
52206,6,0,0
52207,day,0,0
52208,and,0,0
52209,7,0,0
52210,day,0,1
52211,miconazole,1,1
52212,courses,0,1
52213,for,0,0
52214,uncomplicated,0,0
52215,VVC,0,1
52216,at,0,0
52217,day,0,0
52218,14,0,0
52219,was,0,0
52220,96.0,0,0
52221,%,0,0
52222,",",0,0
52223,93.5,0,0
52224,%,0,0
52225,and,0,0
52226,98.0,0,0
52227,%,0,0
52228,",",0,0
52229,respectively,0,0
52230,(,0,0
52231,P,0,0
52232,>,0,0
52233,0.05,0,0
52234,),0,0
52235,.,0,0
52236,Eradication,0,0
52237,rate,0,0
52238,of,0,0
52239,3,0,0
52240,day,0,0
52241,",",0,0
52242,6,0,0
52243,day,0,0
52244,and,0,0
52245,7,0,0
52246,day,0,1
52247,miconazole,1,1
52248,courses,0,1
52249,for,0,0
52250,complicated,0,0
52251,VVC,0,1
52252,at,0,0
52253,day,0,0
52254,14,0,0
52255,was,0,0
52256,86.7,0,0
52257,%,0,0
52258,",",0,0
52259,92.5,0,0
52260,%,0,0
52261,",",0,0
52262,and,0,0
52263,86.4,0,0
52264,%,0,0
52265,",",0,0
52266,respectively,0,0
52267,(,0,0
52268,P,0,0
52269,>,0,0
52270,0.05,0,0
52271,),0,0
52272,.,0,0
52273,Eradication,0,0
52274,rate,0,0
52275,of,0,0
52276,3,0,0
52277,day,0,0
52278,",",0,0
52279,6,0,0
52280,day,0,0
52281,and,0,0
52282,7,0,0
52283,day,0,1
52284,miconazole,1,1
52285,courses,0,1
52286,for,0,0
52287,uncomplicated,0,0
52288,VVC,0,1
52289,at,0,0
52290,day,0,0
52291,35,0,0
52292,was,0,0
52293,93.8,0,0
52294,%,0,0
52295,",",0,0
52296,95.3,0,0
52297,%,0,0
52298,",",0,0
52299,and,0,0
52300,89.8,0,0
52301,%,0,0
52302,",",0,0
52303,respectively,0,0
52304,(,0,0
52305,P,0,0
52306,>,0,0
52307,0.05,0,0
52308,),0,0
52309,.,0,0
52310,Eradication,0,0
52311,rate,0,0
52312,of,0,0
52313,3,0,0
52314,day,0,0
52315,",",0,0
52316,6,0,0
52317,day,0,0
52318,and,0,0
52319,7,0,0
52320,day,0,1
52321,miconazole,1,1
52322,courses,0,1
52323,for,0,0
52324,complicated,0,0
52325,VVC,0,1
52326,at,0,0
52327,day,0,0
52328,35,0,0
52329,was,0,0
52330,89.7,0,0
52331,%,0,0
52332,",",0,0
52333,97.3,0,0
52334,%,0,0
52335,and,0,0
52336,86.8,0,0
52337,%,0,0
52338,",",0,0
52339,respectively,0,0
52340,(,0,0
52341,P,0,0
52342,>,0,0
52343,0.05,0,0
52344,),0,0
52345,.,0,0
52346,CONCLUSION,0,0
52347,Treatment,0,0
52348,of,0,0
52349,VVC,0,1
52350,should,0,0
52351,be,0,0
52352,individualized,0,0
52353,",",0,0
52354,and,0,0
52355,women,0,0
52356,with,0,0
52357,complicated,0,0
52358,VVC,0,1
52359,achieve,0,0
52360,superior,0,0
52361,mycologic,0,0
52362,eradication,0,0
52363,by,0,0
52364,a,0,0
52365,6,0,0
52366,day,0,0
52367,miconazole,1,1
52368,course,0,0
52369,.,0,0
52370,Secondary,0,0
52371,prevention,0,0
52372,of,0,0
52373,macrovascular,0,0
52374,events,0,0
52375,in,0,0
52376,patients,0,0
52377,with,0,0
52378,type,0,0
52379,2,0,0
52380,diabetes,0,0
52381,in,0,0
52382,the,0,0
52383,PROactive,0,1
52384,Study,0,0
52385,(,0,0
52386,PROspective,0,1
52387,pioglitAzone,0,1
52388,Clinical,0,0
52389,Trial,0,0
52390,In,0,0
52391,macroVascular,0,0
52392,Events,0,1
52393,),0,0
52394,:,0,0
52395,a,0,0
52396,randomised,0,0
52397,controlled,0,0
52398,trial,0,0
52399,.,0,0
52400,BACKGROUND,0,0
52401,Patients,0,0
52402,with,0,0
52403,type,0,0
52404,2,0,0
52405,diabetes,0,0
52406,are,0,0
52407,at,0,0
52408,high,0,0
52409,risk,0,0
52410,of,0,0
52411,fatal,0,0
52412,and,0,0
52413,non-fatal,0,0
52414,myocardial,0,0
52415,infarction,0,0
52416,and,0,0
52417,stroke,0,0
52418,.,0,0
52419,There,0,0
52420,is,0,0
52421,indirect,0,0
52422,evidence,0,0
52423,that,0,0
52424,agonists,0,1
52425,of,0,0
52426,peroxisome,0,0
52427,proliferator-activated,0,0
52428,receptor,0,0
52429,gamma,0,1
52430,(,0,1
52431,PPAR,0,0
52432,gamma,0,1
52433,),0,0
52434,could,0,0
52435,reduce,0,0
52436,macrovascular,0,0
52437,complications,0,0
52438,.,0,0
52439,Our,0,0
52440,aim,0,0
52441,",",0,0
52442,therefore,0,0
52443,",",0,0
52444,was,0,0
52445,to,0,0
52446,ascertain,0,0
52447,whether,0,0
52448,pioglitazone,1,1
52449,reduces,0,0
52450,macrovascular,0,0
52451,morbidity,0,0
52452,and,0,0
52453,mortality,0,0
52454,in,0,0
52455,high-risk,0,0
52456,patients,0,0
52457,with,0,0
52458,type,0,0
52459,2,0,0
52460,diabetes,0,0
52461,.,0,0
52462,METHODS,0,0
52463,We,0,0
52464,did,0,0
52465,a,0,0
52466,prospective,0,0
52467,",",0,0
52468,randomised,0,0
52469,controlled,0,0
52470,trial,0,0
52471,in,0,0
52472,5238,0,0
52473,patients,0,0
52474,with,0,0
52475,type,0,0
52476,2,0,0
52477,diabetes,0,0
52478,who,0,0
52479,had,0,0
52480,evidence,0,0
52481,of,0,0
52482,macrovascular,0,0
52483,disease,0,0
52484,.,0,0
52485,We,0,0
52486,recruited,0,0
52487,patients,0,0
52488,from,0,0
52489,primary-care,0,0
52490,practices,0,0
52491,and,0,0
52492,hospitals,0,0
52493,.,0,0
52494,We,0,0
52495,assigned,0,0
52496,patients,0,0
52497,to,0,0
52498,oral,1,1
52499,pioglitazone,1,1
52500,titrated,1,0
52501,from,1,0
52502,15,1,0
52503,mg,1,0
52504,to,1,0
52505,45,1,0
52506,mg,1,1
52507,(,0,0
52508,n=2605,0,0
52509,),0,1
52510,or,1,1
52511,matching,1,1
52512,placebo,1,1
52513,(,0,1
52514,n=2633,0,1
52515,),0,0
52516,",",0,0
52517,to,0,0
52518,be,0,0
52519,taken,0,0
52520,in,1,0
52521,addition,1,0
52522,to,1,0
52523,their,1,0
52524,glucose-lowering,1,1
52525,drugs,1,1
52526,and,1,0
52527,other,1,0
52528,medications,1,1
52529,.,1,0
52530,Our,0,0
52531,primary,0,0
52532,endpoint,0,0
52533,was,0,0
52534,the,0,0
52535,composite,0,1
52536,of,0,0
52537,all-cause,0,0
52538,mortality,0,0
52539,",",0,0
52540,non,0,0
52541,fatal,0,0
52542,myocardial,0,0
52543,infarction,0,0
52544,(,0,1
52545,including,0,0
52546,silent,0,1
52547,myocardial,0,0
52548,infarction,0,0
52549,),0,0
52550,",",0,0
52551,stroke,0,0
52552,",",0,0
52553,acute,0,0
52554,coronary,0,0
52555,syndrome,0,0
52556,",",0,0
52557,endovascular,0,1
52558,or,0,1
52559,surgical,0,1
52560,intervention,0,1
52561,in,0,0
52562,the,0,0
52563,coronary,0,0
52564,or,0,1
52565,leg,0,0
52566,arteries,0,0
52567,",",0,0
52568,and,0,0
52569,amputation,0,0
52570,above,0,0
52571,the,0,0
52572,ankle,0,0
52573,.,0,0
52574,Analysis,0,0
52575,was,0,0
52576,by,0,0
52577,intention,0,0
52578,to,0,0
52579,treat,0,0
52580,.,0,0
52581,This,0,0
52582,study,0,0
52583,is,0,0
52584,registered,0,0
52585,as,0,0
52586,an,0,0
52587,International,0,0
52588,Standard,0,1
52589,Randomised,0,1
52590,Controlled,0,1
52591,Trial,0,0
52592,",",0,0
52593,number,0,0
52594,ISRCTN,0,1
52595,NCT00174993,0,0
52596,.,0,0
52597,FINDINGS,0,0
52598,Two,0,0
52599,patients,0,0
52600,were,0,0
52601,lost,0,0
52602,to,0,0
52603,follow-up,0,0
52604,",",0,0
52605,but,0,0
52606,were,0,0
52607,included,0,0
52608,in,0,0
52609,analyses,0,0
52610,.,0,0
52611,The,0,0
52612,average,0,0
52613,time,0,0
52614,of,0,0
52615,observation,0,1
52616,was,0,0
52617,34.5,0,0
52618,months,0,0
52619,.,0,0
52620,514,0,0
52621,of,0,0
52622,2605,0,0
52623,patients,0,0
52624,in,0,0
52625,the,0,0
52626,pioglitazone,0,1
52627,group,0,0
52628,and,0,0
52629,572,0,0
52630,of,0,0
52631,2633,0,0
52632,patients,0,0
52633,in,0,0
52634,the,0,0
52635,placebo,0,1
52636,group,0,0
52637,had,0,0
52638,at,0,0
52639,least,0,0
52640,one,0,0
52641,event,0,0
52642,in,0,0
52643,the,0,0
52644,primary,0,0
52645,composite,0,1
52646,endpoint,0,0
52647,(,0,0
52648,HR,0,0
52649,0.90,0,0
52650,",",0,0
52651,95,0,0
52652,%,0,0
52653,CI,0,0
52654,0.80-1.02,0,0
52655,",",0,0
52656,p=0.095,0,0
52657,),0,0
52658,.,0,0
52659,The,0,0
52660,main,0,0
52661,secondary,0,0
52662,endpoint,0,0
52663,was,0,0
52664,the,0,0
52665,composite,0,1
52666,of,0,0
52667,all-cause,0,0
52668,mortality,0,0
52669,",",0,0
52670,non-fatal,0,0
52671,myocardial,0,0
52672,infarction,0,0
52673,",",0,0
52674,and,0,0
52675,stroke,0,0
52676,.,0,0
52677,301,0,0
52678,patients,0,0
52679,in,0,0
52680,the,0,0
52681,pioglitazone,0,1
52682,group,0,0
52683,and,0,0
52684,358,0,0
52685,in,0,0
52686,the,0,0
52687,placebo,0,1
52688,group,0,0
52689,reached,0,0
52690,this,0,0
52691,endpoint,0,0
52692,(,0,0
52693,0.84,0,0
52694,",",0,0
52695,0.72-0.98,0,0
52696,",",0,0
52697,p=0.027,0,0
52698,),0,0
52699,.,0,0
52700,Overall,0,0
52701,safety,0,0
52702,and,0,0
52703,tolerability,0,0
52704,was,0,0
52705,good,0,0
52706,with,0,0
52707,no,0,0
52708,change,0,0
52709,in,0,0
52710,the,0,0
52711,safety,0,0
52712,profile,0,0
52713,of,0,0
52714,pioglitazone,0,1
52715,identified,0,0
52716,.,0,0
52717,6,0,0
52718,%,0,0
52719,(,0,0
52720,149,0,0
52721,of,0,0
52722,2065,0,0
52723,),0,0
52724,and,0,0
52725,4,0,1
52726,%,0,0
52727,(,0,0
52728,108,0,0
52729,of,0,0
52730,2633,0,0
52731,),0,0
52732,of,0,0
52733,those,0,0
52734,in,0,0
52735,the,0,0
52736,pioglitazone,0,1
52737,and,0,0
52738,placebo,0,1
52739,groups,0,0
52740,",",0,0
52741,respectively,0,0
52742,",",0,0
52743,were,0,0
52744,admitted,0,0
52745,to,0,0
52746,hospital,0,0
52747,with,0,0
52748,heart,0,0
52749,failure,0,0
52750,;,0,0
52751,mortality,0,0
52752,rates,0,0
52753,from,0,0
52754,heart,0,0
52755,failure,0,0
52756,did,0,0
52757,not,0,0
52758,differ,0,0
52759,between,0,0
52760,groups,0,0
52761,.,0,0
52762,INTERPRETATION,0,0
52763,Pioglitazone,0,1
52764,reduces,0,0
52765,the,0,0
52766,composite,0,0
52767,of,0,0
52768,all-cause,0,0
52769,mortality,0,0
52770,",",0,0
52771,non-fatal,0,0
52772,myocardial,0,0
52773,infarction,0,0
52774,",",0,0
52775,and,0,0
52776,stroke,0,0
52777,in,0,0
52778,patients,0,0
52779,with,0,0
52780,type,0,0
52781,2,0,0
52782,diabetes,0,0
52783,who,0,0
52784,have,0,0
52785,a,0,0
52786,high,0,0
52787,risk,0,0
52788,of,0,0
52789,macrovascular,0,0
52790,events,0,0
52791,.,0,0
52792,A,0,0
52793,comparison,0,0
52794,of,0,0
52795,two,0,0
52796,double-injection,0,1
52797,techniques,0,1
52798,for,0,0
52799,peribulbar,0,1
52800,block,0,1
52801,analgesia,0,0
52802,:,0,0
52803,infero-temporal,1,0
52804,plus,1,1
52805,supero-medial,1,0
52806,vs.,1,0
52807,infero-temporal,1,0
52808,plus,1,1
52809,medial-percaruncular,1,1
52810,.,1,0
52811,BACKGROUND,0,0
52812,Combinations,0,0
52813,of,0,0
52814,infero-temporal,0,0
52815,and,0,0
52816,either,0,1
52817,supero-nasal,1,1
52818,(,1,0
52819,'inferior-superior,1,1
52820,',1,1
52821,),1,0
52822,or,0,1
52823,medial,1,1
52824,percaruncular,1,1
52825,(,1,0
52826,'inferior-medial,1,1
52827,',1,1
52828,),1,0
52829,injections,0,1
52830,are,0,0
52831,popular,0,0
52832,double-injection,0,1
52833,techniques,0,1
52834,for,0,0
52835,establishing,0,0
52836,peribulbar,0,1
52837,block,0,1
52838,analgesia,0,0
52839,.,0,0
52840,This,0,0
52841,study,0,0
52842,compared,0,0
52843,the,0,0
52844,efficacy,0,0
52845,of,0,0
52846,these,0,0
52847,two,0,0
52848,techniques,0,1
52849,in,0,0
52850,achieving,0,0
52851,ocular,0,0
52852,and,0,0
52853,lid,0,0
52854,akinesia,0,0
52855,.,0,0
52856,METHODS,0,0
52857,One,0,0
52858,hundred,0,0
52859,patients,0,0
52860,were,0,0
52861,randomized,0,0
52862,to,0,0
52863,receive,0,1
52864,inferior-superior,1,0
52865,or,1,1
52866,inferior-medial,1,0
52867,injections,1,1
52868,in,0,0
52869,a,0,0
52870,study,0,0
52871,in,0,0
52872,which,0,0
52873,injectate,0,1
52874,",",0,0
52875,injectate,0,1
52876,volumes,0,0
52877,",",0,0
52878,5-min,0,1
52879,ocular,1,0
52880,akinesia,1,1
52881,scoring,0,0
52882,(,0,1
52883,0-8,0,0
52884,),0,0
52885,",",0,0
52886,lid,1,1
52887,scoring,1,0
52888,(,0,1
52889,0-2,0,0
52890,),0,1
52891,and,0,0
52892,supplemental,0,1
52893,injection,0,1
52894,protocols,0,0
52895,were,0,0
52896,standardized,0,0
52897,.,0,0
52898,The,0,0
52899,numbers,0,0
52900,of,0,0
52901,supplemental,0,1
52902,injections,0,1
52903,required,0,0
52904,at,0,0
52905,each,0,0
52906,observation,0,1
52907,period,0,0
52908,and,0,0
52909,the,0,0
52910,total,0,0
52911,volume,0,0
52912,of,0,0
52913,injectate,0,1
52914,required,0,0
52915,to,0,0
52916,produce,0,0
52917,ocular,0,0
52918,and,0,0
52919,lid,0,1
52920,akinesia,0,0
52921,were,0,0
52922,compared,0,0
52923,.,0,0
52924,RESULTS,0,0
52925,The,0,0
52926,two,0,0
52927,test,0,0
52928,groups,0,0
52929,were,0,0
52930,demographically,0,0
52931,similar,0,0
52932,.,0,0
52933,The,0,0
52934,inferior-medial,0,0
52935,combination,0,0
52936,achieved,0,0
52937,greater,0,0
52938,ocular,0,0
52939,akinesia,0,0
52940,than,0,0
52941,the,0,0
52942,inferior-superior,0,0
52943,combination,0,1
52944,5,0,1
52945,min,0,0
52946,after,0,0
52947,the,0,0
52948,initial,0,0
52949,injections,0,1
52950,(,0,0
52951,mean,0,0
52952,score,0,0
52953,+/-,0,0
52954,standard,0,1
52955,deviation,0,0
52956,of,0,0
52957,1.74,0,0
52958,+/-,0,0
52959,1.86,0,0
52960,vs.,0,0
52961,2.66,0,0
52962,+/-,0,0
52963,2.39,0,0
52964,;,0,0
52965,P,0,0
52966,<,0,0
52967,0.05,0,0
52968,),0,0
52969,",",0,0
52970,with,0,0
52971,a,0,0
52972,reduced,0,0
52973,requirement,0,0
52974,for,0,0
52975,supplementary,0,1
52976,injections,0,1
52977,(,0,0
52978,3,0,0
52979,vs.,0,0
52980,23,0,0
52981,supplementary,0,1
52982,injections,0,1
52983,;,0,0
52984,P,0,0
52985,<,0,0
52986,0.025,0,0
52987,),0,0
52988,.,0,0
52989,The,0,0
52990,inferior-superior,0,0
52991,technique,0,0
52992,achieved,0,0
52993,greater,0,0
52994,lid,0,0
52995,akinesia,0,0
52996,at,0,0
52997,5,0,0
52998,min,0,0
52999,than,0,0
53000,the,0,0
53001,inferior-medial,0,0
53002,technique,0,1
53003,(,0,0
53004,mean,0,0
53005,score,0,0
53006,+/-,0,0
53007,standard,0,1
53008,deviation,0,0
53009,of,0,0
53010,0.7,0,0
53011,+/-,0,0
53012,0.9,0,0
53013,vs.,0,0
53014,0.3,0,0
53015,+/-,0,0
53016,0.58,0,0
53017,;,0,0
53018,P,0,0
53019,<,0,0
53020,0.005,0,0
53021,),0,0
53022,.,0,0
53023,A,0,0
53024,medial,0,0
53025,subconjunctival,0,1
53026,hemorrhage,0,0
53027,occurred,0,0
53028,in,0,0
53029,one,0,0
53030,patient,0,0
53031,in,0,0
53032,the,0,0
53033,inferior-medial,0,0
53034,group,0,0
53035,.,0,0
53036,CONCLUSION,0,0
53037,Compared,0,0
53038,with,0,0
53039,the,0,0
53040,inferior-superior,0,0
53041,technique,0,1
53042,",",0,0
53043,the,0,0
53044,inferior-medial,0,0
53045,combination,0,1
53046,achieved,0,0
53047,more,0,0
53048,rapid,0,0
53049,ocular,0,0
53050,akinesia,0,0
53051,with,0,0
53052,less,0,0
53053,need,0,0
53054,for,0,0
53055,supplementation,0,1
53056,",",0,0
53057,but,0,0
53058,induced,0,0
53059,less,0,0
53060,efficient,0,0
53061,lid,0,1
53062,akinesia,0,0
53063,and,0,0
53064,had,0,0
53065,a,0,0
53066,propensity,0,0
53067,to,0,0
53068,cause,0,0
53069,iatrogenic,0,0
53070,subconjunctival,0,1
53071,hemorrhage,0,0
53072,.,0,0
53073,The,0,0
53074,latter,0,0
53075,complication,0,0
53076,is,0,0
53077,considered,0,0
53078,by,0,0
53079,our,0,0
53080,surgeons,0,0
53081,to,0,0
53082,be,0,0
53083,a,0,0
53084,contraindication,0,0
53085,to,0,0
53086,the,0,0
53087,inferior-medial,0,0
53088,technique,0,1
53089,in,0,0
53090,patients,0,0
53091,undergoing,0,0
53092,trabeculectomy,0,1
53093,.,0,0
53094,Supplemental,1,1
53095,perioperative,1,1
53096,oxygen,1,1
53097,and,0,0
53098,the,0,0
53099,risk,0,0
53100,of,0,0
53101,surgical,0,1
53102,wound,0,0
53103,infection,0,0
53104,:,0,0
53105,a,0,0
53106,randomized,0,0
53107,controlled,0,0
53108,trial,0,0
53109,.,0,0
53110,CONTEXT,0,0
53111,Supplemental,1,1
53112,perioperative,1,1
53113,oxygen,1,1
53114,has,0,0
53115,been,0,0
53116,variously,0,0
53117,reported,0,0
53118,to,0,0
53119,halve,0,0
53120,or,0,1
53121,double,0,1
53122,the,0,0
53123,risk,0,0
53124,of,0,0
53125,surgical,0,1
53126,wound,0,0
53127,infection,0,0
53128,.,0,0
53129,OBJECTIVE,0,0
53130,To,0,0
53131,test,0,0
53132,the,0,0
53133,hypothesis,0,0
53134,that,0,0
53135,supplemental,1,1
53136,oxygen,1,1
53137,reduces,0,0
53138,infection,0,0
53139,risk,0,0
53140,in,0,0
53141,patients,0,0
53142,following,0,0
53143,colorectal,0,0
53144,surgery,0,1
53145,.,0,0
53146,DESIGN,0,0
53147,",",0,0
53148,SETTING,0,0
53149,",",0,0
53150,AND,0,0
53151,PATIENTS,0,1
53152,A,0,0
53153,double-blind,0,0
53154,",",0,0
53155,randomized,0,0
53156,controlled,0,0
53157,trial,0,0
53158,of,0,0
53159,300,0,1
53160,patients,0,0
53161,aged,0,0
53162,18,0,0
53163,to,0,0
53164,80,0,0
53165,years,0,0
53166,who,0,0
53167,underwent,0,0
53168,elective,0,1
53169,colorectal,0,0
53170,surgery,0,1
53171,in,0,0
53172,14,0,0
53173,Spanish,0,0
53174,hospitals,0,0
53175,from,0,0
53176,March,0,0
53177,1,0,0
53178,",",0,0
53179,2003,0,0
53180,",",0,0
53181,to,0,0
53182,October,0,0
53183,31,0,0
53184,",",0,0
53185,2004,0,0
53186,.,0,0
53187,Wound,0,0
53188,infections,0,0
53189,were,0,0
53190,diagnosed,0,0
53191,by,0,0
53192,blinded,0,0
53193,investigators,0,0
53194,using,0,0
53195,Centers,0,0
53196,for,0,0
53197,Disease,0,0
53198,Control,0,1
53199,and,0,0
53200,Prevention,0,1
53201,criteria,0,0
53202,.,0,0
53203,Baseline,0,0
53204,patient,0,0
53205,characteristics,0,0
53206,",",0,0
53207,anesthetic,0,1
53208,treatment,0,0
53209,",",0,0
53210,and,0,0
53211,potential,0,0
53212,confounding,0,0
53213,factors,0,0
53214,were,0,0
53215,recorded,0,0
53216,.,0,0
53217,INTERVENTIONS,0,0
53218,Patients,0,0
53219,were,0,0
53220,randomly,0,0
53221,assigned,0,0
53222,to,0,0
53223,either,0,0
53224,30,1,1
53225,%,1,0
53226,or,1,1
53227,80,1,0
53228,%,1,0
53229,fraction,1,0
53230,of,1,0
53231,inspired,1,1
53232,oxygen,1,1
53233,(,0,1
53234,FIO2,0,0
53235,),0,1
53236,intraoperatively,0,1
53237,and,0,0
53238,for,0,0
53239,6,0,0
53240,hours,0,0
53241,after,0,0
53242,surgery,0,0
53243,.,0,0
53244,Anesthetic,0,1
53245,treatment,0,0
53246,and,0,0
53247,antibiotic,0,1
53248,administration,0,0
53249,were,0,0
53250,standardized,0,0
53251,.,0,0
53252,MAIN,0,0
53253,OUTCOME,0,0
53254,MEASURES,0,0
53255,Any,0,0
53256,surgical,0,1
53257,site,0,0
53258,infection,0,0
53259,(,0,1
53260,SSI,0,1
53261,),0,1
53262,;,0,0
53263,secondary,0,0
53264,outcomes,0,0
53265,included,0,0
53266,return,0,0
53267,of,0,0
53268,bowel,0,0
53269,function,0,0
53270,and,0,0
53271,ability,0,0
53272,to,0,0
53273,tolerate,0,0
53274,solid,0,0
53275,food,0,0
53276,",",0,0
53277,ambulation,0,0
53278,",",0,0
53279,suture,0,1
53280,removal,0,0
53281,",",0,0
53282,and,0,0
53283,duration,0,0
53284,of,0,0
53285,hospitalization,0,0
53286,.,0,0
53287,RESULTS,0,0
53288,A,0,0
53289,total,0,0
53290,of,0,0
53291,143,0,0
53292,patients,0,0
53293,received,0,0
53294,30,1,0
53295,%,1,0
53296,perioperative,1,1
53297,oxygen,1,1
53298,and,0,0
53299,148,0,0
53300,received,0,0
53301,80,1,0
53302,%,1,0
53303,perioperative,1,0
53304,oxygen,1,1
53305,.,1,0
53306,Surgical,0,1
53307,site,0,0
53308,infection,0,0
53309,occurred,0,0
53310,in,0,0
53311,35,0,0
53312,patients,0,0
53313,(,0,0
53314,24.4,0,0
53315,%,0,0
53316,),0,0
53317,administered,0,0
53318,30,0,0
53319,%,0,0
53320,FIO2,0,0
53321,and,0,0
53322,in,0,0
53323,22,0,0
53324,patients,0,0
53325,(,0,0
53326,14.9,0,0
53327,%,0,0
53328,),0,0
53329,administered,0,0
53330,80,0,0
53331,%,0,0
53332,FIO2,0,0
53333,(,0,1
53334,P=.04,0,0
53335,),0,0
53336,.,0,0
53337,The,0,0
53338,risk,0,0
53339,of,0,0
53340,SSI,0,1
53341,was,0,0
53342,39,0,0
53343,%,0,0
53344,lower,0,0
53345,in,0,0
53346,the,0,0
53347,80,1,0
53348,%,1,0
53349,FIO2,1,0
53350,group,0,1
53351,(,0,0
53352,relative,0,0
53353,risk,0,0
53354,[,0,0
53355,RR,0,1
53356,],0,0
53357,",",0,0
53358,0.61,0,0
53359,;,0,0
53360,95,0,0
53361,%,0,0
53362,confidence,0,0
53363,interval,0,0
53364,[,0,0
53365,CI,0,0
53366,],0,0
53367,",",0,0
53368,0.38-0.98,0,0
53369,),0,0
53370,vs,0,0
53371,the,0,0
53372,30,1,0
53373,%,1,0
53374,FIO2,1,0
53375,group,0,0
53376,.,0,0
53377,After,0,0
53378,adjustment,0,0
53379,for,0,0
53380,important,0,0
53381,covariates,0,0
53382,",",0,0
53383,the,0,0
53384,RR,0,0
53385,of,0,0
53386,infection,0,0
53387,in,0,0
53388,patients,0,0
53389,administered,0,0
53390,supplemental,0,1
53391,oxygen,0,1
53392,was,0,0
53393,0.46,0,0
53394,(,0,0
53395,95,0,0
53396,%,0,0
53397,CI,0,0
53398,",",0,0
53399,0.22-0.95,0,0
53400,;,0,0
53401,P,0,0
53402,=,0,0
53403,.04,0,0
53404,),0,0
53405,.,0,0
53406,None,0,0
53407,of,0,0
53408,the,0,0
53409,secondary,0,0
53410,outcomes,0,0
53411,varied,0,0
53412,significantly,0,0
53413,between,0,0
53414,the,0,0
53415,2,0,0
53416,treatment,0,0
53417,groups,0,0
53418,.,0,0
53419,CONCLUSIONS,0,0
53420,Patients,0,0
53421,receiving,0,0
53422,supplemental,1,1
53423,inspired,1,1
53424,oxygen,1,1
53425,had,0,0
53426,a,0,0
53427,significant,0,0
53428,reduction,0,0
53429,in,0,0
53430,the,0,0
53431,risk,0,0
53432,of,0,0
53433,wound,0,0
53434,infection,0,0
53435,.,0,0
53436,Supplemental,1,1
53437,oxygen,1,0
53438,appears,0,0
53439,to,0,0
53440,be,0,0
53441,an,0,0
53442,effective,0,0
53443,intervention,0,1
53444,to,0,0
53445,reduce,0,0
53446,SSI,0,1
53447,in,0,0
53448,patients,0,0
53449,undergoing,0,0
53450,colon,0,0
53451,or,0,1
53452,rectal,0,0
53453,surgery,0,1
53454,.,0,0
53455,Trial,0,0
53456,Registration,0,0
53457,ClinicalTrials.gov,0,0
53458,Identifier,0,0
53459,:,0,0
53460,NCT00235456,0,0
53461,.,0,0
53462,Randomized,0,0
53463,",",0,0
53464,controlled,0,0
53465,",",0,0
53466,crossover,0,0
53467,trial,0,0
53468,of,0,0
53469,methylphenidate,1,1
53470,in,0,0
53471,pervasive,0,0
53472,developmental,0,0
53473,disorders,0,0
53474,with,0,0
53475,hyperactivity,0,0
53476,.,0,0
53477,CONTEXT,0,0
53478,Hyperactivity,0,0
53479,and,0,0
53480,inattention,0,0
53481,are,0,0
53482,common,0,0
53483,symptoms,0,0
53484,in,0,0
53485,children,0,0
53486,with,0,0
53487,autistic,0,0
53488,disorder,0,0
53489,and,0,0
53490,related,0,0
53491,pervasive,0,0
53492,developmental,0,0
53493,disorders,0,0
53494,",",0,0
53495,but,0,0
53496,studies,0,0
53497,of,0,0
53498,stimulants,0,1
53499,in,0,0
53500,these,0,0
53501,conditions,0,0
53502,have,0,0
53503,been,0,0
53504,inconclusive,0,0
53505,.,0,0
53506,OBJECTIVES,0,0
53507,To,0,0
53508,determine,0,0
53509,the,0,0
53510,efficacy,0,0
53511,and,0,0
53512,safety,0,0
53513,of,0,0
53514,methylphenidate,1,1
53515,hydrochloride,1,1
53516,in,0,0
53517,children,0,0
53518,with,0,0
53519,pervasive,0,0
53520,developmental,0,0
53521,disorders,0,0
53522,and,0,0
53523,hyperactivity,0,0
53524,.,0,0
53525,DESIGN,0,0
53526,Double-blind,0,0
53527,",",0,0
53528,placebo-controlled,0,1
53529,",",0,0
53530,crossover,0,0
53531,trial,0,0
53532,followed,0,1
53533,by,0,0
53534,open-label,0,0
53535,continuation,0,0
53536,.,0,0
53537,SETTING,0,0
53538,Five,0,0
53539,academic,0,0
53540,outpatient,0,0
53541,clinics,0,0
53542,.,0,0
53543,PARTICIPANTS,0,0
53544,Seventy-two,0,0
53545,drug-free,0,1
53546,children,0,0
53547,",",0,0
53548,aged,0,0
53549,5,0,0
53550,to,0,0
53551,14,0,0
53552,years,0,0
53553,",",0,0
53554,with,0,0
53555,pervasive,0,0
53556,developmental,0,0
53557,disorders,0,0
53558,accompanied,0,0
53559,by,0,0
53560,moderate,0,0
53561,to,0,0
53562,severe,0,0
53563,hyperactivity,0,0
53564,.,0,0
53565,INTERVENTIONS,0,0
53566,Prior,0,0
53567,to,0,0
53568,randomization,0,0
53569,",",0,0
53570,subjects,0,0
53571,entered,0,0
53572,a,0,0
53573,1-week,0,0
53574,test-dose,0,1
53575,phase,0,0
53576,in,0,0
53577,which,0,0
53578,each,0,0
53579,subject,0,0
53580,received,0,1
53581,placebo,1,1
53582,for,0,0
53583,1,0,0
53584,day,0,0
53585,followed,0,1
53586,by,0,0
53587,increasing,0,0
53588,doses,1,0
53589,of,1,0
53590,methylphenidate,1,1
53591,(,0,0
53592,low,0,0
53593,",",0,0
53594,medium,0,0
53595,",",0,0
53596,and,0,0
53597,high,0,0
53598,doses,0,1
53599,),0,0
53600,that,0,0
53601,were,0,0
53602,each,0,0
53603,given,0,0
53604,for,0,0
53605,2,0,0
53606,days,0,0
53607,.,0,0
53608,The,0,0
53609,low,0,0
53610,",",0,0
53611,medium,0,0
53612,",",0,0
53613,and,0,0
53614,high,0,0
53615,doses,0,1
53616,of,0,0
53617,methylphenidate,1,1
53618,hydrochloride,1,1
53619,were,0,0
53620,based,0,0
53621,on,0,0
53622,weight,0,0
53623,",",0,0
53624,and,0,0
53625,they,0,0
53626,ranged,0,0
53627,from,0,0
53628,7.5,0,0
53629,mg/d,0,0
53630,to,0,0
53631,50.0,0,0
53632,mg/d,0,1
53633,in,0,0
53634,divided,0,0
53635,doses,0,0
53636,.,0,0
53637,Subjects,0,0
53638,who,0,0
53639,tolerated,0,0
53640,the,0,0
53641,test,0,1
53642,dose,0,1
53643,(,0,0
53644,n,0,0
53645,=,0,0
53646,66,0,0
53647,),0,0
53648,were,0,0
53649,assigned,0,0
53650,to,0,0
53651,receive,0,0
53652,placebo,1,1
53653,for,0,0
53654,1,0,0
53655,week,0,0
53656,and,0,0
53657,then,0,1
53658,3,0,0
53659,methylphenidate,1,1
53660,doses,0,0
53661,in,0,0
53662,random,0,0
53663,order,0,0
53664,during,0,0
53665,a,0,0
53666,double-blind,0,0
53667,",",0,0
53668,crossover,0,0
53669,phase,0,0
53670,.,0,0
53671,Children,0,0
53672,responding,0,0
53673,to,0,0
53674,methylphenidate,1,1
53675,then,0,0
53676,entered,0,0
53677,8,0,0
53678,weeks,0,0
53679,of,0,0
53680,open-label,0,0
53681,treatment,0,0
53682,at,0,0
53683,the,0,0
53684,individually,0,1
53685,determined,0,0
53686,best,0,0
53687,dose,0,0
53688,.,0,0
53689,MAIN,0,0
53690,OUTCOME,0,0
53691,MEASURES,0,0
53692,The,0,0
53693,primary,0,0
53694,outcome,0,0
53695,measure,0,0
53696,was,0,0
53697,the,0,0
53698,teacher-rated,0,0
53699,hyperactivity,0,0
53700,subscale,0,0
53701,of,0,0
53702,the,0,0
53703,Aberrant,0,0
53704,Behavior,0,0
53705,Checklist,0,0
53706,.,0,0
53707,Response,0,0
53708,was,0,0
53709,defined,0,0
53710,as,0,0
53711,much,0,0
53712,improved,0,0
53713,or,0,1
53714,very,0,0
53715,much,0,0
53716,improved,0,0
53717,on,0,0
53718,the,0,0
53719,Clinical,0,0
53720,Global,0,0
53721,Impressions,0,1
53722,Improvement,0,0
53723,item,0,1
53724,coupled,0,0
53725,with,0,0
53726,considerable,0,0
53727,reductions,0,0
53728,in,0,0
53729,the,0,0
53730,parent-rated,0,0
53731,and/or,0,0
53732,teacher-rated,0,0
53733,Aberrant,0,0
53734,Behavior,0,0
53735,Checklist,0,1
53736,hyperactivity,0,0
53737,subscale,0,0
53738,score,0,0
53739,.,0,0
53740,RESULTS,0,0
53741,Methylphenidate,1,1
53742,was,0,0
53743,superior,0,0
53744,to,0,0
53745,placebo,1,1
53746,on,0,0
53747,the,0,0
53748,primary,0,0
53749,outcome,0,0
53750,measure,0,0
53751,",",0,0
53752,with,0,0
53753,effect,0,0
53754,sizes,0,0
53755,ranging,0,0
53756,from,0,0
53757,0.20,0,0
53758,to,0,0
53759,0.54,0,0
53760,depending,0,0
53761,on,0,0
53762,dose,0,1
53763,and,0,0
53764,rater,0,0
53765,.,0,1
53766,Thirty-five,0,0
53767,(,0,0
53768,49,0,0
53769,%,0,0
53770,),0,0
53771,of,0,0
53772,72,0,0
53773,enrolled,0,0
53774,subjects,0,0
53775,were,0,0
53776,classified,0,0
53777,as,0,0
53778,methylphenidate,1,1
53779,responders,0,0
53780,.,0,0
53781,Adverse,0,0
53782,effects,0,0
53783,led,0,0
53784,to,0,0
53785,the,0,0
53786,discontinuation,0,0
53787,of,0,0
53788,study,0,0
53789,medication,0,1
53790,in,0,0
53791,13,0,0
53792,(,0,0
53793,18,0,0
53794,%,0,0
53795,),0,0
53796,of,0,0
53797,72,0,0
53798,subjects,0,0
53799,.,0,0
53800,CONCLUSIONS,0,0
53801,Methylphenidate,1,1
53802,was,0,0
53803,often,0,0
53804,efficacious,0,0
53805,in,0,0
53806,treating,0,0
53807,hyperactivity,0,0
53808,associated,0,0
53809,with,0,0
53810,pervasive,0,0
53811,developmental,0,0
53812,disorders,0,0
53813,",",0,0
53814,but,0,0
53815,the,0,0
53816,magnitude,0,0
53817,of,0,0
53818,response,0,0
53819,was,0,0
53820,less,0,0
53821,than,0,0
53822,that,0,0
53823,seen,0,0
53824,in,0,0
53825,typically,0,0
53826,developing,0,0
53827,children,0,0
53828,with,0,0
53829,attention-deficit/hyperactivity,0,0
53830,disorder,0,0
53831,.,0,0
53832,Adverse,0,0
53833,effects,0,0
53834,were,0,0
53835,more,0,0
53836,frequent,0,0
53837,.,0,0
53838,Virtual,1,1
53839,reality,1,1
53840,colonoscopy,1,1
53841,simulation,1,1
53842,:,1,0
53843,a,0,0
53844,compulsory,0,1
53845,practice,0,0
53846,for,0,0
53847,the,0,0
53848,future,0,0
53849,colonoscopist,0,0
53850,?,0,0
53851,BACKGROUND,0,0
53852,AND,0,0
53853,STUDY,0,0
53854,AIM,0,0
53855,As,0,0
53856,for,0,0
53857,any,0,0
53858,manual,0,1
53859,procedure,0,0
53860,",",0,0
53861,the,0,0
53862,learning,0,1
53863,curves,0,0
53864,for,0,0
53865,medical,0,0
53866,interventions,0,0
53867,can,0,0
53868,have,0,0
53869,undesirable,0,0
53870,phases,0,0
53871,",",0,0
53872,occurring,0,0
53873,mostly,0,0
53874,in,0,0
53875,the,0,0
53876,early,0,0
53877,experience,0,0
53878,of,0,0
53879,applying,0,0
53880,a,0,0
53881,technique,0,1
53882,.,0,0
53883,There,0,0
53884,have,0,0
53885,been,0,0
53886,impressive,0,0
53887,advances,0,0
53888,in,0,0
53889,endoscopic,0,1
53890,procedures,0,0
53891,during,0,0
53892,recent,0,0
53893,years,0,0
53894,",",0,0
53895,and,0,0
53896,there,0,0
53897,is,0,0
53898,an,0,0
53899,emerging,0,0
53900,trend,0,0
53901,that,0,0
53902,the,0,0
53903,number,0,0
53904,of,0,0
53905,procedures,0,1
53906,is,0,0
53907,increasing,0,0
53908,in,0,0
53909,parallel,0,0
53910,with,0,0
53911,these,0,0
53912,.,0,0
53913,In,0,0
53914,addition,0,0
53915,",",0,0
53916,the,0,0
53917,introduction,0,0
53918,of,0,0
53919,screening,0,0
53920,programs,0,1
53921,for,0,0
53922,colorectal,0,0
53923,cancer,0,0
53924,will,0,0
53925,also,0,0
53926,increase,0,0
53927,the,0,0
53928,numbers,0,0
53929,of,0,0
53930,procedures,0,0
53931,needed,0,0
53932,.,0,0
53933,Recent,0,0
53934,developments,0,0
53935,in,0,0
53936,medical,0,0
53937,simulation,0,1
53938,seem,0,0
53939,promising,0,0
53940,with,0,0
53941,regard,0,0
53942,to,0,0
53943,the,0,0
53944,possibility,0,0
53945,of,0,0
53946,training,0,1
53947,out,0,0
53948,undesirable,0,0
53949,parts,0,0
53950,of,0,0
53951,the,0,0
53952,learning,0,1
53953,curve,0,0
53954,outside,0,1
53955,the,0,0
53956,operating,0,0
53957,room,0,0
53958,.,0,0
53959,The,0,0
53960,aim,0,0
53961,of,0,0
53962,this,0,0
53963,study,0,0
53964,was,0,0
53965,to,0,0
53966,investigate,0,0
53967,whether,0,0
53968,the,0,0
53969,use,0,0
53970,of,0,0
53971,the,0,0
53972,AccuTouch,1,0
53973,flexible,1,1
53974,endoscopy,1,1
53975,simulator,1,1
53976,improves,0,0
53977,the,0,0
53978,early,0,0
53979,part,0,0
53980,of,0,0
53981,the,0,0
53982,learning,0,1
53983,curve,0,0
53984,in,0,0
53985,colonoscopy,0,1
53986,training,0,1
53987,.,0,0
53988,METHOD,0,0
53989,12,0,0
53990,endoscopy,0,1
53991,trainees,0,0
53992,",",0,0
53993,10,0,0
53994,surgeons,0,0
53995,and,0,0
53996,two,0,0
53997,medical,0,0
53998,gastroenterologists,0,0
53999,",",0,0
54000,all,0,0
54001,with,0,0
54002,experience,0,0
54003,in,0,0
54004,gastroscopy,0,1
54005,but,0,0
54006,with,0,0
54007,no,0,0
54008,specific,0,0
54009,colonoscopy,0,1
54010,experience,0,0
54011,",",0,0
54012,were,0,0
54013,randomly,0,0
54014,assigned,0,0
54015,to,0,0
54016,either,0,1
54017,simulator,1,1
54018,training,1,1
54019,or,1,1
54020,to,1,0
54021,a,1,0
54022,control,1,1
54023,group,1,0
54024,.,1,0
54025,They,0,0
54026,all,0,0
54027,received,0,0
54028,the,0,0
54029,same,0,0
54030,theoretical,0,0
54031,study,0,0
54032,package,0,1
54033,and,0,0
54034,the,0,0
54035,training,0,1
54036,group,0,0
54037,practiced,0,0
54038,with,0,0
54039,the,0,0
54040,AccuTouch,1,1
54041,colonoscopy,1,1
54042,simulator,1,1
54043,until,0,0
54044,a,0,0
54045,predefined,0,0
54046,expert,0,0
54047,level,0,0
54048,of,0,0
54049,performance,0,0
54050,was,0,0
54051,reached,0,0
54052,.,0,0
54053,All,0,0
54054,trainees,0,0
54055,performed,0,0
54056,their,0,0
54057,first,0,0
54058,ten,0,0
54059,individual,0,0
54060,colonoscopies,0,0
54061,described,0,0
54062,in,0,0
54063,detail,0,0
54064,in,0,0
54065,a,0,0
54066,separate,0,0
54067,protocol,0,0
54068,.,0,0
54069,RESULTS,0,0
54070,Trainees,0,0
54071,in,0,0
54072,the,0,0
54073,simulator-trained,0,1
54074,group,0,0
54075,performed,0,0
54076,significantly,0,0
54077,better,0,0
54078,(,0,0
54079,P=0.0011,0,0
54080,),0,1
54081,and,0,0
54082,managed,0,0
54083,to,0,0
54084,reach,0,0
54085,the,0,0
54086,cecum,0,0
54087,in,0,0
54088,52,0,0
54089,%,0,0
54090,of,0,0
54091,their,0,0
54092,cases,0,0
54093,(,0,0
54094,vs.,0,0
54095,19,0,0
54096,%,0,0
54097,in,0,0
54098,the,0,0
54099,control,0,1
54100,group,0,0
54101,),0,0
54102,",",0,0
54103,and,0,0
54104,were,0,0
54105,4.53,0,0
54106,times,0,0
54107,more,0,0
54108,likely,0,0
54109,to,0,0
54110,succeed,0,0
54111,compared,0,0
54112,with,0,0
54113,the,0,0
54114,controls,0,0
54115,.,0,0
54116,Additionally,0,0
54117,",",0,0
54118,there,0,0
54119,was,0,0
54120,a,0,0
54121,significantly,0,0
54122,shorter,0,0
54123,procedure,0,0
54124,time,0,0
54125,and,0,0
54126,less,0,0
54127,patient,0,0
54128,discomfort,0,0
54129,in,0,0
54130,the,0,0
54131,hands,0,0
54132,of,0,0
54133,the,0,0
54134,simulator-trained,0,1
54135,group,0,0
54136,.,0,0
54137,CONCLUSION,0,0
54138,Skills,0,0
54139,acquired,0,0
54140,using,0,0
54141,the,0,0
54142,AccuTouch,0,1
54143,simulator,0,1
54144,transfer,0,0
54145,well,0,0
54146,into,0,0
54147,the,0,0
54148,clinical,0,0
54149,colonoscopy,0,1
54150,environment,0,0
54151,.,0,0
54152,The,0,0
54153,results,0,0
54154,of,0,0
54155,this,0,0
54156,trial,0,0
54157,clearly,0,0
54158,support,0,0
54159,the,0,0
54160,plan,0,0
54161,to,0,0
54162,integrate,0,1
54163,simulator,1,1
54164,training,1,1
54165,into,0,0
54166,endoscopic,0,1
54167,education,0,1
54168,curricula,0,1
54169,.,0,0
54170,Phytase,1,1
54171,and,1,0
54172,1alpha-hydroxycholecalciferol,1,1
54173,supplementation,1,1
54174,of,0,0
54175,broiler,0,0
54176,chickens,0,0
54177,during,0,0
54178,the,0,0
54179,starting,0,0
54180,and,0,0
54181,growing/finishing,0,0
54182,phases,0,0
54183,.,0,0
54184,Supplemental,0,1
54185,1alpha-hydroxycholecalciferol,0,1
54186,(,0,1
54187,1alpha-OHD3,0,1
54188,),0,1
54189,has,0,0
54190,been,0,0
54191,shown,0,0
54192,to,0,0
54193,have,0,0
54194,qualitatively,0,0
54195,similar,0,0
54196,and,0,0
54197,quantitatively,0,0
54198,additive,0,1
54199,effects,0,0
54200,to,0,0
54201,exogenous,0,0
54202,phytase,0,1
54203,.,0,0
54204,Two,0,0
54205,experiments,0,0
54206,were,0,0
54207,conducted,0,0
54208,from,0,0
54209,0,0,0
54210,to,0,0
54211,35,0,0
54212,d,0,1
54213,in,0,0
54214,floor,0,1
54215,pens,0,1
54216,to,0,0
54217,determine,0,0
54218,the,0,0
54219,additive,0,1
54220,effect,0,0
54221,of,0,0
54222,phytase,1,1
54223,and,1,0
54224,1alpha-OHD3,1,1
54225,when,0,0
54226,supplemented,0,1
54227,to,0,0
54228,Ca-,1,1
54229,and,1,0
54230,P-deficient,1,1
54231,diets,1,1
54232,.,1,0
54233,In,0,0
54234,both,0,0
54235,experiments,0,0
54236,",",0,0
54237,at,0,0
54238,least,0,0
54239,4,0,0
54240,replicates,0,0
54241,per,0,0
54242,treatment,0,0
54243,(,0,0
54244,50,0,0
54245,chicks,0,0
54246,per,0,0
54247,replicate,0,0
54248,),0,0
54249,were,0,0
54250,used,0,0
54251,.,0,0
54252,Corn-soybean-meal-and,1,1
54253,soybean-oil-based,1,1
54254,diets,1,1
54255,were,1,0
54256,fed,1,1
54257,and,1,0
54258,birds,1,0
54259,were,1,0
54260,raised,1,0
54261,in,1,0
54262,a,1,0
54263,house,1,0
54264,impervious,1,0
54265,to,1,0
54266,ultraviolet,1,1
54267,light,1,1
54268,.,1,0
54269,During,0,0
54270,the,0,0
54271,starter,0,1
54272,phase,0,0
54273,(,0,1
54274,ST,0,0
54275,),0,0
54276,",",0,0
54277,from,0,0
54278,0,0,0
54279,to,0,0
54280,18,0,0
54281,d,0,0
54282,",",0,0
54283,chicks,0,0
54284,were,0,0
54285,fed,0,0
54286,a,0,0
54287,23,0,0
54288,%,0,0
54289,CP,0,1
54290,diet,0,1
54291,containing,0,1
54292,0.60,0,0
54293,%,0,0
54294,Ca,0,0
54295,and,0,0
54296,0.47,0,0
54297,%,0,0
54298,total,0,0
54299,P,0,0
54300,(,0,1
54301,tP,0,0
54302,),0,0
54303,.,0,0
54304,During,0,0
54305,the,0,0
54306,grower/finisher,0,1
54307,phase,0,0
54308,(,0,1
54309,GF,0,1
54310,),0,0
54311,",",0,0
54312,from,0,0
54313,19,0,0
54314,to,0,0
54315,35,0,0
54316,d,0,0
54317,",",0,0
54318,birds,0,0
54319,were,0,0
54320,fed,0,0
54321,a,0,0
54322,19,0,0
54323,%,0,0
54324,CP,0,1
54325,diet,0,1
54326,containing,0,1
54327,0.30,0,0
54328,%,0,0
54329,Ca,0,0
54330,and,0,0
54331,0.37,0,0
54332,%,0,0
54333,tP,0,0
54334,.,0,0
54335,A,0,0
54336,combination,0,0
54337,of,0,0
54338,"1,000",0,0
54339,phytase,0,1
54340,units/kg,0,0
54341,of,0,0
54342,Natuphos,0,1
54343,phytase,0,1
54344,and,0,0
54345,5,0,1
54346,microg/kg,0,1
54347,of,0,0
54348,1alpha-OHD3,0,1
54349,(,0,1
54350,P+1A,0,1
54351,),0,1
54352,was,0,0
54353,supplemented,0,1
54354,to,0,0
54355,some,0,0
54356,of,0,0
54357,the,0,0
54358,feed,0,0
54359,during,0,0
54360,the,0,0
54361,ST,0,0
54362,and,0,0
54363,GF,0,1
54364,.,0,0
54365,Diets,0,1
54366,containing,0,0
54367,adequate,0,0
54368,Ca,0,1
54369,and,0,0
54370,P,0,0
54371,were,0,0
54372,also,0,0
54373,fed,0,0
54374,during,0,0
54375,the,0,0
54376,ST,0,0
54377,(,0,0
54378,0.90,0,0
54379,%,0,0
54380,Ca,0,0
54381,",",0,0
54382,0.68,0,0
54383,%,0,0
54384,tP,0,0
54385,),0,1
54386,and,0,1
54387,GF,0,1
54388,(,0,1
54389,0.80,0,0
54390,%,0,0
54391,Ca,0,0
54392,",",0,0
54393,0.67,0,0
54394,%,0,0
54395,tP,0,0
54396,),0,0
54397,.,0,0
54398,Performance,0,0
54399,characteristics,0,0
54400,and,0,0
54401,the,0,0
54402,incidence,0,0
54403,of,0,0
54404,rickets,0,0
54405,and,0,0
54406,tibial,0,1
54407,dyschondroplasia,0,0
54408,were,0,0
54409,measured,0,0
54410,at,0,0
54411,18,0,0
54412,and,0,0
54413,35,0,0
54414,d.,0,0
54415,In,0,0
54416,experiment,0,0
54417,1,0,0
54418,",",0,0
54419,unsupplemented,0,1
54420,chicks,0,0
54421,performed,0,0
54422,well,0,0
54423,but,0,0
54424,had,0,0
54425,considerable,0,0
54426,leg,0,0
54427,problems,0,0
54428,.,0,0
54429,Chicks,0,0
54430,fed,0,0
54431,P+1A,0,1
54432,during,0,0
54433,the,0,0
54434,ST,0,0
54435,or,0,1
54436,GF,0,1
54437,did,0,0
54438,not,0,0
54439,perform,0,0
54440,as,0,0
54441,well,0,0
54442,as,0,0
54443,birds,0,0
54444,fed,0,0
54445,P+1A,0,1
54446,throughout,0,0
54447,.,0,0
54448,Birds,0,0
54449,fed,0,0
54450,P+1A,0,1
54451,throughout,0,0
54452,performed,0,0
54453,as,0,0
54454,well,0,0
54455,birds,0,0
54456,fed,0,0
54457,the,0,0
54458,adequate,0,0
54459,diets,0,1
54460,without,0,0
54461,any,0,0
54462,indication,0,0
54463,of,0,0
54464,leg,0,0
54465,problems,0,0
54466,.,0,0
54467,In,0,0
54468,experiment,0,0
54469,2,0,0
54470,",",0,0
54471,unsupplemented,0,1
54472,birds,0,0
54473,performed,0,0
54474,similarly,0,0
54475,to,0,0
54476,unsupplemented,0,1
54477,birds,0,0
54478,in,0,0
54479,experiment,0,0
54480,1,0,0
54481,.,0,0
54482,However,0,0
54483,",",0,0
54484,chicks,0,0
54485,fed,0,0
54486,the,0,0
54487,supplements,0,1
54488,or,0,0
54489,the,0,0
54490,control,0,1
54491,diets,0,1
54492,did,0,0
54493,not,0,0
54494,perform,0,0
54495,as,0,0
54496,well,0,0
54497,or,0,0
54498,accumulate,0,0
54499,as,0,0
54500,much,0,0
54501,bone,0,0
54502,ash,0,1
54503,as,0,0
54504,birds,0,0
54505,in,0,0
54506,experiment,0,0
54507,1,0,0
54508,",",0,0
54509,although,0,0
54510,the,0,0
54511,diets,0,1
54512,were,0,0
54513,formulated,0,0
54514,identically,0,0
54515,in,0,0
54516,both,0,0
54517,experiments,0,0
54518,.,0,0
54519,Diets,0,0
54520,with,0,0
54521,as,0,0
54522,little,0,0
54523,as,0,0
54524,0.30,0,0
54525,%,0,0
54526,Ca,0,0
54527,and,0,0
54528,0.37,0,0
54529,%,0,0
54530,tP,0,0
54531,appear,0,0
54532,to,0,0
54533,be,0,0
54534,adequate,0,0
54535,for,0,0
54536,broilers,0,0
54537,older,0,0
54538,than,0,0
54539,18,0,0
54540,d,0,0
54541,if,0,0
54542,supplemented,0,1
54543,with,0,0
54544,the,0,0
54545,correct,0,0
54546,amounts,0,0
54547,of,0,0
54548,phytase,0,1
54549,and,0,0
54550,1alpha-OHD3,0,1
54551,.,0,0
54552,However,0,0
54553,",",0,0
54554,there,0,0
54555,are,0,0
54556,unknown,0,0
54557,variables,0,0
54558,that,0,0
54559,may,0,0
54560,limit,0,0
54561,the,0,0
54562,potential,0,0
54563,of,0,0
54564,broilers,0,0
54565,in,0,0
54566,terms,0,0
54567,of,0,0
54568,bone,0,0
54569,mineralization,0,0
54570,and,0,0
54571,bone,0,0
54572,pathology,0,0
54573,",",0,0
54574,even,0,0
54575,when,0,0
54576,adequate,0,0
54577,diets,0,1
54578,are,0,0
54579,fed,0,0
54580,.,0,0
54581,Acute,0,0
54582,and,0,0
54583,long-term,0,0
54584,safety,0,0
54585,and,0,0
54586,tolerability,0,0
54587,of,0,0
54588,risperidone,1,1
54589,in,0,0
54590,children,0,0
54591,with,0,0
54592,autism,0,0
54593,.,0,0
54594,Treatment-emergent,0,0
54595,adverse,0,0
54596,events,0,0
54597,(,0,0
54598,AEs,0,1
54599,),0,1
54600,were,0,0
54601,monitored,0,0
54602,during,0,0
54603,an,0,0
54604,8-week,0,0
54605,",",0,0
54606,double-blind,0,0
54607,",",0,0
54608,placebo-controlled,1,1
54609,trial,0,0
54610,of,0,0
54611,risperidone,1,1
54612,(,0,0
54613,0.5-3.5,0,0
54614,mg/day,0,1
54615,),0,0
54616,in,0,0
54617,101,0,0
54618,children,0,0
54619,and,0,0
54620,adolescents,0,0
54621,with,0,0
54622,a,0,0
54623,lifetime,0,0
54624,diagnosis,0,0
54625,of,0,0
54626,autistic,0,0
54627,disorder,0,0
54628,.,0,0
54629,In,0,0
54630,addition,0,0
54631,",",0,0
54632,37,0,0
54633,placebo,1,1
54634,nonresponders,0,0
54635,received,0,0
54636,open-label,0,0
54637,risperidone,1,1
54638,for,0,0
54639,another,0,0
54640,8,0,0
54641,weeks,0,0
54642,.,0,0
54643,Of,0,0
54644,all,0,0
54645,the,0,0
54646,risperidone,1,1
54647,responders,0,0
54648,(,0,0
54649,n=65,0,0
54650,),0,0
54651,",",0,0
54652,63,0,0
54653,entered,0,0
54654,an,0,0
54655,open,0,1
54656,extension,0,0
54657,of,0,0
54658,another,0,0
54659,16,0,0
54660,weeks,0,0
54661,(,0,0
54662,6,0,0
54663,months,0,0
54664,total,0,0
54665,risperidone,1,1
54666,exposure,0,0
54667,),0,0
54668,",",0,0
54669,and,0,0
54670,32,0,0
54671,of,0,0
54672,them,0,0
54673,were,0,0
54674,rerandomized,0,0
54675,to,0,0
54676,either,0,1
54677,continued,0,0
54678,risperidone,1,1
54679,therapy,0,1
54680,(,0,1
54681,n=16,0,0
54682,),0,1
54683,or,0,1
54684,gradual,0,1
54685,replacement,0,1
54686,with,0,1
54687,placebo,1,1
54688,(,0,1
54689,n=16,0,0
54690,),0,0
54691,over,0,0
54692,8,0,0
54693,weeks,0,0
54694,.,0,0
54695,We,0,0
54696,collected,0,0
54697,the,0,0
54698,following,0,0
54699,measures,0,0
54700,of,0,0
54701,safety,0,0
54702,and,0,0
54703,tolerability,0,0
54704,:,0,1
54705,(,0,0
54706,1,0,0
54707,),0,1
54708,laboratory,0,0
54709,blood,0,0
54710,assessments,0,1
54711,(,0,0
54712,CBC,0,1
54713,with,0,0
54714,differential,0,0
54715,",",0,0
54716,electrolytes,0,1
54717,",",0,0
54718,and,0,0
54719,liver,0,0
54720,function,0,0
54721,tests,0,0
54722,),0,0
54723,and,0,0
54724,urinalyses,0,0
54725,",",0,0
54726,(,0,0
54727,2,0,0
54728,),0,0
54729,vital,0,0
54730,signs,0,0
54731,",",0,0
54732,(,0,0
54733,3,0,0
54734,),0,0
54735,Side,0,1
54736,Effects,0,0
54737,Review,0,1
54738,of,0,0
54739,AEs,0,0
54740,thought,0,0
54741,to,0,0
54742,be,0,0
54743,associated,0,0
54744,with,0,0
54745,risperidone,0,1
54746,",",0,0
54747,(,0,0
54748,4,0,1
54749,),0,0
54750,sleep,0,0
54751,records,0,0
54752,",",0,0
54753,(,0,0
54754,5,0,1
54755,),0,0
54756,Simpson,0,0
54757,Angus,0,0
54758,Neurological,0,0
54759,Rating,0,0
54760,Scale,0,1
54761,(,0,1
54762,SARS,0,1
54763,),0,1
54764,",",0,0
54765,(,0,0
54766,6,0,0
54767,),0,0
54768,Abnormal,0,0
54769,Involuntary,0,1
54770,Movement,0,1
54771,Scale,0,1
54772,(,0,1
54773,AIMS,0,1
54774,),0,1
54775,",",0,0
54776,and,0,0
54777,(,0,0
54778,7,0,1
54779,),0,1
54780,height,0,0
54781,and,0,0
54782,weight,0,0
54783,.,0,0
54784,No,0,0
54785,clinically,0,0
54786,significant,0,0
54787,changes,0,0
54788,were,0,0
54789,found,0,0
54790,on,0,0
54791,the,0,0
54792,lab,0,0
54793,tests,0,0
54794,.,0,0
54795,During,0,0
54796,the,0,0
54797,8-week,0,0
54798,acute,0,0
54799,trial,0,0
54800,",",0,0
54801,the,0,0
54802,most,0,0
54803,common,0,0
54804,AEs,0,1
54805,on,0,0
54806,the,0,0
54807,Side,0,1
54808,Effects,0,0
54809,Review,0,1
54810,",",0,0
54811,scored,0,0
54812,as,0,0
54813,moderate,0,0
54814,or,0,0
54815,higher,0,0
54816,",",0,0
54817,were,0,0
54818,as,0,0
54819,follows,0,0
54820,(,1,0
54821,placebo,1,1
54822,and,0,1
54823,risperidone,0,1
54824,",",0,0
54825,respectively,0,0
54826,),0,0
54827,:,0,1
54828,Somnolence,0,0
54829,(,0,0
54830,12,0,1
54831,%,0,0
54832,and,0,0
54833,37,0,0
54834,%,0,0
54835,),0,0
54836,",",0,0
54837,enuresis,0,0
54838,(,0,0
54839,29,0,0
54840,%,0,0
54841,and,0,0
54842,33,0,0
54843,%,0,0
54844,),0,0
54845,",",0,0
54846,excessive,0,0
54847,appetite,0,0
54848,(,0,0
54849,10,0,1
54850,%,0,0
54851,and,0,0
54852,33,0,0
54853,%,0,0
54854,),0,0
54855,",",0,0
54856,rhinitis,0,0
54857,(,0,0
54858,8,0,1
54859,%,0,0
54860,and,0,0
54861,16,0,0
54862,%,0,0
54863,),0,0
54864,",",0,0
54865,difficulty,0,0
54866,waking,0,1
54867,(,0,0
54868,8,0,1
54869,%,0,0
54870,and,0,0
54871,12,0,1
54872,%,0,0
54873,),0,0
54874,",",0,0
54875,and,0,1
54876,constipation,0,0
54877,(,0,1
54878,12,0,1
54879,%,0,0
54880,and,0,0
54881,10,0,1
54882,%,0,0
54883,),0,0
54884,.,0,0
54885,Difficulty,0,0
54886,falling,0,0
54887,asleep,0,1
54888,and,0,0
54889,anxiety,0,0
54890,actually,0,0
54891,favored,0,0
54892,the,0,0
54893,risperidone,0,1
54894,condition,0,0
54895,at,0,0
54896,statistically,0,0
54897,significant,0,0
54898,levels,0,0
54899,.,0,0
54900,The,0,0
54901,same,0,0
54902,AEs,0,0
54903,tended,0,0
54904,to,0,0
54905,recur,0,0
54906,through,0,0
54907,6,0,0
54908,months,0,0
54909,of,0,0
54910,treatment,0,0
54911,",",0,0
54912,although,0,0
54913,often,0,0
54914,at,0,0
54915,reduced,0,0
54916,levels,0,0
54917,.,0,0
54918,Using,0,0
54919,Centers,0,0
54920,for,0,0
54921,Disease,0,0
54922,Control,0,1
54923,(,0,1
54924,CDC,0,1
54925,),0,1
54926,standardized,0,0
54927,scores,0,0
54928,",",0,0
54929,both,0,0
54930,weight,0,0
54931,and,0,0
54932,body,0,0
54933,mass,0,0
54934,index,0,0
54935,(,0,1
54936,BMI,0,1
54937,),0,1
54938,increased,0,0
54939,with,0,0
54940,risperidone,1,1
54941,during,0,0
54942,the,0,0
54943,acute,0,0
54944,trial,0,0
54945,(,0,0
54946,0.5,0,1
54947,and,0,0
54948,0.6,0,0
54949,SDs,0,1
54950,",",0,0
54951,respectively,0,0
54952,",",0,0
54953,for,0,0
54954,risperidone,1,1
54955,;,1,0
54956,0.0,0,0
54957,and,0,0
54958,0.1,0,1
54959,SDs,0,1
54960,",",0,0
54961,respectively,0,0
54962,",",0,0
54963,for,0,0
54964,placebo,1,1
54965,),1,1
54966,and,0,0
54967,into,0,0
54968,open-label,0,0
54969,extension,0,0
54970,(,0,0
54971,0.19,0,0
54972,and,0,0
54973,0.16,0,0
54974,SDs,0,1
54975,",",0,0
54976,respectively,0,0
54977,),0,0
54978,",",0,0
54979,although,0,0
54980,the,0,0
54981,amount,0,0
54982,of,0,0
54983,gain,0,0
54984,decelerated,0,0
54985,with,0,0
54986,time,0,0
54987,.,0,0
54988,Extrapyramidal,0,0
54989,symptoms,0,0
54990,",",0,0
54991,as,0,0
54992,assessed,0,0
54993,by,0,0
54994,the,0,0
54995,SARS,0,0
54996,",",0,0
54997,were,0,0
54998,no,0,0
54999,more,0,0
55000,common,0,0
55001,for,0,0
55002,drug,0,1
55003,than,0,0
55004,placebo,1,1
55005,",",0,0
55006,although,0,0
55007,drooling,0,0
55008,was,0,0
55009,reported,0,0
55010,more,0,0
55011,often,0,0
55012,in,0,0
55013,the,0,0
55014,risperidone,1,1
55015,group,0,0
55016,.,0,0
55017,There,0,0
55018,were,0,0
55019,no,0,0
55020,differences,0,0
55021,between,0,0
55022,groups,0,0
55023,on,0,0
55024,the,0,0
55025,AIMS,0,0
55026,.,0,0
55027,Two,0,0
55028,subjects,0,0
55029,had,0,0
55030,seizures,0,0
55031,(,0,0
55032,one,0,0
55033,taking,0,1
55034,placebo,1,1
55035,),1,1
55036,",",0,0
55037,but,0,0
55038,these,0,0
55039,were,0,0
55040,considered,0,0
55041,unrelated,0,0
55042,to,0,0
55043,active,0,0
55044,drug,0,1
55045,.,0,0
55046,Most,0,0
55047,AEs,0,0
55048,were,0,0
55049,mild,0,0
55050,to,0,0
55051,moderate,0,0
55052,and,0,0
55053,failed,0,0
55054,to,0,0
55055,interfere,0,0
55056,with,0,0
55057,therapeutic,0,0
55058,changes,0,0
55059,;,0,0
55060,there,0,0
55061,were,0,0
55062,no,0,0
55063,unanticipated,0,0
55064,AEs,0,0
55065,.,0,0
55066,The,0,0
55067,side,0,0
55068,effects,0,0
55069,of,0,0
55070,most,0,0
55071,concern,0,0
55072,were,0,0
55073,somnolence,0,0
55074,and,0,0
55075,weight,0,0
55076,gain,0,0
55077,.,0,0
55078,The,0,0
55079,impact,0,0
55080,of,0,0
55081,emotional,1,0
55082,distress,1,0
55083,on,0,0
55084,HIV,0,1
55085,risk,0,0
55086,reduction,0,0
55087,among,0,0
55088,women,0,0
55089,.,0,0
55090,This,0,0
55091,study,0,0
55092,evaluated,0,0
55093,whether,0,0
55094,333,0,0
55095,seronegative,0,0
55096,African,0,0
55097,American,0,0
55098,female,0,0
55099,drug,0,1
55100,users,0,0
55101,(,0,0
55102,aged,0,0
55103,18-59,0,0
55104,years,0,0
55105,),0,0
55106,participating,0,0
55107,in,0,0
55108,an,0,0
55109,HIV,1,1
55110,intervention,1,1
55111,and,0,0
55112,with,0,0
55113,higher,0,0
55114,levels,0,0
55115,of,0,0
55116,emotional,0,0
55117,distress,0,0
55118,",",0,0
55119,specifically,0,0
55120,symptoms,0,0
55121,of,0,0
55122,depression,0,0
55123,and,0,0
55124,anxiety,0,0
55125,",",0,0
55126,reduced,0,0
55127,HIV,0,1
55128,risk,0,0
55129,behaviors,0,0
55130,to,0,0
55131,a,0,0
55132,lesser,0,0
55133,extent,0,0
55134,than,0,0
55135,those,0,0
55136,with,0,0
55137,lower,0,0
55138,levels,0,0
55139,of,0,0
55140,emotional,0,0
55141,distress,0,0
55142,.,0,0
55143,Participants,0,0
55144,were,0,0
55145,recruited,0,0
55146,between,0,0
55147,June,0,0
55148,1998,0,0
55149,and,0,0
55150,January,0,0
55151,2001,0,0
55152,from,0,0
55153,inner-city,0,0
55154,Atlanta,0,0
55155,(,0,0
55156,Georgia,0,0
55157,",",0,0
55158,U.S.,0,1
55159,),0,1
55160,neighborhoods,0,0
55161,and,0,0
55162,were,0,0
55163,randomly,0,0
55164,assigned,0,0
55165,to,0,0
55166,one,0,0
55167,of,0,0
55168,two,0,0
55169,enhanced,1,0
55170,gender-specific,1,0
55171,and,1,0
55172,culturally,1,1
55173,specific,1,1
55174,HIV,1,1
55175,intervention,1,1
55176,conditions,0,0
55177,or,0,0
55178,to,0,0
55179,the,0,0
55180,NIDA,0,1
55181,standard,0,1
55182,condition,0,0
55183,.,0,0
55184,Participants,0,0
55185,were,0,0
55186,interviewed,0,0
55187,at,0,0
55188,baseline,0,0
55189,",",0,0
55190,post-intervention,0,0
55191,and,0,0
55192,at,0,0
55193,6-month,0,0
55194,follow-up,0,0
55195,with,0,0
55196,a,0,0
55197,structured,1,1
55198,questionnaire,1,0
55199,including,0,0
55200,information,0,0
55201,on,0,0
55202,sociodemographics,0,0
55203,",",0,0
55204,sexual,0,0
55205,and,0,0
55206,drug-using,0,0
55207,behavior,0,0
55208,",",0,0
55209,and,0,0
55210,psychosocial,0,0
55211,characteristics,0,0
55212,.,0,0
55213,Despite,0,0
55214,a,0,0
55215,significant,0,0
55216,decline,0,0
55217,in,0,0
55218,symptoms,0,0
55219,of,0,0
55220,emotional,0,0
55221,distress,0,0
55222,during,0,0
55223,the,0,0
55224,study,0,0
55225,period,0,0
55226,",",0,0
55227,the,0,0
55228,women,0,0
55229,in,0,0
55230,this,0,0
55231,sample,0,0
55232,reported,0,0
55233,high,0,0
55234,levels,0,0
55235,of,0,0
55236,depressive,0,0
55237,and,0,0
55238,anxiety,0,0
55239,symptoms,0,0
55240,at,0,0
55241,baseline,0,0
55242,and,0,0
55243,6-month,0,0
55244,follow-up,0,0
55245,.,0,0
55246,Higher,0,0
55247,levels,0,0
55248,of,0,0
55249,emotional,0,0
55250,distress,0,0
55251,were,0,0
55252,positively,0,0
55253,associated,0,0
55254,with,0,0
55255,post-intervention,0,0
55256,sexual,0,0
55257,and,0,0
55258,drug-taking,0,0
55259,risk,0,0
55260,.,0,0
55261,Women,0,0
55262,in,0,0
55263,both,0,0
55264,enhanced,1,0
55265,intervention,1,1
55266,conditions,1,0
55267,reduced,0,0
55268,their,0,0
55269,sexual,0,0
55270,and,0,0
55271,drug-taking,0,0
55272,risks,0,0
55273,more,0,0
55274,than,0,0
55275,women,0,0
55276,in,0,0
55277,the,0,0
55278,standard,1,1
55279,intervention,1,1
55280,.,1,0
55281,Those,0,0
55282,in,0,0
55283,the,0,0
55284,motivation,1,0
55285,intervention,1,1
55286,arm,0,0
55287,experienced,0,0
55288,a,0,0
55289,greater,0,0
55290,reduction,0,0
55291,in,0,0
55292,depressive,0,0
55293,symptoms,0,0
55294,",",0,0
55295,accompanied,0,0
55296,by,0,0
55297,a,0,0
55298,greater,0,0
55299,reduction,0,0
55300,in,0,0
55301,sexual,0,0
55302,risk,0,0
55303,behavior,0,0
55304,.,0,0
55305,Findings,0,0
55306,suggest,0,0
55307,the,0,0
55308,need,0,0
55309,for,0,0
55310,effective,0,0
55311,interventions,0,1
55312,and,0,0
55313,mental,0,0
55314,health,0,0
55315,resources,0,0
55316,among,0,0
55317,subgroups,0,0
55318,of,0,0
55319,high-risk,0,0
55320,women,0,0
55321,who,0,0
55322,may,0,0
55323,be,0,0
55324,most,0,0
55325,resistant,0,0
55326,to,0,0
55327,behavioral,0,1
55328,change,0,0
55329,.,0,0
55330,Effect,0,0
55331,of,0,0
55332,micronutrient,1,1
55333,supplement,1,1
55334,on,0,0
55335,health,0,0
55336,and,0,0
55337,nutritional,0,1
55338,status,0,0
55339,of,0,0
55340,schoolchildren,0,0
55341,:,0,0
55342,study,0,0
55343,design,0,0
55344,.,0,0
55345,OBJECTIVE,0,0
55346,We,0,0
55347,tested,0,0
55348,the,0,0
55349,hypothesis,0,0
55350,that,0,0
55351,supplementation,1,1
55352,with,1,0
55353,a,1,0
55354,micronutrient-fortified,1,1
55355,beverage,1,1
55356,improves,0,0
55357,micronutrient,0,1
55358,status,0,0
55359,and,0,0
55360,physical,0,1
55361,and,0,0
55362,mental,0,0
55363,development,0,0
55364,in,0,0
55365,apparently,0,0
55366,healthy,0,0
55367,schoolchildren,0,0
55368,.,0,0
55369,METHODS,0,0
55370,The,0,0
55371,study,0,0
55372,was,0,0
55373,carried,0,0
55374,out,0,0
55375,in,0,0
55376,middle-income,0,0
55377,students,0,0
55378,in,0,0
55379,two,0,0
55380,residential,0,0
55381,schools,0,0
55382,that,0,0
55383,catered,0,0
55384,to,0,0
55385,children,0,0
55386,from,0,0
55387,a,0,0
55388,semi-urban,0,0
55389,population,0,0
55390,near,0,0
55391,Hyderabad,0,0
55392,",",0,0
55393,India,0,0
55394,.,0,0
55395,Included,0,0
55396,were,0,0
55397,869,0,0
55398,children,0,0
55399,who,0,0
55400,were,0,0
55401,6,0,0
55402,to,0,0
55403,16,0,0
55404,y,0,0
55405,of,0,0
55406,age,0,0
55407,in,0,0
55408,grades,0,0
55409,1,0,0
55410,to,0,0
55411,10,0,0
55412,.,0,0
55413,Because,0,0
55414,children,0,0
55415,at,0,0
55416,each,0,0
55417,grade,0,0
55418,were,0,0
55419,distributed,0,0
55420,across,0,0
55421,two,0,0
55422,classrooms,0,1
55423,(,0,0
55424,clusters,0,1
55425,),0,0
55426,and,0,0
55427,were,0,0
55428,homogeneous,0,0
55429,",",0,0
55430,each,0,0
55431,grade,0,0
55432,was,0,0
55433,considered,0,0
55434,to,0,0
55435,consist,0,0
55436,of,0,0
55437,a,0,0
55438,matched,0,0
55439,pair,0,0
55440,.,0,0
55441,There,0,0
55442,were,0,0
55443,thus,0,0
55444,10,0,0
55445,pairs,0,0
55446,available,0,0
55447,for,0,0
55448,the,0,0
55449,study,0,0
55450,.,0,0
55451,Classes,0,0
55452,in,0,0
55453,each,0,0
55454,grade,0,0
55455,were,0,0
55456,randomized,0,0
55457,to,0,0
55458,receive,0,0
55459,a,0,0
55460,micronutrient-enriched,1,1
55461,beverage,1,1
55462,or,1,1
55463,a,1,0
55464,placebo,1,1
55465,without,1,0
55466,added,1,0
55467,micronutrients,1,1
55468,.,1,0
55469,The,0,0
55470,study,0,0
55471,was,0,0
55472,double,0,1
55473,blinded,0,0
55474,and,0,0
55475,the,0,0
55476,duration,0,0
55477,was,0,0
55478,14,0,0
55479,mo,0,0
55480,",",0,0
55481,with,0,0
55482,supervised,0,1
55483,feeding,0,1
55484,of,0,0
55485,the,0,0
55486,micronutrient-enriched,1,1
55487,beverage,1,1
55488,.,1,0
55489,The,0,0
55490,effect,0,0
55491,of,0,0
55492,the,0,0
55493,micronutrients,1,0
55494,on,0,0
55495,the,0,0
55496,outcome,0,0
55497,variables,0,0
55498,growth,0,0
55499,",",0,0
55500,biochemical,0,0
55501,status,0,0
55502,",",0,0
55503,mental,0,0
55504,function,0,0
55505,",",0,0
55506,and,0,0
55507,bone,0,0
55508,health,0,0
55509,were,0,0
55510,assessed,0,0
55511,.,0,0
55512,RESULTS,0,0
55513,The,0,0
55514,number,0,0
55515,of,0,0
55516,matched,0,0
55517,pairs,0,1
55518,varied,0,0
55519,between,0,0
55520,seven,0,0
55521,and,0,0
55522,eight,0,0
55523,",",0,0
55524,and,0,0
55525,the,0,0
55526,required,0,0
55527,number,0,0
55528,of,0,0
55529,children,0,0
55530,per,0,0
55531,treatment,0,0
55532,group,0,0
55533,ranged,0,0
55534,from,0,0
55535,32,0,0
55536,in,0,0
55537,the,0,0
55538,case,0,0
55539,of,0,0
55540,bone,0,0
55541,heath,0,0
55542,to,0,0
55543,177,0,0
55544,for,0,0
55545,body,0,0
55546,weight,0,0
55547,.,0,0
55548,The,0,0
55549,power,0,0
55550,of,0,0
55551,the,0,0
55552,outcome,0,0
55553,variables,0,0
55554,ranged,0,0
55555,from,0,0
55556,74,0,0
55557,%,0,0
55558,to,0,0
55559,100,0,0
55560,%,0,0
55561,and,0,0
55562,was,0,0
55563,adequate,0,0
55564,for,0,0
55565,successful,0,0
55566,pairing,0,0
55567,.,0,0
55568,The,0,0
55569,effect,0,0
55570,assessed,0,0
55571,at,0,0
55572,the,0,0
55573,end,0,0
55574,of,0,0
55575,supplementation,1,1
55576,showed,0,0
55577,that,0,0
55578,the,0,0
55579,intervention,0,1
55580,was,0,0
55581,beneficial,0,0
55582,.,0,0
55583,CONCLUSIONS,0,0
55584,Designing,0,0
55585,an,0,0
55586,intervention,0,1
55587,",",0,0
55588,choosing,0,0
55589,outcome,0,0
55590,variables,0,0
55591,",",0,0
55592,and,0,0
55593,implementing,0,1
55594,the,0,0
55595,protocol,0,0
55596,in,0,0
55597,a,0,0
55598,typical,0,0
55599,Indian,0,0
55600,school,0,0
55601,setting,0,0
55602,were,0,0
55603,achieved,0,0
55604,.,0,0
55605,Sleep-anticipating,0,0
55606,effects,0,0
55607,of,0,0
55608,melatonin,1,0
55609,in,0,0
55610,the,0,0
55611,human,0,0
55612,brain,0,0
55613,.,0,0
55614,Melatonin,1,0
55615,",",0,0
55616,the,0,0
55617,hormone,0,1
55618,produced,0,0
55619,nocturnally,0,0
55620,by,0,0
55621,the,0,0
55622,pineal,0,0
55623,gland,0,0
55624,",",0,0
55625,is,0,0
55626,an,0,0
55627,endogenous,0,0
55628,regulator,0,0
55629,of,0,0
55630,the,0,0
55631,sleep-wake,0,0
55632,cycle,0,0
55633,.,0,0
55634,The,0,0
55635,effects,0,0
55636,of,0,0
55637,melatonin,1,1
55638,on,0,0
55639,brain,0,0
55640,activities,0,0
55641,and,0,0
55642,their,0,0
55643,relation,0,0
55644,to,0,0
55645,induction,0,0
55646,of,0,0
55647,sleepiness,0,0
55648,were,0,0
55649,studied,0,0
55650,in,0,0
55651,a,0,0
55652,randomized,0,0
55653,",",0,0
55654,double-blind,0,0
55655,",",0,0
55656,placebo,1,1
55657,controlled,0,0
55658,functional,0,0
55659,magnetic,0,1
55660,resonance,0,1
55661,imaging,0,1
55662,(,0,1
55663,fMRI,0,0
55664,),0,1
55665,study,0,0
55666,.,0,0
55667,Melatonin,1,0
55668,",",0,0
55669,but,0,0
55670,not,0,0
55671,placebo,1,1
55672,",",0,0
55673,reduced,0,0
55674,task-related,0,0
55675,activity,0,0
55676,in,0,0
55677,the,0,0
55678,rostro-medial,0,0
55679,aspect,0,0
55680,of,0,0
55681,the,0,0
55682,occipital,0,0
55683,cortex,0,0
55684,during,0,0
55685,a,0,0
55686,visual-search,0,1
55687,task,0,1
55688,and,0,0
55689,in,0,0
55690,the,0,0
55691,auditory,0,1
55692,cortex,0,0
55693,during,0,0
55694,a,0,0
55695,music,0,1
55696,task,0,1
55697,.,0,0
55698,These,0,0
55699,effects,0,0
55700,correlated,0,0
55701,with,0,0
55702,subjective,0,0
55703,measurements,0,0
55704,of,0,0
55705,fatigue,0,0
55706,.,0,0
55707,In,0,0
55708,addition,0,0
55709,",",0,0
55710,melatonin,1,1
55711,enhanced,0,0
55712,the,0,0
55713,activation,0,0
55714,in,0,0
55715,the,0,0
55716,left,0,0
55717,parahippocampus,0,0
55718,in,0,0
55719,an,0,0
55720,autobiographic,0,0
55721,memory,0,0
55722,task,0,1
55723,.,0,0
55724,Results,0,0
55725,demonstrate,0,0
55726,that,0,0
55727,melatonin,1,1
55728,modulates,0,0
55729,brain,0,0
55730,activity,0,0
55731,in,0,0
55732,a,0,0
55733,manner,0,1
55734,resembling,0,0
55735,actual,0,0
55736,sleep,0,0
55737,although,0,0
55738,subjects,0,0
55739,are,0,0
55740,fully,0,0
55741,awake,0,1
55742,.,0,0
55743,Furthermore,0,0
55744,",",0,0
55745,the,0,0
55746,fatigue,0,0
55747,inducing,0,0
55748,effect,0,0
55749,of,0,0
55750,melatonin,1,1
55751,on,0,0
55752,brain,0,0
55753,activity,0,0
55754,is,0,0
55755,essentially,0,0
55756,different,0,0
55757,from,0,0
55758,that,0,0
55759,of,0,0
55760,sleep,0,0
55761,deprivation,0,1
55762,thus,0,0
55763,revealing,0,0
55764,differences,0,0
55765,between,0,0
55766,fatigues,0,0
55767,related,0,0
55768,to,0,0
55769,the,0,0
55770,circadian,0,0
55771,sleep,0,0
55772,regulation,0,0
55773,as,0,0
55774,opposed,0,0
55775,to,0,0
55776,increased,0,0
55777,homeostatic,0,0
55778,sleep,0,0
55779,need,0,0
55780,.,0,0
55781,Our,0,0
55782,findings,0,0
55783,highlight,0,0
55784,the,0,0
55785,role,0,0
55786,of,0,0
55787,melatonin,1,1
55788,in,0,0
55789,priming,0,1
55790,sleep-associated,0,1
55791,brain,0,0
55792,activation,0,0
55793,patterns,0,0
55794,in,0,0
55795,anticipation,0,0
55796,of,0,0
55797,sleep,0,0
55798,.,0,0
55799,[,0,0
55800,Effect,0,0
55801,of,0,0
55802,Selaginella,1,1
55803,combined,0,1
55804,with,0,0
55805,radiotherapy,1,1
55806,on,0,0
55807,nasopharyngeal,0,0
55808,carcinoma,0,0
55809,],0,0
55810,.,0,0
55811,OBJECTIVE,0,0
55812,To,0,0
55813,observe,0,0
55814,the,0,0
55815,Chinese,0,0
55816,herbal,0,1
55817,medicine,0,1
55818,Selaginella-induced,0,1
55819,radiosensitization,0,1
55820,of,0,0
55821,terminal,0,1
55822,nasopharyngeal,0,1
55823,carcinoma,0,0
55824,(,0,1
55825,NPC,0,1
55826,),0,0
55827,.,0,0
55828,METHODS,0,0
55829,Totally,0,0
55830,180,0,0
55831,patients,0,0
55832,with,0,0
55833,NPC,0,0
55834,were,0,0
55835,divided,0,0
55836,equally,0,0
55837,into,0,0
55838,3,0,0
55839,groups,0,0
55840,with,0,0
55841,the,0,0
55842,same,0,0
55843,radiotherapeutic,0,0
55844,protocols,0,0
55845,.,0,0
55846,The,0,0
55847,patients,0,0
55848,in,0,0
55849,group,1,0
55850,A,1,0
55851,received,1,1
55852,radiotherapy,1,1
55853,alone,1,1
55854,",",1,0
55855,those,1,0
55856,in,1,0
55857,group,1,0
55858,B,1,0
55859,were,1,0
55860,given,1,0
55861,daily,1,1
55862,Selaginella,1,1
55863,(,1,0
55864,30,1,1
55865,g,1,1
55866,),1,0
55867,prepared,1,1
55868,into,1,0
55869,50,1,0
55870,ml,1,1
55871,decoction,1,1
55872,during,1,0
55873,the,1,0
55874,entire,1,0
55875,course,1,0
55876,of,1,0
55877,radiotherapy,1,1
55878,",",0,0
55879,and,0,0
55880,those,0,0
55881,in,0,0
55882,group,1,0
55883,C,1,1
55884,had,1,0
55885,Selaginella,1,1
55886,30,1,0
55887,g,1,1
55888,daily,1,0
55889,in,1,0
55890,the,1,0
55891,late,1,0
55892,course,1,0
55893,of,1,0
55894,radiotherapy,1,1
55895,.,1,0
55896,RESULTS,0,0
55897,The,0,0
55898,complete,0,0
55899,remission,0,0
55900,rate,0,0
55901,of,0,0
55902,nasopharyngeal,0,0
55903,primary,0,0
55904,lesions,0,0
55905,in,0,0
55906,groups,0,0
55907,B,0,0
55908,and,0,0
55909,C,0,1
55910,was,0,0
55911,significantly,0,0
55912,higher,0,0
55913,than,0,0
55914,that,0,0
55915,in,0,0
55916,group,0,0
55917,A,0,0
55918,",",0,0
55919,with,0,0
55920,also,0,0
55921,significantly,0,0
55922,higher,0,0
55923,complete,0,0
55924,remission,0,0
55925,rates,0,0
55926,of,0,0
55927,the,0,0
55928,cervical,0,0
55929,lymph,0,0
55930,nodes,0,0
55931,.,0,0
55932,The,0,0
55933,acute,0,0
55934,toxicity,0,0
55935,of,0,0
55936,the,0,0
55937,skin,0,0
55938,and,0,0
55939,mucous,0,1
55940,membrane,0,0
55941,was,0,0
55942,milder,0,0
55943,in,0,0
55944,the,0,0
55945,latter,0,0
55946,two,0,0
55947,groups,0,0
55948,",",0,0
55949,but,0,0
55950,the,0,0
55951,differences,0,0
55952,were,0,0
55953,not,0,0
55954,significant,0,0
55955,.,0,0
55956,CONCLUSION,0,0
55957,Selaginella,1,1
55958,may,0,0
55959,induce,0,0
55960,radiosensitization,0,0
55961,for,0,0
55962,terminal,0,1
55963,NPC,0,1
55964,and,0,0
55965,does,0,0
55966,not,0,0
55967,increase,0,0
55968,the,0,0
55969,acute,0,0
55970,toxicity,0,0
55971,of,0,0
55972,radiotherapy,0,1
55973,.,0,0
55974,Risperidone,1,1
55975,and,0,0
55976,adaptive,0,1
55977,behavior,0,0
55978,in,0,0
55979,children,0,0
55980,with,0,0
55981,autism,0,0
55982,.,0,0
55983,OBJECTIVE,0,0
55984,To,0,0
55985,evaluate,0,0
55986,the,0,0
55987,impact,0,0
55988,of,0,0
55989,risperidone,1,1
55990,on,0,0
55991,adaptive,0,0
55992,behavior,0,0
55993,in,0,0
55994,children,0,0
55995,with,0,0
55996,autistic,0,0
55997,disorder,0,0
55998,who,0,0
55999,have,0,0
56000,serious,0,0
56001,behavior,0,0
56002,problems,0,0
56003,and,0,0
56004,to,0,0
56005,examine,0,0
56006,different,0,0
56007,methods,0,0
56008,of,0,0
56009,scoring,0,0
56010,the,0,0
56011,Vineland,0,1
56012,Adaptive,0,0
56013,Behavior,0,0
56014,Scales,0,1
56015,to,0,0
56016,measure,0,0
56017,change,0,0
56018,.,0,0
56019,METHOD,0,0
56020,Forty-eight,0,0
56021,children,0,0
56022,(,0,0
56023,5,0,0
56024,years,0,0
56025,to,0,0
56026,16,0,0
56027,years,0,0
56028,",",0,0
56029,5,0,0
56030,months,0,0
56031,),0,0
56032,who,0,0
56033,showed,0,0
56034,behavioral,0,1
56035,improvement,0,0
56036,during,0,0
56037,acute,0,0
56038,treatment,0,0
56039,with,0,0
56040,risperidone,1,1
56041,were,1,0
56042,followed,1,1
56043,for,1,0
56044,6,1,0
56045,months,1,0
56046,and,0,0
56047,assessed,0,0
56048,with,0,0
56049,the,0,0
56050,Vineland,0,0
56051,Scales,0,0
56052,.,0,0
56053,RESULTS,0,0
56054,Raw,0,1
56055,scores,0,0
56056,",",0,0
56057,age-equivalents,0,0
56058,",",0,0
56059,and,0,0
56060,special,0,1
56061,norm,0,0
56062,percentile,0,0
56063,scores,0,0
56064,all,0,0
56065,showed,0,0
56066,significant,0,0
56067,increases,0,0
56068,in,0,0
56069,adaptive,0,0
56070,behavior,0,0
56071,in,0,0
56072,the,0,0
56073,areas,0,0
56074,of,0,0
56075,communication,0,0
56076,",",0,0
56077,daily,0,1
56078,living,0,0
56079,skills,0,1
56080,",",0,0
56081,and,0,0
56082,socialization,0,1
56083,(,0,1
56084,p,0,0
56085,<,0,0
56086,.01,0,0
56087,),0,0
56088,.,0,0
56089,During,0,0
56090,a,0,0
56091,period,0,0
56092,of,0,0
56093,6,0,0
56094,to,0,0
56095,8,0,0
56096,months,0,0
56097,",",0,0
56098,children,0,0
56099,gained,0,0
56100,an,0,0
56101,average,0,0
56102,of,0,0
56103,7.8,0,0
56104,age-equivalent,0,0
56105,months,0,0
56106,in,0,0
56107,the,0,0
56108,area,0,0
56109,of,0,0
56110,socialization,0,0
56111,",",0,0
56112,a,0,0
56113,>,0,0
56114,6,0,0
56115,%,0,0
56116,improvement,0,0
56117,beyond,0,0
56118,what,0,0
56119,would,0,0
56120,be,0,0
56121,expected,0,0
56122,based,0,0
56123,on,0,0
56124,baseline,0,0
56125,growth,0,0
56126,rates,0,0
56127,.,0,0
56128,CONCLUSIONS,0,0
56129,Although,0,0
56130,limited,0,0
56131,by,0,0
56132,the,0,0
56133,absence,0,0
56134,of,0,0
56135,a,0,0
56136,control,0,1
56137,group,0,0
56138,",",0,0
56139,these,0,0
56140,results,0,0
56141,suggest,0,0
56142,that,0,0
56143,risperidone,0,1
56144,may,0,0
56145,improve,0,0
56146,adaptive,0,0
56147,skills,0,0
56148,in,0,0
56149,children,0,0
56150,with,0,0
56151,autistic,0,0
56152,disorder,0,0
56153,accompanied,0,0
56154,by,0,0
56155,serious,0,0
56156,behavioral,0,1
56157,problems,0,0
56158,.,0,0
56159,Vineland,0,0
56160,age-equivalent,0,0
56161,scores,0,0
56162,appear,0,0
56163,to,0,0
56164,be,0,0
56165,most,0,0
56166,useful,0,0
56167,in,0,0
56168,assessing,0,0
56169,change,0,0
56170,with,0,0
56171,treatment,0,0
56172,over,0,0
56173,time,0,0
56174,.,0,0
56175,Evaluation,0,0
56176,of,0,0
56177,a,0,0
56178,novel,1,0
56179,technique,1,1
56180,for,0,0
56181,wound,1,0
56182,closure,1,0
56183,using,1,0
56184,a,1,0
56185,barbed,1,1
56186,suture,1,1
56187,.,1,0
56188,BACKGROUND,0,0
56189,Suture,0,0
56190,knots,0,1
56191,present,0,0
56192,several,0,0
56193,disadvantages,0,0
56194,in,0,0
56195,wound,0,0
56196,closure,0,0
56197,",",0,0
56198,because,0,0
56199,they,0,0
56200,are,0,0
56201,tedious,0,0
56202,to,0,0
56203,tie,0,1
56204,and,0,0
56205,place,0,0
56206,ischemic,0,0
56207,demands,0,0
56208,on,0,0
56209,tissue,0,0
56210,.,0,0
56211,Bulky,0,0
56212,knots,0,0
56213,may,0,0
56214,be,0,0
56215,a,0,0
56216,nidus,0,0
56217,for,0,0
56218,infection,0,0
56219,",",0,0
56220,and,0,0
56221,they,0,0
56222,may,0,0
56223,extrude,0,0
56224,through,0,0
56225,skin,0,0
56226,weeks,0,0
56227,after,0,0
56228,surgery,0,0
56229,.,0,0
56230,Needle,0,1
56231,manipulations,0,0
56232,during,0,0
56233,knot-tying,0,1
56234,predispose,0,0
56235,the,0,0
56236,surgeon,0,0
56237,to,0,0
56238,glove,0,1
56239,perforation,0,0
56240,.,0,0
56241,A,0,0
56242,barbed,1,1
56243,suture,1,1
56244,was,0,0
56245,developed,0,0
56246,that,0,0
56247,is,0,0
56248,self-anchoring,0,0
56249,",",0,0
56250,requiring,0,0
56251,no,0,0
56252,knots,0,1
56253,or,0,0
56254,slack,0,0
56255,management,0,1
56256,for,0,0
56257,wound,0,0
56258,closure,0,0
56259,.,0,0
56260,The,0,0
56261,elimination,0,0
56262,of,0,0
56263,knot,0,1
56264,tying,0,1
56265,may,0,0
56266,have,0,0
56267,advantages,0,0
56268,over,0,0
56269,conventional,0,1
56270,wound,0,0
56271,closure,0,0
56272,methods,0,0
56273,.,0,0
56274,METHODS,0,0
56275,This,0,0
56276,prospective,0,0
56277,",",0,0
56278,randomized,0,0
56279,",",0,0
56280,controlled,0,0
56281,trial,0,0
56282,was,0,0
56283,designed,0,0
56284,to,0,0
56285,show,0,0
56286,that,0,0
56287,the,0,0
56288,use,0,0
56289,of,0,0
56290,barbed,1,1
56291,suture,1,1
56292,in,0,0
56293,dermal,0,1
56294,closure,0,0
56295,of,0,0
56296,the,0,0
56297,Pfannenstiel,0,1
56298,incision,0,1
56299,during,0,0
56300,nonemergent,0,0
56301,cesarean,0,0
56302,delivery,0,0
56303,surgery,0,1
56304,produces,0,0
56305,scar,0,0
56306,cosmesis,0,0
56307,at,0,0
56308,5,0,0
56309,weeks,0,0
56310,that,0,0
56311,is,0,0
56312,no,0,0
56313,worse,0,0
56314,than,0,0
56315,that,0,0
56316,observed,0,0
56317,with,0,0
56318,conventional,1,1
56319,closure,1,0
56320,using,0,0
56321,3-0,1,1
56322,polydioxanone,1,1
56323,suture,1,1
56324,.,1,0
56325,Cosmesis,0,0
56326,was,0,0
56327,assessed,0,0
56328,by,0,0
56329,review,0,0
56330,of,0,0
56331,postoperative,0,0
56332,photographs,0,0
56333,by,0,0
56334,a,0,0
56335,blinded,0,0
56336,",",0,0
56337,independent,0,0
56338,plastic,0,1
56339,surgeon,0,1
56340,using,0,0
56341,the,0,0
56342,modified,0,0
56343,Hollander,0,0
56344,cosmesis,0,0
56345,score,0,0
56346,.,0,0
56347,Secondary,0,0
56348,endpoints,0,0
56349,included,0,0
56350,infection,0,0
56351,",",0,0
56352,dehiscence,0,0
56353,",",0,0
56354,pain,0,0
56355,",",0,0
56356,closure,0,0
56357,time,0,0
56358,",",0,0
56359,and,0,0
56360,other,0,0
56361,adverse,0,0
56362,events,0,0
56363,.,0,0
56364,RESULTS,0,0
56365,The,0,0
56366,study,0,0
56367,enrolled,0,0
56368,195,0,0
56369,patients,0,0
56370,",",0,0
56371,of,0,0
56372,whom,0,0
56373,188,0,0
56374,were,0,0
56375,eligible,0,0
56376,for,0,0
56377,analysis,0,0
56378,.,0,0
56379,Cosmesis,0,0
56380,scores,0,0
56381,did,0,0
56382,not,0,0
56383,significantly,0,0
56384,differ,0,0
56385,between,0,0
56386,the,0,0
56387,barbed,0,1
56388,suture,0,1
56389,group,0,0
56390,and,0,0
56391,the,0,0
56392,control,0,1
56393,group,0,0
56394,.,0,0
56395,Rates,0,0
56396,of,0,0
56397,infection,0,0
56398,",",0,0
56399,dehiscence,0,0
56400,",",0,0
56401,and,0,0
56402,other,0,0
56403,adverse,0,0
56404,events,0,0
56405,did,0,0
56406,not,0,0
56407,significantly,0,0
56408,differ,0,0
56409,between,0,0
56410,the,0,0
56411,two,0,0
56412,groups,0,0
56413,.,0,0
56414,Closure,0,1
56415,time,0,0
56416,and,0,0
56417,pain,0,0
56418,scores,0,0
56419,were,0,0
56420,comparable,0,0
56421,between,0,0
56422,the,0,0
56423,groups,0,0
56424,.,0,0
56425,CONCLUSIONS,0,0
56426,The,0,0
56427,barbed,0,1
56428,suture,0,1
56429,represents,0,0
56430,an,0,0
56431,innovative,0,0
56432,option,0,0
56433,for,0,0
56434,wound,0,0
56435,closure,0,0
56436,.,0,0
56437,With,0,0
56438,a,0,0
56439,cosmesis,0,0
56440,and,0,0
56441,safety,0,0
56442,profile,0,0
56443,that,0,0
56444,is,0,0
56445,similar,0,0
56446,to,0,0
56447,that,0,0
56448,of,0,0
56449,conventional,1,1
56450,suture,1,1
56451,technique,0,1
56452,",",0,0
56453,it,0,0
56454,avoids,0,0
56455,the,0,0
56456,drawbacks,0,0
56457,inherent,0,0
56458,to,0,0
56459,suture,0,1
56460,knots,0,0
56461,.,0,0
56462,Endurance,0,1
56463,training,0,1
56464,has,0,0
56465,little,0,0
56466,effect,0,0
56467,on,0,0
56468,active,0,1
56469,muscle,0,0
56470,free,0,0
56471,fatty,0,1
56472,acid,0,1
56473,",",0,0
56474,lipoprotein,0,0
56475,cholesterol,0,0
56476,",",0,0
56477,or,0,1
56478,triglyceride,0,0
56479,net,0,0
56480,balances,0,0
56481,.,0,0
56482,We,0,0
56483,evaluated,0,0
56484,the,0,0
56485,hypothesis,0,0
56486,that,0,0
56487,net,0,0
56488,leg,0,0
56489,total,0,0
56490,FFA,0,0
56491,",",0,0
56492,LDL-C,0,1
56493,",",0,0
56494,and,0,0
56495,TG,0,1
56496,uptake,0,0
56497,and,0,0
56498,HDL-C,0,1
56499,release,0,0
56500,during,0,0
56501,moderate-intensity,0,1
56502,cycling,0,0
56503,exercise,0,1
56504,would,0,0
56505,be,0,0
56506,increased,0,0
56507,following,0,0
56508,endurance,0,0
56509,training,0,1
56510,.,0,0
56511,Eight,0,0
56512,sedentary,0,0
56513,men,0,0
56514,(,0,0
56515,26,0,0
56516,+/-,0,0
56517,1,0,0
56518,yr,0,0
56519,",",0,0
56520,77.4,0,0
56521,+/-,0,0
56522,3.7,0,0
56523,kg,0,0
56524,),0,0
56525,were,0,0
56526,studied,0,0
56527,in,0,0
56528,the,0,0
56529,postprandial,0,0
56530,state,0,0
56531,during,0,0
56532,90,1,0
56533,min,1,0
56534,of,1,0
56535,rest,1,0
56536,and,1,0
56537,60,1,0
56538,min,1,0
56539,of,1,0
56540,exercise,1,1
56541,twice,1,1
56542,before,0,0
56543,(,0,0
56544,45,0,0
56545,%,0,0
56546,and,0,0
56547,65,0,0
56548,%,0,0
56549,V,0,1
56550,(,0,1
56551,O2,0,1
56552,peak,0,0
56553,),0,1
56554,),0,1
56555,and,0,0
56556,twice,0,1
56557,after,0,0
56558,9,1,0
56559,wk,1,0
56560,of,1,0
56561,endurance,1,0
56562,training,1,1
56563,(,0,0
56564,55,0,0
56565,%,0,0
56566,and,0,0
56567,65,0,0
56568,%,0,0
56569,posttraining,0,1
56570,V,0,1
56571,(,0,1
56572,O2,0,1
56573,peak,0,0
56574,),0,0
56575,),0,0
56576,.,0,0
56577,Measurements,0,0
56578,across,0,0
56579,an,0,0
56580,exercising,0,1
56581,leg,0,0
56582,were,0,0
56583,taken,0,0
56584,to,0,0
56585,be,0,0
56586,a,0,0
56587,surrogate,0,0
56588,for,0,0
56589,active,0,1
56590,skeletal,0,0
56591,muscle,0,0
56592,.,0,0
56593,To,0,0
56594,determine,0,0
56595,limb,0,0
56596,lipid,0,0
56597,exchange,0,1
56598,",",0,0
56599,femoral,0,1
56600,arterial,0,0
56601,and,0,0
56602,venous,0,1
56603,blood,0,0
56604,samples,0,0
56605,drawn,0,0
56606,simultaneously,0,1
56607,at,0,0
56608,rest,0,0
56609,and,0,0
56610,during,0,0
56611,exercise,0,1
56612,were,0,0
56613,analyzed,0,0
56614,for,0,0
56615,total,0,0
56616,and,0,0
56617,individual,0,1
56618,FFA,0,1
56619,(,0,1
56620,e.g.,0,0
56621,",",0,0
56622,palmitate,0,1
56623,",",0,0
56624,oleate,0,1
56625,),0,0
56626,",",0,0
56627,LDL-C,0,1
56628,",",0,0
56629,HDL-C,0,1
56630,",",0,0
56631,and,0,0
56632,TG,0,1
56633,concentrations,0,0
56634,",",0,0
56635,and,0,0
56636,limb,0,0
56637,blood,0,0
56638,flow,0,0
56639,was,0,0
56640,determined,0,0
56641,by,0,0
56642,thermodilution,0,0
56643,.,0,0
56644,The,0,0
56645,transition,0,0
56646,from,0,0
56647,rest,0,0
56648,to,0,0
56649,exercise,0,1
56650,resulted,0,0
56651,in,0,0
56652,a,0,0
56653,shift,0,0
56654,from,0,0
56655,net,0,0
56656,leg,0,0
56657,total,0,0
56658,FFA,0,1
56659,release,0,1
56660,(,0,0
56661,-44,0,0
56662,+/-,0,0
56663,16,0,0
56664,micromol/min,0,0
56665,),0,0
56666,to,0,0
56667,uptake,0,0
56668,(,0,0
56669,193,0,0
56670,+/-,0,0
56671,49,0,0
56672,micromol/min,0,0
56673,),0,0
56674,that,0,0
56675,was,0,0
56676,unaffected,0,0
56677,by,0,0
56678,either,0,1
56679,exercise,0,1
56680,intensity,0,0
56681,or,0,1
56682,endurance,0,0
56683,training,0,1
56684,.,0,0
56685,The,0,0
56686,relative,0,0
56687,net,0,0
56688,leg,0,0
56689,release,0,1
56690,and,0,0
56691,uptake,0,0
56692,of,0,0
56693,individual,0,0
56694,FFA,0,0
56695,closely,0,0
56696,resembled,0,0
56697,their,0,0
56698,relative,0,0
56699,abundances,0,0
56700,in,0,0
56701,the,0,0
56702,plasma,0,0
56703,with,0,0
56704,approximately,0,0
56705,21,0,0
56706,and,0,0
56707,41,0,0
56708,%,0,0
56709,of,0,0
56710,net,0,0
56711,leg,0,0
56712,total,0,0
56713,FFA,0,0
56714,uptake,0,0
56715,during,0,0
56716,exercise,0,1
56717,accounted,0,0
56718,for,0,0
56719,by,0,0
56720,palmitate,0,1
56721,and,0,0
56722,oleate,0,1
56723,",",0,0
56724,respectively,0,0
56725,.,0,0
56726,Endurance,1,1
56727,training,1,1
56728,resulted,0,0
56729,in,0,0
56730,significant,0,0
56731,changes,0,0
56732,in,0,0
56733,arterial,0,0
56734,concentrations,0,0
56735,of,0,0
56736,HDL-C,0,1
56737,(,0,0
56738,49,0,0
56739,+/-,0,0
56740,5,0,0
56741,vs.,0,0
56742,52,0,0
56743,+/-,0,0
56744,5,0,0
56745,mg/dl,0,0
56746,",",0,0
56747,pre,0,0
56748,vs.,0,0
56749,post,0,0
56750,),0,1
56751,and,0,1
56752,LDL-C,0,1
56753,(,0,1
56754,82,0,0
56755,+/-,0,0
56756,9,0,0
56757,vs.,0,0
56758,76,0,0
56759,+/-,0,0
56760,9,0,0
56761,mg/dl,0,0
56762,",",0,0
56763,pre,0,0
56764,vs.,0,0
56765,post,0,0
56766,),0,0
56767,",",0,0
56768,but,0,0
56769,there,0,0
56770,was,0,0
56771,no,0,0
56772,net,0,0
56773,TG,0,0
56774,or,0,1
56775,LDL-C,0,1
56776,uptake,0,0
56777,or,0,1
56778,HDL-C,0,1
56779,release,0,0
56780,across,0,0
56781,the,0,0
56782,resting,0,0
56783,or,0,1
56784,active,0,1
56785,leg,0,0
56786,before,0,0
56787,or,0,1
56788,after,0,0
56789,endurance,0,0
56790,training,0,1
56791,.,0,0
56792,In,0,0
56793,conclusion,0,0
56794,",",0,0
56795,endurance,0,0
56796,training,0,1
56797,favorably,0,1
56798,affects,0,0
56799,blood,0,0
56800,lipoprotein,0,0
56801,profiles,0,0
56802,",",0,0
56803,even,0,0
56804,in,0,0
56805,young,0,0
56806,",",0,0
56807,healthy,0,0
56808,normolipidemic,0,0
56809,men,0,0
56810,",",0,0
56811,but,0,0
56812,muscle,0,0
56813,contractions,0,1
56814,per,0,0
56815,se,0,0
56816,have,0,0
56817,little,0,0
56818,effect,0,0
56819,on,0,0
56820,net,0,0
56821,leg,0,0
56822,LDL-C,0,1
56823,",",0,0
56824,or,0,1
56825,TG,0,1
56826,uptake,0,0
56827,or,0,1
56828,HDL-C,0,1
56829,release,0,0
56830,during,0,0
56831,moderate-intensity,0,1
56832,cycling,0,0
56833,exercise,0,1
56834,.,0,0
56835,Therefore,0,0
56836,",",0,0
56837,the,0,0
56838,favorable,0,0
56839,effects,0,0
56840,of,0,0
56841,physical,0,1
56842,activity,0,0
56843,on,0,0
56844,the,0,0
56845,lipid,0,0
56846,profiles,0,0
56847,of,0,0
56848,young,0,0
56849,",",0,0
56850,healthy,0,0
56851,normolipidemic,0,0
56852,men,0,0
56853,in,0,0
56854,the,0,0
56855,postprandial,0,0
56856,state,0,0
56857,are,0,0
56858,not,0,0
56859,attributable,0,0
56860,to,0,0
56861,changes,0,0
56862,in,0,0
56863,HDL-C,0,1
56864,or,0,1
56865,LDL-C,0,1
56866,exchange,0,1
56867,across,0,0
56868,active,0,1
56869,skeletal,0,0
56870,muscle,0,0
56871,.,0,0
56872,Effect,0,0
56873,of,0,0
56874,step,1,0
56875,aerobics,1,1
56876,training,1,1
56877,on,0,0
56878,anaerobic,0,0
56879,performance,0,0
56880,of,0,0
56881,men,0,0
56882,and,0,0
56883,women,0,0
56884,.,0,0
56885,The,0,0
56886,purpose,0,0
56887,of,0,0
56888,this,0,0
56889,study,0,0
56890,was,0,0
56891,to,0,0
56892,investigate,0,0
56893,the,0,0
56894,effects,0,0
56895,of,0,0
56896,10,0,0
56897,weeks,0,0
56898,of,0,0
56899,step,1,0
56900,aerobics,1,1
56901,training,1,1
56902,on,0,0
56903,anaerobic,0,0
56904,performance,0,0
56905,of,0,0
56906,men,0,0
56907,and,0,0
56908,women,0,0
56909,.,0,0
56910,College-age,0,0
56911,volunteers,0,0
56912,(,0,0
56913,64,0,0
56914,women,0,0
56915,and,0,0
56916,54,0,0
56917,men,0,0
56918,),0,0
56919,were,0,0
56920,divided,0,0
56921,into,0,0
56922,step,1,0
56923,aerobics,1,1
56924,(,0,0
56925,33,0,0
56926,women,0,0
56927,",",0,0
56928,27,0,0
56929,men,0,0
56930,),0,0
56931,and,0,0
56932,control,1,1
56933,(,0,0
56934,31,0,0
56935,women,0,0
56936,",",0,0
56937,27,0,0
56938,men,0,0
56939,),0,0
56940,groups,0,0
56941,.,0,0
56942,Before,0,0
56943,and,0,0
56944,after,0,0
56945,the,0,0
56946,10-week,0,1
56947,period,0,0
56948,",",0,0
56949,the,0,0
56950,subjects,0,0
56951,',0,0
56952,body,0,0
56953,composition,0,0
56954,",",0,0
56955,muscular,0,0
56956,strength,0,0
56957,",",0,0
56958,Wingate,0,1
56959,anaerobic,0,0
56960,performance,0,0
56961,",",0,0
56962,and,0,0
56963,vertical,0,1
56964,jump,0,0
56965,anaerobic,0,0
56966,performance,0,0
56967,were,0,0
56968,determined,0,0
56969,.,0,0
56970,The,0,0
56971,step,1,0
56972,aerobics,1,1
56973,group,0,0
56974,participated,0,0
56975,in,0,0
56976,step,1,0
56977,aerobics,1,1
56978,sessions,0,1
56979,of,0,0
56980,50,0,0
56981,minutes,0,0
56982,per,0,0
56983,day,0,0
56984,",",0,0
56985,3,0,0
56986,days,0,0
56987,per,0,0
56988,week,0,0
56989,for,0,0
56990,10,0,0
56991,weeks,0,0
56992,",",0,0
56993,at,0,0
56994,60-80,0,0
56995,%,0,0
56996,of,0,0
56997,their,0,0
56998,heart,0,0
56999,rate,0,0
57000,reserve,0,0
57001,.,0,0
57002,Results,0,0
57003,of,0,0
57004,2,0,0
57005,x,0,0
57006,2,0,0
57007,analysis,0,0
57008,of,0,0
57009,covariance,0,0
57010,with,0,0
57011,repeated,0,0
57012,measures,0,0
57013,indicated,0,0
57014,significant,0,0
57015,sex,0,0
57016,differences,0,0
57017,in,0,0
57018,percentage,0,0
57019,body,0,0
57020,fat,0,0
57021,",",0,0
57022,lean,0,0
57023,body,0,0
57024,mass,0,0
57025,",",0,0
57026,muscular,0,0
57027,strength,0,0
57028,",",0,0
57029,and,0,0
57030,in,0,0
57031,all,0,0
57032,of,0,0
57033,the,0,0
57034,measured,0,0
57035,indices,0,0
57036,of,0,0
57037,the,0,0
57038,Wingate,0,1
57039,Anaerobic,0,1
57040,Test,0,0
57041,.,0,0
57042,The,0,0
57043,step,0,0
57044,aerobics,1,1
57045,group,0,0
57046,showed,0,0
57047,significant,0,0
57048,improvement,0,0
57049,only,0,0
57050,in,0,0
57051,mean,0,0
57052,power,0,0
57053,relative,0,0
57054,to,0,0
57055,body,0,0
57056,weight,0,0
57057,compared,0,0
57058,with,0,0
57059,the,0,0
57060,control,0,1
57061,group,0,0
57062,and,0,0
57063,women,0,0
57064,showed,0,0
57065,significant,0,0
57066,improvement,0,0
57067,only,0,0
57068,in,0,0
57069,anaerobic,0,0
57070,power,0,0
57071,of,0,0
57072,vertical,0,0
57073,jump,0,0
57074,when,0,0
57075,compared,0,0
57076,with,0,0
57077,men,0,0
57078,.,0,0
57079,It,0,0
57080,can,0,0
57081,be,0,0
57082,concluded,0,0
57083,that,0,0
57084,10,0,0
57085,weeks,0,0
57086,of,0,0
57087,step,0,0
57088,aerobics,0,1
57089,was,0,0
57090,not,0,0
57091,effective,0,0
57092,in,0,0
57093,improving,0,0
57094,all,0,0
57095,of,0,0
57096,the,0,0
57097,measured,0,0
57098,anaerobic,0,0
57099,indices,0,0
57100,in,0,0
57101,men,0,0
57102,and,0,0
57103,women,0,0
57104,.,0,0
57105,Thromboprophylaxis,0,1
57106,by,0,0
57107,low-molecular-weight,1,1
57108,heparin,1,1
57109,in,0,0
57110,elective,0,1
57111,hip,0,0
57112,surgery,0,1
57113,.,0,0
57114,A,0,0
57115,placebo,1,1
57116,controlled,0,0
57117,study,0,0
57118,.,0,0
57119,In,0,0
57120,a,0,0
57121,double-blind,0,0
57122,",",0,0
57123,randomised,0,0
57124,study,0,0
57125,of,0,0
57126,thromboprophylaxis,0,1
57127,in,0,0
57128,patients,0,0
57129,undergoing,0,0
57130,total,0,0
57131,hip,0,0
57132,replacement,0,1
57133,",",0,0
57134,we,0,0
57135,compared,0,0
57136,a,0,0
57137,low-molecular-weight,1,1
57138,heparin,1,1
57139,with,1,0
57140,a,1,0
57141,placebo,1,1
57142,.,1,0
57143,Of,0,0
57144,the,0,0
57145,120,0,0
57146,patients,0,0
57147,enrolled,0,0
57148,",",0,0
57149,112,0,0
57150,completed,0,0
57151,the,0,0
57152,trial,0,0
57153,;,0,0
57154,58,0,0
57155,in,0,0
57156,the,0,0
57157,treatment,0,1
57158,group,0,0
57159,and,0,0
57160,54,0,0
57161,in,0,0
57162,the,0,0
57163,placebo,0,1
57164,group,0,0
57165,.,0,1
57166,Nine,0,1
57167,(,0,0
57168,16,0,0
57169,%,0,0
57170,),0,0
57171,patients,0,0
57172,in,0,0
57173,the,0,0
57174,treatment,0,1
57175,group,0,0
57176,and,0,0
57177,19,0,0
57178,(,0,0
57179,35,0,0
57180,%,0,0
57181,),0,0
57182,in,0,0
57183,the,0,0
57184,placebo,1,1
57185,group,0,0
57186,developed,0,0
57187,deep,0,1
57188,venous,0,0
57189,thrombosis,0,0
57190,",",0,0
57191,diagnosed,0,0
57192,by,0,0
57193,the,0,0
57194,125I-fibrinogen,0,1
57195,uptake,0,0
57196,test,0,1
57197,(,0,0
57198,p,0,0
57199,<,0,0
57200,0.02,0,0
57201,),0,0
57202,.,0,0
57203,Verification,0,0
57204,was,0,0
57205,obtained,0,0
57206,by,0,0
57207,phlebography,0,1
57208,in,0,0
57209,86,0,0
57210,%,0,0
57211,of,0,0
57212,the,0,0
57213,patients,0,0
57214,.,0,0
57215,Prolonged,0,0
57216,surgery,0,0
57217,increased,0,0
57218,the,0,0
57219,risk,0,0
57220,of,0,0
57221,thrombosis,0,0
57222,in,0,0
57223,the,0,0
57224,placebo,0,1
57225,group,0,0
57226,but,0,0
57227,not,0,0
57228,in,0,0
57229,the,0,0
57230,treatment,0,1
57231,group,0,0
57232,(,0,0
57233,p,0,0
57234,<,0,0
57235,0.05,0,0
57236,),0,0
57237,.,0,0
57238,There,0,0
57239,were,0,0
57240,significantly,0,0
57241,more,0,0
57242,cases,0,0
57243,of,0,0
57244,deep,0,1
57245,venous,0,0
57246,thrombosis,0,0
57247,in,0,0
57248,the,0,0
57249,placebo,0,1
57250,group,0,0
57251,during,0,0
57252,the,0,0
57253,first,0,0
57254,four,0,0
57255,postoperative,0,0
57256,days,0,0
57257,(,0,0
57258,p,0,0
57259,<,0,0
57260,0.02,0,0
57261,),0,0
57262,.,0,0
57263,The,0,0
57264,groups,0,0
57265,did,0,0
57266,not,0,0
57267,differ,0,0
57268,with,0,0
57269,respect,0,0
57270,to,0,0
57271,peroperative,0,0
57272,and,0,0
57273,postoperative,0,0
57274,bleeding,0,0
57275,.,0,0
57276,Low-molecular-weight,1,1
57277,heparin,1,1
57278,offers,0,0
57279,safe,0,0
57280,and,0,0
57281,easily,0,1
57282,administered,0,0
57283,thromboprophylaxis,0,1
57284,in,0,0
57285,total,0,0
57286,hip,0,0
57287,replacement,0,1
57288,.,0,0
57289,A,0,0
57290,randomised,0,0
57291,trial,0,0
57292,comparing,0,0
57293,holmium,1,1
57294,laser,1,1
57295,enucleation,1,1
57296,versus,0,1
57297,transurethral,1,1
57298,resection,1,1
57299,in,0,0
57300,the,0,0
57301,treatment,0,0
57302,of,0,0
57303,prostates,0,0
57304,larger,0,0
57305,than,0,0
57306,40,0,0
57307,grams,0,0
57308,:,0,0
57309,results,0,0
57310,at,0,0
57311,2,0,0
57312,years,0,0
57313,.,0,0
57314,OBJECTIVE,0,0
57315,To,0,0
57316,compare,0,0
57317,holmium,1,1
57318,laser,1,1
57319,enucleation,1,0
57320,of,1,0
57321,the,1,0
57322,prostate,1,0
57323,(,1,1
57324,HoLEP,1,1
57325,),1,1
57326,with,0,0
57327,transurethral,1,1
57328,resection,1,1
57329,of,1,0
57330,the,1,0
57331,prostate,1,0
57332,(,1,1
57333,TURP,1,0
57334,),1,1
57335,for,0,0
57336,treatment,0,0
57337,of,0,0
57338,men,0,0
57339,with,0,0
57340,bladder,0,0
57341,outflow,0,0
57342,obstruction,0,0
57343,(,0,1
57344,BOO,0,0
57345,),0,1
57346,secondary,0,0
57347,to,0,0
57348,benign,0,0
57349,prostatic,0,0
57350,hyperplasia,0,0
57351,with,0,0
57352,a,0,0
57353,minimum,0,0
57354,of,0,0
57355,24-month,0,0
57356,follow-up,0,0
57357,.,0,0
57358,PATIENTS,0,0
57359,AND,0,0
57360,METHODS,0,0
57361,Sixty-one,0,0
57362,patients,0,0
57363,were,0,0
57364,randomised,0,0
57365,to,0,0
57366,either,0,1
57367,HoLEP,1,1
57368,or,0,1
57369,TURP,1,0
57370,.,1,0
57371,All,0,0
57372,patients,0,0
57373,had,0,0
57374,BOO,0,0
57375,proven,0,0
57376,on,0,0
57377,urodynamic,0,0
57378,studies,0,0
57379,pre-operatively,0,0
57380,(,0,0
57381,prostate,0,0
57382,size,0,0
57383,40-200,0,1
57384,g,0,1
57385,),0,0
57386,.,0,0
57387,One,0,0
57388,patient,0,0
57389,died,0,0
57390,before,0,0
57391,treatment,0,0
57392,",",0,0
57393,which,0,0
57394,left,0,0
57395,30,0,0
57396,patients,0,0
57397,in,0,0
57398,each,0,0
57399,group,0,0
57400,.,0,0
57401,Perioperative,0,0
57402,data,0,0
57403,",",0,0
57404,as,0,0
57405,well,0,0
57406,as,0,0
57407,symptom,0,0
57408,scores,0,0
57409,",",0,0
57410,Quality,0,0
57411,of,0,0
57412,Life,0,0
57413,(,0,1
57414,QoL,0,0
57415,),0,1
57416,scores,0,0
57417,",",0,0
57418,and,0,0
57419,maximum,0,0
57420,urinary,0,0
57421,flow,0,0
57422,rates,0,0
57423,(,0,0
57424,Qmax,0,0
57425,),0,1
57426,were,0,0
57427,obtained,0,0
57428,at,0,0
57429,one,0,0
57430,",",0,0
57431,three,0,0
57432,",",0,0
57433,"six,12",0,0
57434,",",0,0
57435,and,0,0
57436,24,0,0
57437,months,0,0
57438,.,0,0
57439,Post-void,0,0
57440,residual,0,0
57441,volumes,0,0
57442,",",0,0
57443,transrectal,0,1
57444,ultrasound,0,1
57445,(,0,1
57446,TRUS,0,1
57447,),0,1
57448,volumes,0,0
57449,",",0,0
57450,and,0,0
57451,pressure,0,0
57452,flow,0,0
57453,studies,0,0
57454,were,0,0
57455,obtained,0,0
57456,six,0,0
57457,months,0,0
57458,post-operatively,0,0
57459,.,0,0
57460,Continence,0,0
57461,and,0,0
57462,potency,0,0
57463,data,0,0
57464,were,0,0
57465,also,0,0
57466,recorded,0,0
57467,.,0,0
57468,RESULTS,0,0
57469,There,0,0
57470,were,0,0
57471,no,0,0
57472,significant,0,0
57473,differences,0,0
57474,between,0,0
57475,the,0,0
57476,two,0,0
57477,surgical,0,0
57478,groups,0,0
57479,pre-operatively,0,0
57480,.,0,0
57481,Mean,0,0
57482,pre-operative,0,0
57483,TRUS,0,1
57484,volume,0,0
57485,was,0,0
57486,77.8+/-5.6,0,0
57487,g,0,1
57488,(,0,1
57489,42-152,0,1
57490,),0,0
57491,in,0,0
57492,the,0,0
57493,HoLEP,0,1
57494,group,0,0
57495,and,0,0
57496,70.0+/-5.0,0,0
57497,g,0,1
57498,(,0,1
57499,46-156,0,0
57500,),0,0
57501,in,0,0
57502,the,0,0
57503,TURP,1,0
57504,group,0,0
57505,.,0,0
57506,Patients,0,0
57507,in,0,0
57508,the,0,0
57509,HoLEP,1,1
57510,group,0,0
57511,had,0,0
57512,shorter,0,0
57513,catheter,0,0
57514,times,0,0
57515,and,0,0
57516,hospital,0,0
57517,stays,0,0
57518,.,0,0
57519,More,0,0
57520,prostate,0,0
57521,tissue,0,0
57522,was,0,0
57523,retrieved,0,0
57524,in,0,0
57525,the,0,0
57526,HoLEP,1,1
57527,group,0,0
57528,.,0,0
57529,At,0,0
57530,six,0,0
57531,months,0,0
57532,",",0,0
57533,HoLEP,1,1
57534,was,0,0
57535,urodynamically,0,0
57536,superior,0,0
57537,to,0,0
57538,TURP,1,0
57539,in,0,0
57540,relieving,0,0
57541,BOO,0,0
57542,.,0,0
57543,At,0,0
57544,24,0,0
57545,months,0,0
57546,",",0,0
57547,there,0,0
57548,was,0,0
57549,no,0,0
57550,significant,0,0
57551,difference,0,0
57552,between,0,0
57553,the,0,0
57554,two,0,0
57555,surgical,0,0
57556,groups,0,0
57557,with,0,0
57558,respect,0,0
57559,to,0,0
57560,American,0,0
57561,Urology,0,1
57562,Association,0,0
57563,scores,0,0
57564,",",0,0
57565,QoL,0,0
57566,scores,0,0
57567,",",0,0
57568,or,0,0
57569,Qmax,0,0
57570,values,0,0
57571,;,0,0
57572,however,0,0
57573,",",0,0
57574,two,0,0
57575,patients,0,0
57576,in,0,0
57577,the,0,0
57578,TURP,0,0
57579,group,0,0
57580,required,0,0
57581,re-operation,0,0
57582,.,0,0
57583,CONCLUSIONS,0,0
57584,HoLEP,1,1
57585,has,0,0
57586,less,0,0
57587,perioperative,0,0
57588,morbidity,0,0
57589,and,0,0
57590,produces,0,0
57591,superior,0,0
57592,urodynamic,0,0
57593,outcomes,0,0
57594,than,0,0
57595,TURP,1,0
57596,",",0,0
57597,when,0,0
57598,treating,0,0
57599,prostates,0,0
57600,>,0,0
57601,40,0,0
57602,g.,0,0
57603,At,0,0
57604,24,0,0
57605,months,0,0
57606,of,0,0
57607,follow-up,0,0
57608,",",0,0
57609,HoLEP,1,1
57610,is,0,0
57611,equivalent,0,0
57612,to,0,0
57613,TURP,1,0
57614,.,1,0
57615,Nitroglycerin,1,1
57616,",",1,0
57617,nitroprusside,1,1
57618,",",0,0
57619,or,0,0
57620,both,0,0
57621,",",0,0
57622,in,0,0
57623,preventing,0,0
57624,radial,0,1
57625,artery,0,0
57626,spasm,0,0
57627,during,0,0
57628,transradial,0,1
57629,artery,0,0
57630,catheterization,0,1
57631,.,0,0
57632,OBJECTIVE,0,0
57633,Radial,0,0
57634,artery,0,0
57635,spasm,0,1
57636,remains,0,0
57637,a,0,0
57638,major,0,0
57639,complication,0,0
57640,of,0,0
57641,transradial,0,1
57642,coronary,0,0
57643,interventions,0,0
57644,.,0,0
57645,The,0,0
57646,aim,0,0
57647,of,0,0
57648,this,0,0
57649,study,0,0
57650,was,0,0
57651,to,0,0
57652,compare,0,0
57653,the,0,0
57654,efficacy,0,0
57655,of,0,0
57656,three,0,0
57657,different,0,0
57658,intra-arterial,0,1
57659,vasodilating,1,1
57660,cocktails,1,1
57661,in,0,0
57662,reducing,0,0
57663,the,0,0
57664,incidence,0,0
57665,of,0,0
57666,radial,0,0
57667,artery,0,0
57668,spasm,0,0
57669,in,0,0
57670,patients,0,0
57671,undergoing,0,0
57672,transradial,0,1
57673,coronary,0,0
57674,angiography,0,1
57675,.,0,0
57676,The,0,0
57677,secondary,0,0
57678,goal,0,0
57679,was,0,0
57680,to,0,0
57681,assess,0,0
57682,the,0,0
57683,predictors,0,0
57684,of,0,0
57685,arterial,0,0
57686,spasm,0,0
57687,in,0,0
57688,this,0,0
57689,large,0,0
57690,group,0,0
57691,of,0,0
57692,patients,0,0
57693,.,0,0
57694,METHODS,0,0
57695,A,0,0
57696,total,0,0
57697,of,0,0
57698,379,0,0
57699,patients,0,0
57700,undergoing,0,0
57701,the,0,0
57702,procedure,0,0
57703,were,0,0
57704,randomly,0,0
57705,enrolled,0,0
57706,in,0,0
57707,1,0,0
57708,of,0,0
57709,3,0,0
57710,groups,0,0
57711,.,0,0
57712,Every,0,0
57713,patient,0,0
57714,in,0,0
57715,each,0,0
57716,of,0,0
57717,the,0,0
57718,3,0,0
57719,groups,0,0
57720,received,0,0
57721,intra-arterial,0,1
57722,heparin,1,1
57723,",",1,0
57724,lidocaine,1,1
57725,and,0,0
57726,diltiazem,1,1
57727,.,1,0
57728,Along,0,0
57729,with,0,0
57730,that,0,0
57731,",",0,0
57732,patients,0,0
57733,in,0,0
57734,Group,0,0
57735,A,0,0
57736,received,0,1
57737,nitroglycerin,1,1
57738,;,1,0
57739,patients,0,0
57740,in,0,0
57741,Group,0,0
57742,B,0,1
57743,received,0,1
57744,nitroprusside,1,1
57745,instead,0,0
57746,of,0,0
57747,nitroglycerin,1,1
57748,;,1,0
57749,and,0,0
57750,patients,0,0
57751,in,0,0
57752,Group,0,0
57753,C,0,1
57754,received,0,0
57755,both,0,0
57756,nitroglycerin,1,1
57757,and,1,0
57758,nitroprusside,1,1
57759,.,1,0
57760,A,0,0
57761,single,0,0
57762,experienced,0,0
57763,operator,0,1
57764,",",0,0
57765,blinded,0,0
57766,to,0,0
57767,the,0,0
57768,study,0,0
57769,drug,0,0
57770,",",0,0
57771,subjectively,0,0
57772,determined,0,0
57773,the,0,0
57774,presence,0,0
57775,of,0,0
57776,spasm,0,0
57777,.,0,0
57778,RESULTS,0,0
57779,Of,0,0
57780,379,0,0
57781,patients,0,0
57782,",",0,0
57783,a,0,0
57784,total,0,0
57785,of,0,0
57786,44,0,0
57787,patients,0,0
57788,(,0,0
57789,11.6,0,0
57790,%,0,0
57791,),0,0
57792,experienced,0,0
57793,spasm,0,0
57794,.,0,0
57795,The,0,0
57796,occurrence,0,0
57797,of,0,0
57798,spasm,0,0
57799,was,0,0
57800,similar,0,0
57801,",",0,0
57802,independent,0,0
57803,of,0,0
57804,the,0,0
57805,vasodilator,0,1
57806,cocktail,0,1
57807,used,0,0
57808,(,0,0
57809,Group,0,0
57810,A,0,0
57811,:,0,0
57812,12.2,0,0
57813,%,0,0
57814,",",0,0
57815,Group,0,0
57816,B,0,0
57817,:,0,0
57818,13.4,0,0
57819,%,0,0
57820,",",0,0
57821,Group,0,0
57822,C,0,1
57823,:,0,0
57824,9.5,0,0
57825,%,0,0
57826,;,0,0
57827,p,0,0
57828,=,0,0
57829,0.597,0,0
57830,),0,0
57831,.,0,0
57832,After,0,0
57833,multivariate,0,0
57834,analysis,0,0
57835,",",0,0
57836,the,0,0
57837,following,0,0
57838,variables,0,0
57839,were,0,0
57840,found,0,0
57841,to,0,0
57842,be,0,0
57843,independent,0,0
57844,predictors,0,0
57845,of,0,0
57846,spasm,0,0
57847,:,0,0
57848,radial,0,0
57849,artery,0,1
57850,diameter,0,0
57851,(,0,1
57852,RD,0,1
57853,),0,1
57854,/height,0,0
57855,index,0,0
57856,(,0,0
57857,p,0,0
57858,=,0,0
57859,0.005,0,0
57860,),0,0
57861,",",0,0
57862,RD/BSA,0,1
57863,index,0,0
57864,(,0,0
57865,p,0,0
57866,=,0,0
57867,0.012,0,0
57868,),0,0
57869,",",0,0
57870,and,0,0
57871,sheath,0,1
57872,outer,0,1
57873,diameter,0,0
57874,(,0,1
57875,OD,0,1
57876,),0,1
57877,/RD,0,1
57878,index,0,0
57879,(,0,0
57880,p,0,0
57881,=,0,0
57882,0.024,0,0
57883,),0,0
57884,.,0,0
57885,CONCLUSION,0,0
57886,In,0,0
57887,this,0,0
57888,prospective,0,0
57889,",",0,0
57890,randomized,0,0
57891,trial,0,0
57892,",",0,0
57893,the,0,0
57894,addition,0,0
57895,of,0,0
57896,a,0,0
57897,direct,1,0
57898,nitric,1,1
57899,oxide,1,1
57900,donor,1,0
57901,to,0,0
57902,nitroglycerin,1,1
57903,in,0,0
57904,an,0,0
57905,antispastic,0,1
57906,cocktail,0,1
57907,did,0,0
57908,not,0,0
57909,reduce,0,0
57910,the,0,0
57911,risk,0,0
57912,of,0,0
57913,spasm,0,0
57914,",",0,0
57915,and,0,0
57916,the,0,0
57917,use,0,0
57918,of,0,0
57919,nitroglycerin,1,1
57920,was,0,0
57921,found,0,0
57922,to,0,0
57923,be,0,0
57924,as,0,0
57925,effective,0,0
57926,as,0,0
57927,nitroprusside,1,1
57928,.,1,0
57929,Also,0,0
57930,",",0,0
57931,morphometric,0,0
57932,and,0,0
57933,mechanical,0,0
57934,factors,0,0
57935,play,0,0
57936,a,0,0
57937,significant,0,0
57938,role,0,0
57939,in,0,0
57940,predicting,0,0
57941,the,0,0
57942,occurrence,0,0
57943,of,0,0
57944,radial,0,0
57945,spasm,0,0
57946,.,0,0
57947,The,0,0
57948,sex,0,0
57949,of,0,0
57950,the,0,0
57951,patient,0,0
57952,",",0,0
57953,presence,0,0
57954,of,0,0
57955,diabetes,0,0
57956,",",0,0
57957,body,0,0
57958,surface,0,1
57959,area,0,0
57960,and,0,0
57961,smoking,0,1
57962,history,0,0
57963,appeared,0,0
57964,to,0,0
57965,play,0,0
57966,no,0,0
57967,role,0,0
57968,in,0,0
57969,predicting,0,0
57970,the,0,0
57971,occurrence,0,0
57972,of,0,0
57973,radial,0,0
57974,spasm,0,0
57975,.,0,0
57976,[,0,0
57977,Profiles,0,1
57978,of,0,0
57979,irregular,0,0
57980,bleeding,0,0
57981,induced,0,0
57982,by,0,0
57983,low-dose,1,1
57984,hormone,1,1
57985,therapy,1,1
57986,and,0,0
57987,Chinese,1,0
57988,formulated,1,0
57989,herbs,1,1
57990,products,1,0
57991,],1,0
57992,.,0,0
57993,OBJECTIVE,0,0
57994,To,0,0
57995,compare,0,0
57996,profiles,0,0
57997,and,0,0
57998,related,0,0
57999,factors,0,0
58000,of,0,0
58001,irregular,0,0
58002,bleeding,0,0
58003,induced,0,0
58004,by,0,0
58005,different,0,0
58006,types,0,0
58007,of,0,0
58008,low-dose,1,1
58009,hormone,1,1
58010,therapy,1,1
58011,(,1,1
58012,HT,1,1
58013,),1,1
58014,and,0,0
58015,a,0,0
58016,Chinese,1,0
58017,formulated,1,0
58018,herbs,1,1
58019,products,1,0
58020,.,1,0
58021,METHODS,0,0
58022,Applied,0,0
58023,with,0,0
58024,open-labeled,0,0
58025,",",0,0
58026,randomized,0,0
58027,",",0,0
58028,and,0,0
58029,clinical,0,0
58030,trial,0,0
58031,design,0,0
58032,",",0,0
58033,136,0,0
58034,postmenopausal,0,0
58035,women,0,0
58036,were,0,0
58037,assigned,0,0
58038,into,0,0
58039,four,0,0
58040,groups,0,0
58041,:,0,0
58042,group,0,0
58043,A,0,0
58044,:,0,0
58045,estradiol,1,1
58046,valerate,1,1
58047,(,1,0
58048,E2,1,1
58049,V,1,1
58050,),1,0
58051,1,1,0
58052,mg/d,1,1
58053,+,1,1
58054,medroxyprogesterone,1,1
58055,acetate,1,1
58056,(,1,1
58057,MPA,1,1
58058,),1,1
58059,2,1,0
58060,mg/d,1,1
58061,;,1,0
58062,group,1,0
58063,B,1,1
58064,:,1,0
58065,conjugated,1,1
58066,equine,1,0
58067,estrogen,1,1
58068,0.45,1,0
58069,mg/d,1,1
58070,+,1,1
58071,MPA,1,1
58072,2,1,0
58073,mg/d,0,1
58074,;,0,0
58075,group,1,0
58076,C,1,1
58077,:,1,0
58078,tibolone,1,1
58079,1.25,0,0
58080,mg/d,0,1
58081,;,0,0
58082,group,1,0
58083,D,1,1
58084,:,1,0
58085,a,1,0
58086,Chinese,1,0
58087,formulated,1,0
58088,herbs,1,1
58089,product,1,1
58090,(,1,1
58091,Kuntai,1,1
58092,),1,1
58093,4,0,0
58094,#,0,0
58095,tid,0,1
58096,.,0,0
58097,Each,0,0
58098,subject,0,0
58099,took,0,0
58100,element,0,0
58101,calcium,1,1
58102,400,0,1
58103,mg/d,0,1
58104,and,0,0
58105,vitamin,1,1
58106,D,1,1
58107,200,0,1
58108,IU/d,0,1
58109,concomitantly,0,0
58110,.,0,0
58111,Modified,0,0
58112,Kupperman,0,0
58113,scores,0,0
58114,were,0,0
58115,assessed,0,0
58116,on,0,0
58117,baseline,0,0
58118,and,0,0
58119,every,0,1
58120,3,0,0
58121,months,0,0
58122,thereafter,0,0
58123,and,0,0
58124,irregular,0,0
58125,bleeding,0,0
58126,was,0,0
58127,recorded,0,0
58128,on,0,0
58129,menopausal,0,0
58130,diary,0,1
58131,every,0,1
58132,day,0,0
58133,.,0,0
58134,The,0,0
58135,duration,0,0
58136,of,0,0
58137,this,0,0
58138,study,0,0
58139,was,0,0
58140,1,0,0
58141,year,0,0
58142,.,0,0
58143,Results,0,0
58144,The,0,0
58145,efficacies,0,0
58146,were,0,0
58147,similar,0,0
58148,in,0,0
58149,three,0,0
58150,HT-managed,0,0
58151,groups,0,0
58152,",",0,0
58153,but,0,0
58154,was,0,0
58155,better,0,0
58156,than,0,0
58157,in,0,0
58158,group,0,0
58159,D,0,1
58160,",",0,0
58161,although,0,0
58162,the,0,0
58163,latter,0,0
58164,was,0,0
58165,also,0,0
58166,effective,0,0
58167,in,0,0
58168,alleviating,0,0
58169,menopausal,0,0
58170,symptoms,0,0
58171,.,0,0
58172,Hazard,0,0
58173,ratio,0,0
58174,(,0,1
58175,HR,0,0
58176,),0,1
58177,of,0,0
58178,irregular,0,0
58179,bleeding,0,0
58180,was,0,0
58181,1.00,0,0
58182,in,0,0
58183,group,0,0
58184,C,0,1
58185,",",0,0
58186,2.43,0,0
58187,in,0,0
58188,group,0,0
58189,A,0,0
58190,(,0,0
58191,95,0,0
58192,%,0,0
58193,CI,0,0
58194,:,0,1
58195,1.08-5.46,0,0
58196,),0,0
58197,",",0,0
58198,3.12,0,0
58199,in,0,0
58200,group,0,0
58201,B,0,1
58202,(,0,0
58203,95,0,0
58204,%,0,0
58205,CI,0,0
58206,:,0,1
58207,1.42-6.88,0,0
58208,),0,0
58209,",",0,0
58210,and,0,0
58211,0.73,0,0
58212,in,0,0
58213,group,0,0
58214,D,0,1
58215,(,0,0
58216,95,0,0
58217,%,0,0
58218,CI,0,0
58219,:,0,1
58220,0.26-2.04,0,0
58221,),0,0
58222,.,0,0
58223,Most,0,0
58224,cases,0,0
58225,initially,0,0
58226,experienced,0,0
58227,bleeding,0,0
58228,in,0,0
58229,the,0,0
58230,first,0,0
58231,3,0,0
58232,months,0,0
58233,but,0,0
58234,such,0,0
58235,initiation,0,0
58236,was,0,0
58237,a,0,0
58238,bit,0,0
58239,later,0,0
58240,in,0,0
58241,group,0,0
58242,C.,0,1
58243,Endometrium,0,1
58244,",",0,0
58245,as,0,0
58246,detected,0,0
58247,by,0,0
58248,B-mode,0,1
58249,ultrasound,0,1
58250,",",0,0
58251,increased,0,0
58252,approximately,0,0
58253,1,0,0
58254,mm,0,0
58255,in,0,0
58256,HT,0,1
58257,groups,0,0
58258,",",0,0
58259,while,0,0
58260,it,0,0
58261,was,0,0
58262,a,0,0
58263,bit,0,0
58264,thicker,0,1
58265,in,0,0
58266,group,0,0
58267,C.,0,1
58268,Long,0,0
58269,periods,0,0
58270,in,0,0
58271,reproductive,0,0
58272,age,0,0
58273,and,0,0
58274,short,0,1
58275,time,0,0
58276,since,0,0
58277,menopause,0,0
58278,were,0,0
58279,high,0,0
58280,risk,0,0
58281,factors,0,0
58282,for,0,0
58283,irregular,0,0
58284,bleeding,0,0
58285,.,0,0
58286,CONCLUSION,0,0
58287,Profiles,0,0
58288,of,0,0
58289,irregular,0,0
58290,bleeding,0,0
58291,in,0,0
58292,3,0,0
58293,commonly,0,0
58294,used,0,0
58295,types,0,0
58296,of,0,0
58297,low-dose,1,1
58298,HT,1,1
58299,are,0,0
58300,different,0,0
58301,and,0,0
58302,some,0,0
58303,factors,0,0
58304,such,0,0
58305,as,0,0
58306,long,0,0
58307,period,0,0
58308,in,0,0
58309,reproductive,0,0
58310,age,0,0
58311,and,0,0
58312,short,0,1
58313,time,0,0
58314,since,0,0
58315,menopause,0,0
58316,may,0,0
58317,contribute,0,0
58318,to,0,0
58319,bleeding,0,0
58320,initiation,0,0
58321,.,0,0
58322,[,0,0
58323,Rapidity,0,0
58324,of,0,0
58325,pain,0,0
58326,relief,0,0
58327,",",0,0
58328,medication,0,1
58329,requirement,0,0
58330,and,0,0
58331,patient,0,0
58332,satisfaction,0,0
58333,with,0,0
58334,reflux,0,0
58335,treatment,0,0
58336,in,0,0
58337,the,0,0
58338,physician,0,1
58339,'s,0,0
58340,office,0,1
58341,],0,0
58342,.,0,0
58343,Treatment,0,0
58344,of,0,0
58345,gastroesophageal,0,0
58346,reflux,0,0
58347,disease,0,0
58348,(,0,1
58349,GERD,0,1
58350,),0,1
58351,with,0,0
58352,proton,1,1
58353,pump,1,1
58354,inhibitors,1,1
58355,was,0,0
58356,investigated,0,0
58357,in,0,0
58358,three,0,0
58359,controlled,0,0
58360,prospective,0,0
58361,",",0,0
58362,randomized,0,0
58363,open,0,0
58364,studies,0,0
58365,.,0,0
58366,Lansoprazole,1,1
58367,",",1,0
58368,omeprazole,1,1
58369,MUPS,1,1
58370,and,1,0
58371,esomeprazole,1,1
58372,were,0,0
58373,compared,0,0
58374,under,0,0
58375,doctor,0,0
58376,'s,0,0
58377,office,0,0
58378,conditions,0,0
58379,.,0,0
58380,The,0,0
58381,outcomes,0,0
58382,of,0,0
58383,interest,0,0
58384,were,0,0
58385,the,0,0
58386,rapidity,0,0
58387,of,0,0
58388,pain,0,0
58389,relief,0,0
58390,achieved,0,0
58391,with,0,0
58392,a,0,0
58393,single,0,0
58394,dose,0,0
58395,",",0,0
58396,effectiveness,0,0
58397,and,0,0
58398,patient,0,0
58399,satisfaction,0,0
58400,with,0,0
58401,on,0,0
58402,demand,0,0
58403,therapy,0,1
58404,.,0,0
58405,In,0,0
58406,the,0,0
58407,first,0,0
58408,study,0,0
58409,",",0,0
58410,180,0,0
58411,patients,0,0
58412,with,0,0
58413,chronic,0,0
58414,and,0,0
58415,prolonged,0,0
58416,episodes,0,0
58417,of,0,0
58418,reflux,0,0
58419,were,0,0
58420,investigated,0,0
58421,.,0,0
58422,Time,0,0
58423,to,0,0
58424,pain,0,0
58425,relief,0,0
58426,following,0,0
58427,a,0,0
58428,single,0,1
58429,dose,0,0
58430,was,0,0
58431,1.1,0,0
58432,+/-,0,0
58433,0.8,0,0
58434,hours,0,0
58435,with,0,0
58436,30,0,0
58437,mg,0,1
58438,lansoprazole,1,1
58439,",",0,0
58440,3.0,0,0
58441,+/-,0,0
58442,2.5,0,0
58443,hours,0,0
58444,with,0,0
58445,20,0,0
58446,mgomeprazole,1,1
58447,MUPS,0,0
58448,and,0,0
58449,2.1,0,0
58450,+/-,0,0
58451,1.2,0,0
58452,hours,0,0
58453,with,0,0
58454,40,0,0
58455,mg,0,0
58456,esomeprazole,1,1
58457,.,1,0
58458,Studies,0,0
58459,2,0,0
58460,and,0,0
58461,3,0,0
58462,were,0,0
58463,designed,0,0
58464,as,0,0
58465,cross-over,0,0
58466,studies,0,0
58467,intended,0,0
58468,to,0,0
58469,investigate,0,0
58470,drug,0,1
58471,consumption,0,0
58472,.,0,0
58473,In,0,0
58474,study,0,0
58475,2,0,0
58476,",",0,0
58477,the,0,0
58478,amount,0,0
58479,of,0,0
58480,lansoprazole,1,1
58481,consumed,0,0
58482,was,0,0
58483,approximately,0,0
58484,50,0,0
58485,%,0,0
58486,less,0,0
58487,than,0,0
58488,that,0,0
58489,of,0,0
58490,omeprazole,1,1
58491,",",0,0
58492,and,0,0
58493,this,0,0
58494,translated,0,1
58495,to,0,0
58496,81,0,0
58497,%,0,0
58498,patient,0,0
58499,satisfaction,0,0
58500,with,0,0
58501,lansoprazole,1,1
58502,compared,0,0
58503,with,0,0
58504,only,0,0
58505,9.5,0,0
58506,%,0,0
58507,for,0,0
58508,omeprazole,1,1
58509,.,1,0
58510,In,0,0
58511,study,0,0
58512,3,0,0
58513,comparing,0,0
58514,lansoprazole,0,1
58515,and,0,0
58516,esomeprazole,1,1
58517,",",0,0
58518,consumption,0,0
58519,of,0,0
58520,the,0,0
58521,former,0,0
58522,was,0,0
58523,85,0,0
58524,%,0,0
58525,that,0,0
58526,of,0,0
58527,the,0,0
58528,latter,0,0
58529,.,0,0
58530,58,0,0
58531,%,0,0
58532,of,0,0
58533,the,0,0
58534,patients,0,0
58535,opted,0,0
58536,to,0,0
58537,continuetreatment,0,0
58538,with,0,0
58539,lansoprazole,1,1
58540,",",0,0
58541,compared,0,0
58542,with,0,0
58543,only,0,0
58544,25,0,0
58545,%,0,0
58546,in,0,0
58547,the,0,0
58548,case,0,0
58549,of,0,0
58550,esomeprazole,1,1
58551,.,0,0
58552,The,0,0
58553,appreciably,0,0
58554,greater,0,0
58555,patient,0,0
58556,satisfaction,0,0
58557,with,0,0
58558,lansoprazole,1,1
58559,was,0,0
58560,due,0,0
58561,tothe,0,1
58562,faster,0,0
58563,pain,0,0
58564,relief,0,0
58565,achieved,0,0
58566,with,0,0
58567,this,0,0
58568,drug,0,0
58569,.,0,0
58570,Pelvic,1,1
58571,lymphadenectomy,1,1
58572,for,0,0
58573,cervical,0,0
58574,carcinoma,0,0
58575,:,0,0
58576,laparotomy,1,1
58577,extraperitoneal,1,1
58578,",",1,0
58579,transperitoneal,1,1
58580,or,1,1
58581,laparoscopic,1,1
58582,approach,0,1
58583,?,0,0
58584,A,0,0
58585,randomized,0,0
58586,study,0,0
58587,.,0,0
58588,OBJECTIVE,0,0
58589,To,0,0
58590,compare,0,0
58591,transperitoneal,1,1
58592,",",1,0
58593,extraperitoneal,1,1
58594,and,1,0
58595,laparoscopic,1,1
58596,pelvic,1,1
58597,lymphadenectomy,1,1
58598,in,0,0
58599,terms,0,0
58600,of,0,0
58601,feasibility,0,0
58602,and,0,0
58603,morbidity,0,0
58604,in,0,0
58605,patients,0,0
58606,affected,0,0
58607,by,0,0
58608,cervical,0,1
58609,cancer,0,0
58610,undergoing,0,0
58611,radical,1,1
58612,hysterectomy,1,1
58613,.,1,0
58614,METHODS,0,0
58615,Consecutive,0,0
58616,patients,0,0
58617,affected,0,0
58618,by,0,0
58619,stage,0,0
58620,IB-IIB,0,1
58621,cervical,0,1
58622,carcinoma,0,0
58623,scheduled,0,0
58624,for,0,0
58625,radical,1,1
58626,surgery,1,1
58627,entered,0,0
58628,the,0,0
58629,study,0,0
58630,.,0,0
58631,Patients,0,0
58632,were,0,0
58633,randomly,0,0
58634,assigned,0,0
58635,to,0,0
58636,transperitoneal,1,1
58637,(,1,1
58638,TPL,1,1
58639,),1,0
58640,",",1,0
58641,extraperitoneal,1,1
58642,(,1,0
58643,EPL,1,1
58644,),1,1
58645,or,1,1
58646,laparoscopic,1,1
58647,pelvic,1,1
58648,lymphadenectomy,1,1
58649,(,1,1
58650,LPL,1,1
58651,),1,0
58652,.,1,0
58653,All,0,0
58654,patients,0,0
58655,underwent,0,0
58656,classical,1,1
58657,radical,1,1
58658,hysterectomy,1,1
58659,.,1,0
58660,Perioperative,0,0
58661,data,0,0
58662,were,0,0
58663,recorded,0,0
58664,.,0,0
58665,Follow,0,0
58666,up,0,0
58667,examinations,0,0
58668,were,0,0
58669,performed,0,0
58670,at,0,0
58671,the,0,0
58672,15th,0,0
58673,",",0,0
58674,30th,0,0
58675,and,0,0
58676,60th,0,0
58677,day,0,0
58678,after,0,0
58679,surgery,0,1
58680,.,0,0
58681,RESULTS,0,0
58682,168,0,0
58683,patients,0,0
58684,entered,0,0
58685,the,0,0
58686,study,0,0
58687,.,0,0
58688,The,0,0
58689,mean,0,0
58690,operative,0,0
58691,times,0,0
58692,were,0,0
58693,:,0,0
58694,63+/-7.6,0,0
58695,",",0,0
58696,54+/-6.7,0,0
58697,and,0,0
58698,75+/-8.4,0,0
58699,min,0,1
58700,(,1,0
58701,TPL,1,1
58702,vs,0,0
58703,EPL,1,1
58704,P,0,0
58705,<,0,0
58706,0.001,0,0
58707,;,0,0
58708,EPL,0,1
58709,vs,0,0
58710,LPL,0,0
58711,P,0,0
58712,<,0,0
58713,0.001,0,0
58714,;,0,0
58715,TPL,1,1
58716,vs,0,0
58717,LPL,1,0
58718,P,0,0
58719,<,0,0
58720,0.001,0,0
58721,),0,0
58722,for,0,0
58723,TPL,1,1
58724,",",1,0
58725,EPL,1,1
58726,and,0,0
58727,LPL,1,0
58728,respectively,0,0
58729,.,0,0
58730,The,0,0
58731,feasibility,0,0
58732,of,0,0
58733,the,0,0
58734,procedures,0,0
58735,",",0,0
58736,analyzed,0,0
58737,on,0,0
58738,an,0,0
58739,intention-to-treat,0,0
58740,basis,0,0
58741,",",0,0
58742,was,0,0
58743,96,0,0
58744,%,0,0
58745,",",0,0
58746,93,0,0
58747,%,0,0
58748,and,0,0
58749,95,0,0
58750,%,0,0
58751,for,0,0
58752,TPL,1,1
58753,",",1,0
58754,EPL,1,1
58755,and,1,0
58756,LPL,1,1
58757,group,1,1
58758,respectively,0,0
58759,(,0,0
58760,P=ns,0,0
58761,),0,0
58762,.,0,0
58763,The,0,0
58764,average,0,0
58765,hospitalizations,0,0
58766,were,0,0
58767,:,0,0
58768,5.6+/-0.9,0,0
58769,",",0,0
58770,3.2+/-0.4,0,0
58771,and,0,0
58772,3.1+/-0.3,0,0
58773,days,0,1
58774,(,1,0
58775,TPL,1,1
58776,vs,0,0
58777,EPL,1,1
58778,P,0,0
58779,<,0,0
58780,0.001,0,0
58781,;,0,0
58782,TPL,1,1
58783,vs,0,0
58784,LPL,1,0
58785,P,0,0
58786,<,0,0
58787,0.001,0,0
58788,),0,0
58789,for,0,0
58790,TPL,1,1
58791,",",1,0
58792,EPL,1,1
58793,and,0,0
58794,LPL,1,0
58795,respectively,0,0
58796,.,0,0
58797,CONCLUSIONS,0,0
58798,EPL,1,1
58799,and,0,0
58800,LPL,1,1
58801,are,0,0
58802,as,0,0
58803,feasible,0,0
58804,and,0,0
58805,effective,0,0
58806,as,0,0
58807,TPL,1,1
58808,and,0,0
58809,can,0,0
58810,be,0,0
58811,adequately,0,0
58812,performed,0,0
58813,with,0,0
58814,a,0,0
58815,reasonable,0,0
58816,complication,0,0
58817,rate,0,0
58818,.,0,0
58819,LPL,1,0
58820,showed,0,0
58821,a,0,0
58822,statistically,0,0
58823,significant,0,0
58824,longer,0,0
58825,operative,0,0
58826,time,0,0
58827,.,0,0
58828,However,0,0
58829,",",0,0
58830,both,0,0
58831,EPL,1,1
58832,and,0,0
58833,LPL,1,1
58834,can,0,0
58835,minimize,0,0
58836,some,0,0
58837,postoperative,0,0
58838,complications,0,0
58839,reducing,0,0
58840,length,0,0
58841,of,0,0
58842,stay,0,0
58843,.,0,0
58844,Randomized,0,0
58845,comparison,0,0
58846,of,0,0
58847,two,1,0
58848,communication,1,0
58849,interventions,1,0
58850,for,0,0
58851,preschoolers,0,0
58852,with,0,0
58853,autism,0,0
58854,spectrum,0,0
58855,disorders,0,0
58856,.,0,0
58857,This,0,0
58858,randomized,0,0
58859,group,0,0
58860,experiment,0,0
58861,compared,0,0
58862,the,0,0
58863,efficacy,0,0
58864,of,0,0
58865,2,1,0
58866,communication,1,1
58867,interventions,1,1
58868,(,1,0
58869,Responsive,1,1
58870,Education,1,1
58871,and,1,0
58872,Prelinguistic,1,1
58873,Milieu,1,1
58874,Teaching,1,1
58875,[,1,0
58876,RPMT,1,0
58877,],1,1
58878,and,1,0
58879,the,1,0
58880,Picture,1,1
58881,Exchange,1,1
58882,Communication,1,1
58883,System,1,1
58884,[,1,0
58885,PECS,1,1
58886,],1,1
58887,),1,0
58888,in,0,0
58889,36,0,0
58890,preschoolers,0,0
58891,with,0,0
58892,autism,0,0
58893,spectrum,0,0
58894,disorders,0,0
58895,.,0,0
58896,Each,0,0
58897,treatment,0,0
58898,was,0,0
58899,delivered,0,0
58900,3,0,0
58901,times,0,0
58902,per,0,0
58903,week,0,0
58904,",",0,0
58905,in,0,0
58906,20-min,0,1
58907,sessions,0,1
58908,",",0,0
58909,for,0,0
58910,6,0,0
58911,months,0,0
58912,.,0,0
58913,The,0,0
58914,results,0,0
58915,revealed,0,0
58916,that,0,0
58917,the,0,0
58918,RPMT,1,0
58919,facilitated,0,0
58920,the,0,0
58921,frequency,0,0
58922,of,0,0
58923,generalized,0,0
58924,turn,0,0
58925,taking,0,0
58926,and,0,0
58927,generalized,0,0
58928,initiating,0,0
58929,joint,0,0
58930,attention,0,0
58931,more,0,0
58932,than,0,0
58933,did,0,0
58934,the,0,0
58935,PECS,0,0
58936,.,0,0
58937,The,0,0
58938,latter,0,0
58939,effect,0,0
58940,occurred,0,0
58941,only,0,0
58942,for,0,0
58943,children,0,0
58944,who,0,0
58945,began,0,0
58946,treatment,0,0
58947,with,0,0
58948,at,0,0
58949,least,0,0
58950,some,0,0
58951,initiating,0,0
58952,joint,0,0
58953,attention,0,0
58954,.,0,0
58955,In,0,0
58956,contrast,0,0
58957,",",0,0
58958,the,0,0
58959,PECS,1,0
58960,facilitated,0,0
58961,generalized,0,0
58962,requests,0,0
58963,more,0,0
58964,than,0,0
58965,the,0,0
58966,RPMT,0,0
58967,in,0,0
58968,children,0,0
58969,with,0,0
58970,very,0,0
58971,little,0,0
58972,initiating,0,0
58973,joint,0,0
58974,attention,0,0
58975,prior,0,0
58976,to,0,0
58977,treatment,0,0
58978,.,0,0
58979,These,0,0
58980,effect,0,0
58981,sizes,0,0
58982,were,0,0
58983,large,0,0
58984,.,0,0
58985,The,0,0
58986,efficacy,0,0
58987,of,0,0
58988,early,0,0
58989,continuous,0,1
58990,positive,0,0
58991,airway,0,0
58992,pressure,0,0
58993,therapy,0,1
58994,in,0,0
58995,patients,0,0
58996,with,0,0
58997,acute,0,0
58998,cardiogenic,0,0
58999,pulmonary,0,0
59000,edema,0,0
59001,.,0,0
59002,Although,0,0
59003,continuous,0,0
59004,positive,0,0
59005,airway,0,1
59006,pressure,0,0
59007,(,0,1
59008,CPAP,0,1
59009,),0,1
59010,therapy,0,1
59011,using,0,0
59012,a,0,0
59013,face,0,0
59014,mask,0,1
59015,is,0,0
59016,known,0,0
59017,to,0,0
59018,improve,0,0
59019,oxygenation,0,0
59020,",",0,0
59021,the,0,0
59022,intrapulmonary,0,0
59023,shunt,0,1
59024,reduction,0,0
59025,remains,0,0
59026,unsettled,0,0
59027,.,0,0
59028,Our,0,0
59029,study,0,0
59030,was,0,0
59031,designed,0,0
59032,to,0,0
59033,explore,0,0
59034,this,0,0
59035,issue,0,0
59036,.,0,0
59037,From,0,0
59038,1985,0,0
59039,to,0,0
59040,1987,0,0
59041,80,0,0
59042,patients,0,0
59043,with,0,0
59044,acute,0,0
59045,cardiogenic,0,0
59046,pulmonary,0,0
59047,edema,0,0
59048,were,0,0
59049,randomly,0,0
59050,chosen,0,0
59051,to,0,0
59052,receive,0,0
59053,either,0,0
59054,serial,1,0
59055,CPAP,1,1
59056,therapy,1,1
59057,or,1,1
59058,high-flow,1,1
59059,face,1,1
59060,mask,1,1
59061,oxygen,1,1
59062,therapy,1,1
59063,without,1,1
59064,CPAP,1,1
59065,(,1,1
59066,control,1,1
59067,),1,1
59068,for,0,0
59069,the,0,0
59070,purpose,0,0
59071,of,0,0
59072,evaluating,0,0
59073,the,0,0
59074,efficacy,0,0
59075,of,0,0
59076,CPAP,0,1
59077,therapy,0,1
59078,.,0,0
59079,After,0,0
59080,screening,0,0
59081,for,0,0
59082,exclusion,0,0
59083,",",0,0
59084,only,0,0
59085,55,0,0
59086,patients,0,0
59087,were,0,0
59088,included,0,0
59089,in,0,0
59090,the,0,0
59091,first,0,0
59092,3-hour,0,0
59093,investigation,0,0
59094,period,0,0
59095,.,0,0
59096,PaO2,0,0
59097,in,0,0
59098,the,0,0
59099,CPAP,0,1
59100,group,0,0
59101,showed,0,0
59102,a,0,0
59103,significant,0,0
59104,increase,0,0
59105,by,0,0
59106,the,0,0
59107,end,0,0
59108,of,0,0
59109,the,0,0
59110,initial,0,0
59111,study,0,0
59112,;,0,0
59113,whereas,0,0
59114,intrapulmonary,0,0
59115,shunt,0,1
59116,and,0,0
59117,alveolar-arterial,0,0
59118,oxygen,0,1
59119,tension,0,1
59120,gradient,0,1
59121,AaDO2,0,1
59122,revealed,0,0
59123,simultaneously,0,1
59124,a,0,0
59125,significant,0,0
59126,reduction,0,0
59127,.,0,0
59128,Conversely,0,0
59129,",",0,0
59130,neither,0,0
59131,PaO2,0,1
59132,nor,0,0
59133,intrapulmonary,0,0
59134,shunt,0,1
59135,(,0,0
59136,or,0,1
59137,AaDO2,0,1
59138,),0,1
59139,in,0,0
59140,the,0,0
59141,control,0,1
59142,group,0,0
59143,demonstrated,0,0
59144,any,0,0
59145,significant,0,0
59146,beneficial,0,0
59147,changes,0,0
59148,.,0,0
59149,As,0,0
59150,for,0,0
59151,cardiovascular,0,0
59152,function,0,0
59153,",",0,0
59154,only,0,0
59155,the,0,0
59156,CPAP,0,1
59157,therapy,0,1
59158,achieved,0,0
59159,a,0,0
59160,significant,0,0
59161,reduction,0,0
59162,in,0,0
59163,rate,0,0
59164,pressure,0,0
59165,product,0,1
59166,in,0,0
59167,contrast,0,0
59168,to,0,0
59169,the,0,0
59170,control,0,1
59171,(,0,1
59172,face,0,1
59173,mask,0,1
59174,),0,1
59175,therapy,0,1
59176,alone,0,1
59177,.,0,0
59178,In,0,0
59179,terms,0,0
59180,of,0,0
59181,therapeutic,0,0
59182,failure,0,0
59183,",",0,0
59184,10,0,0
59185,patients,0,0
59186,in,0,0
59187,the,0,0
59188,control,0,1
59189,group,0,0
59190,failed,0,0
59191,.,0,0
59192,However,0,0
59193,",",0,0
59194,in,0,0
59195,the,0,0
59196,CPAP,0,1
59197,group,0,0
59198,only,0,0
59199,5,0,0
59200,patients,0,0
59201,had,0,0
59202,failed,0,0
59203,at,0,0
59204,the,0,0
59205,end,0,0
59206,of,0,0
59207,the,0,0
59208,first,0,0
59209,3-hour,0,0
59210,study,0,0
59211,period,0,0
59212,.,0,0
59213,Overall,0,0
59214,",",0,0
59215,the,0,0
59216,cumulative,0,0
59217,therapeutic,0,0
59218,failure,0,0
59219,rate,0,0
59220,was,0,0
59221,28,0,0
59222,%,0,0
59223,in,0,0
59224,the,0,0
59225,CPAP,0,1
59226,group,0,0
59227,and,0,0
59228,60,0,0
59229,%,0,0
59230,in,0,0
59231,the,0,0
59232,control,0,1
59233,group,0,0
59234,during,0,0
59235,a,0,0
59236,6-hour,0,0
59237,observation,0,1
59238,study,0,0
59239,.,0,0
59240,However,0,0
59241,",",0,0
59242,there,0,0
59243,was,0,0
59244,no,0,0
59245,significant,0,0
59246,difference,0,0
59247,between,0,0
59248,the,0,0
59249,two,0,0
59250,groups,0,0
59251,in,0,0
59252,24-hour,0,1
59253,hospital,0,0
59254,mortality,0,0
59255,.,0,0
59256,(,0,0
59257,ABSTRACT,0,1
59258,TRUNCATED,0,1
59259,AT,0,1
59260,250,0,1
59261,WORDS,0,1
59262,),0,1
59263,Resistance,1,0
59264,training,1,1
59265,increases,0,0
59266,basal,0,0
59267,limb,0,0
59268,blood,0,0
59269,flow,0,0
59270,and,0,0
59271,vascular,0,0
59272,conductance,0,1
59273,in,0,0
59274,aging,0,0
59275,humans,0,0
59276,.,0,0
59277,Age-related,0,0
59278,reductions,0,0
59279,in,0,0
59280,basal,0,0
59281,limb,0,0
59282,blood,0,0
59283,flow,0,0
59284,and,0,0
59285,vascular,0,0
59286,conductance,0,1
59287,are,0,0
59288,associated,0,0
59289,with,0,0
59290,the,0,0
59291,metabolic,0,0
59292,syndrome,0,0
59293,",",0,0
59294,functional,0,0
59295,impairments,0,0
59296,",",0,0
59297,and,0,0
59298,osteoporosis,0,0
59299,.,0,0
59300,We,0,0
59301,tested,0,0
59302,the,0,0
59303,hypothesis,0,0
59304,that,0,0
59305,a,0,0
59306,strength,1,0
59307,training,1,1
59308,program,1,1
59309,would,0,0
59310,increase,0,0
59311,basal,0,0
59312,femoral,0,1
59313,blood,0,0
59314,flow,0,0
59315,in,0,0
59316,aging,0,0
59317,adults,0,0
59318,.,0,0
59319,Twenty-six,0,0
59320,sedentary,0,0
59321,but,0,0
59322,healthy,0,0
59323,middle-aged,0,0
59324,and,0,0
59325,older,0,0
59326,subjects,0,0
59327,were,0,0
59328,randomly,1,0
59329,assigned,1,0
59330,to,1,0
59331,either,1,0
59332,a,1,0
59333,whole,1,1
59334,body,1,0
59335,strength,1,0
59336,training,1,1
59337,intervention,1,1
59338,group,1,1
59339,(,1,0
59340,52,1,0
59341,+/-,1,0
59342,2,1,0
59343,yr,1,0
59344,",",1,0
59345,3,1,0
59346,men,1,0
59347,",",1,0
59348,10,1,0
59349,women,1,0
59350,),1,0
59351,who,1,0
59352,underwent,1,0
59353,three,1,0
59354,supervised,1,1
59355,resistance,1,0
59356,training,1,1
59357,sessions,1,1
59358,per,1,0
59359,week,1,0
59360,for,1,0
59361,13,1,0
59362,wk,1,0
59363,or,1,1
59364,a,1,0
59365,control,1,1
59366,group,1,0
59367,(,1,0
59368,53,1,0
59369,+/-,1,0
59370,2,1,0
59371,yr,1,0
59372,",",1,0
59373,4,1,0
59374,men,1,0
59375,",",1,0
59376,9,1,0
59377,women,1,0
59378,),1,0
59379,who,1,0
59380,participated,1,0
59381,in,1,0
59382,a,1,0
59383,supervised,1,1
59384,stretching,1,1
59385,program,1,1
59386,.,1,0
59387,At,0,0
59388,baseline,0,0
59389,",",0,0
59390,there,0,0
59391,were,0,0
59392,no,0,0
59393,significant,0,0
59394,differences,0,0
59395,in,0,0
59396,blood,0,0
59397,pressure,0,0
59398,",",0,0
59399,cardiac,0,0
59400,output,0,0
59401,",",0,0
59402,basal,0,0
59403,femoral,0,1
59404,blood,0,0
59405,flow,0,0
59406,(,0,0
59407,via,0,1
59408,Doppler,0,1
59409,ultrasound,0,1
59410,),0,0
59411,",",0,0
59412,vascular,0,0
59413,conductance,0,1
59414,",",0,0
59415,and,0,0
59416,vascular,0,0
59417,resistance,0,0
59418,between,0,0
59419,the,0,0
59420,two,0,0
59421,groups,0,0
59422,.,0,0
59423,The,0,0
59424,strength,1,0
59425,training,1,1
59426,group,1,0
59427,increased,0,0
59428,maximal,0,0
59429,strength,0,0
59430,in,0,0
59431,all,0,0
59432,the,0,0
59433,major,0,0
59434,muscle,0,0
59435,groups,0,0
59436,tested,0,0
59437,(,0,0
59438,P,0,0
59439,<,0,0
59440,0.05,0,0
59441,),0,0
59442,.,0,0
59443,Whole,0,1
59444,body,0,0
59445,lean,0,1
59446,body,0,0
59447,mass,0,0
59448,increased,0,0
59449,(,0,0
59450,P,0,0
59451,<,0,0
59452,0.05,0,0
59453,),0,0
59454,with,0,0
59455,strength,0,0
59456,training,0,1
59457,",",0,0
59458,but,0,0
59459,leg,0,0
59460,fat-free,0,1
59461,mass,0,0
59462,did,0,0
59463,not,0,0
59464,.,0,0
59465,Basal,0,0
59466,femoral,0,1
59467,blood,0,0
59468,flow,0,0
59469,and,0,0
59470,vascular,0,0
59471,conductance,0,1
59472,increased,0,0
59473,by,0,0
59474,55-60,0,0
59475,%,0,0
59476,after,0,0
59477,strength,1,0
59478,training,1,1
59479,(,0,0
59480,both,0,0
59481,P,0,0
59482,<,0,0
59483,0.05,0,0
59484,),0,0
59485,.,0,0
59486,No,0,0
59487,such,0,0
59488,changes,0,0
59489,were,0,0
59490,observed,0,0
59491,in,0,0
59492,the,0,0
59493,control,0,0
59494,group,0,0
59495,.,0,0
59496,In,0,0
59497,both,0,0
59498,groups,0,0
59499,",",0,0
59500,there,0,0
59501,were,0,0
59502,no,0,0
59503,significant,0,0
59504,changes,0,0
59505,in,0,0
59506,brachial,0,0
59507,blood,0,0
59508,pressure,0,0
59509,",",0,0
59510,plasma,0,0
59511,endothelin-1,0,1
59512,and,0,0
59513,angiotensin,0,1
59514,II,0,1
59515,concentrations,0,0
59516,",",0,0
59517,femoral,0,1
59518,artery,0,0
59519,wall,0,0
59520,thickness,0,0
59521,",",0,0
59522,cardiac,0,0
59523,output,0,0
59524,",",0,0
59525,and,0,0
59526,systemic,0,0
59527,vascular,0,0
59528,resistance,0,0
59529,.,0,0
59530,Our,0,0
59531,results,0,0
59532,indicate,0,0
59533,that,0,0
59534,short-term,1,0
59535,strength,1,0
59536,training,1,1
59537,increases,0,0
59538,basal,0,0
59539,femoral,0,1
59540,blood,0,0
59541,flow,0,0
59542,and,0,0
59543,vascular,0,0
59544,conductance,0,1
59545,in,0,0
59546,healthy,0,0
59547,middle-aged,0,0
59548,and,0,0
59549,older,0,0
59550,adults,0,0
59551,.,0,0
59552,Divalproex,1,1
59553,versus,1,1
59554,placebo,1,1
59555,for,0,0
59556,the,0,0
59557,prevention,0,0
59558,of,0,0
59559,irritability,0,0
59560,associated,0,0
59561,with,0,0
59562,fluoxetine,1,1
59563,treatment,0,0
59564,in,0,0
59565,autism,0,0
59566,spectrum,0,0
59567,disorder,0,0
59568,.,0,0
59569,Nuclear,0,1
59570,fragments,0,0
59571,and,0,0
59572,holes,0,0
59573,in,0,0
59574,grading,0,0
59575,of,0,0
59576,breast,0,0
59577,cancer,0,0
59578,aspirates,0,0
59579,.,0,0
59580,Left,1,1
59581,thoracoabdominal,1,0
59582,approach,1,1
59583,versus,0,1
59584,abdominal-transhiatal,1,1
59585,approach,1,1
59586,for,0,0
59587,gastric,0,0
59588,cancer,0,0
59589,of,0,0
59590,the,0,0
59591,cardia,0,0
59592,or,0,1
59593,subcardia,0,0
59594,:,0,0
59595,a,0,0
59596,randomised,0,0
59597,controlled,0,0
59598,trial,0,0
59599,.,0,0
59600,BACKGROUND,0,0
59601,Because,0,0
59602,of,0,0
59603,the,0,0
59604,inaccessibility,0,0
59605,of,0,0
59606,mediastinal,0,0
59607,nodal,0,0
59608,metastases,0,0
59609,",",0,0
59610,the,0,0
59611,left,1,0
59612,thoracoabdominal,1,0
59613,approach,1,1
59614,(,1,1
59615,LTA,1,1
59616,),1,1
59617,has,0,0
59618,often,0,0
59619,been,0,0
59620,used,0,0
59621,to,0,0
59622,treat,0,0
59623,gastric,0,0
59624,cancer,0,0
59625,of,0,0
59626,the,0,0
59627,cardia,0,0
59628,or,0,1
59629,subcardia,0,0
59630,.,0,0
59631,In,0,0
59632,a,0,0
59633,randomised,0,0
59634,phase,0,0
59635,III,0,1
59636,study,0,0
59637,",",0,0
59638,we,0,0
59639,aimed,0,0
59640,to,0,0
59641,compare,0,0
59642,LTA,1,1
59643,with,1,0
59644,the,1,0
59645,abdominal-transhiatal,1,1
59646,approach,1,1
59647,(,1,1
59648,TH,1,0
59649,),1,1
59650,in,1,0
59651,the,1,0
59652,treatment,1,0
59653,of,0,0
59654,these,0,0
59655,tumours,0,0
59656,.,0,0
59657,METHODS,0,0
59658,Between,0,0
59659,July,0,0
59660,",",0,0
59661,1995,0,0
59662,",",0,0
59663,and,0,0
59664,December,0,0
59665,",",0,0
59666,2003,0,0
59667,",",0,0
59668,167,0,0
59669,patients,0,0
59670,were,0,0
59671,enrolled,0,0
59672,from,0,0
59673,27,0,0
59674,Japanese,0,0
59675,hospitals,0,0
59676,and,0,0
59677,randomly,0,0
59678,assigned,0,0
59679,to,0,0
59680,TH,0,0
59681,(,0,1
59682,n=82,0,0
59683,),0,1
59684,or,0,1
59685,LTA,0,1
59686,(,0,1
59687,n=85,0,0
59688,),0,0
59689,.,0,0
59690,The,0,0
59691,primary,0,0
59692,endpoint,0,0
59693,was,0,0
59694,overall,0,0
59695,survival,0,0
59696,",",0,0
59697,and,0,0
59698,secondary,0,0
59699,endpoints,0,0
59700,were,0,0
59701,disease-free,0,0
59702,survival,0,0
59703,",",0,0
59704,postoperative,0,0
59705,morbidity,0,0
59706,and,0,0
59707,hospital,0,0
59708,mortality,0,0
59709,",",0,0
59710,and,0,0
59711,postoperative,0,0
59712,symptoms,0,0
59713,and,0,0
59714,change,0,0
59715,of,0,0
59716,respiratory,0,0
59717,function,0,0
59718,.,0,0
59719,The,0,0
59720,projected,0,0
59721,sample,0,0
59722,size,0,0
59723,was,0,0
59724,302,0,0
59725,.,0,0
59726,After,0,0
59727,the,0,0
59728,first,0,0
59729,interim,0,0
59730,analysis,0,0
59731,",",0,0
59732,the,0,0
59733,predicted,0,0
59734,probability,0,0
59735,of,0,0
59736,LTA,0,1
59737,having,0,0
59738,a,0,0
59739,significantly,0,0
59740,better,0,0
59741,overall,0,0
59742,survival,0,0
59743,than,0,0
59744,TH,0,0
59745,at,0,0
59746,the,0,0
59747,final,0,0
59748,analysis,0,0
59749,was,0,0
59750,only,0,0
59751,3.65,0,0
59752,%,0,0
59753,",",0,0
59754,and,0,0
59755,the,0,0
59756,trial,0,0
59757,was,0,0
59758,closed,0,1
59759,immediately,0,0
59760,.,0,0
59761,Analysis,0,0
59762,was,0,0
59763,by,0,0
59764,intention,0,0
59765,to,0,0
59766,treat,0,0
59767,.,0,0
59768,This,0,0
59769,study,0,0
59770,is,0,0
59771,registered,0,0
59772,with,0,0
59773,",",0,0
59774,number,0,0
59775,NCT00149266,0,1
59776,.,0,0
59777,FINDINGS,0,0
59778,5-year,0,0
59779,overall,0,0
59780,survival,0,0
59781,was,0,0
59782,52.3,0,0
59783,%,0,0
59784,(,0,0
59785,95,0,0
59786,%,0,0
59787,CI,0,0
59788,40.4-64.1,0,0
59789,),0,0
59790,in,0,0
59791,the,0,0
59792,TH,0,0
59793,group,0,0
59794,and,0,0
59795,37.9,0,0
59796,%,0,0
59797,(,0,0
59798,26.1-49.6,0,0
59799,),0,0
59800,in,0,0
59801,the,0,0
59802,LTA,0,1
59803,group,0,0
59804,.,0,0
59805,The,0,0
59806,hazard,0,0
59807,ratio,0,0
59808,of,0,0
59809,death,0,0
59810,for,0,0
59811,LTA,0,1
59812,compared,0,0
59813,with,0,0
59814,TH,0,0
59815,was,0,0
59816,1.36,0,0
59817,(,0,0
59818,0.89-2.08,0,0
59819,",",0,0
59820,p=0.92,0,0
59821,),0,0
59822,.,0,0
59823,Three,0,0
59824,patients,0,0
59825,died,0,0
59826,in,0,0
59827,hospital,0,0
59828,after,0,0
59829,LTA,0,1
59830,but,0,0
59831,none,0,0
59832,after,0,0
59833,TH,0,0
59834,.,0,0
59835,Morbidity,0,0
59836,was,0,0
59837,worse,0,0
59838,after,0,0
59839,LTA,0,0
59840,than,0,0
59841,after,0,0
59842,TH,0,0
59843,.,0,0
59844,INTERPRETATION,0,0
59845,Because,0,0
59846,LTA,0,1
59847,does,0,0
59848,not,0,0
59849,improve,0,0
59850,survival,0,0
59851,after,0,0
59852,TH,0,0
59853,and,0,0
59854,leads,0,0
59855,to,0,0
59856,increased,0,0
59857,morbidity,0,0
59858,in,0,0
59859,patients,0,0
59860,with,0,0
59861,cancer,0,0
59862,of,0,0
59863,the,0,0
59864,cardia,0,0
59865,or,0,1
59866,subcardia,0,0
59867,",",0,0
59868,LTA,0,1
59869,can,0,0
59870,not,0,0
59871,be,0,0
59872,justified,0,0
59873,to,0,0
59874,treat,0,0
59875,these,0,0
59876,tumours,0,0
59877,.,0,0
59878,Atorvastatin,1,1
59879,and,1,0
59880,quinapril,1,1
59881,inhibit,0,0
59882,blood,0,0
59883,coagulation,0,1
59884,in,0,0
59885,patients,0,0
59886,with,0,0
59887,coronary,0,0
59888,artery,0,0
59889,disease,0,0
59890,following,0,0
59891,28,0,0
59892,days,0,0
59893,of,0,0
59894,therapy,0,1
59895,.,0,0
59896,BACKGROUND,0,0
59897,We,0,0
59898,evaluated,0,0
59899,the,0,0
59900,antithrombotic,0,0
59901,effects,0,0
59902,of,0,0
59903,statins,1,1
59904,and,0,0
59905,angiotensin-converting,1,1
59906,enzyme,1,1
59907,inhibitor,1,1
59908,(,1,1
59909,ACEI,1,0
59910,),1,1
59911,drugs,1,1
59912,in,0,0
59913,patients,0,0
59914,with,0,0
59915,coronary,0,0
59916,artery,0,1
59917,disease,0,0
59918,(,0,1
59919,CAD,0,1
59920,),0,0
59921,.,0,0
59922,METHODS,0,0
59923,AND,0,0
59924,RESULTS,0,0
59925,Blood,0,0
59926,coagulation,0,1
59927,at,0,0
59928,the,0,0
59929,site,0,0
59930,of,0,0
59931,microvascular,0,0
59932,injury,0,0
59933,was,0,0
59934,assessed,0,0
59935,in,0,0
59936,26,0,0
59937,males,0,0
59938,with,0,0
59939,CAD,0,0
59940,before,0,0
59941,and,0,0
59942,after,0,0
59943,treatment,0,0
59944,with,0,1
59945,quinapril,1,1
59946,(,0,0
59947,10,0,0
59948,mg,0,1
59949,day-1,0,0
59950,;,0,0
59951,n=13,0,0
59952,),0,1
59953,or,0,1
59954,atorvastatin,1,1
59955,(,0,0
59956,40,0,1
59957,mg,0,1
59958,day-1,0,0
59959,;,0,0
59960,n=13,0,0
59961,),0,0
59962,for,0,0
59963,4,0,0
59964,weeks,0,0
59965,and,0,0
59966,an,0,0
59967,additional,0,0
59968,4,0,0
59969,weeks,0,0
59970,of,0,0
59971,combined,0,1
59972,therapy,0,1
59973,(,0,1
59974,quinapril+atorvastatin,0,1
59975,),0,0
59976,.,0,0
59977,Rates,0,0
59978,of,0,0
59979,prothrombin,0,0
59980,and,0,0
59981,factor,0,1
59982,V,0,1
59983,activation,0,1
59984,(,0,1
59985,FVa,0,1
59986,),0,1
59987,",",0,0
59988,fibrinogen,0,1
59989,(,0,1
59990,Fbg,0,0
59991,),0,1
59992,cleavage,0,0
59993,and,0,0
59994,FVa,0,1
59995,inactivation,0,1
59996,showed,0,0
59997,that,0,0
59998,both,0,0
59999,quinapril,0,1
60000,and,0,0
60001,atorvastatin,0,1
60002,decreased,0,0
60003,the,0,0
60004,rates,0,0
60005,of,0,0
60006,:,0,0
60007,formation,0,0
60008,of,0,0
60009,thrombin,0,1
60010,B-chain,0,0
60011,(,0,0
60012,by,0,0
60013,30.6,0,0
60014,%,0,0
60015,",",0,0
60016,P=0.007,0,0
60017,;,0,0
60018,and,0,0
60019,by,0,0
60020,34.3,0,0
60021,%,0,0
60022,",",0,0
60023,P=0.003,0,0
60024,),0,0
60025,",",0,0
60026,formation,0,0
60027,of,0,0
60028,thrombin-antithrombin,0,1
60029,complexes,0,0
60030,(,0,0
60031,by,0,0
60032,30.4,0,0
60033,%,0,0
60034,",",0,0
60035,P=0.0002,0,0
60036,;,0,0
60037,and,0,0
60038,by,0,0
60039,40,0,1
60040,%,0,0
60041,",",0,0
60042,P=0.001,0,0
60043,),0,0
60044,",",0,0
60045,FV,0,1
60046,activation,0,1
60047,(,0,0
60048,by,0,0
60049,19.1,0,0
60050,%,0,0
60051,",",0,0
60052,P=0.03,0,0
60053,;,0,0
60054,and,0,0
60055,by,0,0
60056,21.8,0,0
60057,%,0,0
60058,",",0,0
60059,P=0.005,0,0
60060,),0,1
60061,and,0,0
60062,Fbg,0,1
60063,depletion,0,0
60064,(,0,0
60065,by,0,0
60066,29.2,0,0
60067,%,0,0
60068,",",0,0
60069,P=0.004,0,0
60070,;,0,0
60071,and,0,0
60072,by,0,0
60073,32.7,0,0
60074,%,0,0
60075,",",0,0
60076,P=0.001,0,0
60077,),0,0
60078,.,0,0
60079,Atorvastatin,0,1
60080,alone,0,1
60081,accelerated,0,0
60082,FVa,0,1
60083,inactivation,0,1
60084,(,0,1
60085,P=0.005,0,0
60086,),0,0
60087,.,0,0
60088,A,0,0
60089,further,0,0
60090,4,0,0
60091,weeks,0,0
60092,of,0,0
60093,combined,0,1
60094,therapy,0,1
60095,enhanced,0,0
60096,most,0,0
60097,anticoagulant,0,1
60098,effects,0,0
60099,only,0,0
60100,when,0,0
60101,atorvastatin,0,1
60102,was,0,0
60103,added,0,0
60104,to,0,0
60105,quinapril,0,1
60106,.,0,0
60107,CONCLUSIONS,0,0
60108,In,0,0
60109,CAD,0,0
60110,patients,0,0
60111,",",0,0
60112,atorvastatin,0,1
60113,and,0,0
60114,quinapril,0,1
60115,slowed,0,0
60116,blood,0,0
60117,clotting,0,0
60118,at,0,0
60119,the,0,0
60120,site,0,0
60121,of,0,0
60122,microvascular,0,0
60123,injury,0,0
60124,after,0,0
60125,28,0,0
60126,days,0,0
60127,of,0,0
60128,therapy,0,1
60129,.,0,0
60130,Addition,0,0
60131,of,0,0
60132,atorvastatin,1,1
60133,to,0,0
60134,quinapril,1,1
60135,",",0,0
60136,but,0,0
60137,not,0,0
60138,quinapril,1,1
60139,to,0,0
60140,the,0,0
60141,statin,1,1
60142,",",0,0
60143,enhanced,0,0
60144,the,0,0
60145,anticoagulant,0,1
60146,effects,0,0
60147,.,0,0
60148,Our,0,0
60149,findings,0,0
60150,might,0,0
60151,help,0,0
60152,explain,0,0
60153,the,0,0
60154,reduced,0,0
60155,risk,0,0
60156,of,0,0
60157,myocardial,0,0
60158,infarction,0,0
60159,or,0,1
60160,stroke,0,0
60161,in,0,0
60162,patients,0,0
60163,treated,0,0
60164,with,0,0
60165,statins,1,1
60166,and/or,0,0
60167,ACEIs,0,0
60168,and,0,0
60169,the,0,0
60170,lack,0,0
60171,of,0,0
60172,clinical,0,0
60173,benefits,0,0
60174,from,0,0
60175,ACEI,0,0
60176,added,0,0
60177,to,0,0
60178,prior,0,0
60179,statin,0,1
60180,therapy,0,1
60181,in,0,0
60182,patients,0,0
60183,at,0,0
60184,cardiovascular,0,0
60185,risk,0,0
60186,.,0,0
60187,Topical,0,0
60188,adrenaline,1,1
60189,in,0,0
60190,the,0,0
60191,control,0,0
60192,of,0,0
60193,intraoperative,0,1
60194,bleeding,0,0
60195,in,0,0
60196,adenoidectomy,0,1
60197,:,0,0
60198,a,0,0
60199,randomised,0,0
60200,",",0,0
60201,controlled,0,0
60202,trial,0,0
60203,.,0,0
60204,OBJECTIVES,0,0
60205,To,0,0
60206,evaluate,0,0
60207,the,0,0
60208,efficacy,0,0
60209,of,0,0
60210,topical,0,1
60211,racemic,1,1
60212,adrenaline,1,1
60213,(,1,1
60214,RA,1,1
60215,),1,1
60216,(,0,0
60217,Micronefrin,0,1
60218,;,0,0
60219,Bird,0,0
60220,Products,0,1
60221,",",0,0
60222,Palm,0,0
60223,Springs,0,1
60224,",",0,0
60225,CA,0,1
60226,",",0,0
60227,USA,0,1
60228,),0,0
60229,in,0,0
60230,the,0,0
60231,control,0,0
60232,of,0,0
60233,intraoperative,0,1
60234,bleeding,0,0
60235,and,0,0
60236,the,0,0
60237,prevention,0,0
60238,of,0,0
60239,postoperative,0,0
60240,bleeding,0,0
60241,",",0,0
60242,laryngeal,0,0
60243,spasm,0,1
60244,and,0,0
60245,postoperative,0,0
60246,pain,0,0
60247,in,0,0
60248,adenoidectomy,0,1
60249,among,0,0
60250,children,0,0
60251,<,0,0
60252,6,0,0
60253,years,0,0
60254,of,0,0
60255,age,0,0
60256,.,0,0
60257,DESIGN,0,0
60258,Prospective,0,0
60259,",",0,0
60260,randomised,0,0
60261,",",0,0
60262,blinded,0,0
60263,and,0,0
60264,placebo-controlled,0,1
60265,trial,0,0
60266,.,0,0
60267,SETTING,0,0
60268,Kanta-Hame,0,0
60269,Central,0,0
60270,Hospital,0,0
60271,",",0,0
60272,a,0,0
60273,district,0,0
60274,referral,0,1
60275,center,0,0
60276,in,0,0
60277,Finland,0,0
60278,.,0,0
60279,PATIENTS,0,0
60280,A,0,0
60281,consecutive,0,0
60282,sample,0,0
60283,of,0,0
60284,93,0,0
60285,children,0,0
60286,undergoing,0,0
60287,outpatient,0,0
60288,adenoidectomy,0,1
60289,.,0,0
60290,INTERVENTION,0,0
60291,Patients,0,0
60292,were,0,0
60293,randomised,0,0
60294,to,0,0
60295,receive,0,0
60296,topical,1,1
60297,gauze,1,1
60298,sponges,1,1
60299,soaked,1,0
60300,in,1,0
60301,either,1,0
60302,1:500,1,0
60303,RA,1,0
60304,or,1,1
60305,0.9,1,1
60306,%,1,0
60307,sodium,1,1
60308,chloride,1,1
60309,(,1,1
60310,physiological,1,0
60311,saline,1,1
60312,),1,0
60313,for,1,0
60314,3,1,0
60315,min,1,0
60316,after,1,0
60317,adenoidectomy,1,1
60318,.,1,0
60319,MAIN,0,0
60320,OUTCOME,0,0
60321,MEASURES,0,0
60322,Amount,0,0
60323,of,0,0
60324,intraoperative,0,1
60325,bleeding,0,0
60326,(,0,0
60327,surgeons,0,1
60328,',0,1
60329,subjective,0,0
60330,estimate,0,0
60331,),0,0
60332,",",0,0
60333,need,0,0
60334,for,0,0
60335,additional,0,0
60336,packings,0,1
60337,",",0,0
60338,need,0,0
60339,for,0,0
60340,electrocautery,0,1
60341,",",0,0
60342,laryngeal,0,0
60343,spasm,0,0
60344,",",0,0
60345,postoperative,0,0
60346,bleeding,0,0
60347,and,0,0
60348,pain,0,0
60349,",",0,0
60350,duration,0,0
60351,of,0,0
60352,procedure,0,1
60353,and,0,0
60354,duration,0,0
60355,of,0,0
60356,patients,0,0
60357,',0,0
60358,stay,0,0
60359,in,0,0
60360,the,0,0
60361,operation,0,1
60362,room,0,1
60363,(,0,1
60364,OR,0,0
60365,),0,0
60366,.,0,0
60367,RESULTS,0,0
60368,Adrenaline,1,1
60369,significantly,0,0
60370,decreased,0,0
60371,surgeons,0,0
60372,',0,0
60373,subjective,0,0
60374,estimate,0,0
60375,of,0,0
60376,the,0,0
60377,amount,0,0
60378,of,0,0
60379,intraoperative,0,1
60380,bleeding,0,0
60381,(,0,1
60382,proportion,0,0
60383,of,0,0
60384,patients,0,0
60385,with,0,0
60386,significant,0,0
60387,decrease,0,0
60388,67,0,0
60389,versus,0,0
60390,21,0,0
60391,%,0,0
60392,",",0,0
60393,P,0,0
60394,<,0,0
60395,0.001,0,0
60396,),0,0
60397,",",0,0
60398,reduced,0,0
60399,the,0,0
60400,mean,0,0
60401,number,0,0
60402,of,0,0
60403,packings,0,1
60404,needed,0,0
60405,(,0,0
60406,0.6,0,1
60407,versus,0,0
60408,1.2,0,0
60409,",",0,0
60410,P,0,0
60411,<,0,0
60412,0.001,0,0
60413,),0,0
60414,and,0,0
60415,use,0,0
60416,of,0,0
60417,electrocautery,0,1
60418,(,0,0
60419,22,0,0
60420,versus,0,1
60421,45,0,0
60422,%,0,0
60423,",",0,0
60424,P,0,0
60425,=,0,0
60426,0.015,0,0
60427,),0,0
60428,",",0,0
60429,and,0,0
60430,shortened,0,0
60431,the,0,0
60432,mean,0,0
60433,duration,0,0
60434,of,0,0
60435,the,0,0
60436,procedure,0,1
60437,(,0,0
60438,13,0,0
60439,versus,0,1
60440,18,0,0
60441,min,0,0
60442,",",0,0
60443,P,0,0
60444,=,0,0
60445,0.043,0,0
60446,),0,0
60447,and,0,0
60448,the,0,0
60449,mean,0,0
60450,stay,0,0
60451,in,0,0
60452,the,0,0
60453,OR,0,0
60454,(,0,0
60455,31,0,0
60456,versus,0,1
60457,35,0,0
60458,min,0,0
60459,",",0,0
60460,P,0,0
60461,=,0,0
60462,0.058,0,0
60463,),0,0
60464,.,0,0
60465,The,0,0
60466,impact,0,0
60467,of,0,0
60468,adrenaline,1,1
60469,was,0,0
60470,even,0,0
60471,more,0,0
60472,pronounced,0,0
60473,among,0,0
60474,patients,0,0
60475,with,0,0
60476,extensive,0,0
60477,adenoids,0,0
60478,and/or,0,0
60479,profuse,0,0
60480,intraoperative,0,0
60481,bleeding,0,0
60482,.,0,0
60483,A,0,0
60484,slight,0,0
60485,elevation,0,0
60486,of,0,0
60487,heart,0,0
60488,rate,0,0
60489,was,0,0
60490,observed,0,0
60491,more,0,0
60492,often,0,0
60493,in,0,0
60494,the,0,0
60495,adrenaline,1,1
60496,group,0,0
60497,(,0,0
60498,P,0,0
60499,=,0,0
60500,0.043,0,0
60501,),0,0
60502,.,0,0
60503,CONCLUSIONS,0,0
60504,Use,0,1
60505,of,0,0
60506,topical,0,1
60507,adrenaline,1,1
60508,can,0,0
60509,be,0,0
60510,recommended,0,0
60511,in,0,0
60512,adenoidectomy,0,1
60513,among,0,0
60514,children,0,0
60515,.,0,0
60516,It,0,0
60517,helps,0,0
60518,control,0,0
60519,the,0,0
60520,intraoperative,0,1
60521,bleeding,0,0
60522,",",0,0
60523,reduces,0,0
60524,the,0,0
60525,use,0,0
60526,of,0,0
60527,electrocautery,0,1
60528,and,0,0
60529,shortens,0,0
60530,the,0,0
60531,durations,0,0
60532,of,0,0
60533,procedure,0,0
60534,and,0,0
60535,stay,0,0
60536,in,0,0
60537,the,0,0
60538,OR,0,0
60539,.,0,0
60540,Preventing,0,1
60541,paclitaxel-induced,0,1
60542,peripheral,0,0
60543,neuropathy,0,0
60544,:,0,0
60545,a,0,0
60546,phase,0,0
60547,II,0,0
60548,trial,0,0
60549,of,0,0
60550,vitamin,1,1
60551,E,1,1
60552,supplementation,1,1
60553,.,1,0
60554,A,0,0
60555,randomized,0,0
60556,",",0,0
60557,controlled,0,0
60558,trial,0,0
60559,was,0,0
60560,performed,0,0
60561,to,0,0
60562,assess,0,0
60563,the,0,0
60564,efficacy,0,0
60565,and,0,0
60566,safety,0,0
60567,of,0,0
60568,vitamin,1,1
60569,E,1,1
60570,supplementation,1,1
60571,for,0,0
60572,prophylaxis,0,1
60573,against,0,0
60574,paclitaxel-induced,0,1
60575,peripheral,0,0
60576,neuropathy,0,0
60577,(,0,1
60578,PIPN,0,1
60579,),0,1
60580,.,0,0
60581,Thirty-two,0,0
60582,patients,0,0
60583,undergoing,0,0
60584,six,0,0
60585,courses,0,0
60586,of,0,0
60587,paclitaxel-based,1,1
60588,chemotherapy,1,1
60589,were,0,0
60590,randomly,0,0
60591,assigned,0,0
60592,to,0,0
60593,receive,0,0
60594,either,0,1
60595,chemotherapy,1,1
60596,with,1,0
60597,vitamin,1,1
60598,E,1,1
60599,(,0,0
60600,300,0,1
60601,mg,0,1
60602,twice,0,1
60603,a,0,0
60604,day,0,0
60605,",",0,0
60606,Group,0,0
60607,I,0,0
60608,),0,0
60609,or,0,1
60610,chemotherapy,1,1
60611,without,1,1
60612,vitamin,1,1
60613,E,1,1
60614,supplementation,1,1
60615,(,0,0
60616,Group,0,1
60617,II,0,1
60618,),0,0
60619,.,0,0
60620,A,0,0
60621,detailed,0,0
60622,neurological,0,0
60623,examination,0,0
60624,and,0,0
60625,electrophysiological,0,0
60626,study,0,0
60627,was,0,0
60628,performed,0,0
60629,during,0,0
60630,and,0,0
60631,3,0,0
60632,months,0,0
60633,after,0,0
60634,chemotherapy,1,1
60635,.,1,0
60636,The,0,0
60637,severity,0,0
60638,of,0,0
60639,PIPN,0,1
60640,was,0,0
60641,summarized,0,0
60642,by,0,0
60643,means,0,0
60644,of,0,0
60645,a,0,0
60646,modified,0,0
60647,Peripheral,0,1
60648,Neuropathy,0,0
60649,(,0,1
60650,PNP,0,1
60651,),0,1
60652,score,0,0
60653,.,0,0
60654,The,0,0
60655,incidence,0,0
60656,of,0,0
60657,neurotoxicity,0,0
60658,differed,0,0
60659,significantly,0,0
60660,between,0,0
60661,groups,0,0
60662,",",0,0
60663,occurring,0,0
60664,in,0,0
60665,3/16,0,0
60666,(,0,0
60667,18.7,0,0
60668,%,0,0
60669,),0,0
60670,patients,0,0
60671,assigned,0,0
60672,to,0,0
60673,the,0,0
60674,vitamin,1,1
60675,E,1,1
60676,supplementation,1,1
60677,group,0,0
60678,and,0,0
60679,in,0,0
60680,10/16,0,0
60681,(,0,0
60682,62.5,0,0
60683,%,0,0
60684,),0,1
60685,controls,0,0
60686,(,0,0
60687,P=0.03,0,0
60688,),0,0
60689,.,0,0
60690,The,0,0
60691,relative,0,0
60692,risk,0,0
60693,(,0,1
60694,RR,0,1
60695,),0,1
60696,of,0,0
60697,developing,0,0
60698,PIPN,0,1
60699,was,0,0
60700,significantly,0,0
60701,higher,0,0
60702,in,0,0
60703,controls,0,0
60704,than,0,0
60705,in,0,0
60706,vitamin,1,1
60707,E,1,1
60708,group,0,1
60709,patients,0,0
60710,(,0,0
60711,RR=0.3,0,0
60712,",",0,0
60713,95,0,0
60714,%,0,0
60715,confidence,0,0
60716,interval,0,0
60717,(,0,1
60718,CI,0,0
60719,),0,1
60720,=0.1-0.9,0,0
60721,),0,0
60722,.,0,0
60723,Mean,0,0
60724,PNP,0,0
60725,scores,0,0
60726,were,0,0
60727,2.25+/-5.1,0,0
60728,(,0,0
60729,range,0,0
60730,0-15,0,0
60731,),0,0
60732,for,0,0
60733,patients,0,0
60734,in,0,0
60735,Group,0,0
60736,I,0,0
60737,and,0,0
60738,11+/-11.63,0,0
60739,(,0,0
60740,range,0,0
60741,0-32,0,0
60742,),0,0
60743,for,0,0
60744,those,0,0
60745,in,0,0
60746,Group,0,0
60747,II,0,1
60748,(,0,1
60749,P=0.01,0,0
60750,),0,0
60751,.,0,0
60752,Vitamin,1,1
60753,E,1,1
60754,supplementation,1,1
60755,was,0,0
60756,well,0,0
60757,tolerated,0,0
60758,and,0,0
60759,showed,0,0
60760,an,0,0
60761,excellent,0,0
60762,safety,0,0
60763,profile,0,0
60764,.,0,0
60765,This,0,0
60766,study,0,0
60767,shows,0,0
60768,that,0,0
60769,vitamin,1,1
60770,E,1,1
60771,effectively,0,0
60772,and,0,0
60773,safely,0,0
60774,protects,0,0
60775,patients,0,0
60776,with,0,0
60777,cancer,0,0
60778,from,0,0
60779,the,0,0
60780,occurrence,0,0
60781,of,0,0
60782,paclitaxel-induced,0,1
60783,peripheral,0,0
60784,nerve,0,0
60785,damage,0,0
60786,.,0,0
60787,A,0,0
60788,double-blind,0,0
60789,",",0,0
60790,placebo-controlled,1,1
60791,trial,0,0
60792,is,0,0
60793,needed,0,0
60794,to,0,0
60795,confirm,0,0
60796,these,0,0
60797,results,0,0
60798,.,0,0
60799,Risperidone,1,1
60800,in,0,0
60801,children,0,0
60802,with,0,0
60803,autism,0,0
60804,:,0,0
60805,randomized,0,0
60806,",",0,0
60807,placebo-controlled,0,1
60808,",",0,0
60809,double-blind,0,0
60810,study,0,0
60811,.,0,0
60812,Some,0,0
60813,open-label,0,0
60814,studies,0,0
60815,suggest,0,0
60816,that,0,0
60817,risperidone,1,1
60818,can,0,0
60819,be,0,0
60820,useful,0,0
60821,in,0,0
60822,the,0,0
60823,treatment,0,0
60824,of,0,0
60825,certain,0,0
60826,target,0,0
60827,symptoms,0,0
60828,in,0,0
60829,children,0,0
60830,with,0,0
60831,autism,0,0
60832,.,0,0
60833,We,0,0
60834,aimed,0,0
60835,to,0,0
60836,study,0,0
60837,whether,0,0
60838,the,0,0
60839,use,0,0
60840,of,0,0
60841,risperidone,1,1
60842,in,0,0
60843,comparison,0,0
60844,with,0,0
60845,placebo,1,1
60846,improved,0,0
60847,functioning,0,0
60848,in,0,0
60849,children,0,0
60850,with,0,0
60851,autism,0,0
60852,with,0,0
60853,regard,0,0
60854,to,0,0
60855,behavior,0,0
60856,(,0,0
60857,aggressiveness,0,0
60858,",",0,0
60859,hyperactivity,0,0
60860,",",0,0
60861,irritability,0,0
60862,),0,0
60863,",",0,0
60864,social,0,0
60865,and,0,0
60866,emotional,0,0
60867,responsiveness,0,0
60868,",",0,0
60869,and,0,0
60870,communication,0,1
60871,skills,0,1
60872,.,0,0
60873,We,0,0
60874,conducted,0,0
60875,a,0,0
60876,randomized,0,0
60877,",",0,0
60878,double-blind,0,0
60879,",",0,0
60880,placebo-controlled,1,1
60881,trial,0,0
60882,with,0,0
60883,40,0,0
60884,consecutive,0,0
60885,children,0,0
60886,with,0,0
60887,autism,0,0
60888,",",0,0
60889,whose,0,0
60890,ages,0,0
60891,ranged,0,0
60892,from,0,0
60893,2,0,0
60894,to,0,0
60895,9,0,0
60896,years,0,0
60897,",",0,0
60898,who,0,0
60899,were,0,0
60900,receiving,0,0
60901,either,0,1
60902,risperidone,1,1
60903,or,1,1
60904,placebo,1,1
60905,given,0,0
60906,orally,0,1
60907,at,0,0
60908,a,0,0
60909,dose,0,0
60910,of,0,0
60911,1,0,0
60912,mg/day,0,1
60913,for,0,0
60914,6,0,0
60915,months,0,0
60916,.,0,0
60917,Autism,0,0
60918,symptoms,0,0
60919,were,0,0
60920,monitored,0,0
60921,periodically,0,0
60922,.,0,0
60923,The,0,0
60924,outcome,0,0
60925,variables,0,0
60926,were,0,0
60927,total,0,0
60928,scores,0,0
60929,on,0,0
60930,the,0,0
60931,Childhood,0,0
60932,Autism,0,0
60933,Rating,0,0
60934,Scale,0,1
60935,(,0,1
60936,CARS,0,1
60937,),0,1
60938,and,0,0
60939,the,0,0
60940,Children,0,0
60941,'s,0,0
60942,Global,0,0
60943,Assessment,0,1
60944,Scale,0,1
60945,(,0,1
60946,CGAS,0,1
60947,),0,1
60948,after,0,0
60949,6,0,0
60950,months,0,0
60951,.,0,0
60952,Of,0,0
60953,the,0,0
60954,40,0,0
60955,children,0,0
60956,enrolled,0,0
60957,",",0,0
60958,39,0,0
60959,completed,0,0
60960,the,0,0
60961,trial,0,0
60962,over,0,0
60963,a,0,0
60964,period,0,0
60965,of,0,0
60966,18,0,0
60967,months,0,0
60968,;,0,0
60969,19,0,0
60970,received,0,0
60971,risperidone,1,1
60972,",",0,0
60973,and,0,0
60974,20,0,0
60975,received,0,0
60976,placebo,1,1
60977,.,1,0
60978,In,0,0
60979,the,0,0
60980,risperidone,1,1
60981,group,0,0
60982,",",0,0
60983,12,0,0
60984,of,0,0
60985,19,0,0
60986,children,0,0
60987,showed,0,0
60988,improvement,0,0
60989,in,0,0
60990,the,0,0
60991,total,0,0
60992,Childhood,0,0
60993,Autism,0,0
60994,Rating,0,0
60995,Scale,0,1
60996,score,0,0
60997,and,0,0
60998,17,0,0
60999,of,0,0
61000,19,0,0
61001,children,0,0
61002,in,0,0
61003,the,0,0
61004,Children,0,0
61005,'s,0,0
61006,Global,0,0
61007,Assessment,0,1
61008,Scale,0,1
61009,score,0,0
61010,compared,0,0
61011,with,0,0
61012,0,0,0
61013,of,0,0
61014,20,0,0
61015,children,0,0
61016,for,0,0
61017,the,0,0
61018,Childhood,0,0
61019,Autism,0,0
61020,Rating,0,0
61021,Scale,0,1
61022,score,0,0
61023,and,0,0
61024,2,0,0
61025,of,0,0
61026,20,0,0
61027,children,0,0
61028,for,0,0
61029,the,0,0
61030,Children,0,0
61031,'s,0,0
61032,Global,0,0
61033,Assessment,0,1
61034,Scale,0,1
61035,score,0,0
61036,in,0,0
61037,the,0,0
61038,placebo,1,1
61039,group,0,0
61040,(,0,0
61041,P,0,0
61042,<,0,0
61043,.001,0,0
61044,and,0,0
61045,P,0,0
61046,=,0,0
61047,.035,0,0
61048,",",0,0
61049,respectively,0,0
61050,),0,0
61051,.,0,0
61052,Risperidone,1,1
61053,also,0,0
61054,improved,0,0
61055,social,0,1
61056,responsiveness,0,0
61057,and,0,0
61058,nonverbal,0,0
61059,communication,0,1
61060,and,0,0
61061,reduced,0,0
61062,the,0,0
61063,symptoms,0,0
61064,of,0,0
61065,hyperactivity,0,0
61066,and,0,0
61067,aggression,0,0
61068,.,0,1
61069,Risperidone,1,1
61070,was,0,0
61071,associated,0,0
61072,with,0,0
61073,increased,0,0
61074,appetite,0,0
61075,and,0,0
61076,a,0,0
61077,mild,0,0
61078,weight,0,0
61079,gain,0,0
61080,",",0,0
61081,mild,0,0
61082,sedation,0,0
61083,in,0,0
61084,20,0,0
61085,%,0,0
61086,",",0,0
61087,and,0,0
61088,transient,0,0
61089,dyskinesias,0,0
61090,in,0,0
61091,three,0,0
61092,children,0,0
61093,.,0,0
61094,Risperidone,1,1
61095,improved,0,0
61096,global,0,0
61097,functioning,0,0
61098,and,0,0
61099,social,0,1
61100,responsiveness,0,0
61101,while,0,0
61102,reducing,0,0
61103,hyperactivity,0,0
61104,and,0,0
61105,aggression,0,0
61106,in,0,0
61107,children,0,0
61108,with,0,0
61109,autism,0,0
61110,and,0,0
61111,was,0,0
61112,well,0,0
61113,tolerated,0,0
61114,.,0,0
61115,Anecortave,1,1
61116,acetate,1,1
61117,treatment,1,0
61118,for,0,0
61119,retinal,0,0
61120,angiomatous,0,0
61121,proliferation,0,0
61122,:,0,0
61123,a,0,0
61124,pilot,0,0
61125,study,0,0
61126,.,0,0
61127,PURPOSE,0,0
61128,The,0,0
61129,purpose,0,0
61130,of,0,0
61131,this,0,0
61132,study,0,0
61133,was,0,0
61134,to,0,0
61135,evaluate,0,0
61136,anecortave,1,1
61137,acetate,1,1
61138,treatment,1,0
61139,of,0,0
61140,retinal,0,0
61141,angiomatous,0,1
61142,proliferation,0,0
61143,(,0,1
61144,RAP,0,1
61145,),0,0
61146,",",0,0
61147,a,0,0
61148,neovascular,0,0
61149,form,0,0
61150,of,0,0
61151,age-related,0,0
61152,macular,0,0
61153,degeneration,0,0
61154,",",0,0
61155,with,0,0
61156,specific,0,0
61157,regard,0,0
61158,to,0,0
61159,inhibition,0,0
61160,of,0,0
61161,neovascularization,0,0
61162,and,0,0
61163,maintenance,0,0
61164,of,0,0
61165,vision,0,0
61166,.,0,0
61167,METHODS,0,0
61168,Thirty-four,0,0
61169,patients,0,0
61170,with,0,0
61171,RAP,0,0
61172,with,0,0
61173,any,0,0
61174,stage,0,0
61175,of,0,0
61176,neovascularization,0,0
61177,were,0,0
61178,randomized,0,0
61179,1:1:1,0,1
61180,for,0,0
61181,treatment,0,0
61182,with,0,0
61183,three,0,0
61184,different,0,0
61185,quantities,0,0
61186,(,0,0
61187,30,0,0
61188,mg,0,1
61189,",",0,0
61190,15,0,0
61191,mg,0,1
61192,",",0,0
61193,3,0,0
61194,mg,0,1
61195,),0,0
61196,of,0,0
61197,anecortave,1,1
61198,acetate,1,1
61199,sterile,1,1
61200,suspension,1,1
61201,for,1,0
61202,juxtascleral,1,1
61203,administration,1,0
61204,.,1,0
61205,Best-corrected,0,0
61206,visual,0,0
61207,acuity,0,0
61208,(,0,0
61209,Early,0,1
61210,Treatment,0,1
61211,Diabetic,0,1
61212,Retinopathy,0,0
61213,Study,0,0
61214,chart,0,1
61215,),0,0
61216,",",0,0
61217,intraocular,0,1
61218,pressure,0,0
61219,measurement,0,0
61220,",",0,0
61221,biomicroscopy,0,1
61222,",",0,0
61223,funduscopy,0,1
61224,",",0,0
61225,digital,0,1
61226,fluorescein,0,1
61227,",",0,0
61228,and,0,0
61229,indocyanine,0,1
61230,green,0,1
61231,angiography,0,1
61232,were,0,0
61233,recorded,0,0
61234,at,0,0
61235,baseline,0,0
61236,and,0,0
61237,at,0,0
61238,3,0,0
61239,months,0,0
61240,.,0,0
61241,A,0,0
61242,6-month,0,0
61243,retreatment,0,0
61244,interval,0,0
61245,was,0,0
61246,established,0,0
61247,for,0,0
61248,this,0,0
61249,study,0,0
61250,with,0,0
61251,a,0,0
61252,follow-up,0,0
61253,of,0,0
61254,12,0,0
61255,months,0,0
61256,.,0,0
61257,In,0,0
61258,selected,0,0
61259,patients,0,0
61260,optical,0,1
61261,coherence,0,0
61262,tomography,0,1
61263,was,0,0
61264,performed,0,0
61265,.,0,0
61266,The,0,0
61267,outcomes,0,0
61268,were,0,0
61269,mean,0,0
61270,changes,0,0
61271,in,0,0
61272,visual,0,0
61273,acuity,0,0
61274,and,0,0
61275,lesion,0,0
61276,size,0,0
61277,at,0,0
61278,1,0,0
61279,year,0,0
61280,.,0,0
61281,RESULTS,0,0
61282,The,0,0
61283,detachment,0,0
61284,of,0,0
61285,the,0,0
61286,neurosensory,0,1
61287,retina,0,0
61288,and,0,0
61289,retinal,0,1
61290,pigment,0,0
61291,epithelium,0,0
61292,improved,0,0
61293,in,0,0
61294,all,0,0
61295,eyes,0,0
61296,",",0,0
61297,but,0,0
61298,all,0,0
61299,neovascular,0,0
61300,lesions,0,0
61301,increased,0,0
61302,in,0,0
61303,size,0,0
61304,.,0,0
61305,Vision,0,0
61306,loss,0,0
61307,occurred,0,0
61308,in,0,0
61309,the,0,0
61310,majority,0,0
61311,of,0,0
61312,study,0,0
61313,eyes,0,0
61314,(,0,0
61315,22,0,0
61316,out,0,0
61317,of,0,0
61318,34,0,0
61319,eyes,0,0
61320,",",0,0
61321,64.7,0,0
61322,%,0,0
61323,),0,0
61324,independent,0,0
61325,of,0,0
61326,the,0,0
61327,concentration,0,0
61328,administered,0,0
61329,.,0,0
61330,CONCLUSION,0,0
61331,The,0,0
61332,results,0,0
61333,suggest,0,0
61334,that,0,0
61335,a,0,0
61336,posterior,0,0
61337,juxtascleral,0,1
61338,injection,0,1
61339,of,0,0
61340,anecortave,1,1
61341,acetate,1,1
61342,reduces,0,0
61343,capillary,0,1
61344,permeability,0,0
61345,in,0,0
61346,patients,0,0
61347,with,0,0
61348,RAP,0,0
61349,.,0,0
61350,However,0,0
61351,",",0,0
61352,in,0,0
61353,spite,0,0
61354,of,0,0
61355,improvement,0,0
61356,of,0,0
61357,the,0,0
61358,exudation,0,0
61359,there,0,0
61360,is,0,0
61361,a,0,0
61362,progression,0,0
61363,of,0,0
61364,neovascularization,0,0
61365,and,0,0
61366,a,0,0
61367,significant,0,0
61368,loss,0,0
61369,of,0,0
61370,vision,0,0
61371,in,0,0
61372,all,0,0
61373,these,0,0
61374,patients,0,0
61375,.,0,0
61376,Like,0,0
61377,other,0,0
61378,monotherapeutic,0,0
61379,methods,0,0
61380,used,0,0
61381,to,0,0
61382,treat,0,0
61383,this,0,0
61384,variant,0,0
61385,of,0,0
61386,neovascular,0,0
61387,age-related,0,0
61388,macular,0,0
61389,degeneration,0,0
61390,",",0,0
61391,anecortave,1,1
61392,acetate,1,1
61393,alone,0,1
61394,does,0,0
61395,not,0,0
61396,appear,0,0
61397,to,0,0
61398,benefit,0,0
61399,these,0,0
61400,patients,0,0
61401,.,0,0
61402,Future,0,0
61403,studies,0,0
61404,should,0,0
61405,investigate,0,0
61406,a,0,0
61407,combination,0,1
61408,form,0,0
61409,of,0,0
61410,therapy,0,1
61411,.,0,0
61412,A,0,0
61413,stable,1,0
61414,prostacyclin,1,1
61415,analogue,1,1
61416,(,1,1
61417,iloprost,1,1
61418,),1,1
61419,in,0,0
61420,the,0,0
61421,treatment,0,0
61422,of,0,0
61423,ischaemic,0,0
61424,ulcers,0,0
61425,of,0,0
61426,the,0,0
61427,lower,0,0
61428,limb,0,0
61429,.,0,0
61430,A,0,0
61431,Scandinavian-Polish,0,0
61432,placebo,1,1
61433,controlled,0,0
61434,",",0,0
61435,randomised,0,0
61436,multicenter,0,0
61437,study,0,0
61438,.,0,0
61439,The,0,0
61440,clinical,0,0
61441,efficacy,0,0
61442,of,0,0
61443,the,0,0
61444,prostacyclin,1,1
61445,analogue,1,0
61446,iloprost,1,1
61447,was,0,0
61448,studied,0,0
61449,during,0,0
61450,a,0,0
61451,2,0,0
61452,week,0,0
61453,treatment,0,0
61454,and,0,0
61455,6,0,0
61456,month,0,0
61457,follow-up,0,0
61458,period,0,0
61459,in,0,0
61460,103,0,0
61461,patients,0,0
61462,with,0,0
61463,ischaemic,0,0
61464,ulcers,0,0
61465,who,0,0
61466,were,0,0
61467,randomised,0,0
61468,to,0,0
61469,receive,0,0
61470,active,1,1
61471,treatment,1,1
61472,or,1,1
61473,placebo,1,1
61474,.,1,0
61475,Responders,0,0
61476,were,0,0
61477,defined,0,0
61478,as,0,0
61479,those,0,0
61480,patients,0,0
61481,who,0,0
61482,achieved,0,0
61483,healing,0,0
61484,of,0,0
61485,at,0,0
61486,least,0,0
61487,one,0,0
61488,third,0,0
61489,of,0,0
61490,the,0,0
61491,ulcer,0,0
61492,area,0,0
61493,during,0,0
61494,the,0,0
61495,study,0,0
61496,period,0,0
61497,.,0,0
61498,The,0,0
61499,overall,0,0
61500,responder,0,0
61501,rate,0,0
61502,was,0,0
61503,41.3,0,0
61504,%,0,0
61505,",",0,0
61506,compared,0,0
61507,with,0,0
61508,25,0,0
61509,%,0,0
61510,for,0,0
61511,the,0,0
61512,control,0,1
61513,group,0,0
61514,(,0,0
61515,P,0,0
61516,=,0,0
61517,0.086,0,0
61518,),0,0
61519,.,0,0
61520,Side,0,1
61521,effects,0,0
61522,including,0,0
61523,flushing,0,1
61524,and,0,0
61525,headache,0,0
61526,",",0,0
61527,were,0,0
61528,common,0,0
61529,.,0,0
61530,The,0,0
61531,study,0,0
61532,population,0,0
61533,had,0,0
61534,a,0,0
61535,mortality,0,0
61536,of,0,0
61537,23,0,0
61538,%,0,0
61539,during,0,0
61540,the,0,0
61541,6,0,0
61542,month,0,0
61543,period,0,0
61544,",",0,0
61545,the,0,0
61546,amputation,0,0
61547,rate,0,0
61548,was,0,0
61549,43.5,0,0
61550,%,0,0
61551,for,0,0
61552,iloprost,1,1
61553,and,0,0
61554,50,0,1
61555,%,0,0
61556,for,0,0
61557,placebo,1,1
61558,treated,0,0
61559,patients,0,0
61560,.,0,0
61561,In,0,0
61562,this,0,0
61563,severely,0,0
61564,diseased,0,0
61565,population,0,0
61566,of,0,0
61567,patients,0,0
61568,a,0,0
61569,treatment,0,0
61570,period,0,0
61571,limited,0,0
61572,to,0,0
61573,2,0,0
61574,weeks,0,0
61575,did,0,0
61576,not,0,0
61577,sufficiently,0,0
61578,improve,0,0
61579,ulcer,0,0
61580,healing,0,0
61581,.,0,0
61582,Nordic,1,1
61583,walking,1,1
61584,and,0,0
61585,chronic,0,0
61586,low,0,0
61587,back,0,0
61588,pain,0,0
61589,:,0,0
61590,design,0,0
61591,of,0,0
61592,a,0,0
61593,randomized,0,0
61594,clinical,0,0
61595,trial,0,0
61596,.,0,0
61597,BACKGROUND,0,0
61598,Low,0,0
61599,Back,0,0
61600,Pain,0,0
61601,is,0,0
61602,a,0,0
61603,major,0,0
61604,public,0,0
61605,health,0,0
61606,problem,0,0
61607,all,0,0
61608,over,0,0
61609,the,0,0
61610,western,0,1
61611,world,0,0
61612,.,0,0
61613,Active,0,0
61614,approaches,0,0
61615,including,0,0
61616,exercise,0,1
61617,in,0,0
61618,the,0,0
61619,treatment,0,0
61620,of,0,0
61621,low,0,0
61622,back,0,0
61623,pain,0,0
61624,results,0,0
61625,in,0,0
61626,better,0,0
61627,outcomes,0,0
61628,for,0,0
61629,patients,0,0
61630,",",0,0
61631,but,0,0
61632,it,0,0
61633,is,0,0
61634,not,0,0
61635,known,0,0
61636,exactly,0,0
61637,which,0,0
61638,types,0,0
61639,of,0,0
61640,back,0,0
61641,exercises,0,1
61642,are,0,0
61643,most,0,0
61644,beneficial,0,0
61645,or,0,1
61646,whether,0,0
61647,general,0,0
61648,physical,0,1
61649,activity,0,0
61650,provide,0,0
61651,similar,0,0
61652,benefits,0,0
61653,.,0,0
61654,Nordic,1,0
61655,Walking,1,0
61656,is,0,0
61657,a,0,0
61658,popular,0,0
61659,and,0,0
61660,fast,0,1
61661,growing,0,0
61662,type,0,0
61663,of,0,0
61664,exercise,0,1
61665,in,0,0
61666,Northern,0,1
61667,Europe,0,1
61668,.,0,0
61669,Initial,0,0
61670,studies,0,0
61671,have,0,0
61672,demonstrated,0,0
61673,that,0,0
61674,persons,0,0
61675,performing,0,0
61676,Nordic,1,0
61677,Walking,1,1
61678,are,0,0
61679,able,0,0
61680,to,0,0
61681,exercise,0,1
61682,longer,0,0
61683,and,0,0
61684,harder,0,0
61685,compared,0,0
61686,to,0,0
61687,normal,0,0
61688,walking,0,1
61689,thereby,0,0
61690,increasing,0,0
61691,their,0,0
61692,cardiovascular,0,0
61693,metabolism,0,0
61694,.,0,0
61695,Until,0,1
61696,now,0,0
61697,no,0,0
61698,studies,0,0
61699,have,0,0
61700,been,0,0
61701,performed,0,0
61702,to,0,0
61703,investigate,0,0
61704,whether,0,0
61705,Nordic,1,0
61706,Walking,1,1
61707,has,0,0
61708,beneficial,0,0
61709,effects,0,0
61710,in,0,0
61711,relation,0,0
61712,to,0,0
61713,low,0,0
61714,back,0,0
61715,pain,0,0
61716,.,0,0
61717,The,0,0
61718,primary,0,0
61719,aim,0,0
61720,of,0,0
61721,this,0,0
61722,study,0,0
61723,is,0,0
61724,to,0,0
61725,investigate,0,0
61726,whether,0,0
61727,supervised,1,1
61728,Nordic,1,1
61729,Walking,1,1
61730,can,0,0
61731,reduce,0,0
61732,pain,0,0
61733,and,0,0
61734,improve,0,0
61735,function,0,0
61736,in,0,0
61737,a,0,0
61738,population,0,0
61739,of,0,0
61740,chronic,0,0
61741,low,0,0
61742,back,0,0
61743,pain,0,0
61744,patients,0,0
61745,when,0,0
61746,compared,0,0
61747,to,0,0
61748,unsupervised,1,1
61749,Nordic,1,1
61750,Walking,1,1
61751,and,1,0
61752,advice,1,1
61753,to,1,0
61754,stay,1,0
61755,active,1,0
61756,.,1,0
61757,In,0,0
61758,addition,0,0
61759,we,0,0
61760,investigate,0,0
61761,whether,0,0
61762,there,0,0
61763,is,0,0
61764,an,0,0
61765,increase,0,0
61766,in,0,0
61767,the,0,0
61768,cardiovascular,0,0
61769,metabolism,0,0
61770,in,0,0
61771,persons,0,0
61772,performing,0,0
61773,supervised,1,1
61774,Nordic,1,1
61775,Walking,1,1
61776,compared,0,0
61777,to,0,0
61778,persons,0,0
61779,who,0,0
61780,are,0,0
61781,advised,1,0
61782,to,1,0
61783,stay,1,0
61784,active,1,0
61785,.,1,0
61786,Finally,0,0
61787,",",0,0
61788,we,0,0
61789,investigate,0,0
61790,whether,0,0
61791,there,0,0
61792,is,0,0
61793,a,0,0
61794,difference,0,0
61795,in,0,0
61796,compliance,0,0
61797,between,0,0
61798,persons,0,0
61799,receiving,0,0
61800,supervised,1,1
61801,Nordic,1,1
61802,Walking,1,1
61803,and,0,0
61804,persons,0,0
61805,doing,0,0
61806,unsupervised,1,1
61807,Nordic,1,1
61808,Walking,1,0
61809,.,1,0
61810,METHODS,0,0
61811,One,0,0
61812,hundred,0,0
61813,and,0,0
61814,fifty,0,0
61815,patients,0,0
61816,with,0,0
61817,low,0,0
61818,back,0,0
61819,pain,0,0
61820,for,0,0
61821,at,0,0
61822,least,0,0
61823,eight,0,0
61824,weeks,0,0
61825,and,0,0
61826,referred,0,0
61827,to,0,0
61828,a,0,0
61829,specialized,0,0
61830,secondary,0,0
61831,sector,0,0
61832,outpatient,0,0
61833,back,0,1
61834,pain,0,0
61835,clinic,0,0
61836,are,0,0
61837,included,0,0
61838,in,0,0
61839,the,0,0
61840,study,0,0
61841,.,0,0
61842,After,0,0
61843,completion,0,0
61844,of,0,0
61845,the,0,0
61846,standard,1,1
61847,back,1,0
61848,centre,1,0
61849,treatment,1,0
61850,patients,0,0
61851,are,0,0
61852,randomized,0,0
61853,into,0,0
61854,one,0,0
61855,of,0,0
61856,three,0,0
61857,groups,0,0
61858,:,0,0
61859,A,0,0
61860,),0,0
61861,Nordic,1,0
61862,Walking,1,1
61863,twice,1,1
61864,a,1,0
61865,week,1,0
61866,for,1,0
61867,eight,1,0
61868,weeks,1,0
61869,under,1,0
61870,supervision,1,1
61871,of,1,0
61872,a,1,0
61873,specially,1,1
61874,trained,1,1
61875,instructor,1,1
61876,;,1,0
61877,B,0,0
61878,),0,0
61879,Unsupervised,1,1
61880,Nordic,1,1
61881,Walking,1,1
61882,for,1,0
61883,eight,1,0
61884,weeks,1,0
61885,after,1,0
61886,one,1,0
61887,training,1,1
61888,session,1,1
61889,with,1,0
61890,an,1,0
61891,instructor,1,1
61892,;,1,0
61893,C,0,1
61894,),0,0
61895,A,1,0
61896,one,1,0
61897,hour,1,0
61898,motivational,1,1
61899,talk,1,1
61900,including,1,0
61901,advice,1,1
61902,to,1,0
61903,stay,1,0
61904,active,1,0
61905,.,1,0
61906,Outcome,0,0
61907,measures,0,0
61908,are,0,0
61909,pain,0,0
61910,",",0,0
61911,function,0,0
61912,",",0,0
61913,overall,0,0
61914,health,0,0
61915,",",0,0
61916,cardiovascular,0,0
61917,ability,0,0
61918,and,0,0
61919,activity,0,0
61920,level,0,0
61921,.,0,0
61922,RESULTS,0,0
61923,No,0,0
61924,results,0,0
61925,available,0,0
61926,at,0,0
61927,this,0,0
61928,point,0,0
61929,.,0,0
61930,DISCUSSION,0,0
61931,This,0,0
61932,study,0,0
61933,will,0,0
61934,investigate,0,0
61935,the,0,0
61936,effect,0,0
61937,of,0,0
61938,Nordic,1,0
61939,Walking,1,0
61940,on,0,0
61941,pain,0,0
61942,and,0,0
61943,function,0,0
61944,in,0,0
61945,a,0,0
61946,population,0,0
61947,of,0,0
61948,people,0,0
61949,with,0,0
61950,chronic,0,0
61951,LBP,0,0
61952,.,0,0
61953,Classroom,1,1
61954,intervention,1,1
61955,for,0,0
61956,illness-related,0,0
61957,problem,0,0
61958,behavior,0,0
61959,in,0,0
61960,children,0,0
61961,with,0,0
61962,developmental,0,0
61963,disabilities,0,0
61964,.,0,0
61965,There,0,0
61966,is,0,0
61967,growing,0,0
61968,evidence,0,0
61969,of,0,0
61970,an,0,0
61971,association,0,0
61972,between,0,0
61973,physical,0,1
61974,illness,0,0
61975,and,0,0
61976,problem,0,0
61977,behavior,0,0
61978,in,0,0
61979,children,0,0
61980,with,0,0
61981,developmental,0,0
61982,disabilities,0,0
61983,.,0,0
61984,Such,0,0
61985,behavior,0,0
61986,can,0,0
61987,compromise,0,0
61988,school,0,0
61989,performance,0,0
61990,.,0,0
61991,Therefore,0,0
61992,",",0,0
61993,the,0,0
61994,purpose,0,0
61995,of,0,0
61996,the,0,0
61997,present,0,0
61998,study,0,0
61999,was,0,0
62000,to,0,0
62001,evaluate,0,0
62002,",",0,0
62003,using,0,0
62004,a,0,0
62005,group,0,0
62006,design,0,0
62007,",",0,0
62008,the,0,0
62009,effectiveness,0,0
62010,of,0,0
62011,medical,1,0
62012,intervention,1,1
62013,alone,1,1
62014,(,0,0
62015,N,0,0
62016,=,0,0
62017,11,0,0
62018,),0,0
62019,versus,0,1
62020,behavioral,1,1
62021,plus,1,1
62022,medical,1,1
62023,intervention,1,1
62024,(,0,0
62025,N,0,1
62026,=,0,0
62027,10,0,0
62028,),0,0
62029,for,0,0
62030,illness-related,0,0
62031,problem,0,0
62032,behavior,0,0
62033,in,0,0
62034,a,0,0
62035,school,0,0
62036,setting,0,0
62037,.,0,0
62038,Following,0,0
62039,intervention,0,1
62040,",",0,0
62041,the,0,0
62042,behavioral,0,1
62043,plus,0,1
62044,medical,0,1
62045,intervention,0,1
62046,group,0,0
62047,showed,0,0
62048,lower,0,0
62049,levels,0,0
62050,of,0,0
62051,problem,0,0
62052,behavior,0,0
62053,and,0,0
62054,completed,0,0
62055,more,0,0
62056,academic,0,0
62057,tasks,0,0
62058,than,0,0
62059,did,0,0
62060,the,0,0
62061,medical,0,0
62062,intervention,0,1
62063,alone,0,1
62064,group,0,0
62065,.,0,0
62066,The,0,0
62067,results,0,0
62068,are,0,0
62069,discussed,0,0
62070,with,0,0
62071,respect,0,0
62072,to,0,0
62073,the,0,0
62074,concept,0,0
62075,of,0,0
62076,illness,0,0
62077,and,0,0
62078,pain,0,0
62079,as,0,0
62080,a,0,0
62081,setting,0,0
62082,event,0,0
62083,for,0,0
62084,problem,0,0
62085,behavior,0,0
62086,.,0,0
62087,The,0,0
62088,need,0,0
62089,for,0,0
62090,research,0,0
62091,to,0,0
62092,develop,0,0
62093,algorithms,0,0
62094,that,0,0
62095,allow,0,0
62096,one,0,0
62097,to,0,0
62098,select,0,0
62099,the,0,0
62100,best,0,0
62101,combination,0,1
62102,of,0,0
62103,medical,1,0
62104,and,1,0
62105,behavioral,1,1
62106,interventions,1,1
62107,for,0,0
62108,specific,0,0
62109,illnesses,0,0
62110,and,0,0
62111,contexts,0,0
62112,is,0,0
62113,noted,0,0
62114,.,0,0
62115,The,0,0
62116,Social,1,0
62117,Communication,1,0
62118,Assessment,1,1
62119,for,1,0
62120,Toddlers,1,0
62121,with,1,0
62122,Autism,1,0
62123,(,1,1
62124,SCATA,1,0
62125,),1,1
62126,:,1,0
62127,an,0,0
62128,instrument,0,0
62129,to,0,0
62130,measure,0,0
62131,the,0,0
62132,frequency,0,0
62133,",",0,0
62134,form,0,0
62135,and,0,0
62136,function,0,0
62137,of,0,0
62138,communication,0,1
62139,in,0,0
62140,toddlers,0,0
62141,with,0,0
62142,autism,0,0
62143,spectrum,0,0
62144,disorder,0,0
62145,.,0,0
62146,The,0,0
62147,Social,1,0
62148,Communication,1,0
62149,Assessment,1,1
62150,for,1,0
62151,Toddlers,1,0
62152,with,1,0
62153,Autism,1,0
62154,(,1,1
62155,SCATA,1,0
62156,),1,1
62157,was,0,0
62158,designed,0,0
62159,to,0,0
62160,measure,0,0
62161,non-verbal,0,0
62162,communication,0,1
62163,",",0,0
62164,including,0,0
62165,early,0,0
62166,and,0,0
62167,atypical,0,0
62168,communication,0,1
62169,",",0,0
62170,in,0,0
62171,young,0,0
62172,children,0,0
62173,with,0,0
62174,autism,0,0
62175,spectrum,0,0
62176,disorder,0,0
62177,.,0,0
62178,Each,0,0
62179,communicative,0,0
62180,act,0,0
62181,is,0,0
62182,scored,0,0
62183,according,0,0
62184,to,0,0
62185,its,0,0
62186,form,0,0
62187,",",0,0
62188,function,0,0
62189,",",0,0
62190,role,0,0
62191,and,0,0
62192,complexity,0,0
62193,.,0,0
62194,The,0,0
62195,SCATA,1,0
62196,was,0,0
62197,used,0,0
62198,to,0,0
62199,measure,0,0
62200,communicative,0,0
62201,ability,0,0
62202,longitudinally,0,0
62203,in,0,0
62204,two,0,0
62205,samples,0,0
62206,of,0,0
62207,toddlers,0,0
62208,with,0,0
62209,autism,0,0
62210,spectrum,0,0
62211,disorder,0,0
62212,.,0,0
62213,Overall,0,0
62214,frequency,0,0
62215,of,0,0
62216,non-verbal,0,0
62217,communicative,0,0
62218,acts,0,0
62219,did,0,0
62220,not,0,0
62221,change,0,0
62222,between,0,0
62223,the,0,0
62224,two,0,0
62225,assessments,0,0
62226,.,0,0
62227,However,0,0
62228,",",0,0
62229,the,0,0
62230,form,0,0
62231,and,0,0
62232,complexity,0,0
62233,",",0,0
62234,the,0,0
62235,function,0,0
62236,and,0,0
62237,the,0,0
62238,role,0,0
62239,the,0,0
62240,child,0,0
62241,took,0,0
62242,in,0,0
62243,the,0,0
62244,interaction,0,0
62245,did,0,0
62246,change,0,0
62247,with,0,0
62248,time,0,0
62249,.,0,0
62250,Both,0,1
62251,frequency,0,0
62252,and,0,0
62253,function,0,0
62254,of,0,0
62255,communicative,0,0
62256,acts,0,0
62257,in,0,0
62258,toddlerhood,0,0
62259,were,0,0
62260,positively,0,0
62261,associated,0,0
62262,with,0,0
62263,later,0,0
62264,language,0,1
62265,ability,0,0
62266,:,0,0
62267,social,0,0
62268,acts,0,0
62269,",",0,0
62270,comments,0,0
62271,and,0,0
62272,initiations,0,0
62273,showed,0,0
62274,greater,0,0
62275,predictive,0,0
62276,association,0,0
62277,than,0,0
62278,requests,0,0
62279,and,0,0
62280,responses,0,0
62281,.,0,0
62282,Effect,0,0
62283,of,0,0
62284,CX516,1,0
62285,",",0,0
62286,an,0,0
62287,AMPA-modulating,1,0
62288,compound,1,0
62289,",",0,0
62290,on,0,0
62291,cognition,0,0
62292,and,0,0
62293,behavior,0,0
62294,in,0,0
62295,fragile,0,0
62296,X,0,1
62297,syndrome,0,0
62298,:,0,0
62299,a,0,0
62300,controlled,0,0
62301,trial,0,0
62302,.,0,0
62303,A,0,0
62304,Phase,0,0
62305,II,0,0
62306,",",0,0
62307,4-week,0,0
62308,randomized,0,0
62309,",",0,0
62310,double-blind,0,0
62311,",",0,0
62312,placebo-controlled,1,1
62313,clinical,0,0
62314,trial,0,0
62315,was,0,0
62316,conducted,0,0
62317,to,0,0
62318,evaluate,0,0
62319,the,0,0
62320,safety,0,0
62321,and,0,0
62322,efficacy,0,0
62323,of,0,0
62324,the,0,0
62325,Ampakine,1,1
62326,compound,0,1
62327,CX516,1,1
62328,as,0,0
62329,a,0,0
62330,potential,0,0
62331,treatment,0,0
62332,for,0,0
62333,the,0,0
62334,underlying,0,0
62335,disorder,0,0
62336,in,0,0
62337,fragile,0,0
62338,X,0,1
62339,syndrome,0,0
62340,(,0,1
62341,FXS,0,1
62342,),0,0
62343,.,0,0
62344,After,0,0
62345,baseline,0,0
62346,screening,0,0
62347,",",0,0
62348,subjects,0,0
62349,with,0,0
62350,FXS,0,1
62351,(,0,0
62352,n,0,0
62353,=,0,0
62354,49,0,0
62355,),0,0
62356,underwent,0,0
62357,a,0,0
62358,1-week,1,0
62359,placebo,1,1
62360,lead-in,1,1
62361,and,1,0
62362,then,1,1
62363,were,1,0
62364,randomized,1,0
62365,to,1,0
62366,study,1,0
62367,drug,1,1
62368,or,1,1
62369,placebo,1,1
62370,for,1,0
62371,a,1,0
62372,4-week,1,0
62373,period,1,0
62374,.,1,0
62375,Cognitive,0,0
62376,and,0,0
62377,behavioral,0,1
62378,outcome,0,0
62379,measures,0,0
62380,were,0,0
62381,administered,0,0
62382,prior,0,0
62383,to,0,0
62384,treatment,0,0
62385,",",0,0
62386,at,0,0
62387,the,0,0
62388,end,0,0
62389,of,0,0
62390,treatment,0,0
62391,",",0,0
62392,and,0,0
62393,2,0,0
62394,weeks,0,0
62395,posttreatment,0,0
62396,.,0,0
62397,There,0,0
62398,were,0,0
62399,minimal,0,0
62400,side,0,0
62401,effects,0,0
62402,",",0,0
62403,no,0,0
62404,significant,0,0
62405,changes,0,0
62406,in,0,0
62407,safety,0,0
62408,parameters,0,0
62409,",",0,0
62410,and,0,0
62411,no,0,0
62412,serious,0,0
62413,adverse,0,0
62414,events,0,0
62415,.,0,0
62416,There,0,0
62417,was,0,0
62418,a,0,0
62419,12.5,0,0
62420,%,0,0
62421,frequency,0,0
62422,of,0,0
62423,allergic,0,0
62424,rash,0,0
62425,in,0,0
62426,the,0,0
62427,CX516,1,1
62428,group,0,0
62429,and,0,0
62430,1,0,0
62431,subject,0,0
62432,developed,0,0
62433,a,0,0
62434,substantial,0,0
62435,rash,0,0
62436,.,0,0
62437,There,0,0
62438,was,0,0
62439,also,0,0
62440,no,0,0
62441,significant,0,0
62442,improvement,0,0
62443,in,0,0
62444,memory,0,0
62445,",",0,0
62446,the,0,0
62447,primary,0,0
62448,outcome,0,0
62449,measure,0,0
62450,",",0,0
62451,or,0,1
62452,in,0,0
62453,secondary,0,0
62454,measures,0,0
62455,of,0,0
62456,language,0,0
62457,",",0,0
62458,attention/executive,0,0
62459,function,0,0
62460,",",0,0
62461,behavior,0,0
62462,",",0,0
62463,and,0,0
62464,overall,0,0
62465,functioning,0,0
62466,in,0,0
62467,CX516-treated,1,0
62468,subjects,0,0
62469,compared,0,0
62470,to,0,0
62471,placebo,1,1
62472,.,1,0
62473,This,0,0
62474,study,0,0
62475,did,0,0
62476,demonstrate,0,0
62477,that,0,0
62478,many,0,0
62479,outcome,0,0
62480,measures,0,0
62481,were,0,0
62482,reproducible,0,0
62483,in,0,0
62484,this,0,0
62485,test-retest,0,0
62486,setting,0,0
62487,for,0,0
62488,the,0,0
62489,FXS,0,1
62490,population,0,0
62491,",",0,0
62492,yet,0,0
62493,some,0,0
62494,were,0,0
62495,too,0,0
62496,difficult,0,0
62497,or,0,1
62498,variable,0,0
62499,.,0,0
62500,Adult,0,0
62501,subjects,0,0
62502,with,0,0
62503,FXS,0,1
62504,were,0,0
62505,able,0,0
62506,to,0,0
62507,complete,0,0
62508,an,0,0
62509,intensive,0,1
62510,clinical,0,0
62511,trial,0,0
62512,",",0,0
62513,and,0,0
62514,some,0,0
62515,valid,0,0
62516,outcome,0,0
62517,measures,0,0
62518,were,0,0
62519,identified,0,0
62520,for,0,0
62521,future,0,0
62522,FXS,0,1
62523,trial,0,0
62524,design,0,0
62525,.,0,0
62526,Problems,0,0
62527,with,0,0
62528,potency,0,0
62529,of,0,0
62530,CX516,1,1
62531,in,0,0
62532,other,0,0
62533,studies,0,0
62534,have,0,0
62535,suggested,0,0
62536,dosing,0,0
62537,may,0,0
62538,have,0,0
62539,been,0,0
62540,inadequate,0,0
62541,for,0,0
62542,therapeutic,0,0
62543,effect,0,0
62544,and,0,0
62545,thus,0,0
62546,it,0,0
62547,remains,0,0
62548,unclear,0,0
62549,whether,0,0
62550,modulation,0,0
62551,of,0,0
62552,AMPA-mediated,0,0
62553,neurotransmission,0,0
62554,is,0,0
62555,a,0,0
62556,viable,0,0
62557,therapeutic,0,0
62558,strategy,0,0
62559,for,0,0
62560,the,0,0
62561,treatment,0,0
62562,of,0,0
62563,FXS,0,1
62564,.,0,0
62565,Neuropsychological,0,0
62566,effects,0,0
62567,of,0,0
62568,risperidone,1,1
62569,in,0,0
62570,children,0,0
62571,with,0,0
62572,pervasive,0,0
62573,developmental,0,0
62574,disorders,0,0
62575,:,0,0
62576,a,0,0
62577,blinded,0,0
62578,discontinuation,0,0
62579,study,0,0
62580,.,0,0
62581,OBJECTIVE,0,0
62582,Little,0,0
62583,is,0,0
62584,known,0,0
62585,about,0,0
62586,the,0,0
62587,neuropsychological,0,0
62588,effects,0,0
62589,of,0,0
62590,risperidone,1,1
62591,in,0,0
62592,children,0,0
62593,with,0,0
62594,pervasive,0,0
62595,developmental,0,0
62596,disorders,0,0
62597,.,0,0
62598,METHOD,0,0
62599,Twenty-four,0,0
62600,children,0,0
62601,(,0,0
62602,aged,0,0
62603,5-17,0,0
62604,years,0,0
62605,),0,0
62606,with,0,0
62607,pervasive,0,0
62608,developmental,0,0
62609,disorders,0,0
62610,and,0,0
62611,co-morbid,0,0
62612,disruptive,0,0
62613,behavior,0,0
62614,who,0,0
62615,responded,0,0
62616,favorably,0,0
62617,to,0,0
62618,open-label,0,0
62619,treatment,0,0
62620,with,0,0
62621,risperidone,1,1
62622,as,0,0
62623,part,0,0
62624,of,0,0
62625,a,0,0
62626,previously,0,0
62627,described,0,0
62628,controlled,0,0
62629,discontinuation,0,0
62630,study,0,0
62631,completed,0,0
62632,two,1,0
62633,different,1,0
62634,computerized,1,1
62635,attention,1,0
62636,tasks,1,1
62637,at,1,0
62638,baseline,1,0
62639,",",1,0
62640,weeks,1,0
62641,4,1,0
62642,",",1,0
62643,8,1,0
62644,",",1,0
62645,and,1,0
62646,24,1,0
62647,of,1,0
62648,open-label,1,0
62649,treatment,1,0
62650,",",1,0
62651,and,1,0
62652,",",1,0
62653,at,1,0
62654,8,1,0
62655,weeks,1,0
62656,after,1,0
62657,random,1,0
62658,assignment,1,0
62659,to,1,0
62660,either,1,1
62661,placebo,1,1
62662,or,1,1
62663,risperidone,1,1
62664,.,1,0
62665,The,0,0
62666,primary,0,0
62667,efficacy,0,0
62668,measures,0,0
62669,were,0,0
62670,response,0,0
62671,latencies,0,0
62672,to,0,0
62673,visually,0,0
62674,presented,0,0
62675,stimuli,0,1
62676,requiring,0,0
62677,two,0,0
62678,different,0,0
62679,types,0,0
62680,of,0,0
62681,attention-controlled,0,0
62682,processing,0,0
62683,",",0,0
62684,i.e.,0,0
62685,",",0,0
62686,focused,0,0
62687,and,0,0
62688,divided,0,0
62689,attention,0,0
62690,.,0,0
62691,RESULTS,0,0
62692,About,0,0
62693,half,0,0
62694,of,0,0
62695,the,0,0
62696,clinical,0,0
62697,responders,0,0
62698,did,0,0
62699,not,0,0
62700,produce,0,0
62701,valid,0,0
62702,performance,0,0
62703,measures,0,0
62704,.,0,0
62705,These,0,0
62706,could,0,0
62707,be,0,0
62708,shown,0,0
62709,to,0,0
62710,be,0,0
62711,of,0,0
62712,younger,0,0
62713,mental,0,0
62714,age,0,0
62715,and,0,0
62716,less,0,0
62717,adaptive,0,0
62718,as,0,0
62719,measured,0,0
62720,by,0,0
62721,the,0,0
62722,Vineland,0,1
62723,Behavior,0,0
62724,Scales,0,0
62725,.,0,0
62726,For,0,0
62727,the,0,0
62728,valid,0,0
62729,task,0,1
62730,performers,0,1
62731,divided,0,0
62732,attention,0,0
62733,(,0,0
62734,serial,0,1
62735,search,0,0
62736,in,0,0
62737,working,0,0
62738,memory,0,0
62739,),0,0
62740,was,0,0
62741,shown,0,0
62742,to,0,0
62743,regress,0,0
62744,in,0,0
62745,the,0,0
62746,placebo,0,1
62747,group,0,0
62748,(,0,0
62749,n,0,0
62750,=,0,0
62751,7,0,0
62752,),0,0
62753,",",0,0
62754,while,0,0
62755,in,0,0
62756,the,0,0
62757,risperidone,0,1
62758,group,0,0
62759,(,0,0
62760,n,0,0
62761,=,0,0
62762,7,0,0
62763,),0,0
62764,there,0,0
62765,was,0,0
62766,further,0,0
62767,improvement,0,0
62768,.,0,0
62769,No,0,0
62770,such,0,0
62771,group,0,0
62772,difference,0,0
62773,was,0,0
62774,found,0,0
62775,for,0,0
62776,focused,0,0
62777,attention,0,0
62778,.,0,0
62779,CONCLUSIONS,0,0
62780,The,0,0
62781,study,0,0
62782,suggests,0,0
62783,a,0,0
62784,beneficial,0,0
62785,effect,0,0
62786,of,0,0
62787,risperidone,1,1
62788,after,0,0
62789,several,0,0
62790,months,0,0
62791,of,0,0
62792,treatment,0,0
62793,",",0,0
62794,enhancing,0,0
62795,divided,0,0
62796,attention,0,0
62797,in,0,0
62798,children,0,0
62799,with,0,0
62800,pervasive,0,0
62801,developmental,0,0
62802,disorders,0,0
62803,.,0,0
62804,Treatment,0,1
62805,of,0,0
62806,psoriasis,0,0
62807,vulgaris,0,0
62808,by,0,0
62809,oral,0,1
62810,administration,0,0
62811,of,0,0
62812,yin,1,1
62813,xie,1,1
62814,ping,1,1
62815,granules,1,0
62816,--,1,0
62817,a,1,0
62818,clinical,0,0
62819,report,0,0
62820,of,0,0
62821,60,0,0
62822,cases,0,0
62823,.,0,0
62824,A,0,0
62825,randomized,0,0
62826,controlled,0,0
62827,trial,0,0
62828,of,0,0
62829,a,0,0
62830,cognitive,1,0
62831,behavioural,1,1
62832,intervention,1,1
62833,for,0,0
62834,anger,0,0
62835,management,0,1
62836,in,0,0
62837,children,0,0
62838,diagnosed,0,0
62839,with,0,0
62840,Asperger,0,0
62841,syndrome,0,0
62842,.,0,0
62843,The,0,0
62844,purpose,0,0
62845,of,0,0
62846,the,0,0
62847,study,0,0
62848,described,0,0
62849,was,0,0
62850,to,0,0
62851,evaluate,0,0
62852,the,0,0
62853,effectiveness,0,0
62854,of,0,0
62855,a,0,0
62856,cognitive,0,0
62857,behavioural,0,1
62858,intervention,0,1
62859,for,0,0
62860,anger,0,0
62861,management,0,1
62862,with,0,0
62863,children,0,0
62864,diagnosed,0,0
62865,with,0,0
62866,Asperger,0,0
62867,syndrome,0,0
62868,.,0,0
62869,Forty-five,0,0
62870,children,0,0
62871,and,0,0
62872,their,0,0
62873,parents,0,0
62874,were,0,0
62875,randomly,0,0
62876,assigned,0,0
62877,to,0,0
62878,either,0,1
62879,intervention,1,1
62880,or,0,1
62881,wait-list,1,0
62882,control,1,1
62883,conditions,1,0
62884,.,1,0
62885,Children,0,0
62886,in,0,0
62887,the,0,0
62888,intervention,0,1
62889,participated,0,0
62890,in,0,0
62891,six,1,0
62892,2-h,1,0
62893,weekly,1,1
62894,sessions,1,1
62895,while,0,0
62896,parents,0,0
62897,participated,0,0
62898,in,0,0
62899,a,0,0
62900,larger,0,0
62901,parent,0,0
62902,group,0,0
62903,.,0,0
62904,Parent,0,0
62905,reports,0,0
62906,indicated,0,0
62907,a,0,0
62908,significant,0,0
62909,decrease,0,0
62910,in,0,0
62911,episodes,0,0
62912,of,0,0
62913,anger,0,0
62914,following,0,0
62915,intervention,0,1
62916,and,0,0
62917,a,0,0
62918,significant,0,0
62919,increase,0,0
62920,in,0,0
62921,their,0,0
62922,own,0,0
62923,confidence,0,0
62924,in,0,0
62925,managing,0,0
62926,anger,0,0
62927,in,0,0
62928,their,0,0
62929,child,0,0
62930,.,0,0
62931,Qualitative,0,0
62932,information,0,0
62933,gathered,0,0
62934,from,0,0
62935,parents,0,0
62936,and,0,0
62937,teachers,0,0
62938,indicated,0,0
62939,some,0,0
62940,generalization,0,0
62941,of,0,0
62942,strategies,0,0
62943,learned,0,0
62944,in,0,0
62945,the,0,0
62946,clinic,0,0
62947,setting,0,0
62948,to,0,0
62949,both,0,0
62950,home,0,1
62951,and,0,0
62952,school,0,0
62953,settings,0,0
62954,.,0,0
62955,Limitations,0,0
62956,of,0,0
62957,the,0,0
62958,study,0,0
62959,and,0,0
62960,suggestions,0,0
62961,for,0,0
62962,future,0,0
62963,research,0,0
62964,are,0,0
62965,also,0,0
62966,discussed,0,0
62967,.,0,0
62968,New,0,1
62969,hope,0,0
62970,for,0,0
62971,children,0,0
62972,with,0,0
62973,Kawasaki,0,0
62974,disease,0,0
62975,.,0,0
62976,Kawasaki,0,0
62977,disease,0,0
62978,is,0,0
62979,now,0,0
62980,the,0,0
62981,most,0,0
62982,common,0,0
62983,cause,0,0
62984,of,0,0
62985,acquired,0,0
62986,heart,0,0
62987,disease,0,0
62988,in,0,0
62989,America,0,0
62990,'s,0,0
62991,children,0,0
62992,.,0,0
62993,It,0,0
62994,is,0,0
62995,an,0,0
62996,acute,0,0
62997,febrile,0,0
62998,illness,0,0
62999,that,0,0
63000,may,0,0
63001,cause,0,0
63002,coronary,0,0
63003,artery,0,0
63004,aneurysm,0,0
63005,formation,0,0
63006,in,0,0
63007,infected,0,0
63008,children,0,0
63009,.,0,0
63010,The,0,0
63011,results,0,0
63012,of,0,0
63013,a,0,0
63014,multicenter,0,0
63015,",",0,0
63016,randomized,0,0
63017,trial,0,0
63018,on,0,0
63019,the,0,0
63020,effect,0,0
63021,of,0,0
63022,intravenous,1,1
63023,administration,1,0
63024,of,1,0
63025,gamma,1,1
63026,globulin,1,1
63027,(,1,1
63028,IVGG,1,1
63029,),1,1
63030,plus,1,1
63031,aspirin,1,1
63032,versus,1,1
63033,aspirin,1,1
63034,alone,1,1
63035,upon,0,0
63036,coronary,0,0
63037,aneurysm,0,0
63038,formation,0,0
63039,show,0,0
63040,a,0,0
63041,decrease,0,0
63042,in,0,0
63043,coronary,0,0
63044,aneurysm,0,0
63045,formation,0,0
63046,from,0,0
63047,the,0,0
63048,usual,0,1
63049,20,0,0
63050,%,0,0
63051,-30,0,1
63052,%,0,0
63053,to,0,0
63054,3,0,0
63055,%,0,0
63056,.,0,0
63057,Administration,0,0
63058,of,0,0
63059,IVGG,1,1
63060,presents,0,0
63061,some,0,0
63062,unique,0,0
63063,challenges,0,0
63064,for,0,0
63065,nurses,0,0
63066,.,0,0
63067,Also,0,0
63068,",",0,0
63069,the,0,0
63070,pediatric,0,0
63071,nurse,0,1
63072,must,0,0
63073,educate,0,0
63074,parents,0,0
63075,and,0,0
63076,children,0,0
63077,about,0,0
63078,this,0,0
63079,disease,0,0
63080,to,0,0
63081,prepare,0,0
63082,them,0,0
63083,for,0,0
63084,discharge,0,1
63085,and,0,0
63086,long-term,0,0
63087,follow-up,0,0
63088,care,0,1
63089,.,0,0
63090,A,0,0
63091,randomized,0,0
63092,controlled,0,0
63093,trial,0,0
63094,to,0,0
63095,evaluate,0,0
63096,the,0,0
63097,efficacy,0,0
63098,of,0,0
63099,ultrasound-guided,1,1
63100,laser,1,1
63101,photocoagulation,1,1
63102,for,0,0
63103,treatment,0,0
63104,of,0,0
63105,benign,0,0
63106,thyroid,0,0
63107,nodules,0,0
63108,.,0,0
63109,This,0,0
63110,randomized,0,0
63111,controlled,0,0
63112,study,0,0
63113,was,0,0
63114,designed,0,0
63115,to,0,0
63116,test,0,0
63117,the,0,0
63118,efficacy,0,0
63119,and,0,0
63120,safety,0,0
63121,of,0,0
63122,percutaneous,1,1
63123,ultrasound,1,1
63124,(,1,1
63125,US,1,1
63126,),1,1
63127,-guided,1,1
63128,laser,1,1
63129,photocoagulation,1,1
63130,(,1,1
63131,PLP,1,1
63132,),1,1
63133,for,0,0
63134,treatment,0,0
63135,of,0,0
63136,subjects,0,0
63137,with,0,0
63138,compressive,0,0
63139,symptoms,0,0
63140,due,0,0
63141,to,0,0
63142,benign,0,0
63143,thyroid,0,0
63144,nodules,0,0
63145,and/or,0,0
63146,at,0,0
63147,high,0,0
63148,surgical,0,1
63149,risk,0,0
63150,.,0,0
63151,Twenty,0,0
63152,six,0,0
63153,subjects,0,0
63154,were,0,0
63155,randomized,0,0
63156,to,0,0
63157,the,0,0
63158,intervention,1,1
63159,(,0,0
63160,no,0,0
63161,.,0,0
63162,13,0,0
63163,",",0,0
63164,age,0,0
63165,68+/-3,0,0
63166,yr,0,0
63167,",",0,0
63168,mean+/-SEM,0,0
63169,),0,1
63170,or,1,1
63171,observation,1,1
63172,(,0,0
63173,no,0,0
63174,.,0,0
63175,13,0,0
63176,",",0,0
63177,age,0,0
63178,71+/-2,0,0
63179,yr,0,0
63180,),0,0
63181,groups,0,0
63182,.,0,0
63183,In,0,0
63184,the,0,0
63185,control,0,1
63186,group,0,0
63187,",",0,0
63188,the,0,0
63189,volume,0,0
63190,of,0,0
63191,nodules,0,0
63192,did,0,0
63193,not,0,0
63194,significantly,0,0
63195,change,0,0
63196,over,0,0
63197,the,0,0
63198,30,0,0
63199,week,0,0
63200,period,0,0
63201,of,0,0
63202,observation,0,1
63203,.,0,0
63204,In,0,0
63205,the,0,0
63206,intervention,0,1
63207,group,0,0
63208,",",0,0
63209,median,0,0
63210,nodule,0,0
63211,volume,0,0
63212,at,0,0
63213,baseline,0,0
63214,was,0,0
63215,8.2,0,0
63216,ml,0,1
63217,(,0,0
63218,range,0,0
63219,2.8-26.9,0,0
63220,),0,0
63221,and,0,0
63222,was,0,0
63223,not,0,0
63224,significantly,0,0
63225,different,0,0
63226,from,0,0
63227,that,0,0
63228,of,0,0
63229,the,0,0
63230,control,0,0
63231,group,0,0
63232,.,0,0
63233,Nodules,0,0
63234,decreased,0,0
63235,significantly,0,0
63236,(,0,0
63237,p,0,0
63238,<,0,0
63239,0.0001,0,0
63240,),0,0
63241,by,0,0
63242,22,0,0
63243,%,0,0
63244,after,0,0
63245,2,0,0
63246,weeks,0,0
63247,(,0,0
63248,6.5,0,0
63249,ml,0,1
63250,;,0,0
63251,range,0,0
63252,2.4-16.7,0,0
63253,),0,0
63254,and,0,0
63255,by,0,0
63256,44,0,0
63257,%,0,0
63258,after,0,0
63259,30,0,0
63260,weeks,0,0
63261,(,0,0
63262,4.6,0,0
63263,ml,0,1
63264,;,0,0
63265,range,0,0
63266,0.69-14.2,0,0
63267,),0,0
63268,.,0,0
63269,Energy,0,0
63270,given,0,0
63271,was,0,0
63272,correlated,0,0
63273,(,0,0
63274,p,0,0
63275,<,0,0
63276,0.05,0,0
63277,),0,0
63278,with,0,0
63279,the,0,0
63280,reduction,0,0
63281,of,0,0
63282,thyroid,0,1
63283,nodule,0,0
63284,volume,0,0
63285,.,0,0
63286,All,0,0
63287,patients,0,0
63288,tolerated,0,0
63289,the,0,0
63290,treatment,0,0
63291,well,0,0
63292,and,0,0
63293,reported,0,0
63294,relief,0,0
63295,from,0,0
63296,compressive,0,0
63297,and,0,0
63298,cosmetic,0,1
63299,complaints,0,0
63300,(,0,0
63301,p,0,0
63302,<,0,0
63303,0.05,0,0
63304,),0,0
63305,.,0,0
63306,At,0,0
63307,the,0,0
63308,time,0,0
63309,of,0,0
63310,enrolment,0,0
63311,7/13,0,0
63312,(,0,0
63313,54,0,0
63314,%,0,0
63315,),0,0
63316,and,0,0
63317,6/13,0,0
63318,(,0,0
63319,46,0,0
63320,%,0,0
63321,),0,0
63322,of,0,0
63323,patients,0,0
63324,in,0,0
63325,the,0,0
63326,intervention,0,1
63327,and,0,0
63328,control,0,1
63329,groups,0,0
63330,",",0,0
63331,respectively,0,0
63332,",",0,0
63333,had,0,0
63334,sub,0,0
63335,clinical,0,0
63336,hyperthyroidism,0,0
63337,.,0,0
63338,PLP,0,0
63339,normalized,0,0
63340,thyroid,0,0
63341,function,0,0
63342,at,0,0
63343,6,0,0
63344,and,0,0
63345,30,0,0
63346,weeks,0,0
63347,after,0,0
63348,treatment,0,0
63349,.,0,0
63350,In,0,0
63351,conclusion,0,0
63352,",",0,0
63353,PLP,0,1
63354,is,0,0
63355,a,0,0
63356,promising,0,0
63357,safe,0,0
63358,and,0,0
63359,effective,0,0
63360,procedure,0,1
63361,for,0,0
63362,treatment,0,0
63363,of,0,0
63364,benign,0,0
63365,thyroid,0,0
63366,nodules,0,0
63367,in,0,0
63368,patients,0,0
63369,at,0,0
63370,high,0,0
63371,surgical,0,1
63372,risk,0,0
63373,.,0,0
63374,The,0,0
63375,effects,0,0
63376,of,0,0
63377,chewing,1,1
63378,versus,1,1
63379,caffeine,1,1
63380,on,0,0
63381,alertness,0,0
63382,",",0,0
63383,cognitive,0,1
63384,performance,0,0
63385,and,0,0
63386,cardiac,0,0
63387,autonomic,0,0
63388,activity,0,0
63389,during,0,0
63390,sleep,0,0
63391,deprivation,0,1
63392,.,0,0
63393,Chewing,1,1
63394,has,0,0
63395,been,0,0
63396,shown,0,0
63397,to,0,0
63398,alleviate,0,0
63399,feelings,0,0
63400,of,0,0
63401,sleepiness,0,0
63402,and,0,0
63403,improve,0,0
63404,cognitive,0,1
63405,performance,0,0
63406,during,0,0
63407,the,0,0
63408,day,0,0
63409,.,0,0
63410,This,0,0
63411,study,0,0
63412,investigated,0,0
63413,the,0,0
63414,effect,0,0
63415,of,0,0
63416,chewing,1,1
63417,on,0,0
63418,alertness,0,0
63419,and,0,0
63420,cognitive,0,1
63421,performance,0,0
63422,across,0,0
63423,one,0,0
63424,night,0,0
63425,without,0,0
63426,sleep,0,0
63427,as,0,0
63428,well,0,0
63429,as,0,0
63430,the,0,0
63431,possible,0,0
63432,mediating,0,0
63433,role,0,0
63434,of,0,0
63435,cardiac,0,0
63436,autonomic,0,0
63437,activity,0,0
63438,.,0,0
63439,Fourteen,0,0
63440,adults,0,0
63441,participated,0,0
63442,in,0,0
63443,a,0,0
63444,randomized,0,0
63445,",",0,0
63446,counterbalanced,0,0
63447,protocol,0,1
63448,employing,0,1
63449,a,0,0
63450,chewing,1,1
63451,",",1,0
63452,placebo,1,1
63453,and,1,0
63454,caffeine,1,1
63455,condition,0,0
63456,.,0,0
63457,Participants,0,0
63458,completed,0,0
63459,tasks,0,0
63460,assessing,0,0
63461,psychomotor,0,0
63462,vigilance,0,0
63463,",",0,0
63464,tracking,0,1
63465,",",0,0
63466,grammatical,0,0
63467,reasoning,0,0
63468,",",0,0
63469,alertness,0,0
63470,and,0,0
63471,sleepiness,0,0
63472,each,0,0
63473,hour,0,0
63474,across,0,0
63475,the,0,0
63476,night,0,0
63477,.,0,0
63478,All,0,0
63479,participants,0,0
63480,received,0,0
63481,either,0,1
63482,placebo,1,1
63483,or,1,1
63484,caffeine,1,1
63485,(,0,1
63486,200,0,1
63487,mg,0,1
63488,),0,0
63489,",",0,0
63490,while,0,0
63491,the,0,0
63492,chewing,1,1
63493,condition,0,0
63494,also,0,0
63495,chewed,1,0
63496,on,1,0
63497,a,1,0
63498,tasteless,1,1
63499,and,1,0
63500,odorless,1,1
63501,substance,1,0
63502,for,0,0
63503,15,0,0
63504,min,0,0
63505,each,0,0
63506,hour,0,0
63507,.,0,0
63508,Heart,0,0
63509,rate,0,0
63510,(,0,1
63511,HR,0,0
63512,),0,1
63513,",",0,0
63514,root,0,1
63515,mean,0,0
63516,square,0,0
63517,of,0,0
63518,the,0,0
63519,successive,0,0
63520,differences,0,0
63521,in,0,0
63522,R-R,0,0
63523,intervals,0,0
63524,on,0,0
63525,the,0,0
63526,ECG,0,1
63527,(,0,1
63528,RMSSD,0,1
63529,),0,1
63530,",",0,0
63531,and,0,0
63532,preejection,0,0
63533,period,0,0
63534,(,0,1
63535,PEP,0,1
63536,),0,1
63537,were,0,0
63538,simultaneously,0,1
63539,recorded,0,0
63540,.,0,0
63541,Alertness,0,0
63542,and,0,0
63543,cognitive,0,1
63544,performance,0,0
63545,amongst,0,0
63546,the,0,0
63547,chewing,0,1
63548,condition,0,0
63549,did,0,0
63550,not,0,0
63551,differ,0,0
63552,or,0,0
63553,were,0,0
63554,in,0,0
63555,fact,0,0
63556,worse,0,0
63557,when,0,0
63558,compared,0,0
63559,with,0,0
63560,placebo,1,1
63561,.,1,0
63562,Similarly,0,0
63563,",",0,0
63564,measures,0,0
63565,of,0,0
63566,HR,0,0
63567,and,0,0
63568,RMSSD,0,1
63569,remained,0,0
63570,the,0,0
63571,same,0,0
63572,between,0,0
63573,these,0,0
63574,two,0,0
63575,conditions,0,0
63576,;,0,0
63577,however,0,0
63578,",",0,0
63579,PEP,0,1
63580,was,0,0
63581,reduced,0,0
63582,in,0,0
63583,the,0,0
63584,later,0,0
63585,part,0,0
63586,of,0,0
63587,the,0,0
63588,night,0,0
63589,in,0,0
63590,the,0,0
63591,chewing,1,1
63592,condition,0,0
63593,compared,0,0
63594,with,0,0
63595,a,0,0
63596,relative,0,0
63597,increase,0,0
63598,for,0,0
63599,placebo,1,1
63600,.,1,0
63601,Caffeine,1,1
63602,led,0,0
63603,to,0,0
63604,improved,0,0
63605,speed,0,0
63606,and,0,0
63607,accuracy,0,0
63608,on,0,0
63609,cognitive,0,0
63610,tasks,0,0
63611,and,0,0
63612,increased,0,0
63613,alertness,0,0
63614,when,0,0
63615,compared,0,0
63616,with,0,0
63617,chewing,1,0
63618,.,1,0
63619,Relative,0,0
63620,increases,0,0
63621,in,0,0
63622,RMSSD,0,1
63623,and,0,0
63624,reductions,0,0
63625,in,0,0
63626,HR,0,0
63627,were,0,0
63628,demonstrated,0,0
63629,following,0,0
63630,caffeine,0,1
63631,;,0,0
63632,however,0,0
63633,",",0,0
63634,no,0,0
63635,change,0,0
63636,in,0,0
63637,PEP,0,1
63638,was,0,0
63639,seen,0,0
63640,.,0,0
63641,Strong,0,0
63642,associations,0,0
63643,between,0,0
63644,cardiac,0,0
63645,parasympathetic,0,0
63646,activity,0,0
63647,and,0,0
63648,complex,0,1
63649,cognitive,0,0
63650,tasks,0,0
63651,",",0,0
63652,as,0,0
63653,well,0,0
63654,as,0,0
63655,between,0,0
63656,subjective,0,0
63657,alertness,0,0
63658,and,0,0
63659,simpler,0,0
63660,cognitive,0,0
63661,tasks,0,0
63662,",",0,0
63663,suggest,0,0
63664,a,0,0
63665,differential,0,0
63666,process,0,0
63667,mediating,0,0
63668,complex,0,1
63669,versus,0,1
63670,simple,0,1
63671,cognitive,0,0
63672,performance,0,0
63673,during,0,0
63674,sleep,0,0
63675,deprivation,0,1
63676,.,0,0
63677,Effect,0,0
63678,of,0,0
63679,age,0,0
63680,and,0,0
63681,radiation,1,1
63682,dose,0,1
63683,on,0,0
63684,local,0,1
63685,control,0,1
63686,after,0,0
63687,breast,1,0
63688,conserving,1,1
63689,treatment,1,0
63690,:,1,0
63691,EORTC,0,0
63692,trial,0,0
63693,22881-10882,0,0
63694,.,0,0
63695,PURPOSE,0,0
63696,To,0,0
63697,determine,0,0
63698,whether,0,0
63699,the,0,0
63700,effect,0,0
63701,of,0,0
63702,an,0,0
63703,additional,0,0
63704,boost,1,1
63705,radiation,1,1
63706,after,0,0
63707,breast,1,0
63708,conservative,1,1
63709,therapy,1,1
63710,(,1,1
63711,BCT,1,1
63712,),1,1
63713,on,0,0
63714,local,0,1
63715,control,0,1
63716,depends,0,0
63717,on,0,0
63718,age,0,0
63719,and,0,0
63720,evaluate,0,0
63721,the,0,0
63722,impact,0,0
63723,of,0,0
63724,a,0,0
63725,treatment,0,0
63726,policy,0,0
63727,with,0,0
63728,a,0,0
63729,threshold,0,0
63730,for,0,0
63731,age,0,0
63732,.,0,0
63733,PATIENTS,0,0
63734,AND,0,0
63735,METHODS,0,0
63736,We,0,0
63737,used,0,0
63738,data,0,0
63739,from,0,0
63740,EORTC,0,0
63741,22881-10882,0,0
63742,trial,0,0
63743,",",0,0
63744,with,0,0
63745,median,0,0
63746,follow-up,0,0
63747,of,0,0
63748,77.4,0,0
63749,months,0,0
63750,.,0,0
63751,Patients,0,0
63752,receiving,0,0
63753,BCT,1,1
63754,and,1,0
63755,50Gy,1,1
63756,whole,1,1
63757,breast,1,0
63758,irradiation,1,1
63759,were,0,0
63760,randomized,0,0
63761,to,0,0
63762,no,1,0
63763,boost,1,1
63764,and,1,0
63765,16Gy,1,1
63766,boost,1,1
63767,(,0,1
63768,N=5318,0,1
63769,),0,0
63770,.,0,0
63771,RESULTS,0,0
63772,In,0,0
63773,univariate,0,0
63774,analysis,0,0
63775,",",0,0
63776,a,0,0
63777,boost,1,1
63778,reduced,0,0
63779,local,0,1
63780,failure,0,0
63781,by,0,0
63782,a,0,0
63783,factor,0,0
63784,of,0,0
63785,2,0,0
63786,(,0,0
63787,P,0,0
63788,<,0,0
63789,0.0001,0,0
63790,),0,0
63791,.,0,0
63792,Multivariate,0,0
63793,analysis,0,0
63794,showed,0,0
63795,local,0,1
63796,control,0,0
63797,increased,0,0
63798,with,0,0
63799,age,0,0
63800,(,0,1
63801,P=0.0003,0,0
63802,),0,0
63803,.,0,0
63804,There,0,0
63805,was,0,0
63806,no,0,0
63807,evidence,0,0
63808,that,0,0
63809,the,0,0
63810,relative,0,0
63811,effect,0,0
63812,of,0,0
63813,a,0,0
63814,boost,1,1
63815,on,0,0
63816,local,0,1
63817,control,0,1
63818,depends,0,0
63819,on,0,0
63820,age,0,0
63821,(,0,1
63822,P=0.97,0,0
63823,),0,1
63824,However,0,0
63825,in,0,0
63826,younger,0,0
63827,patients,0,0
63828,the,0,0
63829,5-year,0,0
63830,local,0,1
63831,failure,0,0
63832,was,0,0
63833,higher,0,0
63834,",",0,0
63835,therefore,0,0
63836,the,0,0
63837,absolute,0,0
63838,reduction,0,0
63839,was,0,0
63840,greater,0,0
63841,.,0,0
63842,If,0,0
63843,the,0,0
63844,threshold-age,0,0
63845,for,0,0
63846,boost,0,1
63847,treatment,0,0
63848,were,0,0
63849,set,0,0
63850,at,0,0
63851,40,0,0
63852,years,0,0
63853,",",0,0
63854,8.4,0,0
63855,%,0,0
63856,of,0,0
63857,the,0,0
63858,study,0,0
63859,population,0,0
63860,would,0,0
63861,receive,0,0
63862,a,0,0
63863,boost,1,1
63864,",",0,0
63865,resulting,0,0
63866,in,0,0
63867,a,0,0
63868,5-year,0,0
63869,local,0,1
63870,failure,0,0
63871,of,0,0
63872,6.1,0,0
63873,%,0,0
63874,in,0,0
63875,the,0,0
63876,study,0,0
63877,population,0,0
63878,.,0,0
63879,Changing,0,0
63880,the,0,0
63881,threshold-age,0,0
63882,to,0,0
63883,60,0,0
63884,years,0,0
63885,",",0,0
63886,67,0,0
63887,%,0,0
63888,of,0,0
63889,the,0,0
63890,study,0,0
63891,population,0,0
63892,would,0,0
63893,receive,0,0
63894,a,0,0
63895,boost,1,1
63896,and,0,0
63897,the,0,0
63898,5-year,0,0
63899,local,0,1
63900,failure,0,0
63901,would,0,0
63902,be,0,0
63903,reduced,0,0
63904,to,0,0
63905,4.4,0,0
63906,%,0,0
63907,.,0,0
63908,CONCLUSIONS,0,0
63909,In,0,0
63910,younger,0,0
63911,patients,0,0
63912,a,0,0
63913,boost,0,1
63914,dose,0,0
63915,resulted,0,0
63916,in,0,0
63917,a,0,0
63918,greater,0,0
63919,absolute,0,0
63920,reduction,0,0
63921,of,0,0
63922,local,0,1
63923,failure,0,0
63924,.,0,0
63925,The,0,0
63926,relative,0,0
63927,risk,0,0
63928,reduction,0,0
63929,was,0,0
63930,however,0,0
63931,similar,0,0
63932,for,0,0
63933,all,0,0
63934,ages,0,0
63935,.,0,0
63936,Applying,0,0
63937,a,0,0
63938,treatment,0,0
63939,policy,0,0
63940,with,0,0
63941,a,0,0
63942,threshold-age,0,0
63943,of,0,0
63944,60,0,0
63945,would,0,0
63946,result,0,0
63947,in,0,0
63948,0.6,0,1
63949,%,0,0
63950,increase,0,0
63951,in,0,0
63952,local,0,1
63953,failure,0,0
63954,in,0,0
63955,the,0,0
63956,total,0,0
63957,study,0,0
63958,population,0,0
63959,",",0,0
63960,while,0,0
63961,sparing,0,1
63962,the,0,0
63963,boost,0,1
63964,to,0,0
63965,1/3,0,0
63966,of,0,0
63967,the,0,0
63968,patients,0,0
63969,.,0,0
63970,A,0,0
63971,double-blind,0,0
63972,placebo-controlled,0,1
63973,trial,0,0
63974,of,0,0
63975,zonisamide,1,1
63976,(,1,1
63977,zonegran,1,1
63978,),1,1
63979,in,0,0
63980,the,0,0
63981,treatment,0,0
63982,of,0,0
63983,essential,0,0
63984,tremor,0,0
63985,.,0,0
63986,Medical,0,0
63987,therapy,0,1
63988,for,0,0
63989,essential,0,0
63990,tremor,0,0
63991,(,0,1
63992,ET,0,1
63993,),0,0
63994,",",0,0
63995,a,0,0
63996,common,0,0
63997,movement,0,0
63998,disorder,0,0
63999,",",0,0
64000,is,0,0
64001,often,0,0
64002,inadequate,0,0
64003,.,0,0
64004,We,0,0
64005,performed,0,0
64006,a,0,0
64007,double-blind,0,0
64008,placebo-controlled,0,1
64009,randomized,0,0
64010,trial,0,0
64011,to,0,0
64012,evaluate,0,0
64013,the,0,0
64014,efficacy,0,0
64015,and,0,0
64016,tolerability,0,0
64017,of,0,0
64018,zonisamide,1,1
64019,(,1,1
64020,ZNS,1,1
64021,),1,0
64022,",",0,0
64023,an,0,0
64024,antiepileptic,0,1
64025,agent,0,0
64026,",",0,0
64027,in,0,0
64028,treating,0,0
64029,ET,0,0
64030,.,0,0
64031,Twenty,0,0
64032,patients,0,0
64033,(,0,0
64034,mean,0,0
64035,age,0,0
64036,",",0,0
64037,60,0,0
64038,+/-,0,0
64039,15,0,0
64040,years,0,0
64041,),0,0
64042,with,0,0
64043,ET,0,0
64044,were,0,0
64045,randomized,0,0
64046,to,0,0
64047,receive,0,1
64048,ZNS,1,1
64049,or,1,1
64050,placebo,1,1
64051,.,1,0
64052,ZNS,1,0
64053,was,1,0
64054,initiated,1,0
64055,at,1,0
64056,a,1,0
64057,dosage,1,0
64058,of,1,0
64059,100,1,0
64060,mg/day,1,1
64061,and,1,0
64062,escalated,1,0
64063,to,1,0
64064,200,1,0
64065,mg/day,1,1
64066,at,1,0
64067,day,1,0
64068,14,1,0
64069,.,1,0
64070,Patients,0,0
64071,were,0,0
64072,evaluated,0,0
64073,by,0,0
64074,accelerometry,0,1
64075,and,0,0
64076,the,0,0
64077,Fahn-Tolosa-Marin,0,1
64078,(,0,1
64079,FTM,0,1
64080,),0,1
64081,rating,0,0
64082,scale,0,0
64083,at,0,0
64084,baseline,0,0
64085,and,0,0
64086,days,0,0
64087,14,0,0
64088,and,0,0
64089,28,0,0
64090,",",0,0
64091,as,0,0
64092,well,0,0
64093,as,0,0
64094,the,0,0
64095,Clinical,0,0
64096,Global,0,0
64097,Impression,0,0
64098,(,0,1
64099,CGI-C,0,1
64100,),0,1
64101,scale,0,0
64102,at,0,0
64103,day,0,0
64104,28,0,0
64105,.,0,0
64106,At,0,0
64107,endpoint,0,0
64108,",",0,0
64109,subjects,0,0
64110,assigned,0,0
64111,to,0,0
64112,ZNS,1,0
64113,were,0,0
64114,taking,0,0
64115,a,0,0
64116,mean,0,0
64117,dosage,0,0
64118,of,0,0
64119,160,0,0
64120,+/-,0,0
64121,50,0,0
64122,mg/day,0,1
64123,.,0,0
64124,There,0,0
64125,were,0,0
64126,no,0,0
64127,significant,0,0
64128,improvements,0,0
64129,in,0,0
64130,the,0,0
64131,FTM,0,1
64132,total,0,0
64133,score,0,0
64134,or,0,1
64135,its,0,0
64136,subsections,0,0
64137,.,0,0
64138,Tremor,0,0
64139,amplitude,0,0
64140,as,0,0
64141,assessed,0,0
64142,by,0,0
64143,accelerometry,0,1
64144,significantly,0,0
64145,improved,0,0
64146,in,0,0
64147,the,0,0
64148,ZNS,1,1
64149,group,0,0
64150,compared,0,0
64151,to,0,0
64152,the,0,0
64153,placebo,0,1
64154,group,0,0
64155,at,0,0
64156,endpoint,0,0
64157,relative,0,0
64158,to,0,0
64159,baseline,0,0
64160,(,0,0
64161,-0.50,0,0
64162,+/-,0,0
64163,0.72,0,0
64164,vs.,0,0
64165,0.30,0,0
64166,+/-,0,0
64167,0.79,0,0
64168,m/s,0,0
64169,(,0,0
64170,2,0,0
64171,),0,0
64172,;,0,0
64173,P,0,0
64174,=,0,0
64175,0.03,0,0
64176,),0,0
64177,.,0,0
64178,On,0,0
64179,the,0,0
64180,CGI-C,0,1
64181,",",0,0
64182,60,0,0
64183,%,0,0
64184,(,0,0
64185,n,0,0
64186,=,0,0
64187,6,0,0
64188,),0,0
64189,of,0,0
64190,patients,0,0
64191,in,0,0
64192,the,0,0
64193,ZNS,0,1
64194,group,0,0
64195,felt,0,0
64196,that,0,0
64197,their,0,0
64198,tremor,0,0
64199,was,0,0
64200,unchanged,0,0
64201,",",0,0
64202,while,0,0
64203,the,0,0
64204,remaining,0,0
64205,patients,0,0
64206,felt,0,0
64207,that,0,0
64208,their,0,0
64209,tremor,0,0
64210,was,0,0
64211,minimally,0,0
64212,improved,0,0
64213,.,0,0
64214,Thirty,0,0
64215,percent,0,0
64216,(,0,0
64217,n,0,0
64218,=,0,0
64219,3,0,0
64220,),0,0
64221,of,0,0
64222,patients,0,0
64223,taking,0,0
64224,ZNS,0,0
64225,discontinued,0,0
64226,the,0,0
64227,study,0,0
64228,due,0,0
64229,to,0,0
64230,side,0,0
64231,effects,0,0
64232,(,0,0
64233,fatigue,0,0
64234,",",0,0
64235,headache,0,0
64236,",",0,0
64237,paresthesias,0,0
64238,),0,0
64239,while,0,0
64240,taking,0,0
64241,100,0,0
64242,mg,0,1
64243,per,0,0
64244,day,0,0
64245,.,0,0
64246,ZNS,1,0
64247,did,0,0
64248,not,0,0
64249,provide,0,0
64250,significant,0,0
64251,improvements,0,0
64252,in,0,0
64253,clinical,0,0
64254,rating,0,0
64255,scales,0,0
64256,at,0,0
64257,study,0,0
64258,endpoint,0,0
64259,compared,0,0
64260,to,0,0
64261,placebo,0,1
64262,and,0,0
64263,was,0,0
64264,only,0,0
64265,modestly,0,0
64266,well,0,0
64267,tolerated,0,0
64268,.,0,0
64269,ZNS,1,0
64270,was,0,0
64271,effective,0,0
64272,in,0,0
64273,reducing,0,0
64274,tremor,0,0
64275,amplitude,0,0
64276,as,0,0
64277,measured,0,0
64278,by,0,0
64279,accelerometry,0,0
64280,.,0,0
64281,Assisted,1,1
64282,exercise,1,1
64283,and,0,0
64284,bone,0,0
64285,strength,0,0
64286,in,0,0
64287,preterm,0,0
64288,infants,0,0
64289,.,0,0
64290,Studies,0,0
64291,have,0,0
64292,previously,0,0
64293,demonstrated,0,0
64294,that,0,0
64295,brief,0,1
64296,(,0,0
64297,4,0,1
64298,weeks,0,0
64299,),0,0
64300,passive,0,1
64301,range-of-motion,0,1
64302,exercise,1,1
64303,is,0,0
64304,beneficial,0,0
64305,for,0,0
64306,bone,0,0
64307,development,0,0
64308,in,0,0
64309,very,0,0
64310,low,0,0
64311,birth,0,0
64312,weight,0,0
64313,(,0,1
64314,VLBW,0,1
64315,),0,1
64316,preterm,0,0
64317,infants,0,0
64318,.,0,0
64319,However,0,0
64320,",",0,0
64321,the,0,0
64322,optimal,0,0
64323,duration,0,0
64324,of,0,0
64325,exercise,0,1
64326,for,0,0
64327,bone,0,0
64328,development,0,0
64329,in,0,0
64330,preterm,0,0
64331,infants,0,0
64332,is,0,0
64333,yet,0,0
64334,unknown,0,0
64335,.,0,0
64336,The,0,0
64337,aim,0,0
64338,of,0,0
64339,the,0,0
64340,present,0,0
64341,study,0,0
64342,was,0,0
64343,to,0,0
64344,examine,0,0
64345,the,0,0
64346,effect,0,0
64347,of,0,0
64348,8,0,0
64349,weeks,0,0
64350,of,0,0
64351,assisted,1,1
64352,exercise,1,1
64353,on,0,0
64354,bone,0,0
64355,strength,0,0
64356,and,0,0
64357,metabolism,0,0
64358,in,0,0
64359,VLBW,0,1
64360,premature,0,0
64361,infants,0,0
64362,.,0,0
64363,Sixteen,0,0
64364,infants,0,0
64365,(,0,0
64366,mean,0,0
64367,+/-,0,0
64368,standard,0,1
64369,error,0,0
64370,of,0,0
64371,the,0,0
64372,mean,0,0
64373,birth,0,0
64374,weight,0,0
64375,"1,009",0,0
64376,+/-,0,0
64377,55,0,0
64378,g,0,1
64379,and,0,0
64380,gestational,0,0
64381,age,0,0
64382,27.3,0,0
64383,+/-,0,0
64384,0.3,0,0
64385,weeks,0,0
64386,),0,0
64387,were,0,0
64388,randomly,0,0
64389,assigned,0,0
64390,into,0,0
64391,exercise,0,1
64392,(,0,0
64393,n,0,0
64394,=,0,0
64395,8,0,0
64396,),0,0
64397,and,0,0
64398,control,1,1
64399,(,0,1
64400,n,0,0
64401,=,0,0
64402,8,0,0
64403,),0,0
64404,groups,0,0
64405,.,0,0
64406,The,0,0
64407,intervention,0,1
64408,started,0,0
64409,at,0,0
64410,the,0,0
64411,first,0,0
64412,week,0,0
64413,of,0,0
64414,life,0,0
64415,and,0,0
64416,involved,0,0
64417,8,0,0
64418,weeks,0,0
64419,of,0,0
64420,daily,1,1
64421,passive,1,1
64422,extension,1,0
64423,and,1,0
64424,flexion,1,0
64425,range-of-motion,1,1
64426,exercise,1,1
64427,of,0,0
64428,the,0,0
64429,upper,0,0
64430,and,0,0
64431,lower,0,0
64432,extremities,0,0
64433,.,0,0
64434,Biochemical,0,0
64435,markers,0,0
64436,of,0,0
64437,bone,0,0
64438,turnover,0,0
64439,were,0,0
64440,measured,0,0
64441,at,0,0
64442,enrollment,0,0
64443,and,0,0
64444,after,0,0
64445,8,0,0
64446,weeks,0,0
64447,.,0,0
64448,Bone,0,1
64449,strength,0,0
64450,was,0,0
64451,measured,0,0
64452,weekly,0,1
64453,by,0,0
64454,quantitative,0,0
64455,ultrasound,0,1
64456,measurement,0,0
64457,of,0,0
64458,tibial,0,1
64459,bone,0,0
64460,speed,0,0
64461,of,0,0
64462,sound,0,1
64463,(,0,1
64464,SOS,0,1
64465,),0,0
64466,.,0,0
64467,Bone,0,1
64468,SOS,0,0
64469,decreased,0,0
64470,significantly,0,0
64471,in,0,0
64472,the,0,0
64473,control,0,1
64474,group,0,0
64475,(,0,0
64476,-108.1,0,0
64477,+/-,0,0
64478,33.7,0,0
64479,m/second,0,0
64480,",",0,0
64481,P,0,0
64482,<,0,0
64483,0.0001,0,0
64484,),0,0
64485,during,0,0
64486,the,0,0
64487,study,0,0
64488,period,0,0
64489,",",0,0
64490,while,0,0
64491,remaining,0,0
64492,stable,0,0
64493,in,0,0
64494,the,0,0
64495,exercise,0,1
64496,group,0,0
64497,(,0,0
64498,11.3,0,0
64499,+/-,0,0
64500,22.8,0,0
64501,m/second,0,0
64502,),0,0
64503,.,0,0
64504,The,0,0
64505,main,0,0
64506,beneficial,0,0
64507,effect,0,0
64508,of,0,0
64509,exercise,0,1
64510,occurred,0,0
64511,in,0,0
64512,the,0,0
64513,first,0,0
64514,4,0,0
64515,weeks,0,0
64516,of,0,0
64517,the,0,0
64518,intervention,0,1
64519,.,0,0
64520,There,0,0
64521,were,0,0
64522,no,0,0
64523,significant,0,0
64524,differences,0,0
64525,in,0,0
64526,the,0,0
64527,bone,0,0
64528,turnover,0,0
64529,marker,0,0
64530,changes,0,0
64531,between,0,0
64532,the,0,0
64533,groups,0,0
64534,.,0,0
64535,There,0,0
64536,is,0,0
64537,a,0,0
64538,significant,0,0
64539,postnatal,0,0
64540,decrease,0,0
64541,in,0,0
64542,bone,0,0
64543,SOS,0,1
64544,in,0,0
64545,VLBW,0,1
64546,preterm,0,0
64547,infants,0,0
64548,.,0,0
64549,Eight,0,0
64550,weeks,0,0
64551,of,0,0
64552,assisted,0,1
64553,range-of-motion,0,1
64554,exercise,1,1
64555,attenuates,0,0
64556,the,0,0
64557,decrease,0,0
64558,in,0,0
64559,bone,0,0
64560,strength,0,0
64561,and,0,0
64562,may,0,0
64563,decrease,0,0
64564,the,0,0
64565,risk,0,0
64566,of,0,0
64567,osteopenia,0,0
64568,in,0,0
64569,premature,0,0
64570,infants,0,0
64571,.,0,0
64572,Treating,0,0
64573,anxiety,0,0
64574,disorders,0,0
64575,in,0,0
64576,children,0,0
64577,with,0,0
64578,high,0,0
64579,functioning,0,0
64580,autism,0,0
64581,spectrum,0,0
64582,disorders,0,0
64583,:,0,0
64584,a,0,0
64585,controlled,0,0
64586,trial,0,0
64587,.,0,0
64588,A,0,0
64589,family-based,0,0
64590,",",0,0
64591,cognitive,0,0
64592,behavioural,0,1
64593,treatment,0,0
64594,for,0,0
64595,anxiety,0,0
64596,in,0,0
64597,47,0,0
64598,children,0,0
64599,with,0,0
64600,comorbid,0,0
64601,anxiety,0,0
64602,disorders,0,0
64603,and,0,0
64604,High,0,0
64605,Functioning,0,1
64606,Autism,0,0
64607,Spectrum,0,1
64608,Disorder,0,0
64609,(,0,1
64610,HFA,0,1
64611,),0,1
64612,was,0,0
64613,evaluated,0,0
64614,.,0,0
64615,Treatment,1,0
64616,involved,1,0
64617,12,1,0
64618,weekly,1,1
64619,group,1,0
64620,sessions,1,1
64621,and,1,0
64622,was,1,0
64623,compared,1,0
64624,with,1,0
64625,a,1,0
64626,waiting,1,0
64627,list,1,0
64628,condition,1,0
64629,.,1,0
64630,Changes,1,0
64631,between,1,0
64632,pre-,1,0
64633,and,1,0
64634,post-treatment,1,0
64635,were,1,0
64636,examined,1,0
64637,using,1,0
64638,clinical,1,0
64639,interviews,1,1
64640,as,1,0
64641,well,1,0
64642,as,1,0
64643,child-,1,1
64644,",",1,0
64645,parent-,1,0
64646,and,1,0
64647,teacher-report,1,0
64648,measures,1,0
64649,.,1,0
64650,Following,0,0
64651,treatment,0,0
64652,",",0,0
64653,71.4,0,0
64654,%,0,0
64655,of,0,0
64656,the,0,0
64657,treated,0,0
64658,participants,0,0
64659,no,0,0
64660,longer,0,0
64661,fulfilled,0,0
64662,diagnostic,0,0
64663,criteria,0,0
64664,for,0,0
64665,an,0,0
64666,anxiety,0,0
64667,disorder,0,0
64668,.,0,0
64669,Comparisons,0,0
64670,between,0,0
64671,the,0,0
64672,two,0,0
64673,conditions,0,0
64674,indicated,0,0
64675,significant,0,0
64676,reductions,0,0
64677,in,0,0
64678,anxiety,0,0
64679,symptoms,0,0
64680,as,0,0
64681,measured,0,0
64682,by,0,0
64683,self-report,0,0
64684,",",0,0
64685,parent,0,1
64686,report,0,0
64687,and,0,0
64688,teacher,0,1
64689,report,0,0
64690,.,0,0
64691,Discussion,0,0
64692,focuses,0,0
64693,on,0,0
64694,the,0,0
64695,implications,0,0
64696,for,0,0
64697,the,0,0
64698,use,0,0
64699,of,0,0
64700,cognitive,0,0
64701,behaviour,0,0
64702,therapy,0,1
64703,with,0,0
64704,HFA,0,0
64705,children,0,0
64706,",",0,0
64707,for,0,0
64708,theory,0,1
64709,of,0,0
64710,mind,0,1
64711,research,0,0
64712,and,0,0
64713,for,0,0
64714,further,0,0
64715,research,0,0
64716,on,0,0
64717,the,0,0
64718,treatment,0,0
64719,components,0,0
64720,.,0,0
64721,A,0,0
64722,comparison,0,0
64723,of,0,0
64724,three,0,0
64725,highly,0,0
64726,active,0,0
64727,antiretroviral,0,1
64728,treatment,0,0
64729,strategies,0,0
64730,consisting,0,0
64731,of,0,0
64732,non-nucleoside,1,1
64733,reverse,1,1
64734,transcriptase,1,1
64735,inhibitors,1,1
64736,",",1,0
64737,protease,1,0
64738,inhibitors,1,1
64739,",",1,0
64740,or,1,0
64741,both,1,0
64742,in,1,0
64743,the,1,0
64744,presence,1,0
64745,of,1,0
64746,nucleoside,1,1
64747,reverse,1,1
64748,transcriptase,1,1
64749,inhibitors,1,1
64750,as,0,0
64751,initial,0,0
64752,therapy,0,1
64753,(,0,0
64754,CPCRA,0,1
64755,058,0,0
64756,FIRST,0,0
64757,Study,0,0
64758,),0,0
64759,:,0,0
64760,a,0,0
64761,long-term,0,0
64762,randomised,0,0
64763,trial,0,0
64764,.,0,0
64765,BACKGROUND,0,0
64766,Long-term,0,0
64767,data,0,0
64768,from,0,0
64769,randomised,0,0
64770,trials,0,0
64771,on,0,0
64772,the,0,0
64773,consequences,0,0
64774,of,0,0
64775,treatment,0,0
64776,with,0,0
64777,a,0,0
64778,protease,1,1
64779,inhibitor,1,1
64780,(,1,1
64781,PI,1,1
64782,),1,1
64783,",",1,0
64784,non-nucleoside,1,1
64785,reverse,1,1
64786,transcriptase,1,1
64787,inhibitor,1,1
64788,(,1,1
64789,NNRTI,1,1
64790,),1,1
64791,",",1,0
64792,or,1,1
64793,both,1,0
64794,are,1,0
64795,lacking,1,0
64796,.,1,0
64797,Here,0,0
64798,",",0,0
64799,we,0,0
64800,report,0,0
64801,results,0,0
64802,from,0,0
64803,the,0,0
64804,FIRST,0,0
64805,trial,0,0
64806,",",0,0
64807,which,0,0
64808,compared,0,0
64809,initial,0,0
64810,treatment,0,0
64811,strategies,0,0
64812,for,0,0
64813,clinical,0,0
64814,",",0,0
64815,immunological,0,0
64816,",",0,0
64817,and,0,0
64818,virological,0,0
64819,outcomes,0,0
64820,.,0,0
64821,METHODS,0,0
64822,Between,0,0
64823,1999,0,0
64824,and,0,0
64825,2002,0,0
64826,",",0,0
64827,1397,0,0
64828,antiretroviral-treatment-naive,0,0
64829,patients,0,0
64830,",",0,0
64831,presenting,0,0
64832,at,0,0
64833,18,0,0
64834,clinical,0,0
64835,trial,0,0
64836,units,0,0
64837,with,0,0
64838,80,0,0
64839,research,0,0
64840,sites,0,0
64841,in,0,0
64842,the,0,0
64843,USA,0,1
64844,",",0,0
64845,were,0,0
64846,randomly,0,0
64847,assigned,0,0
64848,in,0,0
64849,a,0,0
64850,ratio,0,0
64851,of,0,0
64852,1:1:1,0,0
64853,to,0,0
64854,a,0,0
64855,protease,1,1
64856,inhibitor,1,1
64857,(,1,1
64858,PI,1,1
64859,),1,1
64860,strategy,1,0
64861,(,1,1
64862,PI,1,1
64863,plus,1,1
64864,nucleoside,1,1
64865,reverse,1,1
64866,transcriptase,1,1
64867,inhibitor,1,1
64868,[,1,0
64869,NRTI,1,1
64870,],1,1
64871,;,1,0
64872,n=470,0,0
64873,),0,0
64874,",",0,0
64875,a,1,0
64876,non-nucleoside,1,1
64877,reverse,1,1
64878,transcriptase,1,1
64879,inhibitor,1,1
64880,(,1,1
64881,NNRTI,1,1
64882,),1,1
64883,strategy,1,0
64884,(,1,1
64885,NNRTI,1,1
64886,plus,1,1
64887,NRTI,1,1
64888,;,1,1
64889,n=463,0,0
64890,),0,0
64891,",",0,0
64892,or,1,1
64893,a,1,0
64894,three-class,1,1
64895,strategy,1,0
64896,(,1,1
64897,PI,1,1
64898,plus,1,1
64899,NNRTI,1,1
64900,plus,1,1
64901,NRTI,1,1
64902,;,1,1
64903,n=464,0,0
64904,),0,0
64905,.,0,0
64906,Primary,0,0
64907,endpoints,0,0
64908,were,0,0
64909,a,0,0
64910,composite,0,1
64911,of,0,0
64912,an,0,0
64913,AIDS-defining,0,0
64914,event,0,0
64915,",",0,0
64916,death,0,0
64917,",",0,0
64918,or,0,1
64919,CD4,0,0
64920,cell,0,0
64921,count,0,0
64922,decline,0,0
64923,to,0,0
64924,less,0,0
64925,than,0,0
64926,200,0,0
64927,cells,0,0
64928,per,0,0
64929,mm3,0,0
64930,for,0,0
64931,the,0,0
64932,PI,0,1
64933,versus,0,1
64934,NNRTI,0,1
64935,comparison,0,0
64936,",",0,0
64937,and,0,0
64938,average,0,0
64939,change,0,0
64940,in,0,0
64941,CD4,0,0
64942,cell,0,0
64943,count,0,0
64944,at,0,0
64945,or,0,0
64946,after,0,0
64947,32,0,0
64948,months,0,0
64949,for,0,0
64950,the,0,0
64951,three-class,0,0
64952,versus,0,0
64953,combined,0,1
64954,two-class,0,0
64955,comparison,0,0
64956,.,0,0
64957,Analyses,0,0
64958,were,0,0
64959,by,0,0
64960,intention-to-treat,0,0
64961,.,0,0
64962,This,0,0
64963,study,0,0
64964,is,0,0
64965,registered,0,0
64966,ClinicalTrials.gov,0,0
64967,",",0,0
64968,number,0,0
64969,NCT00000922,0,0
64970,.,0,0
64971,FINDINGS,0,0
64972,1397,0,0
64973,patients,0,0
64974,were,0,0
64975,assessed,0,0
64976,for,0,0
64977,the,0,0
64978,composite,0,1
64979,endpoint,0,0
64980,.,0,0
64981,A,0,0
64982,total,0,0
64983,of,0,0
64984,388,0,0
64985,participants,0,0
64986,developed,0,0
64987,the,0,0
64988,composite,0,1
64989,endpoint,0,0
64990,",",0,0
64991,302,0,0
64992,developed,0,0
64993,AIDS,0,0
64994,or,0,1
64995,died,0,0
64996,",",0,0
64997,and,0,0
64998,188,0,0
64999,died,0,0
65000,.,0,0
65001,NNRTI,0,0
65002,versus,0,0
65003,PI,0,1
65004,hazard,0,0
65005,ratios,0,0
65006,(,0,0
65007,HRs,0,1
65008,),0,1
65009,for,0,0
65010,the,0,0
65011,composite,0,1
65012,endpoint,0,0
65013,",",0,0
65014,for,0,0
65015,AIDS,0,0
65016,or,0,1
65017,death,0,0
65018,",",0,0
65019,for,0,0
65020,death,0,0
65021,",",0,0
65022,and,0,0
65023,for,0,0
65024,virological,0,0
65025,failure,0,0
65026,were,0,0
65027,1.02,0,0
65028,(,0,0
65029,95,0,0
65030,%,0,0
65031,CI,0,0
65032,0.79-1.31,0,0
65033,),0,0
65034,",",0,0
65035,1.07,0,0
65036,(,0,0
65037,0.80-1.41,0,0
65038,),0,0
65039,",",0,0
65040,0.95,0,0
65041,(,0,0
65042,0.66-1.37,0,0
65043,),0,1
65044,",",0,0
65045,and,0,0
65046,0.66,0,0
65047,(,0,1
65048,0.56-0.78,0,0
65049,),0,0
65050,",",0,0
65051,respectively,0,0
65052,.,0,0
65053,1196,0,0
65054,patients,0,0
65055,were,0,0
65056,assessed,0,0
65057,for,0,0
65058,the,0,0
65059,three-class,0,0
65060,versus,0,1
65061,combined,0,1
65062,two-class,0,0
65063,primary,0,0
65064,endpoint,0,0
65065,.,0,0
65066,Mean,0,0
65067,change,0,0
65068,in,0,0
65069,CD4,0,0
65070,cell,0,0
65071,count,0,0
65072,at,0,0
65073,or,0,0
65074,after,0,0
65075,32,0,0
65076,months,0,0
65077,was,0,0
65078,+234,0,0
65079,cells,0,0
65080,per,0,0
65081,mm3,0,0
65082,and,0,0
65083,+227,0,1
65084,cells,0,0
65085,per,0,0
65086,mm3,0,0
65087,for,0,0
65088,the,0,0
65089,three-class,0,0
65090,and,0,0
65091,the,0,0
65092,combined,0,1
65093,two-class,0,0
65094,strategies,0,1
65095,(,0,0
65096,p=0.62,0,0
65097,),0,0
65098,",",0,0
65099,respectively,0,0
65100,.,0,0
65101,HRs,0,1
65102,(,0,0
65103,three-class,0,0
65104,vs,0,0
65105,combined,0,1
65106,two-class,0,0
65107,),0,0
65108,for,0,0
65109,AIDS,0,1
65110,or,0,1
65111,death,0,0
65112,and,0,0
65113,virological,0,0
65114,failure,0,0
65115,were,0,0
65116,1.15,0,0
65117,(,0,0
65118,0.91-1.45,0,0
65119,),0,1
65120,and,0,0
65121,0.87,0,0
65122,(,0,1
65123,0.75-1.00,0,0
65124,),0,0
65125,",",0,0
65126,respectively,0,0
65127,.,0,0
65128,HRs,0,1
65129,(,0,0
65130,three-class,0,0
65131,vs,0,0
65132,combined,0,1
65133,two-class,0,0
65134,),0,0
65135,for,0,0
65136,AIDS,0,1
65137,or,0,1
65138,death,0,0
65139,were,0,0
65140,similar,0,0
65141,for,0,0
65142,participants,0,0
65143,with,0,0
65144,baseline,0,0
65145,CD4,0,0
65146,cell,0,0
65147,counts,0,0
65148,of,0,0
65149,200,0,0
65150,cells,0,0
65151,per,0,0
65152,mm3,0,0
65153,or,0,0
65154,less,0,0
65155,and,0,0
65156,of,0,0
65157,more,0,0
65158,than,0,0
65159,200,0,0
65160,cells,0,0
65161,per,0,0
65162,mm3,0,0
65163,(,0,0
65164,p=0.38,0,0
65165,for,0,0
65166,interaction,0,0
65167,),0,0
65168,",",0,0
65169,and,0,0
65170,for,0,0
65171,participants,0,0
65172,with,0,0
65173,baseline,0,0
65174,HIV,0,1
65175,RNA,0,0
65176,concentrations,0,0
65177,less,0,0
65178,than,0,0
65179,100,0,0
65180,000,0,0
65181,copies,0,0
65182,per,0,0
65183,mL,0,1
65184,and,0,0
65185,"100,000",0,0
65186,copies,0,0
65187,per,0,0
65188,mL,0,0
65189,or,0,1
65190,more,0,0
65191,(,0,0
65192,p=0.26,0,0
65193,for,0,0
65194,interaction,0,0
65195,),0,0
65196,.,0,0
65197,Participants,0,0
65198,assigned,0,0
65199,the,0,0
65200,three-class,0,0
65201,strategy,0,0
65202,were,0,0
65203,significantly,0,0
65204,more,0,0
65205,likely,0,0
65206,to,0,0
65207,discontinue,0,0
65208,treatment,0,0
65209,because,0,0
65210,of,0,0
65211,toxic,0,0
65212,effects,0,0
65213,than,0,0
65214,were,0,0
65215,those,0,0
65216,assigned,0,0
65217,to,0,0
65218,the,0,0
65219,two-class,0,0
65220,strategies,0,0
65221,(,0,0
65222,HR,0,0
65223,1.58,0,0
65224,;,0,0
65225,p,0,0
65226,<,0,0
65227,0.0001,0,0
65228,),0,0
65229,.,0,0
65230,INTERPRETATION,0,0
65231,Initial,0,0
65232,treatment,0,0
65233,with,0,0
65234,either,0,0
65235,an,0,0
65236,NNRTI-based,1,0
65237,regimen,1,1
65238,or,0,0
65239,a,0,0
65240,PI-based,1,1
65241,regimen,1,1
65242,",",0,0
65243,but,0,0
65244,not,0,0
65245,both,0,0
65246,together,0,0
65247,",",0,0
65248,is,0,0
65249,a,0,0
65250,good,0,0
65251,strategy,0,0
65252,for,0,0
65253,long-term,0,0
65254,antiretroviral,0,1
65255,management,0,1
65256,in,0,0
65257,treatment-naive,0,0
65258,patients,0,0
65259,with,0,0
65260,HIV,0,0
65261,.,0,0
65262,Continuous,0,1
65263,pralidoxime,1,1
65264,infusion,0,1
65265,versus,0,1
65266,repeated,0,0
65267,bolus,0,1
65268,injection,0,1
65269,to,0,0
65270,treat,0,0
65271,organophosphorus,0,1
65272,pesticide,0,1
65273,poisoning,0,0
65274,:,0,0
65275,a,0,0
65276,randomised,0,0
65277,controlled,0,0
65278,trial,0,0
65279,.,0,0
65280,BACKGROUND,0,0
65281,The,0,0
65282,role,0,0
65283,of,0,0
65284,oximes,0,0
65285,for,0,0
65286,the,0,0
65287,treatment,0,0
65288,of,0,0
65289,organophosphorus,0,1
65290,pesticide,0,1
65291,poisoning,0,0
65292,has,0,0
65293,not,0,0
65294,been,0,0
65295,conclusively,0,0
65296,established,0,0
65297,.,0,0
65298,We,0,0
65299,aimed,0,0
65300,to,0,0
65301,assess,0,0
65302,the,0,0
65303,effectiveness,0,0
65304,of,0,0
65305,a,0,0
65306,constant,0,0
65307,pralidoxime,1,1
65308,infusion,0,1
65309,compared,0,0
65310,with,0,0
65311,repeated,0,0
65312,bolus,0,1
65313,doses,0,0
65314,to,0,0
65315,treat,0,0
65316,patients,0,0
65317,with,0,0
65318,moderately,0,0
65319,severe,0,0
65320,poisoning,0,0
65321,from,0,0
65322,organophosphorus,0,0
65323,pesticides,0,1
65324,.,0,0
65325,METHODS,0,0
65326,200,0,0
65327,patients,0,0
65328,were,0,0
65329,recruited,0,0
65330,to,0,0
65331,our,0,0
65332,single-centre,0,0
65333,",",0,0
65334,open,0,1
65335,randomised,0,0
65336,controlled,0,0
65337,trial,0,0
65338,after,0,0
65339,moderately,0,0
65340,severe,0,0
65341,poisoning,0,0
65342,by,0,0
65343,anticholinesterase,0,1
65344,pesticide,0,1
65345,.,0,0
65346,All,0,0
65347,were,0,0
65348,given,0,0
65349,a,0,0
65350,2,0,0
65351,g,0,1
65352,loading,0,1
65353,dose,0,0
65354,of,0,0
65355,pralidoxime,1,1
65356,over,0,0
65357,30,0,0
65358,min,0,0
65359,.,0,0
65360,Patients,0,0
65361,were,0,0
65362,then,0,0
65363,randomly,0,0
65364,assigned,0,0
65365,to,0,0
65366,control,0,1
65367,and,0,0
65368,study,0,0
65369,groups,0,0
65370,.,0,0
65371,Controls,0,0
65372,were,0,0
65373,given,0,0
65374,a,0,0
65375,bolus,1,1
65376,dose,1,0
65377,of,1,0
65378,1,1,0
65379,g,1,1
65380,pralidoxime,1,1
65381,over,1,0
65382,1,1,0
65383,h,1,0
65384,every,1,0
65385,4,1,0
65386,h,1,0
65387,for,1,0
65388,48,1,0
65389,h.,1,0
65390,The,0,0
65391,study,0,0
65392,group,0,0
65393,had,0,0
65394,a,0,0
65395,constant,1,0
65396,infusion,1,1
65397,of,1,0
65398,1,1,0
65399,g,1,1
65400,over,1,0
65401,an,1,0
65402,hour,1,0
65403,every,1,1
65404,hour,1,0
65405,for,1,0
65406,48,1,0
65407,h.,1,0
65408,Thereafter,0,0
65409,",",0,0
65410,all,0,0
65411,patients,0,0
65412,were,0,0
65413,given,1,0
65414,1,1,0
65415,g,1,1
65416,every,1,0
65417,4,1,0
65418,h,1,0
65419,until,1,0
65420,they,1,0
65421,could,1,0
65422,be,1,0
65423,weaned,1,0
65424,from,1,0
65425,ventilators,1,1
65426,.,1,0
65427,Analysis,0,0
65428,was,0,0
65429,by,0,0
65430,intention,0,0
65431,to,0,0
65432,treat,0,0
65433,.,0,0
65434,Primary,0,0
65435,outcome,0,0
65436,measures,0,0
65437,were,0,0
65438,median,0,0
65439,atropine,0,1
65440,dose,0,0
65441,needed,0,0
65442,within,0,0
65443,24,0,0
65444,h,0,0
65445,",",0,0
65446,proportion,0,0
65447,of,0,0
65448,patients,0,0
65449,who,0,0
65450,needed,0,0
65451,intubation,0,1
65452,",",0,0
65453,and,0,0
65454,number,0,0
65455,of,0,0
65456,days,0,0
65457,on,0,0
65458,ventilation,0,1
65459,.,0,0
65460,The,0,0
65461,study,0,0
65462,is,0,0
65463,registered,0,0
65464,at,0,0
65465,http,0,0
65466,:,0,0
65467,//www.clinicaltrials.gov,0,0
65468,with,0,0
65469,the,0,0
65470,identifier,0,0
65471,NCT00333944,0,0
65472,.,0,0
65473,FINDINGS,0,0
65474,100,0,0
65475,patients,0,0
65476,were,0,0
65477,assigned,0,0
65478,the,0,0
65479,high-dose,0,1
65480,regimen,0,1
65481,",",0,0
65482,and,0,0
65483,100,0,0
65484,the,0,0
65485,control,0,0
65486,regimen,0,1
65487,.,0,0
65488,There,0,0
65489,were,0,0
65490,no,0,0
65491,drop-outs,0,0
65492,.,0,0
65493,Patients,0,0
65494,receiving,0,0
65495,the,0,0
65496,high-dose,0,1
65497,pralidoxime,0,1
65498,regimen,0,1
65499,required,0,0
65500,less,0,0
65501,atropine,0,1
65502,during,0,0
65503,the,0,0
65504,first,0,0
65505,24,0,0
65506,h,0,0
65507,than,0,0
65508,controls,0,0
65509,(,0,0
65510,median,0,0
65511,6,0,1
65512,mg,0,1
65513,vs,0,0
65514,30,0,1
65515,mg,0,1
65516,;,0,0
65517,difference,0,0
65518,24,0,0
65519,mg,0,1
65520,[,0,0
65521,95,0,0
65522,%,0,0
65523,CI,0,0
65524,24-26,0,0
65525,",",0,0
65526,p,0,0
65527,<,0,0
65528,0.0001,0,0
65529,],0,0
65530,),0,0
65531,.,0,0
65532,88,0,0
65533,(,0,0
65534,88,0,0
65535,%,0,0
65536,),0,0
65537,and,0,0
65538,64,0,0
65539,(,0,0
65540,64,0,0
65541,%,0,0
65542,),0,0
65543,of,0,0
65544,controls,0,0
65545,and,0,0
65546,high-dose,0,1
65547,patients,0,0
65548,",",0,0
65549,respectively,0,0
65550,",",0,0
65551,needed,0,0
65552,intubation,0,1
65553,during,0,0
65554,admission,0,0
65555,to,0,0
65556,hospital,0,0
65557,(,0,1
65558,relative,0,0
65559,risk=0.72,0,0
65560,",",0,0
65561,0.62-0.86,0,0
65562,",",0,0
65563,p=0.0001,0,0
65564,),0,0
65565,.,0,0
65566,Control,0,0
65567,patients,0,0
65568,required,0,0
65569,ventilatory,0,1
65570,support,0,0
65571,for,0,0
65572,longer,0,0
65573,(,0,0
65574,median,0,0
65575,10,0,0
65576,days,0,0
65577,vs,0,0
65578,5,0,0
65579,days,0,0
65580,;,0,0
65581,difference,0,0
65582,5,0,0
65583,days,0,0
65584,[,0,0
65585,5-6,0,0
65586,",",0,0
65587,p,0,0
65588,<,0,0
65589,0.0001,0,0
65590,],0,0
65591,),0,0
65592,.,0,0
65593,INTERPRETATION,0,0
65594,A,0,0
65595,high-dose,0,1
65596,regimen,0,1
65597,of,0,0
65598,pralidoxime,0,1
65599,",",0,0
65600,consisting,0,0
65601,of,0,0
65602,a,0,0
65603,constant,0,0
65604,infusion,0,1
65605,of,0,0
65606,1,0,0
65607,g/h,0,0
65608,for,0,0
65609,48,0,0
65610,h,0,0
65611,after,0,0
65612,a,0,0
65613,2,0,0
65614,g,0,1
65615,loading,0,1
65616,dose,0,0
65617,",",0,0
65618,reduces,0,0
65619,morbidity,0,0
65620,and,0,0
65621,mortality,0,0
65622,in,0,0
65623,moderately,0,0
65624,severe,0,0
65625,cases,0,0
65626,of,0,0
65627,acute,0,0
65628,organophosphorus-pesticide,0,1
65629,poisoning,0,0
65630,.,0,0
65631,[,0,0
65632,The,0,0
65633,effects,0,0
65634,of,0,0
65635,mexicor,1,0
65636,on,0,0
65637,thrombocyte,0,0
65638,aggregation,0,0
65639,",",0,0
65640,blood,0,0
65641,viscosity,0,0
65642,",",0,0
65643,hemodynamics,0,0
65644,",",0,0
65645,and,0,0
65646,the,0,0
65647,clinical,0,0
65648,course,0,0
65649,of,0,0
65650,coronary,0,0
65651,artery,0,0
65652,disease,0,0
65653,],0,0
65654,.,0,0
65655,The,0,0
65656,authors,0,0
65657,analyze,0,0
65658,their,0,0
65659,experience,0,0
65660,in,0,0
65661,the,0,0
65662,application,0,0
65663,of,0,0
65664,mexicor,1,0
65665,",",1,0
65666,a,1,0
65667,Russian,1,1
65668,cytoprotector,1,0
65669,",",0,0
65670,in,0,0
65671,50patients,0,0
65672,with,0,0
65673,chronic,0,0
65674,coronary,0,0
65675,artery,0,1
65676,disease,0,0
65677,(,0,1
65678,CAD,0,1
65679,),0,1
65680,and,0,0
65681,51,0,0
65682,patients,0,0
65683,with,0,0
65684,acute,0,0
65685,coronary,0,0
65686,syndrome,0,0
65687,.,0,0
65688,In,0,0
65689,additional,0,0
65690,to,0,0
65691,cytoprotective,0,0
65692,action,0,0
65693,",",0,0
65694,the,0,0
65695,use,0,0
65696,of,0,0
65697,mexidor,1,1
65698,in,0,0
65699,complex,0,0
65700,therapy,0,1
65701,of,0,0
65702,CAD,0,1
65703,lowers,0,0
65704,the,0,0
65705,functional,0,0
65706,activity,0,0
65707,of,0,0
65708,thrombocytes,0,0
65709,",",0,0
65710,eliminates,0,0
65711,high,0,0
65712,blood,0,0
65713,viscosity,0,0
65714,syndrome,0,0
65715,",",0,0
65716,and,0,0
65717,lowers,0,0
65718,low,0,0
65719,density,0,0
65720,lipoprotein,0,1
65721,cholesterol,0,0
65722,level,0,0
65723,.,0,0
65724,These,0,0
65725,favorable,0,0
65726,changes,0,0
65727,in,0,0
65728,hemorheological,0,0
65729,parameters,0,0
65730,improves,0,0
65731,myocardial,0,0
65732,perfusion,0,0
65733,",",0,0
65734,lowers,0,0
65735,the,0,0
65736,strength,0,0
65737,and,0,0
65738,frequency,0,0
65739,of,0,0
65740,coronary,0,0
65741,pain,0,0
65742,attacks,0,0
65743,",",0,0
65744,retards,0,0
65745,postinfarction,0,0
65746,left,0,0
65747,ventricular,0,0
65748,remodeling,0,0
65749,",",0,0
65750,and,0,0
65751,increases,0,0
65752,the,0,0
65753,quality,0,0
65754,of,0,0
65755,life,0,0
65756,of,0,0
65757,patients,0,0
65758,with,0,0
65759,various,0,0
65760,CAD,0,0
65761,forms,0,0
65762,.,0,0
65763,How,0,0
65764,does,0,0
65765,Cash,1,0
65766,and,1,0
65767,Counseling,1,1
65768,affect,0,0
65769,costs,0,0
65770,?,0,0
65771,OBJECTIVE,0,0
65772,To,0,0
65773,test,0,0
65774,the,0,0
65775,effect,0,0
65776,of,0,0
65777,a,0,0
65778,consumer-directed,0,1
65779,model,0,0
65780,(,1,1
65781,Cash,1,0
65782,and,1,1
65783,Counseling,1,1
65784,),1,1
65785,of,0,0
65786,Medicaid,0,1
65787,personal,0,1
65788,care,0,1
65789,services,0,1
65790,(,0,0
65791,PCS,0,1
65792,),0,1
65793,or,0,1
65794,home-,0,1
65795,and,0,0
65796,community-based,0,1
65797,waiver,0,1
65798,services,0,1
65799,(,0,0
65800,HCBS,0,1
65801,),0,1
65802,on,0,0
65803,the,0,0
65804,cost,0,0
65805,of,0,0
65806,Medicaid,0,0
65807,services,0,1
65808,.,0,0
65809,DATA,0,0
65810,SOURCES/STUDY,0,0
65811,SETTING,0,1
65812,Medicaid,0,1
65813,claims,0,0
65814,data,0,0
65815,were,0,0
65816,collected,0,0
65817,for,0,0
65818,all,0,0
65819,enrollees,0,0
65820,in,0,0
65821,the,0,0
65822,Cash,0,0
65823,and,0,0
65824,Counseling,0,1
65825,demonstration,0,0
65826,.,0,0
65827,Demonstration,0,0
65828,enrollees,0,0
65829,included,0,0
65830,those,0,0
65831,eligible,0,0
65832,for,0,0
65833,PCS,0,1
65834,(,0,0
65835,in,0,0
65836,Arkansas,0,0
65837,),0,0
65838,",",0,0
65839,those,0,0
65840,assessed,0,0
65841,to,0,0
65842,receive,0,0
65843,such,0,0
65844,services,0,1
65845,(,0,0
65846,in,0,0
65847,New,0,1
65848,Jersey,0,0
65849,),0,0
65850,",",0,0
65851,and,0,0
65852,recipients,0,0
65853,of,0,0
65854,Medicaid,0,1
65855,HCBS,0,1
65856,(,0,0
65857,in,0,0
65858,Florida,0,0
65859,),0,0
65860,.,0,0
65861,Enrollment,0,0
65862,occurred,0,0
65863,from,0,0
65864,December,0,0
65865,1998,0,0
65866,through,0,0
65867,April,0,1
65868,2001,0,0
65869,.,0,0
65870,The,0,0
65871,follow-up,0,0
65872,period,0,0
65873,covered,0,0
65874,up,0,0
65875,to,0,0
65876,24,0,0
65877,months,0,0
65878,after,0,0
65879,enrollment,0,0
65880,.,0,0
65881,STUDY,0,0
65882,DESIGN,0,0
65883,Demonstration,0,0
65884,volunteers,0,0
65885,were,0,0
65886,randomly,0,0
65887,assigned,0,0
65888,to,0,0
65889,have,0,0
65890,the,0,0
65891,option,0,0
65892,to,0,0
65893,participate,0,0
65894,in,0,0
65895,Cash,1,0
65896,and,1,1
65897,Counseling,1,1
65898,(,0,1
65899,the,0,0
65900,treatment,0,1
65901,group,0,0
65902,),0,0
65903,",",0,0
65904,or,0,1
65905,to,0,0
65906,receive,0,1
65907,Medicaid,1,1
65908,services,1,1
65909,as,1,0
65910,usual,1,1
65911,from,1,0
65912,an,1,0
65913,agency,1,1
65914,(,0,0
65915,the,0,0
65916,control,0,1
65917,group,0,0
65918,),0,0
65919,.,0,0
65920,Ordinary,0,0
65921,least,0,0
65922,squares,0,1
65923,regressions,0,0
65924,were,0,0
65925,used,0,0
65926,to,0,0
65927,estimate,0,0
65928,the,0,0
65929,effect,0,0
65930,of,0,0
65931,the,0,0
65932,program,0,1
65933,on,0,0
65934,costs,0,0
65935,for,0,0
65936,Medicaid,0,1
65937,PCS/waiver,0,0
65938,services,0,1
65939,and,0,0
65940,other,0,0
65941,Medicaid,0,1
65942,services,0,1
65943,",",0,0
65944,while,0,0
65945,controlling,0,0
65946,for,0,0
65947,consumers,0,0
65948,',0,0
65949,preenrollment,0,0
65950,characteristics,0,0
65951,and,0,0
65952,preenrollment,0,0
65953,Medicaid,0,1
65954,spending,0,0
65955,.,0,0
65956,Models,0,0
65957,were,0,0
65958,estimated,0,0
65959,separately,0,0
65960,for,0,0
65961,nonelderly,0,0
65962,and,0,0
65963,elderly,0,0
65964,adults,0,0
65965,in,0,0
65966,each,0,0
65967,state,0,0
65968,and,0,0
65969,for,0,0
65970,children,0,0
65971,in,0,0
65972,Florida,0,0
65973,.,0,0
65974,DATA,0,0
65975,EXTRACTION,0,0
65976,METHODS,0,0
65977,Each,0,1
65978,state,0,0
65979,supplied,0,0
65980,claims,0,0
65981,data,0,0
65982,for,0,0
65983,demonstration,0,0
65984,enrollees,0,0
65985,.,0,0
65986,PRINCIPAL,0,0
65987,FINDINGS,0,0
65988,Largely,0,0
65989,because,0,0
65990,the,0,0
65991,program,0,1
65992,increased,0,0
65993,consumers,0,0
65994,',0,0
65995,ability,0,0
65996,to,0,0
65997,get,0,0
65998,the,0,0
65999,authorized,0,0
66000,amount,0,0
66001,of,0,0
66002,paid,0,0
66003,care,0,0
66004,",",0,0
66005,expenditures,0,0
66006,for,0,0
66007,personal,0,0
66008,care/waiver,0,0
66009,services,0,1
66010,were,0,0
66011,higher,0,0
66012,for,0,0
66013,the,0,0
66014,treatment,0,0
66015,group,0,0
66016,than,0,0
66017,for,0,0
66018,the,0,0
66019,control,0,1
66020,group,0,0
66021,in,0,0
66022,each,0,0
66023,state,0,0
66024,and,0,0
66025,age,0,0
66026,group,0,0
66027,",",0,0
66028,except,0,0
66029,among,0,0
66030,the,0,0
66031,elderly,0,0
66032,in,0,0
66033,Florida,0,0
66034,.,0,0
66035,Higher,0,0
66036,costs,0,0
66037,for,0,0
66038,personal,0,1
66039,care/waiver,0,0
66040,services,0,1
66041,were,0,0
66042,partially,0,0
66043,offset,0,0
66044,by,0,0
66045,savings,0,0
66046,in,0,0
66047,other,0,0
66048,Medicaid,0,1
66049,services,0,1
66050,",",0,0
66051,particularly,0,0
66052,those,0,0
66053,related,0,0
66054,to,0,0
66055,long-term,0,0
66056,care,0,1
66057,.,0,0
66058,During,0,0
66059,year,0,0
66060,1,0,0
66061,",",0,0
66062,total,0,0
66063,Medicaid,0,1
66064,costs,0,0
66065,were,0,0
66066,generally,0,0
66067,higher,0,0
66068,for,0,0
66069,the,0,0
66070,treatment,0,0
66071,group,0,0
66072,than,0,0
66073,for,0,0
66074,the,0,0
66075,control,0,1
66076,group,0,0
66077,",",0,0
66078,with,0,0
66079,treatment-control,0,1
66080,cost,0,0
66081,differences,0,0
66082,ranging,0,0
66083,from,0,0
66084,1,0,1
66085,percent,0,0
66086,(,0,0
66087,and,0,0
66088,statistically,0,0
66089,insignificant,0,0
66090,),0,0
66091,for,0,0
66092,the,0,0
66093,elderly,0,0
66094,in,0,0
66095,Florida,0,0
66096,to,0,0
66097,17,0,0
66098,percent,0,0
66099,for,0,0
66100,the,0,0
66101,elderly,0,0
66102,in,0,0
66103,Arkansas,0,0
66104,.,0,0
66105,In,0,0
66106,year,0,0
66107,2,0,0
66108,",",0,0
66109,these,0,0
66110,cost,0,0
66111,differences,0,0
66112,were,0,0
66113,generally,0,0
66114,greater,0,0
66115,than,0,0
66116,in,0,0
66117,year,0,0
66118,1,0,0
66119,.,0,0
66120,Only,0,0
66121,in,0,0
66122,Arkansas,0,0
66123,did,0,0
66124,the,0,0
66125,treatment-control,0,1
66126,difference,0,0
66127,in,0,0
66128,total,0,0
66129,cost,0,0
66130,shrink,0,0
66131,over,0,0
66132,time-to,0,0
66133,less,0,0
66134,than,0,0
66135,5,0,0
66136,percent,0,0
66137,(,0,0
66138,and,0,0
66139,statistically,0,0
66140,insignificant,0,0
66141,),0,0
66142,in,0,0
66143,year,0,0
66144,2,0,0
66145,.,0,0
66146,CONCLUSIONS,0,0
66147,Medicaid,0,0
66148,costs,0,0
66149,were,0,0
66150,generally,0,0
66151,higher,0,0
66152,under,0,0
66153,Cash,1,0
66154,and,1,0
66155,Counseling,1,1
66156,because,0,0
66157,those,0,0
66158,in,0,0
66159,the,0,0
66160,traditional,0,1
66161,system,0,0
66162,did,0,0
66163,not,0,0
66164,get,0,0
66165,the,0,0
66166,services,0,1
66167,they,0,0
66168,were,0,0
66169,entitled,0,0
66170,to,0,0
66171,.,0,0
66172,Compared,0,0
66173,with,0,0
66174,the,0,0
66175,treatment,0,0
66176,group,0,0
66177,",",0,0
66178,(,0,0
66179,1,0,0
66180,),0,1
66181,control,0,1
66182,group,0,0
66183,members,0,0
66184,were,0,0
66185,less,0,0
66186,likely,0,0
66187,to,0,0
66188,receive,0,0
66189,any,0,0
66190,services,0,1
66191,at,0,0
66192,all,0,0
66193,(,0,0
66194,despite,0,0
66195,being,0,0
66196,authorized,0,0
66197,for,0,0
66198,them,0,0
66199,),0,0
66200,",",0,0
66201,and,0,0
66202,(,0,0
66203,2,0,1
66204,),0,0
66205,service,0,1
66206,recipients,0,0
66207,received,0,0
66208,a,0,0
66209,lower,0,0
66210,proportion,0,0
66211,of,0,0
66212,the,0,0
66213,amount,0,0
66214,of,0,0
66215,care,0,1
66216,that,0,0
66217,was,0,0
66218,authorized,0,0
66219,.,0,0
66220,In,0,0
66221,addition,0,0
66222,",",0,0
66223,a,0,0
66224,flaw,0,0
66225,in,0,0
66226,Florida,0,0
66227,'s,0,0
66228,reassessment,0,0
66229,procedures,0,0
66230,led,0,0
66231,to,0,0
66232,treatment,0,0
66233,group,0,0
66234,members,0,0
66235,receiving,0,0
66236,more,0,0
66237,generous,0,1
66238,benefit,0,0
66239,amounts,0,0
66240,than,0,0
66241,control,0,0
66242,group,0,0
66243,members,0,0
66244,.,0,0
66245,To,0,0
66246,keep,0,0
66247,total,0,0
66248,Medicaid,0,1
66249,costs,0,0
66250,per,0,0
66251,recipient,0,0
66252,at,0,0
66253,the,0,0
66254,level,0,0
66255,incurred,0,0
66256,under,0,0
66257,the,0,0
66258,traditional,0,1
66259,system,0,0
66260,",",0,0
66261,consumer-directed,0,1
66262,programs,0,1
66263,need,0,0
66264,to,0,0
66265,be,0,0
66266,carefully,0,0
66267,designed,0,0
66268,and,0,0
66269,closely,0,0
66270,monitored,0,0
66271,.,0,0
66272,Safety,0,1
66273,trial,0,0
66274,of,0,0
66275,the,0,0
66276,vaginal,1,1
66277,microbicide,1,1
66278,cellulose,1,1
66279,sulfate,1,1
66280,gel,1,1
66281,in,0,0
66282,HIV-positive,0,0
66283,men,0,0
66284,.,0,0
66285,OBJECTIVE,0,0
66286,Cellulose,1,1
66287,sulfate,1,1
66288,(,1,1
66289,CS,1,1
66290,),1,1
66291,is,0,0
66292,a,0,0
66293,promising,0,0
66294,vaginal,0,1
66295,microbicide,0,1
66296,.,0,0
66297,Because,0,0
66298,men,0,0
66299,will,0,0
66300,be,0,0
66301,exposed,0,0
66302,to,0,0
66303,the,0,0
66304,microbicide,0,1
66305,when,0,0
66306,engaging,0,1
66307,in,0,0
66308,vaginal,0,1
66309,intercourse,0,0
66310,",",0,0
66311,safety,0,0
66312,and,0,0
66313,acceptability,0,0
66314,need,0,0
66315,to,0,0
66316,be,0,0
66317,assessed,0,0
66318,in,0,0
66319,men,0,0
66320,.,0,0
66321,DESIGN,0,0
66322,This,0,0
66323,randomized,0,0
66324,double-blind,0,0
66325,phase,0,0
66326,I,0,0
66327,study,0,0
66328,assessed,0,0
66329,the,0,0
66330,safety,0,0
66331,and,0,0
66332,acceptability,0,0
66333,of,0,0
66334,seven,0,0
66335,consecutive,0,0
66336,daily,0,0
66337,doses,0,0
66338,of,0,0
66339,CS,1,0
66340,versus,0,1
66341,KY,1,1
66342,Jelly,1,1
66343,in,0,0
66344,36,0,0
66345,HIV-positive,0,0
66346,men,0,0
66347,.,0,0
66348,RESULTS,0,0
66349,No,0,0
66350,new,0,0
66351,or,0,1
66352,worsening,0,0
66353,of,0,0
66354,existing,0,0
66355,genital,0,0
66356,findings,0,0
66357,were,0,0
66358,observed,0,0
66359,during,0,0
66360,the,0,0
66361,follow-up,0,0
66362,examination,0,0
66363,.,0,0
66364,Mild,0,0
66365,genital,0,0
66366,symptoms,0,0
66367,were,0,0
66368,reported,0,0
66369,in,0,0
66370,42,0,0
66371,%,0,0
66372,of,0,0
66373,CS,1,1
66374,users,0,0
66375,(,0,0
66376,itching,0,0
66377,",",0,0
66378,burning,0,0
66379,",",0,0
66380,tingling,0,0
66381,",",0,0
66382,testicular,0,0
66383,pain,0,0
66384,",",0,0
66385,dysuria,0,0
66386,",",0,0
66387,and,0,0
66388,warm,0,1
66389,or,0,1
66390,cold,0,1
66391,feeling,0,0
66392,),0,1
66393,and,0,0
66394,8,0,0
66395,%,0,0
66396,of,0,0
66397,KY,1,1
66398,Jelly,0,1
66399,users,0,0
66400,.,0,0
66401,CONCLUSION,0,0
66402,CS,1,0
66403,gel,0,1
66404,applied,0,0
66405,to,0,0
66406,the,0,0
66407,penis,0,0
66408,was,0,0
66409,well,0,0
66410,tolerated,0,0
66411,in,0,0
66412,this,0,0
66413,HIV-positive,0,0
66414,male,0,0
66415,population,0,0
66416,.,0,0
66417,The,0,0
66418,itching,0,0
66419,and,0,0
66420,burning,0,0
66421,symptoms,0,0
66422,were,0,0
66423,not,0,0
66424,severe,0,0
66425,and,0,0
66426,can,0,0
66427,be,0,0
66428,explained,0,0
66429,by,0,0
66430,the,0,0
66431,preservative,0,1
66432,benzyl,0,1
66433,alcohol,0,1
66434,present,0,0
66435,in,0,0
66436,the,0,0
66437,CS,1,0
66438,gel,0,1
66439,.,0,0
66440,Injection,1,0
66441,sclerotherapy,1,1
66442,versus,1,1
66443,electrocoagulation,1,1
66444,in,0,0
66445,the,0,0
66446,management,0,1
66447,outcome,0,0
66448,of,0,0
66449,early,0,0
66450,haemorrhoids,0,0
66451,.,0,0
66452,OBJECTIVE,0,0
66453,To,0,0
66454,study,0,0
66455,the,0,0
66456,symptomatology,0,0
66457,of,0,0
66458,early,0,0
66459,hemorrhoids,0,0
66460,and,0,0
66461,to,0,0
66462,compare,0,0
66463,injection,1,1
66464,sclerotherapy,1,1
66465,(,1,1
66466,IS,1,1
66467,),1,1
66468,with,1,1
66469,electrocoagulation,1,1
66470,(,1,1
66471,EC,1,1
66472,),1,1
66473,in,0,0
66474,the,0,0
66475,management,0,1
66476,outcome,0,0
66477,of,0,0
66478,early,0,0
66479,haemorrhoids,0,0
66480,with,0,0
66481,respect,0,0
66482,to,0,0
66483,pain,0,0
66484,during,0,0
66485,the,0,0
66486,procedure,0,0
66487,",",0,0
66488,reduction,0,0
66489,in,0,0
66490,bleeding,0,0
66491,per,0,0
66492,rectum,0,0
66493,",",0,0
66494,and,0,0
66495,overall,0,0
66496,patient,0,0
66497,satisfaction,0,0
66498,score,0,0
66499,.,0,0
66500,METHODS,0,0
66501,A,0,0
66502,total,0,0
66503,of,0,0
66504,102,0,0
66505,patients,0,0
66506,were,0,0
66507,included,0,0
66508,in,0,0
66509,this,0,0
66510,experimental,0,0
66511,study,0,0
66512,at,0,0
66513,the,0,0
66514,POF,0,1
66515,Hospital,0,0
66516,",",0,0
66517,Wah,0,0
66518,Cantt,0,1
66519,from,0,0
66520,October,0,0
66521,2004,0,0
66522,to,0,0
66523,June,0,0
66524,2005,0,0
66525,.,0,0
66526,A,0,0
66527,detailed,0,0
66528,history,0,0
66529,was,0,0
66530,taken,0,0
66531,and,0,0
66532,proctoscopic,0,1
66533,examination,0,0
66534,was,0,0
66535,performed,0,0
66536,.,0,0
66537,Patients,0,0
66538,were,0,0
66539,then,0,0
66540,randomly,0,0
66541,divided,0,0
66542,into,0,0
66543,two,0,0
66544,groups,0,0
66545,(,0,0
66546,Lottery,0,1
66547,method,0,1
66548,),0,0
66549,.,0,0
66550,One,0,0
66551,group,0,0
66552,was,0,0
66553,subjected,0,0
66554,to,0,0
66555,EC,0,1
66556,and,0,0
66557,the,0,0
66558,other,0,0
66559,to,0,0
66560,IS,0,1
66561,.,0,0
66562,In,0,0
66563,the,0,0
66564,EC,0,1
66565,",",0,0
66566,using,0,0
66567,the,0,0
66568,EC,0,1
66569,machine,0,1
66570,(,0,0
66571,Wieda,0,1
66572,",",0,0
66573,China,0,0
66574,),0,0
66575,",",0,0
66576,direct,0,0
66577,current,0,0
66578,of,0,0
66579,10-20,0,0
66580,mA,0,0
66581,was,0,0
66582,applied,0,0
66583,in,0,0
66584,the,0,0
66585,submucosal,0,0
66586,plane,0,0
66587,of,0,0
66588,each,0,0
66589,pile,0,1
66590,core,0,0
66591,for,0,0
66592,5-7,0,0
66593,minutes,0,0
66594,.,0,0
66595,In,0,0
66596,the,0,0
66597,IS,0,1
66598,1-2,0,0
66599,ml,0,1
66600,of,0,0
66601,5,0,1
66602,%,0,0
66603,phenol,1,1
66604,in,1,0
66605,almond,1,0
66606,oil,1,1
66607,was,0,0
66608,injected,0,0
66609,in,0,0
66610,the,0,0
66611,same,0,0
66612,plane,0,0
66613,in,0,0
66614,each,0,0
66615,pile,0,0
66616,core,0,0
66617,.,0,0
66618,Pain,0,0
66619,during,0,0
66620,the,0,0
66621,procedure,0,0
66622,",",0,0
66623,reduction,0,0
66624,in,0,0
66625,bleeding,0,0
66626,per,0,1
66627,rectum,0,0
66628,and,0,0
66629,overall,0,0
66630,patient,0,0
66631,satisfaction,0,0
66632,",",0,0
66633,were,0,0
66634,studied,0,0
66635,as,0,0
66636,outcome,0,0
66637,measures,0,0
66638,.,0,0
66639,RESULTS,0,0
66640,The,0,0
66641,mean,0,0
66642,age,0,0
66643,of,0,0
66644,the,0,0
66645,patients,0,0
66646,was,0,0
66647,44,0,0
66648,years,0,0
66649,",",0,0
66650,86,0,0
66651,were,0,0
66652,males,0,0
66653,and,0,0
66654,16,0,0
66655,were,0,0
66656,females,0,0
66657,.,0,0
66658,Two,0,0
66659,thirds,0,0
66660,of,0,0
66661,the,0,0
66662,patients,0,0
66663,were,0,0
66664,having,0,0
66665,symptoms,0,0
66666,for,0,0
66667,more,0,0
66668,than,0,0
66669,6,0,0
66670,months,0,0
66671,.,0,0
66672,A,0,0
66673,third,0,0
66674,of,0,0
66675,patients,0,0
66676,had,0,0
66677,associated,0,0
66678,local,0,1
66679,pain,0,0
66680,while,0,0
66681,another,0,0
66682,third,0,0
66683,had,0,0
66684,associated,0,0
66685,mucous,0,0
66686,discharge,0,1
66687,.,0,0
66688,Chronic,0,0
66689,constipation,0,0
66690,was,0,0
66691,present,0,0
66692,in,0,0
66693,81,0,0
66694,%,0,0
66695,patients,0,0
66696,.,0,0
66697,Only,0,0
66698,24.5,0,0
66699,%,0,0
66700,of,0,0
66701,the,0,0
66702,patients,0,0
66703,had,0,0
66704,a,0,0
66705,positive,0,0
66706,family,0,1
66707,history,0,0
66708,of,0,0
66709,haemorrhoids,0,0
66710,.,0,0
66711,Patients,0,0
66712,in,0,0
66713,the,0,0
66714,electrocoagulation,0,1
66715,(,0,1
66716,EC,0,1
66717,),0,1
66718,group,0,0
66719,experienced,0,0
66720,more,0,0
66721,pain,0,0
66722,during,0,0
66723,the,0,0
66724,procedure,0,0
66725,than,0,0
66726,the,0,0
66727,injection,0,1
66728,sclerotherapy,1,1
66729,(,1,1
66730,IS,1,1
66731,),1,1
66732,group,0,0
66733,(,0,1
66734,P,0,0
66735,<,0,0
66736,0.000,0,0
66737,),0,0
66738,",",0,0
66739,but,0,0
66740,EC,0,1
66741,was,0,0
66742,significantly,0,0
66743,more,0,0
66744,effective,0,0
66745,than,0,0
66746,IS,0,1
66747,in,0,0
66748,terms,0,0
66749,of,0,0
66750,reducing,0,0
66751,the,0,0
66752,bleeding,0,0
66753,per,0,1
66754,rectum,0,0
66755,(,0,0
66756,P,0,0
66757,=,0,0
66758,0.039,0,0
66759,),0,0
66760,",",0,0
66761,and,0,0
66762,also,0,0
66763,significantly,0,0
66764,higher,0,0
66765,number,0,0
66766,of,0,0
66767,patients,0,0
66768,were,0,0
66769,fully,0,0
66770,satisfied,0,0
66771,with,0,0
66772,EC,0,1
66773,than,0,0
66774,with,0,0
66775,IS,0,1
66776,(,0,0
66777,P,0,0
66778,<,0,0
66779,0.04,0,0
66780,),0,0
66781,.,0,0
66782,CONCLUSION,0,0
66783,EC,0,0
66784,",",0,0
66785,although,0,0
66786,more,0,0
66787,painful,0,0
66788,",",0,0
66789,is,0,0
66790,a,0,0
66791,safe,0,0
66792,",",0,0
66793,more,0,0
66794,effective,0,0
66795,and,0,0
66796,a,0,0
66797,highly,0,0
66798,satisfying,0,0
66799,procedure,0,1
66800,for,0,0
66801,treating,0,0
66802,early,0,0
66803,hemorrhoids,0,0
66804,.,0,0
66805,The,0,0
66806,prophylactic,0,1
66807,effect,0,0
66808,of,0,0
66809,itraconazole,1,1
66810,capsules,1,1
66811,and,1,0
66812,fluconazole,1,1
66813,capsules,1,1
66814,for,0,0
66815,systemic,0,0
66816,fungal,0,1
66817,infections,0,0
66818,in,0,0
66819,patients,0,0
66820,with,0,0
66821,acute,0,0
66822,myeloid,0,0
66823,leukemia,0,0
66824,and,0,0
66825,myelodysplastic,0,0
66826,syndromes,0,0
66827,:,0,0
66828,a,0,0
66829,Japanese,0,0
66830,multicenter,0,0
66831,randomized,0,0
66832,",",0,0
66833,controlled,0,0
66834,study,0,0
66835,.,0,0
66836,We,0,0
66837,performed,0,0
66838,a,0,0
66839,randomized,0,0
66840,",",0,0
66841,controlled,0,0
66842,study,0,0
66843,comparing,0,0
66844,the,0,0
66845,prophylactic,0,1
66846,effects,0,0
66847,of,0,0
66848,capsule,0,1
66849,forms,0,0
66850,of,0,0
66851,fluconazole,1,1
66852,(,0,0
66853,n,0,0
66854,=,0,0
66855,110,0,0
66856,),0,0
66857,and,0,0
66858,itraconazole,1,1
66859,(,0,0
66860,n,0,0
66861,=,0,0
66862,108,0,0
66863,),0,0
66864,in,0,0
66865,patients,0,0
66866,with,0,0
66867,acute,0,0
66868,myeloid,0,0
66869,leukemia,0,0
66870,(,0,1
66871,AML,0,1
66872,),0,1
66873,or,0,1
66874,myelodysplastic,0,0
66875,syndromes,0,0
66876,(,0,0
66877,MDS,0,1
66878,),0,1
66879,during,0,0
66880,and,0,0
66881,after,0,0
66882,chemotherapy,0,1
66883,.,0,0
66884,There,0,0
66885,were,0,0
66886,4,0,0
66887,cases,0,0
66888,with,0,0
66889,possible,0,0
66890,systemic,0,0
66891,fungal,0,1
66892,infection,0,0
66893,in,0,0
66894,the,0,0
66895,itraconazole,1,1
66896,group,0,0
66897,",",0,0
66898,and,0,0
66899,there,0,0
66900,were,0,0
66901,8,0,0
66902,possible,0,0
66903,and,0,0
66904,3,0,0
66905,probable,0,0
66906,cases,0,0
66907,in,0,0
66908,the,0,0
66909,fluconazole,1,1
66910,group,0,0
66911,.,0,0
66912,Adverse,0,0
66913,events,0,0
66914,did,0,0
66915,not,0,0
66916,significantly,0,0
66917,differ,0,0
66918,in,0,0
66919,the,0,0
66920,2,0,0
66921,groups,0,0
66922,.,0,0
66923,In,0,0
66924,patients,0,0
66925,with,0,0
66926,MDS,0,1
66927,or,0,1
66928,in,0,0
66929,the,0,0
66930,remission-induction,0,0
66931,phase,0,0
66932,of,0,0
66933,chemotherapy,0,1
66934,",",0,0
66935,the,0,0
66936,numbers,0,0
66937,of,0,0
66938,cases,0,0
66939,with,0,0
66940,probable,0,0
66941,or,0,1
66942,possible,0,0
66943,infections,0,0
66944,were,0,0
66945,lower,0,0
66946,in,0,0
66947,the,0,0
66948,itraconazole,0,1
66949,group,0,0
66950,than,0,0
66951,in,0,0
66952,the,0,0
66953,fluconazole,0,1
66954,group,0,0
66955,",",0,0
66956,whereas,0,0
66957,no,0,0
66958,difference,0,0
66959,was,0,0
66960,seen,0,0
66961,in,0,0
66962,patients,0,0
66963,with,0,0
66964,AML,0,1
66965,or,0,1
66966,in,0,0
66967,the,0,0
66968,consolidation,0,0
66969,phase,0,0
66970,of,0,0
66971,therapy,0,1
66972,.,0,0
66973,In,0,0
66974,patients,0,0
66975,with,0,0
66976,neutrophil,0,0
66977,counts,0,0
66978,of,0,0
66979,>,0,0
66980,0.1,0,0
66981,x,0,0
66982,10,0,0
66983,(,0,0
66984,9,0,0
66985,),0,1
66986,/L,0,1
66987,lasting,0,0
66988,for,0,0
66989,more,0,0
66990,than,0,0
66991,4,0,0
66992,weeks,0,0
66993,",",0,0
66994,the,0,0
66995,frequency,0,0
66996,of,0,0
66997,infection,0,0
66998,in,0,0
66999,the,0,0
67000,fluconazole,0,1
67001,group,0,0
67002,(,0,0
67003,5,0,0
67004,of,0,0
67005,9,0,0
67006,patients,0,0
67007,),0,0
67008,was,0,0
67009,significantly,0,0
67010,higher,0,0
67011,than,0,0
67012,in,0,0
67013,the,0,0
67014,itraconazole,0,1
67015,group,0,0
67016,(,0,0
67017,0,0,0
67018,of,0,0
67019,7,0,0
67020,patients,0,0
67021,;,0,0
67022,P,0,0
67023,=,0,0
67024,.03,0,0
67025,),0,0
67026,.,0,0
67027,Our,0,0
67028,results,0,0
67029,suggest,0,0
67030,that,0,0
67031,both,0,0
67032,drugs,0,1
67033,were,0,0
67034,well,0,0
67035,tolerated,0,0
67036,in,0,0
67037,patients,0,0
67038,with,0,0
67039,AML,0,1
67040,or,0,1
67041,MDS,0,1
67042,who,0,0
67043,received,0,1
67044,chemotherapy,0,1
67045,and,0,0
67046,that,0,0
67047,the,0,0
67048,efficacy,0,0
67049,of,0,0
67050,itraconazole,0,1
67051,for,0,0
67052,prophylaxis,0,1
67053,against,0,0
67054,systemic,0,0
67055,fungal,0,1
67056,disease,0,0
67057,is,0,0
67058,not,0,0
67059,inferior,0,0
67060,to,0,0
67061,that,0,0
67062,of,0,0
67063,fluconazole,0,1
67064,.,0,0
67065,Pathological,0,0
67066,features,0,0
67067,and,0,0
67068,inhaled,0,1
67069,corticosteroid,0,1
67070,response,0,0
67071,of,0,0
67072,eosinophilic,0,0
67073,and,0,0
67074,non-eosinophilic,0,0
67075,asthma,0,0
67076,.,0,0
67077,BACKGROUND,0,0
67078,Non-eosinophilic,0,0
67079,asthma,0,0
67080,is,0,0
67081,a,0,0
67082,potentially,0,0
67083,important,0,0
67084,clinicopathological,0,0
67085,phenotype,0,0
67086,since,0,0
67087,there,0,0
67088,is,0,0
67089,evidence,0,0
67090,that,0,0
67091,it,0,0
67092,responds,0,0
67093,poorly,0,0
67094,to,0,0
67095,inhaled,0,1
67096,corticosteroid,0,1
67097,therapy,0,1
67098,.,0,0
67099,However,0,0
67100,",",0,0
67101,little,0,0
67102,is,0,0
67103,known,0,0
67104,about,0,0
67105,the,0,0
67106,underlying,0,0
67107,airway,0,0
67108,immunopathology,0,0
67109,and,0,0
67110,there,0,0
67111,are,0,0
67112,no,0,0
67113,data,0,0
67114,from,0,0
67115,placebo-controlled,0,1
67116,studies,0,0
67117,examining,0,0
67118,the,0,0
67119,effect,0,0
67120,of,0,0
67121,inhaled,0,1
67122,corticosteroids,0,1
67123,.,0,0
67124,METHODS,0,0
67125,Airway,0,0
67126,immunopathology,0,0
67127,was,0,0
67128,investigated,0,0
67129,using,0,0
67130,induced,0,0
67131,sputum,0,0
67132,",",0,0
67133,bronchial,0,0
67134,biopsies,0,0
67135,",",0,0
67136,bronchial,0,0
67137,wash,0,1
67138,and,0,0
67139,bronchoalveolar,0,0
67140,lavage,0,1
67141,in,0,0
67142,12,0,0
67143,patients,0,0
67144,with,0,0
67145,symptomatic,0,0
67146,eosinophilic,0,0
67147,asthma,0,0
67148,",",0,0
67149,11,0,0
67150,patients,0,0
67151,with,0,0
67152,non-eosinophilic,0,0
67153,asthma,0,0
67154,and,0,0
67155,10,0,0
67156,healthy,0,0
67157,controls,0,0
67158,.,0,0
67159,The,0,0
67160,patients,0,0
67161,with,0,0
67162,non-eosinophilic,0,0
67163,asthma,0,0
67164,and,0,0
67165,6,0,0
67166,different,0,0
67167,patients,0,0
67168,with,0,0
67169,eosinophilic,0,0
67170,asthma,0,0
67171,entered,0,0
67172,a,0,0
67173,randomised,0,0
67174,",",0,0
67175,double-blind,0,0
67176,",",0,0
67177,placebo-controlled,1,1
67178,crossover,0,0
67179,study,0,0
67180,in,0,0
67181,which,0,0
67182,the,0,0
67183,effects,0,0
67184,of,0,0
67185,inhaled,1,1
67186,mometasone,1,1
67187,400,1,1
67188,microg,1,0
67189,once,0,1
67190,daily,0,1
67191,for,0,0
67192,8,0,0
67193,weeks,0,0
67194,on,0,0
67195,airway,0,0
67196,responsiveness,0,0
67197,and,0,0
67198,asthma,0,0
67199,quality,0,0
67200,of,0,0
67201,life,0,0
67202,were,0,0
67203,investigated,0,0
67204,.,0,0
67205,RESULTS,0,0
67206,Patients,0,0
67207,with,0,0
67208,non-eosinophilic,0,0
67209,asthma,0,0
67210,had,0,0
67211,absence,0,0
67212,of,0,0
67213,eosinophils,0,0
67214,in,0,0
67215,the,0,0
67216,mucosa,0,0
67217,(,0,0
67218,median,0,0
67219,4.4,0,0
67220,cells/mm,0,0
67221,(,0,0
67222,2,0,0
67223,),0,0
67224,vs,0,0
67225,23,0,0
67226,cells/mm,0,0
67227,(,0,0
67228,2,0,0
67229,),0,0
67230,in,0,0
67231,eosinophilic,0,0
67232,asthma,0,0
67233,and,0,0
67234,0,0,0
67235,cells/mm,0,0
67236,(,0,0
67237,2,0,0
67238,),0,0
67239,in,0,0
67240,normal,0,0
67241,controls,0,0
67242,;,0,0
67243,p,0,0
67244,=,0,0
67245,0.03,0,0
67246,),0,0
67247,and,0,0
67248,normal,0,1
67249,subepithelial,0,1
67250,layer,0,1
67251,thickness,0,0
67252,(,0,0
67253,5.8,0,0
67254,microm,0,0
67255,vs,0,0
67256,10.3,0,0
67257,microm,0,0
67258,in,0,0
67259,eosinophilic,0,0
67260,asthma,0,0
67261,and,0,0
67262,5.1,0,0
67263,microm,0,0
67264,in,0,0
67265,controls,0,0
67266,",",0,0
67267,p,0,0
67268,=,0,0
67269,0.002,0,0
67270,),0,0
67271,.,0,0
67272,Non-eosinophilic,0,0
67273,and,0,0
67274,eosinophilic,0,0
67275,asthma,0,0
67276,groups,0,0
67277,had,0,0
67278,increased,0,0
67279,mast,0,0
67280,cell,0,0
67281,numbers,0,0
67282,in,0,0
67283,the,0,0
67284,airway,0,0
67285,smooth,0,0
67286,muscle,0,0
67287,compared,0,0
67288,with,0,0
67289,normal,0,0
67290,controls,0,0
67291,(,0,0
67292,9,0,0
67293,vs,0,0
67294,8,0,0
67295,vs,0,0
67296,0,0,0
67297,cells/mm,0,0
67298,(,0,0
67299,2,0,0
67300,),0,0
67301,",",0,0
67302,p,0,0
67303,=,0,0
67304,0.016,0,0
67305,),0,0
67306,.,0,0
67307,Compared,0,0
67308,with,0,0
67309,placebo,0,1
67310,",",0,0
67311,8,0,0
67312,weeks,0,0
67313,of,0,0
67314,treatment,0,0
67315,with,0,0
67316,inhaled,0,1
67317,mometasone,0,1
67318,led,0,0
67319,to,0,0
67320,less,0,0
67321,improvement,0,0
67322,in,0,0
67323,methacholine,0,1
67324,PC,0,1
67325,(,0,1
67326,20,0,1
67327,),0,1
67328,(,0,0
67329,0.5,0,1
67330,vs,0,0
67331,5.5,0,0
67332,doubling,0,0
67333,concentrations,0,0
67334,",",0,0
67335,95,0,0
67336,%,0,0
67337,CI,0,0
67338,of,0,0
67339,difference,0,0
67340,1.1,0,0
67341,to,0,0
67342,9.1,0,0
67343,;,0,0
67344,p,0,0
67345,=,0,0
67346,0.018,0,0
67347,),0,0
67348,and,0,0
67349,asthma,0,0
67350,quality,0,0
67351,of,0,0
67352,life,0,0
67353,(,0,0
67354,0.2,0,1
67355,vs,0,0
67356,1.0,0,0
67357,points,0,0
67358,",",0,0
67359,95,0,0
67360,%,0,0
67361,CI,0,0
67362,of,0,0
67363,difference,0,0
67364,0.27,0,0
67365,to,0,0
67366,1.43,0,0
67367,;,0,0
67368,p,0,0
67369,=,0,0
67370,0.008,0,0
67371,),0,0
67372,.,0,0
67373,CONCLUSIONS,0,0
67374,Non-eosinophilic,0,0
67375,asthma,0,0
67376,represents,0,0
67377,a,0,0
67378,pathologically,0,0
67379,distinct,0,0
67380,disease,0,0
67381,phenotype,0,0
67382,which,0,0
67383,is,0,0
67384,characterised,0,0
67385,by,0,0
67386,the,0,0
67387,absence,0,0
67388,of,0,0
67389,airway,0,0
67390,eosinophilia,0,0
67391,",",0,0
67392,normal,0,0
67393,subepithelial,0,1
67394,layer,0,1
67395,thickness,0,0
67396,and,0,0
67397,a,0,0
67398,poor,0,0
67399,short-term,0,0
67400,response,0,0
67401,to,0,0
67402,treatment,0,0
67403,with,0,0
67404,inhaled,0,1
67405,corticosteroids,0,1
67406,.,0,0
67407,p16,1,1
67408,(,1,1
67409,INK4a,1,1
67410,),1,1
67411,Expression,1,0
67412,does,0,0
67413,not,0,0
67414,predict,0,0
67415,the,0,0
67416,outcome,0,0
67417,of,0,0
67418,cervical,0,0
67419,intraepithelial,0,0
67420,neoplasia,0,0
67421,grade,0,0
67422,2,0,0
67423,.,0,0
67424,Spontaneous,0,0
67425,regression,0,0
67426,of,0,0
67427,cervical,0,0
67428,intraepithelial,0,0
67429,neoplasia,0,0
67430,grade,0,0
67431,2,0,0
67432,(,0,0
67433,CIN2,0,1
67434,),0,1
67435,lesions,0,0
67436,has,0,0
67437,been,0,0
67438,recognized,0,0
67439,since,0,0
67440,1955,0,0
67441,",",0,0
67442,but,0,0
67443,predictors,0,0
67444,of,0,0
67445,this,0,0
67446,are,0,0
67447,poorly,0,0
67448,understood,0,0
67449,.,0,0
67450,Among,0,0
67451,the,0,0
67452,predictive,0,0
67453,markers,0,0
67454,studied,0,0
67455,",",0,0
67456,p16,1,0
67457,(,1,0
67458,INK4a,1,1
67459,),1,1
67460,has,0,0
67461,been,0,0
67462,suggested,0,0
67463,to,0,0
67464,be,0,0
67465,of,0,0
67466,some,0,0
67467,value,0,0
67468,in,0,0
67469,monitoring,0,0
67470,the,0,0
67471,diagnosis,0,0
67472,of,0,0
67473,CIN2,0,1
67474,.,0,0
67475,In,0,0
67476,this,0,0
67477,clinical,0,0
67478,trial,0,0
67479,",",0,0
67480,90,0,0
67481,Brazilian,0,0
67482,women,0,0
67483,",",0,0
67484,diagnosed,0,0
67485,to,0,0
67486,CIN2,0,1
67487,and,0,0
67488,high-risk,0,0
67489,human,0,1
67490,papillomavirus,0,1
67491,infection,0,0
67492,",",0,0
67493,were,0,0
67494,randomized,0,0
67495,into,0,0
67496,two,0,0
67497,groups,0,0
67498,of,0,0
67499,equal,0,0
67500,size,0,0
67501,:,0,0
67502,45,0,0
67503,women,0,0
67504,whose,0,0
67505,lesions,1,0
67506,were,1,0
67507,excised,1,1
67508,and,0,0
67509,45,0,0
67510,women,0,0
67511,subjected,0,0
67512,to,0,0
67513,prospective,1,0
67514,follow-up,1,0
67515,at,0,0
67516,3-month,0,0
67517,intervals,0,0
67518,at,0,0
67519,least,0,0
67520,for,0,0
67521,1,0,0
67522,year,0,0
67523,(,0,0
67524,mean,0,0
67525,6.8,0,0
67526,months,0,0
67527,),0,0
67528,.,0,1
67529,p16,1,0
67530,(,1,0
67531,INK4a,1,1
67532,),1,1
67533,expression,0,0
67534,was,0,0
67535,analyzed,0,0
67536,in,0,0
67537,paraffin-embedded,0,0
67538,sections,0,0
67539,using,0,0
67540,immunohistochemical,1,0
67541,staining,1,0
67542,.,1,0
67543,Among,0,0
67544,the,0,0
67545,45,0,0
67546,women,0,0
67547,in,0,0
67548,the,0,0
67549,follow-up,0,0
67550,group,0,0
67551,",",0,0
67552,42,0,0
67553,%,0,0
67554,experienced,0,0
67555,spontaneous,0,0
67556,regression,0,0
67557,",",0,0
67558,11,0,0
67559,%,0,0
67560,showed,0,0
67561,persistence,0,0
67562,",",0,0
67563,22,0,0
67564,%,0,0
67565,progressed,0,0
67566,to,0,0
67567,CIN3,0,1
67568,",",0,0
67569,and,0,0
67570,20,0,0
67571,%,0,0
67572,had,0,0
67573,partial,0,0
67574,regression,0,0
67575,to,0,0
67576,CIN1,0,1
67577,or,0,1
67578,ASCUS,0,0
67579,(,0,1
67580,atypical,0,0
67581,squamous,0,0
67582,cell,0,0
67583,undetermined,0,0
67584,signifiance,0,0
67585,),0,0
67586,.,0,1
67587,p16,1,0
67588,(,1,0
67589,INK4a,1,1
67590,),1,1
67591,expression,0,0
67592,was,0,0
67593,detected,0,0
67594,in,0,0
67595,68.9,0,0
67596,%,0,0
67597,of,0,0
67598,the,0,0
67599,patients,0,0
67600,.,0,0
67601,In,0,0
67602,univariate,0,0
67603,survival,0,0
67604,(,0,1
67605,Cox,0,1
67606,),0,1
67607,analysis,0,0
67608,",",0,0
67609,no,0,0
67610,significant,0,0
67611,difference,0,0
67612,in,0,0
67613,regression,0,0
67614,was,0,0
67615,obtained,0,0
67616,between,0,0
67617,p16,1,0
67618,(,1,1
67619,INK4a,1,1
67620,),1,1
67621,-negative,1,0
67622,and,1,0
67623,-positive,1,0
67624,CIN2,0,1
67625,lesions,0,0
67626,(,0,0
67627,adjusted,0,0
67628,HR,0,0
67629,=,0,0
67630,1.1,0,0
67631,;,0,0
67632,95,0,0
67633,%,0,0
67634,CI,0,0
67635,0.6-2.0,0,0
67636,),0,0
67637,.,0,0
67638,In,0,0
67639,conclusion,0,0
67640,",",0,0
67641,p16,1,0
67642,(,1,1
67643,INK4a,1,1
67644,),1,1
67645,expression,0,0
67646,could,0,0
67647,be,0,0
67648,useful,0,0
67649,in,0,0
67650,the,0,0
67651,diagnosis,0,0
67652,of,0,0
67653,CIN2,0,1
67654,.,0,0
67655,However,0,0
67656,",",0,0
67657,it,0,0
67658,failed,0,0
67659,to,0,0
67660,predict,0,0
67661,the,0,0
67662,outcome,0,0
67663,of,0,0
67664,CIN2,0,1
67665,.,0,0
67666,Because,0,0
67667,of,0,0
67668,its,0,0
67669,high,0,0
67670,spontaneous,0,0
67671,regression,0,0
67672,rate,0,0
67673,",",0,0
67674,follow-up,0,0
67675,could,0,0
67676,be,0,0
67677,considered,0,0
67678,as,0,0
67679,a,0,0
67680,management,0,1
67681,option,0,0
67682,of,0,0
67683,CIN2,0,1
67684,in,0,0
67685,young,0,0
67686,and,0,0
67687,compliant,0,0
67688,women,0,0
67689,.,0,0
67690,Neurophysiological,0,0
67691,double-blind,0,0
67692,trial,0,0
67693,of,0,0
67694,a,0,0
67695,botulinum,1,1
67696,neurotoxin,1,1
67697,type,1,0
67698,a,1,0
67699,free,0,0
67700,of,0,0
67701,complexing,0,1
67702,proteins,0,0
67703,.,0,0
67704,OBJECTIVE,0,0
67705,Safety,0,1
67706,and,0,0
67707,efficacy,0,0
67708,of,0,0
67709,botulinum,1,1
67710,neurotoxin,1,1
67711,type,1,0
67712,A,1,0
67713,preparation,1,1
67714,NT,1,1
67715,201,1,0
67716,(,0,0
67717,Xeomin,0,1
67718,",",0,0
67719,Merz,0,1
67720,Pharmaceuticals,0,1
67721,GmbH,0,1
67722,",",0,0
67723,Frankfurt,0,0
67724,am,0,0
67725,Main,0,0
67726,",",0,0
67727,Germany,0,0
67728,),0,0
67729,were,0,0
67730,investigated,0,0
67731,over,0,0
67732,52,0,0
67733,weeks,0,0
67734,in,0,0
67735,a,0,0
67736,double-blind,0,0
67737,",",0,0
67738,randomized,0,0
67739,trial,0,0
67740,with,0,0
67741,32,0,0
67742,male,0,0
67743,volunteers,0,0
67744,.,0,0
67745,METHODS,0,0
67746,Electroneurographic,0,0
67747,assessments,0,0
67748,with,0,0
67749,surface,0,0
67750,electrodes,0,1
67751,were,0,0
67752,performed,0,0
67753,after,0,0
67754,single,1,0
67755,injections,1,1
67756,of,1,0
67757,NT,1,1
67758,201,1,0
67759,(,0,0
67760,2,0,0
67761,",",0,0
67762,4,0,0
67763,",",0,0
67764,16,0,0
67765,",",0,0
67766,or,0,0
67767,32,0,0
67768,units,0,0
67769,),0,0
67770,into,0,0
67771,the,0,0
67772,extensor,1,1
67773,digitorum,1,1
67774,brevis,1,0
67775,(,0,1
67776,EDB,0,1
67777,),0,1
67778,muscle,0,0
67779,and,0,0
67780,the,0,0
67781,same,1,1
67782,dose,1,0
67783,(,0,0
67784,Botox,0,1
67785,;,0,0
67786,Allergan,0,1
67787,Pharmaceuticals,0,1
67788,(,0,1
67789,Ireland,0,0
67790,),0,1
67791,Ltd.,0,0
67792,Westport,0,1
67793,",",0,0
67794,Ireland,0,0
67795,),0,0
67796,into,1,0
67797,the,1,0
67798,contralateral,1,0
67799,EDB,1,1
67800,.,1,0
67801,RESULTS,0,0
67802,All,0,0
67803,NT,1,1
67804,201,1,0
67805,and,1,0
67806,BTXCo,1,1
67807,doses,0,1
67808,achieved,0,0
67809,a,0,0
67810,statistically,0,0
67811,significant,0,0
67812,reduction,0,0
67813,of,0,0
67814,the,0,0
67815,compound,0,1
67816,muscle,0,0
67817,action,0,0
67818,potential,0,0
67819,M-wave,0,1
67820,amplitude,0,0
67821,in,0,0
67822,the,0,0
67823,EDB,0,1
67824,muscle,0,0
67825,.,0,0
67826,At,0,0
67827,week,0,0
67828,4,0,0
67829,",",0,0
67830,the,0,0
67831,highest,0,0
67832,dose,0,0
67833,was,0,0
67834,statistically,0,0
67835,significantly,0,0
67836,more,0,0
67837,effective,0,0
67838,than,0,0
67839,the,0,0
67840,lowest,0,0
67841,dose,0,0
67842,(,0,0
67843,NT,0,1
67844,201,0,0
67845,",",0,0
67846,P,0,0
67847,=,0,0
67848,0.019,0,0
67849,;,0,0
67850,95,0,0
67851,%,0,0
67852,confidence,0,0
67853,interval,0,0
67854,",",0,0
67855,0.195-1.370,0,0
67856,;,0,0
67857,and,0,0
67858,BTXCo,0,1
67859,",",0,0
67860,P,0,0
67861,=,0,0
67862,0.002,0,0
67863,;,0,0
67864,95,0,0
67865,%,0,0
67866,confidence,0,0
67867,interval,0,0
67868,",",0,0
67869,0.309-1.167,0,0
67870,),0,0
67871,.,0,0
67872,Duration,0,0
67873,of,0,0
67874,effect,0,0
67875,was,0,0
67876,dose,0,0
67877,dependent,0,0
67878,.,0,0
67879,The,0,0
67880,mean,0,0
67881,values,0,0
67882,of,0,0
67883,compound,0,1
67884,muscle,0,1
67885,action,0,0
67886,potential,0,0
67887,M-wave,0,1
67888,amplitudes,0,0
67889,in,0,0
67890,the,0,0
67891,adjacent,0,1
67892,muscles,0,1
67893,(,0,0
67894,abductor,0,1
67895,digiti,0,1
67896,quinti,0,0
67897,and,0,0
67898,abductor,0,1
67899,hallucis,0,1
67900,),0,0
67901,were,0,0
67902,above,0,0
67903,the,0,0
67904,predefined,0,0
67905,threshold,0,0
67906,of,0,0
67907,effect,0,0
67908,",",0,0
67909,indicating,0,0
67910,that,0,0
67911,there,0,0
67912,was,0,0
67913,no,0,0
67914,relevant,0,0
67915,diffusion-induced,0,0
67916,reduction,0,0
67917,of,0,0
67918,muscle,0,0
67919,activity,0,0
67920,.,0,0
67921,NT,1,1
67922,201,1,0
67923,and,0,0
67924,BTXCo,1,1
67925,were,0,0
67926,well,0,0
67927,tolerated,0,0
67928,.,0,0
67929,CONCLUSIONS,0,0
67930,NT,1,1
67931,201,1,0
67932,is,0,0
67933,effective,0,0
67934,and,0,0
67935,safe,0,0
67936,in,0,0
67937,inducing,0,0
67938,the,0,0
67939,desired,0,0
67940,paretic,0,0
67941,effect,0,0
67942,.,0,0
67943,Recombinant,0,1
67944,human,0,1
67945,granulocyte-macrophage,1,1
67946,colony-stimulating,1,1
67947,factor,1,1
67948,ameliorates,0,0
67949,zidovudine-induced,0,0
67950,neutropenia,0,0
67951,in,0,0
67952,patients,0,0
67953,with,0,0
67954,acquired,0,0
67955,immunodeficiency,0,0
67956,syndrome,0,0
67957,(,0,1
67958,AIDS,0,1
67959,),0,1
67960,/AIDS-related,0,0
67961,complex,0,0
67962,.,0,0
67963,To,0,0
67964,evaluate,0,0
67965,the,0,0
67966,effect,0,0
67967,of,0,0
67968,recombinant,0,1
67969,granulocyte-macrophage,0,1
67970,colony-stimulating,0,1
67971,factor,0,1
67972,(,1,1
67973,GM-CSF,1,1
67974,),1,1
67975,on,0,0
67976,patients,0,0
67977,with,0,0
67978,acquired,0,0
67979,immunodeficiency,0,0
67980,syndrome,0,0
67981,(,0,1
67982,AIDS,0,1
67983,),0,1
67984,or,0,1
67985,AIDS-related,0,0
67986,complex,0,1
67987,(,0,1
67988,ARC,0,1
67989,),0,1
67990,who,0,0
67991,were,0,0
67992,intolerant,0,0
67993,to,0,0
67994,zidovudine,0,1
67995,because,0,0
67996,of,0,0
67997,neutropenia,0,0
67998,",",0,0
67999,we,0,0
68000,performed,0,0
68001,a,0,0
68002,randomized,0,0
68003,",",0,0
68004,open-label,0,0
68005,study,0,0
68006,in,0,0
68007,which,0,0
68008,patients,0,0
68009,were,0,0
68010,assigned,0,0
68011,to,0,0
68012,one,0,0
68013,of,0,0
68014,two,0,0
68015,groups,0,0
68016,.,0,0
68017,Zidovudine,1,1
68018,was,1,0
68019,discontinued,1,0
68020,in,1,0
68021,group,1,0
68022,A,1,0
68023,patients,1,0
68024,before,1,0
68025,instituting,1,0
68026,GM-CSF,1,1
68027,treatment,1,1
68028,and,1,0
68029,was,1,0
68030,restarted,1,0
68031,in,1,0
68032,a,1,0
68033,graduated,1,1
68034,fashion,1,1
68035,over,1,0
68036,4,1,0
68037,weeks,1,0
68038,.,1,0
68039,Group,1,0
68040,B,1,0
68041,patients,1,0
68042,continued,1,0
68043,on,1,0
68044,full-dose,1,1
68045,(,1,0
68046,"1,200",1,1
68047,mg/d,1,1
68048,),1,1
68049,zidovudine,1,1
68050,therapy,1,1
68051,while,1,0
68052,beginning,1,0
68053,GM-CSF,1,1
68054,therapy,1,1
68055,.,1,0
68056,A,0,0
68057,total,0,0
68058,of,0,0
68059,17,0,0
68060,patients,0,0
68061,were,0,0
68062,entered,0,0
68063,",",0,0
68064,eight,0,0
68065,in,0,0
68066,group,0,0
68067,A,0,0
68068,and,0,0
68069,nine,0,0
68070,in,0,0
68071,group,0,0
68072,B,0,0
68073,.,0,0
68074,Five,0,0
68075,of,0,0
68076,eight,0,0
68077,patients,0,0
68078,in,0,0
68079,group,0,0
68080,A,0,0
68081,and,0,0
68082,seven,0,0
68083,of,0,0
68084,nine,0,0
68085,in,0,0
68086,group,0,0
68087,B,0,0
68088,had,0,0
68089,a,0,0
68090,history,0,0
68091,of,0,0
68092,Pneumocystis,0,0
68093,carinii,0,1
68094,pneumonia,0,0
68095,(,0,1
68096,PCP,0,1
68097,),0,0
68098,.,0,0
68099,All,0,0
68100,were,0,0
68101,homosexual,0,0
68102,males,0,0
68103,",",0,0
68104,except,0,0
68105,one,0,0
68106,female,0,0
68107,in,0,0
68108,group,0,0
68109,A,0,0
68110,who,0,0
68111,was,0,0
68112,the,0,0
68113,sex,0,0
68114,partner,0,0
68115,of,0,0
68116,a,0,0
68117,bisexual,0,0
68118,male,0,0
68119,with,0,0
68120,AIDS,0,0
68121,.,0,0
68122,All,0,0
68123,patients,0,0
68124,had,0,0
68125,neutropenia,0,0
68126,(,0,0
68127,absolute,0,0
68128,neutrophil,0,0
68129,count,0,0
68130,[,0,0
68131,ANC,0,1
68132,],0,0
68133,less,0,0
68134,than,0,0
68135,"1,000/microL",0,0
68136,),0,0
68137,while,0,0
68138,taking,0,0
68139,full-dose,0,1
68140,zidovudine,0,1
68141,.,0,0
68142,The,0,0
68143,mean,0,0
68144,CD4,0,0
68145,(,0,0
68146,+/-,0,0
68147,SD,0,0
68148,),0,1
68149,lymphocyte,0,0
68150,level,0,0
68151,was,0,0
68152,37,0,0
68153,(,0,0
68154,+/-,0,0
68155,29,0,0
68156,),0,0
68157,/microL,0,0
68158,and,0,1
68159,39,0,0
68160,(,0,0
68161,+/-,0,0
68162,44,0,0
68163,),0,0
68164,/microL,0,0
68165,in,0,0
68166,groups,0,0
68167,A,0,0
68168,and,0,0
68169,B,0,0
68170,",",0,0
68171,respectively,0,0
68172,.,0,0
68173,After,0,0
68174,randomization,0,0
68175,",",0,0
68176,patients,0,0
68177,were,0,0
68178,begun,0,0
68179,on,0,0
68180,subcutaneous,0,0
68181,GM-CSF,0,1
68182,at,0,0
68183,a,0,0
68184,dose,0,0
68185,of,0,0
68186,1.0,0,0
68187,microgram/kg/d,0,0
68188,.,0,0
68189,Patients,0,0
68190,in,0,0
68191,group,0,0
68192,A,0,0
68193,received,0,0
68194,2,0,0
68195,weeks,0,0
68196,of,0,0
68197,daily,0,0
68198,GM-CSF,0,1
68199,",",0,0
68200,at,0,0
68201,which,0,0
68202,time,0,0
68203,zidovudine,0,1
68204,was,0,0
68205,restarted,0,0
68206,if,0,0
68207,the,0,0
68208,ANC,0,0
68209,was,0,0
68210,greater,0,0
68211,than,0,0
68212,"1,000/microL",0,0
68213,;,0,0
68214,if,0,0
68215,the,0,0
68216,ANC,0,0
68217,was,0,0
68218,less,0,0
68219,than,0,0
68220,"1,000/microL",0,0
68221,",",0,0
68222,the,0,0
68223,dose,0,0
68224,of,0,0
68225,GM-CSF,0,1
68226,was,0,0
68227,increased,0,0
68228,to,0,0
68229,3.0,0,0
68230,micrograms/kg,0,0
68231,",",0,0
68232,and,0,0
68233,at,0,0
68234,2-week,0,0
68235,intervals,0,0
68236,either,0,0
68237,zidovudine,0,1
68238,was,0,0
68239,restarted,0,0
68240,or,0,1
68241,the,0,0
68242,dose,0,0
68243,of,0,0
68244,GM-CSF,0,1
68245,was,0,0
68246,increased,0,0
68247,to,0,0
68248,5,0,0
68249,micrograms/kg,0,0
68250,and,0,0
68251,then,0,0
68252,10,0,0
68253,micrograms/kg,0,0
68254,",",0,0
68255,to,0,0
68256,maintain,0,0
68257,the,0,0
68258,ANC,0,0
68259,greater,0,0
68260,than,0,0
68261,"1,000/microL",0,0
68262,.,0,0
68263,Group,0,0
68264,B,0,0
68265,patients,0,0
68266,received,0,0
68267,full-dose,0,1
68268,zidovudine,0,1
68269,concurrently,0,1
68270,with,0,0
68271,GM-CSF,0,1
68272,administration,0,0
68273,.,0,0
68274,The,0,0
68275,dose,0,0
68276,of,0,0
68277,GM-CSF,0,1
68278,was,0,0
68279,increased,0,0
68280,every,0,0
68281,2,0,0
68282,weeks,0,0
68283,if,0,0
68284,necessary,0,0
68285,to,0,0
68286,keep,0,0
68287,the,0,0
68288,ANC,0,0
68289,greater,0,0
68290,than,0,0
68291,"1,000/microL",0,0
68292,while,0,0
68293,maintaining,0,0
68294,full-dose,0,1
68295,zidovudine,0,1
68296,therapy,0,1
68297,.,0,0
68298,Patients,0,0
68299,in,0,0
68300,each,0,0
68301,group,0,0
68302,showed,0,0
68303,an,0,0
68304,increase,0,0
68305,in,0,0
68306,total,0,0
68307,white,0,0
68308,blood,0,0
68309,cell,0,0
68310,(,0,1
68311,WBC,0,0
68312,),0,1
68313,count,0,0
68314,.,0,1
68315,Neutrophils,0,0
68316,and,0,0
68317,eosinophils,0,0
68318,were,0,0
68319,responsible,0,0
68320,for,0,0
68321,the,0,0
68322,majority,0,0
68323,of,0,0
68324,this,0,0
68325,increase,0,0
68326,.,0,0
68327,Patients,0,0
68328,in,0,0
68329,group,0,0
68330,A,0,0
68331,had,0,0
68332,a,0,0
68333,more,0,0
68334,rapid,0,0
68335,increase,0,0
68336,in,0,0
68337,WBC,0,0
68338,than,0,0
68339,those,0,0
68340,in,0,0
68341,group,0,0
68342,B,0,0
68343,;,0,0
68344,however,0,0
68345,",",0,0
68346,by,0,0
68347,week,0,0
68348,8,0,0
68349,",",0,0
68350,the,0,0
68351,WBC,0,0
68352,in,0,0
68353,each,0,0
68354,group,0,0
68355,was,0,0
68356,essentially,0,0
68357,equal,0,0
68358,.,0,0
68359,Viral,0,0
68360,replication,0,0
68361,as,0,0
68362,measured,0,0
68363,by,0,0
68364,human,0,1
68365,immunodeficiency,0,0
68366,virus,0,1
68367,(,0,1
68368,HIV,0,1
68369,),0,1
68370,p24,0,1
68371,antigen,0,1
68372,(,0,1
68373,Ag,0,1
68374,),0,1
68375,was,0,0
68376,decreased,0,0
68377,in,0,0
68378,four,0,0
68379,patients,0,0
68380,in,0,0
68381,each,0,0
68382,group,0,0
68383,",",0,0
68384,increased,0,0
68385,in,0,0
68386,one,0,0
68387,patient,0,0
68388,in,0,0
68389,each,0,0
68390,group,0,0
68391,",",0,0
68392,and,0,0
68393,remained,0,0
68394,unchanged,0,0
68395,in,0,0
68396,the,0,0
68397,remainder,0,0
68398,.,0,0
68399,The,0,0
68400,ability,0,0
68401,to,0,0
68402,culture,0,0
68403,virus,0,1
68404,from,0,0
68405,peripheral,0,0
68406,blood,0,0
68407,mononuclear,0,0
68408,cells,0,0
68409,was,0,0
68410,not,0,0
68411,changed,0,0
68412,by,0,0
68413,the,0,0
68414,regimen,0,1
68415,.,0,0
68416,The,0,0
68417,major,0,0
68418,toxicities,0,0
68419,of,0,0
68420,the,0,0
68421,regimen,0,1
68422,were,0,0
68423,fever,0,0
68424,and,0,0
68425,malaise,0,0
68426,.,0,0
68427,(,0,0
68428,ABSTRACT,0,1
68429,TRUNCATED,0,1
68430,AT,0,1
68431,400,0,1
68432,WORDS,0,1
68433,),0,1
68434,Temporal,1,0
68435,judgements,1,0
68436,of,0,0
68437,internal,0,0
68438,and,0,0
68439,external,0,1
68440,events,0,0
68441,in,0,0
68442,persons,0,0
68443,with,0,0
68444,and,0,0
68445,without,0,0
68446,autism,0,0
68447,.,0,0
68448,When,0,0
68449,participants,0,0
68450,make,0,0
68451,judgments,1,0
68452,about,0,0
68453,the,0,0
68454,onset,0,0
68455,of,0,0
68456,self-initiated,0,1
68457,movements,0,0
68458,they,0,0
68459,typically,0,0
68460,report,0,0
68461,the,0,0
68462,movement,0,0
68463,occurred,0,0
68464,earlier,0,0
68465,than,0,0
68466,it,0,0
68467,had,0,0
68468,[,0,0
68469,Obhi,0,0
68470,",",0,0
68471,S.,0,1
68472,S.,0,1
68473,",",0,0
68474,&,0,0
68475,Haggard,0,0
68476,",",0,1
68477,P.,0,1
68478,(,0,1
68479,2004,0,0
68480,),0,0
68481,.,0,0
68482,Free,0,0
68483,will,0,0
68484,and,0,0
68485,free,0,0
68486,wo,0,0
68487,n't,0,0
68488,.,0,0
68489,American,0,0
68490,Scientific,0,0
68491,",",0,0
68492,92,0,0
68493,",",0,0
68494,358-365.,0,0
68495,],0,0
68496,.,0,0
68497,One,0,0
68498,interpretation,0,0
68499,is,0,0
68500,that,0,0
68501,feed-forward,0,0
68502,processes,0,0
68503,lead,0,0
68504,to,0,0
68505,awareness,0,0
68506,of,0,0
68507,the,0,0
68508,movement,0,0
68509,prior,0,0
68510,to,0,0
68511,execution,0,0
68512,.,0,0
68513,Because,0,0
68514,individuals,0,0
68515,with,0,0
68516,autism,0,0
68517,experience,0,0
68518,reduced,0,0
68519,preparatory,0,0
68520,activity,0,0
68521,prior,0,0
68522,to,0,0
68523,a,0,0
68524,voluntary,0,1
68525,movement,0,0
68526,",",0,0
68527,the,0,0
68528,present,0,0
68529,study,0,0
68530,sought,0,0
68531,to,0,0
68532,determine,0,0
68533,whether,0,0
68534,these,0,0
68535,anticipatory,0,0
68536,biases,0,0
68537,are,0,0
68538,exhibited,0,0
68539,by,0,0
68540,persons,0,0
68541,with,0,0
68542,autism,0,0
68543,.,0,0
68544,Participants,1,0
68545,watched,1,0
68546,a,1,0
68547,dot,1,1
68548,move,1,0
68549,in,1,0
68550,a,1,0
68551,circle,1,1
68552,and,1,0
68553,pressed,1,0
68554,the,1,0
68555,spacebar,1,0
68556,any,1,0
68557,time,1,0
68558,after,1,0
68559,one,1,0
68560,revolution,1,0
68561,.,1,0
68562,A,0,0
68563,tone,0,0
68564,either,0,0
68565,followed,0,1
68566,the,0,0
68567,participants,0,0
68568,',0,0
68569,voluntary,0,1
68570,movement,0,0
68571,or,0,1
68572,was,0,0
68573,computer,0,1
68574,generated,0,0
68575,.,0,0
68576,Participants,0,0
68577,in,0,0
68578,both,0,0
68579,groups,0,0
68580,made,0,0
68581,anticipatory,0,0
68582,judgements,1,0
68583,regarding,0,0
68584,movement,0,1
68585,initiation,0,1
68586,(,0,0
68587,approximately,0,0
68588,100,0,1
68589,ms,0,0
68590,),0,0
68591,.,0,0
68592,When,0,0
68593,the,0,0
68594,movement,0,1
68595,and,0,0
68596,tone,0,1
68597,occurred,0,0
68598,together,0,0
68599,this,0,0
68600,anticipatory,0,0
68601,bias,0,0
68602,was,0,0
68603,also,0,0
68604,present,0,0
68605,",",0,0
68606,regardless,0,0
68607,of,0,0
68608,which,0,0
68609,event,0,0
68610,participants,0,0
68611,focused,0,0
68612,on,0,0
68613,.,0,0
68614,Individuals,0,0
68615,with,0,0
68616,autism,0,0
68617,appear,0,0
68618,to,0,0
68619,have,0,0
68620,access,0,0
68621,to,0,0
68622,a,0,0
68623,similar,0,0
68624,representation,0,0
68625,of,0,0
68626,voluntary,0,1
68627,movements,0,0
68628,",",0,0
68629,however,0,0
68630,this,0,0
68631,representation,0,0
68632,may,0,0
68633,be,0,0
68634,more,0,0
68635,variable,0,0
68636,.,0,0
68637,Comparison,0,0
68638,of,0,0
68639,three,0,0
68640,methods,0,0
68641,to,0,0
68642,increase,0,0
68643,knowledge,0,0
68644,about,0,0
68645,breast,0,0
68646,cancer,0,0
68647,and,0,0
68648,breast,0,0
68649,cancer,0,0
68650,screening,0,1
68651,in,0,0
68652,screening,0,1
68653,mammography,0,1
68654,patients,0,0
68655,.,0,0
68656,RATIONALE,0,0
68657,AND,0,0
68658,OBJECTIVES,0,1
68659,The,0,0
68660,specific,0,0
68661,aim,0,0
68662,of,0,0
68663,the,0,0
68664,study,0,0
68665,was,0,0
68666,to,0,0
68667,determine,0,0
68668,which,0,0
68669,of,0,0
68670,several,0,0
68671,cost-effective,0,0
68672,interventions,0,1
68673,is,0,0
68674,best,0,0
68675,able,0,0
68676,to,0,0
68677,improve,0,0
68678,the,0,0
68679,breast,0,0
68680,cancer,0,0
68681,knowledge,0,0
68682,of,0,0
68683,women,0,0
68684,who,0,0
68685,present,0,0
68686,for,0,0
68687,screening,0,0
68688,mammography,0,1
68689,.,0,0
68690,MATERIALS,0,0
68691,AND,0,0
68692,METHODS,0,0
68693,A,0,0
68694,total,0,0
68695,of,0,0
68696,198,0,0
68697,English-speaking,0,0
68698,women,0,0
68699,",",0,0
68700,with,0,0
68701,no,0,0
68702,personal,0,1
68703,or,0,1
68704,family,0,1
68705,history,0,0
68706,of,0,0
68707,breast,0,0
68708,cancer,0,0
68709,",",0,0
68710,were,0,0
68711,recruited,0,0
68712,and,0,0
68713,randomized,0,0
68714,to,0,0
68715,four,0,0
68716,groups,0,0
68717,when,0,0
68718,they,0,0
68719,presented,0,0
68720,to,0,0
68721,the,0,0
68722,clinic,0,0
68723,for,0,0
68724,a,0,0
68725,screening,0,0
68726,mammogram,0,0
68727,.,0,0
68728,All,0,0
68729,women,0,0
68730,filled,0,0
68731,in,0,0
68732,a,0,0
68733,demographic,0,0
68734,data,0,0
68735,form,0,1
68736,and,0,0
68737,answered,0,0
68738,a,0,0
68739,questionnaire,0,0
68740,containing,0,1
68741,nine,0,0
68742,questions,0,0
68743,about,0,0
68744,breast,0,0
68745,cancer,0,0
68746,",",0,0
68747,risk,0,0
68748,",",0,0
68749,and,0,0
68750,screening,0,0
68751,to,0,0
68752,assess,0,0
68753,their,0,0
68754,knowledge,0,0
68755,and,0,0
68756,perception,0,0
68757,.,0,0
68758,Three,0,0
68759,educational,1,0
68760,interventions,1,0
68761,were,0,0
68762,tested,0,0
68763,in,0,0
68764,this,0,0
68765,study,0,0
68766,.,0,0
68767,The,0,0
68768,first,0,0
68769,consisted,0,0
68770,of,0,0
68771,a,0,0
68772,brochure,1,1
68773,",",1,0
68774,which,1,0
68775,provided,1,0
68776,answers,1,0
68777,to,1,0
68778,the,1,0
68779,questionnaire,1,0
68780,items,1,1
68781,and,1,0
68782,addressed,1,0
68783,the,1,0
68784,issues,1,0
68785,in,1,0
68786,more,1,0
68787,depth,1,0
68788,.,1,0
68789,The,0,0
68790,second,0,0
68791,intervention,0,1
68792,was,0,0
68793,an,0,0
68794,educational,1,1
68795,conversation,1,1
68796,with,1,0
68797,a,1,0
68798,specially,1,1
68799,trained,1,1
68800,mammography,1,1
68801,technologist,1,0
68802,.,1,0
68803,She,0,0
68804,reviewed,0,0
68805,the,0,0
68806,subject,0,0
68807,'s,0,0
68808,answers,0,0
68809,to,0,0
68810,the,0,0
68811,questionnaire,0,0
68812,items,0,1
68813,correcting,0,0
68814,and/or,0,0
68815,clarifying,0,0
68816,them,0,0
68817,.,0,0
68818,The,0,0
68819,third,0,0
68820,intervention,0,1
68821,consisted,0,0
68822,of,0,0
68823,the,0,0
68824,brochure,1,1
68825,together,1,0
68826,with,1,0
68827,the,1,0
68828,conversation,1,1
68829,with,1,0
68830,a,1,0
68831,trained,1,1
68832,technologist,1,0
68833,.,1,0
68834,There,0,0
68835,was,0,0
68836,also,0,0
68837,a,0,0
68838,control,0,1
68839,group,0,0
68840,that,0,0
68841,just,0,0
68842,filled,0,0
68843,in,0,0
68844,the,0,0
68845,study,0,0
68846,questionnaire,0,0
68847,but,1,0
68848,did,1,0
68849,not,1,0
68850,receive,1,0
68851,an,1,0
68852,educational,1,1
68853,intervention,1,1
68854,.,1,0
68855,The,0,0
68856,same,0,0
68857,questionnaire,0,0
68858,was,0,0
68859,administered,0,0
68860,by,0,0
68861,telephone,0,1
68862,4,0,0
68863,to,0,0
68864,6,0,0
68865,weeks,0,0
68866,after,0,0
68867,the,0,0
68868,screening,0,0
68869,experience,0,0
68870,to,0,0
68871,all,0,0
68872,study,0,0
68873,subjects,0,0
68874,.,0,0
68875,Changes,0,0
68876,in,0,0
68877,their,0,0
68878,knowledge,0,0
68879,and,0,0
68880,perceptions,0,0
68881,of,0,0
68882,breast,0,0
68883,cancer,0,0
68884,were,0,0
68885,measured,0,0
68886,and,0,0
68887,compared,0,0
68888,.,0,0
68889,RESULTS,0,0
68890,A,0,0
68891,statistically,0,0
68892,significant,0,0
68893,increase,0,0
68894,in,0,0
68895,knowledge,0,0
68896,was,0,0
68897,found,0,0
68898,in,0,0
68899,all,0,0
68900,of,0,0
68901,the,0,0
68902,three,0,0
68903,investigated,0,0
68904,groups,0,0
68905,compared,0,0
68906,to,0,0
68907,the,0,0
68908,control,0,1
68909,group,0,0
68910,.,0,0
68911,There,0,0
68912,were,0,0
68913,no,0,0
68914,statistically,0,0
68915,significant,0,0
68916,differences,0,0
68917,in,0,0
68918,the,0,0
68919,amount,0,0
68920,of,0,0
68921,increase,0,0
68922,between,0,0
68923,women,0,0
68924,who,0,0
68925,underwent,0,0
68926,different,0,0
68927,interventions,0,0
68928,.,0,0
68929,CONCLUSIONS,0,0
68930,All,0,0
68931,three,0,0
68932,interventions,0,0
68933,resulted,0,0
68934,in,0,0
68935,increased,0,0
68936,knowledge,0,0
68937,about,0,0
68938,breast,0,0
68939,cancer,0,0
68940,and,0,0
68941,screening,0,0
68942,.,0,0
68943,No,0,0
68944,differences,0,0
68945,in,0,0
68946,the,0,0
68947,amount,0,0
68948,of,0,0
68949,knowledge,0,0
68950,increase,0,0
68951,were,0,0
68952,found,0,0
68953,between,0,0
68954,three,0,0
68955,interventions,0,0
68956,tested,0,0
68957,.,0,0
68958,The,0,0
68959,educational,0,0
68960,brochure,0,1
68961,seems,0,0
68962,to,0,0
68963,represent,0,0
68964,the,0,0
68965,most,0,0
68966,convenient,0,0
68967,and,0,0
68968,least,0,0
68969,costly,0,0
68970,method,0,1
68971,to,0,0
68972,increase,0,0
68973,knowledge,0,0
68974,about,0,0
68975,breast,0,0
68976,cancer,0,0
68977,and,0,0
68978,screening,0,0
68979,among,0,0
68980,women,0,0
68981,who,0,0
68982,present,0,0
68983,for,0,0
68984,screening,0,0
68985,mammography,0,1
68986,.,0,0
68987,Women,0,0
68988,'s,0,0
68989,responses,0,0
68990,to,0,0
68991,information,0,0
68992,on,0,0
68993,mammographic,0,0
68994,breast,0,0
68995,density,0,0
68996,.,0,0
68997,The,0,0
68998,objective,0,0
68999,of,0,0
69000,this,0,0
69001,study,0,0
69002,was,0,0
69003,to,0,0
69004,determine,0,0
69005,the,0,0
69006,negative,0,0
69007,and,0,0
69008,positive,0,0
69009,outcomes,0,0
69010,of,0,0
69011,providing,0,0
69012,mammographic,0,0
69013,breast,0,0
69014,density,0,0
69015,(,0,1
69016,MBD,0,1
69017,),0,1
69018,information,0,0
69019,to,0,0
69020,participants,0,0
69021,of,0,0
69022,a,0,0
69023,screening,1,0
69024,program,1,1
69025,.,1,0
69026,A,0,0
69027,randomized,0,0
69028,experiment,0,0
69029,was,0,0
69030,conducted,0,0
69031,with,0,0
69032,a,0,0
69033,sample,0,0
69034,of,0,0
69035,618,0,0
69036,women,0,0
69037,50,0,0
69038,years,0,0
69039,or,0,0
69040,older,0,0
69041,with,0,0
69042,MBD,0,0
69043,greater,0,0
69044,than,0,0
69045,50,0,0
69046,%,0,0
69047,of,0,0
69048,breast,0,0
69049,volume,0,0
69050,.,0,0
69051,The,0,0
69052,intervention,0,1
69053,consisted,0,0
69054,of,0,0
69055,reporting,1,0
69056,the,1,0
69057,presence,1,0
69058,of,1,0
69059,MBD,1,1
69060,in,1,0
69061,the,1,0
69062,screening,1,0
69063,mammography,1,1
69064,results,1,0
69065,letter,1,1
69066,that,1,0
69067,was,1,0
69068,sent,1,0
69069,along,1,0
69070,with,1,0
69071,an,1,0
69072,information,1,0
69073,pamphlet,1,1
69074,.,1,0
69075,Compared,0,0
69076,to,0,0
69077,the,0,0
69078,controls,1,0
69079,",",0,0
69080,more,0,0
69081,women,0,0
69082,in,0,0
69083,the,0,0
69084,intervention,0,1
69085,group,0,0
69086,described,0,0
69087,the,0,0
69088,term,0,1
69089,breast,0,0
69090,density,0,0
69091,correctly,0,0
69092,and,0,0
69093,recognized,0,0
69094,it,0,0
69095,as,0,0
69096,a,0,0
69097,risk,0,0
69098,factor,0,0
69099,for,0,0
69100,breast,0,0
69101,cancer,0,0
69102,.,0,0
69103,Although,0,0
69104,at,0,0
69105,the,0,0
69106,4-week,0,0
69107,follow-up,0,0
69108,the,0,0
69109,intervention,0,1
69110,group,0,0
69111,indicated,0,0
69112,that,0,0
69113,they,0,0
69114,were,0,0
69115,very,0,0
69116,likely,0,0
69117,to,0,0
69118,have,0,0
69119,an,0,0
69120,annual,1,0
69121,clinical,1,0
69122,breast,1,0
69123,examination,1,0
69124,more,0,0
69125,frequently,0,0
69126,than,0,0
69127,controls,0,0
69128,",",0,0
69129,no,0,0
69130,differences,0,0
69131,were,0,0
69132,detected,0,0
69133,at,0,0
69134,6,0,0
69135,months,0,0
69136,.,0,0
69137,There,0,0
69138,were,0,0
69139,no,0,0
69140,significant,0,0
69141,differences,0,0
69142,on,0,0
69143,other,0,0
69144,behavioural,0,1
69145,or,0,1
69146,psychological,0,0
69147,measures,0,0
69148,",",0,0
69149,although,0,0
69150,at,0,0
69151,the,0,0
69152,4-week,0,0
69153,follow-up,0,0
69154,the,0,0
69155,control,0,1
69156,group,0,0
69157,perceived,0,0
69158,their,0,0
69159,risk,0,0
69160,for,0,0
69161,breast,0,0
69162,cancer,0,0
69163,",",0,0
69164,relative,0,0
69165,to,0,0
69166,other,0,0
69167,women,0,0
69168,their,0,0
69169,age,0,0
69170,",",0,0
69171,as,0,0
69172,a,0,0
69173,lot,0,0
69174,lower,0,0
69175,than,0,0
69176,did,0,0
69177,women,0,0
69178,in,0,0
69179,the,0,0
69180,intervention,0,1
69181,group,0,0
69182,.,0,0
69183,The,0,0
69184,results,0,0
69185,demonstrate,0,0
69186,a,0,0
69187,feasible,0,0
69188,and,0,0
69189,non-threatening,0,0
69190,way,0,0
69191,to,0,0
69192,provide,0,0
69193,women,0,0
69194,with,0,0
69195,important,0,0
69196,personalized,0,1
69197,information,0,0
69198,about,0,0
69199,breast,0,0
69200,cancer,0,0
69201,risk,0,0
69202,.,0,0
69203,Development,0,0
69204,",",0,0
69205,description,0,0
69206,",",0,0
69207,and,0,0
69208,acceptability,0,0
69209,of,0,0
69210,a,0,0
69211,small-group,1,1
69212,",",1,0
69213,behavioral,1,1
69214,intervention,1,1
69215,to,0,0
69216,prevent,0,0
69217,HIV,0,1
69218,and,0,0
69219,hepatitis,0,1
69220,C,0,1
69221,virus,0,1
69222,infections,0,0
69223,among,0,0
69224,young,0,0
69225,adult,0,0
69226,injection,0,1
69227,drug,0,0
69228,users,0,0
69229,.,0,0
69230,Young,0,0
69231,injection,0,1
69232,drug,0,1
69233,users,0,0
69234,(,0,0
69235,IDUs,0,1
69236,),0,1
69237,who,0,0
69238,are,0,0
69239,not,0,0
69240,infected,0,0
69241,with,0,0
69242,HIV,0,1
69243,or,0,1
69244,hepatitis,0,1
69245,C,0,1
69246,virus,0,1
69247,are,0,0
69248,at,0,0
69249,great,0,0
69250,risk,0,0
69251,of,0,0
69252,acquiring,0,0
69253,one,0,0
69254,or,0,0
69255,both,0,0
69256,of,0,0
69257,these,0,0
69258,infections,0,0
69259,through,0,0
69260,their,0,0
69261,sexual,0,0
69262,or,0,1
69263,injection,0,1
69264,behaviors,0,0
69265,.,0,0
69266,We,0,0
69267,describe,0,0
69268,the,0,0
69269,development,0,0
69270,of,0,0
69271,a,0,0
69272,behavioral,0,1
69273,intervention,0,1
69274,designed,0,0
69275,to,0,0
69276,decrease,0,0
69277,sexual,0,0
69278,and,0,0
69279,injection,0,1
69280,risk,0,0
69281,behaviors,0,0
69282,among,0,0
69283,young,0,0
69284,IDUs,0,0
69285,.,0,0
69286,The,0,0
69287,intervention,0,1
69288,was,0,0
69289,developed,0,0
69290,through,0,0
69291,a,0,0
69292,dynamic,0,0
69293,and,0,0
69294,iterative,0,1
69295,process,0,0
69296,that,0,0
69297,involved,0,0
69298,extensive,0,0
69299,development,0,0
69300,activities,0,0
69301,",",0,0
69302,focus,0,0
69303,groups,0,0
69304,with,0,0
69305,the,0,0
69306,target,0,0
69307,population,0,0
69308,to,0,0
69309,pilot,0,0
69310,individual,0,0
69311,activities,0,0
69312,and,0,0
69313,intervention,0,1
69314,sessions,0,1
69315,",",0,0
69316,and,0,0
69317,later,0,0
69318,",",0,0
69319,pilot,0,0
69320,testing,0,0
69321,of,0,0
69322,the,0,0
69323,entire,0,0
69324,intervention,0,1
69325,.,0,0
69326,The,0,0
69327,six-session,0,1
69328,intervention,0,1
69329,that,0,0
69330,emerged,0,0
69331,from,0,0
69332,the,0,0
69333,development,0,0
69334,process,0,0
69335,relied,0,0
69336,on,0,0
69337,both,0,0
69338,social-cognitive,1,1
69339,theories,1,0
69340,and,1,0
69341,peer,1,1
69342,influence,1,0
69343,models,1,0
69344,.,1,0
69345,We,0,0
69346,also,0,0
69347,designed,0,0
69348,a,0,0
69349,control,0,1
69350,intervention,0,1
69351,",",0,0
69352,trained,0,1
69353,facilitators,0,1
69354,to,0,0
69355,deliver,0,0
69356,the,0,0
69357,interventions,0,0
69358,",",0,0
69359,and,0,0
69360,conducted,0,0
69361,quality,0,0
69362,assurance,0,0
69363,of,0,0
69364,intervention,0,1
69365,delivery,0,0
69366,.,0,0
69367,To,0,0
69368,better,0,0
69369,understand,0,0
69370,intervention,0,1
69371,trial,0,0
69372,findings,0,0
69373,",",0,0
69374,we,0,0
69375,asked,0,0
69376,participants,0,0
69377,about,0,0
69378,their,0,0
69379,intervention,0,1
69380,experiences,0,0
69381,and,0,0
69382,examined,0,0
69383,potential,0,0
69384,contamination,0,0
69385,across,0,0
69386,arms,0,0
69387,.,0,0
69388,Both,0,0
69389,interventions,0,0
69390,were,0,0
69391,delivered,0,0
69392,with,0,0
69393,high,0,0
69394,fidelity,0,0
69395,and,0,0
69396,participants,0,0
69397,in,0,0
69398,both,0,0
69399,groups,0,0
69400,reported,0,0
69401,positive,0,0
69402,experiences,0,0
69403,.,0,0
69404,More,0,0
69405,perceived,0,0
69406,impact,0,0
69407,was,0,0
69408,reported,0,0
69409,for,0,0
69410,injection,0,1
69411,risk,0,0
69412,behaviors,0,0
69413,than,0,0
69414,for,0,0
69415,sexual,0,0
69416,risk,0,0
69417,behaviors,0,0
69418,among,0,0
69419,participants,0,0
69420,in,0,0
69421,the,0,0
69422,intervention,0,1
69423,arm,0,0
69424,.,0,0
69425,Minimal,0,0
69426,evidence,0,0
69427,of,0,0
69428,contamination,0,0
69429,was,0,0
69430,found,0,0
69431,.,0,0
69432,Lessons,0,0
69433,learned,0,0
69434,can,0,0
69435,help,0,0
69436,future,0,0
69437,researchers,0,0
69438,to,0,0
69439,develop,0,0
69440,stronger,0,0
69441,interventions,0,0
69442,for,0,0
69443,this,0,0
69444,high-need,0,0
69445,population,0,0
69446,.,0,0
69447,Preliminary,0,1
69448,analysis,0,0
69449,of,0,0
69450,the,0,0
69451,final,0,0
69452,multicenter,0,0
69453,investigation,0,0
69454,of,0,0
69455,rheopheresis,1,1
69456,for,0,0
69457,age,0,0
69458,related,0,0
69459,macular,0,0
69460,degeneration,0,0
69461,(,0,1
69462,AMD,0,1
69463,),0,1
69464,trial,0,0
69465,(,0,1
69466,MIRA-1,0,1
69467,),0,0
69468,results,0,0
69469,.,0,0
69470,PURPOSE,0,0
69471,To,0,0
69472,present,0,0
69473,an,0,0
69474,initial,0,0
69475,evaluation,0,0
69476,of,0,0
69477,the,0,0
69478,final,0,0
69479,data,0,0
69480,from,0,0
69481,the,0,0
69482,Multicenter,0,0
69483,Investigation,0,0
69484,of,0,0
69485,Rheopheresis,1,1
69486,for,0,0
69487,age-related,0,0
69488,macular,0,0
69489,degeneration,0,0
69490,(,0,1
69491,AMD,0,1
69492,),0,1
69493,(,0,1
69494,MIRA-1,0,1
69495,),0,1
69496,trial,0,0
69497,.,0,0
69498,This,0,0
69499,was,0,0
69500,a,0,0
69501,12-month,0,0
69502,randomized,0,0
69503,",",0,0
69504,prospective,0,0
69505,",",0,0
69506,multicenter,0,0
69507,",",0,0
69508,double-masked,0,0
69509,",",0,0
69510,placebo-controlled,1,1
69511,",",0,0
69512,Food,0,0
69513,and,0,0
69514,Drug,0,1
69515,Administration,0,0
69516,approved,0,0
69517,clinical,0,0
69518,trial,0,0
69519,designed,0,0
69520,to,0,0
69521,compare,0,0
69522,rheopheresis,1,1
69523,treatment,1,0
69524,with,0,0
69525,placebo-control,1,0
69526,treatment,1,0
69527,.,1,0
69528,METHODS,0,0
69529,Patients,0,0
69530,that,0,0
69531,had,0,0
69532,nonexudative,0,0
69533,age-related,0,0
69534,macular,0,0
69535,degeneration,0,0
69536,(,0,1
69537,AMD,0,1
69538,),0,1
69539,and,0,0
69540,certain,0,0
69541,hemorheologic,0,0
69542,abnormalities,0,0
69543,were,0,0
69544,randomized,0,0
69545,to,0,0
69546,either,0,1
69547,rheopheresis,1,1
69548,or,1,1
69549,sham,1,1
69550,treatment,1,1
69551,in,0,0
69552,a,0,0
69553,2:1,0,0
69554,fashion,0,0
69555,.,0,0
69556,Best-corrected,0,0
69557,visual,0,0
69558,acuity,0,0
69559,was,0,0
69560,determined,0,0
69561,before,0,0
69562,and,0,0
69563,at,0,0
69564,3,0,0
69565,",",0,0
69566,6,0,0
69567,",",0,0
69568,9,0,0
69569,",",0,0
69570,and,0,0
69571,12,0,0
69572,months,0,0
69573,following,0,0
69574,treatment,0,0
69575,.,0,0
69576,Adverse,0,0
69577,events,0,0
69578,were,0,0
69579,also,0,0
69580,recorded,0,0
69581,.,0,0
69582,RESULTS,0,0
69583,A,0,0
69584,total,0,0
69585,of,0,0
69586,216,0,0
69587,patients,0,0
69588,were,0,0
69589,randomized,0,0
69590,.,0,0
69591,Of,0,0
69592,these,0,0
69593,",",0,0
69594,18,0,0
69595,were,0,0
69596,not,0,0
69597,included,0,0
69598,in,0,0
69599,the,0,0
69600,vision,0,0
69601,or,0,1
69602,adverse,0,0
69603,events,0,0
69604,evaluation,0,0
69605,because,0,0
69606,they,0,0
69607,did,0,0
69608,not,0,0
69609,complete,0,0
69610,one,0,0
69611,treatment,0,0
69612,.,0,0
69613,This,0,0
69614,decreased,0,0
69615,the,0,0
69616,number,0,0
69617,of,0,0
69618,patients,0,0
69619,that,0,0
69620,were,0,0
69621,evaluated,0,0
69622,for,0,0
69623,adverse,0,0
69624,events,0,0
69625,to,0,0
69626,198,0,0
69627,patients,0,0
69628,.,0,0
69629,In,0,0
69630,this,0,0
69631,group,0,0
69632,",",0,0
69633,there,0,0
69634,were,0,0
69635,27,0,0
69636,serious,0,0
69637,adverse,0,0
69638,events,0,0
69639,",",0,0
69640,but,0,0
69641,only,0,0
69642,1.8,0,0
69643,%,0,0
69644,of,0,0
69645,treatments,0,0
69646,were,0,0
69647,suspended,0,0
69648,because,0,0
69649,of,0,0
69650,adverse,0,0
69651,events,0,0
69652,.,0,0
69653,At,0,0
69654,12,0,0
69655,months,0,0
69656,",",0,0
69657,there,0,0
69658,were,0,0
69659,104,0,0
69660,treated,0,0
69661,patients,0,0
69662,and,0,0
69663,63,0,0
69664,placebo,1,1
69665,patients,0,0
69666,that,0,0
69667,had,0,0
69668,follow-up,0,0
69669,.,0,0
69670,The,0,0
69671,treated,0,0
69672,patients,0,0
69673,had,0,0
69674,a,0,0
69675,logMAR,0,1
69676,vision,0,0
69677,improvement,0,0
69678,of,0,0
69679,0.02,0,0
69680,+/-,0,0
69681,0.213,0,0
69682,",",0,0
69683,and,0,0
69684,the,0,0
69685,placebo,1,1
69686,patients,0,0
69687,had,0,0
69688,a,0,0
69689,vision,0,0
69690,improvement,0,0
69691,of,0,0
69692,0.02,0,0
69693,+/-,0,0
69694,0.20,0,0
69695,.,0,0
69696,This,0,0
69697,was,0,0
69698,not,0,0
69699,statistically,0,0
69700,significant,0,0
69701,(,0,0
69702,P,0,0
69703,=,0,0
69704,.977,0,0
69705,),0,0
69706,.,0,0
69707,The,0,0
69708,repeated,0,0
69709,measure,0,0
69710,P,0,0
69711,value,0,0
69712,for,0,0
69713,the,0,0
69714,entire,0,0
69715,time,0,0
69716,interval,0,0
69717,was,0,0
69718,not,0,0
69719,significant,0,0
69720,(,0,0
69721,P,0,0
69722,=,0,0
69723,.69,0,0
69724,),0,0
69725,.,0,0
69726,There,0,0
69727,appeared,0,0
69728,to,0,0
69729,be,0,0
69730,patients,0,0
69731,entered,0,0
69732,into,0,0
69733,the,0,0
69734,study,0,0
69735,that,0,0
69736,did,0,0
69737,not,0,0
69738,meet,0,0
69739,inclusion,0,0
69740,criteria,0,0
69741,.,0,0
69742,Excluding,0,0
69743,37,0,0
69744,%,0,0
69745,of,0,0
69746,the,0,0
69747,treated,0,0
69748,patients,0,0
69749,and,0,0
69750,29,0,0
69751,%,0,0
69752,of,0,0
69753,the,0,0
69754,placebo,0,1
69755,data,0,0
69756,from,0,0
69757,the,0,0
69758,analysis,0,0
69759,",",0,0
69760,there,0,0
69761,appeared,0,0
69762,to,0,0
69763,be,0,0
69764,statistically,0,0
69765,significant,0,0
69766,improvement,0,0
69767,in,0,0
69768,the,0,0
69769,treated,0,0
69770,patients,0,0
69771,compared,0,0
69772,to,0,0
69773,the,0,0
69774,control,0,0
69775,patients,0,0
69776,at,0,0
69777,1,0,0
69778,year,0,0
69779,with,0,0
69780,a,0,0
69781,P,0,0
69782,value,0,0
69783,of,0,0
69784,.001,0,0
69785,(,0,0
69786,repeated,0,0
69787,measures,0,0
69788,P,0,0
69789,value,0,0
69790,=,0,0
69791,.01,0,0
69792,),0,0
69793,.,0,0
69794,CONCLUSIONS,0,0
69795,At,0,0
69796,best,0,0
69797,this,0,0
69798,was,0,0
69799,a,0,0
69800,flawed,0,0
69801,study,0,0
69802,in,0,0
69803,that,0,0
69804,37,0,0
69805,%,0,0
69806,of,0,0
69807,the,0,0
69808,treated,0,0
69809,cases,0,0
69810,did,0,0
69811,not,0,0
69812,meet,0,0
69813,inclusion,0,0
69814,criteria,0,0
69815,",",0,0
69816,and,0,0
69817,at,0,0
69818,worst,0,0
69819,there,0,0
69820,was,0,0
69821,no,0,0
69822,evidence,0,0
69823,of,0,0
69824,effect,0,0
69825,.,0,0
69826,Even,0,0
69827,though,0,0
69828,the,0,0
69829,number,0,0
69830,of,0,0
69831,serious,0,0
69832,adverse,0,0
69833,events,0,0
69834,is,0,0
69835,small,0,0
69836,",",0,0
69837,because,0,0
69838,this,0,0
69839,study,0,0
69840,did,0,0
69841,not,0,0
69842,show,0,0
69843,an,0,0
69844,effect,0,0
69845,in,0,0
69846,the,0,0
69847,intent-to-treat,0,0
69848,group,0,0
69849,",",0,0
69850,rheopheresis,1,1
69851,should,0,0
69852,not,0,0
69853,be,0,0
69854,performed,0,0
69855,for,0,0
69856,AMD,0,0
69857,outside,0,0
69858,of,0,0
69859,an,0,0
69860,approved,0,0
69861,randomized,0,0
69862,controlled,0,0
69863,trial,0,0
69864,.,0,0
69865,Use,0,1
69866,of,0,0
69867,the,0,0
69868,electrothermal,1,1
69869,bipolar,1,1
69870,vessel,1,0
69871,system,1,1
69872,(,1,1
69873,EBVS,1,0
69874,),1,1
69875,in,0,0
69876,laparoscopic,0,1
69877,adrenalectomy,0,1
69878,:,0,0
69879,a,0,0
69880,prospective,0,0
69881,study,0,0
69882,.,0,0
69883,BACKGROUND,0,0
69884,Since,0,0
69885,laparoscopic,0,1
69886,adrenalectomy,0,1
69887,(,0,1
69888,LA,0,1
69889,),0,1
69890,has,0,0
69891,been,0,0
69892,adopted,0,0
69893,as,0,0
69894,the,0,0
69895,gold,0,1
69896,standard,0,1
69897,for,0,0
69898,the,0,0
69899,treatment,0,0
69900,of,0,0
69901,adrenal,0,0
69902,diseases,0,0
69903,",",0,0
69904,the,0,0
69905,development,0,0
69906,of,0,0
69907,technology,0,0
69908,for,0,0
69909,vascular,0,0
69910,control,0,1
69911,and,0,0
69912,dissection,0,0
69913,manoeuvres,0,1
69914,",",0,0
69915,amongst,0,0
69916,other,0,0
69917,things,0,0
69918,",",0,0
69919,may,0,0
69920,play,0,0
69921,a,0,0
69922,pivotal,0,0
69923,role,0,0
69924,in,0,0
69925,its,0,0
69926,further,0,0
69927,improvement,0,0
69928,.,0,0
69929,We,0,0
69930,report,0,0
69931,our,0,0
69932,experience,0,0
69933,with,0,0
69934,the,0,0
69935,electrothermal,1,1
69936,bipolar,1,1
69937,vessel,1,0
69938,sealing,1,0
69939,(,1,1
69940,EBVS,1,0
69941,),1,1
69942,device,0,1
69943,for,0,0
69944,LA,0,1
69945,.,0,0
69946,METHODS,0,0
69947,From,0,0
69948,January,0,0
69949,2004,0,0
69950,to,0,0
69951,January,0,0
69952,2006,0,0
69953,",",0,0
69954,50,0,0
69955,patients,0,0
69956,(,0,0
69957,pts,0,0
69958,),0,0
69959,undergoing,0,0
69960,LA,0,1
69961,were,0,0
69962,selected,0,0
69963,and,0,0
69964,randomized,0,0
69965,for,0,0
69966,use,0,0
69967,of,0,0
69968,the,0,0
69969,EBVS,1,0
69970,(,1,0
69971,25,1,0
69972,pts,1,0
69973,",",1,0
69974,group,1,0
69975,A,1,0
69976,),1,0
69977,versus,1,0
69978,the,1,0
69979,UltraSonic,1,1
69980,Shears,1,1
69981,(,1,1
69982,USS,1,1
69983,),1,1
69984,device,1,1
69985,(,0,0
69986,25,0,0
69987,pts,0,0
69988,",",0,0
69989,group,0,0
69990,B,0,0
69991,),0,0
69992,.,0,0
69993,Age,0,0
69994,",",0,0
69995,sex,0,0
69996,",",0,0
69997,body,0,0
69998,mass,0,0
69999,index,0,0
70000,(,0,1
70001,BMI,0,1
70002,),0,1
70003,",",0,0
70004,previous,0,0
70005,surgery,0,1
70006,and,0,0
70007,associated,0,0
70008,diseases,0,0
70009,were,0,0
70010,similar,0,0
70011,between,0,0
70012,the,0,0
70013,two,0,0
70014,groups,0,0
70015,.,0,0
70016,The,0,0
70017,main,0,0
70018,surgical,0,0
70019,parameters,0,0
70020,collected,0,0
70021,for,0,0
70022,each,0,0
70023,patient,0,0
70024,(,0,1
70025,pt,0,0
70026,),0,1
70027,concerned,0,0
70028,operative,0,0
70029,time,0,0
70030,",",0,0
70031,major,0,0
70032,and,0,0
70033,minor,0,0
70034,complications,0,0
70035,",",0,0
70036,conversion,0,0
70037,rate,0,0
70038,",",0,0
70039,blood,0,0
70040,loss,0,0
70041,",",0,0
70042,hospital,0,0
70043,stay,0,0
70044,and,0,0
70045,histology,0,0
70046,.,0,0
70047,RESULTS,0,0
70048,There,0,0
70049,was,0,0
70050,no,0,0
70051,mortality,0,0
70052,in,0,0
70053,either,0,0
70054,group,0,0
70055,.,0,0
70056,The,0,0
70057,right,0,0
70058,adrenalectomy,0,1
70059,mean,0,0
70060,operative,0,0
70061,time,0,0
70062,(,0,1
70063,OpT,0,1
70064,),0,1
70065,was,0,0
70066,51.8,0,0
70067,mins,0,0
70068,(,0,0
70069,range,0,0
70070,40-90,0,1
70071,mins,0,1
70072,),0,0
70073,and,0,0
70074,68.6,0,0
70075,mins,0,1
70076,(,0,0
70077,range,0,0
70078,50-130,0,1
70079,mins,0,1
70080,),0,0
70081,in,0,0
70082,group,0,0
70083,A,0,0
70084,and,0,0
70085,B,0,0
70086,",",0,0
70087,respectively,0,0
70088,(,0,0
70089,P,0,0
70090,not,0,0
70091,significant,0,0
70092,),0,0
70093,.,0,0
70094,The,0,0
70095,left,0,0
70096,adrenalectomy,0,1
70097,mean,0,0
70098,OpT,0,0
70099,was,0,0
70100,72.2,0,0
70101,mins,0,0
70102,(,0,0
70103,range,0,0
70104,55-100,0,1
70105,mins,0,1
70106,),0,0
70107,and,0,0
70108,94,0,0
70109,mins,0,1
70110,(,0,0
70111,range,0,0
70112,65-140,0,0
70113,mins,0,1
70114,),0,0
70115,for,0,0
70116,group,0,0
70117,A,0,0
70118,and,0,0
70119,B,0,0
70120,",",0,0
70121,respectively,0,0
70122,(,0,0
70123,P,0,0
70124,<,0,0
70125,0.05,0,0
70126,),0,0
70127,.,0,0
70128,The,0,0
70129,mean,0,0
70130,blood,0,0
70131,loss,0,0
70132,was,0,0
70133,83,0,0
70134,ml,0,1
70135,(,0,0
70136,group,0,1
70137,A,0,1
70138,),0,1
70139,and,0,0
70140,210,0,0
70141,ml,0,1
70142,(,0,0
70143,group,0,1
70144,B,0,1
70145,),0,1
70146,(,0,0
70147,p,0,0
70148,<,0,0
70149,0.05,0,0
70150,),0,0
70151,.,0,0
70152,Complications,0,0
70153,were,0,0
70154,not,0,0
70155,different,0,0
70156,for,0,0
70157,the,0,0
70158,two,0,0
70159,groups,0,0
70160,.,0,0
70161,The,0,0
70162,mean,0,0
70163,hospital,0,0
70164,stay,0,0
70165,was,0,0
70166,2.9,0,0
70167,and,0,0
70168,3.1,0,0
70169,days,0,0
70170,in,0,0
70171,group,0,0
70172,A,0,0
70173,and,0,0
70174,B,0,0
70175,",",0,0
70176,respectively,0,0
70177,(,0,0
70178,P,0,0
70179,not,0,0
70180,significant,0,0
70181,),0,0
70182,.,0,0
70183,CONCLUSIONS,0,0
70184,EBVS,0,0
70185,in,0,0
70186,LA,0,1
70187,may,0,0
70188,provide,0,0
70189,a,0,0
70190,significantly,0,0
70191,short,0,0
70192,operating,0,1
70193,time,0,0
70194,and,0,0
70195,blood,0,0
70196,loss,0,0
70197,.,0,0
70198,Ropivacaine,1,1
70199,versus,0,1
70200,lidocaine,1,1
70201,in,0,0
70202,digital,0,1
70203,nerve,0,0
70204,blocks,0,1
70205,:,0,0
70206,a,0,0
70207,prospective,0,0
70208,study,0,0
70209,.,0,0
70210,BACKGROUND,0,0
70211,Ropivacaine,1,1
70212,is,0,0
70213,a,0,0
70214,relatively,0,0
70215,new,0,0
70216,long-acting,0,1
70217,amide,0,1
70218,local,0,1
70219,anesthetic,0,1
70220,.,0,0
70221,Since,0,0
70222,its,0,0
70223,introduction,0,0
70224,in,0,0
70225,1996,0,0
70226,",",0,0
70227,it,0,0
70228,has,0,0
70229,been,0,0
70230,used,0,0
70231,for,0,0
70232,subcutaneous,0,1
70233,infiltration,0,0
70234,;,0,0
70235,epidural,0,1
70236,",",0,0
70237,intrathecal,0,1
70238,",",0,0
70239,and,0,0
70240,peripheral,0,0
70241,nerve,0,1
70242,block,0,1
70243,surgery,0,1
70244,;,0,0
70245,and,0,0
70246,postoperative,0,0
70247,analgesia,0,0
70248,.,0,0
70249,However,0,0
70250,",",0,0
70251,it,0,0
70252,has,0,0
70253,never,0,0
70254,been,0,0
70255,used,0,0
70256,for,0,0
70257,digital,0,1
70258,blocks,0,1
70259,.,0,0
70260,This,0,0
70261,prospective,0,0
70262,",",0,0
70263,randomized,0,0
70264,",",0,0
70265,double-blind,0,0
70266,study,0,0
70267,compares,0,0
70268,the,0,0
70269,digital,0,1
70270,block,0,0
70271,results,0,0
70272,following,0,0
70273,the,0,0
70274,administration,0,0
70275,of,0,0
70276,2.5,1,0
70277,ml,1,0
70278,of,1,0
70279,0.75,1,0
70280,%,1,0
70281,ropivacaine,1,1
70282,solution,1,1
70283,and,1,0
70284,2.5,1,1
70285,ml,1,0
70286,of,1,0
70287,2,1,0
70288,%,1,0
70289,lidocaine,1,1
70290,solution,1,1
70291,.,1,0
70292,METHODS,0,0
70293,From,0,0
70294,March,0,0
70295,of,0,0
70296,1999,0,0
70297,to,0,0
70298,March,0,0
70299,of,0,0
70300,2001,0,0
70301,",",0,0
70302,70,0,0
70303,adult,0,0
70304,patients,0,0
70305,who,0,0
70306,underwent,0,0
70307,immediate,0,0
70308,reconstruction,1,1
70309,for,1,0
70310,traumatic,1,0
70311,injuries,1,0
70312,of,1,0
70313,the,1,0
70314,digits,1,1
70315,were,0,0
70316,prospectively,0,0
70317,randomized,0,0
70318,into,0,0
70319,two,0,0
70320,groups,0,0
70321,.,0,0
70322,Group,0,0
70323,A,0,0
70324,(,0,0
70325,n,0,0
70326,=,0,0
70327,35,0,0
70328,),0,0
70329,received,0,0
70330,2.5,0,0
70331,ml,0,0
70332,0.75,0,0
70333,%,0,0
70334,ropivacaine,1,1
70335,and,0,0
70336,group,0,1
70337,B,0,1
70338,(,0,0
70339,n,0,0
70340,=,0,0
70341,35,0,0
70342,),0,0
70343,received,0,0
70344,2.5,0,1
70345,ml,0,0
70346,of,0,0
70347,2,0,0
70348,%,0,0
70349,lidocaine,1,1
70350,for,0,0
70351,digital,0,1
70352,anesthesia,0,1
70353,.,0,0
70354,Onset,0,0
70355,time,0,0
70356,of,0,0
70357,anesthetic,0,1
70358,action,0,0
70359,",",0,0
70360,duration,0,0
70361,of,0,0
70362,anesthesia,0,1
70363,",",0,0
70364,time,0,0
70365,until,0,0
70366,first,0,0
70367,postoperative,0,0
70368,requirement,0,0
70369,for,0,0
70370,pain,0,0
70371,medication,0,1
70372,",",0,0
70373,and,0,0
70374,digital-brachial,0,1
70375,artery,0,0
70376,systolic,0,0
70377,blood,0,0
70378,pressure,0,0
70379,index,0,0
70380,were,0,0
70381,recorded,0,0
70382,and,0,0
70383,evaluated,0,0
70384,.,0,0
70385,Local,0,0
70386,vascular,0,0
70387,effects,0,0
70388,were,0,0
70389,observed,0,0
70390,visually,0,0
70391,.,0,0
70392,RESULTS,0,0
70393,No,0,0
70394,side,0,0
70395,effects,0,0
70396,were,0,0
70397,observed,0,0
70398,.,0,0
70399,Lidocaine,1,1
70400,had,0,0
70401,the,0,0
70402,quickest,0,0
70403,onset,0,0
70404,of,0,0
70405,anesthesia,0,1
70406,",",0,0
70407,with,0,0
70408,a,0,0
70409,mean,0,0
70410,time,0,0
70411,of,0,0
70412,1.3,0,0
70413,minutes,0,0
70414,(,0,0
70415,range,0,0
70416,",",0,0
70417,1,0,0
70418,to,0,0
70419,2.7,0,0
70420,minutes,0,0
70421,),0,0
70422,.,0,0
70423,Ropivacaine,1,1
70424,had,0,0
70425,a,0,0
70426,mean,0,0
70427,onset,0,0
70428,time,0,0
70429,of,0,0
70430,4.5,0,0
70431,minutes,0,0
70432,(,0,0
70433,range,0,0
70434,",",0,0
70435,3.5,0,0
70436,to,0,0
70437,5.5,0,0
70438,minutes,0,0
70439,),0,0
70440,.,0,0
70441,The,0,0
70442,mean,0,0
70443,duration,0,0
70444,of,0,0
70445,postoperative,0,0
70446,anesthesia,0,1
70447,for,0,0
70448,lidocaine,1,1
70449,was,0,0
70450,2.4,0,0
70451,hours,0,0
70452,(,0,0
70453,range,0,0
70454,",",0,0
70455,1.4,0,0
70456,to,0,0
70457,4,0,0
70458,hours,0,0
70459,),0,0
70460,",",0,0
70461,compared,0,0
70462,with,0,0
70463,21.5,0,0
70464,hours,0,0
70465,for,0,0
70466,ropivacaine,1,1
70467,and,0,0
70468,less,0,0
70469,requirement,0,0
70470,for,0,0
70471,analgesics,0,0
70472,during,0,0
70473,the,0,0
70474,first,0,0
70475,24,0,0
70476,postoperative,0,0
70477,hours,0,0
70478,(,0,0
70479,p,0,0
70480,<,0,0
70481,0.05,0,0
70482,),0,0
70483,(,0,0
70484,range,0,0
70485,",",0,0
70486,19,0,0
70487,to,0,0
70488,23,0,0
70489,hours,0,0
70490,),0,0
70491,.,0,0
70492,No,0,0
70493,significant,0,0
70494,difference,0,0
70495,was,0,0
70496,found,0,0
70497,between,0,0
70498,the,0,0
70499,digital-brachial,0,1
70500,artery,0,0
70501,systolic,0,0
70502,blood,0,0
70503,pressure,0,0
70504,index,0,0
70505,of,0,0
70506,group,0,0
70507,A,0,0
70508,compared,0,0
70509,with,0,0
70510,group,0,0
70511,B,0,0
70512,.,0,0
70513,CONCLUSIONS,0,0
70514,Ropivacaine,1,1
70515,can,0,0
70516,be,0,0
70517,used,0,0
70518,effectively,0,0
70519,as,0,0
70520,a,0,0
70521,local,0,1
70522,anesthetic,0,1
70523,for,0,0
70524,digital,0,1
70525,nerve,0,0
70526,blocks,0,1
70527,.,0,0
70528,It,0,0
70529,can,0,0
70530,be,0,0
70531,used,0,0
70532,for,0,0
70533,prolonged,0,0
70534,operations,0,0
70535,(,0,0
70536,>,0,0
70537,1.5,0,0
70538,hours,0,0
70539,),0,0
70540,without,0,0
70541,additional,0,0
70542,injections,0,1
70543,and,0,0
70544,can,0,0
70545,provide,0,0
70546,long-lasting,0,0
70547,postoperative,0,0
70548,analgesia,0,0
70549,.,0,0
70550,Using,0,0
70551,the,0,0
70552,demand-control,1,1
70553,model,1,0
70554,of,1,0
70555,job,1,0
70556,strain,1,0
70557,to,0,0
70558,predict,0,0
70559,caregiver,0,1
70560,burden,0,0
70561,and,0,0
70562,caregiver,0,1
70563,satisfaction,0,0
70564,in,0,0
70565,the,0,0
70566,informal,0,1
70567,caregivers,0,0
70568,of,0,0
70569,heart,0,0
70570,failure,0,0
70571,patients,0,0
70572,.,0,0
70573,OBJECTIVES,0,0
70574,The,1,0
70575,demand-control,1,1
70576,(,1,1
70577,D-C,1,1
70578,),1,1
70579,model,1,0
70580,of,1,0
70581,job,1,0
70582,strain,1,0
70583,has,0,0
70584,generated,0,0
70585,a,0,0
70586,considerable,0,0
70587,body,0,0
70588,of,0,0
70589,empirical,0,0
70590,support,0,0
70591,in,0,0
70592,predicting,0,0
70593,psychological,0,0
70594,health,0,0
70595,outcomes,0,0
70596,in,0,0
70597,the,0,0
70598,context,0,0
70599,of,0,0
70600,work,0,0
70601,.,0,0
70602,This,0,0
70603,study,0,0
70604,aimed,0,0
70605,to,0,0
70606,extend,0,0
70607,previous,0,0
70608,work,0,0
70609,using,0,0
70610,the,0,0
70611,D-C,1,1
70612,model,1,0
70613,of,1,0
70614,job,1,0
70615,strain,1,0
70616,to,0,0
70617,predict,0,0
70618,caregiver,0,1
70619,burden,0,0
70620,and,0,0
70621,satisfaction,0,0
70622,in,0,0
70623,the,0,0
70624,informal,0,1
70625,caregivers,0,0
70626,of,0,0
70627,patients,0,0
70628,with,0,0
70629,heart,0,0
70630,failure,0,0
70631,.,0,0
70632,DESIGN,0,0
70633,AND,0,0
70634,METHOD,0,1
70635,Data,0,0
70636,were,0,0
70637,gathered,0,0
70638,from,0,0
70639,60,0,0
70640,caregiver/patient,0,0
70641,dyads,0,0
70642,in,0,0
70643,a,0,0
70644,cross-sectional,0,0
70645,design,0,0
70646,.,0,0
70647,Patients,0,0
70648,with,0,0
70649,chronic,0,0
70650,stable,0,0
70651,heart,0,0
70652,failure,0,0
70653,were,0,0
70654,recruited,0,0
70655,from,0,0
70656,out-patient,0,0
70657,clinics,0,0
70658,.,0,0
70659,The,0,0
70660,dependent,0,0
70661,variables,0,0
70662,were,0,0
70663,caregiver,1,0
70664,burden,1,0
70665,and,1,0
70666,satisfaction,1,0
70667,.,1,1
70668,Demand,0,1
70669,and,0,0
70670,control,0,1
70671,were,0,0
70672,measured,0,0
70673,using,0,0
70674,both,0,0
70675,patient-,0,0
70676,and,0,0
70677,caregiver-derived,0,0
70678,measures,0,0
70679,.,0,0
70680,RESULTS,0,0
70681,The,0,0
70682,D-C,1,1
70683,model,1,0
70684,accounted,0,0
70685,for,0,0
70686,15,0,0
70687,and,0,0
70688,19,0,0
70689,%,0,0
70690,of,0,0
70691,the,0,0
70692,variance,0,0
70693,in,0,0
70694,caregiver,0,0
70695,burden,0,0
70696,",",0,0
70697,after,0,0
70698,controlling,0,0
70699,for,0,0
70700,age,0,0
70701,",",0,0
70702,gender,0,0
70703,and,0,0
70704,relationship,0,0
70705,to,0,0
70706,the,0,0
70707,patient,0,0
70708,.,0,0
70709,Lower,0,0
70710,control,0,0
70711,was,0,0
70712,associated,0,0
70713,with,0,0
70714,higher,0,0
70715,burden,0,0
70716,.,0,0
70717,The,0,0
70718,D-C,1,0
70719,model,1,0
70720,did,0,0
70721,not,0,0
70722,predict,0,0
70723,caregiver,0,0
70724,satisfaction,0,0
70725,.,0,0
70726,CONCLUSION,0,0
70727,The,0,0
70728,D-C,1,1
70729,model,1,0
70730,was,0,0
70731,associated,0,0
70732,with,0,0
70733,caregiver,0,0
70734,burden,0,0
70735,",",0,0
70736,but,0,0
70737,not,0,0
70738,satisfaction,0,0
70739,in,0,0
70740,caregivers,0,0
70741,",",0,0
70742,with,0,0
70743,control,0,0
70744,being,0,0
70745,the,0,0
70746,dominant,0,0
70747,predictor,0,0
70748,.,0,0
70749,Research,0,0
70750,linking,0,0
70751,the,0,0
70752,theory,0,1
70753,and,0,0
70754,findings,0,0
70755,from,0,0
70756,job,0,0
70757,strain,0,0
70758,and,0,0
70759,informal,0,1
70760,caregiving,0,0
70761,studies,0,0
70762,may,0,0
70763,elucidate,0,0
70764,both,0,0
70765,fields,0,1
70766,of,0,0
70767,research,0,0
70768,.,0,0
70769,Using,0,0
70770,the,0,0
70771,demand-control,1,1
70772,model,1,0
70773,of,1,0
70774,job,1,0
70775,strain,1,0
70776,to,0,0
70777,predict,0,0
70778,caregiver,0,1
70779,burden,0,0
70780,and,0,0
70781,caregiver,0,1
70782,satisfaction,0,0
70783,in,0,0
70784,the,0,0
70785,informal,0,1
70786,caregivers,0,0
70787,of,0,0
70788,heart,0,0
70789,failure,0,0
70790,patients,0,0
70791,.,0,0
70792,Long-term,0,0
70793,growth,0,1
70794,hormone,0,1
70795,treatment,0,0
70796,in,0,0
70797,growth,0,0
70798,hormone,0,1
70799,deficient,0,0
70800,adults,0,0
70801,.,0,0
70802,Growth,1,0
70803,hormone,1,1
70804,treatment,1,0
70805,in,0,0
70806,GH-deficient,0,1
70807,adults,0,0
70808,has,0,0
70809,proved,0,0
70810,beneficial,0,0
70811,in,0,0
70812,recent,0,0
70813,short-term,0,0
70814,trials,0,0
70815,",",0,0
70816,but,0,0
70817,long-term,0,0
70818,results,0,0
70819,have,0,0
70820,not,0,0
70821,yet,0,0
70822,been,0,0
70823,reported,0,0
70824,.,0,0
70825,Thirteen,0,0
70826,GH-deficient,0,1
70827,adults,0,0
70828,(,0,0
70829,4,0,0
70830,females,0,0
70831,",",0,0
70832,9,0,0
70833,males,0,0
70834,;,0,0
70835,mean,0,0
70836,(,0,0
70837,SEM,0,1
70838,),0,1
70839,age,0,0
70840,26.4,0,0
70841,(,0,0
70842,1.7,0,0
70843,),0,0
70844,years,0,0
70845,),0,0
70846,",",0,0
70847,who,0,0
70848,had,0,0
70849,completed,0,0
70850,4,0,0
70851,months,0,0
70852,of,0,0
70853,GH,1,1
70854,therapy,1,1
70855,in,0,0
70856,a,0,0
70857,double-blind,0,0
70858,placebo-controlled,1,1
70859,cross-over,0,0
70860,study,0,0
70861,were,0,0
70862,followed,0,0
70863,",",0,0
70864,for,0,0
70865,further,0,0
70866,16.1,0,0
70867,(,0,0
70868,0.8,0,0
70869,),0,0
70870,months,0,0
70871,of,0,0
70872,uninterrupted,0,1
70873,GH,1,1
70874,therapy,1,1
70875,in,0,0
70876,an,0,0
70877,open,0,1
70878,design,0,0
70879,.,0,0
70880,A,0,0
70881,significant,0,0
70882,mean,0,0
70883,increase,0,0
70884,of,0,0
70885,1.3,0,0
70886,cm,0,0
70887,in,0,0
70888,linear,0,0
70889,height,0,0
70890,was,0,0
70891,recorded,0,0
70892,",",0,0
70893,whereas,0,0
70894,body,0,0
70895,mass,0,0
70896,index,0,0
70897,remained,0,0
70898,unchanged,0,0
70899,.,0,0
70900,Mean,0,0
70901,muscle,0,0
70902,volume,0,0
70903,of,0,0
70904,the,0,0
70905,thigh,0,0
70906,",",0,0
70907,estimated,0,0
70908,by,0,0
70909,computerised,0,1
70910,tomography,0,1
70911,",",0,0
70912,increased,0,0
70913,significantly,0,0
70914,compared,0,0
70915,with,0,0
70916,that,0,0
70917,of,0,0
70918,the,0,0
70919,initial,0,0
70920,placebo,1,1
70921,period,0,0
70922,(,0,0
70923,p,0,0
70924,=,0,0
70925,0.01,0,0
70926,),0,0
70927,",",0,0
70928,and,0,0
70929,a,0,0
70930,slight,0,0
70931,decrease,0,0
70932,was,0,0
70933,recorded,0,0
70934,in,0,0
70935,adipose,0,1
70936,tissue,0,0
70937,volume,0,0
70938,of,0,0
70939,the,0,0
70940,thigh,0,0
70941,(,0,0
70942,p,0,0
70943,=,0,0
70944,0.10,0,0
70945,),0,0
70946,and,0,0
70947,subscapular,0,0
70948,skinfold,0,0
70949,thickness,0,0
70950,(,0,0
70951,p,0,0
70952,=,0,0
70953,0.10,0,0
70954,),0,0
70955,.,0,0
70956,Still,0,0
70957,",",0,0
70958,the,0,0
70959,muscle,0,0
70960,to,0,0
70961,fat,0,0
70962,ratio,0,0
70963,of,0,0
70964,the,0,0
70965,thigh,0,0
70966,was,0,0
70967,significantly,0,0
70968,lower,0,0
70969,compared,0,0
70970,with,0,0
70971,that,0,0
70972,of,0,0
70973,normal,0,0
70974,subjects,0,0
70975,(,0,0
70976,72.6/27.4,0,0
70977,vs,0,0
70978,77.9/22.1,0,0
70979,),0,0
70980,(,0,0
70981,p,0,0
70982,less,0,0
70983,than,0,0
70984,0.01,0,0
70985,),0,0
70986,.,0,0
70987,The,0,0
70988,mean,0,0
70989,isometric,0,0
70990,strength,0,0
70991,of,0,0
70992,the,0,0
70993,quadriceps,0,0
70994,muscles,0,1
70995,increased,0,0
70996,significantly,0,0
70997,during,0,0
70998,long-term,0,0
70999,GH,0,1
71000,therapy,0,1
71001,(,0,0
71002,p,0,0
71003,less,0,0
71004,than,0,0
71005,0.01,0,0
71006,),0,0
71007,",",0,0
71008,but,0,0
71009,remained,0,0
71010,lower,0,0
71011,compared,0,0
71012,with,0,0
71013,that,0,0
71014,of,0,0
71015,normal,0,0
71016,subjects,0,0
71017,(,0,0
71018,1.66,0,0
71019,(,0,0
71020,0.10,0,0
71021,),0,0
71022,vs,0,0
71023,2.13,0,0
71024,(,0,0
71025,0.11,0,0
71026,),0,0
71027,Nm/kg,0,1
71028,body,0,0
71029,weight,0,0
71030,),0,0
71031,.,0,0
71032,Exercise,0,1
71033,capacity,0,0
71034,performed,0,0
71035,on,0,0
71036,a,0,0
71037,bicycle,0,1
71038,ergometer,0,1
71039,increased,0,0
71040,significantly,0,0
71041,after,0,0
71042,long-term,0,0
71043,therapy,0,1
71044,(,0,0
71045,p,0,0
71046,less,0,0
71047,than,0,0
71048,0.05,0,0
71049,),0,0
71050,",",0,0
71051,but,0,0
71052,still,0,0
71053,did,0,0
71054,not,0,0
71055,reach,0,0
71056,the,0,0
71057,values,0,0
71058,seen,0,0
71059,in,0,0
71060,normal,0,0
71061,subjects,0,0
71062,(,0,0
71063,22.5,0,0
71064,(,0,0
71065,3.4,0,0
71066,),0,0
71067,vs,0,0
71068,37.4,0,0
71069,(,0,0
71070,4.2,0,0
71071,),0,0
71072,watt.min.kg-1,0,1
71073,.,0,0
71074,No,0,0
71075,adverse,0,0
71076,reactions,0,0
71077,were,0,0
71078,recorded,0,0
71079,during,0,0
71080,long-term,0,0
71081,therapy,0,1
71082,and,0,0
71083,hemoglobin,0,0
71084,A1c,0,1
71085,remained,0,0
71086,unchanged,0,0
71087,.,0,0
71088,These,0,0
71089,data,0,0
71090,suggest,0,0
71091,that,0,0
71092,long-term,0,0
71093,GH,0,1
71094,replacement,0,1
71095,therapy,0,1
71096,in,0,0
71097,GH-deficient,0,1
71098,adults,0,0
71099,has,0,0
71100,beneficial,0,0
71101,effects,0,0
71102,on,0,0
71103,several,0,0
71104,physiological,0,0
71105,features,0,0
71106,which,0,0
71107,are,0,0
71108,subnormal,0,0
71109,in,0,0
71110,these,0,0
71111,patients,0,0
71112,.,0,0
71113,[,0,1
71114,Intravenous,0,1
71115,treatment,0,1
71116,of,0,0
71117,postpartum,0,0
71118,anemia,0,0
71119,with,0,0
71120,trivalent,1,1
71121,ferrum,1,1
71122,preparation,1,1
71123,],1,0
71124,.,0,0
71125,AIM,0,0
71126,OF,0,1
71127,THE,0,0
71128,STUDY,0,0
71129,To,0,0
71130,assess,0,0
71131,the,0,0
71132,effectivity,0,0
71133,and,0,0
71134,safeness,0,0
71135,of,0,0
71136,intravenous,0,1
71137,treatment,0,0
71138,of,0,0
71139,pospartal,0,0
71140,anemia,0,0
71141,with,0,0
71142,trivalent,1,1
71143,ferrum,1,1
71144,preparation,1,1
71145,.,1,0
71146,TYPE,0,0
71147,OF,0,1
71148,THE,0,0
71149,STUDY,0,0
71150,Prospective,0,0
71151,randomized,0,0
71152,study,0,0
71153,.,0,0
71154,SETTING,0,0
71155,Department,0,0
71156,of,0,0
71157,Obstetric,0,1
71158,and,0,0
71159,Gynecology,0,0
71160,2nd,0,0
71161,Medical,0,1
71162,Faculty,0,0
71163,Charles,0,1
71164,University,0,0
71165,and,0,0
71166,Teaching,0,1
71167,Hospital,0,0
71168,Motol,0,1
71169,",",0,0
71170,Prague,0,0
71171,",",0,0
71172,and,0,0
71173,Department,0,1
71174,of,0,0
71175,Obstetric,0,1
71176,and,0,0
71177,Gynecology,0,0
71178,1st,0,0
71179,Medical,0,1
71180,Faculty,0,0
71181,and,0,0
71182,Teaching,0,1
71183,Hospital,0,0
71184,Bulovka,0,1
71185,",",0,0
71186,Prague,0,0
71187,.,0,0
71188,METHODS,0,0
71189,500,1,0
71190,mg,1,1
71191,of,1,0
71192,sacharose,1,1
71193,ferric,1,1
71194,oxide,1,1
71195,(,1,1
71196,Venofer,1,1
71197,),1,1
71198,was,0,0
71199,intravenously,0,1
71200,administered,0,0
71201,in,0,0
71202,two,0,0
71203,days,0,0
71204,regimen,0,1
71205,to,0,0
71206,50,0,0
71207,women,0,0
71208,with,0,0
71209,clinical,0,0
71210,and,0,0
71211,lab,0,0
71212,signs,0,0
71213,of,0,0
71214,postpartal,0,0
71215,anemia,0,0
71216,.,0,0
71217,The,0,0
71218,effect,0,0
71219,of,0,0
71220,administered,0,0
71221,drug,0,1
71222,was,0,0
71223,determined,0,0
71224,by,0,0
71225,comparsion,0,0
71226,of,0,0
71227,values,0,0
71228,of,0,0
71229,red,0,0
71230,blood,0,0
71231,count,0,0
71232,recovered,0,0
71233,before,0,0
71234,the,0,0
71235,treatment,0,0
71236,",",0,0
71237,2nd,0,0
71238,or,0,0
71239,3rd,0,0
71240,day,0,1
71241,post,0,0
71242,administration,0,0
71243,and,0,0
71244,two,0,0
71245,weeks,0,0
71246,later,0,0
71247,.,0,0
71248,The,0,0
71249,serum,0,0
71250,values,0,0
71251,of,0,0
71252,soluble,0,1
71253,transferrin,0,0
71254,receptors,0,0
71255,and,0,0
71256,ferritin,0,1
71257,were,0,0
71258,observed,0,0
71259,as,0,0
71260,markers,0,0
71261,of,0,0
71262,iron,0,1
71263,cell,0,0
71264,saturation,0,0
71265,and,0,0
71266,body,0,0
71267,iron,0,1
71268,reserves,0,0
71269,",",0,0
71270,too,0,0
71271,.,0,0
71272,Integral,0,1
71273,part,0,0
71274,of,0,0
71275,the,0,0
71276,study,0,0
71277,was,0,0
71278,the,0,0
71279,monitoring,0,0
71280,of,0,0
71281,adverse,0,0
71282,events,0,0
71283,during,0,0
71284,the,0,0
71285,treatment,0,0
71286,.,0,0
71287,RESULTS,0,0
71288,Venofer,1,1
71289,came,0,0
71290,in,0,0
71291,sight,0,0
71292,as,0,0
71293,effective,0,0
71294,drug,0,1
71295,in,0,0
71296,the,0,0
71297,treatment,0,0
71298,of,0,0
71299,pospartal,0,0
71300,anemia,0,0
71301,and,0,0
71302,could,0,0
71303,become,0,0
71304,as,0,0
71305,the,0,0
71306,alternative,0,0
71307,to,0,0
71308,blood,0,0
71309,transfusion,0,1
71310,in,0,0
71311,mid-severe,0,0
71312,cases,0,0
71313,.,0,0
71314,It,0,0
71315,should,0,0
71316,be,0,0
71317,emphasized,0,0
71318,that,0,0
71319,we,0,0
71320,have,0,0
71321,not,0,0
71322,encountered,0,0
71323,any,0,0
71324,serious,0,0
71325,adverse,0,0
71326,event,0,0
71327,with,0,0
71328,intravenous,0,1
71329,trivalent,1,1
71330,saccharose,1,1
71331,ferric,1,1
71332,oxide,1,0
71333,treatment,1,0
71334,.,1,0
71335,Efficacy,0,0
71336,and,0,0
71337,safety,0,0
71338,of,0,0
71339,sildenafil,1,1
71340,in,0,0
71341,Asian,0,0
71342,males,0,0
71343,with,0,0
71344,erectile,0,0
71345,dysfunction,0,0
71346,and,0,0
71347,cardiovascular,0,0
71348,risk,0,0
71349,.,0,0
71350,OBJECTIVE,0,0
71351,Assess,0,0
71352,the,0,0
71353,effectiveness,0,0
71354,of,0,0
71355,sildenafil,1,1
71356,in,0,0
71357,Asian,0,0
71358,males,0,0
71359,with,0,0
71360,erectile,0,0
71361,dysfunction,0,0
71362,(,0,1
71363,ED,0,1
71364,),0,1
71365,and,0,0
71366,one,0,0
71367,or,0,0
71368,more,0,0
71369,of,0,0
71370,the,0,0
71371,co-morbidities,0,0
71372,",",0,0
71373,mild-to-moderate,0,0
71374,hypertension,0,0
71375,",",0,0
71376,dyslipidemia,0,0
71377,",",0,0
71378,and,0,0
71379,diabetes,0,0
71380,.,0,0
71381,MATERIAL,0,0
71382,AND,0,0
71383,METHOD,0,1
71384,A,0,0
71385,six-week,0,1
71386,",",0,0
71387,double-blind,0,0
71388,",",0,0
71389,randomized,0,0
71390,",",0,0
71391,placebo-controlled,1,1
71392,",",0,0
71393,multicenter,0,0
71394,study,0,0
71395,was,0,0
71396,carried,0,0
71397,out,0,0
71398,in,0,0
71399,Thailand,0,0
71400,",",0,0
71401,Malaysia,0,0
71402,and,0,0
71403,Singapore,0,0
71404,.,0,0
71405,One,0,0
71406,hundred,0,0
71407,and,0,0
71408,fifty,0,0
71409,five,0,0
71410,male,0,0
71411,subjects,0,0
71412,were,0,0
71413,randomized,0,0
71414,(,0,0
71415,2:1,0,0
71416,),0,0
71417,to,0,0
71418,sildenafil,1,1
71419,(,0,0
71420,n,0,0
71421,=,0,0
71422,104,0,0
71423,),0,0
71424,or,0,1
71425,placebo,1,1
71426,(,0,1
71427,n,0,0
71428,=,0,0
71429,51,0,0
71430,),0,0
71431,.,0,0
71432,Sildenafil,1,1
71433,was,0,0
71434,started,0,0
71435,at,0,0
71436,50,0,1
71437,mg,0,1
71438,and,0,0
71439,increased,0,0
71440,(,0,0
71441,100,0,1
71442,mg,0,1
71443,),0,0
71444,or,0,1
71445,decreased,0,0
71446,(,0,0
71447,25,0,1
71448,mg,0,1
71449,),0,0
71450,at,0,0
71451,week,0,0
71452,2,0,0
71453,if,0,0
71454,necessary,0,0
71455,.,0,0
71456,RESULTS,0,0
71457,On,0,0
71458,the,0,0
71459,primary,0,0
71460,efficacy,0,0
71461,endpoint,0,0
71462,",",0,0
71463,sildenafil-treated,1,0
71464,subjects,0,0
71465,had,0,0
71466,significantly,0,0
71467,better,0,0
71468,scores,0,0
71469,on,0,0
71470,the,0,0
71471,International,0,0
71472,Index,0,1
71473,of,0,0
71474,Erectile,0,0
71475,Function,0,0
71476,(,0,1
71477,IIEF,0,1
71478,),0,1
71479,questions,0,0
71480,3,0,0
71481,and,0,0
71482,4,0,0
71483,than,0,0
71484,placebo,0,1
71485,(,0,0
71486,p,0,0
71487,<,0,0
71488,0.001,0,0
71489,",",0,0
71490,both,0,0
71491,questions,0,0
71492,),0,0
71493,.,0,0
71494,When,0,0
71495,accumulated,0,0
71496,into,0,0
71497,IIEF,0,0
71498,domains,0,0
71499,",",0,0
71500,all,0,0
71501,five,0,0
71502,domains,0,0
71503,were,0,0
71504,significant,0,0
71505,in,0,0
71506,favor,0,0
71507,of,0,0
71508,sildenafil,0,1
71509,.,0,0
71510,In,0,0
71511,addition,0,0
71512,",",0,0
71513,sildenafil-treated,1,0
71514,subjects,0,0
71515,were,0,0
71516,more,0,0
71517,satisfied,0,0
71518,with,0,0
71519,treatment,0,0
71520,and,0,0
71521,had,0,0
71522,a,0,0
71523,higher,0,0
71524,intercourse,0,0
71525,success,0,0
71526,rate,0,0
71527,.,0,0
71528,The,0,0
71529,majority,0,0
71530,of,0,0
71531,adverse,0,0
71532,events,0,0
71533,were,0,0
71534,mild,0,0
71535,in,0,0
71536,severity,0,0
71537,;,0,0
71538,the,0,0
71539,most,0,0
71540,commonly,0,0
71541,reported,0,0
71542,treatment-related,0,0
71543,events,0,0
71544,were,0,0
71545,dizziness,0,0
71546,(,0,0
71547,7.7,0,0
71548,%,0,0
71549,),0,1
71550,and,0,1
71551,tinnitus,0,1
71552,(,0,1
71553,2.9,0,0
71554,%,0,0
71555,),0,0
71556,.,0,0
71557,CONCLUSION,0,0
71558,Sildenafil,0,1
71559,(,0,0
71560,25,0,0
71561,",",0,0
71562,50,0,0
71563,",",0,0
71564,and,0,0
71565,100,0,1
71566,mg,0,1
71567,),0,0
71568,was,0,0
71569,found,0,0
71570,to,0,0
71571,be,0,0
71572,an,0,0
71573,effective,0,0
71574,",",0,0
71575,safe,0,0
71576,",",0,0
71577,and,0,0
71578,well-tolerated,0,0
71579,treatment,0,0
71580,for,0,0
71581,ED,0,1
71582,in,0,0
71583,the,0,0
71584,present,0,0
71585,study,0,0
71586,population,0,0
71587,of,0,0
71588,Thai,0,0
71589,",",0,0
71590,Malaysian,0,0
71591,",",0,0
71592,and,0,0
71593,Singaporean,0,0
71594,males,0,0
71595,who,0,0
71596,also,0,0
71597,had,0,0
71598,increased,0,0
71599,cardiovascular,0,0
71600,risk,0,0
71601,A,0,0
71602,pilot,0,0
71603,study,0,0
71604,of,0,0
71605,extended,0,1
71606,duration,0,0
71607,peginterferon,1,1
71608,alfa-2a,1,1
71609,for,0,0
71610,patients,0,0
71611,with,0,0
71612,hepatitis,0,0
71613,B,0,1
71614,e,0,0
71615,antigen-negative,0,0
71616,chronic,0,0
71617,hepatitis,0,0
71618,B,0,0
71619,.,0,0
71620,OBJECTIVES,0,0
71621,Forty-eight,0,0
71622,weeks,0,0
71623,of,0,0
71624,peginterferon,1,1
71625,alfa-2a,1,1
71626,is,0,0
71627,the,0,0
71628,approved,0,0
71629,regimen,0,1
71630,for,0,0
71631,chronic,0,0
71632,hepatitis,0,1
71633,B,0,1
71634,(,0,1
71635,CHB,0,1
71636,),0,0
71637,.,0,0
71638,Standard,0,1
71639,interferon,0,1
71640,is,0,0
71641,more,0,0
71642,effective,0,0
71643,for,0,0
71644,hepatitis,0,1
71645,B,0,1
71646,e,0,1
71647,antigen,0,0
71648,(,0,1
71649,HBeAg,0,0
71650,),0,1
71651,-negative,0,0
71652,CHB,0,0
71653,when,0,0
71654,given,0,0
71655,for,0,0
71656,longer,0,0
71657,than,0,0
71658,1,0,0
71659,yr,0,0
71660,.,0,0
71661,This,0,0
71662,study,0,0
71663,evaluated,0,0
71664,peginterferon,1,1
71665,alfa-2a,1,1
71666,for,0,0
71667,60,0,0
71668,wk,0,0
71669,",",0,0
71670,alone,0,1
71671,or,0,1
71672,in,0,0
71673,combination,0,1
71674,with,0,0
71675,lamivudine,0,1
71676,.,0,0
71677,METHODS,0,0
71678,Thirteen,0,0
71679,patients,0,0
71680,with,0,0
71681,HBeAg-negative,0,0
71682,CHB,0,0
71683,received,0,1
71684,peginterferon,1,1
71685,alfa-2a,1,1
71686,(,0,0
71687,180,0,0
71688,microg/week,0,0
71689,),0,0
71690,for,0,0
71691,60,0,0
71692,wk,0,0
71693,or,0,1
71694,peginterferon,1,1
71695,alfa-2a,1,1
71696,(,0,0
71697,180,0,0
71698,microg/week,0,0
71699,),0,0
71700,for,0,0
71701,12,0,0
71702,wk,0,0
71703,followed,0,1
71704,by,0,0
71705,48,0,0
71706,wk,0,0
71707,of,0,0
71708,peginterferon,1,1
71709,alfa-2a,1,1
71710,plus,1,1
71711,lamivudine,1,1
71712,.,1,0
71713,The,0,0
71714,primary,0,0
71715,end,0,0
71716,point,0,0
71717,",",0,0
71718,sustained,0,0
71719,virologic,0,0
71720,response,0,0
71721,(,0,1
71722,SVR,0,1
71723,),0,0
71724,",",0,0
71725,was,0,0
71726,defined,0,0
71727,as,0,0
71728,a,0,0
71729,reduction,0,0
71730,in,0,0
71731,hepatitis,0,1
71732,B,0,1
71733,virus,0,1
71734,deoxyribonucleic,0,1
71735,acid,0,1
71736,(,0,0
71737,HBV,0,1
71738,DNA,0,1
71739,),0,0
71740,of,0,0
71741,>,0,0
71742,or=2,0,0
71743,log10,0,0
71744,copies/mL,0,0
71745,and,0,0
71746,HBV,0,1
71747,DNA,0,0
71748,<,0,0
71749,"20,000",0,0
71750,copies/mL,0,0
71751,at,0,0
71752,24,0,0
71753,wk,0,0
71754,of,0,0
71755,follow-up,0,0
71756,(,0,0
71757,week,0,0
71758,84,0,0
71759,),0,0
71760,.,0,0
71761,Hepatitis,0,0
71762,B,0,0
71763,surface,0,1
71764,antigen,0,0
71765,(,0,1
71766,HBsAg,0,1
71767,),0,1
71768,concentrations,0,0
71769,were,0,0
71770,analyzed,0,0
71771,and,0,0
71772,compared,0,0
71773,to,0,0
71774,changes,0,0
71775,in,0,0
71776,HBV,0,1
71777,DNA,0,0
71778,.,0,0
71779,RESULTS,0,0
71780,SVR,0,1
71781,was,0,0
71782,achieved,0,0
71783,by,0,0
71784,9/13,0,0
71785,patients,0,0
71786,(,0,0
71787,69,0,0
71788,%,0,0
71789,),0,0
71790,.,0,0
71791,At,0,0
71792,week,0,0
71793,84,0,0
71794,",",0,0
71795,HBV,0,1
71796,DNA,0,0
71797,was,0,0
71798,undetectable,0,0
71799,by,0,0
71800,polymerase,0,0
71801,chain,0,1
71802,reaction,0,1
71803,in,0,0
71804,5/13,0,0
71805,(,0,0
71806,38,0,0
71807,%,0,0
71808,),0,0
71809,patients,0,0
71810,",",0,0
71811,and,0,0
71812,3,0,0
71813,additional,0,0
71814,patients,0,0
71815,had,0,0
71816,a,0,0
71817,sustained,0,0
71818,2-3,0,0
71819,log,0,0
71820,reduction,0,0
71821,in,0,0
71822,HBV,0,1
71823,DNA,0,0
71824,.,0,0
71825,Five,0,0
71826,patients,0,0
71827,demonstrated,0,0
71828,a,0,0
71829,>,0,0
71830,90,0,0
71831,%,0,0
71832,decrease,0,0
71833,in,0,0
71834,HBsAg,0,1
71835,concentration,0,0
71836,at,0,0
71837,week,0,0
71838,60,0,0
71839,",",0,0
71840,including,0,0
71841,3,0,0
71842,with,0,0
71843,undetectable,0,0
71844,HBV,0,1
71845,DNA,0,0
71846,at,0,0
71847,week,0,0
71848,84,0,0
71849,and,0,0
71850,a,0,0
71851,fourth,0,0
71852,who,0,0
71853,met,0,0
71854,criteria,0,0
71855,for,0,0
71856,SVR,0,1
71857,.,0,0
71858,CONCLUSIONS,0,0
71859,Sixty,0,0
71860,weeks,0,0
71861,of,0,0
71862,peginterferon,1,1
71863,alfa-2a,1,1
71864,with,0,0
71865,or,0,1
71866,without,0,0
71867,lamivudine,0,1
71868,resulted,0,0
71869,in,0,0
71870,a,0,0
71871,higher,0,0
71872,rate,0,0
71873,of,0,0
71874,SVR,0,1
71875,compared,0,0
71876,to,0,0
71877,historical,0,0
71878,controls,0,0
71879,with,0,0
71880,HBeAg-negative,0,0
71881,CHB,0,0
71882,treated,0,0
71883,with,0,0
71884,48,0,0
71885,wk,0,0
71886,of,0,0
71887,pegylated,1,1
71888,interferon,1,1
71889,.,1,0
71890,Larger,0,0
71891,studies,0,0
71892,are,0,0
71893,necessary,0,0
71894,to,0,0
71895,assess,0,0
71896,if,0,0
71897,longer,0,0
71898,duration,0,0
71899,therapy,0,1
71900,is,0,0
71901,more,0,0
71902,effective,0,0
71903,than,0,0
71904,the,0,0
71905,standard,0,1
71906,regimen,0,1
71907,and,0,0
71908,results,0,0
71909,in,0,0
71910,a,0,0
71911,greater,0,0
71912,decline,0,0
71913,in,0,0
71914,HBsAg,0,1
71915,concentration,0,0
71916,.,0,0
71917,[,0,0
71918,Application,0,1
71919,of,0,0
71920,tacrolimus,1,1
71921,and,1,0
71922,cyclosporine,1,1
71923,A,1,0
71924,in,0,0
71925,HBV-carrying,0,1
71926,renal,0,0
71927,transplant,0,0
71928,recipients,0,0
71929,],0,0
71930,.,0,0
71931,OBJECTIVE,0,0
71932,To,0,0
71933,compare,0,0
71934,the,0,0
71935,long-term,0,0
71936,effect,0,0
71937,and,0,0
71938,safety,0,0
71939,of,0,0
71940,tacrolimus,1,1
71941,(,1,1
71942,FK506,1,1
71943,),1,1
71944,and,1,1
71945,cyclosporine,1,1
71946,(,1,1
71947,CsA,1,1
71948,),1,1
71949,in,0,0
71950,kidney,0,1
71951,transplant,0,1
71952,(,0,1
71953,KT,0,1
71954,),0,1
71955,recipients,0,0
71956,carrying,0,0
71957,hepatitis,0,0
71958,B,0,1
71959,Virus,0,0
71960,(,0,1
71961,HBV,0,1
71962,),0,1
71963,.,0,0
71964,METHODS,0,0
71965,A,0,0
71966,total,0,0
71967,of,0,0
71968,109,0,0
71969,patients,0,0
71970,with,0,0
71971,HBV,0,1
71972,were,0,0
71973,randomized,0,0
71974,into,0,0
71975,FK506,1,1
71976,group,0,1
71977,(,0,0
71978,52,0,0
71979,cases,0,0
71980,),0,0
71981,and,0,0
71982,CsA,1,1
71983,group,0,1
71984,(,0,0
71985,57,0,0
71986,cases,0,0
71987,),0,0
71988,after,0,0
71989,KT,0,1
71990,",",0,0
71991,and,0,0
71992,a,0,0
71993,2-year-long,0,0
71994,follow-up,0,0
71995,of,0,0
71996,the,0,0
71997,patients,0,0
71998,was,0,0
71999,conducted,0,0
72000,to,0,0
72001,record,0,0
72002,the,0,0
72003,patient,0,0
72004,and,0,0
72005,graft,0,1
72006,survival,0,0
72007,",",0,0
72008,incidence,0,0
72009,of,0,0
72010,acute,0,0
72011,graft,0,1
72012,rejection,0,0
72013,and,0,0
72014,postoperative,0,0
72015,liver,0,0
72016,function,0,0
72017,.,0,0
72018,RESULTS,0,0
72019,The,0,0
72020,2-year,0,0
72021,patient/graft,0,0
72022,survival,0,0
72023,was,0,0
72024,86.0,0,0
72025,%,0,0
72026,/73.7,0,0
72027,%,0,0
72028,and,0,0
72029,94.2,0,0
72030,%,0,0
72031,/90.3,0,0
72032,%,0,0
72033,in,0,0
72034,CsA,0,1
72035,and,0,0
72036,FK506,0,0
72037,groups,0,0
72038,",",0,0
72039,respectively,0,0
72040,(,0,0
72041,P,0,0
72042,<,0,0
72043,0.05,0,0
72044,),0,0
72045,",",0,0
72046,with,0,0
72047,incidence,0,0
72048,of,0,0
72049,acute,0,0
72050,rejection,0,0
72051,of,0,0
72052,10.5,0,0
72053,%,0,0
72054,and,0,0
72055,9.6,0,0
72056,%,0,0
72057,(,0,0
72058,P,0,0
72059,>,0,0
72060,0.05,0,0
72061,),0,0
72062,",",0,0
72063,and,0,0
72064,rate,0,0
72065,of,0,0
72066,abnormal,0,0
72067,liver,0,0
72068,function,0,0
72069,of,0,0
72070,26.3,0,0
72071,%,0,0
72072,and,0,0
72073,15.4,0,0
72074,%,0,0
72075,(,0,0
72076,P,0,0
72077,<,0,0
72078,0.05,0,0
72079,),0,0
72080,",",0,0
72081,respectively,0,0
72082,.,0,0
72083,Eight,0,0
72084,patients,0,0
72085,(,0,0
72086,14.4,0,0
72087,%,0,0
72088,),0,0
72089,in,0,0
72090,CsA,0,1
72091,group,0,0
72092,required,0,0
72093,a,0,0
72094,drug,0,1
72095,conversion,0,0
72096,but,0,0
72097,none,0,0
72098,in,0,0
72099,FK506,0,0
72100,group,0,0
72101,.,0,0
72102,The,0,0
72103,drug,0,0
72104,conversion,0,0
72105,resulted,0,0
72106,in,0,0
72107,significant,0,0
72108,reduction,0,0
72109,of,0,0
72110,ALT/AST,0,1
72111,level,0,0
72112,from,0,0
72113,255.13+/-31.38/201.88+/-21.25,0,0
72114,U/L,0,1
72115,to,0,0
72116,31.25+/-11.50/25.13+/-9.68,0,0
72117,U/L,0,1
72118,(,0,0
72119,P,0,0
72120,<,0,0
72121,0.01,0,0
72122,),0,0
72123,.,0,0
72124,CONCLUSION,0,0
72125,For,0,0
72126,HBV-carrying,0,1
72127,renal,0,0
72128,transplant,0,0
72129,recipients,0,0
72130,",",0,0
72131,FK506,1,0
72132,as,0,0
72133,the,0,0
72134,primary,0,0
72135,choice,0,0
72136,of,0,0
72137,immunosuppressant,0,1
72138,can,0,0
72139,be,0,0
72140,more,0,0
72141,effective,0,0
72142,and,0,0
72143,safer,0,0
72144,than,0,0
72145,CsA,0,0
72146,.,0,0
72147,[,0,0
72148,Effect,0,0
72149,of,0,0
72150,electroacununcture,1,1
72151,on,0,0
72152,sex,0,0
72153,hormone,0,1
72154,levels,0,0
72155,in,0,0
72156,patients,0,0
72157,with,0,0
72158,Sj?gren,0,0
72159,'s,0,0
72160,syndrome,0,0
72161,],0,0
72162,.,0,0
72163,OBJECTIVE,0,0
72164,To,0,0
72165,observe,0,0
72166,the,0,0
72167,effect,0,0
72168,of,1,0
72169,electroacupuncture,1,1
72170,(,1,1
72171,EA,1,0
72172,),1,1
72173,on,0,0
72174,serum,0,0
72175,testosterone,0,1
72176,(,0,1
72177,T,0,0
72178,),0,0
72179,",",0,0
72180,estradiol,0,1
72181,(,0,0
72182,F2,0,0
72183,),0,0
72184,",",0,0
72185,luteotropic,0,1
72186,hormone,0,1
72187,(,0,0
72188,LH,0,1
72189,),0,1
72190,",",0,0
72191,follicle-stimulating,0,1
72192,hormone,0,1
72193,(,0,1
72194,FSH,0,0
72195,),0,1
72196,",",0,0
72197,progesterone,0,1
72198,(,0,1
72199,P,0,0
72200,),0,1
72201,",",0,0
72202,and,0,1
72203,prolactin,0,0
72204,(,0,1
72205,PRL,0,1
72206,),0,1
72207,in,0,0
72208,patients,0,0
72209,with,0,0
72210,Sj?gren,0,0
72211,'s,0,0
72212,Syndrome,0,0
72213,(,0,1
72214,SS,0,1
72215,),0,1
72216,in,0,0
72217,order,0,0
72218,to,0,0
72219,analyze,0,0
72220,the,0,0
72221,correlation,0,0
72222,between,0,0
72223,the,0,0
72224,adjustment,0,0
72225,effect,0,0
72226,of,0,0
72227,EA,1,0
72228,and,1,0
72229,changes,0,0
72230,of,0,0
72231,hormone,0,1
72232,levels,0,0
72233,.,0,0
72234,METHODS,0,0
72235,Fifty-seven,0,0
72236,middle-aged,0,0
72237,and,0,0
72238,old,0,0
72239,women,0,0
72240,with,0,0
72241,SS,0,1
72242,were,0,0
72243,divided,0,0
72244,into,1,0
72245,medication,1,1
72246,group,1,1
72247,(,0,1
72248,n=27,0,1
72249,),0,1
72250,and,1,1
72251,acupuncture,1,1
72252,group,1,1
72253,(,0,1
72254,n=30,0,1
72255,),0,0
72256,.,0,0
72257,Patients,0,0
72258,in,0,0
72259,acupuncture,1,1
72260,group,1,0
72261,were,1,0
72262,treated,1,0
72263,with,1,0
72264,EA,1,0
72265,(,1,0
72266,80,1,0
72267,Hz,1,1
72268,",",1,0
72269,2.5,1,1
72270,mA,1,0
72271,),1,0
72272,of,1,0
72273,Shenshu,1,1
72274,(,1,0
72275,BL,1,1
72276,23,1,0
72277,),1,0
72278,",",1,0
72279,Taixi,1,1
72280,(,1,0
72281,KI,1,0
72282,3,1,1
72283,),1,0
72284,",",1,0
72285,Hegu,1,1
72286,(,1,0
72287,LI,1,1
72288,4,1,1
72289,),1,0
72290,",",1,0
72291,etc,1,0
72292,.,1,0
72293,for,1,0
72294,30,1,0
72295,min,1,0
72296,",",1,0
72297,once,1,0
72298,every,1,1
72299,other,1,0
72300,day,1,0
72301,",",1,0
72302,and,1,0
72303,those,1,0
72304,of,1,0
72305,medication,1,1
72306,group,1,0
72307,were,1,0
72308,treated,1,0
72309,with,1,0
72310,oral,1,1
72311,administration,1,0
72312,of,1,0
72313,hydroxyl-chloroquine,1,1
72314,(,1,0
72315,6,1,0
72316,mg/kg,1,1
72317,per,1,0
72318,day,1,0
72319,),1,0
72320,",",1,0
72321,oral,1,1
72322,transfer,1,1
72323,agent,1,1
72324,liquid,1,1
72325,",",1,0
72326,Vit,1,0
72327,B1,1,1
72328,",",1,0
72329,Vit,1,0
72330,B2,1,0
72331,",",1,0
72332,Vit,1,0
72333,C,1,1
72334,",",1,0
72335,fish-liver,1,0
72336,oil,1,1
72337,",",1,0
72338,one,1,0
72339,tablet/time,1,1
72340,",",1,0
72341,t.i.d.,1,1
72342,",",1,0
72343,and,1,0
72344,pilocarpine,1,1
72345,(,1,1
72346,20,1,1
72347,mg/d,1,1
72348,),1,0
72349,",",1,0
72350,continuously,1,0
72351,for,1,0
72352,2,1,0
72353,months,1,0
72354,.,1,0
72355,Venous,0,0
72356,blood,0,0
72357,samples,0,0
72358,were,0,0
72359,collected,0,0
72360,before,0,0
72361,and,0,0
72362,after,0,0
72363,the,0,0
72364,treatment,0,0
72365,to,0,0
72366,examine,0,0
72367,contents,0,0
72368,of,0,0
72369,the,0,0
72370,abovementioned,0,0
72371,sex,0,0
72372,hormones,0,0
72373,by,0,0
72374,using,1,0
72375,electro-chemiluminescent,1,1
72376,immunoassay,1,0
72377,(,1,1
72378,CLIA,1,1
72379,),1,0
72380,.,1,1
72381,RESULTS,0,0
72382,(,0,0
72383,1,0,0
72384,),0,0
72385,Before,0,0
72386,the,0,0
72387,treatment,0,0
72388,",",0,0
72389,no,0,0
72390,significant,0,0
72391,differences,0,0
72392,were,0,0
72393,found,0,0
72394,between,0,0
72395,two,0,0
72396,groups,0,0
72397,in,0,0
72398,the,0,0
72399,levels,0,0
72400,of,0,0
72401,serum,0,0
72402,T,0,0
72403,",",0,0
72404,E2,0,0
72405,",",0,0
72406,LH,0,0
72407,",",0,0
72408,FSH,0,0
72409,",",0,0
72410,P,0,0
72411,and,0,1
72412,PRL,0,1
72413,(,0,1
72414,P,0,0
72415,>,0,0
72416,0.05,0,0
72417,),0,0
72418,.,0,0
72419,After,0,0
72420,the,0,0
72421,treatment,0,0
72422,",",0,0
72423,self-comparison,0,1
72424,of,0,0
72425,each,0,0
72426,group,0,0
72427,showed,0,0
72428,that,0,0
72429,serum,0,0
72430,EF,0,0
72431,and,0,0
72432,T,0,0
72433,contents,0,0
72434,in,0,0
72435,acupuncture,0,1
72436,group,0,0
72437,increased,0,0
72438,significantly,0,0
72439,(,0,0
72440,P,0,0
72441,<,0,0
72442,0.01,0,0
72443,),0,0
72444,and,0,0
72445,serum,0,0
72446,LH,0,1
72447,content,0,0
72448,decreased,0,0
72449,significantly,0,0
72450,(,0,0
72451,P,0,0
72452,<,0,0
72453,0.01,0,0
72454,),0,0
72455,;,0,0
72456,while,0,0
72457,in,0,0
72458,medication,0,1
72459,group,0,0
72460,",",0,0
72461,only,0,0
72462,serum,0,0
72463,LH,0,1
72464,decreased,0,0
72465,markedly,0,0
72466,(,0,0
72467,P,0,0
72468,<,0,0
72469,0.05,0,0
72470,),0,0
72471,in,0,0
72472,comparison,0,0
72473,with,0,0
72474,its,0,0
72475,basic,0,1
72476,value,0,0
72477,of,0,0
72478,pretreatment,0,0
72479,.,0,0
72480,No,0,0
72481,significant,0,0
72482,changes,0,0
72483,were,0,0
72484,found,0,0
72485,in,0,0
72486,serum,0,0
72487,P,0,0
72488,",",0,0
72489,FSH,0,0
72490,and,0,0
72491,PRL,0,1
72492,levels,0,0
72493,in,0,0
72494,both,0,0
72495,groups,0,0
72496,after,0,0
72497,the,0,0
72498,treatment,0,0
72499,(,0,0
72500,P,0,0
72501,>,0,0
72502,0.05,0,0
72503,),0,0
72504,.,0,0
72505,The,0,0
72506,results,0,0
72507,suggested,0,0
72508,that,0,0
72509,the,0,0
72510,therapeutic,0,0
72511,effect,0,0
72512,of,0,0
72513,acupuncture,0,1
72514,group,0,0
72515,was,0,0
72516,better,0,0
72517,than,0,0
72518,that,0,0
72519,of,0,0
72520,medication,0,1
72521,group,0,0
72522,in,0,0
72523,regulating,0,0
72524,multiple,0,0
72525,sex,0,0
72526,hormones,0,0
72527,.,0,0
72528,CONCLUSION,1,0
72529,EA,1,0
72530,can,1,0
72531,effectively,0,0
72532,adjust,0,0
72533,E2,0,0
72534,",",0,0
72535,T,0,0
72536,and,0,0
72537,LH,0,1
72538,levels,0,0
72539,in,0,0
72540,Sj?gren,0,0
72541,'s,0,0
72542,Syndrome,0,0
72543,patients,0,0
72544,and,0,0
72545,improve,0,0
72546,most,0,0
72547,patients,0,0
72548,',0,0
72549,clinical,0,0
72550,symptoms,0,0
72551,",",0,0
72552,and,0,0
72553,the,0,0
72554,therapeutic,0,0
72555,effect,0,0
72556,of,0,0
72557,EA,1,0
72558,is,0,0
72559,better,0,0
72560,than,0,0
72561,that,0,0
72562,of,0,0
72563,medication,1,0
72564,.,1,0
72565,Anti-inflammatory,0,0
72566,effects,0,0
72567,of,0,0
72568,inhaled,1,1
72569,carbon,1,1
72570,monoxide,1,1
72571,in,0,0
72572,patients,0,0
72573,with,0,0
72574,COPD,0,0
72575,:,0,0
72576,a,0,0
72577,pilot,0,0
72578,study,0,0
72579,.,0,0
72580,In,0,0
72581,vitro,0,0
72582,and,0,0
72583,in,0,0
72584,vivo,0,0
72585,studies,0,0
72586,have,0,0
72587,shown,0,0
72588,that,0,0
72589,carbon,1,1
72590,monoxide,1,1
72591,(,0,1
72592,CO,0,1
72593,),0,1
72594,has,0,0
72595,both,0,0
72596,anti-inflammatory,0,1
72597,and,0,0
72598,anti-oxidant,0,0
72599,capacities,0,0
72600,.,0,0
72601,Since,0,0
72602,chronic,0,0
72603,obstructive,0,0
72604,pulmonary,0,0
72605,disease,0,0
72606,(,0,1
72607,COPD,0,0
72608,),0,1
72609,is,0,0
72610,characterised,0,0
72611,by,0,0
72612,inflammation,0,0
72613,and,0,0
72614,oxidative,0,0
72615,stress,0,0
72616,",",0,0
72617,low-dose,1,1
72618,CO,1,1
72619,could,0,0
72620,be,0,0
72621,of,0,0
72622,therapeutic,0,0
72623,use,0,0
72624,.,0,0
72625,The,0,0
72626,aim,0,0
72627,of,0,0
72628,the,0,0
72629,present,0,0
72630,study,0,0
72631,was,0,0
72632,to,0,0
72633,investigate,0,0
72634,the,0,0
72635,feasibility,0,0
72636,and,0,0
72637,anti-inflammatory,0,1
72638,effects,0,0
72639,of,0,0
72640,100-125,0,0
72641,ppm,0,1
72642,CO,1,1
72643,inhalation,1,1
72644,in,0,0
72645,patients,0,0
72646,with,0,0
72647,stable,0,0
72648,COPD,0,0
72649,.,0,0
72650,In,0,0
72651,total,0,0
72652,",",0,0
72653,20,0,0
72654,ex-smoking,0,0
72655,COPD,0,0
72656,patients,0,0
72657,with,0,0
72658,post-bronchodilator,0,1
72659,forced,0,1
72660,expiratory,0,0
72661,volume,0,0
72662,in,0,0
72663,one,0,0
72664,second,0,0
72665,(,0,1
72666,FEV,0,1
72667,(,0,1
72668,1,0,1
72669,),0,0
72670,),0,0
72671,>,0,0
72672,1.20,0,0
72673,L,0,0
72674,and,0,0
72675,FEV,0,1
72676,(,0,1
72677,1,0,0
72678,),0,0
72679,/forced,0,0
72680,vital,0,0
72681,capacity,0,0
72682,<,0,0
72683,70,0,0
72684,%,0,0
72685,were,0,0
72686,enrolled,0,0
72687,in,0,0
72688,a,0,0
72689,randomised,0,0
72690,",",0,0
72691,placebo-controlled,1,1
72692,",",0,0
72693,crossover,0,0
72694,study,0,0
72695,.,0,0
72696,Effects,0,0
72697,on,0,0
72698,inflammation,0,0
72699,were,0,0
72700,measured,0,0
72701,in,0,0
72702,induced,0,0
72703,sputum,0,0
72704,and,0,0
72705,blood,0,0
72706,.,0,1
72707,CO,0,1
72708,inhalation,0,1
72709,was,0,0
72710,feasible,0,0
72711,and,0,0
72712,patients,0,0
72713,',0,0
72714,vital,0,0
72715,signs,0,0
72716,were,0,0
72717,unaffected,0,0
72718,;,0,0
72719,2,0,0
72720,h.day,0,0
72721,(,0,1
72722,-1,0,1
72723,),0,1
72724,inhalation,0,1
72725,of,0,0
72726,low-dose,0,1
72727,CO,0,1
72728,on,0,0
72729,4,0,0
72730,consecutive,0,0
72731,days,0,0
72732,led,0,0
72733,to,0,0
72734,a,0,0
72735,maximal,0,0
72736,individual,0,0
72737,carboxyhaemoglobin,0,0
72738,level,0,0
72739,of,0,0
72740,4.5,0,0
72741,%,0,0
72742,.,0,0
72743,Two,0,0
72744,exacerbations,0,0
72745,occurred,0,0
72746,in,0,0
72747,the,0,0
72748,CO,0,1
72749,period,0,0
72750,.,0,0
72751,CO,0,1
72752,inhalation,0,1
72753,led,0,0
72754,to,0,0
72755,trends,0,0
72756,in,0,0
72757,reduced,0,0
72758,sputum,0,0
72759,eosinophils,0,1
72760,(,0,0
72761,median,0,0
72762,reduction,0,0
72763,0.25,0,1
72764,%,0,0
72765,point,0,0
72766,),0,1
72767,and,0,0
72768,improved,0,0
72769,responsiveness,0,0
72770,to,0,0
72771,methacholine,0,0
72772,(,0,0
72773,median,0,0
72774,provocative,0,1
72775,concentration,0,0
72776,causing,0,0
72777,a,0,0
72778,20,0,0
72779,%,0,0
72780,fall,0,0
72781,in,0,0
72782,FEV,0,1
72783,(,0,1
72784,1,0,0
72785,),0,0
72786,0.85,0,0
72787,versus,0,0
72788,0.63,0,0
72789,mg.mL,0,1
72790,(,0,1
72791,-1,0,1
72792,),0,1
72793,),0,0
72794,.,0,0
72795,Inhalation,0,0
72796,of,0,0
72797,100-125,0,0
72798,ppm,0,1
72799,carbon,1,1
72800,monoxide,1,1
72801,by,0,0
72802,patients,0,0
72803,with,0,0
72804,chronic,0,0
72805,obstructive,0,0
72806,pulmonary,0,0
72807,disease,0,0
72808,in,0,0
72809,a,0,0
72810,stable,0,0
72811,phase,0,0
72812,was,0,0
72813,feasible,0,0
72814,and,0,0
72815,led,0,0
72816,to,0,0
72817,trends,0,0
72818,in,0,0
72819,reduction,0,0
72820,of,0,0
72821,sputum,0,0
72822,eosinophils,0,0
72823,and,0,0
72824,improvement,0,0
72825,of,0,0
72826,responsiveness,0,0
72827,to,0,0
72828,methacholine,0,0
72829,.,0,0
72830,Further,0,0
72831,studies,0,0
72832,need,0,0
72833,to,0,0
72834,confirm,0,0
72835,the,0,0
72836,safety,0,0
72837,and,0,0
72838,efficacy,0,0
72839,in,0,0
72840,inflammatory,0,0
72841,lung,0,0
72842,diseases,0,0
72843,.,0,0
72844,[,0,0
72845,Observation,0,0
72846,on,0,0
72847,therapeutic,0,0
72848,effect,0,0
72849,of,0,0
72850,acupuncture,1,1
72851,on,0,0
72852,early,0,0
72853,peripheral,0,0
72854,facial,0,1
72855,paralysis,0,0
72856,],0,0
72857,.,0,0
72858,OBJECTIVE,0,0
72859,To,0,0
72860,observe,0,0
72861,therapeutic,0,0
72862,effects,0,0
72863,of,0,0
72864,acupuncture,1,1
72865,at,0,0
72866,different,0,0
72867,opportunities,0,0
72868,on,0,0
72869,peripheral,0,0
72870,facial,0,1
72871,paralysis,0,0
72872,.,0,0
72873,METHODS,0,0
72874,Fifty-two,0,0
72875,cases,0,0
72876,were,0,0
72877,randomly,0,0
72878,divided,0,0
72879,into,0,0
72880,a,0,0
72881,treatment,0,1
72882,group,0,1
72883,(,0,1
72884,n=28,0,0
72885,),0,1
72886,and,0,0
72887,a,0,0
72888,control,0,1
72889,group,0,0
72890,(,0,1
72891,n=24,0,0
72892,),0,0
72893,.,0,0
72894,The,0,0
72895,treatment,0,0
72896,group,0,0
72897,at,0,0
72898,the,0,0
72899,acute,0,0
72900,stage,0,0
72901,(,0,0
72902,1-10,0,0
72903,days,0,0
72904,),0,0
72905,were,0,0
72906,treated,0,0
72907,with,0,0
72908,acupuncture,1,1
72909,at,1,0
72910,Dicang,1,1
72911,(,1,0
72912,ST,1,0
72913,4,1,1
72914,),1,0
72915,",",1,0
72916,Jiache,1,1
72917,(,1,0
72918,ST,1,0
72919,6,1,1
72920,),1,0
72921,",",1,0
72922,Yangbai,1,1
72923,(,1,0
72924,GB,1,0
72925,14,1,1
72926,),1,0
72927,",",1,0
72928,etc.,1,0
72929,",",0,0
72930,with,1,0
72931,less,1,0
72932,than,1,0
72933,4,1,0
72934,points,1,0
72935,selected,1,0
72936,on,1,0
72937,the,1,0
72938,face,1,0
72939,and,1,0
72940,with,1,0
72941,shallow,1,1
72942,puncture,1,0
72943,",",1,0
72944,and,1,0
72945,10,1,0
72946,days,1,0
72947,later,1,0
72948,electroacupuncture,1,1
72949,were,1,0
72950,added,1,0
72951,at,1,0
72952,acupoints,1,1
72953,selected,1,0
72954,routinely,1,0
72955,;,1,0
72956,the,1,0
72957,control,1,1
72958,group,1,0
72959,were,1,0
72960,treated,1,0
72961,with,1,0
72962,the,1,0
72963,same,1,0
72964,methods,1,0
72965,as,1,0
72966,the,1,0
72967,treatment,1,1
72968,group,1,0
72969,but,1,0
72970,acupuncture,1,1
72971,was,1,0
72972,not,1,0
72973,given,1,0
72974,at,1,0
72975,the,1,0
72976,acute,1,0
72977,stage,1,0
72978,.,1,0
72979,RESULTS,0,0
72980,The,0,0
72981,cured,0,0
72982,rate,0,0
72983,of,0,0
72984,78.6,0,0
72985,%,0,0
72986,in,0,0
72987,the,0,0
72988,treatment,0,0
72989,group,0,0
72990,was,0,0
72991,significantly,0,0
72992,higher,0,0
72993,than,0,0
72994,50.0,0,0
72995,%,0,0
72996,in,0,0
72997,the,0,0
72998,control,0,1
72999,group,0,0
73000,(,0,0
73001,P,0,0
73002,<,0,0
73003,0.05,0,0
73004,),0,0
73005,.,0,0
73006,CONCLUSION,0,0
73007,Early,0,1
73008,acupuncture,1,1
73009,is,0,0
73010,a,0,0
73011,key,0,0
73012,for,0,0
73013,achieving,0,0
73014,the,0,0
73015,best,0,0
73016,therapeutic,0,0
73017,effect,0,0
73018,on,0,0
73019,facial,0,0
73020,paralysis,0,0
73021,.,0,0
73022,Comparison,0,0
73023,of,0,0
73024,the,0,0
73025,therapeutic,0,0
73026,efficacy,0,0
73027,of,0,0
73028,phonophoresis,1,1
73029,and,0,0
73030,iontophoresis,1,1
73031,using,0,1
73032,dexamethasone,1,1
73033,sodium,1,1
73034,phosphate,1,1
73035,in,0,0
73036,the,0,0
73037,management,0,0
73038,of,0,0
73039,patients,0,0
73040,with,0,0
73041,knee,0,0
73042,osteoarthritis,0,0
73043,.,0,0
73044,BACKGROUND,0,0
73045,AND,0,0
73046,OBJECTIVE,0,1
73047,Many,0,0
73048,treatment,0,0
73049,options,0,0
73050,",",0,0
73051,including,0,0
73052,non-pharmacological,0,1
73053,and,0,0
73054,pharmacological,0,0
73055,measures,0,0
73056,",",0,0
73057,have,0,0
73058,been,0,0
73059,recommended,0,0
73060,in,0,0
73061,the,0,0
73062,management,0,1
73063,of,0,0
73064,osteoarthritis,0,0
73065,(,0,1
73066,OA,0,1
73067,),0,0
73068,.,0,0
73069,Among,0,0
73070,the,0,0
73071,non-pharmacological,0,1
73072,approach,0,1
73073,is,0,0
73074,physiotherapy,0,1
73075,",",0,0
73076,which,0,0
73077,involves,0,0
73078,the,0,0
73079,use,0,0
73080,of,0,0
73081,physical,0,1
73082,modalities,0,1
73083,like,0,0
73084,",",0,0
73085,heat,0,0
73086,therapy,0,1
73087,",",0,0
73088,exercise,0,1
73089,therapy,0,1
73090,",",0,0
73091,electrical,0,1
73092,stimulation,0,1
73093,",",0,0
73094,therapeutic,0,0
73095,ultrasound,0,1
73096,",",0,0
73097,iontophoresis,0,1
73098,",",0,0
73099,and,0,0
73100,phonophoresis,0,1
73101,.,0,0
73102,This,0,0
73103,study,0,0
73104,was,0,0
73105,therefore,0,0
73106,designed,0,0
73107,to,0,0
73108,compare,0,0
73109,the,0,0
73110,effectiveness,0,0
73111,of,0,0
73112,0.4,0,0
73113,%,0,0
73114,Dexamethasone,1,1
73115,sodium,1,1
73116,phosphate,1,1
73117,(,1,1
73118,DEX-P,1,1
73119,),1,1
73120,phonophoresis,1,1
73121,(,1,1
73122,PH,1,0
73123,),1,1
73124,with,0,0
73125,0.4,1,1
73126,%,1,0
73127,DEX-P,1,1
73128,iontophoresis,1,1
73129,(,1,1
73130,ION,1,0
73131,),1,1
73132,therapy,1,1
73133,in,0,0
73134,the,0,0
73135,management,0,0
73136,of,0,0
73137,patients,0,0
73138,with,0,0
73139,knee,0,0
73140,joint,0,0
73141,OA,0,1
73142,.,0,0
73143,METHODS,0,0
73144,Fifty,0,0
73145,patients,0,0
73146,(,0,0
73147,19,0,0
73148,males,0,0
73149,and,0,0
73150,31,0,0
73151,females,0,0
73152,),0,0
73153,with,0,0
73154,a,0,0
73155,mean,0,0
73156,age,0,0
73157,of,0,0
73158,53.6,0,0
73159,+/-,0,0
73160,8.9,0,0
73161,years,0,0
73162,were,0,0
73163,randomly,0,0
73164,assigned,0,0
73165,to,0,0
73166,PH,1,0
73167,or,0,1
73168,ION,1,0
73169,groups,0,0
73170,with,0,0
73171,25,0,0
73172,patients,0,0
73173,in,0,0
73174,each,0,0
73175,group,0,0
73176,.,0,0
73177,Ultrasound,0,1
73178,waves,0,0
73179,of,0,0
73180,1,0,0
73181,MHz,0,1
73182,frequency,0,0
73183,was,0,0
73184,applied,0,0
73185,for,0,0
73186,5,0,0
73187,minutes,0,0
73188,to,0,0
73189,the,0,0
73190,target,0,0
73191,knee,0,0
73192,",",0,0
73193,so,0,0
73194,also,0,0
73195,was,0,0
73196,the,0,0
73197,direct,0,0
73198,current,0,0
73199,for,0,0
73200,10,0,0
73201,minutes,0,0
73202,for,0,0
73203,10,0,0
73204,sessions,0,1
73205,treatment,0,0
73206,period,0,0
73207,.,0,0
73208,Western,0,0
73209,Ontario,0,1
73210,and,0,0
73211,McMaster,0,1
73212,University,0,0
73213,Osteoarthritis,0,0
73214,Index,0,1
73215,(,0,1
73216,WOMAC,0,1
73217,),0,1
73218,scores,0,0
73219,",",0,0
73220,20,0,0
73221,meters,0,0
73222,ambulatory,0,0
73223,time,0,0
73224,",",0,0
73225,and,0,0
73226,knee,0,1
73227,range,0,0
73228,of,0,0
73229,motion,0,0
73230,(,0,1
73231,ROM,0,0
73232,),0,1
73233,were,0,0
73234,evaluated,0,0
73235,before,0,0
73236,and,0,0
73237,after,0,0
73238,therapy,0,1
73239,as,0,0
73240,the,0,0
73241,outcome,0,0
73242,measures,0,0
73243,.,0,0
73244,RESULTS,0,0
73245,At,0,0
73246,the,0,0
73247,end,0,0
73248,of,0,0
73249,two,0,0
73250,weeks,0,0
73251,",",0,0
73252,significant,0,0
73253,improvement,0,0
73254,in,0,0
73255,total,0,0
73256,WOMAC,0,0
73257,scores,0,0
73258,was,0,0
73259,observed,0,0
73260,in,0,0
73261,15,0,0
73262,(,0,0
73263,60,0,0
73264,%,0,0
73265,),0,0
73266,and,0,0
73267,16,0,0
73268,(,0,0
73269,64,0,0
73270,%,0,0
73271,),0,0
73272,patients,0,0
73273,in,0,0
73274,the,0,0
73275,PH,0,0
73276,and,0,0
73277,ION,0,0
73278,groups,0,0
73279,respectively,0,0
73280,",",0,0
73281,indicating,0,0
73282,no,0,0
73283,significant,0,0
73284,difference,0,0
73285,in,0,0
73286,the,0,0
73287,improvement,0,0
73288,rate,0,0
73289,.,0,1
73290,Twenty,0,0
73291,(,0,0
73292,20,0,0
73293,),0,0
73294,metres,0,0
73295,ambulatory,0,0
73296,time,0,0
73297,and,0,0
73298,knee,0,1
73299,range,0,0
73300,of,0,0
73301,motion,0,0
73302,also,0,0
73303,improved,0,0
73304,significantly,0,0
73305,in,0,0
73306,both,0,0
73307,groups,0,0
73308,",",0,0
73309,yet,0,0
73310,these,0,0
73311,variables,0,0
73312,showed,0,0
73313,no,0,0
73314,significant,0,0
73315,difference,0,0
73316,between,0,0
73317,the,0,0
73318,two,0,0
73319,groups,0,0
73320,.,0,0
73321,CONCLUSION,0,0
73322,Both,0,1
73323,therapeutic,0,0
73324,modalities,0,1
73325,were,0,0
73326,found,0,0
73327,to,0,0
73328,be,0,0
73329,effective,0,0
73330,and,0,0
73331,generally,0,0
73332,well,0,0
73333,tolerated,0,0
73334,after,0,0
73335,10,0,0
73336,treatment,0,0
73337,sessions,0,1
73338,.,0,0
73339,DEX-P,1,0
73340,phonophoresis,1,1
73341,was,0,0
73342,not,0,0
73343,superior,0,0
73344,to,0,0
73345,DEX-P,1,1
73346,iontophoresis,1,1
73347,in,0,0
73348,the,0,0
73349,treatment,0,0
73350,of,0,0
73351,patients,0,0
73352,with,0,0
73353,OA,0,1
73354,of,0,0
73355,the,0,0
73356,knee,0,0
73357,.,0,0
73358,Severe,0,0
73359,enteropathy,0,0
73360,among,0,0
73361,patients,0,0
73362,with,0,0
73363,stage,0,0
73364,II/III,0,1
73365,colon,0,0
73366,cancer,0,0
73367,treated,0,0
73368,on,0,0
73369,a,0,0
73370,randomized,0,0
73371,trial,0,0
73372,of,0,0
73373,bolus,1,1
73374,5-fluorouracil/leucovorin,1,1
73375,plus,1,1
73376,or,1,1
73377,minus,1,1
73378,oxaliplatin,1,1
73379,:,1,0
73380,a,0,0
73381,prospective,0,0
73382,analysis,0,0
73383,.,0,0
73384,BACKGROUND,0,0
73385,Cases,0,0
73386,of,0,0
73387,severe,0,0
73388,gastrointestinal,0,0
73389,toxicity,0,0
73390,were,0,0
73391,monitored,0,0
73392,prospectively,0,0
73393,during,0,0
73394,NSABP,0,0
73395,C-07,0,1
73396,",",0,0
73397,a,0,0
73398,randomized,0,0
73399,clinical,0,0
73400,trial,0,0
73401,of,0,0
73402,adjuvant,0,1
73403,therapy,0,1
73404,for,0,0
73405,patients,0,0
73406,with,0,0
73407,stage,0,0
73408,II/III,0,1
73409,colon,0,0
73410,cancer,0,0
73411,.,0,0
73412,METHODS,0,0
73413,Patients,0,0
73414,were,0,0
73415,treated,0,0
73416,with,0,0
73417,weekly,0,1
73418,bolus,1,1
73419,5-fluorouracil,1,1
73420,(,1,1
73421,5-FU,1,1
73422,),1,1
73423,and,1,0
73424,leucovorin,1,1
73425,(,0,0
73426,FL,0,1
73427,;,0,0
73428,Roswell,0,1
73429,Park,0,1
73430,Regimen,0,1
73431,),0,1
73432,or,0,1
73433,the,0,0
73434,same,1,0
73435,regimen,1,1
73436,plus,1,1
73437,oxaliplatin,1,1
73438,(,1,1
73439,FLOX,1,1
73440,),1,0
73441,.,1,0
73442,RESULTS,0,0
73443,Of,0,0
73444,1857,0,0
73445,patients,0,0
73446,",",0,0
73447,79,0,0
73448,(,0,0
73449,4.3,0,0
73450,%,0,0
73451,),0,0
73452,developed,0,0
73453,a,0,0
73454,syndrome,0,0
73455,of,0,0
73456,bowel,0,0
73457,wall,0,0
73458,injury,0,0
73459,(,0,0
73460,BWI,0,0
73461,",",0,0
73462,small,0,0
73463,or,0,1
73464,large,0,0
73465,),0,1
73466,characterized,0,0
73467,by,0,0
73468,hospitalization,0,0
73469,for,0,0
73470,the,0,0
73471,management,0,1
73472,of,0,0
73473,severe,0,0
73474,diarrhea,0,0
73475,or,0,1
73476,dehydration,0,0
73477,and,0,1
73478,radiographic,0,0
73479,or,0,1
73480,endoscopic,0,1
73481,evidence,0,0
73482,of,0,0
73483,bowel,0,0
73484,wall,0,0
73485,thickening,0,0
73486,or,0,1
73487,ulceration,0,0
73488,.,0,1
73489,Fifty-one,0,0
73490,(,0,0
73491,64.6,0,0
73492,%,0,0
73493,),0,0
73494,of,0,0
73495,these,0,0
73496,adverse,0,0
73497,events,0,0
73498,occurred,0,0
73499,in,0,0
73500,patients,0,0
73501,treated,0,0
73502,with,0,0
73503,FLOX,1,0
73504,and,0,0
73505,28,0,0
73506,(,0,0
73507,35.4,0,0
73508,%,0,0
73509,),0,0
73510,in,0,0
73511,those,0,0
73512,treated,0,0
73513,with,0,0
73514,FL,0,1
73515,(,0,0
73516,P,0,0
73517,<,0,0
73518,.01,0,0
73519,),0,0
73520,.,0,0
73521,Enteric,0,0
73522,sepsis,0,0
73523,(,0,1
73524,ES,0,1
73525,),0,0
73526,",",0,0
73527,characterized,0,0
73528,by,0,0
73529,grade,0,0
73530,3,0,0
73531,or,0,0
73532,greater,0,0
73533,diarrhea,0,0
73534,and,0,0
73535,grade,0,0
73536,4,0,0
73537,neutropenia,0,0
73538,with,0,0
73539,or,0,1
73540,without,0,1
73541,proven,0,0
73542,bacteremia,0,0
73543,occurred,0,0
73544,in,0,0
73545,22,0,0
73546,patients,0,0
73547,treated,0,0
73548,with,0,0
73549,FLOX,1,0
73550,",",0,0
73551,versus,0,0
73552,8,0,0
73553,in,0,0
73554,those,0,0
73555,treated,0,0
73556,with,0,0
73557,FL,1,1
73558,(,0,0
73559,P,0,0
73560,=,0,0
73561,.01,0,0
73562,),0,0
73563,.,0,0
73564,Patients,0,0
73565,>,0,0
73566,60,0,0
73567,years,0,0
73568,were,0,0
73569,at,0,0
73570,higher,0,0
73571,risk,0,0
73572,for,0,0
73573,BWI,0,0
73574,after,0,0
73575,treatment,0,0
73576,with,0,0
73577,FLOX,1,1
73578,(,0,0
73579,6.7,0,0
73580,%,0,0
73581,),0,1
73582,versus,0,1
73583,treatment,0,0
73584,with,0,1
73585,FL,1,1
73586,(,0,0
73587,2.9,0,0
73588,%,0,0
73589,",",0,0
73590,P,0,0
73591,<,0,0
73592,.01,0,0
73593,),0,0
73594,.,0,0
73595,Female,0,0
73596,patients,0,0
73597,had,0,0
73598,a,0,0
73599,higher,0,0
73600,incidence,0,0
73601,of,0,0
73602,BWI,0,0
73603,with,0,0
73604,FLOX,1,1
73605,(,0,0
73606,9.1,0,0
73607,%,0,0
73608,),0,0
73609,than,0,0
73610,with,0,0
73611,FL,0,1
73612,(,0,0
73613,3.9,0,0
73614,%,0,0
73615,",",0,0
73616,P,0,0
73617,<,0,0
73618,.01,0,0
73619,),0,0
73620,.,0,0
73621,Severe,0,0
73622,gastrointestinal,0,0
73623,toxicity,0,0
73624,usually,0,0
73625,occurred,0,0
73626,during,0,0
73627,the,0,0
73628,third,0,0
73629,or,0,1
73630,fourth,0,0
73631,week,0,0
73632,on,0,0
73633,the,0,0
73634,first,0,0
73635,cycle,0,0
73636,of,0,0
73637,therapy,0,1
73638,",",0,0
73639,required,0,0
73640,hospitalization,0,0
73641,",",0,0
73642,and,0,0
73643,was,0,0
73644,managed,0,0
73645,with,0,0
73646,fluids,0,0
73647,",",0,0
73648,antidiarrheals,0,1
73649,",",0,0
73650,and,0,0
73651,antibiotics,0,1
73652,.,0,0
73653,There,0,0
73654,were,0,0
73655,5,0,0
73656,deaths,0,0
73657,(,0,0
73658,0.3,0,1
73659,%,0,0
73660,),0,0
73661,due,0,0
73662,to,0,0
73663,enteropathy,0,0
73664,",",0,0
73665,2,0,0
73666,related,0,0
73667,to,0,0
73668,ES,0,1
73669,and,0,0
73670,3,0,0
73671,related,0,0
73672,to,0,0
73673,both,0,0
73674,BWI,0,0
73675,and,0,0
73676,ES,0,1
73677,.,0,0
73678,Seventy-one,0,0
73679,percent,0,0
73680,of,0,0
73681,patients,0,0
73682,resumed,0,0
73683,treatment,0,0
73684,with,0,0
73685,FL,1,1
73686,after,0,0
73687,recovery,0,0
73688,.,0,0
73689,CONCLUSIONS,0,0
73690,Patients,0,0
73691,treated,0,0
73692,with,0,0
73693,adjuvant,0,1
73694,FL,1,1
73695,should,0,0
73696,be,0,0
73697,closely,0,0
73698,monitored,0,0
73699,for,0,0
73700,diarrhea,0,0
73701,and,0,0
73702,aggressively,0,0
73703,managed,0,0
73704,",",0,0
73705,especially,0,0
73706,if,0,0
73707,oxaliplatin,0,1
73708,has,0,0
73709,been,0,0
73710,added,0,0
73711,to,0,0
73712,the,0,0
73713,regimen,0,1
73714,.,0,0
73715,Society,0,0
73716,.,0,0
73717,Injury,0,1
73718,and,0,0
73719,illness,0,0
73720,costs,0,0
73721,in,0,0
73722,the,0,0
73723,Certified,0,0
73724,Safe,0,1
73725,Farm,0,1
73726,study,0,0
73727,.,0,0
73728,CONTEXT,0,0
73729,The,1,0
73730,Certified,1,0
73731,Safe,1,1
73732,Farm,1,1
73733,(,1,1
73734,CSF,1,1
73735,),1,1
73736,intervention,1,1
73737,program,1,1
73738,aims,0,0
73739,to,0,0
73740,reduce,0,0
73741,occupational,0,1
73742,injuries,0,0
73743,and,0,0
73744,illnesses,0,0
73745,",",0,0
73746,and,0,0
73747,promote,0,1
73748,wellness,0,1
73749,to,0,0
73750,reduce,0,0
73751,health,0,0
73752,care,0,1
73753,and,0,0
73754,related,0,0
73755,costs,0,0
73756,to,0,0
73757,farmers,0,0
73758,",",0,0
73759,insurers,0,0
73760,",",0,0
73761,and,0,0
73762,other,0,0
73763,stakeholders,0,0
73764,.,0,0
73765,PURPOSE,0,0
73766,To,0,0
73767,evaluate,0,0
73768,the,0,0
73769,cost,0,0
73770,effectiveness,0,0
73771,of,0,0
73772,CSF,0,0
73773,.,0,0
73774,METHODS,0,0
73775,Farms,0,1
73776,(,0,1
73777,316,0,0
73778,),0,0
73779,located,0,0
73780,in,0,0
73781,a,0,0
73782,9-county,0,0
73783,area,0,0
73784,of,0,0
73785,northwestern,0,0
73786,Iowa,0,1
73787,were,0,0
73788,recruited,0,0
73789,and,0,0
73790,randomized,0,0
73791,into,0,0
73792,intervention,1,1
73793,and,0,0
73794,control,1,0
73795,cohorts,0,0
73796,.,0,0
73797,Intervention,1,0
73798,farms,0,0
73799,received,0,0
73800,occupational,1,1
73801,health,1,0
73802,screenings,1,0
73803,",",1,0
73804,health,1,0
73805,and,1,0
73806,wellness,1,1
73807,screening,1,1
73808,",",1,0
73809,education,1,1
73810,",",1,0
73811,on-farm,1,1
73812,safety,1,0
73813,reviews,1,0
73814,",",1,0
73815,and,1,0
73816,performance,1,0
73817,incentives,1,0
73818,.,1,0
73819,For,0,0
73820,both,0,0
73821,cohorts,0,0
73822,",",0,0
73823,quarterly,0,0
73824,calls,0,0
73825,over,0,0
73826,3,0,0
73827,years,0,0
73828,were,0,0
73829,used,0,0
73830,to,0,0
73831,collect,0,0
73832,self-reported,0,0
73833,occupational,0,1
73834,injury,0,0
73835,and,0,0
73836,illness,0,0
73837,information,0,0
73838,",",0,0
73839,including,0,0
73840,costs,0,0
73841,to,0,0
73842,the,0,0
73843,farmers,0,0
73844,and,0,0
73845,their,0,0
73846,insurers,0,0
73847,.,0,0
73848,FINDINGS,0,0
73849,Annual,0,0
73850,occupational,0,1
73851,injury,0,0
73852,and,0,0
73853,illness,0,0
73854,costs,0,0
73855,per,0,0
73856,farmer,0,0
73857,paid,0,0
73858,by,0,0
73859,insurers,0,0
73860,were,0,0
73861,45,0,0
73862,%,0,0
73863,lower,0,0
73864,in,0,0
73865,the,0,0
73866,intervention,1,1
73867,cohort,0,0
73868,(,0,0
73869,$,0,0
73870,183,0,0
73871,),0,0
73872,than,0,0
73873,in,0,0
73874,the,0,0
73875,control,1,1
73876,cohort,0,0
73877,(,0,0
73878,$,0,0
73879,332,0,0
73880,),0,0
73881,.,0,0
73882,Although,0,0
73883,out-of-pocket,0,0
73884,expenses,0,0
73885,were,0,0
73886,similar,0,0
73887,for,0,0
73888,both,0,0
73889,cohorts,0,0
73890,",",0,0
73891,combined,0,1
73892,costs,0,0
73893,of,0,0
73894,insurance,0,0
73895,and,0,0
73896,out-of-pocket,0,1
73897,expenses,0,0
73898,were,0,0
73899,27,0,0
73900,%,0,0
73901,lower,0,0
73902,in,0,0
73903,the,0,0
73904,intervention,1,1
73905,cohort,0,0
73906,(,0,0
73907,$,0,0
73908,374/year,0,0
73909,per,0,0
73910,farmer,0,0
73911,),0,0
73912,compared,0,0
73913,to,0,0
73914,the,0,0
73915,control,1,1
73916,cohort,0,0
73917,(,0,0
73918,$,0,0
73919,512/year,0,0
73920,per,0,0
73921,farmer,0,0
73922,),0,0
73923,.,0,0
73924,Within,0,0
73925,the,0,0
73926,cohort,0,0
73927,of,0,0
73928,intervention,1,1
73929,farmers,0,0
73930,",",0,0
73931,annual,0,0
73932,occupational,0,1
73933,injury,0,0
73934,and,0,0
73935,illness,0,0
73936,cost,0,0
73937,savings,0,0
73938,were,0,0
73939,directly,0,0
73940,associated,0,0
73941,with,0,0
73942,on-farm,0,1
73943,safety,0,0
73944,review,0,0
73945,scores,0,0
73946,.,0,0
73947,Reported,0,0
73948,health,0,0
73949,care,0,1
73950,costs,0,0
73951,were,0,0
73952,$,0,0
73953,237,0,0
73954,per,0,0
73955,farmer,0,0
73956,in,0,0
73957,the,0,0
73958,safest,0,0
73959,farms,0,0
73960,(,0,0
73961,those,0,0
73962,farms,0,0
73963,scoring,0,0
73964,in,0,0
73965,the,0,0
73966,highest,0,0
73967,tertile,0,0
73968,),0,0
73969,versus,0,1
73970,$,0,0
73971,485,0,0
73972,per,0,0
73973,farmer,0,0
73974,in,0,0
73975,the,0,0
73976,least,0,0
73977,safe,0,0
73978,farms,0,0
73979,(,0,0
73980,lowest,0,0
73981,tertile,0,0
73982,),0,0
73983,.,0,0
73984,CONCLUSIONS,0,0
73985,Results,0,0
73986,suggest,0,0
73987,that,0,0
73988,farmers,0,0
73989,receiving,0,0
73990,the,0,0
73991,intervention,1,1
73992,had,0,0
73993,lower,0,0
73994,health,0,0
73995,care,0,0
73996,costs,0,0
73997,for,0,0
73998,occupational,0,1
73999,injuries,0,0
74000,and,0,0
74001,illnesses,0,0
74002,than,0,0
74003,control,1,0
74004,farmers,0,0
74005,.,0,0
74006,These,0,0
74007,cost,0,0
74008,savings,0,0
74009,more,0,0
74010,than,0,0
74011,cover,0,0
74012,the,0,0
74013,cost,0,0
74014,of,0,0
74015,providing,0,0
74016,CSF,0,1
74017,services,0,1
74018,(,0,0
74019,about,0,0
74020,$,0,0
74021,100,0,0
74022,per,0,0
74023,farm,0,0
74024,per,0,1
74025,year,0,0
74026,),0,0
74027,.,0,0
74028,The,0,0
74029,logMAR,1,0
74030,Kay,1,0
74031,picture,1,1
74032,test,1,0
74033,and,0,0
74034,the,0,0
74035,logMAR,1,1
74036,acuity,1,0
74037,test,1,0
74038,:,1,0
74039,a,0,0
74040,comparative,0,0
74041,study,0,0
74042,.,0,0
74043,PURPOSE,0,0
74044,To,0,0
74045,compare,0,0
74046,the,0,0
74047,level,0,0
74048,of,0,0
74049,visual,0,0
74050,acuity,0,0
74051,with,0,0
74052,crowded,1,0
74053,and,1,0
74054,uncrowded,1,0
74055,versions,1,0
74056,of,0,0
74057,the,0,0
74058,logMAR,1,1
74059,acuity,1,0
74060,test,1,0
74061,and,0,0
74062,the,0,0
74063,Kay,1,1
74064,picture,1,0
74065,test,1,0
74066,in,0,0
74067,amblyopia,0,0
74068,.,0,0
74069,METHODS,0,0
74070,A,0,0
74071,prospective,0,0
74072,study,0,0
74073,was,0,0
74074,carried,0,0
74075,out,0,0
74076,on,0,0
74077,51,0,0
74078,participants,0,0
74079,with,0,0
74080,amblyopia,0,0
74081,(,0,0
74082,strabismic,0,1
74083,n=17,0,0
74084,;,0,0
74085,anisometropic,0,1
74086,n=10,0,0
74087,;,0,0
74088,combined,0,1
74089,n=24,0,0
74090,),0,0
74091,",",0,0
74092,mean,0,0
74093,age,0,0
74094,10,0,0
74095,years,0,0
74096,8,0,0
74097,months,0,0
74098,.,0,0
74099,The,0,0
74100,amblyopia,0,0
74101,was,0,0
74102,defined,0,0
74103,as,0,0
74104,severe/moderate,0,0
74105,(,0,0
74106,<,0,0
74107,0.250,0,1
74108,logMAR,0,0
74109,),0,0
74110,",",0,0
74111,n=41,0,0
74112,or,0,1
74113,mild,0,0
74114,(,0,0
74115,>,0,0
74116,or,0,1
74117,=,0,0
74118,0.250,0,1
74119,logMAR,0,0
74120,),0,0
74121,",",0,0
74122,n=10,0,0
74123,.,0,0
74124,Visual,0,0
74125,acuity,0,0
74126,was,0,0
74127,assessed,0,0
74128,uniocularly,0,0
74129,using,0,0
74130,the,0,0
74131,crowded,1,0
74132,and,1,0
74133,uncrowded,1,0
74134,logMAR,1,1
74135,acuity,1,0
74136,tests,1,0
74137,and,0,0
74138,the,1,0
74139,logMAR,1,1
74140,crowded,1,0
74141,and,1,0
74142,uncrowded,1,0
74143,Kay,1,1
74144,picture,1,0
74145,tests,1,0
74146,in,0,0
74147,random,0,0
74148,orders,0,0
74149,.,0,0
74150,RESULTS,0,0
74151,The,0,0
74152,mean,0,0
74153,visual,0,0
74154,acuity,0,0
74155,outcome,0,0
74156,using,0,0
74157,the,0,0
74158,logMAR,1,0
74159,crowded,1,0
74160,Kay,1,0
74161,picture,1,1
74162,test,1,1
74163,(,0,1
74164,0.343+/-0.150,0,0
74165,),0,1
74166,was,0,0
74167,comparable,0,0
74168,(,0,1
74169,P=0.084,0,0
74170,),0,1
74171,with,0,0
74172,the,0,0
74173,mean,0,0
74174,outcome,0,0
74175,using,0,0
74176,the,0,0
74177,crowded,1,0
74178,logMAR,1,1
74179,acuity,1,0
74180,test,1,1
74181,(,0,1
74182,0.402+/-0.188,0,0
74183,),0,0
74184,.,0,0
74185,However,0,0
74186,",",0,0
74187,the,0,0
74188,mean,0,0
74189,acuity,0,0
74190,difference,0,0
74191,between,0,0
74192,these,0,0
74193,two,0,0
74194,tests,0,0
74195,in,0,0
74196,the,0,0
74197,subgroup,0,0
74198,with,0,0
74199,severe/moderate,0,0
74200,amblyopia,0,1
74201,(,0,1
74202,0.074+/-0.036,0,0
74203,),0,0
74204,was,0,0
74205,statistically,0,0
74206,significant,0,0
74207,(,0,1
74208,P=0.0382,0,0
74209,),0,0
74210,.,0,0
74211,The,0,0
74212,uncrowded,1,0
74213,logMAR,1,1
74214,acuity,1,0
74215,test,1,0
74216,significantly,0,0
74217,overestimated,0,0
74218,visual,0,0
74219,acuity,0,0
74220,when,0,0
74221,compared,0,0
74222,with,0,0
74223,the,0,0
74224,logMAR,1,0
74225,crowded,1,0
74226,Kay,1,0
74227,picture,1,1
74228,test,1,1
74229,(,0,0
74230,P,0,0
74231,<,0,0
74232,0.005,0,0
74233,),0,0
74234,by,0,0
74235,a,0,0
74236,mean,0,0
74237,of,0,0
74238,0.088+/-0.008,0,0
74239,.,0,0
74240,CONCLUSION,0,0
74241,The,1,0
74242,logMAR,1,0
74243,crowded,1,0
74244,Kay,1,0
74245,picture,1,0
74246,test,1,1
74247,is,0,0
74248,a,0,0
74249,useful,0,0
74250,tool,0,0
74251,in,0,0
74252,clinical,0,0
74253,practice,0,0
74254,.,0,0
74255,The,0,0
74256,test,0,0
74257,design,0,0
74258,takes,0,0
74259,the,0,0
74260,crowding,0,0
74261,phenomenon,0,0
74262,into,0,0
74263,account,0,0
74264,.,0,0
74265,It,0,0
74266,provides,0,0
74267,visual,0,0
74268,acuity,0,0
74269,measures,0,0
74270,more,0,0
74271,comparable,0,0
74272,with,0,0
74273,the,0,0
74274,gold,0,1
74275,standard,0,1
74276,crowded,1,0
74277,logMAR,1,1
74278,acuity,1,0
74279,test,1,0
74280,than,0,0
74281,the,0,0
74282,uncrowded,0,0
74283,logMAR,0,1
74284,acuity,0,0
74285,test,0,0
74286,.,0,0
74287,However,0,0
74288,",",0,0
74289,the,0,0
74290,outcomes,0,0
74291,in,0,0
74292,poorer,0,0
74293,acuities,0,0
74294,should,0,0
74295,still,0,0
74296,be,0,0
74297,viewed,0,0
74298,with,0,0
74299,caution,0,0
74300,.,0,0
74301,A,0,0
74302,study,0,0
74303,on,0,0
74304,the,0,0
74305,effect,0,0
74306,of,0,0
74307,the,0,0
74308,duration,0,0
74309,of,0,0
74310,subcutaneous,1,1
74311,heparin,1,1
74312,injection,1,1
74313,on,0,0
74314,bruising,0,0
74315,and,0,0
74316,pain,0,0
74317,.,0,0
74318,AIM,0,0
74319,This,0,0
74320,study,0,0
74321,was,0,0
74322,carried,0,0
74323,out,0,0
74324,to,0,0
74325,determine,0,0
74326,the,0,0
74327,effect,0,0
74328,of,0,0
74329,injection,0,1
74330,duration,0,0
74331,on,0,0
74332,bruising,0,0
74333,and,0,0
74334,pain,0,0
74335,following,0,0
74336,the,0,0
74337,administration,0,0
74338,of,0,0
74339,the,0,0
74340,subcutaneous,0,1
74341,injection,0,1
74342,of,0,0
74343,heparin,1,1
74344,.,1,0
74345,BACKGROUND,0,0
74346,Although,0,0
74347,different,0,0
74348,methods,0,0
74349,to,0,0
74350,prevent,0,0
74351,bruising,0,0
74352,and,0,0
74353,pain,0,0
74354,following,0,0
74355,the,0,0
74356,subcutaneous,0,1
74357,injection,0,1
74358,of,0,0
74359,heparin,1,1
74360,have,0,0
74361,been,0,0
74362,widely,0,0
74363,studied,0,0
74364,and,0,0
74365,described,0,0
74366,",",0,0
74367,the,0,0
74368,effect,0,0
74369,of,0,0
74370,injection,0,1
74371,duration,0,0
74372,on,0,0
74373,the,0,0
74374,occurrence,0,0
74375,of,0,0
74376,bruising,0,0
74377,and,0,0
74378,pain,0,0
74379,is,0,0
74380,little,0,0
74381,documented,0,0
74382,.,0,0
74383,DESIGN,0,0
74384,This,0,0
74385,study,0,0
74386,was,0,0
74387,designed,0,0
74388,as,0,0
74389,within-subject,0,0
74390,",",0,0
74391,quasi-experimental,0,0
74392,research,0,0
74393,.,0,0
74394,METHOD,0,0
74395,The,0,0
74396,sample,0,0
74397,for,0,0
74398,the,0,0
74399,study,0,0
74400,consisted,0,0
74401,of,0,0
74402,50,0,0
74403,patients,0,0
74404,to,0,0
74405,whom,0,0
74406,subcutaneous,0,1
74407,heparin,1,1
74408,was,0,0
74409,administered,0,0
74410,.,0,0
74411,Heparin,1,1
74412,was,0,0
74413,injected,0,0
74414,over,0,0
74415,10,0,0
74416,seconds,0,0
74417,on,0,0
74418,the,0,0
74419,right,0,0
74420,abdominal,0,0
74421,site,0,0
74422,and,0,0
74423,30,0,0
74424,seconds,0,0
74425,on,0,0
74426,the,0,0
74427,left,0,0
74428,abdominal,0,0
74429,site,0,0
74430,.,0,0
74431,Injections,0,0
74432,areas,0,0
74433,were,0,0
74434,assessed,0,0
74435,for,0,0
74436,the,0,0
74437,presence,0,0
74438,of,0,0
74439,bruising,0,0
74440,at,0,0
74441,48,0,0
74442,and,0,0
74443,72,0,0
74444,hours,0,0
74445,after,0,0
74446,each,0,0
74447,injection,0,1
74448,.,0,0
74449,Dimensions,0,0
74450,of,0,0
74451,the,0,0
74452,bruising,0,0
74453,on,0,0
74454,the,0,0
74455,heparin,0,1
74456,applied,0,0
74457,areas,0,0
74458,were,0,0
74459,measured,0,0
74460,using,0,0
74461,transparent,0,1
74462,millimetric,0,0
74463,measuring,0,0
74464,paper,0,0
74465,.,0,0
74466,The,0,0
74467,visual,0,0
74468,analog,0,1
74469,scale,0,0
74470,(,0,1
74471,VAS,0,1
74472,),0,1
74473,was,0,0
74474,used,0,0
74475,to,0,0
74476,measure,0,0
74477,pain,0,0
74478,intensity,0,0
74479,and,0,0
74480,a,0,0
74481,stop-watch,0,1
74482,was,0,0
74483,used,0,0
74484,to,0,0
74485,time,0,0
74486,the,0,0
74487,pain,0,0
74488,period,0,0
74489,.,0,0
74490,Data,0,0
74491,were,0,0
74492,analysed,0,0
74493,using,0,0
74494,chi-square,0,0
74495,test,0,0
74496,",",0,0
74497,Mann-Whitney,0,0
74498,U,0,1
74499,",",0,0
74500,Wilcoxon,0,0
74501,signed,0,0
74502,ranks,0,0
74503,tests,0,0
74504,and,0,0
74505,correlation,0,0
74506,.,0,0
74507,RESULTS,0,0
74508,The,0,0
74509,percentage,0,0
74510,of,0,0
74511,bruising,0,0
74512,occurrence,0,0
74513,was,0,0
74514,64,0,0
74515,%,0,0
74516,with,0,0
74517,the,0,0
74518,injection,0,1
74519,of,0,0
74520,10,0,0
74521,seconds,0,0
74522,duration,0,0
74523,and,0,0
74524,42,0,0
74525,%,0,0
74526,in,0,0
74527,the,0,0
74528,30-second,0,1
74529,injection,0,1
74530,.,0,0
74531,It,0,0
74532,was,0,0
74533,determined,0,0
74534,that,0,0
74535,the,0,0
74536,size,0,0
74537,of,0,0
74538,the,0,0
74539,bruising,0,0
74540,was,0,0
74541,smaller,0,0
74542,in,0,0
74543,the,0,0
74544,30-second,0,1
74545,injection,0,1
74546,.,0,0
74547,Pain,0,0
74548,intensity,0,0
74549,and,0,0
74550,pain,0,0
74551,period,0,0
74552,were,0,0
74553,statistically,0,0
74554,significantly,0,0
74555,lower,0,0
74556,for,0,0
74557,the,0,0
74558,30-second,0,1
74559,injection,0,1
74560,than,0,0
74561,for,0,0
74562,the,0,0
74563,10-second,0,1
74564,injection,0,1
74565,.,0,0
74566,CONCLUSIONS,0,0
74567,It,0,0
74568,was,0,0
74569,determined,0,0
74570,that,0,0
74571,injection,0,1
74572,duration,0,0
74573,had,0,0
74574,an,0,0
74575,effect,0,0
74576,on,0,0
74577,bruising,0,0
74578,and,0,0
74579,pain,0,0
74580,following,0,0
74581,the,0,0
74582,subcutaneous,0,1
74583,administration,0,0
74584,of,0,0
74585,heparin,1,1
74586,.,1,0
74587,This,0,0
74588,study,0,0
74589,should,0,0
74590,be,0,0
74591,repeated,0,0
74592,on,0,0
74593,a,0,0
74594,larger,0,0
74595,sample,0,0
74596,.,0,0
74597,RELEVANCE,0,0
74598,TO,0,0
74599,CLINICAL,0,1
74600,PRACTICE,0,1
74601,When,0,1
74602,administering,0,1
74603,subcutaneous,0,1
74604,heparin,1,1
74605,injections,0,1
74606,",",0,0
74607,it,0,0
74608,is,0,0
74609,important,0,0
74610,to,0,0
74611,extend,0,0
74612,the,0,0
74613,duration,0,0
74614,of,0,0
74615,the,0,0
74616,injection,0,0
74617,.,0,0
74618,An,0,0
74619,exploratory,0,0
74620,",",0,0
74621,pragmatic,0,0
74622,",",0,0
74623,cluster,0,0
74624,randomised,0,0
74625,trial,0,0
74626,of,0,0
74627,practice,1,0
74628,nurse,1,1
74629,training,1,1
74630,in,0,0
74631,the,0,0
74632,use,0,0
74633,of,0,0
74634,asthma,0,0
74635,action,0,0
74636,plans,0,1
74637,.,0,0
74638,INTRODUCTION,0,0
74639,To,0,0
74640,investigate,0,0
74641,the,0,0
74642,feasibility,0,0
74643,of,0,0
74644,improving,0,0
74645,asthma,0,0
74646,management,0,1
74647,-,0,0
74648,in,0,0
74649,particular,0,0
74650,",",0,0
74651,the,0,0
74652,implementation,0,0
74653,of,0,0
74654,individualised,1,1
74655,asthma,1,0
74656,action,1,0
74657,plans,1,1
74658,(,1,0
74659,AAPs,1,0
74660,),1,1
74661,for,0,0
74662,poorly-controlled,0,0
74663,adult,0,0
74664,asthma,0,0
74665,patients,0,0
74666,-,0,0
74667,by,0,0
74668,providing,0,0
74669,training,0,1
74670,in,0,0
74671,asthma-focused,0,1
74672,clinical,0,0
74673,and,0,0
74674,communication,0,1
74675,skills,0,1
74676,for,0,0
74677,practice,0,0
74678,nurses,0,0
74679,who,0,0
74680,deliver,0,0
74681,asthma,0,0
74682,clinics,0,0
74683,.,0,0
74684,METHODS,0,0
74685,A,0,0
74686,pragmatic,0,0
74687,",",0,0
74688,cluster,0,0
74689,randomised,0,0
74690,trial,0,0
74691,with,0,0
74692,an,0,0
74693,intervention,0,1
74694,(,0,0
74695,an,0,0
74696,interactive,0,1
74697,seminar,0,1
74698,),0,0
74699,delivered,0,1
74700,at,0,0
74701,practice,0,1
74702,level,0,0
74703,(,0,0
74704,n=13,0,0
74705,practices,0,0
74706,;,0,0
74707,6=intervention,0,1
74708,",",0,0
74709,7=control,0,0
74710,),0,0
74711,.,0,0
74712,The,0,0
74713,impact,0,0
74714,of,0,0
74715,the,0,0
74716,intervention,0,1
74717,was,0,0
74718,assessed,0,0
74719,against,0,0
74720,patient,0,0
74721,outcomes,0,0
74722,:,0,0
74723,routinely,0,0
74724,available,0,0
74725,asthma,0,0
74726,outcome,0,0
74727,measures,0,0
74728,(,0,0
74729,beta2-agonist,0,1
74730,prescription,0,1
74731,rate,0,0
74732,and,0,0
74733,number,0,0
74734,of,0,0
74735,oral,0,1
74736,steroid,0,1
74737,courses,0,1
74738,),0,0
74739,for,0,0
74740,asthma,0,0
74741,patients,0,0
74742,identified,0,0
74743,as,0,0
74744,being,0,0
74745,poorly-controlled,0,0
74746,from,0,0
74747,practice,0,0
74748,records,0,0
74749,;,0,0
74750,and,0,0
74751,questionnaire,0,0
74752,data,0,0
74753,-,0,0
74754,Mini,0,0
74755,Asthma,0,0
74756,Quality,0,0
74757,of,0,0
74758,Life,0,0
74759,Questionnaire,0,1
74760,(,0,1
74761,AQLQ,0,1
74762,),0,1
74763,and,0,0
74764,the,0,0
74765,Asthma,0,0
74766,Control,0,1
74767,Questionnaire,0,1
74768,(,0,1
74769,ACQ,0,0
74770,),0,1
74771,-,0,0
74772,from,0,0
74773,a,0,0
74774,subset,0,0
74775,of,0,0
74776,consenting,0,0
74777,patients,0,0
74778,.,0,0
74779,Data,0,0
74780,was,0,0
74781,collected,0,0
74782,at,0,0
74783,baseline,0,0
74784,and,0,0
74785,at,0,0
74786,6-month,0,0
74787,follow-up,0,0
74788,.,0,0
74789,ANALYSISs,0,1
74790,:,0,0
74791,Routine,0,1
74792,data,0,0
74793,was,0,0
74794,analysed,0,0
74795,for,0,0
74796,629,0,0
74797,patients,0,0
74798,.,0,0
74799,236,0,0
74800,(,0,0
74801,37,0,0
74802,%,0,0
74803,),0,0
74804,of,0,0
74805,these,0,0
74806,patients,0,0
74807,consented,0,0
74808,to,0,0
74809,provide,0,0
74810,questionnaire,0,0
74811,data,0,0
74812,at,0,0
74813,baseline,0,0
74814,",",0,0
74815,with,0,0
74816,75,0,0
74817,%,0,0
74818,returning,0,0
74819,questionnaires,0,0
74820,at,0,0
74821,follow-up,0,0
74822,.,0,0
74823,After,0,0
74824,adjustment,0,0
74825,for,0,0
74826,baseline,0,0
74827,and,0,0
74828,practice,0,0
74829,",",0,0
74830,there,0,0
74831,was,0,0
74832,a,0,0
74833,significant,0,0
74834,difference,0,0
74835,at,0,0
74836,followup,0,0
74837,between,0,0
74838,intervention,0,1
74839,and,0,0
74840,control,0,1
74841,practices,0,0
74842,on,0,0
74843,the,0,0
74844,Mini,0,0
74845,AQLQ,0,1
74846,only,0,0
74847,(,0,1
74848,p=0.03,0,0
74849,),0,0
74850,.,0,0
74851,Estimates,0,0
74852,for,0,0
74853,subsequent,0,0
74854,sample,0,0
74855,sizes,0,0
74856,to,0,0
74857,inform,0,0
74858,future,0,0
74859,trials,0,0
74860,of,0,0
74861,asthma,0,0
74862,training,0,1
74863,were,0,0
74864,identified,0,0
74865,.,0,0
74866,CONCLUSION,0,0
74867,Training,0,1
74868,designed,0,0
74869,to,0,0
74870,support,0,0
74871,practice,0,0
74872,nurses,0,0
74873,in,0,0
74874,implementing,0,0
74875,individualised,0,1
74876,AAPs,0,0
74877,impacted,0,0
74878,on,0,0
74879,one,0,0
74880,patient,0,0
74881,outcome,0,0
74882,only,0,0
74883,.,0,0
74884,This,0,0
74885,disappointing,0,0
74886,outcome,0,0
74887,may,0,0
74888,have,0,0
74889,been,0,0
74890,due,0,0
74891,to,0,0
74892,many,0,0
74893,different,0,0
74894,factors,0,0
74895,such,0,0
74896,as,0,0
74897,outcome,0,0
74898,measure,0,0
74899,limitations,0,0
74900,",",0,0
74901,data,0,0
74902,collection,0,0
74903,problems,0,0
74904,",",0,0
74905,and,0,0
74906,underestimating,0,0
74907,the,0,0
74908,complexity,0,0
74909,of,0,0
74910,supporting,0,0
74911,practice,0,0
74912,nurses,0,1
74913,in,0,0
74914,behaviour,0,0
74915,change,0,0
74916,.,0,0
74917,Tubeless,1,1
74918,percutaneous,1,1
74919,nephrolithotomy,1,1
74920,:,1,0
74921,safe,0,0
74922,even,0,0
74923,in,0,0
74924,supracostal,0,1
74925,access,0,0
74926,.,0,0
74927,PURPOSE,0,0
74928,This,0,0
74929,study,0,0
74930,was,0,0
74931,designed,0,0
74932,to,0,0
74933,determine,0,0
74934,the,0,0
74935,outcome,0,0
74936,and,0,0
74937,safety,0,0
74938,of,0,0
74939,tubeless,1,1
74940,percutaneous,1,1
74941,nephrolithotomy,1,1
74942,(,1,1
74943,PCNL,1,1
74944,),1,1
74945,in,0,0
74946,the,0,0
74947,treatment,0,0
74948,of,0,0
74949,renal,0,0
74950,calculi,0,0
74951,.,0,1
74952,PATIENTS,0,0
74953,AND,0,0
74954,METHODS,0,0
74955,Between,0,0
74956,November,0,0
74957,2005,0,0
74958,and,0,0
74959,March,0,0
74960,2006,0,0
74961,",",0,0
74962,48,0,0
74963,patients,0,0
74964,were,0,0
74965,randomized,0,0
74966,to,0,0
74967,either,0,0
74968,an,0,0
74969,18F,1,0
74970,Re-entry,1,1
74971,nephrostomy,1,1
74972,tube,1,1
74973,(,0,1
74974,group,0,1
74975,1,0,1
74976,),0,0
74977,or,1,0
74978,a,1,0
74979,6F,1,0
74980,Double-J,1,0
74981,stent,1,1
74982,(,0,1
74983,group,0,1
74984,2,0,0
74985,),0,0
74986,.,0,0
74987,The,0,0
74988,two,0,0
74989,groups,0,0
74990,were,0,0
74991,well,0,0
74992,matched,0,0
74993,for,0,0
74994,age,0,0
74995,",",0,0
74996,sex,0,0
74997,",",0,0
74998,stone,0,0
74999,size,0,0
75000,",",0,0
75001,stone,0,0
75002,laterality,0,0
75003,",",0,0
75004,and,0,0
75005,number,0,0
75006,of,0,0
75007,previous,0,0
75008,renal,0,0
75009,procedures,0,0
75010,.,0,0
75011,All,0,0
75012,PCNL,0,0
75013,procedures,0,0
75014,were,0,0
75015,performed,0,0
75016,by,0,0
75017,the,0,0
75018,same,0,0
75019,surgeon,0,0
75020,.,0,0
75021,Postoperative,0,0
75022,visual,0,0
75023,analog,0,1
75024,pain,0,0
75025,scale,0,0
75026,(,0,1
75027,VAS,0,1
75028,),0,1
75029,scores,0,0
75030,at,0,0
75031,8,0,0
75032,and,0,0
75033,24,0,0
75034,hours,0,0
75035,and,0,0
75036,14,0,0
75037,days,0,0
75038,after,0,0
75039,surgery,0,0
75040,",",0,0
75041,in-hospital,0,0
75042,analgesic,0,1
75043,use,0,0
75044,",",0,0
75045,length,0,0
75046,of,0,0
75047,hospital,0,0
75048,stay,0,0
75049,",",0,0
75050,success,0,0
75051,rate,0,0
75052,",",0,0
75053,blood,0,0
75054,transfusion,0,1
75055,rate,0,0
75056,",",0,0
75057,and,0,0
75058,postoperative,0,0
75059,complications,0,0
75060,were,0,0
75061,compared,0,0
75062,for,0,0
75063,the,0,0
75064,two,0,0
75065,groups,0,0
75066,.,0,0
75067,RESULTS,0,0
75068,The,0,0
75069,mean,0,0
75070,hospital,0,0
75071,stays,0,0
75072,in,0,0
75073,groups,0,0
75074,1,0,0
75075,and,0,0
75076,2,0,0
75077,were,0,0
75078,3.1,0,0
75079,and,0,0
75080,1.6,0,0
75081,days,0,0
75082,",",0,0
75083,respectively,0,0
75084,(,0,0
75085,P,0,0
75086,=,0,0
75087,0.003,0,0
75088,),0,0
75089,.,0,0
75090,The,0,0
75091,mean,0,0
75092,VAS,0,1
75093,scores,0,0
75094,8,0,0
75095,and,0,0
75096,24,0,0
75097,hours,0,0
75098,after,0,0
75099,surgery,0,0
75100,were,0,0
75101,significantly,0,0
75102,lower,0,0
75103,in,0,0
75104,group,0,0
75105,2,0,0
75106,than,0,0
75107,in,0,0
75108,group,0,0
75109,1,0,0
75110,(,0,0
75111,P,0,0
75112,=,0,0
75113,0.001,0,0
75114,),0,0
75115,.,0,0
75116,The,0,0
75117,postoperative,0,0
75118,analgesic,0,1
75119,requirement,0,0
75120,(,1,1
75121,diclofenac,1,1
75122,sodium,1,1
75123,),1,0
75124,was,0,0
75125,significantly,0,0
75126,higher,0,0
75127,in,0,0
75128,group,0,0
75129,1,0,0
75130,(,0,0
75131,263,0,0
75132,mg,0,1
75133,),0,0
75134,than,0,0
75135,in,0,0
75136,group,0,0
75137,2,0,0
75138,(,0,0
75139,120,0,0
75140,mg,0,1
75141,;,0,0
75142,P,0,0
75143,=,0,0
75144,0.02,0,0
75145,),0,0
75146,.,0,0
75147,The,0,0
75148,rate,0,0
75149,of,0,0
75150,blood,0,0
75151,transfusion,0,1
75152,in,0,0
75153,the,0,0
75154,two,0,0
75155,groups,0,0
75156,was,0,0
75157,similar,0,0
75158,(,0,0
75159,P,0,0
75160,=,0,0
75161,NS,0,0
75162,),0,0
75163,.,0,0
75164,There,0,0
75165,was,0,0
75166,no,0,0
75167,difference,0,0
75168,between,0,0
75169,the,0,0
75170,groups,0,0
75171,in,0,0
75172,VAS,0,1
75173,scores,0,0
75174,on,0,0
75175,postoperative,0,0
75176,day,0,0
75177,14,0,0
75178,.,0,0
75179,The,0,0
75180,number,0,0
75181,of,0,0
75182,supracostal,0,1
75183,accesses,0,0
75184,was,0,0
75185,significantly,0,0
75186,higher,0,0
75187,in,0,0
75188,group,0,0
75189,2,0,0
75190,than,0,0
75191,in,0,0
75192,group,0,0
75193,1,0,0
75194,(,0,0
75195,P,0,0
75196,=,0,0
75197,0.02,0,0
75198,),0,0
75199,.,0,0
75200,The,0,0
75201,stone-free,0,0
75202,rates,0,0
75203,and,0,0
75204,the,0,0
75205,numbers,0,0
75206,of,0,0
75207,patients,0,0
75208,with,0,0
75209,insignificant,0,0
75210,residual,0,0
75211,fragments,0,0
75212,were,0,0
75213,similar,0,0
75214,in,0,0
75215,the,0,0
75216,two,0,0
75217,groups,0,0
75218,.,0,0
75219,There,0,0
75220,was,0,0
75221,no,0,0
75222,urine,0,0
75223,leakage,0,0
75224,or,0,1
75225,formation,0,0
75226,of,0,0
75227,urinoma,0,0
75228,in,0,0
75229,patients,0,0
75230,with,0,0
75231,Double-J,0,0
75232,stents,0,1
75233,.,0,0
75234,CONCLUSION,0,0
75235,Tubeless,1,1
75236,PCNL,1,1
75237,is,0,0
75238,safe,0,0
75239,and,0,0
75240,effective,0,0
75241,even,0,0
75242,after,0,0
75243,supracostal,0,1
75244,access,0,0
75245,and,0,0
75246,is,0,0
75247,associated,0,0
75248,with,0,0
75249,less,0,0
75250,postoperative,0,0
75251,pain,0,0
75252,and,0,0
75253,a,0,0
75254,shorter,0,0
75255,hospital,0,0
75256,stay,0,0
75257,.,0,0
75258,Oral,0,1
75259,amoxicillin,1,1
75260,vs.,0,0
75261,oral,0,1
75262,erythromycin,1,1
75263,in,0,0
75264,the,0,0
75265,treatment,0,0
75266,of,0,0
75267,pyoderma,0,0
75268,in,0,0
75269,Bamako,0,0
75270,",",0,0
75271,Mali,0,0
75272,:,0,0
75273,an,0,0
75274,open,0,1
75275,randomized,0,0
75276,trial,0,0
75277,.,0,0
75278,BACKGROUND,0,0
75279,Pyoderma,0,1
75280,(,0,0
75281,bacterial,0,0
75282,superficial,0,1
75283,skin,0,0
75284,infection,0,0
75285,),0,1
75286,is,0,0
75287,an,0,0
75288,extremely,0,0
75289,common,0,0
75290,disorder,0,0
75291,in,0,0
75292,tropical,0,0
75293,developing,0,0
75294,countries,0,0
75295,.,0,0
75296,In,0,0
75297,these,0,0
75298,settings,0,0
75299,",",0,0
75300,Streptococcus,0,0
75301,pyogenes,0,1
75302,is,0,0
75303,considered,0,0
75304,to,0,0
75305,be,0,0
75306,the,0,0
75307,main,0,0
75308,etiological,0,0
75309,agent,0,0
75310,.,0,0
75311,Apart,0,0
75312,from,0,0
75313,epidemics,0,0
75314,of,0,0
75315,poststreptococcal,0,0
75316,glomerulonephritis,0,0
75317,where,0,0
75318,mass,0,0
75319,treatment,0,0
75320,with,0,0
75321,intramuscular,0,1
75322,benzathine-penicillin,1,1
75323,is,0,0
75324,recommended,0,0
75325,",",0,0
75326,no,0,0
75327,recommendation,0,0
75328,exists,0,0
75329,for,0,0
75330,the,0,0
75331,treatment,0,0
75332,of,0,0
75333,pyoderma,0,0
75334,in,0,0
75335,this,0,0
75336,setting,0,0
75337,.,0,0
75338,The,0,0
75339,aim,0,0
75340,of,0,0
75341,this,0,0
75342,study,0,0
75343,was,0,0
75344,to,0,0
75345,evaluate,0,0
75346,the,0,0
75347,efficacy,0,0
75348,of,0,0
75349,oral,0,1
75350,amoxicillin,1,1
75351,in,0,0
75352,the,0,0
75353,treatment,0,0
75354,of,0,0
75355,pyoderma,0,0
75356,in,0,0
75357,Mali,0,0
75358,",",0,0
75359,by,0,0
75360,comparison,0,0
75361,with,0,0
75362,oral,0,1
75363,erythromycin,1,1
75364,.,1,0
75365,METHODS,0,0
75366,In,0,0
75367,Bamako,0,0
75368,",",0,0
75369,132,0,0
75370,patients,0,0
75371,with,0,0
75372,pyoderma,0,0
75373,",",0,0
75374,diagnosed,0,0
75375,and,0,0
75376,graded,0,0
75377,as,0,0
75378,severe,0,0
75379,on,0,0
75380,clinical,0,0
75381,grounds,0,0
75382,",",0,0
75383,were,0,0
75384,randomly,0,0
75385,assigned,0,0
75386,to,0,0
75387,an,0,0
75388,oral,0,1
75389,treatment,0,0
75390,by,0,0
75391,either,0,1
75392,amoxicillin,1,1
75393,(,0,0
75394,50,0,0
75395,mg/kg,0,1
75396,per,0,0
75397,day,0,0
75398,),0,1
75399,or,0,1
75400,erythromycin,1,1
75401,;,1,0
75402,infections,0,0
75403,of,0,0
75404,the,0,0
75405,follicular,0,0
75406,appendage,0,0
75407,were,0,0
75408,excluded,0,0
75409,.,0,0
75410,Both,0,0
75411,drugs,0,0
75412,were,0,0
75413,associated,0,0
75414,with,0,0
75415,the,0,0
75416,topical,0,1
75417,application,0,1
75418,of,0,0
75419,povidone,0,1
75420,iodine,0,1
75421,.,0,0
75422,The,0,0
75423,patients,0,0
75424,were,0,0
75425,evaluated,0,0
75426,openly,0,1
75427,at,0,0
75428,the,0,0
75429,seventh,0,0
75430,day,0,0
75431,of,0,0
75432,treatment,0,0
75433,for,0,0
75434,cure,0,0
75435,or,0,1
75436,marked,0,0
75437,improvement,0,0
75438,of,0,0
75439,the,0,0
75440,clinical,0,0
75441,features,0,0
75442,",",0,0
75443,indicating,0,0
75444,successful,0,0
75445,treatment,0,0
75446,.,0,0
75447,RESULTS,0,0
75448,Three,0,0
75449,patients,0,0
75450,were,0,0
75451,lost,0,0
75452,to,0,0
75453,follow-up,0,0
75454,.,0,0
75455,Treatment,0,0
75456,was,0,0
75457,successful,0,0
75458,in,0,0
75459,57,0,0
75460,of,0,0
75461,64,0,0
75462,patients,0,0
75463,treated,0,0
75464,with,0,0
75465,amoxicillin,0,1
75466,vs.,0,0
75467,58,0,0
75468,of,0,0
75469,65,0,0
75470,patients,0,0
75471,treated,0,0
75472,with,0,0
75473,erythromycin,0,1
75474,(,0,0
75475,P,0,0
75476,=,0,0
75477,0.00,0,0
75478,),0,0
75479,.,0,0
75480,CONCLUSIONS,0,0
75481,Amoxicillin,0,1
75482,was,0,0
75483,as,0,0
75484,efficacious,0,0
75485,as,0,0
75486,erythromycin,0,1
75487,in,0,0
75488,the,0,0
75489,treatment,0,0
75490,of,0,0
75491,severe,0,0
75492,pyoderma,0,0
75493,in,0,0
75494,Mali,0,1
75495,.,0,0
75496,Owing,0,0
75497,to,0,0
75498,its,0,0
75499,efficacy,0,0
75500,",",0,0
75501,added,0,0
75502,to,0,0
75503,high,0,0
75504,availability,0,0
75505,and,0,0
75506,low,0,0
75507,cost,0,0
75508,",",0,0
75509,this,0,0
75510,compound,0,1
75511,should,0,0
75512,be,0,0
75513,considered,0,0
75514,a,0,0
75515,first-line,0,1
75516,treatment,0,0
75517,of,0,0
75518,this,0,0
75519,disorder,0,0
75520,in,0,0
75521,this,0,0
75522,country,0,0
75523,",",0,0
75524,and,0,0
75525,perhaps,0,0
75526,in,0,0
75527,other,0,0
75528,countries,0,0
75529,where,0,0
75530,this,0,0
75531,condition,0,0
75532,presents,0,0
75533,in,0,0
75534,a,0,0
75535,similar,0,0
75536,way,0,0
75537,.,0,0
75538,Assessment,0,1
75539,of,0,0
75540,response,0,0
75541,to,0,0
75542,induction,0,1
75543,therapy,0,1
75544,and,0,0
75545,its,0,0
75546,influence,0,0
75547,on,0,0
75548,5-year,0,0
75549,failure-free,0,0
75550,survival,0,0
75551,in,0,0
75552,group,0,0
75553,III,0,1
75554,rhabdomyosarcoma,0,0
75555,:,0,0
75556,the,0,0
75557,Intergroup,0,0
75558,Rhabdomyosarcoma,0,0
75559,Study-IV,0,1
75560,experience,0,0
75561,--,0,0
75562,a,0,0
75563,report,0,0
75564,from,0,0
75565,the,0,0
75566,Soft,0,1
75567,Tissue,0,0
75568,Sarcoma,0,0
75569,Committee,0,0
75570,of,0,0
75571,the,0,0
75572,Children,0,0
75573,'s,0,0
75574,Oncology,0,0
75575,Group,0,0
75576,.,0,0
75577,PURPOSE,0,0
75578,Initial,0,0
75579,response,0,0
75580,to,0,0
75581,induction,1,0
75582,chemotherapy,1,1
75583,predicts,0,0
75584,failure-free,0,0
75585,survival,0,0
75586,(,0,1
75587,FFS,0,1
75588,),0,1
75589,in,0,0
75590,osteosarcoma,0,0
75591,and,0,0
75592,Ewing,0,0
75593,'s,0,0
75594,sarcoma,0,0
75595,.,0,0
75596,For,0,0
75597,Intergroup,0,0
75598,Rhabdomyosarcoma,0,0
75599,Study,0,0
75600,(,0,1
75601,IRS,0,1
75602,),0,1
75603,IV,0,0
75604,patients,0,0
75605,with,0,0
75606,group,0,0
75607,III,0,1
75608,rhabdomyosarcoma,0,0
75609,",",0,0
75610,we,0,0
75611,assessed,0,0
75612,whether,0,0
75613,reported,0,0
75614,response,0,0
75615,assessed,0,0
75616,by,0,0
75617,anatomic,0,0
75618,imaging,0,0
75619,at,0,0
75620,week,0,0
75621,8,0,0
75622,predicted,0,0
75623,FFS,0,0
75624,.,0,0
75625,PATIENTS,0,0
75626,AND,0,0
75627,METHODS,0,0
75628,We,0,0
75629,studied,0,0
75630,444,0,0
75631,group,0,0
75632,III,0,0
75633,patients,0,0
75634,who,0,0
75635,received,0,0
75636,induction,1,0
75637,therapy,1,1
75638,",",0,0
75639,had,0,0
75640,response,0,0
75641,assessed,0,0
75642,at,0,0
75643,week,0,0
75644,8,0,0
75645,by,0,0
75646,anatomic,1,0
75647,imaging,1,0
75648,",",1,0
75649,and,1,0
75650,continued,1,0
75651,with,1,0
75652,protocol,1,0
75653,therapy,1,1
75654,.,1,0
75655,Induction,1,0
75656,chemotherapy,1,1
75657,was,0,0
75658,generally,0,0
75659,followed,0,1
75660,by,0,0
75661,radiation,1,1
75662,therapy,1,1
75663,(,1,1
75664,RT,1,1
75665,),1,1
75666,starting,0,0
75667,after,0,0
75668,week,0,0
75669,9,0,0
75670,.,0,0
75671,Response,0,0
75672,to,0,0
75673,induction,0,0
75674,therapy,0,1
75675,was,0,0
75676,determined,0,0
75677,at,0,0
75678,weeks,0,0
75679,0,0,0
75680,and,0,0
75681,8,0,0
75682,.,0,0
75683,Local,0,0
75684,institutions,0,0
75685,coded,0,0
75686,response,0,0
75687,.,0,0
75688,RESULTS,0,0
75689,Response,0,0
75690,rate,0,0
75691,for,0,0
75692,the,0,0
75693,entire,0,0
75694,cohort,0,0
75695,at,0,0
75696,week,0,0
75697,8,0,0
75698,was,0,0
75699,77,0,0
75700,%,0,0
75701,(,0,0
75702,95,0,0
75703,%,0,0
75704,CI,0,0
75705,",",0,0
75706,73,0,0
75707,%,0,0
75708,to,0,0
75709,81,0,0
75710,%,0,0
75711,;,0,0
75712,complete,0,0
75713,response,0,0
75714,[,0,0
75715,CR,0,1
75716,],0,0
75717,",",0,0
75718,21,0,0
75719,%,0,0
75720,;,0,0
75721,partial,0,0
75722,response,0,0
75723,[,0,0
75724,PR,0,1
75725,],0,0
75726,",",0,0
75727,56,0,0
75728,%,0,0
75729,),0,1
75730,but,0,0
75731,response,0,0
75732,had,0,0
75733,no,0,0
75734,influence,0,0
75735,on,0,0
75736,FFS,0,1
75737,(,0,0
75738,P,0,0
75739,=,0,0
75740,.57,0,0
75741,),0,0
75742,.,0,0
75743,Two,0,0
75744,hundred,0,0
75745,seventy-two,0,0
75746,patients,0,0
75747,received,0,0
75748,standard-timing,0,1
75749,RT,0,1
75750,at,0,0
75751,week,0,0
75752,9,0,0
75753,and,0,0
75754,thus,0,0
75755,only,0,0
75756,chemotherapy,0,1
75757,during,0,0
75758,induction,0,0
75759,.,0,0
75760,Response,0,0
75761,rate,0,0
75762,was,0,0
75763,81,0,0
75764,%,0,0
75765,(,0,0
75766,95,0,0
75767,%,0,0
75768,CI,0,0
75769,",",0,0
75770,76,0,0
75771,%,0,0
75772,to,0,0
75773,86,0,0
75774,%,0,0
75775,;,0,0
75776,CR,0,1
75777,",",0,0
75778,22,0,0
75779,%,0,0
75780,;,0,0
75781,PR,0,1
75782,",",0,0
75783,59,0,0
75784,%,0,0
75785,),0,0
75786,.,0,0
75787,In,0,0
75788,these,0,0
75789,patients,0,0
75790,",",0,0
75791,response,0,0
75792,did,0,0
75793,not,0,0
75794,influence,0,0
75795,FFS,0,0
75796,except,0,0
75797,for,0,0
75798,those,0,0
75799,with,0,0
75800,alveolar,0,0
75801,histology,0,0
75802,.,0,0
75803,One,0,0
75804,hundred,0,0
75805,thirty-two,0,0
75806,other,0,0
75807,patients,0,0
75808,received,0,1
75809,chemotherapy,0,1
75810,and,0,0
75811,RT,0,1
75812,during,0,1
75813,induction,0,1
75814,(,0,0
75815,up-front,0,1
75816,RT,0,1
75817,),0,0
75818,.,0,0
75819,Response,0,0
75820,rate,0,0
75821,was,0,0
75822,65,0,0
75823,%,0,0
75824,(,0,0
75825,95,0,0
75826,%,0,0
75827,CI,0,0
75828,",",0,0
75829,57,0,0
75830,%,0,0
75831,to,0,0
75832,73,0,0
75833,%,0,0
75834,;,0,0
75835,CR,0,1
75836,",",0,0
75837,12,0,0
75838,%,0,0
75839,;,0,0
75840,PR,0,1
75841,",",0,0
75842,53,0,0
75843,%,0,0
75844,),0,0
75845,",",0,0
75846,but,0,0
75847,response,0,0
75848,had,0,0
75849,no,0,0
75850,influence,0,0
75851,on,0,0
75852,FFS,0,1
75853,(,0,0
75854,P,0,0
75855,=,0,0
75856,.69,0,0
75857,),0,0
75858,.,0,0
75859,Forty,0,0
75860,patients,0,0
75861,received,0,0
75862,no,0,0
75863,RT,0,0
75864,at,0,0
75865,all,0,0
75866,(,0,0
75867,protocol,0,1
75868,violation,0,0
75869,),0,1
75870,and,0,0
75871,response,0,0
75872,to,0,0
75873,induction,0,0
75874,therapy,0,1
75875,had,0,0
75876,no,0,0
75877,effect,0,0
75878,on,0,0
75879,FFS,0,0
75880,.,0,0
75881,CONCLUSION,0,0
75882,In,0,0
75883,IRS-IV,0,0
75884,",",0,0
75885,response,0,0
75886,rate,0,0
75887,to,0,0
75888,induction,0,0
75889,therapy,0,1
75890,was,0,0
75891,77,0,0
75892,%,0,0
75893,in,0,0
75894,group,0,0
75895,III,0,0
75896,patients,0,0
75897,",",0,0
75898,was,0,0
75899,independent,0,0
75900,of,0,0
75901,histology,0,0
75902,",",0,0
75903,and,0,0
75904,had,0,0
75905,no,0,0
75906,influence,0,0
75907,on,0,0
75908,FFS,0,0
75909,overall,0,0
75910,.,0,0
75911,Hitting,0,0
75912,the,0,0
75913,target,0,0
75914,:,0,0
75915,relatively,0,0
75916,easy,0,0
75917,",",0,0
75918,yet,0,0
75919,absolutely,0,0
75920,difficult,0,0
75921,.,0,0
75922,It,0,0
75923,is,0,0
75924,generally,0,0
75925,agreed,0,0
75926,that,0,0
75927,absolute-direction,0,0
75928,judgments,0,0
75929,require,0,0
75930,information,0,0
75931,about,0,0
75932,eye,0,1
75933,position,0,0
75934,",",0,0
75935,whereas,0,0
75936,relative-direction,0,1
75937,judgments,0,0
75938,do,0,0
75939,not,0,0
75940,.,0,0
75941,The,0,0
75942,source,0,0
75943,of,0,0
75944,this,0,0
75945,eye-position,0,0
75946,information,0,0
75947,",",0,0
75948,particularly,0,0
75949,during,0,0
75950,monocular,0,1
75951,viewing,0,1
75952,",",0,0
75953,is,0,0
75954,a,0,0
75955,matter,0,0
75956,of,0,0
75957,debate,0,0
75958,.,0,0
75959,It,0,0
75960,may,0,0
75961,be,0,0
75962,either,0,0
75963,binocular,0,1
75964,eye,0,1
75965,position,0,0
75966,",",0,0
75967,or,0,1
75968,the,0,0
75969,position,0,0
75970,of,0,0
75971,the,0,0
75972,viewing-eye,0,1
75973,only,0,0
75974,",",0,0
75975,that,0,0
75976,is,0,0
75977,crucial,0,0
75978,.,0,0
75979,Using,0,0
75980,more,0,0
75981,ecologically,0,0
75982,valid,0,0
75983,stimulus,0,0
75984,situations,0,0
75985,than,0,0
75986,the,0,0
75987,traditional,0,1
75988,LED,0,0
75989,in,0,0
75990,the,0,0
75991,dark,0,1
75992,",",0,0
75993,we,0,0
75994,performed,0,0
75995,two,0,0
75996,experiments,0,0
75997,.,0,0
75998,In,0,0
75999,experiment,0,0
76000,1,0,0
76001,",",0,0
76002,observers,1,0
76003,threw,1,0
76004,darts,1,0
76005,at,1,0
76006,targets,1,0
76007,that,1,0
76008,were,1,0
76009,fixated,1,0
76010,either,1,0
76011,monocularly,1,1
76012,or,1,0
76013,binocularly,1,1
76014,.,1,0
76015,In,0,0
76016,experiment,0,0
76017,2,0,0
76018,",",0,0
76019,observers,1,0
76020,aimed,1,0
76021,a,1,0
76022,laser,1,1
76023,gun,1,1
76024,at,1,0
76025,targets,1,0
76026,while,1,0
76027,fixating,1,0
76028,either,1,1
76029,the,1,0
76030,rear,1,1
76031,or,1,1
76032,the,1,0
76033,front,1,0
76034,gunsight,1,0
76035,monocularly,1,1
76036,",",1,0
76037,or,1,1
76038,the,1,0
76039,target,1,0
76040,either,1,1
76041,monocularly,1,1
76042,or,1,1
76043,binocularly,1,1
76044,.,1,0
76045,We,0,0
76046,measured,0,0
76047,the,0,0
76048,accuracy,0,0
76049,and,0,0
76050,precision,0,0
76051,of,0,0
76052,the,0,0
76053,observers,0,0
76054,',0,0
76055,absolute-,0,0
76056,and,0,0
76057,relative-direction,0,1
76058,judgments,0,0
76059,.,0,0
76060,We,0,0
76061,found,0,0
76062,that,0,0
76063,(,0,0
76064,a,0,0
76065,),0,1
76066,relative-direction,0,1
76067,judgments,0,0
76068,were,0,0
76069,precise,0,0
76070,and,0,0
76071,independent,0,0
76072,of,0,0
76073,phoria,0,0
76074,",",0,0
76075,and,0,0
76076,(,0,1
76077,b,0,0
76078,),0,1
76079,monocular,0,1
76080,absolute-direction,0,0
76081,judgments,0,0
76082,were,0,0
76083,inaccurate,0,0
76084,",",0,0
76085,and,0,0
76086,the,0,0
76087,magnitude,0,0
76088,of,0,0
76089,the,0,0
76090,inaccuracy,0,0
76091,was,0,0
76092,predictable,0,0
76093,from,0,0
76094,the,0,0
76095,magnitude,0,0
76096,of,0,0
76097,phoria,0,0
76098,.,0,0
76099,These,0,0
76100,results,0,0
76101,confirm,0,0
76102,that,0,0
76103,relative-direction,0,1
76104,judgments,0,0
76105,do,0,0
76106,not,0,0
76107,require,0,0
76108,information,0,0
76109,about,0,0
76110,eye,0,0
76111,position,0,0
76112,.,0,0
76113,Moreover,0,0
76114,",",0,0
76115,they,0,0
76116,show,0,0
76117,that,0,0
76118,binocular,0,1
76119,eye-position,0,1
76120,information,0,1
76121,is,0,0
76122,crucial,0,0
76123,when,0,0
76124,judging,0,0
76125,the,0,0
76126,absolute,0,0
76127,direction,0,0
76128,of,0,0
76129,both,0,0
76130,monocular,0,1
76131,and,0,0
76132,binocular,0,1
76133,targets,0,0
76134,.,0,0
76135,The,0,0
76136,value-congruence,0,0
76137,model,0,0
76138,of,0,0
76139,memory,0,0
76140,for,0,0
76141,emotional,0,0
76142,experiences,0,0
76143,:,0,0
76144,an,0,0
76145,explanation,0,0
76146,for,0,0
76147,cultural,0,0
76148,differences,0,0
76149,in,0,0
76150,emotional,0,0
76151,self-reports,0,0
76152,.,0,0
76153,In,0,0
76154,3,0,0
76155,studies,0,0
76156,",",0,0
76157,the,0,0
76158,authors,0,0
76159,found,0,0
76160,support,0,0
76161,for,0,0
76162,the,0,0
76163,value-congruence,1,0
76164,model,1,0
76165,that,0,0
76166,accounts,0,0
76167,for,0,0
76168,cultural,0,0
76169,variations,0,0
76170,in,0,0
76171,memory,0,0
76172,for,0,0
76173,emotional,0,0
76174,experiences,0,0
76175,.,0,0
76176,In,0,0
76177,Study,0,0
76178,1,0,0
76179,",",0,0
76180,the,0,0
76181,authors,0,0
76182,found,0,0
76183,that,0,0
76184,in,0,0
76185,the,0,0
76186,made-in-the-U.S.,1,1
76187,scenario,1,0
76188,condition,0,0
76189,",",0,0
76190,European,0,0
76191,Americans,0,0
76192,were,0,0
76193,more,0,0
76194,accurate,0,0
76195,than,0,0
76196,were,0,0
76197,Asian,0,0
76198,Americans,0,0
76199,in,0,0
76200,their,0,0
76201,retrospective,0,0
76202,frequency,0,0
76203,judgments,0,0
76204,of,0,0
76205,emotions,0,0
76206,.,0,0
76207,However,0,0
76208,",",0,0
76209,in,0,0
76210,the,0,0
76211,made-in-Japan,1,1
76212,scenario,1,0
76213,condition,0,0
76214,",",0,0
76215,European,0,0
76216,Americans,0,0
76217,were,0,0
76218,less,0,0
76219,accurate,0,0
76220,than,0,0
76221,were,0,0
76222,Asian,0,0
76223,Americans,0,0
76224,.,0,0
76225,In,0,0
76226,Study,0,0
76227,2,0,0
76228,",",0,0
76229,the,0,0
76230,authors,0,0
76231,demonstrated,0,0
76232,that,0,0
76233,value,0,0
76234,orientation,0,0
76235,mediates,0,0
76236,the,0,0
76237,CulturexType,0,0
76238,of,0,0
76239,Event,0,1
76240,congruence,0,0
76241,effect,0,0
76242,.,0,0
76243,In,0,0
76244,Study,0,0
76245,3,0,0
76246,(,0,0
76247,a,0,0
76248,daily,1,1
76249,event,1,0
76250,sampling,1,0
76251,study,1,0
76252,),1,0
76253,",",0,0
76254,the,0,0
76255,authors,0,0
76256,showed,0,0
76257,that,0,0
76258,the,0,0
76259,congruence,0,0
76260,effect,0,0
76261,was,0,0
76262,explained,0,0
76263,by,0,0
76264,the,0,0
76265,importance,0,0
76266,of,0,0
76267,parental,0,0
76268,approval,0,0
76269,.,0,0
76270,In,0,0
76271,sum,0,0
76272,",",0,0
76273,emotional,0,0
76274,events,0,0
76275,congruent,0,0
76276,with,0,0
76277,personal,0,1
76278,values,0,0
76279,remain,0,0
76280,in,0,0
76281,memory,0,0
76282,longer,0,0
76283,and,0,0
76284,influence,0,0
76285,retrospective,0,0
76286,frequency,0,0
76287,judgments,0,0
76288,of,0,0
76289,emotion,0,0
76290,more,0,0
76291,than,0,0
76292,do,0,0
76293,incongruent,0,0
76294,events,0,0
76295,.,0,0
76296,Results,0,0
76297,of,0,0
76298,a,0,0
76299,phase,0,0
76300,III,0,0
76301,",",0,0
76302,8-week,0,0
76303,",",0,0
76304,multicenter,0,0
76305,",",0,0
76306,prospective,0,0
76307,",",0,0
76308,randomized,0,0
76309,",",0,0
76310,double-blind,0,0
76311,",",0,0
76312,parallel-group,0,0
76313,clinical,0,0
76314,trial,0,0
76315,to,0,0
76316,assess,0,0
76317,the,0,0
76318,effects,0,0
76319,of,0,0
76320,amlodipine,1,1
76321,camsylate,1,1
76322,versus,0,1
76323,amlodipine,1,1
76324,besylate,1,1
76325,in,0,0
76326,Korean,0,0
76327,adults,0,0
76328,with,0,0
76329,mild,0,0
76330,to,0,0
76331,moderate,0,0
76332,hypertension,0,0
76333,.,0,0
76334,BACKGROUND,0,0
76335,Amlodipine,1,1
76336,besylate,1,1
76337,has,0,0
76338,been,0,0
76339,used,0,0
76340,in,0,0
76341,Korea,0,0
76342,for,0,0
76343,the,0,0
76344,treatment,0,0
76345,of,0,0
76346,hypertension,0,0
76347,for,0,0
76348,>,0,0
76349,17,0,0
76350,years,0,0
76351,",",0,0
76352,with,0,0
76353,well-established,0,0
76354,efficacy,0,0
76355,and,0,0
76356,tolerability,0,0
76357,.,0,1
76358,Amlodipine,1,1
76359,camsylate,1,1
76360,is,0,0
76361,a,0,0
76362,newer,0,0
76363,formulation,0,0
76364,developed,0,0
76365,for,0,0
76366,generic,0,0
76367,use,0,0
76368,.,0,0
76369,It,0,0
76370,has,0,0
76371,been,0,0
76372,assessed,0,0
76373,in,0,0
76374,terms,0,0
76375,of,0,0
76376,physical,0,1
76377,stability,0,0
76378,and,0,0
76379,pharmacokinetic,0,0
76380,and,0,0
76381,pharmacodynamic,0,0
76382,properties,0,0
76383,and,0,0
76384,been,0,0
76385,found,0,0
76386,to,0,0
76387,be,0,0
76388,effective,0,0
76389,in,0,0
76390,lowering,0,0
76391,blood,0,0
76392,pressure,0,0
76393,in,0,0
76394,preclinical,0,0
76395,and,0,0
76396,Phase,0,1
76397,I,0,0
76398,and,0,0
76399,II,0,0
76400,trials,0,0
76401,.,0,0
76402,However,0,0
76403,",",0,0
76404,to,0,0
76405,date,0,0
76406,",",0,0
76407,no,0,0
76408,studies,0,0
76409,have,0,0
76410,compared,0,0
76411,the,0,0
76412,clinical,0,0
76413,effectiveness,0,0
76414,of,0,0
76415,amlodipine,1,1
76416,camsylate,1,1
76417,and,0,0
76418,amlodipine,1,1
76419,besylate,1,1
76420,in,0,0
76421,treating,0,0
76422,hypertension,0,0
76423,.,0,0
76424,OBJECTIVE,0,0
76425,This,0,0
76426,study,0,0
76427,was,0,0
76428,designed,0,0
76429,to,0,0
76430,determine,0,0
76431,the,0,0
76432,effectiveness,0,0
76433,and,0,0
76434,tolerability,0,0
76435,of,0,0
76436,amlodipine,1,1
76437,camsylate,1,1
76438,compared,0,0
76439,with,0,0
76440,amlodipine,1,1
76441,besylate,1,1
76442,in,0,0
76443,Korean,0,0
76444,patients,0,0
76445,with,0,0
76446,mild,0,0
76447,to,0,0
76448,moderate,0,0
76449,hypertension,0,0
76450,.,0,0
76451,METHODS,0,0
76452,This,0,0
76453,Phase,0,0
76454,III,0,0
76455,",",0,0
76456,8-week,0,0
76457,",",0,0
76458,prospective,0,0
76459,",",0,0
76460,randomized,0,0
76461,",",0,0
76462,double-blind,0,0
76463,",",0,0
76464,parallel-group,0,0
76465,study,0,0
76466,was,0,0
76467,conducted,0,0
76468,in,0,0
76469,13,0,0
76470,cardiology,0,0
76471,centers,0,0
76472,across,0,0
76473,the,0,0
76474,Republic,0,0
76475,of,0,0
76476,Korea,0,0
76477,.,0,0
76478,Male,0,0
76479,and,0,0
76480,female,0,0
76481,Korean,0,0
76482,patients,0,0
76483,aged,0,0
76484,18,0,0
76485,to,0,0
76486,75,0,0
76487,years,0,0
76488,having,0,0
76489,uncomplicated,0,0
76490,",",0,0
76491,mild,0,0
76492,to,0,0
76493,moderate,0,0
76494,",",0,0
76495,essential,0,0
76496,hypertension,0,0
76497,(,0,1
76498,sitting,0,1
76499,diastolic,0,0
76500,blood,0,0
76501,pressure,0,0
76502,[,0,0
76503,SiDBP,0,0
76504,],0,0
76505,90-,0,1
76506,<,0,0
76507,110,0,0
76508,mm,0,0
76509,Hg,0,0
76510,),0,1
76511,and,0,0
76512,receiving,0,0
76513,no,0,0
76514,antihypertensives,0,1
76515,in,0,0
76516,the,0,0
76517,2,0,0
76518,weeks,0,0
76519,before,0,0
76520,randomization,0,0
76521,were,0,0
76522,eligible,0,0
76523,.,0,0
76524,Patients,0,0
76525,were,0,0
76526,randomly,1,0
76527,assigned,1,0
76528,to,1,0
76529,receive,1,0
76530,oral,1,1
76531,treatment,1,0
76532,with,1,0
76533,amlodipine,1,1
76534,camsylate,1,1
76535,or,1,1
76536,amlodipine,1,1
76537,besylate,1,1
76538,.,1,0
76539,For,1,0
76540,the,1,0
76541,first,1,0
76542,4,1,0
76543,weeks,1,0
76544,",",1,0
76545,patients,1,0
76546,received,1,0
76547,amlodipine,1,1
76548,5,1,0
76549,mg,1,1
76550,QD,1,1
76551,(,1,1
76552,morning,1,0
76553,),1,0
76554,.,1,0
76555,After,1,0
76556,4,1,0
76557,weeks,1,0
76558,",",1,0
76559,if,1,0
76560,either,1,1
76561,blood,1,0
76562,pressure,1,0
76563,was,1,0
76564,>,1,0
76565,or,1,1
76566,=140/,1,0
76567,>,1,0
76568,or,1,1
76569,=90,1,0
76570,mm,1,0
76571,Hg,1,0
76572,or,1,1
76573,SiDBP,1,0
76574,had,1,0
76575,not,1,0
76576,decreased,1,0
76577,by,1,0
76578,>,1,0
76579,or,1,1
76580,=10,1,0
76581,mm,1,0
76582,Hg,1,0
76583,from,1,0
76584,baseline,1,0
76585,",",1,0
76586,the,1,0
76587,dose,1,0
76588,of,1,0
76589,amlodipine,1,1
76590,was,1,0
76591,increased,1,0
76592,to,1,0
76593,10,1,0
76594,mg,1,1
76595,QD,1,0
76596,for,1,0
76597,4,1,0
76598,weeks,1,0
76599,.,1,0
76600,Trough,1,0
76601,blood,1,0
76602,pressure,1,0
76603,and,1,0
76604,heart,1,0
76605,rate,1,0
76606,were,1,0
76607,measured,1,0
76608,in,1,0
76609,duplicate,1,0
76610,with,1,0
76611,the,1,0
76612,patient,1,0
76613,in,1,0
76614,the,1,0
76615,sitting,1,0
76616,position,1,0
76617,at,1,0
76618,each,1,0
76619,clinic,1,0
76620,visit,1,0
76621,(,1,0
76622,baseline,1,0
76623,[,1,1
76624,week,1,0
76625,0,1,0
76626,],1,0
76627,and,1,0
76628,weeks,1,1
76629,4,1,0
76630,and,1,0
76631,8,1,0
76632,of,1,0
76633,treatment,1,0
76634,),1,0
76635,;,1,0
76636,mean,1,0
76637,values,1,0
76638,were,1,0
76639,calculated,1,0
76640,and,1,0
76641,recorded,1,0
76642,.,1,0
76643,At,1,0
76644,weeks,1,0
76645,4,1,0
76646,and,1,0
76647,8,1,0
76648,",",1,0
76649,tolerability,1,0
76650,was,1,0
76651,assessed,1,0
76652,using,1,0
76653,history,1,0
76654,taking,1,1
76655,and,1,0
76656,laboratory,1,0
76657,analysis,1,0
76658,",",1,0
76659,and,1,0
76660,compliance,1,0
76661,was,1,0
76662,assessed,1,0
76663,using,1,0
76664,pill,1,1
76665,counts,1,0
76666,.,1,0
76667,The,0,0
76668,primary,0,0
76669,end,0,0
76670,point,0,0
76671,was,0,0
76672,change,0,0
76673,from,0,0
76674,baseline,0,0
76675,in,0,0
76676,SiDBP,0,0
76677,at,0,0
76678,week,0,0
76679,8,0,0
76680,.,0,0
76681,Secondary,0,0
76682,end,0,0
76683,points,0,0
76684,were,0,0
76685,change,0,0
76686,from,0,0
76687,baseline,0,0
76688,in,0,0
76689,sitting,0,0
76690,systolic,0,0
76691,blood,0,1
76692,pressure,0,0
76693,(,0,1
76694,SiSBP,0,0
76695,),0,1
76696,at,0,0
76697,week,0,0
76698,8,0,0
76699,in,0,0
76700,the,0,0
76701,total,0,0
76702,population,0,0
76703,and,0,0
76704,in,0,0
76705,the,0,0
76706,subgroup,0,0
76707,of,0,0
76708,patients,0,0
76709,who,0,0
76710,had,0,0
76711,previously,0,0
76712,received,0,0
76713,antihypertensive,0,1
76714,treatment,0,0
76715,versus,0,1
76716,those,0,0
76717,who,0,0
76718,had,0,0
76719,not,0,0
76720,.,0,0
76721,RESULTS,0,0
76722,A,0,0
76723,total,0,0
76724,of,0,0
76725,189,0,0
76726,patients,0,0
76727,were,0,0
76728,enrolled,0,0
76729,(,0,0
76730,mean,0,0
76731,age,0,0
76732,",",0,0
76733,53,0,0
76734,years,0,0
76735,;,0,0
76736,105,0,0
76737,women,0,0
76738,",",0,0
76739,84,0,0
76740,men,0,0
76741,;,0,0
76742,mean,0,0
76743,body,0,0
76744,weight,0,0
76745,",",0,0
76746,65.8,0,0
76747,kg,0,0
76748,),0,0
76749,.,0,0
76750,One,0,0
76751,patient,0,0
76752,in,0,0
76753,the,0,0
76754,amlodipine,1,1
76755,camsylate,1,1
76756,group,0,0
76757,dropped,0,0
76758,out,0,0
76759,of,0,0
76760,the,0,0
76761,study,0,0
76762,at,0,0
76763,week,0,0
76764,0,0,0
76765,of,0,0
76766,treatment,0,0
76767,(,0,0
76768,this,0,0
76769,patient,0,0
76770,did,0,0
76771,not,0,0
76772,use,0,0
76773,any,0,0
76774,study,0,0
76775,medication,0,1
76776,),0,1
76777,and,0,0
76778,was,0,0
76779,excluded,0,0
76780,from,0,0
76781,the,0,0
76782,modified,0,1
76783,intent-to-treat,0,0
76784,(,0,1
76785,ITT,0,1
76786,),0,1
76787,analysis,0,0
76788,.,0,0
76789,Thus,0,0
76790,",",0,0
76791,188,0,0
76792,patients,0,0
76793,were,0,0
76794,treated,0,0
76795,and,0,0
76796,included,0,0
76797,in,0,0
76798,the,0,0
76799,ITT,0,1
76800,analysis,0,0
76801,(,0,0
76802,94,0,0
76803,patients,0,0
76804,per,0,0
76805,treatment,0,0
76806,group,0,0
76807,;,0,0
76808,ITT,0,1
76809,analysis,0,0
76810,),0,0
76811,;,0,0
76812,161,0,0
76813,patients,0,0
76814,were,0,0
76815,included,0,0
76816,in,0,0
76817,the,0,0
76818,perprotocol,0,0
76819,(,0,1
76820,PP,0,1
76821,),0,1
76822,analysis,0,0
76823,(,0,0
76824,n,0,0
76825,=,0,0
76826,80,0,0
76827,for,0,0
76828,amlodipine,1,1
76829,camsylate,1,1
76830,",",0,0
76831,n,0,0
76832,=,0,0
76833,81,0,0
76834,for,0,0
76835,amlodipine,1,1
76836,besylate,1,1
76837,),1,1
76838,(,0,0
76839,14,0,0
76840,patients,0,0
76841,in,0,0
76842,the,0,0
76843,amlodipine,1,1
76844,camsylate,1,1
76845,group,0,0
76846,and,0,0
76847,13,0,0
76848,patients,0,0
76849,in,0,0
76850,the,0,0
76851,amlodipine,1,1
76852,besylate,1,1
76853,group,0,0
76854,were,0,0
76855,excluded,0,0
76856,from,0,0
76857,the,0,0
76858,PP,0,1
76859,analysis,0,0
76860,due,0,0
76861,to,0,0
76862,consistent,0,0
76863,withdrawal,0,1
76864,or,0,1
76865,protocol,0,1
76866,violation,0,0
76867,),0,0
76868,.,0,1
76869,Mean,0,0
76870,(,0,0
76871,SD,0,0
76872,),0,1
76873,SiSBP,0,0
76874,and,0,0
76875,SiDBP,0,0
76876,were,0,0
76877,significantly,0,0
76878,decreased,0,0
76879,from,0,0
76880,baseline,0,0
76881,in,0,0
76882,both,0,0
76883,groups,0,0
76884,(,1,0
76885,amlodipine,1,1
76886,camsylate,1,1
76887,",",0,0
76888,from,0,0
76889,146.7,0,0
76890,[,0,0
76891,12.3,0,0
76892,],0,0
76893,/96.6,0,0
76894,[,0,0
76895,5.4,0,0
76896,],0,0
76897,to,0,0
76898,127.9,0,0
76899,[,0,0
76900,14.8,0,0
76901,],0,0
76902,/83.4,0,0
76903,[,0,0
76904,7.7,0,0
76905,],0,0
76906,mm,0,0
76907,Hg,0,0
76908,[,0,0
76909,both,0,0
76910,",",0,0
76911,P,0,0
76912,<,0,0
76913,0.001,0,0
76914,],0,0
76915,;,0,0
76916,amlodipine,1,1
76917,besylate,1,1
76918,",",0,0
76919,from,0,0
76920,146.8,0,0
76921,[,0,0
76922,12.8,0,0
76923,],0,0
76924,/96.7,0,0
76925,[,0,0
76926,5.1,0,0
76927,],0,0
76928,to,0,0
76929,128.0,0,0
76930,[,0,0
76931,10.1,0,0
76932,],0,0
76933,/83.8,0,0
76934,[,0,0
76935,7.5,0,1
76936,],0,0
76937,mm,0,0
76938,Hg,0,0
76939,[,0,0
76940,both,0,0
76941,",",0,0
76942,P,0,0
76943,<,0,0
76944,0.001,0,0
76945,],0,0
76946,),0,0
76947,.,0,0
76948,The,0,0
76949,differences,0,0
76950,in,0,0
76951,SiSBP/SiDBP,0,0
76952,between,0,0
76953,the,0,0
76954,2,0,0
76955,groups,0,0
76956,at,0,0
76957,week,0,0
76958,8,0,0
76959,were,0,0
76960,not,0,0
76961,significant,0,0
76962,.,0,0
76963,The,0,0
76964,SiDBP,0,0
76965,response,0,0
76966,rates,0,0
76967,in,0,0
76968,the,0,0
76969,subgroups,0,0
76970,that,0,0
76971,had,0,0
76972,and,0,0
76973,had,0,0
76974,not,0,0
76975,been,0,0
76976,previously,0,0
76977,treated,0,0
76978,with,0,0
76979,antihypertensives,0,1
76980,were,0,0
76981,statistically,0,0
76982,similar,0,0
76983,(,0,0
76984,56/69,0,0
76985,[,0,0
76986,81.2,0,0
76987,%,0,0
76988,],0,0
76989,and,0,0
76990,83/92,0,0
76991,[,0,0
76992,90.2,0,0
76993,%,0,0
76994,],0,0
76995,",",0,0
76996,respectively,0,0
76997,),0,0
76998,.,0,0
76999,The,0,0
77000,prevalences,0,0
77001,of,0,0
77002,clinical,0,0
77003,adverse,0,0
77004,events,0,0
77005,(,0,0
77006,AEs,0,1
77007,),0,1
77008,were,0,0
77009,not,0,0
77010,significantly,0,0
77011,different,0,0
77012,between,0,0
77013,the,0,0
77014,2,0,0
77015,treatment,0,0
77016,groups,0,0
77017,(,1,0
77018,amlodipine,1,1
77019,camsylate,1,1
77020,",",0,0
77021,27.3,0,0
77022,%,0,0
77023,;,0,0
77024,amlodipine,1,1
77025,besylate,1,1
77026,",",0,0
77027,28.7,0,0
77028,%,0,0
77029,),0,0
77030,.,0,0
77031,The,0,0
77032,most,0,0
77033,common,0,0
77034,AEs,0,1
77035,were,0,0
77036,dizziness,0,0
77037,and,0,1
77038,dyspnea,0,0
77039,(,0,0
77040,both,0,0
77041,in,0,0
77042,3/94,0,0
77043,[,0,0
77044,3.2,0,0
77045,%,0,0
77046,],0,0
77047,and,0,0
77048,1/94,0,0
77049,[,0,0
77050,1.1,0,0
77051,%,0,0
77052,],0,0
77053,patients,0,0
77054,who,0,0
77055,received,0,0
77056,amlodipine,1,1
77057,camsylate,1,1
77058,and,0,0
77059,amlodipine,1,1
77060,besylate,1,1
77061,",",0,0
77062,respectively,0,0
77063,),0,0
77064,.,0,0
77065,CONCLUSION,0,0
77066,The,0,0
77067,effectiveness,0,0
77068,and,0,0
77069,tolerability,0,0
77070,of,0,0
77071,amlodipine,1,1
77072,camsylate,1,1
77073,were,0,0
77074,not,0,0
77075,significantly,0,0
77076,different,0,0
77077,from,0,0
77078,those,0,0
77079,of,0,0
77080,amlodipine,1,1
77081,besylate,1,1
77082,in,0,0
77083,these,0,0
77084,Korean,0,0
77085,adults,0,0
77086,with,0,0
77087,mild,0,0
77088,to,0,0
77089,moderate,0,0
77090,hypertension,0,0
77091,.,0,0
77092,Leucine-enriched,0,1
77093,essential,0,0
77094,amino,0,1
77095,acid,0,1
77096,and,0,0
77097,carbohydrate,0,1
77098,ingestion,0,1
77099,following,0,0
77100,resistance,0,0
77101,exercise,0,1
77102,enhances,0,0
77103,mTOR,0,1
77104,signaling,0,0
77105,and,0,0
77106,protein,0,1
77107,synthesis,0,0
77108,in,0,0
77109,human,0,1
77110,muscle,0,0
77111,.,0,0
77112,We,0,0
77113,recently,0,0
77114,showed,0,0
77115,that,0,0
77116,resistance,0,0
77117,exercise,0,1
77118,and,0,0
77119,ingestion,0,0
77120,of,0,0
77121,essential,1,0
77122,amino,1,1
77123,acids,1,1
77124,with,1,0
77125,carbohydrate,1,1
77126,(,1,1
77127,EAA+CHO,1,0
77128,),1,1
77129,can,0,0
77130,independently,0,0
77131,stimulate,0,0
77132,mammalian,0,0
77133,target,0,0
77134,of,0,0
77135,rapamycin,0,1
77136,(,0,1
77137,mTOR,0,1
77138,),0,1
77139,signaling,0,0
77140,and,0,1
77141,muscle,0,1
77142,protein,0,1
77143,synthesis,0,0
77144,in,0,0
77145,humans,0,0
77146,.,0,0
77147,Providing,0,0
77148,an,0,0
77149,EAA+CHO,0,0
77150,solution,0,1
77151,postexercise,0,0
77152,can,0,0
77153,further,0,0
77154,increase,0,0
77155,muscle,0,0
77156,protein,0,1
77157,synthesis,0,0
77158,.,0,0
77159,Therefore,0,0
77160,",",0,0
77161,we,0,0
77162,hypothesized,0,0
77163,that,0,0
77164,enhanced,0,0
77165,mTOR,0,0
77166,signaling,0,0
77167,might,0,0
77168,be,0,0
77169,responsible,0,0
77170,for,0,0
77171,the,0,0
77172,greater,0,0
77173,muscle,0,0
77174,protein,0,1
77175,synthesis,0,0
77176,when,0,0
77177,leucine-enriched,0,1
77178,EAA+CHOs,0,0
77179,are,0,0
77180,ingested,0,0
77181,during,0,0
77182,postexercise,0,0
77183,recovery,0,0
77184,.,0,0
77185,Sixteen,0,0
77186,male,0,0
77187,subjects,0,0
77188,were,0,0
77189,randomized,0,0
77190,to,0,0
77191,one,0,0
77192,of,0,0
77193,two,0,0
77194,groups,0,0
77195,(,1,0
77196,control,1,1
77197,or,1,1
77198,EAA+CHO,1,0
77199,),1,0
77200,.,0,0
77201,The,1,0
77202,EAA+CHO,1,0
77203,group,1,0
77204,ingested,1,0
77205,the,1,0
77206,nutrient,1,1
77207,solution,1,1
77208,1,1,0
77209,h,1,0
77210,after,1,0
77211,resistance,1,0
77212,exercise,1,1
77213,.,1,1
77214,mTOR,0,0
77215,signaling,0,0
77216,was,0,0
77217,assessed,0,0
77218,by,0,0
77219,immunoblotting,1,1
77220,from,1,0
77221,repeated,1,0
77222,muscle,1,0
77223,biopsy,1,1
77224,samples,1,0
77225,.,1,0
77226,Mixed,0,0
77227,muscle,0,0
77228,fractional,0,0
77229,synthetic,0,1
77230,rate,0,0
77231,(,0,1
77232,FSR,0,1
77233,),0,1
77234,was,0,0
77235,measured,0,0
77236,using,0,0
77237,stable,0,0
77238,isotope,0,1
77239,techniques,0,1
77240,.,0,0
77241,Muscle,0,0
77242,protein,0,1
77243,synthesis,0,0
77244,and,0,0
77245,4E-BP1,0,1
77246,phosphorylation,0,0
77247,during,0,0
77248,exercise,0,1
77249,were,0,0
77250,significantly,0,0
77251,reduced,0,0
77252,(,0,0
77253,P,0,0
77254,<,0,0
77255,0.05,0,0
77256,),0,0
77257,.,0,0
77258,Postexercise,0,0
77259,FSR,0,0
77260,was,0,0
77261,elevated,0,0
77262,above,0,0
77263,baseline,0,0
77264,in,0,0
77265,both,0,0
77266,groups,0,0
77267,at,0,0
77268,1,0,0
77269,h,0,0
77270,but,0,0
77271,was,0,0
77272,even,0,0
77273,further,0,0
77274,elevated,0,0
77275,in,0,0
77276,the,0,0
77277,EAA+CHO,0,0
77278,group,0,0
77279,at,0,0
77280,2,0,0
77281,h,0,0
77282,postexercise,0,0
77283,(,0,0
77284,P,0,0
77285,<,0,0
77286,0.05,0,0
77287,),0,0
77288,.,0,0
77289,Increased,0,0
77290,FSR,0,0
77291,was,0,0
77292,associated,0,0
77293,with,0,0
77294,enhanced,0,0
77295,phosphorylation,0,0
77296,of,0,0
77297,mTOR,0,0
77298,and,0,1
77299,S6K1,0,1
77300,(,0,1
77301,P,0,0
77302,<,0,0
77303,0.05,0,0
77304,),0,0
77305,.,0,0
77306,Akt,0,1
77307,phosphorylation,0,0
77308,was,0,0
77309,elevated,0,0
77310,at,0,0
77311,1,0,0
77312,h,0,0
77313,and,0,0
77314,returned,0,0
77315,to,0,0
77316,baseline,0,0
77317,by,0,0
77318,2,0,0
77319,h,0,0
77320,in,0,0
77321,the,0,0
77322,control,0,1
77323,group,0,0
77324,",",0,0
77325,but,0,0
77326,it,0,0
77327,remained,0,0
77328,elevated,0,0
77329,in,0,0
77330,the,0,0
77331,EAA+CHO,0,1
77332,group,0,0
77333,(,0,0
77334,P,0,0
77335,<,0,0
77336,0.05,0,0
77337,),0,0
77338,.,0,0
77339,4E-BP1,0,0
77340,phosphorylation,0,0
77341,returned,0,0
77342,to,0,0
77343,baseline,0,0
77344,during,0,0
77345,recovery,0,0
77346,in,0,0
77347,control,0,1
77348,but,0,0
77349,became,0,0
77350,elevated,0,0
77351,when,0,0
77352,EAA+CHO,0,0
77353,was,0,0
77354,ingested,0,0
77355,(,0,0
77356,P,0,0
77357,<,0,0
77358,0.05,0,0
77359,),0,0
77360,.,0,0
77361,eEF2,0,1
77362,phosphorylation,0,0
77363,decreased,0,0
77364,at,0,0
77365,1,0,0
77366,and,0,0
77367,2,0,0
77368,h,0,0
77369,postexercise,0,0
77370,to,0,0
77371,a,0,0
77372,similar,0,0
77373,extent,0,0
77374,in,0,0
77375,both,0,0
77376,groups,0,0
77377,(,0,0
77378,P,0,0
77379,<,0,0
77380,0.05,0,0
77381,),0,0
77382,.,0,0
77383,Our,0,0
77384,data,0,0
77385,suggest,0,0
77386,that,0,0
77387,enhanced,0,0
77388,activation,0,0
77389,of,0,0
77390,the,0,0
77391,mTOR,0,1
77392,signaling,0,0
77393,pathway,0,1
77394,is,0,0
77395,playing,0,0
77396,a,0,0
77397,role,0,0
77398,in,0,0
77399,the,0,0
77400,greater,0,0
77401,synthesis,0,0
77402,of,0,0
77403,muscle,0,0
77404,proteins,0,1
77405,when,0,0
77406,resistance,0,0
77407,exercise,0,1
77408,is,0,0
77409,followed,0,0
77410,by,0,0
77411,EAA+CHO,0,0
77412,ingestion,0,0
77413,.,0,0
77414,Enhancing,0,0
77415,attitudes,0,0
77416,and,0,0
77417,intentions,0,0
77418,in,0,0
77419,prospective,0,0
77420,blood,0,0
77421,donors,0,0
77422,:,0,0
77423,evaluation,0,0
77424,of,0,0
77425,a,0,0
77426,new,0,0
77427,donor,1,0
77428,recruitment,1,0
77429,brochure,1,1
77430,.,1,0
77431,BACKGROUND,0,0
77432,Although,0,0
77433,little,0,0
77434,empiric,0,0
77435,evidence,0,0
77436,has,0,0
77437,been,0,0
77438,published,0,0
77439,concerning,0,0
77440,the,0,0
77441,efficacy,0,0
77442,of,0,0
77443,blood,1,0
77444,donor,1,0
77445,recruitment,1,0
77446,materials,1,1
77447,",",0,0
77448,research,0,0
77449,suggests,0,0
77450,that,0,0
77451,simple,0,0
77452,attempts,0,0
77453,to,0,0
77454,enhance,0,0
77455,knowledge,0,0
77456,may,0,0
77457,not,0,0
77458,be,0,0
77459,sufficient,0,0
77460,to,0,0
77461,motivate,0,0
77462,donation,0,0
77463,.,0,0
77464,In,0,0
77465,contrast,0,0
77466,",",0,0
77467,recent,0,0
77468,donor,0,0
77469,motivation,0,0
77470,studies,0,0
77471,highlight,0,0
77472,the,0,0
77473,importance,0,0
77474,of,0,0
77475,anxiety,0,0
77476,",",0,0
77477,attitudes,0,0
77478,",",0,0
77479,and,0,0
77480,perceived,0,0
77481,ability,0,0
77482,to,0,0
77483,cope,0,0
77484,with,0,0
77485,donation,0,0
77486,(,0,0
77487,i.e.,0,0
77488,",",0,0
77489,self-efficacy,0,0
77490,),0,0
77491,as,0,0
77492,crucial,0,0
77493,determinants,0,0
77494,of,0,0
77495,donation,0,0
77496,intention,0,0
77497,.,0,0
77498,Therefore,0,0
77499,",",0,0
77500,recruitment,0,0
77501,materials,0,1
77502,that,0,0
77503,specifically,0,0
77504,address,0,0
77505,these,0,0
77506,constructs,0,0
77507,have,0,0
77508,the,0,0
77509,potential,0,0
77510,to,0,0
77511,outperform,0,0
77512,traditional,0,1
77513,educational,0,0
77514,brochures,0,0
77515,.,0,0
77516,STUDY,0,0
77517,DESIGN,0,0
77518,AND,0,0
77519,METHODS,0,0
77520,Participants,0,0
77521,were,0,0
77522,randomly,0,0
77523,assigned,0,0
77524,to,0,0
77525,read,0,0
77526,one,0,0
77527,of,0,0
77528,three,0,0
77529,brochures,1,0
77530,:,1,0
77531,1,0,0
77532,),0,0
77533,a,1,0
77534,new,1,0
77535,brochure,1,1
77536,addressing,1,0
77537,common,1,0
77538,donor,1,0
77539,concerns,1,0
77540,and,1,0
77541,suggesting,1,0
77542,specific,1,1
77543,coping,1,0
77544,strategies,1,0
77545,",",1,0
77546,2,1,0
77547,),1,0
77548,a,1,0
77549,standard,1,1
77550,blood,1,0
77551,center,1,0
77552,brochure,1,1
77553,",",0,0
77554,or,0,1
77555,3,0,0
77556,),0,0
77557,a,1,0
77558,control,1,1
77559,brochure,1,1
77560,on,1,0
77561,healthy,1,0
77562,eating,1,1
77563,and,1,0
77564,exercise,1,1
77565,.,1,0
77566,Standardized,0,0
77567,questionnaires,0,0
77568,were,0,0
77569,completed,0,0
77570,before,0,0
77571,and,0,0
77572,after,0,0
77573,the,0,0
77574,brochures,0,0
77575,to,0,0
77576,assess,0,0
77577,change,0,0
77578,in,0,0
77579,blood,0,0
77580,donation,0,0
77581,anxiety,0,0
77582,",",0,0
77583,attitude,0,0
77584,",",0,0
77585,self-efficacy,0,0
77586,",",0,0
77587,and,0,0
77588,intention,0,0
77589,.,0,0
77590,RESULTS,0,0
77591,Although,0,0
77592,no,0,0
77593,significant,0,0
77594,changes,0,0
77595,were,0,0
77596,noted,0,0
77597,for,0,0
77598,the,0,0
77599,control,0,1
77600,brochure,0,1
77601,",",0,0
77602,after,0,0
77603,reading,0,0
77604,the,0,0
77605,new,0,0
77606,brochure,0,1
77607,participants,0,0
77608,reported,0,0
77609,significant,0,0
77610,improvements,0,0
77611,in,0,0
77612,attitude,0,0
77613,",",0,0
77614,anxiety,0,0
77615,",",0,0
77616,self-efficacy,0,0
77617,",",0,0
77618,and,0,0
77619,donation,0,0
77620,intention,0,0
77621,.,0,0
77622,The,0,0
77623,standard,0,1
77624,donation,0,0
77625,brochure,0,1
77626,had,0,0
77627,an,0,0
77628,intermediate,0,0
77629,effect,0,0
77630,.,0,0
77631,CONCLUSION,0,0
77632,Efforts,0,0
77633,to,0,0
77634,address,0,0
77635,common,0,0
77636,donor,0,0
77637,fears,0,0
77638,and,0,0
77639,to,0,0
77640,provide,0,0
77641,useful,0,0
77642,coping,0,0
77643,suggestions,0,0
77644,may,0,0
77645,improve,0,0
77646,the,0,0
77647,effectiveness,0,0
77648,of,0,0
77649,blood,0,0
77650,donation,0,0
77651,recruitment,0,0
77652,materials,0,0
77653,.,0,0
77654,Transthoracic,1,1
77655,versus,1,1
77656,transesophageal,1,1
77657,cardioversion,1,1
77658,of,1,0
77659,atrial,1,0
77660,fibrillation,1,0
77661,under,1,0
77662,light,1,1
77663,sedation,1,0
77664,:,1,0
77665,a,0,0
77666,prospective,0,0
77667,randomized,0,0
77668,trial,0,0
77669,.,0,0
77670,BACKGROUND,0,0
77671,Electrical,0,1
77672,cardioversion,0,1
77673,(,0,1
77674,ECV,0,1
77675,),0,1
77676,of,0,0
77677,atrial,0,0
77678,fibrillation,0,0
77679,(,0,1
77680,AF,0,1
77681,),0,1
77682,is,0,0
77683,limited,0,0
77684,by,0,0
77685,a,0,0
77686,5-10,0,1
77687,%,0,0
77688,failure,0,0
77689,rate,0,0
77690,and,0,0
77691,by,0,0
77692,the,0,0
77693,expense,0,0
77694,arising,0,0
77695,from,0,0
77696,a,0,0
77697,perceived,0,0
77698,need,0,0
77699,for,0,0
77700,general,0,0
77701,anesthesia,0,1
77702,.,0,0
77703,A,0,0
77704,transesophageal,0,1
77705,approach,0,1
77706,using,0,0
77707,light,0,1
77708,sedation,0,0
77709,has,0,0
77710,been,0,0
77711,proposed,0,0
77712,as,0,0
77713,a,0,0
77714,means,0,0
77715,of,0,0
77716,augmenting,0,0
77717,the,0,0
77718,success,0,0
77719,rate,0,0
77720,and,0,0
77721,avoiding,0,0
77722,the,0,0
77723,need,0,0
77724,for,0,0
77725,general,0,0
77726,anesthesia,0,1
77727,.,0,0
77728,We,0,0
77729,hypothesized,0,0
77730,that,0,0
77731,the,0,0
77732,high,0,0
77733,rate,0,0
77734,of,0,0
77735,success,0,0
77736,and,0,0
77737,the,0,0
77738,lower,0,0
77739,energy,0,0
77740,requirement,0,0
77741,associated,0,0
77742,with,0,0
77743,biphasic,0,1
77744,cardioversion,0,1
77745,might,0,0
77746,eliminate,0,0
77747,any,0,0
77748,advantage,0,0
77749,of,0,0
77750,the,0,0
77751,transesophageal,0,1
77752,approach,0,1
77753,.,0,0
77754,METHODS,0,0
77755,We,0,0
77756,randomly,0,0
77757,assigned,0,0
77758,60,0,0
77759,patients,0,0
77760,attending,0,0
77761,for,0,0
77762,ECV,1,0
77763,of,1,0
77764,persistent,1,0
77765,AF,1,1
77766,to,1,0
77767,a,1,0
77768,transesophageal,1,1
77769,or,1,1
77770,a,1,0
77771,transthoracic,1,1
77772,approach,1,1
77773,.,1,0
77774,Sedation,0,0
77775,of,0,0
77776,moderate,0,0
77777,depth,0,0
77778,was,0,0
77779,achieved,0,0
77780,with,0,0
77781,intravenous,1,1
77782,midazolam,1,1
77783,.,1,0
77784,The,0,0
77785,dose,0,0
77786,of,0,0
77787,midazolam,0,1
77788,was,0,0
77789,titrated,0,0
77790,in,0,0
77791,the,0,0
77792,same,0,0
77793,manner,0,0
77794,in,0,0
77795,both,0,0
77796,groups,0,0
77797,.,0,0
77798,RESULTS,0,0
77799,Sinus,0,0
77800,rhythm,0,1
77801,was,0,0
77802,restored,0,0
77803,in,0,0
77804,29/30,0,0
77805,patients,0,0
77806,(,0,0
77807,97,0,0
77808,%,0,0
77809,),0,0
77810,in,0,0
77811,each,0,0
77812,group,0,0
77813,using,0,0
77814,a,0,0
77815,similar,0,0
77816,number,0,0
77817,of,0,0
77818,shocks,0,0
77819,for,0,0
77820,both,0,0
77821,groups,0,0
77822,(,0,0
77823,1.3,0,0
77824,+/-,0,0
77825,0.6,0,1
77826,transesophageal,0,1
77827,vs,0,0
77828,1.4,0,0
77829,+/-,0,0
77830,0.7,0,0
77831,transthoracic,0,1
77832,",",0,0
77833,P,0,0
77834,=,0,0
77835,NS,0,0
77836,),0,0
77837,with,0,0
77838,a,0,0
77839,similar,0,0
77840,procedure,0,1
77841,duration,0,0
77842,(,0,0
77843,14.1,0,0
77844,+/-,0,0
77845,8.2,0,0
77846,minutes,0,0
77847,vs,0,0
77848,13.8,0,0
77849,+/-,0,0
77850,7.5,0,0
77851,minutes,0,0
77852,",",0,0
77853,P,0,0
77854,=,0,0
77855,NS,0,0
77856,),0,0
77857,.,0,0
77858,Both,0,1
77859,groups,0,0
77860,received,0,0
77861,similar,0,0
77862,doses,0,0
77863,of,0,0
77864,midazolam,0,1
77865,(,0,0
77866,4.2,0,0
77867,+/-,0,0
77868,2.7,0,0
77869,mg,0,1
77870,vs,0,0
77871,4.4,0,0
77872,+/-,0,0
77873,2.8,0,0
77874,mg,0,1
77875,",",0,0
77876,P,0,0
77877,=,0,0
77878,NS,0,0
77879,),0,1
77880,and,0,0
77881,both,0,0
77882,reported,0,0
77883,a,0,0
77884,similar,0,0
77885,discomfort,0,0
77886,score,0,0
77887,in,0,0
77888,(,0,0
77889,0.9,0,0
77890,+/-,0,0
77891,1.3,0,0
77892,vs,0,0
77893,1.1,0,0
77894,+/-,0,0
77895,1.8,0,0
77896,",",0,0
77897,P,0,0
77898,=,0,0
77899,NS,0,0
77900,),0,0
77901,.,0,0
77902,No,0,0
77903,complication,0,0
77904,occurred,0,0
77905,in,0,0
77906,either,0,0
77907,group,0,0
77908,.,0,0
77909,CONCLUSION,0,0
77910,AF,0,0
77911,may,0,0
77912,be,0,0
77913,cardioverted,0,0
77914,safely,0,0
77915,and,0,0
77916,effectively,0,0
77917,by,0,0
77918,either,0,0
77919,a,0,0
77920,transthoracic,0,1
77921,or,0,1
77922,a,0,0
77923,transesophageal,0,1
77924,approach,0,1
77925,.,0,0
77926,The,0,0
77927,use,0,0
77928,of,0,0
77929,sedation,0,0
77930,of,0,0
77931,moderate,0,0
77932,depth,0,0
77933,renders,0,0
77934,cardioversion,0,1
77935,by,0,0
77936,either,0,1
77937,approach,0,1
77938,acceptable,0,0
77939,.,0,0
77940,As,0,0
77941,transesophageal,0,1
77942,ECV,0,1
77943,shows,0,0
77944,no,0,0
77945,clear,0,0
77946,advantage,0,0
77947,",",0,0
77948,transthoracic,0,1
77949,cardioversion,0,1
77950,should,0,0
77951,remain,0,0
77952,the,0,0
77953,approach,0,1
77954,of,0,0
77955,first,0,0
77956,choice,0,0
77957,.,0,0
77958,Can,0,0
77959,analysis,0,0
77960,of,0,0
77961,the,0,0
77962,bispectral,0,1
77963,index,0,0
77964,prove,0,0
77965,helpful,0,0
77966,when,0,0
77967,monitoring,0,1
77968,titration,0,0
77969,of,0,0
77970,doses,0,0
77971,of,0,0
77972,midazolam,1,1
77973,and,0,0
77974,ketamine,1,1
77975,for,0,0
77976,sedation,0,0
77977,during,0,0
77978,paediatric,0,0
77979,cardiac,0,0
77980,catheterization,0,1
77981,.,0,0
77982,OBJECTIVE,0,0
77983,We,0,0
77984,investigated,0,0
77985,the,0,0
77986,use,0,0
77987,of,0,0
77988,the,0,0
77989,bispectral,1,1
77990,index,1,0
77991,for,0,0
77992,monitoring,0,1
77993,sedation,1,0
77994,during,0,0
77995,cardiac,0,0
77996,catheterization,0,1
77997,.,0,0
77998,The,0,0
77999,scores,0,0
78000,for,0,0
78001,the,0,0
78002,bispectral,0,1
78003,index,0,0
78004,may,0,0
78005,not,0,0
78006,reflect,0,0
78007,correct,0,0
78008,values,0,0
78009,in,0,0
78010,children,0,0
78011,",",0,0
78012,but,0,0
78013,may,0,0
78014,be,0,0
78015,helpful,0,0
78016,during,0,0
78017,titration,0,0
78018,of,0,0
78019,sedatives,0,0
78020,such,0,0
78021,as,0,0
78022,midazolam,1,1
78023,and,1,0
78024,ketamine,1,1
78025,.,1,0
78026,METHODS,0,0
78027,We,0,0
78028,conducted,0,0
78029,a,0,0
78030,prospective,0,0
78031,randomized,0,0
78032,clinical,0,0
78033,trial,0,0
78034,in,0,0
78035,126,0,0
78036,patients,0,0
78037,scheduled,0,0
78038,for,0,0
78039,cardiac,0,0
78040,catheterization,0,1
78041,in,0,0
78042,a,0,0
78043,teaching,0,1
78044,hospital,0,0
78045,.,0,0
78046,They,0,0
78047,ranged,0,0
78048,in,0,0
78049,age,0,0
78050,from,0,0
78051,4,0,0
78052,months,0,0
78053,to,0,0
78054,15,0,0
78055,years,0,0
78056,.,0,0
78057,In,0,0
78058,66,0,0
78059,patients,0,0
78060,",",0,0
78061,sedation,1,0
78062,was,0,0
78063,performed,0,0
78064,without,1,0
78065,use,1,0
78066,of,1,0
78067,the,1,0
78068,bispectral,1,1
78069,index,1,0
78070,",",1,0
78071,while,1,0
78072,the,1,0
78073,index,1,0
78074,was,1,0
78075,used,1,0
78076,in,1,0
78077,the,1,0
78078,other,1,0
78079,60,0,0
78080,patients,0,0
78081,.,0,0
78082,The,0,0
78083,data,0,0
78084,collected,0,0
78085,included,0,0
78086,heart,0,0
78087,rate,0,0
78088,",",0,0
78089,mean,0,0
78090,arterial,0,0
78091,pressure,0,0
78092,",",0,0
78093,respiratory,0,0
78094,rate,0,0
78095,",",0,0
78096,saturation,0,0
78097,of,0,0
78098,oxygen,0,1
78099,",",0,0
78100,amount,0,0
78101,of,0,0
78102,sedatives,0,0
78103,",",0,0
78104,awakening,0,0
78105,time,0,0
78106,and,0,0
78107,adverse,0,0
78108,effects,0,0
78109,.,0,0
78110,We,0,0
78111,subdivided,0,0
78112,the,0,0
78113,patients,0,0
78114,into,0,0
78115,age-related,0,0
78116,groups,0,0
78117,for,0,0
78118,each,0,0
78119,parameter,0,0
78120,.,0,0
78121,RESULTS,0,0
78122,The,0,0
78123,demographic,0,0
78124,data,0,0
78125,were,0,0
78126,not,0,0
78127,statistically,0,0
78128,different,0,0
78129,.,0,0
78130,Monitoring,0,0
78131,with,0,0
78132,the,0,0
78133,bispectral,0,1
78134,index,0,0
78135,in,0,0
78136,those,0,0
78137,aged,0,0
78138,from,0,0
78139,1,0,0
78140,to,0,0
78141,3,0,0
78142,years,0,0
78143,revealed,0,0
78144,use,0,0
78145,of,0,0
78146,lower,0,0
78147,doses,0,0
78148,of,0,0
78149,midazolam,0,1
78150,",",0,0
78151,at,0,0
78152,2.09,0,0
78153,mg,0,1
78154,per,0,0
78155,kg,0,0
78156,per,0,0
78157,hr,0,0
78158,",",0,0
78159,with,0,0
78160,standard,0,1
78161,deviation,0,0
78162,of,0,0
78163,0.36,0,0
78164,",",0,0
78165,and,0,0
78166,similarly,0,0
78167,lowers,0,0
78168,doses,0,0
78169,of,0,0
78170,ketamine,0,1
78171,",",0,0
78172,at,0,0
78173,2.07,0,0
78174,mg,0,1
78175,per,0,0
78176,kg,0,0
78177,per,0,0
78178,hr,0,0
78179,",",0,0
78180,with,0,0
78181,standard,0,1
78182,deviation,0,0
78183,of,0,0
78184,0.22,0,0
78185,",",0,0
78186,the,0,0
78187,values,0,0
78188,in,0,0
78189,those,0,0
78190,not,0,0
78191,monitored,0,0
78192,being,0,0
78193,2.93,0,0
78194,",",0,0
78195,with,0,0
78196,standard,0,1
78197,deviation,0,0
78198,of,0,0
78199,0.45,0,0
78200,",",0,0
78201,and,0,0
78202,2.96,0,0
78203,with,0,0
78204,standard,0,1
78205,deviation,0,0
78206,of,0,0
78207,0.51,0,0
78208,respectively,0,0
78209,",",0,0
78210,these,0,0
78211,difference,0,0
78212,being,0,0
78213,statistically,0,0
78214,significant,0,0
78215,(,0,0
78216,p,0,0
78217,=,0,0
78218,0.001,0,0
78219,and,0,0
78220,p,0,0
78221,=,0,0
78222,0.04,0,0
78223,",",0,0
78224,respectively,0,0
78225,),0,0
78226,.,0,0
78227,In,0,0
78228,those,0,0
78229,aged,0,0
78230,from,0,0
78231,3,0,0
78232,to,0,0
78233,6,0,0
78234,years,0,0
78235,of,0,0
78236,age,0,0
78237,",",0,0
78238,dosage,0,0
78239,of,0,0
78240,midazolam,0,1
78241,was,0,0
78242,2.09,0,0
78243,",",0,0
78244,with,0,0
78245,deviation,0,0
78246,of,0,0
78247,0.36,0,0
78248,",",0,0
78249,and,0,0
78250,of,0,0
78251,ketamine,0,1
78252,1.78,0,0
78253,",",0,0
78254,with,0,0
78255,deviation,0,0
78256,of,0,0
78257,0.27,0,0
78258,",",0,0
78259,following,0,0
78260,use,0,0
78261,of,0,0
78262,the,0,0
78263,bispectral,0,1
78264,index,0,0
78265,",",0,0
78266,compared,0,0
78267,to,0,0
78268,2.89,0,0
78269,with,0,0
78270,deviation,0,0
78271,of,0,0
78272,0.28,0,0
78273,",",0,0
78274,and,0,0
78275,2.62,0,0
78276,with,0,0
78277,deviation,0,0
78278,of,0,0
78279,0.69,0,0
78280,respectively,0,0
78281,",",0,0
78282,when,0,0
78283,the,0,0
78284,bispectral,0,1
78285,index,0,0
78286,was,0,0
78287,not,0,0
78288,used,0,0
78289,",",0,0
78290,these,0,0
78291,again,0,0
78292,being,0,0
78293,significant,0,0
78294,differences,0,0
78295,(,0,0
78296,p,0,0
78297,=,0,0
78298,0.033,0,0
78299,and,0,0
78300,p,0,0
78301,=,0,0
78302,0.04,0,0
78303,),0,0
78304,.,0,0
78305,The,0,0
78306,requirements,0,0
78307,for,0,0
78308,respiratory,0,0
78309,support,0,1
78310,and,0,0
78311,adverse,0,0
78312,effects,0,0
78313,were,0,0
78314,also,0,0
78315,significantly,0,0
78316,lower,0,0
78317,when,0,0
78318,using,0,0
78319,the,0,0
78320,bispectral,0,1
78321,index,0,0
78322,(,0,0
78323,p,0,0
78324,less,0,0
78325,than,0,0
78326,0.05,0,0
78327,),0,0
78328,.,0,0
78329,No,0,0
78330,significant,0,0
78331,difference,0,0
78332,was,0,0
78333,found,0,0
78334,regarding,0,0
78335,dosages,0,0
78336,at,0,0
78337,the,0,0
78338,ages,0,0
78339,of,0,0
78340,4,0,0
78341,months,0,0
78342,to,0,0
78343,1,0,0
78344,year,0,0
78345,",",0,0
78346,and,0,0
78347,6,0,0
78348,to,0,0
78349,15,0,0
78350,years,0,0
78351,.,0,0
78352,The,0,0
78353,awakening,0,0
78354,time,0,0
78355,",",0,0
78356,however,0,0
78357,",",0,0
78358,was,0,0
78359,shorter,0,0
78360,with,0,0
78361,use,0,0
78362,of,0,0
78363,the,0,0
78364,index,0,0
78365,in,0,0
78366,those,0,0
78367,aged,0,0
78368,from,0,0
78369,1,0,0
78370,to,0,0
78371,6,0,0
78372,years,0,0
78373,.,0,0
78374,CONCLUSIONS,0,0
78375,When,0,0
78376,using,0,0
78377,the,0,0
78378,bispectral,0,1
78379,index,0,0
78380,for,0,0
78381,monitoring,0,1
78382,sedation,0,0
78383,during,0,0
78384,catheterization,0,1
78385,in,0,0
78386,children,0,0
78387,",",0,0
78388,we,0,0
78389,noted,0,0
78390,decreased,0,0
78391,need,0,0
78392,for,0,0
78393,doses,0,0
78394,of,0,0
78395,midazolam,0,1
78396,and,0,0
78397,ketamine,0,1
78398,",",0,0
78399,a,0,0
78400,lower,0,0
78401,need,0,0
78402,for,0,0
78403,respiratory,0,0
78404,support,0,0
78405,and,0,0
78406,less,0,0
78407,adverse,0,0
78408,effects,0,0
78409,.,0,0
78410,Impact,0,0
78411,of,0,0
78412,a,0,0
78413,controlled,1,0
78414,heated,1,1
78415,breathing,1,1
78416,tube,1,1
78417,humidifier,1,1
78418,on,0,0
78419,sleep,0,0
78420,quality,0,0
78421,during,0,0
78422,CPAP,1,1
78423,therapy,1,1
78424,in,0,0
78425,a,0,0
78426,cool,0,1
78427,sleeping,0,0
78428,environment,0,0
78429,.,0,0
78430,There,0,0
78431,are,0,0
78432,conflicting,0,0
78433,data,0,0
78434,on,0,0
78435,the,0,0
78436,effect,0,0
78437,of,0,0
78438,adding,0,0
78439,a,0,0
78440,heated,1,1
78441,humidifier,1,1
78442,to,0,0
78443,nasal,0,0
78444,continuous,1,1
78445,positive,1,0
78446,airway,1,1
78447,pressure,1,0
78448,(,1,1
78449,CPAP,1,1
78450,),1,1
78451,therapy,1,1
78452,for,0,0
78453,patients,0,0
78454,with,0,0
78455,obstructive,0,0
78456,sleep,0,0
78457,apnoea,0,1
78458,syndrome,0,0
78459,(,0,1
78460,OSAS,0,1
78461,),0,0
78462,.,0,0
78463,The,0,0
78464,effects,0,0
78465,of,0,0
78466,heated,0,1
78467,humidification,0,1
78468,on,0,0
78469,sleep,0,0
78470,quality,0,0
78471,and,0,0
78472,treatment,0,0
78473,side-effects,0,0
78474,for,0,0
78475,patients,0,0
78476,who,0,0
78477,prefer,0,0
78478,a,0,0
78479,cold,0,1
78480,bedroom,0,1
78481,environment,0,0
78482,have,0,0
78483,not,0,0
78484,been,0,0
78485,studied,0,0
78486,.,0,0
78487,A,0,0
78488,randomised,0,0
78489,",",0,0
78490,controlled,0,0
78491,crossover,0,0
78492,trial,0,0
78493,involving,0,0
78494,19,0,0
78495,patients,0,0
78496,with,0,0
78497,a,0,0
78498,first-ever,0,0
78499,diagnosis,0,0
78500,of,0,0
78501,OSAS,0,1
78502,measured,0,0
78503,the,0,0
78504,effect,0,0
78505,of,0,0
78506,conventional,1,1
78507,heated,1,1
78508,humidification,1,1
78509,added,1,0
78510,to,1,0
78511,CPAP,1,1
78512,compared,0,0
78513,with,0,0
78514,a,0,0
78515,controlled,1,0
78516,heated,1,1
78517,breathing,1,1
78518,tube,1,1
78519,humidifier,1,1
78520,(,1,1
78521,ThermoSmart,1,1
78522,(,1,1
78523,R,1,1
78524,),1,1
78525,;,1,0
78526,Fisher,0,1
78527,and,0,0
78528,Paykel,0,1
78529,Healthcare,0,0
78530,",",0,0
78531,Auckland,0,0
78532,",",0,0
78533,New,0,1
78534,Zealand,0,0
78535,),0,0
78536,on,0,0
78537,sleep,0,0
78538,quality,0,0
78539,.,0,0
78540,During,0,0
78541,the,0,0
78542,night,0,0
78543,in,0,0
78544,the,0,0
78545,sleep,0,0
78546,laboratory,0,0
78547,at,0,0
78548,a,0,0
78549,mean,0,0
78550,room,0,1
78551,temperature,0,0
78552,of,0,0
78553,14,0,0
78554,degrees,0,0
78555,C,0,0
78556,",",0,0
78557,less,0,0
78558,condensation,0,0
78559,formed,0,0
78560,with,0,0
78561,the,0,0
78562,controlled,1,0
78563,heated,1,1
78564,breathing,1,1
78565,tube,1,1
78566,humidifier,1,1
78567,(,0,0
78568,1.9,0,0
78569,mL,0,1
78570,versus,0,1
78571,35.3,0,0
78572,mL,0,1
78573,),0,0
78574,in,0,0
78575,the,0,0
78576,delivery,0,0
78577,system,0,0
78578,.,0,0
78579,In,0,0
78580,addition,0,0
78581,",",0,0
78582,the,0,0
78583,total,0,0
78584,sleep,0,0
78585,time,0,0
78586,",",0,0
78587,time,0,0
78588,spent,0,0
78589,in,0,0
78590,sleep,0,0
78591,stages,0,0
78592,3,0,0
78593,and,0,0
78594,4,0,0
78595,",",0,0
78596,and,0,0
78597,rapid,0,0
78598,eye,0,1
78599,movement,0,1
78600,sleep,0,0
78601,phases,0,0
78602,were,0,0
78603,significantly,0,0
78604,longer,0,0
78605,and,0,0
78606,the,0,0
78607,overall,0,0
78608,side-effect,0,0
78609,score,0,0
78610,was,0,0
78611,lower,0,0
78612,than,0,0
78613,with,0,0
78614,conventional,0,1
78615,heated,0,1
78616,humidification,0,1
78617,.,0,0
78618,Patients,0,0
78619,on,0,0
78620,nasal,0,0
78621,continuous,0,1
78622,positive,0,0
78623,airway,0,0
78624,pressure,0,0
78625,desiring,0,0
78626,a,0,0
78627,cool,0,1
78628,bedroom,0,1
78629,temperature,0,0
78630,could,0,0
78631,benefit,0,0
78632,from,0,0
78633,controlled,1,0
78634,heated,1,1
78635,breathing,1,1
78636,tube,1,1
78637,humidification,1,1
78638,technology,1,1
78639,(,0,0
78640,with,0,0
78641,inputs,0,0
78642,from,0,0
78643,ambient,0,1
78644,temperature,0,0
78645,",",0,0
78646,set,0,0
78647,pressure,0,0
78648,and,0,1
78649,flow,0,0
78650,),0,0
78651,.,0,0
78652,Language,0,1
78653,outcome,0,0
78654,in,0,0
78655,autism,0,0
78656,:,0,0
78657,randomized,0,0
78658,comparison,0,0
78659,of,0,0
78660,joint,1,0
78661,attention,1,0
78662,and,1,0
78663,play,1,0
78664,interventions,1,1
78665,.,1,0
78666,This,0,0
78667,study,0,0
78668,reports,0,0
78669,results,0,0
78670,of,0,0
78671,a,0,0
78672,randomized,0,0
78673,controlled,0,0
78674,trial,0,0
78675,aimed,0,0
78676,at,0,0
78677,joint,1,1
78678,attention,1,0
78679,(,1,1
78680,JA,1,0
78681,),1,1
78682,and,1,0
78683,symbolic,1,1
78684,play,1,0
78685,(,1,1
78686,SP,1,1
78687,),1,1
78688,in,0,0
78689,preschool,0,0
78690,children,0,0
78691,with,0,0
78692,autism,0,0
78693,",",0,0
78694,with,0,0
78695,prediction,0,0
78696,to,0,0
78697,language,0,0
78698,outcome,0,0
78699,12,0,0
78700,months,0,0
78701,later,0,0
78702,.,0,0
78703,Participants,0,0
78704,were,0,0
78705,58,0,0
78706,children,0,0
78707,(,0,0
78708,46,0,0
78709,boys,0,0
78710,),0,0
78711,with,0,0
78712,autism,0,0
78713,between,0,0
78714,3,0,0
78715,and,0,0
78716,4,0,0
78717,years,0,0
78718,of,0,0
78719,age,0,0
78720,.,0,0
78721,Children,0,0
78722,were,0,0
78723,randomized,0,0
78724,to,0,0
78725,a,0,0
78726,JA,1,0
78727,intervention,1,1
78728,",",1,0
78729,an,1,0
78730,SP,1,1
78731,intervention,1,1
78732,",",0,0
78733,or,0,1
78734,control,1,1
78735,group,0,0
78736,.,0,0
78737,Interventions,0,0
78738,were,0,0
78739,conducted,0,0
78740,30,0,0
78741,min,0,0
78742,daily,0,1
78743,for,0,0
78744,5-6,0,0
78745,weeks,0,0
78746,.,0,0
78747,Assessments,0,0
78748,of,0,0
78749,JA,1,0
78750,skills,0,0
78751,",",0,0
78752,SP,1,0
78753,skills,0,0
78754,",",0,0
78755,mother-child,0,0
78756,interactions,0,0
78757,",",0,0
78758,and,0,0
78759,language,0,1
78760,development,0,0
78761,were,0,0
78762,collected,0,0
78763,at,0,0
78764,4,0,0
78765,time,0,0
78766,points,0,0
78767,:,0,0
78768,pre-,0,0
78769,and,0,0
78770,postintervention,0,0
78771,and,0,0
78772,6,0,0
78773,and,0,0
78774,12,0,0
78775,months,0,0
78776,postintervention,0,0
78777,by,0,0
78778,independent,0,0
78779,testers,0,0
78780,.,0,0
78781,Results,0,0
78782,indicate,0,0
78783,that,0,0
78784,expressive,0,0
78785,language,0,1
78786,gains,0,0
78787,were,0,0
78788,greater,0,0
78789,for,0,0
78790,both,0,0
78791,treatment,0,0
78792,groups,0,0
78793,compared,0,0
78794,with,0,0
78795,the,0,0
78796,control,0,1
78797,group,0,0
78798,",",0,0
78799,and,0,0
78800,results,0,0
78801,could,0,0
78802,not,0,0
78803,be,0,0
78804,explained,0,0
78805,by,0,0
78806,differences,0,0
78807,in,0,0
78808,other,0,0
78809,interventions,0,0
78810,in,0,0
78811,which,0,0
78812,children,0,0
78813,participated,0,0
78814,.,0,0
78815,For,0,0
78816,children,0,0
78817,beginning,0,0
78818,treatment,0,0
78819,with,0,0
78820,the,0,0
78821,lowest,0,0
78822,language,0,0
78823,levels,0,0
78824,",",0,0
78825,the,0,0
78826,JA,1,0
78827,intervention,1,1
78828,improved,0,0
78829,language,0,1
78830,outcome,0,0
78831,significantly,0,0
78832,more,0,0
78833,than,0,0
78834,did,0,0
78835,the,0,0
78836,SP,1,1
78837,or,0,1
78838,control,0,0
78839,interventions,0,0
78840,.,0,0
78841,These,0,0
78842,findings,0,0
78843,suggest,0,0
78844,clinically,0,0
78845,significant,0,0
78846,benefits,0,0
78847,of,0,0
78848,actively,0,0
78849,treating,0,0
78850,JA,1,0
78851,and,0,0
78852,SP,1,1
78853,skills,0,1
78854,in,0,0
78855,young,0,0
78856,children,0,0
78857,with,0,0
78858,autism,0,0
78859,.,0,0
78860,Effect,0,0
78861,of,0,0
78862,a,0,0
78863,nutrition,1,1
78864,intervention,1,1
78865,during,0,0
78866,early,0,0
78867,childhood,0,0
78868,on,0,0
78869,economic,0,0
78870,productivity,0,0
78871,in,0,0
78872,Guatemalan,0,0
78873,adults,0,0
78874,.,0,0
78875,BACKGROUND,0,0
78876,Substantial,0,0
78877,",",0,0
78878,but,0,0
78879,indirect,0,0
78880,",",0,0
78881,evidence,0,0
78882,suggests,0,0
78883,that,0,0
78884,improving,0,0
78885,nutrition,0,1
78886,in,0,0
78887,early,0,0
78888,childhood,0,0
78889,in,0,0
78890,developing,0,0
78891,countries,0,0
78892,is,0,0
78893,a,0,0
78894,long-term,0,0
78895,economic,0,0
78896,investment,0,0
78897,.,0,0
78898,We,0,0
78899,investigated,0,0
78900,the,0,0
78901,direct,0,0
78902,effect,0,0
78903,of,0,0
78904,a,0,0
78905,nutrition,1,1
78906,intervention,1,1
78907,in,0,0
78908,early,0,0
78909,childhood,0,0
78910,on,0,0
78911,adult,0,0
78912,economic,0,0
78913,productivity,0,0
78914,.,0,0
78915,METHODS,0,0
78916,We,0,0
78917,obtained,0,0
78918,economic,0,0
78919,data,0,0
78920,from,0,0
78921,1424,0,0
78922,Guatemalan,0,0
78923,individuals,0,0
78924,(,0,0
78925,aged,0,0
78926,25-42,0,0
78927,years,0,0
78928,),0,0
78929,between,0,0
78930,2002,0,0
78931,and,0,0
78932,2004,0,0
78933,.,0,0
78934,They,0,0
78935,accounted,0,0
78936,for,0,0
78937,60,0,0
78938,%,0,0
78939,of,0,0
78940,the,0,0
78941,2392,0,0
78942,children,0,0
78943,(,0,0
78944,aged,0,0
78945,0-7,0,0
78946,years,0,0
78947,),0,0
78948,who,0,0
78949,had,0,0
78950,been,0,0
78951,enrolled,0,0
78952,in,0,0
78953,a,0,0
78954,nutrition,1,1
78955,intervention,1,1
78956,study,0,0
78957,during,0,0
78958,1969-77,0,0
78959,.,0,0
78960,In,0,0
78961,this,0,0
78962,initial,0,0
78963,study,0,0
78964,",",0,0
78965,two,0,0
78966,villages,0,0
78967,were,0,0
78968,randomly,0,0
78969,assigned,0,0
78970,a,0,0
78971,nutritious,1,1
78972,supplement,1,1
78973,(,1,1
78974,atole,1,1
78975,),1,0
78976,for,1,0
78977,all,1,0
78978,children,1,0
78979,and,1,0
78980,two,1,0
78981,villages,1,0
78982,a,1,0
78983,less,1,0
78984,nutritious,1,1
78985,one,1,0
78986,(,1,0
78987,fresco,1,0
78988,),1,0
78989,.,1,0
78990,We,0,0
78991,estimated,0,0
78992,annual,0,0
78993,income,0,0
78994,",",0,0
78995,hours,0,0
78996,worked,0,0
78997,",",0,0
78998,and,0,0
78999,average,0,0
79000,hourly,0,0
79001,wages,0,0
79002,from,0,0
79003,all,0,0
79004,economic,0,0
79005,activities,0,0
79006,.,0,0
79007,We,0,0
79008,used,0,0
79009,linear,0,0
79010,regression,0,0
79011,models,0,0
79012,",",0,0
79013,adjusting,0,0
79014,for,0,0
79015,potentially,0,0
79016,confounding,0,0
79017,factors,0,0
79018,",",0,0
79019,to,0,0
79020,assess,0,0
79021,the,0,0
79022,relation,0,0
79023,between,0,0
79024,economic,0,0
79025,variables,0,0
79026,and,0,0
79027,exposure,0,0
79028,to,0,0
79029,atole,1,1
79030,or,0,1
79031,fresco,1,1
79032,at,0,0
79033,specific,0,0
79034,ages,0,0
79035,between,0,0
79036,birth,0,0
79037,and,0,0
79038,7,0,0
79039,years,0,0
79040,.,0,0
79041,FINDINGS,0,0
79042,Exposure,0,0
79043,to,0,0
79044,atole,1,0
79045,before,0,0
79046,",",0,0
79047,but,0,0
79048,not,0,0
79049,after,0,0
79050,",",0,0
79051,age,0,0
79052,3,0,0
79053,years,0,0
79054,was,0,0
79055,associated,0,0
79056,with,0,0
79057,higher,0,0
79058,hourly,0,0
79059,wages,0,0
79060,",",0,0
79061,but,0,0
79062,only,0,0
79063,for,0,0
79064,men,0,0
79065,.,0,0
79066,For,0,0
79067,exposure,0,0
79068,to,0,0
79069,atole,0,0
79070,from,0,0
79071,0,0,0
79072,to,0,0
79073,2,0,0
79074,years,0,0
79075,",",0,0
79076,the,0,0
79077,increase,0,0
79078,was,0,0
79079,US,0,1
79080,$,0,0
79081,0.67,0,0
79082,per,0,0
79083,hour,0,0
79084,(,0,0
79085,95,0,0
79086,%,0,0
79087,CI,0,0
79088,0.16-1.17,0,0
79089,),0,0
79090,",",0,0
79091,which,0,0
79092,meant,0,0
79093,a,0,0
79094,46,0,0
79095,%,0,0
79096,increase,0,0
79097,in,0,0
79098,average,0,0
79099,wages,0,0
79100,.,0,0
79101,There,0,0
79102,was,0,0
79103,a,0,0
79104,non-significant,0,0
79105,tendency,0,0
79106,for,0,0
79107,hours,0,0
79108,worked,0,0
79109,to,0,0
79110,be,0,0
79111,reduced,0,0
79112,and,0,0
79113,for,0,0
79114,annual,0,0
79115,incomes,0,0
79116,to,0,0
79117,be,0,0
79118,greater,0,0
79119,for,0,0
79120,those,0,0
79121,exposed,0,0
79122,to,0,0
79123,atole,1,0
79124,from,0,0
79125,0,0,0
79126,to,0,0
79127,2,0,0
79128,years,0,0
79129,.,0,0
79130,INTERPRETATION,0,0
79131,Improving,0,0
79132,nutrition,0,1
79133,in,0,0
79134,early,0,0
79135,childhood,0,0
79136,led,0,0
79137,to,0,0
79138,substantial,0,0
79139,increases,0,0
79140,in,0,0
79141,wage,0,0
79142,rates,0,0
79143,for,0,0
79144,men,0,0
79145,",",0,0
79146,which,0,0
79147,suggests,0,0
79148,that,0,0
79149,investments,0,0
79150,in,0,0
79151,early,0,0
79152,childhood,0,0
79153,nutrition,0,1
79154,can,0,0
79155,be,0,0
79156,long-term,0,0
79157,drivers,0,0
79158,of,0,0
79159,economic,0,0
79160,growth,0,0
79161,.,0,0
79162,Effect,0,0
79163,of,0,0
79164,vitamin,1,1
79165,K2,1,0
79166,on,0,0
79167,the,0,0
79168,recurrence,0,0
79169,in,0,0
79170,patients,0,0
79171,with,0,0
79172,hepatocellular,0,0
79173,carcinoma,0,0
79174,.,0,0
79175,BACKGROUND/AIMS,0,0
79176,Vitamin,1,1
79177,K2,1,1
79178,(,1,1
79179,VK2,1,1
79180,),1,1
79181,appears,0,0
79182,to,0,0
79183,have,0,0
79184,a,0,0
79185,potent,0,0
79186,inhibitory,0,0
79187,activity,0,0
79188,for,0,0
79189,cell,0,0
79190,growth,0,0
79191,including,0,0
79192,HCC,0,0
79193,cells,0,0
79194,.,0,0
79195,We,0,0
79196,investigated,0,0
79197,whether,0,0
79198,VK2,1,1
79199,could,0,0
79200,reduce,0,0
79201,incidence,0,0
79202,of,0,0
79203,tumor,0,0
79204,recurrence,0,0
79205,after,0,0
79206,treatment,0,0
79207,of,0,0
79208,HCC,0,0
79209,.,0,0
79210,Forty-five,0,0
79211,patients,0,0
79212,with,0,0
79213,cured,0,0
79214,or,0,1
79215,possibly,0,0
79216,cured,0,0
79217,HCC,0,0
79218,were,0,0
79219,randomly,0,0
79220,selected,0,0
79221,",",0,0
79222,assigning,0,0
79223,patients,0,0
79224,to,0,0
79225,treatment,0,0
79226,(,0,1
79227,n=21,0,0
79228,),0,1
79229,or,0,1
79230,control,1,1
79231,group,0,1
79232,(,0,1
79233,n=24,0,1
79234,),0,1
79235,with,0,0
79236,randomization,0,0
79237,list,0,0
79238,.,0,0
79239,METHODOLOGY,0,0
79240,For,0,0
79241,the,0,0
79242,treatment,0,0
79243,group,0,0
79244,",",0,0
79245,forty-five,0,0
79246,mg,0,1
79247,of,0,0
79248,Glakay,1,0
79249,was,0,0
79250,given,0,0
79251,orally,0,1
79252,every,0,1
79253,day,0,0
79254,after,0,0
79255,therapy,0,1
79256,for,0,0
79257,HCC,0,1
79258,.,0,0
79259,No,0,0
79260,patients,0,0
79261,complained,0,0
79262,of,0,0
79263,adverse,0,0
79264,effects,0,0
79265,.,0,0
79266,Abdominal,0,0
79267,ultrasonography,0,1
79268,and,0,0
79269,dynamic,1,0
79270,CT,1,1
79271,were,0,0
79272,performed,0,0
79273,at,0,0
79274,3-month,0,0
79275,intervals,0,0
79276,.,0,0
79277,Recurrence,0,0
79278,was,0,0
79279,confirmed,0,0
79280,by,0,0
79281,abdominal,1,0
79282,angiography,1,1
79283,.,1,0
79284,RESULTS,0,0
79285,Recurrence,0,0
79286,of,0,0
79287,HCC,0,0
79288,occurred,0,0
79289,in,0,0
79290,7,0,0
79291,cases,0,0
79292,(,0,0
79293,33.3,0,0
79294,%,0,0
79295,),0,0
79296,for,0,0
79297,the,0,0
79298,treatment,0,1
79299,group,0,0
79300,and,0,0
79301,12,0,0
79302,cases,0,0
79303,(,0,0
79304,50.0,0,0
79305,%,0,0
79306,),0,0
79307,for,0,0
79308,the,0,0
79309,control,0,1
79310,group,0,0
79311,during,0,0
79312,mean,0,0
79313,observation,0,1
79314,periods,0,0
79315,of,0,0
79316,19.5,0,0
79317,and,0,0
79318,16.5,0,0
79319,months,0,0
79320,",",0,0
79321,respectively,0,0
79322,.,0,0
79323,Administration,0,0
79324,of,0,0
79325,VK2,0,1
79326,was,0,0
79327,not,0,0
79328,an,0,0
79329,independent,0,0
79330,variable,0,0
79331,for,0,0
79332,the,0,0
79333,recurrence,0,0
79334,on,0,0
79335,univariate,0,0
79336,analysis,0,0
79337,.,0,0
79338,Cumulative,0,0
79339,incidence,0,0
79340,of,0,0
79341,HCC,0,1
79342,recurrence,0,0
79343,did,0,0
79344,not,0,0
79345,differ,0,0
79346,between,0,0
79347,the,0,0
79348,two,0,0
79349,groups,0,0
79350,",",0,0
79351,and,0,0
79352,the,0,0
79353,cumulative,0,0
79354,survival,0,0
79355,rate,0,0
79356,tended,0,0
79357,to,0,0
79358,be,0,0
79359,high,0,0
79360,in,0,0
79361,treatment,0,1
79362,group,0,1
79363,(,0,0
79364,p,0,0
79365,=0.054,0,0
79366,),0,0
79367,.,0,0
79368,Cox,0,1
79369,regression,0,0
79370,analysis,0,0
79371,revealed,0,0
79372,that,0,0
79373,serum,0,0
79374,albumin,0,1
79375,concentration,0,0
79376,alone,0,1
79377,was,0,0
79378,an,0,0
79379,independent,0,0
79380,factor,0,0
79381,affecting,0,0
79382,the,0,0
79383,recurrence,0,0
79384,.,0,0
79385,CONCLUSIONS,0,0
79386,These,0,0
79387,findings,0,0
79388,suggest,0,0
79389,that,0,0
79390,VK2,0,1
79391,does,0,0
79392,not,0,0
79393,appear,0,0
79394,to,0,0
79395,prevent,0,0
79396,recurrence,0,0
79397,of,0,0
79398,HCC,0,0
79399,after,0,0
79400,curative,0,0
79401,treatment,0,0
79402,.,0,0
79403,Our,0,0
79404,study,0,0
79405,is,0,0
79406,preliminary,0,0
79407,and,0,0
79408,large-scale,0,0
79409,trials,0,0
79410,are,0,0
79411,needed,0,0
79412,to,0,0
79413,determine,0,0
79414,whether,0,0
79415,VK2,0,1
79416,is,0,0
79417,of,0,0
79418,benefit,0,0
79419,to,0,0
79420,decrease,0,0
79421,the,0,0
79422,recurrence,0,0
79423,of,0,0
79424,HCC,0,0
79425,.,0,0
79426,[,0,0
79427,4,0,0
79428,years,0,0
79429,',0,0
79430,experience,0,0
79431,with,0,0
79432,a,0,0
79433,balloon-expandable,1,1
79434,endoprosthesis,1,1
79435,.,1,0
79436,Experimental,0,0
79437,and,0,0
79438,clinical,0,0
79439,application,0,1
79440,],0,0
79441,.,0,0
79442,During,0,0
79443,a,0,0
79444,4-year,0,0
79445,period,0,0
79446,of,0,0
79447,clinical,0,0
79448,application,0,0
79449,of,0,0
79450,the,0,0
79451,balloon-expandable,1,1
79452,Palmaz,1,1
79453,stent,1,1
79454,",",0,0
79455,a,0,0
79456,randomized,0,0
79457,trial,0,0
79458,comparing,0,0
79459,stent,1,1
79460,implantation,1,1
79461,and,1,0
79462,traditional,1,1
79463,balloon,1,1
79464,angioplasty,1,1
79465,of,0,0
79466,iliac,0,0
79467,arteries,0,0
79468,in,0,0
79469,arterial,0,0
79470,occlusive,0,1
79471,disease,0,0
79472,was,0,0
79473,started,0,0
79474,.,0,0
79475,The,0,0
79476,first,0,0
79477,long-term,0,0
79478,results,0,0
79479,",",0,0
79480,recorded,0,0
79481,after,0,0
79482,2,0,0
79483,years,0,0
79484,",",0,0
79485,indicate,0,0
79486,statistically,0,0
79487,significant,0,0
79488,differences,0,0
79489,in,0,0
79490,the,0,0
79491,complication,0,0
79492,rate,0,0
79493,(,0,0
79494,after,0,0
79495,stenting,0,1
79496,2/62,0,0
79497,and,0,0
79498,after,0,0
79499,angioplasty,0,1
79500,5/69,0,0
79501,),0,0
79502,and,0,0
79503,patency,0,0
79504,(,0,0
79505,greater,0,0
79506,than,0,0
79507,or,0,0
79508,equal,0,0
79509,to,0,0
79510,70,0,0
79511,%,0,0
79512,of,0,0
79513,original,0,0
79514,lumen,0,0
79515,size,0,0
79516,upon,0,0
79517,stent,1,1
79518,implantation,1,0
79519,or,1,1
79520,balloon,1,1
79521,inflation,1,0
79522,:,1,0
79523,95,0,0
79524,%,0,0
79525,after,0,0
79526,stenting,0,1
79527,and,0,0
79528,72,0,0
79529,%,0,0
79530,after,0,0
79531,angioplasty,0,1
79532,),0,0
79533,.,0,0
79534,Clinical,0,0
79535,improvement,0,0
79536,after,0,0
79537,2,0,0
79538,years,0,0
79539,was,0,0
79540,89,0,0
79541,%,0,0
79542,after,0,0
79543,stenting,0,1
79544,and,0,0
79545,70,0,0
79546,%,0,0
79547,after,0,0
79548,angioplasty,0,1
79549,.,0,0
79550,Parallel,0,0
79551,to,0,0
79552,the,0,0
79553,clinical,0,0
79554,trials,0,0
79555,",",0,0
79556,experimental,0,0
79557,canine,0,1
79558,artery,0,0
79559,stenting,0,1
79560,was,0,0
79561,performed,0,0
79562,to,0,0
79563,evaluate,0,0
79564,differences,0,0
79565,in,0,0
79566,the,0,0
79567,long-term,0,0
79568,patency,0,0
79569,of,0,0
79570,stents,0,1
79571,exposed,0,0
79572,to,0,0
79573,restricted,0,0
79574,flow,0,0
79575,.,0,0
79576,Significant,0,0
79577,differences,0,0
79578,in,0,0
79579,neointimal,0,0
79580,healing,0,0
79581,were,0,0
79582,found,0,0
79583,between,0,0
79584,normally,0,0
79585,perfused,0,0
79586,stents,0,1
79587,and,0,0
79588,stents,0,1
79589,with,0,0
79590,artificially,0,0
79591,reduced,0,0
79592,flow,0,0
79593,:,0,0
79594,during,0,0
79595,the,0,0
79596,total,0,0
79597,observation,0,1
79598,period,0,0
79599,of,0,0
79600,6,0,0
79601,months,0,0
79602,the,0,0
79603,neointimal,0,0
79604,height,0,0
79605,was,0,0
79606,up,0,0
79607,to,0,0
79608,200,0,0
79609,%,0,0
79610,higher,0,0
79611,in,0,0
79612,flow-restricted,0,1
79613,stents,0,1
79614,",",0,0
79615,while,0,0
79616,the,0,0
79617,histological,0,0
79618,composition,0,0
79619,of,0,0
79620,the,0,0
79621,neointima,0,0
79622,was,0,0
79623,the,0,0
79624,same,0,0
79625,as,0,0
79626,with,0,0
79627,normally,0,0
79628,perfused,0,0
79629,stents,0,1
79630,.,0,0
79631,Desogestrel,0,1
79632,and,0,0
79633,gestodene,0,1
79634,in,0,0
79635,oral,0,1
79636,contraceptives,0,1
79637,:,0,0
79638,12,0,0
79639,months,0,0
79640,',0,0
79641,assessment,0,0
79642,of,0,0
79643,carbohydrate,0,1
79644,and,0,0
79645,lipoprotein,0,0
79646,metabolism,0,0
79647,.,0,0
79648,We,0,0
79649,examined,0,0
79650,the,0,0
79651,influence,0,0
79652,on,0,0
79653,carbohydrate,0,1
79654,and,0,0
79655,lipoprotein,0,0
79656,metabolism,0,0
79657,of,0,0
79658,oral,1,1
79659,contraceptives,1,1
79660,(,1,0
79661,OCs,1,1
79662,),1,1
79663,containing,0,1
79664,two,0,0
79665,new,0,0
79666,third-generation,0,0
79667,progestogens,1,1
79668,",",1,0
79669,desogestrel,1,1
79670,and,1,0
79671,gestodene,1,1
79672,.,0,0
79673,This,0,0
79674,was,0,0
79675,a,0,0
79676,prospective,0,0
79677,randomized,0,0
79678,study,0,0
79679,in,0,0
79680,which,0,0
79681,monophasic,0,0
79682,combinations,0,0
79683,of,0,0
79684,20,1,0
79685,micrograms,1,1
79686,ethinyl,1,1
79687,estradiol,1,1
79688,(,1,1
79689,E2,1,1
79690,),1,1
79691,and,0,0
79692,150,1,0
79693,micrograms,1,1
79694,desogestrel,1,1
79695,or,0,0
79696,30,0,0
79697,micrograms,0,1
79698,ethinyl,1,1
79699,E2,1,0
79700,plus,1,1
79701,75,1,0
79702,micrograms,1,1
79703,gestodene,1,1
79704,were,0,0
79705,administered,0,0
79706,to,0,0
79707,15,0,0
79708,and,0,0
79709,19,0,0
79710,healthy,0,0
79711,women,0,0
79712,",",0,0
79713,respectively,0,0
79714,.,0,0
79715,An,0,0
79716,oral,0,1
79717,glucose,0,0
79718,tolerance,0,0
79719,test,0,1
79720,including,0,0
79721,measurement,0,1
79722,of,0,0
79723,insulin,0,1
79724,response,0,0
79725,was,0,0
79726,performed,0,0
79727,before,0,0
79728,treatment,0,0
79729,and,0,0
79730,after,0,0
79731,3,0,0
79732,",",0,0
79733,6,0,0
79734,",",0,0
79735,and,0,0
79736,12,0,0
79737,months,0,0
79738,of,0,0
79739,treatment,0,0
79740,.,0,0
79741,We,0,0
79742,also,0,0
79743,determined,0,0
79744,fasting,0,0
79745,plasma,0,0
79746,concentrations,0,0
79747,of,0,0
79748,total,0,0
79749,cholesterol,0,0
79750,;,0,0
79751,high-density,0,0
79752,lipoprotein,0,0
79753,cholesterol,0,0
79754,",",0,0
79755,including,0,0
79756,the,0,0
79757,subfractions,0,1
79758,high-density,0,0
79759,lipoprotein2,0,0
79760,cholesterol,0,1
79761,and,0,0
79762,high-density,0,1
79763,lipoprotein3,0,0
79764,cholesterol,0,0
79765,;,0,0
79766,low-density,0,0
79767,lipoprotein,0,0
79768,cholesterol,0,0
79769,;,0,0
79770,very,0,0
79771,low-density,0,0
79772,lipoprotein,0,0
79773,cholesterol,0,0
79774,;,0,0
79775,and,0,0
79776,triglycerides,0,0
79777,.,0,0
79778,A,0,0
79779,transient,0,0
79780,deterioration,0,0
79781,of,0,0
79782,glucose,0,0
79783,tolerance,0,0
79784,was,0,0
79785,observed,0,0
79786,despite,0,0
79787,unchanged,0,0
79788,levels,0,0
79789,of,0,0
79790,insulin,0,1
79791,after,0,0
79792,treatment,0,0
79793,with,0,0
79794,both,0,0
79795,compounds,0,1
79796,for,0,0
79797,3,0,0
79798,months,0,0
79799,.,0,0
79800,In,0,0
79801,both,0,0
79802,groups,0,0
79803,plasma,0,0
79804,levels,0,0
79805,of,0,0
79806,triglycerides,0,0
79807,",",0,0
79808,very,0,0
79809,low-density,0,0
79810,lipoprotein,0,0
79811,cholesterol,0,0
79812,",",0,0
79813,and,0,0
79814,high-density,0,1
79815,lipoprotein,0,1
79816,cholesterol,0,0
79817,increased,0,0
79818,significantly,0,0
79819,after,0,0
79820,3,0,0
79821,months,0,0
79822,.,0,0
79823,After,0,0
79824,12,0,0
79825,months,0,0
79826,",",0,0
79827,a,0,0
79828,significant,0,0
79829,increase,0,0
79830,in,0,0
79831,the,0,0
79832,high-density,0,0
79833,lipoprotein,0,0
79834,cholesterol/total,0,1
79835,cholesterol,0,0
79836,ratio,0,0
79837,was,0,0
79838,observed,0,0
79839,in,0,0
79840,the,0,0
79841,ethinyl,0,1
79842,E2-desogestrel,0,1
79843,group,0,0
79844,",",0,0
79845,and,0,0
79846,no,0,0
79847,persistent,0,0
79848,changes,0,0
79849,in,0,0
79850,low-density,0,0
79851,lipoprotein,0,0
79852,cholesterol,0,0
79853,could,0,0
79854,be,0,0
79855,demonstrated,0,0
79856,in,0,0
79857,any,0,0
79858,of,0,0
79859,the,0,0
79860,groups,0,0
79861,.,0,0
79862,Our,0,0
79863,results,0,0
79864,indicate,0,0
79865,that,0,0
79866,treatment,0,0
79867,with,0,0
79868,either,0,1
79869,compound,0,1
79870,for,0,0
79871,12,0,0
79872,months,0,0
79873,has,0,0
79874,no,0,0
79875,effect,0,0
79876,on,0,0
79877,carbohydrate,0,1
79878,or,0,1
79879,lipoprotein,0,0
79880,metabolism,0,0
79881,known,0,0
79882,to,0,0
79883,increase,0,0
79884,the,0,0
79885,risk,0,0
79886,of,0,0
79887,cardiovascular,0,0
79888,disease,0,0
79889,.,0,0
79890,Effect,0,0
79891,of,0,0
79892,sport-tinted,1,1
79893,contact,1,1
79894,lenses,1,1
79895,for,0,0
79896,contrast,0,0
79897,enhancement,0,0
79898,on,0,0
79899,retinal,0,0
79900,straylight,0,0
79901,measurements,0,0
79902,.,0,0
79903,PURPOSE,0,0
79904,To,0,0
79905,investigate,0,0
79906,the,0,0
79907,effect,0,0
79908,of,0,0
79909,two,0,0
79910,tinted,1,1
79911,contact,1,1
79912,lenses,1,1
79913,(,1,0
79914,CL,1,1
79915,),1,1
79916,designed,0,0
79917,for,0,0
79918,outdoor,0,0
79919,sports,0,0
79920,activity,0,0
79921,on,0,0
79922,the,0,0
79923,psychometric,0,0
79924,determination,0,0
79925,of,0,0
79926,retinal,0,0
79927,straylight,0,0
79928,using,0,0
79929,the,0,0
79930,compensation,0,0
79931,comparison,0,0
79932,method,0,1
79933,.,0,0
79934,METHODS,0,0
79935,Thirteen,0,0
79936,emmetropic,0,1
79937,subjects,0,0
79938,were,0,0
79939,randomly,0,0
79940,fitted,0,0
79941,with,0,0
79942,two,1,0
79943,different,1,0
79944,tinted,1,1
79945,Nike,1,0
79946,Maxsight,1,0
79947,(,1,1
79948,Bausch,1,1
79949,&,1,1
79950,Lomb,1,0
79951,",",1,0
79952,Rochester,1,0
79953,",",1,0
79954,NY,1,0
79955,",",1,0
79956,USA,1,1
79957,),1,0
79958,CL,1,1
79959,in,1,0
79960,one,1,0
79961,eye,1,0
79962,",",1,0
79963,while,1,0
79964,the,1,0
79965,contralateral,1,1
79966,eye,1,0
79967,was,1,0
79968,fitted,1,0
79969,with,1,0
79970,a,1,0
79971,clear,1,0
79972,lens,1,1
79973,made,1,0
79974,of,1,0
79975,the,1,0
79976,same,1,0
79977,material,1,0
79978,(,1,0
79979,Optima,1,0
79980,38,1,0
79981,",",1,0
79982,Bausch,1,1
79983,&,1,1
79984,Lomb,1,0
79985,),1,0
79986,.,1,0
79987,Three,0,0
79988,valid,0,0
79989,straylight,0,0
79990,measurements,0,0
79991,were,0,0
79992,taken,0,0
79993,on,0,0
79994,each,0,0
79995,eye,0,0
79996,before,0,0
79997,and,0,0
79998,a,0,0
79999,few,0,0
80000,minutes,0,0
80001,after,0,0
80002,lens,0,1
80003,insertion,0,1
80004,",",0,0
80005,when,0,0
80006,lens,0,1
80007,stabilization,0,0
80008,had,0,0
80009,occurred,0,0
80010,.,0,0
80011,RESULTS,0,0
80012,The,0,0
80013,subjects,0,0
80014,',0,0
80015,mean,0,0
80016,straylight,0,0
80017,values,0,0
80018,were,0,0
80019,0.90,0,0
80020,+/-,0,0
80021,0.09,0,0
80022,at,0,0
80023,baseline,0,0
80024,and,0,0
80025,0.95,0,0
80026,+/-,0,0
80027,0.10,0,0
80028,with,0,0
80029,the,0,0
80030,clear,0,0
80031,Optima,0,0
80032,38,0,0
80033,CL,0,0
80034,.,0,0
80035,Straylight,0,0
80036,values,0,0
80037,were,0,0
80038,0.97,0,0
80039,+/-,0,0
80040,0.10,0,0
80041,and,0,0
80042,1.0,0,0
80043,+/-,0,0
80044,0.10,0,0
80045,log,0,0
80046,units,0,0
80047,with,0,0
80048,the,0,0
80049,amber,0,1
80050,and,0,0
80051,grey-green,0,1
80052,tinted,0,1
80053,CL,0,1
80054,",",0,0
80055,respectively,0,0
80056,.,0,0
80057,Differences,0,0
80058,in,0,0
80059,straylight,0,0
80060,between,0,0
80061,baseline,0,0
80062,(,0,0
80063,without,0,1
80064,CL,0,1
80065,),0,1
80066,and,0,0
80067,with,0,0
80068,the,0,0
80069,clear,0,0
80070,CL,0,1
80071,in,0,0
80072,place,0,0
80073,were,0,0
80074,neither,0,0
80075,statistically,0,0
80076,significant,0,0
80077,(,0,0
80078,p,0,0
80079,=,0,0
80080,0.066,0,0
80081,),0,0
80082,nor,0,0
80083,was,0,0
80084,there,0,0
80085,a,0,0
80086,significant,0,0
80087,difference,0,0
80088,between,0,0
80089,baseline,0,0
80090,and,0,0
80091,the,0,0
80092,amber,0,1
80093,CL,0,1
80094,(,0,0
80095,p,0,0
80096,=,0,0
80097,0.052,0,0
80098,),0,0
80099,.,0,0
80100,However,0,0
80101,",",0,0
80102,the,0,0
80103,grey-green,0,0
80104,CL,0,1
80105,showed,0,0
80106,a,0,0
80107,statistically,0,0
80108,significant,0,0
80109,difference,0,0
80110,from,0,0
80111,baseline,0,0
80112,(,0,0
80113,p,0,0
80114,=,0,0
80115,0.006,0,0
80116,),0,0
80117,.,0,0
80118,Differences,0,0
80119,in,0,0
80120,straylight,0,0
80121,with,0,0
80122,the,0,0
80123,clear,0,0
80124,CL,0,1
80125,compared,0,0
80126,with,0,0
80127,the,0,0
80128,grey-green,0,0
80129,CL,0,1
80130,were,0,0
80131,also,0,0
80132,statistically,0,0
80133,different,0,0
80134,from,0,0
80135,zero,0,0
80136,(,0,0
80137,p,0,0
80138,=,0,0
80139,0.002,0,0
80140,),0,0
80141,showing,0,0
80142,an,0,0
80143,increased,0,0
80144,straylight,0,0
80145,value,0,0
80146,for,0,0
80147,the,0,0
80148,tinted,0,1
80149,CL,0,1
80150,.,0,0
80151,These,0,0
80152,differences,0,0
80153,were,0,0
80154,variable,0,0
80155,",",0,0
80156,but,0,0
80157,consistent,0,0
80158,for,0,0
80159,each,0,0
80160,subject,0,0
80161,",",0,0
80162,thus,0,0
80163,those,0,0
80164,showing,0,0
80165,higher,0,0
80166,or,0,0
80167,lower,0,0
80168,changes,0,0
80169,with,0,0
80170,one,0,0
80171,tinted,0,1
80172,lens,0,1
80173,tended,0,0
80174,to,0,0
80175,show,0,0
80176,the,0,0
80177,same,0,0
80178,trend,0,0
80179,with,0,0
80180,the,0,0
80181,second,0,0
80182,lens,0,1
80183,(,0,1
80184,r,0,0
80185,(,0,1
80186,2,0,0
80187,),0,0
80188,=,0,0
80189,0.736,0,0
80190,),0,0
80191,.,0,0
80192,CONCLUSIONS,0,0
80193,Despite,0,0
80194,increases,0,0
80195,having,0,0
80196,been,0,0
80197,found,0,0
80198,in,0,0
80199,straylight,0,0
80200,values,0,0
80201,with,0,0
80202,tinted,0,1
80203,contact,0,1
80204,lenses,0,1
80205,",",0,0
80206,those,0,0
80207,changes,0,0
80208,are,0,0
80209,not,0,0
80210,likely,0,0
80211,to,0,0
80212,induce,0,0
80213,clinically,0,0
80214,significant,0,0
80215,changes,0,0
80216,in,0,0
80217,visual,0,0
80218,function,0,0
80219,under,0,0
80220,photopic,0,0
80221,conditions,0,0
80222,",",0,0
80223,even,0,0
80224,for,0,0
80225,the,0,0
80226,grey-green,0,0
80227,CL,0,1
80228,",",0,0
80229,which,0,0
80230,seems,0,0
80231,to,0,0
80232,increase,0,0
80233,straylight,0,0
80234,values,0,0
80235,more,0,0
80236,significantly,0,0
80237,than,0,0
80238,the,0,0
80239,amber,0,1
80240,CL,0,1
80241,.,0,0
80242,This,0,0
80243,difference,0,0
80244,between,0,0
80245,the,0,0
80246,tinted,0,1
80247,CL,0,1
80248,could,0,0
80249,suggest,0,0
80250,a,0,0
80251,wavelength,0,0
80252,dependence,0,0
80253,of,0,0
80254,straylight,0,0
80255,values,0,0
80256,",",0,0
80257,although,0,0
80258,this,0,0
80259,should,0,0
80260,be,0,0
80261,investigated,0,0
80262,further,0,0
80263,by,0,0
80264,controlling,0,0
80265,for,0,0
80266,pupil,0,1
80267,size,0,0
80268,and,0,0
80269,subjects,0,0
80270,',0,0
80271,pigmentation,0,0
80272,",",0,0
80273,as,0,0
80274,well,0,0
80275,as,0,0
80276,by,0,0
80277,using,0,0
80278,neutral,0,1
80279,density,0,0
80280,filters,0,1
80281,.,0,0
80282,A,0,0
80283,double-blind,0,0
80284,randomized,0,0
80285,clinical,0,0
80286,evaluation,0,0
80287,of,0,0
80288,enamel,1,0
80289,matrix,1,1
80290,derivative,1,0
80291,proteins,1,0
80292,for,0,0
80293,the,0,0
80294,treatment,0,0
80295,of,0,0
80296,proximal,0,0
80297,class-II,0,1
80298,furcation,0,0
80299,involvements,0,0
80300,.,0,0
80301,OBJECTIVE,0,0
80302,The,0,0
80303,aim,0,0
80304,of,0,0
80305,the,0,0
80306,present,0,0
80307,randomized,0,0
80308,",",0,0
80309,double-blind,0,0
80310,study,0,0
80311,was,0,0
80312,to,0,0
80313,evaluate,0,0
80314,the,0,0
80315,clinical,0,0
80316,response,0,0
80317,of,0,0
80318,proximal,0,0
80319,furcations,0,0
80320,treated,0,0
80321,with,0,0
80322,enamel,1,0
80323,matrix,1,1
80324,derivative,1,0
80325,proteins,1,1
80326,(,1,0
80327,EMD,1,1
80328,),1,0
80329,.,1,0
80330,MATERIAL,0,0
80331,AND,0,0
80332,METHODS,0,0
80333,Fifteen,0,0
80334,patients,0,0
80335,",",0,0
80336,each,0,0
80337,with,0,0
80338,a,0,0
80339,pair,0,0
80340,of,0,0
80341,contralateral,0,0
80342,class-II,0,1
80343,proximal,0,0
80344,furcation,0,0
80345,involvements,0,0
80346,",",0,0
80347,presenting,0,0
80348,probing,0,0
80349,depths,0,1
80350,(,0,0
80351,PDs,0,1
80352,),0,1
80353,>,0,0
80354,/=5,0,0
80355,mm,0,0
80356,and,0,0
80357,bleeding,0,0
80358,on,0,0
80359,probing,0,0
80360,(,0,1
80361,BOP,0,0
80362,),0,1
80363,were,0,0
80364,selected,0,0
80365,.,0,0
80366,The,0,0
80367,patients,0,0
80368,were,0,0
80369,randomly,0,0
80370,assigned,0,0
80371,to,0,0
80372,:,0,0
80373,control,1,1
80374,group,1,1
80375,(,0,1
80376,n=15,0,1
80377,),0,1
80378,-,0,0
80379,open,1,1
80380,flap,1,1
80381,debridement,1,1
80382,(,1,1
80383,OFD,1,1
80384,),1,1
80385,+24,1,1
80386,%,1,0
80387,ethylenediaminetetraacetic,1,1
80388,acid,1,1
80389,(,1,1
80390,EDTA,1,1
80391,),1,1
80392,conditioning,1,1
80393,;,1,0
80394,test,0,1
80395,group,0,1
80396,(,0,1
80397,n=15,0,1
80398,),0,1
80399,-,0,0
80400,OFD+24,1,0
80401,%,1,0
80402,EDTA,1,1
80403,conditioning+EMD,1,1
80404,application,1,0
80405,.,1,0
80406,Plaque,0,0
80407,index,0,0
80408,(,0,1
80409,PI,0,1
80410,),0,0
80411,",",0,0
80412,BOP,0,0
80413,",",0,0
80414,PD,0,1
80415,",",0,0
80416,gingival,0,0
80417,margin,0,1
80418,position,0,0
80419,(,0,1
80420,GMP,0,1
80421,),0,1
80422,",",0,0
80423,relative,0,0
80424,vertical,0,1
80425,and,0,0
80426,horizontal,0,1
80427,clinical,0,0
80428,attachment,0,0
80429,level,0,0
80430,(,0,1
80431,RVCAL,0,1
80432,and,0,1
80433,RHCAL,0,1
80434,),0,0
80435,",",0,0
80436,vertical,0,1
80437,and,0,0
80438,horizontal,0,1
80439,bone,0,1
80440,level,0,0
80441,(,0,1
80442,VBL,0,0
80443,and,0,1
80444,HBL,0,1
80445,),0,1
80446,and,0,0
80447,furcation,0,0
80448,closure,0,0
80449,were,0,0
80450,evaluated,0,0
80451,immediately,0,0
80452,before,0,0
80453,and,0,0
80454,2,0,0
80455,",",0,0
80456,4,0,0
80457,and,0,0
80458,6,0,0
80459,months,0,0
80460,after,0,0
80461,the,0,0
80462,surgeries,0,0
80463,.,0,0
80464,RESULTS,0,0
80465,At,0,0
80466,6,0,0
80467,months,0,0
80468,",",0,0
80469,the,0,0
80470,RVCAL,0,0
80471,gains,0,0
80472,of,0,0
80473,the,0,0
80474,control,0,1
80475,and,0,0
80476,test,0,1
80477,group,0,0
80478,were,0,0
80479,0.39,0,0
80480,+/-,0,0
80481,1.00,0,0
80482,and,0,0
80483,0.54,0,0
80484,+/-,0,0
80485,0.95,0,0
80486,mm,0,0
80487,",",0,0
80488,while,0,0
80489,the,0,0
80490,RHCAL,0,1
80491,gains,0,0
80492,were,0,0
80493,1.21,0,0
80494,+/-,0,0
80495,2.28,0,0
80496,and,0,0
80497,1.36,0,0
80498,+/-,0,0
80499,1.26,0,0
80500,mm,0,0
80501,(,0,0
80502,p,0,0
80503,>,0,0
80504,0.05,0,0
80505,),0,0
80506,.,0,0
80507,The,0,0
80508,VBL,0,0
80509,and,0,0
80510,HBL,0,1
80511,gains,0,0
80512,of,0,0
80513,the,0,0
80514,control,0,1
80515,group,0,0
80516,were,0,0
80517,1.04,0,0
80518,+/-,0,0
80519,1.12,0,0
80520,and,0,0
80521,1.00,0,0
80522,+/-,0,0
80523,1.79,0,0
80524,mm,0,0
80525,",",0,0
80526,and,0,0
80527,0.82,0,0
80528,+/-,0,0
80529,1.82,0,0
80530,and,0,0
80531,1.17,0,0
80532,+/-,0,0
80533,1.38,0,0
80534,mm,0,0
80535,for,0,0
80536,the,0,0
80537,test,0,1
80538,group,0,0
80539,(,0,0
80540,p,0,0
80541,>,0,0
80542,0.05,0,0
80543,),0,0
80544,.,0,0
80545,In,0,0
80546,addition,0,0
80547,",",0,0
80548,a,0,0
80549,statistical,0,0
80550,difference,0,0
80551,was,0,0
80552,observed,0,0
80553,in,0,0
80554,the,0,0
80555,number,0,0
80556,of,0,0
80557,the,0,0
80558,remaining,0,0
80559,class-II,0,1
80560,furcations,0,0
80561,between,0,0
80562,the,0,0
80563,test,0,0
80564,and,0,0
80565,control,0,1
80566,groups,0,0
80567,(,0,0
80568,p,0,0
80569,<,0,0
80570,0.05,0,0
80571,),0,0
80572,in,0,0
80573,this,0,0
80574,period,0,0
80575,.,0,0
80576,CONCLUSION,0,0
80577,It,0,0
80578,may,0,0
80579,be,0,0
80580,concluded,0,0
80581,that,0,0
80582,the,0,0
80583,use,0,0
80584,of,0,0
80585,EMD,1,0
80586,in,0,0
80587,proximal,0,0
80588,furcations,0,0
80589,did,0,0
80590,not,0,0
80591,promote,0,0
80592,a,0,0
80593,superior,0,0
80594,reduction,0,0
80595,in,0,0
80596,PD,0,1
80597,or,0,1
80598,a,0,0
80599,gain,0,0
80600,in,0,0
80601,clinical,0,0
80602,and,0,0
80603,osseous,0,0
80604,attachment,0,0
80605,levels,0,0
80606,",",0,0
80607,but,0,0
80608,resulted,0,0
80609,in,0,0
80610,a,0,0
80611,higher,0,0
80612,rate,0,0
80613,of,0,0
80614,class-II,0,1
80615,to,0,0
80616,class-I,0,1
80617,furcation,0,0
80618,conversion,0,0
80619,.,0,0
80620,Enrollment,0,0
80621,of,0,0
80622,racial,0,0
80623,and,0,0
80624,ethnic,0,0
80625,minorities,0,0
80626,in,0,0
80627,the,0,0
80628,Prostate,0,1
80629,",",0,0
80630,Lung,0,1
80631,",",0,0
80632,Colorectal,0,0
80633,and,0,0
80634,Ovarian,0,0
80635,Cancer,0,1
80636,Screening,0,1
80637,Trial,0,0
80638,.,0,0
80639,BACKGROUND,0,0
80640,Minority,0,0
80641,populations,0,0
80642,in,0,0
80643,the,0,0
80644,United,0,0
80645,States,0,0
80646,",",0,0
80647,especially,0,0
80648,blacks,0,0
80649,and,0,0
80650,Hispanics,0,0
80651,",",0,0
80652,are,0,0
80653,generally,0,0
80654,underrepresented,0,0
80655,among,0,0
80656,participants,0,0
80657,in,0,0
80658,clinical,0,0
80659,trials,0,0
80660,.,0,0
80661,Here,0,0
80662,",",0,0
80663,we,0,0
80664,report,0,0
80665,the,0,0
80666,experience,0,0
80667,of,0,0
80668,enrolling,0,0
80669,ethnic,0,0
80670,minorities,0,0
80671,in,0,0
80672,a,0,0
80673,large,0,0
80674,cancer,0,0
80675,screening,0,1
80676,trial,0,0
80677,.,0,0
80678,METHODS,0,0
80679,The,0,0
80680,Prostate,1,1
80681,",",1,0
80682,Colorectal,1,0
80683,",",1,0
80684,Lung,1,1
80685,and,1,1
80686,Ovarian,1,0
80687,(,1,1
80688,PLCO,1,1
80689,),1,1
80690,Cancer,1,0
80691,Screening,1,1
80692,Trial,0,1
80693,is,0,0
80694,a,0,0
80695,multicenter,0,0
80696,randomized,0,0
80697,trial,0,0
80698,designed,0,0
80699,to,0,0
80700,evaluate,0,0
80701,the,0,0
80702,effectiveness,0,0
80703,of,0,0
80704,screening,1,0
80705,for,1,0
80706,the,1,0
80707,PLCO,1,1
80708,cancers,1,0
80709,.,1,0
80710,Subjects,0,0
80711,were,0,0
80712,recruited,0,0
80713,at,0,0
80714,10,0,0
80715,U.S.,0,1
80716,centers,0,0
80717,between,0,0
80718,1993,0,0
80719,and,0,0
80720,2001,0,0
80721,.,0,0
80722,One,0,0
80723,screening,0,0
80724,center,0,0
80725,had,0,0
80726,a,0,0
80727,major,0,0
80728,special,1,1
80729,recruitment,1,0
80730,effort,1,0
80731,for,1,0
80732,blacks,1,0
80733,and,0,0
80734,another,0,0
80735,center,0,0
80736,had,0,0
80737,a,0,0
80738,major,0,0
80739,special,1,1
80740,recruitment,1,0
80741,effort,1,0
80742,for,1,0
80743,Hispanics,1,0
80744,.,1,0
80745,RESULTS,0,0
80746,Among,0,0
80747,almost,0,0
80748,"155,000",0,0
80749,subjects,0,0
80750,enrolled,0,0
80751,in,0,0
80752,PLCO,0,1
80753,",",0,0
80754,minority,0,0
80755,enrollment,0,0
80756,was,0,0
80757,as,0,0
80758,follows,0,0
80759,:,0,0
80760,black,0,0
80761,(,0,0
80762,5.0,0,1
80763,%,0,0
80764,),0,0
80765,",",0,0
80766,Hispanic,0,0
80767,(,0,0
80768,1.8,0,0
80769,%,0,0
80770,),0,0
80771,and,0,1
80772,Asian,0,0
80773,(,0,1
80774,3.6,0,0
80775,%,0,0
80776,),0,0
80777,.,0,0
80778,This,0,0
80779,compares,0,0
80780,to,0,0
80781,an,0,0
80782,age-eligible,0,0
80783,population,0,0
80784,in,0,0
80785,the,0,0
80786,combined,0,1
80787,catchment,0,0
80788,areas,0,0
80789,of,0,0
80790,the,0,0
80791,PLCO,0,1
80792,centers,0,0
80793,that,0,0
80794,was,0,0
80795,14.0,0,0
80796,%,0,0
80797,black,0,0
80798,",",0,0
80799,2.9,0,0
80800,%,0,0
80801,Hispanic,0,0
80802,and,0,0
80803,5.4,0,0
80804,%,0,0
80805,Asian,0,0
80806,",",0,0
80807,and,0,0
80808,an,0,0
80809,age-eligible,0,0
80810,population,0,0
80811,across,0,0
80812,the,0,0
80813,U.S.,0,1
80814,that,0,0
80815,was,0,0
80816,9.5,0,0
80817,%,0,0
80818,black,0,0
80819,",",0,0
80820,6.5,0,0
80821,%,0,0
80822,Hispanic,0,0
80823,and,0,0
80824,3.0,0,0
80825,%,0,0
80826,Asian,0,0
80827,.,0,0
80828,About,0,0
80829,half,0,0
80830,(,0,0
80831,45,0,0
80832,%,0,0
80833,),0,0
80834,of,0,0
80835,Hispanics,0,0
80836,were,0,0
80837,recruited,0,0
80838,at,0,0
80839,the,0,0
80840,center,0,0
80841,with,0,0
80842,the,0,0
80843,special,0,0
80844,Hispanic,0,0
80845,recruitment,0,0
80846,effort,0,0
80847,.,0,0
80848,Seventy,0,0
80849,percent,0,0
80850,of,0,0
80851,blacks,0,0
80852,were,0,0
80853,recruited,0,0
80854,at,0,0
80855,two,0,0
80856,centers,0,0
80857,;,0,0
80858,the,0,0
80859,one,0,0
80860,with,0,0
80861,the,0,0
80862,major,0,0
80863,special,0,1
80864,recruitment,0,0
80865,effort,0,0
80866,and,0,0
80867,a,0,0
80868,center,0,0
80869,in,0,0
80870,Detroit,0,1
80871,whose,0,0
80872,catchment,0,0
80873,area,0,0
80874,was,0,0
80875,20,0,0
80876,%,0,0
80877,black,0,0
80878,among,0,0
80879,age-eligibles,0,0
80880,.,0,0
80881,Blacks,0,0
80882,",",0,0
80883,Hispanics,0,0
80884,and,0,0
80885,(,0,1
80886,non-Hispanic,0,0
80887,),0,0
80888,whites,0,0
80889,were,0,0
80890,all,0,0
80891,more,0,0
80892,highly,0,0
80893,educated,0,0
80894,",",0,0
80895,less,0,0
80896,likely,0,0
80897,to,0,0
80898,currently,0,0
80899,smoke,0,1
80900,and,0,0
80901,more,0,0
80902,likely,0,0
80903,to,0,0
80904,get,0,0
80905,regular,0,1
80906,exercise,0,1
80907,than,0,0
80908,their,0,0
80909,counterparts,0,0
80910,in,0,0
80911,the,0,0
80912,general,0,0
80913,population,0,0
80914,.,0,0
80915,CONCLUSION,0,0
80916,Significant,0,0
80917,efforts,0,0
80918,were,0,0
80919,made,0,0
80920,to,0,0
80921,recruit,0,0
80922,racial/,0,0
80923,ethnic,0,0
80924,minorities,0,0
80925,into,0,0
80926,PLCO,0,1
80927,",",0,0
80928,and,0,0
80929,these,0,0
80930,efforts,0,0
80931,resulted,0,0
80932,in,0,0
80933,enrollment,0,0
80934,levels,0,0
80935,that,0,0
80936,were,0,0
80937,comparable,0,0
80938,to,0,0
80939,those,0,0
80940,seen,0,0
80941,in,0,0
80942,many,0,0
80943,recent,0,0
80944,cancer,0,0
80945,screening,0,1
80946,or,0,1
80947,prevention,0,0
80948,trials,0,0
80949,.,0,0
80950,Blacks,0,0
80951,and,0,0
80952,Hispanics,0,0
80953,were,0,0
80954,nonetheless,0,0
80955,underrepresented,0,0
80956,in,0,0
80957,PLCO,0,1
80958,compared,0,0
80959,to,0,0
80960,their,0,0
80961,levels,0,0
80962,among,0,0
80963,age-eligibles,0,0
80964,in,0,0
80965,the,0,0
80966,overall,0,0
80967,U.S.,0,1
80968,population,0,0
80969,or,0,1
80970,in,0,0
80971,the,0,0
80972,aggregate,0,0
80973,PLCO,0,1
80974,catchment,0,0
80975,areas,0,0
80976,.,0,0
80977,Benzodiazepine,1,1
80978,and,0,0
80979,opioid,1,1
80980,sedation,1,0
80981,attenuate,0,0
80982,the,0,0
80983,sympathetic,0,1
80984,response,0,0
80985,to,0,0
80986,fiberoptic,0,1
80987,bronchoscopy,0,1
80988,.,0,0
80989,Prophylactic,0,1
80990,labetalol,0,1
80991,gave,0,0
80992,no,0,0
80993,additional,0,0
80994,benefit,0,0
80995,.,0,0
80996,Results,0,0
80997,of,0,0
80998,a,0,0
80999,randomized,0,0
81000,double-blind,0,0
81001,placebo-controlled,0,1
81002,study,0,0
81003,.,0,0
81004,BACKGROUND,0,0
81005,Hypertension,0,0
81006,and,0,0
81007,tachycardia,0,0
81008,are,0,0
81009,common,0,0
81010,during,0,0
81011,fiber-optic,1,1
81012,bronchoscopy,1,1
81013,(,1,1
81014,FOB,1,1
81015,),1,1
81016,",",0,0
81017,and,0,0
81018,this,0,0
81019,may,0,0
81020,lead,0,0
81021,to,0,0
81022,cardiac,0,0
81023,ischemia,0,0
81024,.,0,0
81025,The,0,0
81026,prophylactic,0,1
81027,addition,0,0
81028,of,0,0
81029,a,0,0
81030,beta-adrenergic,1,1
81031,anatagonist,1,0
81032,might,0,0
81033,mask,0,1
81034,this,0,0
81035,response,0,0
81036,and,0,0
81037,prevent,0,0
81038,the,0,0
81039,deleterious,0,0
81040,cardiovascular,0,0
81041,effects,0,0
81042,of,0,0
81043,FOB,0,0
81044,.,0,0
81045,METHODS,0,0
81046,We,0,0
81047,performed,0,0
81048,a,0,0
81049,randomized,0,0
81050,double-blind,0,0
81051,placebo-controlled,0,1
81052,trial,0,0
81053,of,0,0
81054,labetalol,1,1
81055,10mg,1,0
81056,iv,1,0
81057,given,1,0
81058,with,1,0
81059,midazolam-alfentanil,1,1
81060,sedation,1,0
81061,.,1,0
81062,We,0,0
81063,monitored,0,0
81064,heart,0,0
81065,rate,0,0
81066,(,0,1
81067,HR,0,0
81068,),0,1
81069,and,0,0
81070,systolic/diastolic,0,0
81071,blood,0,1
81072,pressure,0,0
81073,(,0,1
81074,SBP/DBP,0,0
81075,),0,1
81076,throughout,0,0
81077,the,0,0
81078,bronchoscopy,0,1
81079,and,0,0
81080,calculated,0,0
81081,the,0,0
81082,rate-pressure,0,1
81083,product,0,1
81084,(,0,1
81085,RPP=,0,1
81086,(,0,1
81087,HRxSBP,0,1
81088,),0,1
81089,/100,0,0
81090,),0,0
81091,.,0,0
81092,One-hundred,0,0
81093,twenty,0,0
81094,patients,0,0
81095,were,0,0
81096,enrolled,0,0
81097,.,0,0
81098,RESULTS,0,0
81099,In,0,0
81100,the,0,0
81101,placebo,0,1
81102,group,0,0
81103,",",0,0
81104,there,0,0
81105,was,0,0
81106,no,0,0
81107,rise,0,0
81108,in,0,0
81109,HR,0,0
81110,",",0,0
81111,SBP,0,0
81112,",",0,0
81113,DBP,0,0
81114,or,0,1
81115,RPP,0,1
81116,",",0,0
81117,and,0,0
81118,there,0,0
81119,was,0,0
81120,no,0,0
81121,difference,0,0
81122,between,0,0
81123,the,0,0
81124,placebo,0,1
81125,and,0,0
81126,labetalol,1,1
81127,groups,0,0
81128,.,0,0
81129,Adverse,0,0
81130,events,0,0
81131,during,0,0
81132,bronchoscopy,0,1
81133,were,0,0
81134,similar,0,0
81135,in,0,0
81136,both,0,0
81137,groups,0,0
81138,.,0,0
81139,In,0,0
81140,a,0,0
81141,subgroup,0,0
81142,of,0,0
81143,patients,0,0
81144,undergoing,0,0
81145,interventional,0,1
81146,bronchoscopy,0,1
81147,",",0,0
81148,there,0,0
81149,was,0,0
81150,a,0,0
81151,trend,0,0
81152,towards,0,0
81153,lower,0,0
81154,SBP,0,0
81155,(,0,0
81156,p=0.06,0,0
81157,),0,1
81158,.,0,0
81159,CONCLUSIONS,0,0
81160,Patients,0,0
81161,undergoing,0,0
81162,FOB,0,1
81163,under,0,0
81164,adequate,0,0
81165,midazolam-alfentanil,1,1
81166,sedation,1,0
81167,do,0,0
81168,not,0,0
81169,develop,0,0
81170,excessive,0,0
81171,sympathetic,0,1
81172,drive,0,0
81173,that,0,0
81174,may,0,0
81175,lead,0,0
81176,to,0,0
81177,cardiac,0,0
81178,stress,0,0
81179,.,0,0
81180,The,0,0
81181,addition,0,0
81182,of,0,0
81183,labetalol,1,1
81184,did,0,0
81185,not,0,0
81186,confer,0,0
81187,additional,0,0
81188,benefit,0,0
81189,or,0,1
81190,risk,0,0
81191,to,0,0
81192,the,0,0
81193,patients,0,0
81194,.,0,0
81195,(,0,0
81196,ClinicalTrials.gov,0,0
81197,number,0,0
81198,",",0,0
81199,NCT00394537,0,0
81200,),0,0
81201,.,0,0
81202,Genital,0,0
81203,responsiveness,0,0
81204,in,0,0
81205,healthy,0,0
81206,women,0,0
81207,with,0,0
81208,and,0,0
81209,without,0,1
81210,sexual,0,0
81211,arousal,0,0
81212,disorder,0,0
81213,.,0,0
81214,INTRODUCTION,0,0
81215,Most,0,0
81216,pharmacological,0,0
81217,treatments,0,0
81218,that,0,0
81219,are,0,0
81220,currently,0,0
81221,being,0,0
81222,developed,0,0
81223,for,0,0
81224,women,0,0
81225,with,0,0
81226,sexual,0,0
81227,arousal,0,0
81228,disorder,0,0
81229,are,0,0
81230,aimed,0,0
81231,at,0,0
81232,remedying,0,0
81233,a,0,0
81234,vasculogenic,0,0
81235,deficit,0,0
81236,.,0,0
81237,AIM,0,0
81238,This,0,0
81239,study,0,0
81240,investigated,0,0
81241,whether,0,0
81242,pre-,0,0
81243,and,0,0
81244,postmenopausal,0,0
81245,women,0,0
81246,with,0,0
81247,sexual,0,0
81248,arousal,0,0
81249,disorder,0,0
81250,are,0,0
81251,less,0,0
81252,genitally,0,0
81253,responsive,0,0
81254,to,0,0
81255,visual,0,0
81256,sexual,0,0
81257,stimuli,0,1
81258,than,0,0
81259,pre-,0,0
81260,and,0,0
81261,postmenopausal,0,0
81262,women,0,0
81263,without,0,0
81264,sexual,0,0
81265,problems,0,0
81266,.,0,0
81267,METHOD,0,0
81268,Twenty-nine,0,0
81269,medically,0,0
81270,healthy,0,0
81271,women,0,0
81272,with,0,0
81273,sexual,0,0
81274,arousal,0,0
81275,disorder,0,0
81276,(,0,0
81277,15,0,1
81278,premenopausal,0,1
81279,and,0,0
81280,14,0,1
81281,postmenopausal,0,0
81282,),0,0
81283,",",0,0
81284,diagnosed,0,0
81285,using,0,0
81286,the,0,0
81287,Diagnostic,0,0
81288,and,0,0
81289,Statistical,0,0
81290,Manual,0,1
81291,of,0,0
81292,Mental,0,0
81293,Disorders,0,0
81294,",",0,0
81295,4th,0,0
81296,Edition,0,0
81297,(,0,1
81298,DSM-IV,0,1
81299,),0,1
81300,criteria,0,0
81301,",",0,0
81302,and,0,0
81303,30,0,0
81304,age-matched,0,0
81305,women,0,0
81306,without,0,0
81307,sexual,0,0
81308,problems,0,0
81309,(,0,0
81310,16,0,0
81311,premenopausal,0,1
81312,and,0,0
81313,14,0,1
81314,postmenopausal,0,0
81315,),0,0
81316,were,0,0
81317,shown,0,0
81318,sexual,1,0
81319,stimuli,1,1
81320,depicting,1,0
81321,cunnilingus,1,0
81322,and,1,0
81323,intercourse,1,0
81324,.,1,0
81325,MAIN,0,0
81326,OUTCOME,0,0
81327,MEASURE,0,1
81328,Genital,0,0
81329,arousal,0,0
81330,was,0,0
81331,assessed,0,0
81332,as,0,0
81333,vaginal,0,1
81334,pulse,0,1
81335,amplitude,0,0
81336,(,0,1
81337,VPA,0,0
81338,),0,1
81339,using,0,0
81340,vaginal,1,1
81341,photoplethysmography,1,1
81342,.,1,0
81343,RESULTS,0,0
81344,Results,0,0
81345,showed,0,0
81346,no,0,0
81347,significant,0,0
81348,differences,0,0
81349,between,0,0
81350,the,0,0
81351,two,0,0
81352,groups,0,0
81353,in,0,0
81354,mean,0,0
81355,and,0,0
81356,maximum,0,0
81357,VPA,0,0
81358,",",0,0
81359,nor,0,0
81360,in,0,0
81361,latency,0,0
81362,of,0,0
81363,VPA,0,0
81364,response,0,0
81365,.,0,0
81366,CONCLUSION,0,0
81367,Women,0,0
81368,with,0,0
81369,sexual,0,0
81370,arousal,0,0
81371,disorder,0,0
81372,diagnosed,0,0
81373,according,0,0
81374,to,0,0
81375,DSM-IV,0,0
81376,criteria,0,0
81377,were,0,0
81378,not,0,0
81379,less,0,0
81380,genitally,0,0
81381,responsive,0,0
81382,to,0,0
81383,visual,0,0
81384,sexual,0,0
81385,stimuli,0,1
81386,than,0,0
81387,women,0,0
81388,without,0,0
81389,such,0,0
81390,problems,0,0
81391,.,0,0
81392,These,0,0
81393,findings,0,0
81394,are,0,0
81395,in,0,0
81396,line,0,0
81397,with,0,0
81398,previous,0,0
81399,studies,0,0
81400,.,0,0
81401,The,0,0
81402,sexual,0,0
81403,problems,0,0
81404,these,0,0
81405,women,0,0
81406,report,0,0
81407,are,0,0
81408,clearly,0,0
81409,not,0,0
81410,related,0,0
81411,to,0,0
81412,their,0,0
81413,potential,0,0
81414,to,0,0
81415,become,0,0
81416,genitally,0,0
81417,aroused,0,0
81418,.,0,0
81419,We,0,0
81420,argue,0,0
81421,that,0,0
81422,the,0,0
81423,DSM-IV,0,0
81424,criteria,0,0
81425,for,0,0
81426,sexual,0,0
81427,arousal,0,0
81428,disorder,0,0
81429,are,0,0
81430,in,0,0
81431,need,0,0
81432,of,0,0
81433,revision,0,0
81434,.,0,0
81435,In,0,0
81436,medically,0,0
81437,healthy,0,0
81438,women,0,0
81439,",",0,0
81440,impaired,0,0
81441,genital,0,0
81442,responsiveness,0,0
81443,is,0,0
81444,not,0,0
81445,a,0,0
81446,valid,0,0
81447,diagnostic,0,0
81448,criterion,0,0
81449,.,0,0
81450,Comparison,0,0
81451,of,0,0
81452,the,0,0
81453,time,0,0
81454,required,0,0
81455,to,0,0
81456,administer,0,0
81457,three,0,0
81458,different,0,0
81459,fluke,1,0
81460,and,1,0
81461,worm,1,1
81462,combination,1,1
81463,products,1,0
81464,to,0,0
81465,commercial,0,1
81466,beef,0,1
81467,cattle,0,0
81468,at,0,0
81469,housing,0,0
81470,.,0,0
81471,Larger,0,0
81472,livestock,0,0
81473,units,0,0
81474,",",0,0
81475,a,0,0
81476,decline,0,0
81477,in,0,0
81478,the,0,0
81479,farm,0,0
81480,labor,0,0
81481,force,0,1
81482,",",0,0
81483,animal,0,0
81484,welfare,0,0
81485,concerns,0,0
81486,",",0,0
81487,and,0,0
81488,a,0,0
81489,trend,0,0
81490,toward,0,0
81491,more,0,0
81492,selective,0,0
81493,use,0,0
81494,of,0,0
81495,drugs,0,1
81496,have,0,0
81497,increased,0,0
81498,the,0,0
81499,focus,0,0
81500,on,0,0
81501,animal,0,0
81502,handling,0,0
81503,",",0,0
81504,time,0,0
81505,management,0,1
81506,",",0,0
81507,convenience,0,0
81508,",",0,0
81509,and,0,0
81510,compliance,0,0
81511,in,0,0
81512,administering,0,1
81513,veterinary,0,0
81514,therapeutics,0,0
81515,.,0,0
81516,This,0,0
81517,study,0,0
81518,was,0,0
81519,undertaken,0,0
81520,to,0,0
81521,quantify,0,0
81522,and,0,0
81523,compare,0,0
81524,the,0,0
81525,time,0,0
81526,needed,0,0
81527,to,0,0
81528,treat,0,0
81529,commercial,0,1
81530,beef,0,0
81531,cattle,0,0
81532,with,0,0
81533,three,1,0
81534,fluke,1,0
81535,and,1,0
81536,worm,1,1
81537,combination,1,1
81538,products,1,0
81539,with,0,0
81540,different,0,0
81541,administration,0,0
81542,profiles,0,0
81543,.,0,0
81544,Young,0,0
81545,beef,0,0
81546,cattle,0,0
81547,(,0,0
81548,n,0,0
81549,=,0,0
81550,270,0,0
81551,),0,0
81552,weighing,0,0
81553,approximately,0,0
81554,400,0,1
81555,kg,0,0
81556,were,0,0
81557,allocated,0,0
81558,to,0,0
81559,batches,0,0
81560,of,0,0
81561,five,0,0
81562,",",0,0
81563,which,0,0
81564,were,0,0
81565,randomly,0,0
81566,assigned,0,0
81567,to,0,0
81568,receive,0,0
81569,ivermectin,1,1
81570,+,1,1
81571,clorsulon,1,1
81572,injection,1,1
81573,",",1,0
81574,ivermectin,1,1
81575,+,1,1
81576,closantel,1,1
81577,injection,1,1
81578,",",1,0
81579,or,1,1
81580,levamisole,1,1
81581,+,1,1
81582,triclabendazole,1,1
81583,oral,1,1
81584,drench,1,1
81585,.,1,0
81586,The,0,0
81587,mean,0,0
81588,time,0,0
81589,needed,0,0
81590,to,0,0
81591,administer,0,0
81592,ivermectin,1,1
81593,+,1,1
81594,clorsulon,1,1
81595,(,1,1
81596,single,1,1
81597,injection,1,1
81598,),1,0
81599,to,0,0
81600,five,0,0
81601,cattle,0,0
81602,was,0,0
81603,31,0,0
81604,seconds,0,0
81605,",",0,0
81606,which,0,0
81607,was,0,0
81608,significantly,0,0
81609,less,0,0
81610,than,0,0
81611,the,0,0
81612,100,0,0
81613,seconds,0,0
81614,needed,0,0
81615,for,0,0
81616,ivermectin,1,1
81617,+,1,1
81618,closantel,1,1
81619,(,0,0
81620,two,0,0
81621,injections,0,1
81622,),0,0
81623,and,0,0
81624,the,0,0
81625,126,0,0
81626,seconds,0,0
81627,needed,0,0
81628,for,0,0
81629,levamisole,1,1
81630,+,1,1
81631,triclabendazole,1,1
81632,(,0,0
81633,P,0,0
81634,<,0,0
81635,.001,0,0
81636,),0,0
81637,.,0,0
81638,Such,0,0
81639,quantitative,0,0
81640,data,0,0
81641,can,0,0
81642,allow,0,0
81643,for,0,0
81644,better,0,0
81645,planning,0,0
81646,and,0,0
81647,selection,0,0
81648,of,0,0
81649,parasiticide,0,1
81650,treatment,0,0
81651,approaches,0,0
81652,at,0,0
81653,the,0,0
81654,farm,0,0
81655,level,0,0
81656,.,0,0
81657,Does,0,0
81658,3-day,0,0
81659,course,0,0
81660,of,0,0
81661,oral,1,1
81662,amoxycillin,1,1
81663,benefit,0,0
81664,children,0,0
81665,of,0,0
81666,non-severe,0,0
81667,pneumonia,0,0
81668,with,0,0
81669,wheeze,0,0
81670,:,0,0
81671,a,0,0
81672,multicentric,0,0
81673,randomised,0,0
81674,controlled,0,0
81675,trial,0,0
81676,.,0,0
81677,BACKGROUND,0,0
81678,WHO-defined,0,0
81679,pneumonias,0,0
81680,",",0,0
81681,treated,0,0
81682,with,0,0
81683,antibiotics,0,1
81684,",",0,0
81685,are,0,0
81686,responsible,0,0
81687,for,0,0
81688,a,0,0
81689,significant,0,0
81690,proportion,0,0
81691,of,0,0
81692,childhood,0,0
81693,morbidity,0,0
81694,and,0,0
81695,mortality,0,0
81696,in,0,0
81697,the,0,0
81698,developing,0,0
81699,countries,0,0
81700,.,0,0
81701,Since,0,0
81702,substantial,0,0
81703,proportion,0,0
81704,pneumonias,0,0
81705,have,0,0
81706,a,0,0
81707,viral,0,0
81708,etiology,0,0
81709,",",0,0
81710,where,0,0
81711,children,0,0
81712,are,0,0
81713,more,0,0
81714,likely,0,0
81715,to,0,0
81716,present,0,0
81717,with,0,0
81718,wheeze,0,0
81719,",",0,0
81720,there,0,0
81721,is,0,0
81722,a,0,0
81723,concern,0,0
81724,that,0,0
81725,currently,0,0
81726,antibiotics,0,1
81727,are,0,0
81728,being,0,0
81729,over-prescribed,0,0
81730,for,0,0
81731,it,0,0
81732,.,0,0
81733,Hence,0,0
81734,the,0,0
81735,current,0,0
81736,trial,0,0
81737,was,0,0
81738,conducted,0,0
81739,with,0,0
81740,the,0,0
81741,objective,0,0
81742,to,0,0
81743,show,0,0
81744,the,0,0
81745,therapeutic,0,0
81746,equivalence,0,0
81747,of,0,0
81748,two,0,0
81749,treatments,0,1
81750,(,1,0
81751,placebo,1,1
81752,and,0,1
81753,amoxycillin,1,1
81754,),1,1
81755,for,0,0
81756,children,0,0
81757,presenting,0,0
81758,with,0,0
81759,non-severe,0,0
81760,pneumonia,0,0
81761,with,0,0
81762,wheeze,0,0
81763,",",0,0
81764,who,0,0
81765,have,0,0
81766,persistent,0,0
81767,fast,0,0
81768,breathing,0,1
81769,after,0,0
81770,nebulisation,0,1
81771,with,0,0
81772,salbutamol,0,1
81773,",",0,0
81774,and,0,0
81775,have,0,0
81776,normal,0,1
81777,chest,0,1
81778,radiograph,0,0
81779,.,0,0
81780,METHODOLOGY,0,0
81781,This,0,0
81782,multi-centric,0,0
81783,",",0,0
81784,randomised,0,0
81785,placebo,1,1
81786,controlled,0,0
81787,double,0,1
81788,blind,0,0
81789,clinical,0,0
81790,trial,0,0
81791,intended,0,1
81792,to,0,0
81793,investigate,0,0
81794,equivalent,0,0
81795,efficacy,0,0
81796,of,0,0
81797,placebo,1,1
81798,and,0,0
81799,amoxicillin,1,1
81800,and,0,0
81801,was,0,0
81802,conducted,0,0
81803,in,0,0
81804,ambulatory,0,0
81805,care,0,1
81806,settings,0,0
81807,in,0,0
81808,eight,0,0
81809,government,0,0
81810,hospitals,0,0
81811,in,0,0
81812,India,0,0
81813,.,0,0
81814,Participants,0,0
81815,were,0,0
81816,children,0,0
81817,aged,0,0
81818,2-59,0,0
81819,months,0,0
81820,of,0,0
81821,age,0,0
81822,",",0,0
81823,who,0,0
81824,received,0,0
81825,either,0,0
81826,oral,0,1
81827,amoxycillin,1,1
81828,(,0,1
81829,31-54,0,0
81830,mg/Kg/day,0,1
81831,",",0,0
81832,in,0,0
81833,three,0,0
81834,divided,0,0
81835,doses,0,0
81836,for,0,0
81837,three,0,0
81838,days,0,0
81839,),0,0
81840,or,0,1
81841,placebo,0,1
81842,",",0,0
81843,and,0,0
81844,standard,1,1
81845,bronchodilator,1,1
81846,therapy,1,1
81847,.,1,0
81848,Primary,0,0
81849,outcome,0,0
81850,was,0,0
81851,clinical,0,0
81852,failure,0,0
81853,on,0,0
81854,or,0,1
81855,before,0,0
81856,day-,0,0
81857,4,0,0
81858,.,0,0
81859,PRINCIPAL,0,0
81860,FINDINGS,0,0
81861,We,0,0
81862,randomized,0,0
81863,836,0,0
81864,cases,0,0
81865,in,0,0
81866,placebo,0,1
81867,and,0,0
81868,835,0,0
81869,in,0,0
81870,amoxycillin,0,1
81871,group,0,0
81872,.,0,0
81873,Clinical,0,0
81874,failures,0,0
81875,occurred,0,0
81876,in,0,0
81877,201,0,0
81878,(,0,0
81879,24.0,0,0
81880,%,0,0
81881,),0,0
81882,on,0,0
81883,placebo,0,1
81884,and,0,0
81885,166,0,0
81886,(,0,0
81887,19.9,0,0
81888,%,0,0
81889,),0,0
81890,on,0,0
81891,amoxycillin,1,1
81892,(,0,1
81893,risk,0,0
81894,difference,0,0
81895,4.2,0,0
81896,%,0,0
81897,in,0,0
81898,favour,0,0
81899,of,0,0
81900,antibiotic,0,1
81901,",",0,0
81902,95,0,0
81903,%,0,0
81904,CI,0,0
81905,:,0,0
81906,0.2,0,0
81907,to,0,0
81908,8.1,0,0
81909,),0,0
81910,.,0,0
81911,Adherence,0,0
81912,for,0,0
81913,both,0,0
81914,placebo,0,1
81915,and,0,0
81916,amoxycillin,1,1
81917,was,0,0
81918,>,0,0
81919,96,0,0
81920,%,0,0
81921,and,0,0
81922,98.9,0,0
81923,%,0,0
81924,subjects,0,0
81925,were,0,0
81926,followed,0,0
81927,up,0,0
81928,on,0,0
81929,day-,0,0
81930,4,0,0
81931,.,0,0
81932,Clinical,0,0
81933,failure,0,0
81934,was,0,0
81935,associated,0,0
81936,with,0,0
81937,(,0,1
81938,i,0,0
81939,),0,1
81940,placebo,0,1
81941,treatment,0,1
81942,(,0,0
81943,adjusted,0,0
81944,OR,0,0
81945,=,0,0
81946,1.28,0,0
81947,",",0,0
81948,95,0,0
81949,%,0,0
81950,CI,0,0
81951,:,0,0
81952,1.01,0,0
81953,to1.62,0,0
81954,),0,0
81955,",",0,0
81956,(,0,1
81957,ii,0,0
81958,),0,1
81959,excess,0,0
81960,respiratory,0,0
81961,rate,0,0
81962,of,0,0
81963,>,0,0
81964,10,0,0
81965,breaths,0,1
81966,per,0,0
81967,minute,0,0
81968,(,0,0
81969,adjusted,0,0
81970,OR,0,0
81971,=,0,0
81972,1.51,0,0
81973,",",0,0
81974,95,0,0
81975,%,0,0
81976,CI,0,0
81977,:,0,0
81978,1.19,0,0
81979,",",0,0
81980,1.92,0,0
81981,),0,0
81982,",",0,0
81983,(,0,1
81984,iii,0,0
81985,),0,1
81986,vomiting,0,0
81987,at,0,1
81988,enrolment,0,0
81989,(,0,0
81990,adjusted,0,0
81991,OR,0,0
81992,=,0,0
81993,1.49,0,0
81994,",",0,0
81995,95,0,0
81996,%,0,0
81997,CI,0,0
81998,:,0,0
81999,1.13,0,0
82000,",",0,0
82001,1.96,0,0
82002,),0,0
82003,",",0,0
82004,(,0,1
82005,iv,0,0
82006,),0,1
82007,history,0,0
82008,of,0,0
82009,use,0,0
82010,of,0,0
82011,broncho-dilators,0,1
82012,(,0,0
82013,adjusted,0,0
82014,OR,0,0
82015,=,0,0
82016,1.71,0,0
82017,",",0,0
82018,95,0,0
82019,%,0,0
82020,CI,0,0
82021,:,0,0
82022,1.30,0,0
82023,",",0,0
82024,2.24,0,0
82025,),0,0
82026,and,0,0
82027,(,0,1
82028,v,0,1
82029,),0,1
82030,non-adherence,0,0
82031,(,0,1
82032,adjusted,0,0
82033,OR,0,0
82034,=,0,0
82035,8.06,0,0
82036,",",0,0
82037,95,0,0
82038,%,0,0
82039,CI,0,0
82040,:,0,0
82041,4.36,0,0
82042,",",0,0
82043,14.92,0,0
82044,),0,0
82045,.,0,0
82046,CONCLUSIONS,0,0
82047,Treating,0,0
82048,children,0,0
82049,with,0,0
82050,non-severe,0,0
82051,pneumonia,0,0
82052,and,0,0
82053,wheeze,0,0
82054,with,0,0
82055,a,0,0
82056,placebo,0,1
82057,is,0,0
82058,not,0,0
82059,equivalent,0,0
82060,to,0,0
82061,treatment,0,0
82062,with,0,0
82063,oral,0,1
82064,amoxycillin,1,1
82065,.,1,0
82066,TRIAL,0,0
82067,REGISTRATION,0,0
82068,ClinicalTrials.gov,0,0
82069,NCT00407394,0,1
82070,.,0,0
82071,Effect,0,0
82072,of,0,0
82073,esomeprazole,1,1
82074,triple,1,1
82075,therapy,1,1
82076,on,0,0
82077,eradication,0,0
82078,rates,0,0
82079,of,0,0
82080,Helicobacter,0,0
82081,pylori,0,0
82082,",",0,0
82083,gastric,0,0
82084,ulcer,0,0
82085,healing,0,0
82086,and,0,0
82087,prevention,0,0
82088,of,0,0
82089,relapse,0,0
82090,in,0,0
82091,gastric,0,0
82092,ulcer,0,0
82093,patients,0,0
82094,.,0,0
82095,OBJECTIVES,0,0
82096,To,0,0
82097,compare,0,0
82098,esomeprazole-based,1,1
82099,triple,0,1
82100,therapy,0,1
82101,with,0,0
82102,esomeprazole,0,1
82103,alone,0,1
82104,for,0,0
82105,the,0,0
82106,eradication,0,0
82107,of,0,0
82108,Helicobacter,0,0
82109,pylori,0,0
82110,(,0,0
82111,H.,0,0
82112,pylori,0,0
82113,),0,0
82114,",",0,0
82115,healing,0,0
82116,of,0,0
82117,ulcer,0,0
82118,and,0,0
82119,prevention,0,0
82120,of,0,0
82121,relapse,0,0
82122,in,0,0
82123,H.,0,0
82124,pylori-related,0,0
82125,gastric,0,0
82126,ulcer,0,0
82127,(,0,1
82128,GU,0,0
82129,),0,1
82130,diseases,0,0
82131,.,0,0
82132,METHODS,0,0
82133,In,0,0
82134,this,0,0
82135,double-blind,0,0
82136,study,0,0
82137,",",0,0
82138,401,0,0
82139,H.,0,0
82140,pylori-positive,0,0
82141,patients,0,0
82142,with,0,0
82143,more,0,0
82144,than,0,0
82145,or,0,0
82146,equal,0,0
82147,to,0,0
82148,two,0,0
82149,GUs,0,0
82150,were,0,0
82151,randomized,0,0
82152,to,0,0
82153,:,0,1
82154,esomeprazole,1,1
82155,(,0,0
82156,20,0,1
82157,mg,0,1
82158,),0,0
82159,twice,0,1
82160,daily,0,1
82161,(,0,1
82162,bid,0,1
82163,),0,1
82164,and,0,1
82165,amoxicillin,1,1
82166,(,0,1
82167,1000,0,1
82168,mg,0,1
82169,),0,1
82170,bid,0,1
82171,and,0,1
82172,clarithromycin,1,1
82173,(,0,1
82174,500,0,1
82175,mg,0,1
82176,),0,1
82177,bid,0,1
82178,(,0,1
82179,EAC,0,1
82180,),0,1
82181,for,0,0
82182,1,0,0
82183,week,0,0
82184,",",0,0
82185,followed,0,1
82186,by,0,0
82187,placebo,1,1
82188,for,0,0
82189,3,0,0
82190,weeks,0,0
82191,(,0,0
82192,EAC,0,1
82193,and,0,1
82194,placebo,0,1
82195,),0,1
82196,;,0,0
82197,EAC,0,0
82198,for,0,0
82199,1,0,0
82200,week,0,0
82201,",",0,0
82202,followed,0,1
82203,by,0,0
82204,esomeprazole,1,1
82205,(,0,0
82206,20,0,1
82207,mg,0,1
82208,),0,0
82209,once,0,1
82210,daily,0,1
82211,(,0,1
82212,E20,0,1
82213,),0,1
82214,for,0,0
82215,3,0,0
82216,weeks,0,0
82217,(,0,0
82218,EAC,0,1
82219,and,0,1
82220,E20,0,1
82221,),0,1
82222,;,0,0
82223,or,0,1
82224,esomeprazole,1,1
82225,(,0,0
82226,20,0,1
82227,mg,0,1
82228,),0,1
82229,bid,0,1
82230,and,0,0
82231,placebo,1,1
82232,antimicrobials,1,1
82233,for,0,0
82234,1,0,0
82235,week,0,0
82236,",",0,0
82237,followed,0,1
82238,by,0,0
82239,E20,0,1
82240,for,0,0
82241,3,0,0
82242,weeks,0,0
82243,(,0,0
82244,E20,0,1
82245,bid,0,1
82246,and,0,0
82247,E20,0,1
82248,),0,0
82249,.,0,0
82250,Patients,0,0
82251,with,0,0
82252,unhealed,0,0
82253,GUs,0,0
82254,at,0,0
82255,4,0,0
82256,weeks,0,0
82257,received,0,0
82258,E20,0,1
82259,for,0,0
82260,an,0,0
82261,additional,0,0
82262,4,0,0
82263,weeks,0,0
82264,.,0,0
82265,Healed,0,0
82266,patients,0,0
82267,were,0,0
82268,followed,0,0
82269,up,0,0
82270,for,0,0
82271,12,0,0
82272,months,0,0
82273,.,0,0
82274,RESULTS,0,0
82275,Eradication,0,0
82276,rates,0,0
82277,at,0,0
82278,4,0,0
82279,weeks,0,0
82280,or,0,0
82281,8,0,0
82282,weeks,0,0
82283,were,0,0
82284,82,0,0
82285,%,0,0
82286,for,0,0
82287,EAC,0,0
82288,and,0,0
82289,E20,0,1
82290,",",0,0
82291,77,0,0
82292,%,0,0
82293,for,0,0
82294,EAC,0,1
82295,and,0,0
82296,placebo,0,1
82297,and,0,0
82298,9.5,0,0
82299,%,0,0
82300,for,0,0
82301,E20,0,1
82302,bid,0,1
82303,and,0,1
82304,E20,0,1
82305,(,0,1
82306,intention-to-treat,0,0
82307,analysis,0,0
82308,),0,0
82309,.,0,0
82310,Significantly,0,0
82311,more,0,0
82312,patients,0,0
82313,receiving,0,0
82314,EAC,0,0
82315,than,0,0
82316,those,0,0
82317,receiving,0,0
82318,esomeprazole,0,1
82319,alone,0,1
82320,remained,0,0
82321,free,0,0
82322,of,0,0
82323,GUs,0,0
82324,during,0,0
82325,follow-up,0,0
82326,[,0,1
82327,EAC,0,1
82328,and,0,0
82329,E20,0,1
82330,",",0,0
82331,90,0,0
82332,%,0,0
82333,;,0,0
82334,EAC,0,1
82335,and,0,0
82336,placebo,0,1
82337,",",0,0
82338,87,0,0
82339,%,0,0
82340,;,0,0
82341,P=0.0005,0,0
82342,for,0,0
82343,combined,0,1
82344,group,0,0
82345,vs.,0,0
82346,esomeprazole,0,1
82347,alone,0,1
82348,[,0,0
82349,E20,0,1
82350,bid,0,1
82351,and,0,1
82352,E20,0,1
82353,(,0,1
82354,74,0,0
82355,%,0,0
82356,),0,0
82357,],0,0
82358,.,0,0
82359,All,0,0
82360,treatments,0,0
82361,were,0,0
82362,well,0,0
82363,tolerated,0,0
82364,.,0,0
82365,CONCLUSION,0,0
82366,Esomeprazole-based,1,1
82367,triple,0,1
82368,therapy,0,1
82369,is,0,0
82370,effective,0,0
82371,for,0,0
82372,the,0,0
82373,eradication,0,0
82374,of,0,0
82375,H.,0,0
82376,pylori,0,0
82377,",",0,0
82378,healing,0,0
82379,of,0,0
82380,GU,0,0
82381,and,0,0
82382,prevention,0,0
82383,of,0,0
82384,relapse,0,0
82385,.,0,0
82386,Esomeprazole,0,1
82387,monotherapy,0,1
82388,for,0,0
82389,3,0,0
82390,weeks,0,0
82391,after,0,0
82392,triple,0,1
82393,therapy,0,1
82394,may,0,0
82395,be,0,0
82396,beneficial,0,0
82397,in,0,0
82398,terms,0,0
82399,of,0,0
82400,healing,0,0
82401,.,0,0
82402,Use,0,1
82403,of,0,0
82404,topical,0,1
82405,selamectin,1,1
82406,for,0,0
82407,the,0,0
82408,treatment,0,0
82409,of,0,0
82410,Syphacia,0,1
82411,muris,0,1
82412,infection,0,0
82413,in,0,0
82414,laboratory,0,0
82415,rats,0,1
82416,.,0,0
82417,Efficacy,0,0
82418,of,0,0
82419,selamectin,1,1
82420,was,0,0
82421,studied,0,0
82422,in,0,0
82423,naturally,0,0
82424,acquired,0,0
82425,S.,0,1
82426,muris,0,1
82427,infections,0,0
82428,in,0,0
82429,rats,0,1
82430,.,0,0
82431,Fourty-eight,0,0
82432,S.,0,1
82433,muris-positive,0,0
82434,rats,0,1
82435,were,0,0
82436,divided,0,0
82437,into,0,0
82438,six,0,0
82439,treated,0,0
82440,and,0,0
82441,two,0,0
82442,control,0,0
82443,groups,0,0
82444,.,0,0
82445,Selamectin,1,1
82446,(,0,0
82447,6,0,1
82448,mg/kg,0,1
82449,),0,0
82450,was,0,0
82451,applied,0,0
82452,topically,0,0
82453,to,0,0
82454,the,0,0
82455,skin,0,0
82456,in,0,0
82457,a,0,0
82458,single,0,0
82459,spot,0,0
82460,at,0,0
82461,the,0,0
82462,base,0,0
82463,of,0,0
82464,the,0,0
82465,neck,0,0
82466,in,0,0
82467,the,0,0
82468,treatment,0,0
82469,group,0,0
82470,.,0,0
82471,The,0,0
82472,rats,0,1
82473,of,0,0
82474,treated,0,0
82475,and,0,0
82476,control,0,1
82477,groups,0,0
82478,were,0,0
82479,necropsied,0,0
82480,on,0,0
82481,the,0,0
82482,24th,0,0
82483,day,0,0
82484,after,0,0
82485,the,0,0
82486,treatment,0,0
82487,.,0,0
82488,Topical,0,0
82489,selamectin,1,1
82490,was,0,0
82491,found,0,0
82492,to,0,0
82493,be,0,0
82494,40.7-63.3,0,0
82495,%,0,0
82496,effective,0,0
82497,(,0,0
82498,based,0,0
82499,on,0,0
82500,egg,0,0
82501,per,0,1
82502,gram,0,0
82503,method,0,1
82504,),0,1
82505,in,0,0
82506,eliminating,0,0
82507,S.,0,1
82508,muris,0,1
82509,infection,0,0
82510,in,0,0
82511,rats,0,1
82512,.,0,0
82513,The,0,0
82514,efficacy,0,0
82515,of,0,0
82516,the,0,0
82517,treatment,0,0
82518,against,0,0
82519,S.,0,1
82520,muris,0,1
82521,(,0,0
82522,based,0,0
82523,on,0,0
82524,adult,0,0
82525,worm,0,1
82526,counts,0,0
82527,),0,0
82528,in,0,0
82529,male,0,0
82530,and,0,0
82531,female,0,0
82532,rats,0,1
82533,was,0,0
82534,35.14-58.88,0,0
82535,%,0,0
82536,",",0,0
82537,respectively,0,0
82538,(,0,0
82539,mean,0,0
82540,48.39,0,0
82541,%,0,0
82542,),0,0
82543,.,0,0
82544,The,0,0
82545,effect,0,0
82546,of,0,0
82547,intravenous,0,1
82548,lidocaine,1,1
82549,on,0,0
82550,QT,0,0
82551,changes,0,0
82552,during,0,0
82553,tracheal,0,0
82554,intubation,0,1
82555,.,0,1
82556,Laryngoscopy,0,1
82557,and,0,0
82558,tracheal,0,1
82559,intubation,0,1
82560,may,0,0
82561,provoke,0,0
82562,changes,0,0
82563,of,0,0
82564,cardiac,0,0
82565,repolarisation,0,0
82566,.,0,0
82567,The,0,0
82568,aim,0,0
82569,of,0,0
82570,this,0,0
82571,study,0,0
82572,was,0,0
82573,to,0,0
82574,assess,0,0
82575,the,0,0
82576,effect,0,0
82577,of,0,0
82578,intravenous,0,1
82579,lidocaine,1,1
82580,on,0,0
82581,the,0,0
82582,ECG,0,0
82583,changes,0,0
82584,induced,0,0
82585,by,0,0
82586,laryngoscopy,0,1
82587,and,0,0
82588,tracheal,0,1
82589,intubation,0,1
82590,.,0,0
82591,Forty-three,0,0
82592,female,0,0
82593,patients,0,0
82594,were,0,0
82595,randomly,0,0
82596,allocated,0,0
82597,to,0,0
82598,receive,0,1
82599,lidocaine,1,1
82600,(,0,0
82601,1.5,0,1
82602,mg.kg,0,1
82603,(,0,1
82604,-1,0,1
82605,),0,1
82606,),0,0
82607,or,0,1
82608,placebo,1,1
82609,immediately,0,0
82610,after,0,0
82611,induction,0,0
82612,of,0,0
82613,anaesthesia,0,1
82614,and,0,0
82615,changes,0,0
82616,in,0,0
82617,the,0,0
82618,ECG,0,1
82619,and,0,0
82620,arterial,0,0
82621,blood,0,0
82622,pressure,0,0
82623,were,0,0
82624,recorded,0,0
82625,.,0,0
82626,Correction,0,0
82627,of,0,0
82628,QT,0,0
82629,interval,0,0
82630,was,0,0
82631,calculated,0,0
82632,using,0,0
82633,Bazett,0,1
82634,'s,0,1
82635,formula,0,1
82636,(,0,1
82637,QTcb,0,1
82638,),0,0
82639,",",0,0
82640,Fridericia,0,1
82641,'s,0,0
82642,correction,0,0
82643,(,0,1
82644,QTcf,0,1
82645,),0,1
82646,",",0,0
82647,and,0,0
82648,Framingham,0,1
82649,formula,0,1
82650,(,0,1
82651,QTcF,0,1
82652,),0,1
82653,.,0,0
82654,Transmural,0,0
82655,dispersion,0,0
82656,of,0,0
82657,repolarisation,0,0
82658,(,0,1
82659,TDR,0,1
82660,),0,1
82661,was,0,0
82662,determined,0,0
82663,as,0,0
82664,Tpeak-Tend,0,0
82665,time,0,0
82666,.,0,0
82667,There,0,0
82668,were,0,0
82669,no,0,0
82670,changes,0,0
82671,in,0,0
82672,the,0,0
82673,QTc,0,0
82674,value,0,0
82675,in,0,0
82676,the,0,0
82677,lidocaine,1,1
82678,group,0,0
82679,.,0,0
82680,In,0,0
82681,the,0,0
82682,placebo,1,1
82683,group,0,0
82684,",",0,0
82685,significant,0,0
82686,increases,0,0
82687,in,0,0
82688,QTcb,0,0
82689,",",0,0
82690,QTcf,0,1
82691,and,0,0
82692,QTcF,0,1
82693,values,0,0
82694,were,0,0
82695,observed,0,0
82696,after,0,0
82697,intubation,0,1
82698,compared,0,0
82699,to,0,0
82700,either,0,0
82701,control,0,1
82702,measurements,0,0
82703,or,0,0
82704,to,0,0
82705,comparative,0,0
82706,measurements,0,0
82707,in,0,0
82708,the,0,0
82709,lidocaine,1,1
82710,group,0,0
82711,.,0,0
82712,There,0,0
82713,were,0,0
82714,no,0,0
82715,significant,0,0
82716,differences,0,0
82717,in,0,0
82718,TDR,0,1
82719,either,0,1
82720,between,0,0
82721,or,0,1
82722,within,0,0
82723,the,0,0
82724,groups,0,0
82725,.,0,0
82726,Lidocaine,1,1
82727,diminishes,0,0
82728,prolongation,0,0
82729,of,0,0
82730,QTc,0,0
82731,",",0,0
82732,induced,0,0
82733,by,0,0
82734,tracheal,0,1
82735,intubation,0,1
82736,but,0,0
82737,there,0,0
82738,is,0,0
82739,no,0,0
82740,effect,0,0
82741,of,0,0
82742,intubation,0,1
82743,on,0,0
82744,TDR,0,1
82745,.,0,0
82746,Anxiety,0,0
82747,sensitivity,0,0
82748,as,0,0
82749,an,0,0
82750,incremental,0,0
82751,predictor,0,0
82752,of,0,0
82753,later,0,0
82754,anxiety,0,0
82755,symptoms,0,0
82756,and,0,0
82757,syndromes,0,0
82758,.,0,0
82759,Although,0,0
82760,anxiety,0,0
82761,sensitivity,0,0
82762,(,0,1
82763,AS,0,1
82764,),0,1
82765,has,0,0
82766,been,0,0
82767,shown,0,0
82768,to,0,0
82769,predict,0,0
82770,anxiety,0,0
82771,symptoms,0,0
82772,and,0,0
82773,panic,0,0
82774,",",0,0
82775,this,0,0
82776,literature,0,0
82777,is,0,0
82778,limited,0,0
82779,in,0,0
82780,regard,0,0
82781,to,0,0
82782,evaluating,0,0
82783,AS,0,1
82784,as,0,0
82785,an,0,0
82786,incremental,0,0
82787,predictor,0,0
82788,of,0,0
82789,anxiety,1,0
82790,psychopathology,1,0
82791,relative,0,0
82792,to,0,0
82793,other,0,0
82794,established,0,0
82795,risk,0,0
82796,factors,0,0
82797,including,0,0
82798,sex,0,0
82799,and,0,0
82800,negative,0,0
82801,affect,0,0
82802,.,0,0
82803,The,0,0
82804,present,0,0
82805,report,0,0
82806,prospectively,0,0
82807,evaluated,0,0
82808,whether,0,0
82809,AS,0,0
82810,was,0,0
82811,predictive,0,0
82812,of,0,0
82813,later,0,0
82814,changes,0,0
82815,in,0,0
82816,anxiety,0,0
82817,symptoms,0,0
82818,after,0,0
82819,controlling,1,0
82820,for,1,0
82821,potential,1,0
82822,confounding,1,0
82823,factors,1,0
82824,.,1,0
82825,Consistent,0,0
82826,with,0,0
82827,hypothesis,0,0
82828,",",0,0
82829,AS,0,0
82830,was,0,0
82831,found,0,0
82832,to,0,0
82833,be,0,0
82834,a,0,0
82835,significant,0,0
82836,",",0,0
82837,incremental,0,0
82838,predictor,0,0
82839,of,0,0
82840,anxiety,0,0
82841,symptoms,0,0
82842,over,0,0
82843,time,0,0
82844,",",0,0
82845,even,0,0
82846,after,0,0
82847,controlling,0,0
82848,for,0,0
82849,sex,0,0
82850,and,0,0
82851,negative,0,0
82852,affectivity,0,0
82853,.,0,0
82854,These,0,0
82855,data,0,0
82856,provide,0,0
82857,novel,0,0
82858,evidence,0,0
82859,for,0,0
82860,the,0,0
82861,unique,0,0
82862,association,0,0
82863,between,0,0
82864,AS,0,0
82865,of,0,0
82866,the,0,0
82867,development,0,0
82868,of,0,0
82869,anxiety,0,0
82870,symptoms,0,0
82871,.,0,0
82872,Best,0,0
82873,evidence,0,0
82874,in,0,0
82875,critical,0,0
82876,care,0,1
82877,medicine,0,1
82878,.,0,0
82879,Steroids,1,0
82880,to,0,0
82881,prevent,0,0
82882,post-extubation,0,0
82883,airway,0,0
82884,obstruction,0,0
82885,in,0,0
82886,adult,0,0
82887,critically,0,0
82888,ill,0,0
82889,patients,0,0
82890,.,0,0
82891,Influence,0,0
82892,of,0,0
82893,infusion,0,1
82894,time,0,0
82895,on,0,0
82896,the,0,0
82897,acute,0,0
82898,toxicity,0,0
82899,of,0,0
82900,amphotericin,1,1
82901,B,1,0
82902,:,1,0
82903,results,0,0
82904,of,0,0
82905,a,0,0
82906,randomized,0,0
82907,double-blind,0,0
82908,study,0,0
82909,.,0,0
82910,Cognitive,0,1
82911,effects,0,0
82912,of,0,0
82913,risperidone,1,1
82914,in,0,0
82915,children,0,0
82916,with,0,0
82917,autism,0,0
82918,and,0,0
82919,irritable,0,0
82920,behavior,0,0
82921,.,0,0
82922,OBJECTIVE,0,0
82923,The,0,0
82924,objective,0,0
82925,of,0,0
82926,this,0,0
82927,research,0,0
82928,was,0,0
82929,to,0,0
82930,explore,0,0
82931,the,0,0
82932,effects,0,0
82933,of,0,0
82934,risperidone,1,1
82935,on,0,0
82936,cognitive,0,0
82937,processes,0,0
82938,in,0,0
82939,children,0,0
82940,with,0,0
82941,autism,0,0
82942,and,0,0
82943,irritable,0,0
82944,behavior,0,0
82945,.,0,0
82946,METHOD,0,0
82947,Thirty-eight,0,0
82948,children,0,0
82949,",",0,0
82950,ages,0,0
82951,5-17,0,0
82952,years,0,0
82953,with,0,0
82954,autism,0,0
82955,and,0,0
82956,severe,0,0
82957,behavioral,0,1
82958,disturbance,0,0
82959,",",0,0
82960,were,0,0
82961,randomly,0,0
82962,assigned,0,0
82963,to,0,0
82964,risperidone,1,1
82965,(,0,0
82966,0.5,0,1
82967,to,0,0
82968,3.5,0,0
82969,mg/day,0,1
82970,),0,1
82971,or,1,1
82972,placebo,1,1
82973,for,0,0
82974,8,0,0
82975,weeks,0,0
82976,.,0,0
82977,This,0,0
82978,sample,0,0
82979,of,0,0
82980,38,0,0
82981,was,0,0
82982,a,0,0
82983,subset,0,0
82984,of,0,0
82985,101,0,0
82986,subjects,0,0
82987,who,0,0
82988,participated,0,0
82989,in,0,0
82990,the,0,0
82991,clinical,0,0
82992,trial,0,0
82993,;,0,0
82994,63,0,0
82995,were,0,0
82996,unable,0,0
82997,to,0,0
82998,perform,0,0
82999,the,0,0
83000,cognitive,0,0
83001,tasks,0,0
83002,.,0,0
83003,A,0,0
83004,double-blind,0,0
83005,placebo-controlled,0,1
83006,parallel,0,0
83007,groups,0,0
83008,design,0,0
83009,was,0,0
83010,used,0,0
83011,.,0,0
83012,Dependent,0,0
83013,measures,0,0
83014,included,0,0
83015,tests,0,0
83016,of,0,0
83017,sustained,0,0
83018,attention,0,0
83019,",",0,0
83020,verbal,0,1
83021,learning,0,1
83022,",",0,0
83023,hand-eye,0,1
83024,coordination,0,1
83025,",",0,0
83026,and,0,0
83027,spatial,0,0
83028,memory,0,0
83029,assessed,0,0
83030,before,0,0
83031,",",0,0
83032,during,0,0
83033,",",0,0
83034,and,0,0
83035,after,0,0
83036,the,0,0
83037,8-week,0,0
83038,treatment,0,0
83039,.,0,0
83040,Changes,0,0
83041,in,0,0
83042,performance,0,0
83043,were,0,0
83044,compared,0,0
83045,by,0,0
83046,repeated,0,0
83047,measures,0,0
83048,ANOVA,0,1
83049,.,0,0
83050,RESULTS,0,0
83051,Twenty-nine,0,0
83052,boys,0,0
83053,and,0,0
83054,9,0,0
83055,girls,0,0
83056,with,0,0
83057,autism,0,0
83058,and,0,0
83059,severe,0,0
83060,behavioral,0,1
83061,disturbance,0,0
83062,and,0,0
83063,a,0,0
83064,mental,0,0
83065,age,0,0
83066,>,0,0
83067,or=18,0,0
83068,months,0,0
83069,completed,0,0
83070,the,0,0
83071,cognitive,0,0
83072,part,0,0
83073,of,0,0
83074,the,0,0
83075,study,0,0
83076,.,0,0
83077,No,0,0
83078,decline,0,0
83079,in,0,0
83080,performance,0,0
83081,occurred,0,0
83082,with,0,0
83083,risperidone,0,1
83084,.,0,0
83085,Performance,0,0
83086,on,0,0
83087,a,0,0
83088,cancellation,0,1
83089,task,0,1
83090,(,0,1
83091,number,0,0
83092,of,0,0
83093,correct,0,0
83094,detections,0,0
83095,),0,0
83096,and,0,0
83097,a,0,0
83098,verbal,0,1
83099,learning,0,1
83100,task,0,1
83101,(,0,1
83102,word,0,1
83103,recognition,0,1
83104,),0,0
83105,was,0,0
83106,better,0,0
83107,on,0,0
83108,risperidone,1,1
83109,than,0,0
83110,on,0,0
83111,placebo,1,1
83112,(,0,0
83113,without,0,1
83114,correction,0,0
83115,for,0,0
83116,multiplicity,0,0
83117,),0,0
83118,.,0,0
83119,Equivocal,0,0
83120,improvement,0,0
83121,also,0,0
83122,occurred,0,0
83123,on,0,0
83124,a,0,0
83125,spatial,0,0
83126,memory,0,0
83127,task,0,1
83128,.,0,0
83129,There,0,0
83130,were,0,0
83131,no,0,0
83132,significant,0,0
83133,differences,0,0
83134,between,0,0
83135,treatment,0,0
83136,conditions,0,0
83137,on,0,0
83138,the,0,0
83139,Purdue,0,1
83140,Pegboard,0,1
83141,(,0,0
83142,hand-eye,0,1
83143,coordination,0,1
83144,),0,1
83145,task,0,1
83146,or,0,1
83147,the,0,0
83148,Analog,0,1
83149,Classroom,0,1
83150,Task,0,1
83151,(,0,0
83152,timed,0,0
83153,math,0,1
83154,test,0,0
83155,),0,0
83156,.,0,0
83157,CONCLUSION,0,0
83158,Risperidone,1,1
83159,given,0,0
83160,to,0,0
83161,children,0,0
83162,with,0,0
83163,autism,0,0
83164,at,0,0
83165,doses,0,0
83166,up,0,0
83167,to,0,0
83168,3.5,0,0
83169,mg,0,1
83170,for,0,0
83171,up,0,0
83172,to,0,0
83173,8,0,0
83174,weeks,0,0
83175,appears,0,0
83176,to,0,0
83177,have,0,0
83178,no,0,0
83179,detrimental,0,0
83180,effect,0,0
83181,on,0,0
83182,cognitive,0,0
83183,performance,0,0
83184,.,0,0
83185,Complementary,0,1
83186,feeding,0,1
83187,with,0,0
83188,fortified,0,1
83189,spread,0,0
83190,and,0,0
83191,incidence,0,0
83192,of,0,0
83193,severe,0,0
83194,stunting,0,0
83195,in,0,0
83196,6-,0,1
83197,to,0,0
83198,18-month-old,0,0
83199,rural,0,0
83200,Malawians,0,0
83201,.,0,0
83202,OBJECTIVE,0,0
83203,To,0,0
83204,compare,0,0
83205,growth,0,0
83206,and,0,0
83207,incidence,0,0
83208,of,0,0
83209,malnutrition,0,0
83210,in,0,0
83211,infants,0,0
83212,receiving,0,0
83213,long-term,0,0
83214,dietary,0,1
83215,supplementation,0,1
83216,with,0,0
83217,ready-to-use,0,1
83218,fortified,1,1
83219,spread,1,0
83220,(,1,1
83221,FS,1,1
83222,),1,1
83223,or,0,1
83224,micronutrient-fortified,1,1
83225,maize-soy,1,1
83226,flour,1,1
83227,(,1,1
83228,likuni,1,0
83229,phala,1,1
83230,[,0,0
83231,LP,0,1
83232,],0,0
83233,),0,0
83234,.,0,0
83235,DESIGN,0,0
83236,Randomized,0,0
83237,",",0,0
83238,controlled,0,0
83239,",",0,0
83240,single-blind,0,0
83241,trial,0,0
83242,.,0,0
83243,SETTING,0,0
83244,Rural,0,0
83245,Malawi,0,0
83246,.,0,0
83247,PARTICIPANTS,0,0
83248,A,0,0
83249,total,0,0
83250,of,0,0
83251,182,0,0
83252,six-month-old,0,0
83253,infants,0,0
83254,.,0,0
83255,INTERVENTION,0,0
83256,Participants,0,0
83257,were,0,0
83258,randomized,0,0
83259,to,0,0
83260,receive,0,0
83261,1,0,0
83262,year,0,0
83263,of,0,0
83264,daily,0,1
83265,supplementation,0,1
83266,with,0,0
83267,71,0,0
83268,g,0,1
83269,of,0,0
83270,LP,1,1
83271,(,0,0
83272,282,0,0
83273,kcal,0,1
83274,),0,0
83275,",",0,0
83276,50,0,1
83277,g,0,1
83278,of,0,0
83279,FS,1,1
83280,(,0,1
83281,FS50,0,1
83282,),0,1
83283,(,0,0
83284,256,0,1
83285,kcal,0,1
83286,),0,0
83287,",",0,0
83288,or,0,1
83289,25,0,0
83290,g,0,1
83291,of,0,0
83292,FS,1,1
83293,(,1,1
83294,FS25,1,1
83295,),1,1
83296,(,0,0
83297,130,0,0
83298,[,0,0
83299,corrected,0,0
83300,],0,0
83301,kcal,0,1
83302,),0,0
83303,.,0,0
83304,OUTCOME,0,0
83305,MEASURES,0,0
83306,Weight,0,0
83307,and,0,0
83308,length,0,1
83309,gains,0,0
83310,and,0,0
83311,the,0,0
83312,incidences,0,0
83313,of,0,0
83314,severe,0,0
83315,stunting,0,0
83316,",",0,0
83317,underweight,0,0
83318,",",0,0
83319,and,0,0
83320,wasting,0,0
83321,.,0,0
83322,RESULTS,0,0
83323,Mean,0,0
83324,weight,0,0
83325,and,0,0
83326,length,0,0
83327,gains,0,0
83328,in,0,0
83329,the,0,0
83330,LP,1,1
83331,",",0,0
83332,FS50,0,0
83333,",",0,0
83334,and,0,0
83335,FS25,0,0
83336,groups,0,0
83337,were,0,0
83338,2.37,0,0
83339,",",0,0
83340,2.47,0,0
83341,",",0,0
83342,and,0,0
83343,2.37,0,0
83344,kg,0,1
83345,(,0,0
83346,P,0,0
83347,=,0,0
83348,.66,0,0
83349,),0,1
83350,and,0,0
83351,12.7,0,0
83352,",",0,0
83353,13.5,0,0
83354,",",0,0
83355,and,0,0
83356,13.2,0,0
83357,cm,0,0
83358,(,0,0
83359,P,0,0
83360,=,0,0
83361,.23,0,0
83362,),0,0
83363,",",0,0
83364,respectively,0,0
83365,.,0,0
83366,In,0,0
83367,the,0,0
83368,same,0,0
83369,groups,0,0
83370,",",0,0
83371,the,0,0
83372,cumulative,0,0
83373,12-month,0,0
83374,incidence,0,0
83375,of,0,0
83376,severe,0,0
83377,stunting,0,0
83378,was,0,0
83379,13.3,0,0
83380,%,0,0
83381,",",0,0
83382,0.0,0,0
83383,%,0,0
83384,",",0,0
83385,and,0,0
83386,3.5,0,1
83387,%,0,0
83388,(,0,0
83389,P,0,0
83390,=,0,0
83391,.01,0,0
83392,),0,0
83393,",",0,0
83394,of,0,0
83395,severe,0,0
83396,underweight,0,0
83397,was,0,0
83398,15.0,0,0
83399,%,0,0
83400,",",0,0
83401,22.5,0,0
83402,%,0,0
83403,",",0,0
83404,and,0,0
83405,16.9,0,0
83406,%,0,0
83407,(,0,0
83408,P,0,0
83409,=,0,0
83410,.71,0,0
83411,),0,0
83412,",",0,0
83413,and,0,0
83414,of,0,0
83415,severe,0,0
83416,wasting,0,0
83417,was,0,0
83418,1.8,0,0
83419,%,0,0
83420,",",0,0
83421,1.9,0,0
83422,%,0,0
83423,",",0,0
83424,and,0,0
83425,1.8,0,0
83426,%,0,0
83427,(,0,0
83428,P,0,0
83429,>,0,0
83430,.99,0,0
83431,),0,0
83432,.,0,0
83433,Compared,0,0
83434,with,0,0
83435,LP-supplemented,1,1
83436,infants,0,0
83437,",",0,0
83438,those,0,0
83439,given,0,0
83440,FS50,0,0
83441,gained,0,0
83442,a,0,0
83443,mean,0,0
83444,of,0,0
83445,100,0,0
83446,g,0,0
83447,more,0,0
83448,weight,0,0
83449,and,0,0
83450,0.8,0,0
83451,cm,0,0
83452,more,0,0
83453,length,0,0
83454,.,0,0
83455,There,0,0
83456,was,0,0
83457,a,0,0
83458,significant,0,0
83459,interaction,0,0
83460,between,0,0
83461,baseline,0,0
83462,length,0,1
83463,and,0,1
83464,intervention,0,1
83465,(,0,1
83466,P,0,0
83467,=,0,0
83468,.04,0,0
83469,),0,0
83470,;,0,0
83471,in,0,0
83472,children,0,0
83473,with,0,0
83474,below-median,0,0
83475,length,0,0
83476,at,0,0
83477,enrollment,0,0
83478,",",0,0
83479,those,0,0
83480,given,0,0
83481,FS50,0,0
83482,gained,0,0
83483,a,0,0
83484,mean,0,0
83485,of,0,0
83486,1.9,0,0
83487,cm,0,0
83488,more,0,0
83489,than,0,0
83490,individuals,0,0
83491,receiving,0,0
83492,LP,1,1
83493,.,1,1
83494,CONCLUSION,0,0
83495,One-year-long,0,0
83496,complementary,0,1
83497,feeding,0,1
83498,with,0,0
83499,FS,1,1
83500,does,0,0
83501,not,0,0
83502,have,0,0
83503,a,0,0
83504,significantly,0,0
83505,larger,0,0
83506,effect,0,0
83507,than,0,0
83508,LP,1,1
83509,on,0,0
83510,mean,0,0
83511,weight,0,0
83512,gain,0,0
83513,in,0,0
83514,all,0,0
83515,infants,0,0
83516,",",0,0
83517,but,0,0
83518,it,0,0
83519,is,0,0
83520,likely,0,0
83521,to,0,0
83522,boost,0,1
83523,linear,0,0
83524,growth,0,0
83525,in,0,0
83526,the,0,0
83527,most,0,0
83528,disadvantaged,0,0
83529,individuals,0,0
83530,and,0,0
83531,",",0,0
83532,hence,0,0
83533,",",0,0
83534,decrease,0,0
83535,the,0,0
83536,incidence,0,0
83537,of,0,0
83538,severe,0,0
83539,stunting,0,0
83540,.,0,0
83541,Randomized,0,0
83542,trial,0,0
83543,of,0,0
83544,a,0,0
83545,decision,0,0
83546,aid,0,0
83547,for,0,0
83548,individuals,0,0
83549,considering,0,0
83550,genetic,0,0
83551,testing,0,1
83552,for,0,0
83553,hereditary,0,0
83554,nonpolyposis,0,0
83555,colorectal,0,0
83556,cancer,0,0
83557,risk,0,0
83558,.,0,0
83559,BACKGROUND,0,0
83560,Despite,0,0
83561,the,0,0
83562,potential,0,0
83563,benefits,0,0
83564,of,0,0
83565,genetic,0,0
83566,testing,0,0
83567,for,0,0
83568,hereditary,0,0
83569,nonpolyposis,0,0
83570,colorectal,0,0
83571,cancer,0,0
83572,(,0,1
83573,HNPCC,0,1
83574,),0,1
83575,risk,0,0
83576,",",0,0
83577,individuals,0,0
83578,can,0,0
83579,find,0,0
83580,the,0,0
83581,genetic,0,0
83582,testing,0,0
83583,decision-making,0,0
83584,process,0,0
83585,complicated,0,0
83586,and,0,0
83587,challenging,0,0
83588,.,0,0
83589,The,0,0
83590,goal,0,0
83591,of,0,0
83592,the,0,0
83593,current,0,0
83594,study,0,0
83595,was,0,0
83596,to,0,0
83597,measure,0,0
83598,the,0,0
83599,effectiveness,0,0
83600,of,0,0
83601,a,0,0
83602,tailored,0,1
83603,decision,0,0
83604,aid,0,0
83605,designed,0,0
83606,specifically,0,0
83607,to,0,0
83608,assist,0,0
83609,individuals,0,0
83610,to,0,0
83611,make,0,0
83612,informed,0,0
83613,decisions,0,0
83614,regarding,0,0
83615,genetic,0,0
83616,testing,0,1
83617,for,0,0
83618,HNPCC,0,0
83619,risk,0,0
83620,.,0,0
83621,METHODS,0,0
83622,In,0,0
83623,all,0,0
83624,",",0,0
83625,153,0,0
83626,individuals,0,0
83627,were,0,0
83628,randomized,0,0
83629,to,0,0
83630,receive,1,0
83631,the,1,0
83632,decision,1,1
83633,aid,1,0
83634,or,1,1
83635,a,1,0
83636,control,1,1
83637,pamphlet,1,1
83638,at,1,0
83639,the,1,0
83640,end,1,0
83641,of,1,0
83642,their,1,0
83643,first,1,0
83644,genetic,1,0
83645,counseling,1,1
83646,consultation,1,1
83647,.,1,0
83648,Of,0,0
83649,these,0,0
83650,",",0,0
83651,109,0,0
83652,(,0,0
83653,71.2,0,0
83654,%,0,0
83655,),0,0
83656,completed,0,0
83657,the,0,0
83658,first,0,0
83659,questionnaire,0,0
83660,1,0,0
83661,week,0,0
83662,after,0,0
83663,consultation,0,1
83664,",",0,0
83665,whereas,0,0
83666,95,0,0
83667,(,0,0
83668,62.1,0,0
83669,%,0,0
83670,),0,0
83671,completed,0,0
83672,the,0,0
83673,6-month,0,0
83674,follow-up,0,0
83675,questionnaire,0,0
83676,.,0,0
83677,RESULTS,0,0
83678,Although,0,0
83679,the,0,0
83680,decision,0,0
83681,aid,0,0
83682,had,0,0
83683,no,0,0
83684,significant,0,0
83685,effect,0,0
83686,on,0,0
83687,postdecisional,0,0
83688,regret,0,0
83689,or,0,1
83690,actual,0,0
83691,genetic,0,0
83692,testing,0,1
83693,decision,0,0
83694,",",0,0
83695,the,0,0
83696,trial,0,0
83697,results,0,0
83698,demonstrated,0,0
83699,that,0,0
83700,participants,0,0
83701,who,0,0
83702,received,0,0
83703,the,0,0
83704,decision,1,0
83705,aid,1,0
83706,had,0,0
83707,significantly,0,0
83708,lower,0,0
83709,levels,0,0
83710,of,0,0
83711,decisional,0,0
83712,conflict,0,0
83713,(,0,0
83714,ie,0,0
83715,",",0,0
83716,uncertainty,0,0
83717,),0,1
83718,regarding,0,0
83719,genetic,0,1
83720,testing,0,1
83721,(,0,1
83722,chi-square,0,0
83723,(,0,1
83724,1,0,0
83725,),0,0
83726,=,0,0
83727,8.97,0,0
83728,;,0,0
83729,P,0,0
83730,=,0,0
83731,.003,0,0
83732,),0,1
83733,and,0,0
83734,were,0,0
83735,more,0,0
83736,likely,0,0
83737,to,0,0
83738,be,0,0
83739,classified,0,0
83740,as,0,0
83741,having,0,0
83742,made,0,0
83743,an,0,0
83744,informed,0,0
83745,choice,0,0
83746,concerning,0,0
83747,genetic,0,0
83748,testing,0,1
83749,(,0,1
83750,chi-square,0,0
83751,(,0,1
83752,1,0,0
83753,),0,0
83754,=,0,0
83755,4.37,0,0
83756,;,0,0
83757,P,0,0
83758,=,0,0
83759,.037,0,0
83760,),0,0
83761,than,0,0
83762,participants,0,0
83763,who,0,0
83764,received,0,0
83765,a,0,0
83766,control,1,0
83767,pamphlet,1,1
83768,.,1,0
83769,Also,0,0
83770,",",0,0
83771,men,0,0
83772,who,0,0
83773,received,0,0
83774,the,0,0
83775,decision,1,0
83776,aid,1,0
83777,had,0,0
83778,significantly,0,0
83779,higher,0,0
83780,knowledge,0,0
83781,levels,0,0
83782,regarding,0,0
83783,genetic,0,0
83784,testing,0,1
83785,compared,0,0
83786,with,0,0
83787,men,0,0
83788,who,0,0
83789,received,0,0
83790,the,0,0
83791,control,1,1
83792,pamphlet,1,1
83793,",",0,0
83794,whereas,0,0
83795,no,0,0
83796,such,0,0
83797,differences,0,0
83798,were,0,0
83799,found,0,0
83800,for,0,0
83801,women,0,0
83802,(,0,0
83803,chi-square,0,0
83804,(,0,1
83805,2,0,0
83806,),0,0
83807,=,0,0
83808,6.76,0,0
83809,;,0,0
83810,P,0,0
83811,=,0,0
83812,.034,0,0
83813,),0,0
83814,.,0,0
83815,CONCLUSIONS,0,0
83816,A,0,0
83817,decision,1,0
83818,aid,1,0
83819,for,0,0
83820,individuals,0,0
83821,considering,0,0
83822,genetic,0,0
83823,testing,0,1
83824,for,0,0
83825,HNPCC,0,0
83826,is,0,0
83827,an,0,0
83828,effective,0,0
83829,intervention,0,1
83830,to,0,0
83831,reduce,0,0
83832,uncertainty,0,0
83833,and,0,0
83834,assist,0,0
83835,individuals,0,0
83836,to,0,0
83837,make,0,0
83838,an,0,0
83839,informed,0,0
83840,choice,0,0
83841,regarding,0,0
83842,genetic,0,0
83843,testing,0,1
83844,for,0,0
83845,HNPCC,0,0
83846,after,0,0
83847,genetic,0,0
83848,counseling,0,1
83849,.,0,0
83850,Comparison,0,0
83851,of,0,0
83852,amantadine,1,1
83853,and,1,0
83854,desipramine,1,1
83855,combined,0,1
83856,with,0,0
83857,psychotherapy,1,1
83858,for,0,0
83859,treatment,0,0
83860,of,0,0
83861,cocaine,0,1
83862,dependence,0,0
83863,.,0,0
83864,We,0,0
83865,conducted,0,0
83866,a,0,0
83867,single-blind,0,0
83868,",",0,0
83869,random,0,0
83870,assignment,0,0
83871,",",0,0
83872,placebo-controlled,1,1
83873,",",0,0
83874,12-week,0,0
83875,comparison,0,0
83876,of,0,0
83877,desipramine,1,1
83878,hydrochloride,1,1
83879,and,1,0
83880,amantadine,1,1
83881,hydrochloride,1,1
83882,as,0,0
83883,adjunctive,0,1
83884,treatments,0,1
83885,to,0,0
83886,counseling,0,1
83887,for,0,0
83888,cocaine,0,1
83889,dependence,0,0
83890,.,0,0
83891,Subjects,0,0
83892,were,0,0
83893,54,0,0
83894,outpatients,0,0
83895,who,0,0
83896,met,0,0
83897,DSM,0,0
83898,III-R,0,1
83899,criteria,0,0
83900,for,0,0
83901,active,0,1
83902,cocaine,0,1
83903,dependence,0,0
83904,and,0,0
83905,who,0,0
83906,completed,0,0
83907,a,0,0
83908,minimum,0,0
83909,of,0,0
83910,2,0,0
83911,weeks,0,0
83912,of,0,0
83913,treatment,0,0
83914,.,0,0
83915,Subjects,0,0
83916,treated,0,0
83917,with,0,0
83918,fixed,0,0
83919,doses,0,0
83920,of,0,0
83921,200,0,1
83922,mg/day,0,1
83923,desipramine,1,1
83924,(,0,0
83925,N,0,1
83926,=,0,0
83927,17,0,0
83928,),0,0
83929,",",0,0
83930,400,0,1
83931,mg/day,0,1
83932,amantadine-placebo,1,1
83933,(,0,0
83934,N,0,1
83935,=,0,0
83936,16,0,0
83937,),0,0
83938,",",0,0
83939,and,0,1
83940,placebo,1,1
83941,(,0,1
83942,N,0,1
83943,=,0,0
83944,21,0,0
83945,),0,0
83946,did,0,0
83947,not,0,0
83948,differ,0,0
83949,for,0,0
83950,lifetime,0,0
83951,cocaine,0,1
83952,use,0,0
83953,",",0,0
83954,lifetime,0,0
83955,histories,0,0
83956,of,0,0
83957,psychopathology,0,0
83958,",",0,0
83959,admission,0,0
83960,scores,0,0
83961,on,0,0
83962,psychometric,0,0
83963,assessments,0,0
83964,",",0,0
83965,and,0,0
83966,sociodemographics,0,0
83967,.,0,0
83968,All,0,0
83969,treatment,0,0
83970,groups,0,0
83971,demonstrated,0,0
83972,dramatic,0,0
83973,and,0,0
83974,persistent,0,0
83975,decreases,0,0
83976,in,0,0
83977,cocaine,0,1
83978,use,0,0
83979,",",0,0
83980,craving,0,0
83981,for,0,0
83982,cocaine,0,1
83983,",",0,0
83984,and,0,0
83985,psychiatric,0,0
83986,symptoms,0,0
83987,consequent,0,0
83988,to,0,0
83989,treatment,0,0
83990,.,0,0
83991,Although,0,0
83992,there,0,0
83993,was,0,0
83994,a,0,0
83995,trend,0,0
83996,for,0,0
83997,more,0,0
83998,dropouts,0,0
83999,by,0,0
84000,subjects,0,0
84001,taking,0,0
84002,desipramine,1,1
84003,",",0,0
84004,there,0,0
84005,were,0,0
84006,no,0,0
84007,significant,0,0
84008,differences,0,0
84009,among,0,0
84010,treatment,0,0
84011,groups,0,0
84012,regarding,0,0
84013,retention,0,0
84014,in,0,0
84015,treatment,0,0
84016,",",0,0
84017,craving,0,0
84018,for,0,0
84019,cocaine,0,1
84020,",",0,0
84021,and,0,0
84022,decreased,0,0
84023,cocaine,0,1
84024,use,0,0
84025,confirmed,0,0
84026,by,0,0
84027,urine,0,0
84028,toxicology,0,0
84029,.,0,0
84030,There,0,0
84031,was,0,0
84032,a,0,0
84033,trend,0,0
84034,for,0,0
84035,subjects,0,0
84036,treated,0,0
84037,with,0,0
84038,desipramine,1,1
84039,to,0,0
84040,maintain,0,0
84041,longer,0,0
84042,periods,0,0
84043,of,0,0
84044,cocaine,0,0
84045,abstinence,0,0
84046,.,0,0
84047,Mean,0,0
84048,plasma,0,0
84049,concentration,0,0
84050,of,0,0
84051,desipramine,1,1
84052,in,0,0
84053,a,0,0
84054,subsample,0,0
84055,of,0,0
84056,our,0,0
84057,subjects,0,0
84058,was,0,0
84059,less,0,0
84060,than,0,0
84061,that,0,0
84062,recommended,0,0
84063,for,0,0
84064,treatment,0,0
84065,of,0,0
84066,depression,0,0
84067,",",0,0
84068,thus,0,0
84069,the,0,0
84070,dosage,0,0
84071,of,0,0
84072,desipramine,1,1
84073,may,0,0
84074,have,0,0
84075,been,0,0
84076,subtherapeutic,0,1
84077,.,0,0
84078,Which,0,0
84079,socio-demographic,1,0
84080,factors,1,0
84081,are,0,0
84082,associated,0,0
84083,with,0,0
84084,participation,1,0
84085,in,1,0
84086,oral,1,1
84087,cancer,1,0
84088,screening,1,0
84089,in,0,0
84090,the,0,0
84091,developing,0,0
84092,world,0,0
84093,?,0,0
84094,Results,0,0
84095,from,0,0
84096,a,0,0
84097,population-based,1,0
84098,screening,1,0
84099,project,0,0
84100,in,0,0
84101,India,0,0
84102,.,0,0
84103,BACKGROUND,0,0
84104,This,0,0
84105,study,0,0
84106,examines,0,0
84107,socio-demographic,0,0
84108,determinants,0,0
84109,of,0,0
84110,participation,0,0
84111,in,0,0
84112,a,0,0
84113,population-based,0,0
84114,randomized,0,0
84115,controlled,0,0
84116,trial,0,0
84117,that,0,0
84118,proved,0,0
84119,that,0,0
84120,oral,1,1
84121,visual,1,0
84122,inspection,1,1
84123,was,0,0
84124,effective,0,0
84125,in,0,0
84126,reducing,0,0
84127,oral,0,1
84128,cancer,0,0
84129,mortality,0,0
84130,in,0,0
84131,high-risk,0,0
84132,individuals,0,0
84133,in,0,0
84134,India,0,0
84135,.,0,0
84136,METHODS,0,0
84137,Multivariate,0,0
84138,logistic,0,0
84139,regression,0,0
84140,was,0,0
84141,used,0,0
84142,to,0,0
84143,establish,0,0
84144,socio-demographic,0,0
84145,characteristics,0,0
84146,of,0,0
84147,participants,0,0
84148,versus,0,0
84149,non-participants,0,0
84150,in,0,0
84151,the,0,0
84152,intervention,1,1
84153,arm,0,0
84154,.,0,0
84155,Compliance,0,0
84156,with,0,0
84157,referral,1,0
84158,was,0,0
84159,analysed,0,0
84160,according,0,0
84161,to,0,0
84162,the,0,0
84163,socio-demographic,0,0
84164,characteristics,0,0
84165,of,0,0
84166,screen-positives,0,0
84167,.,0,0
84168,RESULTS,0,0
84169,Of,0,1
84170,"96,517",0,0
84171,eligible,0,0
84172,subjects,0,0
84173,",",0,0
84174,"87,655",0,0
84175,were,0,0
84176,screened,1,0
84177,",",0,0
84178,8688,0,0
84179,individuals,0,0
84180,never,0,0
84181,received,0,0
84182,the,0,0
84183,invitation,0,1
84184,and,0,0
84185,174,0,0
84186,refused,0,0
84187,screening,1,0
84188,.,1,0
84189,Compared,0,0
84190,to,0,0
84191,the,0,0
84192,non-screened,0,0
84193,",",0,0
84194,a,0,0
84195,higher,0,0
84196,proportion,0,0
84197,of,0,0
84198,screened,1,0
84199,individuals,0,0
84200,were,0,0
84201,women,0,0
84202,(,0,0
84203,OR=4.51,0,0
84204,;,0,0
84205,CI,0,0
84206,:,0,1
84207,4.28-4.75,0,0
84208,),0,0
84209,",",0,0
84210,lived,0,0
84211,in,0,0
84212,better,0,0
84213,housing,0,1
84214,(,0,0
84215,OR=1.35,0,0
84216,;,0,0
84217,CI,0,0
84218,:,0,1
84219,1.25-1.41,0,0
84220,),0,0
84221,",",0,0
84222,had,0,0
84223,television/radio,0,1
84224,(,0,0
84225,OR=1.50,0,0
84226,;,0,0
84227,CI,0,0
84228,:,0,1
84229,1.43-1.58,0,0
84230,),0,0
84231,and,0,0
84232,were,0,0
84233,tobacco,0,1
84234,and,0,0
84235,alcohol,0,1
84236,users,0,0
84237,(,0,0
84238,OR=2.75,0,1
84239,;,0,0
84240,CI,0,0
84241,:,0,1
84242,2.57-2.95,0,0
84243,),0,0
84244,.,0,0
84245,Being,0,0
84246,65,0,0
84247,and,0,0
84248,older,0,0
84249,decreased,0,0
84250,the,0,0
84251,chances,0,0
84252,of,0,0
84253,screening,1,0
84254,(,0,0
84255,OR=0.39,0,0
84256,;,0,0
84257,CI,0,0
84258,:,0,1
84259,0.37-0.42,0,0
84260,),0,0
84261,",",0,0
84262,as,0,0
84263,well,0,0
84264,as,0,0
84265,living,0,0
84266,in,0,0
84267,high-size,0,0
84268,households,0,1
84269,(,0,0
84270,OR=0.73,0,0
84271,;,0,0
84272,CI,0,0
84273,:,0,1
84274,0.68-0.78,0,0
84275,),0,0
84276,.,0,0
84277,Sixty-three,0,0
84278,percent,0,0
84279,of,0,0
84280,5143,0,0
84281,screen-positives,0,0
84282,complied,0,0
84283,with,0,0
84284,referral,0,0
84285,.,0,0
84286,Controlling,0,0
84287,for,0,0
84288,all,0,0
84289,other,0,0
84290,factors,0,0
84291,",",0,0
84292,individuals,0,0
84293,older,0,0
84294,than,0,0
84295,44,0,0
84296,",",0,0
84297,and,0,0
84298,those,0,0
84299,with,0,0
84300,more,0,0
84301,advanced,0,0
84302,lesions,0,0
84303,were,0,0
84304,more,0,0
84305,likely,0,0
84306,to,0,0
84307,comply,0,0
84308,with,0,0
84309,referral,1,1
84310,(,0,0
84311,p,0,0
84312,<,0,0
84313,0.001,0,0
84314,),0,0
84315,.,0,0
84316,Individuals,0,0
84317,living,0,0
84318,in,0,0
84319,better,0,0
84320,housing,0,0
84321,were,0,0
84322,less,0,0
84323,likely,0,0
84324,to,0,0
84325,comply,0,0
84326,with,0,0
84327,referral,0,1
84328,(,0,0
84329,OR=0.79,0,0
84330,;,0,0
84331,CI,0,0
84332,:,0,1
84333,0.65-0.95,0,0
84334,),0,0
84335,.,0,0
84336,CONCLUSIONS,0,0
84337,In,0,0
84338,summary,0,0
84339,",",0,0
84340,adequate,0,0
84341,coverage,0,0
84342,can,0,0
84343,be,0,0
84344,obtained,0,0
84345,in,0,0
84346,population-based,1,0
84347,oral,1,1
84348,screening,1,1
84349,in,0,0
84350,developing,0,0
84351,countries,0,0
84352,.,0,0
84353,The,0,0
84354,study,0,0
84355,underscores,0,0
84356,the,0,0
84357,important,0,0
84358,role,0,0
84359,of,0,0
84360,patient-provider,1,1
84361,communication,1,1
84362,in,0,0
84363,assuring,0,0
84364,high,0,0
84365,compliance,0,0
84366,with,0,0
84367,referral,0,0
84368,.,0,0
84369,Local,0,0
84370,delivery,0,0
84371,of,0,0
84372,a,0,0
84373,recombinant,1,1
84374,adenoassociated,1,1
84375,vector,1,1
84376,containing,1,1
84377,a,1,0
84378,tumour,1,0
84379,necrosis,1,0
84380,factor,1,0
84381,alpha,1,1
84382,antagonist,1,1
84383,gene,1,0
84384,in,0,0
84385,inflammatory,0,0
84386,arthritis,0,0
84387,:,0,0
84388,a,0,0
84389,phase,0,0
84390,1,0,0
84391,dose-escalation,0,0
84392,safety,0,0
84393,and,0,0
84394,tolerability,0,0
84395,study,0,0
84396,.,0,0
84397,OBJECTIVE,0,0
84398,To,0,0
84399,examine,0,0
84400,the,0,0
84401,safety,0,0
84402,and,0,0
84403,tolerability,0,0
84404,of,0,0
84405,a,0,0
84406,single,0,0
84407,intra-articular,0,1
84408,injection,0,1
84409,of,0,0
84410,rAAV2-TNFR,1,0
84411,:,1,0
84412,Fc,1,1
84413,",",1,0
84414,an,1,0
84415,adenoassociated,1,1
84416,virus,1,0
84417,serotype,1,1
84418,2,1,0
84419,vector,1,1
84420,containing,1,1
84421,the,1,0
84422,cDNA,1,0
84423,for,0,0
84424,the,0,0
84425,human,0,1
84426,tumour,0,0
84427,necrosis,0,0
84428,factor-immunoglobulin,0,1
84429,Fc,0,1
84430,fusion,0,1
84431,gene,0,1
84432,(,0,1
84433,tgAAC94,0,1
84434,),0,0
84435,",",0,0
84436,in,0,0
84437,subjects,0,0
84438,with,0,0
84439,inflammatory,0,0
84440,arthritis,0,0
84441,.,0,0
84442,METHODS,0,0
84443,In,0,0
84444,a,0,0
84445,double-blind,0,0
84446,",",0,0
84447,placebo-controlled,1,1
84448,",",0,0
84449,phase,0,0
84450,1,0,0
84451,",",0,0
84452,dose-escalation,0,0
84453,study,0,0
84454,",",0,0
84455,15,0,0
84456,subjects,0,0
84457,with,0,0
84458,inflammatory,0,0
84459,arthritis,0,0
84460,(,0,0
84461,14,0,0
84462,with,0,0
84463,rheumatoid,0,0
84464,arthritis,0,0
84465,and,0,0
84466,1,0,0
84467,with,0,0
84468,ankylosing,0,0
84469,spondylitis,0,1
84470,),0,1
84471,not,0,0
84472,receiving,0,0
84473,tumour,0,0
84474,necrosis,0,1
84475,factor,0,1
84476,alpha,0,1
84477,(,0,1
84478,TNFalpha,0,1
84479,),0,1
84480,inhibitors,0,1
84481,with,0,0
84482,persistent,0,0
84483,moderate,0,0
84484,(,0,0
84485,grade,0,0
84486,2,0,1
84487,),0,0
84488,or,0,1
84489,severe,0,0
84490,(,0,0
84491,grade,0,0
84492,3,0,1
84493,),0,0
84494,swelling,0,0
84495,in,0,0
84496,a,0,0
84497,target,0,0
84498,joint,0,0
84499,due,0,0
84500,to,0,0
84501,inflammatory,0,0
84502,arthritis,0,0
84503,received,0,1
84504,a,0,0
84505,single,0,0
84506,intra-articular,0,1
84507,injection,0,1
84508,of,0,0
84509,rAAV2-TNFR,1,0
84510,:,1,0
84511,Fc,1,1
84512,at,0,0
84513,1,0,0
84514,x,0,0
84515,10,0,0
84516,(,0,0
84517,10,0,1
84518,),0,1
84519,(,0,0
84520,n,0,0
84521,=,0,0
84522,5,0,1
84523,),0,0
84524,or,0,1
84525,1,0,0
84526,x,0,0
84527,10,0,0
84528,(,0,0
84529,11,0,0
84530,),0,1
84531,(,0,0
84532,n,0,0
84533,=,0,0
84534,6,0,0
84535,),0,0
84536,DNase,0,1
84537,resistant,0,0
84538,particles,0,0
84539,per,0,0
84540,ml,0,1
84541,joint,0,1
84542,volume,0,0
84543,or,1,1
84544,placebo,1,1
84545,(,0,1
84546,n,0,0
84547,=,0,0
84548,4,0,0
84549,),0,0
84550,into,0,0
84551,a,0,0
84552,knee,0,1
84553,(,0,0
84554,n,0,0
84555,=,0,0
84556,14,0,1
84557,),0,0
84558,or,0,1
84559,ankle,0,0
84560,(,0,1
84561,n,0,0
84562,=,0,0
84563,1,0,0
84564,),0,0
84565,.,0,0
84566,Safety,0,0
84567,was,0,0
84568,assessed,0,0
84569,through,0,0
84570,adverse,0,0
84571,event,0,0
84572,monitoring,0,0
84573,.,0,0
84574,As,0,0
84575,a,0,0
84576,secondary,0,0
84577,objective,0,0
84578,",",0,0
84579,changes,0,0
84580,in,0,0
84581,injected,0,1
84582,joint,0,1
84583,tenderness,0,0
84584,and,0,0
84585,swelling,0,0
84586,scores,0,0
84587,",",0,0
84588,each,0,0
84589,measured,0,0
84590,on,0,0
84591,a,0,0
84592,four-point,0,0
84593,scale,0,0
84594,",",0,0
84595,were,0,0
84596,evaluated,0,0
84597,.,0,0
84598,RESULTS,0,0
84599,Intra-articular,0,0
84600,injections,0,1
84601,of,0,0
84602,rAAV2-TNFR,0,0
84603,:,0,0
84604,Fc,0,1
84605,were,0,0
84606,well,0,0
84607,tolerated,0,0
84608,with,0,0
84609,no,0,0
84610,major,0,0
84611,safety,0,0
84612,issues,0,0
84613,.,0,0
84614,One,0,0
84615,event,0,0
84616,",",0,0
84617,mild,0,0
84618,knee,0,1
84619,pruritus,0,0
84620,",",0,0
84621,was,0,0
84622,considered,0,0
84623,probably,0,0
84624,related,0,0
84625,.,0,0
84626,Synovial,0,0
84627,fluid,0,0
84628,TNFR,0,1
84629,:,0,1
84630,Fc,0,1
84631,protein,0,1
84632,was,0,0
84633,not,0,0
84634,detected,0,0
84635,(,0,0
84636,nor,0,0
84637,expected,0,0
84638,),0,0
84639,at,0,0
84640,the,0,0
84641,doses,0,0
84642,used,0,0
84643,.,0,0
84644,At,0,0
84645,12,0,0
84646,weeks,0,0
84647,after,0,0
84648,injection,0,0
84649,",",0,0
84650,a,0,0
84651,two-point,0,0
84652,decrease,0,0
84653,in,0,0
84654,swelling,0,0
84655,was,0,0
84656,noted,0,0
84657,in,0,0
84658,2/11,0,0
84659,and,0,0
84660,2/4,0,0
84661,subjects,0,0
84662,injected,0,0
84663,with,0,0
84664,rAAV2-TNFR,0,0
84665,:,0,1
84666,Fc,0,1
84667,and,0,0
84668,placebo,0,1
84669,",",0,0
84670,respectively,0,0
84671,.,0,0
84672,CONCLUSION,0,0
84673,A,0,0
84674,single,0,0
84675,dose,0,0
84676,of,0,0
84677,intra-articular,0,1
84678,rAAV2-TNFR,0,0
84679,:,0,0
84680,Fc,0,1
84681,appears,0,0
84682,to,0,0
84683,be,0,0
84684,safe,0,0
84685,and,0,0
84686,well,0,0
84687,tolerated,0,0
84688,in,0,0
84689,subjects,0,0
84690,without,0,0
84691,concurrent,0,0
84692,systemic,0,0
84693,TNFalpha,0,1
84694,antagonist,0,1
84695,use,0,0
84696,.,0,0
84697,It,0,0
84698,is,0,0
84699,thus,0,0
84700,feasible,0,0
84701,to,0,0
84702,proceed,0,0
84703,with,0,0
84704,larger,0,0
84705,trials,0,0
84706,to,0,0
84707,further,0,0
84708,test,0,0
84709,the,0,0
84710,safety,0,0
84711,and,0,0
84712,efficacy,0,0
84713,of,0,0
84714,local,0,1
84715,TNFR,0,0
84716,:,0,1
84717,Fc,0,1
84718,gene,0,1
84719,transfer,0,0
84720,as,0,0
84721,a,0,0
84722,therapeutic,0,0
84723,modality,0,0
84724,for,0,0
84725,patients,0,0
84726,with,0,0
84727,inflammatory,0,0
84728,arthritis,0,0
84729,.,0,0
84730,Concurrent,1,1
84731,doxorubicin,1,1
84732,plus,1,1
84733,docetaxel,1,1
84734,is,0,0
84735,not,0,0
84736,more,0,0
84737,effective,0,0
84738,than,0,0
84739,concurrent,1,1
84740,doxorubicin,1,1
84741,plus,1,1
84742,cyclophosphamide,1,1
84743,in,0,0
84744,operable,0,0
84745,breast,0,0
84746,cancer,0,0
84747,with,0,0
84748,0,0,0
84749,to,0,0
84750,3,0,0
84751,positive,0,0
84752,axillary,0,0
84753,nodes,0,0
84754,:,0,0
84755,North,0,0
84756,American,0,0
84757,Breast,0,0
84758,Cancer,0,1
84759,Intergroup,0,0
84760,Trial,0,1
84761,E,0,1
84762,2197,0,0
84763,.,0,0
84764,PURPOSE,0,0
84765,The,0,0
84766,combination,0,1
84767,of,0,0
84768,doxorubicin,1,1
84769,and,1,1
84770,cyclophosphamide,1,1
84771,(,1,1
84772,AC,1,0
84773,),1,1
84774,is,0,0
84775,a,0,0
84776,standard,0,0
84777,adjuvant,0,1
84778,regimen,0,1
84779,.,0,0
84780,Doxorubicin,1,1
84781,and,1,0
84782,docetaxel,1,1
84783,(,1,1
84784,AT,1,1
84785,),1,1
84786,is,0,0
84787,one,0,0
84788,of,0,0
84789,the,0,0
84790,most,0,0
84791,active,0,0
84792,cytotoxic,0,0
84793,regimens,0,1
84794,for,0,0
84795,metastatic,0,0
84796,breast,0,0
84797,cancer,0,0
84798,.,0,0
84799,The,0,0
84800,purpose,0,0
84801,of,0,0
84802,this,0,0
84803,trial,0,0
84804,was,0,0
84805,to,0,0
84806,determine,0,0
84807,whether,0,0
84808,adjuvant,0,1
84809,AT,0,1
84810,improved,0,0
84811,disease-free,0,0
84812,survival,0,0
84813,compared,0,0
84814,with,0,0
84815,AC,0,0
84816,in,0,0
84817,operable,0,0
84818,breast,0,0
84819,cancer,0,0
84820,.,0,0
84821,PATIENTS,0,0
84822,AND,0,0
84823,METHODS,0,0
84824,Women,0,0
84825,with,0,0
84826,invasive,0,0
84827,breast,0,0
84828,cancer,0,0
84829,were,0,0
84830,eligible,0,0
84831,if,0,0
84832,there,0,0
84833,were,0,0
84834,one,0,0
84835,to,0,0
84836,three,0,0
84837,positive,0,0
84838,lymph,0,0
84839,nodes,0,0
84840,or,0,0
84841,if,0,0
84842,the,0,0
84843,node-negative,0,0
84844,tumor,0,0
84845,was,0,0
84846,greater,0,0
84847,than,0,0
84848,1,0,0
84849,cm,0,0
84850,.,0,0
84851,Patients,0,0
84852,were,0,0
84853,randomly,0,0
84854,assigned,0,0
84855,after,0,0
84856,surgery,0,0
84857,to,0,0
84858,receive,0,1
84859,doxorubicin,1,1
84860,(,0,0
84861,60,0,1
84862,mg/m,0,1
84863,(,0,0
84864,2,0,1
84865,),0,1
84866,),0,0
84867,plus,1,1
84868,either,1,1
84869,cyclophosphamide,1,1
84870,(,0,0
84871,600,0,1
84872,mg/m,0,1
84873,(,0,0
84874,2,0,0
84875,),0,0
84876,;,0,0
84877,AC,0,0
84878,),0,1
84879,or,1,1
84880,docetaxel,1,1
84881,(,0,1
84882,60,0,1
84883,mg/m,0,1
84884,(,0,0
84885,2,0,0
84886,),0,0
84887,;,0,0
84888,AT,0,1
84889,),0,0
84890,given,0,0
84891,every,0,0
84892,3,0,0
84893,weeks,0,0
84894,for,0,0
84895,four,0,0
84896,cycles,0,0
84897,",",0,0
84898,followed,0,1
84899,by,0,0
84900,hormone,0,1
84901,therapy,0,1
84902,for,0,0
84903,patients,0,0
84904,with,0,0
84905,estrogen,0,1
84906,receptor,0,0
84907,(,0,1
84908,ER,0,1
84909,),0,1
84910,and/or,0,0
84911,progesterone,0,1
84912,receptor,0,0
84913,(,0,1
84914,PR,0,1
84915,),0,1
84916,-positive,0,0
84917,tumors,0,0
84918,.,0,0
84919,RESULTS,0,0
84920,There,0,0
84921,were,0,0
84922,"2,882",0,0
84923,eligible,0,0
84924,patients,0,0
84925,enrolled,0,0
84926,.,0,0
84927,After,0,0
84928,a,0,0
84929,median,0,0
84930,follow-up,0,0
84931,of,0,0
84932,79.5,0,0
84933,months,0,0
84934,",",0,0
84935,there,0,0
84936,was,0,0
84937,no,0,0
84938,significant,0,0
84939,difference,0,0
84940,in,0,0
84941,disease-free,0,0
84942,survival,0,0
84943,(,0,0
84944,DFS,0,0
84945,;,0,0
84946,85,0,0
84947,%,0,0
84948,in,0,0
84949,both,0,0
84950,arms,0,0
84951,),0,0
84952,or,0,1
84953,overall,0,0
84954,survival,0,0
84955,(,0,0
84956,91,0,0
84957,%,0,0
84958,v,0,1
84959,92,0,0
84960,%,0,0
84961,),0,0
84962,at,0,0
84963,5,0,0
84964,years,0,0
84965,.,0,0
84966,The,0,0
84967,hazard,0,0
84968,ratio,0,0
84969,for,0,0
84970,AC,1,0
84971,versus,0,1
84972,AT,0,1
84973,was,0,0
84974,1.02,0,0
84975,(,0,0
84976,95,0,0
84977,%,0,0
84978,CI,0,0
84979,for,0,0
84980,DFS,0,0
84981,",",0,0
84982,0.86,0,0
84983,to,0,0
84984,1.22,0,0
84985,;,0,0
84986,P,0,0
84987,=,0,0
84988,.78,0,0
84989,),0,0
84990,.,0,0
84991,In,0,0
84992,an,0,0
84993,exploratory,0,0
84994,analysis,0,0
84995,of,0,0
84996,prespecified,0,0
84997,stratification,0,0
84998,factors,0,0
84999,by,0,0
85000,ER,0,1
85001,and,0,0
85002,PR,0,1
85003,expression,0,0
85004,there,0,0
85005,were,0,0
85006,trends,0,0
85007,toward,0,0
85008,improved,0,0
85009,DFS,0,0
85010,for,0,0
85011,AT,0,1
85012,in,0,0
85013,ER/PR-negative,0,0
85014,disease,0,0
85015,.,0,0
85016,Grade,0,0
85017,3,0,0
85018,neutropenia,0,0
85019,associated,0,0
85020,with,0,0
85021,fever,0,0
85022,or,0,1
85023,infection,0,0
85024,occurred,0,0
85025,more,0,0
85026,often,0,0
85027,with,0,0
85028,AT,0,1
85029,(,0,0
85030,26,0,0
85031,%,0,0
85032,v,0,1
85033,10,0,0
85034,%,0,0
85035,;,0,0
85036,P,0,0
85037,<,0,0
85038,.05,0,0
85039,),0,0
85040,.,0,0
85041,CONCLUSION,0,0
85042,AT,1,1
85043,did,0,0
85044,not,0,0
85045,improve,0,0
85046,DFS,0,0
85047,or,0,1
85048,overall,0,0
85049,survival,0,0
85050,in,0,0
85051,this,0,0
85052,population,0,0
85053,",",0,0
85054,and,0,0
85055,was,0,0
85056,associated,0,0
85057,with,0,0
85058,more,0,0
85059,toxicity,0,0
85060,.,0,0
85061,Genetic,1,0
85062,testing,1,0
85063,for,1,0
85064,BRCA1,0,1
85065,:,0,0
85066,effects,0,0
85067,of,0,0
85068,a,0,0
85069,randomised,0,0
85070,study,0,0
85071,of,0,0
85072,knowledge,0,0
85073,provision,0,0
85074,on,0,0
85075,interest,0,0
85076,in,0,0
85077,testing,0,1
85078,and,0,0
85079,long,0,1
85080,term,0,1
85081,test,0,1
85082,uptake,0,0
85083,;,0,0
85084,implications,0,0
85085,for,0,0
85086,the,0,0
85087,NICE,0,0
85088,guidelines,0,0
85089,.,0,0
85090,INTRODUCTION,0,0
85091,Interest,0,0
85092,in,0,0
85093,searching,0,0
85094,for,0,0
85095,mutations,0,0
85096,in,0,0
85097,BRCA1,0,1
85098,and,0,0
85099,BRCA2,0,1
85100,is,0,0
85101,high,0,0
85102,.,0,0
85103,Knowledge,0,0
85104,regarding,0,0
85105,these,0,0
85106,genes,0,0
85107,and,0,0
85108,the,0,0
85109,advantages,0,0
85110,and,0,0
85111,limitations,0,0
85112,of,0,0
85113,genetic,0,0
85114,testing,0,1
85115,is,0,0
85116,limited,0,0
85117,.,0,0
85118,It,0,0
85119,is,0,0
85120,unknown,0,0
85121,whether,0,0
85122,increasing,0,0
85123,knowledge,0,0
85124,about,0,0
85125,breast,0,0
85126,cancer,0,0
85127,genetic,0,0
85128,testing,0,1
85129,alters,0,0
85130,interest,0,0
85131,in,0,0
85132,testing,0,0
85133,.,0,0
85134,METHODS,0,0
85135,Three,0,0
85136,hundred,0,0
85137,and,0,0
85138,seventy,0,0
85139,nine,0,0
85140,women,0,0
85141,(,0,0
85142,260,0,0
85143,with,0,0
85144,a,0,0
85145,family,0,1
85146,history,0,0
85147,of,0,0
85148,breast,0,0
85149,cancer,0,0
85150,;,0,0
85151,119,0,0
85152,with,0,0
85153,breast,0,0
85154,cancer,0,0
85155,),0,0
85156,from,0,0
85157,The,0,0
85158,Royal,0,1
85159,Marsden,0,0
85160,NHS,0,1
85161,Foundation,0,0
85162,Trust,0,0
85163,were,0,0
85164,randomised,0,0
85165,to,0,0
85166,receive,1,0
85167,or,1,1
85168,not,1,0
85169,receive,1,1
85170,written,1,1
85171,educational,1,1
85172,information,1,0
85173,on,0,0
85174,cancer,0,0
85175,genetics,0,0
85176,.,0,0
85177,A,0,0
85178,questionnaire,1,0
85179,was,0,0
85180,completed,0,0
85181,assessing,0,0
85182,interest,0,0
85183,in,0,0
85184,BRCA1,0,1
85185,testing,0,1
85186,and,0,0
85187,knowledge,0,0
85188,on,0,0
85189,breast,0,0
85190,cancer,0,0
85191,genetics,0,0
85192,and,0,0
85193,screening,0,0
85194,.,0,1
85195,Actual,0,0
85196,uptake,0,0
85197,of,0,0
85198,BRCA1,0,1
85199,testing,1,1
85200,is,0,0
85201,reported,0,0
85202,with,0,0
85203,a,0,0
85204,six,0,0
85205,year,0,0
85206,follow-up,0,0
85207,.,0,0
85208,RESULTS,0,0
85209,Eighty,0,0
85210,nine,0,0
85211,percent,0,0
85212,of,0,0
85213,women,0,0
85214,at,0,0
85215,risk,0,0
85216,of,0,0
85217,breast,0,0
85218,cancer,0,0
85219,and,0,0
85220,76,0,0
85221,%,0,0
85222,of,0,0
85223,women,0,0
85224,with,0,0
85225,breast,0,0
85226,cancer,0,0
85227,were,0,0
85228,interested,0,0
85229,in,0,0
85230,BRCA1,0,1
85231,testing,0,1
85232,(,0,0
85233,P,0,0
85234,<,0,0
85235,0.0001,0,0
85236,),0,0
85237,.,0,0
85238,Provision,0,0
85239,of,0,0
85240,educational,0,1
85241,information,0,0
85242,did,0,0
85243,not,0,0
85244,affect,0,0
85245,level,0,0
85246,of,0,0
85247,interest,0,0
85248,.,0,0
85249,Knowledge,0,0
85250,about,0,0
85251,breast,0,0
85252,cancer,0,0
85253,susceptibility,0,0
85254,genes,0,0
85255,was,0,0
85256,poor,0,0
85257,.,0,0
85258,According,0,0
85259,to,0,0
85260,the,0,0
85261,NICE,0,0
85262,guidelines,0,0
85263,regarding,0,0
85264,eligibility,0,0
85265,for,0,0
85266,BRCA1,0,1
85267,and,0,0
85268,BRCA2,0,1
85269,testing,0,1
85270,",",0,0
85271,the,0,0
85272,families,0,0
85273,of,0,0
85274,66,0,0
85275,%,0,0
85276,of,0,0
85277,the,0,0
85278,at,0,0
85279,risk,0,0
85280,group,0,0
85281,and,0,0
85282,13,0,0
85283,%,0,0
85284,of,0,0
85285,the,0,0
85286,women,0,0
85287,with,0,0
85288,breast,0,0
85289,cancer,0,0
85290,would,0,0
85291,be,0,0
85292,eligible,0,0
85293,for,0,0
85294,testing,0,1
85295,(,0,0
85296,probability,0,0
85297,of,0,0
85298,BRCA1,0,1
85299,mutation,0,0
85300,>,0,0
85301,or=20,0,0
85302,%,0,0
85303,),0,0
85304,.,0,0
85305,Within,0,0
85306,six,0,0
85307,years,0,0
85308,of,0,0
85309,randomisation,0,0
85310,",",0,0
85311,genetic,0,0
85312,testing,0,0
85313,was,0,0
85314,actually,0,0
85315,undertaken,0,0
85316,on,0,0
85317,12,0,0
85318,women,0,0
85319,",",0,0
85320,only,0,0
85321,10,0,0
85322,of,0,0
85323,whom,0,0
85324,would,0,0
85325,now,0,0
85326,be,0,0
85327,eligible,0,0
85328,",",0,0
85329,on,0,0
85330,the,0,0
85331,NICE,0,0
85332,guidelines,0,0
85333,.,0,0
85334,CONCLUSIONS,0,0
85335,There,0,0
85336,is,0,0
85337,strong,0,0
85338,interest,0,0
85339,in,0,0
85340,BRCA1,0,1
85341,testing,0,0
85342,.,0,0
85343,Despite,0,0
85344,considerable,0,0
85345,ignorance,0,0
85346,of,0,0
85347,factors,0,0
85348,affecting,0,0
85349,the,0,0
85350,inheritance,0,0
85351,of,0,0
85352,breast,0,0
85353,cancer,0,0
85354,",",0,0
85355,education,0,1
85356,neither,0,0
85357,reduced,0,0
85358,nor,0,0
85359,increased,0,0
85360,interest,0,0
85361,to,0,0
85362,undergo,0,0
85363,testing,0,0
85364,.,0,0
85365,The,0,0
85366,NICE,0,0
85367,guidelines,0,0
85368,successfully,0,0
85369,triage,0,0
85370,those,0,0
85371,with,0,0
85372,a,0,0
85373,high,0,0
85374,breast,0,0
85375,cancer,0,0
85376,risk,0,0
85377,to,0,0
85378,be,0,0
85379,managed,0,0
85380,in,0,0
85381,cancer,0,0
85382,genetics,0,0
85383,clinics,0,0
85384,.,0,0
85385,[,1,0
85386,Intra-uterine,1,0
85387,insemination,1,0
85388,with,1,0
85389,controlled,1,0
85390,ovarian,1,0
85391,hyperstimulation,1,0
85392,compared,1,0
85393,to,1,0
85394,an,1,0
85395,expectant,1,1
85396,management,1,0
85397,in,0,0
85398,couples,0,0
85399,with,0,0
85400,unexplained,0,0
85401,subfertility,0,0
85402,and,0,0
85403,an,0,0
85404,intermediate,0,0
85405,prognosis,0,0
85406,:,0,0
85407,a,0,0
85408,randomised,0,0
85409,study,0,0
85410,],0,0
85411,.,0,0
85412,OBJECTIVE,0,0
85413,Intrauterine,1,1
85414,insemination,1,1
85415,(,1,1
85416,IUI,1,1
85417,),1,1
85418,with,1,0
85419,controlled,1,0
85420,ovarian,1,0
85421,hyperstimulation,1,0
85422,(,1,1
85423,COH,1,0
85424,),1,1
85425,is,0,0
85426,commonly,0,0
85427,used,0,0
85428,as,0,0
85429,treatment,0,0
85430,of,0,0
85431,first,0,0
85432,choice,0,0
85433,in,0,0
85434,couples,0,0
85435,with,0,0
85436,unexplained,0,0
85437,subfertility,0,0
85438,.,0,0
85439,This,0,0
85440,treatment,0,0
85441,should,0,0
85442,only,0,0
85443,be,0,0
85444,applied,0,0
85445,when,0,0
85446,there,0,0
85447,is,0,0
85448,a,0,0
85449,realistic,0,0
85450,increase,0,0
85451,in,0,0
85452,chance,0,0
85453,of,0,0
85454,pregnancy,0,0
85455,",",0,0
85456,particularly,0,0
85457,because,0,0
85458,it,0,0
85459,carries,0,0
85460,the,0,0
85461,increased,0,0
85462,risk,0,0
85463,of,0,0
85464,multiple,0,0
85465,pregnancies,0,0
85466,.,0,0
85467,We,0,0
85468,evaluated,0,0
85469,the,0,0
85470,effectiveness,0,0
85471,of,0,0
85472,IUI,1,1
85473,with,1,0
85474,COH,1,0
85475,relative,0,0
85476,to,0,0
85477,expectant,1,1
85478,management,1,1
85479,in,0,0
85480,couples,0,0
85481,with,0,0
85482,unexplained,0,0
85483,subfertility,0,0
85484,and,0,0
85485,an,0,0
85486,intermediate,0,0
85487,prognosis,0,0
85488,of,0,0
85489,a,0,0
85490,spontaneous,0,0
85491,ongoing,0,0
85492,pregnancy,0,0
85493,.,0,0
85494,DESIGN,0,0
85495,Multicentre,0,0
85496,randomised,0,0
85497,clinical,0,0
85498,study,0,0
85499,.,0,0
85500,METHOD,0,0
85501,253,0,0
85502,couples,0,0
85503,with,0,0
85504,unexplained,0,0
85505,subfertility,0,0
85506,and,0,0
85507,a,0,0
85508,probability,0,0
85509,of,0,0
85510,a,0,0
85511,spontaneous,0,0
85512,ongoing,0,0
85513,pregnancy,0,0
85514,of,0,0
85515,30,0,0
85516,%,0,0
85517,to,0,0
85518,40,0,0
85519,%,0,0
85520,within,0,0
85521,12,0,0
85522,months,0,0
85523,",",0,0
85524,were,0,0
85525,randomly,0,0
85526,assigned,0,0
85527,to,0,0
85528,IUI,1,1
85529,with,1,0
85530,COH,1,0
85531,for,0,0
85532,6,0,0
85533,months,0,0
85534,or,0,0
85535,expectant,1,1
85536,management,1,1
85537,for,0,0
85538,6,0,0
85539,months,0,0
85540,.,0,0
85541,The,0,0
85542,primary,0,0
85543,endpoint,0,0
85544,of,0,0
85545,our,0,0
85546,study,0,0
85547,was,0,0
85548,ongoing,0,0
85549,pregnancy,0,0
85550,within,0,0
85551,6,0,0
85552,months,0,0
85553,.,0,0
85554,Analysis,0,0
85555,was,0,0
85556,carried,0,0
85557,out,0,0
85558,according,0,0
85559,to,0,0
85560,the,0,0
85561,intention,0,0
85562,to,0,0
85563,treat,0,0
85564,principle,0,0
85565,.,0,0
85566,This,0,0
85567,study,0,0
85568,was,0,0
85569,registered,0,0
85570,with,0,0
85571,the,0,0
85572,Dutch,0,1
85573,Trial,0,1
85574,Register,0,1
85575,and,0,0
85576,has,0,0
85577,the,0,0
85578,International,0,0
85579,Standard,0,1
85580,Randomised,0,1
85581,Clinical,0,0
85582,Trial,0,1
85583,number,0,0
85584,ISRCTN72675518,0,1
85585,.,0,0
85586,RESULTS,0,0
85587,Of,0,0
85588,the,0,0
85589,253,0,0
85590,couples,0,0
85591,included,0,0
85592,",",0,0
85593,127,0,0
85594,couples,0,0
85595,were,0,0
85596,allocated,0,0
85597,to,0,0
85598,IUI,1,1
85599,with,1,0
85600,COH,1,0
85601,and,0,0
85602,126,0,0
85603,to,0,0
85604,expectant,1,0
85605,management,1,0
85606,.,1,0
85607,In,0,0
85608,the,0,0
85609,intervention,0,1
85610,group,0,0
85611,",",0,0
85612,42,0,0
85613,women,0,0
85614,(,0,0
85615,33,0,0
85616,%,0,0
85617,),0,0
85618,conceived,0,0
85619,",",0,0
85620,of,0,0
85621,which,0,0
85622,29,0,0
85623,pregnancies,0,0
85624,were,0,0
85625,ongoing,0,0
85626,(,0,0
85627,23,0,0
85628,%,0,0
85629,),0,0
85630,.,0,0
85631,In,0,0
85632,the,0,0
85633,expectant,0,1
85634,management,0,1
85635,group,0,0
85636,",",0,0
85637,40,0,1
85638,women,0,0
85639,(,0,0
85640,32,0,0
85641,%,0,0
85642,),0,0
85643,conceived,0,0
85644,",",0,0
85645,of,0,0
85646,which,0,0
85647,34,0,0
85648,pregnancies,0,0
85649,were,0,0
85650,ongoing,0,0
85651,(,0,0
85652,27,0,0
85653,%,0,0
85654,),0,1
85655,(,0,0
85656,relative,0,0
85657,risk,0,0
85658,:,0,0
85659,0.85,0,0
85660,;,0,0
85661,95,0,0
85662,%,0,0
85663,CI,0,0
85664,:,0,1
85665,0.63-1.1,0,0
85666,),0,0
85667,.,0,0
85668,In,0,0
85669,the,0,0
85670,expectant,1,1
85671,management,1,1
85672,group,0,0
85673,one,0,0
85674,twin,0,0
85675,pregnancy,0,0
85676,occurred,0,0
85677,and,0,0
85678,in,0,0
85679,the,0,0
85680,intervention,0,1
85681,group,0,0
85682,one,0,0
85683,woman,0,0
85684,conceived,0,0
85685,twins,0,0
85686,and,0,0
85687,one,0,0
85688,a,0,0
85689,triplet,0,0
85690,.,0,0
85691,CONCLUSION,0,0
85692,A,0,0
85693,substantial,0,0
85694,beneficial,0,0
85695,effect,0,0
85696,of,0,0
85697,IUI,1,1
85698,with,1,0
85699,COH,1,0
85700,in,0,0
85701,couples,0,0
85702,with,0,0
85703,unexplained,0,0
85704,subfertility,0,0
85705,and,0,0
85706,an,0,0
85707,intermediate,0,0
85708,prognosis,0,0
85709,can,0,0
85710,be,0,0
85711,excluded,0,0
85712,.,0,0
85713,Expectant,0,0
85714,management,0,0
85715,for,0,0
85716,a,0,0
85717,period,0,0
85718,of,0,0
85719,6,0,0
85720,months,0,0
85721,therefore,0,0
85722,appears,0,0
85723,justified,0,0
85724,in,0,0
85725,these,0,0
85726,couples,0,0
85727,.,0,0
85728,Long-term,0,0
85729,follow-up,0,0
85730,of,0,0
85731,a,0,0
85732,phase,0,0
85733,I/II,0,1
85734,randomized,0,0
85735,",",0,0
85736,placebo-controlled,1,1
85737,trial,0,0
85738,of,0,0
85739,palifermin,1,1
85740,to,0,0
85741,prevent,0,0
85742,graft-versus-host,0,0
85743,disease,0,0
85744,(,0,1
85745,GVHD,0,0
85746,),0,1
85747,after,0,0
85748,related,0,0
85749,donor,0,0
85750,allogeneic,0,1
85751,hematopoietic,0,1
85752,cell,0,0
85753,transplantation,0,1
85754,(,0,1
85755,HCT,0,0
85756,),0,0
85757,.,0,0
85758,We,0,0
85759,previously,0,0
85760,conducted,0,0
85761,a,0,0
85762,randomized,0,0
85763,",",0,0
85764,double-blind,0,0
85765,",",0,0
85766,placebo-controlled,1,1
85767,study,0,0
85768,conducted,0,0
85769,from,0,0
85770,2000,0,0
85771,to,0,0
85772,2003,0,0
85773,of,0,0
85774,palifermin,1,1
85775,",",0,0
85776,a,0,0
85777,recombinant,0,1
85778,human,0,1
85779,keratinocyte,0,0
85780,growth,0,0
85781,factor,0,0
85782,",",0,0
85783,dosed,0,0
85784,from,0,0
85785,240,0,0
85786,microg/kg,0,1
85787,to,0,0
85788,720,0,0
85789,microg/kg,0,1
85790,",",0,0
85791,in,0,0
85792,100,0,0
85793,allogeneic,0,1
85794,hematopoietic,0,1
85795,stem,0,1
85796,cell,0,0
85797,transplantation,0,1
85798,(,0,1
85799,HCT,0,0
85800,),0,0
85801,recipients,0,0
85802,.,0,0
85803,Treatment,0,0
85804,with,0,0
85805,palifermin,1,1
85806,showed,0,0
85807,beneficial,0,0
85808,effects,0,0
85809,on,0,0
85810,mucositis,0,0
85811,",",0,0
85812,but,0,0
85813,no,0,0
85814,significant,0,0
85815,effect,0,0
85816,on,0,0
85817,engraftment,0,0
85818,",",0,0
85819,acute,0,0
85820,graft-versus-host,0,0
85821,disease,0,0
85822,(,0,1
85823,GVHD,0,0
85824,),0,1
85825,",",0,0
85826,or,0,1
85827,early,0,0
85828,survival,0,0
85829,.,0,0
85830,In,0,0
85831,addition,0,0
85832,to,0,0
85833,the,0,0
85834,effect,0,0
85835,of,0,0
85836,palifermin,1,1
85837,on,0,0
85838,mucosa,0,0
85839,",",0,0
85840,other,0,0
85841,pleotrophic,0,0
85842,effects,0,0
85843,",",0,0
85844,including,0,0
85845,more,0,0
85846,rapid,0,0
85847,immune,0,0
85848,reconstitution,0,0
85849,",",0,0
85850,have,0,0
85851,been,0,0
85852,seen,0,0
85853,in,0,0
85854,experimental,0,0
85855,transplant,0,0
85856,models,0,0
85857,.,0,0
85858,Therefore,0,0
85859,",",0,0
85860,we,0,0
85861,investigated,0,0
85862,whether,0,0
85863,with,0,0
85864,longer,0,0
85865,follow-up,0,0
85866,we,0,0
85867,could,0,0
85868,detect,0,0
85869,additional,0,0
85870,differences,0,0
85871,between,0,0
85872,the,0,0
85873,palifermin-treated,1,0
85874,and,0,0
85875,placebo,1,1
85876,cohorts,0,0
85877,.,0,0
85878,We,0,0
85879,found,0,0
85880,no,0,0
85881,differences,0,0
85882,in,0,0
85883,CMV,0,1
85884,or,0,1
85885,invasive,0,0
85886,fungal,0,1
85887,infections,0,0
85888,",",0,0
85889,chronic,0,0
85890,GVHD,0,0
85891,",",0,0
85892,or,0,1
85893,long-term,0,0
85894,survival,0,0
85895,between,0,0
85896,cohorts,0,0
85897,.,0,0
85898,We,0,0
85899,conclude,0,0
85900,that,0,0
85901,the,0,0
85902,benefits,0,0
85903,of,0,0
85904,palifermin,1,1
85905,appear,0,0
85906,primarily,0,0
85907,to,0,0
85908,be,0,0
85909,limited,0,0
85910,to,0,0
85911,ameliorating,0,0
85912,mucotoxicity,0,0
85913,when,0,0
85914,given,0,0
85915,to,0,0
85916,allogeneic,0,1
85917,HCT,0,0
85918,recipients,0,0
85919,.,0,0
85920,Short-term,0,1
85921,metabolic,0,0
85922,and,0,0
85923,cardiovascular,0,0
85924,effects,0,0
85925,of,0,0
85926,metformin,1,1
85927,in,0,0
85928,markedly,0,0
85929,obese,0,0
85930,adolescents,0,0
85931,with,0,0
85932,normal,0,0
85933,glucose,0,0
85934,tolerance,0,0
85935,.,0,0
85936,OBJECTIVE,0,0
85937,Although,0,0
85938,metformin,1,1
85939,(,0,1
85940,MET,0,1
85941,),0,1
85942,is,0,0
85943,an,0,0
85944,insulin,0,0
85945,sensitizer,0,1
85946,currently,0,0
85947,used,0,0
85948,as,0,0
85949,an,0,0
85950,adjunct,0,0
85951,to,0,0
85952,the,0,0
85953,treatment,0,0
85954,of,0,0
85955,some,0,0
85956,of,0,0
85957,the,0,0
85958,complications,0,0
85959,of,0,0
85960,childhood,0,0
85961,obesity,0,0
85962,besides,0,0
85963,type,0,0
85964,2,0,0
85965,diabetes,0,0
85966,mellitus,0,0
85967,",",0,0
85968,few,0,0
85969,studies,0,0
85970,have,0,0
85971,comprehensively,0,0
85972,examined,0,0
85973,its,0,0
85974,metabolic,0,0
85975,and,0,0
85976,clinical,0,0
85977,effects,0,0
85978,in,0,0
85979,obese,0,0
85980,children,0,0
85981,with,0,0
85982,normal,0,0
85983,glucose,0,1
85984,tolerance,0,0
85985,(,0,1
85986,NGT,0,1
85987,),0,0
85988,.,0,0
85989,METHODS,0,0
85990,We,0,0
85991,therefore,0,0
85992,conducted,0,0
85993,a,0,0
85994,4-month,0,0
85995,double-blind,0,0
85996,clinical,0,0
85997,trial,0,0
85998,in,0,0
85999,28,0,0
86000,obese,0,0
86001,[,0,0
86002,mean,0,0
86003,body,0,0
86004,mass,0,0
86005,index,0,0
86006,(,0,1
86007,BMI,0,1
86008,),0,1
86009,:,0,0
86010,40.3,0,0
86011,+/-,0,0
86012,5.7,0,0
86013,kg/m,0,0
86014,(,0,0
86015,2,0,0
86016,),0,0
86017,],0,0
86018,",",0,0
86019,insulin-resistant,0,0
86020,[,0,0
86021,homeostasis,0,0
86022,model,0,0
86023,assessment,0,0
86024,-,0,0
86025,insulin,0,1
86026,resistance,0,0
86027,:,0,0
86028,7.6,0,0
86029,+/-,0,0
86030,2.8,0,0
86031,and,0,0
86032,whole,0,1
86033,body,0,0
86034,insulin,0,1
86035,sensitivity,0,0
86036,index,0,0
86037,(,0,1
86038,WBISI,0,1
86039,),0,1
86040,:,0,0
86041,1.5,0,0
86042,+/-,0,0
86043,0.7,0,0
86044,],0,0
86045,adolescents,0,0
86046,(,0,0
86047,age,0,0
86048,15.0,0,0
86049,+/-,0,0
86050,1.3,0,0
86051,yr,0,0
86052,),0,0
86053,randomized,0,0
86054,to,0,0
86055,MET,0,1
86056,(,0,1
86057,n,0,0
86058,=,0,0
86059,15,0,0
86060,",",0,0
86061,dose,0,0
86062,1500,0,0
86063,mg,0,1
86064,daily,0,1
86065,),0,1
86066,or,0,1
86067,placebo,1,1
86068,(,0,1
86069,n,0,0
86070,=,0,0
86071,13,0,0
86072,),0,0
86073,.,0,0
86074,RESULTS,0,0
86075,The,0,0
86076,treatment,0,0
86077,with,0,0
86078,MET,0,1
86079,was,0,0
86080,well,0,0
86081,tolerated,0,0
86082,.,0,0
86083,MET,0,1
86084,treatment,0,0
86085,was,0,0
86086,associated,0,0
86087,with,0,0
86088,a,0,0
86089,decreased,0,0
86090,BMI,0,1
86091,(,0,0
86092,p,0,0
86093,=,0,0
86094,0.02,0,0
86095,),0,0
86096,as,0,0
86097,well,0,0
86098,as,0,0
86099,with,0,0
86100,a,0,0
86101,reduction,0,0
86102,in,0,0
86103,subcutaneous,0,1
86104,fat,0,1
86105,(,0,0
86106,p,0,0
86107,=,0,0
86108,0.03,0,0
86109,),0,0
86110,",",0,0
86111,particularly,0,0
86112,the,0,0
86113,deep,0,1
86114,subcutaneous,0,1
86115,fat,0,1
86116,(,0,0
86117,p,0,0
86118,=,0,0
86119,0.04,0,0
86120,),0,0
86121,as,0,0
86122,assessed,0,0
86123,by,0,0
86124,magnetic,0,1
86125,resonance,0,0
86126,imaging,0,0
86127,.,0,0
86128,Postintervention,0,0
86129,",",0,0
86130,the,0,0
86131,MET,0,1
86132,group,0,0
86133,had,0,0
86134,a,0,0
86135,35,0,0
86136,%,0,0
86137,improvement,0,0
86138,in,0,0
86139,insulin,0,1
86140,sensitivity,0,0
86141,(,0,1
86142,WBISI,0,1
86143,),0,1
86144,compared,0,0
86145,with,0,0
86146,the,0,0
86147,placebo,1,1
86148,group,0,0
86149,(,0,0
86150,p,0,0
86151,=,0,0
86152,0.008,0,0
86153,),0,0
86154,.,0,0
86155,However,0,0
86156,",",0,0
86157,significance,0,0
86158,was,0,0
86159,lost,0,0
86160,with,0,0
86161,adjustments,0,0
86162,for,0,0
86163,differences,0,0
86164,in,0,0
86165,baseline,0,0
86166,insulin,0,1
86167,sensitivity,0,0
86168,(,0,0
86169,p,0,0
86170,=,0,0
86171,0.09,0,0
86172,),0,0
86173,.,0,0
86174,While,0,0
86175,there,0,0
86176,was,0,0
86177,no,0,0
86178,change,0,0
86179,in,0,0
86180,inflammatory,0,0
86181,cytokines,0,1
86182,or,0,0
86183,lipid,0,0
86184,parameters,0,0
86185,",",0,0
86186,cardiovascular,0,0
86187,function,0,0
86188,as,0,0
86189,assessed,0,0
86190,by,0,0
86191,heart,0,0
86192,rate,0,0
86193,recovery,0,0
86194,after,0,0
86195,exercise,0,1
86196,improved,0,0
86197,with,0,0
86198,MET,0,1
86199,and,0,0
86200,worsened,0,0
86201,in,0,0
86202,placebo,0,1
86203,(,0,0
86204,p,0,0
86205,=,0,0
86206,0.03,0,0
86207,),0,0
86208,.,0,0
86209,CONCLUSION,0,0
86210,Short-term,0,0
86211,use,0,0
86212,of,0,0
86213,MET,0,1
86214,is,0,0
86215,well,0,0
86216,tolerated,0,0
86217,by,0,0
86218,obese,0,0
86219,children,0,0
86220,with,0,0
86221,NGT,0,0
86222,and,0,0
86223,has,0,0
86224,a,0,0
86225,beneficial,0,0
86226,effect,0,0
86227,on,0,0
86228,BMI,0,1
86229,and,0,0
86230,autonomic,0,0
86231,control,0,1
86232,of,0,0
86233,the,0,0
86234,heart,0,0
86235,as,0,0
86236,well,0,0
86237,as,0,0
86238,a,0,0
86239,trend,0,0
86240,toward,0,0
86241,improved,0,0
86242,insulin,0,1
86243,sensitivity,0,0
86244,.,0,0
86245,Thus,0,0
86246,",",0,0
86247,long-term,0,0
86248,treatment,0,0
86249,with,0,0
86250,MET,0,1
86251,may,0,0
86252,provide,0,0
86253,a,0,0
86254,means,0,0
86255,to,0,0
86256,ameliorate,0,0
86257,the,0,0
86258,cardio-metabolic,0,0
86259,consequences,0,0
86260,of,0,0
86261,adolescent,0,0
86262,obesity,0,0
86263,.,0,0
86264,Efficacy,0,0
86265,of,0,0
86266,topical,0,1
86267,azithromycin,1,1
86268,ophthalmic,0,1
86269,solution,0,1
86270,1,0,0
86271,%,0,0
86272,in,0,0
86273,the,0,0
86274,treatment,0,0
86275,of,0,0
86276,posterior,0,0
86277,blepharitis,0,0
86278,.,0,0
86279,INTRODUCTION,0,0
86280,Azithromycin,1,1
86281,",",0,0
86282,a,0,0
86283,broad-spectrum,0,1
86284,antibiotic,0,1
86285,with,0,0
86286,potent,0,0
86287,anti-inflammatory,0,1
86288,activities,0,0
86289,",",0,0
86290,has,0,0
86291,the,0,0
86292,potential,0,0
86293,to,0,0
86294,effectively,0,0
86295,treat,0,0
86296,blepharitis,0,0
86297,",",0,0
86298,an,0,0
86299,inflammatory,0,0
86300,disease,0,0
86301,of,0,0
86302,the,0,0
86303,eyelid,0,0
86304,with,0,0
86305,abnormal,0,0
86306,eyelid,0,1
86307,flora,0,0
86308,as,0,0
86309,an,0,0
86310,etiologic,0,0
86311,determinant,0,0
86312,.,0,0
86313,The,0,0
86314,present,0,0
86315,study,0,0
86316,compared,0,0
86317,the,0,0
86318,efficacy,0,0
86319,of,0,0
86320,topical,0,1
86321,azithromycin,1,1
86322,ophthalmic,0,1
86323,solution,0,1
86324,1,0,1
86325,%,0,0
86326,(,0,0
86327,AzaSite,0,1
86328,;,0,0
86329,Inspire,0,0
86330,Pharmaceuticals,0,1
86331,",",0,0
86332,Inc,0,0
86333,",",0,0
86334,NC,0,1
86335,",",0,0
86336,USA,0,1
86337,),0,0
86338,combined,0,1
86339,with,0,0
86340,warm,0,1
86341,compresses,0,1
86342,(,0,0
86343,azithromycin,0,1
86344,group,0,1
86345,),0,0
86346,to,0,0
86347,warm,0,0
86348,compresses,0,1
86349,alone,0,1
86350,(,0,0
86351,compress,0,1
86352,group,0,1
86353,),0,0
86354,in,0,0
86355,patients,0,0
86356,with,0,0
86357,posterior,0,0
86358,blepharitis,0,0
86359,.,0,0
86360,METHODS,0,0
86361,Twenty-one,0,0
86362,patients,0,0
86363,diagnosed,0,0
86364,with,0,0
86365,posterior,0,0
86366,blepharitis,0,0
86367,were,0,0
86368,randomized,0,0
86369,in,0,0
86370,an,0,0
86371,open-label,0,0
86372,study,0,0
86373,to,0,0
86374,receive,0,0
86375,either,0,1
86376,azithromycin,1,1
86377,plus,1,1
86378,warm,1,1
86379,compresses,1,1
86380,(,0,0
86381,10,0,0
86382,patients,0,0
86383,),0,0
86384,",",0,0
86385,or,0,1
86386,compresses,0,1
86387,alone,0,1
86388,(,0,0
86389,11,0,0
86390,patients,0,0
86391,),0,0
86392,.,0,0
86393,All,0,0
86394,patients,0,0
86395,were,0,0
86396,instructed,0,0
86397,to,0,0
86398,apply,0,0
86399,compresses,0,1
86400,to,0,0
86401,each,0,0
86402,eye,0,0
86403,for,0,0
86404,5-10,0,0
86405,minutes,0,0
86406,twice,0,0
86407,daily,0,0
86408,for,0,0
86409,14,0,0
86410,days,0,0
86411,.,0,0
86412,Each,0,0
86413,eye,0,0
86414,in,0,0
86415,the,0,0
86416,azithromycin,1,1
86417,group,0,0
86418,also,0,0
86419,received,0,0
86420,azithromycin,0,1
86421,solution,0,1
86422,(,0,0
86423,1,0,1
86424,drop,0,0
86425,),0,0
86426,twice,0,1
86427,daily,0,1
86428,for,0,0
86429,the,0,0
86430,first,0,0
86431,2,0,0
86432,days,0,0
86433,followed,0,0
86434,by,0,0
86435,once,0,0
86436,daily,0,0
86437,for,0,0
86438,the,0,0
86439,next,0,0
86440,12,0,0
86441,days,0,0
86442,.,0,0
86443,Patients,0,0
86444,were,0,0
86445,evaluated,0,0
86446,at,0,0
86447,study,0,0
86448,initiation,0,1
86449,(,0,0
86450,visit,0,0
86451,1,0,0
86452,),0,0
86453,and,0,0
86454,at,0,0
86455,end,0,0
86456,of,0,0
86457,treatment,0,0
86458,(,0,0
86459,visit,0,0
86460,2,0,0
86461,),0,0
86462,for,0,0
86463,the,0,0
86464,severity,0,0
86465,of,0,0
86466,five,0,0
86467,clinical,0,0
86468,signs,0,0
86469,:,0,0
86470,eyelid,0,0
86471,debris,0,0
86472,",",0,0
86473,eyelid,0,1
86474,redness,0,0
86475,",",0,0
86476,eyelid,0,1
86477,swelling,0,0
86478,",",0,0
86479,meibomian,0,1
86480,gland,0,0
86481,(,0,1
86482,MG,0,1
86483,),0,1
86484,plugging,0,0
86485,",",0,0
86486,and,0,0
86487,the,0,0
86488,quality,0,0
86489,of,0,0
86490,MG,0,1
86491,secretion,0,0
86492,.,0,0
86493,At,0,0
86494,visit,0,0
86495,2,0,0
86496,",",0,0
86497,patients,0,0
86498,also,0,0
86499,rated,0,0
86500,their,0,0
86501,degree,0,0
86502,of,0,0
86503,overall,0,0
86504,symptomatic,0,0
86505,relief,0,0
86506,.,0,0
86507,RESULTS,0,0
86508,Twenty,0,0
86509,patients,0,0
86510,completed,0,0
86511,the,0,0
86512,study,0,0
86513,.,0,0
86514,At,0,0
86515,visit,0,0
86516,2,0,0
86517,",",0,0
86518,patients,0,0
86519,in,0,0
86520,the,0,0
86521,azithromycin,1,1
86522,group,0,0
86523,demonstrated,0,0
86524,significant,0,0
86525,improvements,0,0
86526,in,0,0
86527,MG,0,1
86528,plugging,0,0
86529,",",0,0
86530,MG,0,1
86531,secretions,0,0
86532,",",0,0
86533,and,0,0
86534,eyelid,0,1
86535,redness,0,0
86536,as,0,0
86537,compared,0,0
86538,with,0,0
86539,the,0,0
86540,compress,0,1
86541,group,0,0
86542,.,0,0
86543,In,0,0
86544,the,0,0
86545,azithromycin,1,1
86546,group,0,0
86547,",",0,0
86548,MG,0,1
86549,plugging,0,0
86550,resolved,0,0
86551,completely,0,0
86552,in,0,0
86553,three,0,0
86554,patients,0,0
86555,and,0,0
86556,MG,0,1
86557,secretion,0,0
86558,returned,0,0
86559,to,0,0
86560,normal,0,0
86561,in,0,0
86562,two,0,0
86563,patients,0,0
86564,;,0,0
86565,no,0,0
86566,such,0,0
86567,results,0,0
86568,were,0,0
86569,seen,0,0
86570,in,0,0
86571,the,0,0
86572,compress,0,1
86573,group,0,0
86574,.,0,0
86575,Furthermore,0,0
86576,",",0,0
86577,a,0,0
86578,higher,0,0
86579,percentage,0,0
86580,of,0,0
86581,patients,0,0
86582,in,0,0
86583,the,0,0
86584,azithromycin,0,1
86585,group,0,0
86586,rated,0,0
86587,overall,0,0
86588,symptomatic,0,0
86589,relief,0,0
86590,as,0,0
86591,excellent,0,0
86592,or,0,1
86593,good,0,0
86594,.,0,0
86595,Visual,0,0
86596,acuity,0,0
86597,measurements,0,1
86598,and,0,0
86599,biomicroscopic,0,0
86600,evaluation,0,0
86601,revealed,0,0
86602,no,0,0
86603,ocular,0,0
86604,safety,0,0
86605,issues,0,0
86606,.,0,0
86607,CONCLUSION,0,0
86608,Azithromycin,1,1
86609,ophthalmic,0,1
86610,solution,0,1
86611,in,0,0
86612,combination,0,1
86613,with,0,0
86614,warm,0,0
86615,compresses,0,1
86616,provided,0,0
86617,a,0,0
86618,significantly,0,0
86619,greater,0,0
86620,clinical,0,0
86621,benefit,0,0
86622,than,0,0
86623,warm,0,0
86624,compresses,0,1
86625,alone,0,1
86626,in,0,0
86627,treating,0,0
86628,the,0,0
86629,signs,0,0
86630,and,0,0
86631,symptoms,0,0
86632,of,0,0
86633,posterior,0,0
86634,blepharitis,0,0
86635,.,0,0
86636,A,0,0
86637,randomized,0,0
86638,trial,0,0
86639,of,0,0
86640,etoposide,0,1
86641,and,0,0
86642,G-CSF,0,1
86643,with,0,0
86644,or,0,1
86645,without,0,1
86646,rituximab,1,1
86647,for,0,0
86648,PBSC,0,1
86649,mobilization,0,0
86650,in,0,0
86651,B-cell,0,0
86652,non-Hodgkin,0,0
86653,'s,0,0
86654,lymphoma,0,0
86655,.,0,0
86656,Some,0,0
86657,reports,0,0
86658,have,0,0
86659,suggested,0,0
86660,that,0,0
86661,rituximab,0,1
86662,administration,0,0
86663,before,0,0
86664,PBSC,0,1
86665,mobilization,0,0
86666,may,0,0
86667,adversely,0,0
86668,affect,0,0
86669,PBSC,0,1
86670,yield,0,0
86671,.,0,0
86672,We,0,0
86673,conducted,0,0
86674,a,0,0
86675,prospective,0,0
86676,randomized,0,0
86677,trial,0,0
86678,of,0,0
86679,PBSC,0,1
86680,mobilization,0,1
86681,using,0,0
86682,etoposide,1,1
86683,and,1,0
86684,G-CSF,1,1
86685,with,1,0
86686,or,1,1
86687,without,1,1
86688,rituximab,1,1
86689,to,0,0
86690,determine,0,0
86691,whether,0,0
86692,its,0,0
86693,addition,0,0
86694,would,0,0
86695,adversely,0,0
86696,affect,0,0
86697,CD34+,0,1
86698,cell,0,0
86699,yield,0,0
86700,in,0,0
86701,patients,0,0
86702,with,0,0
86703,non-Hodgkin,0,0
86704,'s,0,0
86705,lymphoma,0,0
86706,.,0,0
86707,Twenty,0,0
86708,seven,0,0
86709,patients,0,0
86710,were,0,0
86711,mobilized,0,0
86712,with,0,0
86713,etoposide,1,1
86714,and,0,0
86715,G-CSF,0,1
86716,and,0,0
86717,28,0,0
86718,with,0,0
86719,etoposide,1,1
86720,",",1,0
86721,G-CSF,1,1
86722,and,1,0
86723,rituximab,1,1
86724,.,1,0
86725,There,0,0
86726,were,0,0
86727,no,0,0
86728,adverse,0,0
86729,consequences,0,0
86730,of,0,0
86731,rituximab,0,1
86732,on,0,0
86733,CD34+,0,1
86734,cell,0,0
86735,yield,0,0
86736,",",0,0
86737,or,0,1
86738,hematopoietic,0,1
86739,recovery,0,0
86740,or,0,1
86741,immunoglobulin,0,1
86742,levels,0,0
86743,after,0,0
86744,transplantation,0,0
86745,.,0,0
86746,CASTLE,1,1
86747,data,1,0
86748,show,0,0
86749,no,0,0
86750,gender,0,0
86751,differences,0,0
86752,.,0,0
86753,Endobronchial,0,0
86754,ultrasonography-guided,0,1
86755,transbronchial,1,1
86756,needle,1,1
86757,aspiration,1,1
86758,increases,0,0
86759,the,0,0
86760,diagnostic,0,0
86761,yield,0,0
86762,of,0,0
86763,peripheral,0,0
86764,pulmonary,0,0
86765,lesions,0,0
86766,:,0,0
86767,a,0,0
86768,randomized,0,0
86769,trial,0,0
86770,.,0,0
86771,BACKGROUND,0,0
86772,The,0,0
86773,diagnostic,0,0
86774,yield,0,0
86775,of,0,0
86776,endobronchial,1,0
86777,ultrasonography,1,1
86778,(,1,1
86779,EBUS,1,0
86780,),1,1
86781,-guided,1,1
86782,transbronchial,1,1
86783,needle,1,1
86784,aspiration,1,1
86785,(,1,1
86786,TBNA,1,1
86787,),1,1
86788,for,0,0
86789,peripheral,0,0
86790,pulmonary,0,0
86791,lesions,0,0
86792,(,0,0
86793,PPLs,0,1
86794,),0,1
86795,has,0,0
86796,not,0,0
86797,been,0,0
86798,evaluated,0,0
86799,.,0,0
86800,The,0,0
86801,diagnostic,0,0
86802,impact,0,0
86803,of,0,0
86804,TBNA,0,0
86805,when,0,0
86806,the,0,0
86807,EBUS,0,0
86808,probe,0,1
86809,is,0,0
86810,adjacent,0,0
86811,to,0,0
86812,lesions,0,0
86813,remains,0,0
86814,to,0,0
86815,be,0,0
86816,determined,0,0
86817,.,0,0
86818,DESIGN,0,0
86819,A,0,0
86820,prospective,0,0
86821,",",0,0
86822,randomized,0,0
86823,trial,0,0
86824,.,0,0
86825,METHODS,0,0
86826,Two,0,0
86827,hundred,0,0
86828,two,0,0
86829,patients,0,0
86830,with,0,0
86831,PPLs,0,1
86832,and,0,0
86833,positive,0,0
86834,EBUS,0,0
86835,findings,0,0
86836,were,0,0
86837,enrolled,0,0
86838,.,0,0
86839,They,0,0
86840,were,0,0
86841,randomly,0,0
86842,classified,0,0
86843,into,0,0
86844,two,0,0
86845,groups,0,0
86846,.,0,0
86847,In,0,0
86848,the,0,0
86849,EBUS,0,0
86850,conventional,0,1
86851,diagnostic,0,0
86852,procedures,0,1
86853,(,0,0
86854,CDPs,0,1
86855,),0,1
86856,group,0,0
86857,(,0,0
86858,103,0,0
86859,patients,0,0
86860,),0,0
86861,",",0,0
86862,both,0,0
86863,transbronchial,1,1
86864,biopsy,1,1
86865,(,0,1
86866,TBB,0,1
86867,),0,1
86868,and,0,0
86869,bronchial,0,0
86870,washing,0,1
86871,(,0,1
86872,BW,0,1
86873,),0,1
86874,were,0,0
86875,performed,0,0
86876,.,0,0
86877,In,0,0
86878,the,0,0
86879,EBUS-TBNA,0,0
86880,plus,0,1
86881,CDPs,0,1
86882,group,0,1
86883,(,0,0
86884,99,0,0
86885,patients,0,0
86886,),0,0
86887,",",0,0
86888,TBNA,0,0
86889,",",0,0
86890,TBB,0,1
86891,",",0,0
86892,and,0,0
86893,BW,0,1
86894,were,0,0
86895,performed,0,0
86896,.,0,0
86897,The,0,0
86898,diagnostic,0,0
86899,yield,0,0
86900,in,0,0
86901,each,0,0
86902,group,0,0
86903,was,0,0
86904,compared,0,0
86905,.,0,0
86906,RESULTS,0,0
86907,A,0,0
86908,total,0,0
86909,of,0,0
86910,182,0,0
86911,patients,0,0
86912,(,0,0
86913,94,0,0
86914,in,0,0
86915,the,0,0
86916,EBUS,0,0
86917,CDPs,0,1
86918,group,0,0
86919,and,0,0
86920,88,0,0
86921,in,0,0
86922,the,0,0
86923,EBUS-TBNA,0,0
86924,plus,0,1
86925,CDPs,0,1
86926,group,0,1
86927,),0,0
86928,were,0,0
86929,analyzed,0,0
86930,.,0,0
86931,The,0,0
86932,yield,0,0
86933,in,0,0
86934,the,0,0
86935,EBUS-TBNA,0,0
86936,plus,0,1
86937,CDPs,0,1
86938,group,0,1
86939,(,0,0
86940,78.4,0,0
86941,%,0,0
86942,),0,0
86943,was,0,0
86944,significantly,0,0
86945,higher,0,0
86946,than,0,0
86947,the,0,0
86948,EBUS,0,0
86949,CDPs,0,1
86950,group,0,1
86951,(,0,0
86952,60.6,0,0
86953,%,0,0
86954,",",0,0
86955,p,0,0
86956,=,0,0
86957,0.015,0,0
86958,),0,0
86959,.,0,0
86960,Cases,0,0
86961,in,0,0
86962,which,0,0
86963,the,0,0
86964,EBUS,0,0
86965,probe,0,1
86966,was,0,0
86967,located,0,0
86968,within,0,0
86969,the,0,0
86970,lesions,0,0
86971,had,0,0
86972,a,0,0
86973,significantly,0,0
86974,higher,0,0
86975,diagnostic,0,0
86976,yield,0,0
86977,(,0,0
86978,78.3,0,0
86979,%,0,0
86980,),0,0
86981,than,0,0
86982,when,0,0
86983,the,0,0
86984,EBUS,0,0
86985,probe,0,1
86986,was,0,0
86987,adjacent,0,0
86988,to,0,0
86989,them,0,0
86990,(,0,0
86991,47.2,0,0
86992,%,0,0
86993,",",0,0
86994,p,0,0
86995,<,0,0
86996,0.001,0,0
86997,),0,0
86998,.,0,0
86999,Concerning,0,0
87000,the,0,0
87001,three,0,0
87002,different,0,0
87003,techniques,0,1
87004,",",0,0
87005,TBNA,0,0
87006,showed,0,0
87007,the,0,0
87008,highest,0,0
87009,diagnostic,0,0
87010,yield,0,0
87011,(,0,0
87012,62.5,0,0
87013,%,0,0
87014,),0,0
87015,in,0,0
87016,comparison,0,0
87017,to,0,0
87018,TBB,0,1
87019,(,0,1
87020,48.9,0,0
87021,%,0,0
87022,),0,0
87023,and,0,0
87024,to,0,0
87025,BW,0,1
87026,(,0,1
87027,19.8,0,0
87028,%,0,0
87029,),0,0
87030,.,0,0
87031,The,0,0
87032,diagnostic,0,0
87033,yield,0,0
87034,of,0,0
87035,TBNA,0,0
87036,remained,0,0
87037,unchanged,0,0
87038,even,0,0
87039,when,0,0
87040,the,0,0
87041,EBUS,0,0
87042,probe,0,1
87043,was,0,0
87044,adjacent,0,0
87045,to,0,0
87046,the,0,0
87047,lesions,0,0
87048,(,0,0
87049,p,0,0
87050,=,0,0
87051,0.89,0,0
87052,),0,0
87053,.,0,0
87054,No,0,0
87055,additional,0,0
87056,adverse,0,0
87057,effects,0,0
87058,were,0,0
87059,observed,0,0
87060,in,0,0
87061,the,0,0
87062,EBUS-TBNA,0,0
87063,plus,0,1
87064,CDPs,0,1
87065,group,0,0
87066,.,0,0
87067,CONCLUSIONS,0,0
87068,Applying,0,0
87069,TBNA,0,1
87070,to,0,0
87071,EBUS-guided,0,1
87072,CDPs,0,1
87073,further,0,0
87074,increased,0,0
87075,the,0,0
87076,diagnostic,0,0
87077,yield,0,0
87078,of,0,0
87079,PPLs,0,1
87080,without,0,1
87081,additional,0,0
87082,risk,0,0
87083,.,0,0
87084,The,0,0
87085,diagnostic,0,0
87086,advantage,0,0
87087,of,0,0
87088,TBNA,0,0
87089,became,0,0
87090,more,0,0
87091,obvious,0,0
87092,if,0,0
87093,the,0,0
87094,EBUS,0,0
87095,probe,0,1
87096,was,0,0
87097,adjacent,0,0
87098,to,0,0
87099,the,0,0
87100,lesions,0,0
87101,.,0,0
87102,TRIAL,0,0
87103,REGISTRATION,0,0
87104,Clinicaltrials.gov,0,0
87105,Identifier,0,0
87106,:,0,0
87107,NCT00626587,0,0
87108,.,0,0
87109,Safety,0,1
87110,of,0,0
87111,ferumoxytol,1,1
87112,in,0,0
87113,patients,0,0
87114,with,0,0
87115,anemia,0,0
87116,and,0,0
87117,CKD,0,1
87118,.,0,0
87119,BACKGROUND,0,0
87120,Iron,0,1
87121,deficiency,0,0
87122,anemia,0,0
87123,is,0,0
87124,a,0,0
87125,common,0,0
87126,complication,0,0
87127,in,0,0
87128,patients,0,0
87129,with,0,0
87130,chronic,0,0
87131,kidney,0,1
87132,disease,0,0
87133,(,0,1
87134,CKD,0,1
87135,),0,0
87136,.,0,0
87137,Currently,0,0
87138,available,0,0
87139,intravenous,0,1
87140,(,0,1
87141,IV,0,0
87142,),0,1
87143,iron,1,1
87144,replacement,1,1
87145,therapies,1,1
87146,have,0,0
87147,either,0,0
87148,inconvenient,0,0
87149,regimens,0,1
87150,of,0,0
87151,administration,0,0
87152,or,0,1
87153,adverse,0,0
87154,event,0,0
87155,profiles,0,0
87156,that,0,0
87157,limit,0,0
87158,their,0,0
87159,utility,0,0
87160,in,0,0
87161,the,0,0
87162,outpatient,0,0
87163,setting,0,0
87164,.,0,0
87165,Ferumoxytol,1,1
87166,is,0,0
87167,a,0,0
87168,novel,0,0
87169,",",0,0
87170,semisynthetic,0,1
87171,",",0,0
87172,carbohydrate-coated,0,1
87173,",",0,0
87174,superparamagnetic,0,1
87175,iron,0,1
87176,oxide,0,1
87177,nanoparticle,0,1
87178,that,0,0
87179,is,0,0
87180,administered,0,0
87181,IV,0,0
87182,as,0,0
87183,an,0,0
87184,injection,0,1
87185,.,0,0
87186,The,0,0
87187,main,0,0
87188,objective,0,0
87189,of,0,0
87190,this,0,0
87191,study,0,0
87192,was,0,0
87193,to,0,0
87194,assess,0,0
87195,the,0,0
87196,safety,0,0
87197,of,0,0
87198,ferumoxytol,1,1
87199,for,0,0
87200,the,0,0
87201,treatment,0,0
87202,of,0,0
87203,patients,0,0
87204,with,0,0
87205,CKD,0,1
87206,stages,0,0
87207,1,0,0
87208,to,0,0
87209,5,0,0
87210,and,0,0
87211,5D,0,1
87212,.,0,0
87213,STUDY,0,0
87214,DESIGN,0,0
87215,Phase,0,0
87216,3,0,0
87217,",",0,0
87218,randomized,0,0
87219,",",0,0
87220,double-blind,0,0
87221,",",0,0
87222,placebo-controlled,1,1
87223,",",0,0
87224,crossover,0,0
87225,",",0,0
87226,multicenter,0,0
87227,study,0,0
87228,of,0,0
87229,a,0,0
87230,single,0,0
87231,510-mg,0,1
87232,dose,0,0
87233,of,0,0
87234,ferumoxytol,1,1
87235,versus,1,1
87236,saline,1,1
87237,as,1,0
87238,placebo,1,1
87239,.,1,0
87240,SETTING,0,0
87241,&,0,0
87242,PARTICIPANTS,0,0
87243,750,0,1
87244,patients,0,0
87245,with,0,0
87246,CKD,0,1
87247,stages,0,0
87248,1,0,0
87249,to,0,0
87250,5,0,0
87251,and,0,0
87252,5D,0,1
87253,.,0,0
87254,INTERVENTION,0,0
87255,An,0,0
87256,IV,1,0
87257,injection,1,1
87258,of,0,0
87259,either,0,0
87260,17,0,0
87261,mL,0,1
87262,of,0,0
87263,ferumoxytol,1,1
87264,or,1,1
87265,saline,1,1
87266,placebo,1,1
87267,over,0,0
87268,17,0,0
87269,seconds,0,0
87270,on,0,0
87271,day,0,0
87272,0,0,0
87273,and,0,0
87274,the,0,0
87275,alternate,0,1
87276,agent,0,0
87277,on,0,0
87278,day,0,0
87279,7,0,0
87280,.,0,0
87281,OUTCOMES,0,0
87282,&,0,0
87283,MEASUREMENTS,0,0
87284,Descriptive,0,1
87285,comparison,0,0
87286,of,0,0
87287,adverse,0,0
87288,events,0,0
87289,",",0,0
87290,laboratory,0,0
87291,tests,0,0
87292,",",0,0
87293,and,0,0
87294,vital,0,0
87295,signs,0,0
87296,.,0,0
87297,RESULTS,0,0
87298,Of,0,0
87299,750,0,1
87300,randomly,0,0
87301,assigned,0,0
87302,patients,0,0
87303,with,0,0
87304,CKD,0,1
87305,",",0,0
87306,60,0,0
87307,%,0,0
87308,were,0,0
87309,not,0,0
87310,on,0,0
87311,dialysis,1,1
87312,therapy,1,1
87313,.,1,0
87314,713,0,0
87315,patients,0,0
87316,received,0,0
87317,ferumoxytol,1,1
87318,",",0,0
87319,and,0,0
87320,711,0,0
87321,received,0,0
87322,placebo,1,1
87323,.,1,0
87324,There,0,0
87325,were,0,0
87326,420,0,0
87327,adverse,0,0
87328,events,0,0
87329,reported,0,0
87330,;,0,0
87331,242,0,0
87332,in,0,0
87333,152,0,0
87334,patients,0,0
87335,(,0,0
87336,21.3,0,0
87337,%,0,0
87338,),0,0
87339,with,0,0
87340,ferumoxytol,0,1
87341,and,0,0
87342,178,0,0
87343,in,0,0
87344,119,0,0
87345,patients,0,0
87346,(,0,0
87347,16.7,0,0
87348,%,0,0
87349,),0,0
87350,with,0,0
87351,placebo,1,1
87352,.,1,0
87353,The,0,0
87354,incidence,0,0
87355,of,0,0
87356,related,0,0
87357,adverse,0,0
87358,events,0,0
87359,was,0,0
87360,5.2,0,0
87361,%,0,0
87362,with,0,0
87363,ferumoxytol,1,1
87364,and,0,0
87365,4.5,0,0
87366,%,0,0
87367,with,0,0
87368,placebo,1,1
87369,.,1,0
87370,The,0,0
87371,most,0,0
87372,common,0,0
87373,related,0,0
87374,adverse,0,0
87375,events,0,0
87376,after,0,0
87377,each,0,0
87378,treatment,0,0
87379,included,0,0
87380,symptoms,0,0
87381,related,0,0
87382,to,0,0
87383,the,0,0
87384,injection/infusion,0,1
87385,site,0,0
87386,",",0,0
87387,dizziness,0,0
87388,",",0,0
87389,pruritus,0,0
87390,",",0,0
87391,headache,0,0
87392,",",0,0
87393,fatigue,0,0
87394,",",0,0
87395,and,0,0
87396,nausea,0,0
87397,.,0,0
87398,Serious,0,0
87399,adverse,0,0
87400,events,0,0
87401,occurred,0,0
87402,in,0,0
87403,21,0,0
87404,patients,0,0
87405,(,0,0
87406,2.9,0,0
87407,%,0,0
87408,),0,0
87409,after,0,0
87410,ferumoxytol,1,1
87411,and,0,0
87412,13,0,0
87413,patients,0,0
87414,(,0,0
87415,1.8,0,0
87416,%,0,0
87417,),0,0
87418,after,0,0
87419,placebo,1,1
87420,.,1,0
87421,Serious,0,0
87422,related,0,0
87423,adverse,0,0
87424,events,0,0
87425,were,0,0
87426,observed,0,0
87427,in,0,0
87428,1,0,0
87429,patient,0,0
87430,(,0,0
87431,0.1,0,1
87432,%,0,0
87433,),0,0
87434,after,0,0
87435,each,0,0
87436,treatment,0,0
87437,.,0,0
87438,There,0,0
87439,was,0,0
87440,no,0,0
87441,meaningful,0,0
87442,decrease,0,0
87443,in,0,0
87444,blood,0,0
87445,pressure,0,0
87446,after,0,0
87447,administration,0,0
87448,of,0,0
87449,ferumoxytol,1,1
87450,or,1,1
87451,placebo,1,1
87452,.,1,0
87453,LIMITATIONS,0,0
87454,Follow-up,0,0
87455,was,0,0
87456,7,0,0
87457,days,0,0
87458,after,0,0
87459,each,0,0
87460,study,0,0
87461,treatment,0,0
87462,.,0,0
87463,CONCLUSIONS,0,0
87464,Ferumoxytol,1,1
87465,is,0,0
87466,well,0,0
87467,tolerated,0,0
87468,and,0,0
87469,has,0,0
87470,a,0,0
87471,safety,0,0
87472,profile,0,0
87473,similar,0,0
87474,to,0,0
87475,placebo,1,1
87476,in,0,0
87477,anemic,0,0
87478,patients,0,0
87479,with,0,0
87480,CKD,0,1
87481,stages,0,0
87482,1,0,0
87483,to,0,0
87484,5,0,0
87485,and,0,0
87486,5D,0,0
87487,.,0,0
87488,Identifying,0,0
87489,patients,0,0
87490,at,0,0
87491,high,0,0
87492,risk,0,0
87493,for,0,0
87494,neutropenic,0,0
87495,complications,0,0
87496,during,0,0
87497,chemotherapy,1,1
87498,for,0,0
87499,metastatic,0,0
87500,breast,0,0
87501,cancer,0,0
87502,with,0,0
87503,doxorubicin,1,1
87504,or,1,1
87505,pegylated,1,1
87506,liposomal,1,1
87507,doxorubicin,1,1
87508,:,1,0
87509,the,0,0
87510,development,0,0
87511,of,0,0
87512,a,0,0
87513,prediction,0,0
87514,model,0,0
87515,.,0,0
87516,OBJECTIVE,0,0
87517,To,0,0
87518,develop,0,0
87519,a,0,0
87520,cycle-based,0,0
87521,risk,0,0
87522,prediction,0,0
87523,model,0,0
87524,for,0,0
87525,neutropenic,0,0
87526,complications,0,0
87527,(,0,0
87528,NC,0,1
87529,),0,1
87530,during,0,0
87531,chemotherapy,1,1
87532,with,0,1
87533,doxorubicin,1,1
87534,(,1,1
87535,DOX,1,1
87536,),1,1
87537,or,1,1
87538,a,1,0
87539,pegylated,1,1
87540,liposomal,1,1
87541,formulation,1,1
87542,(,1,1
87543,PLD,1,1
87544,),1,1
87545,for,0,0
87546,patients,0,0
87547,with,0,0
87548,metastatic,0,0
87549,breast,0,0
87550,cancer,0,0
87551,(,0,1
87552,MBC,0,0
87553,),0,0
87554,.,0,0
87555,METHODS,0,0
87556,Data,0,0
87557,analyzed,0,0
87558,was,0,0
87559,from,0,0
87560,a,0,0
87561,phase,0,0
87562,III,0,0
87563,",",0,0
87564,randomized,0,0
87565,clinical,0,0
87566,trial,0,0
87567,of,0,0
87568,DOX,1,1
87569,(,0,0
87570,60,0,0
87571,mg/m,0,1
87572,(,0,0
87573,2,0,0
87574,),0,0
87575,every,0,0
87576,3,0,0
87577,weeks,0,0
87578,),0,0
87579,or,0,1
87580,PLD,1,1
87581,(,0,1
87582,50,0,1
87583,mg/m,0,1
87584,(,0,0
87585,2,0,0
87586,),0,0
87587,every,0,0
87588,4,0,0
87589,weeks,0,0
87590,),0,0
87591,for,0,0
87592,the,0,0
87593,first,0,0
87594,line,0,0
87595,therapy,0,1
87596,for,0,0
87597,MBC,0,0
87598,(,0,0
87599,n,0,0
87600,=,0,0
87601,509,0,0
87602,),0,0
87603,(,0,0
87604,O'Brien,0,1
87605,et,0,0
87606,al,0,0
87607,",",0,0
87608,Ann,0,1
87609,Oncol,0,0
87610,.,0,0
87611,2004,0,0
87612,;,0,0
87613,15:440-449,0,0
87614,),0,0
87615,.,0,0
87616,NC,0,0
87617,were,0,0
87618,defined,0,0
87619,as,0,0
87620,an,0,0
87621,absolute,0,0
87622,neutrophil,0,0
87623,count,0,0
87624,<,0,0
87625,or,0,1
87626,=1.5,0,0
87627,x,0,0
87628,10,0,0
87629,(,0,0
87630,9,0,0
87631,),0,1
87632,cells/L,0,0
87633,(,0,0
87634,ie,0,0
87635,",",0,0
87636,>,0,0
87637,or,0,1
87638,=grade,0,0
87639,II,0,1
87640,),0,0
87641,before,0,0
87642,the,0,0
87643,next,0,0
87644,cycle,0,0
87645,",",0,0
87646,febrile,0,0
87647,neutropenia,0,0
87648,or,0,1
87649,neutropenia,0,0
87650,with,0,0
87651,a,0,0
87652,documented,0,0
87653,infection,0,0
87654,.,0,1
87655,Patient,0,0
87656,and,0,0
87657,hematologic,0,0
87658,factors,0,0
87659,potentially,0,0
87660,associated,0,0
87661,with,0,0
87662,NC,0,1
87663,were,0,0
87664,evaluated,0,0
87665,.,0,0
87666,Factors,0,0
87667,with,0,0
87668,a,0,0
87669,P,0,0
87670,value,0,0
87671,of,0,0
87672,<,0,0
87673,or,0,1
87674,=0.25,0,0
87675,within,0,0
87676,a,0,0
87677,cycle,0,0
87678,were,0,0
87679,included,0,0
87680,in,0,0
87681,a,0,0
87682,generalized,0,0
87683,estimating,0,0
87684,equations,0,0
87685,regression,0,0
87686,model,0,0
87687,.,0,0
87688,Using,0,0
87689,backward,0,1
87690,elimination,0,0
87691,",",0,0
87692,we,0,0
87693,derived,0,0
87694,a,0,0
87695,risk,0,0
87696,scoring,0,0
87697,algorithm,0,1
87698,(,0,1
87699,range,0,0
87700,0-63,0,0
87701,),0,0
87702,from,0,0
87703,the,0,0
87704,final,0,0
87705,reduced,0,0
87706,model,0,0
87707,.,0,0
87708,RESULTS,0,0
87709,Risk,0,0
87710,factors,0,0
87711,retained,0,0
87712,in,0,0
87713,the,0,0
87714,model,0,0
87715,included,0,0
87716,poor,0,0
87717,performance,0,0
87718,status,0,0
87719,",",0,0
87720,absolute,0,0
87721,neutrophil,0,0
87722,count,0,0
87723,<,0,0
87724,or,0,1
87725,=2.0,0,0
87726,x,0,0
87727,10,0,1
87728,(,0,0
87729,9,0,0
87730,),0,0
87731,cells/L,0,0
87732,in,0,0
87733,the,0,0
87734,previous,0,0
87735,cycle,0,0
87736,",",0,0
87737,the,0,0
87738,first,0,0
87739,cycle,0,0
87740,of,0,0
87741,chemotherapy,0,1
87742,",",0,0
87743,DOX,1,1
87744,versus,0,1
87745,PLD,1,1
87746,and,0,0
87747,advanced,0,0
87748,age,0,0
87749,.,0,0
87750,A,0,0
87751,precycle,0,0
87752,risk,0,0
87753,score,0,0
87754,from,0,0
87755,>,0,0
87756,or,0,1
87757,=25,0,0
87758,to,0,0
87759,<,0,0
87760,40,0,0
87761,for,0,0
87762,a,0,0
87763,given,0,0
87764,patient,0,0
87765,was,0,0
87766,identified,0,0
87767,as,0,0
87768,being,0,0
87769,the,0,0
87770,optimal,0,0
87771,threshold,0,0
87772,for,0,0
87773,sensitivity,0,0
87774,(,0,0
87775,58.0,0,0
87776,%,0,0
87777,),0,1
87778,and,0,1
87779,specificity,0,0
87780,(,0,1
87781,78.7,0,0
87782,%,0,0
87783,),0,0
87784,.,0,0
87785,Patients,0,0
87786,with,0,0
87787,a,0,0
87788,score,0,0
87789,at,0,0
87790,or,0,0
87791,beyond,0,0
87792,this,0,0
87793,threshold,0,0
87794,would,0,0
87795,be,0,0
87796,considered,0,0
87797,at,0,0
87798,high,0,0
87799,risk,0,0
87800,for,0,0
87801,developing,0,0
87802,NC,0,1
87803,in,0,0
87804,later,0,0
87805,cycles,0,0
87806,.,0,0
87807,CONCLUSION,0,0
87808,The,0,0
87809,use,0,0
87810,of,0,0
87811,this,0,0
87812,model,0,0
87813,may,0,0
87814,enhance,0,0
87815,patient,0,0
87816,care,0,1
87817,by,0,0
87818,targeting,0,0
87819,preventative,0,1
87820,therapies,0,1
87821,(,0,0
87822,eg,0,0
87823,",",0,0
87824,granulocyte,0,1
87825,colony,0,1
87826,stimulating,0,1
87827,factor,0,0
87828,or,0,1
87829,PLD,0,1
87830,),0,1
87831,to,0,0
87832,those,0,0
87833,MBC,0,0
87834,patients,0,0
87835,most,0,0
87836,likely,0,0
87837,to,0,0
87838,experience,0,0
87839,NC,0,1
87840,during,0,0
87841,anthracycline-based,1,1
87842,chemotherapy,1,1
87843,.,1,0
87844,Safety,0,1
87845,and,0,0
87846,immunogenicity,0,0
87847,of,0,0
87848,a,0,0
87849,cluster,1,0
87850,specific,1,0
87851,immunotherapy,1,1
87852,in,0,0
87853,children,0,0
87854,with,0,0
87855,bronchial,0,0
87856,asthma,0,0
87857,and,0,0
87858,mite,0,0
87859,allergy,0,0
87860,.,0,0
87861,BACKGROUND,0,0
87862,Cluster,1,0
87863,specific,1,1
87864,immunotherapy,1,1
87865,(,1,1
87866,SIT,1,0
87867,),1,1
87868,is,0,0
87869,a,0,0
87870,modern,0,0
87871,form,0,0
87872,of,0,0
87873,allergen,0,1
87874,immunotherapy,0,1
87875,allowing,0,0
87876,safe,0,0
87877,administration,0,0
87878,of,0,0
87879,high,0,0
87880,allergen,0,1
87881,doses,0,0
87882,in,0,0
87883,a,0,0
87884,short,0,0
87885,time,0,0
87886,interval,0,0
87887,compared,0,0
87888,to,0,0
87889,classic,0,0
87890,SIT,0,0
87891,.,0,0
87892,In,0,0
87893,the,0,0
87894,current,0,0
87895,study,0,0
87896,",",0,0
87897,we,0,0
87898,investigated,0,0
87899,the,0,0
87900,safety,0,0
87901,profile,0,0
87902,and,0,0
87903,immunological,0,0
87904,effect,0,0
87905,of,0,0
87906,cluster,0,0
87907,SIT,0,0
87908,in,0,0
87909,children,0,0
87910,with,0,0
87911,allergic,0,0
87912,asthma,0,0
87913,due,0,0
87914,to,0,0
87915,house,0,1
87916,dust,0,1
87917,mite,0,0
87918,allergy,0,0
87919,.,0,0
87920,METHODS,0,0
87921,A,0,0
87922,total,0,0
87923,of,0,0
87924,34,0,0
87925,children,0,0
87926,(,0,0
87927,6-18,0,0
87928,years,0,0
87929,),0,0
87930,with,0,0
87931,allergic,0,0
87932,asthma,0,0
87933,were,0,0
87934,assigned,0,0
87935,to,0,0
87936,cluster,0,0
87937,(,0,0
87938,n,0,0
87939,=,0,0
87940,22,0,0
87941,),0,0
87942,or,0,1
87943,classic,0,1
87944,SIT,0,0
87945,(,0,0
87946,n,0,0
87947,=,0,0
87948,12,0,0
87949,),0,0
87950,.,0,0
87951,To,0,0
87952,achieve,0,0
87953,a,0,0
87954,maintenance,0,0
87955,dose,0,0
87956,of,0,0
87957,allergen,0,1
87958,extract,0,1
87959,",",0,0
87960,cluster,0,0
87961,patients,0,0
87962,received,0,0
87963,14,1,0
87964,injections,1,1
87965,of,1,0
87966,house,1,0
87967,dust,1,1
87968,mite,1,0
87969,allergen,1,1
87970,within,1,0
87971,6,1,0
87972,weeks,1,0
87973,",",0,0
87974,whereas,0,0
87975,the,0,0
87976,classic,1,0
87977,SIT,1,0
87978,group,1,0
87979,received,1,0
87980,14,1,0
87981,injections,1,1
87982,within,0,0
87983,14,0,0
87984,weeks,0,0
87985,.,0,0
87986,Safety,0,0
87987,was,0,0
87988,monitored,0,0
87989,by,0,0
87990,recording,0,0
87991,adverse,0,0
87992,events,0,0
87993,.,0,0
87994,Immunogenicity,0,0
87995,was,0,0
87996,measured,0,0
87997,by,0,0
87998,specific,0,1
87999,IgG,0,1
88000,(,0,1
88001,Mite,0,0
88002,),0,1
88003,and,0,0
88004,IgG4,0,1
88005,(,0,1
88006,Mite,0,0
88007,),0,0
88008,",",0,0
88009,by,0,0
88010,antibody-blocking,0,1
88011,properties,0,0
88012,on,0,0
88013,basophil,0,0
88014,activation,0,0
88015,",",0,0
88016,and,0,0
88017,by,0,0
88018,the,0,0
88019,T,0,0
88020,cell,0,0
88021,subset,0,0
88022,transcription,0,0
88023,factors,0,0
88024,Foxp3,0,0
88025,",",0,0
88026,T-bet,0,1
88027,",",0,0
88028,and,0,0
88029,GATA-3,0,0
88030,.,0,0
88031,RESULTS,0,0
88032,There,0,0
88033,were,0,0
88034,no,0,0
88035,significant,0,0
88036,differences,0,0
88037,in,0,0
88038,local,0,1
88039,and,0,0
88040,systemic,0,0
88041,side,0,0
88042,effects,0,0
88043,between,0,0
88044,the,0,0
88045,two,0,0
88046,groups,0,0
88047,.,0,0
88048,In,0,0
88049,the,0,0
88050,cluster,0,0
88051,group,0,0
88052,",",0,0
88053,serum,0,0
88054,levels,0,0
88055,of,0,0
88056,specific,0,0
88057,IgG,0,1
88058,(,0,1
88059,Mite,0,1
88060,),0,1
88061,(,0,0
88062,p,0,0
88063,<,0,0
88064,0.001,0,0
88065,),0,0
88066,and,0,0
88067,specific,0,1
88068,IgG4,0,1
88069,(,0,1
88070,Mite,0,1
88071,),0,1
88072,(,0,0
88073,p,0,0
88074,<,0,0
88075,0.001,0,0
88076,),0,0
88077,significantly,0,0
88078,increased,0,0
88079,after,0,0
88080,8,0,0
88081,weeks,0,0
88082,",",0,0
88083,while,0,0
88084,it,0,0
88085,took,0,0
88086,12,0,0
88087,weeks,0,0
88088,in,0,0
88089,the,0,0
88090,classic,0,0
88091,SIT,0,0
88092,group,0,0
88093,.,0,0
88094,These,0,0
88095,data,0,0
88096,were,0,0
88097,confirmed,0,0
88098,by,0,0
88099,blocking,0,1
88100,CD63,0,1
88101,expression,0,0
88102,as,0,0
88103,well,0,0
88104,as,0,0
88105,release,0,0
88106,of,0,0
88107,cysteinyl,0,0
88108,leukotrienes,0,1
88109,after,0,0
88110,in,0,0
88111,vitro,0,0
88112,basophil,0,0
88113,stimulation,0,1
88114,.,0,0
88115,No,0,0
88116,differences,0,0
88117,in,0,0
88118,transcription,0,0
88119,factor,0,1
88120,expression,0,0
88121,were,0,0
88122,found,0,0
88123,in,0,0
88124,the,0,0
88125,two,0,0
88126,groups,0,0
88127,.,0,0
88128,CONCLUSION,0,0
88129,Cluster,0,0
88130,SIT,0,0
88131,is,0,0
88132,safe,0,0
88133,in,0,0
88134,children,0,0
88135,.,0,0
88136,Additionally,0,0
88137,",",0,0
88138,our,0,0
88139,data,0,0
88140,demonstrated,0,0
88141,an,0,0
88142,even,0,0
88143,more,0,0
88144,rapid,0,0
88145,induction,0,0
88146,of,0,0
88147,specific,0,0
88148,immune,0,0
88149,tolerance,0,0
88150,.,0,0
88151,Cluster,0,0
88152,SIT,0,0
88153,is,0,0
88154,an,0,0
88155,attractive,0,0
88156,alternative,0,0
88157,to,0,0
88158,conventional,0,1
88159,up-dosing,0,1
88160,schedules,0,0
88161,with,0,0
88162,fewer,0,0
88163,consultations,0,0
88164,for,0,0
88165,the,0,0
88166,patients,0,0
88167,.,0,0
88168,Development,0,0
88169,of,0,0
88170,autistic,0,0
88171,children,0,0
88172,based,0,0
88173,on,0,0
88174,maternal,0,0
88175,responses,0,0
88176,to,0,0
88177,the,0,0
88178,Autism,0,0
88179,Behavior,0,0
88180,Checklist,0,0
88181,.,0,0
88182,BACKGROUND,0,0
88183,language,1,0
88184,and,1,0
88185,speech-language,1,1
88186,intervention,1,1
88187,.,1,0
88188,AIM,0,0
88189,to,0,0
88190,evaluate,0,0
88191,the,0,0
88192,development,0,0
88193,process,0,0
88194,of,0,0
88195,autistic,0,0
88196,children,0,0
88197,",",0,0
88198,in,0,0
88199,a,0,0
88200,direct,1,0
88201,and,1,0
88202,indirect,1,1
88203,intervention,1,1
88204,context,0,0
88205,based,0,0
88206,on,0,0
88207,the,0,0
88208,responses,0,0
88209,of,0,0
88210,mothers,0,0
88211,to,0,0
88212,the,0,0
88213,Autism,0,0
88214,Behavior,0,0
88215,Checklist,0,0
88216,.,0,0
88217,METHOD,0,0
88218,the,0,0
88219,research,0,0
88220,sample,0,0
88221,consisted,0,0
88222,of,0,0
88223,11,0,0
88224,mothers,0,0
88225,of,0,0
88226,children,0,0
88227,diagnosed,0,0
88228,",",0,0
88229,according,0,0
88230,to,0,0
88231,the,0,0
88232,criteria,0,0
88233,established,0,0
88234,by,0,0
88235,the,0,0
88236,DSM,0,1
88237,IVtr,0,1
88238,(,0,0
88239,APA,0,1
88240,",",0,0
88241,2002,0,0
88242,),0,0
88243,",",0,0
88244,with,0,0
88245,autism,0,0
88246,(,0,1
88247,six,0,0
88248,),0,0
88249,and,0,0
88250,with,0,0
88251,Asperger,0,0
88252,Syndrome,0,0
88253,(,0,1
88254,five,0,0
88255,),0,0
88256,and,0,0
88257,who,0,0
88258,were,0,0
88259,seen,0,0
88260,at,0,0
88261,the,0,0
88262,Investigation,0,0
88263,Laboratory,0,0
88264,of,0,0
88265,Global,0,0
88266,Developmental,0,1
88267,Disorders,0,0
88268,of,0,0
88269,the,0,0
88270,Federal,0,1
88271,University,0,0
88272,of,0,0
88273,S?o,0,0
88274,Paulo,0,0
88275,.,0,0
88276,These,0,0
88277,children,0,0
88278,were,0,0
88279,randomly,0,0
88280,divided,0,0
88281,into,0,0
88282,two,0,0
88283,groups,0,0
88284,:,0,0
88285,Six,0,0
88286,were,0,0
88287,receiving,1,0
88288,both,1,0
88289,direct,1,1
88290,and,1,0
88291,indirect,1,1
88292,intervention,1,1
88293,(,1,1
88294,TG,1,1
88295,),1,1
88296,",",1,0
88297,and,0,0
88298,five,0,0
88299,were,0,0
88300,receiving,1,0
88301,indirect,1,1
88302,intervention,1,1
88303,exclusively,1,1
88304,(,0,0
88305,OG,0,1
88306,),0,0
88307,.,0,0
88308,The,1,0
88309,Autism,1,0
88310,Behavior,1,0
88311,Checklist,1,1
88312,(,0,0
88313,Krug,0,1
88314,et,0,0
88315,al.,0,0
88316,",",0,0
88317,1993,0,0
88318,),0,0
88319,was,0,0
88320,used,0,0
88321,",",0,0
88322,adapted,0,0
88323,to,0,0
88324,the,0,0
88325,Portuguese,0,0
88326,language,0,0
88327,by,0,1
88328,Marteleto,0,1
88329,(,0,1
88330,2003,0,0
88331,),0,0
88332,.,0,0
88333,This,0,0
88334,behavior,0,0
88335,checklist,0,1
88336,(,0,0
88337,57,0,0
88338,items,0,1
88339,),0,0
88340,allows,0,0
88341,the,0,0
88342,detailed,0,0
88343,description,0,0
88344,of,0,0
88345,non-adaptable,0,0
88346,characteristics,0,0
88347,regarding,0,0
88348,the,0,0
88349,following,0,0
88350,areas,0,0
88351,:,0,0
88352,sensory,0,0
88353,",",0,0
88354,use,0,0
88355,of,0,0
88356,the,0,0
88357,body,0,0
88358,and,0,0
88359,object,0,0
88360,",",0,0
88361,Language,0,1
88362,",",0,0
88363,Psycho-social,0,1
88364,and,0,0
88365,Relational,0,0
88366,.,0,0
88367,The,0,0
88368,questionnaire,0,0
88369,was,0,0
88370,filled,0,0
88371,in,0,0
88372,during,0,0
88373,an,0,0
88374,interview,0,0
88375,on,0,0
88376,three,0,0
88377,occasions,0,0
88378,:,0,0
88379,at,0,0
88380,the,0,0
88381,beginning,0,0
88382,of,0,0
88383,intervention,0,1
88384,",",0,0
88385,after,0,0
88386,six,0,0
88387,months,0,0
88388,and,0,0
88389,at,0,0
88390,the,0,0
88391,end,0,0
88392,of,0,0
88393,12,0,0
88394,months,0,0
88395,.,0,0
88396,RESULTS,0,0
88397,after,0,0
88398,statistical,0,0
88399,analysis,0,0
88400,it,0,0
88401,was,0,0
88402,observed,0,0
88403,that,0,0
88404,there,0,0
88405,was,0,0
88406,a,0,0
88407,greater,0,0
88408,development,0,0
88409,in,0,0
88410,the,0,0
88411,total,0,0
88412,scores,0,0
88413,and,0,0
88414,in,0,0
88415,the,0,0
88416,areas,0,0
88417,of,0,0
88418,language,0,0
88419,",",0,0
88420,psycho-social,0,0
88421,and,0,0
88422,relational,0,1
88423,for,0,0
88424,the,0,0
88425,TG,0,0
88426,.,0,0
88427,This,0,0
88428,suggests,0,0
88429,a,0,0
88430,greater,0,0
88431,development,0,0
88432,pattern,0,0
88433,during,0,0
88434,the,0,0
88435,studied,0,0
88436,period,0,0
88437,for,0,0
88438,this,0,0
88439,group,0,0
88440,.,0,0
88441,CONCLUSION,0,0
88442,the,0,0
88443,mothers,0,0
88444,of,0,0
88445,both,0,0
88446,groups,0,0
88447,observed,0,0
88448,behavioral,0,1
88449,changes,0,0
88450,.,0,0
88451,The,0,0
88452,better,0,0
88453,scores,0,0
88454,observed,0,0
88455,for,0,0
88456,the,0,0
88457,TG,0,1
88458,is,0,0
88459,probably,0,0
88460,related,0,0
88461,to,0,0
88462,the,0,0
88463,effectiveness,0,0
88464,of,0,0
88465,direct,0,0
88466,intervention,0,1
88467,",",0,0
88468,and,0,0
88469,not,0,0
88470,to,0,0
88471,the,0,0
88472,lack,0,0
88473,of,0,0
88474,attention,0,0
88475,of,0,0
88476,parents,0,0
88477,in,0,0
88478,the,1,0
88479,OG,1,1
88480,in,0,0
88481,recognizing,0,0
88482,behavioral,0,1
88483,changes,0,0
88484,in,0,0
88485,their,0,0
88486,children,0,0
88487,.,0,0
88488,Impact,0,0
88489,of,0,0
88490,isotonic,1,1
88491,and,1,0
88492,hypertonic,1,1
88493,saline,1,1
88494,solutions,1,1
88495,on,0,0
88496,mucociliary,0,0
88497,activity,0,0
88498,in,0,0
88499,various,0,0
88500,nasal,0,0
88501,pathologies,0,0
88502,:,0,0
88503,clinical,0,0
88504,study,0,0
88505,.,0,0
88506,OBJECTIVE,0,0
88507,To,0,0
88508,investigate,0,0
88509,the,0,0
88510,impact,0,0
88511,of,0,0
88512,nasal,0,0
88513,irrigation,0,1
88514,with,0,0
88515,isotonic,1,1
88516,or,1,1
88517,hypertonic,1,1
88518,sodium,1,1
88519,chloride,1,1
88520,solution,1,1
88521,on,0,0
88522,mucociliary,0,0
88523,clearance,0,0
88524,time,0,0
88525,in,0,0
88526,patients,0,0
88527,with,0,0
88528,allergic,0,0
88529,rhinitis,0,0
88530,",",0,0
88531,acute,0,0
88532,sinusitis,0,1
88533,and,0,0
88534,chronic,0,0
88535,sinusitis,0,0
88536,.,0,1
88537,PATIENTS,0,0
88538,AND,0,0
88539,METHODS,0,0
88540,Mucociliary,0,1
88541,clearance,0,0
88542,time,0,0
88543,was,0,0
88544,measured,0,0
88545,using,0,0
88546,the,0,0
88547,saccharine,0,1
88548,clearance,0,0
88549,test,0,0
88550,on,0,0
88551,132,0,0
88552,adults,0,0
88553,before,0,0
88554,and,0,0
88555,after,0,0
88556,10,0,0
88557,days,0,0
88558,',0,0
88559,application,1,0
88560,of,1,0
88561,intranasal,1,1
88562,isotonic,1,1
88563,or,1,1
88564,hypertonic,1,1
88565,saline,1,1
88566,.,1,0
88567,Patient,0,0
88568,numbers,0,0
88569,were,0,0
88570,as,0,0
88571,follows,0,0
88572,:,0,0
88573,controls,0,0
88574,",",0,0
88575,45,0,0
88576,;,0,0
88577,allergic,0,0
88578,rhinitis,0,0
88579,",",0,0
88580,21,0,0
88581,;,0,0
88582,acute,0,0
88583,sinusitis,0,0
88584,",",0,0
88585,24,0,0
88586,;,0,0
88587,and,0,0
88588,chronic,0,0
88589,sinusitis,0,0
88590,",",0,0
88591,42,0,0
88592,.,0,0
88593,The,0,0
88594,results,0,0
88595,before,0,0
88596,and,0,0
88597,after,0,0
88598,irrigation,0,1
88599,were,0,0
88600,compared,0,0
88601,using,0,0
88602,the,0,0
88603,Wilcoxon,0,0
88604,t-test,0,0
88605,.,0,0
88606,RESULTS,0,0
88607,Before,0,0
88608,application,0,0
88609,of,0,0
88610,saline,1,1
88611,solutions,1,1
88612,",",0,0
88613,mucociliary,0,0
88614,clearance,0,0
88615,times,0,0
88616,in,0,0
88617,the,0,0
88618,three,0,0
88619,patient,0,0
88620,treatment,0,0
88621,groups,0,0
88622,were,0,0
88623,found,0,0
88624,to,0,0
88625,be,0,0
88626,significantly,0,0
88627,delayed,0,0
88628,",",0,0
88629,compared,0,0
88630,with,0,0
88631,the,0,0
88632,control,0,0
88633,group,0,0
88634,.,0,0
88635,Irrigation,0,1
88636,with,0,0
88637,hypertonic,1,1
88638,saline,1,1
88639,restored,0,0
88640,impaired,0,0
88641,mucociliary,0,0
88642,clearance,0,0
88643,in,0,0
88644,chronic,0,0
88645,sinusitis,0,1
88646,patients,0,0
88647,(,0,0
88648,p,0,0
88649,<,0,0
88650,0.05,0,0
88651,),0,0
88652,",",0,0
88653,while,0,0
88654,isotonic,1,1
88655,saline,1,1
88656,improved,0,0
88657,mucociliary,0,0
88658,clearance,0,0
88659,times,0,0
88660,significantly,0,0
88661,in,0,0
88662,allergic,0,0
88663,rhinitis,0,0
88664,and,0,0
88665,acute,0,0
88666,sinusitis,0,1
88667,patients,0,0
88668,(,0,0
88669,p,0,0
88670,<,0,0
88671,0.05,0,0
88672,),0,0
88673,.,0,0
88674,CONCLUSION,0,0
88675,Nasal,0,1
88676,irrigation,0,1
88677,with,0,0
88678,isotonic,1,1
88679,or,1,1
88680,hypertonic,1,1
88681,saline,1,1
88682,can,0,0
88683,improve,0,0
88684,mucociliary,0,0
88685,clearance,0,0
88686,time,0,0
88687,in,0,0
88688,various,0,0
88689,nasal,0,0
88690,pathologies,0,0
88691,.,0,0
88692,However,0,0
88693,",",0,0
88694,these,0,0
88695,solutions,0,0
88696,should,0,0
88697,be,0,0
88698,selectively,0,0
88699,prescribed,0,0
88700,rather,0,0
88701,than,0,0
88702,used,0,0
88703,based,0,0
88704,on,0,0
88705,anecdotal,0,0
88706,evidence,0,0
88707,.,0,0
88708,Further,0,0
88709,studies,0,0
88710,should,0,0
88711,be,0,0
88712,conducted,0,0
88713,to,0,0
88714,develop,0,0
88715,a,0,0
88716,protocol,0,0
88717,for,0,0
88718,standardised,0,1
88719,use,0,0
88720,of,0,0
88721,saline,1,1
88722,solution,1,1
88723,irrigation,1,1
88724,in,0,0
88725,various,0,0
88726,nasal,0,0
88727,pathologies,0,0
88728,.,0,0
88729,Neural,0,0
88730,basis,0,0
88731,of,0,0
88732,self,0,1
88733,and,0,0
88734,other,0,0
88735,representation,0,1
88736,in,0,0
88737,autism,0,0
88738,:,0,0
88739,an,0,0
88740,FMRI,0,1
88741,study,0,0
88742,of,0,0
88743,self-face,1,1
88744,recognition,1,0
88745,.,1,0
88746,BACKGROUND,0,0
88747,Autism,0,0
88748,is,0,0
88749,a,0,0
88750,developmental,0,0
88751,disorder,0,0
88752,characterized,0,0
88753,by,0,0
88754,decreased,0,0
88755,interest,0,0
88756,and,0,0
88757,engagement,0,0
88758,in,0,0
88759,social,0,0
88760,interactions,0,0
88761,and,0,0
88762,by,0,0
88763,enhanced,0,0
88764,self-focus,0,0
88765,.,0,0
88766,While,0,0
88767,previous,0,0
88768,theoretical,0,0
88769,approaches,0,0
88770,to,0,0
88771,understanding,0,0
88772,autism,0,0
88773,have,0,0
88774,emphasized,0,0
88775,social,0,0
88776,impairments,0,0
88777,and,0,0
88778,altered,0,0
88779,interpersonal,0,0
88780,interactions,0,0
88781,",",0,0
88782,there,0,0
88783,is,0,0
88784,a,0,0
88785,recent,0,0
88786,shift,0,0
88787,towards,0,0
88788,understanding,0,0
88789,the,0,0
88790,nature,0,0
88791,of,0,0
88792,the,0,0
88793,representation,0,0
88794,of,0,0
88795,the,0,0
88796,self,0,0
88797,in,0,0
88798,individuals,0,0
88799,with,0,0
88800,autism,0,0
88801,spectrum,0,0
88802,disorders,0,0
88803,(,0,0
88804,ASD,0,0
88805,),0,0
88806,.,0,0
88807,Still,0,0
88808,",",0,0
88809,the,0,0
88810,neural,0,0
88811,mechanisms,0,0
88812,subserving,0,0
88813,self-representations,0,0
88814,in,0,0
88815,ASD,0,0
88816,are,0,0
88817,relatively,0,0
88818,unexplored,0,0
88819,.,0,0
88820,METHODOLOGY/PRINCIPAL,0,0
88821,FINDINGS,0,0
88822,We,0,0
88823,used,0,0
88824,event-related,1,0
88825,fMRI,1,0
88826,to,0,0
88827,investigate,0,0
88828,brain,0,0
88829,responsiveness,0,0
88830,to,0,0
88831,images,0,0
88832,of,0,0
88833,the,0,0
88834,subjects,0,0
88835,',0,0
88836,own,0,0
88837,face,0,0
88838,and,0,0
88839,to,0,0
88840,faces,0,0
88841,of,0,0
88842,others,0,0
88843,.,0,0
88844,Children,0,0
88845,with,0,0
88846,ASD,0,0
88847,and,0,0
88848,typically,0,0
88849,developing,0,0
88850,(,0,1
88851,TD,0,1
88852,),0,1
88853,children,0,0
88854,viewed,1,0
88855,randomly,1,0
88856,presented,1,0
88857,digital,1,1
88858,morphs,1,0
88859,between,1,0
88860,their,1,0
88861,own,1,0
88862,face,1,0
88863,and,1,0
88864,a,1,0
88865,gender-matched,1,0
88866,other,1,0
88867,face,1,0
88868,",",1,0
88869,and,1,0
88870,made,1,0
88871,self/other,1,0
88872,judgments,1,0
88873,.,1,0
88874,Both,0,0
88875,groups,0,0
88876,of,0,0
88877,children,0,0
88878,activated,0,0
88879,a,0,0
88880,right,0,0
88881,premotor/prefrontal,0,0
88882,system,0,1
88883,when,0,0
88884,identifying,0,0
88885,images,0,1
88886,containing,0,0
88887,a,0,0
88888,greater,0,0
88889,percentage,0,0
88890,of,0,0
88891,the,0,0
88892,self,0,1
88893,face,0,0
88894,.,0,0
88895,However,0,0
88896,",",0,0
88897,while,0,0
88898,TD,0,1
88899,children,0,0
88900,showed,0,0
88901,activation,0,0
88902,of,0,0
88903,this,0,0
88904,system,0,0
88905,during,0,0
88906,both,0,0
88907,self-,0,0
88908,and,0,0
88909,other-processing,0,0
88910,",",0,0
88911,children,0,0
88912,with,0,0
88913,ASD,0,0
88914,only,0,0
88915,recruited,0,0
88916,this,0,0
88917,system,0,0
88918,while,0,0
88919,viewing,0,1
88920,images,0,1
88921,containing,0,1
88922,mostly,0,0
88923,their,0,0
88924,own,0,0
88925,face,0,0
88926,.,0,0
88927,CONCLUSIONS/SIGNIFICANCE,0,0
88928,This,0,0
88929,functional,0,0
88930,dissociation,0,0
88931,between,0,0
88932,the,0,0
88933,representation,0,0
88934,of,0,0
88935,self,0,1
88936,versus,0,1
88937,others,0,0
88938,points,0,0
88939,to,0,0
88940,a,0,0
88941,potential,0,0
88942,neural,0,0
88943,substrate,0,0
88944,for,0,0
88945,the,0,0
88946,characteristic,0,0
88947,self-focus,0,1
88948,and,0,0
88949,decreased,0,0
88950,social,0,1
88951,understanding,0,0
88952,exhibited,0,0
88953,by,0,0
88954,these,0,0
88955,individuals,0,0
88956,",",0,0
88957,and,0,0
88958,suggests,0,0
88959,that,0,0
88960,individuals,0,0
88961,with,0,0
88962,ASD,0,0
88963,lack,0,0
88964,the,0,0
88965,shared,0,0
88966,neural,0,0
88967,representations,0,1
88968,for,0,0
88969,self,0,0
88970,and,0,0
88971,others,0,0
88972,that,0,0
88973,TD,0,1
88974,children,0,0
88975,and,0,0
88976,adults,0,0
88977,possess,0,0
88978,and,0,0
88979,may,0,0
88980,use,0,0
88981,to,0,0
88982,understand,0,0
88983,others,0,0
88984,.,0,0
88985,Consumer-directed,0,1
88986,care,0,1
88987,for,0,0
88988,beneficiaries,0,0
88989,with,0,0
88990,mental,0,0
88991,illness,0,0
88992,:,0,0
88993,lessons,0,0
88994,from,0,0
88995,New,0,0
88996,Jersey,0,0
88997,'s,0,0
88998,Cash,0,0
88999,and,0,0
89000,Counseling,0,1
89001,program,0,1
89002,.,0,0
89003,OBJECTIVE,0,0
89004,Previous,0,0
89005,research,0,0
89006,from,0,0
89007,the,0,0
89008,Cash,0,0
89009,and,0,0
89010,Counseling,0,1
89011,Demonstration,0,1
89012,and,0,1
89013,Evaluation,0,1
89014,(,0,1
89015,CCDE,0,0
89016,),0,1
89017,programs,0,1
89018,in,0,0
89019,New,0,0
89020,Jersey,0,0
89021,",",0,0
89022,Arkansas,0,0
89023,",",0,0
89024,and,0,0
89025,Florida,0,1
89026,suggests,0,0
89027,that,0,0
89028,consumers,0,0
89029,',0,0
89030,control,0,0
89031,over,0,0
89032,personal,0,1
89033,care,0,1
89034,greatly,0,0
89035,improves,0,0
89036,their,0,0
89037,satisfaction,0,0
89038,with,0,0
89039,care,0,1
89040,arrangements,0,1
89041,and,0,0
89042,their,0,0
89043,outlook,0,0
89044,on,0,0
89045,life,0,0
89046,.,0,0
89047,Still,0,0
89048,",",0,0
89049,some,0,0
89050,argue,0,0
89051,that,0,0
89052,consumer-directed,0,1
89053,care,0,1
89054,may,0,0
89055,not,0,0
89056,be,0,0
89057,appropriate,0,0
89058,for,0,0
89059,consumers,0,0
89060,with,0,0
89061,a,0,0
89062,diagnosis,0,0
89063,of,0,0
89064,mental,0,0
89065,illness,0,0
89066,.,0,0
89067,This,0,0
89068,study,0,0
89069,examined,0,0
89070,the,0,0
89071,effectiveness,0,0
89072,of,0,0
89073,the,0,0
89074,CCDE,0,0
89075,program,0,1
89076,for,0,0
89077,those,0,0
89078,with,0,0
89079,a,0,0
89080,diagnosis,0,0
89081,of,0,0
89082,mental,0,0
89083,illness,0,0
89084,.,0,0
89085,METHODS,0,0
89086,This,0,0
89087,study,0,0
89088,examined,0,0
89089,nonelderly,0,0
89090,Medicaid,0,1
89091,beneficiaries,0,0
89092,in,0,0
89093,New,0,0
89094,Jersey,0,0
89095,with,0,0
89096,a,0,0
89097,diagnosis,0,0
89098,of,0,0
89099,mental,0,0
89100,illness,0,0
89101,and,0,0
89102,compared,1,0
89103,and,1,0
89104,contrasted,1,0
89105,the,1,0
89106,experiences,1,0
89107,of,1,0
89108,those,1,0
89109,in,1,0
89110,New,1,0
89111,Jersey,1,0
89112,'s,1,0
89113,CCDE,1,0
89114,program,1,1
89115,(,1,1
89116,N=109,1,1
89117,),1,1
89118,and,1,0
89119,those,1,0
89120,who,1,0
89121,received,1,0
89122,services,1,1
89123,provided,1,0
89124,by,1,0
89125,an,1,0
89126,agency,1,1
89127,(,1,1
89128,N=119,1,1
89129,),1,1
89130,.,0,0
89131,Logistic,1,0
89132,regression,1,0
89133,analyses,1,0
89134,were,1,0
89135,performed,1,0
89136,on,1,0
89137,baseline,1,0
89138,and,1,0
89139,nine-month,1,1
89140,follow-up,1,0
89141,data,1,0
89142,.,1,0
89143,RESULTS,0,0
89144,By,0,0
89145,examining,0,0
89146,outcome,0,0
89147,measures,0,0
89148,--,0,0
89149,including,0,0
89150,satisfaction,0,0
89151,with,0,0
89152,care,0,1
89153,arrangements,0,1
89154,",",0,0
89155,consumers,0,0
89156,',0,0
89157,perceptions,0,0
89158,of,0,0
89159,paid,0,0
89160,caregivers,0,0
89161,',0,0
89162,attitudes,0,0
89163,",",0,0
89164,unmet,0,0
89165,needs,0,0
89166,",",0,0
89167,adverse,0,0
89168,events,0,0
89169,",",0,0
89170,and,0,0
89171,satisfaction,0,0
89172,with,0,0
89173,life,0,0
89174,--,0,0
89175,this,0,0
89176,study,0,0
89177,offers,0,0
89178,evidence,0,0
89179,that,0,0
89180,",",0,0
89181,from,0,0
89182,the,0,0
89183,perspective,0,0
89184,of,0,0
89185,consumers,0,0
89186,",",0,0
89187,the,0,0
89188,CCDE,0,0
89189,program,0,1
89190,is,0,0
89191,appropriate,0,0
89192,for,0,0
89193,participants,0,0
89194,with,0,0
89195,a,0,0
89196,mental,0,0
89197,illness,0,0
89198,diagnosis,0,0
89199,.,0,0
89200,For,0,0
89201,most,0,0
89202,outcome,0,0
89203,measures,0,0
89204,the,0,0
89205,CCDE,0,0
89206,program,0,1
89207,demonstrated,0,0
89208,a,0,0
89209,positive,0,0
89210,effect,0,0
89211,after,0,0
89212,baseline,0,0
89213,characteristics,0,0
89214,were,0,0
89215,controlled,0,0
89216,for,0,0
89217,.,0,0
89218,The,0,0
89219,analysis,0,0
89220,of,0,0
89221,measures,0,0
89222,of,0,0
89223,adverse,0,0
89224,events,0,0
89225,",",0,0
89226,health,0,0
89227,problems,0,0
89228,",",0,0
89229,and,0,0
89230,general,0,0
89231,health,0,0
89232,status,0,0
89233,did,0,0
89234,not,0,0
89235,yield,0,0
89236,statistically,0,0
89237,significant,0,0
89238,differences,0,0
89239,between,0,0
89240,the,0,0
89241,control,0,1
89242,group,0,0
89243,and,0,0
89244,the,0,0
89245,treatment,0,1
89246,group,0,0
89247,",",0,0
89248,indicating,0,0
89249,that,0,0
89250,CCDE,0,0
89251,care,0,1
89252,was,0,0
89253,at,0,0
89254,least,0,0
89255,as,0,0
89256,safe,0,0
89257,as,0,0
89258,agency-directed,0,1
89259,care,0,1
89260,.,0,0
89261,CONCLUSIONS,0,0
89262,Considering,0,0
89263,the,0,0
89264,growing,0,0
89265,need,0,0
89266,for,0,0
89267,long-term,0,0
89268,care,0,1
89269,services,0,1
89270,and,0,0
89271,the,0,0
89272,limited,0,0
89273,resources,0,0
89274,available,0,0
89275,",",0,0
89276,a,0,0
89277,consumer-directed,0,1
89278,option,0,0
89279,can,0,0
89280,be,0,0
89281,a,0,0
89282,valuable,0,0
89283,alternative,0,0
89284,for,0,0
89285,persons,0,0
89286,with,0,0
89287,a,0,0
89288,diagnosis,0,0
89289,of,0,0
89290,mental,0,0
89291,illness,0,0
89292,.,0,0
89293,Pre-operative,1,1
89294,radiochemotherapy,1,1
89295,for,0,0
89296,rectal,0,0
89297,cancer,0,0
89298,.,0,0
89299,A,0,0
89300,prospective,0,0
89301,randomized,0,0
89302,trial,0,0
89303,comparing,0,0
89304,pre-operative,1,0
89305,vs.,1,0
89306,postoperative,1,0
89307,radiochemotherapy,1,1
89308,in,0,0
89309,rectal,0,0
89310,cancer,0,0
89311,patients,0,0
89312,.,0,0
89313,PURPOSE,0,0
89314,The,0,0
89315,aim,0,0
89316,of,0,0
89317,the,0,0
89318,study,0,0
89319,was,0,0
89320,to,0,0
89321,find,0,0
89322,out,0,0
89323,whether,0,0
89324,pre-operative,1,0
89325,radiochemotherapy,1,1
89326,had,0,0
89327,any,0,0
89328,survival,0,0
89329,advantage,0,0
89330,over,0,0
89331,postoperative,1,0
89332,radiochemotherapy,1,1
89333,for,0,0
89334,rectal,0,0
89335,carcinoma,0,0
89336,patients,0,0
89337,without,0,0
89338,distant,0,0
89339,metastasis,0,0
89340,or,0,1
89341,peritoneal,0,1
89342,carcinomatosis,0,0
89343,.,0,1
89344,MATERIAL,0,0
89345,AND,0,0
89346,METHODS,0,0
89347,Between,0,0
89348,January,0,0
89349,1998,0,0
89350,and,0,0
89351,December,0,0
89352,2003,0,0
89353,",",0,0
89354,51,0,0
89355,rectal,0,0
89356,carcinoma,0,0
89357,patients,0,0
89358,without,0,0
89359,distant,0,0
89360,metastasis,0,0
89361,or,0,1
89362,peritoneal,0,1
89363,carcinomatosis,0,0
89364,were,0,0
89365,randomly,0,0
89366,divided,0,0
89367,into,0,0
89368,pre-operative,1,0
89369,(,1,1
89370,PRE,1,1
89371,),1,1
89372,and,0,0
89373,postoperative,1,0
89374,(,1,1
89375,POST,1,1
89376,),1,1
89377,radiochemotherapy,1,1
89378,groups,0,0
89379,.,0,0
89380,Twenty-six,0,0
89381,were,0,0
89382,assigned,0,0
89383,to,0,0
89384,the,0,0
89385,PRE,0,1
89386,group,0,0
89387,and,0,0
89388,were,0,0
89389,operated,0,0
89390,on,0,0
89391,5,0,0
89392,to,0,0
89393,8,0,0
89394,weeks,0,0
89395,after,0,0
89396,the,0,0
89397,completion,0,0
89398,of,0,0
89399,radiotherapy,1,1
89400,.,1,0
89401,The,0,0
89402,other,0,0
89403,25,0,0
89404,patients,0,0
89405,were,0,0
89406,operated,0,0
89407,on,0,0
89408,immediately,0,0
89409,and,0,0
89410,received,0,1
89411,radiotherapy,0,1
89412,postoperatively,0,0
89413,2,0,0
89414,to,0,0
89415,4,0,0
89416,weeks,0,0
89417,after,0,0
89418,surgery,0,0
89419,.,0,0
89420,The,0,0
89421,patients,0,0
89422,were,0,0
89423,followed,0,0
89424,up,0,0
89425,for,0,0
89426,between,0,0
89427,4,0,0
89428,to,0,0
89429,51,0,0
89430,months,0,0
89431,.,0,0
89432,RESULTS,0,0
89433,In,0,0
89434,the,0,0
89435,PRE,0,1
89436,group,0,0
89437,the,0,0
89438,rates,0,0
89439,of,0,0
89440,disease-free,0,0
89441,survival,0,0
89442,were,0,0
89443,92,0,0
89444,%,0,0
89445,",",0,0
89446,70,0,0
89447,%,0,0
89448,",",0,0
89449,56,0,0
89450,%,0,0
89451,and,0,0
89452,56,0,0
89453,%,0,0
89454,at,0,0
89455,the,0,0
89456,end,0,0
89457,of,0,0
89458,the,0,0
89459,1st,0,0
89460,",",0,0
89461,2nd,0,0
89462,",",0,0
89463,3rd,0,0
89464,and,0,0
89465,4th,0,0
89466,years,0,0
89467,",",0,0
89468,respectively,0,0
89469,.,0,0
89470,In,0,0
89471,the,0,0
89472,POST,0,1
89473,group,0,0
89474,those,0,0
89475,percentages,0,0
89476,were,0,0
89477,83,0,0
89478,%,0,0
89479,",",0,0
89480,68,0,0
89481,%,0,0
89482,",",0,0
89483,51,0,0
89484,%,0,0
89485,and,0,0
89486,51,0,0
89487,%,0,0
89488,at,0,0
89489,the,0,0
89490,1st,0,0
89491,",",0,0
89492,2nd,0,0
89493,",",0,0
89494,3rd,0,0
89495,and,0,0
89496,4th,0,0
89497,years,0,0
89498,",",0,0
89499,respectively,0,0
89500,(,0,0
89501,p,0,0
89502,=,0,0
89503,0.707,0,0
89504,),0,0
89505,.,0,0
89506,One-year,0,0
89507,and,0,0
89508,4-year,0,0
89509,overall,0,0
89510,survival,0,0
89511,rates,0,0
89512,in,0,0
89513,the,0,0
89514,PRE,0,1
89515,group,0,0
89516,were,0,0
89517,100,0,0
89518,%,0,0
89519,and,0,0
89520,86,0,0
89521,%,0,0
89522,respectively,0,0
89523,and,0,0
89524,100,0,1
89525,%,0,0
89526,and,0,0
89527,60,0,0
89528,%,0,0
89529,in,0,0
89530,the,0,0
89531,POST,0,1
89532,group,0,1
89533,(,0,0
89534,p,0,0
89535,=,0,0
89536,0.520,0,0
89537,),0,0
89538,.,0,0
89539,CONCLUSION,0,0
89540,No,0,0
89541,statistical,0,0
89542,difference,0,0
89543,was,0,0
89544,found,0,0
89545,between,0,0
89546,the,0,0
89547,survival,0,0
89548,rates,0,0
89549,of,0,0
89550,the,0,0
89551,rectal,0,0
89552,carcinoma,0,0
89553,patients,0,0
89554,receiving,0,0
89555,radiotherapy,0,1
89556,either,0,1
89557,pre-operatively,0,0
89558,or,0,0
89559,postoperatively,0,0
89560,.,0,0
89561,However,0,0
89562,",",0,0
89563,the,0,0
89564,disease-free,0,0
89565,survival,0,0
89566,rates,0,0
89567,of,0,0
89568,the,0,0
89569,PRE,1,1
89570,group,0,0
89571,were,0,0
89572,higher,0,0
89573,than,0,0
89574,the,0,0
89575,POST,1,1
89576,group,0,0
89577,'s,0,0
89578,during,0,0
89579,each,0,0
89580,year,0,0
89581,and,0,0
89582,overall,0,0
89583,survival,0,0
89584,rates,0,0
89585,were,0,0
89586,higher,0,0
89587,after,0,0
89588,the,0,0
89589,third,0,0
89590,and,0,0
89591,fourth,0,0
89592,years,0,0
89593,.,0,0
89594,We,0,0
89595,conclude,0,0
89596,that,0,0
89597,pre-operative,1,0
89598,radiotherapy,1,1
89599,is,0,0
89600,at,0,0
89601,least,0,0
89602,as,0,0
89603,effective,0,0
89604,as,0,0
89605,postoperative,1,0
89606,radiotherapy,1,1
89607,.,1,0
89608,Timing,0,0
89609,for,0,0
89610,delivering,0,1
89611,individualized,1,1
89612,patient,1,0
89613,education,1,1
89614,intervention,1,1
89615,to,0,0
89616,Coronary,0,0
89617,Artery,0,1
89618,Bypass,0,1
89619,Graft,0,1
89620,patients,0,0
89621,:,0,0
89622,An,0,0
89623,RCT,0,0
89624,.,0,0
89625,BACKGROUND,0,0
89626,The,0,0
89627,primary,0,0
89628,focus,0,0
89629,of,0,0
89630,this,0,0
89631,study,0,0
89632,is,0,0
89633,on,0,0
89634,the,0,0
89635,timing,0,0
89636,of,0,0
89637,the,0,0
89638,delivery,0,0
89639,of,0,0
89640,education,0,1
89641,to,0,0
89642,patients,0,0
89643,who,0,0
89644,had,0,0
89645,CABG,1,0
89646,surgery,1,1
89647,.,1,0
89648,AIM,0,0
89649,To,0,0
89650,determine,0,0
89651,the,0,0
89652,efficacy,0,0
89653,of,0,0
89654,an,0,0
89655,individualized,1,1
89656,telephone,1,1
89657,patient,1,0
89658,education,1,1
89659,intervention,1,1
89660,",",0,0
89661,delivered,0,0
89662,at,0,0
89663,two,0,0
89664,different,0,0
89665,points,0,0
89666,in,0,0
89667,time,0,0
89668,(,0,0
89669,1-2,0,0
89670,days,0,0
89671,pre-discharge,0,0
89672,versus,0,0
89673,1-2,0,0
89674,days,0,1
89675,post-discharge,0,1
89676,),0,0
89677,in,0,0
89678,enhancing,0,0
89679,the,0,0
89680,CABG,0,0
89681,patient,0,0
89682,'s,0,0
89683,knowledge,0,0
89684,of,0,0
89685,self-care,0,0
89686,behaviours,0,0
89687,",",0,0
89688,performance,0,0
89689,of,0,0
89690,self-care,0,0
89691,behaviours,0,0
89692,",",0,0
89693,and,0,0
89694,symptom,0,0
89695,frequency,0,0
89696,.,0,0
89697,METHOD,0,0
89698,A,0,0
89699,randomized,0,0
89700,clinical,0,0
89701,trial,0,0
89702,that,0,0
89703,included,0,0
89704,a,0,0
89705,convenience,0,0
89706,sample,0,0
89707,of,0,0
89708,first,0,0
89709,time,0,0
89710,CABG,0,0
89711,patients,0,0
89712,.,0,0
89713,Individuals,0,0
89714,who,0,0
89715,received,0,0
89716,education,1,1
89717,pre-discharge,1,0
89718,were,0,0
89719,compared,0,0
89720,to,0,0
89721,individuals,0,0
89722,who,0,0
89723,received,0,0
89724,education,0,1
89725,post-discharge,0,1
89726,on,0,0
89727,the,0,0
89728,outcomes,0,0
89729,.,0,0
89730,RESULTS,0,0
89731,Results,0,0
89732,indicated,0,0
89733,no,0,0
89734,statistically,0,0
89735,significant,0,0
89736,difference,0,0
89737,in,0,0
89738,outcomes,0,0
89739,between,0,0
89740,the,0,0
89741,two,0,0
89742,time,0,0
89743,points,0,0
89744,.,0,0
89745,As,0,0
89746,well,0,0
89747,",",0,0
89748,anxiety,0,0
89749,levels,0,0
89750,were,0,0
89751,found,0,0
89752,to,0,0
89753,be,0,0
89754,significantly,0,0
89755,higher,0,0
89756,in,0,0
89757,the,0,0
89758,pre-discharge,0,0
89759,group,0,0
89760,than,0,0
89761,the,0,0
89762,post-discharge,0,1
89763,group,0,0
89764,.,0,0
89765,CONCLUSIONS,0,0
89766,The,0,0
89767,individualized,0,0
89768,nature,0,0
89769,of,0,0
89770,the,0,0
89771,educational,1,1
89772,intervention,1,1
89773,may,0,0
89774,have,0,0
89775,accounted,0,0
89776,for,0,0
89777,non-significant,0,0
89778,findings,0,0
89779,reported,0,0
89780,in,0,0
89781,outcomes,0,0
89782,between,0,0
89783,the,0,0
89784,two,0,0
89785,time,0,0
89786,points,0,0
89787,.,0,0
89788,PRACTICE,0,0
89789,IMPLICATIONS,0,0
89790,Nurses,0,1
89791,may,0,0
89792,consider,0,0
89793,assessing,0,0
89794,anxiety,0,0
89795,levels,0,0
89796,prior,0,0
89797,to,0,0
89798,delivery,0,0
89799,of,0,0
89800,educational,0,0
89801,interventions,0,0
89802,",",0,0
89803,implement,0,0
89804,interventions,0,1
89805,aimed,0,0
89806,at,0,0
89807,reducing,0,0
89808,anxiety,0,0
89809,levels,0,0
89810,",",0,0
89811,and,0,0
89812,provide,0,0
89813,individualized,0,1
89814,teaching,0,1
89815,.,0,0
89816,Effect,0,0
89817,of,0,0
89818,diltiazem,1,1
89819,on,0,0
89820,symptomatic,0,0
89821,and,0,0
89822,asymptomatic,0,0
89823,episodes,0,0
89824,of,0,0
89825,ST,0,0
89826,segment,0,0
89827,depression,0,0
89828,occurring,0,0
89829,during,0,0
89830,daily,0,1
89831,life,0,0
89832,and,0,0
89833,during,0,0
89834,exercise,0,1
89835,.,0,0
89836,BACKGROUND,0,0
89837,Silent,0,0
89838,myocardial,0,0
89839,ischemia,0,0
89840,is,0,0
89841,an,0,0
89842,adverse,0,0
89843,prognostic,0,0
89844,marker,0,0
89845,in,0,0
89846,patients,0,0
89847,with,0,0
89848,coronary,0,0
89849,disease,0,0
89850,;,0,0
89851,however,0,0
89852,",",0,0
89853,controlled,0,0
89854,data,0,0
89855,on,0,0
89856,the,0,0
89857,effect,0,0
89858,of,0,0
89859,treatment,0,0
89860,are,0,0
89861,sparse,0,0
89862,and,0,0
89863,contradictory,0,0
89864,",",0,0
89865,and,0,0
89866,the,0,0
89867,relations,0,0
89868,among,0,0
89869,the,0,0
89870,occurrence,0,0
89871,of,0,0
89872,ST,0,0
89873,segment,0,0
89874,depression,0,0
89875,",",0,0
89876,drug,0,1
89877,efficacy,0,0
89878,",",0,0
89879,and,0,0
89880,heart,0,0
89881,rate,0,0
89882,are,0,0
89883,unclear,0,0
89884,.,0,0
89885,METHODS,0,0
89886,AND,0,0
89887,RESULTS,0,0
89888,Sixty,0,0
89889,patients,0,0
89890,with,0,0
89891,stable,0,0
89892,coronary,0,0
89893,artery,0,0
89894,disease,0,0
89895,",",0,0
89896,a,0,0
89897,positive,0,0
89898,treadmill,0,1
89899,exercise,0,1
89900,test,0,1
89901,and,0,0
89902,asymptomatic,0,0
89903,ST,0,1
89904,segment,0,0
89905,depression,0,0
89906,on,0,0
89907,ambulatory,0,0
89908,electrocardiographic,0,0
89909,recording,0,0
89910,were,0,0
89911,assessed,0,0
89912,in,0,0
89913,a,0,0
89914,multicenter,0,0
89915,",",0,0
89916,double-blind,0,0
89917,",",0,0
89918,placebo-controlled,1,1
89919,",",0,0
89920,cross-over,0,0
89921,trial,0,0
89922,.,0,0
89923,Treadmill,1,1
89924,exercise,1,1
89925,tests,0,0
89926,and,0,0
89927,72-hour,0,0
89928,electrocardiographic,0,0
89929,recordings,0,1
89930,were,0,0
89931,obtained,0,0
89932,at,0,0
89933,the,0,0
89934,end,0,0
89935,of,0,0
89936,two,0,0
89937,2-week,0,0
89938,treatment,0,0
89939,periods,0,0
89940,with,0,0
89941,sustained-release,1,1
89942,diltiazem,1,1
89943,180,0,0
89944,mg,0,1
89945,b.i.d,0,1
89946,.,0,0
89947,or,0,0
89948,equivalent,0,0
89949,placebo,1,1
89950,.,1,0
89951,Episodes,0,0
89952,of,0,0
89953,asymptomatic,0,0
89954,ST,0,0
89955,depression,0,0
89956,decreased,0,0
89957,by,0,0
89958,50,0,1
89959,%,0,0
89960,or,0,0
89961,more,0,0
89962,in,0,0
89963,70,0,0
89964,%,0,0
89965,of,0,0
89966,the,0,0
89967,patients,0,0
89968,from,0,0
89969,a,0,0
89970,median,0,0
89971,number,0,0
89972,of,0,0
89973,4.5,0,0
89974,(,0,0
89975,range,0,0
89976,",",0,1
89977,0-19,0,0
89978,),0,0
89979,to,0,0
89980,1.5,0,0
89981,(,0,0
89982,range,0,0
89983,",",0,1
89984,0-13,0,0
89985,),0,1
89986,(,0,0
89987,p,0,0
89988,=,0,0
89989,0.0001,0,0
89990,),0,0
89991,;,0,0
89992,their,0,0
89993,cumulative,0,0
89994,duration,0,0
89995,also,0,0
89996,decreased,0,0
89997,from,0,0
89998,78.5,0,0
89999,(,0,0
90000,range,0,0
90001,",",0,1
90002,0-60,0,0
90003,),0,0
90004,to,0,0
90005,24.5,0,0
90006,(,0,0
90007,range,0,0
90008,",",0,1
90009,0-411,0,0
90010,),0,1
90011,minutes,0,0
90012,(,0,0
90013,p,0,0
90014,=,0,0
90015,0.001,0,0
90016,),0,0
90017,.,0,0
90018,No,0,0
90019,circadian,0,0
90020,variation,0,0
90021,was,0,0
90022,found,0,0
90023,in,0,0
90024,the,0,0
90025,efficacy,0,0
90026,of,0,0
90027,diltiazem,1,1
90028,.,1,0
90029,The,0,0
90030,occurrence,0,0
90031,of,0,0
90032,ischemic,0,0
90033,type,0,0
90034,ST,0,1
90035,segment,0,0
90036,depression,0,0
90037,was,0,0
90038,modulated,0,0
90039,by,0,0
90040,changes,0,0
90041,in,0,0
90042,heart,0,0
90043,rate,0,0
90044,rather,0,0
90045,than,0,0
90046,by,0,0
90047,absolute,0,0
90048,heart,0,0
90049,rate,0,0
90050,.,0,0
90051,Diltiazem,1,1
90052,also,0,0
90053,improved,0,0
90054,exercise,0,1
90055,test,0,0
90056,end,0,0
90057,points,0,0
90058,but,0,0
90059,to,0,0
90060,a,0,0
90061,lesser,0,0
90062,extent,0,0
90063,.,0,0
90064,Time,0,0
90065,to,0,0
90066,ST,0,0
90067,segment,0,0
90068,depression,0,0
90069,increased,0,0
90070,to,0,0
90071,341,0,0
90072,+/-,0,0
90073,148,0,0
90074,from,0,0
90075,296,0,0
90076,+/-,0,0
90077,154,0,0
90078,seconds,0,0
90079,(,0,0
90080,p,0,0
90081,=,0,0
90082,0.005,0,0
90083,),0,0
90084,.,0,0
90085,Although,0,0
90086,less,0,0
90087,frequent,0,0
90088,with,0,0
90089,diltiazem,1,1
90090,administration,0,0
90091,(,0,0
90092,45,0,0
90093,versus,0,0
90094,54,0,0
90095,patients,0,0
90096,",",0,0
90097,p,0,0
90098,less,0,0
90099,than,0,0
90100,0.03,0,0
90101,),0,0
90102,",",0,0
90103,exercise-induced,0,0
90104,ST,0,0
90105,depression,0,0
90106,was,0,0
90107,more,0,0
90108,often,0,0
90109,asymptomatic,0,0
90110,(,0,0
90111,98,0,0
90112,%,0,0
90113,versus,0,1
90114,72,0,0
90115,%,0,0
90116,of,0,0
90117,patients,0,0
90118,",",0,0
90119,p,0,0
90120,less,0,0
90121,than,0,0
90122,0.0001,0,0
90123,),0,0
90124,.,0,0
90125,CONCLUSIONS,0,0
90126,Diltiazem,1,1
90127,reduces,0,0
90128,the,0,0
90129,frequency,0,0
90130,and,0,0
90131,severity,0,0
90132,of,0,0
90133,ischemic,0,0
90134,type,0,0
90135,ST,0,0
90136,depression,0,0
90137,in,0,0
90138,patients,0,0
90139,with,0,0
90140,stable,0,0
90141,coronary,0,0
90142,artery,0,0
90143,disease,0,0
90144,.,0,0
90145,[,0,0
90146,Safety,0,1
90147,of,0,0
90148,adjuvant,1,1
90149,dose-dense,1,1
90150,chemotherapy,1,1
90151,with,1,0
90152,paclitaxel,1,1
90153,and,1,0
90154,epirubicin,1,1
90155,for,0,0
90156,high-risk,0,0
90157,breast,0,0
90158,cancer,0,0
90159,],0,0
90160,.,0,0
90161,OBJECTIVE,0,0
90162,To,0,0
90163,investigate,0,0
90164,the,0,0
90165,safety,0,0
90166,and,0,0
90167,tolerance,0,0
90168,of,0,0
90169,adjuvant,1,1
90170,dose-dense,1,1
90171,chemotherapy,1,1
90172,with,1,0
90173,paclitaxel,1,1
90174,and,1,0
90175,epirubicin,1,1
90176,for,0,0
90177,high-risk,0,0
90178,breast,0,0
90179,cancer,0,0
90180,.,0,0
90181,METHODS,0,0
90182,From,0,0
90183,January,0,0
90184,2004,0,0
90185,to,0,0
90186,December,0,0
90187,2006,0,0
90188,",",0,0
90189,101,0,0
90190,patients,0,0
90191,with,0,0
90192,high-risk,0,0
90193,breast,0,0
90194,cancer,0,0
90195,after,0,0
90196,surgical,0,1
90197,resection,0,1
90198,were,0,0
90199,enrolled,0,0
90200,into,0,0
90201,this,0,0
90202,study,0,0
90203,.,0,0
90204,The,0,0
90205,patients,0,0
90206,were,0,0
90207,divided,0,0
90208,into,0,0
90209,two,0,0
90210,groups,0,0
90211,:,0,0
90212,dose-dense,0,1
90213,and,0,0
90214,regular,0,0
90215,groups,0,0
90216,.,0,0
90217,Each,0,0
90218,patient,0,0
90219,received,0,0
90220,6,1,0
90221,cycles,1,0
90222,of,1,0
90223,chemotherapy,1,1
90224,with,1,0
90225,intravenous,1,1
90226,administration,1,0
90227,of,1,0
90228,paclitaxel,1,1
90229,(,1,0
90230,175,1,0
90231,mg/m2,1,1
90232,",",1,0
90233,on,1,0
90234,D3,1,1
90235,),1,1
90236,and,1,0
90237,epirubicin,1,1
90238,(,1,0
90239,60,1,0
90240,mg/m2,1,1
90241,",",1,0
90242,on,1,0
90243,Dl,1,1
90244,and,1,0
90245,D2,1,1
90246,),1,0
90247,.,1,0
90248,The,0,0
90249,dose-dense,1,1
90250,group,1,0
90251,had,1,0
90252,repeated,1,0
90253,treatment,1,0
90254,every,1,1
90255,two,1,0
90256,weeks,1,0
90257,",",0,0
90258,while,0,0
90259,the,0,0
90260,regular,1,1
90261,group,1,0
90262,repeated,1,0
90263,it,1,0
90264,every,1,0
90265,three,1,0
90266,weeks,1,0
90267,.,1,0
90268,G-CSF,1,0
90269,was,1,0
90270,used,1,0
90271,in,1,0
90272,a,1,0
90273,dose,1,0
90274,of,1,0
90275,3,1,0
90276,microg/kg,1,1
90277,on,1,0
90278,D5-D9,1,1
90279,during,0,0
90280,each,0,0
90281,cycle,0,0
90282,in,0,0
90283,the,0,0
90284,dose-dense,0,1
90285,group,0,0
90286,.,0,0
90287,While,0,0
90288,in,0,0
90289,the,0,0
90290,regular,0,1
90291,group,0,0
90292,",",0,0
90293,it,0,0
90294,was,0,0
90295,used,0,0
90296,only,0,0
90297,under,0,0
90298,the,0,0
90299,condition,0,0
90300,that,0,0
90301,grade,0,0
90302,II,0,0
90303,neutropenia,0,0
90304,occurred,0,0
90305,.,0,0
90306,RESULTS,0,0
90307,The,0,0
90308,toxicity,0,0
90309,could,0,0
90310,be,0,0
90311,evaluated,0,0
90312,in,0,0
90313,101,0,0
90314,patients,0,0
90315,.,0,0
90316,Major,0,0
90317,grade,0,0
90318,II-IV,0,1
90319,toxicities,0,0
90320,included,0,0
90321,:,0,0
90322,neutropenia,0,0
90323,",",0,0
90324,nausea,0,0
90325,",",0,0
90326,vomiting,0,0
90327,and,0,0
90328,alopecia,0,0
90329,.,0,0
90330,The,0,0
90331,incidence,0,0
90332,of,0,0
90333,grade,0,0
90334,III-IV,0,1
90335,neutropenia,0,0
90336,was,0,0
90337,16.0,0,0
90338,%,0,0
90339,in,0,0
90340,the,0,0
90341,dose-dense,0,1
90342,group,0,0
90343,versus,0,1
90344,54.9,0,0
90345,%,0,0
90346,in,0,0
90347,the,0,0
90348,regular,0,1
90349,group,0,0
90350,(,0,0
90351,P,0,0
90352,=,0,0
90353,0.000,0,0
90354,),0,0
90355,;,0,0
90356,postponing,0,0
90357,of,0,0
90358,chemotherapy,0,1
90359,was,0,0
90360,2.4,0,0
90361,%,0,0
90362,versus,0,1
90363,6.0,0,0
90364,%,0,0
90365,(,0,0
90366,P,0,0
90367,=,0,0
90368,0.027,0,0
90369,),0,0
90370,.,0,0
90371,Ninety-eight,0,0
90372,patients,0,0
90373,completed,0,0
90374,the,0,0
90375,chemotherapy,0,1
90376,as,0,0
90377,planed,0,0
90378,.,0,0
90379,After,0,0
90380,a,0,0
90381,median,0,0
90382,follow-up,0,0
90383,of,0,0
90384,24,0,0
90385,months,0,0
90386,",",0,0
90387,the,0,0
90388,median,0,0
90389,DFS,0,0
90390,and,0,0
90391,OS,0,0
90392,were,0,0
90393,not,0,0
90394,reached,0,0
90395,.,0,0
90396,The,0,0
90397,relapse-free,0,0
90398,rate,0,0
90399,and,0,0
90400,survival,0,0
90401,rate,0,0
90402,were,0,0
90403,89.8,0,0
90404,%,0,0
90405,and,0,0
90406,100,0,1
90407,%,0,0
90408,in,0,0
90409,the,0,0
90410,dose-dense,0,1
90411,group,0,0
90412,",",0,0
90413,which,0,0
90414,were,0,0
90415,87.8,0,0
90416,%,0,0
90417,and,0,0
90418,93.9,0,0
90419,%,0,0
90420,in,0,0
90421,the,0,0
90422,regular,0,0
90423,group,0,0
90424,.,0,0
90425,The,0,0
90426,relapse-free,0,0
90427,rate,0,0
90428,of,0,0
90429,the,0,0
90430,high-risk,0,0
90431,patients,0,0
90432,in,0,0
90433,the,0,0
90434,dose-dense,0,1
90435,group,0,0
90436,was,0,0
90437,86.8,0,0
90438,%,0,0
90439,versus,0,1
90440,81.3,0,0
90441,%,0,0
90442,in,0,0
90443,the,0,0
90444,regular,0,1
90445,group,0,0
90446,",",0,0
90447,and,0,0
90448,the,0,0
90449,corresponding,0,0
90450,survival,0,0
90451,rate,0,0
90452,was,0,0
90453,100,0,0
90454,%,0,0
90455,versus,0,1
90456,90.6,0,0
90457,%,0,0
90458,.,0,0
90459,CONCLUSION,0,0
90460,Adjuvant,1,0
90461,dose-dense,1,1
90462,chemotherapy,1,1
90463,with,1,0
90464,paclitaxel,1,1
90465,and,1,0
90466,epirubicin,1,1
90467,is,0,0
90468,safe,0,0
90469,",",0,0
90470,tolerable,0,0
90471,and,0,0
90472,promising,0,0
90473,for,0,0
90474,high-risk,0,0
90475,breast,0,0
90476,cancer,0,0
90477,.,0,0
90478,Three-year,0,0
90479,clinical,0,0
90480,outcome,0,0
90481,after,0,0
90482,primary,0,0
90483,stenting,0,1
90484,of,0,0
90485,totally,0,1
90486,occluded,0,1
90487,native,0,0
90488,coronary,0,0
90489,arteries,0,0
90490,:,0,0
90491,a,0,0
90492,randomized,0,0
90493,comparison,0,0
90494,of,0,0
90495,bare-metal,1,1
90496,stent,1,1
90497,implantation,1,0
90498,with,1,0
90499,sirolimus-eluting,1,1
90500,stent,1,1
90501,implantation,1,0
90502,for,0,0
90503,the,0,0
90504,treatment,0,0
90505,of,0,0
90506,total,0,0
90507,coronary,0,0
90508,occlusions,0,0
90509,(,0,0
90510,Primary,0,0
90511,Stenting,0,1
90512,of,0,0
90513,Totally,0,0
90514,Occluded,0,1
90515,Native,0,0
90516,Coronary,0,0
90517,Arteries,0,1
90518,[,0,0
90519,PRISON,0,1
90520,],0,1
90521,II,0,1
90522,study,0,0
90523,),0,0
90524,.,0,0
90525,BACKGROUND,0,0
90526,The,0,0
90527,purpose,0,0
90528,of,0,0
90529,this,0,0
90530,study,0,0
90531,was,0,0
90532,to,0,0
90533,examine,0,0
90534,the,0,0
90535,3-year,0,0
90536,clinical,0,0
90537,outcome,0,0
90538,in,0,0
90539,patients,0,0
90540,enrolled,0,0
90541,in,0,0
90542,the,0,0
90543,Primary,0,0
90544,Stenting,0,1
90545,of,0,0
90546,Totally,0,0
90547,Occluded,0,1
90548,Native,0,0
90549,Coronary,0,0
90550,Arteries,0,1
90551,II,0,0
90552,study,0,0
90553,.,0,0
90554,METHODS,0,0
90555,Patients,0,0
90556,with,0,0
90557,totally,0,1
90558,occluded,0,1
90559,coronary,0,0
90560,arteries,0,0
90561,randomized,0,0
90562,to,0,0
90563,either,0,0
90564,sirolimus-eluting,1,1
90565,Cypher,1,1
90566,stents,1,1
90567,(,1,0
90568,SESs,1,1
90569,),1,1
90570,(,0,0
90571,Cordis,0,0
90572,",",0,0
90573,a,0,0
90574,Johnson,0,0
90575,&,0,1
90576,Joshson,0,1
90577,Company,0,0
90578,",",0,0
90579,Miami,0,1
90580,Lakes,0,0
90581,",",0,0
90582,FL,0,1
90583,),0,1
90584,(,0,0
90585,100,0,1
90586,patients,0,0
90587,),0,0
90588,or,0,1
90589,bare-metal,1,1
90590,BxVelocity,1,0
90591,stents,1,1
90592,(,1,0
90593,BMSs,1,1
90594,),1,1
90595,(,0,1
90596,Cordis,0,1
90597,),0,1
90598,(,0,0
90599,100,0,1
90600,patients,0,0
90601,),0,0
90602,were,0,0
90603,followed,0,1
90604,clinically,0,0
90605,for,0,0
90606,3,0,0
90607,years,0,0
90608,.,0,0
90609,RESULTS,0,0
90610,Between,0,0
90611,1,0,0
90612,and,0,0
90613,3,0,0
90614,years,0,0
90615,",",0,0
90616,there,0,0
90617,were,0,0
90618,infrequent,0,0
90619,additional,0,0
90620,clinical,0,0
90621,events,0,0
90622,that,0,0
90623,were,0,0
90624,equally,0,0
90625,distributed,0,0
90626,between,0,0
90627,the,0,0
90628,SES,0,1
90629,and,0,0
90630,the,0,0
90631,BMS,0,1
90632,group,0,0
90633,.,0,0
90634,After,0,0
90635,3,0,0
90636,years,0,0
90637,",",0,0
90638,target,0,0
90639,lesion,0,0
90640,revascularization,0,0
90641,was,0,0
90642,7,0,0
90643,%,0,0
90644,in,0,0
90645,the,0,0
90646,SES,0,1
90647,group,0,0
90648,versus,0,1
90649,27,0,0
90650,%,0,0
90651,in,0,0
90652,the,0,0
90653,BMS,0,1
90654,group,0,0
90655,(,0,0
90656,P,0,0
90657,<,0,0
90658,.001,0,0
90659,),0,1
90660,;,0,0
90661,and,0,0
90662,target,0,0
90663,vessel,0,0
90664,revascularization,0,0
90665,was,0,0
90666,seen,0,0
90667,in,0,0
90668,11,0,0
90669,%,0,0
90670,in,0,0
90671,the,0,0
90672,SES,0,1
90673,group,0,0
90674,versus,0,1
90675,30,0,0
90676,%,0,0
90677,in,0,0
90678,the,0,0
90679,BMS,0,1
90680,group,0,0
90681,(,0,0
90682,P,0,0
90683,=,0,0
90684,.002,0,0
90685,),0,0
90686,.,0,0
90687,Major,0,0
90688,adverse,0,0
90689,cardiac,0,0
90690,events,0,0
90691,were,0,0
90692,noted,0,0
90693,in,0,0
90694,10,0,0
90695,%,0,0
90696,of,0,0
90697,the,0,0
90698,SES,0,1
90699,group,0,0
90700,versus,0,1
90701,34,0,0
90702,%,0,0
90703,in,0,0
90704,the,0,0
90705,BMS,0,1
90706,group,0,0
90707,(,0,0
90708,P,0,0
90709,<,0,0
90710,.001,0,0
90711,),0,0
90712,.,0,0
90713,There,0,0
90714,were,0,0
90715,no,0,0
90716,statistically,0,0
90717,significant,0,0
90718,differences,0,0
90719,in,0,0
90720,death,0,0
90721,",",0,0
90722,myocardial,0,0
90723,infarction,0,0
90724,",",0,0
90725,and,0,0
90726,stent,0,1
90727,thrombosis,0,0
90728,according,0,0
90729,to,0,0
90730,the,0,0
90731,Academic,0,0
90732,Research,0,0
90733,Consortium,0,0
90734,criteria,0,0
90735,between,0,0
90736,the,0,0
90737,2,0,0
90738,groups,0,0
90739,.,0,0
90740,CONCLUSIONS,0,0
90741,Clinical,0,0
90742,outcome,0,0
90743,up,0,0
90744,to,0,0
90745,3,0,0
90746,years,0,0
90747,after,0,0
90748,implantation,0,0
90749,of,0,0
90750,SESs,1,0
90751,for,0,0
90752,total,0,0
90753,coronary,0,0
90754,occlusions,0,0
90755,continues,0,0
90756,to,0,0
90757,demonstrate,0,0
90758,a,0,0
90759,significant,0,0
90760,reduction,0,0
90761,in,0,0
90762,adverse,0,0
90763,clinical,0,0
90764,events,0,0
90765,compared,0,0
90766,with,0,0
90767,BMSs,1,0
90768,without,0,0
90769,the,0,0
90770,evidence,0,0
90771,for,0,0
90772,either,0,1
90773,disproportionate,0,0
90774,late,0,0
90775,restenosis,0,0
90776,or,0,1
90777,late,0,0
90778,stent,0,1
90779,thrombosis,0,0
90780,.,0,0
90781,A,0,0
90782,randomized,0,0
90783,comparison,0,0
90784,of,0,0
90785,parecoxib/valdecoxib,1,1
90786,and,0,0
90787,placebo,1,1
90788,for,0,0
90789,the,0,0
90790,prevention,0,0
90791,of,0,0
90792,cystoid,0,1
90793,macular,0,0
90794,edema,0,0
90795,after,0,0
90796,scleral,0,1
90797,buckling,0,1
90798,surgery,0,1
90799,.,0,0
90800,AIMS,0,0
90801,To,0,0
90802,assess,0,0
90803,the,0,0
90804,impact,0,0
90805,of,0,0
90806,valdecoxib,1,1
90807,on,0,0
90808,the,0,0
90809,incidence,0,0
90810,of,0,0
90811,macular,0,0
90812,edema,0,0
90813,",",0,0
90814,after,0,0
90815,scleral,0,1
90816,buckling,0,1
90817,surgery,0,1
90818,.,0,0
90819,METHODS,0,0
90820,Prospective,0,0
90821,randomized,0,0
90822,double,0,1
90823,masked,0,0
90824,placebo,1,1
90825,controlled,0,0
90826,study,0,0
90827,.,0,0
90828,Patients,0,0
90829,undergoing,0,0
90830,scleral,0,1
90831,buckle,0,1
90832,surgery,0,1
90833,over,0,0
90834,18,0,0
90835,months,0,0
90836,were,0,0
90837,recruited,0,0
90838,and,0,0
90839,randomized,0,0
90840,to,0,0
90841,receive,0,0
90842,either,0,1
90843,oral,1,1
90844,valdecoxib,1,1
90845,or,1,1
90846,placebo,1,1
90847,.,1,0
90848,Patients,0,0
90849,also,0,0
90850,received,0,0
90851,two,0,0
90852,doses,0,0
90853,of,0,0
90854,either,0,1
90855,parecoxib,1,1
90856,(,1,0
90857,pro-drug,1,1
90858,of,1,0
90859,valdecoxib,1,1
90860,),1,0
90861,intravenously,1,1
90862,40,0,0
90863,mg,0,0
90864,6,0,0
90865,hourly,0,0
90866,day,0,0
90867,one,0,0
90868,postoperative,0,0
90869,or,0,1
90870,identical,1,0
90871,placebo,1,1
90872,injection,1,1
90873,Patients,0,0
90874,underwent,0,0
90875,retinal,0,0
90876,examination,0,0
90877,",",0,0
90878,optical,0,1
90879,coherence,0,0
90880,tomography,0,1
90881,and,0,0
90882,retinal,0,1
90883,thickness,0,0
90884,analyzer,0,1
90885,scan,0,1
90886,of,0,0
90887,the,0,0
90888,macula,0,0
90889,preoperatively,0,0
90890,",",0,0
90891,and,0,0
90892,at,0,0
90893,2,0,0
90894,and,0,0
90895,6,0,0
90896,weeks,0,0
90897,postoperatively,0,0
90898,.,0,0
90899,Outcome,0,0
90900,measures,0,0
90901,were,0,0
90902,the,0,0
90903,incidence,0,0
90904,of,0,0
90905,macular,0,0
90906,edema,0,0
90907,",",0,0
90908,retinal,0,0
90909,thickness,0,0
90910,",",0,0
90911,visual,0,0
90912,acuity,0,0
90913,",",0,0
90914,contrast,0,1
90915,sensitivity,0,0
90916,and,0,0
90917,presence,0,0
90918,of,0,0
90919,persistent,0,0
90920,subretinal,0,0
90921,fluid,0,1
90922,.,0,0
90923,RESULTS,0,0
90924,Interim,0,0
90925,analysis,0,0
90926,was,0,0
90927,performed,0,0
90928,with,0,0
90929,116,0,0
90930,patients,0,0
90931,were,0,0
90932,recruited,0,0
90933,",",0,0
90934,58,0,0
90935,to,0,0
90936,each,0,0
90937,treatment,0,0
90938,arm,0,0
90939,.,0,0
90940,The,0,0
90941,incidence,0,0
90942,of,0,0
90943,macular,0,0
90944,edema,0,0
90945,in,0,0
90946,all,0,0
90947,patients,0,0
90948,was,0,0
90949,5,0,0
90950,%,0,0
90951,at,0,0
90952,visit,0,0
90953,1,0,0
90954,and,0,0
90955,2.2,0,0
90956,%,0,0
90957,at,0,0
90958,visit,0,0
90959,2,0,0
90960,postoperatively,0,0
90961,.,0,0
90962,This,0,0
90963,incidence,0,0
90964,was,0,0
90965,much,0,0
90966,lower,0,0
90967,than,0,0
90968,the,0,0
90969,expected,0,0
90970,incidence,0,0
90971,used,0,0
90972,in,0,0
90973,the,0,0
90974,power,0,0
90975,calculation,0,0
90976,to,0,0
90977,determine,0,0
90978,study,0,0
90979,size,0,0
90980,.,0,0
90981,It,0,0
90982,was,0,0
90983,therefore,0,0
90984,apparent,0,0
90985,that,0,0
90986,a,0,0
90987,much,0,0
90988,larger,0,0
90989,study,0,0
90990,population,0,0
90991,would,0,0
90992,be,0,0
90993,required,0,0
90994,to,0,0
90995,test,0,0
90996,for,0,0
90997,an,0,0
90998,effect,0,0
90999,and,0,0
91000,that,0,0
91001,this,0,0
91002,was,0,0
91003,not,0,0
91004,achievable,0,0
91005,within,0,0
91006,the,0,0
91007,study,0,0
91008,time,0,0
91009,period,0,0
91010,.,0,0
91011,The,0,0
91012,study,0,0
91013,was,0,0
91014,therefore,0,0
91015,terminated,0,0
91016,early,0,0
91017,.,0,0
91018,There,0,0
91019,was,0,0
91020,no,0,0
91021,evidence,0,0
91022,of,0,0
91023,a,0,0
91024,difference,0,0
91025,between,0,0
91026,COX,0,0
91027,2,0,1
91028,inhibitor,0,1
91029,and,0,0
91030,placebo,0,1
91031,groups,0,0
91032,in,0,0
91033,the,0,0
91034,incidence,0,0
91035,of,0,0
91036,edema,0,0
91037,",",0,0
91038,retinal,0,0
91039,thickness,0,0
91040,or,0,1
91041,visual,0,0
91042,outcome,0,0
91043,.,0,0
91044,The,0,0
91045,presence,0,0
91046,of,0,0
91047,residual,0,0
91048,subretinal,0,0
91049,fluid,0,1
91050,at,0,0
91051,the,0,0
91052,macula,0,0
91053,was,0,0
91054,significantly,0,0
91055,reduced,0,0
91056,by,0,0
91057,COX,0,0
91058,2,0,0
91059,inhibitor,0,1
91060,treatment,0,0
91061,.,0,0
91062,CONCLUSIONS,0,0
91063,The,0,0
91064,rate,0,0
91065,of,0,0
91066,cystoid,0,1
91067,macular,0,0
91068,edema,0,0
91069,after,0,0
91070,scleral,0,1
91071,buckling,0,1
91072,surgery,0,1
91073,is,0,0
91074,low,0,0
91075,and,0,0
91076,is,0,0
91077,not,0,0
91078,influenced,0,0
91079,by,0,0
91080,prophylactic,0,1
91081,use,0,0
91082,of,0,0
91083,valdecoxib,1,1
91084,.,1,0
91085,The,0,0
91086,rate,0,0
91087,of,0,0
91088,residual,0,0
91089,subretinal,0,0
91090,fluid,0,1
91091,was,0,0
91092,reduced,0,0
91093,by,0,0
91094,COX,0,0
91095,2,0,0
91096,inhibitor,0,1
91097,treatment,0,0
91098,.,0,0
91099,Enhanced,0,0
91100,antiinflammatory,0,1
91101,therapy,0,1
91102,has,0,0
91103,the,0,0
91104,potential,0,0
91105,to,0,0
91106,improve,0,0
91107,outcomes,0,0
91108,in,0,0
91109,scleral,0,1
91110,buckling,0,1
91111,surgery,0,0
91112,.,0,0
91113,Two,0,0
91114,different,0,0
91115,methods,0,0
91116,for,0,0
91117,donor,0,0
91118,hepatic,0,0
91119,transection,0,1
91120,:,0,1
91121,cavitron,1,1
91122,ultrasonic,1,1
91123,surgical,1,1
91124,aspirator,1,1
91125,with,1,0
91126,bipolar,1,1
91127,cautery,1,1
91128,versus,0,1
91129,cavitron,1,1
91130,ultrasonic,1,1
91131,surgical,1,1
91132,aspirator,1,1
91133,with,1,0
91134,radiofrequency,1,1
91135,coagulator-A,1,1
91136,randomized,0,0
91137,controlled,0,0
91138,trial,0,0
91139,.,0,0
91140,The,0,0
91141,aim,0,0
91142,of,0,0
91143,this,0,0
91144,study,0,0
91145,was,0,0
91146,to,0,0
91147,compare,0,0
91148,the,0,0
91149,Cavitron,1,1
91150,ultrasonic,1,1
91151,surgical,1,1
91152,aspirator,1,1
91153,(,1,1
91154,CUSA,1,0
91155,),1,1
91156,with,1,0
91157,bipolar,1,1
91158,cautery,1,1
91159,(,1,1
91160,BP,1,0
91161,),1,1
91162,to,1,0
91163,CUSA,1,0
91164,with,1,0
91165,a,1,0
91166,radiofrequency,1,1
91167,coagulator,1,1
91168,[,0,1
91169,TissueLink,0,1
91170,(,0,1
91171,TL,0,0
91172,),0,1
91173,],0,0
91174,in,0,0
91175,terms,0,0
91176,of,0,0
91177,efficacy,0,0
91178,and,0,0
91179,safety,0,0
91180,for,0,0
91181,hepatic,0,0
91182,transection,0,1
91183,in,0,0
91184,living,0,0
91185,donor,0,0
91186,liver,0,0
91187,transplantation,0,0
91188,.,0,0
91189,Twenty-four,0,0
91190,living,0,0
91191,liver,0,0
91192,donors,0,1
91193,(,0,0
91194,n,0,0
91195,=,0,0
91196,12,0,0
91197,for,0,0
91198,each,0,0
91199,group,0,0
91200,),0,0
91201,were,0,0
91202,randomized,0,0
91203,to,0,0
91204,undergo,0,0
91205,hepatic,0,0
91206,transection,0,1
91207,using,0,0
91208,CUSA,1,0
91209,with,1,0
91210,BP,1,0
91211,or,0,1
91212,CUSA,1,0
91213,with,1,0
91214,TL,1,0
91215,.,1,0
91216,Blood,0,0
91217,loss,0,0
91218,during,0,0
91219,parenchymal,0,0
91220,transection,0,1
91221,and,0,0
91222,speed,0,0
91223,of,0,0
91224,transection,0,1
91225,were,0,0
91226,the,0,0
91227,primary,0,0
91228,endpoints,0,0
91229,",",0,0
91230,whereas,0,0
91231,the,0,0
91232,degree,0,0
91233,of,0,0
91234,postoperative,0,0
91235,liver,0,0
91236,injury,0,0
91237,and,0,0
91238,morbidity,0,0
91239,were,0,0
91240,secondary,0,0
91241,endpoints,0,0
91242,.,0,0
91243,Median,0,0
91244,blood,0,0
91245,loss,0,0
91246,during,0,0
91247,liver,0,0
91248,transection,0,1
91249,was,0,0
91250,significantly,0,0
91251,lower,0,0
91252,in,0,0
91253,the,0,0
91254,TL,0,0
91255,group,0,0
91256,than,0,0
91257,in,0,0
91258,the,0,0
91259,BP,0,0
91260,group,0,0
91261,(,0,0
91262,195.2,0,0
91263,+/-,0,0
91264,84.5,0,0
91265,versus,0,0
91266,343.3,0,0
91267,+/-,0,0
91268,198.4,0,0
91269,mL,0,0
91270,;,0,0
91271,P,0,0
91272,=,0,0
91273,0.023,0,0
91274,),0,0
91275,",",0,0
91276,and,0,0
91277,liver,0,0
91278,transection,0,1
91279,was,0,0
91280,significantly,0,0
91281,faster,0,0
91282,in,0,0
91283,the,0,0
91284,TL,0,0
91285,group,0,0
91286,than,0,0
91287,in,0,0
91288,the,0,0
91289,BP,0,0
91290,group,0,0
91291,(,0,0
91292,0.7,0,0
91293,+/-,0,0
91294,0.2,0,1
91295,versus,0,0
91296,0.5,0,1
91297,+/-,0,0
91298,0.2,0,1
91299,cm,0,0
91300,(,0,0
91301,2,0,0
91302,),0,0
91303,/minute,0,0
91304,;,0,0
91305,P,0,0
91306,=,0,0
91307,0.048,0,0
91308,),0,0
91309,.,0,0
91310,Significantly,0,0
91311,fewer,0,0
91312,ties,0,0
91313,were,0,0
91314,required,0,0
91315,during,0,0
91316,liver,0,0
91317,transection,0,1
91318,in,0,0
91319,the,0,0
91320,TL,0,0
91321,group,0,0
91322,than,0,0
91323,in,0,0
91324,the,0,0
91325,BP,0,0
91326,group,0,0
91327,(,0,0
91328,15.8,0,0
91329,+/-,0,0
91330,4.8,0,0
91331,versus,0,0
91332,22.8,0,0
91333,+/-,0,0
91334,7.9,0,0
91335,ties,0,0
91336,;,0,0
91337,P,0,0
91338,=,0,0
91339,0.023,0,0
91340,),0,0
91341,.,0,0
91342,The,0,0
91343,morbidity,0,0
91344,rates,0,0
91345,were,0,0
91346,similar,0,0
91347,for,0,0
91348,the,0,0
91349,2,0,0
91350,groups,0,0
91351,.,0,0
91352,In,0,0
91353,conclusion,0,0
91354,",",0,0
91355,CUSA,0,0
91356,with,0,0
91357,TL,0,0
91358,is,0,0
91359,superior,0,0
91360,to,0,0
91361,CUSA,0,0
91362,with,0,0
91363,BP,0,0
91364,for,0,0
91365,donor,0,0
91366,hepatectomy,0,1
91367,in,0,0
91368,terms,0,0
91369,of,0,0
91370,blood,0,0
91371,loss,0,0
91372,and,0,0
91373,speed,0,0
91374,of,0,0
91375,transection,0,1
91376,with,0,0
91377,no,0,0
91378,increase,0,0
91379,in,0,0
91380,morbidity,0,0
91381,.,0,0
91382,A,0,0
91383,double-blind,0,0
91384,",",0,0
91385,placebo-controlled,1,1
91386,trial,0,0
91387,of,0,0
91388,oral,1,1
91389,human,1,1
91390,immunoglobulin,1,1
91391,for,0,0
91392,gastrointestinal,0,0
91393,dysfunction,0,0
91394,in,0,0
91395,children,0,0
91396,with,0,0
91397,autistic,0,0
91398,disorder,0,0
91399,.,0,0
91400,Controversy,0,0
91401,exists,0,0
91402,regarding,0,0
91403,the,0,0
91404,extent,0,0
91405,and,0,0
91406,possible,0,0
91407,causal,0,0
91408,relationship,0,0
91409,between,0,0
91410,gastrointestinal,0,0
91411,symptoms,0,0
91412,and,0,0
91413,autism,0,0
91414,.,0,0
91415,A,0,0
91416,randomized,0,0
91417,",",0,0
91418,double-blind,0,0
91419,",",0,0
91420,placebo-controlled,1,1
91421,",",0,0
91422,parallel,0,0
91423,groups,0,0
91424,",",0,0
91425,dose-ranging,0,0
91426,study,0,0
91427,of,0,0
91428,oral,1,1
91429,",",1,0
91430,human,1,1
91431,immunoglobulin,1,1
91432,(,1,0
91433,IGOH,1,1
91434,140,0,0
91435,",",0,0
91436,420,0,0
91437,",",0,0
91438,or,0,0
91439,840,0,0
91440,mg/day,0,1
91441,),0,0
91442,was,0,0
91443,utilized,0,0
91444,with,0,0
91445,125,0,0
91446,children,0,0
91447,(,0,0
91448,ages,0,0
91449,2-17,0,0
91450,years,0,0
91451,),0,0
91452,with,0,0
91453,autism,0,0
91454,and,0,0
91455,persistent,0,0
91456,GI,0,0
91457,symptoms,0,0
91458,.,0,0
91459,Endpoint,0,0
91460,analysis,0,0
91461,revealed,0,0
91462,no,0,0
91463,significant,0,0
91464,differences,0,0
91465,across,0,0
91466,treatment,0,0
91467,groups,0,0
91468,on,0,0
91469,a,0,0
91470,modified,0,0
91471,global,0,0
91472,improvement,0,0
91473,scale,0,0
91474,(,0,0
91475,validated,0,0
91476,in,0,0
91477,irritable,0,0
91478,bowel,0,0
91479,syndrome,0,0
91480,studies,0,0
91481,),0,0
91482,",",0,0
91483,number,0,0
91484,of,0,0
91485,daily,0,1
91486,bowel,0,0
91487,movements,0,0
91488,",",0,0
91489,days,0,0
91490,of,0,0
91491,constipation,0,0
91492,",",0,0
91493,or,0,1
91494,severity,0,0
91495,of,0,0
91496,problem,0,0
91497,behaviors,0,0
91498,.,0,0
91499,IGOH,1,0
91500,was,0,0
91501,well-tolerated,0,0
91502,;,0,0
91503,there,0,0
91504,were,0,0
91505,no,0,0
91506,serious,0,0
91507,adverse,0,0
91508,events,0,0
91509,.,0,0
91510,This,0,0
91511,study,0,0
91512,demonstrates,0,0
91513,the,0,0
91514,importance,0,0
91515,of,0,0
91516,conducting,0,1
91517,rigorous,0,0
91518,trials,0,0
91519,in,0,0
91520,children,0,0
91521,with,0,0
91522,autism,0,0
91523,and,0,0
91524,casts,0,1
91525,doubt,0,0
91526,on,0,0
91527,one,0,0
91528,GI,0,0
91529,mechanism,0,0
91530,presumed,0,0
91531,to,0,0
91532,exert,0,0
91533,etiological,0,0
91534,and/or,0,0
91535,symptomatic,0,0
91536,effects,0,0
91537,in,0,0
91538,this,0,0
91539,population,0,0
91540,.,0,0
91541,Adjuvant,0,1
91542,goserelin,0,1
91543,and,0,0
91544,ovarian,0,0
91545,preservation,0,0
91546,in,0,0
91547,chemotherapy,0,1
91548,treated,0,0
91549,patients,0,0
91550,with,0,0
91551,early,0,0
91552,breast,0,0
91553,cancer,0,0
91554,:,0,0
91555,results,0,0
91556,from,0,0
91557,a,0,0
91558,randomized,0,0
91559,trial,0,0
91560,.,0,0
91561,The,0,0
91562,purpose,0,0
91563,of,0,0
91564,this,0,0
91565,randomized,0,0
91566,study,0,0
91567,was,0,0
91568,to,0,0
91569,examine,0,0
91570,if,0,0
91571,goserelin,0,1
91572,concomitant,0,0
91573,to,0,0
91574,CMF-chemotherapy,0,1
91575,as,0,0
91576,adjuvant,0,1
91577,treatment,0,0
91578,for,0,0
91579,premenopausal,0,1
91580,breast,0,0
91581,cancer,0,0
91582,",",0,0
91583,protects,0,0
91584,the,0,0
91585,ovaries,0,0
91586,from,0,0
91587,premature,0,0
91588,failure,0,0
91589,.,0,0
91590,A,0,0
91591,total,0,0
91592,of,0,0
91593,285,0,0
91594,premenopausal,0,1
91595,breast,0,0
91596,cancer,0,0
91597,patients,0,0
91598,",",0,0
91599,in,0,0
91600,a,0,0
91601,randomized,0,0
91602,adjuvant,0,1
91603,trial,0,0
91604,(,1,0
91605,Zoladex,1,1
91606,in,0,0
91607,premenopausal,0,1
91608,patients,0,0
91609,(,0,0
91610,ZIPP,0,1
91611,),0,1
91612,),0,0
91613,",",0,0
91614,were,0,0
91615,assigned,0,0
91616,to,0,0
91617,a,0,0
91618,study,0,0
91619,on,0,0
91620,ovarian,0,0
91621,function,0,0
91622,.,0,0
91623,Node,0,0
91624,positive,0,0
91625,patients,0,0
91626,were,0,0
91627,assigned,0,0
91628,to,0,0
91629,CMF-,1,1
91630,(,1,1
91631,cyclophosphamide,1,1
91632,",",1,1
91633,methotrexate,1,1
91634,and,1,1
91635,5-fluorouracil,1,1
91636,),1,1
91637,chemotherapy,1,1
91638,in,1,0
91639,addition,1,0
91640,to,1,0
91641,endocrine,1,0
91642,therapy,1,1
91643,.,1,0
91644,All,0,0
91645,patients,0,0
91646,were,0,0
91647,randomly,0,0
91648,assigned,0,0
91649,to,0,0
91650,receive,0,0
91651,2,0,0
91652,years,0,0
91653,of,0,0
91654,goserelin,1,1
91655,",",1,0
91656,goserelin,1,1
91657,plus,1,1
91658,tamoxifen,1,1
91659,",",1,0
91660,tamoxifen,1,1
91661,alone,1,1
91662,or,1,1
91663,no,1,0
91664,endocrine,1,0
91665,treatment,1,0
91666,.,1,0
91667,We,0,0
91668,studied,0,0
91669,",",0,0
91670,if,0,0
91671,menses,0,0
91672,were,0,0
91673,affected,0,0
91674,in,0,0
91675,the,0,0
91676,treatment,0,0
91677,groups,0,0
91678,",",0,0
91679,up,0,0
91680,to,0,0
91681,36,0,0
91682,months,0,0
91683,after,0,0
91684,randomization,0,0
91685,.,0,0
91686,One,0,0
91687,year,0,0
91688,after,0,0
91689,completed,0,0
91690,CMF-,0,0
91691,and,0,0
91692,endocrine,0,1
91693,therapy,0,1
91694,",",0,0
91695,36,0,0
91696,%,0,0
91697,of,0,0
91698,the,0,0
91699,women,0,0
91700,in,0,0
91701,the,0,0
91702,goserelin,0,1
91703,group,0,0
91704,reported,0,0
91705,menses,0,0
91706,",",0,0
91707,compared,0,0
91708,to,0,0
91709,7,0,0
91710,%,0,0
91711,in,0,0
91712,the,0,0
91713,goserelin,0,1
91714,plus,0,1
91715,tamoxifen,0,1
91716,group,0,0
91717,",",0,0
91718,13,0,0
91719,%,0,0
91720,in,0,0
91721,the,0,0
91722,tamoxifen,0,1
91723,group,0,0
91724,and,0,0
91725,10,0,1
91726,%,0,0
91727,of,0,0
91728,the,0,0
91729,controls,0,0
91730,.,0,0
91731,Among,0,0
91732,women,0,0
91733,treated,0,0
91734,with,0,0
91735,goserelin,0,1
91736,",",0,0
91737,there,0,0
91738,was,0,0
91739,a,0,0
91740,statistically,0,0
91741,significant,0,0
91742,increase,0,0
91743,in,0,0
91744,the,0,0
91745,proportion,0,0
91746,of,0,0
91747,menstruating,0,0
91748,women,0,0
91749,",",0,0
91750,1,0,0
91751,year,0,0
91752,after,0,0
91753,completed,0,0
91754,treatment,0,0
91755,compared,0,0
91756,to,0,0
91757,at,0,0
91758,24,0,0
91759,months,0,0
91760,of,0,0
91761,treatment,0,0
91762,(,0,0
91763,P,0,0
91764,=,0,0
91765,0.006,0,0
91766,),0,0
91767,",",0,0
91768,in,0,0
91769,contrast,0,0
91770,to,0,0
91771,all,0,0
91772,other,0,0
91773,treatment,0,0
91774,groups,0,0
91775,",",0,0
91776,who,0,0
91777,were,0,0
91778,unchanged,0,0
91779,or,0,1
91780,more,0,0
91781,often,0,0
91782,amenorrheic,0,0
91783,.,0,0
91784,In,0,0
91785,our,0,0
91786,study,0,0
91787,",",0,0
91788,there,0,0
91789,is,0,0
91790,some,0,0
91791,evidence,0,0
91792,of,0,0
91793,protective,0,0
91794,effect,0,0
91795,of,0,0
91796,goserelin,0,1
91797,on,0,0
91798,ovarian,0,0
91799,function,0,0
91800,in,0,0
91801,CMF,0,0
91802,treated,0,0
91803,women,0,0
91804,.,0,0
91805,This,0,0
91806,effect,0,0
91807,was,0,0
91808,not,0,0
91809,observed,0,0
91810,in,0,0
91811,the,0,0
91812,combined,0,1
91813,tamoxifen,0,1
91814,and,0,0
91815,goserelin,0,1
91816,treatment,0,0
91817,.,0,0
91818,Effects,0,0
91819,of,0,0
91820,propranolol,1,1
91821,on,0,0
91822,bone,0,0
91823,metabolism,0,0
91824,in,0,0
91825,the,0,0
91826,rat,0,0
91827,.,0,0
91828,Propranolol,1,1
91829,",",0,0
91830,a,0,0
91831,nonspecific,0,0
91832,beta-blocker,0,1
91833,has,0,0
91834,many,0,0
91835,physiologic,0,0
91836,effects,0,0
91837,.,0,0
91838,Its,0,0
91839,effects,0,0
91840,on,0,0
91841,bone,0,0
91842,in,0,0
91843,vivo,0,0
91844,are,0,0
91845,unknown,0,0
91846,",",0,0
91847,although,0,0
91848,beta,0,1
91849,receptor,0,0
91850,sites,0,0
91851,have,0,0
91852,been,0,0
91853,found,0,0
91854,on,0,0
91855,osteoblasts,0,0
91856,.,0,0
91857,In,0,0
91858,this,0,0
91859,study,0,0
91860,",",0,0
91861,the,0,0
91862,hypothesis,0,0
91863,tested,0,0
91864,was,0,0
91865,that,0,0
91866,low,0,0
91867,doses,0,0
91868,of,0,0
91869,propranolol,1,1
91870,could,0,0
91871,alter,0,0
91872,bone,0,0
91873,properties,0,0
91874,and,0,0
91875,enhance,0,0
91876,orthotopic,0,1
91877,endochondral,0,0
91878,bone,0,0
91879,formation,0,0
91880,.,0,0
91881,In,0,0
91882,a,0,0
91883,group,0,0
91884,of,0,0
91885,nonsurgical,0,0
91886,rats,0,1
91887,",",0,0
91888,propranolol,1,1
91889,treatment,0,0
91890,increased,0,0
91891,femoral,0,1
91892,torsional,0,1
91893,strength,0,0
91894,on,0,0
91895,biomechanical,0,0
91896,testing,0,0
91897,.,0,0
91898,In,0,0
91899,the,0,0
91900,rat,0,1
91901,surgical,0,1
91902,model,0,0
91903,used,0,0
91904,",",0,0
91905,right,0,0
91906,femora,0,0
91907,were,0,0
91908,fixed,0,0
91909,to,0,0
91910,a,0,0
91911,polyethylene,0,1
91912,plate,0,1
91913,and,0,0
91914,then,0,1
91915,defects,0,0
91916,were,0,0
91917,created,0,0
91918,mid-diaphysis,0,0
91919,and,0,0
91920,subsequently,0,1
91921,filled,0,1
91922,with,0,0
91923,demineralized,0,1
91924,bone,0,0
91925,matrix,0,1
91926,.,0,0
91927,These,0,0
91928,rats,0,1
91929,(,0,0
91930,defect,0,0
91931,rats,0,1
91932,),0,0
91933,were,0,0
91934,randomly,0,0
91935,divided,0,0
91936,into,0,0
91937,groups,0,0
91938,that,0,0
91939,were,0,0
91940,given,0,0
91941,propranolol,1,1
91942,or,0,0
91943,a,0,0
91944,saline,1,1
91945,carrier,0,0
91946,for,0,0
91947,19,0,0
91948,consecutive,0,0
91949,days,0,0
91950,.,0,0
91951,In,0,0
91952,the,0,0
91953,defect,0,0
91954,rats,0,1
91955,",",0,0
91956,increased,0,0
91957,trabecular,0,0
91958,femoral,0,1
91959,metaphyseal,0,1
91960,mineral,0,0
91961,apposition,0,0
91962,rates,0,0
91963,were,0,0
91964,observed,0,0
91965,in,0,0
91966,propranolol-treated,0,0
91967,groups,0,0
91968,.,0,0
91969,Densitometry,0,1
91970,and,0,0
91971,roentgenographic,0,0
91972,scoring,0,0
91973,of,0,0
91974,callus,0,0
91975,formation,0,0
91976,after,0,0
91977,12,0,0
91978,weeks,0,0
91979,in,0,0
91980,propranolol-treated,0,0
91981,rats,0,1
91982,revealed,0,0
91983,increased,0,0
91984,callus,0,0
91985,and,0,0
91986,bone,0,0
91987,union,0,0
91988,.,0,0
91989,The,0,0
91990,results,0,0
91991,of,0,0
91992,this,0,0
91993,study,0,0
91994,indicate,0,0
91995,that,0,0
91996,propranolol,1,1
91997,treatment,0,0
91998,can,0,0
91999,significantly,0,0
92000,affect,0,0
92001,bone,0,0
92002,properties,0,0
92003,.,0,0
92004,Cardiac,0,1
92005,failure,0,0
92006,:,0,0
92007,symptoms,0,0
92008,and,0,0
92009,functional,0,0
92010,status,0,0
92011,.,0,0
92012,The,0,0
92013,associations,0,0
92014,between,0,0
92015,exercise,0,1
92016,capacity,0,0
92017,",",0,0
92018,symptoms,0,0
92019,and,0,0
92020,specific,0,0
92021,aspects,0,0
92022,of,0,0
92023,quality,0,0
92024,of,0,0
92025,life,0,0
92026,were,0,0
92027,examined,0,0
92028,in,0,0
92029,subjects,0,0
92030,participating,0,0
92031,in,0,0
92032,a,0,0
92033,trial,0,0
92034,of,0,0
92035,the,0,0
92036,treatment,1,0
92037,of,1,0
92038,heart,1,0
92039,failure,1,0
92040,.,1,0
92041,Patients,1,0
92042,were,1,0
92043,assessed,1,0
92044,on,0,0
92045,entry,0,0
92046,and,0,0
92047,after,0,0
92048,three,0,0
92049,months,0,0
92050,treatment,1,0
92051,.,1,0
92052,The,0,0
92053,principle,0,0
92054,symptoms,0,0
92055,were,0,0
92056,fatigue,0,0
92057,",",0,0
92058,breathlessness,0,0
92059,and,0,0
92060,chest,0,1
92061,pain,0,0
92062,.,0,0
92063,These,0,0
92064,limited,0,0
92065,the,0,0
92066,extent,0,0
92067,and,0,0
92068,speed,0,0
92069,of,0,0
92070,physical,0,1
92071,activities,0,0
92072,",",0,0
92073,restricted,0,0
92074,social,0,0
92075,",",0,0
92076,leisure,0,1
92077,and,0,0
92078,family,0,1
92079,life,0,0
92080,and,0,0
92081,were,0,0
92082,associated,0,0
92083,with,0,0
92084,emotional,0,0
92085,distress,0,0
92086,.,0,0
92087,There,0,0
92088,were,0,0
92089,associations,0,0
92090,between,0,0
92091,baseline,0,0
92092,exercise,0,1
92093,capacity,0,0
92094,and,0,0
92095,measures,0,0
92096,of,0,0
92097,quality,0,0
92098,of,0,0
92099,life,0,0
92100,.,0,0
92101,Change,0,1
92102,in,0,0
92103,exercise,0,1
92104,capacity,0,0
92105,during,0,0
92106,three,0,0
92107,months,0,0
92108,treatment,1,0
92109,was,0,0
92110,correlated,0,0
92111,with,0,0
92112,changes,0,0
92113,in,0,0
92114,measures,0,0
92115,of,0,0
92116,symptoms,0,0
92117,",",0,0
92118,limitation,0,0
92119,of,0,0
92120,activity,0,0
92121,and,0,0
92122,quality,0,0
92123,of,0,0
92124,life,0,0
92125,.,0,0
92126,The,0,0
92127,findings,0,0
92128,confirm,0,0
92129,the,0,0
92130,value,0,0
92131,of,0,0
92132,change,0,0
92133,in,0,0
92134,exercise,0,1
92135,capacity,0,0
92136,as,0,0
92137,a,0,0
92138,measure,0,0
92139,of,0,0
92140,functional,0,0
92141,status,0,0
92142,and,0,0
92143,suggest,0,0
92144,that,0,0
92145,it,0,0
92146,should,0,0
92147,be,0,0
92148,supported,0,0
92149,by,0,0
92150,a,0,0
92151,limited,0,0
92152,number,0,0
92153,of,0,0
92154,specific,0,0
92155,measures,0,0
92156,of,0,0
92157,quality,0,0
92158,of,0,0
92159,life,0,0
92160,.,0,0
92161,Intensive,1,1
92162,insulin,1,1
92163,therapy,1,1
92164,on,0,0
92165,infection,0,0
92166,rate,0,0
92167,",",0,0
92168,days,0,0
92169,in,0,0
92170,NICU,0,0
92171,",",0,0
92172,in-hospital,0,0
92173,mortality,0,0
92174,and,0,0
92175,neurological,0,0
92176,outcome,0,0
92177,in,0,0
92178,severe,0,0
92179,traumatic,0,0
92180,brain,0,0
92181,injury,0,0
92182,patients,0,0
92183,:,0,0
92184,a,0,0
92185,randomized,0,0
92186,controlled,0,0
92187,trial,0,0
92188,.,0,0
92189,OBJECTIVES,0,0
92190,Evaluate,0,0
92191,the,0,0
92192,impact,0,0
92193,of,0,0
92194,an,0,0
92195,intensive,1,1
92196,insulin,1,1
92197,therapy,1,1
92198,and,0,0
92199,conventional,1,1
92200,glucose,1,1
92201,control,1,1
92202,protocol,1,1
92203,during,0,0
92204,staying,0,0
92205,in,0,0
92206,neurological,0,0
92207,intensive,0,1
92208,care,0,1
92209,unit,0,1
92210,(,0,1
92211,NICU,0,1
92212,),0,1
92213,on,0,0
92214,infection,0,0
92215,rate,0,0
92216,",",0,0
92217,days,0,0
92218,in,0,0
92219,NICU,0,0
92220,",",0,0
92221,in-hospital,0,0
92222,mortality,0,0
92223,and,0,0
92224,long-term,0,0
92225,neurological,0,0
92226,outcome,0,0
92227,in,0,0
92228,severe,0,0
92229,traumatic,0,0
92230,brain,0,0
92231,injury,0,0
92232,(,0,1
92233,TBI,0,0
92234,),0,0
92235,patients,0,0
92236,.,0,0
92237,METHODS,0,0
92238,A,0,0
92239,total,0,0
92240,of,0,0
92241,240,0,0
92242,patients,0,0
92243,with,0,0
92244,severe,0,0
92245,TBI,0,0
92246,(,0,0
92247,GCS,0,0
92248,score,0,0
92249,3-8,0,0
92250,),0,0
92251,admitted,0,0
92252,to,0,0
92253,NICU,0,0
92254,were,0,0
92255,prospectively,0,0
92256,enrolled,0,0
92257,and,0,0
92258,randomly,0,0
92259,assigned,0,0
92260,either,0,0
92261,to,0,0
92262,conventional,1,1
92263,insulin,1,1
92264,therapy,1,1
92265,or,0,1
92266,to,0,0
92267,intensive,1,1
92268,insulin,1,1
92269,therapy,1,1
92270,.,1,0
92271,Patients,0,0
92272,in,0,0
92273,intensive,1,0
92274,glucose,1,0
92275,control,1,1
92276,group,1,1
92277,(,0,1
92278,n=121,0,0
92279,),0,1
92280,received,0,1
92281,continuous,1,1
92282,insulin,1,1
92283,infusion,1,1
92284,to,0,0
92285,maintain,0,0
92286,glucose,0,0
92287,levels,0,0
92288,between,0,0
92289,4.4,0,0
92290,m,0,0
92291,mol/l,0,0
92292,(,0,0
92293,80,0,0
92294,mg/dl,0,0
92295,),0,0
92296,and,0,0
92297,6.1,0,0
92298,m,0,0
92299,mol/l,0,0
92300,(,0,0
92301,110,0,0
92302,mg/dl,0,0
92303,),0,0
92304,.,0,0
92305,Patients,0,0
92306,in,0,0
92307,the,0,0
92308,conventional,1,1
92309,treatment,1,1
92310,group,1,1
92311,(,0,1
92312,n=119,0,0
92313,),0,0
92314,were,0,0
92315,not,0,0
92316,given,0,0
92317,insulin,1,1
92318,unless,0,0
92319,glucose,0,0
92320,levels,0,0
92321,were,0,0
92322,greater,0,0
92323,than,0,0
92324,11.1,0,0
92325,m,0,0
92326,mol/l,0,0
92327,(,0,1
92328,200mg/dl,0,0
92329,),0,0
92330,.,0,0
92331,Both,0,1
92332,groups,0,0
92333,were,0,0
92334,treated,0,0
92335,with,0,0
92336,insulin,1,1
92337,infusion,0,1
92338,to,0,0
92339,maintain,0,0
92340,normoglycemia,0,1
92341,after,0,0
92342,leaving,0,0
92343,NICU,0,0
92344,.,0,0
92345,Comparison,0,0
92346,was,0,0
92347,made,0,0
92348,against,0,0
92349,conventional,1,1
92350,insulin,1,1
92351,therapy,1,1
92352,using,0,0
92353,a,0,0
92354,randomized,0,0
92355,trial,0,0
92356,design,0,0
92357,.,0,0
92358,The,0,0
92359,primary,0,0
92360,outcomes,0,0
92361,is,0,0
92362,the,0,0
92363,mortality,0,0
92364,rate,0,0
92365,at,0,0
92366,6,0,0
92367,months,0,0
92368,follow-up,0,0
92369,.,0,0
92370,The,0,0
92371,second,0,0
92372,outcomes,0,0
92373,including,0,0
92374,ICU,0,1
92375,infection,0,0
92376,rate,0,0
92377,",",0,0
92378,duration,0,0
92379,of,0,0
92380,ICU,0,1
92381,stay,0,0
92382,",",0,0
92383,in-hospital,0,0
92384,mortality,0,0
92385,rate,0,0
92386,and,0,0
92387,neurologic,0,0
92388,outcome,0,0
92389,at,0,0
92390,6,0,0
92391,months,0,0
92392,follow-up,0,0
92393,.,0,0
92394,RESULTS,0,0
92395,There,0,0
92396,was,0,0
92397,no,0,0
92398,significant,0,0
92399,difference,0,0
92400,in,0,0
92401,gender,0,0
92402,(,0,0
92403,66,0,0
92404,%,0,0
92405,vs.,0,0
92406,67,0,0
92407,%,0,0
92408,male,0,0
92409,),0,0
92410,",",0,0
92411,age,0,0
92412,(,0,0
92413,46+/-11,0,0
92414,years,0,0
92415,vs.,0,0
92416,45+/-10,0,0
92417,years,0,0
92418,),0,0
92419,",",0,0
92420,APACHE,0,0
92421,II,0,1
92422,score,0,0
92423,(,0,0
92424,30,0,0
92425,vs.,0,0
92426,29,0,0
92427,),0,0
92428,",",0,0
92429,TISS-28,0,1
92430,score,0,0
92431,(,0,0
92432,47,0,0
92433,vs.,0,0
92434,46,0,0
92435,),0,0
92436,",",0,0
92437,and,0,0
92438,Glasgow,0,0
92439,Coma,0,0
92440,Score,0,1
92441,(,0,0
92442,GCS,0,0
92443,",",0,0
92444,5.3,0,0
92445,vs.,0,0
92446,5.3,0,0
92447,),0,0
92448,between,0,0
92449,the,0,0
92450,two,0,0
92451,groups,0,0
92452,.,0,0
92453,Overall,0,0
92454,mortality,0,0
92455,rates,0,0
92456,at,0,0
92457,6,0,0
92458,months,0,0
92459,follow-up,0,0
92460,were,0,0
92461,similar,0,0
92462,in,0,0
92463,the,0,0
92464,2,0,0
92465,groups,0,0
92466,(,0,0
92467,61,0,0
92468,of,0,0
92469,117,0,0
92470,",",0,0
92471,52.1,0,0
92472,%,0,0
92473,vs.,0,0
92474,62,0,0
92475,of,0,0
92476,116,0,0
92477,",",0,0
92478,53.4,0,0
92479,%,0,0
92480,;,0,0
92481,P=0.8,0,0
92482,),0,0
92483,.,0,0
92484,The,0,0
92485,infection,0,0
92486,rate,0,0
92487,during,0,0
92488,the,0,0
92489,study,0,0
92490,was,0,0
92491,significantly,0,0
92492,higher,0,0
92493,in,0,0
92494,patients,0,0
92495,who,0,0
92496,received,0,0
92497,conventional,1,1
92498,insulin,1,1
92499,therapy,1,1
92500,than,0,0
92501,that,0,0
92502,in,0,0
92503,patients,0,0
92504,who,0,0
92505,received,0,0
92506,intensive,1,1
92507,insulin,1,1
92508,therapy,1,1
92509,(,0,0
92510,46.2,0,0
92511,%,0,0
92512,vs.,0,0
92513,31.4,0,0
92514,%,0,0
92515,;,0,0
92516,P,0,0
92517,<,0,0
92518,0.05,0,0
92519,),0,0
92520,.,0,0
92521,The,0,0
92522,days,0,0
92523,stay,0,0
92524,in,0,0
92525,NICU,0,0
92526,was,0,0
92527,shorter,0,0
92528,in,0,0
92529,intensive,1,1
92530,insulin,1,1
92531,control,1,1
92532,group,1,0
92533,than,0,0
92534,that,0,0
92535,in,0,0
92536,conventional,1,1
92537,therapy,1,1
92538,group,1,0
92539,[,0,0
92540,4.2,0,0
92541,days,0,0
92542,vs.,0,0
92543,5.6,0,0
92544,days,0,0
92545,(,0,0
92546,medians,0,0
92547,),0,0
92548,P,0,0
92549,<,0,0
92550,0.05,0,0
92551,],0,0
92552,.,0,0
92553,The,0,0
92554,in-hospital,0,0
92555,mortality,0,0
92556,during,0,0
92557,the,0,0
92558,study,0,0
92559,was,0,0
92560,similar,0,0
92561,in,0,0
92562,conventional,1,1
92563,and,1,0
92564,intensive,1,1
92565,therapy,1,1
92566,groups,1,0
92567,(,0,0
92568,34,0,0
92569,of,0,0
92570,119,0,0
92571,",",0,0
92572,28.6,0,0
92573,%,0,0
92574,vs.,0,0
92575,35,0,0
92576,of,0,0
92577,121,0,0
92578,",",0,0
92579,28.9,0,0
92580,%,0,0
92581,in,0,0
92582,the,0,0
92583,conventional,1,1
92584,and,1,0
92585,intensive,1,1
92586,insulin,1,1
92587,therapy,1,1
92588,groups,0,0
92589,;,0,0
92590,P=0.85,0,0
92591,),0,0
92592,.,0,0
92593,The,0,0
92594,neurologic,0,0
92595,outcome,0,0
92596,according,0,0
92597,to,0,0
92598,Glasgow,0,0
92599,Outcome,0,0
92600,Score,0,1
92601,(,0,1
92602,GOS,0,1
92603,),0,1
92604,at,0,0
92605,6,0,0
92606,months,0,0
92607,(,0,0
92608,GOS,0,1
92609,5,0,1
92610,and,0,0
92611,4,0,0
92612,),0,0
92613,was,0,0
92614,better,0,0
92615,in,0,0
92616,the,0,0
92617,intensive,1,1
92618,insulin,1,1
92619,therapy,1,1
92620,group,0,1
92621,(,0,0
92622,34,0,0
92623,of,0,0
92624,117,0,0
92625,",",0,0
92626,29.1,0,0
92627,%,0,0
92628,),0,0
92629,than,0,0
92630,that,0,0
92631,in,0,0
92632,the,0,0
92633,conventional,1,1
92634,therapy,1,1
92635,group,0,1
92636,(,0,0
92637,26,0,0
92638,of,0,0
92639,116,0,0
92640,",",0,0
92641,22.4,0,0
92642,%,0,0
92643,",",0,0
92644,P,0,0
92645,<,0,0
92646,0.05,0,0
92647,),0,0
92648,.,0,0
92649,CONCLUSIONS,0,0
92650,Mortality,0,0
92651,rates,0,0
92652,at,0,0
92653,6,0,0
92654,months,0,0
92655,follow-up,0,0
92656,are,0,0
92657,not,0,0
92658,affected,0,0
92659,by,0,0
92660,intensive,0,0
92661,glucose,0,0
92662,control,0,0
92663,in,0,0
92664,patients,0,0
92665,with,0,0
92666,severe,0,0
92667,TBI,0,0
92668,.,0,0
92669,Intensive,1,0
92670,insulin,1,1
92671,therapy,1,1
92672,decreases,0,0
92673,infection,0,0
92674,rate,0,0
92675,and,0,0
92676,days,0,0
92677,in,0,0
92678,NICU,0,0
92679,and,0,0
92680,improves,0,0
92681,the,0,0
92682,neurological,0,0
92683,outcome,0,0
92684,at,0,0
92685,6,0,0
92686,months,0,0
92687,follow-up,0,0
92688,",",0,0
92689,while,0,0
92690,has,0,0
92691,no,0,0
92692,obvious,0,0
92693,influence,0,0
92694,on,0,0
92695,in-hospital,0,0
92696,mortality,0,0
92697,of,0,0
92698,severe,0,0
92699,TBI,0,0
92700,patients,0,0
92701,.,0,0
92702,A,0,0
92703,randomized,0,0
92704,",",0,0
92705,controlled,0,0
92706,study,0,0
92707,on,0,0
92708,the,0,0
92709,influence,0,0
92710,of,0,0
92711,acetaminophen,1,1
92712,",",1,0
92713,diclofenac,1,1
92714,",",1,0
92715,or,1,0
92716,naproxen,1,1
92717,on,1,0
92718,aspirin-induced,1,0
92719,inhibition,0,0
92720,of,0,0
92721,platelet,0,0
92722,aggregation,0,0
92723,.,0,0
92724,Nonsteroidal,1,1
92725,anti-inflammatory,1,1
92726,drugs,1,1
92727,(,1,0
92728,NSAID,1,0
92729,),1,1
92730,may,0,0
92731,interfere,0,0
92732,with,0,0
92733,aspirin,1,1
92734,(,1,0
92735,acetylsalicylic,1,1
92736,acid,1,1
92737,),1,1
92738,and,0,0
92739,increase,0,0
92740,the,0,0
92741,risk,0,0
92742,for,0,0
92743,cardiovascular,0,0
92744,events,0,0
92745,.,0,0
92746,The,0,0
92747,clinical,0,0
92748,relevance,0,0
92749,is,0,0
92750,uncertain,0,0
92751,.,0,0
92752,The,0,0
92753,aim,0,0
92754,of,0,0
92755,this,0,0
92756,study,0,0
92757,was,0,0
92758,to,0,0
92759,analyse,0,0
92760,the,0,0
92761,influence,0,0
92762,of,0,0
92763,a,0,0
92764,co-administration,0,1
92765,of,0,0
92766,aspirin,1,1
92767,and,0,0
92768,NSAID,1,1
92769,on,0,0
92770,platelet,0,0
92771,aggregation,0,0
92772,.,0,0
92773,In,0,0
92774,a,0,0
92775,randomized,0,0
92776,",",0,0
92777,placebo,0,1
92778,controlled,0,0
92779,trial,0,0
92780,",",0,0
92781,eleven,0,0
92782,healthy,0,0
92783,volunteers,0,0
92784,were,0,0
92785,studied,0,0
92786,during,0,0
92787,4,0,0
92788,separate,0,0
92789,study,0,0
92790,periods,0,0
92791,of,0,0
92792,4,0,0
92793,days,0,0
92794,each,0,0
92795,.,0,0
92796,Individuals,0,0
92797,were,0,0
92798,treated,0,0
92799,on,0,0
92800,each,0,0
92801,occasion,0,0
92802,with,0,0
92803,100,0,0
92804,mg,0,1
92805,aspirin,1,1
92806,daily,0,1
92807,in,0,0
92808,combination,0,1
92809,with,0,0
92810,either,0,0
92811,3,1,0
92812,x,1,0
92813,1,1,0
92814,g,1,1
92815,acetaminophen,1,1
92816,",",1,0
92817,3,1,0
92818,x,1,0
92819,50,1,1
92820,mg,1,1
92821,diclofenac,1,1
92822,",",1,0
92823,3,1,0
92824,x,1,0
92825,250,1,1
92826,mg,1,1
92827,naproxen,1,1
92828,",",1,0
92829,or,1,1
92830,3,1,0
92831,x,1,0
92832,1,1,0
92833,placebo,1,1
92834,.,1,0
92835,Primary,0,0
92836,hemostasis,0,0
92837,was,0,0
92838,assessed,0,0
92839,with,0,0
92840,a,0,0
92841,platelet,0,0
92842,function,0,0
92843,analyser,0,1
92844,(,0,1
92845,PFA-100,0,1
92846,),0,0
92847,",",0,0
92848,which,0,0
92849,measures,0,0
92850,the,0,0
92851,closure,0,0
92852,time,0,0
92853,(,0,1
92854,CT,0,1
92855,),0,1
92856,of,0,0
92857,a,0,0
92858,collagen-,0,1
92859,and,0,0
92860,epinephrine-coated,0,1
92861,pore,0,0
92862,by,0,0
92863,aggregating,0,0
92864,platelets,0,1
92865,in,0,0
92866,flowing,0,0
92867,blood,0,0
92868,.,0,0
92869,Naproxen,1,1
92870,enhanced,0,0
92871,the,0,0
92872,anti-aggregatory,0,1
92873,action,0,0
92874,of,0,0
92875,aspirin,1,1
92876,after,0,0
92877,24,0,0
92878,h,0,0
92879,(,0,0
92880,CT,0,1
92881,rising,0,0
92882,from,0,0
92883,104+/-16,0,0
92884,s,0,0
92885,at,0,0
92886,baseline,0,0
92887,to,0,0
92888,212+/-69,0,0
92889,s,0,0
92890,at,0,0
92891,24,0,0
92892,h,0,0
92893,",",0,0
92894,P,0,0
92895,<,0,0
92896,0.001,0,0
92897,),0,0
92898,",",0,0
92899,which,0,0
92900,was,0,0
92901,not,0,0
92902,seen,0,0
92903,with,0,0
92904,any,0,0
92905,other,0,0
92906,drug,0,1
92907,combination,0,1
92908,.,0,0
92909,Diclofenac,1,1
92910,reduced,0,0
92911,the,0,0
92912,anti-aggregatory,0,1
92913,action,0,0
92914,of,0,0
92915,aspirin,1,1
92916,in,0,0
92917,the,0,0
92918,first,0,0
92919,two,0,0
92920,days,0,0
92921,",",0,0
92922,since,0,0
92923,the,0,0
92924,CT,0,0
92925,did,0,0
92926,not,0,0
92927,rise,0,0
92928,significantly,0,0
92929,(,0,0
92930,109+/-19,0,0
92931,s,0,0
92932,",",0,0
92933,148+/-56,0,0
92934,s,0,0
92935,",",0,0
92936,and,0,0
92937,168+/-66,0,0
92938,s,0,0
92939,at,0,0
92940,0,0,0
92941,h,0,0
92942,",",0,0
92943,24,0,0
92944,h,0,0
92945,",",0,0
92946,48,0,0
92947,h,0,0
92948,",",0,0
92949,respectively,0,0
92950,",",0,0
92951,P,0,0
92952,>,0,0
92953,0.05,0,0
92954,),0,0
92955,.,0,0
92956,Acetaminophen,1,0
92957,had,0,0
92958,no,0,0
92959,effect,0,0
92960,compared,0,0
92961,with,0,0
92962,placebo,1,1
92963,.,1,0
92964,After,0,0
92965,4,0,0
92966,days,0,0
92967,of,0,0
92968,treatment,0,0
92969,platelet,0,0
92970,aggregation,0,0
92971,was,0,0
92972,similarly,0,0
92973,inhibited,0,0
92974,by,0,0
92975,all,0,0
92976,combinations,0,0
92977,.,0,0
92978,We,0,0
92979,conclude,0,0
92980,that,0,0
92981,a,0,0
92982,co-administration,0,1
92983,of,0,0
92984,NSAID,1,1
92985,and,0,0
92986,aspirin,1,1
92987,may,0,0
92988,interfere,0,0
92989,with,0,0
92990,platelet,0,0
92991,inhibition,0,0
92992,at,0,0
92993,the,0,0
92994,beginning,0,0
92995,of,0,0
92996,a,0,0
92997,treatment,0,0
92998,with,0,0
92999,an,0,0
93000,increase,0,0
93001,of,0,0
93002,naproxen,1,1
93003,and,0,0
93004,a,0,0
93005,decrease,0,0
93006,of,0,0
93007,diclofenac,1,1
93008,.,1,0
93009,This,0,0
93010,effect,0,0
93011,is,0,0
93012,lost,0,0
93013,after,0,0
93014,4,0,0
93015,days,0,0
93016,",",0,0
93017,suggesting,0,0
93018,that,0,0
93019,a,0,0
93020,regular,0,1
93021,daily,0,1
93022,co-administration,0,1
93023,of,0,0
93024,NSAID,1,0
93025,does,0,0
93026,not,0,0
93027,have,0,0
93028,an,0,0
93029,influence,0,0
93030,on,0,0
93031,platelet,0,0
93032,inhibition,0,0
93033,by,0,0
93034,aspirin,1,1
93035,.,1,0
93036,Ongoing,1,0
93037,Telmisartan,1,1
93038,Alone,1,1
93039,and,1,0
93040,in,1,0
93041,Combination,1,1
93042,With,1,0
93043,Ramipril,1,1
93044,Global,1,0
93045,Endpoint,1,0
93046,Trial,1,1
93047,(,1,1
93048,ONTARGET,1,1
93049,),1,1
93050,:,1,0
93051,implications,0,0
93052,for,0,0
93053,reduced,0,0
93054,cardiovascular,0,0
93055,risk,0,0
93056,.,0,0
93057,The,0,0
93058,recently,0,0
93059,published,0,0
93060,Ongoing,1,0
93061,Telmisartan,1,1
93062,Alone,1,1
93063,and,1,0
93064,in,1,0
93065,Combination,1,1
93066,With,1,0
93067,Ramipril,1,1
93068,Global,1,0
93069,Endpoint,1,0
93070,Trial,1,1
93071,(,1,1
93072,ONTARGET,1,1
93073,),1,1
93074,in,0,0
93075,patients,0,0
93076,with,0,0
93077,vascular,0,0
93078,disease,0,0
93079,or,0,1
93080,high-risk,0,0
93081,diabetes,0,0
93082,",",0,0
93083,as,0,0
93084,the,0,0
93085,largest,0,0
93086,published,0,0
93087,comparative,0,0
93088,trial,0,0
93089,of,0,0
93090,these,0,0
93091,agent,0,0
93092,classes,0,0
93093,",",0,0
93094,provides,0,0
93095,further,0,0
93096,evidence,0,0
93097,concerning,0,0
93098,the,0,0
93099,comparison,0,0
93100,between,0,0
93101,the,0,0
93102,angiotensin-receptor,1,1
93103,blockers,1,1
93104,(,1,0
93105,ARBs,1,0
93106,),1,1
93107,and,0,0
93108,the,0,0
93109,angiotensin-converting,1,1
93110,enzyme,1,0
93111,inhibitors,1,1
93112,(,1,0
93113,ACEIs,1,0
93114,),1,0
93115,.,1,0
93116,In,0,0
93117,this,0,0
93118,trial,0,0
93119,",",0,0
93120,telmisartan,1,1
93121,(,1,0
93122,an,1,0
93123,ARB,1,1
93124,),1,0
93125,was,0,0
93126,non-inferior,0,0
93127,to,0,0
93128,ramipril,1,1
93129,(,1,0
93130,an,1,0
93131,ACEI,1,0
93132,),1,0
93133,in,0,0
93134,reducing,0,0
93135,fatal,0,0
93136,and,0,0
93137,nonfatal,0,0
93138,cardiovascular,0,0
93139,events,0,0
93140,.,0,0
93141,Moreover,0,0
93142,",",0,0
93143,ONTARGET,1,1
93144,is,0,0
93145,an,0,0
93146,example,0,0
93147,of,0,0
93148,a,0,0
93149,high-quality,0,0
93150,noninferiority,0,0
93151,trial,0,0
93152,.,0,0
93153,However,0,0
93154,",",0,0
93155,the,0,0
93156,combination,0,1
93157,of,0,0
93158,the,0,0
93159,2,0,0
93160,agents,0,0
93161,was,0,0
93162,associated,0,0
93163,with,0,0
93164,more,0,0
93165,adverse,0,0
93166,effects,0,0
93167,without,0,0
93168,an,0,0
93169,increase,0,0
93170,in,0,0
93171,benefit,0,0
93172,.,0,0
93173,The,0,0
93174,study,0,0
93175,differed,0,0
93176,from,0,0
93177,several,0,0
93178,other,0,0
93179,comparative,0,0
93180,studies,0,0
93181,in,0,0
93182,which,0,0
93183,the,0,0
93184,dose,0,0
93185,and,0,0
93186,choice,0,0
93187,of,0,0
93188,ACEI,1,0
93189,was,0,0
93190,left,0,0
93191,to,0,0
93192,individual,0,0
93193,physicians,0,0
93194,.,0,0
93195,Further,0,0
93196,",",0,0
93197,in,0,0
93198,ONTARGET,1,0
93199,",",0,0
93200,the,0,0
93201,ACEI,1,0
93202,was,0,0
93203,not,0,0
93204,titrated,0,0
93205,to,0,0
93206,the,0,0
93207,maximum,0,0
93208,dose,0,0
93209,and,0,0
93210,patients,0,0
93211,with,0,0
93212,heart,0,0
93213,failure,0,0
93214,were,0,0
93215,excluded,0,0
93216,.,0,0
93217,A,0,0
93218,comparison,0,0
93219,of,0,0
93220,continuous,1,1
93221,femoral,1,1
93222,nerve,1,1
93223,block,1,1
93224,(,1,1
93225,CFNB,1,1
93226,),1,1
93227,and,0,0
93228,continuous,1,1
93229,epidural,1,1
93230,infusion,1,1
93231,(,1,1
93232,CEI,1,0
93233,),1,1
93234,in,0,0
93235,postoperative,0,0
93236,analgesia,0,1
93237,and,0,0
93238,knee,0,1
93239,rehabilitation,0,1
93240,after,0,0
93241,total,0,0
93242,knee,0,1
93243,arthroplasty,0,1
93244,(,0,1
93245,TKA,0,1
93246,),0,0
93247,.,0,0
93248,BACKGROUND,0,0
93249,Postoperative,0,0
93250,epidural,1,1
93251,analgesia,1,1
93252,(,1,1
93253,EA,1,0
93254,),1,1
93255,and,0,0
93256,femoral,1,1
93257,nerve,1,1
93258,block,1,1
93259,(,1,1
93260,FNB,1,1
93261,),1,1
93262,provided,0,0
93263,effective,0,0
93264,pain,0,0
93265,relief,0,0
93266,However,0,0
93267,",",0,0
93268,EA,0,0
93269,has,0,0
93270,common,0,0
93271,side,0,0
93272,effects,0,0
93273,such,0,0
93274,as,0,0
93275,nausea,0,0
93276,",",0,0
93277,vomiting,0,0
93278,",",0,0
93279,pruritus,0,0
93280,",",0,0
93281,dizziness,0,0
93282,",",0,0
93283,and,0,0
93284,hypotension,0,0
93285,.,0,0
93286,Some,0,0
93287,investigations,0,0
93288,found,0,0
93289,that,0,0
93290,those,0,0
93291,side,0,0
93292,effects,0,0
93293,were,0,0
93294,less,0,0
93295,in,0,0
93296,FNB,1,1
93297,than,0,0
93298,in,0,0
93299,EA,1,0
93300,.,1,0
93301,However,0,0
93302,the,0,0
93303,analgesic,0,1
93304,equivalent,0,0
93305,of,0,0
93306,both,0,0
93307,techniques,0,1
93308,have,0,0
93309,not,0,0
93310,been,0,0
93311,confirmed,0,0
93312,.,0,0
93313,OBJECTIVE,0,0
93314,The,0,0
93315,authors,0,0
93316,compared,0,0
93317,continuous,1,0
93318,epidural,1,1
93319,infusion,1,1
93320,(,1,1
93321,CEI,1,0
93322,),1,1
93323,with,0,0
93324,continuous,1,1
93325,femoral,1,1
93326,nerve,1,1
93327,block,1,1
93328,(,1,1
93329,CFNB,1,1
93330,),1,1
93331,regarding,0,0
93332,the,0,0
93333,postoperative,0,0
93334,analgesic,0,1
93335,efficacy,0,0
93336,",",0,0
93337,side,0,0
93338,effects,0,0
93339,",",0,0
93340,postoperative,0,0
93341,knee,0,1
93342,rehabilitation,0,1
93343,",",0,0
93344,and,0,0
93345,hospital,0,0
93346,length,0,1
93347,of,0,0
93348,stay,0,0
93349,(,0,1
93350,LOS,0,1
93351,),0,0
93352,.,0,0
93353,MATERIAL,0,0
93354,AND,0,0
93355,METHOD,0,1
93356,In,0,0
93357,this,0,0
93358,prospective,0,0
93359,",",0,0
93360,randomized,0,0
93361,controlled,0,0
93362,study,0,0
93363,",",0,0
93364,61,0,0
93365,ASA,0,1
93366,physical,0,1
93367,status,0,0
93368,I-III,0,0
93369,patients,0,0
93370,scheduled,0,0
93371,for,0,0
93372,elective,0,0
93373,unilateral,0,0
93374,total,0,0
93375,knee,0,1
93376,arthroplasty,0,1
93377,(,0,1
93378,TKA,0,1
93379,),0,1
93380,under,0,0
93381,spinal,0,1
93382,anesthesia,0,1
93383,(,0,1
93384,SA,0,1
93385,),0,0
93386,participated,0,0
93387,.,0,0
93388,The,0,0
93389,patients,0,0
93390,were,0,0
93391,allocated,0,0
93392,into,0,0
93393,two,0,0
93394,groups,0,0
93395,.,0,0
93396,In,0,0
93397,the,0,0
93398,ward,0,0
93399,",",0,0
93400,patients,0,0
93401,in,0,0
93402,Group,0,0
93403,I,0,0
93404,(,1,0
93405,CEI,1,0
93406,),1,1
93407,were,0,0
93408,maintained,0,0
93409,by,0,0
93410,continuous,1,1
93411,infusion,1,1
93412,of,1,0
93413,0.125,1,1
93414,%,1,0
93415,levobupivacaine,1,1
93416,with,1,0
93417,morphine,1,1
93418,0.0125,0,1
93419,mg/ml,0,1
93420,(,0,0
93421,4,0,1
93422,ml/hr,0,0
93423,),0,0
93424,",",0,0
93425,Group,0,0
93426,II,0,1
93427,(,1,1
93428,CFNB,1,1
93429,),1,1
93430,were,0,0
93431,maintained,0,0
93432,by,0,0
93433,0.125,1,1
93434,%,1,0
93435,levobupivacaine,1,1
93436,(,0,0
93437,8,0,1
93438,ml/hr,0,0
93439,),0,0
93440,.,0,0
93441,RESULTS,0,0
93442,Patients,0,0
93443,in,0,0
93444,the,0,0
93445,CFNB,1,1
93446,group,0,0
93447,",",0,0
93448,the,0,0
93449,VAS,0,1
93450,scores,0,0
93451,at,0,0
93452,PO6-12,0,1
93453,hr,0,0
93454,and,0,0
93455,tramadol,0,1
93456,IV,0,0
93457,requirement,0,0
93458,were,0,0
93459,significantly,0,0
93460,greater,0,0
93461,than,0,0
93462,the,0,0
93463,CEI,1,0
93464,group,0,0
93465,(,0,0
93466,VAS,0,1
93467,:,0,1
93468,PO6,0,0
93469,hr,0,0
93470,p-value,0,0
93471,=,0,0
93472,0.001,0,0
93473,",",0,0
93474,PO12,0,0
93475,hr,0,0
93476,p-value,0,0
93477,=,0,0
93478,0.004,0,0
93479,),0,0
93480,.,0,0
93481,Patients,0,0
93482,in,0,0
93483,the,0,0
93484,CEI,1,0
93485,group,0,0
93486,experienced,0,0
93487,dizziness,0,0
93488,",",0,0
93489,pruritus,0,0
93490,",",0,0
93491,and,0,0
93492,PONV,0,0
93493,more,0,0
93494,than,0,0
93495,the,0,0
93496,CFNB,1,1
93497,group,0,0
93498,significantly,0,0
93499,.,0,0
93500,Patient,0,0
93501,satisfaction,0,0
93502,was,0,0
93503,greater,0,0
93504,with,0,0
93505,the,0,0
93506,CFNB,1,1
93507,group,0,0
93508,although,0,0
93509,postoperative,0,0
93510,knee,0,1
93511,rehabilitation,0,1
93512,and,0,0
93513,the,0,0
93514,hospital,0,0
93515,LOS,0,1
93516,were,0,0
93517,not,0,0
93518,different,0,0
93519,.,0,0
93520,CONCLUSION,0,0
93521,CFNB,1,1
93522,represents,0,0
93523,the,0,0
93524,optimal,0,0
93525,analgesia,0,0
93526,with,0,0
93527,fewer,0,0
93528,side,0,0
93529,effects,0,0
93530,and,0,0
93531,greater,0,0
93532,patient,0,0
93533,",",0,0
93534,satisfaction,0,0
93535,.,0,0
93536,The,0,0
93537,rehabilitation,0,0
93538,indices,0,0
93539,and,0,0
93540,duration,0,0
93541,of,0,0
93542,hospital,0,0
93543,stay,0,0
93544,are,0,0
93545,comparable,0,0
93546,in,0,0
93547,both,0,0
93548,groups,0,0
93549,.,0,0
93550,Acute,0,0
93551,effects,0,0
93552,of,0,0
93553,decaffeinated,1,1
93554,coffee,1,1
93555,and,0,0
93556,the,0,0
93557,major,0,0
93558,coffee,0,1
93559,components,0,0
93560,chlorogenic,1,1
93561,acid,0,1
93562,and,0,0
93563,trigonelline,1,1
93564,on,0,0
93565,glucose,0,0
93566,tolerance,0,0
93567,.,0,0
93568,OBJECTIVE,0,0
93569,Coffee,1,1
93570,consumption,0,0
93571,has,0,0
93572,been,0,0
93573,associated,0,0
93574,with,0,0
93575,lower,0,0
93576,risk,0,0
93577,of,0,0
93578,type,0,0
93579,2,0,0
93580,diabetes,0,0
93581,.,0,0
93582,We,0,0
93583,evaluated,0,0
93584,the,0,0
93585,acute,0,0
93586,effects,0,0
93587,of,0,0
93588,decaffeinated,1,1
93589,coffee,1,1
93590,and,0,0
93591,the,0,0
93592,major,0,0
93593,coffee,0,1
93594,components,0,0
93595,chlorogenic,0,1
93596,acid,0,1
93597,and,0,0
93598,trigonelline,0,1
93599,on,0,0
93600,glucose,0,0
93601,tolerance,0,0
93602,.,0,0
93603,RESEARCH,0,0
93604,DESIGN,0,0
93605,AND,0,0
93606,METHODS,0,0
93607,We,0,0
93608,conducted,0,0
93609,a,0,0
93610,randomized,0,0
93611,crossover,0,0
93612,trial,0,0
93613,of,0,0
93614,the,0,0
93615,effects,0,0
93616,of,0,0
93617,12,0,0
93618,g,0,1
93619,decaffeinated,1,1
93620,coffee,1,1
93621,",",0,0
93622,1,0,0
93623,g,0,1
93624,chlorogenic,1,1
93625,acid,1,1
93626,",",0,0
93627,500,0,1
93628,mg,0,1
93629,trigonelline,1,1
93630,",",1,0
93631,and,1,0
93632,placebo,1,1
93633,(,0,1
93634,1,0,1
93635,g,0,1
93636,mannitol,1,1
93637,),1,1
93638,on,0,0
93639,glucose,0,0
93640,and,0,0
93641,insulin,0,1
93642,concentrations,0,0
93643,during,0,0
93644,a,0,0
93645,2-h,0,0
93646,oral,0,1
93647,glucose,0,0
93648,tolerance,0,0
93649,test,0,1
93650,(,0,1
93651,OGTT,0,1
93652,),0,1
93653,in,0,0
93654,15,0,0
93655,overweight,0,0
93656,men,0,0
93657,.,0,0
93658,RESULTS,0,0
93659,Chlorogenic,0,1
93660,acid,0,1
93661,and,0,0
93662,trigonelline,0,1
93663,ingestion,0,0
93664,significantly,0,0
93665,reduced,0,0
93666,glucose,0,0
93667,(,0,0
93668,-0.7,0,0
93669,mmol/l,0,0
93670,",",0,0
93671,P,0,0
93672,=,0,0
93673,0.007,0,0
93674,",",0,0
93675,and,0,0
93676,-0.5,0,0
93677,mmol/l,0,0
93678,",",0,0
93679,P,0,0
93680,=,0,0
93681,0.024,0,0
93682,",",0,0
93683,respectively,0,0
93684,),0,0
93685,and,0,1
93686,insulin,0,1
93687,(,0,1
93688,-73,0,0
93689,pmol/l,0,0
93690,",",0,0
93691,P,0,0
93692,=,0,0
93693,0.038,0,0
93694,",",0,0
93695,and,0,0
93696,-117,0,1
93697,pmol/l,0,0
93698,",",0,0
93699,P,0,0
93700,=,0,0
93701,0.007,0,0
93702,),0,0
93703,concentrations,0,0
93704,15,0,0
93705,min,0,0
93706,following,0,0
93707,an,0,0
93708,OGTT,0,0
93709,compared,0,0
93710,with,0,0
93711,placebo,0,1
93712,.,0,0
93713,None,0,0
93714,of,0,0
93715,the,0,0
93716,treatments,0,0
93717,affected,0,0
93718,insulin,0,1
93719,or,0,1
93720,glucose,0,0
93721,area,0,0
93722,under,0,0
93723,the,0,0
93724,curve,0,0
93725,values,0,0
93726,during,0,0
93727,the,0,0
93728,OGTT,0,0
93729,compared,0,0
93730,with,0,0
93731,placebo,1,1
93732,.,1,0
93733,CONCLUSIONS,0,0
93734,Chlorogenic,0,1
93735,acid,0,1
93736,and,0,0
93737,trigonelline,0,1
93738,reduced,0,0
93739,early,0,0
93740,glucose,0,0
93741,and,0,0
93742,insulin,0,1
93743,responses,0,0
93744,during,0,0
93745,an,0,0
93746,OGTT,0,0
93747,.,0,0
93748,Feasibility,0,0
93749,of,0,0
93750,a,0,0
93751,telephone-based,1,1
93752,intervention,1,1
93753,for,0,0
93754,support,0,0
93755,persons,0,0
93756,to,0,0
93757,help,0,0
93758,smokers,0,0
93759,quit,0,0
93760,:,0,0
93761,a,0,0
93762,pilot,0,0
93763,study,0,0
93764,.,0,0
93765,BACKGROUND,0,0
93766,Nonsmokers,0,0
93767,have,0,0
93768,a,0,0
93769,potentially,0,0
93770,supportive,0,1
93771,role,0,0
93772,in,0,0
93773,tobacco,0,1
93774,cessation,0,1
93775,efforts,0,0
93776,.,0,0
93777,The,0,0
93778,present,0,0
93779,study,0,0
93780,examined,0,0
93781,the,0,0
93782,feasibility,0,0
93783,",",0,0
93784,acceptability,0,0
93785,",",0,0
93786,and,0,0
93787,potential,0,0
93788,efficacy,0,0
93789,of,0,0
93790,a,0,0
93791,telephone-based,1,1
93792,intervention,1,1
93793,for,0,0
93794,nonsmoking,0,0
93795,support,0,0
93796,persons,0,0
93797,.,0,0
93798,METHODS,0,0
93799,A,0,0
93800,total,0,0
93801,of,0,0
93802,59,0,0
93803,support,0,0
93804,persons,0,0
93805,(,0,0
93806,mean,0,0
93807,age,0,0
93808,=,0,0
93809,36,0,0
93810,years,0,0
93811,",",0,0
93812,92,0,0
93813,%,0,0
93814,female,0,0
93815,",",0,0
93816,95,0,0
93817,%,0,0
93818,White,0,0
93819,),0,0
93820,were,0,0
93821,randomly,0,0
93822,assigned,0,0
93823,to,0,0
93824,a,0,0
93825,control,1,1
93826,condition,1,0
93827,(,0,0
93828,N,0,1
93829,=,0,0
93830,30,0,0
93831,;,0,0
93832,written,1,1
93833,materials,1,1
93834,only,1,0
93835,),1,0
93836,or,0,1
93837,to,0,0
93838,a,0,0
93839,social,1,0
93840,cognitive,1,0
93841,theory-based,1,1
93842,intervention,1,1
93843,(,0,0
93844,N,0,1
93845,=,0,0
93846,29,0,0
93847,;,0,0
93848,written,1,1
93849,materials,1,1
93850,and,1,0
93851,5,0,0
93852,weekly,0,1
93853,",",0,0
93854,20-,0,1
93855,to,0,0
93856,30-min,0,1
93857,telephone,1,1
93858,counseling,1,1
93859,sessions,1,1
93860,),1,0
93861,.,0,0
93862,Both,0,1
93863,support,0,0
93864,persons,0,0
93865,and,0,0
93866,smokers,0,0
93867,completed,0,0
93868,assessments,0,0
93869,separately,0,0
93870,by,0,0
93871,mail,0,1
93872,at,0,0
93873,baseline,0,0
93874,and,0,0
93875,at,0,0
93876,weeks,0,1
93877,6,0,0
93878,(,0,0
93879,end,0,0
93880,of,0,0
93881,treatment,0,0
93882,),0,1
93883,and,0,0
93884,26,0,0
93885,.,0,0
93886,RESULTS,0,0
93887,Two,0,0
93888,thirds,0,0
93889,of,0,0
93890,the,0,0
93891,smokers,0,0
93892,reported,0,0
93893,low-moderate,0,0
93894,levels,0,0
93895,of,0,0
93896,motivation,0,0
93897,to,0,0
93898,quit,0,0
93899,at,0,0
93900,baseline,0,0
93901,as,0,0
93902,assessed,0,0
93903,by,0,0
93904,the,0,0
93905,contemplation,0,0
93906,ladder,0,1
93907,.,0,0
93908,Study,0,0
93909,retention,0,0
93910,rates,0,0
93911,were,0,0
93912,excellent,0,0
93913,",",0,0
93914,with,0,0
93915,95,0,0
93916,%,0,0
93917,of,0,0
93918,both,0,0
93919,support,0,0
93920,persons,0,0
93921,and,0,0
93922,smokers,0,0
93923,completing,0,0
93924,the,0,0
93925,week,0,0
93926,26,0,0
93927,assessment,0,0
93928,.,0,0
93929,Moreover,0,0
93930,",",0,0
93931,86,0,0
93932,%,0,0
93933,of,0,0
93934,support,0,0
93935,persons,0,0
93936,in,0,0
93937,the,0,0
93938,intervention,0,1
93939,group,0,0
93940,completed,0,0
93941,all,0,0
93942,five,0,0
93943,telephone,0,1
93944,sessions,0,1
93945,.,0,0
93946,Treatment,0,0
93947,acceptability,0,0
93948,was,0,0
93949,high,0,0
93950,for,0,0
93951,both,0,0
93952,support,0,0
93953,persons,0,0
93954,and,0,0
93955,smokers,0,0
93956,.,0,0
93957,Compared,0,0
93958,with,0,0
93959,the,0,0
93960,control,0,1
93961,condition,0,0
93962,",",0,0
93963,the,0,0
93964,intervention,0,1
93965,was,0,0
93966,associated,0,0
93967,with,0,0
93968,a,0,0
93969,significant,0,0
93970,increase,0,0
93971,in,0,0
93972,support,0,1
93973,person,0,0
93974,self-efficacy,0,1
93975,to,0,0
93976,help,0,0
93977,their,0,0
93978,smoker,0,1
93979,(,0,0
93980,p,0,0
93981,=,0,0
93982,.034,0,0
93983,),0,1
93984,and,0,0
93985,outcome,0,0
93986,expectancies,0,0
93987,(,0,0
93988,p,0,0
93989,=,0,0
93990,.025,0,0
93991,),0,0
93992,from,0,0
93993,baseline,0,0
93994,to,0,0
93995,week,0,0
93996,6,0,0
93997,.,0,0
93998,However,0,0
93999,",",0,0
94000,the,0,0
94001,intervention,0,1
94002,was,0,0
94003,not,0,0
94004,associated,0,0
94005,with,0,0
94006,higher,0,0
94007,smoking,0,0
94008,abstinence,0,0
94009,rates,0,0
94010,or,0,0
94011,quit,0,0
94012,attempts,0,0
94013,.,0,0
94014,DISCUSSION,0,0
94015,The,0,0
94016,program,0,1
94017,was,0,0
94018,successful,0,0
94019,in,0,0
94020,reaching,0,0
94021,smokers,0,0
94022,with,0,0
94023,lower,0,0
94024,levels,0,0
94025,of,0,0
94026,readiness,0,0
94027,to,0,0
94028,quit,0,0
94029,.,0,0
94030,The,0,0
94031,intervention,0,1
94032,was,0,0
94033,feasible,0,0
94034,and,0,0
94035,acceptable,0,0
94036,to,0,0
94037,both,0,0
94038,support,0,0
94039,persons,0,0
94040,and,0,0
94041,smokers,0,0
94042,.,0,0
94043,Although,0,0
94044,support,0,0
94045,persons,0,0
94046,and,0,0
94047,smokers,0,0
94048,can,0,0
94049,be,0,0
94050,engaged,0,0
94051,in,0,0
94052,this,0,0
94053,type,0,0
94054,of,0,0
94055,outreach,0,1
94056,program,0,1
94057,",",0,0
94058,refinements,0,0
94059,in,0,0
94060,the,0,0
94061,intervention,0,1
94062,approach,0,1
94063,are,0,0
94064,needed,0,0
94065,to,0,0
94066,improve,0,0
94067,the,0,0
94068,smoking,0,0
94069,outcomes,0,0
94070,.,0,0
94071,Social,1,1
94072,competence,1,0
94073,and,1,0
94074,social,1,0
94075,skills,1,1
94076,training,1,1
94077,and,1,0
94078,intervention,1,1
94079,for,0,0
94080,children,0,0
94081,with,0,0
94082,Autism,0,0
94083,Spectrum,0,1
94084,Disorders,0,0
94085,.,0,0
94086,This,0,0
94087,study,0,0
94088,examined,0,0
94089,the,0,0
94090,effectiveness,0,0
94091,of,0,0
94092,a,0,0
94093,30,0,0
94094,week,0,0
94095,social,1,1
94096,competence,1,0
94097,and,1,0
94098,social,1,0
94099,skills,1,1
94100,group,1,0
94101,intervention,1,1
94102,program,1,1
94103,with,0,0
94104,children,0,0
94105,",",0,0
94106,ages,0,0
94107,7-11,0,0
94108,",",0,0
94109,diagnosed,0,0
94110,with,0,0
94111,Autism,0,0
94112,Spectrum,0,1
94113,Disorders,0,0
94114,(,0,1
94115,ASD,0,0
94116,),0,1
94117,.,0,0
94118,Eighteen,0,0
94119,children,0,0
94120,with,0,0
94121,ASD,0,0
94122,were,0,0
94123,assessed,0,0
94124,with,0,0
94125,pretreatment,0,0
94126,and,0,0
94127,posttreatment,0,0
94128,measures,0,0
94129,on,0,0
94130,the,0,0
94131,Walker-McConnell,0,1
94132,Scale,0,1
94133,(,0,1
94134,WMS,0,1
94135,),0,1
94136,and,0,0
94137,the,0,0
94138,MGH,0,1
94139,YouthCare,0,0
94140,Social,0,0
94141,Competence,0,0
94142,Development,0,0
94143,Scale,0,0
94144,.,0,0
94145,Each,0,0
94146,received,0,0
94147,the,0,0
94148,30-week,0,0
94149,intervention,0,1
94150,program,0,1
94151,.,0,0
94152,For,0,0
94153,comparison,0,0
94154,",",0,0
94155,a,0,0
94156,matched,0,0
94157,sample,0,0
94158,of,0,0
94159,ten,0,0
94160,non-ASD,0,0
94161,children,0,0
94162,was,0,0
94163,also,0,0
94164,assessed,0,0
94165,",",0,0
94166,but,0,0
94167,received,0,1
94168,no,0,0
94169,treatment,0,0
94170,.,0,0
94171,The,0,0
94172,findings,0,0
94173,indicated,0,0
94174,that,0,0
94175,each,0,0
94176,ASD,0,0
94177,intervention,0,1
94178,group,0,0
94179,demonstrated,0,0
94180,significant,0,0
94181,gains,0,0
94182,on,0,0
94183,the,0,0
94184,WMS,0,1
94185,and,0,0
94186,significant,0,0
94187,improvement,0,0
94188,in,0,0
94189,the,0,0
94190,areas,0,0
94191,of,0,0
94192,anxiety,0,0
94193,management,0,1
94194,",",0,0
94195,joint,0,0
94196,attention,0,0
94197,",",0,0
94198,and,0,0
94199,flexibility/transitions,0,0
94200,.,0,0
94201,Results,0,0
94202,suggest,0,0
94203,that,0,0
94204,this,0,0
94205,approach,0,1
94206,can,0,0
94207,be,0,0
94208,effective,0,0
94209,in,0,0
94210,improving,0,0
94211,core,0,0
94212,social,0,0
94213,deficits,0,0
94214,in,0,0
94215,individuals,0,0
94216,with,0,0
94217,ASD,0,0
94218,.,0,0
94219,Randomized,0,0
94220,evaluation,0,0
94221,of,0,0
94222,octreotide,1,1
94223,vs,0,0
94224,prochlorperazine,1,1
94225,for,0,0
94226,ED,0,1
94227,treatment,0,0
94228,of,0,0
94229,migraine,0,0
94230,headache,0,0
94231,.,0,0
94232,UNLABELLED,0,0
94233,Patients,0,0
94234,with,0,0
94235,headaches,0,0
94236,account,0,0
94237,for,0,0
94238,approximately,0,0
94239,2,0,0
94240,%,0,0
94241,of,0,0
94242,all,0,0
94243,ED,0,1
94244,visits,0,0
94245,",",0,0
94246,with,0,0
94247,migraines,0,0
94248,being,0,0
94249,the,0,0
94250,most,0,0
94251,common,0,0
94252,defined,0,0
94253,primary,0,0
94254,headache,0,0
94255,syndrome,0,0
94256,.,0,0
94257,Our,0,0
94258,goals,0,0
94259,were,0,0
94260,to,0,0
94261,evaluate,0,0
94262,the,0,0
94263,efficacy,0,0
94264,of,0,0
94265,intravenous,0,1
94266,octreotide,1,1
94267,(,1,1
94268,OC,1,0
94269,),1,1
94270,for,0,0
94271,the,0,0
94272,treatment,0,0
94273,of,0,0
94274,migraines,0,0
94275,",",0,0
94276,when,0,0
94277,compared,0,0
94278,to,0,0
94279,standard,0,1
94280,therapy,0,1
94281,with,0,0
94282,prochlorperazine,1,1
94283,.,1,0
94284,METHODS,0,0
94285,The,0,0
94286,study,0,0
94287,was,0,0
94288,conducted,0,0
94289,as,0,0
94290,a,0,0
94291,double-blinded,0,0
94292,",",0,0
94293,randomized,0,0
94294,controlled,0,0
94295,trial,0,0
94296,.,0,0
94297,Each,0,0
94298,subject,0,0
94299,received,0,1
94300,either,0,0
94301,100,1,0
94302,microg,1,1
94303,of,1,0
94304,octreotide,1,1
94305,or,1,1
94306,10,1,1
94307,mg,1,1
94308,of,1,0
94309,prochlorperazine,1,1
94310,intravenously,1,1
94311,for,0,0
94312,a,0,0
94313,2-minute,0,1
94314,period,0,0
94315,.,0,0
94316,RESULTS,0,0
94317,Comparison,0,0
94318,of,0,0
94319,the,0,0
94320,change,0,0
94321,in,0,0
94322,median,0,0
94323,visual,0,1
94324,analog,0,1
94325,scale,0,0
94326,scores,0,0
94327,for,0,0
94328,60,0,0
94329,minutes,0,0
94330,demonstrated,0,0
94331,that,0,0
94332,octreotide,1,1
94333,was,0,0
94334,less,0,0
94335,effective,0,0
94336,at,0,0
94337,reducing,0,0
94338,pain,0,0
94339,(,0,1
94340,P,0,0
94341,=,0,0
94342,.03,0,0
94343,),0,1
94344,and,0,0
94345,producing,0,0
94346,clinical,0,0
94347,success,0,0
94348,(,0,0
94349,P,0,0
94350,<,0,0
94351,.01,0,0
94352,),0,0
94353,.,0,0
94354,Restlessness,0,0
94355,consistent,0,0
94356,with,0,0
94357,akathisia,0,0
94358,was,0,0
94359,noted,0,0
94360,by,0,0
94361,35,0,0
94362,%,0,0
94363,of,0,0
94364,the,0,0
94365,PC,0,1
94366,group,0,0
94367,and,0,0
94368,8,0,0
94369,%,0,0
94370,of,0,0
94371,the,0,0
94372,OC,0,1
94373,group,0,0
94374,(,0,0
94375,P,0,0
94376,<,0,0
94377,.01,0,0
94378,),0,0
94379,.,0,0
94380,At,0,0
94381,60,0,0
94382,minutes,0,0
94383,",",0,0
94384,rescue,0,0
94385,medication,0,1
94386,was,0,0
94387,required,0,0
94388,by,0,0
94389,48,0,0
94390,%,0,0
94391,of,0,0
94392,the,0,0
94393,patients,0,0
94394,in,0,0
94395,the,0,0
94396,OC,0,0
94397,group,0,0
94398,",",0,0
94399,whereas,0,0
94400,10,0,0
94401,%,0,0
94402,of,0,0
94403,the,0,0
94404,PC,0,1
94405,group,0,0
94406,required,0,0
94407,such,0,0
94408,therapy,0,1
94409,(,0,0
94410,P,0,0
94411,<,0,0
94412,.01,0,0
94413,),0,0
94414,.,0,0
94415,All,0,0
94416,44,0,0
94417,patients,0,0
94418,were,0,0
94419,contacted,0,0
94420,for,0,0
94421,follow-up,0,0
94422,at,0,0
94423,48,0,0
94424,to,0,0
94425,72,0,0
94426,hours,0,0
94427,after,0,0
94428,enrollment,0,0
94429,.,0,0
94430,At,0,0
94431,that,0,0
94432,time,0,0
94433,",",0,0
94434,10,0,0
94435,%,0,0
94436,of,0,0
94437,the,0,0
94438,prochlorperazine,1,1
94439,and,0,0
94440,25,0,0
94441,%,0,0
94442,of,0,0
94443,the,0,0
94444,octreotide,1,1
94445,patients,0,0
94446,had,0,0
94447,experienced,0,0
94448,some,0,0
94449,headache,0,0
94450,recurrence,0,0
94451,(,0,0
94452,P,0,0
94453,=,0,0
94454,.1,0,0
94455,),0,0
94456,.,0,0
94457,CONCLUSION,0,0
94458,Prochlorperazine,0,1
94459,was,0,0
94460,statistically,0,0
94461,superior,0,0
94462,to,0,0
94463,octreotide,0,1
94464,in,0,0
94465,clinical,0,0
94466,success,0,0
94467,rate,0,0
94468,and,0,0
94469,decrease,0,0
94470,in,0,0
94471,pain,0,0
94472,in,0,0
94473,migraine,0,0
94474,patients,0,0
94475,but,0,0
94476,caused,0,0
94477,more,0,0
94478,restlessness,0,0
94479,and,0,0
94480,sedation,0,0
94481,.,0,0
94482,Rationale,0,1
94483,and,0,0
94484,design,0,0
94485,of,0,0
94486,RE-LY,0,1
94487,:,0,0
94488,randomized,0,0
94489,evaluation,0,0
94490,of,0,0
94491,long-term,1,0
94492,anticoagulant,1,1
94493,therapy,1,1
94494,",",1,0
94495,warfarin,1,1
94496,",",0,0
94497,compared,0,0
94498,with,0,0
94499,dabigatran,1,1
94500,.,1,0
94501,Vitamin,0,1
94502,K,0,0
94503,antagonists,0,1
94504,(,0,0
94505,VKAs,0,1
94506,),0,1
94507,are,0,0
94508,effective,0,0
94509,for,0,0
94510,stroke,0,0
94511,prevention,0,0
94512,in,0,0
94513,patients,0,0
94514,with,0,0
94515,atrial,0,0
94516,fibrillation,0,0
94517,(,0,1
94518,AF,0,1
94519,),0,1
94520,but,0,0
94521,are,0,0
94522,difficult,0,0
94523,to,0,0
94524,use,0,0
94525,.,0,0
94526,Dabigatran,1,1
94527,etexilate,1,1
94528,is,0,0
94529,a,0,0
94530,prodrug,0,1
94531,that,0,0
94532,is,0,0
94533,rapidly,0,0
94534,converted,0,0
94535,to,0,0
94536,the,0,0
94537,active,0,1
94538,direct,0,1
94539,thrombin,0,1
94540,inhibitor,0,1
94541,dabigatran,1,1
94542,.,1,0
94543,It,0,0
94544,is,0,0
94545,administered,0,0
94546,in,0,0
94547,a,0,0
94548,fixed,0,1
94549,dose,0,0
94550,without,0,1
94551,laboratory,0,0
94552,monitoring,0,1
94553,and,0,1
94554,is,0,0
94555,being,0,0
94556,compared,0,0
94557,with,0,1
94558,warfarin,1,1
94559,(,0,0
94560,international,0,0
94561,normalized,0,0
94562,ratio,0,0
94563,2-3,0,0
94564,),0,0
94565,in,0,0
94566,the,0,0
94567,RE-LY,0,0
94568,trial,0,0
94569,.,0,0
94570,Two,0,0
94571,doses,0,0
94572,of,0,0
94573,dabigatran,1,1
94574,(,0,0
94575,110,0,0
94576,and,0,0
94577,150,0,0
94578,mg,0,1
94579,BID,0,1
94580,),0,0
94581,are,0,0
94582,being,0,0
94583,evaluated,0,0
94584,.,0,0
94585,RE-LY,0,0
94586,is,0,0
94587,a,0,0
94588,phase,0,0
94589,3,0,0
94590,",",0,0
94591,prospective,0,0
94592,",",0,0
94593,randomized,0,0
94594,",",0,0
94595,open-label,0,0
94596,multinational,0,0
94597,(,0,0
94598,44,0,0
94599,countries,0,0
94600,),0,0
94601,trial,0,0
94602,of,0,0
94603,patients,0,0
94604,with,0,0
94605,nonvalvular,0,0
94606,AF,0,1
94607,and,0,0
94608,at,0,0
94609,least,0,0
94610,1,0,0
94611,risk,0,0
94612,factor,0,0
94613,for,0,0
94614,stroke,0,0
94615,.,0,0
94616,Recruitment,0,0
94617,concluded,0,0
94618,with,0,0
94619,a,0,0
94620,total,0,0
94621,of,0,0
94622,"18,113",0,0
94623,patients,0,0
94624,.,0,0
94625,Patients,0,0
94626,who,0,0
94627,were,0,0
94628,VKA-naive,0,0
94629,and,0,0
94630,experienced,0,0
94631,are,0,0
94632,included,0,0
94633,in,0,0
94634,balanced,0,0
94635,proportions,0,0
94636,.,0,0
94637,The,0,0
94638,primary,0,0
94639,outcome,0,0
94640,is,0,0
94641,stroke,0,0
94642,(,0,0
94643,including,0,1
94644,hemorrhagic,0,0
94645,),0,1
94646,or,0,1
94647,systemic,0,0
94648,embolism,0,0
94649,.,0,0
94650,Safety,0,0
94651,outcomes,0,0
94652,are,0,0
94653,bleeding,0,0
94654,",",0,0
94655,liver,0,0
94656,function,0,0
94657,abnormalities,0,0
94658,",",0,0
94659,and,0,0
94660,other,0,0
94661,adverse,0,0
94662,events,0,0
94663,.,0,0
94664,Adjudication,0,0
94665,of,0,0
94666,end,0,0
94667,points,0,0
94668,is,0,0
94669,blinded,0,0
94670,to,0,0
94671,drug,0,1
94672,assignment,0,0
94673,.,0,0
94674,The,0,0
94675,trial,0,0
94676,is,0,0
94677,expected,0,0
94678,to,0,0
94679,accrue,0,0
94680,a,0,0
94681,minimum,0,0
94682,of,0,0
94683,450,0,0
94684,events,0,0
94685,with,0,0
94686,a,0,0
94687,minimum,0,0
94688,1-year,0,0
94689,of,0,0
94690,follow-up,0,0
94691,.,0,0
94692,RE-LY,0,0
94693,is,0,0
94694,the,0,0
94695,largest,0,0
94696,AF,0,0
94697,stroke,0,0
94698,prevention,0,0
94699,trial,0,0
94700,yet,0,0
94701,undertaken,0,0
94702,.,0,0
94703,It,0,0
94704,is,0,0
94705,unique,0,0
94706,because,0,0
94707,it,0,0
94708,includes,0,0
94709,equal,0,0
94710,numbers,0,0
94711,of,0,0
94712,VKA-experienced,0,0
94713,and,0,0
94714,naive,0,0
94715,patients,0,0
94716,and,0,0
94717,evaluates,0,0
94718,2,0,0
94719,different,0,0
94720,dosages,0,0
94721,of,0,0
94722,dabigatran,1,1
94723,",",0,0
94724,which,0,0
94725,may,0,0
94726,allow,0,0
94727,tailoring,0,0
94728,of,0,0
94729,dosing,0,0
94730,to,0,0
94731,individual,0,0
94732,patient,0,0
94733,needs,0,0
94734,.,0,0
94735,The,0,0
94736,worldwide,0,0
94737,site,0,0
94738,distribution,0,0
94739,and,0,0
94740,broad,0,0
94741,range,0,0
94742,of,0,0
94743,stroke,0,0
94744,risk,0,0
94745,further,0,0
94746,increase,0,0
94747,the,0,0
94748,general,0,0
94749,applicability,0,0
94750,of,0,0
94751,the,0,0
94752,trial,0,0
94753,.,0,0
94754,Results,0,0
94755,are,0,0
94756,expected,0,0
94757,in,0,0
94758,2009,0,0
94759,.,0,0
94760,Pulse,0,1
94761,oximeter,0,1
94762,perfusion,0,1
94763,index,0,0
94764,as,0,0
94765,an,0,0
94766,early,0,0
94767,indicator,0,0
94768,of,0,0
94769,sympathectomy,0,1
94770,after,0,0
94771,epidural,0,1
94772,anesthesia,0,1
94773,.,0,0
94774,BACKGROUND,0,0
94775,The,0,0
94776,pulse,0,1
94777,oximeter,0,1
94778,perfusion,0,1
94779,index,0,0
94780,(,0,1
94781,PI,0,1
94782,),0,1
94783,has,0,0
94784,been,0,0
94785,used,0,0
94786,to,0,0
94787,indicate,0,0
94788,sympathectomy-induced,0,1
94789,vasodilatation,0,0
94790,.,0,0
94791,We,0,0
94792,hypothesized,0,0
94793,that,0,0
94794,pulse,0,1
94795,oximeter,0,1
94796,PI,0,1
94797,provides,0,0
94798,an,0,0
94799,earlier,0,0
94800,and,0,0
94801,clearer,0,0
94802,indication,0,0
94803,of,0,0
94804,sympathectomy,0,1
94805,following,0,0
94806,epidural,0,1
94807,anesthesia,0,1
94808,than,0,0
94809,skin,0,0
94810,temperature,0,0
94811,and,0,0
94812,arterial,0,0
94813,pressure,0,0
94814,.,0,0
94815,METHODS,0,0
94816,Forty,0,0
94817,patients,0,0
94818,received,1,0
94819,lumbar,1,1
94820,epidural,1,1
94821,catheters,1,1
94822,.,1,0
94823,Patients,0,0
94824,were,0,0
94825,randomized,0,0
94826,to,0,0
94827,receive,1,0
94828,either,1,0
94829,10,1,0
94830,ml,1,0
94831,0.5,1,1
94832,%,1,0
94833,bupivacaine,1,1
94834,or,1,1
94835,10,1,0
94836,ml,1,1
94837,0.25,1,1
94838,%,1,0
94839,bupivacaine,1,1
94840,.,1,0
94841,PI,0,0
94842,in,0,0
94843,the,0,0
94844,toe,0,0
94845,",",0,0
94846,mean,1,0
94847,arterial,1,1
94848,pressure,1,0
94849,(,1,1
94850,MAP,1,1
94851,),1,1
94852,and,1,0
94853,toe,1,1
94854,temperature,1,0
94855,were,1,0
94856,all,1,0
94857,assessed,1,0
94858,at,1,0
94859,baseline,1,0
94860,and,1,0
94861,at,1,0
94862,5,1,0
94863,",",1,0
94864,10,1,0
94865,and,1,0
94866,20,1,0
94867,min,1,0
94868,following,1,0
94869,epidural,1,1
94870,anesthesia,1,1
94871,.,1,0
94872,The,0,0
94873,effect,0,0
94874,of,0,0
94875,epidural,1,1
94876,anesthesia,1,1
94877,over,0,0
94878,time,0,0
94879,was,0,0
94880,assessed,0,0
94881,by,0,0
94882,repeated,0,0
94883,measures,0,0
94884,analysis,0,0
94885,of,0,0
94886,variance,0,0
94887,.,0,0
94888,Additionally,0,0
94889,",",0,0
94890,we,0,0
94891,defined,0,0
94892,clinically,0,0
94893,evident,0,0
94894,sympathectomy,0,1
94895,criteria,0,0
94896,(,0,0
94897,a,0,0
94898,100,0,1
94899,%,0,0
94900,increase,0,0
94901,in,0,0
94902,the,0,0
94903,PI,0,1
94904,",",0,0
94905,a,0,0
94906,15,0,0
94907,%,0,0
94908,decrease,0,0
94909,in,0,0
94910,MAP,0,1
94911,and,0,0
94912,a,0,0
94913,1,0,0
94914,degrees,0,0
94915,C,0,0
94916,increase,0,0
94917,in,0,0
94918,toe,0,1
94919,temperature,0,0
94920,),0,0
94921,.,0,0
94922,The,0,0
94923,numbers,0,0
94924,of,0,0
94925,patients,0,0
94926,demonstrating,0,0
94927,these,0,0
94928,changes,0,0
94929,for,0,0
94930,each,0,0
94931,test,0,0
94932,were,0,0
94933,compared,0,0
94934,using,0,0
94935,the,0,0
94936,McNemar,0,1
94937,test,0,0
94938,for,0,0
94939,each,0,0
94940,time,0,0
94941,point,0,0
94942,.,0,0
94943,RESULTS,0,0
94944,Twenty-nine,0,0
94945,subjects,0,0
94946,had,0,0
94947,photoplethysmography,0,1
94948,signals,0,0
94949,that,0,0
94950,met,0,0
94951,a,0,0
94952,priori,0,0
94953,signal,0,0
94954,quality,0,0
94955,criteria,0,0
94956,for,0,0
94957,analysis,0,0
94958,.,0,0
94959,By,0,0
94960,20,0,0
94961,min,0,0
94962,",",0,0
94963,PI,0,1
94964,increased,0,0
94965,by,0,0
94966,326,0,0
94967,%,0,0
94968,",",0,0
94969,compared,0,0
94970,with,0,0
94971,a,0,0
94972,10,0,0
94973,%,0,0
94974,decrease,0,0
94975,and,0,0
94976,a,0,0
94977,3,0,0
94978,%,0,0
94979,increase,0,0
94980,in,0,0
94981,MAP,0,1
94982,and,0,0
94983,toe,0,0
94984,temperature,0,0
94985,",",0,0
94986,respectively,0,0
94987,.,0,0
94988,For,0,0
94989,PI,0,1
94990,15/29,0,0
94991,",",0,0
94992,26/29,0,0
94993,and,0,0
94994,29/29,0,0
94995,of,0,0
94996,the,0,0
94997,subjects,0,0
94998,met,0,0
94999,the,0,0
95000,sympathectomy,0,1
95001,criteria,0,0
95002,at,0,0
95003,5,0,0
95004,",",0,0
95005,10,0,0
95006,and,0,0
95007,20,0,0
95008,min,0,0
95009,",",0,0
95010,respectively,0,0
95011,",",0,0
95012,compared,0,0
95013,with,0,0
95014,4/29,0,0
95015,",",0,0
95016,6/29,0,0
95017,and,0,0
95018,18/29,0,0
95019,for,0,0
95020,MAP,0,1
95021,changes,0,0
95022,and,0,0
95023,3/29,0,0
95024,",",0,0
95025,8/29,0,0
95026,and,0,0
95027,14/29,0,0
95028,for,0,0
95029,toe,0,0
95030,temperature,0,0
95031,changes,0,0
95032,.,0,0
95033,CONCLUSIONS,0,0
95034,PI,0,1
95035,was,0,0
95036,an,0,0
95037,earlier,0,0
95038,",",0,0
95039,clearer,0,0
95040,and,0,0
95041,more,0,0
95042,sensitive,0,0
95043,indicator,0,0
95044,of,0,0
95045,the,0,0
95046,development,0,0
95047,of,0,0
95048,epidural-induced,0,0
95049,sympathectomy,0,1
95050,than,0,0
95051,either,0,1
95052,skin,0,0
95053,temperature,0,0
95054,or,0,1
95055,MAP,0,1
95056,.,0,0
95057,The,0,0
95058,influence,0,0
95059,of,0,0
95060,dietary,1,1
95061,fibre,1,1
95062,source,1,0
95063,and,0,0
95064,gender,0,0
95065,on,0,0
95066,the,0,0
95067,postprandial,0,0
95068,glucose,0,0
95069,and,0,0
95070,lipid,0,1
95071,response,0,0
95072,in,0,0
95073,healthy,0,0
95074,subjects,0,0
95075,.,0,0
95076,BACKGROUND,0,0
95077,Consumption,0,0
95078,of,0,0
95079,soluble,1,1
95080,dietary,1,1
95081,fibre,1,1
95082,is,0,0
95083,correlated,0,0
95084,with,0,0
95085,decreased,0,0
95086,postprandial,0,0
95087,glucose,0,0
95088,and,0,0
95089,insulin,0,1
95090,responses,0,0
95091,and,0,0
95092,hence,0,0
95093,has,0,0
95094,beneficial,0,0
95095,effects,0,0
95096,on,0,0
95097,the,0,0
95098,metabolic,0,0
95099,syndrome,0,0
95100,.,0,0
95101,AIM,0,0
95102,OF,0,1
95103,THE,0,0
95104,STUDY,0,0
95105,To,0,0
95106,investigate,0,0
95107,the,0,0
95108,effects,0,0
95109,on,0,0
95110,postprandial,0,0
95111,glucose,0,0
95112,",",0,0
95113,insulin,0,1
95114,and,0,0
95115,triglyceride,0,0
95116,concentrations,0,0
95117,of,0,0
95118,meals,0,1
95119,enriched,0,1
95120,with,0,0
95121,soluble,0,1
95122,dietary,0,1
95123,fibres,0,1
95124,from,0,0
95125,oats,0,1
95126,",",0,0
95127,rye,0,1
95128,bran,0,1
95129,",",0,0
95130,sugar,0,1
95131,beet,0,1
95132,fibre,0,1
95133,or,0,1
95134,a,0,0
95135,mixture,0,1
95136,of,0,0
95137,these,0,0
95138,three,0,0
95139,fibres,0,0
95140,.,0,0
95141,METHODS,0,0
95142,Thirteen,0,0
95143,healthy,0,0
95144,human,0,1
95145,volunteers,0,0
95146,(,0,0
95147,6,0,0
95148,men,0,0
95149,and,0,0
95150,7,0,0
95151,women,0,0
95152,",",0,0
95153,aged,0,0
95154,20-28,0,0
95155,years,0,0
95156,),0,0
95157,were,0,0
95158,included,0,0
95159,in,0,0
95160,the,0,0
95161,study,0,0
95162,.,0,0
95163,The,0,0
95164,subjects,0,0
95165,came,0,0
95166,to,0,0
95167,the,0,0
95168,study,0,0
95169,centre,0,0
95170,once,0,1
95171,a,0,0
95172,week,0,0
95173,after,0,0
95174,an,0,0
95175,overnight,0,0
95176,fast,0,0
95177,to,0,0
95178,ingest,0,1
95179,test,0,0
95180,meals,1,1
95181,and,0,0
95182,a,0,0
95183,control,0,1
95184,meal,0,1
95185,in,0,0
95186,random,0,0
95187,order,0,0
95188,.,0,0
95189,The,0,0
95190,meals,0,1
95191,contained,0,0
95192,either,0,0
95193,oat,1,1
95194,powder,1,1
95195,(,0,0
95196,62,0,0
95197,g,0,1
95198,",",0,0
95199,of,0,0
95200,which,0,0
95201,2.7,0,0
95202,soluble,0,1
95203,fibre,0,1
95204,),0,0
95205,",",0,0
95206,rye,1,1
95207,bran,1,1
95208,(,0,0
95209,31,0,0
95210,g,0,1
95211,",",0,0
95212,of,0,0
95213,which,0,0
95214,1.7,0,0
95215,g,0,1
95216,soluble,0,1
95217,fibre,0,1
95218,),0,0
95219,",",0,0
95220,sugar,1,1
95221,beet,1,1
95222,fibre,1,1
95223,(,0,0
95224,19,0,0
95225,g,0,1
95226,",",0,0
95227,of,0,0
95228,which,0,0
95229,5,0,0
95230,g,0,1
95231,soluble,0,1
95232,fibre,0,1
95233,),0,0
95234,",",0,0
95235,a,1,0
95236,mixture,1,1
95237,of,1,0
95238,these,1,0
95239,three,1,0
95240,fibres,1,1
95241,(,0,0
95242,74,0,0
95243,g,0,1
95244,",",0,0
95245,of,0,0
95246,which,0,0
95247,1.7,0,0
95248,g,0,1
95249,soluble,0,1
95250,fibre,0,1
95251,from,0,0
95252,each,0,0
95253,source,0,0
95254,",",0,0
95255,giving,0,0
95256,5,0,1
95257,g,0,1
95258,soluble,0,1
95259,fibre,0,1
95260,),0,1
95261,or,1,1
95262,no,1,0
95263,added,1,1
95264,fibre,1,1
95265,(,1,1
95266,control,1,1
95267,),1,1
95268,and,0,0
95269,were,0,0
95270,all,0,0
95271,adjusted,0,0
95272,to,0,0
95273,contain,0,0
95274,the,0,0
95275,same,0,0
95276,total,0,0
95277,amount,0,0
95278,of,0,0
95279,available,0,0
95280,carbohydrates,1,1
95281,.,1,0
95282,Blood,0,0
95283,samples,0,0
95284,were,0,0
95285,drawn,0,0
95286,before,0,0
95287,and,0,0
95288,every,0,1
95289,30,0,0
95290,min,0,0
95291,up,0,0
95292,to,0,0
95293,180,0,0
95294,min,0,0
95295,after,0,0
95296,the,0,0
95297,meals,0,1
95298,.,0,0
95299,RESULTS,0,0
95300,Meals,1,0
95301,with,1,0
95302,rye,1,1
95303,bran,1,1
95304,gave,0,0
95305,a,0,0
95306,lower,0,0
95307,postprandial,0,0
95308,glucose,0,0
95309,peak,0,0
95310,when,0,0
95311,compared,0,0
95312,with,0,0
95313,the,0,0
95314,control,0,1
95315,meal,0,1
95316,",",0,0
95317,and,0,0
95318,this,0,0
95319,effect,0,0
95320,was,0,0
95321,more,0,0
95322,pronounced,0,0
95323,in,0,0
95324,women,0,0
95325,compared,0,0
95326,to,0,0
95327,men,0,0
95328,.,0,0
95329,Oat,1,1
95330,powder,1,1
95331,",",0,0
95332,containing,0,1
95333,a,0,0
95334,low,0,0
95335,amount,0,0
95336,of,0,0
95337,total,0,0
95338,fibre,0,1
95339,and,0,0
95340,a,0,0
95341,high,0,0
95342,amount,0,0
95343,of,0,0
95344,carbohydrates,0,1
95345,in,0,0
95346,liquid,0,1
95347,matrix,0,1
95348,",",0,0
95349,gave,0,0
95350,a,0,0
95351,higher,0,0
95352,incremental,0,0
95353,glucose,0,0
95354,peak,0,0
95355,concentration,0,0
95356,compared,0,0
95357,to,0,0
95358,rye,0,1
95359,bran,0,1
95360,and,0,0
95361,sugar,0,1
95362,beet,0,1
95363,fibre,0,1
95364,and,0,0
95365,higher,0,0
95366,insulin,0,1
95367,incremental,0,0
95368,area,0,0
95369,under,0,0
95370,curve,0,0
95371,compared,0,0
95372,to,0,0
95373,control,0,0
95374,.,0,0
95375,The,0,0
95376,oat,1,0
95377,powder,1,1
95378,also,0,0
95379,influenced,0,0
95380,the,0,0
95381,effects,0,0
95382,of,0,0
95383,the,0,0
95384,mixed,0,1
95385,meal,0,0
95386,",",0,0
95387,diminishing,0,0
95388,the,0,0
95389,glucose-lowering,0,1
95390,effects,0,0
95391,.,0,0
95392,Postprandial,0,0
95393,triglyceride,0,0
95394,levels,0,0
95395,tended,0,0
95396,to,0,0
95397,be,0,0
95398,higher,0,0
95399,after,0,0
95400,all,0,0
95401,fibre-rich,0,1
95402,meals,0,1
95403,",",0,0
95404,but,0,0
95405,only,0,0
95406,significant,0,0
95407,for,0,0
95408,oat,0,1
95409,powder,0,1
95410,and,0,0
95411,the,0,0
95412,mixed,0,1
95413,meal,1,0
95414,when,0,0
95415,compared,0,0
95416,with,0,0
95417,the,0,0
95418,control,0,0
95419,meal,1,0
95420,.,1,0
95421,CONCLUSIONS,0,0
95422,Postprandial,0,0
95423,glucose,0,0
95424,",",0,0
95425,insulin,0,1
95426,and,0,0
95427,triglyceride,0,0
95428,concentrations,0,0
95429,are,0,0
95430,influenced,0,0
95431,by,0,0
95432,dietary,1,1
95433,fibre-rich,1,1
95434,meals,1,1
95435,",",0,0
95436,depending,0,0
95437,on,0,0
95438,fibre,0,1
95439,source,0,0
95440,",",0,0
95441,dose,0,0
95442,of,0,0
95443,soluble,0,1
95444,and,0,0
95445,total,0,0
95446,fibre,0,1
95447,and,0,0
95448,possibly,0,0
95449,gender,0,0
95450,.,0,0
95451,Local,0,0
95452,anaesthetic,0,1
95453,use,0,0
95454,for,0,0
95455,the,0,0
95456,iliac,0,0
95457,crest-donor,0,0
95458,site,0,0
95459,:,0,1
95460,pharmacokinetic,0,0
95461,and,0,0
95462,pharmacodynamic,0,0
95463,evaluations,0,0
95464,.,0,0
95465,During,0,0
95466,orthopaedic,1,0
95467,surgery,1,1
95468,of,0,0
95469,the,0,0
95470,limb,0,0
95471,",",0,0
95472,we,0,0
95473,performed,0,0
95474,a,0,0
95475,prospective,0,0
95476,",",0,0
95477,double,0,1
95478,blind,0,0
95479,controlled,0,0
95480,study,0,0
95481,on,0,0
95482,three,0,0
95483,parallel,0,0
95484,groups,0,0
95485,in,0,0
95486,30,0,0
95487,patients,0,0
95488,to,0,0
95489,evaluate,0,0
95490,the,0,0
95491,pharmacokinetic,0,0
95492,and,0,0
95493,pharmacodynamic,0,0
95494,effect,0,0
95495,of,0,0
95496,infiltration,0,0
95497,of,0,0
95498,the,0,0
95499,iliac,0,1
95500,crest,0,0
95501,bone,0,0
95502,graft,0,1
95503,harvest,0,0
95504,site,0,0
95505,with,0,0
95506,20,1,0
95507,ml,1,0
95508,of,1,0
95509,bupivacaine,1,1
95510,(,1,0
95511,100,1,1
95512,mg,1,1
95513,),1,0
95514,",",1,0
95515,ropivacaine,1,1
95516,(,1,0
95517,150,1,0
95518,mg,1,1
95519,),1,0
95520,or,1,1
95521,saline,1,1
95522,as,1,0
95523,control,1,1
95524,group,1,1
95525,(,1,1
95526,n,1,0
95527,=,1,0
95528,10,1,0
95529,in,1,0
95530,each,1,0
95531,group,1,0
95532,),1,0
95533,.,0,0
95534,Then,0,0
95535,",",0,0
95536,in,0,0
95537,a,0,0
95538,sheep,0,0
95539,model,0,0
95540,of,0,0
95541,iliac,0,1
95542,crest,0,0
95543,infiltration,0,0
95544,",",0,0
95545,we,0,0
95546,compared,0,0
95547,the,0,0
95548,pharmacokinetics,0,0
95549,of,0,0
95550,single,1,0
95551,administration,1,0
95552,of,1,0
95553,plain,1,1
95554,bupivacaine,1,1
95555,(,1,0
95556,100,1,1
95557,mg,1,1
95558,),1,1
95559,and,1,1
95560,bupivacaine,1,1
95561,(,1,1
95562,500,1,1
95563,mg,1,1
95564,),1,0
95565,-loaded,1,1
95566,microspheres,1,1
95567,.,1,0
95568,In,0,0
95569,the,0,0
95570,clinical,0,0
95571,control,0,1
95572,group,0,0
95573,",",0,0
95574,pain,0,0
95575,from,0,0
95576,the,0,0
95577,iliac,0,0
95578,crest,0,0
95579,was,0,0
95580,worse,0,0
95581,than,0,0
95582,pain,0,0
95583,from,0,0
95584,the,0,0
95585,primary,0,0
95586,surgical,0,0
95587,site,0,0
95588,.,0,0
95589,Pain,0,0
95590,from,0,0
95591,the,0,0
95592,iliac,0,0
95593,crest,0,0
95594,was,0,0
95595,significantly,0,0
95596,reduced,0,0
95597,during,0,0
95598,the,0,0
95599,first,0,0
95600,12,0,0
95601,postoperative,0,0
95602,hours,0,0
95603,in,0,0
95604,local,0,0
95605,anaesthetic,0,1
95606,groups,0,0
95607,compared,0,0
95608,to,0,0
95609,the,0,0
95610,control,0,1
95611,group,0,0
95612,.,0,0
95613,However,0,0
95614,",",0,0
95615,during,0,0
95616,this,0,0
95617,period,0,0
95618,",",0,0
95619,pain,0,0
95620,from,0,0
95621,the,0,0
95622,primary,0,0
95623,surgical,0,1
95624,site,0,0
95625,was,0,0
95626,increased,0,0
95627,compared,0,0
95628,to,0,0
95629,the,0,0
95630,control,0,1
95631,group,0,0
95632,.,0,0
95633,Finally,0,0
95634,",",0,0
95635,there,0,0
95636,was,0,0
95637,no,0,0
95638,difference,0,0
95639,between,0,0
95640,the,0,0
95641,three,0,0
95642,groups,0,0
95643,in,0,0
95644,the,0,0
95645,average,0,0
95646,intake,0,0
95647,of,0,0
95648,PCA,0,1
95649,morphine,1,1
95650,.,1,0
95651,There,0,0
95652,was,0,0
95653,no,0,0
95654,significant,0,0
95655,pharmacokinetic,0,0
95656,and,0,0
95657,pharmacodynamic,0,0
95658,difference,0,0
95659,between,0,0
95660,plain,0,1
95661,bupivacaine,1,1
95662,and,0,0
95663,ropivacaine,1,1
95664,.,1,0
95665,The,0,0
95666,maximal,0,0
95667,plasma,0,0
95668,concentration,0,0
95669,(,0,1
95670,Cmax,0,0
95671,),0,1
95672,of,0,0
95673,ropivacaine,1,1
95674,and,0,0
95675,bupivacaine,1,1
95676,were,0,0
95677,964,0,0
95678,(,0,0
95679,282,0,0
95680,),0,1
95681,ng,0,1
95682,ml,0,1
95683,(,0,1
95684,-1,0,1
95685,),0,1
95686,and,0,0
95687,638,0,0
95688,(,0,0
95689,366,0,0
95690,),0,1
95691,ng,0,1
95692,ml,0,1
95693,(,0,1
95694,-1,0,0
95695,),0,0
95696,",",0,0
95697,respectively,0,0
95698,.,0,0
95699,In,0,0
95700,the,0,0
95701,sheep,0,0
95702,model,0,0
95703,",",0,0
95704,it,0,0
95705,was,0,0
95706,clearly,0,0
95707,shown,0,0
95708,that,0,0
95709,the,0,0
95710,release,0,0
95711,of,0,0
95712,bupivacaine,1,1
95713,from,0,0
95714,microspheres,0,1
95715,was,0,0
95716,controlled,0,0
95717,and,0,0
95718,prolonged,0,0
95719,despite,0,0
95720,the,0,0
95721,largest,0,0
95722,dose,0,0
95723,of,0,0
95724,bupivacaine,1,1
95725,used,0,0
95726,(,0,0
95727,500,0,1
95728,mg,0,1
95729,;,0,0
95730,n,0,0
95731,=,0,0
95732,4,0,0
95733,),0,0
95734,.,0,0
95735,Wound,0,0
95736,infiltration,0,0
95737,of,0,0
95738,iliac,0,1
95739,crest,0,1
95740,harvest,0,0
95741,site,0,0
95742,with,0,0
95743,local,0,1
95744,anaesthetic,0,1
95745,is,0,0
95746,an,0,0
95747,easy,0,0
95748,technique,0,1
95749,for,0,0
95750,postoperative,0,0
95751,analgesia,0,0
95752,.,0,0
95753,However,0,0
95754,",",0,0
95755,this,0,0
95756,effect,0,0
95757,lasts,0,0
95758,only,0,0
95759,12,0,0
95760,hours,0,0
95761,without,0,0
95762,reducing,0,0
95763,the,0,0
95764,morphine,0,1
95765,consumption,0,0
95766,due,0,0
95767,to,0,0
95768,an,0,0
95769,increase,0,0
95770,of,0,0
95771,pain,0,0
95772,from,0,0
95773,the,0,0
95774,primary,0,0
95775,surgical,0,0
95776,site,0,0
95777,.,0,0
95778,The,0,0
95779,local,0,0
95780,anaesthetic,0,1
95781,infiltration,0,0
95782,produced,0,0
95783,a,0,0
95784,significant,0,0
95785,peak,0,0
95786,of,0,0
95787,plasma,0,0
95788,level,0,0
95789,",",0,0
95790,which,0,0
95791,could,0,0
95792,be,0,0
95793,dangerous,0,0
95794,if,0,0
95795,another,0,0
95796,infiltration,0,0
95797,or,0,1
95798,regional,0,0
95799,anaesthetic,0,1
95800,technique,0,1
95801,was,0,0
95802,associated,0,0
95803,with,0,0
95804,it,0,0
95805,.,0,0
95806,Experimentally,0,0
95807,",",0,0
95808,as,0,0
95809,a,0,0
95810,drug,0,1
95811,delivery,0,0
95812,system,0,0
95813,",",0,0
95814,the,0,0
95815,use,0,0
95816,of,0,0
95817,local,0,1
95818,anaesthetic-loaded,1,1
95819,microspheres,1,1
95820,could,0,0
95821,be,0,0
95822,an,0,0
95823,interesting,0,0
95824,alternative,0,0
95825,.,0,0
95826,Gamma-hydroxybutyric,1,1
95827,acid,1,1
95828,versus,0,1
95829,clomethiazole,1,1
95830,for,0,0
95831,the,0,0
95832,treatment,0,0
95833,of,0,0
95834,alcohol,0,1
95835,withdrawal,0,1
95836,syndrome,0,0
95837,in,0,0
95838,a,0,0
95839,medical,0,0
95840,intensive,0,1
95841,care,0,1
95842,unit,0,0
95843,:,0,0
95844,an,0,0
95845,open,0,0
95846,",",0,0
95847,single-center,0,0
95848,randomized,0,0
95849,study,0,0
95850,.,0,0
95851,BACKGROUND,0,0
95852,Clomethiazole,1,1
95853,(,1,1
95854,CLO,1,1
95855,),1,1
95856,has,0,0
95857,been,0,0
95858,shown,0,0
95859,to,0,0
95860,be,0,0
95861,effective,0,0
95862,in,0,0
95863,treating,0,0
95864,alcohol,0,1
95865,withdrawal,0,1
95866,syndrome,0,0
95867,(,0,1
95868,AWS,0,0
95869,),0,1
95870,.,0,0
95871,Gamma-Hydroxybutyric,1,1
95872,acid,1,1
95873,(,1,1
95874,GHB,1,1
95875,),1,1
95876,has,0,0
95877,also,0,0
95878,been,0,0
95879,introduced,0,0
95880,in,0,0
95881,the,0,0
95882,treatment,0,0
95883,of,0,0
95884,alcoholic,0,0
95885,patients,0,0
95886,and,0,0
95887,is,0,0
95888,effective,0,0
95889,in,0,0
95890,surgical,0,1
95891,intensive,0,1
95892,care,0,1
95893,unit,0,1
95894,(,0,1
95895,ICU,0,1
95896,),0,1
95897,patients,0,0
95898,in,0,0
95899,preventing,0,0
95900,and,0,0
95901,treating,0,0
95902,AWS,0,0
95903,.,0,0
95904,There,0,0
95905,are,0,0
95906,no,0,0
95907,comparative,0,0
95908,studies,0,0
95909,between,0,0
95910,CLO,1,1
95911,and,0,0
95912,GHB,1,1
95913,in,0,0
95914,a,0,0
95915,medical,0,0
95916,ICU,0,0
95917,setting,0,0
95918,.,0,0
95919,METHODS,0,0
95920,Twenty-six,0,0
95921,alcoholic,0,0
95922,patients,0,0
95923,with,0,0
95924,severe,0,0
95925,AWS,0,0
95926,and,0,0
95927,concomitant,0,0
95928,medical,0,0
95929,diseases,0,0
95930,were,0,0
95931,randomally,0,0
95932,enrolled,0,0
95933,in,0,0
95934,the,0,0
95935,study,0,0
95936,.,0,0
95937,CLO,1,1
95938,was,0,0
95939,given,0,0
95940,orally,0,1
95941,to,0,0
95942,12,0,0
95943,patients,0,0
95944,in,0,0
95945,a,0,0
95946,dosage,0,0
95947,of,0,0
95948,250,0,1
95949,mg,0,1
95950,every,0,0
95951,4,0,0
95952,hours,0,0
95953,as,0,0
95954,a,0,0
95955,liquid,0,1
95956,;,0,0
95957,GHB,1,1
95958,(,0,0
95959,initially,0,0
95960,30,0,0
95961,mg/kg,0,1
95962,body,0,0
95963,weight,0,0
95964,(,0,1
95965,BW,0,1
95966,),0,1
95967,followed,0,1
95968,by,0,0
95969,15,0,0
95970,mg/kg,0,1
95971,BW,0,1
95972,),0,0
95973,was,0,0
95974,administered,0,0
95975,intravenously,0,1
95976,to,0,0
95977,14,0,0
95978,patients,0,0
95979,.,0,0
95980,Four,0,0
95981,major,0,0
95982,AWS,0,0
95983,symptoms,0,0
95984,(,0,0
95985,tremor,0,0
95986,",",0,0
95987,sweating,0,0
95988,",",0,0
95989,nausea,0,0
95990,",",0,0
95991,restlessness,0,0
95992,),0,0
95993,were,0,0
95994,scored,0,0
95995,",",0,0
95996,and,0,0
95997,the,0,0
95998,administration,0,0
95999,of,0,0
96000,additional,0,0
96001,medication,0,1
96002,was,0,0
96003,registered,0,0
96004,.,0,0
96005,RESULTS,0,0
96006,GHB,1,1
96007,was,0,0
96008,more,0,0
96009,effective,0,0
96010,in,0,0
96011,treating,0,0
96012,AWS,0,0
96013,symptoms,0,0
96014,.,0,0
96015,In,0,0
96016,the,0,0
96017,GHB,1,1
96018,group,0,0
96019,",",0,0
96020,AWS,0,0
96021,score,0,0
96022,dropped,0,0
96023,from,0,0
96024,6.6,0,0
96025,+/-,0,0
96026,2.6,0,0
96027,to,0,0
96028,1.8,0,0
96029,+/-,0,0
96030,2.1,0,0
96031,(,0,0
96032,p,0,0
96033,<,0,0
96034,.01,0,0
96035,),0,0
96036,",",0,0
96037,while,0,0
96038,in,0,0
96039,the,0,0
96040,CLO,1,1
96041,group,0,0
96042,",",0,0
96043,the,0,0
96044,score,0,0
96045,dropped,0,0
96046,from,0,0
96047,6,0,0
96048,+/-,0,0
96049,2.5,0,0
96050,to,0,0
96051,4.1,0,0
96052,+/-,0,0
96053,2.4,0,0
96054,(,0,0
96055,n.,0,1
96056,s.,0,0
96057,),0,0
96058,.,0,0
96059,Differences,0,0
96060,between,0,0
96061,groups,0,0
96062,were,0,0
96063,significant,0,0
96064,(,0,0
96065,p,0,0
96066,=.021,0,0
96067,",",0,0
96068,two-way,0,1
96069,ANOVA,0,1
96070,),0,0
96071,.,0,0
96072,The,0,0
96073,treatment,0,0
96074,did,0,0
96075,not,0,0
96076,alter,0,0
96077,outcome,0,0
96078,or,0,1
96079,the,0,0
96080,duration,0,0
96081,of,0,0
96082,ICU,0,0
96083,stay,0,0
96084,.,0,0
96085,No,0,0
96086,serious,0,0
96087,side,0,0
96088,effects,0,0
96089,were,0,0
96090,detected,0,0
96091,.,0,0
96092,CONCLUSION,0,0
96093,GHB,1,1
96094,effectively,0,0
96095,controls,0,0
96096,AWS,0,0
96097,symptoms,0,0
96098,in,0,0
96099,medical,0,0
96100,ICU,0,0
96101,patients,0,0
96102,.,0,0
96103,The,0,0
96104,rapid,0,0
96105,initial,0,0
96106,treatment,0,1
96107,response,0,0
96108,of,0,0
96109,GHB,0,1
96110,in,0,0
96111,contrast,0,0
96112,to,0,0
96113,CLO,1,1
96114,has,0,0
96115,no,0,0
96116,influence,0,0
96117,on,0,0
96118,duration,0,0
96119,of,0,0
96120,patient,0,0
96121,withdrawal,0,0
96122,.,0,0
96123,Randomized,0,0
96124,clinical,0,0
96125,trial,0,0
96126,of,0,0
96127,balance-based,0,1
96128,torso,1,0
96129,weighting,1,1
96130,for,0,0
96131,improving,0,0
96132,upright,0,1
96133,mobility,0,0
96134,in,0,0
96135,people,0,0
96136,with,0,0
96137,multiple,0,0
96138,sclerosis,0,1
96139,.,0,0
96140,BACKGROUND,0,0
96141,Torso,0,1
96142,weighting,0,1
96143,has,0,0
96144,sometimes,0,0
96145,been,0,0
96146,effective,0,0
96147,for,0,0
96148,improving,0,0
96149,upright,0,1
96150,mobility,0,0
96151,in,0,0
96152,people,0,0
96153,with,0,0
96154,multiple,0,0
96155,sclerosis,0,1
96156,",",0,0
96157,but,0,0
96158,parameters,0,0
96159,for,0,0
96160,weighting,0,0
96161,have,0,0
96162,been,0,0
96163,inconsistent,0,0
96164,.,0,0
96165,OBJECTIVE,0,0
96166,To,0,0
96167,determine,0,0
96168,whether,0,0
96169,balance-based,1,1
96170,torso,1,0
96171,weighting,1,1
96172,(,1,1
96173,BBTW,1,1
96174,),1,1
96175,has,0,0
96176,immediate,0,0
96177,effects,0,0
96178,on,0,0
96179,upright,0,0
96180,mobility,0,0
96181,in,0,0
96182,people,0,0
96183,with,0,0
96184,multiple,0,0
96185,sclerosis,0,1
96186,.,0,0
96187,METHODS,0,0
96188,This,0,0
96189,was,0,0
96190,a,0,0
96191,2-phase,0,0
96192,randomized,0,0
96193,clinical,0,0
96194,trial,0,0
96195,.,0,0
96196,In,0,0
96197,phase,0,0
96198,1,0,0
96199,",",0,0
96200,36,0,0
96201,participants,0,0
96202,were,0,0
96203,randomly,0,0
96204,assigned,0,0
96205,to,0,0
96206,experimental,0,0
96207,and,0,0
96208,control,0,0
96209,groups,0,0
96210,.,0,0
96211,In,0,0
96212,phase,0,0
96213,2,0,0
96214,",",0,0
96215,the,0,0
96216,control,0,1
96217,group,0,0
96218,was,0,0
96219,subsequently,0,0
96220,randomized,0,0
96221,into,0,0
96222,2,0,0
96223,groups,0,0
96224,with,0,0
96225,alternate,0,0
96226,weight-placement,0,1
96227,.,0,0
96228,Tests,0,0
96229,of,0,0
96230,upright,0,0
96231,mobility,0,0
96232,included,0,0
96233,:,0,0
96234,timed,0,0
96235,up,0,0
96236,and,0,0
96237,go,0,1
96238,(,0,1
96239,TUG,0,0
96240,),0,0
96241,",",0,0
96242,sharpened,0,0
96243,Romberg,0,0
96244,",",0,0
96245,360-degree,0,1
96246,turns,0,0
96247,",",0,0
96248,25-foot,0,1
96249,walk,0,0
96250,",",0,0
96251,and,0,0
96252,computerized,1,1
96253,platform,1,1
96254,posturography,1,1
96255,.,1,0
96256,Participants,0,0
96257,were,0,0
96258,tested,0,0
96259,at,0,0
96260,baseline,0,0
96261,and,0,0
96262,again,0,0
96263,with,0,0
96264,weights,0,0
96265,placed,0,0
96266,according,0,0
96267,to,0,0
96268,group,0,0
96269,membership,0,0
96270,.,0,0
96271,In,0,0
96272,both,0,0
96273,phases,0,0
96274,",",0,0
96275,a,0,0
96276,physical,0,1
96277,therapist,0,1
96278,assessed,0,0
96279,balance,0,0
96280,for,0,0
96281,the,0,0
96282,BBTW,0,1
96283,group,0,0
96284,and,0,0
96285,then,0,1
96286,placed,0,0
96287,weights,0,0
96288,to,0,0
96289,decrease,0,0
96290,balance,0,0
96291,loss,0,0
96292,.,0,0
96293,In,0,0
96294,phase,0,0
96295,1,0,0
96296,",",0,0
96297,the,0,0
96298,control,0,1
96299,group,0,0
96300,had,0,0
96301,no,0,0
96302,weights,0,0
96303,placed,0,0
96304,.,0,0
96305,In,0,0
96306,phase,0,0
96307,2,0,0
96308,",",0,0
96309,the,0,0
96310,alternate,0,1
96311,treatment,0,0
96312,group,0,0
96313,received,0,1
96314,standard,0,1
96315,weight,0,0
96316,placement,0,1
96317,of,0,0
96318,1.5,0,0
96319,%,0,0
96320,body,0,0
96321,weight,0,0
96322,.,0,0
96323,RESULTS,0,0
96324,People,0,0
96325,with,0,0
96326,BBTW,1,0
96327,showed,0,0
96328,a,0,0
96329,significant,0,0
96330,improvement,0,0
96331,in,0,0
96332,the,0,0
96333,25-foot,0,1
96334,walk,0,0
96335,(,0,0
96336,P,0,0
96337,=,0,0
96338,.01,0,0
96339,),0,0
96340,over,0,0
96341,those,0,0
96342,with,0,0
96343,no,0,0
96344,weight,0,0
96345,",",0,0
96346,and,0,0
96347,the,0,0
96348,TUG,0,0
96349,(,0,0
96350,P,0,0
96351,=,0,0
96352,.01,0,0
96353,),0,0
96354,over,0,0
96355,those,0,0
96356,with,0,0
96357,standard,0,1
96358,weight,0,0
96359,placement,0,1
96360,.,0,0
96361,BBTW,0,0
96362,participants,0,0
96363,received,0,0
96364,an,0,0
96365,average,0,0
96366,of,0,0
96367,0.5,0,0
96368,kg,0,0
96369,",",0,0
96370,less,0,0
96371,than,0,0
96372,1.5,0,0
96373,%,0,0
96374,of,0,0
96375,any,0,0
96376,participant,0,0
96377,'s,0,0
96378,body,0,0
96379,weight,0,0
96380,.,0,0
96381,CONCLUSION,0,0
96382,BBTW,1,0
96383,can,0,0
96384,have,0,0
96385,immediate,0,0
96386,advantages,0,0
96387,over,0,0
96388,a,0,0
96389,nonweighted,0,0
96390,condition,0,0
96391,for,0,0
96392,gait,0,0
96393,velocity,0,0
96394,and,0,0
96395,over,0,0
96396,a,0,0
96397,standardized,0,0
96398,weighted,0,1
96399,condition,0,0
96400,for,0,0
96401,a,0,0
96402,functional,0,0
96403,activity,0,0
96404,in,0,0
96405,people,0,0
96406,with,0,0
96407,multiple,0,0
96408,sclerosis,0,1
96409,(,0,1
96410,MS,0,0
96411,),0,1
96412,who,0,0
96413,are,0,0
96414,ambulatory,0,0
96415,but,0,0
96416,have,0,0
96417,balance,0,0
96418,and,0,0
96419,mobility,0,0
96420,abnormalities,0,0
96421,.,0,0
96422,Leucocyte,0,1
96423,depletion,0,0
96424,of,0,0
96425,perioperative,1,1
96426,blood,1,0
96427,transfusion,1,1
96428,does,0,0
96429,not,0,0
96430,affect,0,0
96431,long-term,0,0
96432,survival,0,0
96433,and,0,0
96434,recurrence,0,0
96435,in,0,0
96436,patients,0,0
96437,with,0,0
96438,gastrointestinal,0,0
96439,cancer,0,0
96440,.,0,0
96441,BACKGROUND,0,0
96442,Perioperative,1,0
96443,red,1,1
96444,blood,1,0
96445,cell,1,0
96446,(,1,1
96447,RBC,1,1
96448,),1,1
96449,transfusion,1,1
96450,may,0,0
96451,be,0,0
96452,associated,0,0
96453,with,0,0
96454,a,0,0
96455,poor,0,0
96456,prognosis,0,0
96457,in,0,0
96458,cancer,0,0
96459,surgery,0,1
96460,.,0,0
96461,Allogeneic,0,1
96462,leucocytes,0,0
96463,are,0,0
96464,assumed,0,0
96465,to,0,0
96466,play,0,0
96467,a,0,0
96468,causal,0,0
96469,role,0,0
96470,.,0,0
96471,This,0,0
96472,study,0,0
96473,evaluated,0,0
96474,the,0,0
96475,long-term,0,0
96476,effect,0,0
96477,of,0,0
96478,transfusion,1,1
96479,with,1,0
96480,leucocyte-depleted,1,1
96481,(,0,1
96482,LD,0,0
96483,),0,1
96484,blood,0,0
96485,in,0,0
96486,patients,0,0
96487,with,0,0
96488,gastrointestinal,0,0
96489,cancer,0,0
96490,.,0,0
96491,METHODS,0,0
96492,The,0,0
96493,Transfusion,0,1
96494,Associated,0,0
96495,Complications,0,0
96496,=,0,0
96497,Transfusion,0,1
96498,Induced,0,0
96499,Complications,0,0
96500,?,0,0
96501,(,0,0
96502,TACTIC,0,1
96503,),0,1
96504,study,0,0
96505,is,0,0
96506,a,0,0
96507,multicentre,0,0
96508,randomized,0,0
96509,controlled,0,0
96510,trial,0,0
96511,evaluating,0,0
96512,the,0,0
96513,short-term,0,0
96514,benefits,0,0
96515,of,0,0
96516,LD,1,0
96517,versus,1,1
96518,non-LD,1,0
96519,RBC,1,1
96520,transfusions,1,0
96521,.,1,0
96522,The,0,0
96523,present,0,0
96524,study,0,0
96525,evaluated,0,0
96526,5-year,0,0
96527,survival,0,0
96528,and,0,0
96529,cancer,0,0
96530,recurrence,0,0
96531,among,0,0
96532,512,0,0
96533,patients,0,0
96534,with,0,0
96535,gastrointestinal,0,0
96536,cancer,0,0
96537,included,0,0
96538,in,0,0
96539,the,0,0
96540,TACTIC,0,1
96541,study,0,0
96542,.,0,0
96543,RESULTS,0,0
96544,Some,0,0
96545,89.2,0,0
96546,per,0,0
96547,cent,0,0
96548,of,0,0
96549,patients,0,0
96550,had,0,0
96551,a,0,0
96552,primary,0,0
96553,tumour,0,0
96554,and,0,0
96555,79.7,0,0
96556,per,0,0
96557,cent,0,0
96558,underwent,0,0
96559,surgery,1,1
96560,with,0,0
96561,curative,0,0
96562,intent,0,0
96563,;,0,0
96564,243,0,0
96565,patients,0,0
96566,received,0,0
96567,perioperative,1,0
96568,RBC,1,1
96569,transfusion,1,1
96570,(,0,0
96571,median,0,0
96572,3,0,0
96573,units,0,0
96574,),0,0
96575,.,0,0
96576,The,0,0
96577,5-year,0,0
96578,overall,0,0
96579,survival,0,0
96580,rate,0,0
96581,of,0,0
96582,patients,0,0
96583,with,0,0
96584,any,0,0
96585,type,0,0
96586,of,0,0
96587,gastrointestinal,0,0
96588,cancer,0,0
96589,was,0,0
96590,50.8,0,0
96591,per,0,0
96592,cent,0,0
96593,in,0,0
96594,the,0,0
96595,LD,0,0
96596,group,0,0
96597,and,0,0
96598,45.8,0,0
96599,per,0,0
96600,cent,0,0
96601,in,0,0
96602,the,0,0
96603,non-LD,0,0
96604,group,0,0
96605,(,0,0
96606,P,0,0
96607,=,0,0
96608,0.191,0,0
96609,),0,0
96610,.,0,0
96611,Corresponding,0,0
96612,5-year,0,0
96613,disease-free,0,0
96614,survival,0,0
96615,rates,0,0
96616,were,0,0
96617,60.0,0,0
96618,and,0,0
96619,56.6,0,0
96620,per,0,1
96621,cent,0,0
96622,(,0,0
96623,P,0,0
96624,=,0,0
96625,0.482,0,0
96626,),0,0
96627,",",0,0
96628,and,0,0
96629,recurrence,0,0
96630,rates,0,0
96631,32.9,0,0
96632,and,0,0
96633,34.3,0,0
96634,per,0,1
96635,cent,0,0
96636,(,0,0
96637,P,0,0
96638,=,0,0
96639,0.864,0,0
96640,),0,0
96641,.,0,0
96642,CONCLUSION,0,0
96643,Leucocyte,0,0
96644,depletion,0,0
96645,is,0,0
96646,not,0,0
96647,associated,0,0
96648,with,0,0
96649,better,0,0
96650,long-term,0,0
96651,survival,0,0
96652,and,0,0
96653,lower,0,0
96654,recurrence,0,0
96655,rates,0,0
96656,in,0,0
96657,patients,0,0
96658,with,0,0
96659,gastrointestinal,0,0
96660,cancer,0,0
96661,.,0,0
96662,[,0,0
96663,Effect,0,0
96664,of,0,0
96665,liu,1,0
96666,wei,1,1
96667,di,1,1
96668,huang,1,0
96669,or,1,1
96670,jin,1,1
96671,gui,1,1
96672,shen,1,1
96673,qi,1,0
96674,decoction,1,1
96675,as,0,0
96676,on,0,0
96677,adjuvant,0,1
96678,treatment,0,0
96679,in,0,0
96680,small,0,0
96681,cell,0,0
96682,lung,0,0
96683,cancer,0,0
96684,],0,0
96685,.,0,0
96686,Eighty-three,0,0
96687,patients,0,0
96688,with,0,0
96689,small,0,0
96690,cell,0,0
96691,lung,0,0
96692,cancer,0,0
96693,were,0,0
96694,randomized,0,0
96695,with,1,0
96696,or,1,1
96697,without,1,0
96698,using,1,0
96699,a,1,0
96700,traditional,1,1
96701,Chinese,1,0
96702,Kidney-tonifying,1,1
96703,decoction,1,1
96704,(,1,0
96705,Liu,1,1
96706,Wei,1,1
96707,Di,1,1
96708,Huang,1,1
96709,or,1,1
96710,Jin,1,1
96711,Gui,1,1
96712,Shen,1,0
96713,Qi,1,1
96714,medicinal,1,1
96715,decoction,1,1
96716,),1,1
96717,in,1,0
96718,chemotherapy,1,1
96719,or,1,1
96720,radiotherapy,1,1
96721,courses,1,1
96722,.,1,0
96723,74,0,0
96724,patients,0,0
96725,were,0,0
96726,availble,0,0
96727,to,0,0
96728,be,0,0
96729,analysis,0,0
96730,.,0,0
96731,The,0,0
96732,two,0,0
96733,treatment,0,0
96734,groups,0,0
96735,were,0,0
96736,well-matched,0,0
96737,in,0,0
96738,age,0,0
96739,",",0,0
96740,sex,0,0
96741,",",0,0
96742,stage,0,0
96743,and,0,0
96744,performance,0,0
96745,status,0,0
96746,.,0,0
96747,There,0,0
96748,was,0,0
96749,a,0,0
96750,statistically,0,0
96751,significant,0,0
96752,difference,0,0
96753,in,0,0
96754,response,0,0
96755,rate,0,0
96756,and,0,0
96757,the,0,0
96758,median,0,0
96759,survival,0,0
96760,between,0,0
96761,two,0,0
96762,groups,0,0
96763,.,0,0
96764,The,0,0
96765,overall,0,0
96766,response,0,0
96767,rate,0,0
96768,(,0,1
96769,CR+PR,0,1
96770,),0,1
96771,was,0,0
96772,91.5,0,0
96773,%,0,0
96774,for,0,0
96775,Chinese,1,0
96776,herb,1,1
96777,group,0,0
96778,and,0,0
96779,46.9,0,0
96780,%,0,0
96781,for,0,0
96782,control,0,1
96783,group,0,1
96784,(,0,0
96785,P,0,0
96786,less,0,0
96787,than,0,0
96788,0.001,0,0
96789,),0,0
96790,.,0,0
96791,The,0,0
96792,median,0,0
96793,survival,0,0
96794,was,0,0
96795,16,0,0
96796,months,0,0
96797,for,0,0
96798,the,0,0
96799,traditional,0,1
96800,Chinese,1,0
96801,Kidney-tonifying,1,1
96802,decoction,1,1
96803,group,0,0
96804,",",0,0
96805,and,0,0
96806,10,0,0
96807,months,0,0
96808,for,0,0
96809,the,0,0
96810,control,0,1
96811,group,0,0
96812,(,0,0
96813,P,0,0
96814,less,0,0
96815,than,0,0
96816,0.05,0,0
96817,),0,0
96818,.,0,0
96819,Survival,0,0
96820,curve,0,0
96821,(,0,0
96822,Kaplan-meire,0,1
96823,'s,0,0
96824,),0,0
96825,of,0,0
96826,the,0,0
96827,Chinese,0,0
96828,herb,0,1
96829,group,0,0
96830,was,0,0
96831,better,0,0
96832,than,0,0
96833,that,0,0
96834,of,0,0
96835,the,0,0
96836,control,0,0
96837,group,0,0
96838,.,0,0
96839,10,0,0
96840,patients,0,0
96841,of,0,0
96842,Chinese,1,0
96843,herb,1,1
96844,group,0,0
96845,was,0,0
96846,alive,0,0
96847,beyond,0,0
96848,more,0,0
96849,than,0,0
96850,2,0,0
96851,years,0,0
96852,.,0,0
96853,Until,0,1
96854,now,0,0
96855,",",0,0
96856,4,0,0
96857,patients,0,0
96858,in,0,0
96859,the,0,0
96860,Chinese,1,0
96861,herb,1,1
96862,group,0,0
96863,",",0,0
96864,one,0,0
96865,in,0,0
96866,the,0,0
96867,control,0,1
96868,group,0,0
96869,are,0,0
96870,still,0,0
96871,enjoying,0,0
96872,their,0,0
96873,disease-free,0,0
96874,life,0,0
96875,for,0,0
96876,more,0,0
96877,than,0,0
96878,7,0,0
96879,years,0,0
96880,.,0,0
96881,Hematologic,0,0
96882,toxicities,0,0
96883,were,0,0
96884,observed,0,0
96885,much,0,0
96886,frequently,0,0
96887,in,0,0
96888,the,0,0
96889,patients,0,0
96890,of,0,0
96891,the,0,0
96892,control,0,1
96893,group,0,0
96894,(,0,0
96895,P,0,0
96896,less,0,0
96897,than,0,0
96898,0.005,0,0
96899,and,0,0
96900,0.01/WBC,0,0
96901,and,0,0
96902,BPC,0,1
96903,),0,0
96904,.,0,0
96905,Results,0,0
96906,of,0,0
96907,animal,0,0
96908,experiments,0,0
96909,with,0,0
96910,the,0,0
96911,same,0,0
96912,traditional,0,1
96913,medicinal,0,1
96914,decoctions,0,1
96915,as,0,0
96916,used,0,0
96917,in,0,0
96918,clinic,0,0
96919,have,0,0
96920,showed,0,0
96921,immuno-enhancement,0,1
96922,activities,0,0
96923,.,0,0
96924,These,0,0
96925,results,0,0
96926,have,0,0
96927,showed,0,0
96928,that,0,0
96929,the,0,0
96930,traditional,1,1
96931,Chinese,1,0
96932,Kidney-tonifying,1,1
96933,decoction,1,1
96934,may,0,0
96935,enhance,0,0
96936,non-specific,0,0
96937,immunology,0,0
96938,activities,0,0
96939,and,0,0
96940,may,0,0
96941,be,0,0
96942,much,0,0
96943,useful,0,0
96944,for,0,0
96945,solid,0,0
96946,cancer,0,0
96947,patients,0,0
96948,as,0,0
96949,an,0,0
96950,adjuvant,0,1
96951,treatment,0,0
96952,.,0,0
96953,Prognostic,0,0
96954,value,0,0
96955,of,0,0
96956,postoperative,1,0
96957,CEA,1,0
96958,clearance,1,0
96959,in,0,0
96960,rectal,0,0
96961,cancer,0,0
96962,patients,0,0
96963,with,0,0
96964,high,0,0
96965,preoperative,0,1
96966,CEA,0,0
96967,levels,0,0
96968,.,0,0
96969,PURPOSE,0,0
96970,We,0,0
96971,determined,0,0
96972,the,0,0
96973,prognostic,0,0
96974,value,0,0
96975,of,0,0
96976,carcinoembryonic,0,1
96977,antigen,0,0
96978,(,0,1
96979,CEA,0,1
96980,),0,1
96981,clearance,0,0
96982,after,0,0
96983,tumor,1,0
96984,resection,1,1
96985,with,0,0
96986,serial,0,0
96987,evaluation,0,0
96988,of,0,0
96989,postoperative,0,0
96990,CEA,0,0
96991,levels,0,0
96992,in,0,0
96993,rectal,0,0
96994,cancer,0,0
96995,.,0,0
96996,METHODS,0,0
96997,Between,0,0
96998,1994,0,0
96999,and,0,0
97000,2004,0,0
97001,",",0,0
97002,we,0,0
97003,retrospectively,0,0
97004,reviewed,0,0
97005,122,0,0
97006,patients,0,0
97007,with,0,0
97008,rectal,0,0
97009,cancer,0,0
97010,whose,0,0
97011,serum,0,0
97012,CEA,0,0
97013,levels,0,0
97014,were,0,0
97015,measured,0,0
97016,on,0,0
97017,the,0,0
97018,preoperative,0,1
97019,day,0,1
97020,and,0,0
97021,postoperative,0,0
97022,days,0,0
97023,7,0,0
97024,and,0,0
97025,30,0,0
97026,.,0,0
97027,Patients,0,0
97028,with,0,0
97029,preoperative,0,0
97030,CEA,0,0
97031,levels,0,0
97032,<,0,0
97033,5.0,0,0
97034,ng/ml,0,0
97035,were,0,0
97036,excluded,0,0
97037,.,0,0
97038,An,0,0
97039,exponential,0,0
97040,trend,0,0
97041,line,0,0
97042,was,0,0
97043,drawn,0,0
97044,using,0,0
97045,the,0,0
97046,three,0,0
97047,CEA,0,0
97048,values,0,0
97049,.,0,0
97050,Patients,0,0
97051,were,0,0
97052,categorized,0,0
97053,into,0,0
97054,three,0,0
97055,groups,0,0
97056,based,0,0
97057,on,0,0
97058,R,0,1
97059,(,0,1
97060,2,0,0
97061,),0,0
97062,values,0,0
97063,calculated,0,0
97064,through,0,0
97065,trend,0,0
97066,line,0,0
97067,",",0,0
97068,which,0,0
97069,indicates,0,0
97070,the,0,0
97071,correlation,0,0
97072,coefficient,0,0
97073,between,0,0
97074,exponential,0,0
97075,graph,0,1
97076,and,0,0
97077,measured,0,0
97078,CEA,0,0
97079,values,0,0
97080,:,0,0
97081,exponential,0,0
97082,decrease,0,0
97083,group,0,1
97084,(,0,1
97085,group,0,0
97086,1,0,0
97087,:,0,0
97088,0.9,0,0
97089,<,0,0
97090,R,0,1
97091,(,0,1
97092,2,0,0
97093,),0,1
97094,<,0,0
97095,or,0,1
97096,=,0,0
97097,1.0,0,0
97098,),0,0
97099,",",0,0
97100,nearly,0,0
97101,exponential,0,0
97102,decrease,0,0
97103,group,0,1
97104,(,0,1
97105,group,0,0
97106,2,0,0
97107,:,0,0
97108,0.5,0,0
97109,<,0,0
97110,R,0,1
97111,(,0,1
97112,2,0,0
97113,),0,1
97114,<,0,0
97115,or,0,1
97116,=,0,0
97117,0.9,0,0
97118,),0,0
97119,",",0,0
97120,and,0,0
97121,randomized,0,0
97122,clearance,0,0
97123,group,0,1
97124,(,0,1
97125,group,0,0
97126,3,0,0
97127,:,0,0
97128,0.5,0,1
97129,<,0,0
97130,or,0,1
97131,=,0,0
97132,R,0,1
97133,(,0,1
97134,2,0,1
97135,),0,0
97136,),0,0
97137,.,0,0
97138,We,0,0
97139,then,0,0
97140,analyzed,0,0
97141,the,0,0
97142,CEA,0,1
97143,clearance,0,0
97144,pattern,0,0
97145,as,0,0
97146,a,0,0
97147,prognostic,0,0
97148,indicator,0,0
97149,.,0,0
97150,RESULTS,0,0
97151,With,0,0
97152,a,0,0
97153,median,0,0
97154,follow-up,0,0
97155,of,0,0
97156,57,0,0
97157,months,0,0
97158,",",0,0
97159,the,0,0
97160,5-year,0,0
97161,overall,0,0
97162,survival,0,0
97163,was,0,0
97164,62.3,0,0
97165,%,0,0
97166,vs.,0,0
97167,48.1,0,0
97168,%,0,0
97169,vs.,0,0
97170,25,0,0
97171,%,0,0
97172,and,0,0
97173,the,0,0
97174,5-year,0,0
97175,disease-free,0,0
97176,survival,0,0
97177,was,0,0
97178,58.6,0,0
97179,%,0,0
97180,vs.,0,0
97181,52.7,0,0
97182,%,0,0
97183,vs.,0,0
97184,25,0,0
97185,%,0,0
97186,among,0,0
97187,groups,0,0
97188,1,0,0
97189,",",0,0
97190,2,0,0
97191,",",0,0
97192,and,0,0
97193,3,0,0
97194,(,0,0
97195,P,0,0
97196,=,0,0
97197,0.014,0,0
97198,",",0,0
97199,P,0,0
97200,=,0,0
97201,0.027,0,0
97202,",",0,0
97203,respectively,0,0
97204,),0,0
97205,in,0,0
97206,patients,0,0
97207,with,0,0
97208,stage,0,0
97209,III,0,1
97210,rectal,0,0
97211,cancer,0,0
97212,.,0,0
97213,For,0,0
97214,those,0,0
97215,with,0,0
97216,stage,0,0
97217,II,0,1
97218,rectal,0,0
97219,cancer,0,0
97220,",",0,0
97221,the,0,0
97222,5-year,0,0
97223,overall,0,0
97224,survival,0,0
97225,rate,0,0
97226,of,0,0
97227,group,0,0
97228,1,0,0
97229,was,0,0
97230,significantly,0,0
97231,better,0,0
97232,than,0,0
97233,groups,0,0
97234,2,0,0
97235,and,0,0
97236,3,0,0
97237,(,0,0
97238,88.8,0,0
97239,%,0,0
97240,vs.,0,0
97241,74.1,0,0
97242,%,0,0
97243,",",0,0
97244,respectively,0,0
97245,",",0,0
97246,P,0,0
97247,=,0,0
97248,0.021,0,0
97249,),0,0
97250,.,0,0
97251,CONCLUSIONS,0,0
97252,The,0,0
97253,postoperative,1,0
97254,pattern,1,0
97255,of,1,0
97256,CEA,1,0
97257,clearance,1,0
97258,is,0,0
97259,a,0,0
97260,useful,0,0
97261,prognostic,0,0
97262,determinant,0,0
97263,in,0,0
97264,patients,0,0
97265,with,0,0
97266,rectal,0,0
97267,cancer,0,0
97268,.,0,0
97269,Patients,0,0
97270,with,0,0
97271,a,0,0
97272,randomized,0,0
97273,pattern,0,0
97274,of,0,0
97275,CEA,0,0
97276,clearance,0,0
97277,after,0,0
97278,tumor,0,0
97279,resection,0,1
97280,should,0,0
97281,be,0,0
97282,regarded,0,0
97283,as,0,0
97284,having,0,0
97285,the,0,0
97286,possibility,0,0
97287,of,0,0
97288,a,0,0
97289,persistent,0,0
97290,CEA,0,1
97291,source,0,0
97292,and,0,0
97293,may,0,0
97294,require,0,0
97295,consideration,0,0
97296,of,0,0
97297,intensive,0,1
97298,follow-up,0,0
97299,or,0,1
97300,adjuvant,0,1
97301,therapy,0,1
97302,.,0,0
97303,Norfloxacin,1,1
97304,modulates,0,0
97305,the,0,0
97306,inflammatory,0,0
97307,response,0,0
97308,and,0,0
97309,directly,0,0
97310,affects,0,0
97311,neutrophils,0,0
97312,in,0,0
97313,patients,0,0
97314,with,0,0
97315,decompensated,0,0
97316,cirrhosis,0,0
97317,.,0,1
97318,BACKGROUND,0,0
97319,&,0,0
97320,AIMS,0,0
97321,Patients,0,0
97322,with,0,0
97323,cirrhosis,0,0
97324,undergoing,0,0
97325,selective,0,0
97326,intestinal,0,0
97327,decontamination,0,1
97328,with,0,0
97329,norfloxacin,1,1
97330,show,0,0
97331,a,0,0
97332,reduction,0,0
97333,in,0,0
97334,serum,0,0
97335,cytokine,0,0
97336,levels,0,0
97337,",",0,0
97338,probably,0,0
97339,because,0,0
97340,of,0,0
97341,a,0,0
97342,combined,0,1
97343,effect,0,0
97344,of,0,0
97345,norfloxacin,1,1
97346,on,0,0
97347,bowel,0,0
97348,flora,0,0
97349,and,0,0
97350,neutrophils,0,0
97351,.,0,0
97352,METHODS,0,0
97353,Thirty-one,0,0
97354,patients,0,0
97355,with,0,0
97356,cirrhosis,0,0
97357,receiving,0,1
97358,norfloxacin,1,1
97359,(,0,1
97360,400,0,1
97361,mg/day,0,1
97362,),0,0
97363,were,0,0
97364,included,0,0
97365,.,0,0
97366,Blood,0,0
97367,samples,0,0
97368,were,0,0
97369,collected,0,0
97370,at,0,0
97371,0.5-4,0,0
97372,hours,0,0
97373,(,0,0
97374,peak,0,0
97375,samples,0,0
97376,group,0,0
97377,",",0,0
97378,n,0,0
97379,=,0,0
97380,47,0,0
97381,),0,0
97382,and,0,0
97383,at,0,0
97384,22-24,0,1
97385,hours,0,0
97386,(,0,0
97387,trough,0,0
97388,samples,0,0
97389,group,0,0
97390,",",0,0
97391,n,0,0
97392,=,0,0
97393,84,0,0
97394,),0,0
97395,after,0,0
97396,dose,0,0
97397,.,0,0
97398,Fifty-nine,0,0
97399,ascitic,0,0
97400,fluid,0,1
97401,samples,0,0
97402,were,0,0
97403,obtained,0,0
97404,.,0,0
97405,Single,0,0
97406,doses,0,0
97407,of,0,0
97408,norfloxacin,1,1
97409,and,1,0
97410,trimethoprim/sulfamethoxazole,1,1
97411,were,0,0
97412,administered,0,0
97413,to,0,0
97414,13,0,0
97415,and,0,0
97416,5,0,0
97417,patients,0,0
97418,",",0,0
97419,respectively,0,0
97420,",",0,0
97421,(,0,0
97422,temporal,0,1
97423,profile,0,0
97424,group,0,1
97425,),0,1
97426,and,0,0
97427,samples,0,0
97428,were,0,0
97429,collected,0,0
97430,at,0,0
97431,0,0,0
97432,",",0,0
97433,0.5,0,0
97434,",",0,0
97435,1,0,0
97436,",",0,0
97437,1.5,0,0
97438,",",0,0
97439,2,0,0
97440,",",0,0
97441,4,0,0
97442,",",0,0
97443,and,0,0
97444,24,0,0
97445,hours,0,0
97446,.,0,0
97447,Norfloxacin,1,1
97448,",",1,0
97449,trimethoprim/sulfamethoxazole,1,1
97450,",",1,0
97451,cytokines,1,0
97452,",",1,0
97453,nitric,1,1
97454,oxide,1,0
97455,",",0,0
97456,expression,0,0
97457,levels,0,0
97458,of,0,0
97459,nuclear,0,0
97460,factor,0,1
97461,(,0,1
97462,NF,0,1
97463,),0,1
97464,-kappaB,0,0
97465,and,0,0
97466,inhibitor,0,1
97467,of,0,0
97468,NF-kappaB,0,1
97469,(,0,1
97470,IkB-alpha,0,1
97471,),0,1
97472,",",0,0
97473,neutrophil,0,0
97474,oxidative,0,0
97475,burst,0,0
97476,",",0,0
97477,and,0,0
97478,rate,0,0
97479,of,0,0
97480,apoptotic,0,0
97481,events,0,0
97482,were,0,0
97483,determined,0,0
97484,.,0,0
97485,RESULTS,0,0
97486,All,0,0
97487,samples,0,0
97488,were,0,0
97489,bacterial,0,0
97490,DNA,0,1
97491,negative,0,0
97492,and,0,0
97493,had,0,0
97494,no,0,0
97495,significant,0,0
97496,levels,0,0
97497,of,0,0
97498,lipopolysaccharide,0,0
97499,.,0,0
97500,Serum,0,0
97501,and,0,0
97502,ascitic,0,0
97503,levels,0,0
97504,of,0,0
97505,tumor,0,0
97506,necrosis,0,0
97507,factor-alpha,0,0
97508,",",0,0
97509,interferon-gamma,0,1
97510,",",0,0
97511,interleukin-12,0,1
97512,",",0,0
97513,and,0,0
97514,nitric,0,1
97515,oxide,0,1
97516,were,0,0
97517,significantly,0,0
97518,lower,0,0
97519,in,0,0
97520,peak,0,0
97521,than,0,0
97522,in,0,0
97523,trough,0,0
97524,samples,0,0
97525,.,0,0
97526,A,0,0
97527,correlation,0,0
97528,was,0,0
97529,present,0,0
97530,between,0,0
97531,serum,0,0
97532,norfloxacins,1,1
97533,concentrations,0,0
97534,and,0,0
97535,tumor,0,0
97536,necrosis,0,1
97537,factor-alpha,0,1
97538,(,0,0
97539,r,0,0
97540,=,0,0
97541,-0.68,0,0
97542,;,0,0
97543,P,0,0
97544,<,0,0
97545,.001,0,0
97546,),0,0
97547,",",0,0
97548,interferon-gamma,1,1
97549,(,0,0
97550,r,0,0
97551,=,0,0
97552,-0.66,0,0
97553,;,0,0
97554,P,0,0
97555,<,0,0
97556,.001,0,0
97557,),0,0
97558,",",0,0
97559,interleukin-12,1,1
97560,(,0,0
97561,r,0,0
97562,=,0,0
97563,-0.66,0,0
97564,;,0,0
97565,P,0,0
97566,<,0,0
97567,.001,0,0
97568,),0,0
97569,",",0,0
97570,and,0,0
97571,nitric,1,1
97572,oxide,1,1
97573,(,0,0
97574,r,0,0
97575,=,0,0
97576,-0.68,0,0
97577,;,0,0
97578,P,0,0
97579,<,0,0
97580,.001,0,0
97581,),0,0
97582,.,0,0
97583,Serum,0,0
97584,norfloxacin,0,1
97585,'s,0,0
97586,highest,0,0
97587,concentrations,0,0
97588,(,0,0
97589,1,0,0
97590,+/-,0,0
97591,0.5,0,1
97592,microg/mL,0,0
97593,),0,0
97594,were,0,0
97595,achieved,0,0
97596,at,0,0
97597,1-2,0,0
97598,hours,0,0
97599,and,0,0
97600,concurred,0,0
97601,in,0,0
97602,time,0,0
97603,with,0,0
97604,the,0,0
97605,lower,0,0
97606,levels,0,0
97607,of,0,0
97608,cytokines,0,0
97609,and,0,0
97610,nitric,0,1
97611,oxide,0,1
97612,.,0,0
97613,Intracellular,0,0
97614,norfloxacin,0,1
97615,'s,0,0
97616,highest,0,0
97617,levels,0,0
97618,(,0,0
97619,2,0,0
97620,+/-,0,0
97621,1,0,0
97622,microg/mL/10,0,0
97623,(,0,0
97624,7,0,0
97625,),0,0
97626,cells,0,0
97627,),0,0
97628,were,0,0
97629,observed,0,0
97630,at,0,0
97631,2,0,0
97632,hours,0,0
97633,and,0,0
97634,concurred,0,0
97635,with,0,0
97636,a,0,0
97637,lower,0,0
97638,NF-kappaB,0,0
97639,expression,0,0
97640,",",0,0
97641,a,0,0
97642,reduced,0,0
97643,anion,0,1
97644,superoxide,0,1
97645,generation,0,0
97646,",",0,0
97647,and,0,0
97648,apoptotic,0,0
97649,rate,0,0
97650,in,0,0
97651,response,0,0
97652,to,0,0
97653,phorbol,0,1
97654,myristate,0,1
97655,acetate,0,1
97656,.,0,0
97657,Trimethoprim/sulfamethoxazole,1,0
97658,did,0,0
97659,not,0,0
97660,significantly,0,0
97661,modulate,0,0
97662,cytokine,0,0
97663,expression,0,0
97664,.,0,0
97665,CONCLUSIONS,0,0
97666,Norfloxacin,1,1
97667,but,0,0
97668,not,0,0
97669,trimethoprim/sulfamethoxazole,1,1
97670,modulates,0,0
97671,inflammatory,0,0
97672,response,0,0
97673,and,0,0
97674,directly,0,0
97675,affects,0,0
97676,neutrophils,0,0
97677,in,0,0
97678,patients,0,0
97679,with,0,0
97680,cirrhosis,0,0
97681,.,0,0
97682,Preliminary,0,1
97683,evaluation,0,0
97684,of,0,0
97685,psychoeducational,1,1
97686,support,1,0
97687,interventions,1,1
97688,on,0,0
97689,quality,0,0
97690,of,0,0
97691,life,0,0
97692,in,0,0
97693,rural,0,0
97694,breast,0,0
97695,cancer,0,0
97696,survivors,0,0
97697,after,0,0
97698,primary,0,0
97699,treatment,0,0
97700,.,0,0
97701,Although,0,0
97702,most,0,0
97703,cancer,0,0
97704,survivors,0,0
97705,are,0,0
97706,at,0,0
97707,risk,0,0
97708,for,0,0
97709,being,0,0
97710,lost,0,0
97711,in,0,0
97712,the,0,0
97713,transition,0,0
97714,from,0,0
97715,treatment,0,0
97716,to,0,0
97717,survivorship,0,0
97718,",",0,0
97719,rural,0,0
97720,breast,0,0
97721,cancer,0,0
97722,survivors,0,0
97723,face,0,0
97724,special,0,0
97725,challenges,0,0
97726,that,0,0
97727,might,0,0
97728,place,0,0
97729,them,0,0
97730,at,0,0
97731,particular,0,0
97732,risk,0,0
97733,.,0,0
97734,This,0,0
97735,small-scale,0,0
97736,preliminary,0,0
97737,study,0,0
97738,had,0,0
97739,2,0,0
97740,specific,0,0
97741,aims,0,0
97742,:,0,0
97743,(,0,0
97744,aim,0,0
97745,1,0,0
97746,),0,0
97747,establish,0,0
97748,the,0,0
97749,feasibility,0,0
97750,of,0,0
97751,rural,0,0
97752,breast,0,0
97753,cancer,0,0
97754,survivors,0,0
97755,participation,0,0
97756,in,0,0
97757,a,0,0
97758,longitudinal,1,0
97759,quality,1,0
97760,of,1,0
97761,life,1,0
97762,(,1,1
97763,QOL,1,1
97764,),1,1
97765,intervention,1,1
97766,trial,0,0
97767,and,0,0
97768,(,0,0
97769,aim,0,0
97770,2,0,0
97771,),0,0
97772,determine,0,0
97773,the,0,0
97774,effects,0,0
97775,of,0,0
97776,the,0,0
97777,Breast,1,0
97778,Cancer,1,0
97779,Education,1,1
97780,Intervention,1,1
97781,(,1,1
97782,BCEI,1,1
97783,),1,1
97784,on,0,0
97785,overall,0,0
97786,QOL,0,0
97787,.,0,0
97788,Fifty-three,0,0
97789,rural,0,0
97790,breast,0,0
97791,cancer,0,0
97792,survivors,0,0
97793,were,0,0
97794,randomized,0,0
97795,to,0,0
97796,either,0,0
97797,an,0,0
97798,experimental,0,0
97799,(,0,0
97800,n,0,0
97801,=,0,0
97802,27,0,0
97803,),0,0
97804,or,0,1
97805,a,0,0
97806,wait-control,0,1
97807,arm,0,0
97808,(,0,0
97809,n,0,0
97810,=,0,0
97811,26,0,0
97812,),0,0
97813,.,0,0
97814,Participants,0,0
97815,in,0,0
97816,the,0,0
97817,experimental,0,0
97818,arm,0,0
97819,received,0,0
97820,the,0,0
97821,BCEI,0,1
97822,consisting,0,0
97823,of,0,0
97824,3,1,0
97825,face-to-face,1,1
97826,education,1,1
97827,and,1,0
97828,support,1,1
97829,sessions,1,1
97830,and,0,0
97831,2,0,0
97832,face-to-face,0,1
97833,and,0,0
97834,3,0,0
97835,telephone,1,1
97836,follow-up,1,0
97837,sessions,1,1
97838,",",0,0
97839,along,0,0
97840,with,0,0
97841,supplemental,0,1
97842,written,0,1
97843,and,0,0
97844,audiotape,0,1
97845,materials,0,1
97846,over,0,0
97847,a,0,0
97848,6-month,0,0
97849,period,0,0
97850,.,0,0
97851,Breast,1,0
97852,Cancer,1,0
97853,Education,1,1
97854,Intervention,1,1
97855,modules,1,1
97856,and,1,0
97857,interventions,1,0
97858,are,0,0
97859,organized,0,1
97860,within,0,0
97861,a,0,0
97862,QOL,0,0
97863,framework,0,0
97864,.,0,0
97865,To,0,0
97866,address,0,0
97867,the,0,0
97868,possible,0,0
97869,effects,0,0
97870,of,0,0
97871,attention,0,0
97872,",",0,0
97873,wait-control,0,1
97874,participants,0,0
97875,received,0,0
97876,3,0,0
97877,face-to-face,0,1
97878,sessions,0,1
97879,and,0,0
97880,3,0,0
97881,telephone,0,1
97882,sessions,0,1
97883,during,0,0
97884,the,0,0
97885,first,0,0
97886,6,0,0
97887,months,0,0
97888,of,0,0
97889,participation,0,0
97890,in,0,0
97891,the,0,0
97892,study,0,0
97893,",",0,0
97894,but,0,0
97895,not,0,0
97896,the,0,0
97897,BCEI,1,1
97898,intervention,1,1
97899,.,1,0
97900,Research,0,0
97901,questions,0,0
97902,addressing,0,0
97903,aim,0,0
97904,1,0,0
97905,were,0,0
97906,as,0,0
97907,follows,0,0
97908,:,0,0
97909,(,0,0
97910,a,0,0
97911,),0,0
97912,can,0,0
97913,rural,0,0
97914,breast,0,0
97915,cancer,0,0
97916,survivors,0,0
97917,be,0,0
97918,recruited,0,0
97919,into,0,0
97920,a,0,0
97921,longitudinal,0,0
97922,intervention,0,1
97923,trial,0,0
97924,",",0,0
97925,and,0,0
97926,(,0,1
97927,b,0,0
97928,),0,1
97929,can,0,0
97930,their,0,0
97931,participation,0,0
97932,be,0,0
97933,retained,0,0
97934,.,0,0
97935,Research,0,0
97936,questions,0,0
97937,for,0,0
97938,aim,0,0
97939,2,0,0
97940,were,0,0
97941,as,0,0
97942,follows,0,0
97943,:,0,0
97944,(,0,0
97945,a,0,0
97946,),0,0
97947,do,0,0
97948,participants,0,0
97949,who,0,0
97950,received,0,0
97951,the,0,0
97952,BCEI,0,1
97953,show,0,0
97954,improvement,0,0
97955,in,0,0
97956,overall,0,0
97957,QOL,0,0
97958,",",0,0
97959,and,0,0
97960,(,0,1
97961,b,0,0
97962,),0,1
97963,is,0,0
97964,the,0,0
97965,QOL,0,0
97966,improvement,0,0
97967,sustained,0,0
97968,over,0,0
97969,time,0,0
97970,.,0,0
97971,Data,0,0
97972,were,0,0
97973,analyzed,0,0
97974,using,0,0
97975,repeated-measures,0,0
97976,general,0,0
97977,linear,0,0
97978,mixed,0,1
97979,models,0,0
97980,.,0,0
97981,Results,0,0
97982,demonstrated,0,0
97983,the,0,0
97984,ability,0,0
97985,to,0,0
97986,recruit,0,0
97987,and,0,0
97988,retain,0,0
97989,53,0,0
97990,rural,0,0
97991,breast,0,0
97992,cancer,0,0
97993,survivors,0,0
97994,",",0,0
97995,that,0,0
97996,the,0,0
97997,experimental,0,0
97998,arm,0,0
97999,showed,0,0
98000,improvement,0,0
98001,in,0,0
98002,overall,0,0
98003,QOL,0,1
98004,(,0,0
98005,P,0,0
98006,=,0,0
98007,.013,0,0
98008,),0,0
98009,",",0,0
98010,and,0,0
98011,that,0,0
98012,there,0,0
98013,were,0,0
98014,significant,0,0
98015,differences,0,0
98016,in,0,0
98017,overall,0,0
98018,QOL,0,0
98019,between,0,0
98020,the,0,0
98021,experimental,0,0
98022,and,0,0
98023,wait-control,0,1
98024,groups,0,0
98025,at,0,0
98026,both,0,0
98027,months,0,0
98028,3,0,0
98029,and,0,0
98030,6,0,0
98031,.,0,0
98032,Thus,0,0
98033,",",0,0
98034,it,0,0
98035,appears,0,0
98036,that,0,0
98037,at,0,0
98038,least,0,0
98039,some,0,0
98040,rural,0,0
98041,breast,0,0
98042,cancer,0,0
98043,survivors,0,0
98044,can,0,0
98045,and,0,0
98046,will,0,0
98047,participate,0,0
98048,in,0,0
98049,a,0,0
98050,larger,0,0
98051,trial,0,0
98052,and,0,0
98053,will,0,0
98054,maintain,0,1
98055,their,0,0
98056,participation,0,0
98057,and,0,0
98058,that,0,0
98059,those,0,0
98060,that,0,0
98061,do,0,0
98062,participate,0,0
98063,experience,0,0
98064,significant,0,0
98065,QOL,0,0
98066,benefit,0,0
98067,.,0,0
98068,Clinical,0,0
98069,effects,0,0
98070,of,0,0
98071,nanocrystalline,1,0
98072,hydroxyapatite,1,1
98073,paste,1,1
98074,in,0,0
98075,the,0,0
98076,treatment,0,0
98077,of,0,0
98078,intrabony,0,0
98079,periodontal,0,0
98080,defects,0,0
98081,:,0,0
98082,a,0,0
98083,randomized,0,0
98084,controlled,0,0
98085,clinical,0,0
98086,study,0,0
98087,.,0,0
98088,The,0,0
98089,purpose,0,0
98090,of,0,0
98091,the,0,0
98092,present,0,0
98093,randomized,0,0
98094,controlled,0,0
98095,clinical,0,0
98096,study,0,0
98097,was,0,0
98098,to,0,0
98099,compare,0,0
98100,the,0,0
98101,clinical,0,0
98102,outcomes,0,0
98103,of,0,0
98104,papilla,0,0
98105,preservation,0,0
98106,flap,0,1
98107,surgery,0,1
98108,with,0,0
98109,or,0,0
98110,without,0,0
98111,the,0,0
98112,application,0,0
98113,of,0,0
98114,a,0,0
98115,novel,0,0
98116,nanocrystalline,1,1
98117,hydroxyapatite,1,1
98118,(,1,1
98119,nano-HA,1,1
98120,),1,1
98121,bone,1,0
98122,graft,1,1
98123,substitute,1,0
98124,.,1,0
98125,Fourteen,0,0
98126,patients,0,0
98127,with,0,0
98128,paired,0,0
98129,intrabony,0,0
98130,periodontal,0,0
98131,defects,0,0
98132,of,0,0
98133,?,0,0
98134,4,0,0
98135,mm,0,0
98136,participated,0,0
98137,in,0,0
98138,this,0,0
98139,split-mouth,0,1
98140,design,0,0
98141,study,0,0
98142,.,0,0
98143,The,0,0
98144,defects,0,0
98145,in,0,0
98146,each,0,0
98147,subject,0,0
98148,were,1,0
98149,randomly,1,0
98150,selected,1,0
98151,to,1,0
98152,receive,1,0
98153,nano-HA,1,1
98154,paste,1,1
98155,in,1,0
98156,conjunction,1,1
98157,with,1,0
98158,papilla,1,0
98159,preservation,1,0
98160,flaps,1,1
98161,or,1,1
98162,papilla,1,0
98163,preservation,1,0
98164,flaps,1,1
98165,alone,1,1
98166,.,1,0
98167,Probing,1,0
98168,bone,1,0
98169,levels,1,0
98170,(,1,0
98171,PBL,1,1
98172,),1,1
98173,from,1,0
98174,a,1,0
98175,customized,1,1
98176,acrylic,1,1
98177,stent,1,1
98178,and,1,0
98179,probing,1,0
98180,pocket,1,0
98181,depths,1,1
98182,(,1,0
98183,PPD,1,1
98184,),1,1
98185,were,1,0
98186,measured,1,0
98187,at,1,0
98188,baseline,1,0
98189,and,1,0
98190,again,1,0
98191,6,1,0
98192,months,1,0
98193,following,1,0
98194,surgery,1,0
98195,.,1,0
98196,No,0,0
98197,differences,0,0
98198,in,0,0
98199,any,0,0
98200,of,0,0
98201,the,0,0
98202,investigated,0,0
98203,parameters,0,0
98204,were,0,0
98205,observed,0,0
98206,at,0,0
98207,baseline,0,0
98208,between,0,0
98209,the,0,0
98210,two,0,0
98211,groups,0,0
98212,.,0,0
98213,Healing,0,0
98214,was,0,0
98215,uneventful,0,0
98216,in,0,0
98217,all,0,0
98218,patients,0,0
98219,.,0,0
98220,Both,0,0
98221,treatments,0,0
98222,resulted,0,0
98223,in,0,0
98224,significant,0,0
98225,improvements,0,0
98226,between,0,0
98227,baseline,0,0
98228,and,0,0
98229,6,0,1
98230,months,0,0
98231,(,0,0
98232,p,0,0
98233,<,0,0
98234,0.05,0,0
98235,),0,0
98236,.,0,0
98237,At,0,0
98238,6,0,0
98239,months,0,0
98240,after,0,0
98241,therapy,0,1
98242,",",0,0
98243,the,0,0
98244,sites,0,0
98245,treated,0,0
98246,with,1,0
98247,nano-HA,1,1
98248,paste,1,1
98249,showed,1,0
98250,a,0,0
98251,reduction,0,0
98252,in,0,0
98253,mean,0,0
98254,PPD,0,1
98255,from,0,0
98256,8.3,0,0
98257,?,0,0
98258,1.2,0,0
98259,to,0,0
98260,4.0,0,0
98261,?,0,0
98262,1.1,0,0
98263,mm,0,0
98264,and,0,0
98265,a,0,0
98266,gain,0,0
98267,in,0,0
98268,PBL,0,1
98269,of,0,0
98270,4.3,0,0
98271,?,0,0
98272,1.4,0,0
98273,mm,0,0
98274,",",0,0
98275,whereas,0,0
98276,in,0,0
98277,the,0,0
98278,control,0,1
98279,group,0,0
98280,",",0,0
98281,the,0,0
98282,mean,0,0
98283,PPD,0,1
98284,changed,0,0
98285,from,0,0
98286,7.9,0,0
98287,?,0,0
98288,1.2,0,0
98289,mm,0,0
98290,to,0,0
98291,5.0,0,0
98292,?,0,0
98293,1.2,0,0
98294,mm,0,0
98295,and,0,0
98296,PBL,0,1
98297,gain,0,0
98298,was,0,0
98299,2.6,0,0
98300,?,0,0
98301,1.4,0,0
98302,mm,0,0
98303,.,0,0
98304,Results,0,0
98305,demonstrated,0,0
98306,statistically,0,0
98307,greater,0,0
98308,PPD,0,1
98309,reduction,0,0
98310,and,0,0
98311,PBL,0,1
98312,gain,0,1
98313,(,0,0
98314,p,0,0
98315,<,0,0
98316,0.05,0,0
98317,),0,0
98318,in,0,0
98319,the,0,0
98320,test,0,0
98321,group,0,0
98322,as,0,0
98323,compared,0,0
98324,with,0,0
98325,the,0,0
98326,control,0,0
98327,group,0,0
98328,.,0,0
98329,In,0,0
98330,conclusion,0,0
98331,",",0,0
98332,after,0,0
98333,6,0,0
98334,months,0,0
98335,",",0,0
98336,the,0,0
98337,treatment,0,0
98338,of,0,0
98339,intrabony,0,0
98340,periodontal,0,0
98341,defects,0,0
98342,with,0,0
98343,a,0,0
98344,nano-HA,0,1
98345,paste,0,1
98346,leads,0,0
98347,to,0,0
98348,significantly,0,0
98349,improved,0,0
98350,clinical,0,0
98351,outcomes,0,0
98352,when,0,0
98353,compared,0,0
98354,with,1,0
98355,papilla,1,0
98356,preservation,1,0
98357,flap,1,1
98358,surgery,1,0
98359,alone,0,1
98360,.,0,0
98361,A,0,0
98362,randomized,0,0
98363,controlled,0,0
98364,trial,0,0
98365,of,0,0
98366,R-salbutamol,1,1
98367,for,0,0
98368,topical,0,1
98369,treatment,0,0
98370,of,0,0
98371,discoid,0,0
98372,lupus,0,0
98373,erythematosus,0,0
98374,.,0,0
98375,BACKGROUND,0,0
98376,In,0,0
98377,a,0,0
98378,recent,0,0
98379,open,0,1
98380,pilot,0,0
98381,trial,0,0
98382,",",0,0
98383,R-salbutamol,1,1
98384,sulphate,1,1
98385,",",0,0
98386,a,0,0
98387,well-known,0,0
98388,molecule,0,0
98389,with,0,0
98390,anti-inflammatory,0,1
98391,effects,0,0
98392,",",0,0
98393,was,0,0
98394,tested,0,0
98395,successfully,0,0
98396,on,0,0
98397,patients,0,0
98398,with,0,0
98399,therapy-resistant,0,0
98400,discoid,0,0
98401,lupus,0,0
98402,erythematosus,0,0
98403,(,0,1
98404,DLE,0,1
98405,),0,0
98406,.,0,0
98407,OBJECTIVES,0,0
98408,To,0,0
98409,compare,0,0
98410,the,0,0
98411,efficacy,0,0
98412,and,0,0
98413,safety,0,0
98414,of,0,0
98415,R-salbutamol,1,1
98416,cream,1,1
98417,0.5,0,1
98418,%,0,0
98419,vs.,1,0
98420,placebo,1,1
98421,on,0,0
98422,DLE,0,0
98423,lesions,0,0
98424,in,0,0
98425,a,0,0
98426,multicentre,0,0
98427,",",0,0
98428,double-blinded,0,0
98429,",",0,0
98430,randomized,0,0
98431,",",0,0
98432,placebo-controlled,0,1
98433,phase,0,0
98434,II,0,0
98435,trial,0,0
98436,.,0,0
98437,METHODS,0,0
98438,Thirty-seven,0,0
98439,patients,0,0
98440,with,0,0
98441,at,0,0
98442,least,0,0
98443,one,0,0
98444,newly,0,0
98445,developed,0,0
98446,DLE,0,1
98447,lesion,0,0
98448,were,0,0
98449,randomized,1,0
98450,-,1,0
98451,19,1,0
98452,to,1,0
98453,the,1,0
98454,R-salbutamol,1,1
98455,cream,1,1
98456,0.5,1,1
98457,%,1,0
98458,and,1,0
98459,18,1,0
98460,to,1,0
98461,placebo,1,1
98462,-,1,0
98463,and,1,0
98464,treated,1,0
98465,twice,1,1
98466,daily,1,1
98467,for,1,0
98468,8,1,0
98469,weeks,1,0
98470,.,1,0
98471,Efficacy,0,0
98472,was,0,0
98473,evaluated,0,0
98474,through,0,0
98475,scores,0,0
98476,of,0,0
98477,erythema,0,0
98478,",",0,0
98479,scaling/hypertrophy,0,0
98480,and,0,0
98481,induration,0,0
98482,as,0,0
98483,well,0,0
98484,as,0,0
98485,pain,0,0
98486,and,0,0
98487,itching,0,0
98488,;,0,0
98489,general,0,0
98490,improvement,0,0
98491,scored,0,0
98492,by,0,0
98493,the,0,0
98494,investigator,0,0
98495,and,0,0
98496,global,0,0
98497,improvement,0,0
98498,scored,0,0
98499,by,0,0
98500,patients,0,0
98501,',0,0
98502,assessment,0,0
98503,were,0,0
98504,also,0,0
98505,evaluated,0,0
98506,.,0,0
98507,RESULTS,0,0
98508,The,0,0
98509,mean,0,0
98510,area,0,0
98511,under,0,0
98512,the,0,0
98513,curve,0,0
98514,of,0,0
98515,improvement,0,0
98516,for,0,0
98517,scaling/hypertrophy,0,0
98518,",",0,0
98519,pain,0,0
98520,",",0,0
98521,itching,0,0
98522,and,0,0
98523,global,0,0
98524,patient,0,0
98525,assessment,0,0
98526,was,0,0
98527,significantly,0,0
98528,better,0,0
98529,for,0,0
98530,the,0,0
98531,actively,0,0
98532,treated,0,0
98533,patients,0,0
98534,as,0,0
98535,compared,0,0
98536,with,0,0
98537,placebo,1,1
98538,(,0,0
98539,scaling/hypertrophy,0,0
98540,",",0,0
98541,P,0,0
98542,=,0,0
98543,0.0262,0,0
98544,;,0,0
98545,pain,0,0
98546,",",0,0
98547,P,0,0
98548,=,0,0
98549,0.0238,0,0
98550,;,0,0
98551,itching,0,0
98552,",",0,0
98553,P,0,0
98554,=,0,0
98555,0.0135,0,0
98556,;,0,0
98557,global,0,0
98558,patient,0,0
98559,assessment,0,0
98560,",",0,0
98561,P,0,0
98562,=,0,0
98563,0.045,0,0
98564,),0,0
98565,.,0,0
98566,Moreover,0,0
98567,",",0,0
98568,the,0,0
98569,percentage,0,0
98570,of,0,0
98571,patients,0,0
98572,without,0,0
98573,induration,0,0
98574,was,0,0
98575,significantly,0,0
98576,higher,0,0
98577,in,0,0
98578,the,0,0
98579,active,0,1
98580,group,0,0
98581,compared,0,0
98582,with,0,0
98583,the,0,0
98584,placebo,0,1
98585,group,0,0
98586,(,0,0
98587,P,0,0
98588,=,0,0
98589,0.013,0,0
98590,),0,0
98591,",",0,0
98592,and,0,0
98593,a,0,0
98594,statistically,0,0
98595,significantly,0,0
98596,greater,0,0
98597,decrease,0,0
98598,in,0,0
98599,the,0,0
98600,size,0,0
98601,of,0,0
98602,the,0,0
98603,lesional,0,0
98604,area,0,0
98605,was,0,0
98606,also,0,0
98607,seen,0,0
98608,in,0,0
98609,the,0,0
98610,overall,0,0
98611,analysis,0,0
98612,of,0,0
98613,the,0,0
98614,R-salbutamol-treated,0,1
98615,patients,0,0
98616,(,0,0
98617,P,0,0
98618,=,0,0
98619,0.0197,0,0
98620,),0,0
98621,.,0,0
98622,No,0,0
98623,serious,0,0
98624,adverse,0,0
98625,events,0,0
98626,were,0,0
98627,reported,0,0
98628,.,0,0
98629,CONCLUSIONS,0,0
98630,Application,0,1
98631,of,0,0
98632,R-salbutamol,0,1
98633,cream,0,1
98634,0.5,0,1
98635,%,0,0
98636,was,0,0
98637,safe,0,0
98638,and,0,0
98639,well,0,0
98640,tolerated,0,0
98641,.,0,0
98642,Statistically,0,0
98643,significant,0,0
98644,effects,0,0
98645,were,0,0
98646,seen,0,0
98647,on,0,0
98648,scaling/hypertrophy,0,0
98649,",",0,0
98650,induration,0,0
98651,",",0,0
98652,pain,0,0
98653,and,0,0
98654,itching,0,0
98655,as,0,0
98656,well,0,0
98657,as,0,0
98658,patient,0,0
98659,global,0,0
98660,assessment,0,0
98661,",",0,0
98662,suggesting,0,0
98663,that,0,0
98664,R-salbutamol,0,1
98665,could,0,0
98666,be,0,0
98667,a,0,0
98668,promising,0,0
98669,new,0,0
98670,topical,0,1
98671,therapy,0,1
98672,alternative,0,1
98673,for,0,0
98674,DLE,0,0
98675,.,0,0
98676,Large-dose,0,1
98677,intravenous,0,1
98678,ferric,1,1
98679,carboxymaltose,1,1
98680,injection,1,1
98681,for,0,0
98682,iron,0,1
98683,deficiency,0,0
98684,anemia,0,0
98685,in,0,0
98686,heavy,0,0
98687,uterine,0,0
98688,bleeding,0,0
98689,:,0,0
98690,a,0,0
98691,randomized,0,0
98692,",",0,0
98693,controlled,0,0
98694,trial,0,0
98695,.,0,0
98696,BACKGROUND,0,0
98697,The,0,0
98698,objective,0,0
98699,was,0,0
98700,to,0,0
98701,evaluate,0,0
98702,efficacy,0,0
98703,and,0,0
98704,safety,0,0
98705,of,0,0
98706,rapid,0,0
98707,",",0,0
98708,large-dose,1,1
98709,intravenous,1,1
98710,(,1,1
98711,IV,1,0
98712,),1,1
98713,administration,1,0
98714,of,1,0
98715,ferric,1,1
98716,carboxymaltose,1,1
98717,compared,0,0
98718,to,0,0
98719,oral,1,1
98720,iron,1,1
98721,in,0,0
98722,correcting,0,0
98723,iron,0,1
98724,deficiency,0,0
98725,anemia,0,0
98726,due,0,0
98727,to,0,0
98728,heavy,0,0
98729,uterine,0,0
98730,bleeding,0,0
98731,.,0,0
98732,STUDY,0,0
98733,DESIGN,0,0
98734,AND,0,0
98735,METHODS,0,0
98736,In,0,0
98737,a,0,0
98738,randomized,0,0
98739,",",0,0
98740,controlled,0,0
98741,trial,0,0
98742,",",0,0
98743,477,0,0
98744,women,0,0
98745,with,0,0
98746,anemia,0,0
98747,",",0,0
98748,iron,0,1
98749,deficiency,0,0
98750,",",0,0
98751,and,0,0
98752,heavy,0,1
98753,uterine,0,0
98754,bleeding,0,0
98755,were,0,0
98756,assigned,0,0
98757,to,0,0
98758,receive,0,0
98759,either,0,1
98760,IV,1,0
98761,ferric,1,1
98762,carboxymaltose,1,1
98763,(,0,1
98764,<,0,0
98765,or=1000,0,0
98766,mg,0,1
98767,over,0,0
98768,15,0,0
98769,min,0,0
98770,",",0,0
98771,repeated,0,0
98772,weekly,0,1
98773,to,0,0
98774,achieve,0,0
98775,a,0,0
98776,total,0,0
98777,calculated,0,0
98778,replacement,0,1
98779,dose,0,1
98780,),0,1
98781,or,0,1
98782,325,0,1
98783,mg,0,1
98784,of,1,0
98785,ferrous,1,1
98786,sulfate,1,1
98787,(,0,0
98788,65,0,0
98789,mg,0,1
98790,elemental,0,1
98791,iron,0,1
98792,),0,0
98793,prescribed,0,0
98794,orally,0,1
98795,thrice,0,1
98796,daily,0,1
98797,for,0,0
98798,6,0,0
98799,weeks,0,0
98800,.,0,0
98801,RESULTS,0,0
98802,Compared,0,0
98803,to,0,0
98804,those,0,0
98805,assigned,0,0
98806,to,0,0
98807,ferrous,1,1
98808,sulfate,1,1
98809,",",0,0
98810,more,0,0
98811,patients,0,0
98812,assigned,0,0
98813,to,0,0
98814,ferric,1,1
98815,carboxymaltose,1,1
98816,responded,0,0
98817,with,0,0
98818,a,0,0
98819,hemoglobin,0,0
98820,(,0,1
98821,Hb,0,1
98822,),0,1
98823,increase,0,0
98824,of,0,0
98825,2.0,0,1
98826,g/dL,0,0
98827,or,0,0
98828,more,0,0
98829,(,0,0
98830,82,0,0
98831,%,0,0
98832,vs.,0,0
98833,62,0,0
98834,%,0,0
98835,",",0,0
98836,95,0,0
98837,%,0,0
98838,confidence,0,0
98839,interval,0,0
98840,for,0,0
98841,treatment,0,0
98842,difference,0,0
98843,12.2-28.3,0,0
98844,",",0,0
98845,p,0,0
98846,<,0,0
98847,0.001,0,0
98848,),0,0
98849,",",0,0
98850,more,0,0
98851,achieved,0,0
98852,a,0,0
98853,3.0,0,0
98854,g/dL,0,0
98855,or,0,0
98856,more,0,0
98857,increase,0,0
98858,(,0,0
98859,53,0,0
98860,%,0,0
98861,vs.,0,0
98862,36,0,0
98863,%,0,0
98864,",",0,0
98865,p,0,0
98866,<,0,0
98867,0.001,0,0
98868,),0,0
98869,",",0,0
98870,and,0,0
98871,more,0,0
98872,achieved,0,0
98873,correction,0,0
98874,(,0,0
98875,Hb,0,1
98876,>,0,0
98877,or=,0,0
98878,12,0,0
98879,g/dL,0,0
98880,),0,0
98881,of,0,0
98882,anemia,0,0
98883,(,0,0
98884,73,0,0
98885,%,0,0
98886,vs.,0,0
98887,50,0,0
98888,%,0,0
98889,",",0,0
98890,p,0,0
98891,<,0,0
98892,0.001,0,0
98893,),0,0
98894,.,0,0
98895,Patients,0,0
98896,treated,0,0
98897,with,0,0
98898,ferric,1,1
98899,carboxymaltose,1,1
98900,compared,0,0
98901,to,0,0
98902,those,0,0
98903,prescribed,0,1
98904,ferrous,1,1
98905,sulfate,1,1
98906,reported,0,0
98907,greater,0,0
98908,gains,0,0
98909,in,0,0
98910,vitality,0,0
98911,and,0,0
98912,physical,0,1
98913,function,0,0
98914,and,0,0
98915,experienced,0,0
98916,greater,0,0
98917,improvement,0,0
98918,in,0,0
98919,symptoms,0,0
98920,of,0,0
98921,fatigue,0,0
98922,(,0,0
98923,p,0,0
98924,<,0,0
98925,0.05,0,0
98926,),0,0
98927,.,0,0
98928,There,0,0
98929,were,0,0
98930,no,0,0
98931,serious,0,0
98932,adverse,0,0
98933,drug,0,0
98934,events,0,0
98935,.,0,0
98936,CONCLUSIONS,0,0
98937,In,0,0
98938,patients,0,0
98939,with,0,0
98940,iron,0,1
98941,deficiency,0,0
98942,anemia,0,0
98943,due,0,0
98944,to,0,0
98945,heavy,0,0
98946,uterine,0,0
98947,bleeding,0,0
98948,",",0,0
98949,rapid,0,0
98950,IV,0,0
98951,administration,0,0
98952,of,0,0
98953,large,0,0
98954,doses,0,0
98955,of,0,0
98956,a,0,0
98957,new,1,0
98958,iron,1,1
98959,agent,1,0
98960,",",1,0
98961,ferric,1,1
98962,carboxymaltose,1,1
98963,",",0,0
98964,is,0,0
98965,more,0,0
98966,effective,0,0
98967,than,0,0
98968,oral,1,1
98969,iron,1,1
98970,therapy,1,1
98971,in,0,0
98972,correcting,0,0
98973,anemia,0,0
98974,",",0,0
98975,replenishing,0,1
98976,iron,0,1
98977,stores,0,1
98978,",",0,0
98979,and,0,0
98980,improving,0,0
98981,quality,0,0
98982,of,0,0
98983,life,0,0
98984,.,0,0
98985,Pharmacokinetic-pharmacodynamic,0,0
98986,modelling,0,0
98987,of,0,0
98988,the,0,0
98989,antihistaminic,0,1
98990,(,0,1
98991,H1,0,0
98992,),0,1
98993,effect,0,0
98994,of,0,0
98995,bilastine,1,1
98996,.,1,0
98997,OBJECTIVE,0,0
98998,To,0,0
98999,model,0,0
99000,the,0,0
99001,pharmacokinetic,0,0
99002,and,0,0
99003,pharmacodynamic,0,0
99004,relationship,0,0
99005,of,0,0
99006,bilastine,1,1
99007,",",0,0
99008,a,0,0
99009,new,0,0
99010,histamine,0,1
99011,H,0,1
99012,(,0,1
99013,1,0,0
99014,),0,1
99015,receptor,0,0
99016,antagonist,0,1
99017,",",0,0
99018,from,0,0
99019,single-,0,1
99020,and,0,0
99021,multiple-dose,0,1
99022,studies,0,0
99023,in,0,0
99024,healthy,0,0
99025,adult,0,0
99026,subjects,0,0
99027,.,0,0
99028,METHODS,0,0
99029,The,0,0
99030,pharmacokinetic,0,0
99031,model,0,0
99032,was,0,0
99033,developed,0,0
99034,from,0,0
99035,different,0,0
99036,single-dose,0,1
99037,and,0,0
99038,multiple-dose,0,1
99039,studies,0,0
99040,.,0,0
99041,In,0,0
99042,the,0,0
99043,single-dose,0,1
99044,studies,0,0
99045,",",0,0
99046,a,0,0
99047,total,0,0
99048,of,0,0
99049,183,0,0
99050,subjects,0,0
99051,received,0,0
99052,oral,0,1
99053,doses,0,0
99054,of,0,0
99055,bilastine,1,1
99056,2.5,0,0
99057,",",0,0
99058,5,0,0
99059,",",0,0
99060,10,0,0
99061,",",0,0
99062,20,0,0
99063,",",0,0
99064,50,0,0
99065,",",0,0
99066,100,0,0
99067,",",0,0
99068,120,0,0
99069,",",0,0
99070,160,0,0
99071,",",0,0
99072,200,0,0
99073,and,0,0
99074,220,0,0
99075,mg,0,1
99076,.,0,0
99077,In,0,0
99078,the,0,0
99079,multiple-dose,0,1
99080,studies,0,0
99081,",",0,0
99082,127,0,0
99083,healthy,0,0
99084,subjects,0,0
99085,received,0,0
99086,bilastine,1,1
99087,10,0,0
99088,",",0,0
99089,20,0,0
99090,",",0,0
99091,40,0,0
99092,",",0,0
99093,50,0,0
99094,",",0,0
99095,80,0,0
99096,",",0,0
99097,100,0,0
99098,",",0,0
99099,140,0,0
99100,or,0,0
99101,200,0,1
99102,mg/day,0,1
99103,as,0,0
99104,multiple,0,0
99105,doses,0,0
99106,during,0,0
99107,a,0,0
99108,4-,0,0
99109,",",0,0
99110,7-,0,1
99111,or,0,1
99112,14-day,0,1
99113,period,0,0
99114,.,0,0
99115,The,0,0
99116,pharmacokinetic,0,0
99117,profile,0,0
99118,of,0,0
99119,bilastine,0,1
99120,was,0,0
99121,investigated,0,0
99122,using,0,0
99123,a,0,0
99124,simultaneous,0,1
99125,analysis,0,0
99126,of,0,0
99127,all,0,0
99128,concentration-time,0,0
99129,data,0,0
99130,by,0,0
99131,means,0,0
99132,of,0,0
99133,nonlinear,0,0
99134,mixed-effects,0,0
99135,modelling,0,0
99136,population,0,0
99137,pharmacokinetic,0,0
99138,software,0,1
99139,NONMEM,0,1
99140,version,0,0
99141,6.1,0,0
99142,.,0,0
99143,Plasma,0,0
99144,concentrations,0,0
99145,were,0,0
99146,modelled,0,0
99147,according,0,0
99148,to,0,0
99149,a,0,0
99150,two-compartment,0,1
99151,open,0,1
99152,model,0,0
99153,with,0,0
99154,first-order,0,0
99155,absorption,0,0
99156,and,0,0
99157,elimination,0,0
99158,.,0,0
99159,For,0,0
99160,the,0,0
99161,pharmacodynamic,0,0
99162,analysis,0,0
99163,",",0,0
99164,the,0,0
99165,inhibitory,0,0
99166,effect,0,0
99167,of,0,0
99168,bilastine,1,1
99169,(,0,0
99170,inhibition,0,0
99171,of,0,0
99172,histamine-induced,0,1
99173,wheal,0,0
99174,and,0,1
99175,flare,0,0
99176,),0,1
99177,was,0,0
99178,assessed,0,0
99179,on,0,0
99180,a,0,0
99181,preselected,0,0
99182,time,0,0
99183,schedule,0,1
99184,",",0,0
99185,and,0,0
99186,the,0,0
99187,predicted,0,0
99188,typical,0,0
99189,pharmacokinetic,0,0
99190,profile,0,0
99191,(,0,0
99192,based,0,0
99193,on,0,0
99194,the,0,0
99195,pharmacokinetic,0,0
99196,model,0,0
99197,previously,0,0
99198,developed,0,0
99199,),0,0
99200,was,0,0
99201,used,0,0
99202,.,0,0
99203,An,0,0
99204,indirect,0,0
99205,response,0,0
99206,model,0,0
99207,was,0,0
99208,developed,0,0
99209,to,0,0
99210,describe,0,0
99211,the,0,0
99212,pharmacodynamic,0,0
99213,relationships,0,0
99214,between,0,0
99215,flare,0,0
99216,or,0,1
99217,wheal,0,0
99218,areas,0,0
99219,and,0,0
99220,bilastine,1,1
99221,plasma,0,0
99222,concentrations,0,0
99223,.,0,0
99224,Finally,0,0
99225,",",0,0
99226,once,0,0
99227,values,0,0
99228,of,0,0
99229,the,0,0
99230,concentration,0,0
99231,that,0,0
99232,produced,0,0
99233,50,0,1
99234,%,0,0
99235,inhibition,0,0
99236,(,0,1
99237,IC,0,1
99238,(,0,1
99239,50,0,1
99240,),0,0
99241,),0,0
99242,had,0,0
99243,been,0,0
99244,estimated,0,0
99245,for,0,0
99246,wheal,0,0
99247,and,0,0
99248,flare,0,0
99249,effects,0,0
99250,",",0,0
99251,simulations,0,0
99252,were,0,0
99253,carried,0,0
99254,out,0,0
99255,to,0,0
99256,predict,0,0
99257,plasma,0,0
99258,concentrations,0,0
99259,for,0,0
99260,the,0,0
99261,doses,0,0
99262,of,0,0
99263,bilastine,1,1
99264,5,0,0
99265,",",0,0
99266,10,0,0
99267,and,0,0
99268,20,0,0
99269,mg,0,1
99270,at,0,0
99271,steady,0,0
99272,state,0,0
99273,(,0,0
99274,72-96,0,0
99275,hours,0,0
99276,),0,0
99277,.,0,0
99278,RESULTS,0,0
99279,A,0,0
99280,non-compartmental,0,0
99281,analysis,0,0
99282,resulted,0,0
99283,in,0,0
99284,linear,0,0
99285,kinetics,0,0
99286,of,0,0
99287,bilastine,1,1
99288,in,0,0
99289,the,0,0
99290,dose,0,0
99291,range,0,0
99292,studied,0,0
99293,.,0,0
99294,Bilastine,0,1
99295,was,0,0
99296,characterized,0,0
99297,by,0,0
99298,two-compartmental,0,0
99299,kinetics,0,0
99300,with,0,0
99301,a,0,0
99302,rapid-absorption,0,1
99303,phase,0,0
99304,(,0,1
99305,first-order,0,0
99306,absorption,0,0
99307,rate,0,0
99308,constant,0,0
99309,=,0,0
99310,1.50,0,0
99311,h,0,0
99312,(,0,1
99313,-1,0,1
99314,),0,1
99315,),0,0
99316,",",0,0
99317,plasma,0,0
99318,peak,0,0
99319,concentrations,0,0
99320,were,0,0
99321,observed,0,0
99322,at,0,0
99323,1,0,0
99324,hour,0,0
99325,following,0,0
99326,administration,0,0
99327,and,0,0
99328,the,0,0
99329,maximal,0,0
99330,response,0,0
99331,was,0,0
99332,observed,0,0
99333,at,0,0
99334,approximately,0,0
99335,4,0,0
99336,hours,0,0
99337,or,0,0
99338,later,0,0
99339,.,0,0
99340,Concerning,0,0
99341,the,0,0
99342,selected,0,0
99343,pharmacodynamic,0,0
99344,model,0,0
99345,to,0,0
99346,fit,0,0
99347,the,0,0
99348,data,0,0
99349,(,0,0
99350,type,0,0
99351,I,0,0
99352,indirect,0,1
99353,response,0,0
99354,model,0,0
99355,),0,0
99356,",",0,0
99357,this,0,0
99358,selection,0,0
99359,is,0,0
99360,attributable,0,0
99361,to,0,0
99362,the,0,0
99363,presence,0,0
99364,of,0,0
99365,inhibitory,0,0
99366,bilastine,0,1
99367,plasma,0,0
99368,concentrations,0,0
99369,that,0,0
99370,decrease,0,0
99371,the,0,0
99372,input,0,1
99373,response,0,0
99374,function,0,0
99375,",",0,0
99376,i.e,0,1
99377,.,0,0
99378,the,0,0
99379,production,0,0
99380,of,0,0
99381,the,0,0
99382,skin,0,0
99383,reaction,0,0
99384,.,0,0
99385,This,0,0
99386,model,0,0
99387,resulted,0,0
99388,in,0,0
99389,the,0,0
99390,best,0,0
99391,fit,0,0
99392,of,0,0
99393,wheal,0,0
99394,and,0,0
99395,flare,0,0
99396,data,0,0
99397,.,0,0
99398,The,0,0
99399,estimates,0,0
99400,(,0,0
99401,with,0,0
99402,relative,0,0
99403,standard,0,1
99404,errors,0,0
99405,expressed,0,0
99406,in,0,0
99407,percentages,0,0
99408,in,0,0
99409,parentheses,0,0
99410,),0,0
99411,of,0,0
99412,the,0,0
99413,apparent,0,0
99414,zero-order,0,1
99415,rate,0,0
99416,constant,0,0
99417,for,0,0
99418,flare,0,0
99419,or,0,1
99420,wheal,0,0
99421,spontaneous,0,1
99422,appearance,0,0
99423,(,0,1
99424,k,0,0
99425,(,0,1
99426,in,0,0
99427,),0,1
99428,),0,0
99429,",",0,0
99430,the,0,0
99431,first-order,0,0
99432,rate,0,0
99433,constant,0,0
99434,for,0,0
99435,flare,0,0
99436,or,0,1
99437,wheal,0,0
99438,disappearance,0,0
99439,(,0,1
99440,k,0,0
99441,(,0,1
99442,out,0,0
99443,),0,1
99444,),0,1
99445,and,0,0
99446,bilastine,0,1
99447,IC,0,1
99448,(,0,1
99449,50,0,1
99450,),0,0
99451,values,0,0
99452,were,0,0
99453,0.44,0,0
99454,ng/mL/h,0,0
99455,(,0,0
99456,14.60,0,0
99457,%,0,0
99458,),0,0
99459,",",0,0
99460,1.09,0,0
99461,h,0,0
99462,(,0,1
99463,-1,0,1
99464,),0,1
99465,(,0,0
99466,15.14,0,0
99467,%,0,0
99468,),0,0
99469,and,0,0
99470,5.15,0,0
99471,ng/mL,0,0
99472,(,0,0
99473,16.16,0,0
99474,%,0,0
99475,),0,0
99476,",",0,0
99477,respectively,0,0
99478,",",0,0
99479,for,0,0
99480,wheal,0,0
99481,inhibition,0,0
99482,",",0,0
99483,and,0,0
99484,11.10,0,0
99485,ng/mL/h,0,0
99486,(,0,0
99487,8.48,0,0
99488,%,0,0
99489,),0,0
99490,",",0,0
99491,1.03,0,0
99492,h,0,0
99493,(,0,1
99494,-1,0,1
99495,),0,1
99496,(,0,0
99497,8.35,0,0
99498,%,0,0
99499,),0,0
99500,and,0,0
99501,1.25,0,1
99502,ng/mL,0,0
99503,(,0,0
99504,14.56,0,0
99505,%,0,0
99506,),0,0
99507,",",0,0
99508,respectively,0,0
99509,",",0,0
99510,for,0,0
99511,flare,0,0
99512,inhibition,0,0
99513,.,0,0
99514,The,0,0
99515,simulation,0,0
99516,results,0,0
99517,revealed,0,0
99518,that,0,0
99519,bilastine,0,1
99520,plasma,0,0
99521,concentrations,0,0
99522,do,0,0
99523,not,0,0
99524,remain,0,0
99525,over,0,0
99526,the,0,0
99527,IC,0,1
99528,(,0,0
99529,50,0,1
99530,),0,0
99531,value,0,0
99532,throughout,0,0
99533,the,0,0
99534,inter-dose,0,0
99535,period,0,0
99536,for,0,0
99537,doses,0,0
99538,of,0,0
99539,5,0,0
99540,and,0,0
99541,10,0,0
99542,mg,0,1
99543,.,0,0
99544,However,0,0
99545,",",0,0
99546,with,0,0
99547,a,0,0
99548,dose,0,0
99549,of,0,0
99550,20,0,0
99551,mg,0,1
99552,of,0,0
99553,bilastine,1,1
99554,administered,0,0
99555,every,0,0
99556,24,0,0
99557,hours,0,0
99558,",",0,0
99559,plasma,0,0
99560,concentrations,0,0
99561,remained,0,0
99562,over,0,0
99563,the,0,0
99564,IC,0,1
99565,(,0,0
99566,50,0,1
99567,),0,0
99568,value,0,0
99569,during,0,0
99570,the,0,0
99571,considered,0,0
99572,period,0,0
99573,for,0,0
99574,the,0,0
99575,flare,0,0
99576,effect,0,0
99577,",",0,0
99578,and,0,0
99579,up,0,0
99580,to,0,0
99581,20,0,0
99582,hours,0,0
99583,for,0,0
99584,the,0,0
99585,wheal,0,0
99586,effect,0,0
99587,.,0,0
99588,CONCLUSION,0,0
99589,Pharmacokinetic,0,0
99590,and,0,0
99591,pharmacodynamic,0,0
99592,relationships,0,0
99593,of,0,0
99594,bilastine,0,1
99595,were,0,0
99596,reliably,0,0
99597,described,0,0
99598,with,0,0
99599,the,0,0
99600,use,0,0
99601,of,0,0
99602,an,0,0
99603,indirect,0,0
99604,response,0,0
99605,pharmacodynamic,0,0
99606,model,0,0
99607,;,0,0
99608,this,0,0
99609,led,0,0
99610,to,0,0
99611,an,0,0
99612,accurate,0,0
99613,prediction,0,0
99614,of,0,0
99615,the,0,0
99616,pharmacodynamic,0,0
99617,activity,0,0
99618,of,0,0
99619,bilastine,0,1
99620,.,0,0
99621,Azelnidipine,1,1
99622,and,0,0
99623,amlodipine,1,1
99624,anti-coronary,0,0
99625,atherosclerosis,0,0
99626,trial,0,0
99627,in,0,0
99628,hypertensive,0,0
99629,patients,0,0
99630,undergoing,0,0
99631,coronary,0,0
99632,intervention,0,1
99633,by,0,0
99634,serial,0,0
99635,volumetric,0,1
99636,intravascular,0,0
99637,ultrasound,0,1
99638,analysis,0,0
99639,in,0,0
99640,Juntendo,0,1
99641,university,0,0
99642,(,0,1
99643,ALPS-J,0,1
99644,),0,0
99645,.,0,0
99646,PURPOSE,0,0
99647,Many,0,0
99648,trials,0,0
99649,have,0,0
99650,shown,0,0
99651,that,0,0
99652,calcium,0,1
99653,channel,0,1
99654,blockers,0,1
99655,(,0,0
99656,CCBs,0,0
99657,),0,1
99658,can,0,0
99659,reduce,0,0
99660,the,0,0
99661,cardiovascular,0,0
99662,(,0,1
99663,CV,0,1
99664,),0,1
99665,events,0,0
99666,in,0,0
99667,patients,0,0
99668,with,0,0
99669,coronary,0,0
99670,artery,0,1
99671,disease,0,0
99672,(,0,1
99673,CAD,0,1
99674,),0,0
99675,.,0,0
99676,The,0,0
99677,mechanisms,0,0
99678,of,0,0
99679,this,0,0
99680,effect,0,0
99681,could,0,0
99682,be,0,0
99683,associated,0,0
99684,with,0,0
99685,plaque,0,0
99686,regression,0,0
99687,due,0,0
99688,to,0,0
99689,the,0,0
99690,anti-atherosclerotic,0,0
99691,properties,0,0
99692,of,0,0
99693,CCBs,0,0
99694,.,0,0
99695,The,0,0
99696,goal,0,0
99697,of,0,0
99698,this,0,0
99699,study,0,0
99700,is,0,0
99701,to,0,0
99702,determine,0,0
99703,the,0,0
99704,effects,0,0
99705,of,0,0
99706,CCB,0,0
99707,on,0,0
99708,volumetric,0,0
99709,quantitative,0,0
99710,changes,0,0
99711,of,0,0
99712,coronary,0,0
99713,plaques,0,0
99714,accessed,0,0
99715,by,0,0
99716,intravascular,0,0
99717,ultrasound,0,1
99718,(,0,1
99719,IVUS,0,1
99720,),0,0
99721,.,0,0
99722,To,0,0
99723,confirm,0,0
99724,this,0,0
99725,hypothesis,0,0
99726,",",0,0
99727,a,0,0
99728,multicenter,0,0
99729,randomized,0,0
99730,trial,0,0
99731,of,0,0
99732,CCBs,0,0
99733,treatment,0,0
99734,with,0,0
99735,azelnidipine,1,1
99736,or,0,1
99737,amlodipine,1,1
99738,will,0,0
99739,be,0,0
99740,conducted,0,0
99741,in,0,0
99742,hypertensive,0,0
99743,CAD,0,1
99744,patients,0,0
99745,undergoing,0,0
99746,elective,0,0
99747,percutaneous,0,1
99748,coronary,0,1
99749,intervention,0,1
99750,(,0,1
99751,PCI,0,1
99752,),0,0
99753,.,0,0
99754,METHODS,0,0
99755,AND,0,0
99756,RESULTS,0,0
99757,Patients,0,0
99758,who,0,0
99759,have,0,0
99760,hypertension,0,0
99761,and,0,0
99762,are,0,0
99763,scheduled,0,0
99764,for,0,0
99765,PCI,0,1
99766,will,0,0
99767,be,0,0
99768,enrolled,0,0
99769,.,0,0
99770,Subjects,0,0
99771,will,0,0
99772,be,0,0
99773,randomized,0,0
99774,to,0,0
99775,azelnidipine,1,1
99776,or,0,1
99777,amlodipine,1,1
99778,and,0,0
99779,observed,0,0
99780,for,0,0
99781,48,0,0
99782,weeks,0,0
99783,.,0,0
99784,The,0,0
99785,primary,0,0
99786,endpoint,0,0
99787,will,0,0
99788,be,0,0
99789,the,0,0
99790,percent,0,0
99791,change,0,0
99792,of,0,0
99793,coronary,0,0
99794,plaque,0,0
99795,volume,0,0
99796,.,0,0
99797,The,0,0
99798,secondary,0,0
99799,endpoint,0,0
99800,will,0,0
99801,include,0,0
99802,inflammatory,0,0
99803,markers,0,0
99804,",",0,0
99805,antioxidant,0,1
99806,activity,0,0
99807,",",0,0
99808,and,0,0
99809,incidence,0,0
99810,of,0,0
99811,composite,0,1
99812,cardiovascular,0,0
99813,events,0,0
99814,.,0,0
99815,CONCLUSIONS,0,0
99816,In,0,0
99817,this,0,0
99818,study,0,0
99819,",",0,0
99820,we,0,0
99821,will,0,0
99822,investigate,0,0
99823,the,0,0
99824,improvement,0,0
99825,of,0,0
99826,coronary,0,0
99827,plaque,0,0
99828,with,0,0
99829,IVUS,0,1
99830,by,0,0
99831,treatment,0,0
99832,with,0,0
99833,two,0,0
99834,dihydropyridine,0,1
99835,CCBs,0,0
99836,in,0,0
99837,hypertensive,0,0
99838,patients,0,0
99839,undergoing,0,0
99840,elective,0,0
99841,PCI,0,1
99842,.,0,0
99843,This,0,0
99844,result,0,0
99845,will,0,0
99846,lead,0,0
99847,to,0,0
99848,the,0,0
99849,discovery,0,0
99850,of,0,0
99851,more,0,0
99852,effective,0,0
99853,drug,0,1
99854,therapy,0,1
99855,for,0,0
99856,inhibition,0,0
99857,of,0,0
99858,coronary,0,0
99859,events,0,0
99860,.,0,0
99861,Double-blind,0,0
99862,placebo-controlled,0,1
99863,trial,0,0
99864,of,0,0
99865,pentoxifylline,1,1
99866,added,1,0
99867,to,1,0
99868,risperidone,1,1
99869,:,1,0
99870,effects,0,0
99871,on,0,0
99872,aberrant,0,0
99873,behavior,0,0
99874,in,0,0
99875,children,0,0
99876,with,0,0
99877,autism,0,0
99878,.,0,0
99879,BACKGROUND,0,0
99880,There,0,0
99881,are,0,0
99882,several,0,0
99883,lines,0,0
99884,of,0,0
99885,evidence,0,0
99886,to,0,0
99887,indicate,0,0
99888,that,0,0
99889,the,0,0
99890,immune,0,0
99891,system,0,1
99892,plays,0,0
99893,an,0,0
99894,important,0,0
99895,role,0,0
99896,in,0,0
99897,the,0,0
99898,pathophysiology,0,0
99899,of,0,0
99900,autism,0,0
99901,.,0,0
99902,The,0,0
99903,objective,0,0
99904,of,0,0
99905,this,0,0
99906,study,0,0
99907,was,0,0
99908,to,0,0
99909,access,0,0
99910,the,0,0
99911,effects,0,0
99912,of,0,0
99913,pentoxifylline,1,1
99914,plus,1,1
99915,risperidone,1,1
99916,in,0,0
99917,the,0,0
99918,treatment,0,0
99919,of,0,0
99920,autistic,0,0
99921,disorder,0,0
99922,.,0,0
99923,METHODS,0,0
99924,Forty,0,0
99925,children,0,0
99926,between,0,0
99927,the,0,0
99928,ages,0,0
99929,4,0,0
99930,and,0,0
99931,12,0,0
99932,years,0,0
99933,with,0,0
99934,a,0,0
99935,DSM,0,0
99936,IV-TR,0,0
99937,clinical,0,0
99938,diagnosis,0,0
99939,of,0,0
99940,autism,0,0
99941,were,0,0
99942,recruited,0,0
99943,.,0,0
99944,The,0,0
99945,children,0,0
99946,presented,0,0
99947,with,0,0
99948,a,0,0
99949,chief,0,0
99950,complaint,0,0
99951,of,0,0
99952,severely,0,0
99953,disruptive,0,0
99954,symptoms,0,0
99955,related,0,0
99956,to,0,0
99957,autistic,0,0
99958,disorder,0,0
99959,.,0,0
99960,Patients,0,0
99961,were,0,0
99962,randomly,0,0
99963,allocated,0,0
99964,to,0,0
99965,pentoxifylline+risperidone,1,1
99966,or,1,1
99967,placebo+risperidone,1,1
99968,for,0,0
99969,a,0,0
99970,10-week,0,1
99971,",",0,0
99972,double-blind,0,0
99973,",",0,0
99974,placebo-controlled,0,1
99975,study,0,0
99976,.,0,0
99977,The,0,0
99978,dose,0,0
99979,of,0,0
99980,risperidone,1,1
99981,was,0,0
99982,titrated,0,0
99983,up,0,0
99984,to,0,0
99985,3,0,0
99986,mg/day,0,1
99987,",",0,0
99988,pentoxifylline,1,1
99989,was,0,0
99990,titrated,0,0
99991,to,0,0
99992,600,0,0
99993,mg/day,0,1
99994,.,0,0
99995,Patients,0,0
99996,were,0,0
99997,assessed,0,0
99998,at,0,0
99999,baseline,0,0
100000,and,0,0
100001,after,0,0
100002,2,0,0
100003,",",0,0
100004,4,0,0
100005,",",0,0
100006,6,0,0
100007,",",0,0
100008,8,0,0
100009,and,0,0
100010,10,0,0
100011,weeks,0,0
100012,of,0,0
100013,starting,0,0
100014,medication,0,1
100015,.,0,0
100016,The,0,0
100017,measure,0,0
100018,of,0,0
100019,the,0,0
100020,outcome,0,0
100021,was,0,0
100022,the,0,0
100023,Aberrant,0,0
100024,Behavior,0,0
100025,Checklist-Community,0,0
100026,(,0,1
100027,ABC-C,0,1
100028,),0,0
100029,.,0,0
100030,RESULTS,0,0
100031,The,0,0
100032,difference,0,0
100033,between,0,0
100034,the,0,0
100035,two,0,0
100036,protocols,0,0
100037,was,0,0
100038,significant,0,0
100039,as,0,0
100040,the,0,0
100041,group,0,0
100042,that,0,0
100043,received,0,0
100044,pentoxifylline,1,1
100045,had,0,0
100046,greater,0,0
100047,reduction,0,0
100048,in,0,0
100049,ABC-C,0,1
100050,subscale,0,0
100051,scores,0,0
100052,for,0,0
100053,Irritability,0,0
100054,",",0,0
100055,Lethargy/Social,0,0
100056,Withdrawal,0,1
100057,",",0,0
100058,Stereotypic,0,0
100059,Behavior,0,0
100060,",",0,0
100061,Hyperactivity/Noncompliance,0,1
100062,and,0,0
100063,Inappropriate,0,0
100064,Speech,0,1
100065,.,0,0
100066,CONCLUSION,0,0
100067,The,0,0
100068,results,0,0
100069,suggest,0,0
100070,that,0,0
100071,combination,1,1
100072,of,1,0
100073,atypical,1,0
100074,antipsychotic,1,1
100075,medications,1,1
100076,and,1,0
100077,pentoxifylline,1,1
100078,might,0,0
100079,have,0,0
100080,synergistic,0,0
100081,effects,0,0
100082,in,0,0
100083,treatment,0,0
100084,of,0,0
100085,behavioral,0,1
100086,problems,0,0
100087,of,0,0
100088,children,0,0
100089,with,0,0
100090,autism,0,0
100091,.,0,0
100092,Phase,0,1
100093,III,0,0
100094,",",0,0
100095,randomised,0,0
100096,",",0,0
100097,multicentre,0,0
100098,trial,0,0
100099,of,0,0
100100,maintenance,0,0
100101,immunotherapy,1,1
100102,with,0,0
100103,low-dose,0,1
100104,interleukin-2,1,1
100105,and,1,0
100106,interferon-alpha,1,1
100107,for,0,0
100108,metastatic,0,0
100109,renal,0,0
100110,cell,0,0
100111,cancer,0,0
100112,.,0,0
100113,This,0,0
100114,is,0,0
100115,the,0,0
100116,first,0,0
100117,phase,0,0
100118,III,0,0
100119,randomised,0,0
100120,trial,0,0
100121,to,0,0
100122,evaluate,0,0
100123,maintenance,0,0
100124,immunotherapy,0,1
100125,in,0,0
100126,metastatic,0,0
100127,renal,0,0
100128,cell,0,0
100129,cancer,0,0
100130,(,0,1
100131,mRCC,0,1
100132,),0,0
100133,.,0,0
100134,Patients,0,0
100135,were,0,0
100136,randomised,0,0
100137,to,0,0
100138,receive,0,0
100139,treatment,0,0
100140,with,0,0
100141,a,0,0
100142,4-week,0,0
100143,cycle,0,0
100144,of,0,0
100145,subcutaneous,1,0
100146,low,1,0
100147,doses,1,0
100148,IL-2,1,1
100149,+,1,1
100150,IFN,1,0
100151,in,0,0
100152,months,0,0
100153,1,0,0
100154,",",0,0
100155,3,0,0
100156,and,0,0
100157,5,0,0
100158,",",0,0
100159,and,0,0
100160,then,0,1
100161,every,0,1
100162,3,0,0
100163,months,0,0
100164,until,0,0
100165,the,0,0
100166,first,0,0
100167,documented,0,0
100168,disease,0,0
100169,progression,0,0
100170,(,0,1
100171,arm,0,0
100172,A,0,0
100173,",",0,0
100174,suspension,0,1
100175,),0,0
100176,",",0,0
100177,or,0,1
100178,the,0,0
100179,same,0,0
100180,regimen,0,1
100181,",",0,0
100182,with,0,0
100183,chronic,0,0
100184,maintenance,0,0
100185,of,0,0
100186,immunotherapy,0,1
100187,",",0,0
100188,regardless,0,0
100189,of,0,0
100190,tumour,0,0
100191,response,0,0
100192,",",0,0
100193,until,0,0
100194,death,0,0
100195,or,0,1
100196,intolerable,0,0
100197,toxicity,0,0
100198,(,0,1
100199,arm,0,0
100200,B,0,1
100201,",",0,0
100202,maintenance,0,0
100203,),0,0
100204,.,0,0
100205,The,0,0
100206,primary,0,0
100207,endpoint,0,0
100208,was,0,0
100209,overall,0,0
100210,survival,0,0
100211,(,0,1
100212,OS,0,0
100213,),0,1
100214,;,0,0
100215,secondary,0,0
100216,endpoints,0,0
100217,were,0,0
100218,time,0,0
100219,from,0,0
100220,first,0,0
100221,progression,0,0
100222,to,0,0
100223,death,0,0
100224,(,0,1
100225,TFPTD,0,1
100226,),0,1
100227,and,0,0
100228,tolerability,0,0
100229,.,0,0
100230,One,0,0
100231,hundred,0,0
100232,and,0,0
100233,eighty-three,0,0
100234,patients,0,0
100235,were,0,0
100236,enrolled,0,0
100237,between,0,0
100238,January,0,0
100239,1998,0,0
100240,and,0,0
100241,November,0,0
100242,2003,0,0
100243,.,0,0
100244,After,0,0
100245,a,0,0
100246,median,0,0
100247,follow-up,0,0
100248,of,0,0
100249,53.9,0,0
100250,months,0,0
100251,",",0,0
100252,response,0,0
100253,rate,0,0
100254,",",0,0
100255,median,0,0
100256,OS,0,0
100257,and,0,0
100258,median,0,0
100259,TFPTD,0,1
100260,were,0,0
100261,14.7,0,0
100262,%,0,0
100263,(,0,0
100264,6.3,0,0
100265,%,0,0
100266,CR,0,1
100267,),0,0
100268,versus,0,1
100269,11.3,0,0
100270,%,0,0
100271,(,0,0
100272,5.5,0,0
100273,%,0,0
100274,CR,0,1
100275,),0,0
100276,",",0,0
100277,14,0,0
100278,versus,0,0
100279,14,0,0
100280,months,0,0
100281,",",0,0
100282,6,0,0
100283,versus,0,0
100284,5,0,0
100285,months,0,0
100286,",",0,0
100287,in,0,0
100288,arms,0,0
100289,A,0,0
100290,and,0,0
100291,B,0,0
100292,",",0,0
100293,respectively,0,0
100294,with,0,0
100295,no,0,0
100296,significant,0,0
100297,differences,0,0
100298,between,0,0
100299,the,0,0
100300,groups,0,0
100301,.,0,0
100302,Cox,0,0
100303,regression,0,0
100304,analysis,0,0
100305,showed,0,0
100306,that,0,0
100307,the,0,0
100308,use,0,0
100309,of,0,0
100310,chemotherapy,1,1
100311,after,0,0
100312,first,0,0
100313,progression,0,0
100314,(,0,0
100315,HR,0,0
100316,0.54,0,0
100317,;,0,0
100318,95,0,0
100319,%,0,0
100320,CI,0,0
100321,0.35-0.86,0,0
100322,;,0,0
100323,p,0,0
100324,=,0,0
100325,0.008,0,0
100326,),0,0
100327,",",0,0
100328,PS,0,0
100329,=,0,0
100330,0,0,0
100331,(,0,0
100332,HR,0,0
100333,0.53,0,0
100334,;,0,0
100335,95,0,0
100336,%,0,0
100337,CI,0,0
100338,0.35-0.81,0,0
100339,;,0,0
100340,p,0,0
100341,=,0,0
100342,0.001,0,0
100343,),0,0
100344,and,0,0
100345,female,0,0
100346,gender,0,0
100347,(,0,0
100348,HR,0,0
100349,0.63,0,0
100350,;,0,0
100351,95,0,0
100352,%,0,0
100353,CI,0,0
100354,0.41-0.98,0,0
100355,;,0,0
100356,p,0,0
100357,=,0,0
100358,0.038,0,0
100359,),0,0
100360,were,0,0
100361,significantly,0,0
100362,associated,0,0
100363,with,0,0
100364,a,0,0
100365,longer,0,0
100366,TFPTD,0,0
100367,;,0,0
100368,treatment,0,0
100369,arm,0,0
100370,was,0,0
100371,not,0,0
100372,significant,0,0
100373,(,0,0
100374,HR,0,0
100375,0.88,0,0
100376,;,0,0
100377,95,0,0
100378,%,0,0
100379,CI,0,0
100380,0.60-1.31,0,0
100381,;,0,0
100382,p,0,0
100383,=,0,0
100384,0.54,0,0
100385,),0,0
100386,.,0,0
100387,Toxicity,0,0
100388,was,0,0
100389,mainly,0,0
100390,limited,0,0
100391,to,0,0
100392,WHO,0,1
100393,grades,0,0
100394,1,0,0
100395,or,0,0
100396,2,0,0
100397,.,0,0
100398,Chronic,1,0
100399,maintenance,1,0
100400,immunotherapy,1,1
100401,after,0,0
100402,disease,0,0
100403,progression,0,0
100404,is,0,0
100405,feasible,0,0
100406,",",0,0
100407,but,0,0
100408,does,0,0
100409,not,0,0
100410,significantly,0,0
100411,increase,0,0
100412,OS,0,0
100413,or,0,1
100414,the,0,0
100415,TFPTD,0,0
100416,.,0,0
100417,A,0,0
100418,placebo-controlled,1,1
100419,",",0,0
100420,fixed-dose,0,1
100421,study,0,0
100422,of,0,0
100423,aripiprazole,1,1
100424,in,0,0
100425,children,0,0
100426,and,0,0
100427,adolescents,0,0
100428,with,0,0
100429,irritability,0,0
100430,associated,0,0
100431,with,0,0
100432,autistic,0,0
100433,disorder,0,0
100434,.,0,0
100435,OBJECTIVE,0,0
100436,To,0,0
100437,evaluate,0,0
100438,the,0,0
100439,short-term,0,0
100440,efficacy,0,0
100441,and,0,0
100442,safety,0,0
100443,of,0,0
100444,aripiprazole,1,1
100445,in,0,0
100446,the,0,0
100447,treatment,0,0
100448,of,0,0
100449,irritability,0,0
100450,in,0,0
100451,children,0,0
100452,and,0,0
100453,adolescents,0,0
100454,with,0,0
100455,autistic,0,0
100456,disorder,0,0
100457,.,0,0
100458,METHOD,0,0
100459,Two,0,0
100460,hundred,0,0
100461,eighteen,0,0
100462,children,0,0
100463,and,0,0
100464,adolescents,0,0
100465,(,0,0
100466,aged,0,0
100467,6-17,0,0
100468,years,0,0
100469,),0,0
100470,with,0,0
100471,a,0,0
100472,diagnosis,0,0
100473,of,0,0
100474,autistic,0,0
100475,disorder,0,0
100476,",",0,0
100477,and,0,0
100478,with,0,0
100479,behaviors,0,0
100480,such,0,0
100481,as,0,0
100482,tantrums,0,0
100483,",",0,0
100484,aggression,0,0
100485,",",0,0
100486,self-injurious,0,0
100487,behavior,0,0
100488,",",0,0
100489,or,0,1
100490,a,0,0
100491,combination,0,1
100492,of,0,0
100493,these,0,0
100494,symptoms,0,0
100495,",",0,0
100496,were,0,0
100497,randomized,0,0
100498,1:1:1:1,0,0
100499,to,0,0
100500,aripiprazole,1,1
100501,(,1,0
100502,5,1,0
100503,",",1,0
100504,10,1,0
100505,",",1,0
100506,or,1,0
100507,15,1,1
100508,mg/day,1,1
100509,),1,1
100510,or,1,1
100511,placebo,1,1
100512,in,0,0
100513,this,0,0
100514,8-week,0,0
100515,double-blind,0,0
100516,",",0,0
100517,randomized,0,0
100518,",",0,0
100519,placebo-controlled,0,1
100520,",",0,0
100521,parallel-group,0,0
100522,study,0,0
100523,.,0,0
100524,Efficacy,0,0
100525,was,0,0
100526,evaluated,0,0
100527,using,0,0
100528,the,0,0
100529,caregiver-rated,0,0
100530,Aberrant,0,0
100531,Behavior,0,0
100532,Checklist,0,1
100533,Irritability,0,0
100534,subscale,0,0
100535,(,0,0
100536,primary,0,0
100537,efficacy,0,0
100538,measure,0,0
100539,),0,1
100540,and,0,0
100541,the,0,0
100542,clinician-rated,0,0
100543,Clinical,0,0
100544,Global,0,0
100545,Impressions-Improvement,0,0
100546,score,0,0
100547,.,0,0
100548,Safety,0,0
100549,and,0,0
100550,tolerability,0,0
100551,were,0,0
100552,also,0,0
100553,assessed,0,0
100554,.,0,0
100555,RESULTS,0,0
100556,At,0,0
100557,week,0,0
100558,8,0,0
100559,",",0,0
100560,all,0,0
100561,aripiprazole,1,1
100562,doses,0,0
100563,produced,0,0
100564,significantly,0,0
100565,greater,0,0
100566,improvement,0,0
100567,than,0,0
100568,placebo,0,1
100569,in,0,0
100570,mean,0,0
100571,Aberrant,0,0
100572,Behavior,0,0
100573,Checklist,0,1
100574,Irritability,0,0
100575,subscale,0,0
100576,scores,0,0
100577,(,0,0
100578,5,0,1
100579,mg/day,0,1
100580,",",0,0
100581,-12.4,0,0
100582,;,0,0
100583,10,0,0
100584,mg/day,0,1
100585,",",0,0
100586,-13.2,0,0
100587,;,0,0
100588,15,0,0
100589,mg/day,0,1
100590,",",0,0
100591,-14.4,0,0
100592,;,0,0
100593,versus,0,1
100594,placebo,0,1
100595,",",0,0
100596,-8.4,0,0
100597,;,0,0
100598,all,0,0
100599,p,0,0
100600,<,0,0
100601,.05,0,0
100602,),0,0
100603,.,0,0
100604,All,0,0
100605,aripiprazole,1,1
100606,doses,0,0
100607,demonstrated,0,0
100608,significantly,0,0
100609,greater,0,0
100610,improvements,0,0
100611,in,0,0
100612,mean,0,0
100613,Clinical,0,0
100614,Global,0,0
100615,Impressions-Improvement,0,1
100616,score,0,0
100617,than,0,0
100618,placebo,1,1
100619,at,0,0
100620,week,0,0
100621,8,0,0
100622,.,0,0
100623,Discontinuation,0,0
100624,rates,0,0
100625,due,0,0
100626,to,0,0
100627,adverse,0,0
100628,events,0,0
100629,were,0,0
100630,as,0,0
100631,follows,0,0
100632,:,0,0
100633,placebo,0,1
100634,7.7,0,0
100635,%,0,0
100636,",",0,0
100637,aripiprazole,0,1
100638,5,0,0
100639,mg/day,0,1
100640,9.4,0,0
100641,%,0,0
100642,",",0,0
100643,10,0,0
100644,mg/day,0,1
100645,13.6,0,0
100646,%,0,0
100647,",",0,0
100648,and,0,0
100649,15,0,0
100650,mg/day,0,1
100651,7.4,0,0
100652,%,0,0
100653,.,0,0
100654,The,0,0
100655,most,0,0
100656,common,0,0
100657,adverse,0,0
100658,event,0,0
100659,leading,0,0
100660,to,0,0
100661,discontinuation,0,0
100662,was,0,0
100663,sedation,0,0
100664,.,0,0
100665,There,0,0
100666,were,0,0
100667,two,0,0
100668,serious,0,0
100669,adverse,0,0
100670,events,0,0
100671,:,0,0
100672,presyncope,0,0
100673,(,0,0
100674,5,0,1
100675,mg/day,0,1
100676,),0,1
100677,and,0,1
100678,aggression,0,0
100679,(,0,1
100680,10,0,1
100681,mg/day,0,1
100682,),0,0
100683,.,0,0
100684,At,0,0
100685,week,0,0
100686,8,0,0
100687,",",0,0
100688,mean,0,0
100689,weight,0,0
100690,change,0,0
100691,(,0,1
100692,last,0,0
100693,observation,0,1
100694,carried,0,0
100695,forward,0,0
100696,),0,0
100697,was,0,0
100698,as,0,0
100699,follows,0,0
100700,:,0,0
100701,placebo,0,1
100702,+0.3,0,1
100703,kg,0,0
100704,",",0,0
100705,aripiprazole,1,1
100706,5,0,0
100707,mg/day,0,1
100708,+1.3,0,1
100709,kg,0,0
100710,",",0,0
100711,10,0,0
100712,mg/day,0,1
100713,+1.3,0,1
100714,kg,0,1
100715,",",0,0
100716,and,0,0
100717,15,0,0
100718,mg/day,0,1
100719,+1.5,0,1
100720,kg,0,0
100721,;,0,0
100722,all,0,0
100723,p,0,0
100724,<,0,0
100725,.05,0,0
100726,versus,0,1
100727,placebo,1,1
100728,.,1,0
100729,CONCLUSIONS,0,0
100730,Aripiprazole,1,1
100731,was,0,0
100732,efficacious,0,0
100733,and,0,0
100734,generally,0,0
100735,safe,0,0
100736,and,0,0
100737,well,0,0
100738,tolerated,0,0
100739,in,0,0
100740,the,0,0
100741,treatment,0,0
100742,of,0,0
100743,children,0,0
100744,and,0,0
100745,adolescents,0,0
100746,with,0,0
100747,irritability,0,0
100748,associated,0,0
100749,with,0,0
100750,autistic,0,0
100751,disorder,0,0
100752,.,0,0
100753,Comparison,0,0
100754,of,0,0
100755,the,0,0
100756,effect,0,0
100757,of,0,0
100758,intra-arterial,1,1
100759,versus,0,1
100760,intravenous,1,1
100761,heparin,1,1
100762,on,0,0
100763,radial,0,0
100764,artery,0,0
100765,occlusion,0,0
100766,after,0,0
100767,transradial,0,1
100768,catheterization,0,1
100769,.,0,0
100770,Radial,0,0
100771,artery,0,0
100772,occlusion,0,0
100773,(,0,1
100774,RAO,0,1
100775,),0,1
100776,is,0,0
100777,an,0,0
100778,infrequent,0,0
100779,",",0,0
100780,asymptomatic,0,0
100781,",",0,0
100782,complication,0,0
100783,of,0,0
100784,transradial,0,1
100785,catheterization,0,1
100786,and,0,0
100787,probably,0,0
100788,1,0,0
100789,of,0,0
100790,the,0,0
100791,few,0,0
100792,.,0,0
100793,Intravenous,0,1
100794,heparin,0,1
100795,and,0,0
100796,patent,0,1
100797,hemostasis,0,0
100798,lower,0,0
100799,its,0,0
100800,incidence,0,0
100801,.,0,0
100802,A,0,0
100803,possible,0,0
100804,local,0,1
100805,effect,0,0
100806,of,0,0
100807,intra-arterially,0,1
100808,administered,0,0
100809,heparin,1,1
100810,during,0,0
100811,transradial,0,0
100812,procedures,0,0
100813,has,0,0
100814,not,0,0
100815,been,0,0
100816,evaluated,0,0
100817,.,0,0
100818,We,0,0
100819,studied,0,0
100820,500,0,0
100821,consecutive,0,0
100822,patients,0,0
100823,randomized,1,0
100824,to,1,0
100825,an,1,0
100826,intravenous,1,1
100827,group,1,0
100828,(,1,0
100829,n,1,0
100830,=,1,0
100831,250,1,1
100832,),1,0
100833,",",1,0
100834,receiving,1,0
100835,50,1,0
100836,U/kg,1,1
100837,of,1,0
100838,unfractionated,1,1
100839,heparin,1,1
100840,(,1,0
100841,maximal,1,0
100842,dose,1,0
100843,"5,000",1,1
100844,U,1,1
100845,),1,0
100846,intravenously,1,1
100847,",",1,0
100848,and,1,0
100849,an,1,0
100850,intra-arterial,1,1
100851,group,1,0
100852,(,1,0
100853,n,1,0
100854,=,1,0
100855,250,1,1
100856,),1,0
100857,receiving,1,0
100858,the,1,0
100859,same,1,0
100860,dose,1,0
100861,intra-arterially,1,1
100862,.,1,0
100863,All,0,0
100864,patients,0,0
100865,received,0,0
100866,a,0,0
100867,vasodilator,1,1
100868,cocktail,1,1
100869,intra-arterially,1,1
100870,and,1,0
100871,underwent,1,0
100872,cardiac,1,0
100873,catheterization,1,1
100874,using,1,0
100875,a,1,0
100876,5F,1,0
100877,introducer,1,1
100878,sheath,1,0
100879,and,1,0
100880,catheters,1,1
100881,.,1,0
100882,The,0,0
100883,activated,0,0
100884,clotting,0,0
100885,time,0,0
100886,was,0,0
100887,measured,0,0
100888,at,0,0
100889,the,0,0
100890,end,0,0
100891,of,0,0
100892,the,0,0
100893,procedure,0,0
100894,.,0,0
100895,All,0,0
100896,patients,0,0
100897,received,0,0
100898,hemostasis,0,0
100899,with,0,0
100900,a,0,0
100901,radial,0,0
100902,compression,0,1
100903,device,0,1
100904,(,0,0
100905,TR,0,0
100906,Band,0,1
100907,),0,0
100908,",",0,0
100909,applied,0,0
100910,after,0,0
100911,sheath,0,0
100912,removal,0,0
100913,",",0,0
100914,for,0,0
100915,2,0,0
100916,hours,0,0
100917,.,0,0
100918,A,0,0
100919,plethysmographic,0,0
100920,evaluation,0,0
100921,for,0,0
100922,RAO,0,0
100923,was,0,0
100924,performed,0,0
100925,at,0,0
100926,24,0,0
100927,hours,0,0
100928,and,0,0
100929,30,0,0
100930,days,0,0
100931,after,0,0
100932,the,0,0
100933,procedure,0,0
100934,.,0,0
100935,Early,0,0
100936,RAO,0,0
100937,occurred,0,0
100938,in,0,0
100939,5.6,0,0
100940,%,0,0
100941,(,0,0
100942,n,0,0
100943,=,0,0
100944,14,0,0
100945,),0,0
100946,of,0,0
100947,the,0,0
100948,intravenous,0,1
100949,group,0,0
100950,and,0,0
100951,6,0,1
100952,%,0,0
100953,(,0,0
100954,n,0,0
100955,=,0,0
100956,15,0,0
100957,),0,0
100958,of,0,0
100959,the,0,0
100960,intra-arterial,0,1
100961,group,0,0
100962,.,0,0
100963,The,0,0
100964,difference,0,0
100965,was,0,0
100966,not,0,0
100967,statistically,0,0
100968,significant,0,0
100969,(,0,0
100970,chi-square,0,0
100971,=,0,0
100972,0.037,0,0
100973,",",0,0
100974,p,0,0
100975,>,0,0
100976,0.8,0,0
100977,),0,0
100978,.,0,0
100979,Chronic,0,0
100980,RAO,0,0
100981,occurred,0,0
100982,in,0,0
100983,3.2,0,0
100984,%,0,0
100985,",",0,0
100986,(,0,0
100987,n,0,0
100988,=,0,0
100989,8,0,0
100990,),0,0
100991,of,0,0
100992,the,0,0
100993,intravenous,0,1
100994,group,0,0
100995,compared,0,0
100996,to,0,0
100997,4,0,1
100998,%,0,0
100999,(,0,0
101000,n,0,0
101001,=,0,0
101002,10,0,0
101003,),0,0
101004,of,0,0
101005,the,0,0
101006,intra-arterial,0,1
101007,group,0,0
101008,.,0,0
101009,The,0,0
101010,difference,0,0
101011,was,0,0
101012,not,0,0
101013,statistically,0,0
101014,significant,0,0
101015,(,0,0
101016,chi-square,0,0
101017,=,0,0
101018,0.231,0,0
101019,",",0,0
101020,p,0,0
101021,>,0,0
101022,0.6,0,0
101023,),0,0
101024,.,0,0
101025,The,0,0
101026,activated,0,0
101027,clotting,0,0
101028,time,0,0
101029,was,0,0
101030,211,0,0
101031,+/-,0,0
101032,16,0,0
101033,seconds,0,0
101034,in,0,0
101035,the,0,0
101036,intravenous,0,1
101037,group,0,0
101038,and,0,0
101039,213,0,0
101040,+/-,0,0
101041,17,0,0
101042,seconds,0,0
101043,in,0,0
101044,the,0,0
101045,intra-arterial,0,1
101046,group,0,0
101047,",",0,0
101048,a,0,0
101049,statistically,0,0
101050,insignificant,0,0
101051,difference,0,0
101052,(,0,0
101053,t,0,0
101054,=,0,0
101055,-1.095,0,0
101056,",",0,0
101057,p,0,0
101058,>,0,0
101059,0.2,0,1
101060,),0,0
101061,.,0,0
101062,In,0,0
101063,conclusion,0,0
101064,",",0,0
101065,intra-arterial,0,1
101066,and,0,0
101067,intravenous,0,1
101068,heparin,0,1
101069,administration,0,0
101070,provide,0,0
101071,comparable,0,0
101072,efficacy,0,0
101073,in,0,0
101074,preventing,0,0
101075,RAO,0,1
101076,",",0,0
101077,favoring,0,0
101078,a,0,0
101079,probable,0,0
101080,systemically,0,0
101081,mediated,0,0
101082,mechanism,0,0
101083,of,0,0
101084,action,0,0
101085,",",0,0
101086,rather,0,0
101087,than,0,0
101088,a,0,0
101089,local,0,1
101090,effect,0,0
101091,.,0,0
101092,Safety,0,1
101093,and,0,0
101094,efficacy,0,0
101095,of,0,0
101096,oral,0,1
101097,DMSA,1,1
101098,therapy,1,1
101099,for,0,0
101100,children,0,0
101101,with,0,0
101102,autism,0,0
101103,spectrum,0,0
101104,disorders,0,0
101105,:,0,0
101106,Part,0,0
101107,A,0,0
101108,--,0,0
101109,medical,0,0
101110,results,0,0
101111,.,0,0
101112,BACKGROUND,0,0
101113,This,0,0
101114,study,0,0
101115,investigated,0,0
101116,the,0,0
101117,effect,0,0
101118,of,0,0
101119,oral,1,1
101120,dimercapto,1,1
101121,succinic,1,1
101122,acid,1,1
101123,(,1,1
101124,DMSA,1,1
101125,),1,1
101126,therapy,1,1
101127,for,0,0
101128,children,0,0
101129,with,0,0
101130,autism,0,0
101131,spectrum,0,0
101132,disorders,0,0
101133,ages,0,0
101134,3-8,0,0
101135,years,0,0
101136,.,0,0
101137,METHODS,0,0
101138,Phase,0,0
101139,1,0,0
101140,involved,0,0
101141,65,0,0
101142,children,0,0
101143,who,0,0
101144,received,0,0
101145,one,0,0
101146,round,0,0
101147,of,0,0
101148,DMSA,1,1
101149,(,0,0
101150,3,0,0
101151,days,0,0
101152,),0,0
101153,.,0,0
101154,Participants,0,0
101155,who,0,0
101156,had,0,0
101157,high,0,0
101158,urinary,0,0
101159,excretion,0,0
101160,of,0,0
101161,toxic,0,0
101162,metals,0,0
101163,were,0,0
101164,selected,0,0
101165,to,0,0
101166,continue,0,0
101167,on,0,0
101168,to,0,0
101169,phase,0,0
101170,2,0,0
101171,.,0,0
101172,In,0,0
101173,phase,0,0
101174,2,0,0
101175,",",0,0
101176,49,0,0
101177,participants,0,0
101178,were,0,0
101179,randomly,0,0
101180,assigned,0,0
101181,in,0,0
101182,a,0,0
101183,double-blind,0,0
101184,design,0,0
101185,to,0,0
101186,receive,0,0
101187,an,0,0
101188,additional,0,0
101189,6,0,0
101190,rounds,0,1
101191,of,0,0
101192,either,0,0
101193,DMSA,1,1
101194,or,1,1
101195,placebo,1,1
101196,.,1,0
101197,RESULTS,0,0
101198,DMSA,0,0
101199,greatly,0,0
101200,increased,0,0
101201,the,0,0
101202,excretion,0,0
101203,of,0,0
101204,lead,0,0
101205,",",0,0
101206,substantially,0,0
101207,increased,0,0
101208,excretion,0,0
101209,of,0,0
101210,tin,0,1
101211,and,0,0
101212,bismuth,0,1
101213,",",0,0
101214,and,0,0
101215,somewhat,0,0
101216,increased,0,0
101217,the,0,0
101218,excretion,0,0
101219,of,0,0
101220,thallium,0,1
101221,",",0,0
101222,mercury,0,0
101223,",",0,0
101224,antimony,0,1
101225,",",0,0
101226,and,0,0
101227,tungsten,0,1
101228,.,0,0
101229,There,0,0
101230,was,0,0
101231,some,0,0
101232,increase,0,0
101233,in,0,0
101234,urinary,0,0
101235,excretion,0,0
101236,of,0,0
101237,essential,0,0
101238,minerals,0,1
101239,",",0,0
101240,especially,0,0
101241,potassium,0,1
101242,and,0,0
101243,chromium,0,1
101244,.,0,0
101245,The,0,0
101246,Phase,0,0
101247,1,0,0
101248,single,0,0
101249,round,0,0
101250,of,0,0
101251,DMSA,1,0
101252,led,0,0
101253,to,0,0
101254,a,0,0
101255,dramatic,0,0
101256,normalization,0,0
101257,of,0,0
101258,RBC,0,1
101259,glutathione,0,1
101260,in,0,0
101261,almost,0,0
101262,all,0,0
101263,cases,0,0
101264,",",0,0
101265,and,0,0
101266,greatly,0,0
101267,improved,0,0
101268,abnormal,0,0
101269,platelet,0,0
101270,counts,0,0
101271,",",0,0
101272,suggesting,0,0
101273,a,0,0
101274,significant,0,0
101275,decrease,0,0
101276,in,0,0
101277,inflammation,0,0
101278,.,0,0
101279,CONCLUSION,0,0
101280,Overall,0,0
101281,",",0,0
101282,DMSA,1,1
101283,therapy,0,1
101284,seems,0,0
101285,to,0,0
101286,be,0,0
101287,reasonably,0,0
101288,safe,0,0
101289,",",0,0
101290,effective,0,0
101291,in,0,0
101292,removing,0,0
101293,several,0,0
101294,toxic,0,0
101295,metals,0,1
101296,(,0,0
101297,especially,0,0
101298,lead,0,0
101299,),0,0
101300,",",0,0
101301,dramatically,0,0
101302,effective,0,0
101303,in,0,0
101304,normalizing,0,0
101305,RBC,0,1
101306,glutathione,0,1
101307,",",0,0
101308,and,0,0
101309,effective,0,0
101310,in,0,0
101311,normalizing,0,0
101312,platelet,0,0
101313,counts,0,0
101314,.,0,0
101315,Only,0,0
101316,1,0,0
101317,round,0,0
101318,(,0,0
101319,3,0,0
101320,days,0,0
101321,),0,0
101322,was,0,0
101323,sufficient,0,0
101324,to,0,0
101325,improve,0,0
101326,glutathione,0,1
101327,and,0,0
101328,platelets,0,0
101329,.,0,0
101330,Additional,0,0
101331,rounds,0,0
101332,increased,0,0
101333,excretion,0,0
101334,of,0,0
101335,toxic,0,0
101336,metals,0,0
101337,.,0,0
101338,Immunologic,0,1
101339,profiles,0,0
101340,of,0,0
101341,persons,0,0
101342,recruited,0,0
101343,for,0,0
101344,a,0,0
101345,randomized,0,0
101346,",",0,0
101347,placebo-controlled,1,1
101348,clinical,0,0
101349,trial,0,0
101350,of,0,0
101351,hookworm,0,1
101352,infection,0,0
101353,.,0,0
101354,Data,0,0
101355,from,0,0
101356,epidemiologic,0,0
101357,studies,0,0
101358,suggest,0,0
101359,that,0,0
101360,hookworm,0,1
101361,infections,0,0
101362,",",0,0
101363,in,0,0
101364,establishing,0,0
101365,an,0,0
101366,immunologic,0,0
101367,phenotype,0,0
101368,conducive,0,0
101369,to,0,0
101370,parasite,0,0
101371,survival,0,0
101372,",",0,0
101373,may,0,0
101374,protect,0,0
101375,against,0,0
101376,the,0,0
101377,development,0,0
101378,of,0,0
101379,allergic,0,0
101380,disease,0,0
101381,.,0,0
101382,We,0,0
101383,describe,0,0
101384,immunologic,0,0
101385,findings,0,0
101386,from,0,0
101387,a,0,0
101388,clinical,0,0
101389,study,0,0
101390,designed,0,0
101391,to,0,0
101392,investigate,0,0
101393,the,0,0
101394,safety,0,0
101395,of,0,0
101396,iatrogenic,1,0
101397,hookworm,1,1
101398,infection,1,0
101399,in,0,0
101400,participants,0,0
101401,with,0,0
101402,allergic,0,0
101403,rhinitis,0,0
101404,.,0,0
101405,The,0,0
101406,low,0,0
101407,",",0,0
101408,relatively,0,0
101409,safe,0,0
101410,level,0,0
101411,of,0,0
101412,hookworm,1,1
101413,infection,1,0
101414,used,0,0
101415,in,0,0
101416,this,0,0
101417,study,0,0
101418,was,0,0
101419,immunogenic,0,0
101420,",",0,0
101421,inducing,0,0
101422,eosinophilia,0,0
101423,and,0,0
101424,a,0,0
101425,significant,0,0
101426,specific,0,0
101427,IgG,0,1
101428,response,0,0
101429,.,0,0
101430,Importantly,0,0
101431,",",0,0
101432,no,0,0
101433,potentiation,0,0
101434,of,0,0
101435,IgE,0,1
101436,responses,0,0
101437,to,0,0
101438,the,0,0
101439,environmental,0,0
101440,allergens,0,0
101441,to,0,0
101442,which,0,0
101443,the,0,0
101444,participants,0,0
101445,were,0,0
101446,sensitized,0,0
101447,was,0,0
101448,seen,0,0
101449,.,0,0
101450,However,0,0
101451,",",0,0
101452,no,0,0
101453,evidence,0,0
101454,of,0,0
101455,systemic,0,0
101456,immune,0,0
101457,regulation,0,0
101458,was,0,0
101459,seen,0,0
101460,in,0,0
101461,infected,0,0
101462,participants,0,0
101463,.,0,0
101464,This,0,0
101465,finding,0,0
101466,may,0,0
101467,indicate,0,0
101468,that,0,0
101469,the,0,0
101470,level,0,0
101471,of,0,0
101472,infection,0,0
101473,or,0,1
101474,the,0,0
101475,frequency,0,0
101476,of,0,0
101477,infection,0,0
101478,may,0,0
101479,have,0,0
101480,to,0,0
101481,be,0,0
101482,altered,0,0
101483,in,0,0
101484,future,0,0
101485,trials,0,0
101486,to,0,0
101487,induce,0,0
101488,a,0,0
101489,therapeutically,0,0
101490,conducive,0,0
101491,immunologic,0,0
101492,phenotype,0,0
101493,.,0,0
101494,Enhancing,0,0
101495,antiepileptic,1,1
101496,drug,1,1
101497,adherence,0,0
101498,:,0,0
101499,a,0,0
101500,randomized,0,0
101501,controlled,0,0
101502,trial,0,0
101503,.,0,0
101504,Suboptimal,0,0
101505,adherence,0,0
101506,to,0,0
101507,antiepileptic,1,1
101508,drug,1,1
101509,(,1,1
101510,AED,1,1
101511,),1,1
101512,treatment,1,1
101513,is,0,0
101514,commonplace,0,0
101515,",",0,0
101516,and,0,0
101517,increases,0,0
101518,the,0,0
101519,risk,0,0
101520,of,0,0
101521,status,0,0
101522,epilepticus,0,1
101523,and,0,0
101524,sudden,0,0
101525,unexplained,0,0
101526,death,0,0
101527,in,0,0
101528,epilepsy,0,0
101529,.,0,0
101530,This,0,0
101531,randomized,0,0
101532,controlled,0,0
101533,trial,0,0
101534,was,0,0
101535,designed,0,0
101536,to,0,0
101537,demonstrate,0,0
101538,whether,0,0
101539,an,0,0
101540,implementation,1,0
101541,intention,1,0
101542,intervention,1,1
101543,involving,0,0
101544,the,0,0
101545,completion,0,0
101546,of,0,0
101547,a,0,0
101548,simple,0,1
101549,self-administered,1,1
101550,questionnaire,1,1
101551,linking,0,0
101552,the,0,0
101553,intention,1,0
101554,of,1,0
101555,taking,1,0
101556,medication,1,1
101557,with,1,0
101558,a,1,0
101559,particular,1,0
101560,time,1,0
101561,",",1,0
101562,place,1,0
101563,",",1,0
101564,and,1,0
101565,other,1,0
101566,activity,1,0
101567,can,0,0
101568,improve,0,0
101569,AED,1,1
101570,treatment,0,1
101571,schedule,0,1
101572,adherence,0,0
101573,.,0,0
101574,Of,0,0
101575,the,0,0
101576,81,0,0
101577,patients,0,0
101578,with,0,0
101579,epilepsy,0,0
101580,who,0,0
101581,were,0,0
101582,randomized,0,0
101583,",",0,0
101584,69,0,0
101585,completed,0,0
101586,a,0,0
101587,1-month,0,0
101588,monitoring,0,1
101589,period,0,0
101590,with,0,0
101591,an,0,0
101592,objective,0,0
101593,measure,0,0
101594,of,0,0
101595,tablet,0,1
101596,taking,0,1
101597,(,0,1
101598,electronic,0,1
101599,registration,0,0
101600,of,0,0
101601,pill,0,1
101602,bottle,0,1
101603,openings,0,0
101604,",",0,0
101605,Medication,0,1
101606,Event,0,1
101607,Monitoring,0,1
101608,System,0,1
101609,[,0,0
101610,MEMS,0,1
101611,],0,0
101612,),0,0
101613,.,0,0
101614,Intervention,1,1
101615,participants,0,0
101616,showed,0,0
101617,improved,0,0
101618,adherence,0,0
101619,relative,0,0
101620,to,0,0
101621,controls,0,0
101622,on,0,0
101623,all,0,0
101624,three,0,0
101625,outcomes,0,0
101626,:,0,0
101627,doses,0,0
101628,taken,0,0
101629,in,0,0
101630,total,0,0
101631,(,0,0
101632,93.4,0,0
101633,%,0,0
101634,vs.,0,0
101635,79.1,0,0
101636,%,0,0
101637,),0,0
101638,",",0,0
101639,days,0,0
101640,on,0,0
101641,which,0,0
101642,correct,0,0
101643,dose,0,0
101644,was,0,0
101645,taken,0,0
101646,(,0,0
101647,88.7,0,0
101648,%,0,0
101649,vs.,0,0
101650,65.3,0,0
101651,%,0,0
101652,),0,0
101653,",",0,0
101654,and,0,0
101655,doses,0,1
101656,taken,0,0
101657,on,0,0
101658,schedule,0,1
101659,(,0,0
101660,78.8,0,0
101661,%,0,0
101662,vs.,0,0
101663,55.3,0,0
101664,%,0,0
101665,),0,1
101666,(,0,0
101667,P,0,0
101668,<,0,0
101669,0.01,0,0
101670,),0,0
101671,.,0,0
101672,The,0,0
101673,implementation,0,0
101674,intention,1,0
101675,intervention,1,1
101676,may,0,0
101677,be,0,0
101678,an,0,0
101679,easy-to-administer,0,1
101680,and,0,0
101681,effective,0,0
101682,means,0,0
101683,of,0,0
101684,promoting,0,0
101685,AED,1,1
101686,adherence,0,0
101687,.,0,0
101688,Bipolar,1,0
101689,transurethral,1,1
101690,resection,1,1
101691,of,1,0
101692,the,1,0
101693,prostate,1,0
101694,causes,0,0
101695,less,0,0
101696,bleeding,0,0
101697,than,0,0
101698,the,0,0
101699,monopolar,1,1
101700,technique,1,1
101701,:,1,0
101702,a,0,0
101703,single-centre,0,0
101704,randomized,0,0
101705,trial,0,0
101706,of,0,0
101707,202,0,0
101708,patients,0,0
101709,.,0,0
101710,OBJECTIVE,0,0
101711,To,0,0
101712,compare,0,0
101713,bipolar,1,1
101714,with,0,0
101715,the,0,0
101716,conventional,1,1
101717,monopolar,1,1
101718,transurethral,1,1
101719,resection,1,1
101720,of,1,0
101721,the,1,0
101722,prostate,1,0
101723,(,1,1
101724,TURP,1,0
101725,),1,1
101726,for,0,0
101727,blood,0,0
101728,loss,0,0
101729,and,0,0
101730,speed,0,0
101731,of,0,0
101732,resection,0,0
101733,.,0,0
101734,PATIENTS,0,0
101735,AND,0,0
101736,METHODS,0,0
101737,In,0,0
101738,all,0,0
101739,",",0,0
101740,202,0,0
101741,consecutive,0,0
101742,patients,0,0
101743,from,0,0
101744,the,0,0
101745,hospital,0,0
101746,waiting,0,0
101747,list,0,0
101748,were,0,0
101749,randomized,0,0
101750,to,0,0
101751,undergo,1,0
101752,TURP,1,0
101753,using,1,0
101754,either,1,0
101755,a,1,0
101756,bipolar,1,1
101757,system,1,1
101758,(,1,0
101759,Surgmaster,1,1
101760,TURis,1,0
101761,",",1,0
101762,Olympus,1,1
101763,",",1,0
101764,Tokyo,1,0
101765,",",1,0
101766,Japan,1,1
101767,),1,1
101768,or,1,1
101769,a,1,0
101770,monopolar,1,1
101771,system,1,1
101772,(,1,0
101773,24,1,0
101774,F,1,0
101775,",",1,0
101776,Storz,1,1
101777,",",1,0
101778,T?bingen,1,0
101779,",",1,0
101780,Germany,1,0
101781,),1,0
101782,.,1,0
101783,The,0,0
101784,blood,0,0
101785,loss,0,0
101786,during,0,0
101787,and,0,0
101788,after,0,0
101789,surgery,0,1
101790,was,0,0
101791,measured,0,0
101792,using,0,0
101793,a,0,0
101794,photometer,1,1
101795,.,1,0
101796,Other,0,0
101797,variables,0,0
101798,compared,0,0
101799,included,0,0
101800,indices,0,0
101801,of,0,0
101802,resection,0,1
101803,speed,0,0
101804,and,0,0
101805,transfusion,0,1
101806,rate,0,0
101807,.,0,0
101808,RESULTS,0,0
101809,There,0,0
101810,were,0,0
101811,no,0,0
101812,statistically,0,0
101813,significant,0,0
101814,differences,0,0
101815,in,0,0
101816,operative,0,0
101817,duration,0,0
101818,",",0,0
101819,resection,0,1
101820,weight,0,0
101821,",",0,0
101822,resection,0,1
101823,speed,0,0
101824,or,0,1
101825,radicality,0,0
101826,of,0,0
101827,resection,0,0
101828,.,0,0
101829,However,0,0
101830,",",0,0
101831,the,0,0
101832,median,0,0
101833,blood,0,0
101834,loss,0,0
101835,was,0,0
101836,235,0,0
101837,mL,0,0
101838,for,0,0
101839,the,0,0
101840,bipolar,0,1
101841,and,0,0
101842,350,0,1
101843,mL,0,1
101844,for,0,0
101845,monopolar,0,1
101846,TURP,0,0
101847,(,0,0
101848,P,0,0
101849,<,0,0
101850,0.001,0,0
101851,),0,0
101852,.,0,0
101853,The,0,0
101854,decrease,0,0
101855,in,0,0
101856,blood,0,0
101857,haemoglobin,0,0
101858,concentration,0,0
101859,during,0,0
101860,the,0,0
101861,day,0,0
101862,of,0,0
101863,surgery,0,0
101864,was,0,0
101865,smaller,0,0
101866,in,0,0
101867,the,0,0
101868,bipolar,0,1
101869,group,0,0
101870,(,0,0
101871,5.5,0,0
101872,%,0,0
101873,vs,0,0
101874,9.6,0,0
101875,%,0,0
101876,P,0,0
101877,<,0,0
101878,0.001,0,0
101879,),0,0
101880,.,0,0
101881,Fewer,0,0
101882,patients,0,0
101883,were,0,0
101884,transfused,0,0
101885,with,0,0
101886,erythrocytes,0,0
101887,(,0,0
101888,4,0,0
101889,%,0,0
101890,vs,0,0
101891,11,0,0
101892,%,0,0
101893,",",0,0
101894,P,0,0
101895,<,0,0
101896,0.01,0,0
101897,),0,0
101898,",",0,0
101899,which,0,0
101900,can,0,0
101901,be,0,0
101902,explained,0,0
101903,by,0,0
101904,the,0,0
101905,much,0,0
101906,lower,0,0
101907,75th,0,0
101908,percentile,0,0
101909,for,0,0
101910,blood,0,0
101911,loss,0,0
101912,in,0,0
101913,the,0,0
101914,bipolar,0,1
101915,group,0,0
101916,(,0,0
101917,at,0,0
101918,472,0,0
101919,vs,0,0
101920,855,0,0
101921,mL,0,0
101922,",",0,0
101923,respectively,0,0
101924,),0,0
101925,.,0,0
101926,CONCLUSIONS,1,0
101927,Bipolar,1,0
101928,TURP,1,0
101929,using,1,0
101930,the,1,0
101931,TURis,1,0
101932,system,1,0
101933,was,0,0
101934,performed,0,0
101935,with,0,0
101936,the,0,0
101937,same,0,0
101938,speed,0,0
101939,as,1,0
101940,monopolar,1,1
101941,TURP,1,0
101942,but,0,0
101943,caused,0,0
101944,34,0,0
101945,%,0,0
101946,less,0,0
101947,bleeding,0,0
101948,",",0,0
101949,the,0,0
101950,difference,0,0
101951,being,0,0
101952,greatest,0,0
101953,(,0,0
101954,81,0,0
101955,%,0,0
101956,),0,0
101957,for,0,0
101958,the,0,0
101959,largest,0,0
101960,blood,0,0
101961,losses,0,0
101962,.,0,0
101963,Bipolar,1,0
101964,TURP,1,0
101965,also,0,0
101966,required,0,0
101967,fewer,0,0
101968,erythrocyte,0,0
101969,transfusions,0,0
101970,than,0,0
101971,the,0,0
101972,conventional,0,1
101973,monopolar,0,1
101974,technique,0,1
101975,.,0,0
101976,Effects,0,0
101977,of,0,0
101978,fluoride,1,1
101979,and,1,0
101980,chlorhexidine,1,1
101981,on,0,0
101982,the,0,0
101983,microflora,0,0
101984,of,0,0
101985,dental,0,0
101986,root,0,1
101987,surfaces,0,1
101988,and,0,0
101989,progression,0,0
101990,of,0,0
101991,root-surface,0,0
101992,caries,0,0
101993,.,0,0
101994,The,0,0
101995,effects,0,0
101996,of,0,0
101997,fluoride,1,1
101998,and,1,0
101999,chlorhexidine,1,1
102000,varnishes,0,1
102001,on,0,0
102002,the,0,0
102003,microflora,0,0
102004,of,0,0
102005,dental,0,0
102006,root,0,1
102007,surfaces,0,1
102008,and,0,0
102009,on,0,0
102010,the,0,0
102011,progression,0,0
102012,of,0,0
102013,root-surface,0,0
102014,caries,0,0
102015,were,0,0
102016,studied,0,0
102017,.,0,0
102018,Forty-four,0,0
102019,patients,0,0
102020,",",0,0
102021,surgically,0,0
102022,treated,0,0
102023,for,0,0
102024,advanced,0,0
102025,periodontal,0,0
102026,disease,0,0
102027,",",0,0
102028,were,0,0
102029,distributed,0,0
102030,at,0,0
102031,random,0,0
102032,among,0,0
102033,three,0,0
102034,groups,0,0
102035,.,0,0
102036,All,0,0
102037,patients,0,0
102038,received,0,0
102039,a,0,0
102040,standardized,0,0
102041,preventive,0,0
102042,treatment,0,0
102043,.,0,0
102044,Furthermore,0,0
102045,",",0,0
102046,the,0,0
102047,dentition,0,0
102048,of,0,0
102049,the,0,0
102050,patients,0,0
102051,in,0,0
102052,the,0,0
102053,two,0,0
102054,experimental,0,0
102055,groups,0,0
102056,was,0,0
102057,treated,0,0
102058,",",0,0
102059,at,0,0
102060,three-month,0,0
102061,intervals,0,0
102062,",",0,0
102063,with,0,0
102064,chlorhexidine,1,1
102065,and,1,0
102066,fluoride,1,1
102067,varnish,1,1
102068,",",0,0
102069,respectively,0,0
102070,.,0,0
102071,Patients,0,0
102072,in,0,0
102073,the,0,0
102074,control,1,1
102075,group,1,0
102076,received,0,1
102077,no,0,0
102078,additional,0,0
102079,treatment,0,0
102080,.,0,0
102081,In,0,0
102082,the,0,0
102083,experimental,0,0
102084,groups,0,0
102085,",",0,0
102086,plaque,0,0
102087,samples,0,0
102088,were,0,0
102089,collected,0,0
102090,from,0,0
102091,selected,0,0
102092,sound,0,0
102093,and,0,0
102094,carious,0,1
102095,root,0,1
102096,surfaces,0,1
102097,at,0,0
102098,baseline,0,0
102099,and,0,0
102100,at,0,0
102101,three,0,0
102102,",",0,0
102103,six,0,0
102104,",",0,0
102105,and,0,0
102106,nine,0,0
102107,months,0,0
102108,after,0,0
102109,the,0,0
102110,onset,0,0
102111,of,0,0
102112,the,0,0
102113,study,0,0
102114,.,0,0
102115,The,0,0
102116,presence,0,0
102117,of,0,0
102118,root-surface,0,0
102119,caries,0,0
102120,was,0,0
102121,scored,0,0
102122,at,0,0
102123,baseline,0,0
102124,and,0,0
102125,after,0,0
102126,one,0,0
102127,year,0,0
102128,.,0,0
102129,In,0,0
102130,addition,0,0
102131,",",0,0
102132,the,0,0
102133,texture,0,0
102134,",",0,0
102135,depth,0,0
102136,",",0,0
102137,and,0,0
102138,color,0,0
102139,of,0,0
102140,the,0,0
102141,root-surface,0,0
102142,lesions,0,0
102143,were,0,0
102144,monitored,0,0
102145,.,0,0
102146,Mutans,0,0
102147,streptococci,0,1
102148,on,0,0
102149,root,0,0
102150,surfaces,0,1
102151,were,0,0
102152,suppressed,0,0
102153,significantly,0,0
102154,(,0,0
102155,p,0,0
102156,less,0,0
102157,than,0,0
102158,0.05,0,0
102159,),0,0
102160,during,0,0
102161,the,0,0
102162,whole,0,0
102163,experimental,0,0
102164,period,0,0
102165,in,0,0
102166,the,0,0
102167,chlorhexidine,1,1
102168,varnish,0,1
102169,group,0,0
102170,",",0,0
102171,but,0,0
102172,not,0,0
102173,in,0,0
102174,the,0,0
102175,fluoride,1,1
102176,varnish,0,1
102177,group,0,0
102178,.,0,0
102179,A,0,0
102180,non-significant,0,0
102181,increase,0,0
102182,in,0,0
102183,the,0,0
102184,number,0,0
102185,of,0,0
102186,Actinomyces,0,1
102187,viscosus/naeslundii,0,0
102188,was,0,0
102189,noted,0,0
102190,after,0,0
102191,treatment,0,0
102192,with,0,0
102193,chlorhexidine,1,1
102194,and,0,0
102195,fluoride,1,1
102196,varnish,0,1
102197,.,0,0
102198,The,0,0
102199,increase,0,0
102200,in,0,0
102201,the,0,0
102202,number,0,0
102203,of,0,0
102204,decayed,0,0
102205,and,0,0
102206,filled,0,1
102207,root,0,1
102208,surfaces,0,1
102209,after,0,0
102210,one,0,0
102211,year,0,0
102212,was,0,0
102213,significantly,0,0
102214,lower,0,0
102215,in,0,0
102216,the,0,0
102217,experimental,0,0
102218,groups,0,0
102219,than,0,0
102220,in,0,0
102221,the,0,0
102222,control,0,0
102223,group,0,0
102224,.,0,0
102225,After,0,0
102226,treatment,0,0
102227,with,0,0
102228,chlorhexidine,1,1
102229,varnish,0,1
102230,",",0,0
102231,significantly,0,0
102232,more,0,0
102233,initial,0,0
102234,root-surface,0,1
102235,lesions,0,0
102236,had,0,0
102237,hardened,0,0
102238,than,0,0
102239,in,0,0
102240,the,0,0
102241,other,0,0
102242,groups,0,0
102243,.,0,0
102244,Routine,1,1
102245,antibiotic,1,1
102246,use,1,0
102247,in,0,0
102248,preterm,0,0
102249,neonates,0,0
102250,:,0,0
102251,a,0,0
102252,randomised,0,0
102253,controlled,0,0
102254,trial,0,0
102255,.,0,0
102256,The,0,0
102257,immature,0,0
102258,immune,0,0
102259,system,0,1
102260,of,0,0
102261,preterm,0,0
102262,neonates,0,0
102263,puts,0,0
102264,them,0,0
102265,at,0,0
102266,higher,0,0
102267,risk,0,0
102268,of,0,0
102269,neonatal,0,0
102270,sepsis,0,0
102271,.,0,0
102272,We,0,0
102273,conducted,0,0
102274,a,0,0
102275,part-blinded,0,0
102276,randomised,0,0
102277,controlled,0,0
102278,trial,0,0
102279,to,0,0
102280,compare,0,0
102281,the,0,0
102282,effect,0,0
102283,of,0,0
102284,routine,1,0
102285,antibiotic,1,1
102286,treatment,1,0
102287,on,0,0
102288,the,0,0
102289,incidence,0,0
102290,of,0,0
102291,clinical,0,0
102292,sepsis,0,0
102293,in,0,0
102294,preterm,0,0
102295,neonates,0,0
102296,.,0,0
102297,Preterm,0,0
102298,neonates,0,0
102299,without,0,0
102300,other,0,0
102301,risk,0,0
102302,factors,0,0
102303,for,0,0
102304,infection,0,0
102305,admitted,0,0
102306,in,0,0
102307,the,0,0
102308,first,0,0
102309,12h,0,0
102310,of,0,0
102311,life,0,0
102312,were,0,0
102313,randomised,0,0
102314,to,0,0
102315,receive,0,0
102316,routine,1,0
102317,antibiotics,1,1
102318,or,0,0
102319,to,0,0
102320,a,0,0
102321,control,1,1
102322,group,1,0
102323,(,1,0
102324,no,1,0
102325,antibiotics,1,1
102326,unless,1,0
102327,clinically,1,0
102328,indicated,1,0
102329,),1,0
102330,.,1,0
102331,The,0,0
102332,primary,0,0
102333,outcome,0,0
102334,variable,0,0
102335,was,0,0
102336,the,0,0
102337,incidence,0,0
102338,of,0,0
102339,clinical,0,0
102340,sepsis,0,0
102341,.,0,0
102342,Secondary,0,0
102343,outcomes,0,0
102344,were,0,0
102345,the,0,0
102346,incidence,0,0
102347,of,0,0
102348,positive,0,0
102349,blood,0,0
102350,cultures,0,0
102351,",",0,0
102352,necrotising,0,0
102353,enterocolitis,0,0
102354,(,0,1
102355,NEC,0,1
102356,),0,1
102357,stage,0,0
102358,II,0,1
102359,or,0,1
102360,III,0,0
102361,",",0,0
102362,or,0,1
102363,death,0,0
102364,",",0,0
102365,and,0,0
102366,the,0,0
102367,duration,0,0
102368,of,0,0
102369,hospital,0,0
102370,stay,0,0
102371,.,0,0
102372,The,0,0
102373,incidence,0,0
102374,of,0,0
102375,clinical,0,0
102376,sepsis,0,0
102377,was,0,0
102378,comparable,0,0
102379,in,0,0
102380,both,0,0
102381,groups,0,0
102382,(,0,0
102383,intervention,0,1
102384,31.9,0,0
102385,%,0,0
102386,",",0,0
102387,control,0,1
102388,25.4,0,0
102389,%,0,0
102390,;,0,0
102391,P=0.392,0,0
102392,),0,0
102393,.,0,0
102394,Mortality,0,0
102395,was,0,0
102396,equivalent,0,0
102397,in,0,0
102398,both,0,0
102399,groups,0,0
102400,.,0,0
102401,The,0,0
102402,control,0,0
102403,group,0,0
102404,had,0,0
102405,significantly,0,0
102406,more,0,0
102407,positive,0,0
102408,blood,0,0
102409,cultures,0,0
102410,(,0,0
102411,P=0.002,0,0
102412,),0,0
102413,.,0,0
102414,The,0,0
102415,incidence,0,0
102416,of,0,0
102417,NEC,0,1
102418,and,0,0
102419,the,0,0
102420,duration,0,0
102421,of,0,0
102422,hospital,0,0
102423,stay,0,0
102424,were,0,0
102425,comparable,0,0
102426,in,0,0
102427,both,0,0
102428,groups,0,0
102429,.,0,0
102430,In,0,0
102431,low,0,0
102432,risk,0,0
102433,preterm,0,0
102434,neonates,0,0
102435,we,0,0
102436,found,0,0
102437,no,0,0
102438,evidence,0,0
102439,that,0,0
102440,routine,0,0
102441,antibiotic,1,1
102442,use,0,0
102443,has,0,0
102444,a,0,0
102445,protective,0,0
102446,effect,0,0
102447,.,0,0
102448,Aripiprazole,1,1
102449,in,0,0
102450,the,0,0
102451,treatment,0,0
102452,of,0,0
102453,irritability,0,0
102454,in,0,0
102455,children,0,0
102456,and,0,0
102457,adolescents,0,0
102458,with,0,0
102459,autistic,0,0
102460,disorder,0,0
102461,.,0,0
102462,OBJECTIVE,0,0
102463,The,0,0
102464,objective,0,0
102465,of,0,0
102466,this,0,0
102467,study,0,0
102468,was,0,0
102469,to,0,0
102470,evaluate,0,0
102471,short-term,0,0
102472,efficacy,0,0
102473,and,0,0
102474,safety,0,0
102475,of,0,0
102476,aripiprazole,1,1
102477,in,0,0
102478,the,0,0
102479,treatment,0,0
102480,of,0,0
102481,irritability,0,0
102482,in,0,0
102483,children,0,0
102484,and,0,0
102485,adolescents,0,0
102486,with,0,0
102487,autistic,0,0
102488,disorder,0,0
102489,who,0,0
102490,were,0,0
102491,manifesting,0,0
102492,behaviors,0,0
102493,such,0,0
102494,as,0,0
102495,tantrums,0,0
102496,",",0,0
102497,aggression,0,0
102498,",",0,0
102499,self-injurious,0,0
102500,behavior,0,0
102501,",",0,0
102502,or,0,1
102503,a,0,0
102504,combination,0,1
102505,of,0,0
102506,these,0,0
102507,.,0,0
102508,METHODS,0,0
102509,This,0,0
102510,8-week,0,0
102511,",",0,0
102512,double-blind,0,0
102513,",",0,0
102514,randomized,0,0
102515,",",0,0
102516,placebo-controlled,0,1
102517,",",0,0
102518,parallel-group,0,0
102519,study,0,0
102520,was,0,0
102521,conducted,0,0
102522,of,0,0
102523,children,0,0
102524,and,0,0
102525,adolescents,0,0
102526,(,0,0
102527,aged,0,0
102528,6-17,0,0
102529,years,0,0
102530,),0,0
102531,with,0,0
102532,autistic,0,0
102533,disorder,0,0
102534,.,0,0
102535,Patients,1,0
102536,were,1,0
102537,randomly,1,0
102538,assigned,1,0
102539,(,1,0
102540,1:1,1,1
102541,),1,0
102542,to,1,0
102543,flexibly,1,1
102544,dosed,1,1
102545,aripiprazole,1,1
102546,(,1,1
102547,target,1,0
102548,dosage,1,0
102549,:,1,0
102550,5,1,0
102551,",",1,0
102552,10,1,0
102553,",",1,0
102554,or,1,0
102555,15,1,1
102556,mg/day,1,1
102557,),1,1
102558,or,1,1
102559,placebo,1,1
102560,.,1,1
102561,Efficacy,0,0
102562,outcome,0,0
102563,measures,0,0
102564,included,0,0
102565,the,0,0
102566,Aberrant,0,0
102567,Behavior,0,0
102568,Checklist,0,1
102569,irritability,0,0
102570,subscale,0,0
102571,and,0,0
102572,the,0,0
102573,Clinical,0,0
102574,Global,0,0
102575,Impression-Improvement,0,0
102576,score,0,0
102577,(,0,1
102578,CGI-I,0,1
102579,),0,1
102580,.,0,0
102581,Safety,0,0
102582,and,0,0
102583,tolerability,0,0
102584,were,0,0
102585,also,0,0
102586,assessed,0,0
102587,.,0,0
102588,RESULTS,0,0
102589,Ninety-eight,0,0
102590,patients,0,0
102591,were,0,0
102592,randomly,0,0
102593,assigned,0,0
102594,to,0,0
102595,receive,0,1
102596,placebo,1,1
102597,(,0,0
102598,n,0,0
102599,=,0,0
102600,51,0,0
102601,),0,0
102602,or,0,1
102603,aripiprazole,0,1
102604,(,0,0
102605,n,0,0
102606,=,0,0
102607,47,0,0
102608,),0,0
102609,.,0,0
102610,Mean,0,0
102611,improvement,0,0
102612,in,0,0
102613,Aberrant,0,0
102614,Behavior,0,0
102615,Checklist,0,1
102616,irritability,0,0
102617,subscale,0,0
102618,score,0,0
102619,was,0,0
102620,significantly,0,0
102621,greater,0,0
102622,with,0,0
102623,aripiprazole,1,1
102624,than,0,0
102625,with,0,0
102626,placebo,1,1
102627,from,0,0
102628,week,0,0
102629,1,0,0
102630,through,0,0
102631,week,0,0
102632,8,0,0
102633,.,0,0
102634,Aripiprazole,0,1
102635,demonstrated,0,0
102636,significantly,0,0
102637,greater,0,0
102638,global,0,0
102639,improvements,0,0
102640,than,0,0
102641,placebo,0,1
102642,",",0,0
102643,as,0,0
102644,assessed,0,0
102645,by,0,0
102646,the,0,0
102647,mean,0,0
102648,CGI-I,0,1
102649,score,0,0
102650,from,0,0
102651,week,0,0
102652,1,0,0
102653,through,0,0
102654,week,0,0
102655,8,0,0
102656,;,0,0
102657,however,0,0
102658,",",0,0
102659,clinically,0,0
102660,significant,0,0
102661,residual,0,0
102662,symptoms,0,0
102663,may,0,0
102664,still,0,0
102665,persist,0,0
102666,for,0,0
102667,some,0,0
102668,patients,0,0
102669,.,0,0
102670,Discontinuation,0,0
102671,rates,0,0
102672,as,0,0
102673,a,0,0
102674,result,0,0
102675,of,0,0
102676,adverse,0,0
102677,events,0,0
102678,(,0,0
102679,AEs,0,1
102680,),0,1
102681,were,0,0
102682,10.6,0,0
102683,%,0,0
102684,for,0,0
102685,aripiprazole,1,1
102686,and,0,0
102687,5.9,0,0
102688,%,0,0
102689,for,0,0
102690,placebo,1,1
102691,.,1,0
102692,Extrapyramidal,0,0
102693,symptom-related,0,0
102694,AE,0,0
102695,rates,0,0
102696,were,0,0
102697,14.9,0,0
102698,%,0,0
102699,for,0,0
102700,aripiprazole,1,1
102701,and,0,0
102702,8.0,0,0
102703,%,0,0
102704,for,0,0
102705,placebo,1,1
102706,.,1,0
102707,No,0,0
102708,serious,0,0
102709,AEs,0,0
102710,were,0,0
102711,reported,0,0
102712,.,0,0
102713,Mean,0,0
102714,weight,0,0
102715,gain,0,0
102716,was,0,0
102717,2.0,0,0
102718,kg,0,0
102719,on,0,0
102720,aripiprazole,0,1
102721,and,0,0
102722,0.8,0,1
102723,kg,0,0
102724,on,0,0
102725,placebo,0,1
102726,at,0,0
102727,week,0,0
102728,8,0,0
102729,.,0,0
102730,CONCLUSIONS,0,0
102731,Aripiprazole,1,1
102732,was,0,0
102733,efficacious,0,0
102734,in,0,0
102735,children,0,0
102736,and,0,0
102737,adolescents,0,0
102738,with,0,0
102739,irritability,0,0
102740,associated,0,0
102741,with,0,0
102742,autistic,0,0
102743,disorder,0,0
102744,and,0,0
102745,was,0,0
102746,generally,0,0
102747,safe,0,0
102748,and,0,0
102749,well,0,0
102750,tolerated,0,0
102751,.,0,0
102752,Comparison,0,0
102753,between,0,0
102754,obtained,0,0
102755,mydriasis,0,0
102756,in,0,0
102757,type,0,0
102758,2,0,0
102759,diabetics,0,0
102760,and,0,0
102761,non-diabetic,0,0
102762,patients,0,0
102763,.,0,0
102764,BACKGROUND/AIMS,0,0
102765,To,0,0
102766,evaluate,0,0
102767,and,0,0
102768,compare,0,0
102769,obtained,0,0
102770,mydriasis,0,0
102771,with,0,0
102772,phenylephrine,1,1
102773,10,0,0
102774,%,0,0
102775,associated,0,0
102776,with,0,0
102777,tropicamide,1,1
102778,1,0,0
102779,%,0,0
102780,in,0,0
102781,type,0,0
102782,2,0,0
102783,diabetics,0,0
102784,and,0,0
102785,non-diabetic,0,0
102786,patients,0,0
102787,.,0,0
102788,METHODS,0,0
102789,A,0,0
102790,total,0,0
102791,of,0,0
102792,50,0,1
102793,patients,0,0
102794,(,0,0
102795,100,0,0
102796,eyes,0,0
102797,),0,0
102798,scheduled,0,0
102799,for,0,0
102800,fundoscopy,0,1
102801,were,0,0
102802,dilated,0,0
102803,with,0,0
102804,phenylephrine,1,1
102805,10,1,1
102806,%,1,0
102807,and,1,0
102808,yropicamide,1,1
102809,1,1,1
102810,%,1,0
102811,(,0,0
102812,group,0,0
102813,0,0,0
102814,:,0,0
102815,n,0,0
102816,=,0,0
102817,20,0,0
102818,type,0,0
102819,2,0,0
102820,diabetic,0,0
102821,patients,0,0
102822,",",0,0
102823,40,0,0
102824,eyes,0,0
102825,",",0,0
102826,and,0,0
102827,group,0,0
102828,1,0,0
102829,:,0,0
102830,n,0,0
102831,=,0,0
102832,30,0,0
102833,non-diabetic,0,0
102834,patients,0,0
102835,",",0,0
102836,60,0,0
102837,eyes,0,0
102838,),0,0
102839,.,0,0
102840,Only,0,0
102841,one,0,0
102842,drop,0,0
102843,per,0,0
102844,eye,0,0
102845,of,0,0
102846,each,0,0
102847,drug,0,0
102848,was,0,0
102849,administered,0,0
102850,.,0,0
102851,In,0,0
102852,both,0,0
102853,groups,0,0
102854,",",0,0
102855,pupil,0,1
102856,diameter,0,0
102857,was,0,0
102858,measured,0,0
102859,after,0,0
102860,40,0,0
102861,minutes,0,0
102862,of,0,0
102863,eye,0,0
102864,drops,0,1
102865,instillation,0,0
102866,.,0,0
102867,RESULTS,0,0
102868,Both,0,1
102869,groups,0,0
102870,were,0,0
102871,similar,0,0
102872,regarding,0,0
102873,age,0,0
102874,(,0,1
102875,p,0,0
102876,=,0,0
102877,0.06,0,0
102878,",",0,0
102879,Mann-Whitney,0,0
102880,test,0,0
102881,),0,0
102882,.,0,0
102883,Mean,0,0
102884,pupil,0,1
102885,diameter,0,0
102886,in,0,0
102887,group,0,0
102888,0,0,0
102889,was,0,0
102890,8.57,0,0
102891,and,0,0
102892,8.73,0,0
102893,in,0,0
102894,group,0,0
102895,1,0,0
102896,.,0,0
102897,There,0,0
102898,was,0,0
102899,no,0,0
102900,statistic,0,0
102901,difference,0,0
102902,between,0,0
102903,both,0,0
102904,groups,0,0
102905,(,0,0
102906,p,0,0
102907,=,0,0
102908,0.44,0,0
102909,),0,0
102910,.,0,0
102911,Pupil,0,1
102912,diameter,0,0
102913,was,0,0
102914,greater,0,0
102915,than,0,0
102916,7,0,0
102917,mm,0,0
102918,in,0,0
102919,all,0,0
102920,patients,0,0
102921,(,0,0
102922,100,0,1
102923,%,0,0
102924,),0,0
102925,.,0,0
102926,CONCLUSION,0,0
102927,When,0,0
102928,an,0,0
102929,appropriate,0,1
102930,drug,0,1
102931,combination,0,1
102932,is,0,0
102933,used,0,0
102934,",",0,0
102935,diabetic,0,0
102936,patients,0,0
102937,can,0,0
102938,achieve,0,0
102939,mydriasis,0,0
102940,as,0,0
102941,satisfactory,0,0
102942,as,0,0
102943,non-diabetic,0,0
102944,patients,0,0
102945,",",0,0
102946,allowing,0,0
102947,adequate,0,0
102948,fundus,0,1
102949,examination,0,0
102950,and/or,0,0
102951,retinopathy,0,0
102952,treatment,0,0
102953,.,0,0
102954,Different,0,0
102955,therapeutic,0,0
102956,modalities,0,1
102957,for,0,0
102958,treatment,0,0
102959,of,0,0
102960,melasma,0,0
102961,.,0,0
102962,BACKGROUND,0,0
102963,Chemical,1,0
102964,peels,1,1
102965,and,0,0
102966,topical,1,1
102967,depigmenting,1,1
102968,agents,1,1
102969,have,0,0
102970,become,0,0
102971,a,0,0
102972,popular,0,1
102973,modality,0,0
102974,in,0,0
102975,the,0,0
102976,treatment,0,0
102977,of,0,0
102978,melasma,0,0
102979,.,0,0
102980,AIMS,0,0
102981,To,0,0
102982,compare,0,0
102983,the,0,0
102984,clinical,0,0
102985,efficacy,0,0
102986,of,0,0
102987,trichloroacetic,1,1
102988,acid,1,1
102989,peel,1,1
102990,20,1,0
102991,%,1,0
102992,vs,1,0
102993,.,0,0
102994,Jessner,1,0
102995,'s,1,0
102996,solution,1,1
102997,peel,1,1
102998,vs.,1,0
102999,the,1,0
103000,topical,1,1
103001,mixture,1,1
103002,of,1,0
103003,hydroquinone,1,1
103004,2,1,0
103005,%,1,0
103006,and,1,0
103007,kojic,1,1
103008,acid,1,1
103009,.,1,0
103010,PATIENTS,0,0
103011,AND,0,0
103012,METHODS,0,0
103013,Forty,0,0
103014,five,0,0
103015,patients,0,0
103016,with,0,0
103017,melasma,0,0
103018,were,0,0
103019,randomly,0,0
103020,assigned,0,0
103021,into,0,0
103022,three,0,0
103023,groups,0,0
103024,of,0,0
103025,fifteen,0,0
103026,patients,0,0
103027,each,0,0
103028,.,0,0
103029,Group,0,0
103030,A,0,0
103031,received,0,1
103032,Jessner,1,0
103033,'s,1,0
103034,solution,1,1
103035,peel,1,1
103036,",",0,0
103037,group,0,0
103038,B,0,1
103039,received,0,1
103040,trichloroacetic,1,1
103041,acid,1,1
103042,peel,1,1
103043,20,1,0
103044,%,1,0
103045,",",0,0
103046,and,0,0
103047,group,0,0
103048,C,0,1
103049,received,0,1
103050,topical,1,1
103051,hydroquinone,1,1
103052,2,1,1
103053,%,1,0
103054,and,1,0
103055,kojic,1,1
103056,acid,1,1
103057,.,1,0
103058,All,0,0
103059,patients,0,0
103060,were,0,0
103061,seen,0,0
103062,in,0,0
103063,follow-up,0,0
103064,period,0,0
103065,after,0,0
103066,16,0,0
103067,weeks,0,0
103068,;,0,0
103069,clinical,0,0
103070,evaluation,0,0
103071,using,0,0
103072,Melasma,0,0
103073,Area,0,1
103074,and,0,0
103075,Severity,0,0
103076,Index,0,1
103077,(,0,1
103078,MASI,0,1
103079,),0,1
103080,score,0,0
103081,and,0,0
103082,photography,0,1
103083,were,0,0
103084,recorded,0,0
103085,before,0,0
103086,and,0,0
103087,after,0,0
103088,treatment,0,0
103089,and,0,0
103090,after,0,0
103091,16,0,0
103092,weeks,0,0
103093,.,0,0
103094,RESULTS,0,0
103095,There,0,0
103096,was,0,0
103097,a,0,0
103098,decrease,0,0
103099,in,0,0
103100,MASI,0,1
103101,score,0,0
103102,in,0,0
103103,all,0,0
103104,three,0,0
103105,groups,0,0
103106,after,0,0
103107,treatment,0,0
103108,and,0,0
103109,after,0,0
103110,follow-up,0,0
103111,period,0,0
103112,but,0,0
103113,after,0,0
103114,treatment,0,1
103115,MASI,0,1
103116,score,0,0
103117,was,0,0
103118,statistically,0,0
103119,significantly,0,0
103120,lower,0,0
103121,in,0,0
103122,group,0,0
103123,A,0,0
103124,than,0,0
103125,group,0,0
103126,C,0,1
103127,(,0,0
103128,P,0,0
103129,=,0,0
103130,0.01,0,0
103131,),0,0
103132,",",0,0
103133,and,0,0
103134,it,0,0
103135,was,0,0
103136,also,0,0
103137,statistically,0,0
103138,significantly,0,0
103139,lower,0,0
103140,in,0,0
103141,group,0,0
103142,B,0,1
103143,than,0,0
103144,group,0,0
103145,C,0,1
103146,(,0,0
103147,P,0,0
103148,<,0,0
103149,0.001,0,0
103150,),0,0
103151,but,0,0
103152,there,0,0
103153,was,0,0
103154,no,0,0
103155,statistically,0,0
103156,significant,0,0
103157,difference,0,0
103158,between,0,0
103159,groups,0,0
103160,A,0,0
103161,and,0,0
103162,B,0,0
103163,.,0,0
103164,After,0,0
103165,the,0,0
103166,follow-up,0,0
103167,period,0,0
103168,",",0,0
103169,MASI,0,1
103170,score,0,0
103171,was,0,0
103172,statistically,0,0
103173,significantly,0,0
103174,lower,0,0
103175,in,0,0
103176,group,0,0
103177,A,0,0
103178,than,0,0
103179,group,0,0
103180,C,0,1
103181,(,0,0
103182,P,0,0
103183,<,0,0
103184,0.001,0,0
103185,),0,0
103186,",",0,0
103187,statistically,0,0
103188,significantly,0,0
103189,lower,0,0
103190,in,0,0
103191,group,0,0
103192,B,0,1
103193,than,0,0
103194,group,0,0
103195,C,0,1
103196,(,0,0
103197,P,0,0
103198,<,0,0
103199,0.001,0,0
103200,),0,0
103201,",",0,0
103202,and,0,0
103203,statistically,0,0
103204,significantly,0,0
103205,lower,0,0
103206,in,0,0
103207,group,0,0
103208,B,0,1
103209,than,0,0
103210,group,0,0
103211,A,0,0
103212,(,0,0
103213,P,0,0
103214,=,0,0
103215,0.035,0,0
103216,),0,0
103217,.,0,0
103218,The,0,0
103219,statistical,0,0
103220,analysis,0,0
103221,was,0,0
103222,done,0,0
103223,through,0,0
103224,one-way,0,1
103225,anova,0,0
103226,followed,0,1
103227,by,0,0
103228,least,0,0
103229,significant,0,0
103230,difference,0,0
103231,(,0,1
103232,LSD,0,1
103233,),0,0
103234,.,0,0
103235,CONCLUSION,0,0
103236,Trichloroacetic,1,1
103237,acid,1,1
103238,20,1,0
103239,%,1,0
103240,showed,0,0
103241,better,0,0
103242,results,0,0
103243,than,0,0
103244,Jessner,1,0
103245,'s,1,0
103246,solution,1,1
103247,as,0,0
103248,peeling,0,1
103249,agent,0,0
103250,and,0,0
103251,hydroquinone,1,1
103252,2,1,0
103253,%,1,0
103254,with,1,0
103255,kojic,1,1
103256,acid,1,1
103257,as,0,0
103258,a,0,0
103259,topical,0,1
103260,agent,0,0
103261,in,0,0
103262,the,0,0
103263,treatment,0,0
103264,of,0,0
103265,melasma,0,0
103266,.,0,0
103267,Sinemet,1,1
103268,CR,1,1
103269,in,0,0
103270,Parkinson,0,0
103271,'s,0,0
103272,disease,0,0
103273,.,0,0
103274,Sinemet,1,1
103275,CR,1,1
103276,",",0,0
103277,a,0,0
103278,controlled,0,0
103279,release,0,0
103280,carbidopa/levodopa,1,1
103281,preparation,1,1
103282,",",0,0
103283,was,0,0
103284,compared,0,0
103285,to,0,0
103286,conventional,0,1
103287,carbidopa/levodopa,1,1
103288,in,0,0
103289,a,0,0
103290,double,0,1
103291,blind,0,0
103292,",",0,0
103293,placebo-controlled,1,1
103294,trial,0,0
103295,.,0,0
103296,Comparable,0,0
103297,clinical,0,0
103298,benefits,0,0
103299,and,0,0
103300,adverse,0,0
103301,effects,0,0
103302,were,0,0
103303,noted,0,0
103304,with,0,0
103305,the,0,0
103306,two,0,0
103307,medications,0,0
103308,.,0,0
103309,However,0,0
103310,significantly,0,0
103311,less,0,0
103312,frequent,0,0
103313,dosing,0,0
103314,was,0,0
103315,necessary,0,0
103316,with,0,0
103317,Sinemet,0,1
103318,CR,0,1
103319,.,0,0
103320,The,0,0
103321,6,0,0
103322,minute,0,0
103323,walk,0,0
103324,in,0,0
103325,idiopathic,0,0
103326,pulmonary,0,0
103327,fibrosis,0,0
103328,:,0,0
103329,longitudinal,0,0
103330,changes,0,0
103331,and,0,0
103332,minimum,0,0
103333,important,0,0
103334,difference,0,0
103335,.,0,0
103336,RATIONALE,0,0
103337,The,0,0
103338,response,0,0
103339,characteristics,0,0
103340,of,0,0
103341,the,0,0
103342,6,1,0
103343,minute,1,0
103344,walk,1,1
103345,test,1,1
103346,(,1,1
103347,6MWT,1,0
103348,),1,0
103349,in,0,0
103350,studies,0,0
103351,of,0,0
103352,idiopathic,0,0
103353,pulmonary,0,0
103354,fibrosis,0,0
103355,(,0,1
103356,IPF,0,1
103357,),0,1
103358,are,0,0
103359,only,0,0
103360,poorly,0,0
103361,understood,0,0
103362,",",0,0
103363,and,0,0
103364,the,0,0
103365,change,0,0
103366,in,0,0
103367,walk,0,0
103368,distance,0,0
103369,that,0,0
103370,constitutes,0,0
103371,the,0,0
103372,minimum,0,0
103373,important,0,0
103374,difference,0,0
103375,(,0,1
103376,MID,0,0
103377,),0,1
103378,over,0,0
103379,time,0,0
103380,is,0,0
103381,unknown,0,0
103382,.,0,0
103383,OBJECTIVES,0,0
103384,To,0,0
103385,examine,0,0
103386,changes,0,0
103387,over,0,0
103388,time,0,0
103389,in,0,0
103390,distance,0,0
103391,walked,0,0
103392,(,0,0
103393,ie,0,0
103394,",",0,0
103395,6MWD,0,0
103396,),0,0
103397,during,0,0
103398,the,0,0
103399,6MWT,1,0
103400,and,0,0
103401,to,0,0
103402,estimate,0,0
103403,the,0,0
103404,change,0,0
103405,in,0,0
103406,distance,0,0
103407,that,0,0
103408,constitutes,0,0
103409,the,0,0
103410,MID,0,0
103411,in,0,0
103412,patients,0,0
103413,with,0,0
103414,IPF,0,1
103415,.,0,0
103416,METHODS,0,0
103417,Data,0,0
103418,from,0,0
103419,a,0,0
103420,recently,0,0
103421,completed,0,0
103422,trial,0,0
103423,that,0,0
103424,included,0,0
103425,subjects,0,0
103426,with,0,0
103427,IPF,0,1
103428,who,0,0
103429,completed,0,0
103430,the,0,0
103431,6MWT,1,0
103432,",",0,0
103433,Saint,0,0
103434,George,0,0
103435,'s,0,0
103436,Respiratory,0,0
103437,Questionnaire,0,1
103438,(,0,1
103439,SGRQ,0,1
103440,),0,1
103441,and,0,0
103442,forced,0,1
103443,vital,0,0
103444,capacity,0,0
103445,(,0,1
103446,FVC,0,1
103447,),0,1
103448,at,0,0
103449,6,0,0
103450,and,0,0
103451,12,0,0
103452,months,0,0
103453,were,0,0
103454,used,0,0
103455,to,0,0
103456,examine,0,0
103457,longitudinal,0,0
103458,changes,0,0
103459,in,0,0
103460,6MWD,0,0
103461,.,0,0
103462,Both,0,1
103463,anchor-,0,0
103464,and,0,0
103465,distribution-based,0,0
103466,approaches,0,0
103467,as,0,0
103468,well,0,0
103469,as,0,0
103470,linear,0,0
103471,regression,0,0
103472,analyses,0,0
103473,were,0,0
103474,used,0,0
103475,to,0,0
103476,determine,0,0
103477,the,0,0
103478,MID,0,0
103479,for,0,0
103480,6MWD,0,0
103481,.,0,0
103482,The,0,0
103483,SGRQ,0,1
103484,Total,0,1
103485,score,0,0
103486,and,0,0
103487,FVC,0,1
103488,were,0,0
103489,used,0,0
103490,as,0,0
103491,clinical,0,0
103492,anchors,0,0
103493,.,0,0
103494,MAIN,0,0
103495,RESULTS,0,0
103496,Among,0,0
103497,123,0,0
103498,subjects,0,0
103499,alive,0,0
103500,and,0,0
103501,able,0,0
103502,to,0,0
103503,complete,0,0
103504,the,0,0
103505,6MWT,0,0
103506,at,0,0
103507,both,0,0
103508,follow-up,0,0
103509,time,0,0
103510,points,0,0
103511,",",0,0
103512,6MWD,0,0
103513,did,0,0
103514,not,0,0
103515,change,0,0
103516,significantly,0,0
103517,over,0,0
103518,time,0,0
103519,(,0,0
103520,378.1,0,0
103521,m,0,0
103522,at,0,0
103523,baseline,0,0
103524,vs,0,0
103525,376.8,0,0
103526,m,0,0
103527,at,0,0
103528,6,0,0
103529,months,0,0
103530,vs,0,0
103531,361.3,0,0
103532,m,0,0
103533,at,0,0
103534,12,0,0
103535,months,0,0
103536,",",0,0
103537,p=0.5,0,0
103538,),0,0
103539,.,0,0
103540,The,0,0
103541,point,0,0
103542,estimate,0,0
103543,for,0,0
103544,the,0,0
103545,6MWD,0,0
103546,MID,0,0
103547,was,0,0
103548,28,0,0
103549,m,0,0
103550,with,0,0
103551,a,0,0
103552,range,0,0
103553,of,0,0
103554,10.8-58.5,0,0
103555,m.,0,1
103556,CONCLUSION,0,1
103557,In,0,0
103558,a,0,0
103559,group,0,0
103560,of,0,0
103561,patients,0,0
103562,with,0,0
103563,IPF,0,1
103564,with,0,0
103565,moderate,0,0
103566,physiological,0,0
103567,impairment,0,0
103568,",",0,0
103569,for,0,0
103570,those,0,0
103571,alive,0,0
103572,and,0,0
103573,able,0,0
103574,to,0,0
103575,complete,0,0
103576,a,0,0
103577,6MWT,0,0
103578,",",0,0
103579,6MWD,0,0
103580,does,0,0
103581,not,0,0
103582,change,0,0
103583,over,0,0
103584,12,0,0
103585,months,0,0
103586,.,0,0
103587,At,0,0
103588,the,0,0
103589,population,0,0
103590,level,0,0
103591,",",0,0
103592,the,0,0
103593,MID,0,0
103594,for,0,0
103595,6MWD,0,0
103596,appears,0,0
103597,to,0,0
103598,be,0,0
103599,approximately,0,0
103600,28,0,0
103601,m.,0,0
103602,Further,0,0
103603,investigation,0,0
103604,using,0,0
103605,other,0,0
103606,anchors,0,1
103607,and,0,0
103608,derivation,0,0
103609,methods,0,1
103610,is,0,0
103611,required,0,0
103612,to,0,0
103613,refine,0,0
103614,estimates,0,0
103615,of,0,0
103616,the,0,0
103617,MID,0,0
103618,for,0,0
103619,6MWD,0,0
103620,in,0,0
103621,this,0,0
103622,patient,0,0
103623,population,0,0
103624,.,0,0
103625,A,0,0
103626,multi-center,0,0
103627,",",0,0
103628,randomized,0,0
103629,",",0,0
103630,controlled,0,0
103631,trial,0,0
103632,of,0,0
103633,parenteral,1,1
103634,nutrition,1,1
103635,titrated,0,1
103636,to,0,0
103637,resting,0,0
103638,energy,0,1
103639,expenditure,0,0
103640,in,0,0
103641,children,0,0
103642,undergoing,0,0
103643,hematopoietic,0,1
103644,stem,0,1
103645,cell,0,0
103646,transplantation,0,1
103647,(,0,1
103648,PNTREE,0,1
103649,),0,1
103650,:,0,1
103651,rationale,0,0
103652,and,0,0
103653,design,0,0
103654,.,0,0
103655,BACKGROUND,0,0
103656,Children,0,0
103657,undergoing,0,0
103658,hematopoietic,0,1
103659,stem,0,1
103660,cell,0,0
103661,transplantation,0,1
103662,(,0,1
103663,HSCT,0,1
103664,),0,1
103665,frequently,0,0
103666,require,0,0
103667,prolonged,0,0
103668,courses,0,1
103669,of,0,0
103670,parenteral,1,1
103671,nutrition,1,1
103672,(,1,1
103673,PN,1,1
103674,),1,1
103675,as,0,0
103676,a,0,0
103677,consequence,0,0
103678,of,0,0
103679,gastrointestinal,0,0
103680,dysfunction,0,0
103681,related,0,0
103682,to,0,0
103683,preparative,0,1
103684,chemotherapy,0,1
103685,and,0,0
103686,radiation,0,1
103687,.,0,0
103688,PN,0,1
103689,has,0,0
103690,been,0,0
103691,associated,0,0
103692,with,0,0
103693,shorter,0,0
103694,engraftment,0,0
103695,time,0,0
103696,and,0,0
103697,decreased,0,0
103698,mortality,0,0
103699,during,0,0
103700,HSCT,0,1
103701,",",0,0
103702,however,0,0
103703,",",0,0
103704,it,0,0
103705,is,0,0
103706,also,0,0
103707,linked,0,0
103708,with,0,0
103709,complications,0,0
103710,",",0,0
103711,including,0,0
103712,infections,0,0
103713,",",0,0
103714,liver,0,0
103715,disease,0,0
103716,",",0,0
103717,and,0,0
103718,metabolic,0,0
103719,disturbances,0,0
103720,.,0,0
103721,Some,0,0
103722,of,0,0
103723,these,0,0
103724,complications,0,0
103725,may,0,0
103726,be,0,0
103727,a,0,0
103728,result,0,0
103729,of,0,0
103730,providing,0,0
103731,PN,0,1
103732,in,0,0
103733,excess,0,0
103734,of,0,0
103735,nutrient,0,0
103736,requirements,0,0
103737,.,0,0
103738,We,0,0
103739,previously,0,0
103740,described,0,0
103741,significant,0,0
103742,reductions,0,0
103743,in,0,0
103744,resting,0,0
103745,energy,0,1
103746,expenditure,0,0
103747,(,0,1
103748,REE,0,1
103749,),0,0
103750,",",0,0
103751,as,0,0
103752,measured,0,0
103753,by,0,0
103754,indirect,0,0
103755,calorimetry,0,1
103756,",",0,0
103757,over,0,0
103758,the,0,0
103759,course,0,0
103760,of,0,0
103761,HSCT,0,1
103762,.,0,0
103763,We,0,0
103764,also,0,0
103765,documented,0,0
103766,a,0,0
103767,decline,0,0
103768,in,0,0
103769,mid-arm,0,0
103770,muscle,0,0
103771,area,0,0
103772,",",0,0
103773,suggesting,0,0
103774,depletion,0,0
103775,of,0,0
103776,muscle,0,0
103777,mass,0,0
103778,",",0,0
103779,while,0,0
103780,triceps,0,0
103781,skinfold,0,0
103782,",",0,0
103783,a,0,0
103784,marker,0,0
103785,of,0,0
103786,fat,0,0
103787,stores,0,0
103788,",",0,0
103789,was,0,0
103790,unchanged,0,0
103791,.,0,0
103792,These,0,0
103793,results,0,0
103794,suggested,0,0
103795,the,0,0
103796,need,0,0
103797,for,0,0
103798,further,0,0
103799,study,0,0
103800,of,0,0
103801,energy,0,0
103802,expenditure,0,0
103803,",",0,0
103804,body,0,0
103805,composition,0,0
103806,and,0,0
103807,nutritional,0,1
103808,intake,0,0
103809,in,0,0
103810,this,0,0
103811,group,0,0
103812,of,0,0
103813,high,0,0
103814,risk,0,0
103815,patients,0,0
103816,.,0,0
103817,DESIGN,0,0
103818,AND,0,0
103819,HYPOTHESIS,0,1
103820,We,0,0
103821,hypothesize,0,0
103822,that,0,0
103823,changes,0,0
103824,in,0,0
103825,body,0,0
103826,composition,0,0
103827,affect,0,0
103828,REE,0,1
103829,during,0,0
103830,HSCT,0,1
103831,",",0,0
103832,and,0,0
103833,that,0,0
103834,standard,0,1
103835,nutritional,0,1
103836,support,0,0
103837,may,0,0
103838,lead,0,0
103839,to,0,0
103840,overfeeding,0,0
103841,.,0,0
103842,We,0,0
103843,are,0,0
103844,performing,0,0
103845,a,0,0
103846,randomized,0,0
103847,controlled,0,0
103848,trial,0,0
103849,of,0,0
103850,parenteral,1,1
103851,nutrition,1,1
103852,among,0,0
103853,children,0,0
103854,undergoing,0,0
103855,allogeneic,0,1
103856,HSCT,0,1
103857,.,0,0
103858,Subjects,0,0
103859,are,0,0
103860,randomized,0,0
103861,to,0,0
103862,receive,1,0
103863,PN,1,1
103864,designed,1,0
103865,to,1,0
103866,provide,1,0
103867,100,1,0
103868,%,1,0
103869,of,1,0
103870,measured,1,0
103871,REE,1,1
103872,",",1,0
103873,or,1,1
103874,standard,1,1
103875,PN,1,1
103876,",",1,0
103877,i.e.,1,0
103878,",",0,0
103879,140,1,0
103880,%,1,0
103881,of,1,0
103882,estimated,1,0
103883,energy,1,0
103884,expenditure,1,0
103885,.,1,0
103886,The,0,0
103887,primary,0,0
103888,outcome,0,0
103889,variable,0,0
103890,is,0,0
103891,change,0,0
103892,in,0,0
103893,percent,0,0
103894,body,0,0
103895,fat,0,0
103896,.,0,0
103897,Secondary,0,0
103898,outcomes,0,0
103899,include,0,0
103900,glycemic,0,0
103901,control,0,1
103902,and,0,0
103903,frequency,0,0
103904,of,0,0
103905,infections,0,0
103906,",",0,0
103907,changes,0,0
103908,in,0,0
103909,REE,0,1
103910,and,0,0
103911,body,0,0
103912,composition,0,0
103913,.,0,0
103914,CONCLUSION,0,0
103915,This,0,0
103916,study,0,0
103917,will,0,0
103918,provide,0,0
103919,unique,0,0
103920,and,0,0
103921,comprehensive,0,0
103922,nutritional,0,1
103923,data,0,0
103924,and,0,0
103925,its,0,0
103926,results,0,0
103927,will,0,0
103928,guide,0,0
103929,nutritional,0,0
103930,therapy,0,1
103931,for,0,0
103932,children,0,0
103933,undergoing,0,0
103934,HSCT,0,1
103935,and,0,0
103936,possibly,0,0
103937,other,0,0
103938,catabolic,0,0
103939,patients,0,0
103940,.,0,0
103941,Optimum,0,1
103942,frequency,0,0
103943,of,0,0
103944,exercise,1,1
103945,for,0,0
103946,bone,0,0
103947,health,0,0
103948,:,0,0
103949,randomised,0,0
103950,controlled,0,0
103951,trial,0,0
103952,of,0,0
103953,a,0,0
103954,high-impact,0,0
103955,unilateral,0,0
103956,intervention,0,1
103957,.,0,0
103958,INTRODUCTION,0,0
103959,Exercise,1,1
103960,can,0,0
103961,increase,0,0
103962,bone,0,0
103963,strength,0,0
103964,",",0,0
103965,but,0,0
103966,to,0,0
103967,be,0,0
103968,effective,0,0
103969,in,0,0
103970,reducing,0,0
103971,fracture,0,0
103972,risk,0,0
103973,",",0,0
103974,exercise,1,1
103975,must,0,0
103976,be,0,0
103977,feasible,0,0
103978,enough,0,0
103979,to,0,0
103980,be,0,0
103981,adopted,0,0
103982,into,0,0
103983,daily,0,1
103984,life,0,0
103985,and,0,0
103986,influence,0,0
103987,potentially,0,0
103988,vulnerable,0,0
103989,skeletal,0,0
103990,sites,0,0
103991,such,0,0
103992,as,0,0
103993,the,0,0
103994,superolateral,0,0
103995,cortex,0,0
103996,of,0,0
103997,the,0,0
103998,femoral,0,1
103999,neck,0,0
104000,",",0,0
104001,where,0,0
104002,thinning,0,0
104003,is,0,0
104004,associated,0,0
104005,with,0,0
104006,increased,0,0
104007,fracture,0,0
104008,risk,0,0
104009,.,0,0
104010,Brief,1,0
104011,",",1,0
104012,high-impact,1,0
104013,exercise,1,1
104014,increases,0,0
104015,femoral,0,1
104016,neck,0,0
104017,bone,0,0
104018,density,0,0
104019,but,0,0
104020,the,0,0
104021,optimal,0,0
104022,frequency,0,0
104023,of,0,0
104024,such,0,0
104025,exercise,0,1
104026,and,0,0
104027,the,0,0
104028,location,0,0
104029,of,0,0
104030,bone,0,0
104031,accrual,0,0
104032,is,0,0
104033,unknown,0,0
104034,.,0,0
104035,This,0,0
104036,study,0,0
104037,thus,0,0
104038,examined,0,0
104039,(,0,0
104040,1,0,0
104041,),0,0
104042,the,0,0
104043,effectiveness,0,0
104044,of,0,0
104045,different,0,0
104046,weekly,0,1
104047,frequencies,0,0
104048,of,0,0
104049,exercise,0,1
104050,on,0,0
104051,femoral,0,1
104052,neck,0,1
104053,BMD,0,1
104054,and,0,0
104055,(,0,0
104056,2,0,0
104057,),0,0
104058,whether,0,0
104059,BMD,0,0
104060,change,0,0
104061,differed,0,0
104062,between,0,0
104063,hip,0,0
104064,sites,0,0
104065,using,0,0
104066,a,0,0
104067,high-impact,0,0
104068,",",0,0
104069,unilateral,0,0
104070,intervention,0,1
104071,.,0,0
104072,METHODS,0,0
104073,Healthy,0,0
104074,premenopausal,0,1
104075,women,0,0
104076,were,0,0
104077,randomly,0,0
104078,assigned,0,0
104079,to,0,0
104080,exercise,1,1
104081,0,0,0
104082,",",0,0
104083,2,0,0
104084,",",0,0
104085,4,0,0
104086,",",0,0
104087,or,0,0
104088,7,0,0
104089,days/week,0,1
104090,for,0,0
104091,6,0,0
104092,months,0,0
104093,.,0,0
104094,The,0,0
104095,exercise,1,1
104096,intervention,1,1
104097,incorporated,0,0
104098,50,0,0
104099,multidirectional,0,0
104100,hops,0,0
104101,on,0,0
104102,one,0,0
104103,randomly,0,0
104104,selected,0,0
104105,leg,0,0
104106,.,0,0
104107,BMD,0,0
104108,was,0,0
104109,measured,0,0
104110,by,0,0
104111,DXA,0,1
104112,at,0,0
104113,baseline,0,0
104114,and,0,0
104115,after,0,0
104116,6,0,0
104117,months,0,0
104118,of,0,0
104119,exercise,0,1
104120,.,0,0
104121,Changes,0,0
104122,in,0,0
104123,the,0,0
104124,exercise,0,1
104125,leg,0,0
104126,were,0,0
104127,compared,0,0
104128,between,0,0
104129,groups,0,0
104130,using,0,0
104131,ANCOVA,0,0
104132,",",0,0
104133,with,0,0
104134,change,0,0
104135,in,0,0
104136,the,0,0
104137,control,0,1
104138,leg,0,0
104139,and,0,0
104140,baseline,0,0
104141,BMD,0,0
104142,as,0,0
104143,covariates,0,0
104144,.,0,0
104145,RM-MANOVA,0,0
104146,was,0,0
104147,conducted,0,0
104148,to,0,0
104149,determine,0,0
104150,whether,0,0
104151,bone,0,0
104152,changes,0,0
104153,from,0,0
104154,exercise,1,1
104155,differed,0,0
104156,between,0,0
104157,hip,0,0
104158,sites,0,0
104159,.,0,0
104160,RESULTS,0,0
104161,61,0,0
104162,women,0,0
104163,(,0,0
104164,age,0,0
104165,33.6+/-11.1,0,0
104166,years,0,0
104167,),0,0
104168,completed,0,0
104169,the,0,0
104170,intervention,0,1
104171,.,0,0
104172,Compliance,0,0
104173,amongst,0,0
104174,exercisers,0,0
104175,was,0,0
104176,86.7+/-10.6,0,0
104177,%,0,0
104178,.,0,0
104179,Peak,0,0
104180,ground,0,0
104181,reaction,0,1
104182,forces,0,0
104183,during,0,0
104184,exercise,0,1
104185,increased,0,0
104186,from,0,0
104187,2.5,0,0
104188,to,0,0
104189,2.8,0,0
104190,times,0,0
104191,body,0,0
104192,weight,0,0
104193,.,0,0
104194,The,0,0
104195,change,0,0
104196,in,0,0
104197,femoral,0,1
104198,neck,0,1
104199,BMD,0,0
104200,in,0,0
104201,the,0,0
104202,exercise,1,1
104203,limb,0,0
104204,(,0,0
104205,adjusted,0,0
104206,for,0,0
104207,change,0,0
104208,in,0,0
104209,the,0,0
104210,control,0,1
104211,limb,0,0
104212,and,0,0
104213,baseline,0,0
104214,BMD,0,0
104215,),0,0
104216,differed,0,0
104217,between,0,0
104218,groups,0,0
104219,(,0,0
104220,p=0.015,0,0
104221,),0,1
104222,",",0,0
104223,being,0,0
104224,-0.3,0,0
104225,%,0,0
104226,(,0,0
104227,-1.2,0,0
104228,to,0,0
104229,0.6,0,0
104230,),0,0
104231,",",0,0
104232,0.0,0,0
104233,%,0,0
104234,(,0,0
104235,-1.0,0,0
104236,to,0,0
104237,1.0,0,0
104238,),0,0
104239,",",0,0
104240,0.9,0,1
104241,%,0,0
104242,(,0,0
104243,-0.1,0,0
104244,to,0,0
104245,2.0,0,0
104246,),0,0
104247,and,0,0
104248,1.8,0,0
104249,%,0,0
104250,(,0,0
104251,0.8,0,0
104252,to,0,0
104253,2.8,0,0
104254,),0,0
104255,in,0,0
104256,those,0,0
104257,exercising,0,1
104258,0,0,0
104259,",",0,0
104260,2,0,0
104261,",",0,0
104262,4,0,0
104263,and,0,0
104264,7,0,0
104265,days,0,0
104266,per,0,0
104267,week,0,0
104268,",",0,0
104269,respectively,0,0
104270,.,0,0
104271,When,0,0
104272,BMD,0,0
104273,changes,0,0
104274,at,0,0
104275,upper,0,0
104276,neck,0,0
104277,",",0,0
104278,lower,0,0
104279,neck,0,0
104280,and,0,0
104281,trochanter,0,0
104282,were,0,0
104283,compared,0,0
104284,using,0,0
104285,RM-MANOVA,0,1
104286,",",0,0
104287,a,0,0
104288,significant,0,0
104289,exercise,0,1
104290,effect,0,0
104291,was,0,0
104292,observed,0,0
104293,(,0,1
104294,p=0.048,0,0
104295,),0,1
104296,",",0,0
104297,but,0,0
104298,this,0,0
104299,did,0,0
104300,not,0,0
104301,differ,0,0
104302,significantly,0,0
104303,between,0,0
104304,sites,0,0
104305,(,0,0
104306,p=0.439,0,0
104307,),0,1
104308,despite,0,0
104309,greatest,0,0
104310,mean,0,0
104311,increases,0,0
104312,at,0,0
104313,the,0,0
104314,upper,0,0
104315,femoral,0,1
104316,neck,0,0
104317,.,0,0
104318,CONCLUSIONS,0,0
104319,Brief,0,0
104320,",",0,0
104321,daily,0,1
104322,hopping,0,0
104323,exercises,1,1
104324,increased,0,0
104325,femoral,0,1
104326,neck,0,1
104327,BMD,0,0
104328,in,0,0
104329,premenopausal,0,1
104330,women,0,0
104331,but,0,0
104332,less,0,0
104333,frequent,0,0
104334,exercise,0,1
104335,was,0,0
104336,not,0,0
104337,effective,0,0
104338,.,0,0
104339,Brief,1,0
104340,high-impact,1,0
104341,exercise,1,1
104342,may,0,0
104343,have,0,0
104344,a,0,0
104345,role,0,0
104346,in,0,0
104347,reducing,0,0
104348,hip,0,0
104349,fragility,0,0
104350,",",0,0
104351,but,0,0
104352,may,0,0
104353,need,0,0
104354,to,0,0
104355,be,0,0
104356,performed,0,0
104357,frequently,0,0
104358,for,0,0
104359,optimal,0,0
104360,response,0,0
104361,.,0,0
104362,Phase,0,1
104363,III,0,0
104364,",",0,0
104365,randomized,0,0
104366,",",0,0
104367,open-label,0,0
104368,study,0,0
104369,of,0,0
104370,daily,0,1
104371,imatinib,1,1
104372,mesylate,1,1
104373,400,0,1
104374,mg,0,1
104375,versus,0,1
104376,800,0,1
104377,mg,0,1
104378,in,0,0
104379,patients,0,0
104380,with,0,0
104381,newly,0,0
104382,diagnosed,0,0
104383,",",0,0
104384,previously,0,0
104385,untreated,0,0
104386,chronic,0,0
104387,myeloid,0,0
104388,leukemia,0,0
104389,in,0,0
104390,chronic,0,0
104391,phase,0,0
104392,using,0,0
104393,molecular,0,0
104394,end,0,0
104395,points,0,0
104396,:,0,0
104397,tyrosine,0,1
104398,kinase,0,1
104399,inhibitor,0,1
104400,optimization,0,0
104401,and,0,0
104402,selectivity,0,0
104403,study,0,0
104404,.,0,0
104405,PURPOSE,0,0
104406,To,0,0
104407,evaluate,0,0
104408,the,0,0
104409,safety,0,0
104410,and,0,0
104411,efficacy,0,0
104412,of,0,0
104413,initial,0,0
104414,treatment,0,0
104415,with,0,0
104416,imatinib,1,1
104417,mesylate,1,1
104418,800,0,1
104419,mg/d,0,1
104420,(,0,0
104421,400,0,1
104422,mg,0,1
104423,twice,0,1
104424,daily,0,1
104425,),0,0
104426,versus,0,1
104427,400,0,1
104428,mg/d,0,1
104429,in,0,0
104430,patients,0,0
104431,with,0,0
104432,newly,0,0
104433,diagnosed,0,0
104434,chronic,0,0
104435,myeloid,0,0
104436,leukemia,0,0
104437,in,0,0
104438,chronic,0,0
104439,phase,0,0
104440,.,0,1
104441,PATIENTS,0,0
104442,AND,0,0
104443,METHODS,0,0
104444,A,0,1
104445,total,0,0
104446,of,0,0
104447,476,0,0
104448,patients,0,0
104449,were,0,0
104450,randomly,0,0
104451,assigned,0,0
104452,2:1,0,0
104453,to,0,0
104454,imatinib,1,1
104455,800,1,1
104456,mg,1,1
104457,(,0,0
104458,n,0,0
104459,=,0,0
104460,319,0,0
104461,),0,0
104462,or,1,1
104463,400,1,1
104464,mg,1,1
104465,(,0,0
104466,n,0,0
104467,=,0,0
104468,157,0,0
104469,),0,0
104470,daily,0,0
104471,.,0,0
104472,The,0,0
104473,primary,0,0
104474,end,0,0
104475,point,0,0
104476,was,0,0
104477,the,0,0
104478,major,0,0
104479,molecular,0,0
104480,response,0,0
104481,(,0,1
104482,MMR,0,1
104483,),0,1
104484,rate,0,0
104485,at,0,0
104486,12,0,0
104487,months,0,0
104488,.,0,0
104489,RESULTS,0,0
104490,At,0,0
104491,12,0,0
104492,months,0,0
104493,",",0,0
104494,differences,0,0
104495,in,0,0
104496,MMR,0,1
104497,and,0,0
104498,complete,0,0
104499,cytogenetic,0,1
104500,response,0,0
104501,(,0,1
104502,CCyR,0,0
104503,),0,1
104504,rates,0,0
104505,were,0,0
104506,not,0,0
104507,statistically,0,0
104508,significant,0,0
104509,(,0,0
104510,MMR,0,1
104511,",",0,0
104512,46,0,0
104513,%,0,0
104514,v,0,1
104515,40,0,1
104516,%,0,0
104517,;,0,0
104518,P,0,0
104519,=,0,0
104520,.2035,0,0
104521,;,0,0
104522,CCyR,0,0
104523,",",0,0
104524,70,0,0
104525,%,0,0
104526,v,0,1
104527,66,0,0
104528,%,0,0
104529,;,0,0
104530,P,0,0
104531,=,0,0
104532,.3470,0,0
104533,),0,0
104534,.,0,0
104535,However,0,0
104536,",",0,0
104537,MMR,0,1
104538,occurred,0,0
104539,faster,0,0
104540,among,0,0
104541,patients,0,0
104542,randomly,0,0
104543,assigned,0,0
104544,to,0,0
104545,imatinib,1,1
104546,800,0,0
104547,mg/d,0,0
104548,",",0,0
104549,who,0,0
104550,had,0,0
104551,higher,0,0
104552,rates,0,0
104553,of,0,0
104554,MMR,0,0
104555,at,0,0
104556,3,0,0
104557,and,0,0
104558,6,0,0
104559,months,0,0
104560,compared,0,0
104561,with,0,0
104562,those,0,0
104563,in,0,0
104564,the,0,0
104565,imatinib,0,1
104566,400-mg/d,0,1
104567,arm,0,0
104568,(,0,0
104569,P,0,0
104570,=,0,0
104571,.0035,0,0
104572,by,0,0
104573,log-rank,0,0
104574,test,0,0
104575,),0,0
104576,.,0,0
104577,CCyR,0,0
104578,also,0,0
104579,occurred,0,0
104580,faster,0,0
104581,in,0,0
104582,the,0,0
104583,800-mg/d,0,1
104584,arm,0,0
104585,(,0,0
104586,CCyR,0,0
104587,at,0,0
104588,6,0,0
104589,months,0,0
104590,",",0,0
104591,57,0,0
104592,%,0,0
104593,v,0,1
104594,45,0,0
104595,%,0,0
104596,;,0,0
104597,P,0,0
104598,=,0,0
104599,.0146,0,0
104600,),0,0
104601,.,0,0
104602,The,0,0
104603,most,0,0
104604,common,0,0
104605,adverse,0,0
104606,events,0,0
104607,were,0,0
104608,edema,0,0
104609,",",0,0
104610,gastrointestinal,0,0
104611,problems,0,0
104612,",",0,0
104613,and,0,0
104614,rash,0,0
104615,",",0,0
104616,and,0,0
104617,all,0,0
104618,were,0,0
104619,more,0,0
104620,common,0,0
104621,in,0,0
104622,patients,0,0
104623,in,0,0
104624,the,0,0
104625,800-mg/d,0,1
104626,arm,0,0
104627,.,0,0
104628,Grades,0,0
104629,3,0,0
104630,to,0,0
104631,4,0,0
104632,hematologic,0,0
104633,toxicity,0,0
104634,also,0,0
104635,occurred,0,0
104636,more,0,0
104637,frequently,0,0
104638,in,0,0
104639,patients,0,0
104640,receiving,0,0
104641,imatinib,0,1
104642,800,0,1
104643,mg/d,0,0
104644,.,0,0
104645,CONCLUSION,0,0
104646,MMR,0,0
104647,rates,0,0
104648,at,0,0
104649,1,0,0
104650,year,0,0
104651,were,0,0
104652,similar,0,0
104653,with,0,0
104654,imatinib,0,1
104655,800,0,1
104656,mg/d,0,1
104657,and,0,0
104658,400,0,1
104659,mg/d,0,1
104660,",",0,0
104661,but,0,0
104662,MMR,0,1
104663,and,0,0
104664,CCyR,0,0
104665,occurred,0,0
104666,earlier,0,0
104667,in,0,0
104668,patients,0,0
104669,treated,0,0
104670,with,0,0
104671,800,0,0
104672,mg/d,0,0
104673,.,0,0
104674,Continued,0,0
104675,follow-up,0,0
104676,is,0,0
104677,needed,0,0
104678,to,0,0
104679,determine,0,0
104680,the,0,0
104681,clinical,0,0
104682,significance,0,0
104683,of,0,0
104684,earlier,0,0
104685,responses,0,0
104686,on,0,0
104687,high-dose,0,1
104688,imatinib,1,1
104689,.,1,0
104690,Lack,0,1
104691,of,0,0
104692,lipotoxicity,0,0
104693,effect,0,0
104694,on,0,0
104695,{,0,0
104696,beta,0,1
104697,},0,1
104698,-cell,0,0
104699,dysfunction,0,0
104700,in,0,0
104701,ketosis-prone,0,0
104702,type,0,0
104703,2,0,0
104704,diabetes,0,0
104705,.,0,0
104706,OBJECTIVE,0,0
104707,Over,0,0
104708,half,0,0
104709,of,0,0
104710,newly,0,0
104711,diagnosed,0,0
104712,obese,0,0
104713,African,0,0
104714,Americans,0,0
104715,with,0,0
104716,diabetic,0,0
104717,ketoacidosis,0,0
104718,(,0,1
104719,DKA,0,1
104720,),0,1
104721,discontinue,0,0
104722,insulin,0,1
104723,therapy,0,1
104724,and,0,0
104725,go,0,0
104726,through,0,0
104727,a,0,0
104728,period,0,0
104729,of,0,0
104730,near-normoglycemia,0,0
104731,remission,0,0
104732,.,0,0
104733,This,0,0
104734,subtype,0,0
104735,of,0,0
104736,diabetes,0,0
104737,is,0,0
104738,known,0,0
104739,as,0,0
104740,ketosis-prone,0,0
104741,type,0,0
104742,2,0,0
104743,diabetes,0,0
104744,(,0,0
104745,KPDM,0,1
104746,),0,0
104747,.,0,0
104748,RESEARCH,0,0
104749,DESIGN,0,0
104750,AND,0,0
104751,METHODS,0,0
104752,To,0,0
104753,investigate,0,0
104754,the,0,0
104755,role,0,0
104756,of,0,0
104757,lipotoxicity,0,0
104758,on,0,0
104759,beta-cell,0,1
104760,function,0,0
104761,",",0,0
104762,eight,0,0
104763,obese,0,0
104764,African,0,0
104765,Americans,0,0
104766,with,0,0
104767,KPDM,0,1
104768,",",0,0
104769,eight,0,0
104770,obese,0,0
104771,subjects,0,0
104772,with,0,0
104773,type,0,0
104774,2,0,0
104775,diabetes,0,0
104776,with,0,0
104777,severe,0,0
104778,hyperglycemia,0,0
104779,without,0,1
104780,ketosis,0,0
104781,(,0,0
104782,ketosis-resistant,0,1
104783,type,0,0
104784,2,0,0
104785,diabetes,0,0
104786,),0,0
104787,",",0,0
104788,and,0,0
104789,nine,0,0
104790,nondiabetic,0,0
104791,obese,0,0
104792,control,0,1
104793,subjects,0,0
104794,underwent,0,0
104795,intravenous,1,1
104796,infusion,1,1
104797,of,1,0
104798,20,1,0
104799,%,1,0
104800,intralipid,1,1
104801,at,1,0
104802,40,1,0
104803,ml/h,1,0
104804,for,0,0
104805,48,0,0
104806,h.,0,0
104807,beta-Cell,0,1
104808,function,0,0
104809,was,0,0
104810,assessed,0,0
104811,by,0,0
104812,changes,0,0
104813,in,0,0
104814,insulin,0,1
104815,and,0,0
104816,C-peptide,0,1
104817,concentration,0,0
104818,during,0,0
104819,infusions,0,1
104820,and,0,0
104821,by,0,0
104822,changes,0,0
104823,in,0,0
104824,acute,0,0
104825,insulin,0,1
104826,response,0,0
104827,to,0,0
104828,arginine,0,1
104829,stimulation,0,1
104830,(,0,1
104831,AIR,0,1
104832,(,0,1
104833,arg,0,1
104834,),0,1
104835,),0,0
104836,before,0,0
104837,and,0,0
104838,after,0,0
104839,lipid,1,0
104840,infusion,1,1
104841,.,1,0
104842,RESULTS,0,0
104843,The,0,0
104844,mean,0,0
104845,time,0,0
104846,to,0,0
104847,discontinue,0,0
104848,insulin,0,1
104849,therapy,0,1
104850,was,0,0
104851,11.0,0,0
104852,+/-,0,0
104853,8.0,0,0
104854,weeks,0,0
104855,in,0,0
104856,KPDM,0,1
104857,and,0,0
104858,9.6,0,0
104859,+/-,0,0
104860,2.2,0,0
104861,weeks,0,0
104862,in,0,0
104863,ketosis-resistant,0,0
104864,type,0,0
104865,2,0,0
104866,diabetes,0,0
104867,(,0,0
104868,P,0,0
104869,=,0,0
104870,NS,0,0
104871,),0,0
104872,.,0,0
104873,At,0,0
104874,remission,0,0
104875,",",0,0
104876,KPDM,0,1
104877,and,0,0
104878,ketosis-resistant,0,1
104879,type,0,0
104880,2,0,0
104881,diabetes,0,0
104882,had,0,0
104883,similar,0,0
104884,glucose,0,0
104885,(,0,0
104886,94,0,0
104887,+/-,0,0
104888,14,0,0
104889,vs.,0,0
104890,109,0,0
104891,+/-,0,0
104892,20,0,0
104893,mg/dl,0,0
104894,),0,0
104895,",",0,0
104896,A1C,0,1
104897,(,0,0
104898,5.7,0,0
104899,+/-,0,0
104900,0.4,0,0
104901,vs.,0,0
104902,6.3,0,0
104903,+/-,0,0
104904,1.1,0,0
104905,%,0,0
104906,),0,0
104907,",",0,0
104908,and,0,0
104909,baseline,0,0
104910,AIR,0,1
104911,(,0,1
104912,arg,0,1
104913,),0,1
104914,response,0,0
104915,(,0,0
104916,34.8,0,0
104917,+/-,0,0
104918,30,0,0
104919,vs.,0,0
104920,64,0,0
104921,+/-,0,0
104922,69,0,0
104923,microU/ml,0,0
104924,),0,0
104925,.,0,0
104926,P,0,0
104927,=,0,0
104928,NS,0,0
104929,despite,0,0
104930,a,0,0
104931,fourfold,0,0
104932,increase,0,0
104933,in,0,0
104934,free,0,0
104935,fatty,0,1
104936,acid,0,1
104937,(,0,1
104938,FFA,0,1
104939,),0,1
104940,levels,0,0
104941,(,0,0
104942,0.4,0,0
104943,+/-,0,0
104944,0.3,0,0
104945,to,0,0
104946,1.8,0,0
104947,+/-,0,0
104948,1.1,0,0
104949,mmol/l,0,0
104950,",",0,0
104951,P,0,0
104952,<,0,0
104953,0.01,0,0
104954,),0,0
104955,during,0,0
104956,the,0,0
104957,48-h,0,0
104958,intralipid,1,1
104959,infusion,1,1
104960,;,1,0
104961,the,0,0
104962,response,0,0
104963,to,0,0
104964,AIR,0,0
104965,(,0,1
104966,arg,0,1
104967,),0,1
104968,stimulation,0,1
104969,",",0,0
104970,as,0,0
104971,well,0,0
104972,as,0,0
104973,changes,0,0
104974,in,0,0
104975,insulin,0,1
104976,and,0,0
104977,C-peptide,0,1
104978,levels,0,0
104979,",",0,0
104980,were,0,0
104981,similar,0,0
104982,among,0,0
104983,obese,0,0
104984,patients,0,0
104985,with,0,0
104986,KPDM,0,1
104987,",",0,0
104988,patients,0,0
104989,with,0,0
104990,ketosis-resistant,0,0
104991,type,0,0
104992,2,0,0
104993,diabetes,0,0
104994,",",0,0
104995,and,0,0
104996,nondiabetic,0,0
104997,control,0,1
104998,subjects,0,0
104999,.,0,0
105000,CONCLUSIONS,0,0
105001,Near-normoglycemia,0,1
105002,remission,0,0
105003,in,0,0
105004,obese,0,0
105005,African,0,0
105006,American,0,0
105007,patients,0,0
105008,with,0,0
105009,KPDM,0,1
105010,and,0,0
105011,ketosis-resistant,0,1
105012,type,0,0
105013,2,0,0
105014,diabetes,0,0
105015,is,0,0
105016,associated,0,0
105017,with,0,0
105018,a,0,0
105019,remarkable,0,0
105020,recovery,0,0
105021,in,0,0
105022,basal,0,0
105023,and,0,0
105024,stimulated,0,0
105025,insulin,0,1
105026,secretion,0,0
105027,.,0,0
105028,A,0,0
105029,high,0,0
105030,FFA,0,0
105031,level,0,0
105032,by,0,0
105033,intralipid,1,1
105034,infusion,1,1
105035,for,0,0
105036,48,0,0
105037,h,0,0
105038,was,0,0
105039,not,0,0
105040,associated,0,0
105041,with,0,0
105042,beta-cell,0,1
105043,decompensation,0,0
105044,(,0,1
105045,lipotoxicity,0,1
105046,),0,1
105047,in,0,0
105048,KPDM,0,1
105049,patients,0,0
105050,.,0,0
105051,Stress,1,1
105052,reduction,1,0
105053,prolongs,0,1
105054,life,0,0
105055,in,0,0
105056,women,0,0
105057,with,0,0
105058,coronary,0,0
105059,disease,0,0
105060,:,0,0
105061,the,0,0
105062,Stockholm,0,0
105063,Women,0,0
105064,'s,0,0
105065,Intervention,0,1
105066,Trial,0,0
105067,for,0,0
105068,Coronary,0,0
105069,Heart,0,1
105070,Disease,0,0
105071,(,0,1
105072,SWITCHD,0,1
105073,),0,0
105074,.,0,0
105075,BACKGROUND,0,0
105076,Psychosocial,0,0
105077,stress,0,0
105078,may,0,0
105079,increase,0,0
105080,risk,0,0
105081,and,0,0
105082,worsen,0,0
105083,prognosis,0,0
105084,of,0,0
105085,coronary,0,0
105086,heart,0,0
105087,disease,0,0
105088,in,0,0
105089,women,0,0
105090,.,0,0
105091,Interventions,0,0
105092,that,0,0
105093,counteract,0,0
105094,women,0,0
105095,'s,0,0
105096,psychosocial,0,0
105097,stress,0,0
105098,have,0,0
105099,not,0,0
105100,previously,0,0
105101,been,0,0
105102,presented,0,0
105103,.,0,0
105104,This,0,0
105105,study,0,0
105106,implemented,0,0
105107,a,0,0
105108,stress,1,0
105109,reduction,1,0
105110,program,1,1
105111,for,0,0
105112,women,0,0
105113,and,0,0
105114,investigated,0,0
105115,its,0,0
105116,ability,0,0
105117,to,0,0
105118,improve,0,0
105119,survival,0,0
105120,in,0,0
105121,women,0,0
105122,coronary,0,0
105123,patients,0,0
105124,.,0,0
105125,METHODS,0,0
105126,AND,0,0
105127,RESULTS,0,0
105128,Two,0,1
105129,hundred,0,0
105130,thirty-seven,0,0
105131,consecutive,0,0
105132,women,0,0
105133,patients,0,0
105134,",",0,0
105135,aged,0,0
105136,75,0,0
105137,years,0,0
105138,or,0,0
105139,younger,0,0
105140,",",0,0
105141,hospitalized,0,0
105142,for,0,0
105143,acute,0,0
105144,myocardial,0,0
105145,infarction,0,0
105146,",",0,0
105147,coronary,0,0
105148,artery,0,0
105149,bypass,0,1
105150,grafting,0,1
105151,",",0,0
105152,or,0,1
105153,percutaneous,0,1
105154,coronary,0,0
105155,intervention,0,1
105156,were,0,0
105157,randomized,0,0
105158,to,0,0
105159,a,0,0
105160,group-based,1,1
105161,psychosocial,1,0
105162,intervention,1,1
105163,program,1,1
105164,or,1,1
105165,usual,1,1
105166,care,1,1
105167,.,1,0
105168,Initiated,0,0
105169,4,0,0
105170,months,0,0
105171,after,0,0
105172,hospitalization,0,0
105173,",",0,0
105174,intervention,0,1
105175,groups,0,0
105176,of,0,0
105177,4,0,0
105178,to,0,0
105179,8,0,0
105180,women,0,0
105181,met,0,0
105182,for,0,0
105183,a,0,0
105184,total,0,0
105185,of,0,0
105186,20,0,0
105187,sessions,0,1
105188,that,0,0
105189,were,0,0
105190,spread,0,0
105191,over,0,0
105192,a,0,0
105193,year,0,0
105194,.,0,0
105195,We,0,0
105196,provided,0,0
105197,education,1,1
105198,about,1,0
105199,risk,1,0
105200,factors,1,0
105201,",",1,0
105202,relaxation,1,1
105203,training,1,1
105204,techniques,1,1
105205,",",1,0
105206,methods,1,0
105207,for,1,0
105208,self-monitoring,1,1
105209,and,1,0
105210,cognitive,1,1
105211,restructuring,1,1
105212,",",1,0
105213,with,1,0
105214,an,1,0
105215,emphasis,1,0
105216,on,1,0
105217,coping,1,0
105218,with,1,0
105219,stress,1,0
105220,exposure,1,0
105221,from,1,0
105222,family,1,1
105223,and,1,0
105224,work,1,0
105225,",",1,0
105226,and,1,0
105227,self-care,1,1
105228,and,1,0
105229,compliance,1,0
105230,with,1,0
105231,clinical,1,0
105232,advice,1,1
105233,.,1,0
105234,From,0,0
105235,randomization,0,0
105236,until,0,0
105237,end,0,0
105238,of,0,0
105239,follow-up,0,0
105240,(,0,0
105241,mean,0,0
105242,duration,0,0
105243,",",0,0
105244,7.1,0,0
105245,years,0,0
105246,),0,0
105247,",",0,0
105248,25,0,0
105249,women,0,0
105250,(,0,0
105251,20,0,1
105252,%,0,0
105253,),0,0
105254,in,0,0
105255,the,0,0
105256,usual,0,1
105257,care,0,1
105258,and,0,0
105259,8,0,0
105260,women,0,0
105261,(,0,0
105262,7,0,0
105263,%,0,0
105264,),0,0
105265,in,0,0
105266,the,0,0
105267,stress,0,0
105268,reduction,0,0
105269,died,0,0
105270,",",0,0
105271,yielding,0,0
105272,an,0,0
105273,almost,0,0
105274,3-fold,0,0
105275,protective,0,0
105276,effect,0,0
105277,of,0,0
105278,the,0,0
105279,intervention,0,1
105280,(,0,0
105281,odds,0,0
105282,ratio,0,0
105283,",",0,0
105284,0.33,0,0
105285,;,0,0
105286,95,0,0
105287,%,0,0
105288,CI,0,0
105289,",",0,0
105290,0.15,0,0
105291,to,0,0
105292,0.74,0,0
105293,;,0,0
105294,P=0.007,0,0
105295,),0,0
105296,.,0,0
105297,Introducing,0,0
105298,baseline,0,0
105299,measures,0,0
105300,of,0,0
105301,clinical,0,0
105302,prognostic,0,0
105303,factors,0,0
105304,",",0,0
105305,including,0,0
105306,use,1,0
105307,of,1,0
105308,aspirin,1,1
105309,",",1,0
105310,beta-blockers,1,1
105311,",",1,0
105312,angiotensin-converting,1,1
105313,enzyme,1,0
105314,inhibitors,1,1
105315,",",1,0
105316,calcium-channel,1,1
105317,blockers,1,1
105318,",",1,0
105319,and,1,0
105320,statins,1,1
105321,into,1,0
105322,multivariate,1,0
105323,models,1,0
105324,confirmed,0,0
105325,the,0,0
105326,unadjusted,0,0
105327,results,0,0
105328,(,0,0
105329,P=0.009,0,0
105330,),0,0
105331,.,0,0
105332,CONCLUSIONS,0,0
105333,Although,0,0
105334,mechanisms,0,0
105335,remain,0,0
105336,unclear,0,0
105337,",",0,0
105338,a,0,0
105339,group-based,1,1
105340,psychosocial,1,0
105341,intervention,1,1
105342,program,1,1
105343,for,0,0
105344,women,0,0
105345,with,0,0
105346,coronary,0,0
105347,heart,0,0
105348,disease,0,0
105349,may,0,0
105350,prolong,0,0
105351,lives,0,0
105352,independent,0,0
105353,of,0,0
105354,other,0,0
105355,prognostic,0,0
105356,factors,0,0
105357,.,0,0
105358,Effect,0,0
105359,of,0,0
105360,pravastatin,1,1
105361,on,0,0
105362,kidney,0,1
105363,function,0,0
105364,and,0,0
105365,urinary,0,0
105366,protein,0,1
105367,excretion,0,0
105368,in,0,0
105369,autosomal,0,0
105370,dominant,0,0
105371,polycystic,0,0
105372,kidney,0,0
105373,disease,0,0
105374,.,0,0
105375,OBJECTIVE,0,0
105376,Autosomal,0,0
105377,dominant,0,0
105378,polycystic,0,0
105379,kidney,0,1
105380,disease,0,0
105381,(,0,1
105382,ADPKD,0,1
105383,),0,1
105384,is,0,0
105385,progressive,0,0
105386,",",0,0
105387,resulting,0,0
105388,in,0,0
105389,end-stage,0,0
105390,kidney,0,1
105391,failure,0,0
105392,in,0,0
105393,most,0,0
105394,patients,0,0
105395,.,0,0
105396,Experimental,0,0
105397,and,0,0
105398,clinical,0,0
105399,studies,0,0
105400,have,0,0
105401,suggested,0,0
105402,that,0,0
105403,statins,1,1
105404,may,0,0
105405,slow,0,0
105406,the,0,0
105407,progression,0,0
105408,of,0,0
105409,chronic,0,0
105410,kidney,0,0
105411,disease,0,0
105412,in,0,0
105413,general,0,0
105414,and,0,0
105415,ADPKD,0,1
105416,specifically,0,0
105417,.,0,0
105418,MATERIAL,0,0
105419,AND,0,0
105420,METHODS,0,0
105421,This,0,0
105422,randomized,0,0
105423,open-label,0,0
105424,clinical,0,0
105425,trial,0,0
105426,was,0,0
105427,conducted,0,0
105428,to,0,0
105429,assess,0,0
105430,the,0,0
105431,effect,0,0
105432,of,0,0
105433,pravastatin,1,1
105434,20,0,0
105435,mg,0,1
105436,on,0,0
105437,kidney,0,1
105438,function,0,0
105439,and,0,0
105440,urinary,0,0
105441,protein,0,1
105442,excretion,0,0
105443,in,0,0
105444,patients,0,0
105445,with,0,0
105446,ADPKD,0,0
105447,.,0,0
105448,Sixty,0,0
105449,patients,0,0
105450,were,0,0
105451,initially,0,0
105452,recruited,0,0
105453,but,0,0
105454,49,0,0
105455,of,0,0
105456,these,0,0
105457,received,0,0
105458,either,0,0
105459,pravastatin,1,1
105460,20,0,1
105461,mg,0,1
105462,or,0,1
105463,no,1,0
105464,treatment,1,0
105465,for,0,0
105466,2,0,0
105467,years,0,0
105468,.,0,0
105469,Trial,0,0
105470,visits,0,0
105471,were,0,0
105472,conducted,0,0
105473,every,0,0
105474,3,0,0
105475,months,0,0
105476,",",0,0
105477,assessing,0,0
105478,kidney,0,1
105479,function,0,0
105480,by,0,0
105481,estimated,0,0
105482,glomerular,0,0
105483,filtration,0,0
105484,rate,0,0
105485,and,0,0
105486,24,0,0
105487,h,0,0
105488,urine,0,0
105489,creatinine,0,0
105490,clearance,0,0
105491,and,0,0
105492,urinary,0,0
105493,protein,0,1
105494,excretion,0,0
105495,.,0,0
105496,RESULTS,0,0
105497,There,0,0
105498,were,0,0
105499,no,0,0
105500,significant,0,0
105501,(,0,0
105502,p,0,0
105503,>,0,0
105504,0.05,0,0
105505,),0,0
105506,changes,0,0
105507,in,0,0
105508,markers,0,0
105509,of,0,0
105510,kidney,0,0
105511,function,0,0
105512,or,0,1
105513,urinary,0,0
105514,protein,0,1
105515,excretion,0,0
105516,between,0,0
105517,groups,0,0
105518,over,0,0
105519,the,0,0
105520,2,0,0
105521,years,0,0
105522,despite,0,0
105523,a,0,0
105524,significant,0,0
105525,fall,0,0
105526,in,0,0
105527,total,0,0
105528,serum,0,0
105529,cholesterol,0,0
105530,in,0,0
105531,pravastatin-treated,1,1
105532,patients,0,0
105533,(,0,0
105534,p,0,0
105535,=,0,0
105536,0.029,0,0
105537,),0,0
105538,.,0,0
105539,CONCLUSION,0,0
105540,This,0,0
105541,trial,0,0
105542,found,0,0
105543,that,0,0
105544,taking,0,0
105545,20,0,1
105546,mg,0,1
105547,pravastatin,1,1
105548,for,0,0
105549,2,0,0
105550,years,0,0
105551,had,0,0
105552,no,0,0
105553,significant,0,0
105554,effect,0,0
105555,on,0,0
105556,kidney,0,1
105557,function,0,0
105558,or,0,1
105559,urinary,0,0
105560,protein,0,1
105561,excretion,0,0
105562,in,0,0
105563,patients,0,0
105564,with,0,0
105565,ADPKD,0,0
105566,.,0,0
105567,The,0,0
105568,lack,0,0
105569,of,0,0
105570,statistical,0,0
105571,power,0,0
105572,limits,0,0
105573,the,0,0
105574,external,0,0
105575,validity,0,0
105576,of,0,0
105577,these,0,0
105578,findings,0,0
105579,.,0,0
105580,A,0,0
105581,larger,0,0
105582,",",0,0
105583,longer,0,0
105584,duration,0,0
105585,study,0,0
105586,using,0,0
105587,a,0,0
105588,higher,0,0
105589,dose,0,0
105590,of,0,0
105591,a,0,0
105592,more,0,0
105593,potent,0,0
105594,statin,0,1
105595,is,0,0
105596,required,0,0
105597,.,0,0
105598,A,0,0
105599,randomized,0,0
105600,controlled,0,0
105601,study,0,0
105602,of,0,0
105603,parent-assisted,1,1
105604,Children,1,0
105605,'s,1,0
105606,Friendship,1,0
105607,Training,1,1
105608,with,0,0
105609,children,0,0
105610,having,0,0
105611,autism,0,0
105612,spectrum,0,0
105613,disorders,0,0
105614,.,0,0
105615,This,0,0
105616,study,0,0
105617,evaluated,0,0
105618,Children,1,0
105619,'s,1,0
105620,Friendship,1,0
105621,Training,1,1
105622,(,1,1
105623,CFT,1,1
105624,),1,0
105625,",",1,0
105626,a,1,0
105627,manualized,1,1
105628,parent-assisted,1,1
105629,intervention,1,1
105630,to,0,0
105631,improve,0,0
105632,social,0,0
105633,skills,0,0
105634,among,0,0
105635,second,0,0
105636,to,0,0
105637,fifth,0,0
105638,grade,0,0
105639,children,0,0
105640,with,0,0
105641,autism,0,0
105642,spectrum,0,0
105643,disorders,0,0
105644,.,0,0
105645,Comparison,0,0
105646,was,0,0
105647,made,0,0
105648,with,0,0
105649,a,0,0
105650,delayed,1,0
105651,treatment,1,0
105652,control,1,1
105653,group,1,1
105654,(,1,1
105655,DTC,1,1
105656,),1,0
105657,.,0,0
105658,Targeted,0,0
105659,skills,0,0
105660,included,0,0
105661,conversational,0,0
105662,skills,0,0
105663,",",0,0
105664,peer,0,1
105665,entry,0,0
105666,skills,0,1
105667,",",0,0
105668,developing,0,0
105669,friendship,0,1
105670,networks,0,1
105671,",",0,0
105672,good,0,0
105673,sportsmanship,0,0
105674,",",0,0
105675,good,0,0
105676,host,0,0
105677,behavior,0,0
105678,during,0,0
105679,play,0,0
105680,dates,0,0
105681,",",0,0
105682,and,0,0
105683,handling,0,0
105684,teasing,0,1
105685,.,0,0
105686,At,0,0
105687,post-testing,0,0
105688,",",0,0
105689,the,0,0
105690,CFT,0,1
105691,group,0,0
105692,was,0,0
105693,superior,0,0
105694,to,0,0
105695,the,0,0
105696,DTC,0,1
105697,group,0,0
105698,on,0,0
105699,parent,0,1
105700,measures,0,0
105701,of,0,0
105702,social,0,0
105703,skill,0,1
105704,and,0,0
105705,play,0,0
105706,date,0,0
105707,behavior,0,0
105708,",",0,0
105709,and,0,0
105710,child,0,0
105711,measures,0,0
105712,of,0,0
105713,popularity,0,0
105714,and,0,0
105715,loneliness,0,0
105716,",",0,0
105717,At,0,1
105718,3-month,0,0
105719,follow-up,0,0
105720,",",0,0
105721,parent,0,1
105722,measures,0,0
105723,showed,0,0
105724,significant,0,0
105725,improvement,0,0
105726,from,0,0
105727,baseline,0,0
105728,.,0,0
105729,Post-hoc,0,0
105730,analysis,0,0
105731,indicated,0,0
105732,more,0,0
105733,than,0,0
105734,87,0,0
105735,%,0,0
105736,of,0,0
105737,children,0,0
105738,receiving,0,0
105739,CFT,1,1
105740,showed,0,0
105741,reliable,0,0
105742,change,0,0
105743,on,0,0
105744,at,0,0
105745,least,0,0
105746,one,0,0
105747,measure,0,0
105748,at,0,0
105749,post-test,0,0
105750,and,0,0
105751,66.7,0,0
105752,%,0,0
105753,after,0,0
105754,3,0,0
105755,months,0,0
105756,follow-up,0,0
105757,.,0,0
105758,Catheter,1,1
105759,ablation,1,1
105760,of,1,0
105761,stable,1,0
105762,ventricular,1,0
105763,tachycardia,1,0
105764,before,0,0
105765,defibrillator,1,1
105766,implantation,0,0
105767,in,0,0
105768,patients,0,0
105769,with,0,0
105770,coronary,0,0
105771,heart,0,0
105772,disease,0,0
105773,(,0,1
105774,VTACH,0,1
105775,),0,1
105776,:,0,0
105777,a,0,0
105778,multicentre,0,0
105779,randomised,0,0
105780,controlled,0,0
105781,trial,0,0
105782,.,0,0
105783,BACKGROUND,0,0
105784,In,0,0
105785,patients,0,0
105786,with,0,0
105787,ventricular,0,0
105788,tachycardia,0,0
105789,(,0,1
105790,VT,0,1
105791,),0,1
105792,and,0,0
105793,a,0,0
105794,history,0,0
105795,of,0,0
105796,myocardial,0,0
105797,infarction,0,0
105798,",",0,0
105799,intervention,0,1
105800,with,0,0
105801,an,0,0
105802,implantable,1,1
105803,cardioverter,1,1
105804,defibrillator,1,1
105805,(,1,1
105806,ICD,1,1
105807,),1,1
105808,can,0,0
105809,prevent,0,0
105810,sudden,0,0
105811,cardiac,0,0
105812,death,0,0
105813,and,0,0
105814,thereby,0,0
105815,reduce,0,0
105816,total,0,0
105817,mortality,0,0
105818,.,0,0
105819,However,0,0
105820,",",0,0
105821,ICD,0,1
105822,shocks,0,1
105823,are,0,0
105824,painful,0,0
105825,and,0,0
105826,do,0,0
105827,not,0,0
105828,provide,0,0
105829,complete,0,0
105830,protection,0,0
105831,against,0,0
105832,sudden,0,0
105833,cardiac,0,0
105834,death,0,0
105835,.,0,0
105836,We,0,0
105837,assessed,0,0
105838,the,0,0
105839,potential,0,0
105840,benefit,0,0
105841,of,0,0
105842,catheter,1,1
105843,ablation,1,1
105844,before,0,0
105845,implantation,0,0
105846,of,0,0
105847,a,0,0
105848,cardioverter,0,1
105849,defibrillator,0,1
105850,.,0,0
105851,METHODS,0,0
105852,The,0,0
105853,Ventricular,0,0
105854,Tachycardia,0,1
105855,Ablation,0,1
105856,in,0,0
105857,Coronary,0,0
105858,Heart,0,1
105859,Disease,0,0
105860,(,0,1
105861,VTACH,0,1
105862,),0,1
105863,study,0,0
105864,was,0,0
105865,a,0,0
105866,prospective,0,0
105867,",",0,0
105868,open,0,0
105869,",",0,0
105870,randomised,0,0
105871,controlled,0,0
105872,trial,0,0
105873,",",0,0
105874,undertaken,0,0
105875,in,0,0
105876,16,0,0
105877,centres,0,0
105878,in,0,0
105879,four,0,0
105880,European,0,0
105881,countries,0,0
105882,.,0,0
105883,Patients,0,0
105884,aged,0,0
105885,18-80,0,0
105886,years,0,0
105887,were,0,0
105888,eligible,0,0
105889,for,0,0
105890,enrolment,0,0
105891,if,0,0
105892,they,0,0
105893,had,0,0
105894,stable,0,0
105895,VT,0,0
105896,",",0,0
105897,previous,0,0
105898,myocardial,0,0
105899,infarction,0,0
105900,",",0,0
105901,and,0,0
105902,reduced,0,0
105903,left-ventricular,0,0
105904,ejection,0,0
105905,fraction,0,1
105906,(,0,0
105907,LVEF,0,1
105908,;,0,0
105909,<,0,0
105910,or=50,0,0
105911,%,0,0
105912,),0,0
105913,.,0,0
105914,110,0,0
105915,patients,0,0
105916,were,0,0
105917,randomly,0,0
105918,allocated,0,0
105919,in,0,0
105920,a,0,0
105921,1:1,0,1
105922,ratio,0,0
105923,to,0,0
105924,receive,1,1
105925,catheter,1,1
105926,ablation,1,1
105927,and,1,0
105928,an,1,0
105929,ICD,1,1
105930,(,1,1
105931,ablation,1,1
105932,group,1,0
105933,",",1,0
105934,n=54,1,1
105935,),1,0
105936,or,1,1
105937,ICD,1,1
105938,alone,1,1
105939,(,1,0
105940,control,1,1
105941,group,1,0
105942,",",1,0
105943,n=56,1,0
105944,),1,0
105945,.,1,0
105946,Randomisation,0,0
105947,was,0,0
105948,done,0,0
105949,by,0,0
105950,computer-generated,0,0
105951,randomly,0,0
105952,permuted,0,0
105953,blocks,0,1
105954,and,0,0
105955,stratified,0,0
105956,by,0,0
105957,centre,0,0
105958,and,0,1
105959,LVEF,0,1
105960,(,0,1
105961,<,0,0
105962,or=30,0,0
105963,%,0,0
105964,or,0,1
105965,>,0,0
105966,30,0,1
105967,%,0,0
105968,),0,0
105969,.,0,0
105970,Patients,0,0
105971,were,0,0
105972,followed,0,0
105973,up,0,0
105974,for,0,0
105975,at,0,0
105976,least,0,0
105977,1,0,0
105978,year,0,0
105979,.,0,0
105980,The,0,0
105981,primary,0,0
105982,endpoint,0,0
105983,was,0,0
105984,the,0,0
105985,time,0,0
105986,to,0,0
105987,first,0,0
105988,recurrence,0,0
105989,of,0,0
105990,VT,0,1
105991,or,0,1
105992,ventricular,0,0
105993,fibrillation,0,0
105994,(,0,1
105995,VF,0,0
105996,),0,1
105997,.,0,0
105998,Analysis,0,0
105999,was,0,0
106000,by,0,0
106001,intention,0,0
106002,to,0,0
106003,treat,0,0
106004,(,0,1
106005,ITT,0,1
106006,),0,0
106007,.,0,0
106008,This,0,0
106009,study,0,0
106010,is,0,0
106011,registered,0,0
106012,with,0,0
106013,ClinicalTrials.gov,0,0
106014,",",0,0
106015,number,0,0
106016,NCT00919373,0,0
106017,.,0,0
106018,FINDINGS,0,0
106019,107,0,0
106020,patients,0,0
106021,were,0,0
106022,included,0,0
106023,in,0,0
106024,the,0,0
106025,ITT,0,1
106026,population,0,0
106027,(,1,1
106028,ablation,1,1
106029,group,1,0
106030,",",0,0
106031,n=52,0,0
106032,;,0,0
106033,control,1,1
106034,group,0,0
106035,",",0,0
106036,n=55,0,0
106037,),0,0
106038,.,0,0
106039,Two,0,0
106040,patients,0,0
106041,(,0,0
106042,one,0,0
106043,in,0,0
106044,each,0,0
106045,group,0,0
106046,),0,0
106047,withdrew,0,0
106048,consent,0,0
106049,immediately,0,0
106050,after,0,0
106051,randomisation,0,0
106052,without,0,0
106053,any,0,0
106054,follow-up,0,0
106055,data,0,0
106056,and,0,0
106057,one,0,0
106058,patient,0,0
106059,(,0,1
106060,ablation,0,1
106061,group,0,1
106062,),0,0
106063,was,0,0
106064,excluded,0,0
106065,because,0,0
106066,of,0,0
106067,a,0,0
106068,protocol,0,0
106069,violaton,0,0
106070,.,0,0
106071,Mean,0,0
106072,follow-up,0,0
106073,was,0,0
106074,22.5,0,0
106075,months,0,0
106076,(,0,0
106077,SD,0,0
106078,9.0,0,0
106079,),0,0
106080,.,0,0
106081,Time,0,0
106082,to,0,0
106083,recurrence,0,0
106084,of,0,0
106085,VT,0,1
106086,or,0,1
106087,VF,0,0
106088,was,0,0
106089,longer,0,0
106090,in,0,0
106091,the,0,0
106092,ablation,1,1
106093,group,1,0
106094,(,0,0
106095,median,0,0
106096,18.6,0,0
106097,months,0,0
106098,[,0,0
106099,lower,0,0
106100,quartile,0,0
106101,2.4,0,0
106102,",",0,0
106103,upper,0,0
106104,quartile,0,0
106105,not,0,0
106106,determinable,0,0
106107,],0,0
106108,),0,0
106109,than,0,0
106110,in,0,0
106111,the,0,0
106112,control,1,1
106113,group,1,0
106114,(,0,0
106115,5.9,0,0
106116,months,0,0
106117,[,0,0
106118,IQR,0,1
106119,0.8-26.7,0,0
106120,],0,0
106121,),0,0
106122,.,0,0
106123,At,0,0
106124,2,0,0
106125,years,0,0
106126,",",0,0
106127,estimates,0,0
106128,for,0,0
106129,survival,0,0
106130,free,0,0
106131,from,0,0
106132,VT,0,1
106133,or,0,1
106134,VF,0,0
106135,were,0,0
106136,47,0,0
106137,%,0,0
106138,in,0,0
106139,the,0,0
106140,ablation,1,1
106141,group,1,0
106142,and,0,0
106143,29,0,0
106144,%,0,0
106145,in,0,0
106146,the,0,0
106147,control,1,1
106148,group,1,0
106149,(,0,1
106150,hazard,0,0
106151,ratio,0,0
106152,0.61,0,0
106153,;,0,0
106154,95,0,0
106155,%,0,0
106156,CI,0,0
106157,0.37-0.99,0,0
106158,;,0,0
106159,p=0.045,0,0
106160,),0,0
106161,.,0,0
106162,Complications,0,0
106163,related,0,0
106164,to,0,0
106165,the,0,0
106166,ablation,0,1
106167,procedure,0,0
106168,occurred,0,0
106169,in,0,0
106170,two,0,0
106171,patients,0,0
106172,;,0,0
106173,no,0,0
106174,deaths,0,0
106175,occurred,0,0
106176,within,0,0
106177,30,0,0
106178,days,0,0
106179,after,0,0
106180,ablation,0,1
106181,.,0,0
106182,15,0,0
106183,device-related,0,0
106184,complications,0,0
106185,requiring,0,0
106186,surgical,0,1
106187,intervention,0,1
106188,occurred,0,0
106189,in,0,0
106190,13,0,0
106191,patients,0,0
106192,(,1,0
106193,ablation,1,1
106194,group,1,0
106195,",",0,0
106196,four,0,0
106197,;,0,0
106198,control,1,0
106199,group,1,0
106200,",",0,0
106201,nine,0,0
106202,),0,0
106203,.,0,0
106204,Nine,0,1
106205,patients,0,0
106206,died,0,0
106207,during,0,0
106208,the,0,0
106209,study,0,0
106210,(,1,1
106211,ablation,1,1
106212,group,0,0
106213,",",0,0
106214,five,0,0
106215,;,0,0
106216,control,1,0
106217,group,0,0
106218,",",0,0
106219,four,0,0
106220,),0,0
106221,.,0,0
106222,INTERPRETATION,0,0
106223,Prophylactic,1,1
106224,VT,1,1
106225,ablation,1,1
106226,before,0,0
106227,defibrillator,1,1
106228,implantation,1,0
106229,seemed,0,0
106230,to,0,0
106231,prolong,0,0
106232,time,0,0
106233,to,0,0
106234,recurrence,0,0
106235,of,0,0
106236,VT,0,0
106237,in,0,0
106238,patients,0,0
106239,with,0,0
106240,stable,0,0
106241,VT,0,0
106242,",",0,0
106243,previous,0,0
106244,myocardial,0,0
106245,infarction,0,0
106246,",",0,0
106247,and,0,0
106248,reduced,0,0
106249,LVEF,0,1
106250,.,0,0
106251,Prophylactic,1,1
106252,catheter,1,1
106253,ablation,1,1
106254,should,0,0
106255,therefore,0,0
106256,be,0,0
106257,considered,0,0
106258,before,0,0
106259,implantation,0,0
106260,of,0,0
106261,a,0,0
106262,cardioverter,1,1
106263,defibrillator,1,1
106264,in,0,0
106265,such,0,0
106266,patients,0,0
106267,.,0,0
106268,FUNDING,0,0
106269,St,0,0
106270,Jude,0,0
106271,Medical,0,1
106272,.,0,0
106273,Hunter,0,1
106274,DBT,0,1
106275,project,0,0
106276,:,0,0
106277,randomized,0,0
106278,controlled,0,0
106279,trial,0,0
106280,of,0,0
106281,dialectical,1,1
106282,behaviour,1,0
106283,therapy,1,1
106284,in,0,0
106285,women,0,0
106286,with,0,0
106287,borderline,0,0
106288,personality,0,0
106289,disorder,0,0
106290,.,0,0
106291,OBJECTIVE,0,0
106292,Deliberate,0,1
106293,self-harm,0,0
106294,(,0,1
106295,DSH,0,0
106296,),0,1
106297,",",0,0
106298,general,0,0
106299,hospital,0,0
106300,admission,0,0
106301,and,0,0
106302,psychiatric,0,0
106303,hospital,0,0
106304,admission,0,0
106305,are,0,0
106306,common,0,0
106307,in,0,0
106308,women,0,0
106309,meeting,0,0
106310,criteria,0,0
106311,for,0,0
106312,borderline,0,0
106313,personality,0,0
106314,disorder,0,0
106315,(,0,1
106316,BPD,0,0
106317,),0,1
106318,.,0,0
106319,Dialectical,1,1
106320,behaviour,1,0
106321,therapy,1,1
106322,(,1,1
106323,DBT,1,1
106324,),1,1
106325,has,0,0
106326,been,0,0
106327,reported,0,0
106328,to,0,0
106329,be,0,0
106330,effective,0,0
106331,in,0,0
106332,reducing,0,0
106333,DSH,0,0
106334,and,0,0
106335,hospitalization,0,0
106336,.,0,0
106337,METHOD,0,0
106338,A,0,0
106339,randomized,0,0
106340,controlled,0,0
106341,trial,0,0
106342,of,0,0
106343,73,0,0
106344,female,0,0
106345,subjects,0,0
106346,meeting,0,0
106347,criteria,0,0
106348,for,0,0
106349,BPD,0,0
106350,was,0,0
106351,carried,0,0
106352,out,0,0
106353,with,0,0
106354,intention-to-treat,0,0
106355,analyses,0,0
106356,and,0,0
106357,per-protocol,0,0
106358,analyses,0,0
106359,.,0,0
106360,The,0,0
106361,intervention,0,1
106362,was,0,0
106363,DBT,1,0
106364,and,0,0
106365,the,0,0
106366,control,0,1
106367,condition,0,0
106368,was,0,0
106369,treatment,1,0
106370,as,1,0
106371,usual,1,1
106372,plus,1,1
106373,waiting,1,0
106374,list,1,1
106375,for,1,0
106376,DBT,1,1
106377,(,1,1
106378,TAU+WL,1,1
106379,),1,0
106380,",",0,0
106381,with,0,0
106382,outcomes,0,0
106383,measured,0,0
106384,after,0,0
106385,6,0,0
106386,months,0,0
106387,.,0,0
106388,Primary,0,0
106389,outcomes,0,0
106390,were,0,0
106391,differences,0,0
106392,in,0,0
106393,proportions,0,0
106394,and,0,0
106395,event,0,0
106396,rates,0,0
106397,of,0,0
106398,:,0,0
106399,any,0,0
106400,DSH,0,0
106401,;,0,0
106402,general,0,0
106403,hospital,0,0
106404,admission,0,0
106405,for,0,0
106406,DSH,0,0
106407,and,0,0
106408,any,0,0
106409,psychiatric,0,0
106410,admission,0,0
106411,;,0,0
106412,and,0,0
106413,mean,0,0
106414,difference,0,0
106415,in,0,0
106416,length,0,0
106417,of,0,0
106418,stay,0,0
106419,for,0,0
106420,any,0,0
106421,hospitalization,0,0
106422,.,0,0
106423,Secondary,0,0
106424,outcomes,0,0
106425,were,0,0
106426,disability,0,0
106427,and,0,0
106428,quality,0,0
106429,of,0,0
106430,life,0,0
106431,measures,0,0
106432,.,0,0
106433,RESULTS,0,0
106434,Both,0,1
106435,groups,0,0
106436,showed,0,0
106437,a,0,0
106438,reduction,0,0
106439,in,0,0
106440,DSH,0,0
106441,and,0,0
106442,hospitalizations,0,0
106443,",",0,0
106444,but,0,0
106445,there,0,0
106446,were,0,0
106447,no,0,0
106448,significant,0,0
106449,differences,0,0
106450,in,0,0
106451,DSH,0,0
106452,",",0,0
106453,hospital,0,0
106454,admissions,0,0
106455,or,0,1
106456,length,0,0
106457,of,0,0
106458,stay,0,0
106459,in,0,0
106460,hospital,0,0
106461,between,0,0
106462,groups,0,0
106463,.,0,0
106464,Disability,0,0
106465,(,0,0
106466,days,0,0
106467,spent,0,0
106468,in,0,0
106469,bed,0,0
106470,),0,1
106471,and,0,0
106472,quality,0,0
106473,of,0,0
106474,life,0,0
106475,(,0,0
106476,Physical,0,0
106477,",",0,0
106478,Psychological,0,0
106479,and,0,0
106480,Environmental,0,1
106481,domains,0,1
106482,),0,0
106483,were,0,0
106484,significantly,0,0
106485,improved,0,0
106486,for,0,0
106487,the,0,0
106488,DBT,0,0
106489,group,0,0
106490,.,0,0
106491,CONCLUSION,0,0
106492,DBT,1,0
106493,produced,0,0
106494,non-significant,0,0
106495,reductions,0,0
106496,in,0,0
106497,DSH,0,0
106498,and,0,0
106499,hospitalization,0,0
106500,when,0,0
106501,compared,0,0
106502,to,0,0
106503,the,0,0
106504,TAU+WL,0,1
106505,control,0,0
106506,",",0,0
106507,due,0,0
106508,in,0,0
106509,part,0,0
106510,to,0,0
106511,the,0,0
106512,lower,0,0
106513,than,0,0
106514,expected,0,0
106515,rates,0,0
106516,of,0,0
106517,hospitalization,0,0
106518,in,0,0
106519,the,0,0
106520,control,0,0
106521,condition,0,0
106522,.,0,0
106523,Nevertheless,0,0
106524,",",0,0
106525,DBT,1,0
106526,showed,0,0
106527,significant,0,0
106528,benefits,0,0
106529,for,0,0
106530,the,0,0
106531,secondary,0,0
106532,outcomes,0,0
106533,of,0,0
106534,improved,0,0
106535,disability,0,0
106536,and,0,0
106537,quality,0,0
106538,of,0,0
106539,life,0,0
106540,scores,0,0
106541,",",0,0
106542,a,0,0
106543,clinically,0,0
106544,useful,0,0
106545,result,0,0
106546,that,0,0
106547,is,0,0
106548,also,0,0
106549,in,0,0
106550,keeping,0,0
106551,with,0,0
106552,the,0,0
106553,theoretical,0,0
106554,constructs,0,0
106555,of,0,0
106556,the,0,0
106557,benefits,0,0
106558,of,0,0
106559,DBT,1,0
106560,.,1,0
106561,Minimally,0,1
106562,invasive,0,0
106563,compared,0,0
106564,with,0,0
106565,traditional,0,1
106566,transgluteal,0,1
106567,approach,0,1
106568,for,0,0
106569,total,0,0
106570,hip,0,0
106571,arthroplasty,0,1
106572,:,0,0
106573,a,0,0
106574,comparative,0,0
106575,gait,0,0
106576,analysis,0,0
106577,.,0,0
106578,BACKGROUND,0,0
106579,Minimally,0,1
106580,invasive,0,0
106581,total,0,0
106582,hip,0,0
106583,arthroplasty,0,1
106584,is,0,0
106585,purported,0,0
106586,to,0,0
106587,allow,0,0
106588,an,0,0
106589,improved,0,0
106590,and,0,0
106591,faster,0,0
106592,rehabilitation,0,1
106593,in,0,0
106594,the,0,0
106595,immediate,0,0
106596,postoperative,0,0
106597,period,0,0
106598,because,0,0
106599,of,0,0
106600,reduced,0,0
106601,soft-tissue,0,0
106602,damage,0,0
106603,compared,0,0
106604,with,0,0
106605,total,0,0
106606,hip,0,0
106607,arthroplasty,0,1
106608,performed,0,0
106609,with,0,0
106610,use,0,0
106611,of,0,0
106612,a,0,0
106613,standard,0,1
106614,approach,0,1
106615,.,0,0
106616,In,0,0
106617,the,0,0
106618,present,0,0
106619,study,0,0
106620,",",0,0
106621,a,0,0
106622,minimally,0,1
106623,invasive,0,0
106624,approach,0,1
106625,was,0,0
106626,compared,0,0
106627,with,0,0
106628,a,0,0
106629,traditional,0,1
106630,standard,0,1
106631,approach,0,1
106632,in,0,0
106633,terms,0,0
106634,of,0,0
106635,the,0,0
106636,effect,0,0
106637,on,0,0
106638,gait,0,0
106639,kinematics,0,0
106640,as,0,0
106641,demonstrated,0,0
106642,with,0,0
106643,gait,0,0
106644,analysis,0,0
106645,and,0,0
106646,electromyography,0,0
106647,.,0,0
106648,METHODS,0,0
106649,Twenty,0,0
106650,randomized,0,0
106651,patients,0,0
106652,who,0,0
106653,underwent,0,0
106654,a,0,0
106655,primary,1,0
106656,total,1,0
106657,hip,1,0
106658,replacement,1,1
106659,with,1,0
106660,use,1,0
106661,of,1,0
106662,a,1,0
106663,minimally,1,0
106664,invasive,1,0
106665,modified,1,0
106666,Watson-Jones,1,1
106667,approach,1,1
106668,(,1,0
106669,minimally,1,1
106670,invasive,1,0
106671,group,1,0
106672,),1,0
106673,were,0,0
106674,compared,0,0
106675,with,0,0
106676,a,0,0
106677,group,0,0
106678,of,0,0
106679,twenty,0,0
106680,patients,0,0
106681,who,0,0
106682,underwent,0,0
106683,a,0,0
106684,total,1,0
106685,hip,1,0
106686,arthroplasty,1,1
106687,with,1,0
106688,use,1,0
106689,of,1,0
106690,a,1,0
106691,standard,1,1
106692,transgluteal,1,1
106693,Hardinge,1,1
106694,approach,1,1
106695,(,1,0
106696,standard,1,1
106697,group,1,0
106698,),1,0
106699,.,1,0
106700,All,0,0
106701,patients,0,0
106702,received,0,0
106703,the,0,0
106704,same,0,0
106705,cementless,1,1
106706,implant,1,1
106707,",",0,0
106708,inserted,0,1
106709,with,0,0
106710,use,0,0
106711,of,0,0
106712,standard,0,1
106713,instruments,0,0
106714,",",0,0
106715,and,0,0
106716,all,0,0
106717,operations,0,0
106718,were,0,0
106719,performed,0,0
106720,by,0,0
106721,a,0,0
106722,single,0,0
106723,",",0,0
106724,experienced,0,0
106725,surgeon,0,1
106726,.,0,0
106727,The,0,0
106728,patients,0,0
106729,were,0,0
106730,evaluated,0,0
106731,with,0,0
106732,use,0,0
106733,of,0,0
106734,three-dimensional,0,1
106735,gait,0,0
106736,analysis,0,0
106737,and,0,0
106738,dynamic,0,0
106739,electromyograms,0,1
106740,at,0,0
106741,three,0,0
106742,time,0,0
106743,points,0,0
106744,:,0,0
106745,preoperatively,0,0
106746,",",0,0
106747,ten,0,0
106748,days,0,0
106749,postoperatively,0,0
106750,",",0,0
106751,and,0,0
106752,twelve,0,0
106753,weeks,0,0
106754,postoperatively,0,0
106755,.,0,0
106756,Temporospatial,0,0
106757,and,0,0
106758,joint-kinematic,0,0
106759,parameters,0,0
106760,were,0,0
106761,evaluated,0,0
106762,.,0,0
106763,RESULTS,0,0
106764,There,0,0
106765,were,0,0
106766,no,0,0
106767,significant,0,0
106768,differences,0,0
106769,between,0,0
106770,the,0,0
106771,two,0,0
106772,groups,0,0
106773,with,0,0
106774,regard,0,0
106775,to,0,0
106776,the,0,0
106777,temporospatial,0,0
106778,variables,0,0
106779,of,0,0
106780,velocity,0,0
106781,",",0,0
106782,cadence,0,0
106783,",",0,0
106784,step,0,0
106785,length,0,0
106786,",",0,0
106787,and,0,0
106788,stride,0,1
106789,length,0,0
106790,at,0,0
106791,any,0,0
106792,tested,0,0
106793,time,0,0
106794,point,0,0
106795,.,0,0
106796,With,0,0
106797,regard,0,0
106798,to,0,0
106799,the,0,0
106800,range,0,0
106801,of,0,0
106802,motion,0,0
106803,of,0,0
106804,the,0,0
106805,operatively,0,0
106806,treated,0,0
106807,hip,0,0
106808,",",0,0
106809,the,0,0
106810,minimally,0,1
106811,invasive,0,0
106812,group,0,0
106813,had,0,0
106814,a,0,0
106815,smaller,0,0
106816,decrease,0,0
106817,at,0,0
106818,the,0,0
106819,ten-day,0,0
106820,time,0,0
106821,point,0,0
106822,in,0,0
106823,comparison,0,0
106824,with,0,0
106825,the,0,0
106826,standard,0,1
106827,group,0,0
106828,.,0,0
106829,However,0,0
106830,",",0,0
106831,this,0,0
106832,finding,0,0
106833,was,0,0
106834,not,0,0
106835,significant,0,0
106836,.,0,0
106837,The,0,0
106838,reduction,0,0
106839,in,0,0
106840,the,0,0
106841,range,0,0
106842,of,0,0
106843,motion,0,0
106844,was,0,0
106845,mainly,0,0
106846,caused,0,0
106847,by,0,0
106848,reduced,0,0
106849,hip,0,0
106850,extension,0,0
106851,.,0,0
106852,A,0,0
106853,compensatory,0,0
106854,increase,0,0
106855,in,0,0
106856,the,0,0
106857,pelvic,0,1
106858,tilt,0,1
106859,was,0,0
106860,observed,0,0
106861,in,0,0
106862,both,0,0
106863,groups,0,0
106864,.,0,0
106865,One,0,0
106866,patient,0,0
106867,in,0,0
106868,the,0,0
106869,standard,0,1
106870,group,0,0
106871,showed,0,0
106872,a,0,0
106873,positive,0,0
106874,Trendelenburg,0,1
106875,gait,0,0
106876,ten,0,0
106877,days,0,0
106878,postoperatively,0,0
106879,;,0,0
106880,it,0,0
106881,had,0,0
106882,disappeared,0,0
106883,completely,0,0
106884,at,0,0
106885,the,0,0
106886,twelve-week,0,0
106887,time,0,0
106888,point,0,0
106889,.,0,0
106890,CONCLUSIONS,0,0
106891,With,0,0
106892,regard,0,0
106893,to,0,0
106894,gait,0,0
106895,kinematics,0,0
106896,in,0,0
106897,the,0,0
106898,early,0,0
106899,postoperative,0,0
106900,period,0,0
106901,(,0,0
106902,three,0,1
106903,months,0,0
106904,),0,0
106905,",",0,0
106906,the,0,0
106907,present,0,0
106908,study,0,0
106909,showed,0,0
106910,no,0,0
106911,significant,0,0
106912,benefit,0,0
106913,for,0,0
106914,patients,0,0
106915,who,0,0
106916,underwent,0,0
106917,a,0,0
106918,total,0,0
106919,hip,0,0
106920,arthroplasty,0,1
106921,through,0,0
106922,a,0,0
106923,minimally,0,0
106924,invasive,0,0
106925,Watson-Jones,0,1
106926,approach,0,1
106927,in,0,0
106928,comparison,0,0
106929,with,0,0
106930,those,0,0
106931,who,0,0
106932,were,0,0
106933,managed,0,0
106934,with,0,0
106935,a,0,0
106936,standard,0,1
106937,transgluteal,0,1
106938,approach,0,1
106939,.,0,0
106940,Helping,0,1
106941,women,0,0
106942,make,0,0
106943,choices,0,0
106944,about,0,0
106945,mammography,0,1
106946,screening,0,0
106947,:,0,0
106948,an,0,0
106949,online,0,1
106950,randomized,0,0
106951,trial,0,0
106952,of,0,0
106953,a,0,0
106954,decision,0,0
106955,aid,0,0
106956,for,0,0
106957,40-year-old,0,0
106958,women,0,0
106959,.,0,0
106960,OBJECTIVE,0,0
106961,To,0,0
106962,evaluate,0,0
106963,the,0,0
106964,effect,0,0
106965,of,0,0
106966,a,0,0
106967,decision,1,1
106968,aid,1,0
106969,(,1,1
106970,DA,1,1
106971,),1,1
106972,on,0,0
106973,women,0,0
106974,'s,0,0
106975,knowledge,0,0
106976,of,0,0
106977,the,0,0
106978,benefits,0,0
106979,and,0,0
106980,harms,0,0
106981,of,0,0
106982,screening,0,0
106983,and,0,0
106984,on,0,0
106985,their,0,0
106986,ability,0,0
106987,to,0,0
106988,make,0,0
106989,an,0,0
106990,informed,0,0
106991,decision,0,0
106992,.,0,0
106993,METHODS,0,0
106994,An,0,0
106995,online,0,1
106996,randomized,0,0
106997,controlled,0,0
106998,trial,0,0
106999,among,0,0
107000,321,0,0
107001,women,0,0
107002,aged,0,0
107003,38-45,0,0
107004,years,0,0
107005,was,0,0
107006,conducted,0,0
107007,.,0,0
107008,Participants,0,0
107009,were,0,0
107010,randomized,0,0
107011,to,0,0
107012,either,0,1
107013,immediate,1,1
107014,or,1,1
107015,delayed,1,0
107016,access,1,0
107017,to,1,0
107018,the,1,0
107019,online,1,1
107020,DA,1,1
107021,which,0,0
107022,(,0,1
107023,i,0,0
107024,),0,1
107025,explained,0,0
107026,the,0,0
107027,benefits,0,0
107028,and,0,0
107029,harms,0,0
107030,",",0,0
107031,(,0,0
107032,ii,0,0
107033,),0,1
107034,included,0,0
107035,a,0,0
107036,values,0,0
107037,clarification,0,0
107038,exercise,0,1
107039,and,0,0
107040,a,0,0
107041,worksheet,0,1
107042,to,0,0
107043,support,0,1
107044,decision,0,0
107045,making,0,0
107046,.,0,0
107047,The,0,0
107048,primary,0,0
107049,outcome,0,0
107050,",",0,0
107051,knowledge,0,0
107052,of,0,0
107053,benefits,0,0
107054,and,0,0
107055,harms,0,0
107056,of,0,0
107057,screening,0,0
107058,",",0,0
107059,and,0,0
107060,secondary,0,0
107061,outcomes,0,0
107062,",",0,0
107063,informed,0,1
107064,choice,0,0
107065,(,0,0
107066,composite,0,1
107067,of,0,0
107068,knowledge,0,0
107069,",",0,0
107070,values,0,0
107071,and,0,0
107072,intention,0,0
107073,),0,1
107074,",",0,0
107075,anxiety,0,0
107076,and,0,0
107077,acceptability,0,0
107078,of,0,0
107079,the,0,0
107080,DA,0,0
107081,were,0,0
107082,measured,0,0
107083,using,0,0
107084,online,0,1
107085,questionnaires,0,0
107086,.,0,0
107087,RESULTS,0,0
107088,Women,0,0
107089,in,0,0
107090,the,0,0
107091,intervention,0,1
107092,group,0,0
107093,were,0,0
107094,more,0,0
107095,knowledgeable,0,0
107096,(,0,0
107097,mean,0,0
107098,score,0,0
107099,out,0,0
107100,of,0,0
107101,10,0,0
107102,",",0,0
107103,7.35,0,0
107104,vs,0,0
107105,6.27,0,0
107106,",",0,0
107107,p,0,0
107108,<,0,0
107109,0.001,0,0
107110,),0,0
107111,and,0,0
107112,were,0,0
107113,more,0,0
107114,likely,0,0
107115,to,0,0
107116,have,0,0
107117,made,0,0
107118,a,0,0
107119,decision,0,1
107120,(,0,0
107121,82,0,0
107122,%,0,0
107123,vs,0,0
107124,61,0,0
107125,%,0,0
107126,p,0,0
107127,<,0,0
107128,0.001,0,0
107129,),0,0
107130,.,0,0
107131,Of,0,0
107132,those,0,0
107133,who,0,0
107134,made,0,0
107135,a,0,0
107136,decision,0,0
107137,",",0,0
107138,women,0,0
107139,in,0,0
107140,the,0,0
107141,intervention,0,1
107142,group,0,0
107143,were,0,0
107144,less,0,0
107145,likely,0,0
107146,to,0,0
107147,start,0,0
107148,screening,0,1
107149,now,0,0
107150,(,0,0
107151,52,0,0
107152,%,0,0
107153,vs,0,0
107154,65,0,0
107155,%,0,0
107156,p=0.05,0,0
107157,),0,0
107158,.,0,0
107159,There,0,0
107160,was,0,0
107161,no,0,0
107162,significant,0,0
107163,difference,0,0
107164,in,0,0
107165,the,0,0
107166,proportion,0,0
107167,of,0,0
107168,women,0,0
107169,who,0,0
107170,made,0,0
107171,an,0,0
107172,informed,0,1
107173,choice,0,0
107174,(,0,0
107175,71,0,0
107176,%,0,0
107177,intervention,0,1
107178,group,0,0
107179,vs,0,0
107180,64,0,0
107181,%,0,0
107182,control,1,1
107183,group,0,0
107184,",",0,0
107185,p=0.24,0,0
107186,),0,0
107187,.,0,0
107188,The,0,0
107189,DA,0,0
107190,was,0,0
107191,helpful,0,0
107192,",",0,0
107193,balanced,0,1
107194,and,0,0
107195,clear,0,1
107196,",",0,0
107197,and,0,0
107198,did,0,0
107199,not,0,0
107200,make,0,0
107201,women,0,0
107202,anxious,0,0
107203,.,0,0
107204,CONCLUSIONS,0,0
107205,The,0,0
107206,DA,0,0
107207,increased,0,0
107208,knowledge,0,0
107209,and,0,0
107210,reduced,0,0
107211,indecision,0,0
107212,",",0,0
107213,without,0,0
107214,increasing,0,0
107215,feelings,0,0
107216,of,0,0
107217,anxiety,0,0
107218,.,0,0
107219,PRACTICE,0,0
107220,IMPLICATIONS,0,0
107221,This,0,0
107222,decision,0,0
107223,aid,0,0
107224,is,0,0
107225,easy,0,0
107226,to,0,0
107227,access,0,1
107228,online,0,1
107229,and,0,0
107230,could,0,0
107231,be,0,0
107232,an,0,0
107233,inexpensive,0,0
107234,way,0,0
107235,of,0,0
107236,supporting,0,0
107237,women,0,0
107238,aged,0,0
107239,40,0,0
107240,who,0,0
107241,are,0,0
107242,considering,0,0
107243,whether,0,0
107244,to,0,0
107245,start,0,0
107246,screening,0,0
107247,now,0,0
107248,",",0,0
107249,or,0,0
107250,wait,0,1
107251,until,0,0
107252,they,0,0
107253,are,0,0
107254,50,0,0
107255,.,0,0
107256,The,0,0
107257,results,0,0
107258,of,0,0
107259,this,0,0
107260,study,0,0
107261,demonstrate,0,0
107262,the,0,0
107263,potential,0,0
107264,of,0,0
107265,DAs,0,0
107266,to,0,0
107267,help,0,0
107268,inform,0,0
107269,women,0,0
107270,about,0,0
107271,both,0,0
107272,the,0,0
107273,benefits,0,0
107274,and,0,0
107275,risks,0,0
107276,of,0,0
107277,screening,0,0
107278,at,0,0
107279,this,0,0
107280,age,0,0
107281,and,0,0
107282,to,0,0
107283,support,0,1
107284,women,0,0
107285,and,0,0
107286,clinicians,0,0
107287,in,0,0
107288,this,0,0
107289,decision,0,1
107290,making,0,0
107291,process,0,0
107292,.,0,0
107293,Can,0,0
107294,incentives,1,0
107295,undermine,0,0
107296,intrinsic,0,0
107297,motivation,0,0
107298,to,0,0
107299,participate,0,0
107300,in,0,0
107301,epidemiologic,0,0
107302,surveys,0,0
107303,?,0,0
107304,Response,0,0
107305,rates,0,0
107306,to,0,0
107307,surveys,0,0
107308,are,0,0
107309,decreasing,0,0
107310,.,0,0
107311,The,0,0
107312,purpose,0,0
107313,of,0,0
107314,this,0,0
107315,study,0,0
107316,was,0,0
107317,to,0,0
107318,evaluate,0,0
107319,the,0,0
107320,use,1,0
107321,of,1,0
107322,lottery,1,1
107323,tickets,1,1
107324,as,1,0
107325,incentives,1,0
107326,in,0,0
107327,an,0,0
107328,epidemiologic,0,0
107329,control,0,0
107330,group,0,0
107331,.,0,0
107332,A,0,0
107333,self-administered,0,0
107334,questionnaire,0,0
107335,was,0,0
107336,sent,0,0
107337,to,0,0
107338,parents,0,0
107339,in,0,0
107340,the,0,0
107341,municipality,0,0
107342,of,0,0
107343,Stockholm,0,0
107344,",",0,0
107345,Sweden,0,0
107346,",",0,0
107347,who,0,0
107348,were,0,0
107349,to,0,0
107350,be,0,0
107351,used,0,0
107352,as,0,0
107353,a,0,0
107354,control,0,1
107355,group,0,0
107356,in,0,0
107357,a,0,0
107358,study,0,0
107359,addressing,0,0
107360,stress,0,0
107361,in,0,0
107362,parents,0,0
107363,of,0,0
107364,children,0,0
107365,with,0,0
107366,cancer,0,0
107367,.,0,0
107368,A,0,0
107369,stratified,0,0
107370,random,0,0
107371,sample,0,0
107372,of,0,0
107373,450,0,0
107374,parents,0,0
107375,were,0,0
107376,randomized,0,0
107377,into,0,0
107378,three,1,0
107379,incentive,1,1
107380,groups,1,0
107381,:,1,0
107382,(,1,0
107383,a,1,0
107384,),1,0
107385,no,1,0
107386,incentive,1,1
107387,;,1,0
107388,(,1,1
107389,b,1,0
107390,),1,1
107391,a,1,0
107392,promised,1,0
107393,incentive,1,1
107394,of,1,0
107395,one,1,0
107396,lottery,1,1
107397,ticket,1,1
107398,to,1,0
107399,be,1,0
107400,received,1,0
107401,upon,1,0
107402,reply,1,0
107403,;,1,0
107404,(,1,1
107405,c,1,0
107406,),1,1
107407,a,1,0
107408,promised,1,0
107409,incentive,1,1
107410,of,1,0
107411,one,1,0
107412,lottery,1,1
107413,ticket,1,1
107414,to,1,0
107415,be,1,0
107416,received,1,0
107417,upon,1,0
107418,reply,1,0
107419,and,1,0
107420,an,1,0
107421,additional,1,0
107422,lottery,1,1
107423,ticket,1,1
107424,upon,1,0
107425,reply,1,0
107426,within,1,0
107427,1,1,0
107428,week,1,0
107429,.,1,0
107430,The,0,0
107431,overall,0,0
107432,response,0,0
107433,rate,0,0
107434,across,0,0
107435,the,0,0
107436,three,0,0
107437,groups,0,0
107438,was,0,0
107439,65.3,0,0
107440,%,0,0
107441,.,0,0
107442,The,0,0
107443,response,0,0
107444,rate,0,0
107445,was,0,0
107446,highest,0,0
107447,in,0,0
107448,the,0,0
107449,no,1,0
107450,incentive,1,1
107451,group,1,0
107452,(,0,0
107453,69.3,0,0
107454,%,0,0
107455,),0,0
107456,and,0,0
107457,lowest,0,0
107458,in,0,0
107459,the,0,0
107460,one,1,0
107461,plus,1,1
107462,one,1,0
107463,lottery,1,1
107464,ticket,1,1
107465,group,1,1
107466,(,0,0
107467,62.0,0,0
107468,%,0,0
107469,),0,0
107470,.,0,0
107471,In,0,0
107472,a,0,0
107473,survival,0,0
107474,analysis,0,0
107475,",",0,0
107476,the,0,0
107477,difference,0,0
107478,between,0,0
107479,the,0,0
107480,two,0,0
107481,response,0,0
107482,curves,0,0
107483,was,0,0
107484,significant,0,0
107485,by,0,0
107486,the,0,0
107487,log-rank,0,0
107488,test,0,0
107489,(,0,0
107490,P,0,0
107491,=,0,0
107492,0.04,0,0
107493,),0,0
107494,",",0,0
107495,with,0,0
107496,the,0,0
107497,no,0,0
107498,incentive,0,1
107499,group,0,0
107500,having,0,0
107501,a,0,0
107502,shorter,0,0
107503,time,0,0
107504,to,0,0
107505,response,0,0
107506,than,0,0
107507,the,0,0
107508,incentive,1,1
107509,group,1,0
107510,.,1,0
107511,Our,0,0
107512,findings,0,0
107513,suggest,0,0
107514,that,0,0
107515,the,0,0
107516,use,0,0
107517,of,0,0
107518,lottery,1,1
107519,tickets,1,1
107520,as,0,0
107521,incentives,0,0
107522,to,0,0
107523,increase,0,0
107524,participation,0,0
107525,in,0,0
107526,a,0,0
107527,mail,0,1
107528,questionnaire,0,0
107529,among,0,0
107530,parents,0,0
107531,may,0,0
107532,be,0,0
107533,less,0,0
107534,valuable,0,0
107535,or,0,1
107536,even,0,0
107537,harmful,0,0
107538,.,0,0
107539,Incentives,1,0
107540,may,0,0
107541,undermine,0,0
107542,motivation,0,0
107543,in,0,0
107544,studies,0,0
107545,in,0,0
107546,which,0,0
107547,the,0,0
107548,intrinsic,0,0
107549,motivation,0,0
107550,of,0,0
107551,the,0,0
107552,respondents,0,0
107553,is,0,0
107554,already,0,0
107555,high,0,0
107556,.,0,0
107557,A,0,0
107558,randomized,0,0
107559,",",0,0
107560,double-blind,0,0
107561,",",0,0
107562,placebo-controlled,1,1
107563,",",0,0
107564,phase,0,0
107565,I,0,0
107566,study,0,0
107567,of,0,0
107568,MEDI-545,1,0
107569,",",0,0
107570,an,0,0
107571,anti-interferon-alfa,0,1
107572,monoclonal,0,1
107573,antibody,0,0
107574,",",0,0
107575,in,0,0
107576,subjects,0,0
107577,with,0,0
107578,chronic,0,0
107579,psoriasis,0,0
107580,.,0,0
107581,BACKGROUND,0,0
107582,Interferon-alfa,0,1
107583,(,0,1
107584,IFN-alpha,0,1
107585,),0,1
107586,has,0,0
107587,been,0,0
107588,implicated,0,0
107589,in,0,0
107590,the,0,0
107591,pathogenesis,0,0
107592,of,0,0
107593,psoriasis,0,0
107594,.,0,0
107595,OBJECTIVE,0,0
107596,To,0,0
107597,evaluate,0,0
107598,the,0,0
107599,safety,0,0
107600,profile,0,0
107601,of,0,0
107602,MEDI-545,1,0
107603,",",0,0
107604,a,0,0
107605,fully,0,0
107606,human,0,1
107607,anti-IFN-alpha,0,1
107608,monoclonal,0,1
107609,antibody,0,1
107610,and,0,0
107611,to,0,0
107612,explore,0,0
107613,its,0,0
107614,effect,0,0
107615,on,0,0
107616,the,0,0
107617,involvement,0,0
107618,of,0,0
107619,type,0,0
107620,I,0,0
107621,IFN-alpha,0,1
107622,activity,0,0
107623,in,0,0
107624,the,0,0
107625,maintenance,0,0
107626,of,0,0
107627,established,0,0
107628,plaque,0,0
107629,psoriasis,0,0
107630,.,0,0
107631,METHODS,0,0
107632,We,0,0
107633,conducted,0,0
107634,an,0,0
107635,18-week,0,0
107636,",",0,0
107637,randomized,0,0
107638,",",0,0
107639,double-blind,0,0
107640,",",0,0
107641,placebo-controlled,1,1
107642,",",0,0
107643,dose-escalating,0,1
107644,study,0,0
107645,in,0,0
107646,36,0,0
107647,subjects,0,0
107648,with,0,0
107649,chronic,0,0
107650,plaque,0,0
107651,psoriasis,0,0
107652,.,0,0
107653,Subjects,0,0
107654,received,0,0
107655,one,0,0
107656,intravenous,0,1
107657,dose,0,0
107658,of,0,0
107659,MEDI-545,1,1
107660,(,1,0
107661,0.3-30.0,1,0
107662,mg/kg,1,1
107663,),1,1
107664,or,1,1
107665,placebo,1,1
107666,.,1,0
107667,Study,0,0
107668,outcomes,0,0
107669,were,0,0
107670,safety,0,0
107671,profile,0,0
107672,",",0,0
107673,pharmacokinetics,0,0
107674,",",0,0
107675,immunogenicity,0,0
107676,",",0,0
107677,and,0,0
107678,clinical,0,0
107679,effects,0,0
107680,.,0,0
107681,RESULTS,0,0
107682,There,0,0
107683,was,0,0
107684,no,0,0
107685,difference,0,0
107686,in,0,0
107687,adverse,0,0
107688,events,0,0
107689,between,0,0
107690,MEDI-545,1,1
107691,and,1,0
107692,placebo,1,1
107693,.,1,0
107694,Two,0,0
107695,serious,0,0
107696,adverse,0,0
107697,events,0,0
107698,were,0,0
107699,reported,0,0
107700,;,0,0
107701,one,0,0
107702,drug-related,0,0
107703,hypotensive,0,0
107704,infusion,0,1
107705,reaction,0,1
107706,occurred,0,0
107707,in,0,0
107708,one,0,0
107709,subject,0,0
107710,in,0,0
107711,the,0,0
107712,30.0,0,0
107713,mg/kg,0,1
107714,MEDI-545,1,1
107715,dose,0,1
107716,group,0,0
107717,",",0,0
107718,causing,0,0
107719,discontinuation,0,0
107720,of,0,0
107721,study,0,0
107722,drug,0,1
107723,in,0,0
107724,that,0,0
107725,subject,0,0
107726,and,0,0
107727,study,0,0
107728,dismissal,0,0
107729,of,0,0
107730,the,0,0
107731,other,0,0
107732,subjects,0,0
107733,in,0,0
107734,the,0,0
107735,same,0,0
107736,cohort,0,0
107737,;,0,0
107738,and,0,0
107739,a,0,0
107740,myocardial,0,0
107741,infarction,0,0
107742,occurred,0,0
107743,in,0,0
107744,one,0,0
107745,subject,0,0
107746,in,0,0
107747,the,0,0
107748,10,0,0
107749,mg/kg,0,1
107750,MEDI-545,1,1
107751,dose,0,1
107752,group,0,0
107753,",",0,0
107754,which,0,0
107755,was,0,0
107756,considered,0,0
107757,to,0,0
107758,be,0,0
107759,unrelated,0,0
107760,to,0,0
107761,treatment,0,0
107762,.,0,0
107763,MEDI-545,1,0
107764,was,0,0
107765,nonimmunogenic,0,0
107766,",",0,0
107767,had,0,0
107768,a,0,0
107769,half-life,0,0
107770,of,0,0
107771,21,0,0
107772,days,0,0
107773,",",0,0
107774,showed,0,0
107775,no,0,0
107776,significant,0,0
107777,inhibition,0,0
107778,of,0,0
107779,the,0,0
107780,type,0,0
107781,I,0,0
107782,IFN,0,0
107783,gene,0,1
107784,signature,0,1
107785,",",0,0
107786,and,0,0
107787,had,0,0
107788,no,0,0
107789,clinical,0,0
107790,activity,0,0
107791,.,0,0
107792,LIMITATIONS,0,0
107793,The,0,0
107794,study,0,0
107795,addressed,0,0
107796,only,0,0
107797,IFN-alpha,0,1
107798,and,0,0
107799,chronic,0,0
107800,psoriatic,0,0
107801,lesions,0,0
107802,.,0,0
107803,CONCLUSION,0,0
107804,The,0,0
107805,safety,0,0
107806,profile,0,0
107807,of,0,0
107808,MEDI-545,1,0
107809,supports,0,0
107810,further,0,0
107811,clinical,0,0
107812,development,0,0
107813,.,0,0
107814,IFN-alpha,0,1
107815,does,0,0
107816,not,0,0
107817,appear,0,0
107818,to,0,0
107819,be,0,0
107820,significantly,0,0
107821,involved,0,0
107822,in,0,0
107823,the,0,0
107824,maintenance,0,0
107825,of,0,0
107826,established,0,0
107827,plaque,0,0
107828,psoriasis,0,0
107829,.,0,0
107830,Relief,0,0
107831,of,0,0
107832,periorbital,0,0
107833,pain,0,0
107834,after,0,0
107835,acute,0,0
107836,angle,0,0
107837,closure,0,1
107838,glaucoma,0,1
107839,attack,0,0
107840,by,0,0
107841,botulinum,1,1
107842,toxin,1,1
107843,type,1,0
107844,A,1,0
107845,.,1,0
107846,PURPOSE,0,0
107847,To,0,0
107848,assess,0,0
107849,the,0,0
107850,efficacy,0,0
107851,and,0,0
107852,safety,0,0
107853,of,0,0
107854,botulinum,1,1
107855,toxin,1,1
107856,type,1,0
107857,A,1,1
107858,(,1,1
107859,BoNT-A,1,1
107860,),1,1
107861,injection,0,1
107862,in,0,0
107863,patients,0,0
107864,suffering,0,0
107865,from,0,0
107866,intractable,0,0
107867,periorbital,0,1
107868,pain,0,0
107869,after,0,0
107870,acute,0,0
107871,angle,0,0
107872,closure,0,1
107873,glaucoma,0,1
107874,(,0,1
107875,AACG,0,1
107876,),0,0
107877,.,0,0
107878,PATIENTS,0,0
107879,AND,0,0
107880,METHODS,0,0
107881,In,0,0
107882,this,0,0
107883,prospective,0,0
107884,randomized,0,0
107885,intervention,0,1
107886,study,0,0
107887,",",0,0
107888,19,0,0
107889,patients,0,0
107890,suffering,0,0
107891,from,0,0
107892,periorbital,0,1
107893,pain,0,0
107894,after,0,0
107895,an,0,0
107896,AACG,0,1
107897,attack,0,0
107898,were,0,0
107899,injected,1,0
107900,with,1,0
107901,BoNT-A,1,1
107902,or,1,1
107903,placebo,1,1
107904,for,0,0
107905,pain,0,0
107906,relief,0,0
107907,.,0,0
107908,Patients,0,0
107909,were,0,0
107910,assessed,0,0
107911,on,0,0
107912,days,0,0
107913,1,0,0
107914,",",0,0
107915,2,0,0
107916,",",0,0
107917,7,0,0
107918,",",0,0
107919,14,0,0
107920,",",0,0
107921,30,0,0
107922,",",0,0
107923,60,0,0
107924,",",0,0
107925,and,0,0
107926,90,0,0
107927,.,0,0
107928,The,0,0
107929,main,0,0
107930,outcomes,0,0
107931,were,0,0
107932,mean,0,0
107933,change,0,0
107934,of,0,0
107935,visual,0,0
107936,analog,0,1
107937,rating,0,1
107938,scale,0,0
107939,(,0,1
107940,VARS,0,1
107941,),0,1
107942,and,0,0
107943,index,0,0
107944,scores,0,0
107945,measured,0,0
107946,through,0,0
107947,a,0,0
107948,quality-of-life,0,0
107949,questionnaire,0,1
107950,(,0,1
107951,EQ-5D,0,1
107952,),0,1
107953,",",0,0
107954,and,0,0
107955,changes,0,0
107956,in,0,0
107957,the,0,0
107958,visual,0,0
107959,analog,0,1
107960,scale,0,0
107961,(,0,1
107962,VAS,0,1
107963,),0,0
107964,",",0,0
107965,all,0,0
107966,of,0,0
107967,which,0,0
107968,were,0,0
107969,assessed,0,0
107970,at,0,0
107971,each,0,0
107972,visit,0,0
107973,.,0,0
107974,A,0,0
107975,secondary,0,0
107976,outcome,0,0
107977,was,0,0
107978,the,0,0
107979,frequency,0,0
107980,and,0,0
107981,nature,0,0
107982,of,0,0
107983,adverse,0,0
107984,events,0,0
107985,and,0,0
107986,the,0,0
107987,number,0,0
107988,of,0,0
107989,patients,0,0
107990,who,0,0
107991,withdrew,0,0
107992,from,0,0
107993,the,0,0
107994,study,0,0
107995,as,0,0
107996,a,0,0
107997,result,0,0
107998,.,0,0
107999,RESULTS,0,0
108000,In,0,0
108001,the,0,0
108002,treatment,0,1
108003,group,0,1
108004,(,0,1
108005,n=10,0,0
108006,),0,0
108007,",",0,0
108008,the,0,0
108009,mean,0,0
108010,index,0,0
108011,score,0,0
108012,of,0,0
108013,EQ-5D,0,0
108014,and,0,0
108015,VAS,0,1
108016,changed,0,0
108017,significantly,0,0
108018,from,0,0
108019,the,0,0
108020,placebo,1,1
108021,group,0,0
108022,(,0,0
108023,by,0,0
108024,0.299,0,0
108025,and,0,0
108026,2.61,0,0
108027,",",0,0
108028,respectively,0,0
108029,),0,0
108030,from,0,0
108031,day,0,1
108032,2,0,0
108033,(,0,0
108034,P,0,0
108035,<,0,0
108036,0.01,0,0
108037,),0,0
108038,.,0,0
108039,The,0,0
108040,VARS,0,0
108041,of,0,0
108042,EQ-5D,0,0
108043,also,0,0
108044,disclosed,0,0
108045,significant,0,0
108046,changes,0,0
108047,from,0,0
108048,day,0,0
108049,2,0,0
108050,(,0,0
108051,17,0,0
108052,",",0,0
108053,P,0,0
108054,<,0,0
108055,0.01,0,0
108056,),0,0
108057,.,0,0
108058,In,0,0
108059,addition,0,0
108060,",",0,0
108061,efficacy,0,0
108062,was,0,0
108063,maintained,0,0
108064,mainly,0,0
108065,between,0,0
108066,days,0,0
108067,2,0,0
108068,and,0,0
108069,60,0,0
108070,but,0,0
108071,declined,0,0
108072,slightly,0,0
108073,by,0,0
108074,day,0,0
108075,90,0,0
108076,.,0,0
108077,The,0,0
108078,most,0,0
108079,frequently,0,0
108080,reported,0,0
108081,treatment-related,0,0
108082,adverse,0,0
108083,events,0,0
108084,in,0,0
108085,the,0,0
108086,treatment,0,0
108087,and,0,0
108088,placebo,0,1
108089,groups,0,0
108090,were,0,0
108091,local,0,1
108092,tenderness,0,0
108093,(,0,0
108094,21,0,0
108095,%,0,0
108096,),0,0
108097,",",0,0
108098,subcutaneous,0,1
108099,hemorrhage,0,0
108100,(,0,0
108101,10.5,0,0
108102,%,0,0
108103,),0,0
108104,",",0,0
108105,and,0,1
108106,conjunctivitis,0,0
108107,(,0,1
108108,10.5,0,0
108109,%,0,0
108110,),0,0
108111,.,0,0
108112,No,0,0
108113,severe,0,0
108114,adverse,0,0
108115,events,0,0
108116,were,0,0
108117,reported,0,0
108118,during,0,0
108119,the,0,0
108120,study,0,0
108121,or,0,1
108122,follow-up,0,0
108123,period,0,0
108124,.,0,0
108125,CONCLUSIONS,0,0
108126,BoNT-A,1,1
108127,is,0,0
108128,effective,0,0
108129,and,0,0
108130,well,0,0
108131,tolerated,0,0
108132,for,0,0
108133,the,0,0
108134,treatment,0,0
108135,of,0,0
108136,periorbital,0,0
108137,pain,0,0
108138,after,0,0
108139,an,0,0
108140,AACG,0,0
108141,attack,0,0
108142,.,0,0
108143,Its,0,0
108144,effects,0,0
108145,may,0,0
108146,be,0,0
108147,maintained,0,0
108148,for,0,0
108149,3,0,0
108150,months,0,0
108151,.,0,0
108152,Differential,0,1
108153,response,0,0
108154,to,0,0
108155,resistance,1,0
108156,training,1,1
108157,in,0,0
108158,CHF,0,0
108159,according,0,0
108160,to,0,0
108161,ACE,0,0
108162,genotype,0,0
108163,.,0,0
108164,BACKGROUND,0,0
108165,The,0,0
108166,Angiotensin,0,1
108167,Converting,0,1
108168,Enzyme,0,1
108169,(,0,1
108170,ACE,0,0
108171,),0,1
108172,gene,0,0
108173,may,0,0
108174,influence,0,0
108175,the,0,0
108176,risk,0,0
108177,of,0,0
108178,heart,0,0
108179,disease,0,0
108180,and,0,0
108181,the,0,0
108182,response,0,0
108183,to,0,0
108184,various,0,0
108185,forms,0,0
108186,of,0,0
108187,exercise,0,1
108188,training,0,1
108189,may,0,0
108190,be,0,0
108191,at,0,0
108192,least,0,0
108193,partly,0,0
108194,dependent,0,0
108195,on,0,0
108196,the,0,0
108197,ACE,0,0
108198,genotype,0,0
108199,.,0,0
108200,We,0,0
108201,aimed,0,0
108202,to,0,0
108203,determine,0,0
108204,the,0,0
108205,effect,0,0
108206,of,0,0
108207,ACE,0,0
108208,genotype,0,0
108209,on,0,0
108210,the,0,0
108211,response,0,0
108212,to,0,0
108213,moderate,0,0
108214,intensity,0,0
108215,circuit,0,1
108216,resistance,1,0
108217,training,1,1
108218,in,0,0
108219,chronic,0,0
108220,heart,0,0
108221,failure,0,0
108222,(,0,1
108223,CHF,0,0
108224,),0,0
108225,patients,0,0
108226,.,0,0
108227,METHODS,0,0
108228,The,0,0
108229,relationship,0,0
108230,between,0,0
108231,ACE,0,0
108232,genotype,0,0
108233,and,0,0
108234,the,0,0
108235,response,0,0
108236,to,0,0
108237,11weeks,1,0
108238,of,1,0
108239,resistance,1,0
108240,exercise,1,1
108241,training,1,1
108242,was,0,0
108243,determined,0,0
108244,in,0,0
108245,37,0,0
108246,CHF,0,0
108247,patients,0,0
108248,(,0,0
108249,New,0,1
108250,York,0,1
108251,Heart,0,1
108252,Association,0,0
108253,Functional,0,1
108254,Class=2.3?0.5,0,1
108255,;,0,0
108256,left,0,0
108257,ventricular,0,0
108258,ejection,0,0
108259,fraction,0,0
108260,28?7,0,0
108261,%,0,0
108262,;,0,0
108263,age,0,0
108264,64?12years,0,0
108265,;,0,0
108266,32:5,0,0
108267,male,0,0
108268,:,0,1
108269,female,0,0
108270,),0,0
108271,who,0,0
108272,were,0,0
108273,randomised,0,0
108274,to,0,0
108275,either,1,1
108276,resistance,1,0
108277,exercise,1,1
108278,(,1,1
108279,n=19,1,1
108280,),0,1
108281,or,0,1
108282,inactive,1,1
108283,control,1,1
108284,group,1,1
108285,(,1,1
108286,n=18,1,0
108287,),0,0
108288,.,0,0
108289,Outcome,0,0
108290,measures,0,0
108291,included,0,0
108292,V?O,0,0
108293,(,0,1
108294,2peak,0,0
108295,),0,0
108296,",",0,0
108297,peak,0,0
108298,power,0,0
108299,output,0,0
108300,and,0,0
108301,muscle,0,1
108302,strength,0,0
108303,and,0,0
108304,endurance,0,0
108305,.,0,1
108306,ACE,0,0
108307,genotype,0,0
108308,was,0,0
108309,determined,0,0
108310,using,0,0
108311,standard,0,1
108312,methods,0,0
108313,.,0,0
108314,RESULTS,0,0
108315,At,0,0
108316,baseline,0,0
108317,",",0,0
108318,patients,0,0
108319,who,0,0
108320,were,0,0
108321,homozygous,0,0
108322,for,0,0
108323,the,0,0
108324,I,0,0
108325,allele,0,0
108326,had,0,0
108327,higher,0,0
108328,V?O,0,0
108329,(,0,0
108330,2peak,0,1
108331,),0,1
108332,(,0,1
108333,p=0.02,0,0
108334,),0,1
108335,and,0,0
108336,peak,0,0
108337,power,0,0
108338,(,0,1
108339,p=0.003,0,0
108340,),0,1
108341,compared,0,0
108342,to,0,0
108343,patients,0,0
108344,who,0,0
108345,were,0,0
108346,homozygous,0,0
108347,for,0,0
108348,the,0,0
108349,D,0,1
108350,allele,0,0
108351,.,0,0
108352,Patients,0,0
108353,with,0,0
108354,the,0,0
108355,D,0,1
108356,allele,0,0
108357,",",0,0
108358,who,0,0
108359,were,0,0
108360,randomised,1,0
108361,to,1,0
108362,resistance,1,0
108363,training,1,1
108364,",",1,0
108365,compared,1,0
108366,to,1,0
108367,non-exercising,1,0
108368,controls,1,0
108369,",",0,0
108370,had,0,0
108371,greater,0,0
108372,peak,0,0
108373,power,0,0
108374,increases,0,0
108375,(,0,0
108376,ID,0,1
108377,p,0,0
108378,<,0,0
108379,0.001,0,0
108380,;,0,0
108381,DD,0,0
108382,p,0,0
108383,<,0,0
108384,0.001,0,0
108385,),0,0
108386,when,0,0
108387,compared,0,0
108388,with,0,0
108389,patients,0,0
108390,homozygous,0,0
108391,for,0,0
108392,the,0,0
108393,I,0,0
108394,allele,0,0
108395,",",0,0
108396,who,0,0
108397,did,0,0
108398,not,0,0
108399,improve,0,0
108400,.,0,0
108401,No,0,0
108402,significant,0,0
108403,genotype-dependent,0,0
108404,changes,0,0
108405,were,0,0
108406,observed,0,0
108407,in,0,0
108408,V?O,0,0
108409,(,0,1
108410,2peak,0,0
108411,),0,0
108412,",",0,0
108413,muscle,0,0
108414,strength,0,0
108415,",",0,0
108416,muscle,0,0
108417,endurance,0,0
108418,or,0,1
108419,lactate,0,0
108420,threshold,0,0
108421,.,0,0
108422,CONCLUSION,0,0
108423,ACE,0,0
108424,genotype,0,0
108425,may,0,0
108426,have,0,0
108427,a,0,0
108428,role,0,0
108429,in,0,0
108430,exercise,0,1
108431,tolerance,0,0
108432,in,0,0
108433,CHF,0,0
108434,and,0,0
108435,could,0,0
108436,also,0,0
108437,influence,0,0
108438,the,0,0
108439,effectiveness,0,0
108440,of,0,0
108441,resistance,0,0
108442,training,0,1
108443,in,0,0
108444,this,0,0
108445,condition,0,0
108446,.,0,0
108447,Final,0,0
108448,analysis,0,0
108449,of,0,0
108450,the,0,0
108451,UKLG,0,1
108452,LY02,0,1
108453,trial,0,0
108454,comparing,0,0
108455,6-8,0,1
108456,cycles,0,0
108457,of,0,0
108458,CHOP,1,1
108459,with,0,0
108460,3,0,0
108461,cycles,0,0
108462,of,1,0
108463,CHOP,1,1
108464,followed,1,1
108465,by,1,0
108466,a,1,0
108467,BEAM,1,1
108468,autograft,1,1
108469,in,0,0
108470,patients,0,0
108471,<,0,0
108472,65,0,0
108473,years,0,0
108474,with,0,0
108475,poor,0,0
108476,prognosis,0,0
108477,histologically,0,0
108478,aggressive,0,0
108479,NHL,0,1
108480,.,0,0
108481,This,0,0
108482,trial,0,0
108483,involved,0,0
108484,457,0,0
108485,patients,0,0
108486,and,0,0
108487,sought,0,0
108488,to,0,0
108489,assess,0,0
108490,the,0,0
108491,value,0,0
108492,of,0,0
108493,early,0,0
108494,intensification,0,1
108495,with,0,0
108496,autologous,0,1
108497,transplantation,0,0
108498,in,0,0
108499,patients,0,0
108500,with,0,0
108501,poor,0,0
108502,prognosis,0,0
108503,histologically,0,0
108504,aggressive,0,0
108505,non-Hodgkin,0,0
108506,lymphoma,0,0
108507,(,0,1
108508,NHL,0,1
108509,),0,1
108510,showing,0,0
108511,a,0,0
108512,response,0,0
108513,to,0,0
108514,initial,0,0
108515,CHOP,1,1
108516,(,1,1
108517,cyclophosphamide,1,1
108518,",",1,0
108519,doxorubicin,1,1
108520,",",1,0
108521,vincristine,1,1
108522,",",1,0
108523,prednisolone,1,1
108524,),1,0
108525,chemotherapy,1,1
108526,.,1,1
108527,Randomization,0,0
108528,was,0,0
108529,made,0,0
108530,at,0,0
108531,the,0,0
108532,time,0,0
108533,of,0,0
108534,diagnosis,0,0
108535,with,0,0
108536,223,0,0
108537,assigned,0,0
108538,to,0,0
108539,continuing,0,0
108540,CHOP,1,1
108541,and,0,0
108542,234,0,0
108543,to,0,0
108544,3,0,0
108545,cycles,0,0
108546,of,0,0
108547,CHOP,1,1
108548,followed,1,1
108549,by,1,0
108550,a,1,0
108551,BEAM,1,1
108552,(,1,0
108553,carmustine,1,1
108554,",",1,0
108555,etoposide,1,1
108556,",",1,0
108557,cytarabine,1,1
108558,",",1,0
108559,melphalan,1,1
108560,),1,0
108561,autograft,1,1
108562,.,1,1
108563,Analysis,0,0
108564,was,0,0
108565,on,0,0
108566,an,0,0
108567,intention,0,0
108568,to,0,0
108569,treat,0,0
108570,basis,0,0
108571,.,0,0
108572,After,0,0
108573,the,0,0
108574,initial,0,0
108575,three,0,0
108576,cycles,0,0
108577,of,0,0
108578,CHOP,1,1
108579,19,0,0
108580,%,0,0
108581,of,0,0
108582,the,0,0
108583,whole,0,0
108584,group,0,0
108585,were,0,0
108586,in,0,0
108587,complete,0,0
108588,response,0,0
108589,(,0,1
108590,CR,0,1
108591,),0,1
108592,and,0,0
108593,53,0,0
108594,%,0,0
108595,in,0,0
108596,partial,0,0
108597,remission,0,0
108598,(,0,1
108599,PR,0,1
108600,),0,0
108601,.,0,0
108602,At,0,0
108603,the,0,0
108604,end,0,0
108605,of,0,0
108606,treatment,0,0
108607,86,0,0
108608,%,0,0
108609,of,0,0
108610,patients,0,0
108611,in,0,0
108612,the,0,0
108613,CHOP,1,1
108614,arm,0,0
108615,had,0,0
108616,responded,0,0
108617,with,0,0
108618,58,0,0
108619,%,0,0
108620,in,0,0
108621,CR,0,1
108622,.,0,0
108623,In,0,0
108624,the,0,0
108625,high-dose,0,1
108626,therapy,0,1
108627,arm,0,0
108628,the,0,0
108629,overall,0,0
108630,response,0,0
108631,rate,0,0
108632,was,0,0
108633,83,0,0
108634,%,0,0
108635,with,0,0
108636,64,0,0
108637,%,0,0
108638,in,0,0
108639,CR,0,1
108640,(,0,0
108641,difference,0,0
108642,between,0,0
108643,arms,0,0
108644,not,0,0
108645,significant,0,0
108646,),0,0
108647,.,0,0
108648,The,0,0
108649,progression-free,0,0
108650,survival,0,0
108651,(,0,1
108652,PFS,0,1
108653,),0,1
108654,and,0,0
108655,overall,0,0
108656,survival,0,0
108657,at,0,0
108658,5,0,0
108659,years,0,0
108660,for,0,0
108661,the,0,0
108662,continuing,0,0
108663,CHOP,0,1
108664,arm,0,0
108665,were,0,0
108666,38,0,0
108667,%,0,0
108668,and,0,0
108669,50,0,1
108670,%,0,0
108671,respectively,0,0
108672,",",0,0
108673,and,0,0
108674,for,0,0
108675,the,0,0
108676,autograft,0,1
108677,arm,0,0
108678,were,0,0
108679,44,0,0
108680,%,0,0
108681,and,0,0
108682,50,0,1
108683,%,0,0
108684,(,0,0
108685,differences,0,0
108686,not,0,0
108687,significant,0,0
108688,),0,0
108689,.,0,0
108690,Of,0,0
108691,the,0,0
108692,patients,0,0
108693,who,0,0
108694,attained,0,0
108695,CR,0,1
108696,and,0,0
108697,subsequently,0,0
108698,relapsed,0,0
108699,",",0,0
108700,there,0,0
108701,were,0,0
108702,no,0,0
108703,long-term,0,0
108704,survivors,0,0
108705,in,0,0
108706,the,0,0
108707,autograft,0,1
108708,recipients,0,0
108709,compared,0,0
108710,to,0,0
108711,46,0,0
108712,%,0,0
108713,of,0,0
108714,the,0,0
108715,continuing,0,0
108716,CHOP,1,1
108717,recipients,0,0
108718,(,0,0
108719,P,0,0
108720,=,0,0
108721,0.0008,0,0
108722,),0,0
108723,.,0,0
108724,In,0,0
108725,conclusion,0,0
108726,",",0,0
108727,no,0,0
108728,survival,0,0
108729,benefit,0,0
108730,was,0,0
108731,demonstrated,0,0
108732,for,0,0
108733,an,0,0
108734,early,0,0
108735,autograft,0,1
108736,in,0,0
108737,first,0,0
108738,response,0,0
108739,.,0,0
108740,Promoting,1,1
108741,social,1,1
108742,skill,1,1
108743,development,1,0
108744,in,0,0
108745,children,0,0
108746,with,0,0
108747,pervasive,0,0
108748,developmental,0,0
108749,disorders,0,0
108750,:,0,0
108751,a,0,0
108752,feasibility,0,0
108753,and,0,0
108754,efficacy,0,0
108755,study,0,0
108756,.,0,0
108757,A,0,0
108758,randomized,0,0
108759,controlled,0,0
108760,design,0,0
108761,was,0,0
108762,employed,0,0
108763,to,0,0
108764,evaluate,0,0
108765,a,0,0
108766,social,1,0
108767,skills,1,0
108768,intervention,1,1
108769,for,0,0
108770,children,0,0
108771,with,0,0
108772,pervasive,0,0
108773,developmental,0,0
108774,disorders,0,0
108775,.,0,0
108776,Aims,0,0
108777,included,0,0
108778,evaluating,0,0
108779,the,0,0
108780,acceptability,0,0
108781,of,0,0
108782,the,0,0
108783,program,0,1
108784,and,0,0
108785,gathering,0,1
108786,preliminary,0,0
108787,evidence,0,0
108788,on,0,0
108789,efficacy,0,0
108790,.,0,0
108791,Forty-four,0,0
108792,children,0,0
108793,",",0,0
108794,ages,0,0
108795,8-11,0,0
108796,years,0,0
108797,",",0,0
108798,were,0,0
108799,randomly,0,0
108800,assigned,0,0
108801,to,0,0
108802,treatment,1,0
108803,or,0,1
108804,wait,1,1
108805,list,1,0
108806,.,1,0
108807,Treatment,0,0
108808,consisted,0,0
108809,of,0,0
108810,a,0,0
108811,16-week,0,0
108812,group,1,0
108813,intervention,1,1
108814,designed,1,0
108815,to,1,0
108816,teach,1,1
108817,appropriate,1,0
108818,social,1,0
108819,behavior,1,0
108820,.,1,0
108821,Between,0,0
108822,group,0,0
108823,comparisons,0,0
108824,showed,0,0
108825,that,0,0
108826,children,0,0
108827,in,0,0
108828,treatment,0,0
108829,were,0,0
108830,rated,0,0
108831,as,0,0
108832,improved,0,0
108833,on,0,0
108834,the,0,0
108835,primary,0,0
108836,outcome,0,0
108837,measure,0,0
108838,",",0,0
108839,(,0,0
108840,unblinded,0,0
108841,parent,0,1
108842,report,0,0
108843,),0,0
108844,",",0,0
108845,but,0,0
108846,not,0,0
108847,on,0,0
108848,the,0,0
108849,secondary,0,0
108850,outcome,0,0
108851,measure,0,0
108852,",",0,0
108853,a,0,0
108854,parent,0,1
108855,questionnaire,0,0
108856,.,0,0
108857,Parents,0,0
108858,reported,0,0
108859,a,0,0
108860,high,0,0
108861,level,0,0
108862,of,0,0
108863,satisfaction,0,0
108864,with,0,0
108865,the,0,0
108866,intervention,0,1
108867,.,0,0
108868,The,0,0
108869,study,0,0
108870,supports,0,0
108871,the,0,0
108872,feasibility,0,0
108873,of,0,0
108874,this,0,0
108875,intervention,0,1
108876,to,0,0
108877,families,0,1
108878,and,0,0
108879,highlights,0,0
108880,challenges,0,0
108881,for,0,0
108882,future,0,0
108883,research,0,0
108884,in,0,0
108885,social,1,0
108886,skills,1,0
108887,intervention,1,1
108888,.,1,0
108889,[,0,0
108890,Observation,0,0
108891,of,0,0
108892,curative,0,0
108893,effect,0,0
108894,on,0,0
108895,fixed-point,0,1
108896,spin,0,1
108897,reduction,0,0
108898,of,0,0
108899,spinal,1,0
108900,manipulation,1,1
108901,therapy,1,1
108902,for,0,0
108903,cervical,0,1
108904,vertigo,0,0
108905,],0,0
108906,.,0,0
108907,OBJECTIVE,0,0
108908,To,0,0
108909,explore,0,0
108910,the,0,0
108911,role,0,0
108912,of,0,0
108913,fixed-point,0,1
108914,spin,0,1
108915,reduction,0,0
108916,of,0,0
108917,spinal,1,0
108918,manipulation,1,1
108919,therapy,1,1
108920,in,0,0
108921,the,0,0
108922,treatment,0,0
108923,of,0,0
108924,cervical,0,1
108925,vertigo,0,1
108926,and,0,0
108927,its,0,0
108928,effect,0,0
108929,on,0,0
108930,cervical,0,1
108931,artery,0,0
108932,spasm,0,1
108933,index,0,0
108934,(,0,1
108935,RI,0,1
108936,),0,1
108937,and,0,0
108938,atlantoaxial,0,1
108939,displacement,0,0
108940,index,0,0
108941,(,0,1
108942,ADI,0,0
108943,),0,1
108944,.,0,0
108945,METHODS,0,0
108946,From,0,0
108947,January,0,0
108948,2002,0,0
108949,to,0,0
108950,May,0,1
108951,2008,0,0
108952,",",0,0
108953,168,0,0
108954,patients,0,0
108955,with,0,0
108956,cervical,0,0
108957,vertigo,0,0
108958,were,0,0
108959,randomly,0,0
108960,divided,0,0
108961,into,0,0
108962,treatment,0,1
108963,group,0,1
108964,(,0,0
108965,84,0,0
108966,cases,0,0
108967,),0,0
108968,and,0,0
108969,the,0,0
108970,control,0,1
108971,group,0,0
108972,(,0,0
108973,84,0,0
108974,cases,0,0
108975,),0,0
108976,",",0,0
108977,22,0,0
108978,males,0,0
108979,and,0,0
108980,62,0,0
108981,females,0,0
108982,in,0,0
108983,treatment,0,0
108984,group,0,0
108985,;,0,0
108986,24,0,0
108987,males,0,0
108988,and,0,0
108989,60,0,0
108990,females,0,0
108991,in,0,0
108992,control,0,0
108993,group,0,0
108994,.,0,0
108995,The,0,0
108996,patients,0,0
108997,of,0,0
108998,treatment,0,0
108999,group,0,1
109000,and,0,0
109001,control,0,1
109002,group,0,0
109003,were,0,0
109004,respectively,0,0
109005,treated,0,0
109006,with,0,0
109007,fixed-point,1,1
109008,spin,1,1
109009,reduction,1,0
109010,of,1,0
109011,spinal,1,0
109012,manipulation,1,1
109013,therapy,1,1
109014,and,1,0
109015,dialectical,1,1
109016,prescription,1,1
109017,.,1,0
109018,The,0,0
109019,score,0,0
109020,of,0,0
109021,symptoms,0,0
109022,and,0,0
109023,signs,0,0
109024,",",0,0
109025,RI,0,0
109026,",",0,0
109027,ADI,0,0
109028,were,0,0
109029,observed,0,0
109030,and,0,0
109031,compared,0,0
109032,between,0,0
109033,two,0,0
109034,groups,0,0
109035,.,0,0
109036,RESULTS,0,0
109037,The,0,0
109038,score,0,0
109039,of,0,0
109040,symptoms,0,0
109041,and,0,0
109042,signs,0,0
109043,markedly,0,0
109044,decreased,0,0
109045,after,0,0
109046,treatment,0,0
109047,",",0,0
109048,in,0,0
109049,treatment,0,0
109050,group,0,0
109051,:,0,0
109052,vertigo,0,1
109053,had,0,0
109054,(,0,0
109055,2.75,0,0
109056,+/-,0,0
109057,1.01,0,0
109058,),0,0
109059,scores,0,0
109060,",",0,0
109061,neck-shoulder,0,1
109062,pain,0,0
109063,(,0,0
109064,1.58,0,0
109065,+/-,0,0
109066,0.36,0,0
109067,),0,0
109068,",",0,0
109069,headache,0,0
109070,(,0,0
109071,0.39,0,0
109072,+/-,0,0
109073,0.09,0,0
109074,),0,0
109075,",",0,0
109076,nausea-vomiting,0,0
109077,(,0,0
109078,1.58,0,0
109079,+/-,0,0
109080,1.30,0,0
109081,),0,0
109082,",",0,0
109083,ear,0,1
109084,noises,0,0
109085,(,0,0
109086,0.48,0,0
109087,+/-,0,0
109088,0.32,0,0
109089,),0,0
109090,",",0,0
109091,positive,0,0
109092,neck,0,1
109093,rotation,0,1
109094,test,0,1
109095,(,0,0
109096,0.59,0,0
109097,+/-,0,0
109098,0.21,0,0
109099,),0,0
109100,;,0,0
109101,and,0,0
109102,in,0,0
109103,control,0,1
109104,group,0,0
109105,:,0,0
109106,vertigo,0,1
109107,had,0,0
109108,(,0,0
109109,5.68,0,0
109110,+/-,0,0
109111,2.02,0,0
109112,),0,0
109113,scores,0,0
109114,",",0,0
109115,neck-shoulder,0,1
109116,pain,0,0
109117,(,0,0
109118,3.12,0,0
109119,+/-,0,0
109120,1.82,0,0
109121,),0,0
109122,",",0,0
109123,headache,0,0
109124,(,0,0
109125,1.86,0,0
109126,+/-,0,0
109127,0.65,0,0
109128,),0,0
109129,",",0,0
109130,nausea-vomiting,0,0
109131,(,0,0
109132,3.25,0,0
109133,+/-,0,0
109134,0.69,0,0
109135,),0,0
109136,",",0,0
109137,ear,0,1
109138,noises,0,0
109139,(,0,0
109140,1.64,0,0
109141,+/-,0,0
109142,0.61,0,0
109143,),0,0
109144,",",0,0
109145,positive,0,0
109146,neck,0,1
109147,rotation,0,1
109148,test,0,1
109149,(,0,0
109150,1.79,0,0
109151,+/-,0,0
109152,0.67,0,0
109153,),0,0
109154,.,0,0
109155,Cervical,0,0
109156,artery,0,0
109157,spasm,0,1
109158,index,0,0
109159,and,0,0
109160,atlantoaxial,0,1
109161,displacement,0,0
109162,index,0,0
109163,had,0,0
109164,been,0,0
109165,significantly,0,0
109166,improved,0,0
109167,",",0,0
109168,cervical,0,1
109169,artery,0,0
109170,spasm,0,1
109171,index,0,0
109172,was,0,0
109173,respectively,0,0
109174,0.54,0,0
109175,+/-,0,0
109176,0.07,0,0
109177,and,0,0
109178,0.52,0,0
109179,+/-,0,0
109180,0.13,0,0
109181,",",0,0
109182,atlantoaxial,0,1
109183,displacement,0,0
109184,index,0,0
109185,was,0,0
109186,respectively,0,0
109187,2.92,0,0
109188,+/-,0,0
109189,0.82,0,0
109190,and,0,0
109191,4.50,0,0
109192,+/-,0,0
109193,1.32,0,0
109194,between,0,0
109195,treatment,0,0
109196,group,0,1
109197,and,0,0
109198,control,0,1
109199,group,0,0
109200,.,0,0
109201,CONCLUSION,0,0
109202,Fixed-point,0,0
109203,spin,0,1
109204,reduction,0,0
109205,of,0,0
109206,spinal,1,0
109207,manipulation,1,1
109208,therapy,1,1
109209,for,0,0
109210,cervical,0,0
109211,vertigo,0,0
109212,can,0,0
109213,accurately,0,0
109214,correct,0,0
109215,single,0,1
109216,or,0,1
109217,multiple,0,0
109218,vertebral,0,0
109219,body,0,0
109220,displacement,0,0
109221,",",0,0
109222,restore,0,0
109223,normal,0,0
109224,spinal,0,0
109225,position,0,0
109226,",",0,0
109227,reduce,0,0
109228,the,0,0
109229,oppression,0,0
109230,and,0,0
109231,stimulus,0,1
109232,of,0,0
109233,the,0,0
109234,vertebral,0,0
109235,artery,0,0
109236,",",0,0
109237,release,0,0
109238,ischemia,0,0
109239,of,0,0
109240,vestibular,0,1
109241,labyrinth,0,0
109242,",",0,0
109243,eliminate,0,0
109244,symptoms,0,0
109245,of,0,0
109246,vertigo,0,0
109247,.,0,0
109248,Effects,0,0
109249,of,0,0
109250,10,0,0
109251,Hz,0,1
109252,repetitive,1,1
109253,transcranial,1,1
109254,magnetic,1,1
109255,stimulation,1,1
109256,(,1,1
109257,rTMS,1,1
109258,),1,1
109259,on,0,0
109260,clinical,0,0
109261,global,0,0
109262,impression,0,0
109263,in,0,0
109264,chronic,0,0
109265,schizophrenia,0,0
109266,.,0,0
109267,UNLABELLED,0,0
109268,We,0,0
109269,conducted,0,0
109270,a,0,0
109271,randomized,0,0
109272,",",0,0
109273,sham-controlled,0,1
109274,repetitive,1,1
109275,transcranial,1,1
109276,magnetic,1,1
109277,stimulation,1,1
109278,(,1,1
109279,rTMS,1,1
109280,),1,1
109281,study,0,0
109282,in,0,0
109283,chronic,0,0
109284,schizophrenia,0,0
109285,in-patients,0,0
109286,(,0,0
109287,n=35,0,0
109288,),0,1
109289,to,0,0
109290,evaluate,0,0
109291,the,0,0
109292,therapeutic,0,0
109293,efficacy,0,0
109294,of,0,0
109295,10,1,0
109296,Hz,1,1
109297,stimulation,0,1
109298,.,0,0
109299,Patients,0,0
109300,",",0,0
109301,who,0,0
109302,were,0,0
109303,on,0,0
109304,stable,0,0
109305,antipsychotic,0,1
109306,treatment,0,0
109307,",",0,0
109308,were,0,0
109309,randomly,0,0
109310,assigned,0,0
109311,to,0,0
109312,the,0,0
109313,active,0,1
109314,or,0,1
109315,sham,0,1
109316,condition,0,0
109317,.,0,0
109318,In,0,0
109319,the,0,0
109320,active,0,1
109321,rTMS,1,1
109322,group,0,0
109323,",",0,0
109324,ten,0,0
109325,sessions,0,1
109326,with,0,0
109327,a,0,0
109328,total,0,0
109329,of,0,0
109330,"10,000",0,0
109331,stimuli,0,0
109332,were,0,0
109333,applied,0,0
109334,over,0,0
109335,the,0,0
109336,left,0,0
109337,dorsolateral,0,1
109338,prefrontal,0,0
109339,cortex,0,0
109340,at,0,0
109341,110,0,0
109342,%,0,0
109343,of,0,0
109344,motor,0,0
109345,threshold,0,0
109346,.,0,0
109347,The,0,0
109348,sham,1,1
109349,group,0,0
109350,received,0,1
109351,corresponding,0,0
109352,sham,1,1
109353,stimulation,1,1
109354,.,1,0
109355,Clinical,0,0
109356,improvement,0,0
109357,was,0,0
109358,measured,0,0
109359,by,0,0
109360,the,0,0
109361,Clinical,0,0
109362,Global,0,0
109363,Impression,0,1
109364,scale,0,0
109365,(,0,0
109366,primary,0,0
109367,outcome,0,0
109368,measure,0,0
109369,),0,0
109370,",",0,0
109371,the,0,0
109372,Global,0,0
109373,Assessment,0,1
109374,of,0,0
109375,Functioning,0,0
109376,Scale,0,1
109377,(,0,1
109378,GAF,0,1
109379,),0,1
109380,and,0,0
109381,the,0,0
109382,Positive,0,0
109383,and,0,0
109384,Negative,0,0
109385,Symptom,0,1
109386,Scale,0,1
109387,(,0,0
109388,PANSS,0,0
109389,;,0,0
109390,secondary,0,0
109391,outcome,0,0
109392,measures,0,0
109393,),0,0
109394,.,0,0
109395,Between-group,0,0
109396,comparisons,0,0
109397,revealed,0,0
109398,no,0,0
109399,significant,0,0
109400,differences,0,0
109401,in,0,0
109402,clinical,0,0
109403,outcome,0,0
109404,variables,0,0
109405,.,0,0
109406,Only,0,0
109407,a,0,0
109408,subgroup,0,0
109409,of,0,0
109410,patients,0,0
109411,with,0,0
109412,pronounced,0,0
109413,negative,0,0
109414,symptoms,0,0
109415,developed,0,0
109416,some,0,0
109417,clinical,0,0
109418,improvement,0,0
109419,as,0,0
109420,indicated,0,0
109421,by,0,0
109422,significant,0,0
109423,changes,0,0
109424,in,0,0
109425,the,0,0
109426,GAF-scale,0,0
109427,.,0,0
109428,Besides,0,0
109429,there,0,0
109430,is,0,0
109431,some,0,0
109432,evidence,0,0
109433,for,0,0
109434,a,0,0
109435,more,0,0
109436,favourable,0,0
109437,clinical,0,0
109438,outcome,0,0
109439,within,0,0
109440,this,0,0
109441,subgroup,0,0
109442,after,0,0
109443,rTMS,1,1
109444,in,0,0
109445,the,0,0
109446,CGI-S,0,1
109447,and,0,0
109448,PANSS,0,0
109449,negative,0,1
109450,scale,0,0
109451,",",0,0
109452,too,0,0
109453,.,0,0
109454,In,0,0
109455,line,0,0
109456,with,0,0
109457,earlier,0,0
109458,investigations,0,0
109459,",",0,0
109460,our,0,0
109461,results,0,0
109462,suggest,0,0
109463,a,0,0
109464,moderate,0,0
109465,-,0,0
109466,potentially,0,0
109467,clinically,0,0
109468,relevant,0,0
109469,-,0,0
109470,treatment,0,0
109471,effect,0,0
109472,of,0,0
109473,prefrontal,1,0
109474,10,1,0
109475,Hz,1,1
109476,rTMS,1,1
109477,stimulation,0,1
109478,in,0,0
109479,chronic,0,0
109480,patients,0,0
109481,.,0,0
109482,However,0,0
109483,",",0,0
109484,in,0,0
109485,our,0,0
109486,study,0,0
109487,this,0,0
109488,beneficial,0,0
109489,effect,0,0
109490,was,0,0
109491,restricted,0,0
109492,to,0,0
109493,subjects,0,0
109494,with,0,0
109495,pronounced,0,0
109496,negative,0,0
109497,symptoms,0,0
109498,.,0,0
109499,CLINICAL,0,0
109500,TRIAL,0,0
109501,REGISTRATION,0,0
109502,INFORMATION,0,1
109503,ClinicalTrial.gov,0,1
109504,Identifier,0,0
109505,:,0,0
109506,NCT00169689,0,0
109507,",",0,0
109508,http,0,0
109509,:,0,0
109510,//www.clinicaltrials.gov,0,0
109511,.,0,0
109512,The,0,0
109513,ScanBrit,0,0
109514,randomised,0,0
109515,",",0,0
109516,controlled,0,0
109517,",",0,0
109518,single-blind,0,0
109519,study,0,0
109520,of,0,0
109521,a,0,0
109522,gluten-,1,1
109523,and,1,0
109524,casein-free,1,1
109525,dietary,1,1
109526,intervention,1,1
109527,for,0,0
109528,children,0,0
109529,with,0,0
109530,autism,0,0
109531,spectrum,0,0
109532,disorders,0,0
109533,.,0,0
109534,There,0,0
109535,is,0,0
109536,increasing,0,0
109537,interest,0,0
109538,in,0,0
109539,the,0,0
109540,use,0,0
109541,of,0,0
109542,gluten-,1,1
109543,and,1,0
109544,casein-free,1,1
109545,diets,1,1
109546,for,0,0
109547,children,0,0
109548,with,0,0
109549,autism,0,0
109550,spectrum,0,0
109551,disorders,0,0
109552,(,0,0
109553,ASDs,0,0
109554,),0,0
109555,.,0,0
109556,We,0,0
109557,report,0,0
109558,results,0,0
109559,from,0,0
109560,a,0,0
109561,two-stage,0,0
109562,",",0,0
109563,24-month,0,0
109564,",",0,0
109565,randomised,0,0
109566,",",0,0
109567,controlled,0,0
109568,trial,0,0
109569,incorporating,0,0
109570,an,0,0
109571,adaptive,0,0
109572,'catch-up,0,0
109573,',0,1
109574,design,0,0
109575,and,0,0
109576,interim,0,0
109577,analysis,0,0
109578,.,0,0
109579,Stage,0,0
109580,1,0,0
109581,of,0,0
109582,the,0,0
109583,trial,0,0
109584,saw,0,0
109585,72,0,0
109586,Danish,0,0
109587,children,0,0
109588,(,0,0
109589,aged,0,0
109590,4,0,0
109591,years,0,0
109592,to,0,0
109593,10,0,0
109594,years,0,0
109595,11,0,0
109596,months,0,0
109597,),0,0
109598,assigned,0,0
109599,to,0,0
109600,diet,0,1
109601,(,0,0
109602,A,0,0
109603,),0,1
109604,or,0,1
109605,non-diet,1,1
109606,(,0,1
109607,B,0,1
109608,),0,1
109609,groups,0,0
109610,by,0,0
109611,stratified,0,0
109612,randomisation,0,0
109613,.,0,0
109614,Autism,0,0
109615,Diagnostic,0,0
109616,Observation,0,1
109617,Schedule,0,1
109618,(,0,1
109619,ADOS,0,1
109620,),0,1
109621,and,0,0
109622,the,0,0
109623,Gilliam,0,1
109624,Autism,0,0
109625,Rating,0,0
109626,Scale,0,1
109627,(,0,1
109628,GARS,0,1
109629,),0,1
109630,were,0,0
109631,used,0,0
109632,to,0,0
109633,assess,0,0
109634,core,0,0
109635,autism,0,0
109636,behaviours,0,0
109637,",",0,0
109638,Vineland,0,0
109639,Adaptive,0,0
109640,Behaviour,0,1
109641,Scales,0,1
109642,(,0,1
109643,VABS,0,1
109644,),0,1
109645,to,0,0
109646,ascertain,0,0
109647,developmental,0,0
109648,level,0,0
109649,",",0,0
109650,and,0,0
109651,Attention-Deficit,0,0
109652,Hyperactivity,0,0
109653,Disorder,0,0
109654,-,0,0
109655,IV,0,0
109656,scale,0,0
109657,(,0,1
109658,ADHD-IV,0,1
109659,),0,1
109660,to,0,0
109661,determine,0,0
109662,inattention,0,1
109663,and,0,0
109664,hyperactivity,0,0
109665,.,0,0
109666,Participants,0,0
109667,were,0,0
109668,tested,0,0
109669,at,0,0
109670,baseline,0,0
109671,",",0,0
109672,8,0,0
109673,",",0,0
109674,and,0,0
109675,12,0,0
109676,months,0,0
109677,.,0,0
109678,Based,0,0
109679,on,0,0
109680,per,0,0
109681,protocol,0,0
109682,repeated,0,0
109683,measures,0,0
109684,analysis,0,0
109685,",",0,0
109686,data,0,0
109687,for,0,0
109688,26,0,0
109689,diet,0,1
109690,children,0,0
109691,and,0,0
109692,29,0,0
109693,controls,0,0
109694,were,0,0
109695,available,0,0
109696,at,0,0
109697,12,0,0
109698,months,0,0
109699,.,0,0
109700,At,0,0
109701,this,0,0
109702,point,0,0
109703,",",0,0
109704,there,0,0
109705,was,0,0
109706,a,0,0
109707,significant,0,0
109708,improvement,0,0
109709,to,0,0
109710,mean,0,0
109711,diet,0,1
109712,group,0,0
109713,scores,0,0
109714,(,0,0
109715,time*treatment,0,1
109716,interaction,0,0
109717,),0,0
109718,on,0,0
109719,sub-domains,0,0
109720,of,0,0
109721,ADOS,0,0
109722,",",0,0
109723,GARS,0,1
109724,and,0,0
109725,ADHD-IV,0,0
109726,measures,0,0
109727,.,0,0
109728,Surpassing,0,0
109729,of,0,0
109730,predefined,0,0
109731,statistical,0,0
109732,thresholds,0,0
109733,as,0,0
109734,evidence,0,0
109735,of,0,0
109736,improvement,0,0
109737,in,0,0
109738,group,0,0
109739,A,0,0
109740,at,0,0
109741,12,0,0
109742,months,0,0
109743,sanctioned,0,0
109744,the,0,0
109745,re-assignment,0,0
109746,of,0,0
109747,group,0,0
109748,B,0,0
109749,participants,0,0
109750,to,0,0
109751,active,0,0
109752,dietary,0,1
109753,treatment,0,0
109754,.,0,0
109755,Stage,0,0
109756,2,0,0
109757,data,0,0
109758,for,0,0
109759,18,0,0
109760,group,0,0
109761,A,0,0
109762,and,0,0
109763,17,0,0
109764,group,0,0
109765,B,0,0
109766,participants,0,0
109767,were,0,0
109768,available,0,0
109769,at,0,0
109770,24,0,0
109771,months,0,0
109772,.,0,0
109773,Multiple,0,0
109774,scenario,0,0
109775,analysis,0,0
109776,based,0,0
109777,on,0,0
109778,inter-,0,0
109779,and,0,0
109780,intra-group,0,0
109781,comparisons,0,0
109782,showed,0,0
109783,some,0,0
109784,evidence,0,0
109785,of,0,0
109786,sustained,0,0
109787,clinical,0,0
109788,group,0,0
109789,improvements,0,0
109790,although,0,0
109791,possibly,0,0
109792,indicative,0,0
109793,of,0,0
109794,a,0,0
109795,plateau,0,0
109796,effect,0,0
109797,for,0,0
109798,intervention,0,1
109799,.,0,0
109800,Our,0,0
109801,results,0,0
109802,suggest,0,0
109803,that,0,0
109804,dietary,1,1
109805,intervention,1,1
109806,may,0,0
109807,positively,0,0
109808,affect,0,0
109809,developmental,0,0
109810,outcome,0,0
109811,for,0,0
109812,some,0,0
109813,children,0,0
109814,diagnosed,0,0
109815,with,0,0
109816,ASD,0,0
109817,.,0,0
109818,In,0,0
109819,the,0,0
109820,absence,0,0
109821,of,0,0
109822,a,0,0
109823,placebo,1,1
109824,condition,0,0
109825,to,0,0
109826,the,0,0
109827,current,0,0
109828,investigation,0,0
109829,",",0,0
109830,we,0,0
109831,are,0,0
109832,",",0,0
109833,however,0,0
109834,",",0,0
109835,unable,0,0
109836,to,0,0
109837,disqualify,0,0
109838,potential,0,0
109839,effects,0,0
109840,derived,0,0
109841,from,0,0
109842,intervention,0,1
109843,outside,0,0
109844,of,0,0
109845,dietary,0,0
109846,changes,0,0
109847,.,0,0
109848,Further,0,0
109849,studies,0,0
109850,are,0,0
109851,required,0,0
109852,to,0,0
109853,ascertain,0,0
109854,potential,0,0
109855,best-,0,0
109856,and,0,0
109857,non-responders,0,0
109858,to,0,0
109859,intervention,0,1
109860,.,0,0
109861,The,0,0
109862,study,0,0
109863,was,0,0
109864,registered,0,0
109865,with,0,0
109866,ClincialTrials.gov,0,0
109867,",",0,0
109868,number,0,0
109869,NCT00614198,0,0
109870,.,0,0
109871,Catheter-related,0,0
109872,infections,0,0
109873,via,0,0
109874,temporary,0,1
109875,vascular,0,0
109876,access,0,0
109877,catheters,0,1
109878,:,0,0
109879,a,0,0
109880,randomized,0,0
109881,prospective,0,0
109882,study,0,0
109883,.,0,0
109884,Temporary,0,0
109885,vascular,0,0
109886,access,0,1
109887,catheters,0,1
109888,(,0,0
109889,VACs,0,1
109890,),0,1
109891,are,0,0
109892,important,0,0
109893,devices,0,1
109894,used,0,0
109895,in,0,0
109896,acute,0,0
109897,blood,0,0
109898,purification,0,0
109899,therapies,0,0
109900,.,0,0
109901,The,0,0
109902,aim,0,0
109903,of,0,0
109904,this,0,0
109905,study,0,0
109906,was,0,0
109907,to,0,0
109908,determine,0,0
109909,whether,0,0
109910,a,0,0
109911,catheterization,1,1
109912,duration,0,0
109913,of,0,0
109914,2,0,0
109915,weeks,0,0
109916,increased,0,0
109917,the,0,0
109918,risk,0,0
109919,of,0,0
109920,nosocomial,0,0
109921,complications,0,0
109922,when,0,0
109923,compared,0,0
109924,with,0,0
109925,a,0,0
109926,1-week,0,0
109927,duration,0,0
109928,.,0,0
109929,Fifty-six,0,0
109930,patients,0,0
109931,with,0,0
109932,90,0,0
109933,double,0,0
109934,lumen,0,0
109935,VACs,0,0
109936,were,0,0
109937,randomly,0,0
109938,chosen,0,0
109939,",",0,0
109940,and,0,0
109941,received,0,0
109942,either,0,1
109943,1-,0,1
109944,or,0,1
109945,2-week,0,0
109946,catheterizations,1,1
109947,from,0,0
109948,operators,0,0
109949,experienced,0,0
109950,in,0,0
109951,the,0,0
109952,placement,0,1
109953,of,0,0
109954,such,0,0
109955,catheters,0,1
109956,at,0,0
109957,three,0,0
109958,sites,0,0
109959,such,0,0
109960,as,0,0
109961,the,0,0
109962,internal,0,0
109963,jugular,0,0
109964,",",0,0
109965,subclavian,0,0
109966,",",0,0
109967,or,0,1
109968,femoral,0,1
109969,vein,0,0
109970,.,0,0
109971,The,0,0
109972,characteristics,0,0
109973,of,0,0
109974,the,0,0
109975,VACs,0,0
109976,",",0,0
109977,including,0,0
109978,the,0,0
109979,sites,0,0
109980,",",0,0
109981,procedures,0,0
109982,",",0,0
109983,and,0,0
109984,lengths,0,0
109985,",",0,0
109986,were,0,0
109987,similar,0,0
109988,in,0,0
109989,both,0,0
109990,groups,0,0
109991,.,0,0
109992,No,0,0
109993,significant,0,0
109994,difference,0,0
109995,in,0,0
109996,the,0,0
109997,rate,0,0
109998,of,0,0
109999,catheter,0,1
110000,colonization,0,0
110001,was,0,0
110002,observed,0,0
110003,between,0,0
110004,the,0,0
110005,groups,0,0
110006,(,0,0
110007,14.6,0,0
110008,%,0,0
110009,vs,0,0
110010,26.2,0,0
110011,%,0,0
110012,",",0,0
110013,P,0,0
110014,=,0,0
110015,0.1371,0,0
110016,),0,0
110017,.,0,0
110018,No,0,0
110019,significant,0,0
110020,difference,0,0
110021,in,0,0
110022,the,0,0
110023,rate,0,0
110024,of,0,0
110025,catheter-related,0,0
110026,bloodstream,0,0
110027,infections,0,0
110028,was,0,0
110029,observed,0,0
110030,between,0,0
110031,the,0,0
110032,groups,0,0
110033,(,0,0
110034,2.1,0,0
110035,%,0,0
110036,vs,0,0
110037,4.8,0,0
110038,%,0,0
110039,",",0,0
110040,P,0,0
110041,=,0,0
110042,0.5967,0,0
110043,),0,0
110044,.,0,0
110045,Two-week,0,1
110046,indwelling,0,1
110047,did,0,0
110048,not,0,0
110049,increase,0,0
110050,the,0,0
110051,risk,0,0
110052,of,0,0
110053,infection,0,0
110054,compared,0,0
110055,with,0,0
110056,1-week,0,0
110057,indwelling,0,1
110058,at,0,0
110059,any,0,0
110060,of,0,0
110061,the,0,0
110062,sites,0,0
110063,in,0,0
110064,critically,0,0
110065,ill,0,0
110066,patients,0,0
110067,.,0,0
110068,Capsaicin,1,1
110069,jelly,1,1
110070,against,0,0
110071,migraine,0,0
110072,pain,0,0
110073,.,0,0
110074,OBJECTIVE,0,0
110075,Recent,0,0
110076,studies,0,0
110077,support,0,0
110078,the,0,0
110079,role,0,0
110080,of,0,0
110081,extracranial,0,0
110082,perivascular,0,0
110083,afferents,0,0
110084,in,0,0
110085,a,0,0
110086,substantial,0,0
110087,percentage,0,0
110088,of,0,0
110089,migraineurs,0,0
110090,.,0,0
110091,Perivascular,0,0
110092,afferent,0,0
110093,fibres,0,1
110094,of,0,0
110095,the,0,0
110096,superficial,0,0
110097,temporal,0,0
110098,artery,0,0
110099,contain,0,0
110100,peptides,0,0
110101,",",0,0
110102,like,0,0
110103,calcitonin,0,1
110104,gene-related,0,1
110105,peptide,0,0
110106,(,0,1
110107,CGRP,0,1
110108,),0,1
110109,and,0,0
110110,substance,0,1
110111,P,0,0
110112,(,0,1
110113,SP,0,1
110114,),0,0
110115,.,0,0
110116,CGRP,0,0
110117,and,0,0
110118,SP,0,1
110119,are,0,0
110120,considered,0,0
110121,relevant,0,0
110122,in,0,0
110123,the,0,0
110124,genesis,0,0
110125,of,0,0
110126,migraine,0,0
110127,pain,0,0
110128,.,0,0
110129,Capsaicin,1,1
110130,is,0,0
110131,an,0,0
110132,agonist,0,1
110133,of,0,0
110134,the,0,0
110135,transient,0,0
110136,receptor,0,0
110137,potential,0,0
110138,vanilloid,0,0
110139,type,0,0
110140,1,0,0
110141,.,0,0
110142,It,0,0
110143,causes,0,0
110144,membrane,0,0
110145,depolarisation,0,0
110146,of,0,0
110147,sensory,0,0
110148,neurons,0,0
110149,",",0,0
110150,which,0,0
110151,release,0,0
110152,CGRP,0,0
110153,",",0,0
110154,SP,0,1
110155,and,0,0
110156,other,0,0
110157,pain,0,0
110158,peptides,0,0
110159,;,0,0
110160,excitation,0,1
110161,is,0,0
110162,followed,0,0
110163,by,0,0
110164,a,0,0
110165,refractory,0,0
110166,state,0,0
110167,",",0,0
110168,causing,0,0
110169,inactivation,0,0
110170,.,0,1
110171,Topical,1,0
110172,capsaicin,1,1
110173,has,0,0
110174,been,0,0
110175,found,0,0
110176,to,0,0
110177,be,0,0
110178,efficacious,0,0
110179,in,0,0
110180,several,0,0
110181,types,0,0
110182,of,0,0
110183,neuropathic,0,0
110184,pain,0,0
110185,.,0,0
110186,We,0,0
110187,attempted,0,0
110188,to,0,0
110189,verify,0,0
110190,whether,0,0
110191,topical,1,1
110192,periarterial,1,1
110193,capsaicin,1,1
110194,could,0,0
110195,ameliorate,0,0
110196,pain,0,0
110197,in,0,0
110198,absence,0,0
110199,of,0,0
110200,and,0,0
110201,during,0,0
110202,a,0,0
110203,migraine,0,0
110204,attack,0,0
110205,.,0,0
110206,METHODS,0,0
110207,On,0,0
110208,23,0,0
110209,migraineurs,0,0
110210,showing,0,0
110211,pain,0,0
110212,at,0,0
110213,pressure,0,0
110214,on,0,0
110215,scalp,0,0
110216,arteries,0,0
110217,",",0,0
110218,we,0,0
110219,administered,0,0
110220,topical,1,1
110221,capsaicin,1,1
110222,0.1,1,1
110223,%,1,0
110224,or,1,1
110225,vaseline,1,1
110226,jelly,1,1
110227,on,0,0
110228,painful,0,0
110229,arteries,0,0
110230,in,0,0
110231,absence,0,0
110232,of,0,0
110233,migraine,0,0
110234,attack,0,0
110235,.,0,0
110236,In,0,0
110237,those,0,0
110238,having,0,0
110239,pain,0,0
110240,reduction,0,0
110241,>,0,0
110242,50,0,0
110243,%,0,0
110244,",",0,0
110245,we,0,0
110246,made,0,0
110247,the,0,0
110248,same,0,0
110249,comparison,0,0
110250,during,0,0
110251,a,0,0
110252,migraine,0,0
110253,attack,0,0
110254,.,0,0
110255,RESULTS,0,0
110256,Topical,1,0
110257,capsaicin,1,1
110258,caused,0,0
110259,>,0,0
110260,50,0,1
110261,%,0,0
110262,reduction,0,0
110263,of,0,0
110264,arterial,0,0
110265,pain,0,0
110266,in,0,0
110267,absence,0,0
110268,of,0,0
110269,attack,0,0
110270,in,0,0
110271,17/23,0,0
110272,patients,0,0
110273,",",0,0
110274,as,0,0
110275,opposed,0,0
110276,to,0,0
110277,two,0,0
110278,with,0,0
110279,vaseline,0,1
110280,.,0,0
110281,During,0,0
110282,attacks,0,0
110283,of,0,0
110284,mild-,0,0
110285,to,0,0
110286,moderate-intensity,0,0
110287,",",0,0
110288,>,0,0
110289,50,0,1
110290,%,0,0
110291,improvement,0,0
110292,was,0,0
110293,obtained,0,0
110294,in,0,0
110295,11/17,0,0
110296,with,0,0
110297,capsaicin,1,1
110298,and,0,0
110299,in,0,0
110300,one,0,0
110301,with,0,0
110302,vaseline,1,1
110303,.,1,0
110304,CONCLUSIONS,0,0
110305,Although,0,0
110306,referring,0,0
110307,to,0,0
110308,a,0,0
110309,small,0,0
110310,number,0,0
110311,of,0,0
110312,patients,0,0
110313,",",0,0
110314,our,0,0
110315,data,0,0
110316,show,0,0
110317,that,0,0
110318,topical,1,1
110319,capsaicin,1,1
110320,may,0,0
110321,relieve,0,0
110322,arterial,0,0
110323,pain,0,0
110324,in,0,0
110325,absence,0,0
110326,of,0,0
110327,and,0,0
110328,during,0,0
110329,a,0,0
110330,migraine,0,0
110331,attack,0,0
110332,in,0,0
110333,a,0,0
110334,substantial,0,0
110335,number,0,0
110336,of,0,0
110337,patients,0,0
110338,experiencing,0,0
110339,scalp,0,1
110340,arterial,0,0
110341,tenderness,0,0
110342,.,0,0
110343,More,0,0
110344,active,0,0
110345,capsacinoids,1,1
110346,might,0,0
110347,be,0,0
110348,tried,0,0
110349,in,0,0
110350,the,0,0
110351,future,0,0
110352,and,0,0
110353,could,0,0
110354,provide,0,0
110355,a,0,0
110356,new,0,0
110357,method,0,1
110358,for,0,0
110359,treating,0,0
110360,migraine,0,0
110361,attacks,0,0
110362,.,0,0
110363,Effects,0,0
110364,of,0,0
110365,fish,1,1
110366,oil,1,1
110367,supplementation,1,1
110368,on,0,0
110369,markers,0,0
110370,of,0,0
110371,the,0,0
110372,metabolic,0,0
110373,syndrome,0,0
110374,.,0,0
110375,OBJECTIVE,0,0
110376,To,0,0
110377,investigate,0,0
110378,whether,0,0
110379,fish,1,1
110380,oil,1,1
110381,affects,0,0
110382,cardiovascular,0,0
110383,risk,0,0
110384,factors,0,0
110385,during,0,0
110386,the,0,0
110387,adolescent,0,0
110388,growth,0,0
110389,spurt,0,0
110390,.,0,0
110391,STUDY,0,0
110392,DESIGN,0,0
110393,A,0,0
110394,total,0,0
110395,of,0,0
110396,78,0,0
110397,boys,0,0
110398,age,0,0
110399,13-15,0,0
110400,years,0,0
110401,with,0,0
110402,a,0,0
110403,mean,0,0
110404,body,0,0
110405,fat,0,0
110406,percentage,0,0
110407,of,0,0
110408,30,0,0
110409,%,0,0
110410,+/-9,0,0
110411,%,0,0
110412,were,0,0
110413,randomly,0,0
110414,assigned,0,0
110415,to,0,0
110416,consume,0,0
110417,fish,1,1
110418,oil,1,1
110419,(,0,0
110420,providing,0,0
110421,1.5,0,1
110422,g,0,1
110423,of,0,0
110424,n-3,0,1
110425,long-chain,1,1
110426,polyunsaturated,1,1
110427,fatty,1,1
110428,acid/day,1,1
110429,),1,1
110430,or,1,1
110431,vegetable,1,1
110432,oil,1,1
110433,(,1,1
110434,control,1,1
110435,),1,1
110436,for,0,0
110437,16,0,0
110438,weeks,0,0
110439,.,0,0
110440,The,0,0
110441,oils,0,1
110442,were,0,0
110443,included,0,0
110444,in,0,0
110445,bread,0,1
110446,.,0,0
110447,RESULTS,0,0
110448,After,0,0
110449,the,0,0
110450,intervention,0,1
110451,",",0,0
110452,the,0,0
110453,red,0,0
110454,blood,0,0
110455,cell,0,0
110456,(,0,1
110457,RBC,0,1
110458,),0,1
110459,content,0,0
110460,of,0,0
110461,eicosapentaenoic,0,1
110462,acid,0,1
110463,(,0,1
110464,EPA,0,1
110465,),0,1
110466,and,0,0
110467,docosahexaenoic,0,1
110468,acid,0,1
110469,(,0,1
110470,DHA,0,1
110471,),0,1
110472,were,0,0
110473,1.2,0,0
110474,%,0,0
110475,+/-0.5,0,0
110476,%,0,0
110477,and,0,0
110478,6.7,0,0
110479,%,0,0
110480,+/-1.6,0,0
110481,%,0,0
110482,",",0,0
110483,respectively,0,0
110484,",",0,0
110485,in,0,0
110486,the,0,0
110487,those,0,0
110488,receiving,0,0
110489,fish,1,1
110490,oil,1,1
110491,(,1,1
110492,FO,1,1
110493,group,1,1
110494,),1,0
110495,",",0,0
110496,compared,0,0
110497,with,0,0
110498,0.6,0,0
110499,%,0,0
110500,+/-0.3,0,0
110501,%,0,0
110502,and,0,0
110503,4.1,0,0
110504,%,0,0
110505,+/-0.9,0,0
110506,%,0,0
110507,in,0,0
110508,the,0,0
110509,control,1,0
110510,group,0,0
110511,.,0,0
110512,Systolic,0,0
110513,blood,0,0
110514,pressure,0,0
110515,(,0,1
110516,SBP,0,0
110517,),0,1
110518,was,0,0
110519,3.8+/-1.4,0,0
110520,mm,0,0
110521,Hg,0,0
110522,lower,0,0
110523,(,0,0
110524,P,0,0
110525,<,0,0
110526,.006,0,0
110527,),0,1
110528,and,0,0
110529,diastolic,0,0
110530,blood,0,1
110531,pressure,0,0
110532,(,0,1
110533,DBP,0,0
110534,),0,1
110535,was,0,0
110536,2.6+/-1.1,0,0
110537,mm,0,0
110538,Hg,0,0
110539,lower,0,0
110540,(,0,0
110541,P,0,0
110542,<,0,0
110543,.01,0,0
110544,),0,0
110545,in,0,0
110546,the,0,0
110547,FO,0,1
110548,group,0,0
110549,compared,0,0
110550,with,0,0
110551,the,0,0
110552,control,0,0
110553,group,0,0
110554,.,0,0
110555,Plasma,0,0
110556,triacylglycerol,0,0
110557,(,0,1
110558,TAG,0,1
110559,),0,1
110560,concentration,0,0
110561,and,0,0
110562,insulin,0,1
110563,sensitivity,0,0
110564,were,0,0
110565,unaffected,0,0
110566,by,0,0
110567,either,0,0
110568,of,0,0
110569,the,0,0
110570,treatments,0,0
110571,.,0,0
110572,Plasma,0,0
110573,high-density,0,0
110574,lipoprotein,0,0
110575,(,0,1
110576,HDL,0,1
110577,),0,1
110578,and,0,0
110579,non-HDL,0,1
110580,cholesterol,0,0
110581,were,0,0
110582,increased,0,0
110583,by,0,0
110584,5,0,1
110585,%,0,0
110586,and,0,0
110587,7,0,0
110588,%,0,0
110589,",",0,0
110590,respectively,0,0
110591,",",0,0
110592,in,0,0
110593,the,0,0
110594,FO,1,1
110595,group,0,0
110596,",",0,0
110597,and,0,0
110598,by,0,0
110599,2,0,0
110600,%,0,0
110601,and,0,0
110602,0,0,0
110603,%,0,0
110604,in,0,0
110605,the,0,0
110606,control,1,1
110607,group,1,0
110608,(,0,0
110609,P,0,0
110610,<,0,0
110611,.01-.02,0,0
110612,),0,0
110613,.,0,0
110614,The,0,0
110615,changes,0,0
110616,in,0,0
110617,RBC,0,1
110618,EPA,0,1
110619,content,0,0
110620,were,0,0
110621,inversely,0,0
110622,correlated,0,0
110623,with,0,0
110624,the,0,0
110625,changes,0,0
110626,in,0,0
110627,SBP,0,0
110628,and,0,0
110629,DBP,0,0
110630,and,0,0
110631,directly,0,0
110632,correlated,0,0
110633,with,0,0
110634,the,0,0
110635,increases,0,0
110636,in,0,0
110637,HDL,0,1
110638,cholesterol,0,0
110639,and,0,0
110640,non-HDL,0,0
110641,cholesterol,0,0
110642,concentrations,0,0
110643,.,0,0
110644,No,0,0
110645,association,0,0
110646,was,0,0
110647,seen,0,0
110648,between,0,0
110649,RBC,0,1
110650,EPA,0,1
110651,and,0,0
110652,plasma,0,0
110653,TAG,0,1
110654,concentration,0,0
110655,or,0,1
110656,insulin,0,1
110657,sensitivity,0,0
110658,.,0,0
110659,CONCLUSION,0,0
110660,Fish,1,0
110661,oil,1,1
110662,improves,0,0
110663,BP,0,0
110664,in,0,0
110665,normotensive,0,0
110666,and,0,0
110667,normolipidemic,0,0
110668,slightly,0,0
110669,overweight,0,0
110670,adolescent,0,0
110671,boys,0,0
110672,.,0,0
110673,Effects,0,0
110674,of,0,0
110675,a,0,0
110676,leisure,1,0
110677,programme,1,1
110678,on,0,0
110679,quality,0,0
110680,of,0,0
110681,life,0,0
110682,and,0,0
110683,stress,0,0
110684,of,0,0
110685,individuals,0,0
110686,with,0,0
110687,ASD,0,0
110688,.,0,0
110689,BACKGROUND,0,0
110690,Even,0,1
110691,though,0,0
110692,there,0,0
110693,is,0,0
110694,research,0,0
110695,demonstrating,0,0
110696,a,0,0
110697,positive,0,0
110698,relationship,0,0
110699,between,0,0
110700,leisure,0,1
110701,participation,0,0
110702,and,0,0
110703,the,0,0
110704,two,0,0
110705,constructs,0,0
110706,of,0,0
110707,quality,0,0
110708,of,0,0
110709,life,0,0
110710,and,0,0
110711,stress,0,0
110712,reduction,0,0
110713,",",0,0
110714,current,0,0
110715,conceptualisation,0,0
110716,of,0,0
110717,leisure,0,0
110718,as,0,0
110719,a,0,0
110720,contributor,0,0
110721,to,0,0
110722,quality,0,0
110723,of,0,0
110724,life,0,0
110725,is,0,0
110726,limited,0,0
110727,.,0,0
110728,In,0,0
110729,addition,0,0
110730,",",0,0
110731,in,0,0
110732,spite,0,0
110733,of,0,0
110734,improvements,0,0
110735,in,0,0
110736,accurate,0,0
110737,diagnosis,0,0
110738,of,0,0
110739,autism,0,0
110740,spectrum,0,0
110741,disorder,0,0
110742,(,0,1
110743,ASD,0,0
110744,),0,1
110745,at,0,0
110746,increasingly,0,0
110747,earlier,0,0
110748,ages,0,0
110749,and,0,0
110750,proliferation,0,0
110751,of,0,0
110752,interventions,0,0
110753,",",0,0
110754,research,0,0
110755,associated,0,0
110756,with,0,0
110757,leisure,0,1
110758,and,0,0
110759,quality,0,0
110760,of,0,0
110761,life,0,0
110762,for,0,0
110763,people,0,0
110764,with,0,0
110765,ASD,0,0
110766,is,0,0
110767,lacking,0,0
110768,.,0,0
110769,METHODS,0,0
110770,Therefore,0,0
110771,",",0,0
110772,a,0,0
110773,study,0,0
110774,using,0,0
110775,a,0,0
110776,repeated,0,0
110777,measures,0,0
110778,design,0,0
110779,was,0,0
110780,used,0,0
110781,to,0,0
110782,measure,0,0
110783,effects,0,0
110784,of,0,0
110785,a,0,0
110786,1-year,1,0
110787,group,1,0
110788,leisure,1,1
110789,programme,1,1
110790,intended,0,1
110791,to,0,0
110792,facilitate,0,0
110793,interaction,1,0
110794,with,1,0
110795,media,1,1
110796,",",1,0
110797,engagement,1,0
110798,in,1,0
110799,exercise,1,1
110800,",",1,0
110801,playing,1,0
110802,games,1,1
110803,and,1,0
110804,doing,1,0
110805,crafts,1,1
110806,",",1,0
110807,attending,1,0
110808,events,1,0
110809,",",1,0
110810,and,1,0
110811,participating,1,0
110812,in,1,0
110813,other,1,0
110814,recreation,1,0
110815,activities,1,0
110816,on,0,0
110817,quality,0,0
110818,of,0,0
110819,life,0,0
110820,and,0,0
110821,stress,0,0
110822,of,0,0
110823,37,0,0
110824,participants,0,0
110825,(,0,0
110826,22,0,0
110827,male,0,0
110828,",",0,0
110829,15,0,0
110830,female,0,0
110831,),0,0
110832,",",0,0
110833,ages,0,0
110834,17-39,0,0
110835,(,0,0
110836,M,0,0
110837,=,0,0
110838,31.49,0,0
110839,),0,0
110840,years,0,0
110841,at,0,0
110842,the,0,0
110843,beginning,0,0
110844,of,0,0
110845,the,0,0
110846,programme,0,1
110847,),0,0
110848,diagnosed,0,0
110849,with,0,0
110850,an,0,0
110851,ASD,0,0
110852,and,0,0
110853,a,0,0
110854,group,0,0
110855,of,0,0
110856,34,0,0
110857,adults,0,0
110858,with,0,0
110859,ASD,0,0
110860,as,0,0
110861,control,1,1
110862,group,1,1
110863,(,1,1
110864,waiting,1,1
110865,list,1,1
110866,),1,1
110867,(,0,0
110868,19,0,0
110869,male,0,0
110870,",",0,0
110871,15,0,0
110872,female,0,0
110873,),0,0
110874,",",0,0
110875,ages,0,0
110876,24-38,0,0
110877,(,0,0
110878,M,0,0
110879,=,0,0
110880,30,0,0
110881,at,0,0
110882,programme,0,1
110883,initiation,0,0
110884,),0,0
110885,years,0,0
110886,.,0,0
110887,RESULTS,0,0
110888,There,0,0
110889,was,0,0
110890,a,0,0
110891,significant,0,0
110892,decrease,0,0
110893,in,0,0
110894,overall,0,0
110895,scores,0,0
110896,of,0,0
110897,stress,0,0
110898,levels,0,0
110899,for,0,0
110900,participants,0,0
110901,over,0,0
110902,the,0,0
110903,course,0,0
110904,of,0,0
110905,the,0,0
110906,study,0,0
110907,and,0,0
110908,there,0,0
110909,was,0,0
110910,a,0,0
110911,significant,0,0
110912,increase,0,0
110913,in,0,0
110914,the,0,0
110915,four,0,0
110916,factors,0,0
110917,of,0,0
110918,quality,0,0
110919,of,0,0
110920,life,0,0
110921,that,0,0
110922,were,0,0
110923,measured,0,0
110924,(,0,0
110925,satisfaction,0,0
110926,",",0,0
110927,independence,0,0
110928,",",0,0
110929,competence,0,0
110930,and,0,0
110931,social,0,1
110932,interaction,0,0
110933,),0,0
110934,as,0,0
110935,well,0,0
110936,as,0,0
110937,the,0,0
110938,total,0,0
110939,score,0,0
110940,for,0,0
110941,quality,0,0
110942,of,0,0
110943,life,0,0
110944,from,0,0
110945,baseline,0,0
110946,to,0,0
110947,the,0,0
110948,end,0,0
110949,of,0,0
110950,the,0,0
110951,intervention,0,1
110952,12,0,0
110953,months,0,0
110954,later,0,0
110955,.,0,0
110956,In,0,0
110957,contrast,0,0
110958,",",0,0
110959,the,0,0
110960,control,0,1
110961,group,0,0
110962,demonstrated,0,0
110963,no,0,0
110964,significant,0,0
110965,improvements,0,0
110966,related,0,0
110967,to,0,0
110968,stress,0,0
110969,or,0,1
110970,quality,0,0
110971,of,0,0
110972,life,0,0
110973,.,0,0
110974,Implications,0,0
110975,of,0,0
110976,these,0,0
110977,findings,0,0
110978,to,0,0
110979,leisure,0,0
110980,services,0,1
110981,and,0,0
110982,the,0,0
110983,quality,0,0
110984,of,0,0
110985,life,0,0
110986,of,0,0
110987,individuals,0,0
110988,with,0,0
110989,ASD,0,0
110990,are,0,0
110991,discussed,0,0
110992,.,0,0
110993,CONCLUSION,0,0
110994,Findings,0,0
110995,support,0,1
110996,the,0,0
110997,contention,0,0
110998,that,0,0
110999,participation,0,0
111000,in,0,0
111001,recreation,0,0
111002,activities,0,0
111003,positively,0,0
111004,influenced,0,0
111005,the,0,0
111006,stress,0,0
111007,and,0,0
111008,quality,0,0
111009,of,0,0
111010,life,0,0
111011,of,0,0
111012,adults,0,0
111013,with,0,0
111014,ASD,0,0
111015,.,0,0
111016,A,0,0
111017,first-in-man,0,0
111018,",",0,0
111019,randomized,0,0
111020,",",0,0
111021,placebo-controlled,1,1
111022,study,0,0
111023,to,0,0
111024,evaluate,0,0
111025,the,0,0
111026,safety,0,0
111027,and,0,0
111028,feasibility,0,0
111029,of,0,0
111030,autologous,1,1
111031,delipidated,1,1
111032,high-density,1,0
111033,lipoprotein,1,0
111034,plasma,1,0
111035,infusions,1,1
111036,in,0,0
111037,patients,0,0
111038,with,0,0
111039,acute,0,0
111040,coronary,0,0
111041,syndrome,0,0
111042,.,0,0
111043,OBJECTIVES,0,0
111044,This,0,0
111045,study,0,0
111046,aimed,0,0
111047,to,0,0
111048,determine,0,0
111049,whether,0,0
111050,serial,1,0
111051,autologous,1,1
111052,infusions,1,1
111053,of,1,0
111054,selective,1,0
111055,high-density,1,1
111056,lipoprotein,1,0
111057,(,1,1
111058,HDL,1,1
111059,),1,1
111060,delipidated,1,1
111061,plasma,1,0
111062,are,0,0
111063,feasible,0,0
111064,and,0,0
111065,well,0,0
111066,tolerated,0,0
111067,in,0,0
111068,patients,0,0
111069,with,0,0
111070,acute,0,0
111071,coronary,0,1
111072,syndrome,0,0
111073,(,0,1
111074,ACS,0,1
111075,),0,0
111076,.,0,0
111077,BACKGROUND,0,0
111078,Low,0,0
111079,HDL,0,1
111080,is,0,0
111081,associated,0,0
111082,with,0,0
111083,increased,0,0
111084,risk,0,0
111085,of,0,0
111086,cardiovascular,0,0
111087,disease,0,0
111088,.,0,0
111089,Plasma,0,0
111090,selective,0,0
111091,delipidation,0,0
111092,converts,0,0
111093,alphaHDL,0,0
111094,to,0,0
111095,prebeta-like,0,0
111096,HDL,0,0
111097,",",0,0
111098,the,0,0
111099,most,0,0
111100,effective,0,0
111101,form,0,0
111102,of,0,0
111103,HDL,0,0
111104,for,0,0
111105,lipid,0,0
111106,removal,0,0
111107,from,0,0
111108,arterial,0,0
111109,plaques,0,0
111110,.,0,0
111111,METHODS,0,0
111112,ACS,0,1
111113,patients,0,0
111114,undergoing,0,0
111115,cardiac,0,0
111116,catheterization,0,1
111117,with,0,0
111118,>,0,0
111119,or=1,0,0
111120,nonobstructive,0,0
111121,native,0,0
111122,coronary,0,0
111123,artery,0,0
111124,atheroma,0,0
111125,were,0,0
111126,randomized,0,0
111127,to,0,0
111128,either,0,0
111129,7,0,0
111130,weekly,0,1
111131,HDL,1,1
111132,selective,1,0
111133,delipidated,1,1
111134,or,1,1
111135,control,1,1
111136,plasma,1,0
111137,apheresis/reinfusions,1,1
111138,.,1,0
111139,Patients,0,0
111140,underwent,0,0
111141,intravascular,1,0
111142,ultrasound,1,1
111143,(,0,1
111144,IVUS,0,1
111145,),0,1
111146,evaluation,0,0
111147,of,0,0
111148,the,0,0
111149,target,0,0
111150,vessel,0,0
111151,during,0,0
111152,the,0,0
111153,catheterization,0,1
111154,for,0,0
111155,ACS,0,1
111156,and,0,0
111157,up,0,0
111158,to,0,0
111159,14,0,0
111160,days,0,0
111161,following,0,0
111162,the,0,0
111163,final,0,0
111164,apheresis/reinfusion,1,1
111165,session,0,1
111166,.,0,0
111167,2-D,0,0
111168,gel,0,1
111169,electrophoresis,0,1
111170,of,0,0
111171,delipidated,0,1
111172,plasmas,0,0
111173,established,0,0
111174,successful,0,0
111175,conversion,0,0
111176,of,0,0
111177,alphaHDL,0,1
111178,to,0,0
111179,prebeta-like,0,0
111180,HDL,0,0
111181,.,0,0
111182,The,0,0
111183,trial,0,0
111184,was,0,0
111185,complete,0,0
111186,with,0,0
111187,28,0,0
111188,patients,0,0
111189,randomized,0,0
111190,.,0,0
111191,RESULTS,0,0
111192,All,0,0
111193,reinfusion,0,1
111194,sessions,0,1
111195,were,0,0
111196,tolerated,0,0
111197,well,0,0
111198,by,0,0
111199,all,0,0
111200,patients,0,0
111201,.,0,0
111202,The,0,0
111203,levels,0,0
111204,of,0,0
111205,prebeta-like,0,1
111206,HDL,0,1
111207,and,0,0
111208,alphaHDL,0,1
111209,in,0,0
111210,the,0,0
111211,delipidated,0,1
111212,plasma,0,0
111213,converted,0,0
111214,from,0,0
111215,5.6,0,0
111216,%,0,0
111217,to,0,0
111218,79.1,0,0
111219,%,0,0
111220,and,0,0
111221,92.8,0,0
111222,%,0,0
111223,to,0,0
111224,20.9,0,0
111225,%,0,0
111226,",",0,0
111227,respectively,0,0
111228,.,0,0
111229,The,0,0
111230,IVUS,0,1
111231,data,0,0
111232,demonstrated,0,0
111233,a,0,0
111234,numeric,0,0
111235,trend,0,0
111236,toward,0,0
111237,regression,0,0
111238,in,0,0
111239,the,0,0
111240,total,0,0
111241,atheroma,0,0
111242,volume,0,0
111243,of,0,0
111244,-12.18,0,0
111245,+/-,0,0
111246,36.75,0,0
111247,mm,0,0
111248,(,0,0
111249,3,0,0
111250,),0,0
111251,in,0,0
111252,the,0,0
111253,delipidated,0,1
111254,group,0,0
111255,versus,0,1
111256,an,0,0
111257,increase,0,0
111258,of,0,0
111259,total,0,0
111260,atheroma,0,0
111261,volume,0,0
111262,of,0,0
111263,2.80,0,0
111264,+/-,0,0
111265,21.25,0,0
111266,mm,0,0
111267,(,0,0
111268,3,0,0
111269,),0,0
111270,in,0,0
111271,the,0,0
111272,control,0,1
111273,group,0,0
111274,(,0,0
111275,p,0,0
111276,=,0,0
111277,0.268,0,0
111278,),0,0
111279,.,0,0
111280,CONCLUSIONS,0,0
111281,In,0,0
111282,ACS,0,1
111283,patients,0,0
111284,",",0,0
111285,serial,0,0
111286,autologous,0,1
111287,infusions,0,1
111288,of,0,0
111289,selective,1,0
111290,HDL,1,0
111291,delipidated,1,1
111292,plasma,1,0
111293,are,0,0
111294,clinically,0,0
111295,feasible,0,0
111296,and,0,0
111297,well,0,0
111298,tolerated,0,0
111299,.,0,0
111300,This,0,0
111301,therapy,0,1
111302,may,0,0
111303,offer,0,0
111304,a,0,0
111305,novel,0,0
111306,adjunct,0,0
111307,treatment,0,0
111308,for,0,0
111309,patients,0,0
111310,presenting,0,0
111311,with,0,0
111312,ACS,0,1
111313,.,0,0
111314,Further,0,0
111315,study,0,0
111316,will,0,0
111317,be,0,0
111318,needed,0,0
111319,to,0,0
111320,determine,0,0
111321,its,0,0
111322,ability,0,0
111323,to,0,0
111324,reduce,0,0
111325,clinical,0,0
111326,cardiovascular,0,0
111327,events,0,0
111328,.,0,0
111329,Early,0,1
111330,combination,0,1
111331,disease-modifying,0,1
111332,antirheumatic,1,1
111333,drug,1,1
111334,therapy,1,1
111335,and,0,0
111336,tight,0,1
111337,disease,0,0
111338,control,0,1
111339,improve,0,0
111340,long-term,0,0
111341,radiologic,0,0
111342,outcome,0,0
111343,in,0,0
111344,patients,0,0
111345,with,0,0
111346,early,0,0
111347,rheumatoid,0,0
111348,arthritis,0,0
111349,:,0,0
111350,the,0,0
111351,11-year,0,0
111352,results,0,0
111353,of,0,0
111354,the,0,0
111355,Finnish,0,0
111356,Rheumatoid,0,0
111357,Arthritis,0,0
111358,Combination,0,1
111359,Therapy,0,1
111360,trial,0,0
111361,.,0,0
111362,INTRODUCTION,0,0
111363,Early,0,1
111364,treatment,0,0
111365,of,0,0
111366,rheumatoid,0,1
111367,arthritis,0,1
111368,(,0,1
111369,RA,0,0
111370,),0,1
111371,has,0,0
111372,been,0,0
111373,shown,0,0
111374,to,0,0
111375,retard,0,0
111376,the,0,0
111377,development,0,0
111378,of,0,0
111379,joint,0,0
111380,damage,0,0
111381,for,0,0
111382,a,0,0
111383,period,0,0
111384,of,0,0
111385,up,0,0
111386,to,0,0
111387,5,0,0
111388,years,0,0
111389,.,0,0
111390,The,0,0
111391,aim,0,0
111392,of,0,0
111393,this,0,0
111394,study,0,0
111395,was,0,0
111396,to,0,0
111397,evaluate,0,0
111398,the,0,0
111399,radiologic,0,0
111400,progression,0,0
111401,beyond,0,0
111402,that,0,0
111403,time,0,0
111404,in,0,0
111405,patients,0,0
111406,with,0,0
111407,early,0,0
111408,RA,0,0
111409,initially,0,0
111410,treated,0,0
111411,with,0,0
111412,a,0,0
111413,combination,0,1
111414,of,0,0
111415,three,1,0
111416,disease-modifying,1,0
111417,antirheumatic,1,1
111418,drugs,1,1
111419,(,1,0
111420,DMARDs,1,1
111421,),1,1
111422,or,0,1
111423,a,0,0
111424,single,1,0
111425,DMARD,1,1
111426,.,1,0
111427,METHODS,0,0
111428,A,0,0
111429,cohort,0,0
111430,of,0,0
111431,199,0,0
111432,patients,0,0
111433,with,0,0
111434,early,0,0
111435,active,0,1
111436,RA,0,0
111437,were,0,0
111438,initially,0,0
111439,randomized,0,0
111440,to,0,0
111441,receive,0,0
111442,treatment,0,0
111443,with,0,0
111444,a,0,0
111445,combination,1,1
111446,of,1,0
111447,methotrexate,1,1
111448,",",1,0
111449,sulfasalazine,1,1
111450,",",1,0
111451,and,1,0
111452,hydroxychloroquine,1,1
111453,with,1,1
111454,prednisolone,1,1
111455,(,1,1
111456,FIN-RACo,1,1
111457,),1,1
111458,",",1,0
111459,or,1,1
111460,treatment,1,0
111461,with,1,0
111462,a,1,0
111463,single,1,1
111464,DMARD,1,1
111465,(,1,0
111466,initially,1,0
111467,",",1,0
111468,sulfasalazine,1,1
111469,),1,1
111470,with,1,0
111471,or,1,1
111472,without,1,1
111473,prednisolone,1,1
111474,(,1,1
111475,SINGLE,1,1
111476,),1,0
111477,.,1,0
111478,After,0,0
111479,2,0,0
111480,years,0,0
111481,",",0,0
111482,the,0,0
111483,drug-treatment,0,1
111484,strategy,0,0
111485,became,0,0
111486,unrestricted,0,1
111487,",",0,0
111488,but,0,0
111489,still,0,0
111490,targeted,0,1
111491,remission,0,0
111492,.,0,0
111493,The,0,0
111494,radiographs,0,0
111495,of,0,0
111496,hands,0,0
111497,and,0,0
111498,feet,0,0
111499,were,0,0
111500,analyzed,0,0
111501,by,0,0
111502,using,0,0
111503,the,0,0
111504,Larsen,0,0
111505,score,0,0
111506,at,0,0
111507,baseline,0,0
111508,",",0,0
111509,2,0,0
111510,",",0,0
111511,5,0,0
111512,",",0,0
111513,and,0,0
111514,11,0,0
111515,years,0,0
111516,",",0,0
111517,and,0,0
111518,the,0,0
111519,radiographs,0,1
111520,of,0,0
111521,large,0,0
111522,joints,0,0
111523,",",0,0
111524,at,0,0
111525,11,0,0
111526,years,0,0
111527,.,0,0
111528,RESULTS,0,0
111529,Sixty-five,0,0
111530,patients,0,0
111531,in,0,0
111532,the,0,0
111533,FIN-RACo,1,0
111534,and,0,0
111535,65,0,0
111536,in,0,0
111537,the,0,0
111538,SINGLE,1,1
111539,group,0,0
111540,had,0,0
111541,radiographs,0,1
111542,of,0,0
111543,hands,0,0
111544,and,0,0
111545,feet,0,0
111546,available,0,0
111547,at,0,0
111548,baseline,0,0
111549,and,0,0
111550,at,0,0
111551,11,0,0
111552,years,0,0
111553,.,0,0
111554,The,0,0
111555,mean,0,0
111556,change,0,0
111557,from,0,0
111558,baseline,0,0
111559,to,0,0
111560,11,0,0
111561,years,0,0
111562,in,0,0
111563,Larsen,0,0
111564,score,0,0
111565,was,0,0
111566,17,0,0
111567,(,0,0
111568,95,0,0
111569,%,0,0
111570,CI,0,0
111571,",",0,0
111572,12,0,0
111573,to,0,0
111574,26,0,0
111575,),0,0
111576,in,0,0
111577,the,0,0
111578,FIN-RACo,1,0
111579,group,0,0
111580,and,0,0
111581,27,0,0
111582,(,0,0
111583,95,0,0
111584,%,0,0
111585,CI,0,0
111586,",",0,0
111587,22,0,0
111588,to,0,0
111589,33,0,0
111590,),0,0
111591,in,0,0
111592,the,0,0
111593,SINGLE,1,1
111594,group,0,0
111595,(,0,1
111596,P=0.037,0,0
111597,),0,0
111598,.,0,0
111599,In,0,0
111600,total,0,0
111601,",",0,0
111602,87,0,0
111603,%,0,0
111604,(,0,0
111605,95,0,0
111606,%,0,0
111607,CI,0,0
111608,",",0,0
111609,74,0,0
111610,to,0,0
111611,94,0,0
111612,),0,0
111613,and,0,0
111614,72,0,0
111615,%,0,0
111616,(,0,0
111617,95,0,0
111618,%,0,0
111619,CI,0,0
111620,",",0,0
111621,58,0,0
111622,to,0,0
111623,84,0,0
111624,),0,0
111625,of,0,0
111626,the,0,0
111627,patients,0,0
111628,in,0,0
111629,the,0,0
111630,FIN-RACo,0,0
111631,and,0,0
111632,the,0,0
111633,SINGLE,0,1
111634,treatment,0,0
111635,arms,0,0
111636,",",0,0
111637,respectively,0,0
111638,",",0,0
111639,had,0,0
111640,no,0,0
111641,erosive,0,0
111642,changes,0,0
111643,in,0,0
111644,large,0,0
111645,joints,0,0
111646,at,0,0
111647,11,0,0
111648,years,0,0
111649,.,0,0
111650,CONCLUSIONS,0,0
111651,Targeting,0,0
111652,to,0,0
111653,remission,0,0
111654,with,0,0
111655,tight,0,0
111656,clinical,0,0
111657,controls,0,0
111658,results,0,0
111659,in,0,0
111660,low,0,0
111661,radiologic,0,0
111662,progression,0,0
111663,in,0,0
111664,most,0,0
111665,RA,0,0
111666,patients,0,0
111667,.,0,0
111668,Patients,0,0
111669,treated,0,0
111670,initially,0,0
111671,with,0,0
111672,a,0,0
111673,combination,1,1
111674,of,1,0
111675,DMARDs,1,1
111676,have,0,0
111677,less,0,0
111678,long-term,0,0
111679,radiologic,0,0
111680,damage,0,0
111681,than,0,0
111682,do,0,0
111683,those,0,0
111684,treated,0,0
111685,initially,0,0
111686,with,0,0
111687,DMARD,1,1
111688,monotherapy,1,1
111689,.,1,0
111690,TRIAL,0,0
111691,REGISTRATION,0,0
111692,Current,0,1
111693,Controlled,0,1
111694,Trials,0,1
111695,ISRCTN18445519,0,0
111696,.,0,0
111697,Types,0,0
111698,of,0,0
111699,parent,1,1
111700,verbal,1,1
111701,responsiveness,1,0
111702,that,0,0
111703,predict,0,0
111704,language,0,0
111705,in,0,0
111706,young,0,0
111707,children,0,0
111708,with,0,0
111709,autism,0,0
111710,spectrum,0,0
111711,disorder,0,0
111712,.,0,0
111713,PURPOSE,0,0
111714,This,0,0
111715,study,0,0
111716,examined,0,0
111717,short-term,0,0
111718,predictive,0,0
111719,associations,0,0
111720,between,0,0
111721,5,0,0
111722,different,0,0
111723,types,0,0
111724,of,0,0
111725,parent,1,1
111726,verbal,1,1
111727,responsiveness,1,0
111728,and,0,0
111729,later,0,0
111730,spoken,0,1
111731,vocabulary,0,1
111732,for,0,0
111733,32,0,0
111734,young,0,0
111735,children,0,0
111736,with,0,0
111737,a,0,0
111738,confirmed,0,0
111739,diagnosis,0,0
111740,of,0,0
111741,autism,0,0
111742,spectrum,0,0
111743,disorder,0,0
111744,(,0,1
111745,ASD,0,0
111746,),0,0
111747,.,0,0
111748,METHOD,0,0
111749,Parent,1,0
111750,verbal,1,0
111751,utterances,1,0
111752,were,0,0
111753,coded,0,0
111754,from,0,0
111755,videotapes,1,1
111756,of,1,0
111757,naturalistic,1,0
111758,parent-child,1,1
111759,play,1,0
111760,sessions,1,1
111761,using,0,0
111762,interval,1,0
111763,and,0,0
111764,event-based,1,1
111765,coding,1,1
111766,.,1,0
111767,A,0,0
111768,vocabulary,0,1
111769,difference,0,0
111770,score,0,0
111771,",",0,0
111772,calculated,0,0
111773,using,0,0
111774,the,0,0
111775,MacArthur,0,0
111776,Communicative,0,0
111777,Development,0,0
111778,Inventories,0,1
111779,(,0,0
111780,L.,0,1
111781,Fenson,0,0
111782,et,0,0
111783,al.,0,0
111784,",",0,0
111785,1993,0,0
111786,),0,0
111787,",",0,0
111788,was,0,0
111789,used,0,0
111790,as,0,0
111791,the,0,0
111792,outcome,0,0
111793,measure,0,0
111794,of,0,0
111795,spoken,0,0
111796,vocabulary,0,1
111797,6,0,0
111798,months,0,0
111799,later,0,0
111800,.,0,0
111801,RESULTS,0,0
111802,Parent,0,0
111803,follow-in,0,1
111804,comments,0,0
111805,and,0,0
111806,follow-in,0,1
111807,directives,0,1
111808,predicted,0,0
111809,spoken,0,0
111810,vocabulary,0,1
111811,after,0,0
111812,controlling,0,0
111813,for,0,0
111814,child,0,0
111815,engagement,0,0
111816,.,0,0
111817,Parent,0,0
111818,expansions,0,0
111819,of,0,0
111820,child,0,0
111821,verbal,0,0
111822,utterances,0,0
111823,predicted,0,0
111824,spoken,0,0
111825,vocabulary,0,1
111826,after,0,0
111827,controlling,0,0
111828,for,0,0
111829,child,0,0
111830,talkativeness,0,0
111831,.,0,0
111832,When,0,0
111833,entered,0,0
111834,together,0,0
111835,into,0,0
111836,a,0,0
111837,regression,0,0
111838,analysis,0,0
111839,",",0,0
111840,metrics,0,0
111841,that,0,0
111842,represented,0,0
111843,(,0,0
111844,a,0,0
111845,),0,0
111846,the,0,0
111847,number,0,0
111848,of,0,0
111849,parent,1,1
111850,utterances,1,0
111851,following,0,0
111852,into,0,0
111853,the,0,0
111854,child,0,0
111855,'s,0,0
111856,focus,0,0
111857,of,0,0
111858,attention,0,0
111859,and,0,1
111860,(,0,1
111861,b,0,0
111862,),0,1
111863,the,0,0
111864,number,0,0
111865,of,0,0
111866,parent,1,1
111867,utterances,1,0
111868,responding,0,0
111869,to,0,0
111870,child,0,0
111871,verbal,0,1
111872,communication,0,1
111873,acts,0,0
111874,both,0,0
111875,accounted,0,0
111876,for,0,0
111877,unique,0,0
111878,variance,0,0
111879,in,0,0
111880,predicting,0,0
111881,change,0,0
111882,in,0,0
111883,spoken,0,1
111884,vocabulary,0,1
111885,from,0,0
111886,Time,0,1
111887,1,0,0
111888,to,0,0
111889,Time,0,0
111890,2,0,0
111891,.,0,0
111892,CONCLUSION,0,0
111893,Parent,1,0
111894,verbal,1,0
111895,utterances,1,0
111896,that,0,0
111897,follow,0,0
111898,into,0,0
111899,the,0,0
111900,child,0,0
111901,'s,0,0
111902,current,0,0
111903,focus,0,0
111904,of,0,0
111905,attention,0,0
111906,or,0,1
111907,respond,0,0
111908,to,0,0
111909,child,0,0
111910,verbal,0,1
111911,communication,0,1
111912,acts,0,0
111913,may,0,0
111914,facilitate,0,0
111915,the,0,0
111916,process,0,0
111917,of,0,0
111918,early,0,0
111919,vocabulary,0,1
111920,acquisition,0,0
111921,by,0,0
111922,mitigating,0,0
111923,the,0,0
111924,need,0,0
111925,for,0,0
111926,children,0,0
111927,with,0,0
111928,ASD,0,0
111929,to,0,0
111930,use,0,0
111931,attention-following,0,0
111932,as,0,0
111933,a,0,0
111934,word-learning,0,1
111935,strategy,0,0
111936,.,0,0
111937,Translucency,0,0
111938,of,0,0
111939,zirconia,0,1
111940,copings,0,1
111941,made,0,0
111942,with,0,0
111943,different,0,0
111944,CAD/CAM,0,0
111945,systems,0,0
111946,.,0,0
111947,STATEMENT,0,0
111948,OF,0,1
111949,PROBLEM,0,0
111950,Zirconia,0,1
111951,cores,0,1
111952,are,0,0
111953,reported,0,0
111954,to,0,0
111955,be,0,0
111956,less,0,0
111957,translucent,0,0
111958,than,0,0
111959,glass,0,1
111960,",",0,0
111961,lithium,0,1
111962,disilicate,0,1
111963,",",0,0
111964,or,0,1
111965,alumina,0,0
111966,cores,0,1
111967,.,0,0
111968,This,0,0
111969,could,0,0
111970,affect,0,0
111971,the,0,0
111972,esthetic,0,1
111973,appearance,0,0
111974,and,0,0
111975,the,0,0
111976,clinical,0,0
111977,choices,0,0
111978,made,0,0
111979,when,0,0
111980,using,0,0
111981,zirconia-based,0,1
111982,restorations,0,1
111983,.,0,0
111984,PURPOSE,0,0
111985,The,0,0
111986,purpose,0,0
111987,of,0,0
111988,this,0,0
111989,in,0,0
111990,vitro,0,0
111991,study,0,0
111992,was,0,0
111993,to,0,0
111994,evaluate,0,0
111995,the,0,0
111996,translucency,0,0
111997,of,0,0
111998,zirconia,1,1
111999,copings,1,1
112000,for,0,0
112001,single,0,0
112002,crowns,0,1
112003,fabricated,0,1
112004,using,0,0
112005,different,0,0
112006,CAD/CAM,0,0
112007,systems,0,0
112008,",",0,0
112009,using,0,0
112010,lithium,1,1
112011,disilicate,1,1
112012,glass,1,1
112013,ceramic,1,1
112014,as,0,0
112015,a,0,0
112016,control,0,0
112017,.,0,0
112018,MATERIAL,0,0
112019,AND,0,0
112020,METHODS,0,0
112021,Using,0,0
112022,impressions,0,0
112023,made,0,0
112024,from,0,0
112025,a,0,0
112026,stainless,0,1
112027,steel,0,1
112028,complete-crown,0,1
112029,master,0,1
112030,die,0,1
112031,",",0,0
112032,9,0,0
112033,stone,0,0
112034,cast,0,1
112035,replicas,0,1
112036,were,0,0
112037,fabricated,0,1
112038,",",0,0
112039,numbered,0,0
112040,",",0,0
112041,and,0,0
112042,distributed,0,0
112043,into,0,0
112044,8,0,0
112045,ceramic,0,1
112046,ZrO,0,0
112047,(,0,1
112048,2,0,0
112049,),0,0
112050,CAD/CAM,0,0
112051,system,0,1
112052,groups,0,0
112053,(,0,0
112054,Lava,0,0
112055,Frame,0,0
112056,0.3,0,0
112057,and,0,0
112058,0.5,0,0
112059,",",0,0
112060,IPS,0,1
112061,e.max,0,1
112062,ZirCAD,0,0
112063,",",0,0
112064,VITA,0,0
112065,YZ,0,0
112066,",",0,0
112067,Procera,0,1
112068,AllZircon,0,1
112069,",",0,0
112070,Digizon,0,1
112071,",",0,0
112072,DC,0,1
112073,Zircon,0,1
112074,",",0,0
112075,and,0,0
112076,Cercon,0,1
112077,Base,0,0
112078,),0,1
112079,and,0,0
112080,to,0,0
112081,a,0,0
112082,lithium,0,1
112083,disilicate,0,1
112084,glass-ceramic,0,1
112085,control,0,1
112086,group,0,1
112087,(,0,0
112088,IPS,0,1
112089,e.max,0,1
112090,Press,0,1
112091,),0,1
112092,using,0,0
112093,a,0,0
112094,simple,0,1
112095,computer-generated,0,1
112096,randomization,0,0
112097,method,0,1
112098,.,0,0
112099,From,0,0
112100,each,0,0
112101,die,0,0
112102,",",0,0
112103,the,0,0
112104,manufacturer,0,0
112105,'s,0,0
112106,authorized,0,0
112107,milling,0,1
112108,centers,0,0
112109,supplied,0,0
112110,5,0,0
112111,copings,0,1
112112,per,0,0
112113,group,0,0
112114,without,0,0
112115,applying,0,0
112116,any,0,0
112117,dying,0,0
112118,technique,0,1
112119,to,0,0
112120,the,0,0
112121,ceramic,0,1
112122,base,0,0
112123,material,0,0
112124,.,0,0
112125,The,0,0
112126,copings,0,1
112127,were,0,0
112128,prepared,0,1
112129,to,0,0
112130,allow,0,0
112131,for,0,0
112132,a,0,0
112133,40-mum,0,1
112134,cement,0,1
112135,layer,0,1
112136,and,0,0
112137,were,0,0
112138,of,0,0
112139,different,0,0
112140,thicknesses,0,0
112141,according,0,0
112142,to,0,0
112143,system,0,0
112144,specifications,0,0
112145,.,0,0
112146,Translucency,0,0
112147,was,0,0
112148,measured,0,0
112149,by,0,0
112150,the,0,0
112151,direct,0,1
112152,transmission,0,0
112153,method,0,1
112154,with,0,0
112155,a,0,0
112156,digital,0,1
112157,photoradiometer,0,1
112158,mounted,0,0
112159,in,0,0
112160,a,0,0
112161,dark,0,1
112162,chamber,0,1
112163,.,0,0
112164,The,0,0
112165,light,0,1
112166,source,0,0
112167,was,0,0
112168,a,0,0
112169,150-W,0,0
112170,halogen,0,1
112171,lamp,0,1
112172,beam,0,1
112173,.,0,0
112174,Measurements,0,0
112175,were,0,0
112176,repeated,0,0
112177,3,0,0
112178,times,0,0
112179,for,0,0
112180,each,0,0
112181,specimen,0,0
112182,.,0,0
112183,Data,0,0
112184,obtained,0,0
112185,were,0,0
112186,analyzed,0,0
112187,using,0,0
112188,1-way,0,1
112189,ANOVA,0,1
112190,and,0,0
112191,the,0,0
112192,Bonferroni,0,1
112193,multiple,0,1
112194,comparison,0,0
112195,test,0,1
112196,(,0,1
112197,alpha=.05,0,0
112198,),0,0
112199,.,0,0
112200,RESULTS,0,0
112201,Among,0,0
112202,ZrO,0,0
112203,(,0,1
112204,2,0,0
112205,),0,0
112206,copings,0,1
112207,",",0,0
112208,Lava,0,0
112209,(,0,0
112210,0.3,0,1
112211,mm,0,0
112212,and,0,0
112213,0.5,0,1
112214,mm,0,0
112215,thick,0,0
112216,),0,0
112217,showed,0,0
112218,the,0,0
112219,highest,0,0
112220,(,0,0
112221,P,0,0
112222,<,0,0
112223,.05,0,0
112224,),0,0
112225,values,0,0
112226,of,0,0
112227,translucency,0,0
112228,measured,0,0
112229,as,0,0
112230,light,0,1
112231,flow,0,0
112232,units,0,1
112233,(,0,0
112234,3.572,0,0
112235,+,0,1
112236,or,0,1
112237,-,0,0
112238,018,0,0
112239,x,0,0
112240,10,0,0
112241,(,0,0
112242,3,0,0
112243,),0,1
112244,lx,0,1
112245,and,0,0
112246,3.181,0,0
112247,+,0,1
112248,or,0,1
112249,-,0,0
112250,0.13,0,0
112251,x,0,0
112252,10,0,0
112253,(,0,0
112254,3,0,0
112255,),0,0
112256,lx,0,1
112257,",",0,0
112258,respectively,0,0
112259,),0,0
112260,.,0,0
112261,These,0,0
112262,values,0,0
112263,represent,0,0
112264,71.7,0,0
112265,%,0,0
112266,and,0,0
112267,63.9,0,0
112268,%,0,0
112269,",",0,0
112270,respectively,0,0
112271,",",0,0
112272,of,0,0
112273,the,0,0
112274,glass-ceramic,0,1
112275,control,0,1
112276,group,0,1
112277,(,0,0
112278,4.98,0,0
112279,x,0,0
112280,10,0,0
112281,(,0,0
112282,3,0,0
112283,),0,1
112284,lx,0,1
112285,),0,0
112286,.,0,0
112287,CONCLUSIONS,0,0
112288,All,0,1
112289,ZrO,0,0
112290,(,0,1
112291,2,0,0
112292,),0,0
112293,copings,0,1
112294,demonstrated,0,0
112295,different,0,0
112296,levels,0,0
112297,of,0,0
112298,light,0,1
112299,transmission,0,0
112300,",",0,0
112301,with,0,0
112302,the,0,0
112303,2,0,0
112304,Lava,0,0
112305,specimens,0,0
112306,showing,0,0
112307,the,0,0
112308,highest,0,0
112309,values,0,0
112310,.,0,0
112311,Translucency,0,0
112312,of,0,0
112313,zirconia,0,1
112314,copings,0,1
112315,was,0,0
112316,significantly,0,0
112317,lower,0,0
112318,(,0,0
112319,P=.001,0,0
112320,),0,1
112321,than,0,0
112322,that,0,0
112323,of,0,0
112324,the,0,0
112325,lithium,0,1
112326,disilicate,0,1
112327,glass-ceramic,0,1
112328,control,0,0
112329,.,0,0
112330,Effects,0,0
112331,of,0,0
112332,two,0,0
112333,combined,0,1
112334,hormonal,1,0
112335,contraceptives,1,1
112336,with,0,0
112337,the,0,0
112338,same,0,0
112339,composition,0,0
112340,and,0,0
112341,different,0,0
112342,doses,0,0
112343,on,0,0
112344,female,0,0
112345,sexual,0,0
112346,function,0,0
112347,and,0,0
112348,plasma,0,0
112349,androgen,0,1
112350,levels,0,0
112351,.,0,0
112352,BACKGROUND,0,0
112353,This,0,0
112354,study,0,0
112355,was,0,0
112356,conducted,0,0
112357,to,0,0
112358,compare,0,0
112359,the,0,0
112360,effects,0,0
112361,of,0,0
112362,two,0,0
112363,contraceptive,1,1
112364,pills,1,1
112365,with,0,0
112366,different,0,0
112367,doses,0,0
112368,of,0,0
112369,the,0,0
112370,same,0,0
112371,components,0,0
112372,",",0,0
112373,on,0,0
112374,plasma,0,0
112375,androgen,0,1
112376,levels,0,0
112377,and,0,0
112378,female,0,0
112379,sexual,0,0
112380,function,0,0
112381,among,0,0
112382,women,0,0
112383,without,0,0
112384,previous,0,0
112385,sexual,0,0
112386,dysfunction,0,0
112387,.,0,0
112388,STUDY,0,0
112389,DESIGN,0,0
112390,The,0,0
112391,participants,0,0
112392,were,0,0
112393,randomized,0,0
112394,into,0,0
112395,two,0,0
112396,groups,0,0
112397,",",0,0
112398,to,0,0
112399,receive,0,0
112400,pills,0,1
112401,containing,0,1
112402,ethynylestradiol,1,1
112403,(,1,1
112404,EE,1,1
112405,),1,1
112406,30,1,1
112407,mcg,1,1
112408,and,1,1
112409,levonorgestrel,1,1
112410,(,1,1
112411,LNG,1,1
112412,),1,1
112413,150,1,0
112414,mcg,1,1
112415,or,1,1
112416,EE,1,1
112417,20,1,1
112418,mcg,1,1
112419,and,1,0
112420,LNG,1,1
112421,100,1,1
112422,mcg,1,1
112423,",",0,0
112424,for,0,0
112425,six,0,0
112426,cycles,0,0
112427,.,0,0
112428,Sexual,0,0
112429,function,0,0
112430,was,0,0
112431,assessed,0,0
112432,using,0,0
112433,a,0,0
112434,standardized,0,1
112435,questionnaire,0,0
112436,[,0,0
112437,Female,0,0
112438,Sexual,0,0
112439,Function,0,1
112440,Index,0,1
112441,(,0,1
112442,FSFI,0,1
112443,),0,1
112444,],0,0
112445,.,0,0
112446,Hormone,0,0
112447,assays,0,0
112448,were,0,0
112449,performed,0,0
112450,at,0,0
112451,baseline,0,0
112452,and,0,0
112453,after,0,0
112454,the,0,0
112455,sixth,0,0
112456,cycle,0,0
112457,.,0,0
112458,RESULTS,0,0
112459,Forty-nine,0,0
112460,women,0,0
112461,were,0,0
112462,included,0,0
112463,in,0,0
112464,the,0,0
112465,EE30/LNG150,1,1
112466,group,0,0
112467,and,0,0
112468,48,0,0
112469,in,0,0
112470,the,0,0
112471,EE20/LNG100,1,1
112472,group,0,0
112473,.,0,0
112474,EE30/LNG150,1,0
112475,group,0,0
112476,presented,0,0
112477,54,0,0
112478,%,0,0
112479,and,0,0
112480,67,0,0
112481,%,0,0
112482,decreases,0,0
112483,of,0,0
112484,total,0,0
112485,testosterone,0,1
112486,and,0,0
112487,free,0,0
112488,androgen,0,1
112489,index,0,0
112490,",",0,0
112491,respectively,0,0
112492,",",0,0
112493,with,0,0
112494,statistical,0,0
112495,significance,0,0
112496,.,0,0
112497,EE20/LNG100,1,1
112498,presented,0,0
112499,reductions,0,0
112500,of,0,0
112501,20,0,0
112502,%,0,0
112503,and,0,0
112504,42,0,0
112505,%,0,0
112506,",",0,0
112507,respectively,0,0
112508,",",0,0
112509,but,0,0
112510,without,0,1
112511,statistical,0,0
112512,significance,0,0
112513,.,0,0
112514,Both,0,0
112515,groups,0,0
112516,showed,0,0
112517,improvements,0,0
112518,in,0,0
112519,the,0,0
112520,FSFI,0,1
112521,desire,0,0
112522,score,0,0
112523,",",0,0
112524,but,0,0
112525,with,0,0
112526,statistical,0,0
112527,significance,0,0
112528,only,0,0
112529,for,0,0
112530,EE20/LNG100,1,1
112531,group,0,0
112532,.,0,0
112533,CONCLUSIONS,0,0
112534,EE30/LNG150,1,0
112535,decreased,0,0
112536,plasma,0,0
112537,androgen,0,1
112538,levels,0,0
112539,",",0,0
112540,but,0,0
112541,there,0,0
112542,was,0,0
112543,no,0,0
112544,impairment,0,0
112545,in,0,0
112546,sexual,0,0
112547,desire,0,0
112548,",",0,0
112549,on,0,0
112550,the,0,0
112551,other,0,0
112552,hand,0,0
112553,",",0,0
112554,sexual,0,0
112555,desire,0,0
112556,score,0,0
112557,increased,0,0
112558,with,0,0
112559,EE20/LNG100,1,1
112560,formulation,0,1
112561,.,0,0
112562,A,0,0
112563,comparison,0,0
112564,of,0,0
112565,the,0,0
112566,effect,0,0
112567,of,0,0
112568,short-term,0,0
112569,aromatase,1,1
112570,inhibitor,1,1
112571,(,1,1
112572,letrozole,1,1
112573,),1,1
112574,and,1,0
112575,GnRH,1,1
112576,agonist,1,1
112577,(,1,1
112578,triptorelin,1,1
112579,),1,1
112580,versus,0,1
112581,case,0,0
112582,control,0,1
112583,on,0,0
112584,pregnancy,0,0
112585,rate,0,0
112586,and,0,1
112587,symptom,0,0
112588,and,0,1
112589,sign,0,0
112590,recurrence,0,0
112591,after,0,0
112592,laparoscopic,0,1
112593,treatment,0,0
112594,of,0,0
112595,endometriosis,0,0
112596,.,0,0
112597,PURPOSE,0,0
112598,To,0,0
112599,compare,0,0
112600,the,0,0
112601,role,0,0
112602,of,0,0
112603,an,0,0
112604,aromatase,1,1
112605,inhibitor,1,1
112606,(,1,1
112607,letrozole,1,1
112608,),1,0
112609,with,0,0
112610,a,0,0
112611,GnRH,1,1
112612,agonist,1,1
112613,(,1,1
112614,triptorelin,1,1
112615,),1,1
112616,versus,0,1
112617,case,0,0
112618,control,0,1
112619,on,0,0
112620,the,0,0
112621,pregnancy,0,0
112622,rate,0,0
112623,and,0,0
112624,recurrence,0,0
112625,of,0,0
112626,symptoms,0,0
112627,and,0,0
112628,signs,0,0
112629,in,0,0
112630,patients,0,0
112631,with,0,0
112632,endometriosis,0,0
112633,.,0,0
112634,METHODS,0,0
112635,In,0,0
112636,a,0,0
112637,prospective,0,0
112638,randomized,0,0
112639,clinical,0,0
112640,trial,0,0
112641,",",0,0
112642,after,0,0
112643,treatment,0,0
112644,of,0,0
112645,144,0,0
112646,infertile,0,0
112647,women,0,0
112648,in,0,0
112649,their,0,0
112650,reproductive,0,0
112651,age,0,0
112652,by,0,1
112653,laparoscopy,1,1
112654,(,0,0
112655,whose,0,0
112656,endometriosis,1,0
112657,was,0,0
112658,confirmed,0,0
112659,by,0,0
112660,prior,0,0
112661,laparoscopy,1,1
112662,),1,0
112663,",",0,0
112664,they,0,0
112665,were,0,0
112666,divided,0,0
112667,into,0,0
112668,3,0,0
112669,groups,0,0
112670,:,0,0
112671,group,0,0
112672,1,0,0
112673,(,0,0
112674,47,0,0
112675,cases,0,0
112676,),0,0
112677,who,0,0
112678,received,0,1
112679,letrozole,1,1
112680,for,0,0
112681,2,0,0
112682,months,0,0
112683,",",0,0
112684,group,0,0
112685,2,0,0
112686,(,0,0
112687,40,0,1
112688,patients,0,0
112689,),0,0
112690,who,0,0
112691,were,0,0
112692,prescribed,0,0
112693,triptorelin,1,1
112694,for,0,0
112695,2,0,0
112696,months,0,0
112697,and,0,0
112698,group,0,0
112699,3,0,0
112700,who,0,0
112701,were,0,0
112702,57,0,0
112703,patients,0,0
112704,in,0,0
112705,the,0,0
112706,control,1,1
112707,group,0,0
112708,and,0,0
112709,did,1,0
112710,not,1,0
112711,receive,1,0
112712,any,1,0
112713,medication,1,0
112714,.,1,0
112715,We,0,0
112716,followed,0,0
112717,up,0,0
112718,each,0,0
112719,group,0,0
112720,at,0,0
112721,least,0,0
112722,for,0,0
112723,12,0,0
112724,months,0,0
112725,after,0,0
112726,their,0,0
112727,restoration,0,0
112728,of,0,0
112729,regular,0,1
112730,cycle,0,0
112731,.,0,0
112732,RESULTS,0,0
112733,Pregnancy,0,0
112734,rate,0,0
112735,was,0,0
112736,23.4,0,0
112737,%,0,0
112738,in,0,0
112739,group,0,0
112740,1,0,0
112741,",",0,0
112742,27.5,0,0
112743,%,0,0
112744,in,0,0
112745,group,0,0
112746,2,0,0
112747,",",0,0
112748,and,0,0
112749,28.1,0,0
112750,%,0,0
112751,in,0,0
112752,group,0,0
112753,3,0,0
112754,.,0,0
112755,The,0,0
112756,results,0,0
112757,did,0,0
112758,not,0,0
112759,show,0,0
112760,significant,0,0
112761,differences,0,0
112762,among,0,0
112763,the,0,0
112764,3,0,0
112765,groups,0,0
112766,.,0,0
112767,Recurrence,0,0
112768,rate,0,0
112769,of,0,0
112770,endometriosis,0,0
112771,was,0,0
112772,6.4,0,0
112773,%,0,0
112774,in,0,0
112775,group,0,0
112776,1,0,0
112777,",",0,0
112778,5,0,0
112779,%,0,0
112780,group,0,0
112781,2,0,0
112782,and,0,0
112783,5.3,0,0
112784,%,0,0
112785,in,0,0
112786,group,0,0
112787,3,0,0
112788,",",0,0
112789,which,0,0
112790,was,0,0
112791,not,0,0
112792,statistically,0,0
112793,significantly,0,0
112794,different,0,0
112795,as,0,0
112796,well,0,0
112797,.,0,0
112798,CONCLUSION,0,0
112799,Pregnancy,0,0
112800,rate,0,0
112801,and,0,0
112802,endometriosis,0,0
112803,recurrence,0,0
112804,rate,0,0
112805,are,0,0
112806,comparable,0,0
112807,among,0,0
112808,the,0,0
112809,3,0,0
112810,groups,0,0
112811,.,0,0
112812,Tracheal,0,0
112813,soiling,0,0
112814,with,0,0
112815,blood,0,0
112816,during,0,0
112817,intranasal,1,1
112818,surgery,1,1
112819,--,1,1
112820,comparison,1,0
112821,of,0,0
112822,two,0,0
112823,endotracheal,0,0
112824,tubes,0,1
112825,.,0,0
112826,Sixty,0,0
112827,adult,0,0
112828,patients,0,0
112829,",",0,0
112830,ASA,0,1
112831,Classes,0,1
112832,I,0,0
112833,&,0,0
112834,II,0,0
112835,",",0,0
112836,were,0,0
112837,involved,0,0
112838,in,0,0
112839,a,0,0
112840,study,0,0
112841,to,0,0
112842,compare,0,0
112843,the,0,0
112844,effectiveness,0,0
112845,of,0,0
112846,Mallinckrodt,1,1
112847,Hi-Lo-Evac,1,1
112848,tube,1,1
112849,and,1,0
112850,Portex,1,1
112851,blue,1,1
112852,line,1,0
112853,tube,1,1
112854,in,0,0
112855,preventing,0,0
112856,soiling,0,0
112857,of,0,0
112858,the,0,0
112859,lower,0,0
112860,airways,0,0
112861,during,0,0
112862,intranasal,0,1
112863,surgery,0,1
112864,.,0,0
112865,The,0,0
112866,Hi-Lo-Evac,0,1
112867,tube,0,1
112868,with,0,0
112869,and,0,0
112870,without,0,1
112871,pack,0,1
112872,was,0,0
112873,significantly,0,0
112874,more,0,0
112875,effective,0,0
112876,than,0,0
112877,the,0,0
112878,Portex,0,0
112879,tube,0,1
112880,with,0,0
112881,pharyngeal,0,1
112882,pack,0,1
112883,(,0,0
112884,P,0,0
112885,less,0,0
112886,than,0,0
112887,0.002,0,0
112888,),0,0
112889,and,0,0
112890,(,0,0
112891,P,0,0
112892,less,0,0
112893,than,0,0
112894,0.01,0,0
112895,respectively,0,0
112896,),0,0
112897,.,0,0
112898,There,0,0
112899,was,0,0
112900,no,0,0
112901,significant,0,0
112902,difference,0,0
112903,when,0,0
112904,the,0,0
112905,Hi-Lo-Evac,0,1
112906,tube,0,1
112907,was,0,0
112908,used,0,0
112909,with,0,0
112910,or,0,0
112911,without,0,0
112912,a,0,0
112913,pack,0,1
112914,(,0,0
112915,P,0,0
112916,greater,0,0
112917,than,0,0
112918,0.2,0,0
112919,),0,0
112920,.,0,0
112921,The,0,0
112922,more,0,0
112923,effective,0,0
112924,protection,0,0
112925,of,0,0
112926,the,0,0
112927,lower,0,0
112928,airways,0,0
112929,by,0,0
112930,the,0,0
112931,Hi-Lo-Evac,0,1
112932,tube,0,1
112933,is,0,0
112934,attributed,0,0
112935,to,0,0
112936,the,0,0
112937,facility,0,0
112938,of,0,0
112939,subglottic,0,0
112940,aspiration,0,1
112941,during,0,0
112942,surgery,0,0
112943,.,0,0
112944,It,0,0
112945,is,0,0
112946,suggested,0,0
112947,that,0,0
112948,the,0,0
112949,Hi-Lo-Evac,0,1
112950,tube,0,1
112951,could,0,0
112952,be,0,0
112953,used,0,0
112954,with,0,0
112955,safety,0,0
112956,during,0,0
112957,intranasal,0,1
112958,surgery,0,1
112959,in,0,0
112960,order,0,0
112961,to,0,0
112962,reduce,0,0
112963,postoperative,0,0
112964,morbidity,0,0
112965,associated,0,0
112966,with,0,0
112967,the,0,0
112968,use,0,0
112969,of,0,0
112970,pharyngeal,0,0
112971,pack,0,1
112972,.,0,0
112973,Anxiety,0,0
112974,disorders,0,0
112975,in,0,0
112976,typically,0,0
112977,developing,0,0
112978,youth,0,0
112979,:,0,1
112980,autism,0,0
112981,spectrum,0,0
112982,symptoms,0,0
112983,as,0,0
112984,a,0,0
112985,predictor,0,0
112986,of,0,0
112987,cognitive-behavioral,1,1
112988,treatment,1,0
112989,.,1,0
112990,Symptoms,0,0
112991,of,0,0
112992,autism,0,0
112993,spectrum,0,0
112994,disorder,0,0
112995,(,0,1
112996,ASD,0,0
112997,),0,1
112998,were,0,0
112999,assessed,0,0
113000,(,0,0
113001,Social,0,1
113002,Responsiveness,0,0
113003,Scale-Parent,0,0
113004,(,0,1
113005,SRS-P,0,0
113006,),0,1
113007,;,0,0
113008,coded,0,0
113009,in-session,0,1
113010,behavior,0,0
113011,),0,1
113012,in,0,0
113013,typically-developing,0,0
113014,",",0,0
113015,anxiety-disordered,0,0
113016,children,0,0
113017,(,0,0
113018,N,0,0
113019,=,0,0
113020,50,0,1
113021,),0,0
113022,treated,0,0
113023,with,1,0
113024,cognitive-behavioral,1,1
113025,therapy,1,1
113026,(,1,1
113027,CBT,1,1
113028,),1,0
113029,.,1,0
113030,Study,0,0
113031,1,0,0
113032,:,0,0
113033,children,0,0
113034,with,0,0
113035,moderate,0,0
113036,autistic,0,0
113037,symptomology,0,0
113038,(,0,0
113039,per,0,1
113040,SRS-P,0,0
113041,),0,0
113042,were,0,0
113043,significantly,0,0
113044,more,0,0
113045,likely,0,0
113046,to,0,0
113047,improve,0,0
113048,from,1,0
113049,family,1,1
113050,CBT,1,1
113051,(,1,1
113052,FCBT,1,1
113053,),1,1
113054,than,1,0
113055,individual,1,0
113056,CBT,1,1
113057,(,1,0
113058,ICBT,1,1
113059,;,1,0
113060,OR,1,0
113061,=,0,0
113062,8.67,0,0
113063,),0,0
113064,.,0,0
113065,Coded,0,0
113066,behavior,0,0
113067,did,0,0
113068,not,0,0
113069,predict,0,0
113070,outcome,0,0
113071,.,0,0
113072,Study,1,0
113073,2,1,0
113074,:,1,0
113075,CBT,1,1
113076,components,0,0
113077,were,0,0
113078,compared,0,0
113079,by,0,0
113080,treatment,0,0
113081,and,0,0
113082,ASD,0,1
113083,symptom,0,0
113084,status,0,0
113085,.,0,0
113086,At-home,0,1
113087,exposure,0,0
113088,completion,0,0
113089,was,0,0
113090,greater,1,0
113091,in,1,0
113092,FCBT,1,0
113093,and,1,0
113094,there,0,0
113095,was,0,0
113096,an,0,0
113097,interaction,0,0
113098,in,0,0
113099,child,0,0
113100,involvement,0,0
113101,for,0,0
113102,treatment,0,0
113103,and,0,0
113104,ASD,0,0
113105,status,0,0
113106,.,0,0
113107,Though,0,0
113108,both,0,0
113109,treatments,0,0
113110,reduced,0,0
113111,anxiety,1,0
113112,",",1,0
113113,FCBT,1,0
113114,outperformed,1,0
113115,ICBT,1,1
113116,for,1,0
113117,children,0,0
113118,with,0,0
113119,moderate,0,0
113120,ASD,0,0
113121,symptoms,0,0
113122,",",0,0
113123,a,0,0
113124,benefit,0,0
113125,potentially,0,0
113126,linked,0,0
113127,to,0,0
113128,more,0,0
113129,at-home,0,1
113130,exposures,0,0
113131,and,0,0
113132,greater,0,0
113133,child,0,0
113134,involvement,1,0
113135,in,1,0
113136,FCBT,1,0
113137,.,1,0
113138,A,0,0
113139,cluster,0,0
113140,randomised,0,0
113141,trial,0,0
113142,to,0,0
113143,evaluate,0,0
113144,a,0,0
113145,physical,1,1
113146,activity,1,0
113147,intervention,1,1
113148,among,0,0
113149,3-5,0,0
113150,year,0,0
113151,old,0,0
113152,children,0,0
113153,attending,0,0
113154,long,0,0
113155,day,0,1
113156,care,0,1
113157,services,0,1
113158,:,0,0
113159,study,0,0
113160,protocol,0,0
113161,.,0,0
113162,BACKGROUND,0,0
113163,Young,0,0
113164,children,0,0
113165,are,0,0
113166,not,0,0
113167,participating,0,0
113168,in,0,0
113169,recommended,0,0
113170,levels,0,0
113171,of,0,0
113172,physical,0,1
113173,activity,0,0
113174,and,0,0
113175,exhibit,0,0
113176,high,0,0
113177,levels,0,0
113178,of,0,0
113179,sedentary,0,0
113180,behaviour,0,0
113181,.,0,0
113182,Childcare,0,0
113183,services,0,1
113184,provide,0,0
113185,access,0,0
113186,to,0,0
113187,large,0,0
113188,numbers,0,0
113189,of,0,0
113190,young,0,0
113191,children,0,0
113192,for,0,0
113193,prolonged,0,0
113194,periods,0,0
113195,",",0,0
113196,yet,0,0
113197,there,0,0
113198,is,0,0
113199,limited,0,0
113200,experimental,0,0
113201,evidence,0,0
113202,regarding,0,0
113203,the,0,0
113204,effectiveness,0,0
113205,of,0,0
113206,physical,0,1
113207,activity,0,0
113208,interventions,0,1
113209,implemented,0,0
113210,in,0,0
113211,this,0,0
113212,setting,0,0
113213,.,0,0
113214,The,0,0
113215,aim,0,0
113216,of,0,0
113217,this,0,0
113218,study,0,0
113219,is,0,0
113220,to,0,0
113221,assess,0,0
113222,the,0,0
113223,effectiveness,0,0
113224,and,0,0
113225,acceptability,0,0
113226,of,0,0
113227,a,0,0
113228,multi-component,0,1
113229,physical,1,1
113230,activity,1,0
113231,intervention,1,1
113232,",",0,0
113233,delivered,0,1
113234,by,0,0
113235,childcare,0,1
113236,service,0,1
113237,staff,0,0
113238,",",0,0
113239,in,0,0
113240,increasing,0,0
113241,the,0,0
113242,physical,0,1
113243,activity,0,0
113244,levels,0,0
113245,of,0,0
113246,children,0,0
113247,attending,0,0
113248,long,0,0
113249,day,0,1
113250,care,0,1
113251,services,0,1
113252,.,0,0
113253,METHODS/DESIGN,0,0
113254,The,0,0
113255,study,0,0
113256,will,0,0
113257,employ,0,0
113258,a,0,0
113259,cluster,0,0
113260,randomised,0,0
113261,controlled,0,0
113262,trial,0,0
113263,design,0,0
113264,.,0,0
113265,Three,0,0
113266,hundred,0,0
113267,children,0,0
113268,aged,0,0
113269,between,0,0
113270,3-5,0,0
113271,years,0,0
113272,from,0,0
113273,twenty,0,0
113274,randomly,0,0
113275,selected,0,0
113276,long,0,0
113277,day,0,0
113278,care,0,1
113279,services,0,1
113280,in,0,0
113281,the,0,0
113282,Hunter,0,0
113283,Region,0,1
113284,of,0,0
113285,New,0,1
113286,South,0,0
113287,Wales,0,0
113288,",",0,0
113289,Australia,0,0
113290,will,0,0
113291,be,0,0
113292,invited,0,0
113293,to,0,0
113294,participate,0,0
113295,in,0,0
113296,the,0,0
113297,trial,0,0
113298,.,0,0
113299,Ten,0,0
113300,of,0,0
113301,the,0,0
113302,20,0,0
113303,long,0,0
113304,day,0,0
113305,care,0,1
113306,services,0,1
113307,will,0,0
113308,be,0,0
113309,randomly,0,0
113310,allocated,0,0
113311,to,0,0
113312,deliver,0,1
113313,the,0,0
113314,intervention,0,1
113315,with,0,0
113316,the,0,0
113317,remaining,0,0
113318,ten,0,0
113319,services,0,1
113320,allocated,0,0
113321,to,0,0
113322,a,0,0
113323,wait,1,1
113324,list,1,1
113325,control,1,1
113326,group,0,0
113327,.,0,0
113328,The,0,0
113329,physical,1,0
113330,activity,1,0
113331,intervention,1,1
113332,will,1,0
113333,consist,1,0
113334,of,1,0
113335,a,1,0
113336,number,1,0
113337,of,1,0
113338,strategies,1,0
113339,including,1,0
113340,:,1,0
113341,delivering,1,1
113342,structured,1,1
113343,fundamental,1,0
113344,movement,1,1
113345,skill,1,0
113346,activities,1,0
113347,",",1,0
113348,increasing,1,0
113349,physical,1,1
113350,activity,1,0
113351,opportunities,1,0
113352,",",1,0
113353,increasing,1,0
113354,staff,1,0
113355,role,1,0
113356,modelling,1,0
113357,",",1,0
113358,providing,1,0
113359,children,1,0
113360,with,1,0
113361,a,1,0
113362,physical,1,1
113363,activity,1,0
113364,promoting,1,1
113365,indoor,1,0
113366,and,1,0
113367,outdoor,1,1
113368,environment,1,0
113369,and,1,0
113370,limiting,1,0
113371,children,1,0
113372,'s,1,0
113373,small,1,0
113374,screen,1,0
113375,recreation,1,1
113376,and,1,0
113377,sedentary,1,0
113378,behaviours,1,0
113379,.,1,0
113380,Intervention,0,1
113381,effectiveness,0,0
113382,will,0,0
113383,be,0,0
113384,measured,0,0
113385,via,0,0
113386,child,0,0
113387,physical,0,1
113388,activity,0,0
113389,levels,0,0
113390,during,0,0
113391,attendance,0,0
113392,at,0,0
113393,long,0,0
113394,day,0,0
113395,care,0,1
113396,.,0,0
113397,The,0,0
113398,study,0,0
113399,also,0,0
113400,seeks,0,0
113401,to,0,0
113402,determine,0,0
113403,the,0,0
113404,acceptability,0,0
113405,and,0,0
113406,extent,0,0
113407,of,0,0
113408,implementation,0,0
113409,of,0,0
113410,the,0,0
113411,intervention,0,1
113412,by,0,0
113413,services,0,1
113414,and,0,0
113415,their,0,0
113416,staff,0,0
113417,participating,0,0
113418,in,0,0
113419,the,0,0
113420,study,0,0
113421,.,0,0
113422,DISCUSSION,0,0
113423,The,0,0
113424,trial,0,0
113425,will,0,0
113426,address,0,0
113427,current,0,0
113428,gaps,0,0
113429,in,0,0
113430,the,0,0
113431,research,0,0
113432,evidence,0,0
113433,base,0,1
113434,and,0,0
113435,contribute,0,0
113436,to,0,0
113437,the,0,0
113438,design,0,0
113439,and,0,0
113440,delivery,0,0
113441,of,0,0
113442,future,0,0
113443,interventions,0,1
113444,promoting,0,0
113445,physical,0,1
113446,activity,0,0
113447,for,0,0
113448,young,0,0
113449,children,0,0
113450,in,0,0
113451,long,0,0
113452,day,0,1
113453,care,0,1
113454,settings,0,0
113455,.,0,0
113456,TRIAL,0,0
113457,REGISTRATION,0,0
113458,Australian,0,0
113459,New,0,1
113460,Zealand,0,0
113461,Clinical,0,0
113462,Trials,0,1
113463,Registry,0,0
113464,ACTRN12610000087055,0,0
113465,.,0,0
113466,A,0,0
113467,web-based,1,1
113468,patient,1,0
113469,activation,1,1
113470,intervention,1,1
113471,to,0,0
113472,improve,0,0
113473,hypertension,0,0
113474,care,0,1
113475,:,0,1
113476,study,0,0
113477,design,0,0
113478,and,0,0
113479,baseline,0,0
113480,characteristics,0,0
113481,in,0,0
113482,the,0,0
113483,web,0,1
113484,hypertension,0,0
113485,study,0,0
113486,.,0,0
113487,BACKGROUND,0,0
113488,Despite,0,0
113489,the,0,0
113490,known,0,0
113491,health,0,0
113492,risks,0,0
113493,of,0,0
113494,hypertension,0,0
113495,",",0,0
113496,many,0,0
113497,hypertensive,0,0
113498,patients,0,0
113499,still,0,0
113500,have,0,0
113501,uncontrolled,0,0
113502,blood,0,0
113503,pressure,0,0
113504,.,0,0
113505,Clinical,0,0
113506,inertia,0,0
113507,",",0,0
113508,the,0,0
113509,tendency,0,0
113510,of,0,0
113511,physicians,0,0
113512,not,0,0
113513,to,0,0
113514,intensify,0,0
113515,treatment,0,0
113516,",",0,0
113517,is,0,0
113518,a,0,0
113519,common,0,0
113520,barrier,0,0
113521,in,0,0
113522,controlling,0,0
113523,chronic,0,0
113524,diseases,0,0
113525,.,0,0
113526,This,0,0
113527,trial,0,0
113528,is,0,0
113529,aimed,0,0
113530,at,0,0
113531,determining,0,0
113532,the,0,0
113533,impact,0,0
113534,of,0,0
113535,activating,0,0
113536,patients,0,0
113537,to,0,0
113538,ask,0,0
113539,providers,0,0
113540,to,0,0
113541,make,0,0
113542,changes,0,0
113543,to,0,0
113544,their,0,0
113545,care,0,1
113546,through,0,0
113547,tailored,0,1
113548,feedback,0,1
113549,.,0,0
113550,METHODS,0,0
113551,Diagnosed,0,0
113552,hypertensive,0,0
113553,patients,0,0
113554,were,0,0
113555,enrolled,0,0
113556,in,0,0
113557,this,0,0
113558,RCT,0,0
113559,and,0,0
113560,randomized,0,0
113561,to,0,0
113562,one,0,0
113563,of,0,0
113564,two,0,0
113565,study,0,0
113566,groups,0,0
113567,:,0,0
113568,(,0,0
113569,1,0,0
113570,),0,0
113571,the,1,0
113572,intervention,1,1
113573,condition,1,0
113574,--,1,1
113575,Web-based,1,1
113576,hypertension,1,0
113577,feedback,1,1
113578,",",1,0
113579,based,1,0
113580,on,1,0
113581,the,1,0
113582,individual,1,0
113583,patient,1,0
113584,'s,1,0
113585,self-report,1,0
113586,of,1,0
113587,health,1,0
113588,variables,1,0
113589,and,1,0
113590,previous,1,0
113591,BP,1,0
113592,measurements,1,0
113593,",",1,0
113594,to,1,0
113595,prompt,1,0
113596,them,1,0
113597,to,1,0
113598,ask,1,0
113599,questions,1,0
113600,during,1,0
113601,their,1,0
113602,next,1,0
113603,physician,1,1
113604,'s,1,0
113605,visit,1,0
113606,about,1,0
113607,hypertension,1,0
113608,care,1,1
113609,(,0,1
113610,2,0,0
113611,),0,0
113612,the,1,0
113613,control,1,1
113614,condition,1,0
113615,--,1,0
113616,Web-based,1,1
113617,preventive,1,1
113618,health,1,0
113619,feedback,1,1
113620,",",1,0
113621,based,1,0
113622,on,1,0
113623,the,1,0
113624,individual,1,0
113625,'s,1,0
113626,self-report,1,0
113627,of,1,0
113628,receiving,1,0
113629,preventive,1,1
113630,care,1,1
113631,(,1,0
113632,e.g.,1,0
113633,",",0,0
113634,pap,1,1
113635,testing,1,1
113636,),1,0
113637,",",1,0
113638,to,1,0
113639,prompt,1,0
113640,them,1,0
113641,to,1,0
113642,ask,1,0
113643,questions,1,0
113644,during,1,0
113645,their,1,0
113646,next,1,0
113647,physician,1,1
113648,'s,1,0
113649,visit,1,0
113650,about,1,0
113651,preventive,1,0
113652,care,1,1
113653,.,1,0
113654,The,0,0
113655,primary,0,0
113656,outcome,0,0
113657,of,0,0
113658,the,0,0
113659,study,0,0
113660,is,0,0
113661,change,0,0
113662,in,0,0
113663,blood,0,0
113664,pressure,0,0
113665,and,0,0
113666,change,0,0
113667,in,0,0
113668,the,0,0
113669,percentage,0,0
113670,of,0,0
113671,patients,0,0
113672,in,0,0
113673,each,0,0
113674,group,0,0
113675,with,0,0
113676,controlled,0,0
113677,blood,0,0
113678,pressure,0,0
113679,.,0,0
113680,CONCLUSION,0,0
113681,Five,0,0
113682,hundred,0,0
113683,participants,0,0
113684,were,0,0
113685,enrolled,0,0
113686,and,0,0
113687,baseline,0,0
113688,characteristics,0,0
113689,include,0,0
113690,a,0,0
113691,mean,0,0
113692,age,0,0
113693,of,0,0
113694,60.0,0,0
113695,years,0,0
113696,;,0,0
113697,57.6,0,0
113698,%,0,0
113699,female,0,0
113700,;,0,0
113701,and,0,0
113702,77.6,0,0
113703,%,0,0
113704,white,0,0
113705,.,0,0
113706,Overall,0,0
113707,37.7,0,0
113708,%,0,0
113709,participants,0,0
113710,had,0,0
113711,uncontrolled,0,0
113712,blood,0,0
113713,pressure,0,0
113714,;,0,0
113715,the,0,0
113716,mean,0,0
113717,body,0,0
113718,mass,0,0
113719,index,0,0
113720,(,0,1
113721,BMI,0,1
113722,),0,1
113723,was,0,0
113724,in,0,0
113725,the,0,0
113726,obese,0,0
113727,range,0,0
113728,(,0,1
113729,32.4,0,0
113730,),0,0
113731,and,0,0
113732,21.8,0,0
113733,%,0,0
113734,had,0,0
113735,diabetes,0,0
113736,.,0,0
113737,By,0,0
113738,activating,0,0
113739,patients,0,0
113740,to,0,0
113741,become,0,0
113742,involved,0,0
113743,in,0,0
113744,their,0,0
113745,own,0,0
113746,care,0,1
113747,",",0,0
113748,we,0,0
113749,believe,0,0
113750,the,0,0
113751,addition,0,0
113752,of,0,0
113753,the,0,0
113754,web-based,0,1
113755,intervention,0,1
113756,will,0,0
113757,improve,0,0
113758,blood,0,0
113759,pressure,0,0
113760,control,0,1
113761,compared,0,0
113762,to,0,0
113763,a,0,0
113764,control,0,1
113765,group,0,0
113766,who,0,0
113767,receive,0,0
113768,web-based,0,1
113769,preventive,0,0
113770,messages,0,1
113771,unrelated,0,0
113772,to,0,0
113773,hypertension,0,0
113774,.,0,0
113775,Acamprosate,1,1
113776,appears,0,0
113777,to,0,0
113778,decrease,0,0
113779,alcohol,0,1
113780,intake,0,0
113781,in,0,0
113782,weaned,0,0
113783,alcoholics,0,0
113784,.,0,0
113785,Five,0,0
113786,hundred,0,0
113787,and,0,0
113788,sixty-nine,0,0
113789,alcoholics,0,0
113790,were,0,0
113791,included,0,0
113792,in,0,0
113793,a,0,0
113794,double-blind,0,0
113795,placebo-controlled,1,1
113796,randomized,0,0
113797,multicenter,0,0
113798,study,0,0
113799,of,0,0
113800,the,0,0
113801,effects,0,0
113802,of,0,0
113803,Acamprosate,1,1
113804,(,1,1
113805,calcium,1,1
113806,acetylhomotaurinate,1,1
113807,(,1,1
113808,CA,1,1
113809,),1,0
113810,",",1,0
113811,1.3,1,0
113812,g/day,1,0
113813,),1,0
113814,on,0,0
113815,indicators,0,0
113816,of,0,0
113817,alcoholic,0,0
113818,relapse,0,0
113819,after,0,0
113820,withdrawal,0,0
113821,.,0,0
113822,One,0,0
113823,hundred,0,0
113824,and,0,0
113825,eighty-one,0,0
113826,patients,0,0
113827,in,0,0
113828,the,0,0
113829,CA,1,1
113830,group,0,0
113831,versus,0,1
113832,175,0,0
113833,in,0,0
113834,the,0,0
113835,placebo,1,1
113836,group,0,0
113837,completed,0,0
113838,the,0,0
113839,three-month,0,0
113840,study,0,0
113841,.,0,0
113842,The,0,0
113843,major,0,0
113844,efficacy,0,0
113845,criterion,0,0
113846,was,0,0
113847,plasma,0,0
113848,gamma-glutamyl,0,0
113849,transpeptidase,0,0
113850,(,0,1
113851,GGT,0,1
113852,),0,0
113853,",",0,0
113854,as,0,0
113855,an,0,0
113856,indicator,0,0
113857,of,0,0
113858,recent,0,0
113859,alcohol,0,1
113860,ingestion,0,0
113861,.,0,0
113862,This,0,0
113863,analysis,0,0
113864,was,0,0
113865,completed,0,0
113866,by,0,0
113867,criteria,0,0
113868,concordance,0,0
113869,analysis,0,0
113870,on,0,0
113871,a,0,0
113872,number,0,0
113873,of,0,0
113874,indicators,0,0
113875,of,0,0
113876,alcohol,0,0
113877,intake,0,0
113878,.,0,0
113879,Patients,0,0
113880,in,0,0
113881,both,0,0
113882,groups,0,0
113883,were,0,0
113884,similar,0,0
113885,initially,0,0
113886,.,0,0
113887,After,0,0
113888,3,0,0
113889,months,0,0
113890,of,0,0
113891,treatment,0,0
113892,",",0,0
113893,the,0,0
113894,patients,0,0
113895,in,0,0
113896,the,0,0
113897,CA,1,1
113898,group,0,0
113899,had,0,0
113900,significantly,0,0
113901,lower,0,0
113902,GGT,0,0
113903,(,0,0
113904,1.4,0,0
113905,+/-,0,0
113906,1.56,0,0
113907,versus,0,0
113908,2.0,0,0
113909,+/-,0,0
113910,3.19,0,0
113911,times,0,0
113912,normal,0,0
113913,",",0,0
113914,P,0,0
113915,=,0,0
113916,0.016,0,0
113917,),0,0
113918,.,0,0
113919,All,0,0
113920,significant,0,0
113921,differences,0,0
113922,(,0,0
113923,P,0,0
113924,less,0,0
113925,than,0,0
113926,0.05,0,0
113927,),0,0
113928,or,0,1
113929,trends,0,0
113930,(,0,0
113931,0.10,0,0
113932,greater,0,0
113933,than,0,0
113934,P,0,0
113935,greater,0,0
113936,than,0,0
113937,0.05,0,0
113938,),0,0
113939,were,0,0
113940,in,0,0
113941,favor,0,0
113942,of,0,0
113943,a,0,0
113944,superior,0,0
113945,effect,0,0
113946,of,0,0
113947,CA,1,1
113948,over,0,0
113949,placebo,1,1
113950,.,1,0
113951,The,0,0
113952,major,0,0
113953,side-effect,0,0
113954,of,0,0
113955,CA,1,1
113956,was,0,0
113957,diarrhea,0,0
113958,(,0,0
113959,present,0,0
113960,in,0,0
113961,13,0,0
113962,%,0,0
113963,of,0,0
113964,CA,0,1
113965,patients,0,0
113966,versus,0,0
113967,7,0,0
113968,%,0,0
113969,of,0,0
113970,placebo,1,1
113971,",",0,0
113972,P,0,0
113973,=,0,0
113974,0.04,0,0
113975,),0,0
113976,.,0,0
113977,CA,1,0
113978,proved,0,0
113979,superior,0,0
113980,to,0,0
113981,placebo,1,1
113982,on,0,0
113983,the,0,0
113984,evolution,0,0
113985,of,0,0
113986,markers,0,0
113987,of,0,0
113988,alcohol,0,0
113989,ingestion,0,0
113990,at,0,0
113991,three,0,0
113992,months,0,0
113993,",",0,0
113994,in,0,0
113995,this,0,0
113996,large-scale,0,0
113997,multicenter,0,0
113998,study,0,0
113999,.,0,0
114000,It,0,0
114001,could,0,0
114002,be,0,0
114003,a,0,0
114004,new,0,0
114005,modality,0,0
114006,in,0,0
114007,the,0,0
114008,drug,0,1
114009,therapy,0,1
114010,of,0,0
114011,alcoholism,0,0
114012,",",0,0
114013,not,0,0
114014,involving,0,0
114015,an,0,0
114016,antabuse,0,1
114017,effect,0,0
114018,",",0,0
114019,an,0,0
114020,antidepressant,0,1
114021,action,0,0
114022,",",0,0
114023,or,0,1
114024,conditioning,0,1
114025,.,0,0
114026,Tomato,1,1
114027,paste,1,1
114028,rich,1,1
114029,in,1,0
114030,lycopene,1,1
114031,protects,0,0
114032,against,0,0
114033,cutaneous,0,0
114034,photodamage,0,0
114035,in,0,0
114036,humans,0,0
114037,in,0,0
114038,vivo,0,0
114039,:,0,0
114040,a,0,0
114041,randomized,0,0
114042,controlled,0,0
114043,trial,0,0
114044,.,0,0
114045,BACKGROUND,0,0
114046,Previous,0,0
114047,epidemiological,0,0
114048,",",0,0
114049,animal,0,0
114050,and,0,0
114051,human,0,1
114052,data,0,0
114053,report,0,0
114054,that,0,0
114055,lycopene,0,1
114056,has,0,0
114057,a,0,0
114058,protective,0,0
114059,effect,0,0
114060,against,0,0
114061,ultraviolet,0,1
114062,radiation,0,1
114063,(,0,1
114064,UVR,0,1
114065,),0,1
114066,-induced,0,1
114067,erythema,0,0
114068,.,0,0
114069,OBJECTIVES,0,0
114070,We,0,0
114071,examined,0,0
114072,whether,0,0
114073,tomato,1,1
114074,paste,1,1
114075,--,1,0
114076,rich,1,1
114077,in,1,0
114078,lycopene,1,1
114079,",",0,0
114080,a,0,0
114081,powerful,0,0
114082,antioxidant,0,1
114083,--,0,0
114084,can,0,0
114085,protect,0,0
114086,human,0,0
114087,skin,0,0
114088,against,0,0
114089,UVR-induced,0,0
114090,effects,0,0
114091,partially,0,0
114092,mediated,0,0
114093,by,0,0
114094,oxidative,0,0
114095,stress,0,0
114096,",",0,0
114097,i.e,0,1
114098,.,0,0
114099,erythema,0,0
114100,",",0,0
114101,matrix,0,1
114102,changes,0,0
114103,and,0,0
114104,mitochondrial,0,0
114105,DNA,0,1
114106,(,0,1
114107,mtDNA,0,1
114108,),0,1
114109,damage,0,0
114110,.,0,0
114111,METHODS,0,0
114112,In,0,0
114113,a,0,0
114114,randomized,0,0
114115,controlled,0,0
114116,study,0,0
114117,",",0,0
114118,20,0,0
114119,healthy,0,0
114120,women,0,0
114121,(,0,0
114122,median,0,0
114123,age,0,0
114124,33,0,0
114125,years,0,0
114126,",",0,0
114127,range,0,0
114128,21-47,0,0
114129,;,0,0
114130,phototype,0,0
114131,I/II,0,1
114132,),0,0
114133,ingested,0,0
114134,55,1,0
114135,g,1,1
114136,tomato,1,1
114137,paste,1,1
114138,(,1,0
114139,16,1,0
114140,mg,1,1
114141,lycopene,1,1
114142,),1,0
114143,in,1,0
114144,olive,1,1
114145,oil,1,1
114146,",",1,0
114147,or,1,1
114148,olive,1,1
114149,oil,1,1
114150,alone,1,1
114151,",",1,0
114152,daily,1,0
114153,for,1,0
114154,12,1,0
114155,weeks,1,0
114156,.,1,0
114157,Pre-,0,0
114158,and,0,0
114159,postsupplementation,0,1
114160,",",0,0
114161,UVR,0,1
114162,erythemal,0,0
114163,sensitivity,0,0
114164,was,0,0
114165,assessed,0,0
114166,visually,0,0
114167,as,0,0
114168,the,0,0
114169,minimal,0,0
114170,erythema,0,0
114171,dose,0,1
114172,(,0,1
114173,MED,0,1
114174,),0,1
114175,and,0,0
114176,quantified,0,0
114177,with,0,0
114178,a,0,0
114179,reflectance,0,0
114180,instrument,0,0
114181,.,0,0
114182,Biopsies,0,0
114183,were,0,0
114184,taken,0,0
114185,from,0,0
114186,unexposed,0,0
114187,and,0,0
114188,UVR-exposed,0,0
114189,(,0,0
114190,3,0,0
114191,?,0,0
114192,MED,0,0
114193,24,0,0
114194,h,0,0
114195,earlier,0,0
114196,),0,0
114197,buttock,0,0
114198,skin,0,0
114199,pre-,0,1
114200,and,0,0
114201,postsupplementation,0,1
114202,",",0,0
114203,and,0,0
114204,analysed,0,0
114205,immunohistochemically,0,0
114206,for,0,0
114207,procollagen,0,0
114208,(,0,1
114209,pC,0,0
114210,),0,1
114211,I,0,0
114212,",",0,0
114213,fibrillin-1,0,0
114214,and,0,0
114215,matrix,0,1
114216,metalloproteinase,0,0
114217,(,0,1
114218,MMP,0,1
114219,),0,1
114220,-1,0,0
114221,",",0,0
114222,and,0,0
114223,by,0,0
114224,quantitative,0,0
114225,polymerase,0,1
114226,chain,0,1
114227,reaction,0,1
114228,for,0,0
114229,mtDNA,0,0
114230,3895-bp,0,1
114231,deletion,0,0
114232,.,0,0
114233,RESULTS,0,0
114234,Mean,0,0
114235,?,0,0
114236,SD,0,0
114237,erythemal,0,0
114238,D,0,1
114239,(,0,1
114240,30,0,1
114241,),0,0
114242,was,0,0
114243,significantly,0,0
114244,higher,0,0
114245,following,0,0
114246,tomato,0,1
114247,paste,0,1
114248,vs.,0,0
114249,control,0,1
114250,(,0,0
114251,baseline,0,0
114252,",",0,0
114253,26?5,0,0
114254,?,0,0
114255,7?5,0,0
114256,mJ,0,1
114257,cm,0,0
114258,(,0,1
114259,-2,0,0
114260,),0,1
114261,;,0,0
114262,control,0,0
114263,",",0,0
114264,23,0,0
114265,?,0,0
114266,6?6,0,0
114267,mJ,0,1
114268,cm,0,0
114269,(,0,1
114270,-2,0,0
114271,),0,1
114272,;,0,0
114273,tomato,0,1
114274,paste,0,1
114275,",",0,0
114276,36?6,0,0
114277,?,0,0
114278,14?7,0,0
114279,mJ,0,1
114280,cm,0,0
114281,(,0,1
114282,-2,0,0
114283,),0,1
114284,;,0,0
114285,P,0,0
114286,=,0,0
114287,0?03,0,1
114288,),0,0
114289,",",0,0
114290,while,0,0
114291,the,0,0
114292,MED,0,1
114293,was,0,0
114294,not,0,0
114295,significantly,0,0
114296,different,0,0
114297,between,0,0
114298,groups,0,0
114299,(,0,0
114300,baseline,0,0
114301,",",0,0
114302,35?1,0,0
114303,?,0,0
114304,9?9,0,1
114305,mJ,0,1
114306,cm,0,0
114307,(,0,1
114308,-2,0,0
114309,),0,1
114310,;,0,0
114311,control,0,0
114312,",",0,0
114313,32?6,0,0
114314,?,0,0
114315,9?6,0,1
114316,mJ,0,1
114317,cm,0,0
114318,(,0,1
114319,-2,0,0
114320,),0,1
114321,;,0,0
114322,tomato,0,1
114323,paste,0,1
114324,",",0,0
114325,42?2,0,0
114326,?,0,0
114327,11?3,0,0
114328,mJ,0,1
114329,cm,0,0
114330,(,0,1
114331,-2,0,0
114332,),0,1
114333,),0,0
114334,.,0,0
114335,Presupplementation,0,1
114336,",",0,0
114337,UVR,0,1
114338,induced,0,0
114339,an,0,0
114340,increase,0,0
114341,in,0,0
114342,MMP-1,0,0
114343,(,0,0
114344,P,0,0
114345,=,0,0
114346,0?01,0,1
114347,),0,0
114348,and,0,0
114349,a,0,0
114350,reduction,0,0
114351,in,0,0
114352,fibrillin-1,0,1
114353,(,0,0
114354,P,0,0
114355,=,0,0
114356,0?03,0,1
114357,),0,0
114358,.,0,0
114359,Postsupplementation,0,0
114360,",",0,0
114361,UVR-induced,0,0
114362,MMP-1,0,0
114363,was,0,0
114364,reduced,0,0
114365,in,0,0
114366,the,0,0
114367,tomato,0,1
114368,paste,0,1
114369,vs.,0,0
114370,control,0,1
114371,group,0,1
114372,(,0,0
114373,P,0,0
114374,=,0,0
114375,0?04,0,1
114376,),0,0
114377,",",0,0
114378,while,0,0
114379,the,0,0
114380,UVR-induced,0,0
114381,reduction,0,0
114382,in,0,0
114383,fibrillin-1,0,0
114384,was,0,0
114385,similarly,0,0
114386,abrogated,0,0
114387,in,0,0
114388,both,0,0
114389,groups,0,0
114390,",",0,0
114391,and,0,0
114392,an,0,0
114393,increase,0,0
114394,in,0,0
114395,pCI,0,1
114396,deposition,0,0
114397,was,0,0
114398,seen,0,0
114399,following,0,0
114400,tomato,0,1
114401,paste,0,1
114402,(,0,0
114403,P,0,0
114404,=,0,0
114405,0?05,0,0
114406,),0,0
114407,.,0,0
114408,mtDNA,0,0
114409,3895-bp,0,1
114410,deletion,0,1
114411,following,0,0
114412,3,0,0
114413,?,0,0
114414,MED,0,0
114415,UVR,0,0
114416,was,0,0
114417,significantly,0,0
114418,reduced,0,0
114419,postsupplementation,0,1
114420,with,0,0
114421,tomato,1,1
114422,paste,1,1
114423,(,1,0
114424,P,1,0
114425,=,1,0
114426,0?01,1,1
114427,),0,0
114428,.,0,0
114429,CONCLUSIONS,1,0
114430,Tomato,1,1
114431,paste,1,1
114432,containing,0,1
114433,lycopene,0,1
114434,provides,0,0
114435,protection,0,0
114436,against,0,0
114437,acute,0,0
114438,and,0,0
114439,potentially,0,0
114440,longer-term,0,0
114441,aspects,0,0
114442,of,0,0
114443,photodamage,0,0
114444,.,0,0
114445,A,0,0
114446,phase,0,0
114447,II,0,0
114448,randomized,0,0
114449,trial,0,0
114450,comparing,0,0
114451,radiotherapy,1,1
114452,with,0,0
114453,concurrent,0,1
114454,weekly,0,1
114455,cisplatin,1,1
114456,or,0,1
114457,weekly,0,1
114458,paclitaxel,1,1
114459,in,0,0
114460,patients,0,0
114461,with,0,0
114462,advanced,0,0
114463,cervical,0,0
114464,cancer,0,0
114465,.,0,0
114466,PURPOSE/OBJECTIVE,0,0
114467,This,0,0
114468,is,0,0
114469,a,0,0
114470,prospective,0,0
114471,comparison,0,0
114472,of,0,0
114473,weekly,0,1
114474,cisplatin,1,1
114475,to,0,0
114476,weekly,0,1
114477,paclitaxel,1,1
114478,as,0,0
114479,concurrent,0,1
114480,chemotherapy,0,1
114481,with,0,0
114482,standard,1,1
114483,radiotherapy,1,1
114484,for,0,0
114485,locally,0,1
114486,advanced,0,0
114487,cervical,0,0
114488,carcinoma,0,0
114489,.,0,0
114490,MATERIALS/METHODS,0,0
114491,Between,0,0
114492,May,0,1
114493,2000,0,0
114494,and,0,0
114495,May,0,1
114496,2004,0,0
114497,",",0,0
114498,31,0,0
114499,women,0,0
114500,with,0,0
114501,FIGO,0,0
114502,stage,0,0
114503,IB2-IVA,0,1
114504,cervical,0,1
114505,cancer,0,0
114506,or,0,1
114507,with,0,0
114508,postsurgical,0,0
114509,pelvic,0,1
114510,recurrence,0,0
114511,were,0,0
114512,enrolled,0,0
114513,into,0,0
114514,this,0,0
114515,phase,0,0
114516,II,0,1
114517,study,0,0
114518,and,0,0
114519,randomized,0,0
114520,to,0,0
114521,receive,0,0
114522,on,0,0
114523,a,0,0
114524,weekly,0,1
114525,basis,0,0
114526,either,0,1
114527,40,1,1
114528,mg/m?,1,1
114529,Cisplatin,1,1
114530,(,1,1
114531,group,1,0
114532,I,1,0
114533,;,1,0
114534,16,1,0
114535,patients,1,0
114536,),1,0
114537,or,1,1
114538,50,1,1
114539,mg/m?,1,1
114540,paclitaxel,1,1
114541,(,1,0
114542,group,1,0
114543,II,1,1
114544,;,1,0
114545,15,1,0
114546,patients,1,0
114547,),1,0
114548,concurrently,1,1
114549,with,1,0
114550,radiotherapy,1,1
114551,.,1,0
114552,Median,0,0
114553,total,0,0
114554,dose,0,0
114555,to,0,0
114556,point,0,0
114557,A,0,0
114558,was,0,0
114559,74,0,0
114560,Gy,0,1
114561,(,0,0
114562,range,0,0
114563,:,0,0
114564,66-92,0,0
114565,Gy,0,1
114566,),0,1
114567,for,0,0
114568,group,0,0
114569,I,0,0
114570,and,0,0
114571,66,0,0
114572,Gy,0,1
114573,(,0,0
114574,range,0,0
114575,:,0,0
114576,40-98,0,0
114577,Gy,0,1
114578,),0,1
114579,for,0,0
114580,group,0,0
114581,II,0,0
114582,.,0,0
114583,Median,0,0
114584,follow-up,0,0
114585,time,0,0
114586,was,0,0
114587,46,0,0
114588,months,0,0
114589,.,0,0
114590,RESULTS,0,0
114591,Patient,0,1
114592,and,0,0
114593,tumor,0,0
114594,characteristics,0,0
114595,were,0,0
114596,similar,0,0
114597,in,0,0
114598,both,0,0
114599,groups,0,0
114600,.,0,0
114601,The,0,0
114602,mean,0,0
114603,number,0,0
114604,of,0,0
114605,chemotherapy,0,1
114606,cycles,0,0
114607,was,0,0
114608,also,0,0
114609,comparable,0,0
114610,with,0,0
114611,87,0,0
114612,%,0,0
114613,and,0,0
114614,80,0,0
114615,%,0,0
114616,of,0,0
114617,patients,0,0
114618,receiving,0,0
114619,at,0,0
114620,least,0,0
114621,4,0,0
114622,doses,0,0
114623,in,0,0
114624,groups,0,0
114625,I,0,0
114626,and,0,0
114627,II,0,0
114628,",",0,0
114629,respectively,0,0
114630,.,0,0
114631,Seven,0,0
114632,patients,0,0
114633,(,0,0
114634,44,0,0
114635,%,0,0
114636,),0,0
114637,of,0,0
114638,group,0,0
114639,I,0,0
114640,and,0,0
114641,8,0,0
114642,patients,0,0
114643,(,0,0
114644,53,0,0
114645,%,0,0
114646,),0,0
114647,of,0,0
114648,group,0,0
114649,II,0,0
114650,developed,0,0
114651,tumor,0,0
114652,recurrence,0,0
114653,.,0,0
114654,The,0,0
114655,Median,0,0
114656,Survival,0,0
114657,time,0,0
114658,was,0,0
114659,not,0,0
114660,reached,0,0
114661,for,0,0
114662,Group,0,0
114663,I,0,0
114664,and,0,0
114665,53,0,0
114666,months,0,0
114667,for,0,0
114668,group,0,0
114669,II,0,0
114670,.,0,0
114671,The,0,0
114672,proportion,0,0
114673,of,0,0
114674,patients,0,0
114675,surviving,0,0
114676,at,0,0
114677,2,0,0
114678,and,0,0
114679,5,0,0
114680,years,0,0
114681,was,0,0
114682,78,0,0
114683,%,0,0
114684,and,0,0
114685,54,0,0
114686,%,0,0
114687,for,0,0
114688,group,0,0
114689,I,0,0
114690,and,0,0
114691,73,0,0
114692,%,0,0
114693,and,0,0
114694,43,0,0
114695,%,0,0
114696,for,0,0
114697,group,0,0
114698,II,0,0
114699,respectively,0,0
114700,.,0,0
114701,CONCLUSIONS,0,0
114702,This,0,0
114703,small,0,0
114704,prospective,0,0
114705,study,0,0
114706,shows,0,0
114707,that,0,0
114708,weekly,1,1
114709,paclitaxel,1,1
114710,does,1,0
114711,not,0,0
114712,provide,0,0
114713,any,0,0
114714,clinical,0,0
114715,advantage,0,0
114716,over,0,0
114717,weekly,1,1
114718,cisplatin,1,1
114719,for,1,0
114720,concurrent,1,1
114721,chemoradiation,1,1
114722,for,1,0
114723,advanced,0,0
114724,carcinoma,0,0
114725,of,0,0
114726,the,0,0
114727,cervix,0,0
114728,.,0,0
114729,Influence,0,0
114730,of,0,0
114731,exercise,1,1
114732,training,1,1
114733,on,0,0
114734,leptin,0,0
114735,levels,0,0
114736,in,0,0
114737,patients,0,0
114738,with,0,0
114739,stable,0,0
114740,coronary,0,0
114741,artery,0,0
114742,disease,0,0
114743,:,0,0
114744,A,0,0
114745,pilot,0,0
114746,study,0,0
114747,.,0,0
114748,BACKGROUND,0,0
114749,This,0,0
114750,study,0,0
114751,was,0,0
114752,designed,0,0
114753,to,0,0
114754,examine,0,0
114755,the,0,0
114756,influence,0,0
114757,of,0,0
114758,exercise,1,1
114759,training,1,1
114760,on,0,0
114761,leptin,0,0
114762,levels,0,0
114763,in,0,0
114764,patients,0,0
114765,with,0,0
114766,stable,0,0
114767,coronary,0,0
114768,artery,0,1
114769,disease,0,0
114770,(,0,1
114771,CAD,0,1
114772,),0,0
114773,.,0,0
114774,METHODS,0,0
114775,Sixty-four,0,0
114776,male,0,0
114777,patients,0,0
114778,",",0,0
114779,mean,0,0
114780,age,0,0
114781,55.6,0,0
114782,?,0,0
114783,6.0,0,0
114784,years,0,0
114785,",",0,0
114786,were,0,0
114787,randomized,0,0
114788,either,0,0
114789,to,0,0
114790,six,0,0
114791,weeks,0,0
114792,of,1,0
114793,aerobic,1,1
114794,training,1,1
114795,",",1,0
114796,three,0,0
114797,times,0,0
114798,a,0,0
114799,week,0,0
114800,",",0,0
114801,at,0,0
114802,60-80,0,0
114803,%,0,0
114804,of,0,0
114805,maximal,0,0
114806,heart,0,0
114807,rate,0,0
114808,(,0,1
114809,training,0,1
114810,group,0,0
114811,",",0,0
114812,Ex,0,1
114813,",",0,0
114814,n,0,0
114815,=,0,0
114816,32,0,0
114817,),0,0
114818,or,0,0
114819,to,0,0
114820,a,0,0
114821,control,1,1
114822,group,0,0
114823,(,0,0
114824,n,0,0
114825,=,0,0
114826,32,0,0
114827,),0,0
114828,.,0,0
114829,Exercise,0,1
114830,stress,0,0
114831,test,0,0
114832,was,0,0
114833,performed,0,0
114834,and,0,0
114835,body,0,0
114836,mass,0,0
114837,index,0,0
114838,(,0,1
114839,BMI,0,1
114840,),0,1
114841,",",0,0
114842,waist-to-hip,0,0
114843,ratio,0,0
114844,(,0,1
114845,WHR,0,1
114846,),0,1
114847,",",0,0
114848,waist,0,0
114849,circumference,0,0
114850,and,0,0
114851,plasma,0,0
114852,leptin,0,1
114853,levels,0,0
114854,were,0,0
114855,measured,0,0
114856,at,0,0
114857,the,0,0
114858,beginning,0,0
114859,and,0,0
114860,end,0,0
114861,of,0,0
114862,the,0,0
114863,study,0,0
114864,.,0,0
114865,RESULTS,0,0
114866,Physical,0,0
114867,capacity,0,0
114868,increased,0,0
114869,significantly,0,0
114870,only,0,0
114871,in,0,0
114872,Ex,0,1
114873,patients,0,0
114874,(,0,0
114875,max,0,0
114876,workload,0,0
114877,in,0,0
114878,METs,0,1
114879,from,0,0
114880,7.7,0,0
114881,?,0,0
114882,1.4,0,0
114883,to,0,0
114884,8.2,0,0
114885,?,0,0
114886,1.4,0,0
114887,",",0,0
114888,p,0,0
114889,<,0,0
114890,0.05,0,0
114891,),0,0
114892,.,0,0
114893,There,0,0
114894,were,0,0
114895,no,0,0
114896,significant,0,0
114897,differences,0,0
114898,between,0,0
114899,initial,0,0
114900,and,0,0
114901,final,0,0
114902,results,0,0
114903,in,0,0
114904,either,0,0
114905,group,0,0
114906,in,0,0
114907,terms,0,0
114908,of,0,0
114909,BMI,0,0
114910,",",0,0
114911,WHR,0,0
114912,or,0,1
114913,waist,0,0
114914,circumference,0,0
114915,.,0,0
114916,Although,0,0
114917,",",0,0
114918,at,0,0
114919,the,0,0
114920,end,0,0
114921,of,0,0
114922,the,0,0
114923,study,0,0
114924,",",0,0
114925,leptin,0,0
114926,levels,0,0
114927,did,0,0
114928,not,0,0
114929,change,0,0
114930,in,0,0
114931,Ex,0,1
114932,patients,0,0
114933,(,0,0
114934,6.7,0,0
114935,?,0,0
114936,3.2,0,0
114937,vs,0,0
114938,6.9,0,0
114939,?,0,0
114940,3.6,0,0
114941,ng/mL,0,0
114942,",",0,0
114943,NS,0,0
114944,),0,0
114945,",",0,0
114946,they,0,0
114947,did,0,0
114948,increase,0,0
114949,significantly,0,0
114950,in,0,0
114951,the,0,0
114952,control,0,1
114953,group,0,0
114954,(,0,0
114955,8.0,0,0
114956,?,0,0
114957,4.0,0,0
114958,vs,0,0
114959,9.3,0,0
114960,?,0,0
114961,5.2,0,0
114962,ng/mL,0,0
114963,",",0,0
114964,p,0,0
114965,<,0,0
114966,0.02,0,0
114967,),0,0
114968,.,0,0
114969,CONCLUSIONS,0,0
114970,A,0,0
114971,short,0,0
114972,period,0,0
114973,of,1,0
114974,exercise,1,1
114975,training,1,1
114976,in,1,0
114977,CAD,1,0
114978,patients,0,0
114979,improved,0,0
114980,their,0,0
114981,physical,0,1
114982,capacity,0,0
114983,",",0,0
114984,but,0,0
114985,did,0,0
114986,not,0,0
114987,influence,0,0
114988,BMI,0,0
114989,",",0,0
114990,WHR,0,0
114991,and,0,0
114992,waist,0,0
114993,circumference,1,0
114994,.,1,1
114995,Exercise,1,1
114996,training,1,1
114997,prevented,1,0
114998,an,0,0
114999,increase,0,0
115000,in,0,0
115001,leptin,0,0
115002,levels,0,0
115003,during,0,0
115004,the,0,0
115005,study,0,0
115006,period,0,0
115007,.,0,0
115008,Anatomical,0,1
115009,benefit,0,0
115010,from,0,0
115011,ranibizumab,1,1
115012,treatment,0,0
115013,of,0,0
115014,predominantly,0,0
115015,classic,0,0
115016,neovascular,0,0
115017,age-related,0,0
115018,macular,0,0
115019,degeneration,0,0
115020,in,0,0
115021,the,0,0
115022,2-year,0,0
115023,anchor,0,0
115024,study,0,0
115025,.,0,0
115026,PURPOSE,0,0
115027,To,0,0
115028,compare,0,0
115029,lesion,0,0
115030,anatomical,0,0
115031,responses,0,0
115032,to,0,0
115033,ranibizumab,1,1
115034,versus,0,1
115035,verteporfin,1,1
115036,photodynamic,1,1
115037,therapy,1,1
115038,(,1,1
115039,PDT,1,1
115040,),1,1
115041,in,0,0
115042,the,0,0
115043,ANCHOR,0,1
115044,(,0,0
115045,Anti-VEGF,0,1
115046,Antibody,0,1
115047,for,0,0
115048,the,0,0
115049,Treatment,0,0
115050,of,0,0
115051,Predominantly,0,0
115052,Classic,0,1
115053,Choroidal,0,1
115054,Neovascularization,0,0
115055,[,0,0
115056,CNV,0,1
115057,],0,0
115058,in,0,0
115059,Age-Related,0,1
115060,Macular,0,0
115061,Degeneration,0,0
115062,),0,0
115063,study,0,0
115064,.,0,0
115065,METHODS,0,0
115066,In,0,0
115067,this,0,0
115068,2-year,0,0
115069,",",0,0
115070,Phase,0,0
115071,III,0,0
115072,",",0,0
115073,randomized,0,0
115074,",",0,0
115075,multicenter,0,0
115076,",",0,0
115077,double-masked,0,0
115078,trial,0,0
115079,",",0,0
115080,423,0,0
115081,patients,0,0
115082,received,0,0
115083,ranibizumab,1,1
115084,(,0,0
115085,0.3,0,0
115086,or,0,1
115087,0.5,0,1
115088,mg,0,1
115089,),0,0
115090,monthly,0,1
115091,+,0,1
115092,sham,1,1
115093,PDT,1,1
115094,or,1,1
115095,PDT,1,1
115096,+,1,1
115097,monthly,0,1
115098,sham,1,1
115099,injection,1,1
115100,.,1,0
115101,Photodynamic,1,1
115102,therapy,1,1
115103,(,1,0
115104,or,1,1
115105,sham,1,1
115106,PDT,1,1
115107,),1,0
115108,was,0,0
115109,administered,0,0
115110,at,0,0
115111,Day,0,1
115112,0,0,0
115113,and,0,0
115114,then,0,0
115115,quarterly,0,1
115116,as,0,0
115117,needed,0,0
115118,.,0,0
115119,A,0,0
115120,central,0,0
115121,reading,0,1
115122,center,0,0
115123,assessed,0,0
115124,fundus,0,1
115125,photography,0,1
115126,and,0,0
115127,fluorescein,0,1
115128,angiography,0,1
115129,images,0,1
115130,.,0,0
115131,A,0,0
115132,subset,0,0
115133,(,0,0
115134,n,0,0
115135,=,0,0
115136,61,0,0
115137,),0,0
115138,had,0,0
115139,optical,0,1
115140,coherence,0,0
115141,tomography,0,1
115142,assessments,0,0
115143,.,0,0
115144,Main,0,0
115145,outcome,0,0
115146,measures,0,0
115147,included,0,0
115148,mean,0,0
115149,change,0,0
115150,from,0,0
115151,baseline,0,0
115152,at,0,0
115153,Months,0,1
115154,12,0,0
115155,and,0,0
115156,24,0,0
115157,for,0,0
115158,area,0,0
115159,of,0,0
115160,classic,0,1
115161,CNV,0,1
115162,and,0,0
115163,total,0,0
115164,area,0,0
115165,of,0,0
115166,leakage,0,0
115167,from,0,0
115168,CNV,0,0
115169,.,0,0
115170,RESULTS,0,0
115171,At,0,0
115172,Months,0,0
115173,12,0,0
115174,and,0,0
115175,24,0,0
115176,",",0,0
115177,ranibizumab,1,1
115178,was,0,0
115179,superior,0,0
115180,to,0,0
115181,PDT,1,1
115182,(,0,1
115183,P,0,0
115184,<,0,0
115185,0.0001,0,0
115186,),0,0
115187,for,0,0
115188,mean,0,0
115189,changes,0,0
115190,from,0,0
115191,baseline,0,0
115192,in,0,0
115193,total,0,0
115194,area,0,0
115195,of,0,0
115196,lesion,0,0
115197,",",0,0
115198,CNV,0,1
115199,area,0,0
115200,",",0,0
115201,and,0,0
115202,total,0,0
115203,area,0,0
115204,CNV,0,1
115205,leakage,0,0
115206,.,0,0
115207,Month,0,0
115208,12,0,0
115209,optical,0,0
115210,coherence,0,0
115211,tomographies,0,1
115212,showed,0,0
115213,greater,0,0
115214,center,0,0
115215,point,0,0
115216,thickness,0,0
115217,decrease,0,0
115218,from,0,0
115219,baseline,0,0
115220,with,0,0
115221,ranibizumab,1,1
115222,than,0,0
115223,with,0,0
115224,PDT,1,1
115225,(,0,0
115226,P,0,0
115227,=,0,0
115228,0.0003,0,0
115229,),0,0
115230,.,0,0
115231,Ranibizumab,1,1
115232,benefits,0,0
115233,over,0,0
115234,PDT,1,1
115235,were,0,0
115236,evident,0,0
115237,by,0,0
115238,3,0,0
115239,months,0,0
115240,(,0,0
115241,fluorescein,0,1
115242,angiography,0,1
115243,),0,1
115244,and,0,0
115245,7,0,0
115246,days,0,0
115247,(,0,0
115248,optical,0,1
115249,coherence,0,0
115250,tomography,0,1
115251,),0,0
115252,.,0,0
115253,CONCLUSION,0,0
115254,Differences,0,0
115255,between,0,0
115256,the,0,0
115257,PDT,1,1
115258,and,0,0
115259,the,0,0
115260,ranibizumab,1,1
115261,groups,0,0
115262,in,0,0
115263,lesion,0,0
115264,anatomical,0,0
115265,outcomes,0,0
115266,were,0,0
115267,early,0,0
115268,",",0,0
115269,sustained,0,0
115270,",",0,0
115271,and,0,0
115272,favored,0,0
115273,ranibizumab,1,1
115274,.,1,0
115275,Cardiovascular,0,0
115276,safety,0,0
115277,of,0,0
115278,degarelix,1,1
115279,:,1,0
115280,results,0,0
115281,from,0,0
115282,a,0,0
115283,12-month,0,0
115284,",",0,0
115285,comparative,0,0
115286,",",0,0
115287,randomized,0,0
115288,",",0,0
115289,open,0,1
115290,label,0,0
115291,",",0,0
115292,parallel,0,0
115293,group,0,0
115294,phase,0,0
115295,III,0,1
115296,trial,0,0
115297,in,0,0
115298,patients,0,0
115299,with,0,0
115300,prostate,0,0
115301,cancer,0,0
115302,.,0,0
115303,PURPOSE,0,0
115304,We,0,0
115305,assessed,0,0
115306,the,0,0
115307,cardiovascular,0,0
115308,safety,0,0
115309,profile,0,0
115310,of,0,0
115311,degarelix,1,1
115312,",",0,0
115313,a,0,0
115314,new,0,0
115315,gonadotropin-releasing,1,1
115316,hormone,1,1
115317,antagonist,1,1
115318,.,1,0
115319,MATERIALS,0,0
115320,AND,0,0
115321,METHODS,0,0
115322,This,0,0
115323,is,0,0
115324,the,0,0
115325,first,0,0
115326,report,0,0
115327,to,0,0
115328,our,0,0
115329,knowledge,0,0
115330,on,0,0
115331,cardiovascular,0,0
115332,safety,0,0
115333,data,0,0
115334,from,0,0
115335,a,0,0
115336,completed,0,0
115337,1-year,0,0
115338,randomized,0,0
115339,controlled,0,0
115340,trial,0,0
115341,of,0,0
115342,leuprolide,1,1
115343,acetate,1,1
115344,vs,1,0
115345,degarelix,1,1
115346,.,1,0
115347,Outcomes,0,0
115348,considered,0,0
115349,in,0,0
115350,these,0,0
115351,analyses,0,0
115352,included,0,0
115353,the,0,0
115354,QT,0,0
115355,interval,0,0
115356,by,0,0
115357,central,0,0
115358,reading,0,1
115359,and,0,0
115360,analysis,0,0
115361,",",0,0
115362,and,0,0
115363,cardiovascular,0,0
115364,adverse,0,0
115365,events,0,0
115366,.,0,0
115367,On,0,0
115368,multivariate,0,0
115369,analyses,0,0
115370,relationships,0,0
115371,between,0,0
115372,selected,0,0
115373,baseline,0,0
115374,factors,0,0
115375,and,0,0
115376,cardiovascular,0,0
115377,events,0,0
115378,were,0,0
115379,evaluated,0,0
115380,.,0,0
115381,RESULTS,0,0
115382,There,0,0
115383,were,0,0
115384,no,0,0
115385,significant,0,0
115386,differences,0,0
115387,between,0,0
115388,treatment,0,0
115389,groups,0,0
115390,for,0,0
115391,mean,0,0
115392,change,0,0
115393,in,0,0
115394,Fridericia,0,0
115395,'s,0,0
115396,correction,0,0
115397,of,0,0
115398,QT,0,0
115399,during,0,0
115400,the,0,0
115401,trial,0,0
115402,.,0,0
115403,Markedly,0,0
115404,abnormal,0,0
115405,Fridericia,0,1
115406,'s,0,0
115407,correction,0,0
115408,of,0,0
115409,QT,0,0
115410,values,0,0
115411,(,0,0
115412,500,0,1
115413,milliseconds,0,0
115414,or,0,0
115415,greater,0,0
115416,),0,0
115417,were,0,0
115418,observed,0,0
115419,in,0,0
115420,only,0,0
115421,a,0,0
115422,small,0,0
115423,number,0,0
115424,of,0,0
115425,subjects,0,0
115426,by,0,0
115427,treatment,0,0
115428,group,0,0
115429,",",0,0
115430,that,0,0
115431,is,0,0
115432,2,0,0
115433,(,0,0
115434,less,0,0
115435,than,0,0
115436,1,0,0
115437,%,0,0
115438,),0,0
115439,in,0,0
115440,the,0,0
115441,pooled,0,0
115442,degarelix,1,1
115443,group,0,0
115444,and,0,0
115445,2,0,0
115446,(,0,0
115447,1,0,1
115448,%,0,0
115449,),0,0
115450,in,0,0
115451,the,0,0
115452,leuprolide,1,1
115453,group,0,0
115454,.,0,0
115455,Supraventricular,0,0
115456,arrhythmias,0,0
115457,were,0,0
115458,the,0,0
115459,most,0,0
115460,common,0,0
115461,type,0,0
115462,of,0,0
115463,arrhythmias,0,0
115464,",",0,0
115465,affecting,0,0
115466,2,0,0
115467,%,0,0
115468,of,0,0
115469,subjects,0,0
115470,in,0,0
115471,the,0,0
115472,pooled,0,0
115473,degarelix,1,1
115474,group,0,0
115475,and,0,0
115476,4,0,0
115477,%,0,0
115478,in,0,0
115479,the,0,0
115480,leuprolide,1,1
115481,group,0,0
115482,.,0,0
115483,Other,0,0
115484,arrhythmias,0,0
115485,occurred,0,0
115486,in,0,0
115487,1,0,0
115488,%,0,0
115489,or,0,0
115490,less,0,0
115491,of,0,0
115492,subjects,0,0
115493,by,0,0
115494,treatment,0,0
115495,group,0,0
115496,.,0,0
115497,The,0,0
115498,most,0,0
115499,frequently,0,0
115500,reported,0,0
115501,cardiac,0,0
115502,disorder,0,0
115503,was,0,0
115504,ischemic,0,0
115505,heart,0,0
115506,disease,0,0
115507,",",0,0
115508,which,0,0
115509,occurred,0,0
115510,in,0,0
115511,4,0,0
115512,%,0,0
115513,of,0,0
115514,subjects,0,0
115515,treated,0,0
115516,with,0,0
115517,degarelix,1,1
115518,and,0,0
115519,10,0,1
115520,%,0,0
115521,of,0,0
115522,those,0,0
115523,on,0,0
115524,leuprolide,1,1
115525,.,1,0
115526,Cox,0,0
115527,proportional,0,0
115528,hazard,0,0
115529,ratio,0,0
115530,estimates,0,0
115531,for,0,0
115532,selected,0,0
115533,baseline,0,0
115534,covariates,0,0
115535,showed,0,0
115536,a,0,0
115537,significantly,0,0
115538,increased,0,0
115539,risk,0,0
115540,of,0,0
115541,cardiovascular,0,0
115542,events,0,0
115543,by,0,0
115544,age,0,0
115545,(,0,1
115546,p=0.0459,0,0
115547,),0,1
115548,and,0,0
115549,systolic,0,0
115550,blood,0,1
115551,pressure,0,1
115552,(,0,1
115553,p=0.0061,0,0
115554,),0,0
115555,.,0,0
115556,CONCLUSIONS,0,0
115557,In,0,0
115558,men,0,0
115559,with,0,0
115560,prostate,0,0
115561,cancer,0,0
115562,degarelix,1,1
115563,and,0,0
115564,leuprolide,1,1
115565,have,0,0
115566,similar,0,0
115567,cardiovascular,0,0
115568,safety,0,0
115569,profiles,0,0
115570,.,0,0
115571,These,0,0
115572,observations,0,0
115573,suggest,0,0
115574,that,0,0
115575,the,0,0
115576,cardiovascular,0,0
115577,events,0,0
115578,associated,0,0
115579,with,0,0
115580,both,0,0
115581,agents,0,0
115582,result,0,0
115583,from,0,0
115584,hypogonadism,0,0
115585,rather,0,0
115586,than,0,0
115587,a,0,0
115588,direct,0,1
115589,drug,0,1
115590,effect,0,0
115591,.,0,0
115592,Ipilimumab,1,1
115593,efficacy,0,0
115594,and,0,0
115595,safety,0,0
115596,in,0,0
115597,patients,0,0
115598,with,0,0
115599,advanced,0,0
115600,melanoma,0,0
115601,:,0,0
115602,a,0,0
115603,retrospective,0,0
115604,analysis,0,0
115605,of,0,0
115606,HLA,0,1
115607,subtype,0,0
115608,from,0,0
115609,four,0,0
115610,trials,0,0
115611,.,0,0
115612,Ipilimumab,1,1
115613,is,0,0
115614,a,0,0
115615,fully,0,0
115616,human,0,0
115617,",",0,0
115618,monoclonal,0,1
115619,antibody,0,0
115620,that,0,0
115621,blocks,0,1
115622,cytotoxic,0,0
115623,T-lymphocyte,0,0
115624,antigen-4,0,0
115625,to,0,0
115626,potentiate,0,0
115627,an,0,0
115628,antitumor,0,0
115629,T-cell,0,0
115630,response,0,0
115631,.,0,0
115632,This,0,0
115633,agent,0,0
115634,improved,0,0
115635,overall,0,0
115636,survival,0,0
115637,in,0,0
115638,a,0,0
115639,phase,0,0
115640,III,0,0
115641,trial,0,0
115642,in,0,0
115643,previously,0,0
115644,treated,0,0
115645,patients,0,0
115646,with,0,0
115647,advanced,0,0
115648,melanoma,0,0
115649,.,0,0
115650,Because,0,0
115651,the,0,0
115652,mechanism,0,0
115653,of,0,0
115654,action,0,0
115655,for,0,0
115656,ipilimumab,1,1
115657,is,0,0
115658,thought,0,0
115659,to,0,0
115660,be,0,0
115661,HLA,0,1
115662,independent,0,0
115663,",",0,0
115664,most,0,0
115665,trials,0,0
115666,enrolled,0,0
115667,patients,0,0
115668,without,0,0
115669,regard,0,0
115670,to,0,0
115671,HLA,0,0
115672,subtype,0,0
115673,.,0,0
115674,However,0,0
115675,",",0,0
115676,enrollment,0,0
115677,in,0,0
115678,the,0,0
115679,phase,0,0
115680,III,0,0
115681,trial,0,0
115682,was,0,0
115683,restricted,0,0
115684,to,0,0
115685,class-I,0,0
115686,HLA-A*0201-positive,0,0
115687,patients,0,0
115688,because,0,0
115689,two,0,0
115690,of,0,0
115691,the,0,0
115692,three,0,0
115693,arms,0,0
115694,contained,0,0
115695,an,0,0
115696,HLA-A*0201-restricted,1,0
115697,gp100,1,0
115698,vaccine,1,1
115699,.,1,0
115700,HLA,0,0
115701,typing,0,0
115702,was,0,0
115703,also,0,0
115704,performed,0,0
115705,prospectively,0,0
115706,in,0,0
115707,several,0,0
115708,phase,0,0
115709,II,0,1
115710,trials,0,0
115711,and,0,0
115712,was,0,0
115713,available,0,0
115714,for,0,0
115715,93.5,0,0
115716,%,0,0
115717,of,0,0
115718,patients,0,0
115719,.,0,0
115720,In,0,0
115721,this,0,0
115722,retrospective,0,0
115723,analysis,0,0
115724,",",0,0
115725,pooled,0,0
115726,efficacy,0,0
115727,and,0,0
115728,safety,0,0
115729,data,0,0
115730,are,0,0
115731,presented,0,0
115732,according,0,0
115733,to,0,0
115734,HLA-A*0201,0,1
115735,status,0,0
115736,and,0,0
115737,dose,0,0
115738,from,0,0
115739,pretreated,0,0
115740,patients,0,0
115741,randomized,0,0
115742,to,0,0
115743,0.3,0,0
115744,",",0,0
115745,3,0,0
115746,",",0,0
115747,or,0,0
115748,10,0,0
115749,mg/kg,0,1
115750,ipilimumab,0,0
115751,in,0,0
115752,four,0,0
115753,phase,0,0
115754,II,0,0
115755,trials,0,0
115756,.,0,0
115757,Median,0,0
115758,overall,0,0
115759,survival,0,0
115760,(,0,1
115761,OS,0,0
115762,),0,1
115763,was,0,0
115764,similar,0,0
115765,for,0,0
115766,the,0,0
115767,187,0,0
115768,HLA-A*0201-positive,0,0
115769,[,0,0
115770,9.3,0,0
115771,months,0,0
115772,",",0,0
115773,95,0,0
115774,%,0,0
115775,CI,0,0
115776,(,0,1
115777,confidence,0,0
115778,interval,0,0
115779,),0,1
115780,7.4-11.5,0,0
115781,],0,0
115782,and,0,0
115783,266,0,0
115784,HLA-A*0201-negative,0,0
115785,patients,0,0
115786,[,0,0
115787,11.4,0,0
115788,months,0,0
115789,",",0,0
115790,95,0,0
115791,%,0,0
115792,CI,0,0
115793,9.3-15.1,0,0
115794,],0,0
115795,randomized,0,0
115796,to,0,0
115797,ipilimumab,0,1
115798,at,0,0
115799,all,0,0
115800,doses,0,0
115801,across,0,0
115802,the,0,0
115803,four,0,0
115804,phase,0,0
115805,II,0,0
115806,trials,0,0
115807,.,0,0
115808,These,0,0
115809,data,0,0
115810,are,0,0
115811,comparable,0,0
115812,to,0,0
115813,the,0,0
115814,OS,0,0
115815,for,0,0
115816,the,0,0
115817,137,0,1
115818,HLA-A*0201-positive,0,0
115819,patients,0,0
115820,randomized,0,0
115821,to,0,0
115822,ipilimumab,0,1
115823,in,0,0
115824,the,0,0
115825,phase,0,0
115826,III,0,0
115827,study,0,0
115828,[,0,0
115829,10.1,0,0
115830,months,0,0
115831,",",0,0
115832,95,0,0
115833,%,0,0
115834,CI,0,0
115835,8.0-13.8,0,0
115836,],0,0
115837,.,0,0
115838,Ipilimumab-induced,1,0
115839,adverse,0,0
115840,events,0,0
115841,and,0,0
115842,immune-related,0,0
115843,adverse,0,0
115844,events,0,0
115845,(,0,0
115846,skin,0,0
115847,",",0,0
115848,gastrointestinal,0,0
115849,",",0,0
115850,hepatic,0,0
115851,",",0,0
115852,other,0,0
115853,),0,0
115854,also,0,0
115855,occurred,0,0
115856,at,0,0
115857,similar,0,0
115858,frequencies,0,0
115859,among,0,0
115860,patients,0,0
115861,in,0,0
115862,the,0,0
115863,phase,0,0
115864,II,0,0
115865,and,0,0
115866,III,0,0
115867,trials,0,0
115868,",",0,0
115869,regardless,0,0
115870,of,0,0
115871,HLA-A*0201,0,1
115872,status,0,0
115873,.,0,0
115874,These,0,0
115875,findings,0,0
115876,support,0,0
115877,the,0,0
115878,hypothesis,0,0
115879,that,0,0
115880,ipilimumab-treated,1,0
115881,patients,0,0
115882,with,0,0
115883,advanced,0,0
115884,melanoma,0,0
115885,have,0,0
115886,similar,0,0
115887,outcomes,0,0
115888,regardless,0,0
115889,of,0,0
115890,their,0,0
115891,HLA-A*0201,0,0
115892,status,0,0
115893,.,0,0
115894,Stepwise,0,0
115895,assessment,0,0
115896,tool,0,0
115897,of,0,0
115898,operative,1,0
115899,skills,1,1
115900,(,1,0
115901,SATOS,1,1
115902,),1,1
115903,:,1,0
115904,validity,0,0
115905,testing,0,0
115906,on,0,0
115907,a,0,0
115908,porcine,1,1
115909,training,1,1
115910,model,1,0
115911,of,0,0
115912,open,0,1
115913,gastrectomy,0,0
115914,.,0,0
115915,BACKGROUND,0,0
115916,The,0,0
115917,aim,0,0
115918,of,0,0
115919,this,0,0
115920,prospective,0,0
115921,study,0,0
115922,was,0,0
115923,to,0,0
115924,evaluate,0,0
115925,and,0,0
115926,compare,0,0
115927,operative,0,0
115928,performance,0,0
115929,and,0,0
115930,technical,0,0
115931,improvement,0,0
115932,of,0,0
115933,surgical,0,1
115934,trainees,0,1
115935,learning,0,1
115936,open,0,1
115937,gastrectomy,0,1
115938,using,0,0
115939,an,0,0
115940,objective,0,0
115941,structured,0,1
115942,stepwise,1,0
115943,assessment,1,0
115944,tool,1,0
115945,of,1,0
115946,operative,1,0
115947,skills,1,1
115948,(,1,0
115949,SATOS,1,1
115950,),1,1
115951,previously,0,0
115952,validated,0,0
115953,for,0,0
115954,open,0,1
115955,surgery,0,0
115956,.,0,0
115957,STUDY,0,0
115958,DESIGN,0,0
115959,Thirty,0,0
115960,residents,0,0
115961,in,0,0
115962,general,0,0
115963,surgery,0,1
115964,performed,0,0
115965,2,0,0
115966,open,1,1
115967,partial,1,0
115968,gastrectomy,1,1
115969,training,1,1
115970,events,1,0
115971,on,0,0
115972,a,0,0
115973,porcine,1,1
115974,model,1,0
115975,.,1,0
115976,Earlier,0,0
115977,instruction,0,1
115978,was,0,0
115979,provided,0,0
115980,for,0,0
115981,the,0,0
115982,critical,0,0
115983,operative,0,0
115984,steps,0,0
115985,",",0,0
115986,with,0,0
115987,additional,0,0
115988,intraoperative,0,1
115989,instruction,0,1
115990,when,0,0
115991,required,0,0
115992,.,0,0
115993,Performance,0,0
115994,was,0,0
115995,assessed,0,0
115996,by,0,0
115997,postgraduate,0,1
115998,year,0,0
115999,(,0,1
116000,PGY,0,1
116001,),0,1
116002,according,0,0
116003,to,0,0
116004,operative,0,0
116005,time,0,0
116006,",",0,0
116007,technical,0,0
116008,skills,0,1
116009,using,0,0
116010,a,0,0
116011,23-step,0,0
116012,objective,0,0
116013,structured,0,1
116014,tool,0,0
116015,",",0,0
116016,and,0,0
116017,error,0,0
116018,rate,0,0
116019,.,0,0
116020,RESULTS,0,0
116021,There,0,0
116022,were,0,0
116023,11,0,0
116024,PGY-3,0,1
116025,",",0,0
116026,11,0,0
116027,PGY-4,0,0
116028,",",0,0
116029,and,0,0
116030,8,0,0
116031,PGY-5,0,0
116032,residents,0,0
116033,.,0,0
116034,At,0,0
116035,the,0,0
116036,initial,0,0
116037,assessment,0,0
116038,",",0,0
116039,performance,0,0
116040,significantly,0,0
116041,differentiated,0,0
116042,the,0,0
116043,3,0,0
116044,PGY,0,0
116045,grades,0,0
116046,according,0,0
116047,to,0,0
116048,technical,0,0
116049,skills,0,1
116050,and,0,0
116051,error,0,0
116052,rate,0,0
116053,.,0,0
116054,At,0,0
116055,the,0,0
116056,second,0,0
116057,assessment,0,0
116058,",",0,0
116059,all,0,0
116060,3,0,0
116061,PGY,0,0
116062,classes,0,0
116063,were,0,0
116064,still,0,0
116065,significantly,0,0
116066,differentiable,0,0
116067,by,0,0
116068,technical,0,0
116069,skills,0,0
116070,",",0,0
116071,with,0,0
116072,no,0,0
116073,difference,0,0
116074,in,0,0
116075,error,0,0
116076,rate,0,0
116077,.,0,0
116078,Comparing,0,0
116079,performances,0,0
116080,",",0,0
116081,residents,0,0
116082,improved,0,0
116083,operative,0,0
116084,time,0,0
116085,(,0,0
116086,p,0,0
116087,<,0,0
116088,0.001,0,0
116089,),0,0
116090,",",0,0
116091,technical,0,0
116092,skills,0,1
116093,(,0,0
116094,p,0,0
116095,<,0,0
116096,0.001,0,0
116097,),0,0
116098,",",0,0
116099,and,0,0
116100,error,0,1
116101,rate,0,0
116102,(,0,0
116103,p,0,0
116104,=,0,0
116105,0.019,0,0
116106,),0,0
116107,over,0,0
116108,the,0,0
116109,2,0,0
116110,training,0,1
116111,events,0,0
116112,.,0,0
116113,CONCLUSIONS,0,0
116114,SATOS,0,1
116115,demonstrated,0,0
116116,relevant,0,0
116117,and,0,0
116118,accurate,0,0
116119,objective,0,0
116120,assessment,0,0
116121,of,0,0
116122,trainees,0,0
116123,',0,0
116124,operative,0,0
116125,skills,0,1
116126,and,0,0
116127,improvement,0,0
116128,for,0,0
116129,open,0,1
116130,gastrectomy,0,0
116131,in,0,0
116132,a,0,0
116133,porcine,0,1
116134,model,0,0
116135,.,0,0
116136,This,0,0
116137,tool,0,0
116138,may,0,0
116139,be,0,0
116140,useful,0,0
116141,to,0,0
116142,standardize,0,0
116143,instruction,0,1
116144,",",0,0
116145,to,0,0
116146,expose,0,0
116147,weaknesses,0,0
116148,of,0,0
116149,trainees,0,0
116150,",",0,0
116151,and,0,0
116152,to,0,0
116153,determine,0,0
116154,minimal,0,0
116155,technical,0,0
116156,standards,0,0
116157,in,0,0
116158,residency,0,0
116159,programs,0,1
116160,.,0,0
116161,[,0,0
116162,Effect,0,0
116163,of,0,0
116164,treatment,0,0
116165,of,0,0
116166,non-nephrotic,0,0
116167,syndrome,0,0
116168,IgA,0,1
116169,nephropathy,0,0
116170,with,0,0
116171,Shenyanning,1,1
116172,],1,0
116173,.,0,0
116174,OBJECTIVE,0,0
116175,To,0,0
116176,observe,0,0
116177,the,0,0
116178,curative,0,0
116179,effect,0,0
116180,of,0,0
116181,Shenyanning,1,1
116182,(,1,1
116183,SYN,1,0
116184,),1,1
116185,on,0,0
116186,non-nephrotic,0,0
116187,syndrome,0,0
116188,IgA,0,1
116189,nephropathy,0,0
116190,(,0,1
116191,IgAN,0,1
116192,),0,0
116193,.,0,0
116194,METHODS,0,0
116195,Seventy,0,0
116196,primary,0,0
116197,IgAN,0,1
116198,patients,0,0
116199,were,0,0
116200,equally,0,0
116201,randomized,0,0
116202,into,0,0
116203,two,0,0
116204,groups,0,0
116205,",",0,0
116206,the,0,0
116207,treatment,0,1
116208,group,0,0
116209,and,0,0
116210,the,0,0
116211,control,0,1
116212,group,0,0
116213,",",0,0
116214,they,0,0
116215,were,0,0
116216,orally,0,1
116217,treated,0,0
116218,with,0,0
116219,SYN,1,0
116220,Decoction,1,1
116221,(,0,0
116222,one,0,0
116223,dose,0,0
116224,per,0,1
116225,day,0,1
116226,),0,1
116227,and,0,1
116228,Losartan,1,1
116229,(,0,0
116230,50,0,0
116231,mg,0,1
116232,per,0,0
116233,day,0,0
116234,),0,0
116235,respectively,0,0
116236,for,0,0
116237,1,0,0
116238,year,0,0
116239,.,0,0
116240,Efficacy,0,0
116241,of,0,0
116242,treatment,0,0
116243,",",0,0
116244,Chinese,0,0
116245,medicine,0,1
116246,syndrome,0,0
116247,scores,0,0
116248,",",0,0
116249,end-point,0,0
116250,events,0,0
116251,occurrence,0,0
116252,as,0,0
116253,well,0,0
116254,as,0,0
116255,changes,0,0
116256,of,0,0
116257,related,0,0
116258,laboratory,0,0
116259,indices,0,0
116260,were,0,0
116261,observed,0,0
116262,.,0,0
116263,RESULTS,0,0
116264,The,0,0
116265,total,0,0
116266,effective,0,0
116267,rate,0,0
116268,in,0,0
116269,the,0,0
116270,treatment,0,0
116271,group,0,0
116272,was,0,0
116273,obviously,0,0
116274,higher,0,0
116275,than,0,0
116276,that,0,0
116277,in,0,0
116278,the,0,0
116279,control,0,1
116280,group,0,0
116281,(,0,0
116282,77.1,0,0
116283,%,0,0
116284,vs.,0,0
116285,54.3,0,0
116286,%,0,0
116287,",",0,0
116288,P,0,0
116289,<,0,0
116290,0.05,0,0
116291,),0,0
116292,.,0,0
116293,After,0,0
116294,treatment,0,0
116295,",",0,0
116296,the,0,0
116297,Chinese,0,0
116298,medicine,0,1
116299,syndrome,0,0
116300,scores,0,0
116301,",",0,0
116302,urinary,0,0
116303,protein,0,1
116304,and,0,0
116305,urinary,0,0
116306,red-cell,0,1
116307,count,0,0
116308,reduced,0,0
116309,significantly,0,0
116310,in,0,0
116311,the,0,0
116312,treatment,0,1
116313,group,0,0
116314,(,0,0
116315,P,0,0
116316,<,0,0
116317,0.05,0,0
116318,or,0,0
116319,P,0,0
116320,<,0,0
116321,0.01,0,0
116322,),0,0
116323,and,0,0
116324,showed,0,0
116325,significant,0,0
116326,difference,0,0
116327,as,0,0
116328,compared,0,0
116329,with,0,0
116330,those,0,0
116331,in,0,0
116332,the,0,0
116333,control,0,1
116334,group,0,0
116335,(,0,0
116336,P,0,0
116337,<,0,0
116338,0.05,0,0
116339,or,0,0
116340,P,0,0
116341,<,0,0
116342,0.01,0,0
116343,),0,0
116344,;,0,0
116345,while,0,0
116346,the,0,0
116347,endogenous,0,0
116348,creatinine,0,0
116349,clearance,0,0
116350,was,0,0
116351,changed,0,0
116352,insignificantly,0,0
116353,in,0,0
116354,both,0,0
116355,groups,0,0
116356,.,0,0
116357,Beside,0,0
116358,",",0,0
116359,the,0,0
116360,occurrence,0,0
116361,of,0,0
116362,end-point,0,0
116363,events,0,0
116364,in,0,0
116365,the,0,0
116366,treatment,0,0
116367,group,0,0
116368,was,0,0
116369,slightly,0,0
116370,lower,0,0
116371,than,0,0
116372,that,0,0
116373,in,0,0
116374,the,0,0
116375,control,0,1
116376,group,0,0
116377,",",0,0
116378,though,0,0
116379,showed,0,0
116380,no,0,0
116381,statistical,0,0
116382,difference,0,0
116383,between,0,0
116384,them,0,0
116385,.,0,0
116386,CONCLUSION,0,0
116387,The,0,0
116388,curative,0,0
116389,effect,0,0
116390,of,0,0
116391,SYN,1,0
116392,in,0,0
116393,treating,0,0
116394,IgAN,0,1
116395,was,0,0
116396,obviously,0,0
116397,better,0,0
116398,than,0,0
116399,that,0,0
116400,of,0,0
116401,simple,0,0
116402,Western,0,0
116403,medicine,0,1
116404,.,0,0
116405,Intensive,1,1
116406,case,1,0
116407,management,1,1
116408,before,0,0
116409,and,0,0
116410,after,0,0
116411,prison,0,0
116412,release,0,1
116413,is,0,0
116414,no,0,0
116415,more,0,0
116416,effective,0,0
116417,than,0,0
116418,comprehensive,1,0
116419,pre-release,1,1
116420,discharge,1,1
116421,planning,1,0
116422,in,0,0
116423,linking,0,0
116424,HIV-infected,0,0
116425,prisoners,0,0
116426,to,0,0
116427,care,0,0
116428,:,0,0
116429,a,0,0
116430,randomized,0,0
116431,trial,0,0
116432,.,0,0
116433,Imprisonment,0,0
116434,provides,0,0
116435,opportunities,0,0
116436,for,0,0
116437,the,0,0
116438,diagnosis,0,0
116439,and,0,0
116440,successful,0,0
116441,treatment,0,0
116442,of,0,0
116443,HIV,0,0
116444,",",0,0
116445,however,0,0
116446,",",0,0
116447,the,0,0
116448,benefits,0,0
116449,of,0,0
116450,antiretroviral,1,1
116451,therapy,1,1
116452,are,0,0
116453,frequently,0,0
116454,lost,0,0
116455,following,0,0
116456,release,0,0
116457,due,0,0
116458,to,0,0
116459,suboptimal,0,0
116460,access,0,1
116461,and,0,0
116462,utilization,0,0
116463,of,0,0
116464,health,0,0
116465,care,0,1
116466,and,0,0
116467,services,0,1
116468,.,0,0
116469,In,0,0
116470,response,0,0
116471,",",0,0
116472,some,0,0
116473,have,0,0
116474,advocated,0,0
116475,for,0,0
116476,development,0,0
116477,of,0,0
116478,intensive,0,0
116479,case-management,0,1
116480,interventions,0,1
116481,spanning,0,0
116482,incarceration,0,0
116483,and,0,0
116484,release,0,0
116485,to,0,0
116486,support,0,1
116487,treatment,0,1
116488,adherence,0,0
116489,and,0,0
116490,community,0,1
116491,re-entry,0,1
116492,for,0,0
116493,HIV-infected,0,0
116494,releasees,0,0
116495,.,0,0
116496,We,0,0
116497,conducted,0,0
116498,a,0,0
116499,randomized,0,0
116500,controlled,0,0
116501,trial,0,0
116502,of,0,0
116503,a,0,0
116504,motivational,1,1
116505,Strengths,1,0
116506,Model,1,1
116507,bridging,1,1
116508,case,1,0
116509,management,1,1
116510,intervention,1,1
116511,(,1,1
116512,BCM,1,1
116513,),1,1
116514,beginning,0,0
116515,approximately,0,0
116516,3,0,0
116517,months,0,0
116518,prior,0,0
116519,to,0,0
116520,and,0,0
116521,continuing,0,0
116522,6,0,0
116523,months,0,0
116524,after,0,0
116525,release,0,0
116526,versus,0,1
116527,a,0,0
116528,standard,1,1
116529,of,1,0
116530,care,1,1
116531,prison-administered,1,1
116532,discharge,1,1
116533,planning,1,1
116534,program,1,1
116535,(,1,1
116536,SOC,1,0
116537,),1,1
116538,for,1,0
116539,HIV-infected,0,0
116540,state,0,0
116541,prison,0,0
116542,inmates,0,0
116543,.,0,0
116544,The,0,0
116545,primary,0,0
116546,outcome,0,0
116547,variable,0,0
116548,was,0,0
116549,self-reported,0,0
116550,access,0,0
116551,to,0,0
116552,post-release,0,1
116553,medical,0,0
116554,care,0,1
116555,.,0,0
116556,Of,0,0
116557,the,0,0
116558,104,0,0
116559,inmates,0,0
116560,enrolled,0,0
116561,",",0,0
116562,89,0,0
116563,had,0,0
116564,at,0,0
116565,least,0,0
116566,1,0,0
116567,post-release,0,1
116568,study,0,0
116569,visit,0,0
116570,.,0,0
116571,Of,0,0
116572,these,0,0
116573,",",0,0
116574,65.1,0,0
116575,%,0,0
116576,of,0,0
116577,BCM,0,1
116578,and,0,0
116579,54.4,0,0
116580,%,0,0
116581,of,0,0
116582,SOC,1,0
116583,assigned,1,0
116584,participants,0,0
116585,attended,0,0
116586,a,0,0
116587,routine,0,0
116588,medical,0,0
116589,appointment,0,1
116590,within,0,0
116591,4,0,0
116592,weeks,0,0
116593,of,0,0
116594,release,0,0
116595,(,0,0
116596,P,0,0
116597,>,0,0
116598,0.3,0,0
116599,),0,0
116600,.,0,0
116601,By,0,0
116602,week,0,0
116603,12,0,0
116604,post-release,0,0
116605,",",0,0
116606,88.4,0,0
116607,%,0,0
116608,of,0,0
116609,the,1,0
116610,BCM,1,1
116611,arm,0,0
116612,and,0,0
116613,78.3,0,0
116614,%,0,0
116615,of,0,0
116616,the,0,0
116617,SOC,0,0
116618,arm,0,0
116619,had,0,0
116620,at,0,0
116621,attended,0,0
116622,at,0,0
116623,least,0,0
116624,one,0,0
116625,medical,0,0
116626,appointment,0,1
116627,(,0,0
116628,P,0,0
116629,=,0,0
116630,0.2,0,1
116631,),0,0
116632,",",0,0
116633,increasing,0,0
116634,in,0,0
116635,both,0,0
116636,arms,0,0
116637,at,0,0
116638,week,0,0
116639,24-90.7,0,1
116640,%,0,0
116641,with,0,0
116642,BCM,0,1
116643,and,0,0
116644,89.1,0,0
116645,%,0,0
116646,with,0,0
116647,SOC,0,0
116648,(,0,0
116649,P,0,0
116650,>,0,0
116651,0.5,0,1
116652,),0,0
116653,.,0,0
116654,No,0,0
116655,participant,0,0
116656,without,0,0
116657,a,0,0
116658,routine,0,0
116659,medical,0,0
116660,visit,0,0
116661,by,0,0
116662,week,0,0
116663,24,0,0
116664,attended,0,0
116665,an,0,0
116666,appointment,0,1
116667,from,0,0
116668,weeks,0,0
116669,24,0,0
116670,to,0,0
116671,48,0,0
116672,.,0,0
116673,The,0,0
116674,mean,0,0
116675,number,0,0
116676,of,0,0
116677,clinic,0,0
116678,visits,0,0
116679,during,0,0
116680,the,0,0
116681,48,0,0
116682,weeks,0,0
116683,post,0,0
116684,release,0,0
116685,was,0,0
116686,5.23,0,0
116687,(,0,0
116688,SD,0,0
116689,=,0,0
116690,3.14,0,0
116691,),0,0
116692,for,0,0
116693,BCM,0,1
116694,and,0,0
116695,4.07,0,0
116696,(,0,0
116697,SD,0,0
116698,=,0,0
116699,3.20,0,0
116700,),0,0
116701,for,0,0
116702,SOC,0,0
116703,(,0,0
116704,P,0,0
116705,>,0,0
116706,0.5,0,1
116707,),0,0
116708,.,0,0
116709,There,0,0
116710,were,0,0
116711,no,0,0
116712,significant,0,0
116713,differences,0,0
116714,between,0,0
116715,arms,0,0
116716,in,0,0
116717,social,0,0
116718,service,0,1
116719,utilization,0,0
116720,and,0,0
116721,re-incarceration,0,0
116722,rates,0,0
116723,were,0,0
116724,also,0,0
116725,similar,0,0
116726,.,0,0
116727,We,0,0
116728,found,0,0
116729,that,0,0
116730,a,0,0
116731,case,1,0
116732,management,1,1
116733,intervention,1,1
116734,bridging,1,1
116735,incarceration,1,1
116736,and,1,0
116737,release,0,0
116738,was,0,0
116739,no,0,0
116740,more,0,0
116741,effective,0,0
116742,than,0,0
116743,a,0,0
116744,less,0,0
116745,intensive,0,0
116746,pre-release,1,1
116747,discharge,1,1
116748,planning,1,1
116749,program,1,1
116750,in,1,0
116751,supporting,1,0
116752,health,0,0
116753,and,0,0
116754,social,0,1
116755,service,0,1
116756,utilization,0,0
116757,for,0,0
116758,HIV-infected,0,0
116759,individuals,0,0
116760,released,0,0
116761,from,0,0
116762,prison,0,0
116763,.,0,0
116764,Pharmacogenetic,0,0
116765,interaction,0,0
116766,analysis,0,0
116767,for,0,0
116768,the,0,0
116769,efficacy,0,0
116770,of,0,0
116771,systemic,0,0
116772,treatment,0,0
116773,in,0,0
116774,metastatic,0,0
116775,colorectal,0,0
116776,cancer,0,0
116777,.,0,0
116778,BACKGROUND,0,0
116779,Pharmacogenetic,0,0
116780,markers,0,0
116781,related,0,0
116782,to,0,0
116783,drug,0,1
116784,metabolism,0,0
116785,and,0,0
116786,mechanisms,0,0
116787,of,0,0
116788,action,0,0
116789,could,0,0
116790,help,0,0
116791,to,0,0
116792,better,0,0
116793,select,0,0
116794,patients,0,0
116795,with,0,0
116796,metastatic,0,0
116797,colorectal,0,0
116798,cancer,0,0
116799,(,0,1
116800,mCRC,0,1
116801,),0,1
116802,for,0,0
116803,treatment,0,0
116804,.,0,0
116805,Genetic,0,0
116806,interaction,0,0
116807,analysis,0,0
116808,is,0,0
116809,used,0,0
116810,as,0,0
116811,a,0,0
116812,rational,0,0
116813,tool,0,0
116814,to,0,0
116815,study,0,0
116816,the,0,0
116817,contribution,0,0
116818,of,0,0
116819,polygenic,0,0
116820,variation,0,0
116821,in,0,0
116822,relation,0,0
116823,to,0,0
116824,drug,0,1
116825,response,0,0
116826,.,0,0
116827,PATIENTS,0,0
116828,AND,0,0
116829,METHODS,0,0
116830,A,0,1
116831,selection,0,0
116832,of,0,0
116833,17,0,0
116834,polymorphisms,0,0
116835,in,0,0
116836,genes,0,0
116837,encoding,0,1
116838,drug,0,1
116839,targets,0,0
116840,",",0,0
116841,pathway,0,1
116842,molecules,0,0
116843,and,0,0
116844,detoxification,0,0
116845,enzymes,0,1
116846,was,0,0
116847,analyzed,0,0
116848,in,0,0
116849,279,0,0
116850,previously,0,0
116851,untreated,0,0
116852,mCRC,0,0
116853,patients,0,0
116854,treated,0,0
116855,with,0,0
116856,capecitabine,1,1
116857,",",1,0
116858,oxaliplatin,1,1
116859,and,1,1
116860,bevacizumab,1,1
116861,(,1,1
116862,CAPOX-B,1,1
116863,),1,0
116864,.,1,0
116865,Multifactor,0,0
116866,dimensionality,0,0
116867,reduction,0,0
116868,analysis,0,0
116869,was,0,0
116870,used,0,0
116871,to,0,0
116872,identify,0,0
116873,a,0,0
116874,genetic,0,0
116875,interaction,0,0
116876,profile,0,0
116877,for,0,0
116878,progression-free,0,0
116879,survival,0,0
116880,(,0,1
116881,PFS,0,0
116882,),0,0
116883,.,0,0
116884,RESULTS,0,0
116885,Median,0,0
116886,PFS,0,0
116887,was,0,0
116888,10.9,0,0
116889,[,0,0
116890,95,0,0
116891,%,0,0
116892,confidence,0,0
116893,interval,0,0
116894,(,0,1
116895,CI,0,0
116896,),0,1
116897,9.4-12.4,0,0
116898,],0,0
116899,months,0,0
116900,.,0,0
116901,A,0,0
116902,genetic,0,0
116903,interaction,0,0
116904,profile,0,0
116905,consisting,0,0
116906,of,0,0
116907,the,0,0
116908,TYMS,0,0
116909,enhancer,0,0
116910,region,0,0
116911,and,0,0
116912,VEGF,0,1
116913,+405G,0,1
116914,>,0,0
116915,C,0,1
116916,polymorphisms,0,0
116917,was,0,0
116918,significantly,0,0
116919,associated,0,0
116920,with,0,0
116921,PFS,0,0
116922,.,0,0
116923,Median,0,0
116924,PFS,0,0
116925,was,0,0
116926,13.3,0,0
116927,(,0,0
116928,95,0,0
116929,%,0,0
116930,CI,0,0
116931,11.4-15.3,0,0
116932,),0,0
116933,and,0,0
116934,9.7,0,0
116935,(,0,0
116936,95,0,0
116937,%,0,0
116938,CI,0,0
116939,7.6-11.8,0,0
116940,),0,0
116941,months,0,0
116942,for,0,0
116943,the,0,0
116944,beneficial,0,0
116945,and,0,0
116946,unfavorable,0,0
116947,genetic,0,0
116948,profiles,0,0
116949,",",0,0
116950,respectively,0,0
116951,",",0,0
116952,corresponding,0,0
116953,to,0,0
116954,a,0,0
116955,hazards,0,0
116956,ratio,0,0
116957,for,0,0
116958,PFS,0,0
116959,of,0,0
116960,1.58,0,0
116961,(,0,0
116962,95,0,0
116963,%,0,0
116964,CI,0,0
116965,1.14-2.19,0,0
116966,),0,0
116967,.,0,0
116968,None,0,0
116969,of,0,0
116970,the,0,0
116971,studied,0,0
116972,polymorphisms,0,0
116973,were,0,0
116974,individually,0,0
116975,associated,0,0
116976,with,0,0
116977,PFS,0,0
116978,.,0,0
116979,CONCLUSIONS,0,0
116980,Our,0,0
116981,results,0,0
116982,support,0,0
116983,a,0,0
116984,genetic,0,0
116985,interaction,0,0
116986,between,0,0
116987,the,0,0
116988,TYMS,0,0
116989,enhancer,0,0
116990,region,0,0
116991,and,0,0
116992,VEGF,0,1
116993,+405G,0,1
116994,>,0,0
116995,C,0,1
116996,polymorphisms,0,0
116997,as,0,0
116998,a,0,0
116999,predictor,0,0
117000,of,0,0
117001,the,0,0
117002,efficacy,0,0
117003,of,0,0
117004,CAPOX-B,0,1
117005,in,0,0
117006,mCRC,0,0
117007,patients,0,0
117008,.,0,0
117009,Endoscopic,1,1
117010,versus,1,1
117011,operative,1,0
117012,gastrostomy,1,1
117013,:,1,0
117014,final,0,0
117015,results,0,0
117016,of,0,0
117017,a,0,0
117018,prospective,0,0
117019,randomized,0,0
117020,trial,0,0
117021,.,0,0
117022,This,0,0
117023,study,0,0
117024,compared,0,0
117025,operative,1,0
117026,gastrostomy,1,1
117027,(,1,1
117028,OG,1,1
117029,),1,1
117030,(,0,0
117031,by,0,0
117032,surgeons,0,1
117033,),0,0
117034,with,1,0
117035,endoscopic,1,1
117036,gastrostomy,1,1
117037,(,1,1
117038,PEG,1,1
117039,),1,1
117040,(,0,0
117041,by,0,0
117042,physicians,0,1
117043,),0,0
117044,in,0,0
117045,a,0,0
117046,prospective,0,0
117047,randomized,0,0
117048,fashion,0,1
117049,to,0,0
117050,determine,0,0
117051,whether,0,0
117052,one,0,0
117053,technique,0,1
117054,was,0,0
117055,superior,0,0
117056,.,0,1
117057,PEG,1,1
117058,(,1,0
117059,Sachs-Vine,1,1
117060,),1,1
117061,and,1,0
117062,OG,1,1
117063,(,1,1
117064,Stamm,1,1
117065,),1,1
117066,were,0,0
117067,done,0,0
117068,using,0,0
117069,local,1,1
117070,anesthesia,1,1
117071,.,1,0
117072,Patients,0,0
117073,were,0,0
117074,assessed,0,0
117075,for,0,0
117076,complications,0,0
117077,",",0,0
117078,mortality,0,0
117079,",",0,0
117080,tube,0,1
117081,function,0,0
117082,",",0,0
117083,and,0,0
117084,cost,0,0
117085,.,0,0
117086,Groups,0,0
117087,were,0,0
117088,equally,0,0
117089,matched,0,0
117090,for,0,0
117091,indications,0,0
117092,and,0,0
117093,underlying,0,0
117094,disease,0,0
117095,.,0,0
117096,Fifty-seven,0,0
117097,had,0,0
117098,OG,0,1
117099,and,0,0
117100,64,0,0
117101,had,0,0
117102,attempted,0,0
117103,PEG,0,1
117104,.,0,0
117105,Complications,0,0
117106,occurred,0,0
117107,in,0,0
117108,26,0,0
117109,%,0,0
117110,of,0,0
117111,OG,0,1
117112,patients,0,0
117113,and,0,0
117114,9,0,0
117115,%,0,0
117116,died,0,0
117117,.,0,0
117118,Complications,0,0
117119,occurred,0,0
117120,in,0,0
117121,25,0,0
117122,%,0,0
117123,of,0,0
117124,PEG,0,1
117125,patients,0,0
117126,and,0,0
117127,12,0,0
117128,%,0,0
117129,died,0,0
117130,.,0,0
117131,Tube,0,0
117132,feeding,0,0
117133,was,0,0
117134,initiated,0,0
117135,in,0,0
117136,both,0,0
117137,groups,0,0
117138,within,0,0
117139,a,0,0
117140,mean,0,0
117141,of,0,0
117142,29,0,0
117143,(,0,0
117144,24,0,0
117145,to,0,0
117146,72,0,0
117147,),0,0
117148,hours,0,0
117149,of,0,0
117150,the,0,0
117151,gastrostomy,0,1
117152,placement,0,0
117153,.,0,0
117154,OG,0,0
117155,cost,0,0
117156,$,0,0
117157,1675,0,0
117158,and,0,0
117159,PEG,0,1
117160,$,0,0
117161,979,0,0
117162,to,0,0
117163,perform,0,0
117164,.,0,0
117165,Twenty-one,0,0
117166,PEG,1,1
117167,patients,0,0
117168,required,0,0
117169,endoscopic,0,1
117170,tube,0,1
117171,change,0,0
117172,which,0,0
117173,raised,0,0
117174,their,0,0
117175,total,0,0
117176,cost,0,0
117177,to,0,0
117178,$,0,0
117179,1574,0,0
117180,.,0,0
117181,We,0,0
117182,conclude,0,0
117183,there,0,0
117184,is,0,0
117185,no,0,0
117186,difference,0,0
117187,between,0,0
117188,OG,0,1
117189,(,0,0
117190,using,0,0
117191,local,0,1
117192,anesthesia,0,1
117193,),0,1
117194,and,0,0
117195,PEG,1,1
117196,with,0,0
117197,regard,0,0
117198,to,0,0
117199,morbidity,0,0
117200,",",0,0
117201,mortality,0,0
117202,",",0,0
117203,or,0,1
117204,tube,0,1
117205,function,0,0
117206,.,0,0
117207,The,0,0
117208,endoscopic,0,1
117209,technique,0,1
117210,does,0,0
117211,appear,0,0
117212,to,0,0
117213,have,0,0
117214,economic,0,0
117215,advantage,0,0
117216,.,0,0
117217,A,0,0
117218,placebo-controlled,1,1
117219,",",0,0
117220,randomized,0,0
117221,clinical,0,0
117222,trial,0,0
117223,using,0,1
117224,testosterone,1,1
117225,undecanoate,1,1
117226,with,1,0
117227,injectable,1,1
117228,norethisterone,1,1
117229,enanthate,1,1
117230,:,1,0
117231,effect,0,0
117232,on,0,0
117233,anthropometric,0,0
117234,",",0,0
117235,metabolic,0,0
117236,and,0,0
117237,biochemical,0,0
117238,parameters,0,0
117239,.,0,0
117240,Testosterone,0,0
117241,administered,0,0
117242,alone,0,1
117243,or,0,1
117244,in,0,0
117245,combination,0,1
117246,with,0,0
117247,progestogens,0,1
117248,in,0,0
117249,male,0,0
117250,contraception,0,1
117251,induces,0,0
117252,reversible,0,0
117253,oligo-azoospermia,0,0
117254,",",0,0
117255,but,0,0
117256,its,0,0
117257,effects,0,0
117258,on,0,0
117259,body,0,0
117260,composition,0,0
117261,and,0,0
117262,metabolism,0,0
117263,are,0,0
117264,less,0,0
117265,known,0,0
117266,.,0,0
117267,We,0,0
117268,analysed,0,0
117269,anthropometric,0,0
117270,and,0,0
117271,metabolic,0,0
117272,parameters,0,0
117273,in,0,0
117274,five,0,0
117275,groups,0,0
117276,of,0,0
117277,10,0,0
117278,males,0,0
117279,:,0,0
117280,four,0,0
117281,receiving,0,0
117282,testosterone,1,1
117283,undecanoate,1,1
117284,(,0,0
117285,TU,0,1
117286,:,0,1
117287,1000,0,0
117288,mg,0,1
117289,),0,0
117290,plus,1,1
117291,norethisterone,1,1
117292,enanthate,1,1
117293,(,0,0
117294,NETE,0,1
117295,:,0,1
117296,200,0,1
117297,mg,0,1
117298,),0,0
117299,at,0,0
117300,different,0,1
117301,intervals,0,0
117302,(,0,0
117303,every,0,0
117304,8,0,0
117305,weeks,0,0
117306,:,0,0
117307,NETE-8,0,1
117308,;,0,0
117309,every,0,0
117310,12,0,0
117311,weeks,0,0
117312,:,0,0
117313,NETE-12,0,0
117314,;,0,0
117315,every,0,0
117316,6,0,0
117317,weeks,0,0
117318,for,0,0
117319,12,0,0
117320,weeks,0,0
117321,and,0,0
117322,then,0,0
117323,every,0,1
117324,12,0,0
117325,weeks,0,0
117326,:,0,0
117327,NETE-6/12,0,0
117328,;,0,0
117329,every,0,0
117330,6,0,0
117331,weeks,0,0
117332,for,0,0
117333,12,0,0
117334,weeks,0,0
117335,and,0,0
117336,then,0,1
117337,TU,1,1
117338,plus,1,1
117339,placebo,1,1
117340,every,0,1
117341,12,0,0
117342,weeks,0,0
117343,:,0,0
117344,NETE-6/12/0,0,1
117345,),0,1
117346,and,0,0
117347,one,0,1
117348,placebo,1,1
117349,(,0,1
117350,NETE-0/0,0,1
117351,),0,1
117352,for,0,0
117353,a,0,0
117354,total,0,0
117355,of,0,0
117356,48,0,0
117357,weeks,0,0
117358,.,0,0
117359,Body,0,1
117360,mass,0,0
117361,index,0,0
117362,(,0,1
117363,BMI,0,1
117364,),0,1
117365,and,0,0
117366,waist,0,0
117367,circumference,0,0
117368,did,0,0
117369,not,0,0
117370,change,0,0
117371,in,0,0
117372,any,0,0
117373,groups,0,0
117374,except,0,0
117375,for,0,0
117376,the,0,0
117377,NETE-8,0,1
117378,in,0,0
117379,which,0,0
117380,BMI,0,0
117381,increased,0,0
117382,significantly,0,0
117383,(,0,0
117384,p,0,0
117385,=,0,0
117386,0.02,0,0
117387,),0,0
117388,at,0,0
117389,the,0,0
117390,end,0,0
117391,of,0,0
117392,the,0,0
117393,treatment,0,0
117394,period,0,0
117395,.,0,0
117396,Lean,0,0
117397,body,0,0
117398,mass,0,0
117399,(,0,1
117400,MAMC,0,0
117401,or,0,1
117402,AMA,0,1
117403,),0,1
117404,increased,0,0
117405,significantly,0,0
117406,in,0,0
117407,the,0,0
117408,highest,0,0
117409,hormonal,0,0
117410,dose,0,1
117411,groups,0,0
117412,(,0,0
117413,p,0,0
117414,=,0,0
117415,0.04,0,0
117416,",",0,0
117417,NETE-6/12,0,1
117418,;,0,0
117419,p,0,0
117420,=,0,0
117421,0.004,0,0
117422,",",0,0
117423,NETE-8,0,1
117424,),0,0
117425,.,0,0
117426,No,0,0
117427,differences,0,0
117428,were,0,0
117429,observed,0,0
117430,in,0,0
117431,glucose,0,0
117432,levels,0,0
117433,",",0,0
117434,insulin,0,1
117435,sensitivity,0,0
117436,index,0,0
117437,and,0,0
117438,lipid,0,1
117439,profile,0,0
117440,as,0,0
117441,well,0,0
117442,as,0,0
117443,in,0,0
117444,biochemical,0,0
117445,and,0,0
117446,cell,0,0
117447,count,0,0
117448,parameters,0,0
117449,in,0,0
117450,any,0,0
117451,groups,0,0
117452,.,0,0
117453,In,0,0
117454,conclusion,0,0
117455,",",0,0
117456,NETE,0,1
117457,and,0,0
117458,TU,0,1
117459,for,0,0
117460,48,0,0
117461,weeks,0,0
117462,were,0,0
117463,not,0,0
117464,accompanied,0,0
117465,by,0,0
117466,any,0,0
117467,metabolic,0,0
117468,changes,0,0
117469,and,0,0
117470,any,0,0
117471,adverse,0,0
117472,effects,0,0
117473,.,0,0
117474,The,0,0
117475,weight,0,0
117476,gain,0,0
117477,of,0,0
117478,the,0,0
117479,highest,0,0
117480,NETE,0,0
117481,plus,0,1
117482,TU,0,1
117483,dosage,0,0
117484,was,0,0
117485,mainly,0,0
117486,because,0,0
117487,of,0,0
117488,gain,0,0
117489,in,0,0
117490,muscle,0,0
117491,mass,0,0
117492,.,0,0
117493,Intervention,1,1
117494,targeting,0,0
117495,development,0,0
117496,of,0,0
117497,socially,0,0
117498,synchronous,0,1
117499,engagement,0,0
117500,in,0,0
117501,toddlers,0,0
117502,with,0,0
117503,autism,0,0
117504,spectrum,0,0
117505,disorder,0,0
117506,:,0,0
117507,a,0,0
117508,randomized,0,0
117509,controlled,0,0
117510,trial,0,0
117511,.,0,0
117512,BACKGROUND,0,0
117513,Social,0,0
117514,and,0,0
117515,communication,0,1
117516,impairments,0,0
117517,are,0,0
117518,core,0,0
117519,deficits,0,0
117520,and,0,0
117521,prognostic,0,0
117522,indicators,0,0
117523,of,0,0
117524,autism,0,0
117525,.,0,0
117526,We,0,0
117527,evaluated,0,0
117528,the,0,0
117529,impact,0,0
117530,of,0,0
117531,supplementing,0,1
117532,a,0,0
117533,comprehensive,1,0
117534,intervention,1,1
117535,with,0,0
117536,a,0,0
117537,curriculum,0,1
117538,targeting,0,0
117539,socially,0,0
117540,synchronous,0,1
117541,behavior,0,0
117542,on,0,0
117543,social,0,0
117544,outcomes,0,0
117545,of,0,0
117546,toddlers,0,0
117547,with,0,0
117548,autism,0,0
117549,spectrum,0,0
117550,disorders,0,0
117551,(,0,0
117552,ASD,0,0
117553,),0,0
117554,.,0,0
117555,METHODS,0,0
117556,Fifty,0,0
117557,toddlers,0,0
117558,with,0,0
117559,ASD,0,0
117560,",",0,0
117561,ages,0,0
117562,21,0,0
117563,to,0,0
117564,33,0,0
117565,months,0,0
117566,",",0,0
117567,were,0,0
117568,randomized,0,0
117569,to,0,0
117570,one,0,0
117571,of,0,0
117572,two,0,0
117573,six-month,0,0
117574,interventions,0,0
117575,:,0,0
117576,Interpersonal,1,1
117577,Synchrony,1,0
117578,or,0,1
117579,Non-Interpersonal,1,0
117580,Synchrony,1,0
117581,.,1,0
117582,The,0,0
117583,interventions,0,0
117584,provided,0,0
117585,identical,0,0
117586,intensity,0,0
117587,(,0,0
117588,10,0,0
117589,hours,0,0
117590,per,0,0
117591,week,0,0
117592,in,0,0
117593,classroom,0,1
117594,),0,0
117595,",",0,0
117596,student-to-teacher,0,1
117597,ratio,0,0
117598,",",0,0
117599,schedule,0,1
117600,",",0,0
117601,home-based,0,1
117602,parent,0,1
117603,training,0,1
117604,(,0,0
117605,1.5,0,0
117606,hours,0,0
117607,per,0,0
117608,month,0,0
117609,),0,0
117610,",",0,0
117611,parent,0,1
117612,education,0,1
117613,(,0,0
117614,38,0,0
117615,hours,0,0
117616,),0,0
117617,",",0,0
117618,and,0,0
117619,instructional,0,1
117620,strategies,0,0
117621,",",0,0
117622,except,0,0
117623,the,0,0
117624,Interpersonal,0,1
117625,Synchrony,0,0
117626,condition,0,0
117627,provided,0,0
117628,a,0,0
117629,supplementary,0,1
117630,curriculum,0,1
117631,targeting,0,0
117632,socially,0,0
117633,engaged,0,0
117634,imitation,0,0
117635,",",0,0
117636,joint,0,0
117637,attention,0,0
117638,",",0,0
117639,and,0,0
117640,affect,0,0
117641,sharing,0,0
117642,;,0,0
117643,measures,0,0
117644,of,0,0
117645,these,0,0
117646,were,0,0
117647,primary,0,0
117648,outcomes,0,0
117649,.,0,0
117650,Assessments,0,0
117651,were,0,0
117652,conducted,0,0
117653,pre-intervention,0,0
117654,",",0,0
117655,immediately,0,0
117656,post-intervention,0,0
117657,",",0,0
117658,and,0,0
117659,",",0,0
117660,to,0,0
117661,assess,0,0
117662,maintenance,0,0
117663,",",0,0
117664,at,0,0
117665,six-month,0,0
117666,follow-up,0,0
117667,.,0,0
117668,Random,0,0
117669,effects,0,0
117670,models,0,0
117671,were,0,0
117672,used,0,0
117673,to,0,0
117674,examine,0,0
117675,differences,0,0
117676,between,0,0
117677,groups,0,0
117678,over,0,0
117679,time,0,0
117680,.,0,0
117681,Secondary,0,0
117682,analyses,0,0
117683,examined,0,0
117684,gains,0,0
117685,in,0,0
117686,expressive,0,0
117687,language,0,1
117688,and,0,0
117689,nonverbal,0,0
117690,cognition,0,0
117691,",",0,0
117692,and,0,0
117693,time,0,0
117694,effects,0,0
117695,during,0,0
117696,the,0,0
117697,intervention,0,1
117698,and,0,0
117699,follow-up,0,0
117700,periods,0,0
117701,.,0,0
117702,RESULTS,0,0
117703,A,0,0
117704,significant,0,0
117705,treatment,0,0
117706,effect,0,0
117707,was,0,0
117708,found,0,0
117709,for,0,0
117710,socially,0,0
117711,engaged,0,0
117712,imitation,0,1
117713,(,0,0
117714,p,0,0
117715,=,0,0
117716,.02,0,0
117717,),0,0
117718,",",0,0
117719,with,0,0
117720,more,0,0
117721,than,0,0
117722,doubling,0,0
117723,(,0,0
117724,17,0,0
117725,%,0,0
117726,to,0,0
117727,42,0,0
117728,%,0,0
117729,),0,0
117730,of,0,0
117731,imitated,0,0
117732,acts,0,0
117733,paired,0,0
117734,with,0,0
117735,eye,0,1
117736,contact,0,1
117737,in,0,0
117738,the,0,0
117739,Interpersonal,0,1
117740,Synchrony,0,0
117741,group,0,0
117742,after,0,0
117743,the,0,0
117744,intervention,0,1
117745,.,0,0
117746,This,0,0
117747,skill,0,0
117748,was,0,0
117749,generalized,0,0
117750,to,0,0
117751,unfamiliar,0,1
117752,contexts,0,0
117753,and,0,0
117754,maintained,0,0
117755,through,0,0
117756,follow-up,0,0
117757,.,0,0
117758,Similar,0,0
117759,gains,0,0
117760,were,0,0
117761,observed,0,0
117762,for,0,0
117763,initiation,0,0
117764,of,0,0
117765,joint,0,0
117766,attention,0,0
117767,and,0,0
117768,shared,0,0
117769,positive,0,0
117770,affect,0,0
117771,",",0,0
117772,but,0,0
117773,between-group,0,0
117774,differences,0,0
117775,did,0,0
117776,not,0,0
117777,reach,0,0
117778,statistical,0,0
117779,significance,0,0
117780,.,0,0
117781,A,0,0
117782,significant,0,0
117783,time,0,0
117784,effect,0,0
117785,was,0,0
117786,found,0,0
117787,for,0,0
117788,all,0,0
117789,outcomes,0,0
117790,(,0,0
117791,p,0,0
117792,<,0,0
117793,.001,0,0
117794,),0,0
117795,;,0,0
117796,greatest,0,0
117797,change,0,0
117798,occurred,0,0
117799,during,0,0
117800,the,0,0
117801,intervention,0,1
117802,period,0,0
117803,",",0,0
117804,particularly,0,0
117805,in,0,0
117806,the,0,0
117807,Interpersonal,0,1
117808,Synchrony,0,0
117809,group,0,0
117810,.,0,0
117811,CONCLUSIONS,0,0
117812,This,0,0
117813,is,0,0
117814,the,0,0
117815,first,0,0
117816,ASD,0,0
117817,randomized,0,0
117818,trial,0,0
117819,involving,0,0
117820,toddlers,0,0
117821,to,0,0
117822,identify,0,0
117823,an,0,0
117824,active,0,1
117825,ingredient,0,1
117826,for,0,0
117827,enhancing,0,0
117828,socially,0,0
117829,engaged,0,0
117830,imitation,0,0
117831,.,0,0
117832,Adding,0,0
117833,social,0,0
117834,engagement,0,0
117835,targets,0,0
117836,to,0,0
117837,intervention,0,1
117838,improves,0,0
117839,short-term,0,0
117840,outcome,0,0
117841,at,0,0
117842,no,0,0
117843,additional,0,0
117844,cost,0,0
117845,to,0,0
117846,the,0,0
117847,intervention,0,1
117848,.,0,0
117849,The,0,0
117850,social,0,0
117851,",",0,0
117852,language,0,1
117853,",",0,0
117854,and,0,0
117855,cognitive,0,0
117856,gains,0,0
117857,in,0,0
117858,our,0,0
117859,participants,0,0
117860,provide,0,0
117861,evidence,0,0
117862,for,0,0
117863,plasticity,0,0
117864,of,0,0
117865,these,0,0
117866,developmental,0,0
117867,systems,0,0
117868,in,0,0
117869,toddlers,0,0
117870,with,0,0
117871,ASD,0,0
117872,.,0,0
117873,http,0,0
117874,:,0,0
117875,//www.clinicaltrials.gov/ct2/show/NCT00106210,0,0
117876,?,0,0
117877,term,0,0
117878,=,0,0
117879,landa,0,1
117880,&,0,1
117881,rank,0,0
117882,=,0,0
117883,3,0,0
117884,.,0,0
117885,Effects,0,0
117886,of,0,0
117887,the,0,0
117888,810-nm,1,1
117889,diode,1,1
117890,laser,1,1
117891,on,0,0
117892,hair,0,0
117893,and,0,0
117894,on,0,0
117895,the,0,0
117896,biophysical,0,0
117897,properties,0,0
117898,of,0,0
117899,skin,0,0
117900,.,0,0
117901,INTRODUCTION,0,0
117902,Laser,1,1
117903,therapy,1,1
117904,is,0,0
117905,clinically,0,0
117906,effective,0,0
117907,in,0,0
117908,hair,0,0
117909,removal,0,0
117910,;,0,0
117911,however,0,0
117912,",",0,0
117913,despite,0,0
117914,the,0,0
117915,development,0,0
117916,of,0,0
117917,various,0,0
117918,strategies,0,0
117919,",",0,0
117920,laser,0,1
117921,procedures,0,0
117922,still,0,0
117923,present,0,0
117924,a,0,0
117925,risk,0,0
117926,of,0,0
117927,adverse,0,0
117928,effects,0,0
117929,due,0,0
117930,to,0,0
117931,the,0,0
117932,overheating,0,0
117933,of,0,0
117934,the,0,0
117935,skin,0,0
117936,.,0,0
117937,OBJECTIVE,0,0
117938,To,0,0
117939,investigate,0,0
117940,the,0,0
117941,effects,0,0
117942,of,0,0
117943,810-nm,1,1
117944,diode,1,1
117945,laser,1,1
117946,treatment,1,0
117947,on,0,0
117948,hair,0,0
117949,and,0,0
117950,on,0,0
117951,the,0,0
117952,biophysical,0,0
117953,properties,0,0
117954,of,0,0
117955,skin,0,0
117956,by,0,0
117957,using,0,0
117958,various,0,0
117959,non-invasive,1,1
117960,techniques,1,1
117961,on,0,0
117962,various,0,0
117963,parameters,0,0
117964,",",0,0
117965,including,0,0
117966,hair,0,0
117967,analysis,0,0
117968,",",0,0
117969,surface,0,1
117970,color,0,0
117971,changes,0,0
117972,",",0,0
117973,integrity,0,0
117974,of,0,0
117975,skin,0,0
117976,barrier,0,0
117977,",",0,0
117978,sebum,0,0
117979,production,0,0
117980,rate,0,0
117981,and,0,0
117982,pH,0,1
117983,level,0,0
117984,.,0,0
117985,METHODS,0,0
117986,In,0,0
117987,this,0,0
117988,randomized,0,0
117989,",",0,0
117990,right-left,0,1
117991,comparison,0,0
117992,study,0,0
117993,",",0,0
117994,35,0,0
117995,women,0,0
117996,with,0,0
117997,axillary,0,0
117998,hair,0,0
117999,received,0,1
118000,single-session,1,1
118001,diode,1,1
118002,laser,1,1
118003,therapy,1,1
118004,.,1,0
118005,Hair,0,0
118006,analysis,0,0
118007,and,0,0
118008,biophysical,0,0
118009,properties,0,0
118010,of,0,0
118011,the,0,0
118012,skin,0,0
118013,were,0,0
118014,assessed,0,0
118015,before,0,0
118016,treatment,0,0
118017,and,0,0
118018,at,0,0
118019,weeks,0,0
118020,2,0,0
118021,",",0,0
118022,4,0,0
118023,and,0,0
118024,6,0,0
118025,after,0,0
118026,the,0,0
118027,therapy,0,1
118028,.,0,0
118029,RESULTS,0,0
118030,Hair,0,1
118031,density,0,0
118032,and,0,0
118033,thicknesses,0,0
118034,statistically,0,0
118035,significantly,0,0
118036,decreased,0,0
118037,after,0,0
118038,the,0,0
118039,first,0,0
118040,post-treatment,0,0
118041,evaluation,0,0
118042,.,0,0
118043,Regarding,0,0
118044,comparison,0,0
118045,of,0,0
118046,the,0,0
118047,biophysical,0,0
118048,properties,0,0
118049,of,0,0
118050,the,0,0
118051,skin,0,0
118052,",",0,0
118053,there,0,0
118054,was,0,0
118055,no,0,0
118056,statistically,0,0
118057,significant,0,0
118058,difference,0,0
118059,in,0,0
118060,the,0,0
118061,assessments,0,0
118062,",",0,0
118063,except,0,0
118064,for,0,0
118065,the,0,0
118066,increase,0,0
118067,determined,0,0
118068,during,0,0
118069,the,0,0
118070,second,0,0
118071,week,0,0
118072,in,0,0
118073,the,0,0
118074,erythema,0,0
118075,index,0,0
118076,in,0,0
118077,the,0,0
118078,laser-treated,0,0
118079,areas,0,0
118080,.,0,0
118081,CONCLUSION,0,0
118082,The,0,0
118083,findings,0,0
118084,of,0,0
118085,this,0,0
118086,study,0,0
118087,showed,0,0
118088,that,0,0
118089,the,0,0
118090,diode,1,1
118091,laser,1,1
118092,can,1,0
118093,perform,0,0
118094,a,0,0
118095,significant,0,0
118096,reduction,0,0
118097,in,0,0
118098,the,0,0
118099,hair,0,0
118100,amount,0,0
118101,without,0,0
118102,significant,0,0
118103,epidermal,0,1
118104,damage,0,0
118105,",",0,0
118106,at,0,0
118107,least,0,0
118108,for,0,0
118109,a,0,0
118110,short,0,0
118111,period,0,0
118112,.,0,0
118113,Interleukin-6,0,1
118114,receptor,0,0
118115,inhibition,0,0
118116,with,0,0
118117,tocilizumab,1,1
118118,and,0,0
118119,attainment,0,0
118120,of,0,0
118121,disease,0,0
118122,remission,0,0
118123,in,0,0
118124,rheumatoid,0,0
118125,arthritis,0,0
118126,:,0,0
118127,the,0,0
118128,role,0,0
118129,of,0,0
118130,acute-phase,0,0
118131,reactants,0,1
118132,.,0,0
118133,OBJECTIVE,0,0
118134,To,0,0
118135,determine,0,0
118136,the,0,0
118137,effects,0,0
118138,of,0,0
118139,tocilizumab,1,1
118140,on,0,0
118141,rheumatoid,0,1
118142,arthritis,0,1
118143,(,0,1
118144,RA,0,0
118145,),0,1
118146,disease,0,0
118147,activity,0,0
118148,and,0,0
118149,remission,0,0
118150,assessment,0,0
118151,",",0,0
118152,using,0,0
118153,measures,0,0
118154,that,0,0
118155,do,0,0
118156,or,0,0
118157,do,0,0
118158,not,0,0
118159,comprise,0,0
118160,acute-phase,0,0
118161,reactants,0,1
118162,.,0,0
118163,METHODS,0,0
118164,Simplified,0,0
118165,Disease,0,0
118166,Activity,0,0
118167,Index,0,1
118168,(,0,1
118169,SDAI,0,0
118170,),0,1
118171,scores,0,0
118172,",",0,0
118173,Clinical,0,0
118174,Disease,0,0
118175,Activity,0,0
118176,Index,0,1
118177,(,0,1
118178,CDAI,0,0
118179,),0,1
118180,scores,0,0
118181,",",0,0
118182,and,0,0
118183,the,0,0
118184,Disease,0,0
118185,Activity,0,0
118186,Score,0,0
118187,in,0,0
118188,28,0,0
118189,joints,0,0
118190,(,0,0
118191,DAS28,0,0
118192,),0,1
118193,were,0,0
118194,calculated,0,0
118195,using,0,0
118196,data,0,0
118197,from,0,0
118198,tocilizumab,1,1
118199,trials,0,0
118200,in,0,0
118201,patients,0,0
118202,with,0,0
118203,RA,0,0
118204,in,0,0
118205,whom,0,0
118206,disease,0,0
118207,had,0,0
118208,remained,0,0
118209,active,0,0
118210,despite,0,0
118211,treatment,0,0
118212,with,0,0
118213,disease-modifying,1,1
118214,antirheumatic,1,1
118215,drugs,1,1
118216,.,1,0
118217,The,0,0
118218,CDAI,0,0
118219,does,0,0
118220,not,0,0
118221,contain,0,0
118222,an,0,0
118223,acute-phase,0,0
118224,reactant,0,0
118225,component,0,0
118226,.,0,0
118227,Disease,0,0
118228,activity,0,0
118229,states,0,0
118230,",",0,0
118231,including,0,0
118232,remission,0,0
118233,",",0,0
118234,were,0,0
118235,defined,0,0
118236,using,0,0
118237,established,0,0
118238,cut,0,0
118239,points,0,0
118240,;,0,0
118241,for,0,0
118242,the,0,0
118243,DAS28,0,0
118244,",",0,0
118245,an,0,0
118246,alternative,0,1
118247,cut,0,0
118248,point,0,0
118249,of,0,0
118250,<,0,0
118251,2.4,0,0
118252,was,0,0
118253,also,0,0
118254,used,0,0
118255,.,0,0
118256,RESULTS,0,0
118257,Changes,0,0
118258,in,0,0
118259,the,0,0
118260,DAS28,0,0
118261,",",0,0
118262,the,0,0
118263,SDAI,0,0
118264,score,0,0
118265,",",0,0
118266,and,0,0
118267,the,0,0
118268,CDAI,0,0
118269,score,0,0
118270,among,0,0
118271,patients,0,0
118272,receiving,0,0
118273,tocilizumab,1,1
118274,were,0,0
118275,significantly,0,0
118276,higher,0,0
118277,than,0,0
118278,those,0,0
118279,among,0,0
118280,patients,0,0
118281,receiving,0,0
118282,placebo,1,1
118283,",",0,0
118284,and,0,0
118285,the,0,0
118286,magnitude,0,0
118287,of,0,0
118288,these,0,0
118289,changes,0,0
118290,was,0,0
118291,similar,0,0
118292,for,0,0
118293,the,0,0
118294,SDAI,0,0
118295,and,0,0
118296,the,0,0
118297,CDAI,0,0
118298,.,0,0
118299,Among,0,0
118300,patients,0,0
118301,who,0,0
118302,achieved,0,0
118303,50,0,1
118304,%,0,0
118305,improvement,0,0
118306,in,0,0
118307,disease,0,0
118308,activity,0,0
118309,according,0,0
118310,to,0,0
118311,the,0,0
118312,American,0,0
118313,College,0,0
118314,of,0,0
118315,Rheumatology,0,0
118316,criteria,0,0
118317,",",0,0
118318,only,0,0
118319,?20,0,0
118320,%,0,0
118321,required,0,0
118322,a,0,0
118323,reduction,0,0
118324,in,0,0
118325,acute-phase,0,0
118326,reactant,0,0
118327,values,0,0
118328,in,0,0
118329,order,0,0
118330,to,0,0
118331,fulfill,0,0
118332,the,0,0
118333,criteria,0,0
118334,.,0,0
118335,However,0,0
118336,",",0,0
118337,DAS28,0,0
118338,remission,0,0
118339,rates,0,0
118340,were,0,0
118341,higher,0,0
118342,(,0,0
118343,even,0,0
118344,when,0,0
118345,using,0,0
118346,the,0,0
118347,lower,0,0
118348,cut,0,0
118349,point,0,0
118350,),0,0
118351,than,0,0
118352,the,0,0
118353,SDAI,0,0
118354,and,0,0
118355,CDAI,0,0
118356,remission,0,0
118357,rates,0,0
118358,.,0,0
118359,Only,0,0
118360,a,0,0
118361,minority,0,0
118362,of,0,0
118363,tocilizumab-treated,1,0
118364,patients,1,0
118365,with,0,0
118366,DAS28,0,0
118367,remission,0,0
118368,also,0,0
118369,had,0,0
118370,disease,0,0
118371,remission,0,0
118372,according,0,0
118373,to,0,0
118374,the,0,0
118375,SDAI,0,0
118376,(,0,0
118377,26,0,0
118378,%,0,0
118379,),0,0
118380,or,0,1
118381,CDAI,0,0
118382,(,0,1
118383,?21,0,1
118384,%,0,0
118385,),0,0
118386,.,0,0
118387,With,0,0
118388,infliximab,1,1
118389,treatment,1,0
118390,",",0,0
118391,SDAI,0,0
118392,and,0,0
118393,CDAI,0,0
118394,remission,0,0
118395,rates,0,0
118396,were,0,0
118397,of,0,0
118398,the,0,0
118399,same,0,0
118400,magnitude,0,0
118401,as,0,0
118402,those,0,0
118403,observed,0,0
118404,with,0,0
118405,tocilizumab,1,1
118406,treatment,1,0
118407,",",0,0
118408,and,0,0
118409,DAS28,0,0
118410,remission,0,0
118411,rates,0,0
118412,were,0,0
118413,lower,1,0
118414,.,1,0
118415,Tocilizumab-treated,1,0
118416,patients,1,0
118417,with,0,0
118418,DAS28,0,0
118419,remission,0,0
118420,but,0,0
118421,without,0,1
118422,CDAI,0,0
118423,remission,0,0
118424,had,0,0
118425,significantly,0,0
118426,higher,0,0
118427,swollen,0,0
118428,joint,0,0
118429,counts,0,0
118430,but,0,0
118431,lower,0,0
118432,erythrocyte,0,0
118433,sedimentation,0,0
118434,rates,0,0
118435,(,0,0
118436,ESRs,0,1
118437,),0,1
118438,compared,0,0
118439,with,0,0
118440,patients,0,0
118441,with,0,0
118442,SDAI,0,0
118443,or,0,1
118444,CDAI,0,0
118445,remission,0,0
118446,.,0,0
118447,CONCLUSION,0,0
118448,Disease,0,0
118449,activity,0,0
118450,in,0,0
118451,RA,0,0
118452,is,0,0
118453,reduced,1,0
118454,by,1,0
118455,tocilizumab,1,1
118456,treatment,1,0
118457,",",0,0
118458,irrespective,0,0
118459,of,0,0
118460,the,0,0
118461,type,0,0
118462,of,0,0
118463,composite,0,1
118464,measure,0,0
118465,used,0,0
118466,to,0,0
118467,evaluate,0,0
118468,disease,0,0
118469,activity,0,0
118470,.,0,0
118471,Remission,0,0
118472,rates,0,0
118473,were,0,0
118474,much,0,0
118475,higher,0,0
118476,using,0,0
118477,the,0,0
118478,DAS28,0,0
118479,compared,0,0
118480,with,0,0
118481,the,0,0
118482,SDAI,0,0
118483,and,0,0
118484,CDAI,0,0
118485,",",0,0
118486,due,0,0
118487,to,0,0
118488,the,0,0
118489,high,0,0
118490,weight,0,0
118491,of,0,0
118492,the,0,0
118493,ESR,0,1
118494,in,0,0
118495,the,0,0
118496,DAS28,0,0
118497,and,0,0
118498,the,0,0
118499,effect,0,0
118500,of,0,0
118501,tocilizumab,0,1
118502,on,0,0
118503,the,0,0
118504,ESR,0,1
118505,.,0,0
118506,Using,0,0
118507,the,0,0
118508,stringent,0,0
118509,SDAI,0,0
118510,and,0,0
118511,CDAI,0,0
118512,criteria,0,0
118513,",",0,0
118514,however,0,0
118515,",",0,0
118516,remission,0,0
118517,rates,0,0
118518,in,0,0
118519,patients,0,0
118520,treated,0,0
118521,with,0,0
118522,tocilizumab,1,1
118523,were,1,0
118524,in,0,0
118525,the,0,0
118526,same,0,0
118527,range,0,0
118528,as,0,0
118529,those,0,0
118530,seen,0,0
118531,in,0,0
118532,patients,0,0
118533,treated,0,0
118534,with,0,0
118535,tumor,0,0
118536,necrosis,0,0
118537,factor,0,0
118538,inhibitors,0,1
118539,.,0,0
118540,Triple,1,1
118541,antiretroviral,1,1
118542,compared,0,0
118543,with,0,0
118544,zidovudine,1,1
118545,and,0,0
118546,single-dose,0,1
118547,nevirapine,1,1
118548,prophylaxis,1,1
118549,during,0,0
118550,pregnancy,0,0
118551,and,0,0
118552,breastfeeding,0,0
118553,for,0,0
118554,prevention,0,0
118555,of,0,0
118556,mother-to-child,0,1
118557,transmission,0,0
118558,of,0,0
118559,HIV-1,0,0
118560,(,0,0
118561,Kesho,0,1
118562,Bora,0,1
118563,study,0,0
118564,),0,0
118565,:,0,0
118566,a,0,0
118567,randomised,0,0
118568,controlled,0,0
118569,trial,0,0
118570,.,0,0
118571,BACKGROUND,0,0
118572,Breastfeeding,0,0
118573,is,0,0
118574,essential,0,0
118575,for,0,0
118576,child,0,0
118577,health,0,0
118578,and,0,0
118579,development,0,0
118580,in,0,0
118581,low-resource,0,0
118582,settings,0,0
118583,but,0,0
118584,carries,0,0
118585,a,0,0
118586,significant,0,0
118587,risk,0,0
118588,of,0,0
118589,transmission,0,0
118590,of,0,0
118591,HIV-1,0,0
118592,",",0,0
118593,especially,0,0
118594,in,0,0
118595,late,0,0
118596,stages,0,0
118597,of,0,0
118598,maternal,0,0
118599,disease,0,0
118600,.,0,0
118601,We,0,0
118602,aimed,0,0
118603,to,0,0
118604,assess,0,0
118605,the,0,0
118606,efficacy,0,0
118607,and,0,0
118608,safety,0,0
118609,of,0,0
118610,triple,0,1
118611,antiretroviral,0,1
118612,compared,0,0
118613,with,0,0
118614,zidovudine,0,1
118615,and,0,0
118616,single-dose,0,1
118617,nevirapine,0,1
118618,prophylaxis,0,1
118619,in,0,0
118620,pregnant,0,0
118621,women,0,0
118622,infected,0,0
118623,with,0,0
118624,HIV,0,0
118625,.,0,0
118626,METHODS,0,0
118627,Pregnant,0,0
118628,women,0,0
118629,with,0,0
118630,WHO,0,1
118631,stage,0,0
118632,1,0,0
118633,",",0,0
118634,2,0,0
118635,",",0,0
118636,or,0,0
118637,3,0,0
118638,HIV-1,0,0
118639,infection,0,0
118640,who,0,0
118641,had,0,0
118642,CD4,0,0
118643,cell,0,0
118644,counts,0,0
118645,of,0,0
118646,200-500,0,0
118647,cells,0,0
118648,per,0,0
118649,?L,0,0
118650,were,0,0
118651,enrolled,0,0
118652,at,0,0
118653,five,0,0
118654,study,0,0
118655,sites,0,0
118656,in,0,0
118657,Burkina,0,0
118658,Faso,0,0
118659,",",0,0
118660,Kenya,0,0
118661,",",0,0
118662,and,0,0
118663,South,0,0
118664,Africa,0,1
118665,to,0,0
118666,start,0,0
118667,study,0,0
118668,treatment,0,0
118669,at,0,0
118670,28-36,0,0
118671,weeks,0,0
118672,',0,0
118673,gestation,0,0
118674,.,0,0
118675,Women,0,0
118676,were,0,0
118677,randomly,0,0
118678,assigned,0,0
118679,(,0,0
118680,1:1,0,1
118681,),0,0
118682,by,0,0
118683,a,0,0
118684,computer,0,1
118685,generated,0,0
118686,random,0,0
118687,sequence,0,0
118688,to,0,0
118689,either,0,0
118690,triple,0,1
118691,antiretroviral,0,1
118692,prophylaxis,0,1
118693,(,0,0
118694,a,0,0
118695,combination,0,1
118696,of,0,0
118697,300,0,1
118698,mg,1,1
118699,zidovudine,1,1
118700,",",1,0
118701,150,0,0
118702,mg,1,1
118703,lamivudine,1,1
118704,",",1,0
118705,and,0,0
118706,400,0,1
118707,mg,1,1
118708,lopinavir,1,1
118709,plus,1,1
118710,100,0,1
118711,mg,1,1
118712,ritonavir,1,1
118713,twice,0,1
118714,daily,0,1
118715,until,0,0
118716,cessation,0,1
118717,of,0,0
118718,breastfeeding,0,0
118719,to,0,0
118720,a,0,0
118721,maximum,0,0
118722,of,0,0
118723,6?5,0,0
118724,months,0,0
118725,post,0,0
118726,partum,0,1
118727,),0,0
118728,or,0,1
118729,zidovudine,1,1
118730,and,1,0
118731,single-dose,1,1
118732,nevirapine,1,1
118733,(,1,0
118734,300,0,1
118735,mg,0,1
118736,zidovudine,1,1
118737,twice,1,1
118738,daily,0,1
118739,until,0,0
118740,delivery,0,0
118741,and,0,0
118742,a,0,0
118743,dose,0,0
118744,of,0,0
118745,600,0,0
118746,mg,0,1
118747,zidovudine,1,1
118748,plus,1,1
118749,200,0,1
118750,mg,0,1
118751,nevirapine,1,1
118752,at,1,0
118753,the,0,0
118754,onset,0,0
118755,of,0,0
118756,labour,0,0
118757,and,0,0
118758,",",0,0
118759,after,0,0
118760,a,0,0
118761,protocol,0,1
118762,amendment,0,0
118763,in,0,0
118764,December,0,0
118765,",",0,0
118766,2006,0,0
118767,",",0,0
118768,1,0,0
118769,week,0,0
118770,post-partum,1,0
118771,zidovudine,1,1
118772,300,1,1
118773,mg,0,1
118774,twice,0,1
118775,daily,0,1
118776,and,0,0
118777,lamivudine,0,1
118778,150,0,0
118779,mg,0,1
118780,twice,0,1
118781,daily,0,1
118782,),0,0
118783,.,0,0
118784,All,0,0
118785,infants,0,0
118786,received,0,0
118787,a,0,0
118788,0?6,0,1
118789,mL,0,1
118790,dose,0,0
118791,of,0,0
118792,nevirapine,1,1
118793,at,1,0
118794,birth,0,0
118795,and,0,0
118796,",",0,0
118797,from,0,0
118798,December,0,0
118799,",",0,0
118800,2006,0,0
118801,",",0,0
118802,4,0,0
118803,mg/kg,0,1
118804,twice,0,1
118805,daily,0,1
118806,of,0,0
118807,zidovudine,0,1
118808,for,0,0
118809,1,0,0
118810,week,0,0
118811,after,0,0
118812,birth,0,0
118813,.,0,0
118814,Patients,0,0
118815,and,0,0
118816,investigators,0,0
118817,were,0,0
118818,not,0,0
118819,masked,0,0
118820,to,0,0
118821,treatment,0,0
118822,.,0,0
118823,The,0,0
118824,primary,0,0
118825,endpoints,0,0
118826,were,0,0
118827,HIV-free,0,0
118828,infant,0,0
118829,survival,0,0
118830,at,0,0
118831,6,0,0
118832,weeks,0,0
118833,and,0,0
118834,12,0,0
118835,months,0,0
118836,;,0,0
118837,HIV-free,0,0
118838,survival,0,0
118839,at,0,0
118840,12,0,0
118841,months,0,0
118842,in,0,0
118843,infants,0,0
118844,who,0,0
118845,were,0,0
118846,ever,0,0
118847,breastfed,0,0
118848,;,0,0
118849,AIDS-free,0,0
118850,survival,0,0
118851,in,0,0
118852,mothers,0,0
118853,at,0,0
118854,18,0,0
118855,months,0,0
118856,;,0,0
118857,and,0,0
118858,serious,0,0
118859,adverse,0,0
118860,events,0,0
118861,in,0,0
118862,mothers,0,0
118863,and,0,0
118864,babies,0,0
118865,.,0,0
118866,Analysis,0,0
118867,was,0,0
118868,by,0,0
118869,intention,0,0
118870,to,0,0
118871,treat,0,0
118872,.,0,0
118873,This,0,0
118874,trial,0,0
118875,is,0,0
118876,registered,0,0
118877,with,0,0
118878,Current,0,0
118879,Controlled,0,1
118880,Trials,0,1
118881,",",0,0
118882,ISRCTN71468401,0,0
118883,.,0,0
118884,FINDINGS,0,0
118885,From,0,0
118886,June,0,0
118887,",",0,0
118888,2005,0,0
118889,",",0,0
118890,to,0,0
118891,August,0,0
118892,",",0,0
118893,2008,0,0
118894,",",0,0
118895,882,0,0
118896,women,0,0
118897,were,0,0
118898,enrolled,0,0
118899,",",0,0
118900,824,0,0
118901,of,0,0
118902,whom,0,0
118903,were,0,0
118904,randomised,0,0
118905,and,0,0
118906,gave,0,0
118907,birth,0,0
118908,to,0,0
118909,805,0,0
118910,singleton,0,0
118911,or,0,1
118912,first,0,0
118913,",",0,0
118914,liveborn,0,0
118915,infants,0,0
118916,.,0,0
118917,The,0,0
118918,cumulative,0,0
118919,rate,0,0
118920,of,0,0
118921,HIV,0,1
118922,transmission,0,0
118923,at,0,0
118924,6,0,0
118925,weeks,0,0
118926,was,0,0
118927,3?3,0,0
118928,%,0,0
118929,(,0,0
118930,95,0,0
118931,%,0,0
118932,CI,0,0
118933,1?9-5?6,0,1
118934,%,0,0
118935,),0,0
118936,in,0,0
118937,the,0,0
118938,triple,0,1
118939,antiretroviral,0,1
118940,group,0,0
118941,compared,0,0
118942,with,0,0
118943,5?0,0,1
118944,%,0,0
118945,(,0,0
118946,3?3-7?7,1,1
118947,%,1,0
118948,),1,0
118949,in,1,0
118950,the,1,0
118951,zidovudine,1,1
118952,and,1,0
118953,single-dose,1,1
118954,nevirapine,1,1
118955,group,1,0
118956,",",1,0
118957,and,1,0
118958,at,0,0
118959,12,0,0
118960,months,0,0
118961,was,0,0
118962,5?4,0,1
118963,%,0,0
118964,(,0,0
118965,3?6-8?1,0,1
118966,%,0,0
118967,),0,0
118968,in,0,0
118969,the,0,0
118970,triple,0,1
118971,antiretroviral,0,1
118972,group,0,0
118973,compared,0,0
118974,with,0,0
118975,9?5,0,1
118976,%,0,0
118977,(,0,0
118978,7?0-12?9,0,0
118979,%,0,0
118980,),0,0
118981,in,1,0
118982,the,1,0
118983,zidovudine,1,1
118984,and,0,0
118985,single-dose,0,1
118986,nevirapine,1,1
118987,group,1,1
118988,(,0,1
118989,p=0?029,0,1
118990,),0,0
118991,.,0,0
118992,The,0,0
118993,cumulative,0,0
118994,rate,0,0
118995,of,0,0
118996,HIV,0,1
118997,transmission,0,0
118998,or,0,1
118999,death,0,0
119000,at,0,0
119001,12,0,0
119002,months,0,0
119003,was,0,0
119004,10?2,0,0
119005,%,0,0
119006,(,0,0
119007,95,0,0
119008,%,0,0
119009,CI,0,0
119010,7?6-13?6,0,1
119011,%,0,0
119012,),0,0
119013,in,0,0
119014,the,0,0
119015,triple,0,1
119016,antiretroviral,0,1
119017,group,0,0
119018,compared,0,0
119019,with,0,0
119020,16?0,0,0
119021,%,0,0
119022,(,0,0
119023,12?7-20?0,0,1
119024,%,0,0
119025,),0,0
119026,in,0,0
119027,the,0,0
119028,zidovudine,1,1
119029,and,1,0
119030,single-dose,1,1
119031,nevirapine,1,1
119032,group,1,1
119033,(,1,1
119034,p=0?017,1,0
119035,),0,0
119036,.,0,0
119037,In,0,0
119038,infants,0,0
119039,whose,0,0
119040,mothers,0,0
119041,declared,0,0
119042,they,0,0
119043,intended,0,0
119044,to,0,0
119045,breastfeed,0,0
119046,",",0,0
119047,the,0,0
119048,cumulative,0,0
119049,rate,0,0
119050,of,0,0
119051,HIV,0,1
119052,transmission,0,0
119053,at,0,0
119054,12,0,0
119055,months,0,0
119056,was,0,0
119057,5?6,0,1
119058,%,0,0
119059,(,0,0
119060,95,0,0
119061,%,0,0
119062,CI,0,0
119063,3?4-8?9,0,1
119064,%,0,0
119065,),0,0
119066,in,0,0
119067,the,0,0
119068,triple,0,1
119069,antiretroviral,0,1
119070,group,0,0
119071,compared,0,0
119072,with,0,0
119073,10?7,0,0
119074,%,0,0
119075,(,0,0
119076,7?6-14?8,0,0
119077,%,0,0
119078,),0,0
119079,in,0,0
119080,the,1,0
119081,zidovudine,1,1
119082,and,1,0
119083,single-dose,1,1
119084,nevirapine,1,1
119085,group,1,1
119086,(,0,1
119087,p=0?02,0,0
119088,),0,1
119089,.,0,0
119090,AIDS-free,0,0
119091,survival,0,0
119092,in,0,0
119093,mothers,0,0
119094,at,0,0
119095,18,0,0
119096,months,0,0
119097,will,0,0
119098,be,0,0
119099,reported,0,0
119100,in,0,0
119101,a,0,0
119102,different,0,0
119103,publication,0,0
119104,.,0,0
119105,The,0,0
119106,incidence,0,0
119107,of,0,0
119108,laboratory,0,0
119109,and,0,0
119110,clinical,0,0
119111,serious,0,0
119112,adverse,0,0
119113,events,0,0
119114,in,0,0
119115,both,0,0
119116,mothers,0,0
119117,and,0,0
119118,their,0,0
119119,babies,0,0
119120,was,0,0
119121,similar,0,0
119122,between,0,0
119123,groups,0,0
119124,.,0,0
119125,INTERPRETATION,0,0
119126,Triple,0,1
119127,antiretroviral,0,1
119128,prophylaxis,0,1
119129,during,0,0
119130,pregnancy,0,0
119131,and,0,0
119132,breastfeeding,0,0
119133,is,0,0
119134,safe,0,0
119135,and,0,0
119136,reduces,0,0
119137,the,0,0
119138,risk,0,0
119139,of,0,0
119140,HIV,0,1
119141,transmission,0,0
119142,to,0,0
119143,infants,0,0
119144,.,0,0
119145,Revised,0,0
119146,WHO,0,0
119147,guidelines,0,0
119148,now,0,0
119149,recommend,0,0
119150,antiretroviral,0,1
119151,prophylaxis,0,1
119152,(,0,0
119153,either,0,1
119154,to,0,0
119155,the,0,0
119156,mother,0,0
119157,or,0,1
119158,to,0,0
119159,the,0,0
119160,baby,0,0
119161,),0,0
119162,during,0,0
119163,breastfeeding,0,0
119164,if,0,0
119165,the,0,0
119166,mother,0,0
119167,is,0,0
119168,not,0,0
119169,already,0,0
119170,receiving,0,0
119171,antiretroviral,0,1
119172,treatment,0,0
119173,for,0,0
119174,her,0,0
119175,own,0,0
119176,health,0,0
119177,.,0,0
119178,FUNDING,0,0
119179,Agence,0,0
119180,nationale,0,0
119181,de,0,0
119182,recherches,0,0
119183,sur,0,0
119184,le,0,0
119185,sida,0,1
119186,et,0,0
119187,les,0,0
119188,h?patites,0,0
119189,virales,0,0
119190,",",0,0
119191,Department,0,0
119192,for,0,0
119193,International,0,0
119194,Development,0,0
119195,",",0,0
119196,European,0,0
119197,and,0,0
119198,Developing,0,0
119199,Countries,0,0
119200,Clinical,0,0
119201,Trials,0,1
119202,Partnership,0,0
119203,",",0,0
119204,Thrasher,0,0
119205,Research,0,0
119206,Fund,0,0
119207,",",0,0
119208,Belgian,0,0
119209,Directorate,0,0
119210,General,0,1
119211,for,0,0
119212,International,0,0
119213,Cooperation,0,0
119214,",",0,0
119215,Centers,0,0
119216,for,0,0
119217,Disease,0,0
119218,Control,0,1
119219,and,0,0
119220,Prevention,0,1
119221,",",0,0
119222,Eunice,0,1
119223,Kennedy,0,0
119224,Shriver,0,1
119225,National,0,0
119226,Institute,0,0
119227,of,0,0
119228,Child,0,0
119229,Health,0,1
119230,and,0,0
119231,Human,0,1
119232,Development,0,0
119233,",",0,0
119234,and,0,0
119235,UNDP/UNFPA/World,0,1
119236,Bank/WHO,0,0
119237,Special,0,0
119238,Programme,0,1
119239,of,0,0
119240,Research,0,0
119241,",",0,0
119242,Development,0,0
119243,and,0,0
119244,Research,0,0
119245,Training,0,1
119246,in,0,0
119247,Human,0,1
119248,Reproduction,0,0
119249,.,0,0
119250,Dark-phase,0,1
119251,light,0,1
119252,contamination,0,0
119253,disrupts,0,0
119254,circadian,0,0
119255,rhythms,0,0
119256,in,0,0
119257,plasma,0,0
119258,measures,0,0
119259,of,0,0
119260,endocrine,0,0
119261,physiology,0,0
119262,and,0,0
119263,metabolism,0,0
119264,in,0,0
119265,rats,0,1
119266,.,0,0
119267,Dark-phase,1,0
119268,light,1,1
119269,contamination,1,0
119270,can,0,0
119271,significantly,0,0
119272,disrupt,0,0
119273,chronobiologic,0,0
119274,rhythms,0,0
119275,",",0,0
119276,thereby,0,0
119277,potentially,0,0
119278,altering,0,0
119279,the,0,0
119280,endocrine,0,1
119281,physiology,0,0
119282,and,0,0
119283,metabolism,0,0
119284,of,0,0
119285,experimental,0,0
119286,animals,0,0
119287,and,0,0
119288,influencing,0,0
119289,the,0,0
119290,outcome,0,0
119291,of,0,0
119292,scientific,0,0
119293,investigations,0,0
119294,.,0,0
119295,We,0,0
119296,sought,0,0
119297,to,0,0
119298,determine,0,0
119299,whether,0,0
119300,exposure,0,0
119301,to,0,0
119302,low-level,0,1
119303,light,0,1
119304,contamination,0,0
119305,during,0,0
119306,the,0,0
119307,dark,0,1
119308,phase,0,0
119309,influenced,0,0
119310,the,0,0
119311,normally,0,0
119312,entrained,0,1
119313,circadian,0,0
119314,rhythms,0,0
119315,of,0,0
119316,various,0,0
119317,substances,0,0
119318,in,0,0
119319,plasma,0,0
119320,.,0,0
119321,Male,0,0
119322,Sprague-Dawley,0,0
119323,rats,0,1
119324,(,0,0
119325,n,0,0
119326,=,0,0
119327,6,0,0
119328,per,0,0
119329,group,0,0
119330,),0,0
119331,were,0,0
119332,housed,0,1
119333,in,0,0
119334,photobiologic,1,0
119335,light-exposure,1,1
119336,chambers,1,1
119337,configured,0,0
119338,to,0,0
119339,create,0,0
119340,1,0,0
119341,),0,0
119342,a,0,0
119343,12:12-h,0,0
119344,light,1,1
119345,:,1,0
119346,dark,1,1
119347,cycle,1,0
119348,without,1,0
119349,dark-phase,1,1
119350,light,1,1
119351,contamination,1,0
119352,(,0,1
119353,control,0,1
119354,condition,0,0
119355,;,0,0
119356,123,0,0
119357,?W/cm,0,1
119358,(,0,0
119359,2,0,0
119360,),0,0
119361,",",0,0
119362,lights,0,1
119363,on,0,0
119364,at,0,0
119365,0600,0,0
119366,),0,0
119367,",",0,0
119368,2,0,0
119369,),0,0
119370,experimental,0,0
119371,exposure,0,0
119372,to,0,0
119373,a,0,0
119374,low,1,0
119375,level,1,0
119376,of,1,0
119377,light,1,1
119378,during,0,0
119379,the,0,0
119380,12-h,0,1
119381,dark,0,1
119382,phase,0,0
119383,(,0,0
119384,with,0,0
119385,0.02,0,0
119386,",",0,0
119387,0.05,0,0
119388,",",0,0
119389,0.06,0,0
119390,",",0,0
119391,or,0,0
119392,0.08,0,0
119393,?W/cm,0,1
119394,(,0,0
119395,2,0,0
119396,),0,0
119397,light,0,1
119398,at,0,0
119399,night,0,0
119400,),0,0
119401,",",0,0
119402,or,0,1
119403,3,0,0
119404,),0,0
119405,constant,1,0
119406,bright,1,1
119407,light,1,1
119408,(,1,0
119409,123,0,1
119410,?W/cm,0,1
119411,(,0,0
119412,2,0,1
119413,),0,0
119414,),0,0
119415,.,0,1
119416,Dietary,0,1
119417,and,0,0
119418,water,0,1
119419,intakes,0,0
119420,were,0,0
119421,recorded,0,0
119422,daily,0,0
119423,.,0,0
119424,After,0,0
119425,2,0,0
119426,wk,0,0
119427,",",0,0
119428,rats,0,1
119429,underwent,0,0
119430,6,0,0
119431,low-volume,0,1
119432,blood,0,0
119433,draws,0,0
119434,at,0,0
119435,4-h,0,0
119436,intervals,0,0
119437,(,0,0
119438,beginning,0,0
119439,at,0,0
119440,0400,0,1
119441,),0,0
119442,during,0,0
119443,both,0,0
119444,the,0,0
119445,light,0,1
119446,and,0,0
119447,dark,0,1
119448,phases,0,0
119449,.,0,0
119450,Circadian,0,0
119451,rhythms,0,0
119452,in,0,0
119453,dietary,0,1
119454,and,0,0
119455,water,0,1
119456,intake,0,1
119457,and,0,0
119458,levels,0,0
119459,of,0,0
119460,plasma,0,0
119461,total,0,0
119462,fatty,0,1
119463,acids,0,1
119464,and,0,0
119465,lipid,0,0
119466,fractions,0,1
119467,remained,0,0
119468,entrained,0,0
119469,during,0,0
119470,exposure,0,0
119471,to,0,0
119472,either,0,1
119473,control,0,1
119474,conditions,0,0
119475,or,0,1
119476,low-intensity,0,1
119477,light,0,1
119478,during,0,0
119479,the,0,0
119480,dark,0,1
119481,phase,0,0
119482,.,0,0
119483,However,0,0
119484,",",0,0
119485,these,0,0
119486,patterns,0,0
119487,were,0,0
119488,disrupted,0,0
119489,in,0,0
119490,rats,0,1
119491,exposed,0,0
119492,to,0,0
119493,constant,1,0
119494,bright,1,1
119495,light,1,1
119496,.,1,0
119497,Circadian,1,0
119498,patterns,0,0
119499,of,0,0
119500,plasma,0,0
119501,melatonin,0,1
119502,",",0,0
119503,glucose,0,0
119504,",",0,0
119505,lactic,0,1
119506,acid,0,1
119507,",",0,0
119508,and,0,0
119509,corticosterone,0,0
119510,were,0,0
119511,maintained,0,0
119512,in,0,0
119513,all,0,0
119514,rats,0,1
119515,except,0,0
119516,those,0,0
119517,exposed,0,0
119518,to,0,0
119519,constant,1,0
119520,bright,1,1
119521,light,1,1
119522,or,1,1
119523,the,0,0
119524,highest,0,0
119525,level,0,0
119526,of,0,0
119527,light,0,1
119528,during,0,0
119529,the,0,0
119530,dark,0,1
119531,phase,0,0
119532,.,0,0
119533,Therefore,0,0
119534,even,0,0
119535,minimal,0,0
119536,light,0,1
119537,contamination,0,0
119538,during,0,0
119539,the,0,0
119540,dark,0,1
119541,phase,0,0
119542,can,0,0
119543,disrupt,0,0
119544,normal,0,0
119545,circadian,0,0
119546,rhythms,0,0
119547,of,0,0
119548,endocrine,0,1
119549,metabolism,0,0
119550,and,0,1
119551,physiology,0,0
119552,and,0,0
119553,may,0,0
119554,alter,0,0
119555,the,0,0
119556,outcome,0,0
119557,of,0,0
119558,scientific,0,0
119559,investigations,0,0
119560,.,0,0
119561,Intermittent,1,0
119562,theta-burst,1,1
119563,transcranial,1,1
119564,magnetic,1,1
119565,stimulation,1,1
119566,for,0,0
119567,treatment,0,0
119568,of,0,0
119569,Parkinson,0,0
119570,disease,0,0
119571,.,0,0
119572,OBJECTIVE,0,0
119573,To,0,0
119574,investigate,0,0
119575,the,0,0
119576,safety,0,0
119577,and,0,0
119578,efficacy,0,0
119579,of,0,0
119580,intermittent,1,0
119581,theta-burst,1,1
119582,stimulation,1,1
119583,(,1,1
119584,iTBS,1,0
119585,),1,1
119586,in,0,0
119587,the,0,0
119588,treatment,0,0
119589,of,0,0
119590,motor,0,0
119591,symptoms,0,0
119592,in,0,0
119593,Parkinson,0,0
119594,disease,0,0
119595,(,0,1
119596,PD,0,1
119597,),0,0
119598,.,0,0
119599,BACKGROUND,0,0
119600,Progression,0,0
119601,of,0,0
119602,PD,0,1
119603,is,0,0
119604,characterized,0,0
119605,by,0,0
119606,the,0,0
119607,emergence,0,0
119608,of,0,0
119609,motor,0,0
119610,deficits,0,0
119611,",",0,0
119612,which,0,0
119613,eventually,0,0
119614,respond,0,0
119615,less,0,0
119616,to,0,0
119617,dopaminergic,0,0
119618,therapy,0,1
119619,and,0,0
119620,pose,0,0
119621,a,0,0
119622,therapeutic,0,0
119623,challenge,0,0
119624,.,0,0
119625,Repetitive,1,1
119626,transcranial,1,1
119627,magnetic,1,1
119628,stimulation,1,1
119629,(,1,1
119630,rTMS,1,1
119631,),1,1
119632,has,0,0
119633,shown,0,0
119634,promising,0,0
119635,results,0,0
119636,in,0,0
119637,improving,0,0
119638,gait,0,0
119639,",",0,0
119640,a,0,0
119641,major,0,0
119642,cause,0,0
119643,of,0,0
119644,disability,0,0
119645,",",0,0
119646,and,0,0
119647,may,0,0
119648,provide,0,0
119649,a,0,0
119650,therapeutic,0,0
119651,alternative,0,0
119652,.,0,0
119653,iTBS,1,0
119654,is,0,0
119655,a,0,0
119656,novel,0,0
119657,type,0,0
119658,of,0,0
119659,rTMS,1,1
119660,that,0,0
119661,may,0,0
119662,be,0,0
119663,more,0,0
119664,efficacious,0,0
119665,than,0,0
119666,conventional,0,1
119667,rTMS,1,1
119668,.,1,0
119669,METHODS,0,0
119670,In,0,0
119671,this,0,0
119672,randomized,0,0
119673,",",0,0
119674,double-blind,0,0
119675,",",0,0
119676,sham-controlled,0,1
119677,study,0,0
119678,",",0,0
119679,we,0,0
119680,investigated,0,0
119681,safety,0,0
119682,and,0,0
119683,efficacy,0,0
119684,of,0,0
119685,iTBS,1,0
119686,of,0,0
119687,the,0,0
119688,motor,0,0
119689,and,0,0
119690,dorsolateral,0,1
119691,prefrontal,0,0
119692,cortices,0,0
119693,in,0,0
119694,8,0,0
119695,sessions,0,1
119696,over,0,0
119697,2,0,0
119698,weeks,0,0
119699,(,0,0
119700,evidence,0,0
119701,Class,0,1
119702,I,0,0
119703,),0,0
119704,.,0,0
119705,Assessment,0,0
119706,of,0,0
119707,safety,0,0
119708,and,0,0
119709,clinical,0,0
119710,efficacy,0,0
119711,over,0,0
119712,a,0,0
119713,1-month,0,0
119714,period,0,0
119715,included,0,0
119716,timed,0,0
119717,tests,0,0
119718,of,0,0
119719,gait,0,0
119720,and,0,0
119721,bradykinesia,0,0
119722,",",0,0
119723,Unified,0,0
119724,Parkinson,0,0
119725,'s,0,0
119726,Disease,0,0
119727,Rating,0,0
119728,Scale,0,1
119729,(,0,1
119730,UPDRS,0,1
119731,),0,1
119732,",",0,0
119733,and,0,0
119734,additional,0,0
119735,clinical,0,0
119736,",",0,0
119737,neuropsychological,0,0
119738,",",0,0
119739,and,0,0
119740,neurophysiologic,0,0
119741,measures,0,0
119742,.,0,0
119743,RESULTS,0,0
119744,We,0,0
119745,investigated,0,0
119746,26,0,0
119747,patients,0,0
119748,with,0,0
119749,mild,0,0
119750,to,0,0
119751,moderate,0,0
119752,PD,0,1
119753,:,0,0
119754,13,0,0
119755,received,0,0
119756,iTBS,1,0
119757,and,0,0
119758,13,0,0
119759,sham,1,1
119760,stimulation,1,1
119761,.,1,0
119762,We,0,0
119763,found,0,0
119764,beneficial,0,0
119765,effects,0,0
119766,of,0,0
119767,iTBS,1,0
119768,on,0,0
119769,mood,0,0
119770,",",0,0
119771,but,0,0
119772,no,0,0
119773,improvement,0,0
119774,of,0,0
119775,gait,0,0
119776,",",0,0
119777,bradykinesia,0,0
119778,",",0,0
119779,UPDRS,0,1
119780,",",0,0
119781,and,0,0
119782,other,0,0
119783,measures,0,0
119784,.,0,0
119785,EEG/EMG,0,0
119786,monitoring,0,0
119787,recorded,0,0
119788,no,0,0
119789,pathologic,0,0
119790,increase,0,0
119791,of,0,0
119792,cortical,0,0
119793,excitability,0,0
119794,or,0,1
119795,epileptic,0,0
119796,activity,0,0
119797,.,0,0
119798,Few,0,0
119799,reported,0,0
119800,discomfort,0,0
119801,or,0,1
119802,pain,0,0
119803,and,0,0
119804,one,0,0
119805,experienced,0,0
119806,tinnitus,0,0
119807,during,0,0
119808,real,0,0
119809,stimulation,0,1
119810,.,0,0
119811,CONCLUSION,0,0
119812,iTBS,1,0
119813,of,0,0
119814,the,0,0
119815,motor,0,0
119816,and,0,0
119817,prefrontal,0,0
119818,cortices,0,1
119819,appears,0,0
119820,safe,0,0
119821,and,0,0
119822,improves,0,0
119823,mood,0,0
119824,",",0,0
119825,but,0,0
119826,failed,0,0
119827,to,0,0
119828,improve,0,0
119829,motor,0,1
119830,performance,0,0
119831,and,0,0
119832,functional,0,0
119833,status,0,0
119834,in,0,0
119835,PD,0,0
119836,.,0,0
119837,CLASSIFICATION,0,0
119838,OF,0,1
119839,EVIDENCE,0,0
119840,This,0,0
119841,study,0,0
119842,provides,0,0
119843,Class,0,0
119844,I,0,0
119845,evidence,0,0
119846,that,0,0
119847,iTBS,1,0
119848,was,0,0
119849,not,0,0
119850,effective,0,0
119851,for,0,0
119852,gait,0,0
119853,",",0,0
119854,upper,0,0
119855,extremity,0,0
119856,bradykinesia,0,0
119857,",",0,0
119858,or,0,1
119859,other,0,0
119860,motor,0,0
119861,symptoms,0,0
119862,in,0,0
119863,PD,0,0
119864,.,0,0
119865,Quitting,0,1
119866,a,0,0
119867,weight,1,0
119868,loss,1,0
119869,program,1,1
119870,is,0,0
119871,associated,0,0
119872,with,0,0
119873,anhedonia,0,0
119874,:,0,0
119875,preliminary,0,0
119876,findings,0,0
119877,of,0,0
119878,the,0,0
119879,Lifestyle,0,1
119880,Intervention,0,1
119881,Treatment,0,1
119882,Evaluation,0,1
119883,Study,0,0
119884,in,0,0
119885,northern,0,0
119886,Finland,0,0
119887,.,0,0
119888,OBJECTIVES,0,0
119889,To,0,0
119890,examine,0,0
119891,whether,0,0
119892,a,0,0
119893,diagnosis,0,0
119894,for,0,0
119895,major,0,0
119896,depression,0,0
119897,",",0,0
119898,chronic,0,0
119899,depression,0,0
119900,or,0,1
119901,specific,0,0
119902,symptoms,0,0
119903,of,0,0
119904,depression,0,0
119905,is,0,0
119906,associated,0,0
119907,with,0,0
119908,the,0,0
119909,risk,0,0
119910,of,0,0
119911,quitting,0,0
119912,a,0,0
119913,weight,1,0
119914,loss,1,0
119915,program,1,1
119916,.,1,0
119917,STUDY,0,0
119918,DESIGN,0,0
119919,The,0,0
119920,study,0,0
119921,involved,0,0
119922,82,0,0
119923,overweight,0,0
119924,adults,0,0
119925,participating,0,0
119926,in,0,0
119927,the,0,0
119928,Lifestyle,1,1
119929,Intervention,1,1
119930,Treatment,1,1
119931,Evaluation,1,1
119932,(,0,1
119933,LITE,0,1
119934,),0,1
119935,follow-up,0,0
119936,study,0,0
119937,at,0,0
119938,Oulu,0,0
119939,University,0,0
119940,Hospital,0,0
119941,in,0,0
119942,northern,0,0
119943,Finland,0,0
119944,.,0,0
119945,METHODS,0,0
119946,Psychiatric,0,0
119947,diagnostic,0,0
119948,assessments,0,0
119949,were,0,0
119950,based,0,0
119951,on,0,0
119952,the,0,0
119953,Structured,0,1
119954,Clinical,0,0
119955,Interview,0,1
119956,for,0,0
119957,DSMIV,0,1
119958,disorders,0,0
119959,(,0,0
119960,SCID-I,0,1
119961,),0,1
119962,conducted,0,0
119963,by,0,0
119964,a,0,0
119965,clinical,0,0
119966,psychiatrist,0,0
119967,.,0,1
119968,Anhedonia,0,0
119969,(,0,0
119970,lack,0,0
119971,of,0,0
119972,pleasure,0,0
119973,),0,0
119974,was,0,0
119975,assessed,0,0
119976,as,0,0
119977,one,0,0
119978,of,0,0
119979,the,0,0
119980,core,0,0
119981,symptoms,0,0
119982,of,0,0
119983,major,0,0
119984,depression,0,0
119985,and,0,0
119986,chronic,0,0
119987,depression,0,1
119988,(,0,1
119989,dysthymia,0,0
119990,),0,0
119991,.,0,0
119992,Anhedonia,0,0
119993,was,0,0
119994,defined,0,0
119995,to,0,0
119996,be,0,0
119997,present,0,0
119998,if,0,0
119999,the,0,0
120000,participants,0,0
120001,reported,0,0
120002,having,0,0
120003,suffered,0,0
120004,a,0,0
120005,major,0,0
120006,loss,0,0
120007,of,0,0
120008,interest,0,0
120009,during,0,0
120010,the,0,0
120011,previous,0,0
120012,month,0,0
120013,.,0,0
120014,RESULTS,0,0
120015,Twenty,0,0
120016,participants,0,0
120017,(,0,0
120018,24.4,0,0
120019,%,0,0
120020,),0,0
120021,quit,0,0
120022,during,0,0
120023,the,0,0
120024,6-month,0,0
120025,intervention,0,1
120026,period,0,0
120027,.,0,0
120028,Anhedonia,0,0
120029,put,0,0
120030,individuals,0,0
120031,at,0,0
120032,risk,0,0
120033,of,0,0
120034,quitting,0,0
120035,the,0,0
120036,weight,0,0
120037,loss,0,0
120038,program,0,1
120039,(,0,1
120040,bivariate,0,0
120041,analysis,0,0
120042,OR,0,0
120043,3.1,0,0
120044,",",0,0
120045,95,0,0
120046,%,0,0
120047,CI,0,0
120048,0.8-11.6,0,0
120049,",",0,0
120050,p=0.091,0,0
120051,",",0,0
120052,multivariate,0,0
120053,analysis,0,0
120054,OR,0,0
120055,6.5,0,0
120056,",",0,0
120057,95,0,0
120058,%,0,0
120059,CI,0,0
120060,1.1-38.2,0,0
120061,",",0,0
120062,p=0.038,0,0
120063,),0,0
120064,.,0,0
120065,However,0,0
120066,",",0,0
120067,a,0,0
120068,diagnosis,0,0
120069,for,0,0
120070,major,0,0
120071,depression,0,0
120072,or,0,1
120073,chronic,0,0
120074,depression,0,0
120075,did,0,0
120076,not,0,0
120077,predict,0,0
120078,quitting,0,0
120079,.,0,0
120080,CONCLUSIONS,0,0
120081,Individual,0,0
120082,assessments,0,0
120083,of,0,0
120084,obesity,0,0
120085,and,0,0
120086,overweight,0,0
120087,should,0,0
120088,also,0,0
120089,include,0,0
120090,an,0,0
120091,assessment,0,0
120092,for,0,0
120093,subthreshold,0,0
120094,depression,0,0
120095,",",0,0
120096,mainly,0,0
120097,anhedonia,0,0
120098,.,0,0
120099,Augmented,1,1
120100,soft,1,1
120101,tissue,1,0
120102,mobilization,1,0
120103,vs,0,0
120104,natural,1,0
120105,history,1,0
120106,in,0,0
120107,the,0,0
120108,treatment,0,0
120109,of,0,0
120110,lateral,0,1
120111,epicondylitis,0,0
120112,:,0,0
120113,a,0,0
120114,pilot,0,0
120115,study,0,0
120116,.,0,0
120117,OBJECTIVE,0,0
120118,The,0,0
120119,purpose,0,0
120120,of,0,0
120121,this,0,0
120122,study,0,0
120123,was,0,0
120124,to,0,0
120125,evaluate,0,0
120126,the,0,0
120127,effect,0,0
120128,of,0,0
120129,augmented,1,0
120130,soft,1,1
120131,tissue,1,1
120132,mobilization,1,1
120133,(,0,1
120134,ASTM,0,0
120135,),0,1
120136,on,0,0
120137,the,0,0
120138,treatment,0,0
120139,of,0,0
120140,lateral,0,1
120141,epicondylitis,0,0
120142,.,0,0
120143,METHODS,0,0
120144,This,0,0
120145,randomized,0,0
120146,clinical,0,0
120147,study,0,0
120148,assessed,0,0
120149,27,0,0
120150,subjects,0,0
120151,(,0,0
120152,12,0,0
120153,men,0,0
120154,and,0,0
120155,15,0,0
120156,women,0,0
120157,),0,0
120158,with,0,0
120159,lateral,0,1
120160,epicondylitis,0,0
120161,and,0,0
120162,were,0,0
120163,divided,0,0
120164,randomly,0,0
120165,into,0,0
120166,2,0,0
120167,groups,0,0
120168,.,0,0
120169,The,1,0
120170,experimental,1,0
120171,group,1,0
120172,(,1,0
120173,n,1,0
120174,=,1,0
120175,15,1,0
120176,),1,0
120177,received,1,0
120178,ASTM,1,0
120179,twice,1,1
120180,a,1,0
120181,week,1,0
120182,for,1,0
120183,5,1,0
120184,weeks,1,0
120185,.,1,0
120186,The,1,0
120187,subjects,1,0
120188,of,1,0
120189,the,1,0
120190,control,1,1
120191,group,1,0
120192,(,1,0
120193,n,1,0
120194,=,1,0
120195,12,1,0
120196,),1,0
120197,received,1,0
120198,advice,1,1
120199,on,1,0
120200,the,1,0
120201,natural,1,0
120202,evolution,1,0
120203,of,1,0
120204,lateral,1,1
120205,epicondylitis,1,0
120206,",",1,0
120207,computer,1,1
120208,ergonomics,1,0
120209,",",1,0
120210,and,1,0
120211,stretching,1,1
120212,exercises,1,1
120213,.,1,0
120214,Patient-rated,1,0
120215,outcome,1,0
120216,was,1,0
120217,assessed,1,0
120218,at,1,0
120219,baseline,1,0
120220,and,1,0
120221,after,1,0
120222,6,1,0
120223,weeks,1,0
120224,and,1,0
120225,3,1,0
120226,months,1,0
120227,using,1,0
120228,a,1,0
120229,visual,1,1
120230,analog,1,1
120231,scale,1,0
120232,and,1,0
120233,the,1,0
120234,Patient-Rated,1,0
120235,Tennis,1,1
120236,Elbow,1,0
120237,Evaluation,1,1
120238,.,1,0
120239,The,0,0
120240,function,0,0
120241,was,0,0
120242,assessed,0,0
120243,using,0,0
120244,the,0,0
120245,pain-free,0,0
120246,grip,0,0
120247,strength,0,0
120248,at,0,0
120249,baseline,0,0
120250,and,0,0
120251,after,0,0
120252,6,0,0
120253,weeks,0,0
120254,.,0,0
120255,RESULTS,0,0
120256,Both,0,1
120257,groups,0,0
120258,showed,0,0
120259,improvements,0,0
120260,in,0,0
120261,pain-free,0,0
120262,grip,0,0
120263,strength,0,0
120264,",",0,0
120265,visual,0,0
120266,analog,0,1
120267,scale,0,0
120268,",",0,0
120269,and,0,0
120270,Patient-Rated,0,0
120271,Tennis,0,1
120272,Elbow,0,0
120273,Evaluation,0,1
120274,.,0,0
120275,Sample,0,0
120276,size,0,0
120277,for,0,0
120278,larger,0,0
120279,future,0,0
120280,randomized,0,0
120281,clinical,0,0
120282,trial,0,0
120283,was,0,0
120284,116,0,0
120285,participants,0,0
120286,.,0,0
120287,CONCLUSION,0,0
120288,A,0,0
120289,larger,0,0
120290,study,0,0
120291,investigating,0,0
120292,the,0,0
120293,same,0,0
120294,hypothesis,0,0
120295,is,0,0
120296,warranted,0,0
120297,to,0,0
120298,detect,0,0
120299,difference,0,0
120300,in,0,0
120301,the,0,0
120302,effects,0,0
120303,of,0,0
120304,these,0,0
120305,treatments,0,0
120306,strategies,0,0
120307,.,0,0
120308,The,0,0
120309,study,0,0
120310,design,0,0
120311,is,0,0
120312,feasible,0,0
120313,",",0,0
120314,and,0,0
120315,minor,0,0
120316,improvements,0,0
120317,will,0,0
120318,help,0,0
120319,to,0,0
120320,minimize,0,0
120321,the,0,0
120322,potential,0,0
120323,bias,0,0
120324,.,0,0
120325,[,0,0
120326,Effects,0,0
120327,of,0,0
120328,parecoxib,1,1
120329,on,0,0
120330,morphine,1,1
120331,dosage,0,0
120332,in,0,0
120333,postoperative,0,0
120334,patient-controlled,1,1
120335,analgesia,1,1
120336,following,0,0
120337,thoracoscope-assisted,1,1
120338,thoracotomy,1,1
120339,],1,0
120340,.,0,0
120341,OBJECTIVE,0,0
120342,To,0,0
120343,observe,0,0
120344,the,0,0
120345,effect,0,0
120346,of,0,0
120347,parecoxib,1,1
120348,on,0,0
120349,morphine,0,1
120350,dosage,0,0
120351,in,0,0
120352,patient-controlled,1,1
120353,analgesia,1,1
120354,(,1,1
120355,PCA,1,1
120356,),1,1
120357,following,0,0
120358,thoracoscope-assisted,1,1
120359,thoracotomy,1,1
120360,.,1,0
120361,METHODS,0,0
120362,A,0,0
120363,consecutive,0,0
120364,series,0,0
120365,of,0,0
120366,100,0,0
120367,patients,0,0
120368,undergoing,0,0
120369,thoracoscope-assisted,1,1
120370,thoracotomy,1,1
120371,were,0,0
120372,randomized,0,0
120373,into,0,0
120374,5,0,0
120375,groups,0,0
120376,and,0,0
120377,received,0,0
120378,PCA,1,1
120379,with,1,0
120380,morphine,1,1
120381,doses,0,0
120382,at,0,0
120383,0,0,0
120384,",",0,0
120385,5,0,0
120386,",",0,0
120387,10,0,0
120388,",",0,0
120389,15,0,0
120390,",",0,0
120391,and,0,0
120392,20,0,0
120393,mg,0,1
120394,given,0,0
120395,in,0,0
120396,200,0,1
120397,ml,0,1
120398,saline,1,1
120399,(,0,0
120400,groups,0,0
120401,P,0,0
120402,(,0,0
120403,1,0,0
120404,),0,0
120405,",",0,0
120406,P,0,0
120407,(,0,1
120408,2,0,0
120409,),0,0
120410,",",0,0
120411,P,0,0
120412,(,0,1
120413,3,0,0
120414,),0,0
120415,",",0,0
120416,P,0,0
120417,(,0,1
120418,4,0,0
120419,),0,0
120420,",",0,0
120421,and,0,0
120422,P,0,0
120423,(,0,1
120424,5,0,1
120425,),0,0
120426,",",0,0
120427,respectively,0,0
120428,),0,0
120429,.,0,1
120430,Parecoxib,1,1
120431,(,0,0
120432,40,0,1
120433,mg,0,1
120434,),0,0
120435,was,0,0
120436,given,0,0
120437,in,0,0
120438,all,0,0
120439,the,0,0
120440,patients,0,0
120441,immediately,0,0
120442,before,0,0
120443,the,0,0
120444,operation,0,0
120445,",",0,0
120446,and,0,0
120447,the,0,0
120448,mixture,0,1
120449,(,1,0
120450,4-5,1,1
120451,ml,1,1
120452,),1,1
120453,of,1,0
120454,lidocaine,1,1
120455,and,1,0
120456,ropivacaine,1,1
120457,was,0,0
120458,administered,0,0
120459,into,0,0
120460,the,0,0
120461,3,0,0
120462,intercostal,0,0
120463,spaces,0,1
120464,upper,0,0
120465,and,0,0
120466,lower,0,0
120467,to,0,0
120468,the,0,0
120469,incision,0,1
120470,before,0,0
120471,chest,0,1
120472,closure,0,0
120473,.,0,0
120474,PCA,1,0
120475,was,0,0
120476,administered,0,0
120477,for,0,0
120478,each,0,0
120479,patient,0,0
120480,.,0,0
120481,The,0,0
120482,visual,0,0
120483,analogue,0,1
120484,scale,0,0
120485,(,0,1
120486,VAS,0,1
120487,),0,1
120488,at,0,0
120489,rest,0,0
120490,and,0,0
120491,coughing,0,0
120492,and,0,0
120493,the,0,0
120494,respiratory,0,0
120495,functional,0,0
120496,parameters,0,0
120497,were,0,0
120498,recorded,0,0
120499,at,0,0
120500,1,0,0
120501,",",0,0
120502,2,0,0
120503,",",0,0
120504,4,0,0
120505,",",0,0
120506,8,0,0
120507,",",0,0
120508,12,0,0
120509,",",0,0
120510,24,0,0
120511,",",0,0
120512,36,0,0
120513,",",0,0
120514,and,0,0
120515,48,0,0
120516,h,0,0
120517,after,0,0
120518,the,0,0
120519,start,0,0
120520,of,0,0
120521,PCA,1,1
120522,",",0,0
120523,and,0,0
120524,the,0,0
120525,actual,0,0
120526,and,0,0
120527,effective,0,0
120528,button-pressing,0,1
120529,times,0,0
120530,(,0,0
120531,D,0,1
120532,(,0,1
120533,1,0,0
120534,),0,1
120535,/D,0,1
120536,(,0,1
120537,2,0,1
120538,),0,0
120539,),0,0
120540,in,0,0
120541,PCA,1,1
120542,were,0,0
120543,also,0,0
120544,recorded,0,0
120545,.,0,0
120546,RESULTS,0,0
120547,No,0,0
120548,patients,0,0
120549,showed,0,0
120550,signs,0,0
120551,of,0,0
120552,respiratory,0,0
120553,inhibition,0,0
120554,within,0,0
120555,24,0,0
120556,h,0,0
120557,after,0,0
120558,the,0,0
120559,operation,0,0
120560,",",0,0
120561,and,0,0
120562,the,0,0
120563,resting,0,0
120564,VAS,0,1
120565,was,0,0
120566,comparable,0,0
120567,between,0,0
120568,the,0,0
120569,groups,0,0
120570,within,0,0
120571,the,0,0
120572,initial,0,0
120573,6,0,0
120574,postoperative,0,0
120575,hours,0,0
120576,.,0,0
120577,At,0,0
120578,8,0,0
120579,to,0,0
120580,24,0,0
120581,h,0,0
120582,postoperatively,0,0
120583,",",0,0
120584,the,0,0
120585,VAS,0,1
120586,scores,0,0
120587,at,0,0
120588,rest,0,0
120589,and,0,0
120590,coughing,0,0
120591,were,0,0
120592,significantly,0,0
120593,higher,0,0
120594,in,0,0
120595,P,0,0
120596,(,0,1
120597,1,0,0
120598,),0,0
120599,group,0,0
120600,than,0,0
120601,in,0,0
120602,the,0,0
120603,other,0,0
120604,groups,0,0
120605,(,0,0
120606,P,0,0
120607,<,0,0
120608,0.05,0,0
120609,),0,0
120610,",",0,0
120611,and,0,0
120612,no,0,0
120613,significant,0,0
120614,differences,0,0
120615,were,0,0
120616,found,0,0
120617,between,0,0
120618,the,0,0
120619,groups,0,0
120620,at,0,0
120621,36,0,0
120622,to,0,0
120623,48,0,0
120624,h.,0,0
120625,D,0,1
120626,(,0,1
120627,1,0,0
120628,),0,1
120629,/D,0,1
120630,(,0,1
120631,2,0,0
120632,),0,0
120633,in,0,0
120634,groups,0,0
120635,P,0,0
120636,(,0,0
120637,1,0,0
120638,),0,0
120639,and,0,0
120640,P,0,0
120641,(,0,1
120642,2,0,0
120643,),0,0
120644,were,0,0
120645,significantly,0,0
120646,different,0,0
120647,from,0,0
120648,those,0,0
120649,in,0,0
120650,the,0,0
120651,other,0,0
120652,3,0,0
120653,groups,0,0
120654,at,0,0
120655,4-24,0,0
120656,h,0,0
120657,",",0,0
120658,but,0,0
120659,no,0,0
120660,such,0,0
120661,difference,0,0
120662,was,0,0
120663,found,0,0
120664,between,0,0
120665,groups,0,0
120666,P,0,0
120667,(,0,0
120668,3,0,0
120669,),0,0
120670,",",0,0
120671,P,0,0
120672,(,0,1
120673,4,0,0
120674,),0,0
120675,",",0,0
120676,and,0,0
120677,P,0,0
120678,(,0,1
120679,5,0,0
120680,),0,0
120681,.,0,0
120682,CONCLUSION,0,0
120683,The,0,0
120684,application,0,0
120685,of,0,0
120686,parecoxib,1,1
120687,may,0,0
120688,reduce,0,0
120689,the,0,0
120690,dosage,0,0
120691,of,0,0
120692,morphine,1,1
120693,in,0,0
120694,PCA,1,1
120695,following,0,0
120696,thoracoscope-assisted,0,1
120697,thoracotomy,0,1
120698,and,0,0
120699,results,0,0
120700,in,0,0
120701,good,0,0
120702,analgesic,0,1
120703,effect,0,0
120704,without,0,1
120705,affecting,0,0
120706,the,0,0
120707,patients,0,0
120708,respiratory,0,0
120709,function,0,0
120710,and,0,0
120711,sputum,0,0
120712,elimination,0,0
120713,.,0,0
120714,Role,0,0
120715,of,0,0
120716,oxidized,1,0
120717,regenerated,1,0
120718,cellulose,1,1
120719,in,0,0
120720,preventing,0,0
120721,infections,0,0
120722,at,0,0
120723,the,0,0
120724,surgical,0,1
120725,site,0,0
120726,:,0,0
120727,prospective,0,0
120728,",",0,0
120729,randomized,0,0
120730,study,0,0
120731,in,0,0
120732,98,0,0
120733,patients,0,0
120734,affected,0,0
120735,by,0,0
120736,a,0,0
120737,dirty,0,0
120738,wound,0,0
120739,.,0,0
120740,AIM,0,0
120741,The,0,0
120742,aim,0,0
120743,of,0,0
120744,this,0,0
120745,study,0,0
120746,was,0,0
120747,to,0,0
120748,evaluate,0,0
120749,whether,0,0
120750,oxidized,1,0
120751,regenerated,1,0
120752,cellulose,1,1
120753,(,1,1
120754,ORC,1,0
120755,),1,0
120756,",",0,0
120757,applied,0,0
120758,to,0,0
120759,dirty,0,0
120760,surgical,0,0
120761,wounds,0,0
120762,",",0,0
120763,is,0,0
120764,able,0,0
120765,to,0,0
120766,reduce,0,0
120767,the,0,0
120768,microbial,0,0
120769,load,0,0
120770,and,0,0
120771,",",0,0
120772,consequently,0,0
120773,",",0,0
120774,the,0,0
120775,infection,0,0
120776,rate,0,0
120777,as,0,0
120778,compared,0,0
120779,to,0,0
120780,conventional,0,1
120781,local,0,1
120782,wound,0,0
120783,treatment,0,0
120784,.,0,0
120785,METHODS,0,0
120786,The,0,0
120787,study,0,0
120788,included,0,0
120789,98,0,0
120790,patients,0,0
120791,who,0,0
120792,underwent,0,0
120793,intestinal,0,0
120794,recanalization,0,0
120795,procedures,0,0
120796,between,0,0
120797,December,0,0
120798,2003,0,0
120799,and,0,0
120800,December,0,0
120801,2008,0,0
120802,",",0,0
120803,with,0,0
120804,the,0,0
120805,stoma,0,0
120806,as,0,0
120807,the,0,0
120808,surgical,0,0
120809,site,0,0
120810,.,0,0
120811,Authors,0,0
120812,considered,0,0
120813,several,0,0
120814,risk,0,0
120815,factors,0,0
120816,for,0,0
120817,SSI,0,0
120818,.,0,0
120819,The,0,0
120820,patients,0,0
120821,were,0,0
120822,divided,0,0
120823,into,0,0
120824,two,0,0
120825,groups,0,0
120826,.,0,0
120827,In,0,0
120828,group,0,0
120829,A,0,0
120830,(,0,0
120831,50,0,1
120832,patients,0,0
120833,),0,0
120834,",",0,0
120835,the,0,0
120836,surgical,0,1
120837,wound,0,0
120838,",",0,0
120839,previous,0,0
120840,site,0,0
120841,of,0,0
120842,the,0,0
120843,stoma,0,0
120844,",",0,0
120845,was,0,0
120846,packed,1,0
120847,with,1,0
120848,ORC,1,0
120849,",",0,0
120850,whereas,0,0
120851,in,0,0
120852,group,0,0
120853,B,0,1
120854,(,0,0
120855,48,0,0
120856,patients,0,0
120857,),0,0
120858,gauze,1,1
120859,soaked,1,1
120860,in,1,0
120861,iodine,1,1
120862,was,0,0
120863,used,0,0
120864,.,0,0
120865,Microbial,0,0
120866,contamination,0,0
120867,was,0,0
120868,evaluated,0,0
120869,with,0,0
120870,three,0,0
120871,swabs,0,0
120872,(,0,0
120873,in,0,0
120874,subcutaneous,0,1
120875,tissue,0,0
120876,and,0,0
120877,the,0,0
120878,dermis,0,0
120879,),0,0
120880,",",0,0
120881,in,0,0
120882,the,0,0
120883,operating,0,0
120884,room,0,1
120885,before,0,0
120886,wound,0,0
120887,packing,0,1
120888,and,0,0
120889,on,0,0
120890,the,0,0
120891,2nd,0,0
120892,and,0,0
120893,3rd,0,0
120894,postoperative,0,0
120895,day,0,1
120896,(,0,0
120897,before,0,0
120898,suturing,0,1
120899,the,0,0
120900,skin,0,0
120901,),0,0
120902,.,0,0
120903,RESULTS,0,0
120904,There,0,0
120905,were,0,0
120906,no,0,0
120907,cases,0,0
120908,of,0,0
120909,wound,0,0
120910,dehiscence,0,0
120911,and,0,0
120912,no,0,0
120913,clinically,0,0
120914,evident,0,0
120915,superficial,0,1
120916,or,0,1
120917,deep,0,1
120918,surgical,0,1
120919,site,0,0
120920,infections,0,0
120921,in,0,0
120922,either,0,0
120923,group,0,0
120924,.,0,0
120925,Analysis,0,0
120926,of,0,0
120927,all,0,0
120928,data,0,0
120929,revealed,0,0
120930,that,0,0
120931,there,0,0
120932,was,0,0
120933,no,0,0
120934,or,0,1
120935,reduced,0,0
120936,bacterial,0,0
120937,contamination,0,0
120938,in,0,0
120939,the,0,0
120940,second,0,0
120941,and,0,0
120942,third,0,0
120943,swab,0,1
120944,in,0,0
120945,33,0,0
120946,patients,0,0
120947,(,0,0
120948,66,0,0
120949,%,0,0
120950,),0,0
120951,of,0,0
120952,Group,0,0
120953,A,0,0
120954,versus,0,1
120955,12,0,0
120956,patients,0,0
120957,(,0,0
120958,25,0,0
120959,%,0,0
120960,),0,0
120961,of,0,0
120962,Group,0,0
120963,B,0,0
120964,.,0,0
120965,CONCLUSION,0,0
120966,Although,0,0
120967,it,0,0
120968,is,0,0
120969,necessary,0,0
120970,to,0,0
120971,consider,0,0
120972,all,0,0
120973,factors,0,0
120974,which,0,0
120975,can,0,0
120976,have,0,0
120977,an,0,0
120978,influence,0,0
120979,on,0,0
120980,SSI,0,1
120981,and,0,0
120982,use,0,0
120983,all,0,0
120984,the,0,0
120985,means,0,0
120986,shown,0,0
120987,to,0,0
120988,be,0,0
120989,effective,0,0
120990,to,0,0
120991,reduce,0,0
120992,the,0,0
120993,risk,0,0
120994,of,0,0
120995,SSI,0,1
120996,",",0,0
120997,there,0,0
120998,is,0,0
120999,a,0,0
121000,rationale,0,0
121001,for,0,0
121002,using,0,0
121003,ORC,1,0
121004,to,0,0
121005,prevent,0,0
121006,this,0,0
121007,kind,0,0
121008,of,0,0
121009,infection,0,0
121010,",",0,0
121011,especially,0,0
121012,in,0,0
121013,patients,0,0
121014,who,0,0
121015,undergo,0,0
121016,dirty,0,0
121017,surgery,0,0
121018,.,0,0
121019,Distinct,0,0
121020,fast,0,1
121021,and,0,0
121022,slow,0,0
121023,processes,0,0
121024,contribute,0,0
121025,to,0,0
121026,the,0,0
121027,selection,0,0
121028,of,0,0
121029,preferred,0,0
121030,step,0,0
121031,frequency,0,0
121032,during,0,0
121033,human,0,0
121034,walking,0,1
121035,.,0,0
121036,Humans,0,0
121037,spontaneously,0,0
121038,select,0,0
121039,a,0,0
121040,step,0,0
121041,frequency,0,0
121042,that,0,0
121043,minimizes,0,0
121044,the,0,0
121045,energy,0,0
121046,expenditure,0,0
121047,of,0,0
121048,walking,0,1
121049,.,0,0
121050,This,0,0
121051,selection,0,0
121052,might,0,0
121053,be,0,0
121054,embedded,0,0
121055,within,0,0
121056,the,0,0
121057,neural,0,0
121058,circuits,0,1
121059,that,0,0
121060,generate,0,0
121061,gait,0,0
121062,so,0,0
121063,that,0,0
121064,the,0,0
121065,optimum,0,0
121066,is,0,0
121067,pre-programmed,0,0
121068,for,0,0
121069,a,0,0
121070,given,0,0
121071,walking,0,1
121072,speed,0,0
121073,.,0,0
121074,Or,0,0
121075,perhaps,0,0
121076,step,0,0
121077,frequency,0,0
121078,is,0,0
121079,directly,0,0
121080,optimized,0,0
121081,",",0,0
121082,based,0,0
121083,on,0,0
121084,sensed,0,0
121085,feedback,0,1
121086,of,0,0
121087,energy,0,0
121088,expenditure,0,0
121089,.,0,0
121090,Direct,0,0
121091,optimization,0,0
121092,is,0,0
121093,expected,0,0
121094,to,0,0
121095,be,0,0
121096,slow,0,0
121097,due,0,0
121098,to,0,0
121099,the,0,0
121100,compounded,0,1
121101,effect,0,0
121102,of,0,0
121103,delays,0,0
121104,and,0,0
121105,iteration,0,1
121106,",",0,0
121107,whereas,0,0
121108,a,0,0
121109,pre-programmed,0,0
121110,mechanism,0,0
121111,presumably,0,0
121112,allows,0,0
121113,for,0,0
121114,faster,0,0
121115,step,0,0
121116,frequency,0,0
121117,selection,0,0
121118,",",0,0
121119,albeit,0,0
121120,dependent,0,0
121121,on,0,0
121122,prior,0,0
121123,experience,0,0
121124,.,0,0
121125,To,0,0
121126,test,0,0
121127,for,0,0
121128,both,0,0
121129,pre-programmed,0,1
121130,selection,0,0
121131,and,0,0
121132,direct,0,1
121133,optimization,0,0
121134,",",0,0
121135,we,0,0
121136,applied,0,0
121137,perturbations,1,0
121138,to,1,0
121139,treadmill,1,1
121140,walking,1,1
121141,to,0,0
121142,elicit,0,0
121143,transient,0,0
121144,changes,0,0
121145,in,0,0
121146,step,1,0
121147,frequency,1,0
121148,.,1,0
121149,We,0,0
121150,found,0,0
121151,that,0,0
121152,human,0,1
121153,step,0,0
121154,frequency,0,0
121155,adjustments,0,0
121156,(,0,0
121157,n,0,0
121158,=,0,0
121159,7,0,0
121160,),0,0
121161,occurred,0,0
121162,with,0,0
121163,two,0,0
121164,components,0,0
121165,",",0,0
121166,the,0,0
121167,first,0,0
121168,dominating,0,0
121169,the,0,0
121170,response,0,0
121171,(,0,0
121172,66,0,0
121173,?,0,0
121174,10,0,0
121175,%,0,0
121176,of,0,0
121177,total,0,0
121178,amplitude,0,0
121179,change,0,0
121180,;,0,0
121181,mean,0,0
121182,?,0,0
121183,SD,0,0
121184,),0,0
121185,and,0,0
121186,occurring,0,0
121187,quite,0,0
121188,quickly,0,0
121189,(,0,0
121190,1.44,0,0
121191,?,0,0
121192,1.14,0,0
121193,s,0,0
121194,to,0,0
121195,complete,0,0
121196,95,0,0
121197,%,0,0
121198,of,0,0
121199,total,0,0
121200,change,0,0
121201,),0,0
121202,.,0,0
121203,The,0,0
121204,other,0,0
121205,component,0,0
121206,was,0,0
121207,of,0,0
121208,smaller,0,0
121209,amplitude,0,0
121210,(,0,0
121211,35,0,0
121212,?,0,0
121213,10,0,0
121214,%,0,0
121215,of,0,0
121216,total,0,0
121217,change,0,0
121218,),0,1
121219,and,0,0
121220,took,0,0
121221,tens,0,1
121222,of,0,0
121223,seconds,0,0
121224,(,0,0
121225,27.56,0,0
121226,?,0,0
121227,16.18,0,0
121228,s,0,0
121229,for,0,0
121230,95,0,0
121231,%,0,0
121232,completion,0,0
121233,),0,0
121234,.,0,0
121235,The,0,0
121236,fast,0,0
121237,process,0,0
121238,appeared,0,0
121239,to,0,0
121240,be,0,0
121241,too,0,0
121242,fast,0,0
121243,for,0,0
121244,direct,0,1
121245,optimization,0,0
121246,and,0,0
121247,more,0,0
121248,indicative,0,0
121249,of,0,0
121250,a,0,0
121251,pre-programmed,0,0
121252,response,0,0
121253,.,0,0
121254,It,0,0
121255,also,0,0
121256,persisted,0,0
121257,even,0,0
121258,with,0,0
121259,unusual,1,0
121260,closed-loop,1,1
121261,perturbations,1,0
121262,that,1,0
121263,conflicted,0,0
121264,with,0,0
121265,prior,0,0
121266,experience,0,0
121267,and,0,0
121268,rendered,0,0
121269,the,0,0
121270,response,0,0
121271,energetically,0,0
121272,suboptimal,0,0
121273,.,0,0
121274,The,0,0
121275,slow,0,0
121276,process,0,0
121277,was,0,0
121278,more,0,0
121279,consistent,0,0
121280,with,0,0
121281,the,0,0
121282,timing,0,0
121283,expected,0,0
121284,for,0,0
121285,direct,0,0
121286,optimization,0,0
121287,.,0,0
121288,Our,0,0
121289,interpretation,0,0
121290,of,0,0
121291,these,0,0
121292,results,0,0
121293,is,0,0
121294,that,0,0
121295,humans,0,0
121296,may,0,0
121297,rely,0,0
121298,heavily,0,0
121299,on,0,0
121300,pre-programmed,0,0
121301,gaits,0,0
121302,to,0,0
121303,rapidly,0,0
121304,select,0,0
121305,their,0,0
121306,preferred,0,0
121307,step,0,0
121308,frequency,0,0
121309,and,0,0
121310,then,0,1
121311,gradually,0,0
121312,fine-tune,0,0
121313,that,0,0
121314,selection,0,0
121315,with,0,0
121316,direct,0,0
121317,optimization,0,0
121318,.,0,0
121319,Correlation,0,0
121320,of,0,0
121321,adenosinergic,0,0
121322,activity,0,0
121323,with,0,0
121324,superior,0,0
121325,efficacy,0,0
121326,of,0,0
121327,clozapine,1,1
121328,for,0,0
121329,treatment,0,0
121330,of,0,0
121331,chronic,0,0
121332,schizophrenia,0,0
121333,:,0,0
121334,a,0,0
121335,double,0,1
121336,blind,0,0
121337,randomised,0,0
121338,trial,0,0
121339,.,0,0
121340,OBJECTIVE,0,0
121341,It,0,0
121342,has,0,0
121343,been,0,0
121344,proposed,0,0
121345,that,0,0
121346,a,0,0
121347,deficit,0,0
121348,of,0,0
121349,adenosinergic,0,0
121350,activity,0,0
121351,could,0,0
121352,contribute,0,0
121353,to,0,0
121354,the,0,0
121355,pathophysiology,0,0
121356,of,0,0
121357,schizophrenia,0,0
121358,.,0,0
121359,The,0,0
121360,authors,0,0
121361,undertook,0,0
121362,this,0,0
121363,study,0,0
121364,to,0,0
121365,further,0,0
121366,evaluate,0,0
121367,the,0,0
121368,level,0,0
121369,of,0,0
121370,adenosine,0,1
121371,deaminase,0,1
121372,(,0,1
121373,ADA,0,1
121374,),0,1
121375,in,0,0
121376,patients,0,0
121377,with,0,0
121378,chronic,0,0
121379,schizophrenia,0,0
121380,treated,0,0
121381,with,0,0
121382,monotherapy,1,1
121383,of,1,0
121384,haloperidol,1,1
121385,",",1,0
121386,risperidone,1,1
121387,or,1,1
121388,clozapine,1,1
121389,and,0,0
121390,correlation,0,0
121391,between,0,0
121392,the,0,0
121393,ADA,0,1
121394,level,0,0
121395,with,0,0
121396,response,0,0
121397,to,0,0
121398,treatment,0,0
121399,.,0,0
121400,METHODS,0,0
121401,The,0,0
121402,trial,0,0
121403,was,0,0
121404,a,0,0
121405,prospective,0,0
121406,",",0,0
121407,8-week,0,0
121408,",",0,0
121409,double,0,1
121410,blind,0,0
121411,study,0,0
121412,of,0,0
121413,parallel,0,0
121414,groups,0,0
121415,of,0,0
121416,patients,0,0
121417,with,0,0
121418,chronic,0,0
121419,schizophrenia,0,0
121420,.,0,0
121421,Eligible,0,0
121422,participants,0,0
121423,in,0,0
121424,the,0,0
121425,study,0,0
121426,were,0,0
121427,51,0,0
121428,patients,0,0
121429,with,0,0
121430,chronic,0,0
121431,schizophrenia,0,0
121432,with,0,0
121433,ages,0,0
121434,ranging,0,0
121435,from,0,0
121436,20,0,0
121437,to,0,0
121438,45,0,0
121439,years,0,0
121440,.,0,0
121441,All,0,0
121442,participants,0,0
121443,were,0,0
121444,inpatients,0,0
121445,",",0,0
121446,in,0,0
121447,the,0,0
121448,active,0,1
121449,phase,0,0
121450,of,0,0
121451,illness,0,0
121452,",",0,0
121453,and,0,0
121454,met,0,0
121455,DSM-IV-TR,0,0
121456,criteria,0,0
121457,for,0,0
121458,schizophrenia,0,0
121459,.,0,0
121460,Patients,0,0
121461,were,0,0
121462,randomly,0,0
121463,allocated,0,0
121464,(,0,0
121465,17,0,0
121466,patients,0,0
121467,in,0,0
121468,each,0,0
121469,group,0,0
121470,),0,0
121471,to,0,0
121472,risperidone,1,1
121473,(,0,0
121474,6,0,1
121475,mg/day,0,1
121476,),0,0
121477,or,0,1
121478,haloperidol,1,1
121479,15,0,0
121480,mg/day,0,1
121481,or,0,1
121482,clozapine,1,1
121483,(,0,1
121484,300,0,1
121485,mg/day,0,1
121486,),0,0
121487,.,0,0
121488,Serum,0,0
121489,ADA,0,1
121490,activity,0,0
121491,was,0,0
121492,measured,0,0
121493,at,0,0
121494,baseline,0,0
121495,and,0,0
121496,week,0,0
121497,8,0,0
121498,.,0,0
121499,RESULTS,0,0
121500,The,0,0
121501,plasma,0,0
121502,levels,0,0
121503,of,0,0
121504,ADA,0,0
121505,in,0,0
121506,patients,0,0
121507,with,0,0
121508,chronic,0,0
121509,schizophrenia,0,0
121510,who,0,0
121511,received,0,0
121512,clozapine,1,1
121513,were,0,0
121514,significantly,0,0
121515,higher,0,0
121516,than,0,0
121517,patients,0,0
121518,who,0,0
121519,received,0,0
121520,haloperidol,0,1
121521,.,0,0
121522,In,0,0
121523,addition,0,0
121524,",",0,0
121525,response,0,0
121526,to,0,0
121527,treatment,0,0
121528,was,0,0
121529,positively,0,0
121530,correlated,0,0
121531,with,0,0
121532,plasma,0,0
121533,levels,0,0
121534,of,0,0
121535,ADA,0,0
121536,only,0,0
121537,in,0,0
121538,the,0,0
121539,clozapine,1,1
121540,group,0,1
121541,(,0,1
121542,r,0,0
121543,=,0,0
121544,0.46,0,0
121545,and,0,0
121546,p,0,0
121547,=,0,0
121548,0.04,0,0
121549,),0,0
121550,.,0,0
121551,CONCLUSION,0,0
121552,The,0,0
121553,results,0,0
121554,indicate,0,0
121555,an,0,0
121556,increased,0,0
121557,activity,0,0
121558,of,0,0
121559,the,0,0
121560,enzyme,0,0
121561,ADA,0,1
121562,in,0,0
121563,the,0,0
121564,serum,0,0
121565,of,0,0
121566,schizophrenic,0,0
121567,patients,0,0
121568,being,0,0
121569,treated,0,0
121570,with,1,0
121571,clozapine,1,1
121572,and,1,0
121573,this,1,0
121574,increase,0,0
121575,may,0,0
121576,be,0,0
121577,correlated,1,0
121578,with,1,0
121579,clozapine,1,1
121580,'s,1,0
121581,superior,1,0
121582,antipsychotic,0,1
121583,efficacy,0,0
121584,.,0,0
121585,Evaluation,0,0
121586,of,0,0
121587,a,0,0
121588,preventive,1,0
121589,intervention,1,1
121590,for,0,0
121591,child,0,0
121592,anxiety,0,0
121593,in,0,0
121594,two,0,0
121595,randomized,0,0
121596,attention-control,0,1
121597,school,0,0
121598,trials,0,0
121599,.,0,0
121600,The,0,0
121601,present,0,0
121602,research,0,0
121603,examined,0,0
121604,the,0,0
121605,effectiveness,0,0
121606,of,0,0
121607,a,0,0
121608,cognitive-behavioral,1,1
121609,therapy,1,1
121610,(,1,1
121611,CBT,1,1
121612,),1,1
121613,based,1,0
121614,intervention,1,1
121615,program,1,1
121616,",",1,0
121617,FRIENDS,1,0
121618,",",0,0
121619,for,0,0
121620,children,0,0
121621,from,0,0
121622,grades,0,0
121623,4,0,0
121624,to,0,0
121625,6,0,0
121626,",",0,0
121627,using,0,0
121628,random,0,0
121629,assignment,0,0
121630,at,0,0
121631,the,0,0
121632,school-level,0,0
121633,and,0,0
121634,an,0,0
121635,attention-control,0,1
121636,design,0,0
121637,in,0,0
121638,two,0,0
121639,longitudinal,0,0
121640,studies,0,0
121641,.,0,0
121642,The,0,0
121643,first,0,0
121644,study,0,0
121645,targeted,0,1
121646,children,0,0
121647,with,0,0
121648,anxiety,0,0
121649,symptoms,0,0
121650,(,0,0
121651,N=191,0,0
121652,",",0,0
121653,mean,0,0
121654,age=10.1,0,0
121655,),0,0
121656,as,0,0
121657,screened,0,0
121658,with,0,0
121659,self,0,0
121660,",",0,0
121661,parent,0,1
121662,",",0,0
121663,and,0,0
121664,teacher-reports,0,0
121665,;,0,0
121666,the,0,0
121667,second,0,0
121668,study,0,0
121669,took,0,0
121670,a,0,0
121671,universal,0,0
121672,approach,0,1
121673,with,0,0
121674,full,0,0
121675,classrooms,0,1
121676,of,0,0
121677,children,0,0
121678,participating,0,0
121679,(,0,0
121680,N=253,0,0
121681,",",0,0
121682,mean,0,0
121683,age=9.8,0,0
121684,),0,0
121685,.,0,0
121686,The,0,0
121687,results,0,0
121688,showed,0,0
121689,no,0,0
121690,intervention,0,1
121691,effect,0,0
121692,in,0,0
121693,both,0,0
121694,studies,0,0
121695,",",0,0
121696,with,0,0
121697,children,0,0
121698,'s,0,0
121699,anxiety,0,0
121700,symptoms,0,0
121701,decreasing,0,0
121702,over,0,0
121703,time,0,0
121704,regardless,0,0
121705,of,0,0
121706,whether,0,0
121707,they,0,0
121708,were,0,0
121709,in,0,0
121710,the,1,0
121711,story-reading,1,1
121712,(,0,1
121713,attention,0,1
121714,control,0,1
121715,),0,1
121716,or,1,1
121717,FRIENDS,1,0
121718,condition,0,0
121719,.,0,0
121720,The,0,0
121721,findings,0,0
121722,also,0,0
121723,indicated,0,0
121724,that,0,0
121725,girls,0,0
121726,reported,0,0
121727,a,0,0
121728,higher,0,0
121729,level,0,0
121730,of,0,0
121731,anxiety,0,0
121732,than,0,0
121733,boys,0,0
121734,and,0,0
121735,children,0,0
121736,in,0,0
121737,higher,0,0
121738,grades,0,0
121739,reported,0,0
121740,lower,0,0
121741,anxiety,0,0
121742,relative,0,0
121743,to,0,0
121744,younger,0,0
121745,children,0,0
121746,in,0,0
121747,both,0,0
121748,studies,0,0
121749,.,0,0
121750,In,0,0
121751,addition,0,0
121752,",",0,0
121753,similar,0,0
121754,patterns,0,0
121755,were,0,0
121756,found,0,0
121757,using,0,0
121758,a,0,0
121759,subgroup,0,0
121760,of,0,0
121761,children,0,0
121762,with,0,0
121763,high-anxiety,0,0
121764,symptoms,0,0
121765,from,0,0
121766,both,0,0
121767,studies,0,0
121768,.,0,0
121769,Improving,0,0
121770,emotion,0,0
121771,regulation,0,0
121772,with,0,0
121773,CBT,1,1
121774,in,0,0
121775,young,0,0
121776,children,0,0
121777,with,0,0
121778,high,0,0
121779,functioning,0,0
121780,autism,0,0
121781,spectrum,0,0
121782,disorders,0,0
121783,:,0,0
121784,a,0,0
121785,pilot,0,0
121786,study,0,0
121787,.,0,0
121788,BACKGROUND,0,0
121789,AND,0,0
121790,AIMS,0,1
121791,This,0,0
121792,pilot,0,0
121793,study,0,0
121794,tested,0,0
121795,the,0,0
121796,efficacy,0,0
121797,of,0,0
121798,a,0,0
121799,developmentally,0,0
121800,modified,0,0
121801,CBT,1,1
121802,for,0,0
121803,young,0,0
121804,children,0,0
121805,with,0,0
121806,Autism,0,0
121807,Spectrum,0,1
121808,Disorders,0,0
121809,(,0,1
121810,ASD,0,0
121811,),0,1
121812,to,0,0
121813,teach,0,1
121814,emotion,0,0
121815,regulation,0,0
121816,strategies,0,0
121817,for,0,0
121818,reducing,0,0
121819,anger,0,0
121820,and,0,0
121821,anxiety,0,0
121822,",",0,0
121823,commonly,0,0
121824,noted,0,0
121825,problems,0,0
121826,in,0,0
121827,this,0,0
121828,population,0,0
121829,.,0,0
121830,METHOD,0,0
121831,Eleven,0,1
121832,5-7,0,1
121833,year-old,0,0
121834,children,0,0
121835,participated,0,0
121836,in,0,0
121837,a,0,0
121838,CBT-group,1,0
121839,while,0,0
121840,parents,0,0
121841,participated,1,0
121842,in,1,0
121843,psychoeducation,1,1
121844,.,1,0
121845,Children,1,0
121846,were,1,0
121847,randomly,1,0
121848,assigned,1,0
121849,to,1,0
121850,an,1,0
121851,experimental,1,0
121852,or,1,1
121853,delayed-treatment,1,1
121854,control,1,1
121855,group,1,0
121856,.,1,0
121857,RESULTS,0,0
121858,From,0,0
121859,pre-,0,0
121860,to,0,0
121861,post-treatment,0,0
121862,",",0,0
121863,all,0,0
121864,children,0,0
121865,had,0,0
121866,less,0,0
121867,parent,0,1
121868,reported,0,0
121869,negativity/lability,0,0
121870,",",0,0
121871,better,0,0
121872,parent,0,1
121873,reported,0,0
121874,emotion,0,0
121875,regulation,0,0
121876,",",0,0
121877,and,0,0
121878,shorter,0,0
121879,outbursts,0,0
121880,",",0,0
121881,and,0,0
121882,also,0,0
121883,generated,0,0
121884,more,0,0
121885,coping,0,0
121886,strategies,0,0
121887,in,0,0
121888,response,0,0
121889,to,0,0
121890,vignettes,0,0
121891,.,0,0
121892,Parents,0,0
121893,also,0,0
121894,reported,0,0
121895,increases,0,0
121896,in,0,0
121897,their,0,0
121898,own,0,0
121899,confidence,0,0
121900,and,0,0
121901,their,0,0
121902,child,0,0
121903,'s,0,0
121904,ability,0,0
121905,to,0,0
121906,deal,0,0
121907,with,0,0
121908,anger,0,0
121909,and,0,0
121910,anxiety,0,0
121911,.,0,0
121912,CONCLUSIONS,0,0
121913,This,0,0
121914,study,0,0
121915,suggests,0,0
121916,that,0,0
121917,young,0,0
121918,children,0,0
121919,with,0,0
121920,high,0,0
121921,functioning,0,0
121922,ASD,0,0
121923,may,0,0
121924,benefit,0,0
121925,from,0,0
121926,CBT,1,1
121927,to,0,0
121928,improve,0,0
121929,regulation,0,0
121930,of,0,0
121931,anger,0,0
121932,and,0,0
121933,anxiety,0,0
121934,",",0,0
121935,and,0,0
121936,parent,0,1
121937,training,0,1
121938,may,0,0
121939,improve,0,0
121940,parental,0,0
121941,self-efficacy,0,0
121942,.,0,0
121943,Future,0,0
121944,studies,0,0
121945,are,0,0
121946,needed,0,0
121947,to,0,0
121948,make,0,0
121949,conclusions,0,0
121950,about,0,0
121951,its,0,0
121952,efficacy,0,0
121953,.,0,0
121954,Influence,0,0
121955,of,0,0
121956,two,0,0
121957,different,0,0
121958,flap,0,1
121959,designs,0,0
121960,on,0,0
121961,the,0,0
121962,sequelae,0,0
121963,of,0,0
121964,mandibular,0,0
121965,third,0,0
121966,molar,0,0
121967,surgery,0,0
121968,.,0,0
121969,PURPOSE,0,0
121970,The,0,0
121971,aim,0,0
121972,of,0,0
121973,this,0,0
121974,study,0,0
121975,was,0,0
121976,to,0,0
121977,compare,0,0
121978,the,0,0
121979,influence,0,0
121980,of,0,0
121981,triangular,0,1
121982,and,0,0
121983,envelope,0,1
121984,flaps,0,1
121985,on,0,0
121986,trismus,0,0
121987,",",0,0
121988,pain,0,0
121989,",",0,0
121990,and,0,0
121991,facial,0,1
121992,swelling,0,0
121993,after,0,0
121994,mandibular,0,0
121995,third,0,0
121996,molar,0,0
121997,surgery,0,0
121998,.,0,0
121999,METHODS,0,0
122000,Twenty,0,0
122001,healthy,0,0
122002,patients,0,0
122003,with,0,0
122004,bilateral,0,0
122005,",",0,0
122006,symmetrically,0,1
122007,impacted,0,0
122008,mandibular,0,0
122009,third,0,0
122010,molars,0,0
122011,were,0,0
122012,included,0,0
122013,in,0,0
122014,this,0,0
122015,double-blinded,0,0
122016,",",0,0
122017,prospective,0,0
122018,",",0,0
122019,cross-over,0,0
122020,",",0,0
122021,randomized,0,0
122022,study,0,0
122023,.,0,0
122024,The,0,0
122025,patients,0,0
122026,were,0,0
122027,operated,1,0
122028,with,1,0
122029,envelope,1,0
122030,flap,1,1
122031,on,1,0
122032,one,1,0
122033,side,1,0
122034,and,1,0
122035,triangular,1,1
122036,flap,1,1
122037,on,1,0
122038,the,1,0
122039,other,1,0
122040,side,1,0
122041,.,1,0
122042,Trismus,1,0
122043,was,1,0
122044,determined,1,0
122045,by,1,0
122046,measuring,1,0
122047,maximum,1,0
122048,interincisal,1,0
122049,opening,1,0
122050,",",1,0
122051,and,1,0
122052,facial,1,1
122053,swelling,1,0
122054,was,1,0
122055,evaluated,1,0
122056,using,1,0
122057,a,1,0
122058,tape,1,1
122059,measuring,1,0
122060,method,1,1
122061,.,1,0
122062,Pain,0,0
122063,was,0,0
122064,determined,0,0
122065,using,0,0
122066,visual,1,1
122067,analog,1,1
122068,scale,1,0
122069,(,1,1
122070,VAS,1,1
122071,),1,1
122072,and,1,0
122073,recording,1,1
122074,the,1,0
122075,number,1,0
122076,of,1,0
122077,pain,1,0
122078,pills,1,1
122079,taken,1,0
122080,.,1,0
122081,RESULTS,0,0
122082,The,0,0
122083,facial,0,1
122084,swelling,0,0
122085,measurements,0,1
122086,and,0,0
122087,VAS,0,1
122088,scores,0,0
122089,were,0,0
122090,lower,0,0
122091,in,0,0
122092,the,0,0
122093,envelope,0,1
122094,flap,0,1
122095,group,0,0
122096,compared,0,0
122097,to,0,0
122098,the,0,0
122099,triangular,0,1
122100,flap,0,1
122101,group,0,0
122102,.,0,0
122103,There,0,0
122104,was,0,0
122105,no,0,0
122106,significant,0,0
122107,difference,0,0
122108,between,0,0
122109,the,0,0
122110,two,0,0
122111,flap,0,0
122112,designs,0,0
122113,in,0,0
122114,operation,0,0
122115,time,0,0
122116,",",0,0
122117,maximum,0,0
122118,interincisal,0,0
122119,opening,0,0
122120,",",0,0
122121,and,0,0
122122,the,0,0
122123,number,0,0
122124,of,0,0
122125,analgesics,0,0
122126,taken,0,0
122127,.,0,0
122128,CONCLUSION,0,0
122129,Envelope,0,1
122130,flap,0,1
122131,yields,0,0
122132,to,0,0
122133,less,0,0
122134,facial,0,1
122135,swelling,0,0
122136,and,0,0
122137,reduced,0,0
122138,VAS,0,1
122139,scores,0,0
122140,in,0,0
122141,comparison,0,0
122142,to,0,0
122143,triangular,0,1
122144,flap,0,1
122145,.,0,0
122146,There,0,0
122147,is,0,0
122148,no,0,0
122149,clinical,0,0
122150,difference,0,0
122151,in,0,0
122152,trismus,0,1
122153,between,0,0
122154,the,0,0
122155,two,0,0
122156,flap,0,0
122157,designs,0,0
122158,.,0,0
122159,Despite,0,0
122160,the,0,0
122161,higher,0,0
122162,VAS,0,0
122163,scores,0,0
122164,with,0,0
122165,triangular,0,1
122166,flap,0,1
122167,",",0,0
122168,no,0,0
122169,additional,0,0
122170,doses,0,0
122171,of,0,0
122172,analgesics,0,0
122173,were,0,0
122174,required,0,0
122175,in,0,0
122176,triangular,0,1
122177,flap,0,1
122178,.,0,0
122179,Theory-driven,1,1
122180,intervention,1,1
122181,improves,0,0
122182,calcium,0,1
122183,intake,0,0
122184,",",0,0
122185,osteoporosis,0,0
122186,knowledge,0,0
122187,",",0,0
122188,and,0,0
122189,self-efficacy,0,1
122190,in,0,0
122191,community-dwelling,0,0
122192,older,0,0
122193,Black,0,0
122194,adults,0,0
122195,.,0,0
122196,OBJECTIVE,0,0
122197,To,0,0
122198,assess,0,0
122199,the,0,0
122200,effectiveness,0,0
122201,of,0,0
122202,an,0,0
122203,osteoporosis,1,0
122204,education,1,1
122205,program,1,1
122206,to,0,0
122207,improve,0,0
122208,calcium,0,1
122209,intake,0,0
122210,",",0,0
122211,knowledge,0,0
122212,",",0,0
122213,and,0,0
122214,self-efficacy,0,1
122215,in,0,0
122216,community-dwelling,0,0
122217,older,0,0
122218,Black,0,0
122219,adults,0,0
122220,.,0,0
122221,DESIGN,0,0
122222,Randomized,0,0
122223,repeated,0,0
122224,measures,0,0
122225,experimental,0,0
122226,design,0,0
122227,.,0,0
122228,SETTING,0,0
122229,Churches,0,0
122230,and,0,0
122231,community-based,0,1
122232,organizations,0,1
122233,.,0,0
122234,PARTICIPANTS,0,0
122235,Men,0,0
122236,and,0,0
122237,women,0,0
122238,(,0,0
122239,n,0,0
122240,=,0,0
122241,110,0,0
122242,),0,0
122243,50,0,0
122244,years,0,0
122245,old,0,0
122246,and,0,0
122247,older,0,0
122248,from,0,0
122249,3,0,0
122250,south,0,0
122251,Florida,0,0
122252,counties,0,0
122253,.,0,0
122254,INTERVENTION,0,0
122255,Participants,0,0
122256,randomly,0,0
122257,assigned,0,0
122258,to,0,0
122259,either,0,0
122260,of,0,0
122261,2,0,0
122262,groups,0,0
122263,:,0,0
122264,Group,0,0
122265,1,0,0
122266,(,0,0
122267,experimental,0,0
122268,group,0,1
122269,),0,1
122270,or,0,1
122271,Group,0,1
122272,2,0,1
122273,(,1,0
122274,wait-list,1,1
122275,control,1,1
122276,group,1,0
122277,),1,0
122278,.,0,0
122279,Group,0,0
122280,1,0,0
122281,participated,0,0
122282,in,0,0
122283,6,1,0
122284,weekly,1,1
122285,education,1,1
122286,program,1,1
122287,sessions,1,1
122288,immediately,0,0
122289,following,0,0
122290,baseline,1,0
122291,assessment,1,0
122292,",",0,0
122293,and,0,0
122294,Group,0,0
122295,2,0,0
122296,started,0,0
122297,the,0,0
122298,program,0,1
122299,following,0,0
122300,Group,0,0
122301,1,0,0
122302,'s,0,0
122303,program,0,1
122304,completion,0,0
122305,.,0,0
122306,A,0,0
122307,tested,0,0
122308,curriculum,0,1
122309,was,0,0
122310,adapted,0,0
122311,to,0,0
122312,meet,0,0
122313,the,0,0
122314,needs,0,0
122315,of,0,0
122316,the,0,0
122317,target,0,0
122318,population,0,0
122319,.,0,0
122320,MAIN,0,0
122321,OUTCOME,0,0
122322,MEASURES,0,0
122323,Dietary,0,1
122324,calcium,0,1
122325,intake,0,0
122326,",",0,0
122327,osteoporosis,0,0
122328,knowledge,0,0
122329,",",0,0
122330,health,0,0
122331,beliefs,0,1
122332,",",0,0
122333,and,0,0
122334,self-efficacy,0,0
122335,.,0,0
122336,ANALYSIS,0,0
122337,Descriptive,0,0
122338,and,0,0
122339,summary,0,0
122340,statistics,0,0
122341,",",0,0
122342,repeated,0,0
122343,measures,0,0
122344,analysis,0,0
122345,of,0,0
122346,variance,0,0
122347,",",0,0
122348,and,0,0
122349,regression,0,0
122350,analysis,0,0
122351,.,0,0
122352,RESULTS,0,0
122353,Of,0,1
122354,the,0,0
122355,total,0,0
122356,participants,0,0
122357,",",0,0
122358,84.6,0,0
122359,%,0,0
122360,completed,0,0
122361,the,0,0
122362,study,0,0
122363,(,0,0
122364,mean,0,0
122365,age,0,0
122366,=,0,0
122367,70.2,0,0
122368,years,0,0
122369,),0,0
122370,.,0,0
122371,Overall,0,0
122372,",",0,0
122373,an,0,0
122374,educational,1,1
122375,program,1,1
122376,developed,0,0
122377,with,0,0
122378,a,0,0
122379,theoretical,0,0
122380,background,0,0
122381,was,0,0
122382,associated,0,0
122383,with,0,0
122384,improvement,0,0
122385,in,0,0
122386,calcium,0,1
122387,intake,0,0
122388,",",0,0
122389,knowledge,0,0
122390,",",0,0
122391,and,0,0
122392,self-efficacy,0,0
122393,",",0,0
122394,with,0,0
122395,no,0,0
122396,effect,0,0
122397,on,0,0
122398,most,0,0
122399,health,0,0
122400,belief,0,0
122401,subscales,0,0
122402,.,0,0
122403,Assigned,0,0
122404,group,0,0
122405,was,0,0
122406,the,0,0
122407,major,0,0
122408,predictor,0,0
122409,of,0,0
122410,change,0,0
122411,in,0,0
122412,calcium,0,1
122413,intake,0,0
122414,.,0,0
122415,CONCLUSIONS,0,0
122416,AND,0,0
122417,IMPLICATIONS,0,1
122418,A,0,0
122419,theory-driven,0,1
122420,approach,0,1
122421,is,0,0
122422,valuable,0,0
122423,in,0,0
122424,improving,0,0
122425,behavior,0,0
122426,to,0,0
122427,promote,0,1
122428,bone,0,0
122429,health,0,0
122430,in,0,0
122431,this,0,0
122432,population,0,0
122433,.,0,0
122434,Health,0,0
122435,professionals,0,0
122436,should,0,0
122437,consider,0,0
122438,using,0,0
122439,more,0,0
122440,theory-driven,0,0
122441,approaches,0,0
122442,in,0,0
122443,intervention,0,1
122444,studies,0,0
122445,.,0,0
122446,Literacy,0,1
122447,skills,0,1
122448,in,0,0
122449,primary,0,0
122450,school-aged,0,0
122451,children,0,0
122452,with,0,0
122453,pragmatic,0,0
122454,language,0,1
122455,impairment,0,0
122456,:,0,0
122457,a,0,0
122458,comparison,0,0
122459,with,0,0
122460,children,0,0
122461,with,0,0
122462,specific,0,0
122463,language,0,1
122464,impairment,0,0
122465,.,0,0
122466,BACKGROUND,0,0
122467,Children,0,0
122468,with,0,0
122469,pragmatic,0,1
122470,language,0,1
122471,impairment,0,0
122472,(,0,1
122473,CwPLI,0,1
122474,),0,1
122475,are,0,0
122476,characterized,0,0
122477,by,0,0
122478,difficulties,0,0
122479,with,0,0
122480,the,0,0
122481,interpersonal,0,0
122482,use,0,0
122483,of,0,0
122484,language,0,0
122485,in,0,0
122486,social,0,1
122487,contexts,0,0
122488,and,0,0
122489,they,0,0
122490,possess,0,0
122491,a,0,0
122492,range,0,0
122493,of,0,0
122494,language,0,0
122495,difficulties,0,0
122496,that,0,0
122497,affect,0,0
122498,their,0,0
122499,educational,0,1
122500,attainment,0,0
122501,.,0,0
122502,Since,0,0
122503,literacy,0,0
122504,skills,0,1
122505,are,0,0
122506,central,0,0
122507,to,0,0
122508,this,0,0
122509,attainment,0,0
122510,",",0,0
122511,one,0,0
122512,way,0,0
122513,of,0,0
122514,identifying,0,0
122515,appropriate,0,1
122516,support,0,0
122517,needs,0,0
122518,for,0,0
122519,CwPLI,0,0
122520,would,0,0
122521,be,0,0
122522,to,0,0
122523,profile,0,0
122524,their,0,0
122525,reading,0,1
122526,and,0,0
122527,writing,0,1
122528,skills,0,1
122529,as,0,0
122530,a,0,0
122531,group,0,0
122532,.,0,0
122533,AIMS,0,0
122534,To,0,0
122535,investigate,0,0
122536,the,0,0
122537,word,0,1
122538,reading,0,0
122539,",",0,0
122540,non-word,0,1
122541,reading,0,1
122542,",",0,0
122543,reading,0,1
122544,comprehension,0,1
122545,",",0,0
122546,and,0,0
122547,written,0,1
122548,expression,0,0
122549,skills,0,0
122550,of,0,0
122551,CwPLI,0,1
122552,and,0,0
122553,a,0,0
122554,comparison,0,0
122555,group,0,0
122556,of,0,0
122557,children,0,0
122558,with,0,0
122559,specific,0,0
122560,language,0,1
122561,impairment,0,0
122562,(,0,1
122563,CwSLI,0,1
122564,),0,0
122565,.,0,0
122566,CwSLI,0,0
122567,were,0,0
122568,recruited,0,0
122569,in,0,0
122570,order,0,0
122571,to,0,0
122572,examine,0,0
122573,any,0,0
122574,overlaps,0,0
122575,in,0,0
122576,literacy,0,0
122577,impairments,0,0
122578,for,0,0
122579,the,0,0
122580,two,0,0
122581,groups,0,0
122582,.,0,0
122583,METHODS,0,0
122584,&,0,0
122585,PROCEDURES,0,1
122586,Primary,0,1
122587,school-aged,0,0
122588,CwPLI,0,1
122589,(,0,0
122590,n=,0,0
122591,59,0,0
122592,),0,0
122593,and,0,0
122594,CwSLI,0,1
122595,(,0,1
122596,n=,0,0
122597,12,0,0
122598,),0,0
122599,were,0,0
122600,recruited,0,0
122601,from,0,0
122602,speech,0,1
122603,and,0,0
122604,language,0,1
122605,therapists,0,1
122606,.,0,0
122607,Children,0,0
122608,completed,0,0
122609,standardized,1,0
122610,assessments,1,0
122611,of,0,0
122612,literacy,0,0
122613,skills,0,0
122614,.,0,0
122615,The,0,0
122616,level,0,0
122617,of,0,0
122618,impairment,0,0
122619,for,0,0
122620,each,0,0
122621,component,0,0
122622,literacy,0,0
122623,skill,0,0
122624,was,0,0
122625,examined,0,0
122626,for,0,0
122627,CwPLI,0,1
122628,and,0,0
122629,CwSLI,0,1
122630,.,0,1
122631,OUTCOMES,0,0
122632,&,0,0
122633,RESULTS,0,0
122634,For,0,0
122635,the,0,0
122636,CwPLI,0,1
122637,",",0,0
122638,group,0,0
122639,mean,0,0
122640,scores,0,0
122641,on,0,0
122642,each,0,0
122643,of,0,0
122644,the,0,0
122645,literacy,0,0
122646,skills,0,0
122647,were,0,0
122648,at,0,0
122649,the,0,0
122650,lower,0,0
122651,end,0,0
122652,of,0,0
122653,the,0,0
122654,normal,0,0
122655,range,0,0
122656,compared,0,0
122657,with,0,0
122658,population,0,0
122659,norms,0,0
122660,.,0,0
122661,The,0,0
122662,range,0,0
122663,of,0,0
122664,individual,0,0
122665,scores,0,0
122666,was,0,0
122667,large,0,0
122668,",",0,0
122669,with,0,0
122670,some,0,0
122671,children,0,0
122672,scoring,0,0
122673,near,0,0
122674,floor,0,1
122675,level,0,0
122676,and,0,0
122677,others,0,0
122678,scoring,0,0
122679,up,0,0
122680,to,0,0
122681,2,0,0
122682,SDs,0,1
122683,(,0,0
122684,standard,0,1
122685,deviations,0,0
122686,),0,0
122687,above,0,0
122688,the,0,0
122689,mean,0,0
122690,",",0,0
122691,illustrating,0,0
122692,the,0,0
122693,heterogeneity,0,0
122694,of,0,0
122695,literacy,0,0
122696,skills,0,0
122697,within,0,0
122698,the,0,0
122699,group,0,0
122700,.,0,0
122701,For,0,0
122702,the,0,0
122703,CwSLI,0,0
122704,",",0,0
122705,group,0,0
122706,mean,0,0
122707,scores,0,0
122708,on,0,0
122709,each,0,0
122710,of,0,0
122711,the,0,0
122712,literacy,0,0
122713,skills,0,0
122714,were,0,0
122715,between,0,0
122716,1,0,0
122717,SD,0,0
122718,and,0,0
122719,2,0,0
122720,SDs,0,1
122721,below,0,0
122722,the,0,0
122723,population,0,0
122724,mean,0,0
122725,.,0,0
122726,CwSLI,0,0
122727,were,0,0
122728,significantly,0,0
122729,more,0,0
122730,impaired,0,0
122731,on,0,0
122732,all,0,0
122733,of,0,0
122734,the,0,0
122735,literacy,0,0
122736,measures,0,0
122737,compared,0,0
122738,with,0,0
122739,CwPLI,0,0
122740,.,0,0
122741,This,0,0
122742,difference,0,0
122743,remained,0,0
122744,even,0,0
122745,when,0,0
122746,receptive,0,1
122747,language,0,1
122748,ability,0,0
122749,and,0,0
122750,non-verbal,0,0
122751,intelligence,0,0
122752,were,0,0
122753,controlled,0,0
122754,for,0,0
122755,.,0,0
122756,CONCLUSIONS,0,0
122757,&,0,0
122758,IMPLICATIONS,0,1
122759,The,0,0
122760,results,0,0
122761,demonstrate,0,0
122762,that,0,0
122763,there,0,0
122764,is,0,0
122765,a,0,0
122766,high,0,0
122767,level,0,0
122768,of,0,0
122769,literacy,0,0
122770,impairment,0,0
122771,within,0,0
122772,CwPLI,0,1
122773,and,0,0
122774,CwSLI,0,1
122775,",",0,0
122776,providing,0,0
122777,evidence,0,0
122778,that,0,0
122779,individualized,0,1
122780,literacy,0,0
122781,skill,0,1
122782,intervention,0,1
122783,is,0,0
122784,important,0,0
122785,for,0,0
122786,the,0,0
122787,long-term,0,0
122788,academic,0,0
122789,outcome,0,0
122790,of,0,0
122791,these,0,0
122792,children,0,0
122793,.,0,0
122794,Safety,0,1
122795,and,0,0
122796,pharmacokinetics,0,0
122797,of,0,0
122798,a,0,0
122799,glycoPEGylated,1,1
122800,recombinant,1,1
122801,activated,1,1
122802,factor,1,0
122803,VII,1,1
122804,derivative,1,0
122805,:,1,0
122806,a,0,0
122807,randomized,0,0
122808,first,0,0
122809,human,0,1
122810,dose,0,0
122811,trial,0,0
122812,in,0,0
122813,healthy,0,0
122814,subjects,0,0
122815,.,0,0
122816,BACKGROUND,0,0
122817,Extensive,0,0
122818,research,0,0
122819,is,0,0
122820,currently,0,0
122821,ongoing,0,0
122822,to,0,0
122823,prolong,0,0
122824,the,0,0
122825,half-life,0,0
122826,of,0,0
122827,coagulation,0,0
122828,factors,0,0
122829,.,0,0
122830,One,0,0
122831,of,0,0
122832,these,0,0
122833,techniques,0,1
122834,is,1,0
122835,glycoPEGylation,1,0
122836,",",1,0
122837,which,0,0
122838,has,0,0
122839,also,0,0
122840,been,0,0
122841,applied,0,0
122842,to,0,0
122843,recombinant,0,1
122844,activated,0,1
122845,factor,0,1
122846,VII,0,1
122847,(,0,1
122848,rFVIIa,0,1
122849,),0,1
122850,",",0,0
122851,resulting,0,0
122852,in,0,0
122853,a,0,0
122854,rFVIIa,1,1
122855,derivative,1,1
122856,(,1,1
122857,N7-GP,1,1
122858,),1,1
122859,with,0,0
122860,a,0,0
122861,prolonged,0,0
122862,terminal,0,1
122863,half-life,0,0
122864,(,0,1
122865,t,0,0
122866,(,0,1
122867,1/2,0,1
122868,),0,0
122869,),0,0
122870,.,0,0
122871,The,0,0
122872,main,0,0
122873,clinical,0,0
122874,purpose,0,0
122875,of,1,0
122876,N7-GP,1,1
122877,is,0,0
122878,to,0,0
122879,provide,0,0
122880,safe,0,0
122881,and,0,0
122882,effective,0,0
122883,prophylaxis,0,1
122884,to,0,0
122885,patients,0,0
122886,with,0,0
122887,hemophilia,0,0
122888,and,0,0
122889,inhibitors,0,1
122890,.,0,0
122891,The,0,0
122892,prolonged,0,0
122893,t,0,0
122894,(,0,1
122895,1/2,0,1
122896,),0,0
122897,of,0,0
122898,N7-GP,0,1
122899,can,0,0
122900,potentially,0,0
122901,reduce,0,0
122902,the,0,0
122903,dosing,0,0
122904,frequency,0,0
122905,and,0,0
122906,thereby,0,0
122907,facilitate,0,0
122908,convenience,0,1
122909,and,0,0
122910,compliance,0,0
122911,",",0,0
122912,which,0,0
122913,are,0,0
122914,two,0,0
122915,significant,0,0
122916,barriers,0,0
122917,to,0,0
122918,effective,0,0
122919,prophylaxis,0,1
122920,.,0,0
122921,OBJECTIVES,0,0
122922,To,0,0
122923,determine,0,0
122924,the,0,0
122925,safety,0,0
122926,and,0,0
122927,pharmacokinetics,0,0
122928,of,0,0
122929,single,0,0
122930,doses,0,0
122931,of,0,0
122932,N7-GP,0,1
122933,in,0,0
122934,healthy,0,0
122935,men,0,0
122936,.,0,0
122937,METHODS,0,0
122938,A,0,0
122939,randomized,0,0
122940,",",0,0
122941,placebo-controlled,0,1
122942,",",0,0
122943,dose-escalation,0,0
122944,trial,0,0
122945,with,0,0
122946,five,0,0
122947,cohorts,0,0
122948,(,0,0
122949,N7-GP,0,1
122950,dose,0,1
122951,of,0,0
122952,12.5-100,0,0
122953,?g,0,1
122954,kg,0,1
122955,(,0,1
122956,-1,0,1
122957,),0,1
122958,),0,0
122959,was,0,0
122960,performed,0,0
122961,.,0,0
122962,In,0,0
122963,each,0,0
122964,cohort,0,0
122965,",",0,0
122966,eight,0,0
122967,subjects,0,0
122968,were,0,0
122969,randomized,0,0
122970,to,0,0
122971,receive,0,1
122972,N7-GP,0,1
122973,(,0,0
122974,n,0,0
122975,=,0,0
122976,6,0,1
122977,),0,0
122978,or,0,1
122979,placebo,1,1
122980,(,1,1
122981,n,0,0
122982,=,0,0
122983,2,0,0
122984,),0,0
122985,.,0,0
122986,RESULTS,0,0
122987,The,0,0
122988,mean,0,0
122989,FVIIa,0,1
122990,activity,0,0
122991,was,0,0
122992,measurable,0,0
122993,for,0,0
122994,up,0,0
122995,to,0,0
122996,at,0,0
122997,least,0,0
122998,72,0,0
122999,h,0,0
123000,after,0,0
123001,dosing,0,0
123002,",",0,0
123003,and,0,0
123004,the,0,0
123005,overall,0,0
123006,mean,0,0
123007,t,0,0
123008,(,0,1
123009,1/2,0,1
123010,),0,0
123011,for,0,0
123012,FVIIa,0,1
123013,activity,0,0
123014,was,0,0
123015,15,0,0
123016,h.,0,0
123017,The,0,0
123018,pharmacokinetics,0,0
123019,of,0,0
123020,N7-GP,0,1
123021,appeared,0,0
123022,to,0,0
123023,be,0,0
123024,dose-proportional,0,0
123025,in,0,0
123026,the,0,0
123027,dose,0,0
123028,range,0,0
123029,investigated,0,0
123030,.,0,0
123031,No,0,0
123032,serious,0,0
123033,adverse,0,0
123034,events,0,0
123035,(,0,0
123036,including,0,0
123037,thromboembolic,0,1
123038,events,0,0
123039,),0,0
123040,were,0,0
123041,reported,0,0
123042,.,0,0
123043,The,0,0
123044,frequency,0,0
123045,of,0,0
123046,adverse,0,0
123047,events,0,0
123048,was,0,0
123049,similar,0,0
123050,in,0,0
123051,both,0,0
123052,the,0,0
123053,placebo,0,1
123054,and,0,0
123055,N7-GP,0,1
123056,groups,0,0
123057,.,0,0
123058,No,0,0
123059,neutralizing,0,0
123060,antibodies,0,0
123061,against,0,0
123062,N7-GP,0,1
123063,were,0,0
123064,detected,0,0
123065,.,0,0
123066,A,0,0
123067,pharmacologic,0,0
123068,effect,0,0
123069,was,0,0
123070,apparent,0,0
123071,from,0,0
123072,a,0,0
123073,dose-dependent,0,0
123074,statistically,0,0
123075,significant,0,0
123076,decrease,0,0
123077,in,0,0
123078,the,0,0
123079,mean,0,0
123080,prothrombin,0,0
123081,time,0,0
123082,in,0,0
123083,all,0,0
123084,N7-GP,0,1
123085,groups,0,0
123086,as,0,0
123087,compared,0,0
123088,with,0,0
123089,placebo,0,1
123090,.,0,0
123091,CONCLUSIONS,0,0
123092,N7-GP,0,1
123093,had,0,0
123094,a,0,0
123095,plasma,0,0
123096,half-life,0,0
123097,of,0,0
123098,15,0,0
123099,h,0,0
123100,and,0,0
123101,a,0,0
123102,profile,0,0
123103,that,0,0
123104,makes,0,0
123105,it,0,0
123106,a,0,0
123107,potential,0,0
123108,candidate,0,0
123109,for,0,0
123110,prophylaxis,0,0
123111,in,0,0
123112,patients,0,0
123113,with,0,0
123114,hemophilia,0,0
123115,and,0,0
123116,inhibitors,0,0
123117,.,0,0
123118,Effect,0,0
123119,of,0,0
123120,a,0,0
123121,multi-faceted,1,0
123122,intervention,1,1
123123,on,0,0
123124,gingival,0,0
123125,health,0,0
123126,among,0,0
123127,adults,0,0
123128,with,0,0
123129,systemic,0,0
123130,sclerosis,0,1
123131,.,0,0
123132,OBJECTIVES,0,0
123133,To,0,0
123134,evaluate,0,0
123135,the,0,0
123136,effect,0,0
123137,of,0,0
123138,adaptive,1,0
123139,oral,1,1
123140,hygiene,1,0
123141,devices,1,1
123142,and,0,0
123143,orofacial,1,0
123144,exercise,1,1
123145,to,0,0
123146,improve,0,0
123147,gingival,0,0
123148,health,0,0
123149,among,0,0
123150,adults,0,0
123151,with,0,0
123152,systemic,0,0
123153,sclerosis,0,1
123154,(,0,1
123155,SSc,0,1
123156,),0,0
123157,.,0,0
123158,METHODS,0,0
123159,Forty-eight,0,0
123160,patients,0,0
123161,with,0,0
123162,SSc,0,0
123163,were,0,0
123164,assigned,0,0
123165,randomly,0,0
123166,to,0,0
123167,the,0,0
123168,multifaceted,1,0
123169,oral,1,1
123170,health,1,0
123171,intervention,1,1
123172,or,0,1
123173,usual,1,1
123174,dental,1,1
123175,care,1,1
123176,control,0,1
123177,group,0,0
123178,.,0,0
123179,Participants,0,0
123180,in,0,0
123181,the,0,0
123182,intervention,0,1
123183,group,0,0
123184,received,0,1
123185,a,0,0
123186,rechargeable,0,1
123187,",",0,0
123188,powered,0,0
123189,Oral-B?,1,1
123190,oscillating-rotating-pulsating,1,1
123191,toothbrush,1,1
123192,and,1,0
123193,a,1,0
123194,Reach?,1,1
123195,Access?,1,1
123196,Flosser,1,1
123197,that,1,0
123198,has,0,0
123199,a,0,0
123200,toothbrush-like,0,1
123201,handle,0,0
123202,.,0,0
123203,For,0,0
123204,those,0,0
123205,with,0,0
123206,an,0,0
123207,oral,0,1
123208,aperture,0,0
123209,of,0,0
123210,less,0,0
123211,than,0,0
123212,40,0,0
123213,mm,0,0
123214,",",0,0
123215,orofacial,1,0
123216,exercises,1,1
123217,were,1,0
123218,taught,0,0
123219,.,0,0
123220,Participants,0,0
123221,in,0,0
123222,the,0,0
123223,control,0,1
123224,group,0,0
123225,were,0,0
123226,each,0,0
123227,given,0,0
123228,a,0,0
123229,manual,0,1
123230,toothbrush,0,1
123231,and,0,0
123232,dental,0,0
123233,floss,0,1
123234,.,0,0
123235,Participants,0,0
123236,in,0,0
123237,both,0,0
123238,groups,0,0
123239,received,0,0
123240,instructions,0,1
123241,and,0,0
123242,demonstration,0,0
123243,on,0,0
123244,the,0,0
123245,use,0,0
123246,of,0,0
123247,the,0,0
123248,devices,0,0
123249,",",0,0
123250,and,0,0
123251,were,0,0
123252,requested,0,0
123253,to,0,0
123254,perform,0,0
123255,the,0,0
123256,respective,0,0
123257,intervention,0,1
123258,twice,0,1
123259,a,0,0
123260,day,0,0
123261,for,0,0
123262,6,0,0
123263,months,0,0
123264,.,0,0
123265,Evaluations,0,0
123266,were,0,0
123267,at,0,0
123268,baseline,0,0
123269,",",0,0
123270,3-,0,1
123271,",",0,0
123272,and,0,0
123273,6-months,0,0
123274,.,0,0
123275,The,0,0
123276,main,0,0
123277,outcome,0,0
123278,was,0,0
123279,gingival,0,1
123280,index,0,0
123281,(,0,1
123282,GI,0,0
123283,),0,0
123284,",",0,0
123285,an,0,0
123286,indicator,0,0
123287,of,0,0
123288,gingival,0,0
123289,inflammation,0,0
123290,.,0,0
123291,RESULTS,0,0
123292,Both,0,1
123293,groups,0,0
123294,showed,0,0
123295,significant,0,0
123296,reduction,0,0
123297,in,0,0
123298,GI,0,0
123299,scores,0,0
123300,at,0,0
123301,6,0,0
123302,months,0,0
123303,(,0,0
123304,ps,0,1
123305,<,0,0
123306,0.005,0,0
123307,),0,0
123308,.,0,0
123309,Reduction,0,0
123310,in,0,0
123311,GI,0,0
123312,scores,0,0
123313,of,0,0
123314,the,0,0
123315,intervention,0,1
123316,group,0,0
123317,at,0,0
123318,6,0,0
123319,months,0,0
123320,was,0,0
123321,20.8,0,0
123322,%,0,0
123323,which,0,0
123324,is,0,0
123325,considered,0,0
123326,to,0,0
123327,be,0,0
123328,clinically,0,0
123329,significant,0,0
123330,.,0,0
123331,Compared,0,0
123332,to,0,0
123333,the,0,0
123334,control,0,1
123335,group,0,0
123336,",",0,0
123337,the,0,0
123338,intervention,0,1
123339,group,0,0
123340,showed,0,0
123341,a,0,0
123342,significant,0,0
123343,and,0,0
123344,larger,0,0
123345,reduction,0,0
123346,in,0,0
123347,GI,0,0
123348,score,0,0
123349,by,0,0
123350,8,0,0
123351,%,0,0
123352,at,0,0
123353,6,0,0
123354,months,0,0
123355,(,0,0
123356,p=0.0007,0,0
123357,),0,1
123358,.,0,0
123359,CONCLUSIONS,0,0
123360,Results,0,0
123361,support,0,1
123362,the,0,0
123363,use,0,0
123364,of,1,0
123365,adaptive,1,0
123366,devices,1,1
123367,and,1,0
123368,orofacial,1,0
123369,exercise,1,1
123370,to,1,0
123371,improve,0,0
123372,gingival,0,0
123373,health,0,0
123374,in,0,0
123375,adults,0,0
123376,with,0,0
123377,SSc,0,0
123378,when,0,0
123379,compared,0,0
123380,to,0,0
123381,use,0,0
123382,of,1,0
123383,manual,1,1
123384,toothbrushing,1,1
123385,and,1,0
123386,finger-held,1,1
123387,flossing,1,1
123388,.,1,1
123389,Recommending,1,0
123390,and,0,0
123391,educating,0,1
123392,patients,0,0
123393,with,0,0
123394,SSc,0,0
123395,to,0,0
123396,use,0,0
123397,adaptive,0,0
123398,devices,0,0
123399,to,0,0
123400,clean,0,1
123401,the,0,0
123402,tooth,0,0
123403,surfaces,0,1
123404,looks,0,0
123405,promising,0,0
123406,for,0,0
123407,long-term,0,0
123408,oral,0,1
123409,health,0,0
123410,improvement,0,0
123411,.,0,0
123412,Effects,0,0
123413,of,0,0
123414,vitamin,1,1
123415,A,1,0
123416,or,1,1
123417,beta,1,1
123418,carotene,1,1
123419,supplementation,1,1
123420,on,0,0
123421,pregnancy-related,0,0
123422,mortality,0,0
123423,and,0,0
123424,infant,0,0
123425,mortality,0,0
123426,in,0,0
123427,rural,0,0
123428,Bangladesh,0,0
123429,:,0,0
123430,a,0,0
123431,cluster,0,0
123432,randomized,0,0
123433,trial,0,0
123434,.,0,0
123435,CONTEXT,0,0
123436,Maternal,0,0
123437,vitamin,0,1
123438,A,0,0
123439,deficiency,0,0
123440,is,0,0
123441,a,0,0
123442,public,0,0
123443,health,0,0
123444,concern,0,0
123445,in,0,0
123446,the,0,0
123447,developing,0,0
123448,world,0,0
123449,.,0,0
123450,Its,0,0
123451,prevention,0,0
123452,may,0,0
123453,improve,0,0
123454,maternal,0,0
123455,and,0,0
123456,infant,0,0
123457,survival,0,0
123458,.,0,0
123459,OBJECTIVE,0,0
123460,To,0,0
123461,assess,0,0
123462,efficacy,0,0
123463,of,0,0
123464,maternal,0,0
123465,vitamin,1,1
123466,A,1,0
123467,or,0,1
123468,beta,1,1
123469,carotene,1,1
123470,supplementation,0,1
123471,in,0,0
123472,reducing,0,0
123473,pregnancy-related,0,0
123474,and,0,0
123475,infant,0,0
123476,mortality,0,0
123477,.,0,0
123478,DESIGN,0,0
123479,",",0,0
123480,SETTING,0,0
123481,",",0,0
123482,AND,0,0
123483,PARTICIPANTS,0,0
123484,Cluster,0,0
123485,randomized,0,0
123486,",",0,0
123487,double-masked,0,0
123488,",",0,0
123489,placebo-controlled,1,1
123490,trial,0,0
123491,among,0,0
123492,pregnant,0,0
123493,women,0,0
123494,13,0,0
123495,to,0,0
123496,45,0,0
123497,years,0,0
123498,of,0,0
123499,age,0,0
123500,and,0,0
123501,their,0,0
123502,live-born,0,0
123503,infants,0,0
123504,to,0,0
123505,12,0,0
123506,weeks,0,0
123507,(,0,0
123508,84,0,0
123509,days,0,0
123510,),0,0
123511,postpartum,0,0
123512,in,0,0
123513,rural,0,0
123514,northern,0,0
123515,Bangladesh,0,0
123516,between,0,0
123517,2001,0,0
123518,and,0,0
123519,2007,0,0
123520,.,0,0
123521,Interventions,0,0
123522,Five,0,0
123523,hundred,0,0
123524,ninety-six,0,0
123525,community,0,1
123526,clusters,0,1
123527,(,0,0
123528,study,0,0
123529,sectors,0,0
123530,),0,0
123531,were,0,0
123532,randomized,0,0
123533,for,0,0
123534,pregnant,0,0
123535,women,0,0
123536,to,0,0
123537,receive,0,0
123538,weekly,0,1
123539,",",0,0
123540,from,0,0
123541,the,0,0
123542,first,0,0
123543,trimester,0,0
123544,through,0,0
123545,12,0,0
123546,weeks,0,0
123547,postpartum,0,0
123548,",",0,0
123549,7000,1,1
123550,?g,1,0
123551,of,1,0
123552,retinol,1,1
123553,equivalents,1,0
123554,as,1,0
123555,retinyl,1,1
123556,palmitate,1,1
123557,",",1,0
123558,42,1,0
123559,mg,1,1
123560,of,1,0
123561,all-trans,1,1
123562,beta,1,0
123563,carotene,1,1
123564,",",1,0
123565,or,1,1
123566,placebo,1,1
123567,.,1,0
123568,Married,0,0
123569,women,0,0
123570,(,0,0
123571,n,0,0
123572,=,0,0
123573,"125,257",0,0
123574,),0,0
123575,underwent,0,0
123576,5-week,0,1
123577,surveillance,0,0
123578,for,0,0
123579,pregnancy,0,0
123580,",",0,0
123581,ascertained,0,0
123582,by,0,0
123583,a,0,0
123584,history,0,0
123585,of,0,0
123586,amenorrhea,0,0
123587,and,0,0
123588,confirmed,0,0
123589,by,0,0
123590,urine,0,0
123591,test,0,0
123592,.,0,0
123593,Blood,0,0
123594,samples,0,0
123595,were,0,0
123596,obtained,0,0
123597,from,0,0
123598,participants,0,0
123599,in,0,0
123600,32,0,0
123601,sectors,0,0
123602,(,0,0
123603,5,0,1
123604,%,0,0
123605,),0,0
123606,for,0,0
123607,biochemical,0,0
123608,studies,0,0
123609,.,0,0
123610,MAIN,0,0
123611,OUTCOME,0,0
123612,MEASURES,0,0
123613,All-cause,0,0
123614,mortality,0,0
123615,of,0,0
123616,women,0,0
123617,related,0,0
123618,to,0,0
123619,pregnancy,0,0
123620,",",0,0
123621,stillbirth,0,0
123622,",",0,0
123623,and,0,0
123624,infant,0,0
123625,mortality,0,0
123626,to,0,0
123627,12,0,0
123628,weeks,0,0
123629,(,0,0
123630,84,0,0
123631,days,0,0
123632,),0,0
123633,following,0,0
123634,pregnancy,0,0
123635,outcome,0,0
123636,.,0,0
123637,RESULTS,0,0
123638,Groups,0,0
123639,were,0,0
123640,comparable,0,0
123641,across,0,0
123642,risk,0,0
123643,factors,0,0
123644,.,0,0
123645,For,0,0
123646,the,0,0
123647,mortality,0,0
123648,outcomes,0,0
123649,",",0,0
123650,neither,0,0
123651,of,0,0
123652,the,0,0
123653,supplement,0,1
123654,group,0,0
123655,outcomes,0,0
123656,was,0,0
123657,significantly,0,0
123658,different,0,0
123659,from,0,0
123660,the,0,0
123661,placebo,0,1
123662,group,0,0
123663,outcomes,0,0
123664,.,0,0
123665,The,0,0
123666,numbers,0,0
123667,of,0,0
123668,deaths,0,0
123669,and,0,0
123670,all-cause,0,0
123671,",",0,0
123672,pregnancy-related,0,0
123673,mortality,0,0
123674,rates,0,0
123675,(,0,0
123676,per,0,0
123677,"100,000",0,0
123678,pregnancies,0,0
123679,),0,0
123680,were,0,0
123681,41,0,0
123682,and,0,0
123683,206,0,0
123684,(,0,0
123685,95,0,0
123686,%,0,0
123687,confidence,0,0
123688,interval,0,0
123689,[,0,0
123690,CI,0,0
123691,],0,0
123692,",",0,0
123693,140-273,0,1
123694,),0,0
123695,in,0,0
123696,the,1,0
123697,placebo,1,1
123698,group,0,0
123699,",",0,0
123700,47,0,0
123701,and,0,0
123702,237,0,0
123703,(,0,0
123704,95,0,0
123705,%,0,0
123706,CI,0,0
123707,",",0,0
123708,166-309,0,0
123709,),0,0
123710,in,0,0
123711,the,0,0
123712,vitamin,0,1
123713,A,0,0
123714,group,0,0
123715,",",0,0
123716,and,0,0
123717,50,0,1
123718,and,0,0
123719,250,0,1
123720,(,0,0
123721,95,0,0
123722,%,0,0
123723,CI,0,0
123724,",",0,0
123725,177-323,0,0
123726,),0,0
123727,in,0,0
123728,the,0,0
123729,beta,0,1
123730,carotene,0,1
123731,group,0,0
123732,.,0,0
123733,Relative,0,0
123734,risks,0,0
123735,for,0,0
123736,mortality,0,0
123737,in,0,0
123738,the,1,0
123739,vitamin,1,1
123740,A,1,0
123741,and,1,0
123742,beta,1,1
123743,carotene,1,1
123744,groups,0,0
123745,were,0,0
123746,1.15,0,0
123747,(,0,0
123748,95,0,0
123749,%,0,0
123750,CI,0,0
123751,",",0,0
123752,0.75-1.76,0,0
123753,),0,1
123754,and,0,0
123755,1.21,0,0
123756,(,0,0
123757,95,0,0
123758,%,0,0
123759,CI,0,0
123760,",",0,0
123761,0.81-1.81,0,0
123762,),0,0
123763,",",0,0
123764,respectively,0,0
123765,.,0,0
123766,In,0,0
123767,the,1,0
123768,placebo,1,1
123769,",",1,0
123770,vitamin,1,1
123771,A,1,0
123772,",",1,0
123773,and,1,0
123774,beta,1,1
123775,carotene,1,1
123776,groups,0,0
123777,the,0,0
123778,rates,0,0
123779,of,0,0
123780,stillbirth,0,0
123781,and,0,0
123782,infant,0,0
123783,mortality,0,0
123784,were,0,0
123785,47.9,0,0
123786,(,0,0
123787,95,0,0
123788,%,0,0
123789,CI,0,0
123790,",",0,0
123791,44.3-51.5,0,0
123792,),0,0
123793,",",0,0
123794,45.6,0,0
123795,(,0,0
123796,95,0,0
123797,%,0,0
123798,CI,0,0
123799,",",0,0
123800,42.1-49.2,0,0
123801,),0,0
123802,",",0,0
123803,and,0,0
123804,51.8,0,0
123805,(,0,0
123806,95,0,0
123807,%,0,0
123808,CI,0,0
123809,",",0,0
123810,48.0-55.6,0,0
123811,),0,0
123812,per,0,0
123813,1000,0,0
123814,births,0,0
123815,and,0,0
123816,68.1,0,0
123817,(,0,0
123818,95,0,0
123819,%,0,0
123820,CI,0,0
123821,",",0,0
123822,63.7-72.5,0,0
123823,),0,0
123824,",",0,0
123825,65.0,0,0
123826,(,0,0
123827,95,0,0
123828,%,0,0
123829,CI,0,0
123830,",",0,0
123831,60.7-69.4,0,0
123832,),0,0
123833,",",0,0
123834,and,0,0
123835,69.8,0,0
123836,(,0,0
123837,95,0,0
123838,%,0,0
123839,CI,0,0
123840,",",0,0
123841,65.4-72.3,0,0
123842,),0,0
123843,per,0,0
123844,1000,0,0
123845,live,0,0
123846,births,0,0
123847,",",0,0
123848,respectively,0,0
123849,.,0,0
123850,Vitamin,0,1
123851,A,0,0
123852,compared,0,0
123853,with,0,0
123854,either,0,1
123855,placebo,0,1
123856,or,0,1
123857,beta,0,1
123858,carotene,0,1
123859,supplementation,0,1
123860,increased,0,0
123861,plasma,0,0
123862,retinol,0,1
123863,concentrations,0,0
123864,by,0,0
123865,end,0,0
123866,of,0,0
123867,study,0,0
123868,(,0,0
123869,1.46,0,0
123870,[,0,0
123871,95,0,0
123872,%,0,0
123873,CI,0,0
123874,",",0,0
123875,1.42-1.50,0,0
123876,],0,0
123877,?mol/L,0,1
123878,vs,0,0
123879,1.13,0,0
123880,[,0,0
123881,95,0,0
123882,%,0,0
123883,CI,0,0
123884,",",0,0
123885,1.09-1.17,0,0
123886,],0,1
123887,?mol/L,0,1
123888,and,0,0
123889,1.18,0,0
123890,[,0,0
123891,95,0,0
123892,%,0,0
123893,CI,0,0
123894,",",0,0
123895,1.14-1.22,0,0
123896,],0,0
123897,?mol/L,0,1
123898,",",0,0
123899,respectively,0,0
123900,;,0,0
123901,P,0,0
123902,<,0,0
123903,.001,0,0
123904,),0,1
123905,and,0,0
123906,reduced,0,0
123907,",",0,0
123908,but,0,0
123909,did,0,0
123910,not,0,0
123911,eliminate,0,0
123912,",",0,0
123913,gestational,0,0
123914,night,0,1
123915,blindness,0,0
123916,(,0,0
123917,7.1,0,0
123918,%,0,0
123919,for,0,0
123920,vitamin,0,1
123921,A,0,0
123922,vs,0,0
123923,9.2,0,0
123924,%,0,0
123925,for,0,0
123926,placebo,0,1
123927,and,0,0
123928,8.9,0,0
123929,%,0,0
123930,for,0,0
123931,beta,0,1
123932,carotene,0,1
123933,[,0,0
123934,P,0,0
123935,<,0,0
123936,.001,0,0
123937,for,0,0
123938,both,0,0
123939,],0,0
123940,),0,0
123941,.,0,0
123942,CONCLUSION,0,0
123943,Use,0,1
123944,of,0,0
123945,weekly,1,1
123946,vitamin,1,1
123947,A,1,0
123948,or,1,1
123949,beta,1,1
123950,carotene,1,1
123951,in,1,0
123952,pregnant,0,0
123953,women,0,0
123954,in,0,0
123955,Bangladesh,0,0
123956,",",0,0
123957,compared,0,0
123958,with,0,0
123959,placebo,0,1
123960,",",0,0
123961,did,0,0
123962,not,0,0
123963,reduce,0,0
123964,all-cause,0,0
123965,maternal,0,0
123966,",",0,0
123967,fetal,0,0
123968,",",0,0
123969,or,0,1
123970,infant,0,0
123971,mortality,0,0
123972,.,0,0
123973,TRIAL,0,0
123974,REGISTRATION,0,0
123975,clinicaltrials.gov,0,0
123976,Identifier,0,0
123977,:,0,0
123978,NCT00198822,0,0
123979,.,0,0
123980,Effects,0,0
123981,of,0,0
123982,alcohol,1,0
123983,on,0,0
123984,the,0,0
123985,pharmacokinetics,0,0
123986,of,0,0
123987,morphine,1,1
123988,sulfate,1,1
123989,and,0,0
123990,naltrexone,1,1
123991,hydrochloride,1,1
123992,extended,0,1
123993,release,0,0
123994,capsules,0,1
123995,.,0,0
123996,Although,0,0
123997,contraindicated,0,0
123998,",",0,0
123999,coingestion,0,1
124000,of,0,0
124001,alcohol,0,1
124002,and,0,0
124003,opioids,1,1
124004,by,0,0
124005,patients,0,0
124006,or,0,1
124007,drug,0,1
124008,abusers,0,0
124009,is,0,0
124010,a,0,0
124011,major,0,0
124012,health,0,0
124013,concern,0,0
124014,because,0,0
124015,of,0,0
124016,dangerous,0,0
124017,additive,0,1
124018,and,0,0
124019,potentially,0,0
124020,life-threatening,0,0
124021,sedative,0,1
124022,and,0,0
124023,respiratory,0,0
124024,effects,0,0
124025,.,0,0
124026,In,0,0
124027,addition,0,0
124028,",",0,0
124029,alcohol,0,1
124030,has,0,0
124031,been,0,0
124032,shown,0,0
124033,to,0,0
124034,disrupt,0,0
124035,the,0,0
124036,extended-release,0,1
124037,characteristics,0,0
124038,of,0,0
124039,certain,0,0
124040,extended-release,0,1
124041,opioid,0,1
124042,formulations,0,1
124043,",",0,0
124044,releasing,0,1
124045,a,0,0
124046,hazardous,0,0
124047,amount,0,0
124048,of,0,0
124049,opioid,0,0
124050,over,0,0
124051,a,0,0
124052,short,0,1
124053,time,0,0
124054,period,0,0
124055,.,0,0
124056,Morphine,1,1
124057,sulfate,1,1
124058,and,1,0
124059,naltrexone,1,1
124060,hydrochloride,1,1
124061,extended,1,1
124062,release,1,0
124063,capsules,1,1
124064,(,1,0
124065,MS-sNT,1,1
124066,),1,0
124067,",",0,0
124068,which,0,0
124069,contain,0,0
124070,naltrexone,0,1
124071,sequestered,0,0
124072,in,0,0
124073,each,0,0
124074,pellet,0,1
124075,core,0,0
124076,",",0,0
124077,are,0,0
124078,indicated,0,0
124079,for,0,0
124080,management,0,1
124081,of,0,0
124082,chronic,0,0
124083,",",0,0
124084,moderate,0,0
124085,to,0,0
124086,severe,0,0
124087,pain,0,0
124088,.,0,0
124089,Sequestered,0,0
124090,naltrexone,0,1
124091,is,0,0
124092,designed,0,0
124093,for,0,0
124094,release,0,0
124095,upon,0,0
124096,product,0,1
124097,tampering,0,1
124098,(,0,1
124099,crushing,0,1
124100,),0,1
124101,to,0,0
124102,potentially,0,0
124103,mitigate,0,0
124104,morphine-induced,0,1
124105,subjective,0,0
124106,effects,0,0
124107,.,0,0
124108,This,0,0
124109,open-label,0,0
124110,",",0,0
124111,single-dose,0,1
124112,",",0,0
124113,4-way,0,1
124114,crossover,0,0
124115,",",0,0
124116,pharmacokinetic,0,0
124117,drug,0,1
124118,interaction,0,0
124119,study,0,0
124120,compared,0,0
124121,the,0,0
124122,relative,0,0
124123,bioavailability,0,0
124124,of,0,0
124125,morphine,0,1
124126,and,0,0
124127,naltrexone,0,1
124128,when,0,0
124129,MS-sNT,0,1
124130,is,0,0
124131,administered,0,0
124132,(,0,0
124133,under,0,0
124134,fasting,0,0
124135,conditions,0,0
124136,),0,0
124137,with,0,0
124138,increasing,0,0
124139,doses,0,0
124140,of,0,0
124141,alcohol,0,0
124142,.,0,0
124143,Thirty-two,0,0
124144,healthy,0,0
124145,",",0,0
124146,opioid-naive,0,0
124147,adults,0,0
124148,were,0,0
124149,randomized,0,0
124150,to,0,0
124151,MS-sNT,1,1
124152,administered,0,0
124153,with,0,0
124154,240,0,0
124155,mL,0,0
124156,of,0,0
124157,4,0,0
124158,%,0,0
124159,",",0,0
124160,20,0,0
124161,%,0,0
124162,",",0,0
124163,or,0,1
124164,40,0,1
124165,%,0,0
124166,alcohol,1,1
124167,or,0,1
124168,water,0,1
124169,.,0,0
124170,No,0,0
124171,drug,0,0
124172,interaction,0,0
124173,was,0,0
124174,found,0,0
124175,between,0,0
124176,morphine,0,1
124177,in,0,0
124178,MS-sNT,0,1
124179,and,0,0
124180,4,0,1
124181,%,0,0
124182,or,0,1
124183,20,0,1
124184,%,0,0
124185,alcohol,0,0
124186,.,0,0
124187,Administration,0,0
124188,with,0,0
124189,40,0,1
124190,%,0,0
124191,alcohol,0,0
124192,did,0,0
124193,not,0,0
124194,affect,0,0
124195,overall,0,0
124196,morphine,0,1
124197,exposure,0,0
124198,but,0,0
124199,was,0,0
124200,associated,0,0
124201,with,0,0
124202,a,0,0
124203,2-fold,0,0
124204,increase,0,0
124205,in,0,0
124206,C,0,1
124207,(,0,1
124208,max,0,0
124209,),0,1
124210,and,0,0
124211,reduction,0,0
124212,of,0,0
124213,t,0,0
124214,(,0,1
124215,max,0,0
124216,),0,1
124217,from,0,0
124218,9,0,0
124219,to,0,0
124220,4,0,0
124221,hours,0,0
124222,versus,0,0
124223,MS-sNT,0,1
124224,taken,0,0
124225,with,0,0
124226,water,0,1
124227,.,0,0
124228,Naltrexone,1,1
124229,sequestering,0,0
124230,was,0,0
124231,successful,0,0
124232,in,0,0
124233,all,0,0
124234,treatment,0,0
124235,arms,0,0
124236,and,0,0
124237,not,0,0
124238,affected,0,0
124239,by,0,0
124240,coadministration,0,1
124241,with,0,0
124242,alcohol,0,0
124243,over,0,0
124244,the,0,0
124245,dose,0,0
124246,range,0,0
124247,tested,0,0
124248,.,0,0
124249,Effectiveness,0,0
124250,of,0,0
124251,a,0,0
124252,short-term,0,0
124253,treatment,0,0
124254,with,0,0
124255,progesterone,1,1
124256,injections,0,1
124257,on,0,0
124258,synchrony,0,0
124259,of,0,0
124260,lambing,0,0
124261,and,0,0
124262,fertility,0,0
124263,in,0,0
124264,tropical,0,0
124265,hair,0,0
124266,sheep,0,0
124267,.,0,0
124268,The,0,0
124269,efficacy,0,0
124270,of,0,0
124271,using,0,0
124272,a,0,0
124273,low,0,0
124274,cost,0,0
124275,system,0,1
124276,for,0,0
124277,delivering,0,1
124278,progesterone,1,1
124279,as,0,0
124280,part,0,0
124281,of,0,0
124282,an,0,0
124283,estrous,0,0
124284,synchronization,0,1
124285,protocol,0,1
124286,in,0,0
124287,sheep,0,0
124288,was,0,0
124289,evaluated,0,0
124290,.,0,0
124291,In,0,0
124292,experiment,0,0
124293,1,0,0
124294,",",0,0
124295,Barbados,0,0
124296,Black,0,1
124297,Belly,0,1
124298,ewes,0,1
124299,(,0,1
124300,n=34,0,0
124301,),0,1
124302,and,0,0
124303,ewe,0,1
124304,lambs,0,1
124305,(,0,0
124306,n=35,0,0
124307,;,0,0
124308,37.5?0.9,0,0
124309,kg,0,0
124310,),0,0
124311,were,1,0
124312,assigned,1,0
124313,to,1,0
124314,be,1,0
124315,untreated,1,0
124316,",",1,0
124317,control,1,1
124318,animals,1,0
124319,(,1,0
124320,C,1,1
124321,),1,1
124322,",",1,0
124323,or,1,1
124324,to,1,0
124325,receive,1,1
124326,PGF,1,1
124327,(,1,1
124328,2?,1,1
124329,),1,0
124330,on,1,0
124331,d0,1,0
124332,(,1,1
124333,PG,1,1
124334,),1,1
124335,",",1,0
124336,or,1,1
124337,receive,1,0
124338,two,1,0
124339,injections,1,1
124340,of,1,0
124341,progesterone,1,1
124342,(,1,0
124343,200mg,1,1
124344,",",1,0
124345,i.m,1,1
124346,.,1,0
124347,each,1,0
124348,),1,0
124349,on,1,0
124350,D,1,1
124351,-5,1,0
124352,and,1,0
124353,on,1,0
124354,D,1,1
124355,-2.5,1,0
124356,",",1,0
124357,prior,1,0
124358,to,1,0
124359,PGF,1,1
124360,(,1,1
124361,2?,1,1
124362,),1,0
124363,",",1,0
124364,on,1,0
124365,D,1,1
124366,0,1,0
124367,(,1,0
124368,2PPG,1,1
124369,),1,0
124370,.,1,0
124371,Treatment,1,0
124372,with,0,0
124373,2PPG,0,1
124374,increased,0,0
124375,the,0,0
124376,proportion,0,0
124377,of,0,0
124378,animals,0,0
124379,lambing,0,0
124380,to,0,0
124381,the,0,0
124382,first,0,0
124383,service,0,1
124384,(,0,0
124385,P,0,0
124386,<,0,0
124387,0.05,0,0
124388,),0,0
124389,",",0,0
124390,an,0,0
124391,effect,0,0
124392,that,0,0
124393,was,0,0
124394,greater,0,0
124395,in,0,0
124396,ewe,0,1
124397,lambs,0,0
124398,than,0,0
124399,ewes,0,1
124400,(,0,0
124401,treatment,0,0
124402,?,0,0
124403,parity,0,0
124404,;,0,0
124405,P,0,0
124406,<,0,0
124407,0.05,0,0
124408,),0,0
124409,.,0,0
124410,The,0,0
124411,interval,0,0
124412,from,0,0
124413,ram,0,1
124414,introduction,0,0
124415,to,0,0
124416,lambing,0,0
124417,and,0,0
124418,the,0,0
124419,mean,0,0
124420,lambing,0,0
124421,day,0,0
124422,was,0,0
124423,less,0,0
124424,(,0,0
124425,P=0.04,0,0
124426,),0,1
124427,in,0,0
124428,the,0,0
124429,2PPG-treated,0,0
124430,animals,0,0
124431,compared,0,0
124432,to,0,0
124433,control,0,0
124434,animals,0,0
124435,.,0,0
124436,In,0,0
124437,Experiment,0,0
124438,2,0,0
124439,",",0,0
124440,lactating,0,0
124441,ewes,0,1
124442,from,0,0
124443,experiment,0,0
124444,1,0,0
124445,(,0,0
124446,n=61,0,0
124447,),0,1
124448,60-85,0,0
124449,days,0,0
124450,postpartum,0,0
124451,were,0,0
124452,assigned,0,0
124453,within,0,0
124454,parity,0,0
124455,and,0,0
124456,number,0,0
124457,of,0,0
124458,lambs,0,0
124459,reared,0,0
124460,to,0,0
124461,remain,0,0
124462,nursing,0,1
124463,(,0,0
124464,S,0,1
124465,;,0,1
124466,n=29,0,0
124467,),0,1
124468,or,0,1
124469,weaned,0,0
124470,(,0,0
124471,W,0,1
124472,;,0,1
124473,n=32,0,0
124474,),0,0
124475,3,0,0
124476,weeks,0,0
124477,prior,0,0
124478,to,0,0
124479,treatment,0,0
124480,with,0,0
124481,the,0,0
124482,2PPG,0,1
124483,protocol,0,0
124484,.,0,0
124485,There,0,0
124486,was,0,0
124487,no,0,0
124488,effect,0,0
124489,of,0,0
124490,treatment,0,0
124491,on,0,0
124492,the,0,0
124493,proportion,0,0
124494,of,0,0
124495,animals,0,0
124496,lambing,0,0
124497,to,0,0
124498,the,0,0
124499,first,0,0
124500,service,0,1
124501,or,0,1
124502,overall,0,0
124503,",",0,0
124504,interval,0,0
124505,from,0,0
124506,ram,0,1
124507,introduction,0,0
124508,to,0,0
124509,lambing,0,0
124510,and,0,0
124511,lambing,0,0
124512,interval,0,0
124513,.,0,0
124514,An,0,0
124515,8-month,0,0
124516,lambing,0,0
124517,interval,0,0
124518,was,0,0
124519,observed,0,0
124520,in,0,0
124521,ewes,0,0
124522,in,0,0
124523,which,0,0
124524,estrus,0,0
124525,was,0,0
124526,synchronized,0,1
124527,regardless,0,0
124528,of,0,0
124529,physiological,0,0
124530,state,0,0
124531,.,0,0
124532,In,0,0
124533,conclusion,0,0
124534,",",0,0
124535,the,0,0
124536,two-progesterone,0,1
124537,injection,0,1
124538,synchronization,0,1
124539,protocol,0,1
124540,may,0,0
124541,be,0,0
124542,used,0,0
124543,as,0,0
124544,a,0,0
124545,practical,0,0
124546,low,0,0
124547,cost,0,0
124548,and,0,0
124549,efficient,0,0
124550,method,0,1
124551,of,0,0
124552,synchronizing,0,0
124553,estrus,0,0
124554,to,0,0
124555,reduce,0,0
124556,the,0,0
124557,lambing,0,0
124558,interval,0,0
124559,and,0,0
124560,maximize,0,0
124561,productivity,0,0
124562,in,0,0
124563,tropical,0,0
124564,breeds,0,0
124565,of,0,0
124566,sheep,0,0
124567,.,0,0
124568,Positive,0,0
124569,impact,0,0
124570,of,0,0
124571,crisis,1,0
124572,resource,1,1
124573,management,1,1
124574,training,1,1
124575,on,0,0
124576,no-flow,0,1
124577,time,0,0
124578,and,0,0
124579,team,0,0
124580,member,0,0
124581,verbalisations,0,0
124582,during,0,0
124583,simulated,1,1
124584,cardiopulmonary,1,1
124585,resuscitation,1,1
124586,:,1,0
124587,a,0,0
124588,randomised,0,0
124589,controlled,0,0
124590,trial,0,0
124591,.,0,0
124592,OBJECTIVES,0,0
124593,To,0,0
124594,evaluate,0,0
124595,the,0,0
124596,impact,0,0
124597,of,0,0
124598,video-based,1,1
124599,interactive,1,1
124600,crisis,1,0
124601,resource,1,1
124602,management,1,1
124603,(,1,1
124604,CRM,1,1
124605,),1,1
124606,training,1,1
124607,on,0,0
124608,no-flow,0,1
124609,time,0,0
124610,(,0,1
124611,NFT,0,1
124612,),0,1
124613,and,0,0
124614,on,0,0
124615,proportions,0,0
124616,of,0,0
124617,team,0,0
124618,member,0,0
124619,verbalisations,0,0
124620,(,0,0
124621,TMV,0,1
124622,),0,1
124623,during,0,0
124624,simulated,1,1
124625,cardiopulmonary,1,1
124626,resuscitation,1,1
124627,(,1,1
124628,CPR,1,1
124629,),1,0
124630,.,0,0
124631,Further,0,0
124632,",",0,0
124633,to,0,0
124634,investigate,0,0
124635,the,0,0
124636,link,0,0
124637,between,0,0
124638,team,0,0
124639,leader,0,0
124640,verbalisation,0,1
124641,accuracy,0,0
124642,and,0,0
124643,NFT,0,0
124644,.,0,0
124645,METHODS,0,0
124646,The,0,0
124647,randomised,0,0
124648,controlled,0,0
124649,study,0,0
124650,was,0,0
124651,embedded,0,0
124652,in,0,0
124653,the,0,0
124654,obligatory,0,0
124655,advanced,0,0
124656,life,0,0
124657,support,0,1
124658,(,0,1
124659,ALS,0,1
124660,),0,1
124661,course,0,0
124662,for,0,0
124663,final-year,0,0
124664,medical,0,0
124665,students,0,0
124666,.,0,0
124667,Students,0,0
124668,(,0,0
124669,176,0,0
124670,;,0,0
124671,25.35?1.03,0,0
124672,years,0,0
124673,",",0,0
124674,63,0,0
124675,%,0,0
124676,female,0,0
124677,),0,0
124678,were,0,0
124679,alphabetically,0,1
124680,assigned,0,0
124681,to,0,0
124682,44,0,0
124683,four-person,0,1
124684,teams,0,0
124685,that,0,0
124686,were,0,0
124687,then,0,1
124688,randomly,0,0
124689,(,0,0
124690,computer-generated,0,1
124691,),0,1
124692,assigned,0,0
124693,to,0,0
124694,either,1,1
124695,CRM,1,1
124696,intervention,1,1
124697,(,0,1
124698,n=26,0,0
124699,),0,1
124700,",",0,0
124701,receiving,1,0
124702,interactive,1,1
124703,video-based,1,1
124704,CRM-training,1,1
124705,",",1,0
124706,or,1,0
124707,to,1,0
124708,control,1,1
124709,intervention,1,1
124710,(,1,1
124711,n=18,1,0
124712,),1,1
124713,",",1,0
124714,receiving,1,0
124715,an,1,0
124716,additional,1,0
124717,ALS-training,1,1
124718,.,1,0
124719,Primary,0,0
124720,outcomes,0,0
124721,were,0,0
124722,NFT,0,0
124723,and,0,0
124724,proportions,0,0
124725,of,0,0
124726,TMV,0,0
124727,",",0,0
124728,which,0,0
124729,were,0,0
124730,subdivided,0,0
124731,into,0,0
124732,eight,0,0
124733,categories,0,0
124734,:,0,0
124735,four,0,0
124736,team,0,0
124737,leader,0,0
124738,verbalisations,0,0
124739,(,0,0
124740,TLV,0,0
124741,),0,1
124742,with,0,0
124743,different,0,0
124744,accuracy,0,0
124745,levels,0,0
124746,and,0,0
124747,four,0,0
124748,follower,0,0
124749,verbalisation,0,0
124750,categories,0,0
124751,(,0,0
124752,FV,0,0
124753,),0,0
124754,.,0,0
124755,Measurements,0,0
124756,were,0,0
124757,made,0,0
124758,of,0,0
124759,all,0,0
124760,groups,0,0
124761,administering,0,0
124762,simulated,0,1
124763,adult,0,0
124764,CPR,0,1
124765,.,0,0
124766,RESULTS,0,0
124767,NFT,0,0
124768,rates,0,0
124769,were,0,0
124770,significantly,0,0
124771,lower,0,0
124772,in,0,0
124773,the,0,0
124774,CRM-training,0,1
124775,group,0,0
124776,(,0,0
124777,31.4?6.1,0,0
124778,%,0,0
124779,vs.,0,0
124780,36.3?6.6,0,0
124781,%,0,0
124782,",",0,0
124783,p=0.014,0,0
124784,),0,0
124785,.,0,0
124786,Proportions,0,0
124787,of,0,0
124788,all,0,0
124789,TLV,1,0
124790,categories,1,0
124791,were,0,0
124792,higher,0,0
124793,in,0,0
124794,the,0,0
124795,CRM-training,0,1
124796,group,0,1
124797,(,0,0
124798,p,0,0
124799,<,0,0
124800,0.001,0,0
124801,),0,0
124802,.,0,0
124803,Differences,0,0
124804,in,0,0
124805,FV,0,0
124806,were,0,0
124807,only,0,0
124808,found,0,0
124809,for,0,0
124810,one,0,0
124811,category,0,0
124812,(,0,0
124813,unsolicited,0,0
124814,information,0,1
124815,),0,1
124816,(,0,1
124817,p=0.012,0,0
124818,),0,0
124819,.,0,0
124820,The,0,0
124821,highest,0,0
124822,correlation,0,0
124823,with,0,0
124824,NFT,0,0
124825,was,0,0
124826,found,0,0
124827,for,0,0
124828,high,0,0
124829,accuracy,1,0
124830,TLV,1,0
124831,(,1,0
124832,direct,1,1
124833,orders,0,1
124834,),0,0
124835,(,0,1
124836,p=0.06,0,0
124837,),0,0
124838,.,0,0
124839,CONCLUSIONS,0,0
124840,The,0,0
124841,inclusion,0,0
124842,of,0,0
124843,CRM,1,1
124844,training,1,1
124845,in,1,0
124846,undergraduate,0,0
124847,medical,0,0
124848,education,0,1
124849,reduces,0,0
124850,NFT,0,0
124851,in,0,0
124852,simulated,1,1
124853,CPR,1,1
124854,and,1,0
124855,improves,0,0
124856,TLV,0,0
124857,proportions,0,0
124858,during,1,0
124859,simulated,1,1
124860,CPR,1,0
124861,.,1,0
124862,Further,1,0
124863,research,0,0
124864,will,0,0
124865,test,0,0
124866,how,0,0
124867,these,0,0
124868,results,0,0
124869,translate,0,0
124870,into,0,0
124871,clinical,0,0
124872,performance,0,0
124873,and,0,0
124874,patient,0,0
124875,outcome,0,0
124876,.,0,0
124877,Single-agent,0,1
124878,irinotecan,1,1
124879,or,1,1
124880,FOLFIRI,1,1
124881,as,0,0
124882,second-line,0,1
124883,chemotherapy,1,1
124884,for,0,0
124885,advanced,0,0
124886,colorectal,0,0
124887,cancer,0,0
124888,;,0,0
124889,results,0,0
124890,of,0,0
124891,a,0,0
124892,randomised,0,0
124893,phase,0,0
124894,II,0,1
124895,study,0,0
124896,(,0,1
124897,DaVINCI,0,0
124898,),0,1
124899,and,0,0
124900,meta-analysis,0,0
124901,[,0,0
124902,corrected,0,0
124903,],0,0
124904,.,0,0
124905,BACKGROUND,0,0
124906,Second-line,0,1
124907,treatment,0,0
124908,with,0,0
124909,irinotecan,1,1
124910,for,0,0
124911,advanced,0,0
124912,or,0,1
124913,metastatic,0,0
124914,colorectal,0,0
124915,cancer,0,0
124916,prolongs,0,1
124917,survival,0,0
124918,.,0,0
124919,It,0,0
124920,is,0,0
124921,uncertain,0,0
124922,whether,0,0
124923,irinotecan,1,1
124924,is,0,0
124925,better,0,0
124926,administered,0,0
124927,with,0,0
124928,5-fluorouracil,1,1
124929,or,0,1
124930,alone,0,1
124931,in,0,0
124932,patients,0,0
124933,previously,0,0
124934,treated,0,0
124935,with,0,0
124936,a,0,0
124937,fluoropyrimidine,1,1
124938,.,1,0
124939,We,0,0
124940,compared,0,0
124941,toxicity,0,0
124942,(,0,0
124943,particularly,0,0
124944,diarrhoea,0,0
124945,),0,0
124946,",",0,0
124947,quality,0,0
124948,of,0,0
124949,life,0,0
124950,",",0,0
124951,and,0,0
124952,efficacy,0,0
124953,of,0,0
124954,combination,0,1
124955,chemotherapy,1,1
124956,and,0,0
124957,irinotecan,1,1
124958,in,0,0
124959,these,0,0
124960,patients,0,0
124961,.,0,0
124962,METHODS,0,0
124963,In,0,0
124964,DaVINCI,0,0
124965,",",0,0
124966,a,0,0
124967,randomised,0,0
124968,phase,0,0
124969,II,0,1
124970,trial,0,0
124971,",",0,0
124972,patients,0,0
124973,with,0,0
124974,advanced,0,0
124975,colorectal,0,0
124976,cancer,0,0
124977,were,0,0
124978,randomly,0,0
124979,allocated,0,0
124980,to,0,0
124981,:,0,0
124982,Combination,1,1
124983,therapy,1,1
124984,(,1,1
124985,FOLFIRI,1,1
124986,),1,1
124987,",",1,0
124988,irinotecan,1,1
124989,(,0,0
124990,180,0,0
124991,mg/m,0,1
124992,(,0,0
124993,2,0,0
124994,),0,0
124995,IV,0,0
124996,over,0,0
124997,90,0,0
124998,min,0,0
124999,",",0,0
125000,day,0,0
125001,1,0,0
125002,),0,0
125003,",",0,0
125004,5-fluorouracil,1,1
125005,(,0,1
125006,400mg/m,0,1
125007,(,0,0
125008,2,0,0
125009,),0,0
125010,IV,0,0
125011,bolus,0,1
125012,and,0,0
125013,2400,0,1
125014,mg/m,0,1
125015,(,0,0
125016,2,0,0
125017,),0,0
125018,by,0,0
125019,46-hour,0,0
125020,infusion,0,1
125021,from,0,0
125022,day,0,1
125023,1,0,0
125024,),0,0
125025,and,0,0
125026,folinic,1,1
125027,acid,1,1
125028,(,0,1
125029,20mg/m,0,1
125030,(,0,0
125031,2,0,0
125032,),0,0
125033,IV,0,0
125034,bolus,0,1
125035,",",0,0
125036,day,0,1
125037,1,0,0
125038,),0,0
125039,",",0,0
125040,2-weekly,0,1
125041,;,0,0
125042,or,0,1
125043,Single-agent,0,1
125044,",",0,0
125045,irinotecan,1,1
125046,(,0,0
125047,350,0,1
125048,mg/m,0,1
125049,(,0,0
125050,2,0,0
125051,),0,0
125052,IV,0,0
125053,over,0,0
125054,90,0,0
125055,min,0,0
125056,),0,0
125057,",",0,0
125058,3-weekly,0,1
125059,.,0,0
125060,Toxicity,0,0
125061,was,0,0
125062,evaluated,0,0
125063,every,0,1
125064,treatment,0,0
125065,cycle,0,0
125066,;,0,0
125067,QOL,0,1
125068,and,0,0
125069,response,0,0
125070,6-weekly,0,1
125071,.,0,0
125072,Analysis,0,0
125073,was,0,0
125074,by,0,0
125075,intention,0,0
125076,to,0,0
125077,treat,0,0
125078,.,0,0
125079,The,0,0
125080,trial,0,0
125081,",",0,0
125082,amended,0,1
125083,from,0,0
125084,a,0,0
125085,larger,0,0
125086,factorial,0,0
125087,design,0,0
125088,",",0,0
125089,was,0,0
125090,terminated,0,0
125091,early,0,0
125092,due,0,0
125093,to,0,0
125094,slow,0,0
125095,recruitment,0,0
125096,.,0,0
125097,Results,0,0
125098,were,0,0
125099,also,0,0
125100,combined,0,1
125101,with,0,0
125102,other,0,0
125103,second-line,0,1
125104,irinotecan,1,1
125105,trials,0,0
125106,.,0,0
125107,FINDINGS,0,0
125108,We,0,0
125109,randomised,0,0
125110,44,0,0
125111,patients,0,0
125112,to,0,0
125113,combination,0,1
125114,and,0,0
125115,45,0,0
125116,to,0,0
125117,single,0,0
125118,agent,0,0
125119,.,0,0
125120,Eight,0,0
125121,patients,0,0
125122,in,0,0
125123,the,0,0
125124,irinotecan,0,1
125125,arm,0,0
125126,and,0,0
125127,4,0,0
125128,in,0,0
125129,the,0,0
125130,combination,0,1
125131,arm,0,0
125132,had,0,0
125133,grade,0,0
125134,3/4,0,0
125135,diarrhoea,0,0
125136,(,0,1
125137,P=0.24,0,0
125138,),0,1
125139,.,0,0
125140,Treatment,0,0
125141,groups,0,0
125142,did,0,0
125143,not,0,0
125144,differ,0,0
125145,significantly,0,0
125146,in,0,0
125147,overall,0,0
125148,QOL,0,0
125149,changes,0,0
125150,",",0,0
125151,response,0,0
125152,rate,0,0
125153,or,0,1
125154,progression,0,0
125155,free,0,0
125156,or,0,1
125157,overall-survival,0,0
125158,.,0,0
125159,In,0,0
125160,a,0,0
125161,systematic,0,0
125162,review,0,0
125163,of,0,0
125164,29,0,0
125165,trials,0,0
125166,of,0,0
125167,second-line,0,1
125168,irinotecan-based,1,1
125169,treatment,0,0
125170,",",0,0
125171,single-agent,0,1
125172,irinotecan,1,1
125173,was,0,0
125174,associated,0,0
125175,with,0,0
125176,more,0,0
125177,diarrhoea,0,0
125178,and,0,0
125179,alopecia,0,0
125180,than,0,0
125181,the,0,0
125182,combination,0,1
125183,but,0,0
125184,efficacy,0,0
125185,was,0,0
125186,similar,0,0
125187,.,0,0
125188,INTERPRETATION,0,0
125189,Combination,1,1
125190,treatment,1,0
125191,compared,0,0
125192,with,0,0
125193,single-agent,0,1
125194,irinotecan,1,1
125195,reduces,0,0
125196,alopecia,0,0
125197,and,0,0
125198,diarrhoea,0,0
125199,without,0,1
125200,compromising,0,0
125201,efficacy,0,0
125202,on,0,0
125203,clinical,0,0
125204,outcomes,0,0
125205,.,0,0
125206,Both,0,0
125207,regimens,0,0
125208,remain,0,0
125209,as,0,0
125210,reasonable,0,0
125211,treatment,0,0
125212,options,0,0
125213,.,0,0
125214,FUNDING,0,0
125215,Research,0,0
125216,grant,0,0
125217,(,0,1
125218,Pfizer,0,1
125219,),0,0
125220,.,0,0
125221,Preoperative,0,1
125222,beta-blocker,1,1
125223,usage,1,0
125224,:,1,0
125225,is,0,0
125226,it,0,0
125227,really,0,0
125228,worthy,0,0
125229,of,0,0
125230,being,0,0
125231,a,0,0
125232,quality,0,0
125233,indicator,0,0
125234,?,0,0
125235,BACKGROUND,0,0
125236,Since,0,0
125237,2007,0,0
125238,",",0,0
125239,the,0,0
125240,use,0,0
125241,of,0,0
125242,preoperative,1,0
125243,?-blockers,1,1
125244,has,0,0
125245,been,0,0
125246,used,0,0
125247,as,0,0
125248,a,0,0
125249,quality,0,0
125250,standard,0,1
125251,for,0,0
125252,patients,0,0
125253,undergoing,0,0
125254,coronary,0,0
125255,artery,0,1
125256,bypass,0,1
125257,graft,0,1
125258,surgery,0,1
125259,.,0,0
125260,Recent,0,0
125261,studies,0,0
125262,have,0,0
125263,called,0,0
125264,into,0,0
125265,question,0,0
125266,of,0,0
125267,the,0,0
125268,benefit,0,0
125269,of,0,0
125270,empiric,0,0
125271,preoperative,0,1
125272,?-blocker,0,1
125273,use,0,0
125274,.,0,0
125275,METHODS,0,0
125276,Data,0,0
125277,were,0,0
125278,extracted,0,0
125279,from,0,0
125280,our,0,0
125281,Society,0,0
125282,of,0,0
125283,Thoracic,0,0
125284,Surgeons,0,1
125285,certified,0,0
125286,database,0,0
125287,for,0,0
125288,patients,0,0
125289,undergoing,0,0
125290,isolated,0,0
125291,coronary,0,0
125292,artery,0,0
125293,bypass,0,1
125294,graft,0,1
125295,surgery,0,1
125296,from,0,0
125297,2000,0,0
125298,to,0,0
125299,2008,0,0
125300,.,0,0
125301,We,0,0
125302,compared,0,0
125303,the,0,0
125304,outcomes,0,0
125305,for,0,0
125306,patients,0,0
125307,who,0,0
125308,received,1,0
125309,preoperative,1,0
125310,?-blockers,1,1
125311,with,1,0
125312,those,0,0
125313,of,0,0
125314,patients,0,0
125315,who,0,0
125316,did,0,0
125317,not,0,0
125318,.,0,0
125319,RESULTS,0,0
125320,The,0,0
125321,study,0,0
125322,group,0,0
125323,had,0,0
125324,"12,855",0,0
125325,patients,0,0
125326,",",0,0
125327,of,0,0
125328,whom,0,0
125329,"7,967",0,0
125330,(,0,0
125331,62.0,0,0
125332,%,0,0
125333,),0,0
125334,were,0,0
125335,treated,0,0
125336,preoperatively,0,0
125337,with,0,0
125338,?-blockers,0,1
125339,.,0,0
125340,Using,0,0
125341,propensity,0,0
125342,matching,0,0
125343,",",0,0
125344,we,0,0
125345,selected,0,0
125346,two,0,0
125347,matched,0,0
125348,groups,0,0
125349,of,0,0
125350,"4,474",0,0
125351,patients,0,0
125352,with,0,0
125353,preoperative,1,1
125354,?-blocker,1,1
125355,use,1,0
125356,and,0,0
125357,"4,474",0,0
125358,not,0,0
125359,using,0,0
125360,preoperative,0,0
125361,?-blockers,0,1
125362,.,0,0
125363,In,0,0
125364,the,0,0
125365,unmatched,0,0
125366,cohort,0,0
125367,",",0,0
125368,only,0,0
125369,deep,0,1
125370,sternal,0,1
125371,infection,0,0
125372,(,0,0
125373,0.3,0,1
125374,%,0,0
125375,versus,0,1
125376,0.5,0,1
125377,%,0,0
125378,without,0,0
125379,?-blockers,0,1
125380,;,0,0
125381,p=0.032,0,0
125382,),0,0
125383,",",0,0
125384,pneumonia,0,0
125385,(,0,0
125386,1.9,0,0
125387,%,0,0
125388,versus,0,1
125389,2.4,0,0
125390,%,0,0
125391,without,0,0
125392,?-blockers,0,1
125393,;,0,0
125394,p=0.039,0,0
125395,),0,0
125396,",",0,0
125397,and,0,0
125398,intraoperative,0,1
125399,blood,0,1
125400,usage,0,0
125401,(,0,0
125402,37.2,0,0
125403,%,0,0
125404,versus,0,1
125405,34.1,0,0
125406,%,0,0
125407,without,0,0
125408,?-blockers,0,1
125409,;,0,0
125410,p,0,0
125411,<,0,0
125412,0.001,0,0
125413,),0,0
125414,reached,0,0
125415,statistically,0,0
125416,significant,0,0
125417,difference,0,0
125418,.,0,0
125419,In,0,0
125420,the,0,0
125421,matched,0,0
125422,groups,0,0
125423,",",0,0
125424,there,0,0
125425,was,0,0
125426,no,0,0
125427,difference,0,0
125428,between,0,0
125429,adverse,0,0
125430,event,0,0
125431,rates,0,0
125432,in,0,0
125433,patients,0,0
125434,treated,0,0
125435,with,0,0
125436,?-blockers,0,1
125437,and,0,0
125438,those,0,0
125439,who,0,0
125440,were,0,0
125441,not,0,0
125442,.,0,0
125443,The,0,0
125444,number,0,0
125445,of,0,0
125446,patients,0,0
125447,requiring,0,0
125448,intraoperative,0,1
125449,blood,0,0
125450,product,0,1
125451,use,0,0
125452,was,0,0
125453,significantly,0,0
125454,higher,0,0
125455,among,0,0
125456,?-blocker-treated,0,0
125457,patients,0,0
125458,(,0,0
125459,p=0.004,0,0
125460,),0,1
125461,.,0,0
125462,Calculating,0,0
125463,the,0,0
125464,adjusted,0,0
125465,odds,0,0
125466,ratios,0,0
125467,showed,0,0
125468,that,0,0
125469,in,0,0
125470,the,0,0
125471,matched,0,0
125472,groups,0,0
125473,",",0,0
125474,the,0,0
125475,preoperative,0,0
125476,use,0,0
125477,of,0,0
125478,?-blockers,0,1
125479,was,0,0
125480,not,0,0
125481,an,0,0
125482,independent,0,0
125483,predictor,0,0
125484,of,0,0
125485,mortality,0,0
125486,.,0,0
125487,CONCLUSIONS,0,0
125488,A,0,0
125489,rational,0,0
125490,for,0,0
125491,preoperative,0,0
125492,?-blockade,0,1
125493,exists,0,0
125494,.,0,0
125495,However,0,0
125496,",",0,0
125497,as,0,0
125498,with,0,0
125499,any,0,0
125500,medical,0,0
125501,intervention,0,1
125502,",",0,0
125503,its,0,0
125504,application,0,0
125505,should,0,0
125506,be,0,0
125507,tailored,0,0
125508,to,0,0
125509,specific,0,0
125510,clinical,0,0
125511,scenarios,0,0
125512,.,0,0
125513,With,0,0
125514,no,0,0
125515,differences,0,0
125516,in,0,0
125517,mortality,0,0
125518,or,0,1
125519,morbidity,0,0
125520,",",0,0
125521,our,0,0
125522,findings,0,0
125523,do,0,0
125524,not,0,0
125525,support,0,0
125526,preoperative,0,0
125527,?-blockade,0,1
125528,as,0,0
125529,a,0,0
125530,useful,0,0
125531,quality,0,0
125532,indicator,0,0
125533,for,0,0
125534,coronary,0,0
125535,artery,0,0
125536,bypass,0,1
125537,graft,0,1
125538,surgery,0,0
125539,.,0,0
125540,Insulin,1,1
125541,pump,1,1
125542,therapy,1,1
125543,started,0,0
125544,at,0,0
125545,the,0,0
125546,time,0,0
125547,of,0,0
125548,diagnosis,0,0
125549,:,0,0
125550,effects,0,0
125551,on,0,0
125552,glycemic,0,0
125553,control,0,1
125554,and,0,0
125555,pancreatic,0,0
125556,?-cell,0,0
125557,function,0,0
125558,in,0,0
125559,type,0,0
125560,1,0,0
125561,diabetes,0,0
125562,.,0,0
125563,BACKGROUND,0,0
125564,In,0,0
125565,the,0,0
125566,interest,0,0
125567,of,0,0
125568,preserving,0,0
125569,residual,0,0
125570,insulin,0,1
125571,secretory,0,0
125572,capacity,0,0
125573,present,0,0
125574,at,0,0
125575,the,0,0
125576,time,0,0
125577,of,0,0
125578,diagnosis,0,0
125579,with,0,0
125580,type,0,0
125581,1,0,0
125582,diabetes,0,0
125583,(,0,0
125584,T1D,0,1
125585,),0,0
125586,",",0,0
125587,we,0,0
125588,compared,0,0
125589,the,0,0
125590,efficacy,0,0
125591,of,0,0
125592,starting,1,0
125593,insulin,1,1
125594,pump,1,1
125595,therapy,1,1
125596,at,0,0
125597,diagnosis,0,0
125598,with,1,0
125599,standard,1,1
125600,multiple,1,0
125601,daily,1,1
125602,insulin,1,1
125603,injections,1,1
125604,(,1,0
125605,MDIs,1,0
125606,),1,0
125607,.,1,0
125608,METHODS,0,0
125609,We,0,0
125610,conducted,0,0
125611,a,0,0
125612,prospective,0,0
125613,",",0,0
125614,randomized,0,0
125615,",",0,0
125616,pilot,0,0
125617,trial,0,0
125618,comparing,1,0
125619,MDI,1,0
125620,therapy,1,1
125621,with,1,0
125622,continuous,1,1
125623,subcutaneous,1,1
125624,insulin,1,1
125625,therapy,1,1
125626,(,1,1
125627,pump,1,1
125628,therapy,1,1
125629,),1,0
125630,in,0,0
125631,24,0,0
125632,patients,0,0
125633,",",0,0
125634,8-18,0,0
125635,years,0,0
125636,old,0,0
125637,",",0,0
125638,with,0,0
125639,newly,0,0
125640,diagnosed,0,0
125641,T1D,0,1
125642,.,0,0
125643,Subjects,0,0
125644,were,0,0
125645,evaluated,0,0
125646,at,0,0
125647,enrollment,0,0
125648,and,0,0
125649,1,0,0
125650,",",0,0
125651,3,0,0
125652,",",0,0
125653,6,0,0
125654,",",0,0
125655,9,0,0
125656,",",0,0
125657,and,0,0
125658,12,0,0
125659,months,0,0
125660,after,0,0
125661,initial,0,0
125662,diagnosis,0,0
125663,of,0,0
125664,T1D,0,1
125665,.,0,0
125666,Preservation,0,0
125667,of,0,0
125668,insulin,0,1
125669,secretion,0,0
125670,",",0,0
125671,measured,0,0
125672,by,0,0
125673,mixed-meal-stimulated,0,1
125674,C-peptide,0,1
125675,secretion,0,0
125676,",",0,0
125677,was,0,0
125678,compared,0,0
125679,after,0,0
125680,6,0,0
125681,and,0,0
125682,12,0,0
125683,months,0,0
125684,of,0,0
125685,treatment,0,0
125686,.,0,0
125687,Between-group,0,0
125688,differences,0,0
125689,in,0,0
125690,glycosylated,0,0
125691,hemoglobin,0,0
125692,(,0,1
125693,HbA1c,0,1
125694,),0,1
125695,",",0,0
125696,continuous,0,1
125697,glucose,0,0
125698,sensor,0,1
125699,data,0,0
125700,",",0,0
125701,insulin,0,1
125702,utilization,0,0
125703,",",0,0
125704,anthropometric,0,0
125705,measures,0,0
125706,",",0,0
125707,and,0,0
125708,patient,0,0
125709,satisfaction,0,0
125710,with,1,0
125711,therapy,1,1
125712,were,0,0
125713,also,0,0
125714,compared,0,0
125715,at,0,0
125716,multiple,0,0
125717,time,0,0
125718,points,0,0
125719,.,0,0
125720,RESULTS,0,0
125721,Initiation,0,0
125722,of,1,0
125723,pump,1,1
125724,therapy,1,1
125725,within,0,0
125726,1,0,0
125727,month,0,0
125728,of,0,0
125729,diagnosis,0,0
125730,resulted,0,0
125731,in,0,0
125732,consistently,0,0
125733,higher,0,0
125734,mixed-meal,0,1
125735,tolerance,0,0
125736,test-stimulated,0,0
125737,C-peptide,0,1
125738,values,0,0
125739,at,0,0
125740,all,0,0
125741,time,0,0
125742,points,0,0
125743,",",0,0
125744,although,0,0
125745,these,0,0
125746,differences,0,0
125747,were,0,0
125748,not,0,0
125749,statistically,0,0
125750,significant,0,0
125751,.,0,0
125752,Nonetheless,0,0
125753,",",0,0
125754,improved,0,0
125755,glycemic,0,0
125756,control,0,1
125757,was,0,0
125758,observed,0,0
125759,in,1,0
125760,insulin,1,1
125761,pump-treated,1,1
125762,subjects,0,0
125763,(,0,0
125764,more,0,0
125765,time,0,0
125766,spent,0,0
125767,with,0,0
125768,normoglycemia,0,0
125769,",",0,0
125770,better,0,0
125771,mean,0,0
125772,HbA1c,0,1
125773,),0,0
125774,",",0,0
125775,and,1,0
125776,pump-treated,1,0
125777,subjects,0,0
125778,reported,0,0
125779,comparatively,0,0
125780,greater,0,0
125781,satisfaction,0,0
125782,with,0,0
125783,route,0,1
125784,of,0,0
125785,treatment,0,0
125786,administration,0,0
125787,.,0,0
125788,CONCLUSIONS,0,0
125789,Initiation,0,0
125790,of,1,0
125791,insulin,1,1
125792,pump,1,1
125793,therapy,1,1
125794,at,0,0
125795,diagnosis,0,0
125796,improved,0,0
125797,glycemic,0,0
125798,control,0,0
125799,",",0,0
125800,was,0,0
125801,well,0,0
125802,tolerated,0,0
125803,",",0,0
125804,and,0,0
125805,contributed,0,0
125806,to,0,0
125807,improved,0,0
125808,patient,0,0
125809,satisfaction,0,0
125810,with,0,0
125811,treatment,0,0
125812,.,0,0
125813,This,0,0
125814,study,0,0
125815,also,0,0
125816,suggests,0,0
125817,that,0,0
125818,earlier,0,0
125819,use,0,0
125820,of,1,0
125821,pump,1,1
125822,therapy,1,1
125823,might,0,0
125824,help,0,0
125825,to,0,0
125826,preserve,0,0
125827,residual,0,0
125828,?-cell,0,0
125829,function,0,0
125830,",",0,0
125831,although,0,0
125832,a,0,0
125833,larger,0,0
125834,clinical,0,0
125835,trial,0,0
125836,would,0,0
125837,be,0,0
125838,required,0,0
125839,to,0,0
125840,confirm,0,0
125841,this,0,0
125842,.,0,0
125843,Beverage,1,0
125844,vs.,1,0
125845,solid,1,0
125846,fruits,1,1
125847,and,1,0
125848,vegetables,1,1
125849,:,1,0
125850,effects,0,0
125851,on,0,0
125852,energy,0,0
125853,intake,0,1
125854,and,0,0
125855,body,0,0
125856,weight,0,0
125857,.,0,1
125858,Beverage,0,0
125859,consumption,0,0
125860,has,0,0
125861,been,0,0
125862,implicated,0,0
125863,in,0,0
125864,weight,0,0
125865,gain,0,0
125866,",",0,0
125867,but,0,0
125868,questions,0,0
125869,remain,0,0
125870,about,0,0
125871,the,0,0
125872,veracity,0,0
125873,of,0,0
125874,the,0,0
125875,association,0,0
125876,",",0,0
125877,whether,0,0
125878,the,0,0
125879,relationship,0,0
125880,is,0,0
125881,causal,0,0
125882,and,0,0
125883,what,0,0
125884,property,0,0
125885,of,0,0
125886,beverages,0,1
125887,is,0,0
125888,responsible,0,0
125889,.,0,0
125890,It,0,0
125891,was,0,0
125892,hypothesized,0,0
125893,that,0,0
125894,food,0,0
125895,form,0,1
125896,is,0,0
125897,the,0,0
125898,most,0,0
125899,salient,0,0
125900,attribute,0,0
125901,.,0,0
125902,Thus,0,0
125903,",",0,0
125904,a,0,0
125905,randomized,0,0
125906,controlled,0,0
125907,trial,0,0
125908,of,0,0
125909,food,0,1
125910,form,0,0
125911,was,0,0
125912,conducted,0,0
125913,.,0,0
125914,Energy-matched,1,0
125915,beverage,1,1
125916,or,1,1
125917,solid,1,0
125918,forms,1,0
125919,of,1,0
125920,fruits,1,1
125921,and,1,0
125922,vegetables,1,1
125923,were,0,0
125924,provided,0,0
125925,to,0,0
125926,34,0,0
125927,",",0,0
125928,lean,0,0
125929,or,0,1
125930,overweight/obese,0,0
125931,adults,0,0
125932,for,0,0
125933,two,0,0
125934,8-week,0,0
125935,periods,0,0
125936,with,0,0
125937,a,0,0
125938,3-week,0,0
125939,washout,0,0
125940,interspersed,0,1
125941,.,0,0
125942,Dietary,0,1
125943,compensation,0,0
125944,was,0,0
125945,incomplete,0,0
125946,(,0,0
125947,beverage,0,1
125948,53,0,0
125949,%,0,0
125950,;,0,0
125951,solid,0,0
125952,78,0,0
125953,%,0,0
125954,),0,0
125955,and,0,0
125956,body,0,0
125957,weight,0,0
125958,increased,0,0
125959,after,0,0
125960,the,0,0
125961,beverage,0,1
125962,(,0,0
125963,1.95,0,0
125964,?,0,0
125965,0.33,0,0
125966,kg,0,0
125967,),0,1
125968,(,0,0
125969,77,0,0
125970,%,0,0
125971,fat,0,1
125972,mass,0,0
125973,),0,1
125974,and,0,0
125975,solid,0,1
125976,(,0,0
125977,1.36,0,0
125978,?,0,0
125979,0.30,0,0
125980,kg,0,0
125981,),0,1
125982,(,0,0
125983,85,0,0
125984,%,0,0
125985,fat,0,1
125986,mass,0,0
125987,),0,1
125988,treatments,0,1
125989,(,0,0
125990,both,0,0
125991,P,0,0
125992,<,0,0
125993,0.0005,0,0
125994,),0,0
125995,.,0,0
125996,Differences,0,0
125997,between,0,0
125998,food,0,0
125999,forms,0,0
126000,were,0,0
126001,not,0,0
126002,significant,0,0
126003,.,0,0
126004,The,0,0
126005,lean,0,0
126006,group,0,0
126007,had,0,0
126008,the,0,0
126009,highest,0,0
126010,dietary,0,1
126011,compensation,0,0
126012,(,0,0
126013,119,0,0
126014,%,0,0
126015,),0,0
126016,and,0,0
126017,no,0,0
126018,significant,0,0
126019,weight,0,0
126020,change,0,0
126021,(,0,0
126022,0.84,0,0
126023,?,0,0
126024,0.53,0,0
126025,kg,0,0
126026,),0,0
126027,after,0,0
126028,consuming,0,0
126029,the,0,0
126030,solid,0,0
126031,fruits,0,1
126032,and,0,0
126033,vegetables,0,1
126034,whereas,0,0
126035,the,0,0
126036,overweight/obese,0,0
126037,group,0,0
126038,had,0,0
126039,lower,0,0
126040,compensation,0,0
126041,and,0,0
126042,significant,0,0
126043,weight,0,0
126044,gain,0,0
126045,during,0,0
126046,the,0,0
126047,solid,0,0
126048,arm,0,0
126049,(,0,0
126050,46,0,0
126051,%,0,0
126052,",",0,0
126053,1.77,0,0
126054,?,0,0
126055,0.32,0,0
126056,kg,0,0
126057,",",0,0
126058,P,0,0
126059,<,0,0
126060,0.0001,0,0
126061,),0,0
126062,.,0,0
126063,In,0,0
126064,contrast,0,0
126065,",",0,0
126066,incomplete,0,0
126067,dietary,0,1
126068,compensation,0,0
126069,and,0,0
126070,weight,0,0
126071,gain,0,0
126072,occurred,0,0
126073,in,0,0
126074,both,0,0
126075,the,0,0
126076,lean,0,1
126077,(,0,0
126078,43,0,0
126079,%,0,0
126080,",",0,0
126081,1.61,0,0
126082,?,0,0
126083,0.44,0,0
126084,kg,0,0
126085,",",0,0
126086,P,0,0
126087,=,0,0
126088,0.003,0,0
126089,),0,0
126090,and,0,0
126091,overweight/obese,0,0
126092,(,0,0
126093,61,0,0
126094,%,0,0
126095,",",0,0
126096,2.22,0,0
126097,?,0,0
126098,0.47,0,0
126099,kg,0,0
126100,",",0,0
126101,P,0,0
126102,<,0,0
126103,0.0005,0,0
126104,),0,0
126105,groups,0,0
126106,during,0,0
126107,the,0,0
126108,beverage,0,1
126109,arm,0,0
126110,.,0,0
126111,Secondary,0,0
126112,analyses,0,0
126113,revealed,0,0
126114,the,0,0
126115,obese,0,0
126116,group,0,0
126117,gained,0,0
126118,more,0,0
126119,weight,0,0
126120,than,0,0
126121,the,0,0
126122,lean,0,0
126123,and,0,0
126124,overweight,0,0
126125,groups,0,0
126126,during,0,0
126127,the,0,0
126128,beverage,0,1
126129,intervention,0,1
126130,(,0,0
126131,P,0,0
126132,=,0,0
126133,0.024,0,0
126134,),0,0
126135,.,0,0
126136,These,0,0
126137,data,0,0
126138,demonstrate,0,0
126139,energy,0,0
126140,consumed,0,0
126141,as,0,0
126142,beverages,0,1
126143,may,0,0
126144,be,0,0
126145,especially,0,0
126146,problematic,0,0
126147,for,0,0
126148,weight,0,0
126149,gain,0,0
126150,.,0,0
126151,They,0,0
126152,also,0,0
126153,indicate,0,0
126154,that,0,0
126155,advice,0,1
126156,to,0,0
126157,increase,0,0
126158,fruit,0,1
126159,and,0,0
126160,vegetable,0,1
126161,consumption,0,0
126162,should,0,0
126163,emphasize,0,0
126164,total,0,0
126165,energy,0,1
126166,intake,0,0
126167,because,0,0
126168,the,0,0
126169,additional,0,0
126170,energy,0,0
126171,contributed,0,0
126172,may,0,0
126173,promote,0,1
126174,weight,0,0
126175,gain,0,0
126176,",",0,0
126177,especially,0,0
126178,among,0,0
126179,overweight,0,0
126180,and,0,0
126181,obese,0,0
126182,individuals,0,0
126183,.,0,0
126184,Validity,0,0
126185,and,0,0
126186,reliability,0,0
126187,assessment,0,0
126188,of,0,0
126189,the,0,0
126190,Siriraj,1,0
126191,Asthma,1,0
126192,Control,1,1
126193,Questionnaire,1,1
126194,.,1,0
126195,OBJECTIVE,0,0
126196,The,0,0
126197,present,0,0
126198,study,0,0
126199,assessed,0,0
126200,the,0,0
126201,validity,0,0
126202,and,0,0
126203,reliability,0,0
126204,of,0,0
126205,the,0,0
126206,Siriraj,1,0
126207,Asthma,1,0
126208,Control,1,1
126209,Questionnaire,1,1
126210,in,0,0
126211,Asthma,0,0
126212,Clinic,0,1
126213,",",0,0
126214,Siriraj,0,0
126215,Hospital,0,0
126216,.,0,0
126217,MATERIAL,0,0
126218,AND,0,0
126219,METHOD,0,1
126220,The,0,0
126221,data,0,0
126222,of,0,0
126223,the,0,0
126224,questionnaire,0,0
126225,responses,0,0
126226,and,0,0
126227,spirometric,0,0
126228,results,0,0
126229,from,0,0
126230,20,0,0
126231,randomized,0,0
126232,asthmatic,0,0
126233,patients,0,0
126234,in,0,0
126235,the,0,0
126236,clinic,0,0
126237,including,0,0
126238,the,0,0
126239,record,0,0
126240,of,0,0
126241,3,0,0
126242,visits,0,0
126243,for,0,0
126244,each,0,0
126245,subject,0,0
126246,.,0,0
126247,The,0,0
126248,validation,0,0
126249,was,0,0
126250,performed,0,0
126251,by,0,0
126252,Kruskal-Wallis,1,0
126253,test,1,0
126254,comparing,0,0
126255,the,0,0
126256,scores,0,0
126257,with,0,0
126258,the,0,0
126259,level,0,0
126260,of,0,0
126261,asthma,0,0
126262,control,0,0
126263,determined,0,0
126264,by,0,0
126265,physicians,0,0
126266,according,0,0
126267,to,0,0
126268,GINA,0,0
126269,guideline,0,1
126270,.,0,0
126271,Internal,0,0
126272,consistency,0,0
126273,reliability,0,0
126274,was,0,0
126275,analyzed,0,0
126276,by,0,0
126277,Cronbach,0,0
126278,'s,0,0
126279,alpha,0,0
126280,.,0,0
126281,RESULTS,0,0
126282,Sixty,0,0
126283,questionnaires,0,0
126284,from,0,0
126285,20,0,0
126286,patients,0,0
126287,with,0,0
126288,age,0,0
126289,29-73,0,0
126290,years,0,0
126291,were,0,0
126292,analyzed,0,0
126293,.,0,0
126294,There,0,0
126295,were,0,0
126296,40,0,0
126297,controlled,0,0
126298,",",0,0
126299,7,0,0
126300,partly,0,0
126301,controlled,0,0
126302,and,0,0
126303,13,0,0
126304,uncontrolled,0,0
126305,visits,0,0
126306,.,0,0
126307,The,0,0
126308,scores,0,0
126309,from,0,0
126310,5-items,0,0
126311,questionnaires,0,0
126312,and,0,0
126313,6-items,0,0
126314,clinical,0,0
126315,score,0,0
126316,were,0,0
126317,significantly,0,0
126318,associated,0,0
126319,with,0,0
126320,the,0,0
126321,physician-diagnosed,0,0
126322,groups,0,0
126323,(,0,0
126324,i.e.,0,0
126325,",",0,0
126326,controlled,0,0
126327,",",0,0
126328,partly,0,0
126329,controlled,0,0
126330,and,0,0
126331,uncontrolled,0,0
126332,groups,0,0
126333,),0,0
126334,.,0,0
126335,Median,0,0
126336,scores,0,0
126337,(,0,0
126338,min,0,0
126339,",",0,1
126340,max,0,0
126341,),0,0
126342,were,0,0
126343,0,0,0
126344,(,0,0
126345,0,0,0
126346,",",0,0
126347,5,0,0
126348,),0,0
126349,",",0,0
126350,2,0,0
126351,(,0,0
126352,0,0,0
126353,",",0,0
126354,6,0,0
126355,),0,0
126356,",",0,0
126357,4,0,0
126358,(,0,0
126359,0,0,0
126360,",",0,0
126361,12,0,0
126362,),0,0
126363,respectively,0,0
126364,",",0,0
126365,(,0,0
126366,5-items,0,0
126367,",",0,0
126368,p,0,0
126369,<,0,0
126370,0.001,0,0
126371,),0,0
126372,and,0,0
126373,2,0,1
126374,(,0,0
126375,0,0,0
126376,",",0,0
126377,7,0,0
126378,),0,0
126379,",",0,0
126380,3,0,0
126381,(,0,0
126382,1,0,0
126383,",",0,0
126384,7,0,0
126385,),0,0
126386,",",0,0
126387,6,0,0
126388,(,0,0
126389,"2,15",0,0
126390,),0,0
126391,respectively,0,0
126392,",",0,0
126393,(,0,0
126394,6-items,0,0
126395,",",0,0
126396,p,0,0
126397,<,0,0
126398,0.001,0,0
126399,),0,0
126400,.,0,0
126401,Internal,0,0
126402,consistency,0,0
126403,reliability,0,0
126404,of,0,0
126405,both,0,0
126406,5-items,0,0
126407,questionnaire,0,0
126408,and,0,0
126409,6-items,0,0
126410,clinical,0,0
126411,score,0,0
126412,were,0,0
126413,within,0,0
126414,the,0,0
126415,acceptable,0,0
126416,range,0,0
126417,(,0,0
126418,0.829,0,0
126419,and,0,0
126420,0.708,0,0
126421,respectively,0,0
126422,),0,0
126423,.,0,0
126424,5-items,0,0
126425,questionnaire,0,0
126426,is,0,0
126427,more,0,0
126428,associated,0,0
126429,with,0,0
126430,the,0,0
126431,physician,0,1
126432,diagnosed,0,0
126433,group,0,0
126434,and,0,0
126435,more,0,0
126436,consistent,0,0
126437,than,0,0
126438,6-items,0,0
126439,clinical,0,0
126440,score,0,0
126441,.,0,0
126442,Further,0,0
126443,analysis,0,0
126444,revealed,0,0
126445,cutoff,0,0
126446,point,0,0
126447,at,0,0
126448,2.5,0,0
126449,to,0,0
126450,separate,0,0
126451,uncontrolled,0,0
126452,from,0,0
126453,controlled,0,0
126454,or,0,0
126455,partly,0,0
126456,controlled,0,0
126457,patient,0,0
126458,with,0,0
126459,sensitivity,0,0
126460,76.9,0,0
126461,%,0,0
126462,and,0,0
126463,specificity,0,0
126464,89.4,0,0
126465,%,0,0
126466,and,0,0
126467,cutoff,0,0
126468,point,0,0
126469,at,0,0
126470,1.5,0,0
126471,to,0,0
126472,separate,0,0
126473,uncontrolled,0,0
126474,or,0,1
126475,partly,0,0
126476,controlled,0,0
126477,from,0,0
126478,controlled,0,0
126479,patient,0,0
126480,with,0,0
126481,sensitivity,0,0
126482,70.0,0,0
126483,%,0,0
126484,and,0,0
126485,specificity,0,0
126486,85.0,0,0
126487,%,0,0
126488,.,0,0
126489,CONCLUSION,0,0
126490,The,0,0
126491,validity,0,0
126492,and,0,0
126493,reliability,0,0
126494,of,0,0
126495,Siriraj,1,0
126496,Asthma,1,0
126497,Control,1,1
126498,Questionnaire,1,1
126499,is,0,0
126500,acceptable,0,0
126501,and,0,0
126502,might,0,0
126503,be,0,0
126504,used,0,0
126505,in,0,0
126506,the,0,0
126507,clinical,0,0
126508,practice,0,0
126509,and,0,0
126510,research,0,0
126511,in,0,0
126512,Thai,0,0
126513,asthmatic,0,0
126514,patients,0,0
126515,.,0,0
126516,Low-dose,1,1
126517,magnesium,1,1
126518,sulfate,1,1
126519,versus,1,1
126520,Pritchard,1,1
126521,regimen,1,1
126522,for,0,0
126523,the,0,0
126524,treatment,0,0
126525,of,0,0
126526,eclampsia,0,0
126527,imminent,0,0
126528,eclampsia,0,0
126529,.,0,0
126530,The,0,0
126531,effect,0,0
126532,of,0,0
126533,knee,1,0
126534,position,1,0
126535,on,0,0
126536,blood,0,0
126537,loss,0,0
126538,and,0,0
126539,range,0,0
126540,of,0,0
126541,motion,0,0
126542,following,0,0
126543,total,0,0
126544,knee,0,1
126545,arthroplasty,0,1
126546,.,0,0
126547,PURPOSE,0,0
126548,This,0,0
126549,study,0,0
126550,prospectively,0,0
126551,assessed,0,0
126552,the,0,0
126553,effects,0,0
126554,of,0,0
126555,knee,1,0
126556,position,1,0
126557,on,0,0
126558,blood,0,0
126559,loss,0,0
126560,and,0,0
126561,range,0,0
126562,of,0,0
126563,motion,0,0
126564,after,0,0
126565,primary,0,0
126566,total,0,0
126567,knee,0,1
126568,arthroplasty,0,1
126569,(,0,1
126570,TKA,0,1
126571,),0,0
126572,.,0,0
126573,METHODS,0,0
126574,One,0,0
126575,hundred,0,0
126576,and,0,0
126577,ten,0,0
126578,consecutive,0,0
126579,TKA,0,1
126580,patients,0,0
126581,were,0,0
126582,randomized,0,0
126583,into,0,0
126584,flexion,0,0
126585,group,0,1
126586,and,0,0
126587,extension,0,0
126588,group,0,0
126589,.,0,0
126590,Both,0,0
126591,groups,0,0
126592,had,0,0
126593,the,0,0
126594,leg,1,0
126595,elevated,1,0
126596,30?,1,0
126597,at,1,0
126598,the,1,0
126599,hip,1,0
126600,over,1,0
126601,an,1,0
126602,inactive,1,0
126603,CPM,1,0
126604,for,1,0
126605,72,1,0
126606,h,1,0
126607,postoperatively,1,0
126608,.,1,0
126609,The,0,0
126610,flexion,0,0
126611,group,0,0
126612,had,0,0
126613,the,1,0
126614,knee,1,0
126615,flexed,1,1
126616,to,1,0
126617,30?,1,0
126618,during,1,0
126619,this,1,0
126620,period,1,0
126621,.,1,0
126622,The,0,0
126623,extension,0,0
126624,group,0,0
126625,had,0,0
126626,the,1,0
126627,knee,1,0
126628,extended,1,0
126629,fully,1,0
126630,.,1,0
126631,Perioperative,0,0
126632,blood,0,0
126633,loss,0,0
126634,",",0,0
126635,hidden,0,1
126636,blood,0,0
126637,loss,0,0
126638,",",0,0
126639,knee,0,0
126640,swelling,0,0
126641,",",0,0
126642,ecchymosis,0,0
126643,",",0,0
126644,analgesia,0,0
126645,requirements,0,0
126646,",",0,0
126647,range,0,0
126648,of,0,0
126649,motion,0,0
126650,(,0,1
126651,ROM,0,0
126652,),0,0
126653,",",0,0
126654,fixed,0,1
126655,flexion,0,0
126656,deformity,0,0
126657,(,0,1
126658,FFD,0,1
126659,),0,1
126660,",",0,0
126661,straight-leg,0,1
126662,raising,0,0
126663,action,0,0
126664,",",0,0
126665,and,0,0
126666,postoperative,0,0
126667,complications,0,0
126668,within,0,0
126669,6,0,0
126670,weeks,0,0
126671,of,0,0
126672,surgery,0,0
126673,were,0,0
126674,measured,0,0
126675,for,0,0
126676,evaluation,0,0
126677,and,0,0
126678,comparison,0,0
126679,.,0,0
126680,RESULTS,0,0
126681,The,0,0
126682,postoperative,0,0
126683,hidden,0,1
126684,blood,0,0
126685,loss,0,0
126686,",",0,0
126687,knee,0,0
126688,swelling,0,0
126689,",",0,0
126690,and,0,0
126691,scope,0,0
126692,of,0,0
126693,ecchymosis,0,0
126694,were,0,0
126695,significantly,0,0
126696,lower,0,0
126697,in,0,0
126698,the,0,0
126699,flexion,0,0
126700,group,0,0
126701,than,0,0
126702,in,0,0
126703,the,0,0
126704,extension,0,0
126705,group,0,0
126706,",",0,0
126707,and,0,0
126708,ROM,0,0
126709,and,0,0
126710,straight-leg,0,1
126711,raising,0,0
126712,action,0,0
126713,were,0,0
126714,significantly,0,0
126715,higher,0,0
126716,during,0,0
126717,the,0,0
126718,early,0,0
126719,period,0,0
126720,after,0,0
126721,operation,0,0
126722,.,0,0
126723,No,0,0
126724,significant,0,0
126725,difference,0,0
126726,was,0,0
126727,observed,0,0
126728,in,0,0
126729,perioperative,0,1
126730,blood,0,0
126731,loss,0,0
126732,",",0,0
126733,the,0,0
126734,amount,0,0
126735,of,0,0
126736,morphine,0,1
126737,used,0,0
126738,",",0,0
126739,or,0,1
126740,FFD,0,1
126741,in,0,0
126742,the,0,0
126743,early,0,0
126744,postoperative,0,0
126745,period,0,0
126746,or,0,1
126747,in,0,0
126748,ROM,0,0
126749,and,0,0
126750,FFD,0,1
126751,at,0,0
126752,6,0,0
126753,weeks,0,0
126754,postoperatively,0,0
126755,.,0,0
126756,CONCLUSIONS,0,0
126757,The,0,0
126758,findings,0,0
126759,of,0,0
126760,this,0,0
126761,study,0,0
126762,indicate,0,0
126763,that,1,0
126764,flexion,1,0
126765,of,1,0
126766,the,1,0
126767,knee,1,0
126768,to,1,0
126769,30?,0,0
126770,with,0,0
126771,the,0,0
126772,leg,0,0
126773,elevated,0,0
126774,30?,0,0
126775,at,0,0
126776,the,0,0
126777,hip,0,0
126778,after,0,0
126779,total,0,0
126780,knee,0,1
126781,arthroplasty,0,1
126782,may,0,0
126783,mitigate,0,0
126784,knee,0,0
126785,swelling,0,0
126786,and,0,0
126787,provide,0,0
126788,other,0,0
126789,beneficial,0,0
126790,results,0,0
126791,during,0,0
126792,the,0,0
126793,early,0,0
126794,rehabilitation,0,1
126795,following,0,0
126796,TKA,0,1
126797,.,0,0
126798,LEVEL,0,0
126799,OF,0,1
126800,EVIDENCE,0,0
126801,Prospective,0,0
126802,comparative,0,0
126803,study,0,0
126804,",",0,0
126805,Level,0,0
126806,I,0,0
126807,.,0,0
126808,Effect,0,0
126809,of,0,0
126810,gravity,0,0
126811,on,0,0
126812,robot-assisted,1,1
126813,motor,1,0
126814,training,1,1
126815,after,0,0
126816,chronic,0,0
126817,stroke,0,0
126818,:,0,0
126819,a,0,0
126820,randomized,0,0
126821,trial,0,0
126822,.,0,0
126823,OBJECTIVES,0,0
126824,To,0,0
126825,determine,0,0
126826,the,0,0
126827,efficacy,0,0
126828,of,0,0
126829,2,0,0
126830,distinct,0,0
126831,6-week,0,0
126832,robot-assisted,1,1
126833,reaching,1,0
126834,programs,1,1
126835,compared,0,0
126836,with,0,0
126837,an,0,0
126838,intensive,0,1
126839,conventional,1,1
126840,arm,1,0
126841,exercise,1,1
126842,program,1,1
126843,(,0,1
126844,ICAE,0,1
126845,),0,1
126846,for,0,0
126847,chronic,0,0
126848,",",0,0
126849,stroke-related,0,0
126850,upper-extremity,0,0
126851,(,0,1
126852,UE,0,1
126853,),0,1
126854,impairment,0,0
126855,.,0,0
126856,To,0,0
126857,examine,0,0
126858,whether,0,0
126859,the,0,0
126860,addition,0,0
126861,of,0,0
126862,robot-assisted,1,1
126863,training,1,1
126864,out,0,0
126865,of,0,0
126866,the,0,0
126867,horizontal,0,1
126868,plane,0,1
126869,leads,0,0
126870,to,0,0
126871,improved,0,0
126872,outcomes,0,0
126873,.,0,0
126874,DESIGN,0,0
126875,Randomized,0,0
126876,controlled,0,0
126877,trial,0,0
126878,",",0,0
126879,single-blinded,0,0
126880,",",0,0
126881,with,0,0
126882,12-week,0,0
126883,follow-up,0,0
126884,.,0,0
126885,SETTING,0,0
126886,Research,0,0
126887,setting,0,0
126888,in,0,0
126889,a,0,0
126890,large,0,0
126891,medical,0,0
126892,center,0,0
126893,.,0,0
126894,PARTICIPANTS,0,0
126895,Adults,0,0
126896,(,0,1
126897,N=62,0,1
126898,),0,1
126899,with,0,0
126900,chronic,0,0
126901,",",0,0
126902,stroke-related,0,0
126903,arm,0,0
126904,weakness,0,0
126905,stratified,0,0
126906,by,0,0
126907,impairment,0,0
126908,severity,0,0
126909,using,0,0
126910,baseline,0,0
126911,UE,0,1
126912,motor,0,0
126913,assessments,0,0
126914,.,0,0
126915,INTERVENTIONS,0,0
126916,Sixty,0,0
126917,minutes,0,0
126918,",",0,0
126919,3,0,0
126920,times,0,0
126921,a,0,0
126922,week,0,0
126923,for,0,0
126924,6,0,0
126925,weeks,0,0
126926,of,0,0
126927,robot-assisted,1,1
126928,planar,1,1
126929,reaching,1,0
126930,(,1,1
126931,gravity,1,1
126932,compensated,1,0
126933,),1,0
126934,",",1,0
126935,combined,1,1
126936,planar,1,0
126937,with,1,0
126938,vertical,1,0
126939,robot-assisted,1,1
126940,reaching,1,0
126941,",",0,0
126942,or,0,1
126943,intensive,1,1
126944,conventional,1,1
126945,arm,1,0
126946,exercise,1,1
126947,program,1,1
126948,.,1,0
126949,MAIN,0,0
126950,OUTCOME,0,0
126951,MEASURE,0,0
126952,UE,0,1
126953,Fugl-Meyer,0,1
126954,Assessment,0,1
126955,(,0,1
126956,FMA,0,1
126957,),0,1
126958,mean,0,0
126959,change,0,0
126960,from,0,0
126961,baseline,0,0
126962,to,0,0
126963,final,0,0
126964,training,0,1
126965,.,0,0
126966,RESULTS,0,0
126967,All,0,0
126968,groups,0,0
126969,showed,0,0
126970,modest,0,0
126971,gains,0,0
126972,in,0,0
126973,the,0,0
126974,FMA,0,0
126975,from,0,0
126976,baseline,0,0
126977,to,0,0
126978,final,0,0
126979,with,0,0
126980,no,0,0
126981,significant,0,0
126982,between,0,0
126983,group,0,0
126984,differences,0,0
126985,.,0,0
126986,Most,0,0
126987,change,0,0
126988,occurred,0,0
126989,in,0,0
126990,the,0,0
126991,planar,0,1
126992,robot,0,1
126993,group,0,1
126994,(,0,1
126995,mean,0,0
126996,change,0,0
126997,?,0,0
126998,SD,0,0
126999,",",0,0
127000,2.94,0,0
127001,?,0,0
127002,0.77,0,0
127003,;,0,0
127004,95,0,0
127005,%,0,0
127006,confidence,0,0
127007,interval,0,0
127008,[,0,0
127009,CI,0,0
127010,],0,0
127011,",",0,0
127012,1.40-4.47,0,0
127013,),0,0
127014,.,0,0
127015,Participants,0,0
127016,with,0,0
127017,greater,0,0
127018,motor,0,0
127019,impairment,0,0
127020,(,0,1
127021,n=41,0,0
127022,),0,0
127023,demonstrated,0,0
127024,a,0,0
127025,larger,0,0
127026,difference,0,0
127027,in,0,0
127028,response,0,0
127029,(,0,0
127030,mean,0,0
127031,change,0,0
127032,?,0,0
127033,SD,0,0
127034,",",0,0
127035,2.29,0,0
127036,?,0,0
127037,0.72,0,0
127038,;,0,0
127039,95,0,0
127040,%,0,0
127041,CI,0,0
127042,",",0,0
127043,0.85-3.72,0,0
127044,),0,0
127045,for,0,0
127046,planar,0,1
127047,robot-assisted,0,1
127048,exercise,0,1
127049,compared,0,0
127050,with,0,0
127051,the,0,0
127052,intensive,0,1
127053,conventional,0,1
127054,arm,0,0
127055,exercise,0,1
127056,program,0,1
127057,(,0,1
127058,mean,0,0
127059,change,0,0
127060,?,0,0
127061,SD,0,0
127062,",",0,0
127063,0.43,0,0
127064,?,0,0
127065,0.72,0,0
127066,;,0,0
127067,95,0,0
127068,%,0,0
127069,CI,0,0
127070,",",0,0
127071,-1.00,0,0
127072,to,0,0
127073,1.86,0,0
127074,),0,0
127075,.,0,0
127076,CONCLUSIONS,0,0
127077,Chronic,0,0
127078,UE,0,1
127079,deficits,0,0
127080,because,0,0
127081,of,0,0
127082,stroke,0,0
127083,are,0,0
127084,responsive,0,0
127085,to,0,0
127086,intensive,0,1
127087,motor,0,1
127088,task,0,1
127089,training,0,1
127090,.,0,0
127091,However,0,0
127092,",",0,0
127093,training,0,1
127094,outside,0,0
127095,the,0,0
127096,horizontal,0,1
127097,plane,0,0
127098,in,0,0
127099,a,0,0
127100,gravity,0,0
127101,present,0,0
127102,environment,0,0
127103,using,0,0
127104,a,0,0
127105,combination,0,1
127106,of,0,0
127107,vertical,0,0
127108,with,0,0
127109,planar,0,0
127110,robots,0,1
127111,was,0,0
127112,not,0,0
127113,superior,0,0
127114,to,0,0
127115,training,0,1
127116,with,0,0
127117,the,0,0
127118,planar,0,1
127119,robot,0,1
127120,alone,0,1
127121,.,0,0
127122,Effect,0,0
127123,of,0,0
127124,prophylactic,1,1
127125,amiodarone,1,1
127126,in,0,0
127127,patients,0,0
127128,with,0,0
127129,rheumatic,0,0
127130,valve,0,0
127131,disease,0,0
127132,undergoing,0,0
127133,valve,0,1
127134,replacement,0,1
127135,surgery,0,1
127136,.,0,0
127137,The,0,0
127138,study,0,0
127139,was,0,0
127140,carried,0,0
127141,out,0,0
127142,to,0,0
127143,evaluate,0,0
127144,the,0,0
127145,effect,0,0
127146,of,0,0
127147,prophylactic,0,1
127148,single-dose,0,1
127149,intravenous,0,1
127150,amiodarone,1,1
127151,in,0,0
127152,patients,0,0
127153,undergoing,0,0
127154,valve,0,0
127155,replacement,0,1
127156,surgery,0,1
127157,.,0,0
127158,Maintenance,0,0
127159,of,0,0
127160,sinus,0,0
127161,rhythm,0,1
127162,is,0,0
127163,better,0,0
127164,than,0,0
127165,maintenance,0,0
127166,of,0,0
127167,fixed,0,1
127168,ventricular,0,0
127169,rate,0,0
127170,in,0,0
127171,atrial,0,0
127172,fibrillation,0,0
127173,(,0,1
127174,AF,0,1
127175,),0,1
127176,especially,0,0
127177,in,0,0
127178,the,0,0
127179,presence,0,0
127180,of,0,0
127181,irritable,0,0
127182,left,0,0
127183,or,0,1
127184,right,0,0
127185,atrium,0,0
127186,because,0,0
127187,of,0,0
127188,enlargement,0,0
127189,.,0,0
127190,Fifty-six,0,0
127191,patients,0,0
127192,with,0,0
127193,valvular,0,0
127194,heart,0,0
127195,disease,0,0
127196,with,0,0
127197,or,0,0
127198,without,0,0
127199,AF,0,1
127200,were,0,0
127201,randomly,0,0
127202,divided,0,0
127203,into,0,0
127204,two,0,0
127205,groups,0,0
127206,.,0,0
127207,Group,0,0
127208,I,0,0
127209,or,0,1
127210,the,0,0
127211,amiodarone,1,1
127212,group,1,1
127213,(,0,1
127214,n=28,0,0
127215,),0,1
127216,received,0,1
127217,amiodarone,1,1
127218,(,0,0
127219,3,0,0
127220,mg/kg,0,1
127221,in,0,0
127222,100,0,0
127223,ml,0,0
127224,normal,0,0
127225,saline,0,1
127226,),0,1
127227,and,0,0
127228,group,0,1
127229,II,0,1
127230,or,0,1
127231,the,0,0
127232,control,1,1
127233,group,0,0
127234,received,0,1
127235,same,0,0
127236,volume,0,0
127237,of,0,0
127238,normal,1,0
127239,saline,1,1
127240,.,1,0
127241,The,0,0
127242,standardized,0,0
127243,protocol,0,0
127244,for,0,0
127245,cardiopulmonary,0,0
127246,bypass,0,1
127247,was,0,0
127248,maintained,0,0
127249,for,0,0
127250,all,0,0
127251,the,0,0
127252,patients,0,0
127253,.,0,0
127254,AF,0,0
127255,occurred,0,0
127256,in,0,0
127257,7.14,0,0
127258,%,0,0
127259,patients,0,0
127260,in,0,0
127261,group,0,0
127262,I,0,0
127263,",",0,0
127264,and,0,0
127265,in,0,0
127266,group,0,0
127267,II,0,0
127268,",",0,0
127269,28.57,0,0
127270,%,0,0
127271,(,0,1
127272,P=0.035,0,0
127273,),0,1
127274,;,0,0
127275,ventricular,0,0
127276,tachycardia/fibrillation,0,0
127277,was,0,0
127278,observed,0,0
127279,in,0,0
127280,21.43,0,0
127281,%,0,0
127282,patients,0,0
127283,in,0,0
127284,group,0,0
127285,I,0,0
127286,and,0,0
127287,46.43,0,0
127288,%,0,0
127289,patients,0,0
127290,in,0,0
127291,group,0,0
127292,II,0,1
127293,(,0,1
127294,P=0.089,0,0
127295,),0,1
127296,after,0,0
127297,release,0,0
127298,of,0,0
127299,aortic,0,0
127300,clamp,0,1
127301,.,0,0
127302,Most,0,0
127303,of,0,0
127304,the,0,0
127305,patients,0,0
127306,in,0,0
127307,group,0,0
127308,I,0,0
127309,(,0,0
127310,92.86,0,0
127311,%,0,0
127312,),0,0
127313,maintained,0,0
127314,sinus,0,0
127315,rhythm,0,1
127316,without,0,1
127317,cardioversion,0,1
127318,or,0,1
127319,defibrillation,0,1
127320,after,0,0
127321,release,0,0
127322,of,0,0
127323,aortic,0,0
127324,cross,0,0
127325,clamp,0,1
127326,(,0,1
127327,P=0.002,0,0
127328,),0,1
127329,.,0,0
127330,Defibrillation,0,0
127331,or,0,1
127332,cardio,0,0
127333,version,0,0
127334,was,0,0
127335,needed,0,0
127336,in,0,0
127337,7.14,0,0
127338,%,0,0
127339,patients,0,0
127340,in,0,0
127341,group,0,0
127342,I,0,0
127343,and,0,0
127344,28.57,0,0
127345,%,0,0
127346,patients,0,0
127347,in,0,0
127348,group,0,0
127349,II,0,1
127350,(,0,1
127351,P=0.078,0,0
127352,),0,0
127353,.,0,0
127354,A,0,0
127355,single,0,0
127356,prophylactic,0,1
127357,intraoperative,0,1
127358,dose,0,0
127359,of,0,0
127360,intravenous,0,1
127361,amiodarone,1,1
127362,decreased,0,0
127363,post,0,0
127364,bypass,0,1
127365,arrhythmia,0,0
127366,in,0,0
127367,this,0,0
127368,study,0,0
127369,in,0,0
127370,comparison,0,0
127371,to,0,0
127372,the,0,0
127373,control,0,1
127374,group,0,0
127375,.,0,0
127376,Single,0,1
127377,dose,0,0
127378,of,0,0
127379,intraoperative,0,1
127380,amiodarone,1,1
127381,may,0,0
127382,be,0,0
127383,used,0,0
127384,to,0,0
127385,decrease,0,0
127386,postoperative,0,0
127387,arrhythmia,0,0
127388,in,0,0
127389,open,0,1
127390,heart,0,0
127391,surgery,0,0
127392,.,0,0
127393,Effects,0,0
127394,of,0,0
127395,three,0,0
127396,oral,0,1
127397,analgesics,1,0
127398,on,0,0
127399,postoperative,0,0
127400,pain,0,0
127401,following,0,0
127402,root,0,1
127403,canal,0,0
127404,preparation,0,1
127405,:,0,0
127406,a,0,0
127407,controlled,0,0
127408,clinical,0,0
127409,trial,0,0
127410,.,0,0
127411,AIM,0,0
127412,To,0,0
127413,compare,0,0
127414,the,0,0
127415,effects,0,0
127416,of,0,0
127417,single,0,0
127418,doses,0,0
127419,of,0,0
127420,three,0,0
127421,oral,0,1
127422,medications,0,0
127423,on,0,0
127424,postoperative,0,0
127425,pain,0,0
127426,following,0,0
127427,instrumentation,0,1
127428,of,0,0
127429,root,0,1
127430,canals,0,0
127431,in,0,0
127432,teeth,0,0
127433,with,0,0
127434,irreversible,0,0
127435,pulpitis,0,0
127436,.,0,0
127437,METHODOLOGY,0,0
127438,In,0,0
127439,this,0,0
127440,double-blind,0,0
127441,clinical,0,0
127442,trial,0,0
127443,",",0,0
127444,100,0,0
127445,patients,0,0
127446,who,0,0
127447,had,0,0
127448,anterior,0,0
127449,or,0,1
127450,premolar,0,0
127451,teeth,0,0
127452,with,0,0
127453,irreversible,0,0
127454,pulpitis,0,0
127455,without,0,0
127456,any,0,0
127457,signs,0,0
127458,and,0,0
127459,symptoms,0,0
127460,of,0,0
127461,acute,0,0
127462,or,0,1
127463,chronic,0,0
127464,apical,0,0
127465,periodontitis,0,0
127466,and,0,0
127467,moderate,0,0
127468,to,0,0
127469,severe,0,0
127470,pain,0,0
127471,were,0,0
127472,divided,0,0
127473,by,0,0
127474,balanced,0,1
127475,block,0,1
127476,random,0,0
127477,allocation,0,0
127478,into,0,0
127479,four,0,0
127480,groups,0,0
127481,of,0,0
127482,25,0,0
127483,each,0,0
127484,",",0,0
127485,a,0,0
127486,control,1,1
127487,group,1,0
127488,receiving,1,1
127489,a,1,0
127490,placebo,1,1
127491,medication,1,1
127492,",",1,0
127493,and,1,0
127494,three,1,0
127495,experimental,1,0
127496,groups,1,0
127497,receiving,1,0
127498,a,1,0
127499,single,1,1
127500,dose,1,0
127501,of,1,0
127502,either,1,1
127503,Tramadol,1,1
127504,(,1,0
127505,100,1,1
127506,mg,1,1
127507,),1,0
127508,",",1,0
127509,Novafen,1,1
127510,(,1,0
127511,325,1,0
127512,mg,1,1
127513,of,1,0
127514,paracetamol,1,1
127515,",",1,0
127516,200,1,1
127517,mg,1,1
127518,ibuprofen,1,1
127519,and,1,0
127520,40,1,0
127521,mg,1,1
127522,caffeine,1,1
127523,anhydrous,1,1
127524,),1,0
127525,or,1,1
127526,Naproxen,1,1
127527,(,1,1
127528,500,1,1
127529,mg,1,1
127530,),1,0
127531,immediately,1,0
127532,after,1,0
127533,the,1,0
127534,first,1,0
127535,appointment,1,1
127536,where,1,0
127537,the,1,0
127538,pulp,1,0
127539,was,1,0
127540,removed,1,0
127541,",",1,0
127542,and,1,0
127543,the,1,0
127544,canals,1,0
127545,were,1,0
127546,fully,1,0
127547,prepared,1,1
127548,.,1,0
127549,The,0,0
127550,intensity,0,0
127551,of,0,0
127552,pain,0,0
127553,was,0,0
127554,scored,0,0
127555,based,0,0
127556,on,0,0
127557,10-point,0,0
127558,VAS,0,1
127559,before,0,0
127560,and,0,0
127561,after,0,0
127562,treatment,0,0
127563,for,0,0
127564,up,0,0
127565,to,0,0
127566,24,0,0
127567,h,0,0
127568,postoperatively,0,0
127569,.,0,0
127570,Data,0,0
127571,were,0,0
127572,submitted,0,0
127573,to,0,0
127574,repeated,0,0
127575,analysis,0,0
127576,of,0,0
127577,variance,0,0
127578,.,0,0
127579,RESULTS,0,0
127580,At,0,0
127581,the,0,0
127582,6,0,0
127583,",",0,0
127584,12,0,0
127585,and,0,0
127586,24,0,0
127587,h,0,0
127588,postoperative,0,0
127589,intervals,0,0
127590,after,0,0
127591,drug,0,1
127592,administration,0,0
127593,",",0,0
127594,the,0,0
127595,intensity,0,0
127596,of,0,0
127597,pain,0,0
127598,was,0,0
127599,significantly,0,0
127600,lower,0,0
127601,in,0,0
127602,the,0,0
127603,experimental,0,0
127604,groups,0,0
127605,than,0,0
127606,in,0,0
127607,the,1,0
127608,placebo,1,1
127609,group,1,0
127610,(,0,0
127611,P,0,0
127612,<,0,0
127613,0.01,1,0
127614,),1,0
127615,.,1,0
127616,Tramadol,1,1
127617,was,1,0
127618,significantly,1,0
127619,less,0,0
127620,effective,0,0
127621,(,0,0
127622,P,0,0
127623,<,0,0
127624,0.05,1,0
127625,),1,0
127626,than,1,0
127627,Naproxen,1,1
127628,",",1,0
127629,and,1,0
127630,Novafen,1,1
127631,that,0,0
127632,were,0,0
127633,similar,0,0
127634,to,0,0
127635,each,0,0
127636,other,0,0
127637,(,0,0
127638,P,0,0
127639,>,0,0
127640,0.05,0,0
127641,),0,0
127642,.,0,0
127643,CONCLUSION,0,0
127644,A,0,0
127645,single,0,0
127646,oral,0,1
127647,dose,1,0
127648,of,1,0
127649,Naproxen,1,1
127650,",",1,0
127651,Novafen,1,1
127652,and,1,0
127653,Tramadol,1,1
127654,taken,1,0
127655,immediately,0,0
127656,after,0,0
127657,treatment,0,0
127658,reduced,0,0
127659,postoperative,0,0
127660,pain,0,0
127661,following,0,0
127662,pulpectomy,0,1
127663,and,0,0
127664,root,0,1
127665,canal,0,0
127666,preparation,0,1
127667,of,0,0
127668,teeth,0,0
127669,with,0,0
127670,irreversible,0,0
127671,pulpitis,0,0
127672,.,0,0
127673,Safety,0,1
127674,and,0,0
127675,efficacy,0,0
127676,of,0,0
127677,dalcetrapib,1,1
127678,on,0,0
127679,atherosclerotic,0,0
127680,disease,0,0
127681,using,0,0
127682,novel,1,0
127683,non-invasive,1,1
127684,multimodality,1,1
127685,imaging,1,1
127686,(,1,1
127687,dal-PLAQUE,1,1
127688,),1,0
127689,:,1,0
127690,a,0,0
127691,randomised,0,0
127692,clinical,0,0
127693,trial,0,0
127694,.,0,0
127695,BACKGROUND,0,0
127696,Dalcetrapib,1,1
127697,modulates,0,0
127698,cholesteryl,0,0
127699,ester,0,1
127700,transfer,0,1
127701,protein,0,1
127702,(,0,1
127703,CETP,0,1
127704,),0,1
127705,activity,0,0
127706,to,0,0
127707,raise,0,0
127708,high-density,0,1
127709,lipoprotein,0,1
127710,cholesterol,0,1
127711,(,0,1
127712,HDL-C,0,1
127713,),0,0
127714,.,0,0
127715,After,0,0
127716,the,0,0
127717,failure,0,0
127718,of,0,0
127719,torcetrapib,0,1
127720,it,0,0
127721,was,0,0
127722,unknown,0,0
127723,if,0,0
127724,HDL,0,1
127725,produced,0,0
127726,by,0,0
127727,interaction,0,0
127728,with,0,0
127729,CETP,0,1
127730,had,0,0
127731,pro-atherogenic,0,0
127732,or,0,1
127733,pro-inflammatory,0,0
127734,properties,0,0
127735,.,0,0
127736,dal-PLAQUE,0,0
127737,is,0,0
127738,the,0,0
127739,first,0,0
127740,multicentre,0,0
127741,study,0,0
127742,using,0,0
127743,novel,0,0
127744,non-invasive,0,1
127745,multimodality,0,1
127746,imaging,0,0
127747,to,0,0
127748,assess,0,0
127749,structural,0,0
127750,and,0,0
127751,inflammatory,0,0
127752,indices,0,0
127753,of,0,0
127754,atherosclerosis,0,0
127755,as,0,0
127756,primary,0,0
127757,endpoints,0,0
127758,.,0,0
127759,METHODS,0,0
127760,In,0,0
127761,this,0,0
127762,phase,0,0
127763,2b,0,1
127764,",",0,0
127765,double-blind,0,0
127766,",",0,0
127767,multicentre,0,0
127768,trial,0,0
127769,",",0,0
127770,patients,0,0
127771,(,0,0
127772,aged,0,0
127773,18-75,0,0
127774,years,0,0
127775,),0,0
127776,with,0,0
127777,",",0,0
127778,or,0,1
127779,with,0,0
127780,high,0,0
127781,risk,0,0
127782,of,0,0
127783,",",0,0
127784,coronary,0,0
127785,heart,0,0
127786,disease,0,0
127787,were,0,0
127788,randomly,0,0
127789,assigned,0,0
127790,(,0,0
127791,1:1,0,1
127792,),0,0
127793,to,0,0
127794,dalcetrapib,1,1
127795,600,1,1
127796,mg/day,1,1
127797,or,1,1
127798,placebo,1,1
127799,for,1,0
127800,24,1,0
127801,months,1,0
127802,.,1,0
127803,Randomisation,0,0
127804,was,0,0
127805,done,0,0
127806,with,0,0
127807,a,0,0
127808,computer-generated,0,1
127809,randomisation,0,0
127810,code,0,1
127811,and,0,0
127812,was,0,0
127813,stratified,0,0
127814,by,0,0
127815,centre,0,0
127816,.,0,0
127817,Patients,0,0
127818,and,0,0
127819,investigators,0,0
127820,were,0,0
127821,masked,0,0
127822,to,0,0
127823,treatment,0,0
127824,.,0,0
127825,Coprimary,0,0
127826,endpoints,0,0
127827,were,0,0
127828,MRI-assessed,0,0
127829,indices,0,0
127830,(,0,0
127831,total,0,0
127832,vessel,0,0
127833,area,0,0
127834,",",0,0
127835,wall,0,0
127836,area,0,0
127837,",",0,0
127838,wall,0,0
127839,thickness,0,0
127840,",",0,0
127841,and,0,0
127842,normalised,0,0
127843,wall,0,0
127844,index,0,0
127845,[,0,0
127846,average,0,0
127847,carotid,0,0
127848,],0,0
127849,),0,0
127850,after,0,0
127851,24,0,0
127852,months,0,0
127853,and,0,0
127854,(,0,0
127855,18,0,0
127856,),0,1
127857,F-fluorodeoxyglucose,0,1
127858,(,0,1
127859,(,0,1
127860,18,0,0
127861,),0,1
127862,F-FDG,0,0
127863,),0,1
127864,PET/CT,0,1
127865,assessment,0,0
127866,of,0,0
127867,arterial,0,0
127868,inflammation,0,0
127869,within,0,0
127870,an,0,0
127871,index,0,0
127872,vessel,0,0
127873,(,0,1
127874,right,0,0
127875,carotid,0,0
127876,",",0,0
127877,left,0,0
127878,carotid,0,0
127879,",",0,0
127880,or,0,1
127881,ascending,0,1
127882,thoracic,0,1
127883,aorta,0,0
127884,),0,0
127885,after,0,0
127886,6,0,0
127887,months,0,0
127888,",",0,0
127889,with,0,0
127890,no-harm,0,0
127891,boundaries,0,0
127892,established,0,0
127893,before,0,0
127894,unblinding,0,0
127895,of,0,0
127896,the,0,0
127897,trial,0,0
127898,.,0,0
127899,Analysis,0,0
127900,was,0,0
127901,by,0,0
127902,intention,0,0
127903,to,0,0
127904,treat,0,0
127905,.,0,0
127906,This,0,0
127907,trial,0,0
127908,is,0,0
127909,registered,0,0
127910,at,0,0
127911,ClinicalTrials.gov,0,0
127912,",",0,0
127913,NCT00655473,0,0
127914,.,0,0
127915,FINDINGS,0,0
127916,189,0,0
127917,patients,0,0
127918,were,0,0
127919,screened,0,0
127920,and,0,0
127921,130,0,0
127922,randomly,0,0
127923,assigned,0,0
127924,to,0,0
127925,placebo,1,1
127926,(,0,0
127927,66,0,0
127928,patients,0,0
127929,),0,0
127930,or,0,1
127931,dalcetrapib,1,1
127932,(,0,0
127933,64,0,0
127934,patients,0,0
127935,),0,0
127936,.,0,0
127937,For,0,0
127938,the,0,0
127939,coprimary,0,0
127940,MRI,0,1
127941,and,0,0
127942,PET/CT,0,1
127943,endpoints,0,0
127944,",",0,0
127945,CIs,0,0
127946,were,0,0
127947,below,0,0
127948,the,0,0
127949,no-harm,0,1
127950,boundary,0,0
127951,or,0,1
127952,the,0,0
127953,adverse,0,0
127954,change,0,0
127955,was,0,0
127956,numerically,0,0
127957,lower,0,0
127958,in,0,0
127959,the,0,0
127960,dalcetrapib,1,1
127961,group,0,0
127962,than,0,0
127963,in,0,0
127964,the,0,0
127965,placebo,0,1
127966,group,0,0
127967,.,0,0
127968,MRI-derived,0,0
127969,change,0,0
127970,in,0,0
127971,total,0,0
127972,vessel,0,0
127973,area,0,0
127974,was,0,0
127975,reduced,0,0
127976,in,0,0
127977,patients,0,0
127978,given,0,0
127979,dalcetrapib,1,1
127980,compared,0,0
127981,with,0,0
127982,those,0,0
127983,given,0,0
127984,placebo,0,1
127985,after,0,0
127986,24,0,0
127987,months,0,0
127988,;,0,0
127989,absolute,0,0
127990,change,0,0
127991,from,0,0
127992,baseline,0,0
127993,relative,0,0
127994,to,0,0
127995,placebo,1,1
127996,was,0,0
127997,-4?01,0,1
127998,mm,0,0
127999,(,0,1
128000,2,0,1
128001,),0,1
128002,(,0,0
128003,90,0,1
128004,%,0,0
128005,CI,0,0
128006,-7?23,0,1
128007,to,0,0
128008,-0?80,0,0
128009,;,0,0
128010,nominal,0,0
128011,p=0?04,0,0
128012,),0,0
128013,.,0,0
128014,The,0,0
128015,PET/CT,0,0
128016,measure,0,0
128017,of,0,0
128018,index,0,0
128019,vessel,0,0
128020,most-diseased-segment,0,0
128021,target-to-background,0,1
128022,ratio,0,0
128023,(,0,1
128024,TBR,0,0
128025,),0,1
128026,was,0,0
128027,not,0,0
128028,different,0,0
128029,between,0,0
128030,groups,0,0
128031,",",0,0
128032,but,0,0
128033,carotid,0,0
128034,artery,0,0
128035,analysis,0,0
128036,showed,0,0
128037,a,0,0
128038,7,0,0
128039,%,0,0
128040,reduction,0,0
128041,in,0,0
128042,most-diseased-segment,0,0
128043,TBR,0,0
128044,in,0,0
128045,the,0,0
128046,dalcetrapib,1,1
128047,group,1,0
128048,compared,0,0
128049,with,0,0
128050,the,0,0
128051,placebo,1,1
128052,group,1,0
128053,(,0,0
128054,-7?3,0,1
128055,[,0,1
128056,90,0,0
128057,%,0,0
128058,CI,0,0
128059,-13?5,0,1
128060,to,0,0
128061,-0?8,0,0
128062,],0,0
128063,;,0,0
128064,nominal,0,0
128065,p=0?07,0,0
128066,),0,0
128067,.,1,0
128068,Dalcetrapib,1,1
128069,did,1,0
128070,not,1,0
128071,increase,0,0
128072,office,0,1
128073,blood,0,0
128074,pressure,0,0
128075,and,0,0
128076,the,0,0
128077,frequency,0,0
128078,of,0,0
128079,adverse,0,0
128080,events,0,0
128081,was,0,0
128082,similar,0,0
128083,between,0,0
128084,groups,0,0
128085,.,0,0
128086,INTERPRETATION,1,0
128087,Dalcetrapib,1,1
128088,showed,1,0
128089,no,0,0
128090,evidence,0,0
128091,of,0,0
128092,a,0,0
128093,pathological,0,0
128094,effect,0,0
128095,related,0,0
128096,to,0,0
128097,the,0,0
128098,arterial,0,0
128099,wall,0,0
128100,over,0,0
128101,24,0,0
128102,months,0,0
128103,.,0,0
128104,Moreover,0,0
128105,",",0,0
128106,this,0,0
128107,trial,0,0
128108,suggests,0,0
128109,possible,0,0
128110,beneficial,0,0
128111,vascular,0,0
128112,effects,0,0
128113,of,1,0
128114,dalcetrapib,1,1
128115,",",1,0
128116,including,1,0
128117,the,0,0
128118,reduction,0,0
128119,in,0,0
128120,total,0,0
128121,vessel,0,0
128122,enlargement,0,0
128123,over,0,0
128124,24,0,0
128125,months,0,0
128126,",",0,0
128127,but,0,0
128128,long-term,0,0
128129,safety,0,0
128130,and,0,0
128131,clinical,0,0
128132,outcomes,0,0
128133,efficacy,0,0
128134,of,0,0
128135,dalcetrapib,0,1
128136,need,0,0
128137,to,0,0
128138,be,0,0
128139,analysed,0,0
128140,.,0,0
128141,FUNDING,0,0
128142,F,0,0
128143,Hoffmann-La,0,1
128144,Roche,0,0
128145,Ltd,0,1
128146,.,0,0
128147,The,0,0
128148,effects,0,0
128149,of,0,0
128150,therapeutic,1,0
128151,instrumental,1,0
128152,music,1,1
128153,performance,1,0
128154,on,0,0
128155,endurance,0,0
128156,level,0,0
128157,",",0,0
128158,self-perceived,0,0
128159,fatigue,0,0
128160,level,0,0
128161,",",0,0
128162,and,0,0
128163,self-perceived,0,0
128164,exertion,0,0
128165,of,0,0
128166,inpatients,0,0
128167,in,0,0
128168,physical,0,1
128169,rehabilitation,0,1
128170,.,0,0
128171,The,0,0
128172,present,0,0
128173,study,0,0
128174,investigated,0,0
128175,the,0,0
128176,effects,0,0
128177,of,0,0
128178,a,0,0
128179,Neurologic,1,0
128180,Music,1,1
128181,Therapy,1,1
128182,(,1,1
128183,NMT,1,0
128184,),1,1
128185,sensory-motor,1,1
128186,rehabilitation,1,1
128187,technique,1,1
128188,",",1,0
128189,Therapeutic,1,0
128190,Instrumental,1,0
128191,Music,1,1
128192,Performance,1,0
128193,(,1,1
128194,TIMP,1,1
128195,),1,1
128196,as,0,0
128197,compared,0,0
128198,to,0,0
128199,Traditional,1,0
128200,Occupational,1,1
128201,Therapy,1,1
128202,(,1,1
128203,TOT,1,1
128204,),1,0
128205,",",0,0
128206,on,0,0
128207,endurance,0,0
128208,",",0,0
128209,self-perceived,0,0
128210,fatigue,0,0
128211,",",0,0
128212,and,0,0
128213,self-perceived,0,0
128214,exertion,0,0
128215,of,0,0
128216,35,0,0
128217,hospitalized,0,0
128218,patients,0,0
128219,in,0,0
128220,physical,0,1
128221,rehabilitation,0,1
128222,.,0,0
128223,The,0,0
128224,present,0,0
128225,study,0,0
128226,attempted,0,0
128227,to,0,0
128228,examine,0,0
128229,whether,0,0
128230,an,0,0
128231,active,0,1
128232,musical,0,1
128233,experience,0,0
128234,such,0,0
128235,as,0,0
128236,TIMP,1,1
128237,with,0,0
128238,musical,0,1
128239,cueing,0,1
128240,(,0,0
128241,i.e.,0,0
128242,",",0,0
128243,rhythmic,0,0
128244,auditory,0,1
128245,cueing,0,1
128246,),0,0
128247,during,0,0
128248,physical,0,1
128249,exercises,0,1
128250,influences,0,0
128251,one,0,0
128252,'s,0,0
128253,perception,0,0
128254,of,0,0
128255,pain,0,0
128256,",",0,0
128257,fatigue,0,0
128258,",",0,0
128259,and,0,0
128260,exertion,0,0
128261,.,0,0
128262,All,0,0
128263,participants,0,0
128264,were,0,0
128265,diagnosed,0,0
128266,with,0,0
128267,a,0,0
128268,neurologic,0,0
128269,disorder,0,0
128270,or,0,1
128271,had,0,0
128272,recently,0,0
128273,undergone,0,0
128274,orthopedic,0,0
128275,surgery,0,0
128276,.,0,0
128277,Investigators,0,0
128278,measured,0,0
128279,the,0,0
128280,effects,0,0
128281,of,0,0
128282,TOT,1,0
128283,and,0,0
128284,TIMP,1,1
128285,during,0,0
128286,upper,1,0
128287,extremity,1,0
128288,exercise,1,1
128289,of,1,0
128290,the,1,0
128291,less,1,0
128292,affected,1,0
128293,or,1,0
128294,stronger,1,0
128295,upper,1,0
128296,extremity,1,0
128297,.,1,0
128298,Results,0,0
128299,showed,0,0
128300,no,0,0
128301,significant,0,0
128302,difference,0,0
128303,on,0,0
128304,endurance,0,0
128305,measures,0,0
128306,between,0,0
128307,the,0,0
128308,2,0,0
128309,treatment,0,0
128310,conditions,0,0
128311,(,1,0
128312,TIMP,1,1
128313,and,1,1
128314,TOT,1,1
128315,),1,0
128316,.,0,0
128317,Statistically,0,0
128318,significant,0,0
128319,differences,0,0
128320,were,0,0
128321,found,0,0
128322,between,0,0
128323,TIMP,1,1
128324,and,0,0
128325,TOT,1,1
128326,when,0,0
128327,measuring,0,0
128328,their,0,0
128329,effects,0,0
128330,on,0,0
128331,perceived,0,0
128332,exertion,0,0
128333,and,0,0
128334,perceived,0,0
128335,fatigue,0,0
128336,.,0,0
128337,TIMP,1,0
128338,resulted,0,0
128339,in,0,0
128340,significantly,0,0
128341,less,0,0
128342,perception,0,0
128343,of,0,0
128344,fatigue,0,0
128345,and,0,0
128346,exertion,0,0
128347,levels,0,0
128348,than,0,0
128349,TOT,1,0
128350,.,1,0
128351,TIMP,1,0
128352,can,0,0
128353,be,0,0
128354,used,0,0
128355,foran,0,0
128356,effective,0,0
128357,sensory-motor,0,1
128358,rehabilitation,0,1
128359,technique,0,1
128360,to,0,0
128361,decrease,0,0
128362,perceived,0,0
128363,exertion,0,0
128364,and,0,0
128365,fatigue,0,0
128366,level,0,0
128367,of,0,0
128368,inpatients,0,0
128369,in,0,0
128370,physical,0,1
128371,rehabilitation,0,1
128372,.,0,0
128373,Learning,0,0
128374,through,0,0
128375,interaction,0,0
128376,in,0,0
128377,children,0,0
128378,with,0,0
128379,autism,0,0
128380,:,0,0
128381,preliminary,0,0
128382,data,0,0
128383,from,0,0
128384,asocial-communication-based,0,0
128385,intervention,0,1
128386,.,0,0
128387,The,0,0
128388,study,0,0
128389,evaluates,0,0
128390,a,0,0
128391,social-communication-based,1,0
128392,approach,1,1
128393,to,0,0
128394,autism,0,0
128395,intervention,0,1
128396,aimed,0,0
128397,at,0,0
128398,improving,0,0
128399,the,0,0
128400,social,0,0
128401,interaction,0,0
128402,skills,0,0
128403,of,0,0
128404,children,0,0
128405,with,0,0
128406,autism,0,0
128407,spectrum,0,0
128408,disorder,0,0
128409,.,0,0
128410,We,0,0
128411,report,0,0
128412,preliminary,0,0
128413,results,0,0
128414,from,0,0
128415,an,0,0
128416,ongoing,0,0
128417,randomized,0,0
128418,controlled,0,0
128419,trial,0,0
128420,of,0,0
128421,51,0,0
128422,children,0,0
128423,aged,0,0
128424,2,0,0
128425,years,0,0
128426,0,0,0
128427,months,0,0
128428,to,0,0
128429,4,0,0
128430,years,0,0
128431,11,0,0
128432,months,0,0
128433,.,0,0
128434,Participants,0,0
128435,were,0,0
128436,assigned,0,0
128437,to,0,0
128438,either,0,0
128439,a,0,0
128440,target,0,0
128441,treatment,0,1
128442,or,0,1
128443,community,0,1
128444,treatment,0,1
128445,group,0,0
128446,.,0,0
128447,Families,0,0
128448,in,0,0
128449,the,0,0
128450,target,0,0
128451,treatment,0,0
128452,group,0,0
128453,were,0,0
128454,given,0,0
128455,2,0,0
128456,hours,0,0
128457,of,0,0
128458,therapy,1,1
128459,and,1,0
128460,coaching,1,1
128461,each,0,0
128462,week,0,0
128463,in,0,0
128464,an,0,0
128465,intervention,0,1
128466,emphasizing,0,0
128467,social-interaction,1,1
128468,and,1,0
128469,the,1,0
128470,parent-child,1,1
128471,relationship,1,0
128472,.,1,0
128473,Children,0,0
128474,in,0,0
128475,the,0,0
128476,community,1,1
128477,treatment,1,0
128478,group,0,0
128479,received,0,1
128480,a,0,0
128481,variety,1,0
128482,of,1,0
128483,services,1,1
128484,averaging,1,0
128485,3.9,1,0
128486,hours,1,0
128487,per,1,0
128488,week,1,0
128489,.,1,0
128490,After,0,0
128491,12,0,0
128492,months,0,0
128493,",",0,0
128494,outcomes,0,0
128495,were,0,0
128496,measured,0,0
128497,to,0,0
128498,determine,0,0
128499,changes,0,0
128500,in,0,0
128501,the,0,0
128502,groups,0,0
128503,in,0,0
128504,social,0,0
128505,interaction,0,0
128506,and,0,0
128507,communication,0,1
128508,.,0,0
128509,In,0,0
128510,addition,0,0
128511,",",0,0
128512,a,0,0
128513,regression,0,0
128514,analysis,0,0
128515,was,0,0
128516,conducted,0,0
128517,to,0,0
128518,determine,0,0
128519,whether,0,0
128520,changes,0,0
128521,in,0,0
128522,social,0,0
128523,interaction,0,0
128524,skills,0,0
128525,were,0,0
128526,associated,0,0
128527,with,0,0
128528,language,0,0
128529,development,0,0
128530,.,0,0
128531,Results,0,0
128532,suggest,0,0
128533,that,0,0
128534,children,0,0
128535,in,0,0
128536,the,0,0
128537,treatment,0,0
128538,group,0,0
128539,made,0,0
128540,significantly,0,0
128541,greater,0,0
128542,gains,0,0
128543,in,0,0
128544,social,0,0
128545,interaction,0,0
128546,skills,0,1
128547,in,0,0
128548,comparison,0,0
128549,to,0,0
128550,the,0,0
128551,community,0,1
128552,treatment,0,0
128553,group,0,0
128554,",",0,0
128555,but,0,0
128556,no,0,0
128557,between-group,0,0
128558,differences,0,0
128559,were,0,0
128560,found,0,0
128561,for,0,0
128562,standard,0,1
128563,language,0,0
128564,assessments,0,0
128565,.,0,0
128566,Initiation,0,0
128567,of,0,0
128568,joint,0,0
128569,attention,0,0
128570,",",0,0
128571,involvement,0,0
128572,",",0,0
128573,and,0,0
128574,severity,0,0
128575,of,0,0
128576,language,0,1
128577,delay,0,0
128578,were,0,0
128579,found,0,0
128580,to,0,0
128581,be,0,0
128582,significantly,0,0
128583,associated,0,0
128584,with,0,0
128585,improvement,0,0
128586,of,0,0
128587,language,0,0
128588,skills,0,0
128589,in,0,0
128590,children,0,0
128591,with,0,0
128592,autism,0,0
128593,.,0,0
128594,Finally,0,0
128595,caregiver,0,0
128596,skills,0,1
128597,targeted,0,0
128598,by,0,0
128599,the,0,0
128600,intervention,0,1
128601,were,0,0
128602,found,0,0
128603,to,0,0
128604,be,0,0
128605,significantly,0,0
128606,associated,0,0
128607,with,0,0
128608,changes,0,0
128609,in,0,0
128610,children,0,0
128611,'s,0,0
128612,interaction,0,0
128613,skills,0,0
128614,.,0,0
128615,Polymorphisms,0,0
128616,of,0,0
128617,ADORA2A,0,1
128618,modulate,0,0
128619,psychomotor,0,0
128620,vigilance,0,0
128621,and,0,0
128622,the,0,0
128623,effects,0,0
128624,of,0,0
128625,caffeine,0,1
128626,on,0,0
128627,neurobehavioural,0,0
128628,performance,0,0
128629,and,0,0
128630,sleep,0,0
128631,EEG,0,1
128632,after,0,0
128633,sleep,0,0
128634,deprivation,0,1
128635,.,0,1
128636,BACKGROUND,0,0
128637,AND,0,0
128638,PURPOSE,0,1
128639,Prolonged,0,1
128640,wakefulness,0,0
128641,impairs,0,0
128642,sustained,0,0
128643,vigilant,0,0
128644,attention,0,0
128645,",",0,0
128646,measured,0,0
128647,with,0,0
128648,the,0,0
128649,psychomotor,0,0
128650,vigilance,0,0
128651,task,0,1
128652,(,0,1
128653,PVT,0,1
128654,),0,1
128655,",",0,0
128656,and,0,0
128657,induces,0,0
128658,a,0,0
128659,compensatory,0,0
128660,increase,0,0
128661,in,0,0
128662,sleep,0,0
128663,intensity,0,0
128664,in,0,0
128665,recovery,0,0
128666,sleep,0,0
128667,",",0,0
128668,quantified,0,0
128669,by,0,0
128670,slow-wave,0,1
128671,activity,0,0
128672,(,0,1
128673,SWA,0,1
128674,),0,1
128675,in,0,0
128676,the,0,0
128677,sleep,0,0
128678,electroencephalogram,0,1
128679,(,0,1
128680,EEG,0,1
128681,),0,0
128682,.,0,0
128683,These,0,0
128684,effects,0,0
128685,of,0,0
128686,sleep,0,0
128687,deprivation,0,1
128688,are,0,0
128689,counteracted,0,0
128690,by,0,0
128691,the,0,0
128692,adenosine,0,1
128693,receptor,0,0
128694,antagonist,0,1
128695,caffeine,0,1
128696,",",0,0
128697,implying,0,0
128698,involvement,0,0
128699,of,0,0
128700,the,0,0
128701,adenosine,0,1
128702,neuromodulator/receptor,0,1
128703,system,0,0
128704,.,0,0
128705,To,0,0
128706,examine,0,0
128707,a,0,0
128708,role,0,0
128709,for,0,0
128710,adenosine,0,1
128711,A,0,0
128712,(,0,1
128713,2A,0,1
128714,),0,0
128715,receptors,0,0
128716,",",0,0
128717,we,0,0
128718,investigated,0,0
128719,whether,0,0
128720,variation,0,0
128721,of,0,0
128722,the,0,0
128723,A,0,0
128724,(,0,0
128725,2A,0,1
128726,),0,1
128727,receptor,0,0
128728,gene,0,1
128729,(,0,1
128730,ADORA2A,0,1
128731,),0,1
128732,modified,0,0
128733,effects,0,0
128734,of,0,0
128735,caffeine,1,1
128736,on,0,0
128737,PVT,0,1
128738,and,0,0
128739,SWA,0,1
128740,after,0,0
128741,sleep,1,0
128742,deprivation,1,1
128743,.,1,0
128744,EXPERIMENTAL,0,0
128745,APPROACH,0,0
128746,A,0,0
128747,haplotype,0,1
128748,analysis,0,0
128749,of,0,0
128750,eight,0,0
128751,single-nucleotide,0,0
128752,polymorphisms,0,0
128753,of,0,0
128754,ADORA2A,0,0
128755,was,0,0
128756,performed,0,0
128757,in,0,0
128758,82,0,0
128759,volunteers,0,0
128760,.,0,0
128761,In,0,0
128762,45,0,0
128763,young,0,0
128764,men,0,0
128765,carrying,0,0
128766,five,0,0
128767,different,0,0
128768,allele,0,0
128769,combinations,0,0
128770,",",0,0
128771,we,0,0
128772,investigated,0,0
128773,the,0,0
128774,effects,0,0
128775,of,0,0
128776,prolonged,1,0
128777,waking,1,0
128778,and,1,0
128779,2,1,0
128780,?,1,0
128781,200,1,0
128782,mg,1,1
128783,caffeine,1,1
128784,or,1,1
128785,2,1,0
128786,?,1,0
128787,100,1,0
128788,mg,1,0
128789,modafinil,1,1
128790,on,1,0
128791,psychomotor,1,0
128792,vigilance,1,0
128793,",",1,0
128794,sleepiness,1,0
128795,",",1,0
128796,and,1,0
128797,the,1,0
128798,waking,1,0
128799,and,1,0
128800,sleep,1,0
128801,EEG,1,1
128802,.,1,0
128803,KEY,0,0
128804,RESULTS,0,0
128805,Throughout,0,0
128806,extended,0,1
128807,wakefulness,0,0
128808,",",0,0
128809,the,0,0
128810,carriers,0,1
128811,of,0,0
128812,haplotype,0,0
128813,HT4,0,1
128814,performed,0,0
128815,faster,0,0
128816,on,0,0
128817,the,0,0
128818,PVT,0,1
128819,than,0,0
128820,carriers,0,0
128821,of,0,0
128822,non-HT4,0,0
128823,haplotype,0,0
128824,alleles,0,0
128825,.,0,0
128826,In,0,0
128827,haplotype,0,0
128828,HT4,0,1
128829,",",0,0
128830,caffeine,0,1
128831,failed,0,0
128832,to,0,0
128833,counteract,0,0
128834,the,0,0
128835,waking-induced,0,0
128836,impairment,0,0
128837,of,0,0
128838,PVT,0,1
128839,performance,0,0
128840,and,0,0
128841,the,0,0
128842,rebound,0,0
128843,of,0,0
128844,SWA,0,1
128845,in,0,0
128846,recovery,0,0
128847,sleep,0,0
128848,.,0,0
128849,However,1,0
128850,",",1,0
128851,caffeine,1,1
128852,was,1,0
128853,effective,0,0
128854,in,0,0
128855,non-HT4,0,0
128856,allele,0,0
128857,carriers,0,1
128858,",",0,0
128859,and,0,0
128860,modafinil,0,1
128861,reduced,0,0
128862,the,0,0
128863,consequences,0,0
128864,of,0,0
128865,prolonged,0,0
128866,waking,0,0
128867,",",0,0
128868,independently,0,0
128869,of,0,0
128870,ADORA2A,0,0
128871,haplotype,0,1
128872,.,0,0
128873,CONCLUSIONS,0,0
128874,AND,0,0
128875,IMPLICATIONS,0,1
128876,Common,0,0
128877,genetic,0,0
128878,variation,0,0
128879,of,0,0
128880,ADORA2A,0,1
128881,is,0,0
128882,an,0,0
128883,important,0,0
128884,determinant,0,0
128885,of,0,0
128886,psychomotor,0,0
128887,vigilance,0,0
128888,in,0,0
128889,rested,0,1
128890,and,0,0
128891,sleep-deprived,0,0
128892,state,0,0
128893,.,0,0
128894,It,0,0
128895,also,0,0
128896,modulates,0,0
128897,individual,0,0
128898,responses,0,0
128899,to,0,0
128900,caffeine,1,1
128901,after,1,0
128902,sleep,0,0
128903,deprivation,0,1
128904,.,0,0
128905,These,0,0
128906,findings,0,0
128907,demonstrate,0,0
128908,a,0,0
128909,role,0,0
128910,for,0,0
128911,adenosine,0,1
128912,A,0,0
128913,(,0,1
128914,2A,0,1
128915,),0,0
128916,receptors,0,0
128917,in,0,0
128918,the,0,0
128919,effects,0,0
128920,of,0,0
128921,prolonged,0,0
128922,wakefulness,0,0
128923,on,0,0
128924,vigilant,0,0
128925,attention,0,0
128926,and,0,0
128927,the,0,0
128928,sleep,0,0
128929,EEG,0,1
128930,.,0,0
128931,The,0,0
128932,effectiveness,0,0
128933,and,0,0
128934,cost,0,0
128935,of,0,0
128936,passive,0,1
128937,warming,0,0
128938,in,0,0
128939,adult,0,0
128940,ambulatory,0,0
128941,surgery,0,0
128942,patients,0,0
128943,.,0,0
128944,Hypothermia,0,0
128945,is,0,0
128946,a,0,0
128947,common,0,0
128948,problem,0,0
128949,for,0,0
128950,surgical,0,1
128951,patients,0,0
128952,and,0,0
128953,can,0,0
128954,result,0,0
128955,in,0,0
128956,many,0,0
128957,complications,0,0
128958,.,0,0
128959,Because,0,0
128960,few,0,0
128961,studies,0,0
128962,compare,0,0
128963,methods,0,0
128964,of,0,0
128965,passive,0,0
128966,warming,0,0
128967,",",0,0
128968,we,0,0
128969,used,0,0
128970,an,0,0
128971,unblinded,0,0
128972,",",0,0
128973,prospective,0,0
128974,",",0,0
128975,experimental,0,0
128976,",",0,0
128977,randomized,0,0
128978,design,0,0
128979,to,0,0
128980,compare,0,0
128981,the,0,0
128982,effectiveness,0,0
128983,of,0,0
128984,two,0,0
128985,passive,0,0
128986,methods,0,0
128987,of,0,0
128988,normothermia,0,1
128989,management,0,1
128990,in,0,0
128991,the,0,0
128992,postanesthesia,0,1
128993,care,0,1
128994,unit,0,1
128995,(,0,1
128996,PACU,0,1
128997,),0,0
128998,.,0,0
128999,We,0,0
129000,assigned,0,0
129001,a,0,0
129002,total,0,0
129003,of,0,0
129004,578,0,0
129005,adult,0,0
129006,ambulatory,0,0
129007,surgery,0,1
129008,patients,0,0
129009,to,0,0
129010,either,0,0
129011,a,0,0
129012,control,1,1
129013,group,1,0
129014,that,0,0
129015,was,0,0
129016,given,0,0
129017,two,1,0
129018,folded,1,0
129019,",",1,0
129020,warmed,1,1
129021,cotton,1,1
129022,blankets,1,1
129023,or,1,0
129024,a,1,0
129025,treatment,1,1
129026,group,1,0
129027,that,1,0
129028,was,1,0
129029,given,1,0
129030,a,1,0
129031,warmed,1,1
129032,",",1,0
129033,unfolded,1,0
129034,cotton,1,1
129035,sheet,1,1
129036,and,1,0
129037,cotton,1,1
129038,blanket,1,1
129039,.,1,0
129040,We,0,0
129041,recorded,0,0
129042,patients,0,0
129043,',0,0
129044,temperatures,0,0
129045,on,0,0
129046,their,0,0
129047,arrival,0,0
129048,in,0,0
129049,the,0,0
129050,PACU,0,1
129051,and,0,0
129052,at,0,0
129053,30,0,0
129054,minutes,0,0
129055,after,0,0
129056,arrival,0,0
129057,.,0,0
129058,The,0,0
129059,treatment,0,0
129060,group,0,0
129061,had,0,0
129062,temperatures,0,0
129063,that,0,0
129064,were,0,0
129065,significantly,0,0
129066,higher,0,0
129067,than,0,0
129068,those,0,0
129069,of,0,0
129070,the,0,0
129071,control,0,1
129072,group,0,0
129073,30,0,0
129074,minutes,0,0
129075,after,0,0
129076,arrival,0,0
129077,in,0,0
129078,the,0,0
129079,PACU,0,1
129080,",",0,0
129081,and,0,0
129082,the,0,0
129083,treatment,0,1
129084,group,0,0
129085,experienced,0,0
129086,a,0,0
129087,greater,0,0
129088,change,0,0
129089,in,0,0
129090,temperature,0,0
129091,from,0,0
129092,baseline,0,0
129093,measurements,0,0
129094,to,0,0
129095,those,0,0
129096,taken,0,0
129097,at,0,0
129098,30,0,0
129099,minutes,0,0
129100,.,0,0
129101,The,0,0
129102,treatment,0,0
129103,group,0,0
129104,also,0,0
129105,used,0,0
129106,fewer,0,0
129107,warmed,0,0
129108,blankets,0,1
129109,",",0,0
129110,resulting,0,0
129111,in,0,0
129112,cost,0,0
129113,savings,0,0
129114,for,0,0
129115,the,0,0
129116,PACU,0,0
129117,.,0,0
129118,Design,0,1
129119,and,0,0
129120,implementation,0,0
129121,of,0,0
129122,the,0,0
129123,TRACIA,0,0
129124,:,0,0
129125,intracoronary,0,1
129126,autologous,0,1
129127,transplant,0,0
129128,of,0,0
129129,bone,0,0
129130,marrow-derived,0,0
129131,stem,0,0
129132,cells,0,0
129133,for,0,0
129134,acute,0,0
129135,ST,0,0
129136,elevation,0,0
129137,myocardial,0,0
129138,infarction,0,0
129139,.,0,0
129140,OBJECTIVE,0,0
129141,To,0,0
129142,describe,0,0
129143,the,0,0
129144,design,0,0
129145,of,0,0
129146,a,0,0
129147,protocol,0,0
129148,of,0,0
129149,intracoronary,1,1
129150,autologous,1,1
129151,transplant,1,0
129152,of,1,0
129153,bone,1,0
129154,marrow-derived,1,0
129155,stem,1,0
129156,cells,1,0
129157,for,0,0
129158,acute,0,0
129159,ST-elevation,0,0
129160,myocardial,0,0
129161,infarction,0,0
129162,(,0,1
129163,STEMI,0,1
129164,),0,1
129165,and,0,0
129166,to,0,0
129167,report,0,0
129168,the,0,0
129169,safety,0,0
129170,of,0,0
129171,the,0,0
129172,procedure,0,0
129173,in,0,0
129174,the,0,0
129175,first,0,0
129176,patients,0,0
129177,included,0,0
129178,.,0,0
129179,METHODS,0,0
129180,The,0,0
129181,TRACIA,0,0
129182,study,0,0
129183,was,0,0
129184,implemented,0,0
129185,following,0,0
129186,predetermined,0,0
129187,inclusion,0,0
129188,and,0,0
129189,exclusion,0,0
129190,criteria,0,0
129191,.,0,0
129192,The,0,0
129193,protocol,0,0
129194,includes,0,0
129195,procedures,0,0
129196,such,0,0
129197,as,0,0
129198,randomization,1,0
129199,",",1,0
129200,bone,1,0
129201,marrow,1,0
129202,retrieval,1,1
129203,",",1,0
129204,stem,1,0
129205,cells,1,0
129206,processing,1,0
129207,",",1,0
129208,intracoronary,1,1
129209,infusion,1,1
129210,of,1,0
129211,stem,1,0
129212,cells,1,0
129213,in,1,0
129214,the,1,0
129215,infarct-related,1,0
129216,artery,1,0
129217,",",1,0
129218,preand-,1,1
129219,post,1,0
129220,MRI,1,1
129221,",",1,0
129222,pre-and-post,1,0
129223,SPECT,1,1
129224,with,1,0
129225,radioisotope,1,1
129226,ventriculography,1,1
129227,",",1,0
129228,and,1,0
129229,clinical,1,0
129230,follow-up,1,0
129231,at,1,0
129232,6,1,0
129233,months,1,0
129234,.,1,0
129235,RESULTS,0,0
129236,Eight,0,0
129237,patients,0,0
129238,with,0,0
129239,a,0,0
129240,diagnosis,0,0
129241,of,0,0
129242,acute,0,0
129243,STEMI,0,1
129244,and,0,0
129245,duration,0,0
129246,of,0,0
129247,symptoms,0,0
129248,of,0,0
129249,?,0,0
129250,24,0,0
129251,hours,0,0
129252,that,0,0
129253,were,0,0
129254,perfused,0,0
129255,successfully,0,0
129256,through,0,0
129257,primary,0,0
129258,percutaneous,0,1
129259,coronary,0,1
129260,intervention,0,1
129261,(,0,1
129262,PPCI,0,1
129263,),0,1
129264,with,0,0
129265,a,0,0
129266,LVEF,0,0
129267,of,0,0
129268,?,0,0
129269,45,0,0
129270,%,0,0
129271,were,0,0
129272,assigned,0,0
129273,randomly,0,0
129274,to,0,0
129275,two,0,0
129276,groups,0,0
129277,(,0,0
129278,n,0,0
129279,=,0,0
129280,4,0,0
129281,each,0,0
129282,),0,0
129283,.,0,0
129284,One,0,0
129285,group,0,0
129286,treated,0,0
129287,with,0,0
129288,stem,1,0
129289,cells,1,0
129290,and,0,0
129291,the,0,0
129292,other,0,0
129293,corresponded,0,0
129294,to,0,0
129295,the,0,0
129296,control,1,1
129297,group,1,0
129298,.,1,1
129299,Neither,0,0
129300,death,0,0
129301,",",0,0
129302,re-infarction,0,0
129303,",",0,0
129304,no,0,0
129305,need,0,0
129306,for,0,0
129307,revascularization,0,0
129308,or,0,1
129309,thrombosis,0,0
129310,of,0,0
129311,the,0,0
129312,stent,0,1
129313,were,0,0
129314,observed,0,0
129315,at,0,0
129316,follow-up,0,0
129317,.,0,0
129318,CONCLUSIONS,0,0
129319,The,0,0
129320,initial,0,0
129321,experience,0,0
129322,at,0,0
129323,the,0,0
129324,Instituto,0,0
129325,Nacional,0,0
129326,de,0,0
129327,Cardiolog?a,0,1
129328,Ignacio,0,1
129329,Ch?vez,0,1
129330,in,0,0
129331,the,0,0
129332,treatment,0,0
129333,of,0,0
129334,acute,0,0
129335,STEMI,0,0
129336,by,0,0
129337,means,0,0
129338,of,0,0
129339,autologous,0,1
129340,transplantation,0,1
129341,of,0,0
129342,bone,1,0
129343,marrow-derived,1,0
129344,stem,1,0
129345,cells,1,0
129346,is,1,0
129347,encouraging,0,0
129348,.,0,0
129349,Implementation,0,0
129350,was,0,0
129351,possible,0,0
129352,in,0,0
129353,the,0,0
129354,first,0,0
129355,eight,0,0
129356,patients,0,0
129357,with,0,0
129358,no,0,0
129359,complications,0,0
129360,.,0,0
129361,Residual,0,1
129362,platelet,0,0
129363,reactivity,0,0
129364,",",0,0
129365,bleedings,0,0
129366,",",0,0
129367,and,0,0
129368,adherence,0,0
129369,to,0,0
129370,treatment,0,0
129371,in,0,0
129372,patients,0,0
129373,having,0,0
129374,coronary,0,0
129375,stent,0,1
129376,implantation,0,0
129377,treated,0,0
129378,with,0,0
129379,prasugrel,1,1
129380,.,1,0
129381,Recent,0,0
129382,guidelines,0,0
129383,have,0,0
129384,recommended,0,0
129385,the,0,0
129386,use,0,0
129387,of,0,0
129388,aspirin,0,1
129389,and,0,0
129390,prasugrel,1,1
129391,in,0,0
129392,patients,0,0
129393,with,0,0
129394,acute,0,0
129395,coronary,0,0
129396,syndromes,0,0
129397,undergoing,0,0
129398,percutaneous,0,1
129399,coronary,0,0
129400,intervention,0,1
129401,.,0,0
129402,However,0,0
129403,",",0,0
129404,prasugrel,1,1
129405,use,0,0
129406,has,0,0
129407,been,0,0
129408,evaluated,0,0
129409,only,0,0
129410,in,0,0
129411,randomized,0,0
129412,trials,0,0
129413,.,0,0
129414,This,0,0
129415,study,0,0
129416,sought,0,0
129417,to,0,0
129418,evaluate,0,0
129419,bleeding,0,0
129420,rates,0,0
129421,and,0,0
129422,adherence,0,0
129423,to,0,0
129424,treatment,0,0
129425,in,0,0
129426,real-world,0,0
129427,patients,0,0
129428,treated,0,0
129429,with,0,0
129430,prasugrel,1,1
129431,.,1,0
129432,In,0,0
129433,total,0,0
129434,298,0,0
129435,consecutive,0,0
129436,patients,0,0
129437,68,0,0
129438,?,0,0
129439,10,0,0
129440,years,0,0
129441,old,0,0
129442,(,0,0
129443,31,0,0
129444,%,0,0
129445,>,0,0
129446,75,0,0
129447,years,0,0
129448,old,0,0
129449,),0,0
129450,underwent,1,0
129451,stent,1,1
129452,implantation,1,0
129453,and,1,0
129454,received,1,1
129455,prasugrel,1,1
129456,therapy,1,1
129457,.,1,0
129458,Indications,0,0
129459,to,0,0
129460,prasugrel,0,1
129461,therapy,0,1
129462,were,0,0
129463,(,0,0
129464,1,0,0
129465,),0,0
129466,ST-elevation,0,0
129467,acute,0,0
129468,myocardial,0,0
129469,infarction,0,0
129470,(,0,0
129471,41,0,0
129472,%,0,0
129473,),0,0
129474,",",0,0
129475,(,0,0
129476,2,0,0
129477,),0,0
129478,drug-eluting,0,1
129479,stent,0,1
129480,implantation,0,0
129481,in,0,0
129482,diabetics,0,0
129483,(,0,0
129484,24,0,0
129485,%,0,0
129486,),0,0
129487,",",0,0
129488,(,0,0
129489,3,0,0
129490,),0,1
129491,stent,0,1
129492,thrombosis,0,0
129493,(,0,0
129494,3,0,1
129495,%,0,0
129496,),0,0
129497,",",0,0
129498,(,0,0
129499,4,0,0
129500,),0,0
129501,left,0,0
129502,main,0,0
129503,coronary,0,0
129504,artery,0,0
129505,drug-eluting,0,1
129506,stent,0,1
129507,implantation,0,1
129508,(,0,0
129509,6,0,1
129510,%,0,0
129511,),0,0
129512,",",0,0
129513,and,0,0
129514,(,0,0
129515,5,0,1
129516,),0,0
129517,percutaneous,0,1
129518,coronary,0,0
129519,intervention,0,1
129520,in,0,0
129521,patients,0,0
129522,with,0,0
129523,high,0,0
129524,residual,0,0
129525,platelet,0,0
129526,reactivity,0,0
129527,on,0,0
129528,clopidogrel,0,1
129529,therapy,0,1
129530,(,0,0
129531,26,0,0
129532,%,0,0
129533,),0,0
129534,.,0,0
129535,All,0,0
129536,patients,0,0
129537,received,0,0
129538,a,0,0
129539,loading,0,0
129540,of,1,0
129541,prasugrel,1,1
129542,60,0,0
129543,mg,0,1
129544,.,0,0
129545,Patients,0,0
129546,?75,0,0
129547,years,0,0
129548,old,0,0
129549,and,0,0
129550,with,0,0
129551,body,0,0
129552,weight,0,0
129553,?60,0,1
129554,kg,0,0
129555,received,0,1
129556,a,0,0
129557,maintenance,0,0
129558,dose,0,0
129559,of,0,0
129560,5,0,1
129561,mg/day,0,1
129562,(,0,0
129563,10,0,1
129564,mg/day,0,1
129565,for,0,0
129566,all,0,0
129567,the,0,0
129568,other,0,0
129569,patients,0,0
129570,),0,0
129571,.,0,0
129572,Follow-up,0,0
129573,data,0,0
129574,including,0,0
129575,adherence,0,0
129576,to,0,0
129577,prasugrel,0,1
129578,therapy,0,1
129579,were,0,0
129580,collected,0,0
129581,by,0,0
129582,telephone,0,1
129583,interviews,0,1
129584,or,0,0
129585,outpatient,0,0
129586,visits,0,0
129587,.,0,0
129588,Minimal,0,0
129589,follow-up,0,0
129590,length,0,0
129591,was,0,0
129592,6,0,0
129593,months,0,0
129594,(,0,0
129595,mean,0,0
129596,9,0,0
129597,?,0,0
129598,3,0,0
129599,),0,0
129600,.,0,0
129601,Major,0,0
129602,",",0,0
129603,minor,0,0
129604,",",0,0
129605,and,0,0
129606,minimal,0,0
129607,bleedings,0,0
129608,(,0,0
129609,Thrombolysis,0,1
129610,In,0,0
129611,Myocardial,0,0
129612,Infarction,0,1
129613,criteria,0,0
129614,),0,0
129615,occurred,0,0
129616,in,0,0
129617,2.7,0,0
129618,%,0,0
129619,",",0,0
129620,4.7,0,0
129621,%,0,0
129622,",",0,0
129623,and,0,0
129624,15.1,0,0
129625,%,0,0
129626,of,0,0
129627,enrolled,0,0
129628,patients,0,0
129629,.,0,0
129630,Low,0,0
129631,residual,0,0
129632,platelet,0,0
129633,reactivity,0,0
129634,(,0,0
129635,p,0,0
129636,=,0,0
129637,0.001,0,0
129638,),0,0
129639,and,0,0
129640,female,0,0
129641,gender,0,0
129642,(,0,0
129643,p,0,0
129644,=,0,0
129645,0.29,0,0
129646,),0,0
129647,were,0,0
129648,independent,0,0
129649,predictors,0,0
129650,of,0,0
129651,bleeding,0,0
129652,events,0,0
129653,.,0,0
129654,The,0,0
129655,most,0,0
129656,frequent,0,0
129657,minimal,0,0
129658,bleeding,0,0
129659,event,0,0
129660,was,0,0
129661,epistaxis,0,0
129662,.,0,0
129663,Only,0,0
129664,8,0,0
129665,patients,0,0
129666,(,0,0
129667,2.7,0,0
129668,%,0,0
129669,),0,0
129670,permanently,0,1
129671,discontinued,0,0
129672,prasugrel,0,1
129673,therapy,0,1
129674,because,0,0
129675,of,0,0
129676,bleeding,0,0
129677,events,0,0
129678,(,0,0
129679,n,0,0
129680,=,0,0
129681,4,0,0
129682,),0,0
129683,",",0,0
129684,possible,0,0
129685,side,0,0
129686,effects,0,0
129687,(,0,0
129688,n,0,0
129689,=,0,0
129690,2,0,0
129691,),0,0
129692,",",0,0
129693,or,0,1
129694,medical,0,0
129695,decisions,0,0
129696,not,0,0
129697,associated,0,0
129698,with,0,0
129699,bleeding,0,0
129700,or,0,1
129701,side,0,0
129702,effects,0,0
129703,(,0,0
129704,n,0,0
129705,=,0,0
129706,2,0,0
129707,),0,0
129708,.,0,0
129709,Fourteen,0,0
129710,patients,0,0
129711,(,0,0
129712,4.7,0,0
129713,%,0,0
129714,),0,0
129715,temporarily,0,0
129716,discontinued,0,1
129717,prasugrel,0,1
129718,(,0,0
129719,average,0,0
129720,6.5,0,0
129721,days,0,0
129722,),0,0
129723,mainly,0,0
129724,because,0,0
129725,of,0,0
129726,surgical,0,0
129727,procedures,0,0
129728,.,0,0
129729,No,0,0
129730,definite,0,0
129731,or,0,1
129732,probable,0,0
129733,stent,0,1
129734,thrombosis,0,0
129735,occurred,0,0
129736,",",0,0
129737,although,0,0
129738,3,0,0
129739,patients,0,0
129740,develop,0,0
129741,de,0,0
129742,novo,0,0
129743,myocardial,0,0
129744,infarction,0,0
129745,and,0,0
129746,1,0,0
129747,an,0,0
129748,ischemic,0,0
129749,stroke,0,0
129750,.,0,0
129751,There,0,0
129752,were,0,0
129753,11,0,0
129754,deaths,0,0
129755,because,0,0
129756,of,0,0
129757,heart,0,0
129758,failure,0,0
129759,or,0,1
129760,refractory,0,1
129761,cardiogenic,0,0
129762,shock,0,0
129763,in,0,0
129764,9,0,0
129765,",",0,0
129766,pulmonary,0,0
129767,embolism,0,0
129768,in,0,0
129769,1,0,0
129770,",",0,0
129771,and,0,0
129772,cancer,0,0
129773,in,0,0
129774,1,0,0
129775,.,0,0
129776,In,0,0
129777,conclusion,0,0
129778,",",0,0
129779,in,0,0
129780,clinical,0,0
129781,practice,0,0
129782,",",0,0
129783,major,0,0
129784,and,0,0
129785,minor,0,1
129786,bleeding,0,0
129787,event,0,0
129788,rates,0,0
129789,associated,0,0
129790,with,0,0
129791,prasugrel,0,1
129792,therapy,0,1
129793,are,0,0
129794,comparable,0,0
129795,to,0,0
129796,those,0,0
129797,reported,0,0
129798,in,0,0
129799,controlled,0,0
129800,randomized,0,0
129801,trials,0,0
129802,.,0,0
129803,The,0,0
129804,minimal,0,0
129805,bleeding,0,0
129806,event,0,0
129807,rate,0,0
129808,is,0,0
129809,higher,0,0
129810,than,0,0
129811,reported,0,0
129812,but,0,0
129813,does,0,0
129814,not,0,0
129815,seem,0,0
129816,to,0,0
129817,affect,0,0
129818,adherence,0,0
129819,to,0,0
129820,treatment,0,0
129821,.,0,0
129822,Epicutaneous,0,1
129823,allergen-specific,1,1
129824,immunotherapy,1,1
129825,ameliorates,0,0
129826,grass,0,1
129827,pollen-induced,0,0
129828,rhinoconjunctivitis,0,0
129829,:,0,0
129830,A,0,0
129831,double-blind,0,0
129832,",",0,0
129833,placebo-controlled,0,1
129834,dose,0,1
129835,escalation,0,0
129836,study,0,0
129837,.,0,0
129838,BACKGROUND,0,0
129839,Epicutaneous,1,1
129840,allergen,1,1
129841,administration,0,0
129842,using,0,0
129843,a,0,0
129844,patch,0,1
129845,may,0,0
129846,be,0,0
129847,an,0,0
129848,alternative,0,0
129849,to,0,0
129850,subcutaneous,0,1
129851,or,0,1
129852,sublingual,0,1
129853,immunotherapy,0,1
129854,.,0,0
129855,OBJECTIVE,0,0
129856,To,0,0
129857,optimize,0,0
129858,treatment,0,1
129859,dose,0,0
129860,and,0,0
129861,to,0,0
129862,demonstrate,0,0
129863,the,0,0
129864,efficacy,0,0
129865,and,0,0
129866,safety,0,0
129867,of,0,0
129868,epicutaneous,0,1
129869,immunotherapy,0,1
129870,.,0,0
129871,METHODS,0,0
129872,This,0,0
129873,monocentric,0,0
129874,",",0,0
129875,placebo-controlled,0,1
129876,",",0,0
129877,double-blind,0,0
129878,trial,0,0
129879,included,0,0
129880,132,0,0
129881,patients,0,0
129882,with,0,0
129883,grass,0,1
129884,pollen-induced,0,0
129885,rhinoconjunctivitis,0,0
129886,.,0,0
129887,In,0,0
129888,February,0,0
129889,2008,0,0
129890,",",0,0
129891,patients,0,0
129892,were,0,0
129893,randomly,0,0
129894,allocated,0,0
129895,to,0,0
129896,receive,1,1
129897,placebo,1,1
129898,or,1,1
129899,3,1,0
129900,different,1,0
129901,doses,1,0
129902,of,1,0
129903,allergen,1,1
129904,.,1,0
129905,Before,0,0
129906,and,0,0
129907,during,0,0
129908,the,0,0
129909,pollen,0,1
129910,season,0,0
129911,2008,0,0
129912,",",0,0
129913,patients,0,0
129914,received,0,0
129915,6,0,0
129916,weekly,0,0
129917,patches,0,0
129918,.,0,0
129919,Efficacy,0,0
129920,was,0,0
129921,assessed,0,0
129922,4,0,0
129923,to,0,0
129924,5,0,0
129925,months,0,0
129926,later,0,0
129927,(,0,0
129928,n,0,0
129929,=,0,0
129930,110,0,0
129931,),0,0
129932,and,0,0
129933,during,0,0
129934,the,0,0
129935,pollen,0,1
129936,season,0,0
129937,of,0,0
129938,the,0,0
129939,treatment-free,0,0
129940,follow-up,0,0
129941,year,0,0
129942,in,0,0
129943,2009,0,0
129944,(,0,0
129945,n,0,0
129946,=,0,0
129947,93,0,0
129948,),0,0
129949,.,0,0
129950,The,0,0
129951,primary,0,0
129952,outcome,0,0
129953,was,0,0
129954,patient-reported,0,0
129955,changes,0,0
129956,in,0,0
129957,hay,0,0
129958,fever,0,0
129959,symptoms,0,0
129960,assessed,0,0
129961,by,0,0
129962,a,0,0
129963,visual,0,0
129964,analog,0,1
129965,scale,0,0
129966,.,0,0
129967,Secondary,0,0
129968,outcome,0,0
129969,measures,0,0
129970,were,0,0
129971,weekly,0,1
129972,visual,0,0
129973,analog,0,1
129974,scale,0,0
129975,symptom,0,0
129976,scores,0,0
129977,during,0,0
129978,pollen,0,0
129979,season,0,0
129980,",",0,0
129981,use,0,0
129982,of,0,0
129983,rescue,0,0
129984,medication,0,1
129985,",",0,0
129986,changes,0,0
129987,in,0,0
129988,conjunctival,0,0
129989,and,0,0
129990,skin,0,0
129991,reactivity,0,0
129992,",",0,0
129993,as,0,0
129994,well,0,0
129995,as,0,0
129996,safety,0,0
129997,.,0,0
129998,RESULTS,0,0
129999,Hay,0,0
130000,fever,0,0
130001,symptoms,0,0
130002,during,0,0
130003,the,0,0
130004,pollen,0,1
130005,season,0,0
130006,were,0,0
130007,reduced,0,0
130008,by,0,0
130009,more,0,0
130010,than,0,0
130011,30,0,0
130012,%,0,0
130013,in,0,0
130014,2008,0,0
130015,and,0,0
130016,by,0,0
130017,24,0,0
130018,%,0,0
130019,in,0,0
130020,2009,0,0
130021,in,0,0
130022,the,0,0
130023,high-dose,0,1
130024,group,0,0
130025,as,0,0
130026,compared,0,0
130027,with,0,0
130028,that,0,0
130029,in,0,0
130030,the,0,0
130031,placebo,0,1
130032,group,0,0
130033,",",0,0
130034,and,0,0
130035,the,0,0
130036,alleviation,0,0
130037,of,0,0
130038,symptoms,0,0
130039,in,0,0
130040,the,0,0
130041,follow-up,0,0
130042,year,0,0
130043,was,0,0
130044,dependent,0,0
130045,on,0,0
130046,the,0,0
130047,treatment,0,0
130048,dose,0,0
130049,.,0,0
130050,Higher,0,0
130051,allergen,0,0
130052,doses,0,0
130053,were,0,0
130054,associated,0,0
130055,with,0,0
130056,drug-related,0,0
130057,adverse,0,0
130058,events,0,0
130059,(,0,0
130060,AEs,0,1
130061,),0,0
130062,",",0,0
130063,predominantly,0,0
130064,manifested,0,0
130065,by,0,0
130066,pruritus,0,0
130067,",",0,0
130068,erythema,0,0
130069,",",0,0
130070,wheal,0,0
130071,",",0,0
130072,or,0,1
130073,eczema,0,0
130074,.,0,1
130075,Eleven,0,0
130076,systemic,0,0
130077,AEs,0,1
130078,of,0,0
130079,grades,0,0
130080,1,0,0
130081,to,0,0
130082,2,0,0
130083,required,0,0
130084,treatment,0,0
130085,and,0,0
130086,led,0,0
130087,to,0,0
130088,study,0,0
130089,exclusion,0,0
130090,.,0,0
130091,The,0,0
130092,dropout,0,0
130093,rate,0,0
130094,due,0,0
130095,to,0,0
130096,AEs,0,0
130097,was,0,0
130098,8.3,0,0
130099,%,0,0
130100,.,0,0
130101,No,0,0
130102,drug-related,0,0
130103,serious,0,0
130104,AE,0,0
130105,was,0,0
130106,recorded,0,0
130107,.,0,0
130108,CONCLUSION,0,0
130109,Epicutaneous,1,0
130110,immunotherapy,1,1
130111,is,0,0
130112,safe,0,0
130113,and,0,0
130114,efficacious,0,0
130115,in,0,0
130116,a,0,0
130117,dose-dependent,0,0
130118,manner,0,0
130119,after,0,0
130120,6,0,0
130121,patches,0,0
130122,only,0,0
130123,.,0,0
130124,Changes,0,0
130125,in,0,0
130126,H,0,1
130127,reflex,0,0
130128,and,0,0
130129,V,0,1
130130,wave,0,1
130131,following,0,0
130132,short-term,1,0
130133,endurance,1,0
130134,and,1,0
130135,strength,1,0
130136,training,1,1
130137,.,1,0
130138,This,0,0
130139,study,0,0
130140,examined,0,0
130141,the,0,0
130142,effects,0,0
130143,of,0,0
130144,3,0,0
130145,wk,0,0
130146,of,0,0
130147,either,0,1
130148,endurance,1,0
130149,or,1,1
130150,strength,1,0
130151,training,1,1
130152,on,0,0
130153,plasticity,0,0
130154,of,0,0
130155,the,0,0
130156,neural,0,0
130157,mechanisms,0,0
130158,involved,0,0
130159,in,0,0
130160,the,0,0
130161,soleus,0,1
130162,H,0,1
130163,reflex,0,0
130164,and,0,0
130165,V,0,1
130166,wave,0,1
130167,.,0,0
130168,Twenty-five,0,0
130169,sedentary,0,0
130170,healthy,0,0
130171,subjects,0,0
130172,were,0,0
130173,randomized,0,0
130174,into,0,0
130175,an,0,0
130176,endurance,1,0
130177,group,1,0
130178,(,0,0
130179,n,0,0
130180,=,0,0
130181,13,0,0
130182,),0,0
130183,or,0,1
130184,strength,1,0
130185,group,1,1
130186,(,0,0
130187,n,0,0
130188,=,0,0
130189,12,0,0
130190,),0,0
130191,.,0,0
130192,Evoked,0,0
130193,V-wave,0,0
130194,",",0,0
130195,H-reflex,0,1
130196,",",0,0
130197,and,0,0
130198,M-wave,0,1
130199,recruitment,0,0
130200,curves,0,0
130201,",",0,0
130202,maximal,0,0
130203,voluntary,0,1
130204,contraction,0,1
130205,(,0,1
130206,MVC,0,1
130207,),0,1
130208,",",0,0
130209,and,0,1
130210,time-to-task-failure,0,0
130211,(,0,1
130212,isometric,0,1
130213,contraction,0,1
130214,at,0,0
130215,40,0,0
130216,%,0,0
130217,MVC,0,1
130218,),0,0
130219,of,0,0
130220,the,0,0
130221,plantar,0,0
130222,flexors,0,0
130223,were,0,0
130224,recorded,0,0
130225,before,0,0
130226,and,0,0
130227,after,0,0
130228,training,0,1
130229,.,0,0
130230,Following,0,0
130231,strength,1,0
130232,training,1,1
130233,",",0,0
130234,MVC,0,0
130235,of,0,0
130236,the,0,0
130237,plantar,0,0
130238,flexors,0,0
130239,increased,0,0
130240,by,0,0
130241,14.4,0,0
130242,?,0,0
130243,5.2,0,0
130244,%,0,0
130245,in,0,0
130246,the,0,0
130247,strength,0,0
130248,group,0,0
130249,(,0,0
130250,P,0,0
130251,<,0,0
130252,0.001,0,0
130253,),0,0
130254,",",0,0
130255,whereas,0,0
130256,time-to-task-failure,0,0
130257,was,0,0
130258,prolonged,0,0
130259,in,0,0
130260,the,0,0
130261,endurance,0,0
130262,group,0,0
130263,(,0,0
130264,22.7,0,0
130265,?,0,0
130266,17.1,0,0
130267,%,0,0
130268,;,0,0
130269,P,0,0
130270,<,0,0
130271,0.05,0,0
130272,),0,0
130273,.,0,0
130274,The,0,0
130275,V,0,1
130276,wave-to-maximal,0,0
130277,M,0,0
130278,wave,0,1
130279,(,0,1
130280,V/M,0,1
130281,(,0,1
130282,max,0,0
130283,),0,1
130284,),0,1
130285,ratio,0,0
130286,increased,0,0
130287,significantly,0,0
130288,(,0,0
130289,55.1,0,0
130290,?,0,0
130291,28.3,0,0
130292,%,0,0
130293,;,0,0
130294,P,0,0
130295,<,0,0
130296,0.001,0,0
130297,),0,0
130298,following,0,0
130299,strength,0,0
130300,training,0,1
130301,",",0,0
130302,but,0,0
130303,the,0,0
130304,maximal,0,0
130305,H,0,0
130306,wave-to-maximal,0,0
130307,M,0,0
130308,wave,0,1
130309,(,0,1
130310,H,0,1
130311,(,0,1
130312,max,0,0
130313,),0,1
130314,/M,0,1
130315,(,0,1
130316,max,0,0
130317,),0,1
130318,),0,1
130319,ratio,0,0
130320,remained,0,0
130321,unchanged,0,0
130322,.,0,0
130323,Conversely,0,0
130324,",",0,0
130325,in,0,0
130326,the,0,0
130327,endurance,0,0
130328,group,0,0
130329,the,0,0
130330,V/M,0,1
130331,(,0,1
130332,max,0,0
130333,),0,1
130334,ratio,0,0
130335,was,0,0
130336,not,0,0
130337,altered,0,0
130338,",",0,0
130339,whereas,0,0
130340,the,0,0
130341,H,0,1
130342,(,0,1
130343,max,0,0
130344,),0,1
130345,/M,0,1
130346,(,0,1
130347,max,0,0
130348,),0,1
130349,ratio,0,0
130350,increased,0,0
130351,by,0,0
130352,30.8,0,0
130353,?,0,0
130354,21.7,0,0
130355,%,0,0
130356,(,0,0
130357,P,0,0
130358,<,0,0
130359,0.05,0,0
130360,),0,0
130361,.,0,0
130362,The,0,0
130363,endurance,1,0
130364,training,1,1
130365,group,1,0
130366,also,0,0
130367,displayed,0,0
130368,a,0,0
130369,reduction,0,0
130370,in,0,0
130371,the,0,0
130372,H-reflex,0,1
130373,excitability,0,0
130374,threshold,0,0
130375,while,0,0
130376,the,0,0
130377,H-reflex,0,1
130378,amplitude,0,0
130379,on,0,0
130380,the,0,0
130381,ascending,0,0
130382,limb,0,0
130383,of,0,0
130384,the,0,0
130385,recruitment,0,0
130386,curve,0,0
130387,increased,0,0
130388,.,0,0
130389,Strength,0,0
130390,training,0,1
130391,only,0,0
130392,elicited,0,0
130393,a,0,0
130394,significant,0,0
130395,decrease,0,0
130396,in,0,0
130397,H-reflex,0,1
130398,excitability,0,0
130399,threshold,0,0
130400,",",0,0
130401,while,0,0
130402,H-reflex,0,0
130403,amplitudes,0,0
130404,over,0,0
130405,the,0,0
130406,ascending,0,0
130407,limb,0,0
130408,remained,0,0
130409,unchanged,0,0
130410,.,0,0
130411,These,0,0
130412,observations,0,0
130413,indicate,0,0
130414,that,0,0
130415,the,0,0
130416,H-reflex,0,1
130417,pathway,0,1
130418,is,0,0
130419,strongly,0,0
130420,involved,0,0
130421,in,0,0
130422,the,0,0
130423,enhanced,0,0
130424,endurance,0,0
130425,resistance,0,0
130426,that,0,0
130427,occurs,0,0
130428,following,1,0
130429,endurance,1,0
130430,training,1,1
130431,.,1,0
130432,On,1,0
130433,the,0,0
130434,contrary,0,0
130435,",",0,0
130436,the,0,0
130437,improvements,0,0
130438,in,0,0
130439,MVC,0,1
130440,following,0,0
130441,strength,0,0
130442,training,0,1
130443,are,0,0
130444,likely,0,0
130445,attributed,0,0
130446,to,0,0
130447,increased,0,0
130448,descending,0,0
130449,drive,0,0
130450,and/or,0,1
130451,modulation,0,0
130452,in,0,0
130453,afferents,0,0
130454,other,0,0
130455,than,0,0
130456,Ia,0,1
130457,afferents,0,0
130458,.,0,0
130459,A,0,0
130460,phase,0,0
130461,IIb,0,1
130462,dose-ranging,0,1
130463,study,0,0
130464,of,0,0
130465,the,0,0
130466,oral,1,1
130467,JAK,1,1
130468,inhibitor,1,1
130469,tofacitinib,1,1
130470,(,1,1
130471,"CP-690,550",1,1
130472,),1,1
130473,versus,1,1
130474,placebo,1,1
130475,in,0,0
130476,combination,0,1
130477,with,0,0
130478,background,1,0
130479,methotrexate,1,1
130480,in,0,0
130481,patients,0,0
130482,with,0,0
130483,active,0,1
130484,rheumatoid,0,0
130485,arthritis,0,0
130486,and,0,0
130487,an,0,0
130488,inadequate,0,0
130489,response,0,0
130490,to,0,0
130491,methotrexate,1,1
130492,alone,1,1
130493,.,1,0
130494,OBJECTIVE,0,0
130495,To,0,0
130496,compare,0,0
130497,the,0,0
130498,efficacy,0,0
130499,",",0,0
130500,safety,0,0
130501,",",0,0
130502,and,0,0
130503,tolerability,0,0
130504,of,0,0
130505,6,0,0
130506,dosages,0,0
130507,of,0,0
130508,oral,1,1
130509,tofacitinib,1,1
130510,(,1,1
130511,"CP-690,550",1,1
130512,),1,1
130513,with,1,0
130514,placebo,1,1
130515,for,0,0
130516,the,0,0
130517,treatment,0,0
130518,of,0,0
130519,active,0,1
130520,rheumatoid,0,1
130521,arthritis,0,1
130522,(,0,1
130523,RA,0,0
130524,),0,1
130525,in,0,0
130526,patients,0,0
130527,receiving,0,0
130528,a,0,0
130529,stable,0,0
130530,background,0,0
130531,regimen,0,1
130532,of,0,0
130533,methotrexate,1,1
130534,(,1,1
130535,MTX,1,1
130536,),1,1
130537,who,0,0
130538,have,0,0
130539,an,0,0
130540,inadequate,0,0
130541,response,0,0
130542,to,0,0
130543,MTX,1,1
130544,monotherapy,1,1
130545,.,1,0
130546,METHODS,0,0
130547,In,0,0
130548,this,0,0
130549,24-week,0,0
130550,",",0,0
130551,double-blind,0,0
130552,",",0,0
130553,phase,0,0
130554,IIb,0,1
130555,study,0,0
130556,",",0,0
130557,patients,0,0
130558,with,0,0
130559,active,0,1
130560,RA,0,0
130561,(,0,0
130562,n,0,0
130563,=,0,0
130564,507,0,0
130565,),0,0
130566,were,0,0
130567,randomized,0,0
130568,to,0,0
130569,receive,0,1
130570,placebo,1,1
130571,or,1,1
130572,tofacitinib,1,1
130573,(,0,1
130574,20,0,0
130575,mg/day,0,1
130576,",",0,0
130577,1,0,0
130578,mg,0,1
130579,twice,0,1
130580,daily,0,0
130581,",",0,0
130582,3,0,0
130583,mg,0,1
130584,twice,0,1
130585,daily,0,0
130586,",",0,0
130587,5,0,0
130588,mg,0,1
130589,twice,0,1
130590,daily,0,0
130591,",",0,0
130592,10,0,0
130593,mg,0,1
130594,twice,0,1
130595,daily,0,1
130596,",",0,0
130597,or,0,1
130598,15,0,0
130599,mg,0,1
130600,twice,0,1
130601,daily,0,1
130602,),0,0
130603,.,0,0
130604,All,0,0
130605,patients,0,0
130606,continued,0,0
130607,to,0,0
130608,receive,0,0
130609,a,0,0
130610,stable,0,0
130611,dosage,0,0
130612,of,0,0
130613,MTX,1,1
130614,.,1,0
130615,The,0,0
130616,primary,0,0
130617,end,0,0
130618,point,0,0
130619,was,0,0
130620,the,0,0
130621,American,0,0
130622,College,0,0
130623,of,0,0
130624,Rheumatology,0,0
130625,20,0,1
130626,%,0,0
130627,improvement,0,0
130628,criteria,0,0
130629,(,0,1
130630,ACR20,0,1
130631,),0,1
130632,response,0,0
130633,rate,0,0
130634,at,0,0
130635,week,0,0
130636,12,0,0
130637,.,0,0
130638,RESULTS,0,0
130639,At,0,0
130640,week,0,0
130641,12,0,0
130642,",",0,0
130643,ACR20,0,1
130644,response,0,0
130645,rates,0,0
130646,for,0,0
130647,patients,0,0
130648,receiving,0,0
130649,all,0,0
130650,tofacitinib,1,1
130651,dosages,0,1
130652,?3,0,1
130653,mg,0,1
130654,twice,0,1
130655,daily,0,1
130656,(,0,0
130657,52.9,0,0
130658,%,0,0
130659,for,0,0
130660,3,0,0
130661,mg,0,1
130662,twice,0,0
130663,daily,0,0
130664,",",0,0
130665,50.7,0,0
130666,%,0,0
130667,for,0,0
130668,5,0,0
130669,mg,0,1
130670,twice,0,0
130671,daily,0,0
130672,",",0,0
130673,58.1,0,0
130674,%,0,0
130675,for,0,0
130676,10,0,0
130677,mg,0,1
130678,twice,0,0
130679,daily,0,0
130680,",",0,0
130681,56.0,0,0
130682,%,0,0
130683,for,0,0
130684,15,0,0
130685,mg,0,1
130686,twice,0,0
130687,daily,0,1
130688,",",0,0
130689,and,0,0
130690,53.8,0,0
130691,%,0,0
130692,for,0,0
130693,20,0,0
130694,mg/day,0,1
130695,),0,0
130696,were,0,0
130697,significantly,0,0
130698,(,0,0
130699,P,0,0
130700,?,0,0
130701,0.05,0,0
130702,),0,0
130703,greater,0,0
130704,than,0,0
130705,those,0,0
130706,for,0,0
130707,placebo,1,1
130708,(,1,0
130709,33.3,1,0
130710,%,0,0
130711,),0,0
130712,.,0,0
130713,Improvements,0,0
130714,were,0,0
130715,sustained,0,0
130716,at,0,0
130717,week,0,0
130718,24,0,0
130719,for,0,0
130720,the,0,0
130721,ACR20,0,1
130722,",",0,0
130723,ACR50,0,0
130724,",",0,0
130725,and,0,0
130726,ACR70,0,0
130727,responses,0,0
130728,",",0,0
130729,scores,0,0
130730,for,0,0
130731,the,0,0
130732,Health,0,0
130733,Assessment,0,1
130734,Questionnaire,0,1
130735,disability,0,0
130736,index,0,0
130737,",",0,0
130738,the,0,0
130739,3-variable,0,0
130740,Disease,0,0
130741,Activity,0,0
130742,Score,0,0
130743,in,0,0
130744,28,0,0
130745,joints,0,0
130746,using,0,0
130747,the,0,0
130748,C-reactive,0,0
130749,protein,0,1
130750,level,0,0
130751,(,0,1
130752,DAS28-CRP,0,1
130753,),0,1
130754,",",0,0
130755,and,0,0
130756,a,0,0
130757,3-variable,0,1
130758,DAS28-CRP,0,0
130759,of,0,0
130760,<,0,0
130761,2.6,0,0
130762,.,0,0
130763,The,0,0
130764,most,0,0
130765,common,0,0
130766,treatment-emergent,0,0
130767,adverse,0,0
130768,events,0,0
130769,occurring,0,0
130770,in,0,0
130771,>,0,0
130772,10,0,0
130773,%,0,0
130774,of,0,0
130775,patients,0,0
130776,in,0,0
130777,any,0,0
130778,tofacitinib,0,1
130779,group,0,0
130780,were,0,0
130781,diarrhea,0,0
130782,",",0,0
130783,upper,0,0
130784,respiratory,0,0
130785,tract,0,0
130786,infection,0,0
130787,",",0,0
130788,and,0,0
130789,headache,0,0
130790,;,0,0
130791,21,0,0
130792,patients,0,0
130793,(,0,0
130794,4.1,0,0
130795,%,0,0
130796,),0,0
130797,experienced,0,0
130798,serious,0,0
130799,adverse,0,0
130800,events,0,0
130801,.,0,0
130802,Sporadic,0,0
130803,increases,0,0
130804,in,0,0
130805,transaminase,0,0
130806,levels,0,0
130807,",",0,0
130808,increases,0,0
130809,in,0,0
130810,cholesterol,0,0
130811,and,0,0
130812,serum,0,0
130813,creatinine,0,0
130814,levels,0,0
130815,",",0,0
130816,and,0,0
130817,decreases,0,0
130818,in,0,0
130819,neutrophil,0,0
130820,and,0,0
130821,hemoglobin,0,0
130822,levels,0,0
130823,were,0,0
130824,observed,0,0
130825,.,0,0
130826,CONCLUSION,0,0
130827,In,0,0
130828,patients,0,0
130829,with,0,0
130830,active,0,0
130831,RA,0,0
130832,in,0,0
130833,whom,0,0
130834,the,0,0
130835,response,1,0
130836,to,1,0
130837,MTX,1,1
130838,has,0,0
130839,been,0,0
130840,inadequate,0,0
130841,",",0,0
130842,the,0,0
130843,addition,1,0
130844,of,1,0
130845,tofacitinib,1,1
130846,at,1,0
130847,a,0,0
130848,dosage,0,0
130849,?3,0,1
130850,mg,0,1
130851,twice,0,1
130852,daily,0,1
130853,showed,0,0
130854,sustained,0,0
130855,efficacy,0,0
130856,and,0,0
130857,a,0,0
130858,manageable,0,0
130859,safety,0,0
130860,profile,0,0
130861,over,0,0
130862,24,0,0
130863,weeks,0,0
130864,.,0,0
130865,Reduced,0,0
130866,mortality,0,0
130867,among,0,0
130868,children,0,0
130869,in,0,0
130870,southern,0,0
130871,India,0,1
130872,receiving,0,0
130873,a,0,0
130874,small,0,0
130875,weekly,0,1
130876,dose,0,0
130877,of,0,0
130878,vitamin,1,1
130879,A,1,0
130880,.,1,0
130881,BACKGROUND,0,0
130882,Clinical,0,0
130883,vitamin,0,1
130884,A,0,0
130885,deficiency,0,0
130886,affects,0,0
130887,millions,0,0
130888,of,0,0
130889,children,0,0
130890,worldwide,0,0
130891,",",0,0
130892,and,0,0
130893,subclinical,0,0
130894,deficiency,0,0
130895,is,0,0
130896,even,0,0
130897,more,0,0
130898,common,0,0
130899,.,0,0
130900,Supplemental,0,1
130901,vitamin,0,1
130902,A,0,0
130903,has,0,0
130904,been,0,0
130905,reported,0,0
130906,to,0,0
130907,reduce,0,0
130908,mortality,0,0
130909,among,0,0
130910,these,0,0
130911,children,0,0
130912,",",0,0
130913,but,0,0
130914,the,0,0
130915,results,0,0
130916,have,0,0
130917,been,0,0
130918,questioned,0,0
130919,.,0,0
130920,METHODS,0,0
130921,We,0,0
130922,conducted,0,0
130923,a,0,0
130924,randomized,0,0
130925,",",0,0
130926,controlled,0,0
130927,",",0,0
130928,masked,0,0
130929,clinical,0,0
130930,trial,0,0
130931,for,0,0
130932,one,0,0
130933,year,0,0
130934,in,0,0
130935,southern,0,0
130936,India,0,1
130937,involving,0,0
130938,"15,419",0,0
130939,preschool-age,0,0
130940,children,0,0
130941,who,0,0
130942,received,0,0
130943,either,0,0
130944,8.7,1,0
130945,mumol,1,0
130946,(,1,0
130947,8333,1,0
130948,IU,1,1
130949,),1,0
130950,of,1,0
130951,vitamin,1,1
130952,A,1,0
130953,and,1,0
130954,46,1,0
130955,mumol,1,0
130956,(,1,0
130957,20,1,1
130958,mg,1,1
130959,),1,0
130960,of,1,0
130961,vitamin,1,1
130962,E,1,1
130963,(,1,0
130964,the,1,0
130965,treated,1,0
130966,group,1,0
130967,),1,1
130968,or,1,1
130969,vitamin,1,1
130970,E,1,1
130971,alone,1,1
130972,(,1,0
130973,the,1,0
130974,control,1,1
130975,group,1,0
130976,),1,0
130977,.,0,0
130978,Vitamin,1,1
130979,supplements,1,1
130980,were,0,0
130981,delivered,0,0
130982,weekly,0,1
130983,by,0,0
130984,community,0,1
130985,health,0,0
130986,volunteers,0,0
130987,who,0,0
130988,also,0,0
130989,recorded,0,0
130990,mortality,0,0
130991,and,0,0
130992,morbidity,0,0
130993,.,0,1
130994,Weekly,0,0
130995,contact,0,0
130996,was,0,0
130997,made,0,0
130998,with,0,0
130999,at,0,0
131000,least,0,0
131001,88,0,0
131002,percent,0,0
131003,of,0,0
131004,the,0,0
131005,children,0,0
131006,in,0,0
131007,both,0,0
131008,study,0,0
131009,groups,0,0
131010,.,0,0
131011,The,0,0
131012,base-line,0,0
131013,characteristics,0,0
131014,of,0,0
131015,the,0,0
131016,children,0,0
131017,were,0,0
131018,similar,0,0
131019,and,0,0
131020,documented,0,0
131021,a,0,0
131022,high,0,0
131023,prevalence,0,0
131024,of,0,0
131025,vitamin,0,1
131026,A,0,1
131027,deficiency,0,0
131028,and,0,0
131029,undernutrition,0,0
131030,.,0,0
131031,RESULTS,0,0
131032,One,0,0
131033,hundred,0,0
131034,twenty-five,0,0
131035,deaths,0,0
131036,occurred,0,0
131037,",",0,0
131038,of,0,0
131039,which,0,0
131040,117,0,0
131041,were,0,0
131042,not,0,0
131043,accidental,0,0
131044,.,0,0
131045,The,0,0
131046,risk,0,0
131047,of,0,0
131048,death,0,0
131049,in,0,0
131050,the,0,0
131051,group,0,0
131052,treated,0,0
131053,with,0,0
131054,vitamin,0,1
131055,A,0,0
131056,was,0,0
131057,less,0,0
131058,than,0,0
131059,half,0,0
131060,that,0,0
131061,in,0,0
131062,the,0,0
131063,control,0,1
131064,group,0,0
131065,(,0,1
131066,relative,0,0
131067,risk,0,0
131068,",",0,0
131069,0.46,0,0
131070,;,0,0
131071,95,0,0
131072,percent,0,0
131073,confidence,0,0
131074,interval,0,0
131075,",",0,0
131076,0.30,0,0
131077,to,0,0
131078,0.71,0,0
131079,),0,0
131080,.,0,0
131081,The,0,0
131082,risk,0,0
131083,was,0,0
131084,most,0,0
131085,reduced,0,0
131086,among,0,0
131087,children,0,0
131088,under,0,0
131089,3,0,0
131090,years,0,0
131091,of,0,0
131092,age,0,0
131093,(,0,0
131094,6,0,0
131095,to,0,0
131096,11,0,0
131097,months,0,0
131098,--,0,0
131099,relative,0,0
131100,risk,0,0
131101,",",0,0
131102,0.28,0,0
131103,;,0,0
131104,95,0,0
131105,percent,0,0
131106,confidence,0,0
131107,interval,0,0
131108,",",0,0
131109,0.09,0,0
131110,to,0,0
131111,0.85,0,0
131112,;,0,0
131113,12,0,0
131114,to,0,0
131115,35,0,0
131116,months,0,0
131117,--,0,0
131118,relative,0,0
131119,risk,0,0
131120,",",0,0
131121,0.46,0,0
131122,;,0,0
131123,95,0,0
131124,percent,0,0
131125,confidence,0,0
131126,interval,0,0
131127,",",0,0
131128,0.26,0,0
131129,to,0,0
131130,0.81,0,0
131131,),0,0
131132,and,0,0
131133,among,0,0
131134,those,0,0
131135,who,0,0
131136,were,0,0
131137,chronically,0,0
131138,undernourished,0,0
131139,",",0,0
131140,as,0,0
131141,manifested,0,0
131142,by,0,0
131143,stunting,0,0
131144,(,0,0
131145,relative,0,0
131146,risk,0,0
131147,",",0,0
131148,0.11,0,0
131149,;,0,0
131150,95,0,0
131151,percent,0,0
131152,confidence,0,0
131153,interval,0,0
131154,",",0,0
131155,0.03,0,0
131156,to,0,0
131157,0.36,0,0
131158,),0,0
131159,.,0,0
131160,The,0,0
131161,symptom-specific,0,0
131162,risk,0,0
131163,of,0,0
131164,mortality,0,0
131165,was,0,0
131166,significantly,0,0
131167,associated,0,0
131168,with,0,0
131169,diarrhea,0,0
131170,",",0,0
131171,convulsions,0,0
131172,",",0,0
131173,and,0,0
131174,other,0,0
131175,infection-related,0,0
131176,symptoms,0,0
131177,.,0,0
131178,CONCLUSIONS,0,0
131179,The,0,0
131180,regular,0,1
131181,provision,0,0
131182,of,0,0
131183,a,0,0
131184,supplement,0,1
131185,of,0,0
131186,vitamin,1,1
131187,A,1,0
131188,to,0,0
131189,children,0,0
131190,",",0,0
131191,at,0,0
131192,a,0,0
131193,level,0,0
131194,potentially,0,0
131195,obtainable,0,0
131196,from,0,0
131197,foods,0,1
131198,",",0,0
131199,in,0,0
131200,an,0,0
131201,area,0,0
131202,where,0,0
131203,vitamin,0,1
131204,A,0,0
131205,deficiency,0,0
131206,and,0,0
131207,under-nutrition,0,0
131208,are,0,0
131209,documented,0,0
131210,public,0,0
131211,health,0,0
131212,problems,0,0
131213,contributed,0,0
131214,substantially,0,0
131215,to,0,0
131216,children,0,0
131217,'s,0,0
131218,survival,0,0
131219,;,0,0
131220,mortality,0,0
131221,was,0,0
131222,reduced,0,0
131223,on,0,0
131224,average,0,0
131225,by,0,0
131226,54,0,0
131227,percent,0,0
131228,.,0,0
131229,Comparison,0,0
131230,of,0,0
131231,epidural,1,1
131232,tramadol-ropivacaine,1,1
131233,and,1,0
131234,fentanyl-ropivacaine,1,1
131235,for,0,0
131236,labor,0,0
131237,analgesia,0,0
131238,:,0,0
131239,a,0,0
131240,prospective,0,0
131241,randomized,0,0
131242,study,0,0
131243,.,0,0
131244,BACKGROUND,0,0
131245,To,0,0
131246,test,0,0
131247,the,0,0
131248,hypothesis,0,0
131249,that,0,0
131250,5,0,1
131251,mg/mL,0,1
131252,tramadol,1,1
131253,is,0,0
131254,superior,0,0
131255,to,0,0
131256,3,0,0
131257,?,0,0
131258,g/mL,0,0
131259,fentanyl,1,1
131260,when,0,0
131261,combined,0,1
131262,with,0,0
131263,0.125,0,1
131264,%,0,0
131265,ropivacaine,1,1
131266,in,0,0
131267,parturients,0,0
131268,undergoing,0,0
131269,labor,0,0
131270,during,0,0
131271,epidural,0,1
131272,analgesia,0,0
131273,.,0,0
131274,METHODS,0,0
131275,Sixty-one,0,0
131276,parturients,0,0
131277,undergoing,0,0
131278,labor,0,0
131279,selected,0,0
131280,for,0,0
131281,delivery,0,0
131282,with,0,0
131283,epidural,0,1
131284,analgesia,0,0
131285,were,0,0
131286,randomized,0,0
131287,into,0,0
131288,two,0,0
131289,groups,0,0
131290,:,0,0
131291,Group,0,0
131292,tramadol,1,1
131293,(,1,0
131294,0.125,1,1
131295,%,1,0
131296,ropivacaine,1,1
131297,plus,1,1
131298,tramadol,1,1
131299,5,1,1
131300,mg/mL,1,1
131301,),1,0
131302,and,0,0
131303,Group,0,1
131304,fentanyl,1,1
131305,(,1,0
131306,0.125,1,1
131307,%,1,0
131308,ropivacaine,1,1
131309,plus,1,1
131310,fentanyl,1,1
131311,3,1,1
131312,ug/mL,1,0
131313,),1,0
131314,.,0,0
131315,Hemodynamics,0,0
131316,",",0,0
131317,rate,0,0
131318,of,0,0
131319,cesarean,0,0
131320,delivery,0,0
131321,",",0,0
131322,sensory,0,1
131323,block,0,0
131324,level,0,0
131325,",",0,0
131326,Bromage,0,0
131327,motor,0,0
131328,scale,0,0
131329,scores,0,0
131330,",",0,0
131331,instrument-assisted,0,1
131332,delivery,0,0
131333,",",0,0
131334,oxytocin,0,1
131335,use,0,0
131336,",",0,0
131337,visual,0,0
131338,analog,0,1
131339,scale,0,0
131340,(,0,1
131341,VAS,0,1
131342,),0,1
131343,scores,0,0
131344,",",0,0
131345,Apgar,0,0
131346,scores,0,0
131347,",",0,0
131348,umbilical,0,0
131349,cord,0,0
131350,artery,0,0
131351,gas,0,1
131352,analysis,0,0
131353,",",0,0
131354,and,0,0
131355,maternal,0,0
131356,side-effects,0,0
131357,including,0,0
131358,nausea,0,0
131359,",",0,0
131360,vomiting,0,0
131361,",",0,0
131362,pruritus,0,0
131363,",",0,0
131364,urinary,0,0
131365,retention,0,0
131366,",",0,0
131367,shivering,0,0
131368,",",0,0
131369,hypotension,0,0
131370,",",0,0
131371,and,0,0
131372,respiratory,0,0
131373,depression,0,0
131374,were,0,0
131375,recorded,0,0
131376,.,0,0
131377,RESULTS,0,0
131378,The,0,0
131379,two,0,0
131380,groups,0,0
131381,had,0,0
131382,no,0,0
131383,significant,0,0
131384,differences,0,0
131385,with,0,0
131386,respect,0,0
131387,to,0,0
131388,maternal,0,0
131389,hemodynamics,0,0
131390,",",0,0
131391,neonatal,0,0
131392,heart,0,0
131393,rate,0,0
131394,",",0,0
131395,VAS,0,1
131396,scores,0,0
131397,",",0,0
131398,rate,0,0
131399,of,0,0
131400,cesarean,0,0
131401,delivery,0,0
131402,",",0,0
131403,sensory,0,1
131404,block,0,0
131405,level,0,0
131406,",",0,0
131407,Bromage,0,0
131408,motor,0,0
131409,scale,0,0
131410,scores,0,0
131411,",",0,0
131412,instrument-assisted,0,1
131413,delivery,0,0
131414,",",0,0
131415,oxytocin,0,1
131416,use,0,0
131417,",",0,0
131418,hypotension,0,0
131419,",",0,0
131420,nausea,0,0
131421,",",0,0
131422,vomiting,0,0
131423,",",0,0
131424,and,0,0
131425,respiratory,0,0
131426,depression,0,1
131427,(,0,0
131428,p,0,0
131429,>,0,0
131430,0.05,0,0
131431,),0,0
131432,.,0,0
131433,The,0,0
131434,incidence,0,0
131435,of,0,0
131436,pruritus,0,0
131437,",",0,0
131438,shivering,0,0
131439,",",0,0
131440,and,0,0
131441,urinary,0,0
131442,retention,0,0
131443,were,0,0
131444,more,0,0
131445,commonly,0,0
131446,observed,0,0
131447,in,0,0
131448,Group,0,0
131449,fentanyl,0,1
131450,despite,0,0
131451,there,0,0
131452,was,0,0
131453,no,0,0
131454,significant,0,0
131455,difference,0,0
131456,between,0,0
131457,the,0,0
131458,two,0,0
131459,groups,0,0
131460,.,0,0
131461,Umbilical,0,0
131462,artery,0,0
131463,pH,0,1
131464,was,0,0
131465,significantly,0,0
131466,lower,0,0
131467,while,0,0
131468,PCO,0,0
131469,(,0,1
131470,2,0,0
131471,),0,0
131472,was,0,0
131473,higher,0,0
131474,in,0,0
131475,Group,0,0
131476,fentanyl,1,1
131477,than,0,0
131478,Group,0,0
131479,tramadol,1,1
131480,(,0,0
131481,p,0,0
131482,=,0,0
131483,0.003,0,0
131484,and,0,0
131485,p,0,0
131486,=,0,0
131487,0.026,0,0
131488,",",0,0
131489,respectively,0,0
131490,),0,0
131491,.,0,0
131492,Birth-weight,0,0
131493,",",0,0
131494,umbilical,0,0
131495,artery,0,0
131496,PO,0,1
131497,(,0,1
131498,2,0,0
131499,),0,1
131500,and,0,0
131501,base,0,1
131502,deficit,0,1
131503,",",0,0
131504,and,0,0
131505,Apgar,0,0
131506,scores,0,0
131507,at,0,0
131508,1,0,0
131509,and,0,0
131510,5,0,0
131511,min,0,0
131512,were,0,0
131513,comparable,0,0
131514,between,0,0
131515,the,0,0
131516,two,0,0
131517,groups,0,0
131518,(,0,0
131519,p,0,0
131520,>,0,0
131521,0.05,0,0
131522,),0,0
131523,.,0,0
131524,CONCLUSIONS,0,0
131525,Our,0,0
131526,observations,0,0
131527,suggest,0,0
131528,that,0,0
131529,tramadol,1,1
131530,seems,0,0
131531,to,0,0
131532,be,0,0
131533,a,0,0
131534,safe,0,0
131535,alternative,0,0
131536,to,0,0
131537,fentanyl,1,1
131538,for,0,0
131539,labor,0,0
131540,analgesia,0,0
131541,due,0,0
131542,to,0,0
131543,its,0,0
131544,similar,0,0
131545,analgesic,0,1
131546,efficacy,0,0
131547,.,0,0
131548,Instant,1,0
131549,Recess?,1,0
131550,:,1,0
131551,a,0,0
131552,practical,0,0
131553,tool,0,0
131554,for,0,0
131555,increasing,0,0
131556,physical,0,1
131557,activity,0,0
131558,during,0,0
131559,the,0,0
131560,school,0,0
131561,day,0,0
131562,.,0,0
131563,BACKGROUND,0,0
131564,An,0,0
131565,increased,0,0
131566,prevalence,0,0
131567,of,0,0
131568,overweight/obesity,0,0
131569,among,0,0
131570,children,0,0
131571,has,0,0
131572,led,0,0
131573,to,0,0
131574,school,0,0
131575,district,0,1
131576,level,0,0
131577,policies,0,0
131578,to,0,0
131579,increase,1,0
131580,physical,1,1
131581,activity,1,0
131582,(,1,1
131583,PA,1,1
131584,),1,1
131585,among,0,0
131586,elementary,0,0
131587,school,0,0
131588,students,0,0
131589,.,0,0
131590,Interventions,0,0
131591,are,0,0
131592,needed,0,0
131593,that,0,0
131594,increase,0,0
131595,activity,0,0
131596,levels,0,0
131597,without,0,0
131598,sacrificing,0,0
131599,time,0,0
131600,spent,0,0
131601,in,0,0
131602,academics,0,0
131603,.,0,0
131604,OBJECTIVES,0,0
131605,We,0,0
131606,evaluated,0,0
131607,a,0,0
131608,policy,1,0
131609,implementation,1,0
131610,intervention,1,1
131611,for,0,0
131612,to,0,0
131613,increase,0,0
131614,in-school,1,1
131615,PA,1,1
131616,in,0,0
131617,elementary,0,0
131618,schools,0,0
131619,in,0,0
131620,Forsyth,0,0
131621,County,0,0
131622,",",0,0
131623,North,0,0
131624,Carolina,0,0
131625,",",0,0
131626,in,0,0
131627,a,0,0
131628,randomized,0,0
131629,study,0,0
131630,with,0,0
131631,a,0,0
131632,delayed,0,0
131633,intervention,0,1
131634,control,0,1
131635,group,0,0
131636,.,0,0
131637,METHODS,0,0
131638,The,0,0
131639,study,0,0
131640,included,0,0
131641,third-,0,0
131642,through,0,0
131643,fifth-grade,0,0
131644,classrooms,0,1
131645,in,0,0
131646,eight,0,0
131647,elementary,0,0
131648,schools,0,0
131649,.,0,0
131650,Instant,1,0
131651,Recess?,1,0
131652,was,1,0
131653,used,0,0
131654,to,0,0
131655,introduce,0,0
131656,10-minute,1,1
131657,PA,1,1
131658,breaks,1,1
131659,in,1,0
131660,classrooms,0,1
131661,on,0,0
131662,schedules,0,1
131663,determined,0,0
131664,by,0,0
131665,teachers,0,0
131666,.,0,0
131667,Direct,0,0
131668,observation,0,0
131669,was,0,0
131670,used,0,0
131671,to,0,0
131672,measure,0,0
131673,activity,0,0
131674,levels,0,0
131675,",",0,0
131676,other,0,0
131677,student,0,0
131678,behaviors,0,0
131679,",",0,0
131680,and,0,0
131681,teacher,0,1
131682,behaviors,0,0
131683,related,0,0
131684,to,0,0
131685,PA,0,0
131686,in,0,0
131687,the,0,0
131688,classrooms,0,1
131689,.,0,0
131690,RESULTS,0,0
131691,Twenty-eight,0,0
131692,visits,0,0
131693,to,0,0
131694,schools,0,0
131695,were,0,0
131696,made,0,0
131697,during,0,0
131698,the,0,0
131699,spring,0,0
131700,and,0,0
131701,fall,0,0
131702,semesters,0,0
131703,of,0,0
131704,2009,0,0
131705,.,0,0
131706,At,0,0
131707,baseline,0,0
131708,11,0,0
131709,%,0,0
131710,to,0,0
131711,44,0,0
131712,%,0,0
131713,of,0,0
131714,intervention,0,1
131715,and,0,0
131716,control,0,1
131717,schools,0,0
131718,were,0,0
131719,engaged,0,0
131720,in,0,0
131721,classroom-based,1,1
131722,PA.,1,1
131723,PA,1,1
131724,increased,1,0
131725,from,0,0
131726,baseline,0,0
131727,to,0,0
131728,spring,0,0
131729,follow-up,0,0
131730,in,0,0
131731,intervention,0,1
131732,schools,0,0
131733,and,0,0
131734,was,0,0
131735,maintained,0,0
131736,the,0,0
131737,following,0,0
131738,fall,0,0
131739,.,0,0
131740,Control,0,0
131741,schools,0,0
131742,decreased,0,0
131743,PA,0,0
131744,from,0,0
131745,baseline,0,0
131746,to,0,0
131747,spring,0,0
131748,and,0,0
131749,increased,1,0
131750,PA,1,1
131751,once,1,1
131752,they,0,0
131753,began,0,0
131754,the,0,0
131755,intervention,0,1
131756,.,0,0
131757,Students,0,0
131758,in,0,0
131759,classrooms,0,1
131760,engaged,0,0
131761,in,0,0
131762,Instant,0,0
131763,Recess,0,0
131764,exhibited,0,0
131765,statistically,0,0
131766,significant,0,0
131767,increases,0,0
131768,in,0,0
131769,light,0,1
131770,(,0,0
131771,51,0,0
131772,%,0,0
131773,),0,1
131774,and,0,1
131775,moderate-intensity,0,1
131776,(,0,1
131777,16,1,0
131778,%,1,0
131779,),1,1
131780,PA,1,1
131781,and,1,0
131782,increases,0,0
131783,in,0,0
131784,time,0,0
131785,spent,0,0
131786,in,0,0
131787,on-task,0,1
131788,behavior,0,0
131789,(,0,0
131790,11,0,0
131791,%,0,0
131792,),0,0
131793,.,0,0
131794,Control,0,0
131795,schools,0,0
131796,experienced,0,0
131797,similar,0,0
131798,benefits,0,0
131799,after,0,0
131800,they,0,0
131801,began,0,0
131802,implementing,0,0
131803,Instant,0,0
131804,Recess,0,0
131805,.,0,0
131806,CONCLUSIONS,0,0
131807,Instant,0,0
131808,Recess,0,1
131809,is,0,0
131810,useful,0,0
131811,for,0,0
131812,increasing,1,0
131813,PA,1,1
131814,and,1,1
131815,improving,0,0
131816,behavior,0,0
131817,among,0,0
131818,elementary,0,0
131819,school,0,0
131820,children,0,0
131821,.,0,0
131822,Additional,0,0
131823,research,0,0
131824,may,0,0
131825,be,0,0
131826,needed,0,0
131827,to,0,0
131828,understand,0,0
131829,how,0,0
131830,to,0,0
131831,create,0,0
131832,policies,0,0
131833,supporting,0,0
131834,classroom,0,1
131835,activity,0,0
131836,breaks,0,1
131837,and,0,0
131838,how,0,0
131839,to,0,0
131840,assess,0,0
131841,policy,0,0
131842,adherence,0,0
131843,.,0,0
131844,Activator,1,1
131845,protein-1,1,1
131846,(,1,1
131847,AP-1,1,1
131848,),1,1
131849,signalling,0,0
131850,in,0,0
131851,human,0,1
131852,atherosclerosis,0,0
131853,:,0,0
131854,results,0,0
131855,of,0,0
131856,a,0,0
131857,systematic,0,0
131858,evaluation,0,0
131859,and,0,0
131860,intervention,0,1
131861,study,0,0
131862,.,0,0
131863,Animal,0,0
131864,studies,0,0
131865,implicate,0,0
131866,the,0,0
131867,AP-1,1,1
131868,(,1,0
131869,activator,1,1
131870,protein-1,1,1
131871,),1,1
131872,pro-inflammatory,0,0
131873,pathway,0,1
131874,as,0,0
131875,a,0,0
131876,promising,0,0
131877,target,0,0
131878,in,0,0
131879,the,0,0
131880,treatment,0,0
131881,of,0,0
131882,atherosclerotic,0,0
131883,disease,0,0
131884,.,0,0
131885,It,0,0
131886,is,0,0
131887,",",0,0
131888,however,0,0
131889,",",0,0
131890,unclear,0,0
131891,whether,0,0
131892,these,0,0
131893,observations,0,0
131894,apply,0,0
131895,to,0,0
131896,human,0,0
131897,atherosclerosis,0,0
131898,.,0,0
131899,Therefore,0,0
131900,we,0,0
131901,evaluated,0,0
131902,the,0,0
131903,profile,0,0
131904,of,0,0
131905,AP-1,1,1
131906,activation,1,0
131907,through,0,0
131908,histological,0,0
131909,analysis,0,0
131910,and,0,0
131911,tested,0,0
131912,the,0,0
131913,potential,0,0
131914,benefit,0,0
131915,of,0,0
131916,AP-1,1,1
131917,inhibition,1,0
131918,in,0,0
131919,a,0,0
131920,clinical,0,0
131921,trial,0,0
131922,.,0,0
131923,AP-1,1,1
131924,activation,1,0
131925,was,0,0
131926,quantified,0,0
131927,by,0,0
131928,phospho-c-Jun,0,1
131929,nuclear,0,1
131930,translocation,0,0
131931,(,0,1
131932,immunohistochemistry,0,0
131933,),0,1
131934,on,0,0
131935,a,0,0
131936,biobank,0,0
131937,of,0,0
131938,aortic,0,0
131939,wall,0,0
131940,samples,0,0
131941,from,0,0
131942,organ,0,0
131943,donors,0,0
131944,.,0,0
131945,The,0,0
131946,effect,0,0
131947,of,0,0
131948,AP-1,1,1
131949,inhibition,1,0
131950,on,0,0
131951,vascular,0,0
131952,parameters,0,0
131953,was,0,0
131954,tested,0,0
131955,through,0,0
131956,a,0,0
131957,double,0,1
131958,blind,0,0
131959,placebo-controlled,0,1
131960,cross-over,0,0
131961,study,0,0
131962,of,0,0
131963,28,1,0
131964,days,1,0
131965,doxycycline,1,1
131966,or,1,1
131967,placebo,1,1
131968,in,0,0
131969,patients,0,0
131970,with,0,0
131971,symptomatic,0,0
131972,peripheral,0,0
131973,artery,0,0
131974,disease,0,0
131975,.,0,0
131976,Vascular,0,0
131977,function,0,0
131978,was,0,0
131979,assessed,0,0
131980,by,0,0
131981,brachial,0,0
131982,dilation,0,0
131983,as,0,0
131984,well,0,0
131985,as,0,0
131986,by,0,0
131987,plasma,0,0
131988,samples,0,0
131989,analysed,0,0
131990,for,0,0
131991,hs-CRP,0,1
131992,(,0,0
131993,high-sensitivity,0,1
131994,C-reactive,0,1
131995,protein,0,1
131996,),0,0
131997,",",0,0
131998,IL-6,0,1
131999,(,0,1
132000,interleukin-6,0,1
132001,),0,0
132002,",",0,0
132003,IL-8,0,1
132004,",",0,0
132005,ICAM-1,0,1
132006,(,0,0
132007,intercellular,0,0
132008,adhesion,0,1
132009,molecule-1,0,0
132010,),0,0
132011,",",0,0
132012,vWF,0,1
132013,(,0,0
132014,von,0,0
132015,Willebrand,0,0
132016,factor,0,0
132017,),0,0
132018,",",0,0
132019,MCP-1,0,1
132020,(,0,0
132021,monocyte,0,0
132022,chemoattractant,0,1
132023,protein-1,0,1
132024,),0,0
132025,",",0,0
132026,PAI-1,0,1
132027,(,0,0
132028,plasminogen,0,1
132029,activator,0,1
132030,inhibitor-1,0,1
132031,),0,1
132032,and,0,0
132033,fibrinogen,0,0
132034,.,0,1
132035,Histological,0,0
132036,evaluation,0,0
132037,of,0,0
132038,human,0,1
132039,atherosclerosis,0,0
132040,showed,0,0
132041,minimal,1,0
132042,AP-1,1,1
132043,activation,1,0
132044,in,0,0
132045,non-diseased,0,0
132046,arterial,0,1
132047,wall,0,0
132048,(,0,0
132049,i.e,0,1
132050,.,0,1
132051,vessel,0,0
132052,wall,0,0
132053,without,0,0
132054,any,0,0
132055,signs,0,0
132056,of,0,0
132057,atherosclerotic,0,0
132058,disease,0,0
132059,),0,0
132060,.,0,0
132061,A,0,0
132062,gradual,0,0
132063,increase,0,0
132064,of,1,0
132065,AP-1,1,1
132066,activation,1,0
132067,was,0,0
132068,found,0,0
132069,in,0,0
132070,non-progressive,0,0
132071,and,0,0
132072,progressive,0,0
132073,phases,0,0
132074,of,0,0
132075,atherosclerosis,0,0
132076,respectively,0,0
132077,(,0,0
132078,P,0,0
132079,<,0,0
132080,0.044,0,0
132081,),0,0
132082,.,0,0
132083,No,0,0
132084,significant,0,0
132085,difference,0,0
132086,was,0,0
132087,found,0,0
132088,between,0,0
132089,progressive,0,0
132090,and,0,0
132091,vulnerable,0,0
132092,lesions,0,0
132093,.,0,0
132094,The,0,0
132095,expression,0,0
132096,of,0,0
132097,phospho-c-Jun,0,1
132098,diminished,0,0
132099,as,0,0
132100,the,0,0
132101,lesion,0,0
132102,stabilized,0,1
132103,(,0,0
132104,P,0,0
132105,<,0,0
132106,0.016,0,0
132107,),0,0
132108,and,0,0
132109,does,0,0
132110,not,0,0
132111,significantly,0,0
132112,differ,0,0
132113,from,0,0
132114,the,0,0
132115,normal,0,0
132116,aortic,0,0
132117,wall,0,0
132118,(,0,0
132119,P,0,0
132120,<,0,0
132121,0.33,0,0
132122,),0,0
132123,.,0,0
132124,Evaluation,0,0
132125,of,0,0
132126,the,1,0
132127,doxycycline,1,1
132128,intervention,1,1
132129,only,0,0
132130,revealed,0,0
132131,a,0,0
132132,borderline-significant,0,0
132133,reduction,0,0
132134,of,0,0
132135,circulating,0,0
132136,hs-CRP,0,1
132137,levels,0,0
132138,(,0,0
132139,-0.51,0,0
132140,?g/ml,0,0
132141,",",0,0
132142,P=0.05,0,0
132143,),0,1
132144,and,0,0
132145,did,0,0
132146,not,0,0
132147,affect,0,0
132148,any,0,0
132149,of,0,0
132150,the,0,0
132151,other,0,0
132152,markers,0,0
132153,of,0,0
132154,systemic,0,0
132155,inflammation,0,0
132156,and,0,0
132157,vascular,0,0
132158,function,0,0
132159,.,0,0
132160,Our,0,0
132161,studies,0,0
132162,do,0,0
132163,not,0,0
132164,characterize,1,0
132165,AP-1,1,1
132166,as,1,0
132167,a,0,0
132168,therapeutic,0,0
132169,target,0,0
132170,for,0,0
132171,progressive,0,0
132172,human,0,1
132173,atherosclerotic,0,0
132174,disease,0,0
132175,.,0,0
132176,Predictive,0,0
132177,and,0,0
132178,prognostic,0,0
132179,roles,0,0
132180,of,0,0
132181,BRAF,0,0
132182,mutation,0,0
132183,in,0,0
132184,stage,0,0
132185,III,0,1
132186,colon,0,0
132187,cancer,0,0
132188,:,0,0
132189,results,0,0
132190,from,0,0
132191,intergroup,0,0
132192,trial,0,0
132193,CALGB,0,0
132194,89803,0,0
132195,.,0,0
132196,PURPOSE,0,0
132197,Alterations,0,0
132198,in,0,0
132199,the,0,0
132200,RAS-RAF-MAP2K,0,1
132201,(,0,1
132202,MEK,0,1
132203,),0,1
132204,-MAPK,0,1
132205,signaling,0,0
132206,pathway,0,1
132207,are,0,0
132208,major,0,0
132209,drivers,0,0
132210,in,0,0
132211,colorectal,0,0
132212,carcinogenesis,0,0
132213,.,0,0
132214,In,0,0
132215,colorectal,0,0
132216,cancer,0,0
132217,",",0,0
132218,BRAF,0,0
132219,mutation,0,0
132220,is,0,0
132221,associated,0,0
132222,with,0,0
132223,microsatellite,0,1
132224,instability,0,0
132225,(,0,1
132226,MSI,0,1
132227,),0,1
132228,",",0,0
132229,and,0,0
132230,typically,0,0
132231,predicts,0,0
132232,inferior,0,0
132233,prognosis,0,0
132234,.,0,0
132235,We,0,0
132236,examined,0,0
132237,the,0,0
132238,effect,0,0
132239,of,0,0
132240,BRAF,0,0
132241,mutation,0,0
132242,on,0,0
132243,survival,0,0
132244,and,0,0
132245,treatment,0,1
132246,efficacy,0,0
132247,in,0,0
132248,patients,0,0
132249,with,0,0
132250,stage,0,0
132251,III,0,1
132252,colon,0,0
132253,cancer,0,0
132254,.,0,0
132255,METHODS,0,0
132256,We,0,0
132257,assessed,0,0
132258,status,1,0
132259,of,1,0
132260,BRAF,1,0
132261,c.1799T,1,0
132262,>,1,0
132263,A,1,0
132264,(,1,0
132265,p.V600E,1,1
132266,),1,1
132267,mutation,1,0
132268,and,1,0
132269,MSI,1,1
132270,in,0,0
132271,506,0,0
132272,stage,0,0
132273,III,0,1
132274,colon,0,0
132275,cancer,0,0
132276,patients,0,0
132277,enrolled,0,0
132278,in,0,0
132279,a,0,0
132280,randomized,0,0
132281,adjuvant,0,1
132282,chemotherapy,1,1
132283,trial,1,0
132284,[,1,1
132285,5-fluorouracil,1,1
132286,and,1,0
132287,leucovorin,1,1
132288,(,1,1
132289,FU/LV,1,1
132290,),1,1
132291,vs.,1,0
132292,irinotecan,1,1
132293,(,1,1
132294,CPT11,1,1
132295,),1,0
132296,",",1,0
132297,FU,1,1
132298,and,1,1
132299,LV,1,1
132300,(,1,1
132301,IFL,1,1
132302,),1,1
132303,;,1,0
132304,CALGB,0,0
132305,89803,0,0
132306,],0,0
132307,.,0,0
132308,Cox,0,0
132309,proportional,0,0
132310,hazards,0,0
132311,model,0,0
132312,was,0,0
132313,used,0,0
132314,to,0,0
132315,assess,0,0
132316,the,0,0
132317,prognostic,0,0
132318,role,0,0
132319,of,0,0
132320,BRAF,0,0
132321,mutation,0,0
132322,",",0,0
132323,adjusting,0,0
132324,for,0,0
132325,clinical,0,0
132326,features,0,0
132327,",",0,0
132328,adjuvant,0,1
132329,chemotherapy,1,1
132330,arm,0,0
132331,",",0,0
132332,and,0,0
132333,MSI,0,1
132334,status,0,0
132335,.,0,0
132336,RESULTS,0,0
132337,Compared,0,0
132338,with,0,0
132339,431,0,0
132340,BRAF,0,0
132341,wild-type,0,0
132342,patients,0,0
132343,",",0,0
132344,75,0,0
132345,BRAF-mutated,0,0
132346,patients,0,0
132347,experienced,0,0
132348,significantly,0,0
132349,worse,0,0
132350,overall,0,0
132351,survival,0,0
132352,[,0,0
132353,OS,0,0
132354,;,0,0
132355,log-rank,0,0
132356,P,0,0
132357,=,0,0
132358,0.015,0,0
132359,;,0,0
132360,multivariate,0,0
132361,HR,0,0
132362,=,0,0
132363,1.66,0,0
132364,;,0,0
132365,95,0,0
132366,%,0,0
132367,CI,0,0
132368,:,0,0
132369,1.05-2.63,0,0
132370,],0,0
132371,.,0,0
132372,By,0,0
132373,assessing,0,0
132374,combined,0,1
132375,status,0,0
132376,of,0,0
132377,BRAF,0,0
132378,and,0,0
132379,MSI,0,1
132380,",",0,0
132381,it,0,0
132382,seemed,0,0
132383,that,0,0
132384,BRAF-mutated,0,0
132385,MSS,0,1
132386,(,0,0
132387,microsatellite,0,1
132388,stable,0,0
132389,),0,1
132390,tumor,0,0
132391,was,0,0
132392,an,0,0
132393,unfavorable,0,0
132394,subtype,0,0
132395,",",0,0
132396,whereas,0,0
132397,BRAF,0,0
132398,wild-type,0,1
132399,MSI-high,0,1
132400,tumor,0,0
132401,was,0,0
132402,a,0,0
132403,favorable,0,0
132404,subtype,0,0
132405,",",0,0
132406,and,0,0
132407,BRAF-mutated,0,0
132408,MSI-high,0,1
132409,tumor,0,0
132410,and,0,0
132411,BRAF,0,0
132412,wild-type,0,1
132413,MSS,0,1
132414,tumor,0,0
132415,were,0,0
132416,intermediate,0,0
132417,subtypes,0,0
132418,.,0,0
132419,Among,0,0
132420,patients,0,0
132421,with,0,0
132422,BRAF-mutated,0,0
132423,tumors,0,0
132424,",",0,0
132425,a,0,0
132426,nonsignificant,0,0
132427,trend,0,0
132428,toward,0,0
132429,improved,0,0
132430,OS,0,0
132431,was,0,0
132432,observed,0,0
132433,for,0,0
132434,IFL,1,1
132435,versus,0,1
132436,FU/LV,1,1
132437,arm,0,1
132438,(,0,0
132439,multivariate,0,0
132440,HR,0,0
132441,=,0,0
132442,0.52,0,0
132443,;,0,0
132444,95,0,0
132445,%,0,0
132446,CI,0,0
132447,:,0,1
132448,0.25-1.10,0,0
132449,),0,0
132450,.,0,0
132451,Among,0,0
132452,patients,0,0
132453,with,0,0
132454,BRAF,0,0
132455,wild-type,0,1
132456,cancer,0,0
132457,",",0,0
132458,IFL,1,1
132459,conferred,0,0
132460,no,0,0
132461,suggestion,0,0
132462,of,0,0
132463,benefit,0,0
132464,beyond,0,0
132465,FU/LV,1,1
132466,alone,0,1
132467,(,0,0
132468,multivariate,0,0
132469,HR,0,0
132470,=,0,0
132471,1.02,0,0
132472,;,0,0
132473,95,0,0
132474,%,0,0
132475,CI,0,0
132476,:,0,1
132477,0.72-1.46,0,0
132478,),0,0
132479,.,0,0
132480,CONCLUSIONS,0,0
132481,BRAF,0,0
132482,mutation,0,0
132483,is,0,0
132484,associated,0,0
132485,with,0,0
132486,inferior,0,0
132487,survival,0,0
132488,in,0,0
132489,stage,0,0
132490,III,0,1
132491,colon,0,0
132492,cancer,0,0
132493,.,0,0
132494,Additional,0,0
132495,studies,0,0
132496,are,0,0
132497,necessary,0,0
132498,to,0,0
132499,assess,0,0
132500,whether,0,0
132501,there,0,0
132502,is,0,0
132503,any,0,0
132504,predictive,0,0
132505,role,0,0
132506,of,0,0
132507,BRAF,0,0
132508,mutation,0,0
132509,for,0,0
132510,irinotecan-based,1,1
132511,therapy,1,1
132512,.,1,0
132513,Effect,0,0
132514,of,0,0
132515,different,0,0
132516,rates,1,0
132517,of,1,0
132518,infusion,1,1
132519,of,0,0
132520,propofol,1,1
132521,for,0,0
132522,induction,0,0
132523,of,0,0
132524,anaesthesia,0,1
132525,in,0,0
132526,elderly,0,0
132527,patients,0,0
132528,.,0,0
132529,The,0,0
132530,effect,0,0
132531,of,0,0
132532,changing,0,0
132533,the,0,0
132534,rate,1,0
132535,of,1,0
132536,infusion,1,1
132537,of,0,0
132538,propofol,1,1
132539,for,0,0
132540,induction,0,0
132541,of,0,0
132542,anaesthesia,0,1
132543,was,0,0
132544,studied,0,0
132545,in,0,0
132546,60,0,0
132547,elderly,0,0
132548,patients,0,0
132549,.,0,0
132550,Propofol,1,1
132551,was,0,0
132552,administered,0,0
132553,at,0,0
132554,300,0,1
132555,",",0,0
132556,600,0,0
132557,or,0,0
132558,1200,0,0
132559,ml,0,1
132560,h-1,0,0
132561,until,0,0
132562,loss,0,0
132563,of,0,0
132564,consciousness,0,0
132565,(,0,0
132566,as,0,0
132567,judged,0,0
132568,by,0,0
132569,loss,0,0
132570,of,0,0
132571,verbal,0,1
132572,contact,0,1
132573,with,0,0
132574,the,0,0
132575,patient,0,0
132576,),0,0
132577,had,0,0
132578,been,0,0
132579,achieved,0,0
132580,.,0,0
132581,The,0,0
132582,duration,0,0
132583,of,0,0
132584,induction,0,0
132585,was,0,0
132586,significantly,0,0
132587,longer,0,0
132588,(,0,0
132589,P,0,0
132590,less,0,0
132591,than,0,0
132592,0.001,0,0
132593,),0,0
132594,with,0,0
132595,the,0,0
132596,slower,0,0
132597,infusion,0,0
132598,rates,0,0
132599,(,0,0
132600,104,0,0
132601,",",0,0
132602,68,0,0
132603,and,0,0
132604,51,0,0
132605,s,0,0
132606,),0,0
132607,",",0,0
132608,but,0,0
132609,the,0,0
132610,total,0,0
132611,dose,0,0
132612,used,0,0
132613,was,0,0
132614,significantly,0,0
132615,less,0,0
132616,(,0,0
132617,P,0,0
132618,less,0,0
132619,than,0,0
132620,0.001,0,0
132621,),0,0
132622,in,0,0
132623,these,0,0
132624,patients,0,0
132625,(,0,0
132626,1.2,0,0
132627,",",0,0
132628,1.6,0,0
132629,and,0,0
132630,2.5,0,1
132631,mg,0,1
132632,kg-1,0,1
132633,",",0,0
132634,respectively,0,0
132635,),0,0
132636,.,0,0
132637,The,0,0
132638,decrease,0,0
132639,in,0,0
132640,systolic,0,0
132641,and,0,0
132642,diastolic,0,0
132643,arterial,0,0
132644,pressure,0,0
132645,was,0,0
132646,significantly,0,0
132647,less,0,0
132648,in,0,0
132649,the,0,0
132650,300-ml,0,1
132651,h-1,0,0
132652,group,0,0
132653,at,0,0
132654,the,0,0
132655,end,0,0
132656,of,0,0
132657,induction,0,0
132658,and,0,0
132659,immediately,0,0
132660,after,0,0
132661,induction,0,0
132662,(,0,0
132663,P,0,0
132664,less,0,0
132665,than,0,0
132666,0.01,0,0
132667,),0,0
132668,.,0,0
132669,The,0,0
132670,incidence,0,0
132671,of,0,0
132672,apnoea,0,1
132673,was,0,0
132674,also,0,0
132675,significantly,0,0
132676,less,0,0
132677,in,0,0
132678,the,0,0
132679,slower,0,0
132680,infusion,0,0
132681,group,0,0
132682,.,0,0
132683,Impact,0,0
132684,of,0,0
132685,antisecretory,1,1
132686,treatment,1,0
132687,on,0,0
132688,respiratory,0,0
132689,symptoms,0,0
132690,of,0,0
132691,gastroesophageal,0,0
132692,reflux,0,0
132693,disease,0,0
132694,in,0,0
132695,children,0,0
132696,.,0,0
132697,The,0,0
132698,effect,0,0
132699,of,0,0
132700,antisecretory,1,1
132701,treatment,1,0
132702,on,0,0
132703,extraesophageal,0,0
132704,symptoms,0,0
132705,of,0,0
132706,gastroesophageal,0,0
132707,reflux,0,0
132708,disease,0,0
132709,was,0,0
132710,evaluated,0,0
132711,.,0,0
132712,Seventy-eight,0,0
132713,children,0,0
132714,presenting,0,0
132715,with,0,0
132716,typical,0,0
132717,and,0,0
132718,extraesophageal,0,0
132719,symptoms,0,0
132720,of,0,0
132721,gastroesophageal,0,0
132722,reflux,0,0
132723,disease,0,0
132724,underwent,0,0
132725,a,0,0
132726,multichannel,0,1
132727,intraluminal,0,1
132728,impedance,0,1
132729,and,0,0
132730,pH,0,1
132731,monitoring,0,1
132732,(,0,1
132733,MII/pH,0,1
132734,),0,0
132735,.,0,0
132736,Children,0,0
132737,with,0,0
132738,a,0,0
132739,positive,0,0
132740,MII/pH,0,0
132741,were,0,0
132742,randomly,0,0
132743,treated,0,0
132744,with,0,0
132745,proton,1,1
132746,pump,1,1
132747,inhibitors,1,1
132748,(,1,0
132749,PPIs,1,0
132750,),1,1
132751,or,1,1
132752,histamine,1,1
132753,H,1,1
132754,(,1,1
132755,2,1,0
132756,),1,0
132757,-receptor,1,1
132758,antagonists,1,1
132759,(,1,0
132760,H,1,1
132761,(,1,1
132762,2,1,0
132763,),1,0
132764,RAs,1,0
132765,),1,0
132766,during,0,0
132767,3,0,0
132768,months,0,0
132769,.,0,0
132770,At,0,0
132771,the,0,0
132772,end,0,0
132773,of,0,0
132774,the,0,0
132775,treatment,0,0
132776,period,0,0
132777,",",0,0
132778,all,0,0
132779,patients,0,0
132780,were,0,0
132781,recalled,0,0
132782,.,0,0
132783,A,0,0
132784,second,0,0
132785,treatment,0,0
132786,period,0,0
132787,of,0,0
132788,3,0,0
132789,months,0,0
132790,was,0,0
132791,given,0,0
132792,to,0,0
132793,those,0,0
132794,patients,0,0
132795,who,0,0
132796,were,0,0
132797,not,0,0
132798,symptom-free,0,0
132799,after,0,0
132800,3,0,0
132801,months,0,0
132802,.,0,0
132803,Thirty-five,0,0
132804,of,0,0
132805,the,0,0
132806,forty-one,0,0
132807,(,0,0
132808,85.4,0,0
132809,%,0,0
132810,),0,0
132811,children,0,0
132812,with,0,0
132813,a,0,0
132814,pathologic,0,0
132815,MII/pH,0,0
132816,presented,0,0
132817,with,0,0
132818,extraesophageal,0,0
132819,symptoms,0,0
132820,and,0,0
132821,were,0,0
132822,treated,0,0
132823,with,0,0
132824,PPIs,1,0
132825,(,1,0
132826,omeprazole,1,1
132827,;,1,1
132828,n:19,0,0
132829,),0,1
132830,or,0,1
132831,H,1,1
132832,(,1,1
132833,2,1,0
132834,),1,1
132835,RAs,1,0
132836,(,1,1
132837,ranitidine,1,1
132838,;,1,1
132839,n:16,0,0
132840,),0,0
132841,for,0,0
132842,12,0,0
132843,weeks,0,0
132844,.,0,0
132845,After,0,0
132846,3,0,0
132847,months,0,0
132848,",",0,0
132849,11/19,0,0
132850,(,0,0
132851,57.9,0,0
132852,%,0,0
132853,),0,0
132854,PPI-treated,1,0
132855,patients,0,0
132856,had,0,0
132857,a,0,0
132858,complete,0,0
132859,resolution,0,0
132860,of,0,0
132861,symptoms,0,0
132862,;,0,0
132863,6/8,0,0
132864,nonresponders,0,0
132865,were,0,0
132866,treated,0,0
132867,with,0,0
132868,PPI,1,1
132869,for,0,0
132870,another,0,0
132871,3,0,0
132872,months,0,0
132873,and,0,0
132874,became,0,0
132875,all,0,0
132876,symptom-free,0,0
132877,.,0,0
132878,The,0,0
132879,other,0,0
132880,two,0,0
132881,underwent,0,0
132882,a,0,0
132883,Nissen,0,0
132884,fundoplication,0,1
132885,.,0,0
132886,Only,0,0
132887,5/16,0,0
132888,(,0,0
132889,31.2,0,0
132890,%,0,0
132891,),0,0
132892,patients,0,0
132893,treated,0,0
132894,with,0,0
132895,H,1,1
132896,(,1,1
132897,2,1,0
132898,),1,0
132899,RAs,1,0
132900,had,0,0
132901,a,0,0
132902,complete,0,0
132903,resolution,0,0
132904,of,0,0
132905,symptoms,0,0
132906,after,0,0
132907,3,0,0
132908,months,0,0
132909,;,0,0
132910,1/11,0,0
132911,was,0,0
132912,treated,0,0
132913,again,0,0
132914,with,0,0
132915,H,1,1
132916,(,1,1
132917,2,1,0
132918,),1,0
132919,RAs,1,0
132920,during,0,0
132921,3,0,0
132922,months,0,0
132923,",",0,0
132924,and,0,0
132925,10/11,0,0
132926,were,0,0
132927,changed,0,0
132928,to,0,0
132929,PPIs,1,0
132930,.,1,0
132931,In,0,0
132932,3/10,0,0
132933,",",0,0
132934,a,0,0
132935,partial,0,0
132936,resolution,0,0
132937,of,0,0
132938,symptoms,0,0
132939,was,0,0
132940,achieved,0,0
132941,",",0,0
132942,while,0,0
132943,in,0,0
132944,7/10,0,0
132945,",",0,0
132946,a,0,0
132947,complete,0,0
132948,remission,0,0
132949,was,0,0
132950,obtained,0,0
132951,(,0,0
132952,P,0,0
132953,<,0,0
132954,0.05,0,0
132955,),0,0
132956,.,0,0
132957,Antisecretory,1,0
132958,reflux,1,0
132959,treatment,1,1
132960,improves,0,0
132961,extraesophageal,0,0
132962,reflux,0,0
132963,symptoms,0,0
132964,.,0,0
132965,The,0,0
132966,efficacy,0,0
132967,of,0,0
132968,PPIs,1,0
132969,is,0,0
132970,superior,0,0
132971,to,0,0
132972,that,0,0
132973,of,0,0
132974,H,1,0
132975,(,1,1
132976,2,1,0
132977,),1,0
132978,RAs,1,0
132979,in,0,0
132980,these,0,0
132981,children,0,0
132982,.,0,0
132983,Effect,0,0
132984,of,0,0
132985,acute,1,0
132986,exercise,1,1
132987,on,0,0
132988,executive,0,0
132989,function,0,0
132990,in,0,0
132991,children,0,0
132992,with,0,0
132993,attention,0,0
132994,deficit,0,1
132995,hyperactivity,0,0
132996,disorder,0,0
132997,.,0,0
132998,This,0,0
132999,study,0,0
133000,was,0,0
133001,conducted,0,0
133002,to,0,0
133003,determine,0,0
133004,the,0,0
133005,effect,0,0
133006,of,0,0
133007,acute,1,0
133008,aerobic,1,1
133009,exercise,1,1
133010,on,0,0
133011,executive,0,0
133012,function,0,0
133013,in,0,0
133014,children,0,0
133015,with,0,0
133016,attention,0,0
133017,deficit,0,1
133018,hyperactivity,0,1
133019,disorder,0,0
133020,(,0,1
133021,ADHD,0,1
133022,),0,0
133023,.,0,0
133024,Forty,0,0
133025,children,0,0
133026,with,0,0
133027,ADHD,0,1
133028,were,0,0
133029,randomly,0,0
133030,assigned,0,0
133031,into,0,0
133032,exercise,0,1
133033,or,0,1
133034,control,0,0
133035,groups,0,0
133036,.,0,0
133037,Participants,0,0
133038,in,0,0
133039,the,0,0
133040,exercise,0,1
133041,group,0,0
133042,performed,0,0
133043,a,0,0
133044,moderate,1,0
133045,intensity,1,0
133046,aerobic,1,1
133047,exercise,1,1
133048,for,1,0
133049,30,1,0
133050,min,1,0
133051,",",0,0
133052,whereas,0,0
133053,the,0,0
133054,control,0,1
133055,group,0,0
133056,watched,0,0
133057,a,0,0
133058,running/exercise-related,1,0
133059,video,1,1
133060,.,1,0
133061,Neuropsychological,0,0
133062,tasks,0,0
133063,",",0,0
133064,the,0,0
133065,Stroop,0,1
133066,Test,0,0
133067,and,0,0
133068,the,0,0
133069,Wisconsin,0,1
133070,Card,0,1
133071,Sorting,0,1
133072,Test,0,0
133073,(,0,1
133074,WCST,0,1
133075,),0,0
133076,",",0,0
133077,were,0,0
133078,assessed,0,0
133079,before,0,0
133080,and,0,0
133081,after,0,0
133082,each,0,0
133083,treatment,0,0
133084,.,0,0
133085,The,0,0
133086,results,0,0
133087,indicated,0,0
133088,that,0,0
133089,acute,0,0
133090,exercise,0,1
133091,facilitated,0,0
133092,performance,0,0
133093,in,0,0
133094,the,0,0
133095,Stroop,0,1
133096,Test,0,0
133097,",",0,0
133098,particularly,0,0
133099,in,0,0
133100,the,0,0
133101,Stroop,0,1
133102,Color-Word,0,1
133103,condition,0,0
133104,.,0,0
133105,Additionally,0,0
133106,",",0,0
133107,children,0,0
133108,in,0,0
133109,the,0,0
133110,exercise,0,1
133111,group,0,0
133112,demonstrated,0,0
133113,improvement,0,0
133114,in,0,0
133115,specific,0,0
133116,WCST,0,0
133117,performances,0,0
133118,in,0,0
133119,Non-perseverative,0,0
133120,Errors,0,0
133121,and,0,0
133122,Categories,0,0
133123,Completed,0,0
133124,",",0,0
133125,whereas,0,0
133126,no,0,0
133127,influences,0,0
133128,were,0,0
133129,found,0,0
133130,in,0,0
133131,those,0,0
133132,performances,0,0
133133,in,0,0
133134,the,0,0
133135,control,0,0
133136,group,0,0
133137,.,0,0
133138,Tentative,0,0
133139,explanations,0,0
133140,for,0,0
133141,the,0,0
133142,exercise,0,1
133143,effect,0,0
133144,postulate,0,0
133145,that,0,0
133146,exercise,0,1
133147,allocates,0,0
133148,attention,0,0
133149,resources,0,0
133150,",",0,0
133151,influences,0,0
133152,the,0,0
133153,dorsolateral,0,0
133154,prefrontal,0,0
133155,cortex,0,0
133156,",",0,0
133157,and,0,0
133158,is,0,0
133159,implicated,0,0
133160,in,0,0
133161,exercise-induced,0,0
133162,dopamine,0,1
133163,release,0,0
133164,.,0,0
133165,These,0,0
133166,findings,0,0
133167,are,0,0
133168,promising,0,0
133169,and,0,0
133170,additional,0,0
133171,investigations,0,0
133172,to,0,0
133173,explore,0,0
133174,the,0,0
133175,efficacy,1,0
133176,of,1,0
133177,exercise,1,1
133178,on,0,0
133179,executive,0,0
133180,function,0,0
133181,in,0,0
133182,children,0,0
133183,with,0,0
133184,ADHD,0,1
133185,are,0,0
133186,encouraged,0,0
133187,.,0,0
133188,Azathioprine,1,1
133189,and,0,0
133190,the,0,0
133191,treatment,0,0
133192,of,0,0
133193,chronic,0,0
133194,inflammatory,0,0
133195,bowel,0,0
133196,disease,0,0
133197,.,0,0
133198,Infrared,1,1
133199,LED,1,0
133200,irradiation,1,1
133201,applied,0,0
133202,during,0,0
133203,high-intensity,0,1
133204,treadmill,0,1
133205,training,0,1
133206,improves,0,0
133207,maximal,0,0
133208,exercise,0,1
133209,tolerance,0,0
133210,in,0,0
133211,postmenopausal,0,0
133212,women,0,0
133213,:,0,0
133214,a,0,0
133215,6-month,0,0
133216,longitudinal,0,0
133217,study,0,0
133218,.,0,0
133219,Reduced,0,0
133220,aerobic,0,1
133221,fitness,0,0
133222,is,0,0
133223,associated,0,0
133224,with,0,0
133225,an,0,0
133226,increased,0,0
133227,risk,0,0
133228,of,0,0
133229,cardiovascular,0,0
133230,diseases,0,0
133231,among,0,0
133232,the,0,0
133233,older,0,0
133234,population,0,0
133235,.,0,0
133236,The,0,0
133237,aim,0,0
133238,of,0,0
133239,this,0,0
133240,study,0,0
133241,was,0,0
133242,to,0,0
133243,investigate,0,0
133244,the,0,0
133245,effects,0,0
133246,of,0,0
133247,LED,1,0
133248,irradiation,1,1
133249,(,0,0
133250,850,0,1
133251,nm,0,0
133252,),0,0
133253,applied,0,0
133254,during,0,0
133255,treadmill,0,1
133256,training,0,1
133257,on,0,0
133258,the,0,0
133259,maximal,0,0
133260,exercise,0,1
133261,tolerance,0,0
133262,in,0,0
133263,postmenopausal,0,0
133264,women,0,0
133265,.,0,0
133266,At,0,0
133267,the,0,0
133268,beginning,0,0
133269,of,0,0
133270,the,0,0
133271,study,0,0
133272,",",0,0
133273,45,0,0
133274,postmenopausal,0,0
133275,women,0,0
133276,were,0,0
133277,assigned,0,0
133278,randomly,0,0
133279,to,0,0
133280,three,0,0
133281,groups,0,0
133282,",",0,0
133283,and,0,0
133284,30,0,0
133285,women,0,0
133286,completed,0,0
133287,the,0,0
133288,entire,0,0
133289,6,0,0
133290,months,0,0
133291,of,0,0
133292,the,0,0
133293,study,0,0
133294,.,0,0
133295,The,0,0
133296,groups,0,0
133297,were,0,0
133298,:,0,0
133299,(,1,0
133300,1,1,0
133301,),1,0
133302,the,1,0
133303,LED,1,1
133304,group,1,0
133305,(,1,0
133306,treadmill,1,1
133307,training,1,1
133308,associated,1,0
133309,with,1,0
133310,phototherapy,1,1
133311,",",1,0
133312,n,1,0
133313,=,1,0
133314,10,1,0
133315,),1,0
133316,",",1,0
133317,(,1,0
133318,2,1,0
133319,),1,0
133320,the,1,0
133321,exercise,1,1
133322,group,1,0
133323,(,1,0
133324,treadmill,1,1
133325,training,1,1
133326,",",1,0
133327,n,1,0
133328,=,1,0
133329,10,1,0
133330,),1,0
133331,",",1,0
133332,and,1,0
133333,(,1,0
133334,3,1,0
133335,),1,0
133336,the,1,0
133337,sedentary,1,1
133338,group,1,0
133339,(,1,0
133340,neither,1,0
133341,physical,1,1
133342,training,1,1
133343,nor,1,0
133344,phototherapy,1,1
133345,",",1,0
133346,n,1,0
133347,=,1,0
133348,10,1,0
133349,),1,0
133350,.,1,0
133351,The,1,0
133352,training,1,1
133353,was,0,0
133354,performed,0,0
133355,for,0,0
133356,45,0,0
133357,min,0,0
133358,twice,0,1
133359,a,0,0
133360,week,0,0
133361,for,0,0
133362,6,0,0
133363,months,0,0
133364,at,0,0
133365,intensities,0,0
133366,between,0,0
133367,85,0,0
133368,%,0,0
133369,and,0,0
133370,90,0,0
133371,%,0,0
133372,maximal,0,0
133373,heart,0,0
133374,rate,0,0
133375,(,0,1
133376,HRmax,0,0
133377,),0,0
133378,.,0,0
133379,The,0,0
133380,irradiation,0,1
133381,parameters,0,0
133382,were,0,0
133383,39,0,0
133384,mW/cm,0,0
133385,(,0,0
133386,2,0,0
133387,),0,0
133388,",",0,0
133389,45,0,0
133390,min,0,0
133391,and,0,0
133392,108,0,0
133393,J/cm,0,1
133394,(,0,0
133395,2,0,0
133396,),0,0
133397,.,0,0
133398,The,0,0
133399,cardiovascular,0,0
133400,parameters,0,0
133401,were,0,0
133402,measured,0,0
133403,at,0,0
133404,baseline,0,0
133405,and,0,0
133406,after,0,0
133407,6,0,0
133408,months,0,0
133409,.,0,0
133410,As,0,0
133411,expected,0,0
133412,",",0,0
133413,no,0,0
133414,significant,0,0
133415,differences,0,0
133416,were,0,0
133417,found,0,0
133418,in,0,0
133419,the,0,0
133420,sedentary,0,1
133421,group,0,0
133422,(,0,0
133423,p,0,0
133424,?,0,0
133425,0.05,0,0
133426,),0,0
133427,.,0,0
133428,The,0,0
133429,maximal,0,0
133430,time,0,0
133431,of,0,0
133432,tolerance,0,0
133433,(,0,1
133434,Tlim,0,1
133435,),0,1
133436,",",0,0
133437,metabolic,0,0
133438,equivalents,0,0
133439,(,0,0
133440,METs,0,1
133441,),0,1
133442,and,0,0
133443,Bruce,0,0
133444,stage,0,0
133445,reached,0,0
133446,significantly,0,0
133447,higher,0,0
133448,values,0,0
133449,in,0,0
133450,the,1,0
133451,LED,1,0
133452,group,0,0
133453,and,0,0
133454,the,0,0
133455,exercise,1,1
133456,group,0,0
133457,(,0,0
133458,p,0,0
133459,<,0,0
133460,0.01,0,0
133461,),0,0
133462,.,0,0
133463,Furthermore,0,0
133464,",",0,0
133465,the,0,0
133466,HR,0,0
133467,",",0,0
133468,double,0,1
133469,product,0,1
133470,and,0,0
133471,Borg,0,1
133472,score,0,0
133473,at,0,0
133474,isotime,0,0
133475,were,0,0
133476,significantly,0,0
133477,lower,0,0
133478,in,0,0
133479,the,0,0
133480,LED,0,0
133481,group,0,0
133482,and,0,0
133483,in,0,0
133484,the,0,0
133485,exercise,0,1
133486,group,0,0
133487,(,0,0
133488,p,0,0
133489,<,0,0
133490,0.05,0,0
133491,),0,0
133492,.,0,0
133493,However,0,0
133494,",",0,0
133495,the,0,0
133496,time,0,0
133497,of,0,0
133498,recovery,0,0
133499,showed,0,0
133500,a,0,0
133501,significant,0,0
133502,decrease,0,0
133503,only,0,0
133504,in,0,0
133505,the,0,0
133506,LED,0,0
133507,group,0,1
133508,(,0,0
133509,p,0,0
133510,=,0,0
133511,0.003,0,0
133512,),0,0
133513,.,0,0
133514,Moreover,0,0
133515,",",0,0
133516,the,0,0
133517,differences,0,0
133518,between,0,0
133519,before,0,0
133520,and,0,0
133521,after,0,0
133522,training,0,1
133523,(,0,0
133524,delta,0,0
133525,values,0,0
133526,),0,0
133527,for,0,0
133528,the,0,0
133529,Tlim,0,1
133530,",",0,0
133531,METs,0,1
133532,and,0,0
133533,HR,0,0
133534,at,0,0
133535,isotime,0,0
133536,were,0,0
133537,greater,0,0
133538,in,0,0
133539,the,0,0
133540,LED,0,0
133541,group,0,0
133542,than,0,0
133543,in,0,0
133544,the,0,0
133545,exercise,0,1
133546,group,0,0
133547,with,0,0
133548,a,0,0
133549,significant,0,0
133550,intergroup,0,0
133551,difference,0,0
133552,(,0,0
133553,p,0,0
133554,<,0,0
133555,0.05,0,0
133556,),0,0
133557,.,0,0
133558,Therefore,1,0
133559,",",1,0
133560,the,1,0
133561,infrared,1,1
133562,LED,1,0
133563,irradiation,1,1
133564,during,0,0
133565,treadmill,0,1
133566,training,0,1
133567,can,0,0
133568,improve,0,0
133569,maximal,0,0
133570,performance,0,0
133571,and,0,0
133572,post-exercise,0,0
133573,recovery,0,0
133574,in,0,0
133575,postmenopausal,0,0
133576,women,0,0
133577,.,0,0
133578,Development,0,0
133579,of,0,0
133580,an,0,0
133581,adaptive,1,0
133582,low-pass,1,1
133583,filtered,1,1
133584,speech,1,1
133585,test,1,0
133586,for,0,0
133587,the,0,0
133588,identification,0,0
133589,of,0,0
133590,auditory,0,1
133591,processing,0,0
133592,disorders,0,0
133593,.,0,0
133594,OBJECTIVE,0,0
133595,One,0,0
133596,type,0,0
133597,of,0,0
133598,test,0,0
133599,commonly,0,0
133600,used,0,0
133601,to,0,0
133602,examine,0,0
133603,auditory,0,1
133604,processing,0,1
133605,disorders,0,0
133606,(,0,0
133607,APD,0,1
133608,),0,1
133609,is,0,0
133610,the,0,0
133611,low-pass,1,0
133612,filtered,1,1
133613,speech,1,1
133614,test,1,0
133615,(,0,1
133616,LPFST,0,1
133617,),0,0
133618,",",0,0
133619,of,0,0
133620,which,0,0
133621,there,0,0
133622,are,0,0
133623,various,0,0
133624,versions,0,0
133625,.,0,0
133626,In,0,0
133627,LPFSTs,0,0
133628,",",0,0
133629,a,0,0
133630,monaural,0,1
133631,",",0,0
133632,low-redundancy,0,1
133633,speech,0,1
133634,sample,0,0
133635,is,0,0
133636,distorted,0,0
133637,by,0,0
133638,using,0,0
133639,filtering,0,0
133640,to,0,0
133641,modify,0,0
133642,its,0,0
133643,frequency,0,0
133644,content,0,0
133645,.,0,0
133646,Due,0,1
133647,to,0,0
133648,the,0,0
133649,richness,0,0
133650,of,0,0
133651,the,0,0
133652,neural,0,0
133653,pathways,0,0
133654,in,0,0
133655,the,0,0
133656,auditory,0,1
133657,system,0,1
133658,and,0,0
133659,the,0,0
133660,redundancy,0,0
133661,of,0,0
133662,acoustic,0,1
133663,information,0,0
133664,in,0,0
133665,spoken,0,1
133666,language,0,0
133667,",",0,0
133668,a,0,0
133669,normal,0,0
133670,listener,0,0
133671,is,0,0
133672,able,0,0
133673,to,0,0
133674,recognize,0,0
133675,speech,0,1
133676,even,0,0
133677,when,0,0
133678,parts,0,0
133679,of,0,0
133680,the,0,0
133681,signal,0,0
133682,are,0,0
133683,missing,0,0
133684,",",0,0
133685,whereas,0,0
133686,this,0,0
133687,ability,0,0
133688,is,0,0
133689,often,0,0
133690,impaired,0,0
133691,in,0,0
133692,listeners,0,0
133693,with,0,0
133694,APD,0,0
133695,.,0,0
133696,One,0,0
133697,limitation,0,0
133698,of,0,0
133699,the,0,0
133700,various,0,0
133701,versions,0,0
133702,of,0,0
133703,the,0,0
133704,LPFST,1,0
133705,is,0,0
133706,that,0,0
133707,they,0,0
133708,are,0,0
133709,carried,0,0
133710,out,0,0
133711,using,0,0
133712,a,0,0
133713,constant,0,0
133714,level,0,0
133715,of,0,0
133716,low-pass,0,1
133717,filtering,0,1
133718,(,0,0
133719,e.g,0,0
133720,.,0,0
133721,a,0,0
133722,fixed,0,0
133723,1kHz,0,0
133724,corner,0,0
133725,frequency,0,0
133726,),0,0
133727,which,0,0
133728,makes,0,0
133729,them,0,0
133730,prone,0,0
133731,to,0,0
133732,ceiling,0,1
133733,and,0,0
133734,floor,0,1
133735,effects,0,0
133736,.,0,0
133737,The,0,0
133738,purpose,0,0
133739,of,0,0
133740,this,0,0
133741,study,0,0
133742,was,0,0
133743,to,0,0
133744,counter,0,0
133745,these,0,0
133746,effects,0,0
133747,by,0,0
133748,modifying,0,0
133749,the,0,0
133750,LPFST,0,1
133751,using,0,0
133752,a,0,0
133753,computer-based,0,1
133754,adaptive,0,0
133755,procedure,0,1
133756,",",0,0
133757,and,0,0
133758,to,0,0
133759,evaluate,0,0
133760,the,0,0
133761,performance,0,0
133762,of,0,0
133763,normal-hearing,0,0
133764,participants,0,0
133765,of,0,0
133766,varying,0,0
133767,ages,0,0
133768,on,0,0
133769,the,0,0
133770,test,0,0
133771,.,0,0
133772,METHODS,0,0
133773,In,0,0
133774,this,0,0
133775,preliminary,0,0
133776,study,0,0
133777,",",0,0
133778,33,0,0
133779,adults,0,0
133780,and,0,0
133781,30,0,1
133782,children,0,0
133783,(,0,0
133784,aged,0,0
133785,8-11,0,1
133786,years,0,0
133787,),0,0
133788,with,0,0
133789,no,0,0
133790,known,0,0
133791,history,0,0
133792,of,0,0
133793,listening,0,1
133794,difficulties,0,0
133795,were,0,0
133796,tested,0,0
133797,.,0,0
133798,The,1,0
133799,University,1,0
133800,of,1,0
133801,Canterbury,1,0
133802,Adaptive,1,0
133803,Speech,1,1
133804,Test,1,0
133805,(,1,1
133806,UCAST,1,1
133807,),1,1
133808,platform,1,1
133809,was,1,0
133810,used,1,0
133811,to,1,0
133812,administer,1,0
133813,a,1,0
133814,four-alternative,1,1
133815,forced-choice,1,1
133816,adaptive,1,1
133817,test,1,0
133818,that,1,0
133819,altered,1,0
133820,a,1,0
133821,low-pass,1,1
133822,filter,1,1
133823,(,1,1
133824,LPF,1,0
133825,),1,1
133826,to,1,0
133827,track,1,1
133828,the,1,0
133829,corner,1,0
133830,frequency,1,0
133831,at,1,0
133832,which,1,0
133833,participants,1,0
133834,correctly,1,0
133835,identified,1,0
133836,a,1,0
133837,certain,1,0
133838,percentage,1,0
133839,of,1,0
133840,the,1,0
133841,word,1,1
133842,stimuli,1,1
133843,.,1,0
133844,RESULTS,0,0
133845,Findings,0,0
133846,on,0,0
133847,the,0,0
133848,University,0,0
133849,of,0,0
133850,Canterbury,0,0
133851,Adaptive,0,0
133852,Speech,0,1
133853,Test-Filtered,0,1
133854,Words,0,1
133855,(,0,1
133856,UCAST-FW,0,1
133857,),0,1
133858,indicated,0,0
133859,a,0,0
133860,significant,0,0
133861,maturational,0,0
133862,effect,0,0
133863,.,0,0
133864,Adult,0,0
133865,participants,0,0
133866,performed,0,0
133867,significantly,0,0
133868,better,0,0
133869,on,0,0
133870,the,0,0
133871,UCAST-FW,1,1
133872,in,0,0
133873,comparison,0,0
133874,to,0,0
133875,the,0,0
133876,child,0,0
133877,participants,0,0
133878,.,0,0
133879,The,0,0
133880,UCAST-FW,1,1
133881,test,0,0
133882,was,0,0
133883,reliable,0,0
133884,over,0,0
133885,repeated,0,0
133886,administrations,0,0
133887,.,0,0
133888,CONCLUSIONS,0,0
133889,An,0,0
133890,adaptive,0,0
133891,low-pass,0,1
133892,filtered,0,1
133893,speech,0,1
133894,test,0,0
133895,such,0,0
133896,as,0,0
133897,the,0,0
133898,UCAST-FW,1,1
133899,is,0,0
133900,sensitive,0,0
133901,to,0,0
133902,maturational,0,0
133903,changes,0,0
133904,in,0,0
133905,auditory,0,1
133906,processing,0,1
133907,ability,0,0
133908,.,0,0
133909,Noradrenergic,0,1
133910,moderation,0,0
133911,of,0,0
133912,working,0,0
133913,memory,0,0
133914,impairments,0,0
133915,in,0,0
133916,adults,0,0
133917,with,0,0
133918,autism,0,0
133919,spectrum,0,0
133920,disorder,0,0
133921,.,0,0
133922,In,0,0
133923,addition,0,0
133924,to,0,0
133925,having,0,0
133926,difficulties,0,0
133927,with,0,0
133928,social,0,0
133929,communications,0,1
133930,",",0,0
133931,individuals,0,0
133932,with,0,0
133933,an,0,0
133934,autism,0,0
133935,spectrum,0,0
133936,disorder,0,0
133937,(,0,1
133938,ASD,0,0
133939,),0,1
133940,often,0,0
133941,also,0,0
133942,experience,0,0
133943,impairment,0,0
133944,in,0,0
133945,higher-order,0,0
133946,",",0,0
133947,executive,0,0
133948,skills,0,0
133949,.,0,0
133950,The,0,0
133951,present,0,0
133952,study,0,0
133953,examined,0,0
133954,the,0,0
133955,effects,0,0
133956,of,0,0
133957,pharmacological,0,0
133958,modulation,0,0
133959,of,0,0
133960,the,0,0
133961,norepinephrine,0,1
133962,system,0,0
133963,on,0,0
133964,the,0,0
133965,severity,0,0
133966,of,0,0
133967,such,0,0
133968,impairments,0,0
133969,.,0,0
133970,A,0,0
133971,sample,0,0
133972,of,0,0
133973,14,0,0
133974,high-functioning,0,0
133975,adults,0,0
133976,with,0,0
133977,ASD,0,0
133978,and,0,0
133979,a,0,0
133980,demographically-matched,0,0
133981,comparison,0,0
133982,group,0,0
133983,of,0,0
133984,13,0,0
133985,typically,0,0
133986,developing,0,0
133987,individuals,0,0
133988,participated,0,0
133989,.,0,0
133990,An,0,0
133991,AX,0,0
133992,continuous,0,1
133993,performance,0,0
133994,test,0,1
133995,(,0,1
133996,AX-CPT,0,1
133997,),0,1
133998,was,0,0
133999,used,0,0
134000,to,0,0
134001,evaluate,0,0
134002,working,0,0
134003,memory,0,0
134004,and,0,1
134005,inhibitory,0,0
134006,control,0,1
134007,.,0,0
134008,AX-CPT,0,0
134009,performance,0,0
134010,was,0,0
134011,assessed,0,0
134012,following,0,0
134013,administration,0,0
134014,of,0,0
134015,a,0,0
134016,single,0,0
134017,dose,0,0
134018,of,0,0
134019,propranolol,1,1
134020,(,1,0
134021,a,1,0
134022,beta,1,1
134023,adrenergic,1,1
134024,antagonist,1,1
134025,),1,1
134026,and,1,0
134027,following,1,1
134028,placebo,1,1
134029,(,0,1
134030,sugar,0,1
134031,pill,0,1
134032,),0,0
134033,administration,0,0
134034,.,0,0
134035,Individuals,0,0
134036,with,0,0
134037,ASD,0,0
134038,performed,0,0
134039,more,0,0
134040,poorly,0,0
134041,than,0,0
134042,non-ASD,0,0
134043,individuals,0,0
134044,in,0,0
134045,the,0,0
134046,working,0,0
134047,memory,0,0
134048,condition,0,1
134049,(,0,0
134050,BX,0,1
134051,trials,0,0
134052,),0,0
134053,.,0,0
134054,Importantly,0,0
134055,",",0,0
134056,administration,0,0
134057,of,0,0
134058,propranolol,1,1
134059,attenuated,0,0
134060,this,0,0
134061,impairment,0,0
134062,",",0,0
134063,with,0,0
134064,the,0,0
134065,ASD,0,0
134066,group,0,0
134067,performing,0,1
134068,significantly,0,0
134069,better,0,0
134070,in,0,0
134071,the,0,0
134072,propranolol,0,1
134073,condition,0,0
134074,than,0,0
134075,the,0,0
134076,placebo,0,1
134077,condition,0,0
134078,.,0,0
134079,Working,0,0
134080,memory,0,0
134081,performance,0,0
134082,of,0,0
134083,the,0,0
134084,non-ASD,0,0
134085,group,0,0
134086,was,0,0
134087,unaffected,0,0
134088,by,0,0
134089,propranolol/placebo,0,1
134090,administration,0,0
134091,.,0,0
134092,No,0,0
134093,group,0,0
134094,or,0,1
134095,medication,0,1
134096,effects,0,0
134097,were,0,0
134098,observed,0,0
134099,for,0,0
134100,the,0,0
134101,inhibition,0,0
134102,condition,0,0
134103,(,0,0
134104,AY,0,1
134105,trials,0,0
134106,),0,0
134107,.,0,0
134108,The,0,0
134109,present,0,0
134110,findings,0,0
134111,suggest,0,0
134112,that,0,0
134113,norepinephrine,0,0
134114,may,0,0
134115,play,0,0
134116,a,0,0
134117,role,0,0
134118,in,0,0
134119,some,0,0
134120,",",0,0
134121,but,0,0
134122,not,0,0
134123,necessarily,0,0
134124,all,0,0
134125,",",0,0
134126,cognitive,0,0
134127,impairments,0,0
134128,associated,0,0
134129,with,0,0
134130,ASD,0,0
134131,.,0,0
134132,Additional,0,0
134133,research,0,0
134134,is,0,0
134135,needed,0,0
134136,to,0,0
134137,fully,0,0
134138,understand,0,0
134139,whether,0,0
134140,this,0,0
134141,role,0,0
134142,is,0,0
134143,primarily,0,0
134144,causal,0,0
134145,or,0,1
134146,compensatory,0,0
134147,in,0,0
134148,nature,0,0
134149,.,0,0
134150,[,1,0
134151,Simvastatin,1,1
134152,versus,1,1
134153,gemfibrozil,1,1
134154,in,0,0
134155,the,0,0
134156,treatment,0,0
134157,of,0,0
134158,primary,0,0
134159,hypercholesterolemia,0,0
134160,in,0,0
134161,hypertensive,0,0
134162,patients,0,0
134163,treated,0,0
134164,with,0,0
134165,hydrochlorothiazide,1,1
134166,],1,0
134167,.,0,0
134168,Recent,0,0
134169,pharmacological,0,0
134170,studies,0,0
134171,confirmed,0,0
134172,the,0,0
134173,role,0,0
134174,of,0,0
134175,hypercholesterolemia,0,0
134176,in,0,0
134177,the,0,0
134178,pathogenesis,0,0
134179,of,0,0
134180,coronary,0,0
134181,atherosclerosis,0,0
134182,.,0,0
134183,A,0,0
134184,10,0,0
134185,%,0,0
134186,reduction,0,0
134187,in,0,0
134188,cholesterol,0,0
134189,levels,0,0
134190,can,0,0
134191,reduce,0,0
134192,the,0,0
134193,risk,0,0
134194,of,0,0
134195,coronary,0,0
134196,heart,0,0
134197,disease,0,0
134198,by,0,0
134199,15,0,0
134200,%,0,0
134201,.,0,0
134202,However,0,0
134203,many,0,0
134204,hypercholesterolemic,0,0
134205,patients,0,0
134206,often,0,0
134207,suffer,0,0
134208,from,0,0
134209,arterial,0,0
134210,hypertension,0,0
134211,and,0,0
134212,drugs,0,1
134213,such,0,0
134214,as,0,0
134215,thiazide,1,1
134216,diuretics,1,1
134217,cause,0,0
134218,an,0,0
134219,imbalance,0,0
134220,in,0,0
134221,lipid,0,0
134222,metabolism,0,0
134223,.,0,0
134224,The,0,0
134225,efficacy,0,0
134226,and,0,0
134227,the,0,0
134228,tolerability,0,0
134229,of,0,0
134230,simvastatin,1,1
134231,(,0,0
134232,a,0,0
134233,inhibitor,0,1
134234,of,0,0
134235,HGM-CoA,0,0
134236,reductase,0,1
134237,),0,0
134238,with,0,0
134239,that,0,0
134240,of,0,0
134241,gemfibrozil,1,1
134242,(,0,0
134243,a,0,0
134244,fibric,0,1
134245,acid,0,1
134246,derivative,0,0
134247,",",0,0
134248,which,0,0
134249,can,0,0
134250,reduce,0,0
134251,the,0,0
134252,VLDL,0,1
134253,level,0,0
134254,),0,0
134255,were,0,0
134256,compared,0,0
134257,in,0,0
134258,a,0,0
134259,placebo-controlled,1,1
134260,study,0,0
134261,in,0,0
134262,2,0,0
134263,groups,0,0
134264,of,0,0
134265,patients,0,0
134266,with,0,0
134267,primary,0,0
134268,hypercholesterolemia,0,0
134269,and,0,0
134270,mild-to-moderate,0,0
134271,essential,0,0
134272,hypertension,0,0
134273,treated,0,0
134274,with,0,0
134275,hydrochlorothiazide,0,1
134276,.,0,0
134277,After,0,0
134278,10,0,0
134279,weeks,0,0
134280,standard,1,1
134281,hypolipidemic,1,1
134282,diet,1,1
134283,and,1,1
134284,hydrochlorothiazide,1,1
134285,(,0,0
134286,25,0,0
134287,mg,0,1
134288,od,0,1
134289,),0,1
134290,therapy,0,1
134291,",",0,0
134292,30,0,0
134293,patients,0,0
134294,whose,0,0
134295,cholesterol,0,0
134296,levels,0,0
134297,were,0,0
134298,still,0,0
134299,greater,0,0
134300,than,0,0
134301,or,0,0
134302,equal,0,0
134303,to,0,0
134304,250,0,1
134305,mg/100,0,0
134306,ml,0,0
134307,and,0,0
134308,whose,0,0
134309,diastolic,0,0
134310,blood,0,0
134311,pressure,0,0
134312,was,0,0
134313,less,0,0
134314,than,0,0
134315,95,0,0
134316,mmHg,0,0
134317,were,0,0
134318,randomized,0,0
134319,to,0,0
134320,one,0,0
134321,of,0,0
134322,the,0,0
134323,following,0,0
134324,treatments,0,0
134325,:,0,0
134326,simvastatin,1,1
134327,",",0,0
134328,20,0,0
134329,mg,0,1
134330,od,0,1
134331,",",0,0
134332,gemfibrozil,1,1
134333,",",0,0
134334,600,0,1
134335,mg,0,1
134336,bid,0,1
134337,or,1,1
134338,placebo,1,1
134339,",",0,0
134340,while,0,0
134341,continuing,0,0
134342,dietetic,0,1
134343,and,0,0
134344,diuretic,0,1
134345,treatment,0,0
134346,.,0,0
134347,After,0,0
134348,24,0,0
134349,weeks,0,0
134350,treatment,0,0
134351,",",0,0
134352,simvastatin,1,1
134353,induced,0,0
134354,a,0,0
134355,37,0,0
134356,%,0,0
134357,reduction,0,0
134358,in,0,0
134359,cholesterol,0,0
134360,plasma,0,0
134361,levels,0,0
134362,",",0,0
134363,a,0,0
134364,9,0,0
134365,%,0,0
134366,increase,0,0
134367,of,0,0
134368,HDL,0,1
134369,and,0,0
134370,a,0,0
134371,16,0,0
134372,%,0,0
134373,reduction,0,0
134374,of,0,0
134375,LDL,0,0
134376,.,0,0
134377,APO-A1,0,0
134378,showed,0,0
134379,a,0,0
134380,4,0,0
134381,%,0,0
134382,increase,0,0
134383,",",0,0
134384,while,0,0
134385,APO-B,0,1
134386,showed,0,0
134387,a,0,0
134388,3,0,0
134389,%,0,0
134390,reduction,0,0
134391,.,0,0
134392,Gemfibrozil,1,1
134393,induced,0,0
134394,a,0,0
134395,20,0,0
134396,%,0,0
134397,reduction,0,0
134398,in,0,0
134399,plasma,0,0
134400,triglycerides,0,0
134401,and,0,0
134402,a,0,0
134403,13,0,0
134404,%,0,0
134405,decrease,0,0
134406,in,0,0
134407,plasma,0,0
134408,cholesterol,0,0
134409,",",0,0
134410,with,0,0
134411,a,0,0
134412,significant,0,0
134413,19,0,0
134414,%,0,0
134415,increase,0,0
134416,in,0,0
134417,HDL,0,1
134418,and,0,0
134419,a,0,0
134420,11,0,0
134421,%,0,0
134422,reduction,0,0
134423,in,0,0
134424,LDL,0,0
134425,.,0,0
134426,No,0,0
134427,significant,0,0
134428,variations,0,0
134429,in,0,0
134430,any,0,0
134431,of,0,0
134432,the,0,0
134433,lipid,0,0
134434,parameters,0,0
134435,monitored,0,0
134436,were,0,0
134437,observed,0,0
134438,in,0,0
134439,the,0,0
134440,placebo,1,1
134441,group,0,0
134442,.,0,0
134443,Treatment,0,0
134444,with,0,0
134445,simvastatin,1,1
134446,or,0,1
134447,gemfibrozil,1,1
134448,in,0,0
134449,hypertensive,0,0
134450,patients,0,0
134451,in,0,0
134452,hydrochlorothiazide,1,1
134453,monotherapy,0,1
134454,can,0,0
134455,reduce,0,0
134456,total,0,0
134457,cholesterol,0,0
134458,and,0,0
134459,LDL-cholesterol,0,1
134460,plasma,0,0
134461,levels,0,0
134462,",",0,0
134463,while,0,0
134464,significantly,0,0
134465,increasing,0,0
134466,HDL,0,1
134467,plasma,0,0
134468,levels,0,0
134469,compared,0,0
134470,to,0,0
134471,placebo,0,1
134472,.,0,0
134473,Simvastatin,1,1
134474,",",0,0
134475,however,0,0
134476,",",0,0
134477,resulted,0,0
134478,more,0,0
134479,efficient,0,0
134480,than,0,0
134481,gemfibrozil,1,1
134482,on,0,0
134483,total,0,0
134484,cholesterol,0,0
134485,or,0,1
134486,cholesterol,0,0
134487,fractions,0,1
134488,.,0,0
134489,Effect,0,0
134490,of,0,0
134491,sulfasalazine,1,1
134492,on,0,0
134493,inflammation,0,0
134494,and,0,0
134495,endothelial,0,0
134496,function,0,0
134497,in,0,0
134498,patients,0,0
134499,with,0,0
134500,established,0,0
134501,coronary,0,0
134502,artery,0,0
134503,disease,0,0
134504,.,0,0
134505,Inflammation,0,0
134506,is,0,0
134507,critical,0,0
134508,for,0,0
134509,atherosclerosis,0,0
134510,development,0,0
134511,and,0,0
134512,may,0,0
134513,be,0,0
134514,a,0,0
134515,target,0,0
134516,for,0,0
134517,risk-reduction,0,1
134518,therapy,0,1
134519,.,0,0
134520,In,0,0
134521,experimental,0,0
134522,studies,0,0
134523,",",0,0
134524,activation,0,0
134525,of,0,0
134526,the,0,0
134527,inflammatory,0,0
134528,regulator,0,0
134529,",",0,0
134530,nuclear,0,0
134531,factor,0,0
134532,kappa,0,0
134533,B,0,1
134534,(,0,1
134535,NFlB,0,1
134536,),0,0
134537,",",0,0
134538,contributes,0,0
134539,to,0,0
134540,endothelial,0,0
134541,activation,0,1
134542,and,0,0
134543,reduced,0,0
134544,nitric,0,1
134545,oxide,0,1
134546,production,0,0
134547,.,0,0
134548,We,0,0
134549,treated,0,0
134550,patients,0,0
134551,with,0,0
134552,coronary,0,0
134553,artery,0,0
134554,disease,0,0
134555,with,0,0
134556,sulfasalazine,1,1
134557,",",1,0
134558,an,1,0
134559,inhibitor,1,1
134560,of,1,0
134561,NF?B,1,0
134562,",",1,0
134563,and,1,0
134564,placebo,1,1
134565,in,1,0
134566,a,1,0
134567,randomized,1,0
134568,",",1,0
134569,double-blind,1,0
134570,",",1,0
134571,crossover,1,0
134572,study,1,0
134573,design,1,0
134574,.,1,0
134575,Brachial,1,0
134576,artery,1,0
134577,flow-mediated,1,1
134578,dilation,1,1
134579,(,1,1
134580,FMD,1,1
134581,),1,1
134582,and,1,0
134583,digital,1,1
134584,vascular,1,0
134585,function,1,0
134586,were,0,0
134587,measured,0,0
134588,at,0,0
134589,baseline,0,0
134590,and,0,0
134591,after,0,0
134592,each,0,0
134593,6-week,0,0
134594,treatment,0,0
134595,period,0,0
134596,.,0,0
134597,Of,0,0
134598,the,0,0
134599,53,0,0
134600,patients,0,0
134601,enrolled,0,0
134602,in,0,0
134603,the,0,0
134604,crossover,0,0
134605,study,0,0
134606,",",0,0
134607,32,0,0
134608,(,0,0
134609,age,0,0
134610,60,0,0
134611,?,0,0
134612,10,0,0
134613,",",0,0
134614,22,0,0
134615,%,0,0
134616,female,0,0
134617,),0,0
134618,completed,0,0
134619,all,0,0
134620,the,0,0
134621,visits,0,0
134622,",",0,0
134623,with,0,0
134624,a,0,0
134625,high,0,0
134626,rate,0,0
134627,of,0,0
134628,study,0,0
134629,withdrawal,0,1
134630,due,0,0
134631,to,0,0
134632,gastrointestinal,0,0
134633,side,0,0
134634,effects,0,0
134635,.,0,0
134636,In,0,0
134637,a,0,0
134638,subset,0,0
134639,of,0,0
134640,10,0,0
134641,participants,0,0
134642,",",0,0
134643,we,0,0
134644,compared,0,0
134645,the,0,0
134646,effects,0,0
134647,of,0,0
134648,4,0,0
134649,days,0,0
134650,of,0,0
134651,sulfasalazine,1,1
134652,treatment,1,1
134653,(,0,0
134654,n,0,0
134655,=,0,0
134656,5,0,1
134657,),0,0
134658,to,0,0
134659,no,0,0
134660,treatment,0,1
134661,(,0,0
134662,n,0,0
134663,=,0,0
134664,5,0,1
134665,),0,0
134666,on,0,0
134667,NF?B-regulated,0,0
134668,gene,0,1
134669,expression,0,0
134670,in,0,0
134671,peripheral,0,0
134672,blood,0,0
134673,mononuclear,0,0
134674,cells,0,0
134675,.,0,0
134676,Tumor,0,0
134677,necrosis,0,0
134678,factor,0,0
134679,?-stimulated,0,0
134680,expression,0,0
134681,of,0,0
134682,CD69,0,1
134683,and,0,0
134684,NFlB,0,1
134685,subunit,0,1
134686,p50,0,0
134687,was,0,0
134688,significantly,0,0
134689,blunted,0,0
134690,after,0,0
134691,4,0,0
134692,days,0,0
134693,of,0,0
134694,sulfasalazine,0,1
134695,treatment,0,0
134696,but,0,0
134697,not,0,0
134698,after,0,0
134699,no,0,0
134700,treatment,0,0
134701,.,0,0
134702,However,0,0
134703,",",0,0
134704,FMD,0,1
134705,and,0,0
134706,digital,0,1
134707,vasodilator,0,1
134708,response,0,0
134709,did,0,0
134710,not,0,0
134711,significantly,0,0
134712,change,0,0
134713,from,0,0
134714,baseline,0,0
134715,with,0,0
134716,long-term,1,0
134717,sulfasalazine,1,1
134718,treatment,1,0
134719,.,0,0
134720,Short-term,1,0
134721,sulfasalazine,1,1
134722,inhibited,1,0
134723,NFlB,0,0
134724,activity,0,0
134725,;,0,0
134726,however,0,0
134727,",",0,0
134728,long-term,0,0
134729,treatment,0,0
134730,was,0,0
134731,poorly,0,0
134732,tolerated,0,0
134733,and,0,0
134734,did,0,0
134735,not,0,0
134736,improve,0,0
134737,endothelial,0,0
134738,function,0,0
134739,.,0,0
134740,Our,0,0
134741,findings,0,0
134742,suggest,0,0
134743,that,0,0
134744,sulfasalazine,0,1
134745,therapy,0,1
134746,is,0,0
134747,not,0,0
134748,the,0,0
134749,optimal,0,0
134750,anti-inflammatory,0,1
134751,treatment,0,0
134752,for,0,0
134753,reversing,0,0
134754,endothelial,0,0
134755,dysfunction,0,0
134756,in,0,0
134757,cardiovascular,0,0
134758,disease,0,0
134759,.,0,0
134760,Further,0,0
134761,studies,0,0
134762,are,0,0
134763,warranted,0,0
134764,to,0,0
134765,investigate,0,0
134766,the,0,0
134767,potential,0,0
134768,for,0,0
134769,NFlB,0,0
134770,inhibition,0,0
134771,to,0,0
134772,reduce,0,0
134773,cardiovascular,0,0
134774,risk,0,0
134775,.,0,0
134776,Successful,0,0
134777,treatment,0,0
134778,of,0,0
134779,blepharitis,0,0
134780,with,0,1
134781,bibrocathol,1,1
134782,(,1,0
134783,Posiformin?,1,1
134784,2,1,1
134785,%,1,0
134786,),1,0
134787,.,1,0
134788,BACKGROUND,1,0
134789,Bibrocathol,1,1
134790,is,0,0
134791,a,0,0
134792,well-established,1,0
134793,antiseptic,1,1
134794,drug,1,1
134795,for,0,0
134796,the,0,0
134797,treatment,0,0
134798,of,0,0
134799,acute,0,0
134800,eyelid,0,0
134801,diseases,0,0
134802,like,0,0
134803,blepharitis,0,0
134804,.,0,0
134805,Despite,0,0
134806,its,0,0
134807,frequent,0,0
134808,use,0,0
134809,in,0,0
134810,clinical,0,0
134811,practice,0,0
134812,",",0,0
134813,no,0,0
134814,controlled,0,0
134815,clinical,0,0
134816,trial,0,0
134817,on,0,0
134818,the,0,0
134819,efficacy,0,0
134820,of,1,0
134821,bibrocathol,1,1
134822,2,1,0
134823,%,1,0
134824,eye,0,1
134825,ointment,0,1
134826,has,0,0
134827,been,0,0
134828,performed,0,0
134829,until,0,0
134830,now,0,0
134831,.,0,0
134832,The,0,0
134833,aim,0,0
134834,of,0,0
134835,the,0,0
134836,study,0,0
134837,was,0,0
134838,to,0,0
134839,investigate,0,0
134840,efficacy,0,0
134841,",",0,0
134842,safety,0,0
134843,and,0,0
134844,tolerability,0,0
134845,of,1,0
134846,bibrocathol,1,1
134847,(,1,0
134848,Posiformin?,1,1
134849,2,1,1
134850,%,0,0
134851,),0,1
134852,eye,0,1
134853,ointment,0,1
134854,in,0,0
134855,patients,0,0
134856,diagnosed,0,0
134857,with,0,0
134858,blepharitis,0,0
134859,.,0,0
134860,METHODS,0,0
134861,In,0,0
134862,this,0,0
134863,multi-center,0,0
134864,",",0,0
134865,randomized,0,0
134866,",",0,0
134867,double-masked,1,0
134868,",",1,0
134869,placebo-controlled,1,1
134870,parallel-group,1,0
134871,comparison,0,0
134872,",",0,0
134873,the,0,0
134874,change,0,0
134875,of,0,0
134876,signs,0,0
134877,and,0,0
134878,symptoms,0,0
134879,(,0,0
134880,sum,0,0
134881,score,0,0
134882,),0,0
134883,of,0,0
134884,blepharitis,0,0
134885,in,0,0
134886,197,0,0
134887,patients,0,0
134888,(,0,0
134889,ITT,0,1
134890,(,0,1
134891,intention-to-treat-group,0,0
134892,),0,1
134893,;,0,0
134894,mean,0,0
134895,age,0,0
134896,56,0,0
134897,?,0,0
134898,18,0,0
134899,years,0,0
134900,",",0,0
134901,56,0,0
134902,%,0,0
134903,female,0,0
134904,",",0,0
134905,active,0,1
134906,drug,0,1
134907,:,0,0
134908,vehicle,0,1
134909,=,0,0
134910,97:100,0,0
134911,),0,0
134912,over,0,0
134913,2,0,0
134914,weeks,0,0
134915,treatment,0,0
134916,with,0,0
134917,bibrocathol,1,1
134918,2,1,0
134919,%,1,0
134920,eye,1,1
134921,ointment,1,1
134922,was,1,0
134923,evaluated,0,0
134924,.,0,0
134925,RESULTS,0,0
134926,Patients,0,0
134927,receiving,1,0
134928,bibrocathol,1,1
134929,2,1,0
134930,%,1,0
134931,showed,0,0
134932,greater,0,0
134933,improvement,0,0
134934,in,0,0
134935,the,0,0
134936,sum,0,0
134937,score,0,0
134938,than,0,0
134939,the,1,0
134940,placebo,1,1
134941,patients,0,0
134942,(,0,0
134943,p,0,0
134944,<,0,0
134945,0.0001,0,0
134946,",",0,0
134947,Cohen,0,0
134948,'s,0,0
134949,effect,0,0
134950,size,0,0
134951,d,0,1
134952,=,0,0
134953,0.73,0,0
134954,),0,0
134955,.,0,0
134956,Also,0,0
134957,",",0,0
134958,the,0,0
134959,results,0,0
134960,from,0,0
134961,further,0,0
134962,efficacy,0,0
134963,assessments,0,0
134964,improvement,0,0
134965,of,0,0
134966,single,0,0
134967,symptoms,0,0
134968,and,0,0
134969,ocular,0,0
134970,discomfort,0,0
134971,measured,0,0
134972,by,0,0
134973,a,0,0
134974,VAS,0,1
134975,(,0,0
134976,visual,0,1
134977,analogue,0,1
134978,scale,0,0
134979,),0,1
134980,supported,0,0
134981,treatment,0,0
134982,with,0,0
134983,bibrocathol,1,1
134984,.,1,0
134985,Patients,1,0
134986,and,0,0
134987,investigators,0,0
134988,provided,0,0
134989,favorable,0,0
134990,tolerability,0,0
134991,ratings,0,0
134992,preferring,1,0
134993,bibrocathol,1,1
134994,over,1,0
134995,placebo,1,1
134996,.,0,0
134997,No,0,0
134998,safety,0,0
134999,issues,0,0
135000,were,0,0
135001,observed,0,0
135002,with,0,0
135003,regard,0,0
135004,to,0,0
135005,intraocular,0,1
135006,pressure,0,0
135007,",",0,0
135008,visual,0,0
135009,acuity,0,0
135010,",",0,0
135011,or,0,1
135012,occurrence,0,0
135013,of,0,0
135014,adverse,0,0
135015,events,0,0
135016,.,0,0
135017,CONCLUSIONS,0,0
135018,Blepharitis,0,0
135019,therapy,0,1
135020,with,0,0
135021,the,1,0
135022,antiseptic,1,1
135023,bibrocathol,1,1
135024,2,1,0
135025,%,1,0
135026,in,1,0
135027,this,1,0
135028,trial,0,0
135029,was,0,0
135030,highly,0,0
135031,efficacious,0,0
135032,and,0,0
135033,safe,0,0
135034,.,0,0
135035,Breaking,0,0
135036,it,0,0
135037,down,0,0
135038,is,0,0
135039,better,0,0
135040,:,0,0
135041,haptic,1,1
135042,decomposition,1,0
135043,of,1,0
135044,complex,1,0
135045,movements,1,0
135046,aids,0,0
135047,in,0,0
135048,robot-assisted,1,1
135049,motor,1,0
135050,learning,1,1
135051,.,1,0
135052,Training,1,0
135053,with,1,0
135054,haptic,1,1
135055,guidance,1,1
135056,has,0,0
135057,been,0,0
135058,proposed,0,0
135059,as,0,0
135060,a,0,0
135061,technique,0,1
135062,for,0,0
135063,learning,0,1
135064,complex,0,0
135065,movements,0,0
135066,in,0,0
135067,rehabilitation,0,1
135068,and,0,0
135069,sports,0,0
135070,",",0,0
135071,but,0,0
135072,it,0,0
135073,is,0,0
135074,unclear,0,0
135075,how,0,0
135076,to,0,0
135077,best,0,0
135078,deliver,0,1
135079,guidance-based,0,1
135080,training,0,1
135081,.,0,0
135082,Here,0,0
135083,",",0,0
135084,we,0,0
135085,hypothesized,0,0
135086,that,0,0
135087,breaking,0,0
135088,down,0,0
135089,a,0,0
135090,complex,0,0
135091,movement,0,0
135092,",",0,0
135093,similar,0,0
135094,to,0,0
135095,a,0,0
135096,tennis,0,0
135097,backhand,0,1
135098,",",0,0
135099,into,0,0
135100,simpler,0,0
135101,parts,0,1
135102,and,0,0
135103,then,0,1
135104,using,0,0
135105,haptic,1,1
135106,feedback,1,1
135107,from,1,0
135108,a,1,0
135109,robotic,1,1
135110,exoskeleton,1,0
135111,would,0,0
135112,help,0,0
135113,the,0,0
135114,motor,0,0
135115,system,0,0
135116,learn,0,1
135117,the,0,0
135118,movement,0,0
135119,.,0,0
135120,We,0,0
135121,also,0,0
135122,examined,0,0
135123,how,0,0
135124,the,0,0
135125,particular,0,0
135126,form,0,0
135127,of,0,0
135128,the,0,0
135129,decomposition,0,0
135130,affected,0,0
135131,learning,0,0
135132,.,0,0
135133,Three,0,0
135134,groups,0,0
135135,of,0,0
135136,unimpaired,0,0
135137,participants,0,0
135138,trained,0,1
135139,with,0,0
135140,the,0,0
135141,target,0,0
135142,arm,0,0
135143,movement,0,0
135144,broken,0,0
135145,down,0,0
135146,in,0,0
135147,three,0,0
135148,ways,0,0
135149,:,0,0
135150,1,0,0
135151,),0,0
135152,elbow,1,1
135153,flexion/extension,1,0
135154,and,1,0
135155,the,1,0
135156,unified,1,1
135157,shoulder,1,0
135158,motion,1,0
135159,independently,1,0
135160,(,1,0
135161,anatomical,1,0
135162,decomposition,1,1
135163,),1,0
135164,",",1,0
135165,2,1,0
135166,),1,0
135167,three,1,0
135168,component,1,0
135169,shoulder,1,0
135170,motions,1,0
135171,in,1,0
135172,Euler,1,0
135173,coordinates,1,1
135174,and,1,0
135175,elbow,1,1
135176,flexion/extension,1,0
135177,(,1,1
135178,Euler,1,1
135179,decomposition,1,1
135180,),1,0
135181,",",1,0
135182,or,1,1
135183,3,1,0
135184,),1,0
135185,the,1,0
135186,motion,1,0
135187,of,1,0
135188,the,1,0
135189,tip,1,1
135190,of,1,0
135191,the,1,0
135192,elbow,1,1
135193,and,1,0
135194,motion,1,0
135195,of,1,0
135196,the,1,0
135197,hand,1,1
135198,with,1,0
135199,respect,1,0
135200,to,1,0
135201,the,1,0
135202,elbow,1,0
135203,",",1,0
135204,independently,1,0
135205,(,1,0
135206,visual,1,1
135207,decomposition,1,1
135208,),1,0
135209,.,1,0
135210,A,0,0
135211,control,0,0
135212,group,0,0
135213,practiced,0,0
135214,the,0,0
135215,same,0,0
135216,number,0,0
135217,of,0,0
135218,movements,1,0
135219,",",1,0
135220,but,1,0
135221,experienced,1,0
135222,the,1,0
135223,target,1,0
135224,motion,1,0
135225,only,1,0
135226,",",0,0
135227,achieving,0,0
135228,eight,0,0
135229,times,0,0
135230,more,0,0
135231,direct,0,0
135232,practice,0,0
135233,with,0,0
135234,this,0,0
135235,motion,0,0
135236,.,0,0
135237,Despite,0,0
135238,less,0,0
135239,experience,0,0
135240,with,0,0
135241,the,0,0
135242,target,0,0
135243,motion,0,0
135244,",",0,0
135245,part,0,0
135246,training,0,1
135247,was,0,0
135248,better,0,0
135249,",",0,0
135250,but,0,0
135251,only,0,0
135252,when,0,0
135253,the,0,0
135254,arm,0,0
135255,trajectory,0,0
135256,was,0,0
135257,decomposed,0,0
135258,into,0,0
135259,anatomical,0,0
135260,components,0,0
135261,.,0,0
135262,Varying,0,0
135263,robotic,0,1
135264,movement,0,1
135265,training,0,1
135266,to,0,0
135267,include,0,0
135268,practice,0,0
135269,of,0,0
135270,simpler,1,0
135271,",",1,0
135272,anatomically-isolated,1,0
135273,motions,1,0
135274,may,0,0
135275,enhance,0,0
135276,its,0,0
135277,efficacy,0,0
135278,.,0,0
135279,Internet-based,1,1
135280,program,1,1
135281,for,0,0
135282,coping,0,0
135283,with,0,0
135284,cancer,0,0
135285,:,0,0
135286,a,0,0
135287,randomized,0,0
135288,controlled,0,0
135289,trial,0,0
135290,with,0,0
135291,hematologic,0,0
135292,cancer,0,0
135293,patients,0,0
135294,.,0,0
135295,OBJECTIVE,0,0
135296,Psychosocial,0,0
135297,patient,0,0
135298,care,0,1
135299,in,0,0
135300,oncology,0,0
135301,is,0,0
135302,no,0,0
135303,longer,0,0
135304,limited,0,0
135305,to,0,0
135306,the,0,0
135307,inpatient,0,0
135308,setting,0,0
135309,.,0,0
135310,Outpatient,0,0
135311,services,0,0
135312,are,0,0
135313,in,0,0
135314,demand,0,0
135315,.,0,0
135316,Internet-based,1,0
135317,interventions,1,0
135318,could,0,0
135319,aid,0,0
135320,in,0,0
135321,optimizing,0,0
135322,service,0,1
135323,delivery,0,0
135324,across,0,0
135325,disciplines,0,0
135326,.,0,0
135327,The,0,0
135328,effectiveness,0,0
135329,of,0,0
135330,an,0,0
135331,Internet-based,0,1
135332,program,0,1
135333,for,0,0
135334,hematologic,0,0
135335,cancer,0,0
135336,patients,0,0
135337,was,0,0
135338,tested,0,0
135339,in,0,0
135340,a,0,0
135341,randomized,0,0
135342,controlled,0,0
135343,trial,0,0
135344,under,0,0
135345,field,0,0
135346,experimental,0,0
135347,conditions,0,0
135348,.,0,0
135349,METHODS,0,0
135350,A,0,0
135351,4-week,1,0
135352,cognitive-behavioral,1,1
135353,program,1,1
135354,for,1,0
135355,coping,1,0
135356,with,0,0
135357,cancer,0,0
135358,was,0,0
135359,offered,0,0
135360,to,0,0
135361,hematologic,0,0
135362,cancer,0,0
135363,patients,0,0
135364,online,0,1
135365,.,0,0
135366,One,0,0
135367,hundred,0,0
135368,eighty-six,0,0
135369,registrants,0,0
135370,were,0,0
135371,randomly,0,0
135372,assigned,0,0
135373,to,0,0
135374,an,0,0
135375,intervention,1,1
135376,group,1,0
135377,(,0,0
135378,n,0,0
135379,=,0,0
135380,105,0,0
135381,),0,0
135382,or,0,1
135383,a,0,0
135384,waiting,1,1
135385,list,1,1
135386,(,0,0
135387,n,0,0
135388,=,0,0
135389,81,0,0
135390,),0,0
135391,.,0,0
135392,The,0,0
135393,outcome,0,0
135394,measures,0,0
135395,",",0,0
135396,'mental,0,0
135397,adjustment,0,0
135398,',0,1
135399,(,0,0
135400,MAC,0,1
135401,),0,1
135402,and,0,0
135403,'psychological,0,1
135404,distress,0,0
135405,',0,1
135406,(,0,0
135407,BSI,0,0
135408,),0,0
135409,",",0,0
135410,were,0,0
135411,assessed,0,0
135412,at,0,0
135413,registration,0,0
135414,and,0,0
135415,after,0,0
135416,4,0,0
135417,weeks,0,0
135418,.,0,0
135419,Patient,0,0
135420,satisfaction,0,0
135421,was,0,0
135422,assessed,0,0
135423,(,0,0
135424,ZUF-8,0,1
135425,),0,1
135426,",",0,0
135427,and,0,0
135428,complete-cases,0,0
135429,and,0,0
135430,intention-to-treat,0,0
135431,analyses,0,0
135432,were,0,0
135433,performed,0,0
135434,.,0,0
135435,RESULTS,0,0
135436,At,0,0
135437,registration,0,0
135438,",",0,0
135439,the,0,0
135440,majority,0,0
135441,of,0,0
135442,participants,0,0
135443,displayed,0,0
135444,clinically,0,0
135445,significant,0,0
135446,distress,0,0
135447,(,0,1
135448,BSI,0,0
135449,),0,1
135450,and,0,0
135451,lacked,0,0
135452,alternative,0,1
135453,access,0,0
135454,concerning,0,0
135455,psychosocial,0,0
135456,care,0,1
135457,.,0,0
135458,One,0,0
135459,hundred,0,0
135460,eleven,0,0
135461,patients,0,0
135462,filled,0,0
135463,out,0,0
135464,the,0,0
135465,post,0,0
135466,questionnaire,0,0
135467,at,0,0
135468,4,0,0
135469,weeks,0,0
135470,.,0,0
135471,In,0,0
135472,contrast,0,0
135473,to,0,0
135474,the,0,0
135475,waiting,0,0
135476,list,0,0
135477,",",0,0
135478,the,0,0
135479,intervention,0,1
135480,group,0,0
135481,displayed,0,0
135482,a,0,0
135483,significant,0,0
135484,increase,0,0
135485,in,0,0
135486,fighting,0,1
135487,spirit,0,1
135488,(,0,1
135489,d,0,1
135490,=,0,0
135491,0.42,0,0
135492,;,0,0
135493,CI,0,0
135494,95,0,0
135495,%,0,0
135496,",",0,0
135497,0.04,0,0
135498,to,0,0
135499,0.80,0,0
135500,),0,0
135501,.,0,0
135502,The,0,0
135503,effect,0,0
135504,was,0,0
135505,confirmed,0,0
135506,by,0,0
135507,intention-to-treat,0,0
135508,analysis,0,0
135509,(,0,0
135510,d,0,1
135511,=,0,0
135512,0.33,0,0
135513,;,0,0
135514,CI,0,0
135515,95,0,0
135516,%,0,0
135517,",",0,0
135518,0.04,0,0
135519,to,0,0
135520,0.62,0,0
135521,),0,0
135522,.,0,0
135523,Otherwise,0,0
135524,",",0,0
135525,no,0,0
135526,effects,0,0
135527,were,0,0
135528,observed,0,0
135529,.,0,0
135530,Patient,0,0
135531,satisfaction,0,0
135532,with,0,0
135533,the,0,0
135534,program,0,1
135535,was,0,0
135536,high,0,0
135537,.,0,0
135538,CONCLUSION,0,0
135539,The,0,0
135540,results,0,0
135541,demonstrate,0,0
135542,the,0,0
135543,potential,0,0
135544,efficacy,0,0
135545,of,0,0
135546,Internet-based,0,1
135547,programs,0,1
135548,while,0,0
135549,highlighting,0,0
135550,their,0,0
135551,limitations,0,0
135552,.,0,0
135553,Future,0,1
135554,research,0,0
135555,is,0,0
135556,needed,0,0
135557,to,0,0
135558,clarify,0,0
135559,and,0,0
135560,optimize,0,0
135561,efficacy,0,0
135562,",",0,0
135563,taking,0,0
135564,different,0,1
135565,program,0,1
135566,components,0,0
135567,and,0,0
135568,patient,0,0
135569,characteristics,0,0
135570,into,0,0
135571,particular,0,0
135572,consideration,0,0
135573,.,0,0
135574,Carbon,1,1
135575,dioxide,1,1
135576,insufflation,1,1
135577,in,0,0
135578,open-chamber,0,1
135579,cardiac,0,0
135580,surgery,0,1
135581,:,0,0
135582,a,0,0
135583,double-blind,0,0
135584,",",0,0
135585,randomized,0,0
135586,clinical,0,0
135587,trial,0,0
135588,of,0,0
135589,neurocognitive,0,0
135590,effects,0,0
135591,.,0,0
135592,OBJECTIVE,0,0
135593,The,0,0
135594,aims,0,0
135595,of,0,0
135596,this,0,0
135597,study,0,0
135598,were,0,0
135599,first,0,0
135600,to,0,0
135601,analyze,0,0
135602,neurocognitive,0,0
135603,outcomes,0,0
135604,of,0,0
135605,patients,0,0
135606,after,0,0
135607,open-chamber,0,1
135608,cardiac,0,0
135609,surgery,0,1
135610,to,0,0
135611,determine,0,0
135612,whether,0,0
135613,carbon,1,1
135614,dioxide,1,1
135615,pericardial,1,0
135616,insufflation,1,1
135617,reduces,0,0
135618,incidence,0,0
135619,of,0,0
135620,neurocognitive,0,0
135621,decline,0,0
135622,(,0,1
135623,primary,0,0
135624,end,0,0
135625,point,0,0
135626,),0,0
135627,as,0,0
135628,measured,0,0
135629,6,0,0
135630,weeks,0,0
135631,postoperatively,0,0
135632,and,0,0
135633,second,0,0
135634,to,0,0
135635,assess,0,0
135636,the,0,0
135637,utility,0,0
135638,of,0,0
135639,carbon,1,1
135640,dioxide,1,1
135641,insufflation,1,1
135642,in,0,0
135643,cardiac,0,0
135644,chamber,0,1
135645,deairing,0,0
135646,as,0,0
135647,assessed,0,0
135648,by,0,0
135649,transesophageal,0,1
135650,echocardiography,0,0
135651,.,0,0
135652,METHODS,0,0
135653,A,0,0
135654,multicenter,0,0
135655,",",0,0
135656,prospective,0,0
135657,",",0,0
135658,double-blind,0,0
135659,",",0,0
135660,randomized,0,0
135661,",",0,0
135662,controlled,0,0
135663,trial,0,0
135664,compared,0,0
135665,neurocognitive,0,0
135666,outcomes,0,0
135667,in,0,0
135668,patients,0,0
135669,undergoing,0,0
135670,open-chamber,0,1
135671,(,0,1
135672,left-sided,0,0
135673,),0,1
135674,cardiac,0,0
135675,surgery,0,1
135676,who,0,0
135677,were,0,0
135678,assigned,0,0
135679,carbon,1,1
135680,dioxide,1,1
135681,insufflation,1,1
135682,or,1,1
135683,placebo,1,1
135684,(,0,1
135685,control,0,1
135686,group,0,0
135687,),0,0
135688,in,0,0
135689,addition,0,0
135690,to,0,0
135691,standardized,0,1
135692,mechanical,0,0
135693,deairing,0,0
135694,maneuvers,0,1
135695,.,0,0
135696,RESULTS,0,0
135697,One,0,0
135698,hundred,0,0
135699,twenty-five,0,0
135700,patients,0,0
135701,underwent,0,0
135702,surgery,0,1
135703,and,0,0
135704,were,0,0
135705,randomly,0,0
135706,allocated,0,0
135707,.,0,0
135708,Neurocognitive,0,0
135709,testing,0,0
135710,showed,0,0
135711,no,0,0
135712,clinically,0,0
135713,significant,0,0
135714,differences,0,0
135715,in,0,0
135716,z,0,0
135717,scores,0,0
135718,between,0,0
135719,preoperative,0,0
135720,and,0,0
135721,postoperative,0,0
135722,testing,0,1
135723,.,0,0
135724,Linear,0,0
135725,regression,0,0
135726,was,0,0
135727,used,0,0
135728,to,0,0
135729,identify,0,0
135730,factors,0,0
135731,associated,0,0
135732,with,0,0
135733,neurocognitive,0,0
135734,decline,0,0
135735,.,0,0
135736,Factors,0,0
135737,most,0,0
135738,strongly,0,0
135739,associated,0,0
135740,with,0,0
135741,neurocognitive,0,0
135742,decline,0,0
135743,were,0,0
135744,hypercholesterolemia,0,0
135745,",",0,0
135746,aortic,0,0
135747,atheroma,0,0
135748,grade,0,0
135749,",",0,0
135750,and,0,0
135751,coronary,0,0
135752,artery,0,0
135753,disease,0,0
135754,.,0,0
135755,There,0,0
135756,was,0,0
135757,significantly,0,0
135758,more,0,0
135759,intracardiac,0,0
135760,gas,0,1
135761,noted,0,0
135762,on,0,0
135763,intraoperative,0,1
135764,transesophageal,0,1
135765,echocardiography,0,0
135766,in,0,0
135767,all,0,0
135768,cardiac,0,0
135769,chambers,0,1
135770,(,0,0
135771,left,0,0
135772,atrium,0,0
135773,",",0,0
135774,left,0,0
135775,ventricle,0,0
135776,",",0,0
135777,and,0,0
135778,aorta,0,0
135779,),0,1
135780,at,0,0
135781,all,0,0
135782,measured,0,0
135783,times,0,0
135784,(,0,0
135785,after,0,0
135786,crossclamp,0,1
135787,removal,0,0
135788,",",0,0
135789,during,0,0
135790,weaning,0,0
135791,from,0,0
135792,cardiopulmonary,0,1
135793,bypass,0,1
135794,",",0,0
135795,and,0,0
135796,at,0,0
135797,declaration,0,0
135798,of,0,0
135799,adequate,0,0
135800,deairing,0,0
135801,by,0,0
135802,the,0,0
135803,anesthetist,0,0
135804,),0,0
135805,in,0,0
135806,the,0,0
135807,control,0,1
135808,group,0,0
135809,than,0,0
135810,in,0,0
135811,the,0,0
135812,carbon,0,1
135813,dioxide,0,1
135814,group,0,1
135815,(,0,0
135816,P,0,0
135817,<,0,0
135818,.04,0,0
135819,),0,0
135820,.,0,0
135821,Deairing,0,0
135822,time,0,0
135823,was,0,0
135824,also,0,0
135825,significantly,0,0
135826,longer,0,0
135827,in,0,0
135828,the,0,0
135829,control,0,1
135830,group,0,0
135831,(,0,0
135832,12,0,0
135833,minutes,0,0
135834,[,0,0
135835,interquartile,0,0
135836,range,0,0
135837,",",0,0
135838,9-18,0,0
135839,],0,0
135840,versus,0,0
135841,9,0,0
135842,minutes,0,0
135843,[,0,0
135844,interquartile,0,0
135845,range,0,0
135846,",",0,0
135847,7-14,0,0
135848,minutes,0,0
135849,],0,0
135850,;,0,0
135851,P,0,0
135852,=,0,0
135853,.002,0,0
135854,),0,0
135855,.,0,0
135856,CONCLUSIONS,0,0
135857,Carbon,1,0
135858,dioxide,1,1
135859,pericardial,0,0
135860,insufflation,0,1
135861,in,0,0
135862,open-chamber,0,1
135863,cardiac,0,0
135864,surgery,0,1
135865,does,0,0
135866,not,0,0
135867,affect,0,0
135868,postoperative,0,0
135869,neurocognitive,0,0
135870,decline,0,0
135871,.,0,0
135872,The,0,0
135873,most,0,0
135874,important,0,0
135875,factor,0,1
135876,is,0,0
135877,atheromatous,0,0
135878,vascular,0,0
135879,disease,0,0
135880,.,0,0
135881,Teacher-implemented,1,1
135882,joint,1,1
135883,attention,1,0
135884,intervention,1,1
135885,:,1,0
135886,pilot,0,0
135887,randomized,0,0
135888,controlled,0,0
135889,study,0,0
135890,for,0,0
135891,preschoolers,0,0
135892,with,0,0
135893,autism,0,0
135894,.,0,0
135895,OBJECTIVE,0,0
135896,The,0,0
135897,vast,0,0
135898,majority,0,0
135899,of,0,0
135900,children,0,0
135901,with,0,0
135902,an,0,0
135903,autism,0,0
135904,spectrum,0,0
135905,disorder,0,0
135906,(,0,1
135907,ASD,0,0
135908,),0,1
135909,attend,0,1
135910,public,0,0
135911,preschools,0,0
135912,at,0,0
135913,some,0,0
135914,point,0,0
135915,in,0,0
135916,their,0,0
135917,childhood,0,0
135918,.,0,0
135919,Community,0,0
135920,preschool,0,0
135921,practices,0,0
135922,often,0,0
135923,are,0,0
135924,not,0,0
135925,evidence,0,0
135926,based,0,0
135927,",",0,0
135928,and,0,0
135929,almost,0,0
135930,none,0,0
135931,target,0,0
135932,the,0,0
135933,prelinguistic,0,1
135934,core,0,0
135935,deficits,0,0
135936,of,0,0
135937,ASD,0,0
135938,.,0,0
135939,This,0,0
135940,study,0,0
135941,investigated,0,0
135942,the,0,0
135943,effectiveness,0,0
135944,of,0,0
135945,public,0,0
135946,preschool,0,0
135947,teachers,0,0
135948,implementing,0,0
135949,a,0,0
135950,validated,0,0
135951,intervention,0,1
135952,(,1,0
135953,the,1,0
135954,Joint,1,1
135955,Attention,1,0
135956,and,1,0
135957,Symbolic,1,1
135958,Play/Engagement,1,1
135959,and,1,0
135960,Regulation,1,0
135961,intervention,1,1
135962,;,1,0
135963,JASP/ER,1,1
135964,),1,0
135965,on,0,0
135966,a,0,0
135967,core,0,0
135968,deficit,0,0
135969,of,0,0
135970,autism,0,0
135971,",",0,0
135972,initiating,0,0
135973,joint,0,0
135974,attention,0,0
135975,.,0,0
135976,METHOD,0,0
135977,Sixteen,0,0
135978,dyads,0,0
135979,(,0,0
135980,preschoolers,0,0
135981,with,0,0
135982,ASD,0,0
135983,and,0,0
135984,the,0,0
135985,public,0,0
135986,school,0,0
135987,teachers,0,0
135988,who,0,0
135989,worked,0,0
135990,in,0,0
135991,the,0,0
135992,child,0,0
135993,'s,0,0
135994,classroom,0,1
135995,),0,0
135996,were,0,0
135997,randomly,0,0
135998,assigned,0,0
135999,to,0,0
136000,the,0,0
136001,6-week,0,0
136002,JASP/ER,1,1
136003,intervention,1,1
136004,or,0,1
136005,a,0,0
136006,control,1,1
136007,group,1,0
136008,.,1,0
136009,RESULTS,0,0
136010,At,0,0
136011,the,0,0
136012,end,0,0
136013,of,0,0
136014,the,0,0
136015,intervention,0,1
136016,",",0,0
136017,JASP/ER,1,1
136018,teachers,0,0
136019,used,0,0
136020,more,0,0
136021,JASP/ER,1,1
136022,strategies,0,0
136023,than,0,0
136024,the,0,0
136025,control,0,0
136026,teachers,0,0
136027,",",0,0
136028,and,0,0
136029,JASP/ER,1,1
136030,preschoolers,0,0
136031,used,0,0
136032,more,0,0
136033,joint,0,0
136034,attention,0,0
136035,in,0,0
136036,their,0,0
136037,classroom,0,1
136038,than,0,0
136039,control,0,0
136040,children,0,0
136041,.,0,0
136042,Additionally,0,0
136043,",",0,0
136044,JASP/ER,1,1
136045,children,0,0
136046,spent,0,0
136047,more,0,0
136048,time,0,0
136049,in,0,0
136050,supported,0,0
136051,engagement,0,0
136052,and,0,0
136053,less,0,0
136054,time,0,0
136055,in,0,0
136056,object,0,0
136057,engagement,0,0
136058,than,0,0
136059,control,0,0
136060,preschoolers,0,0
136061,on,0,0
136062,a,0,0
136063,taped,1,1
136064,play,1,0
136065,interaction,1,0
136066,.,1,0
136067,CONCLUSIONS,0,0
136068,Findings,0,0
136069,suggest,0,0
136070,that,0,0
136071,teachers,0,0
136072,were,0,0
136073,able,0,0
136074,to,0,0
136075,improve,0,0
136076,a,0,0
136077,core,0,0
136078,deficit,0,0
136079,of,0,0
136080,children,0,0
136081,with,0,0
136082,ASD,0,0
136083,in,0,0
136084,a,0,0
136085,public,0,0
136086,preschool,0,0
136087,context,0,0
136088,.,0,0
136089,Immunologic,0,1
136090,response,0,0
136091,after,0,0
136092,laparoscopic,0,1
136093,colon,0,0
136094,cancer,0,0
136095,operation,0,0
136096,within,0,0
136097,an,0,0
136098,enhanced,0,0
136099,recovery,0,0
136100,program,0,1
136101,.,0,0
136102,OBJECTIVE,0,0
136103,It,0,0
136104,has,0,0
136105,been,0,0
136106,demonstrated,0,0
136107,that,0,0
136108,colon,0,0
136109,operation,0,1
136110,combined,0,1
136111,with,0,0
136112,fast-track,0,1
136113,(,0,1
136114,FT,0,1
136115,),0,1
136116,surgery,0,1
136117,and,0,1
136118,laparoscopic,0,1
136119,technique,0,1
136120,can,0,0
136121,shorten,0,0
136122,the,0,0
136123,length,0,0
136124,of,0,0
136125,hospital,0,0
136126,stay,0,0
136127,",",0,0
136128,accelerate,0,0
136129,recovery,0,0
136130,of,0,0
136131,intestinal,0,0
136132,function,0,0
136133,",",0,0
136134,and,0,0
136135,reduce,0,0
136136,the,0,0
136137,occurrence,0,0
136138,of,0,0
136139,post-operative,0,0
136140,complications,0,0
136141,.,0,0
136142,However,0,0
136143,",",0,0
136144,there,0,0
136145,are,0,0
136146,no,0,0
136147,reports,0,0
136148,regarding,0,0
136149,the,0,0
136150,combined,0,1
136151,effects,0,0
136152,of,0,0
136153,FT,0,1
136154,colon,0,0
136155,operation,0,1
136156,and,0,0
136157,laparoscopic,0,1
136158,technique,0,1
136159,on,0,0
136160,humoral,0,0
136161,inflammatory,0,0
136162,cellular,0,0
136163,immunity,0,0
136164,.,0,0
136165,METHODS,0,0
136166,This,0,0
136167,was,0,0
136168,a,0,0
136169,prospective,0,0
136170,",",0,0
136171,controlled,0,0
136172,study,0,0
136173,.,0,0
136174,One,0,0
136175,hundred,0,0
136176,sixty-three,0,0
136177,colon,0,0
136178,cancer,0,0
136179,patients,0,0
136180,underwent,0,0
136181,the,0,0
136182,traditional,1,1
136183,protocol,1,1
136184,and,1,0
136185,open,1,1
136186,operation,1,1
136187,(,0,0
136188,traditional,0,1
136189,open,0,1
136190,group,0,0
136191,",",0,0
136192,n=42,0,0
136193,),0,0
136194,",",0,0
136195,the,0,0
136196,traditional,1,1
136197,protocol,1,1
136198,and,1,0
136199,laparoscopic,1,1
136200,operation,1,1
136201,(,0,1
136202,traditional,0,1
136203,laparoscopic,0,1
136204,group,0,0
136205,",",0,0
136206,n=40,0,1
136207,),0,0
136208,",",0,0
136209,the,0,0
136210,FT,1,1
136211,protocol,1,1
136212,and,1,0
136213,open,1,1
136214,operation,1,1
136215,(,0,1
136216,FT,0,1
136217,open,0,1
136218,group,0,0
136219,",",0,0
136220,n=41,0,0
136221,),0,0
136222,",",0,0
136223,or,0,1
136224,the,0,0
136225,FT,1,1
136226,protocol,1,1
136227,and,1,0
136228,laparoscopic,1,1
136229,operation,1,1
136230,(,0,1
136231,FT,0,1
136232,laparoscopic,0,1
136233,group,0,0
136234,",",0,0
136235,n=40,0,1
136236,),0,0
136237,.,0,0
136238,Blood,0,0
136239,samples,0,0
136240,were,0,0
136241,taken,0,0
136242,prior,0,0
136243,to,0,0
136244,operation,0,0
136245,as,0,0
136246,well,0,0
136247,as,0,0
136248,on,0,0
136249,days,0,0
136250,1,0,0
136251,",",0,0
136252,3,0,0
136253,",",0,0
136254,and,0,0
136255,5,0,0
136256,after,0,0
136257,operation,0,0
136258,.,0,0
136259,The,0,0
136260,number,0,0
136261,of,0,0
136262,lymphocyte,0,0
136263,subpopulations,0,0
136264,was,0,0
136265,determined,0,0
136266,by,0,0
136267,flow,0,0
136268,cytometry,0,1
136269,",",0,0
136270,and,0,0
136271,serum,0,0
136272,interleukin-6,0,1
136273,and,0,0
136274,C-reactive,0,0
136275,protein,0,1
136276,levels,0,0
136277,were,0,0
136278,measured,0,0
136279,.,0,0
136280,Post-operative,0,0
136281,hospital,0,0
136282,stay,0,0
136283,",",0,0
136284,post-operative,0,0
136285,morbidity,0,0
136286,",",0,0
136287,readmission,0,0
136288,rate,0,0
136289,",",0,0
136290,and,0,0
136291,in-hospital,0,0
136292,mortality,0,0
136293,were,0,0
136294,recorded,0,0
136295,.,0,0
136296,RESULTS,0,0
136297,Compared,0,0
136298,with,0,0
136299,open,0,1
136300,operation,0,0
136301,",",0,0
136302,laparoscopic,0,1
136303,colon,0,0
136304,operation,0,0
136305,effectively,0,0
136306,inhibited,0,0
136307,the,0,0
136308,release,0,0
136309,of,0,0
136310,post-operative,0,0
136311,inflammatory,0,0
136312,factors,0,0
136313,and,0,0
136314,yielded,0,0
136315,good,0,0
136316,protection,0,0
136317,via,0,1
136318,post-operative,0,0
136319,cell,0,0
136320,immunity,0,0
136321,.,0,0
136322,FT,0,0
136323,surgery,0,0
136324,had,0,0
136325,a,0,0
136326,better,0,0
136327,protective,0,0
136328,role,0,0
136329,with,0,0
136330,respect,0,0
136331,to,0,0
136332,the,0,0
136333,post-operative,0,0
136334,immune,0,0
136335,system,0,1
136336,compared,0,0
136337,with,0,0
136338,traditional,0,1
136339,peri-operative,0,0
136340,care,0,1
136341,.,0,0
136342,Inflammatory,0,0
136343,reactions,0,0
136344,",",0,0
136345,based,0,0
136346,on,0,0
136347,interleukin-6,0,0
136348,and,0,0
136349,C-reactive,0,0
136350,protein,0,1
136351,levels,0,0
136352,",",0,0
136353,were,0,0
136354,less,0,0
136355,intense,0,0
136356,following,0,0
136357,FT,0,1
136358,laparoscopic,0,1
136359,operation,0,1
136360,compared,0,0
136361,to,0,0
136362,FT,0,1
136363,open,0,1
136364,operation,0,0
136365,;,0,0
136366,however,0,0
136367,",",0,0
136368,there,0,0
136369,were,0,0
136370,no,0,0
136371,differences,0,0
136372,in,0,0
136373,specific,0,1
136374,immunity,0,0
136375,(,0,1
136376,CD3+,0,1
136377,and,0,0
136378,CD4+,0,0
136379,counts,0,0
136380,",",0,0
136381,and,0,0
136382,the,0,0
136383,CD4+/CD8+,0,1
136384,ratio,0,0
136385,),0,0
136386,during,0,0
136387,these,0,0
136388,two,0,0
136389,types,0,0
136390,of,0,0
136391,surgical,0,0
136392,procedures,0,0
136393,.,0,0
136394,Post-operative,0,0
136395,hospital,0,0
136396,stay,0,0
136397,in,0,0
136398,patients,0,0
136399,randomized,0,0
136400,to,0,0
136401,the,0,0
136402,FT,0,1
136403,laparoscopic,0,1
136404,group,0,0
136405,was,0,0
136406,significantly,0,0
136407,shorter,0,0
136408,than,0,0
136409,in,0,0
136410,the,0,0
136411,other,0,0
136412,three,0,0
136413,treatment,0,0
136414,groups,0,0
136415,(,0,0
136416,P,0,0
136417,<,0,0
136418,0.01,0,0
136419,),0,0
136420,.,0,0
136421,Post-operative,0,0
136422,complications,0,0
136423,in,0,0
136424,patients,0,0
136425,who,0,0
136426,underwent,0,0
136427,FT,0,1
136428,laparoscopic,0,1
136429,treatment,0,0
136430,were,0,0
136431,less,0,0
136432,than,0,0
136433,in,0,0
136434,the,0,0
136435,other,0,0
136436,three,0,0
136437,treatment,0,0
136438,groups,0,0
136439,(,0,0
136440,P,0,0
136441,<,0,0
136442,0.05,0,0
136443,),0,0
136444,.,0,0
136445,There,0,0
136446,were,0,0
136447,no,0,0
136448,significant,0,0
136449,differences,0,0
136450,between,0,0
136451,the,0,0
136452,four,0,0
136453,treatment,0,0
136454,groups,0,0
136455,regarding,0,0
136456,readmission,0,0
136457,rate,0,0
136458,and,0,0
136459,in-hospital,0,0
136460,mortality,0,0
136461,.,0,0
136462,CONCLUSIONS,0,0
136463,The,0,0
136464,laparoscopic,0,1
136465,technique,0,1
136466,and,0,0
136467,FT,0,1
136468,surgery,0,1
136469,rehabilitation,0,1
136470,program,0,1
136471,effectively,0,0
136472,inhibited,0,0
136473,release,0,0
136474,of,0,0
136475,post-operative,0,0
136476,inflammatory,0,0
136477,factors,0,0
136478,with,0,0
136479,a,0,0
136480,reduction,0,0
136481,in,0,0
136482,peri-operative,0,1
136483,trauma,0,1
136484,and,0,0
136485,stress,0,0
136486,",",0,0
136487,which,0,0
136488,together,0,0
136489,played,0,0
136490,a,0,0
136491,protective,0,0
136492,role,0,0
136493,on,0,0
136494,the,0,0
136495,post-operative,0,0
136496,immune,0,0
136497,system,0,1
136498,.,0,0
136499,Combining,0,0
136500,two,0,0
136501,treatment,0,0
136502,measures,0,0
136503,during,0,0
136504,colon,0,0
136505,operation,0,0
136506,produced,0,0
136507,better,0,0
136508,protective,0,0
136509,effects,0,0
136510,via,0,0
136511,the,0,0
136512,immune,0,0
136513,system,0,0
136514,.,0,0
136515,The,0,0
136516,beneficial,0,0
136517,clinical,0,0
136518,effects,0,0
136519,support,0,0
136520,that,0,0
136521,the,0,0
136522,better-preserved,0,0
136523,post-operative,0,0
136524,immune,0,0
136525,system,0,0
136526,may,0,0
136527,also,0,0
136528,contribute,0,0
136529,to,0,0
136530,the,0,0
136531,improvement,0,0
136532,of,0,0
136533,post-operative,0,0
136534,results,0,0
136535,in,0,0
136536,FT,0,1
136537,laparoscopic,0,1
136538,patients,0,0
136539,.,0,0
136540,The,0,0
136541,Coping,0,0
136542,Cat,0,0
136543,program,0,1
136544,for,0,0
136545,children,0,0
136546,with,0,0
136547,anxiety,0,0
136548,and,0,0
136549,autism,0,0
136550,spectrum,0,0
136551,disorder,0,0
136552,:,0,0
136553,a,0,0
136554,pilot,0,0
136555,randomized,0,0
136556,controlled,0,0
136557,trial,0,0
136558,.,0,0
136559,The,0,0
136560,purpose,0,0
136561,of,0,0
136562,this,0,0
136563,pilot,0,0
136564,study,0,0
136565,was,0,0
136566,to,0,0
136567,evaluate,0,0
136568,whether,0,0
136569,a,0,0
136570,modified,1,0
136571,version,1,0
136572,of,1,0
136573,the,1,0
136574,Coping,1,0
136575,Cat,1,0
136576,program,1,1
136577,could,0,0
136578,be,0,0
136579,effective,0,0
136580,in,0,0
136581,reducing,0,0
136582,anxiety,0,0
136583,in,0,0
136584,children,0,0
136585,with,0,0
136586,autism,0,0
136587,spectrum,0,0
136588,disorder,0,0
136589,(,0,1
136590,ASD,0,0
136591,),0,1
136592,.,0,0
136593,Twenty-two,0,0
136594,children,0,0
136595,(,0,0
136596,ages,0,0
136597,8-14,0,0
136598,;,0,0
136599,IQ,0,0
136600,?,0,0
136601,70,0,0
136602,),0,0
136603,with,0,0
136604,ASD,0,0
136605,and,0,0
136606,clinically,0,0
136607,significant,0,0
136608,anxiety,0,0
136609,were,0,0
136610,randomly,0,0
136611,assigned,1,0
136612,to,1,0
136613,16,1,0
136614,sessions,1,1
136615,of,1,0
136616,the,1,0
136617,Coping,1,0
136618,Cat,1,0
136619,program,1,1
136620,(,1,0
136621,cognitive-behavioral,1,1
136622,therapy,1,1
136623,;,1,0
136624,CBT,1,1
136625,),1,1
136626,or,1,1
136627,a,0,0
136628,16-week,1,0
136629,waitlist,1,0
136630,.,1,0
136631,Children,1,0
136632,in,0,0
136633,the,0,0
136634,CBT,0,1
136635,condition,0,0
136636,evidenced,0,0
136637,significantly,0,0
136638,larger,0,0
136639,reductions,0,0
136640,in,0,0
136641,anxiety,0,0
136642,than,0,0
136643,those,0,0
136644,in,0,0
136645,the,0,0
136646,waitlist,0,0
136647,.,0,0
136648,Treatment,0,0
136649,gains,0,0
136650,were,0,0
136651,largely,0,0
136652,maintained,0,0
136653,at,0,0
136654,two-month,0,0
136655,follow-up,0,0
136656,.,0,0
136657,Results,0,0
136658,provide,0,0
136659,preliminary,0,0
136660,evidence,0,0
136661,that,0,0
136662,a,0,0
136663,modified,0,0
136664,version,0,0
136665,of,0,0
136666,the,0,0
136667,Coping,1,0
136668,Cat,1,0
136669,program,1,1
136670,may,1,0
136671,be,0,0
136672,a,0,0
136673,feasible,0,0
136674,and,0,0
136675,effective,0,0
136676,program,0,1
136677,for,0,0
136678,reducing,0,0
136679,clinically,0,0
136680,significant,0,0
136681,levels,0,0
136682,of,0,0
136683,anxiety,0,0
136684,in,0,0
136685,children,0,0
136686,with,0,0
136687,high-functioning,0,0
136688,ASD,0,0
136689,.,0,0
136690,A,0,0
136691,comparison,0,0
136692,of,0,0
136693,a,0,0
136694,short,1,0
136695,nurse-based,1,1
136696,and,1,0
136697,a,1,0
136698,long,1,0
136699,multidisciplinary,1,1
136700,version,1,0
136701,of,1,0
136702,structured,1,1
136703,patient,1,0
136704,education,1,1
136705,in,0,0
136706,irritable,0,0
136707,bowel,0,0
136708,syndrome,0,0
136709,.,0,0
136710,OBJECTIVE,0,0
136711,Structured,1,1
136712,multidisciplinary,1,1
136713,patient,1,0
136714,group,1,0
136715,education,1,1
136716,has,0,0
136717,positive,0,0
136718,effects,0,0
136719,on,0,0
136720,symptoms,0,0
136721,",",0,0
136722,health-related,0,0
136723,quality,0,0
136724,of,0,0
136725,life,0,0
136726,",",0,0
136727,and,0,0
136728,disease-related,0,0
136729,knowledge,0,0
136730,in,0,0
136731,patients,0,0
136732,with,0,0
136733,irritable,0,0
136734,bowel,0,1
136735,syndrome,0,0
136736,(,0,1
136737,IBS,0,0
136738,),0,1
136739,",",0,0
136740,but,0,0
136741,few,0,0
136742,studies,0,0
136743,comparing,0,0
136744,different,0,0
136745,forms,0,0
136746,of,0,0
136747,educational,0,0
136748,interventions,0,1
136749,are,0,0
136750,available,0,0
136751,.,0,0
136752,Our,0,0
136753,aim,0,0
136754,was,0,0
136755,to,0,0
136756,compare,0,0
136757,the,0,0
136758,effects,0,0
136759,of,0,0
136760,long,1,0
136761,multidisciplinary,1,1
136762,group,1,0
136763,education,1,1
136764,with,0,0
136765,a,0,0
136766,short,1,0
136767,nurse-based,1,1
136768,group,1,0
136769,education,1,1
136770,with,0,0
136771,regard,0,0
136772,to,0,0
136773,symptoms,0,0
136774,",",0,0
136775,knowledge,0,0
136776,",",0,0
136777,quality,0,0
136778,of,0,0
136779,life,0,0
136780,",",0,0
136781,and,0,0
136782,satisfaction,0,0
136783,with,0,0
136784,the,0,0
136785,intervention,0,1
136786,in,0,0
136787,IBS,0,0
136788,patients,0,0
136789,.,0,0
136790,METHODS,0,0
136791,Patients,0,0
136792,with,0,0
136793,IBS,0,0
136794,according,0,0
136795,to,0,0
136796,the,0,0
136797,Rome,0,0
136798,II,0,0
136799,criteria,0,0
136800,were,0,0
136801,randomized,0,0
136802,to,0,0
136803,either,0,0
136804,short,1,1
136805,nurse-based,1,1
136806,or,1,1
136807,a,1,0
136808,long,1,0
136809,multidisciplinary-based,1,1
136810,education,1,1
136811,.,1,0
136812,The,0,0
136813,effects,0,0
136814,were,0,0
136815,evaluated,0,0
136816,by,0,0
136817,self-administered,1,1
136818,questionnaires,1,0
136819,at,0,0
136820,3,0,0
136821,",",0,0
136822,6,0,0
136823,",",0,0
136824,and,0,0
136825,12,0,0
136826,months,0,0
136827,after,0,0
136828,baseline,0,0
136829,",",0,0
136830,and,0,0
136831,compared,0,0
136832,between,0,0
136833,the,0,0
136834,groups,0,0
136835,.,0,0
136836,RESULTS,0,0
136837,No,0,0
136838,differences,0,0
136839,in,0,0
136840,effects,0,0
136841,were,0,0
136842,detected,0,0
136843,in,0,0
136844,the,0,0
136845,between-group,0,0
136846,comparisons,0,0
136847,at,0,0
136848,any,0,0
136849,of,0,0
136850,the,0,0
136851,follow-up,0,0
136852,assessments,0,0
136853,.,0,0
136854,However,0,0
136855,",",0,0
136856,positive,0,0
136857,effects,0,0
136858,on,0,0
136859,symptoms,0,0
136860,",",0,0
136861,knowledge,0,0
136862,",",0,0
136863,quality,0,0
136864,of,0,0
136865,life,0,0
136866,",",0,0
136867,and,0,0
136868,satisfaction,0,0
136869,with,0,0
136870,the,0,0
136871,intervention,0,1
136872,were,0,0
136873,found,0,0
136874,in,0,0
136875,both,0,0
136876,the,0,0
136877,short,0,1
136878,and,0,0
136879,the,0,0
136880,long,0,0
136881,version,0,0
136882,.,0,0
136883,CONCLUSION,0,0
136884,A,0,0
136885,short,1,0
136886,",",1,0
136887,nurse-based,1,1
136888,educational,1,1
136889,intervention,1,1
136890,seems,0,0
136891,to,0,0
136892,be,0,0
136893,as,0,0
136894,efficacious,0,0
136895,as,0,0
136896,a,0,0
136897,longer,1,0
136898,multidisciplinary,1,0
136899,version,0,0
136900,.,0,0
136901,In,0,0
136902,both,0,0
136903,groups,0,0
136904,",",0,0
136905,positive,0,0
136906,effects,0,0
136907,on,0,0
136908,patients,0,0
136909,',0,0
136910,well-being,0,0
136911,were,0,0
136912,found,0,0
136913,to,0,0
136914,a,0,0
136915,similar,0,0
136916,extent,0,0
136917,.,0,0
136918,This,0,0
136919,is,0,0
136920,an,0,0
136921,important,0,0
136922,finding,0,0
136923,that,0,0
136924,",",0,0
136925,from,0,0
136926,a,0,0
136927,cost-effective,0,0
136928,perspective,0,0
136929,",",0,0
136930,could,0,0
136931,contribute,0,0
136932,toward,0,0
136933,an,0,0
136934,optimized,0,0
136935,management,0,0
136936,of,0,0
136937,patients,0,0
136938,with,0,0
136939,IBS,0,0
136940,.,0,0
136941,Enhancing,0,0
136942,HIV,0,1
136943,medication,0,1
136944,adherence,0,0
136945,in,0,0
136946,India,0,0
136947,.,0,0
136948,BACKGROUND,0,0
136949,This,0,0
136950,pilot,0,0
136951,study,0,0
136952,evaluated,0,0
136953,an,0,0
136954,intervention,0,1
136955,designed,0,0
136956,to,0,0
136957,enhance,0,0
136958,adherence,0,0
136959,among,0,0
136960,those,0,0
136961,new,0,0
136962,to,0,0
136963,antiretroviral,0,1
136964,therapy,0,1
136965,.,0,0
136966,METHODS,0,0
136967,Participants,0,0
136968,(,0,0
136969,n,0,0
136970,=,0,0
136971,80,0,0
136972,),0,0
136973,were,0,0
136974,recruited,0,0
136975,from,0,0
136976,a,0,0
136977,hospital,0,0
136978,clinic,0,0
136979,in,0,0
136980,Chandigarh,0,0
136981,",",0,0
136982,India,0,0
136983,",",0,0
136984,and,0,0
136985,randomized,0,0
136986,to,0,0
136987,a,0,0
136988,3-month,1,0
136989,group,1,0
136990,intervention,1,1
136991,or,1,1
136992,individual,1,0
136993,enhanced,1,0
136994,standard,1,1
136995,of,1,0
136996,care,1,1
136997,followed,1,1
136998,by,1,0
136999,crossover,1,0
137000,of,1,0
137001,condition,1,0
137002,and,1,0
137003,assessed,1,0
137004,over,1,0
137005,6,1,0
137006,months,1,0
137007,.,1,0
137008,Adherence,0,0
137009,was,0,0
137010,measured,0,0
137011,by,0,0
137012,prescription,0,1
137013,refill,0,0
137014,",",0,0
137015,pill,0,1
137016,count,0,0
137017,",",0,0
137018,and,0,0
137019,self-report,0,0
137020,.,0,0
137021,RESULTS,0,0
137022,At,0,0
137023,baseline,0,0
137024,",",0,0
137025,56,0,0
137026,%,0,0
137027,of,0,0
137028,group,0,1
137029,condition,0,1
137030,(,0,1
137031,immediate,0,1
137032,intervention,0,1
137033,),0,1
137034,and,0,0
137035,54,0,0
137036,%,0,0
137037,of,0,0
137038,individual,0,0
137039,condition,0,0
137040,(,0,1
137041,delayed,0,1
137042,intervention,0,1
137043,),0,0
137044,participants,0,0
137045,were,0,0
137046,nonadherent,0,1
137047,by,0,0
137048,pill,0,1
137049,count,0,0
137050,and,0,0
137051,23,0,0
137052,%,0,0
137053,of,0,0
137054,group,0,0
137055,and,0,0
137056,26,0,0
137057,%,0,0
137058,of,0,0
137059,individual,0,0
137060,condition,0,0
137061,participants,0,0
137062,self-reported,0,0
137063,skipping,0,1
137064,medication,0,1
137065,at,0,0
137066,least,0,0
137067,once,0,0
137068,over,0,0
137069,the,0,0
137070,last,0,0
137071,3,0,0
137072,months,0,0
137073,.,0,0
137074,From,0,0
137075,the,0,0
137076,postintervention,0,0
137077,to,0,0
137078,long-term,0,0
137079,follow-up,0,0
137080,",",0,0
137081,adherence,0,0
137082,in,0,0
137083,the,0,0
137084,group,0,1
137085,condition,0,0
137086,(,0,1
137087,immediate,0,1
137088,intervention,0,1
137089,),0,1
137090,improved,0,0
137091,in,0,0
137092,comparison,0,0
137093,with,0,0
137094,adherence,0,0
137095,in,0,0
137096,the,0,0
137097,individual,0,0
137098,condition,0,0
137099,(,0,1
137100,delayed,0,0
137101,intervention,0,1
137102,;,0,0
137103,?,0,0
137104,(,0,0
137105,2,0,0
137106,),0,0
137107,=,0,0
137108,5.67,0,0
137109,",",0,0
137110,P,0,0
137111,=,0,0
137112,.02,0,0
137113,),0,0
137114,.,0,0
137115,CONCLUSIONS,0,0
137116,Results,0,0
137117,support,0,1
137118,the,0,0
137119,use,0,0
137120,of,0,0
137121,interventions,0,0
137122,early,0,0
137123,in,0,0
137124,treatment,0,0
137125,to,0,0
137126,provide,0,0
137127,information,0,0
137128,and,0,0
137129,social,0,1
137130,support,0,0
137131,to,0,0
137132,establish,0,0
137133,long-term,0,0
137134,healthy,0,0
137135,adherence,0,0
137136,behaviors,0,0
137137,.,0,0
137138,Propofol,1,1
137139,sedation,0,0
137140,with,0,0
137141,bispectral,0,1
137142,index,0,0
137143,monitoring,0,1
137144,is,0,0
137145,useful,0,0
137146,for,0,0
137147,endoscopic,0,1
137148,submucosal,1,1
137149,dissection,0,0
137150,:,0,0
137151,a,0,0
137152,randomized,0,0
137153,prospective,0,0
137154,phase,0,0
137155,II,0,1
137156,clinical,0,0
137157,trial,0,0
137158,.,0,0
137159,BACKGROUND,0,0
137160,AND,0,0
137161,STUDY,0,0
137162,AIMS,0,1
137163,Endoscopic,0,1
137164,submucosal,0,1
137165,dissection,0,1
137166,(,0,1
137167,ESD,0,1
137168,),0,1
137169,has,0,0
137170,become,0,0
137171,a,0,0
137172,standard,0,1
137173,treatment,0,0
137174,.,0,0
137175,However,0,0
137176,",",0,0
137177,the,0,0
137178,treatment,0,0
137179,time,0,0
137180,tends,0,0
137181,to,0,0
137182,be,0,0
137183,relatively,0,0
137184,long,0,0
137185,and,0,0
137186,insufflation,0,1
137187,and,0,0
137188,manipulation,0,1
137189,of,0,0
137190,the,0,0
137191,endoscope,0,1
137192,can,0,0
137193,increase,0,0
137194,pain,0,0
137195,and,0,0
137196,discomfort,0,0
137197,.,0,0
137198,We,0,0
137199,aimed,0,0
137200,to,0,0
137201,find,0,0
137202,an,0,0
137203,optimal,0,0
137204,method,0,1
137205,for,0,0
137206,sedation,0,0
137207,during,0,0
137208,ESD,0,0
137209,.,0,0
137210,PATIENTS,0,0
137211,AND,0,0
137212,METHODS,0,0
137213,Patients,0,0
137214,scheduled,0,0
137215,to,0,0
137216,undergo,0,0
137217,ESD,0,0
137218,for,0,0
137219,early,0,0
137220,gastric,0,0
137221,cancer,0,0
137222,or,0,1
137223,adenoma,0,0
137224,were,0,0
137225,randomly,0,0
137226,assigned,0,0
137227,to,0,0
137228,sedation,0,0
137229,with,0,1
137230,midazolam,1,1
137231,or,1,1
137232,propofol,1,1
137233,",",0,0
137234,and,0,0
137235,consciousness,0,0
137236,level,0,0
137237,was,0,0
137238,evaluated,0,0
137239,by,0,0
137240,bispectral,0,1
137241,index,0,0
137242,(,0,1
137243,BIS,0,1
137244,),0,1
137245,monitoring,0,0
137246,.,0,1
137247,Primary,0,0
137248,end,0,0
137249,points,0,0
137250,of,0,0
137251,effectiveness,0,0
137252,(,0,0
137253,three,0,1
137254,parameters,0,0
137255,),0,0
137256,and,0,0
137257,secondary,0,0
137258,end,0,0
137259,points,0,0
137260,of,0,0
137261,safety,0,0
137262,during,0,0
137263,ESD,0,0
137264,and,0,0
137265,after,0,0
137266,return,0,0
137267,to,0,0
137268,the,0,0
137269,ward,0,0
137270,were,0,0
137271,compared,0,0
137272,between,0,0
137273,the,0,0
137274,groups,0,0
137275,.,0,0
137276,Study,0,0
137277,registration,0,0
137278,was,0,0
137279,in,0,0
137280,the,0,0
137281,UMIN,0,0
137282,Clinical,0,0
137283,Trial,0,1
137284,Registry,0,0
137285,(,0,0
137286,UMIN,0,0
137287,000001497,0,0
137288,),0,0
137289,",",0,0
137290,and,0,0
137291,the,0,0
137292,institutional,0,0
137293,trial,0,0
137294,number,0,0
137295,was,0,0
137296,KDOG,0,1
137297,0801,0,0
137298,.,0,0
137299,RESULTS,0,0
137300,From,0,0
137301,June,0,0
137302,2008,0,0
137303,through,0,0
137304,June,0,0
137305,2009,0,0
137306,",",0,0
137307,we,0,0
137308,enrolled,0,0
137309,178,0,0
137310,patients,0,0
137311,(,0,0
137312,90,0,0
137313,midazolam,0,1
137314,",",0,0
137315,88,0,0
137316,propofol,0,1
137317,),0,0
137318,.,0,0
137319,Regarding,0,0
137320,safety,0,0
137321,after,0,0
137322,ESD,0,0
137323,",",0,0
137324,recovery,0,0
137325,was,0,0
137326,significantly,0,0
137327,better,0,0
137328,in,0,0
137329,the,0,0
137330,propofol,0,1
137331,group,0,0
137332,immediately,0,1
137333,after,0,0
137334,and,0,0
137335,at,0,0
137336,1,0,0
137337,hour,0,0
137338,and,0,0
137339,2,0,0
137340,hours,0,0
137341,after,0,0
137342,return,0,0
137343,to,0,0
137344,the,0,0
137345,ward,0,1
137346,(,0,0
137347,P,0,0
137348,<,0,0
137349,0.001,0,0
137350,),0,0
137351,.,0,0
137352,The,0,0
137353,number,0,0
137354,of,0,0
137355,patients,0,0
137356,who,0,0
137357,required,0,0
137358,a,0,0
137359,continuous,0,1
137360,supply,0,0
137361,of,0,0
137362,oxygen,0,1
137363,2,0,0
137364,hours,0,0
137365,after,0,0
137366,returning,0,0
137367,to,0,0
137368,the,0,0
137369,ward,0,0
137370,was,0,0
137371,significantly,0,0
137372,lower,0,0
137373,in,0,0
137374,the,0,0
137375,propofol,0,1
137376,group,0,0
137377,(,0,0
137378,midazolam,0,1
137379,18,0,0
137380,;,0,0
137381,propofol,0,1
137382,6,0,0
137383,;,0,0
137384,P,0,0
137385,=,0,0
137386,0.010,0,0
137387,),0,0
137388,.,0,0
137389,Though,0,0
137390,propofol,0,1
137391,seemed,0,0
137392,to,0,0
137393,be,0,0
137394,better,0,0
137395,for,0,0
137396,effectiveness,0,0
137397,and,0,0
137398,safety,0,0
137399,",",0,0
137400,there,0,0
137401,were,0,0
137402,no,0,0
137403,statistically,0,0
137404,significant,0,0
137405,differences,0,0
137406,for,0,0
137407,all,0,0
137408,three,0,0
137409,primary,0,0
137410,end,0,0
137411,points,0,0
137412,and,0,0
137413,the,0,0
137414,safety,0,0
137415,parameters,0,0
137416,(,0,0
137417,hypotension,0,0
137418,",",0,0
137419,hypoxia,0,0
137420,",",0,0
137421,bradycardia,0,0
137422,),0,0
137423,.,0,0
137424,CONCLUSIONS,0,0
137425,Propofol,1,1
137426,with,0,0
137427,BIS,0,1
137428,monitoring,0,1
137429,improved,0,0
137430,recovery,0,0
137431,of,0,0
137432,patients,0,0
137433,after,0,0
137434,ESD,0,0
137435,",",0,0
137436,though,0,0
137437,this,0,0
137438,study,0,0
137439,was,0,0
137440,underpowered,0,0
137441,to,0,0
137442,prove,0,0
137443,the,0,0
137444,effectiveness,0,0
137445,and,0,0
137446,safety,0,0
137447,of,0,0
137448,propofol,0,1
137449,.,0,0
137450,Impact,0,0
137451,on,0,0
137452,learning,0,1
137453,of,0,0
137454,an,0,0
137455,e-learning,1,1
137456,module,1,1
137457,on,0,0
137458,leukaemia,0,0
137459,:,0,0
137460,a,0,0
137461,randomised,0,0
137462,controlled,0,0
137463,trial,0,0
137464,.,0,0
137465,BACKGROUND,0,0
137466,e-learning,1,1
137467,resources,0,0
137468,may,0,0
137469,be,0,0
137470,beneficial,0,0
137471,for,0,0
137472,complex,0,0
137473,or,0,1
137474,conceptually,0,0
137475,difficult,0,0
137476,topics,0,0
137477,.,0,0
137478,Leukaemia,0,0
137479,is,0,0
137480,one,0,0
137481,such,0,0
137482,topic,0,0
137483,",",0,0
137484,yet,0,0
137485,there,0,0
137486,are,0,0
137487,no,0,0
137488,reports,0,0
137489,on,0,0
137490,the,0,0
137491,efficacy,0,0
137492,of,0,0
137493,e-learning,0,1
137494,for,0,0
137495,leukaemia,0,0
137496,.,0,0
137497,This,0,0
137498,study,0,0
137499,compared,0,0
137500,the,0,0
137501,learning,0,1
137502,impact,0,0
137503,on,0,0
137504,senior,0,0
137505,medical,0,0
137506,students,0,0
137507,of,0,0
137508,a,0,0
137509,purpose-built,0,1
137510,e-learning,1,1
137511,module,1,1
137512,on,0,0
137513,leukaemia,0,0
137514,",",0,0
137515,compared,0,0
137516,with,0,0
137517,existing,1,0
137518,online,1,1
137519,resources,1,0
137520,.,1,0
137521,METHODS,0,0
137522,A,0,0
137523,randomised,0,0
137524,controlled,0,0
137525,trial,0,0
137526,was,0,0
137527,performed,0,0
137528,utilising,0,1
137529,volunteer,0,0
137530,senior,0,0
137531,medical,0,0
137532,students,0,0
137533,.,0,0
137534,Participants,0,0
137535,were,0,0
137536,randomly,0,0
137537,allocated,0,0
137538,to,0,0
137539,Study,0,0
137540,and,0,0
137541,Control,0,1
137542,groups,0,0
137543,.,0,0
137544,Following,0,0
137545,a,0,0
137546,pre-test,0,0
137547,on,0,0
137548,leukaemia,0,0
137549,administered,0,0
137550,to,0,0
137551,both,0,0
137552,groups,0,0
137553,",",0,0
137554,the,0,0
137555,Study,0,0
137556,group,0,0
137557,was,0,0
137558,provided,0,0
137559,with,0,0
137560,access,0,0
137561,to,0,0
137562,the,0,0
137563,new,1,0
137564,e-learning,1,1
137565,module,1,1
137566,",",0,0
137567,while,0,0
137568,the,0,0
137569,Control,0,1
137570,group,0,0
137571,was,0,0
137572,directed,1,0
137573,to,1,0
137574,existing,1,0
137575,online,1,1
137576,resources,1,0
137577,.,1,0
137578,A,0,0
137579,post-test,0,0
137580,and,0,0
137581,an,0,0
137582,evaluation,0,0
137583,questionnaire,0,0
137584,were,0,0
137585,administered,0,0
137586,to,0,0
137587,both,0,0
137588,groups,0,0
137589,at,0,0
137590,the,0,0
137591,end,0,0
137592,of,0,0
137593,the,0,0
137594,trial,0,0
137595,period,0,0
137596,.,0,0
137597,RESULTS,0,0
137598,Study,0,0
137599,and,0,0
137600,Control,0,1
137601,groups,0,0
137602,were,0,0
137603,equivalent,0,0
137604,in,0,0
137605,gender,0,0
137606,distribution,0,0
137607,",",0,0
137608,mean,0,0
137609,academic,0,0
137610,ability,0,0
137611,",",0,0
137612,pre-test,0,0
137613,performance,0,0
137614,and,0,0
137615,time,0,0
137616,studying,0,0
137617,leukaemia,0,0
137618,during,0,0
137619,the,0,0
137620,trial,0,0
137621,.,0,0
137622,The,0,0
137623,Study,0,0
137624,group,0,0
137625,performed,0,0
137626,significantly,0,0
137627,better,0,0
137628,than,0,0
137629,the,0,0
137630,Control,0,1
137631,group,0,0
137632,in,0,0
137633,the,0,0
137634,post-test,0,0
137635,",",0,0
137636,in,0,0
137637,which,0,0
137638,the,0,0
137639,group,0,0
137640,to,0,0
137641,which,0,0
137642,the,0,0
137643,students,0,0
137644,had,0,0
137645,been,0,0
137646,allocated,0,0
137647,was,0,0
137648,the,0,0
137649,only,0,0
137650,significant,0,0
137651,predictor,0,0
137652,of,0,0
137653,performance,0,0
137654,.,0,0
137655,The,0,0
137656,Study,0,0
137657,group,0,0
137658,'s,0,0
137659,evaluation,0,0
137660,of,0,0
137661,the,0,0
137662,module,0,1
137663,was,0,0
137664,overwhelmingly,0,0
137665,positive,0,0
137666,.,0,0
137667,CONCLUSIONS,0,0
137668,A,0,0
137669,targeted,0,1
137670,e-learning,1,1
137671,module,1,1
137672,on,0,0
137673,leukaemia,0,0
137674,had,0,0
137675,a,0,0
137676,significant,0,0
137677,effect,0,0
137678,on,0,0
137679,learning,0,1
137680,in,0,0
137681,this,0,0
137682,cohort,0,0
137683,",",0,0
137684,compared,0,0
137685,with,0,0
137686,existing,0,0
137687,online,0,1
137688,resources,0,0
137689,.,0,0
137690,We,0,0
137691,believe,0,0
137692,that,0,0
137693,the,0,0
137694,interactivity,0,0
137695,",",0,0
137696,dialogic,0,1
137697,feedback,0,1
137698,and,0,0
137699,integration,0,1
137700,with,0,0
137701,the,0,0
137702,curriculum,0,1
137703,offered,0,0
137704,by,0,0
137705,the,0,0
137706,e-learning,1,1
137707,module,1,1
137708,contributed,0,0
137709,to,0,0
137710,its,0,0
137711,impact,0,0
137712,.,0,0
137713,This,0,0
137714,has,0,0
137715,implications,0,0
137716,for,0,0
137717,e-learning,1,1
137718,design,0,0
137719,in,0,0
137720,medicine,0,1
137721,and,0,0
137722,other,0,0
137723,disciplines,0,0
137724,.,0,0
137725,Effectiveness,0,0
137726,of,0,0
137727,web-based,1,1
137728,tailored,1,1
137729,smoking,1,1
137730,cessation,1,1
137731,advice,0,1
137732,reports,0,0
137733,(,0,0
137734,iQuit,0,0
137735,),0,1
137736,:,0,0
137737,a,0,0
137738,randomized,0,0
137739,trial,0,0
137740,.,0,0
137741,AIMS,0,0
137742,To,0,0
137743,determine,0,0
137744,whether,0,0
137745,web-based,0,1
137746,tailored,0,1
137747,cessation,0,1
137748,advice,0,1
137749,",",0,0
137750,based,0,0
137751,on,0,0
137752,social,0,0
137753,cognitive,0,1
137754,theory,0,1
137755,and,0,0
137756,the,0,0
137757,perspectives,0,0
137758,on,0,0
137759,change,0,0
137760,model,0,0
137761,",",0,0
137762,was,0,0
137763,more,0,0
137764,effective,0,0
137765,in,0,0
137766,aiding,0,0
137767,a,0,0
137768,quit,0,0
137769,attempt,0,0
137770,than,0,0
137771,broadly,0,0
137772,similar,0,0
137773,web-based,0,1
137774,advice,0,1
137775,that,0,0
137776,was,0,0
137777,not,0,0
137778,tailored,0,1
137779,.,0,0
137780,DESIGN,0,0
137781,Participants,0,0
137782,were,0,0
137783,allocated,0,0
137784,randomly,0,0
137785,to,0,0
137786,one,0,0
137787,of,0,0
137788,two,0,0
137789,groups,0,0
137790,",",0,0
137791,to,1,0
137792,receive,1,0
137793,either,1,0
137794,a,1,0
137795,cessation,1,1
137796,advice,1,1
137797,report,1,0
137798,and,1,0
137799,progress,1,0
137800,report,1,0
137801,that,1,0
137802,were,1,0
137803,tailored,1,1
137804,to,1,0
137805,individual-level,1,0
137806,characteristics,1,0
137807,or,1,0
137808,a,1,0
137809,cessation,1,1
137810,advice,1,1
137811,report,1,0
137812,that,1,0
137813,presented,1,0
137814,standardized,1,1
137815,(,1,1
137816,non-tailored,1,1
137817,),1,1
137818,content,1,0
137819,.,1,0
137820,Tailoring,0,0
137821,was,0,0
137822,based,0,0
137823,on,0,0
137824,smoking-related,0,0
137825,beliefs,0,0
137826,",",0,0
137827,personal,0,1
137828,characteristics,0,0
137829,and,0,0
137830,smoking,0,0
137831,patterns,0,0
137832,",",0,0
137833,self-efficacy,0,0
137834,and,0,0
137835,outcome,0,0
137836,expectations,0,0
137837,.,0,0
137838,SETTING,0,0
137839,Participant,0,0
137840,enrolment,0,0
137841,and,0,0
137842,baseline,1,0
137843,assessments,1,0
137844,were,0,0
137845,conducted,0,0
137846,remotely,0,1
137847,online,0,1
137848,via,0,0
137849,the,0,0
137850,study,0,0
137851,website,0,1
137852,",",0,0
137853,with,0,0
137854,the,0,0
137855,advice,0,1
137856,reports,0,0
137857,presented,0,0
137858,by,0,0
137859,the,0,0
137860,same,0,0
137861,website,0,1
137862,.,0,0
137863,PARTICIPANTS,0,0
137864,Participants,0,0
137865,(,0,0
137866,n,0,0
137867,=,0,0
137868,1758,0,0
137869,),0,0
137870,were,0,0
137871,visitors,0,0
137872,to,0,0
137873,the,0,0
137874,QUIT,0,1
137875,website,0,1
137876,who,0,0
137877,were,0,0
137878,based,0,0
137879,in,0,0
137880,the,0,0
137881,United,0,0
137882,Kingdom,0,0
137883,",",0,0
137884,aged,0,0
137885,18,0,0
137886,years,0,0
137887,or,0,0
137888,over,0,0
137889,and,0,0
137890,who,0,0
137891,smoked,0,0
137892,cigarettes,0,1
137893,or,0,1
137894,hand-rolled,0,1
137895,tobacco,0,1
137896,.,0,0
137897,MEASUREMENTS,0,0
137898,Follow-up,0,0
137899,assessments,0,0
137900,were,0,0
137901,made,0,0
137902,at,0,0
137903,6,0,0
137904,months,0,0
137905,by,0,0
137906,telephone,0,1
137907,interview,0,0
137908,.,0,0
137909,The,0,0
137910,primary,0,0
137911,outcome,0,0
137912,measure,0,0
137913,was,0,0
137914,self-reported,0,0
137915,3,0,0
137916,months,0,0
137917,prolonged,0,0
137918,abstinence,0,0
137919,",",0,0
137920,and,0,0
137921,secondary,0,0
137922,outcomes,0,0
137923,were,0,0
137924,1,0,0
137925,month,0,0
137926,prolonged,0,0
137927,abstinence,0,0
137928,",",0,0
137929,7-day,0,0
137930,and,0,0
137931,24-hour,0,1
137932,point,0,0
137933,prevalence,0,0
137934,abstinence,0,0
137935,.,0,0
137936,FINDINGS,0,0
137937,The,0,0
137938,intervention,0,1
137939,group,0,0
137940,did,0,0
137941,not,0,0
137942,differ,0,0
137943,from,0,0
137944,the,0,0
137945,control,0,1
137946,group,0,0
137947,on,0,0
137948,the,0,0
137949,primary,0,0
137950,outcome,0,0
137951,(,0,0
137952,9.1,0,0
137953,%,0,0
137954,versus,0,1
137955,9.3,0,0
137956,%,0,0
137957,;,0,0
137958,odds,0,0
137959,ratio,0,0
137960,=,0,0
137961,1.02,0,0
137962,95,0,0
137963,%,0,0
137964,confidence,0,0
137965,interval,0,0
137966,0.73-1.42,0,0
137967,),0,1
137968,or,0,1
137969,on,0,0
137970,any,0,0
137971,of,0,0
137972,the,0,0
137973,secondary,0,0
137974,outcomes,0,0
137975,.,0,0
137976,Intervention,0,0
137977,participants,0,0
137978,gave,0,0
137979,more,0,0
137980,positive,0,0
137981,evaluations,0,0
137982,of,0,0
137983,the,0,0
137984,materials,0,1
137985,than,0,0
137986,control,0,0
137987,participants,0,0
137988,.,0,0
137989,CONCLUSIONS,0,0
137990,A,0,0
137991,web-based,0,1
137992,intervention,0,1
137993,that,0,0
137994,tailored,0,1
137995,content,0,0
137996,according,0,0
137997,to,0,0
137998,smoking-related,0,0
137999,beliefs,0,1
138000,",",0,0
138001,personal,0,1
138002,characteristics,0,0
138003,and,0,0
138004,smoking,0,0
138005,patterns,0,0
138006,",",0,0
138007,self-efficacy,0,0
138008,and,0,0
138009,outcome,0,0
138010,expectations,0,0
138011,",",0,0
138012,was,0,0
138013,not,0,0
138014,more,0,0
138015,effective,0,0
138016,than,0,0
138017,web-based,0,1
138018,materials,0,1
138019,presenting,0,0
138020,broadly,0,0
138021,similar,0,0
138022,non-tailored,0,1
138023,information,0,0
138024,.,0,0
138025,The,0,0
138026,effect,0,0
138027,of,0,0
138028,magnesium,1,1
138029,added,0,0
138030,to,0,0
138031,levobupivacaine,1,1
138032,for,0,0
138033,femoral,0,1
138034,nerve,0,1
138035,block,0,0
138036,on,0,0
138037,postoperative,0,0
138038,analgesia,0,0
138039,in,0,0
138040,patients,0,0
138041,undergoing,0,0
138042,ACL,0,1
138043,reconstruction,0,1
138044,.,0,0
138045,PURPOSE,0,0
138046,The,0,0
138047,aim,0,0
138048,of,0,0
138049,this,0,0
138050,prospective,0,0
138051,randomised,0,0
138052,double-blind,0,0
138053,study,0,0
138054,is,0,0
138055,to,0,0
138056,investigate,0,0
138057,the,0,0
138058,effect,0,0
138059,of,0,0
138060,magnesium,1,1
138061,added,0,0
138062,to,0,0
138063,local,0,0
138064,anaesthetics,0,1
138065,on,0,0
138066,postoperative,0,0
138067,VAS,0,1
138068,scores,0,0
138069,",",0,0
138070,total,0,0
138071,opioid,0,1
138072,consumption,0,0
138073,",",0,0
138074,time,0,0
138075,to,0,0
138076,first,0,0
138077,mobilisation,0,1
138078,",",0,0
138079,patient,0,0
138080,satisfaction,0,0
138081,and,0,0
138082,rescue,0,0
138083,analgesic,0,1
138084,requirements,0,0
138085,in,0,0
138086,arthroscopic,0,1
138087,ACL,0,1
138088,reconstruction,0,1
138089,surgery,0,1
138090,.,0,0
138091,METHODS,0,0
138092,A,0,0
138093,total,0,0
138094,of,0,0
138095,107,0,0
138096,American,0,0
138097,Society,0,0
138098,of,0,0
138099,Anaesthesiologists,0,0
138100,physical,0,1
138101,status,0,0
138102,grade,0,0
138103,I,0,0
138104,and,0,0
138105,II,0,0
138106,patients,0,0
138107,between,0,0
138108,18,0,0
138109,and,0,0
138110,65,0,0
138111,years,0,0
138112,of,0,0
138113,age,0,0
138114,who,0,0
138115,were,0,0
138116,scheduled,0,0
138117,to,0,0
138118,undergo,0,0
138119,elective,0,0
138120,anterior,0,0
138121,crucial,0,0
138122,ligament,0,1
138123,(,0,1
138124,ACL,0,1
138125,),0,1
138126,reconstruction,0,1
138127,with,0,0
138128,hamstring,0,1
138129,autografts,0,1
138130,were,0,0
138131,enrolled,0,0
138132,in,0,0
138133,the,0,0
138134,study,0,0
138135,.,0,0
138136,The,0,0
138137,patients,0,0
138138,were,0,0
138139,randomly,0,0
138140,allocated,0,0
138141,to,0,0
138142,Groups,0,1
138143,L,0,1
138144,(,0,0
138145,n,0,0
138146,=,0,0
138147,51,0,0
138148,),0,0
138149,and,0,0
138150,LM,0,1
138151,(,0,1
138152,n,0,0
138153,=,0,0
138154,56,0,0
138155,),0,0
138156,using,0,0
138157,the,0,0
138158,closed-envelope,0,1
138159,method,0,0
138160,.,0,0
138161,Group,0,0
138162,LM,0,0
138163,was,0,0
138164,administered,0,0
138165,19,0,0
138166,ml,0,0
138167,of,0,0
138168,0.25,1,1
138169,%,1,0
138170,levobupivacaine,1,1
138171,and,1,0
138172,1,1,0
138173,ml,1,0
138174,of,1,0
138175,15,1,0
138176,%,1,0
138177,magnesium,1,1
138178,sulphate,1,1
138179,",",0,0
138180,while,0,0
138181,Group,1,0
138182,L,1,1
138183,was,1,0
138184,administered,1,0
138185,20,1,0
138186,ml,1,0
138187,of,1,0
138188,0.25,1,1
138189,%,1,0
138190,levobupivacaine,1,1
138191,for,0,0
138192,femoral,0,1
138193,blockade,0,0
138194,.,0,0
138195,General,0,0
138196,anaesthesia,0,1
138197,was,0,0
138198,administered,0,0
138199,using,0,0
138200,laryngeal,0,0
138201,airway,0,0
138202,masks,0,1
138203,following,0,0
138204,neural,0,0
138205,blockade,0,1
138206,in,0,0
138207,both,0,0
138208,groups,0,0
138209,.,0,0
138210,The,0,0
138211,patients,0,0
138212,were,0,0
138213,evaluated,0,0
138214,for,0,0
138215,heart,0,0
138216,rate,0,0
138217,and,0,0
138218,mean,0,0
138219,arterial,0,0
138220,pressure,0,0
138221,",",0,0
138222,oxygen,0,1
138223,saturation,0,0
138224,",",0,0
138225,visual,0,0
138226,analogue,0,1
138227,score,0,0
138228,(,0,1
138229,VAS,0,1
138230,),0,1
138231,",",0,0
138232,verbal,0,1
138233,rating,0,1
138234,scale,0,0
138235,(,0,1
138236,VRS,0,1
138237,),0,1
138238,",",0,0
138239,rescue,0,0
138240,analgesic,0,1
138241,requirements,0,0
138242,",",0,0
138243,total,0,0
138244,opioid,0,1
138245,consumption,0,0
138246,",",0,0
138247,side,0,0
138248,effects,0,0
138249,and,0,0
138250,time,0,0
138251,to,0,0
138252,first,0,0
138253,mobilisation,0,1
138254,at,0,0
138255,the,0,0
138256,1st,0,0
138257,",",0,0
138258,2nd,0,0
138259,",",0,0
138260,4th,0,0
138261,",",0,0
138262,6th,0,0
138263,",",0,0
138264,12th,0,0
138265,and,0,0
138266,24th,0,0
138267,hours,0,0
138268,postoperatively,0,0
138269,.,0,0
138270,RESULTS,0,0
138271,There,0,0
138272,was,0,0
138273,no,0,0
138274,statistically,0,0
138275,significant,0,0
138276,difference,0,0
138277,in,0,0
138278,terms,0,0
138279,of,0,0
138280,demographic,0,0
138281,data,0,0
138282,",",0,0
138283,mean,0,0
138284,arterial,0,0
138285,pressure,0,0
138286,",",0,0
138287,heart,0,0
138288,rate,0,0
138289,or,0,1
138290,oxygen,0,1
138291,saturation,0,0
138292,between,0,0
138293,groups,0,0
138294,.,0,0
138295,The,0,0
138296,area,0,0
138297,under,0,0
138298,the,0,0
138299,curve,0,0
138300,VAS,0,1
138301,and,0,0
138302,VRS,0,1
138303,scores,0,0
138304,were,0,0
138305,lower,0,0
138306,at,0,0
138307,4,0,0
138308,",",0,0
138309,6,0,0
138310,",",0,0
138311,12,0,0
138312,and,0,0
138313,24,0,0
138314,h,0,0
138315,in,0,0
138316,Group,0,0
138317,LM,0,1
138318,(,0,0
138319,p,0,0
138320,=,0,0
138321,0.001,0,0
138322,",",0,0
138323,p,0,0
138324,=,0,0
138325,0.016,0,0
138326,",",0,0
138327,respectively,0,0
138328,),0,0
138329,.,0,0
138330,The,0,0
138331,rescue,0,0
138332,analgesic,0,1
138333,requirement,0,0
138334,and,0,0
138335,the,0,0
138336,total,0,0
138337,opioid,0,1
138338,consumption,0,0
138339,were,0,0
138340,significantly,0,0
138341,lower,0,0
138342,in,0,0
138343,Group,0,0
138344,LM,0,1
138345,(,0,0
138346,p,0,0
138347,=,0,0
138348,0.015,0,0
138349,",",0,0
138350,p,0,0
138351,=,0,0
138352,0.019,0,0
138353,",",0,0
138354,respectively,0,0
138355,),0,0
138356,.,0,0
138357,The,0,0
138358,time,0,0
138359,to,0,0
138360,first,0,0
138361,mobilisation,0,1
138362,and,0,0
138363,the,0,0
138364,Likert,0,0
138365,score,0,0
138366,(,0,0
138367,completely,0,0
138368,comfortable,0,1
138369,;,0,0
138370,quite,0,0
138371,comfortable,0,0
138372,;,0,0
138373,slight,0,0
138374,discomfort,0,0
138375,;,0,0
138376,painful,0,0
138377,;,0,0
138378,very,0,0
138379,painful,0,0
138380,),0,0
138381,were,0,0
138382,higher,0,0
138383,",",0,0
138384,and,0,0
138385,the,0,0
138386,block,0,0
138387,onset,0,0
138388,time,0,0
138389,was,0,0
138390,lower,0,0
138391,in,0,0
138392,Group,0,0
138393,LM,0,1
138394,(,0,0
138395,p,0,0
138396,=,0,0
138397,0.014,0,0
138398,and,0,0
138399,p,0,0
138400,=,0,0
138401,0.012,0,0
138402,",",0,0
138403,respectively,0,0
138404,),0,0
138405,.,0,0
138406,There,0,0
138407,was,0,0
138408,no,0,0
138409,difference,0,0
138410,in,0,0
138411,terms,0,0
138412,of,0,0
138413,side,0,0
138414,effects,0,0
138415,.,0,0
138416,CONCLUSIONS,0,0
138417,The,0,0
138418,addition,0,0
138419,of,0,0
138420,magnesium,1,1
138421,to,0,0
138422,levobupivacaine,0,1
138423,prolongs,0,0
138424,the,0,0
138425,sensory,0,1
138426,and,0,0
138427,motor,0,1
138428,block,0,1
138429,duration,0,0
138430,without,0,1
138431,increasing,0,0
138432,side,0,0
138433,effects,0,0
138434,",",0,0
138435,enhances,0,0
138436,the,0,0
138437,quality,0,0
138438,of,0,0
138439,postoperative,0,0
138440,analgesia,0,0
138441,and,0,0
138442,increases,0,0
138443,patient,0,0
138444,satisfaction,0,0
138445,;,0,0
138446,however,0,0
138447,",",0,0
138448,the,0,0
138449,addition,0,0
138450,of,0,0
138451,magnesium,0,1
138452,delays,0,0
138453,the,0,0
138454,time,0,0
138455,to,0,0
138456,first,0,0
138457,mobilisation,0,1
138458,and,0,1
138459,decreases,0,0
138460,rescue,0,0
138461,analgesic,0,0
138462,requirements,0,0
138463,.,0,0
138464,Comparing,0,0
138465,microvascular,0,0
138466,alterations,0,0
138467,during,0,0
138468,minimal,0,0
138469,extracorporeal,1,1
138470,circulation,1,0
138471,and,0,0
138472,conventional,0,1
138473,cardiopulmonary,1,1
138474,bypass,1,1
138475,in,0,0
138476,coronary,1,0
138477,artery,1,0
138478,bypass,1,1
138479,graft,1,1
138480,surgery,1,1
138481,:,1,0
138482,a,0,0
138483,prospective,0,0
138484,",",0,0
138485,randomized,0,0
138486,study,0,0
138487,.,0,0
138488,OBJECTIVES,0,0
138489,Minimal,1,1
138490,extracorporeal,1,1
138491,circulation,1,0
138492,(,1,1
138493,MECC,1,1
138494,),1,1
138495,has,0,0
138496,been,0,0
138497,introduced,0,0
138498,in,0,0
138499,coronary,1,0
138500,artery,1,0
138501,bypass,1,1
138502,graft,1,1
138503,(,1,1
138504,CABG,1,0
138505,),1,1
138506,surgery,1,1
138507,",",0,0
138508,offering,0,0
138509,clinical,0,0
138510,benefits,0,0
138511,owing,0,0
138512,to,0,0
138513,reduced,0,0
138514,hemodilution,0,1
138515,and,0,0
138516,no,0,0
138517,blood-air,0,1
138518,interface,0,0
138519,.,0,0
138520,Yet,0,0
138521,",",0,0
138522,the,0,0
138523,effects,0,0
138524,of,0,0
138525,MECC,1,0
138526,on,0,0
138527,the,0,0
138528,intraoperative,0,1
138529,microvascular,0,0
138530,perfusion,0,0
138531,in,0,0
138532,comparison,0,0
138533,with,0,0
138534,conventional,1,1
138535,extracorporeal,1,1
138536,circulation,1,0
138537,(,1,1
138538,CECC,1,1
138539,),1,1
138540,have,0,0
138541,not,0,0
138542,been,0,0
138543,studied,0,0
138544,so,0,0
138545,far,0,0
138546,.,0,0
138547,METHODS,0,0
138548,The,0,0
138549,current,0,0
138550,study,0,0
138551,aimed,0,0
138552,to,0,0
138553,analyze,0,0
138554,alterations,0,0
138555,in,0,0
138556,microvascular,0,0
138557,perfusion,0,0
138558,at,0,0
138559,4,0,0
138560,predefined,0,0
138561,time,0,0
138562,points,0,0
138563,(,0,0
138564,T1-T4,0,1
138565,),0,1
138566,during,0,0
138567,on-pump,0,1
138568,CABG,0,0
138569,using,0,0
138570,orthogonal,0,1
138571,polarization,0,0
138572,spectral,0,0
138573,imaging,0,0
138574,.,0,0
138575,Forty,0,0
138576,patients,0,0
138577,were,0,0
138578,randomized,0,0
138579,for,0,0
138580,being,0,0
138581,operated,0,0
138582,on,0,0
138583,with,0,0
138584,either,0,1
138585,MECC,1,1
138586,or,1,1
138587,CECC,1,1
138588,.,1,0
138589,Changes,0,0
138590,in,0,0
138591,functional,0,0
138592,capillary,0,1
138593,density,0,0
138594,(,0,1
138595,FCD,0,1
138596,),0,1
138597,",",0,0
138598,blood,0,0
138599,flow,0,0
138600,velocity,0,0
138601,",",0,0
138602,and,0,0
138603,vessel,0,0
138604,diameter,0,0
138605,were,0,0
138606,analyzed,0,0
138607,by,0,0
138608,a,0,0
138609,blinded,0,0
138610,investigator,0,0
138611,.,0,0
138612,RESULTS,0,0
138613,After,0,0
138614,start,0,0
138615,of,0,0
138616,extracorporeal,0,1
138617,circulation,0,0
138618,(,0,1
138619,ECC,0,1
138620,),0,1
138621,and,0,0
138622,aortic,0,0
138623,crossclamping,0,1
138624,(,0,1
138625,T2,0,1
138626,),0,0
138627,",",0,0
138628,both,0,0
138629,groups,0,0
138630,showed,0,0
138631,a,0,0
138632,significant,0,0
138633,drop,0,0
138634,of,0,0
138635,FCD,0,0
138636,",",0,0
138637,with,0,0
138638,a,0,0
138639,significantly,0,0
138640,higher,0,0
138641,FCD,0,0
138642,in,0,0
138643,the,0,0
138644,MECC,0,1
138645,group,0,0
138646,(,0,0
138647,206.8,0,0
138648,?,0,0
138649,33.6,0,0
138650,cm/cm?,0,0
138651,in,0,0
138652,CECC,0,1
138653,group,0,0
138654,versus,0,0
138655,217.8,0,0
138656,?,0,0
138657,35.3,0,0
138658,cm/cm?,0,0
138659,in,0,0
138660,MECC,0,1
138661,group,0,0
138662,;,0,0
138663,P,0,0
138664,=,0,0
138665,.034,0,0
138666,),0,0
138667,.,0,0
138668,In,0,0
138669,the,0,0
138670,late,0,0
138671,phase,0,0
138672,of,0,0
138673,the,0,0
138674,ECC,0,0
138675,(,0,1
138676,T3,0,1
138677,),0,0
138678,",",0,0
138679,FCD,0,0
138680,in,0,0
138681,the,0,0
138682,MECC,0,1
138683,group,0,0
138684,was,0,0
138685,already,0,0
138686,recovered,0,0
138687,",",0,0
138688,whereas,0,0
138689,FCD,0,0
138690,in,0,0
138691,the,0,0
138692,CECC,0,1
138693,group,0,0
138694,was,0,0
138695,still,0,0
138696,significantly,0,0
138697,depressed,0,0
138698,(,0,0
138699,223.1,0,0
138700,?,0,0
138701,35.6,0,0
138702,cm/cm?,0,0
138703,in,0,0
138704,MECC,0,1
138705,group,0,0
138706,;,0,0
138707,P,0,0
138708,=,0,0
138709,.100,0,0
138710,vs,0,0
138711,T1,0,1
138712,;,0,0
138713,211.1,0,0
138714,?,0,0
138715,36.9,0,0
138716,cm/cm?,0,0
138717,in,0,0
138718,CECC,0,1
138719,group,0,0
138720,;,0,0
138721,P,0,0
138722,=,0,0
138723,.017,0,0
138724,vs,0,0
138725,T1,0,1
138726,),0,0
138727,.,0,0
138728,After,0,0
138729,termination,0,0
138730,of,0,0
138731,ECC,0,0
138732,(,0,1
138733,T4,0,0
138734,),0,0
138735,",",0,0
138736,FCD,0,0
138737,recovered,0,0
138738,in,0,0
138739,both,0,0
138740,groups,0,0
138741,to,0,0
138742,baseline,0,0
138743,.,0,0
138744,Blood,0,0
138745,flow,0,0
138746,velocity,0,0
138747,tended,0,0
138748,to,0,0
138749,be,0,0
138750,higher,0,0
138751,in,0,0
138752,the,0,0
138753,MECC,0,1
138754,group,0,0
138755,",",0,0
138756,with,0,0
138757,a,0,0
138758,significant,0,0
138759,intergroup,0,0
138760,difference,0,0
138761,after,0,0
138762,aortic,0,0
138763,crossclamping,0,1
138764,(,0,1
138765,T2,0,0
138766,),0,0
138767,.,0,0
138768,CONCLUSIONS,0,0
138769,Orthogonal,0,1
138770,polarization,0,0
138771,spectral,0,0
138772,imaging,0,0
138773,data,0,0
138774,reveal,0,0
138775,an,0,0
138776,impairment,0,0
138777,of,0,0
138778,microvascular,0,0
138779,perfusion,0,0
138780,during,0,0
138781,on-pump,0,0
138782,CABG,0,0
138783,.,0,0
138784,Changes,0,0
138785,in,0,0
138786,FCD,0,0
138787,indicate,0,0
138788,a,0,0
138789,faster,0,0
138790,recovery,0,0
138791,of,0,0
138792,the,0,0
138793,microvascular,0,0
138794,perfusion,0,0
138795,in,0,0
138796,MECC,0,1
138797,during,0,0
138798,the,0,0
138799,reperfusion,0,1
138800,period,0,0
138801,.,0,0
138802,Beneficial,0,0
138803,recovery,0,0
138804,of,0,0
138805,microvascular,0,0
138806,organ,0,0
138807,perfusion,0,0
138808,could,0,0
138809,partly,0,0
138810,explain,0,0
138811,the,0,0
138812,perioperative,0,0
138813,advantages,0,0
138814,reported,0,0
138815,for,0,0
138816,MECC,0,0
138817,.,0,0
138818,Rationale,0,0
138819,and,0,0
138820,study,0,0
138821,design,0,0
138822,of,0,0
138823,the,0,0
138824,increase,0,0
138825,of,0,0
138826,vagal,0,0
138827,tone,0,1
138828,in,0,0
138829,heart,0,0
138830,failure,0,0
138831,study,0,0
138832,:,0,0
138833,INOVATE-HF,0,0
138834,.,0,0
138835,BACKGROUND,0,0
138836,Imbalance,0,0
138837,between,0,0
138838,the,0,0
138839,parasympathetic,0,0
138840,and,0,0
138841,sympathetic,0,1
138842,nervous,0,0
138843,systems,0,0
138844,is,0,0
138845,a,0,0
138846,recognized,0,0
138847,contributor,0,0
138848,to,0,0
138849,progression,0,0
138850,of,0,0
138851,chronic,0,0
138852,heart,0,0
138853,failure,0,0
138854,.,0,0
138855,Current,0,0
138856,therapy,0,1
138857,with,0,0
138858,beta,0,0
138859,adrenergic,0,1
138860,antagonists,0,1
138861,is,0,0
138862,designed,0,0
138863,to,0,0
138864,moderate,0,0
138865,the,0,0
138866,up-regulation,0,0
138867,of,0,0
138868,norepinephrine,0,1
138869,and,0,0
138870,sympathetic,0,1
138871,effects,0,0
138872,;,0,0
138873,however,0,0
138874,",",0,0
138875,to,0,0
138876,date,0,0
138877,",",0,0
138878,there,0,0
138879,are,0,0
138880,no,0,0
138881,therapies,0,0
138882,that,0,0
138883,specifically,0,0
138884,address,0,0
138885,the,0,0
138886,withdrawal,0,0
138887,of,0,0
138888,parasympathetic,0,0
138889,influences,0,0
138890,on,0,0
138891,cardiac,0,0
138892,function,0,0
138893,and,0,0
138894,structure,0,0
138895,.,0,0
138896,METHODS/RESULTS,0,0
138897,In,0,0
138898,order,0,0
138899,to,0,0
138900,evaluate,0,0
138901,the,0,0
138902,impact,0,0
138903,of,0,0
138904,vagus,0,0
138905,nerve,0,1
138906,stimulation,0,1
138907,",",0,0
138908,an,0,0
138909,international,0,0
138910,multi-center,0,0
138911,randomized,0,0
138912,clinical,0,0
138913,trial,0,0
138914,(,0,1
138915,INOVATE-HF,0,1
138916,),0,1
138917,has,0,0
138918,been,0,0
138919,designed,0,0
138920,to,0,0
138921,assess,0,0
138922,safety,0,0
138923,and,0,0
138924,efficacy,0,0
138925,of,0,0
138926,vagus,0,0
138927,nerve,0,1
138928,stimulation,0,1
138929,in,0,0
138930,symptomatic,0,0
138931,patients,0,0
138932,with,0,0
138933,heart,0,0
138934,failure,0,0
138935,on,0,0
138936,optimal,0,0
138937,medical,0,1
138938,therapy,0,1
138939,using,0,0
138940,the,0,0
138941,CardioFit,1,1
138942,System,1,1
138943,(,0,0
138944,BioControl,0,1
138945,Medical,0,1
138946,",",0,0
138947,Yehud,0,1
138948,",",0,0
138949,Israel,0,1
138950,),0,0
138951,.,0,0
138952,Up,0,0
138953,to,0,0
138954,650,0,0
138955,patients,0,0
138956,from,0,0
138957,80,0,0
138958,sites,0,0
138959,will,0,0
138960,be,0,0
138961,recruited,0,0
138962,and,0,0
138963,randomized,0,0
138964,in,0,0
138965,a,0,0
138966,3:2,0,0
138967,ratio,0,0
138968,to,0,0
138969,receive,0,1
138970,active,0,1
138971,treatment,0,1
138972,or,0,1
138973,standard,1,1
138974,optimal,1,0
138975,medical,1,0
138976,therapy,1,1
138977,.,1,0
138978,Inclusion,0,0
138979,criteria,0,0
138980,include,0,0
138981,left,0,0
138982,ventricular,0,0
138983,systolic,0,0
138984,dysfunction,0,0
138985,",",0,0
138986,the,0,0
138987,presence,0,0
138988,of,0,0
138989,New,0,1
138990,York,0,1
138991,Heart,0,1
138992,Association,0,0
138993,Class,0,0
138994,III,0,0
138995,symptoms,0,0
138996,",",0,0
138997,sinus,0,0
138998,rhythm,0,1
138999,",",0,0
139000,and,0,0
139001,QRS,0,0
139002,width,0,0
139003,less,0,0
139004,than,0,0
139005,120,0,0
139006,milliseconds,0,0
139007,.,0,0
139008,The,0,0
139009,study,0,0
139010,is,0,0
139011,powered,0,0
139012,to,0,0
139013,detect,0,0
139014,differences,0,0
139015,in,0,0
139016,the,0,0
139017,primary,0,0
139018,efficacy,0,0
139019,end,0,0
139020,point,0,0
139021,of,0,0
139022,all-cause,0,0
139023,mortality,0,0
139024,and,0,0
139025,heart,0,0
139026,failure,0,0
139027,hospitalization,0,0
139028,and,0,0
139029,2,0,0
139030,safety,0,0
139031,end,0,0
139032,points,0,0
139033,.,0,0
139034,CONCLUSION,0,0
139035,Vagal,0,1
139036,nerve,0,1
139037,stimulation,0,1
139038,with,0,0
139039,CardioFit,1,1
139040,as,0,0
139041,a,0,0
139042,treatment,0,0
139043,for,0,0
139044,symptomatic,0,0
139045,heart,0,0
139046,failure,0,0
139047,is,0,0
139048,under,0,0
139049,active,0,0
139050,investigation,0,0
139051,as,0,0
139052,a,0,0
139053,novel,0,0
139054,approach,0,1
139055,to,0,0
139056,restore,0,0
139057,balance,0,0
139058,between,0,0
139059,the,0,0
139060,sympathetic,0,1
139061,and,0,0
139062,parasympathetic,0,0
139063,nervous,0,0
139064,systems,0,0
139065,.,0,0
139066,If,0,0
139067,shown,0,0
139068,to,0,0
139069,be,0,0
139070,safe,0,0
139071,and,0,0
139072,effective,0,0
139073,in,0,0
139074,decreasing,0,0
139075,heart,0,0
139076,failure,0,0
139077,events,0,0
139078,and,0,0
139079,mortality,0,0
139080,",",0,0
139081,this,0,0
139082,novel,0,0
139083,approach,0,1
139084,will,0,0
139085,impact,0,0
139086,the,0,0
139087,treatment,0,0
139088,paradigm,0,1
139089,for,0,0
139090,heart,0,0
139091,failure,0,0
139092,.,0,0
139093,Dietary,0,1
139094,patterns,0,0
139095,differ,0,0
139096,between,0,0
139097,urban,0,0
139098,and,0,0
139099,rural,0,0
139100,older,0,0
139101,",",0,0
139102,long-term,0,0
139103,survivors,0,0
139104,of,0,0
139105,breast,0,0
139106,",",0,0
139107,prostate,0,0
139108,",",0,0
139109,and,0,0
139110,colorectal,0,0
139111,cancer,0,0
139112,and,0,0
139113,are,0,0
139114,associated,0,0
139115,with,0,0
139116,body,0,0
139117,mass,0,0
139118,index,0,0
139119,.,0,0
139120,BACKGROUND,0,0
139121,Older,0,1
139122,adult,0,0
139123,cancer,0,0
139124,survivors,0,0
139125,are,0,0
139126,at,0,0
139127,greater,0,0
139128,risk,0,0
139129,of,0,0
139130,cancer,0,0
139131,recurrence,0,0
139132,and,0,0
139133,other,0,0
139134,comorbidities,0,0
139135,that,0,0
139136,can,0,0
139137,be,0,0
139138,prevented,0,0
139139,through,0,0
139140,improved,0,0
139141,diet,0,1
139142,and,0,0
139143,weight,0,0
139144,management,0,1
139145,.,0,0
139146,The,0,0
139147,tertiary,0,0
139148,prevention,0,0
139149,needs,0,0
139150,of,0,0
139151,rural-dwelling,0,0
139152,survivors,0,0
139153,can,0,0
139154,be,0,0
139155,even,0,0
139156,greater,0,0
139157,",",0,0
139158,yet,0,0
139159,little,0,0
139160,is,0,0
139161,known,0,0
139162,about,0,0
139163,rural,0,0
139164,and,0,0
139165,urban,0,0
139166,differences,0,0
139167,in,0,0
139168,lifestyle,0,1
139169,factors,0,0
139170,among,0,0
139171,this,0,0
139172,high-risk,0,0
139173,population,0,0
139174,.,0,0
139175,OBJECTIVES,0,0
139176,To,0,0
139177,compare,1,0
139178,dietary,1,1
139179,patterns,1,0
139180,of,0,0
139181,urban,0,0
139182,and,0,0
139183,rural,0,0
139184,cancer,0,0
139185,survivors,0,0
139186,and,0,0
139187,to,0,0
139188,examine,0,0
139189,associations,0,0
139190,of,0,0
139191,dietary,0,0
139192,patterns,0,0
139193,with,0,0
139194,body,0,0
139195,mass,0,0
139196,index,0,0
139197,(,0,1
139198,BMI,0,1
139199,),0,0
139200,.,0,0
139201,DESIGN,0,0
139202,A,0,0
139203,secondary,0,0
139204,analysis,0,0
139205,was,0,0
139206,performed,0,0
139207,of,0,0
139208,baseline,0,0
139209,data,0,0
139210,from,0,0
139211,the,0,0
139212,Reach,0,0
139213,Out,0,1
139214,to,0,0
139215,Enhance,0,1
139216,Wellness,0,0
139217,(,0,1
139218,RENEW,0,1
139219,),0,1
139220,trial,0,0
139221,",",0,0
139222,a,0,0
139223,diet,1,1
139224,and,1,0
139225,exercise,1,1
139226,intervention,1,1
139227,among,0,0
139228,overweight,0,0
139229,",",0,0
139230,long-term,0,0
139231,(,0,0
139232,?5,0,1
139233,years,0,0
139234,),0,0
139235,",",0,0
139236,older,0,0
139237,survivors,0,0
139238,of,0,0
139239,colorectal,0,0
139240,",",0,0
139241,breast,0,0
139242,",",0,0
139243,and,0,0
139244,prostate,0,0
139245,cancer,0,0
139246,.,0,0
139247,Survivors,0,0
139248,in,0,0
139249,the,0,0
139250,present,0,0
139251,analysis,0,0
139252,(,0,1
139253,n=729,0,1
139254,),0,1
139255,underwent,1,0
139256,two,1,0
139257,45-,1,0
139258,to,1,0
139259,60-minute,1,1
139260,telephone,1,1
139261,surveys,1,0
139262,",",1,0
139263,which,1,0
139264,included,1,0
139265,two,1,0
139266,24-hour,1,0
139267,dietary,1,0
139268,recalls,1,0
139269,.,1,0
139270,Principal,1,0
139271,components,1,0
139272,analysis,1,0
139273,and,1,0
139274,multivariable,1,0
139275,general,1,0
139276,linear,1,0
139277,models,1,0
139278,were,1,0
139279,used,0,0
139280,to,0,0
139281,derive,0,0
139282,dietary,0,1
139283,patterns,0,0
139284,and,0,0
139285,to,0,0
139286,evaluate,0,0
139287,associations,0,0
139288,between,0,0
139289,dietary,0,1
139290,patterns,0,0
139291,and,0,0
139292,BMI,0,0
139293,",",0,0
139294,respectively,0,0
139295,.,0,0
139296,RESULTS,0,0
139297,Principal,0,0
139298,components,0,0
139299,analysis,0,0
139300,identified,0,0
139301,three,0,0
139302,primary,0,0
139303,dietary,0,0
139304,patterns,0,0
139305,among,0,0
139306,rural,0,0
139307,dwellers,0,0
139308,(,0,0
139309,high,0,0
139310,sweets,0,1
139311,and,0,0
139312,starches,0,1
139313,",",0,0
139314,high,0,0
139315,reduced-fat,0,1
139316,dairy,0,0
139317,",",0,0
139318,cereal,0,1
139319,",",0,0
139320,nuts,0,1
139321,",",0,0
139322,and,0,0
139323,fruits,0,1
139324,",",0,0
139325,and,0,0
139326,mixed,0,1
139327,),0,1
139328,and,0,0
139329,three,0,0
139330,among,0,0
139331,urban,0,0
139332,dwellers,0,0
139333,(,0,0
139334,high,0,0
139335,fruits,0,1
139336,and,0,0
139337,vegetables,0,1
139338,",",0,0
139339,high,0,0
139340,meat,0,0
139341,and,0,0
139342,refined,0,0
139343,grains,0,1
139344,",",0,0
139345,and,0,0
139346,high,0,0
139347,sugar-sweetened,0,1
139348,beverages,0,1
139349,),0,0
139350,.,0,0
139351,Among,0,0
139352,rural,0,0
139353,survivors,0,0
139354,",",0,0
139355,greater,0,0
139356,adherence,0,0
139357,to,0,0
139358,the,0,0
139359,high,0,0
139360,reduced-fat,0,1
139361,dairy,0,0
139362,",",0,0
139363,cereal,0,1
139364,",",0,0
139365,nuts,0,1
139366,",",0,0
139367,and,0,0
139368,fruits,0,1
139369,pattern,0,0
139370,was,0,0
139371,positively,0,0
139372,associated,0,0
139373,with,0,0
139374,lower,0,0
139375,BMI,0,0
139376,(,0,0
139377,P,0,0
139378,trend,0,0
139379,<,0,0
139380,0.05,0,0
139381,),0,0
139382,",",0,0
139383,whereas,0,0
139384,higher,0,0
139385,scores,0,0
139386,on,0,0
139387,the,0,0
139388,mixed,0,1
139389,pattern,0,0
139390,was,0,0
139391,associated,0,0
139392,with,0,0
139393,greater,0,0
139394,BMI,0,0
139395,(,0,0
139396,P,0,0
139397,trend,0,0
139398,<,0,0
139399,0.05,0,0
139400,),0,0
139401,.,0,0
139402,Greater,0,0
139403,adherence,0,0
139404,to,0,0
139405,the,0,0
139406,high,0,0
139407,fruits,0,1
139408,and,0,0
139409,vegetables,0,1
139410,pattern,0,0
139411,among,0,0
139412,urban,0,0
139413,survivors,0,0
139414,was,0,0
139415,inversely,0,0
139416,associated,0,0
139417,with,0,0
139418,BMI,0,1
139419,(,0,1
139420,P,0,0
139421,trend,0,0
139422,<,0,0
139423,0.05,0,0
139424,),0,0
139425,.,0,0
139426,CONCLUSIONS,0,0
139427,Urban,0,0
139428,and,0,0
139429,rural,0,0
139430,differences,0,0
139431,in,0,0
139432,dietary,0,1
139433,intake,0,0
139434,behavior,0,0
139435,should,0,0
139436,be,0,0
139437,considered,0,0
139438,in,0,0
139439,designing,0,0
139440,public,0,0
139441,health,0,0
139442,interventions,0,1
139443,among,0,0
139444,the,0,0
139445,increasing,0,0
139446,population,0,0
139447,of,0,0
139448,older,0,0
139449,cancer,0,0
139450,survivors,0,0
139451,.,0,0
139452,In,0,0
139453,addition,0,0
139454,",",0,0
139455,targeting,0,0
139456,overall,0,0
139457,dietary,0,1
139458,patterns,0,0
139459,might,0,0
139460,be,0,0
139461,one,0,0
139462,approach,0,1
139463,to,0,0
139464,help,0,0
139465,reduce,0,0
139466,the,0,0
139467,burden,0,0
139468,of,0,0
139469,obesity,0,0
139470,among,0,0
139471,this,0,0
139472,population,0,0
139473,.,0,0
139474,Parent-implemented,1,1
139475,enhanced,1,0
139476,milieu,1,1
139477,teaching,1,1
139478,with,0,0
139479,preschool,0,0
139480,children,0,0
139481,who,0,0
139482,have,0,0
139483,intellectual,0,0
139484,disabilities,0,0
139485,.,0,0
139486,PURPOSE,0,0
139487,The,0,0
139488,purpose,0,0
139489,of,0,0
139490,this,0,0
139491,study,0,0
139492,was,0,0
139493,to,0,0
139494,compare,0,0
139495,the,0,0
139496,effects,0,0
139497,of,0,0
139498,enhanced,1,0
139499,milieu,1,1
139500,teaching,1,1
139501,(,1,1
139502,EMT,1,0
139503,),1,1
139504,implemented,0,0
139505,by,0,0
139506,parents,0,0
139507,and,0,0
139508,therapists,0,0
139509,versus,0,1
139510,therapists,0,0
139511,only,0,0
139512,on,0,0
139513,the,0,0
139514,language,0,0
139515,skills,0,0
139516,of,0,0
139517,preschool,0,0
139518,children,0,0
139519,with,0,0
139520,intellectual,0,0
139521,disabilities,0,0
139522,(,0,0
139523,IDs,0,1
139524,),0,1
139525,",",0,0
139526,including,0,0
139527,children,0,0
139528,with,0,0
139529,Down,0,0
139530,syndrome,0,0
139531,and,0,0
139532,children,0,0
139533,with,0,0
139534,autism,0,0
139535,spectrum,0,0
139536,disorders,0,0
139537,.,0,0
139538,METHOD,0,0
139539,Seventy-seven,0,0
139540,children,0,0
139541,were,0,0
139542,randomly,0,0
139543,assigned,0,0
139544,to,0,0
139545,2,0,0
139546,treatments,0,1
139547,(,1,0
139548,parent,1,1
139549,+,1,1
139550,therapist,1,1
139551,EMT,1,0
139552,or,0,1
139553,therapist-only,1,1
139554,EMT,1,0
139555,),1,1
139556,and,0,0
139557,received,0,1
139558,36,0,0
139559,intervention,0,1
139560,sessions,0,1
139561,.,0,0
139562,Children,0,0
139563,were,0,0
139564,assessed,0,0
139565,before,0,0
139566,",",0,0
139567,immediately,0,0
139568,after,0,0
139569,",",0,0
139570,6,0,0
139571,months,0,0
139572,after,0,0
139573,",",0,0
139574,and,0,0
139575,12,0,0
139576,months,0,0
139577,after,0,0
139578,intervention,0,1
139579,.,0,0
139580,Separate,0,0
139581,linear,0,0
139582,regressions,0,0
139583,were,0,0
139584,conducted,0,0
139585,for,0,0
139586,each,0,0
139587,standardized,0,0
139588,and,0,0
139589,observational,0,0
139590,measure,0,0
139591,at,0,0
139592,each,0,0
139593,time,0,0
139594,point,0,0
139595,.,0,0
139596,RESULTS,0,0
139597,Parents,0,0
139598,in,0,0
139599,the,0,0
139600,parent,0,1
139601,+,0,1
139602,therapist,0,1
139603,group,0,0
139604,demonstrated,0,0
139605,greater,0,0
139606,use,0,0
139607,of,0,0
139608,EMT,1,0
139609,strategies,1,0
139610,at,0,0
139611,home,0,1
139612,than,0,0
139613,untrained,0,0
139614,parents,0,0
139615,in,0,0
139616,the,0,0
139617,therapist-only,0,1
139618,group,0,0
139619,",",0,0
139620,and,0,0
139621,these,0,0
139622,effects,0,0
139623,maintained,0,0
139624,over,0,0
139625,time,0,0
139626,.,0,0
139627,Effect,0,0
139628,sizes,0,0
139629,for,0,0
139630,observational,0,0
139631,measures,0,0
139632,ranged,0,0
139633,from,0,0
139634,d,0,1
139635,=,0,0
139636,0.10,0,0
139637,to,0,0
139638,d,0,1
139639,=,0,0
139640,1.32,0,0
139641,favoring,0,0
139642,the,0,0
139643,parent,0,1
139644,+,0,1
139645,therapist,0,1
139646,group,0,0
139647,",",0,0
139648,with,0,0
139649,the,0,0
139650,largest,0,0
139651,effect,0,0
139652,sizes,0,0
139653,found,0,0
139654,12,0,0
139655,months,0,0
139656,after,0,0
139657,intervention,0,1
139658,.,0,0
139659,CONCLUSION,0,0
139660,Findings,0,0
139661,from,0,0
139662,this,0,0
139663,study,0,0
139664,indicate,0,0
139665,generally,0,0
139666,that,0,0
139667,there,0,0
139668,are,0,0
139669,benefits,0,0
139670,to,0,0
139671,training,0,1
139672,parents,0,0
139673,to,0,0
139674,implement,0,0
139675,naturalistic,1,0
139676,language,1,1
139677,intervention,1,1
139678,strategies,1,0
139679,with,0,0
139680,preschool,0,0
139681,children,0,0
139682,who,0,0
139683,have,0,0
139684,ID,0,1
139685,and,0,0
139686,significant,0,0
139687,language,0,1
139688,impairments,0,0
139689,.,0,0
139690,Effectiveness,0,0
139691,and,0,0
139692,safety,0,0
139693,of,0,0
139694,donepezil,1,1
139695,in,0,0
139696,boys,0,0
139697,with,0,0
139698,fragile,0,0
139699,x,0,0
139700,syndrome,0,0
139701,:,0,0
139702,a,0,0
139703,double-blind,0,0
139704,",",0,0
139705,randomized,0,0
139706,",",0,0
139707,controlled,0,0
139708,pilot,0,0
139709,study,0,0
139710,.,0,0
139711,The,0,0
139712,present,0,0
139713,study,0,0
139714,was,0,0
139715,designed,0,0
139716,as,0,0
139717,a,0,0
139718,12-week,0,0
139719,",",0,0
139720,randomized,0,0
139721,",",0,0
139722,double-blind,0,0
139723,",",0,0
139724,placebo-controlled,1,1
139725,pilot,0,0
139726,study,0,0
139727,to,0,0
139728,evaluate,0,0
139729,the,0,0
139730,effectiveness,0,0
139731,and,0,0
139732,safety,0,0
139733,of,0,0
139734,donepezil,1,1
139735,in,0,0
139736,boys,0,0
139737,with,0,0
139738,fragile,0,0
139739,X,0,1
139740,syndrome,0,0
139741,.,0,0
139742,Twenty,0,0
139743,boys,0,0
139744,with,0,0
139745,fragile,0,0
139746,X,0,1
139747,syndrome,0,0
139748,were,0,0
139749,randomized,0,0
139750,to,0,0
139751,receive,0,0
139752,12,0,0
139753,weeks,0,0
139754,of,0,0
139755,treatment,0,0
139756,with,0,0
139757,either,0,1
139758,placebo,1,1
139759,or,1,1
139760,donepezil,1,1
139761,(,0,0
139762,2.5,0,1
139763,mg,0,1
139764,daily,0,0
139765,for,0,0
139766,initial,0,0
139767,4,0,0
139768,weeks,0,0
139769,followed,0,0
139770,by,0,0
139771,5,0,0
139772,mg,0,0
139773,daily,0,0
139774,for,0,0
139775,next,0,0
139776,8,0,0
139777,weeks,0,0
139778,),0,0
139779,.,0,0
139780,The,0,0
139781,outcome,0,0
139782,measures,0,0
139783,included,0,0
139784,change,0,0
139785,in,0,0
139786,intelligence,0,0
139787,quotient,0,0
139788,scores,0,0
139789,on,0,0
139790,Stanford-Binet,0,0
139791,Intelligence,0,1
139792,Scale,0,1
139793,(,0,1
139794,Hindi,0,1
139795,adaptation,0,0
139796,by,0,0
139797,Kulshrestha,0,1
139798,),0,0
139799,",",0,0
139800,change,0,0
139801,in,0,0
139802,behavioral,0,1
139803,scores,0,0
139804,by,0,0
139805,Conners,0,0
139806,3,0,0
139807,Parent,0,0
139808,Rating,0,0
139809,Scale,0,1
139810,(,0,1
139811,Short,0,1
139812,),0,1
139813,and,0,0
139814,Childhood,0,0
139815,Autism,0,0
139816,Rating,0,0
139817,Scale,0,1
139818,",",0,0
139819,safety,0,0
139820,",",0,0
139821,and,0,0
139822,tolerability,0,0
139823,of,0,0
139824,donepezil,0,1
139825,.,0,0
139826,The,0,0
139827,study,0,0
139828,failed,0,0
139829,to,0,0
139830,show,0,0
139831,significant,0,0
139832,difference,0,0
139833,in,0,0
139834,intelligence,0,0
139835,quotient,0,0
139836,and,0,0
139837,behavioral,0,1
139838,scales,0,0
139839,with,0,0
139840,donepezil,1,1
139841,therapy,0,1
139842,over,0,0
139843,12,0,0
139844,weeks,0,0
139845,.,0,0
139846,However,0,0
139847,",",0,0
139848,donepezil,1,1
139849,appeared,0,0
139850,to,0,0
139851,be,0,0
139852,safe,0,0
139853,and,0,0
139854,well,0,0
139855,tolerated,0,0
139856,.,0,0
139857,Reaching,0,1
139858,out,0,0
139859,",",0,0
139860,inviting,0,0
139861,back,0,0
139862,:,0,0
139863,using,0,0
139864,Interactive,1,1
139865,voice,1,1
139866,response,1,0
139867,(,1,1
139868,IVR,1,0
139869,),1,1
139870,technology,1,0
139871,to,0,0
139872,recycle,0,0
139873,relapsed,0,0
139874,smokers,0,0
139875,back,0,0
139876,to,0,0
139877,Quitline,1,1
139878,treatment,1,0
139879,--,1,0
139880,a,1,0
139881,randomized,0,0
139882,controlled,0,0
139883,trial,0,0
139884,.,0,0
139885,BACKGROUND,0,0
139886,Tobacco,0,1
139887,dependence,0,0
139888,is,0,0
139889,a,0,0
139890,chronic,0,0
139891,",",0,0
139892,relapsing,0,0
139893,condition,0,0
139894,that,0,0
139895,typically,0,0
139896,requires,0,0
139897,multiple,0,0
139898,quit,0,0
139899,attempts,0,0
139900,and,0,0
139901,extended,0,0
139902,treatment,0,0
139903,.,0,0
139904,When,0,0
139905,offered,0,0
139906,the,0,0
139907,opportunity,0,0
139908,",",0,0
139909,relapsed,0,0
139910,smokers,0,0
139911,are,0,0
139912,interested,0,0
139913,in,0,0
139914,recycling,0,0
139915,back,0,0
139916,into,0,0
139917,treatment,0,0
139918,for,0,0
139919,a,0,0
139920,new,0,0
139921,",",0,0
139922,assisted,0,1
139923,quit,0,0
139924,attempt,0,0
139925,.,0,0
139926,This,0,0
139927,manuscript,0,0
139928,presents,0,0
139929,the,0,0
139930,results,0,0
139931,of,0,0
139932,a,0,0
139933,randomized,0,0
139934,controlled,0,0
139935,trial,0,0
139936,testing,0,1
139937,the,0,0
139938,efficacy,0,0
139939,of,0,0
139940,interactive,1,1
139941,voice,1,1
139942,response,1,0
139943,(,1,1
139944,IVR,1,0
139945,),1,1
139946,in,0,0
139947,recycling,0,0
139948,low,0,0
139949,income,0,0
139950,smokers,0,0
139951,who,0,0
139952,had,0,0
139953,previously,0,0
139954,used,0,0
139955,quitline,1,1
139956,(,1,1
139957,QL,1,0
139958,),1,1
139959,support,1,0
139960,back,0,0
139961,to,0,0
139962,QL,0,0
139963,support,0,0
139964,for,0,0
139965,a,0,0
139966,new,0,0
139967,quit,0,0
139968,attempt,0,0
139969,.,0,0
139970,METHODS,0,0
139971,A,0,0
139972,sample,0,0
139973,of,0,0
139974,2985,0,0
139975,previous,0,0
139976,QL,0,0
139977,callers,0,0
139978,were,0,0
139979,randomized,0,0
139980,to,0,0
139981,either,0,0
139982,receive,0,1
139983,IVR,1,0
139984,screening,1,1
139985,for,1,0
139986,current,1,1
139987,smoking,1,1
139988,(,1,0
139989,control,1,1
139990,group,1,1
139991,),1,1
139992,or,0,1
139993,IVR,1,0
139994,screening,1,1
139995,plus,1,1
139996,an,1,0
139997,IVR,1,0
139998,intervention,1,1
139999,.,1,0
140000,The,0,0
140001,IVR,1,0
140002,intervention,1,1
140003,consists,0,0
140004,of,0,0
140005,automated,0,0
140006,questions,0,0
140007,to,0,0
140008,identify,0,0
140009,and,0,0
140010,address,0,0
140011,barriers,0,0
140012,to,0,0
140013,re-cycling,0,0
140014,in,0,0
140015,QL,0,0
140016,support,0,0
140017,",",0,0
140018,followed,0,1
140019,by,0,0
140020,an,0,0
140021,offer,0,0
140022,to,0,0
140023,be,0,0
140024,transferred,0,0
140025,to,0,0
140026,the,0,0
140027,QL,0,0
140028,and,0,0
140029,reinitiate,0,0
140030,treatment,0,0
140031,.,0,0
140032,Re-enrollment,0,0
140033,in,0,0
140034,QL,0,0
140035,services,0,1
140036,for,0,0
140037,both,0,0
140038,groups,0,0
140039,was,0,0
140040,documented,0,0
140041,.,0,0
140042,RESULTS,0,0
140043,The,0,0
140044,IVR,1,0
140045,system,1,0
140046,successfully,0,0
140047,reached,0,0
140048,715,0,0
140049,(,0,0
140050,23.9,0,0
140051,%,0,0
140052,),0,0
140053,former,0,0
140054,QL,0,0
140055,participants,0,0
140056,.,0,0
140057,Of,0,0
140058,those,0,0
140059,",",0,0
140060,27,0,0
140061,%,0,0
140062,(,0,0
140063,194/715,0,0
140064,),0,0
140065,reported,0,0
140066,to,0,0
140067,the,0,0
140068,IVR,1,0
140069,system,1,0
140070,that,0,0
140071,they,0,0
140072,had,0,0
140073,quit,0,1
140074,smoking,0,1
140075,and,0,0
140076,were,0,0
140077,therefore,0,0
140078,excluded,0,0
140079,from,0,0
140080,the,0,0
140081,study,0,0
140082,and,0,0
140083,analysis,0,0
140084,.,0,0
140085,The,0,0
140086,trial,0,0
140087,'s,0,0
140088,final,0,0
140089,sample,0,0
140090,was,0,0
140091,composed,0,0
140092,of,0,0
140093,521,0,0
140094,current,0,0
140095,smokers,0,0
140096,.,0,0
140097,The,0,0
140098,re-enrollment,0,0
140099,rate,0,0
140100,was,0,0
140101,3.3,0,0
140102,%,0,0
140103,for,0,0
140104,the,0,0
140105,control,0,1
140106,group,0,0
140107,and,0,0
140108,28.2,0,0
140109,%,0,0
140110,for,0,0
140111,the,0,0
140112,intervention,0,1
140113,group,0,0
140114,(,0,0
140115,p,0,0
140116,<,0,0
140117,.001,0,0
140118,),0,0
140119,.,0,0
140120,Logistic,0,0
140121,regression,0,0
140122,results,0,0
140123,indicated,0,0
140124,an,0,0
140125,11.2,0,0
140126,times,0,0
140127,higher,0,0
140128,odds,0,0
140129,for,0,0
140130,re-enrollment,0,0
140131,of,0,0
140132,the,0,0
140133,intervention,0,1
140134,group,0,0
140135,than,0,0
140136,the,0,0
140137,control,0,1
140138,group,0,0
140139,(,0,0
140140,p,0,0
140141,<,0,0
140142,.001,0,0
140143,),0,0
140144,.,0,0
140145,Results,0,0
140146,did,0,0
140147,not,0,0
140148,vary,0,0
140149,by,0,0
140150,gender,0,0
140151,",",0,0
140152,race,0,0
140153,",",0,0
140154,ethnicity,0,0
140155,",",0,0
140156,or,0,1
140157,level,0,0
140158,of,0,0
140159,education,0,1
140160,",",0,0
140161,however,0,0
140162,recycled,0,0
140163,smokers,0,0
140164,were,0,0
140165,older,0,0
140166,(,0,0
140167,Mean,0,0
140168,=,0,0
140169,45.2,0,0
140170,;,0,0
140171,SD,0,0
140172,=,0,0
140173,11.7,0,0
140174,),0,0
140175,than,0,0
140176,smokers,0,0
140177,who,0,0
140178,declined,0,0
140179,a,0,0
140180,new,0,0
140181,treatment,0,1
140182,cycle,0,0
140183,(,0,0
140184,Mean,0,0
140185,=,0,0
140186,41.8,0,0
140187,;,0,0
140188,SD,0,0
140189,=,0,0
140190,13.2,0,0
140191,),0,0
140192,;,0,0
140193,(,0,0
140194,p,0,0
140195,=,0,0
140196,0.013,0,0
140197,),0,0
140198,.,0,0
140199,The,0,0
140200,main,0,0
140201,barriers,0,0
140202,reported,0,0
140203,for,0,0
140204,not,0,0
140205,engaging,0,0
140206,in,0,0
140207,a,0,0
140208,new,0,0
140209,treatment,0,0
140210,cycle,0,0
140211,were,0,0
140212,low,0,0
140213,self-efficacy,0,1
140214,and,0,0
140215,lack,0,0
140216,of,0,0
140217,interest,0,0
140218,in,0,0
140219,quitting,0,0
140220,.,0,0
140221,After,0,0
140222,delivering,0,0
140223,IVR,1,0
140224,messages,1,1
140225,targeting,0,0
140226,these,0,0
140227,reported,0,0
140228,barriers,0,0
140229,",",0,0
140230,32,0,0
140231,%,0,0
140232,of,0,0
140233,the,0,0
140234,smokers,0,0
140235,reporting,0,0
140236,low,0,0
140237,self-efficacy,0,1
140238,and,0,0
140239,4.8,0,0
140240,%,0,0
140241,of,0,0
140242,those,0,0
140243,reporting,0,0
140244,lack,0,0
140245,of,0,0
140246,interest,0,0
140247,in,0,0
140248,quitting,0,0
140249,re-engaged,0,0
140250,in,0,0
140251,a,0,0
140252,new,0,0
140253,QL,0,0
140254,treatment,0,0
140255,cycle,0,0
140256,.,0,0
140257,CONCLUSION,0,0
140258,Proactive,1,1
140259,IVR,1,0
140260,outreach,1,1
140261,is,0,0
140262,a,0,0
140263,promising,0,0
140264,tool,0,0
140265,to,0,0
140266,engage,0,0
140267,low,0,0
140268,income,0,0
140269,",",0,0
140270,relapsed,0,0
140271,smokers,0,0
140272,back,0,0
140273,into,0,0
140274,a,0,0
140275,new,0,0
140276,cycle,0,0
140277,of,0,0
140278,treatment,0,0
140279,.,0,0
140280,Integration,0,0
140281,of,0,0
140282,IVR,1,0
140283,intervention,0,1
140284,for,0,0
140285,recycling,0,0
140286,smokers,0,0
140287,with,0,0
140288,previous,0,0
140289,QL,0,0
140290,treatment,0,1
140291,has,0,0
140292,the,0,0
140293,potential,0,0
140294,to,0,0
140295,decrease,0,0
140296,tobacco-related,0,0
140297,disparities,0,0
140298,.,0,0
140299,TRIAL,0,0
140300,REGISTRATION,0,0
140301,ClinicalTrials.gov,0,0
140302,Identifier,0,0
140303,:,0,0
140304,NCT01260597,0,0
140305,.,0,0
140306,Effectiveness,0,0
140307,of,0,0
140308,vaginal,1,1
140309,tablets,1,1
140310,containing,0,1
140311,lactobacilli,1,1
140312,versus,0,1
140313,pH,1,1
140314,tablets,1,1
140315,on,0,0
140316,vaginal,0,1
140317,health,0,0
140318,and,0,0
140319,inflammatory,0,0
140320,cytokines,0,1
140321,:,0,0
140322,a,0,0
140323,randomized,0,0
140324,",",0,0
140325,double-blind,0,0
140326,study,0,0
140327,.,0,0
140328,The,0,0
140329,purpose,0,0
140330,of,0,0
140331,this,0,0
140332,study,0,0
140333,was,0,0
140334,to,0,0
140335,evaluate,0,0
140336,the,0,0
140337,effectiveness,0,0
140338,of,0,0
140339,lactobacilli,1,1
140340,on,0,0
140341,vaginal,0,1
140342,health,0,0
140343,and,0,0
140344,proinflammatory,0,0
140345,cytokines,0,1
140346,.,0,0
140347,Sixty-seven,0,0
140348,patients,0,0
140349,with,0,0
140350,bacterial,0,0
140351,vaginosis,0,0
140352,(,0,1
140353,BV,0,1
140354,),0,0
140355,",",0,0
140356,50,0,0
140357,with,0,0
140358,intermediate,0,0
140359,flora,0,0
140360,and,0,0
140361,42,0,0
140362,with,0,0
140363,normal,0,0
140364,vaginal,0,1
140365,flora,0,0
140366,were,0,0
140367,enrolled,0,0
140368,in,0,0
140369,this,0,0
140370,double-blind,0,0
140371,study,0,0
140372,.,0,0
140373,The,0,0
140374,subjects,0,0
140375,were,0,0
140376,randomized,0,0
140377,to,0,0
140378,receive,1,0
140379,probiotic,1,1
140380,lactobacilli,1,1
140381,vaginal,1,1
140382,tablets,1,1
140383,(,1,0
140384,L.,1,1
140385,brevis,1,1
140386,CD2,1,0
140387,",",1,0
140388,L.,1,1
140389,salivarius,1,1
140390,subsp,1,0
140391,.,1,0
140392,salicinius,1,0
140393,",",1,0
140394,L.,1,1
140395,plantarum,1,1
140396,),1,1
140397,or,1,1
140398,the,1,0
140399,vaginal,1,1
140400,pH,1,1
140401,tablet,1,1
140402,(,1,1
140403,active,1,1
140404,comparator,1,1
140405,),1,0
140406,.,1,0
140407,Cervico-vaginal,0,0
140408,lavage,0,0
140409,was,0,0
140410,collected,0,0
140411,to,0,0
140412,measure,0,0
140413,the,0,0
140414,concentrations,0,0
140415,of,0,0
140416,IL-1?,0,1
140417,",",0,0
140418,TNF?,0,0
140419,and,0,0
140420,IL-6,0,1
140421,by,0,0
140422,ELISA,0,0
140423,.,0,0
140424,Neutral,0,1
140425,sphingomyelinase,0,1
140426,activity,0,0
140427,was,0,0
140428,also,0,0
140429,quantified,0,0
140430,in,0,0
140431,both,0,0
140432,arms,0,0
140433,before,0,0
140434,and,0,0
140435,after,0,0
140436,treatment,0,0
140437,.,0,0
140438,The,0,0
140439,probiotic,0,1
140440,vaginal,0,1
140441,tablet,0,1
140442,was,0,0
140443,well,0,0
140444,tolerated,0,0
140445,and,0,0
140446,no,0,0
140447,side,0,0
140448,effects,0,0
140449,were,0,0
140450,reported,0,0
140451,.,0,0
140452,The,0,0
140453,study,0,0
140454,demonstrated,0,0
140455,a,0,0
140456,cure,0,0
140457,rate,0,0
140458,of,0,0
140459,nearly,0,0
140460,80,0,0
140461,%,0,0
140462,;,0,0
140463,i.e.,0,0
140464,",",0,0
140465,32,0,0
140466,%,0,0
140467,of,0,0
140468,the,0,0
140469,women,0,0
140470,could,0,0
140471,restore,0,0
140472,normal,0,0
140473,vaginal,0,1
140474,flora,0,0
140475,and,0,0
140476,47,0,0
140477,%,0,0
140478,had,0,0
140479,improved,0,0
140480,Nugent,0,0
140481,score,0,0
140482,",",0,0
140483,whereas,0,0
140484,20,0,0
140485,%,0,0
140486,of,0,0
140487,the,0,0
140488,subjects,0,0
140489,did,0,0
140490,not,0,0
140491,clear,0,0
140492,BV,0,1
140493,in,0,0
140494,the,0,0
140495,first,0,0
140496,follow-up,0,0
140497,(,0,0
140498,after,0,0
140499,8,0,0
140500,days,0,0
140501,treatment,0,0
140502,),0,0
140503,.,0,0
140504,The,0,0
140505,pH,0,1
140506,tablet,0,1
140507,containing,0,1
140508,pH,0,1
140509,lowering,0,0
140510,compounds,0,1
140511,induced,0,0
140512,resolution,0,0
140513,of,0,0
140514,BV,0,1
140515,and,0,0
140516,restoration,0,0
140517,of,0,0
140518,normal,0,0
140519,vaginal,0,1
140520,flora,0,0
140521,in,0,0
140522,74,0,0
140523,%,0,0
140524,and,0,0
140525,26,0,0
140526,%,0,0
140527,",",0,0
140528,respectively,0,0
140529,.,0,0
140530,The,0,0
140531,lactobacilli,0,0
140532,tablet,0,1
140533,was,0,0
140534,found,0,0
140535,to,0,0
140536,be,0,0
140537,better,0,0
140538,than,0,0
140539,the,0,0
140540,pH,0,1
140541,tablet,0,1
140542,in,0,0
140543,preventing,0,0
140544,BV,0,1
140545,in,0,0
140546,healthy,0,0
140547,subjects,0,0
140548,.,0,0
140549,A,0,0
140550,significant,0,0
140551,reduction,0,0
140552,in,0,0
140553,IL-1?,0,1
140554,and,0,0
140555,IL-6,0,1
140556,vaginal,0,1
140557,cytokines,0,0
140558,was,0,0
140559,observed,0,0
140560,after,0,0
140561,treatment,0,0
140562,with,0,0
140563,lactobacilli,0,0
140564,",",0,0
140565,while,0,0
140566,the,0,0
140567,active,0,1
140568,comparator,0,0
140569,did,0,0
140570,not,0,0
140571,have,0,0
140572,any,0,0
140573,effect,0,0
140574,on,0,0
140575,local,0,1
140576,proinflammatory,0,0
140577,cytokines,0,0
140578,.,0,0
140579,Vaginal,0,0
140580,neutral,0,1
140581,sphingomyelinase,0,1
140582,activity,0,0
140583,was,0,0
140584,not,0,0
140585,modified,0,0
140586,in,0,0
140587,either,0,0
140588,group,0,0
140589,.,0,0
140590,Vaginal,0,0
140591,tablets,0,1
140592,containing,0,1
140593,lactobacilli,0,1
140594,can,0,0
140595,cure,0,0
140596,BV,0,0
140597,and,0,0
140598,reduce,0,0
140599,vaginal,0,1
140600,inflammatory,0,0
140601,response,0,0
140602,.,0,0
140603,A,0,0
140604,six-month,0,0
140605,crossover,0,0
140606,chemoprevention,0,1
140607,clinical,0,0
140608,trial,0,0
140609,of,0,0
140610,tea,1,1
140611,in,0,0
140612,smokers,0,0
140613,and,0,0
140614,non-smokers,0,0
140615,:,0,0
140616,methodological,0,0
140617,issues,0,0
140618,in,0,0
140619,a,0,0
140620,feasibility,0,0
140621,study,0,0
140622,.,0,0
140623,BACKGROUND,0,0
140624,Chemoprevention,0,1
140625,crossover,0,0
140626,trials,0,0
140627,of,0,0
140628,tea,0,1
140629,can,0,0
140630,be,0,0
140631,more,0,0
140632,efficient,0,0
140633,than,0,0
140634,parallel,0,0
140635,designs,0,0
140636,but,0,0
140637,the,0,0
140638,attrition,0,0
140639,and,0,0
140640,compliance,0,0
140641,rates,0,0
140642,with,0,0
140643,such,0,0
140644,trials,0,0
140645,are,0,0
140646,unknown,0,0
140647,.,0,0
140648,METHODS,0,0
140649,Attrition,0,0
140650,(,0,1
140651,dropouts,0,0
140652,),0,1
140653,and,0,0
140654,compliance,0,0
140655,with,0,0
140656,treatment,0,0
140657,were,0,0
140658,assessed,0,0
140659,in,0,0
140660,a,0,0
140661,25-week,0,1
140662,randomized,0,0
140663,",",0,0
140664,placebo,0,1
140665,controlled,0,0
140666,",",0,0
140667,crossover,0,0
140668,",",0,0
140669,feasibility,0,0
140670,clinical,0,0
140671,trial,0,0
140672,of,0,0
140673,four,1,0
140674,tea,1,1
140675,treatments,1,0
140676,to,1,0
140677,investigate,1,0
140678,the,1,0
140679,effect,1,0
140680,of,1,0
140681,tea,1,1
140682,on,1,0
140683,oral,1,1
140684,cancer,1,0
140685,biomarkers,1,0
140686,.,1,0
140687,Each,0,0
140688,treatment,0,0
140689,lasted,0,0
140690,4,0,0
140691,weeks,0,0
140692,with,0,0
140693,2,0,0
140694,weeks,0,0
140695,of,0,0
140696,washout,0,0
140697,in,0,0
140698,between,0,0
140699,.,0,0
140700,Participants,0,0
140701,were,0,0
140702,32,0,0
140703,smokers,0,0
140704,and,0,0
140705,33,0,0
140706,non-smokers,0,0
140707,without,0,0
140708,any,0,0
140709,evidence,0,0
140710,of,0,0
140711,premalignant,0,0
140712,oral,0,1
140713,lesions,0,0
140714,.,0,0
140715,The,0,0
140716,interventions,0,0
140717,consisted,0,0
140718,of,0,0
140719,packets,1,1
140720,of,1,0
140721,green,1,1
140722,tea,1,1
140723,",",1,0
140724,black,1,0
140725,tea,1,1
140726,",",1,0
140727,caffeinated,1,1
140728,water,1,1
140729,",",1,0
140730,or,1,1
140731,placebo,1,1
140732,.,1,0
140733,Participants,1,0
140734,were,0,0
140735,assigned,0,0
140736,to,0,0
140737,each,0,0
140738,treatment,0,0
140739,for,0,0
140740,four,0,0
140741,weeks,0,0
140742,",",0,0
140743,and,0,0
140744,were,0,0
140745,instructed,0,1
140746,to,0,0
140747,drink,0,1
140748,five,0,0
140749,packets,0,0
140750,per,0,0
140751,day,0,0
140752,while,0,0
140753,on,0,0
140754,the,0,0
140755,treatment,0,0
140756,.,0,0
140757,Dropout,0,0
140758,from,0,0
140759,the,0,0
140760,trial,0,0
140761,and,0,1
140762,compliance,0,0
140763,(,0,1
140764,consumption,0,0
140765,of,0,0
140766,?85,0,1
140767,%,0,0
140768,of,0,0
140769,the,0,0
140770,prescribed,0,0
140771,treatment,0,0
140772,packets,0,1
140773,),0,0
140774,are,0,0
140775,the,0,0
140776,main,0,0
140777,outcome,0,0
140778,measures,0,0
140779,reported,0,0
140780,.,0,0
140781,RESULTS,0,0
140782,There,0,0
140783,was,0,0
140784,a,0,0
140785,high,0,0
140786,rate,0,0
140787,of,0,0
140788,dropout,0,0
140789,(,0,0
140790,51,0,0
140791,%,0,0
140792,),0,0
140793,from,0,0
140794,the,0,0
140795,study,0,0
140796,",",0,0
140797,and,0,0
140798,the,0,0
140799,rates,0,0
140800,were,0,0
140801,significantly,0,0
140802,higher,0,0
140803,among,0,0
140804,smokers,0,0
140805,(,0,0
140806,64,0,0
140807,%,0,0
140808,),0,0
140809,than,0,0
140810,non-smokers,0,1
140811,(,0,0
140812,36,0,0
140813,%,0,0
140814,),0,0
140815,.,0,0
140816,Among,0,0
140817,participants,0,0
140818,who,0,0
140819,completed,0,0
140820,the,0,0
140821,study,0,0
140822,the,0,0
140823,rate,0,0
140824,of,0,0
140825,compliance,0,0
140826,was,0,0
140827,72,0,0
140828,%,0,0
140829,.,0,0
140830,The,0,0
140831,highest,0,0
140832,rates,0,0
140833,of,0,0
140834,dropouts,0,0
140835,occurred,0,0
140836,between,0,0
140837,the,0,0
140838,first,0,0
140839,and,0,0
140840,second,0,0
140841,treatment,0,0
140842,visits,0,0
140843,in,0,0
140844,both,0,0
140845,smokers,0,0
140846,(,0,0
140847,38,0,0
140848,%,0,0
140849,dropout,0,0
140850,),0,1
140851,and,0,0
140852,non-smokers,0,1
140853,(,0,0
140854,18,0,0
140855,%,0,0
140856,dropout,0,0
140857,),0,0
140858,.,0,0
140859,Throughout,0,0
140860,the,0,0
140861,study,0,0
140862,smokers,0,0
140863,were,0,0
140864,more,0,0
140865,likely,0,0
140866,to,0,0
140867,dropout,0,0
140868,than,0,0
140869,non-smokers,0,0
140870,.,0,0
140871,Black,0,0
140872,tea,0,1
140873,treatment,0,0
140874,was,0,0
140875,associated,0,0
140876,with,0,0
140877,the,0,0
140878,highest,0,0
140879,rates,0,0
140880,of,0,0
140881,dropout,0,0
140882,among,0,0
140883,smokers,0,0
140884,(,0,0
140885,37,0,0
140886,%,0,0
140887,),0,0
140888,",",0,0
140889,but,0,0
140890,was,0,0
140891,associated,0,0
140892,with,0,0
140893,the,0,0
140894,lowest,0,0
140895,rate,0,0
140896,of,0,0
140897,dropout,0,0
140898,among,0,0
140899,non-smokers,0,0
140900,(,0,0
140901,4,0,1
140902,%,0,0
140903,),0,0
140904,.,0,0
140905,CONCLUSIONS,0,0
140906,In,0,0
140907,a,0,0
140908,study,0,0
140909,conducted,0,0
140910,to,0,0
140911,test,0,0
140912,the,0,0
140913,feasibility,0,0
140914,of,0,0
140915,a,0,0
140916,four-treatment,0,1
140917,crossover,0,0
140918,tea,0,1
140919,trial,0,0
140920,",",0,0
140921,a,0,0
140922,high,0,0
140923,rate,0,0
140924,of,0,0
140925,dropout,0,0
140926,among,0,0
140927,smokers,0,0
140928,and,0,0
140929,non-smokers,0,0
140930,was,0,0
140931,observed,0,0
140932,.,0,0
140933,Multi-arm,0,0
140934,crossover,0,0
140935,tea,0,1
140936,trials,0,0
140937,might,0,0
140938,pose,0,0
140939,a,0,0
140940,higher,0,0
140941,burden,0,0
140942,on,0,0
140943,participants,0,0
140944,and,0,0
140945,research,0,0
140946,is,0,0
140947,needed,0,0
140948,to,0,0
140949,improve,0,0
140950,adherence,0,0
140951,and,0,0
140952,treatment,0,1
140953,compliance,0,0
140954,in,0,0
140955,such,0,0
140956,trials,0,0
140957,.,0,0
140958,TRIAL,0,0
140959,REGISTRATION,0,0
140960,NUMBER,0,0
140961,ISRCTN70410203,0,0
140962,.,0,0
140963,[,0,0
140964,Photoplethysmographic,0,0
140965,evaluation,0,0
140966,of,0,0
140967,the,0,0
140968,effect,0,0
140969,of,0,0
140970,a,0,0
140971,vascular,1,0
140972,tonic,1,0
140973,drug,1,1
140974,],1,0
140975,.,0,0
140976,RESPECT-PTSD,0,0
140977,:,0,0
140978,re-engineering,0,0
140979,systems,0,0
140980,for,0,0
140981,the,0,0
140982,primary,0,0
140983,care,0,1
140984,treatment,0,0
140985,of,0,0
140986,PTSD,0,0
140987,",",0,0
140988,a,0,0
140989,randomized,0,0
140990,controlled,0,0
140991,trial,0,0
140992,.,0,0
140993,BACKGROUND,0,0
140994,Although,0,0
140995,collaborative,0,0
140996,care,0,1
140997,is,0,0
140998,effective,0,0
140999,for,0,0
141000,treating,0,0
141001,depression,0,0
141002,and,0,0
141003,other,0,0
141004,mental,0,0
141005,disorders,0,0
141006,in,0,0
141007,primary,0,0
141008,care,0,1
141009,",",0,0
141010,there,0,0
141011,have,0,0
141012,been,0,0
141013,no,0,0
141014,randomized,0,0
141015,trials,0,0
141016,of,0,0
141017,collaborative,0,0
141018,care,0,1
141019,specifically,0,0
141020,for,0,0
141021,patients,0,0
141022,with,0,0
141023,Posttraumatic,0,0
141024,stress,0,0
141025,disorder,0,0
141026,(,0,1
141027,PTSD,0,0
141028,),0,0
141029,.,0,0
141030,OBJECTIVE,0,0
141031,To,0,0
141032,compare,0,0
141033,a,0,0
141034,collaborative,0,0
141035,approach,0,1
141036,",",0,0
141037,the,0,0
141038,Three,1,1
141039,Component,1,0
141040,Model,1,1
141041,(,1,1
141042,3CM,1,1
141043,),1,0
141044,",",0,0
141045,with,0,0
141046,usual,1,1
141047,care,1,1
141048,for,0,0
141049,treating,0,0
141050,PTSD,0,0
141051,in,0,0
141052,primary,0,0
141053,care,0,1
141054,.,0,0
141055,DESIGN,0,0
141056,The,0,0
141057,study,0,0
141058,was,0,0
141059,a,0,0
141060,two-arm,0,0
141061,",",0,0
141062,parallel,0,0
141063,randomized,0,0
141064,clinical,0,0
141065,trial,0,0
141066,.,0,0
141067,PTSD,0,0
141068,patients,0,0
141069,were,0,0
141070,recruited,0,0
141071,from,0,0
141072,five,0,0
141073,primary,0,0
141074,care,0,1
141075,clinics,0,0
141076,at,0,0
141077,four,0,0
141078,Veterans,0,0
141079,Affairs,0,0
141080,healthcare,0,0
141081,facilities,0,1
141082,and,0,0
141083,randomized,0,0
141084,to,0,0
141085,receive,0,0
141086,usual,1,1
141087,care,1,1
141088,or,1,1
141089,usual,1,1
141090,care,1,1
141091,plus,1,1
141092,3CM,1,1
141093,.,1,0
141094,Blinded,0,0
141095,assessors,0,0
141096,collected,0,0
141097,data,0,0
141098,at,0,0
141099,baseline,0,0
141100,and,0,0
141101,3-month,0,0
141102,and,0,0
141103,6-month,0,0
141104,follow-up,0,0
141105,.,0,0
141106,PARTICIPANTS,0,0
141107,Participants,0,0
141108,were,0,0
141109,195,0,0
141110,Veterans,0,0
141111,.,0,0
141112,Their,0,0
141113,average,0,0
141114,age,0,0
141115,was,0,0
141116,45,0,0
141117,years,0,0
141118,",",0,0
141119,91,0,0
141120,%,0,0
141121,were,0,0
141122,male,0,0
141123,",",0,0
141124,58,0,0
141125,%,0,0
141126,were,0,0
141127,white,0,0
141128,",",0,0
141129,40,0,1
141130,%,0,0
141131,served,0,0
141132,in,0,0
141133,Iraq,0,0
141134,or,0,1
141135,Afghanistan,0,0
141136,",",0,0
141137,and,0,0
141138,42,0,0
141139,%,0,0
141140,served,0,0
141141,in,0,0
141142,Vietnam,0,1
141143,.,0,0
141144,INTERVENTION,0,0
141145,All,0,0
141146,participants,0,0
141147,received,0,0
141148,usual,1,1
141149,care,1,1
141150,.,1,0
141151,Participants,0,0
141152,assigned,0,0
141153,to,0,0
141154,3CM,1,1
141155,also,0,0
141156,received,0,0
141157,telephone,1,1
141158,care,1,1
141159,management,1,1
141160,.,1,0
141161,Care,0,0
141162,managers,0,0
141163,received,0,0
141164,supervision,1,1
141165,from,1,0
141166,a,1,0
141167,psychiatrist,1,0
141168,.,1,0
141169,MAIN,0,0
141170,MEASURES,0,0
141171,PTSD,0,0
141172,symptom,0,0
141173,severity,0,0
141174,was,0,0
141175,the,0,0
141176,primary,0,0
141177,outcome,0,0
141178,.,0,0
141179,Depression,0,0
141180,",",0,0
141181,functioning,0,0
141182,",",0,0
141183,perceived,0,0
141184,quality,0,0
141185,of,0,0
141186,care,0,1
141187,",",0,0
141188,utilization,0,0
141189,",",0,0
141190,and,0,0
141191,costs,0,0
141192,were,0,0
141193,secondary,0,0
141194,outcomes,0,0
141195,.,0,0
141196,KEY,0,0
141197,RESULTS,0,0
141198,There,0,0
141199,were,0,0
141200,no,0,0
141201,differences,0,0
141202,between,0,0
141203,3CM,0,1
141204,and,0,0
141205,usual,0,1
141206,care,0,1
141207,in,0,0
141208,symptoms,0,0
141209,or,0,0
141210,functioning,0,0
141211,.,0,0
141212,Participants,0,0
141213,assigned,0,0
141214,to,0,0
141215,3CM,1,1
141216,were,0,0
141217,more,0,0
141218,likely,0,0
141219,to,0,0
141220,have,0,0
141221,a,0,0
141222,mental,0,0
141223,health,0,0
141224,visit,0,0
141225,",",0,0
141226,fill,0,0
141227,an,0,0
141228,antidepressant,0,1
141229,prescription,0,1
141230,",",0,0
141231,and,0,0
141232,have,0,0
141233,adequate,0,0
141234,antidepressant,0,1
141235,refills,0,0
141236,.,0,0
141237,3CM,1,0
141238,participants,0,0
141239,also,0,0
141240,had,0,0
141241,more,0,0
141242,mental,0,0
141243,health,0,0
141244,visits,0,0
141245,and,0,0
141246,higher,0,0
141247,outpatient,0,0
141248,pharmacy,0,0
141249,costs,0,0
141250,.,0,0
141251,CONCLUSIONS,0,0
141252,Results,0,0
141253,suggest,0,0
141254,the,0,0
141255,need,0,0
141256,for,0,0
141257,careful,0,0
141258,examination,0,0
141259,of,0,0
141260,the,0,0
141261,way,0,0
141262,that,0,0
141263,collaborative,0,0
141264,care,0,1
141265,models,0,0
141266,are,0,0
141267,implemented,0,0
141268,for,0,0
141269,treating,0,0
141270,PTSD,0,0
141271,",",0,0
141272,and,0,0
141273,for,0,0
141274,additional,0,0
141275,supports,0,0
141276,to,0,0
141277,encourage,0,0
141278,primary,0,0
141279,care,0,1
141280,providers,0,0
141281,to,0,0
141282,manage,0,0
141283,PTSD,0,0
141284,.,0,0
141285,Effect,0,0
141286,of,0,0
141287,rosuvastatin,1,1
141288,monotherapy,1,1
141289,or,1,1
141290,in,1,0
141291,combination,1,1
141292,with,1,0
141293,fenofibrate,1,1
141294,or,1,1
141295,?-3,1,1
141296,fatty,1,1
141297,acids,1,1
141298,on,1,0
141299,lipoprotein,1,0
141300,subfraction,0,1
141301,profile,0,0
141302,in,0,0
141303,patients,0,0
141304,with,0,0
141305,mixed,0,1
141306,dyslipidaemia,0,0
141307,and,0,0
141308,metabolic,0,0
141309,syndrome,0,0
141310,.,0,0
141311,BACKGROUND,0,0
141312,Raised,0,0
141313,triglycerides,0,0
141314,(,0,0
141315,TG,0,1
141316,),0,0
141317,",",0,0
141318,decreased,0,0
141319,high-density,0,0
141320,lipoprotein,0,1
141321,cholesterol,0,1
141322,(,0,1
141323,HDL-C,0,1
141324,),0,1
141325,levels,0,0
141326,and,0,0
141327,a,0,0
141328,predominance,0,0
141329,of,0,0
141330,small,0,0
141331,dense,0,0
141332,low,0,0
141333,density,0,0
141334,lipoproteins,0,1
141335,(,0,0
141336,sdLDL,0,0
141337,),0,1
141338,are,0,0
141339,characteristics,0,0
141340,of,0,0
141341,the,0,0
141342,metabolic,0,0
141343,syndrome,0,0
141344,(,0,1
141345,MetS,0,0
141346,),0,0
141347,.,0,0
141348,OBJECTIVE,0,0
141349,To,0,0
141350,compare,0,0
141351,the,0,0
141352,effect,0,0
141353,of,0,0
141354,high-dose,1,1
141355,rosuvastatin,1,1
141356,monotherapy,1,1
141357,with,0,0
141358,moderate,0,0
141359,dosing,1,0
141360,combined,1,1
141361,with,1,0
141362,fenofibrate,1,1
141363,or,1,1
141364,?-3,1,1
141365,fatty,1,1
141366,acids,1,1
141367,on,1,0
141368,the,1,0
141369,lipoprotein,1,0
141370,subfraction,1,1
141371,profile,0,0
141372,in,0,0
141373,patients,0,0
141374,with,0,0
141375,mixed,0,1
141376,dyslipidaemia,0,0
141377,and,0,0
141378,MetS,0,0
141379,.,0,0
141380,METHODS,0,0
141381,We,0,0
141382,previously,0,0
141383,randomised,0,0
141384,patients,0,0
141385,with,0,0
141386,low-density,0,0
141387,lipoprotein,0,1
141388,cholesterol,0,0
141389,(,0,1
141390,LDL-C,0,1
141391,),0,1
141392,>,0,0
141393,160,0,0
141394,and,0,0
141395,TG,0,1
141396,>,0,0
141397,200,1,1
141398,mg/dl,1,0
141399,to,1,0
141400,rosuvastatin,1,1
141401,monotherapy,1,1
141402,40,1,1
141403,mg/day,1,1
141404,(,1,0
141405,R,1,1
141406,group,1,0
141407,",",0,0
141408,n,0,0
141409,=,0,0
141410,30,0,0
141411,),0,0
141412,or,0,0
141413,rosuvastatin,1,1
141414,10,1,0
141415,mg/day,1,1
141416,combined,1,1
141417,with,1,0
141418,fenofibrate,1,1
141419,200,1,1
141420,mg/day,1,1
141421,(,1,0
141422,RF,1,1
141423,group,1,0
141424,",",0,0
141425,n,0,0
141426,=,0,0
141427,30,0,0
141428,),0,0
141429,or,0,1
141430,?-3,1,1
141431,fatty,1,1
141432,acids,1,1
141433,2,0,0
141434,g/day,0,0
141435,(,0,0
141436,R?,1,1
141437,group,1,0
141438,",",0,0
141439,n,0,0
141440,=,0,0
141441,30,0,0
141442,),0,0
141443,.,0,0
141444,In,0,0
141445,the,0,0
141446,present,0,0
141447,study,0,0
141448,",",0,0
141449,only,0,0
141450,patients,0,0
141451,with,0,0
141452,MetS,0,0
141453,were,0,0
141454,included,0,0
141455,(,0,0
141456,24,0,0
141457,",",0,0
141458,23,0,0
141459,and,0,0
141460,24,0,0
141461,in,0,0
141462,the,0,0
141463,R,0,0
141464,",",0,0
141465,RF,0,0
141466,and,0,0
141467,R?,0,0
141468,groups,0,0
141469,respectively,0,0
141470,),0,0
141471,.,0,0
141472,At,0,0
141473,baseline,0,0
141474,and,0,0
141475,after,0,0
141476,12,0,0
141477,weeks,0,0
141478,of,0,0
141479,treatment,0,0
141480,",",0,0
141481,the,0,0
141482,lipoprotein,0,0
141483,subfraction,0,1
141484,profile,0,0
141485,was,0,0
141486,determined,0,0
141487,by,0,0
141488,polyacrylamide,0,1
141489,3,0,0
141490,%,0,0
141491,gel,0,1
141492,electrophoresis,0,1
141493,.,0,0
141494,RESULTS,0,0
141495,The,0,0
141496,mean,0,0
141497,LDL,0,0
141498,size,0,0
141499,was,0,0
141500,significantly,0,0
141501,increased,0,0
141502,in,0,0
141503,all,0,0
141504,groups,0,0
141505,.,0,0
141506,This,0,0
141507,change,0,0
141508,was,0,0
141509,more,0,0
141510,prominent,0,0
141511,with,1,0
141512,RF,1,0
141513,than,0,0
141514,with,0,0
141515,other,0,0
141516,treatments,0,0
141517,in,0,0
141518,parallel,0,0
141519,with,0,0
141520,its,0,0
141521,greater,0,0
141522,hypotriglyceridemic,0,0
141523,capacity,0,0
141524,(,0,0
141525,p,0,0
141526,<,0,0
141527,0.05,0,0
141528,compared,0,0
141529,with,0,0
141530,R,0,1
141531,and,0,0
141532,R?,0,0
141533,),0,0
141534,.,0,0
141535,A,0,0
141536,decrease,0,0
141537,in,0,0
141538,insulin,0,1
141539,resistance,0,0
141540,by,0,0
141541,RF,0,0
141542,was,0,0
141543,also,0,0
141544,noted,0,0
141545,.,0,0
141546,Only,1,0
141547,RF,1,0
141548,significantly,0,0
141549,raised,0,0
141550,HDL-C,0,1
141551,levels,0,0
141552,(,0,0
141553,by,0,0
141554,7.7,0,0
141555,%,0,0
141556,",",0,0
141557,p,0,0
141558,<,0,0
141559,0.05,0,0
141560,),0,0
141561,by,0,0
141562,increasing,0,0
141563,the,0,0
141564,cholesterol,0,0
141565,of,0,0
141566,small,0,0
141567,HDL,0,0
141568,particles,0,0
141569,.,0,0
141570,The,0,0
141571,cholesterol,0,0
141572,of,0,0
141573,larger,0,0
141574,HDL,0,0
141575,subclasses,0,0
141576,was,0,0
141577,significantly,0,0
141578,increased,0,0
141579,by,1,0
141580,R,1,1
141581,and,1,0
141582,R?,1,0
141583,.,1,0
141584,CONCLUSIONS,0,0
141585,All,0,0
141586,regimens,0,1
141587,increased,0,0
141588,mean,0,0
141589,LDL,0,1
141590,size,0,0
141591,;,0,0
141592,RF,0,0
141593,was,0,0
141594,the,0,0
141595,most,0,0
141596,effective,0,0
141597,.,0,0
141598,A,0,0
141599,differential,0,0
141600,effect,0,0
141601,of,0,0
141602,treatments,0,0
141603,was,0,0
141604,noted,0,0
141605,on,0,0
141606,the,0,0
141607,HDL,0,1
141608,subfraction,0,0
141609,profile,0,0
141610,.,0,0
141611,Adult,0,0
141612,height,0,0
141613,in,0,0
141614,short,0,0
141615,children,0,0
141616,born,0,0
141617,SGA,0,0
141618,treated,0,0
141619,with,0,0
141620,growth,1,0
141621,hormone,1,1
141622,and,1,0
141623,gonadotropin,1,1
141624,releasing,1,1
141625,hormone,1,1
141626,analog,1,1
141627,:,1,0
141628,results,0,0
141629,of,0,0
141630,a,0,0
141631,randomized,0,0
141632,",",0,0
141633,dose-response,0,0
141634,GH,1,1
141635,trial,0,0
141636,.,0,0
141637,CONTEXT,0,0
141638,GH,1,1
141639,treatment,1,1
141640,is,0,0
141641,effective,0,0
141642,in,0,0
141643,improving,0,0
141644,height,0,0
141645,in,0,0
141646,short,0,0
141647,children,0,0
141648,born,0,0
141649,small,0,0
141650,for,0,0
141651,gestational,0,0
141652,age,0,0
141653,(,0,1
141654,SGA,0,0
141655,),0,0
141656,.,0,0
141657,GH,1,1
141658,is,0,0
141659,thought,0,0
141660,to,0,0
141661,have,0,0
141662,limited,0,0
141663,effect,0,0
141664,when,0,0
141665,started,0,0
141666,during,0,0
141667,adolescence,0,0
141668,.,0,0
141669,OBJECTIVE,0,0
141670,The,0,0
141671,aim,0,0
141672,of,0,0
141673,this,0,0
141674,study,0,0
141675,was,0,0
141676,to,0,0
141677,investigate,0,0
141678,GH,1,1
141679,treatment,1,1
141680,efficacy,0,0
141681,in,0,0
141682,short,0,0
141683,SGA,0,0
141684,children,0,0
141685,when,0,0
141686,treatment,0,0
141687,was,0,0
141688,started,0,0
141689,during,0,0
141690,adolescence,0,0
141691,;,0,0
141692,to,0,0
141693,assess,0,0
141694,whether,0,0
141695,GH,1,1
141696,2,1,1
141697,mg/m,1,1
141698,(,1,0
141699,2,1,0
141700,),1,0
141701,?,0,0
141702,d,0,0
141703,during,0,0
141704,puberty,0,0
141705,improves,0,0
141706,adult,0,0
141707,height,0,0
141708,(,0,1
141709,AH,0,1
141710,),0,1
141711,compared,0,0
141712,with,0,0
141713,1,0,0
141714,mg/m,0,1
141715,(,0,0
141716,2,0,0
141717,),0,0
141718,?,0,0
141719,d,0,0
141720,;,0,0
141721,and,0,0
141722,to,0,0
141723,assess,0,0
141724,whether,0,0
141725,an,0,0
141726,additional,0,0
141727,2-yr,0,0
141728,postponement,0,0
141729,of,0,0
141730,puberty,0,0
141731,by,0,0
141732,GnRH,1,1
141733,analog,1,1
141734,(,1,1
141735,GnRHa,1,0
141736,),1,1
141737,improves,1,0
141738,AH,0,1
141739,in,0,0
141740,children,0,0
141741,who,0,0
141742,are,0,0
141743,short,0,0
141744,at,0,0
141745,the,0,0
141746,start,0,0
141747,of,0,0
141748,puberty,0,0
141749,(,0,0
141750,<,0,0
141751,140,0,1
141752,cm,0,0
141753,),0,0
141754,",",0,0
141755,with,0,0
141756,a,0,0
141757,poor,0,0
141758,AH,0,1
141759,expectation,0,0
141760,.,0,0
141761,PATIENTS,0,0
141762,AND,0,0
141763,DESIGN,0,0
141764,In,0,0
141765,this,0,0
141766,longitudinal,0,0
141767,",",0,0
141768,randomized,0,0
141769,",",0,0
141770,dose-response,0,0
141771,GH,0,1
141772,trial,0,0
141773,",",0,0
141774,we,0,0
141775,included,0,0
141776,121,0,0
141777,short,0,0
141778,SGA,0,0
141779,children,0,0
141780,(,0,0
141781,60,0,0
141782,boys,0,0
141783,),0,0
141784,at,0,0
141785,least,0,0
141786,8,0,0
141787,yr,0,0
141788,of,0,0
141789,age,0,0
141790,.,0,0
141791,We,0,0
141792,performed,0,0
141793,intention-to-treat,0,0
141794,analyses,0,0
141795,on,0,0
141796,all,0,0
141797,children,0,0
141798,and,0,0
141799,uncensored,0,0
141800,case,0,0
141801,analyses,0,0
141802,on,0,0
141803,84,0,0
141804,children,0,0
141805,who,0,0
141806,reached,0,0
141807,AH,0,1
141808,.,0,0
141809,Besides,0,0
141810,",",0,0
141811,we,0,0
141812,evaluated,0,0
141813,growth,0,0
141814,during,0,0
141815,2,0,0
141816,yr,0,0
141817,of,0,0
141818,combined,1,1
141819,GH/GnRHa,1,1
141820,and,1,0
141821,subsequent,1,0
141822,GH,1,1
141823,treatment,1,0
141824,until,1,0
141825,AH,0,1
141826,in,0,0
141827,a,0,0
141828,subgroup,0,0
141829,of,0,0
141830,40,0,0
141831,pubertal,0,0
141832,children,0,0
141833,with,0,0
141834,a,0,0
141835,height,0,0
141836,of,0,0
141837,less,0,0
141838,than,0,0
141839,140,0,0
141840,cm,0,0
141841,at,0,0
141842,the,0,0
141843,start,0,0
141844,.,0,0
141845,RESULTS,0,0
141846,Short,0,0
141847,SGA,0,0
141848,children,0,0
141849,started,0,0
141850,treatment,0,0
141851,at,0,0
141852,a,0,0
141853,median,0,0
141854,age,0,0
141855,of,0,0
141856,11.2,0,0
141857,yr,0,0
141858,",",0,0
141859,when,0,0
141860,46,0,0
141861,%,0,0
141862,had,0,0
141863,already,0,0
141864,started,0,0
141865,puberty,0,0
141866,.,0,0
141867,Median,0,0
141868,height,0,0
141869,increased,0,0
141870,from,0,0
141871,-2.9,0,0
141872,at,0,0
141873,start,0,0
141874,to,0,0
141875,-1.7,0,0
141876,sd,0,0
141877,score,0,0
141878,(,0,1
141879,SDS,0,1
141880,),0,1
141881,at,0,0
141882,AH,0,1
141883,(,0,0
141884,P,0,0
141885,<,0,0
141886,0.001,1,0
141887,),1,0
141888,.,1,0
141889,Treatment,1,0
141890,with,1,0
141891,GH,1,1
141892,2,1,0
141893,vs.,0,0
141894,1,0,0
141895,mg/m,0,1
141896,(,0,0
141897,2,0,0
141898,),0,0
141899,?,0,0
141900,d,0,0
141901,during,0,0
141902,puberty,0,0
141903,resulted,0,0
141904,in,0,0
141905,significantly,0,0
141906,better,0,0
141907,AH,0,1
141908,(,0,0
141909,P,0,0
141910,=,0,0
141911,0.001,0,0
141912,),0,0
141913,",",0,0
141914,also,0,0
141915,after,0,0
141916,correction,0,0
141917,for,0,0
141918,gender,0,0
141919,",",0,0
141920,age,0,0
141921,at,0,0
141922,start,0,0
141923,",",0,0
141924,height,0,0
141925,SDS,0,0
141926,at,0,0
141927,start,0,0
141928,",",0,0
141929,treatment,0,0
141930,years,0,0
141931,before,0,0
141932,puberty,0,0
141933,",",0,0
141934,and,0,0
141935,target,0,0
141936,height,0,0
141937,SDS,0,0
141938,.,0,0
141939,AH,0,0
141940,was,0,0
141941,similar,0,0
141942,in,0,0
141943,children,0,0
141944,who,0,0
141945,started,0,0
141946,puberty,0,0
141947,at,0,0
141948,less,0,0
141949,than,0,0
141950,140,0,0
141951,cm,0,0
141952,and,0,0
141953,received,1,1
141954,GH/GnRHa,1,0
141955,",",1,0
141956,compared,1,0
141957,with,0,0
141958,children,0,0
141959,who,0,0
141960,started,0,0
141961,puberty,0,0
141962,greater,0,0
141963,than,0,0
141964,140,0,0
141965,cm,0,0
141966,and,0,0
141967,received,1,1
141968,GH,1,1
141969,only,1,0
141970,(,1,0
141971,P,1,0
141972,=,0,0
141973,0.795,0,0
141974,),0,0
141975,.,0,0
141976,CONCLUSION,0,0
141977,When,0,0
141978,started,0,0
141979,in,0,0
141980,adolescence,1,0
141981,",",1,0
141982,GH,1,1
141983,treatment,1,0
141984,significantly,1,0
141985,improves,0,0
141986,AH,0,0
141987,in,0,0
141988,short,0,0
141989,SGA,0,0
141990,children,0,0
141991,",",0,0
141992,particularly,0,0
141993,with,1,0
141994,GH,1,1
141995,2,0,1
141996,mg/m,0,1
141997,(,0,0
141998,2,0,0
141999,),0,0
142000,?,0,0
142001,d,0,0
142002,during,0,0
142003,puberty,0,0
142004,.,0,0
142005,When,0,0
142006,SGA,0,0
142007,children,0,0
142008,are,0,0
142009,short,0,0
142010,at,0,0
142011,the,0,0
142012,start,0,0
142013,of,0,0
142014,puberty,0,0
142015,",",0,0
142016,they,0,0
142017,can,0,0
142018,benefit,0,0
142019,from,0,0
142020,combined,1,1
142021,GH/GnRHa,1,1
142022,treatment,1,0
142023,.,1,0
142024,Comparing,0,1
142025,the,0,0
142026,effectiveness,0,0
142027,of,0,0
142028,copper,1,0
142029,intrauterine,1,0
142030,devices,1,1
142031,available,0,0
142032,in,0,0
142033,Canada,0,1
142034,.,0,0
142035,Is,0,0
142036,FlexiT,1,0
142037,non-inferior,0,0
142038,to,0,0
142039,NovaT,1,0
142040,when,0,0
142041,inserted,0,1
142042,immediately,0,0
142043,after,0,0
142044,first-trimester,0,0
142045,abortion,0,0
142046,?,0,0
142047,Study,0,0
142048,protocol,0,0
142049,for,0,0
142050,a,0,0
142051,randomized,0,0
142052,controlled,0,0
142053,trial,0,0
142054,.,0,0
142055,BACKGROUND,0,0
142056,We,0,0
142057,describe,0,0
142058,the,0,0
142059,rationale,0,0
142060,and,0,0
142061,protocol,0,1
142062,for,0,0
142063,a,0,0
142064,randomized,0,0
142065,noninferiority,0,0
142066,controlled,0,0
142067,trial,0,0
142068,(,0,1
142069,RCT,0,0
142070,),0,1
142071,to,0,0
142072,determine,0,0
142073,if,0,0
142074,the,0,0
142075,Flexi-T380,1,1
142076,(,1,1
142077,+,1,1
142078,),1,1
142079,copper,1,0
142080,intrauterine,1,0
142081,contraceptive,1,1
142082,device,1,1
142083,(,1,1
142084,IUD,1,1
142085,),1,1
142086,is,0,0
142087,comparable,0,0
142088,in,0,0
142089,terms,0,0
142090,of,0,0
142091,effectiveness,0,0
142092,and,0,0
142093,expulsion,0,0
142094,rates,0,0
142095,to,0,0
142096,the,0,0
142097,most,0,0
142098,common,0,0
142099,Canadian,0,0
142100,IUD,0,1
142101,currently,0,0
142102,in,0,0
142103,use,0,0
142104,",",0,0
142105,NovaT-200,0,0
142106,",",0,0
142107,when,0,0
142108,placed,0,0
142109,immediately,0,0
142110,after,0,0
142111,a,0,0
142112,first-trimester,0,0
142113,abortion,0,0
142114,.,0,0
142115,METHODS/DESIGN,0,0
142116,Consenting,0,0
142117,women,0,0
142118,choosing,0,0
142119,to,0,0
142120,use,0,0
142121,an,0,0
142122,IUD,0,1
142123,after,0,0
142124,an,0,0
142125,abortion,0,0
142126,for,0,0
142127,a,0,0
142128,pregnancy,0,0
142129,of,0,0
142130,less,0,0
142131,than,0,0
142132,12,0,0
142133,weeks,0,0
142134,of,0,0
142135,gestation,0,0
142136,will,0,0
142137,be,0,0
142138,randomized,0,0
142139,to,0,0
142140,device-type,0,1
142141,groups,0,0
142142,to,0,0
142143,receive,0,0
142144,immediate,0,0
142145,post-abortion,0,1
142146,placement,0,1
142147,of,0,0
142148,either,0,0
142149,a,0,0
142150,Flexi-T380,1,1
142151,(,1,1
142152,+,1,1
142153,),1,1
142154,IUD,1,1
142155,",",0,0
142156,a,0,0
142157,device,0,1
142158,for,0,0
142159,which,0,0
142160,no,0,0
142161,current,0,0
142162,evidence,0,0
142163,on,0,0
142164,expulsion,0,0
142165,or,0,1
142166,effectiveness,0,0
142167,rates,0,0
142168,is,0,0
142169,available,0,0
142170,",",0,0
142171,or,0,1
142172,the,0,0
142173,Nova-T200,1,1
142174,IUD,1,0
142175,",",0,0
142176,the,0,0
142177,only,0,0
142178,other,0,0
142179,brand,0,1
142180,of,0,0
142181,copper,0,0
142182,IUD,0,1
142183,available,0,0
142184,in,0,0
142185,Canada,0,1
142186,at,0,0
142187,the,0,0
142188,time,0,0
142189,of,0,0
142190,study,0,0
142191,initiation,0,0
142192,.,0,0
142193,The,0,0
142194,primary,0,0
142195,outcome,0,0
142196,measure,0,0
142197,is,0,0
142198,IUD,0,1
142199,expulsion,0,0
142200,rate,0,0
142201,at,0,0
142202,1,0,0
142203,year,0,0
142204,.,0,0
142205,Secondary,0,0
142206,outcomes,0,0
142207,include,0,0
142208,:,0,0
142209,pregnancy,0,0
142210,rate,0,0
142211,",",0,0
142212,method,0,1
142213,continuation,0,0
142214,rate,0,0
142215,",",0,0
142216,complication,0,0
142217,rates,0,0
142218,(,0,0
142219,infection,0,0
142220,",",0,1
142221,perforation,0,0
142222,),0,0
142223,",",0,0
142224,and,0,0
142225,satisfaction,0,0
142226,with,0,0
142227,contraceptive,0,1
142228,method,0,0
142229,.,0,0
142230,A,0,0
142231,non-intervention,0,0
142232,group,0,0
142233,of,0,0
142234,consenting,0,0
142235,women,0,0
142236,choosing,0,0
142237,a,0,0
142238,range,0,0
142239,of,0,0
142240,other,0,0
142241,post-abortion,0,1
142242,contraception,0,1
142243,methods,0,0
142244,",",0,0
142245,including,0,0
142246,no,0,0
142247,contraception,0,1
142248,",",0,0
142249,will,0,0
142250,be,0,0
142251,included,0,0
142252,for,0,0
142253,comparison,0,0
142254,of,0,0
142255,secondary,0,0
142256,outcomes,0,0
142257,.,0,0
142258,Web-based,0,1
142259,contraception,0,1
142260,satisfaction,0,0
142261,questionnaires,0,0
142262,",",0,0
142263,clinical,0,0
142264,records,0,0
142265,",",0,0
142266,and,0,0
142267,government-linked,0,1
142268,health,0,0
142269,administrative,0,0
142270,databases,0,0
142271,will,0,0
142272,be,0,0
142273,used,0,0
142274,to,0,0
142275,assess,0,0
142276,primary,0,0
142277,and,0,0
142278,secondary,0,0
142279,outcomes,0,0
142280,.,0,0
142281,DISCUSSION,0,0
142282,The,0,0
142283,RCT,0,0
142284,design,0,0
142285,",",0,0
142286,combined,0,1
142287,with,0,0
142288,access,0,0
142289,to,0,0
142290,clinical,0,0
142291,records,0,0
142292,at,0,0
142293,all,0,0
142294,provincial,0,0
142295,abortion,0,0
142296,clinics,0,0
142297,",",0,0
142298,and,0,0
142299,to,0,0
142300,information,0,0
142301,in,0,0
142302,provincial,0,1
142303,single-payer,0,0
142304,linked,0,0
142305,administrative,0,0
142306,health,0,0
142307,databases,0,0
142308,",",0,0
142309,birth,0,0
142310,registry,0,0
142311,",",0,0
142312,and,0,0
142313,hospital,0,0
142314,records,0,0
142315,",",0,0
142316,offers,0,0
142317,a,0,0
142318,unique,0,0
142319,opportunity,0,0
142320,to,0,0
142321,determine,0,0
142322,if,0,0
142323,a,0,0
142324,novel,0,0
142325,IUD,0,1
142326,has,0,0
142327,a,0,0
142328,comparable,0,0
142329,expulsion,0,0
142330,rate,0,0
142331,to,0,0
142332,that,0,0
142333,of,0,0
142334,the,0,0
142335,current,0,0
142336,standard,0,1
142337,IUD,0,1
142338,in,0,0
142339,Canada,0,0
142340,",",0,0
142341,in,0,0
142342,addition,0,0
142343,to,0,0
142344,the,0,0
142345,first,0,0
142346,opportunity,0,0
142347,to,0,0
142348,determine,0,0
142349,pregnancy,0,0
142350,rate,0,0
142351,and,0,0
142352,method,0,1
142353,satisfaction,0,0
142354,at,0,0
142355,1,0,0
142356,year,0,0
142357,post-abortion,0,0
142358,for,0,0
142359,women,0,0
142360,choosing,0,0
142361,a,0,0
142362,range,0,0
142363,of,0,0
142364,post-abortion,0,1
142365,contraceptive,0,1
142366,options,0,0
142367,.,0,0
142368,We,0,0
142369,highlight,0,0
142370,considerations,0,0
142371,of,0,0
142372,design,0,0
142373,",",0,0
142374,implementation,0,0
142375,",",0,0
142376,and,0,0
142377,evaluation,0,0
142378,of,0,0
142379,the,0,0
142380,first,0,0
142381,trial,0,0
142382,to,0,0
142383,provide,0,0
142384,rigorous,0,0
142385,evidence,0,0
142386,for,0,0
142387,the,0,0
142388,effectiveness,0,0
142389,of,0,0
142390,current,0,0
142391,Canadian,0,0
142392,IUDs,0,0
142393,when,0,0
142394,inserted,0,1
142395,after,0,0
142396,first-trimester,0,0
142397,abortion,0,0
142398,.,0,0
142399,TRIAL,0,0
142400,REGISTRATION,0,0
142401,ClinicalTrials.gov,0,0
142402,Identifier,0,0
142403,NCT01174225,0,1
142404,.,0,0
142405,Computer-delivered,1,1
142406,tailored,1,1
142407,intervention,1,1
142408,improves,0,0
142409,colon,0,0
142410,cancer,0,0
142411,screening,0,1
142412,knowledge,0,0
142413,and,0,0
142414,health,0,0
142415,beliefs,0,1
142416,of,0,0
142417,African-Americans,0,0
142418,.,0,0
142419,We,0,0
142420,conducted,0,0
142421,a,0,0
142422,randomized,0,0
142423,controlled,0,0
142424,trial,0,0
142425,among,0,0
142426,African-American,0,0
142427,patients,0,0
142428,attending,0,0
142429,a,0,0
142430,primary-care,0,1
142431,provider,0,1
142432,visit,0,0
142433,to,0,0
142434,compare,0,0
142435,efficacy,0,0
142436,of,0,0
142437,a,0,0
142438,computer-delivered,1,1
142439,tailored,1,1
142440,intervention,1,1
142441,to,0,0
142442,increase,0,0
142443,colorectal,0,0
142444,cancer,0,0
142445,(,0,1
142446,CRC,0,1
142447,),0,1
142448,screening,0,1
142449,(,0,0
142450,n,0,0
142451,=,0,0
142452,273,0,0
142453,),0,0
142454,with,0,0
142455,non-tailored,1,1
142456,print,1,1
142457,material-an,1,0
142458,American,0,0
142459,Cancer,0,1
142460,Society,0,0
142461,brochure,0,1
142462,on,0,0
142463,CRC,0,1
142464,screening,0,1
142465,(,0,0
142466,n,0,0
142467,=,0,0
142468,283,0,0
142469,),0,0
142470,.,0,0
142471,Health,0,0
142472,Belief,0,1
142473,Model,0,0
142474,constructs,0,0
142475,were,0,0
142476,used,0,0
142477,to,0,0
142478,develop,0,0
142479,tailored,0,1
142480,messages,0,1
142481,and,0,0
142482,examined,0,0
142483,as,0,0
142484,outcomes,0,0
142485,.,0,0
142486,Analysis,0,0
142487,of,0,0
142488,covariance,0,0
142489,models,0,0
142490,were,0,0
142491,used,0,0
142492,to,0,0
142493,compare,0,0
142494,changes,0,0
142495,between,0,0
142496,CRC,0,1
142497,knowledge,0,0
142498,and,0,0
142499,health,0,0
142500,belief,0,0
142501,scores,0,0
142502,at,0,0
142503,baseline,0,0
142504,and,0,0
142505,1,0,1
142506,week,0,0
142507,post-intervention,0,0
142508,.,0,0
142509,At,0,0
142510,1,0,0
142511,week,0,0
142512,",",0,0
142513,patients,0,0
142514,who,0,0
142515,received,0,0
142516,the,0,0
142517,computer-delivered,1,1
142518,tailored,1,1
142519,intervention,1,1
142520,had,0,0
142521,greater,0,0
142522,changes,0,0
142523,in,0,0
142524,CRC,0,1
142525,knowledge,0,0
142526,scores,0,0
142527,(,0,0
142528,P,0,0
142529,<,0,0
142530,0.001,0,0
142531,),0,0
142532,",",0,0
142533,perceived,0,0
142534,CRC,0,1
142535,risk,0,0
142536,scores,0,0
142537,(,0,0
142538,P,0,0
142539,=,0,0
142540,0.005,0,0
142541,),0,0
142542,",",0,0
142543,FOBT,0,1
142544,barriers,0,0
142545,scores,0,0
142546,(,0,0
142547,P,0,0
142548,=,0,0
142549,0.034,0,0
142550,),0,0
142551,and,0,0
142552,colonoscopy,0,1
142553,benefit,0,0
142554,scores,0,0
142555,(,0,0
142556,P,0,0
142557,<,0,0
142558,0.001,0,0
142559,),0,0
142560,.,0,0
142561,Findings,0,0
142562,show,0,0
142563,that,0,0
142564,computer-delivered,0,1
142565,tailored,0,1
142566,interventions,0,1
142567,are,0,0
142568,an,0,0
142569,effective,0,0
142570,adjunct,0,0
142571,to,0,0
142572,the,0,0
142573,clinical,0,0
142574,encounter,0,0
142575,that,0,0
142576,can,0,0
142577,improve,0,0
142578,knowledge,0,0
142579,and,0,0
142580,health,0,0
142581,beliefs,0,1
142582,about,0,0
142583,CRC,0,1
142584,screening,0,0
142585,",",0,0
142586,necessary,0,0
142587,precursors,0,1
142588,to,0,0
142589,behavior,0,0
142590,change,0,0
142591,.,0,0
142592,Psychological,1,1
142593,adjustment,1,0
142594,and,1,0
142595,levels,1,0
142596,of,1,0
142597,self,1,1
142598,esteem,1,0
142599,in,0,0
142600,children,0,0
142601,with,0,0
142602,visual-motor,0,0
142603,integration,0,0
142604,difficulties,0,0
142605,influences,0,0
142606,the,0,0
142607,results,0,0
142608,of,0,0
142609,a,0,0
142610,randomized,0,0
142611,intervention,0,1
142612,trial,0,0
142613,.,0,0
142614,This,0,0
142615,study,0,0
142616,evaluates,0,0
142617,how,0,0
142618,much,0,0
142619,the,0,0
142620,effects,0,0
142621,of,0,0
142622,intervention,0,1
142623,programs,0,1
142624,are,0,0
142625,influenced,0,0
142626,by,0,0
142627,pre-existing,0,0
142628,psychological,0,0
142629,adjustment,0,0
142630,and,0,0
142631,self-esteem,0,0
142632,levels,0,0
142633,in,0,0
142634,kindergarten,0,0
142635,and,0,0
142636,first,0,0
142637,grade,0,0
142638,children,0,0
142639,with,0,0
142640,poor,0,0
142641,visual-motor,0,1
142642,integration,0,1
142643,skills,0,0
142644,",",0,0
142645,from,0,0
142646,low,0,0
142647,socioeconomic,0,0
142648,backgrounds,0,0
142649,.,0,0
142650,One,0,0
142651,hundred,0,0
142652,and,0,0
142653,sixteen,0,0
142654,mainstream,0,1
142655,kindergarten,0,0
142656,and,0,0
142657,first-grade,0,0
142658,children,0,0
142659,",",0,0
142660,from,0,0
142661,low,0,0
142662,socioeconomic,0,0
142663,backgrounds,0,0
142664,",",0,0
142665,scoring,0,0
142666,below,0,0
142667,the,0,0
142668,25th,0,0
142669,percentile,0,0
142670,on,0,0
142671,a,0,0
142672,measure,0,0
142673,of,0,0
142674,visual-motor,0,1
142675,integration,0,1
142676,(,0,1
142677,VMI,0,1
142678,),0,1
142679,were,0,0
142680,recruited,0,0
142681,and,0,0
142682,randomly,0,0
142683,divided,0,0
142684,into,0,0
142685,two,0,0
142686,parallel,0,0
142687,intervention,0,1
142688,groups,0,0
142689,.,0,0
142690,One,0,0
142691,intervention,0,1
142692,group,0,0
142693,received,0,1
142694,directive,1,1
142695,visual-motor,1,1
142696,intervention,1,1
142697,(,1,1
142698,DVMI,1,1
142699,),1,0
142700,",",0,0
142701,while,0,0
142702,the,0,0
142703,second,0,0
142704,intervention,0,1
142705,group,0,0
142706,received,0,1
142707,a,0,0
142708,non-directive,1,1
142709,supportive,1,1
142710,intervention,1,1
142711,(,1,1
142712,NDSI,1,1
142713,),1,0
142714,.,1,0
142715,Tests,0,0
142716,were,0,0
142717,administered,0,0
142718,to,0,0
142719,evaluate,0,0
142720,visual-motor,0,1
142721,integration,0,1
142722,skills,0,1
142723,outcome,0,0
142724,.,0,0
142725,Children,0,0
142726,with,0,0
142727,higher,0,0
142728,baseline,0,0
142729,measures,0,0
142730,of,0,0
142731,psychological,0,0
142732,adjustment,0,0
142733,and,0,0
142734,self-esteem,0,0
142735,responded,0,0
142736,better,0,0
142737,in,0,0
142738,NDSI,1,1
142739,while,0,0
142740,children,0,0
142741,with,0,0
142742,lower,0,0
142743,baseline,0,0
142744,performance,0,0
142745,on,0,0
142746,psychological,0,0
142747,adjustment,0,0
142748,and,0,0
142749,self-esteem,0,0
142750,responded,0,0
142751,better,0,0
142752,in,0,0
142753,DVMI,1,1
142754,.,1,0
142755,This,0,0
142756,study,0,0
142757,suggests,0,0
142758,that,0,0
142759,children,0,0
142760,from,0,0
142761,low,0,0
142762,socioeconomic,0,0
142763,backgrounds,0,0
142764,with,0,0
142765,low,0,0
142766,VMI,0,1
142767,performance,0,0
142768,scores,0,0
142769,will,0,0
142770,benefit,0,0
142771,more,0,0
142772,from,0,0
142773,intervention,0,1
142774,programs,0,1
142775,if,0,0
142776,clinicians,0,0
142777,choose,0,0
142778,the,0,0
142779,type,0,0
142780,of,0,0
142781,intervention,0,1
142782,according,0,0
142783,to,0,0
142784,baseline,0,0
142785,psychological,0,0
142786,adjustment,0,0
142787,and,0,0
142788,self-esteem,0,0
142789,measures,0,0
142790,.,0,0
142791,The,0,0
142792,prognostic,0,0
142793,value,0,0
142794,of,0,0
142795,testicular,1,0
142796,biopsy,1,1
142797,in,0,0
142798,childhood,0,0
142799,acute,0,0
142800,lymphoblastic,0,0
142801,leukemia,0,0
142802,:,0,0
142803,a,0,0
142804,report,0,0
142805,from,0,0
142806,the,0,0
142807,Childrens,0,0
142808,Cancer,0,0
142809,Study,0,0
142810,Group,0,0
142811,.,0,0
142812,One,0,0
142813,of,0,0
142814,the,0,0
142815,objectives,0,0
142816,of,0,0
142817,Childrens,0,0
142818,Cancer,0,1
142819,Study,0,0
142820,Group,0,0
142821,(,0,1
142822,CCSG,0,1
142823,),0,1
142824,study,0,0
142825,141,0,0
142826,(,0,0
142827,CCG-141,0,1
142828,),0,1
142829,was,0,0
142830,to,0,0
142831,determine,0,0
142832,the,0,0
142833,frequency,0,0
142834,of,0,0
142835,occult,0,0
142836,testicular,0,1
142837,leukemia,0,0
142838,(,0,1
142839,TL,0,0
142840,),0,1
142841,after,0,0
142842,3,0,0
142843,years,0,0
142844,of,0,0
142845,disease-free,0,0
142846,survival,0,0
142847,(,0,1
142848,DFS,0,1
142849,),0,1
142850,and,0,0
142851,to,0,0
142852,retreat,0,1
142853,boys,0,0
142854,with,0,0
142855,occult,0,0
142856,TL,0,0
142857,to,0,0
142858,prolong,0,0
142859,their,0,0
142860,subsequent,0,0
142861,DFS,0,0
142862,.,0,0
142863,Of,0,0
142864,the,0,0
142865,494,0,0
142866,boys,0,0
142867,entered,0,0
142868,on,0,0
142869,study,0,0
142870,",",0,0
142871,255,0,0
142872,(,0,0
142873,51.6,0,0
142874,%,0,0
142875,),0,0
142876,were,0,0
142877,in,0,0
142878,complete,0,0
142879,continuous,0,1
142880,remission,0,0
142881,(,0,1
142882,CCR,0,1
142883,),0,1
142884,3,0,0
142885,years,0,0
142886,after,0,0
142887,entering,0,0
142888,remission,0,0
142889,and,0,0
142890,an,0,0
142891,additional,0,0
142892,eight,0,0
142893,were,0,0
142894,in,0,0
142895,CCR,0,0
142896,3,0,0
142897,years,0,0
142898,after,0,0
142899,localized,0,0
142900,extramedullary,0,0
142901,relapse,0,0
142902,and,0,0
142903,retreatment,0,0
142904,;,0,0
142905,263,0,0
142906,boys,0,0
142907,were,0,0
142908,eligible,0,0
142909,for,0,0
142910,testicular,1,0
142911,biopsy,1,1
142912,.,1,0
142913,Elective,0,0
142914,testicular,1,0
142915,biopsy,1,1
142916,was,0,0
142917,performed,0,0
142918,on,0,0
142919,235,0,0
142920,(,0,0
142921,89.4,0,0
142922,%,0,0
142923,),0,0
142924,boys,0,0
142925,.,0,0
142926,Of,0,0
142927,the,0,0
142928,204,0,0
142929,(,0,0
142930,86.8,0,0
142931,%,0,0
142932,),0,0
142933,boys,0,0
142934,with,0,0
142935,negative,0,0
142936,biopsies,0,0
142937,",",0,0
142938,175,0,0
142939,(,0,0
142940,85.8,0,0
142941,%,0,0
142942,),0,0
142943,remained,0,0
142944,in,0,0
142945,CCR,0,0
142946,10,0,0
142947,to,0,0
142948,12,0,0
142949,years,0,0
142950,after,0,0
142951,diagnosis,0,0
142952,and,0,0
142953,25,0,0
142954,(,0,0
142955,12.3,0,0
142956,%,0,0
142957,),0,0
142958,relapsed,0,0
142959,",",0,0
142960,11,0,0
142961,(,0,0
142962,44,0,0
142963,%,0,0
142964,),0,0
142965,of,0,0
142966,whom,0,0
142967,died,0,0
142968,.,0,0
142969,Isolated,0,0
142970,overt,0,0
142971,TL,0,0
142972,occurred,0,0
142973,in,0,0
142974,four,0,0
142975,(,0,0
142976,2.0,0,1
142977,%,0,0
142978,),0,0
142979,and,0,0
142980,all,0,0
142981,remained,0,0
142982,in,0,0
142983,CCR,0,0
142984,22+,0,0
142985,to,0,0
142986,60+,0,0
142987,months,0,0
142988,after,0,0
142989,re-treatment,0,0
142990,.,0,0
142991,Of,0,0
142992,the,0,0
142993,26,0,0
142994,boys,0,0
142995,with,0,0
142996,occult,0,0
142997,TL,0,0
142998,",",0,0
142999,16,0,0
143000,(,0,0
143001,62,0,0
143002,%,0,0
143003,),0,0
143004,remained,0,0
143005,in,0,0
143006,CCR,0,0
143007,.,0,1
143008,Ten,0,0
143009,(,0,0
143010,38,0,0
143011,%,0,0
143012,),0,0
143013,relapsed,0,0
143014,despite,0,0
143015,local,1,1
143016,testicular,1,1
143017,irradiation,1,1
143018,and,0,0
143019,systemic,1,0
143020,re-treatment,1,0
143021,;,1,0
143022,six,0,0
143023,of,0,0
143024,the,0,0
143025,10,0,0
143026,died,0,0
143027,.,0,0
143028,Of,0,0
143029,the,0,0
143030,26,0,0
143031,boys,0,0
143032,who,0,0
143033,did,0,0
143034,not,0,0
143035,undergo,0,0
143036,biopsy,1,0
143037,",",0,0
143038,21,0,0
143039,(,0,0
143040,80.8,0,0
143041,%,0,0
143042,),0,0
143043,remained,0,0
143044,in,0,0
143045,CCR,0,0
143046,;,0,0
143047,two,0,0
143048,(,0,0
143049,7.7,0,0
143050,%,0,0
143051,),0,0
143052,developed,0,0
143053,isolated,0,0
143054,overt,0,0
143055,TL,0,0
143056,.,0,0
143057,DFS,0,0
143058,after,0,0
143059,testicular,1,0
143060,biopsy,1,1
143061,was,0,0
143062,significantly,0,0
143063,better,0,0
143064,in,0,0
143065,boys,0,0
143066,without,0,0
143067,occult,0,0
143068,TL,0,1
143069,(,0,0
143070,P,0,0
143071,=,0,0
143072,.001,0,0
143073,),0,0
143074,.,0,0
143075,Occult,0,0
143076,TL,0,0
143077,after,0,0
143078,3,0,0
143079,years,0,0
143080,of,0,0
143081,CCR,0,1
143082,represents,0,0
143083,aggressive,0,0
143084,minimal-residual,0,0
143085,disease,0,0
143086,and,0,0
143087,carries,0,0
143088,a,0,0
143089,worse,0,0
143090,prognosis,0,0
143091,than,0,0
143092,absence,0,0
143093,of,0,0
143094,TL,0,0
143095,.,0,0
143096,Initial,0,0
143097,treatment,0,0
143098,should,0,0
143099,be,0,0
143100,directed,0,0
143101,at,0,0
143102,obviating,0,0
143103,occult,0,0
143104,and,0,0
143105,overt,0,0
143106,testicular,0,0
143107,relapse,0,0
143108,.,0,0
143109,Conventional,0,0
143110,therapy,0,1
143111,as,0,0
143112,used,0,0
143113,in,0,0
143114,this,0,0
143115,study,0,0
143116,was,0,0
143117,suboptimal,0,0
143118,in,0,0
143119,preventing,0,0
143120,subsequent,0,0
143121,bone,0,1
143122,marrow,0,0
143123,(,0,1
143124,BM,0,1
143125,),0,1
143126,relapse,0,0
143127,and,0,0
143128,death,0,0
143129,.,0,0
143130,If,0,0
143131,occult,0,0
143132,TR,0,0
143133,is,0,0
143134,identified,0,0
143135,during,0,0
143136,or,0,0
143137,at,0,0
143138,the,0,0
143139,end,0,0
143140,of,0,0
143141,planned,0,0
143142,therapy,0,1
143143,",",0,0
143144,a,0,0
143145,higher,0,0
143146,salvage,0,0
143147,rate,0,0
143148,may,0,0
143149,require,0,0
143150,intensified,0,0
143151,alternate,0,1
143152,therapy,0,1
143153,.,0,0
143154,As,0,0
143155,such,0,0
143156,",",0,0
143157,testicular,1,0
143158,biopsies,1,0
143159,may,0,0
143160,be,0,0
143161,clinically,0,0
143162,useful,0,0
143163,.,0,0
143164,Further,0,0
143165,investigation,0,0
143166,is,0,0
143167,limited,0,0
143168,by,0,0
143169,the,0,0
143170,relative,0,0
143171,rarity,0,0
143172,of,0,0
143173,",",0,0
143174,and,0,0
143175,the,0,0
143176,lack,0,0
143177,of,0,0
143178,identifying,0,0
143179,features,0,0
143180,in,0,0
143181,boys,0,0
143182,with,0,0
143183,occult,0,0
143184,TL,0,0
143185,.,0,0
143186,[,0,0
143187,Clinical,0,0
143188,efficiency,0,0
143189,of,0,0
143190,cytokines,1,0
143191,in,0,0
143192,prophylactics,0,1
143193,and,0,0
143194,treatment,0,0
143195,of,0,0
143196,infectious,0,0
143197,and,0,0
143198,inflammatory,0,0
143199,complications,0,0
143200,after,0,0
143201,oral,0,1
143202,surgery,0,1
143203,procedures,0,0
143204,],0,0
143205,.,0,0
143206,The,0,0
143207,study,0,0
143208,presents,0,0
143209,the,0,0
143210,results,0,0
143211,of,0,0
143212,prevention,0,0
143213,and,0,0
143214,treatment,0,0
143215,of,0,0
143216,infectious,0,0
143217,and,0,0
143218,inflammatory,0,0
143219,complications,0,0
143220,after,0,0
143221,oral,0,1
143222,surgery,0,0
143223,procedures,0,0
143224,.,0,0
143225,Combined,1,0
143226,therapy,1,1
143227,with,1,0
143228,antibiotics,1,1
143229,and,1,0
143230,superlimf,1,1
143231,promotes,0,0
143232,a,0,0
143233,more,0,0
143234,rapid,0,0
143235,reduction,0,0
143236,in,0,0
143237,the,0,0
143238,duration,0,0
143239,of,0,0
143240,clinical,0,0
143241,symptoms,0,0
143242,and,0,0
143243,duration,0,0
143244,of,0,0
143245,treatment,0,0
143246,than,0,0
143247,monotherapy,1,1
143248,with,1,0
143249,antibiotics,1,1
143250,.,1,0
143251,Results,0,0
143252,of,0,0
143253,the,0,0
143254,study,0,0
143255,substantiate,0,0
143256,the,0,0
143257,feasibility,0,0
143258,of,0,0
143259,using,0,0
143260,superlimf,1,1
143261,in,0,0
143262,outpatient,0,0
143263,oral,0,1
143264,surgical,0,1
143265,procedures,0,0
143266,for,0,0
143267,infectious,0,0
143268,and,0,0
143269,inflammatory,0,0
143270,complications,0,0
143271,treatment,0,0
143272,.,0,0
143273,Junctional,0,1
143274,ectopic,0,1
143275,tachycardia,0,0
143276,after,0,0
143277,congenital,0,0
143278,heart,0,0
143279,surgery,0,1
143280,in,0,0
143281,the,0,0
143282,current,0,0
143283,surgical,0,0
143284,era,0,0
143285,.,0,0
143286,To,0,0
143287,determine,0,0
143288,the,0,0
143289,incidence,0,0
143290,of,0,0
143291,postoperative,0,0
143292,junctional,1,0
143293,ectopic,1,1
143294,tachycardia,1,0
143295,(,0,1
143296,JET,0,0
143297,),0,1
143298,in,0,0
143299,a,0,0
143300,modern,0,0
143301,cohort,0,0
143302,of,0,0
143303,pediatric,0,0
143304,patients,0,0
143305,",",0,0
143306,evaluate,0,0
143307,possible,0,0
143308,risk,0,0
143309,factors,0,0
143310,for,0,0
143311,JET,0,0
143312,",",0,0
143313,and,0,0
143314,examine,0,0
143315,the,0,0
143316,effects,0,0
143317,of,0,0
143318,JET,0,0
143319,on,0,0
143320,postoperative,0,0
143321,morbidity,0,0
143322,and,0,0
143323,mortality,0,0
143324,.,0,1
143325,JET,0,0
143326,is,0,0
143327,common,0,0
143328,after,0,0
143329,congenital,0,0
143330,heart,0,0
143331,surgery,0,1
143332,.,0,0
143333,JET-related,0,0
143334,mortality,0,0
143335,has,0,0
143336,been,0,0
143337,a,0,0
143338,rare,0,0
143339,event,0,0
143340,at,0,0
143341,our,0,0
143342,center,0,0
143343,",",0,0
143344,which,0,0
143345,is,0,0
143346,different,0,0
143347,from,0,0
143348,previous,0,0
143349,reports,0,0
143350,.,0,0
143351,We,0,0
143352,reviewed,0,0
143353,records,0,0
143354,for,0,0
143355,pediatric,0,0
143356,patients,0,0
143357,who,0,0
143358,had,0,0
143359,postoperative,0,0
143360,arrhythmias,0,0
143361,between,0,0
143362,January,0,0
143363,2006,0,0
143364,and,0,0
143365,June,0,0
143366,2010,0,0
143367,at,0,0
143368,a,0,0
143369,large,0,0
143370,tertiary-care,0,0
143371,children,0,0
143372,'s,0,0
143373,hospital,0,0
143374,.,0,0
143375,We,0,0
143376,performed,0,0
143377,a,0,0
143378,matched,0,0
143379,case-control,0,0
143380,study,0,0
143381,to,0,0
143382,identify,0,0
143383,risk,0,0
143384,factors,0,0
143385,for,0,0
143386,JET,0,0
143387,and,0,0
143388,a,0,0
143389,matched-cohort,0,0
143390,study,0,0
143391,to,0,0
143392,compare,0,0
143393,outcomes,0,0
143394,between,0,0
143395,patients,0,0
143396,and,0,0
143397,controls,0,0
143398,.,0,0
143399,Whenever,0,0
143400,possible,0,0
143401,",",0,0
143402,each,0,0
143403,JET,0,0
143404,case,0,0
143405,was,0,0
143406,randomly,0,0
143407,matched,0,0
143408,to,0,0
143409,two,0,0
143410,controls,0,0
143411,on,0,0
143412,the,0,0
143413,basis,0,0
143414,of,0,0
143415,lesion,0,0
143416,",",0,0
143417,repair,0,1
143418,",",0,0
143419,and,0,0
143420,surgical,0,1
143421,period,0,0
143422,.,0,0
143423,We,0,0
143424,identified,0,0
143425,54,0,0
143426,patients,0,0
143427,with,0,0
143428,JET,0,0
143429,(,0,0
143430,incidence,0,0
143431,=,0,0
143432,1.4,0,0
143433,%,0,0
143434,),0,0
143435,.,0,0
143436,After,0,0
143437,multivariate,0,0
143438,logistic,0,0
143439,regression,0,0
143440,analysis,0,0
143441,",",0,0
143442,low,0,0
143443,operative,0,0
143444,weight,0,0
143445,",",0,0
143446,cardiopulmonary,0,1
143447,bypass,0,1
143448,(,0,1
143449,CPB,0,1
143450,),0,1
143451,duration,0,0
143452,>,0,0
143453,100,0,0
143454,min,0,0
143455,",",0,0
143456,and,0,0
143457,immediate,0,1
143458,postoperative,0,0
143459,serum,0,0
143460,lactic,0,1
143461,acid,0,1
143462,level,0,0
143463,>,0,0
143464,20,0,0
143465,mg/dl,0,0
143466,were,0,0
143467,associated,0,0
143468,with,0,0
143469,increased,0,0
143470,odds,0,0
143471,of,0,0
143472,developing,0,0
143473,JET,0,0
143474,.,0,0
143475,Patients,0,0
143476,with,0,0
143477,JET,1,0
143478,had,0,0
143479,longer,0,0
143480,mechanical,0,0
143481,ventilation,0,1
143482,time,0,0
143483,",",0,0
143484,cardiac,0,0
143485,intensive,0,1
143486,care,0,1
143487,unit,0,1
143488,(,0,1
143489,CICU,0,1
143490,),0,1
143491,stay,0,0
143492,",",0,0
143493,and,0,0
143494,hospital,0,0
143495,stay,0,0
143496,.,0,0
143497,There,0,0
143498,was,0,0
143499,only,0,0
143500,one,0,0
143501,death,0,0
143502,in,0,0
143503,JET,0,0
143504,group,0,1
143505,(,0,0
143506,1.8,0,0
143507,%,0,0
143508,),0,0
143509,with,0,0
143510,no,0,0
143511,significant,0,0
143512,difference,0,0
143513,compared,0,0
143514,with,0,0
143515,the,0,0
143516,control,0,0
143517,group,0,0
143518,.,0,0
143519,JET,0,0
143520,remains,0,0
143521,a,0,0
143522,relatively,0,0
143523,common,0,0
143524,postoperative,0,0
143525,arrhythmia,0,0
143526,",",0,0
143527,but,0,0
143528,it,0,0
143529,is,0,0
143530,less,0,0
143531,frequent,0,0
143532,than,0,0
143533,previously,0,0
143534,reported,0,0
143535,.,0,0
143536,JET,0,0
143537,occurs,0,0
143538,more,0,0
143539,commonly,0,0
143540,in,0,0
143541,smaller,0,0
143542,patients,0,0
143543,with,0,0
143544,longer,0,0
143545,CPB,0,0
143546,runs,0,0
143547,and,0,0
143548,significant,0,0
143549,postoperative,0,0
143550,lactic,0,1
143551,acidosis,0,0
143552,levels,0,0
143553,.,0,0
143554,Mortality,0,0
143555,associated,0,0
143556,with,0,0
143557,JET,0,0
143558,is,0,0
143559,lower,0,0
143560,than,0,0
143561,historically,0,0
143562,reported,0,0
143563,",",0,0
143564,but,0,0
143565,morbidity,0,0
143566,remains,0,0
143567,high,0,0
143568,.,0,0
143569,Airway,0,0
143570,responses,0,0
143571,and,0,0
143572,inflammation,0,0
143573,in,0,0
143574,subjects,0,0
143575,with,0,0
143576,asthma,0,0
143577,after,0,0
143578,four,0,0
143579,days,0,0
143580,of,0,0
143581,repeated,1,0
143582,high-single-dose,1,1
143583,allergen,1,1
143584,challenge,1,0
143585,.,1,0
143586,BACKGROUND,0,0
143587,Both,0,1
143588,standard,0,1
143589,and,0,0
143590,low-dose,0,1
143591,allergen,0,1
143592,provocations,0,0
143593,are,0,0
143594,an,0,0
143595,established,0,0
143596,tool,0,0
143597,in,0,0
143598,asthma,0,0
143599,research,0,0
143600,to,0,0
143601,improve,0,0
143602,our,0,0
143603,understanding,0,0
143604,of,0,0
143605,the,0,0
143606,pathophysiological,0,0
143607,mechanism,0,0
143608,of,0,0
143609,allergic,0,0
143610,asthma,0,0
143611,.,0,0
143612,However,0,0
143613,",",0,0
143614,clinical,0,0
143615,symptoms,0,0
143616,are,0,0
143617,less,0,0
143618,likely,0,0
143619,to,0,0
143620,be,0,0
143621,induced,0,0
143622,.,0,0
143623,Therefore,0,0
143624,",",0,0
143625,we,0,0
143626,designed,0,0
143627,a,0,0
143628,protocol,0,0
143629,for,0,0
143630,repetitive,0,1
143631,high-dose,0,1
143632,bronchial,0,0
143633,allergen,0,1
143634,challenges,0,0
143635,to,0,0
143636,generate,0,0
143637,clinical,0,0
143638,symptoms,0,0
143639,and,0,0
143640,airway,0,0
143641,inflammation,0,0
143642,.,0,0
143643,METHODS,0,0
143644,A,0,0
143645,total,0,0
143646,of,0,0
143647,27,0,0
143648,patients,0,0
143649,aged,0,0
143650,18,0,0
143651,to,0,0
143652,40,0,0
143653,years,0,0
143654,with,0,0
143655,positive,0,0
143656,skin-prick,0,0
143657,tests,0,0
143658,and,0,0
143659,mild,0,0
143660,asthma,0,0
143661,underwent,0,0
143662,repetitive,1,1
143663,high-dose,1,1
143664,allergen,1,1
143665,challenges,1,0
143666,with,1,0
143667,household,1,1
143668,dust,1,0
143669,mites,1,0
143670,for,1,0
143671,four,1,0
143672,consecutive,1,0
143673,days,1,0
143674,.,1,0
143675,Pulmonary,0,0
143676,function,0,0
143677,and,0,0
143678,exhaled,0,0
143679,NO,0,1
143680,were,0,0
143681,measured,0,0
143682,at,0,0
143683,every,0,0
143684,visit,0,0
143685,.,0,0
143686,Induced,0,0
143687,sputum,0,0
143688,was,0,0
143689,analysed,0,0
143690,before,0,0
143691,and,0,0
143692,after,0,0
143693,the,0,0
143694,allergen,0,1
143695,challenges,0,0
143696,for,0,0
143697,cell,0,0
143698,counts,0,0
143699,",",0,0
143700,ECP,0,0
143701,",",0,0
143702,IL-5,0,1
143703,",",0,0
143704,INF-?,0,0
143705,",",0,0
143706,IL-8,0,1
143707,",",0,0
143708,and,0,0
143709,the,0,0
143710,transcription,0,0
143711,factor,0,0
143712,Foxp3,0,1
143713,.,0,0
143714,RESULTS,0,0
143715,We,0,0
143716,found,0,0
143717,a,0,0
143718,significant,0,0
143719,decrease,0,0
143720,in,0,0
143721,pulmonary,0,0
143722,function,0,0
143723,",",0,0
143724,an,0,0
143725,increased,0,0
143726,use,0,0
143727,of,0,0
143728,salbutamol,0,1
143729,and,0,0
143730,the,0,0
143731,development,0,0
143732,of,0,0
143733,a,0,0
143734,late,0,0
143735,asthmatic,0,0
143736,response,0,0
143737,and,0,0
143738,bronchial,0,0
143739,hyperresponsiveness,0,0
143740,",",0,0
143741,as,0,0
143742,well,0,0
143743,as,0,0
143744,a,0,0
143745,significant,0,0
143746,induction,0,0
143747,of,0,0
143748,eNO,0,0
143749,",",0,0
143750,eosinophils,0,0
143751,",",0,0
143752,and,0,0
143753,Th-2,0,0
143754,cytokines,0,1
143755,.,0,0
143756,Repeated,0,0
143757,provocation,0,0
143758,was,0,0
143759,feasible,0,0
143760,in,0,0
143761,the,0,0
143762,majority,0,0
143763,of,0,0
143764,patients,0,0
143765,.,0,0
143766,Two,0,0
143767,subjects,0,0
143768,had,0,0
143769,severe,0,0
143770,adverse,0,0
143771,events,0,0
143772,requiring,1,0
143773,prednisolone,1,1
143774,to,0,0
143775,cope,0,0
143776,with,0,0
143777,nocturnal,0,0
143778,asthma,0,0
143779,symptoms,0,0
143780,.,0,0
143781,CONCLUSIONS,0,0
143782,Repeated,0,0
143783,high-dose,0,1
143784,bronchial,0,0
143785,allergen,0,1
143786,challenges,0,0
143787,resulted,0,0
143788,in,0,0
143789,severe,0,0
143790,asthma,0,0
143791,symptoms,0,0
143792,and,0,0
143793,marked,0,0
143794,Th-2-mediated,0,0
143795,allergic,0,0
143796,airway,0,0
143797,inflammation,0,0
143798,.,0,0
143799,The,0,0
143800,high-dose,0,1
143801,challenge,0,0
143802,model,0,0
143803,is,0,0
143804,suitable,0,0
143805,only,0,0
143806,in,0,0
143807,an,0,0
143808,attenuated,0,0
143809,form,0,0
143810,in,0,0
143811,diseased,0,0
143812,volunteers,0,0
143813,for,0,0
143814,proof-of-concept,0,0
143815,studies,0,0
143816,and,0,0
143817,in,0,0
143818,clinical,0,0
143819,settings,0,0
143820,to,0,0
143821,reduce,0,0
143822,the,0,0
143823,risk,0,0
143824,of,0,0
143825,severe,0,0
143826,asthma,0,0
143827,exacerbations,0,0
143828,.,0,0
143829,TRIAL,0,0
143830,REGISTRATION,0,0
143831,ClinicalTrials.govNCT00677209,0,0
143832,.,0,0
143833,Memantine,1,1
143834,as,0,0
143835,adjunctive,0,1
143836,treatment,0,0
143837,to,0,0
143838,risperidone,1,1
143839,in,0,0
143840,children,0,0
143841,with,0,0
143842,autistic,0,0
143843,disorder,0,0
143844,:,0,0
143845,a,0,0
143846,randomized,0,0
143847,",",0,0
143848,double-blind,0,0
143849,",",0,0
143850,placebo-controlled,1,1
143851,trial,0,0
143852,.,0,0
143853,Autism,0,0
143854,is,0,0
143855,a,0,0
143856,neurodevelopmental,0,0
143857,disorder,0,0
143858,that,0,0
143859,causes,0,0
143860,significant,0,0
143861,impairment,0,0
143862,in,0,0
143863,socialization,0,1
143864,and,0,0
143865,communication,0,1
143866,.,0,0
143867,It,0,0
143868,is,0,0
143869,also,0,0
143870,associated,0,0
143871,with,0,0
143872,ritualistic,0,1
143873,and,0,0
143874,stereotypical,0,0
143875,behaviour,0,0
143876,.,0,0
143877,Recent,0,0
143878,studies,0,0
143879,propose,0,0
143880,both,0,0
143881,hyper-and,0,0
143882,hypoglutamatergic,0,0
143883,ideologies,0,1
143884,for,0,0
143885,autism,0,0
143886,.,0,0
143887,The,0,0
143888,objective,0,0
143889,of,0,0
143890,this,0,0
143891,study,0,0
143892,was,0,0
143893,to,0,0
143894,assess,0,0
143895,the,0,0
143896,effects,0,0
143897,of,0,0
143898,memantine,1,1
143899,plus,1,1
143900,risperidone,1,1
143901,in,0,0
143902,the,0,0
143903,treatment,0,0
143904,of,0,0
143905,children,0,0
143906,with,0,0
143907,autism,0,0
143908,.,0,0
143909,Children,0,0
143910,with,0,0
143911,autism,0,0
143912,were,0,0
143913,randomly,0,0
143914,allocated,0,0
143915,to,0,0
143916,risperidone,1,1
143917,plus,1,1
143918,memantine,1,1
143919,or,0,1
143920,placebo,1,1
143921,plus,1,1
143922,risperidone,1,1
143923,for,0,0
143924,a,0,0
143925,10-wk,0,0
143926,",",0,0
143927,double-blind,0,0
143928,",",0,0
143929,placebo-controlled,0,1
143930,study,0,0
143931,.,0,0
143932,The,0,0
143933,dose,0,0
143934,of,0,0
143935,risperidone,1,1
143936,was,0,0
143937,titrated,0,0
143938,up,0,0
143939,to,0,0
143940,3,0,0
143941,mg/d,0,1
143942,and,1,0
143943,memantine,1,1
143944,was,0,0
143945,titrated,0,0
143946,to,0,0
143947,20,0,0
143948,mg/d,0,0
143949,.,0,0
143950,Children,0,0
143951,were,0,0
143952,assessed,0,0
143953,at,0,0
143954,baseline,0,0
143955,and,0,0
143956,after,0,0
143957,2,0,0
143958,",",0,0
143959,4,0,0
143960,",",0,0
143961,6,0,0
143962,",",0,0
143963,8,0,0
143964,and,0,0
143965,10,0,0
143966,wk,0,0
143967,of,0,0
143968,starting,0,0
143969,medication,0,1
143970,protocol,0,1
143971,.,0,0
143972,The,0,0
143973,primary,0,0
143974,outcome,0,0
143975,measure,0,0
143976,was,0,0
143977,the,0,0
143978,irritability,0,0
143979,subscale,0,0
143980,of,0,0
143981,Aberrant,0,0
143982,Behavior,0,0
143983,Checklist-Community,0,0
143984,(,0,1
143985,ABC-C,0,1
143986,),0,1
143987,.,0,0
143988,Difference,0,0
143989,between,0,0
143990,the,0,0
143991,two,0,0
143992,treatment,0,0
143993,arms,0,0
143994,was,0,0
143995,significant,0,0
143996,as,0,0
143997,the,0,0
143998,group,0,0
143999,that,0,0
144000,received,1,0
144001,memantine,1,1
144002,had,1,0
144003,greater,0,0
144004,reduction,0,0
144005,in,0,0
144006,ABC-C,0,1
144007,subscale,0,0
144008,scores,0,0
144009,for,0,0
144010,irritability,0,0
144011,",",0,0
144012,stereotypic,0,1
144013,behaviour,0,0
144014,and,0,0
144015,hyperactivity,0,0
144016,.,0,0
144017,Eight,0,0
144018,side-effects,0,0
144019,were,0,0
144020,observed,0,0
144021,over,0,0
144022,the,0,0
144023,trial,0,0
144024,",",0,0
144025,out,0,0
144026,of,0,0
144027,the,0,0
144028,25,0,0
144029,side-effects,0,0
144030,that,0,0
144031,the,0,0
144032,checklist,0,0
144033,included,0,0
144034,.,0,0
144035,The,0,0
144036,difference,0,0
144037,between,0,0
144038,the,0,0
144039,two,0,0
144040,groups,0,0
144041,in,0,0
144042,the,0,0
144043,frequency,0,0
144044,of,0,0
144045,side-effects,0,0
144046,was,0,0
144047,not,0,0
144048,significant,0,0
144049,.,0,0
144050,The,0,0
144051,present,0,0
144052,study,0,0
144053,suggests,0,0
144054,that,1,0
144055,memantine,1,1
144056,may,1,0
144057,be,0,0
144058,a,0,0
144059,potential,0,0
144060,adjunctive,0,1
144061,treatment,0,1
144062,strategy,0,0
144063,for,0,0
144064,autism,0,0
144065,and,0,0
144066,it,0,0
144067,was,0,0
144068,generally,0,0
144069,well,0,0
144070,tolerated,0,0
144071,.,0,0
144072,This,0,0
144073,trial,0,0
144074,is,0,0
144075,registered,0,0
144076,with,0,0
144077,the,0,0
144078,Iranian,0,0
144079,Clinical,0,0
144080,Trials,0,1
144081,Registry,0,0
144082,(,0,0
144083,IRCT1138901151556N10,0,1
144084,;,0,1
144085,www.irct.ir,0,0
144086,),0,0
144087,.,0,0
144088,The,0,0
144089,role,0,0
144090,of,0,0
144091,nasal,1,0
144092,IgA,1,0
144093,in,0,0
144094,children,0,0
144095,vaccinated,0,0
144096,with,0,0
144097,live,0,1
144098,attenuated,0,0
144099,influenza,0,1
144100,vaccine,0,1
144101,.,0,0
144102,BACKGROUND,0,0
144103,Immunoglobulin,1,1
144104,A,1,0
144105,(,1,1
144106,IgA,1,1
144107,),1,1
144108,is,0,0
144109,the,0,0
144110,predominant,0,0
144111,antibody,0,0
144112,produced,0,0
144113,in,0,0
144114,response,0,0
144115,to,0,0
144116,mucosal,0,0
144117,infections,0,0
144118,.,0,0
144119,The,0,0
144120,role,0,0
144121,of,0,0
144122,IgA,1,0
144123,in,0,0
144124,providing,0,0
144125,protection,0,0
144126,against,0,0
144127,influenza,0,1
144128,in,0,0
144129,children,0,0
144130,vaccinated,0,0
144131,with,0,0
144132,live,1,1
144133,attenuated,1,0
144134,influenza,1,1
144135,vaccine,1,1
144136,(,1,1
144137,LAIV,1,0
144138,),1,1
144139,has,0,0
144140,not,0,0
144141,been,0,0
144142,well,0,0
144143,described,0,0
144144,.,0,0
144145,METHODS,0,0
144146,Nasal,0,0
144147,IgA,0,0
144148,responses,0,0
144149,were,0,0
144150,assessed,0,0
144151,using,0,0
144152,data,0,0
144153,from,0,0
144154,3,0,0
144155,prospective,0,0
144156,",",0,0
144157,2-year,0,0
144158,",",0,0
144159,randomized,0,0
144160,studies,0,0
144161,comparing,0,0
144162,LAIV,1,0
144163,with,0,0
144164,placebo,1,1
144165,in,0,0
144166,children,0,0
144167,6-36,0,0
144168,months,0,0
144169,of,0,0
144170,age,0,0
144171,.,0,0
144172,In,0,0
144173,each,0,0
144174,study,0,0
144175,",",0,0
144176,samples,0,0
144177,were,0,0
144178,collected,0,0
144179,in,0,0
144180,a,0,0
144181,subset,0,0
144182,of,0,0
144183,patients,0,0
144184,;,0,0
144185,a,0,0
144186,new,0,0
144187,cohort,0,0
144188,was,0,0
144189,enrolled,0,0
144190,each,0,0
144191,year,0,0
144192,.,0,0
144193,Ratios,0,0
144194,of,0,0
144195,strain-specific,0,0
144196,nasal,1,0
144197,IgA,1,0
144198,to,0,0
144199,total,0,0
144200,nasal,0,0
144201,IgA,0,0
144202,were,0,0
144203,calculated,0,0
144204,and,0,0
144205,prevaccination,0,1
144206,to,0,0
144207,postvaccination,0,0
144208,geometric,0,0
144209,mean,0,0
144210,fold-rises,0,0
144211,(,0,0
144212,GMFRs,0,1
144213,),0,1
144214,were,0,0
144215,evaluated,0,0
144216,.,0,0
144217,Mean,0,0
144218,postvaccination,0,0
144219,IgA,1,0
144220,ratios,0,0
144221,were,0,0
144222,compared,0,0
144223,for,0,0
144224,subjects,0,0
144225,with,0,0
144226,and,0,0
144227,without,0,1
144228,confirmed,0,0
144229,influenza,0,1
144230,illness,0,0
144231,by,0,0
144232,study,0,0
144233,and,0,0
144234,in,0,0
144235,pooled,0,0
144236,analyses,0,0
144237,.,0,0
144238,RESULTS,0,0
144239,Across,0,0
144240,studies,0,0
144241,",",0,0
144242,a,0,0
144243,higher,0,0
144244,percentage,0,0
144245,of,0,0
144246,children,0,0
144247,receiving,0,0
144248,LAIV,1,0
144249,had,0,0
144250,a,0,0
144251,?,0,0
144252,2-fold,0,0
144253,increase,0,0
144254,in,0,0
144255,strain-specific,0,0
144256,IgA,0,0
144257,ratio,0,0
144258,compared,0,0
144259,with,0,0
144260,placebo,0,1
144261,recipients,0,0
144262,.,0,0
144263,GMFRs,0,0
144264,after,0,0
144265,LAIV,1,0
144266,in,1,0
144267,years,0,0
144268,1,0,0
144269,and,0,0
144270,2,0,0
144271,ranged,0,0
144272,from,0,0
144273,1.2,0,0
144274,to,0,0
144275,6.2,0,0
144276,",",0,0
144277,compared,0,0
144278,with,0,0
144279,0.5-2.2,0,0
144280,among,0,0
144281,placebo,0,1
144282,recipients,0,0
144283,.,0,0
144284,Similar,0,0
144285,responses,0,0
144286,were,0,0
144287,observed,0,0
144288,in,0,0
144289,subjects,0,0
144290,who,0,0
144291,were,0,0
144292,baseline,0,0
144293,seronegative,0,0
144294,and,0,0
144295,seropositive,0,0
144296,based,0,0
144297,on,0,0
144298,serum,0,0
144299,hemagglutination,0,0
144300,inhibition,0,0
144301,antibody,0,0
144302,titers,0,0
144303,.,0,0
144304,In,0,0
144305,years,0,0
144306,1,0,0
144307,and,0,0
144308,2,0,0
144309,",",0,0
144310,the,0,0
144311,mean,0,0
144312,postvaccination,0,0
144313,strain-specific,0,0
144314,to,0,0
144315,total,0,0
144316,IgA,0,1
144317,ratio,0,0
144318,was,0,0
144319,3.1-fold,0,0
144320,(,0,0
144321,P,0,0
144322,<,0,0
144323,0.01,0,0
144324,),0,0
144325,and,0,0
144326,2.0-fold,0,0
144327,(,0,0
144328,P,0,0
144329,<,0,0
144330,0.03,0,0
144331,),0,0
144332,higher,0,0
144333,among,0,0
144334,LAIV,0,0
144335,recipients,0,0
144336,with,0,0
144337,no,0,0
144338,evidence,0,0
144339,of,0,0
144340,culture-confirmed,0,0
144341,influenza,0,1
144342,illness,0,0
144343,compared,0,0
144344,with,0,0
144345,LAIV,0,0
144346,recipients,0,0
144347,who,0,0
144348,developed,0,0
144349,culture-confirmed,0,0
144350,influenza,0,1
144351,illness,0,0
144352,;,0,0
144353,a,0,0
144354,similar,0,0
144355,and,0,0
144356,consistent,0,0
144357,trend,0,0
144358,was,0,0
144359,observed,0,0
144360,for,0,0
144361,each,0,0
144362,individual,0,0
144363,study,0,0
144364,and,0,0
144365,type/subtype,0,0
144366,.,0,0
144367,CONCLUSIONS,0,0
144368,The,0,0
144369,current,0,0
144370,analysis,0,0
144371,demonstrates,0,0
144372,that,0,0
144373,nasal,0,0
144374,IgA,0,1
144375,contributes,0,0
144376,to,0,0
144377,the,0,0
144378,efficacy,0,0
144379,of,0,0
144380,LAIV,1,0
144381,and,1,0
144382,can,0,0
144383,provide,0,0
144384,evidence,0,0
144385,of,0,0
144386,vaccine-induced,0,0
144387,immunity,0,0
144388,.,0,0
144389,However,0,0
144390,",",0,0
144391,the,0,0
144392,inherent,0,0
144393,heterogeneity,0,0
144394,in,0,0
144395,nasal,0,0
144396,antibody,0,0
144397,levels,0,0
144398,and,0,0
144399,variability,0,0
144400,in,0,0
144401,nasal,0,0
144402,specimen,0,0
144403,collection,0,0
144404,hinders,0,0
144405,the,0,0
144406,precise,0,0
144407,evaluation,0,0
144408,of,0,0
144409,mucosal,0,0
144410,antibody,0,0
144411,responses,0,0
144412,.,0,0
144413,Other,0,0
144414,studies,0,0
144415,have,0,0
144416,demonstrated,0,0
144417,that,1,0
144418,LAIV-induced,1,0
144419,immunity,1,0
144420,is,0,0
144421,also,0,0
144422,partially,0,0
144423,explained,0,0
144424,by,0,0
144425,T-cell,0,0
144426,immunity,0,0
144427,",",0,0
144428,serum,0,0
144429,antibody,0,0
144430,responses,0,0
144431,",",0,0
144432,and,0,0
144433,innate,0,0
144434,immunity,0,0
144435,",",0,0
144436,consistent,0,0
144437,with,0,0
144438,the,0,0
144439,multi-faceted,0,0
144440,nature,0,0
144441,of,0,0
144442,immunity,0,0
144443,induced,0,0
144444,by,0,0
144445,wild-type,0,0
144446,influenza,0,1
144447,infection,0,0
144448,and,0,0
144449,other,0,0
144450,live,0,1
144451,virus,0,0
144452,vaccines,0,0
144453,.,0,0
144454,A,0,0
144455,home-based,1,1
144456,exercise,1,1
144457,program,1,1
144458,to,0,0
144459,improve,0,0
144460,function,0,0
144461,",",0,0
144462,fatigue,0,0
144463,",",0,0
144464,and,0,0
144465,sleep,0,0
144466,quality,0,0
144467,in,0,0
144468,patients,0,0
144469,with,0,0
144470,Stage,0,0
144471,IV,0,0
144472,lung,0,0
144473,and,0,0
144474,colorectal,0,0
144475,cancer,0,0
144476,:,0,0
144477,a,0,0
144478,randomized,0,0
144479,controlled,0,0
144480,trial,0,0
144481,.,0,0
144482,CONTEXT,0,0
144483,Exercise,0,1
144484,benefits,0,0
144485,patients,0,0
144486,with,0,0
144487,cancer,0,0
144488,",",0,0
144489,but,0,0
144490,studies,0,0
144491,of,0,0
144492,home-based,0,1
144493,approaches,0,0
144494,",",0,0
144495,particularly,0,0
144496,among,0,0
144497,those,0,0
144498,with,0,0
144499,Stage,0,0
144500,IV,0,0
144501,disease,0,0
144502,",",0,0
144503,remain,0,0
144504,small,0,0
144505,and,0,0
144506,exploratory,0,0
144507,.,0,0
144508,OBJECTIVES,0,0
144509,To,0,0
144510,conduct,0,0
144511,an,0,0
144512,adequately,0,0
144513,powered,0,0
144514,trial,0,0
144515,of,0,0
144516,a,0,0
144517,home-based,1,1
144518,exercise,1,1
144519,intervention,1,1
144520,that,0,0
144521,can,0,0
144522,be,0,0
144523,facilely,0,0
144524,integrated,0,1
144525,into,0,0
144526,established,0,0
144527,delivery,0,0
144528,and,0,0
144529,reimbursement,0,0
144530,structures,0,0
144531,.,0,0
144532,METHODS,0,0
144533,Sixty-six,0,0
144534,adults,0,0
144535,with,0,0
144536,Stage,0,0
144537,IV,0,0
144538,lung,0,0
144539,or,0,1
144540,colorectal,0,0
144541,cancer,0,0
144542,were,0,0
144543,randomized,0,0
144544,",",0,0
144545,in,0,0
144546,an,0,0
144547,eight-week,0,0
144548,trial,0,0
144549,",",0,0
144550,to,0,0
144551,usual,1,1
144552,care,1,1
144553,or,1,1
144554,incremental,1,0
144555,walking,1,1
144556,and,1,0
144557,home-based,1,1
144558,strength,1,0
144559,training,1,1
144560,.,1,0
144561,The,0,0
144562,exercising,0,0
144563,participants,0,0
144564,were,0,0
144565,instructed,0,0
144566,during,0,0
144567,a,0,0
144568,single,0,1
144569,physiotherapy,1,1
144570,visit,0,0
144571,and,0,0
144572,subsequently,0,1
144573,exercised,0,1
144574,four,0,0
144575,days,0,0
144576,or,0,0
144577,more,0,0
144578,per,0,0
144579,week,0,0
144580,;,0,0
144581,training,0,1
144582,and,0,0
144583,step-count,0,0
144584,goals,0,0
144585,were,0,0
144586,advanced,0,0
144587,during,0,0
144588,bimonthly,0,1
144589,telephone,0,1
144590,calls,0,0
144591,.,0,0
144592,The,0,0
144593,primary,0,0
144594,outcome,0,0
144595,measure,0,0
144596,was,0,0
144597,mobility,0,0
144598,assessed,0,0
144599,with,0,0
144600,the,0,0
144601,Ambulatory,0,0
144602,Post,0,1
144603,Acute,0,0
144604,Care,0,0
144605,Basic,0,0
144606,Mobility,0,0
144607,Short,0,1
144608,Form,0,1
144609,.,0,0
144610,Secondary,0,0
144611,outcomes,0,0
144612,included,0,0
144613,ratings,0,0
144614,of,0,0
144615,pain,0,0
144616,and,0,0
144617,sleep,0,0
144618,quality,0,0
144619,as,0,0
144620,well,0,0
144621,as,0,0
144622,the,0,0
144623,ability,0,0
144624,to,0,0
144625,perform,0,0
144626,daily,0,1
144627,activities,0,0
144628,(,0,0
144629,Ambulatory,0,0
144630,Post,0,1
144631,Acute,0,0
144632,Care,0,0
144633,Daily,0,0
144634,Activities,0,0
144635,Short,0,1
144636,Form,0,1
144637,),0,0
144638,",",0,0
144639,quality,0,0
144640,of,0,0
144641,life,0,0
144642,(,0,0
144643,Functional,0,1
144644,Assessment,0,1
144645,of,0,0
144646,Cancer,0,1
144647,Therapy-General,0,1
144648,),0,0
144649,",",0,0
144650,and,0,1
144651,fatigue,0,0
144652,(,0,1
144653,Functional,0,1
144654,Assessment,0,1
144655,of,0,0
144656,Cancer,0,1
144657,Therapy-Fatigue,0,1
144658,),0,0
144659,.,0,0
144660,RESULTS,0,0
144661,Three,0,0
144662,participants,0,0
144663,dropped,0,0
144664,out,0,0
144665,and,0,0
144666,seven,0,0
144667,died,0,0
144668,(,0,0
144669,five,0,0
144670,in,0,0
144671,the,0,0
144672,intervention,0,1
144673,and,0,0
144674,two,0,0
144675,in,0,0
144676,the,0,0
144677,control,0,1
144678,group,0,0
144679,",",0,0
144680,P=0.28,0,0
144681,),0,0
144682,.,0,0
144683,At,0,0
144684,Week,0,0
144685,8,0,0
144686,",",0,0
144687,the,0,0
144688,intervention,0,1
144689,group,0,0
144690,reported,0,0
144691,improved,0,0
144692,mobility,0,0
144693,(,0,1
144694,P=0.01,0,0
144695,),0,1
144696,",",0,0
144697,fatigue,0,0
144698,(,0,1
144699,P=0.02,0,0
144700,),0,1
144701,",",0,0
144702,and,0,0
144703,sleep,0,1
144704,quality,0,0
144705,(,0,1
144706,P=0.05,0,0
144707,),0,1
144708,compared,0,0
144709,with,0,0
144710,the,0,0
144711,usual,0,1
144712,care,0,1
144713,group,0,0
144714,",",0,0
144715,but,0,0
144716,did,0,0
144717,not,0,0
144718,differ,0,0
144719,on,0,0
144720,the,0,0
144721,other,0,0
144722,measures,0,0
144723,.,0,0
144724,CONCLUSION,1,0
144725,A,1,0
144726,home-based,1,1
144727,exercise,1,1
144728,program,1,1
144729,seems,0,0
144730,capable,0,0
144731,of,0,0
144732,improving,0,0
144733,the,0,0
144734,mobility,0,0
144735,",",0,0
144736,fatigue,0,0
144737,",",0,0
144738,and,0,0
144739,sleep,0,0
144740,quality,0,0
144741,of,0,0
144742,patients,0,0
144743,with,0,0
144744,Stage,0,0
144745,IV,0,0
144746,lung,0,0
144747,and,0,0
144748,colorectal,0,0
144749,cancer,0,0
144750,.,0,0
144751,Dalteparin,1,1
144752,low,0,0
144753,molecular,0,0
144754,weight,0,1
144755,heparin,1,1
144756,(,0,1
144757,LMWH,0,0
144758,),0,1
144759,in,0,0
144760,ovarian,0,0
144761,cancer,0,0
144762,:,0,0
144763,a,0,0
144764,phase,0,0
144765,II,0,0
144766,randomized,0,0
144767,study,0,0
144768,.,0,0
144769,OBJECTIVE,0,0
144770,Low,0,0
144771,molecular,0,0
144772,weight,0,0
144773,heparin,0,1
144774,reduces,0,0
144775,the,0,0
144776,risk,0,0
144777,of,0,0
144778,venous,0,1
144779,thromboembolism,0,0
144780,(,0,1
144781,VTE,0,1
144782,),0,1
144783,and,0,0
144784,may,0,0
144785,have,0,0
144786,antineoplastic,0,1
144787,effects,0,0
144788,by,0,0
144789,interfering,0,0
144790,with,0,0
144791,angiogenesis,0,0
144792,and,0,0
144793,with,0,0
144794,tumor,0,0
144795,growth,0,1
144796,and,0,0
144797,metastasis,0,0
144798,.,0,0
144799,A,0,0
144800,multicentre,0,0
144801,phase,0,0
144802,II,0,1
144803,randomized,0,0
144804,trial,0,0
144805,was,0,0
144806,done,0,0
144807,to,0,0
144808,evaluate,0,0
144809,the,0,0
144810,antineoplastic,0,1
144811,potential,0,0
144812,of,0,0
144813,dalteparin,1,1
144814,in,0,0
144815,ovarian,0,0
144816,cancer,0,0
144817,(,0,1
144818,OC,0,0
144819,),0,0
144820,.,0,0
144821,MATERIALS,0,0
144822,AND,0,0
144823,METHODS,0,0
144824,Women,0,0
144825,with,0,0
144826,newly-diagnosed,0,0
144827,epithelial,0,0
144828,OC,0,0
144829,were,0,0
144830,randomized,0,0
144831,to,0,0
144832,receive,0,0
144833,standard,1,1
144834,chemotherapy,1,1
144835,(,1,1
144836,CT,1,1
144837,),1,1
144838,and,0,0
144839,one,0,0
144840,of,0,0
144841,3,0,0
144842,doses,0,0
144843,of,0,0
144844,dalteparin,1,1
144845,(,0,0
144846,50,0,1
144847,IU/kg,0,0
144848,",",0,0
144849,100,0,0
144850,IU/kg,0,0
144851,",",0,0
144852,or,0,0
144853,150,0,0
144854,IU/kg,0,1
144855,),0,0
144856,subcutaneously,0,1
144857,once,0,1
144858,daily,0,0
144859,during,0,0
144860,the,0,0
144861,first,0,0
144862,3,0,0
144863,of,0,0
144864,6,0,0
144865,cycles,0,0
144866,of,0,0
144867,3-weekly,0,1
144868,CT,0,0
144869,.,0,0
144870,Blood,0,0
144871,was,0,0
144872,drawn,0,0
144873,on,0,0
144874,day,0,0
144875,1,0,0
144876,of,0,0
144877,each,0,0
144878,cycle,0,0
144879,for,0,0
144880,CA125,0,1
144881,and,0,0
144882,",",0,0
144883,in,0,0
144884,a,0,0
144885,substudy,0,0
144886,of,0,0
144887,randomized,0,0
144888,patients,0,0
144889,",",0,0
144890,for,0,0
144891,markers,0,0
144892,of,0,0
144893,coagulation,0,1
144894,activation,0,1
144895,and,0,0
144896,angiogenesis,0,0
144897,.,0,0
144898,The,0,0
144899,primary,0,0
144900,outcome,0,0
144901,was,0,0
144902,tumor,0,0
144903,response,0,0
144904,defined,0,0
144905,by,0,0
144906,?,0,0
144907,50,0,0
144908,%,0,0
144909,reduction,0,0
144910,in,0,0
144911,serum,0,0
144912,CA125,0,1
144913,from,0,0
144914,baseline,0,0
144915,sustained,0,0
144916,for,0,0
144917,at,0,0
144918,least,0,0
144919,28,0,0
144920,days,0,0
144921,.,0,0
144922,Patients,0,0
144923,were,0,0
144924,followed,0,0
144925,until,0,0
144926,the,0,0
144927,end,0,0
144928,of,0,0
144929,CT,0,0
144930,.,0,0
144931,RESULTS,0,0
144932,The,0,0
144933,study,0,0
144934,was,0,0
144935,terminated,0,0
144936,early,0,0
144937,due,0,0
144938,to,0,0
144939,poor,0,0
144940,recruitment,0,0
144941,.,0,0
144942,Seventy-seven,0,0
144943,women,0,0
144944,were,0,0
144945,evaluable,0,0
144946,for,0,0
144947,the,0,0
144948,primary,0,0
144949,outcome,0,0
144950,.,0,0
144951,A,0,0
144952,50,0,0
144953,%,0,0
144954,drop,0,0
144955,in,0,0
144956,CA125,0,1
144957,at,0,0
144958,the,0,0
144959,end,0,0
144960,of,0,0
144961,cycle,0,0
144962,3,0,0
144963,was,0,0
144964,seen,0,0
144965,in,0,0
144966,85,0,0
144967,%,0,0
144968,of,0,0
144969,the,0,0
144970,50,0,0
144971,IU/kg,0,0
144972,group,0,0
144973,",",0,0
144974,92,0,0
144975,%,0,0
144976,of,0,0
144977,the,0,0
144978,100,0,0
144979,IU/kg,0,0
144980,group,0,0
144981,",",0,0
144982,and,0,0
144983,85,0,0
144984,%,0,0
144985,of,0,0
144986,the,0,0
144987,150,0,0
144988,IU/kg,0,0
144989,group,0,0
144990,.,0,0
144991,There,0,0
144992,were,0,0
144993,no,0,0
144994,symptomatic,0,0
144995,VTE,0,0
144996,or,0,1
144997,major,0,0
144998,bleeding,0,0
144999,events,0,0
145000,while,0,0
145001,on,0,0
145002,dalteparin,0,1
145003,.,0,0
145004,Two,0,0
145005,patients,0,0
145006,experienced,0,0
145007,VTE,0,0
145008,several,0,0
145009,days,0,0
145010,after,0,0
145011,discontinuing,0,1
145012,study,0,0
145013,drug,0,1
145014,.,0,0
145015,Women,0,0
145016,on,0,0
145017,dalteparin,0,1
145018,had,0,0
145019,lower,0,0
145020,levels,0,0
145021,of,0,0
145022,D-dimer,0,0
145023,and,0,0
145024,thrombin-antithrombin,0,1
145025,",",0,0
145026,and,0,0
145027,higher,0,0
145028,levels,0,0
145029,of,0,0
145030,tissue,0,0
145031,factor,0,1
145032,pathway,0,1
145033,inhibitor,0,1
145034,",",0,0
145035,relative,0,0
145036,to,0,0
145037,baseline,0,0
145038,.,0,0
145039,CONCLUSION,1,0
145040,Dalteparin,1,1
145041,is,1,0
145042,safe,0,0
145043,and,0,0
145044,well,0,0
145045,tolerated,0,0
145046,in,0,0
145047,women,0,0
145048,receiving,0,0
145049,CT,0,0
145050,for,0,0
145051,newly-diagnosed,0,0
145052,epithelial,0,0
145053,OC,0,0
145054,.,0,0
145055,A,0,0
145056,dose-response,0,0
145057,effect,0,0
145058,was,0,0
145059,not,0,0
145060,identified,0,0
145061,.,0,0
145062,The,0,0
145063,lack,0,0
145064,of,0,0
145065,control,0,1
145066,group,0,0
145067,precluded,0,0
145068,any,0,0
145069,inference,0,0
145070,on,0,0
145071,the,0,0
145072,antineoplastic,0,1
145073,effect,0,0
145074,of,0,0
145075,dalteparin,1,1
145076,.,1,0
145077,End-expiratory,0,1
145078,lung,0,0
145079,volume,0,0
145080,recovers,0,0
145081,more,0,0
145082,slowly,0,0
145083,after,0,0
145084,closed,1,1
145085,endotracheal,1,1
145086,suctioning,1,1
145087,than,0,0
145088,after,0,0
145089,open,1,1
145090,suctioning,1,1
145091,:,1,0
145092,a,0,0
145093,randomized,0,0
145094,crossover,0,0
145095,study,0,0
145096,.,0,0
145097,PURPOSE,0,0
145098,Endotracheal,0,1
145099,suctioning,0,1
145100,causes,0,0
145101,significant,0,0
145102,lung,0,0
145103,derecruitment,0,0
145104,.,0,0
145105,Closed,1,0
145106,suction,1,1
145107,(,1,1
145108,CS,1,1
145109,),1,1
145110,minimizes,0,0
145111,lung,0,0
145112,volume,0,0
145113,loss,0,0
145114,during,0,0
145115,suction,0,1
145116,",",0,0
145117,and,0,0
145118,therefore,0,0
145119,",",0,0
145120,volumes,0,0
145121,are,0,0
145122,presumed,0,0
145123,to,0,0
145124,recover,0,0
145125,more,0,0
145126,quickly,0,0
145127,postsuctioning,0,1
145128,.,0,0
145129,Conflicting,0,0
145130,evidence,0,0
145131,exists,0,0
145132,regarding,0,0
145133,this,0,0
145134,.,0,0
145135,We,0,0
145136,examined,0,0
145137,the,0,0
145138,effects,0,0
145139,of,0,0
145140,open,1,1
145141,suction,1,1
145142,(,1,1
145143,OS,1,1
145144,),1,1
145145,and,1,0
145146,CS,1,1
145147,on,0,0
145148,lung,0,0
145149,volume,0,0
145150,loss,0,0
145151,during,0,0
145152,suctioning,1,1
145153,",",0,0
145154,and,0,0
145155,recovery,0,0
145156,of,0,0
145157,end-expiratory,0,1
145158,lung,0,0
145159,volume,0,0
145160,(,0,1
145161,EELV,0,0
145162,),0,1
145163,up,0,0
145164,to,0,0
145165,30,0,0
145166,minutes,0,0
145167,postsuction,0,0
145168,.,0,0
145169,MATERIAL,0,0
145170,AND,0,0
145171,METHODS,0,0
145172,Randomized,0,1
145173,crossover,0,0
145174,study,0,0
145175,examining,0,0
145176,20,0,0
145177,patients,0,0
145178,postcardiac,0,0
145179,surgery,0,0
145180,.,0,1
145181,CS,1,0
145182,and,0,0
145183,OS,1,0
145184,were,0,0
145185,performed,0,0
145186,in,0,0
145187,random,0,0
145188,order,0,0
145189,",",0,0
145190,30,0,0
145191,minutes,0,0
145192,apart,0,0
145193,.,0,0
145194,Lung,0,1
145195,impedance,0,0
145196,was,0,0
145197,measured,0,0
145198,during,0,0
145199,suction,0,1
145200,",",0,0
145201,and,0,0
145202,end-expiratory,0,1
145203,lung,0,0
145204,impedance,0,1
145205,was,0,0
145206,measured,0,0
145207,at,0,0
145208,baseline,0,0
145209,and,0,0
145210,postsuctioning,0,1
145211,using,0,1
145212,electrical,0,1
145213,impedance,0,1
145214,tomography,0,1
145215,.,0,0
145216,Oximetry,0,0
145217,",",0,0
145218,partial,0,0
145219,pressure,0,0
145220,of,0,0
145221,oxygen,0,1
145222,in,0,0
145223,the,0,0
145224,alveoli/fraction,0,0
145225,of,0,0
145226,inspired,0,1
145227,oxygen,0,1
145228,ratio,0,0
145229,and,0,0
145230,compliance,0,0
145231,were,0,0
145232,collected,0,0
145233,.,0,0
145234,RESULTS,0,0
145235,Reductions,0,0
145236,in,0,0
145237,lung,0,0
145238,impedance,0,1
145239,during,0,0
145240,suctioning,0,0
145241,were,0,0
145242,less,0,0
145243,for,0,0
145244,CS,1,0
145245,than,0,0
145246,for,0,0
145247,OS,1,0
145248,(,0,0
145249,mean,0,0
145250,difference,0,0
145251,",",0,0
145252,-905,0,1
145253,impedance,0,1
145254,units,0,0
145255,;,0,0
145256,95,0,0
145257,%,0,0
145258,confidence,0,0
145259,interval,0,0
145260,[,0,0
145261,CI,0,0
145262,],0,0
145263,",",0,0
145264,-1234,0,1
145265,to,0,0
145266,-587,0,1
145267,;,0,0
145268,P,0,0
145269,<,0,0
145270,.001,0,0
145271,),0,0
145272,.,0,0
145273,However,0,0
145274,",",0,0
145275,at,0,0
145276,all,0,0
145277,points,0,0
145278,postsuctioning,0,0
145279,",",0,0
145280,EELV,0,0
145281,recovered,0,0
145282,more,0,0
145283,slowly,0,0
145284,after,0,0
145285,CS,1,0
145286,than,0,0
145287,after,0,0
145288,OS,1,0
145289,.,1,0
145290,There,0,0
145291,were,0,0
145292,no,0,0
145293,statistically,0,0
145294,significant,0,0
145295,differences,0,0
145296,in,0,0
145297,the,0,0
145298,other,0,0
145299,respiratory,0,0
145300,parameters,0,0
145301,.,0,0
145302,CONCLUSIONS,0,0
145303,Closed,1,0
145304,suctioning,1,1
145305,minimized,0,0
145306,lung,0,0
145307,volume,0,0
145308,loss,0,0
145309,during,0,0
145310,suctioning,0,1
145311,but,0,0
145312,",",0,0
145313,counterintuitively,0,0
145314,",",0,0
145315,resulted,0,0
145316,in,0,0
145317,slower,0,0
145318,recovery,0,0
145319,of,0,0
145320,EELV,0,0
145321,postsuction,0,1
145322,compared,0,0
145323,with,0,0
145324,OS,1,0
145325,.,1,0
145326,Therefore,0,0
145327,",",0,0
145328,the,0,0
145329,use,0,0
145330,of,0,0
145331,CS,1,0
145332,can,0,0
145333,not,0,0
145334,be,0,0
145335,assumed,0,0
145336,to,0,0
145337,be,0,0
145338,protective,0,0
145339,of,0,0
145340,lung,0,0
145341,volumes,0,0
145342,postsuctioning,0,0
145343,.,0,0
145344,Consideration,0,0
145345,should,0,0
145346,be,0,0
145347,given,0,0
145348,to,0,0
145349,restoring,0,0
145350,EELV,0,0
145351,after,0,0
145352,either,0,1
145353,suction,0,1
145354,method,0,1
145355,via,0,0
145356,a,0,0
145357,recruitment,0,0
145358,maneuver,0,0
145359,.,0,0
145360,Linguistic,0,0
145361,alignment,0,0
145362,in,0,0
145363,adults,0,0
145364,with,0,0
145365,and,0,0
145366,without,0,0
145367,Asperger,0,0
145368,'s,0,0
145369,syndrome,0,0
145370,.,0,0
145371,Individuals,0,0
145372,with,0,0
145373,Asperger,0,0
145374,'s,0,0
145375,syndrome,0,0
145376,(,0,1
145377,AS,0,1
145378,),0,0
145379,often,0,0
145380,have,0,0
145381,difficulties,0,0
145382,with,0,0
145383,social,0,0
145384,interactions,0,0
145385,and,0,0
145386,conversations,0,0
145387,.,0,0
145388,We,0,0
145389,investigated,0,0
145390,if,0,0
145391,these,0,0
145392,difficulties,0,0
145393,could,0,0
145394,be,0,0
145395,attributable,0,0
145396,to,0,0
145397,a,0,0
145398,deficit,0,0
145399,in,0,0
145400,the,0,0
145401,ability,0,0
145402,to,0,0
145403,linguistically,0,0
145404,converge,0,0
145405,with,0,0
145406,an,0,0
145407,interlocutor,0,0
145408,",",0,0
145409,which,0,0
145410,is,0,0
145411,posited,0,0
145412,to,0,0
145413,be,0,0
145414,important,0,0
145415,for,0,0
145416,successful,0,0
145417,communication,0,1
145418,.,0,0
145419,To,0,0
145420,that,0,0
145421,end,0,0
145422,",",0,0
145423,participants,0,0
145424,completed,0,0
145425,two,1,0
145426,cooperative,1,0
145427,tasks,1,0
145428,with,1,0
145429,a,1,0
145430,confederate,1,0
145431,",",0,0
145432,which,0,0
145433,allowed,0,0
145434,us,0,0
145435,to,0,0
145436,measure,0,0
145437,linguistic,0,1
145438,alignment,0,0
145439,with,0,0
145440,the,0,0
145441,confederate,0,0
145442,in,0,0
145443,terms,0,0
145444,of,0,0
145445,lexical,0,1
145446,choice,0,0
145447,",",0,0
145448,syntactic,0,0
145449,structure,0,0
145450,and,0,0
145451,spatial,0,0
145452,frame,0,0
145453,of,0,0
145454,reference,0,0
145455,.,0,0
145456,There,0,0
145457,was,0,0
145458,no,0,0
145459,difference,0,0
145460,in,0,0
145461,the,0,0
145462,performance,0,0
145463,of,0,0
145464,individuals,0,0
145465,with,0,0
145466,AS,0,0
145467,and,0,0
145468,matched,0,0
145469,controls,0,0
145470,and,0,0
145471,both,0,0
145472,groups,0,0
145473,showed,0,0
145474,significant,0,0
145475,alignment,0,0
145476,with,0,0
145477,the,0,0
145478,confederate,0,0
145479,at,0,0
145480,all,0,0
145481,three,0,0
145482,levels,0,0
145483,.,0,0
145484,We,0,0
145485,conclude,0,0
145486,that,0,0
145487,linguistic,0,1
145488,alignment,0,1
145489,is,0,0
145490,intact,0,0
145491,in,0,0
145492,adults,0,0
145493,with,0,0
145494,AS,0,0
145495,engaged,0,0
145496,in,0,0
145497,structured,0,1
145498,",",0,0
145499,goal-directed,0,1
145500,social,0,0
145501,interactions,0,0
145502,.,0,0
145503,Custom-fit,1,1
145504,minimally,1,1
145505,invasive,1,0
145506,total,1,0
145507,knee,1,1
145508,arthroplasty,1,1
145509,:,1,0
145510,effect,0,0
145511,on,0,0
145512,blood,0,0
145513,loss,0,0
145514,and,0,0
145515,early,0,0
145516,clinical,0,0
145517,outcomes,0,0
145518,.,0,0
145519,PURPOSE,0,0
145520,Recently,0,0
145521,",",0,0
145522,new,0,0
145523,custom-fit,1,1
145524,pin,1,0
145525,guides,1,1
145526,in,1,0
145527,total,1,0
145528,knee,1,1
145529,arthroplasty,1,1
145530,(,1,1
145531,TKA,1,1
145532,),1,1
145533,have,0,0
145534,been,0,0
145535,introduced,0,0
145536,.,0,0
145537,Use,0,0
145538,of,0,0
145539,these,0,0
145540,guides,0,1
145541,may,0,0
145542,reduce,0,0
145543,operating,0,0
145544,time,0,0
145545,.,0,0
145546,Use,0,0
145547,of,0,0
145548,the,0,0
145549,guides,0,1
145550,combined,0,1
145551,with,0,0
145552,the,0,0
145553,absence,0,0
145554,of,0,0
145555,intramedullary,1,0
145556,alignment,1,0
145557,jigs,1,1
145558,may,0,0
145559,lead,0,0
145560,to,0,0
145561,reduced,0,0
145562,blood,0,0
145563,loss,0,0
145564,and,0,0
145565,improved,0,0
145566,early,0,0
145567,outcomes,0,0
145568,.,0,0
145569,Our,0,0
145570,aim,0,0
145571,was,0,0
145572,to,0,0
145573,evaluate,0,0
145574,blood,0,0
145575,loss,0,0
145576,and,0,0
145577,early,0,0
145578,clinical,0,0
145579,outcomes,0,0
145580,in,0,0
145581,patients,0,0
145582,undergoing,0,0
145583,minimally,1,1
145584,invasive,1,0
145585,TKA,1,1
145586,using,0,0
145587,custom-fit,1,1
145588,magnetic,1,1
145589,resonance,1,1
145590,imaging,1,1
145591,(,1,1
145592,MRI,1,1
145593,),1,1
145594,-based,1,0
145595,pin,1,0
145596,guides,1,1
145597,.,1,0
145598,METHODS,0,0
145599,A,0,0
145600,prospective,0,0
145601,study,0,0
145602,in,0,0
145603,80,0,0
145604,patients,0,0
145605,was,0,0
145606,carried,0,0
145607,out,0,0
145608,.,0,0
145609,Patients,0,0
145610,were,0,0
145611,divided,0,0
145612,randomly,0,0
145613,into,0,0
145614,2,0,0
145615,equal,0,0
145616,groups,0,0
145617,.,0,0
145618,In,0,0
145619,one,0,0
145620,group,0,0
145621,",",0,0
145622,intramedullary,1,0
145623,alignment,1,0
145624,jigs,1,1
145625,were,0,0
145626,used,0,0
145627,.,0,0
145628,In,0,0
145629,the,0,0
145630,second,0,0
145631,group,0,0
145632,",",0,0
145633,custom-fit,1,1
145634,MRI-based,1,0
145635,pin,1,0
145636,guides,1,1
145637,were,0,0
145638,used,0,0
145639,.,0,0
145640,All,0,0
145641,patients,0,0
145642,received,0,0
145643,the,0,0
145644,same,0,0
145645,cemented,1,0
145646,posterior-stabilized,1,1
145647,implant,1,1
145648,through,0,0
145649,a,0,0
145650,mini-midvastus,0,1
145651,approach,0,1
145652,.,0,0
145653,The,0,0
145654,volume,0,0
145655,in,0,0
145656,the,0,0
145657,drain,0,1
145658,bottles,0,1
145659,was,0,0
145660,recorded,0,0
145661,after,0,0
145662,48,0,0
145663,h.,0,0
145664,Hb,0,1
145665,loss,0,0
145666,was,0,0
145667,estimated,0,0
145668,by,0,0
145669,subtracting,0,0
145670,the,0,0
145671,postoperative,0,0
145672,from,0,0
145673,the,0,0
145674,preoperative,0,1
145675,Hb,0,1
145676,level,0,0
145677,.,0,0
145678,Transfusion,0,0
145679,requirements,0,0
145680,and,0,0
145681,surgical,0,1
145682,time,0,0
145683,were,0,0
145684,recorded,0,0
145685,.,0,0
145686,Outcome,0,0
145687,measures,0,0
145688,were,0,0
145689,Knee,0,0
145690,Society,0,1
145691,Scores,0,1
145692,(,0,1
145693,KSS,0,1
145694,),0,1
145695,",",0,0
145696,knee,0,1
145697,flexion,0,0
145698,",",0,0
145699,knee,0,1
145700,swelling,0,0
145701,and,0,0
145702,pain,0,0
145703,.,0,0
145704,RESULTS,0,0
145705,There,0,0
145706,was,0,0
145707,lower,0,0
145708,mean,0,0
145709,drainage,0,1
145710,of,0,0
145711,blood,0,0
145712,in,0,0
145713,the,0,0
145714,custom-fit,1,1
145715,group,0,0
145716,(,0,0
145717,391,0,0
145718,ml,0,1
145719,vs.,0,0
145720,603,0,0
145721,ml,0,0
145722,;,0,0
145723,p,0,0
145724,<,0,0
145725,0.0001,0,0
145726,),0,0
145727,.,0,0
145728,There,0,0
145729,was,0,0
145730,no,0,0
145731,difference,0,0
145732,in,0,0
145733,estimated,0,0
145734,loss,0,0
145735,of,0,0
145736,Hb,0,1
145737,(,0,0
145738,3.6,0,0
145739,g/dl,0,0
145740,vs.,0,0
145741,4.1,0,0
145742,g/dl,0,0
145743,;,0,0
145744,n.s,0,0
145745,.,0,0
145746,),0,0
145747,and,0,0
145748,in,0,0
145749,transfusion,0,1
145750,requirements,0,0
145751,(,0,0
145752,7.5,0,1
145753,%,0,0
145754,vs.,0,0
145755,10,0,0
145756,%,0,0
145757,;,0,0
145758,n.s.,0,0
145759,),0,0
145760,.,0,0
145761,Surgical,0,0
145762,time,0,0
145763,was,0,0
145764,reduced,0,0
145765,in,0,0
145766,the,0,0
145767,custom-fit,1,1
145768,group,0,0
145769,(,0,0
145770,12,0,0
145771,min,0,0
145772,less,0,0
145773,;,0,0
145774,p,0,0
145775,=,0,0
145776,0.001,0,0
145777,),0,0
145778,.,0,0
145779,KSS,0,0
145780,measured,0,0
145781,at,0,0
145782,week,0,0
145783,2,0,0
145784,",",0,0
145785,6,0,0
145786,and,0,0
145787,12,0,0
145788,showed,0,0
145789,no,0,0
145790,significant,0,0
145791,difference,0,0
145792,between,0,0
145793,groups,0,0
145794,.,0,0
145795,Knee,0,0
145796,flexion,0,0
145797,measured,0,0
145798,on,0,0
145799,days,0,0
145800,7,0,0
145801,",",0,0
145802,10,0,0
145803,and,0,0
145804,at,0,0
145805,week,0,0
145806,6,0,0
145807,",",0,0
145808,12,0,0
145809,and,0,0
145810,knee,0,1
145811,swelling,0,0
145812,and,0,0
145813,pain,0,0
145814,measured,0,0
145815,on,0,0
145816,days,0,0
145817,1,0,0
145818,",",0,0
145819,3,0,0
145820,",",0,0
145821,10,0,0
145822,and,0,0
145823,at,0,0
145824,week,0,0
145825,6,0,0
145826,",",0,0
145827,12,0,0
145828,showed,0,0
145829,no,0,0
145830,significant,0,0
145831,difference,0,0
145832,between,0,0
145833,groups,0,0
145834,.,0,0
145835,CONCLUSIONS,0,0
145836,Using,0,0
145837,custom-fit,1,1
145838,pin,1,1
145839,guides,1,1
145840,reduces,0,0
145841,blood,0,0
145842,drainage,0,1
145843,",",0,0
145844,but,0,0
145845,not,0,0
145846,the,0,0
145847,estimated,0,0
145848,Hb,0,1
145849,loss,0,0
145850,in,0,0
145851,minimally,0,0
145852,invasive,0,0
145853,TKA,0,1
145854,and,0,0
145855,does,0,0
145856,not,0,0
145857,affect,0,0
145858,transfusion,0,1
145859,rate,0,0
145860,.,0,0
145861,Surgical,0,0
145862,time,0,0
145863,is,0,0
145864,reduced,0,0
145865,.,0,0
145866,There,0,0
145867,is,0,0
145868,no,0,0
145869,effect,0,0
145870,on,0,0
145871,the,0,0
145872,early,0,0
145873,clinical,0,0
145874,outcomes,0,0
145875,.,0,0
145876,LEVEL,0,0
145877,OF,0,1
145878,EVIDENCE,0,0
145879,Therapeutic,0,1
145880,study,0,0
145881,",",0,0
145882,Level,0,0
145883,I,0,0
145884,.,0,0
145885,Monitoring,0,1
145886,of,0,0
145887,CA19-9,0,1
145888,and,0,0
145889,SPan-1,0,1
145890,can,0,0
145891,facilitate,0,0
145892,the,0,0
145893,earlier,0,0
145894,confirmation,0,0
145895,of,0,0
145896,progressing,0,0
145897,pancreatic,0,0
145898,cancer,0,0
145899,during,0,0
145900,chemotherapy,0,1
145901,.,0,0
145902,BACKGROUND,0,0
145903,Measurement,0,0
145904,of,0,0
145905,objective,0,0
145906,response,0,0
145907,to,0,0
145908,chemotherapy,0,1
145909,using,0,0
145910,imaging,0,0
145911,modalities,0,1
145912,is,0,0
145913,sometimes,0,0
145914,difficult,0,0
145915,in,0,0
145916,pancreatic,0,0
145917,cancer,0,0
145918,(,0,1
145919,PC,0,1
145920,),0,0
145921,.,0,0
145922,We,0,0
145923,aimed,0,0
145924,to,0,0
145925,verify,0,0
145926,whether,0,0
145927,monitoring,0,0
145928,of,0,0
145929,serum,0,0
145930,tumor,0,0
145931,markers,0,0
145932,(,0,0
145933,TMs,0,1
145934,),0,0
145935,",",0,0
145936,namely,0,0
145937,carcinoembryonic,0,0
145938,antigen,0,0
145939,",",0,0
145940,CA19-9,0,1
145941,",",0,0
145942,DUPAN-2,0,0
145943,",",0,0
145944,SPan-1,0,1
145945,",",0,0
145946,can,0,0
145947,facilitate,0,0
145948,earlier,0,0
145949,confirmation,0,0
145950,of,0,0
145951,treatment,0,0
145952,failure,0,0
145953,.,0,0
145954,METHODS,0,0
145955,Monitoring,1,1
145956,of,1,0
145957,serum,1,0
145958,TMs,1,1
145959,and,1,0
145960,computed,1,0
145961,tomography,1,1
145962,were,1,0
145963,performed,1,0
145964,every,1,0
145965,4,1,0
145966,weeks,1,0
145967,until,1,0
145968,progression,1,0
145969,of,1,0
145970,disease,1,0
145971,in,0,0
145972,90,0,0
145973,patients,0,0
145974,with,0,0
145975,PC,0,1
145976,undergoing,0,0
145977,gemcitabine,0,1
145978,therapy,0,1
145979,.,0,0
145980,In,0,0
145981,Group,0,0
145982,A,0,0
145983,(,0,0
145984,January,0,0
145985,2006-October,0,1
145986,2007,0,0
145987,),0,0
145988,",",0,0
145989,we,1,0
145990,analyzed,1,0
145991,the,1,0
145992,fluctuation,1,0
145993,rates,1,0
145994,of,1,0
145995,TMs,1,1
145996,with,1,0
145997,high,1,0
145998,pretreatment,1,0
145999,positive,1,0
146000,rates,1,0
146001,",",1,0
146002,and,1,0
146003,defined,1,0
146004,the,1,0
146005,criteria,1,0
146006,of,1,0
146007,progressive,1,0
146008,disease,1,0
146009,under,1,0
146010,TM,1,1
146011,monitoring,1,1
146012,(,1,1
146013,TM-PD,1,1
146014,),1,0
146015,.,1,0
146016,In,0,0
146017,Group,0,0
146018,B,0,1
146019,(,0,0
146020,November,0,0
146021,2007-October,0,0
146022,2008,0,0
146023,),0,0
146024,",",0,0
146025,we,1,0
146026,calculated,1,0
146027,the,1,0
146028,time,1,0
146029,to,1,0
146030,progression,1,0
146031,(,1,1
146032,TTP,1,1
146033,),1,1
146034,under,1,0
146035,this,1,0
146036,TM-PD,1,0
146037,criteria,1,0
146038,",",1,0
146039,which,1,0
146040,was,1,0
146041,compared,1,0
146042,with,1,0
146043,the,1,0
146044,TTP,1,0
146045,under,1,0
146046,the,1,0
146047,RECIST,1,1
146048,criteria,1,0
146049,.,1,0
146050,RESULTS,0,0
146051,CA19-9,0,1
146052,and,0,0
146053,SPan-1,0,1
146054,had,0,0
146055,the,0,0
146056,highest,0,0
146057,pretreatment,0,0
146058,positive,0,0
146059,rates,0,0
146060,:,0,0
146061,83,0,0
146062,%,0,0
146063,and,0,0
146064,90,0,0
146065,%,0,0
146066,",",0,0
146067,respectively,0,0
146068,.,0,0
146069,In,0,0
146070,Group,0,0
146071,A,0,0
146072,(,0,0
146073,CA19-9,0,1
146074,",",0,0
146075,n,0,0
146076,=,0,0
146077,38,0,0
146078,;,0,0
146079,SPan-1,0,1
146080,",",0,0
146081,n,0,0
146082,=,0,0
146083,36,0,0
146084,),0,0
146085,",",0,0
146086,TM-PD,0,0
146087,criteria,0,0
146088,were,0,0
146089,defined,0,0
146090,as,0,0
146091,follows,0,0
146092,:,0,0
146093,fluctuation,0,0
146094,rates,0,0
146095,were,0,0
146096,?25,0,0
146097,%,0,0
146098,for,0,0
146099,a,0,0
146100,month,0,0
146101,or,0,1
146102,?10,0,1
146103,%,0,0
146104,for,0,0
146105,2,0,0
146106,consecutive,0,0
146107,months,0,0
146108,in,0,0
146109,CA19-9,0,1
146110,",",0,0
146111,and,0,0
146112,?10,0,1
146113,%,0,0
146114,for,0,0
146115,a,0,0
146116,month,0,0
146117,in,0,0
146118,SPan-1,0,1
146119,.,0,0
146120,In,0,0
146121,Group,0,0
146122,B,0,1
146123,(,0,0
146124,CA19-9,0,1
146125,",",0,0
146126,n,0,0
146127,=,0,0
146128,18,0,0
146129,;,0,0
146130,SPan-1,0,1
146131,",",0,0
146132,n,0,0
146133,=,0,0
146134,17,0,0
146135,),0,0
146136,",",0,0
146137,under,0,0
146138,these,0,0
146139,criteria,0,0
146140,",",0,0
146141,one-month,0,0
146142,earlier,0,0
146143,confirmation,0,0
146144,of,0,0
146145,treatment,0,0
146146,failure,0,0
146147,was,0,0
146148,feasible,0,0
146149,in,0,0
146150,61,0,0
146151,%,0,0
146152,by,0,0
146153,CA19-9,0,1
146154,and,0,0
146155,59,0,0
146156,%,0,0
146157,by,0,0
146158,SPan-1,0,1
146159,.,0,0
146160,Furthermore,0,0
146161,",",0,0
146162,the,0,0
146163,combination,0,1
146164,could,0,0
146165,facilitate,0,0
146166,this,0,0
146167,determination,0,0
146168,in,0,0
146169,72,0,0
146170,%,0,0
146171,(,0,0
146172,35/49,0,0
146173,),0,0
146174,",",0,0
146175,significantly,0,0
146176,better,0,0
146177,than,0,0
146178,CA19-9,0,1
146179,alone,0,1
146180,(,0,0
146181,P,0,0
146182,=,0,0
146183,0.004,0,0
146184,),0,0
146185,.,0,0
146186,CONCLUSION,0,0
146187,Monitoring,0,1
146188,of,0,0
146189,serum,0,0
146190,CA19-9,0,1
146191,and,0,0
146192,SPan-1,0,1
146193,is,0,0
146194,helpful,0,0
146195,for,0,0
146196,earlier,0,0
146197,confirmation,0,0
146198,of,0,0
146199,treatment,0,0
146200,failure,0,0
146201,during,0,0
146202,gemcitabine,0,1
146203,therapy,0,1
146204,in,0,0
146205,PC,0,0
146206,.,0,0
146207,The,0,0
146208,paroxetine,1,1
146209,352,1,0
146210,bipolar,0,1
146211,trial,0,0
146212,:,0,0
146213,A,0,0
146214,study,0,0
146215,in,0,0
146216,medical,0,0
146217,ghostwriting,0,0
146218,.,0,0
146219,BACKGROUND,0,0
146220,The,0,0
146221,problem,0,0
146222,of,0,0
146223,ghostwriting,0,0
146224,in,0,0
146225,corporate-sponsored,0,0
146226,clinical,0,0
146227,trials,0,0
146228,is,0,0
146229,of,0,0
146230,concern,0,0
146231,to,0,0
146232,medicine,0,1
146233,",",0,0
146234,bioethics,0,0
146235,",",0,0
146236,and,0,0
146237,government,0,0
146238,agencies,0,0
146239,.,0,0
146240,We,0,0
146241,present,0,0
146242,a,0,0
146243,study,0,0
146244,of,0,0
146245,the,0,0
146246,ghostwritten,0,1
146247,archival,0,0
146248,report,0,0
146249,of,0,0
146250,an,0,0
146251,industry-sponsored,0,0
146252,trial,0,0
146253,comparing,0,0
146254,antidepressant,0,1
146255,treatments,0,1
146256,for,0,0
146257,bipolar,0,1
146258,depression,0,0
146259,:,0,1
146260,GlaxoSmithKline,0,1
146261,(,0,1
146262,GSK,0,1
146263,),0,1
146264,paroxetine,1,1
146265,study,0,0
146266,352,0,0
146267,.,0,0
146268,This,0,0
146269,analysis,0,0
146270,is,0,0
146271,based,0,0
146272,upon,0,0
146273,publicly,0,0
146274,available,0,0
146275,evidence,0,0
146276,presented,0,0
146277,in,0,0
146278,a,0,0
146279,complaint,0,0
146280,of,0,0
146281,research,0,0
146282,misconduct,0,0
146283,filed,0,0
146284,with,0,0
146285,the,0,0
146286,Office,0,1
146287,of,0,0
146288,Research,0,0
146289,Integrity,0,0
146290,of,0,0
146291,the,0,0
146292,Department,0,0
146293,of,0,0
146294,Health,0,0
146295,and,0,0
146296,Human,0,1
146297,Services,0,1
146298,.,0,0
146299,OBJECTIVES,0,0
146300,We,0,0
146301,performed,0,0
146302,a,0,0
146303,deconstruction,0,0
146304,of,0,0
146305,the,0,0
146306,published,0,0
146307,study,0,0
146308,to,0,0
146309,show,0,0
146310,how,0,0
146311,primary,0,0
146312,and,0,0
146313,secondary,0,0
146314,outcome,0,0
146315,analyses,0,0
146316,were,0,0
146317,conflated,0,0
146318,",",0,0
146319,turning,0,0
146320,a,0,0
146321,'negative,0,0
146322,',0,0
146323,clinical,0,0
146324,trial,0,0
146325,into,0,0
146326,a,0,0
146327,'positive,0,0
146328,',0,0
146329,study,0,0
146330,-,0,0
146331,with,0,0
146332,conclusions,0,0
146333,and,0,0
146334,recommendations,0,0
146335,that,0,0
146336,could,0,0
146337,adversely,0,0
146338,affect,0,0
146339,patient,0,0
146340,health,0,0
146341,.,0,0
146342,METHODS,0,0
146343,The,0,0
146344,paroxetine,1,1
146345,352,0,0
146346,study,0,0
146347,was,0,0
146348,a,0,0
146349,randomized,0,0
146350,",",0,0
146351,double-blind,0,0
146352,",",0,0
146353,placebo-controlled,0,1
146354,",",0,0
146355,19-site,0,0
146356,trial,0,0
146357,comparing,0,0
146358,paroxetine,1,1
146359,and,1,0
146360,imipramine,1,1
146361,in,0,0
146362,117,0,0
146363,patients,0,0
146364,with,0,0
146365,bipolar,0,1
146366,type,0,0
146367,I,0,0
146368,major,0,0
146369,depressive,0,0
146370,episode,0,0
146371,which,0,0
146372,was,0,0
146373,unresponsive,0,0
146374,to,0,0
146375,prior,0,0
146376,lithium,0,1
146377,carbonate,0,1
146378,therapy,0,1
146379,.,0,0
146380,RESULTS,0,0
146381,Analysis,0,1
146382,of,0,0
146383,the,0,0
146384,primary,0,0
146385,outcome,0,0
146386,measures,0,0
146387,found,0,0
146388,no,0,0
146389,statistically,0,0
146390,significant,0,0
146391,difference,0,0
146392,between,0,0
146393,paroxetine,1,1
146394,or,1,1
146395,imipramine,1,1
146396,versus,1,1
146397,placebo,1,1
146398,.,1,0
146399,However,0,0
146400,",",0,0
146401,the,0,0
146402,published,0,0
146403,article,0,0
146404,concluded,0,0
146405,that,0,0
146406,both,0,0
146407,drugs,0,1
146408,were,0,0
146409,efficacious,0,0
146410,versus,0,1
146411,placebo,0,1
146412,for,0,0
146413,a,0,0
146414,post,0,0
146415,hoc,0,0
146416,subgroup,0,0
146417,of,0,0
146418,patients,0,0
146419,.,0,0
146420,CONCLUSIONS,0,0
146421,Few,0,0
146422,industry-sponsored,0,0
146423,studies,0,0
146424,gain,0,0
146425,public,0,0
146426,scrutiny,0,0
146427,.,0,0
146428,It,0,0
146429,is,0,0
146430,important,0,0
146431,to,0,0
146432,make,0,0
146433,these,0,0
146434,articles,0,0
146435,transparent,0,1
146436,to,0,0
146437,the,0,0
146438,scientific,0,0
146439,and,0,0
146440,medical,0,0
146441,community,0,0
146442,.,0,0
146443,Effect,0,0
146444,of,0,0
146445,whole-body,1,1
146446,mild-cold,1,1
146447,exposure,1,0
146448,on,0,0
146449,arterial,0,0
146450,stiffness,0,0
146451,and,0,0
146452,central,0,0
146453,haemodynamics,0,0
146454,:,0,0
146455,a,0,0
146456,randomised,0,0
146457,",",0,0
146458,cross-over,0,0
146459,trial,0,0
146460,in,0,0
146461,healthy,0,0
146462,men,0,0
146463,and,0,0
146464,women,0,0
146465,.,0,0
146466,Aortic,0,0
146467,pulse,0,1
146468,wave,0,1
146469,velocity,0,0
146470,(,0,1
146471,PWV,0,1
146472,),0,1
146473,and,0,0
146474,augmentation,0,1
146475,index,0,0
146476,(,0,1
146477,AIx,0,0
146478,),0,1
146479,are,0,0
146480,independent,0,0
146481,predictors,0,0
146482,of,0,0
146483,cardiovascular,0,0
146484,risk,0,0
146485,and,0,0
146486,mortality,0,0
146487,",",0,0
146488,but,0,0
146489,little,0,0
146490,is,0,0
146491,known,0,0
146492,about,0,0
146493,the,0,0
146494,effect,0,0
146495,of,0,0
146496,air,0,0
146497,temperature,0,0
146498,changes,0,0
146499,on,0,0
146500,these,0,0
146501,variables,0,0
146502,.,0,0
146503,Our,0,0
146504,study,0,0
146505,investigated,0,0
146506,the,0,0
146507,effect,0,0
146508,of,0,0
146509,exposure,0,0
146510,to,0,0
146511,whole-body,1,1
146512,mild-cold,1,1
146513,on,0,0
146514,measures,0,0
146515,of,0,0
146516,arterial,0,0
146517,stiffness,0,0
146518,(,0,1
146519,aortic,0,0
146520,and,0,0
146521,brachial,0,0
146522,PWV,0,1
146523,),0,0
146524,",",0,0
146525,and,0,0
146526,on,0,0
146527,central,0,0
146528,haemodynamics,0,0
146529,[,0,0
146530,including,0,0
146531,augmented,0,1
146532,pressure,0,0
146533,(,0,1
146534,AP,0,1
146535,),0,0
146536,",",0,0
146537,AIx,0,0
146538,],0,0
146539,",",0,0
146540,and,0,0
146541,aortic,0,0
146542,reservoir,0,0
146543,components,0,0
146544,[,0,0
146545,including,0,0
146546,reservoir,0,0
146547,and,0,0
146548,excess,0,0
146549,pressures,0,0
146550,(,0,0
146551,P,0,0
146552,ex,0,1
146553,),0,0
146554,],0,0
146555,.,0,0
146556,Sixteen,0,0
146557,healthy,0,0
146558,volunteers,0,0
146559,(,0,0
146560,10,0,0
146561,men,0,0
146562,",",0,0
146563,age,0,0
146564,43,0,0
146565,?,0,0
146566,19,0,0
146567,years,0,0
146568,;,0,0
146569,mean,0,0
146570,?,0,0
146571,SD,0,0
146572,),0,0
146573,were,0,0
146574,randomised,0,0
146575,to,0,0
146576,be,0,0
146577,studied,0,0
146578,under,0,0
146579,conditions,0,0
146580,of,0,0
146581,12,1,0
146582,?C,1,1
146583,(,1,0
146584,mild-cold,1,1
146585,),1,1
146586,and,1,0
146587,21,1,0
146588,?C,1,1
146589,(,1,1
146590,control,1,1
146591,),1,1
146592,on,1,0
146593,separate,0,0
146594,days,0,0
146595,.,0,0
146596,Supine,0,0
146597,resting,0,0
146598,measures,0,0
146599,were,0,0
146600,taken,0,0
146601,at,0,0
146602,baseline,0,0
146603,(,0,0
146604,ambient,0,1
146605,temperature,0,0
146606,),0,1
146607,and,0,0
146608,after,0,0
146609,10,0,0
146610,",",0,0
146611,30,0,0
146612,",",0,0
146613,and,0,0
146614,60,0,0
146615,min,0,0
146616,exposure,0,0
146617,to,0,0
146618,each,0,0
146619,experimental,0,0
146620,condition,0,0
146621,in,0,0
146622,a,0,0
146623,climate,0,0
146624,chamber,0,1
146625,.,0,0
146626,There,0,0
146627,was,0,0
146628,no,0,0
146629,significant,0,0
146630,change,0,0
146631,in,0,0
146632,brachial,0,0
146633,blood,0,0
146634,pressure,0,0
146635,between,1,0
146636,mild-cold,1,1
146637,and,1,0
146638,control,0,0
146639,conditions,0,0
146640,.,0,0
146641,However,0,0
146642,",",0,0
146643,compared,0,0
146644,to,0,0
146645,control,0,0
146646,",",0,0
146647,AP,0,1
146648,[,0,1
146649,+2,0,1
146650,mmHg,0,0
146651,",",0,0
146652,95,0,0
146653,%,0,0
146654,confidence,0,0
146655,interval,0,0
146656,(,0,1
146657,CI,0,0
146658,),0,1
146659,0.36-4.36,0,0
146660,;,0,0
146661,p,0,0
146662,=,0,0
146663,0.01,0,0
146664,],0,0
146665,and,0,0
146666,AIx,0,0
146667,(,0,1
146668,+6,0,1
146669,%,0,0
146670,",",0,0
146671,95,0,0
146672,%,0,0
146673,CI,0,0
146674,1.24-10.1,0,0
146675,;,0,0
146676,p,0,0
146677,=,0,0
146678,0.02,0,0
146679,),0,0
146680,increased,0,0
146681,",",0,0
146682,and,0,0
146683,time,0,0
146684,to,0,0
146685,maximum,0,0
146686,P,0,0
146687,ex,0,1
146688,(,0,0
146689,a,0,0
146690,component,0,0
146691,of,0,0
146692,reservoir,0,0
146693,function,0,0
146694,related,0,0
146695,to,0,0
146696,timing,0,0
146697,of,0,0
146698,peak,0,0
146699,aortic,0,0
146700,in-flow,0,1
146701,),0,1
146702,decreased,0,0
146703,(,0,0
146704,-7,0,1
146705,ms,0,1
146706,",",0,0
146707,95,0,0
146708,%,0,0
146709,CI,0,0
146710,-15.4,0,0
146711,to,0,0
146712,2.03,0,0
146713,;,0,0
146714,p,0,0
146715,=,0,0
146716,0.01,0,0
146717,),0,0
146718,compared,0,0
146719,to,0,0
146720,control,0,0
146721,.,0,0
146722,Yet,0,0
146723,there,0,0
146724,was,0,0
146725,no,0,0
146726,significant,0,0
146727,change,0,0
146728,in,0,0
146729,aortic,0,0
146730,PWV,0,1
146731,(,0,1
146732,+0.04,0,0
146733,m/s,0,0
146734,",",0,0
146735,95,0,0
146736,%,0,0
146737,CI,0,0
146738,-0.47,0,0
146739,to,0,0
146740,0.55,0,0
146741,;,0,0
146742,p,0,0
146743,=,0,0
146744,0.87,0,0
146745,),0,0
146746,or,0,1
146747,brachial,0,0
146748,PWV,0,1
146749,(,0,1
146750,+0.36,0,1
146751,m/s,0,0
146752,;,0,0
146753,-0.41,0,0
146754,to,0,0
146755,1.12,0,0
146756,;,0,0
146757,p,0,0
146758,=,0,0
146759,0.35,0,0
146760,),0,0
146761,between,0,0
146762,conditions,0,0
146763,.,0,0
146764,We,0,0
146765,conclude,0,0
146766,that,0,0
146767,mild-cold,1,1
146768,exposure,1,0
146769,increases,0,0
146770,central,0,0
146771,haemodynamic,0,0
146772,stress,0,0
146773,and,0,0
146774,alters,0,0
146775,timing,0,0
146776,of,0,0
146777,peak,0,0
146778,aortic,0,0
146779,in-flow,0,1
146780,without,0,0
146781,differentially,0,0
146782,affecting,0,0
146783,arterial,0,0
146784,stiffness,0,0
146785,.,0,0
146786,Translating,0,0
146787,the,0,0
146788,Dietary,1,1
146789,Approaches,1,1
146790,to,1,0
146791,Stop,1,1
146792,Hypertension,1,0
146793,(,1,1
146794,DASH,1,1
146795,),1,1
146796,diet,1,1
146797,for,0,0
146798,use,0,0
146799,in,0,0
146800,underresourced,0,0
146801,",",0,0
146802,urban,0,0
146803,African,0,0
146804,American,0,0
146805,communities,0,0
146806,",",0,0
146807,2010,0,0
146808,.,0,0
146809,INTRODUCTION,0,0
146810,Randomized,0,0
146811,trials,0,0
146812,have,0,0
146813,demonstrated,0,0
146814,the,0,0
146815,effectiveness,0,0
146816,of,0,0
146817,the,0,0
146818,Dietary,1,1
146819,Approaches,1,1
146820,to,1,0
146821,Stop,1,1
146822,Hypertension,1,0
146823,(,1,1
146824,DASH,1,1
146825,),1,1
146826,program,0,1
146827,for,0,0
146828,lowering,0,0
146829,blood,0,0
146830,pressure,0,0
146831,;,0,0
146832,however,0,0
146833,",",0,0
146834,program,0,1
146835,participation,0,0
146836,has,0,0
146837,been,0,0
146838,limited,0,0
146839,in,0,0
146840,some,0,0
146841,populations,0,0
146842,.,0,0
146843,The,0,0
146844,objective,0,0
146845,of,0,0
146846,this,0,0
146847,pilot,0,0
146848,study,0,0
146849,was,0,0
146850,to,0,0
146851,test,0,0
146852,the,0,0
146853,feasibility,0,0
146854,of,0,0
146855,using,0,0
146856,a,0,0
146857,culturally,0,1
146858,modified,0,0
146859,version,0,0
146860,of,0,0
146861,DASH,1,1
146862,among,0,0
146863,African,0,0
146864,Americans,0,0
146865,in,0,0
146866,an,0,0
146867,underresourced,0,0
146868,community,0,0
146869,.,0,0
146870,METHODS,0,0
146871,This,0,0
146872,randomized,0,0
146873,controlled,0,0
146874,pilot,0,0
146875,study,0,0
146876,recruited,0,0
146877,African,0,0
146878,Americans,0,0
146879,in,0,0
146880,2,0,0
146881,North,0,0
146882,Carolina,0,0
146883,neighborhoods,0,0
146884,who,0,0
146885,had,0,0
146886,high,0,0
146887,blood,0,0
146888,pressure,0,0
146889,and,0,0
146890,used,0,0
146891,fewer,0,0
146892,than,0,0
146893,3,0,0
146894,antihypertension,0,0
146895,medications,0,0
146896,.,0,0
146897,We,0,0
146898,offered,0,0
146899,2,0,0
146900,individual,1,0
146901,and,1,0
146902,9,0,0
146903,group,1,0
146904,DASH,1,1
146905,sessions,1,1
146906,to,0,0
146907,intervention,0,1
146908,participants,0,0
146909,and,0,0
146910,1,1,0
146911,individual,1,0
146912,session,1,1
146913,and,1,0
146914,printed,1,1
146915,DASH,1,1
146916,educational,1,1
146917,materials,1,1
146918,to,1,0
146919,control,1,0
146920,participants,1,0
146921,.,1,0
146922,We,0,0
146923,collected,0,0
146924,data,0,0
146925,at,0,0
146926,baseline,0,0
146927,(,0,0
146928,March,0,1
146929,2010,0,0
146930,),0,0
146931,and,0,0
146932,12,0,1
146933,weeks,0,0
146934,(,0,0
146935,June,0,0
146936,2010,0,0
146937,),0,0
146938,.,0,0
146939,RESULTS,0,0
146940,Of,0,1
146941,152,0,0
146942,potential,0,0
146943,participants,0,0
146944,",",0,0
146945,25,0,0
146946,were,0,0
146947,randomly,0,0
146948,assigned,0,0
146949,to,0,0
146950,either,0,0
146951,the,0,0
146952,intervention,1,1
146953,(,0,0
146954,n,0,0
146955,=,0,0
146956,14,0,1
146957,),0,0
146958,or,0,1
146959,the,0,0
146960,control,1,1
146961,(,0,0
146962,n,0,0
146963,=,0,0
146964,11,0,0
146965,),0,0
146966,group,0,0
146967,;,0,0
146968,22,0,0
146969,were,0,0
146970,women,0,0
146971,",",0,0
146972,and,0,0
146973,21,0,0
146974,were,0,0
146975,educated,0,0
146976,beyond,0,0
146977,high,0,0
146978,school,0,0
146979,.,0,0
146980,At,0,0
146981,baseline,0,0
146982,",",0,0
146983,mean,0,0
146984,blood,0,0
146985,pressure,0,0
146986,was,0,0
146987,130/78,0,0
146988,mm,0,0
146989,Hg,0,0
146990,;,0,0
146991,19,0,0
146992,participants,0,0
146993,used,0,0
146994,antihypertension,0,0
146995,medications,0,1
146996,",",0,0
146997,and,0,0
146998,mean,0,0
146999,body,0,0
147000,mass,0,0
147001,index,0,0
147002,was,0,0
147003,35.9,0,0
147004,kg/m,0,0
147005,(,0,0
147006,2,0,0
147007,),0,0
147008,.,0,0
147009,Intervention,0,1
147010,participants,0,0
147011,attended,0,0
147012,7,0,0
147013,of,0,0
147014,9,0,0
147015,group,0,0
147016,sessions,0,1
147017,on,0,0
147018,average,0,0
147019,.,0,0
147020,After,0,0
147021,12,0,0
147022,weeks,0,0
147023,",",0,0
147024,we,0,0
147025,observed,0,0
147026,significant,0,0
147027,increases,0,0
147028,in,0,0
147029,fruit,0,0
147030,and,0,0
147031,vegetable,0,1
147032,consumption,0,0
147033,and,0,0
147034,increases,0,0
147035,in,0,0
147036,participants,0,0
147037,',0,0
147038,confidence,0,0
147039,in,0,0
147040,their,0,0
147041,ability,0,0
147042,to,0,0
147043,reduce,0,0
147044,salt,0,1
147045,and,0,0
147046,fat,0,1
147047,consumption,0,1
147048,and,0,0
147049,eat,0,1
147050,healthier,0,0
147051,snacks,0,1
147052,in,0,0
147053,intervention,0,1
147054,compared,0,0
147055,with,0,0
147056,control,0,0
147057,participants,0,0
147058,.,0,0
147059,We,0,0
147060,found,0,0
147061,no,0,0
147062,significant,0,0
147063,decreases,0,0
147064,in,0,0
147065,blood,0,0
147066,pressure,0,0
147067,.,0,0
147068,CONCLUSION,0,0
147069,Implementation,0,1
147070,of,0,0
147071,a,0,0
147072,culturally,0,1
147073,modified,0,0
147074,",",0,0
147075,community-based,1,1
147076,DASH,1,1
147077,intervention,1,1
147078,was,0,0
147079,feasible,0,0
147080,in,0,0
147081,our,0,0
147082,small,0,0
147083,sample,0,0
147084,of,0,0
147085,African,0,0
147086,Americans,0,0
147087,",",0,0
147088,which,0,0
147089,included,0,0
147090,people,0,0
147091,being,0,0
147092,treated,0,0
147093,for,0,0
147094,high,0,0
147095,blood,0,0
147096,pressure,0,0
147097,.,0,0
147098,Future,0,0
147099,studies,0,0
147100,should,0,0
147101,evaluate,0,0
147102,the,0,0
147103,long-term,0,0
147104,effect,0,0
147105,of,0,0
147106,this,0,0
147107,program,0,1
147108,in,0,0
147109,a,0,0
147110,larger,0,0
147111,sample,0,0
147112,.,0,0
147113,Intravenous,0,1
147114,aflibercept,1,1
147115,administered,0,0
147116,in,0,0
147117,combination,0,1
147118,with,0,0
147119,irinotecan,1,1
147120,",",1,0
147121,5-fluorouracil,1,1
147122,and,1,0
147123,leucovorin,1,1
147124,in,0,0
147125,patients,0,0
147126,with,0,0
147127,advanced,0,0
147128,solid,0,0
147129,tumours,0,0
147130,:,0,0
147131,results,0,0
147132,from,0,0
147133,the,0,0
147134,expansion,0,0
147135,cohort,0,0
147136,of,0,0
147137,a,0,0
147138,phase,0,0
147139,I,0,0
147140,study,0,0
147141,.,0,0
147142,BACKGROUND,0,0
147143,Following,0,0
147144,the,0,0
147145,dose-escalation,0,0
147146,stage,0,0
147147,",",0,0
147148,this,0,0
147149,double-blind,0,0
147150,expansion,0,0
147151,stage,0,0
147152,of,0,0
147153,the,0,0
147154,phase,0,0
147155,I,0,0
147156,study,0,0
147157,evaluated,0,0
147158,the,0,0
147159,safety,0,0
147160,",",0,0
147161,pharmacodynamics,0,0
147162,",",0,0
147163,pharmacokinetics,0,0
147164,",",0,0
147165,anti-vascular,0,1
147166,effects,0,0
147167,and,0,0
147168,antitumour,0,0
147169,activity,0,0
147170,of,0,0
147171,aflibercept,1,1
147172,4,0,0
147173,mg/kg,0,1
147174,with,0,0
147175,irinotecan,1,1
147176,",",1,0
147177,5-fluorouracil,1,1
147178,and,1,0
147179,leucovorin,1,1
147180,(,1,1
147181,LV5FU2,1,1
147182,),1,0
147183,.,1,0
147184,PATIENTS,0,0
147185,AND,0,0
147186,METHODS,0,0
147187,Patients,0,0
147188,with,0,0
147189,advanced,0,0
147190,solid,0,0
147191,tumours,0,0
147192,were,0,0
147193,randomised,0,0
147194,at,0,0
147195,cycle-1,0,0
147196,to,0,0
147197,placebo,1,1
147198,or,1,1
147199,aflibercept,1,1
147200,(,0,0
147201,4,0,1
147202,mg/kg,0,1
147203,),0,0
147204,on,0,0
147205,day,0,0
147206,1,0,0
147207,then,0,0
147208,irinotecan-LV5FU2,1,1
147209,on,0,0
147210,days,0,0
147211,1,0,0
147212,and,0,0
147213,2,0,0
147214,.,0,0
147215,Subsequently,0,0
147216,",",0,0
147217,all,0,0
147218,patients,0,0
147219,received,0,0
147220,aflibercept,1,1
147221,with,0,0
147222,irinotecan-LV5FU2,1,1
147223,every,0,0
147224,2,0,0
147225,weeks,0,0
147226,.,0,0
147227,Anti-vascular,0,0
147228,effects,0,0
147229,were,0,0
147230,assessed,0,0
147231,using,0,0
147232,dynamic,0,0
147233,contrast-enhanced,0,1
147234,magnetic,0,1
147235,resonance,0,1
147236,imaging,0,1
147237,(,0,1
147238,DCE-MRI,0,0
147239,),0,1
147240,.,0,0
147241,RESULTS,0,0
147242,Twenty-seven,0,0
147243,patients,0,0
147244,were,0,0
147245,treated,0,0
147246,;,0,0
147247,14,0,0
147248,received,0,0
147249,placebo,1,1
147250,in,0,0
147251,cycle-1,0,0
147252,followed,0,1
147253,by,0,0
147254,aflibercept,1,1
147255,in,0,0
147256,later,0,0
147257,cycles,0,1
147258,and,0,0
147259,13,0,0
147260,received,0,0
147261,aflibercept,1,1
147262,4,0,1
147263,mg/kg,0,1
147264,upfront,0,0
147265,.,0,0
147266,The,0,0
147267,median,0,0
147268,number,0,0
147269,of,0,0
147270,aflibercept,1,1
147271,cycles,0,0
147272,was,0,0
147273,16,0,0
147274,(,0,0
147275,range,0,0
147276,1-44,0,1
147277,),0,0
147278,",",0,0
147279,12,0,0
147280,patients,0,0
147281,received,0,0
147282,?20,0,0
147283,cycles,0,0
147284,.,0,0
147285,Most,0,0
147286,frequent,0,0
147287,grade,0,0
147288,3/4,0,0
147289,adverse,0,0
147290,events,0,0
147291,were,0,0
147292,neutropenia,0,0
147293,(,0,0
147294,37,0,0
147295,%,0,0
147296,),0,0
147297,",",0,0
147298,fatigue,0,0
147299,(,0,0
147300,33,0,0
147301,%,0,0
147302,),0,1
147303,and,0,1
147304,hypertension,0,0
147305,(,0,1
147306,30,0,1
147307,%,0,0
147308,),0,0
147309,.,0,0
147310,No,0,0
147311,anti-aflibercept,0,1
147312,antibodies,0,0
147313,were,0,0
147314,detected,0,0
147315,.,0,0
147316,Four,0,0
147317,patients,0,0
147318,achieved,0,0
147319,partial,0,0
147320,responses,0,0
147321,and,0,0
147322,17,0,0
147323,had,0,0
147324,stable,0,0
147325,disease,0,0
147326,",",0,0
147327,lasting,0,0
147328,>,0,0
147329,3,0,0
147330,months,0,0
147331,in,0,0
147332,14,0,0
147333,patients,0,0
147334,.,0,0
147335,Plasma,0,0
147336,levels,0,0
147337,of,0,0
147338,free,0,0
147339,over,0,0
147340,vascular,0,0
147341,endothelial,0,0
147342,growth,0,0
147343,factor-bound,0,1
147344,aflibercept,0,1
147345,were,0,0
147346,adequate,0,0
147347,",",0,0
147348,with,0,0
147349,steady-state,0,0
147350,achieved,0,0
147351,from,0,0
147352,cycle-3,0,0
147353,.,0,0
147354,Exploratory,0,0
147355,DCE-MRI,0,0
147356,showed,0,0
147357,no,0,0
147358,significant,0,0
147359,perfusion,0,0
147360,changes,0,0
147361,with,0,0
147362,aflibercept,0,1
147363,.,0,0
147364,CONCLUSION,1,0
147365,Aflibercept,1,1
147366,4,1,0
147367,mg/kg,0,1
147368,plus,1,1
147369,irinotecan-LV5FU2,1,1
147370,every,1,1
147371,2,0,0
147372,weeks,0,0
147373,had,0,0
147374,acceptable,0,0
147375,toxicity,0,0
147376,and,0,0
147377,pharmacokinetics,0,0
147378,",",0,0
147379,and,0,0
147380,showed,0,0
147381,promising,0,0
147382,antitumour,0,0
147383,activity,0,0
147384,.,0,0
147385,A,0,0
147386,trial,0,0
147387,with,0,0
147388,"3'-azido-2',3'-dideoxythymidine",1,1
147389,and,0,0
147390,human,0,1
147391,interferon-?,1,1
147392,in,0,0
147393,cats,0,0
147394,naturally,0,0
147395,infected,0,0
147396,with,0,0
147397,feline,0,1
147398,leukaemia,0,0
147399,virus,0,0
147400,.,0,0
147401,Feline,0,1
147402,leukaemia,0,0
147403,virus,0,1
147404,(,0,1
147405,FeLV,0,1
147406,),0,1
147407,infection,0,0
147408,is,0,0
147409,still,0,0
147410,one,0,0
147411,of,0,0
147412,the,0,0
147413,leading,0,0
147414,causes,0,0
147415,of,0,0
147416,infection-related,0,0
147417,deaths,0,0
147418,in,0,0
147419,domestic,0,0
147420,cats,0,0
147421,.,0,0
147422,Treatment,0,0
147423,with,0,0
147424,various,0,0
147425,drugs,0,1
147426,has,0,0
147427,been,0,0
147428,attempted,0,0
147429,",",0,0
147430,but,0,0
147431,none,0,0
147432,has,0,0
147433,resulted,0,0
147434,in,0,0
147435,cure,0,0
147436,or,0,1
147437,complete,0,0
147438,virus,0,1
147439,elimination,0,0
147440,.,0,0
147441,Human,1,0
147442,interferon-?2a,1,1
147443,(,1,1
147444,huIFN-?2a,1,1
147445,),1,1
147446,and,1,0
147447,"3'-azido-2',3'-dideoxythymidine",1,1
147448,(,1,1
147449,AZT,1,0
147450,),1,1
147451,have,1,0
147452,been,0,0
147453,proven,0,0
147454,to,0,0
147455,decrease,0,0
147456,antigenaemia,0,0
147457,in,0,0
147458,cats,0,0
147459,infected,0,0
147460,experimentally,0,0
147461,with,0,0
147462,FeLV,0,0
147463,.,0,0
147464,The,0,0
147465,purpose,0,0
147466,of,0,0
147467,this,0,0
147468,study,0,0
147469,was,0,0
147470,to,0,0
147471,assess,0,0
147472,the,0,0
147473,efficacy,0,0
147474,of,0,0
147475,huIFN-?2a,1,1
147476,",",1,0
147477,AZT,1,0
147478,and,0,0
147479,a,0,0
147480,combination,0,1
147481,of,0,0
147482,both,0,0
147483,drugs,0,1
147484,in,0,0
147485,cats,0,0
147486,infected,0,0
147487,naturally,0,0
147488,with,0,0
147489,FeLV,0,0
147490,in,0,0
147491,a,0,0
147492,placebo-controlled,0,1
147493,double-blinded,0,0
147494,trial,0,0
147495,.,0,0
147496,Fourty-four,0,0
147497,FeLV-infected,0,0
147498,cats,0,0
147499,in,0,0
147500,which,0,0
147501,free,0,0
147502,FeLV,0,1
147503,p27,0,1
147504,antigen,0,0
147505,was,0,0
147506,detected,0,0
147507,in,0,0
147508,serum,0,0
147509,by,0,0
147510,enzyme-linked,0,0
147511,immunosorbent,0,0
147512,assay,0,1
147513,were,0,0
147514,included,0,0
147515,in,0,0
147516,the,0,0
147517,study,0,0
147518,.,0,0
147519,Cats,0,0
147520,were,0,0
147521,assigned,0,0
147522,to,0,0
147523,one,0,0
147524,of,0,0
147525,four,0,0
147526,treatment,0,0
147527,groups,0,0
147528,that,0,0
147529,received,0,0
147530,either,0,0
147531,high,0,0
147532,dose,0,1
147533,huIFN-?2a,1,1
147534,(,1,1
147535,10,1,1
147536,(,1,0
147537,5,0,0
147538,),0,0
147539,IU/kg,0,1
147540,q24h,0,1
147541,;,0,0
147542,12,0,0
147543,cats,0,0
147544,),0,0
147545,",",1,0
147546,AZT,1,0
147547,(,0,0
147548,5,0,1
147549,mg/kg,0,1
147550,q12h,0,1
147551,;,0,0
147552,10,0,0
147553,cats,0,0
147554,",",0,0
147555,both,0,0
147556,of,0,0
147557,these,0,0
147558,treatments,0,1
147559,(,0,0
147560,12,0,0
147561,cats,0,0
147562,),0,0
147563,or,1,1
147564,placebo,1,1
147565,(,1,0
147566,10,1,1
147567,cats,0,0
147568,),0,0
147569,.,0,0
147570,All,0,0
147571,cats,0,0
147572,were,0,0
147573,treated,0,0
147574,for,0,0
147575,6,0,0
147576,weeks,0,0
147577,.,0,0
147578,Clinical,0,0
147579,variables,0,0
147580,",",0,0
147581,including,0,0
147582,stomatitis,0,1
147583,",",0,0
147584,and,0,0
147585,laboratory,0,0
147586,parameters,0,0
147587,",",0,0
147588,such,0,0
147589,as,0,0
147590,CD4,0,0
147591,(,0,1
147592,+,0,1
147593,),0,1
147594,and,0,0
147595,CD8,0,1
147596,(,0,1
147597,+,0,1
147598,),0,1
147599,counts,0,0
147600,and,0,0
147601,serum,0,0
147602,FeLV,0,1
147603,p,0,0
147604,27,0,0
147605,antigen,0,0
147606,concentration,0,0
147607,",",0,0
147608,were,0,0
147609,recorded,0,0
147610,throughout,0,0
147611,the,0,0
147612,treatment,0,0
147613,period,0,0
147614,.,0,0
147615,No,0,0
147616,significant,0,0
147617,difference,0,0
147618,among,0,0
147619,the,0,0
147620,groups,0,0
147621,was,0,0
147622,observed,0,0
147623,during,0,0
147624,the,0,0
147625,treatment,0,0
147626,period,0,0
147627,for,0,0
147628,any,0,0
147629,of,0,0
147630,the,0,0
147631,parameters,0,0
147632,.,0,0
147633,Aside,0,0
147634,from,0,0
147635,anaemia,0,0
147636,in,0,0
147637,one,0,0
147638,cat,0,0
147639,treated,0,0
147640,with,0,0
147641,AZT,0,0
147642,",",0,0
147643,no,0,0
147644,adverse,0,0
147645,effects,0,0
147646,were,0,0
147647,observed,0,0
147648,.,0,0
147649,It,0,0
147650,was,0,0
147651,not,0,0
147652,possible,0,0
147653,to,0,0
147654,demonstrate,0,0
147655,efficacy,1,0
147656,of,1,0
147657,huIFN-?2a,1,1
147658,or,1,1
147659,AZT,1,0
147660,alone,0,1
147661,or,0,0
147662,together,0,0
147663,in,0,0
147664,cats,0,0
147665,infected,0,0
147666,naturally,0,0
147667,with,0,0
147668,FeLV,0,0
147669,when,0,0
147670,given,0,0
147671,according,0,0
147672,to,0,0
147673,this,0,0
147674,regimen,0,1
147675,for,0,0
147676,6,0,0
147677,weeks,0,0
147678,;,0,0
147679,however,0,0
147680,",",0,0
147681,no,0,0
147682,notable,0,0
147683,side,0,0
147684,effects,0,0
147685,were,0,0
147686,detected,0,0
147687,.,0,0
147688,Plasma,0,0
147689,Epstein-Barr,0,1
147690,virus,0,1
147691,DNA,0,0
147692,predicts,0,0
147693,outcome,0,0
147694,in,0,0
147695,advanced,0,0
147696,Hodgkin,0,0
147697,lymphoma,0,0
147698,:,0,0
147699,correlative,0,0
147700,analysis,0,0
147701,from,0,0
147702,a,0,0
147703,large,0,0
147704,North,0,0
147705,American,0,0
147706,cooperative,0,0
147707,group,0,0
147708,trial,0,0
147709,.,0,0
147710,Epstein-Barr,0,1
147711,virus,0,0
147712,(,0,1
147713,EBV,0,1
147714,),0,1
147715,is,0,0
147716,associated,0,0
147717,with,0,0
147718,Hodgkin,0,0
147719,lymphoma,0,0
147720,(,0,1
147721,HL,0,0
147722,),0,1
147723,and,0,0
147724,can,0,0
147725,be,0,0
147726,detected,0,0
147727,by,0,0
147728,in,0,0
147729,situ,0,1
147730,hybridization,0,1
147731,(,0,1
147732,ISH,0,1
147733,),0,1
147734,of,0,0
147735,viral,0,0
147736,nucleic,0,1
147737,acid,0,1
147738,(,0,1
147739,EBER,0,1
147740,),0,1
147741,in,0,0
147742,tumor,0,0
147743,cells,0,0
147744,.,0,0
147745,We,0,0
147746,sought,0,0
147747,to,0,0
147748,determine,0,0
147749,whether,0,0
147750,plasma,0,0
147751,EBV-DNA,0,1
147752,could,0,0
147753,serve,0,0
147754,as,0,0
147755,a,0,0
147756,surrogate,0,0
147757,for,0,0
147758,EBER-ISH,0,1
147759,and,0,0
147760,to,0,0
147761,explore,0,0
147762,its,0,0
147763,prognostic,0,0
147764,utility,0,0
147765,in,0,0
147766,HL,0,0
147767,.,0,0
147768,Specimens,0,0
147769,from,0,0
147770,the,0,0
147771,Cancer,0,0
147772,Cooperative,0,0
147773,Intergroup,0,0
147774,Trial,0,1
147775,E2496,0,1
147776,were,0,0
147777,used,0,0
147778,to,0,0
147779,compare,1,0
147780,pretreatment,1,0
147781,plasma,1,0
147782,EBV-DNA,1,1
147783,quantification,1,0
147784,with,1,0
147785,EBV,1,1
147786,tumor,1,0
147787,status,1,0
147788,by,1,0
147789,EBER-ISH,1,1
147790,.,1,0
147791,A,0,0
147792,cutoff,0,0
147793,of,0,0
147794,>,0,0
147795,60,0,0
147796,viral,0,0
147797,copies/100,0,0
147798,?L,0,0
147799,plasma,0,0
147800,yielded,0,0
147801,96,0,0
147802,%,0,0
147803,concordance,0,0
147804,with,0,0
147805,EBER-ISH,0,1
147806,.,0,0
147807,Pretreatment,0,0
147808,and,0,0
147809,month,0,0
147810,6,0,1
147811,plasma,0,0
147812,specimens,0,0
147813,were,0,0
147814,designated,0,0
147815,EBV,0,0
147816,(,0,1
147817,-,0,1
147818,),0,1
147819,or,0,1
147820,EBV,0,1
147821,(,0,1
147822,+,0,1
147823,),0,1
147824,by,0,0
147825,this,0,0
147826,cutoff,0,0
147827,.,0,0
147828,Patients,0,0
147829,with,0,0
147830,pretreatment,0,0
147831,EBV,0,1
147832,(,0,1
147833,+,0,1
147834,),0,1
147835,plasma,0,0
147836,(,0,0
147837,n,0,0
147838,=,0,0
147839,54,0,0
147840,),0,0
147841,had,0,0
147842,inferior,0,0
147843,failure-free,0,0
147844,survival,0,0
147845,(,0,1
147846,FFS,0,1
147847,),0,1
147848,compared,0,0
147849,with,0,0
147850,those,0,0
147851,with,0,0
147852,pretreatment,0,0
147853,EBV,0,1
147854,(,0,1
147855,-,0,0
147856,),0,1
147857,plasma,0,0
147858,(,0,0
147859,n,0,0
147860,=,0,0
147861,274,0,0
147862,),0,0
147863,",",0,0
147864,log-rank,0,0
147865,P,0,0
147866,=,0,0
147867,.009,0,0
147868,.,0,0
147869,By,0,0
147870,contrast,0,0
147871,",",0,0
147872,no,0,0
147873,difference,0,0
147874,in,0,0
147875,FFS,0,0
147876,was,0,0
147877,observed,0,0
147878,when,0,0
147879,patients,0,0
147880,were,0,0
147881,stratified,0,0
147882,by,0,0
147883,EBER-ISH,0,0
147884,.,0,0
147885,Pretreatment,0,0
147886,plasma,0,0
147887,EBV,0,1
147888,positivity,0,0
147889,was,0,0
147890,an,0,0
147891,independent,0,0
147892,predictor,0,0
147893,of,0,0
147894,treatment,0,0
147895,failure,0,0
147896,on,0,0
147897,multivariate,0,0
147898,analyses,0,0
147899,.,0,0
147900,At,0,0
147901,month,0,0
147902,6,0,0
147903,",",0,0
147904,plasma,0,0
147905,EBV,0,1
147906,(,0,1
147907,+,0,1
147908,),0,1
147909,patients,0,0
147910,(,0,0
147911,n,0,0
147912,=,0,0
147913,7,0,0
147914,),0,0
147915,had,0,0
147916,inferior,0,0
147917,FFS,0,1
147918,compared,0,0
147919,with,0,0
147920,plasma,0,0
147921,EBV,0,1
147922,(,0,1
147923,-,0,0
147924,),0,1
147925,patients,0,0
147926,(,0,0
147927,n,0,0
147928,=,0,0
147929,125,0,0
147930,),0,0
147931,",",0,0
147932,log-rank,0,0
147933,P,0,0
147934,=,0,0
147935,.007,0,0
147936,.,0,0
147937,These,0,0
147938,results,0,0
147939,confirm,0,0
147940,that,0,0
147941,plasma,0,0
147942,EBV-DNA,0,1
147943,is,0,0
147944,highly,0,0
147945,concordant,0,0
147946,with,0,0
147947,EBER-ISH,0,1
147948,in,0,0
147949,HL,0,0
147950,and,0,0
147951,suggest,0,0
147952,that,0,0
147953,it,0,0
147954,may,0,0
147955,have,0,0
147956,prognostic,0,0
147957,utility,0,0
147958,both,0,0
147959,at,0,0
147960,baseline,0,0
147961,and,0,0
147962,after,0,0
147963,therapy,0,1
147964,.,0,0
147965,This,0,0
147966,trial,0,0
147967,was,0,0
147968,registered,0,0
147969,at,0,0
147970,www.clinicaltrials.gov,0,0
147971,as,0,0
147972,#,0,0
147973,NCT00003389,0,0
147974,.,0,0
147975,Sex,0,1
147976,risk,0,0
147977,behavior,0,0
147978,among,0,0
147979,adolescent,0,0
147980,and,0,0
147981,young,0,0
147982,adult,0,0
147983,children,0,0
147984,of,0,0
147985,opiate,0,0
147986,addicts,0,0
147987,:,0,0
147988,outcomes,0,0
147989,from,0,0
147990,the,0,0
147991,focus,0,0
147992,on,0,0
147993,families,0,1
147994,prevention,0,0
147995,trial,0,0
147996,and,0,0
147997,an,0,0
147998,examination,0,0
147999,of,0,0
148000,childhood,0,0
148001,and,0,0
148002,concurrent,0,1
148003,predictors,0,0
148004,of,0,0
148005,sex,0,0
148006,risk,0,0
148007,behavior,0,0
148008,.,0,0
148009,This,0,0
148010,study,0,0
148011,reports,0,0
148012,on,0,0
148013,rates,0,0
148014,and,0,0
148015,predictors,0,0
148016,of,0,0
148017,sex,0,0
148018,risk,0,0
148019,behavior,0,0
148020,among,0,0
148021,a,0,0
148022,sample,0,0
148023,of,0,0
148024,adolescent,0,0
148025,and,0,0
148026,young,0,0
148027,adult,0,0
148028,children,0,0
148029,of,0,0
148030,parents,0,0
148031,enrolled,0,0
148032,in,0,0
148033,methadone,1,1
148034,treatment,0,0
148035,for,0,0
148036,opiate,0,0
148037,addiction,0,0
148038,.,0,0
148039,Data,0,0
148040,are,0,0
148041,from,0,0
148042,151,0,0
148043,participants,0,0
148044,(,0,0
148045,80,0,0
148046,males,0,0
148047,",",0,0
148048,71,0,0
148049,females,0,0
148050,),0,0
148051,in,0,0
148052,the,0,0
148053,Focus,0,0
148054,on,0,0
148055,Families,0,1
148056,(,0,1
148057,FOF,0,1
148058,),0,1
148059,project,0,0
148060,",",0,0
148061,a,0,0
148062,randomized,0,0
148063,trial,0,0
148064,of,0,0
148065,a,0,0
148066,family,1,1
148067,intervention,1,1
148068,and,0,0
148069,a,0,0
148070,study,0,0
148071,of,0,0
148072,the,0,0
148073,development,0,0
148074,of,0,0
148075,at-risk,0,0
148076,children,0,0
148077,.,0,0
148078,The,0,0
148079,study,0,0
148080,participants,0,0
148081,are,0,0
148082,children,0,0
148083,of,0,0
148084,parents,0,0
148085,enrolled,0,0
148086,in,0,0
148087,methadone,1,1
148088,treatment,1,0
148089,between,0,0
148090,1990,0,0
148091,and,0,0
148092,1993,0,0
148093,.,0,0
148094,Participants,0,0
148095,were,0,0
148096,interviewed,0,0
148097,in,0,0
148098,2005,0,0
148099,when,0,0
148100,they,0,0
148101,ranged,0,0
148102,in,0,0
148103,age,0,0
148104,from,0,0
148105,15,0,0
148106,to,0,0
148107,29,0,0
148108,years,0,0
148109,.,0,0
148110,In,0,0
148111,the,0,0
148112,year,0,0
148113,prior,0,0
148114,to,0,0
148115,the,0,0
148116,follow-up,0,0
148117,",",0,0
148118,79,0,0
148119,%,0,0
148120,of,0,0
148121,the,0,0
148122,males,0,0
148123,and,0,0
148124,83,0,0
148125,%,0,0
148126,of,0,0
148127,females,0,0
148128,were,0,0
148129,sexually,0,0
148130,active,0,0
148131,",",0,0
148132,26,0,0
148133,%,0,0
148134,of,0,0
148135,males,0,0
148136,and,0,0
148137,10,0,0
148138,%,0,0
148139,of,0,0
148140,females,0,0
148141,had,0,0
148142,more,0,0
148143,than,0,0
148144,one,0,0
148145,partner,0,0
148146,in,0,0
148147,the,0,0
148148,prior,0,0
148149,year,0,0
148150,",",0,0
148151,and,0,0
148152,34,0,0
148153,%,0,0
148154,of,0,0
148155,males,0,0
148156,and,0,0
148157,24,0,0
148158,%,0,0
148159,of,0,0
148160,females,0,0
148161,reported,0,0
148162,having,0,0
148163,sex,0,0
148164,outside,0,1
148165,of,0,0
148166,a,0,0
148167,committed,0,0
148168,relationship,0,0
148169,.,0,0
148170,Twenty-four,0,0
148171,percent,0,0
148172,of,0,0
148173,males,0,0
148174,and,0,0
148175,17,0,0
148176,%,0,0
148177,of,0,0
148178,females,0,0
148179,met,0,0
148180,criteria,0,0
148181,for,0,0
148182,high-risk,0,0
148183,sexual,0,0
148184,behavior,0,0
148185,",",0,0
148186,reporting,0,0
148187,casual,0,0
148188,or,0,1
148189,multiple,0,0
148190,partners,0,0
148191,in,0,0
148192,the,0,0
148193,prior,0,0
148194,year,0,0
148195,and,0,0
148196,inconsistent,0,0
148197,condom,0,0
148198,use,0,0
148199,.,0,0
148200,Participants,0,0
148201,in,0,0
148202,the,0,0
148203,intervention,1,1
148204,and,0,0
148205,control,1,1
148206,conditions,0,0
148207,did,0,0
148208,not,0,0
148209,differ,0,0
148210,significantly,0,0
148211,in,0,0
148212,terms,0,0
148213,of,0,0
148214,any,0,0
148215,measure,0,0
148216,of,0,0
148217,sex,0,0
148218,risk,0,0
148219,behavior,0,0
148220,examined,0,0
148221,.,0,0
148222,None,0,0
148223,of,0,0
148224,the,0,0
148225,measures,0,0
148226,of,0,0
148227,parent,0,1
148228,behavior,0,1
148229,and,0,0
148230,family,0,1
148231,processes,0,0
148232,derived,0,0
148233,from,0,0
148234,data,0,0
148235,at,0,0
148236,baseline,0,0
148237,of,0,0
148238,the,0,0
148239,FOF,0,1
148240,study,0,0
148241,predicted,0,0
148242,whether,0,0
148243,participants,0,0
148244,engaged,0,0
148245,in,0,0
148246,high-risk,0,0
148247,sex,0,0
148248,.,0,0
148249,Among,0,0
148250,measures,0,0
148251,derived,0,0
148252,from,0,0
148253,data,0,0
148254,collected,0,0
148255,at,0,0
148256,long-term,0,0
148257,follow-up,0,0
148258,",",0,0
148259,however,0,0
148260,",",0,0
148261,having,0,0
148262,ever,0,0
148263,met,0,0
148264,criteria,0,0
148265,for,0,0
148266,substance,0,0
148267,abuse,0,0
148268,or,0,1
148269,dependence,0,0
148270,predicted,0,0
148271,greater,0,0
148272,likelihood,0,0
148273,of,0,0
148274,high-risk,0,0
148275,sexual,0,0
148276,behavior,0,0
148277,",",0,0
148278,and,0,0
148279,being,0,0
148280,married,0,0
148281,or,0,1
148282,being,0,0
148283,in,0,0
148284,a,0,0
148285,romantic,0,0
148286,relationship,0,0
148287,was,0,0
148288,associated,0,0
148289,with,0,0
148290,lower,0,0
148291,likelihood,0,0
148292,of,0,0
148293,high-risk,0,0
148294,sexual,0,0
148295,behavior,0,0
148296,.,0,0
148297,The,0,0
148298,findings,0,0
148299,point,0,0
148300,to,0,0
148301,the,0,0
148302,important,0,0
148303,role,0,0
148304,of,0,0
148305,committed,0,0
148306,relationships,0,0
148307,in,0,0
148308,regulating,0,0
148309,sex,0,0
148310,risk,0,0
148311,behavior,0,0
148312,among,0,0
148313,this,0,0
148314,population,0,0
148315,",",0,0
148316,as,0,0
148317,well,0,0
148318,as,0,0
148319,heightened,0,0
148320,levels,0,0
148321,of,0,0
148322,sex,0,0
148323,risk,0,0
148324,behavior,0,0
148325,associated,0,0
148326,with,0,0
148327,substance,0,0
148328,abuse,0,0
148329,or,0,1
148330,dependence,0,0
148331,.,0,0
148332,Association,0,0
148333,between,0,0
148334,weight,1,0
148335,loss,1,0
148336,and,0,0
148337,improvement,0,0
148338,of,0,0
148339,ventricular,0,0
148340,systolic,0,0
148341,function,0,0
148342,in,0,0
148343,advanced,0,0
148344,heart,0,0
148345,failure,0,0
148346,.,0,0
148347,In,0,0
148348,heart,0,0
148349,failure,0,0
148350,(,0,1
148351,HF,0,0
148352,),0,1
148353,",",0,0
148354,longitudinal,0,0
148355,changes,0,0
148356,in,0,0
148357,ventricular,0,0
148358,ejection,0,0
148359,fraction,0,0
148360,are,0,0
148361,poorly,0,0
148362,studied,0,0
148363,.,0,0
148364,The,0,0
148365,authors,0,0
148366,',0,0
148367,objective,0,0
148368,was,0,0
148369,to,0,0
148370,document,0,0
148371,the,0,0
148372,dynamic,0,0
148373,changes,0,0
148374,in,0,0
148375,systolic,0,0
148376,function,0,0
148377,of,0,0
148378,both,0,0
148379,ventricles,0,0
148380,during,0,0
148381,acute,0,0
148382,HF,0,0
148383,and,0,0
148384,after,0,0
148385,a,0,0
148386,3-month,0,0
148387,follow-up,0,0
148388,period,0,0
148389,",",0,0
148390,and,0,0
148391,to,0,0
148392,identify,0,0
148393,factors,0,0
148394,associated,0,0
148395,with,0,0
148396,ventricular,0,0
148397,improvement,0,0
148398,.,0,0
148399,A,0,0
148400,limited,0,0
148401,access,0,0
148402,dataset,0,0
148403,from,0,0
148404,the,0,0
148405,Evaluation,0,1
148406,Study,0,0
148407,of,0,0
148408,Congestive,0,0
148409,Heart,0,1
148410,Failure,0,1
148411,and,0,0
148412,Pulmonary,0,0
148413,Artery,0,1
148414,Catheterization,0,1
148415,Effectiveness,0,0
148416,(,0,1
148417,ESCAPE,0,1
148418,),0,1
148419,trial,0,0
148420,provided,0,0
148421,by,0,0
148422,The,0,0
148423,National,0,0
148424,Heart,0,0
148425,",",0,0
148426,Lung,0,1
148427,",",0,0
148428,and,0,0
148429,Blood,0,0
148430,Institute,0,0
148431,was,0,0
148432,analyzed,0,0
148433,.,0,0
148434,In,0,0
148435,patients,0,0
148436,admitted,0,0
148437,to,0,0
148438,the,0,0
148439,hospital,0,0
148440,with,0,0
148441,acute,0,0
148442,HF,0,0
148443,",",0,0
148444,both,0,0
148445,ventricles,1,0
148446,were,1,0
148447,evaluated,1,0
148448,by,1,0
148449,echocardiography,1,0
148450,on,0,0
148451,admission,0,0
148452,",",0,0
148453,at,0,0
148454,discharge,0,1
148455,",",0,0
148456,and,0,0
148457,at,0,0
148458,3,0,0
148459,months,0,0
148460,.,0,0
148461,From,0,0
148462,baseline,0,0
148463,to,0,0
148464,3,0,0
148465,months,0,0
148466,",",0,0
148467,left,0,0
148468,ventricular,0,0
148469,ejection,0,0
148470,fraction,0,1
148471,(,0,1
148472,LVEF,0,1
148473,),0,1
148474,increased,0,0
148475,in,0,0
148476,43.4,0,0
148477,%,0,0
148478,of,0,0
148479,patients,0,0
148480,",",0,0
148481,decreased,0,0
148482,in,0,0
148483,23.9,0,0
148484,%,0,0
148485,",",0,0
148486,and,0,0
148487,remained,0,0
148488,unchanged,0,0
148489,in,0,0
148490,32.7,0,0
148491,%,0,0
148492,.,0,0
148493,Similarly,0,0
148494,",",0,0
148495,right,0,0
148496,ventricular,0,0
148497,systolic,0,0
148498,function,0,0
148499,improved,0,0
148500,in,0,0
148501,40.9,0,0
148502,%,0,0
148503,",",0,0
148504,deteriorated,0,0
148505,in,0,0
148506,25.0,0,0
148507,%,0,0
148508,",",0,0
148509,and,0,0
148510,remained,0,0
148511,stable,0,0
148512,in,0,0
148513,34.1,0,0
148514,%,0,0
148515,.,0,0
148516,Weight,1,0
148517,loss,1,0
148518,during,0,0
148519,index,0,0
148520,admission,0,0
148521,and,0,0
148522,cardiac,0,0
148523,index/cardiac,0,1
148524,output,0,0
148525,increase,0,0
148526,were,0,0
148527,the,0,0
148528,only,0,0
148529,factors,0,0
148530,associated,0,0
148531,with,0,0
148532,LVEF,0,1
148533,improvement,0,0
148534,from,0,0
148535,baseline,0,0
148536,to,0,0
148537,month,0,0
148538,3,0,0
148539,.,0,0
148540,There,0,0
148541,was,0,0
148542,no,0,0
148543,difference,0,0
148544,between,0,0
148545,ischemic,0,0
148546,and,0,0
148547,nonischemic,0,1
148548,etiology,0,0
148549,.,0,0
148550,In,0,0
148551,acute,0,0
148552,HF,0,0
148553,",",0,0
148554,ischemic,0,0
148555,or,0,1
148556,nonischemic,0,1
148557,",",0,0
148558,systolic,0,0
148559,function,0,0
148560,of,0,0
148561,the,0,0
148562,ventricles,0,1
148563,improved,0,0
148564,during,0,0
148565,3,0,0
148566,months,0,0
148567,in,0,0
148568,about,0,0
148569,40,0,0
148570,%,0,0
148571,of,0,0
148572,patients,0,0
148573,and,0,0
148574,remained,0,0
148575,unchanged,0,0
148576,or,0,1
148577,deteriorated,0,0
148578,in,0,0
148579,the,0,0
148580,rest,0,0
148581,.,0,0
148582,Weight,1,0
148583,loss,1,0
148584,and,0,0
148585,increase,0,0
148586,in,0,0
148587,cardiac,0,0
148588,index/output,0,0
148589,during,0,0
148590,hospitalization,0,0
148591,was,0,0
148592,associated,0,0
148593,with,0,0
148594,improvement,0,0
148595,in,0,0
148596,LVEF,0,0
148597,.,0,0
148598,Association,0,0
148599,between,0,0
148600,frequency,0,0
148601,of,0,0
148602,ready-to-eat,0,1
148603,cereal,0,1
148604,consumption,0,0
148605,",",0,0
148606,nutrient,0,1
148607,intakes,0,0
148608,",",0,0
148609,and,0,0
148610,body,0,0
148611,mass,0,0
148612,index,0,0
148613,in,0,0
148614,fourth-,0,0
148615,to,0,0
148616,sixth-grade,0,0
148617,low-income,0,0
148618,minority,0,0
148619,children,0,0
148620,.,0,0
148621,BACKGROUND,0,0
148622,The,0,0
148623,consumption,0,0
148624,of,0,0
148625,non-ready-to-eat,0,1
148626,cereal,0,1
148627,and,0,0
148628,ready-to-eat,1,1
148629,cereal,1,1
148630,(,1,1
148631,RTEC,1,1
148632,),1,1
148633,breakfasts,0,1
148634,have,0,0
148635,been,0,0
148636,associated,0,0
148637,with,0,0
148638,increased,0,0
148639,nutrient,0,1
148640,intakes,0,0
148641,and,0,0
148642,lower,0,0
148643,body,0,0
148644,mass,0,0
148645,index,0,0
148646,(,0,1
148647,BMI,0,1
148648,),0,0
148649,.,0,0
148650,These,0,0
148651,relationships,0,0
148652,have,0,0
148653,not,0,0
148654,been,0,0
148655,examined,0,0
148656,in,0,0
148657,low-income,0,0
148658,minority,0,0
148659,children,0,0
148660,.,0,0
148661,OBJECTIVES,0,0
148662,To,0,0
148663,evaluate,0,0
148664,",",0,0
148665,in,0,0
148666,low-income,0,0
148667,minority,0,0
148668,children,0,0
148669,",",0,0
148670,whether,0,0
148671,there,0,0
148672,is,0,0
148673,a,0,0
148674,relationship,0,0
148675,among,0,0
148676,the,0,0
148677,frequency,0,0
148678,of,0,0
148679,RTEC,1,1
148680,consumption,0,0
148681,and,0,0
148682,nutrient,0,1
148683,intakes,0,0
148684,measured,0,0
148685,at,0,0
148686,baseline,0,0
148687,",",0,0
148688,and,0,0
148689,whether,0,0
148690,there,0,0
148691,is,0,0
148692,a,0,0
148693,relationship,0,0
148694,between,0,0
148695,the,0,0
148696,frequency,0,0
148697,of,0,0
148698,RTEC,1,1
148699,and,0,0
148700,BMI,0,1
148701,controlling,0,0
148702,for,0,0
148703,age,0,0
148704,",",0,0
148705,sex,0,0
148706,",",0,0
148707,ethnicity,0,0
148708,",",0,0
148709,and,0,0
148710,energy,0,0
148711,intake,0,0
148712,.,0,0
148713,DESIGN,0,0
148714,A,0,0
148715,longitudinal,0,0
148716,study,0,0
148717,design,0,0
148718,where,0,0
148719,a,0,0
148720,cohort,0,0
148721,was,0,0
148722,followed,0,1
148723,for,0,0
148724,3,0,0
148725,years,0,0
148726,.,0,0
148727,SUBJECTS/SETTING,0,0
148728,Participants,0,0
148729,were,0,0
148730,625,0,0
148731,fourth-,0,0
148732,through,0,0
148733,sixth-grade,0,0
148734,",",0,0
148735,low-income,0,0
148736,children,0,0
148737,living,0,0
148738,in,0,0
148739,San,0,1
148740,Antonio,0,1
148741,",",0,0
148742,Texas,0,0
148743,",",0,0
148744,and,0,0
148745,enrolled,0,0
148746,in,0,0
148747,the,0,0
148748,control,0,1
148749,arm,0,0
148750,of,0,0
148751,the,0,0
148752,Bienestar,0,0
148753,Diabetes,0,0
148754,Prevention,0,1
148755,Program,0,1
148756,'s,0,0
148757,cluster,0,0
148758,randomized,0,0
148759,trial,0,0
148760,.,0,0
148761,Three,0,0
148762,multiple-pass,0,1
148763,24-hour,0,1
148764,dietary,0,1
148765,recalls,0,0
148766,were,0,0
148767,collected,0,0
148768,at,0,0
148769,the,0,0
148770,beginning,0,0
148771,of,0,0
148772,their,0,0
148773,fourth-grade,0,0
148774,year,0,0
148775,and,0,0
148776,at,0,0
148777,the,0,0
148778,end,0,0
148779,of,0,0
148780,their,0,0
148781,fifth-,0,0
148782,and,0,0
148783,sixth-grade,0,0
148784,years,0,0
148785,.,0,0
148786,Children,0,0
148787,'s,0,0
148788,age,0,0
148789,",",0,0
148790,sex,0,0
148791,",",0,0
148792,ethnicity,0,0
148793,",",0,0
148794,and,0,0
148795,height,0,0
148796,and,0,1
148797,weight,0,0
148798,(,0,1
148799,used,0,0
148800,to,0,0
148801,calculate,0,0
148802,BMI,0,1
148803,),0,0
148804,were,0,0
148805,collected,0,0
148806,between,0,0
148807,August,0,0
148808,2001,0,0
148809,and,0,0
148810,May,0,1
148811,2004,0,0
148812,.,0,0
148813,STATISTICAL,0,0
148814,ANALYSES,0,0
148815,PERFORMED,0,1
148816,Descriptive,0,0
148817,and,0,0
148818,inferential,0,0
148819,statistical,0,0
148820,analyses,0,0
148821,were,0,0
148822,performed,0,0
148823,.,0,0
148824,The,0,0
148825,frequency,0,0
148826,of,0,0
148827,breakfast,0,1
148828,consumption,0,0
148829,was,0,0
148830,examined,0,0
148831,using,0,0
148832,a,0,0
148833,6?4,0,0
148834,cross-tabulation,0,0
148835,table,0,0
148836,with,0,0
148837,?,0,0
148838,(,0,0
148839,2,0,0
148840,),0,0
148841,test,0,0
148842,to,0,0
148843,establish,0,0
148844,categorical,0,0
148845,differences,0,0
148846,.,0,0
148847,The,0,0
148848,degree,0,0
148849,of,0,0
148850,association,0,0
148851,between,0,0
148852,BMI,0,1
148853,percentile,0,0
148854,and,0,0
148855,frequency,0,0
148856,of,0,0
148857,RTEC,1,1
148858,consumption,1,0
148859,adjusted,0,0
148860,for,0,0
148861,age,0,0
148862,",",0,0
148863,sex,0,0
148864,",",0,0
148865,ethnicity,0,0
148866,",",0,0
148867,and,0,0
148868,nutrition-related,0,1
148869,parameters,0,0
148870,were,0,0
148871,calculated,0,0
148872,using,0,0
148873,a,0,0
148874,partial,0,0
148875,correlation,0,0
148876,multivariate,0,0
148877,linear,0,0
148878,model,0,0
148879,analysis,0,0
148880,.,0,0
148881,RESULTS,0,0
148882,There,0,0
148883,was,0,0
148884,a,0,0
148885,significant,0,0
148886,positive,0,0
148887,relationship,0,0
148888,between,0,0
148889,the,0,0
148890,frequency,0,0
148891,of,0,0
148892,RTEC,1,1
148893,consumption,1,0
148894,and,0,0
148895,nutrient,0,1
148896,intakes,0,0
148897,measured,0,0
148898,at,0,0
148899,baseline,0,0
148900,.,0,0
148901,There,0,0
148902,was,0,0
148903,also,0,0
148904,a,0,0
148905,significant,0,0
148906,inverse,0,0
148907,relationship,0,0
148908,between,0,0
148909,frequency,0,0
148910,of,0,0
148911,RTEC,1,1
148912,consumption,1,0
148913,and,0,0
148914,BMI,0,1
148915,percentile,0,0
148916,over,0,0
148917,the,0,0
148918,cumulative,0,0
148919,3-year,0,0
148920,period,0,0
148921,controlling,0,0
148922,for,0,0
148923,age,0,0
148924,",",0,0
148925,sex,0,0
148926,",",0,0
148927,ethnicity,0,0
148928,",",0,0
148929,and,0,0
148930,energy,0,0
148931,intake,0,0
148932,.,0,0
148933,CONCLUSIONS,0,0
148934,Children,0,0
148935,who,0,0
148936,frequently,0,0
148937,consumed,1,0
148938,RTEC,1,0
148939,had,1,0
148940,greater,0,0
148941,intakes,0,0
148942,of,0,0
148943,essential,0,0
148944,nutrients,0,1
148945,at,0,0
148946,baseline,0,0
148947,and,0,0
148948,significantly,0,0
148949,lower,0,0
148950,BMI,0,0
148951,over,0,0
148952,a,0,0
148953,3-year,0,0
148954,period,0,0
148955,.,0,0
148956,Effects,0,0
148957,of,0,0
148958,low,0,0
148959,and,0,0
148960,high,0,0
148961,protein,0,1
148962,:,0,0
148963,carbohydrate,0,1
148964,ratios,0,0
148965,in,0,0
148966,the,0,0
148967,diet,0,1
148968,of,0,0
148969,pregnant,0,0
148970,gilts,0,1
148971,on,0,0
148972,maternal,0,0
148973,cortisol,0,0
148974,concentrations,0,0
148975,and,0,0
148976,the,0,0
148977,adrenocortical,0,0
148978,and,0,0
148979,sympathoadrenal,0,0
148980,reactivity,0,0
148981,in,0,0
148982,their,0,0
148983,offspring,0,0
148984,.,0,0
148985,Inadequate,0,0
148986,maternal,0,0
148987,nutrition,0,1
148988,during,0,0
148989,gestation,0,0
148990,may,0,0
148991,cause,0,0
148992,an,0,0
148993,adverse,0,0
148994,environment,0,0
148995,for,0,0
148996,the,0,0
148997,fetus,0,0
148998,leading,0,0
148999,to,0,0
149000,alterations,0,0
149001,of,0,0
149002,the,0,0
149003,hypothalamic-pituitary-adrenal,0,0
149004,(,0,0
149005,HPA,0,1
149006,),0,1
149007,and,0,0
149008,sympatho-adrenomedullary,0,0
149009,(,0,1
149010,SAM,0,0
149011,),0,1
149012,systems,0,0
149013,later,0,0
149014,in,0,0
149015,life,0,0
149016,.,0,0
149017,In,0,0
149018,the,0,0
149019,present,0,0
149020,study,0,0
149021,",",0,0
149022,we,0,0
149023,investigated,0,0
149024,the,0,0
149025,effects,0,0
149026,of,0,0
149027,diets,1,1
149028,with,1,0
149029,low,1,0
149030,and,1,0
149031,high,1,0
149032,protein,1,1
149033,:,1,0
149034,carbohydrate,1,1
149035,ratios,0,0
149036,on,0,0
149037,cortisol,0,0
149038,concentrations,0,0
149039,of,0,0
149040,pregnant,0,0
149041,gilts,0,1
149042,as,0,0
149043,well,0,0
149044,as,0,0
149045,the,0,0
149046,long-term,0,0
149047,effects,0,0
149048,on,0,0
149049,the,0,0
149050,function,0,0
149051,of,0,0
149052,the,0,0
149053,HPA,0,0
149054,and,0,0
149055,SAM,0,0
149056,axes,0,0
149057,in,0,0
149058,their,0,0
149059,offspring,0,0
149060,.,0,0
149061,Throughout,0,0
149062,gestation,0,0
149063,",",0,0
149064,33,0,0
149065,German,0,0
149066,Landrace,0,0
149067,gilts,0,1
149068,were,0,0
149069,fed,0,1
149070,high,1,0
149071,(,1,0
149072,HP,1,1
149073,",",1,0
149074,30,1,1
149075,%,1,0
149076,),1,0
149077,",",1,0
149078,low,1,0
149079,(,1,0
149080,LP,1,1
149081,",",1,0
149082,6.5,1,0
149083,%,1,0
149084,),1,0
149085,",",1,0
149086,or,1,1
149087,adequate,1,0
149088,(,1,1
149089,AP,1,1
149090,",",1,0
149091,12.1,1,0
149092,%,1,0
149093,),1,0
149094,protein,1,1
149095,diets,1,1
149096,",",0,0
149097,which,0,0
149098,were,0,0
149099,made,0,0
149100,isocaloric,0,1
149101,by,0,0
149102,adjusting,0,0
149103,the,0,0
149104,carbohydrate,0,1
149105,content,0,0
149106,.,0,0
149107,The,0,0
149108,salivary,0,0
149109,cortisol,0,0
149110,concentrations,0,0
149111,of,0,0
149112,the,0,0
149113,sows,0,0
149114,were,0,0
149115,measured,0,0
149116,in,0,0
149117,the,0,0
149118,course,0,0
149119,of,0,0
149120,the,0,0
149121,gestation,0,0
149122,period,0,0
149123,.,0,0
149124,The,0,0
149125,offspring,0,0
149126,were,0,0
149127,cross-fostered,0,0
149128,",",0,0
149129,and,0,0
149130,the,0,0
149131,plasma,0,0
149132,cortisol,0,0
149133,and,0,0
149134,catecholamine,0,0
149135,concentrations,0,0
149136,of,0,0
149137,the,0,0
149138,offspring,0,0
149139,were,0,0
149140,determined,0,0
149141,on,0,0
149142,postnatal,0,0
149143,d,0,1
149144,(,0,1
149145,PND,0,1
149146,),0,1
149147,1,0,0
149148,and,0,0
149149,27,0,0
149150,and,0,0
149151,under,0,0
149152,specific,0,0
149153,challenging,0,0
149154,conditions,0,0
149155,:,0,0
149156,after,0,0
149157,weaning,0,0
149158,(,0,0
149159,PND,0,1
149160,29,0,0
149161,),0,0
149162,and,0,0
149163,after,0,0
149164,ACTH,0,1
149165,and,0,0
149166,insulin,0,1
149167,challenges,0,0
149168,(,0,0
149169,PND,0,1
149170,68,0,0
149171,and,0,0
149172,70,0,0
149173,",",0,0
149174,respectively,0,0
149175,),0,0
149176,.,0,0
149177,Glucocorticoid,0,1
149178,receptor,0,0
149179,(,0,1
149180,GR,0,1
149181,),0,1
149182,binding,0,0
149183,and,0,0
149184,neurotransmitter,0,0
149185,concentrations,0,0
149186,were,0,0
149187,measured,0,0
149188,in,0,0
149189,stress-related,0,0
149190,brain,0,0
149191,regions,0,0
149192,",",0,0
149193,and,0,0
149194,histological,0,0
149195,analyses,0,0
149196,of,0,0
149197,the,0,0
149198,adrenal,0,0
149199,were,0,0
149200,performed,0,0
149201,.,0,0
149202,Maternal,0,0
149203,salivary,0,0
149204,cortisol,0,0
149205,concentrations,0,0
149206,increased,0,0
149207,throughout,0,0
149208,gestation,0,0
149209,(,0,0
149210,P,0,0
149211,<,0,0
149212,0.001,0,0
149213,),0,0
149214,and,0,0
149215,the,0,0
149216,LP,0,1
149217,gilts,0,1
149218,had,0,0
149219,greater,0,0
149220,salivary,0,0
149221,cortisol,0,0
149222,compared,0,0
149223,with,0,0
149224,the,0,0
149225,AP,0,1
149226,and,0,0
149227,HP,0,1
149228,gilts,0,1
149229,(,0,0
149230,P,0,0
149231,<,0,0
149232,0.05,0,0
149233,),0,0
149234,.,0,0
149235,No,0,0
149236,differences,0,0
149237,between,0,0
149238,diets,0,1
149239,were,0,0
149240,found,0,0
149241,for,0,0
149242,cortisol,0,0
149243,",",0,0
149244,corticosteroid-binding,0,0
149245,globulin,0,1
149246,",",0,0
149247,and,0,0
149248,catecholamine,0,0
149249,concentrations,0,0
149250,in,0,0
149251,plasma,0,0
149252,and,0,0
149253,for,0,0
149254,GR,0,1
149255,binding,0,0
149256,in,0,0
149257,hippocampus,0,0
149258,and,0,0
149259,hypothalamus,0,0
149260,in,0,0
149261,piglets,0,0
149262,at,0,0
149263,PND,0,1
149264,1,0,0
149265,and,0,0
149266,27,0,0
149267,.,0,0
149268,However,0,0
149269,",",0,0
149270,the,0,0
149271,cortisol,0,0
149272,response,0,0
149273,to,0,0
149274,weaning,0,0
149275,was,0,0
149276,increased,0,0
149277,in,0,0
149278,LP,0,1
149279,piglets,0,1
149280,(,0,0
149281,P,0,0
149282,<,0,0
149283,0.05,0,0
149284,),0,0
149285,",",0,0
149286,and,0,0
149287,in,0,0
149288,HP,0,1
149289,offspring,0,0
149290,the,0,0
149291,basal,0,1
149292,plasma,0,0
149293,noradrenaline,0,0
149294,concentrations,0,0
149295,were,0,0
149296,increased,0,0
149297,(,0,0
149298,P,0,0
149299,<,0,0
149300,0.05,0,0
149301,),0,0
149302,.,0,0
149303,The,0,0
149304,cortisol,0,0
149305,response,0,0
149306,to,0,0
149307,the,0,0
149308,ACTH,0,0
149309,and,0,0
149310,the,0,0
149311,insulin,0,1
149312,challenge,0,0
149313,did,0,0
149314,not,0,0
149315,differ,0,0
149316,between,0,0
149317,diets,0,1
149318,.,0,0
149319,On,0,0
149320,PND,0,1
149321,81,0,0
149322,",",0,0
149323,an,0,0
149324,increased,0,0
149325,adrenal,0,0
149326,medulla,0,0
149327,area,0,0
149328,was,0,0
149329,observed,0,0
149330,in,0,0
149331,LP,0,1
149332,offspring,0,0
149333,compared,0,0
149334,with,0,0
149335,the,0,0
149336,AP,0,1
149337,offspring,0,0
149338,(,0,0
149339,P,0,0
149340,<,0,0
149341,0.05,0,0
149342,),0,0
149343,.,0,0
149344,Our,0,0
149345,results,0,0
149346,show,0,0
149347,that,0,0
149348,maternal,1,0
149349,diets,1,1
149350,with,1,0
149351,aberrant,1,0
149352,protein,1,1
149353,:,1,0
149354,carbohydrate,1,1
149355,ratios,1,0
149356,during,1,0
149357,gestation,1,0
149358,have,0,0
149359,moderate,0,0
149360,long-term,0,0
149361,effects,0,0
149362,on,0,0
149363,the,0,0
149364,function,0,0
149365,of,0,0
149366,the,0,0
149367,HPA,0,0
149368,and,0,0
149369,SAM,0,0
149370,system,0,1
149371,in,0,0
149372,the,0,0
149373,offspring,0,0
149374,",",0,0
149375,which,0,0
149376,indicates,0,0
149377,that,0,0
149378,pigs,0,0
149379,show,0,0
149380,a,0,0
149381,considerable,0,0
149382,plasticity,0,0
149383,to,0,0
149384,cope,0,0
149385,with,0,0
149386,maternal,0,0
149387,malnutrition,0,0
149388,.,0,0
149389,Bizzy,0,1
149390,Break,0,0
149391,!,0,0
149392,The,0,0
149393,effect,0,0
149394,of,0,0
149395,a,0,0
149396,classroom-based,1,1
149397,activity,1,0
149398,break,1,1
149399,on,0,0
149400,in-school,0,1
149401,physical,0,1
149402,activity,0,0
149403,levels,0,0
149404,of,0,0
149405,primary,0,0
149406,school,0,0
149407,children,0,0
149408,.,0,0
149409,The,0,0
149410,school,0,0
149411,has,0,0
149412,been,0,0
149413,identified,0,0
149414,as,0,0
149415,a,0,0
149416,key,0,0
149417,setting,0,0
149418,to,0,0
149419,promote,0,1
149420,physical,0,1
149421,activity,0,0
149422,.,0,0
149423,The,0,0
149424,purpose,0,0
149425,of,0,0
149426,this,0,0
149427,study,0,0
149428,was,0,0
149429,to,0,0
149430,evaluate,0,0
149431,the,0,0
149432,effect,0,0
149433,of,0,0
149434,a,0,0
149435,classroom-based,1,1
149436,activity,1,0
149437,break,1,1
149438,on,0,0
149439,in-school,0,1
149440,step,0,0
149441,counts,0,0
149442,of,0,0
149443,primary,0,0
149444,school,0,0
149445,children,0,0
149446,.,0,0
149447,Data,0,0
149448,for,0,0
149449,90,0,0
149450,children,0,0
149451,(,0,0
149452,49,0,0
149453,boys,0,0
149454,",",0,0
149455,41,0,0
149456,girls,0,0
149457,",",0,0
149458,9.3,0,0
149459,?,0,0
149460,1.4,0,0
149461,years,0,0
149462,),0,0
149463,from,0,0
149464,three,0,0
149465,Irish,0,0
149466,primary,0,0
149467,schools,0,0
149468,is,0,0
149469,presented,0,0
149470,.,0,0
149471,In,0,0
149472,each,0,0
149473,school,0,0
149474,one,0,0
149475,class,0,0
149476,was,0,0
149477,randomly,0,0
149478,assigned,0,0
149479,as,0,0
149480,the,1,0
149481,intervention,1,1
149482,group,0,0
149483,and,0,0
149484,another,0,0
149485,as,1,0
149486,controls,1,0
149487,.,1,0
149488,Children,0,0
149489,'s,0,0
149490,step,0,0
149491,counts,0,0
149492,were,0,0
149493,measured,0,0
149494,for,0,0
149495,five,0,0
149496,consecutive,0,0
149497,days,0,0
149498,during,0,0
149499,school,0,0
149500,hours,0,0
149501,at,0,0
149502,baseline,0,0
149503,and,0,0
149504,follow-up,0,0
149505,.,0,0
149506,Teachers,0,0
149507,of,0,0
149508,the,0,0
149509,intervention,0,1
149510,classes,0,0
149511,led,0,0
149512,a,0,0
149513,10,1,0
149514,min,1,0
149515,activity,1,0
149516,break,1,1
149517,in,0,0
149518,the,0,0
149519,classroom,0,1
149520,each,0,0
149521,day,0,1
149522,(,0,0
149523,Bizzy,0,1
149524,Break,0,0
149525,!,0,0
149526,),0,0
149527,.,0,0
149528,Mean,0,0
149529,daily,0,0
149530,in-school,0,1
149531,steps,0,0
149532,for,0,0
149533,the,0,0
149534,intervention,0,1
149535,at,0,0
149536,baseline,0,0
149537,and,0,0
149538,follow-up,0,0
149539,were,0,0
149540,5351,0,0
149541,and,0,0
149542,5054,0,0
149543,.,0,0
149544,Corresponding,0,0
149545,values,0,0
149546,for,0,0
149547,the,0,0
149548,control,0,1
149549,group,0,0
149550,were,0,0
149551,5469,0,0
149552,and,0,0
149553,4246,0,0
149554,.,0,0
149555,There,0,0
149556,was,0,0
149557,a,0,0
149558,significant,0,0
149559,difference,0,0
149560,in,0,0
149561,the,0,0
149562,change,0,0
149563,in,0,0
149564,daily,0,1
149565,steps,0,0
149566,from,0,0
149567,baseline,0,0
149568,to,0,0
149569,follow-up,0,0
149570,between,0,0
149571,groups,0,0
149572,(,0,0
149573,p,0,0
149574,<,0,0
149575,.05,0,0
149576,),0,0
149577,.,0,0
149578,There,0,0
149579,was,0,0
149580,no,0,0
149581,evidence,0,0
149582,that,0,0
149583,girls,0,0
149584,and,0,0
149585,boys,0,0
149586,responded,0,0
149587,differently,0,0
149588,to,0,0
149589,the,0,0
149590,intervention,0,1
149591,(,0,0
149592,p,0,0
149593,>,0,0
149594,.05,0,0
149595,),0,0
149596,.,0,0
149597,Children,0,0
149598,participating,0,0
149599,in,0,0
149600,a,0,0
149601,daily,0,1
149602,10,0,0
149603,min,1,0
149604,classroom-based,1,1
149605,activity,1,0
149606,break,1,0
149607,undertake,0,0
149608,more,0,0
149609,physical,0,0
149610,activity,0,0
149611,during,0,0
149612,school,0,0
149613,hours,0,0
149614,than,0,0
149615,controls,0,0
149616,.,0,0
149617,Effects,0,0
149618,of,0,0
149619,intranasal,1,1
149620,oxytocin,1,1
149621,on,0,0
149622,the,0,0
149623,neural,0,0
149624,basis,0,0
149625,of,0,0
149626,face,0,0
149627,processing,0,1
149628,in,0,0
149629,autism,0,0
149630,spectrum,0,0
149631,disorder,0,0
149632,.,0,0
149633,BACKGROUND,0,0
149634,Autism,0,0
149635,spectrum,0,0
149636,disorder,0,0
149637,(,0,1
149638,ASD,0,0
149639,),0,1
149640,is,0,0
149641,associated,0,0
149642,with,0,0
149643,altered,0,0
149644,face,0,0
149645,processing,0,1
149646,and,0,0
149647,decreased,0,0
149648,activity,0,0
149649,in,0,0
149650,brain,0,0
149651,regions,0,0
149652,involved,0,0
149653,in,0,0
149654,face,0,0
149655,processing,0,0
149656,.,0,0
149657,The,0,0
149658,neuropeptide,1,0
149659,oxytocin,1,1
149660,has,0,0
149661,been,0,0
149662,shown,0,0
149663,to,0,0
149664,promote,0,1
149665,face,0,0
149666,processing,0,1
149667,and,0,0
149668,modulate,0,0
149669,brain,0,0
149670,activity,0,0
149671,in,0,0
149672,healthy,0,0
149673,adults,0,0
149674,.,0,0
149675,The,0,0
149676,present,0,0
149677,study,0,0
149678,examined,0,0
149679,the,0,0
149680,effects,0,0
149681,of,0,0
149682,oxytocin,1,1
149683,on,0,0
149684,the,0,0
149685,neural,0,0
149686,basis,0,0
149687,of,0,0
149688,face,0,0
149689,processing,0,0
149690,in,0,0
149691,adults,0,0
149692,with,0,0
149693,Asperger,0,0
149694,syndrome,0,0
149695,(,0,1
149696,AS,0,0
149697,),0,0
149698,.,0,0
149699,METHODS,0,0
149700,A,0,0
149701,group,0,0
149702,of,0,0
149703,14,0,0
149704,individuals,0,0
149705,with,0,0
149706,AS,0,0
149707,and,0,0
149708,a,0,0
149709,group,0,0
149710,of,0,0
149711,14,0,0
149712,neurotypical,0,0
149713,control,0,0
149714,participants,0,0
149715,performed,0,0
149716,a,0,0
149717,face-matching,0,1
149718,and,0,0
149719,a,0,0
149720,house-matching,0,1
149721,task,0,1
149722,during,0,0
149723,functional,0,0
149724,magnetic,0,1
149725,resonance,0,0
149726,imaging,0,0
149727,.,0,0
149728,The,0,0
149729,effects,0,0
149730,of,0,0
149731,a,0,0
149732,single,0,0
149733,dose,0,0
149734,of,0,0
149735,24,0,0
149736,IU,0,1
149737,intranasally,0,0
149738,administered,0,0
149739,oxytocin,1,1
149740,were,0,0
149741,tested,0,0
149742,in,0,0
149743,a,0,0
149744,randomized,0,0
149745,",",0,0
149746,placebo-controlled,1,1
149747,",",0,0
149748,within-subject,0,0
149749,",",0,0
149750,cross-over,0,0
149751,design,0,0
149752,.,0,0
149753,RESULTS,0,0
149754,Under,0,0
149755,placebo,1,1
149756,",",0,0
149757,the,0,0
149758,AS,0,0
149759,group,0,0
149760,showed,0,0
149761,decreased,0,0
149762,activity,0,0
149763,in,0,0
149764,the,0,0
149765,right,0,0
149766,amygdala,0,0
149767,",",0,0
149768,fusiform,0,0
149769,gyrus,0,0
149770,",",0,0
149771,and,0,0
149772,inferior,0,0
149773,occipital,0,0
149774,gyrus,0,0
149775,compared,0,0
149776,with,0,0
149777,the,0,0
149778,control,0,1
149779,group,0,0
149780,during,0,0
149781,face,0,0
149782,processing,0,0
149783,.,0,0
149784,After,0,0
149785,oxytocin,0,1
149786,treatment,0,0
149787,",",0,0
149788,right,0,0
149789,amygdala,0,0
149790,activity,0,0
149791,to,0,0
149792,facial,0,0
149793,stimuli,0,1
149794,increased,0,0
149795,in,0,0
149796,the,0,0
149797,AS,0,0
149798,group,0,0
149799,.,0,0
149800,CONCLUSIONS,0,0
149801,These,0,0
149802,findings,0,0
149803,indicate,0,0
149804,that,0,0
149805,oxytocin,0,1
149806,increases,0,0
149807,the,0,0
149808,saliency,0,0
149809,of,0,0
149810,social,0,0
149811,stimuli,0,1
149812,and,0,0
149813,in,0,0
149814,ASD,0,0
149815,and,0,0
149816,suggest,0,0
149817,that,0,0
149818,oxytocin,1,1
149819,might,0,0
149820,promote,0,1
149821,face,0,0
149822,processing,0,1
149823,and,0,0
149824,eye,0,1
149825,contact,0,1
149826,in,0,0
149827,individuals,0,0
149828,with,0,0
149829,ASD,0,0
149830,as,0,0
149831,prerequisites,0,0
149832,for,0,0
149833,neurotypical,0,0
149834,social,0,0
149835,interaction,0,0
149836,.,0,0
149837,Randomized,0,0
149838,",",0,0
149839,controlled,0,0
149840,",",0,0
149841,parallel-group,0,0
149842,trial,0,0
149843,of,0,0
149844,routine,1,0
149845,prophylaxis,1,1
149846,vs.,1,0
149847,on-demand,1,1
149848,treatment,1,0
149849,with,1,0
149850,sucrose-formulated,1,1
149851,recombinant,1,1
149852,factor,1,0
149853,VIII,1,0
149854,in,0,0
149855,adults,0,0
149856,with,0,0
149857,severe,0,0
149858,hemophilia,0,1
149859,A,0,1
149860,(,0,1
149861,SPINART,0,1
149862,),0,0
149863,.,0,0
149864,BACKGROUND,0,0
149865,The,0,0
149866,benefits,0,0
149867,of,0,0
149868,routine,1,0
149869,prophylaxis,1,1
149870,vs.,1,0
149871,on-demand,1,1
149872,treatment,1,0
149873,with,1,0
149874,factor,1,0
149875,VIII,1,0
149876,products,1,0
149877,have,1,0
149878,not,0,0
149879,been,0,0
149880,evaluated,0,0
149881,in,0,0
149882,controlled,0,0
149883,clinical,0,0
149884,trials,0,0
149885,in,0,0
149886,older,0,0
149887,patients,0,0
149888,with,0,0
149889,hemophilia,0,0
149890,A,0,0
149891,.,0,0
149892,OBJECTIVES,0,0
149893,To,0,0
149894,report,0,0
149895,results,0,0
149896,from,0,0
149897,a,0,0
149898,preplanned,0,0
149899,analysis,0,0
149900,of,0,0
149901,data,0,0
149902,from,0,0
149903,the,0,0
149904,first,0,0
149905,year,0,0
149906,of,0,0
149907,the,0,0
149908,3-year,0,0
149909,SPINART,0,0
149910,study,0,0
149911,",",0,0
149912,which,0,0
149913,compares,0,0
149914,routine,0,0
149915,prophylaxis,0,0
149916,with,0,0
149917,on-demand,0,1
149918,treatment,0,0
149919,with,1,0
149920,sucrose-formulated,1,1
149921,recombinant,1,1
149922,FVIII,1,1
149923,(,1,1
149924,rFVIII-FS,1,0
149925,),1,0
149926,.,1,0
149927,PATIENTS/METHODS,0,0
149928,SPINART,0,0
149929,is,0,0
149930,an,0,0
149931,open-label,0,0
149932,",",0,0
149933,randomized,0,0
149934,",",0,0
149935,controlled,0,0
149936,",",0,0
149937,parallel-group,0,0
149938,",",0,0
149939,multinational,0,0
149940,trial,0,0
149941,.,0,0
149942,Males,0,0
149943,aged,0,0
149944,12-50,0,0
149945,years,0,0
149946,with,0,0
149947,severe,0,0
149948,hemophilia,0,0
149949,A,0,0
149950,",",0,0
149951,?,0,0
149952,150,0,0
149953,days,0,0
149954,of,0,0
149955,exposure,0,0
149956,to,0,0
149957,FVIII,0,0
149958,",",0,0
149959,no,0,0
149960,FVIII,0,0
149961,inhibitors,0,1
149962,",",0,0
149963,no,0,0
149964,prophylaxis,0,0
149965,for,0,0
149966,>,0,0
149967,12,0,0
149968,consecutive,0,0
149969,months,0,0
149970,in,0,0
149971,the,0,0
149972,past,0,0
149973,5,0,0
149974,years,0,0
149975,and,0,0
149976,6-24,0,0
149977,bleeding,0,0
149978,episodes,0,0
149979,in,0,0
149980,the,0,0
149981,preceding,0,0
149982,6,0,0
149983,months,0,0
149984,were,0,0
149985,randomized,0,0
149986,1,0,0
149987,:,0,0
149988,1,0,0
149989,to,0,0
149990,rFVIII-FS,1,1
149991,prophylaxis,1,1
149992,(,1,0
149993,25,1,0
149994,IU,1,1
149995,kg,1,1
149996,(,1,1
149997,-1,1,0
149998,),1,0
149999,",",1,0
150000,three,1,0
150001,times,1,0
150002,weekly,1,1
150003,),1,0
150004,or,1,1
150005,on-demand,1,1
150006,treatment,1,0
150007,.,1,0
150008,The,1,0
150009,primary,0,0
150010,efficacy,0,0
150011,endpoint,0,0
150012,",",0,0
150013,number,0,0
150014,of,0,0
150015,total,0,0
150016,bleeding,0,0
150017,episodes,0,0
150018,in,0,0
150019,the,0,0
150020,intent-to-treat,0,0
150021,population,0,0
150022,",",0,0
150023,was,0,0
150024,analyzed,0,0
150025,after,0,0
150026,the,0,0
150027,last,0,0
150028,patient,0,0
150029,had,0,0
150030,completed,0,0
150031,1,0,0
150032,year,0,0
150033,of,0,0
150034,follow-up,0,0
150035,.,0,0
150036,A,0,0
150037,negative,0,0
150038,binomial,0,0
150039,model,0,0
150040,was,0,0
150041,used,0,0
150042,for,0,0
150043,the,0,0
150044,primary,0,0
150045,endpoint,0,0
150046,analysis,0,0
150047,;,0,0
150048,analysis,0,0
150049,of,0,0
150050,variance,0,0
150051,was,0,0
150052,used,0,0
150053,for,0,0
150054,confirmatory,0,0
150055,analysis,0,0
150056,of,0,0
150057,annualized,0,0
150058,bleeding,0,0
150059,rates,0,0
150060,.,0,0
150061,RESULTS,0,0
150062,Eighty-four,0,0
150063,patients,0,0
150064,were,0,0
150065,enrolled,0,0
150066,and,0,0
150067,analyzed,0,0
150068,(,0,0
150069,n,0,0
150070,=,0,0
150071,42,0,0
150072,per,0,0
150073,group,0,0
150074,;,0,0
150075,mean,0,0
150076,age,0,0
150077,",",0,0
150078,30.6,0,0
150079,years,0,0
150080,;,0,0
150081,median,0,0
150082,treatment,0,0
150083,duration,0,0
150084,",",0,0
150085,1.7,0,0
150086,years,0,0
150087,),0,0
150088,.,0,0
150089,The,0,0
150090,median,0,0
150091,number,0,0
150092,of,0,0
150093,total,0,0
150094,bleeding,0,0
150095,episodes,0,0
150096,and,0,0
150097,total,0,0
150098,bleeding,0,0
150099,episodes,0,0
150100,per,0,0
150101,year,0,0
150102,were,0,0
150103,significantly,0,0
150104,lower,0,0
150105,with,0,0
150106,prophylaxis,0,0
150107,than,0,0
150108,with,0,0
150109,on-demand,0,1
150110,treatment,0,1
150111,(,0,0
150112,total,0,0
150113,",",0,0
150114,0,0,0
150115,vs.,0,0
150116,54.5,0,0
150117,;,0,0
150118,total,0,0
150119,per,0,0
150120,year,0,0
150121,",",0,0
150122,0,0,0
150123,vs.,0,0
150124,27.9,0,0
150125,;,0,0
150126,both,0,0
150127,P,0,0
150128,<,0,0
150129,0.0001,0,0
150130,),0,0
150131,.,0,0
150132,No,0,0
150133,treatment-related,0,0
150134,adverse,0,0
150135,events,0,0
150136,occurred,0,0
150137,",",0,0
150138,and,0,0
150139,no,0,0
150140,patients,0,0
150141,developed,0,0
150142,FVIII,0,0
150143,inhibitors,0,1
150144,.,0,0
150145,CONCLUSIONS,0,0
150146,Routine,0,1
150147,prophylaxis,0,1
150148,with,0,0
150149,rFVIII-FS,1,0
150150,leads,1,0
150151,to,0,0
150152,a,0,0
150153,significant,0,0
150154,reduction,0,0
150155,in,0,0
150156,bleeding,0,0
150157,as,0,0
150158,compared,0,0
150159,with,0,0
150160,on-demand,0,1
150161,treatment,0,0
150162,.,0,0
150163,Adverse,0,0
150164,events,0,0
150165,were,0,0
150166,consistent,0,0
150167,with,0,0
150168,the,0,0
150169,established,1,0
150170,rFVIII-FS,1,0
150171,safety,1,0
150172,profile,0,0
150173,.,0,0
150174,Effect,0,0
150175,of,0,0
150176,beta-alanine,1,0
150177,",",0,0
150178,with,0,0
150179,and,0,0
150180,without,0,1
150181,sodium,1,1
150182,bicarbonate,1,1
150183,",",0,0
150184,on,0,0
150185,2000-m,0,1
150186,rowing,0,1
150187,performance,0,0
150188,.,0,0
150189,PURPOSE,0,0
150190,To,0,0
150191,examine,0,0
150192,the,0,0
150193,effect,0,0
150194,of,0,0
150195,beta-alanine,0,0
150196,only,0,0
150197,and,0,0
150198,beta-alanine,1,1
150199,with,1,0
150200,sodium,1,1
150201,bicarbonate,1,1
150202,supplementation,1,1
150203,on,0,0
150204,"2,000-m",0,0
150205,rowing,0,1
150206,performance,0,0
150207,.,0,0
150208,METHODS,0,0
150209,Twenty,0,0
150210,well-trained,0,1
150211,rowers,0,1
150212,(,0,0
150213,age,0,0
150214,23,0,0
150215,?,0,0
150216,4,0,0
150217,y,0,0
150218,;,0,0
150219,height,0,0
150220,1.85,0,0
150221,?,0,0
150222,0.08,0,0
150223,m,0,0
150224,;,0,0
150225,body,0,0
150226,mass,0,0
150227,82.5,0,0
150228,?,0,0
150229,8.9,0,0
150230,kg,0,0
150231,),0,0
150232,were,0,0
150233,assigned,0,0
150234,to,0,0
150235,either,1,0
150236,a,1,0
150237,placebo,1,1
150238,or,1,1
150239,beta-alanine,1,1
150240,(,1,1
150241,6.4,1,0
150242,g,0,1
150243,?,0,0
150244,d,0,0
150245,(,0,0
150246,-1,0,0
150247,),0,1
150248,for,0,0
150249,4,0,0
150250,weeks,0,0
150251,),0,0
150252,group,0,0
150253,.,0,0
150254,A,0,0
150255,"2,000-m",0,0
150256,rowing,0,1
150257,time,0,0
150258,trial,0,0
150259,(,0,1
150260,TT,0,1
150261,),0,1
150262,was,0,0
150263,performed,0,0
150264,before,1,0
150265,supplementation,1,1
150266,(,1,1
150267,Baseline,1,1
150268,),0,1
150269,and,0,0
150270,after,0,0
150271,28,0,0
150272,and,0,0
150273,30,0,0
150274,days,0,0
150275,of,1,0
150276,supplementation,1,1
150277,.,1,0
150278,The,1,0
150279,post,0,0
150280,supplementation,0,1
150281,trials,0,0
150282,involved,0,0
150283,supplementation,0,1
150284,with,0,0
150285,either,0,1
150286,maltodextrin,0,1
150287,or,0,1
150288,sodium,0,1
150289,bicarbonate,0,1
150290,in,0,0
150291,a,0,0
150292,double-blind,0,0
150293,",",0,0
150294,crossover,0,0
150295,design,0,0
150296,",",0,0
150297,creating,0,0
150298,four,0,0
150299,study,0,0
150300,conditions,1,0
150301,(,1,0
150302,placebo,1,1
150303,with,1,0
150304,maltodextrin,1,1
150305,;,1,0
150306,placebo,1,1
150307,with,1,0
150308,sodium,1,1
150309,bicarbonate,1,1
150310,;,1,0
150311,beta-alanine,1,0
150312,with,1,0
150313,maltodextrin,1,1
150314,;,1,0
150315,beta-alanine,1,0
150316,with,1,0
150317,sodium,1,1
150318,bicarbonate,1,1
150319,),1,0
150320,.,1,0
150321,Blood,1,0
150322,lactate,0,0
150323,",",0,0
150324,pH,0,1
150325,",",0,0
150326,bicarbonate,0,1
150327,",",0,0
150328,and,0,0
150329,base,0,0
150330,excess,0,0
150331,were,0,0
150332,measured,0,0
150333,pre-TT,0,0
150334,",",0,0
150335,immediately,0,0
150336,post-TT,0,0
150337,and,0,0
150338,at,0,0
150339,TT+5,0,1
150340,min,0,0
150341,.,0,0
150342,Performance,0,0
150343,data,0,0
150344,were,0,0
150345,analyzed,0,0
150346,using,0,0
150347,magnitude,0,0
150348,based,0,0
150349,inferences,0,0
150350,.,0,0
150351,RESULTS,1,0
150352,Beta-alanine,1,1
150353,supplementation,1,1
150354,was,1,0
150355,very,0,0
150356,likely,0,0
150357,to,0,0
150358,be,0,0
150359,beneficial,0,0
150360,to,0,0
150361,"2,000-m",0,0
150362,rowing,0,1
150363,performance,0,0
150364,(,0,0
150365,6.4,0,0
150366,?,0,0
150367,8.1,0,0
150368,s,0,0
150369,effect,0,0
150370,compared,0,0
150371,with,0,0
150372,placebo,0,1
150373,),0,0
150374,",",0,0
150375,with,0,0
150376,the,0,0
150377,effect,0,0
150378,of,0,0
150379,sodium,0,1
150380,bicarbonate,0,1
150381,having,0,0
150382,a,0,0
150383,likely,0,0
150384,benefit,0,0
150385,(,0,0
150386,3.2,0,0
150387,?,0,0
150388,8.8,0,0
150389,s,0,0
150390,),0,0
150391,.,0,0
150392,There,0,0
150393,was,0,0
150394,a,0,0
150395,small,0,0
150396,(,0,0
150397,1.1,0,0
150398,?,0,0
150399,5.6,0,0
150400,s,0,0
150401,),0,0
150402,but,0,0
150403,possibly,0,0
150404,beneficial,0,0
150405,additional,0,0
150406,effect,0,0
150407,when,0,0
150408,combining,0,0
150409,chronic,0,0
150410,beta-alanine,0,1
150411,supplementation,0,1
150412,with,0,0
150413,acute,0,0
150414,sodium,0,1
150415,bicarbonate,0,1
150416,supplementation,0,1
150417,compared,0,0
150418,with,0,0
150419,chronic,0,0
150420,beta-alanine,0,1
150421,supplementation,0,1
150422,alone,0,1
150423,.,0,0
150424,Sodium,0,1
150425,bicarbonate,0,0
150426,ingestion,0,0
150427,led,0,0
150428,to,0,0
150429,increases,0,0
150430,in,0,0
150431,plasma,0,0
150432,pH,0,1
150433,",",0,0
150434,base,0,0
150435,excess,0,0
150436,",",0,0
150437,bicarbonate,0,1
150438,",",0,0
150439,and,0,0
150440,lactate,0,0
150441,concentrations,0,0
150442,.,0,0
150443,CONCLUSIONS,1,0
150444,Both,1,1
150445,chronic,1,0
150446,beta-alanine,1,1
150447,and,1,0
150448,acute,1,0
150449,sodium,1,1
150450,bicarbonate,1,1
150451,supplementation,1,1
150452,alone,1,1
150453,had,0,0
150454,positive,0,0
150455,effects,0,0
150456,on,0,0
150457,"2,000-m",0,0
150458,rowing,0,1
150459,performance,0,0
150460,.,0,0
150461,The,0,0
150462,addition,1,0
150463,of,1,0
150464,acute,1,0
150465,sodium,1,1
150466,bicarbonate,1,1
150467,to,1,0
150468,chronic,1,0
150469,beta-alanine,1,1
150470,supplementation,1,1
150471,may,1,0
150472,further,1,0
150473,enhance,0,0
150474,rowing,0,1
150475,performance,0,0
150476,.,0,0
150477,Nasal,0,1
150478,eosinophilia,0,0
150479,and,0,0
150480,serum,0,0
150481,soluble,0,1
150482,intercellular,0,0
150483,adhesion,0,0
150484,molecule,0,0
150485,1,0,0
150486,in,0,0
150487,patients,0,0
150488,with,0,0
150489,allergic,0,0
150490,rhinitis,0,0
150491,treated,0,0
150492,with,0,0
150493,montelukast,1,1
150494,alone,1,1
150495,or,0,1
150496,in,0,0
150497,combination,0,1
150498,with,0,0
150499,desloratadine,1,1
150500,or,0,1
150501,levocetirizine,1,1
150502,.,1,0
150503,BACKGROUND,0,0
150504,Because,0,0
150505,intercellular,0,0
150506,adhesion,0,0
150507,molecule,0,0
150508,(,0,1
150509,ICAM,0,1
150510,),0,1
150511,1,0,0
150512,and,0,0
150513,recruitment,0,0
150514,of,0,0
150515,eosinophils,0,0
150516,are,0,0
150517,crucial,0,0
150518,in,0,0
150519,supporting,0,0
150520,allergic,0,0
150521,inflammation,0,0
150522,",",0,0
150523,their,0,0
150524,down-regulation,0,0
150525,may,0,0
150526,bring,0,0
150527,additional,0,0
150528,benefits,0,0
150529,in,0,0
150530,patients,0,0
150531,',0,0
150532,recovery,0,0
150533,.,0,0
150534,We,0,0
150535,have,0,0
150536,assessed,0,0
150537,nasal,0,0
150538,eosinophilia,0,0
150539,and,0,0
150540,serum,0,0
150541,soluble,0,1
150542,ICAM-1,0,1
150543,(,0,1
150544,sICAM-1,0,0
150545,),0,0
150546,concentrations,0,0
150547,in,0,0
150548,relation,0,0
150549,to,0,0
150550,nasal,0,0
150551,symptoms,0,0
150552,in,0,0
150553,patients,0,0
150554,with,0,0
150555,persistent,0,0
150556,allergic,0,0
150557,rhinitis,0,0
150558,(,0,1
150559,AR,0,1
150560,),0,1
150561,treated,0,0
150562,for,0,0
150563,6,0,0
150564,weeks,0,0
150565,with,0,0
150566,either,0,0
150567,desloratadine,1,1
150568,",",1,0
150569,levocetirizine,1,1
150570,",",1,0
150571,montelukast,1,1
150572,alone,1,1
150573,",",0,0
150574,or,0,1
150575,in,0,0
150576,combination,1,1
150577,.,1,0
150578,METHODS,0,0
150579,In,0,0
150580,this,0,0
150581,single-center,0,0
150582,",",0,0
150583,randomized,0,0
150584,",",0,0
150585,double-blind,0,0
150586,",",0,0
150587,placebo-controlled,1,1
150588,",",0,0
150589,crossover,0,0
150590,",",0,0
150591,two-arm,0,0
150592,study,0,0
150593,",",0,0
150594,40,0,0
150595,patients,0,0
150596,with,0,0
150597,persistent,0,0
150598,AR,0,1
150599,were,0,0
150600,randomized,0,0
150601,to,0,0
150602,receive,0,0
150603,either,0,1
150604,montelukast,1,1
150605,and/or,1,0
150606,levocetirizine,1,1
150607,or,1,1
150608,placebo,1,1
150609,(,0,1
150610,n,0,0
150611,=,0,0
150612,20,0,1
150613,),0,0
150614,or,0,0
150615,to,0,0
150616,receive,0,1
150617,treatment,0,0
150618,with,0,0
150619,montelukast,1,1
150620,and/or,1,1
150621,desloratadine,1,1
150622,or,0,1
150623,placebo,1,1
150624,(,0,1
150625,n,0,0
150626,=,0,0
150627,20,0,0
150628,),0,0
150629,.,0,0
150630,Nasal,0,0
150631,eosinophilia,0,0
150632,and,0,0
150633,concentration,0,0
150634,of,0,0
150635,sICAM-1,0,0
150636,in,0,0
150637,peripheral,0,0
150638,blood,0,0
150639,were,0,0
150640,assessed,0,0
150641,before,0,0
150642,and,0,0
150643,on,0,0
150644,the,0,0
150645,last,0,0
150646,day,0,0
150647,of,0,0
150648,each,0,0
150649,treatment,0,0
150650,period,0,0
150651,.,0,0
150652,RESULTS,0,0
150653,All,0,0
150654,active,0,1
150655,treatments,0,0
150656,in,0,0
150657,both,0,0
150658,arms,0,0
150659,of,0,0
150660,the,0,0
150661,study,0,0
150662,resulted,0,0
150663,in,0,0
150664,the,0,0
150665,decrease,0,0
150666,of,0,0
150667,sICAM-1,0,0
150668,and,0,0
150669,nasal,0,1
150670,eosinophilia,0,0
150671,",",0,0
150672,which,0,0
150673,correlated,0,0
150674,with,0,0
150675,the,0,0
150676,severity,0,0
150677,of,0,0
150678,nasal,0,0
150679,symptoms,0,0
150680,.,0,0
150681,In,0,0
150682,the,0,0
150683,montelukast/levocetirizine,1,1
150684,arm,0,0
150685,",",0,0
150686,montelukast,1,1
150687,decreased,0,0
150688,nasal,0,0
150689,eosinophilia,0,0
150690,more,0,0
150691,significantly,0,0
150692,than,0,0
150693,levocetirizine,1,1
150694,",",0,0
150695,whereas,0,0
150696,in,0,0
150697,reduction,0,0
150698,of,0,0
150699,sICAM-1,0,0
150700,all,0,0
150701,active,0,1
150702,treatment,0,0
150703,options,0,0
150704,were,0,0
150705,equally,0,0
150706,effective,0,0
150707,.,0,0
150708,However,0,0
150709,",",0,0
150710,in,0,0
150711,the,0,0
150712,desloratadine/montelukast,1,1
150713,arm,0,0
150714,",",0,0
150715,the,0,0
150716,resulting,0,0
150717,improvement,0,0
150718,of,0,0
150719,combination,0,1
150720,therapy,0,1
150721,of,0,0
150722,sICAM-1,0,0
150723,and,0,0
150724,the,0,0
150725,influx,0,0
150726,of,0,0
150727,eosinophils,0,0
150728,was,0,0
150729,not,0,0
150730,statistically,0,0
150731,significant,0,0
150732,.,0,0
150733,CONCLUSION,0,0
150734,The,0,0
150735,improvement,0,0
150736,of,0,0
150737,nasal,0,0
150738,symptoms,0,0
150739,in,0,0
150740,patients,0,0
150741,with,0,0
150742,AR,0,1
150743,treated,0,0
150744,with,0,0
150745,antihistamines,0,0
150746,",",0,0
150747,with,0,0
150748,or,0,0
150749,without,0,0
150750,montelukast,1,1
150751,",",0,0
150752,may,0,0
150753,additionally,0,0
150754,result,0,0
150755,from,0,0
150756,the,0,0
150757,reduction,0,0
150758,of,0,0
150759,sICAM-1,0,0
150760,and,0,0
150761,nasal,0,0
150762,eosinophilia,0,0
150763,.,0,0
150764,Because,0,0
150765,the,0,0
150766,combination,0,1
150767,therapy,0,1
150768,may,0,0
150769,bring,0,0
150770,inconclusive,0,0
150771,benefits,0,0
150772,in,0,0
150773,this,0,0
150774,area,0,0
150775,there,0,0
150776,is,0,0
150777,a,0,0
150778,strong,0,0
150779,need,0,0
150780,of,0,0
150781,further,0,0
150782,studies,0,0
150783,to,0,0
150784,find,0,0
150785,mechanisms,0,0
150786,that,0,0
150787,favor,0,0
150788,combination,0,1
150789,therapy,0,1
150790,.,0,0
150791,Successful,0,0
150792,treatment,0,0
150793,of,0,0
150794,depressed,0,0
150795,",",0,0
150796,distensible,0,0
150797,acne,0,0
150798,scars,0,0
150799,using,0,0
150800,autologous,1,1
150801,fibroblasts,1,0
150802,:,1,0
150803,a,0,0
150804,multi-site,0,0
150805,",",0,0
150806,prospective,0,0
150807,",",0,0
150808,double,0,1
150809,blind,0,0
150810,",",0,0
150811,placebo-controlled,0,1
150812,clinical,0,0
150813,trial,0,0
150814,.,0,0
150815,BACKGROUND,0,0
150816,A,0,0
150817,previous,0,0
150818,clinical,0,0
150819,trial,0,0
150820,evaluating,0,0
150821,autologous,1,1
150822,fibroblasts,1,1
150823,(,1,0
150824,human,1,1
150825,dermal,1,1
150826,),1,0
150827,injections,1,1
150828,for,0,0
150829,the,0,0
150830,treatment,0,0
150831,of,0,0
150832,facial,0,1
150833,contour,0,1
150834,deformities,0,0
150835,found,0,0
150836,significantly,0,0
150837,greater,0,0
150838,improvements,0,0
150839,in,0,0
150840,wrinkle,0,0
150841,and,0,0
150842,acne,0,0
150843,scar,0,1
150844,appearance,0,0
150845,than,0,0
150846,with,0,0
150847,placebo,1,1
150848,treatment,0,0
150849,.,0,0
150850,OBJECTIVE,0,0
150851,To,0,0
150852,compare,0,0
150853,the,0,0
150854,efficacy,0,0
150855,and,0,0
150856,safety,0,0
150857,of,0,0
150858,autologous,1,1
150859,fibroblast,1,0
150860,treatment,0,0
150861,of,0,0
150862,moderate,0,0
150863,to,0,0
150864,severe,0,0
150865,",",0,0
150866,depressed,0,0
150867,",",0,0
150868,distensible,0,0
150869,facial,0,1
150870,acne,0,0
150871,scars,0,0
150872,with,0,0
150873,that,0,0
150874,of,0,0
150875,vehicle,0,1
150876,control,0,0
150877,.,0,0
150878,METHODS,0,0
150879,This,0,0
150880,was,0,0
150881,a,0,0
150882,randomized,0,0
150883,multicenter,0,0
150884,",",0,0
150885,double-blind,0,0
150886,",",0,0
150887,placebo-controlled,1,1
150888,trial,0,0
150889,in,0,0
150890,subjects,0,0
150891,with,0,0
150892,bilateral,0,1
150893,moderate,0,0
150894,to,0,0
150895,severe,0,0
150896,acne,0,0
150897,scarring,0,0
150898,;,0,0
150899,subjects,0,0
150900,served,0,0
150901,as,0,0
150902,their,0,0
150903,own,0,0
150904,controls,0,0
150905,.,0,0
150906,Skin,0,0
150907,biopsies,0,0
150908,were,0,0
150909,obtained,0,0
150910,from,0,0
150911,randomized,0,0
150912,subjects,0,0
150913,for,0,0
150914,fibroblast,0,0
150915,production,0,0
150916,.,0,1
150917,Subjects,0,0
150918,(,0,0
150919,n,0,0
150920,=,0,0
150921,99,0,0
150922,),0,0
150923,underwent,0,0
150924,three,0,1
150925,intradermal,0,1
150926,injection,0,1
150927,sessions,0,1
150928,with,0,0
150929,2,1,0
150930,mL,1,0
150931,of,1,0
150932,autologous,1,1
150933,fibroblast,1,1
150934,suspension,1,1
150935,(,0,0
150936,10-20,0,0
150937,million,0,0
150938,cells/mL,0,0
150939,),0,0
150940,on,0,0
150941,one,0,0
150942,cheek,0,0
150943,and,0,0
150944,vehicle,1,1
150945,control,1,1
150946,(,0,1
150947,cell,0,0
150948,culture,0,1
150949,medium,0,1
150950,),0,0
150951,on,0,0
150952,the,0,0
150953,other,0,0
150954,at,0,0
150955,14-day,0,0
150956,intervals,0,0
150957,.,0,0
150958,Efficacy,0,0
150959,was,0,0
150960,based,0,0
150961,on,0,0
150962,the,0,0
150963,blinded,0,0
150964,subject,0,0
150965,'s,0,0
150966,",",0,0
150967,evaluator,0,0
150968,'s,0,0
150969,",",0,0
150970,and,0,0
150971,independent,0,0
150972,photographic,0,1
150973,viewer,0,1
150974,'s,0,0
150975,(,0,0
150976,IPR,0,1
150977,),0,1
150978,assessment,0,0
150979,of,0,0
150980,acne,0,0
150981,scarring,0,0
150982,1,0,0
150983,to,0,0
150984,4,0,0
150985,months,0,0
150986,after,0,0
150987,the,0,0
150988,last,0,0
150989,treatment,0,0
150990,.,0,0
150991,RESULTS,0,0
150992,Autologous,1,1
150993,fibroblast,1,0
150994,treatment,1,0
150995,was,0,0
150996,associated,0,0
150997,with,0,0
150998,significantly,0,0
150999,greater,0,0
151000,treatment,0,0
151001,success,0,0
151002,than,0,0
151003,vehicle,0,1
151004,control,0,1
151005,for,0,0
151006,the,0,0
151007,subject,0,0
151008,(,0,0
151009,43,0,0
151010,%,0,0
151011,vs.18,0,0
151012,%,0,0
151013,),0,0
151014,",",0,0
151015,evaluator,0,0
151016,(,0,0
151017,59,0,0
151018,%,0,0
151019,vs.,0,0
151020,2,0,0
151021,%,0,0
151022,),0,0
151023,",",0,0
151024,and,0,0
151025,IPR,0,0
151026,assessments,0,0
151027,.,0,0
151028,Autologous,1,1
151029,fibroblast,1,0
151030,injections,1,1
151031,were,0,0
151032,well,0,0
151033,tolerated,0,0
151034,",",0,0
151035,without,0,0
151036,permanent,0,0
151037,adverse,0,0
151038,effects,0,0
151039,.,0,0
151040,CONCLUSIONS,0,0
151041,Autologous,1,1
151042,fibroblast,1,0
151043,injections,1,1
151044,safely,0,0
151045,and,0,0
151046,effectively,0,0
151047,improved,0,0
151048,the,0,0
151049,appearance,0,0
151050,of,0,0
151051,depressed,0,0
151052,distensible,0,0
151053,acne,0,0
151054,scars,0,0
151055,.,0,0
151056,Memantine,1,1
151057,add-on,1,1
151058,to,1,0
151059,risperidone,1,1
151060,for,0,0
151061,treatment,0,0
151062,of,0,0
151063,negative,0,0
151064,symptoms,0,0
151065,in,0,0
151066,patients,0,0
151067,with,0,0
151068,stable,0,0
151069,schizophrenia,0,0
151070,:,0,0
151071,randomized,0,0
151072,",",0,0
151073,double-blind,0,0
151074,",",0,0
151075,placebo-controlled,0,1
151076,study,0,0
151077,.,0,0
151078,We,0,0
151079,aimed,0,0
151080,to,0,0
151081,evaluate,0,0
151082,the,0,0
151083,efficacy,0,0
151084,of,0,0
151085,memantine,1,1
151086,add-on,0,1
151087,in,0,0
151088,the,0,0
151089,treatment,0,0
151090,of,0,0
151091,primary,0,0
151092,negative,0,0
151093,symptoms,0,0
151094,of,0,0
151095,patients,0,0
151096,with,0,0
151097,stable,0,0
151098,schizophrenia,0,0
151099,.,0,0
151100,In,0,0
151101,a,0,0
151102,double-blind,0,0
151103,placebo-controlled,0,1
151104,clinical,0,0
151105,trial,0,0
151106,",",0,0
151107,40,0,0
151108,patients,0,0
151109,with,0,0
151110,schizophrenia,0,0
151111,(,0,1
151112,Diagnostic,0,0
151113,and,0,0
151114,Statistical,0,0
151115,Manual,0,1
151116,of,0,0
151117,Mental,0,0
151118,Disorders,0,0
151119,",",0,0
151120,Fourth,0,0
151121,Edition,0,1
151122,),0,0
151123,who,0,0
151124,were,0,0
151125,stabilized,0,0
151126,on,0,0
151127,risperidone,1,1
151128,for,0,0
151129,a,0,0
151130,minimum,0,0
151131,of,0,0
151132,8,0,0
151133,weeks,0,0
151134,were,0,0
151135,randomized,0,0
151136,to,0,0
151137,either,0,1
151138,memantine,1,1
151139,(,0,0
151140,20,0,1
151141,mg,0,1
151142,),0,1
151143,or,0,1
151144,placebo,1,1
151145,in,0,0
151146,addition,0,0
151147,to,0,0
151148,risperidone,1,1
151149,",",0,0
151150,6,0,0
151151,mg/d,0,0
151152,",",0,0
151153,for,0,0
151154,eight,0,0
151155,weeks,0,0
151156,.,0,0
151157,Assessment,0,0
151158,was,0,0
151159,done,0,0
151160,using,0,0
151161,the,0,0
151162,Positive,0,0
151163,and,0,0
151164,Negative,0,0
151165,Syndrome,0,0
151166,Scale,0,1
151167,at,0,0
151168,baseline,0,0
151169,",",0,0
151170,week,0,0
151171,4,0,0
151172,",",0,0
151173,and,0,0
151174,week,0,0
151175,8,0,0
151176,.,0,0
151177,The,0,0
151178,Hamilton,0,0
151179,Depression,0,0
151180,Rating,0,0
151181,Scale,0,1
151182,and,0,0
151183,the,0,0
151184,Extrapyramidal,0,0
151185,Symptom,0,0
151186,Rating,0,0
151187,Scale,0,1
151188,at,0,0
151189,baseline,0,0
151190,and,0,0
151191,week,0,0
151192,8,0,0
151193,were,0,0
151194,used,0,0
151195,to,0,0
151196,assess,0,0
151197,depression,0,0
151198,and,0,0
151199,extrapyramidal,0,0
151200,symptoms,0,0
151201,",",0,0
151202,respectively,0,0
151203,.,0,0
151204,All,0,0
151205,40,0,0
151206,patients,0,0
151207,had,0,0
151208,at,0,0
151209,least,0,0
151210,one,0,0
151211,postbaseline,0,0
151212,measurement,0,0
151213,",",0,0
151214,and,0,0
151215,38,0,0
151216,patients,0,0
151217,completed,0,0
151218,the,0,0
151219,trial,0,0
151220,.,0,0
151221,Patients,0,0
151222,in,0,0
151223,the,0,0
151224,memantine,0,1
151225,group,0,0
151226,showed,0,0
151227,a,0,0
151228,significantly,0,0
151229,greater,0,0
151230,improvement,0,0
151231,on,0,0
151232,negative,0,0
151233,subscale,0,0
151234,than,0,0
151235,the,0,0
151236,placebo,1,1
151237,group,0,0
151238,at,0,0
151239,end,0,0
151240,point,0,0
151241,(,0,0
151242,P,0,0
151243,<,0,0
151244,0.001,0,0
151245,),0,0
151246,.,0,0
151247,The,0,0
151248,same,0,0
151249,effect,0,0
151250,was,0,0
151251,observed,0,0
151252,for,0,0
151253,the,0,0
151254,total,0,0
151255,score,0,0
151256,(,0,0
151257,P,0,0
151258,<,0,0
151259,0.001,0,0
151260,),0,0
151261,and,0,0
151262,the,0,0
151263,general,0,0
151264,psychopathology,0,0
151265,subscale,0,0
151266,score,0,0
151267,(,0,0
151268,P,0,0
151269,=,0,0
151270,0.002,0,0
151271,),0,0
151272,.,0,0
151273,There,0,0
151274,was,0,0
151275,no,0,0
151276,significant,0,0
151277,difference,0,0
151278,in,0,0
151279,reduction,0,0
151280,of,0,0
151281,positive,0,0
151282,symptoms,0,0
151283,score,0,0
151284,between,0,0
151285,the,0,0
151286,2,0,0
151287,groups,0,0
151288,(,0,0
151289,P,0,0
151290,=,0,0
151291,0.757,0,0
151292,),0,0
151293,.,0,0
151294,Changes,0,0
151295,in,0,0
151296,the,0,0
151297,Hamilton,0,0
151298,Depression,0,0
151299,Rating,0,0
151300,Scale,0,1
151301,and,0,0
151302,the,0,0
151303,Extrapyramidal,0,0
151304,Symptom,0,0
151305,Rating,0,0
151306,Scale,0,1
151307,scores,0,0
151308,and,0,0
151309,frequency,0,0
151310,of,0,0
151311,adverse,0,0
151312,effects,0,0
151313,did,0,0
151314,not,0,0
151315,differ,0,0
151316,between,0,0
151317,the,0,0
151318,2,0,0
151319,groups,0,0
151320,.,0,0
151321,Our,0,0
151322,study,0,0
151323,showed,0,0
151324,that,0,0
151325,memantine,0,1
151326,is,0,0
151327,a,0,0
151328,tolerable,0,0
151329,and,0,0
151330,efficacious,0,0
151331,add-on,0,1
151332,treatment,0,0
151333,for,0,0
151334,primary,0,0
151335,negative,0,0
151336,symptoms,0,0
151337,of,0,0
151338,schizophrenia,0,0
151339,.,0,0
151340,Impact,0,0
151341,of,0,0
151342,angiotensin,1,1
151343,II,1,1
151344,receptor,1,0
151345,blocker,1,1
151346,therapy,1,1
151347,(,1,1
151348,olmesartan,1,1
151349,or,1,1
151350,valsartan,1,1
151351,),1,1
151352,on,0,0
151353,coronary,0,0
151354,atherosclerotic,0,0
151355,plaque,0,0
151356,volume,0,0
151357,measured,0,0
151358,by,0,0
151359,intravascular,0,0
151360,ultrasound,0,1
151361,in,0,0
151362,patients,0,0
151363,with,0,0
151364,stable,0,0
151365,angina,0,0
151366,pectoris,0,0
151367,.,0,0
151368,Coronary,0,0
151369,plaques,0,0
151370,can,0,0
151371,be,0,0
151372,reduced,0,0
151373,by,0,0
151374,some,0,0
151375,medications,0,0
151376,.,0,0
151377,The,0,0
151378,aim,0,0
151379,of,0,0
151380,this,0,0
151381,study,0,0
151382,was,0,0
151383,to,0,0
151384,compare,0,0
151385,the,0,0
151386,effects,0,0
151387,of,0,0
151388,2,0,0
151389,angiotensin,0,1
151390,II,0,0
151391,receptor,0,0
151392,blockers,0,1
151393,(,1,0
151394,olmesartan,1,1
151395,at,0,0
151396,20,0,0
151397,mg/day,0,1
151398,or,1,1
151399,valsartan,1,1
151400,at,0,0
151401,80,0,0
151402,mg/day,0,1
151403,),0,0
151404,on,0,0
151405,coronary,0,0
151406,plaque,0,0
151407,by,0,0
151408,coronary,0,0
151409,intravascular,0,0
151410,ultrasound,0,1
151411,.,0,0
151412,One,0,0
151413,hundred,0,0
151414,hypertensive,0,0
151415,patients,0,0
151416,with,0,0
151417,stable,0,0
151418,angina,0,0
151419,pectoris,0,0
151420,who,0,0
151421,underwent,0,0
151422,elective,0,0
151423,percutaneous,0,1
151424,coronary,0,0
151425,intervention,0,1
151426,were,0,0
151427,randomly,0,0
151428,selected,0,0
151429,to,0,0
151430,receive,0,0
151431,1,0,0
151432,of,0,0
151433,the,0,0
151434,2,0,0
151435,angiotensin,0,1
151436,II,0,0
151437,receptor,0,0
151438,blockers,0,1
151439,after,0,0
151440,coronary,0,0
151441,intervention,0,1
151442,.,0,0
151443,Nontarget,0,0
151444,coronary,0,0
151445,lesions,0,0
151446,with,0,0
151447,mild,0,0
151448,to,0,0
151449,moderate,0,0
151450,stenosis,0,0
151451,were,0,0
151452,measured,0,0
151453,by,0,0
151454,volumetric,0,0
151455,intravascular,0,0
151456,ultrasound,0,1
151457,at,0,0
151458,baseline,0,0
151459,and,0,0
151460,after,0,0
151461,6,0,0
151462,months,0,0
151463,.,0,0
151464,After,0,0
151465,6,0,0
151466,months,0,0
151467,",",0,0
151468,both,0,0
151469,the,0,0
151470,olmesartan,1,1
151471,and,0,0
151472,the,0,0
151473,valsartan,1,1
151474,groups,0,0
151475,showed,0,0
151476,significant,0,0
151477,reduction,0,0
151478,of,0,0
151479,the,0,0
151480,examined,0,0
151481,coronary,0,0
151482,plaque,0,0
151483,volume,0,0
151484,(,0,0
151485,46.2,0,0
151486,?,0,0
151487,24.1,0,0
151488,mm?,0,0
151489,at,0,0
151490,baseline,0,0
151491,vs,0,0
151492,41.6,0,0
151493,?,0,0
151494,21.1,0,0
151495,mm?,0,0
151496,at,0,0
151497,6,0,0
151498,months,0,0
151499,:,0,0
151500,4.7,0,0
151501,%,0,0
151502,decrease,0,0
151503,",",0,0
151504,p,0,0
151505,=,0,0
151506,0.0002,0,0
151507,;,0,0
151508,and,0,0
151509,47.2,0,0
151510,?,0,0
151511,32.7,0,0
151512,mm?,0,0
151513,at,0,0
151514,baseline,0,0
151515,vs,0,0
151516,42.5,0,0
151517,?,0,0
151518,30.2,0,0
151519,mm?,0,0
151520,at,0,0
151521,6,0,0
151522,months,0,0
151523,:,0,0
151524,4.8,0,0
151525,%,0,0
151526,decrease,0,0
151527,",",0,0
151528,p,0,0
151529,=,0,0
151530,0.002,0,0
151531,",",0,0
151532,respectively,0,0
151533,),0,0
151534,.,0,0
151535,There,0,0
151536,was,0,0
151537,no,0,0
151538,statistically,0,0
151539,significant,0,0
151540,difference,0,0
151541,of,0,0
151542,plaque,0,0
151543,regression,0,0
151544,between,0,0
151545,the,0,0
151546,2,0,0
151547,groups,0,0
151548,(,0,0
151549,p,0,0
151550,=,0,0
151551,0.96,0,0
151552,),0,0
151553,.,0,0
151554,In,0,0
151555,conclusion,0,0
151556,",",0,0
151557,there,0,0
151558,was,0,0
151559,a,0,0
151560,significant,0,0
151561,decrease,0,0
151562,from,0,0
151563,baseline,0,0
151564,in,0,0
151565,the,0,0
151566,coronary,0,0
151567,plaque,0,0
151568,volume,0,0
151569,in,0,0
151570,patients,0,0
151571,with,0,0
151572,stable,0,0
151573,angina,0,0
151574,pectoris,0,0
151575,who,0,0
151576,received,0,0
151577,olmesartan,1,1
151578,or,1,0
151579,valsartan,1,1
151580,for,1,0
151581,6,1,0
151582,months,1,0
151583,.,0,0
151584,In,0,0
151585,addition,0,0
151586,",",0,0
151587,there,0,0
151588,was,0,0
151589,no,0,0
151590,significant,0,0
151591,difference,0,0
151592,in,0,0
151593,the,0,0
151594,reduction,0,0
151595,of,0,0
151596,plaque,0,0
151597,volume,0,0
151598,achieved,0,0
151599,by,0,0
151600,these,0,0
151601,2,0,0
151602,medications,0,0
151603,.,0,0
151604,Are,0,0
151605,postural,0,0
151606,responses,0,0
151607,to,0,0
151608,backward,0,1
151609,and,0,0
151610,forward,0,0
151611,perturbations,0,0
151612,processed,0,0
151613,by,0,0
151614,different,0,0
151615,neural,0,0
151616,circuits,0,1
151617,?,0,0
151618,Startle,0,0
151619,pathways,0,0
151620,may,0,0
151621,contribute,0,0
151622,to,0,0
151623,rapid,0,0
151624,accomplishment,0,0
151625,of,0,0
151626,postural,0,0
151627,stability,0,0
151628,.,0,0
151629,Here,0,0
151630,we,0,0
151631,investigate,0,0
151632,the,0,0
151633,possible,0,0
151634,influence,0,0
151635,of,0,0
151636,a,0,0
151637,startling,1,0
151638,auditory,1,1
151639,stimulus,1,1
151640,(,1,1
151641,SAS,1,1
151642,),1,1
151643,on,0,0
151644,postural,0,0
151645,responses,0,0
151646,.,0,0
151647,We,0,0
151648,formulated,0,0
151649,four,0,0
151650,specific,0,0
151651,questions,0,0
151652,:,0,0
151653,(,0,0
151654,1,0,0
151655,),0,0
151656,can,0,0
151657,a,0,0
151658,concurrent,0,0
151659,SAS,0,1
151660,shorten,0,0
151661,the,0,0
151662,onset,0,0
151663,of,0,0
151664,automatic,0,1
151665,postural,0,0
151666,responses,0,0
151667,?,0,0
151668,;,0,0
151669,and,0,0
151670,if,0,0
151671,so,0,0
151672,(,0,0
151673,2,0,0
151674,),0,0
151675,is,0,0
151676,this,0,0
151677,effect,0,0
151678,different,0,0
151679,for,0,0
151680,forward,0,0
151681,versus,0,1
151682,backward,0,0
151683,perturbations,0,0
151684,?,0,0
151685,;,0,0
151686,(,0,0
151687,3,0,0
151688,),0,0
151689,does,0,0
151690,this,0,0
151691,effect,0,0
151692,depend,0,0
151693,on,0,0
151694,prior,0,0
151695,knowledge,0,0
151696,of,0,0
151697,the,0,0
151698,perturbation,0,0
151699,direction,0,0
151700,?,0,0
151701,;,0,0
151702,and,0,0
151703,(,0,0
151704,4,0,1
151705,),0,0
151706,is,0,0
151707,this,0,0
151708,effect,0,0
151709,different,0,0
151710,for,0,0
151711,low-,0,1
151712,and,0,0
151713,high-magnitude,0,0
151714,perturbations,0,0
151715,?,0,0
151716,Balance,0,0
151717,was,0,0
151718,perturbed,0,0
151719,in,0,0
151720,11,0,0
151721,healthy,0,0
151722,participants,0,0
151723,by,0,0
151724,a,0,0
151725,movable,0,1
151726,platform,0,1
151727,that,0,0
151728,suddenly,0,0
151729,translated,0,1
151730,forward,0,0
151731,or,0,0
151732,backward,0,1
151733,.,0,0
151734,Each,0,0
151735,participant,0,0
151736,received,0,0
151737,160,0,0
151738,perturbations,1,0
151739,",",0,0
151740,25,0,0
151741,%,0,0
151742,of,0,0
151743,which,0,0
151744,were,0,0
151745,combined,0,1
151746,with,0,0
151747,a,0,0
151748,SAS,1,1
151749,.,1,0
151750,We,0,0
151751,varied,0,0
151752,the,0,0
151753,direction,0,1
151754,and,0,0
151755,magnitude,0,0
151756,of,0,0
151757,the,0,0
151758,perturbations,0,0
151759,",",0,0
151760,as,0,0
151761,well,0,0
151762,as,0,0
151763,the,0,0
151764,prior,0,0
151765,knowledge,0,0
151766,of,0,0
151767,perturbation,0,0
151768,direction,0,1
151769,.,0,0
151770,Perturbation,0,0
151771,trials,0,0
151772,were,0,0
151773,interspersed,0,0
151774,with,0,0
151775,SAS-only,1,0
151776,trials,0,0
151777,.,0,0
151778,The,0,0
151779,SAS,1,1
151780,accelerated,0,0
151781,and,0,0
151782,strengthened,0,0
151783,postural,0,0
151784,responses,0,0
151785,with,0,0
151786,clear,0,0
151787,functional,0,0
151788,benefits,0,0
151789,(,0,0
151790,better,0,0
151791,balance,0,0
151792,control,0,0
151793,),0,0
151794,",",0,0
151795,but,0,0
151796,this,0,0
151797,was,0,0
151798,only,0,0
151799,true,0,0
151800,for,0,0
151801,responses,0,0
151802,that,0,0
151803,protected,0,0
151804,against,0,0
151805,falling,0,0
151806,backwards,0,1
151807,(,0,0
151808,i.e,0,1
151809,.,0,0
151810,in,0,0
151811,tibialis,0,0
151812,anterior,0,0
151813,and,0,0
151814,rectus,0,1
151815,femoris,0,0
151816,),0,0
151817,.,0,0
151818,These,0,0
151819,muscles,0,0
151820,also,0,0
151821,demonstrated,0,0
151822,the,0,0
151823,most,0,0
151824,common,0,0
151825,SAS-triggered,1,0
151826,responses,0,0
151827,without,0,0
151828,perturbation,0,0
151829,.,0,0
151830,Increasing,0,0
151831,the,0,0
151832,perturbation,0,0
151833,magnitude,0,0
151834,accelerated,0,0
151835,postural,0,0
151836,responses,0,0
151837,",",0,0
151838,but,0,0
151839,again,0,0
151840,with,0,0
151841,a,0,0
151842,larger,0,0
151843,acceleration,0,0
151844,for,0,0
151845,backward,0,0
151846,perturbations,0,0
151847,.,0,0
151848,We,0,0
151849,conclude,0,0
151850,that,0,0
151851,postural,0,0
151852,responses,0,0
151853,to,0,0
151854,backward,0,1
151855,and,0,0
151856,forward,0,0
151857,perturbations,0,0
151858,may,0,0
151859,be,0,0
151860,processed,0,0
151861,by,0,0
151862,different,0,0
151863,neural,0,0
151864,circuits,0,1
151865,",",0,0
151866,with,0,0
151867,influence,0,0
151868,of,0,0
151869,startle,0,0
151870,pathways,0,0
151871,on,0,0
151872,postural,0,0
151873,responses,0,0
151874,to,0,0
151875,backward,0,0
151876,perturbations,0,0
151877,.,0,0
151878,These,0,0
151879,findings,0,0
151880,give,0,0
151881,directions,0,0
151882,for,0,0
151883,future,0,0
151884,studies,0,0
151885,investigating,0,0
151886,whether,0,0
151887,deficits,0,0
151888,in,0,0
151889,startle,0,0
151890,pathways,0,0
151891,may,0,0
151892,explain,0,0
151893,the,0,0
151894,prominent,0,0
151895,backward,0,1
151896,instability,0,0
151897,seen,0,0
151898,in,0,0
151899,patients,0,0
151900,with,0,0
151901,Parkinson,0,0
151902,'s,0,0
151903,disease,0,0
151904,and,0,0
151905,progressive,0,0
151906,supranuclear,0,0
151907,palsy,0,0
151908,.,0,0
151909,Study,0,0
151910,design,0,0
151911,and,0,0
151912,rationale,0,0
151913,of,0,0
151914,a,0,0
151915,dose-ranging,0,0
151916,trial,0,0
151917,of,0,0
151918,LX4211,1,0
151919,",",0,0
151920,a,0,0
151921,dual,0,0
151922,inhibitor,0,1
151923,of,0,0
151924,SGLT1,0,0
151925,and,0,0
151926,SGLT2,0,0
151927,",",0,0
151928,in,0,0
151929,type,0,0
151930,2,0,0
151931,diabetes,0,0
151932,inadequately,0,0
151933,controlled,0,0
151934,on,0,0
151935,metformin,0,1
151936,monotherapy,0,1
151937,.,0,0
151938,Sodium-glucose,0,0
151939,cotransporters,0,0
151940,1,0,0
151941,(,0,0
151942,SGLT1,0,1
151943,),0,1
151944,and,0,0
151945,2,0,1
151946,(,0,0
151947,SGLT2,0,1
151948,),0,1
151949,are,0,0
151950,the,0,0
151951,major,0,0
151952,cellular,0,0
151953,transporters,0,0
151954,responsible,0,0
151955,for,0,0
151956,gastrointestinal,0,0
151957,(,0,1
151958,GI,0,0
151959,),0,1
151960,glucose,0,0
151961,absorption,0,0
151962,and,0,0
151963,renal,0,0
151964,glucose,0,0
151965,reabsorption,0,0
151966,",",0,0
151967,respectively,0,0
151968,.,0,0
151969,LX4211,1,0
151970,",",0,0
151971,a,0,0
151972,dual,0,0
151973,inhibitor,0,1
151974,of,0,0
151975,SGLT1,0,0
151976,and,0,0
151977,SGLT2,0,0
151978,",",0,0
151979,reduces,0,0
151980,glucose,0,0
151981,absorption,0,0
151982,from,0,0
151983,the,0,0
151984,GI,0,0
151985,tract,0,0
151986,and,0,0
151987,enhances,0,0
151988,urinary,0,0
151989,glucose,0,0
151990,excretion,0,0
151991,.,0,0
151992,Although,0,0
151993,several,0,0
151994,SGLT2-selective,0,0
151995,inhibitors,0,1
151996,have,0,0
151997,been,0,0
151998,tested,0,0
151999,in,0,0
152000,large,0,0
152001,phase,0,0
152002,2,0,0
152003,studies,0,0
152004,",",0,0
152005,dual,0,0
152006,inhibition,0,0
152007,of,0,0
152008,SGLT1,0,0
152009,and,0,0
152010,SGLT2,0,1
152011,is,0,0
152012,novel,0,0
152013,at,0,0
152014,this,0,0
152015,stage,0,0
152016,of,0,0
152017,drug,0,1
152018,development,0,0
152019,",",0,0
152020,and,0,0
152021,it,0,0
152022,has,0,0
152023,implications,0,0
152024,for,0,0
152025,clinical-trial,0,0
152026,design,0,0
152027,.,0,0
152028,In,0,0
152029,this,0,0
152030,article,0,0
152031,",",0,0
152032,we,0,0
152033,describe,0,0
152034,the,0,0
152035,design,0,0
152036,and,0,0
152037,rationale,0,0
152038,of,0,0
152039,a,0,0
152040,phase,0,0
152041,2,0,0
152042,",",0,0
152043,multicenter,0,0
152044,",",0,0
152045,randomized,0,0
152046,",",0,0
152047,double-blind,0,0
152048,",",0,0
152049,placebo-controlled,1,1
152050,",",0,0
152051,parallel,0,0
152052,group,0,0
152053,study,0,0
152054,to,0,0
152055,evaluate,0,0
152056,the,0,0
152057,safety,0,0
152058,and,0,0
152059,efficacy,0,0
152060,of,0,0
152061,LX4211,1,0
152062,in,0,0
152063,subjects,0,0
152064,with,0,0
152065,type,0,0
152066,2,0,0
152067,diabetes,0,0
152068,mellitus,0,0
152069,who,0,0
152070,have,0,0
152071,inadequate,0,0
152072,glycemic,0,0
152073,control,0,0
152074,on,0,0
152075,metformin,0,1
152076,monotherapy,0,1
152077,.,0,0
152078,The,0,0
152079,primary,0,0
152080,endpoint,0,0
152081,is,0,0
152082,the,0,0
152083,change,0,0
152084,in,0,0
152085,glycated,0,0
152086,hemoglobin,0,0
152087,A1c,0,1
152088,from,0,0
152089,baseline,0,0
152090,to,0,0
152091,week,0,0
152092,12,0,0
152093,.,0,0
152094,Secondary,0,0
152095,endpoints,0,0
152096,include,0,0
152097,the,0,0
152098,proportion,0,0
152099,of,0,0
152100,subjects,0,0
152101,achieving,0,0
152102,a,0,0
152103,glycated,0,1
152104,hemoglobin,0,0
152105,A1c,0,1
152106,value,0,0
152107,of,0,0
152108,<,0,0
152109,7,0,0
152110,%,0,0
152111,",",0,0
152112,change,0,0
152113,from,0,0
152114,baseline,0,0
152115,in,0,0
152116,fasting,0,0
152117,plasma,0,0
152118,glucose,0,1
152119,and,0,0
152120,postprandial,0,0
152121,glucose,0,1
152122,(,0,0
152123,as,0,0
152124,part,0,0
152125,of,0,0
152126,an,0,0
152127,oral,0,1
152128,glucose,0,0
152129,tolerance,0,0
152130,test,0,0
152131,),0,0
152132,",",0,0
152133,body,0,0
152134,weight,0,0
152135,",",0,0
152136,and,0,0
152137,blood,0,0
152138,pressure,0,0
152139,.,0,0
152140,Safety,0,0
152141,is,0,0
152142,evaluated,0,0
152143,with,0,0
152144,particular,0,0
152145,focus,0,0
152146,on,0,0
152147,hypoglycemia,0,0
152148,",",0,0
152149,GI,0,0
152150,symptoms,0,0
152151,",",0,0
152152,and,0,0
152153,incidence,0,0
152154,of,0,0
152155,genitourinary,0,0
152156,tract,0,0
152157,infections,0,0
152158,.,0,0
152159,[,0,0
152160,Study,0,0
152161,of,0,0
152162,setting,1,0
152163,of,1,0
152164,ventilator,1,1
152165,volume,1,0
152166,tidal,1,0
152167,and,1,0
152168,airway,1,1
152169,pressure,1,1
152170,alarm,1,1
152171,threshold,1,0
152172,with,0,0
152173,continuous,1,1
152174,extra-sternum,1,0
152175,heart,1,0
152176,compression,1,1
152177,in,0,0
152178,cardiopulmonary,0,0
152179,resuscitation,0,1
152180,],0,0
152181,.,0,0
152182,OBJECTIVE,0,0
152183,To,0,0
152184,investigate,0,0
152185,the,0,0
152186,setting,0,0
152187,of,0,0
152188,ventilator,1,1
152189,volume,1,1
152190,tidal,1,0
152191,(,1,1
152192,VT,1,1
152193,),1,1
152194,and,1,0
152195,airway,1,1
152196,pressure,1,1
152197,alarm,1,1
152198,threshold,1,0
152199,during,0,0
152200,cardiopulmonary,1,1
152201,resuscitation,1,1
152202,(,1,1
152203,CPR,1,1
152204,),1,1
152205,by,0,0
152206,continuous,1,1
152207,extra-sternum,1,0
152208,heart,1,0
152209,compression,1,1
152210,.,1,0
152211,METHODS,0,0
152212,Forty,0,0
152213,cases,0,0
152214,with,0,0
152215,respiration,0,1
152216,and,0,0
152217,cardiac,0,0
152218,arrest,0,0
152219,in,0,0
152220,the,0,0
152221,department,0,0
152222,of,0,0
152223,critical,0,0
152224,care,0,1
152225,medicine,0,1
152226,were,0,0
152227,randomly,0,0
152228,divided,0,0
152229,into,0,0
152230,low,1,0
152231,VT,1,1
152232,ventilation,1,1
152233,group,1,0
152234,and,1,0
152235,conventional,1,1
152236,VT,1,1
152237,group,1,0
152238,.,1,0
152239,Both,0,0
152240,groups,0,0
152241,were,0,0
152242,given,0,0
152243,the,0,0
152244,volume,0,0
152245,control,0,1
152246,mode,0,0
152247,.,0,0
152248,In,0,0
152249,the,0,0
152250,low,1,0
152251,VT,1,1
152252,ventilation,1,1
152253,group,0,0
152254,",",0,0
152255,VT,0,0
152256,was,0,0
152257,set,0,0
152258,on,0,0
152259,6,0,0
152260,-,0,0
152261,7,0,0
152262,ml/kg,0,0
152263,",",0,0
152264,and,0,0
152265,high,0,0
152266,pressure,0,1
152267,alarm,0,1
152268,threshold,0,0
152269,was,0,0
152270,adjusted,0,0
152271,to,0,0
152272,60,0,0
152273,cm,0,0
152274,H2O,0,0
152275,by,0,0
152276,the,0,0
152277,conventional,1,1
152278,40,0,0
152279,cm,0,0
152280,H2O,0,1
152281,during,0,0
152282,CPR,0,0
152283,.,0,0
152284,In,0,0
152285,the,0,0
152286,conventional,1,1
152287,VT,1,1
152288,group,1,0
152289,",",0,0
152290,VT,0,1
152291,and,0,0
152292,high,0,0
152293,pressure,0,1
152294,alarm,0,1
152295,threshold,0,0
152296,were,0,0
152297,set,0,0
152298,at,0,0
152299,8,0,0
152300,-,0,0
152301,12,0,0
152302,ml/kg,0,0
152303,and,0,0
152304,40,0,1
152305,cm,0,0
152306,H2O,0,1
152307,",",0,0
152308,respectively,0,0
152309,.,0,0
152310,Real-time,0,0
152311,actual,0,0
152312,VT,0,0
152313,",",0,0
152314,peak,0,0
152315,inspiratory,0,1
152316,pressure,0,0
152317,(,0,1
152318,PIP,0,1
152319,),0,1
152320,",",0,0
152321,and,0,0
152322,arterial,0,0
152323,blood,0,0
152324,gas,0,1
152325,test,0,0
152326,",",0,0
152327,blood,0,0
152328,lactic,0,1
152329,acid,0,1
152330,at,0,0
152331,10,0,0
152332,minutes,0,0
152333,and,0,0
152334,30,0,0
152335,minutes,0,0
152336,after,0,0
152337,CPR,0,0
152338,were,0,0
152339,observed,0,0
152340,.,0,0
152341,RESULTS,0,0
152342,At,0,0
152343,10,0,0
152344,minutes,0,0
152345,after,0,0
152346,CPR,0,0
152347,",",0,0
152348,in,0,0
152349,the,0,0
152350,low,1,0
152351,VT,1,1
152352,ventilation,1,1
152353,group,0,0
152354,",",0,0
152355,arterial,0,0
152356,blood,0,0
152357,pH,0,1
152358,",",0,0
152359,arterial,0,0
152360,partial,0,0
152361,pressure,0,0
152362,of,0,0
152363,oxygen,0,1
152364,(,0,1
152365,PaO2,0,1
152366,),0,1
152367,",",0,0
152368,arterial,0,0
152369,partial,0,0
152370,pressure,0,0
152371,of,0,0
152372,carbon,0,1
152373,dioxide,0,1
152374,(,0,1
152375,PaCO2,0,1
152376,),0,0
152377,",",0,0
152378,HCO3,0,1
152379,(,0,1
152380,-,0,0
152381,),0,0
152382,",",0,0
152383,arterial,0,0
152384,oxygen,0,1
152385,saturation,0,0
152386,(,0,1
152387,SaO2,0,1
152388,),0,1
152389,and,0,0
152390,blood,0,0
152391,lactic,0,1
152392,acid,0,1
152393,were,0,0
152394,better,0,0
152395,as,0,0
152396,compared,0,0
152397,with,0,0
152398,those,0,0
152399,in,0,0
152400,the,0,0
152401,conventional,1,1
152402,VT,1,1
152403,ventilation,1,1
152404,group,0,1
152405,(,0,1
152406,pH,0,1
152407,:,0,0
152408,7.21?0.09,0,0
152409,vs.,0,0
152410,7.13?0.07,0,0
152411,",",0,0
152412,PaO2,0,1
152413,:,0,0
152414,45.35?5.92,0,0
152415,mm,0,0
152416,Hg,0,0
152417,vs.,0,0
152418,40.70?4.70,0,0
152419,mm,0,0
152420,Hg,0,0
152421,",",0,0
152422,PaCO2,0,1
152423,:,0,0
152424,57.10?7.59,0,0
152425,mm,0,0
152426,Hg,0,0
152427,vs.,0,0
152428,61.60?5.47,0,0
152429,mm,0,0
152430,Hg,0,0
152431,",",0,0
152432,HCO3,0,1
152433,(,0,1
152434,-,0,0
152435,),0,0
152436,:,0,0
152437,18.50?3.50,0,0
152438,mmol/L,0,0
152439,vs.,0,0
152440,14.75?2.65,0,0
152441,mmol/L,0,0
152442,",",0,0
152443,SaO2,0,1
152444,:,0,0
152445,0.796?0.069,0,0
152446,vs.,0,0
152447,0.699?0.066,0,0
152448,",",0,0
152449,blood,0,0
152450,lactic,0,1
152451,acid,0,1
152452,:,0,0
152453,7.07?1.60,0,0
152454,mmol/L,0,0
152455,vs.,0,0
152456,8.13?1.56,0,0
152457,mmol/L,0,0
152458,",",0,0
152459,all,0,0
152460,P,0,0
152461,<,0,0
152462,0.05,0,0
152463,),0,0
152464,.,0,0
152465,The,0,0
152466,success,0,0
152467,rate,0,0
152468,of,0,0
152469,resuscitation,1,1
152470,in,1,0
152471,the,1,0
152472,low,1,0
152473,VT,1,1
152474,ventilation,1,1
152475,group,0,0
152476,was,0,0
152477,higher,0,0
152478,than,0,0
152479,that,0,0
152480,of,0,0
152481,the,0,0
152482,conventional,1,1
152483,VT,1,1
152484,ventilation,1,1
152485,group,0,1
152486,(,0,0
152487,45,0,0
152488,%,0,0
152489,vs.,0,0
152490,15,0,0
152491,%,0,0
152492,",",0,0
152493,P,0,0
152494,<,0,0
152495,0.05,0,0
152496,),0,0
152497,",",0,0
152498,and,0,0
152499,PIP,0,1
152500,(,0,1
152501,cm,0,0
152502,H2O,0,1
152503,),0,0
152504,of,0,0
152505,low,1,0
152506,VT,1,1
152507,ventilation,1,1
152508,group,0,0
152509,was,0,0
152510,lower,0,0
152511,than,0,0
152512,that,0,0
152513,of,0,0
152514,the,0,0
152515,conventional,1,1
152516,VT,1,1
152517,group,1,1
152518,(,1,0
152519,37.25?7.99,1,0
152520,cm,0,0
152521,H2O,0,1
152522,vs.,0,0
152523,42.70?7.40,0,0
152524,cm,0,0
152525,H2O,0,1
152526,",",0,0
152527,P,0,0
152528,<,0,0
152529,0.05,0,0
152530,),0,0
152531,.,0,0
152532,In,0,0
152533,all,0,0
152534,the,0,0
152535,patients,0,0
152536,in,0,0
152537,both,0,0
152538,groups,0,0
152539,barotrauma,0,0
152540,did,0,0
152541,not,0,0
152542,occur,0,0
152543,.,0,0
152544,CONCLUSION,0,0
152545,The,0,0
152546,strategy,0,0
152547,of,1,0
152548,low,1,0
152549,ventilator,1,1
152550,VT,1,1
152551,(,0,0
152552,6,0,0
152553,-,0,0
152554,7,0,0
152555,ml/kg,0,0
152556,),0,0
152557,with,0,0
152558,appropriate,0,1
152559,elevation,0,0
152560,of,0,0
152561,airway,0,0
152562,pressure,0,0
152563,alarm,0,1
152564,threshold,0,0
152565,was,0,0
152566,better,0,0
152567,than,0,0
152568,that,1,0
152569,of,1,0
152570,conventional,1,1
152571,ventilation,1,1
152572,setting,1,0
152573,",",0,0
152574,with,0,0
152575,no,0,0
152576,increase,0,0
152577,in,0,0
152578,incidence,0,0
152579,of,0,0
152580,barotraumas,0,0
152581,during,0,0
152582,CPR,0,0
152583,.,0,0
152584,[,0,0
152585,The,0,0
152586,effects,0,0
152587,of,0,0
152588,early,1,0
152589,enteral,1,1
152590,nutrition,1,1
152591,with,1,0
152592,addition,1,0
152593,of,1,0
152594,probiotics,1,1
152595,on,0,0
152596,the,0,0
152597,prognosis,0,0
152598,of,0,0
152599,patients,0,0
152600,suffering,0,0
152601,from,0,0
152602,severe,0,0
152603,acute,0,0
152604,pancreatitis,0,0
152605,],0,0
152606,.,0,0
152607,OBJECTIVE,0,0
152608,To,0,0
152609,investigate,0,0
152610,the,0,0
152611,curative,0,0
152612,effect,0,0
152613,of,0,0
152614,early,1,0
152615,enteral,1,1
152616,nutrition,1,1
152617,(,1,1
152618,EN,1,1
152619,),1,1
152620,supplemented,1,1
152621,with,1,0
152622,probiotics,1,1
152623,(,1,0
152624,bifidobacterium,1,1
152625,),1,1
152626,in,0,0
152627,patients,0,0
152628,with,0,0
152629,severe,0,0
152630,acute,0,0
152631,pancreatitis,0,0
152632,(,0,1
152633,ASP,0,1
152634,),0,0
152635,.,0,0
152636,METHODS,0,0
152637,Seventy,0,0
152638,SAP,0,0
152639,cases,0,0
152640,admitted,0,0
152641,from,0,0
152642,January,0,0
152643,2005,0,0
152644,to,0,0
152645,October,0,0
152646,2012,0,0
152647,were,0,0
152648,randomly,0,0
152649,assigned,0,0
152650,into,0,0
152651,parenteral,1,1
152652,nutrition,1,1
152653,(,1,1
152654,PN,1,1
152655,),1,1
152656,group,0,1
152657,(,0,1
152658,n=22,0,0
152659,),0,0
152660,",",0,0
152661,EN,1,1
152662,group,0,1
152663,(,0,1
152664,n=25,0,0
152665,),0,1
152666,and,0,0
152667,bifidobacterium,1,1
152668,added,1,1
152669,EN,1,1
152670,(,1,1
152671,P+EN,1,1
152672,),1,1
152673,group,0,0
152674,(,0,1
152675,n=23,0,0
152676,),0,0
152677,.,0,0
152678,In,0,0
152679,P+EN,1,1
152680,group,0,0
152681,",",0,0
152682,patients,0,0
152683,were,0,0
152684,given,0,0
152685,their,0,0
152686,nutrition,0,1
152687,the,0,0
152688,same,0,0
152689,as,0,0
152690,that,0,0
152691,of,0,0
152692,EN,1,0
152693,",",0,0
152694,and,0,0
152695,also,0,0
152696,probiotics,1,1
152697,(,1,0
152698,bifidobacterium,1,1
152699,",",0,0
152700,4,0,0
152701,capsules,0,1
152702,every,0,0
152703,12,0,0
152704,hours,0,0
152705,",",0,0
152706,given,0,0
152707,through,0,0
152708,nasal,0,0
152709,gastric,0,0
152710,tube,0,1
152711,",",0,0
152712,each,0,0
152713,capsule,0,1
152714,weighing,0,0
152715,210,0,0
152716,mg,0,1
152717,),0,0
152718,.,0,0
152719,The,0,0
152720,routine,0,0
152721,treatment,0,0
152722,including,0,1
152723,anti-infection,1,1
152724,and,1,0
152725,anti-acid,1,1
152726,agents,1,1
152727,",",0,0
152728,and,0,0
152729,that,0,0
152730,of,0,0
152731,inhibition,0,0
152732,of,0,0
152733,pancreatic,0,0
152734,secretion,0,0
152735,were,0,0
152736,given,0,0
152737,",",0,0
152738,except,0,0
152739,for,0,0
152740,the,0,0
152741,different,0,0
152742,nutritional,0,1
152743,interventions,0,1
152744,in,0,0
152745,all,0,0
152746,groups,0,0
152747,.,0,0
152748,The,0,0
152749,blood,0,0
152750,samples,0,0
152751,were,0,0
152752,collected,0,0
152753,for,0,0
152754,e,0,0
152755,same,0,0
152756,measurements,0,0
152757,of,0,0
152758,interleukin-8,0,1
152759,(,0,1
152760,IL-8,0,1
152761,),0,1
152762,and,0,0
152763,tumor,0,0
152764,necrosis,0,1
152765,factor,0,1
152766,(,0,1
152767,TNF-?,0,0
152768,),0,1
152769,by,0,0
152770,enzyme,0,0
152771,linked,0,0
152772,immunosorbent,0,1
152773,assay,0,1
152774,(,0,1
152775,ELISA,0,0
152776,),0,1
152777,",",0,0
152778,and,0,0
152779,for,0,0
152780,the,0,0
152781,C-reactive,0,1
152782,protein,0,1
152783,(,0,1
152784,CRP,0,1
152785,),0,1
152786,",",0,0
152787,lactic,0,1
152788,acid,0,1
152789,dehydrogenase,0,0
152790,(,0,1
152791,LDH,0,1
152792,),0,1
152793,",",0,0
152794,white,0,0
152795,blood,0,0
152796,cell,0,0
152797,(,0,1
152798,WBC,0,0
152799,),0,1
152800,count,0,0
152801,",",0,0
152802,amylase,0,0
152803,and,0,0
152804,lipase,0,0
152805,by,0,0
152806,biochemistry,0,0
152807,assay,0,1
152808,1,0,0
152809,day,0,0
152810,before,0,0
152811,intervention,0,1
152812,of,0,0
152813,nutrition,0,1
152814,",",0,0
152815,and,0,0
152816,7,0,0
152817,days,0,0
152818,and,0,0
152819,14,0,0
152820,days,0,0
152821,after,0,0
152822,intervention,0,1
152823,.,0,0
152824,Changes,0,0
152825,in,0,0
152826,organ,0,0
152827,function,0,0
152828,and,0,0
152829,outcome,0,0
152830,were,0,0
152831,also,0,0
152832,recorded,0,0
152833,at,0,0
152834,the,0,0
152835,same,0,0
152836,time,0,0
152837,points,0,0
152838,.,0,0
152839,RESULTS,0,0
152840,The,0,0
152841,plasma,0,0
152842,levels,0,0
152843,of,0,0
152844,IL-8,0,0
152845,",",0,0
152846,TNF-?,0,0
152847,",",0,0
152848,CRP,0,1
152849,",",0,0
152850,LDH,0,0
152851,",",0,0
152852,WBC,0,0
152853,count,0,0
152854,",",0,0
152855,amylase,0,0
152856,and,0,0
152857,lipase,0,0
152858,were,0,0
152859,significantly,0,0
152860,reduced,0,0
152861,after,0,0
152862,nutritional,0,1
152863,intervention,0,1
152864,compared,0,0
152865,with,0,0
152866,their,0,0
152867,levels,0,0
152868,on,0,0
152869,day,0,0
152870,1,0,0
152871,before,0,0
152872,intervention,0,1
152873,in,0,0
152874,all,0,0
152875,three,0,0
152876,groups,0,0
152877,.,0,0
152878,The,0,0
152879,plasma,0,0
152880,IL-8,0,0
152881,",",0,0
152882,TNF-?,0,0
152883,",",0,0
152884,CRP,0,1
152885,",",0,0
152886,lipase,0,0
152887,",",0,0
152888,LDH,0,0
152889,at,0,0
152890,14,0,0
152891,days,0,0
152892,after,0,0
152893,intervention,0,1
152894,of,0,0
152895,nutrition,0,1
152896,in,0,0
152897,P+EN,1,1
152898,group,1,0
152899,were,0,0
152900,significantly,0,0
152901,lower,0,0
152902,than,0,0
152903,those,0,0
152904,in,0,0
152905,PN,1,1
152906,group,0,0
152907,and,0,0
152908,EN,1,1
152909,group,0,1
152910,(,0,0
152911,IL-8,0,1
152912,:,0,0
152913,21.00,0,0
152914,?,0,0
152915,7.07,0,0
152916,?g/L,0,0
152917,vs.,0,0
152918,48.00,0,0
152919,?,0,0
152920,10.32,0,0
152921,?g/L,0,0
152922,",",0,0
152923,32.00,0,0
152924,?,0,0
152925,9.30,0,0
152926,?g/L,0,0
152927,;,0,0
152928,TNF-?,0,0
152929,:,0,0
152930,44.3,0,0
152931,?,0,0
152932,10.9,0,0
152933,ng/L,0,0
152934,vs.,0,0
152935,132.1,0,0
152936,?,0,0
152937,34.1,0,0
152938,ng/L,0,0
152939,",",0,0
152940,67.8,0,0
152941,?,0,0
152942,22.3,0,0
152943,ng/L,0,0
152944,;,0,0
152945,CRP,0,1
152946,:,0,0
152947,35.0,0,0
152948,?,0,0
152949,12.4,0,0
152950,mg/L,0,0
152951,vs.,0,0
152952,103.2,0,0
152953,?,0,0
152954,49.2,0,0
152955,mg/L,0,0
152956,",",0,0
152957,63.0,0,0
152958,?,0,0
152959,29.2,0,0
152960,mg/L,0,0
152961,;,0,0
152962,lipase,0,0
152963,:,0,0
152964,269,0,0
152965,?,0,0
152966,79,0,0
152967,U/L,0,0
152968,vs.,0,0
152969,670,0,0
152970,?,0,0
152971,145,0,0
152972,U/L,0,0
152973,",",0,0
152974,310,0,0
152975,?,0,0
152976,78,0,0
152977,U/L,0,0
152978,;,0,0
152979,LDH,0,0
152980,:,0,0
152981,21.8,0,0
152982,?,0,0
152983,10.3,0,0
152984,U/L,0,0
152985,vs.,0,0
152986,78.1,0,0
152987,?,0,0
152988,37.4,0,0
152989,U/L,0,0
152990,",",0,0
152991,37.9,0,0
152992,?,0,0
152993,25.1,0,0
152994,U/L,0,0
152995,",",0,0
152996,P,0,0
152997,<,0,0
152998,0.05,0,0
152999,or,0,0
153000,P,0,0
153001,<,0,0
153002,0.01,0,0
153003,),0,0
153004,.,0,0
153005,The,0,0
153006,WBC,0,0
153007,count,0,0
153008,in,1,0
153009,P+EN,1,1
153010,group,0,0
153011,was,0,0
153012,significantly,0,0
153013,lower,0,0
153014,than,1,0
153015,that,1,0
153016,in,1,0
153017,PN,1,1
153018,group,0,1
153019,(,0,0
153020,5.9,0,0
153021,?,0,0
153022,3.0,0,0
153023,?,0,0
153024,10?/L,0,0
153025,",",0,0
153026,6.3,0,0
153027,?,0,0
153028,3.2,0,0
153029,?,0,0
153030,10?/L,0,0
153031,vs.,0,0
153032,9.6,0,0
153033,?,0,0
153034,3.0,0,0
153035,?10?/L,0,0
153036,",",0,0
153037,both,0,0
153038,P,0,0
153039,<,0,0
153040,0.05,0,0
153041,),0,0
153042,",",0,0
153043,but,0,0
153044,there,0,0
153045,was,0,0
153046,no,0,0
153047,significant,0,0
153048,difference,0,0
153049,in,0,0
153050,amylase,0,0
153051,between,1,0
153052,P+EN,1,1
153053,group,1,0
153054,and,1,0
153055,PN,1,1
153056,group,0,1
153057,(,0,0
153058,211,0,0
153059,?,0,0
153060,49,0,0
153061,U/L,0,0
153062,",",0,0
153063,236,0,0
153064,?,0,0
153065,52,0,0
153066,U/L,0,0
153067,vs.,0,0
153068,298,0,0
153069,?,0,0
153070,71,0,0
153071,U/L,0,0
153072,",",0,0
153073,P,0,0
153074,>,0,0
153075,0.05,0,0
153076,),0,0
153077,.,0,0
153078,The,0,0
153079,gastrointestinal,0,0
153080,dysfunction,0,0
153081,score,0,0
153082,in,0,0
153083,P+EN,1,1
153084,",",1,0
153085,EN,1,0
153086,",",1,0
153087,PN,1,1
153088,groups,1,0
153089,14,0,0
153090,days,0,0
153091,after,0,0
153092,nutritional,0,1
153093,intervention,0,1
153094,was,0,0
153095,0.28,0,0
153096,?,0,0
153097,0.05,0,0
153098,",",0,0
153099,0.43,0,0
153100,?,0,0
153101,0.09,0,0
153102,",",0,0
153103,0.71,0,0
153104,?,0,0
153105,0.11,0,0
153106,",",0,0
153107,respectively,0,0
153108,",",0,0
153109,with,0,0
153110,statistically,0,0
153111,significant,0,0
153112,differences,0,0
153113,(,0,0
153114,all,0,0
153115,P,0,0
153116,<,0,0
153117,0.01,0,0
153118,),0,0
153119,.,0,0
153120,Compared,0,0
153121,with,0,0
153122,PN,1,1
153123,and,1,0
153124,EN,1,1
153125,groups,1,0
153126,",",0,0
153127,the,0,0
153128,incidence,0,0
153129,of,0,0
153130,upper,0,0
153131,gastrointestinal,0,0
153132,bleeding,0,0
153133,(,0,0
153134,1,0,0
153135,vs.,0,0
153136,9,0,0
153137,",",0,0
153138,2,0,0
153139,),0,0
153140,",",0,0
153141,infection,0,0
153142,and,0,1
153143,abscess,0,1
153144,(,0,0
153145,2,0,0
153146,vs.,0,0
153147,12,0,0
153148,",",0,0
153149,5,0,0
153150,),0,0
153151,was,0,0
153152,lower,0,0
153153,(,0,0
153154,all,0,0
153155,P,0,0
153156,<,0,0
153157,0.01,0,0
153158,),0,0
153159,",",0,0
153160,and,0,0
153161,hospital,0,0
153162,day,0,1
153163,was,0,0
153164,significantly,0,0
153165,shortened,0,0
153166,in,0,0
153167,P+EN,0,1
153168,group,0,1
153169,(,0,0
153170,10.4,0,0
153171,?,0,0
153172,3.9,0,0
153173,days,0,0
153174,vs.,0,0
153175,25.8,0,0
153176,?,0,0
153177,6.4,0,0
153178,days,0,0
153179,",",0,0
153180,13.4,0,0
153181,?,0,0
153182,5.2,0,0
153183,days,0,0
153184,",",0,0
153185,both,0,0
153186,P,0,0
153187,<,0,0
153188,0.01,0,0
153189,),0,0
153190,.,0,0
153191,There,0,0
153192,was,0,0
153193,no,0,0
153194,significant,0,0
153195,statistical,0,0
153196,difference,0,0
153197,in,0,0
153198,mortality,0,0
153199,rate,0,0
153200,among,0,0
153201,three,0,0
153202,groups,0,0
153203,.,0,0
153204,CONCLUSION,0,0
153205,Our,0,0
153206,results,0,0
153207,indicated,0,0
153208,that,1,0
153209,early,1,0
153210,EN,1,1
153211,with,1,0
153212,addition,1,0
153213,of,1,0
153214,probiotics,1,1
153215,(,1,0
153216,bifidobacterium,1,1
153217,),1,1
153218,resulted,1,0
153219,in,0,0
153220,significant,0,0
153221,lowering,0,0
153222,of,0,0
153223,the,0,0
153224,level,0,0
153225,of,0,0
153226,pro-inflammatory,0,0
153227,cytokines,0,0
153228,",",0,0
153229,earlier,0,0
153230,restoration,0,0
153231,of,0,0
153232,gastrointestinal,0,0
153233,function,0,0
153234,",",0,0
153235,decrease,0,0
153236,of,0,0
153237,complications,0,0
153238,such,0,0
153239,as,0,0
153240,infection,0,0
153241,",",0,0
153242,and,0,0
153243,shortening,0,0
153244,of,0,0
153245,hospital,0,0
153246,day,0,0
153247,in,0,0
153248,patients,0,0
153249,with,0,0
153250,SAP,0,0
153251,.,0,0
153252,Pregnancy,0,0
153253,outcome,0,0
153254,and,0,0
153255,glycemic,0,0
153256,control,0,1
153257,in,0,0
153258,women,0,0
153259,with,0,0
153260,type,0,0
153261,1,0,0
153262,diabetes,0,0
153263,:,0,0
153264,a,0,0
153265,retrospective,0,0
153266,comparison,0,0
153267,between,0,0
153268,CSII,1,0
153269,and,0,0
153270,MDI,1,0
153271,treatment,0,0
153272,.,0,0
153273,AIM,0,0
153274,Present,0,1
153275,study,0,0
153276,was,0,0
153277,aimed,0,0
153278,to,0,0
153279,evaluate,0,0
153280,glycemic,0,0
153281,control,0,1
153282,and,0,0
153283,maternal-fetal,0,0
153284,outcome,0,0
153285,in,0,0
153286,pregnant,0,0
153287,type,0,0
153288,1,0,0
153289,diabetic,0,0
153290,patient,0,0
153291,treated,0,0
153292,with,0,0
153293,continuous,1,1
153294,subcutaneous,1,1
153295,insulin,1,1
153296,infusion,1,1
153297,(,1,1
153298,CSII,1,1
153299,),1,1
153300,or,1,1
153301,multiple,1,0
153302,daily,1,1
153303,injections,1,1
153304,of,1,0
153305,insulin,1,1
153306,(,1,1
153307,MDI,1,0
153308,),1,0
153309,.,1,0
153310,PATIENTS,0,0
153311,AND,0,0
153312,METHODS,0,0
153313,A,0,1
153314,retrospective,0,0
153315,observational,0,0
153316,study,0,0
153317,included,0,0
153318,thirty-four,0,0
153319,pregnant,0,0
153320,type,0,0
153321,1,0,0
153322,diabetic,0,0
153323,patients,0,0
153324,.,0,0
153325,Patients,0,0
153326,were,0,0
153327,divided,0,0
153328,into,0,0
153329,two,0,0
153330,group,0,0
153331,",",0,0
153332,CSII,1,0
153333,treated,1,0
153334,group,1,1
153335,(,0,1
153336,n=14,0,0
153337,),0,1
153338,and,1,0
153339,MDI,1,0
153340,treated,1,1
153341,group,1,0
153342,(,0,1
153343,n=20,0,1
153344,),0,0
153345,.,0,0
153346,The,0,0
153347,HbA1c,0,1
153348,level,0,0
153349,and,0,0
153350,maternal-fetal,0,0
153351,outcome,0,0
153352,were,0,0
153353,evaluated,0,0
153354,in,0,0
153355,both,0,0
153356,the,0,0
153357,treatment,0,0
153358,group,0,0
153359,.,0,0
153360,Outcome,0,0
153361,parameters,0,0
153362,such,0,0
153363,as,0,0
153364,glycemic,0,0
153365,control,0,1
153366,(,0,1
153367,HbA1c,0,1
153368,),0,1
153369,",",0,0
153370,hypoglycemic,0,1
153371,events,0,0
153372,",",0,0
153373,time,0,0
153374,and,0,0
153375,mode,0,0
153376,of,0,0
153377,delivery,0,0
153378,and,0,0
153379,labor,0,0
153380,results,0,0
153381,(,0,0
153382,abortion,0,0
153383,",",0,0
153384,premature,0,0
153385,labor,0,0
153386,",",0,0
153387,perinatal,0,0
153388,mortality,0,0
153389,",",0,0
153390,neonatal,0,0
153391,weight,0,0
153392,",",0,0
153393,Apgar,0,0
153394,score,0,0
153395,",",0,0
153396,neonatal,0,0
153397,hypoglycaemia,0,0
153398,",",0,0
153399,presence,0,0
153400,of,0,0
153401,congenital,0,0
153402,abnormalities,0,0
153403,),0,0
153404,were,0,0
153405,analyzed,0,0
153406,.,0,0
153407,RESULTS,0,0
153408,Pregnancy,0,0
153409,outcome,0,0
153410,and,0,0
153411,glycemic,0,0
153412,control,0,1
153413,in,0,0
153414,pregnant,0,0
153415,type,0,0
153416,1,0,0
153417,diabetic,0,0
153418,patients,0,0
153419,treated,0,0
153420,with,0,0
153421,CSII,0,0
153422,and,0,0
153423,MDI,0,0
153424,were,0,0
153425,evaluated,0,0
153426,and,0,0
153427,compared,0,0
153428,.,0,0
153429,Two,0,0
153430,groups,0,0
153431,were,0,0
153432,compared,0,0
153433,for,0,0
153434,their,0,0
153435,epidemiological,0,0
153436,parameters,0,0
153437,",",0,0
153438,although,0,0
153439,patients,0,0
153440,on,0,0
153441,CSII,0,0
153442,treatment,0,0
153443,had,0,0
153444,longer,0,0
153445,duration,0,0
153446,of,0,0
153447,diabetes,0,0
153448,compared,0,0
153449,to,0,0
153450,MDI,0,0
153451,treated,0,0
153452,group,0,0
153453,.,0,0
153454,Reduction,0,0
153455,in,0,0
153456,HbA1c,0,1
153457,level,0,0
153458,was,0,0
153459,higher,0,0
153460,in,0,0
153461,CSII,0,0
153462,treated,0,0
153463,patients,0,0
153464,at,0,0
153465,first,0,0
153466,(,0,0
153467,CSII,0,0
153468,:,0,1
153469,0.9,0,0
153470,%,0,0
153471,vs,0,0
153472,MDI,0,0
153473,:,0,0
153474,0.46,0,0
153475,%,0,0
153476,),0,0
153477,",",0,0
153478,second,0,0
153479,(,0,0
153480,CSII,0,0
153481,:,0,1
153482,1.58,0,0
153483,%,0,0
153484,vs,0,0
153485,MDI,0,0
153486,:,0,0
153487,0.78,0,0
153488,%,0,0
153489,),0,0
153490,and,0,0
153491,third,0,1
153492,trimester,0,0
153493,(,0,0
153494,CSII,0,0
153495,:,0,1
153496,1.74,0,0
153497,%,0,0
153498,vs,0,0
153499,MDI,0,0
153500,:,0,0
153501,1.09,0,0
153502,%,0,0
153503,),0,0
153504,of,0,0
153505,pregnancy,0,0
153506,compared,0,0
153507,to,0,0
153508,MDI,0,0
153509,treated,0,0
153510,patients,0,0
153511,.,0,0
153512,Duration,0,0
153513,of,0,0
153514,pregnancy,0,0
153515,and,0,0
153516,new,0,0
153517,born,0,0
153518,baby,0,0
153519,weight,0,0
153520,were,0,0
153521,founded,0,0
153522,similar,0,0
153523,in,0,0
153524,both,0,0
153525,group,0,0
153526,.,0,0
153527,Moreover,0,0
153528,",",0,0
153529,the,0,0
153530,rate,0,0
153531,of,0,0
153532,abortion,0,0
153533,",",0,0
153534,preterm,0,0
153535,labor,0,0
153536,",",0,0
153537,cesarean,0,0
153538,section,0,1
153539,and,0,0
153540,hypoglycemia,0,0
153541,in,0,0
153542,new,0,0
153543,born,0,0
153544,were,0,0
153545,founded,0,0
153546,less,0,0
153547,in,0,0
153548,CSII,0,0
153549,treated,0,0
153550,group,0,0
153551,compared,0,0
153552,to,0,0
153553,MDI,0,0
153554,treated,0,0
153555,group,0,0
153556,and,0,0
153557,Apgar,0,0
153558,score,0,0
153559,was,0,0
153560,significantly,0,0
153561,(,0,0
153562,p,0,0
153563,<,0,0
153564,0.05,0,0
153565,),0,0
153566,higher,0,0
153567,in,0,0
153568,CSII,0,0
153569,treated,0,0
153570,group,0,0
153571,compared,0,0
153572,to,0,0
153573,MDI,0,0
153574,treated,0,0
153575,group,0,0
153576,.,0,0
153577,CONCLUSION,0,0
153578,Results,0,0
153579,of,0,0
153580,present,0,0
153581,study,0,0
153582,revealed,0,0
153583,that,0,0
153584,the,0,0
153585,CSII,0,0
153586,gives,0,0
153587,better,0,0
153588,glycemic,0,0
153589,control,0,0
153590,and,0,0
153591,pregnancy,0,0
153592,outcome,0,0
153593,in,0,0
153594,pregnant,0,0
153595,type,0,0
153596,1,0,0
153597,diabetic,0,0
153598,patients,0,0
153599,compared,0,0
153600,to,0,0
153601,MDI,0,0
153602,treatment,0,0
153603,.,0,0
153604,CSII,0,0
153605,also,0,0
153606,decreases,0,0
153607,the,0,0
153608,daily,0,0
153609,insulin,0,1
153610,requirement,0,0
153611,compared,0,0
153612,MDI,0,0
153613,.,0,0
153614,Effects,0,0
153615,of,0,0
153616,exposure,0,0
153617,to,0,0
153618,thin-ideal,0,0
153619,media,0,1
153620,images,0,0
153621,on,0,0
153622,body,0,0
153623,dissatisfaction,0,0
153624,:,0,0
153625,testing,0,0
153626,the,0,0
153627,inclusion,0,0
153628,of,0,0
153629,a,0,0
153630,disclaimer,1,0
153631,versus,1,1
153632,warning,1,0
153633,label,1,0
153634,.,1,0
153635,The,0,0
153636,current,0,0
153637,study,0,0
153638,was,0,0
153639,designed,0,0
153640,to,0,0
153641,determine,0,0
153642,whether,0,0
153643,the,0,0
153644,inclusion,0,0
153645,of,0,0
153646,a,0,0
153647,disclaimer,0,0
153648,(,0,0
153649,i.e.,0,0
153650,",",0,0
153651,Retouched,0,1
153652,photograph,0,1
153653,aimed,0,0
153654,at,0,0
153655,changing,0,0
153656,a,0,0
153657,person,0,0
153658,'s,0,0
153659,physical,0,1
153660,appearance,0,0
153661,.,0,1
153662,),0,0
153663,or,0,1
153664,warning,0,0
153665,(,0,0
153666,i.e.,0,0
153667,",",0,0
153668,Warning,0,0
153669,:,0,0
153670,Trying,0,0
153671,to,0,0
153672,look,0,0
153673,as,0,0
153674,thin,0,1
153675,as,0,0
153676,this,0,0
153677,model,0,0
153678,may,0,0
153679,be,0,0
153680,dangerous,0,0
153681,to,0,0
153682,your,0,0
153683,health,0,0
153684,.,0,0
153685,),0,0
153686,added,0,0
153687,to,0,0
153688,images,0,0
153689,of,0,0
153690,thin/attractive,0,0
153691,models,0,0
153692,would,0,0
153693,affect,0,0
153694,body,0,0
153695,dissatisfaction,0,0
153696,and,0,0
153697,intent,0,0
153698,to,0,0
153699,diet,0,1
153700,in,0,0
153701,female,0,0
153702,undergraduate,0,0
153703,students,0,0
153704,(,0,0
153705,n=342,0,0
153706,),0,0
153707,.,0,0
153708,Participants,0,0
153709,were,0,0
153710,randomly,0,0
153711,assigned,0,0
153712,to,0,0
153713,one,0,0
153714,of,0,0
153715,four,0,0
153716,groups,1,0
153717,:,1,0
153718,(,1,0
153719,a,1,0
153720,),1,1
153721,disclaimer,1,0
153722,",",1,0
153723,(,1,1
153724,b,1,0
153725,),1,1
153726,warning,1,0
153727,",",1,0
153728,(,1,1
153729,c,1,1
153730,),1,1
153731,model,1,0
153732,control,1,1
153733,",",1,0
153734,or,1,1
153735,(,1,1
153736,d,1,1
153737,),1,1
153738,car,1,1
153739,control,1,1
153740,.,1,0
153741,Results,0,0
153742,revealed,0,0
153743,a,0,0
153744,significant,0,0
153745,interaction,0,0
153746,between,0,0
153747,group,0,0
153748,and,0,0
153749,time,0,0
153750,",",0,0
153751,whereby,0,0
153752,only,0,0
153753,the,0,0
153754,car,0,1
153755,control,0,1
153756,group,0,0
153757,reported,0,0
153758,a,0,0
153759,significant,0,0
153760,change,0,0
153761,(,0,0
153762,i.e.,0,0
153763,",",0,0
153764,decrease,0,0
153765,),0,0
153766,in,0,0
153767,body,0,0
153768,dissatisfaction,0,0
153769,over,0,0
153770,time,0,0
153771,.,0,0
153772,Groups,0,0
153773,did,0,0
153774,not,0,0
153775,differ,0,0
153776,on,0,0
153777,intent,0,0
153778,to,0,0
153779,diet,0,1
153780,measured,0,0
153781,at,0,0
153782,post-exposure,0,0
153783,.,0,0
153784,The,0,0
153785,results,0,0
153786,largely,0,0
153787,replicate,0,0
153788,other,0,0
153789,findings,0,0
153790,in,0,0
153791,this,0,0
153792,area,0,0
153793,and,0,0
153794,call,0,0
153795,into,0,0
153796,question,0,0
153797,advocacy,0,0
153798,efforts,0,0
153799,to,0,0
153800,label,0,0
153801,media,0,1
153802,images,0,0
153803,as,0,0
153804,a,0,0
153805,strategy,0,0
153806,to,0,0
153807,decrease,0,0
153808,women,0,0
153809,'s,0,0
153810,identification,0,0
153811,with,0,0
153812,the,0,0
153813,stimuli,0,0
153814,.,0,0
153815,[,0,0
153816,Efficacy,0,0
153817,observation,0,1
153818,on,0,0
153819,chronic,0,0
153820,tension-type,0,0
153821,headache,0,0
153822,treated,0,0
153823,with,0,0
153824,acupuncture,0,1
153825,at,0,0
153826,galea,0,1
153827,tendon-muscle,0,1
153828,node,0,0
153829,],0,0
153830,.,0,0
153831,OBJECTIVE,0,0
153832,To,0,0
153833,explore,0,0
153834,the,0,0
153835,better,0,0
153836,therapy,0,1
153837,for,0,0
153838,chronic,0,0
153839,tension-type,0,0
153840,headache,0,0
153841,(,0,1
153842,CTTH,0,0
153843,),0,0
153844,.,0,0
153845,METHODS,0,0
153846,Two,0,0
153847,hundred,0,0
153848,and,0,0
153849,eighty-eight,0,0
153850,cases,0,0
153851,were,0,0
153852,randomized,0,0
153853,into,0,0
153854,a,0,0
153855,sticking,1,1
153856,needling,1,1
153857,group,1,1
153858,(,1,0
153859,150,1,0
153860,cases,1,0
153861,),1,0
153862,and,1,0
153863,an,1,0
153864,acupuncture,1,1
153865,group,1,0
153866,(,0,0
153867,138,0,0
153868,cases,0,0
153869,),0,0
153870,.,0,0
153871,In,0,0
153872,the,0,0
153873,sticking,1,1
153874,needling,1,1
153875,group,0,0
153876,",",0,0
153877,the,1,0
153878,manual,1,1
153879,sticking,1,1
153880,needling,1,1
153881,technique,1,1
153882,was,0,0
153883,adopted,0,0
153884,to,0,0
153885,stimulate,0,0
153886,the,0,0
153887,galea,0,1
153888,tendon-muscle,0,1
153889,node,0,0
153890,.,0,0
153891,In,0,0
153892,the,0,0
153893,acupuncture,0,1
153894,group,0,0
153895,",",0,0
153896,the,0,0
153897,conventional,1,1
153898,acupuncture,1,1
153899,therapy,1,1
153900,was,1,0
153901,applied,1,0
153902,to,0,0
153903,Baihui,0,1
153904,(,0,1
153905,GV,0,0
153906,20,0,1
153907,),0,0
153908,",",0,0
153909,Sishencong,0,1
153910,(,0,0
153911,EX-HN,0,1
153912,1,0,1
153913,),0,0
153914,",",0,0
153915,Fengchi,0,0
153916,(,0,0
153917,GB,0,0
153918,20,0,1
153919,),0,0
153920,",",0,0
153921,Taiyang,0,0
153922,(,0,0
153923,EX-HN,0,1
153924,5,0,1
153925,),0,0
153926,",",0,0
153927,Touwei,0,1
153928,(,0,0
153929,ST,0,0
153930,18,0,0
153931,),0,0
153932,",",0,0
153933,Hegu,0,1
153934,(,0,0
153935,LI,0,1
153936,4,0,1
153937,),0,0
153938,",",0,0
153939,etc,0,0
153940,.,0,0
153941,The,0,0
153942,treatment,0,0
153943,was,0,0
153944,given,0,0
153945,once,0,0
153946,a,0,0
153947,day,0,0
153948,",",0,0
153949,and,0,0
153950,30,0,0
153951,days,0,0
153952,made,0,0
153953,one,0,0
153954,session,0,1
153955,.,0,0
153956,After,0,0
153957,two,0,0
153958,sessions,0,1
153959,of,0,0
153960,treatment,0,0
153961,and,0,0
153962,after,0,0
153963,three,0,0
153964,months,0,0
153965,follow-up,0,0
153966,",",0,0
153967,CTTH,0,0
153968,score,0,0
153969,(,0,0
153970,including,0,0
153971,the,0,0
153972,score,0,0
153973,of,0,0
153974,headache,0,0
153975,attack,0,0
153976,frequency,0,0
153977,and,0,0
153978,the,0,0
153979,score,0,0
153980,of,0,0
153981,headache,0,0
153982,severity,0,0
153983,),0,0
153984,was,0,0
153985,observed,0,0
153986,and,0,0
153987,compared,0,0
153988,before,0,0
153989,and,0,0
153990,after,0,0
153991,treatment,0,0
153992,separately,0,0
153993,.,0,0
153994,The,0,0
153995,efficacy,0,0
153996,was,0,0
153997,evaluated,0,0
153998,in,0,0
153999,two,0,0
154000,groups,0,0
154001,.,0,0
154002,RESULTS,0,0
154003,CTTH,0,0
154004,score,0,0
154005,was,0,0
154006,all,0,0
154007,reduced,0,0
154008,after,0,0
154009,treatment,0,0
154010,in,0,0
154011,the,0,0
154012,two,0,0
154013,groups,0,0
154014,(,0,0
154015,both,0,0
154016,P,0,0
154017,<,0,0
154018,0.01,0,0
154019,),0,0
154020,",",0,0
154021,the,0,0
154022,score,0,0
154023,in,0,0
154024,the,0,0
154025,sticking,0,1
154026,needling,0,1
154027,group,0,0
154028,was,0,0
154029,lower,0,0
154030,than,0,0
154031,that,0,0
154032,in,0,0
154033,the,0,0
154034,acupuncture,1,1
154035,group,0,0
154036,(,0,0
154037,2.38,0,0
154038,+/-,0,0
154039,1.22,0,0
154040,vs,0,0
154041,4.16,0,0
154042,+/-,0,0
154043,2.54,0,0
154044,",",0,0
154045,P,0,0
154046,<,0,0
154047,0.01,0,0
154048,),0,0
154049,.,0,0
154050,The,0,0
154051,effective,0,0
154052,rate,0,0
154053,was,0,0
154054,97.3,0,0
154055,%,0,0
154056,(,0,0
154057,146/150,0,0
154058,),0,0
154059,in,0,0
154060,the,0,0
154061,sticking,0,1
154062,needling,0,1
154063,group,0,0
154064,",",0,0
154065,which,0,0
154066,was,0,0
154067,better,0,0
154068,than,0,0
154069,88.4,0,0
154070,%,0,0
154071,(,0,0
154072,122/138,0,0
154073,),0,0
154074,in,0,0
154075,the,0,0
154076,acupuncture,1,1
154077,group,0,0
154078,(,0,0
154079,P,0,0
154080,<,0,0
154081,0.05,0,0
154082,),0,0
154083,.,0,0
154084,CONCLUSION,0,0
154085,The,0,0
154086,manual,1,1
154087,sticking,1,1
154088,needling,1,1
154089,technique,1,1
154090,at,0,0
154091,galea,0,1
154092,tendon-muscle,0,1
154093,node,0,0
154094,achieves,0,0
154095,the,0,0
154096,superior,0,0
154097,results,0,0
154098,of,0,0
154099,reducing,0,0
154100,the,0,0
154101,pain,0,0
154102,attack,0,0
154103,frequency,0,0
154104,and,0,0
154105,severity,0,0
154106,of,0,0
154107,CTTH,0,0
154108,as,0,0
154109,compared,0,0
154110,with,0,0
154111,the,0,0
154112,acupuncture,0,1
154113,therapy,0,1
154114,of,0,0
154115,the,0,0
154116,routine,0,1
154117,acupoint,0,1
154118,selection,0,0
154119,.,0,0
154120,The,0,0
154121,effectiveness,0,0
154122,of,0,0
154123,educational,1,0
154124,interventions,1,0
154125,to,0,0
154126,enhance,0,0
154127,the,0,0
154128,adoption,0,0
154129,of,0,0
154130,fee-based,0,1
154131,arsenic,0,1
154132,testing,0,0
154133,in,0,0
154134,Bangladesh,0,0
154135,:,0,0
154136,a,0,0
154137,cluster,0,0
154138,randomized,0,0
154139,controlled,0,0
154140,trial,0,0
154141,.,0,1
154142,Arsenic,0,0
154143,(,0,0
154144,As,0,0
154145,),0,1
154146,testing,0,0
154147,could,0,0
154148,help,0,0
154149,22,0,0
154150,million,0,0
154151,people,0,0
154152,",",0,0
154153,using,0,0
154154,drinking,0,0
154155,water,0,1
154156,sources,0,0
154157,that,0,0
154158,exceed,0,0
154159,the,0,0
154160,Bangladesh,0,0
154161,As,0,0
154162,standard,0,1
154163,",",0,0
154164,to,0,0
154165,identify,0,0
154166,safe,0,0
154167,sources,0,0
154168,.,0,0
154169,A,0,0
154170,cluster,0,0
154171,randomized,0,0
154172,controlled,0,0
154173,trial,0,0
154174,was,0,0
154175,conducted,0,0
154176,to,0,0
154177,evaluate,0,0
154178,the,0,0
154179,effectiveness,0,0
154180,of,0,0
154181,household,1,1
154182,education,1,1
154183,and,1,0
154184,local,1,1
154185,media,1,1
154186,in,0,0
154187,the,0,0
154188,increasing,0,0
154189,demand,0,0
154190,for,0,0
154191,fee-based,0,1
154192,As,0,0
154193,testing,0,0
154194,.,0,0
154195,Randomly,0,0
154196,selected,0,0
154197,households,0,0
154198,(,0,0
154199,N,0,0
154200,=,0,0
154201,452,0,0
154202,),0,0
154203,were,0,0
154204,divided,0,0
154205,into,0,0
154206,three,1,0
154207,interventions,1,0
154208,implemented,1,0
154209,by,1,0
154210,community,1,0
154211,workers,1,0
154212,:,1,0
154213,1,1,0
154214,),1,0
154215,fee-based,1,1
154216,As,1,0
154217,testing,1,0
154218,with,1,0
154219,household,1,1
154220,education,1,1
154221,(,1,1
154222,HE,1,1
154223,),1,1
154224,;,1,0
154225,2,1,0
154226,),1,0
154227,fee-based,1,1
154228,As,1,0
154229,testing,1,0
154230,with,1,0
154231,household,1,1
154232,education,1,1
154233,and,1,0
154234,a,1,0
154235,local,1,1
154236,media,1,1
154237,campaign,1,1
154238,(,1,1
154239,HELM,1,1
154240,),1,1
154241,;,1,0
154242,and,1,0
154243,3,1,0
154244,),1,0
154245,fee-based,1,1
154246,As,1,0
154247,testing,1,1
154248,alone,1,1
154249,(,1,1
154250,Control,1,1
154251,),1,0
154252,.,1,0
154253,The,0,0
154254,fee,0,0
154255,for,0,0
154256,the,0,0
154257,As,0,0
154258,test,0,0
154259,was,0,0
154260,US,0,1
154261,$,0,0
154262,0.28,0,0
154263,",",0,0
154264,higher,0,0
154265,than,0,0
154266,the,0,0
154267,cost,0,0
154268,of,0,0
154269,the,0,0
154270,test,0,0
154271,(,0,0
154272,US,0,1
154273,$,0,0
154274,0.16,0,0
154275,),0,0
154276,.,0,0
154277,Of,0,0
154278,households,0,0
154279,with,0,0
154280,untested,0,0
154281,wells,0,0
154282,",",0,0
154283,93,0,0
154284,%,0,0
154285,in,0,0
154286,both,0,0
154287,intervention,0,1
154288,groups,0,0
154289,HE,0,0
154290,and,0,0
154291,HELM,0,1
154292,purchased,0,1
154293,an,0,0
154294,As,0,0
154295,test,0,0
154296,",",0,0
154297,whereas,0,0
154298,only,0,0
154299,53,0,0
154300,%,0,0
154301,in,0,0
154302,the,0,0
154303,control,0,0
154304,group,0,0
154305,.,0,0
154306,In,0,0
154307,conclusion,0,0
154308,",",0,0
154309,fee-based,1,1
154310,As,1,0
154311,testing,1,0
154312,with,1,0
154313,household,1,1
154314,education,1,1
154315,is,0,0
154316,effective,0,0
154317,in,0,0
154318,the,0,0
154319,increasing,0,0
154320,demand,0,0
154321,for,0,0
154322,As,0,0
154323,testing,0,0
154324,in,0,0
154325,rural,0,0
154326,Bangladesh,0,0
154327,.,0,0
154328,Prospective,0,0
154329,",",0,0
154330,blinded,0,0
154331,exploratory,0,0
154332,evaluation,0,0
154333,of,0,0
154334,the,0,0
154335,PlayWisely,1,0
154336,program,1,1
154337,in,0,0
154338,children,0,0
154339,with,0,0
154340,autism,0,0
154341,spectrum,0,0
154342,disorder,0,0
154343,.,0,0
154344,The,0,0
154345,purpose,0,0
154346,of,0,0
154347,the,0,0
154348,study,0,0
154349,was,0,0
154350,to,0,0
154351,explore,0,0
154352,a,0,0
154353,low-cost,1,0
154354,intervention,1,1
154355,that,0,0
154356,targets,0,0
154357,an,0,0
154358,increasingly,0,0
154359,common,0,0
154360,developmental,0,0
154361,disorder,0,0
154362,.,0,0
154363,The,0,0
154364,study,0,0
154365,was,0,0
154366,a,0,0
154367,blinded,0,0
154368,",",0,0
154369,exploratory,0,1
154370,evaluation,0,0
154371,of,0,0
154372,the,0,0
154373,PlayWisely,1,0
154374,program,1,1
154375,on,0,0
154376,autism,0,0
154377,symptoms,0,0
154378,and,0,0
154379,essential,0,0
154380,learning,0,1
154381,foundation,0,0
154382,skills,0,1
154383,(,0,0
154384,attention,0,0
154385,",",0,0
154386,recognition,0,0
154387,",",0,0
154388,and,0,0
154389,memory,0,0
154390,skills,0,1
154391,),0,0
154392,in,0,0
154393,children,0,0
154394,with,0,0
154395,a,0,0
154396,diagnosis,0,0
154397,of,0,0
154398,autism,0,0
154399,",",0,0
154400,autism,0,0
154401,spectrum,0,0
154402,disorder,0,0
154403,(,0,1
154404,ASD,0,0
154405,),0,1
154406,",",0,0
154407,pervasive,0,0
154408,developmental,0,0
154409,disorder,0,0
154410,-,0,0
154411,not,0,0
154412,otherwise,0,0
154413,specified,0,0
154414,(,0,0
154415,PDD-NOS,0,1
154416,),0,1
154417,",",0,0
154418,and,0,0
154419,Asperger,0,0
154420,syndrome,0,1
154421,(,0,0
154422,AS,0,0
154423,),0,0
154424,.,0,0
154425,Eighteen,0,0
154426,children,0,0
154427,",",0,0
154428,1,0,0
154429,to,0,0
154430,10,0,0
154431,years,0,0
154432,of,0,0
154433,age,0,0
154434,",",0,0
154435,were,0,0
154436,evaluated,0,0
154437,using,0,0
154438,the,0,0
154439,Childhood,0,0
154440,Autism,0,0
154441,Rating,0,0
154442,Scale,0,0
154443,",",0,0
154444,Second,0,1
154445,Edition,0,1
154446,(,0,1
154447,CARS2,0,1
154448,),0,1
154449,;,0,0
154450,the,0,0
154451,PlayWisely,0,0
154452,Interactive,0,1
154453,Test,0,0
154454,of,0,0
154455,Attention,0,0
154456,",",0,0
154457,Recognition,0,0
154458,",",0,0
154459,and,0,0
154460,Memory,0,0
154461,Skills,0,1
154462,;,0,0
154463,Autism,0,0
154464,Treatment,0,1
154465,Evaluation,0,1
154466,Checklist,0,1
154467,(,0,1
154468,ATEC,0,1
154469,),0,1
154470,",",0,0
154471,and,0,0
154472,the,0,0
154473,Modified,0,1
154474,Checklist,0,0
154475,for,0,0
154476,Autism,0,0
154477,in,0,0
154478,Toddlers,0,0
154479,(,0,1
154480,M-CHAT,0,1
154481,),0,0
154482,.,0,0
154483,There,0,0
154484,were,0,0
154485,significant,0,0
154486,treatment,0,0
154487,effects,0,0
154488,for,0,0
154489,the,0,0
154490,PlayWisely,0,0
154491,measure,0,0
154492,on,0,0
154493,the,0,0
154494,Yellow,0,0
154495,Sets,0,0
154496,that,0,0
154497,examine,0,0
154498,recognition,0,0
154499,;,0,0
154500,Purple,0,1
154501,Sets,0,0
154502,that,0,0
154503,examine,0,0
154504,brain,0,0
154505,region,0,1
154506,agility,0,1
154507,and,0,0
154508,early,0,0
154509,memory,0,0
154510,skills,0,0
154511,;,0,0
154512,Blue,0,0
154513,Sets,0,0
154514,that,0,0
154515,examine,0,0
154516,phonemic,0,1
154517,awareness,0,0
154518,and,0,0
154519,recognition,0,0
154520,;,0,0
154521,and,0,0
154522,for,0,0
154523,the,0,0
154524,Total,0,0
154525,Sets,0,0
154526,",",0,0
154527,with,0,0
154528,a,0,0
154529,similar,0,0
154530,trend,0,0
154531,toward,0,0
154532,improvement,0,0
154533,in,0,0
154534,the,0,0
154535,Green,0,1
154536,Sets,0,0
154537,that,0,0
154538,examine,0,0
154539,perception,0,0
154540,and,0,0
154541,Red,0,0
154542,Sets,0,1
154543,that,0,0
154544,examine,0,0
154545,attention,0,0
154546,.,0,0
154547,No,0,0
154548,other,0,0
154549,measures,0,0
154550,reached,0,0
154551,statistical,0,0
154552,significance,0,0
154553,.,0,0
154554,The,0,0
154555,results,0,0
154556,suggest,0,0
154557,that,0,0
154558,PlayWisely,0,0
154559,can,0,0
154560,improve,0,0
154561,recognition,0,0
154562,",",0,0
154563,brain,0,0
154564,region,0,0
154565,agility,0,0
154566,",",0,0
154567,phonemic,0,1
154568,awareness,0,0
154569,",",0,0
154570,letter,0,1
154571,recognition,0,0
154572,",",0,0
154573,and,0,0
154574,early,0,0
154575,memory,0,0
154576,skills,0,0
154577,in,0,0
154578,ASD,0,0
154579,.,0,0
154580,It,0,0
154581,was,0,0
154582,observed,0,0
154583,by,0,0
154584,the,0,0
154585,parents,0,0
154586,",",0,0
154587,coaches,0,1
154588,",",0,0
154589,and,0,0
154590,study,0,0
154591,investigators,0,0
154592,that,0,0
154593,the,0,0
154594,children,0,0
154595,who,0,0
154596,were,0,0
154597,less,0,0
154598,than,0,0
154599,3,0,0
154600,years,0,0
154601,of,0,0
154602,age,0,0
154603,showed,0,0
154604,improvements,0,0
154605,in,0,0
154606,autism,0,0
154607,symptoms,0,0
154608,;,0,0
154609,however,0,0
154610,",",0,0
154611,the,0,0
154612,group,0,0
154613,was,0,0
154614,too,0,0
154615,small,0,0
154616,to,0,0
154617,reach,0,0
154618,statistical,0,0
154619,significance,0,0
154620,.,0,0
154621,Future,0,0
154622,studies,0,0
154623,are,0,0
154624,needed,0,0
154625,to,0,0
154626,see,0,0
154627,if,0,0
154628,this,0,0
154629,intervention,0,1
154630,can,0,0
154631,mitigate,0,0
154632,autism,0,0
154633,symptoms,0,0
154634,in,0,0
154635,very,0,0
154636,young,0,0
154637,children,0,0
154638,with,0,0
154639,ASD,0,0
154640,.,0,0
154641,Targeting,0,1
154642,alpha-7,1,1
154643,nicotinic,1,1
154644,neurotransmission,1,0
154645,in,0,0
154646,schizophrenia,0,0
154647,:,0,0
154648,a,0,0
154649,novel,0,0
154650,agonist,0,1
154651,strategy,0,0
154652,.,0,0
154653,Alpha7,1,1
154654,nicotinic,1,1
154655,acetylcholine,1,1
154656,receptor,1,0
154657,(,1,0
154658,?7,1,1
154659,nAChR,1,1
154660,),1,0
154661,agonists,1,1
154662,may,0,0
154663,be,0,0
154664,valuable,0,0
154665,treatments,0,0
154666,for,0,0
154667,negative,0,0
154668,symptoms,0,0
154669,and,0,0
154670,cognitive,0,0
154671,impairment,0,0
154672,in,0,0
154673,schizophrenia,0,0
154674,.,0,0
154675,Unfortunately,0,0
154676,",",0,0
154677,chronic,0,0
154678,exposure,0,0
154679,to,0,0
154680,an,0,0
154681,agonist,0,1
154682,may,0,0
154683,reduce,0,0
154684,the,0,0
154685,receptor,0,0
154686,'s,0,0
154687,sensitivity,0,0
154688,.,0,0
154689,Therefore,0,0
154690,",",0,0
154691,we,0,0
154692,combined,1,1
154693,CDP-choline,1,1
154694,",",1,0
154695,a,0,0
154696,dietary,0,1
154697,source,0,0
154698,of,0,0
154699,the,0,0
154700,direct,0,1
154701,agonist,0,1
154702,choline,0,1
154703,",",0,0
154704,with,1,0
154705,galantamine,1,1
154706,",",1,0
154707,a,1,0
154708,positive,1,0
154709,allosteric,1,0
154710,modulator,1,1
154711,(,1,1
154712,PAM,1,1
154713,),1,1
154714,of,1,0
154715,nicotinic,1,1
154716,acetylcholine,1,1
154717,receptors,1,0
154718,",",1,0
154719,to,0,0
154720,improve,0,0
154721,the,0,0
154722,efficiency,0,0
154723,of,0,0
154724,transducing,0,0
154725,the,0,0
154726,choline,0,1
154727,signal,0,0
154728,and,0,0
154729,",",0,0
154730,possibly,0,0
154731,",",0,0
154732,preserve,0,0
154733,the,0,0
154734,receptor,0,0
154735,in,0,0
154736,a,0,0
154737,sensitive,0,0
154738,state,0,0
154739,.,0,0
154740,We,0,0
154741,conducted,0,0
154742,a,0,0
154743,single-site,0,0
154744,",",0,0
154745,double-blind,0,0
154746,randomized,0,0
154747,clinical,0,0
154748,trial,0,0
154749,comparing,1,0
154750,galantamine/CDP-choline,1,1
154751,to,1,0
154752,placebos,1,1
154753,in,0,0
154754,schizophrenia,0,0
154755,patients,0,0
154756,with,0,0
154757,negative,0,0
154758,symptoms,0,0
154759,who,0,0
154760,were,0,0
154761,receiving,0,0
154762,second,0,0
154763,generation,0,0
154764,antipsychotics,0,1
154765,.,0,0
154766,Forty-three,0,0
154767,subjects,0,0
154768,received,1,0
154769,galantamine,1,1
154770,and,1,0
154771,CDP-choline,1,1
154772,or,0,1
154773,matching,1,0
154774,placebos,1,1
154775,for,0,0
154776,16weeks,0,0
154777,.,0,0
154778,The,0,0
154779,primary,0,0
154780,outcome,0,0
154781,measure,0,0
154782,was,0,0
154783,the,0,0
154784,5-item,0,0
154785,Marder,0,1
154786,negative-symptoms,0,1
154787,factor,0,0
154788,of,0,0
154789,the,0,0
154790,Positive,0,0
154791,and,0,0
154792,Negative,0,0
154793,Syndrome,0,1
154794,Scale,0,1
154795,(,0,1
154796,PANSS,0,0
154797,),0,1
154798,.,0,0
154799,Cognition,0,0
154800,and,0,0
154801,functioning,0,0
154802,were,0,0
154803,also,0,0
154804,assessed,0,0
154805,.,0,0
154806,Trial,0,0
154807,completion,0,0
154808,was,0,0
154809,high,0,0
154810,;,0,0
154811,79,0,0
154812,%,0,0
154813,.,0,0
154814,There,0,0
154815,was,0,0
154816,no,0,0
154817,significant,0,0
154818,treatment,0,0
154819,effect,0,0
154820,on,0,0
154821,negative,0,0
154822,symptoms,0,0
154823,",",0,0
154824,other,0,0
154825,PANSS,0,0
154826,symptom,0,0
154827,factors,0,0
154828,",",0,0
154829,or,0,0
154830,the,0,0
154831,MATRICS,0,1
154832,Cognitive,0,1
154833,Consensus,0,0
154834,Battery,0,1
154835,.,0,0
154836,There,0,0
154837,were,0,0
154838,significant,0,0
154839,treatment,0,0
154840,effects,0,0
154841,in,0,0
154842,overall,0,0
154843,functioning,0,0
154844,and,0,0
154845,a,0,0
154846,test,0,0
154847,of,0,0
154848,free,0,0
154849,verbal,0,0
154850,recall,0,0
154851,.,0,0
154852,Three,0,0
154853,subjects,0,0
154854,discontinued,0,0
154855,treatment,0,0
154856,in,0,0
154857,the,0,0
154858,active,0,1
154859,treatment,0,0
154860,group,0,0
154861,for,0,0
154862,gastro-intestinal,0,0
154863,adverse,0,0
154864,events,0,0
154865,(,0,0
154866,AE,0,0
154867,),0,0
154868,.,0,0
154869,The,0,0
154870,most,0,0
154871,common,0,0
154872,AE,0,0
154873,for,1,0
154874,galantamine/CDP-choline,1,1
154875,was,0,0
154876,abdominal,0,0
154877,pain,0,0
154878,;,0,0
154879,for,1,0
154880,placebo,1,1
154881,it,0,0
154882,was,0,0
154883,headache,0,0
154884,and,0,0
154885,sweating,0,0
154886,.,0,0
154887,Although,0,0
154888,there,0,0
154889,was,0,0
154890,no,0,0
154891,significant,0,0
154892,treatment,0,0
154893,effect,0,0
154894,on,0,0
154895,negative,0,0
154896,symptoms,0,0
154897,",",0,0
154898,the,0,0
154899,direction,0,0
154900,of,0,0
154901,effect,0,0
154902,mirrored,0,0
154903,the,0,0
154904,effects,0,0
154905,on,0,0
154906,a,0,0
154907,cognitive,0,1
154908,measure,0,0
154909,and,0,0
154910,overall,0,0
154911,functioning,0,0
154912,.,0,0
154913,Further,0,0
154914,study,0,0
154915,of,1,0
154916,?7,1,0
154917,nAChR,1,0
154918,agonist/PAMs,1,1
154919,is,1,0
154920,warranted,0,0
154921,in,0,0
154922,larger,0,0
154923,studies,0,0
154924,that,0,0
154925,will,0,0
154926,have,0,0
154927,greater,0,0
154928,power,0,0
154929,.,0,0
154930,Long-term,0,0
154931,effects,0,0
154932,of,0,0
154933,choline,1,1
154934,on,0,0
154935,productive,0,0
154936,performance,0,0
154937,and,0,0
154938,egg,0,1
154939,quality,0,0
154940,of,0,0
154941,brown-egg,0,1
154942,laying,0,0
154943,hens,0,0
154944,.,0,0
154945,A,0,0
154946,total,0,0
154947,of,0,0
154948,five,0,0
154949,hundred,0,0
154950,forty,0,0
154951,19-wk-old,0,0
154952,HyLine,0,1
154953,Brown,0,0
154954,hens,0,0
154955,were,0,0
154956,used,0,0
154957,to,0,0
154958,study,0,0
154959,the,0,0
154960,long-term,0,0
154961,effects,0,0
154962,of,0,0
154963,increasing,0,0
154964,choline,1,1
154965,with,1,0
154966,0,1,0
154967,(,1,0
154968,control,1,1
154969,),1,0
154970,",",1,0
154971,425,1,0
154972,",",1,0
154973,850,1,0
154974,",",1,0
154975,"1,700",1,0
154976,",",1,0
154977,"3,400",1,0
154978,",",0,0
154979,and,0,0
154980,"6,800",1,1
154981,mg/kg,1,1
154982,of,1,0
154983,corn-soybean,1,1
154984,meal-based,1,1
154985,diets,1,1
154986,on,0,0
154987,productive,0,0
154988,performance,0,0
154989,and,0,0
154990,egg,0,1
154991,quality,0,0
154992,.,0,0
154993,Phase,0,0
154994,1,0,0
154995,was,0,0
154996,from,0,0
154997,19,0,0
154998,to,0,0
154999,58,0,0
155000,wk,0,0
155001,",",0,0
155002,and,0,0
155003,phase,0,0
155004,2,0,0
155005,was,0,0
155006,from,0,0
155007,59,0,0
155008,to,0,0
155009,68,0,0
155010,wk,0,0
155011,.,0,0
155012,During,0,0
155013,the,0,0
155014,whole,0,0
155015,experimental,0,0
155016,period,0,0
155017,",",0,0
155018,dietary,0,1
155019,choline,0,1
155020,had,0,0
155021,no,0,0
155022,significant,0,0
155023,effects,0,0
155024,on,0,0
155025,feed,0,0
155026,intake,0,0
155027,",",0,0
155028,egg,0,1
155029,weight,0,0
155030,",",0,0
155031,and,0,0
155032,egg,0,1
155033,mass,0,0
155034,(,0,0
155035,P,0,0
155036,>,0,0
155037,0.05,0,0
155038,),0,0
155039,.,0,0
155040,During,0,0
155041,phase,0,0
155042,1,0,0
155043,",",0,0
155044,egg,0,0
155045,production,0,0
155046,decreased,0,0
155047,linearly,0,1
155048,(,0,0
155049,P,0,0
155050,<,0,0
155051,0.05,0,0
155052,),0,0
155053,and,0,0
155054,feed,0,1
155055,conversion,0,0
155056,ratio,0,0
155057,(,0,1
155058,FCR,0,0
155059,),0,1
155060,tended,0,0
155061,to,0,0
155062,increase,0,0
155063,linearly,0,1
155064,(,0,0
155065,P,0,0
155066,=,0,0
155067,0.057,0,0
155068,),0,0
155069,with,0,0
155070,increasing,0,0
155071,choline,0,1
155072,level,0,0
155073,in,0,0
155074,the,0,0
155075,diet,0,1
155076,.,0,0
155077,Moreover,0,0
155078,",",0,0
155079,BW,0,1
155080,decreased,0,0
155081,both,0,0
155082,linearly,0,1
155083,(,0,0
155084,P,0,0
155085,<,0,0
155086,0.01,0,0
155087,),0,0
155088,and,0,0
155089,quadratically,0,1
155090,(,0,0
155091,P,0,0
155092,<,0,0
155093,0.05,0,0
155094,),0,0
155095,as,0,0
155096,choline,0,1
155097,increased,0,0
155098,from,0,0
155099,0,0,0
155100,to,0,0
155101,"6,800",0,0
155102,mg/kg,0,1
155103,.,0,0
155104,No,0,0
155105,significant,0,0
155106,treatment,0,0
155107,effects,0,0
155108,were,0,0
155109,found,0,0
155110,for,0,0
155111,shell,0,1
155112,thickness,0,0
155113,and,0,0
155114,shell,0,1
155115,strength,0,0
155116,of,0,0
155117,eggs,0,1
155118,(,0,0
155119,P,0,0
155120,>,0,0
155121,0.05,0,0
155122,),0,0
155123,.,0,0
155124,However,0,0
155125,",",0,0
155126,albumen,0,0
155127,height,0,0
155128,and,0,0
155129,Haugh,0,0
155130,units,0,1
155131,increased,0,0
155132,linearly,0,0
155133,(,0,0
155134,P,0,0
155135,<,0,0
155136,0.01,0,0
155137,and,0,0
155138,P,0,0
155139,<,0,0
155140,0.05,0,0
155141,",",0,0
155142,respectively,0,0
155143,),0,0
155144,as,0,0
155145,choline,0,1
155146,increased,0,0
155147,during,0,0
155148,phase,0,0
155149,2,0,0
155150,.,0,0
155151,Compared,0,0
155152,with,0,0
155153,the,0,0
155154,control,0,1
155155,group,0,0
155156,",",0,0
155157,diets,0,1
155158,supplemented,0,1
155159,with,0,0
155160,425,0,0
155161,or,0,0
155162,850,0,1
155163,mg,0,1
155164,of,0,0
155165,choline/kg,0,1
155166,significantly,0,0
155167,(,0,0
155168,P,0,0
155169,<,0,0
155170,0.01,0,0
155171,),0,0
155172,improved,0,0
155173,yolk,0,1
155174,color,0,0
155175,during,0,0
155176,phase,0,0
155177,1,0,0
155178,.,0,0
155179,This,0,0
155180,study,0,0
155181,indicates,0,0
155182,that,0,0
155183,a,0,0
155184,dietary,0,1
155185,choline,0,1
155186,level,0,0
155187,of,0,0
155188,no,0,0
155189,more,0,0
155190,than,0,0
155191,700,0,0
155192,mg/kg,0,1
155193,is,0,0
155194,sufficient,0,0
155195,to,0,0
155196,maintain,0,1
155197,egg,0,1
155198,production,0,0
155199,.,0,0
155200,The,0,0
155201,effect,0,0
155202,of,0,0
155203,choline,0,1
155204,on,0,0
155205,egg,0,1
155206,quality,0,0
155207,was,0,0
155208,minimal,0,0
155209,when,0,0
155210,hens,0,0
155211,were,0,0
155212,fed,0,0
155213,a,0,0
155214,corn-soybean,1,1
155215,meal-based,1,1
155216,diet,1,1
155217,from,0,0
155218,19,0,0
155219,to,0,0
155220,68,0,0
155221,wk,0,0
155222,of,0,0
155223,age,0,0
155224,.,0,0
155225,Tetrahydrobiopterin,1,1
155226,as,0,0
155227,a,0,0
155228,treatment,0,0
155229,for,0,0
155230,autism,0,0
155231,spectrum,0,0
155232,disorders,0,0
155233,:,0,0
155234,a,0,0
155235,double-blind,0,0
155236,",",0,0
155237,placebo-controlled,1,1
155238,trial,0,0
155239,.,0,0
155240,OBJECTIVE,0,0
155241,The,0,0
155242,purpose,0,0
155243,of,0,0
155244,this,0,0
155245,study,0,0
155246,was,0,0
155247,to,0,0
155248,determine,0,0
155249,if,0,0
155250,tetrahydrobiopterin,1,1
155251,(,1,1
155252,BH4,1,1
155253,),1,1
155254,reduced,0,0
155255,core,0,0
155256,symptoms,0,0
155257,of,0,0
155258,autism,0,0
155259,spectrum,0,0
155260,disorder,0,0
155261,(,0,1
155262,ASD,0,0
155263,),0,0
155264,.,0,0
155265,METHOD,0,0
155266,In,0,0
155267,this,0,0
155268,study,0,0
155269,",",0,0
155270,46,0,0
155271,children,0,0
155272,",",0,0
155273,3-7,0,0
155274,years,0,0
155275,of,0,0
155276,age,0,0
155277,diagnosed,0,0
155278,with,0,0
155279,an,0,0
155280,ASD,0,0
155281,were,0,0
155282,randomly,0,0
155283,assigned,0,0
155284,to,0,0
155285,double-blind,0,0
155286,treatment,0,0
155287,with,0,0
155288,20,1,0
155289,mg/kg/day,1,1
155290,BH4,1,1
155291,or,1,1
155292,placebo,1,1
155293,for,1,0
155294,16,0,0
155295,weeks,0,0
155296,.,0,0
155297,The,0,0
155298,primary,0,0
155299,outcome,0,0
155300,measure,0,0
155301,was,0,0
155302,the,0,0
155303,Clinical,0,0
155304,Global,0,0
155305,Impressions,0,1
155306,Improvement,0,0
155307,and,0,0
155308,Severity,0,0
155309,Scales,0,1
155310,(,0,1
155311,CGI-I,0,1
155312,and,0,1
155313,CGI-S,0,1
155314,),0,1
155315,;,0,0
155316,secondary,0,0
155317,outcomes,0,0
155318,were,0,0
155319,the,0,0
155320,Preschool,0,0
155321,Language,0,1
155322,Scale-4,0,1
155323,(,0,1
155324,PLS-4,0,1
155325,),0,0
155326,",",0,0
155327,Social,0,0
155328,Responsiveness,0,0
155329,Scale,0,1
155330,(,0,1
155331,SRS,0,1
155332,),0,0
155333,",",0,0
155334,Aberrant,0,0
155335,Behavior,0,0
155336,Checklist,0,1
155337,(,0,1
155338,ABC,0,1
155339,),0,1
155340,",",0,0
155341,and,0,0
155342,Vineland,0,1
155343,Adaptive,0,0
155344,Behavior,0,0
155345,Scales,0,1
155346,(,0,1
155347,Vineland,0,1
155348,),0,0
155349,.,0,0
155350,RESULTS,0,0
155351,Overall,0,0
155352,",",0,0
155353,no,0,0
155354,differences,0,0
155355,were,0,0
155356,found,0,0
155357,on,0,0
155358,global,0,0
155359,improvement,0,0
155360,as,0,0
155361,measured,0,0
155362,with,0,0
155363,the,0,0
155364,CGI-I,0,1
155365,or,0,1
155366,CGI-S,0,1
155367,.,0,0
155368,Secondary,0,0
155369,measures,0,0
155370,indicated,0,0
155371,significant,0,0
155372,improvements,0,0
155373,for,1,0
155374,BH4,1,0
155375,relative,1,0
155376,to,0,0
155377,placebo,1,1
155378,with,1,0
155379,regard,0,0
155380,to,0,0
155381,social,0,0
155382,awareness,0,0
155383,",",0,0
155384,autism,0,0
155385,mannerisms,0,1
155386,",",0,0
155387,hyperactivity,0,0
155388,",",0,0
155389,and,0,0
155390,inappropriate,0,0
155391,speech,0,1
155392,.,0,0
155393,Side,0,0
155394,effects,0,0
155395,were,0,0
155396,minimal,0,0
155397,and,0,0
155398,similar,0,0
155399,between,0,0
155400,both,0,0
155401,active,0,1
155402,medication,0,1
155403,and,1,0
155404,placebo,1,1
155405,.,1,0
155406,CONCLUSIONS,0,0
155407,These,0,0
155408,results,0,0
155409,indicate,0,0
155410,that,1,0
155411,BH4,1,1
155412,offers,1,0
155413,promise,0,0
155414,in,0,0
155415,reducing,0,0
155416,symptoms,0,0
155417,of,0,0
155418,ASD,0,0
155419,.,0,0
155420,Clinical,0,0
155421,Trials.gov,0,0
155422,Identifier,0,0
155423,:,0,0
155424,NCT00850070,0,0
155425,.,0,0
155426,A,0,0
155427,head-to-head,0,0
155428,comparison,0,0
155429,of,0,0
155430,aripiprazole,1,1
155431,and,1,0
155432,risperidone,1,1
155433,for,0,0
155434,safety,0,0
155435,and,0,0
155436,treating,0,0
155437,autistic,0,0
155438,disorders,0,0
155439,",",0,0
155440,a,0,0
155441,randomized,0,0
155442,double,0,0
155443,blind,0,0
155444,clinical,0,0
155445,trial,0,0
155446,.,0,1
155447,Aripiprazole,1,1
155448,and,1,0
155449,risperidone,1,1
155450,are,0,0
155451,the,0,0
155452,only,0,0
155453,FDA,0,1
155454,approved,0,0
155455,medications,0,1
155456,for,0,0
155457,treating,0,0
155458,irritability,0,0
155459,in,0,0
155460,autistic,0,0
155461,disorder,0,0
155462,",",0,0
155463,however,0,0
155464,there,0,0
155465,are,0,0
155466,no,0,0
155467,head-to-head,0,0
155468,data,0,0
155469,comparing,0,0
155470,these,0,0
155471,agents,0,0
155472,.,0,0
155473,This,0,0
155474,is,0,0
155475,the,0,0
155476,first,0,0
155477,prospective,0,0
155478,randomized,0,0
155479,clinical,0,0
155480,trial,0,0
155481,comparing,0,0
155482,the,0,0
155483,safety,0,0
155484,and,0,0
155485,efficacy,0,0
155486,of,0,0
155487,these,0,0
155488,two,0,0
155489,medications,0,0
155490,in,0,0
155491,patients,0,0
155492,with,0,0
155493,autism,0,0
155494,spectrum,0,0
155495,disorders,0,0
155496,.,0,0
155497,Fifty,0,0
155498,nine,0,0
155499,children,0,0
155500,and,0,0
155501,adolescents,0,0
155502,with,0,0
155503,autism,0,0
155504,spectrum,0,0
155505,disorders,0,0
155506,were,0,0
155507,randomized,0,0
155508,to,0,0
155509,receive,0,0
155510,either,0,1
155511,aripiprazole,1,1
155512,or,1,1
155513,risperidone,1,1
155514,for,0,0
155515,2,0,0
155516,months,0,0
155517,.,0,0
155518,The,0,0
155519,primary,0,0
155520,outcome,0,0
155521,measure,0,0
155522,was,0,0
155523,change,0,0
155524,in,0,0
155525,Aberrant,0,0
155526,Behavior,0,0
155527,Checklist,0,1
155528,(,0,1
155529,ABC,0,1
155530,),0,1
155531,scores,0,0
155532,.,0,0
155533,Adverse,0,0
155534,events,0,0
155535,were,0,0
155536,assessed,0,0
155537,.,0,0
155538,Aripiprazole,1,1
155539,as,0,0
155540,well,0,0
155541,as,0,0
155542,risperidone,0,1
155543,lowered,0,0
155544,ABC,0,0
155545,scores,0,0
155546,during,0,0
155547,2,0,0
155548,months,0,0
155549,.,0,0
155550,The,0,0
155551,rates,0,0
155552,of,0,0
155553,adverse,0,0
155554,effects,0,0
155555,were,0,0
155556,not,0,0
155557,significantly,0,0
155558,different,0,0
155559,between,0,0
155560,the,0,0
155561,two,0,0
155562,groups,0,0
155563,.,0,0
155564,The,0,0
155565,safety,0,0
155566,and,0,0
155567,efficacy,0,0
155568,of,0,0
155569,aripiprazole,0,1
155570,(,0,0
155571,mean,0,0
155572,dose,0,1
155573,5.5,0,0
155574,mg/day,0,1
155575,),0,1
155576,and,0,1
155577,risperidone,0,1
155578,(,0,1
155579,mean,0,0
155580,dose,0,1
155581,1.12,0,0
155582,mg/day,0,1
155583,),0,0
155584,were,0,0
155585,comparable,0,0
155586,.,0,0
155587,The,0,0
155588,choice,0,0
155589,between,0,0
155590,these,0,0
155591,two,0,0
155592,medications,0,0
155593,should,0,0
155594,be,0,0
155595,on,0,0
155596,the,0,0
155597,basis,0,0
155598,of,0,0
155599,clinical,0,0
155600,equipoise,0,0
155601,considering,0,0
155602,the,0,0
155603,patient,0,0
155604,'s,0,0
155605,preference,0,0
155606,and,0,0
155607,clinical,0,0
155608,profile,0,0
155609,.,0,0
155610,Patient,0,1
155611,satisfaction,0,0
155612,with,0,0
155613,nutrition,0,1
155614,services,0,1
155615,amongst,0,0
155616,cancer,0,0
155617,patients,0,0
155618,treated,0,0
155619,with,0,0
155620,autologous,0,1
155621,stem,0,1
155622,cell,0,0
155623,transplantation,0,1
155624,:,0,0
155625,a,0,0
155626,comparison,0,0
155627,of,0,0
155628,usual,1,1
155629,and,0,0
155630,extended,1,1
155631,care,1,1
155632,.,1,0
155633,BACKGROUND,0,0
155634,This,0,0
155635,study,0,0
155636,aimed,0,0
155637,to,0,0
155638,determine,0,0
155639,patient,0,0
155640,satisfaction,0,0
155641,with,0,0
155642,clinical,0,0
155643,nutrition,1,1
155644,services,1,1
155645,delivered,0,0
155646,by,0,0
155647,an,0,0
155648,accredited,0,0
155649,practicing,0,0
155650,dietitian,0,1
155651,amongst,0,0
155652,cancer,0,0
155653,patients,0,0
155654,treated,0,0
155655,with,0,0
155656,autologous,0,1
155657,stem,0,1
155658,cell,0,0
155659,transplantation,0,1
155660,that,0,0
155661,was,0,0
155662,provided,0,0
155663,with,0,0
155664,usual,1,1
155665,and,0,0
155666,extended,1,1
155667,care,1,1
155668,at,0,0
155669,100,0,0
155670,days,0,0
155671,post-transplantation,0,0
155672,.,0,0
155673,METHODS,0,0
155674,Patients,0,0
155675,were,0,0
155676,randomised,0,0
155677,to,0,0
155678,receive,1,0
155679,usual,1,1
155680,nutrition,1,1
155681,care,1,1
155682,or,1,1
155683,extended,1,1
155684,nutrition,1,1
155685,care,1,1
155686,during,0,0
155687,the,0,0
155688,course,0,0
155689,of,0,0
155690,their,0,0
155691,stem,0,1
155692,cell,0,0
155693,transplantation,0,0
155694,.,0,0
155695,After,0,0
155696,hospital,0,0
155697,discharge,0,1
155698,",",0,0
155699,usual,1,1
155700,care,1,1
155701,patients,1,0
155702,received,1,0
155703,no,1,0
155704,further,1,0
155705,nutrition,1,1
155706,support,1,0
155707,",",1,0
155708,whereas,1,0
155709,extended,1,1
155710,care,1,1
155711,patients,1,0
155712,received,1,0
155713,telephone,1,1
155714,dietary,1,1
155715,counselling,1,1
155716,from,1,0
155717,the,1,0
155718,same,1,0
155719,dietitian,1,0
155720,for,1,0
155721,up,1,0
155722,to,1,0
155723,100,1,0
155724,days,1,0
155725,post-transplantation,1,0
155726,.,1,0
155727,The,0,0
155728,patient,0,0
155729,satisfaction,0,0
155730,with,0,0
155731,clinical,0,0
155732,nutrition,0,1
155733,service,0,1
155734,questionnaire,0,0
155735,was,0,0
155736,completed,0,0
155737,anonymously,0,0
155738,at,0,0
155739,100,0,0
155740,days,0,0
155741,post-transplantation,0,0
155742,.,0,0
155743,Group,0,0
155744,comparisons,0,0
155745,were,0,0
155746,made,0,0
155747,using,0,0
155748,independent,0,0
155749,t-tests,0,0
155750,.,0,0
155751,RESULTS,0,0
155752,Thirty-seven,0,0
155753,patients,0,0
155754,consented,0,0
155755,to,0,0
155756,participate,0,0
155757,in,0,0
155758,the,0,0
155759,study,0,0
155760,(,0,0
155761,54,0,0
155762,%,0,0
155763,male,0,0
155764,;,0,0
155765,mean,0,0
155766,age,0,0
155767,58.7,0,0
155768,?,0,0
155769,9.5,0,0
155770,years,0,0
155771,;,0,0
155772,median,0,0
155773,body,0,0
155774,mass,0,0
155775,index,0,0
155776,26.8,0,0
155777,kg,0,1
155778,m,0,0
155779,(,0,1
155780,-2,0,0
155781,),0,0
155782,",",0,0
155783,range,0,0
155784,16.4-47.6,0,0
155785,kg,0,1
155786,m,0,0
155787,(,0,1
155788,-2,0,0
155789,),0,1
155790,),0,0
155791,;,0,0
155792,33,0,0
155793,patients,0,0
155794,completed,0,0
155795,the,0,0
155796,study,0,0
155797,and,0,0
155798,28,0,0
155799,patients,0,0
155800,returned,0,0
155801,the,0,0
155802,questionnaire,0,1
155803,(,0,1
155804,response,0,0
155805,rate,0,0
155806,=,0,0
155807,85,0,0
155808,%,0,0
155809,),0,0
155810,.,0,0
155811,All,0,0
155812,components,0,0
155813,of,0,0
155814,the,0,0
155815,questionnaire,0,0
155816,were,0,0
155817,rated,0,0
155818,highly,0,0
155819,by,0,0
155820,both,0,0
155821,groups,0,0
155822,;,0,0
155823,there,0,0
155824,was,0,0
155825,no,0,0
155826,significant,0,0
155827,difference,0,0
155828,between,0,0
155829,the,0,0
155830,groups,0,0
155831,(,0,0
155832,P,0,0
155833,>,0,0
155834,0.05,0,0
155835,),0,0
155836,.,0,0
155837,Although,0,0
155838,not,0,0
155839,statistically,0,0
155840,significant,0,0
155841,",",0,0
155842,extended,0,1
155843,care,0,1
155844,patients,0,0
155845,who,0,0
155846,received,0,0
155847,at,0,0
155848,least,0,0
155849,three,0,0
155850,telephone,0,1
155851,calls,0,0
155852,rated,0,0
155853,a,0,0
155854,higher,0,0
155855,overall,0,0
155856,satisfaction,0,0
155857,compared,0,0
155858,to,0,0
155859,those,0,0
155860,who,0,0
155861,received,0,0
155862,less,0,0
155863,calls,0,0
155864,;,0,0
155865,this,0,0
155866,difference,0,0
155867,was,0,0
155868,clinically,0,0
155869,important,0,0
155870,(,0,0
155871,score,0,0
155872,difference,0,0
155873,=,0,0
155874,0.56,0,0
155875,),0,0
155876,.,0,0
155877,CONCLUSIONS,0,0
155878,Cancer,0,0
155879,patients,0,0
155880,treated,0,0
155881,with,0,0
155882,autologous,0,1
155883,stem,0,1
155884,cell,0,0
155885,transplantation,0,1
155886,were,0,0
155887,satisfied,0,0
155888,with,1,0
155889,usual,1,1
155890,and,1,0
155891,extended,1,1
155892,nutrition,1,1
155893,care,1,1
155894,.,1,0
155895,Extended,1,0
155896,care,1,0
155897,patients,1,0
155898,who,0,0
155899,received,0,0
155900,at,0,0
155901,least,0,0
155902,three,0,0
155903,telephone,0,1
155904,calls,0,0
155905,after,0,0
155906,hospital,0,0
155907,discharge,0,0
155908,were,0,0
155909,more,0,0
155910,satisfied,0,0
155911,than,0,0
155912,those,0,0
155913,with,0,0
155914,less,0,0
155915,frequent,0,0
155916,intervention,0,1
155917,.,0,0
155918,Further,0,0
155919,exploration,0,0
155920,regarding,0,0
155921,the,0,0
155922,frequency,0,0
155923,and,0,0
155924,intensity,0,0
155925,of,0,0
155926,nutrition,0,1
155927,service,0,1
155928,is,0,0
155929,required,0,0
155930,.,0,0
155931,Arm-cranking,1,1
155932,exercise,1,1
155933,reduced,0,0
155934,oxidative,0,0
155935,damage,0,0
155936,in,0,0
155937,adults,0,0
155938,with,0,0
155939,chronic,0,0
155940,spinal,0,1
155941,cord,0,0
155942,injury,0,0
155943,.,0,0
155944,OBJECTIVE,0,0
155945,To,0,0
155946,assess,0,0
155947,the,0,0
155948,effect,0,0
155949,of,0,0
155950,a,0,0
155951,12-week,0,0
155952,arm-cranking,1,1
155953,exercise,1,1
155954,program,1,1
155955,on,0,0
155956,reducing,0,0
155957,oxidative,0,0
155958,damage,0,0
155959,in,0,0
155960,untrained,0,0
155961,adults,0,0
155962,with,0,0
155963,chronic,0,0
155964,spinal,0,1
155965,cord,0,1
155966,injury,0,0
155967,(,0,1
155968,SCI,0,1
155969,),0,0
155970,.,0,0
155971,DESIGN,0,0
155972,Randomized,0,0
155973,controlled,0,0
155974,trial,0,0
155975,.,0,0
155976,SETTING,0,0
155977,Community-based,0,0
155978,supervised,0,1
155979,intervention,0,1
155980,.,0,0
155981,PARTICIPANTS,0,0
155982,Male,0,0
155983,adults,0,0
155984,with,0,0
155985,complete,0,0
155986,SCI,0,1
155987,at,0,0
155988,or,0,0
155989,below,0,0
155990,the,0,0
155991,fifth,0,0
155992,thoracic,0,1
155993,level,0,0
155994,(,0,1
155995,T5,0,1
155996,),0,1
155997,(,0,1
155998,N=17,0,1
155999,),0,1
156000,volunteered,0,0
156001,for,0,0
156002,this,0,0
156003,study,0,0
156004,.,0,0
156005,Participants,0,0
156006,were,0,0
156007,randomly,0,0
156008,allocated,0,0
156009,to,0,0
156010,the,0,0
156011,intervention,0,1
156012,(,0,0
156013,n=9,0,0
156014,),0,1
156015,or,0,1
156016,control,1,1
156017,(,0,1
156018,n=8,0,1
156019,),0,1
156020,group,0,0
156021,using,0,0
156022,a,0,0
156023,concealed,0,0
156024,method,0,0
156025,.,0,0
156026,INTERVENTION,0,0
156027,A,0,0
156028,12-week,1,0
156029,arm-cranking,1,1
156030,exercise,1,1
156031,program,1,1
156032,",",0,0
156033,3,0,0
156034,sessions/wk,0,0
156035,",",0,0
156036,consisting,1,0
156037,of,1,0
156038,warming-up,1,1
156039,(,1,1
156040,10-15min,1,0
156041,),1,1
156042,followed,1,1
156043,by,1,0
156044,a,1,0
156045,main,1,0
156046,part,1,0
156047,in,1,0
156048,arm-crank,1,1
156049,(,0,0
156050,20-30min,0,1
156051,[,0,0
156052,increasing,0,0
156053,2min,0,1
156054,and,0,0
156055,30s,0,0
156056,every,0,1
156057,3wk,0,1
156058,],0,0
156059,),0,0
156060,at,0,0
156061,a,0,0
156062,moderate,0,0
156063,work,0,0
156064,intensity,0,0
156065,of,0,0
156066,50,0,0
156067,%,0,0
156068,to,0,0
156069,65,0,0
156070,%,0,0
156071,of,0,0
156072,the,0,0
156073,heart,0,0
156074,rate,0,0
156075,reserve,0,0
156076,(,0,0
156077,starting,0,0
156078,at,0,0
156079,50,0,1
156080,%,0,0
156081,and,0,0
156082,increasing,0,0
156083,5,0,1
156084,%,0,0
156085,every,0,0
156086,3,0,0
156087,weeks,0,0
156088,),0,0
156089,and,0,0
156090,by,0,0
156091,a,0,0
156092,cooling-down,1,1
156093,period,0,0
156094,(,0,1
156095,5-10min,0,0
156096,),0,0
156097,.,0,0
156098,MAIN,0,0
156099,OUTCOME,0,0
156100,MEASURES,0,0
156101,Plasmatic,0,0
156102,levels,0,0
156103,of,0,0
156104,total,0,0
156105,antioxidant,0,1
156106,status,0,0
156107,as,0,0
156108,well,0,0
156109,as,0,0
156110,erythrocyte,0,0
156111,glutathione,0,1
156112,peroxidase,0,1
156113,activity,0,0
156114,were,0,0
156115,measured,0,0
156116,.,0,0
156117,Lipid,0,0
156118,and,0,0
156119,protein,0,1
156120,oxidation,0,1
156121,were,0,0
156122,determined,0,0
156123,as,0,0
156124,malondialdehyde,0,0
156125,and,0,0
156126,carbonyl,0,1
156127,group,0,0
156128,levels,0,0
156129,",",0,0
156130,respectively,0,0
156131,.,0,0
156132,Furthermore,0,0
156133,",",0,0
156134,physical,0,1
156135,fitness,0,0
156136,and,0,0
156137,body,0,0
156138,composition,0,0
156139,were,0,0
156140,assessed,0,0
156141,.,0,0
156142,RESULTS,0,0
156143,When,0,0
156144,compared,0,0
156145,with,0,0
156146,baseline,0,0
156147,results,0,0
156148,",",0,0
156149,maximum,0,0
156150,oxygen,0,1
156151,consumption,0,0
156152,was,0,0
156153,significantly,0,0
156154,increased,0,0
156155,(,0,0
156156,P=.031,0,0
156157,),0,1
156158,",",0,0
156159,suggesting,0,0
156160,an,0,0
156161,improvement,0,0
156162,in,0,0
156163,physical,0,1
156164,fitness,0,0
156165,in,0,0
156166,the,0,0
156167,intervention,0,1
156168,group,0,0
156169,.,0,0
156170,Regarding,0,0
156171,the,0,0
156172,antioxidant,0,1
156173,defense,0,1
156174,system,0,0
156175,",",0,0
156176,it,0,0
156177,was,0,0
156178,found,0,0
156179,that,0,0
156180,both,0,0
156181,total,0,0
156182,antioxidant,0,1
156183,status,0,0
156184,(,0,1
156185,P=.014,0,1
156186,),0,1
156187,and,0,0
156188,erythrocyte,0,0
156189,glutathione,0,1
156190,peroxidase,0,1
156191,activity,0,0
156192,(,0,1
156193,P=.027,0,0
156194,),0,1
156195,were,0,0
156196,significantly,0,0
156197,increased,0,0
156198,at,0,0
156199,the,0,0
156200,end,0,0
156201,of,0,0
156202,the,0,0
156203,training,0,1
156204,program,0,1
156205,.,0,0
156206,As,0,0
156207,a,0,0
156208,consequence,0,0
156209,",",0,0
156210,plasmatic,0,0
156211,levels,0,0
156212,of,0,0
156213,malondialdehyde,0,0
156214,(,0,1
156215,P=.008,0,0
156216,),0,1
156217,and,0,0
156218,carbonyl,0,1
156219,groups,0,0
156220,(,0,0
156221,P=.022,0,0
156222,),0,1
156223,were,0,0
156224,significantly,0,0
156225,reduced,0,0
156226,.,0,0
156227,CONCLUSION,0,0
156228,A,0,0
156229,12-week,0,0
156230,arm-cranking,1,1
156231,exercise,1,1
156232,program,1,1
156233,improved,0,0
156234,the,0,0
156235,antioxidant,0,1
156236,defense,0,1
156237,system,0,0
156238,in,0,0
156239,adults,0,0
156240,with,0,0
156241,chronic,0,0
156242,SCI,0,1
156243,",",0,0
156244,which,0,0
156245,may,0,0
156246,finally,0,0
156247,attenuate,0,0
156248,both,0,0
156249,lipid,0,0
156250,and,0,0
156251,protein,0,1
156252,oxidation,0,1
156253,in,0,0
156254,this,0,0
156255,population,0,0
156256,.,0,0
156257,Perceptual,1,1
156258,learning,1,1
156259,of,1,0
156260,speech,1,1
156261,under,0,0
156262,optimal,0,0
156263,and,0,0
156264,adverse,0,0
156265,conditions,0,0
156266,.,0,0
156267,Humans,0,0
156268,have,0,0
156269,a,0,0
156270,remarkable,0,0
156271,ability,0,0
156272,to,0,0
156273,understand,0,0
156274,spoken,0,1
156275,language,0,1
156276,despite,0,0
156277,the,0,0
156278,large,0,0
156279,amount,0,0
156280,of,0,0
156281,variability,0,0
156282,in,0,0
156283,speech,0,1
156284,.,0,0
156285,Previous,0,0
156286,research,0,0
156287,has,0,0
156288,shown,0,0
156289,that,0,0
156290,listeners,0,0
156291,can,0,0
156292,use,0,0
156293,lexical,1,0
156294,information,1,0
156295,to,0,0
156296,guide,0,0
156297,their,0,0
156298,interpretation,0,0
156299,of,0,0
156300,atypical,0,0
156301,sounds,0,1
156302,in,0,0
156303,speech,0,1
156304,(,0,0
156305,Norris,0,0
156306,",",0,0
156307,McQueen,0,0
156308,",",0,0
156309,&,0,0
156310,Cutler,0,0
156311,",",0,0
156312,2003,0,0
156313,),0,0
156314,.,0,0
156315,This,0,0
156316,kind,0,0
156317,of,0,0
156318,lexically,1,1
156319,induced,1,0
156320,perceptual,1,0
156321,learning,1,1
156322,enables,0,0
156323,people,0,0
156324,to,0,0
156325,adjust,0,0
156326,to,0,0
156327,the,0,0
156328,variations,0,0
156329,in,0,0
156330,utterances,0,0
156331,due,0,0
156332,to,0,0
156333,talker-specific,0,0
156334,characteristics,0,0
156335,",",0,0
156336,such,0,0
156337,as,0,0
156338,individual,0,0
156339,identity,0,0
156340,and,0,0
156341,dialect,0,1
156342,.,0,0
156343,The,0,0
156344,current,0,0
156345,study,0,0
156346,investigated,0,0
156347,perceptual,1,0
156348,learning,1,1
156349,in,0,0
156350,two,0,0
156351,optimal,0,0
156352,conditions,0,0
156353,:,0,0
156354,conversational,1,1
156355,speech,1,1
156356,(,1,0
156357,Experiment,1,0
156358,1,0,1
156359,),0,0
156360,versus,0,1
156361,clear,1,1
156362,speech,1,1
156363,(,0,0
156364,Experiment,0,0
156365,2,0,0
156366,),0,0
156367,",",0,0
156368,and,0,0
156369,three,0,0
156370,adverse,0,0
156371,conditions,0,0
156372,:,0,0
156373,noise,1,0
156374,(,0,0
156375,Experiment,0,0
156376,3a,0,1
156377,),0,0
156378,versus,0,0
156379,two,1,0
156380,cognitive,1,0
156381,loads,1,0
156382,(,0,0
156383,Experiments,0,0
156384,4a,0,1
156385,and,0,0
156386,4b,0,1
156387,),0,0
156388,.,0,0
156389,Perceptual,1,0
156390,learning,1,0
156391,occurred,0,0
156392,in,0,0
156393,the,0,0
156394,two,0,0
156395,optimal,1,0
156396,conditions,1,0
156397,and,0,0
156398,in,0,0
156399,the,0,0
156400,two,0,0
156401,cognitive,1,0
156402,load,1,0
156403,conditions,1,0
156404,",",0,0
156405,but,0,0
156406,not,0,0
156407,in,0,0
156408,the,0,0
156409,noise,1,0
156410,condition,1,0
156411,.,1,0
156412,Furthermore,0,0
156413,",",0,0
156414,perceptual,1,0
156415,learning,1,1
156416,occurred,0,0
156417,only,0,0
156418,in,0,0
156419,the,0,0
156420,first,0,0
156421,of,0,0
156422,two,0,0
156423,sessions,0,1
156424,for,0,0
156425,each,0,0
156426,participant,0,0
156427,",",0,0
156428,and,0,0
156429,only,0,0
156430,for,0,0
156431,atypical,0,0
156432,/s/,0,1
156433,sounds,0,1
156434,and,0,0
156435,not,0,0
156436,for,0,0
156437,atypical,0,0
156438,/f/,0,0
156439,sounds,0,1
156440,.,0,0
156441,This,0,0
156442,pattern,0,0
156443,of,0,0
156444,learning,0,1
156445,and,0,0
156446,nonlearning,0,1
156447,reflects,0,0
156448,a,0,0
156449,balance,0,0
156450,between,0,0
156451,flexibility,0,0
156452,and,0,0
156453,stability,0,0
156454,that,0,0
156455,the,0,0
156456,speech,0,1
156457,system,0,0
156458,must,0,0
156459,have,0,0
156460,to,0,0
156461,deal,0,0
156462,with,0,0
156463,speech,0,1
156464,variability,0,0
156465,in,0,0
156466,the,0,0
156467,diverse,0,0
156468,conditions,0,0
156469,that,0,0
156470,speech,0,1
156471,is,0,0
156472,encountered,0,0
156473,.,0,0
156474,Intravenous,0,1
156475,adenosine,1,1
156476,activates,0,0
156477,diffuse,0,0
156478,nociceptive,0,0
156479,inhibitory,0,0
156480,controls,0,0
156481,in,0,0
156482,humans,0,0
156483,.,0,0
156484,Experimentally,0,0
156485,induced,0,0
156486,pain,0,0
156487,can,0,0
156488,be,0,0
156489,attenuated,0,0
156490,by,0,0
156491,concomitant,0,0
156492,heterotopic,0,0
156493,nociceptive,0,0
156494,stimuli,0,1
156495,(,0,1
156496,counterirritation,0,0
156497,),0,0
156498,.,0,0
156499,Animal,0,0
156500,data,0,0
156501,indicate,0,0
156502,that,0,0
156503,this,0,0
156504,stems,0,0
156505,from,0,0
156506,supraspinal,0,0
156507,diffuse,0,0
156508,noxious,0,0
156509,inhibitory,0,0
156510,controls,0,0
156511,(,0,0
156512,DNICs,0,1
156513,),0,1
156514,triggered,0,0
156515,by,0,0
156516,C,0,1
156517,and,0,0
156518,A?,0,1
156519,fibers,0,1
156520,.,0,0
156521,In,0,0
156522,humans,0,0
156523,",",0,0
156524,only,0,0
156525,noxious,0,0
156526,stimuli,0,1
156527,induce,0,0
156528,counterirritation,0,0
156529,.,0,0
156530,This,0,0
156531,points,0,0
156532,at,0,0
156533,C,0,0
156534,fibers,0,1
156535,",",0,0
156536,but,0,0
156537,the,0,0
156538,effects,0,0
156539,of,0,0
156540,pharmacologically,0,0
156541,stimulating,0,0
156542,C,0,1
156543,fibers,0,1
156544,have,0,0
156545,not,0,0
156546,been,0,0
156547,studied,0,0
156548,.,0,0
156549,Intravenous,0,0
156550,adenosine,0,1
156551,activates,0,0
156552,pulmonary,0,0
156553,C,0,0
156554,fibers,0,1
156555,and,0,0
156556,induces,0,0
156557,dyspnea,0,0
156558,.,0,0
156559,This,0,0
156560,study,0,0
156561,tests,0,0
156562,the,0,0
156563,hypothesis,0,0
156564,that,0,0
156565,putative,0,0
156566,activation,0,0
156567,of,0,0
156568,pulmonary,0,0
156569,C,0,1
156570,fibers,0,1
156571,by,1,0
156572,adenosine,1,0
156573,would,0,0
156574,trigger,0,0
156575,DNICs,0,0
156576,in,0,0
156577,humans,0,0
156578,and,0,0
156579,induce,0,0
156580,counterirritation,0,0
156581,.,0,0
156582,Twelve,0,0
156583,healthy,0,0
156584,volunteers,0,0
156585,were,0,0
156586,included,0,0
156587,(,0,0
156588,with,0,0
156589,valid,0,0
156590,results,0,0
156591,available,0,0
156592,in,0,0
156593,9,0,0
156594,),0,0
156595,and,0,0
156596,studied,0,0
156597,according,0,0
156598,to,0,0
156599,a,0,0
156600,double-blind,0,0
156601,",",0,0
156602,randomized,0,0
156603,",",0,0
156604,cross-over,0,0
156605,design,0,0
156606,(,0,1
156607,intravenous,1,1
156608,adenosine,1,1
156609,",",1,0
156610,140,1,0
156611,?g?kg,1,1
156612,(,1,1
156613,-1,1,0
156614,),1,1
156615,?min,1,1
156616,(,1,1
156617,-1,1,0
156618,),1,0
156619,",",1,0
156620,during,1,0
156621,5,1,0
156622,min,1,0
156623,vs.,1,0
156624,placebo,1,1
156625,),1,0
156626,.,1,0
156627,We,1,0
156628,measured,0,0
156629,ventilatory,0,1
156630,variables,0,0
156631,and,0,0
156632,end-tidal,0,1
156633,CO2,0,1
156634,tension,0,1
156635,",",0,0
156636,dyspnea,0,0
156637,intensity,0,0
156638,by,0,0
156639,visual,0,0
156640,analog,0,1
156641,scale,0,0
156642,",",0,0
156643,and,0,0
156644,the,0,0
156645,intensity,0,0
156646,of,0,0
156647,putative,0,0
156648,chest,0,1
156649,pain,0,0
156650,.,0,0
156651,The,0,0
156652,primary,0,0
156653,outcome,0,0
156654,was,0,0
156655,the,0,0
156656,amplitude,0,0
156657,of,0,0
156658,the,0,0
156659,RIII,0,1
156660,component,0,0
156661,of,0,0
156662,the,0,0
156663,nociceptive,0,0
156664,flexor,0,1
156665,reflex,0,0
156666,recorded,0,0
156667,by,0,0
156668,biceps,0,0
156669,femoris,0,0
156670,electromyogram,0,0
156671,in,0,0
156672,response,0,0
156673,to,0,0
156674,painful,0,0
156675,electrical,0,1
156676,sural,0,1
156677,nerve,0,1
156678,stimulation,0,1
156679,(,0,1
156680,RIII,0,1
156681,),0,0
156682,",",0,0
156683,taken,0,0
156684,as,0,0
156685,a,0,0
156686,substitute,0,0
156687,for,0,0
156688,pain,0,0
156689,perception,1,0
156690,.,1,0
156691,Placebo,1,0
156692,did,1,0
156693,not,0,0
156694,induce,0,0
156695,any,0,0
156696,significant,0,0
156697,effect,1,0
156698,.,1,0
156699,Adenosine,1,1
156700,induced,1,0
156701,dyspnea,0,0
156702,",",0,0
156703,hyperpnea,0,1
156704,",",0,0
156705,tachycardia,0,0
156706,",",0,0
156707,and,0,0
156708,significant,0,0
156709,RIII,0,1
156710,inhibition,0,0
156711,(,0,0
156712,24,0,0
156713,?,0,0
156714,8,0,0
156715,%,0,0
156716,at,0,0
156717,the,0,0
156718,4th,0,0
156719,min,0,0
156720,",",0,0
156721,P,0,0
156722,<,0,0
156723,0.0001,0,0
156724,),0,0
156725,.,0,0
156726,The,0,0
156727,temporal,0,0
156728,dynamics,0,0
156729,of,0,0
156730,adenosine-induced,0,0
156731,dyspnea,0,0
156732,and,0,0
156733,RIII,0,1
156734,inhibition,0,1
156735,differed,0,0
156736,(,0,0
156737,immediate,0,1
156738,onset,0,0
156739,followed,0,1
156740,by,0,0
156741,a,0,0
156742,slow,0,0
156743,decrease,0,0
156744,for,0,0
156745,dyspnea,0,0
156746,",",0,0
156747,slower,0,0
156748,onset,0,0
156749,for,0,0
156750,RIII,0,1
156751,inhibition,0,0
156752,),0,0
156753,.,0,0
156754,Intravenous,1,1
156755,adenosine,1,0
156756,in,1,0
156757,normal,1,0
156758,humans,0,0
156759,induces,0,0
156760,counterirritation,0,0
156761,",",0,0
156762,fueling,0,0
156763,the,0,0
156764,notion,0,0
156765,that,0,0
156766,C-fiber,0,1
156767,stimulation,0,1
156768,trigger,0,0
156769,DNICs,0,1
156770,in,0,0
156771,humans,0,0
156772,.,0,0
156773,The,0,0
156774,temporal,0,0
156775,dissociation,0,0
156776,between,0,0
156777,adenosine-induced,0,0
156778,dyspnea,0,0
156779,and,0,0
156780,RIII,0,1
156781,inhibition,0,1
156782,suggests,0,0
156783,that,0,0
156784,C,0,0
156785,fibers,0,1
156786,other,0,0
156787,than,0,0
156788,pulmonary,0,0
156789,ones,0,0
156790,might,0,0
156791,be,0,0
156792,involved,0,0
156793,.,0,0
156794,A,0,0
156795,cognitive-behavioral,1,1
156796,intervention,1,1
156797,for,0,0
156798,emotion,0,0
156799,regulation,0,0
156800,in,0,0
156801,adults,0,0
156802,with,0,0
156803,high-functioning,0,0
156804,autism,0,0
156805,spectrum,0,0
156806,disorders,0,0
156807,:,0,0
156808,study,0,0
156809,protocol,0,1
156810,for,0,0
156811,a,0,0
156812,randomized,0,0
156813,controlled,0,0
156814,trial,0,0
156815,.,0,0
156816,BACKGROUND,0,0
156817,Adults,0,0
156818,with,0,0
156819,high-functioning,0,0
156820,autism,0,0
156821,spectrum,0,0
156822,disorders,0,0
156823,(,0,0
156824,ASD,0,0
156825,),0,1
156826,have,0,0
156827,difficulties,0,0
156828,in,0,0
156829,social,0,0
156830,communication,0,1
156831,;,0,0
156832,thus,0,0
156833,",",0,0
156834,these,0,0
156835,individuals,0,0
156836,have,0,0
156837,trouble,0,0
156838,understanding,0,0
156839,the,0,0
156840,mental,0,0
156841,states,0,0
156842,of,0,0
156843,others,0,0
156844,.,0,0
156845,Recent,0,0
156846,research,0,0
156847,also,0,0
156848,suggests,0,0
156849,that,0,0
156850,adults,0,0
156851,with,0,0
156852,ASD,0,0
156853,are,0,0
156854,unable,0,0
156855,to,0,0
156856,understand,0,0
156857,their,0,0
156858,own,0,0
156859,mental,0,0
156860,states,0,0
156861,",",0,0
156862,which,0,0
156863,could,0,0
156864,lead,0,0
156865,to,0,0
156866,difficulties,0,0
156867,in,0,0
156868,emotion-regulation,0,0
156869,.,0,0
156870,Some,0,0
156871,studies,0,0
156872,have,0,0
156873,reported,0,0
156874,the,0,0
156875,efficacy,0,0
156876,of,0,0
156877,cognitive-behavioral,1,1
156878,therapy,1,1
156879,(,1,1
156880,CBT,1,1
156881,),1,1
156882,in,0,0
156883,improving,0,0
156884,emotion-regulation,0,0
156885,among,0,0
156886,children,0,0
156887,with,0,0
156888,ASD,0,0
156889,.,0,0
156890,The,0,0
156891,current,0,0
156892,study,0,0
156893,will,0,0
156894,investigate,0,0
156895,the,0,0
156896,efficacy,0,0
156897,of,0,0
156898,group-based,0,1
156899,CBT,0,1
156900,for,0,0
156901,adults,0,0
156902,with,0,0
156903,ASD,0,0
156904,.,0,0
156905,METHODS/DESIGN,0,0
156906,The,0,0
156907,study,0,0
156908,is,0,0
156909,a,0,0
156910,randomized,0,0
156911,",",0,0
156912,waitlist,0,0
156913,controlled,0,0
156914,",",0,0
156915,single-blinded,0,0
156916,trial,0,0
156917,.,0,0
156918,The,0,0
156919,participants,0,0
156920,will,0,0
156921,be,0,0
156922,60,0,0
156923,adults,0,0
156924,with,0,0
156925,ASD,0,0
156926,;,0,0
156927,30,0,0
156928,will,0,0
156929,be,0,0
156930,assigned,0,0
156931,to,0,0
156932,a,0,0
156933,CBT,1,1
156934,group,0,0
156935,and,0,0
156936,30,0,0
156937,to,0,0
156938,a,0,0
156939,waitlist,1,0
156940,control,1,1
156941,group,1,0
156942,.,1,0
156943,Primary,0,0
156944,outcome,0,0
156945,measures,0,0
156946,are,0,0
156947,the,0,0
156948,20-item,0,0
156949,Toronto,0,0
156950,Alexithymia,0,0
156951,Scale,0,0
156952,",",0,0
156953,the,0,0
156954,Coping,0,0
156955,Inventory,0,0
156956,for,0,0
156957,Stressful,0,0
156958,Situations,0,0
156959,",",0,0
156960,the,0,0
156961,Motion,0,0
156962,Picture,0,1
156963,Mind-Reading,0,0
156964,task,0,1
156965,",",0,0
156966,and,0,0
156967,an,0,0
156968,ASD,0,0
156969,questionnaire,0,0
156970,.,0,0
156971,The,0,0
156972,secondary,0,0
156973,outcome,0,0
156974,measures,0,0
156975,are,0,0
156976,the,0,0
156977,Center,0,0
156978,for,0,0
156979,Epidemiological,0,0
156980,Studies,0,0
156981,Depression,0,0
156982,Scale,0,0
156983,",",0,0
156984,the,0,0
156985,World,0,1
156986,Health,0,1
156987,Organization,0,1
156988,Quality,0,0
156989,of,0,0
156990,Life,0,0
156991,Scale,0,1
156992,26-item,0,1
156993,version,0,0
156994,",",0,0
156995,the,0,0
156996,Global,0,0
156997,Assessment,0,1
156998,of,0,0
156999,Functioning,0,0
157000,",",0,0
157001,State-trait,0,0
157002,Anxiety,0,0
157003,Inventory,0,0
157004,",",0,0
157005,Social,0,0
157006,Phobia,0,0
157007,and,0,0
157008,Anxiety,0,0
157009,Inventory,0,1
157010,",",0,0
157011,and,0,0
157012,Liebowitz,0,0
157013,Social,0,1
157014,Anxiety,0,0
157015,Scale,0,0
157016,.,0,0
157017,All,0,0
157018,will,0,0
157019,be,0,0
157020,administered,0,0
157021,during,0,0
157022,the,0,0
157023,pre-,0,0
157024,and,0,0
157025,post-intervention,0,0
157026,",",0,0
157027,and,0,0
157028,12,0,0
157029,week,0,0
157030,follow-up,0,0
157031,periods,0,0
157032,.,0,0
157033,The,0,0
157034,CBT,0,1
157035,group,0,0
157036,will,0,0
157037,receive,0,1
157038,group,0,0
157039,therapy,0,1
157040,over,0,0
157041,an,0,0
157042,8,0,0
157043,week,0,0
157044,period,0,0
157045,(,0,0
157046,one,0,0
157047,session,0,1
157048,per,0,1
157049,week,0,0
157050,),0,0
157051,with,0,0
157052,each,0,0
157053,session,0,1
157054,lasting,0,0
157055,approximately,0,0
157056,100,0,0
157057,minutes,0,0
157058,.,0,0
157059,Group,0,0
157060,therapy,0,1
157061,will,0,0
157062,consist,0,0
157063,of,0,0
157064,four,0,0
157065,or,0,0
157066,five,0,0
157067,adults,0,0
157068,with,0,0
157069,ASD,0,0
157070,and,0,0
157071,two,0,0
157072,psychologists,0,0
157073,.,0,0
157074,We,0,0
157075,will,0,0
157076,be,0,0
157077,using,0,0
157078,visual,0,0
157079,materials,0,1
157080,for,0,0
157081,this,0,0
157082,program,0,1
157083,",",0,0
157084,mainly,0,0
157085,the,0,0
157086,Cognitive,0,1
157087,Affective,0,1
157088,Training,0,1
157089,kit,0,1
157090,.,0,0
157091,DISCUSSION,0,0
157092,This,0,0
157093,trial,0,0
157094,will,0,0
157095,hopefully,0,0
157096,indicate,0,0
157097,the,0,0
157098,efficacy,0,0
157099,of,0,0
157100,group-based,0,1
157101,CBT,0,1
157102,for,0,0
157103,adults,0,0
157104,with,0,0
157105,high-,0,1
157106,functioning,0,0
157107,ASD,0,0
157108,.,0,0
157109,TRIAL,0,0
157110,REGISTRATION,0,0
157111,This,0,0
157112,trial,0,0
157113,was,0,0
157114,registered,0,0
157115,in,0,0
157116,The,0,0
157117,University,0,0
157118,Hospital,0,0
157119,Medical,0,1
157120,Information,0,1
157121,Network,0,0
157122,Clinical,0,0
157123,Trials,0,1
157124,Registry,0,0
157125,No,0,0
157126,.,0,0
157127,UMIN000006236,0,0
157128,.,0,0
157129,Randomised,0,1
157130,trial,0,0
157131,comparing,0,0
157132,the,0,0
157133,recording,0,1
157134,ability,0,0
157135,of,0,0
157136,a,0,0
157137,novel,1,0
157138,",",1,0
157139,electronic,1,1
157140,emergency,1,1
157141,documentation,1,0
157142,system,1,0
157143,with,0,0
157144,the,0,0
157145,AHA,1,1
157146,paper,1,0
157147,cardiac,1,0
157148,arrest,1,0
157149,record,1,0
157150,.,1,0
157151,OBJECTIVE,0,0
157152,To,0,0
157153,evaluate,0,0
157154,the,0,0
157155,ability,0,0
157156,of,0,0
157157,an,0,0
157158,electronic,1,1
157159,system,1,0
157160,created,0,0
157161,at,0,0
157162,the,0,0
157163,University,0,0
157164,of,0,0
157165,Washington,0,0
157166,to,0,0
157167,accurately,0,0
157168,document,0,0
157169,prerecorded,0,0
157170,VF,0,0
157171,and,0,0
157172,pulseless,0,1
157173,electrical,0,1
157174,activity,0,0
157175,(,0,1
157176,PEA,0,1
157177,),0,1
157178,cardiac,0,0
157179,arrest,0,0
157180,scenarios,0,0
157181,compared,0,0
157182,with,0,0
157183,the,0,0
157184,American,0,0
157185,Heart,0,1
157186,Association,0,0
157187,paper,0,0
157188,cardiac,0,0
157189,arrest,0,0
157190,record,0,0
157191,.,0,0
157192,METHODS,0,0
157193,16,0,0
157194,anaesthesiology,0,0
157195,residents,0,0
157196,were,0,0
157197,randomly,0,0
157198,assigned,0,0
157199,to,0,0
157200,view,0,0
157201,one,0,0
157202,of,0,0
157203,two,0,0
157204,prerecorded,0,0
157205,",",0,0
157206,simulated,1,1
157207,VF,1,0
157208,and,1,0
157209,PEA,1,1
157210,scenarios,1,1
157211,and,0,0
157212,asked,0,0
157213,to,0,0
157214,document,0,0
157215,the,0,0
157216,event,0,0
157217,with,0,0
157218,either,0,0
157219,the,0,0
157220,paper,1,0
157221,or,1,1
157222,electronic,1,1
157223,system,1,0
157224,.,1,0
157225,Each,0,0
157226,subject,0,0
157227,then,0,0
157228,repeated,0,0
157229,the,0,0
157230,process,0,0
157231,with,0,0
157232,the,0,0
157233,other,0,0
157234,video,0,1
157235,and,0,0
157236,documentation,0,0
157237,method,0,1
157238,.,0,0
157239,Five,0,0
157240,types,0,0
157241,of,0,0
157242,documentation,0,0
157243,errors,0,0
157244,were,0,0
157245,defined,0,0
157246,:,0,0
157247,(,0,0
157248,1,0,0
157249,),0,0
157250,omission,0,0
157251,",",0,0
157252,(,0,0
157253,2,0,0
157254,),0,0
157255,specification,0,0
157256,",",0,0
157257,(,0,0
157258,3,0,0
157259,),0,0
157260,timing,0,0
157261,",",0,0
157262,(,0,0
157263,4,0,1
157264,),0,1
157265,commission,0,1
157266,and,0,1
157267,(,0,1
157268,5,0,1
157269,),0,0
157270,noise,0,0
157271,.,0,0
157272,The,0,0
157273,mean,0,0
157274,difference,0,0
157275,in,0,0
157276,errors,0,0
157277,between,0,0
157278,the,0,0
157279,paper,1,0
157280,and,0,0
157281,electronic,1,1
157282,methods,1,0
157283,was,0,0
157284,analysed,0,0
157285,using,0,0
157286,a,0,0
157287,single,0,1
157288,factor,0,0
157289,repeated,0,0
157290,measures,0,0
157291,ANOVA,0,1
157292,model,0,0
157293,.,0,0
157294,RESULTS,0,0
157295,Compared,0,0
157296,with,0,0
157297,paper,0,0
157298,records,0,0
157299,",",0,0
157300,the,0,0
157301,electronic,0,1
157302,system,0,0
157303,omitted,0,0
157304,6.3,0,0
157305,fewer,0,0
157306,events,0,0
157307,(,0,0
157308,95,0,0
157309,%,0,0
157310,CI,0,0
157311,-10.1,0,0
157312,to,0,0
157313,-2.5,0,0
157314,",",0,0
157315,p=0.003,0,0
157316,),0,0
157317,",",0,0
157318,which,0,0
157319,represents,0,0
157320,a,0,0
157321,28,0,0
157322,%,0,0
157323,reduction,0,0
157324,in,0,0
157325,omission,0,0
157326,errors,0,0
157327,.,0,0
157328,Users,0,0
157329,recorded,0,0
157330,2.9,0,0
157331,fewer,0,0
157332,noise,0,0
157333,items,0,1
157334,(,0,0
157335,95,0,0
157336,%,0,0
157337,CI,0,0
157338,-5.3,0,0
157339,to,0,0
157340,-0.6,0,0
157341,",",0,0
157342,p=0.003,0,0
157343,),0,0
157344,when,0,0
157345,compared,0,0
157346,with,0,0
157347,paper,1,0
157348,",",0,0
157349,representing,0,0
157350,a,0,0
157351,36,0,0
157352,%,0,0
157353,decrease,0,0
157354,in,0,0
157355,redundant,0,0
157356,or,0,1
157357,irrelevant,0,0
157358,information,0,0
157359,.,0,0
157360,The,0,0
157361,rate,0,0
157362,of,0,0
157363,timing,0,0
157364,(,0,0
157365,?=-3.2,0,0
157366,",",0,0
157367,95,0,0
157368,%,0,0
157369,CI,0,0
157370,-9.3,0,0
157371,to,0,0
157372,3.0,0,0
157373,",",0,0
157374,p=0.286,0,0
157375,),0,1
157376,and,0,1
157377,commission,0,1
157378,(,0,1
157379,?=-4.4,0,0
157380,",",0,0
157381,95,0,0
157382,%,0,0
157383,CI,0,0
157384,-9.4,0,0
157385,to,0,0
157386,0.5,0,0
157387,",",0,0
157388,p=0.075,0,0
157389,),0,0
157390,errors,0,0
157391,were,0,0
157392,similar,0,0
157393,between,0,0
157394,the,1,0
157395,electronic,1,1
157396,system,1,1
157397,and,1,0
157398,paper,1,0
157399,",",1,0
157400,while,0,0
157401,the,0,0
157402,rate,0,0
157403,of,0,0
157404,specification,0,0
157405,errors,0,0
157406,were,0,0
157407,about,0,0
157408,a,0,0
157409,third,0,0
157410,lower,0,0
157411,for,0,0
157412,the,0,0
157413,electronic,0,1
157414,system,0,0
157415,when,0,0
157416,compared,0,0
157417,with,0,0
157418,the,0,0
157419,paper,0,0
157420,record,0,1
157421,(,0,0
157422,?=-3.2,0,0
157423,",",0,0
157424,95,0,0
157425,%,0,0
157426,CI,0,0
157427,-6.3,0,0
157428,to,0,0
157429,-0.2,0,0
157430,",",0,0
157431,p=0.037,0,0
157432,),0,0
157433,.,0,0
157434,CONCLUSIONS,0,0
157435,Compared,0,0
157436,with,1,0
157437,paper,1,0
157438,documentation,1,0
157439,",",1,0
157440,documentation,1,0
157441,with,1,0
157442,the,1,0
157443,electronic,1,1
157444,system,1,0
157445,captured,1,0
157446,24,0,0
157447,%,0,0
157448,more,0,0
157449,critical,0,0
157450,information,0,0
157451,during,0,0
157452,a,0,0
157453,simulated,0,1
157454,medical,0,0
157455,emergency,0,1
157456,without,0,1
157457,loss,0,0
157458,in,0,0
157459,data,0,0
157460,quality,0,0
157461,.,0,0
157462,A,0,0
157463,randomized,0,0
157464,controlled,0,0
157465,trial,0,0
157466,to,0,0
157467,improve,0,0
157468,colon,1,0
157469,cancer,1,0
157470,screening,1,1
157471,in,0,0
157472,rural,0,0
157473,family,0,1
157474,medicine,0,1
157475,:,0,0
157476,an,0,0
157477,Iowa,0,1
157478,Research,0,0
157479,Network,0,1
157480,(,0,1
157481,IRENE,0,1
157482,),0,1
157483,study,0,0
157484,.,0,0
157485,BACKGROUND,0,0
157486,Many,0,0
157487,adults,0,0
157488,have,0,0
157489,not,0,0
157490,been,0,0
157491,screened,0,0
157492,for,0,0
157493,colon,0,0
157494,cancer,0,0
157495,",",0,0
157496,a,0,0
157497,potentially,0,0
157498,preventable,0,0
157499,cause,0,0
157500,of,0,0
157501,death,0,0
157502,.,0,0
157503,METHODS,0,0
157504,This,0,0
157505,was,0,0
157506,a,0,0
157507,randomized,0,0
157508,controlled,0,0
157509,trial,0,0
157510,conducted,0,0
157511,between,0,0
157512,December,0,0
157513,2008,0,0
157514,and,0,0
157515,April,0,1
157516,2011,0,0
157517,to,0,0
157518,improve,0,0
157519,CRC,0,1
157520,screening,0,0
157521,in,0,0
157522,16,0,0
157523,rural,0,0
157524,family,0,1
157525,physician,0,1
157526,offices,0,0
157527,.,0,0
157528,Subjects,0,0
157529,due,0,0
157530,for,0,0
157531,CRC,1,1
157532,screening,1,0
157533,were,0,0
157534,randomized,0,0
157535,within,0,0
157536,each,0,0
157537,practice,0,0
157538,to,0,0
157539,1,0,0
157540,of,0,0
157541,4,0,0
157542,groups,0,0
157543,:,0,0
157544,(,0,0
157545,1,0,0
157546,),0,0
157547,usual,1,1
157548,care,1,1
157549,;,1,0
157550,(,1,0
157551,2,1,0
157552,),1,0
157553,physician,1,1
157554,chart,1,1
157555,reminder,1,1
157556,;,1,0
157557,(,1,0
157558,3,1,0
157559,),1,0
157560,physician,1,1
157561,chart,1,1
157562,reminder,1,1
157563,",",1,0
157564,mailed,1,0
157565,education,1,1
157566,",",1,0
157567,CRC,1,1
157568,reminder,1,1
157569,magnet,1,1
157570,",",1,0
157571,and,1,0
157572,fecal,1,0
157573,immunochemical,1,1
157574,test,1,1
157575,(,1,1
157576,FIT,1,1
157577,),1,1
157578,(,1,0
157579,mailed,1,1
157580,education/FIT,1,1
157581,),1,1
157582,;,1,1
157583,or,1,1
157584,(,1,0
157585,4,1,1
157586,),1,0
157587,all,1,0
157588,the,1,0
157589,preceding,1,0
157590,plus,1,1
157591,a,1,0
157592,structured,1,1
157593,telephone,1,1
157594,call,1,0
157595,to,1,0
157596,the,1,0
157597,patient,1,0
157598,from,1,0
157599,project,1,0
157600,staff,1,0
157601,to,1,0
157602,provide,1,0
157603,education,1,1
157604,",",1,0
157605,assess,1,0
157606,interest,1,0
157607,in,1,0
157608,screening,1,0
157609,",",1,0
157610,explain,1,0
157611,the,1,0
157612,screening,1,0
157613,tests,1,0
157614,",",1,0
157615,and,1,0
157616,address,1,0
157617,barriers,1,0
157618,(,0,0
157619,mailed,0,0
157620,education/FIT,0,1
157621,plus,0,1
157622,phone,0,1
157623,call,0,0
157624,),0,0
157625,.,0,0
157626,The,0,0
157627,main,0,0
157628,outcome,0,0
157629,was,0,0
157630,completion,0,0
157631,of,0,0
157632,any,0,0
157633,CRC,1,1
157634,screening,1,0
157635,.,1,0
157636,RESULTS,0,0
157637,This,0,0
157638,study,0,0
157639,enrolled,0,0
157640,743,0,0
157641,patients,0,0
157642,.,0,0
157643,CRC,1,1
157644,screening,1,0
157645,was,0,0
157646,completed,0,0
157647,by,0,0
157648,17.8,0,0
157649,%,0,0
157650,in,0,0
157651,the,0,0
157652,usual,0,1
157653,care,0,1
157654,group,0,0
157655,",",0,0
157656,20.5,0,0
157657,%,0,0
157658,in,0,0
157659,the,0,0
157660,chart,0,1
157661,reminder,0,1
157662,group,0,0
157663,",",0,0
157664,56.5,0,0
157665,%,0,0
157666,in,0,0
157667,the,0,0
157668,mailed,0,0
157669,education/FIT,0,0
157670,group,0,0
157671,",",0,0
157672,and,0,0
157673,57.2,0,0
157674,%,0,0
157675,in,0,0
157676,the,0,0
157677,mailed,0,0
157678,education/FIT,0,0
157679,plus,0,1
157680,phone,0,1
157681,call,0,0
157682,group,0,0
157683,.,0,0
157684,We,0,0
157685,found,0,0
157686,no,0,0
157687,effect,0,0
157688,from,0,0
157689,the,0,0
157690,chart,0,1
157691,reminder,0,1
157692,compared,0,0
157693,with,0,0
157694,usual,0,1
157695,care,0,1
157696,(,0,0
157697,odds,0,0
157698,ratio,0,0
157699,[,0,0
157700,OR,0,0
157701,],0,0
157702,",",0,0
157703,1.2,0,0
157704,;,0,0
157705,95,0,0
157706,%,0,0
157707,confidence,0,0
157708,interval,0,0
157709,[,0,0
157710,CI,0,0
157711,],0,0
157712,",",0,0
157713,0.7-2.0,0,0
157714,),0,1
157715,;,0,0
157716,and,0,0
157717,a,0,0
157718,beneficial,0,0
157719,effect,0,0
157720,from,0,0
157721,the,0,0
157722,mailed,0,1
157723,education/FIT,0,0
157724,(,0,0
157725,OR,0,0
157726,",",0,0
157727,6.0,0,0
157728,;,0,0
157729,95,0,0
157730,%,0,0
157731,CI,0,0
157732,",",0,0
157733,3.7-9.6,0,0
157734,),0,0
157735,and,0,0
157736,the,0,0
157737,mailed,0,1
157738,education/FIT,0,0
157739,plus,0,1
157740,phone,0,1
157741,call,0,0
157742,(,0,0
157743,OR,0,0
157744,",",0,0
157745,6.2,0,0
157746,;,0,0
157747,95,0,0
157748,%,0,0
157749,CI,0,0
157750,",",0,0
157751,3.8-9.9,0,0
157752,),0,0
157753,.,0,0
157754,Both,0,1
157755,FIT,0,0
157756,and,0,0
157757,colonoscopy,0,1
157758,rates,0,0
157759,increased,0,0
157760,significantly,0,0
157761,in,0,0
157762,both,0,0
157763,mailed,0,0
157764,education,0,1
157765,groups,0,0
157766,.,0,0
157767,CONCLUSION,0,0
157768,CRC,0,1
157769,screening,0,0
157770,rates,0,0
157771,increased,0,0
157772,significantly,0,0
157773,among,0,0
157774,patients,0,0
157775,who,0,0
157776,were,0,0
157777,overdue,0,0
157778,for,0,0
157779,screening,0,0
157780,after,0,0
157781,they,0,0
157782,received,0,0
157783,mailed,0,0
157784,educational,0,1
157785,materials,0,1
157786,and,0,0
157787,a,0,0
157788,FIT,0,0
157789,.,0,0
157790,The,0,0
157791,addition,0,0
157792,of,0,0
157793,a,0,0
157794,phone,0,1
157795,call,0,0
157796,did,0,0
157797,not,0,0
157798,further,0,0
157799,increase,0,0
157800,screening,0,0
157801,rates,0,0
157802,.,0,0
157803,Intravesical,1,1
157804,seeding,1,0
157805,of,1,0
157806,upper,1,0
157807,urinary,1,0
157808,tract,1,0
157809,urothelial,1,0
157810,carcinoma,1,0
157811,cells,1,0
157812,during,0,0
157813,nephroureterectomy,1,1
157814,:,1,0
157815,an,0,0
157816,exploratory,0,0
157817,analysis,0,0
157818,from,0,0
157819,the,0,0
157820,THPMG,0,0
157821,trial,0,0
157822,.,0,0
157823,OBJECTIVE,0,0
157824,The,0,0
157825,Pirarubicin,0,1
157826,Monotherapy,0,1
157827,Study,0,0
157828,Group,0,0
157829,trial,0,0
157830,was,0,0
157831,a,0,0
157832,randomized,0,0
157833,Phase,0,1
157834,II,0,1
157835,study,0,0
157836,that,0,0
157837,evaluated,0,0
157838,the,0,0
157839,efficacy,0,0
157840,of,0,0
157841,intravesical,0,1
157842,instillation,0,1
157843,of,0,0
157844,pirarubicin,1,1
157845,in,0,0
157846,the,0,0
157847,prevention,0,0
157848,of,0,0
157849,bladder,0,0
157850,recurrence,0,0
157851,after,0,0
157852,nephroureterectomy,0,1
157853,for,0,0
157854,upper,0,0
157855,urinary,0,0
157856,tract,0,0
157857,urothelial,0,0
157858,carcinoma,0,0
157859,.,0,0
157860,This,0,0
157861,study,0,0
157862,conducted,0,0
157863,further,0,0
157864,analysis,0,0
157865,of,0,0
157866,the,0,0
157867,Pirarubicin,0,1
157868,Monotherapy,0,1
157869,Study,0,0
157870,Group,0,0
157871,cohort,0,0
157872,",",0,0
157873,focusing,0,0
157874,on,0,0
157875,intravesical,1,1
157876,seeding,1,0
157877,of,1,0
157878,cancer,1,0
157879,cells,1,0
157880,.,1,0
157881,METHODS,0,0
157882,Using,0,0
157883,the,0,0
157884,data,0,0
157885,from,0,0
157886,the,0,0
157887,Pirarubicin,0,1
157888,Monotherapy,0,1
157889,Study,0,0
157890,Group,0,0
157891,trial,0,0
157892,",",0,0
157893,bladder,0,0
157894,recurrence-free,0,0
157895,survival,0,0
157896,rates,0,0
157897,and,0,0
157898,factors,0,0
157899,associated,0,0
157900,with,0,0
157901,bladder,0,0
157902,recurrence,0,0
157903,in,0,0
157904,the,0,0
157905,control,0,1
157906,group,0,0
157907,were,0,0
157908,analyzed,0,0
157909,.,0,0
157910,RESULTS,0,0
157911,Of,0,0
157912,36,0,0
157913,patients,0,0
157914,in,0,0
157915,the,0,0
157916,control,1,1
157917,group,0,0
157918,",",0,0
157919,14,0,0
157920,with,0,0
157921,positive,0,0
157922,urine,0,0
157923,cytology,0,1
157924,had,0,0
157925,more,0,0
157926,frequent,0,0
157927,recurrence,0,0
157928,when,0,0
157929,compared,0,0
157930,with,0,0
157931,the,0,0
157932,22,0,0
157933,patients,0,0
157934,with,0,0
157935,negative,0,0
157936,cytology,0,1
157937,(,0,0
157938,P,0,0
157939,=,0,0
157940,0.004,0,0
157941,),0,0
157942,.,0,0
157943,Based,0,0
157944,on,0,0
157945,the,0,0
157946,multivariate,0,0
157947,analysis,0,0
157948,in,0,0
157949,the,0,0
157950,control,0,1
157951,group,0,0
157952,",",0,0
157953,voided,0,0
157954,urine,0,0
157955,cytology,0,1
157956,was,0,0
157957,an,0,0
157958,independent,0,0
157959,predictive,0,0
157960,factor,0,0
157961,of,0,0
157962,bladder,0,1
157963,recurrence,0,0
157964,(,0,1
157965,hazard,0,0
157966,ratio,0,0
157967,",",0,0
157968,5.54,0,0
157969,;,0,0
157970,95,0,0
157971,%,0,0
157972,confidence,0,0
157973,interval,0,0
157974,1.12-27.5,0,0
157975,;,0,0
157976,P,0,0
157977,=,0,0
157978,0.036,0,0
157979,),0,0
157980,.,0,0
157981,Of,0,0
157982,72,0,0
157983,patients,0,0
157984,in,0,0
157985,the,0,0
157986,Pirarubicin,0,1
157987,Monotherapy,0,1
157988,Study,0,0
157989,Group,0,0
157990,trial,0,0
157991,",",0,0
157992,31,0,0
157993,had,0,0
157994,positive,0,0
157995,urine,0,0
157996,cytology,0,1
157997,.,0,0
157998,Among,0,0
157999,the,0,0
158000,31,0,0
158001,patients,0,0
158002,",",0,0
158003,17,0,0
158004,patients,0,0
158005,who,0,0
158006,received,0,0
158007,pirarubicin,1,1
158008,instillation,1,0
158009,had,0,0
158010,fewer,0,0
158011,recurrences,0,0
158012,when,0,0
158013,compared,0,0
158014,with,0,0
158015,14,0,0
158016,patients,0,0
158017,who,0,0
158018,received,0,0
158019,control,1,1
158020,treatment,0,1
158021,(,0,0
158022,P,0,0
158023,=,0,0
158024,0.0001,0,0
158025,),0,0
158026,.,0,0
158027,On,0,0
158028,multivariate,0,0
158029,analysis,0,0
158030,",",0,0
158031,pirarubicin,1,1
158032,instillation,1,1
158033,was,0,0
158034,an,0,0
158035,independent,0,0
158036,predictor,0,0
158037,of,0,0
158038,better,0,0
158039,recurrence-free,0,0
158040,survival,0,0
158041,rates,0,0
158042,in,0,0
158043,the,0,0
158044,patients,0,0
158045,with,0,0
158046,positive,0,0
158047,urine,0,0
158048,cytology,0,1
158049,(,0,1
158050,hazard,0,0
158051,ratio,0,0
158052,",",0,0
158053,0.02,0,0
158054,;,0,0
158055,95,0,0
158056,%,0,0
158057,confidence,0,0
158058,interval,0,0
158059,",",0,0
158060,0.00-0.53,0,0
158061,;,0,0
158062,P,0,0
158063,=,0,0
158064,0.018,0,0
158065,),0,0
158066,.,0,0
158067,Of,0,0
158068,21,0,0
158069,patients,0,0
158070,with,0,0
158071,bladder,0,0
158072,recurrence,0,0
158073,",",0,0
158074,17,0,0
158075,had,0,0
158076,recurrent,0,0
158077,tumor,0,0
158078,around,0,0
158079,cystotomy,0,1
158080,or,0,1
158081,in,0,0
158082,the,0,0
158083,bladder,0,0
158084,neck,0,1
158085,compromised,0,0
158086,by,0,0
158087,the,0,0
158088,urethral,0,0
158089,catheter,0,1
158090,",",0,0
158091,supporting,0,0
158092,the,0,0
158093,notion,0,0
158094,that,0,0
158095,tumor,0,0
158096,cells,0,0
158097,seeded,0,0
158098,in,0,0
158099,the,0,0
158100,injured,0,0
158101,urothelium,0,0
158102,.,0,0
158103,CONCLUSIONS,0,0
158104,Intravesical,1,1
158105,instillation,1,1
158106,of,1,0
158107,pirarubicin,1,1
158108,immediately,0,0
158109,after,0,0
158110,nephroureterectomy,1,1
158111,significantly,0,0
158112,reduced,0,0
158113,the,0,0
158114,bladder,0,1
158115,recurrence,0,0
158116,rate,0,0
158117,in,0,0
158118,patients,0,0
158119,with,0,0
158120,positive,0,0
158121,voided,0,0
158122,urine,0,0
158123,cytology,0,1
158124,.,0,0
158125,The,0,0
158126,results,0,0
158127,suggest,0,0
158128,that,0,0
158129,intravesical,0,1
158130,seeding,0,0
158131,of,0,0
158132,upper,0,0
158133,urinary,0,0
158134,tract,0,0
158135,urothelial,0,0
158136,carcinoma,0,0
158137,occurs,0,0
158138,during,0,0
158139,nephroureterectomy,0,0
158140,.,0,0
158141,Novel,0,1
158142,population,0,0
158143,pharmacokinetic,0,0
158144,method,0,1
158145,compared,0,0
158146,to,0,0
158147,the,0,0
158148,standard,0,1
158149,noncompartmental,0,0
158150,approach,0,1
158151,to,0,0
158152,assess,0,0
158153,bioequivalence,0,1
158154,of,0,0
158155,iron,0,1
158156,gluconate,0,1
158157,formulations,0,1
158158,.,0,0
158159,PURPOSE,0,0
158160,Iron-containing,0,1
158161,products,0,0
158162,are,0,0
158163,atypical,0,0
158164,in,0,0
158165,terms,0,0
158166,of,0,0
158167,their,0,0
158168,pharmacokinetic,0,0
158169,properties,0,0
158170,because,0,0
158171,iron,0,1
158172,is,0,0
158173,only,0,0
158174,removed,0,0
158175,by,0,0
158176,plasma,0,0
158177,sampling,0,0
158178,and,0,0
158179,is,0,0
158180,non-linear,0,0
158181,.,0,0
158182,This,0,0
158183,study,0,0
158184,aims,0,0
158185,to,0,0
158186,present,0,0
158187,a,0,0
158188,novel,0,0
158189,way,0,0
158190,of,0,0
158191,assessing,0,0
158192,the,0,0
158193,relative,0,0
158194,bioavailability,0,0
158195,of,0,0
158196,two,0,0
158197,sodium,1,1
158198,ferric,1,1
158199,gluconate,1,1
158200,complex,1,1
158201,(,1,1
158202,SFGC,1,1
158203,),1,1
158204,formulations,0,1
158205,and,0,0
158206,compare,0,0
158207,this,0,0
158208,approach,0,1
158209,to,0,0
158210,a,0,0
158211,standard,0,1
158212,previously,0,0
158213,published,0,0
158214,noncompartmental,0,0
158215,approach,0,1
158216,.,0,0
158217,METHODS,0,0
158218,Data,0,0
158219,were,0,0
158220,from,0,0
158221,open-label,0,0
158222,",",0,0
158223,randomized,0,0
158224,",",0,0
158225,single-dose,0,1
158226,studies,0,0
158227,(,0,0
158228,Study,0,0
158229,1,0,0
158230,was,0,0
158231,parallel,0,0
158232,whereas,0,0
158233,Study,0,0
158234,2,0,0
158235,was,0,0
158236,crossover,0,0
158237,),0,0
158238,.,0,0
158239,Subjects,0,0
158240,with,0,0
158241,low,0,0
158242,but,0,0
158243,normal,0,0
158244,iron,0,1
158245,levels,0,0
158246,were,0,0
158247,infused,0,0
158248,IV,1,0
158249,SFGC,1,1
158250,in,1,0
158251,sucrose,1,1
158252,by,0,0
158253,GeneraMedix,0,1
158254,Inc.,0,0
158255,and/or,0,0
158256,Ferrlecit,1,1
158257,?,1,0
158258,Injection,1,0
158259,(,0,0
158260,Watson,0,0
158261,Laboratories,0,1
158262,Inc.,0,0
158263,),0,0
158264,.,0,0
158265,In,0,0
158266,Study,0,0
158267,1,0,1
158268,(,0,0
158269,n=240,0,1
158270,),0,0
158271,",",0,0
158272,125,0,0
158273,mg,0,1
158274,was,0,0
158275,infused,0,0
158276,over,0,0
158277,10,0,0
158278,minutes,0,0
158279,.,0,0
158280,In,0,0
158281,Study,0,0
158282,2,0,1
158283,(,0,0
158284,n=29,0,0
158285,),0,0
158286,",",0,0
158287,62.5,0,0
158288,mg,0,1
158289,was,0,0
158290,infused,0,0
158291,over,0,0
158292,30,0,0
158293,minutes,0,0
158294,.,0,0
158295,Samples,0,0
158296,were,0,0
158297,assayed,0,0
158298,for,0,0
158299,total,0,0
158300,iron,0,1
158301,(,0,1
158302,TI,0,1
158303,),0,1
158304,and,0,0
158305,transferrin-bound,0,1
158306,iron,0,1
158307,(,0,1
158308,TBI,0,0
158309,),0,1
158310,over,0,0
158311,36,0,0
158312,hours,0,0
158313,(,0,0
158314,Study,0,0
158315,1,0,1
158316,),0,0
158317,or,0,0
158318,72,0,0
158319,hours,0,0
158320,(,0,0
158321,Study,0,0
158322,2,0,1
158323,),0,0
158324,post-dose,0,0
158325,.,0,1
158326,Studies,0,0
158327,1,0,0
158328,and,0,0
158329,2,0,0
158330,used,0,0
158331,standard,0,1
158332,noncompartmental,0,0
158333,analysis,0,0
158334,.,0,0
158335,Study,0,0
158336,2,0,0
158337,also,0,0
158338,used,0,0
158339,population,0,0
158340,PK,0,1
158341,(,0,1
158342,PPK,0,1
158343,),0,1
158344,analyses,0,0
158345,with,0,0
158346,ADAPT,0,0
158347,5?,0,0
158348,.,0,0
158349,The,0,0
158350,final,0,0
158351,model,0,0
158352,predicted,0,0
158353,SFGC,0,1
158354,area-under-the-curve,0,0
158355,(,0,1
158356,AUCpred,0,1
158357,),0,1
158358,and,0,0
158359,maximal,0,0
158360,concentration,0,0
158361,(,0,1
158362,Cmaxpred,0,1
158363,),0,0
158364,.,0,0
158365,Analyses,0,0
158366,of,0,0
158367,variance,0,0
158368,was,0,0
158369,conducted,0,0
158370,on,0,0
158371,ln-transformed,0,0
158372,PK,0,1
158373,parameters,0,0
158374,.,0,0
158375,Ratios,0,0
158376,of,0,0
158377,means,0,0
158378,and,0,0
158379,90,0,0
158380,%,0,0
158381,confidence,0,0
158382,intervals,0,0
158383,(,0,0
158384,CIs,0,1
158385,),0,1
158386,were,0,0
158387,estimated,0,0
158388,.,0,0
158389,Bioequivalence,0,0
158390,was,0,0
158391,demonstrated,0,0
158392,if,0,0
158393,values,0,0
158394,were,0,0
158395,within,0,0
158396,80-125,0,0
158397,%,0,0
158398,.,0,0
158399,RESULTS,0,0
158400,For,0,0
158401,Study,0,0
158402,1,0,0
158403,",",0,0
158404,ratios,0,0
158405,and,0,0
158406,90,0,0
158407,%,0,0
158408,CIs,0,1
158409,for,0,0
158410,TI,0,0
158411,baseline-corrected,0,0
158412,Cmax,0,0
158413,and,0,0
158414,AUC0-36,0,0
158415,were,0,0
158416,100.4,0,0
158417,(,0,0
158418,96.5,0,0
158419,-,0,0
158420,104.5,0,0
158421,),0,0
158422,and,0,0
158423,99.7,0,0
158424,(,0,0
158425,94.2,0,0
158426,-,0,0
158427,105.5,0,0
158428,),0,0
158429,.,0,0
158430,For,0,0
158431,TBI,0,0
158432,",",0,0
158433,results,0,0
158434,for,0,0
158435,TI,0,0
158436,baseline-corrected,0,0
158437,Cmax,0,0
158438,and,0,0
158439,AUC0-36,0,0
158440,were,0,0
158441,86.8,0,0
158442,(,0,0
158443,82.7,0,0
158444,-,0,0
158445,91.1,0,0
158446,),0,0
158447,and,0,0
158448,92.4,0,0
158449,(,0,0
158450,85.6,0,0
158451,-,0,0
158452,99.7,0,0
158453,),0,0
158454,.,0,0
158455,For,0,0
158456,Study,0,0
158457,2,0,0
158458,",",0,0
158459,a,0,0
158460,multi-compartmental,0,0
158461,model,0,0
158462,simultaneously,0,1
158463,described,0,0
158464,the,0,0
158465,PK,0,1
158466,of,0,0
158467,TI,0,0
158468,",",0,0
158469,TBI,0,0
158470,and,0,0
158471,SFGC,0,1
158472,.,0,1
158473,Ratios,0,0
158474,and,0,0
158475,90,0,0
158476,%,0,0
158477,CIs,0,1
158478,for,0,0
158479,SFGC,0,1
158480,Cmaxpred,0,1
158481,and,0,0
158482,AUCpred,0,1
158483,were,0,0
158484,89.9,0,0
158485,(,0,0
158486,85.9,0,0
158487,-,0,0
158488,94.0,0,0
158489,),0,0
158490,and,0,0
158491,89.7,0,0
158492,(,0,0
158493,85.7,0,0
158494,-,0,0
158495,93.9,0,0
158496,),0,0
158497,",",0,0
158498,while,0,0
158499,ratios,0,0
158500,and,0,0
158501,90,0,0
158502,%,0,0
158503,CI,0,0
158504,obtained,0,0
158505,from,0,0
158506,the,0,0
158507,noncompartmental,0,0
158508,analysis,0,0
158509,of,0,0
158510,Study,0,0
158511,2,0,0
158512,did,0,0
158513,not,0,0
158514,meet,0,0
158515,BE,0,1
158516,criteria,0,0
158517,because,0,0
158518,of,0,0
158519,low,0,0
158520,power,0,0
158521,.,0,0
158522,CONCLUSIONS,0,0
158523,Both,0,1
158524,the,0,0
158525,standard,0,1
158526,and,0,0
158527,PPK,0,1
158528,modeling,0,1
158529,approach,0,1
158530,suggested,0,0
158531,bioequivalence,0,1
158532,between,0,0
158533,the,0,0
158534,iron,0,1
158535,products,0,0
158536,.,0,0
158537,However,0,0
158538,",",0,0
158539,with,0,0
158540,the,0,0
158541,PPK,0,1
158542,method,0,0
158543,",",0,0
158544,less,0,0
158545,subjects,0,0
158546,were,0,0
158547,required,0,0
158548,to,0,0
158549,meet,0,0
158550,study,0,0
158551,objectives,0,0
158552,compared,0,0
158553,to,0,0
158554,the,0,0
158555,standard,0,1
158556,noncompartmental,0,0
158557,approach,0,1
158558,which,0,0
158559,required,0,0
158560,considerably,0,0
158561,more,0,0
158562,subjects,0,0
158563,(,0,0
158564,29,0,0
158565,vs,0,0
158566,240,0,0
158567,),0,0
158568,.,0,0
158569,The,0,0
158570,effect,0,0
158571,of,0,0
158572,person-centred,1,1
158573,dementia,1,0
158574,care,1,1
158575,to,0,0
158576,prevent,0,0
158577,agitation,0,0
158578,and,0,0
158579,other,0,0
158580,neuropsychiatric,0,0
158581,symptoms,0,0
158582,and,0,0
158583,enhance,0,0
158584,quality,0,0
158585,of,0,0
158586,life,0,0
158587,in,0,0
158588,nursing,0,1
158589,home,0,1
158590,patients,0,0
158591,:,0,0
158592,a,0,0
158593,10-month,0,0
158594,randomized,0,0
158595,controlled,0,0
158596,trial,0,0
158597,.,0,0
158598,AIMS,0,0
158599,We,0,0
158600,examined,0,0
158601,whether,0,0
158602,Dementia,1,1
158603,Care,1,1
158604,Mapping,1,0
158605,(,1,1
158606,DCM,1,1
158607,),1,1
158608,or,0,1
158609,the,0,0
158610,VIPS,1,1
158611,practice,1,1
158612,model,1,0
158613,(,1,1
158614,VPM,1,0
158615,),1,1
158616,is,0,0
158617,more,0,0
158618,effective,0,0
158619,than,0,0
158620,education,0,1
158621,of,0,0
158622,the,0,0
158623,nursing,0,1
158624,home,0,1
158625,staff,0,0
158626,about,0,0
158627,dementia,1,0
158628,(,0,0
158629,control,0,1
158630,group,0,0
158631,),0,0
158632,in,0,0
158633,reducing,0,0
158634,agitation,0,0
158635,and,0,0
158636,other,0,0
158637,neuropsychiatric,0,0
158638,symptoms,0,0
158639,as,0,0
158640,well,0,0
158641,as,0,0
158642,in,0,0
158643,enhancing,0,0
158644,the,0,0
158645,quality,0,0
158646,of,0,0
158647,life,0,0
158648,among,0,0
158649,nursing,0,1
158650,home,0,1
158651,patients,0,0
158652,.,0,0
158653,METHODS,0,0
158654,A,0,0
158655,10-month,0,0
158656,three-armed,0,0
158657,cluster-randomized,0,0
158658,controlled,0,0
158659,trial,0,0
158660,compared,0,0
158661,DCM,1,0
158662,and,0,0
158663,VPM,1,0
158664,with,0,0
158665,control,0,0
158666,.,0,0
158667,Of,0,0
158668,624,0,0
158669,nursing,0,0
158670,home,0,1
158671,patients,0,0
158672,with,0,0
158673,dementia,0,0
158674,",",0,0
158675,446,0,0
158676,completed,0,0
158677,follow-up,0,0
158678,assessments,0,0
158679,.,0,0
158680,The,0,0
158681,primary,0,0
158682,outcome,0,0
158683,was,0,0
158684,the,0,0
158685,change,0,0
158686,on,0,0
158687,the,0,0
158688,Brief,0,0
158689,Agitation,0,0
158690,Rating,0,0
158691,Scale,0,1
158692,(,0,1
158693,BARS,0,1
158694,),0,1
158695,.,0,0
158696,Secondary,0,0
158697,outcomes,0,0
158698,were,0,0
158699,changes,0,0
158700,on,0,0
158701,the,0,0
158702,10-item,0,0
158703,version,0,0
158704,of,0,0
158705,the,0,0
158706,Neuropsychiatric,0,0
158707,Inventory,0,1
158708,Questionnaire,0,1
158709,(,0,1
158710,NPI-Q,0,1
158711,),0,0
158712,",",0,0
158713,the,0,0
158714,Cornell,0,0
158715,Scale,0,0
158716,for,0,0
158717,Depression,0,0
158718,in,0,0
158719,Dementia,0,1
158720,(,0,1
158721,CSDD,0,1
158722,),0,1
158723,and,0,0
158724,the,0,0
158725,Quality,0,0
158726,of,0,0
158727,Life,0,0
158728,in,0,0
158729,Late-Stage,0,0
158730,Dementia,0,1
158731,(,0,1
158732,QUALID,0,1
158733,),0,1
158734,scale,0,0
158735,.,0,0
158736,RESULTS,0,0
158737,Changes,0,0
158738,in,0,0
158739,the,0,0
158740,BARS,0,1
158741,score,0,0
158742,did,0,0
158743,not,0,0
158744,differ,0,0
158745,significantly,0,0
158746,between,0,0
158747,the,0,0
158748,DCM,0,0
158749,and,0,0
158750,the,0,0
158751,control,0,1
158752,group,0,0
158753,or,0,1
158754,between,0,0
158755,the,0,0
158756,VPM,0,0
158757,and,0,0
158758,the,0,0
158759,control,0,1
158760,group,0,0
158761,after,0,0
158762,10,0,0
158763,months,0,0
158764,.,0,0
158765,Positive,0,0
158766,differences,0,0
158767,were,0,0
158768,found,0,0
158769,for,0,0
158770,changes,0,0
158771,in,0,0
158772,the,0,0
158773,secondary,0,0
158774,outcomes,0,0
158775,:,0,0
158776,the,0,0
158777,NPI-Q,0,1
158778,sum,0,0
158779,score,0,0
158780,as,0,0
158781,well,0,0
158782,as,0,0
158783,the,0,0
158784,subscales,0,0
158785,NPI-Q,0,1
158786,agitation,0,0
158787,and,0,0
158788,NPI-Q,0,1
158789,psychosis,0,0
158790,were,0,0
158791,in,0,0
158792,favour,0,0
158793,of,0,0
158794,both,0,0
158795,interventions,0,0
158796,versus,0,0
158797,control,0,0
158798,",",0,0
158799,the,0,0
158800,QUALID,0,1
158801,score,0,0
158802,was,0,0
158803,in,0,0
158804,favour,0,0
158805,of,0,0
158806,DCM,0,1
158807,versus,0,1
158808,control,0,1
158809,and,0,0
158810,the,0,0
158811,CSDD,0,1
158812,score,0,0
158813,was,0,0
158814,in,0,0
158815,favour,0,0
158816,of,0,0
158817,VPM,0,0
158818,versus,0,1
158819,control,0,0
158820,.,0,0
158821,CONCLUSIONS,0,0
158822,This,0,0
158823,study,0,0
158824,failed,0,0
158825,to,0,0
158826,find,0,0
158827,a,0,0
158828,significant,0,0
158829,effect,0,0
158830,of,0,0
158831,both,0,0
158832,interventions,0,0
158833,on,0,0
158834,the,0,0
158835,primary,0,0
158836,outcome,0,0
158837,.,0,0
158838,Positive,0,0
158839,effects,0,0
158840,on,0,0
158841,the,0,0
158842,secondary,0,0
158843,outcomes,0,0
158844,indicate,0,0
158845,that,0,0
158846,the,0,0
158847,methods,0,0
158848,merit,0,0
158849,further,0,0
158850,investigation,0,0
158851,.,0,0
158852,The,0,0
158853,effect,0,0
158854,of,0,0
158855,leukocyte,1,0
158856,reduction,1,0
158857,filters,1,1
158858,on,0,0
158859,inflammatory,0,0
158860,mediator,0,0
158861,release,0,0
158862,during,0,0
158863,coronary,0,0
158864,artery,0,0
158865,bypass,0,1
158866,grafting,0,1
158867,.,0,0
158868,BACKGROUND,0,0
158869,Extracorporeal,0,1
158870,circulation,0,0
158871,used,0,0
158872,during,0,0
158873,coronary,0,0
158874,artery,0,0
158875,bypass,0,1
158876,grafting,0,1
158877,triggers,0,0
158878,systemic,0,0
158879,inflammatory,0,0
158880,response,0,0
158881,with,0,0
158882,neutrophil,0,0
158883,activation,0,0
158884,which,0,0
158885,adversely,0,0
158886,affects,0,0
158887,ischaemic/reperfused,0,1
158888,myocardium,0,0
158889,.,0,0
158890,One,0,0
158891,method,0,0
158892,of,0,0
158893,myocardial,0,0
158894,protection,0,0
158895,during,0,0
158896,cardiac,0,0
158897,surgery,0,1
158898,is,0,0
158899,the,0,0
158900,use,0,0
158901,of,0,0
158902,blood,0,0
158903,cardioplegia,0,1
158904,.,0,0
158905,Its,0,0
158906,protective,0,0
158907,effect,0,0
158908,is,0,0
158909,related,0,0
158910,to,0,0
158911,cardiac,0,0
158912,cooling,0,1
158913,and,0,0
158914,metabolism,0,0
158915,reduction,0,0
158916,",",0,0
158917,oxygen,0,1
158918,supply,0,0
158919,from,0,0
158920,erythrocytes,0,0
158921,",",0,0
158922,and,0,0
158923,reactive,0,0
158924,oxygen,0,1
158925,species,0,0
158926,scavenging,0,0
158927,.,0,0
158928,However,0,0
158929,",",0,0
158930,blood,0,0
158931,cardioplegia,0,1
158932,is,0,0
158933,also,0,0
158934,associated,0,0
158935,with,0,0
158936,myocardial,0,0
158937,damage,0,0
158938,induced,0,0
158939,by,0,0
158940,undesirable,0,0
158941,morphotic,0,0
158942,blood,0,0
158943,elements,0,0
158944,.,0,0
158945,AIM,0,0
158946,To,0,0
158947,evaluate,0,0
158948,the,0,0
158949,effect,0,0
158950,of,0,0
158951,the,0,0
158952,use,0,0
158953,of,0,0
158954,leukocyte,1,0
158955,reduction,1,0
158956,filters,1,1
158957,on,0,0
158958,the,0,0
158959,activity,0,0
158960,of,0,0
158961,polymorphonuclear,0,0
158962,neutrophils,0,0
158963,(,0,0
158964,PMN,0,1
158965,),0,1
158966,in,0,0
158967,patients,0,0
158968,undergoing,0,0
158969,surgical,0,1
158970,myocardial,0,0
158971,revascularisation,0,0
158972,.,0,0
158973,PMN,0,1
158974,activity,0,0
158975,was,0,0
158976,evaluated,0,0
158977,based,0,0
158978,on,0,0
158979,measurements,0,0
158980,of,0,0
158981,plasma,0,0
158982,activity,0,0
158983,of,0,0
158984,granulocyte,0,1
158985,enzymes,0,1
158986,",",0,0
158987,lysozyme,0,0
158988,and,0,0
158989,beta-glucuronidase,0,1
158990,.,0,0
158991,METHODS,0,0
158992,We,0,0
158993,studied,0,0
158994,40,0,0
158995,patients,0,0
158996,who,0,0
158997,underwent,0,0
158998,myocardial,0,0
158999,revascularisation,0,0
159000,using,0,0
159001,extracorporeal,1,1
159002,circulation,1,0
159003,.,1,0
159004,Patients,0,0
159005,were,0,0
159006,randomly,0,0
159007,assigned,0,0
159008,to,0,0
159009,two,0,0
159010,equal,0,0
159011,groups,0,0
159012,:,0,0
159013,in,0,0
159014,Group,0,0
159015,I,0,0
159016,",",0,0
159017,blood,1,0
159018,cardioplegia,1,1
159019,was,1,0
159020,administered,1,0
159021,using,1,0
159022,leukocyte,1,0
159023,reduction,1,0
159024,filters,1,1
159025,",",0,0
159026,and,0,0
159027,in,0,0
159028,Group,0,0
159029,II,0,0
159030,",",0,0
159031,leukocyte,1,0
159032,reduction,1,0
159033,filters,1,1
159034,were,1,0
159035,not,1,0
159036,used,1,0
159037,for,1,0
159038,blood,1,0
159039,cardioplegia,1,1
159040,.,1,0
159041,Measurements,0,0
159042,were,0,0
159043,performed,0,0
159044,in,0,0
159045,plasma,0,0
159046,of,0,0
159047,arterial,0,0
159048,and,0,0
159049,coronary,0,0
159050,sinus,0,0
159051,blood,0,0
159052,samples,0,0
159053,collected,0,0
159054,before,0,0
159055,aortic,0,0
159056,clamping,0,1
159057,",",0,0
159058,immediately,0,0
159059,after,0,0
159060,unclamping,0,1
159061,",",0,0
159062,and,0,0
159063,after,0,0
159064,25,0,0
159065,min,0,0
159066,of,0,0
159067,reperfusion,0,0
159068,.,0,0
159069,In,0,0
159070,addition,0,0
159071,",",0,0
159072,blood,0,0
159073,cardioplegic,0,1
159074,solution,0,1
159075,samples,0,0
159076,were,0,0
159077,collected,0,0
159078,in,0,0
159079,Group,0,0
159080,I,0,0
159081,from,0,0
159082,the,0,0
159083,lines,0,0
159084,proximal,0,0
159085,and,0,0
159086,distal,0,0
159087,to,0,0
159088,the,0,0
159089,filter,0,1
159090,during,0,0
159091,first,0,0
159092,and,0,0
159093,last,0,0
159094,administration,0,0
159095,.,0,0
159096,Plasma,0,0
159097,levels,0,0
159098,of,0,0
159099,lysozyme,0,0
159100,and,0,0
159101,beta-glucuronidase,0,1
159102,were,0,0
159103,determined,0,0
159104,using,0,0
159105,previously,0,0
159106,described,0,0
159107,methods,0,0
159108,.,0,0
159109,RESULTS,0,0
159110,We,0,0
159111,found,0,0
159112,a,0,0
159113,significant,0,0
159114,decrease,0,0
159115,in,0,0
159116,PMN,0,1
159117,count,0,0
159118,in,0,0
159119,filtered,0,1
159120,blood,0,0
159121,cardioplegic,0,1
159122,solution,0,1
159123,during,0,0
159124,its,0,0
159125,first,0,0
159126,administration,0,0
159127,(,0,0
159128,0.27,0,0
159129,?,0,0
159130,0.07,0,0
159131,G/L,0,0
159132,),0,0
159133,compared,0,0
159134,to,0,0
159135,samples,0,0
159136,collected,0,0
159137,before,0,0
159138,filter,0,1
159139,passage,0,0
159140,(,0,0
159141,1.73,0,0
159142,?,0,0
159143,0.049,0,0
159144,G/L,0,0
159145,),0,0
159146,.,0,0
159147,Also,0,0
159148,during,0,0
159149,last,0,0
159150,administration,0,0
159151,",",0,0
159152,PMN,0,1
159153,count,0,0
159154,in,0,0
159155,filtered,0,1
159156,blood,0,0
159157,cardioplegic,0,1
159158,solution,0,1
159159,was,0,0
159160,decreased,0,0
159161,compared,0,0
159162,to,0,0
159163,samples,0,0
159164,collected,0,0
159165,before,0,0
159166,filter,0,1
159167,passage,0,0
159168,(,0,0
159169,0.66,0,0
159170,?,0,0
159171,0.35,0,0
159172,G/L,0,0
159173,vs.,0,0
159174,3.64,0,0
159175,?,0,0
159176,1.14,0,0
159177,G/L,0,0
159178,",",0,0
159179,respectively,0,0
159180,),0,0
159181,.,0,0
159182,Significantly,0,0
159183,lower,0,0
159184,(,0,0
159185,p,0,0
159186,<,0,0
159187,0.02,0,0
159188,),0,0
159189,plasma,0,0
159190,beta-glucuronidase,0,1
159191,levels,0,0
159192,were,0,0
159193,found,0,0
159194,in,0,0
159195,arterial,0,0
159196,blood,0,0
159197,samples,0,0
159198,in,0,0
159199,Group,0,0
159200,I,0,0
159201,compared,0,0
159202,to,0,0
159203,Group,0,0
159204,II,0,1
159205,(,0,0
159206,5.59,0,0
159207,?,0,0
159208,1.63,0,0
159209,?g/mL,0,0
159210,immediately,0,0
159211,after,0,0
159212,aortic,0,0
159213,unclamping,0,1
159214,and,0,0
159215,6.59,0,0
159216,?,0,0
159217,1.98,0,0
159218,?g/mL,0,0
159219,after,0,0
159220,25,0,0
159221,min,0,0
159222,of,0,0
159223,reperfusion,0,0
159224,in,0,0
159225,Group,0,0
159226,I,0,0
159227,vs.,0,0
159228,10.19,0,0
159229,?,0,0
159230,2.66,0,0
159231,and,0,0
159232,12.83,0,0
159233,?,0,0
159234,1.88,0,0
159235,?g/mL,0,0
159236,",",0,0
159237,respectively,0,0
159238,",",0,0
159239,in,0,0
159240,Group,0,0
159241,II,0,0
159242,),0,0
159243,.,0,0
159244,Beta-glucuronidase,0,0
159245,levels,0,0
159246,in,0,0
159247,coronary,0,0
159248,sinus,0,0
159249,blood,0,0
159250,samples,0,0
159251,collected,0,0
159252,after,0,0
159253,aortic,0,0
159254,unclamping,0,1
159255,and,0,0
159256,at,0,0
159257,the,0,0
159258,end,0,0
159259,of,0,0
159260,reperfusion,0,0
159261,were,0,0
159262,significantly,0,0
159263,higher,0,0
159264,in,0,0
159265,Group,0,0
159266,II,0,0
159267,compared,0,0
159268,to,0,0
159269,Group,0,0
159270,I,0,0
159271,(,0,0
159272,p,0,0
159273,<,0,0
159274,0.04,0,0
159275,),0,0
159276,.,0,0
159277,In,0,0
159278,Group,0,0
159279,I,0,0
159280,",",0,0
159281,plasma,0,0
159282,lysozyme,0,0
159283,levels,0,0
159284,in,0,0
159285,arterial,0,0
159286,and,0,0
159287,venous,0,1
159288,blood,0,0
159289,samples,0,0
159290,did,0,0
159291,not,0,0
159292,show,0,0
159293,significant,0,0
159294,changes,0,0
159295,during,0,0
159296,the,0,0
159297,surgery,0,0
159298,.,0,0
159299,In,0,0
159300,contrast,0,0
159301,",",0,0
159302,plasma,0,0
159303,lysozyme,0,0
159304,level,0,0
159305,in,0,0
159306,coronary,0,0
159307,sinus,0,0
159308,blood,0,0
159309,samples,0,0
159310,at,0,0
159311,the,0,0
159312,end,0,0
159313,of,0,0
159314,reperfusion,0,0
159315,in,0,0
159316,Group,0,0
159317,II,0,0
159318,was,0,0
159319,significantly,0,0
159320,higher,0,0
159321,compared,0,0
159322,to,0,0
159323,that,0,0
159324,in,0,0
159325,pre-clamping,0,0
159326,samples,0,0
159327,(,0,0
159328,p,0,0
159329,<,0,0
159330,0.014,0,0
159331,),0,0
159332,.,0,0
159333,CONCLUSIONS,0,0
159334,With,0,0
159335,the,0,0
159336,use,0,0
159337,of,0,0
159338,leukocyte,1,0
159339,reduction,1,0
159340,filters,1,1
159341,",",1,0
159342,we,1,0
159343,found,0,0
159344,significantly,0,0
159345,lower,0,0
159346,beta-glucuronidase,0,0
159347,levels,0,0
159348,in,0,0
159349,arterial,0,0
159350,and,0,0
159351,coronary,0,0
159352,sinus,0,0
159353,blood,0,0
159354,samples,0,0
159355,.,0,0
159356,These,0,0
159357,findings,0,0
159358,seem,0,0
159359,to,0,0
159360,confirm,0,0
159361,reduced,0,0
159362,PMN,0,1
159363,activation,0,1
159364,and/or,0,0
159365,reduced,0,0
159366,myocardial,0,0
159367,infiltration,0,0
159368,by,0,0
159369,activated,0,0
159370,PMN,0,1
159371,.,0,0
159372,Plasma,0,0
159373,levels,0,0
159374,of,0,0
159375,lysozyme,0,0
159376,",",0,0
159377,a,0,0
159378,characteristic,0,0
159379,product,0,0
159380,of,0,0
159381,PMN,0,1
159382,degranulation,0,0
159383,",",0,0
159384,did,0,0
159385,not,0,0
159386,show,0,0
159387,significant,0,0
159388,differences,0,0
159389,between,0,0
159390,the,0,0
159391,study,0,0
159392,groups,0,0
159393,.,0,0
159394,Bismuth,1,1
159395,subsalicylate,1,1
159396,in,0,0
159397,the,0,0
159398,treatment,0,0
159399,of,0,0
159400,gastritis,0,0
159401,due,0,0
159402,to,0,0
159403,Campylobacter,0,0
159404,pylori,0,0
159405,.,0,0
159406,Fifty,0,0
159407,patients,0,0
159408,completed,0,0
159409,an,0,0
159410,investigator-blind,0,0
159411,trial,0,0
159412,comparing,0,0
159413,bismuth,1,1
159414,subsalicylate,1,1
159415,",",1,0
159416,erythromycin,1,1
159417,ethylsuccinate,1,1
159418,",",1,0
159419,and,1,0
159420,placebo,1,1
159421,matched,0,0
159422,to,0,0
159423,the,0,0
159424,bismuth,1,1
159425,salt,0,1
159426,in,0,0
159427,the,0,0
159428,treatment,0,0
159429,of,0,0
159430,gastritis,0,0
159431,associated,0,0
159432,with,0,0
159433,Campylobacter,0,0
159434,pylori,0,0
159435,.,0,0
159436,C.,0,0
159437,pylori,0,0
159438,was,0,0
159439,cleared,0,0
159440,from,0,0
159441,14,0,0
159442,(,0,0
159443,77.8,0,0
159444,%,0,0
159445,),0,0
159446,of,0,0
159447,18,0,0
159448,patients,0,0
159449,given,0,0
159450,locally,0,0
159451,active,1,1
159452,bismuth,1,1
159453,",",0,0
159454,from,0,0
159455,one,0,0
159456,(,0,0
159457,6.7,0,0
159458,%,0,0
159459,),0,0
159460,of,0,0
159461,15,0,0
159462,patients,0,0
159463,given,0,0
159464,erythromycin,1,1
159465,",",0,0
159466,and,0,0
159467,from,0,0
159468,none,0,0
159469,of,0,0
159470,17,0,0
159471,patients,0,0
159472,given,0,0
159473,placebo,1,1
159474,.,1,0
159475,Gastritis,0,0
159476,resolved,0,0
159477,in,0,0
159478,13,0,0
159479,(,0,0
159480,81,0,0
159481,%,0,0
159482,),0,0
159483,of,0,0
159484,16,0,0
159485,patients,0,0
159486,treated,0,0
159487,with,0,0
159488,bismuth,1,1
159489,but,0,0
159490,in,0,0
159491,only,0,0
159492,three,0,0
159493,of,0,0
159494,13,0,0
159495,receiving,0,0
159496,erythromycin,1,1
159497,and,0,0
159498,in,0,0
159499,none,0,0
159500,of,0,0
159501,16,0,0
159502,patients,0,0
159503,given,0,0
159504,placebo,1,1
159505,.,1,0
159506,Results,0,0
159507,of,0,0
159508,endoscopic,0,1
159509,examination,0,0
159510,showed,0,0
159511,greater,0,0
159512,improvement,0,0
159513,in,0,0
159514,patients,0,0
159515,cleared,0,0
159516,of,0,0
159517,C.,0,1
159518,pylori,0,0
159519,than,0,0
159520,in,0,0
159521,those,0,0
159522,with,0,0
159523,persistent,0,0
159524,infection,0,0
159525,.,0,0
159526,Heartburn,0,0
159527,improved,0,0
159528,in,0,0
159529,50,0,0
159530,%,0,0
159531,of,0,0
159532,patients,0,0
159533,who,0,0
159534,received,0,0
159535,bismuth,1,1
159536,compared,0,0
159537,with,0,0
159538,17,0,0
159539,%,0,0
159540,of,0,0
159541,those,0,0
159542,given,0,0
159543,placebo,1,1
159544,.,1,0
159545,The,0,0
159546,success,0,0
159547,of,0,0
159548,bismuth,1,1
159549,is,0,0
159550,probably,0,0
159551,due,0,0
159552,to,0,0
159553,its,0,0
159554,local,0,1
159555,antimicrobial,0,1
159556,activity,0,0
159557,.,0,0
159558,Erythromycin,1,1
159559,may,0,0
159560,have,0,0
159561,been,0,0
159562,inactivated,0,1
159563,by,0,0
159564,the,0,0
159565,low,0,0
159566,pH,0,1
159567,in,0,0
159568,the,0,0
159569,areas,0,0
159570,colonized,0,0
159571,with,0,0
159572,C.,0,1
159573,pylori,0,0
159574,.,0,0
159575,Relapse,0,0
159576,is,0,0
159577,less,0,0
159578,frequent,0,0
159579,when,0,0
159580,a,0,0
159581,combination,0,1
159582,of,0,0
159583,bismuth,1,1
159584,and,0,0
159585,an,0,0
159586,antimicrobial,0,1
159587,agent,0,0
159588,is,0,0
159589,used,0,0
159590,;,0,0
159591,such,0,0
159592,a,0,0
159593,combination,0,1
159594,is,0,0
159595,characterized,0,0
159596,by,0,0
159597,local,0,1
159598,and,0,0
159599,systemic,0,0
159600,activity,0,0
159601,",",0,0
159602,stability,0,0
159603,at,0,0
159604,low,0,0
159605,pH,0,1
159606,",",0,0
159607,and,0,0
159608,good,0,0
159609,penetration,0,0
159610,into,0,0
159611,gastric,0,0
159612,mucus,0,0
159613,.,0,0
159614,Intrathecal,0,1
159615,lentivirus-mediated,0,1
159616,transfer,0,0
159617,of,0,0
159618,interleukin-10,1,1
159619,attenuates,0,0
159620,chronic,0,0
159621,constriction,0,0
159622,injury-induced,0,0
159623,neuropathic,0,0
159624,pain,0,0
159625,through,0,0
159626,modulation,0,0
159627,of,0,0
159628,spinal,0,0
159629,high-mobility,0,1
159630,group,0,1
159631,box,0,1
159632,1,0,0
159633,in,0,0
159634,rats,0,1
159635,.,0,0
159636,BACKGROUND,0,0
159637,Neuropathic,0,0
159638,pain,0,0
159639,is,0,0
159640,a,0,0
159641,complex,0,0
159642,state,0,0
159643,of,0,0
159644,chronic,0,0
159645,pain,0,0
159646,that,0,0
159647,is,0,0
159648,usually,0,0
159649,accompanied,0,0
159650,by,0,0
159651,peripheral,0,0
159652,and,0,0
159653,central,0,0
159654,nervous,0,0
159655,system,0,1
159656,damage,0,0
159657,or,0,1
159658,dysfunction,0,0
159659,.,0,0
159660,Previous,0,0
159661,studies,0,0
159662,have,0,0
159663,indicated,0,0
159664,that,0,0
159665,neuroinflammation,0,0
159666,in,0,0
159667,the,0,0
159668,spinal,0,0
159669,cord,0,0
159670,is,0,0
159671,an,0,0
159672,important,0,0
159673,contributor,0,0
159674,to,0,0
159675,neuropathological,0,0
159676,and,0,0
159677,behavioral,0,1
159678,abnormalities,0,0
159679,.,0,0
159680,A,0,0
159681,series,0,0
159682,of,0,0
159683,early,0,0
159684,inflammatory,0,0
159685,markers,0,0
159686,",",0,0
159687,such,0,0
159688,as,0,0
159689,IL-1,0,0
159690,",",0,0
159691,TNF-?,0,0
159692,",",0,0
159693,and,0,0
159694,IFN-?,0,1
159695,",",0,0
159696,and,0,0
159697,advanced,0,0
159698,inflammatory,0,0
159699,markers,0,0
159700,",",0,0
159701,such,0,0
159702,as,0,0
159703,high-mobility,0,1
159704,group,0,0
159705,box,0,1
159706,1,0,0
159707,(,0,0
159708,HMGB1,0,1
159709,),0,0
159710,",",0,0
159711,are,0,0
159712,involved,0,0
159713,in,0,0
159714,neuroinflammation,0,0
159715,.,0,0
159716,STUDY,0,0
159717,DESIGN,0,0
159718,A,0,0
159719,randomized,0,0
159720,",",0,0
159721,double,0,1
159722,blind,0,0
159723,",",0,0
159724,controlled,0,0
159725,animal,0,0
159726,trial,0,0
159727,.,0,0
159728,OBJECTIVE,0,0
159729,In,0,0
159730,this,0,0
159731,study,0,0
159732,",",0,0
159733,a,0,0
159734,lentivirus,1,1
159735,delivering,1,1
159736,human,1,1
159737,IL-10,1,1
159738,(,1,1
159739,LV/hIL-10,1,1
159740,),1,1
159741,was,1,0
159742,administered,0,0
159743,intrathecally,0,1
159744,to,0,0
159745,determine,0,0
159746,the,0,0
159747,effects,0,0
159748,of,0,0
159749,IL-10,0,0
159750,on,0,0
159751,allodynia,0,0
159752,and,0,0
159753,hyperalgesia,0,0
159754,in,0,0
159755,a,0,0
159756,chronic,0,0
159757,constriction,0,0
159758,injury-induced,0,0
159759,(,0,1
159760,CCI,0,0
159761,),0,1
159762,rat,0,1
159763,model,0,0
159764,of,0,0
159765,neuropathic,0,0
159766,pain,0,0
159767,.,0,0
159768,METHODS,0,0
159769,Sprague-Dawley,0,0
159770,rats,0,1
159771,weighting,0,0
159772,260,0,0
159773,-,0,0
159774,320,0,0
159775,g,0,1
159776,were,0,0
159777,randomly,0,0
159778,divided,0,0
159779,into,0,0
159780,4,0,0
159781,groups,0,0
159782,.,0,0
159783,Group,0,0
159784,Sham,0,1
159785,(,0,1
159786,Sham,0,1
159787,),0,0
159788,",",0,0
159789,Group,1,0
159790,CCI?Normal,1,1
159791,Saline,1,1
159792,(,1,1
159793,NS,1,0
159794,),1,0
159795,",",1,0
159796,Group,1,0
159797,CCI?LV/hIL-10,1,1
159798,(,1,1
159799,LV/hIL-10,1,1
159800,),1,1
159801,",",1,0
159802,and,1,0
159803,Group,1,1
159804,CCI?LV/control,1,1
159805,(,1,1
159806,vector,1,1
159807,),1,0
159808,.,1,0
159809,Rats,1,0
159810,in,0,0
159811,each,0,0
159812,group,0,0
159813,were,0,0
159814,intrathecally,0,1
159815,delivered,0,0
159816,with,0,0
159817,NS,1,0
159818,",",1,0
159819,LV/control,1,0
159820,",",1,0
159821,or,1,1
159822,recombinant,1,1
159823,vector,1,1
159824,LV/hIL-10,1,1
159825,in,1,0
159826,a,1,0
159827,total,0,0
159828,volume,0,0
159829,of,0,0
159830,10,0,0
159831,?l,0,0
159832,.,0,0
159833,Paw,0,0
159834,withdrawal,0,0
159835,mechanical,0,0
159836,thresholds,0,0
159837,(,0,0
159838,PWMT,0,1
159839,),0,1
159840,and,0,0
159841,paw,0,1
159842,withdrawal,0,1
159843,thermal,0,0
159844,latency,0,0
159845,PWTL,0,1
159846,were,0,0
159847,measured,0,0
159848,one,0,0
159849,day,0,0
159850,before,0,0
159851,CCI,0,1
159852,(,0,1
159853,baseline,0,0
159854,),0,1
159855,and,0,0
159856,0,0,0
159857,",",0,0
159858,3,0,0
159859,",",0,0
159860,7,0,0
159861,",",0,0
159862,14,0,0
159863,",",0,0
159864,and,0,0
159865,28,0,0
159866,days,0,0
159867,after,0,0
159868,intrathecal,0,1
159869,administration,0,0
159870,.,0,0
159871,Cerebrospinal,0,0
159872,fluid,0,1
159873,(,0,1
159874,CSF,0,0
159875,),0,1
159876,samples,0,0
159877,were,0,0
159878,collected,0,0
159879,during,0,0
159880,surgical,0,1
159881,plane,0,1
159882,anesthesia,0,1
159883,and,0,0
159884,the,0,0
159885,collected,0,0
159886,CSF,0,0
159887,samples,0,0
159888,were,0,0
159889,used,0,0
159890,to,0,0
159891,assay,0,1
159892,for,0,0
159893,human,0,1
159894,IL-10,0,0
159895,",",0,0
159896,rat,0,1
159897,IL-1?,0,0
159898,",",0,0
159899,rat,0,1
159900,IL-6,0,0
159901,",",0,0
159902,and,0,0
159903,rat,0,1
159904,TNF-?,0,0
159905,by,0,0
159906,enzyme-linked,0,0
159907,immunosorbent,0,1
159908,assay,0,1
159909,(,0,1
159910,ELISA,0,0
159911,),0,0
159912,.,0,0
159913,Animals,0,0
159914,were,0,0
159915,sacrificed,0,0
159916,and,0,0
159917,the,0,0
159918,L4-5,0,1
159919,lumbar,0,1
159920,segment,0,0
159921,of,0,0
159922,the,0,0
159923,spinal,0,0
159924,cord,0,0
159925,was,0,0
159926,removed,0,0
159927,for,0,0
159928,determination,0,0
159929,of,0,0
159930,green,0,1
159931,fluorescent,0,1
159932,protein,0,1
159933,(,0,1
159934,GFP,0,1
159935,),0,1
159936,expression,0,0
159937,.,0,1
159938,Immunohistochemical,0,0
159939,analysis,0,0
159940,was,0,0
159941,performed,0,0
159942,using,0,0
159943,anti,0,1
159944,HMGB1,0,1
159945,antibodies,0,0
159946,and,0,0
159947,the,0,0
159948,expression,0,0
159949,of,0,0
159950,HMGB1,0,1
159951,protein,0,1
159952,in,0,0
159953,the,0,0
159954,spinal,0,0
159955,cord,0,0
159956,was,0,0
159957,determined,0,0
159958,by,0,0
159959,western,0,1
159960,blot,0,0
159961,analysis,0,0
159962,after,0,0
159963,intrathecal,0,1
159964,delivery,0,1
159965,(,0,0
159966,n,0,0
159967,=,0,0
159968,8,0,0
159969,each,0,0
159970,),0,0
159971,.,0,0
159972,RESULTS,0,0
159973,The,0,0
159974,results,0,0
159975,show,0,0
159976,that,1,0
159977,intrathecal,1,1
159978,LV/hIL-10,1,1
159979,reverses,1,0
159980,enhanced,0,0
159981,pain,0,0
159982,states,0,0
159983,.,0,0
159984,Moreover,0,0
159985,",",0,0
159986,the,0,0
159987,increased,0,0
159988,level,0,0
159989,of,0,0
159990,HMGB1,0,1
159991,exhibited,0,0
159992,in,0,0
159993,a,0,0
159994,late,0,0
159995,stage,0,0
159996,of,0,0
159997,CCI,0,0
159998,was,0,0
159999,inhibited,0,0
160000,by,0,0
160001,exogenous,0,0
160002,overexpression,0,0
160003,of,0,0
160004,hIL-10,0,0
160005,in,0,0
160006,the,0,0
160007,CCI,0,0
160008,model,0,0
160009,.,0,0
160010,Expression,0,0
160011,of,0,0
160012,HMGB1,0,1
160013,",",0,0
160014,RAGE,0,1
160015,",",0,0
160016,and,0,0
160017,pAkt,0,0
160018,were,0,0
160019,lower,0,0
160020,in,0,0
160021,CCI-induced,0,0
160022,rats,0,1
160023,treated,0,0
160024,with,0,0
160025,LV/hIL-10,0,1
160026,than,0,0
160027,in,0,0
160028,those,0,0
160029,treated,0,0
160030,with,0,0
160031,LV/control,0,1
160032,(,0,1
160033,vector,0,1
160034,),0,1
160035,or,0,1
160036,saline,0,1
160037,(,0,1
160038,NS,0,0
160039,),0,0
160040,.,0,0
160041,Our,0,0
160042,results,0,0
160043,showed,0,0
160044,that,0,0
160045,IL-10,0,1
160046,inhibits,0,0
160047,activation,0,0
160048,of,0,0
160049,the,0,0
160050,inflammatory,0,0
160051,HMGB1-RAGE,0,1
160052,pathway,0,1
160053,in,0,0
160054,the,0,0
160055,CCI,0,0
160056,rat,0,1
160057,model,0,0
160058,.,0,0
160059,LIMITATIONS,0,0
160060,Further,0,0
160061,experimental,0,0
160062,investigations,0,0
160063,are,0,0
160064,needed,0,0
160065,to,0,0
160066,clarify,0,0
160067,the,0,0
160068,specific,0,0
160069,biological,0,0
160070,roles,0,0
160071,played,0,0
160072,by,0,0
160073,HMGB1,0,1
160074,in,0,0
160075,IL-10-mediated,0,0
160076,regulation,0,0
160077,of,0,0
160078,neuropathic,0,0
160079,pain,0,0
160080,.,0,0
160081,CONCLUSION,0,0
160082,Our,0,0
160083,results,0,0
160084,indicate,0,0
160085,that,0,0
160086,intrathecal,0,1
160087,lentiviral-mediated,0,1
160088,transfer,0,0
160089,of,1,0
160090,IL-10,1,1
160091,attenuates,1,0
160092,CCI-induced,0,0
160093,neuropathic,0,0
160094,pain,0,0
160095,in,0,0
160096,rats,0,1
160097,.,0,0
160098,The,0,0
160099,anti-thermal,0,1
160100,hyperalgesia,0,0
160101,and,0,0
160102,anti-mechanical,0,1
160103,allodynia,0,0
160104,may,0,0
160105,be,0,0
160106,partly,0,0
160107,attributable,0,0
160108,to,0,0
160109,the,0,0
160110,decreased,0,0
160111,expression,0,0
160112,of,0,0
160113,HMGB1,0,1
160114,and,0,0
160115,inhibition,0,0
160116,of,0,0
160117,HMGB1-RAGE,0,1
160118,pathway,0,0
160119,.,0,0
160120,18F-FDG,1,0
160121,PET/CT,1,1
160122,for,0,0
160123,early,0,0
160124,prediction,0,0
160125,of,0,0
160126,response,0,0
160127,to,0,0
160128,neoadjuvant,1,1
160129,lapatinib,1,1
160130,",",1,0
160131,trastuzumab,1,1
160132,",",1,0
160133,and,1,0
160134,their,1,0
160135,combination,1,1
160136,in,0,0
160137,HER2-positive,0,0
160138,breast,0,0
160139,cancer,0,0
160140,:,0,0
160141,results,0,0
160142,from,0,0
160143,Neo-ALTTO,0,1
160144,.,0,0
160145,UNLABELLED,0,0
160146,Molecular,0,0
160147,imaging,0,0
160148,receives,0,0
160149,increased,0,0
160150,attention,0,0
160151,for,0,0
160152,selecting,0,0
160153,patients,0,0
160154,who,0,0
160155,will,0,0
160156,benefit,0,0
160157,from,0,0
160158,targeted,0,1
160159,anticancer,0,1
160160,therapies,0,1
160161,.,0,0
160162,Neo-ALTTO,1,0
160163,(,1,0
160164,Neoadjuvant,1,1
160165,Lapatinib,1,1
160166,and/or,1,0
160167,Trastuzumab,1,1
160168,Treatment,0,1
160169,Optimisation,0,0
160170,),0,0
160171,enrolled,0,0
160172,455,0,0
160173,women,0,0
160174,with,0,0
160175,invasive,0,0
160176,human,0,1
160177,epidermal,0,1
160178,growth,0,1
160179,factor,0,1
160180,receptor,0,0
160181,2,0,0
160182,(,0,0
160183,HER2,0,1
160184,),0,1
160185,-positive,0,0
160186,breast,0,0
160187,cancer,0,0
160188,and,0,0
160189,compared,0,0
160190,rates,0,0
160191,of,0,0
160192,pathologic,0,0
160193,complete,0,0
160194,response,0,0
160195,(,0,1
160196,pCR,0,0
160197,),0,1
160198,to,0,0
160199,neoadjuvant,1,1
160200,lapatinib,1,1
160201,",",1,0
160202,trastuzumab,1,1
160203,",",1,0
160204,and,1,0
160205,their,1,0
160206,combination,1,1
160207,.,1,0
160208,Each,0,0
160209,anti-HER2,1,1
160210,therapy,1,1
160211,was,0,0
160212,given,0,0
160213,alone,0,1
160214,for,0,0
160215,6,0,0
160216,wk,0,0
160217,",",0,0
160218,followed,0,1
160219,by,0,0
160220,12,0,0
160221,wk,0,0
160222,of,0,0
160223,the,0,0
160224,same,0,0
160225,therapy,0,1
160226,plus,0,1
160227,weekly,0,1
160228,paclitaxel,1,1
160229,.,1,0
160230,The,0,0
160231,early,0,0
160232,metabolic,0,0
160233,effects,0,0
160234,of,0,0
160235,the,0,0
160236,anti-HER2,1,1
160237,therapies,1,0
160238,on,0,0
160239,the,0,0
160240,primary,0,0
160241,tumors,0,0
160242,and,0,0
160243,their,0,0
160244,predictive,0,0
160245,values,0,0
160246,for,0,0
160247,pCR,0,0
160248,were,0,0
160249,assessed,0,0
160250,in,0,0
160251,a,0,0
160252,subset,0,0
160253,of,0,0
160254,patients,0,0
160255,.,0,0
160256,METHODS,0,0
160257,Eighty-six,0,0
160258,patients,0,0
160259,underwent,0,0
160260,(,1,0
160261,18,1,0
160262,),1,0
160263,F-FDG,1,0
160264,PET/CT,1,1
160265,at,0,0
160266,baseline,0,0
160267,and,0,0
160268,weeks,0,1
160269,2,0,0
160270,and,0,0
160271,6,0,0
160272,of,0,0
160273,anti-HER2,1,1
160274,treatment,1,0
160275,.,1,0
160276,An,0,0
160277,imaging,0,0
160278,core,0,0
160279,laboratory,0,0
160280,provided,0,0
160281,central,0,0
160282,validation,0,0
160283,",",0,0
160284,and,0,0
160285,2,0,0
160286,independent,0,0
160287,reviewers,0,0
160288,",",0,0
160289,masked,0,0
160290,to,0,0
160291,assigned,0,0
160292,treatment,0,1
160293,arm,0,0
160294,and,0,0
160295,clinical,0,0
160296,outcomes,0,0
160297,",",0,0
160298,performed,0,0
160299,consensus,0,0
160300,(,0,1
160301,18,0,0
160302,),0,0
160303,F-FDG,0,0
160304,PET/CT,0,1
160305,readings,0,0
160306,.,0,0
160307,Maximum,0,0
160308,standardized,0,0
160309,uptake,0,0
160310,value,0,0
160311,(,0,1
160312,SUVmax,0,1
160313,),0,1
160314,reductions,0,0
160315,from,0,0
160316,baseline,0,0
160317,were,0,0
160318,used,0,0
160319,to,0,0
160320,measure,0,0
160321,metabolic,0,0
160322,response,0,0
160323,.,0,0
160324,RESULTS,0,0
160325,Seventy-seven,0,0
160326,of,0,0
160327,the,0,0
160328,86,0,0
160329,enrolled,0,0
160330,patients,0,0
160331,presented,0,0
160332,an,0,0
160333,evaluable,0,0
160334,baseline,0,0
160335,(,0,1
160336,18,0,0
160337,),0,0
160338,F-FDG,0,0
160339,PET/CT,0,1
160340,scan,0,1
160341,;,0,0
160342,of,0,0
160343,these,0,0
160344,",",0,0
160345,68,0,0
160346,and,0,0
160347,66,0,0
160348,were,0,0
160349,evaluable,0,0
160350,at,0,0
160351,weeks,0,0
160352,2,0,0
160353,and,0,0
160354,6,0,0
160355,",",0,0
160356,respectively,0,0
160357,.,0,0
160358,Metabolic,0,0
160359,responses,0,0
160360,in,0,0
160361,the,0,0
160362,primary,0,0
160363,tumors,0,0
160364,were,0,0
160365,evident,0,0
160366,after,0,0
160367,2,0,0
160368,wk,0,0
160369,of,0,0
160370,targeted,0,1
160371,therapy,0,1
160372,and,0,0
160373,correlated,0,0
160374,highly,0,0
160375,with,0,0
160376,metabolic,0,0
160377,responses,0,0
160378,at,0,0
160379,week,0,0
160380,6,0,1
160381,(,0,0
160382,R,0,1
160383,(,0,1
160384,2,0,0
160385,),0,0
160386,=,0,0
160387,0.81,0,0
160388,),0,0
160389,.,0,0
160390,pCRs,0,0
160391,were,0,0
160392,associated,0,0
160393,with,0,0
160394,greater,0,0
160395,SUVmax,0,0
160396,reductions,0,0
160397,at,0,0
160398,both,0,0
160399,time,0,0
160400,points,0,0
160401,.,0,0
160402,Mean,0,0
160403,SUVmax,0,0
160404,reductions,0,0
160405,for,0,0
160406,pCR,0,0
160407,and,0,0
160408,non-pCR,0,0
160409,",",0,0
160410,respectively,0,0
160411,",",0,0
160412,were,0,0
160413,54.3,0,0
160414,%,0,0
160415,versus,0,1
160416,32.8,0,0
160417,%,0,0
160418,at,0,0
160419,week,0,0
160420,2,0,0
160421,(,0,0
160422,P,0,0
160423,=,0,0
160424,0.02,0,0
160425,),0,0
160426,and,0,0
160427,61.5,0,0
160428,%,0,0
160429,versus,0,1
160430,34.1,0,0
160431,%,0,0
160432,at,0,0
160433,week,0,0
160434,6,0,1
160435,(,0,0
160436,P,0,0
160437,=,0,0
160438,0.02,0,0
160439,),0,0
160440,.,0,0
160441,(,0,0
160442,18,0,0
160443,),0,0
160444,F-FDG,0,0
160445,PET/CT,0,1
160446,metabolic,0,0
160447,response,0,0
160448,rates,0,0
160449,at,0,0
160450,weeks,0,0
160451,2,0,0
160452,and,0,0
160453,6,0,0
160454,were,0,0
160455,71.6,0,0
160456,%,0,0
160457,and,0,0
160458,60,0,0
160459,%,0,0
160460,",",0,0
160461,respectively,0,0
160462,using,0,0
160463,European,0,0
160464,Organization,0,1
160465,for,0,0
160466,Research,0,0
160467,and,0,0
160468,Treatment,0,1
160469,of,0,0
160470,Cancer,0,0
160471,criteria,0,0
160472,;,0,0
160473,pCR,0,0
160474,rates,0,0
160475,were,0,0
160476,twice,0,0
160477,as,0,0
160478,high,0,0
160479,for,0,0
160480,(,0,0
160481,18,0,0
160482,),0,0
160483,F-FDG,0,0
160484,PET/CT,0,1
160485,responders,0,0
160486,than,0,0
160487,nonresponders,0,0
160488,(,0,0
160489,week,0,0
160490,2,0,0
160491,:,0,0
160492,42,0,0
160493,%,0,0
160494,vs.,0,0
160495,21,0,0
160496,%,0,0
160497,",",0,0
160498,P,0,0
160499,=,0,0
160500,0.12,0,0
160501,;,0,0
160502,week,0,0
160503,6,0,0
160504,:,0,0
160505,44,0,0
160506,%,0,0
160507,vs.,0,0
160508,19,0,0
160509,%,0,0
160510,",",0,0
160511,P,0,0
160512,=,0,0
160513,0.05,0,0
160514,),0,0
160515,.,0,0
160516,CONCLUSION,0,0
160517,Early,0,1
160518,metabolic,0,0
160519,assessment,0,0
160520,using,0,0
160521,(,0,1
160522,18,0,0
160523,),0,0
160524,F-FDG,0,0
160525,PET/CT,0,0
160526,can,0,0
160527,identify,0,0
160528,patients,0,0
160529,with,0,0
160530,an,0,0
160531,increased,0,0
160532,likelihood,0,0
160533,of,0,0
160534,pCR,0,0
160535,after,0,0
160536,neoadjuvant,1,1
160537,trastuzumab,1,1
160538,",",1,0
160539,lapatinib,1,1
160540,",",1,0
160541,or,1,1
160542,their,1,0
160543,combination,1,1
160544,when,0,0
160545,given,0,0
160546,with,0,0
160547,chemotherapy,1,1
160548,.,1,0
160549,Immunological,0,0
160550,changes,0,0
160551,after,0,0
160552,minimally,1,1
160553,invasive,1,0
160554,or,1,1
160555,conventional,1,1
160556,esophageal,1,0
160557,resection,1,1
160558,for,0,0
160559,cancer,0,0
160560,:,0,0
160561,a,0,0
160562,randomized,0,0
160563,trial,0,0
160564,.,0,0
160565,BACKGROUND,0,0
160566,This,0,0
160567,study,0,0
160568,was,0,0
160569,performed,0,0
160570,as,0,0
160571,a,0,0
160572,substudy,0,0
160573,analysis,0,0
160574,of,0,0
160575,a,0,0
160576,randomized,0,0
160577,trial,0,0
160578,comparing,0,0
160579,conventional,1,1
160580,open,1,1
160581,esophagectomy,1,1
160582,[,0,0
160583,open,0,1
160584,surgical,0,1
160585,technique,0,1
160586,(,0,1
160587,OE,0,1
160588,),0,1
160589,],0,0
160590,by,0,1
160591,thoracotomy,1,1
160592,and,1,0
160593,laparotomy,1,1
160594,with,0,0
160595,minimally,1,1
160596,invasive,1,0
160597,esophagectomy,1,1
160598,[,1,0
160599,minimally,1,1
160600,invasive,1,0
160601,procedure,1,1
160602,(,1,1
160603,MIE,1,1
160604,),1,1
160605,],1,0
160606,by,1,1
160607,thoracoscopy,1,1
160608,and,1,0
160609,laparoscopy,1,1
160610,.,1,0
160611,This,0,0
160612,additional,0,0
160613,analysis,0,0
160614,focuses,0,0
160615,on,0,0
160616,the,0,0
160617,immunological,0,0
160618,changes,0,0
160619,and,0,0
160620,surgical,0,1
160621,stress,0,0
160622,response,0,0
160623,in,0,0
160624,these,0,0
160625,two,0,0
160626,randomized,0,0
160627,groups,0,0
160628,of,0,0
160629,a,0,0
160630,single,0,0
160631,center,0,0
160632,.,0,0
160633,METHODS,0,0
160634,Patients,0,0
160635,with,0,0
160636,a,0,0
160637,resectable,0,0
160638,esophageal,0,0
160639,cancer,0,0
160640,were,0,0
160641,randomized,0,0
160642,to,0,0
160643,OE,0,1
160644,(,0,0
160645,n,0,0
160646,=,0,0
160647,13,0,0
160648,),0,0
160649,or,0,1
160650,MIE,0,1
160651,(,0,1
160652,n,0,0
160653,=,0,0
160654,14,0,0
160655,),0,0
160656,.,0,0
160657,All,0,0
160658,patients,0,0
160659,received,0,0
160660,neoadjuvant,1,1
160661,chemoradiotherapy,1,0
160662,.,1,0
160663,The,0,0
160664,immunological,0,0
160665,response,0,0
160666,was,0,0
160667,measured,0,0
160668,by,0,0
160669,means,0,0
160670,of,0,0
160671,leukocyte,0,0
160672,counts,0,0
160673,",",0,0
160674,HLA-DR,0,1
160675,expression,0,0
160676,on,0,0
160677,monocytes,0,0
160678,",",0,0
160679,the,0,0
160680,acute-phase,0,0
160681,response,0,0
160682,by,0,0
160683,means,0,0
160684,of,0,0
160685,C-reactive,0,0
160686,protein,0,1
160687,(,0,1
160688,CRP,0,1
160689,),0,1
160690,",",0,0
160691,interleukin-6,0,1
160692,(,0,1
160693,IL-6,0,1
160694,),0,1
160695,",",0,0
160696,and,0,0
160697,interleukin-8,0,1
160698,(,0,1
160699,IL-8,0,1
160700,),0,1
160701,",",0,0
160702,and,0,0
160703,the,0,0
160704,stress,0,0
160705,response,0,0
160706,was,0,0
160707,measured,0,0
160708,by,0,0
160709,cortisol,0,0
160710,",",0,0
160711,growth,0,0
160712,hormone,0,1
160713,",",0,0
160714,and,0,0
160715,prolactin,0,0
160716,.,0,0
160717,All,0,0
160718,parameters,0,0
160719,were,0,0
160720,determined,0,0
160721,at,0,0
160722,baseline,0,0
160723,(,0,1
160724,preoperatively,0,1
160725,),0,1
160726,and,0,0
160727,24,0,0
160728,",",0,0
160729,72,0,0
160730,",",0,0
160731,96,0,0
160732,",",0,0
160733,and,0,0
160734,168,0,0
160735,h,0,0
160736,postoperatively,0,0
160737,.,0,0
160738,RESULTS,0,0
160739,Significant,0,0
160740,differences,0,0
160741,between,0,0
160742,the,0,0
160743,two,0,0
160744,groups,0,0
160745,were,0,0
160746,seen,0,0
160747,in,0,0
160748,favor,0,0
160749,of,0,0
160750,the,0,0
160751,MIE,0,0
160752,group,0,0
160753,with,0,0
160754,regard,0,0
160755,to,0,0
160756,leukocyte,0,0
160757,counts,0,0
160758,",",0,0
160759,IL-8,0,0
160760,",",0,0
160761,and,0,0
160762,prolactin,0,0
160763,at,0,0
160764,168,0,0
160765,h,0,0
160766,(,0,0
160767,1,0,1
160768,week,0,0
160769,),0,0
160770,postoperatively,0,0
160771,.,0,0
160772,For,0,0
160773,HLA-DR,0,0
160774,expression,0,0
160775,",",0,0
160776,IL-6,0,1
160777,",",0,0
160778,and,0,0
160779,CRP,0,1
160780,levels,0,0
160781,",",0,0
160782,there,0,0
160783,were,0,0
160784,no,0,0
160785,significant,0,0
160786,differences,0,0
160787,between,0,0
160788,the,0,0
160789,two,0,0
160790,groups,0,0
160791,",",0,0
160792,although,0,0
160793,there,0,0
160794,was,0,0
160795,a,0,0
160796,clear,0,1
160797,rise,0,0
160798,in,0,0
160799,levels,0,0
160800,upon,0,0
160801,operation,0,0
160802,in,0,0
160803,both,0,0
160804,groups,0,0
160805,.,0,0
160806,CONCLUSION,0,0
160807,In,0,0
160808,this,0,0
160809,substudy,0,0
160810,of,0,0
160811,a,0,0
160812,randomized,0,0
160813,trial,0,0
160814,comparing,0,0
160815,minimally,0,1
160816,invasive,0,0
160817,and,0,0
160818,conventional,0,1
160819,open,0,1
160820,esophagectomies,0,0
160821,for,0,0
160822,cancer,0,0
160823,",",0,0
160824,significantly,0,0
160825,better,0,0
160826,preserved,0,0
160827,leukocyte,0,0
160828,counts,0,0
160829,and,0,0
160830,IL-8,0,0
160831,levels,0,0
160832,were,0,0
160833,observed,0,0
160834,in,0,0
160835,the,0,0
160836,MIE,0,0
160837,group,0,0
160838,compared,0,0
160839,to,0,0
160840,the,0,0
160841,open,0,1
160842,group,0,0
160843,.,0,0
160844,Both,0,0
160845,findings,0,0
160846,can,0,0
160847,be,0,0
160848,related,0,0
160849,to,0,0
160850,fewer,0,0
160851,respiratory,0,0
160852,infections,0,0
160853,found,0,0
160854,postoperatively,0,0
160855,in,0,0
160856,the,0,0
160857,MIE,0,0
160858,group,0,0
160859,.,0,0
160860,Moreover,0,0
160861,",",0,0
160862,significant,0,0
160863,differences,0,0
160864,in,0,0
160865,the,0,0
160866,prolactin,0,0
160867,levels,0,0
160868,at,0,0
160869,168,0,0
160870,h,0,0
160871,after,0,0
160872,surgery,0,1
160873,imply,0,0
160874,that,0,0
160875,the,0,0
160876,stress,0,0
160877,response,0,0
160878,is,0,0
160879,better,0,0
160880,preserved,0,0
160881,in,0,0
160882,the,0,0
160883,MIE,1,0
160884,group,0,0
160885,.,0,0
160886,These,0,0
160887,findings,0,0
160888,indicate,0,0
160889,that,0,0
160890,less,0,0
160891,surgical,0,0
160892,trauma,0,0
160893,could,0,0
160894,lead,0,0
160895,to,0,0
160896,better,0,0
160897,preserved,0,0
160898,acute-phase,0,0
160899,and,0,0
160900,stress,0,0
160901,responses,0,0
160902,and,0,0
160903,fewer,0,0
160904,clinical,0,0
160905,manifestations,0,0
160906,of,0,0
160907,respiratory,0,0
160908,infections,0,0
160909,.,0,0
160910,Comparison,1,0
160911,of,1,0
160912,three,1,0
160913,software,1,1
160914,systems,1,0
160915,for,0,0
160916,semi-automatic,0,1
160917,volumetry,0,0
160918,of,0,0
160919,pulmonary,0,0
160920,nodules,0,0
160921,on,0,0
160922,baseline,0,0
160923,and,0,0
160924,follow-up,0,0
160925,CT,0,0
160926,examinations,0,0
160927,.,0,0
160928,BACKGROUND,0,0
160929,Early,0,1
160930,diagnosis,0,0
160931,of,0,0
160932,lung,0,0
160933,cancer,0,0
160934,in,0,0
160935,a,0,0
160936,treatable,0,0
160937,stage,0,0
160938,is,0,0
160939,the,0,0
160940,main,0,0
160941,purpose,0,0
160942,of,0,0
160943,lung,0,0
160944,cancer,0,0
160945,screening,0,0
160946,by,0,0
160947,computed,1,1
160948,tomography,1,1
160949,(,1,1
160950,CT,1,1
160951,),1,0
160952,.,1,0
160953,Accurate,0,0
160954,three-dimensional,0,1
160955,size,0,0
160956,and,0,0
160957,growth,0,0
160958,measurements,0,1
160959,are,0,0
160960,essential,0,0
160961,to,0,0
160962,assess,0,0
160963,the,0,0
160964,risk,0,0
160965,of,0,0
160966,malignancy,0,0
160967,.,0,0
160968,Nodule,0,0
160969,volumes,0,0
160970,can,0,0
160971,be,0,0
160972,calculated,0,0
160973,by,0,0
160974,using,0,0
160975,semi-automated,0,1
160976,volumetric,0,0
160977,software,0,1
160978,.,0,0
160979,Systematic,0,0
160980,differences,0,0
160981,in,0,0
160982,volume,0,0
160983,measurements,0,0
160984,between,0,0
160985,packages,0,1
160986,could,0,0
160987,influence,0,0
160988,nodule,0,0
160989,categorization,0,0
160990,and,0,0
160991,management,0,1
160992,decisions,0,0
160993,.,0,0
160994,PURPOSE,0,0
160995,To,0,0
160996,compare,0,0
160997,volumetric,0,0
160998,measurements,0,0
160999,of,0,0
161000,solid,0,0
161001,pulmonary,0,0
161002,nodules,0,0
161003,on,0,0
161004,baseline,0,0
161005,and,0,0
161006,follow-up,0,0
161007,CT,1,1
161008,scans,1,0
161009,as,0,0
161010,well,0,0
161011,as,0,0
161012,the,0,0
161013,volume,0,0
161014,doubling,0,0
161015,time,0,0
161016,(,0,1
161017,VDT,0,1
161018,),0,1
161019,for,0,0
161020,three,1,0
161021,software,1,1
161022,packages,1,1
161023,.,1,0
161024,MATERIAL,0,0
161025,AND,0,0
161026,METHODS,0,0
161027,From,0,0
161028,a,0,0
161029,Lung,0,1
161030,Cancer,0,1
161031,Screening,0,1
161032,study,0,0
161033,(,0,1
161034,NELSON,0,1
161035,),0,0
161036,",",0,0
161037,50,0,0
161038,participants,0,0
161039,were,0,0
161040,randomly,0,0
161041,selected,0,0
161042,from,0,0
161043,the,0,0
161044,baseline,0,0
161045,round,0,0
161046,.,0,0
161047,The,0,0
161048,study,0,0
161049,population,0,0
161050,comprised,0,0
161051,participants,0,0
161052,with,0,0
161053,at,0,0
161054,least,0,0
161055,one,0,0
161056,pulmonary,0,0
161057,nodule,0,0
161058,at,0,0
161059,the,0,0
161060,baseline,0,0
161061,and,0,0
161062,consecutive,0,0
161063,CT,0,1
161064,examination,0,0
161065,.,0,0
161066,The,0,0
161067,volume,0,0
161068,of,0,0
161069,each,0,0
161070,nodule,0,0
161071,was,0,0
161072,determined,0,0
161073,for,0,0
161074,both,0,0
161075,time,0,0
161076,points,0,0
161077,using,0,0
161078,three,1,0
161079,semi-automated,1,0
161080,software,1,1
161081,packages,1,1
161082,(,1,0
161083,P1,1,0
161084,",",1,0
161085,P2,1,1
161086,",",1,0
161087,and,1,0
161088,P3,1,0
161089,),1,0
161090,.,0,0
161091,Manual,0,0
161092,modification,0,0
161093,was,0,0
161094,performed,0,0
161095,when,0,0
161096,automated,0,0
161097,assessment,0,0
161098,was,0,0
161099,visually,0,0
161100,inaccurate,0,0
161101,.,0,0
161102,VDT,0,0
161103,was,0,0
161104,calculated,0,0
161105,to,0,0
161106,evaluate,0,0
161107,nodule,0,0
161108,growth,0,0
161109,.,0,0
161110,Volume,0,0
161111,",",0,0
161112,VDT,0,1
161113,",",0,0
161114,and,0,0
161115,nodule,0,0
161116,management,0,1
161117,were,0,0
161118,compared,0,0
161119,for,0,0
161120,the,0,0
161121,three,0,0
161122,software,0,1
161123,packages,0,1
161124,",",0,0
161125,using,0,0
161126,P1,0,0
161127,as,0,0
161128,the,0,0
161129,reference,0,0
161130,standard,0,1
161131,.,0,0
161132,RESULTS,0,0
161133,In,0,0
161134,25,0,0
161135,participants,0,0
161136,",",0,0
161137,147,0,0
161138,nodules,0,0
161139,were,0,0
161140,present,0,0
161141,on,0,0
161142,both,0,0
161143,examinations,0,1
161144,(,0,0
161145,volume,0,0
161146,:,0,1
161147,12.0-436.6,0,0
161148,mm,0,0
161149,(,0,1
161150,3,0,1
161151,),0,0
161152,),0,0
161153,.,0,0
161154,Initial,0,0
161155,segmentation,0,0
161156,at,0,0
161157,baseline,0,0
161158,was,0,0
161159,evaluated,0,0
161160,to,0,0
161161,be,0,0
161162,satisfactory,0,0
161163,in,0,0
161164,93.9,0,0
161165,%,0,0
161166,of,0,0
161167,nodules,0,0
161168,for,0,0
161169,P1,0,0
161170,",",0,0
161171,84.4,0,0
161172,%,0,0
161173,for,0,0
161174,P2,0,1
161175,",",0,0
161176,and,0,0
161177,88.4,0,0
161178,%,0,0
161179,for,0,0
161180,P3,0,0
161181,.,0,0
161182,Significant,0,0
161183,difference,0,0
161184,was,0,0
161185,found,0,0
161186,in,0,0
161187,measured,0,0
161188,volume,0,0
161189,between,0,0
161190,P1,0,0
161191,and,0,0
161192,the,0,0
161193,other,0,0
161194,two,0,0
161195,packages,0,1
161196,(,0,0
161197,P,0,0
161198,<,0,0
161199,0.001,0,0
161200,),0,0
161201,.,0,0
161202,P2,0,1
161203,overestimated,0,0
161204,the,0,0
161205,volume,0,0
161206,by,0,0
161207,38,0,0
161208,?,0,0
161209,24,0,0
161210,%,0,0
161211,",",0,0
161212,and,0,0
161213,P3,0,0
161214,by,0,0
161215,50,0,0
161216,?,0,0
161217,22,0,0
161218,%,0,0
161219,.,0,0
161220,At,0,0
161221,baseline,0,0
161222,",",0,0
161223,there,0,0
161224,was,0,0
161225,consensus,0,0
161226,on,0,0
161227,nodule,0,0
161228,size,0,0
161229,categorization,0,0
161230,in,0,0
161231,80,0,0
161232,%,0,0
161233,for,0,0
161234,P1,0,0
161235,&,0,1
161236,P2,0,1
161237,and,0,0
161238,74,0,0
161239,%,0,0
161240,for,0,0
161241,P1,0,0
161242,&,0,1
161243,P3,0,0
161244,.,0,0
161245,At,0,0
161246,follow-up,0,0
161247,",",0,0
161248,consensus,0,0
161249,on,0,0
161250,VDT,0,1
161251,categorization,0,0
161252,was,0,0
161253,present,0,0
161254,in,0,0
161255,47,0,0
161256,%,0,0
161257,for,0,0
161258,P1,0,0
161259,&,0,1
161260,P2,0,1
161261,and,0,0
161262,44,0,0
161263,%,0,0
161264,for,0,0
161265,P1,0,0
161266,&,0,1
161267,P3,0,0
161268,.,0,0
161269,CONCLUSION,1,0
161270,Software,1,1
161271,packages,1,1
161272,for,1,0
161273,lung,1,0
161274,nodule,1,0
161275,evaluation,1,0
161276,yield,1,0
161277,significant,0,0
161278,differences,0,0
161279,in,0,0
161280,volumetric,0,0
161281,measurements,0,0
161282,and,0,0
161283,VDT,0,1
161284,.,0,0
161285,This,0,0
161286,variation,0,0
161287,affects,0,0
161288,the,0,0
161289,classification,0,0
161290,of,0,0
161291,lung,0,0
161292,nodules,0,0
161293,",",0,0
161294,especially,0,0
161295,in,0,0
161296,follow-up,0,0
161297,examinations,0,0
161298,.,0,0
161299,Comparative,0,0
161300,study,0,0
161301,of,0,0
161302,actinic,0,0
161303,keratosis,0,0
161304,treatment,0,0
161305,with,0,0
161306,3,1,0
161307,%,1,0
161308,diclofenac,1,1
161309,sodium,1,1
161310,and,1,0
161311,5,1,1
161312,%,1,0
161313,5-fluorouracil,1,1
161314,.,1,0
161315,BACKGROUND,0,0
161316,Actinic,0,1
161317,keratosis,0,0
161318,is,0,0
161319,a,0,0
161320,frequent,0,0
161321,lesion,0,0
161322,which,0,0
161323,occurs,0,0
161324,in,0,0
161325,sunlight,0,0
161326,exposed,0,0
161327,areas,0,0
161328,.,0,0
161329,Diclofenac,1,1
161330,sodium,1,1
161331,and,1,0
161332,5-Fluorouracil,1,1
161333,are,0,0
161334,effective,0,0
161335,",",0,0
161336,non-invasive,0,1
161337,and,0,0
161338,easy-to-apply,0,0
161339,topical,0,1
161340,treatment,0,0
161341,options,0,0
161342,.,0,0
161343,OBJECTIVES,0,0
161344,To,0,0
161345,assess,0,0
161346,and,0,0
161347,compare,0,0
161348,the,0,0
161349,effectiveness,0,0
161350,of,0,0
161351,3,1,0
161352,%,1,0
161353,diclofenac,1,1
161354,sodium,1,1
161355,associated,0,0
161356,with,0,0
161357,2.5,1,0
161358,%,1,0
161359,hyaluronic,1,1
161360,acid,1,1
161361,and,1,0
161362,of,1,0
161363,5,1,1
161364,%,1,0
161365,5-Fluorouracil,1,1
161366,for,0,0
161367,the,0,0
161368,treatment,0,0
161369,of,0,0
161370,actinic,0,0
161371,keratosis,0,0
161372,",",0,0
161373,as,0,0
161374,well,0,0
161375,as,0,0
161376,the,0,0
161377,patient,0,0
161378,'s,0,0
161379,degree,0,0
161380,of,0,0
161381,satisfaction,0,0
161382,and,0,0
161383,tolerability,0,0
161384,.,0,0
161385,METHODS,0,0
161386,28,0,0
161387,patients,0,0
161388,with,0,0
161389,a,0,0
161390,clinical,0,0
161391,diagnosis,0,0
161392,of,0,0
161393,actinic,0,0
161394,keratosis,0,0
161395,were,0,0
161396,randomized,0,0
161397,to,0,0
161398,receive,0,0
161399,diclofenac,1,1
161400,sodium,1,1
161401,or,1,1
161402,5-Fluorouracil,1,1
161403,and,0,0
161404,were,0,0
161405,clinically,0,0
161406,assessed,0,0
161407,before,0,0
161408,and,0,0
161409,after,0,0
161410,treatment,0,0
161411,as,0,0
161412,well,0,0
161413,as,0,0
161414,8,0,0
161415,weeks,0,0
161416,after,0,0
161417,the,0,0
161418,end,0,0
161419,of,0,0
161420,treatment,0,0
161421,.,0,0
161422,Modified,0,0
161423,versions,0,0
161424,of,0,0
161425,the,0,0
161426,Investigator,0,0
161427,and,0,0
161428,Patient,0,1
161429,Global,0,0
161430,Improvement,0,0
161431,Scores,0,0
161432,were,0,0
161433,used,0,0
161434,.,0,0
161435,RESULTS,0,0
161436,The,0,0
161437,average,0,0
161438,number,0,0
161439,of,0,0
161440,lesions,0,0
161441,in,0,0
161442,the,0,0
161443,diclofenac,1,1
161444,sodium,1,1
161445,group,0,0
161446,before,0,0
161447,and,0,0
161448,after,0,0
161449,treatment,0,0
161450,was,0,0
161451,13.6,0,0
161452,and,0,0
161453,6.6,0,0
161454,(,0,0
161455,p,0,0
161456,<,0,0
161457,"0,001",0,0
161458,),0,0
161459,",",0,0
161460,respectively,0,0
161461,",",0,0
161462,while,0,0
161463,it,0,0
161464,was,0,0
161465,17.4,0,0
161466,and,0,0
161467,3.15,0,0
161468,(,0,0
161469,p,0,0
161470,<,0,0
161471,0.001,0,0
161472,),0,0
161473,in,0,0
161474,the,0,0
161475,5-Fluorouracil,1,1
161476,group,0,0
161477,.,0,0
161478,There,0,0
161479,was,0,0
161480,a,0,0
161481,significant,0,0
161482,reduction,0,0
161483,in,0,0
161484,the,0,0
161485,number,0,0
161486,of,0,0
161487,lesions,0,0
161488,in,0,0
161489,the,0,0
161490,5-Fluorouracil,1,1
161491,group,0,0
161492,in,0,0
161493,relation,0,0
161494,to,0,0
161495,the,0,0
161496,diclofenac,1,1
161497,sodium,0,1
161498,group,0,1
161499,(,0,0
161500,p,0,0
161501,<,0,0
161502,0.001,0,0
161503,),0,0
161504,.,0,0
161505,To,0,0
161506,the,0,0
161507,non-blinded,0,0
161508,physician,0,1
161509,",",0,0
161510,there,0,0
161511,was,0,0
161512,a,0,0
161513,higher,0,0
161514,satisfactory,0,0
161515,therapeutic,0,0
161516,response,0,0
161517,in,0,0
161518,the,0,0
161519,5-Fluorouracil,1,1
161520,group,0,0
161521,(,0,0
161522,p,0,0
161523,<,0,0
161524,0.001,0,0
161525,),0,0
161526,;,0,0
161527,to,0,0
161528,the,0,0
161529,blinded,0,0
161530,physician,0,1
161531,",",0,0
161532,there,0,0
161533,was,0,0
161534,a,0,0
161535,higher,0,0
161536,satisfactory,0,0
161537,response,0,0
161538,in,0,0
161539,this,0,0
161540,same,0,0
161541,group,0,0
161542,",",0,0
161543,although,0,0
161544,not,0,0
161545,statistically,0,0
161546,significant,0,0
161547,(,0,1
161548,p=0.09,0,0
161549,),0,0
161550,.,0,0
161551,There,0,0
161552,was,0,0
161553,a,0,0
161554,high,0,0
161555,degree,0,0
161556,of,0,0
161557,satisfaction,0,0
161558,in,0,0
161559,both,0,0
161560,groups,0,0
161561,(,0,0
161562,73,0,0
161563,%,0,0
161564,in,0,0
161565,the,0,0
161566,diclofenac,1,1
161567,sodium,0,1
161568,group,0,0
161569,and,0,0
161570,77,0,0
161571,%,0,0
161572,in,0,0
161573,the,0,0
161574,5-Fluorouracil,1,1
161575,group,0,0
161576,;,0,1
161577,p=0.827,0,0
161578,),0,0
161579,.,0,0
161580,Regarding,0,0
161581,adverse,0,0
161582,effects,0,0
161583,",",0,0
161584,the,0,0
161585,diclofenac,1,1
161586,sodium,1,1
161587,group,0,0
161588,presented,0,0
161589,a,0,0
161590,higher,0,0
161591,degree,0,0
161592,of,0,0
161593,satisfaction,0,0
161594,(,0,0
161595,93.3,0,0
161596,%,0,0
161597,vs,0,0
161598,38.4,0,0
161599,%,0,0
161600,;,0,0
161601,p=0.008,0,0
161602,),0,0
161603,.,0,0
161604,Erythema,0,0
161605,",",0,0
161606,edema,0,0
161607,",",0,0
161608,crusts,0,0
161609,and,0,0
161610,itching,0,0
161611,were,0,0
161612,significantly,0,0
161613,higher,0,0
161614,in,0,0
161615,the,0,0
161616,5-Fluorouracil,1,1
161617,group,0,0
161618,.,0,0
161619,CONCLUSION,0,0
161620,We,0,0
161621,concluded,0,0
161622,that,0,0
161623,5-Fluorouracil,1,1
161624,was,0,0
161625,more,0,0
161626,effective,0,0
161627,;,0,0
161628,however,0,0
161629,",",0,0
161630,it,0,0
161631,showed,0,0
161632,lower,0,0
161633,tolerability,0,0
161634,than,0,0
161635,diclofenac,1,1
161636,sodium,1,1
161637,.,1,0
161638,Evaluating,0,0
161639,proton,1,1
161640,stereotactic,1,1
161641,body,1,0
161642,radiotherapy,1,1
161643,to,0,0
161644,reduce,0,0
161645,chest,0,1
161646,wall,0,0
161647,dose,0,0
161648,in,0,0
161649,the,0,0
161650,treatment,0,0
161651,of,0,0
161652,lung,0,0
161653,cancer,0,0
161654,.,0,0
161655,Stereotactic,1,1
161656,body,1,0
161657,radiotherapy,1,1
161658,(,1,1
161659,SBRT,1,1
161660,),1,1
161661,can,0,0
161662,produce,0,0
161663,excellent,0,0
161664,local,0,1
161665,control,0,1
161666,of,0,0
161667,several,0,0
161668,types,0,0
161669,of,0,0
161670,solid,0,0
161671,tumor,0,0
161672,;,0,0
161673,however,0,0
161674,",",0,0
161675,toxicity,0,0
161676,to,0,0
161677,nearby,0,0
161678,critical,0,0
161679,structures,0,0
161680,is,0,0
161681,a,0,0
161682,concern,0,0
161683,.,0,0
161684,We,0,0
161685,found,0,0
161686,previously,0,0
161687,that,0,0
161688,in,0,0
161689,SBRT,1,1
161690,for,0,0
161691,lung,0,0
161692,cancer,0,0
161693,",",0,0
161694,the,0,0
161695,chest,0,1
161696,wall,0,0
161697,(,0,1
161698,CW,0,1
161699,),0,1
161700,volume,0,0
161701,receiving,0,0
161702,20,1,0
161703,",",1,0
161704,30,1,0
161705,",",1,0
161706,or,1,1
161707,40Gy,1,0
161708,(,0,0
161709,V20,0,0
161710,",",0,0
161711,V30,0,1
161712,",",0,0
161713,or,0,1
161714,V40,0,1
161715,),0,1
161716,was,0,0
161717,linked,0,0
161718,with,0,0
161719,the,0,0
161720,development,0,0
161721,of,0,0
161722,neuropathy,0,0
161723,.,0,0
161724,Here,0,0
161725,we,0,0
161726,sought,0,0
161727,to,0,0
161728,determine,0,0
161729,whether,0,0
161730,the,0,0
161731,dosimetric,0,0
161732,advantages,0,0
161733,of,0,0
161734,protons,0,1
161735,could,0,0
161736,produce,0,0
161737,lower,0,0
161738,CW,0,1
161739,doses,0,0
161740,than,0,0
161741,traditional,0,1
161742,photon-based,1,0
161743,SBRT,1,0
161744,.,1,0
161745,We,0,0
161746,searched,0,0
161747,an,0,0
161748,institutional,0,0
161749,database,0,0
161750,to,0,0
161751,identify,0,0
161752,patients,0,0
161753,treated,0,0
161754,with,0,0
161755,photon,1,1
161756,SBRT,1,1
161757,for,0,0
161758,lung,0,0
161759,cancer,0,0
161760,with,0,0
161761,tumors,0,0
161762,within,0,0
161763,<,0,0
161764,2.5cm,0,0
161765,of,0,0
161766,the,0,0
161767,CW,0,1
161768,.,0,0
161769,We,0,0
161770,found,0,0
161771,260,0,0
161772,cases,0,0
161773,;,0,0
161774,of,0,0
161775,these,0,0
161776,",",0,0
161777,chronic,0,0
161778,grade,0,0
161779,?,0,0
161780,2,0,0
161781,CW,0,1
161782,pain,0,0
161783,was,0,0
161784,identified,0,0
161785,in,0,0
161786,23,0,0
161787,patients,0,0
161788,.,0,0
161789,We,0,0
161790,then,0,0
161791,selected,0,0
161792,10,0,0
161793,representative,0,0
161794,patients,0,0
161795,from,0,0
161796,this,0,0
161797,group,0,0
161798,and,0,0
161799,generated,1,0
161800,proton,1,1
161801,SBRT,1,1
161802,treatment,1,0
161803,plans,0,1
161804,",",0,0
161805,using,0,0
161806,the,0,0
161807,identical,0,0
161808,dose,0,0
161809,of,0,0
161810,50Gy,0,1
161811,in,0,0
161812,4,0,0
161813,fractions,0,1
161814,",",0,0
161815,and,0,0
161816,assessed,0,0
161817,potential,0,0
161818,differences,0,0
161819,in,0,0
161820,CW,0,1
161821,dose,0,0
161822,between,0,0
161823,the,0,0
161824,2,0,0
161825,plans,0,0
161826,.,0,0
161827,The,0,0
161828,proton,1,1
161829,SBRT,1,1
161830,plans,1,1
161831,reduced,0,0
161832,the,0,0
161833,CW,0,1
161834,doses,0,0
161835,at,0,0
161836,all,0,0
161837,dose,0,0
161838,levels,0,0
161839,measured,0,0
161840,.,0,0
161841,The,0,0
161842,median,0,0
161843,CW,0,1
161844,V20,0,1
161845,was,0,0
161846,364.0cm,0,0
161847,(,0,0
161848,3,0,0
161849,),0,0
161850,and,0,0
161851,160.0cm,0,0
161852,(,0,0
161853,3,0,1
161854,),0,1
161855,(,0,0
161856,p,0,0
161857,<,0,0
161858,0.0001,0,0
161859,),0,0
161860,",",0,0
161861,V30,0,1
161862,was,0,0
161863,144.6cm,0,0
161864,(,0,0
161865,3,0,0
161866,),0,0
161867,vs,0,0
161868,77.0cm,0,0
161869,(,0,0
161870,3,0,1
161871,),0,1
161872,(,0,0
161873,p,0,0
161874,=,0,0
161875,0.0012,0,0
161876,),0,0
161877,",",0,0
161878,V35,0,0
161879,was,0,0
161880,93.9cm,0,0
161881,(,0,0
161882,3,0,0
161883,),0,0
161884,vs,0,0
161885,57.9cm,0,0
161886,(,0,0
161887,3,0,1
161888,),0,1
161889,(,0,0
161890,p,0,0
161891,=,0,0
161892,0.005,0,0
161893,),0,0
161894,",",0,0
161895,V40,0,0
161896,was,0,0
161897,66.5cm,0,0
161898,(,0,0
161899,3,0,0
161900,),0,0
161901,vs,0,0
161902,45.4cm,0,0
161903,(,0,0
161904,3,0,1
161905,),0,1
161906,(,0,0
161907,p,0,0
161908,=,0,0
161909,0.0112,0,0
161910,),0,0
161911,",",0,0
161912,and,0,0
161913,mean,0,0
161914,lung,0,0
161915,dose,0,0
161916,was,0,0
161917,5.9Gy,0,1
161918,vs,0,0
161919,3.8Gy,0,0
161920,(,0,0
161921,p,0,0
161922,=,0,0
161923,0.0001,0,0
161924,),0,0
161925,for,0,0
161926,photons,0,1
161927,and,0,0
161928,protons,0,1
161929,",",0,0
161930,respectively,0,0
161931,.,0,0
161932,Coverage,0,0
161933,of,0,0
161934,the,0,0
161935,planning,0,0
161936,target,0,0
161937,volume,0,0
161938,(,0,1
161939,PTV,0,1
161940,),0,1
161941,was,0,0
161942,comparable,0,0
161943,between,0,0
161944,the,0,0
161945,2,0,0
161946,sets,0,0
161947,of,0,0
161948,plans,0,1
161949,(,0,0
161950,96.4,0,0
161951,%,0,0
161952,for,0,0
161953,photons,0,1
161954,and,0,0
161955,97,0,0
161956,%,0,0
161957,for,0,0
161958,protons,0,1
161959,),0,0
161960,.,0,0
161961,From,0,0
161962,a,0,0
161963,dosimetric,0,0
161964,standpoint,1,0
161965,",",1,0
161966,proton,1,1
161967,SBRT,1,1
161968,can,1,0
161969,achieve,0,0
161970,the,0,0
161971,same,0,0
161972,coverage,0,0
161973,of,0,0
161974,the,0,0
161975,PTV,0,0
161976,while,0,0
161977,significantly,0,0
161978,reducing,0,0
161979,the,0,0
161980,dose,0,0
161981,to,0,0
161982,the,0,0
161983,CW,0,1
161984,and,0,0
161985,lung,0,0
161986,relative,0,0
161987,to,0,0
161988,photon,1,1
161989,SBRT,1,1
161990,and,1,0
161991,therefore,0,0
161992,may,0,0
161993,be,0,0
161994,beneficial,0,0
161995,for,0,0
161996,the,0,0
161997,treatment,0,0
161998,of,0,0
161999,lesions,0,0
162000,closer,0,0
162001,to,0,0
162002,critical,0,0
162003,structures,0,0
162004,.,0,0
162005,Effect,0,0
162006,of,0,0
162007,augmented,1,0
162008,sensorimotor,1,1
162009,input,1,1
162010,on,0,0
162011,learning,0,1
162012,verbal,0,1
162013,and,0,0
162014,nonverbal,0,0
162015,tasks,0,0
162016,among,0,0
162017,children,0,0
162018,with,0,0
162019,autism,0,0
162020,spectrum,0,0
162021,disorders,0,0
162022,.,0,0
162023,Thirty-four,0,0
162024,children,0,0
162025,",",0,0
162026,with,0,0
162027,autism,0,0
162028,spectrum,0,0
162029,disorders,0,0
162030,",",0,0
162031,ages,0,0
162032,4-14,0,0
162033,years,0,0
162034,",",0,0
162035,were,0,0
162036,matched,0,0
162037,and,0,0
162038,randomly,0,0
162039,assigned,0,0
162040,to,0,0
162041,one,0,0
162042,of,0,0
162043,two,0,0
162044,conditions,0,0
162045,for,0,0
162046,learning,0,0
162047,a,0,0
162048,novel,0,0
162049,juice-making,0,1
162050,task,0,1
162051,and,0,0
162052,producing,0,0
162053,two,0,0
162054,novel,0,0
162055,words,0,1
162056,about,0,0
162057,the,0,0
162058,event,0,0
162059,.,0,0
162060,Seventeen,0,0
162061,sighted,0,0
162062,children,0,0
162063,were,0,0
162064,manually,1,0
162065,guided,1,1
162066,to,0,0
162067,perform,0,0
162068,the,0,0
162069,task,0,1
162070,and,0,0
162071,tactually,0,1
162072,prompted,0,0
162073,during,0,0
162074,imitated,0,0
162075,productions,0,0
162076,of,0,0
162077,novel,0,0
162078,words,0,1
162079,for,0,0
162080,the,0,0
162081,event,0,0
162082,.,0,0
162083,Their,0,0
162084,matched,0,0
162085,controls,0,0
162086,heard,0,0
162087,the,0,0
162088,novel,0,0
162089,words,0,1
162090,and,0,0
162091,watched,0,0
162092,the,0,0
162093,juice-making,0,1
162094,task,0,1
162095,being,0,0
162096,performed,0,0
162097,.,0,0
162098,Performances,0,0
162099,on,0,0
162100,four,0,0
162101,verbal,0,0
162102,and,0,0
162103,two,0,0
162104,nonverbal,0,0
162105,measures,0,0
162106,right,0,0
162107,after,0,0
162108,instruction,0,1
162109,and,0,0
162110,at,0,0
162111,24-48,0,0
162112,h,0,1
162113,post-instruction,0,1
162114,",",0,0
162115,revealed,0,0
162116,higher,0,0
162117,scores,0,0
162118,for,0,0
162119,the,0,0
162120,??hands-on??,0,1
162121,",",0,0
162122,participation,0,0
162123,than,0,0
162124,observation,0,1
162125,group,0,0
162126,on,0,0
162127,both,0,0
162128,verbal,0,1
162129,and,0,0
162130,nonverbal,0,0
162131,tasks,0,0
162132,.,0,0
162133,This,0,0
162134,study,0,0
162135,offers,0,0
162136,a,0,0
162137,paradigm,0,0
162138,for,0,0
162139,exploring,0,0
162140,the,0,0
162141,instructional,0,1
162142,advantage,0,0
162143,of,0,0
162144,enhanced,0,0
162145,participatory,0,1
162146,experience,0,0
162147,.,0,0
162148,Remission,0,1
162149,in,0,0
162150,rheumatoid,0,0
162151,arthritis,0,0
162152,patients,0,0
162153,treated,0,0
162154,with,0,0
162155,etanercept,1,1
162156,monotherapy,1,1
162157,:,1,0
162158,clinical,0,0
162159,practice,0,1
162160,and,0,0
162161,clinical,0,0
162162,trial,0,0
162163,experience,0,0
162164,.,0,0
162165,OBJECTIVES,0,0
162166,To,0,0
162167,assess,0,0
162168,",",0,0
162169,in,0,0
162170,a,0,0
162171,randomised,0,0
162172,controlled,0,0
162173,trial,0,0
162174,(,0,1
162175,RCT,0,0
162176,),0,1
162177,and,0,0
162178,in,0,0
162179,clinical,0,0
162180,practice,0,0
162181,",",0,0
162182,an,0,0
162183,association,0,0
162184,of,0,0
162185,time,0,0
162186,to,0,0
162187,remission,0,0
162188,and,0,0
162189,baseline,0,0
162190,disease,0,0
162191,activity,0,0
162192,with,0,0
162193,both,0,0
162194,induction,0,0
162195,of,0,0
162196,remission,0,0
162197,and,0,0
162198,sustained,0,0
162199,remission,0,0
162200,in,0,0
162201,etanercept-treated,1,0
162202,patients,0,0
162203,with,0,0
162204,rheumatoid,0,0
162205,arthritis,0,0
162206,(,0,1
162207,RA,0,0
162208,),0,0
162209,.,0,0
162210,METHODS,0,0
162211,Data,0,0
162212,from,0,0
162213,an,0,0
162214,RCT,0,0
162215,(,0,0
162216,Trial,0,0
162217,of,0,0
162218,Etanercept,1,1
162219,and,1,0
162220,Methotrexate,1,1
162221,with,0,0
162222,Radiographic,0,0
162223,Patient,0,1
162224,Outcomes,0,0
162225,[,0,0
162226,TEMPO,0,1
162227,],0,1
162228,;,0,0
162229,n=682,0,0
162230,),0,1
162231,and,0,0
162232,an,0,0
162233,observational,0,0
162234,registry,0,0
162235,(,0,0
162236,Rheumatoid,0,0
162237,Arthritis,0,0
162238,DMARD,0,1
162239,Intervention,0,1
162240,and,0,0
162241,Utilization,0,1
162242,Study,0,0
162243,[,0,0
162244,RADIUS,0,0
162245,II,0,0
162246,],0,1
162247,;,0,0
162248,n=4341,0,0
162249,),0,0
162250,were,0,0
162251,used,0,0
162252,to,0,0
162253,evaluate,0,0
162254,disease,0,0
162255,activity,0,0
162256,(,0,0
162257,Clinical,0,0
162258,Disease,0,0
162259,Activity,0,0
162260,Index,0,1
162261,[,0,0
162262,CDAI,0,0
162263,],0,1
162264,score,0,0
162265,),0,0
162266,over,0,0
162267,time,0,0
162268,in,0,0
162269,patients,0,0
162270,initiating,0,0
162271,etanercept,1,1
162272,(,1,1
162273,monotherapy,1,1
162274,or,1,1
162275,with,1,1
162276,methotrexate,1,1
162277,),1,0
162278,.,1,0
162279,CDAI,0,0
162280,remission,0,0
162281,(,0,1
162282,CDAI?2.8,0,1
162283,),0,1
162284,and,0,0
162285,sustained,0,1
162286,remission,0,0
162287,(,0,0
162288,?6,0,1
162289,months,0,0
162290,),0,0
162291,were,0,0
162292,determined,0,0
162293,through,0,0
162294,year,0,0
162295,3,0,0
162296,by,0,0
162297,treatment,0,0
162298,group,0,0
162299,",",0,0
162300,study,0,0
162301,",",0,0
162302,time,0,0
162303,to,0,0
162304,remission,0,0
162305,",",0,0
162306,and,0,0
162307,disease,0,0
162308,severity,0,0
162309,.,0,0
162310,RESULTS,0,0
162311,Patients,0,0
162312,from,0,0
162313,TEMPO,0,0
162314,and,0,0
162315,RADIUS,0,0
162316,II,0,1
162317,who,0,0
162318,received,1,0
162319,etanercept,1,1
162320,monotherapy,1,1
162321,showed,1,0
162322,similar,0,0
162323,CDAI,0,0
162324,remission,0,0
162325,rates,0,0
162326,(,0,0
162327,39,0,0
162328,%,0,0
162329,and,0,0
162330,35,0,0
162331,%,0,0
162332,",",0,0
162333,respectively,0,0
162334,",",0,0
162335,at,0,0
162336,3,0,0
162337,years,0,0
162338,),0,0
162339,.,0,0
162340,Among,0,0
162341,patients,0,0
162342,who,0,0
162343,received,1,0
162344,etanercept,1,1
162345,with,1,0
162346,methotrexate,1,1
162347,",",1,0
162348,remission,1,0
162349,rates,0,0
162350,were,0,0
162351,54,0,0
162352,%,0,0
162353,and,0,0
162354,36,0,0
162355,%,0,0
162356,",",0,0
162357,respectively,0,0
162358,.,0,0
162359,Remission,0,0
162360,occurred,0,0
162361,more,0,0
162362,rapidly,0,0
162363,in,0,0
162364,TEMPO,0,0
162365,than,0,0
162366,RADIUS,0,0
162367,II,0,0
162368,perhaps,0,0
162369,from,0,0
162370,differences,0,0
162371,in,0,0
162372,compliance,0,0
162373,",",0,0
162374,patient,0,0
162375,populations,0,0
162376,",",0,0
162377,or,0,1
162378,sequence,0,1
162379,of,0,0
162380,combination,0,1
162381,therapy,0,1
162382,initiation,0,0
162383,.,0,0
162384,Generally,0,0
162385,",",0,0
162386,more,0,0
162387,patients,0,0
162388,with,0,0
162389,lower,0,0
162390,baseline,0,0
162391,CDAI,0,0
162392,scores,0,0
162393,achieved,0,0
162394,remission,0,0
162395,than,0,0
162396,those,0,0
162397,with,0,0
162398,higher,0,0
162399,scores,0,0
162400,.,0,0
162401,Continued,0,0
162402,remission,0,0
162403,appeared,0,0
162404,more,0,0
162405,likely,0,0
162406,in,0,0
162407,patients,0,0
162408,achieving,0,0
162409,remission,0,0
162410,earlier,0,0
162411,in,0,0
162412,the,0,0
162413,course,0,0
162414,of,0,0
162415,their,0,0
162416,therapy,0,1
162417,(,0,0
162418,0-6,0,1
162419,months,0,0
162420,),0,0
162421,.,0,0
162422,CONCLUSIONS,0,0
162423,Remission,0,1
162424,by,0,0
162425,year,0,0
162426,3,0,0
162427,in,0,0
162428,etanercept-treated,1,0
162429,(,1,0
162430,with,1,0
162431,and,1,0
162432,without,1,1
162433,methotrexate,1,1
162434,),1,0
162435,patients,1,0
162436,with,0,0
162437,RA,0,0
162438,occurred,0,0
162439,in,0,0
162440,?35,0,1
162441,%,0,0
162442,of,0,0
162443,patients,0,0
162444,in,0,0
162445,both,0,0
162446,an,0,0
162447,RCT,0,0
162448,(,0,1
162449,TEMPO,0,1
162450,),0,1
162451,and,0,0
162452,a,0,0
162453,clinical,0,0
162454,practice,0,1
162455,setting,0,0
162456,(,0,0
162457,RADIUS,0,1
162458,II,0,1
162459,),0,0
162460,",",0,0
162461,and,0,0
162462,more,0,0
162463,frequently,0,0
162464,in,0,0
162465,those,0,0
162466,with,0,0
162467,lower,0,0
162468,baseline,0,0
162469,disease,0,0
162470,severity,0,0
162471,.,0,0
162472,Patients,0,0
162473,with,0,0
162474,lower,0,0
162475,RA,0,0
162476,disease,0,0
162477,activity,0,0
162478,were,0,0
162479,more,0,0
162480,likely,0,0
162481,to,0,0
162482,reach,0,0
162483,remission,0,0
162484,.,0,0
162485,Continued,0,0
162486,remission,0,0
162487,may,0,0
162488,be,0,0
162489,more,0,0
162490,likely,0,0
162491,in,0,0
162492,patients,0,0
162493,who,0,0
162494,achieved,0,0
162495,remission,0,0
162496,earlier,0,0
162497,.,0,0
162498,Testing,0,0
162499,the,0,0
162500,efficacy,0,0
162501,of,0,0
162502,an,0,0
162503,HIV,1,1
162504,stigma,1,1
162505,reduction,1,0
162506,intervention,1,1
162507,with,0,0
162508,medical,0,0
162509,students,0,0
162510,in,0,0
162511,Puerto,0,0
162512,Rico,0,1
162513,:,0,0
162514,the,0,0
162515,SPACES,0,0
162516,project,0,0
162517,.,0,0
162518,INTRODUCTION,0,0
162519,Stigma,0,0
162520,associated,0,0
162521,with,0,0
162522,HIV,0,1
162523,has,0,0
162524,been,0,0
162525,documented,0,0
162526,as,0,0
162527,a,0,0
162528,barrier,0,0
162529,for,0,0
162530,accessing,0,1
162531,quality,0,0
162532,health-related,0,0
162533,services,0,1
162534,.,0,0
162535,When,0,0
162536,the,0,0
162537,stigma,0,0
162538,manifests,0,0
162539,in,0,0
162540,the,0,0
162541,health,0,0
162542,care,0,1
162543,setting,0,0
162544,",",0,0
162545,people,0,0
162546,living,0,0
162547,with,0,0
162548,HIV,0,1
162549,receive,0,1
162550,substandard,0,0
162551,services,0,1
162552,or,0,0
162553,even,0,0
162554,be,0,0
162555,denied,0,0
162556,care,0,0
162557,altogether,0,0
162558,.,0,0
162559,Although,0,0
162560,the,0,0
162561,consequences,0,0
162562,of,0,0
162563,HIV,0,1
162564,stigma,0,0
162565,have,0,0
162566,been,0,0
162567,documented,0,0
162568,extensively,0,0
162569,",",0,0
162570,efforts,0,0
162571,to,0,0
162572,reduce,0,0
162573,these,0,0
162574,negative,0,0
162575,attitudes,0,0
162576,have,0,0
162577,been,0,0
162578,scarce,0,0
162579,.,0,0
162580,Interventions,1,0
162581,to,1,0
162582,reduce,1,0
162583,HIV,1,1
162584,stigma,1,0
162585,should,0,0
162586,be,0,0
162587,implemented,0,0
162588,as,0,0
162589,part,0,0
162590,of,0,0
162591,the,0,0
162592,formal,0,1
162593,training,0,1
162594,of,0,0
162595,future,0,0
162596,health,0,0
162597,care,0,1
162598,professionals,0,0
162599,.,0,0
162600,The,0,0
162601,interventions,0,0
162602,that,0,0
162603,have,0,0
162604,been,0,0
162605,tested,0,0
162606,with,0,0
162607,health,0,0
162608,care,0,1
162609,professionals,0,0
162610,and,0,0
162611,published,0,0
162612,have,0,0
162613,several,0,0
162614,limitations,0,0
162615,that,0,0
162616,must,0,0
162617,be,0,0
162618,surpassed,0,0
162619,(,0,0
162620,i.e,0,1
162621,.,0,1
162622,lack,0,0
162623,of,0,0
162624,comparison,0,0
162625,groups,0,0
162626,in,0,0
162627,research,0,0
162628,designs,0,0
162629,and,0,0
162630,longitudinal,0,0
162631,follow-up,0,0
162632,data,0,0
162633,),0,0
162634,.,0,0
162635,Furthermore,0,0
162636,",",0,0
162637,Latino,0,0
162638,health,0,0
162639,care,0,1
162640,professionals,0,0
162641,have,0,0
162642,been,0,0
162643,absent,0,0
162644,from,0,0
162645,these,0,0
162646,intervention,0,1
162647,efforts,0,0
162648,even,0,0
162649,though,0,0
162650,the,0,0
162651,epidemic,0,0
162652,has,0,0
162653,affected,0,0
162654,this,0,0
162655,population,0,0
162656,disproportionately,0,0
162657,.,0,0
162658,METHODS,0,0
162659,In,0,0
162660,this,0,0
162661,article,0,0
162662,",",0,0
162663,we,0,0
162664,describe,0,0
162665,an,0,0
162666,intervention,1,1
162667,developed,1,0
162668,to,1,0
162669,reduce,1,0
162670,HIV,1,1
162671,stigma,1,0
162672,among,1,0
162673,medical,1,0
162674,students,1,0
162675,in,1,0
162676,Puerto,1,0
162677,Rico,1,1
162678,.,1,0
162679,A,0,0
162680,total,0,0
162681,of,0,0
162682,507,0,0
162683,medical,0,0
162684,students,0,0
162685,were,0,0
162686,randomly,0,0
162687,introduced,0,0
162688,into,0,0
162689,our,0,0
162690,intervention,1,1
162691,and,1,0
162692,control,1,0
162693,conditions,1,0
162694,.,1,0
162695,RESULTS,0,0
162696,The,0,0
162697,results,0,0
162698,show,0,0
162699,statistically,0,0
162700,significant,0,0
162701,differences,0,0
162702,between,0,0
162703,the,0,0
162704,intervention,1,1
162705,and,0,0
162706,control,1,1
162707,groups,0,0
162708,;,0,0
162709,intervention,0,1
162710,group,0,0
162711,participants,0,0
162712,had,0,0
162713,lower,0,0
162714,HIV,0,0
162715,stigma,0,0
162716,levels,0,0
162717,than,0,0
162718,control,0,0
162719,participants,0,0
162720,after,0,0
162721,the,0,0
162722,intervention,0,1
162723,.,0,0
162724,In,0,0
162725,addition,0,0
162726,",",0,0
162727,differences,0,0
162728,in,0,0
162729,HIV,0,1
162730,stigma,0,0
162731,levels,0,0
162732,between,0,0
162733,the,0,0
162734,groups,0,0
162735,were,0,0
162736,sustained,0,0
162737,for,0,0
162738,a,0,0
162739,12-month,0,0
162740,period,0,0
162741,.,0,0
162742,CONCLUSION,0,0
162743,The,0,0
162744,results,0,0
162745,of,0,0
162746,our,0,0
162747,study,0,0
162748,demonstrate,0,0
162749,the,0,0
162750,efficacy,0,0
162751,of,0,0
162752,the,0,0
162753,modes,0,0
162754,of,0,0
162755,intervention,0,1
162756,developed,0,0
162757,by,0,0
162758,us,0,0
162759,and,0,0
162760,serve,0,0
162761,as,0,0
162762,a,0,0
162763,new,0,0
162764,training,0,1
162765,tool,0,0
162766,for,0,0
162767,future,0,0
162768,health,0,0
162769,care,0,1
162770,professionals,0,0
162771,with,0,0
162772,regard,0,0
162773,to,0,0
162774,stigma,0,0
162775,reduction,0,0
162776,.,0,0
162777,Randomized,0,0
162778,controlled,0,0
162779,effectiveness,0,0
162780,trial,0,0
162781,of,0,0
162782,executive,1,1
162783,function,1,0
162784,intervention,1,1
162785,for,0,0
162786,children,0,0
162787,on,0,0
162788,the,0,0
162789,autism,0,0
162790,spectrum,0,0
162791,.,0,0
162792,BACKGROUND,0,0
162793,Unstuck,1,0
162794,and,1,0
162795,On,1,1
162796,Target,1,1
162797,(,1,1
162798,UOT,1,1
162799,),1,1
162800,is,0,0
162801,an,0,0
162802,executive,1,0
162803,function,1,0
162804,(,1,1
162805,EF,1,1
162806,),1,1
162807,intervention,1,1
162808,for,0,0
162809,children,0,0
162810,with,0,0
162811,autism,0,0
162812,spectrum,0,0
162813,disorders,0,0
162814,(,0,0
162815,ASD,0,0
162816,),0,1
162817,targeting,0,0
162818,insistence,0,0
162819,on,0,0
162820,sameness,0,0
162821,",",0,0
162822,flexibility,0,0
162823,",",0,0
162824,goal-setting,0,1
162825,",",0,0
162826,and,0,0
162827,planning,0,0
162828,through,0,0
162829,a,0,0
162830,cognitive-behavioral,0,1
162831,program,0,1
162832,of,0,0
162833,self-regulatory,0,0
162834,scripts,0,1
162835,",",0,0
162836,guided/faded,0,1
162837,practice,0,0
162838,",",0,0
162839,and,0,0
162840,visual/verbal,0,1
162841,cueing,0,0
162842,.,0,0
162843,UOT,1,0
162844,is,0,0
162845,contextually-based,0,0
162846,because,0,0
162847,it,0,0
162848,is,0,0
162849,implemented,0,0
162850,in,0,0
162851,school,0,0
162852,and,0,0
162853,at,0,0
162854,home,0,1
162855,",",0,0
162856,the,0,0
162857,contexts,0,0
162858,in,0,0
162859,which,0,0
162860,a,0,0
162861,child,0,0
162862,uses,0,0
162863,EF,0,0
162864,skills,0,0
162865,.,0,0
162866,METHODS,0,0
162867,To,0,0
162868,evaluate,0,0
162869,the,0,0
162870,effectiveness,0,0
162871,of,0,0
162872,UOT,1,1
162873,compared,0,0
162874,with,0,0
162875,a,0,0
162876,social,1,0
162877,skills,1,1
162878,intervention,1,1
162879,(,1,1
162880,SS,1,1
162881,),1,1
162882,",",0,0
162883,3rd-5th,0,0
162884,graders,0,0
162885,with,0,0
162886,ASD,0,0
162887,(,0,0
162888,mean,0,0
162889,IQ,0,0
162890,=,0,0
162891,108,0,0
162892,;,0,0
162893,UOT,0,0
162894,n,0,0
162895,=,0,0
162896,47,0,0
162897,;,0,0
162898,SS,0,1
162899,n,0,0
162900,=,0,0
162901,20,0,0
162902,),0,0
162903,received,0,0
162904,interventions,0,1
162905,delivered,0,0
162906,by,0,0
162907,school,0,0
162908,staff,0,0
162909,in,0,0
162910,small,0,0
162911,group,0,0
162912,sessions,0,1
162913,.,0,0
162914,Students,0,0
162915,were,0,0
162916,matched,0,0
162917,for,0,0
162918,gender,0,0
162919,",",0,0
162920,age,0,0
162921,",",0,0
162922,race,0,0
162923,",",0,0
162924,IQ,0,0
162925,",",0,0
162926,ASD,0,0
162927,symptomotolgy,0,0
162928,",",0,0
162929,medication,0,1
162930,status,0,0
162931,",",0,0
162932,and,0,0
162933,parents,0,0
162934,',0,0
162935,education,0,0
162936,.,0,0
162937,Interventions,0,0
162938,were,0,0
162939,matched,0,0
162940,for,0,0
162941,'dose,0,1
162942,',0,1
162943,of,0,0
162944,intervention,0,1
162945,and,0,0
162946,training,0,1
162947,.,0,0
162948,Measures,0,0
162949,of,0,0
162950,pre-post,0,0
162951,change,0,0
162952,included,0,0
162953,classroom,0,1
162954,observations,0,1
162955,",",0,0
162956,parent/teacher,0,0
162957,report,0,0
162958,",",0,0
162959,and,0,0
162960,direct,0,1
162961,child,0,0
162962,measures,0,0
162963,of,0,0
162964,problem-solving,0,0
162965,",",0,0
162966,EF,0,0
162967,",",0,0
162968,and,0,0
162969,social,0,0
162970,skills,0,0
162971,.,0,0
162972,Schools,0,0
162973,were,0,0
162974,randomized,0,0
162975,and,0,0
162976,evaluators,0,0
162977,",",0,0
162978,but,0,0
162979,not,0,0
162980,parents,0,0
162981,or,0,0
162982,teachers,0,0
162983,",",0,0
162984,were,0,0
162985,blinded,0,0
162986,to,0,0
162987,intervention,0,1
162988,type,0,0
162989,.,0,0
162990,RESULTS,0,0
162991,Interventions,0,1
162992,were,0,0
162993,administered,0,0
162994,with,0,0
162995,high,0,0
162996,fidelity,0,0
162997,.,0,0
162998,Children,0,0
162999,in,0,0
163000,both,0,0
163001,groups,0,0
163002,improved,0,0
163003,with,0,0
163004,intervention,0,1
163005,",",0,0
163006,but,0,0
163007,mean,0,0
163008,change,0,0
163009,scores,0,0
163010,from,0,0
163011,pre-,0,0
163012,to,0,0
163013,postintervention,0,0
163014,indicated,0,0
163015,significantly,0,0
163016,greater,0,0
163017,improvements,1,0
163018,for,1,0
163019,UOT,1,0
163020,than,1,0
163021,SS,1,1
163022,groups,1,0
163023,in,0,0
163024,:,0,0
163025,problem-solving,0,1
163026,",",0,0
163027,flexibility,0,0
163028,",",0,0
163029,and,0,0
163030,planning/organizing,0,1
163031,.,0,0
163032,Also,0,0
163033,",",0,0
163034,classroom,0,1
163035,observations,0,0
163036,revealed,0,0
163037,that,0,0
163038,participants,1,0
163039,in,1,0
163040,UOT,1,0
163041,made,1,0
163042,greater,0,0
163043,improvements,1,0
163044,than,1,0
163045,SS,1,1
163046,participants,1,0
163047,in,0,0
163048,their,0,0
163049,ability,0,0
163050,to,0,0
163051,follow,0,0
163052,rules,0,0
163053,",",0,0
163054,make,0,0
163055,transitions,0,0
163056,",",0,0
163057,and,0,0
163058,be,0,0
163059,flexible,0,1
163060,.,0,0
163061,Children,0,0
163062,in,0,0
163063,both,0,0
163064,groups,0,0
163065,made,0,0
163066,equivalent,0,0
163067,improvements,0,0
163068,in,0,0
163069,social,0,0
163070,skills,0,0
163071,.,0,0
163072,CONCLUSIONS,0,0
163073,These,0,0
163074,data,0,0
163075,support,0,0
163076,the,0,0
163077,effectiveness,0,0
163078,of,0,0
163079,the,0,0
163080,first,0,0
163081,contextually-based,0,1
163082,EF,0,0
163083,intervention,0,1
163084,for,0,0
163085,children,0,0
163086,with,0,0
163087,ASD,1,0
163088,.,1,0
163089,UOT,1,0
163090,improved,0,0
163091,classroom,0,1
163092,behavior,0,0
163093,",",0,0
163094,flexibility,0,0
163095,",",0,0
163096,and,0,0
163097,problem-solving,0,1
163098,in,0,0
163099,children,0,0
163100,with,0,0
163101,ASD,0,0
163102,.,0,0
163103,Individuals,0,0
163104,with,0,0
163105,variable,0,0
163106,background/training,0,0
163107,in,0,0
163108,ASD,0,0
163109,successfully,0,0
163110,implemented,1,0
163111,UOT,1,0
163112,in,1,0
163113,mainstream,0,1
163114,educational,0,0
163115,settings,0,0
163116,.,0,0
163117,[,0,0
163118,Preoperative,0,0
163119,chemotherapy,1,1
163120,of,0,0
163121,esophageal,0,0
163122,cancer,0,0
163123,],0,0
163124,.,0,0
163125,A,0,0
163126,series,0,0
163127,of,0,0
163128,25,0,0
163129,patients,0,0
163130,with,0,0
163131,advanced,0,0
163132,esophageal,0,0
163133,cancer,0,0
163134,treated,0,0
163135,from,0,0
163136,Mar,0,1
163137,.,0,0
163138,1981,0,0
163139,to,0,0
163140,Sep.,0,0
163141,1982,0,0
163142,by,0,0
163143,preoperative,1,1
163144,chemotherapy,1,1
163145,plus,1,1
163146,surgery,1,1
163147,is,0,0
163148,reported,0,0
163149,.,0,0
163150,All,0,0
163151,the,0,0
163152,patients,0,0
163153,came,0,0
163154,from,0,0
163155,the,0,0
163156,hospitals,0,0
163157,of,0,0
163158,the,0,0
163159,cooperative,0,0
163160,research,0,0
163161,group,0,0
163162,and,0,0
163163,were,0,0
163164,randomized,0,0
163165,into,0,0
163166,chemotherapy,1,1
163167,and,0,0
163168,control,1,0
163169,groups,0,0
163170,.,0,0
163171,They,0,0
163172,were,0,0
163173,proved,0,0
163174,by,0,0
163175,X-ray,0,0
163176,",",0,0
163177,cytology,0,1
163178,and,0,0
163179,histopathology,0,0
163180,prior,0,1
163181,to,0,0
163182,treatment,0,0
163183,.,0,0
163184,By,0,0
163185,histology,0,0
163186,",",0,0
163187,22,0,0
163188,cases,0,0
163189,were,0,0
163190,squamous,0,0
163191,cell,0,0
163192,carcinoma,0,0
163193,",",0,0
163194,1,0,0
163195,adenocarcinoma,0,0
163196,and,0,0
163197,2,0,0
163198,squamous,0,0
163199,adenocarcinoma,0,0
163200,.,0,0
163201,The,0,0
163202,COF,0,1
163203,chemotherapy,1,1
163204,consisted,0,0
163205,of,0,0
163206,Vincristine,1,1
163207,1,1,0
163208,mg,1,1
163209,",",1,0
163210,cyclophosphamide,1,1
163211,600,1,0
163212,mg,1,1
163213,and,1,0
163214,5-fluorouracil,1,1
163215,500,1,1
163216,mg,1,1
163217,IV,1,0
163218,on,0,0
163219,days,0,0
163220,1,0,0
163221,and,0,0
163222,8,0,0
163223,with,0,0
163224,or,0,0
163225,without,0,0
163226,the,0,0
163227,addition,0,0
163228,of,0,0
163229,Pingyangmycin,1,1
163230,",",0,0
163231,a,0,0
163232,drug,0,1
163233,equivalent,0,0
163234,to,0,0
163235,Bleomycin,1,1
163236,A5,1,1
163237,",",0,0
163238,at,0,0
163239,the,0,0
163240,dose,0,0
163241,of,0,0
163242,10,0,0
163243,mg,0,1
163244,IM,0,1
163245,on,0,0
163246,days,0,0
163247,1,0,0
163248,",",0,0
163249,3,0,0
163250,",",0,0
163251,6,0,0
163252,and,0,0
163253,8,0,0
163254,.,0,0
163255,The,0,0
163256,interval,0,0
163257,between,0,0
163258,the,0,0
163259,ending,0,0
163260,of,0,0
163261,chemotherapy,1,1
163262,and,0,0
163263,the,0,0
163264,surgical,1,1
163265,resection,1,0
163266,was,0,0
163267,5-6,0,0
163268,days,0,0
163269,.,0,0
163270,The,0,0
163271,results,0,0
163272,showed,0,0
163273,that,0,0
163274,preoperative,0,0
163275,chemotherapy,0,1
163276,caused,0,0
163277,no,0,0
163278,myelosuppression,0,0
163279,",",0,0
163280,but,0,0
163281,merely,0,0
163282,mild,0,0
163283,gastrointestinal,0,0
163284,symptoms,0,0
163285,.,0,0
163286,All,0,0
163287,patients,0,0
163288,were,0,0
163289,operated,0,0
163290,and,0,0
163291,resected,0,0
163292,without,0,0
163293,difficulty,0,0
163294,.,0,0
163295,The,0,0
163296,subjective,0,0
163297,improvement,0,0
163298,in,0,0
163299,various,0,0
163300,degrees,0,0
163301,and,0,0
163302,the,0,0
163303,shrinkage,0,1
163304,of,0,0
163305,tumor,0,0
163306,in,0,0
163307,the,0,0
163308,X-ray,0,0
163309,films,0,1
163310,were,0,0
163311,present,0,0
163312,in,0,0
163313,5/25,0,0
163314,cases,0,0
163315,who,0,0
163316,received,0,0
163317,preoperative,0,0
163318,chemotherapy,1,1
163319,.,1,0
163320,The,0,0
163321,histopathological,0,0
163322,changes,0,0
163323,in,0,0
163324,the,0,0
163325,chemotherapy,0,1
163326,and,0,0
163327,control,0,1
163328,groups,0,0
163329,(,0,0
163330,16,0,0
163331,specimens,0,0
163332,),0,0
163333,were,0,0
163334,different,0,0
163335,.,0,0
163336,In,0,0
163337,the,0,0
163338,chemotherapy,1,1
163339,group,0,0
163340,",",0,0
163341,excessive,0,0
163342,keratinization,0,0
163343,in,0,0
163344,the,0,0
163345,squamous,0,0
163346,component,0,0
163347,of,0,0
163348,the,0,0
163349,esophageal,0,0
163350,cancerous,0,0
163351,tissue,0,0
163352,appeared,0,0
163353,in,0,0
163354,the,0,0
163355,resected,0,0
163356,specimens,0,0
163357,.,0,0
163358,The,0,0
163359,incidence,0,0
163360,of,0,0
163361,degeneration,0,0
163362,and,0,0
163363,necrosis,0,0
163364,in,0,0
163365,the,0,0
163366,squamous,0,0
163367,epithelium,0,0
163368,adjacent,0,0
163369,to,0,0
163370,carcinoma,0,0
163371,was,0,0
163372,higher,0,0
163373,in,0,0
163374,the,0,0
163375,chemotherapy,1,1
163376,group,0,0
163377,(,0,0
163378,P,0,0
163379,less,0,0
163380,than,0,0
163381,0.01,0,0
163382,),0,0
163383,.,0,0
163384,The,0,0
163385,results,0,0
163386,suggested,0,0
163387,that,0,0
163388,such,0,0
163389,combined,0,1
163390,modality,0,0
163391,is,0,0
163392,worth,0,0
163393,further,0,0
163394,study,0,0
163395,.,0,0
163396,Continuous,0,1
163397,glucose,0,0
163398,monitoring,0,1
163399,in,0,0
163400,acute,0,0
163401,coronary,0,0
163402,syndrome,0,0
163403,.,0,0
163404,BACKGROUND,0,0
163405,Diabetes,0,0
163406,mellitus,0,0
163407,is,0,0
163408,an,0,0
163409,independent,0,0
163410,risk,0,0
163411,factor,0,0
163412,for,0,0
163413,cardiovascular,0,0
163414,disease,0,0
163415,.,0,0
163416,OBJECTIVE,0,0
163417,To,0,0
163418,compare,0,0
163419,the,0,0
163420,efficacy,0,0
163421,of,0,0
163422,devices,0,0
163423,for,0,0
163424,continuous,0,0
163425,glucose,0,0
163426,monitoring,0,1
163427,and,0,0
163428,capillary,0,1
163429,glucose,0,0
163430,monitoring,0,1
163431,in,0,0
163432,hospitalized,0,0
163433,patients,0,0
163434,with,0,0
163435,acute,0,0
163436,coronary,0,0
163437,syndrome,0,0
163438,using,0,0
163439,the,0,0
163440,following,0,0
163441,parameters,0,0
163442,:,0,0
163443,time,0,0
163444,to,0,0
163445,achieve,0,0
163446,normoglycemia,0,1
163447,",",0,0
163448,period,0,0
163449,of,0,0
163450,time,0,0
163451,in,0,0
163452,normoglycemia,0,1
163453,",",0,0
163454,and,0,0
163455,episodes,0,0
163456,of,0,0
163457,hypoglycemia,0,0
163458,.,0,0
163459,METHODS,0,0
163460,We,0,0
163461,performed,0,0
163462,a,0,0
163463,pilot,0,0
163464,",",0,0
163465,non-randomized,0,0
163466,",",0,0
163467,unblinded,0,0
163468,clinical,0,0
163469,trial,0,0
163470,that,0,0
163471,included,0,0
163472,16,0,0
163473,patients,0,0
163474,with,0,0
163475,acute,0,0
163476,coronary,0,0
163477,artery,0,0
163478,syndrome,0,0
163479,",",0,0
163480,a,0,0
163481,capillary,0,1
163482,or,0,1
163483,venous,0,1
163484,blood,0,0
163485,glucose,0,0
163486,?,0,0
163487,140,0,0
163488,mg/dl,0,0
163489,",",0,0
163490,and,0,0
163491,treatment,0,0
163492,with,0,0
163493,a,0,0
163494,continuous,0,1
163495,infusion,0,1
163496,of,0,0
163497,fast,0,1
163498,acting,0,0
163499,human,1,1
163500,insulin,1,1
163501,.,1,0
163502,These,0,0
163503,patients,0,0
163504,were,0,0
163505,randomized,0,0
163506,into,0,0
163507,2,0,0
163508,groups,0,0
163509,:,0,0
163510,a,0,0
163511,conventional,0,1
163512,group,0,0
163513,",",0,0
163514,in,0,0
163515,which,1,0
163516,capillary,1,1
163517,measurement,1,1
163518,and,1,0
163519,recording,1,1
163520,as,1,0
163521,well,1,0
163522,as,1,0
163523,insulin,1,1
163524,adjustment,1,0
163525,were,1,0
163526,made,0,0
163527,every,0,0
163528,4h,0,0
163529,",",0,0
163530,and,0,0
163531,an,0,0
163532,intervention,0,1
163533,group,0,0
163534,",",0,0
163535,in,0,0
163536,which,1,0
163537,measurement,1,0
163538,and,1,0
163539,recording,1,1
163540,as,1,0
163541,well,1,0
163542,as,1,0
163543,insulin,1,1
163544,adjustment,1,0
163545,were,1,0
163546,made,1,0
163547,every,1,1
163548,hour,1,0
163549,with,1,0
163550,a,1,0
163551,subcutaneous,1,1
163552,continuous,1,1
163553,monitoring,1,1
163554,system,1,1
163555,.,1,0
163556,Student,0,0
163557,'s,0,0
163558,t-test,0,0
163559,was,0,0
163560,applied,0,0
163561,for,0,0
163562,mean,0,0
163563,differences,0,0
163564,and,0,0
163565,the,0,0
163566,X,0,1
163567,(,0,0
163568,2,0,0
163569,),0,0
163570,test,0,0
163571,for,0,0
163572,qualitative,0,0
163573,variables,0,0
163574,.,0,0
163575,RESULTS,0,0
163576,We,0,0
163577,observed,0,0
163578,a,0,0
163579,statistically,0,0
163580,significant,0,0
163581,difference,0,0
163582,in,0,0
163583,the,0,0
163584,mean,0,0
163585,time,0,0
163586,for,0,0
163587,achieving,0,0
163588,normoglycemia,0,1
163589,",",0,0
163590,favoring,0,0
163591,the,0,0
163592,conventional,0,1
163593,group,0,0
163594,with,0,0
163595,a,0,0
163596,P,0,0
163597,=,0,0
163598,0.02,0,0
163599,.,0,0
163600,CONCLUSION,0,0
163601,Continuous,0,1
163602,monitoring,0,1
163603,systems,0,0
163604,are,0,0
163605,as,0,0
163606,useful,0,0
163607,as,0,0
163608,capillary,0,1
163609,monitoring,0,1
163610,for,0,0
163611,achieving,0,0
163612,normoglycemia,0,0
163613,.,0,0
163614,Exercise,1,1
163615,for,0,0
163616,methamphetamine,1,1
163617,dependence,0,0
163618,:,0,0
163619,rationale,0,0
163620,",",0,0
163621,design,0,0
163622,",",0,0
163623,and,0,0
163624,methodology,0,0
163625,.,0,0
163626,BACKGROUND,0,0
163627,Effective,0,0
163628,pharmacotherapies,0,1
163629,to,0,0
163630,treat,0,0
163631,methamphetamine,0,1
163632,(,0,1
163633,MA,0,0
163634,),0,1
163635,dependence,0,0
163636,have,0,0
163637,not,0,0
163638,been,0,0
163639,identified,0,0
163640,",",0,0
163641,and,0,0
163642,behavioral,0,1
163643,therapies,0,1
163644,are,0,0
163645,marginally,0,0
163646,effective,0,0
163647,.,0,0
163648,Based,0,0
163649,on,0,0
163650,behavioral,0,1
163651,studies,0,0
163652,demonstrating,0,0
163653,the,0,0
163654,potential,0,0
163655,efficacy,0,0
163656,of,0,0
163657,aerobic,1,1
163658,exercise,1,1
163659,for,0,0
163660,improving,0,0
163661,depressive,0,0
163662,symptoms,0,0
163663,",",0,0
163664,anxiety,0,0
163665,",",0,0
163666,cognitive,0,0
163667,deficits,0,0
163668,",",0,0
163669,and,0,0
163670,substance,0,0
163671,use,0,0
163672,outcomes,0,0
163673,",",0,0
163674,the,0,0
163675,study,0,0
163676,described,0,0
163677,here,0,0
163678,is,0,0
163679,examining,0,0
163680,exercise,1,1
163681,as,0,0
163682,a,0,0
163683,potential,0,0
163684,treatment,0,0
163685,for,0,0
163686,MA-dependent,0,0
163687,individuals,0,0
163688,.,0,0
163689,METHODS,0,0
163690,This,0,0
163691,study,0,0
163692,is,0,0
163693,randomizing,0,0
163694,150,0,0
163695,participants,0,0
163696,with,0,0
163697,MA,0,0
163698,dependence,0,0
163699,at,0,0
163700,a,0,0
163701,residential,0,1
163702,treatment,0,0
163703,facility,0,1
163704,for,0,0
163705,addictive,0,0
163706,disorders,0,0
163707,to,0,0
163708,receive,0,0
163709,either,0,0
163710,a,0,0
163711,thrice-weekly,1,1
163712,structured,1,1
163713,aerobic,1,1
163714,and,1,0
163715,resistance,1,0
163716,exercise,1,1
163717,intervention,1,1
163718,or,1,1
163719,a,1,0
163720,health,1,0
163721,education,1,1
163722,condition,1,0
163723,.,1,0
163724,Recruitment,0,0
163725,commenced,0,0
163726,in,0,0
163727,March,0,0
163728,",",0,0
163729,2010,0,0
163730,.,0,0
163731,Enrollment,0,0
163732,and,0,0
163733,follow-up,0,0
163734,phases,0,0
163735,are,0,0
163736,ongoing,0,0
163737,",",0,0
163738,and,0,0
163739,recruitment,0,0
163740,is,0,0
163741,exceeding,0,0
163742,targeted,0,0
163743,enrollment,0,0
163744,rates,0,0
163745,.,0,0
163746,CONCLUSIONS,0,0
163747,Seeking,0,0
163748,evidence,0,0
163749,for,0,0
163750,a,0,0
163751,possibly,0,0
163752,effective,0,0
163753,adjunct,0,0
163754,to,0,0
163755,traditional,0,1
163756,behavioral,0,1
163757,approaches,0,0
163758,for,0,0
163759,treatment,0,0
163760,of,0,0
163761,MA,0,0
163762,dependence,0,0
163763,",",0,0
163764,this,0,0
163765,study,0,0
163766,is,0,0
163767,assessing,0,0
163768,the,0,0
163769,ability,0,0
163770,of,0,0
163771,an,0,0
163772,8-week,0,0
163773,aerobic,1,1
163774,and,1,0
163775,resistance,1,0
163776,exercise,1,1
163777,protocol,0,1
163778,to,0,0
163779,reduce,0,0
163780,relapse,0,0
163781,to,0,0
163782,MA,0,0
163783,use,0,0
163784,during,0,0
163785,a,0,0
163786,12-week,0,0
163787,follow-up,0,0
163788,period,0,0
163789,after,0,0
163790,discharge,0,1
163791,from,0,0
163792,residential-based,0,1
163793,treatment,0,0
163794,.,0,0
163795,The,0,0
163796,study,0,0
163797,also,0,0
163798,is,0,0
163799,evaluating,0,0
163800,improvements,0,0
163801,in,0,0
163802,health,0,0
163803,and,0,0
163804,functional,0,0
163805,outcomes,0,0
163806,during,0,0
163807,and,0,0
163808,after,0,0
163809,the,0,0
163810,protocol,0,0
163811,.,0,0
163812,This,0,0
163813,paper,0,0
163814,describes,0,0
163815,the,0,0
163816,design,0,0
163817,and,0,0
163818,methods,0,0
163819,of,0,0
163820,the,0,0
163821,study,0,0
163822,.,0,0
163823,An,0,0
163824,intervention,0,1
163825,to,0,0
163826,decrease,0,0
163827,stigma,0,0
163828,in,0,0
163829,young,0,0
163830,adults,0,0
163831,with,0,0
163832,sickle,0,0
163833,cell,0,0
163834,disease,0,0
163835,.,0,0
163836,Young,0,0
163837,adults,0,0
163838,with,0,0
163839,sickle,0,0
163840,cell,0,0
163841,disease,0,0
163842,(,0,1
163843,SCD,0,0
163844,),0,1
163845,are,0,0
163846,often,0,0
163847,stigmatized,0,0
163848,when,0,0
163849,they,0,0
163850,seek,0,0
163851,care,0,1
163852,for,0,0
163853,pain,0,0
163854,.,0,0
163855,The,0,0
163856,purpose,0,0
163857,of,0,0
163858,this,0,0
163859,pilot,0,0
163860,study,0,0
163861,was,0,0
163862,to,0,0
163863,test,0,0
163864,an,0,0
163865,intervention,0,1
163866,to,0,0
163867,decrease,0,0
163868,health-related,0,0
163869,stigma,0,0
163870,during,0,0
163871,care-seeking,0,0
163872,.,0,0
163873,Young,0,0
163874,adults,0,0
163875,with,0,0
163876,SCD,0,0
163877,ages,0,0
163878,18,0,0
163879,to,0,0
163880,35,0,0
163881,years,0,0
163882,(,0,0
163883,n,0,0
163884,=,0,0
163885,90,0,0
163886,),0,0
163887,were,0,0
163888,randomized,0,0
163889,to,0,0
163890,either,1,0
163891,the,1,0
163892,care-seeking,1,0
163893,intervention,1,1
163894,(,1,1
163895,CSI,1,1
163896,),1,1
163897,or,1,1
163898,an,1,0
163899,attention,1,0
163900,control,1,1
163901,group,1,0
163902,that,1,0
163903,participated,1,0
163904,in,1,0
163905,life,1,0
163906,review,1,0
163907,interviews,1,1
163908,.,1,0
163909,The,0,0
163910,two,0,0
163911,groups,0,0
163912,were,0,0
163913,compared,0,0
163914,by,0,0
163915,t,0,0
163916,tests,0,0
163917,and,0,0
163918,longitudinal,0,0
163919,data,0,0
163920,analyses,0,0
163921,on,0,0
163922,the,0,0
163923,change,0,0
163924,from,0,0
163925,baseline,0,0
163926,to,0,0
163927,the,0,0
163928,last,0,0
163929,time,0,0
163930,point,0,0
163931,in,0,0
163932,total,0,0
163933,health-related,0,0
163934,stigma,0,1
163935,and,0,0
163936,health-related,0,0
163937,stigma,0,0
163938,by,0,0
163939,doctors,0,0
163940,.,0,0
163941,Findings,0,0
163942,suggest,0,0
163943,that,0,0
163944,the,0,0
163945,CSI,1,1
163946,was,0,0
163947,associated,0,0
163948,with,0,0
163949,significant,0,0
163950,increased,0,0
163951,awareness,0,0
163952,of,0,0
163953,perceived,0,0
163954,total,0,0
163955,stigma,0,1
163956,and,0,0
163957,stigma,0,0
163958,by,0,0
163959,doctors,0,0
163960,compared,0,0
163961,with,0,0
163962,the,0,0
163963,attention,0,0
163964,control,0,1
163965,group,0,0
163966,.,0,0
163967,These,0,0
163968,findings,0,0
163969,are,0,0
163970,promising,0,0
163971,in,0,0
163972,terms,0,0
163973,of,0,0
163974,lessons,0,0
163975,learned,0,0
163976,from,0,0
163977,a,0,0
163978,pilot,0,0
163979,intervention,0,1
163980,that,0,0
163981,focused,0,0
163982,on,0,0
163983,the,0,0
163984,role,0,0
163985,communication,0,1
163986,skills,0,0
163987,play,0,0
163988,in,0,0
163989,decreasing,0,0
163990,health-related,0,0
163991,stigma,0,1
163992,in,0,0
163993,young,0,0
163994,adults,0,0
163995,with,0,0
163996,SCD,0,0
163997,.,0,0
163998,The,0,0
163999,effect,0,0
164000,of,0,0
164001,four,0,0
164002,different,0,0
164003,irrigation,1,1
164004,systems,1,0
164005,in,0,0
164006,the,0,0
164007,removal,0,0
164008,of,0,0
164009,a,0,0
164010,root,0,1
164011,canal,0,0
164012,sealer,0,1
164013,.,0,0
164014,OBJECTIVES,0,0
164015,The,0,0
164016,aim,0,0
164017,of,0,0
164018,this,0,0
164019,study,0,0
164020,was,0,0
164021,to,0,0
164022,compare,0,0
164023,the,0,0
164024,efficiency,0,0
164025,of,0,0
164026,sonic,1,0
164027,",",1,0
164028,ultrasonic,1,1
164029,",",1,0
164030,and,1,0
164031,hydrodynamic,1,0
164032,devices,1,1
164033,in,0,0
164034,the,0,0
164035,removal,0,0
164036,of,0,0
164037,a,0,0
164038,root,0,1
164039,canal,0,0
164040,sealer,0,1
164041,from,0,0
164042,the,0,0
164043,surface,0,1
164044,and,0,0
164045,from,0,0
164046,simulated,0,1
164047,irregularities,0,0
164048,of,0,0
164049,root,0,0
164050,canals,0,0
164051,.,0,0
164052,MATERIALS,0,0
164053,AND,0,0
164054,METHODS,0,0
164055,Fifty-three,0,0
164056,root,0,1
164057,canals,0,0
164058,with,0,0
164059,two,0,0
164060,standardized,0,0
164061,grooves,0,0
164062,in,0,0
164063,the,0,0
164064,apical,0,0
164065,and,0,0
164066,coronal,0,0
164067,parts,0,0
164068,of,0,0
164069,longitudinally,0,0
164070,split,0,1
164071,roots,0,1
164072,were,0,0
164073,covered,0,0
164074,with,0,0
164075,AH,0,1
164076,Plus,0,0
164077,root,0,1
164078,canal,0,0
164079,sealer,0,1
164080,.,0,0
164081,Compared,0,0
164082,were,0,0
164083,the,0,0
164084,effects,0,0
164085,of,0,0
164086,(,1,0
164087,control,1,1
164088,),1,1
164089,syringe,1,1
164090,irrigation,1,1
164091,",",1,0
164092,(,1,0
164093,1,1,0
164094,),1,0
164095,CanalBrush,1,1
164096,",",1,0
164097,(,1,0
164098,2,1,0
164099,),1,0
164100,passive,1,1
164101,ultrasonic,1,1
164102,irrigation,1,1
164103,",",1,0
164104,(,1,0
164105,3,1,0
164106,),1,0
164107,EndoActivator,1,1
164108,",",1,1
164109,and,1,0
164110,(,1,0
164111,4,1,1
164112,),1,0
164113,RinsEndo,1,0
164114,on,0,0
164115,the,0,0
164116,removal,0,0
164117,of,0,0
164118,the,0,0
164119,sealer,0,1
164120,.,0,0
164121,The,0,0
164122,specimens,0,0
164123,were,0,0
164124,divided,0,0
164125,into,0,0
164126,four,0,0
164127,groups,0,0
164128,(,0,0
164129,N,0,0
164130,=,0,0
164131,12,0,0
164132,),0,0
164133,and,0,0
164134,one,0,1
164135,control,0,1
164136,group,0,0
164137,(,0,0
164138,N,0,1
164139,=,0,0
164140,5,0,1
164141,),0,0
164142,via,0,0
164143,randomization,0,0
164144,.,0,0
164145,The,0,0
164146,amount,0,0
164147,of,0,0
164148,remaining,0,0
164149,sealer,0,1
164150,in,0,0
164151,the,0,0
164152,root,0,1
164153,canal,0,0
164154,irregularities,0,0
164155,was,0,0
164156,evaluated,0,0
164157,under,0,0
164158,a,0,0
164159,microscope,0,1
164160,using,0,0
164161,a,0,0
164162,4-grade,0,0
164163,scoring,0,0
164164,system,0,0
164165,",",0,0
164166,whereas,0,0
164167,the,0,0
164168,remaining,0,0
164169,sealer,0,1
164170,on,0,0
164171,the,0,0
164172,root,0,1
164173,canal,0,0
164174,surface,0,1
164175,was,0,0
164176,evaluated,0,0
164177,with,0,0
164178,a,0,0
164179,7-grade,0,0
164180,scoring,0,0
164181,system,0,0
164182,.,0,0
164183,RESULTS,0,0
164184,Passive,1,0
164185,ultrasonic,1,1
164186,irrigation,1,1
164187,is,1,0
164188,more,1,0
164189,effective,0,0
164190,than,0,0
164191,the,0,0
164192,other,0,0
164193,tested,1,0
164194,irrigation,1,1
164195,systems,1,0
164196,or,1,1
164197,syringe,1,1
164198,irrigation,1,1
164199,in,1,0
164200,removing,1,0
164201,sealer,0,1
164202,from,0,0
164203,root,0,1
164204,canal,0,0
164205,walls,0,1
164206,(,0,0
164207,p,0,0
164208,<,0,0
164209,0.01,0,0
164210,),0,0
164211,.,0,0
164212,None,0,0
164213,of,0,0
164214,the,0,0
164215,techniques,0,1
164216,had,0,0
164217,a,0,0
164218,significant,0,0
164219,effect,0,0
164220,on,0,0
164221,cleaning,0,1
164222,the,0,0
164223,lateral,0,0
164224,grooves,0,0
164225,.,0,0
164226,CONCLUSIONS,0,0
164227,Within,0,0
164228,the,0,0
164229,limitations,0,0
164230,of,0,0
164231,this,0,0
164232,study,0,0
164233,protocol,1,1
164234,ultrasonic,1,1
164235,irrigation,1,1
164236,shows,0,0
164237,a,0,0
164238,superior,0,0
164239,effect,0,0
164240,on,0,0
164241,sealer,0,1
164242,removal,0,0
164243,from,0,0
164244,the,0,0
164245,root,0,1
164246,canal,0,0
164247,surface,0,1
164248,during,0,0
164249,endodontic,0,1
164250,retreatment,0,0
164251,.,0,0
164252,Cleaning,0,0
164253,of,0,0
164254,lateral,0,0
164255,grooves,0,1
164256,seems,0,0
164257,not,0,0
164258,to,0,0
164259,be,0,0
164260,possible,0,0
164261,with,0,0
164262,one,0,0
164263,of,0,0
164264,the,0,0
164265,techniques,0,1
164266,investigated,0,0
164267,.,0,0
164268,CLINICAL,0,0
164269,RELEVANCE,0,0
164270,Incomplete,0,0
164271,removal,0,0
164272,of,0,0
164273,root,0,1
164274,canal,0,0
164275,sealer,0,1
164276,during,0,0
164277,re-treatment,0,0
164278,may,0,0
164279,cause,0,0
164280,treatment,0,0
164281,failure,1,0
164282,.,1,0
164283,Passive,1,0
164284,Ultrasonic,1,1
164285,irrigation,1,1
164286,seems,0,0
164287,to,0,0
164288,be,0,0
164289,the,0,0
164290,most,0,0
164291,effective,0,0
164292,system,0,0
164293,to,0,0
164294,remove,0,0
164295,sealer,0,1
164296,from,0,0
164297,a,0,0
164298,root,0,1
164299,canal,0,0
164300,.,0,0
164301,Learning,0,0
164302,the,0,0
164303,'traceback,1,1
164304,',1,1
164305,approach,1,1
164306,for,0,0
164307,interscalene,0,1
164308,block,0,0
164309,.,0,0
164310,Using,0,0
164311,the,0,0
164312,virtual,1,1
164313,reality-cognitive,1,1
164314,rehabilitation,1,1
164315,approach,0,1
164316,to,0,0
164317,improve,0,0
164318,contextual,0,1
164319,processing,0,0
164320,in,0,0
164321,children,0,0
164322,with,0,0
164323,autism,0,0
164324,.,0,0
164325,BACKGROUND,0,0
164326,This,0,0
164327,pilot,0,0
164328,study,0,0
164329,investigated,0,0
164330,the,0,0
164331,efficacy,0,0
164332,of,0,0
164333,a,0,0
164334,novel,1,0
164335,virtual,1,1
164336,reality-cognitive,1,1
164337,rehabilitation,1,1
164338,(,1,1
164339,VR-CR,1,1
164340,),1,1
164341,intervention,1,1
164342,to,0,0
164343,improve,0,0
164344,contextual,0,1
164345,processing,0,0
164346,of,0,0
164347,objects,0,1
164348,in,0,0
164349,children,0,0
164350,with,0,0
164351,autism,0,0
164352,.,0,0
164353,Previous,0,0
164354,research,0,0
164355,supports,0,0
164356,that,0,0
164357,children,0,0
164358,with,0,0
164359,autism,0,0
164360,show,0,0
164361,deficits,0,0
164362,in,0,0
164363,contextual,0,1
164364,processing,0,0
164365,",",0,0
164366,as,0,0
164367,well,0,0
164368,as,0,0
164369,deficits,0,0
164370,in,0,0
164371,its,0,0
164372,elementary,0,0
164373,components,0,0
164374,:,0,0
164375,abstraction,0,0
164376,and,0,0
164377,cognitive,0,0
164378,flexibility,0,0
164379,.,0,0
164380,METHODS,0,0
164381,Four,0,0
164382,children,0,0
164383,with,0,0
164384,autism,0,0
164385,participated,0,0
164386,in,0,0
164387,a,0,0
164388,multiple-baseline,0,1
164389,",",0,0
164390,single-subject,0,1
164391,study,0,0
164392,.,0,0
164393,The,0,0
164394,children,0,0
164395,were,0,0
164396,taught,0,0
164397,how,0,0
164398,to,0,0
164399,see,0,0
164400,objects,0,1
164401,in,0,0
164402,context,0,0
164403,by,0,0
164404,reinforcing,0,1
164405,attention,0,0
164406,to,0,0
164407,pivotal,0,0
164408,contextual,0,1
164409,information,0,0
164410,.,0,0
164411,RESULTS,0,0
164412,All,0,0
164413,children,0,0
164414,demonstrated,0,0
164415,statistically,0,0
164416,significant,0,0
164417,improvements,0,0
164418,in,0,0
164419,contextual,0,1
164420,processing,0,1
164421,and,0,0
164422,cognitive,0,0
164423,flexibility,0,0
164424,.,0,0
164425,Mixed,0,0
164426,results,0,0
164427,were,0,0
164428,found,0,0
164429,on,0,0
164430,the,0,0
164431,control,0,1
164432,test,0,0
164433,and,0,0
164434,changes,0,0
164435,in,0,0
164436,context-related,0,0
164437,behaviours,0,0
164438,.,0,0
164439,CONCLUSIONS,0,0
164440,Larger-scale,0,0
164441,studies,0,0
164442,are,0,0
164443,warranted,0,0
164444,to,0,0
164445,determine,0,0
164446,the,0,0
164447,effectiveness,0,0
164448,and,0,0
164449,usability,0,0
164450,in,0,0
164451,comprehensive,0,0
164452,educational,0,0
164453,programs,0,1
164454,.,0,0
164455,TGF-beta,0,1
164456,receptor,0,0
164457,type-2,0,0
164458,expression,0,0
164459,in,0,0
164460,cancer-associated,0,0
164461,fibroblasts,0,0
164462,regulates,0,0
164463,breast,0,0
164464,cancer,0,0
164465,cell,0,0
164466,growth,0,1
164467,and,0,1
164468,survival,0,0
164469,and,0,0
164470,is,0,0
164471,a,0,0
164472,prognostic,0,0
164473,marker,0,0
164474,in,0,0
164475,pre-menopausal,0,0
164476,breast,0,0
164477,cancer,0,0
164478,.,0,0
164479,Transforming,0,0
164480,growth,0,0
164481,factor-beta,0,1
164482,(,1,1
164483,TGF-?,1,0
164484,),1,1
164485,is,0,0
164486,a,0,0
164487,pleiotropic,0,0
164488,cytokine,0,0
164489,with,0,0
164490,the,0,0
164491,capability,0,0
164492,to,0,0
164493,act,0,0
164494,as,0,0
164495,tumour,0,0
164496,suppressor,0,0
164497,or,0,1
164498,tumour,0,0
164499,promoter,0,1
164500,depending,0,0
164501,on,0,0
164502,the,0,0
164503,cellular,0,0
164504,context,0,0
164505,.,0,0
164506,TGF-beta,1,1
164507,receptor,1,0
164508,type-2,1,0
164509,(,1,1
164510,TGFBR2,1,1
164511,),1,1
164512,is,0,0
164513,the,0,0
164514,ligand-binding,0,0
164515,receptor,0,0
164516,for,0,0
164517,all,0,0
164518,members,0,0
164519,of,0,0
164520,the,0,0
164521,TGF-?,0,0
164522,family,0,0
164523,.,0,0
164524,Data,0,0
164525,from,0,0
164526,mouse,0,1
164527,model,0,0
164528,experiments,0,0
164529,demonstrated,0,0
164530,that,0,0
164531,loss,0,0
164532,of,0,0
164533,Tgfbr2,0,1
164534,expression,0,0
164535,in,0,0
164536,mammary,0,0
164537,fibroblasts,0,0
164538,was,0,0
164539,linked,0,0
164540,to,0,0
164541,tumour,0,0
164542,initiation,0,1
164543,and,0,0
164544,metastasis,0,0
164545,.,0,0
164546,Using,0,0
164547,a,0,0
164548,randomised,1,0
164549,tamoxifen,1,1
164550,trial,1,0
164551,cohort,0,0
164552,including,0,0
164553,in,0,0
164554,total,0,0
164555,564,0,0
164556,invasive,0,0
164557,breast,0,0
164558,carcinomas,0,0
164559,",",0,0
164560,we,0,0
164561,examined,1,0
164562,TGFBR2,1,1
164563,expression,1,0
164564,(,0,1
164565,n=252,0,1
164566,),0,1
164567,and,0,0
164568,phosphorylation,0,0
164569,level,0,0
164570,of,0,0
164571,downstream,0,0
164572,target,1,0
164573,SMAD2,1,1
164574,(,1,1
164575,pSMAD2,1,1
164576,),1,1
164577,(,1,1
164578,n=319,0,0
164579,),0,1
164580,in,0,0
164581,cancer-associated,1,0
164582,fibroblasts,1,0
164583,(,1,0
164584,CAFs,1,1
164585,),1,1
164586,and,1,0
164587,assessed,0,0
164588,links,0,0
164589,to,0,0
164590,clinicopathological,0,0
164591,markers,0,0
164592,",",0,0
164593,prognostic,0,0
164594,and,0,0
164595,treatment-predictive,0,0
164596,values,0,0
164597,.,0,0
164598,The,0,0
164599,study,0,0
164600,revealed,0,0
164601,that,0,0
164602,CAF-specific,0,0
164603,TGFBR2,0,1
164604,expression,0,0
164605,correlated,0,0
164606,with,0,0
164607,improved,0,0
164608,recurrence-free,0,0
164609,survival,0,0
164610,.,0,0
164611,Multivariate,0,0
164612,analysis,0,0
164613,confirmed,0,0
164614,CAF-TGFBR2,0,0
164615,to,0,0
164616,be,0,0
164617,an,0,0
164618,independent,0,0
164619,prognostic,0,0
164620,marker,0,0
164621,(,0,0
164622,multivariate,0,0
164623,Cox,0,1
164624,regression,0,0
164625,",",0,0
164626,hazard,0,0
164627,ratio,0,0
164628,:,0,0
164629,0.534,0,0
164630,",",0,0
164631,95,0,0
164632,%,0,0
164633,(,0,1
164634,CI,0,0
164635,),0,1
164636,:,0,0
164637,0.360-0.793,0,0
164638,",",0,0
164639,P=0.002,0,0
164640,),0,0
164641,.,0,0
164642,CAF-specific,0,0
164643,pSMAD2,0,0
164644,levels,0,0
164645,",",0,0
164646,however,0,0
164647,",",0,0
164648,did,0,0
164649,not,0,0
164650,associate,0,0
164651,with,0,0
164652,survival,0,0
164653,outcome,0,0
164654,.,0,0
164655,Experimentally,0,0
164656,",",0,0
164657,TGF-?,0,0
164658,signalling,0,0
164659,in,0,0
164660,fibroblasts,0,0
164661,was,0,0
164662,modulated,0,0
164663,using,0,0
164664,a,0,0
164665,TGF-?,0,0
164666,ligand,0,0
164667,and,0,1
164668,inhibitor,0,1
164669,or,0,1
164670,through,0,0
164671,lentiviral,0,1
164672,short,0,1
164673,hairpin,0,0
164674,RNA-mediated,0,0
164675,TGFBR2-specific,0,0
164676,knockdown,0,0
164677,.,0,0
164678,To,0,0
164679,determine,0,0
164680,the,0,0
164681,role,0,0
164682,of,0,0
164683,fibroblastic,0,0
164684,TGF-?,0,0
164685,pathway,0,1
164686,on,0,0
164687,breast,0,0
164688,cancer,0,0
164689,cells,0,0
164690,",",0,0
164691,we,0,0
164692,used,0,0
164693,cell,0,0
164694,contact-dependent,0,1
164695,cell,0,0
164696,growth,0,1
164697,and,0,0
164698,clonogenicity,0,0
164699,assays,0,0
164700,",",0,0
164701,which,0,0
164702,showed,0,0
164703,that,0,0
164704,knockdown,0,0
164705,of,0,0
164706,TGFBR2,0,0
164707,in,0,0
164708,CAFs,0,1
164709,resulted,0,0
164710,in,0,0
164711,increased,0,0
164712,cell,0,0
164713,growth,0,0
164714,",",0,0
164715,proliferation,0,0
164716,and,0,0
164717,clonogenic,0,0
164718,survival,0,0
164719,.,0,0
164720,Further,0,0
164721,",",0,0
164722,in,0,0
164723,a,0,0
164724,mouse,0,1
164725,model,0,0
164726,transfected,1,0
164727,CAFs,1,1
164728,were,0,0
164729,co-injected,0,1
164730,with,0,0
164731,MCF7,1,1
164732,and,0,0
164733,tumour,0,0
164734,weight,0,0
164735,and,0,0
164736,proportion,0,0
164737,was,0,0
164738,monitored,0,0
164739,.,0,0
164740,We,0,0
164741,found,0,0
164742,that,0,0
164743,mouse,0,1
164744,xenograft,0,1
164745,tumours,0,0
164746,comprising,0,0
164747,TGFBR2,0,0
164748,knockdown,0,0
164749,fibroblasts,0,0
164750,were,0,0
164751,slightly,0,0
164752,bigger,0,0
164753,and,0,0
164754,displayed,0,0
164755,increased,0,0
164756,tumour,0,0
164757,cell,0,0
164758,capacity,0,0
164759,.,0,0
164760,Overall,0,0
164761,",",0,0
164762,our,0,0
164763,data,0,0
164764,demonstrate,0,0
164765,that,0,0
164766,fibroblast-related,0,0
164767,biomarkers,0,0
164768,possess,0,0
164769,clinically,0,0
164770,relevant,0,0
164771,information,0,0
164772,and,0,0
164773,that,0,0
164774,fibroblasts,0,0
164775,confer,0,0
164776,effects,0,0
164777,on,0,0
164778,breast,0,0
164779,cancer,0,0
164780,cell,0,0
164781,growth,0,1
164782,and,0,0
164783,survival,0,0
164784,.,0,1
164785,Regulation,0,0
164786,of,0,0
164787,tumour-stromal,0,0
164788,cross-talk,0,0
164789,through,0,0
164790,fibroblastic,0,0
164791,TGF-?,0,0
164792,pathway,0,1
164793,may,0,0
164794,depend,0,0
164795,on,0,0
164796,fibroblast,0,0
164797,phenotype,0,0
164798,",",0,0
164799,emphasising,0,0
164800,the,0,0
164801,importance,0,0
164802,to,0,0
164803,characterise,0,0
164804,tumour,0,0
164805,microenvironment,0,0
164806,subtypes,0,0
164807,.,0,0
164808,Dietary,1,1
164809,docosahexaenoic,1,1
164810,acid,1,1
164811,supplementation,1,1
164812,in,0,0
164813,children,0,0
164814,with,0,0
164815,autism,0,0
164816,.,0,0
164817,OBJECTIVE,0,0
164818,The,0,0
164819,aim,0,0
164820,of,0,0
164821,the,0,0
164822,study,0,0
164823,was,0,0
164824,to,0,0
164825,determine,0,0
164826,whether,0,0
164827,docosahexaenoic,1,1
164828,acid,1,1
164829,(,1,1
164830,DHA,1,1
164831,),1,1
164832,supplementation,1,1
164833,improves,0,0
164834,the,0,0
164835,behavior,0,0
164836,of,0,0
164837,children,0,0
164838,with,0,0
164839,autism,0,0
164840,.,0,0
164841,METHODS,0,0
164842,A,0,0
164843,group,0,0
164844,of,0,0
164845,3-,0,0
164846,to,0,0
164847,10-year-old,0,0
164848,children,0,0
164849,with,0,0
164850,autism,0,0
164851,were,0,0
164852,randomized,0,0
164853,in,0,0
164854,a,0,0
164855,double-blind,0,0
164856,fashion,0,1
164857,to,0,0
164858,receive,0,0
164859,a,0,0
164860,supplement,1,1
164861,containing,0,1
164862,200,0,1
164863,mg,0,1
164864,of,0,0
164865,DHA,1,1
164866,or,0,1
164867,a,0,0
164868,placebo,1,1
164869,for,0,0
164870,6,0,0
164871,months,0,0
164872,.,0,0
164873,The,0,0
164874,parents,0,0
164875,and,0,0
164876,the,0,0
164877,investigator,0,0
164878,completed,0,0
164879,the,0,0
164880,Clinical,0,0
164881,Global,0,0
164882,Impressions-Improvement,0,1
164883,scale,0,0
164884,to,0,0
164885,rate,0,0
164886,changes,0,0
164887,in,0,0
164888,core,0,0
164889,symptoms,0,0
164890,of,0,0
164891,autism,0,0
164892,after,0,0
164893,3,0,0
164894,and,0,0
164895,6,0,0
164896,months,0,0
164897,.,0,0
164898,The,0,0
164899,parents,0,0
164900,completed,0,0
164901,the,0,0
164902,Child,0,0
164903,Development,0,0
164904,Inventory,0,1
164905,and,0,0
164906,the,0,0
164907,Aberrant,0,0
164908,Behavior,0,0
164909,Checklist,0,1
164910,",",0,0
164911,and,0,0
164912,both,0,0
164913,parents,0,0
164914,and,0,0
164915,teachers,0,0
164916,completed,0,0
164917,the,0,0
164918,Behavior,0,0
164919,Assessment,0,1
164920,Scale,0,0
164921,for,0,0
164922,Children,0,0
164923,(,0,1
164924,BASC,0,1
164925,),0,1
164926,at,0,0
164927,enrollment,0,0
164928,and,0,0
164929,after,0,0
164930,6,0,0
164931,months,0,0
164932,.,0,0
164933,RESULTS,0,0
164934,A,0,0
164935,total,0,0
164936,of,0,0
164937,48,0,0
164938,children,0,0
164939,(,0,0
164940,40,0,0
164941,[,0,0
164942,83,0,0
164943,%,0,0
164944,],0,0
164945,boys,0,0
164946,",",0,0
164947,mean,0,0
164948,age,0,0
164949,[,0,1
164950,standard,0,1
164951,deviation,0,0
164952,],0,0
164953,6.1,0,0
164954,[,0,0
164955,2.0,0,0
164956,],0,0
164957,years,0,0
164958,),0,0
164959,were,0,0
164960,enrolled,0,0
164961,;,0,0
164962,24,0,0
164963,received,0,0
164964,DHA,1,1
164965,and,0,0
164966,24,0,0
164967,placebo,1,1
164968,.,1,0
164969,Despite,0,0
164970,a,0,0
164971,median,0,0
164972,431,0,0
164973,%,0,0
164974,increase,0,0
164975,in,0,0
164976,total,0,0
164977,plasma,0,0
164978,DHA,1,1
164979,levels,0,0
164980,after,0,0
164981,6,0,0
164982,months,0,0
164983,",",0,0
164984,the,0,0
164985,DHA,1,1
164986,group,0,0
164987,was,0,0
164988,not,0,0
164989,rated,0,0
164990,as,0,0
164991,improved,0,0
164992,in,0,0
164993,core,0,0
164994,symptoms,0,0
164995,of,0,0
164996,autism,0,0
164997,compared,0,0
164998,to,0,0
164999,the,0,0
165000,placebo,1,1
165001,group,0,0
165002,on,0,0
165003,the,0,0
165004,CGI-I,0,0
165005,.,0,0
165006,Based,0,0
165007,on,0,0
165008,the,0,0
165009,analysis,0,0
165010,of,0,0
165011,covariance,0,0
165012,models,0,0
165013,adjusted,0,0
165014,for,0,0
165015,the,0,0
165016,baseline,0,0
165017,rating,0,0
165018,scores,0,0
165019,",",0,0
165020,parents,0,0
165021,(,0,0
165022,but,0,0
165023,not,0,0
165024,teachers,0,0
165025,),0,0
165026,provided,0,0
165027,a,0,0
165028,higher,0,0
165029,average,0,0
165030,rating,0,0
165031,of,0,0
165032,social,0,0
165033,skills,0,0
165034,on,0,0
165035,the,0,0
165036,BASC,0,0
165037,for,0,0
165038,the,0,0
165039,children,0,0
165040,in,0,0
165041,the,0,0
165042,placebo,0,1
165043,group,0,0
165044,compared,0,0
165045,to,0,0
165046,the,0,0
165047,DHA,1,1
165048,group,0,0
165049,(,0,0
165050,P,0,0
165051,=,0,0
165052,0.04,0,0
165053,),0,0
165054,",",0,0
165055,and,0,0
165056,teachers,0,1
165057,(,0,0
165058,but,0,0
165059,not,0,0
165060,parents,0,0
165061,),0,0
165062,provided,0,0
165063,a,0,0
165064,higher,0,0
165065,average,0,0
165066,rating,0,0
165067,of,0,0
165068,functional,0,0
165069,communication,0,1
165070,on,0,0
165071,the,0,0
165072,BASC,0,0
165073,for,0,0
165074,the,0,0
165075,children,0,0
165076,in,0,0
165077,the,0,0
165078,DHA,1,1
165079,group,0,0
165080,compared,0,0
165081,to,0,0
165082,the,0,0
165083,placebo,0,1
165084,group,0,0
165085,(,0,0
165086,P,0,0
165087,=,0,0
165088,0.02,0,0
165089,),0,0
165090,.,0,0
165091,CONCLUSIONS,1,0
165092,Dietary,1,1
165093,DHA,1,1
165094,supplementation,1,1
165095,of,1,0
165096,200,1,1
165097,mg/day,0,1
165098,for,0,0
165099,6,0,0
165100,months,0,0
165101,does,0,0
165102,not,0,0
165103,improve,0,0
165104,the,0,0
165105,core,0,0
165106,symptoms,0,0
165107,of,0,0
165108,autism,0,0
165109,.,0,0
165110,Our,0,0
165111,results,0,0
165112,may,0,0
165113,have,0,0
165114,been,0,0
165115,limited,0,0
165116,by,0,0
165117,inadequate,0,0
165118,sample,0,0
165119,size,0,0
165120,.,0,0
165121,A,0,0
165122,randomized,0,0
165123,controlled,0,0
165124,trial,0,0
165125,of,0,0
165126,nonlinear,1,0
165127,frequency,1,0
165128,compression,1,1
165129,versus,1,1
165130,conventional,1,1
165131,processing,1,0
165132,in,1,0
165133,hearing,1,0
165134,aids,1,0
165135,:,1,0
165136,speech,0,1
165137,and,0,0
165138,language,0,1
165139,of,0,0
165140,children,0,0
165141,at,0,0
165142,three,0,0
165143,years,0,0
165144,of,0,0
165145,age,0,0
165146,.,0,0
165147,OBJECTIVE,0,0
165148,To,0,0
165149,determine,0,0
165150,the,0,0
165151,effect,0,0
165152,of,0,0
165153,nonlinear,1,0
165154,frequency,1,0
165155,compression,1,1
165156,(,1,1
165157,NLFC,1,1
165158,),1,1
165159,on,0,0
165160,children,0,0
165161,'s,0,0
165162,development,0,0
165163,of,0,0
165164,speech,0,1
165165,and,0,0
165166,language,0,1
165167,at,0,0
165168,three,0,0
165169,years,0,0
165170,of,0,0
165171,age,0,0
165172,.,0,0
165173,DESIGN,0,0
165174,A,0,0
165175,randomized,0,0
165176,controlled,0,0
165177,trial,0,0
165178,was,0,0
165179,conducted,0,0
165180,as,0,0
165181,part,0,0
165182,of,0,0
165183,the,0,0
165184,population-based,0,0
165185,longitudinal,0,0
165186,study,0,0
165187,on,0,0
165188,outcomes,0,0
165189,of,0,0
165190,children,0,0
165191,with,0,0
165192,hearing,0,0
165193,impairment,0,0
165194,(,0,1
165195,LOCHI,0,1
165196,),0,0
165197,.,0,0
165198,Participants,0,0
165199,were,0,0
165200,randomly,0,0
165201,assigned,0,0
165202,to,0,0
165203,fitting,0,0
165204,with,0,1
165205,NLFC,1,1
165206,(,1,0
165207,Phonak,1,1
165208,Naida,1,1
165209,V,1,1
165210,SP,1,1
165211,or,1,1
165212,UP,1,1
165213,),1,1
165214,or,0,1
165215,with,0,0
165216,conventional,1,1
165217,processing,1,0
165218,in,1,0
165219,hearing,1,0
165220,aids,1,0
165221,",",0,0
165222,prescribed,0,0
165223,by,0,0
165224,using,0,0
165225,either,0,0
165226,the,0,0
165227,NAL,1,1
165228,or,0,1
165229,the,0,0
165230,DSL,1,1
165231,formula,0,1
165232,.,0,0
165233,Standardized,0,0
165234,tests,0,0
165235,of,0,0
165236,speech,0,1
165237,production,0,0
165238,",",0,0
165239,receptive,0,1
165240,and,0,0
165241,expressive,0,0
165242,language,0,1
165243,were,0,0
165244,administered,0,0
165245,",",0,0
165246,and,0,0
165247,parent,0,1
165248,ratings,0,0
165249,were,0,0
165250,collected,0,0
165251,.,0,0
165252,All,0,0
165253,assessments,0,0
165254,were,0,0
165255,double-blinded,0,0
165256,.,0,0
165257,STUDY,0,0
165258,SAMPLE,0,1
165259,Participants,0,0
165260,were,0,0
165261,44,0,0
165262,of,0,0
165263,the,0,0
165264,450,0,0
165265,children,0,0
165266,in,0,0
165267,the,0,0
165268,LOCHI,0,1
165269,cohort,0,0
165270,.,0,0
165271,RESULTS,0,0
165272,Compared,0,0
165273,to,0,0
165274,children,0,0
165275,using,0,0
165276,conventional,1,1
165277,processing,1,0
165278,",",0,0
165279,receptive,0,1
165280,and,0,0
165281,expressive,0,0
165282,language,0,0
165283,was,0,0
165284,higher,0,0
165285,but,0,0
165286,receptive,0,0
165287,vocabulary,0,1
165288,and,0,0
165289,consonant,0,1
165290,articulation,0,1
165291,scores,0,0
165292,were,0,0
165293,lower,0,0
165294,for,0,0
165295,children,0,0
165296,who,0,0
165297,use,0,0
165298,NLFC,1,0
165299,.,1,0
165300,There,0,0
165301,was,0,0
165302,increased,0,0
165303,substitution,0,0
165304,of,0,0
165305,affricates,0,0
165306,by,0,0
165307,fricatives,0,0
165308,for,0,0
165309,children,0,0
165310,using,0,0
165311,NLFC,1,0
165312,",",0,0
165313,compared,0,0
165314,to,0,0
165315,children,0,0
165316,using,0,0
165317,conventional,1,1
165318,amplification,1,0
165319,.,1,0
165320,After,0,0
165321,allowing,0,0
165322,for,0,0
165323,the,0,0
165324,effect,0,0
165325,of,0,0
165326,multiple,0,0
165327,demographic,0,0
165328,variables,0,0
165329,",",0,0
165330,the,0,0
165331,difference,0,0
165332,in,0,0
165333,global,0,0
165334,language,0,1
165335,scores,0,0
165336,between,0,0
165337,groups,0,0
165338,was,0,0
165339,not,0,0
165340,significant,0,0
165341,(,0,0
165342,effect,0,0
165343,:,0,0
165344,0.8,0,0
165345,[,0,0
165346,95,0,0
165347,%,0,0
165348,confidence,0,0
165349,interval,0,0
165350,:,0,0
165351,-,0,0
165352,6.7,0,0
165353,",",0,0
165354,8.3,0,0
165355,],0,0
165356,),0,0
165357,.,0,0
165358,CONCLUSIONS,0,0
165359,There,0,0
165360,is,0,0
165361,insufficient,0,0
165362,evidence,0,0
165363,to,0,0
165364,indicate,0,0
165365,a,0,0
165366,difference,0,0
165367,in,0,0
165368,language,0,1
165369,ability,0,0
165370,between,0,0
165371,children,0,0
165372,using,0,0
165373,NLFC,1,1
165374,and,0,0
165375,those,0,0
165376,using,0,0
165377,conventional,1,1
165378,amplification,1,0
165379,.,1,0
165380,Mitigation,0,0
165381,of,0,0
165382,sociocommunicational,0,0
165383,deficits,0,0
165384,of,0,0
165385,autism,0,0
165386,through,0,0
165387,oxytocin-induced,1,1
165388,recovery,0,0
165389,of,0,0
165390,medial,0,0
165391,prefrontal,0,0
165392,activity,0,0
165393,:,0,0
165394,a,0,0
165395,randomized,0,0
165396,trial,0,0
165397,.,0,0
165398,IMPORTANCE,0,0
165399,Sociocommunicational,0,0
165400,deficits,0,0
165401,make,0,0
165402,it,0,0
165403,difficult,0,0
165404,for,0,0
165405,individuals,0,0
165406,with,0,0
165407,autism,0,0
165408,spectrum,0,0
165409,disorders,0,0
165410,(,0,0
165411,ASD,0,0
165412,),0,1
165413,to,0,0
165414,understand,0,0
165415,communication,0,1
165416,content,0,0
165417,with,0,0
165418,conflicting,0,0
165419,verbal,0,1
165420,and,0,0
165421,nonverbal,0,0
165422,information,0,0
165423,.,0,0
165424,Despite,0,0
165425,growing,0,0
165426,prospects,0,0
165427,for,0,0
165428,oxytocin,1,1
165429,as,0,0
165430,a,0,0
165431,therapeutic,0,0
165432,agent,0,0
165433,for,0,0
165434,ASD,0,0
165435,",",0,0
165436,no,0,0
165437,direct,0,0
165438,neurobiological,0,0
165439,evidence,0,0
165440,exists,0,0
165441,for,0,0
165442,oxytocin,1,1
165443,'s,1,0
165444,beneficial,0,0
165445,effects,0,0
165446,on,0,0
165447,this,0,0
165448,core,0,0
165449,symptom,0,0
165450,of,0,0
165451,ASD,0,0
165452,.,0,0
165453,This,0,0
165454,is,0,0
165455,slowing,0,0
165456,clinical,0,0
165457,application,0,1
165458,of,0,0
165459,the,0,0
165460,neuropeptide,0,1
165461,.,0,0
165462,OBJECTIVE,0,0
165463,To,0,0
165464,directly,0,0
165465,examine,0,0
165466,whether,0,0
165467,oxytocin,1,1
165468,has,0,0
165469,beneficial,0,0
165470,effects,0,0
165471,on,0,0
165472,the,0,0
165473,sociocommunicational,0,0
165474,deficits,0,0
165475,of,0,0
165476,ASD,0,0
165477,using,0,0
165478,both,0,0
165479,behavioral,0,1
165480,and,0,0
165481,neural,0,0
165482,measures,0,0
165483,.,0,0
165484,DESIGN,0,0
165485,",",0,0
165486,SETTING,0,0
165487,",",0,0
165488,AND,0,0
165489,PARTICIPANTS,0,0
165490,At,0,1
165491,the,0,0
165492,University,0,0
165493,of,0,0
165494,Tokyo,0,0
165495,Hospital,0,0
165496,",",0,0
165497,we,0,0
165498,conducted,0,0
165499,a,0,0
165500,randomized,0,0
165501,",",0,0
165502,double-blind,0,0
165503,",",0,0
165504,placebo-controlled,1,1
165505,",",0,0
165506,within-subject-crossover,0,0
165507,",",0,0
165508,single-site,0,0
165509,experimental,0,0
165510,trial,0,0
165511,in,0,0
165512,which,0,0
165513,intranasal,0,1
165514,oxytocin,1,1
165515,and,0,0
165516,placebo,1,1
165517,were,0,0
165518,administered,0,0
165519,.,0,0
165520,A,0,0
165521,total,0,0
165522,of,0,0
165523,40,0,0
165524,highly,0,0
165525,functioning,0,0
165526,men,0,0
165527,with,0,0
165528,ASD,0,0
165529,participated,0,0
165530,and,0,0
165531,were,0,0
165532,randomized,0,0
165533,in,0,0
165534,the,0,0
165535,trial,0,0
165536,.,0,0
165537,INTERVENTIONS,0,0
165538,Single-dose,0,0
165539,intranasal,0,1
165540,administration,0,0
165541,of,0,0
165542,oxytocin,1,1
165543,(,1,0
165544,24,1,0
165545,IU,1,1
165546,),1,1
165547,and,0,0
165548,placebo,1,1
165549,.,1,0
165550,MAIN,0,0
165551,OUTCOMES,0,0
165552,AND,0,0
165553,MEASURES,0,0
165554,Using,0,0
165555,functional,0,0
165556,magnetic,0,1
165557,resonance,0,0
165558,imaging,0,0
165559,",",0,0
165560,we,0,0
165561,examined,0,0
165562,effects,0,0
165563,of,0,0
165564,oxytocin,1,1
165565,on,0,0
165566,behavioral,0,1
165567,neural,0,0
165568,responses,0,0
165569,of,0,0
165570,the,0,0
165571,participants,0,0
165572,to,0,0
165573,a,0,0
165574,social,0,0
165575,psychological,0,0
165576,task,0,1
165577,.,0,0
165578,In,0,0
165579,our,0,0
165580,previous,0,0
165581,case-control,0,0
165582,study,0,0
165583,using,0,0
165584,the,0,0
165585,same,0,0
165586,psychological,0,0
165587,task,0,1
165588,",",0,0
165589,when,0,0
165590,making,0,0
165591,decisions,0,0
165592,about,0,0
165593,social,0,0
165594,information,0,0
165595,with,0,0
165596,conflicting,0,0
165597,verbal,0,1
165598,and,0,0
165599,nonverbal,0,0
165600,contents,0,0
165601,",",0,0
165602,participants,0,0
165603,with,0,0
165604,ASD,0,0
165605,made,0,0
165606,judgments,0,0
165607,based,0,0
165608,on,0,0
165609,nonverbal,0,0
165610,contents,0,0
165611,less,0,0
165612,frequently,0,0
165613,with,0,0
165614,longer,0,0
165615,time,0,0
165616,and,0,0
165617,could,0,0
165618,not,0,0
165619,induce,0,0
165620,enough,0,0
165621,activation,0,0
165622,in,0,0
165623,the,0,0
165624,medial,0,0
165625,prefrontal,0,0
165626,cortex,0,0
165627,.,0,0
165628,Therefore,0,0
165629,",",0,0
165630,our,0,0
165631,main,0,0
165632,outcomes,0,0
165633,and,0,0
165634,measures,0,0
165635,were,0,0
165636,the,0,0
165637,frequency,0,0
165638,of,0,0
165639,the,0,0
165640,nonverbal,0,0
165641,information-based,0,1
165642,judgments,0,0
165643,(,0,0
165644,NVJs,0,1
165645,),0,0
165646,",",0,0
165647,the,0,0
165648,response,0,0
165649,time,0,0
165650,for,0,0
165651,NVJs,0,1
165652,",",0,0
165653,and,0,0
165654,brain,0,0
165655,activity,0,0
165656,of,0,0
165657,the,0,0
165658,medial,0,0
165659,prefrontal,0,0
165660,cortex,0,0
165661,during,0,0
165662,NVJs,0,1
165663,.,0,0
165664,RESULTS,0,0
165665,Intranasal,0,0
165666,oxytocin,1,1
165667,enabled,0,0
165668,the,0,0
165669,participants,0,0
165670,to,0,0
165671,make,0,0
165672,NVJs,0,1
165673,more,0,0
165674,frequently,0,0
165675,(,0,0
165676,P,0,0
165677,=,0,0
165678,.03,0,0
165679,),0,0
165680,with,0,0
165681,shorter,0,0
165682,response,0,0
165683,time,0,0
165684,(,0,0
165685,P,0,0
165686,=,0,0
165687,.02,0,0
165688,),0,0
165689,.,0,0
165690,During,0,0
165691,the,0,0
165692,mitigated,0,0
165693,behavior,1,0
165694,",",1,0
165695,oxytocin,1,1
165696,increased,1,0
165697,the,0,0
165698,originally,0,0
165699,diminished,0,0
165700,brain,0,0
165701,activity,0,0
165702,in,0,0
165703,the,0,0
165704,medial,0,1
165705,prefrontal,0,1
165706,cortex,0,0
165707,(,0,0
165708,P,0,0
165709,<,0,0
165710,.001,0,0
165711,),0,0
165712,.,0,0
165713,Moreover,1,0
165714,",",1,0
165715,oxytocin,1,1
165716,enhanced,1,0
165717,functional,0,0
165718,coordination,0,1
165719,in,0,0
165720,the,0,0
165721,area,0,0
165722,(,0,0
165723,P,0,0
165724,<,0,0
165725,.001,0,0
165726,),0,0
165727,",",0,0
165728,and,0,0
165729,the,0,0
165730,magnitude,0,0
165731,of,0,0
165732,these,0,0
165733,neural,0,0
165734,effects,0,0
165735,was,0,0
165736,predictive,0,0
165737,of,0,0
165738,the,0,0
165739,behavioral,0,1
165740,effects,0,0
165741,(,0,0
165742,P,0,0
165743,?,0,0
165744,.01,0,0
165745,),0,0
165746,.,0,0
165747,CONCLUSIONS,0,0
165748,AND,0,0
165749,RELEVANCE,0,0
165750,These,0,0
165751,findings,0,0
165752,provide,0,0
165753,the,0,0
165754,first,0,0
165755,neurobiological,0,0
165756,evidence,0,0
165757,for,1,0
165758,oxytocin,1,1
165759,'s,1,0
165760,beneficial,0,0
165761,effects,0,0
165762,on,0,0
165763,sociocommunicational,0,0
165764,deficits,0,0
165765,of,0,0
165766,ASD,0,0
165767,and,0,0
165768,give,0,0
165769,us,0,0
165770,the,0,0
165771,initial,0,0
165772,account,0,0
165773,for,0,0
165774,neurobiological,0,0
165775,mechanisms,0,0
165776,underlying,0,0
165777,any,0,0
165778,beneficial,0,0
165779,effects,0,0
165780,of,0,0
165781,the,0,0
165782,neuropeptide,0,1
165783,.,0,0
165784,TRIAL,0,0
165785,REGISTRATION,0,0
165786,umin.ac.jp/ctr,0,0
165787,Identifier,0,0
165788,:,0,1
165789,UMIN000002241,0,0
165790,and,0,0
165791,UMIN000004393,0,0
165792,.,0,0
165793,Evaluating,0,0
165794,the,0,0
165795,acceptability,0,0
165796,and,0,0
165797,efficacy,0,0
165798,of,0,0
165799,a,0,0
165800,psycho-educational,1,1
165801,intervention,1,1
165802,for,0,0
165803,coping,0,0
165804,and,0,0
165805,symptom,0,0
165806,management,0,1
165807,by,0,0
165808,children,0,0
165809,with,0,0
165810,cancer,0,0
165811,:,0,0
165812,a,0,0
165813,randomized,0,0
165814,controlled,0,0
165815,study,0,0
165816,.,0,0
165817,AIMS,0,0
165818,To,0,0
165819,evaluate,0,0
165820,the,0,0
165821,acceptability,0,0
165822,and,0,0
165823,efficacy,0,0
165824,of,0,0
165825,a,0,0
165826,psycho-educational,1,1
165827,intervention,1,1
165828,designed,0,0
165829,to,0,0
165830,improve,0,0
165831,effective,0,0
165832,coping,0,0
165833,and,0,0
165834,reduce,0,0
165835,symptom,0,0
165836,severity,0,0
165837,in,0,0
165838,children,0,0
165839,with,0,0
165840,cancer,0,0
165841,.,0,0
165842,BACKGROUND,0,0
165843,Cancer,0,0
165844,treatments,0,1
165845,increase,0,0
165846,survival,0,0
165847,rates,0,0
165848,and,0,0
165849,also,0,0
165850,cause,0,0
165851,physical,0,1
165852,and,0,0
165853,psychological,0,0
165854,effects,0,0
165855,on,0,0
165856,children,0,0
165857,with,0,0
165858,cancer,0,0
165859,.,0,0
165860,A,0,0
165861,psycho-educational,1,0
165862,intervention,1,1
165863,is,0,0
165864,used,0,0
165865,to,0,0
165866,assist,0,0
165867,children,0,0
165868,and,0,0
165869,adolescents,0,0
165870,with,0,0
165871,these,0,0
165872,effects,0,0
165873,and,0,0
165874,its,0,0
165875,efficacy,0,0
165876,has,0,0
165877,been,0,0
165878,described,0,0
165879,in,0,0
165880,several,0,0
165881,studies,0,0
165882,.,0,0
165883,DESIGN,0,0
165884,A,0,0
165885,randomized,0,0
165886,controlled,0,0
165887,trial,0,0
165888,.,0,0
165889,METHODS,0,0
165890,Participants,0,0
165891,being,0,0
165892,treated,0,0
165893,were,0,0
165894,recruited,0,0
165895,and,0,0
165896,randomly,0,0
165897,assigned,0,0
165898,to,0,0
165899,two,0,0
165900,groups,0,0
165901,from,0,0
165902,September,0,0
165903,2011-February,0,0
165904,2013,0,0
165905,in,0,0
165906,Taiwan,0,0
165907,.,0,0
165908,The,0,0
165909,intervention,0,1
165910,group,0,0
165911,received,0,1
165912,a,0,0
165913,psycho-educational,1,1
165914,intervention,1,1
165915,in,1,0
165916,addition,1,0
165917,to,1,0
165918,standard,1,1
165919,care,1,1
165920,",",1,0
165921,while,1,0
165922,the,1,0
165923,control,1,1
165924,group,1,0
165925,received,1,1
165926,only,1,0
165927,standard,1,1
165928,care,1,1
165929,.,1,0
165930,Each,0,0
165931,participant,0,0
165932,was,0,0
165933,assessed,0,0
165934,using,0,0
165935,a,0,0
165936,paediatric,0,0
165937,cancer,0,0
165938,coping,0,0
165939,scale,0,0
165940,and,0,0
165941,perceived,0,0
165942,symptom,0,0
165943,severity,0,0
165944,was,0,0
165945,evaluated,0,0
165946,at,0,0
165947,three,0,0
165948,time,0,0
165949,points,0,0
165950,(,0,0
165951,baseline,0,0
165952,",",0,0
165953,1,0,0
165954,month,0,0
165955,and,0,0
165956,3,0,0
165957,months,0,0
165958,),0,0
165959,.,0,0
165960,A,0,0
165961,repeated-measures,0,0
165962,analysis,0,0
165963,of,0,0
165964,variance,0,0
165965,was,0,0
165966,used,0,0
165967,to,0,0
165968,estimate,0,0
165969,the,0,0
165970,effects,0,0
165971,of,0,0
165972,intervention,0,1
165973,.,0,0
165974,Qualitative,0,0
165975,findings,0,0
165976,were,0,0
165977,analysed,0,0
165978,using,0,0
165979,content,0,0
165980,analysis,0,0
165981,.,0,0
165982,RESULTS,0,0
165983,No,0,0
165984,significant,0,0
165985,difference,0,0
165986,in,0,0
165987,coping,0,0
165988,scores,0,0
165989,was,0,0
165990,found,0,0
165991,between,0,0
165992,groups,0,0
165993,",",0,0
165994,but,0,0
165995,the,0,0
165996,experimental,0,0
165997,group,0,0
165998,reported,0,0
165999,significantly,0,0
166000,lower,0,0
166001,scores,0,0
166002,in,0,0
166003,gastrointestinal,0,0
166004,problems,0,0
166005,and,0,0
166006,pain,0,0
166007,.,0,0
166008,Most,0,0
166009,symptoms,0,0
166010,decreased,0,0
166011,significantly,0,0
166012,over,0,0
166013,time,0,0
166014,in,0,0
166015,both,0,0
166016,groups,0,0
166017,",",0,0
166018,except,0,0
166019,for,0,0
166020,gastrointestinal,0,0
166021,problems,0,0
166022,.,0,0
166023,The,0,0
166024,scores,0,0
166025,in,0,0
166026,pain,0,0
166027,",",0,0
166028,bone,0,0
166029,marrow,0,0
166030,suppression,0,0
166031,and,0,0
166032,body,0,0
166033,image,0,1
166034,showed,0,0
166035,significant,0,0
166036,interaction,0,0
166037,effects,0,0
166038,between,0,0
166039,groups,0,0
166040,on,0,0
166041,changes,0,0
166042,over,0,0
166043,time,0,0
166044,.,0,0
166045,Qualitative,0,0
166046,results,0,0
166047,reported,0,0
166048,that,0,0
166049,participants,0,0
166050,evaluated,0,0
166051,the,0,0
166052,intervention,0,1
166053,positively,0,0
166054,",",0,0
166055,especially,0,0
166056,about,0,0
166057,receipt,0,0
166058,of,0,0
166059,psychological,0,0
166060,support,0,1
166061,and,0,0
166062,learnt,0,0
166063,coping,0,0
166064,skills,0,0
166065,.,0,0
166066,CONCLUSIONS,0,0
166067,The,0,0
166068,psycho-educational,1,1
166069,intervention,1,1
166070,administered,0,0
166071,was,0,0
166072,acceptable,0,0
166073,for,0,0
166074,children,0,0
166075,with,0,0
166076,cancer,0,0
166077,and,0,0
166078,was,0,0
166079,found,0,0
166080,to,0,0
166081,reduce,0,0
166082,gastrointestinal,0,0
166083,problems,0,0
166084,and,0,0
166085,pain,0,0
166086,.,0,0
166087,A,0,0
166088,phase,0,0
166089,II,0,0
166090,",",0,0
166091,randomized,0,0
166092,",",0,0
166093,multicenter,0,0
166094,study,0,0
166095,evaluating,0,0
166096,the,0,0
166097,combination,0,1
166098,of,0,0
166099,lapatinib,0,1
166100,and,0,0
166101,vinorelbine,0,1
166102,in,0,0
166103,women,0,0
166104,with,0,0
166105,ErbB2,0,1
166106,overexpressing,0,0
166107,metastatic,0,0
166108,breast,0,0
166109,cancer,0,0
166110,.,0,0
166111,Lapatinib,0,1
166112,is,0,0
166113,approved,0,0
166114,in,0,0
166115,combination,0,1
166116,with,0,0
166117,capecitabine,0,1
166118,for,0,0
166119,treatment,0,0
166120,of,0,0
166121,patients,0,0
166122,with,0,0
166123,human,0,1
166124,epidermal,0,1
166125,growth,0,1
166126,factor,0,1
166127,receptor,0,0
166128,2,0,0
166129,(,0,0
166130,HER2,0,1
166131,),0,1
166132,-positive,0,0
166133,metastatic,0,0
166134,breast,0,0
166135,cancer,0,0
166136,(,0,1
166137,MBC,0,0
166138,),0,1
166139,who,0,0
166140,have,0,0
166141,progressed,0,0
166142,on,0,0
166143,prior,0,0
166144,trastuzumab,0,1
166145,in,0,0
166146,the,0,0
166147,metastatic,0,0
166148,setting,0,0
166149,.,0,0
166150,Vinorelbine,0,1
166151,is,0,0
166152,an,0,0
166153,important,0,0
166154,chemotherapy,0,1
166155,option,0,0
166156,for,0,0
166157,MBC,0,0
166158,.,0,0
166159,We,0,0
166160,evaluated,0,0
166161,efficacy,0,0
166162,and,0,0
166163,safety,0,0
166164,of,0,0
166165,lapatinib,0,1
166166,plus,0,1
166167,vinorelbine,0,1
166168,",",0,0
166169,compared,0,0
166170,with,0,0
166171,lapatinib,0,1
166172,plus,0,1
166173,capecitabine,0,1
166174,",",0,0
166175,in,0,0
166176,women,0,0
166177,with,0,0
166178,HER2-positive,0,0
166179,MBC,0,0
166180,.,0,0
166181,In,0,0
166182,this,0,0
166183,open-label,0,0
166184,",",0,0
166185,multicenter,0,0
166186,",",0,0
166187,phase,0,0
166188,II,0,1
166189,study,0,0
166190,",",0,0
166191,eligible,0,0
166192,patients,0,0
166193,(,0,0
166194,N,0,0
166195,=,0,0
166196,112,0,0
166197,),0,0
166198,were,0,0
166199,randomized,0,0
166200,2:1,0,0
166201,to,0,0
166202,lapatinib,1,1
166203,plus,1,1
166204,vinorelbine,1,1
166205,[,1,1
166206,(,1,0
166207,N,1,0
166208,=,1,0
166209,75,1,0
166210,),1,0
166211,"1,250",1,1
166212,mg,1,1
166213,orally,1,1
166214,once,1,1
166215,daily,1,1
166216,(,1,1
166217,QD,1,1
166218,),1,1
166219,continuously,1,0
166220,plus,1,1
166221,20,1,1
166222,mg/m,1,1
166223,(,1,0
166224,2,1,0
166225,),1,0
166226,/day,1,0
166227,intravenously,1,1
166228,],1,0
166229,or,1,0
166230,lapatinib,1,1
166231,plus,1,1
166232,capecitabine,1,1
166233,[,1,1
166234,(,1,0
166235,N,1,0
166236,=,1,0
166237,37,1,0
166238,),1,0
166239,"1,250",1,1
166240,mg,1,1
166241,orally,1,1
166242,QD,1,1
166243,continuously,1,1
166244,plus,1,1
166245,"2,000",1,1
166246,mg/m,1,1
166247,(,1,0
166248,2,1,0
166249,),1,0
166250,/day,1,0
166251,orally,1,1
166252,",",1,0
166253,2,1,0
166254,doses,1,0
166255,],1,0
166256,.,1,0
166257,The,0,0
166258,primary,0,0
166259,endpoint,0,0
166260,was,0,0
166261,progression-free,0,0
166262,survival,0,0
166263,(,0,1
166264,PFS,0,0
166265,),0,1
166266,.,0,0
166267,Other,0,0
166268,endpoints,0,0
166269,included,0,0
166270,overall,0,0
166271,survival,0,0
166272,(,0,1
166273,OS,0,1
166274,),0,1
166275,and,0,0
166276,safety,0,0
166277,.,0,0
166278,Patients,0,0
166279,progressing,0,0
166280,within,0,0
166281,the,0,0
166282,study,0,0
166283,were,0,0
166284,given,0,0
166285,the,0,0
166286,option,0,0
166287,of,0,0
166288,crossover,0,0
166289,to,0,0
166290,the,0,0
166291,other,0,0
166292,treatment,0,0
166293,arm,0,0
166294,;,0,0
166295,time,0,0
166296,to,0,0
166297,second,0,0
166298,progression,0,0
166299,was,0,0
166300,an,0,0
166301,exploratory,0,0
166302,endpoint,0,0
166303,.,0,0
166304,Patient,0,0
166305,demographics,0,0
166306,",",0,0
166307,stratification,0,0
166308,",",0,0
166309,and,0,0
166310,prognostic,0,0
166311,factors,0,0
166312,were,0,0
166313,well,0,0
166314,balanced,0,0
166315,between,0,0
166316,treatments,0,0
166317,.,0,0
166318,Median,0,0
166319,PFS,0,0
166320,in,0,0
166321,both,0,0
166322,arms,0,0
166323,was,0,0
166324,6.2,0,0
166325,months,0,0
166326,[,0,0
166327,95,0,0
166328,%,0,0
166329,confidence,0,0
166330,interval,0,0
166331,(,0,1
166332,CI,0,0
166333,),0,1
166334,4.2,0,0
166335,",",0,0
166336,8.8,0,0
166337,(,0,0
166338,lapatinib,0,1
166339,plus,0,1
166340,vinorelbine,0,1
166341,),0,0
166342,;,0,0
166343,4.4,0,0
166344,",",0,0
166345,8.3,0,0
166346,(,0,0
166347,lapatinib,0,1
166348,plus,0,1
166349,capecitabine,0,1
166350,),0,1
166351,],0,0
166352,.,0,0
166353,Median,0,0
166354,OS,0,0
166355,on,0,0
166356,lapatinib,0,1
166357,plus,0,1
166358,vinorelbine,0,1
166359,was,0,0
166360,24.3,0,0
166361,months,0,0
166362,(,0,0
166363,95,0,0
166364,%,0,0
166365,CI,0,0
166366,16.4,0,0
166367,",",0,0
166368,NE,0,1
166369,),0,1
166370,and,0,0
166371,19.4,0,0
166372,months,0,0
166373,(,0,0
166374,95,0,0
166375,%,0,0
166376,CI,0,0
166377,16.4,0,0
166378,",",0,0
166379,27.2,0,0
166380,),0,0
166381,on,0,0
166382,lapatinib,0,1
166383,plus,0,1
166384,capecitabine,0,1
166385,.,0,0
166386,In,0,0
166387,total,0,0
166388,",",0,0
166389,42,0,0
166390,patients,0,0
166391,opted,0,0
166392,to,0,0
166393,cross,0,0
166394,over,0,0
166395,;,0,0
166396,median,0,0
166397,PFS,0,0
166398,was,0,0
166399,3.2,0,0
166400,months,0,0
166401,(,0,0
166402,95,0,0
166403,%,0,0
166404,CI,0,0
166405,1.7,0,0
166406,",",0,0
166407,5.1,0,0
166408,),0,0
166409,on,0,0
166410,lapatinib,0,1
166411,plus,0,1
166412,vinorelbine,0,1
166413,and,0,0
166414,4.0,0,0
166415,months,0,0
166416,(,0,0
166417,95,0,0
166418,%,0,0
166419,CI,0,0
166420,2.1,0,0
166421,",",0,0
166422,5.8,0,0
166423,),0,0
166424,on,0,0
166425,lapatinib,0,1
166426,plus,0,1
166427,capecitabine,0,1
166428,.,0,1
166429,Lapatinib,0,1
166430,plus,0,1
166431,vinorelbine,0,1
166432,offers,0,0
166433,an,0,0
166434,effective,0,0
166435,treatment,0,0
166436,option,0,0
166437,for,0,0
166438,patients,0,0
166439,with,0,0
166440,HER2-overexpressing,0,0
166441,MBC,0,0
166442,",",0,0
166443,having,0,0
166444,displayed,0,0
166445,comparable,0,0
166446,efficacy,0,0
166447,and,0,0
166448,tolerability,0,0
166449,rates,0,0
166450,to,0,0
166451,lapatinib,0,1
166452,plus,0,1
166453,capecitabine,0,1
166454,.,0,0
166455,Changes,0,0
166456,in,0,0
166457,body,0,0
166458,weight,0,0
166459,and,0,0
166460,blood,0,0
166461,pressure,0,0
166462,:,0,0
166463,paradoxical,0,0
166464,outcome,0,0
166465,events,0,0
166466,in,0,0
166467,overweight,0,0
166468,and,0,0
166469,obese,0,0
166470,subjects,0,0
166471,with,0,0
166472,cardiovascular,0,0
166473,disease,0,0
166474,.,0,0
166475,BACKGROUND/OBJECTIVES,0,0
166476,The,0,0
166477,Sibutramine,0,1
166478,Cardiovascular,0,0
166479,OUTcomes,0,1
166480,(,0,1
166481,SCOUT,0,1
166482,),0,1
166483,trial,0,0
166484,showed,0,0
166485,a,0,0
166486,significantly,0,0
166487,increased,0,0
166488,relative,0,0
166489,risk,0,0
166490,of,0,0
166491,nonfatal,0,0
166492,cardiovascular,0,0
166493,events,0,0
166494,",",0,0
166495,but,0,0
166496,not,0,0
166497,mortality,0,0
166498,",",0,0
166499,in,0,0
166500,overweight,0,0
166501,and,0,0
166502,obese,0,0
166503,subjects,0,0
166504,receiving,0,0
166505,long-term,1,0
166506,sibutramine,1,1
166507,treatment,1,0
166508,with,1,0
166509,diet,1,1
166510,and,1,0
166511,exercise,1,1
166512,.,1,0
166513,We,0,0
166514,examined,0,0
166515,the,0,0
166516,relationship,0,0
166517,between,0,0
166518,early,0,0
166519,changes,0,0
166520,(,0,0
166521,both,0,0
166522,increases,0,0
166523,and,0,0
166524,decreases,0,0
166525,),0,0
166526,in,0,0
166527,body,0,0
166528,weight,0,0
166529,and,0,0
166530,blood,0,0
166531,pressure,0,0
166532,",",0,0
166533,and,0,0
166534,the,0,0
166535,impact,0,0
166536,of,0,0
166537,these,0,0
166538,changes,0,0
166539,on,0,0
166540,subsequent,0,0
166541,cardiovascular,0,0
166542,outcome,0,0
166543,events,0,0
166544,.,0,0
166545,SUBJECTS/METHODS,0,0
166546,A,0,0
166547,total,0,0
166548,of,0,0
166549,9804,0,1
166550,male,0,0
166551,and,0,0
166552,female,0,0
166553,subjects,0,0
166554,",",0,0
166555,aged,0,0
166556,55,0,0
166557,years,0,0
166558,or,0,0
166559,older,0,0
166560,",",0,0
166561,with,0,0
166562,a,0,0
166563,body,0,0
166564,mass,0,0
166565,index,0,0
166566,of,0,0
166567,27-45,0,0
166568,kg,0,1
166569,m,0,0
166570,(,0,1
166571,-2,0,0
166572,),0,1
166573,were,0,0
166574,included,0,0
166575,in,0,0
166576,this,0,0
166577,current,0,0
166578,subanalysis,0,0
166579,of,0,0
166580,the,0,0
166581,SCOUT,0,1
166582,trial,0,0
166583,.,0,0
166584,Subjects,0,0
166585,were,0,0
166586,required,0,0
166587,to,0,0
166588,have,0,0
166589,a,0,0
166590,history,0,0
166591,of,0,0
166592,cardiovascular,0,0
166593,disease,0,0
166594,and/or,0,0
166595,type,0,0
166596,2,0,0
166597,diabetes,0,0
166598,mellitus,0,0
166599,with,0,0
166600,at,0,0
166601,least,0,0
166602,one,0,0
166603,cardiovascular,0,0
166604,risk,0,0
166605,factor,0,1
166606,(,0,1
166607,hypertension,0,0
166608,",",0,0
166609,dyslipidemia,0,0
166610,",",0,0
166611,current,0,1
166612,smoking,0,1
166613,or,0,1
166614,diabetic,0,0
166615,nephropathy,0,0
166616,),0,0
166617,to,0,0
166618,assess,0,0
166619,cardiovascular,0,0
166620,outcomes,0,0
166621,.,0,0
166622,Post,0,1
166623,hoc,0,0
166624,subgroup,0,0
166625,analyses,0,0
166626,of,0,0
166627,weight,0,0
166628,change,0,0
166629,(,0,1
166630,categories,0,0
166631,),0,1
166632,and,0,0
166633,blood,0,0
166634,pressure,0,0
166635,were,0,0
166636,performed,0,0
166637,overall,0,0
166638,and,0,0
166639,by,0,0
166640,treatment,0,1
166641,group,0,1
166642,(,0,1
166643,6-week,1,0
166644,sibutramine,1,1
166645,followed,1,1
166646,by,0,0
166647,randomized,1,0
166648,placebo,1,1
166649,or,1,1
166650,continued,1,1
166651,sibutramine,1,1
166652,),1,0
166653,.,1,0
166654,The,1,0
166655,primary,0,0
166656,outcome,0,0
166657,event,0,0
166658,(,0,1
166659,POE,0,1
166660,),0,1
166661,was,0,0
166662,a,0,0
166663,composite,0,1
166664,of,0,0
166665,nonfatal,0,0
166666,myocardial,0,0
166667,infarction,0,0
166668,",",0,0
166669,nonfatal,0,0
166670,stroke,0,0
166671,",",0,0
166672,resuscitated,0,0
166673,cardiac,0,0
166674,arrest,0,0
166675,or,0,1
166676,cardiovascular,0,0
166677,death,0,0
166678,.,0,0
166679,Time-to-event,0,0
166680,analyses,0,0
166681,of,0,0
166682,the,0,0
166683,POE,0,1
166684,were,0,0
166685,performed,0,0
166686,using,0,0
166687,Cox,0,1
166688,regression,0,0
166689,models,0,0
166690,with,0,0
166691,factors,0,0
166692,for,0,0
166693,treatment,0,0
166694,",",0,0
166695,subgroups,0,0
166696,and,0,0
166697,interactions,0,0
166698,.,0,0
166699,RESULTS,0,0
166700,During,0,0
166701,the,0,0
166702,initial,0,0
166703,6-week,1,0
166704,sibutramine,1,1
166705,treatment,1,1
166706,period,0,0
166707,",",0,0
166708,systolic,0,0
166709,blood,0,0
166710,pressure,0,0
166711,decreased,0,0
166712,progressively,0,0
166713,with,0,0
166714,increasing,0,0
166715,weight,0,0
166716,loss,0,0
166717,in,0,0
166718,hypertensive,0,0
166719,subjects,0,0
166720,(,0,0
166721,-8.1?10.5,0,0
166722,mm,0,0
166723,Hg,0,0
166724,with,0,0
166725,<,0,0
166726,5,0,1
166727,kg,0,0
166728,weight,0,0
166729,loss,0,0
166730,to,0,0
166731,-10.8?11.0,0,0
166732,mm,0,0
166733,Hg,0,0
166734,with,0,0
166735,?5,0,1
166736,kg,0,1
166737,weight,0,0
166738,loss,0,0
166739,),0,0
166740,.,0,0
166741,The,0,0
166742,highest,0,0
166743,POE,0,1
166744,incidence,0,0
166745,occurred,0,0
166746,mainly,0,0
166747,in,0,0
166748,groups,0,0
166749,with,0,0
166750,increases,0,0
166751,in,0,0
166752,both,0,0
166753,weight,0,0
166754,and,0,0
166755,blood,0,0
166756,pressure,0,0
166757,.,0,0
166758,However,0,0
166759,",",0,0
166760,with,0,0
166761,long-term,1,0
166762,sibutramine,1,1
166763,treatment,1,0
166764,",",0,0
166765,a,0,0
166766,markedly,0,0
166767,lower,0,0
166768,blood,0,0
166769,pressure,0,0
166770,tended,0,0
166771,to,0,0
166772,increase,0,0
166773,POEs,0,1
166774,.,0,0
166775,CONCLUSION,0,0
166776,Modest,0,0
166777,weight,0,0
166778,loss,0,0
166779,and,0,0
166780,modest,0,0
166781,lower,0,0
166782,blood,0,0
166783,pressure,0,0
166784,each,0,0
166785,reduced,0,0
166786,the,0,0
166787,incidence,0,0
166788,of,0,0
166789,cardiovascular,0,0
166790,events,0,0
166791,",",0,0
166792,as,0,0
166793,expected,0,0
166794,.,0,0
166795,However,0,0
166796,",",0,0
166797,the,0,0
166798,combination,0,1
166799,of,0,0
166800,early,0,0
166801,marked,0,0
166802,weight,0,0
166803,loss,0,0
166804,and,0,0
166805,rapid,0,0
166806,blood,0,0
166807,pressure,0,0
166808,reduction,0,0
166809,seems,0,0
166810,to,0,0
166811,be,0,0
166812,harmful,0,0
166813,in,0,0
166814,this,0,0
166815,obese,0,0
166816,elderly,0,0
166817,cardiovascular,0,0
166818,diseased,0,0
166819,population,0,0
166820,.,0,0
166821,Examining,0,0
166822,the,0,0
166823,effectiveness,0,0
166824,of,0,0
166825,psychological,1,0
166826,strategies,1,0
166827,on,0,0
166828,physiologic,0,0
166829,markers,0,0
166830,:,0,0
166831,evidence-based,0,0
166832,suggestions,0,0
166833,for,0,0
166834,holistic,0,1
166835,care,0,1
166836,of,0,0
166837,the,0,0
166838,athlete,0,0
166839,.,0,0
166840,CONTEXT,0,0
166841,Current,0,0
166842,holistic,1,1
166843,rehabilitation,1,1
166844,blends,0,1
166845,both,0,0
166846,physical,0,0
166847,and,0,0
166848,psychological,0,0
166849,techniques,0,1
166850,.,0,0
166851,However,0,0
166852,",",0,0
166853,validation,0,0
166854,of,0,0
166855,the,0,0
166856,usefulness,0,0
166857,of,0,0
166858,psychological,1,0
166859,strategies,1,0
166860,is,0,0
166861,limited,0,0
166862,in,0,0
166863,the,0,0
166864,literature,0,0
166865,.,0,0
166866,OBJECTIVE,0,0
166867,To,0,0
166868,quantify,0,0
166869,the,0,0
166870,effects,0,0
166871,of,0,0
166872,psychological,0,0
166873,strategies,0,0
166874,on,0,0
166875,both,0,0
166876,physiologic,0,0
166877,(,0,0
166878,salivary,0,0
166879,cortisol,0,0
166880,),0,1
166881,and,0,0
166882,subjective,0,0
166883,assessments,0,0
166884,of,0,0
166885,stress,0,0
166886,.,0,0
166887,DESIGN,0,0
166888,Randomized,0,0
166889,controlled,0,0
166890,clinical,0,0
166891,trial,0,0
166892,.,0,0
166893,SETTING,0,0
166894,Laboratory,0,0
166895,.,0,0
166896,PATIENTS,0,0
166897,OR,0,0
166898,OTHER,0,0
166899,PARTICIPANTS,0,0
166900,A,0,0
166901,total,0,0
166902,of,0,0
166903,97,0,0
166904,college-aged,0,0
166905,students,0,0
166906,(,0,0
166907,age,0,0
166908,=,0,0
166909,20.65,0,0
166910,?,0,0
166911,4.38,0,0
166912,years,0,0
166913,),0,0
166914,",",0,0
166915,most,0,0
166916,with,0,0
166917,little,0,0
166918,to,0,0
166919,no,0,0
166920,experience,0,0
166921,with,0,0
166922,psychological,0,0
166923,strategies,0,0
166924,.,0,0
166925,INTERVENTION,0,0
166926,(,0,0
166927,S,0,1
166928,),0,1
166929,A,0,0
166930,15-minute,1,1
166931,script,1,0
166932,via,1,1
166933,an,1,0
166934,iPod,1,0
166935,led,0,0
166936,the,0,0
166937,participant,0,0
166938,through,1,0
166939,visual,1,1
166940,imagery,1,1
166941,(,1,1
166942,cognitive,1,1
166943,relaxation,1,1
166944,),1,1
166945,or,1,1
166946,deep,1,1
166947,breathing,1,1
166948,exercises,1,1
166949,(,1,0
166950,somatic,1,0
166951,relaxation,1,1
166952,),1,0
166953,cues,0,0
166954,.,0,0
166955,The,0,0
166956,control,0,0
166957,group,0,0
166958,listened,0,0
166959,to,0,0
166960,15,0,0
166961,minutes,0,0
166962,of,1,0
166963,ambient,1,1
166964,nature,1,0
166965,sounds,1,1
166966,.,1,0
166967,MAIN,0,0
166968,OUTCOME,0,0
166969,MEASURE,0,1
166970,(,0,1
166971,S,0,1
166972,),0,1
166973,Two,0,1
166974,samples,0,0
166975,(,0,0
166976,pretest,0,0
166977,",",0,0
166978,posttest,0,0
166979,),0,0
166980,of,0,0
166981,salivary,0,0
166982,cortisol,0,0
166983,were,0,0
166984,analyzed,0,0
166985,using,0,0
166986,an,0,0
166987,enzyme,0,1
166988,immunoassay,0,0
166989,kit,0,1
166990,;,0,0
166991,the,0,0
166992,average,0,0
166993,was,0,0
166994,used,0,0
166995,for,0,0
166996,statistical,0,0
166997,analysis,0,0
166998,.,0,0
166999,Descriptive,0,0
167000,statistics,0,0
167001,and,0,0
167002,correlations,0,0
167003,were,0,0
167004,conducted,0,0
167005,to,0,0
167006,examine,0,0
167007,group,0,0
167008,differences,0,0
167009,in,0,0
167010,time,0,0
167011,of,0,0
167012,day,0,0
167013,",",0,0
167014,salivary,0,0
167015,cortisol,0,0
167016,",",0,0
167017,sex,0,0
167018,",",0,0
167019,Stress-O-Meter,0,0
167020,values,0,0
167021,",",0,0
167022,and,0,0
167023,Perceived,0,1
167024,Stress,0,1
167025,Scale,0,0
167026,scores,0,0
167027,.,0,0
167028,RESULTS,0,0
167029,Salivary,0,0
167030,cortisol,0,0
167031,levels,0,0
167032,were,0,0
167033,lower,0,0
167034,in,0,0
167035,the,1,0
167036,treatment,1,0
167037,group,1,0
167038,than,0,0
167039,the,1,0
167040,control,1,1
167041,group,1,0
167042,(,0,0
167043,"F2,97",0,0
167044,=,0,0
167045,15.62,0,0
167046,",",0,0
167047,P,0,0
167048,<,0,0
167049,.001,0,0
167050,),0,0
167051,.,0,0
167052,Females,0,0
167053,had,0,0
167054,higher,0,0
167055,scores,0,0
167056,on,0,0
167057,both,0,0
167058,the,0,0
167059,pretest,0,0
167060,Stress-O-Meter,0,1
167061,(,0,0
167062,5.15,0,0
167063,?,0,0
167064,1.796,0,0
167065,),0,0
167066,and,0,0
167067,the,0,0
167068,Perceived,0,1
167069,Stress,0,1
167070,Scale,0,1
167071,(,0,0
167072,18.31,0,0
167073,?,0,0
167074,5.833,0,0
167075,),0,0
167076,than,0,0
167077,males,0,0
167078,(,0,0
167079,4.25,0,0
167080,?,0,0
167081,1.741,0,0
167082,and,0,0
167083,15.272,0,0
167084,?,0,0
167085,5.390,0,0
167086,",",0,0
167087,respectively,0,0
167088,),0,0
167089,.,0,0
167090,CONCLUSIONS,0,0
167091,Both,0,1
167092,cognitive,1,1
167093,and,1,0
167094,somatic,1,0
167095,relaxation,1,1
167096,strategies,1,0
167097,reduced,1,0
167098,cortisol,0,0
167099,levels,0,0
167100,.,0,0
167101,Participants,0,0
167102,who,0,0
167103,received,0,0
167104,verbal,0,0
167105,guidance,0,1
167106,achieved,0,0
167107,a,0,0
167108,larger,0,0
167109,cortisol,0,0
167110,reduction,0,0
167111,.,0,0
167112,However,0,0
167113,",",0,0
167114,the,0,0
167115,change,0,0
167116,in,0,0
167117,cortisol,0,0
167118,level,0,0
167119,was,0,0
167120,uncorrelated,0,0
167121,with,0,0
167122,the,0,0
167123,change,0,0
167124,in,0,0
167125,report,0,0
167126,of,0,0
167127,acute,0,0
167128,stress,0,0
167129,;,0,0
167130,females,0,0
167131,reported,0,0
167132,higher,0,0
167133,levels,0,0
167134,of,0,0
167135,stress,0,0
167136,.,0,0
167137,Clinical,0,0
167138,implications,0,0
167139,include,0,0
167140,attention,0,0
167141,to,0,0
167142,sex,0,0
167143,when,0,0
167144,assessing,0,0
167145,stress,0,0
167146,and,0,1
167147,providing,0,0
167148,coping,0,0
167149,skills,0,1
167150,during,0,0
167151,the,0,0
167152,rehabilitation,0,1
167153,process,0,0
167154,.,0,0
167155,Management,0,0
167156,of,0,0
167157,large,0,0
167158,bowel,0,0
167159,obstruction,0,0
167160,with,0,0
167161,self-expanding,1,1
167162,metal,1,0
167163,stents,1,1
167164,.,1,0
167165,A,0,0
167166,multicentre,0,0
167167,retrospective,0,0
167168,study,0,0
167169,of,0,0
167170,factors,0,0
167171,determining,0,0
167172,outcome,0,0
167173,.,0,0
167174,AIM,0,0
167175,UK,0,0
167176,cancer,0,0
167177,guidelines,0,0
167178,recommend,0,0
167179,patients,0,0
167180,with,0,0
167181,colonic,0,0
167182,obstruction,0,0
167183,due,0,0
167184,to,0,0
167185,suspected,0,0
167186,malignancy,0,0
167187,be,0,0
167188,considered,0,0
167189,for,0,0
167190,stenting,1,1
167191,with,1,0
167192,a,1,0
167193,self-expanding,1,1
167194,metal,1,1
167195,stent,1,1
167196,(,1,1
167197,SEMS,1,1
167198,),1,1
167199,.,1,0
167200,Considerable,0,0
167201,variation,0,0
167202,in,0,0
167203,practice,0,0
167204,exists,0,0
167205,due,0,0
167206,to,0,0
167207,a,0,0
167208,lack,0,0
167209,of,0,0
167210,expertise,0,0
167211,",",0,0
167212,technical,0,0
167213,difficulties,0,0
167214,and,0,0
167215,other,0,0
167216,",",0,0
167217,as,0,0
167218,yet,0,0
167219,ill-defined,0,0
167220,features,0,0
167221,.,0,0
167222,This,0,0
167223,retrospective,0,0
167224,multi-centre,0,0
167225,study,0,0
167226,aims,0,0
167227,to,0,0
167228,determine,0,0
167229,the,0,0
167230,outcome,0,0
167231,following,0,0
167232,colonic,0,0
167233,stenting,0,1
167234,for,0,0
167235,large,0,0
167236,bowel,0,0
167237,obstruction,0,0
167238,and,0,0
167239,identify,0,0
167240,factors,0,0
167241,associated,0,0
167242,with,0,0
167243,successful,0,0
167244,intervention,0,1
167245,.,0,0
167246,METHOD,0,0
167247,A,0,0
167248,regional,0,0
167249,programme,0,1
167250,of,0,0
167251,colonic,0,0
167252,stenting,0,1
167253,for,0,0
167254,large,0,0
167255,bowel,0,0
167256,obstruction,0,0
167257,",",0,0
167258,in,0,0
167259,five,0,0
167260,UK,0,0
167261,centres,0,0
167262,from,0,0
167263,2005,0,0
167264,to,0,0
167265,2010,0,0
167266,was,0,0
167267,evaluated,0,0
167268,for,0,0
167269,outcome,0,0
167270,including,0,0
167271,technical,0,0
167272,and,0,0
167273,clinical,0,0
167274,success,0,0
167275,",",0,0
167276,survival,0,0
167277,",",0,0
167278,complications,0,0
167279,and,0,0
167280,reoperation,0,0
167281,.,0,0
167282,RESULTS,0,0
167283,A,0,0
167284,SEMS,1,1
167285,was,0,0
167286,inserted,0,1
167287,in,0,0
167288,334,0,0
167289,patients,0,0
167290,",",0,0
167291,including,0,0
167292,264,0,0
167293,(,0,0
167294,79.0,0,0
167295,%,0,0
167296,),0,0
167297,for,0,0
167298,palliation,0,0
167299,and,0,0
167300,52,0,0
167301,(,0,0
167302,15.6,0,0
167303,%,0,0
167304,),0,0
167305,as,0,0
167306,a,0,0
167307,bridge,0,1
167308,to,0,0
167309,surgery,0,0
167310,.,0,1
167311,Technical,0,0
167312,success,0,0
167313,was,0,0
167314,achieved,0,0
167315,in,0,0
167316,292,0,0
167317,(,0,0
167318,87.4,0,0
167319,%,0,0
167320,),0,0
167321,patients,0,0
167322,",",0,0
167323,with,0,0
167324,46,0,0
167325,(,0,0
167326,13.8,0,0
167327,%,0,0
167328,),0,0
167329,experiencing,0,0
167330,a,0,0
167331,complication,0,0
167332,or,0,1
167333,technical,0,0
167334,failure,0,0
167335,.,0,0
167336,Reoperation,0,0
167337,was,0,0
167338,required,0,0
167339,in,0,0
167340,39,0,0
167341,(,0,0
167342,14.8,0,0
167343,%,0,0
167344,),0,0
167345,patients,0,0
167346,stented,0,0
167347,for,0,0
167348,palliation,0,0
167349,of,0,0
167350,colorectal,0,0
167351,cancer,0,0
167352,of,0,0
167353,whom,0,0
167354,16,0,0
167355,(,0,0
167356,6.1,0,0
167357,%,0,0
167358,),0,0
167359,subsequently,0,0
167360,required,0,0
167361,a,0,0
167362,colostomy,0,1
167363,.,0,0
167364,A,0,0
167365,one-stage,0,0
167366,primary,0,0
167367,anastomosis,0,1
167368,was,0,0
167369,achieved,0,0
167370,in,0,0
167371,35,0,0
167372,(,0,0
167373,67.3,0,0
167374,%,0,0
167375,),0,0
167376,of,0,0
167377,the,0,0
167378,52,0,0
167379,patients,0,0
167380,undergoing,0,0
167381,stenting,0,1
167382,as,0,0
167383,a,0,0
167384,bridge,0,1
167385,to,0,0
167386,resection,0,0
167387,.,0,0
167388,Technical,0,0
167389,success,0,0
167390,did,0,0
167391,not,0,0
167392,vary,0,0
167393,by,0,0
167394,indication,0,0
167395,or,0,1
167396,site,0,0
167397,of,0,0
167398,obstruction,0,0
167399,(,0,0
167400,P,0,0
167401,=,0,0
167402,0.60,0,0
167403,),0,0
167404,but,0,0
167405,was,0,0
167406,higher,0,0
167407,for,0,0
167408,operators,0,0
167409,who,0,0
167410,had,0,0
167411,performed,0,0
167412,more,0,0
167413,than,0,0
167414,10,0,0
167415,procedures,0,0
167416,(,0,0
167417,OR,0,0
167418,3.34,0,0
167419,",",0,0
167420,P,0,0
167421,=,0,0
167422,0.001,0,0
167423,),0,0
167424,.,0,0
167425,ASA,0,0
167426,grade,0,0
167427,?3,0,1
167428,predicted,0,0
167429,a,0,0
167430,worse,0,0
167431,clinical,0,0
167432,outcome,0,0
167433,(,0,0
167434,OR,0,0
167435,0.43,0,0
167436,",",0,0
167437,P,0,0
167438,=,0,0
167439,0.04,0,0
167440,),0,0
167441,.,0,0
167442,The,0,0
167443,through-the-scope,0,1
167444,(,0,1
167445,TTS,0,0
167446,),0,1
167447,endoscopy,0,1
167448,technique,0,1
167449,was,0,0
167450,more,0,0
167451,successful,0,0
167452,than,0,0
167453,radiological,0,0
167454,placement,0,1
167455,alone,0,1
167456,(,0,0
167457,90.3,0,0
167458,%,0,0
167459,vs,0,0
167460,74.8,0,0
167461,%,0,0
167462,",",0,0
167463,P,0,0
167464,<,0,0
167465,0.001,0,0
167466,),0,0
167467,.,0,0
167468,CONCLUSION,0,0
167469,Experienced,0,0
167470,operators,0,0
167471,using,0,0
167472,a,0,0
167473,TTS,0,0
167474,technique,0,1
167475,achieved,0,0
167476,a,0,0
167477,better,0,0
167478,outcome,0,0
167479,for,0,0
167480,the,0,0
167481,emergency,0,1
167482,management,0,1
167483,of,0,0
167484,large,0,0
167485,bowel,0,0
167486,obstruction,0,0
167487,.,0,0
167488,Older,0,0
167489,",",0,0
167490,sicker,0,0
167491,patients,0,0
167492,and,0,0
167493,those,0,0
167494,with,0,0
167495,extracolonic,0,0
167496,and,0,0
167497,benign,0,0
167498,strictures,0,0
167499,fared,0,0
167500,less,0,0
167501,well,0,0
167502,.,0,0
167503,Non-contrast-enhanced,1,1
167504,4D,1,1
167505,MR,1,1
167506,angiography,1,1
167507,with,0,0
167508,STAR,0,0
167509,spin,0,1
167510,labeling,0,1
167511,and,0,0
167512,variable,0,0
167513,flip,0,1
167514,angle,0,0
167515,sampling,0,0
167516,:,0,0
167517,a,0,0
167518,feasibility,0,0
167519,study,0,0
167520,for,0,0
167521,the,0,0
167522,assessment,0,0
167523,of,0,0
167524,Dural,0,0
167525,Arteriovenous,0,1
167526,Fistula,0,0
167527,.,0,0
167528,INTRODUCTION,0,0
167529,This,0,0
167530,study,0,0
167531,aimed,0,0
167532,to,0,0
167533,evaluate,0,0
167534,the,0,0
167535,feasibility,0,0
167536,of,0,0
167537,non-contrast-enhanced,0,1
167538,4D,0,1
167539,magnetic,0,1
167540,resonance,0,1
167541,angiography,0,1
167542,(,0,0
167543,NCE,0,1
167544,4D,0,1
167545,MRA,0,1
167546,),0,0
167547,with,0,0
167548,signal,0,0
167549,targeting,0,0
167550,with,0,0
167551,alternative,0,1
167552,radiofrequency,0,1
167553,(,0,1
167554,STAR,0,0
167555,),0,1
167556,spin,0,1
167557,labeling,0,1
167558,and,0,0
167559,variable,0,0
167560,flip,0,1
167561,angle,0,0
167562,(,0,1
167563,VFA,0,0
167564,),0,1
167565,sampling,0,0
167566,in,0,0
167567,the,0,0
167568,assessment,0,0
167569,of,0,0
167570,dural,0,1
167571,arteriovenous,0,1
167572,fistula,0,1
167573,(,0,1
167574,DAVF,0,1
167575,),0,1
167576,in,0,0
167577,the,0,0
167578,transverse,0,0
167579,sinus,0,0
167580,.,0,0
167581,METHODS,0,0
167582,Nine,0,1
167583,patients,0,0
167584,underwent,0,0
167585,NCE,1,1
167586,4D,1,1
167587,MRA,1,1
167588,for,0,0
167589,the,0,0
167590,evaluation,0,0
167591,of,0,0
167592,DAVF,0,1
167593,in,0,0
167594,the,0,0
167595,transverse,0,0
167596,sinus,0,0
167597,at,0,0
167598,3,0,0
167599,T.,0,0
167600,One,0,1
167601,patient,0,0
167602,was,0,0
167603,examined,0,0
167604,twice,0,0
167605,",",0,0
167606,once,0,1
167607,before,0,0
167608,and,0,0
167609,once,0,1
167610,after,0,0
167611,the,0,0
167612,interventional,0,1
167613,treatment,0,0
167614,.,0,0
167615,All,0,0
167616,patients,0,0
167617,also,0,0
167618,underwent,1,0
167619,digital,1,1
167620,subtraction,1,1
167621,angiography,1,1
167622,(,0,1
167623,DSA,0,0
167624,),0,1
167625,and/or,1,0
167626,contrast-enhanced,1,1
167627,magnetic,1,1
167628,resonance,1,1
167629,angiography,1,1
167630,(,0,1
167631,CEMRA,0,1
167632,),0,0
167633,.,0,0
167634,For,0,0
167635,the,0,0
167636,acquisition,0,0
167637,of,0,0
167638,NCE,0,1
167639,4D,0,1
167640,MRA,0,1
167641,",",0,0
167642,a,0,0
167643,STAR,0,0
167644,spin,0,1
167645,tagging,0,1
167646,method,0,1
167647,was,0,0
167648,used,0,0
167649,",",0,0
167650,and,0,0
167651,a,0,0
167652,VFA,0,0
167653,sampling,0,0
167654,was,0,0
167655,applied,0,0
167656,in,0,0
167657,the,0,0
167658,data,0,0
167659,readout,0,0
167660,module,0,1
167661,instead,0,0
167662,of,0,0
167663,a,0,0
167664,constant,0,0
167665,flip,0,0
167666,angle,0,0
167667,.,0,0
167668,Two,0,0
167669,readers,0,0
167670,evaluated,0,0
167671,the,0,0
167672,NCE,0,1
167673,4D,0,1
167674,MRA,0,1
167675,data,0,0
167676,for,0,0
167677,the,0,0
167678,diagnosis,0,0
167679,of,0,0
167680,DAVF,0,1
167681,and,0,0
167682,its,0,0
167683,type,0,0
167684,with,0,0
167685,consensus,0,0
167686,.,0,0
167687,The,0,0
167688,results,0,0
167689,were,0,0
167690,compared,0,0
167691,with,0,0
167692,those,0,0
167693,from,0,0
167694,DSA,0,0
167695,and/or,0,0
167696,CEMRA,0,0
167697,.,0,0
167698,RESULTS,0,0
167699,All,0,0
167700,patients,0,0
167701,underwent,1,0
167702,NCE,1,1
167703,4D,1,1
167704,MRA,1,1
167705,without,0,0
167706,any,0,0
167707,difficulty,0,0
167708,.,0,0
167709,Among,0,0
167710,seven,0,0
167711,patients,0,0
167712,with,0,0
167713,patent,0,0
167714,DAVFs,0,1
167715,",",0,0
167716,all,0,0
167717,cases,0,0
167718,showed,0,0
167719,an,0,0
167720,early,0,0
167721,visualization,0,1
167722,of,0,0
167723,the,0,0
167724,transverse,0,0
167725,sinus,0,0
167726,on,1,0
167727,NCE,1,1
167728,4D,1,1
167729,MRA,1,1
167730,.,1,0
167731,Except,0,0
167732,for,0,0
167733,one,0,0
167734,case,0,0
167735,",",0,0
167736,the,0,0
167737,type,0,0
167738,of,0,0
167739,DAVF,0,1
167740,of,1,0
167741,NCE,1,1
167742,4D,1,1
167743,MRA,1,1
167744,was,0,0
167745,agreed,0,0
167746,with,0,0
167747,that,0,0
167748,of,0,0
167749,reference,0,0
167750,standard,0,1
167751,study,0,0
167752,.,0,0
167753,Cortical,0,0
167754,venous,0,0
167755,reflux,0,0
167756,(,0,1
167757,CVR,0,1
167758,),0,1
167759,was,0,0
167760,demonstrated,0,0
167761,in,0,0
167762,two,0,0
167763,cases,0,0
167764,out,0,0
167765,of,0,0
167766,three,0,0
167767,patients,0,0
167768,with,0,0
167769,CVR,0,0
167770,.,0,0
167771,CONCLUSION,0,0
167772,NCE,0,0
167773,4D,0,1
167774,MRA,0,1
167775,with,0,0
167776,STAR,0,0
167777,tagging,0,1
167778,and,0,0
167779,VFA,0,0
167780,sampling,0,0
167781,is,0,0
167782,technically,0,0
167783,and,0,0
167784,clinically,0,0
167785,feasible,0,0
167786,and,0,0
167787,represents,0,0
167788,a,0,0
167789,promising,0,0
167790,technique,0,1
167791,for,0,0
167792,assessment,0,0
167793,of,0,0
167794,DAVF,0,1
167795,in,0,0
167796,the,0,0
167797,transverse,0,0
167798,sinus,0,0
167799,.,0,0
167800,Further,0,0
167801,technical,0,0
167802,developments,0,0
167803,should,0,0
167804,aim,0,0
167805,at,0,0
167806,improvements,0,0
167807,of,0,0
167808,spatial,0,0
167809,and,0,0
167810,temporal,0,0
167811,coverage,0,0
167812,.,0,0
167813,Evaluation,0,1
167814,of,0,0
167815,the,0,0
167816,efficacy,0,0
167817,and,0,0
167818,safety,0,0
167819,of,0,0
167820,the,0,0
167821,ophthalmic,1,1
167822,insert,1,0
167823,Mydriasert,1,1
167824,in,0,0
167825,patients,0,0
167826,undergoing,0,0
167827,retinal,0,0
167828,angiography,0,1
167829,.,0,0
167830,PURPOSE,0,0
167831,To,0,0
167832,verify,0,0
167833,the,0,0
167834,efficacy,0,0
167835,to,0,0
167836,obtain,0,0
167837,mydriasis,0,1
167838,and,0,0
167839,cardiovascular,0,0
167840,safety,0,0
167841,of,0,0
167842,Mydriasert,1,1
167843,(,1,0
167844,ophthalmic,1,1
167845,insert,1,1
167846,containing,1,1
167847,tropicamide,1,1
167848,and,1,1
167849,phenylephrine,1,1
167850,),1,1
167851,in,0,0
167852,diabetic,0,0
167853,and,0,0
167854,nondiabetic,0,0
167855,patients,0,0
167856,undergoing,0,0
167857,retinal,0,0
167858,angiography,0,1
167859,by,0,0
167860,comparing,0,0
167861,it,0,0
167862,with,0,0
167863,usually,0,0
167864,administered,0,0
167865,eyedrops,0,1
167866,(,1,0
167867,tropicamide,1,1
167868,1,1,1
167869,%,1,0
167870,and,1,0
167871,phenylephrine,1,1
167872,10,1,1
167873,%,1,0
167874,),1,0
167875,.,0,0
167876,METHODS,0,0
167877,This,0,0
167878,was,0,0
167879,a,0,0
167880,prospective,0,0
167881,randomized,0,0
167882,study,0,0
167883,.,0,0
167884,A,0,0
167885,total,0,0
167886,of,0,0
167887,154,0,0
167888,eyes,0,0
167889,of,0,0
167890,77,0,0
167891,patients,0,0
167892,were,0,0
167893,randomly,0,0
167894,divided,0,0
167895,into,0,0
167896,2,0,0
167897,groups,0,0
167898,:,0,0
167899,group,0,0
167900,1,0,0
167901,consisted,0,0
167902,of,0,0
167903,78,0,0
167904,eyes,0,0
167905,",",0,0
167906,group,0,0
167907,2,0,0
167908,consisted,0,0
167909,of,0,0
167910,76,0,0
167911,eyes,0,0
167912,",",0,0
167913,and,0,0
167914,the,0,0
167915,patients,0,0
167916,were,0,0
167917,monitored,0,0
167918,for,0,0
167919,pupillary,0,0
167920,dilation,0,0
167921,",",0,0
167922,blood,0,0
167923,pressure,0,0
167924,",",0,0
167925,heart,0,0
167926,rate,0,0
167927,",",0,0
167928,and,0,0
167929,possible,0,0
167930,adverse,0,0
167931,effects,0,0
167932,at,0,0
167933,0,0,0
167934,",",0,0
167935,20,0,0
167936,",",0,0
167937,40,0,0
167938,",",0,0
167939,60,0,0
167940,",",0,0
167941,and,0,0
167942,90,0,0
167943,minutes,0,0
167944,.,0,0
167945,RESULTS,0,0
167946,No,0,0
167947,severe,0,0
167948,adverse,0,0
167949,effects,0,0
167950,were,0,0
167951,observed,0,0
167952,in,0,0
167953,either,0,0
167954,group,0,0
167955,.,0,0
167956,In,0,0
167957,the,0,0
167958,entire,0,0
167959,sample,0,0
167960,studied,0,0
167961,",",0,0
167962,the,0,0
167963,mean,0,0
167964,pupillary,0,0
167965,diameter,0,0
167966,was,0,0
167967,greater,0,0
167968,in,0,0
167969,the,0,0
167970,eyedrops,0,1
167971,group,0,0
167972,after,0,0
167973,20,0,0
167974,and,0,0
167975,40,0,0
167976,minutes,0,0
167977,",",0,0
167978,while,0,0
167979,mydriasis,0,0
167980,was,0,0
167981,similar,0,0
167982,in,0,0
167983,the,0,0
167984,2,0,0
167985,groups,0,0
167986,after,0,0
167987,60,0,0
167988,minutes,0,0
167989,.,0,0
167990,The,0,0
167991,diabetic,0,0
167992,patients,0,0
167993,treated,0,0
167994,with,0,0
167995,Mydriasert,1,1
167996,had,0,0
167997,less,0,0
167998,mydriasis,0,0
167999,than,0,0
168000,those,0,0
168001,treated,0,0
168002,with,0,0
168003,eyedrops,0,1
168004,after,0,0
168005,20,0,0
168006,and,0,0
168007,40,0,0
168008,minutes,0,0
168009,",",0,0
168010,and,0,0
168011,diabetic,0,0
168012,patients,0,0
168013,showed,0,0
168014,less,0,0
168015,mydriasis,0,0
168016,than,0,0
168017,the,0,0
168018,nondiabetic,0,0
168019,patients,0,0
168020,after,0,0
168021,60,0,0
168022,and,0,0
168023,90,0,0
168024,minutes,0,0
168025,.,0,0
168026,There,0,0
168027,was,0,0
168028,no,0,0
168029,significant,0,0
168030,between-group,0,0
168031,difference,0,0
168032,in,0,0
168033,mean,0,0
168034,heart,0,0
168035,rate,0,0
168036,or,0,1
168037,systolic,0,0
168038,and,0,0
168039,diastolic,0,0
168040,blood,0,0
168041,pressure,0,0
168042,at,0,0
168043,any,0,0
168044,of,0,0
168045,the,0,0
168046,time,0,0
168047,points,0,0
168048,.,0,0
168049,CONCLUSIONS,0,0
168050,Mydriasert,1,1
168051,assures,0,0
168052,an,0,0
168053,adequate,0,0
168054,degree,0,0
168055,of,0,0
168056,mydriasis,0,0
168057,for,0,0
168058,retinal,0,0
168059,angiography,0,1
168060,in,0,0
168061,both,0,0
168062,diabetic,0,0
168063,and,0,0
168064,nondiabetic,0,0
168065,patients,0,0
168066,.,0,0
168067,There,0,0
168068,are,0,0
168069,no,0,0
168070,differences,0,0
168071,in,0,0
168072,efficacy,0,0
168073,or,0,1
168074,safety,0,0
168075,between,0,0
168076,the,0,0
168077,insert,0,0
168078,and,0,0
168079,the,0,0
168080,usually,0,0
168081,administered,0,0
168082,eyedrops,0,1
168083,",",0,0
168084,but,0,0
168085,the,0,0
168086,low,0,0
168087,total,0,0
168088,drug,0,1
168089,dose,0,0
168090,administered,0,0
168091,with,0,0
168092,the,0,0
168093,insert,0,0
168094,reduces,0,0
168095,the,0,0
168096,risk,0,0
168097,of,0,0
168098,cardiovascular,0,0
168099,side,0,0
168100,effects,0,0
168101,.,0,0
168102,Are,0,0
168103,'leaky,0,1
168104,gut,0,0
168105,',0,1
168106,and,0,0
168107,behavior,0,0
168108,associated,0,0
168109,with,0,0
168110,gluten,1,1
168111,and,1,0
168112,dairy,1,0
168113,containing,0,1
168114,diet,0,1
168115,in,0,0
168116,children,0,0
168117,with,0,0
168118,autism,0,0
168119,spectrum,0,0
168120,disorders,0,0
168121,?,0,0
168122,OBJECTIVES,0,0
168123,Studies,0,0
168124,have,0,0
168125,suggested,0,0
168126,a,0,0
168127,link,0,0
168128,between,0,0
168129,diet,0,1
168130,and,0,0
168131,behavior,0,0
168132,in,0,0
168133,children,0,0
168134,with,0,0
168135,autism,0,0
168136,spectrum,0,0
168137,disorders,0,0
168138,(,0,0
168139,ASDs,0,0
168140,),0,1
168141,.,0,0
168142,Parental,0,0
168143,reports,0,0
168144,of,0,0
168145,behavioral,0,1
168146,changes,0,0
168147,upon,0,0
168148,exposure,0,0
168149,to,0,0
168150,gluten,0,1
168151,and/or,0,0
168152,casein,0,1
168153,are,0,0
168154,common,0,0
168155,in,0,0
168156,clinical,0,0
168157,practice,0,0
168158,.,0,0
168159,An,0,0
168160,association,0,0
168161,between,0,0
168162,diet,0,1
168163,type,0,0
168164,",",0,0
168165,intestinal,0,0
168166,permeability,0,0
168167,(,0,1
168168,IP,0,1
168169,),0,1
168170,(,0,0
168171,'leaky,0,1
168172,gut,0,0
168173,',0,1
168174,),0,0
168175,",",0,0
168176,and,0,0
168177,behavior,0,0
168178,has,0,0
168179,been,0,0
168180,long,0,0
168181,proposed,0,0
168182,but,0,0
168183,not,0,0
168184,substantiated,0,0
168185,.,0,0
168186,We,0,0
168187,explored,0,0
168188,this,0,0
168189,possible,0,0
168190,association,0,0
168191,in,0,0
168192,this,0,0
168193,trial,0,0
168194,.,0,0
168195,METHODS,0,0
168196,This,0,0
168197,randomized,0,0
168198,double-blind,0,0
168199,",",0,0
168200,placebo-controlled,0,1
168201,study,0,0
168202,explored,0,0
168203,the,0,0
168204,effects,0,0
168205,of,0,0
168206,gluten,1,1
168207,and,1,0
168208,milk,1,1
168209,on,0,0
168210,IP,0,1
168211,and,0,0
168212,behavior,0,0
168213,in,0,0
168214,children,0,0
168215,with,0,0
168216,ASDs,0,0
168217,over,0,0
168218,a,0,0
168219,period,0,0
168220,of,0,0
168221,4,0,0
168222,weeks,0,0
168223,.,0,0
168224,IP,1,1
168225,assessed,1,0
168226,by,1,0
168227,lactulose,1,1
168228,:,1,1
168229,mannitol,1,1
168230,(,1,1
168231,L/M,1,0
168232,),1,1
168233,sugar,1,1
168234,permeability,1,0
168235,test,1,1
168236,and,1,0
168237,behavior,1,0
168238,assessed,1,0
168239,by,1,0
168240,the,1,0
168241,Aberrant,1,0
168242,Behavior,1,0
168243,Checklist,1,1
168244,and,1,0
168245,Conners,1,1
168246,Parent,1,0
168247,Rating,1,0
168248,were,0,0
168249,measured,0,0
168250,.,0,0
168251,Gastrointestinal,0,0
168252,symptoms,0,0
168253,in,0,0
168254,both,0,0
168255,groups,0,0
168256,were,0,0
168257,also,0,0
168258,monitored,0,0
168259,.,0,0
168260,RESULTS,0,0
168261,Neither,0,0
168262,the,0,0
168263,L/M,0,0
168264,ratio,0,0
168265,nor,0,0
168266,behavioral,0,1
168267,scores,0,0
168268,were,0,0
168269,different,0,0
168270,between,0,0
168271,groups,0,0
168272,exposed,0,0
168273,to,0,0
168274,gluten/dairy,0,1
168275,or,0,0
168276,placebo,0,1
168277,.,0,0
168278,The,0,0
168279,changes,0,0
168280,observed,0,0
168281,were,0,0
168282,noted,0,0
168283,to,0,0
168284,be,0,0
168285,small,0,0
168286,and,0,0
168287,not,0,0
168288,clinically,0,0
168289,significant,0,0
168290,.,0,0
168291,DISCUSSION,0,0
168292,Our,0,0
168293,study,0,0
168294,although,0,0
168295,underpowered,0,0
168296,to,0,0
168297,show,0,0
168298,small,0,0
168299,differences,0,0
168300,does,0,0
168301,not,0,0
168302,support,0,0
168303,an,0,0
168304,association,0,0
168305,between,0,0
168306,dietary,0,1
168307,gluten/milk,0,1
168308,",",0,0
168309,IP,0,1
168310,",",0,0
168311,and,0,0
168312,behavioral,0,1
168313,changes,0,0
168314,in,0,0
168315,subjects,0,0
168316,with,0,0
168317,ASD,0,0
168318,.,0,0
168319,Safety,0,1
168320,and,0,0
168321,efficacy,0,0
168322,of,0,0
168323,a,0,0
168324,low,0,0
168325,molecular,0,0
168326,weight,0,1
168327,heparin,0,1
168328,(,0,1
168329,Logiparin,0,1
168330,),0,1
168331,versus,0,1
168332,dextran,0,1
168333,as,0,0
168334,prophylaxis,0,1
168335,against,0,0
168336,thrombosis,0,0
168337,after,0,0
168338,total,0,0
168339,hip,0,0
168340,replacement,0,1
168341,.,0,0
168342,In,0,0
168343,order,0,0
168344,to,0,0
168345,study,0,0
168346,the,0,0
168347,plasma,0,0
168348,levels,0,0
168349,of,0,0
168350,factor,0,0
168351,XaI,0,1
168352,and,0,0
168353,IIaI,0,1
168354,activity,0,0
168355,an,0,0
168356,enzymatically,1,0
168357,depolymerized,1,1
168358,low,1,0
168359,molecular,1,0
168360,weight,1,1
168361,heparin,1,1
168362,(,1,0
168363,LMW-heparin,1,1
168364,;,1,1
168365,Logiparin,1,1
168366,),1,0
168367,was,0,0
168368,given,0,0
168369,s.c.,0,1
168370,in,0,0
168371,a,0,0
168372,dose,0,0
168373,of,0,0
168374,35,0,0
168375,XaI,0,1
168376,mu/kg,0,1
168377,b.w,0,1
168378,.,0,0
168379,once,0,0
168380,daily,0,0
168381,for,0,0
168382,7,0,0
168383,days,0,0
168384,to,0,0
168385,10,0,0
168386,patients,0,0
168387,undergoing,0,0
168388,total,0,0
168389,hip,0,0
168390,replacement,0,1
168391,(,0,1
168392,THR,0,1
168393,),0,1
168394,in,0,0
168395,a,0,0
168396,pilot,0,0
168397,study,0,0
168398,.,0,0
168399,The,0,0
168400,XaI,0,0
168401,activity,0,0
168402,was,0,0
168403,less,0,0
168404,than,0,0
168405,or,0,0
168406,equal,0,0
168407,to,0,0
168408,0.24,0,0
168409,XaI,0,1
168410,units/ml,0,0
168411,and,0,0
168412,the,0,0
168413,IIaI,0,1
168414,activity,0,0
168415,less,0,0
168416,than,0,0
168417,or,0,0
168418,equal,0,0
168419,to,0,0
168420,0.043,0,0
168421,IIaI,0,1
168422,mu/ml,0,0
168423,.,0,0
168424,No,0,0
168425,accumulation,0,0
168426,of,0,0
168427,the,0,0
168428,activities,0,0
168429,were,0,0
168430,seen,0,0
168431,.,0,0
168432,No,0,0
168433,phlebographically,0,0
168434,verified,0,0
168435,thrombi,0,1
168436,or,0,1
168437,any,0,0
168438,bleeding,0,0
168439,complications,0,0
168440,were,0,0
168441,registered,0,0
168442,.,0,0
168443,From,0,0
168444,this,0,0
168445,study,0,0
168446,it,0,0
168447,was,0,0
168448,concluded,0,0
168449,that,0,0
168450,the,0,0
168451,given,0,0
168452,dose,0,0
168453,of,0,0
168454,Logiparin,0,1
168455,was,0,0
168456,safe,0,0
168457,with,0,0
168458,regard,0,0
168459,to,0,0
168460,bleeding,0,0
168461,complications,0,0
168462,.,0,0
168463,Based,0,0
168464,on,0,0
168465,these,0,0
168466,data,0,0
168467,",",0,0
168468,an,0,0
168469,open,0,0
168470,",",0,0
168471,randomized,0,0
168472,controlled,0,0
168473,trial,0,0
168474,was,0,0
168475,started,0,0
168476,.,0,0
168477,In,0,0
168478,this,0,0
168479,main,0,0
168480,study,0,0
168481,the,0,0
168482,thromboprophylactic,0,1
168483,effect,0,0
168484,of,0,0
168485,the,0,0
168486,LMW-heparin,0,1
168487,(,0,1
168488,Logiparin,0,1
168489,),0,1
168490,in,0,0
168491,a,0,0
168492,dose,0,0
168493,of,0,0
168494,35,0,0
168495,XaI,0,1
168496,mu/kg,0,1
168497,b.w,0,1
168498,.,0,0
168499,once,0,0
168500,daily,0,0
168501,was,0,0
168502,compared,0,0
168503,with,0,0
168504,that,0,0
168505,of,0,0
168506,dextran,0,1
168507,70,0,0
168508,in,0,0
168509,patients,0,0
168510,undergoing,0,0
168511,THR,0,1
168512,.,0,0
168513,100,0,0
168514,patients,0,0
168515,were,0,0
168516,randomized,0,0
168517,.,0,0
168518,The,0,0
168519,over-all,0,0
168520,thrombosis,0,0
168521,rate,0,0
168522,was,0,0
168523,28,0,0
168524,%,0,0
168525,in,0,0
168526,patients,0,0
168527,treated,0,0
168528,with,0,0
168529,LMW-heparin,0,1
168530,and,0,0
168531,39,0,0
168532,%,0,0
168533,in,0,0
168534,those,0,0
168535,given,0,0
168536,dextran,0,1
168537,",",0,0
168538,a,0,0
168539,non-significant,0,0
168540,difference,0,0
168541,.,0,0
168542,No,0,0
168543,bleeding,0,0
168544,complications,0,0
168545,",",0,0
168546,deaths,0,0
168547,or,0,1
168548,pulmonary,0,0
168549,embolism,0,0
168550,were,0,0
168551,recorded,0,0
168552,in,0,0
168553,either,0,0
168554,group,0,0
168555,.,0,0
168556,Peroperative,0,0
168557,blood,0,0
168558,loss,0,0
168559,and,0,0
168560,transfusion,0,1
168561,requirements,0,0
168562,were,0,0
168563,similar,0,0
168564,in,0,0
168565,the,0,0
168566,two,0,0
168567,groups,0,0
168568,.,0,0
168569,In,0,0
168570,conclusion,0,0
168571,",",0,0
168572,the,0,0
168573,investigated,0,0
168574,LMW-heparin,0,1
168575,(,0,1
168576,Logiparin,0,1
168577,),0,1
168578,is,0,0
168579,safe,0,0
168580,and,0,0
168581,effective,0,0
168582,in,0,0
168583,preventing,0,0
168584,postoperative,0,0
168585,thromboembolism,0,0
168586,in,0,0
168587,patients,0,0
168588,undergoing,0,0
168589,total,0,0
168590,hip,0,0
168591,replacement,0,1
168592,",",0,0
168593,but,0,0
168594,the,0,0
168595,dosage,0,0
168596,can,0,0
168597,probably,0,0
168598,be,0,0
168599,optimized,0,0
168600,.,0,0
168601,The,0,0
168602,effect,0,0
168603,of,0,0
168604,lowering,0,0
168605,LDL,0,1
168606,cholesterol,0,0
168607,on,0,0
168608,vascular,0,0
168609,access,0,0
168610,patency,0,0
168611,:,0,1
168612,post,0,0
168613,hoc,0,0
168614,analysis,0,0
168615,of,0,0
168616,the,0,0
168617,Study,0,0
168618,of,0,0
168619,Heart,0,1
168620,and,0,0
168621,Renal,0,0
168622,Protection,0,0
168623,.,0,0
168624,BACKGROUND,0,0
168625,AND,0,0
168626,OBJECTIVES,0,1
168627,Reducing,0,0
168628,LDL,0,1
168629,cholesterol,0,1
168630,(,0,1
168631,LDL-C,0,1
168632,),0,1
168633,with,0,0
168634,statin-based,1,1
168635,therapy,1,1
168636,reduces,0,0
168637,the,0,0
168638,risk,0,0
168639,of,0,0
168640,major,0,0
168641,atherosclerotic,0,0
168642,events,0,0
168643,among,0,0
168644,patients,0,0
168645,with,0,0
168646,CKD,0,1
168647,",",0,0
168648,including,0,0
168649,dialysis,0,1
168650,patients,0,0
168651,",",0,0
168652,but,0,0
168653,the,0,0
168654,effect,0,0
168655,of,0,0
168656,lowering,0,0
168657,LDL-C,0,1
168658,on,0,0
168659,vascular,0,0
168660,access,0,0
168661,patency,0,0
168662,is,0,0
168663,unclear,0,0
168664,.,0,0
168665,DESIGN,0,0
168666,",",0,0
168667,SETTING,0,0
168668,",",0,0
168669,PARTICIPANTS,0,0
168670,",",0,0
168671,&,0,0
168672,MEASUREMENTS,0,0
168673,The,0,0
168674,Study,0,0
168675,of,0,0
168676,Heart,0,1
168677,and,0,0
168678,Renal,0,1
168679,Protection,0,1
168680,(,0,1
168681,SHARP,0,1
168682,),0,1
168683,randomized,0,0
168684,patients,0,0
168685,with,0,0
168686,CKD,0,1
168687,to,0,0
168688,20,1,0
168689,mg,1,1
168690,simvastatin,1,1
168691,plus,1,1
168692,10,1,0
168693,mg,1,1
168694,ezetimibe,1,1
168695,daily,1,1
168696,versus,1,1
168697,matching,1,1
168698,placebo,1,1
168699,.,1,0
168700,This,0,0
168701,study,0,0
168702,aimed,0,0
168703,to,0,0
168704,explore,0,0
168705,the,0,0
168706,effects,0,0
168707,of,0,0
168708,treatment,0,0
168709,on,0,0
168710,vascular,0,0
168711,access,0,0
168712,occlusive,0,1
168713,events,0,0
168714,",",0,0
168715,defined,0,0
168716,as,0,0
168717,any,0,0
168718,access,0,0
168719,revision,0,0
168720,procedure,0,1
168721,",",0,0
168722,access,0,0
168723,thrombosis,0,0
168724,",",0,0
168725,removal,0,0
168726,of,0,0
168727,an,0,0
168728,old,0,0
168729,dialysis,0,1
168730,access,0,0
168731,",",0,0
168732,or,0,1
168733,formation,0,0
168734,of,0,0
168735,new,0,0
168736,permanent,0,0
168737,dialysis,0,1
168738,access,0,0
168739,.,0,0
168740,RESULTS,0,0
168741,Among,0,0
168742,2353,0,0
168743,SHARP,0,0
168744,participants,0,0
168745,who,0,0
168746,had,0,0
168747,functioning,0,0
168748,vascular,0,0
168749,access,0,1
168750,at,0,0
168751,randomization,0,0
168752,",",0,0
168753,allocation,0,0
168754,to,0,0
168755,simvastatin,0,1
168756,plus,0,1
168757,ezetimibe,0,1
168758,resulted,0,0
168759,in,0,0
168760,a,0,0
168761,13,0,0
168762,%,0,0
168763,proportional,0,0
168764,reduction,0,0
168765,in,0,0
168766,vascular,0,0
168767,access,0,0
168768,occlusive,0,1
168769,events,0,0
168770,(,0,0
168771,355,0,0
168772,[,0,0
168773,29.7,0,0
168774,%,0,0
168775,],0,0
168776,for,0,0
168777,simvastatin/ezetimibe,1,1
168778,versus,0,1
168779,388,0,0
168780,[,0,0
168781,33.5,0,0
168782,%,0,0
168783,],0,0
168784,for,0,0
168785,placebo,1,1
168786,;,1,0
168787,risk,0,0
168788,ratio,0,0
168789,[,0,0
168790,RR,0,1
168791,],0,0
168792,",",0,0
168793,0.87,0,0
168794,;,0,0
168795,95,0,0
168796,%,0,0
168797,confidence,0,0
168798,interval,0,0
168799,[,0,0
168800,95,0,0
168801,%,0,0
168802,CI,0,0
168803,],0,0
168804,",",0,0
168805,0.75,0,0
168806,to,0,0
168807,1.00,0,0
168808,;,0,0
168809,P=0.05,0,0
168810,),0,0
168811,.,0,0
168812,There,0,0
168813,was,0,0
168814,no,0,0
168815,evidence,0,0
168816,that,0,0
168817,the,0,0
168818,effects,0,0
168819,of,0,0
168820,treatment,0,0
168821,differed,0,0
168822,for,0,0
168823,any,0,0
168824,of,0,0
168825,the,0,0
168826,separate,0,0
168827,components,0,0
168828,of,0,0
168829,this,0,0
168830,outcome,0,0
168831,.,0,0
168832,To,0,0
168833,test,0,0
168834,the,0,0
168835,hypothesis,0,0
168836,raised,0,0
168837,by,0,0
168838,SHARP,0,1
168839,",",0,0
168840,comparable,0,0
168841,analyses,0,0
168842,were,0,0
168843,performed,0,0
168844,using,0,0
168845,the,0,0
168846,AURORA,0,1
168847,(,0,0
168848,A,0,0
168849,Study,0,0
168850,to,0,0
168851,Evaluate,0,0
168852,the,0,0
168853,Use,0,1
168854,of,0,0
168855,Rosuvastatin,0,1
168856,in,0,0
168857,Subjects,0,0
168858,on,0,0
168859,Regular,0,1
168860,Hemodialysis,0,1
168861,:,0,0
168862,An,0,0
168863,Assessment,0,0
168864,of,0,0
168865,Survival,0,0
168866,and,0,0
168867,Cardiovascular,0,0
168868,Events,0,1
168869,),0,1
168870,trial,0,0
168871,cohort,0,0
168872,.,0,0
168873,AURORA,0,0
168874,did,0,0
168875,not,0,0
168876,provide,0,0
168877,independent,0,0
168878,confirmation,0,0
168879,(,0,1
168880,vascular,0,0
168881,access,0,1
168882,occlusive,0,1
168883,events,0,0
168884,:,0,0
168885,352,0,0
168886,[,0,0
168887,28.9,0,0
168888,%,0,0
168889,],0,0
168890,for,0,0
168891,rosuvastatin,0,1
168892,versus,0,1
168893,337,0,0
168894,[,0,0
168895,27.6,0,0
168896,%,0,0
168897,],0,0
168898,for,0,0
168899,placebo,0,1
168900,;,0,0
168901,RR,0,0
168902,",",0,0
168903,1.06,0,0
168904,",",0,0
168905,95,0,0
168906,%,0,0
168907,CI,0,0
168908,",",0,0
168909,0.91,0,0
168910,to,0,0
168911,1.23,0,0
168912,;,0,0
168913,P=0.44,0,0
168914,),0,0
168915,.,0,0
168916,After,0,0
168917,combining,0,0
168918,the,0,0
168919,two,0,0
168920,trials,0,0
168921,",",0,0
168922,the,0,0
168923,overall,0,0
168924,effect,0,0
168925,of,0,0
168926,reducing,0,0
168927,LDL-C,0,1
168928,with,0,0
168929,a,0,0
168930,statin-based,0,1
168931,regimen,0,1
168932,on,0,0
168933,vascular,0,0
168934,access,0,0
168935,occlusive,0,1
168936,events,0,0
168937,was,0,0
168938,not,0,0
168939,statistically,0,0
168940,significant,0,0
168941,(,0,0
168942,707,0,0
168943,[,0,0
168944,29.3,0,0
168945,%,0,0
168946,],0,0
168947,with,0,0
168948,any,0,0
168949,LDL-C-lowering,0,1
168950,therapy,0,1
168951,versus,0,1
168952,725,0,0
168953,[,0,0
168954,30.5,0,0
168955,%,0,0
168956,],0,0
168957,with,0,0
168958,placebo,0,1
168959,;,0,0
168960,RR,0,0
168961,",",0,0
168962,0.95,0,0
168963,",",0,0
168964,95,0,0
168965,%,0,0
168966,CI,0,0
168967,",",0,0
168968,0.85,0,0
168969,to,0,0
168970,1.05,0,0
168971,;,0,0
168972,P=0.29,0,0
168973,),0,0
168974,.,0,0
168975,CONCLUSIONS,0,0
168976,Exploratory,0,0
168977,analyses,0,0
168978,from,0,0
168979,SHARP,0,0
168980,suggest,0,0
168981,that,0,0
168982,lowering,0,0
168983,LDL-C,0,1
168984,with,0,0
168985,statin-based,1,1
168986,therapy,1,1
168987,may,0,0
168988,improve,0,0
168989,vascular,0,0
168990,access,0,0
168991,patency,0,0
168992,",",0,0
168993,but,0,0
168994,there,0,0
168995,was,0,0
168996,no,0,0
168997,evidence,0,0
168998,of,0,0
168999,benefit,0,0
169000,in,0,0
169001,AURORA,0,0
169002,.,0,0
169003,Taken,0,0
169004,together,0,0
169005,",",0,0
169006,the,0,0
169007,available,0,0
169008,evidence,0,0
169009,suggests,0,0
169010,that,0,0
169011,any,0,0
169012,benefits,0,0
169013,of,0,0
169014,lowering,0,0
169015,LDL-C,0,1
169016,on,0,0
169017,vascular,0,0
169018,access,0,0
169019,patency,0,0
169020,are,0,0
169021,likely,0,0
169022,to,0,0
169023,be,0,0
169024,modest,0,0
169025,.,0,0
169026,Randomized,0,0
169027,clinical,0,0
169028,trial,0,0
169029,of,0,0
169030,hydrocodone/acetaminophen,0,1
169031,versus,0,1
169032,codeine/acetaminophen,0,1
169033,in,0,0
169034,the,0,0
169035,treatment,0,0
169036,of,0,0
169037,acute,0,0
169038,extremity,0,0
169039,pain,0,0
169040,after,0,0
169041,emergency,0,1
169042,department,0,0
169043,discharge,0,1
169044,.,0,0
169045,OBJECTIVES,0,0
169046,The,0,0
169047,objective,0,0
169048,was,0,0
169049,to,0,0
169050,test,0,0
169051,the,0,0
169052,hypothesis,0,0
169053,that,0,0
169054,hydrocodone/acetaminophen,1,1
169055,(,0,0
169056,Vicodin,0,1
169057,[,0,1
169058,5/500,0,1
169059,],0,0
169060,),0,0
169061,provides,0,0
169062,more,0,0
169063,efficacious,0,0
169064,analgesia,0,0
169065,than,0,0
169066,codeine/acetaminophen,1,1
169067,(,0,0
169068,Tylenol,0,1
169069,#,0,0
169070,3,0,0
169071,[,0,0
169072,30/300,0,1
169073,],0,0
169074,),0,0
169075,in,0,0
169076,patients,0,0
169077,discharged,0,0
169078,from,0,0
169079,the,0,0
169080,emergency,0,1
169081,department,0,0
169082,(,0,1
169083,ED,0,1
169084,),0,0
169085,.,0,0
169086,Both,0,1
169087,are,0,0
169088,currently,0,0
169089,Drug,0,1
169090,Enforcement,0,1
169091,Administration,0,1
169092,(,0,1
169093,DEA,0,1
169094,),0,1
169095,Schedule,0,1
169096,III,0,0
169097,narcotics,0,1
169098,.,0,0
169099,METHODS,0,0
169100,This,0,0
169101,was,0,0
169102,a,0,0
169103,prospective,0,0
169104,",",0,0
169105,randomized,0,0
169106,",",0,0
169107,double-blind,0,0
169108,",",0,0
169109,clinical,0,0
169110,trial,0,0
169111,of,0,0
169112,patients,0,0
169113,with,0,0
169114,acute,0,0
169115,extremity,0,0
169116,pain,0,0
169117,who,0,0
169118,were,0,0
169119,discharged,0,0
169120,home,0,1
169121,from,0,0
169122,the,0,0
169123,ED,0,1
169124,",",0,0
169125,comparing,0,0
169126,a,0,0
169127,3-day,0,1
169128,supply,0,0
169129,of,0,0
169130,oral,1,1
169131,hydrocodone/acetaminophen,1,1
169132,(,1,0
169133,5,1,1
169134,mg/500,1,1
169135,mg,1,1
169136,),1,0
169137,to,1,0
169138,oral,1,1
169139,codeine/acetaminophen,1,1
169140,(,1,0
169141,30,1,1
169142,mg/300,1,1
169143,mg,1,1
169144,),1,0
169145,.,1,0
169146,Pain,0,0
169147,was,0,0
169148,measured,0,0
169149,on,0,0
169150,a,0,0
169151,valid,0,0
169152,and,0,0
169153,reproducible,0,0
169154,verbal,0,1
169155,numeric,0,0
169156,rating,0,1
169157,scale,0,0
169158,(,0,1
169159,NRS,0,1
169160,),0,1
169161,ranging,0,0
169162,from,0,0
169163,0,0,0
169164,to,0,0
169165,10,0,0
169166,",",0,0
169167,and,0,0
169168,patients,0,0
169169,were,0,0
169170,contacted,0,0
169171,by,0,0
169172,telephone,0,1
169173,approximately,0,0
169174,24,0,0
169175,hours,0,0
169176,after,0,0
169177,being,0,0
169178,discharged,0,0
169179,.,0,0
169180,The,0,0
169181,primary,0,0
169182,outcome,0,0
169183,was,0,0
169184,the,0,0
169185,between-group,0,0
169186,difference,0,0
169187,in,0,0
169188,improvement,0,0
169189,in,0,0
169190,pain,0,0
169191,at,0,0
169192,2,0,0
169193,hours,0,0
169194,following,0,0
169195,the,0,0
169196,most,0,0
169197,recent,0,0
169198,ingestion,0,0
169199,of,0,0
169200,the,0,0
169201,study,0,0
169202,drug,0,1
169203,",",0,0
169204,relative,0,0
169205,to,0,0
169206,the,0,0
169207,time,0,0
169208,of,0,0
169209,phone,0,1
169210,contact,0,1
169211,after,0,0
169212,ED,0,1
169213,discharge,0,1
169214,.,0,0
169215,Secondary,0,0
169216,outcomes,0,0
169217,compared,0,0
169218,side-effect,0,0
169219,profiles,0,0
169220,and,0,0
169221,patient,0,0
169222,satisfaction,0,0
169223,.,0,0
169224,RESULTS,0,0
169225,The,0,0
169226,median,0,0
169227,time,0,0
169228,from,0,0
169229,ED,0,1
169230,discharge,0,1
169231,to,0,0
169232,follow-up,0,0
169233,was,0,0
169234,26,0,0
169235,hours,0,0
169236,(,0,0
169237,interquartile,0,0
169238,range,0,0
169239,[,0,0
169240,IQR,0,1
169241,],0,0
169242,=,0,0
169243,24,0,0
169244,to,0,0
169245,39,0,0
169246,hours,0,0
169247,),0,0
169248,.,0,0
169249,The,0,0
169250,mean,0,0
169251,NRS,0,1
169252,pain,0,0
169253,score,0,0
169254,before,0,0
169255,the,0,0
169256,most,0,0
169257,recent,0,0
169258,dose,0,0
169259,of,0,0
169260,pain,0,0
169261,medication,0,1
169262,after,0,0
169263,ED,0,1
169264,discharge,0,1
169265,was,0,0
169266,7.6,0,0
169267,NRS,0,1
169268,units,0,0
169269,for,0,0
169270,both,0,0
169271,groups,0,0
169272,.,0,0
169273,The,0,0
169274,mean,0,0
169275,decrease,0,0
169276,in,0,0
169277,pain,0,0
169278,scores,0,0
169279,2,0,0
169280,hours,0,0
169281,after,0,0
169282,pain,0,0
169283,medications,0,1
169284,were,0,0
169285,taken,0,0
169286,were,0,0
169287,3.9,0,0
169288,NRS,0,1
169289,units,0,0
169290,in,0,0
169291,the,0,0
169292,hydrocodone/acetaminophen,1,1
169293,group,0,0
169294,versus,0,1
169295,3.5,0,0
169296,NRS,0,1
169297,units,0,0
169298,in,0,0
169299,the,0,0
169300,codeine/acetaminophen,1,1
169301,group,0,0
169302,",",0,0
169303,for,0,0
169304,a,0,0
169305,difference,0,0
169306,of,0,0
169307,0.4,0,0
169308,NRS,0,1
169309,units,0,1
169310,(,0,0
169311,95,0,0
169312,%,0,0
169313,confidence,0,0
169314,interval,0,0
169315,[,0,0
169316,CI,0,0
169317,],0,1
169318,=,0,0
169319,-0.3,0,0
169320,to,0,0
169321,1.2,0,0
169322,NRS,0,1
169323,units,0,0
169324,),0,0
169325,.,0,0
169326,No,0,0
169327,differences,0,0
169328,were,0,0
169329,found,0,0
169330,in,0,0
169331,side,0,0
169332,effects,0,0
169333,or,0,1
169334,patient,0,0
169335,satisfaction,0,0
169336,.,0,0
169337,CONCLUSIONS,0,0
169338,Both,0,1
169339,medications,0,1
169340,decreased,0,0
169341,NRS,0,1
169342,pain,0,0
169343,scores,0,0
169344,by,0,0
169345,approximately,0,0
169346,50,0,0
169347,%,0,0
169348,.,0,0
169349,However,0,0
169350,",",0,0
169351,the,0,0
169352,oral,0,1
169353,hydrocodone/acetaminophen,0,1
169354,failed,0,0
169355,to,0,0
169356,provide,0,0
169357,clinically,0,0
169358,or,0,1
169359,statistically,0,0
169360,superior,0,0
169361,pain,0,0
169362,relief,0,0
169363,compared,0,0
169364,to,0,0
169365,oral,0,1
169366,codeine/acetaminophen,1,1
169367,when,0,0
169368,prescribed,0,0
169369,to,0,0
169370,patients,0,0
169371,discharged,0,0
169372,from,0,0
169373,the,0,0
169374,ED,0,1
169375,with,0,0
169376,acute,0,0
169377,extremity,0,0
169378,pain,0,0
169379,.,0,0
169380,Similarly,0,0
169381,",",0,0
169382,there,0,0
169383,were,0,0
169384,no,0,0
169385,clinically,0,0
169386,or,0,0
169387,statistically,0,0
169388,important,0,0
169389,differences,0,0
169390,in,0,0
169391,side-effect,0,0
169392,profiles,0,0
169393,or,0,1
169394,patient,0,0
169395,satisfaction,0,0
169396,.,0,0
169397,If,0,0
169398,the,0,0
169399,DEA,0,1
169400,reclassifies,0,0
169401,hydrocodone,0,1
169402,as,0,0
169403,a,0,0
169404,Schedule,0,1
169405,II,0,0
169406,narcotic,0,0
169407,",",0,0
169408,as,0,0
169409,recently,0,0
169410,recommended,0,0
169411,by,0,0
169412,its,0,0
169413,advisory,0,1
169414,board,0,1
169415,",",0,0
169416,our,0,0
169417,data,0,0
169418,suggest,0,0
169419,that,0,0
169420,the,0,0
169421,codeine/acetaminophen,1,1
169422,may,0,0
169423,be,0,0
169424,a,0,0
169425,clinically,0,0
169426,reasonable,0,0
169427,Schedule,0,1
169428,III,0,1
169429,substitute,0,0
169430,for,0,0
169431,hydrocodone/acetaminophen,0,1
169432,at,0,0
169433,ED,0,1
169434,discharge,0,1
169435,.,0,0
169436,These,0,0
169437,findings,0,0
169438,should,0,0
169439,be,0,0
169440,regarded,0,0
169441,as,0,0
169442,tentative,0,0
169443,and,0,0
169444,require,0,0
169445,independent,0,0
169446,validation,0,0
169447,in,0,0
169448,similar,0,0
169449,and,0,0
169450,other,0,0
169451,acute,0,0
169452,pain,0,0
169453,models,0,0
169454,.,0,0
169455,Compensation,0,0
169456,in,0,0
169457,intergroup,0,0
169458,relations,0,0
169459,:,0,0
169460,an,0,0
169461,investigation,0,0
169462,of,0,0
169463,its,0,0
169464,structural,0,0
169465,and,0,0
169466,strategic,0,0
169467,foundations,0,0
169468,.,0,0
169469,Recent,0,0
169470,work,0,0
169471,in,0,0
169472,intergroup,0,0
169473,relations,0,0
169474,stresses,0,0
169475,the,0,0
169476,role,0,0
169477,of,0,0
169478,two,0,0
169479,fundamental,0,0
169480,dimensions,0,0
169481,",",0,0
169482,competence,0,0
169483,and,0,0
169484,warmth,0,0
169485,",",0,0
169486,which,0,0
169487,organize,0,0
169488,the,0,0
169489,perception,0,0
169490,of,0,0
169491,social,0,0
169492,groups,0,0
169493,.,0,0
169494,A,0,0
169495,pattern,0,0
169496,often,0,0
169497,encountered,0,0
169498,in,0,0
169499,people,0,0
169500,'s,0,0
169501,ratings,0,0
169502,is,0,0
169503,one,0,0
169504,of,0,0
169505,compensation,0,0
169506,in,0,0
169507,that,0,0
169508,a,0,0
169509,group,0,0
169510,that,0,0
169511,is,0,0
169512,evaluated,0,0
169513,higher,0,0
169514,than,0,0
169515,another,0,0
169516,group,0,0
169517,on,0,0
169518,one,0,0
169519,of,0,0
169520,the,0,0
169521,two,0,0
169522,fundamental,0,0
169523,dimensions,0,0
169524,is,0,0
169525,also,0,0
169526,judged,0,0
169527,lower,0,0
169528,on,0,0
169529,the,0,0
169530,other,0,0
169531,fundamental,0,0
169532,dimension,0,0
169533,.,0,0
169534,Based,0,0
169535,on,0,0
169536,Social,0,0
169537,Identity,0,0
169538,Theory,0,1
169539,",",0,0
169540,the,0,0
169541,present,0,0
169542,work,0,0
169543,extends,0,0
169544,previous,0,0
169545,research,0,0
169546,on,0,0
169547,compensation,0,0
169548,by,0,0
169549,examining,0,0
169550,boundary,0,0
169551,conditions,0,0
169552,as,0,0
169553,well,0,0
169554,as,0,0
169555,underlying,0,0
169556,psychological,0,0
169557,processes,0,0
169558,.,0,0
169559,Two,0,0
169560,studies,0,0
169561,involving,0,0
169562,experimental,0,0
169563,and,0,0
169564,correlational,0,0
169565,evidence,0,0
169566,",",0,0
169567,minimal,0,0
169568,and,0,0
169569,real,0,0
169570,groups,0,0
169571,",",0,0
169572,and,0,0
169573,different,1,0
169574,kinds,1,0
169575,of,1,0
169576,conflict,1,0
169577,",",0,0
169578,reveal,0,0
169579,that,0,0
169580,compensation,0,0
169581,is,0,0
169582,more,0,0
169583,likely,0,0
169584,when,0,0
169585,the,0,0
169586,groups,0,0
169587,are,0,0
169588,in,0,0
169589,asymmetrical,0,1
169590,relation,0,0
169591,and,0,0
169592,share,0,0
169593,a,0,0
169594,cooperative,0,0
169595,view,0,0
169596,of,0,0
169597,the,0,0
169598,intergroup,0,0
169599,setting,0,0
169600,.,0,0
169601,Our,0,0
169602,data,0,0
169603,also,0,0
169604,suggest,0,0
169605,that,0,0
169606,",",0,0
169607,among,0,0
169608,members,0,0
169609,of,0,0
169610,low,0,0
169611,status,0,0
169612,groups,0,0
169613,",",0,0
169614,compensation,0,0
169615,is,0,0
169616,associated,0,0
169617,with,0,0
169618,social,0,0
169619,creativity,0,0
169620,.,0,0
169621,In,0,0
169622,contrast,0,0
169623,",",0,0
169624,and,0,0
169625,in,0,0
169626,line,0,0
169627,with,0,0
169628,the,0,0
169629,'noblesse,0,1
169630,oblige,0,0
169631,',0,1
169632,effect,0,0
169633,",",0,0
169634,members,0,0
169635,of,0,0
169636,the,0,0
169637,high,0,0
169638,status,0,0
169639,group,0,0
169640,would,0,0
169641,seem,0,0
169642,to,0,0
169643,rely,0,0
169644,on,0,0
169645,compensation,0,0
169646,as,0,0
169647,a,0,0
169648,means,0,0
169649,to,0,0
169650,appear,0,0
169651,non-discriminatory,0,0
169652,.,0,0
169653,Pegylated,1,1
169654,feline,1,0
169655,granulocyte,1,1
169656,colony-stimulating,1,1
169657,factor,1,0
169658,increases,0,0
169659,neutrophil,0,0
169660,levels,0,0
169661,in,0,0
169662,cats,0,0
169663,.,0,0
169664,Neutropenia,0,0
169665,can,0,0
169666,often,0,0
169667,be,0,0
169668,corrected,0,0
169669,by,0,0
169670,treatment,0,0
169671,with,0,0
169672,granulocyte-colony,1,1
169673,stimulating,1,1
169674,factor,1,1
169675,(,1,1
169676,G-CSF,1,1
169677,),1,1
169678,and,0,0
169679,off-label,1,1
169680,use,1,0
169681,of,1,0
169682,commercial,1,1
169683,human,1,1
169684,G-CSF,1,1
169685,(,1,1
169686,HuG-CSF,1,1
169687,),1,1
169688,is,0,0
169689,a,0,0
169690,commonly,0,0
169691,used,0,0
169692,treatment,0,0
169693,for,0,0
169694,neutropenic,0,0
169695,animals,0,0
169696,.,0,0
169697,However,0,0
169698,",",0,0
169699,long-term,0,0
169700,HuG-CSF,1,1
169701,treatment,1,0
169702,can,0,0
169703,be,0,0
169704,associated,0,0
169705,with,0,0
169706,adverse,0,0
169707,effects,0,0
169708,",",0,0
169709,including,0,0
169710,neutropenia,0,0
169711,.,0,0
169712,Here,0,0
169713,",",0,0
169714,feline,0,1
169715,(,0,1
169716,Fe,0,1
169717,),0,1
169718,G-CSF,0,1
169719,was,0,0
169720,produced,0,0
169721,in,0,0
169722,Pichia,0,0
169723,pastoris,0,1
169724,",",0,0
169725,pegylated,0,1
169726,(,0,0
169727,Peg,0,1
169728,),0,1
169729,FeG-CSF,0,1
169730,and,0,0
169731,tested,0,0
169732,in,0,0
169733,cats,0,0
169734,.,0,0
169735,A,0,0
169736,randomized,0,0
169737,controlled,0,0
169738,clinical,0,0
169739,trial,0,0
169740,was,0,0
169741,conducted,0,0
169742,to,0,0
169743,evaluate,0,0
169744,the,0,0
169745,efficacy,0,0
169746,of,0,0
169747,PegFeG-CSF,1,0
169748,compared,0,0
169749,to,0,0
169750,FeG-CSF,1,1
169751,or,1,1
169752,HuG-CSF,1,1
169753,in,0,0
169754,FIV-infected,0,0
169755,(,0,1
169756,n=14,0,0
169757,),0,1
169758,",",0,0
169759,FIV-uninfected,0,0
169760,healthy,0,0
169761,cats,0,0
169762,(,0,0
169763,n=19,0,0
169764,),0,1
169765,",",0,0
169766,and,0,0
169767,in,0,0
169768,HuG-CSF-induced,0,0
169769,neutropenic,0,0
169770,cats,0,0
169771,(,0,0
169772,n=4,0,0
169773,),0,1
169774,.,0,0
169775,Daily,0,0
169776,FeG-CSF,1,0
169777,doses,0,0
169778,induced,0,0
169779,higher,0,0
169780,neutrophil,0,0
169781,production,0,0
169782,than,0,0
169783,HuG-CSF,1,1
169784,after,0,0
169785,the,0,0
169786,second,0,0
169787,week,0,0
169788,of,0,0
169789,treatment,0,0
169790,(,0,0
169791,P,0,0
169792,?,0,0
169793,0.002,0,0
169794,),0,0
169795,.,0,0
169796,Weekly,0,0
169797,doses,0,0
169798,of,0,0
169799,PegFeG-CSF,1,0
169800,induced,1,0
169801,higher,0,0
169802,neutrophil,0,0
169803,counts,0,0
169804,and,0,0
169805,showed,0,0
169806,greater,0,0
169807,sustained,0,0
169808,activity,0,0
169809,than,0,0
169810,weekly,0,1
169811,doses,0,0
169812,of,0,0
169813,FeG-CSF,1,0
169814,.,1,0
169815,PegFeG-CSF,1,0
169816,provided,1,0
169817,the,0,0
169818,most,0,0
169819,therapeutic,0,0
169820,and,0,0
169821,sustainable,0,1
169822,neutrophil,0,1
169823,production,0,0
169824,(,0,0
169825,P,0,0
169826,<,0,0
169827,0.001,0,0
169828,),0,0
169829,in,0,0
169830,both,0,0
169831,FIV-uninfected,0,0
169832,and,0,0
169833,FIV-infected,0,0
169834,cats,0,0
169835,",",0,0
169836,without,0,0
169837,the,0,0
169838,development,0,0
169839,of,0,0
169840,neutralizing,0,0
169841,antibodies,0,0
169842,.,0,0
169843,Conversely,0,0
169844,",",0,0
169845,all,1,0
169846,HuG-CSF-treated,1,0
169847,cats,1,0
169848,developed,0,0
169849,neutralizing,0,0
169850,antibodies,0,0
169851,",",0,0
169852,suggesting,0,0
169853,cross-reactive,0,0
169854,antibodies,0,0
169855,to,0,0
169856,endogenous,0,0
169857,G-CSF,0,1
169858,in,0,0
169859,a,0,0
169860,majority,0,0
169861,of,0,0
169862,the,0,0
169863,cases,0,0
169864,with,0,0
169865,severe,0,0
169866,neutropenia,0,0
169867,.,0,0
169868,Strikingly,0,0
169869,",",0,0
169870,when,1,0
169871,PegFeG-CSF,1,0
169872,was,1,0
169873,used,0,0
169874,to,0,0
169875,rescue,0,0
169876,cats,0,0
169877,with,1,0
169878,HuG-CSF-induced,1,0
169879,neutropenia,1,0
169880,",",0,0
169881,clinically,0,0
169882,normal,0,0
169883,neutrophil,0,0
169884,numbers,0,0
169885,returned,0,0
169886,.,0,0
169887,Thus,1,0
169888,",",1,0
169889,PegFeG-CSF,1,0
169890,appears,1,0
169891,to,0,0
169892,be,0,0
169893,a,0,0
169894,superior,0,0
169895,treatment,0,0
169896,for,0,0
169897,neutropenia,0,0
169898,in,0,0
169899,feline,0,0
169900,patients,0,0
169901,.,0,0
169902,A,0,0
169903,study,0,0
169904,of,0,0
169905,noninvasive,1,0
169906,positive-pressure,1,1
169907,mechanical,1,0
169908,ventilation,1,1
169909,in,0,0
169910,the,0,0
169911,treatment,0,0
169912,of,0,0
169913,acute,0,0
169914,lung,0,0
169915,injury,0,0
169916,with,0,0
169917,a,0,0
169918,complex,0,0
169919,critical,0,0
169920,care,0,1
169921,ventilator,0,1
169922,.,0,0
169923,OBJECTIVE,0,0
169924,To,0,0
169925,test,0,0
169926,the,0,0
169927,hypothesis,0,0
169928,that,0,0
169929,there,0,0
169930,would,0,0
169931,be,0,0
169932,better,0,0
169933,clinical,0,0
169934,outcomes,0,0
169935,following,0,0
169936,the,0,0
169937,treatment,0,0
169938,of,0,0
169939,patients,0,0
169940,with,0,0
169941,acute,0,0
169942,lung,0,0
169943,injury,0,0
169944,(,0,1
169945,ALI,0,1
169946,),0,1
169947,using,0,0
169948,noninvasive,1,1
169949,positive-pressure,1,1
169950,mechanical,1,1
169951,ventilation,1,1
169952,(,1,1
169953,NIPPV,1,1
169954,),1,1
169955,delivered,1,1
169956,via,1,0
169957,a,1,0
169958,complex,1,0
169959,critical,1,0
169960,care,1,1
169961,ventilator,1,1
169962,compared,1,0
169963,with,1,0
169964,a,1,0
169965,conventional,1,1
169966,mini-ventilator,1,1
169967,.,1,0
169968,METHODS,0,0
169969,Patients,0,0
169970,with,0,0
169971,ALI,0,1
169972,who,0,0
169973,required,0,0
169974,NIPPV,0,0
169975,were,0,0
169976,prospectively,0,0
169977,enrolled,0,0
169978,and,0,0
169979,randomly,0,0
169980,divided,0,0
169981,between,0,0
169982,three,0,0
169983,intervention,0,1
169984,groups,0,0
169985,:,0,0
169986,group,0,0
169987,A,0,0
169988,was,0,0
169989,ventilated,0,1
169990,using,0,0
169991,a,0,0
169992,mini-ventilator,1,1
169993,;,1,0
169994,groups,0,0
169995,B,0,0
169996,and,0,0
169997,C,0,1
169998,were,0,0
169999,ventilated,0,1
170000,using,0,0
170001,a,0,0
170002,complex,1,1
170003,critical,1,0
170004,care,1,1
170005,ventilator,1,1
170006,using,1,0
170007,different,1,0
170008,settings,1,0
170009,.,1,0
170010,Clinical,0,0
170011,parameters,0,0
170012,were,0,0
170013,recorded,0,0
170014,before,0,0
170015,and,0,0
170016,after,0,0
170017,8,0,0
170018,h,0,0
170019,of,0,0
170020,mechanical,0,0
170021,ventilation,0,1
170022,.,0,0
170023,RESULTS,0,0
170024,A,0,0
170025,total,0,0
170026,of,0,0
170027,51,0,0
170028,patients,0,0
170029,with,0,0
170030,ALI,0,1
170031,were,0,0
170032,enrolled,0,0
170033,in,0,0
170034,the,0,0
170035,study,0,0
170036,.,0,0
170037,Clinical,0,0
170038,parameters,0,0
170039,in,0,0
170040,groups,0,0
170041,B,0,0
170042,and,0,0
170043,C,0,0
170044,underwent,0,0
170045,greater,0,0
170046,improvements,0,0
170047,than,0,0
170048,those,0,0
170049,in,0,0
170050,group,0,0
170051,A,0,0
170052,.,0,0
170053,Group,0,0
170054,C,0,0
170055,demonstrated,0,0
170056,the,0,0
170057,lowest,0,0
170058,treatment,0,0
170059,failure,0,0
170060,rate,0,0
170061,(,0,0
170062,23.5,0,0
170063,%,0,0
170064,),0,0
170065,.,0,0
170066,Failure,0,0
170067,rates,0,0
170068,were,0,0
170069,highest,0,0
170070,in,0,0
170071,group,0,0
170072,A,0,0
170073,(,0,0
170074,58.8,0,0
170075,%,0,0
170076,),0,0
170077,.,0,0
170078,CONCLUSION,0,0
170079,The,0,0
170080,findings,0,0
170081,of,0,0
170082,this,0,0
170083,present,0,0
170084,study,0,0
170085,suggest,0,0
170086,that,0,0
170087,there,0,0
170088,were,0,0
170089,more,0,0
170090,satisfactory,0,0
170091,clinical,0,0
170092,outcomes,0,0
170093,following,0,0
170094,the,0,0
170095,treatment,0,0
170096,of,0,0
170097,patients,0,0
170098,with,0,0
170099,ALI,0,1
170100,when,0,0
170101,NIPPV,0,0
170102,was,0,0
170103,delivered,0,1
170104,using,0,0
170105,a,0,0
170106,complex,0,1
170107,critical,0,0
170108,care,0,1
170109,ventilator,0,1
170110,compared,0,0
170111,with,0,0
170112,a,0,0
170113,conventional,0,1
170114,mini-ventilator,0,1
170115,.,0,0
170116,An,0,0
170117,oxytocin-induced,0,0
170118,facilitation,0,1
170119,of,0,0
170120,neural,0,0
170121,and,0,0
170122,emotional,0,0
170123,responses,0,0
170124,to,0,0
170125,social,0,0
170126,touch,0,1
170127,correlates,0,0
170128,inversely,0,0
170129,with,0,0
170130,autism,0,0
170131,traits,0,0
170132,.,0,0
170133,Social,0,0
170134,communication,0,0
170135,through,0,1
170136,touch,0,1
170137,and,0,0
170138,mutual,0,0
170139,grooming,0,0
170140,can,0,0
170141,convey,0,0
170142,highly,0,0
170143,salient,0,0
170144,socio-emotional,0,0
170145,signals,0,1
170146,and,0,0
170147,has,0,0
170148,been,0,0
170149,shown,0,0
170150,to,0,0
170151,involve,0,0
170152,the,0,0
170153,neuropeptide,0,1
170154,oxytocin,1,1
170155,(,0,1
170156,OXT,0,0
170157,),0,1
170158,in,0,0
170159,several,0,0
170160,species,0,0
170161,.,0,0
170162,Less,0,0
170163,is,0,0
170164,known,0,0
170165,about,0,0
170166,the,0,0
170167,modulatory,0,0
170168,influence,0,0
170169,of,0,0
170170,OXT,0,0
170171,on,0,0
170172,the,0,0
170173,neural,0,0
170174,and,0,0
170175,emotional,0,0
170176,responses,0,0
170177,to,0,0
170178,human,0,1
170179,interpersonal,0,1
170180,touch,0,1
170181,.,0,0
170182,The,0,0
170183,present,0,0
170184,randomized,0,0
170185,placebo,1,1
170186,(,0,1
170187,PLC,0,1
170188,),0,1
170189,-controlled,0,1
170190,within-subject,0,0
170191,pharmaco-functional,0,1
170192,magnetic,1,1
170193,resonance,1,1
170194,imaging,1,1
170195,(,1,1
170196,fMRI,1,0
170197,),1,1
170198,study,0,0
170199,was,0,0
170200,designed,0,0
170201,to,0,0
170202,test,0,0
170203,the,0,0
170204,hypothesis,0,0
170205,that,0,0
170206,a,0,0
170207,single,1,1
170208,intranasal,1,1
170209,dose,1,0
170210,of,1,0
170211,synthetic,1,1
170212,OXT,1,0
170213,(,0,0
170214,24,0,0
170215,IU,0,1
170216,),0,0
170217,would,0,0
170218,facilitate,0,0
170219,both,0,0
170220,neural,0,0
170221,and,0,0
170222,emotional,0,0
170223,responses,0,0
170224,to,0,0
170225,interpersonal,0,0
170226,touch,0,1
170227,in,0,0
170228,a,0,0
170229,context-,0,1
170230,(,0,0
170231,female,0,0
170232,vs,0,0
170233,male,0,0
170234,touch,0,1
170235,),0,1
170236,and,0,0
170237,trait-,0,0
170238,(,0,1
170239,autistic,0,0
170240,trait,0,0
170241,load,0,0
170242,),0,1
170243,specific,0,0
170244,manner,0,1
170245,.,0,0
170246,Specifically,0,0
170247,",",0,0
170248,the,0,0
170249,experimental,0,0
170250,rationale,0,0
170251,was,0,0
170252,to,0,0
170253,manipulate,0,0
170254,the,0,0
170255,reward,0,0
170256,value,0,0
170257,of,0,0
170258,interpersonal,0,0
170259,touch,0,1
170260,independent,0,0
170261,of,0,0
170262,the,0,0
170263,intensity,0,0
170264,and,0,0
170265,type,0,0
170266,of,0,0
170267,actual,0,0
170268,cutaneous,0,0
170269,stimulation,0,1
170270,administered,0,0
170271,.,0,0
170272,Thus,0,0
170273,",",0,0
170274,40,0,0
170275,heterosexual,0,0
170276,males,0,0
170277,believed,0,0
170278,that,0,0
170279,they,0,0
170280,were,0,0
170281,touched,0,0
170282,by,0,0
170283,either,0,0
170284,a,0,0
170285,man,0,0
170286,or,0,1
170287,a,0,0
170288,woman,0,0
170289,",",0,0
170290,although,0,0
170291,in,0,0
170292,fact,0,0
170293,an,0,0
170294,identical,0,0
170295,pattern,0,0
170296,of,0,0
170297,touch,0,1
170298,was,0,0
170299,always,0,0
170300,given,0,0
170301,by,0,0
170302,the,0,0
170303,same,0,0
170304,female,0,0
170305,experimenter,0,1
170306,blind,0,0
170307,to,0,0
170308,condition,0,0
170309,type,0,0
170310,.,0,0
170311,Our,0,0
170312,results,0,0
170313,show,0,0
170314,that,0,0
170315,OXT,0,0
170316,increased,0,0
170317,the,0,0
170318,perceived,0,0
170319,pleasantness,0,0
170320,of,0,0
170321,female,0,0
170322,",",0,0
170323,but,0,0
170324,not,0,0
170325,male,0,0
170326,touch,0,1
170327,",",0,0
170328,and,0,0
170329,associated,0,0
170330,neural,0,0
170331,responses,0,0
170332,in,0,0
170333,insula,0,0
170334,",",0,0
170335,precuneus,0,0
170336,",",0,0
170337,orbitofrontal,0,1
170338,",",0,0
170339,and,0,0
170340,pregenual,0,0
170341,anterior,0,1
170342,cingulate,0,0
170343,cortex,0,0
170344,.,0,0
170345,Moreover,0,0
170346,",",0,0
170347,the,0,0
170348,behavioral,0,1
170349,and,0,0
170350,neural,0,0
170351,effects,0,0
170352,of,0,0
170353,OXT,0,0
170354,were,0,0
170355,negatively,0,0
170356,correlated,0,0
170357,with,0,0
170358,autistic-like,0,0
170359,traits,0,0
170360,.,0,0
170361,Taken,0,0
170362,together,0,0
170363,",",0,0
170364,this,0,0
170365,is,0,0
170366,the,0,0
170367,first,0,0
170368,study,0,0
170369,to,0,0
170370,show,0,0
170371,that,0,0
170372,the,0,0
170373,perceived,0,0
170374,hedonic,0,0
170375,value,0,0
170376,of,0,0
170377,human,0,1
170378,heterosexual,0,0
170379,interpersonal,0,1
170380,touch,0,1
170381,is,0,0
170382,facilitated,0,0
170383,by,0,0
170384,OXT,0,0
170385,in,0,0
170386,men,0,0
170387,",",0,0
170388,but,0,0
170389,that,0,0
170390,its,0,0
170391,behavioral,0,1
170392,and,0,0
170393,neural,0,0
170394,effects,0,0
170395,in,0,0
170396,this,0,0
170397,context,0,0
170398,are,0,0
170399,blunted,0,0
170400,in,0,0
170401,individuals,0,0
170402,with,0,0
170403,autistic,0,0
170404,traits,0,0
170405,.,0,0
170406,An,0,0
170407,RCT,0,0
170408,comparing,0,0
170409,patient-centred,0,1
170410,outcome,0,0
170411,variables,0,0
170412,of,0,0
170413,guided,0,1
170414,surgery,0,1
170415,(,1,1
170416,bone,1,0
170417,or,1,1
170418,mucosa,1,0
170419,supported,1,0
170420,),1,0
170421,with,0,0
170422,conventional,0,1
170423,implant,0,1
170424,placement,0,1
170425,.,0,0
170426,AIM,0,0
170427,To,0,0
170428,assess,0,0
170429,in,0,0
170430,a,0,0
170431,randomized,0,0
170432,study,0,0
170433,the,0,0
170434,patient-centred,0,1
170435,outcome,0,0
170436,of,0,0
170437,two,0,0
170438,guided,0,1
170439,surgery,1,1
170440,systems,0,1
170441,(,1,0
170442,mucosa,1,0
170443,or,1,1
170444,bone,1,0
170445,supported,1,0
170446,),1,0
170447,compared,0,0
170448,to,0,0
170449,conventional,1,1
170450,implant,1,1
170451,placement,1,1
170452,",",0,0
170453,in,0,0
170454,fully,0,0
170455,edentulous,0,1
170456,patients,0,0
170457,.,0,0
170458,MATERIAL,0,0
170459,AND,0,0
170460,METHODS,0,0
170461,Fifty-nine,0,0
170462,patients,0,0
170463,(,0,0
170464,72,0,0
170465,jaws,0,1
170466,),0,0
170467,with,0,0
170468,edentulous,0,1
170469,maxillas,0,0
170470,and/,0,0
170471,or,0,0
170472,mandibles,0,0
170473,",",0,0
170474,were,0,0
170475,consecutively,0,0
170476,recruited,0,0
170477,and,0,0
170478,randomly,0,0
170479,assigned,0,0
170480,to,0,0
170481,one,0,0
170482,of,0,0
170483,the,0,0
170484,treatment,0,0
170485,groups,0,0
170486,.,0,0
170487,Outcome,0,0
170488,measures,0,0
170489,were,0,0
170490,the,0,0
170491,Dutch,0,1
170492,version,0,0
170493,of,0,0
170494,the,0,0
170495,McGill,0,0
170496,Pain,0,0
170497,Questionnaire,0,1
170498,(,0,1
170499,MPQ-DLV,0,1
170500,),0,0
170501,",",0,0
170502,the,0,0
170503,Health-related,0,0
170504,quality,0,0
170505,of,0,0
170506,life,0,0
170507,instrument,0,1
170508,(,0,1
170509,HRQOL,0,0
170510,),0,1
170511,",",0,0
170512,visual,0,0
170513,analogue,0,0
170514,scales,0,0
170515,(,0,0
170516,VAS,0,1
170517,),0,0
170518,",",0,0
170519,the,0,0
170520,duration,0,0
170521,of,0,0
170522,the,0,0
170523,procedure,0,0
170524,",",0,0
170525,and,0,0
170526,the,0,0
170527,analgesic,0,1
170528,doses,0,0
170529,taken,0,0
170530,each,0,0
170531,day,0,0
170532,.,0,0
170533,RESULTS,0,0
170534,Three,0,0
170535,hundred,0,0
170536,and,0,0
170537,fourteen,0,0
170538,implants,0,1
170539,were,0,0
170540,placed,0,0
170541,successfully,0,0
170542,.,0,0
170543,No,0,0
170544,statistical,0,0
170545,differences,0,0
170546,could,0,0
170547,be,0,0
170548,shown,0,0
170549,between,0,0
170550,treatment,0,0
170551,groups,0,0
170552,on,0,0
170553,pain,0,0
170554,response,0,0
170555,(,0,1
170556,MPQ-DLV,0,1
170557,),0,1
170558,",",0,0
170559,treatment,0,1
170560,perception,0,0
170561,(,0,1
170562,VAS,0,1
170563,),0,1
170564,or,0,1
170565,number,0,0
170566,or,0,1
170567,kind,0,0
170568,of,0,0
170569,pain,0,0
170570,killers,0,1
170571,.,0,0
170572,For,0,0
170573,the,0,0
170574,HRQOLI-instrument,0,1
170575,",",0,0
170576,a,0,0
170577,significant,0,0
170578,difference,0,0
170579,was,0,0
170580,found,0,0
170581,between,0,0
170582,the,0,0
170583,Materialise,1,1
170584,Mucosa,1,1
170585,and,0,0
170586,Materialise,1,1
170587,Bone,1,1
170588,group,0,0
170589,at,0,0
170590,day,0,1
170591,1,0,1
170592,(,0,0
170593,p,0,0
170594,=,0,0
170595,0.02,0,0
170596,),0,0
170597,and,0,0
170598,day,0,1
170599,2,0,1
170600,(,0,0
170601,p,0,0
170602,=,0,0
170603,0.01,0,0
170604,),0,0
170605,.,0,0
170606,For,0,0
170607,the,0,0
170608,duration,0,0
170609,of,0,0
170610,the,0,0
170611,surgery,0,0
170612,",",0,0
170613,a,0,0
170614,statistical,0,0
170615,difference,0,0
170616,(,0,0
170617,p,0,0
170618,=,0,0
170619,0.005,0,0
170620,),0,0
170621,was,0,0
170622,found,0,0
170623,between,0,0
170624,the,0,0
170625,Materialise,1,1
170626,mucosa,1,0
170627,and,0,0
170628,the,0,0
170629,Mental,0,0
170630,group,0,0
170631,",",0,0
170632,in,0,0
170633,favour,0,0
170634,of,0,0
170635,the,0,0
170636,first,0,0
170637,.,0,0
170638,CONCLUSION,0,0
170639,In,0,0
170640,this,0,0
170641,study,0,0
170642,little,0,0
170643,difference,0,0
170644,could,0,0
170645,be,0,0
170646,found,0,0
170647,in,0,0
170648,the,0,0
170649,patient,0,0
170650,outcome,0,0
170651,variables,0,0
170652,of,0,0
170653,the,0,0
170654,different,0,0
170655,treatment,0,0
170656,groups,0,0
170657,.,0,0
170658,However,0,0
170659,there,0,0
170660,was,0,0
170661,a,0,0
170662,tendency,0,0
170663,for,0,0
170664,patients,0,0
170665,treated,0,0
170666,with,0,0
170667,conventional,0,1
170668,flapped,0,1
170669,implant,0,1
170670,placement,0,1
170671,to,0,0
170672,experience,0,0
170673,the,0,0
170674,pain,0,0
170675,for,0,0
170676,a,0,0
170677,longer,0,0
170678,period,0,0
170679,of,0,0
170680,time,0,0
170681,.,0,0
170682,Directed,1,0
170683,forgetting,1,0
170684,in,0,0
170685,high-functioning,0,0
170686,adults,0,0
170687,with,0,0
170688,autism,0,0
170689,spectrum,0,0
170690,disorders,0,0
170691,.,0,0
170692,Rehearsal,0,0
170693,strategies,0,0
170694,of,0,0
170695,adults,0,0
170696,with,0,0
170697,autism,0,0
170698,spectrum,0,0
170699,disorders,0,0
170700,(,0,0
170701,ASDs,0,1
170702,),0,1
170703,and,0,0
170704,demographically,0,0
170705,matched,0,0
170706,typically,0,0
170707,developed,0,0
170708,(,0,0
170709,TD,0,1
170710,),0,1
170711,adults,0,0
170712,were,0,0
170713,strategically,0,0
170714,manipulated,0,0
170715,by,0,0
170716,cueing,0,0
170717,participants,0,0
170718,to,0,0
170719,either,0,0
170720,learn,1,0
170721,",",0,0
170722,or,0,0
170723,forget,1,0
170724,each,0,0
170725,list,0,0
170726,word,0,1
170727,prior,0,0
170728,to,0,0
170729,a,0,0
170730,recognition,1,0
170731,task,1,1
170732,.,1,0
170733,Participants,0,0
170734,were,0,0
170735,also,0,0
170736,asked,0,0
170737,to,0,0
170738,distinguish,0,0
170739,between,0,0
170740,autonoetic,0,0
170741,and,0,0
170742,noetic,0,0
170743,states,0,0
170744,of,0,0
170745,awareness,0,0
170746,using,0,0
170747,the,0,0
170748,Remember/Know,0,1
170749,paradigm,0,1
170750,.,0,0
170751,The,0,0
170752,ASD,0,0
170753,group,0,0
170754,recognised,0,0
170755,a,0,0
170756,similar,0,0
170757,number,0,0
170758,of,0,0
170759,to-be-forgotten,0,1
170760,words,0,1
170761,as,0,0
170762,the,0,0
170763,TD,0,1
170764,group,0,0
170765,",",0,0
170766,but,0,0
170767,significantly,0,0
170768,fewer,0,0
170769,to-be-learned,0,0
170770,words,0,0
170771,.,0,0
170772,This,0,0
170773,deficit,0,0
170774,was,0,0
170775,only,0,0
170776,evident,0,0
170777,in,0,0
170778,Remember,0,0
170779,responses,0,0
170780,that,0,0
170781,reflect,0,0
170782,autonoetic,0,0
170783,awareness,0,0
170784,",",0,0
170785,or,0,1
170786,episodic,0,1
170787,memory,0,0
170788,",",0,0
170789,and,0,0
170790,not,0,0
170791,Know,0,1
170792,responses,0,0
170793,.,0,0
170794,These,0,0
170795,findings,0,0
170796,support,0,0
170797,the,0,0
170798,elaborative,0,1
170799,encoding,0,1
170800,deficit,0,1
170801,hypothesis,0,0
170802,and,0,0
170803,provide,0,0
170804,a,0,0
170805,link,0,0
170806,between,0,0
170807,the,0,0
170808,previously,0,0
170809,established,0,0
170810,mild,0,0
170811,episodic,0,1
170812,memory,0,0
170813,impairments,0,0
170814,in,0,0
170815,adults,0,0
170816,with,0,0
170817,high,0,0
170818,functioning,0,0
170819,autism,0,0
170820,and,0,0
170821,the,0,0
170822,encoding,0,1
170823,strategies,0,0
170824,employed,0,0
170825,.,0,0
170826,Assessment,0,1
170827,of,0,0
170828,acute,0,0
170829,bronchodilator,0,1
170830,effects,0,0
170831,from,0,0
170832,specific,0,0
170833,airway,0,0
170834,resistance,0,0
170835,changes,0,0
170836,in,0,0
170837,stable,0,0
170838,COPD,0,0
170839,patients,0,0
170840,.,0,0
170841,BACKGROUND,0,0
170842,In,0,0
170843,COPD,0,0
170844,patients,0,0
170845,",",0,0
170846,reversibility,0,0
170847,is,0,0
170848,currently,0,0
170849,evaluated,0,0
170850,from,0,0
170851,the,0,0
170852,changes,0,0
170853,of,0,0
170854,forced,0,1
170855,expiratory,0,0
170856,volume,0,0
170857,at,0,0
170858,1s,0,0
170859,(,0,0
170860,?FEV1,0,1
170861,),0,1
170862,and,0,0
170863,forced,0,1
170864,vital,0,0
170865,capacity,0,0
170866,(,0,1
170867,?FVC,0,1
170868,),0,0
170869,.,0,0
170870,By,0,0
170871,lowering,0,0
170872,peripheral,0,0
170873,airway,0,0
170874,smooth,0,0
170875,muscle,0,0
170876,tone,0,0
170877,",",0,0
170878,bronchodilators,0,0
170879,should,0,0
170880,decrease,0,0
170881,dynamic,0,0
170882,hyperinflation,0,0
170883,",",0,0
170884,gas,0,1
170885,trapping,0,0
170886,",",0,0
170887,and,0,0
170888,possibly,0,0
170889,dyspnea,0,0
170890,at,0,0
170891,rest,0,0
170892,.,0,0
170893,Hence,0,0
170894,",",0,0
170895,we,0,0
170896,hypothesize,0,0
170897,that,0,0
170898,specific,0,0
170899,airway,0,0
170900,resistance,0,0
170901,changes,0,0
170902,(,0,0
170903,?sRAW,0,0
170904,),0,1
170905,should,0,0
170906,better,0,0
170907,characterize,0,0
170908,the,0,0
170909,acute,0,0
170910,response,0,0
170911,to,0,0
170912,bronchodilators,0,0
170913,.,0,0
170914,METHODS,0,0
170915,On,0,0
170916,two,0,0
170917,days,0,0
170918,",",0,0
170919,60,0,0
170920,COPD,0,0
170921,patients,0,0
170922,underwent,1,0
170923,dyspnea,1,0
170924,evaluation,1,0
170925,(,1,1
170926,VAS,1,1
170927,score,1,0
170928,),1,1
170929,and,1,0
170930,pulmonary,1,0
170931,function,1,0
170932,testing,1,1
170933,at,1,0
170934,baseline,1,0
170935,and,1,0
170936,one,1,0
170937,hour,1,0
170938,after,1,0
170939,placebo,1,1
170940,or,1,1
170941,300?g,1,0
170942,indacaterol,1,1
170943,administration,1,0
170944,.,1,0
170945,RESULTS,1,0
170946,Spirographic,0,0
170947,and,0,0
170948,?sRAW-based,0,1
170949,criteria,0,0
170950,identified,0,0
170951,as,0,0
170952,responders,0,0
170953,24,0,0
170954,and,0,0
170955,45,0,0
170956,patients,0,0
170957,",",0,0
170958,respectively,0,0
170959,.,0,0
170960,?sRAW,0,0
170961,correlated,0,0
170962,with,0,0
170963,changes,0,0
170964,of,0,0
170965,intrathoracic,0,0
170966,gas,0,1
170967,volume,0,0
170968,(,0,1
170969,?ITGV,0,1
170970,),0,1
170971,(,0,0
170972,r=0.61,0,0
170973,;,0,0
170974,p,0,0
170975,<,0,0
170976,0.001,0,0
170977,),0,0
170978,",",0,0
170979,residual,0,0
170980,volume,0,0
170981,(,0,1
170982,?RV,0,1
170983,),0,1
170984,(,0,0
170985,r=0.60,0,0
170986,;,0,0
170987,p,0,0
170988,<,0,0
170989,0.001,0,0
170990,),0,0
170991,",",0,0
170992,?FVC,0,1
170993,(,0,0
170994,r=0.44,0,0
170995,;,0,1
170996,p=0.001,0,0
170997,),0,0
170998,",",0,0
170999,and,0,0
171000,?VAS,0,1
171001,(,0,1
171002,r=0.73,0,0
171003,;,0,0
171004,p,0,0
171005,<,0,0
171006,0.001,0,0
171007,),0,0
171008,",",0,0
171009,while,0,0
171010,?FEV1,0,0
171011,correlated,0,0
171012,only,0,0
171013,with,0,0
171014,?FVC,0,1
171015,(,0,0
171016,r=0.34,0,0
171017,;,0,1
171018,p=0.008,0,0
171019,),0,0
171020,.,0,0
171021,Significant,0,0
171022,differences,0,0
171023,in,0,0
171024,terms,0,0
171025,of,0,0
171026,?ITGV,0,0
171027,(,0,1
171028,p=0.002,0,0
171029,),0,0
171030,",",0,0
171031,?RV,0,1
171032,(,0,1
171033,p=0.023,0,0
171034,),0,1
171035,",",0,0
171036,and,0,0
171037,?VAS,0,1
171038,(,0,1
171039,p,0,0
171040,<,0,0
171041,0.001,0,0
171042,),0,0
171043,occurred,0,0
171044,only,0,0
171045,if,0,0
171046,patients,0,0
171047,were,0,0
171048,stratified,0,0
171049,according,0,0
171050,to,0,0
171051,?sRAW,0,0
171052,.,0,0
171053,CONCLUSIONS,0,0
171054,In,0,0
171055,assessing,0,0
171056,the,0,0
171057,acute,0,0
171058,functional,0,0
171059,effect,0,0
171060,of,0,0
171061,bronchodilators,0,0
171062,",",0,0
171063,?sRAW-based,0,0
171064,criterion,0,0
171065,is,0,0
171066,preferable,0,0
171067,to,0,0
171068,FEV1-FVC-based,0,0
171069,criteria,0,0
171070,",",0,0
171071,being,0,0
171072,more,0,0
171073,closely,0,0
171074,related,0,0
171075,to,0,0
171076,bronchodilator-induced,0,1
171077,improvements,0,0
171078,of,0,0
171079,lung,0,0
171080,mechanics,0,0
171081,and,0,0
171082,dyspnea,0,0
171083,at,0,0
171084,rest,0,0
171085,.,0,0
171086,Effect,0,0
171087,of,0,0
171088,propranolol,1,1
171089,on,0,0
171090,facial,0,1
171091,scanning,0,1
171092,in,0,0
171093,autism,0,0
171094,spectrum,0,0
171095,disorder,0,0
171096,:,0,0
171097,a,0,0
171098,preliminary,0,0
171099,investigation,0,0
171100,.,0,0
171101,BACKGROUND,0,0
171102,Autism,0,0
171103,spectrum,0,0
171104,disorder,0,0
171105,(,0,1
171106,ASD,0,0
171107,),0,1
171108,is,0,0
171109,a,0,0
171110,neurodevelopmental,0,0
171111,disorder,0,0
171112,characterized,0,0
171113,by,0,0
171114,social,0,0
171115,communication,0,1
171116,impairments,0,0
171117,and,0,0
171118,restricted,0,0
171119,",",0,0
171120,repetitive,0,1
171121,behaviors,0,0
171122,.,0,0
171123,Whereas,0,0
171124,current,0,0
171125,pharmacological,0,0
171126,interventions,0,1
171127,for,0,0
171128,ASD,0,0
171129,focus,0,0
171130,primarily,0,0
171131,on,0,0
171132,psychiatric,0,0
171133,symptoms,0,0
171134,",",0,0
171135,including,0,0
171136,agitation,0,0
171137,and,0,0
171138,obsessive,0,0
171139,behaviors,0,0
171140,",",0,0
171141,few,0,0
171142,agents,0,1
171143,target,0,0
171144,core,0,0
171145,symptomatology,0,0
171146,.,0,0
171147,It,0,0
171148,has,0,0
171149,been,0,0
171150,previously,0,0
171151,hypothesized,0,0
171152,that,0,0
171153,abnormalities,0,0
171154,in,0,0
171155,facial,0,0
171156,scanning,0,1
171157,",",0,0
171158,such,0,0
171159,as,0,0
171160,reduced,0,0
171161,eye,0,1
171162,contact,0,1
171163,or,0,1
171164,increased,0,0
171165,mouth,0,0
171166,fixation,0,1
171167,",",0,0
171168,contribute,0,0
171169,to,0,0
171170,social,0,0
171171,communication,0,1
171172,deficits,0,0
171173,in,0,0
171174,ASD,0,0
171175,.,0,0
171176,In,0,0
171177,addition,0,0
171178,",",0,0
171179,previous,0,0
171180,reports,0,0
171181,have,0,0
171182,suggested,0,0
171183,elevated,0,0
171184,stress,0,0
171185,and,0,0
171186,anxiety,0,0
171187,in,0,0
171188,ASD,0,0
171189,",",0,0
171190,symptoms,0,0
171191,that,0,0
171192,are,0,0
171193,believed,0,0
171194,to,0,0
171195,impact,0,0
171196,facial,0,1
171197,scanning,0,1
171198,patterns,0,0
171199,.,0,0
171200,OBJECTIVES,0,0
171201,The,0,0
171202,present,0,0
171203,pilot,0,0
171204,study,0,0
171205,sought,0,0
171206,to,0,0
171207,explore,0,0
171208,the,0,0
171209,effects,0,0
171210,of,0,0
171211,pharmacological,0,0
171212,intervention,0,1
171213,via,0,1
171214,propranolol,1,1
171215,",",0,0
171216,a,0,0
171217,nonselective,0,1
171218,?-adrenergic,0,1
171219,antagonist,0,1
171220,and,0,0
171221,known,0,0
171222,anxiolytic,0,1
171223,",",0,0
171224,on,0,0
171225,facial,0,1
171226,scanning,0,1
171227,in,0,0
171228,ASD,0,0
171229,.,0,0
171230,Specifically,0,0
171231,",",0,0
171232,we,0,0
171233,wished,0,0
171234,to,0,0
171235,determine,0,0
171236,whether,0,0
171237,there,0,0
171238,is,0,0
171239,an,0,0
171240,increase,0,0
171241,in,0,0
171242,eye,0,1
171243,contact,0,1
171244,and,0,0
171245,a,0,0
171246,decrease,0,0
171247,in,0,0
171248,mouth,0,0
171249,fixation,0,1
171250,with,0,0
171251,administration,0,0
171252,of,0,0
171253,propranolol,0,1
171254,.,0,0
171255,METHOD,0,0
171256,A,0,0
171257,sample,0,0
171258,of,0,0
171259,14,0,0
171260,participants,0,0
171261,with,0,0
171262,ASD,0,0
171263,and,0,0
171264,14,0,0
171265,matched,0,0
171266,controls,0,0
171267,participated,0,0
171268,in,0,0
171269,two,0,0
171270,study,0,0
171271,sessions,0,1
171272,in,0,0
171273,which,1,0
171274,propranolol,1,1
171275,and,1,0
171276,placebo,1,1
171277,were,1,0
171278,administered,1,0
171279,in,1,0
171280,a,1,0
171281,counterbalanced,1,0
171282,",",1,0
171283,double-blinded,1,0
171284,manner,1,0
171285,.,1,0
171286,At,0,0
171287,each,0,0
171288,session,0,1
171289,",",0,0
171290,ocular,0,0
171291,fixation,0,1
171292,data,0,0
171293,were,0,0
171294,collected,0,0
171295,during,1,0
171296,presentation,1,0
171297,of,1,0
171298,video,1,1
171299,stimuli,1,1
171300,of,1,0
171301,16,1,0
171302,human,1,0
171303,faces,1,0
171304,.,1,0
171305,Fixation,0,0
171306,time,0,0
171307,on,0,0
171308,the,0,0
171309,eye,0,0
171310,",",0,0
171311,nose,0,0
171312,",",0,0
171313,and,0,0
171314,mouth,0,0
171315,regions,0,0
171316,of,0,0
171317,the,0,0
171318,face,0,0
171319,stimuli,0,1
171320,was,0,0
171321,analyzed,0,0
171322,.,0,0
171323,RESULTS,0,0
171324,The,0,0
171325,baseline,0,0
171326,fixation,0,1
171327,patterns,0,0
171328,for,0,0
171329,the,0,0
171330,ASD,0,0
171331,and,0,0
171332,control,0,1
171333,groups,0,0
171334,did,0,0
171335,not,0,0
171336,significantly,0,0
171337,differ,0,0
171338,;,0,0
171339,however,0,0
171340,",",0,0
171341,administration,0,0
171342,of,0,0
171343,propranolol,0,1
171344,was,0,0
171345,associated,0,0
171346,with,0,0
171347,a,0,0
171348,significant,0,0
171349,reduction,0,0
171350,in,0,0
171351,mouth,0,0
171352,fixation,0,1
171353,for,0,0
171354,the,0,0
171355,ASD,0,0
171356,group,0,0
171357,.,0,0
171358,Additionally,0,0
171359,",",0,0
171360,mouth,0,0
171361,fixation,0,1
171362,was,0,0
171363,positively,0,0
171364,related,0,0
171365,to,0,0
171366,nonverbal,0,0
171367,communication,0,1
171368,impairment,0,0
171369,in,0,0
171370,the,0,0
171371,ASD,0,0
171372,group,0,0
171373,.,0,0
171374,CONCLUSIONS,0,0
171375,Although,0,0
171376,eye,0,1
171377,fixation,0,1
171378,in,0,0
171379,ASD,0,0
171380,appears,0,0
171381,typical,0,0
171382,in,0,0
171383,the,0,0
171384,present,0,0
171385,study,0,0
171386,",",0,0
171387,the,0,0
171388,effect,0,0
171389,of,0,0
171390,propranolol,0,1
171391,in,0,0
171392,reducing,0,0
171393,mouth,0,0
171394,fixation,0,1
171395,suggests,0,0
171396,an,0,0
171397,important,0,0
171398,focus,0,0
171399,for,0,0
171400,further,0,0
171401,research,0,0
171402,.,0,0
171403,Future,0,0
171404,studies,0,0
171405,are,0,0
171406,needed,0,0
171407,to,0,0
171408,better,0,0
171409,characterize,0,0
171410,the,0,0
171411,relationship,0,0
171412,between,0,0
171413,stress,0,0
171414,and,0,0
171415,anxiety,0,0
171416,and,0,0
171417,facial,0,1
171418,scanning,0,1
171419,in,0,0
171420,ASD,0,0
171421,",",0,0
171422,as,0,0
171423,well,0,0
171424,as,0,0
171425,the,0,0
171426,effects,0,0
171427,of,0,0
171428,pharmacological,0,0
171429,intervention,0,1
171430,.,0,0
171431,Effect,0,0
171432,of,0,0
171433,a,0,0
171434,mixed,1,1
171435,kinesio,1,1
171436,taping-compression,1,1
171437,technique,1,1
171438,on,0,0
171439,quality,0,0
171440,of,0,0
171441,life,0,0
171442,and,0,0
171443,clinical,0,0
171444,and,0,0
171445,gait,0,0
171446,parameters,0,0
171447,in,0,0
171448,postmenopausal,0,0
171449,women,0,0
171450,with,0,0
171451,chronic,0,0
171452,venous,0,0
171453,insufficiency,0,0
171454,:,0,0
171455,double-blinded,0,0
171456,",",0,0
171457,randomized,0,0
171458,controlled,0,0
171459,trial,0,0
171460,.,0,0
171461,OBJECTIVE,0,0
171462,To,0,0
171463,investigate,0,0
171464,the,0,0
171465,short-term,0,0
171466,effect,0,0
171467,of,0,0
171468,a,0,0
171469,mixed,0,1
171470,Kinesio,1,1
171471,taping,1,1
171472,(,0,1
171473,KT,0,1
171474,),0,1
171475,model,0,0
171476,on,0,0
171477,range,0,0
171478,of,0,0
171479,ankle,0,0
171480,motion,0,0
171481,(,0,1
171482,ROAM,0,1
171483,),0,1
171484,",",0,0
171485,gait,0,0
171486,",",0,0
171487,pain,0,0
171488,",",0,0
171489,perimeter,0,0
171490,of,0,0
171491,lower,0,0
171492,limbs,0,0
171493,",",0,0
171494,and,0,0
171495,quality,0,0
171496,of,0,0
171497,life,0,0
171498,in,0,0
171499,postmenopausal,0,0
171500,women,0,0
171501,with,0,0
171502,chronic,0,0
171503,venous,0,1
171504,insufficiency,0,0
171505,(,0,1
171506,CVI,0,1
171507,),0,0
171508,.,0,0
171509,DESIGN,0,0
171510,Double-blinded,0,0
171511,",",0,0
171512,randomized,0,0
171513,controlled,0,0
171514,trial,0,0
171515,.,0,0
171516,SETTING,0,0
171517,Clinical,0,0
171518,setting,0,0
171519,.,0,0
171520,PARTICIPANTS,0,0
171521,Consecutive,0,0
171522,postmenopausal,0,0
171523,women,0,0
171524,(,0,0
171525,N=130,0,1
171526,;,0,0
171527,mean,0,0
171528,age,0,0
171529,?,0,0
171530,SD,0,0
171531,",",0,0
171532,65.44?14.7y,0,0
171533,),0,0
171534,with,0,0
171535,mild,0,0
171536,CVI,0,0
171537,.,0,0
171538,No,0,0
171539,participant,0,0
171540,withdrew,0,0
171541,because,0,0
171542,of,0,0
171543,adverse,0,0
171544,effects,0,0
171545,.,0,0
171546,INTERVENTION,0,0
171547,Participants,0,0
171548,were,0,0
171549,randomly,0,0
171550,assigned,0,0
171551,to,0,0
171552,either,0,1
171553,(,0,0
171554,1,0,0
171555,),1,0
171556,an,1,0
171557,experimental,1,0
171558,group,1,0
171559,to,1,0
171560,receive,1,0
171561,a,1,0
171562,mixed,1,1
171563,KT-compression,1,1
171564,treatment,1,1
171565,following,1,0
171566,KT,1,1
171567,recommendations,1,1
171568,for,1,0
171569,gastrocnemius,1,1
171570,muscle,1,1
171571,enhancement,1,0
171572,and,1,0
171573,functional,1,0
171574,correction,1,0
171575,of,1,0
171576,the,1,0
171577,ankle,1,0
171578,",",1,0
171579,and,1,0
171580,adding,1,0
171581,2,1,0
171582,tapes,1,1
171583,to,1,0
171584,simulate,1,0
171585,traditional,1,1
171586,compression,1,1
171587,bandages,1,1
171588,(,1,0
171589,no,1,0
171590,KT,1,1
171591,guidelines,1,0
171592,),1,0
171593,;,1,0
171594,or,1,1
171595,(,1,0
171596,2,1,0
171597,),1,0
171598,a,1,0
171599,placebo,1,1
171600,control,1,1
171601,group,1,0
171602,for,1,0
171603,sham,1,1
171604,KT,1,1
171605,.,1,0
171606,Both,0,0
171607,interventions,0,0
171608,were,0,0
171609,performed,0,0
171610,3,0,0
171611,times,0,0
171612,a,0,0
171613,week,0,0
171614,during,0,0
171615,a,0,0
171616,4-week,0,0
171617,period,0,0
171618,.,0,0
171619,MAIN,0,0
171620,OUTCOME,0,0
171621,MEASURES,0,0
171622,ROAM,0,1
171623,",",0,0
171624,gait,0,0
171625,",",0,0
171626,pain,0,0
171627,",",0,0
171628,perimeter,0,0
171629,of,0,0
171630,right,0,0
171631,and,0,0
171632,left,0,0
171633,lower,0,0
171634,limb,0,0
171635,",",0,0
171636,and,0,0
171637,quality,0,0
171638,of,0,0
171639,life,0,0
171640,were,0,0
171641,assessed,0,0
171642,at,0,0
171643,baseline,0,0
171644,and,0,0
171645,48,0,0
171646,hours,0,0
171647,posttreatment,0,0
171648,.,0,0
171649,RESULTS,0,0
171650,Quality,0,0
171651,of,0,0
171652,life,0,0
171653,was,0,0
171654,better,0,0
171655,in,0,0
171656,the,0,0
171657,intervention,0,1
171658,group,0,0
171659,by,0,0
171660,a,0,0
171661,mean,0,0
171662,of,0,0
171663,8.76,0,0
171664,points,0,0
171665,(,0,0
171666,95,0,0
171667,%,0,0
171668,confidence,0,0
171669,interval,0,0
171670,[,0,0
171671,CI,0,0
171672,],0,0
171673,",",0,0
171674,4.96-12.55,0,0
171675,),0,0
171676,.,0,0
171677,The,0,0
171678,experimental,0,0
171679,group,0,0
171680,also,0,0
171681,showed,0,0
171682,significant,0,0
171683,pre-/posttreatment,0,0
171684,improvements,0,0
171685,in,0,0
171686,both,0,0
171687,lower,0,0
171688,limbs,0,0
171689,in,0,0
171690,gait,0,0
171691,dorsiflexion,0,0
171692,ROAM,0,1
171693,(,0,0
171694,95,0,0
171695,%,0,0
171696,CI,0,0
171697,",",0,0
171698,1.02-2.49,0,0
171699,),0,0
171700,",",0,0
171701,cadence,0,1
171702,(,0,0
171703,95,0,0
171704,%,0,0
171705,CI,0,0
171706,",",0,0
171707,3.45-1.47,0,0
171708,),0,0
171709,",",0,0
171710,stride,0,1
171711,length,0,1
171712,(,0,0
171713,95,0,0
171714,%,0,0
171715,CI,0,0
171716,",",0,0
171717,21.48-10.83,0,0
171718,),0,0
171719,",",0,0
171720,step,0,0
171721,length,0,1
171722,(,0,0
171723,95,0,0
171724,%,0,0
171725,CI,0,0
171726,",",0,0
171727,1.68-6.61,0,0
171728,),0,0
171729,",",0,0
171730,stance,0,1
171731,phase,0,0
171732,(,0,0
171733,95,0,0
171734,%,0,0
171735,CI,0,0
171736,",",0,0
171737,61-107,0,0
171738,),0,0
171739,",",0,0
171740,and,0,1
171741,foot,0,1
171742,(,0,1
171743,95,0,0
171744,%,0,0
171745,CI,0,0
171746,",",0,0
171747,.56-.92,0,0
171748,),0,1
171749,and,0,0
171750,malleolus,0,0
171751,(,0,0
171752,95,0,0
171753,%,0,0
171754,CI,0,0
171755,",",0,0
171756,1.15-1.63,0,0
171757,),0,0
171758,circumference,0,0
171759,.,0,1
171760,None,0,0
171761,of,0,0
171762,these,0,0
171763,variables,0,0
171764,were,0,0
171765,significantly,0,0
171766,modified,0,0
171767,in,0,0
171768,the,0,0
171769,placebo,0,1
171770,group,0,0
171771,.,0,0
171772,Both,0,0
171773,groups,0,0
171774,reported,0,0
171775,a,0,0
171776,significant,0,0
171777,reduction,0,0
171778,in,0,0
171779,pain,0,0
171780,.,0,0
171781,CONCLUSIONS,0,0
171782,Ankle,0,0
171783,dorsiflexion,0,0
171784,during,0,0
171785,gait,0,0
171786,",",0,0
171787,walking,0,1
171788,parameters,0,0
171789,",",0,0
171790,peripheral,0,0
171791,edema,0,0
171792,",",0,0
171793,venous,0,0
171794,pain,0,0
171795,",",0,0
171796,and,0,0
171797,quality,0,0
171798,of,0,0
171799,life,0,0
171800,remain,0,0
171801,improved,0,0
171802,in,0,0
171803,patients,0,0
171804,with,0,0
171805,CVI,0,0
171806,at,0,0
171807,1,0,0
171808,month,0,0
171809,after,1,0
171810,mixed,1,1
171811,KT-compression,1,1
171812,therapy,1,1
171813,.,1,0
171814,KT,0,1
171815,may,0,0
171816,have,0,0
171817,a,0,0
171818,placebo,1,1
171819,effect,1,0
171820,on,0,0
171821,pain,0,0
171822,perception,0,0
171823,.,0,0
171824,LNH-84,0,0
171825,regimen,0,1
171826,:,0,0
171827,a,0,0
171828,multicenter,0,0
171829,study,0,0
171830,of,0,0
171831,intensive,0,1
171832,chemotherapy,0,1
171833,in,0,0
171834,737,0,0
171835,patients,0,0
171836,with,0,0
171837,aggressive,0,0
171838,malignant,0,0
171839,lymphoma,0,0
171840,.,0,0
171841,From,0,0
171842,July,0,0
171843,1984,0,0
171844,to,0,0
171845,September,0,0
171846,1987,0,0
171847,",",0,0
171848,737,0,0
171849,patients,0,0
171850,with,0,0
171851,aggressive,0,0
171852,malignant,0,0
171853,lymphoma,0,0
171854,(,0,1
171855,ML,0,1
171856,),0,1
171857,were,0,0
171858,treated,0,0
171859,by,0,0
171860,an,0,0
171861,intensive,1,1
171862,regimen,1,1
171863,(,1,0
171864,LNH-84,1,1
171865,),1,1
171866,comprising,0,1
171867,three,1,1
171868,or,1,0
171869,four,1,0
171870,courses,1,1
171871,of,1,0
171872,doxorubicin,1,1
171873,",",1,0
171874,75,1,0
171875,mg/m2,1,1
171876,;,1,0
171877,cyclophosphamide,1,1
171878,",",1,0
171879,"1,200",1,0
171880,mg/m2,1,1
171881,;,1,0
171882,vindesine,1,1
171883,",",1,0
171884,2,1,0
171885,mg/m2,1,1
171886,x,1,0
171887,2,1,0
171888,;,1,0
171889,bleomycin,1,1
171890,",",1,0
171891,10,1,0
171892,mg,1,1
171893,x,1,0
171894,2,1,0
171895,;,1,0
171896,and,1,0
171897,prednisolone,1,1
171898,",",1,0
171899,60,1,0
171900,mg/m2,1,1
171901,x,1,0
171902,5,1,1
171903,(,1,0
171904,ACVB,1,1
171905,),1,1
171906,",",1,0
171907,consolidation,1,0
171908,with,1,0
171909,high-dose,1,1
171910,methotrexate,1,1
171911,",",1,0
171912,ifosfamide,1,1
171913,",",1,0
171914,etoposide,1,1
171915,",",1,0
171916,asparaginase,1,1
171917,",",1,0
171918,and,1,0
171919,cytarabine,1,1
171920,",",1,0
171921,and,1,0
171922,a,1,0
171923,randomized,1,0
171924,late,1,0
171925,intensification,1,1
171926,with,1,0
171927,two,1,0
171928,courses,1,0
171929,of,1,0
171930,cytarabine,1,1
171931,",",1,0
171932,cyclophosphamide,1,1
171933,",",1,0
171934,teniposide,1,1
171935,",",1,0
171936,bleomycin,1,1
171937,",",1,0
171938,and,1,0
171939,prednisone,1,1
171940,(,1,1
171941,AraCVmB,1,1
171942,),1,0
171943,.,1,0
171944,Four,0,0
171945,hundred,0,0
171946,forty-two,0,0
171947,patients,0,0
171948,had,0,0
171949,intermediate-grade,0,0
171950,ML,0,1
171951,",",0,0
171952,221,0,0
171953,highgrade,0,0
171954,ML,0,1
171955,",",0,0
171956,and,0,0
171957,74,0,0
171958,unclassified,0,0
171959,ML,0,0
171960,.,0,0
171961,Most,0,0
171962,of,0,0
171963,the,0,0
171964,patients,0,0
171965,had,0,0
171966,advanced,0,0
171967,disease,0,0
171968,:,0,0
171969,stage,0,0
171970,IIE,0,0
171971,(,0,0
171972,23,0,0
171973,%,0,0
171974,),0,0
171975,",",0,0
171976,III,0,1
171977,(,0,0
171978,13,0,0
171979,%,0,0
171980,),0,0
171981,",",0,0
171982,or,0,1
171983,IV,0,0
171984,(,0,1
171985,47,0,0
171986,%,0,0
171987,),0,0
171988,;,0,0
171989,38,0,0
171990,%,0,0
171991,disseminated,0,0
171992,nodes,0,0
171993,;,0,0
171994,38,0,0
171995,%,0,0
171996,two,0,0
171997,or,0,0
171998,more,0,0
171999,extranodal,0,0
172000,sites,0,0
172001,;,0,0
172002,and,0,0
172003,41,0,0
172004,%,0,0
172005,a,0,0
172006,tumoral,0,0
172007,mass,0,0
172008,greater,0,0
172009,than,0,0
172010,10,0,0
172011,cm,0,0
172012,.,0,0
172013,Five,0,0
172014,hundred,0,0
172015,fifty-three,0,0
172016,patients,0,0
172017,(,0,0
172018,75,0,0
172019,%,0,0
172020,),0,0
172021,went,0,0
172022,into,0,0
172023,complete,0,0
172024,remission,0,0
172025,(,0,1
172026,CR,0,1
172027,),0,0
172028,",",0,0
172029,63,0,0
172030,(,0,0
172031,9,0,0
172032,%,0,0
172033,),0,0
172034,into,0,0
172035,partial,0,0
172036,remission,0,0
172037,",",0,0
172038,62,0,0
172039,(,0,0
172040,8,0,0
172041,%,0,0
172042,),0,0
172043,failed,0,0
172044,to,0,0
172045,respond,0,0
172046,",",0,0
172047,and,0,0
172048,59,0,0
172049,(,0,0
172050,8,0,0
172051,%,0,0
172052,),0,0
172053,died,0,0
172054,during,0,0
172055,ACVB,0,0
172056,courses,0,1
172057,",",0,0
172058,17,0,0
172059,of,0,0
172060,them,0,0
172061,from,0,0
172062,progression,0,0
172063,of,0,0
172064,the,0,0
172065,disease,0,0
172066,.,0,0
172067,With,0,0
172068,a,0,0
172069,median,0,0
172070,follow-up,0,0
172071,of,0,0
172072,23,0,0
172073,months,0,0
172074,",",0,0
172075,the,0,0
172076,estimated,0,0
172077,2-year,0,0
172078,overall,0,0
172079,survival,0,0
172080,time,0,0
172081,to,0,0
172082,failure,0,0
172083,(,0,1
172084,TTF,0,1
172085,),0,1
172086,",",0,0
172087,and,0,0
172088,time,0,0
172089,to,0,0
172090,relapse,0,0
172091,(,0,1
172092,TTR,0,1
172093,),0,1
172094,survival,0,0
172095,are,0,0
172096,67,0,0
172097,%,0,0
172098,",",0,0
172099,56,0,0
172100,%,0,0
172101,",",0,0
172102,and,0,0
172103,67,0,0
172104,%,0,0
172105,",",0,0
172106,respectively,0,0
172107,.,0,0
172108,Patients,0,0
172109,receiving,0,0
172110,a,0,0
172111,late,0,0
172112,intensification,0,1
172113,had,0,0
172114,the,0,0
172115,same,0,0
172116,relapse,0,0
172117,rate,0,0
172118,as,0,0
172119,the,0,0
172120,other,0,0
172121,patients,0,0
172122,.,0,0
172123,A,0,0
172124,persistent,0,0
172125,fibronecrotic,0,0
172126,mass,0,0
172127,was,0,0
172128,found,0,0
172129,in,0,0
172130,150,0,0
172131,patients,0,0
172132,(,0,0
172133,20,0,1
172134,%,0,0
172135,),0,0
172136,and,0,0
172137,did,0,0
172138,not,0,0
172139,influence,0,0
172140,the,0,0
172141,relapse,0,0
172142,rate,0,0
172143,.,0,0
172144,Toxicity,0,0
172145,was,0,0
172146,mainly,0,0
172147,neutropenia,0,0
172148,and,0,0
172149,infection,0,0
172150,during,0,0
172151,the,0,0
172152,ACVB,0,0
172153,courses,0,0
172154,",",0,0
172155,with,0,0
172156,40,0,1
172157,patients,0,0
172158,(,0,0
172159,5,0,1
172160,%,0,0
172161,),0,0
172162,dying,0,0
172163,from,0,0
172164,septic,0,0
172165,complications,0,0
172166,while,0,0
172167,responding,0,0
172168,to,0,0
172169,treatment,0,0
172170,.,0,0
172171,Fifty-three,0,0
172172,percent,0,0
172173,of,0,0
172174,the,0,0
172175,patients,0,0
172176,had,0,0
172177,a,0,0
172178,neutropenia,0,0
172179,less,0,0
172180,than,0,0
172181,0.500,0,0
172182,x,0,0
172183,10,0,0
172184,(,0,0
172185,9,0,0
172186,),0,0
172187,/L,0,1
172188,",",0,0
172189,58,0,0
172190,%,0,0
172191,fever,0,0
172192,(,0,0
172193,6,0,1
172194,%,0,0
172195,grade,0,0
172196,4,0,0
172197,),0,0
172198,",",0,0
172199,and,0,0
172200,49,0,0
172201,%,0,0
172202,a,0,0
172203,documented,0,0
172204,infection,0,0
172205,(,0,0
172206,8,0,0
172207,%,0,0
172208,grade,0,0
172209,4,0,0
172210,),0,0
172211,.,0,0
172212,These,0,0
172213,results,0,0
172214,obtained,0,0
172215,with,0,0
172216,the,0,0
172217,LNH-84,0,0
172218,regimen,0,1
172219,demonstrate,0,0
172220,that,0,0
172221,this,0,0
172222,therapeutic,0,0
172223,scheme,0,1
172224,is,0,0
172225,an,0,0
172226,effective,0,0
172227,treatment,0,0
172228,for,0,0
172229,aggressive,0,0
172230,ML,0,0
172231,.,0,0
172232,A,0,0
172233,trial,0,0
172234,of,0,0
172235,D-cycloserine,1,1
172236,to,0,0
172237,treat,0,0
172238,stereotypies,0,0
172239,in,0,0
172240,older,0,0
172241,adolescents,0,0
172242,and,0,0
172243,young,0,0
172244,adults,0,0
172245,with,0,0
172246,autism,0,0
172247,spectrum,0,0
172248,disorder,0,0
172249,.,0,0
172250,OBJECTIVES,0,0
172251,Autism,0,0
172252,spectrum,0,0
172253,disorders,0,0
172254,(,0,0
172255,ASDs,0,1
172256,),0,1
172257,have,0,0
172258,core,0,0
172259,impairments,0,0
172260,in,0,0
172261,social,0,0
172262,communication,0,1
172263,as,0,0
172264,well,0,0
172265,as,0,0
172266,the,0,0
172267,presence,0,0
172268,of,0,0
172269,repetitive,0,1
172270,",",0,0
172271,stereotypic,0,0
172272,behaviors,0,0
172273,and,0,0
172274,restricted,0,0
172275,interests,0,0
172276,.,0,0
172277,Older,0,0
172278,adolescents,0,0
172279,and,0,0
172280,young,0,0
172281,adults,0,0
172282,are,0,0
172283,particularly,0,0
172284,impacted,0,0
172285,by,0,0
172286,these,0,0
172287,deficits,0,0
172288,.,0,0
172289,Preclinical,0,0
172290,data,0,0
172291,implicate,0,0
172292,glutamatergic,0,0
172293,dysfunction,0,0
172294,in,0,0
172295,the,0,0
172296,pathophysiology,0,0
172297,of,0,0
172298,ASDs,0,0
172299,.,0,1
172300,D-Cycloserine,1,1
172301,(,1,0
172302,DCS,1,1
172303,),1,0
172304,",",0,0
172305,a,0,0
172306,partial,0,0
172307,glycineB,0,0
172308,agonist,0,1
172309,at,0,0
172310,the,0,0
172311,N-methyl-D-aspartic,0,1
172312,acid,0,1
172313,receptor,0,0
172314,site,0,0
172315,",",0,0
172316,has,0,0
172317,been,0,0
172318,shown,0,0
172319,to,0,0
172320,improve,0,0
172321,sociability,0,0
172322,in,0,0
172323,mouse,0,1
172324,models,0,0
172325,and,0,0
172326,a,0,0
172327,small,0,0
172328,human,0,1
172329,study,0,0
172330,.,0,0
172331,The,0,0
172332,sensitivity,0,0
172333,of,0,0
172334,the,0,0
172335,obligatory,0,0
172336,glycineB,0,1
172337,co-agonist,0,1
172338,binding,0,0
172339,site,0,0
172340,may,0,0
172341,change,0,0
172342,with,0,0
172343,daily,0,1
172344,administration,0,0
172345,of,0,0
172346,DCS,0,0
172347,as,0,0
172348,a,0,0
172349,result,0,0
172350,of,0,0
172351,agonist-induced,0,1
172352,desensitization,0,1
172353,.,0,0
172354,The,0,0
172355,efficacy,0,0
172356,of,0,0
172357,a,0,0
172358,pulsed,0,1
172359,once-weekly,0,1
172360,administration,0,0
172361,versus,0,1
172362,daily,0,1
172363,administration,0,0
172364,of,0,0
172365,DCS,0,0
172366,was,0,0
172367,compared,0,0
172368,.,0,0
172369,METHODS,0,0
172370,Males,0,0
172371,and,0,0
172372,females,0,0
172373,",",0,0
172374,ages,0,0
172375,14,0,0
172376,to,0,0
172377,25,0,0
172378,years,0,0
172379,",",0,0
172380,with,0,0
172381,a,0,0
172382,Diagnostic,0,0
172383,and,0,0
172384,Statistical,0,0
172385,Manual,0,1
172386,of,0,0
172387,Mental,0,0
172388,Disorders,0,0
172389,",",0,0
172390,Fourth,0,0
172391,Edition,0,1
172392,Text,0,1
172393,Revision,0,1
172394,diagnosis,0,0
172395,of,0,0
172396,an,0,0
172397,ASD,0,0
172398,were,0,0
172399,enrolled,0,0
172400,in,0,0
172401,a,0,0
172402,double-blind,0,0
172403,",",0,0
172404,randomized,0,0
172405,10-week,0,1
172406,trial,0,0
172407,consisting,0,0
172408,of,0,0
172409,8,0,0
172410,weeks,0,0
172411,of,0,0
172412,active,0,0
172413,drug,0,1
172414,with,0,0
172415,either,0,1
172416,weekly,0,1
172417,or,0,1
172418,daily,0,1
172419,administration,0,0
172420,of,0,0
172421,50,0,0
172422,mg,0,1
172423,of,0,0
172424,DCS,1,1
172425,followed,0,1
172426,by,0,0
172427,a,0,0
172428,2-week,0,0
172429,follow-up,0,0
172430,visit,0,0
172431,.,0,0
172432,RESULTS,0,0
172433,For,0,0
172434,the,0,0
172435,purposes,0,0
172436,of,0,0
172437,this,0,0
172438,study,0,0
172439,",",0,0
172440,no,0,0
172441,statistical,0,0
172442,or,0,1
172443,clinical,0,0
172444,differences,0,0
172445,existed,0,0
172446,between,0,0
172447,the,0,0
172448,2,0,0
172449,dosage,0,0
172450,groups,0,0
172451,on,0,0
172452,the,0,0
172453,Aberrant,0,0
172454,Behavior,0,0
172455,Checklist,0,1
172456,subscale,0,0
172457,3,0,0
172458,",",0,0
172459,which,0,0
172460,measures,0,0
172461,stereotypies/repetitive,0,0
172462,movements,0,0
172463,.,0,0
172464,When,0,0
172465,combining,0,0
172466,groups,0,0
172467,",",0,0
172468,a,0,0
172469,statistically,0,0
172470,significant,0,0
172471,decrease,0,0
172472,of,0,0
172473,37,0,0
172474,%,0,0
172475,was,0,0
172476,found,0,0
172477,from,0,0
172478,baseline,0,0
172479,to,0,0
172480,week,0,0
172481,8,0,0
172482,when,0,0
172483,study,0,0
172484,drug,0,1
172485,was,0,0
172486,completed,0,0
172487,using,0,0
172488,a,0,0
172489,linear,0,0
172490,mixed,0,1
172491,effects,0,0
172492,model,0,0
172493,(,0,0
172494,P,0,0
172495,=,0,0
172496,0.003,0,0
172497,),0,0
172498,.,0,0
172499,CONCLUSIONS,0,0
172500,D-Cycloserine,1,1
172501,was,0,0
172502,shown,0,0
172503,to,0,0
172504,be,0,0
172505,effective,0,0
172506,in,0,0
172507,improving,0,0
172508,stereotypic,0,0
172509,symptoms,0,0
172510,in,0,0
172511,older,0,0
172512,adolescents,0,0
172513,and,0,0
172514,young,0,0
172515,adults,0,0
172516,with,0,0
172517,ASDs,0,0
172518,measured,0,0
172519,by,0,0
172520,the,0,0
172521,Aberrant,0,0
172522,Behavior,0,0
172523,Checklist,0,0
172524,subscale,0,0
172525,3,0,0
172526,.,0,0
172527,In,0,0
172528,addition,0,0
172529,",",0,0
172530,DCS,1,0
172531,was,0,0
172532,safe,0,0
172533,and,0,0
172534,well,0,0
172535,tolerated,0,0
172536,.,0,0
172537,Oral,1,1
172538,magnesium,1,1
172539,supplementation,1,1
172540,improves,0,0
172541,the,0,0
172542,metabolic,0,0
172543,profile,0,0
172544,of,0,0
172545,metabolically,0,0
172546,obese,0,0
172547,",",0,0
172548,normal-weight,0,0
172549,individuals,0,0
172550,:,0,0
172551,a,0,0
172552,randomized,0,0
172553,double-blind,0,0
172554,placebo-controlled,0,1
172555,trial,0,0
172556,.,0,1
172557,BACKGROUND,0,0
172558,AND,0,0
172559,AIMS,0,0
172560,We,0,0
172561,undertook,0,0
172562,this,0,0
172563,study,0,0
172564,to,0,0
172565,determine,0,0
172566,the,0,0
172567,efficacy,0,0
172568,of,0,0
172569,oral,0,1
172570,magnesium,1,1
172571,supplementation,0,1
172572,in,0,0
172573,the,0,0
172574,improvement,0,0
172575,of,0,0
172576,the,0,0
172577,metabolic,0,0
172578,profile,0,0
172579,and,0,0
172580,blood,0,0
172581,pressure,0,0
172582,in,0,0
172583,metabolically,0,0
172584,obese,0,0
172585,",",0,0
172586,normal-weight,0,0
172587,(,0,1
172588,MONW,0,1
172589,),0,0
172590,individuals,0,0
172591,.,0,0
172592,METHODS,0,0
172593,A,0,0
172594,total,0,0
172595,of,0,0
172596,47,0,0
172597,MONW,0,0
172598,individuals,0,0
172599,with,0,0
172600,hypomagnesemia,0,0
172601,were,0,0
172602,enrolled,0,0
172603,in,0,0
172604,clinical,0,0
172605,a,0,0
172606,randomized,0,0
172607,double-blind,0,0
172608,placebo-controlled,0,1
172609,trial,0,0
172610,.,0,0
172611,Individuals,0,0
172612,in,0,0
172613,the,0,0
172614,intervention,0,1
172615,group,0,0
172616,received,0,1
172617,30,1,0
172618,mL,1,0
172619,of,1,0
172620,MgCl2,1,1
172621,5,1,1
172622,%,1,0
172623,solution,1,1
172624,(,1,0
172625,equivalent,1,0
172626,to,1,0
172627,382,1,0
172628,mg,1,1
172629,of,1,0
172630,magnesium,1,1
172631,),1,1
172632,and,1,0
172633,individuals,1,0
172634,in,1,0
172635,the,1,0
172636,control,1,1
172637,group,1,0
172638,30,1,1
172639,mL,1,1
172640,of,1,0
172641,placebo,1,1
172642,solution,1,1
172643,",",1,0
172644,once,1,0
172645,daily,1,0
172646,during,1,0
172647,4,1,0
172648,months,1,0
172649,.,1,0
172650,In,0,0
172651,the,0,0
172652,absence,0,0
172653,of,0,0
172654,obesity,0,0
172655,or,0,1
172656,overweight,0,0
172657,",",0,0
172658,the,0,0
172659,presence,0,0
172660,of,0,0
172661,fasting,0,0
172662,glucose,0,0
172663,levels,0,0
172664,?100,0,1
172665,mg/dL,0,0
172666,",",0,0
172667,HOMA-IR,0,0
172668,index,0,0
172669,?3,0,1
172670,",",0,0
172671,triglyceride,0,0
172672,levels,0,0
172673,?150,0,1
172674,mg/dL,0,0
172675,and/or,0,1
172676,systolic,0,0
172677,and,0,0
172678,diastolic,0,0
172679,blood,0,0
172680,pressure,0,0
172681,?140,0,1
172682,and,0,0
172683,90,0,0
172684,mmHg,0,0
172685,defined,0,0
172686,the,0,0
172687,presence,0,0
172688,of,0,0
172689,the,0,0
172690,MONW,0,1
172691,phenotype,0,0
172692,.,0,0
172693,Hypomagnesemia,0,0
172694,was,0,0
172695,defined,0,0
172696,by,0,0
172697,serum,0,0
172698,magnesium,0,1
172699,concentration,0,0
172700,?1.8,0,0
172701,mg/dL,0,0
172702,.,0,0
172703,RESULTS,0,0
172704,At,0,0
172705,basal,0,0
172706,conditions,0,0
172707,there,0,0
172708,were,0,0
172709,no,0,0
172710,significant,0,0
172711,differences,0,0
172712,between,0,0
172713,groups,0,0
172714,.,0,0
172715,At,0,0
172716,the,0,0
172717,end,0,0
172718,of,0,0
172719,follow-up,0,0
172720,",",0,0
172721,changes,0,0
172722,in,0,0
172723,the,0,0
172724,mean,0,0
172725,of,0,0
172726,systolic,0,0
172727,(,0,0
172728,-2.1,0,0
172729,vs.,0,0
172730,3.9,0,0
172731,%,0,0
172732,mmHg,0,0
172733,",",0,0
172734,p,0,0
172735,<,0,0
172736,0.05,0,0
172737,),0,0
172738,and,0,0
172739,diastolic,0,0
172740,(,0,0
172741,-3.8,0,0
172742,vs.,0,0
172743,7.5,0,1
172744,%,0,0
172745,mmHg,0,0
172746,",",0,0
172747,p,0,0
172748,<,0,0
172749,0.05,0,0
172750,),0,0
172751,blood,0,0
172752,pressures,0,0
172753,",",0,0
172754,HOMA-IR,0,1
172755,index,0,0
172756,(,0,0
172757,-46.5,0,0
172758,vs.,0,0
172759,-5.4,0,0
172760,%,0,0
172761,",",0,0
172762,p,0,0
172763,<,0,0
172764,0.0001,0,0
172765,),0,0
172766,",",0,0
172767,fasting,0,1
172768,glucose,0,0
172769,(,0,1
172770,-12.3,0,0
172771,vs.,0,0
172772,-1.8,0,0
172773,%,0,0
172774,mg/dL,0,0
172775,",",0,0
172776,p,0,0
172777,<,0,0
172778,0.05,0,0
172779,),0,0
172780,and,0,0
172781,triglyceride,0,0
172782,levels,0,0
172783,(,0,0
172784,-47.4,0,0
172785,%,0,0
172786,vs.,0,0
172787,10.1,0,0
172788,%,0,0
172789,mg/dL,0,0
172790,",",0,0
172791,p,0,0
172792,<,0,0
172793,0.0001,0,0
172794,),0,0
172795,were,0,0
172796,significantly,0,0
172797,lower,0,0
172798,in,0,0
172799,the,0,0
172800,subjects,0,0
172801,who,0,0
172802,received,1,0
172803,MgCl2,1,1
172804,compared,1,0
172805,with,0,0
172806,individuals,1,0
172807,in,1,0
172808,the,1,0
172809,control,1,0
172810,group,1,0
172811,.,0,0
172812,CONCLUSIONS,1,0
172813,Oral,1,1
172814,magnesium,1,1
172815,supplementation,0,1
172816,improves,0,0
172817,the,0,0
172818,metabolic,0,0
172819,profile,0,0
172820,and,0,0
172821,blood,0,0
172822,pressure,0,0
172823,of,0,0
172824,MONW,0,0
172825,individuals,0,0
172826,.,0,0
172827,Causes,0,0
172828,of,0,0
172829,variation,0,0
172830,in,0,0
172831,BCG,1,1
172832,vaccine,1,1
172833,efficacy,0,0
172834,:,0,1
172835,examining,0,0
172836,evidence,0,0
172837,from,0,0
172838,the,0,0
172839,BCG,0,1
172840,REVAC,0,1
172841,cluster,0,0
172842,randomized,0,0
172843,trial,0,0
172844,to,0,0
172845,explore,0,0
172846,the,0,0
172847,masking,0,1
172848,and,0,0
172849,the,0,0
172850,blocking,0,0
172851,hypotheses,0,0
172852,.,0,0
172853,BCG,0,0
172854,protection,0,0
172855,varies,0,0
172856,and,0,0
172857,in,0,0
172858,some,0,0
172859,places,0,0
172860,(,0,0
172861,nearest,0,1
172862,the,0,0
172863,equator,0,0
172864,),0,1
172865,is,0,0
172866,low,0,0
172867,or,0,0
172868,absent,0,0
172869,.,0,0
172870,Understanding,0,0
172871,this,0,0
172872,variation,0,0
172873,can,0,0
172874,inform,0,0
172875,the,0,0
172876,efforts,0,0
172877,to,0,0
172878,develop,0,0
172879,new,0,0
172880,vaccines,0,1
172881,against,0,0
172882,tuberculosis,0,0
172883,.,0,0
172884,Two,0,0
172885,main,0,0
172886,hypotheses,0,0
172887,are,0,0
172888,used,0,0
172889,to,0,0
172890,explain,0,0
172891,this,0,0
172892,variation,0,0
172893,:,0,0
172894,under,0,0
172895,masking,0,1
172896,",",0,0
172897,new,0,0
172898,vaccines,0,1
172899,are,0,0
172900,unlikely,0,0
172901,to,0,0
172902,increase,0,0
172903,protection,0,0
172904,;,0,0
172905,under,0,0
172906,blocking,0,0
172907,new,0,0
172908,vaccines,0,1
172909,have,0,0
172910,a,0,0
172911,greater,0,0
172912,potential,0,0
172913,to,0,0
172914,be,0,0
172915,effective,0,0
172916,when,0,0
172917,BCG,0,1
172918,is,0,0
172919,not,0,0
172920,.,0,0
172921,We,0,0
172922,conducted,0,0
172923,a,0,0
172924,cluster,0,0
172925,randomized,0,0
172926,trial,0,0
172927,to,0,0
172928,explored,0,0
172929,the,0,0
172930,masking,0,1
172931,and,0,0
172932,blocking,0,1
172933,hypotheses,0,0
172934,by,0,0
172935,studying,0,0
172936,BCG,1,1
172937,vaccine,1,1
172938,efficacy,0,0
172939,of,0,0
172940,neonatal,0,0
172941,vaccination,0,1
172942,and,0,0
172943,when,0,0
172944,administered,0,0
172945,for,0,0
172946,the,0,0
172947,first,0,0
172948,or,0,1
172949,a,0,0
172950,second,0,0
172951,(,0,1
172952,revaccination,0,1
172953,),0,1
172954,time,0,0
172955,at,0,0
172956,school,0,0
172957,age,0,0
172958,in,0,0
172959,two,0,0
172960,sites,0,0
172961,(,0,0
172962,Manaus,0,0
172963,close,0,0
172964,and,0,0
172965,Salvador,0,0
172966,further,0,0
172967,south,0,0
172968,from,0,0
172969,the,0,0
172970,equator,0,0
172971,),0,0
172972,.,0,0
172973,Seven,0,0
172974,hundred,0,0
172975,and,0,0
172976,sixty,0,0
172977,three,0,0
172978,state,0,0
172979,schools,0,0
172980,were,0,0
172981,matched,0,0
172982,on,0,0
172983,socio,0,0
172984,economic,0,0
172985,characteristics,0,0
172986,of,0,0
172987,the,0,0
172988,neighborhood,0,0
172989,and,0,0
172990,"239,934",0,0
172991,children,0,0
172992,were,0,0
172993,randomized,0,0
172994,to,0,0
172995,vaccine,0,1
172996,(,1,0
172997,BCG,1,1
172998,vaccination,1,1
172999,at,0,0
173000,school,0,0
173001,age,0,0
173002,),0,1
173003,or,0,1
173004,control,1,1
173005,group,1,0
173006,.,1,0
173007,Protection,0,0
173008,by,0,0
173009,first,0,0
173010,BCG,1,1
173011,vaccination,1,1
173012,at,0,0
173013,school,0,0
173014,age,0,0
173015,was,0,0
173016,high,0,0
173017,in,0,0
173018,Salvador,0,0
173019,(,0,0
173020,34,0,0
173021,%,0,0
173022,",",0,0
173023,95,0,0
173024,%,0,0
173025,CI,0,0
173026,7-53,0,1
173027,%,0,0
173028,",",0,0
173029,p=0.017,0,0
173030,),0,1
173031,but,0,0
173032,low,0,0
173033,in,0,0
173034,Manaus,0,0
173035,(,0,0
173036,8,0,0
173037,%,0,0
173038,",",0,0
173039,95,0,0
173040,%,0,0
173041,CI,0,0
173042,t0,0,0
173043,39-40,0,0
173044,%,0,0
173045,",",0,0
173046,p=0.686,0,0
173047,),0,0
173048,.,0,0
173049,For,0,0
173050,revaccination,0,1
173051,at,0,0
173052,school,0,0
173053,age,0,0
173054,",",0,0
173055,protection,0,0
173056,was,0,0
173057,modest,0,0
173058,in,0,0
173059,Salvador,0,0
173060,(,0,0
173061,19,0,0
173062,%,0,0
173063,",",0,0
173064,95,0,0
173065,%,0,0
173066,CI,0,0
173067,3-33,0,0
173068,%,0,0
173069,",",0,0
173070,p=0.022,0,0
173071,),0,1
173072,and,0,0
173073,absent,0,0
173074,in,0,0
173075,Manaus,0,0
173076,(,0,0
173077,1,0,0
173078,%,0,0
173079,",",0,0
173080,95,0,0
173081,%,0,0
173082,CI,0,0
173083,to,0,0
173084,27-23,0,0
173085,%,0,0
173086,",",0,0
173087,p=0.932,0,0
173088,),0,0
173089,.,0,0
173090,Vaccine,0,0
173091,efficacy,0,0
173092,for,0,0
173093,neonatal,0,0
173094,vaccination,0,1
173095,was,0,0
173096,similar,0,0
173097,in,0,0
173098,Salvador,0,0
173099,(,0,0
173100,40,0,1
173101,%,0,0
173102,",",0,0
173103,95,0,0
173104,%,0,0
173105,CI,0,0
173106,22-54,0,0
173107,%,0,0
173108,",",0,0
173109,p,0,0
173110,<,0,0
173111,0.001,0,0
173112,),0,0
173113,and,0,0
173114,Manaus,0,1
173115,(,0,1
173116,36,0,0
173117,%,0,0
173118,",",0,0
173119,95,0,0
173120,%,0,0
173121,CI,0,0
173122,11-53,0,0
173123,%,0,0
173124,",",0,0
173125,p=0.008,0,0
173126,),0,0
173127,.,0,0
173128,Variation,0,0
173129,in,0,0
173130,BCG,1,1
173131,efficacy,0,0
173132,was,0,0
173133,marked,0,0
173134,when,0,0
173135,vaccine,0,1
173136,was,0,0
173137,given,0,0
173138,at,0,0
173139,school,0,0
173140,age,0,0
173141,but,0,0
173142,absent,0,0
173143,at,0,0
173144,birth,0,0
173145,",",0,0
173146,which,0,0
173147,points,0,0
173148,towards,0,0
173149,blocking,0,0
173150,as,0,0
173151,the,0,0
173152,dominant,0,0
173153,mechanism,0,0
173154,.,0,0
173155,New,0,0
173156,tuberculosis,0,0
173157,vaccines,0,1
173158,that,0,0
173159,overcome,0,0
173160,or,0,1
173161,by,0,0
173162,pass,0,0
173163,this,0,0
173164,blocking,0,1
173165,effect,0,0
173166,could,0,0
173167,confer,0,0
173168,protection,0,0
173169,in,0,0
173170,situations,0,0
173171,where,0,0
173172,BCG,0,1
173173,is,0,0
173174,not,0,0
173175,protective,0,0
173176,.,0,0
173177,The,0,0
173178,effect,0,0
173179,of,0,0
173180,arm,1,0
173181,support,1,0
173182,combined,1,1
173183,with,1,0
173184,rehabilitation,1,1
173185,games,1,1
173186,on,0,0
173187,upper-extremity,0,0
173188,function,0,0
173189,in,0,0
173190,subacute,0,0
173191,stroke,0,0
173192,:,0,0
173193,a,0,0
173194,randomized,0,0
173195,controlled,0,0
173196,trial,0,0
173197,.,0,0
173198,BACKGROUND,0,0
173199,Use,0,1
173200,of,0,0
173201,rehabilitation,1,1
173202,technology,1,0
173203,",",0,0
173204,such,0,0
173205,as,0,0
173206,(,1,1
173207,electro,1,1
173208,),1,1
173209,mechanical,1,0
173210,devices,1,1
173211,or,1,0
173212,robotics,1,1
173213,",",0,0
173214,could,0,0
173215,partly,0,0
173216,relieve,0,0
173217,the,0,0
173218,increasing,0,0
173219,strain,0,0
173220,on,0,0
173221,stroke,0,0
173222,rehabilitation,0,1
173223,caused,0,0
173224,by,0,0
173225,an,0,0
173226,increasing,0,0
173227,prevalence,0,0
173228,of,0,0
173229,stroke,0,0
173230,.,0,0
173231,Arm,1,0
173232,support,1,0
173233,(,1,1
173234,AS,1,1
173235,),1,1
173236,training,1,1
173237,showed,0,0
173238,improvement,0,0
173239,of,0,0
173240,unsupported,0,1
173241,arm,0,0
173242,function,0,0
173243,in,0,0
173244,chronic,0,0
173245,stroke,0,0
173246,.,0,0
173247,OBJECTIVE,0,0
173248,To,0,0
173249,examine,0,0
173250,the,0,0
173251,effect,0,0
173252,of,0,0
173253,weight-supported,1,1
173254,arm,1,0
173255,training,1,1
173256,combined,0,1
173257,with,0,0
173258,computerized,1,1
173259,exercises,1,1
173260,on,0,0
173261,arm,0,0
173262,function,0,0
173263,and,0,0
173264,capacity,0,0
173265,",",0,0
173266,compared,0,0
173267,with,0,0
173268,dose-matched,0,0
173269,conventional,1,1
173270,reach,1,0
173271,training,1,1
173272,in,0,0
173273,subacute,0,0
173274,stroke,0,0
173275,patients,0,0
173276,.,0,0
173277,METHODS,0,0
173278,In,0,0
173279,a,0,0
173280,single-blind,0,0
173281,",",0,0
173282,multicenter,0,0
173283,",",0,0
173284,randomized,0,0
173285,controlled,0,0
173286,trial,0,0
173287,",",0,0
173288,70,0,0
173289,subacute,0,0
173290,stroke,0,0
173291,patients,0,0
173292,received,0,0
173293,6,0,0
173294,weeks,0,0
173295,of,0,0
173296,training,1,1
173297,with,0,0
173298,either,0,0
173299,an,0,0
173300,AS,1,0
173301,device,1,1
173302,combined,1,1
173303,with,1,0
173304,computerized,1,1
173305,exercises,1,1
173306,or,1,0
173307,dose-matched,1,0
173308,conventional,1,1
173309,training,1,1
173310,(,1,1
173311,CON,1,1
173312,),1,0
173313,.,1,0
173314,Arm,0,0
173315,function,0,0
173316,was,0,0
173317,evaluated,0,0
173318,pretraining,0,1
173319,and,0,0
173320,posttraining,0,0
173321,by,0,0
173322,Fugl-Meyer,0,0
173323,assessment,0,0
173324,(,0,1
173325,FM,0,1
173326,),0,1
173327,",",0,0
173328,maximal,0,0
173329,reach,0,0
173330,distance,0,0
173331,",",0,0
173332,Stroke,0,1
173333,Upper,0,1
173334,Limb,0,1
173335,Capacity,0,0
173336,Scale,0,1
173337,(,0,1
173338,SULCS,0,1
173339,),0,1
173340,",",0,0
173341,and,0,0
173342,arm,0,0
173343,pain,0,0
173344,via,0,1
173345,Visual,0,0
173346,Analogue,0,1
173347,Scale,0,0
173348,",",0,0
173349,in,0,0
173350,addition,0,0
173351,to,0,0
173352,perceived,0,0
173353,motivation,0,0
173354,by,0,0
173355,Intrinsic,0,1
173356,Motivation,0,1
173357,Inventory,0,0
173358,posttraining,0,0
173359,.,0,0
173360,RESULTS,0,0
173361,FM,0,0
173362,and,0,0
173363,SULCS,0,1
173364,scores,0,0
173365,and,0,0
173366,reach,0,0
173367,distance,0,0
173368,improved,0,0
173369,significantly,0,0
173370,within,0,0
173371,both,0,0
173372,groups,0,0
173373,.,0,0
173374,These,0,0
173375,improvements,0,0
173376,and,0,0
173377,experienced,0,0
173378,pain,0,0
173379,did,0,0
173380,not,0,0
173381,differ,0,0
173382,between,0,0
173383,groups,0,0
173384,.,0,0
173385,The,0,0
173386,AS,0,0
173387,group,0,0
173388,reported,0,0
173389,higher,0,0
173390,interest/enjoyment,0,0
173391,during,0,0
173392,training,0,1
173393,than,0,0
173394,the,0,0
173395,CON,0,1
173396,group,0,0
173397,.,0,0
173398,CONCLUSIONS,0,0
173399,AS,0,0
173400,training,1,1
173401,with,1,0
173402,computerized,1,1
173403,exercises,1,1
173404,is,0,0
173405,as,0,0
173406,effective,0,0
173407,as,0,0
173408,conventional,0,1
173409,therapy,0,1
173410,dedicated,0,1
173411,to,0,0
173412,the,0,0
173413,arm,0,0
173414,to,0,0
173415,improve,0,0
173416,arm,0,0
173417,function,0,0
173418,and,0,0
173419,activity,0,0
173420,in,0,0
173421,subacute,0,0
173422,stroke,0,0
173423,rehabilitation,0,1
173424,",",0,0
173425,when,0,0
173426,applied,0,0
173427,at,0,0
173428,the,0,0
173429,same,0,0
173430,dose,0,0
173431,.,0,0
173432,Quantifying,0,0
173433,narrative,0,1
173434,ability,0,0
173435,in,0,0
173436,autism,0,0
173437,spectrum,0,0
173438,disorder,0,0
173439,:,0,0
173440,a,0,0
173441,computational,0,0
173442,linguistic,0,1
173443,analysis,0,0
173444,of,0,0
173445,narrative,0,1
173446,coherence,0,0
173447,.,0,0
173448,Autism,0,0
173449,is,0,0
173450,a,0,0
173451,neurodevelopmental,0,0
173452,disorder,0,0
173453,characterized,0,0
173454,by,0,0
173455,serious,0,0
173456,difficulties,0,0
173457,with,0,0
173458,the,0,0
173459,social,0,0
173460,use,0,0
173461,of,0,0
173462,language,0,0
173463,",",0,0
173464,along,0,0
173465,with,0,0
173466,impaired,0,0
173467,social,0,1
173468,functioning,0,0
173469,and,0,0
173470,ritualistic/repetitive,0,1
173471,behaviors,0,0
173472,(,0,0
173473,American,0,0
173474,Psychiatric,0,1
173475,Association,0,0
173476,in,0,0
173477,Diagnostic,0,0
173478,and,0,0
173479,statistical,0,0
173480,manual,0,1
173481,of,0,0
173482,mental,0,0
173483,disorders,0,0
173484,:,0,0
173485,DSM-5,0,0
173486,",",0,0
173487,5th,0,0
173488,edn,0,0
173489,.,0,0
173490,American,0,0
173491,Psychiatric,0,0
173492,Association,0,0
173493,",",0,0
173494,Arlington,0,0
173495,",",0,0
173496,2013,0,0
173497,),0,0
173498,.,0,0
173499,While,0,0
173500,substantial,0,0
173501,heterogeneity,0,0
173502,exists,0,0
173503,in,0,0
173504,symptom,0,0
173505,expression,0,0
173506,",",0,0
173507,impairments,0,0
173508,in,0,0
173509,language,0,1
173510,discourse,0,1
173511,skills,0,1
173512,",",0,0
173513,including,0,0
173514,narrative,0,1
173515,(,0,1
173516,or,0,1
173517,storytelling,0,1
173518,),0,0
173519,",",0,0
173520,are,0,0
173521,universally,0,0
173522,observed,0,0
173523,in,0,0
173524,autism,0,0
173525,(,0,0
173526,Tager-Flusberg,0,0
173527,et,0,0
173528,al,0,0
173529,.,0,0
173530,in,0,0
173531,Handbook,0,1
173532,on,0,0
173533,autism,0,0
173534,and,0,0
173535,pervasive,0,0
173536,developmental,0,0
173537,disorders,0,0
173538,",",0,0
173539,3rd,0,0
173540,edn,0,0
173541,.,0,0
173542,Wiley,0,0
173543,",",0,0
173544,New,0,1
173545,York,0,1
173546,",",0,0
173547,pp,0,0
173548,335-364,0,0
173549,",",0,0
173550,2005,0,0
173551,),0,0
173552,.,0,0
173553,This,0,0
173554,study,0,0
173555,applied,0,0
173556,a,0,0
173557,computational,1,0
173558,linguistic,1,1
173559,tool,1,0
173560,",",1,0
173561,Latent,1,0
173562,Semantic,1,1
173563,Analysis,1,1
173564,(,1,1
173565,LSA,1,1
173566,),1,0
173567,",",0,0
173568,to,0,0
173569,objectively,0,0
173570,characterize,0,0
173571,narrative,0,1
173572,performance,0,0
173573,in,0,0
173574,high-functioning,0,0
173575,individuals,0,0
173576,with,0,0
173577,autism,0,0
173578,and,0,0
173579,typically-developing,0,0
173580,controls,0,0
173581,",",0,0
173582,across,0,0
173583,two,0,0
173584,different,0,0
173585,narrative,0,1
173586,contexts,0,0
173587,that,0,0
173588,differ,0,0
173589,in,0,0
173590,the,0,0
173591,interpersonal,0,0
173592,and,0,0
173593,cognitive,0,0
173594,demands,0,0
173595,placed,0,0
173596,on,0,0
173597,the,0,0
173598,narrator,0,0
173599,.,0,0
173600,Results,0,0
173601,indicated,0,0
173602,that,0,0
173603,high-functioning,0,0
173604,individuals,0,0
173605,with,0,0
173606,autism,0,0
173607,produced,0,0
173608,narratives,0,1
173609,comparable,0,0
173610,in,0,0
173611,semantic,0,1
173612,content,0,0
173613,to,0,0
173614,those,0,0
173615,produced,0,0
173616,by,0,0
173617,controls,0,0
173618,when,0,0
173619,narrating,0,1
173620,from,0,0
173621,a,0,0
173622,picture,0,0
173623,book,0,1
173624,",",0,0
173625,but,0,0
173626,produced,0,0
173627,narratives,0,1
173628,diminished,0,0
173629,in,0,0
173630,semantic,0,1
173631,quality,0,0
173632,in,0,0
173633,a,0,0
173634,more,0,0
173635,demanding,0,0
173636,narrative,0,1
173637,recall,0,1
173638,task,0,1
173639,.,0,0
173640,This,0,0
173641,pattern,0,0
173642,is,0,0
173643,similar,0,0
173644,to,0,0
173645,that,0,0
173646,detected,0,0
173647,from,0,0
173648,analyses,0,0
173649,of,0,0
173650,hand-coded,0,1
173651,picture,0,0
173652,book,0,1
173653,narratives,0,1
173654,in,0,0
173655,prior,0,0
173656,research,0,0
173657,",",0,0
173658,and,0,0
173659,extends,0,0
173660,findings,0,0
173661,to,0,0
173662,an,0,0
173663,additional,0,0
173664,narrative,0,1
173665,context,0,0
173666,that,0,0
173667,proves,0,0
173668,particularly,0,0
173669,challenging,0,0
173670,for,0,0
173671,individuals,0,0
173672,with,0,0
173673,autism,0,0
173674,.,0,0
173675,Results,0,0
173676,are,0,0
173677,discussed,0,0
173678,in,0,0
173679,terms,0,0
173680,of,0,0
173681,the,0,0
173682,utility,0,0
173683,of,0,0
173684,LSA,0,1
173685,as,0,0
173686,a,0,0
173687,quantitative,0,0
173688,",",0,0
173689,objective,0,0
173690,",",0,0
173691,and,0,0
173692,efficient,0,0
173693,measure,0,0
173694,of,0,0
173695,narrative,0,1
173696,ability,0,0
173697,.,0,0
173698,Failure,0,0
173699,of,0,0
173700,lithium,1,1
173701,to,0,0
173702,reduce,0,0
173703,period,0,0
173704,of,0,0
173705,neutropenia,0,0
173706,during,0,0
173707,induction,1,0
173708,therapy,1,1
173709,of,0,0
173710,acute,0,0
173711,myeloid,0,0
173712,leukemia,0,0
173713,.,0,0
173714,Fifty-four,0,0
173715,patients,0,0
173716,treated,0,0
173717,with,0,0
173718,daunorubicin,1,1
173719,",",1,0
173720,cytosine,1,1
173721,arabinoside,1,1
173722,and,1,0
173723,thioquanine,1,1
173724,for,0,0
173725,acute,0,0
173726,myeloid,0,0
173727,leukemia,0,0
173728,were,0,0
173729,randomly,0,0
173730,assigned,0,0
173731,to,0,0
173732,receive,0,0
173733,oral,1,1
173734,lithium,1,1
173735,carbonate,1,1
173736,1200,1,1
173737,mg,1,1
173738,daily,1,1
173739,or,1,1
173740,no,1,0
173741,lithium,1,1
173742,.,1,0
173743,The,0,0
173744,duration,0,0
173745,of,0,0
173746,neutropenia,0,0
173747,(,0,0
173748,less,0,0
173749,than,0,0
173750,0.5,0,0
173751,x,0,0
173752,10,0,0
173753,(,0,0
173754,9,0,0
173755,),0,1
173756,/L,0,1
173757,),0,1
173758,was,0,0
173759,similar,0,0
173760,between,0,0
173761,controls,0,0
173762,(,0,0
173763,median,0,0
173764,22.5,0,0
173765,days,0,0
173766,),0,0
173767,and,0,0
173768,patients,0,0
173769,treated,0,0
173770,with,0,0
173771,lithium,1,1
173772,(,0,0
173773,median,0,0
173774,24,0,0
173775,days,0,0
173776,),0,0
173777,.,0,0
173778,The,0,0
173779,number,0,0
173780,of,0,0
173781,remissions,0,0
173782,",",0,0
173783,relapse-free,0,0
173784,survival,0,0
173785,and,0,0
173786,survival,0,0
173787,were,0,0
173788,similar,0,0
173789,for,0,0
173790,the,0,0
173791,lithium,1,1
173792,treated,0,0
173793,and,0,0
173794,control,0,1
173795,groups,0,0
173796,of,0,0
173797,patients,0,0
173798,.,0,0
173799,There,0,0
173800,was,0,0
173801,no,0,0
173802,apparent,0,0
173803,clinical,0,0
173804,efficacy,0,0
173805,in,0,0
173806,the,0,0
173807,use,0,0
173808,of,0,0
173809,lithium,1,1
173810,to,0,0
173811,reduce,0,0
173812,the,0,0
173813,period,0,0
173814,of,0,0
173815,neutropenia,0,0
173816,in,0,0
173817,patients,0,0
173818,undergoing,0,0
173819,remission,0,0
173820,induction,1,1
173821,therapy,1,1
173822,for,0,0
173823,acute,0,0
173824,myeloid,0,0
173825,leukemia,0,0
173826,.,0,0
173827,Chocolate,1,1
173828,frogs,1,0
173829,do,0,0
173830,not,0,0
173831,increase,0,0
173832,completion,0,0
173833,of,0,0
173834,parent,0,1
173835,survey,0,0
173836,:,0,1
173837,randomised,0,0
173838,study,0,0
173839,.,0,0
173840,Four,0,0
173841,months,0,0
173842,into,0,0
173843,a,0,0
173844,year-long,0,0
173845,",",0,0
173846,national,0,0
173847,survey,0,0
173848,assessing,0,0
173849,parents,0,0
173850,',0,0
173851,experiences,0,0
173852,of,0,0
173853,a,0,0
173854,child,0,0
173855,'s,0,0
173856,diagnosis,0,0
173857,of,0,0
173858,autism,0,0
173859,spectrum,0,0
173860,disorder,0,0
173861,",",0,0
173862,our,0,0
173863,response,0,0
173864,fraction,0,0
173865,was,0,0
173866,only,0,0
173867,23,0,0
173868,%,0,0
173869,.,0,0
173870,We,0,0
173871,aimed,0,0
173872,to,0,0
173873,determine,0,0
173874,whether,0,0
173875,including,0,0
173876,a,0,0
173877,chocolate,1,1
173878,incentive,1,1
173879,in,0,0
173880,the,0,0
173881,postal,0,1
173882,survey,0,0
173883,would,0,0
173884,increase,0,0
173885,the,0,0
173886,response,0,0
173887,fraction,0,0
173888,.,0,0
173889,Families,0,0
173890,enrolled,0,0
173891,between,0,0
173892,15,0,0
173893,March,0,0
173894,and,0,0
173895,25,0,0
173896,May,0,1
173897,2012,0,0
173898,were,0,0
173899,randomised,0,0
173900,to,0,0
173901,receive,0,0
173902,a,0,0
173903,chocolate,1,1
173904,frog,1,1
173905,versus,1,1
173906,no,1,0
173907,chocolate,1,1
173908,frog,1,0
173909,.,1,0
173910,Both,0,0
173911,groups,0,0
173912,received,0,0
173913,a,0,0
173914,written,1,1
173915,reminder,1,1
173916,and,0,0
173917,replacement,0,1
173918,survey,0,0
173919,2,0,0
173920,weeks,0,0
173921,after,0,0
173922,the,0,0
173923,survey,0,0
173924,was,0,0
173925,posted,0,1
173926,and,0,0
173927,up,0,0
173928,to,0,0
173929,two,0,0
173930,telephone,0,1
173931,reminders,0,1
173932,thereafter,0,0
173933,.,0,0
173934,We,0,0
173935,analysed,0,0
173936,the,0,0
173937,effect,0,0
173938,of,0,0
173939,the,0,0
173940,incentive,0,1
173941,using,0,0
173942,?,0,0
173943,(,0,0
173944,2,0,0
173945,),0,0
173946,tests,0,0
173947,for,0,0
173948,the,0,0
173949,categorical,0,0
173950,response,0,0
173951,variable,0,0
173952,and,0,0
173953,t-tests,0,0
173954,for,0,0
173955,the,0,0
173956,continuous,0,1
173957,reminder,0,1
173958,and,0,0
173959,length,0,1
173960,of,0,0
173961,response,0,0
173962,variables,0,0
173963,at,0,0
173964,the,0,0
173965,end,0,0
173966,of,0,0
173967,(,0,1
173968,i,0,0
173969,),0,1
173970,randomisation,0,1
173971,and,0,1
173972,(,0,1
173973,ii,0,1
173974,),0,1
173975,the,0,0
173976,study,0,0
173977,(,0,0
173978,1,0,0
173979,November,0,0
173980,2012,0,0
173981,),0,0
173982,.,0,0
173983,A,0,0
173984,total,0,0
173985,of,0,0
173986,137,0,0
173987,families,0,0
173988,were,0,0
173989,randomised,0,0
173990,in,0,0
173991,the,0,0
173992,6-week,0,0
173993,period,0,0
173994,.,0,0
173995,Parents,0,0
173996,who,0,0
173997,received,0,0
173998,an,0,0
173999,incentive,0,1
174000,were,0,0
174001,more,0,0
174002,likely,0,0
174003,to,0,0
174004,return,0,0
174005,a,0,0
174006,completed,0,0
174007,survey,0,0
174008,in,0,0
174009,the,0,0
174010,6,0,0
174011,weeks,0,0
174012,than,0,0
174013,those,0,0
174014,who,0,0
174015,did,0,0
174016,not,0,0
174017,(,0,0
174018,21,0,0
174019,%,0,0
174020,vs.,0,0
174021,6,0,0
174022,%,0,0
174023,",",0,0
174024,P,0,0
174025,=,0,0
174026,0.009,0,0
174027,),0,0
174028,.,0,0
174029,This,0,0
174030,effect,0,0
174031,faded,0,0
174032,by,0,0
174033,the,0,0
174034,end,0,0
174035,of,0,0
174036,the,0,0
174037,study,0,0
174038,(,0,0
174039,53,0,0
174040,%,0,0
174041,vs.,0,0
174042,42,0,0
174043,%,0,0
174044,",",0,0
174045,P,0,0
174046,=,0,0
174047,0.4,0,0
174048,),0,0
174049,.,0,0
174050,There,0,0
174051,were,0,0
174052,no,0,0
174053,differences,0,0
174054,between,0,0
174055,groups,0,0
174056,at,0,0
174057,either,0,0
174058,follow-up,0,0
174059,in,0,0
174060,the,0,0
174061,number,0,0
174062,of,0,0
174063,reminders,0,1
174064,that,0,0
174065,parents,0,0
174066,received,0,0
174067,or,0,0
174068,the,0,0
174069,number,0,0
174070,of,0,0
174071,days,0,0
174072,it,0,0
174073,took,0,0
174074,parents,0,0
174075,to,0,0
174076,return,0,0
174077,the,0,0
174078,survey,0,0
174079,.,0,0
174080,Including,0,0
174081,a,0,0
174082,chocolate-based,1,1
174083,incentive,1,1
174084,does,0,0
174085,not,0,0
174086,significantly,0,0
174087,increase,0,0
174088,response,0,0
174089,rate,0,0
174090,in,0,0
174091,a,0,0
174092,postal,0,1
174093,survey,0,0
174094,over,0,0
174095,and,0,0
174096,above,0,0
174097,standard,0,1
174098,reminder,0,1
174099,techniques,0,1
174100,like,0,0
174101,posting,0,0
174102,follow-up,0,0
174103,survey,0,0
174104,packs,0,1
174105,or,0,1
174106,phoning,0,1
174107,families,0,1
174108,.,0,0
174109,The,0,0
174110,effects,0,0
174111,of,0,0
174112,two,0,0
174113,Chinese,1,0
174114,herbal,1,1
174115,medicinal,1,1
174116,formulae,1,1
174117,vs.,0,0
174118,placebo,1,1
174119,controls,0,0
174120,for,0,0
174121,treatment,0,0
174122,of,0,0
174123,allergic,0,0
174124,rhinitis,0,0
174125,:,0,0
174126,a,0,0
174127,randomised,0,0
174128,controlled,0,0
174129,trial,0,0
174130,.,0,0
174131,BACKGROUND,0,0
174132,Allergic,0,0
174133,rhinitis,0,0
174134,is,0,0
174135,a,0,0
174136,chronic,0,0
174137,illness,0,0
174138,",",0,0
174139,affecting,0,0
174140,10,0,0
174141,to,0,0
174142,40,0,0
174143,%,0,0
174144,of,0,0
174145,the,0,0
174146,worldwide,0,0
174147,population,0,0
174148,.,0,0
174149,Chinese,0,0
174150,herbal,0,1
174151,medicines,0,1
174152,",",0,0
174153,the,0,0
174154,treatment,0,0
174155,of,0,0
174156,allergic,0,0
174157,rhinitis,0,0
174158,",",0,0
174159,adopted,0,0
174160,thousands,0,0
174161,of,0,0
174162,years,0,0
174163,in,0,0
174164,ancient,0,0
174165,China,0,0
174166,",",0,0
174167,has,0,0
174168,recently,0,0
174169,raised,0,0
174170,much,0,0
174171,attention,0,0
174172,among,0,0
174173,researchers,0,0
174174,globally,0,0
174175,.,0,0
174176,This,0,0
174177,study,0,0
174178,evaluates,0,0
174179,the,0,0
174180,effects,0,0
174181,of,0,0
174182,two,0,0
174183,Chinese,1,0
174184,herbal,1,1
174185,formulae,1,1
174186,[,1,0
174187,Cure-allergic-rhinitis,1,1
174188,Syrup,1,0
174189,(,1,1
174190,CS,1,1
174191,),1,1
174192,and,1,0
174193,Yu-ping-feng,1,1
174194,San,1,1
174195,(,1,1
174196,YS,1,1
174197,),1,1
174198,],1,0
174199,in,0,0
174200,treating,0,0
174201,undergraduate,0,0
174202,nursing,0,1
174203,students,0,0
174204,with,0,0
174205,allergic,0,0
174206,rhinitis,0,0
174207,over,0,0
174208,a,0,0
174209,3-month,0,0
174210,follow-up,0,0
174211,",",0,0
174212,when,0,0
174213,compared,0,0
174214,to,0,0
174215,a,0,0
174216,placebo,0,1
174217,control,0,1
174218,group,0,0
174219,.,0,0
174220,METHODS,0,0
174221,A,0,0
174222,double-blind,0,0
174223,",",0,0
174224,randomised,0,0
174225,controlled,0,0
174226,trial,0,0
174227,with,0,0
174228,repeated-measures,0,0
174229,",",0,0
174230,three-parallel-groups,0,0
174231,design,0,0
174232,was,0,0
174233,conducted,0,0
174234,in,0,0
174235,a,0,0
174236,random,0,0
174237,sample,0,0
174238,of,0,0
174239,249,0,0
174240,participants,0,0
174241,recruited,0,0
174242,from,0,0
174243,one,0,0
174244,university,0,0
174245,in,0,0
174246,Hong,0,0
174247,Kong,0,0
174248,.,0,0
174249,After,0,0
174250,baseline,0,0
174251,measurements,0,0
174252,",",0,0
174253,participants,0,0
174254,were,0,0
174255,randomly,0,0
174256,assigned,0,0
174257,to,0,0
174258,CS,1,0
174259,",",1,0
174260,YS,1,1
174261,",",1,0
174262,or,1,1
174263,placebo,1,1
174264,groups,0,0
174265,(,0,0
174266,n=83,0,0
174267,per,0,1
174268,group,0,0
174269,),0,0
174270,.,0,0
174271,The,0,0
174272,main,0,0
174273,outcomes,0,0
174274,",",0,0
174275,including,0,0
174276,symptom,0,0
174277,severity,0,0
174278,",",0,0
174279,quality,0,0
174280,of,0,0
174281,life,0,0
174282,",",0,0
174283,and,0,0
174284,body,0,0
174285,constitution,0,0
174286,",",0,0
174287,were,0,0
174288,measured,0,0
174289,with,0,0
174290,self-administered,0,1
174291,questionnaires,0,0
174292,at,0,0
174293,baseline,0,0
174294,and,0,0
174295,immediately,0,0
174296,",",0,0
174297,1,0,0
174298,and,0,0
174299,3,0,0
174300,months,0,0
174301,after,0,0
174302,the,0,0
174303,4-week,0,0
174304,interventions,0,0
174305,.,0,0
174306,RESULTS,0,0
174307,240,0,0
174308,participants,0,0
174309,completed,0,0
174310,the,0,0
174311,trial,0,0
174312,",",0,0
174313,with,0,0
174314,9,0,0
174315,(,0,0
174316,3.6,0,0
174317,%,0,0
174318,),0,0
174319,drop-outs,0,0
174320,.,0,0
174321,The,0,0
174322,results,0,0
174323,of,0,0
174324,Generalised,0,0
174325,Estimating,0,0
174326,Equations,0,1
174327,test,0,0
174328,followed,0,1
174329,by,0,0
174330,pairwise,0,0
174331,contrasts,0,0
174332,tests,0,0
174333,indicated,0,0
174334,that,0,0
174335,the,0,0
174336,participants,0,0
174337,who,0,0
174338,received,0,0
174339,CS,1,0
174340,showed,0,0
174341,significantly,0,0
174342,greater,0,0
174343,reduction,0,0
174344,of,0,0
174345,symptoms,0,0
174346,(,0,0
174347,mean,0,0
174348,difference,0,0
174349,of,0,0
174350,CS,0,0
174351,vs.,0,0
174352,placebo=26.13-34.55,0,1
174353,",",0,0
174354,P,0,0
174355,<,0,0
174356,0.0005,0,0
174357,),0,0
174358,and,0,0
174359,improvements,0,0
174360,in,0,0
174361,quality,0,0
174362,of,0,0
174363,life,0,0
174364,(,0,0
174365,mean,0,0
174366,difference,0,0
174367,of,0,0
174368,CS,0,0
174369,vs.,0,0
174370,placebo=12.81-16.76,0,0
174371,",",0,0
174372,P,0,0
174373,<,0,0
174374,0.001,0,0
174375,),0,0
174376,",",0,0
174377,and,0,0
174378,body,0,0
174379,constitution,0,0
174380,in,0,0
174381,'Qi-deficiency,0,0
174382,',0,0
174383,",",0,0
174384,'Yang-deficiency,0,0
174385,',0,1
174386,",",0,0
174387,and,0,0
174388,'Inherited,0,0
174389,Special,0,1
174390,',0,1
174391,(,0,0
174392,mean,0,0
174393,difference,0,0
174394,of,0,0
174395,CS,0,0
174396,vs.,0,0
174397,placebo=7.05-8.12,0,0
174398,",",0,0
174399,7.56-8.92,0,0
174400,",",0,0
174401,and,0,0
174402,4.48-8.10,0,0
174403,",",0,0
174404,P=0.01-,0,0
174405,<,0,0
174406,0.0005,0,0
174407,",",0,0
174408,0.001-0.004,0,0
174409,",",0,0
174410,and,0,0
174411,0.01-,0,0
174412,<,0,0
174413,0.0005,0,0
174414,",",0,0
174415,accordingly,0,0
174416,",",0,0
174417,at,0,0
174418,three,0,0
174419,post-tests,0,1
174420,),0,0
174421,.,0,0
174422,The,0,0
174423,participants,0,0
174424,who,0,0
174425,received,0,0
174426,YS,0,1
174427,also,0,0
174428,indicated,0,0
174429,significant,0,0
174430,greater,0,0
174431,improvements,0,0
174432,in,0,0
174433,symptom,0,0
174434,severity,0,0
174435,",",0,0
174436,quality,0,0
174437,of,0,0
174438,life,0,0
174439,",",0,0
174440,and,0,0
174441,a,0,0
174442,few,0,0
174443,patterns,0,0
174444,of,0,0
174445,body,0,0
174446,constitution,0,0
174447,when,0,0
174448,compared,0,0
174449,to,0,0
174450,the,0,0
174451,placebo,0,1
174452,group,0,0
174453,.,0,0
174454,However,0,0
174455,",",0,0
174456,its,0,0
174457,effects,0,0
174458,were,0,0
174459,lesser,0,0
174460,in,0,0
174461,strength,0,0
174462,(,0,0
174463,i.e.,0,0
174464,",",0,0
174465,smaller,0,0
174466,effect,0,0
174467,sizes,0,0
174468,),0,0
174469,",",0,0
174470,varieties,0,0
174471,of,0,0
174472,symptoms,0,0
174473,",",0,0
174474,and,0,0
174475,body,0,0
174476,constitution,0,1
174477,and,0,0
174478,sustainability,0,0
174479,over,0,0
174480,the,0,0
174481,3,0,0
174482,months,0,0
174483,.,0,0
174484,CONCLUSIONS,0,0
174485,The,0,0
174486,herbal,0,1
174487,formula,0,1
174488,CS,0,1
174489,was,0,0
174490,found,0,0
174491,effective,0,0
174492,to,0,0
174493,reduce,0,0
174494,symptoms,0,0
174495,and,0,0
174496,enhance,0,0
174497,quality,0,0
174498,of,0,0
174499,life,0,0
174500,in,0,0
174501,young,0,0
174502,adults,0,0
174503,(,0,0
174504,nursing,0,1
174505,students,0,0
174506,),0,0
174507,with,0,0
174508,allergic,0,0
174509,rhinitis,0,0
174510,in,0,0
174511,'Yang-,0,1
174512,and/or,0,0
174513,Qi-deficiency,0,0
174514,',0,1
174515,body,0,0
174516,constitution,0,0
174517,.,0,0
174518,Further,0,0
174519,controlled,0,0
174520,trials,0,0
174521,of,0,0
174522,its,0,0
174523,effects,0,0
174524,in,0,0
174525,Chinese,0,0
174526,and/or,0,0
174527,Asians,0,0
174528,with,0,0
174529,allergic,0,0
174530,rhinitis,0,0
174531,in,0,0
174532,terms,0,0
174533,of,0,0
174534,socio-demographic,0,0
174535,",",0,0
174536,ethnic,0,0
174537,and,0,0
174538,illness,0,0
174539,characteristics,0,0
174540,and,0,0
174541,a,0,0
174542,longer-term,0,0
174543,follow-up,0,0
174544,are,0,0
174545,recommended,0,0
174546,.,0,0
174547,TRIAL,0,0
174548,REGISTRATION,0,0
174549,The,0,0
174550,trial,0,0
174551,has,0,0
174552,registered,0,0
174553,at,0,0
174554,ClinicalTrials.gov,0,0
174555,with,0,0
174556,an,0,0
174557,ID,0,0
174558,:,0,1
174559,NCT02027194,0,0
174560,(,0,0
174561,3,0,0
174562,January,0,0
174563,2014,0,0
174564,),0,0
174565,.,0,0
174566,Traumatic,0,0
174567,brain,0,0
174568,injury-related,0,1
174569,attention,0,0
174570,deficits,0,0
174571,:,0,0
174572,treatment,0,0
174573,outcomes,0,0
174574,with,0,0
174575,lisdexamfetamine,1,1
174576,dimesylate,1,1
174577,(,1,1
174578,Vyvanse,1,1
174579,),1,0
174580,.,1,0
174581,BACKGROUND,0,0
174582,AND,0,0
174583,OBJECTIVES,0,1
174584,Attention,0,0
174585,deficits,0,0
174586,are,0,0
174587,often,0,0
174588,among,0,0
174589,the,0,0
174590,most,0,0
174591,persistent,0,0
174592,and,0,0
174593,debilitating,0,0
174594,impairments,0,0
174595,resulting,0,0
174596,from,0,0
174597,traumatic,0,0
174598,brain,0,0
174599,injury,0,0
174600,(,0,1
174601,TBI,0,0
174602,),0,0
174603,.,0,0
174604,This,0,0
174605,study,0,0
174606,examined,0,0
174607,the,0,0
174608,effects,0,0
174609,of,0,0
174610,lisdexamfetamine,1,1
174611,dimesylate,1,1
174612,(,1,1
174613,Vyvanse,1,1
174614,),1,1
174615,in,0,0
174616,treating,0,0
174617,attention,0,0
174618,deficits,0,0
174619,due,0,0
174620,to,0,0
174621,moderate-to-severe,0,0
174622,TBI,0,0
174623,.,0,0
174624,It,0,0
174625,was,0,0
174626,the,0,0
174627,first,0,0
174628,study,0,0
174629,of,0,0
174630,lisdexamfetamine,1,1
174631,dimesylate,1,1
174632,with,0,0
174633,this,0,0
174634,population,0,0
174635,and,0,0
174636,",",0,0
174637,in,0,0
174638,fact,0,0
174639,",",0,0
174640,was,0,0
174641,the,0,0
174642,first,0,0
174643,controlled,0,0
174644,trial,0,0
174645,in,0,0
174646,this,0,0
174647,area,0,0
174648,examining,0,0
174649,a,0,0
174650,stimulant,0,1
174651,medication,0,1
174652,option,0,0
174653,other,0,0
174654,than,0,0
174655,methylphenidate,1,1
174656,.,1,0
174657,METHODS,0,0
174658,This,0,0
174659,was,0,0
174660,a,0,0
174661,12-week,0,0
174662,",",0,0
174663,randomized,0,0
174664,",",0,0
174665,double-blind,0,0
174666,",",0,0
174667,placebo-controlled,1,1
174668,",",0,0
174669,cross-over,0,0
174670,trial,0,0
174671,.,0,0
174672,A,0,0
174673,total,0,0
174674,of,0,0
174675,22,0,0
174676,rigorously,0,0
174677,selected,0,0
174678,cases,0,0
174679,were,0,0
174680,enrolled,0,0
174681,",",0,0
174682,13,0,0
174683,of,0,0
174684,whom,0,0
174685,completed,0,0
174686,the,0,0
174687,trial,0,0
174688,.,0,0
174689,They,0,0
174690,were,0,0
174691,16-42,0,0
174692,years,0,0
174693,of,0,0
174694,age,0,0
174695,and,0,0
174696,had,0,0
174697,newly,0,0
174698,acquired,0,0
174699,attention,0,0
174700,deficits,0,0
174701,persisting,0,0
174702,for,0,0
174703,6-34,0,0
174704,months,0,0
174705,post-injury,0,0
174706,.,0,0
174707,They,0,0
174708,were,0,0
174709,assessed,0,0
174710,on,0,0
174711,a,0,0
174712,broad,0,0
174713,range,0,0
174714,of,0,0
174715,neuropsychological,0,0
174716,and,0,0
174717,behavioural,0,1
174718,measures,0,0
174719,at,0,0
174720,baseline,0,0
174721,",",0,0
174722,6-weeks,0,1
174723,and,0,0
174724,at,0,0
174725,12-weeks,0,0
174726,.,0,0
174727,RESULTS,0,0
174728,AND,0,0
174729,CONCLUSIONS,0,1
174730,Positive,0,0
174731,treatment,0,0
174732,effects,0,0
174733,were,0,0
174734,found,0,0
174735,involving,0,0
174736,selective,0,0
174737,measures,0,0
174738,of,0,0
174739,sustained,0,0
174740,attention,0,0
174741,",",0,0
174742,working,0,0
174743,memory,0,0
174744,",",0,0
174745,response,0,0
174746,speed,0,0
174747,stability,0,0
174748,and,0,1
174749,endurance,0,0
174750,and,0,0
174751,in,0,0
174752,aspects,0,0
174753,of,0,0
174754,executive,0,0
174755,functioning,0,0
174756,.,0,0
174757,No,0,0
174758,major,0,0
174759,problems,0,0
174760,with,0,0
174761,safety,0,0
174762,or,0,1
174763,tolerability,0,0
174764,were,0,0
174765,observed,0,0
174766,.,0,0
174767,Some,0,0
174768,moderating,0,0
174769,treatment,0,0
174770,effects,0,0
174771,were,0,0
174772,found,0,0
174773,from,0,0
174774,a,0,0
174775,broad,0,0
174776,range,0,0
174777,of,0,0
174778,pre-treatment,0,0
174779,subject,0,0
174780,characteristics,0,0
174781,and,0,0
174782,injury,0,0
174783,variables,0,0
174784,examined,0,0
174785,.,0,0
174786,Avenues,0,0
174787,for,0,0
174788,further,0,0
174789,research,0,0
174790,and,0,0
174791,treatment,0,0
174792,applications,0,1
174793,in,0,0
174794,this,0,0
174795,area,0,0
174796,are,0,0
174797,discussed,0,0
174798,.,0,0
174799,A,0,0
174800,randomized,0,0
174801,controlled,0,0
174802,study,0,0
174803,of,0,0
174804,a,0,0
174805,social,1,0
174806,skills,1,0
174807,training,1,1
174808,for,0,0
174809,preadolescent,0,0
174810,children,0,0
174811,with,0,0
174812,autism,0,0
174813,spectrum,0,0
174814,disorders,0,0
174815,:,0,0
174816,generalization,0,0
174817,of,0,0
174818,skills,0,0
174819,by,0,0
174820,training,0,1
174821,parents,0,0
174822,and,0,0
174823,teachers,0,0
174824,?,0,0
174825,BACKGROUND,0,0
174826,Social,1,0
174827,skills,1,1
174828,training,1,1
174829,(,1,1
174830,SST,1,1
174831,),1,1
174832,is,0,0
174833,a,0,0
174834,common,0,0
174835,intervention,0,1
174836,for,0,0
174837,children,0,0
174838,with,0,0
174839,autism,0,0
174840,spectrum,0,0
174841,disorders,0,0
174842,(,0,0
174843,ASDs,0,1
174844,),0,1
174845,to,0,0
174846,improve,0,0
174847,their,0,0
174848,social,0,0
174849,and,0,0
174850,communication,0,1
174851,skills,0,1
174852,.,0,0
174853,Despite,0,0
174854,the,0,0
174855,fact,0,0
174856,that,0,0
174857,SSTs,1,0
174858,are,0,0
174859,often,0,0
174860,applied,0,0
174861,in,0,0
174862,clinical,0,0
174863,practice,0,0
174864,",",0,0
174865,the,0,0
174866,evidence,0,0
174867,for,0,0
174868,the,0,0
174869,effectiveness,0,0
174870,of,0,0
174871,these,0,0
174872,trainings,0,1
174873,for,0,0
174874,children,0,0
174875,with,0,0
174876,ASD,0,0
174877,is,0,0
174878,inconclusive,0,0
174879,.,0,0
174880,Moreover,0,0
174881,",",0,0
174882,long,0,0
174883,term,0,1
174884,outcome,0,0
174885,and,0,0
174886,generalization,0,0
174887,of,0,0
174888,learned,0,0
174889,skills,0,0
174890,are,0,0
174891,little,0,0
174892,evaluated,0,0
174893,.,0,0
174894,Additionally,0,0
174895,",",0,0
174896,there,0,0
174897,is,0,0
174898,no,0,0
174899,research,0,0
174900,on,0,0
174901,the,0,0
174902,influence,0,0
174903,of,0,0
174904,involvement,0,0
174905,of,0,0
174906,parents,1,0
174907,and,0,0
174908,teachers,1,0
174909,on,0,0
174910,effectiveness,0,0
174911,of,0,0
174912,SST,1,1
174913,and,0,0
174914,on,0,0
174915,the,0,0
174916,generalization,0,0
174917,of,0,0
174918,learned,0,0
174919,social,0,0
174920,skills,0,0
174921,to,0,0
174922,daily,0,0
174923,life,0,0
174924,.,0,0
174925,We,0,0
174926,expect,0,0
174927,parent,1,1
174928,and,1,0
174929,teacher,1,1
174930,involvement,1,0
174931,in,0,0
174932,SST,1,0
174933,to,0,0
174934,enhance,0,0
174935,treatment,0,1
174936,efficacy,0,0
174937,and,0,0
174938,to,0,0
174939,facilitate,0,0
174940,generalization,0,0
174941,of,0,0
174942,learned,0,0
174943,skills,0,0
174944,to,0,0
174945,daily,0,0
174946,life,0,0
174947,.,0,0
174948,METHOD/DESIGN,0,0
174949,In,0,0
174950,a,0,0
174951,randomized,0,0
174952,controlled,0,0
174953,trial,0,0
174954,(,0,1
174955,RCT,0,0
174956,),0,1
174957,with,0,0
174958,three,0,0
174959,conditions,0,0
174960,",",0,0
174961,120,0,0
174962,participants,0,0
174963,with,0,0
174964,ASD,0,0
174965,at,0,0
174966,the,0,0
174967,end,0,0
174968,of,0,0
174969,primary,0,0
174970,school,0,0
174971,(,0,0
174972,10-12,0,0
174973,years,0,0
174974,of,0,0
174975,calendar,0,0
174976,age,0,0
174977,),0,0
174978,have,0,0
174979,been,0,0
174980,randomized,0,0
174981,to,0,0
174982,SST,1,0
174983,",",1,0
174984,SST-PTI,1,1
174985,(,1,0
174986,SST,1,1
174987,with,1,1
174988,Parent,1,0
174989,&,1,1
174990,Teacher,1,1
174991,Involvement,1,0
174992,),1,0
174993,",",0,0
174994,or,0,1
174995,care-as-usual,1,1
174996,.,1,0
174997,The,0,0
174998,SST,1,0
174999,consists,0,0
175000,of,0,0
175001,18,0,0
175002,group,0,0
175003,sessions,0,1
175004,of,0,0
175005,1.5,0,0
175006,hours,0,0
175007,for,0,0
175008,the,0,0
175009,children,0,0
175010,.,0,0
175011,In,0,0
175012,the,0,0
175013,SST-PTI,1,0
175014,condition,0,0
175015,",",0,0
175016,parents,0,0
175017,additionally,0,0
175018,participate,0,0
175019,in,0,0
175020,8,0,0
175021,parent,0,1
175022,sessions,0,1
175023,and,0,0
175024,parents,0,0
175025,and,0,0
175026,teachers,0,0
175027,are,0,0
175028,actively,0,0
175029,involved,0,0
175030,in,0,0
175031,homework,0,1
175032,assignments,0,0
175033,.,0,0
175034,Assessment,0,0
175035,takes,0,0
175036,place,0,0
175037,at,0,0
175038,three,0,0
175039,moments,0,0
175040,:,0,0
175041,before,0,0
175042,and,0,0
175043,immediately,0,0
175044,after,0,0
175045,the,0,0
175046,intervention,0,1
175047,period,0,0
175048,and,0,0
175049,at,0,0
175050,6,0,0
175051,months,0,0
175052,follow-up,0,0
175053,.,0,0
175054,Primary,0,0
175055,outcome,0,0
175056,is,0,0
175057,socialization,0,0
175058,",",0,0
175059,as,0,0
175060,an,0,0
175061,aspect,0,0
175062,of,0,0
175063,adaptive,0,0
175064,functioning,0,0
175065,.,0,0
175066,Secondary,0,0
175067,outcomes,0,0
175068,focus,0,0
175069,on,0,0
175070,specific,0,0
175071,social,0,0
175072,skills,0,0
175073,children,0,0
175074,learn,0,0
175075,during,0,0
175076,SST,1,1
175077,and,0,0
175078,on,0,0
175079,more,0,0
175080,general,0,0
175081,social,0,0
175082,skills,0,1
175083,pertaining,0,0
175084,to,0,0
175085,home,0,1
175086,and,0,0
175087,community,0,1
175088,settings,0,0
175089,from,0,0
175090,a,0,0
175091,multi-informant,0,0
175092,perspective,0,0
175093,.,0,0
175094,Additionally,0,0
175095,",",0,0
175096,possible,0,0
175097,predictors,0,0
175098,of,0,0
175099,treatment,0,0
175100,outcome,0,0
175101,will,0,0
175102,be,0,0
175103,assessed,0,0
175104,.,0,0
175105,DISCUSSION,0,0
175106,The,0,0
175107,current,0,0
175108,study,0,0
175109,is,0,0
175110,an,0,0
175111,RCT,0,0
175112,study,0,0
175113,evaluating,0,0
175114,SST,1,1
175115,in,0,0
175116,a,0,0
175117,large,0,0
175118,sample,0,0
175119,of,0,0
175120,Dutch,0,1
175121,children,0,0
175122,with,0,0
175123,ASD,0,0
175124,in,0,0
175125,a,0,0
175126,specific,0,0
175127,age,0,0
175128,range,0,0
175129,(,0,0
175130,10-12,0,0
175131,years,0,0
175132,),0,0
175133,.,0,0
175134,Strengths,0,0
175135,of,0,0
175136,the,0,0
175137,study,0,0
175138,are,0,0
175139,the,0,0
175140,use,0,0
175141,of,0,0
175142,one,0,0
175143,manualized,0,1
175144,protocol,0,0
175145,",",0,0
175146,application,0,0
175147,of,0,0
175148,standardized,0,0
175149,and,0,0
175150,internationally,0,0
175151,used,0,0
175152,rating,0,0
175153,instruments,0,0
175154,",",0,0
175155,use,0,0
175156,of,0,0
175157,multiple,0,0
175158,raters,0,0
175159,",",0,0
175160,investigation,0,0
175161,of,0,0
175162,generalization,0,0
175163,of,0,0
175164,learned,0,0
175165,skills,0,0
175166,to,0,0
175167,daily,0,1
175168,life,0,0
175169,",",0,0
175170,and,0,0
175171,the,0,0
175172,evaluation,0,0
175173,of,0,0
175174,efficacy,0,0
175175,in,0,0
175176,the,0,0
175177,longer,0,0
175178,term,0,0
175179,by,0,0
175180,follow-up,0,0
175181,measures,0,0
175182,at,0,0
175183,6,0,0
175184,months,0,0
175185,after,0,0
175186,the,0,0
175187,end,0,0
175188,of,0,0
175189,training,0,1
175190,.,0,0
175191,TRIAL,0,0
175192,REGISTRATION,0,0
175193,NTR2405,0,1
175194,.,0,0
175195,Comparison,0,0
175196,of,0,0
175197,clinical,0,0
175198,effectiveness,0,0
175199,of,0,0
175200,acupuncture,1,1
175201,and,0,0
175202,a,0,0
175203,Western,1,0
175204,drug,1,1
175205,on,0,0
175206,allergic,0,0
175207,rhinitis,0,0
175208,:,0,1
175209,study,0,0
175210,protocol,0,1
175211,for,0,0
175212,a,0,0
175213,randomized,0,0
175214,controlled,0,0
175215,trial,0,0
175216,.,0,0
175217,OBJECTIVE,0,0
175218,To,0,0
175219,compare,0,0
175220,the,0,0
175221,efficacy,0,0
175222,of,0,0
175223,an,0,0
175224,acupuncture,1,1
175225,regimen,1,1
175226,for,0,0
175227,persistent,0,0
175228,allergic,0,0
175229,rhinitis,0,0
175230,(,0,1
175231,PER,0,1
175232,),0,0
175233,",",0,0
175234,aimed,0,0
175235,at,0,0
175236,improving,0,0
175237,a,0,0
175238,patient,0,0
175239,'s,0,0
175240,mind,0,0
175241,or,0,1
175242,Shen,0,0
175243,in,0,0
175244,Traditional,1,0
175245,Chinese,1,0
175246,Medicine,1,1
175247,",",0,0
175248,to,0,0
175249,that,0,0
175250,of,0,0
175251,a,0,0
175252,second-generation,1,0
175253,Hi-receptor,1,0
175254,antagonist,1,1
175255,",",1,0
175256,cetirizine,1,1
175257,hydrochloride,1,1
175258,.,1,0
175259,METHODS,0,0
175260,This,0,0
175261,multicenter,0,0
175262,",",0,0
175263,randomized,0,0
175264,",",0,0
175265,controlled,0,0
175266,clinical,0,0
175267,trial,0,0
175268,on,0,0
175269,PER,0,1
175270,will,0,0
175271,be,0,0
175272,conducted,0,0
175273,at,0,0
175274,three,0,0
175275,institutions,0,0
175276,in,0,0
175277,China,0,0
175278,.,0,0
175279,The,0,0
175280,total,0,0
175281,study,0,0
175282,period,0,0
175283,will,0,0
175284,be,0,0
175285,9,0,0
175286,weeks,0,0
175287,.,0,0
175288,After,0,0
175289,a,0,0
175290,1-week,0,0
175291,preparatory,0,1
175292,screening,0,1
175293,period,0,0
175294,",",0,0
175295,240,0,0
175296,eligible,0,0
175297,participants,0,0
175298,with,0,0
175299,PER,0,1
175300,will,0,0
175301,be,0,0
175302,randomized,0,0
175303,to,0,0
175304,receive,0,1
175305,acupuncture,1,1
175306,or,1,1
175307,pharmacotherapy,1,1
175308,(,0,1
175309,1:1,0,1
175310,),0,0
175311,for,0,0
175312,4,0,0
175313,weeks,0,0
175314,with,0,0
175315,a,0,0
175316,4-week,0,0
175317,follow-up,0,0
175318,.,0,0
175319,The,0,0
175320,primary,0,0
175321,outcome,0,0
175322,will,0,0
175323,be,0,0
175324,changes,0,0
175325,in,0,0
175326,7-day,0,0
175327,average,0,0
175328,total,0,0
175329,nasal,0,1
175330,symptom,0,0
175331,score,0,0
175332,.,0,0
175333,Secondary,0,0
175334,outcome,0,0
175335,measures,0,0
175336,include,0,0
175337,rhinoconjunctivitis,0,0
175338,quality,0,0
175339,of,0,0
175340,life,0,0
175341,questionnaire,0,1
175342,score,0,0
175343,and,0,0
175344,total,0,0
175345,non-nasal,0,0
175346,symptom,0,0
175347,score,0,0
175348,.,0,0
175349,RESULTS,0,0
175350,The,0,0
175351,presence,0,0
175352,and,0,0
175353,seriousness,0,0
175354,of,0,0
175355,psychological,0,0
175356,and,0,0
175357,emotional,0,0
175358,impairments,0,0
175359,should,0,0
175360,be,0,0
175361,considered,0,0
175362,in,0,0
175363,therapeutic,0,0
175364,programs,0,1
175365,for,0,0
175366,allergic,0,0
175367,rhinitis,0,0
175368,.,0,0
175369,No,0,0
175370,clinical,0,0
175371,trial,0,0
175372,for,0,0
175373,treating,0,0
175374,allergic,0,0
175375,rhinitis,0,0
175376,via,0,1
175377,acupuncture,1,1
175378,regulation,0,0
175379,of,0,0
175380,psychological,0,0
175381,and,0,0
175382,emotional,0,0
175383,activities,0,0
175384,has,0,0
175385,been,0,0
175386,reported,0,0
175387,.,0,0
175388,CONCLUSION,0,0
175389,The,0,0
175390,findings,0,0
175391,of,0,0
175392,the,0,0
175393,trial,0,0
175394,will,0,0
175395,allow,0,0
175396,us,0,0
175397,to,0,0
175398,determine,0,0
175399,the,0,0
175400,effects,0,0
175401,of,0,0
175402,the,0,0
175403,mind,1,0
175404,(,1,1
175405,Shen,1,0
175406,),1,1
175407,-regulation,1,0
175408,treatment,1,1
175409,approach,0,1
175410,.,0,0
175411,We,0,0
175412,will,0,0
175413,also,0,0
175414,be,0,0
175415,able,0,0
175416,to,0,0
175417,confirm,0,0
175418,if,0,0
175419,the,0,0
175420,effects,0,0
175421,of,0,0
175422,acupuncture,1,1
175423,are,0,0
175424,equivalent,0,0
175425,to,0,0
175426,those,0,0
175427,of,0,0
175428,the,0,0
175429,conventional,0,1
175430,drug,0,1
175431,cetirizine,1,1
175432,hydrochloride,1,1
175433,.,1,0
175434,Quality,0,0
175435,of,0,0
175436,life,0,0
175437,and,0,0
175438,fatigue,0,0
175439,of,0,0
175440,patients,0,0
175441,with,0,0
175442,spinal,0,0
175443,bone,0,0
175444,metastases,0,0
175445,under,0,0
175446,combined,0,1
175447,treatment,0,0
175448,with,0,0
175449,resistance,1,0
175450,training,1,1
175451,and,1,0
175452,radiation,1,1
175453,therapy-,1,1
175454,a,0,0
175455,randomized,0,0
175456,pilot,0,0
175457,trial,0,0
175458,.,0,0
175459,BACKGROUND,0,0
175460,The,0,0
175461,aim,0,0
175462,of,0,0
175463,this,0,0
175464,trial,0,0
175465,was,0,0
175466,to,0,0
175467,compare,0,0
175468,the,0,0
175469,effects,0,0
175470,of,0,0
175471,resistance,1,0
175472,training,1,1
175473,versus,1,1
175474,passive,1,1
175475,physical,1,1
175476,therapy,1,1
175477,on,0,0
175478,quality,0,0
175479,of,0,0
175480,life,0,0
175481,(,0,1
175482,QoL,0,0
175483,),0,1
175484,",",0,0
175485,fatigue,0,0
175486,",",0,0
175487,and,0,0
175488,emotional,0,0
175489,distress,0,0
175490,outcomes,0,0
175491,during,0,0
175492,radiation,0,1
175493,therapy,0,1
175494,in,0,0
175495,patients,0,0
175496,with,0,0
175497,spinal,0,0
175498,bone,0,0
175499,metastases,0,0
175500,under,0,0
175501,radiotherapy,1,1
175502,(,1,1
175503,RT,1,1
175504,),1,0
175505,.,1,0
175506,METHODS,0,0
175507,In,0,0
175508,this,0,0
175509,randomized,0,0
175510,trial,0,0
175511,",",0,0
175512,60,0,0
175513,patients,0,0
175514,were,0,0
175515,treated,0,0
175516,from,0,0
175517,September,0,0
175518,2011,0,0
175519,until,0,0
175520,March,0,0
175521,2013,0,0
175522,into,0,0
175523,one,0,0
175524,of,0,0
175525,the,0,0
175526,two,0,0
175527,groups,0,0
175528,:,0,0
175529,isometric,1,0
175530,resistance,1,0
175531,training,1,1
175532,or,1,1
175533,physical,1,1
175534,therapy,1,1
175535,with,0,0
175536,thirty,0,0
175537,patients,0,0
175538,in,0,0
175539,each,0,0
175540,group,0,0
175541,during,0,0
175542,RT,1,0
175543,.,1,0
175544,EORTC,0,0
175545,QLQ-BM22,0,0
175546,",",0,0
175547,EORTC,0,0
175548,QLQ-FA13,0,1
175549,",",0,0
175550,and,0,0
175551,FBK-R10,0,1
175552,were,0,0
175553,assessed,0,0
175554,at,0,0
175555,baseline,0,0
175556,",",0,0
175557,three,0,0
175558,months,0,0
175559,",",0,0
175560,and,0,0
175561,six,0,0
175562,months,0,0
175563,after,0,0
175564,RT,1,0
175565,.,1,0
175566,RESULTS,0,0
175567,Psychosocial,0,0
175568,aspects,0,0
175569,in,0,0
175570,resistance,1,0
175571,training,1,1
175572,group,0,1
175573,(,0,0
175574,Arm,0,1
175575,A,0,1
175576,),0,0
175577,were,0,0
175578,significantly,0,0
175579,improved,0,0
175580,after,0,0
175581,three,0,0
175582,(,0,0
175583,p,0,0
175584,=,0,0
175585,0.001,0,0
175586,),0,0
175587,and,0,0
175588,six,0,1
175589,months,0,0
175590,(,0,0
175591,p,0,0
175592,=,0,0
175593,0.010,0,0
175594,),0,0
175595,.,0,0
175596,Other,0,0
175597,rated,0,0
175598,items,0,1
175599,of,0,0
175600,the,0,0
175601,QLQ-BM22,0,1
175602,painful,0,0
175603,site,0,0
175604,",",0,0
175605,and,0,0
175606,pain,0,0
175607,characteristics,0,0
175608,were,0,0
175609,without,0,0
175610,significant,0,0
175611,differences,0,0
175612,.,0,0
175613,Functional,0,0
175614,interference,0,0
175615,showed,0,0
175616,a,0,0
175617,positive,0,0
175618,trend,0,0
175619,after,0,0
175620,six,0,0
175621,months,0,0
175622,(,0,0
175623,p,0,0
175624,=,0,0
175625,0.081,0,0
175626,),0,0
175627,.,0,0
175628,After,0,0
175629,six,0,0
175630,months,0,0
175631,",",0,0
175632,physical,0,1
175633,fatigue,0,0
175634,(,0,0
175635,p,0,0
175636,=,0,0
175637,0.013,0,0
175638,),0,0
175639,",",0,0
175640,and,0,0
175641,interference,0,0
175642,with,0,0
175643,daily,0,1
175644,life,0,0
175645,(,0,0
175646,p,0,0
175647,=,0,0
175648,0.006,0,0
175649,),0,0
175650,according,0,0
175651,to,0,0
175652,the,0,0
175653,QLQ-FA13,0,1
175654,assessment,0,0
175655,improved,0,0
175656,in,0,0
175657,Arm,0,0
175658,A,0,0
175659,significantly,0,0
175660,.,0,0
175661,Emotional,0,0
175662,distress,0,0
175663,was,0,0
175664,in,0,0
175665,Arm,0,0
175666,A,0,0
175667,lower,0,0
175668,after,0,0
175669,six,0,0
175670,months,0,0
175671,(,0,0
175672,p,0,0
175673,=,0,0
175674,0.016,0,0
175675,),0,0
175676,.,0,0
175677,The,0,0
175678,Cohen,0,0
175679,'s,0,0
175680,effect,0,0
175681,size,0,0
175682,confirmed,0,0
175683,the,0,0
175684,clinically,0,0
175685,significant,0,0
175686,improvement,0,0
175687,of,0,0
175688,these,0,0
175689,findings,0,0
175690,.,0,0
175691,CONCLUSIONS,0,0
175692,In,0,0
175693,this,0,0
175694,group,0,0
175695,of,0,0
175696,patients,0,0
175697,we,0,0
175698,were,0,0
175699,able,0,0
175700,to,0,0
175701,show,0,0
175702,that,1,0
175703,guided,1,1
175704,isometric,1,0
175705,resistance,1,0
175706,training,1,1
175707,of,1,0
175708,the,1,0
175709,paravertebral,1,1
175710,muscles,1,1
175711,can,1,0
175712,improve,0,0
175713,functional,0,0
175714,capacity,0,0
175715,",",0,0
175716,reduce,0,0
175717,fatigue,0,0
175718,and,0,0
175719,thereby,0,0
175720,enhance,0,0
175721,QoL,0,0
175722,over,0,0
175723,a,0,0
175724,6-months,0,0
175725,period,0,0
175726,in,0,0
175727,patients,0,0
175728,with,0,0
175729,stable,0,0
175730,spinal,0,0
175731,metastases,0,0
175732,.,0,0
175733,The,0,0
175734,results,0,0
175735,offer,0,0
175736,a,0,0
175737,rationale,0,0
175738,for,0,0
175739,future,0,0
175740,large,0,0
175741,controlled,0,0
175742,investigations,0,0
175743,to,0,0
175744,confirm,0,0
175745,these,0,0
175746,findings,0,0
175747,.,0,0
175748,TRIAL,0,0
175749,REGISTRATION,0,0
175750,Clinical,0,0
175751,trial,0,0
175752,identifier,0,0
175753,NCT01409720,0,0
175754,.,0,0
175755,A,0,0
175756,further,0,0
175757,investigation,0,0
175758,of,0,0
175759,goal-directed,1,1
175760,intention,1,0
175761,understanding,1,0
175762,in,0,0
175763,young,0,0
175764,children,0,0
175765,with,0,0
175766,autism,0,0
175767,spectrum,0,0
175768,disorders,0,0
175769,.,0,0
175770,Findings,0,0
175771,from,0,0
175772,research,0,0
175773,investigating,0,0
175774,goal-directed,1,1
175775,intention,1,0
175776,understanding,1,0
175777,in,0,0
175778,children,0,0
175779,with,0,0
175780,autism,0,0
175781,spectrum,0,0
175782,disorders,0,0
175783,(,0,0
175784,ASD,0,0
175785,),0,1
175786,have,0,0
175787,been,0,0
175788,equivocal,0,0
175789,",",0,0
175790,in,0,0
175791,part,0,0
175792,because,0,0
175793,of,0,0
175794,the,0,0
175795,varying,0,0
175796,methodologies,0,0
175797,used,0,0
175798,across,0,0
175799,studies,0,0
175800,.,0,0
175801,This,0,0
175802,study,0,0
175803,compares,0,0
175804,both,0,0
175805,object-oriented,1,1
175806,and,1,0
175807,social-communicatively,1,0
175808,cued,1,1
175809,goal-directed,1,1
175810,intention,1,0
175811,understanding,1,0
175812,in,0,0
175813,children,0,0
175814,with,0,0
175815,ASD,0,0
175816,and,0,0
175817,typically-developing,0,0
175818,children,0,0
175819,.,0,0
175820,Relative,0,0
175821,to,0,0
175822,matched,0,0
175823,controls,0,0
175824,",",0,0
175825,children,0,0
175826,with,0,0
175827,ASD,0,0
175828,did,0,0
175829,not,0,0
175830,exhibit,0,0
175831,deficits,0,0
175832,in,0,0
175833,object-oriented,1,1
175834,intention,1,0
175835,understanding,1,0
175836,.,1,0
175837,While,0,0
175838,children,0,0
175839,with,0,0
175840,ASD,0,0
175841,also,0,0
175842,demonstrated,0,0
175843,the,0,0
175844,ability,0,0
175845,to,0,0
175846,understand,0,0
175847,intention,0,0
175848,when,0,0
175849,cued,0,0
175850,by,0,0
175851,social-communication,0,0
175852,indicators,0,0
175853,",",0,0
175854,typically-developing,0,0
175855,children,0,0
175856,differentiated,0,0
175857,between,0,0
175858,intentional,0,0
175859,and,0,0
175860,unintentional,0,0
175861,acts,0,0
175862,at,0,0
175863,a,0,0
175864,significantly,0,0
175865,greater,0,0
175866,level,0,0
175867,.,0,0
175868,Group,0,0
175869,differences,0,0
175870,in,0,0
175871,performance,0,0
175872,were,0,0
175873,eliminated,0,0
175874,if,0,0
175875,only,0,0
175876,trials,0,0
175877,in,0,0
175878,which,0,0
175879,children,0,0
175880,attended,0,0
175881,to,0,0
175882,the,0,0
175883,experimenter,0,0
175884,'s,0,0
175885,face,0,0
175886,were,0,0
175887,considered,0,0
175888,.,0,0
175889,Results,0,0
175890,suggest,0,0
175891,that,0,0
175892,children,0,0
175893,with,0,0
175894,ASD,0,0
175895,have,0,0
175896,intact,0,0
175897,object-oriented,0,1
175898,intention,0,0
175899,understanding,0,0
175900,abilities,0,0
175901,",",0,0
175902,and,0,0
175903,are,0,0
175904,able,0,0
175905,to,0,0
175906,use,0,0
175907,social-communicative,0,0
175908,cues,0,0
175909,to,0,0
175910,understand,0,0
175911,intention,0,0
175912,.,0,0
175913,However,0,0
175914,",",0,0
175915,their,0,0
175916,ability,0,0
175917,to,0,0
175918,demonstrate,0,0
175919,social-communicatively,1,0
175920,cued,1,1
175921,intention,1,0
175922,understanding,1,0
175923,is,0,0
175924,limited,0,0
175925,by,0,0
175926,a,0,0
175927,lack,0,0
175928,of,0,0
175929,attention,0,0
175930,to,0,0
175931,relevant,0,0
175932,social-communicative,0,0
175933,information,0,0
175934,.,0,0
175935,TEN,1,1
175936,versus,0,1
175937,TPN,1,1
175938,following,0,0
175939,major,0,0
175940,abdominal,0,0
175941,trauma,0,0
175942,--,0,0
175943,reduced,0,0
175944,septic,0,0
175945,morbidity,0,0
175946,.,0,0
175947,Recent,0,0
175948,animal,0,0
175949,models,0,0
175950,suggest,0,0
175951,that,0,0
175952,enteral,1,1
175953,feeding,1,1
175954,(,1,1
175955,TEN,1,1
175956,),1,1
175957,compared,0,0
175958,to,0,0
175959,parenteral,1,1
175960,nutrition,1,1
175961,(,1,1
175962,TPN,1,1
175963,),1,1
175964,improves,0,0
175965,resistance,0,0
175966,to,0,0
175967,infection,0,0
175968,.,0,0
175969,This,0,0
175970,prospective,0,0
175971,clinical,0,0
175972,trial,0,0
175973,examined,0,0
175974,the,0,0
175975,impact,0,0
175976,of,0,0
175977,early,0,0
175978,TEN,1,1
175979,vs.,0,0
175980,TPN,1,1
175981,in,0,0
175982,the,0,0
175983,critically,0,0
175984,injured,0,0
175985,.,0,0
175986,Seventy-five,0,0
175987,patients,0,0
175988,with,0,0
175989,an,0,0
175990,abdominal,0,0
175991,trauma,0,1
175992,index,0,0
175993,(,0,1
175994,ATI,0,1
175995,),0,0
175996,greater,0,0
175997,than,0,0
175998,15,0,0
175999,and,0,0
176000,less,0,0
176001,than,0,0
176002,40,0,0
176003,were,0,0
176004,randomized,0,0
176005,at,0,0
176006,initial,1,0
176007,laparotomy,1,1
176008,to,0,0
176009,receive,1,0
176010,either,1,1
176011,TEN,1,1
176012,(,1,0
176013,Vivonex,1,1
176014,TEN,1,1
176015,),1,1
176016,or,1,1
176017,TPN,1,1
176018,(,1,1
176019,Freamine,1,1
176020,HBC,1,1
176021,6.9,1,0
176022,%,1,0
176023,and,1,0
176024,Trophamine,1,1
176025,6,1,1
176026,%,1,0
176027,),1,0
176028,;,1,0
176029,both,0,0
176030,regimens,0,1
176031,contained,0,0
176032,2.5,0,0
176033,%,0,0
176034,fat,0,0
176035,",",0,0
176036,33,0,0
176037,%,0,0
176038,branched,0,0
176039,chain,0,0
176040,amino,0,1
176041,acids,0,1
176042,",",0,0
176043,and,0,0
176044,had,0,0
176045,a,0,0
176046,calorie,0,1
176047,to,0,0
176048,nitrogen,0,0
176049,ratio,0,0
176050,of,0,0
176051,150:1,0,1
176052,.,0,0
176053,TEN,1,0
176054,was,0,0
176055,delivered,0,0
176056,via,0,0
176057,a,0,0
176058,needle,0,1
176059,catheter,0,1
176060,jejunostomy,0,1
176061,.,0,0
176062,Nutritional,0,0
176063,support,0,0
176064,was,0,0
176065,initiated,0,0
176066,within,0,0
176067,12,0,0
176068,hours,0,0
176069,postoperatively,0,0
176070,in,0,0
176071,both,0,0
176072,groups,0,0
176073,",",0,0
176074,and,0,0
176075,infused,0,0
176076,at,0,0
176077,a,0,0
176078,rate,0,0
176079,sufficient,0,0
176080,to,0,0
176081,render,0,0
176082,the,0,0
176083,patients,0,0
176084,in,0,0
176085,positive,0,0
176086,nitrogen,0,0
176087,balance,0,0
176088,.,0,0
176089,The,0,0
176090,study,0,0
176091,groups,0,0
176092,(,1,0
176093,TEN,1,1
176094,=,0,0
176095,29,0,0
176096,vs,0,0
176097,TPN,1,1
176098,=,0,0
176099,30,0,0
176100,),0,0
176101,were,0,0
176102,comparable,0,0
176103,in,0,0
176104,age,0,0
176105,",",0,0
176106,injury,0,0
176107,severity,0,0
176108,and,0,0
176109,initial,0,0
176110,metabolic,0,0
176111,stress,0,0
176112,.,0,0
176113,Jejunal,0,0
176114,feeding,0,0
176115,was,0,0
176116,tolerated,0,0
176117,unconditionally,0,0
176118,in,0,0
176119,25,0,0
176120,(,0,0
176121,86,0,0
176122,%,0,0
176123,),0,0
176124,of,0,0
176125,the,0,0
176126,TEN,1,1
176127,group,0,0
176128,.,0,0
176129,Nitrogen,0,0
176130,balance,0,0
176131,remained,0,0
176132,equivalent,0,0
176133,throughout,0,0
176134,the,0,0
176135,study,0,0
176136,period,0,0
176137,",",0,0
176138,at,0,0
176139,day,0,0
176140,5,0,0
176141,TEN,1,1
176142,=,0,0
176143,-0.3,0,0
176144,+/-,0,0
176145,1.0,0,0
176146,vs.,0,0
176147,TPN,1,1
176148,0.1,0,1
176149,+/-,0,0
176150,0.8,0,0
176151,gm/day,0,1
176152,.,0,0
176153,Traditional,0,0
176154,nutritional,0,1
176155,protein,0,1
176156,markers,0,0
176157,(,0,0
176158,albumin,0,1
176159,",",0,0
176160,transferrin,0,0
176161,",",0,0
176162,and,0,0
176163,retinol,0,1
176164,binding,0,0
176165,protein,0,1
176166,),0,0
176167,were,0,0
176168,restored,0,0
176169,better,0,0
176170,in,0,0
176171,the,0,0
176172,TEN,1,1
176173,group,0,0
176174,.,0,0
176175,Infections,0,0
176176,developed,0,0
176177,in,0,0
176178,5,0,0
176179,(,0,0
176180,17,0,0
176181,%,0,0
176182,),0,0
176183,of,0,0
176184,the,0,0
176185,TEN,1,1
176186,patients,0,0
176187,compared,0,0
176188,to,0,0
176189,11,0,0
176190,(,0,0
176191,37,0,0
176192,%,0,0
176193,),0,0
176194,of,0,0
176195,the,0,0
176196,TPN,1,1
176197,group,0,0
176198,.,0,0
176199,The,0,0
176200,incidence,0,0
176201,of,0,0
176202,major,0,0
176203,septic,0,0
176204,morbidity,0,0
176205,was,0,0
176206,3,0,0
176207,%,0,0
176208,(,0,0
176209,1,0,0
176210,=,0,0
176211,abdominal,0,0
176212,abscess,0,0
176213,),0,0
176214,in,0,0
176215,the,0,0
176216,TEN,1,1
176217,group,0,0
176218,contrasted,0,0
176219,to,0,0
176220,20,0,1
176221,%,0,0
176222,(,0,0
176223,2,0,0
176224,=,0,0
176225,abdominal,0,0
176226,abscess,0,0
176227,",",0,0
176228,6,0,0
176229,=,0,0
176230,pneumonia,0,0
176231,),0,0
176232,with,0,0
176233,TPN,1,1
176234,.,1,0
176235,This,0,0
176236,clinical,0,0
176237,study,0,0
176238,demonstrates,0,0
176239,that,0,0
176240,TEN,1,1
176241,is,0,0
176242,well,0,0
176243,tolerated,0,0
176244,in,0,0
176245,the,0,0
176246,severely,0,0
176247,injured,0,0
176248,",",0,0
176249,and,0,0
176250,that,0,0
176251,early,0,0
176252,feeding,0,1
176253,via,0,1
176254,the,0,0
176255,gut,0,0
176256,reduces,0,0
176257,septic,0,0
176258,complications,0,0
176259,in,0,0
176260,the,0,0
176261,stressed,0,0
176262,patient,0,0
176263,.,0,0
176264,[,0,0
176265,Case-controll,0,1
176266,study,0,0
176267,on,0,0
176268,the,0,0
176269,synergistic,0,1
176270,effects,0,0
176271,of,0,0
176272,electroacupuncture,1,1
176273,on,0,0
176274,knee,0,0
176275,osteoarthritis,0,0
176276,after,0,0
176277,arthroscopic,1,1
176278,debridement,1,1
176279,],1,0
176280,.,0,0
176281,OBJECTIVE,0,0
176282,To,0,0
176283,study,0,0
176284,the,0,0
176285,synergistic,0,1
176286,effects,0,0
176287,of,0,0
176288,electroacupuncture,1,1
176289,on,0,0
176290,the,0,0
176291,treatment,0,0
176292,of,0,0
176293,knee,0,0
176294,osteoarthritis,0,0
176295,after,0,0
176296,arthroscopic,1,1
176297,debridement,1,1
176298,.,1,0
176299,METHODS,0,0
176300,From,0,0
176301,May,0,1
176302,2008,0,0
176303,to,0,0
176304,July,0,0
176305,2010,0,0
176306,",",0,0
176307,78,0,0
176308,patients,0,0
176309,with,0,0
176310,knee,0,0
176311,osteoarthritis,0,0
176312,were,0,0
176313,randomly,0,0
176314,divided,0,0
176315,into,0,0
176316,two,0,0
176317,groups,0,0
176318,.,0,0
176319,There,0,0
176320,were,0,0
176321,42,0,0
176322,patients,0,0
176323,in,0,0
176324,the,0,0
176325,experimental,0,0
176326,group,0,0
176327,",",0,0
176328,including,0,0
176329,16,0,0
176330,males,0,0
176331,and,0,0
176332,26,0,0
176333,females,0,0
176334,",",0,0
176335,ranging,0,0
176336,in,0,0
176337,age,0,0
176338,from,0,0
176339,41,0,0
176340,to,0,0
176341,63,0,0
176342,years,0,0
176343,",",0,0
176344,with,0,0
176345,an,0,0
176346,average,0,0
176347,of,0,0
176348,(,0,0
176349,53.62,0,0
176350,+/-,0,0
176351,6.53,0,0
176352,),0,0
176353,years,0,0
176354,;,0,0
176355,the,0,0
176356,disease,0,0
176357,course,0,0
176358,ranged,0,0
176359,from,0,0
176360,8,0,0
176361,to,0,0
176362,24,0,0
176363,months,0,0
176364,",",0,0
176365,with,0,0
176366,an,0,0
176367,average,0,0
176368,of,0,0
176369,(,0,0
176370,10.35,0,0
176371,+/-,0,0
176372,6.42,0,0
176373,),0,0
176374,months,0,0
176375,.,0,0
176376,The,0,0
176377,patients,0,0
176378,were,0,0
176379,treated,0,0
176380,with,0,0
176381,arthroscopic,1,1
176382,debridement,1,1
176383,combined,1,1
176384,with,1,0
176385,electroacupuncture,1,1
176386,after,1,0
176387,operation,1,0
176388,.,1,0
176389,There,0,0
176390,were,0,0
176391,36,0,0
176392,patients,0,0
176393,in,0,0
176394,the,0,0
176395,control,0,1
176396,group,0,0
176397,",",0,0
176398,including,0,0
176399,14,0,0
176400,males,0,0
176401,and,0,0
176402,22,0,0
176403,females,0,0
176404,",",0,0
176405,ranging,0,0
176406,in,0,0
176407,age,0,0
176408,from,0,0
176409,40,0,0
176410,to,0,0
176411,62,0,0
176412,years,0,0
176413,",",0,0
176414,with,0,0
176415,an,0,0
176416,average,0,0
176417,of,0,0
176418,(,0,0
176419,54.34,0,0
176420,+/-,0,0
176421,7.67,0,0
176422,),0,0
176423,years,0,0
176424,;,0,0
176425,the,0,0
176426,disease,0,0
176427,course,0,0
176428,ranged,0,0
176429,from,0,0
176430,6,0,0
176431,to,0,0
176432,25,0,0
176433,months,0,0
176434,",",0,0
176435,with,0,0
176436,an,0,0
176437,average,0,0
176438,of,0,0
176439,(,0,0
176440,11.94,0,0
176441,+/-,0,0
176442,5.13,0,0
176443,),0,0
176444,months,0,0
176445,.,0,0
176446,Those,0,0
176447,patients,0,0
176448,were,0,0
176449,treated,0,0
176450,only,0,0
176451,with,0,0
176452,arthroscopic,1,0
176453,debridment,1,1
176454,.,1,0
176455,All,0,0
176456,the,0,0
176457,patients,0,0
176458,performed,0,0
176459,isometric,1,0
176460,quadriceps,1,1
176461,femoris,1,0
176462,contraction,1,1
176463,exercise,1,1
176464,and,1,0
176465,knee,1,1
176466,flexion,1,0
176467,and,1,0
176468,extension,1,0
176469,activities,1,0
176470,after,1,0
176471,operation,1,0
176472,.,1,0
176473,The,0,0
176474,visual,0,0
176475,analog,0,1
176476,scale,0,0
176477,(,0,1
176478,VAS,0,1
176479,),0,1
176480,score,0,0
176481,and,0,0
176482,Lysholm,0,1
176483,knee,0,1
176484,score,0,0
176485,were,0,0
176486,used,0,0
176487,to,0,0
176488,evaluate,0,0
176489,the,0,0
176490,therapeutic,0,0
176491,effects,0,0
176492,.,0,0
176493,RESULTS,0,0
176494,All,0,0
176495,the,0,0
176496,patients,0,0
176497,were,0,0
176498,followed,0,0
176499,up,0,0
176500,",",0,0
176501,and,0,0
176502,the,0,0
176503,duration,0,0
176504,ranged,0,0
176505,from,0,0
176506,12,0,0
176507,to,0,0
176508,30,0,0
176509,months,0,0
176510,",",0,0
176511,with,0,0
176512,an,0,0
176513,average,0,0
176514,of,0,0
176515,15.6,0,0
176516,months,0,0
176517,.,0,0
176518,At,0,0
176519,the,0,0
176520,final,0,0
176521,follow-up,0,0
176522,",",0,0
176523,VAS,0,1
176524,score,0,0
176525,was,0,0
176526,significantly,0,0
176527,decreased,0,0
176528,",",0,0
176529,and,0,0
176530,the,0,0
176531,Lysholm,0,1
176532,score,0,0
176533,",",0,0
176534,except,0,0
176535,for,0,0
176536,the,0,0
176537,item,0,1
176538,demanding,0,0
176539,for,0,0
176540,support,0,0
176541,",",0,0
176542,significantly,0,0
176543,increased,0,0
176544,",",0,0
176545,compared,0,0
176546,with,0,0
176547,those,0,0
176548,before,0,0
176549,surgery,0,0
176550,respectively,0,0
176551,in,0,0
176552,both,0,0
176553,groups,0,0
176554,.,0,0
176555,There,0,0
176556,was,0,0
176557,significant,0,0
176558,difference,0,0
176559,in,0,0
176560,VAS,0,1
176561,score,0,0
176562,between,0,0
176563,two,0,0
176564,groups,0,0
176565,after,0,0
176566,treatment,0,0
176567,.,0,0
176568,As,0,0
176569,to,0,0
176570,Lysholm,0,0
176571,score,0,0
176572,",",0,0
176573,there,0,0
176574,were,0,0
176575,significant,0,0
176576,differences,0,0
176577,in,0,0
176578,limp,0,0
176579,",",0,0
176580,pain,0,0
176581,",",0,0
176582,swelling,0,0
176583,",",0,0
176584,stair,0,1
176585,activity,0,0
176586,and,0,0
176587,squat,0,1
176588,",",0,0
176589,but,0,0
176590,there,0,0
176591,were,0,0
176592,no,0,0
176593,significant,0,0
176594,differences,0,0
176595,in,0,0
176596,items,0,1
176597,of,0,0
176598,interlocking,0,1
176599,and,0,0
176600,instability,0,0
176601,between,0,0
176602,two,0,0
176603,groups,0,0
176604,after,0,0
176605,treatment,0,0
176606,.,0,0
176607,CONCLUSION,0,0
176608,Electroacupuncture,0,1
176609,can,0,0
176610,effectively,0,0
176611,improve,0,0
176612,the,0,0
176613,clinical,0,0
176614,symptoms,0,0
176615,and,0,0
176616,knee,0,1
176617,joint,0,0
176618,'s,0,0
176619,motor,0,0
176620,function,0,0
176621,of,0,0
176622,knee,0,0
176623,joints,0,0
176624,in,0,0
176625,patients,0,0
176626,with,0,0
176627,knee,0,0
176628,osteoarthritis,0,0
176629,",",0,0
176630,as,0,0
176631,well,0,0
176632,as,0,0
176633,the,0,0
176634,synergistic,0,1
176635,effects,0,0
176636,on,0,0
176637,the,0,0
176638,treatment,0,0
176639,of,0,0
176640,knee,0,0
176641,osteoarthritis,0,0
176642,after,0,0
176643,arthroscopic,0,1
176644,debridement,0,1
176645,",",0,0
176646,leading,0,0
176647,to,0,0
176648,a,0,0
176649,much,0,0
176650,better,0,0
176651,long-term,0,0
176652,therapeutic,0,0
176653,effect,0,0
176654,with,0,0
176655,respect,0,0
176656,of,0,0
176657,improving,0,0
176658,the,0,0
176659,function,0,0
176660,of,0,0
176661,knee,0,0
176662,joint,0,0
176663,.,0,0
176664,This,0,0
176665,therapy,0,1
176666,",",0,0
176667,combined,0,1
176668,with,0,0
176669,traditional,0,1
176670,Chinese,0,0
176671,medicine,0,1
176672,and,0,0
176673,Western,0,0
176674,Medicine,0,1
176675,",",0,0
176676,is,0,0
176677,worth,0,0
176678,of,0,0
176679,clinical,0,0
176680,application,0,0
176681,in,0,0
176682,the,0,0
176683,treatment,0,0
176684,of,0,0
176685,knee,0,0
176686,osteoarthritis,0,0
176687,.,0,0
176688,Reducing,0,0
176689,the,0,0
176690,psychological,0,0
176691,distress,0,0
176692,of,0,0
176693,family,0,0
176694,caregivers,0,0
176695,of,0,0
176696,home,0,1
176697,based,0,0
176698,palliative,0,0
176699,care,0,1
176700,patients,0,0
176701,:,0,0
176702,longer,0,0
176703,term,0,0
176704,effects,0,0
176705,from,0,0
176706,a,0,0
176707,randomised,0,0
176708,controlled,0,0
176709,trial,0,0
176710,.,0,0
176711,BACKGROUND,0,0
176712,Palliative,0,0
176713,care,0,1
176714,incorporates,0,0
176715,comprehensive,0,0
176716,support,0,0
176717,of,0,0
176718,family,0,0
176719,caregivers,0,0
176720,because,0,0
176721,many,0,0
176722,of,0,0
176723,them,0,0
176724,experience,0,0
176725,burden,0,0
176726,and,0,0
176727,distress,0,0
176728,.,0,0
176729,However,0,0
176730,",",0,0
176731,evidence-based,0,0
176732,support,0,0
176733,initiatives,0,0
176734,are,0,0
176735,few,0,0
176736,.,0,0
176737,PURPOSE,0,0
176738,We,0,0
176739,evaluated,0,0
176740,a,0,0
176741,one-to-one,1,1
176742,psychoeducational,1,1
176743,intervention,0,1
176744,aimed,0,0
176745,at,0,0
176746,mitigating,0,0
176747,the,0,0
176748,distress,0,0
176749,of,0,0
176750,caregivers,0,0
176751,of,0,0
176752,patients,0,0
176753,with,0,0
176754,advanced,0,0
176755,cancer,0,0
176756,receiving,0,1
176757,home-based,0,1
176758,palliative,0,0
176759,care,0,1
176760,.,0,0
176761,We,0,0
176762,hypothesised,0,0
176763,that,0,0
176764,caregivers,0,0
176765,would,0,0
176766,report,0,0
176767,decreased,0,0
176768,distress,0,0
176769,as,0,0
176770,assessed,0,0
176771,by,0,0
176772,the,0,0
176773,General,0,0
176774,Health,0,1
176775,Questionnaire,0,1
176776,(,0,1
176777,GHQ,0,0
176778,),0,1
176779,.,0,0
176780,METHOD,0,0
176781,A,0,0
176782,randomised,0,0
176783,controlled,0,0
176784,trial,0,0
176785,comparing,0,0
176786,two,1,0
176787,versions,1,0
176788,of,1,0
176789,the,1,0
176790,delivery,1,0
176791,of,1,0
176792,the,1,0
176793,intervention,1,1
176794,(,1,0
176795,one,1,0
176796,face-to-face,1,1
176797,home,1,1
176798,visit,1,0
176799,plus,1,1
176800,telephone,1,1
176801,calls,1,1
176802,versus,1,0
176803,two,1,0
176804,visits,1,0
176805,),1,0
176806,plus,1,1
176807,standard,1,1
176808,care,1,1
176809,to,1,0
176810,a,1,0
176811,control,1,1
176812,group,1,0
176813,(,1,1
176814,standard,1,1
176815,care,1,1
176816,only,1,0
176817,),1,0
176818,across,0,0
176819,four,0,0
176820,sites,0,0
176821,in,0,0
176822,Australia,0,0
176823,.,0,0
176824,RESULTS,0,0
176825,Recruitment,0,0
176826,to,0,0
176827,the,0,0
176828,one,0,0
176829,visit,0,0
176830,condition,0,0
176831,was,0,0
176832,57,0,0
176833,",",0,0
176834,the,0,0
176835,two,0,0
176836,visit,0,0
176837,condition,0,0
176838,93,0,0
176839,",",0,0
176840,and,0,0
176841,the,0,0
176842,control,0,0
176843,148,0,0
176844,.,0,0
176845,We,0,0
176846,previously,0,0
176847,reported,0,0
176848,non-significant,0,0
176849,changes,0,0
176850,in,0,0
176851,distress,0,0
176852,between,0,0
176853,times,0,0
176854,1,0,0
176855,(,0,0
176856,baseline,0,0
176857,),0,1
176858,and,0,0
176859,2,0,1
176860,(,0,0
176861,1-week,0,1
176862,post-intervention,0,0
176863,),0,1
176864,but,0,0
176865,significant,0,0
176866,gains,0,0
176867,in,0,0
176868,competence,0,0
176869,and,0,0
176870,preparedness,0,0
176871,.,0,0
176872,We,0,0
176873,report,0,0
176874,here,0,0
176875,changes,0,0
176876,in,0,0
176877,distress,0,0
176878,between,0,0
176879,times,0,0
176880,1,0,0
176881,and,0,0
176882,3,0,0
176883,(,0,0
176884,8-week,0,1
176885,post-death,0,0
176886,),0,0
176887,.,0,0
176888,There,0,0
176889,was,0,0
176890,significantly,0,0
176891,less,0,0
176892,worsening,0,0
176893,in,0,0
176894,distress,0,0
176895,between,0,0
176896,times,0,0
176897,1,0,0
176898,and,0,0
176899,3,0,0
176900,in,0,0
176901,the,0,0
176902,one,0,0
176903,visit,0,0
176904,intervention,0,1
176905,group,0,0
176906,than,0,0
176907,in,0,0
176908,the,0,0
176909,control,0,1
176910,group,0,0
176911,;,0,0
176912,however,0,0
176913,",",0,0
176914,no,0,0
176915,significant,0,0
176916,difference,0,0
176917,was,0,0
176918,found,0,0
176919,between,0,0
176920,the,0,0
176921,two,0,0
176922,visit,0,0
176923,intervention,0,1
176924,and,0,0
176925,the,0,0
176926,control,0,1
176927,group,0,0
176928,.,0,0
176929,CONCLUSIONS,0,0
176930,These,0,0
176931,results,0,0
176932,are,0,0
176933,consistent,0,0
176934,with,0,0
176935,the,0,0
176936,aim,0,0
176937,of,0,0
176938,the,0,0
176939,intervention,0,1
176940,",",0,0
176941,and,0,0
176942,they,0,0
176943,support,0,1
176944,existing,0,1
176945,evidence,0,0
176946,demonstrating,0,0
176947,that,0,0
176948,relatively,0,0
176949,short,0,0
176950,psychoeducational,0,1
176951,interventions,0,1
176952,can,0,0
176953,help,0,0
176954,family,0,0
176955,caregivers,0,0
176956,who,0,0
176957,are,0,0
176958,supporting,0,0
176959,a,0,0
176960,dying,0,0
176961,relative,0,0
176962,.,0,0
176963,The,0,0
176964,sustained,0,0
176965,benefit,0,0
176966,during,0,0
176967,the,0,0
176968,bereavement,0,0
176969,period,0,0
176970,may,0,0
176971,also,0,0
176972,have,0,0
176973,positive,0,0
176974,resource,0,0
176975,implications,0,0
176976,",",0,0
176977,which,0,0
176978,should,0,0
176979,be,0,0
176980,the,0,0
176981,subject,0,0
176982,of,0,0
176983,future,0,0
176984,inquiry,0,0
176985,.,0,0
176986,Egg,1,1
176987,intake,1,0
176988,during,0,0
176989,carbohydrate,0,1
176990,restriction,0,1
176991,alters,0,0
176992,peripheral,0,0
176993,blood,0,0
176994,mononuclear,0,0
176995,cell,0,0
176996,inflammation,0,0
176997,and,0,0
176998,cholesterol,0,0
176999,homeostasis,0,0
177000,in,0,0
177001,metabolic,0,0
177002,syndrome,0,0
177003,.,0,0
177004,Egg,0,1
177005,yolk,0,0
177006,contains,0,0
177007,bioactive,0,0
177008,components,0,0
177009,that,0,0
177010,improve,0,0
177011,plasma,0,0
177012,inflammatory,0,0
177013,markers,0,0
177014,and,0,0
177015,HDL,0,0
177016,profiles,0,0
177017,in,0,0
177018,metabolic,0,0
177019,syndrome,0,0
177020,(,0,1
177021,MetS,0,0
177022,),0,1
177023,under,0,0
177024,carbohydrate,0,1
177025,restriction,0,1
177026,.,0,0
177027,We,0,0
177028,further,0,0
177029,sought,0,0
177030,to,0,0
177031,determine,0,0
177032,whether,0,0
177033,egg,1,0
177034,yolk,1,0
177035,intake,1,0
177036,affects,0,0
177037,peripheral,0,0
177038,blood,0,0
177039,mononuclear,0,0
177040,cell,0,0
177041,(,0,1
177042,PBMC,0,1
177043,),0,1
177044,inflammation,0,0
177045,and,0,1
177046,cholesterol,0,0
177047,homeostasis,0,0
177048,in,0,0
177049,MetS,0,0
177050,",",0,0
177051,as,0,0
177052,HDL,0,1
177053,and,0,0
177054,its,0,0
177055,associated,0,0
177056,lipid,0,0
177057,transporter,0,0
177058,ATP-binding,0,0
177059,cassette,0,1
177060,transporter,0,0
177061,A1,0,1
177062,(,0,1
177063,ABCA1,0,0
177064,),0,1
177065,reduce,0,0
177066,the,0,0
177067,inflammatory,0,0
177068,potential,0,0
177069,of,0,0
177070,leukocytes,0,0
177071,through,0,0
177072,modulation,0,0
177073,of,0,0
177074,cellular,0,0
177075,cholesterol,0,1
177076,content,0,1
177077,and,0,0
177078,distribution,0,0
177079,.,0,0
177080,Thirty-seven,0,0
177081,men,0,0
177082,and,0,0
177083,women,0,0
177084,classified,0,0
177085,with,0,0
177086,MetS,0,0
177087,consumed,0,0
177088,a,0,0
177089,moderate,1,0
177090,carbohydrate-restricted,1,1
177091,diet,1,1
177092,(,0,0
177093,25,0,0
177094,%,0,0
177095,-30,0,1
177096,%,0,0
177097,of,0,0
177098,energy,0,0
177099,),0,0
177100,for,0,0
177101,12,0,0
177102,weeks,0,0
177103,",",0,0
177104,in,0,0
177105,addition,0,0
177106,to,0,0
177107,consuming,0,0
177108,either,1,1
177109,three,1,0
177110,whole,1,0
177111,eggs,1,0
177112,per,1,1
177113,day,1,0
177114,(,1,1
177115,EGG,1,1
177116,),1,1
177117,or,1,1
177118,the,1,0
177119,equivalent,1,0
177120,amount,1,0
177121,of,1,0
177122,yolk-free,1,1
177123,egg,1,1
177124,substitute,1,1
177125,(,1,1
177126,SUB,1,1
177127,),1,0
177128,.,0,0
177129,Interestingly,0,0
177130,",",0,0
177131,lipopolysaccharide-induced,0,0
177132,PBMC,0,1
177133,IL-1?,0,1
177134,and,0,0
177135,TNF?,0,0
177136,secretion,0,0
177137,increased,0,0
177138,from,0,0
177139,baseline,0,0
177140,to,0,0
177141,week,0,0
177142,12,0,0
177143,in,0,0
177144,the,0,0
177145,SUB,0,1
177146,group,0,0
177147,only,0,0
177148,",",0,0
177149,despite,0,0
177150,increases,0,0
177151,in,0,0
177152,PBMC,0,0
177153,toll-like,0,1
177154,receptor,0,0
177155,4,0,1
177156,(,0,0
177157,TLR4,0,1
177158,),0,1
177159,mRNA,0,0
177160,expression,0,0
177161,in,0,0
177162,the,0,0
177163,EGG,0,1
177164,group,0,0
177165,.,0,0
177166,Compared,0,0
177167,to,0,0
177168,baseline,0,0
177169,",",0,0
177170,ABCA1,0,0
177171,and,0,1
177172,3-hydroxy-3-methyl-glutaryl,0,1
177173,(,0,1
177174,HMG,0,1
177175,),0,1
177176,-CoA,0,0
177177,reductase,0,1
177178,mRNA,0,0
177179,expression,0,0
177180,increased,0,0
177181,by,0,0
177182,week,0,0
177183,12,0,0
177184,in,0,0
177185,the,0,0
177186,EGG,0,1
177187,group,0,0
177188,only,0,0
177189,",",0,0
177190,whereas,0,0
177191,changes,0,0
177192,in,0,0
177193,PBMC,0,0
177194,total,0,0
177195,cholesterol,0,0
177196,positively,0,0
177197,correlated,0,0
177198,with,0,0
177199,changes,0,0
177200,in,0,0
177201,lipid,0,0
177202,raft,0,1
177203,content,0,0
177204,.,0,0
177205,Together,0,0
177206,",",0,0
177207,these,0,0
177208,findings,0,0
177209,suggest,0,0
177210,that,0,0
177211,intake,0,0
177212,of,0,0
177213,whole,0,0
177214,eggs,0,0
177215,during,0,0
177216,carbohydrate,0,1
177217,restriction,0,1
177218,alters,0,0
177219,PBMC,0,0
177220,inflammation,0,0
177221,and,0,0
177222,cholesterol,0,0
177223,homeostasis,0,0
177224,in,0,0
177225,MetS,0,0
177226,.,0,0
177227,Transcervical,1,1
177228,Foley,1,1
177229,'s,1,0
177230,catheter,1,1
177231,versus,0,1
177232,Cook,1,1
177233,balloon,1,1
177234,for,0,0
177235,cervical,0,0
177236,ripening,0,1
177237,in,0,0
177238,stillbirth,0,0
177239,with,0,0
177240,a,0,0
177241,scarred,0,0
177242,uterus,0,0
177243,:,0,0
177244,a,0,0
177245,randomized,0,0
177246,controlled,0,0
177247,trial,0,0
177248,.,0,0
177249,OBJECTIVE,0,0
177250,To,0,0
177251,compare,0,0
177252,the,0,0
177253,efficacy,0,0
177254,and,0,0
177255,safety,0,0
177256,of,0,0
177257,the,0,0
177258,use,0,0
177259,of,0,0
177260,transcervical,1,1
177261,Foley,1,1
177262,'s,1,0
177263,catheter,1,1
177264,versus,0,1
177265,Cook,1,1
177266,cervical,1,1
177267,ripening,1,1
177268,balloon,1,1
177269,in,0,0
177270,pregnant,0,0
177271,women,0,0
177272,with,0,0
177273,stillbirth,0,0
177274,",",0,0
177275,unfavorable,0,0
177276,cervix,0,1
177277,and,0,0
177278,scarred,0,0
177279,uterus,0,0
177280,.,0,0
177281,DESIGN,0,0
177282,Randomized,0,0
177283,controlled,0,0
177284,study,0,0
177285,.,0,0
177286,SETTING,0,0
177287,El,0,1
177288,Minia,0,0
177289,University,0,0
177290,Hospital,0,0
177291,",",0,0
177292,El,0,1
177293,Minia,0,0
177294,",",0,0
177295,Egypt,0,0
177296,.,0,0
177297,PATIENTS,0,0
177298,AND,0,0
177299,METHODS,0,0
177300,Two-hundred,0,0
177301,pregnant,0,0
177302,women,0,0
177303,with,0,0
177304,stillbirth,0,0
177305,",",0,0
177306,unfavorable,0,0
177307,cervix,0,1
177308,and,0,0
177309,scarred,0,0
177310,uterus,0,0
177311,were,0,0
177312,recruited,0,0
177313,into,0,0
177314,this,0,0
177315,study,0,0
177316,.,0,0
177317,They,0,0
177318,were,0,0
177319,randomized,0,0
177320,into,0,0
177321,two,0,0
177322,groups,0,0
177323,.,0,0
177324,In,0,0
177325,group,0,0
177326,I,0,0
177327,(,0,0
177328,n,0,0
177329,=,0,0
177330,100,0,0
177331,),0,0
177332,",",0,0
177333,cervical,0,1
177334,ripening,0,0
177335,was,0,0
177336,done,0,0
177337,using,0,0
177338,Foley,1,1
177339,'s,1,0
177340,catheter,1,1
177341,.,1,0
177342,In,0,0
177343,group,0,0
177344,II,0,1
177345,(,0,0
177346,n,0,0
177347,=,0,0
177348,100,0,0
177349,),0,0
177350,",",0,0
177351,cervical,0,1
177352,ripening,0,0
177353,was,0,0
177354,done,0,0
177355,using,0,0
177356,Cook,1,0
177357,cervical,1,1
177358,ripening,1,1
177359,balloon,1,1
177360,.,1,0
177361,MAIN,0,0
177362,OUTCOME,0,0
177363,MEASURES,0,0
177364,Balloon,0,1
177365,insertion,0,1
177366,to,0,0
177367,delivery,0,0
177368,interval,0,0
177369,",",0,0
177370,successful,0,0
177371,ripening,0,1
177372,rate,0,0
177373,",",0,0
177374,cesarean,0,0
177375,delivery,0,0
177376,rate,0,0
177377,",",0,0
177378,maternal,0,0
177379,adverse,0,0
177380,events,0,0
177381,and,0,0
177382,maternal,0,0
177383,satisfaction,0,0
177384,.,0,0
177385,RESULTS,0,0
177386,Time,0,1
177387,from,0,0
177388,balloon,0,1
177389,insertion,0,1
177390,to,0,0
177391,expulsion,0,0
177392,and,0,0
177393,from,0,0
177394,balloon,0,1
177395,insertion,0,1
177396,to,0,0
177397,delivery,0,0
177398,was,0,0
177399,significantly,0,0
177400,shorter,0,0
177401,in,0,0
177402,Foley,0,1
177403,'s,0,0
177404,catheter,0,1
177405,group,0,0
177406,.,0,0
177407,However,0,0
177408,",",0,0
177409,the,0,0
177410,difference,0,0
177411,between,0,0
177412,the,0,0
177413,two,0,0
177414,groups,0,0
177415,regarding,0,0
177416,time,0,0
177417,from,0,0
177418,balloon,0,1
177419,insertion,0,1
177420,to,0,0
177421,active,0,1
177422,labor,0,0
177423,",",0,0
177424,time,0,0
177425,from,0,0
177426,balloon,0,1
177427,expulsion,0,0
177428,to,0,0
177429,delivery,0,0
177430,",",0,0
177431,cervical,0,0
177432,ripening,0,0
177433,",",0,0
177434,cesarean,0,0
177435,section,0,0
177436,",",0,0
177437,instrumental,0,0
177438,delivery,0,0
177439,",",0,0
177440,pain,0,0
177441,score,0,0
177442,",",0,0
177443,need,0,0
177444,for,0,0
177445,analgesia,0,0
177446,",",0,0
177447,hospital,0,0
177448,stay,0,0
177449,and,0,0
177450,maternal,0,0
177451,satisfaction,0,0
177452,was,0,0
177453,not,0,0
177454,statistically,0,0
177455,significant,0,0
177456,.,0,0
177457,CONCLUSIONS,0,0
177458,Foley,1,1
177459,'s,1,0
177460,catheter,1,1
177461,and,0,0
177462,Cook,1,1
177463,cervical,1,1
177464,ripening,0,1
177465,balloon,0,1
177466,are,0,0
177467,comparable,0,0
177468,regarding,0,0
177469,efficacy,0,0
177470,and,0,1
177471,safety,0,0
177472,profile,0,0
177473,when,0,0
177474,used,0,0
177475,to,0,0
177476,ripen,0,1
177477,the,0,0
177478,cervix,0,0
177479,in,0,0
177480,pregnant,0,0
177481,women,0,0
177482,with,0,0
177483,stillbirth,0,0
177484,",",0,0
177485,unfavorable,0,0
177486,cervix,0,1
177487,and,0,0
177488,scarred,0,0
177489,uterus,0,0
177490,.,0,0
177491,However,0,0
177492,",",0,0
177493,Foley,0,1
177494,'s,0,0
177495,catheter,0,1
177496,has,0,0
177497,a,0,0
177498,shorter,0,0
177499,induction,0,0
177500,to,0,0
177501,delivery,0,1
177502,interval,0,0
177503,and,0,0
177504,is,0,0
177505,relatively,0,0
177506,cheaper,0,0
177507,device,0,1
177508,.,0,0
177509,Physical,1,0
177510,and,1,0
177511,perceptual,1,0
177512,cooling,1,1
177513,with,1,0
177514,beverages,1,1
177515,to,0,0
177516,increase,0,0
177517,cycle,0,0
177518,performance,0,0
177519,in,0,0
177520,a,0,0
177521,tropical,0,0
177522,climate,0,0
177523,.,0,0
177524,PURPOSE,0,0
177525,This,0,0
177526,study,0,0
177527,compares,0,0
177528,the,0,0
177529,effects,0,0
177530,of,0,0
177531,neutral,1,1
177532,temperature,1,0
177533,",",1,0
177534,cold,1,1
177535,and,1,0
177536,ice-slush,1,1
177537,beverages,1,1
177538,",",1,0
177539,with,1,0
177540,and,1,0
177541,without,1,0
177542,0.5,1,1
177543,%,1,0
177544,menthol,1,1
177545,on,0,0
177546,cycling,0,0
177547,performance,0,0
177548,",",0,0
177549,core,0,0
177550,temperature,0,0
177551,(,0,1
177552,Tco,0,1
177553,),0,1
177554,and,0,0
177555,stress,0,0
177556,responses,0,0
177557,in,0,0
177558,a,0,0
177559,tropical,0,1
177560,climate,0,0
177561,(,0,1
177562,hot,0,1
177563,and,0,0
177564,humid,0,0
177565,conditions,0,0
177566,),0,0
177567,.,0,0
177568,METHODS,0,0
177569,Twelve,0,0
177570,trained,0,1
177571,male,0,0
177572,cyclists/triathletes,0,0
177573,completed,0,0
177574,six,1,0
177575,20-km,1,1
177576,exercise,1,1
177577,trials,1,0
177578,against,1,0
177579,the,1,0
177580,clock,1,0
177581,in,1,0
177582,30.7?C?0.8?C,1,0
177583,and,1,0
177584,78,1,0
177585,%,1,0
177586,?0.03,1,0
177587,%,1,0
177588,relative,1,0
177589,humidity,1,0
177590,.,1,0
177591,Before,1,0
177592,and,0,0
177593,after,0,0
177594,warm-up,0,1
177595,",",0,0
177596,and,0,0
177597,before,0,0
177598,exercise,0,1
177599,and,0,0
177600,every,0,1
177601,5,0,1
177602,km,0,0
177603,during,0,0
177604,exercise,0,1
177605,",",0,0
177606,athletes,0,0
177607,drank,0,0
177608,190,0,0
177609,mL,0,0
177610,of,0,0
177611,either,1,1
177612,aromatized,1,1
177613,(,1,0
177614,i.e.,1,0
177615,",",0,0
177616,with,0,0
177617,0.5,0,0
177618,mL,0,0
177619,of,1,0
177620,menthol,1,1
177621,(,1,0
177622,5,1,1
177623,gr/L,0,1
177624,),0,1
177625,),0,1
177626,or,0,1
177627,a,0,0
177628,non-aromatized,1,1
177629,beverage,1,1
177630,(,1,1
177631,neutral,1,1
177632,temperature,1,0
177633,:,1,0
177634,23?C?0.1?C,1,0
177635,",",1,0
177636,cold,1,0
177637,:,1,0
177638,3?C?0.1?C,1,0
177639,",",1,0
177640,or,1,1
177641,ice-slush,1,1
177642,:,1,1
177643,-1?C?0.7?C,1,0
177644,),1,0
177645,.,1,0
177646,During,1,0
177647,the,1,0
177648,trials,0,0
177649,",",0,0
177650,heart,0,0
177651,rate,0,0
177652,(,0,1
177653,HR,0,0
177654,),0,1
177655,was,0,0
177656,continuously,0,0
177657,monitored,0,0
177658,",",0,0
177659,whereas,0,0
177660,core,0,0
177661,temperature,0,0
177662,(,0,1
177663,Tco,0,1
177664,),0,1
177665,",",0,0
177666,thermal,0,1
177667,comfort,0,0
177668,(,0,1
177669,TC,0,1
177670,),0,1
177671,",",0,0
177672,thermal,0,1
177673,sensation,0,0
177674,(,0,1
177675,TS,0,0
177676,),0,1
177677,and,0,0
177678,rate,0,0
177679,of,0,0
177680,perceived,0,0
177681,exertion,0,0
177682,(,0,1
177683,RPE,0,1
177684,),0,1
177685,were,0,0
177686,measured,0,0
177687,before,0,0
177688,and,0,0
177689,after,0,0
177690,warm-up,0,1
177691,",",0,0
177692,every,0,1
177693,5,0,0
177694,km,0,0
177695,of,0,0
177696,exercise,0,1
177697,",",0,0
177698,and,0,0
177699,at,0,0
177700,the,0,0
177701,end,0,0
177702,of,0,0
177703,exercise,0,1
177704,and,0,0
177705,after,0,0
177706,recovery,0,0
177707,.,0,0
177708,RESULTS,0,0
177709,Both,0,1
177710,the,1,0
177711,beverage,1,1
177712,aroma,1,1
177713,(,1,0
177714,P,1,0
177715,<,1,0
177716,0.02,1,0
177717,),0,0
177718,and,0,0
177719,beverage,1,1
177720,temperature,1,0
177721,(,0,0
177722,P,0,0
177723,<,0,0
177724,0.02,0,0
177725,),0,0
177726,had,0,0
177727,significant,0,0
177728,and,0,0
177729,positive,0,0
177730,effects,0,0
177731,on,0,0
177732,performance,0,0
177733,",",0,0
177734,which,0,0
177735,was,0,0
177736,considerably,0,0
177737,better,1,0
177738,with,1,0
177739,ice-slush,1,1
177740,than,1,0
177741,with,1,0
177742,a,1,0
177743,neutral,1,1
177744,temperature,1,0
177745,beverage,0,1
177746,",",0,0
177747,whatever,0,0
177748,the,0,0
177749,aroma,1,1
177750,(,1,0
177751,P,1,0
177752,<,0,0
177753,0.002,0,0
177754,),0,0
177755,",",0,0
177756,and,1,0
177757,with,1,0
177758,menthol,1,1
177759,vs,1,0
177760,non-menthol,1,1
177761,(,0,0
177762,P,0,0
177763,<,0,0
177764,0.02,0,0
177765,),0,0
177766,.,0,0
177767,The,0,0
177768,best,0,0
177769,performances,0,0
177770,were,0,0
177771,obtained,0,0
177772,with,0,0
177773,ice-slush/menthol,1,1
177774,and,1,0
177775,cold/menthol,1,1
177776,",",0,0
177777,as,0,0
177778,opposed,0,0
177779,to,0,0
177780,neutral/menthol,1,1
177781,.,1,0
177782,No,1,0
177783,differences,1,0
177784,were,0,0
177785,noted,0,0
177786,in,0,0
177787,HR,0,0
177788,and,0,0
177789,Tco,0,0
177790,between,0,0
177791,trials,0,0
177792,.,0,0
177793,CONCLUSION,1,0
177794,Cold,1,0
177795,water,1,1
177796,or,1,1
177797,ice-slush,1,1
177798,with,1,1
177799,menthol,1,1
177800,aroma,1,1
177801,seems,1,0
177802,to,0,0
177803,be,0,0
177804,the,0,0
177805,most,0,0
177806,effective,0,0
177807,beverage,0,1
177808,for,0,0
177809,endurance,0,0
177810,exercise,0,1
177811,in,0,0
177812,a,0,0
177813,tropical,0,0
177814,climate,0,0
177815,.,0,0
177816,Further,0,0
177817,studies,0,0
177818,are,0,0
177819,needed,0,0
177820,to,0,0
177821,explore,0,0
177822,its,0,0
177823,effects,0,0
177824,in,0,0
177825,field,0,0
177826,competition,0,0
177827,.,0,0
177828,The,0,0
177829,Impact,0,0
177830,of,0,0
177831,Pupillary,1,0
177832,Dilation,1,0
177833,on,0,0
177834,Intraocular,0,1
177835,Pressure,0,1
177836,and,0,0
177837,Anterior,0,1
177838,Segment,0,0
177839,Morphology,0,1
177840,in,0,0
177841,Subjects,0,0
177842,with,0,0
177843,and,0,0
177844,without,0,0
177845,Pseudoexfoliation,0,1
177846,.,0,0
177847,PURPOSE,0,0
177848,To,0,0
177849,investigate,0,0
177850,the,0,0
177851,change,0,0
177852,in,0,0
177853,pre-,0,0
177854,and,0,0
177855,post-dilation,0,1
177856,anterior,0,1
177857,segment,0,0
177858,parameters,0,0
177859,and,0,0
177860,intraocular,0,1
177861,pressure,0,0
177862,(,0,1
177863,IOP,0,1
177864,),0,1
177865,of,0,0
177866,patients,0,0
177867,with,0,0
177868,and,0,0
177869,without,0,1
177870,pseudoexfoliation,0,1
177871,",",0,0
177872,after,0,0
177873,topical,1,1
177874,application,1,1
177875,of,1,0
177876,phenylephrine,1,1
177877,HCl,1,1
177878,10,1,1
177879,%,1,0
177880,and,1,0
177881,tropicamide,1,1
177882,1,1,0
177883,%,1,0
177884,.,1,0
177885,MATERIALS,0,0
177886,AND,0,0
177887,METHODS,0,0
177888,Totally,0,0
177889,129,0,0
177890,eyes,0,0
177891,of,0,0
177892,129,0,0
177893,patients,0,0
177894,were,0,0
177895,included,0,0
177896,in,0,0
177897,the,0,0
177898,study,0,0
177899,.,0,0
177900,Of,0,0
177901,the,0,0
177902,129,0,0
177903,eyes,0,0
177904,;,0,0
177905,31,0,0
177906,had,0,0
177907,pseudoexfoliation,0,1
177908,syndrome,0,0
177909,(,0,1
177910,PXS,0,0
177911,),0,0
177912,",",0,0
177913,37,0,0
177914,had,0,0
177915,pseudoexfoliation,0,1
177916,glaucoma,0,1
177917,(,0,1
177918,PXG,0,0
177919,),0,0
177920,",",0,0
177921,31,0,0
177922,eyes,0,0
177923,were,0,0
177924,the,0,0
177925,fellow,0,0
177926,eyes,0,0
177927,of,0,0
177928,subjects,0,0
177929,with,0,0
177930,unilateral,0,0
177931,pseudoexfoliation,0,1
177932,syndrome,0,0
177933,(,0,0
177934,subclinical,0,0
177935,PXS,0,0
177936,),0,1
177937,and,0,0
177938,30,0,0
177939,eyes,0,0
177940,were,0,0
177941,the,0,0
177942,eyes,0,0
177943,of,0,0
177944,subjects,0,0
177945,without,0,0
177946,PXS,0,0
177947,(,0,1
177948,controls,0,0
177949,),0,0
177950,.,0,0
177951,Patients,0,0
177952,underwent,0,0
177953,Pentacam,0,1
177954,analysis,0,0
177955,and,0,0
177956,IOP,0,1
177957,measurement,0,1
177958,before,0,0
177959,and,0,0
177960,after,0,0
177961,dilation,0,0
177962,.,0,0
177963,The,0,0
177964,changes,0,0
177965,in,0,0
177966,IOP,0,0
177967,",",0,0
177968,anterior,0,0
177969,chamber,0,1
177970,depth,0,0
177971,(,0,1
177972,ACD,0,1
177973,),0,1
177974,",",0,0
177975,anterior,0,1
177976,chamber,0,1
177977,volume,0,0
177978,(,0,1
177979,ACV,0,0
177980,),0,1
177981,",",0,0
177982,anterior,0,1
177983,chamber,0,1
177984,angle,0,0
177985,(,0,1
177986,ACA,0,1
177987,),0,1
177988,",",0,0
177989,central,0,0
177990,corneal,0,0
177991,thickness,0,0
177992,(,0,1
177993,CCT,0,1
177994,),0,1
177995,and,0,0
177996,pupillary,0,0
177997,diameter,0,0
177998,(,0,1
177999,PD,0,1
178000,),0,1
178001,were,0,0
178002,investigated,0,0
178003,30,0,0
178004,min,0,0
178005,after,0,0
178006,the,0,0
178007,application,0,0
178008,of,0,0
178009,mydriatic,1,1
178010,agents,1,0
178011,.,1,0
178012,RESULTS,0,0
178013,The,0,0
178014,mean,0,0
178015,change,0,0
178016,of,0,0
178017,IOP,0,1
178018,in,0,0
178019,eyes,0,0
178020,with,0,0
178021,PXS,0,0
178022,",",0,0
178023,in,0,0
178024,eyes,0,0
178025,with,0,0
178026,PXG,0,0
178027,",",0,0
178028,in,0,0
178029,eyes,0,0
178030,with,0,0
178031,subclinical,0,0
178032,PXS,0,0
178033,and,0,0
178034,eyes,0,0
178035,of,0,0
178036,control,0,0
178037,subjects,0,0
178038,were,0,0
178039,1.45,0,0
178040,?,0,0
178041,2.03,0,0
178042,mmhg,0,0
178043,",",0,0
178044,0.27,0,0
178045,?,0,0
178046,2.25,0,0
178047,mmhg,0,0
178048,",",0,0
178049,-0.35,0,0
178050,?,0,0
178051,1.58,0,0
178052,mmHg,0,0
178053,and,0,0
178054,-1.06,0,0
178055,?,0,0
178056,1.59mmHg,0,0
178057,",",0,0
178058,respectively,0,0
178059,.,0,0
178060,Post-dilation,0,0
178061,IOP,0,0
178062,values,0,0
178063,were,0,0
178064,lower,0,0
178065,(,0,0
178066,p,0,0
178067,=,0,0
178068,0.001,0,0
178069,),0,0
178070,in,0,0
178071,eyes,0,0
178072,of,0,0
178073,controls,0,0
178074,but,0,0
178075,higher,0,0
178076,(,0,0
178077,p,0,0
178078,<,0,0
178079,0.001,0,0
178080,),0,0
178081,in,0,0
178082,eyes,0,0
178083,of,0,0
178084,PXS,0,0
178085,than,0,0
178086,the,0,0
178087,pre-dilation,0,1
178088,levels,0,0
178089,.,0,0
178090,All,0,0
178091,patients,0,0
178092,exhibited,0,0
178093,statistically,0,0
178094,significant,0,0
178095,increase,0,0
178096,in,0,0
178097,ACD,0,0
178098,",",0,0
178099,ACV,0,0
178100,and,0,0
178101,PD,0,1
178102,after,0,0
178103,the,0,0
178104,dilation,0,1
178105,procedure,0,1
178106,(,0,0
178107,p,0,0
178108,<,0,0
178109,0.001,0,0
178110,),0,0
178111,.,0,0
178112,Additionally,0,0
178113,",",0,0
178114,post,0,0
178115,dilation,0,0
178116,CCT,0,1
178117,values,0,0
178118,were,0,0
178119,significantly,0,0
178120,lower,0,0
178121,than,0,0
178122,pre-dilation,0,0
178123,values,0,0
178124,in,0,0
178125,all,0,0
178126,groups,0,0
178127,;,0,0
178128,the,0,0
178129,difference,0,0
178130,was,0,0
178131,statistically,0,0
178132,significant,0,0
178133,only,0,0
178134,for,0,0
178135,eyes,0,0
178136,with,0,0
178137,PXG,0,0
178138,",",0,0
178139,eyes,0,0
178140,with,0,0
178141,subclinical,0,0
178142,PXS,0,0
178143,and,0,0
178144,eyes,0,0
178145,of,0,0
178146,controls,0,0
178147,.,0,0
178148,CONCLUSION,0,0
178149,Eyes,0,0
178150,with,0,0
178151,PXS,0,0
178152,had,0,0
178153,a,0,0
178154,higher,0,0
178155,tendency,0,0
178156,of,0,0
178157,IOP,0,1
178158,elevation,0,0
178159,after,0,0
178160,pupillary,0,0
178161,dilation,0,0
178162,.,0,0
178163,Eyes,0,0
178164,with,0,0
178165,subclinical,0,0
178166,PXS,0,0
178167,",",0,0
178168,however,0,0
178169,",",0,0
178170,exhibited,0,0
178171,a,0,0
178172,minor,0,0
178173,increase,0,0
178174,in,0,0
178175,IOP,0,1
178176,",",0,0
178177,reflecting,0,0
178178,the,0,0
178179,asymmetrical,0,1
178180,character,0,0
178181,of,0,0
178182,the,0,0
178183,disease,0,0
178184,.,0,0
178185,Anti-glaucoma,1,1
178186,medications,1,0
178187,may,0,0
178188,have,0,0
178189,blunted,0,0
178190,any,0,0
178191,IOP,0,1
178192,elevation,0,0
178193,induced,0,0
178194,by,0,0
178195,pupillary,0,0
178196,dilation,0,0
178197,in,0,0
178198,eyes,0,0
178199,with,0,0
178200,PXG,0,0
178201,.,0,0
178202,Safety,0,1
178203,",",0,0
178204,pharmacokinetics,0,0
178205,",",0,0
178206,pharmacogenomics,0,0
178207,and,0,0
178208,QT,0,0
178209,concentration-effect,0,0
178210,modelling,0,0
178211,of,0,0
178212,the,0,0
178213,SirT1,1,1
178214,inhibitor,1,1
178215,selisistat,1,1
178216,in,0,0
178217,healthy,0,0
178218,volunteers,0,0
178219,.,0,0
178220,AIM,0,0
178221,Selisistat,1,1
178222,(,1,1
178223,SEN0014196,1,1
178224,),1,0
178225,",",1,0
178226,a,1,0
178227,first-in-class,1,0
178228,SirT1,1,1
178229,inhibitor,1,1
178230,",",0,0
178231,is,0,0
178232,being,0,0
178233,developed,0,0
178234,as,0,0
178235,a,0,0
178236,disease-modifying,0,1
178237,therapy,0,1
178238,for,0,0
178239,Huntington,0,0
178240,'s,0,0
178241,disease,0,0
178242,.,0,0
178243,This,0,0
178244,first-in-human,0,0
178245,study,0,0
178246,investigated,0,0
178247,the,0,0
178248,safety,0,0
178249,",",0,0
178250,pharmacokinetics,0,0
178251,and,0,0
178252,pharmacogenomics,0,0
178253,of,0,0
178254,single,0,0
178255,and,0,0
178256,multiple,0,0
178257,doses,0,1
178258,of,0,0
178259,selisistat,1,1
178260,in,0,0
178261,healthy,0,0
178262,male,0,0
178263,and,0,0
178264,female,0,0
178265,subjects,0,0
178266,.,0,0
178267,METHOD,0,0
178268,In,0,0
178269,this,0,0
178270,double-blind,0,0
178271,",",0,0
178272,randomized,0,0
178273,",",0,0
178274,placebo-controlled,1,1
178275,study,0,0
178276,",",0,0
178277,seven,0,0
178278,cohorts,0,0
178279,of,0,0
178280,eight,0,0
178281,subjects,0,0
178282,received,0,0
178283,a,0,0
178284,single,0,0
178285,dose,0,0
178286,of,0,0
178287,selisistat,1,1
178288,at,0,0
178289,dose,0,0
178290,levels,0,0
178291,of,0,0
178292,5,0,0
178293,",",0,0
178294,25,0,0
178295,",",0,0
178296,75,0,0
178297,",",0,0
178298,150,0,0
178299,",",0,0
178300,300,0,1
178301,and,0,0
178302,600,0,0
178303,mg,0,1
178304,and,0,0
178305,four,0,0
178306,cohorts,0,0
178307,of,0,0
178308,eight,0,0
178309,subjects,0,0
178310,were,0,0
178311,administered,0,0
178312,100,0,0
178313,",",0,0
178314,200,0,0
178315,and,0,0
178316,300,0,1
178317,mg,0,1
178318,once,0,1
178319,daily,0,1
178320,for,0,0
178321,7,0,0
178322,days,0,0
178323,.,0,0
178324,Blood,0,0
178325,sampling,0,0
178326,and,0,0
178327,safety,0,0
178328,assessments,0,0
178329,were,0,0
178330,conducted,0,0
178331,throughout,0,0
178332,the,0,0
178333,study,0,0
178334,.,0,0
178335,RESULTS,0,0
178336,Selisistat,1,1
178337,was,0,0
178338,rapidly,0,0
178339,absorbed,0,0
178340,and,0,0
178341,systemic,0,0
178342,exposure,0,0
178343,increased,0,0
178344,in,0,0
178345,proportion,0,0
178346,to,0,0
178347,dose,0,0
178348,in,0,0
178349,the,0,0
178350,5-300,0,1
178351,mg,0,1
178352,range,0,0
178353,.,0,0
178354,Steady-state,0,0
178355,plasma,0,0
178356,concentrations,0,0
178357,were,0,0
178358,achieved,0,0
178359,within,0,0
178360,4,0,0
178361,days,0,0
178362,of,0,0
178363,repeated,0,0
178364,dosing,0,0
178365,.,0,0
178366,The,0,0
178367,incidence,0,0
178368,of,0,0
178369,drug,0,1
178370,related,0,0
178371,adverse,0,0
178372,events,0,0
178373,showed,0,0
178374,no,0,0
178375,correlation,0,0
178376,with,0,0
178377,dose,0,1
178378,level,0,0
178379,or,0,1
178380,number,0,0
178381,of,0,0
178382,doses,0,0
178383,received,0,0
178384,and,0,0
178385,was,0,0
178386,comparable,0,0
178387,with,0,0
178388,the,0,0
178389,placebo,1,1
178390,group,0,0
178391,.,0,0
178392,No,0,0
178393,serious,0,0
178394,adverse,0,0
178395,events,0,0
178396,were,0,0
178397,reported,0,0
178398,and,0,0
178399,no,0,0
178400,subjects,0,0
178401,were,0,0
178402,withdrawn,0,0
178403,due,0,0
178404,to,0,0
178405,adverse,0,0
178406,events,0,0
178407,.,0,0
178408,There,0,0
178409,were,0,0
178410,no,0,0
178411,trends,0,0
178412,in,0,0
178413,clinical,0,0
178414,laboratory,0,0
178415,parameters,0,0
178416,or,0,0
178417,vital,0,0
178418,signs,0,0
178419,.,0,0
178420,No,0,0
178421,trends,0,0
178422,in,0,0
178423,heart,0,0
178424,rate,0,0
178425,or,0,1
178426,ECG,0,1
178427,parameters,0,0
178428,",",0,0
178429,including,0,0
178430,the,0,0
178431,QTc,0,0
178432,interval,0,0
178433,and,0,0
178434,T-wave,0,1
178435,morphology,0,0
178436,",",0,0
178437,were,0,0
178438,observed,0,0
178439,.,0,0
178440,There,0,0
178441,were,0,0
178442,no,0,0
178443,findings,0,0
178444,in,0,0
178445,physical,0,1
178446,or,0,1
178447,neurological,0,0
178448,examinations,0,1
178449,or,0,1
178450,postural,0,0
178451,control,0,1
178452,.,0,0
178453,Transcriptional,0,0
178454,alteration,0,0
178455,was,0,0
178456,observed,0,0
178457,in,0,0
178458,peripheral,0,0
178459,blood,0,0
178460,.,0,0
178461,CONCLUSION,0,0
178462,Selisistat,1,1
178463,was,0,0
178464,safe,0,0
178465,and,0,0
178466,well,0,0
178467,tolerated,0,0
178468,by,0,0
178469,healthy,0,0
178470,male,0,0
178471,and,0,0
178472,female,0,0
178473,subjects,0,0
178474,after,0,0
178475,single,0,0
178476,doses,0,0
178477,up,0,0
178478,to,0,0
178479,600,0,0
178480,mg,0,1
178481,and,0,0
178482,multiple,0,0
178483,doses,0,1
178484,up,0,0
178485,to,0,0
178486,300,0,1
178487,mg,0,1
178488,day,0,0
178489,(,0,1
178490,-1,0,0
178491,),0,0
178492,.,0,0
178493,A,0,0
178494,neuropsychological,1,0
178495,rehabilitation,1,1
178496,program,1,1
178497,for,0,0
178498,patients,0,0
178499,with,0,0
178500,Multiple,0,0
178501,Sclerosis,0,0
178502,based,0,0
178503,on,0,0
178504,the,0,0
178505,model,0,0
178506,of,0,0
178507,the,0,0
178508,ICF,0,0
178509,.,0,0
178510,BACKGROUND,0,0
178511,Forty,0,0
178512,to,0,0
178513,sixty,0,0
178514,percent,0,0
178515,of,0,0
178516,MS,0,0
178517,patients,0,0
178518,suffer,0,0
178519,from,0,0
178520,cognitive,0,0
178521,impairments,0,0
178522,.,0,0
178523,Cognitive,0,0
178524,deficits,0,0
178525,are,0,0
178526,a,0,0
178527,great,0,0
178528,burden,0,0
178529,for,0,0
178530,patients,0,0
178531,affected,0,0
178532,.,0,0
178533,In,0,0
178534,particular,0,0
178535,they,0,0
178536,may,0,0
178537,lead,0,0
178538,to,0,0
178539,a,0,0
178540,reduced,0,0
178541,quality,0,0
178542,of,0,0
178543,life,0,0
178544,",",0,0
178545,loss,0,0
178546,of,0,0
178547,work,0,0
178548,and,0,0
178549,problems,0,0
178550,with,0,0
178551,the,0,0
178552,social,0,0
178553,environment,0,0
178554,.,0,0
178555,OBJECTIVE,0,0
178556,The,0,0
178557,aim,0,0
178558,of,0,0
178559,this,0,0
178560,study,0,0
178561,was,0,0
178562,to,0,0
178563,evaluate,0,0
178564,a,0,0
178565,specific,1,0
178566,neuropsychological,1,0
178567,rehabilitation,1,1
178568,program,1,1
178569,for,0,0
178570,MS,0,0
178571,patients,0,0
178572,according,0,0
178573,to,0,0
178574,the,0,0
178575,ICF,0,0
178576,to,0,0
178577,be,0,0
178578,able,0,0
178579,to,0,0
178580,meet,0,0
178581,more,0,0
178582,properly,0,0
178583,individual,0,0
178584,requirements,0,0
178585,on,0,0
178586,the,0,0
178587,therapy,0,1
178588,level,0,0
178589,of,0,0
178590,function,0,0
178591,as,0,0
178592,well,0,0
178593,as,0,0
178594,of,0,0
178595,activities,0,0
178596,and,0,0
178597,participation,0,0
178598,.,0,0
178599,METHODS,0,0
178600,Forty,0,0
178601,patients,0,0
178602,with,0,0
178603,MS,0,0
178604,were,0,0
178605,randomised,0,0
178606,in,0,0
178607,an,0,0
178608,intervention,1,1
178609,(,1,1
178610,IG,1,0
178611,),1,1
178612,-,1,0
178613,and,1,0
178614,a,1,0
178615,control,1,1
178616,group,1,0
178617,(,1,1
178618,CG,1,0
178619,),1,0
178620,.,0,0
178621,The,0,0
178622,outcome,0,0
178623,measure,0,0
178624,of,0,0
178625,the,0,0
178626,IG,0,0
178627,",",0,0
178628,who,0,0
178629,started,0,0
178630,an,0,0
178631,intensive,1,1
178632,computer,1,1
178633,based,1,0
178634,home,1,1
178635,training,1,1
178636,of,1,0
178637,attention,1,0
178638,and,0,0
178639,attended,0,0
178640,psychological,1,0
178641,counselling,1,1
178642,was,0,0
178643,compared,0,0
178644,to,0,0
178645,the,0,0
178646,untrained,1,0
178647,CG,1,0
178648,.,1,0
178649,RESULTS,0,0
178650,In,0,0
178651,specific,0,0
178652,domains,0,0
178653,of,0,0
178654,attention,0,0
178655,(,0,1
178656,simple,0,1
178657,and,0,0
178658,cued,0,1
178659,alertness,0,0
178660,and,0,0
178661,divided,0,0
178662,attention,0,0
178663,),0,1
178664,significant,0,0
178665,group,0,0
178666,differences,0,0
178667,between,0,0
178668,CG,0,0
178669,and,0,0
178670,IG,0,0
178671,could,0,0
178672,be,0,0
178673,found,0,0
178674,.,0,0
178675,The,0,0
178676,IG,1,0
178677,reported,0,0
178678,an,0,0
178679,improvement,0,0
178680,of,0,0
178681,mental,0,0
178682,fatigue,0,0
178683,and,0,0
178684,retardation,0,0
178685,.,0,0
178686,CONCLUSION,0,0
178687,These,0,0
178688,findings,0,0
178689,support,0,0
178690,the,0,0
178691,idea,0,0
178692,that,0,0
178693,a,0,0
178694,neuropsychological,0,0
178695,rehabilitation,0,1
178696,program,0,1
178697,",",0,0
178698,which,0,0
178699,based,0,0
178700,on,0,0
178701,the,0,0
178702,model,0,0
178703,of,0,0
178704,ICF,0,0
178705,",",0,0
178706,could,0,0
178707,improve,0,0
178708,cognitive,0,0
178709,impairment,0,0
178710,and,0,0
178711,could,0,0
178712,also,0,0
178713,have,0,0
178714,a,0,0
178715,positive,0,0
178716,influence,0,0
178717,of,0,0
178718,activities,0,0
178719,and,0,0
178720,participation,0,0
178721,.,0,0
178722,Fluticasone,1,1
178723,or,0,0
178724,montelukast,1,1
178725,in,0,0
178726,preschool,0,0
178727,wheeze,0,0
178728,:,0,0
178729,a,0,0
178730,randomized,0,0
178731,controlled,0,0
178732,trial,0,0
178733,.,0,0
178734,INTRODUCTION,0,0
178735,Approximately,0,0
178736,30,0,0
178737,%,0,0
178738,of,0,0
178739,children,0,0
178740,younger,0,0
178741,than,0,0
178742,3,0,0
178743,years,0,0
178744,experience,0,0
178745,at,0,0
178746,least,0,0
178747,1,0,0
178748,episode,0,0
178749,of,0,0
178750,wheezing,0,0
178751,.,0,0
178752,Antiasthmatic,1,0
178753,medication,1,1
178754,is,0,0
178755,routinely,0,0
178756,prescribed,0,0
178757,",",0,0
178758,but,0,0
178759,its,0,0
178760,effectiveness,0,0
178761,remains,0,0
178762,unclear,0,0
178763,.,0,0
178764,Our,0,0
178765,study,0,0
178766,was,0,0
178767,aimed,0,0
178768,to,0,0
178769,evaluate,0,0
178770,the,0,0
178771,effect,0,0
178772,of,0,0
178773,anti-inflammatory,1,1
178774,treatment,1,0
178775,on,0,0
178776,frequency,0,0
178777,and,0,0
178778,severity,0,0
178779,of,0,0
178780,preschool,0,0
178781,wheeze,0,0
178782,episodes,0,0
178783,(,0,0
178784,PWEs,0,0
178785,),0,0
178786,.,0,0
178787,METHODS,0,0
178788,Children,0,0
178789,aged,0,0
178790,6,0,0
178791,to,0,0
178792,36,0,0
178793,months,0,0
178794,with,0,0
178795,the,0,0
178796,first,0,0
178797,up,0,0
178798,to,0,0
178799,the,0,0
178800,third,0,0
178801,PWE,0,1
178802,were,0,0
178803,randomly,0,0
178804,assigned,0,0
178805,to,0,0
178806,receive,0,0
178807,montelukast,1,1
178808,",",1,0
178809,fluticasone,1,1
178810,",",1,0
178811,or,1,1
178812,no,1,0
178813,treatment,1,0
178814,for,1,0
178815,12,1,0
178816,weeks,1,0
178817,.,1,0
178818,The,0,0
178819,outcome,0,0
178820,measures,0,0
178821,were,0,0
178822,the,0,0
178823,number,0,0
178824,of,0,0
178825,PWEs,0,0
178826,",",0,0
178827,the,0,0
178828,number,0,0
178829,of,0,0
178830,hospitalizations,0,0
178831,due,0,0
178832,to,0,0
178833,PWE,0,1
178834,",",0,0
178835,and,0,0
178836,the,0,0
178837,severity,0,0
178838,of,0,0
178839,respiratory,0,0
178840,symptoms,0,0
178841,.,0,0
178842,results,0,0
178843,:,0,0
178844,There,0,0
178845,were,0,0
178846,no,0,0
178847,significant,0,0
178848,differences,0,0
178849,in,0,0
178850,outcome,0,0
178851,measures,0,0
178852,between,0,0
178853,the,0,0
178854,groups,0,0
178855,.,0,0
178856,However,0,0
178857,",",0,0
178858,tobacco-exposed,0,0
178859,children,0,0
178860,treated,0,0
178861,with,0,0
178862,fluticasone,1,1
178863,had,0,0
178864,significantly,0,0
178865,fewer,0,0
178866,PWEs,0,0
178867,(,0,0
178868,P,0,0
178869,=,0,0
178870,.01,0,0
178871,),0,0
178872,.,0,0
178873,CONCLUSION,0,0
178874,Neither,0,1
178875,montelukast,1,1
178876,nor,0,0
178877,fluticasone,1,1
178878,has,0,0
178879,proven,0,0
178880,effective,0,0
178881,in,0,0
178882,the,0,0
178883,prevention,0,0
178884,of,0,0
178885,PWE,0,1
178886,recurrence,0,0
178887,.,0,0
178888,Children,0,0
178889,of,0,0
178890,smoking,0,0
178891,parents,0,0
178892,may,0,0
178893,benefit,0,0
178894,from,0,0
178895,fluticasone,1,1
178896,treatment,0,0
178897,after,0,0
178898,PWE,0,1
178899,.,0,0
178900,This,0,0
178901,observation,0,1
178902,requires,0,0
178903,confirmation,0,0
178904,in,0,0
178905,larger,0,0
178906,studies,0,0
178907,.,0,0
178908,The,0,0
178909,REFLO-STEMI,0,0
178910,trial,0,0
178911,comparing,0,0
178912,intracoronary,1,1
178913,adenosine,1,1
178914,",",1,0
178915,sodium,1,1
178916,nitroprusside,1,1
178917,and,1,0
178918,standard,1,1
178919,therapy,1,1
178920,for,0,0
178921,the,0,0
178922,attenuation,0,0
178923,of,0,0
178924,infarct,0,0
178925,size,0,0
178926,and,0,0
178927,microvascular,0,0
178928,obstruction,0,0
178929,during,0,0
178930,primary,0,0
178931,percutaneous,0,1
178932,coronary,0,0
178933,intervention,0,1
178934,:,0,1
178935,study,0,0
178936,protocol,0,1
178937,for,0,0
178938,a,0,0
178939,randomised,0,0
178940,controlled,0,0
178941,trial,0,0
178942,.,0,0
178943,BACKGROUND,0,0
178944,Microvascular,0,1
178945,obstruction,0,0
178946,(,0,1
178947,MVO,0,1
178948,),0,1
178949,secondary,0,0
178950,to,0,0
178951,ischaemic-reperfusion,0,1
178952,injury,0,0
178953,is,0,0
178954,an,0,0
178955,important,0,0
178956,but,0,0
178957,underappreciated,0,0
178958,determinant,0,0
178959,of,0,0
178960,short-,0,0
178961,and,0,0
178962,longer-term,0,0
178963,outcome,0,0
178964,following,0,0
178965,percutaneous,1,1
178966,coronary,1,1
178967,intervention,1,1
178968,(,1,1
178969,PCI,1,1
178970,),1,1
178971,treatment,0,0
178972,of,0,0
178973,ST-elevation,0,0
178974,myocardial,0,0
178975,infarction,0,0
178976,(,0,1
178977,STEMI,0,0
178978,),0,1
178979,.,0,0
178980,Several,0,0
178981,small,0,0
178982,studies,0,0
178983,have,0,0
178984,demonstrated,0,0
178985,a,0,0
178986,reduction,0,0
178987,in,0,0
178988,the,0,0
178989,degree,0,0
178990,of,0,0
178991,MVO,0,1
178992,utilising,0,1
178993,a,0,0
178994,variety,0,0
178995,of,0,0
178996,vasoactive,1,1
178997,agents,1,0
178998,",",1,0
178999,with,1,0
179000,adenosine,1,1
179001,and,1,0
179002,sodium,1,1
179003,nitroprusside,1,1
179004,(,1,1
179005,SNP,1,1
179006,),1,1
179007,being,0,0
179008,most,0,0
179009,evaluated,0,0
179010,.,0,0
179011,However,0,0
179012,",",0,0
179013,the,0,0
179014,evidence,0,0
179015,base,0,0
179016,remains,0,0
179017,weak,0,0
179018,as,0,0
179019,the,0,0
179020,trials,0,0
179021,have,0,0
179022,had,0,0
179023,variable,0,0
179024,endpoints,0,0
179025,",",0,0
179026,differing,0,0
179027,drug,0,1
179028,doses,0,1
179029,and,0,0
179030,delivery,0,0
179031,.,0,0
179032,As,0,0
179033,such,0,0
179034,",",0,0
179035,the,0,0
179036,results,0,0
179037,regarding,0,0
179038,benefit,0,0
179039,are,0,0
179040,conflicting,0,0
179041,.,0,0
179042,METHODS,0,0
179043,The,0,0
179044,REperfusion,0,1
179045,Facilitated,0,0
179046,by,0,0
179047,LOcal,1,1
179048,adjunctive,1,1
179049,therapy,1,1
179050,in,1,0
179051,STEMI,1,0
179052,(,1,1
179053,REFLO-STEMI,1,0
179054,),1,1
179055,trial,0,0
179056,is,0,0
179057,a,0,0
179058,multicentre,0,0
179059,",",0,0
179060,prospective,0,0
179061,",",0,0
179062,randomised,0,0
179063,",",0,0
179064,controlled,0,0
179065,",",0,0
179066,open,0,1
179067,label,0,0
179068,",",0,0
179069,study,0,0
179070,with,0,0
179071,blinded,0,0
179072,endpoint,0,0
179073,analysis,0,0
179074,:,0,0
179075,Patients,0,0
179076,presenting,0,0
179077,within,0,0
179078,6,0,0
179079,h,0,0
179080,of,0,0
179081,onset,0,0
179082,of,0,0
179083,STEMI,0,0
179084,and,0,0
179085,undergoing,0,0
179086,planned,0,0
179087,primary,0,0
179088,PCI,0,1
179089,(,0,1
179090,P-PCI,0,1
179091,),0,1
179092,with,0,0
179093,TIMI,0,1
179094,0/1,0,0
179095,flow,0,0
179096,in,0,0
179097,the,0,0
179098,infarct-related,0,0
179099,artery,0,0
179100,(,0,1
179101,IRA,0,1
179102,),0,1
179103,and,0,0
179104,no,0,0
179105,significant,0,0
179106,bystander,0,1
179107,coronary,0,0
179108,artery,0,0
179109,disease,0,0
179110,on,0,0
179111,angiography,1,1
179112,",",0,0
179113,are,0,0
179114,randomised,0,0
179115,into,0,0
179116,one,0,0
179117,of,0,0
179118,three,0,0
179119,groups,0,0
179120,:,0,0
179121,PCI,0,0
179122,with,0,0
179123,adjunctive,0,1
179124,pharmacotherapy,0,1
179125,(,0,1
179126,intracoronary,0,1
179127,adenosine,0,1
179128,or,0,1
179129,SNP,0,1
179130,),0,1
179131,or,0,1
179132,control,0,1
179133,(,0,1
179134,standard,0,1
179135,PCI,0,1
179136,),0,0
179137,.,0,0
179138,All,0,0
179139,receive,0,0
179140,Bivalirudin,1,1
179141,anticoagulation,1,1
179142,and,1,0
179143,thrombus,1,0
179144,aspiration,1,0
179145,.,1,0
179146,The,0,0
179147,primary,0,0
179148,outcome,0,0
179149,is,0,0
179150,infarct,0,0
179151,size,0,0
179152,(,0,1
179153,IS,0,1
179154,),0,1
179155,(,0,0
179156,determined,0,0
179157,as,0,0
179158,a,0,0
179159,percentage,0,0
179160,of,0,0
179161,total,0,0
179162,left,0,0
179163,ventricular,0,0
179164,mass,0,0
179165,),0,1
179166,measured,0,0
179167,by,0,0
179168,cardiac,0,0
179169,magnetic,0,1
179170,resonance,0,1
179171,imaging,0,1
179172,(,0,1
179173,CMRI,0,1
179174,),0,1
179175,undertaken,0,0
179176,at,0,0
179177,48,0,0
179178,to,0,0
179179,72,0,0
179180,h,0,0
179181,post,0,0
179182,P-PCI,0,0
179183,.,0,0
179184,Secondary,0,0
179185,outcome,0,0
179186,measures,0,0
179187,include,0,0
179188,MVO,0,1
179189,(,0,0
179190,hypoenhancement,0,0
179191,within,0,0
179192,infarct,0,0
179193,core,0,0
179194,),0,0
179195,on,0,0
179196,CMRI,0,1
179197,",",0,0
179198,angiographic,0,0
179199,markers,0,0
179200,of,0,0
179201,microvascular,0,0
179202,perfusion,0,0
179203,and,0,0
179204,MACE,0,1
179205,during,0,0
179206,1-month,0,0
179207,follow-up,0,0
179208,.,0,0
179209,The,0,0
179210,study,0,0
179211,aims,0,0
179212,to,0,0
179213,recruit,0,0
179214,240,0,0
179215,patients,0,0
179216,(,0,0
179217,powered,0,0
179218,at,0,0
179219,80,0,0
179220,%,0,0
179221,to,0,0
179222,detect,0,0
179223,a,0,0
179224,5,0,0
179225,%,0,0
179226,absolute,0,0
179227,reduction,0,0
179228,in,0,0
179229,IS,0,1
179230,),0,0
179231,.,0,0
179232,DISCUSSION,0,0
179233,The,0,0
179234,REFLO-STEMI,0,0
179235,study,0,0
179236,has,0,0
179237,been,0,0
179238,designed,0,0
179239,to,0,0
179240,address,0,0
179241,the,0,0
179242,weaknesses,0,0
179243,of,0,0
179244,previous,0,0
179245,trials,0,0
179246,",",0,0
179247,which,0,0
179248,have,0,0
179249,collectively,0,0
179250,failed,0,0
179251,to,0,0
179252,demonstrate,0,0
179253,whether,0,0
179254,adjunctive,1,1
179255,pharmacotherapy,1,1
179256,with,0,0
179257,adenosine,0,1
179258,and/or,0,0
179259,SNP,0,1
179260,can,0,0
179261,reduce,0,0
179262,measures,0,0
179263,of,0,0
179264,myocardial,0,0
179265,injury,0,0
179266,(,0,1
179267,infarct,0,0
179268,size,0,0
179269,and,0,0
179270,MVO,0,1
179271,),0,1
179272,and,0,0
179273,improve,0,0
179274,clinical,0,0
179275,outcome,0,0
179276,",",0,0
179277,despite,0,0
179278,good,0,0
179279,basic,0,1
179280,evidence,0,0
179281,that,0,0
179282,they,0,0
179283,have,0,0
179284,the,0,0
179285,potential,0,0
179286,to,0,0
179287,attenuate,0,0
179288,this,0,0
179289,process,0,0
179290,.,0,0
179291,The,0,0
179292,REFLO-STEMI,0,0
179293,study,0,0
179294,will,0,0
179295,be,0,0
179296,the,0,0
179297,most,0,0
179298,scientifically,0,0
179299,robust,0,0
179300,trial,0,0
179301,to,0,0
179302,date,0,0
179303,evaluating,0,0
179304,whether,0,0
179305,adjunctive,1,1
179306,therapy,1,1
179307,(,1,1
179308,intracoronary,1,1
179309,adenosine,1,1
179310,or,1,1
179311,SNP,1,1
179312,following,1,0
179313,thrombus,1,0
179314,aspiration,1,1
179315,),1,1
179316,reduces,0,0
179317,CMRI,0,1
179318,measured,0,0
179319,IS,0,1
179320,and,0,0
179321,MVO,0,1
179322,in,0,0
179323,patients,0,0
179324,undergoing,0,0
179325,P-PCI,0,0
179326,within,0,0
179327,6,0,0
179328,h,0,0
179329,of,0,0
179330,onset,0,0
179331,of,0,0
179332,STEMI,0,0
179333,.,0,0
179334,TRIAL,0,0
179335,REGISTRATION,0,0
179336,Trial,0,0
179337,registered,0,0
179338,20th,0,0
179339,November,0,0
179340,2012,0,0
179341,:,0,0
179342,ClinicalTrials.gov,0,0
179343,Identifier,0,0
179344,NCT01747174,0,1
179345,.,0,0
179346,Dental,1,1
179347,prophylaxis,1,1
179348,decreases,0,0
179349,the,0,0
179350,risk,0,0
179351,of,0,0
179352,esophageal,0,0
179353,cancer,0,0
179354,in,0,0
179355,males,0,0
179356,;,0,0
179357,a,0,0
179358,nationwide,0,0
179359,population-based,0,0
179360,study,0,0
179361,in,0,0
179362,Taiwan,0,0
179363,.,0,0
179364,BACKGROUND,0,0
179365,Periodontal,0,0
179366,disease,0,0
179367,(,0,1
179368,PD,0,1
179369,),0,1
179370,is,0,0
179371,one,0,0
179372,of,0,0
179373,the,0,0
179374,most,0,0
179375,common,0,0
179376,chronic,0,0
179377,inflammatory,0,0
179378,diseases,0,0
179379,.,0,0
179380,Esophageal,0,0
179381,cancer,0,0
179382,(,0,1
179383,EC,0,1
179384,),0,1
179385,is,0,0
179386,also,0,0
179387,a,0,0
179388,common,0,0
179389,cause,0,0
179390,of,0,0
179391,death,0,0
179392,due,0,0
179393,to,0,0
179394,cancer,0,0
179395,among,0,0
179396,males,0,0
179397,.,0,0
179398,Systemic,0,0
179399,inflammatory,0,0
179400,processes,0,0
179401,have,0,0
179402,been,0,0
179403,shown,0,0
179404,to,0,0
179405,increase,0,0
179406,the,0,0
179407,risk,0,0
179408,of,0,0
179409,cancer,0,0
179410,.,0,0
179411,We,0,0
179412,conducted,0,0
179413,a,0,0
179414,retrospective,0,0
179415,cohort,0,0
179416,study,0,0
179417,to,0,0
179418,investigate,0,0
179419,the,0,0
179420,association,0,0
179421,between,0,0
179422,PD,0,1
179423,and,0,0
179424,EC,0,1
179425,.,0,0
179426,METHODS,0,0
179427,A,0,0
179428,total,0,0
179429,of,0,0
179430,"718,409",0,0
179431,subjects,0,0
179432,were,0,0
179433,recruited,0,0
179434,from,0,0
179435,the,0,0
179436,Taiwan,0,0
179437,National,0,0
179438,Health,0,1
179439,Insurance,0,0
179440,Research,0,0
179441,Database,0,0
179442,(,0,1
179443,NHIRD,0,1
179444,),0,1
179445,and,0,0
179446,followed,0,1
179447,from,0,0
179448,January,0,0
179449,1,0,0
179450,",",0,0
179451,2000,0,0
179452,to,0,0
179453,December,0,0
179454,31,0,0
179455,",",0,0
179456,2010,0,0
179457,.,0,0
179458,Of,0,0
179459,these,0,0
179460,",",0,0
179461,"519,831",0,0
179462,subjects,0,0
179463,were,0,0
179464,diagnosed,0,0
179465,with,0,0
179466,PD,0,1
179467,and,0,0
179468,were,0,0
179469,grouped,0,0
179470,according,0,0
179471,to,0,0
179472,the,0,0
179473,most,0,0
179474,advanced,0,0
179475,treatment,0,0
179476,they,0,0
179477,received,0,0
179478,:,0,0
179479,dental,1,0
179480,prophylaxis,1,1
179481,",",1,0
179482,intensive,1,1
179483,treatment,1,0
179484,",",1,0
179485,or,1,1
179486,no,1,0
179487,treatment,1,0
179488,.,1,0
179489,The,0,0
179490,IRs,0,1
179491,of,0,0
179492,EC,0,1
179493,were,0,0
179494,compared,0,0
179495,among,0,0
179496,groups,0,0
179497,.,0,0
179498,RESULTS,0,0
179499,A,0,0
179500,total,0,0
179501,of,0,0
179502,682,0,0
179503,patients,0,0
179504,developed,0,0
179505,EC,0,1
179506,",",0,0
179507,resulting,0,0
179508,in,0,0
179509,an,0,0
179510,overall,0,0
179511,IR,0,1
179512,of,0,0
179513,0.11,0,0
179514,case-number,0,0
179515,per,0,0
179516,1000,0,0
179517,person-years,0,0
179518,(,0,0
179519,?/y,0,0
179520,),0,0
179521,.,0,0
179522,The,0,0
179523,dental,0,0
179524,prophylaxis,0,1
179525,group,0,0
179526,had,0,0
179527,a,0,0
179528,significantly,0,0
179529,lower,0,0
179530,IR,0,0
179531,of,0,0
179532,EC,0,1
179533,(,0,1
179534,0.06?/y,0,1
179535,),0,0
179536,than,0,0
179537,other,0,0
179538,groups,0,0
179539,(,0,0
179540,p,0,0
179541,<,0,0
179542,0.001,0,0
179543,),0,0
179544,.,0,0
179545,Multivariable,0,0
179546,Cox,0,1
179547,regression,0,0
179548,analysis,0,0
179549,further,0,0
179550,revealed,0,0
179551,that,0,0
179552,male,0,0
179553,subjects,0,0
179554,[,0,0
179555,hazard,0,0
179556,ratio,0,0
179557,(,0,1
179558,HR,0,0
179559,),0,1
179560,=,0,0
179561,10.04,0,0
179562,",",0,0
179563,95,0,0
179564,%,0,0
179565,confidence,0,0
179566,interval,0,0
179567,(,0,1
179568,CI,0,0
179569,),0,1
179570,=,0,0
179571,7.58-13.30,0,0
179572,],0,0
179573,",",0,0
179574,as,0,0
179575,well,0,0
179576,as,0,0
179577,a,0,0
179578,history,0,0
179579,of,0,0
179580,esophageal,0,0
179581,ulcers,0,0
179582,(,0,0
179583,HR,0,0
179584,=,0,0
179585,7.10,0,0
179586,",",0,0
179587,95,0,0
179588,%,0,0
179589,CI,0,0
179590,=,0,0
179591,5.03-10.01,0,0
179592,),0,0
179593,",",0,0
179594,alcohol,0,1
179595,abuse,0,0
179596,(,0,0
179597,HR,0,0
179598,=,0,0
179599,5.46,0,0
179600,",",0,0
179601,95,0,0
179602,%,0,0
179603,CI,0,0
179604,=,0,0
179605,2.26-13.18,0,0
179606,),0,0
179607,",",0,0
179608,or,0,1
179609,esophageal,0,0
179610,reflux,0,0
179611,(,0,0
179612,HR,0,0
179613,=,0,0
179614,1.86,0,0
179615,",",0,0
179616,95,0,0
179617,%,0,0
179618,CI,0,0
179619,=,0,0
179620,1.02-3.52,0,0
179621,),0,0
179622,",",0,0
179623,were,0,0
179624,factors,0,0
179625,associated,0,0
179626,with,0,0
179627,a,0,0
179628,higher,0,0
179629,risk,0,0
179630,of,0,0
179631,EC,0,1
179632,.,0,0
179633,And,0,0
179634,the,0,0
179635,dental,0,1
179636,prophylaxis,0,1
179637,group,0,0
179638,showed,0,0
179639,a,0,0
179640,significantly,0,0
179641,lower,0,0
179642,risk,0,0
179643,for,0,0
179644,EC,0,1
179645,(,0,0
179646,HR,0,0
179647,=,0,0
179648,0.53,0,0
179649,",",0,0
179650,95,0,0
179651,%,0,0
179652,CI,0,0
179653,=,0,0
179654,0.44-0.65,0,0
179655,),0,0
179656,.,0,0
179657,Further,0,0
179658,subgroup,0,0
179659,analysis,0,0
179660,showed,0,0
179661,that,0,0
179662,the,0,0
179663,dental,0,1
179664,prophylaxis,0,1
179665,group,0,0
179666,among,0,0
179667,males,0,0
179668,had,0,0
179669,a,0,0
179670,significant,0,0
179671,lower,0,0
179672,risk,0,0
179673,(,0,0
179674,HR,0,0
179675,=,0,0
179676,0.54,0,0
179677,",",0,0
179678,95,0,0
179679,%,0,0
179680,CI,0,0
179681,=,0,0
179682,0.44-0.66,0,0
179683,),0,0
179684,for,0,0
179685,EC,0,1
179686,",",0,0
179687,while,0,0
179688,that,0,0
179689,of,0,0
179690,the,0,0
179691,females,0,0
179692,did,0,0
179693,not,0,0
179694,has,0,0
179695,statistically,0,0
179696,significant,0,0
179697,difference,0,0
179698,.,0,0
179699,CONCLUSION,0,0
179700,For,0,0
179701,this,0,0
179702,cohort,0,0
179703,",",0,0
179704,subjects,0,0
179705,received,0,0
179706,dental,0,0
179707,prophylaxis,0,1
179708,reduced,0,0
179709,the,0,0
179710,risk,0,0
179711,of,0,0
179712,EC,0,1
179713,compared,0,0
179714,to,0,0
179715,all,0,0
179716,PD,0,1
179717,and,0,0
179718,no,0,0
179719,PD,0,1
179720,groups,0,0
179721,among,0,0
179722,males,0,0
179723,.,0,0
179724,Inhibition,0,0
179725,of,0,0
179726,PCSK9,0,1
179727,with,0,0
179728,evolocumab,1,1
179729,in,0,0
179730,homozygous,0,0
179731,familial,0,0
179732,hypercholesterolaemia,0,0
179733,(,0,0
179734,TESLA,0,1
179735,Part,0,1
179736,B,0,1
179737,),0,0
179738,:,0,0
179739,a,0,0
179740,randomised,0,0
179741,",",0,0
179742,double-blind,0,0
179743,",",0,0
179744,placebo-controlled,1,1
179745,trial,0,0
179746,.,0,0
179747,BACKGROUND,0,0
179748,Homozygous,0,1
179749,familial,0,0
179750,hypercholesterolaemia,0,0
179751,is,0,0
179752,a,0,0
179753,rare,0,0
179754,",",0,0
179755,serious,0,0
179756,disorder,0,0
179757,caused,0,0
179758,by,0,0
179759,very,0,0
179760,low,0,0
179761,or,0,1
179762,absent,0,0
179763,plasma,0,0
179764,clearance,0,0
179765,of,0,0
179766,LDL,0,0
179767,",",0,0
179768,substantially,0,0
179769,raised,0,0
179770,LDL,0,0
179771,cholesterol,0,0
179772,",",0,0
179773,and,0,0
179774,accelerated,0,1
179775,development,0,0
179776,of,0,0
179777,cardiovascular,0,0
179778,disease,0,0
179779,.,0,0
179780,Conventional,0,0
179781,lipid-lowering,0,1
179782,treatments,0,0
179783,are,0,0
179784,modestly,0,0
179785,effective,0,0
179786,.,0,0
179787,Evolocumab,1,1
179788,",",0,0
179789,a,0,0
179790,monoclonal,1,1
179791,antibody,1,0
179792,to,0,0
179793,proprotein,1,1
179794,convertase,1,1
179795,subtilisin/kexin,1,1
179796,type,1,0
179797,9,1,0
179798,(,0,0
179799,PCSK9,0,1
179800,),0,0
179801,",",0,0
179802,reduced,0,0
179803,LDL,0,0
179804,cholesterol,0,0
179805,by,0,0
179806,16,0,0
179807,%,0,0
179808,in,0,0
179809,a,0,0
179810,pilot,0,0
179811,study,0,0
179812,.,0,0
179813,We,0,0
179814,now,0,0
179815,report,0,0
179816,results,0,0
179817,with,0,0
179818,evolocumab,1,1
179819,in,0,0
179820,a,0,0
179821,randomised,0,0
179822,",",0,0
179823,double-blind,0,0
179824,",",0,0
179825,placebo-controlled,1,1
179826,phase,0,0
179827,3,0,0
179828,trial,0,0
179829,.,0,0
179830,METHODS,0,0
179831,This,0,0
179832,randomised,0,0
179833,",",0,0
179834,double-blind,0,0
179835,",",0,0
179836,placebo-controlled,1,1
179837,phase,0,0
179838,3,0,0
179839,trial,0,0
179840,was,0,0
179841,undertaken,0,0
179842,at,0,0
179843,17,0,0
179844,sites,0,0
179845,in,0,0
179846,ten,0,0
179847,countries,0,0
179848,in,0,0
179849,North,0,0
179850,America,0,0
179851,",",0,0
179852,Europe,0,1
179853,",",0,0
179854,the,0,0
179855,Middle,0,1
179856,East,0,1
179857,",",0,0
179858,and,0,0
179859,South,0,0
179860,Africa,0,1
179861,.,0,0
179862,50,0,0
179863,eligible,0,0
179864,patients,0,0
179865,(,0,0
179866,aged,0,0
179867,?12,0,1
179868,years,0,0
179869,),0,0
179870,with,0,0
179871,homozygous,0,0
179872,familial,0,0
179873,hypercholesterolaemia,0,0
179874,",",0,0
179875,on,0,0
179876,stable,1,0
179877,lipid-regulating,1,1
179878,therapy,1,1
179879,for,1,0
179880,at,0,0
179881,least,0,0
179882,4,0,0
179883,weeks,0,0
179884,",",0,0
179885,and,0,0
179886,not,0,0
179887,receiving,0,1
179888,lipoprotein,0,0
179889,apheresis,0,1
179890,",",0,0
179891,were,0,0
179892,randomly,0,0
179893,allocated,0,0
179894,by,0,0
179895,a,0,0
179896,computer-generated,0,1
179897,randomisation,0,0
179898,sequence,0,0
179899,in,0,0
179900,a,0,0
179901,2:1,0,0
179902,ratio,0,0
179903,to,0,0
179904,receive,1,0
179905,subcutaneous,1,0
179906,evolocumab,1,1
179907,420,1,0
179908,mg,1,1
179909,or,1,1
179910,placebo,1,1
179911,every,1,1
179912,4,0,0
179913,weeks,0,0
179914,for,0,0
179915,12,0,0
179916,weeks,0,0
179917,.,0,0
179918,Randomisation,0,0
179919,was,0,0
179920,stratified,0,0
179921,by,0,0
179922,LDL,0,0
179923,cholesterol,0,0
179924,at,0,0
179925,screening,0,1
179926,(,0,0
179927,<,0,0
179928,11,0,0
179929,mmol/L,0,0
179930,or,0,1
179931,?11,0,0
179932,mmol/L,0,0
179933,),0,1
179934,and,0,0
179935,implemented,0,0
179936,by,0,0
179937,a,0,0
179938,computerised,1,1
179939,interactive,1,1
179940,voice-response,1,1
179941,system,1,0
179942,.,1,0
179943,Patients,1,0
179944,",",0,0
179945,study,0,0
179946,personnel,0,1
179947,",",0,0
179948,and,0,0
179949,the,0,0
179950,funder,0,0
179951,were,0,0
179952,masked,0,0
179953,to,0,0
179954,treatment,0,0
179955,and,0,0
179956,to,0,0
179957,the,0,0
179958,efficacy,0,0
179959,results,0,0
179960,by,0,0
179961,the,0,0
179962,central,0,0
179963,laboratory,0,0
179964,not,0,0
179965,returning,0,0
179966,LDL,0,1
179967,cholesterol,0,1
179968,or,0,1
179969,any,0,0
179970,lipid,0,0
179971,results,0,0
179972,to,0,0
179973,the,0,0
179974,clinical,0,0
179975,sites,0,0
179976,after,0,0
179977,the,0,0
179978,baseline,0,0
179979,visit,0,0
179980,.,0,0
179981,The,0,0
179982,primary,0,0
179983,endpoint,0,0
179984,was,0,0
179985,percentage,0,0
179986,change,0,0
179987,in,0,0
179988,ultracentrifugation,0,1
179989,LDL,0,1
179990,cholesterol,0,0
179991,from,0,0
179992,baseline,0,0
179993,at,0,0
179994,week,0,0
179995,12,0,0
179996,compared,0,0
179997,with,0,0
179998,placebo,0,1
179999,",",0,0
180000,analysed,0,0
180001,by,0,0
180002,intention-to-treat,0,0
180003,.,0,0
180004,This,0,0
180005,trial,0,0
180006,is,0,0
180007,registered,0,0
180008,with,0,0
180009,ClinicalTrials.gov,0,0
180010,",",0,0
180011,number,0,0
180012,NCT01588496,0,0
180013,.,0,0
180014,FINDINGS,0,0
180015,Of,0,0
180016,the,0,0
180017,50,0,0
180018,eligible,0,0
180019,patients,0,0
180020,randomly,0,0
180021,assigned,0,0
180022,to,0,0
180023,the,0,0
180024,two,0,0
180025,treatment,0,0
180026,groups,0,0
180027,",",0,0
180028,49,0,0
180029,actually,0,0
180030,received,0,0
180031,the,0,0
180032,study,0,0
180033,drug,0,1
180034,and,0,0
180035,completed,0,0
180036,the,0,0
180037,study,0,0
180038,(,0,0
180039,16,0,0
180040,in,0,0
180041,the,0,0
180042,placebo,1,1
180043,group,1,0
180044,and,0,0
180045,33,0,0
180046,in,0,0
180047,the,0,0
180048,evolocumab,1,1
180049,group,1,0
180050,),0,0
180051,.,0,0
180052,Compared,0,0
180053,with,0,0
180054,placebo,1,1
180055,",",1,0
180056,evolocumab,1,1
180057,significantly,1,0
180058,reduced,0,0
180059,ultracentrifugation,0,1
180060,LDL,0,1
180061,cholesterol,0,0
180062,at,0,0
180063,12,0,0
180064,weeks,0,0
180065,by,0,0
180066,30?9,0,0
180067,%,0,0
180068,(,0,0
180069,95,0,0
180070,%,0,0
180071,CI,0,0
180072,-43?9,0,1
180073,%,0,0
180074,to,0,0
180075,-18?0,0,1
180076,%,0,0
180077,;,0,0
180078,p,0,0
180079,<,0,0
180080,0?0001,0,0
180081,),0,0
180082,.,0,0
180083,Treatment-emergent,0,0
180084,adverse,0,0
180085,events,0,0
180086,occurred,0,0
180087,in,0,0
180088,ten,0,0
180089,(,0,0
180090,63,0,0
180091,%,0,0
180092,),0,0
180093,of,0,0
180094,16,0,0
180095,patients,0,0
180096,in,1,0
180097,the,1,0
180098,placebo,1,1
180099,group,0,0
180100,and,0,0
180101,12,0,0
180102,(,0,0
180103,36,0,0
180104,%,0,0
180105,),0,0
180106,of,0,0
180107,33,0,0
180108,in,0,0
180109,the,1,0
180110,evolocumab,1,1
180111,group,1,0
180112,.,1,0
180113,No,0,0
180114,serious,0,0
180115,clinical,0,0
180116,or,0,1
180117,laboratory,0,0
180118,adverse,0,0
180119,events,0,0
180120,occurred,0,0
180121,",",0,0
180122,and,0,0
180123,no,0,0
180124,anti-evolocumab,1,1
180125,antibody,1,0
180126,development,0,0
180127,was,0,0
180128,detected,0,0
180129,during,0,0
180130,the,0,0
180131,study,0,0
180132,.,0,0
180133,INTERPRETATION,0,0
180134,In,0,0
180135,patients,0,0
180136,with,0,0
180137,homozygous,0,0
180138,familial,0,0
180139,hypercholesterolaemia,0,0
180140,receiving,0,0
180141,stable,0,0
180142,background,0,0
180143,lipid-lowering,0,1
180144,treatment,0,0
180145,and,0,0
180146,not,0,0
180147,on,0,0
180148,apheresis,1,1
180149,",",1,0
180150,evolocumab,1,1
180151,420,1,0
180152,mg,1,0
180153,administered,0,0
180154,every,0,0
180155,4,0,0
180156,weeks,0,0
180157,was,0,0
180158,well,0,0
180159,tolerated,0,0
180160,and,0,0
180161,significantly,0,0
180162,reduced,0,0
180163,LDL,0,0
180164,cholesterol,0,0
180165,compared,0,0
180166,with,1,0
180167,placebo,1,1
180168,.,0,0
180169,FUNDING,0,0
180170,Amgen,0,1
180171,Inc,0,0
180172,.,0,0
180173,Pharmacodynamic,0,0
180174,analysis,0,0
180175,of,0,0
180176,intravenous,1,1
180177,recombinant,1,1
180178,urate,1,1
180179,oxidase,1,0
180180,using,0,0
180181,an,0,0
180182,indirect,0,1
180183,pharmacological,0,0
180184,response,0,0
180185,model,0,0
180186,in,0,0
180187,healthy,0,0
180188,subjects,0,0
180189,.,0,0
180190,AIM,0,0
180191,Pharmacodynamic,0,0
180192,analysis,0,0
180193,of,0,0
180194,intravenous,1,1
180195,recombinant,1,1
180196,urate,1,0
180197,oxidase,1,0
180198,produced,0,0
180199,by,0,0
180200,Escherichia,0,1
180201,coli,0,0
180202,was,0,0
180203,performed,0,0
180204,in,0,0
180205,healthy,0,0
180206,subjects,0,0
180207,using,0,0
180208,a,0,0
180209,pharmacokinetic/pharmacodynamic,0,0
180210,(,0,0
180211,PK/PD,0,1
180212,),0,1
180213,model,0,0
180214,.,0,0
180215,METHODS,0,0
180216,A,0,0
180217,randomized,0,0
180218,",",0,0
180219,single-blind,0,0
180220,",",0,0
180221,placebo-controlled,1,1
180222,study,0,0
180223,was,0,0
180224,performed,0,0
180225,in,0,0
180226,40,0,0
180227,healthy,0,0
180228,Chinese,0,0
180229,subjects,0,0
180230,(,0,0
180231,4,0,0
180232,groups,0,0
180233,of,0,0
180234,10,0,0
180235,subjects,0,0
180236,each,0,0
180237,",",0,0
180238,placebo,0,1
180239,4:1,0,0
180240,ratio,0,0
180241,),0,0
180242,who,0,0
180243,received,0,0
180244,infusions,0,1
180245,of,0,0
180246,uricase,1,1
180247,(,0,0
180248,single,0,1
180249,doses,0,0
180250,of,0,0
180251,0.1,0,0
180252,",",0,0
180253,0.2,0,0
180254,",",0,0
180255,and,0,0
180256,0.3,0,0
180257,mg/kg,0,1
180258,;,0,0
180259,multiple,0,0
180260,doses,0,0
180261,of,0,0
180262,0.2,0,1
180263,mg?kg,0,1
180264,(,0,1
180265,-1,0,1
180266,),0,1
180267,?d,0,0
180268,(,0,1
180269,-1,0,0
180270,),0,1
180271,for,0,0
180272,7,0,0
180273,d,0,0
180274,),0,0
180275,.,0,0
180276,PK,0,1
180277,profiles,0,0
180278,were,0,0
180279,determined,0,0
180280,through,0,0
180281,plasma,0,0
180282,uricase,0,1
180283,activity,0,0
180284,",",0,0
180285,and,0,0
180286,PD,0,1
180287,profiles,0,0
180288,were,0,0
180289,established,0,0
180290,using,0,0
180291,uric,0,0
180292,acid,0,1
180293,levels,0,0
180294,in,0,0
180295,plasma,0,0
180296,and,0,0
180297,urine,0,0
180298,.,0,0
180299,The,0,0
180300,plasma,0,0
180301,PD,0,1
180302,parameter,0,0
180303,was,0,0
180304,estimated,0,0
180305,as,0,0
180306,changes,0,0
180307,in,0,0
180308,plasma,0,0
180309,uric,0,0
180310,acid,0,1
180311,levels,0,0
180312,as,0,0
180313,the,0,0
180314,effect,0,0
180315,in,0,0
180316,the,0,0
180317,indirect,0,1
180318,response,0,0
180319,model,0,0
180320,.,0,0
180321,Adverse,0,0
180322,events,0,0
180323,were,0,0
180324,also,0,0
180325,monitored,0,0
180326,.,0,0
180327,RESULTS,0,0
180328,A,0,0
180329,two-compartment,0,1
180330,PK,0,1
180331,model,0,0
180332,with,0,0
180333,constant,0,0
180334,iv,0,0
180335,input,0,1
180336,and,0,0
180337,first-order,0,0
180338,output,0,0
180339,was,0,0
180340,used,0,0
180341,to,0,0
180342,describe,0,0
180343,the,0,0
180344,kinetic,0,0
180345,process,0,0
180346,of,0,0
180347,plasma,0,0
180348,uricase,0,1
180349,.,0,0
180350,The,0,0
180351,low,0,0
180352,value,0,0
180353,(,0,0
180354,2.8,0,0
180355,U/L,0,1
180356,),0,0
180357,of,0,0
180358,drug,0,1
180359,concentration,0,0
180360,that,0,0
180361,achieved,0,0
180362,50,0,0
180363,%,0,0
180364,of,0,0
180365,maximum,0,0
180366,effect,0,0
180367,(,0,1
180368,EC50,0,0
180369,),0,1
180370,indicated,0,0
180371,that,0,0
180372,low,0,0
180373,plasma,0,0
180374,uricase,0,1
180375,concentrations,0,0
180376,were,0,0
180377,sufficient,0,0
180378,to,0,0
180379,produce,0,0
180380,pharmacological,0,0
180381,effects,0,0
180382,.,0,0
180383,A,0,0
180384,strong,0,0
180385,relationship,0,0
180386,(,0,1
180387,r,0,0
180388,(,0,1
180389,2,0,0
180390,),0,1
180391,=0.9991,0,0
180392,),0,0
180393,between,0,0
180394,the,0,0
180395,mean,0,0
180396,uric,0,0
180397,acid,0,1
180398,concentration,0,0
180399,in,0,0
180400,blood,0,0
180401,and,0,0
180402,the,0,0
180403,mean,0,0
180404,uric,0,0
180405,acid,0,1
180406,excretion,0,0
180407,rate,0,0
180408,in,0,0
180409,urine,0,0
180410,in,0,0
180411,the,0,0
180412,range,0,0
180413,of,0,0
180414,11,0,0
180415,to,0,0
180416,30,0,0
180417,h,0,0
180418,after,0,0
180419,single,0,1
180420,dosing,0,0
180421,was,0,0
180422,found,0,0
180423,.,0,0
180424,Infusions,0,0
180425,of,0,0
180426,uricase,1,1
180427,were,1,0
180428,well,0,0
180429,tolerated,0,0
180430,in,0,0
180431,all,0,0
180432,subjects,0,0
180433,.,0,0
180434,CONCLUSION,0,0
180435,The,0,0
180436,PK/PD,0,1
180437,model,0,0
180438,predicted,0,0
180439,the,0,0
180440,effective,0,0
180441,dose,0,0
180442,to,0,0
180443,be,0,0
180444,0.1,0,1
180445,mg/kg,0,1
180446,in,0,0
180447,healthy,0,0
180448,subjects,0,0
180449,.,0,0
180450,The,0,0
180451,excretion,0,0
180452,rate,0,0
180453,of,0,0
180454,uric,0,0
180455,acid,0,1
180456,in,0,0
180457,urine,0,0
180458,may,0,0
180459,be,0,0
180460,used,0,0
180461,as,0,0
180462,a,0,0
180463,new,0,0
180464,index,0,0
180465,for,0,0
180466,pharmacological,0,0
180467,effects,0,0
180468,in,0,0
180469,further,0,0
180470,clinical,0,0
180471,trials,0,0
180472,.,0,0
180473,Detection,0,1
180474,and,0,0
180475,quantification,0,0
180476,of,0,0
180477,the,0,0
180478,solid,0,0
180479,component,0,0
180480,in,0,0
180481,pulmonary,0,0
180482,subsolid,0,0
180483,nodules,0,0
180484,by,0,0
180485,semiautomatic,1,0
180486,segmentation,1,0
180487,.,1,0
180488,OBJECTIVE,0,0
180489,To,0,0
180490,determine,0,0
180491,whether,0,0
180492,semiautomatic,1,0
180493,volumetric,1,0
180494,software,1,1
180495,can,0,0
180496,differentiate,0,0
180497,part-solid,0,0
180498,from,0,0
180499,nonsolid,0,0
180500,pulmonary,0,0
180501,nodules,0,0
180502,and,0,0
180503,aid,0,0
180504,quantification,0,0
180505,of,0,0
180506,the,0,0
180507,solid,0,0
180508,component,0,0
180509,.,0,0
180510,METHODS,0,0
180511,As,0,0
180512,per,0,0
180513,reference,0,0
180514,standard,0,1
180515,",",0,0
180516,115,0,0
180517,nodules,0,0
180518,were,0,0
180519,differentiated,0,0
180520,into,0,0
180521,nonsolid,0,0
180522,and,0,0
180523,part-solid,0,0
180524,by,0,0
180525,two,0,0
180526,radiologists,0,0
180527,;,0,0
180528,disagreements,0,0
180529,were,0,0
180530,adjudicated,0,0
180531,by,0,0
180532,a,0,0
180533,third,0,0
180534,radiologist,0,0
180535,.,0,0
180536,The,0,0
180537,diameters,0,0
180538,of,0,0
180539,solid,0,0
180540,components,0,0
180541,were,0,0
180542,measured,0,0
180543,manually,0,0
180544,.,0,0
180545,Semiautomatic,0,0
180546,volumetric,0,0
180547,measurements,0,0
180548,were,0,0
180549,used,0,0
180550,to,0,0
180551,identify,0,0
180552,and,0,0
180553,quantify,0,0
180554,a,0,0
180555,possible,0,0
180556,solid,0,0
180557,component,0,0
180558,",",0,0
180559,using,0,0
180560,different,0,1
180561,Hounsfield,0,1
180562,unit,0,1
180563,(,0,1
180564,HU,0,1
180565,),0,0
180566,thresholds,0,0
180567,.,0,0
180568,The,0,0
180569,measurements,0,0
180570,were,0,0
180571,compared,0,0
180572,with,0,0
180573,the,0,0
180574,reference,0,0
180575,standard,0,1
180576,and,0,0
180577,manual,0,0
180578,measurements,0,0
180579,.,0,0
180580,RESULTS,0,0
180581,The,0,0
180582,reference,0,0
180583,standard,0,1
180584,detected,0,0
180585,a,0,0
180586,solid,0,0
180587,component,0,0
180588,in,0,0
180589,86,0,0
180590,nodules,0,0
180591,.,0,0
180592,Diagnosis,0,0
180593,of,0,0
180594,a,0,0
180595,solid,0,0
180596,component,0,0
180597,by,0,0
180598,semiautomatic,0,0
180599,software,0,1
180600,depended,0,0
180601,on,0,0
180602,the,0,0
180603,threshold,0,0
180604,chosen,0,0
180605,.,0,0
180606,A,0,0
180607,threshold,0,0
180608,of,0,0
180609,-300,0,0
180610,HU,0,0
180611,resulted,0,0
180612,in,0,0
180613,the,0,0
180614,detection,0,0
180615,of,0,0
180616,a,0,0
180617,solid,0,0
180618,component,0,0
180619,in,0,0
180620,75,0,0
180621,nodules,0,0
180622,with,0,0
180623,good,0,0
180624,sensitivity,0,0
180625,(,0,0
180626,90,0,1
180627,%,0,0
180628,),0,1
180629,and,0,1
180630,specificity,0,0
180631,(,0,1
180632,88,0,0
180633,%,0,0
180634,),0,0
180635,.,0,0
180636,At,0,0
180637,a,0,0
180638,threshold,0,0
180639,of,0,0
180640,-130,0,1
180641,HU,0,0
180642,",",0,0
180643,semiautomatic,0,0
180644,measurements,0,0
180645,of,0,0
180646,the,0,0
180647,diameter,0,0
180648,of,0,0
180649,the,0,0
180650,solid,0,0
180651,component,0,0
180652,(,0,0
180653,mean,0,0
180654,2.4,0,0
180655,mm,0,0
180656,",",0,0
180657,SD,0,0
180658,2.7,0,0
180659,mm,0,0
180660,),0,0
180661,were,0,0
180662,comparable,0,0
180663,to,0,0
180664,manual,0,0
180665,measurements,0,0
180666,at,0,0
180667,the,0,0
180668,mediastinal,0,0
180669,window,0,1
180670,setting,0,0
180671,(,0,0
180672,mean,0,0
180673,2.3,0,0
180674,mm,0,0
180675,",",0,0
180676,SD,0,0
180677,2.5,0,1
180678,mm,0,0
180679,[,0,0
180680,p,0,0
180681,=,0,0
180682,0.63,0,0
180683,],0,0
180684,),0,0
180685,.,0,0
180686,CONCLUSION,0,0
180687,Semiautomatic,0,0
180688,segmentation,0,1
180689,of,0,0
180690,subsolid,0,0
180691,nodules,0,0
180692,could,0,0
180693,diagnose,0,0
180694,part-solid,0,0
180695,nodules,0,0
180696,and,0,0
180697,quantify,0,0
180698,the,0,0
180699,solid,0,0
180700,component,0,0
180701,similar,0,0
180702,to,0,0
180703,human,0,0
180704,observers,0,0
180705,.,0,0
180706,Performance,0,0
180707,depends,0,0
180708,on,0,0
180709,the,0,0
180710,attenuation,0,0
180711,segmentation,0,0
180712,thresholds,0,0
180713,.,0,0
180714,This,0,0
180715,method,0,0
180716,may,0,0
180717,prove,0,0
180718,useful,0,0
180719,in,0,0
180720,managing,0,0
180721,subsolid,0,0
180722,nodules,0,0
180723,.,0,0
180724,KEY,0,0
180725,POINTS,0,0
180726,?,0,0
180727,Semiautomatic,0,0
180728,segmentation,0,0
180729,can,0,0
180730,accurately,0,0
180731,differentiate,0,0
180732,nonsolid,0,0
180733,from,0,0
180734,part-solid,0,0
180735,pulmonary,0,0
180736,nodules,0,0
180737,?,0,0
180738,Semiautomatic,0,0
180739,segmentation,0,0
180740,can,0,0
180741,quantify,0,0
180742,the,0,0
180743,solid,0,0
180744,component,0,0
180745,similar,0,0
180746,to,0,0
180747,manual,0,0
180748,measurements,0,0
180749,?,0,0
180750,Semiautomatic,0,0
180751,segmentation,0,0
180752,may,0,0
180753,aid,0,0
180754,management,0,0
180755,of,0,0
180756,subsolid,0,0
180757,nodules,0,0
180758,following,0,0
180759,Fleischner,0,0
180760,Society,0,0
180761,recommendations,0,0
180762,?,0,0
180763,Performance,0,0
180764,for,0,0
180765,the,0,0
180766,segmentation,0,0
180767,of,0,0
180768,subsolid,0,0
180769,nodules,0,0
180770,depends,0,0
180771,on,0,0
180772,the,0,0
180773,chosen,0,0
180774,attenuation,0,0
180775,thresholds,0,0
180776,.,0,0
180777,Secondary,0,0
180778,analysis,0,0
180779,of,0,0
180780,RTOG,0,0
180781,9508,0,0
180782,",",0,0
180783,a,0,0
180784,phase,0,0
180785,3,0,0
180786,randomized,0,0
180787,trial,0,0
180788,of,0,0
180789,whole-brain,1,1
180790,radiation,1,1
180791,therapy,1,1
180792,versus,1,1
180793,WBRT,1,1
180794,plus,1,1
180795,stereotactic,1,1
180796,radiosurgery,1,1
180797,in,0,0
180798,patients,0,0
180799,with,0,0
180800,1-3,0,0
180801,brain,0,0
180802,metastases,0,0
180803,;,0,0
180804,poststratified,0,0
180805,by,0,0
180806,the,0,0
180807,graded,0,0
180808,prognostic,0,0
180809,assessment,0,0
180810,(,0,1
180811,GPA,0,1
180812,),0,0
180813,.,0,0
180814,PURPOSE,0,0
180815,Radiation,1,1
180816,Therapy,1,1
180817,Oncology,1,0
180818,Group,1,0
180819,(,1,1
180820,RTOG,1,1
180821,),1,1
180822,9508,1,0
180823,showed,0,0
180824,a,0,0
180825,survival,0,0
180826,advantage,0,0
180827,for,0,0
180828,patients,0,0
180829,with,0,0
180830,1,0,0
180831,but,0,0
180832,not,0,0
180833,2,0,0
180834,or,0,0
180835,3,0,0
180836,brain,0,0
180837,metastasis,0,0
180838,(,0,1
180839,BM,0,1
180840,),0,1
180841,treated,0,0
180842,with,0,0
180843,whole-brain,1,1
180844,radiation,1,1
180845,therapy,1,1
180846,(,1,1
180847,WBRT,1,1
180848,),1,1
180849,and,1,0
180850,stereotactic,1,1
180851,radiosurgery,1,1
180852,(,1,1
180853,SRS,1,1
180854,),1,1
180855,versus,1,1
180856,WBRT,1,1
180857,alone,1,1
180858,.,1,0
180859,An,0,0
180860,improved,0,0
180861,prognostic,0,0
180862,index,0,0
180863,",",0,0
180864,the,0,0
180865,graded,0,0
180866,prognostic,0,0
180867,assessment,0,0
180868,(,0,1
180869,GPA,0,1
180870,),0,1
180871,has,0,0
180872,been,0,0
180873,developed,0,0
180874,.,0,0
180875,Our,0,0
180876,hypothesis,0,0
180877,was,0,0
180878,that,0,0
180879,if,0,0
180880,the,0,0
180881,data,0,0
180882,from,0,0
180883,RTOG,1,0
180884,9508,1,0
180885,were,0,0
180886,poststratified,0,0
180887,by,0,0
180888,the,0,0
180889,GPA,0,0
180890,",",0,0
180891,the,0,0
180892,conclusions,0,0
180893,may,0,0
180894,vary,0,0
180895,.,0,0
180896,METHODS,0,0
180897,AND,0,0
180898,MATERIALS,0,1
180899,In,0,0
180900,this,0,0
180901,analysis,0,0
180902,",",0,0
180903,252,0,0
180904,of,0,0
180905,the,0,0
180906,331,0,0
180907,patients,0,0
180908,were,0,0
180909,evaluable,0,0
180910,by,0,0
180911,GPA,0,0
180912,.,0,0
180913,Of,0,0
180914,those,0,0
180915,",",0,0
180916,211,0,0
180917,had,0,0
180918,lung,0,0
180919,cancer,0,0
180920,.,0,0
180921,Breast,0,0
180922,cancer,0,0
180923,patients,0,0
180924,were,0,0
180925,excluded,0,0
180926,because,0,0
180927,the,0,0
180928,components,0,0
180929,of,0,0
180930,the,0,0
180931,breast,0,0
180932,GPA,0,0
180933,are,0,0
180934,not,0,0
180935,in,0,0
180936,the,0,0
180937,RTOG,0,0
180938,database,0,0
180939,.,0,0
180940,Multiple,0,0
180941,Cox,0,1
180942,regression,0,0
180943,was,0,0
180944,used,0,0
180945,to,0,0
180946,compare,0,0
180947,survival,0,0
180948,between,0,0
180949,treatment,0,0
180950,groups,0,0
180951,",",0,0
180952,adjusting,0,0
180953,for,0,0
180954,GPA,0,0
180955,.,0,0
180956,Treatment,0,0
180957,comparisons,0,0
180958,within,0,0
180959,subgroups,0,0
180960,were,0,0
180961,performed,0,0
180962,with,0,0
180963,the,0,0
180964,log-rank,0,0
180965,test,0,0
180966,.,0,0
180967,A,0,0
180968,free,0,0
180969,online,0,1
180970,tool,0,1
180971,(,0,1
180972,brainmetgpa.com,0,1
180973,),0,1
180974,simplified,0,0
180975,GPA,0,1
180976,use,0,0
180977,.,0,0
180978,RESULTS,0,0
180979,The,0,0
180980,fundamental,0,0
180981,conclusions,0,0
180982,of,0,0
180983,the,0,0
180984,primary,0,0
180985,analysis,0,0
180986,were,0,0
180987,confirmed,0,0
180988,in,0,0
180989,that,0,0
180990,there,0,0
180991,was,0,0
180992,no,0,0
180993,survival,0,0
180994,benefit,0,0
180995,overall,0,0
180996,for,0,0
180997,patients,0,0
180998,with,0,0
180999,1,0,0
181000,to,0,0
181001,3,0,0
181002,metastases,0,0
181003,;,0,0
181004,however,0,0
181005,",",0,0
181006,there,0,0
181007,was,0,0
181008,a,0,0
181009,benefit,0,0
181010,for,0,0
181011,the,0,0
181012,subset,0,0
181013,of,0,0
181014,patients,0,0
181015,with,0,0
181016,GPA,0,0
181017,3.5,0,0
181018,to,0,0
181019,4.0,0,0
181020,(,0,0
181021,median,0,0
181022,survival,0,0
181023,time,0,0
181024,[,0,0
181025,MST,0,1
181026,],0,0
181027,for,0,0
181028,WBRT,1,1
181029,+,1,1
181030,SRS,1,1
181031,vs,0,0
181032,WBRT,0,1
181033,alone,0,1
181034,was,0,0
181035,21.0,0,0
181036,versus,0,0
181037,10.3,0,0
181038,months,0,0
181039,",",0,0
181040,P=.05,0,0
181041,),0,1
181042,regardless,0,0
181043,of,0,0
181044,the,0,0
181045,number,0,0
181046,of,0,0
181047,metastases,0,0
181048,.,0,0
181049,Among,0,0
181050,patients,0,0
181051,with,0,0
181052,GPA,0,0
181053,3.5,0,0
181054,to,0,0
181055,4.0,0,0
181056,treated,0,0
181057,with,0,0
181058,WBRT,1,1
181059,and,1,0
181060,SRS,1,1
181061,",",0,0
181062,the,0,0
181063,MST,0,1
181064,for,0,0
181065,patients,0,0
181066,with,0,0
181067,1,0,0
181068,versus,0,0
181069,2,0,0
181070,to,0,0
181071,3,0,0
181072,metastases,0,0
181073,was,0,0
181074,21,0,0
181075,and,0,0
181076,14.1,0,0
181077,months,0,0
181078,",",0,0
181079,respectively,0,0
181080,.,0,0
181081,CONCLUSIONS,0,0
181082,This,0,0
181083,secondary,0,0
181084,analysis,0,0
181085,of,0,0
181086,predominantly,0,0
181087,lung,0,0
181088,cancer,0,0
181089,patients,0,0
181090,",",0,0
181091,consistent,0,0
181092,with,0,0
181093,the,0,0
181094,original,0,0
181095,analysis,0,0
181096,",",0,0
181097,shows,0,0
181098,no,0,0
181099,survival,0,0
181100,advantage,0,0
181101,for,0,0
181102,the,0,0
181103,group,0,0
181104,overall,0,0
181105,when,0,0
181106,treated,0,0
181107,with,0,0
181108,WBRT,0,1
181109,and,0,0
181110,SRS,0,1
181111,;,0,0
181112,however,0,0
181113,",",0,0
181114,in,0,0
181115,patients,0,0
181116,with,0,0
181117,high,0,0
181118,GPA,0,1
181119,(,0,1
181120,3.5-4,0,0
181121,),0,0
181122,",",0,0
181123,there,0,0
181124,is,0,0
181125,a,0,0
181126,survival,0,0
181127,advantage,0,0
181128,regardless,0,0
181129,of,0,0
181130,whether,0,0
181131,they,0,0
181132,have,0,0
181133,1,0,0
181134,",",0,0
181135,2,0,0
181136,",",0,0
181137,or,0,0
181138,3,0,0
181139,BM,0,0
181140,.,0,0
181141,This,0,0
181142,benefit,0,0
181143,did,0,0
181144,not,0,0
181145,extend,0,0
181146,to,0,0
181147,patients,0,0
181148,with,0,0
181149,lower,0,0
181150,GPA,0,0
181151,.,0,0
181152,Prospective,0,0
181153,validation,0,0
181154,of,0,0
181155,this,0,0
181156,survival,0,0
181157,benefit,0,0
181158,for,0,0
181159,patients,0,0
181160,with,0,0
181161,multiple,0,0
181162,BM,0,0
181163,and,0,0
181164,high,0,0
181165,GPA,0,1
181166,when,0,0
181167,treated,0,0
181168,with,0,0
181169,WBRT,1,1
181170,and,1,0
181171,SRS,1,1
181172,is,0,0
181173,warranted,0,0
181174,.,0,0
181175,Sulforaphane,1,1
181176,treatment,0,0
181177,of,0,0
181178,autism,0,0
181179,spectrum,0,0
181180,disorder,0,0
181181,(,0,1
181182,ASD,0,0
181183,),0,0
181184,.,0,0
181185,Autism,0,0
181186,spectrum,0,0
181187,disorder,0,0
181188,(,0,1
181189,ASD,0,0
181190,),0,0
181191,",",0,0
181192,characterized,0,0
181193,by,0,0
181194,both,0,0
181195,impaired,0,0
181196,communication,0,1
181197,and,0,0
181198,social,0,1
181199,interaction,0,0
181200,",",0,0
181201,and,0,0
181202,by,0,0
181203,stereotypic,0,1
181204,behavior,0,0
181205,",",0,0
181206,affects,0,0
181207,about,0,0
181208,1,0,0
181209,in,0,0
181210,68,0,0
181211,",",0,0
181212,predominantly,0,0
181213,males,0,0
181214,.,0,0
181215,The,0,0
181216,medico-economic,0,0
181217,burdens,0,0
181218,of,0,0
181219,ASD,0,0
181220,are,0,0
181221,enormous,0,0
181222,",",0,0
181223,and,0,0
181224,no,0,0
181225,recognized,0,0
181226,treatment,0,0
181227,targets,0,0
181228,the,0,0
181229,core,0,0
181230,features,0,0
181231,of,0,0
181232,ASD,0,0
181233,.,0,0
181234,In,0,0
181235,a,0,0
181236,placebo-controlled,0,1
181237,",",0,0
181238,double-blind,0,0
181239,",",0,0
181240,randomized,0,0
181241,trial,0,0
181242,",",0,0
181243,young,0,0
181244,men,0,0
181245,(,0,0
181246,aged,0,0
181247,13-27,0,0
181248,),0,0
181249,with,0,0
181250,moderate,0,0
181251,to,0,0
181252,severe,0,0
181253,ASD,0,0
181254,received,0,0
181255,the,0,0
181256,phytochemical,1,1
181257,sulforaphane,1,1
181258,(,1,0
181259,n,1,0
181260,=,1,0
181261,29,1,0
181262,),1,0
181263,--,1,0
181264,derived,1,0
181265,from,1,0
181266,broccoli,1,1
181267,sprout,1,0
181268,extracts,1,1
181269,--,1,0
181270,or,1,1
181271,indistinguishable,1,0
181272,placebo,1,1
181273,(,0,0
181274,n,0,0
181275,=,0,0
181276,15,0,0
181277,),0,0
181278,.,0,0
181279,The,0,0
181280,effects,0,0
181281,on,0,0
181282,behavior,0,0
181283,of,0,0
181284,daily,0,1
181285,oral,0,1
181286,doses,0,0
181287,of,0,0
181288,sulforaphane,1,1
181289,(,0,0
181290,50-150,0,1
181291,?mol,0,1
181292,),0,0
181293,for,0,0
181294,18,0,0
181295,wk,0,0
181296,",",0,0
181297,followed,0,1
181298,by,0,0
181299,4,0,0
181300,wk,0,0
181301,without,0,0
181302,treatment,0,0
181303,",",0,0
181304,were,0,0
181305,quantified,0,0
181306,by,0,0
181307,three,0,0
181308,widely,0,0
181309,accepted,0,0
181310,behavioral,0,1
181311,measures,0,0
181312,completed,0,0
181313,by,0,0
181314,parents/caregivers,0,0
181315,and,0,0
181316,physicians,0,0
181317,:,0,0
181318,the,0,0
181319,Aberrant,0,0
181320,Behavior,0,0
181321,Checklist,0,1
181322,(,0,1
181323,ABC,0,1
181324,),0,0
181325,",",0,0
181326,Social,0,0
181327,Responsiveness,0,0
181328,Scale,0,1
181329,(,0,1
181330,SRS,0,1
181331,),0,1
181332,",",0,0
181333,and,0,0
181334,Clinical,0,0
181335,Global,0,0
181336,Impression,0,0
181337,Improvement,0,1
181338,Scale,0,1
181339,(,0,1
181340,CGI-I,0,1
181341,),0,1
181342,.,0,0
181343,Initial,0,0
181344,scores,0,0
181345,for,0,0
181346,ABC,0,0
181347,and,0,0
181348,SRS,0,1
181349,were,0,0
181350,closely,0,0
181351,matched,0,0
181352,for,0,0
181353,participants,0,0
181354,assigned,0,0
181355,to,1,0
181356,placebo,1,1
181357,and,1,0
181358,sulforaphane,1,1
181359,.,1,0
181360,After,0,0
181361,18,0,0
181362,wk,0,0
181363,",",0,0
181364,participants,0,0
181365,receiving,1,0
181366,placebo,1,1
181367,experienced,0,0
181368,minimal,0,1
181369,change,0,0
181370,(,0,0
181371,<,0,0
181372,3.3,0,0
181373,%,0,0
181374,),0,0
181375,",",0,0
181376,whereas,0,0
181377,those,0,0
181378,receiving,1,0
181379,sulforaphane,1,1
181380,showed,0,0
181381,substantial,0,0
181382,declines,0,0
181383,(,0,0
181384,improvement,0,0
181385,of,0,0
181386,behavior,0,0
181387,),0,0
181388,:,0,0
181389,34,0,0
181390,%,0,0
181391,for,0,0
181392,ABC,0,1
181393,(,0,0
181394,P,0,0
181395,<,0,0
181396,0.001,0,0
181397,",",0,0
181398,comparing,0,0
181399,treatments,0,1
181400,),0,0
181401,and,0,0
181402,17,0,0
181403,%,0,0
181404,for,0,0
181405,SRS,0,1
181406,scores,0,0
181407,(,0,0
181408,P,0,0
181409,=,0,0
181410,0.017,0,0
181411,),0,0
181412,.,0,0
181413,On,0,0
181414,CGI-I,0,0
181415,",",0,0
181416,a,0,0
181417,significantly,0,0
181418,greater,0,0
181419,number,0,0
181420,of,0,0
181421,participants,0,0
181422,receiving,1,0
181423,sulforaphane,1,1
181424,had,0,0
181425,improvement,0,0
181426,in,0,0
181427,social,0,0
181428,interaction,0,0
181429,",",0,0
181430,abnormal,0,0
181431,behavior,0,0
181432,",",0,0
181433,and,0,0
181434,verbal,0,1
181435,communication,0,1
181436,(,0,0
181437,P,0,0
181438,=,0,0
181439,0.015-0.007,0,0
181440,),0,0
181441,.,0,0
181442,Upon,0,0
181443,discontinuation,0,0
181444,of,1,0
181445,sulforaphane,1,1
181446,",",1,0
181447,total,0,0
181448,scores,0,0
181449,on,0,0
181450,all,0,0
181451,scales,0,0
181452,rose,0,0
181453,toward,0,0
181454,pretreatment,0,0
181455,levels,0,0
181456,.,0,0
181457,Dietary,1,1
181458,sulforaphane,1,1
181459,",",1,0
181460,of,0,0
181461,recognized,0,0
181462,low,0,0
181463,toxicity,0,0
181464,",",0,0
181465,was,0,0
181466,selected,0,0
181467,for,0,0
181468,its,0,0
181469,capacity,0,0
181470,to,0,0
181471,reverse,0,0
181472,abnormalities,0,0
181473,that,0,0
181474,have,0,0
181475,been,0,0
181476,associated,0,0
181477,with,0,0
181478,ASD,0,0
181479,",",0,0
181480,including,0,0
181481,oxidative,0,0
181482,stress,0,0
181483,and,0,0
181484,lower,0,0
181485,antioxidant,0,0
181486,capacity,0,0
181487,",",0,0
181488,depressed,0,0
181489,glutathione,0,1
181490,synthesis,0,0
181491,",",0,0
181492,reduced,0,0
181493,mitochondrial,0,0
181494,function,0,0
181495,and,0,0
181496,oxidative,0,0
181497,phosphorylation,0,0
181498,",",0,0
181499,increased,0,0
181500,lipid,0,0
181501,peroxidation,0,0
181502,",",0,0
181503,and,0,0
181504,neuroinflammmation,0,0
181505,.,0,0
181506,Benefit,0,0
181507,of,0,0
181508,adjuvant,1,1
181509,interferon,1,1
181510,alfa-2b,1,1
181511,(,1,1
181512,IFN-?,1,1
181513,),1,1
181514,therapy,1,1
181515,in,0,0
181516,melanoma,0,0
181517,patients,0,0
181518,with,0,0
181519,high,0,0
181520,serum,0,0
181521,MMP-8,0,1
181522,levels,0,0
181523,.,0,0
181524,Matrix,0,1
181525,metalloproteinases,0,0
181526,(,0,0
181527,MMPs,0,1
181528,),0,1
181529,are,0,0
181530,important,0,0
181531,enzymes,0,1
181532,in,0,0
181533,tissue,0,0
181534,turnover,0,0
181535,and,0,0
181536,various,0,0
181537,inflammatory,0,0
181538,processes,0,0
181539,.,0,0
181540,In,0,0
181541,this,0,0
181542,study,0,0
181543,",",0,0
181544,it,0,0
181545,was,0,0
181546,evaluated,0,0
181547,whether,0,0
181548,serum,0,0
181549,MMP-8,0,1
181550,can,0,0
181551,predict,0,0
181552,the,0,0
181553,response,0,0
181554,to,1,0
181555,adjuvant,1,1
181556,interferon,1,1
181557,alfa-2b,1,1
181558,(,1,1
181559,IFN-?,1,1
181560,),1,1
181561,therapy,1,1
181562,in,1,0
181563,patients,0,0
181564,with,0,0
181565,operated,0,0
181566,high-risk,0,0
181567,cutaneous,0,0
181568,melanoma,0,0
181569,.,0,0
181570,Pre-treatment,0,0
181571,sera,0,0
181572,from,0,0
181573,460,0,0
181574,patients,0,0
181575,with,0,0
181576,stage,0,0
181577,IIB-IIIC,0,1
181578,melanoma,0,0
181579,were,0,0
181580,analyzed,0,0
181581,for,0,0
181582,MMP-8,0,1
181583,.,0,0
181584,The,0,0
181585,patients,0,0
181586,were,0,0
181587,randomized,0,0
181588,after,1,0
181589,surgery,1,0
181590,to,1,0
181591,adjuvant,1,1
181592,IFN-?,1,0
181593,for,1,0
181594,12,0,0
181595,or,0,0
181596,24,0,0
181597,months,0,0
181598,(,0,0
181599,n,0,0
181600,=,0,0
181601,313,0,0
181602,),0,0
181603,or,0,1
181604,observation,1,1
181605,only,1,0
181606,(,1,0
181607,n,1,0
181608,=,0,0
181609,147,0,0
181610,),0,0
181611,.,0,0
181612,The,0,0
181613,median,0,0
181614,serum,0,0
181615,MMP-8,0,1
181616,level,0,0
181617,was,0,0
181618,used,0,0
181619,to,0,0
181620,classify,0,0
181621,the,0,0
181622,patients,0,0
181623,into,0,0
181624,a,0,0
181625,low,0,0
181626,MMP-8,0,1
181627,(,0,0
181628,n,0,0
181629,=,0,0
181630,232,0,0
181631,),0,0
181632,and,0,0
181633,a,0,0
181634,high,0,0
181635,MMP-8,0,1
181636,(,0,0
181637,n,0,0
181638,=,0,0
181639,228,0,0
181640,),0,0
181641,group,0,0
181642,.,0,0
181643,In,0,0
181644,the,0,0
181645,high,0,0
181646,MMP-8,0,1
181647,subgroup,1,0
181648,",",1,0
181649,IFN-?,1,0
181650,therapy,1,1
181651,significantly,1,0
181652,improved,0,0
181653,relapse-free,0,0
181654,survival,0,0
181655,(,0,1
181656,RFS,0,0
181657,),0,0
181658,.,0,0
181659,RFS,0,0
181660,was,0,0
181661,36.8,0,0
181662,months,0,0
181663,in,0,0
181664,patients,0,0
181665,with,0,0
181666,high,0,0
181667,MMP-8,0,1
181668,levels,0,0
181669,receiving,1,0
181670,IFN-?,1,1
181671,therapy,1,1
181672,",",1,0
181673,whereas,1,0
181674,RFS,0,0
181675,for,0,0
181676,those,0,0
181677,with,0,0
181678,high,0,0
181679,MMP-8,0,1
181680,levels,0,0
181681,with,0,0
181682,observation,0,0
181683,only,0,0
181684,was,0,0
181685,10.6,0,0
181686,months,0,0
181687,(,0,0
181688,P,0,0
181689,=,0,0
181690,0.027,0,0
181691,),0,0
181692,.,0,0
181693,Median,0,0
181694,overall,0,0
181695,survival,0,0
181696,for,0,0
181697,patients,0,0
181698,with,0,0
181699,high,0,0
181700,MMP-8,0,1
181701,and,0,0
181702,observation,0,1
181703,only,0,0
181704,was,0,0
181705,36.7,0,0
181706,versus,0,0
181707,71.7,0,0
181708,months,0,0
181709,in,0,0
181710,those,0,0
181711,receiving,0,1
181712,IFN-?,0,1
181713,(,0,1
181714,P,0,0
181715,=,0,0
181716,0.13,0,0
181717,),0,0
181718,.,0,0
181719,In,0,0
181720,a,0,0
181721,multivariate,0,0
181722,model,0,0
181723,",",0,0
181724,IFN-?,1,0
181725,therapy,1,1
181726,was,1,0
181727,a,1,0
181728,significant,0,0
181729,predictor,0,0
181730,of,0,0
181731,favorable,0,0
181732,RFS,0,1
181733,(,0,0
181734,HR,0,0
181735,0.74,0,0
181736,;,0,0
181737,95,0,0
181738,%,0,0
181739,CI,0,0
181740,0.55-0.99,0,0
181741,;,0,0
181742,P,0,0
181743,=,0,0
181744,0.048,0,0
181745,),0,0
181746,",",0,0
181747,after,0,0
181748,adjustment,0,0
181749,for,0,0
181750,pre-treatment,0,1
181751,MMP-8,0,1
181752,(,0,0
181753,HR,0,0
181754,1.17,0,0
181755,;,0,0
181756,95,0,0
181757,%,0,0
181758,CI,0,0
181759,0.88-1.55,0,0
181760,;,0,0
181761,P,0,0
181762,=,0,0
181763,0.28,0,0
181764,),0,0
181765,",",0,0
181766,gender,0,0
181767,(,0,0
181768,HR,0,0
181769,1.16,0,0
181770,;,0,0
181771,95,0,0
181772,%,0,0
181773,CI,0,0
181774,0.86-1.56,0,0
181775,;,0,0
181776,P,0,0
181777,=,0,0
181778,0.32,0,0
181779,),0,0
181780,",",0,0
181781,age,0,0
181782,(,0,0
181783,HR,0,0
181784,1.00,0,0
181785,;,0,0
181786,95,0,0
181787,%,0,0
181788,CI,0,0
181789,1.00-1.02,0,0
181790,;,0,0
181791,P,0,0
181792,=,0,0
181793,0.12,0,0
181794,),0,0
181795,",",0,0
181796,ulceration,0,0
181797,(,0,0
181798,HR,0,0
181799,1.09,0,0
181800,;,0,0
181801,95,0,0
181802,%,0,0
181803,CI,0,0
181804,0.81-1.46,0,0
181805,;,0,0
181806,P,0,0
181807,=,0,0
181808,0.58,0,0
181809,),0,0
181810,",",0,0
181811,and,0,0
181812,the,0,0
181813,presence,0,0
181814,of,0,0
181815,node,0,0
181816,metastases,0,0
181817,(,0,0
181818,HR,0,0
181819,1.36,0,0
181820,;,0,0
181821,95,0,0
181822,%,0,0
181823,CI,0,0
181824,1.17-1.58,0,0
181825,;,0,0
181826,P,0,0
181827,<,0,0
181828,0.0001,0,0
181829,),0,0
181830,.,0,0
181831,In,0,0
181832,conclusion,0,0
181833,",",0,0
181834,patients,0,0
181835,with,0,0
181836,high,0,0
181837,serum,0,0
181838,MMP-8,0,1
181839,levels,0,0
181840,may,0,0
181841,benefit,0,0
181842,from,1,0
181843,adjuvant,1,1
181844,IFN-?,1,1
181845,therapy,1,1
181846,",",0,0
181847,but,0,0
181848,this,0,0
181849,observation,0,1
181850,should,0,0
181851,be,0,0
181852,further,0,0
181853,investigated,0,0
181854,.,0,0
181855,Benefits,0,0
181856,of,0,0
181857,an,0,0
181858,oxygen,1,1
181859,reservoir,1,0
181860,cannula,1,1
181861,versus,1,1
181862,a,1,0
181863,conventional,1,1
181864,nasal,1,0
181865,cannula,1,1
181866,during,0,0
181867,exercise,0,1
181868,in,0,0
181869,hypoxemic,0,0
181870,COPD,0,0
181871,patients,0,0
181872,:,0,0
181873,a,0,0
181874,crossover,0,0
181875,trial,0,0
181876,.,0,0
181877,BACKGROUND,0,0
181878,The,0,0
181879,Oxymizer?,1,1
181880,is,0,0
181881,a,0,0
181882,special,0,0
181883,nasal,0,0
181884,cannula,0,1
181885,that,0,0
181886,provides,0,0
181887,a,0,0
181888,higher,0,0
181889,luminal,0,0
181890,diameter,0,0
181891,in,0,0
181892,combination,0,1
181893,with,0,0
181894,an,0,0
181895,incorporated,0,0
181896,oxygen,0,1
181897,(,0,1
181898,O2,0,1
181899,),0,1
181900,reservoir,0,0
181901,.,0,0
181902,It,0,0
181903,is,0,0
181904,assumed,0,0
181905,that,0,0
181906,a,0,0
181907,higher,0,0
181908,O2,0,0
181909,concentration,0,0
181910,can,0,0
181911,be,0,0
181912,delivered,0,0
181913,breath,0,0
181914,by,0,0
181915,breath,0,0
181916,in,0,0
181917,order,0,0
181918,to,0,0
181919,increase,0,0
181920,oxygenation,0,0
181921,.,0,0
181922,OBJECTIVE,0,0
181923,We,0,0
181924,aimed,0,0
181925,to,0,0
181926,investigate,0,0
181927,the,0,0
181928,effects,0,0
181929,of,0,0
181930,the,1,0
181931,Oxymizer,1,1
181932,on,0,0
181933,endurance,0,0
181934,time,0,0
181935,in,0,0
181936,comparison,0,0
181937,to,0,0
181938,a,0,0
181939,conventional,1,1
181940,nasal,1,1
181941,cannula,1,1
181942,(,1,1
181943,CNC,1,0
181944,),1,0
181945,.,1,0
181946,METHODS,0,0
181947,Forty-three,0,0
181948,patients,0,0
181949,with,0,0
181950,severe,0,0
181951,chronic,0,0
181952,obstructive,0,0
181953,pulmonary,0,0
181954,disease,0,0
181955,(,0,0
181956,COPD,0,0
181957,",",0,0
181958,age,0,0
181959,60,0,0
181960,?,0,0
181961,9,0,0
181962,years,0,0
181963,",",0,0
181964,FEV1,0,0
181965,37,0,0
181966,?,0,0
181967,16,0,0
181968,%,0,0
181969,pred,0,0
181970,.,0,0
181971,),0,0
181972,and,0,0
181973,indications,0,0
181974,for,0,0
181975,LTOT,0,0
181976,were,0,0
181977,recruited,0,0
181978,during,0,0
181979,pulmonary,0,0
181980,rehabilitation,0,1
181981,for,0,0
181982,this,0,0
181983,cross-over,0,0
181984,study,0,0
181985,.,0,0
181986,After,0,0
181987,an,0,0
181988,initial,0,0
181989,maximal,0,0
181990,incremental,0,0
181991,cycle,0,0
181992,test,0,0
181993,",",0,0
181994,all,0,0
181995,patients,0,0
181996,performed,1,0
181997,4,1,0
181998,cycling,1,0
181999,endurance,1,0
182000,time,1,0
182001,tests,1,0
182002,at,1,0
182003,70,0,0
182004,%,0,0
182005,of,0,0
182006,their,0,0
182007,peak,0,0
182008,work,0,1
182009,rate,0,0
182010,(,0,0
182011,twice,0,1
182012,with,0,0
182013,the,0,0
182014,Oxymizer,1,1
182015,and,1,0
182016,twice,0,1
182017,with,1,0
182018,a,1,0
182019,CNC,1,0
182020,",",1,0
182021,in,1,0
182022,reverse,0,1
182023,order,0,0
182024,),0,0
182025,.,0,0
182026,RESULTS,0,0
182027,The,0,0
182028,endurance,0,0
182029,time,0,0
182030,was,0,0
182031,significantly,0,0
182032,higher,0,0
182033,when,0,0
182034,patients,0,0
182035,cycled,0,0
182036,while,0,0
182037,using,0,0
182038,the,0,0
182039,Oxymizer,1,1
182040,in,1,0
182041,comparison,0,0
182042,to,0,0
182043,while,0,0
182044,using,0,0
182045,the,0,0
182046,CNC,1,0
182047,[,1,0
182048,858,1,0
182049,?,0,0
182050,754,0,0
182051,vs.,0,0
182052,766,0,0
182053,?,0,0
182054,652,0,0
182055,s,0,0
182056,;,0,0
182057,between-group,0,0
182058,difference,0,0
182059,92,0,0
182060,s,0,0
182061,(,0,0
182062,95,0,0
182063,%,0,0
182064,confidence,0,0
182065,interval,0,0
182066,32-152,0,1
182067,),0,0
182068,",",0,0
182069,p,0,0
182070,<,0,0
182071,0.001,0,0
182072,],0,0
182073,.,0,0
182074,In,0,0
182075,addition,0,0
182076,to,0,0
182077,a,0,0
182078,longer,0,0
182079,cycling,0,0
182080,duration,0,0
182081,",",0,0
182082,O2,0,1
182083,saturation,0,0
182084,at,0,0
182085,isotime,0,0
182086,was,0,0
182087,significantly,0,0
182088,higher,0,0
182089,with,0,0
182090,the,0,0
182091,Oxymizer,0,1
182092,(,0,0
182093,93.5,0,0
182094,?,0,0
182095,5.4,0,0
182096,vs.,0,0
182097,90.4,0,0
182098,?,0,0
182099,5.3,0,0
182100,%,0,0
182101,;,0,0
182102,p,0,0
182103,=,0,0
182104,0.027,0,0
182105,),0,0
182106,.,0,0
182107,Furthermore,0,0
182108,",",0,0
182109,there,0,0
182110,was,0,0
182111,a,0,0
182112,positive,0,0
182113,correlation,0,0
182114,(,0,1
182115,r,0,0
182116,=,0,0
182117,0.427,0,0
182118,",",0,0
182119,p,0,0
182120,=,0,0
182121,0.002,0,0
182122,),0,0
182123,between,0,0
182124,the,0,0
182125,O2,0,1
182126,flow,0,0
182127,rate,0,0
182128,and,0,0
182129,improvements,0,0
182130,in,0,0
182131,the,0,0
182132,constant,0,0
182133,work,0,0
182134,rate,0,0
182135,test,0,0
182136,",",0,0
182137,showing,0,0
182138,greater,0,0
182139,improvements,0,0
182140,in,0,0
182141,favor,0,0
182142,of,0,0
182143,the,0,0
182144,Oxymizer,1,1
182145,in,1,0
182146,patients,1,0
182147,with,0,0
182148,a,0,0
182149,higher,0,0
182150,demand,0,0
182151,for,0,0
182152,O2,0,1
182153,(,0,0
182154,?,0,0
182155,4,0,0
182156,liters/min,0,0
182157,),0,0
182158,.,0,0
182159,CONCLUSION,0,0
182160,We,0,0
182161,show,0,0
182162,that,0,0
182163,O2,0,1
182164,delivery,0,0
182165,via,1,0
182166,the,1,0
182167,Oxymizer,1,1
182168,is,0,0
182169,superior,0,0
182170,to,1,0
182171,a,1,0
182172,CNC,1,0
182173,with,0,0
182174,regard,0,0
182175,to,0,0
182176,endurance,0,0
182177,capacity,0,0
182178,and,0,0
182179,oxygenation,0,1
182180,during,0,0
182181,exercise,0,1
182182,in,0,0
182183,patients,0,0
182184,with,0,0
182185,severe,0,0
182186,COPD,0,0
182187,.,0,0
182188,It,0,0
182189,seems,0,0
182190,that,0,0
182191,patients,0,0
182192,with,0,0
182193,a,0,0
182194,higher,0,0
182195,demand,0,0
182196,for,0,0
182197,O2,0,1
182198,(,0,0
182199,?,0,0
182200,4,0,0
182201,liters/min,0,0
182202,),0,0
182203,",",0,0
182204,in,0,0
182205,particular,0,0
182206,",",0,0
182207,may,0,0
182208,benefit,0,0
182209,more,0,0
182210,from,0,0
182211,the,0,0
182212,use,0,0
182213,of,0,0
182214,the,0,0
182215,Oxymizer,1,1
182216,.,1,0
182217,Topiramate,1,1
182218,impairs,0,0
182219,cognitive,0,0
182220,function,0,0
182221,in,0,0
182222,methadone-maintained,0,0
182223,individuals,0,0
182224,with,0,0
182225,concurrent,0,1
182226,cocaine,0,1
182227,dependence,0,0
182228,.,0,0
182229,Topiramate,1,1
182230,is,0,0
182231,being,0,0
182232,investigated,0,0
182233,as,0,0
182234,a,0,0
182235,potential,0,0
182236,pharmacotherapy,1,1
182237,for,0,0
182238,the,0,0
182239,treatment,0,0
182240,of,0,0
182241,addictive,0,0
182242,disorders,0,0
182243,.,0,0
182244,However,0,0
182245,",",0,0
182246,its,0,0
182247,cognitive,0,0
182248,side,0,0
182249,effects,0,0
182250,raise,0,0
182251,concerns,0,0
182252,about,0,0
182253,its,0,0
182254,use,0,0
182255,",",0,0
182256,especially,0,0
182257,in,0,0
182258,populations,0,0
182259,with,0,0
182260,cognitive,0,0
182261,impairment,0,0
182262,",",0,0
182263,such,0,0
182264,as,0,0
182265,persons,0,0
182266,with,0,0
182267,chronic,0,0
182268,substance,0,0
182269,use,0,0
182270,disorders,0,0
182271,.,0,0
182272,This,0,0
182273,study,0,0
182274,investigated,0,0
182275,topiramate,1,1
182276,'s,1,0
182277,cognitive,0,0
182278,effects,0,0
182279,in,0,0
182280,individuals,0,0
182281,dually,0,0
182282,dependent,0,0
182283,on,0,0
182284,cocaine,0,1
182285,and,0,0
182286,opioids,0,1
182287,as,0,0
182288,part,0,0
182289,of,0,0
182290,a,0,0
182291,double-blind,0,0
182292,",",0,0
182293,randomized,0,0
182294,",",0,0
182295,controlled,0,0
182296,trial,0,0
182297,of,0,0
182298,topiramate,1,1
182299,for,0,0
182300,cocaine,0,1
182301,dependence,0,0
182302,treatment,0,0
182303,.,0,0
182304,After,0,0
182305,5,0,0
182306,weeks,0,0
182307,of,0,0
182308,stabilization,0,0
182309,on,0,0
182310,daily,0,1
182311,oral,0,1
182312,methadone,1,1
182313,(,0,0
182314,M,0,0
182315,=,0,0
182316,96,0,0
182317,mg,0,0
182318,),0,0
182319,",",0,0
182320,participants,0,0
182321,were,0,0
182322,randomized,0,0
182323,to,0,0
182324,topiramate,1,1
182325,(,0,0
182326,n,0,0
182327,=,0,0
182328,18,0,0
182329,),0,0
182330,or,0,1
182331,placebo,1,1
182332,(,0,1
182333,n,0,0
182334,=,0,0
182335,22,0,0
182336,),0,0
182337,.,0,0
182338,Cognitive,0,0
182339,testing,0,0
182340,took,0,0
182341,place,0,0
182342,at,0,0
182343,2,0,0
182344,time,0,0
182345,points,0,0
182346,:,0,0
182347,study,0,0
182348,weeks,0,0
182349,4,0,0
182350,through,0,0
182351,5,0,0
182352,to,0,0
182353,assess,0,0
182354,baseline,0,0
182355,performance,0,0
182356,and,0,0
182357,10,0,0
182358,to,0,0
182359,13,0,0
182360,weeks,0,0
182361,later,0,0
182362,to,0,0
182363,assess,0,0
182364,performance,0,0
182365,during,0,0
182366,stable,0,0
182367,dosing,0,0
182368,(,0,0
182369,300,0,1
182370,mg,0,1
182371,topiramate,1,1
182372,or,0,1
182373,placebo,1,1
182374,),1,0
182375,.,0,0
182376,All,0,0
182377,participants,0,0
182378,were,0,0
182379,maintained,0,0
182380,on,0,0
182381,methadone,0,1
182382,at,0,0
182383,both,0,0
182384,testing,0,0
182385,times,0,0
182386,",",0,0
182387,and,0,0
182388,testing,0,0
182389,occurred,0,0
182390,2,0,0
182391,hours,0,0
182392,after,0,0
182393,the,0,0
182394,daily,0,1
182395,methadone,0,1
182396,plus,0,1
182397,topiramate/placebo,1,1
182398,administration,0,0
182399,.,0,0
182400,The,0,0
182401,topiramate,1,1
182402,and,0,0
182403,placebo,1,1
182404,groups,0,0
182405,did,0,0
182406,not,0,0
182407,differ,0,0
182408,on,0,0
182409,sex,0,0
182410,",",0,0
182411,level,0,0
182412,of,0,0
182413,education,0,1
182414,",",0,0
182415,premorbid,0,0
182416,intelligence,0,0
182417,",",0,0
182418,methadone,0,1
182419,dose,0,0
182420,",",0,0
182421,or,0,1
182422,illicit,0,1
182423,drug,0,1
182424,use,0,0
182425,.,0,0
182426,Topiramate,1,1
182427,slowed,0,0
182428,psychomotor,0,0
182429,and,0,0
182430,information,0,1
182431,processing,0,1
182432,speed,0,0
182433,",",0,0
182434,worsened,0,0
182435,divided,0,0
182436,attention,0,0
182437,",",0,0
182438,reduced,0,0
182439,n-back,0,1
182440,working,0,0
182441,memory,0,0
182442,accuracy,0,0
182443,",",0,0
182444,and,0,0
182445,increased,0,0
182446,the,0,0
182447,false,0,0
182448,alarm,0,0
182449,rate,0,0
182450,in,0,0
182451,recognition,0,0
182452,memory,0,0
182453,.,0,0
182454,Topiramate,1,1
182455,had,0,0
182456,no,0,0
182457,effects,0,0
182458,on,0,0
182459,visual,0,0
182460,processing,0,0
182461,",",0,0
182462,other,0,0
182463,measures,0,0
182464,of,0,0
182465,psychomotor,0,0
182466,function,0,0
182467,",",0,0
182468,risk-taking,0,0
182469,",",0,0
182470,self-control,0,0
182471,",",0,0
182472,Sternberg,0,0
182473,working,0,0
182474,memory,0,0
182475,",",0,0
182476,free,0,0
182477,recall,0,1
182478,",",0,0
182479,and,0,0
182480,metamemory,0,0
182481,.,0,0
182482,These,0,0
182483,findings,0,0
182484,indicate,0,0
182485,that,0,0
182486,topiramate,0,1
182487,may,0,0
182488,cause,0,0
182489,cognitive,0,0
182490,impairment,0,0
182491,in,0,0
182492,this,0,0
182493,population,0,0
182494,.,0,0
182495,This,0,0
182496,effect,0,0
182497,may,0,0
182498,limit,0,0
182499,its,0,0
182500,acceptability,0,0
182501,and,0,0
182502,use,0,0
182503,as,0,0
182504,a,0,0
182505,treatment,0,0
182506,in,0,0
182507,individuals,0,0
182508,with,0,0
182509,chronic,0,0
182510,opioid,0,1
182511,and,0,0
182512,cocaine,0,1
182513,use,0,0
182514,disorders,0,0
182515,",",0,0
182516,among,0,0
182517,whom,0,0
182518,preexisting,0,0
182519,cognitive,0,0
182520,impairments,0,0
182521,are,0,0
182522,common,0,0
182523,.,0,0
182524,(,0,0
182525,PsycINFO,0,1
182526,Database,0,0
182527,Record,0,1
182528,Parent-implemented,1,1
182529,social,1,1
182530,intervention,1,1
182531,for,0,0
182532,toddlers,0,0
182533,with,0,0
182534,autism,0,0
182535,:,0,0
182536,an,0,0
182537,RCT,0,0
182538,.,0,0
182539,OBJECTIVES,0,0
182540,To,0,0
182541,compare,0,0
182542,the,0,0
182543,effects,0,0
182544,of,0,0
182545,two,0,0
182546,9-month,0,0
182547,parent-implemented,1,0
182548,interventions,1,1
182549,within,0,0
182550,the,0,0
182551,Early,1,1
182552,Social,1,1
182553,Interaction,1,1
182554,(,1,1
182555,ESI,1,1
182556,),1,1
182557,Project,1,0
182558,.,1,0
182559,Both,0,0
182560,individual-ESI,1,0
182561,",",0,0
182562,offered,0,0
182563,2,0,0
182564,or,0,0
182565,3,0,0
182566,times,0,0
182567,per,0,0
182568,week,0,0
182569,at,0,0
182570,home,0,1
182571,or,0,1
182572,in,0,0
182573,the,0,0
182574,community,0,1
182575,",",0,0
182576,and,0,0
182577,group-ESI,1,1
182578,",",0,0
182579,offered,0,0
182580,once,0,0
182581,per,0,0
182582,week,0,0
182583,in,0,0
182584,a,0,0
182585,clinic,0,0
182586,",",0,0
182587,taught,0,0
182588,parents,0,0
182589,how,0,0
182590,to,0,0
182591,embed,1,0
182592,strategies,1,0
182593,to,1,0
182594,support,1,0
182595,social,1,0
182596,communication,1,1
182597,throughout,0,0
182598,everyday,0,0
182599,activities,0,0
182600,.,0,0
182601,METHODS,0,0
182602,Participants,0,0
182603,in,0,0
182604,the,0,0
182605,randomized,0,0
182606,controlled,0,0
182607,trial,0,0
182608,included,0,0
182609,82,0,0
182610,children,0,0
182611,diagnosed,0,0
182612,with,0,0
182613,autism,0,0
182614,spectrum,0,0
182615,disorder,0,0
182616,at,0,0
182617,16,0,0
182618,to,0,0
182619,20,0,0
182620,months,0,0
182621,.,0,0
182622,Children,0,0
182623,were,0,0
182624,matched,0,0
182625,on,0,0
182626,pretreatment,0,0
182627,nonverbal,0,0
182628,developmental,0,0
182629,level,0,0
182630,and,0,0
182631,pairs,0,1
182632,were,0,0
182633,randomly,0,0
182634,assigned,0,0
182635,to,0,0
182636,treatment,0,0
182637,condition,0,0
182638,.,0,0
182639,Child,0,0
182640,outcomes,0,0
182641,included,0,0
182642,measures,0,0
182643,of,0,0
182644,social,0,0
182645,communication,0,1
182646,",",0,0
182647,autism,0,0
182648,symptoms,0,0
182649,",",0,0
182650,adaptive,0,0
182651,behavior,0,0
182652,",",0,0
182653,and,0,0
182654,developmental,0,0
182655,level,0,0
182656,.,0,0
182657,Child,0,0
182658,outcomes,0,0
182659,are,0,0
182660,reported,0,0
182661,from,0,0
182662,baseline,0,0
182663,to,0,0
182664,the,0,0
182665,end,0,0
182666,of,0,0
182667,the,0,0
182668,9-month,0,0
182669,interventions,0,0
182670,.,0,0
182671,RESULTS,0,0
182672,Children,0,0
182673,in,0,0
182674,individual-ESI,1,1
182675,showed,0,0
182676,differential,0,0
182677,change,0,0
182678,on,0,0
182679,a,0,0
182680,standardized,0,0
182681,examiner-administered,0,1
182682,observational,0,0
182683,measure,0,0
182684,of,0,0
182685,social,0,0
182686,communication,0,1
182687,",",0,0
182688,as,0,0
182689,they,0,0
182690,improved,0,0
182691,at,0,0
182692,a,0,0
182693,faster,0,0
182694,rate,0,0
182695,than,0,0
182696,children,0,0
182697,in,0,0
182698,group-ESI,1,1
182699,.,1,0
182700,Individual-ESI,1,0
182701,also,0,0
182702,showed,0,0
182703,differential,0,0
182704,efficacy,0,0
182705,on,0,0
182706,a,0,0
182707,parent,0,1
182708,report,0,0
182709,measure,0,0
182710,of,0,0
182711,communication,0,0
182712,",",0,0
182713,daily,0,1
182714,living,0,0
182715,",",0,0
182716,and,0,0
182717,social,0,0
182718,skills,0,0
182719,",",0,0
182720,as,0,0
182721,they,0,0
182722,showed,0,0
182723,improvement,0,0
182724,or,0,1
182725,stability,0,0
182726,",",0,0
182727,whereas,0,0
182728,group-ESI,1,1
182729,led,0,0
182730,to,0,0
182731,worsening,0,0
182732,or,0,1
182733,no,0,0
182734,significant,0,0
182735,change,0,0
182736,on,0,0
182737,these,0,0
182738,skills,0,0
182739,.,0,0
182740,Finally,0,0
182741,",",0,0
182742,individual-ESI,1,1
182743,showed,0,0
182744,differential,0,0
182745,change,0,0
182746,on,0,0
182747,examiner-administered,0,1
182748,measures,0,0
182749,of,0,0
182750,receptive,0,0
182751,language,0,1
182752,skills,0,0
182753,",",0,0
182754,as,0,0
182755,children,0,0
182756,in,0,0
182757,individual-ESI,0,1
182758,improved,0,0
182759,significantly,0,0
182760,",",0,0
182761,whereas,0,0
182762,group-ESI,1,1
182763,showed,0,0
182764,no,0,0
182765,change,0,0
182766,.,0,0
182767,CONCLUSIONS,0,0
182768,These,0,0
182769,findings,0,0
182770,support,0,0
182771,the,0,0
182772,efficacy,0,0
182773,of,0,0
182774,individual-ESI,1,1
182775,compared,0,0
182776,with,0,0
182777,group-ESI,1,1
182778,on,0,0
182779,child,0,0
182780,outcomes,0,0
182781,",",0,0
182782,suggesting,0,0
182783,the,0,0
182784,importance,0,0
182785,of,0,0
182786,individualized,1,1
182787,parent,1,1
182788,coaching,1,1
182789,in,0,0
182790,natural,0,0
182791,environments,0,0
182792,.,0,0
182793,The,0,0
182794,efficacy,0,0
182795,of,0,0
182796,a,0,0
182797,parent-implemented,1,1
182798,intervention,1,1
182799,using,0,0
182800,little,0,0
182801,professional,0,1
182802,time,0,0
182803,has,0,0
182804,potential,0,0
182805,for,0,0
182806,community,0,1
182807,viability,0,0
182808,",",0,0
182809,which,0,0
182810,is,0,0
182811,particularly,0,0
182812,important,0,0
182813,in,0,0
182814,light,0,1
182815,of,0,0
182816,the,0,0
182817,lack,0,0
182818,of,0,0
182819,main,0,0
182820,effects,0,0
182821,on,0,0
182822,child,0,0
182823,outcomes,0,0
182824,of,0,0
182825,most,0,0
182826,other,0,0
182827,parent-implemented,1,0
182828,interventions,1,0
182829,.,1,0
182830,Zoledronic,1,1
182831,acid,1,1
182832,combined,1,1
182833,with,1,0
182834,adjuvant,1,1
182835,endocrine,1,1
182836,therapy,1,1
182837,of,1,0
182838,tamoxifen,1,1
182839,versus,0,1
182840,anastrozol,1,1
182841,plus,1,1
182842,ovarian,1,0
182843,function,1,0
182844,suppression,1,0
182845,in,0,0
182846,premenopausal,0,1
182847,early,0,0
182848,breast,0,0
182849,cancer,0,0
182850,:,0,0
182851,final,0,0
182852,analysis,0,0
182853,of,0,0
182854,the,0,0
182855,Austrian,0,0
182856,Breast,0,0
182857,and,0,0
182858,Colorectal,0,0
182859,Cancer,0,1
182860,Study,0,0
182861,Group,0,0
182862,Trial,0,0
182863,12,0,0
182864,.,0,0
182865,BACKGROUND,0,0
182866,Zoledronic,1,1
182867,acid,1,1
182868,(,1,1
182869,ZOL,1,1
182870,),1,1
182871,plus,1,1
182872,adjuvant,1,1
182873,endocrine,1,1
182874,therapy,1,1
182875,significantly,0,0
182876,improved,0,0
182877,disease-free,0,0
182878,survival,0,0
182879,(,0,1
182880,DFS,0,0
182881,),0,1
182882,at,0,0
182883,48-,0,1
182884,and,0,0
182885,62-month,0,0
182886,follow-up,0,0
182887,in,0,0
182888,the,0,0
182889,ABCSG-12,0,0
182890,trial,0,0
182891,.,0,0
182892,We,0,0
182893,present,0,0
182894,efficacy,0,0
182895,results,0,0
182896,of,0,0
182897,a,0,0
182898,final,0,0
182899,additional,0,0
182900,analysis,0,0
182901,after,0,0
182902,94.4,0,0
182903,months,0,0
182904,.,0,0
182905,PATIENTS,0,0
182906,AND,0,0
182907,METHODS,0,0
182908,Patients,0,0
182909,were,0,0
182910,premenopausal,0,0
182911,women,0,0
182912,who,0,0
182913,had,0,0
182914,undergone,0,0
182915,primary,0,0
182916,surgery,0,1
182917,for,0,0
182918,stage,0,0
182919,I/II,0,1
182920,estrogen-receptor-positive,0,1
182921,and/or,0,0
182922,progesterone-receptor-positive,0,1
182923,breast,0,0
182924,cancer,0,0
182925,with,0,0
182926,<,0,0
182927,10,0,0
182928,positive,0,0
182929,lymph,0,0
182930,nodes,0,0
182931,",",0,0
182932,and,0,0
182933,were,0,0
182934,scheduled,0,0
182935,for,0,0
182936,standard,0,1
182937,goserelin,0,1
182938,therapy,0,1
182939,.,0,0
182940,All,0,0
182941,1803,0,0
182942,patients,0,0
182943,received,0,0
182944,goserelin,1,1
182945,(,1,0
182946,3.6,1,0
182947,mg,1,1
182948,every,1,0
182949,28,1,0
182950,days,1,0
182951,),1,0
182952,and,1,0
182953,were,1,0
182954,randomized,1,0
182955,to,1,0
182956,tamoxifen,1,1
182957,(,1,0
182958,20,1,0
182959,mg/days,1,1
182960,),1,0
182961,or,1,1
182962,anastrozole,1,1
182963,(,1,0
182964,1,1,0
182965,mg/days,1,1
182966,),1,0
182967,",",1,0
182968,both,1,0
182969,with,1,0
182970,or,1,0
182971,without,1,1
182972,ZOL,1,0
182973,(,1,0
182974,4,1,1
182975,mg,1,1
182976,every,1,0
182977,6,1,0
182978,months,1,0
182979,),1,0
182980,for,1,0
182981,3,1,0
182982,years,1,0
182983,.,1,0
182984,The,0,0
182985,primary,0,0
182986,end,0,0
182987,point,0,0
182988,was,0,0
182989,DFS,0,0
182990,;,0,0
182991,recurrence-free,0,0
182992,survival,0,0
182993,and,0,0
182994,overall,0,0
182995,survival,0,0
182996,(,0,1
182997,OS,0,0
182998,),0,1
182999,were,0,0
183000,secondary,0,0
183001,end,0,0
183002,points,0,0
183003,.,0,0
183004,RESULTS,0,0
183005,After,0,0
183006,94.4-month,0,0
183007,median,0,0
183008,follow-up,0,0
183009,(,0,1
183010,range,0,0
183011,",",0,0
183012,0-114,0,0
183013,months,0,0
183014,),0,0
183015,",",0,0
183016,relative,0,0
183017,risks,0,0
183018,of,0,0
183019,disease,0,0
183020,progression,0,0
183021,[,0,1
183022,hazard,0,0
183023,ratio,0,0
183024,(,0,1
183025,HR,0,0
183026,),0,1
183027,=,0,0
183028,0.77,0,0
183029,;,0,0
183030,95,0,0
183031,%,0,0
183032,confidence,0,0
183033,interval,0,0
183034,(,0,1
183035,CI,0,0
183036,),0,1
183037,0.60-0.99,0,0
183038,;,0,0
183039,P,0,0
183040,=,0,0
183041,0.042,0,0
183042,],0,0
183043,and,0,0
183044,of,0,0
183045,death,0,0
183046,(,0,0
183047,HR,0,0
183048,=,0,0
183049,0.66,0,0
183050,;,0,0
183051,95,0,0
183052,%,0,0
183053,CI,0,0
183054,0.43-1.02,0,0
183055,;,0,0
183056,P,0,0
183057,=,0,0
183058,0.064,0,0
183059,),0,0
183060,are,0,0
183061,still,0,0
183062,reduced,0,0
183063,by,0,0
183064,ZOL,0,0
183065,although,0,0
183066,no,0,0
183067,longer,0,0
183068,significant,0,0
183069,at,0,0
183070,the,0,0
183071,predefined,0,0
183072,significance,0,0
183073,level,0,0
183074,.,0,0
183075,Overall,0,0
183076,",",0,0
183077,251,0,0
183078,DFS,0,0
183079,events,0,0
183080,and,0,0
183081,86,0,0
183082,deaths,0,0
183083,were,0,0
183084,reported,0,0
183085,.,0,0
183086,Absolute,0,0
183087,risk,0,0
183088,reductions,0,0
183089,with,0,0
183090,ZOL,0,0
183091,were,0,0
183092,3.4,0,0
183093,%,0,0
183094,for,0,0
183095,DFS,0,0
183096,and,0,0
183097,2.2,0,0
183098,%,0,0
183099,for,0,0
183100,OS,0,0
183101,.,0,0
183102,There,0,0
183103,was,0,0
183104,no,0,0
183105,DFS,0,0
183106,difference,0,0
183107,between,0,0
183108,tamoxifen,0,1
183109,alone,0,1
183110,versus,0,0
183111,anastrozole,0,1
183112,alone,0,1
183113,",",0,0
183114,but,0,0
183115,there,0,0
183116,was,0,0
183117,a,0,0
183118,pronounced,0,0
183119,higher,0,0
183120,risk,0,0
183121,of,0,0
183122,death,0,0
183123,for,0,0
183124,anastrozole-treated,0,1
183125,patients,0,0
183126,(,0,0
183127,HR,0,0
183128,=,0,0
183129,1.63,0,0
183130,;,0,0
183131,95,0,0
183132,%,0,0
183133,CI,0,0
183134,1.05-1.45,0,0
183135,;,0,0
183136,P,0,0
183137,=,0,0
183138,0.030,0,0
183139,),0,0
183140,.,0,0
183141,Treatments,0,0
183142,were,0,0
183143,generally,0,0
183144,well,0,0
183145,tolerated,0,0
183146,",",0,0
183147,with,0,0
183148,no,0,0
183149,reports,0,0
183150,of,0,0
183151,renal,0,0
183152,failure,0,0
183153,or,0,1
183154,osteonecrosis,0,0
183155,of,0,0
183156,the,0,0
183157,jaw,0,0
183158,.,0,0
183159,CONCLUSION,0,0
183160,These,0,0
183161,final,0,0
183162,results,0,0
183163,from,0,0
183164,ABCSG,0,0
183165,12,0,0
183166,suggest,0,0
183167,that,0,0
183168,twice-yearly,0,1
183169,ZOL,1,0
183170,enhances,0,0
183171,the,0,0
183172,efficacy,0,0
183173,of,0,0
183174,adjuvant,0,1
183175,endocrine,0,1
183176,treatment,0,0
183177,",",0,0
183178,and,0,0
183179,this,0,0
183180,benefit,0,0
183181,is,0,0
183182,maintained,0,0
183183,long-term,0,0
183184,.,0,0
183185,CLINICALTRIALSGOV,0,1
183186,NCT00295646,0,0
183187,(,0,0
183188,http,0,0
183189,:,0,0
183190,//www.clinicaltrials.gov/ct2/results,0,0
183191,?,0,0
183192,term=00295646,0,0
183193,),0,0
183194,.,0,0
183195,A,0,0
183196,randomized,0,0
183197,controlled,0,0
183198,trial,0,0
183199,of,0,0
183200,cognitive-behavioral,1,1
183201,therapy,1,1
183202,versus,1,1
183203,treatment,1,0
183204,as,1,0
183205,usual,1,1
183206,for,0,0
183207,adolescents,0,0
183208,with,0,0
183209,autism,0,0
183210,spectrum,0,0
183211,disorders,0,0
183212,and,0,0
183213,comorbid,0,0
183214,anxiety,0,0
183215,.,0,0
183216,OBJECTIVE,0,0
183217,Examine,0,1
183218,the,0,0
183219,efficacy,0,0
183220,of,0,0
183221,a,0,0
183222,personalized,1,1
183223,",",1,0
183224,modular,1,0
183225,cognitive-behavioral,1,1
183226,therapy,1,1
183227,(,1,1
183228,CBT,1,1
183229,),1,1
183230,protocol,1,1
183231,among,0,0
183232,early,0,0
183233,adolescents,0,0
183234,with,0,0
183235,high-functioning,0,0
183236,autism,0,0
183237,spectrum,0,0
183238,disorders,0,0
183239,(,0,0
183240,ASDs,0,1
183241,),0,1
183242,and,0,0
183243,co-occurring,0,0
183244,anxiety,0,0
183245,relative,0,0
183246,to,0,0
183247,treatment,1,0
183248,as,1,0
183249,usual,1,1
183250,(,1,1
183251,TAU,1,1
183252,),1,0
183253,.,1,0
183254,METHOD,0,0
183255,Thirty-one,0,0
183256,children,0,0
183257,(,0,0
183258,11-16,0,0
183259,years,0,0
183260,),0,0
183261,with,0,0
183262,ASD,0,0
183263,and,0,0
183264,clinically,0,0
183265,significant,0,0
183266,anxiety,0,0
183267,were,0,0
183268,randomly,0,0
183269,assigned,0,0
183270,to,0,0
183271,receive,0,0
183272,16,0,0
183273,weekly,0,1
183274,CBT,1,1
183275,sessions,1,1
183276,or,1,0
183277,an,1,0
183278,equivalent,1,0
183279,duration,1,0
183280,of,1,0
183281,TAU,1,1
183282,.,1,0
183283,Participants,0,0
183284,were,0,0
183285,assessed,0,0
183286,by,0,0
183287,blinded,0,0
183288,raters,0,0
183289,at,0,0
183290,screening,0,0
183291,",",0,0
183292,posttreatment,0,0
183293,",",0,0
183294,and,0,0
183295,1-month,0,0
183296,follow-up,0,0
183297,.,0,0
183298,RESULTS,0,0
183299,Youth,0,0
183300,randomized,0,0
183301,to,0,0
183302,CBT,1,1
183303,demonstrated,0,0
183304,superior,0,0
183305,improvement,0,0
183306,across,0,0
183307,primary,0,0
183308,outcomes,0,0
183309,relative,0,0
183310,to,0,0
183311,those,0,0
183312,receiving,0,0
183313,TAU,1,1
183314,.,1,0
183315,Eleven,0,0
183316,of,0,0
183317,16,0,0
183318,adolescents,0,0
183319,randomized,0,0
183320,to,0,0
183321,CBT,1,1
183322,were,0,0
183323,treatment,0,0
183324,responders,0,0
183325,",",0,0
183326,versus,0,0
183327,4,0,0
183328,of,0,0
183329,15,0,0
183330,in,0,0
183331,the,0,0
183332,TAU,1,1
183333,condition,0,0
183334,.,0,0
183335,Gains,0,0
183336,were,0,0
183337,maintained,0,0
183338,at,0,0
183339,1-month,0,0
183340,follow-up,0,0
183341,for,0,0
183342,CBT,0,1
183343,responders,0,0
183344,.,0,0
183345,CONCLUSIONS,0,0
183346,These,0,0
183347,data,0,0
183348,extend,0,0
183349,findings,0,0
183350,of,0,0
183351,the,0,0
183352,promising,0,0
183353,effects,0,0
183354,of,0,0
183355,CBT,1,1
183356,in,0,0
183357,anxious,0,0
183358,youth,0,0
183359,with,0,0
183360,ASD,0,0
183361,to,0,0
183362,early,0,0
183363,adolescents,0,0
183364,.,0,0
183365,Evaluating,0,0
183366,the,0,0
183367,efficacy,0,0
183368,of,0,0
183369,thoracoscopy,1,1
183370,and,1,0
183371,talc,1,1
183372,poudrage,1,1
183373,versus,1,1
183374,pleurodesis,1,1
183375,using,1,0
183376,talc,1,1
183377,slurry,1,1
183378,(,0,1
183379,TAPPS,0,1
183380,trial,0,0
183381,),0,0
183382,:,0,0
183383,protocol,0,0
183384,of,0,0
183385,an,0,0
183386,open-label,0,0
183387,randomised,0,0
183388,controlled,0,0
183389,trial,0,0
183390,.,0,0
183391,INTRODUCTION,0,0
183392,The,0,0
183393,management,0,1
183394,of,0,0
183395,recurrent,0,0
183396,malignant,0,0
183397,pleural,0,0
183398,effusions,0,0
183399,(,0,0
183400,MPE,0,1
183401,),0,1
183402,can,0,0
183403,be,0,0
183404,challenging,0,0
183405,.,0,0
183406,Various,0,0
183407,options,0,0
183408,are,0,0
183409,available,0,0
183410,",",0,0
183411,with,0,0
183412,the,0,0
183413,most,0,0
183414,efficacious,0,0
183415,and,0,0
183416,widely,0,0
183417,used,0,0
183418,being,0,0
183419,talc,1,1
183420,pleurodesis,1,1
183421,.,1,0
183422,Talc,1,0
183423,can,0,0
183424,either,0,0
183425,be,0,0
183426,applied,0,0
183427,via,0,0
183428,a,0,0
183429,chest,0,1
183430,drain,0,1
183431,in,0,0
183432,the,0,0
183433,form,0,0
183434,of,0,0
183435,slurry,0,1
183436,",",0,0
183437,or,0,1
183438,at,0,0
183439,medical,1,1
183440,thoracoscopy,1,1
183441,using,1,0
183442,poudrage,1,1
183443,.,1,1
183444,Current,0,0
183445,evidence,0,0
183446,regarding,0,0
183447,which,0,0
183448,method,0,1
183449,is,0,0
183450,most,0,0
183451,effective,0,0
183452,is,0,0
183453,conflicting,0,0
183454,and,0,0
183455,often,0,0
183456,methodologically,0,0
183457,flawed,0,0
183458,.,0,0
183459,The,0,0
183460,TAPPS,0,1
183461,trial,0,0
183462,is,0,0
183463,a,0,0
183464,suitably,0,0
183465,powered,0,0
183466,",",0,0
183467,multicentre,0,0
183468,",",0,0
183469,open-label,0,0
183470,",",0,0
183471,randomised,0,0
183472,controlled,0,0
183473,trial,0,0
183474,designed,0,0
183475,to,0,0
183476,compare,0,0
183477,the,0,0
183478,pleurodesis,0,1
183479,success,0,0
183480,rate,0,0
183481,of,0,0
183482,medical,1,1
183483,thoracoscopy,1,1
183484,and,1,0
183485,talc,1,1
183486,poudrage,1,1
183487,with,1,0
183488,chest,1,1
183489,drain,1,1
183490,insertion,1,1
183491,and,1,0
183492,talc,1,1
183493,slurry,1,1
183494,.,1,0
183495,METHODS,0,0
183496,AND,0,0
183497,ANALYSIS,0,1
183498,330,0,0
183499,patients,0,0
183500,with,0,0
183501,a,0,0
183502,confirmed,0,0
183503,MPE,0,1
183504,requiring,0,0
183505,intervention,0,1
183506,will,0,0
183507,be,0,0
183508,recruited,0,0
183509,from,0,0
183510,UK,0,0
183511,hospitals,0,0
183512,.,0,0
183513,Patients,0,0
183514,will,0,0
183515,be,0,0
183516,randomised,0,0
183517,(,0,0
183518,1:1,0,1
183519,),0,0
183520,to,0,0
183521,undergo,0,0
183522,either,0,1
183523,small,1,0
183524,bore,1,1
183525,(,1,0
183526,<,1,0
183527,14,1,1
183528,Fr,1,0
183529,),1,0
183530,Seldinger,1,1
183531,chest,1,1
183532,drain,1,1
183533,insertion,1,1
183534,followed,1,1
183535,by,1,0
183536,instillation,1,0
183537,of,1,0
183538,sterile,1,1
183539,talc,1,1
183540,(,1,0
183541,4,0,1
183542,g,0,1
183543,),0,0
183544,",",0,0
183545,or,0,1
183546,to,1,0
183547,undergo,1,0
183548,medical,1,1
183549,thoracoscopy,1,1
183550,and,1,0
183551,simultaneous,1,1
183552,poudrage,1,1
183553,(,1,0
183554,4,1,1
183555,g,0,1
183556,),0,0
183557,.,0,0
183558,The,0,0
183559,allocated,0,0
183560,procedure,0,0
183561,will,0,0
183562,be,0,0
183563,performed,0,0
183564,as,0,0
183565,an,0,0
183566,inpatient,0,0
183567,within,0,0
183568,3,0,0
183569,days,0,0
183570,of,0,0
183571,randomisation,0,0
183572,taking,0,0
183573,place,0,0
183574,.,0,1
183575,Following,0,0
183576,discharge,0,0
183577,",",0,0
183578,patients,0,0
183579,will,0,0
183580,be,0,0
183581,followed,0,0
183582,up,0,0
183583,at,0,0
183584,regular,0,0
183585,intervals,0,0
183586,for,0,0
183587,6,0,0
183588,months,0,0
183589,.,0,0
183590,The,0,0
183591,primary,0,0
183592,outcome,0,0
183593,measure,0,0
183594,is,0,0
183595,pleurodesis,0,1
183596,failure,0,0
183597,rates,0,0
183598,at,0,0
183599,3,0,0
183600,months,0,0
183601,.,0,0
183602,Pleurodesis,0,1
183603,failure,0,0
183604,is,0,0
183605,defined,0,0
183606,as,0,0
183607,the,0,0
183608,need,0,0
183609,for,0,0
183610,further,0,0
183611,pleural,0,0
183612,intervention,0,1
183613,for,0,0
183614,fluid,0,1
183615,management,0,1
183616,on,0,0
183617,the,0,0
183618,side,0,0
183619,of,0,0
183620,the,0,0
183621,trial,0,0
183622,intervention,0,1
183623,.,0,0
183624,ETHICS,0,1
183625,AND,0,0
183626,DISSEMINATION,0,0
183627,The,0,0
183628,trial,0,0
183629,has,0,0
183630,received,0,0
183631,ethical,0,0
183632,approval,0,0
183633,from,0,0
183634,the,0,0
183635,National,0,0
183636,Research,0,0
183637,Ethics,0,0
183638,Service,0,1
183639,Committee,0,1
183640,North,0,1
183641,West-Preston,0,1
183642,(,0,1
183643,12/NW/0467,0,1
183644,),0,0
183645,.,0,0
183646,There,0,0
183647,is,0,0
183648,a,0,0
183649,trial,0,0
183650,steering,0,0
183651,committee,0,0
183652,which,0,0
183653,includes,0,0
183654,independent,0,0
183655,members,0,0
183656,and,0,0
183657,a,0,0
183658,patient,0,0
183659,and,0,0
183660,public,0,0
183661,representative,0,0
183662,.,0,0
183663,The,0,0
183664,trial,0,0
183665,results,0,0
183666,will,0,0
183667,be,0,0
183668,published,0,0
183669,in,0,0
183670,a,0,0
183671,peer-reviewed,0,0
183672,journal,0,0
183673,and,0,0
183674,presented,0,0
183675,at,0,0
183676,international,0,0
183677,conferences,0,1
183678,",",0,0
183679,as,0,0
183680,well,0,0
183681,as,0,0
183682,being,0,0
183683,disseminated,0,0
183684,via,0,1
183685,local,0,1
183686,and,0,0
183687,national,0,0
183688,charities,0,0
183689,and,0,0
183690,patient,0,0
183691,groups,0,0
183692,.,0,0
183693,All,0,0
183694,participants,0,0
183695,who,0,0
183696,wish,0,0
183697,to,0,0
183698,know,0,0
183699,the,0,0
183700,study,0,0
183701,results,0,0
183702,will,0,0
183703,also,0,0
183704,be,0,0
183705,contacted,0,0
183706,directly,0,0
183707,on,0,0
183708,their,0,0
183709,publication,0,0
183710,.,0,0
183711,TRIAL,0,0
183712,REGISTRATION,0,0
183713,NUMBER,0,0
183714,ISRCTN47845793,0,0
183715,.,0,0
183716,Effectiveness,0,0
183717,of,0,0
183718,a,0,0
183719,fundamental,1,0
183720,motor,1,0
183721,skill,1,1
183722,intervention,1,1
183723,for,0,0
183724,4-year-old,0,0
183725,children,0,0
183726,with,0,0
183727,autism,0,0
183728,spectrum,0,0
183729,disorder,0,0
183730,:,0,0
183731,A,0,0
183732,pilot,0,0
183733,study,0,0
183734,.,0,0
183735,A,0,0
183736,wait-list,1,0
183737,control,1,1
183738,experimental,0,0
183739,design,0,0
183740,was,0,0
183741,employed,0,0
183742,to,0,0
183743,investigate,0,0
183744,the,0,0
183745,effectiveness,0,0
183746,of,0,0
183747,a,0,0
183748,fundamental,1,0
183749,motor,1,0
183750,skill,1,1
183751,intervention,1,1
183752,at,0,0
183753,improving,0,0
183754,the,0,0
183755,motor,0,0
183756,skills,0,0
183757,",",0,0
183758,adaptive,0,0
183759,behavior,0,0
183760,",",0,0
183761,and,0,0
183762,social,0,0
183763,skills,0,1
183764,of,0,0
183765,4-year-old,0,0
183766,children,0,0
183767,with,0,0
183768,autism,0,0
183769,spectrum,0,0
183770,disorder,0,0
183771,(,0,1
183772,experimental,0,0
183773,n,0,0
183774,=,0,0
183775,5,0,0
183776,",",0,0
183777,control,0,0
183778,n,0,0
183779,=,0,0
183780,4,0,0
183781,),0,0
183782,;,0,0
183783,the,0,0
183784,impact,0,0
183785,of,0,0
183786,intervention,0,1
183787,intensity,0,0
183788,was,0,0
183789,also,0,0
183790,explored,0,0
183791,.,0,0
183792,The,0,0
183793,experimental,0,0
183794,group,0,0
183795,significantly,0,0
183796,improved,0,0
183797,their,0,0
183798,object,0,0
183799,manipulation,0,1
183800,and,0,0
183801,overall,0,0
183802,motor,0,0
183803,scores,0,0
183804,from,0,0
183805,pre-,0,0
183806,to,0,0
183807,post-intervention,1,0
183808,.,1,0
183809,The,1,0
183810,wait-list,1,0
183811,control,0,1
183812,design,0,0
183813,revealed,0,0
183814,no,0,0
183815,group-by-time,0,0
183816,interactions,0,0
183817,;,0,0
183818,however,0,0
183819,",",0,0
183820,with,0,0
183821,the,0,0
183822,groups,0,0
183823,combined,0,1
183824,time,0,0
183825,was,0,0
183826,a,0,0
183827,significant,0,0
183828,factor,0,0
183829,for,0,0
183830,all,0,0
183831,motor,0,0
183832,variables,0,0
183833,.,0,0
183834,There,0,0
183835,were,0,0
183836,no,0,0
183837,significant,0,0
183838,changes,0,0
183839,in,0,0
183840,adaptive,0,0
183841,behavior,0,0
183842,and,0,0
183843,social,0,0
183844,skills,0,0
183845,.,0,0
183846,These,0,0
183847,preliminary,0,0
183848,findings,0,0
183849,suggest,0,0
183850,that,0,0
183851,a,0,0
183852,fundamental,0,0
183853,motor,0,0
183854,skill,0,1
183855,intervention,0,1
183856,may,0,0
183857,benefit,0,0
183858,young,0,0
183859,children,0,0
183860,with,0,0
183861,autism,0,0
183862,spectrum,0,0
183863,disorder,0,0
183864,.,0,0
183865,Future,0,1
183866,research,0,0
183867,with,0,0
183868,larger,0,0
183869,samples,0,0
183870,is,0,0
183871,warranted,0,0
183872,.,0,0
183873,Time,0,1
183874,to,0,0
183875,onset,0,0
183876,of,0,0
183877,clinically,0,0
183878,meaningful,0,0
183879,improvement,0,0
183880,with,0,0
183881,tadalafil,1,1
183882,5,0,0
183883,mg,0,1
183884,once,0,1
183885,daily,0,0
183886,for,0,0
183887,lower,0,0
183888,urinary,0,0
183889,tract,0,0
183890,symptoms,0,0
183891,secondary,0,0
183892,to,0,0
183893,benign,0,0
183894,prostatic,0,0
183895,hyperplasia,0,0
183896,:,0,0
183897,analysis,0,0
183898,of,0,0
183899,data,0,0
183900,pooled,0,0
183901,from,0,0
183902,4,0,0
183903,pivotal,0,0
183904,",",0,0
183905,double-blind,0,0
183906,",",0,0
183907,placebo,1,1
183908,controlled,0,0
183909,studies,0,0
183910,.,0,0
183911,PURPOSE,0,0
183912,Tadalafil,1,1
183913,once,0,1
183914,daily,0,0
183915,for,0,0
183916,lower,0,0
183917,urinary,0,0
183918,tract,0,0
183919,symptoms,0,0
183920,secondary,0,0
183921,to,0,0
183922,benign,0,0
183923,prostatic,0,0
183924,hyperplasia,0,0
183925,consistently,0,0
183926,shows,0,0
183927,statistically,0,0
183928,significant,0,0
183929,I-PSS,0,1
183930,improvements,0,0
183931,.,0,0
183932,However,0,0
183933,",",0,0
183934,physicians,0,1
183935,and,0,0
183936,patients,0,0
183937,wish,0,0
183938,to,0,0
183939,know,0,0
183940,whether,0,0
183941,tadalafil,1,1
183942,provides,0,0
183943,rapid,0,0
183944,",",0,0
183945,clinically,0,0
183946,meaningful,0,0
183947,improvement,0,0
183948,in,0,0
183949,lower,0,0
183950,urinary,0,0
183951,tract,0,0
183952,symptoms,0,0
183953,.,0,0
183954,In,0,0
183955,this,0,0
183956,post,0,0
183957,hoc,0,0
183958,analysis,0,0
183959,we,0,0
183960,integrated,0,1
183961,results,0,0
183962,from,0,0
183963,4,0,0
183964,placebo,1,1
183965,controlled,0,0
183966,studies,0,0
183967,to,0,0
183968,determine,0,0
183969,the,0,0
183970,duration,0,0
183971,of,0,0
183972,tadalafil,1,1
183973,once,0,1
183974,daily,0,1
183975,required,0,0
183976,to,0,0
183977,achieve,0,0
183978,clinically,0,0
183979,meaningful,0,0
183980,improvement,0,0
183981,.,0,1
183982,MATERIALS,0,0
183983,AND,0,0
183984,METHODS,0,0
183985,We,0,0
183986,performed,0,0
183987,post,0,0
183988,hoc,0,0
183989,analysis,0,0
183990,of,0,0
183991,data,0,0
183992,integrated,0,1
183993,from,0,0
183994,4,0,0
183995,double-blind,0,0
183996,studies,0,0
183997,of,0,0
183998,tadalafil,1,1
183999,5,0,1
184000,mg,0,1
184001,and,1,0
184002,placebo,1,1
184003,once,0,1
184004,daily,0,1
184005,in,0,0
184006,742,0,0
184007,and,0,0
184008,735,0,0
184009,men,0,0
184010,",",0,0
184011,respectively,0,0
184012,",",0,0
184013,45,0,0
184014,years,0,0
184015,old,0,0
184016,or,0,0
184017,older,0,0
184018,with,0,0
184019,total,0,0
184020,I-PSS,0,1
184021,13,0,0
184022,or,0,0
184023,greater,0,0
184024,.,0,0
184025,Two,0,0
184026,clinically,0,0
184027,meaningful,0,0
184028,improvement,0,0
184029,categories,0,0
184030,were,0,0
184031,assessed,0,0
184032,",",0,0
184033,including,0,0
184034,1,0,0
184035,),0,0
184036,3-point,0,0
184037,or,0,0
184038,greater,0,0
184039,baseline,0,0
184040,to,0,0
184041,end,0,0
184042,point,0,0
184043,total,0,0
184044,I-PSS,0,1
184045,improvement,0,0
184046,and,0,0
184047,2,0,0
184048,),0,0
184049,25,0,0
184050,%,0,0
184051,or,0,0
184052,greater,0,0
184053,baseline,0,0
184054,to,0,0
184055,end,0,0
184056,point,0,0
184057,total,0,0
184058,I-PSS,0,1
184059,improvement,0,0
184060,.,0,0
184061,I-PSS,0,0
184062,was,0,0
184063,assessed,0,0
184064,at,0,0
184065,weeks,0,0
184066,4,0,0
184067,",",0,0
184068,8,0,0
184069,and,0,0
184070,12,0,0
184071,in,0,0
184072,all,0,0
184073,studies,0,0
184074,",",0,0
184075,week,0,0
184076,1,0,0
184077,in,0,0
184078,2,0,0
184079,and,0,0
184080,week,0,0
184081,2,0,0
184082,in,0,0
184083,1,0,0
184084,.,0,0
184085,Results,0,0
184086,in,0,0
184087,men,0,0
184088,treated,0,0
184089,with,0,0
184090,tadalafil,1,1
184091,who,0,0
184092,showed,0,0
184093,clinically,0,0
184094,meaningful,0,0
184095,improvement,0,0
184096,(,0,1
184097,responders,0,0
184098,),0,0
184099,were,0,0
184100,further,0,0
184101,examined,0,0
184102,to,0,0
184103,determine,0,0
184104,the,0,0
184105,earliest,0,0
184106,time,0,0
184107,to,0,0
184108,clinically,0,0
184109,meaningful,0,0
184110,improvement,0,0
184111,.,0,0
184112,RESULTS,0,0
184113,Of,0,0
184114,742,0,0
184115,tadalafil,1,1
184116,treated,0,0
184117,patients,0,0
184118,513,0,0
184119,(,0,0
184120,69.1,0,0
184121,%,0,0
184122,),0,0
184123,and,0,0
184124,444,0,0
184125,(,0,0
184126,59.8,0,0
184127,%,0,0
184128,),0,0
184129,demonstrated,0,0
184130,category,0,0
184131,1,0,0
184132,and,0,0
184133,2,0,0
184134,clinically,0,0
184135,meaningful,0,0
184136,improvement,0,0
184137,",",0,0
184138,respectively,0,0
184139,",",0,0
184140,at,0,0
184141,the,0,0
184142,study,0,0
184143,end,0,0
184144,point,0,0
184145,.,0,0
184146,Of,0,0
184147,234,0,0
184148,category,0,0
184149,1,0,0
184150,responders,0,0
184151,with,0,0
184152,week,0,0
184153,1,0,0
184154,assessments,0,0
184155,140,0,0
184156,(,0,0
184157,59.8,0,0
184158,%,0,0
184159,),0,0
184160,achieved,0,0
184161,clinically,0,0
184162,meaningful,0,0
184163,improvement,0,0
184164,by,0,0
184165,week,0,0
184166,1,0,0
184167,and,0,0
184168,407,0,0
184169,of,0,0
184170,the,0,0
184171,total,0,0
184172,of,0,0
184173,513,0,0
184174,category,0,0
184175,1,0,0
184176,responders,0,0
184177,(,0,0
184178,79.3,0,0
184179,%,0,0
184180,),0,0
184181,showed,0,0
184182,it,0,0
184183,by,0,0
184184,week,0,0
184185,4,0,0
184186,.,0,0
184187,Of,0,0
184188,the,0,0
184189,205,0,0
184190,category,0,0
184191,2,0,0
184192,responders,0,0
184193,with,0,0
184194,week,0,0
184195,1,0,0
184196,assessments,0,0
184197,103,0,0
184198,(,0,0
184199,50.2,0,0
184200,%,0,0
184201,),0,0
184202,achieved,0,0
184203,clinically,0,0
184204,meaningful,0,0
184205,improvement,0,0
184206,by,0,0
184207,week,0,0
184208,1,0,0
184209,while,0,0
184210,322,0,0
184211,of,0,0
184212,the,0,0
184213,444,0,0
184214,category,0,0
184215,2,0,0
184216,responders,0,0
184217,(,0,0
184218,72.5,0,0
184219,%,0,0
184220,),0,0
184221,did,0,0
184222,so,0,0
184223,by,0,0
184224,week,0,0
184225,4,0,0
184226,.,0,0
184227,CONCLUSIONS,0,0
184228,Tadalafil,1,1
184229,5,0,1
184230,mg,0,1
184231,once,0,0
184232,daily,0,1
184233,led,0,0
184234,to,0,0
184235,clinically,0,0
184236,meaningful,0,0
184237,improvement,0,0
184238,in,0,0
184239,approximately,0,0
184240,two-thirds,0,0
184241,of,0,0
184242,men,0,0
184243,with,0,0
184244,lower,0,0
184245,urinary,0,0
184246,tract,0,0
184247,symptoms,0,0
184248,secondary,0,0
184249,to,0,0
184250,benign,0,0
184251,prostatic,0,0
184252,hyperplasia,0,0
184253,.,0,0
184254,More,0,0
184255,than,0,0
184256,half,0,0
184257,of,0,0
184258,this,0,0
184259,group,0,0
184260,of,0,0
184261,tadalafil,1,1
184262,treated,0,0
184263,responders,0,0
184264,achieved,0,0
184265,clinically,0,0
184266,meaningful,0,0
184267,improvement,0,0
184268,after,0,0
184269,1,0,0
184270,week,0,0
184271,of,0,0
184272,therapy,0,1
184273,and,0,0
184274,more,0,0
184275,than,0,0
184276,70,0,0
184277,%,0,0
184278,did,0,0
184279,so,0,0
184280,within,0,0
184281,4,0,0
184282,weeks,0,0
184283,.,0,0
184284,Randomized,0,0
184285,trial,0,0
184286,of,0,0
184287,a,0,0
184288,secondhand,1,0
184289,smoke,1,1
184290,exposure,1,1
184291,reduction,1,0
184292,intervention,1,1
184293,among,0,0
184294,hospital-based,0,1
184295,pregnant,0,0
184296,women,0,0
184297,.,0,0
184298,OBJECTIVE,0,0
184299,This,0,0
184300,study,0,0
184301,sought,0,0
184302,to,0,0
184303,assess,0,0
184304,the,0,0
184305,effectiveness,0,0
184306,of,0,0
184307,a,0,0
184308,secondhand,1,0
184309,tobacco,1,1
184310,smoke,1,1
184311,(,1,1
184312,SHS,1,1
184313,),1,1
184314,prevention,1,0
184315,program,1,1
184316,based,0,0
184317,on,0,0
184318,an,0,0
184319,expanded,0,0
184320,Health,0,0
184321,Belief,0,1
184322,Model,0,1
184323,(,0,1
184324,HBM,0,1
184325,),0,1
184326,incorporating,0,0
184327,self-efficacy,0,1
184328,among,0,0
184329,pregnant,0,0
184330,women,0,0
184331,in,0,0
184332,a,0,0
184333,hospital,0,0
184334,setting,0,0
184335,in,0,0
184336,Taiwan,0,0
184337,.,0,0
184338,METHODOLOGY,0,0
184339,This,0,0
184340,study,0,0
184341,utilized,0,0
184342,a,0,0
184343,two-group,0,0
184344,longitudinal,0,0
184345,randomized,0,0
184346,controlled,0,0
184347,trial,0,0
184348,design,0,0
184349,.,0,0
184350,Participants,1,0
184351,in,1,0
184352,the,1,0
184353,intervention,1,1
184354,group,1,0
184355,(,1,1
184356,n=50,1,1
184357,),1,0
184358,enrolled,1,0
184359,in,1,0
184360,a,1,0
184361,SHS,1,1
184362,prevention,1,0
184363,program,1,1
184364,based,1,0
184365,on,1,0
184366,the,1,0
184367,HBM,1,1
184368,",",1,0
184369,while,1,0
184370,participants,1,0
184371,in,1,0
184372,the,1,0
184373,comparison,1,0
184374,group,1,1
184375,(,1,1
184376,n=50,1,1
184377,),1,1
184378,received,1,1
184379,standard,1,1
184380,government-mandated,1,1
184381,counseling,1,1
184382,care,1,1
184383,.,1,0
184384,Both,1,0
184385,groups,1,0
184386,were,1,0
184387,given,1,0
184388,questionnaires,1,0
184389,as,1,0
184390,a,1,0
184391,pre-test,1,0
184392,",",1,0
184393,two,1,0
184394,weeks,1,0
184395,into,1,0
184396,the,1,0
184397,intervention,1,1
184398,",",1,0
184399,and,1,0
184400,one,1,0
184401,month,1,0
184402,following,1,0
184403,the,1,0
184404,conclusion,1,0
184405,of,1,0
184406,the,1,0
184407,intervention,1,1
184408,.,1,0
184409,The,0,0
184410,questionnaire,0,0
184411,and,0,0
184412,intervention,0,1
184413,were,0,0
184414,developed,0,0
184415,based,0,0
184416,on,0,0
184417,the,0,0
184418,understanding,0,0
184419,gained,0,0
184420,through,0,0
184421,a,0,0
184422,series,0,0
184423,of,0,0
184424,in-depth,0,0
184425,interviews,0,1
184426,and,0,0
184427,a,0,0
184428,focus-group,0,1
184429,conducted,0,0
184430,among,0,0
184431,pregnant,0,0
184432,women,0,0
184433,.,0,0
184434,Exhaled,0,0
184435,carbon,0,1
184436,monoxide,0,1
184437,was,0,0
184438,also,0,0
184439,measured,0,0
184440,and,0,0
184441,used,0,0
184442,as,0,0
184443,a,0,0
184444,proxy,0,0
184445,for,0,0
184446,SHS,0,1
184447,exposure,0,0
184448,.,0,0
184449,RESULTS,0,0
184450,Intervention,0,1
184451,group,0,0
184452,scores,0,0
184453,were,0,0
184454,all,0,0
184455,significantly,0,0
184456,higher,0,0
184457,than,0,0
184458,comparison,0,0
184459,group,0,1
184460,scores,0,0
184461,(,0,0
184462,p,0,0
184463,<,0,0
184464,0.001,0,0
184465,),0,0
184466,",",0,0
184467,indicating,0,0
184468,a,0,0
184469,significant,0,0
184470,increase,0,0
184471,in,0,0
184472,knowledge,0,0
184473,",",0,0
184474,HBM,0,1
184475,scores,0,0
184476,",",0,0
184477,cues,0,0
184478,to,0,0
184479,action,0,0
184480,",",0,0
184481,self-efficacy,0,0
184482,",",0,0
184483,preventative,0,0
184484,behaviors,0,0
184485,",",0,0
184486,and,0,0
184487,a,0,0
184488,significant,0,0
184489,decrease,0,0
184490,in,0,0
184491,smoking,0,0
184492,exposure,0,0
184493,.,0,0
184494,These,0,0
184495,differences,0,0
184496,remained,0,0
184497,significant,0,0
184498,at,0,0
184499,the,0,0
184500,one-month,0,0
184501,follow-up,0,0
184502,assessment,0,0
184503,(,0,0
184504,p,0,0
184505,<,0,0
184506,0.001,0,0
184507,),0,0
184508,.,0,0
184509,CONCLUSIONS,0,0
184510,These,0,0
184511,results,0,0
184512,should,0,0
184513,encourage,0,0
184514,health,0,0
184515,professionals,0,0
184516,to,0,0
184517,educate,0,0
184518,pregnant,0,0
184519,women,0,0
184520,regarding,0,0
184521,the,0,0
184522,harms,0,0
184523,of,0,0
184524,SHS,0,1
184525,while,0,0
184526,both,0,0
184527,empowering,0,1
184528,and,0,0
184529,equipping,0,0
184530,them,0,0
184531,with,0,0
184532,the,0,0
184533,tools,0,0
184534,to,0,0
184535,confront,0,0
184536,their,0,0
184537,family,0,1
184538,members,0,0
184539,and,0,0
184540,effectively,0,0
184541,reduce,0,0
184542,their,0,0
184543,SHS,0,1
184544,exposure,0,0
184545,while,0,0
184546,promoting,0,0
184547,smoke-free,0,1
184548,social,0,0
184549,norms,0,0
184550,.,0,0
184551,A,0,0
184552,step-by-step,0,0
184553,introduction,0,0
184554,to,0,0
184555,vegetables,1,1
184556,at,0,0
184557,the,0,0
184558,beginning,0,0
184559,of,0,0
184560,complementary,0,1
184561,feeding,0,0
184562,.,0,0
184563,The,0,0
184564,effects,0,0
184565,of,0,0
184566,early,0,0
184567,and,0,0
184568,repeated,0,0
184569,exposure,0,0
184570,.,0,1
184571,Breastfeeding,0,0
184572,(,0,0
184573,BF,0,1
184574,),0,1
184575,is,0,0
184576,associated,0,0
184577,with,0,0
184578,willingness,0,0
184579,to,0,0
184580,accept,0,0
184581,vegetables,0,1
184582,.,0,0
184583,This,0,0
184584,may,0,0
184585,be,0,0
184586,due,0,0
184587,to,0,0
184588,the,0,0
184589,variety,0,0
184590,of,0,0
184591,flavours,0,1
184592,delivered,0,0
184593,via,0,0
184594,breast,0,0
184595,milk,0,1
184596,.,0,0
184597,Some,0,0
184598,mothers,0,0
184599,add,0,0
184600,vegetables,0,1
184601,to,0,0
184602,milk,0,1
184603,during,0,0
184604,complementary,0,1
184605,feeding,0,1
184606,(,0,1
184607,CF,0,1
184608,),0,1
184609,to,0,0
184610,enhance,0,0
184611,acceptance,0,0
184612,.,0,0
184613,The,0,0
184614,present,0,0
184615,study,0,0
184616,tested,0,0
184617,a,0,0
184618,step-by-step,0,1
184619,exposure,0,0
184620,to,0,0
184621,vegetables,1,1
184622,in,1,0
184623,milk,1,1
184624,then,1,1
184625,rice,1,1
184626,during,0,0
184627,CF,0,1
184628,",",0,0
184629,on,0,0
184630,intake,0,0
184631,and,0,0
184632,liking,0,0
184633,of,0,0
184634,vegetables,0,1
184635,.,0,0
184636,Just,0,0
184637,before,0,0
184638,CF,0,1
184639,",",0,0
184640,enrolled,0,0
184641,mothers,0,0
184642,were,0,0
184643,randomised,0,0
184644,to,0,0
184645,an,0,0
184646,intervention,0,1
184647,(,0,0
184648,IG,0,0
184649,",",0,0
184650,n,0,0
184651,=,0,0
184652,18,0,0
184653,;,0,0
184654,6,0,0
184655,BF,0,1
184656,),0,0
184657,or,0,1
184658,control,0,1
184659,group,0,1
184660,(,0,0
184661,CG,0,0
184662,",",0,0
184663,n,0,0
184664,=,0,0
184665,18,0,0
184666,;,0,0
184667,6,0,0
184668,BF,0,1
184669,),0,0
184670,.,0,0
184671,IG,0,0
184672,infants,0,0
184673,received,0,0
184674,12,0,0
184675,daily,0,0
184676,exposures,1,0
184677,to,1,0
184678,vegetable,1,1
184679,puree,1,1
184680,added,1,0
184681,to,1,0
184682,milk,1,1
184683,(,0,0
184684,days,0,0
184685,1-12,0,0
184686,),0,0
184687,",",0,0
184688,then,0,0
184689,12,0,0
184690,?,0,0
184691,2,0,0
184692,daily,0,0
184693,exposures,0,0
184694,to,0,0
184695,vegetable,1,1
184696,puree,1,1
184697,added,1,0
184698,to,1,0
184699,rice,1,1
184700,at,1,0
184701,home,1,1
184702,(,0,0
184703,days,0,1
184704,13-24,0,0
184705,),0,0
184706,.,0,0
184707,Plain,1,0
184708,milk,1,1
184709,and,1,0
184710,rice,1,1
184711,were,1,0
184712,given,0,0
184713,to,0,0
184714,CG,0,0
184715,.,0,0
184716,Then,0,0
184717,both,0,0
184718,received,0,0
184719,11,0,0
184720,daily,0,0
184721,exposures,0,0
184722,to,0,0
184723,vegetable,1,1
184724,puree,1,1
184725,.,1,0
184726,Intake,1,0
184727,was,0,0
184728,weighed,0,0
184729,and,0,0
184730,liking,0,0
184731,rated,0,0
184732,on,0,0
184733,days,0,0
184734,25-26,0,0
184735,and,0,0
184736,33-35,0,0
184737,after,0,0
184738,the,0,0
184739,start,0,0
184740,of,0,0
184741,CF,0,1
184742,in,0,0
184743,the,0,0
184744,laboratory,0,0
184745,",",0,0
184746,supplemented,0,1
184747,by,0,0
184748,the,0,0
184749,same,0,0
184750,data,0,0
184751,recorded,0,0
184752,at,0,0
184753,home,0,1
184754,.,0,0
184755,Vegetables,0,0
184756,were,0,0
184757,rotated,0,1
184758,daily,0,1
184759,(,0,0
184760,carrots,0,1
184761,",",0,0
184762,green,0,1
184763,beans,0,1
184764,",",0,0
184765,spinach,0,1
184766,",",0,0
184767,broccoli,0,1
184768,),0,0
184769,.,0,0
184770,Intake,0,0
184771,",",0,0
184772,liking,0,0
184773,and,0,0
184774,pace,0,1
184775,of,0,0
184776,eating,0,0
184777,were,0,0
184778,greater,0,0
184779,for,0,0
184780,IG,0,0
184781,than,0,0
184782,CG,0,0
184783,infants,0,0
184784,.,0,0
184785,Intake,0,0
184786,and,0,0
184787,liking,0,0
184788,of,0,0
184789,carrots,0,1
184790,were,0,0
184791,greater,0,0
184792,than,0,0
184793,green,0,0
184794,beans,0,1
184795,.,0,0
184796,However,0,0
184797,",",0,0
184798,at,0,0
184799,6m,0,0
184800,then,0,0
184801,18m,0,0
184802,follow,0,0
184803,up,0,0
184804,",",0,0
184805,vegetable,0,1
184806,(,0,0
184807,carrot,0,1
184808,>,0,0
184809,green,0,1
184810,beans,0,1
184811,),0,0
184812,but,0,0
184813,not,0,0
184814,group,0,0
184815,differences,0,0
184816,were,0,0
184817,observed,0,0
184818,.,0,0
184819,Mothers,0,0
184820,reported,0,0
184821,appreciation,0,0
184822,of,0,0
184823,the,0,0
184824,structure,0,0
184825,and,0,0
184826,guidance,0,1
184827,of,0,0
184828,this,0,0
184829,systematic,0,0
184830,approach,0,1
184831,.,0,0
184832,Early,0,0
184833,exposure,0,0
184834,to,0,0
184835,vegetables,1,1
184836,in,1,0
184837,a,0,0
184838,step-by-step,0,1
184839,method,0,0
184840,could,0,0
184841,be,0,0
184842,included,0,0
184843,in,0,0
184844,CF,0,1
184845,guidelines,0,0
184846,and,0,0
184847,longer,0,0
184848,term,0,0
184849,benefits,0,0
184850,assessed,0,0
184851,by,0,0
184852,extending,0,0
184853,the,0,0
184854,exposure,0,0
184855,period,0,0
184856,.,0,0
184857,Reducing,0,0
184858,iodine,0,1
184859,load,0,0
184860,in,0,0
184861,hepatic,0,0
184862,CT,0,0
184863,for,0,0
184864,patients,0,0
184865,with,0,0
184866,chronic,0,0
184867,liver,0,0
184868,disease,0,0
184869,with,0,0
184870,a,0,0
184871,combination,1,1
184872,of,1,0
184873,low-tube-voltage,1,1
184874,and,1,0
184875,adaptive,1,0
184876,statistical,1,0
184877,iterative,1,1
184878,reconstruction,1,1
184879,.,1,0
184880,PURPOSE,0,0
184881,To,0,0
184882,prospectively,0,0
184883,assess,0,0
184884,the,0,0
184885,effect,0,0
184886,of,0,0
184887,reduced,0,0
184888,iodine,0,1
184889,load,0,0
184890,to,0,0
184891,contrast,0,1
184892,enhancement,0,0
184893,",",0,0
184894,image,0,1
184895,quality,0,0
184896,",",0,0
184897,and,0,0
184898,detectability,0,0
184899,of,0,0
184900,hepatocellular,0,0
184901,carcinomas,0,0
184902,(,0,1
184903,HCCs,0,1
184904,),0,1
184905,in,0,0
184906,hepatic,0,0
184907,CT,0,0
184908,with,0,0
184909,a,0,0
184910,combination,0,1
184911,of,0,0
184912,80,1,0
184913,kVp,1,0
184914,tube,1,1
184915,voltage,1,1
184916,setting,1,0
184917,and,1,0
184918,adaptive,1,0
184919,statistical,1,0
184920,iterative,1,1
184921,reconstruction,1,1
184922,(,1,1
184923,ASIR,1,1
184924,),1,1
184925,technique,1,1
184926,in,0,0
184927,patients,0,0
184928,with,0,0
184929,chronic,0,0
184930,liver,0,0
184931,disease,0,0
184932,.,0,0
184933,MATERIALS,0,0
184934,AND,0,0
184935,METHODS,0,0
184936,This,0,0
184937,HIPAA-compliant,0,0
184938,study,0,0
184939,was,0,0
184940,approved,0,0
184941,by,0,0
184942,our,0,0
184943,institutional,0,0
184944,review,0,0
184945,board,0,1
184946,and,0,0
184947,written,0,1
184948,informed,0,0
184949,consent,0,0
184950,was,0,0
184951,obtained,0,0
184952,in,0,0
184953,all,0,0
184954,patients,0,0
184955,.,0,0
184956,During,0,0
184957,a,0,0
184958,recent,0,0
184959,9-month,0,0
184960,period,0,0
184961,",",0,0
184962,170,0,0
184963,consecutive,0,0
184964,patients,0,0
184965,(,0,0
184966,114,0,0
184967,men,0,0
184968,and,0,0
184969,56,0,0
184970,women,0,0
184971,;,0,0
184972,age,0,0
184973,range,0,0
184974,",",0,0
184975,40-85,0,0
184976,years,0,0
184977,;,0,0
184978,mean,0,0
184979,",",0,0
184980,67.7,0,0
184981,years,0,0
184982,),0,0
184983,with,0,0
184984,suspected,0,0
184985,chronic,0,0
184986,liver,0,0
184987,diseases,0,0
184988,were,0,0
184989,randomized,1,0
184990,into,1,0
184991,three,1,0
184992,CT,1,0
184993,groups,1,0
184994,according,0,0
184995,to,0,0
184996,the,0,0
184997,following,0,0
184998,iodine-load,1,1
184999,and,1,0
185000,tube-voltage,1,1
185001,protocols,1,1
185002,:,1,0
185003,600,1,0
185004,milligram,1,1
185005,per,1,1
185006,kilogram,1,1
185007,body,1,0
185008,weight,1,1
185009,(,1,1
185010,mg/kg,1,1
185011,),1,1
185012,iodine,1,1
185013,load,1,0
185014,and,1,0
185015,120,1,0
185016,peak,1,0
185017,kilovolt,1,1
185018,(,1,1
185019,kVp,1,1
185020,),1,1
185021,tube,1,1
185022,voltage,1,1
185023,setting,1,0
185024,(,1,0
185025,600-120,1,1
185026,group,1,1
185027,),1,0
185028,",",1,0
185029,500,1,1
185030,mg/kg,1,1
185031,and,1,0
185032,80,1,0
185033,kVp,1,1
185034,(,1,0
185035,500-80,1,1
185036,group,1,1
185037,),1,0
185038,",",1,0
185039,and,1,0
185040,400mg/kg,1,1
185041,and,1,0
185042,80,1,0
185043,kVp,1,1
185044,(,1,0
185045,400-80,1,1
185046,group,1,0
185047,),1,0
185048,.,0,0
185049,Analysis,0,0
185050,of,0,0
185051,variance,0,0
185052,was,0,0
185053,conducted,0,0
185054,to,0,0
185055,evaluate,0,0
185056,differences,0,0
185057,in,0,0
185058,CT,0,0
185059,number,0,0
185060,",",0,0
185061,background,0,0
185062,noise,0,0
185063,",",0,0
185064,signal-to-noise,0,1
185065,ratio,0,0
185066,(,0,1
185067,SNR,0,1
185068,),0,1
185069,",",0,0
185070,effective,0,0
185071,dose,0,0
185072,",",0,0
185073,HCC-to-liver,0,0
185074,contrast-to-noise,0,0
185075,ratio,0,0
185076,(,0,1
185077,CNR,0,0
185078,),0,1
185079,",",0,0
185080,and,0,0
185081,figure,0,0
185082,of,0,0
185083,merit,0,0
185084,(,0,1
185085,FOM,0,1
185086,),0,0
185087,.,0,0
185088,Sensitivity,0,0
185089,",",0,0
185090,specificity,0,0
185091,",",0,0
185092,and,0,0
185093,area,0,0
185094,under,0,0
185095,the,0,0
185096,receiver-operating-characteristic,0,0
185097,curve,0,0
185098,(,0,1
185099,AUC,0,0
185100,),0,1
185101,were,0,0
185102,compared,0,0
185103,to,0,0
185104,assess,0,0
185105,the,0,0
185106,detectability,0,0
185107,of,0,0
185108,HCCs,0,1
185109,.,0,0
185110,RESULTS,0,0
185111,Vascular,0,0
185112,and,0,0
185113,hepatic,0,0
185114,enhancement,0,0
185115,in,0,0
185116,the,0,0
185117,400-80,0,1
185118,and,0,0
185119,500-80,0,1
185120,groups,0,0
185121,was,0,0
185122,comparable,0,0
185123,to,0,0
185124,or,0,0
185125,greater,0,0
185126,than,0,0
185127,that,0,0
185128,in,0,0
185129,the,0,0
185130,600-120,0,1
185131,group,0,0
185132,(,0,0
185133,P,0,0
185134,<,0,0
185135,.05,0,0
185136,),0,0
185137,.,0,0
185138,Subjective,0,0
185139,image,0,0
185140,quality,0,0
185141,was,0,0
185142,comparable,0,0
185143,among,0,0
185144,the,0,0
185145,three,0,0
185146,groups,0,0
185147,.,0,0
185148,Sensitivity,0,0
185149,",",0,0
185150,specificity,0,0
185151,",",0,0
185152,and,0,0
185153,AUC,0,0
185154,for,0,0
185155,detecting,0,0
185156,HCCs,0,1
185157,were,0,0
185158,comparable,0,0
185159,among,0,0
185160,the,0,0
185161,groups,0,0
185162,.,0,0
185163,The,0,0
185164,effective,0,0
185165,dose,0,0
185166,was,0,0
185167,kept,0,0
185168,low,0,0
185169,(,0,0
185170,3.3-4.1,0,0
185171,mSv,0,1
185172,),0,0
185173,in,0,0
185174,all,0,0
185175,three,0,0
185176,groups,0,0
185177,.,0,0
185178,CONCLUSION,0,0
185179,Iodine,0,1
185180,load,0,0
185181,can,0,0
185182,be,0,0
185183,reduced,0,0
185184,by,0,0
185185,33,0,0
185186,%,0,0
185187,in,0,0
185188,CT,0,0
185189,of,0,0
185190,the,0,0
185191,liver,0,0
185192,with,0,0
185193,a,0,0
185194,combination,0,1
185195,of,0,0
185196,80,1,0
185197,kVp,1,0
185198,tube,1,1
185199,voltage,1,1
185200,setting,1,0
185201,and,1,0
185202,ASIR,1,1
185203,technique,1,1
185204,",",0,0
185205,without,0,0
185206,compromising,0,0
185207,the,0,0
185208,contrast,0,1
185209,enhancement,0,0
185210,",",0,0
185211,image,0,1
185212,quality,0,0
185213,",",0,0
185214,and,0,0
185215,detection,0,1
185216,of,0,0
185217,HCCs,0,1
185218,.,0,0
185219,Everolimus,1,1
185220,for,0,0
185221,subependymal,0,0
185222,giant,0,1
185223,cell,0,0
185224,astrocytoma,0,0
185225,in,0,0
185226,patients,0,0
185227,with,0,0
185228,tuberous,0,0
185229,sclerosis,0,1
185230,complex,0,0
185231,:,0,0
185232,2-year,0,0
185233,open-label,0,0
185234,extension,0,0
185235,of,0,0
185236,the,0,0
185237,randomised,0,0
185238,EXIST-1,0,0
185239,study,0,0
185240,.,0,0
185241,BACKGROUND,0,0
185242,In,0,0
185243,the,0,0
185244,EXIST-1,0,1
185245,trial,0,0
185246,",",0,0
185247,initiated,0,0
185248,on,0,0
185249,Aug,0,0
185250,10,0,0
185251,",",0,0
185252,2009,0,0
185253,",",0,0
185254,more,0,0
185255,than,0,0
185256,35,0,0
185257,%,0,0
185258,of,0,0
185259,patients,0,0
185260,with,0,0
185261,subependymal,0,0
185262,giant,0,1
185263,cell,0,0
185264,astrocytoma,0,0
185265,(,0,1
185266,SEGA,0,1
185267,),0,1
185268,associated,0,0
185269,with,0,0
185270,tuberous,0,0
185271,sclerosis,0,1
185272,complex,0,0
185273,had,0,0
185274,at,0,0
185275,least,0,0
185276,50,0,1
185277,%,0,0
185278,reduction,0,0
185279,in,0,0
185280,SEGA,0,0
185281,volume,0,0
185282,after,0,0
185283,9?6,0,1
185284,months,0,0
185285,of,0,0
185286,treatment,0,0
185287,with,0,0
185288,everolimus,0,1
185289,.,0,0
185290,In,0,0
185291,this,0,0
185292,Article,0,0
185293,",",0,0
185294,we,0,0
185295,report,0,0
185296,interim,0,0
185297,data,0,0
185298,(,0,0
185299,up,0,0
185300,to,0,0
185301,Jan,0,0
185302,11,0,0
185303,",",0,0
185304,2013,0,0
185305,),0,0
185306,to,0,0
185307,support,0,1
185308,longer-term,0,0
185309,tolerability,0,0
185310,and,0,0
185311,efficacy,0,0
185312,of,1,0
185313,everolimus,1,1
185314,from,0,0
185315,the,0,0
185316,continuing,0,0
185317,4-year,0,0
185318,extension,0,0
185319,phase,0,0
185320,of,0,0
185321,EXIST-1,0,0
185322,.,0,0
185323,METHODS,0,0
185324,We,0,0
185325,assessed,0,0
185326,data,0,0
185327,from,0,0
185328,a,0,0
185329,prospective,0,0
185330,",",0,0
185331,open-label,0,0
185332,extension,0,0
185333,of,0,0
185334,a,0,0
185335,multicentre,0,0
185336,",",0,0
185337,phase,0,0
185338,3,0,0
185339,",",0,0
185340,randomised,0,0
185341,",",0,0
185342,double-blind,0,0
185343,",",0,0
185344,placebo-controlled,1,1
185345,study,0,0
185346,in,0,0
185347,patients,0,0
185348,with,0,0
185349,tuberous,0,0
185350,sclerosis,0,1
185351,complex,0,0
185352,who,0,0
185353,had,0,0
185354,SEGA,0,0
185355,that,0,0
185356,was,0,0
185357,growing,0,0
185358,and,0,0
185359,needed,0,0
185360,treatment,0,0
185361,.,0,0
185362,In,0,0
185363,this,0,0
185364,extension,0,0
185365,study,0,0
185366,",",0,0
185367,we,0,0
185368,included,0,0
185369,all,0,0
185370,patients,0,0
185371,who,0,0
185372,had,0,0
185373,been,0,0
185374,assigned,1,0
185375,everolimus,1,1
185376,during,0,0
185377,the,0,0
185378,double-blind,0,0
185379,",",0,0
185380,randomised,0,0
185381,phase,0,0
185382,of,0,0
185383,the,0,0
185384,trial,0,0
185385,and,0,0
185386,those,0,0
185387,patients,0,0
185388,who,0,0
185389,crossed,0,1
185390,over,0,0
185391,from,0,0
185392,the,1,0
185393,placebo,1,1
185394,group,0,0
185395,to,0,0
185396,receive,1,1
185397,everolimus,1,1
185398,during,0,0
185399,the,0,0
185400,randomised,0,0
185401,phase,0,0
185402,or,0,1
185403,at,0,0
185404,the,0,0
185405,start,0,0
185406,of,0,0
185407,the,0,0
185408,extension,0,0
185409,phase,0,0
185410,.,0,0
185411,All,0,0
185412,patients,0,0
185413,received,0,0
185414,oral,1,1
185415,everolimus,1,1
185416,at,0,0
185417,a,0,0
185418,starting,0,0
185419,dose,0,0
185420,of,0,0
185421,4?5,0,1
185422,mg/m,0,1
185423,(,0,0
185424,2,0,0
185425,),0,0
185426,per,0,0
185427,day,1,0
185428,.,1,0
185429,Everolimus,1,1
185430,dose,1,0
185431,was,0,0
185432,subsequently,0,0
185433,adjusted,0,0
185434,subject,0,0
185435,to,0,0
185436,tolerability,0,0
185437,to,0,0
185438,attain,0,0
185439,blood,0,0
185440,trough,0,0
185441,concentrations,0,0
185442,of,0,0
185443,5-15,0,0
185444,ng/mL,0,0
185445,.,0,0
185446,An,0,0
185447,independent,0,0
185448,central,0,0
185449,radiology,0,1
185450,review,0,0
185451,team,0,0
185452,assessed,0,0
185453,SEGA,0,1
185454,response,0,0
185455,(,0,0
185456,at,0,0
185457,least,0,0
185458,a,0,0
185459,50,0,1
185460,%,0,0
185461,reduction,0,0
185462,from,0,0
185463,baseline,0,0
185464,in,0,0
185465,total,0,0
185466,volume,0,0
185467,of,0,0
185468,all,0,0
185469,target,0,0
185470,SEGAs,0,0
185471,;,0,0
185472,the,0,0
185473,primary,0,0
185474,endpoint,0,0
185475,),0,0
185476,by,0,0
185477,MRI,0,0
185478,at,0,0
185479,12,0,0
185480,",",0,0
185481,24,0,0
185482,",",0,0
185483,and,0,0
185484,48,0,0
185485,weeks,0,0
185486,",",0,0
185487,then,0,0
185488,every,0,1
185489,year,0,0
185490,thereafter,0,0
185491,in,0,0
185492,all,0,0
185493,patients,0,0
185494,who,0,0
185495,received,0,0
185496,at,0,0
185497,least,0,0
185498,one,0,0
185499,dose,0,0
185500,of,0,0
185501,everolimus,0,1
185502,.,0,0
185503,This,0,0
185504,study,0,0
185505,was,0,0
185506,registered,0,0
185507,with,0,0
185508,ClinicalTrials.gov,0,0
185509,",",0,0
185510,number,0,0
185511,NCT00789828,0,0
185512,.,0,0
185513,FINDINGS,0,0
185514,Of,0,1
185515,the,0,0
185516,original,0,0
185517,117,0,0
185518,randomly,0,0
185519,assigned,0,0
185520,patients,0,0
185521,",",0,0
185522,111,0,0
185523,were,0,0
185524,given,0,0
185525,everolimus,0,1
185526,between,0,0
185527,Aug,0,0
185528,20,0,0
185529,",",0,0
185530,2009,0,0
185531,",",0,0
185532,and,0,0
185533,Jan,0,0
185534,11,0,0
185535,",",0,0
185536,2013,0,0
185537,(,0,0
185538,date,0,0
185539,of,0,0
185540,data,0,0
185541,cutoff,0,0
185542,),0,0
185543,;,0,0
185544,we,0,0
185545,included,0,0
185546,these,0,0
185547,patients,0,0
185548,in,0,0
185549,our,0,0
185550,longer-term,0,0
185551,analysis,0,0
185552,.,0,0
185553,Median,0,0
185554,duration,0,0
185555,of,0,0
185556,everolimus,0,1
185557,exposure,0,0
185558,was,0,0
185559,29?3,0,1
185560,months,0,0
185561,(,0,0
185562,IQR,0,1
185563,19?4-33?8,0,1
185564,),0,0
185565,.,0,0
185566,Median,0,0
185567,follow-up,0,0
185568,was,0,0
185569,28?3,0,0
185570,months,0,0
185571,(,0,0
185572,IQR,0,1
185573,19?3-33?0,0,1
185574,),0,0
185575,.,0,0
185576,54,0,0
185577,(,0,0
185578,49,0,0
185579,%,0,0
185580,),0,0
185581,patients,0,0
185582,had,0,0
185583,a,0,0
185584,response,0,0
185585,of,0,0
185586,50,0,1
185587,%,0,0
185588,or,0,0
185589,greater,0,0
185590,reduction,0,0
185591,in,0,0
185592,SEGA,0,1
185593,volume,0,0
185594,(,0,0
185595,95,0,0
185596,%,0,0
185597,CI,0,0
185598,39?0-58?3,0,1
185599,),0,0
185600,",",0,0
185601,and,0,0
185602,duration,0,0
185603,of,0,0
185604,response,0,0
185605,was,0,0
185606,between,0,0
185607,2?1,0,0
185608,and,0,0
185609,31?1,0,1
185610,months,0,0
185611,(,0,0
185612,median,0,0
185613,not,0,0
185614,reached,0,0
185615,),0,0
185616,.,0,0
185617,SEGA,0,0
185618,volume,0,0
185619,was,0,0
185620,reduced,0,0
185621,by,0,0
185622,50,0,1
185623,%,0,0
185624,or,0,0
185625,more,0,0
185626,in,0,0
185627,39,0,0
185628,(,0,0
185629,37,0,0
185630,%,0,0
185631,),0,0
185632,of,0,0
185633,105,0,0
185634,patients,0,0
185635,at,0,0
185636,24,0,0
185637,weeks,0,0
185638,",",0,0
185639,48,0,0
185640,(,0,0
185641,46,0,0
185642,%,0,0
185643,),0,0
185644,of,0,0
185645,104,0,0
185646,patients,0,0
185647,at,0,0
185648,48,0,0
185649,weeks,0,0
185650,",",0,0
185651,36,0,0
185652,(,0,0
185653,47,0,0
185654,%,0,0
185655,),0,0
185656,of,0,0
185657,76,0,0
185658,patients,0,0
185659,at,0,0
185660,96,0,0
185661,weeks,0,0
185662,",",0,0
185663,and,0,0
185664,11,0,0
185665,(,0,0
185666,38,0,0
185667,%,0,0
185668,),0,0
185669,of,0,0
185670,29,0,0
185671,patients,0,0
185672,at,0,0
185673,144,0,0
185674,weeks,0,0
185675,.,0,0
185676,Stomatitis,0,0
185677,(,0,0
185678,48,0,0
185679,[,0,0
185680,43,0,0
185681,%,0,0
185682,],0,0
185683,patients,0,0
185684,),0,0
185685,and,0,0
185686,mouth,0,1
185687,ulceration,0,0
185688,(,0,0
185689,33,0,0
185690,[,0,0
185691,30,0,0
185692,%,0,0
185693,],0,0
185694,patients,0,0
185695,),0,0
185696,were,0,0
185697,the,0,0
185698,most,0,0
185699,frequent,0,0
185700,treatment-related,0,0
185701,adverse,0,0
185702,events,0,0
185703,;,0,0
185704,infections,0,0
185705,were,0,0
185706,the,0,0
185707,most,0,0
185708,commonly,0,0
185709,reported,0,0
185710,treatment-related,0,0
185711,serious,0,0
185712,adverse,0,0
185713,event,0,0
185714,",",0,0
185715,occurring,0,0
185716,in,0,0
185717,15,0,0
185718,(,0,0
185719,14,0,1
185720,%,0,0
185721,),0,0
185722,patients,0,0
185723,.,0,0
185724,35,0,0
185725,(,0,0
185726,32,0,0
185727,%,0,0
185728,),0,0
185729,patients,0,0
185730,reported,0,0
185731,treatment-related,0,0
185732,grade,0,0
185733,3,0,0
185734,or,0,0
185735,4,0,0
185736,adverse,0,0
185737,events,0,0
185738,",",0,0
185739,the,0,0
185740,most,0,0
185741,common,0,0
185742,of,0,0
185743,which,0,0
185744,were,0,0
185745,stomatitis,0,1
185746,(,0,0
185747,nine,0,0
185748,[,0,0
185749,8,0,0
185750,%,0,0
185751,],0,0
185752,),0,1
185753,and,0,1
185754,pneumonia,0,0
185755,(,0,0
185756,nine,0,0
185757,[,0,0
185758,8,0,0
185759,%,0,0
185760,],0,0
185761,),0,0
185762,.,0,0
185763,18,0,0
185764,(,0,0
185765,16,0,0
185766,%,0,0
185767,),0,0
185768,patients,0,0
185769,had,0,0
185770,treatment-related,0,0
185771,serious,0,0
185772,adverse,0,0
185773,events,0,0
185774,.,0,0
185775,Six,0,0
185776,(,0,0
185777,5,0,1
185778,%,0,0
185779,),0,0
185780,patients,0,0
185781,withdrew,0,0
185782,because,0,0
185783,of,0,0
185784,adverse,0,0
185785,events,0,0
185786,.,0,0
185787,INTERPRETATION,0,0
185788,These,0,0
185789,results,0,0
185790,support,0,0
185791,the,0,0
185792,longer-term,0,0
185793,use,0,0
185794,of,0,0
185795,everolimus,0,1
185796,in,0,0
185797,patients,0,0
185798,who,0,0
185799,have,0,0
185800,few,0,0
185801,treatment,0,0
185802,options,0,0
185803,and,0,0
185804,who,0,0
185805,need,0,0
185806,continued,0,0
185807,treatment,0,0
185808,for,0,0
185809,tuberous,0,1
185810,sclerosis,0,1
185811,complex,0,1
185812,and,0,0
185813,its,0,0
185814,varied,0,0
185815,manifestations,0,0
185816,.,0,0
185817,Reduction,0,0
185818,or,0,1
185819,stabilisation,0,0
185820,of,0,0
185821,tumour,0,0
185822,volume,0,0
185823,with,0,0
185824,everolimus,1,1
185825,will,0,0
185826,hopefully,0,0
185827,provide,0,0
185828,long-term,0,0
185829,clinical,0,0
185830,benefit,0,0
185831,in,0,0
185832,patients,0,0
185833,with,0,0
185834,SEGA,0,0
185835,.,0,1
185836,FUNDING,0,0
185837,Novartis,0,0
185838,Pharmaceuticals,0,1
185839,.,0,0
185840,Increased,0,0
185841,dietary,1,1
185842,?-linolenic,1,1
185843,acid,1,1
185844,has,0,0
185845,sex-specific,0,0
185846,effects,0,0
185847,upon,0,0
185848,eicosapentaenoic,0,1
185849,acid,0,1
185850,status,0,0
185851,in,0,0
185852,humans,0,0
185853,:,0,0
185854,re-examination,0,0
185855,of,0,0
185856,data,0,0
185857,from,0,0
185858,a,0,0
185859,randomised,0,0
185860,",",0,0
185861,placebo-controlled,0,1
185862,",",0,0
185863,parallel,0,0
185864,study,0,0
185865,.,0,0
185866,BACKGROUND,0,0
185867,There,0,0
185868,is,0,0
185869,a,0,0
185870,metabolic,0,0
185871,pathway,0,0
185872,by,0,0
185873,which,0,0
185874,mammals,0,0
185875,can,0,0
185876,convert,0,0
185877,the,0,0
185878,omega-3,1,1
185879,(,1,0
185880,n-3,1,1
185881,),1,1
185882,essential,1,0
185883,fatty,1,1
185884,acid,1,1
185885,?-linolenic,1,1
185886,acid,1,1
185887,(,1,1
185888,ALA,1,1
185889,),1,1
185890,into,1,0
185891,longer-chain,1,0
185892,n-3,1,1
185893,polyunsaturated,1,1
185894,fatty,1,1
185895,acids,1,1
185896,(,1,0
185897,LC,0,0
185898,n-3,0,1
185899,PUFA,0,1
185900,),0,1
185901,including,1,0
185902,eicosapentaenoic,1,1
185903,acid,1,1
185904,(,1,1
185905,EPA,0,1
185906,),0,1
185907,and,1,0
185908,docosahexaenoic,1,1
185909,acid,1,1
185910,(,1,1
185911,DHA,0,1
185912,),0,0
185913,.,0,0
185914,As,0,0
185915,far,0,0
185916,as,0,0
185917,we,0,0
185918,know,0,0
185919,there,0,0
185920,are,0,0
185921,currently,0,0
185922,no,0,0
185923,studies,0,0
185924,that,0,0
185925,have,0,0
185926,specifically,0,0
185927,examined,0,0
185928,sex,0,0
185929,differences,0,0
185930,in,0,0
185931,the,0,0
185932,LC,0,0
185933,n-3,0,1
185934,PUFA,0,0
185935,response,0,0
185936,to,0,0
185937,increased,0,0
185938,dietary,0,1
185939,ALA,0,1
185940,intake,0,0
185941,in,0,0
185942,humans,0,0
185943,",",0,0
185944,although,0,0
185945,acute,0,0
185946,studies,0,0
185947,with,0,0
185948,isotope-labelled,0,0
185949,ALA,0,0
185950,identified,0,0
185951,that,0,0
185952,women,0,0
185953,have,0,0
185954,a,0,0
185955,significantly,0,0
185956,greater,0,0
185957,capacity,0,0
185958,to,0,0
185959,synthesise,0,0
185960,EPA,0,1
185961,and,0,0
185962,DHA,0,1
185963,from,0,0
185964,ALA,0,1
185965,compared,0,0
185966,to,0,0
185967,men,0,0
185968,.,0,0
185969,FINDINGS,0,0
185970,Available,0,0
185971,data,0,0
185972,from,0,0
185973,a,0,0
185974,placebo-controlled,0,1
185975,",",0,0
185976,randomised,0,0
185977,study,0,0
185978,were,0,0
185979,re-examined,0,0
185980,to,0,0
185981,identify,0,0
185982,whether,0,0
185983,there,0,0
185984,are,0,0
185985,sex,0,0
185986,differences,0,0
185987,in,0,0
185988,the,0,0
185989,LC,0,0
185990,n-3,0,1
185991,PUFA,0,0
185992,response,0,0
185993,to,0,0
185994,increased,1,0
185995,dietary,1,1
185996,ALA,1,1
185997,intake,1,0
185998,in,1,0
185999,humans,0,0
186000,.,0,0
186001,There,0,0
186002,was,0,0
186003,a,0,0
186004,significant,0,0
186005,difference,0,0
186006,between,0,0
186007,sexes,0,0
186008,in,0,0
186009,the,0,0
186010,response,0,0
186011,to,0,0
186012,increased,1,0
186013,dietary,1,1
186014,ALA,1,0
186015,",",1,0
186016,with,0,0
186017,women,0,0
186018,having,0,0
186019,a,0,0
186020,significantly,0,0
186021,greater,0,0
186022,increase,0,0
186023,in,0,0
186024,the,0,0
186025,EPA,0,1
186026,content,0,0
186027,of,0,0
186028,plasma,0,0
186029,phospholipids,0,0
186030,(,0,0
186031,mean,0,0
186032,+2.0,0,1
186033,%,0,0
186034,of,0,0
186035,total,0,0
186036,fatty,0,1
186037,acids,0,1
186038,),0,0
186039,after,0,0
186040,six,0,0
186041,months,0,0
186042,of,0,0
186043,an,0,0
186044,ALA-rich,1,1
186045,diet,1,1
186046,compared,1,0
186047,to,0,0
186048,men,0,0
186049,(,0,0
186050,mean,0,0
186051,+0.7,0,0
186052,%,0,0
186053,",",0,0
186054,P,0,0
186055,=,0,0
186056,0.039,0,0
186057,),0,0
186058,.,0,0
186059,Age,0,1
186060,and,0,0
186061,BMI,0,1
186062,were,0,0
186063,identified,0,0
186064,as,0,0
186065,predictors,0,0
186066,of,0,0
186067,response,0,0
186068,to,0,0
186069,dietary,0,1
186070,ALA,0,1
186071,among,0,0
186072,women,0,0
186073,.,0,0
186074,CONCLUSIONS,0,0
186075,Women,0,0
186076,show,0,0
186077,a,0,0
186078,greater,0,0
186079,increase,0,0
186080,in,0,0
186081,circulating,0,0
186082,EPA,0,1
186083,than,0,0
186084,men,0,0
186085,during,0,0
186086,increased,0,0
186087,dietary,0,1
186088,ALA,0,1
186089,consumption,0,0
186090,.,0,0
186091,Further,0,0
186092,understanding,0,0
186093,of,0,0
186094,individual,0,0
186095,variation,0,0
186096,in,0,0
186097,the,0,0
186098,response,1,0
186099,to,1,0
186100,dietary,1,1
186101,ALA,1,1
186102,could,1,0
186103,inform,0,0
186104,nutrition,0,1
186105,advice,0,1
186106,",",0,0
186107,with,0,0
186108,recommendations,0,0
186109,being,0,0
186110,specifically,0,0
186111,tailored,0,1
186112,according,0,0
186113,to,0,0
186114,habitual,0,0
186115,diet,0,1
186116,",",0,0
186117,sex,0,0
186118,",",0,0
186119,age,0,0
186120,and,0,0
186121,BMI,0,0
186122,.,0,0
186123,Rationale,0,1
186124,and,0,0
186125,design,0,0
186126,of,0,0
186127,the,0,0
186128,Clinical,0,0
186129,Evaluation,0,1
186130,of,0,0
186131,Magnetic,1,1
186132,Resonance,1,1
186133,Imaging,1,0
186134,in,0,0
186135,Coronary,0,0
186136,heart,0,0
186137,disease,0,0
186138,2,0,1
186139,trial,0,0
186140,(,0,0
186141,CE-MARC,0,1
186142,2,0,0
186143,),0,0
186144,:,0,0
186145,a,0,0
186146,prospective,0,0
186147,",",0,0
186148,multicenter,0,0
186149,",",0,0
186150,randomized,0,0
186151,trial,0,0
186152,of,0,0
186153,diagnostic,0,0
186154,strategies,0,0
186155,in,0,0
186156,suspected,0,0
186157,coronary,0,0
186158,heart,0,0
186159,disease,0,0
186160,.,0,0
186161,BACKGROUND,0,0
186162,A,0,0
186163,number,0,0
186164,of,0,0
186165,investigative,0,0
186166,strategies,0,0
186167,exist,0,0
186168,for,0,0
186169,the,0,0
186170,diagnosis,0,0
186171,of,0,0
186172,coronary,0,0
186173,heart,0,0
186174,disease,0,0
186175,(,0,1
186176,CHD,0,1
186177,),0,0
186178,.,0,0
186179,Despite,0,0
186180,the,0,0
186181,widespread,0,0
186182,availability,0,0
186183,of,0,0
186184,noninvasive,0,0
186185,imaging,0,0
186186,",",0,0
186187,invasive,1,0
186188,angiography,1,1
186189,is,0,0
186190,commonly,0,0
186191,used,0,0
186192,early,0,0
186193,in,0,0
186194,the,0,0
186195,diagnostic,0,0
186196,pathway,0,0
186197,.,0,0
186198,Consequently,0,0
186199,",",0,0
186200,approximately,0,0
186201,60,0,0
186202,%,0,0
186203,of,0,0
186204,angiograms,0,1
186205,reveal,0,0
186206,no,0,0
186207,evidence,0,0
186208,of,0,0
186209,obstructive,0,0
186210,coronary,0,0
186211,disease,0,0
186212,.,0,0
186213,Reducing,0,0
186214,unnecessary,0,0
186215,angiography,0,1
186216,has,0,0
186217,potential,0,0
186218,financial,0,0
186219,savings,0,0
186220,and,0,0
186221,avoids,0,0
186222,exposing,0,0
186223,the,0,0
186224,patient,0,0
186225,to,0,0
186226,unnecessary,0,0
186227,risk,0,0
186228,.,0,0
186229,There,0,0
186230,are,0,0
186231,no,0,0
186232,large-scale,0,0
186233,comparative,0,0
186234,effectiveness,0,0
186235,trials,0,0
186236,of,0,0
186237,the,0,0
186238,different,0,0
186239,diagnostic,0,0
186240,strategies,0,0
186241,recommended,0,0
186242,in,0,0
186243,international,0,0
186244,guidelines,0,0
186245,and,0,0
186246,none,0,0
186247,that,0,0
186248,have,0,0
186249,evaluated,0,0
186250,the,0,0
186251,safety,0,0
186252,and,0,0
186253,efficacy,0,0
186254,of,0,0
186255,cardiovascular,0,0
186256,magnetic,0,1
186257,resonance,0,0
186258,.,0,0
186259,TRIAL,0,0
186260,DESIGN,0,0
186261,CE-MARC,0,0
186262,2,0,0
186263,is,0,0
186264,a,0,0
186265,prospective,0,0
186266,",",0,0
186267,multicenter,0,0
186268,",",0,0
186269,3-arm,0,1
186270,parallel,0,0
186271,group,0,0
186272,",",0,0
186273,randomized,0,0
186274,controlled,0,0
186275,trial,0,0
186276,of,0,0
186277,patients,0,0
186278,with,0,0
186279,suspected,0,0
186280,CHD,0,1
186281,(,0,0
186282,pretest,0,0
186283,likelihood,0,0
186284,10,0,0
186285,%,0,0
186286,-90,0,0
186287,%,0,0
186288,),0,1
186289,requiring,0,0
186290,further,0,0
186291,investigation,0,0
186292,.,0,0
186293,A,0,0
186294,total,0,0
186295,of,0,0
186296,"1,200",0,0
186297,patients,0,0
186298,will,0,0
186299,be,0,0
186300,randomized,0,0
186301,on,0,0
186302,a,0,0
186303,2:2:1,0,0
186304,basis,0,0
186305,to,0,0
186306,receive,0,0
186307,3.0-T,1,0
186308,cardiovascular,1,0
186309,magnetic,1,1
186310,resonance-guided,1,1
186311,care,1,1
186312,",",1,0
186313,single-photon,1,0
186314,emission,1,0
186315,computed,1,0
186316,tomography-guided,1,1
186317,care,1,1
186318,(,0,0
186319,according,0,0
186320,to,0,0
186321,American,0,0
186322,College,0,0
186323,of,0,0
186324,Cardiology/American,0,0
186325,Heart,0,1
186326,Association,0,0
186327,appropriate-use,0,0
186328,criteria,0,0
186329,),0,0
186330,",",0,0
186331,or,1,1
186332,National,1,0
186333,Institute,1,0
186334,for,1,0
186335,Health,1,0
186336,and,1,0
186337,Care,1,0
186338,Excellence,1,0
186339,guidelines-based,1,1
186340,management,1,0
186341,.,1,0
186342,The,0,0
186343,primary,0,0
186344,(,0,1
186345,efficacy,0,0
186346,),0,1
186347,end,0,0
186348,point,0,0
186349,is,0,0
186350,the,0,0
186351,occurrence,0,0
186352,of,0,0
186353,unnecessary,0,0
186354,angiography,0,1
186355,as,0,0
186356,defined,0,0
186357,by,0,0
186358,a,0,0
186359,normal,0,0
186360,(,0,0
186361,>,0,0
186362,0.8,0,1
186363,),0,0
186364,invasive,0,0
186365,fractional,0,0
186366,flow,0,0
186367,reserve,0,0
186368,.,0,0
186369,Safety,0,0
186370,of,0,0
186371,each,0,0
186372,strategy,0,0
186373,will,0,0
186374,be,0,0
186375,assessed,0,0
186376,by,0,0
186377,3-year,0,0
186378,major,0,0
186379,adverse,0,0
186380,cardiovascular,0,0
186381,event,0,0
186382,rates,0,0
186383,.,0,0
186384,Cost-effectiveness,0,0
186385,and,0,0
186386,health-related,0,0
186387,quality-of-life,0,0
186388,measures,0,0
186389,will,0,0
186390,be,0,0
186391,performed,0,0
186392,.,0,0
186393,CONCLUSIONS,0,0
186394,The,0,0
186395,CE-MARC,0,0
186396,2,0,0
186397,trial,0,0
186398,will,0,0
186399,provide,0,0
186400,comparative,0,0
186401,efficacy,0,0
186402,and,0,0
186403,safety,0,0
186404,evidence,0,0
186405,for,0,0
186406,3,0,0
186407,different,0,0
186408,strategies,0,0
186409,of,0,0
186410,investigating,0,0
186411,patients,0,0
186412,with,0,0
186413,suspected,0,0
186414,CHD,0,1
186415,",",0,0
186416,with,0,0
186417,the,0,0
186418,intension,0,0
186419,of,0,0
186420,reducing,0,0
186421,unnecessary,0,0
186422,invasive,0,0
186423,angiography,0,1
186424,rates,0,0
186425,.,0,0
186426,Evaluation,0,0
186427,of,0,0
186428,these,0,0
186429,management,0,0
186430,strategies,0,0
186431,has,0,0
186432,the,0,0
186433,potential,0,0
186434,to,0,0
186435,improve,0,0
186436,patient,0,0
186437,care,0,1
186438,",",0,0
186439,health-related,0,0
186440,quality,0,0
186441,of,0,0
186442,life,0,0
186443,",",0,0
186444,and,0,0
186445,the,0,0
186446,cost-effectiveness,0,0
186447,of,0,0
186448,CHD,0,1
186449,investigation,0,0
186450,.,0,0
186451,Comparison,0,0
186452,on,0,0
186453,therapeutic,0,0
186454,effect,0,0
186455,of,0,0
186456,plasma,1,0
186457,exchange,1,1
186458,and,1,0
186459,intravenous,1,1
186460,immunoglobulin,1,1
186461,for,0,0
186462,Guillian-Barre,0,1
186463,syndrome,0,0
186464,.,0,0
186465,OBJECTIVES,0,0
186466,To,0,0
186467,observe,0,0
186468,and,0,0
186469,compare,0,0
186470,the,0,0
186471,clinical,0,0
186472,curative,0,0
186473,effect,0,0
186474,of,0,0
186475,the,0,0
186476,plasma,1,0
186477,exchange,1,1
186478,(,1,1
186479,PE,1,1
186480,),1,1
186481,and,0,0
186482,intravenous,1,1
186483,immunoglobulin,1,1
186484,(,1,1
186485,IVIg,1,1
186486,),1,1
186487,for,0,0
186488,Guillian-Barre,0,1
186489,Syndrome,0,0
186490,(,0,1
186491,GBS,0,1
186492,),0,0
186493,.,0,0
186494,METHODS,0,0
186495,Overall,0,0
186496,",",0,0
186497,64,0,0
186498,adult,0,0
186499,patients,0,0
186500,with,0,0
186501,GBS,0,1
186502,for,0,0
186503,PE,1,1
186504,and,0,0
186505,IVIg,1,1
186506,treatment,0,0
186507,",",0,0
186508,respectively,0,0
186509,",",0,0
186510,and,0,0
186511,nerve,0,1
186512,function,0,0
186513,were,0,0
186514,observed,0,0
186515,pre-treatment,0,0
186516,and,0,0
186517,at,0,0
186518,1,0,0
186519,week/2,0,0
186520,weeks,0,0
186521,after,0,0
186522,completion,0,0
186523,of,0,0
186524,treatment,0,0
186525,;,0,0
186526,the,0,0
186527,blood,0,0
186528,immunoglobulin,0,1
186529,",",0,0
186530,complement,0,0
186531,",",0,0
186532,fibrinogen,0,0
186533,(,0,1
186534,Fib,0,1
186535,),0,1
186536,and,0,0
186537,monocyte,0,0
186538,percentage,0,0
186539,(,0,1
186540,MON,0,1
186541,%,0,0
186542,),0,0
186543,were,0,0
186544,detected,0,0
186545,simultaneously,0,0
186546,.,0,0
186547,RESULTS,0,0
186548,After,1,0
186549,PE,1,1
186550,treatment,0,0
186551,",",0,0
186552,nerve,0,1
186553,function,0,0
186554,defect,0,0
186555,appeared,0,0
186556,to,0,0
186557,improve,0,0
186558,better,0,0
186559,than,0,0
186560,the,0,0
186561,IVIg,1,1
186562,group,1,0
186563,and,0,0
186564,clinical,0,0
186565,effect,0,0
186566,was,0,0
186567,better,0,0
186568,than,0,0
186569,the,0,0
186570,IVIg,1,0
186571,group,1,0
186572,.,0,0
186573,Treatment,0,0
186574,effective,0,0
186575,rates,0,0
186576,of,0,0
186577,the,0,0
186578,two,0,0
186579,groups,0,0
186580,after,0,0
186581,2,0,0
186582,weeks,0,0
186583,",",0,0
186584,respectively,0,0
186585,",",0,0
186586,are,0,0
186587,96,0,0
186588,and,0,0
186589,79,0,0
186590,%,1,0
186591,.,1,0
186592,PE,1,0
186593,and,1,0
186594,IVIg,1,0
186595,can,0,0
186596,significantly,0,0
186597,reduce,0,0
186598,the,0,0
186599,GBS,0,1
186600,patients,0,0
186601,',0,0
186602,blood,0,0
186603,immunoglobulin,0,1
186604,IgG,0,1
186605,",",0,0
186606,IgA,0,0
186607,",",0,0
186608,IgM,0,0
186609,",",0,0
186610,C3,0,0
186611,and,0,0
186612,C4,0,0
186613,",",0,0
186614,but,0,0
186615,these,0,0
186616,were,0,0
186617,significantly,0,0
186618,lower,0,0
186619,in,0,0
186620,the,0,0
186621,PE,1,1
186622,group,1,0
186623,than,0,0
186624,in,0,0
186625,the,0,0
186626,IVIg,1,0
186627,group,0,0
186628,.,0,0
186629,Fib,0,1
186630,and,0,0
186631,MON,0,1
186632,%,0,0
186633,were,0,0
186634,significantly,0,0
186635,lower,0,0
186636,in,0,0
186637,the,0,0
186638,PE,1,1
186639,group,1,0
186640,than,0,0
186641,in,0,0
186642,the,0,0
186643,IVIg,1,0
186644,group,0,0
186645,.,0,0
186646,CONCLUSION,1,0
186647,Both,1,1
186648,PE,1,1
186649,and,1,0
186650,IVIg,1,0
186651,have,0,0
186652,a,0,0
186653,high,0,0
186654,response,0,0
186655,as,0,0
186656,therapy,0,1
186657,and,0,0
186658,are,0,0
186659,reasonable,0,0
186660,therapeutic,0,0
186661,options,0,0
186662,for,0,0
186663,GBS,0,1
186664,.,0,0
186665,However,1,0
186666,",",1,0
186667,PE,1,1
186668,treatment,1,1
186669,has,0,0
186670,a,0,0
186671,more,0,0
186672,significantly,0,0
186673,curative,0,0
186674,effect,0,0
186675,",",0,0
186676,as,0,0
186677,it,0,0
186678,can,0,0
186679,effectively,0,0
186680,improve,0,0
186681,symptoms,0,0
186682,and,0,0
186683,be,0,0
186684,helpful,0,0
186685,in,0,0
186686,the,0,0
186687,early,0,0
186688,rehabilitation,0,1
186689,of,0,0
186690,patients,0,0
186691,.,0,0
186692,TRANSCONJUNCTIVAL,1,1
186693,NONVITRECTOMIZING,1,1
186694,VITREOUS,1,1
186695,SURGERY,1,1
186696,VERSUS,1,0
186697,25-GAUGE,1,1
186698,VITRECTOMY,1,1
186699,IN,0,0
186700,PATIENTS,0,1
186701,WITH,0,0
186702,EPIRETINAL,0,1
186703,MEMBRANE,0,1
186704,:,0,0
186705,A,0,0
186706,Prospective,0,0
186707,Randomized,0,0
186708,Study,0,0
186709,.,0,0
186710,PURPOSE,0,0
186711,To,0,0
186712,compare,0,0
186713,the,0,0
186714,clinical,0,0
186715,outcomes,0,0
186716,and,0,0
186717,the,0,0
186718,rate,0,0
186719,of,0,0
186720,complications,0,0
186721,of,0,0
186722,27-gauge,1,1
186723,transconjunctival,1,1
186724,nonvitrectomizing,1,1
186725,vitreous,1,1
186726,surgery,1,1
186727,(,1,1
186728,NVS,1,1
186729,),1,1
186730,and,0,0
186731,of,0,0
186732,25-gauge,1,1
186733,transconjunctival,1,1
186734,sutureless,1,1
186735,vitrectomy,1,1
186736,surgery,1,1
186737,for,0,0
186738,idiopathic,0,0
186739,epiretinal,0,0
186740,membrane,0,0
186741,removal,0,0
186742,.,0,0
186743,METHODS,0,0
186744,In,0,0
186745,this,0,0
186746,prospective,0,0
186747,randomized,0,0
186748,study,0,0
186749,",",0,0
186750,83,0,0
186751,phakic,0,1
186752,eyes,0,0
186753,of,0,0
186754,83,0,0
186755,consecutive,0,0
186756,patients,0,0
186757,with,0,0
186758,an,0,0
186759,idiopathic,0,0
186760,epiretinal,0,0
186761,membrane,0,0
186762,were,0,0
186763,randomized,0,0
186764,to,0,0
186765,receive,0,0
186766,27-gauge,1,1
186767,NVS,1,1
186768,(,1,1
186769,NVS-group,1,1
186770,),1,1
186771,or,0,1
186772,25-gauge,1,1
186773,vitrectomy,1,1
186774,(,0,1
186775,Standard-group,0,1
186776,),0,0
186777,.,0,0
186778,Main,0,0
186779,outcome,0,0
186780,measures,0,0
186781,were,0,0
186782,best-corrected,0,0
186783,visual,0,0
186784,acuity,0,0
186785,",",0,0
186786,central,0,0
186787,retinal,0,0
186788,thickness,0,0
186789,",",0,0
186790,nuclear,0,0
186791,density,0,0
186792,units,0,0
186793,',0,0
186794,changes,0,0
186795,",",0,0
186796,and,0,0
186797,rate,0,0
186798,of,0,0
186799,complications,0,0
186800,.,0,0
186801,RESULTS,0,0
186802,Thirty-nine,0,0
186803,eyes,0,0
186804,of,0,0
186805,the,0,0
186806,Standard-group,0,1
186807,and,0,0
186808,40,0,0
186809,of,0,0
186810,the,0,0
186811,NVS-group,0,0
186812,were,0,0
186813,considered,0,0
186814,in,0,0
186815,final,0,0
186816,analysis,0,0
186817,.,0,0
186818,Mean,0,0
186819,best-corrected,0,0
186820,visual,0,0
186821,acuity,0,0
186822,improved,0,0
186823,significantly,0,0
186824,in,0,0
186825,both,0,0
186826,groups,0,0
186827,",",0,0
186828,with,0,0
186829,a,0,0
186830,significant,0,0
186831,better,0,0
186832,result,0,0
186833,at,0,0
186834,12,0,0
186835,months,0,0
186836,in,0,0
186837,NVS-group,1,0
186838,(,0,0
186839,P,0,0
186840,=,0,0
186841,0.039,0,0
186842,;,0,0
186843,t-test,0,0
186844,),0,0
186845,.,0,0
186846,Central,0,0
186847,retinal,0,0
186848,thickness,0,0
186849,decreased,0,0
186850,significantly,0,0
186851,in,0,0
186852,both,0,0
186853,groups,0,0
186854,(,0,0
186855,P,0,0
186856,<,0,0
186857,0.001,0,0
186858,",",0,0
186859,Tukey,0,1
186860,test,0,0
186861,),0,0
186862,",",0,0
186863,without,0,0
186864,significant,0,0
186865,difference,0,0
186866,between,0,0
186867,the,0,0
186868,two,0,0
186869,groups,0,0
186870,at,0,0
186871,any,0,0
186872,time,0,0
186873,point,0,0
186874,.,0,0
186875,At,0,0
186876,12,0,0
186877,months,0,0
186878,",",0,0
186879,nuclear,0,0
186880,density,0,0
186881,increased,0,0
186882,significantly,0,0
186883,in,0,0
186884,the,0,0
186885,Standard-group,0,1
186886,(,0,0
186887,analysis,0,0
186888,of,0,0
186889,variance,0,0
186890,",",0,0
186891,P,0,0
186892,<,0,0
186893,0.001,0,0
186894,),0,0
186895,",",0,0
186896,and,0,0
186897,it,0,0
186898,did,0,0
186899,not,0,0
186900,change,0,0
186901,in,0,0
186902,the,0,0
186903,NVS-group,0,1
186904,(,0,0
186905,analysis,0,0
186906,of,0,0
186907,variance,0,0
186908,",",0,0
186909,P,0,0
186910,=,0,0
186911,0.537,0,0
186912,),0,0
186913,.,0,0
186914,Epiretinal,0,0
186915,membrane,0,0
186916,recurred,0,0
186917,in,0,0
186918,5.1,0,0
186919,%,0,0
186920,of,0,0
186921,eyes,0,0
186922,in,0,0
186923,the,0,0
186924,Standard-group,0,1
186925,and,0,0
186926,in,0,0
186927,7.5,0,1
186928,%,0,0
186929,of,0,0
186930,eyes,0,0
186931,in,0,0
186932,the,0,0
186933,NVS-group,0,1
186934,(,0,0
186935,Fisher,0,1
186936,'s,0,0
186937,exact,0,0
186938,test,0,0
186939,",",0,0
186940,P,0,0
186941,=,0,0
186942,1.000,0,0
186943,),0,0
186944,.,0,0
186945,CONCLUSION,0,0
186946,The,0,0
186947,27-gauge,1,1
186948,NVS,1,1
186949,is,0,0
186950,an,0,0
186951,effective,0,0
186952,surgical,0,1
186953,procedure,0,0
186954,in,0,0
186955,eyes,0,0
186956,with,0,0
186957,epiretinal,0,0
186958,membrane,0,0
186959,and,0,0
186960,it,0,0
186961,induces,0,0
186962,less,0,0
186963,progression,0,0
186964,of,0,0
186965,nuclear,0,0
186966,sclerosis,0,1
186967,than,0,0
186968,25-gauge,1,1
186969,vitrectomy,1,1
186970,.,1,0
186971,Diet-Related,0,0
186972,Colorectal,0,0
186973,Cancer,0,0
186974,Prevention,0,1
186975,Beliefs,0,1
186976,and,0,0
186977,Dietary,1,1
186978,Intakes,1,1
186979,in,0,0
186980,an,0,0
186981,Urban,0,0
186982,Minority,0,0
186983,Population,0,0
186984,.,0,0
186985,In,0,0
186986,the,0,0
186987,United,0,0
186988,States,0,0
186989,",",0,0
186990,colorectal,0,0
186991,cancer,0,0
186992,(,0,1
186993,CRC,0,1
186994,),0,1
186995,is,0,0
186996,the,0,0
186997,third,0,0
186998,leading,0,0
186999,cause,0,0
187000,of,0,0
187001,cancer-related,0,0
187002,death,0,0
187003,and,0,0
187004,third,0,0
187005,most,0,0
187006,commonly,0,0
187007,diagnosed,0,0
187008,cancer,0,0
187009,among,0,0
187010,adults,0,0
187011,.,0,0
187012,This,0,0
187013,study,0,0
187014,is,0,0
187015,the,0,0
187016,first,0,0
187017,to,0,0
187018,examine,0,0
187019,the,0,0
187020,relationship,0,0
187021,between,0,0
187022,diet-related,0,0
187023,beliefs,0,0
187024,for,0,0
187025,colorectal,0,0
187026,cancer,0,0
187027,prevention,0,0
187028,and,0,0
187029,dietary,1,1
187030,intake,1,0
187031,among,0,0
187032,an,0,0
187033,urban,0,0
187034,",",0,0
187035,predominantly,0,0
187036,Black,0,1
187037,population,0,0
187038,(,0,0
187039,n,0,0
187040,=,0,0
187041,169,0,0
187042,),0,0
187043,.,0,0
187044,More,0,0
187045,than,0,0
187046,two-thirds,0,0
187047,reported,0,0
187048,diet-related,0,0
187049,CRC,0,1
187050,prevention,0,0
187051,beliefs,0,0
187052,.,0,0
187053,Those,0,0
187054,with,0,0
187055,diet-related,1,0
187056,CRC,0,1
187057,prevention,0,0
187058,beliefs,0,0
187059,had,0,0
187060,healthier,0,0
187061,intakes,0,0
187062,for,0,0
187063,dietary,1,1
187064,fiber,1,1
187065,(,0,0
187066,p,0,0
187067,=,0,0
187068,.005,0,0
187069,),0,0
187070,",",0,0
187071,fruit,1,0
187072,",",1,0
187073,vegetable,1,1
187074,",",1,0
187075,bean,1,1
187076,(,0,0
187077,p,0,0
187078,=,0,0
187079,.027,0,0
187080,),0,0
187081,",",0,0
187082,red,1,1
187083,meat,1,1
187084,(,0,0
187085,p,0,0
187086,=,0,0
187087,.032,0,0
187088,),0,0
187089,",",0,0
187090,vitamin,0,1
187091,C,0,1
187092,(,0,0
187093,p,0,0
187094,=,0,0
187095,.039,0,0
187096,),0,0
187097,",",0,0
187098,and,0,1
187099,cholesterol,0,1
187100,(,0,1
187101,p,0,0
187102,=,0,0
187103,.045,0,0
187104,),0,0
187105,.,0,0
187106,Most,0,0
187107,people,0,0
187108,may,0,0
187109,already,0,0
187110,have,0,0
187111,diet-related,1,0
187112,CRC,1,1
187113,prevention,1,0
187114,beliefs,1,1
187115,and,0,0
187116,having,0,0
187117,them,0,0
187118,is,0,0
187119,associated,0,0
187120,with,0,0
187121,a,0,0
187122,more,0,0
187123,healthful,0,1
187124,dietary,1,1
187125,intake,1,0
187126,.,1,0
187127,Wrist,0,1
187128,Rehabilitation,0,1
187129,Assisted,0,1
187130,by,0,0
187131,an,0,0
187132,Electromyography-Driven,1,0
187133,Neuromuscular,1,1
187134,Electrical,1,1
187135,Stimulation,1,1
187136,Robot,1,1
187137,After,0,0
187138,Stroke,0,1
187139,.,0,0
187140,BACKGROUND,0,0
187141,Augmented,1,1
187142,physical,1,1
187143,training,1,1
187144,with,1,0
187145,assistance,1,0
187146,from,1,0
187147,robot,1,1
187148,and,1,0
187149,neuromuscular,1,1
187150,electrical,1,1
187151,stimulation,1,1
187152,(,1,1
187153,NMES,1,0
187154,),1,1
187155,may,0,0
187156,introduce,0,0
187157,intensive,0,0
187158,motor,0,0
187159,improvement,0,0
187160,in,0,0
187161,chronic,0,0
187162,stroke,0,0
187163,.,0,0
187164,OBJECTIVE,0,0
187165,To,0,0
187166,compare,0,0
187167,the,0,0
187168,rehabilitation,0,1
187169,effectiveness,0,0
187170,achieved,0,0
187171,by,0,0
187172,NMES,1,0
187173,robot-assisted,1,1
187174,wrist,1,1
187175,training,1,1
187176,and,0,0
187177,that,0,0
187178,by,0,0
187179,robot-assisted,1,1
187180,training,1,1
187181,.,1,0
187182,METHODS,0,0
187183,This,0,0
187184,study,0,0
187185,was,0,0
187186,a,0,0
187187,single-blinded,0,0
187188,randomized,0,0
187189,controlled,0,0
187190,trial,0,0
187191,with,0,0
187192,a,0,0
187193,3-month,0,0
187194,follow-up,0,0
187195,.,0,0
187196,Twenty-six,0,0
187197,hemiplegic,0,0
187198,subjects,0,0
187199,with,0,0
187200,chronic,0,0
187201,stroke,0,0
187202,were,0,0
187203,randomly,0,0
187204,assigned,0,0
187205,to,0,0
187206,receive,0,0
187207,20-session,1,1
187208,wrist,1,1
187209,training,1,1
187210,with,1,0
187211,an,1,0
187212,electromyography,1,1
187213,(,1,1
187214,EMG,1,0
187215,),1,1
187216,-driven,1,1
187217,NMES,1,1
187218,robot,1,1
187219,(,0,0
187220,NMES,0,0
187221,robot,0,1
187222,group,0,0
187223,",",0,0
187224,n,0,0
187225,=,0,0
187226,11,0,0
187227,),0,0
187228,and,0,0
187229,with,0,0
187230,an,0,0
187231,EMG-driven,1,0
187232,robot,1,1
187233,(,0,1
187234,robot,0,1
187235,group,0,0
187236,",",0,0
187237,n,0,0
187238,=,0,0
187239,15,0,0
187240,),0,0
187241,",",0,0
187242,completed,0,0
187243,within,0,0
187244,7,0,0
187245,consecutive,0,0
187246,weeks,0,0
187247,.,0,0
187248,Clinical,0,0
187249,scores,0,0
187250,",",0,0
187251,Fugl-Meyer,0,0
187252,Assessment,0,1
187253,(,0,1
187254,FMA,0,1
187255,),0,0
187256,",",0,0
187257,Modified,0,0
187258,Ashworth,0,1
187259,Score,0,1
187260,(,0,1
187261,MAS,0,1
187262,),0,1
187263,",",0,0
187264,and,0,0
187265,Action,0,1
187266,Research,0,0
187267,Arm,0,1
187268,Test,0,0
187269,(,0,1
187270,ARAT,0,1
187271,),0,1
187272,were,0,0
187273,used,0,0
187274,to,0,0
187275,evaluate,0,0
187276,the,0,0
187277,training,0,1
187278,effects,0,0
187279,before,0,0
187280,and,0,0
187281,after,0,0
187282,the,0,0
187283,training,0,1
187284,",",0,0
187285,as,0,0
187286,well,0,0
187287,as,0,0
187288,3,0,0
187289,months,0,0
187290,later,0,0
187291,.,0,0
187292,An,0,0
187293,EMG,0,0
187294,parameter,0,0
187295,",",0,0
187296,muscle,0,0
187297,co-contraction,0,1
187298,index,0,0
187299,",",0,0
187300,was,0,0
187301,also,0,0
187302,applied,0,0
187303,to,0,0
187304,investigate,0,0
187305,the,0,0
187306,session-by-session,0,1
187307,variation,0,0
187308,in,0,0
187309,muscular,0,0
187310,coordination,0,1
187311,patterns,0,0
187312,during,0,0
187313,the,0,0
187314,training,0,1
187315,.,0,0
187316,RESULTS,0,0
187317,The,0,0
187318,improvement,0,0
187319,in,0,0
187320,FMA,0,1
187321,(,0,0
187322,shoulder/elbow,0,0
187323,",",0,1
187324,wrist/hand,0,1
187325,),0,0
187326,obtained,0,0
187327,in,0,0
187328,the,0,0
187329,NMES,1,0
187330,robot,1,1
187331,group,0,0
187332,was,0,0
187333,more,0,0
187334,significant,0,0
187335,than,0,0
187336,the,0,0
187337,robot,0,1
187338,group,0,0
187339,(,0,0
187340,P,0,0
187341,<,0,0
187342,.05,0,0
187343,),0,0
187344,.,0,0
187345,Significant,0,0
187346,improvement,0,0
187347,in,0,0
187348,ARAT,0,1
187349,was,0,0
187350,achieved,0,0
187351,in,0,0
187352,the,0,0
187353,NMES,0,0
187354,robot,0,1
187355,group,0,1
187356,(,0,0
187357,P,0,0
187358,<,0,0
187359,.05,0,0
187360,),0,1
187361,but,0,0
187362,absent,0,0
187363,in,0,0
187364,the,0,0
187365,robot,0,1
187366,group,0,0
187367,.,0,0
187368,NMES,0,0
187369,robot-assisted,0,1
187370,training,0,1
187371,showed,0,0
187372,better,0,0
187373,performance,0,0
187374,in,0,0
187375,releasing,0,1
187376,muscle,0,0
187377,co-contraction,0,1
187378,than,0,0
187379,the,0,0
187380,robot-assisted,0,1
187381,across,0,0
187382,the,0,0
187383,training,0,1
187384,sessions,0,1
187385,(,0,0
187386,P,0,0
187387,<,0,0
187388,.05,0,0
187389,),0,0
187390,.,0,0
187391,CONCLUSIONS,0,0
187392,The,0,0
187393,NMES,1,0
187394,robot-assisted,1,1
187395,wrist,1,1
187396,training,1,1
187397,was,0,0
187398,more,0,0
187399,effective,0,0
187400,than,0,0
187401,the,0,0
187402,pure,0,0
187403,robot,0,1
187404,.,0,0
187405,The,0,0
187406,additional,0,0
187407,NMES,0,0
187408,application,0,1
187409,in,0,0
187410,the,0,0
187411,treatment,0,0
187412,could,0,0
187413,bring,0,0
187414,more,0,0
187415,improvements,0,0
187416,in,0,0
187417,the,0,0
187418,distal,0,0
187419,motor,0,0
187420,functions,0,0
187421,and,0,0
187422,faster,0,0
187423,rehabilitation,0,1
187424,progress,0,0
187425,.,0,0
187426,Concentrated,0,1
187427,parenteral,1,1
187428,nutrition,1,1
187429,solutions,0,1
187430,and,0,0
187431,central,0,0
187432,venous,0,1
187433,catheter,0,1
187434,complications,0,0
187435,in,0,0
187436,preterm,0,0
187437,infants,0,0
187438,.,0,0
187439,UNLABELLED,0,0
187440,Standardised,0,0
187441,",",0,0
187442,concentrated,1,0
187443,neonatal,1,0
187444,parenteral,1,1
187445,nutrition,1,1
187446,(,1,1
187447,PN,1,1
187448,),1,1
187449,regimens,1,1
187450,can,0,0
187451,overcome,0,0
187452,early,0,0
187453,nutritional,0,1
187454,deficits,0,0
187455,in,0,0
187456,very,0,0
187457,preterm,0,0
187458,infants,0,0
187459,.,0,0
187460,A,0,0
187461,PN,0,1
187462,regimen,0,1
187463,with,0,0
187464,increased,0,0
187465,macronutrient,0,1
187466,content,0,1
187467,(,1,0
187468,standardised,1,1
187469,",",1,0
187470,concentrated,1,0
187471,",",1,0
187472,added,1,0
187473,macronutrients,1,1
187474,parenteral,1,1
187475,(,1,0
187476,SCAMP,1,1
187477,),1,1
187478,),1,1
187479,has,0,0
187480,been,0,0
187481,shown,0,0
187482,to,0,0
187483,improve,0,0
187484,early,0,0
187485,head,0,0
187486,growth,0,0
187487,in,0,0
187488,a,0,0
187489,randomised,0,0
187490,controlled,0,0
187491,trial,0,0
187492,.,0,0
187493,Line,0,1
187494,complications,0,0
187495,including,0,0
187496,late,0,0
187497,onset,0,0
187498,sepsis,0,0
187499,were,0,0
187500,secondary,0,0
187501,outcomes,0,0
187502,of,0,0
187503,this,0,0
187504,study,0,0
187505,.,0,0
187506,Infants,0,0
187507,were,0,0
187508,started,0,0
187509,on,0,0
187510,standardised,0,0
187511,",",0,0
187512,concentrated,1,0
187513,PN,1,1
187514,at,0,0
187515,birth,0,0
187516,and,0,0
187517,randomised,0,0
187518,at,0,0
187519,2-5,0,0
187520,days,0,0
187521,to,0,0
187522,either,0,0
187523,switch,0,0
187524,to,0,0
187525,SCAMP,1,0
187526,or,0,1
187527,remain,1,0
187528,on,1,0
187529,control,1,0
187530,PN,1,1
187531,.,1,0
187532,Central,0,0
187533,venous,0,0
187534,catheter,0,1
187535,(,0,1
187536,CVC,0,1
187537,),0,1
187538,",",0,0
187539,blood,0,0
187540,culture,0,0
187541,(,0,1
187542,BC,0,1
187543,),0,1
187544,and,0,0
187545,inflammatory,0,0
187546,marker,0,0
187547,data,0,0
187548,were,0,0
187549,collected,0,0
187550,for,0,0
187551,the,0,0
187552,28-day,0,0
187553,intervention,0,1
187554,period,0,0
187555,.,0,0
187556,150,0,0
187557,infants,0,0
187558,were,0,0
187559,randomised,0,0
187560,with,0,0
187561,mean,0,0
187562,(,0,1
187563,SD,0,0
187564,),0,1
187565,birth,0,0
187566,weight,0,1
187567,(,0,1
187568,g,0,1
187569,),0,1
187570,of,0,0
187571,900,0,1
187572,(,0,0
187573,158,0,0
187574,),0,0
187575,versus,0,1
187576,884,0,0
187577,(,0,0
187578,183,0,0
187579,),0,0
187580,in,0,0
187581,SCAMP,0,1
187582,(,0,1
187583,n=74,0,0
187584,),0,1
187585,and,0,1
187586,control,0,1
187587,(,0,1
187588,n=76,0,1
187589,),0,0
187590,groups,0,0
187591,",",0,0
187592,respectively,0,0
187593,.,0,0
187594,There,0,0
187595,were,0,0
187596,no,0,0
187597,differences,0,0
187598,in,0,0
187599,CVC,0,1
187600,use/type,0,0
187601,or,0,1
187602,duration,0,0
187603,or,0,1
187604,in,0,0
187605,positive/negative,0,0
187606,BC,0,1
187607,with/without,0,1
187608,associated,0,0
187609,C,0,1
187610,reactive,0,0
187611,protein,0,1
187612,rise,0,0
187613,in,0,0
187614,SCAMP,1,1
187615,versus,0,1
187616,control,0,0
187617,groups,0,0
187618,.,0,0
187619,Increasing,0,0
187620,the,0,0
187621,macronutrient,0,1
187622,content,0,0
187623,of,0,0
187624,a,0,0
187625,standardised,0,0
187626,",",0,0
187627,concentrated,0,0
187628,neonatal,0,0
187629,PN,1,1
187630,regimen,0,1
187631,does,0,0
187632,not,0,0
187633,increase,0,0
187634,CVC,0,0
187635,complication,0,0
187636,rates,0,0
187637,.,0,0
187638,TRIAL,0,0
187639,REGISTRATION,0,0
187640,NUMBER,0,1
187641,ISRCTN,0,1
187642,76597892,0,0
187643,.,0,0
187644,Effects,0,0
187645,of,0,0
187646,stellate,1,0
187647,ganglionic,1,1
187648,block,1,0
187649,on,0,0
187650,hemodynamic,0,0
187651,changes,0,0
187652,and,0,0
187653,intrapulmonary,0,0
187654,shunt,0,1
187655,in,0,0
187656,perioperative,0,0
187657,patients,0,0
187658,with,0,0
187659,esophageal,0,0
187660,cancer,0,0
187661,.,0,0
187662,OBJECTIVE,0,0
187663,The,0,0
187664,aim,0,0
187665,of,0,0
187666,this,0,0
187667,study,0,0
187668,was,0,0
187669,to,0,0
187670,observe,0,0
187671,the,0,0
187672,effects,0,0
187673,of,1,0
187674,stellate,1,1
187675,ganglion,1,1
187676,block,1,1
187677,(,1,1
187678,SGB,1,0
187679,),1,1
187680,on,0,0
187681,hemodynamic,0,0
187682,changes,0,0
187683,and,0,0
187684,intrapulmonary,0,0
187685,shunt,0,1
187686,during,0,0
187687,one-lung,0,1
187688,ventilation,0,1
187689,(,0,1
187690,OLV,0,0
187691,),0,0
187692,.,0,0
187693,PATIENTS,0,0
187694,AND,0,0
187695,METHODS,0,0
187696,Thirty,0,0
187697,ASA,0,1
187698,class,0,0
187699,I-II,0,1
187700,patients,0,0
187701,undergoing,0,0
187702,elective,0,1
187703,esophageal,0,0
187704,surgery,0,1
187705,were,0,0
187706,randomly,0,0
187707,divided,0,0
187708,into,0,0
187709,two,0,0
187710,groups,1,0
187711,:,1,0
187712,general,1,0
187713,anesthesia,1,1
187714,group,1,1
187715,(,1,1
187716,group,1,0
187717,N,1,1
187718,",",1,0
187719,n=15,1,0
187720,),1,1
187721,and,1,0
187722,general,1,0
187723,anesthesia,1,1
187724,combined,1,1
187725,SGB,1,0
187726,group,1,1
187727,(,1,0
187728,group,1,0
187729,S,1,1
187730,",",1,0
187731,n=15,1,0
187732,),1,0
187733,",",1,0
187734,patients,1,0
187735,in,1,0
187736,group,1,0
187737,S,1,1
187738,were,1,0
187739,received,1,0
187740,left,1,0
187741,SGB,1,0
187742,before,1,0
187743,induction,1,0
187744,.,1,0
187745,Radial,1,0
187746,artery,1,0
187747,was,1,0
187748,cannulated,1,1
187749,for,1,0
187750,arterial,1,0
187751,blood,1,0
187752,pressure,1,0
187753,(,1,1
187754,ABP,1,0
187755,),1,1
187756,monitoring,1,1
187757,and,1,1
187758,blood,1,0
187759,sampling,1,0
187760,and,1,0
187761,Swan-Ganz,1,1
187762,catheter,1,1
187763,was,1,0
187764,position,1,0
187765,in,1,0
187766,the,1,0
187767,pulmonary,1,0
187768,artery,1,0
187769,via,1,1
187770,right,1,0
187771,internal,1,1
187772,jugular,1,0
187773,vein,1,0
187774,under,1,0
187775,local,1,1
187776,anesthesia,1,1
187777,.,1,0
187778,ECG,1,0
187779,",",1,0
187780,MAP,1,1
187781,",",1,0
187782,HR,1,0
187783,",",1,0
187784,CVP,1,0
187785,",",1,0
187786,continuous,1,1
187787,cardiac,1,0
187788,output,1,0
187789,(,1,1
187790,CCO,1,1
187791,),1,1
187792,index,1,0
187793,and,1,0
187794,BIS,1,1
187795,were,0,0
187796,continuously,0,0
187797,monitored,0,0
187798,during,0,0
187799,anesthesia,0,1
187800,.,0,0
187801,General,0,0
187802,anesthesia,0,1
187803,was,0,0
187804,induced,0,0
187805,with,0,0
187806,propofol,0,1
187807,1.5-2.0,0,0
187808,mg/kg,0,1
187809,",",0,0
187810,sufentanil,0,1
187811,0.4,0,0
187812,?g/kg,0,0
187813,",",0,0
187814,and,0,0
187815,Rocuronium,0,1
187816,0.6-0.9,0,0
187817,mg/kg,0,1
187818,.,0,0
187819,Endobronchial,0,0
187820,occluder,0,0
187821,was,0,0
187822,placed,0,0
187823,blindly,0,1
187824,after,0,0
187825,tracheal,0,1
187826,indubation,0,1
187827,and,0,0
187828,the,0,0
187829,correct,0,0
187830,position,0,0
187831,was,0,0
187832,verified,0,0
187833,by,0,0
187834,auscultation,0,1
187835,and,0,0
187836,fiberoptic,0,1
187837,bronchoscopy,0,1
187838,.,0,0
187839,The,0,0
187840,patients,0,0
187841,were,0,0
187842,mechanically,0,0
187843,ventilated,0,1
187844,.,0,0
187845,The,0,0
187846,ventilation,0,0
187847,conditions,0,0
187848,were,0,0
187849,Fio2=100,0,0
187850,%,0,0
187851,",",0,0
187852,VT,0,1
187853,=,0,0
187854,8-10,0,0
187855,ml/kg,0,0
187856,",",0,0
187857,I,0,0
187858,:,0,0
187859,E,0,1
187860,=,0,0
187861,1:2,0,0
187862,and,0,0
187863,respiratory,0,0
187864,rate,0,0
187865,was,0,0
187866,adjusted,0,0
187867,to,0,0
187868,maintained,0,0
187869,PETCO2,0,0
187870,at,0,0
187871,35-45,0,1
187872,mmHg,0,0
187873,during,0,0
187874,both,0,0
187875,two-lung,0,1
187876,ventilation,0,1
187877,(,0,1
187878,TLV,0,0
187879,),0,1
187880,and,0,0
187881,OLV,0,0
187882,.,0,0
187883,Anesthesia,0,0
187884,was,0,0
187885,maintained,0,0
187886,with,0,0
187887,continuous,0,1
187888,infusion,0,1
187889,of,0,0
187890,propofol,0,1
187891,4-10,0,0
187892,mg/kg?h,0,1
187893,",",0,0
187894,sufentanil,0,1
187895,0.2,0,1
187896,?g/kg?h,0,1
187897,",",0,0
187898,vecuronium,0,1
187899,o.1,0,1
187900,mg/kg?h,0,1
187901,",",0,0
187902,BIS,0,1
187903,was,0,0
187904,maintained,0,0
187905,at,0,0
187906,45-55,0,0
187907,.,0,0
187908,Blood,0,0
187909,samples,0,0
187910,were,0,0
187911,taken,0,0
187912,from,0,0
187913,radial,0,0
187914,artery,0,0
187915,and,0,0
187916,S-G,0,1
187917,catheter,0,1
187918,for,0,0
187919,blood,0,0
187920,gas,0,1
187921,analysis,0,0
187922,at,0,0
187923,following,0,0
187924,intervals,0,0
187925,:,0,0
187926,during,0,0
187927,spontaneous,0,0
187928,breathing,0,1
187929,when,0,0
187930,the,0,0
187931,patient,0,0
187932,was,0,0
187933,awake,0,1
187934,(,0,1
187935,T0,0,1
187936,),0,0
187937,",",0,0
187938,1,0,0
187939,min,0,0
187940,after,0,0
187941,tracheal,0,1
187942,indubation,0,1
187943,(,0,1
187944,T1,0,1
187945,),0,0
187946,",",0,0
187947,1,0,0
187948,min,0,0
187949,after,0,0
187950,patient,0,0
187951,was,0,0
187952,placed,0,0
187953,in,0,0
187954,lateral,0,1
187955,position,0,0
187956,(,0,1
187957,T2,0,1
187958,),0,1
187959,and,0,0
187960,15,0,0
187961,min,0,0
187962,after,0,0
187963,it,0,0
187964,(,0,0
187965,T3,0,1
187966,),0,0
187967,",",0,0
187968,1,0,0
187969,min,0,0
187970,after,0,0
187971,ribs,0,0
187972,was,0,0
187973,braced,0,1
187974,(,0,0
187975,T4,0,0
187976,),0,0
187977,",",0,0
187978,30,0,0
187979,",",0,0
187980,60,0,0
187981,",",0,0
187982,120,0,0
187983,min,0,0
187984,during,0,0
187985,the,0,0
187986,course,0,0
187987,of,0,0
187988,OLV,0,0
187989,(,0,0
187990,T5,0,0
187991,",",0,0
187992,T6,0,1
187993,",",0,0
187994,T7,0,1
187995,),0,0
187996,",",0,0
187997,the,0,0
187998,two,0,0
187999,lungs,0,0
188000,were,0,0
188001,ventilated,0,1
188002,again,0,0
188003,for,0,0
188004,30,0,1
188005,min,0,0
188006,(,0,1
188007,T8,0,1
188008,),0,1
188009,and,0,0
188010,Qs/Qt,0,1
188011,was,0,0
188012,calculated,0,0
188013,.,0,0
188014,RESULTS,0,0
188015,SVRI,0,1
188016,",",0,0
188017,MAP,0,1
188018,",",0,0
188019,HR,0,0
188020,in,0,0
188021,group,0,0
188022,N,0,0
188023,increased,0,0
188024,significantly,0,0
188025,at,0,0
188026,T1,0,0
188027,",",0,0
188028,T2,0,0
188029,",",0,0
188030,T4,0,0
188031,compared,0,0
188032,with,0,0
188033,group,0,0
188034,S,0,1
188035,(,0,0
188036,p,0,0
188037,<,0,0
188038,0.05,0,0
188039,),0,0
188040,.,0,0
188041,Qs/Qt,0,1
188042,was,0,0
188043,significantly,0,0
188044,increased,0,0
188045,after,0,0
188046,patient,0,0
188047,was,0,0
188048,placed,0,0
188049,in,0,0
188050,lateral,0,1
188051,position,0,0
188052,and,0,0
188053,increased,0,0
188054,further,0,0
188055,during,0,0
188056,OLV,0,0
188057,;,0,0
188058,the,0,0
188059,calculated,0,0
188060,Qs/Qt,0,1
188061,values,0,0
188062,were,0,0
188063,highest,0,0
188064,at,0,0
188065,T5?,0,1
188066,PaO2,0,1
188067,was,0,0
188068,significantly,0,0
188069,lower,0,0
188070,after,0,0
188071,OLV,0,0
188072,was,0,0
188073,started,0,0
188074,and,0,0
188075,reached,0,0
188076,the,0,0
188077,lowest,0,0
188078,level,0,0
188079,at,0,0
188080,T6,0,1
188081,then,0,1
188082,was,0,0
188083,gradually,0,0
188084,increasing,0,0
188085,.,0,0
188086,There,0,0
188087,was,0,0
188088,no,0,0
188089,significant,0,0
188090,difference,0,0
188091,in,0,0
188092,Qs/Qt,0,1
188093,and,0,0
188094,PaO2,0,1
188095,at,0,0
188096,all,0,0
188097,time,0,0
188098,points,0,0
188099,between,0,0
188100,two,0,0
188101,groups,0,0
188102,.,0,0
188103,CONCLUSIONS,1,0
188104,SGB,1,0
188105,before,1,0
188106,induction,0,0
188107,effectively,0,0
188108,suppress,0,0
188109,the,0,0
188110,stress,0,0
188111,response,0,0
188112,work,0,0
188113,as,0,0
188114,stable,0,0
188115,blood,0,0
188116,dynamics,0,0
188117,and,0,0
188118,does,0,0
188119,not,0,0
188120,affect,0,0
188121,Qs/Qt,0,1
188122,and,0,0
188123,arterial,0,0
188124,oxygenation,0,1
188125,during,0,0
188126,OLV,0,0
188127,",",0,0
188128,SGB,0,0
188129,is,0,0
188130,a,0,0
188131,safe,0,0
188132,technique,0,1
188133,of,0,0
188134,anesthesia,0,1
188135,for,0,0
188136,general,0,0
188137,thoracic,0,1
188138,surgery,0,0
188139,.,0,0
188140,Hepatectomy,1,1
188141,Versus,1,1
188142,Hepatectomy,1,1
188143,With,1,0
188144,Lymphadenectomy,1,1
188145,in,0,0
188146,Hepatocellular,0,0
188147,Carcinoma,0,1
188148,:,0,0
188149,A,0,0
188150,Prospective,0,0
188151,",",0,0
188152,Randomized,0,0
188153,Controlled,0,1
188154,Clinical,0,0
188155,Trial,0,0
188156,.,0,0
188157,GOALS,0,0
188158,AND,0,0
188159,BACKGROUND,0,0
188160,The,0,0
188161,role,0,0
188162,of,0,0
188163,preventive,0,1
188164,lymphadenectomy,0,1
188165,has,0,0
188166,not,0,0
188167,yet,0,0
188168,been,0,0
188169,determined,0,0
188170,for,0,0
188171,hepatocellular,0,0
188172,carcinoma,0,0
188173,(,0,1
188174,HCC,0,1
188175,),0,0
188176,patients,0,0
188177,.,0,0
188178,We,0,0
188179,designed,0,0
188180,a,0,0
188181,study,0,0
188182,to,0,0
188183,evaluate,0,0
188184,the,0,0
188185,effect,0,0
188186,of,0,0
188187,hepatectomy,1,1
188188,combined,1,1
188189,with,1,0
188190,preventive,1,0
188191,lymphadenectomy,1,1
188192,on,0,0
188193,HCC,0,0
188194,patients,0,0
188195,.,0,0
188196,STUDY,0,0
188197,Patients,0,0
188198,were,0,0
188199,randomly,0,0
188200,divided,0,0
188201,into,0,0
188202,group,0,0
188203,A,0,0
188204,(,1,0
188205,treated,1,0
188206,with,1,0
188207,hepatectomy,1,1
188208,alone,1,1
188209,),1,0
188210,and,0,0
188211,group,0,1
188212,B,0,1
188213,(,1,1
188214,underwent,1,0
188215,hepatectomy,1,1
188216,combined,1,1
188217,with,1,0
188218,lymphadenectomy,1,1
188219,),1,0
188220,.,0,0
188221,The,0,0
188222,postoperative,0,0
188223,complications,0,0
188224,and,0,0
188225,oncologic,0,0
188226,prognoses,0,0
188227,were,0,0
188228,analyzed,0,0
188229,.,0,0
188230,RESULTS,0,0
188231,Of,0,0
188232,the,0,0
188233,85,0,0
188234,patients,0,0
188235,enrolled,0,0
188236,into,0,0
188237,this,0,0
188238,study,0,0
188239,",",0,0
188240,79,0,0
188241,cases,0,0
188242,(,0,0
188243,38,0,0
188244,in,0,0
188245,group,0,0
188246,A,0,0
188247,and,0,0
188248,41,0,0
188249,in,0,0
188250,group,0,0
188251,B,0,1
188252,),0,0
188253,were,0,0
188254,pathologically,0,0
188255,confirmed,0,0
188256,to,0,0
188257,have,0,0
188258,HCC,0,1
188259,and,0,0
188260,received,0,1
188261,curative,0,0
188262,resection,0,0
188263,.,0,0
188264,One,0,0
188265,hundred,0,0
188266,and,0,0
188267,sixteen,0,0
188268,lymph,0,0
188269,nodes,0,0
188270,were,0,0
188271,dissected,0,0
188272,and,0,0
188273,evaluated,0,0
188274,as,0,0
188275,negative,0,0
188276,by,0,0
188277,the,0,0
188278,pathologist,0,0
188279,.,0,0
188280,The,0,0
188281,12-,0,0
188282,",",0,0
188283,36-,0,0
188284,",",0,0
188285,and,0,0
188286,60-month,0,0
188287,disease-free,0,0
188288,survival,0,0
188289,rates,0,0
188290,of,0,0
188291,group,0,0
188292,A,0,0
188293,were,0,0
188294,81.6,0,0
188295,%,0,0
188296,",",0,0
188297,68.4,0,0
188298,%,0,0
188299,",",0,0
188300,and,0,0
188301,63.2,0,0
188302,%,0,0
188303,",",0,0
188304,respectively,0,0
188305,",",0,0
188306,whereas,0,0
188307,they,0,0
188308,were,0,0
188309,78.0,0,0
188310,%,0,0
188311,",",0,0
188312,65.9,0,0
188313,%,0,0
188314,",",0,0
188315,and,0,0
188316,63.4,0,0
188317,%,0,0
188318,",",0,0
188319,respectively,0,0
188320,",",0,0
188321,for,0,0
188322,group,0,0
188323,B,0,0
188324,.,0,0
188325,The,0,0
188326,12-,0,0
188327,",",0,0
188328,36-,0,0
188329,",",0,0
188330,and,0,0
188331,60-month,0,0
188332,overall,0,0
188333,survival,0,0
188334,rates,0,0
188335,in,0,0
188336,group,0,0
188337,A,0,0
188338,were,0,0
188339,94.7,0,0
188340,%,0,0
188341,",",0,0
188342,78.9,0,0
188343,%,0,0
188344,",",0,0
188345,and,0,0
188346,65.8,0,0
188347,%,0,0
188348,",",0,0
188349,respectively,0,0
188350,",",0,0
188351,whereas,0,0
188352,they,0,0
188353,were,0,0
188354,87.8,0,0
188355,%,0,0
188356,",",0,0
188357,78.0,0,0
188358,%,0,0
188359,",",0,0
188360,and,0,0
188361,70.7,0,0
188362,%,0,0
188363,",",0,0
188364,respectively,0,0
188365,",",0,0
188366,in,0,0
188367,group,0,0
188368,B,0,0
188369,.,0,0
188370,The,0,0
188371,differences,0,0
188372,in,0,0
188373,the,0,0
188374,disease-free,0,0
188375,survival,0,0
188376,and,0,0
188377,overall,0,0
188378,survival,0,0
188379,between,0,0
188380,the,0,0
188381,2,0,0
188382,groups,0,0
188383,were,0,0
188384,not,0,0
188385,statistically,0,0
188386,significant,0,0
188387,according,0,0
188388,to,0,0
188389,the,0,0
188390,log-rank,0,0
188391,test,0,0
188392,(,0,1
188393,P=0.811,0,0
188394,and,0,0
188395,P=0.881,0,0
188396,",",0,0
188397,respectively,0,0
188398,),0,0
188399,.,0,0
188400,The,0,0
188401,difference,0,0
188402,in,0,0
188403,the,0,0
188404,surgical,0,1
188405,complication,0,0
188406,rate,0,0
188407,between,0,0
188408,groups,0,0
188409,A,0,0
188410,and,0,0
188411,B,0,0
188412,was,0,0
188413,not,0,0
188414,statistically,0,0
188415,significant,0,0
188416,(,0,0
188417,47.4,0,0
188418,%,0,0
188419,vs.,0,0
188420,36.6,0,0
188421,%,0,0
188422,",",0,0
188423,P=0.332,0,0
188424,),0,0
188425,.,0,0
188426,CONCLUSIONS,0,0
188427,Although,0,0
188428,hepatectomy,1,1
188429,combined,1,1
188430,with,1,0
188431,regional,1,0
188432,lymphadenectomy,1,1
188433,is,0,0
188434,a,0,0
188435,safe,0,0
188436,procedure,0,0
188437,",",0,0
188438,preventive,0,1
188439,lymphadenectomy,0,1
188440,may,0,0
188441,not,0,0
188442,decrease,0,0
188443,the,0,0
188444,rate,0,0
188445,of,0,0
188446,tumor,0,0
188447,recurrence,0,0
188448,nor,0,0
188449,improve,0,0
188450,the,0,0
188451,prognosis,0,0
188452,in,0,0
188453,early-stage,0,0
188454,HCC,0,0
188455,patients,0,0
188456,.,0,0
188457,Continual,1,1
188458,feeding,1,1
188459,of,0,0
188460,two,0,0
188461,types,0,0
188462,of,0,0
188463,microalgal,1,0
188464,biomass,1,0
188465,affected,0,0
188466,protein,0,1
188467,digestion,0,1
188468,and,0,0
188469,metabolism,0,0
188470,in,0,0
188471,laying,0,0
188472,hens,0,0
188473,.,0,0
188474,A,0,0
188475,14-wk,0,0
188476,study,0,0
188477,was,0,0
188478,conducted,0,0
188479,to,0,0
188480,determine,0,0
188481,the,0,0
188482,nutritional,0,1
188483,efficacy,0,0
188484,and,0,0
188485,ssmetabolic,0,0
188486,impact,0,0
188487,of,0,0
188488,2,0,0
188489,types,0,0
188490,of,0,0
188491,microalgal,1,0
188492,biomass,1,0
188493,as,0,0
188494,alternative,0,1
188495,protein,0,1
188496,sources,0,0
188497,in,0,0
188498,laying,0,0
188499,hen,0,0
188500,diets,0,1
188501,.,0,0
188502,Shaver,0,0
188503,hens,0,0
188504,(,0,0
188505,total,0,0
188506,=,0,0
188507,150,0,0
188508,and,0,0
188509,26,0,0
188510,wk,0,0
188511,old,0,0
188512,),0,0
188513,were,0,0
188514,fed,0,1
188515,1,0,0
188516,of,0,0
188517,5,0,0
188518,diets,0,1
188519,:,0,0
188520,a,1,0
188521,control,1,1
188522,or,1,1
188523,a,1,0
188524,defatted,1,1
188525,green,1,1
188526,microalgal,1,0
188527,biomass,1,0
188528,(,1,0
188529,DG,1,1
188530,;,1,1
188531,Desmodesmus,1,1
188532,spp,1,1
188533,.,1,0
188534,),1,0
188535,at,0,0
188536,25,0,0
188537,%,0,0
188538,and,0,0
188539,a,1,0
188540,full-fatted,1,1
188541,diatom,1,1
188542,biomass,1,0
188543,(,1,0
188544,FD,1,0
188545,;,1,1
188546,Staurosira,1,1
188547,spp,1,1
188548,.,1,0
188549,),1,0
188550,at,0,0
188551,11.7,0,0
188552,%,0,0
188553,inclusion,1,0
188554,with,1,0
188555,or,1,1
188556,without,1,0
188557,protease,1,1
188558,.,1,0
188559,This,0,0
188560,experiment,0,0
188561,consisted,0,0
188562,of,0,0
188563,5,0,0
188564,replicates,0,0
188565,per,0,0
188566,treatment,0,0
188567,and,0,0
188568,each,0,0
188569,replicate,0,0
188570,contained,0,0
188571,6,0,0
188572,hens,0,0
188573,individually,0,0
188574,reared,0,0
188575,in,0,0
188576,cages,0,1
188577,(,0,0
188578,1,0,0
188579,hen,0,0
188580,for,0,0
188581,biochemical,0,0
188582,data/replicate,0,0
188583,),0,0
188584,.,0,0
188585,Despite,0,0
188586,decreased,0,0
188587,ADFI,0,1
188588,(,0,0
188589,P,0,0
188590,=,0,0
188591,0.03,0,0
188592,),0,0
188593,",",0,0
188594,hens,0,0
188595,fed,0,0
188596,DG,0,0
188597,or,0,1
188598,FD,0,0
188599,had,0,0
188600,final,0,0
188601,BW,0,1
188602,",",0,0
188603,overall,0,0
188604,hen-day,0,0
188605,egg,0,1
188606,production,0,0
188607,",",0,0
188608,and,0,0
188609,egg,0,1
188610,quality,0,0
188611,similar,0,0
188612,to,0,0
188613,the,0,0
188614,controls,0,0
188615,.,0,0
188616,Feeding,0,0
188617,DG,0,0
188618,or,0,1
188619,FD,0,0
188620,did,0,0
188621,not,0,0
188622,alter,0,0
188623,plasma,0,0
188624,concentrations,0,0
188625,of,0,0
188626,insulin,0,0
188627,",",0,0
188628,glutamine,0,1
188629,",",0,0
188630,and,0,0
188631,uric,0,0
188632,acid,0,1
188633,or,0,1
188634,alkaline,0,1
188635,phosphatase,0,0
188636,activity,0,0
188637,at,0,0
188638,wk,0,0
188639,8,0,0
188640,or,0,0
188641,14,0,0
188642,but,0,0
188643,decreased,0,0
188644,plasma,0,0
188645,3-methyhistine,0,1
188646,concentrations,0,0
188647,(,0,0
188648,P,0,0
188649,=,0,0
188650,0.03,0,0
188651,),0,0
188652,and,0,0
188653,tartrate-resistant,0,0
188654,acid,0,1
188655,phosphatase,0,0
188656,(,0,1
188657,TRAP,0,1
188658,),0,1
188659,activities,0,0
188660,(,0,0
188661,P,0,0
188662,<,0,0
188663,0.001,0,0
188664,),0,0
188665,at,0,0
188666,wk,0,0
188667,14,0,0
188668,and,0,0
188669,improved,0,0
188670,(,0,0
188671,P,0,0
188672,=,0,0
188673,0.002,0,0
188674,),0,0
188675,ileal,0,0
188676,total,0,0
188677,AA,0,1
188678,digestibility,0,0
188679,.,0,0
188680,Although,0,0
188681,DG,0,0
188682,or,0,1
188683,FD,0,0
188684,exhibited,0,0
188685,moderate,0,0
188686,effects,0,0
188687,on,0,0
188688,intestinal,0,0
188689,brush,0,1
188690,border,0,0
188691,protease,0,1
188692,activities,0,0
188693,and,0,0
188694,mRNA,0,0
188695,levels,0,0
188696,of,0,0
188697,duodenal,0,0
188698,transporters,0,0
188699,Pept1,0,0
188700,",",0,0
188701,Lat1,0,1
188702,",",0,0
188703,and,0,0
188704,Cat1,0,0
188705,",",0,0
188706,both,0,0
188707,substantially,0,0
188708,enhanced,0,0
188709,(,0,0
188710,P,0,0
188711,<,0,0
188712,0.05,0,0
188713,),0,0
188714,phosphorylation,0,0
188715,of,0,0
188716,hepatic,0,0
188717,protein,0,1
188718,synthesis,0,0
188719,key,0,0
188720,regulator,0,0
188721,S6,0,1
188722,ribosomal,0,1
188723,protein,0,1
188724,(,0,1
188725,S6,0,1
188726,),0,1
188727,and,0,0
188728,the,0,0
188729,ratio,0,0
188730,of,0,0
188731,phospho-S6,0,0
188732,to,0,0
188733,S6,0,1
188734,in,0,0
188735,the,0,0
188736,liver,0,0
188737,of,0,0
188738,hens,0,0
188739,.,0,0
188740,However,0,0
188741,",",0,0
188742,DG,0,1
188743,and,0,0
188744,FD,0,0
188745,manifested,0,0
188746,with,0,0
188747,different,0,0
188748,impacts,0,0
188749,on,0,0
188750,weights,0,0
188751,of,0,0
188752,egg,0,1
188753,and,0,0
188754,egg,0,1
188755,albumen,0,0
188756,",",0,0
188757,proteolytic,0,0
188758,activity,0,0
188759,of,0,0
188760,jejunal,0,1
188761,digesta,0,0
188762,",",0,0
188763,plasma,0,0
188764,TRAP,0,0
188765,activity,0,0
188766,",",0,0
188767,ileal,0,0
188768,total,0,0
188769,AA,0,1
188770,digestibility,0,0
188771,",",0,0
188772,and,0,0
188773,several,0,0
188774,intestinal,0,0
188775,genes,0,0
188776,and,0,0
188777,hepatic,0,0
188778,proteins,0,1
188779,.,0,0
188780,Supplemental,0,1
188781,protease,0,0
188782,in,0,0
188783,the,0,0
188784,DG,0,1
188785,and,0,0
188786,FD,0,0
188787,diets,0,1
188788,produced,0,0
188789,mixed,0,1
188790,effects,0,0
188791,on,0,0
188792,a,0,0
188793,number,0,0
188794,of,0,0
188795,measures,0,0
188796,.,0,0
188797,In,0,0
188798,conclusion,0,0
188799,",",0,0
188800,our,0,0
188801,findings,0,0
188802,revealed,0,0
188803,the,0,0
188804,feasibility,0,0
188805,of,0,0
188806,including,0,0
188807,greater,0,0
188808,levels,0,0
188809,of,0,0
188810,microalgal,1,0
188811,biomass,1,0
188812,as,0,0
188813,a,0,0
188814,source,0,0
188815,of,0,0
188816,feed,0,1
188817,protein,0,1
188818,for,0,0
188819,laying,0,0
188820,hens,0,0
188821,and,0,0
188822,a,0,0
188823,novel,0,0
188824,potential,0,0
188825,of,0,0
188826,the,0,0
188827,biomass,0,0
188828,in,0,0
188829,improving,0,0
188830,dietary,0,1
188831,protein,0,1
188832,digestion,0,1
188833,and,0,0
188834,body,0,0
188835,protein,0,1
188836,metabolism,0,0
188837,than,0,0
188838,previously,0,0
188839,perceived,0,0
188840,.,0,0
188841,Hepatic,0,1
188842,cytoprotective,0,0
188843,effect,0,0
188844,of,0,0
188845,ischemic,1,0
188846,and,1,0
188847,anesthetic,1,1
188848,preconditioning,1,1
188849,before,0,0
188850,liver,0,0
188851,resection,0,1
188852,when,0,0
188853,using,0,0
188854,intermittent,0,1
188855,vascular,0,0
188856,inflow,0,0
188857,occlusion,0,0
188858,:,0,0
188859,a,0,0
188860,randomized,0,0
188861,clinical,0,0
188862,trial,0,0
188863,.,0,0
188864,BACKGROUND,0,0
188865,Ischemic,1,0
188866,preconditioning,1,1
188867,(,1,1
188868,IPC,1,1
188869,),1,1
188870,and,0,0
188871,anesthetic,1,1
188872,preconditioning,1,1
188873,(,1,1
188874,APC,1,1
188875,),1,1
188876,have,0,0
188877,been,0,0
188878,reported,0,0
188879,to,0,0
188880,attenuate,0,0
188881,ischemia-reperfusion,0,1
188882,(,0,1
188883,IR,0,1
188884,),0,1
188885,injury,0,0
188886,after,0,0
188887,liver,0,0
188888,resection,0,1
188889,under,0,0
188890,continuous,0,1
188891,inflow,0,0
188892,occlusion,0,0
188893,.,0,0
188894,This,0,0
188895,study,0,0
188896,evaluates,0,0
188897,whether,0,0
188898,these,0,0
188899,strategies,0,0
188900,enhance,0,0
188901,hepatic,0,0
188902,protection,0,0
188903,of,0,0
188904,remnant,0,0
188905,liver,0,0
188906,against,0,0
188907,IR,0,1
188908,after,0,0
188909,liver,0,0
188910,resection,0,1
188911,with,0,0
188912,intermittent,1,1
188913,clamping,1,1
188914,(,1,1
188915,INT,1,1
188916,),1,1
188917,.,1,0
188918,METHODS,0,0
188919,A,0,0
188920,total,0,0
188921,of,0,0
188922,106,0,0
188923,patients,0,0
188924,without,0,0
188925,underlying,0,0
188926,liver,0,0
188927,disease,0,0
188928,and,0,0
188929,submitted,0,0
188930,to,0,0
188931,liver,0,0
188932,resection,0,1
188933,using,0,0
188934,INT,0,1
188935,were,0,0
188936,randomized,0,0
188937,into,0,0
188938,3,0,0
188939,groups,0,0
188940,:,0,0
188941,IPC,1,0
188942,(,1,0
188943,10,1,0
188944,minutes,1,0
188945,of,1,0
188946,inflow,1,0
188947,occlusion,1,0
188948,followed,1,1
188949,by,1,0
188950,10,1,0
188951,minutes,1,0
188952,of,1,0
188953,reperfusion,1,0
188954,before,1,0
188955,liver,1,0
188956,transection,1,1
188957,),1,0
188958,",",1,0
188959,APC,1,1
188960,(,1,0
188961,sevoflurane,1,1
188962,administration,1,0
188963,for,1,0
188964,20,1,0
188965,minutes,1,0
188966,before,1,0
188967,liver,1,0
188968,transection,1,1
188969,),1,0
188970,",",1,0
188971,and,1,0
188972,INT,1,1
188973,(,1,1
188974,no,1,0
188975,preconditioning,1,1
188976,),1,0
188977,.,1,0
188978,Patients,0,0
188979,were,0,0
188980,also,0,0
188981,stratified,0,0
188982,according,0,0
188983,to,0,0
188984,the,0,0
188985,extent,0,0
188986,of,0,0
188987,the,0,0
188988,hepatectomy,0,1
188989,.,0,0
188990,Cytoprotection,0,0
188991,was,0,0
188992,evaluated,0,0
188993,by,0,0
188994,comparing,0,0
188995,hepatocyte,0,0
188996,and,0,0
188997,endothelial,0,0
188998,dysfunction,0,0
188999,markers,0,0
189000,",",0,0
189001,apoptosis,0,0
189002,",",0,0
189003,histologic,0,0
189004,lesions,0,0
189005,",",0,0
189006,and,0,0
189007,postoperative,0,0
189008,outcome,0,0
189009,.,0,0
189010,RESULTS,0,0
189011,No,0,0
189012,differences,0,0
189013,were,0,0
189014,observed,0,0
189015,in,0,0
189016,preoperative,0,1
189017,chemotherapy,0,1
189018,and,0,0
189019,steatosis,0,0
189020,",",0,0
189021,total,0,0
189022,warm,0,1
189023,ischemia,0,0
189024,time,0,0
189025,",",0,0
189026,operative,0,0
189027,time,0,0
189028,",",0,0
189029,or,0,1
189030,blood,0,0
189031,loss,0,0
189032,.,0,0
189033,Kinetics,0,0
189034,of,0,0
189035,transaminases,0,0
189036,(,0,0
189037,aspartate,0,1
189038,aminotransferase,0,0
189039,",",0,0
189040,P,0,0
189041,=,0,0
189042,.137,0,0
189043,;,0,0
189044,alanine,0,0
189045,aminotransferase,0,0
189046,",",0,0
189047,P,0,0
189048,=,0,0
189049,.616,0,0
189050,),0,0
189051,",",0,0
189052,bilirubin,0,0
189053,(,0,0
189054,P,0,0
189055,=,0,0
189056,.980,0,0
189057,),0,0
189058,",",0,0
189059,and,0,0
189060,hyaluronic,0,1
189061,acid,0,1
189062,increase,0,0
189063,(,0,0
189064,P,0,0
189065,=,0,0
189066,.514,0,0
189067,),0,0
189068,revealed,0,0
189069,no,0,0
189070,differences,0,0
189071,.,0,0
189072,Significant,0,0
189073,apoptosis,0,0
189074,was,0,0
189075,present,0,0
189076,in,0,0
189077,40,0,1
189078,%,0,0
189079,of,0,0
189080,patients,0,0
189081,",",0,0
189082,mild-to-moderate,0,0
189083,leukocyte,0,0
189084,infiltration,0,1
189085,and,0,0
189086,steatosis,0,0
189087,in,0,0
189088,45,0,0
189089,%,0,0
189090,and,0,0
189091,55,0,0
189092,%,0,0
189093,",",0,0
189094,respectively,0,0
189095,",",0,0
189096,and,0,0
189097,mild,0,0
189098,sinusoidal,0,1
189099,congestion,0,0
189100,in,0,0
189101,65,0,0
189102,%,0,0
189103,",",0,0
189104,with,0,0
189105,a,0,0
189106,similar,0,0
189107,distribution,0,0
189108,in,0,0
189109,the,0,0
189110,3,0,0
189111,groups,0,0
189112,.,0,0
189113,When,0,0
189114,patients,0,0
189115,were,0,0
189116,stratified,0,0
189117,by,0,0
189118,major,0,0
189119,versus,0,1
189120,minor,0,0
189121,resections,0,0
189122,",",0,0
189123,no,0,0
189124,differences,0,0
189125,were,0,0
189126,observed,0,0
189127,in,0,0
189128,any,0,0
189129,of,0,0
189130,the,0,0
189131,variables,0,0
189132,studied,0,0
189133,.,0,0
189134,Postoperative,0,0
189135,clinical,0,0
189136,outcomes,0,0
189137,were,0,0
189138,also,0,0
189139,similar,0,0
189140,.,0,0
189141,CONCLUSION,0,0
189142,These,0,0
189143,results,0,0
189144,suggest,0,0
189145,that,0,0
189146,these,0,0
189147,protocols,1,0
189148,of,1,0
189149,IPC,1,0
189150,and,1,0
189151,APC,1,1
189152,used,0,0
189153,in,0,0
189154,this,0,0
189155,study,0,0
189156,do,0,0
189157,not,0,0
189158,provide,0,0
189159,better,0,0
189160,cytoprotection,0,0
189161,from,0,0
189162,IR,0,1
189163,when,0,0
189164,INT,1,1
189165,is,0,0
189166,used,0,0
189167,.,0,0
189168,The,0,0
189169,effect,0,0
189170,of,0,0
189171,power,0,0
189172,asymmetries,0,0
189173,on,0,0
189174,cooperation,1,0
189175,and,1,0
189176,punishment,1,1
189177,in,0,0
189178,a,0,0
189179,prisoner,1,0
189180,'s,1,0
189181,dilemma,1,0
189182,game,1,1
189183,.,1,0
189184,Recent,0,0
189185,work,0,0
189186,has,0,0
189187,suggested,0,0
189188,that,0,0
189189,punishment,1,1
189190,is,0,0
189191,detrimental,0,0
189192,because,0,0
189193,punishment,0,0
189194,provokes,0,0
189195,retaliation,0,0
189196,",",0,0
189197,not,0,0
189198,cooperation,0,0
189199,",",0,0
189200,resulting,0,0
189201,in,0,0
189202,lower,0,0
189203,overall,0,0
189204,payoffs,0,0
189205,.,0,0
189206,These,0,0
189207,findings,0,0
189208,may,0,0
189209,stem,0,0
189210,from,0,0
189211,the,0,0
189212,unrealistic,0,0
189213,assumption,0,0
189214,that,0,0
189215,all,0,0
189216,players,0,0
189217,are,0,0
189218,equal,0,0
189219,:,0,0
189220,in,0,0
189221,reality,0,0
189222,individuals,0,0
189223,are,0,0
189224,expected,0,0
189225,to,0,0
189226,vary,0,0
189227,in,0,0
189228,the,0,0
189229,power,0,0
189230,with,0,0
189231,which,0,0
189232,they,0,0
189233,can,0,0
189234,punish,0,0
189235,defectors,0,0
189236,.,0,0
189237,Here,0,0
189238,",",0,0
189239,we,0,0
189240,allowed,0,0
189241,strong,0,0
189242,players,0,0
189243,to,0,0
189244,interact,0,0
189245,with,0,0
189246,weak,0,0
189247,players,0,0
189248,in,0,0
189249,an,0,0
189250,iterated,1,0
189251,prisoner,1,0
189252,'s,1,0
189253,dilemma,1,0
189254,game,1,1
189255,with,1,0
189256,punishment,1,0
189257,.,1,0
189258,Defecting,0,0
189259,players,0,0
189260,were,0,0
189261,most,0,0
189262,likely,0,0
189263,to,0,0
189264,switch,0,0
189265,to,0,0
189266,cooperation,0,0
189267,if,0,0
189268,the,0,0
189269,partner,0,0
189270,cooperated,0,0
189271,:,0,0
189272,adding,0,0
189273,punishment,1,1
189274,yielded,0,0
189275,no,0,0
189276,additional,0,0
189277,benefit,0,0
189278,and,0,0
189279,",",0,0
189280,under,0,0
189281,some,0,0
189282,circumstances,0,0
189283,",",0,0
189284,increased,0,0
189285,the,0,0
189286,chance,0,0
189287,that,0,0
189288,the,0,0
189289,partner,0,0
189290,would,0,0
189291,both,0,0
189292,defect,0,0
189293,and,0,0
189294,retaliate,0,0
189295,against,0,0
189296,the,0,0
189297,punisher,0,0
189298,.,0,0
189299,Our,0,0
189300,findings,0,0
189301,show,0,0
189302,that,0,0
189303,",",0,0
189304,in,0,0
189305,a,0,0
189306,two-player,1,0
189307,game,1,1
189308,",",0,0
189309,cooperation,0,0
189310,begets,0,0
189311,cooperation,0,0
189312,and,0,0
189313,that,0,0
189314,punishment,0,1
189315,does,0,0
189316,not,0,0
189317,seem,0,0
189318,to,0,0
189319,yield,0,0
189320,any,0,0
189321,additional,0,0
189322,benefits,0,0
189323,.,0,0
189324,Further,0,0
189325,work,0,0
189326,should,0,0
189327,explore,0,0
189328,whether,0,0
189329,strong,0,0
189330,punishers,0,0
189331,might,0,0
189332,prevail,0,0
189333,in,0,0
189334,multi-player,0,1
189335,games,0,1
189336,.,0,0
189337,Randomized,0,0
189338,Controlled,0,1
189339,Trial,0,0
189340,of,0,0
189341,Mind,1,1
189342,Reading,1,0
189343,and,0,0
189344,In,1,0
189345,Vivo,1,1
189346,Rehearsal,1,1
189347,for,0,0
189348,High-Functioning,0,1
189349,Children,0,0
189350,with,0,0
189351,ASD,0,0
189352,.,0,0
189353,This,0,0
189354,randomized,0,0
189355,controlled,0,0
189356,trial,0,0
189357,evaluated,0,0
189358,the,0,0
189359,efficacy,0,0
189360,of,0,0
189361,a,0,0
189362,computer,1,1
189363,software,1,1
189364,(,1,0
189365,i.e.,1,0
189366,",",0,0
189367,Mind,1,1
189368,Reading,1,0
189369,),1,1
189370,and,1,0
189371,in,1,0
189372,vivo,1,0
189373,rehearsal,1,1
189374,treatment,1,0
189375,on,0,0
189376,the,0,0
189377,emotion,0,0
189378,decoding,0,0
189379,and,0,0
189380,encoding,0,1
189381,skills,0,1
189382,",",0,0
189383,autism,0,0
189384,symptoms,0,0
189385,",",0,0
189386,and,0,0
189387,social,0,0
189388,skills,0,1
189389,of,0,0
189390,43,0,0
189391,children,0,0
189392,",",0,0
189393,ages,0,0
189394,7-12,0,0
189395,years,0,0
189396,with,0,0
189397,high-functioning,0,0
189398,autism,0,0
189399,spectrum,0,0
189400,disorder,0,0
189401,(,0,1
189402,HFASD,0,1
189403,),0,0
189404,.,0,0
189405,Children,0,0
189406,in,0,0
189407,treatment,0,0
189408,(,0,0
189409,n,0,0
189410,=,0,0
189411,22,0,0
189412,),0,0
189413,received,0,0
189414,the,0,0
189415,manualized,1,1
189416,protocol,1,0
189417,over,1,0
189418,12,0,0
189419,weeks,0,0
189420,.,0,0
189421,Primary,0,0
189422,analyses,0,0
189423,indicated,0,0
189424,significantly,0,0
189425,better,0,0
189426,posttest,0,0
189427,performance,0,0
189428,for,0,0
189429,the,0,0
189430,treatment,1,1
189431,group,1,0
189432,(,1,0
189433,compared,1,0
189434,to,1,0
189435,controls,1,0
189436,),1,0
189437,on,1,0
189438,3,0,0
189439,of,0,0
189440,the,0,0
189441,4,0,0
189442,measures,0,0
189443,of,0,0
189444,emotion,0,0
189445,decoding,0,0
189446,and,0,1
189447,encoding,0,1
189448,and,0,0
189449,these,0,0
189450,were,0,0
189451,maintained,0,0
189452,at,0,0
189453,5-week,0,1
189454,follow-up,0,0
189455,.,0,0
189456,Analyses,0,0
189457,of,0,0
189458,secondary,0,0
189459,measures,0,0
189460,favored,0,0
189461,the,0,0
189462,treatment,1,0
189463,group,1,0
189464,for,1,0
189465,1,0,0
189466,of,0,0
189467,the,0,0
189468,2,0,0
189469,measures,0,0
189470,;,0,0
189471,specifically,0,0
189472,",",0,0
189473,ASD,0,0
189474,symptoms,0,0
189475,were,0,0
189476,significantly,0,0
189477,lower,0,0
189478,at,0,0
189479,posttest,0,0
189480,and,0,0
189481,follow-up,0,0
189482,.,0,0
189483,Esmolol,1,1
189484,versus,0,1
189485,verapamil,1,1
189486,in,0,0
189487,the,0,0
189488,acute,0,0
189489,treatment,0,0
189490,of,0,0
189491,atrial,0,0
189492,fibrillation,0,0
189493,or,0,1
189494,atrial,0,0
189495,flutter,0,0
189496,.,0,0
189497,The,0,0
189498,effects,0,0
189499,of,0,0
189500,esmolol,1,1
189501,",",0,0
189502,an,0,0
189503,ultrashort-acting,0,1
189504,beta,0,1
189505,blocker,0,1
189506,",",0,0
189507,and,0,0
189508,verapamil,1,1
189509,were,0,0
189510,compared,0,0
189511,in,0,0
189512,controlling,0,0
189513,ventricular,0,0
189514,response,0,0
189515,in,0,0
189516,45,0,0
189517,patients,0,0
189518,with,0,0
189519,atrial,0,0
189520,fibrillation,0,0
189521,or,0,1
189522,atrial,0,0
189523,flutter,0,0
189524,",",0,0
189525,in,0,0
189526,a,0,0
189527,randomized,0,0
189528,",",0,0
189529,parallel,0,0
189530,",",0,0
189531,open-label,0,0
189532,study,0,0
189533,.,0,0
189534,Patients,0,0
189535,with,0,0
189536,either,0,0
189537,new,0,0
189538,onset,0,0
189539,(,0,0
189540,less,0,0
189541,than,0,0
189542,48,0,0
189543,hours,0,0
189544,",",0,0
189545,n,0,0
189546,=,0,0
189547,31,0,0
189548,),0,0
189549,or,0,1
189550,old,0,0
189551,onset,0,0
189552,(,0,0
189553,greater,0,0
189554,than,0,0
189555,48,0,0
189556,hours,0,0
189557,",",0,0
189558,n,0,0
189559,=,0,0
189560,14,0,0
189561,),0,0
189562,of,0,0
189563,atrial,0,0
189564,fibrillation,0,0
189565,or,0,1
189566,flutter,0,0
189567,with,0,0
189568,rapid,0,0
189569,ventricular,0,0
189570,rate,0,0
189571,were,0,0
189572,stratified,0,0
189573,to,0,0
189574,receive,0,1
189575,esmolol,1,1
189576,(,0,0
189577,n,0,0
189578,=,0,0
189579,21,0,0
189580,),0,0
189581,or,0,1
189582,verapamil,1,1
189583,(,0,1
189584,n,0,0
189585,=,0,0
189586,24,0,0
189587,),0,0
189588,.,0,0
189589,Drug,0,0
189590,efficacy,0,0
189591,was,0,0
189592,measured,0,0
189593,by,0,0
189594,ventricular,0,0
189595,rate,0,0
189596,reduction,0,0
189597,and,0,0
189598,conversion,0,0
189599,to,0,0
189600,sinus,0,0
189601,rhythm,0,1
189602,.,0,0
189603,The,0,0
189604,heart,0,0
189605,rate,0,0
189606,declined,0,0
189607,with,0,0
189608,esmolol,1,1
189609,from,0,0
189610,139,0,0
189611,to,0,0
189612,100,0,0
189613,beats/min,0,0
189614,(,0,0
189615,p,0,0
189616,less,0,0
189617,than,0,0
189618,0.001,0,0
189619,),0,0
189620,and,0,0
189621,with,0,0
189622,verapamil,1,1
189623,from,0,0
189624,142,0,0
189625,to,0,0
189626,97,0,0
189627,beats/min,0,0
189628,(,0,0
189629,p,0,0
189630,less,0,0
189631,than,0,0
189632,0.001,0,0
189633,),0,0
189634,.,0,0
189635,Fifty,0,0
189636,percent,0,0
189637,of,0,0
189638,esmolol-treated,1,0
189639,patients,0,0
189640,with,0,0
189641,new,0,0
189642,onset,0,0
189643,of,0,0
189644,arrhythmias,0,0
189645,converted,0,0
189646,to,0,0
189647,sinus,0,0
189648,rhythm,0,1
189649,",",0,0
189650,whereas,0,0
189651,only,0,0
189652,12,0,0
189653,%,0,0
189654,of,0,0
189655,those,0,0
189656,who,0,0
189657,received,0,0
189658,verapamil,1,1
189659,converted,0,0
189660,(,0,0
189661,p,0,0
189662,less,0,0
189663,than,0,0
189664,0.03,0,0
189665,),0,0
189666,.,0,0
189667,Mild,0,0
189668,hypotension,0,0
189669,was,0,0
189670,observed,0,0
189671,in,0,0
189672,both,0,0
189673,treatment,0,0
189674,groups,0,0
189675,.,0,0
189676,Esmolol,1,1
189677,compares,0,0
189678,favorably,0,0
189679,with,0,0
189680,verapamil,1,1
189681,with,0,0
189682,respect,0,0
189683,to,0,0
189684,both,0,0
189685,efficacy,0,0
189686,and,0,0
189687,safety,0,0
189688,in,0,0
189689,acutely,0,0
189690,decreasing,0,0
189691,ventricular,0,0
189692,response,0,0
189693,during,0,0
189694,atrial,0,0
189695,fibrillation,0,0
189696,or,0,1
189697,flutter,0,0
189698,.,0,0
189699,Moreover,0,0
189700,",",0,0
189701,conversion,0,0
189702,to,0,0
189703,sinus,0,0
189704,rhythm,0,1
189705,is,0,0
189706,significantly,0,0
189707,more,0,0
189708,likely,0,0
189709,with,0,0
189710,esmolol,1,1
189711,.,1,0
189712,Effects,0,0
189713,of,0,0
189714,adjunctive,0,1
189715,zonisamide,1,1
189716,treatment,0,1
189717,on,0,0
189718,weight,0,0
189719,and,0,0
189720,body,0,0
189721,mass,0,0
189722,index,0,0
189723,in,0,0
189724,children,0,0
189725,with,0,0
189726,partial,0,0
189727,epilepsy,0,0
189728,.,0,0
189729,BACKGROUND,0,0
189730,Zonisamide,1,1
189731,has,0,0
189732,been,0,0
189733,associated,0,0
189734,with,0,0
189735,weight,0,0
189736,loss,0,0
189737,in,0,0
189738,children,0,0
189739,and,0,0
189740,adults,0,0
189741,.,0,0
189742,AIMS,0,0
189743,OF,0,1
189744,THE,0,0
189745,STUDY,0,0
189746,To,0,0
189747,assess,0,0
189748,the,0,0
189749,effects,0,0
189750,of,0,0
189751,adjunctive,0,1
189752,zonisamide,1,1
189753,on,0,0
189754,weight,0,0
189755,and,0,0
189756,body,0,0
189757,mass,0,0
189758,index,0,0
189759,(,0,1
189760,BMI,0,1
189761,),0,1
189762,in,0,0
189763,children,0,0
189764,with,0,0
189765,partial,0,0
189766,epilepsy,0,0
189767,.,0,0
189768,METHODS,0,0
189769,A,0,0
189770,subanalysis,0,0
189771,was,0,0
189772,conducted,0,0
189773,of,0,0
189774,a,0,0
189775,Phase,0,1
189776,III,0,1
189777,trial,0,0
189778,and,0,0
189779,extension,0,0
189780,study,0,0
189781,",",0,0
189782,in,0,0
189783,which,0,0
189784,children,0,0
189785,with,0,0
189786,partial,0,0
189787,epilepsy,0,0
189788,received,0,1
189789,adjunctive,1,1
189790,zonisamide,1,1
189791,(,1,1
189792,target,1,0
189793,dose,1,1
189794,8,1,0
189795,mg/kg/day,1,1
189796,;,1,0
189797,maximum,1,0
189798,500,1,1
189799,mg/day,1,1
189800,),1,0
189801,.,0,0
189802,Changes,0,0
189803,in,0,0
189804,weight,0,0
189805,were,0,0
189806,correlated,0,0
189807,with,0,0
189808,skeletal,0,0
189809,development,0,0
189810,and,0,0
189811,sexual,0,0
189812,maturation,0,0
189813,.,0,0
189814,RESULTS,0,0
189815,Overall,0,0
189816,",",0,0
189817,179,0,0
189818,children,0,0
189819,(,0,0
189820,93,0,0
189821,male,0,0
189822,",",0,0
189823,86,0,0
189824,female,0,0
189825,;,0,0
189826,age,0,0
189827,6-18,0,0
189828,years,0,0
189829,),0,0
189830,received,0,1
189831,zonisamide,1,1
189832,(,0,0
189833,mean,0,0
189834,duration,0,0
189835,370.6,0,0
189836,days,0,0
189837,),0,0
189838,.,0,0
189839,Weight,0,0
189840,loss,0,0
189841,?,0,0
189842,5,0,0
189843,%,0,0
189844,was,0,0
189845,reported,0,0
189846,for,0,0
189847,64,0,0
189848,of,0,0
189849,179,0,0
189850,(,0,0
189851,35.8,1,0
189852,%,1,0
189853,),1,0
189854,zonisamide-treated,1,0
189855,children,1,0
189856,.,0,0
189857,Of,0,0
189858,these,0,0
189859,",",0,0
189860,46.9,0,0
189861,%,0,0
189862,were,0,0
189863,overweight/obese,0,0
189864,at,0,0
189865,study,0,0
189866,entry,0,0
189867,",",0,0
189868,compared,0,0
189869,with,0,0
189870,23.4,0,0
189871,%,0,0
189872,at,0,0
189873,study,0,0
189874,end,0,0
189875,(,0,0
189876,P,0,0
189877,=,0,0
189878,0.0007,0,0
189879,),0,0
189880,;,0,0
189881,48.4,0,0
189882,%,0,0
189883,had,0,0
189884,normal,0,0
189885,weight,0,0
189886,at,0,0
189887,study,0,0
189888,entry,0,0
189889,",",0,0
189890,compared,0,0
189891,with,0,0
189892,65.6,0,0
189893,%,0,0
189894,at,0,0
189895,study,0,0
189896,end,0,0
189897,(,0,0
189898,P,0,0
189899,=,0,0
189900,0.03,0,0
189901,),0,0
189902,.,0,0
189903,Three,0,0
189904,patients,0,0
189905,were,0,0
189906,underweight,0,0
189907,at,0,0
189908,study,0,0
189909,entry,0,0
189910,",",0,0
189911,and,0,0
189912,four,0,0
189913,more,0,0
189914,became,0,0
189915,underweight,0,0
189916,by,0,0
189917,study,0,0
189918,end,0,0
189919,.,0,0
189920,No,0,0
189921,consistent,0,0
189922,correlations,0,0
189923,between,0,0
189924,weight,0,0
189925,loss,0,0
189926,and,0,0
189927,skeletal,0,1
189928,development,0,0
189929,or,0,1
189930,sexual,0,0
189931,maturation,0,0
189932,were,0,0
189933,observed,0,0
189934,.,0,0
189935,CONCLUSIONS,0,0
189936,Approximately,0,0
189937,one-third,0,0
189938,of,0,0
189939,children,0,0
189940,treated,0,0
189941,with,1,0
189942,zonisamide,1,1
189943,experienced,1,0
189944,?,0,0
189945,5,0,0
189946,%,0,0
189947,weight,0,0
189948,loss,0,0
189949,.,0,0
189950,Weight,0,0
189951,loss,0,0
189952,was,0,0
189953,most,0,0
189954,apparent,0,0
189955,in,0,0
189956,children,0,0
189957,with,0,0
189958,high,0,0
189959,baseline,0,0
189960,BMI,0,1
189961,values,0,0
189962,and,0,0
189963,did,0,0
189964,not,0,0
189965,appear,0,0
189966,to,0,0
189967,be,0,0
189968,associated,0,0
189969,with,0,0
189970,any,0,0
189971,consistent,0,0
189972,effects,0,0
189973,on,0,0
189974,growth,0,0
189975,and,0,0
189976,development,0,0
189977,.,0,0
189978,Lung,0,1
189979,cancer,0,0
189980,diagnosis,0,0
189981,and,0,0
189982,staging,0,0
189983,with,0,0
189984,endobronchial,1,0
189985,ultrasound-guided,1,1
189986,transbronchial,1,1
189987,needle,1,1
189988,aspiration,1,1
189989,compared,0,0
189990,with,0,0
189991,conventional,0,1
189992,approaches,0,0
189993,:,0,0
189994,an,0,0
189995,open-label,0,0
189996,",",0,0
189997,pragmatic,0,0
189998,",",0,0
189999,randomised,0,0
190000,controlled,0,0
190001,trial,0,0
190002,.,0,0
190003,BACKGROUND,0,0
190004,The,0,0
190005,diagnosis,0,0
190006,and,0,0
190007,staging,0,0
190008,of,0,0
190009,lung,0,0
190010,cancer,0,0
190011,is,0,0
190012,an,0,0
190013,important,0,0
190014,process,0,0
190015,that,0,0
190016,identifies,0,0
190017,treatment,0,0
190018,options,0,0
190019,and,0,0
190020,guides,0,1
190021,disease,0,0
190022,prognosis,0,0
190023,.,0,0
190024,We,0,0
190025,aimed,0,0
190026,to,0,0
190027,assess,0,0
190028,endobronchial,1,0
190029,ultrasound-guided,1,1
190030,transbronchial,1,1
190031,needle,1,1
190032,aspiration,1,0
190033,as,0,0
190034,an,0,0
190035,initial,0,0
190036,investigation,0,0
190037,technique,0,1
190038,for,0,0
190039,patients,0,0
190040,with,0,0
190041,suspected,0,0
190042,lung,0,0
190043,cancer,0,0
190044,.,0,0
190045,METHODS,0,0
190046,In,0,0
190047,this,0,0
190048,open-label,0,0
190049,",",0,0
190050,multicentre,0,0
190051,",",0,0
190052,pragmatic,0,0
190053,",",0,0
190054,randomised,0,0
190055,controlled,0,0
190056,trial,0,0
190057,",",0,0
190058,we,0,0
190059,recruited,0,0
190060,patients,0,0
190061,who,0,0
190062,had,0,0
190063,undergone,0,0
190064,a,0,0
190065,CT,0,1
190066,scan,0,1
190067,and,0,0
190068,had,0,0
190069,suspected,0,0
190070,stage,0,0
190071,I,0,0
190072,to,0,0
190073,IIIA,0,1
190074,lung,0,0
190075,cancer,0,0
190076,",",0,0
190077,from,0,0
190078,six,0,0
190079,UK,0,0
190080,centres,0,0
190081,and,0,0
190082,randomly,0,0
190083,assigned,0,0
190084,them,0,0
190085,to,0,0
190086,either,0,0
190087,endobronchial,1,0
190088,ultrasound-guided,1,1
190089,transbronchial,1,1
190090,needle,1,1
190091,aspiration,1,1
190092,(,0,1
190093,EBUS-TBNA,0,1
190094,),0,1
190095,or,0,1
190096,conventional,1,1
190097,diagnosis,1,0
190098,and,1,1
190099,staging,1,1
190100,(,0,1
190101,CDS,0,0
190102,),0,0
190103,",",0,0
190104,for,0,0
190105,further,0,0
190106,investigation,0,0
190107,and,0,0
190108,staging,0,0
190109,.,0,0
190110,If,0,0
190111,a,0,0
190112,target,0,0
190113,node,0,0
190114,could,0,0
190115,not,0,0
190116,be,0,0
190117,accessed,0,0
190118,by,0,0
190119,EBUS-TBNA,0,0
190120,",",0,0
190121,then,0,1
190122,endoscopic,1,1
190123,ultrasound-guided,1,1
190124,fine,1,1
190125,needle,1,1
190126,aspiration,1,1
190127,(,0,1
190128,EUS-FNA,0,1
190129,),0,1
190130,was,0,0
190131,allowed,0,0
190132,as,0,0
190133,an,0,0
190134,alternative,0,0
190135,procedure,0,0
190136,.,0,0
190137,Randomisation,0,0
190138,was,0,0
190139,stratified,0,0
190140,according,0,0
190141,to,0,0
190142,the,0,0
190143,presence,0,0
190144,of,0,0
190145,mediastinal,0,0
190146,lymph,0,0
190147,nodes,0,0
190148,measuring,0,0
190149,1,0,0
190150,cm,0,0
190151,or,0,1
190152,more,0,0
190153,in,0,0
190154,the,0,0
190155,short,0,1
190156,axis,0,0
190157,and,0,0
190158,by,0,0
190159,recruiting,0,0
190160,centre,0,0
190161,.,0,0
190162,We,0,0
190163,used,0,0
190164,a,0,0
190165,telephone,0,1
190166,randomisation,0,0
190167,method,0,1
190168,with,0,0
190169,permuted,0,0
190170,blocks,0,1
190171,of,0,0
190172,four,0,0
190173,generated,0,0
190174,by,0,0
190175,a,0,0
190176,computer,0,1
190177,.,0,0
190178,Because,0,0
190179,of,0,0
190180,the,0,0
190181,nature,0,0
190182,of,0,0
190183,the,0,0
190184,intervention,0,1
190185,",",0,0
190186,masking,0,1
190187,of,0,0
190188,participants,0,0
190189,and,0,0
190190,consenting,0,0
190191,investigators,0,0
190192,was,0,0
190193,not,0,0
190194,possible,0,0
190195,.,0,0
190196,The,0,0
190197,primary,0,0
190198,endpoint,0,0
190199,was,0,0
190200,the,0,0
190201,time-to-treatment,0,0
190202,decision,0,0
190203,after,0,0
190204,completion,0,0
190205,of,0,0
190206,the,0,0
190207,diagnostic,0,0
190208,and,0,0
190209,staging,0,0
190210,investigations,0,0
190211,and,0,0
190212,analysis,0,0
190213,was,0,0
190214,by,0,0
190215,intention-to-diagnose,0,0
190216,.,0,0
190217,This,0,0
190218,trial,0,0
190219,is,0,0
190220,registered,0,0
190221,with,0,0
190222,ClinicalTrials.gov,0,0
190223,",",0,0
190224,number,0,0
190225,NCT00652769,0,0
190226,.,0,0
190227,FINDINGS,0,0
190228,Between,0,0
190229,June,0,0
190230,10,0,0
190231,",",0,0
190232,2008,0,0
190233,",",0,0
190234,and,0,0
190235,July,0,0
190236,4,0,0
190237,",",0,0
190238,2011,0,0
190239,",",0,0
190240,we,0,0
190241,randomly,0,0
190242,allocated,0,0
190243,133,0,0
190244,patients,0,0
190245,to,0,0
190246,treatment,0,0
190247,:,0,0
190248,66,0,0
190249,to,0,0
190250,EBUS-TBNA,0,0
190251,and,0,0
190252,67,0,0
190253,to,0,0
190254,CDS,0,0
190255,(,0,0
190256,one,0,0
190257,later,0,0
190258,withdrew,0,0
190259,consent,0,0
190260,),0,0
190261,.,0,0
190262,Two,0,0
190263,patients,0,0
190264,from,0,0
190265,the,0,0
190266,EBUS-TBNA,0,1
190267,group,0,0
190268,underwent,0,0
190269,EUS-FNA,0,1
190270,.,0,0
190271,The,0,0
190272,median,0,0
190273,time,0,0
190274,to,0,0
190275,treatment,0,0
190276,decision,0,0
190277,was,0,0
190278,shorter,0,0
190279,with,0,0
190280,EBUS-TBNA,0,0
190281,(,0,0
190282,14,0,0
190283,days,0,0
190284,;,0,0
190285,95,0,0
190286,%,0,0
190287,CI,0,0
190288,14-15,0,0
190289,),0,0
190290,than,0,0
190291,with,0,0
190292,CDS,0,0
190293,(,0,0
190294,29,0,0
190295,days,0,0
190296,;,0,0
190297,23-35,0,0
190298,),0,0
190299,resulting,0,0
190300,in,0,0
190301,a,0,0
190302,hazard,0,0
190303,ratio,0,0
190304,of,0,0
190305,1?98,0,0
190306,",",0,0
190307,(,0,0
190308,1?39-2?82,0,0
190309,",",0,0
190310,p,0,0
190311,<,0,0
190312,0?0001,0,0
190313,),0,0
190314,.,0,0
190315,One,0,0
190316,patient,0,0
190317,in,0,0
190318,each,0,0
190319,group,0,0
190320,had,0,0
190321,a,0,0
190322,pneumothorax,0,0
190323,from,0,0
190324,a,0,0
190325,CT-guided,0,1
190326,biopsy,0,1
190327,sample,0,0
190328,;,0,0
190329,the,0,0
190330,patient,0,0
190331,from,0,0
190332,the,0,0
190333,CDS,0,0
190334,group,0,0
190335,needed,0,0
190336,intercostal,0,1
190337,drainage,0,1
190338,and,0,0
190339,was,0,0
190340,admitted,0,0
190341,to,0,0
190342,hospital,0,0
190343,.,0,0
190344,INTERPRETATION,1,0
190345,Transbronchial,1,1
190346,needle,1,1
190347,aspiration,1,1
190348,guided,1,1
190349,by,1,0
190350,endobronchial,1,0
190351,ultrasound,1,1
190352,should,1,0
190353,be,0,0
190354,considered,0,0
190355,as,0,0
190356,the,0,0
190357,initial,0,0
190358,investigation,0,0
190359,for,0,0
190360,patients,0,0
190361,with,0,0
190362,suspected,0,0
190363,lung,0,0
190364,cancer,0,0
190365,",",0,0
190366,because,0,0
190367,it,0,0
190368,reduces,0,0
190369,the,0,0
190370,time,0,0
190371,to,0,0
190372,treatment,0,0
190373,decision,0,1
190374,compared,0,0
190375,with,0,0
190376,conventional,0,1
190377,diagnosis,0,0
190378,and,0,0
190379,staging,0,0
190380,techniques,0,1
190381,.,0,0
190382,FUNDING,0,0
190383,UK,0,0
190384,Medical,0,1
190385,Research,0,0
190386,Council,0,1
190387,.,0,0
190388,The,0,0
190389,clinical,0,0
190390,effectiveness,0,0
190391,and,0,0
190392,cost-effectiveness,0,0
190393,of,0,0
190394,telephone,1,1
190395,triage,1,1
190396,for,0,0
190397,managing,0,0
190398,same-day,0,1
190399,consultation,0,1
190400,requests,0,0
190401,in,0,0
190402,general,0,0
190403,practice,0,0
190404,:,0,0
190405,a,0,0
190406,cluster,0,0
190407,randomised,0,0
190408,controlled,0,0
190409,trial,0,0
190410,comparing,0,0
190411,general,1,0
190412,practitioner-led,1,1
190413,and,1,0
190414,nurse-led,1,1
190415,management,1,1
190416,systems,1,0
190417,with,0,0
190418,usual,0,1
190419,care,0,1
190420,(,0,0
190421,the,0,0
190422,ESTEEM,0,1
190423,trial,0,0
190424,),0,0
190425,.,0,0
190426,BACKGROUND,0,0
190427,Telephone,1,1
190428,triage,1,1
190429,is,0,0
190430,proposed,0,0
190431,as,0,0
190432,a,0,0
190433,method,0,1
190434,of,0,0
190435,managing,0,0
190436,increasing,0,0
190437,demand,0,0
190438,for,0,0
190439,primary,0,0
190440,care,0,1
190441,.,0,0
190442,Previous,0,0
190443,studies,0,0
190444,have,0,0
190445,involved,0,0
190446,small,0,0
190447,samples,0,0
190448,in,0,0
190449,limited,0,0
190450,settings,0,0
190451,",",0,0
190452,and,0,0
190453,focused,0,0
190454,on,0,0
190455,nurse,0,1
190456,roles,0,0
190457,.,0,0
190458,Evidence,0,0
190459,is,0,0
190460,limited,0,0
190461,regarding,0,0
190462,the,0,0
190463,impact,0,0
190464,on,0,0
190465,primary,0,0
190466,care,0,1
190467,workload,0,0
190468,",",0,0
190469,costs,0,0
190470,",",0,0
190471,and,0,0
190472,patient,0,0
190473,safety,0,0
190474,and,0,0
190475,experience,0,0
190476,when,0,0
190477,triage,1,1
190478,is,0,0
190479,used,0,0
190480,to,0,0
190481,manage,0,0
190482,patients,0,0
190483,requesting,0,0
190484,same-day,0,1
190485,consultations,0,1
190486,in,0,0
190487,general,0,0
190488,practice,0,0
190489,.,0,0
190490,OBJECTIVES,0,0
190491,In,0,0
190492,comparison,0,0
190493,with,0,0
190494,usual,1,1
190495,care,1,1
190496,(,1,1
190497,UC,1,0
190498,),1,0
190499,",",0,0
190500,to,0,0
190501,assess,0,0
190502,the,0,0
190503,impact,0,0
190504,of,0,0
190505,GP-led,1,1
190506,telephone,1,1
190507,triage,1,1
190508,(,1,1
190509,GPT,1,0
190510,),1,1
190511,and,1,0
190512,nurse-led,1,1
190513,computer-supported,1,1
190514,telephone,1,1
190515,triage,1,1
190516,(,1,1
190517,NT,1,1
190518,),1,1
190519,on,0,0
190520,primary,0,0
190521,care,0,1
190522,workload,0,0
190523,and,0,0
190524,cost,0,0
190525,",",0,0
190526,patient,0,0
190527,experience,0,0
190528,of,0,0
190529,care,0,1
190530,",",0,0
190531,and,0,0
190532,patient,0,0
190533,safety,0,0
190534,and,0,0
190535,health,0,0
190536,status,0,0
190537,for,0,0
190538,patients,0,0
190539,requesting,0,0
190540,same-day,0,1
190541,consultations,0,1
190542,in,0,0
190543,general,0,0
190544,practice,0,0
190545,.,0,0
190546,DESIGN,0,0
190547,Pragmatic,0,0
190548,cluster,0,0
190549,randomised,0,0
190550,controlled,0,0
190551,trial,0,0
190552,",",0,0
190553,incorporating,0,0
190554,economic,0,1
190555,evaluation,0,0
190556,and,0,0
190557,qualitative,0,1
190558,process,0,0
190559,evaluation,0,0
190560,.,0,0
190561,SETTING,0,0
190562,General,0,0
190563,practices,0,1
190564,(,0,0
190565,n,0,0
190566,=,0,0
190567,42,0,0
190568,),0,0
190569,in,0,0
190570,four,0,0
190571,regions,0,0
190572,of,0,0
190573,England,0,0
190574,",",0,0
190575,UK,0,0
190576,(,0,0
190577,Devon,0,1
190578,",",0,0
190579,Bristol/Somerset,0,1
190580,",",0,0
190581,Warwickshire/Coventry,0,0
190582,",",0,0
190583,Norfolk/Suffolk,0,0
190584,),0,0
190585,.,0,0
190586,PARTICIPANTS,0,0
190587,Patients,0,0
190588,requesting,0,0
190589,same-day,0,1
190590,consultations,0,1
190591,.,0,0
190592,INTERVENTIONS,0,0
190593,Practices,0,0
190594,were,0,0
190595,randomised,1,0
190596,to,1,0
190597,GPT,1,0
190598,",",1,0
190599,NT,1,1
190600,or,1,1
190601,UC,1,0
190602,.,1,1
190603,Data,0,0
190604,collection,0,0
190605,was,0,0
190606,not,0,0
190607,blinded,0,0
190608,;,0,0
190609,however,0,0
190610,",",0,0
190611,analysis,0,0
190612,was,0,0
190613,conducted,0,0
190614,by,0,0
190615,a,0,0
190616,statistician,0,0
190617,blinded,0,0
190618,to,0,0
190619,practice,0,0
190620,allocation,0,0
190621,.,0,0
190622,MAIN,0,0
190623,OUTCOME,0,0
190624,MEASURES,0,0
190625,Primary,0,0
190626,-,0,0
190627,primary,0,0
190628,care,0,1
190629,contacts,0,1
190630,[,0,0
190631,general,0,0
190632,practice,0,0
190633,",",0,0
190634,out-of-hours,0,1
190635,primary,0,0
190636,care,0,1
190637,",",0,0
190638,accident,0,0
190639,and,0,1
190640,emergency,0,1
190641,(,0,1
190642,A,0,0
190643,&,0,1
190644,E,0,1
190645,),0,1
190646,and,0,0
190647,walk-in,0,1
190648,centre,0,0
190649,attendances,0,0
190650,],0,0
190651,in,0,0
190652,the,0,0
190653,28,0,0
190654,days,0,0
190655,following,0,0
190656,the,0,0
190657,index,0,0
190658,consultation,0,1
190659,request,0,0
190660,.,0,0
190661,Secondary,0,0
190662,-,0,0
190663,resource,0,1
190664,use,0,0
190665,and,0,0
190666,costs,0,0
190667,",",0,0
190668,patient,0,0
190669,safety,0,0
190670,(,0,0
190671,deaths,0,0
190672,and,0,0
190673,emergency,0,1
190674,hospital,0,0
190675,admissions,0,0
190676,within,0,0
190677,7,0,0
190678,days,0,0
190679,of,0,0
190680,index,0,0
190681,request,0,0
190682,",",0,0
190683,and,0,0
190684,A,0,0
190685,&,0,1
190686,E,0,1
190687,attendance,0,0
190688,within,0,0
190689,28,0,0
190690,days,0,0
190691,),0,0
190692,",",0,0
190693,health,0,0
190694,status,0,0
190695,and,0,0
190696,experience,0,0
190697,of,0,0
190698,care,0,1
190699,.,0,0
190700,RESULTS,0,0
190701,Of,0,1
190702,"20,990",0,0
190703,eligible,0,0
190704,randomised,0,0
190705,patients,0,0
190706,(,0,0
190707,UC,0,0
190708,n,0,0
190709,=,0,0
190710,7283,0,0
190711,;,0,0
190712,GPT,0,0
190713,n,0,0
190714,=,0,0
190715,6695,0,0
190716,;,0,0
190717,NT,0,1
190718,n,0,0
190719,=,0,0
190720,7012,0,1
190721,),0,0
190722,",",0,0
190723,primary,0,0
190724,outcome,0,0
190725,data,0,0
190726,were,0,0
190727,analysed,0,0
190728,for,0,0
190729,"16,211",0,0
190730,patients,0,0
190731,(,0,0
190732,UC,0,0
190733,n,0,0
190734,=,0,0
190735,5572,0,0
190736,;,0,0
190737,GPT,0,0
190738,n,0,0
190739,=,0,0
190740,5171,0,0
190741,;,0,0
190742,NT,0,1
190743,n,0,0
190744,=,0,0
190745,5468,0,0
190746,),0,0
190747,.,0,0
190748,Compared,0,0
190749,with,0,0
190750,UC,0,0
190751,",",0,0
190752,GPT,0,0
190753,and,0,0
190754,NT,0,1
190755,increased,0,0
190756,primary,0,0
190757,outcome,0,0
190758,contacts,0,1
190759,(,0,0
190760,over,0,0
190761,28-day,0,0
190762,follow-up,0,0
190763,),0,0
190764,by,0,0
190765,33,0,0
190766,%,0,0
190767,[,0,0
190768,rate,0,0
190769,ratio,0,0
190770,(,0,1
190771,RR,0,1
190772,),0,1
190773,1.33,0,0
190774,",",0,0
190775,95,0,0
190776,%,0,0
190777,confidence,0,0
190778,interval,0,0
190779,(,0,1
190780,CI,0,0
190781,),0,1
190782,1.30,0,0
190783,to,0,0
190784,1.36,0,0
190785,],0,0
190786,and,0,0
190787,48,0,0
190788,%,0,0
190789,(,0,0
190790,RR,0,0
190791,1.48,0,0
190792,",",0,0
190793,95,0,0
190794,%,0,0
190795,CI,0,0
190796,1.44,0,0
190797,to,0,0
190798,1.52,0,0
190799,),0,0
190800,",",0,0
190801,respectively,0,0
190802,.,0,0
190803,Compared,0,0
190804,with,0,0
190805,GPT,0,0
190806,",",0,0
190807,NT,0,1
190808,was,0,0
190809,associated,0,0
190810,with,0,0
190811,a,0,0
190812,marginal,0,0
190813,increase,0,0
190814,in,0,0
190815,primary,0,0
190816,outcome,0,0
190817,contacts,0,0
190818,by,0,0
190819,4,0,0
190820,%,0,0
190821,(,0,0
190822,RR,0,0
190823,1.04,0,0
190824,",",0,0
190825,95,0,0
190826,%,0,0
190827,CI,0,0
190828,1.01,0,0
190829,to,0,0
190830,1.08,0,0
190831,),0,0
190832,.,0,0
190833,Triage,0,0
190834,was,0,0
190835,associated,0,0
190836,with,0,0
190837,a,0,0
190838,redistribution,0,0
190839,of,0,0
190840,primary,0,0
190841,care,0,1
190842,contacts,0,0
190843,.,0,0
190844,Although,0,0
190845,GPT,0,0
190846,",",0,0
190847,compared,0,0
190848,with,0,0
190849,UC,0,0
190850,",",0,0
190851,increased,0,0
190852,the,0,0
190853,rate,0,0
190854,of,0,0
190855,overall,0,0
190856,GP,0,0
190857,contacts,0,1
190858,(,0,0
190859,face,0,0
190860,to,0,0
190861,face,0,0
190862,and,0,1
190863,telephone,0,1
190864,),0,1
190865,over,0,0
190866,the,0,0
190867,28,0,0
190868,days,0,0
190869,by,0,0
190870,38,0,0
190871,%,0,0
190872,(,0,0
190873,RR,0,0
190874,1.38,0,0
190875,",",0,0
190876,95,0,0
190877,%,0,0
190878,CI,0,0
190879,1.28,0,0
190880,to,0,0
190881,1.50,0,0
190882,),0,0
190883,",",0,0
190884,GP,0,0
190885,face-to-face,0,1
190886,contacts,0,0
190887,were,0,0
190888,reduced,0,0
190889,by,0,0
190890,39,0,0
190891,%,0,0
190892,(,0,0
190893,RR,0,0
190894,0.61,0,0
190895,",",0,0
190896,95,0,0
190897,%,0,0
190898,CI,0,0
190899,0.54,0,0
190900,to,0,0
190901,0.69,0,0
190902,),0,0
190903,.,0,0
190904,NT,0,1
190905,reduced,0,0
190906,the,0,0
190907,rate,0,0
190908,of,0,0
190909,overall,0,0
190910,GP,0,0
190911,contacts,0,0
190912,by,0,0
190913,16,0,0
190914,%,0,0
190915,(,0,0
190916,RR,0,0
190917,0.84,0,0
190918,",",0,0
190919,95,0,0
190920,%,0,0
190921,CI,0,0
190922,0.78,0,0
190923,to,0,0
190924,0.91,0,0
190925,),0,0
190926,and,0,0
190927,GP,0,1
190928,face-to-face,0,1
190929,contacts,0,0
190930,by,0,0
190931,20,0,0
190932,%,0,0
190933,(,0,0
190934,RR,0,0
190935,0.80,0,0
190936,",",0,0
190937,95,0,0
190938,%,0,0
190939,CI,0,0
190940,0.71,0,0
190941,to,0,0
190942,0.90,0,0
190943,),0,0
190944,",",0,0
190945,whereas,0,0
190946,nurse,0,1
190947,contacts,0,0
190948,increased,0,0
190949,.,0,0
190950,The,0,0
190951,increased,0,0
190952,rate,0,0
190953,of,0,0
190954,primary,0,0
190955,care,0,1
190956,contacts,0,1
190957,in,0,0
190958,triage,0,0
190959,arms,0,1
190960,is,0,0
190961,largely,0,0
190962,attributable,0,0
190963,to,0,0
190964,increased,0,0
190965,telephone,0,1
190966,contacts,0,0
190967,.,0,0
190968,Estimated,0,0
190969,overall,0,0
190970,patient-clinician,0,1
190971,contact,0,1
190972,time,0,0
190973,on,0,0
190974,the,0,0
190975,index,0,0
190976,day,0,0
190977,increased,0,0
190978,in,0,0
190979,triage,0,1
190980,(,0,0
190981,GPT,0,0
190982,=,0,0
190983,10.3,0,0
190984,minutes,0,0
190985,;,0,0
190986,NT,0,1
190987,=,0,0
190988,14.8,0,0
190989,minutes,0,0
190990,;,0,0
190991,UC,0,0
190992,=,0,0
190993,9.6,0,0
190994,minutes,0,0
190995,),0,0
190996,",",0,0
190997,although,0,0
190998,patterns,0,0
190999,of,0,0
191000,clinician,0,0
191001,use,0,0
191002,varied,0,0
191003,between,0,0
191004,arms,0,0
191005,.,0,0
191006,Taking,0,0
191007,account,0,0
191008,of,0,0
191009,both,0,0
191010,the,0,0
191011,pattern,0,0
191012,and,0,0
191013,duration,0,0
191014,of,0,0
191015,primary,0,0
191016,outcome,0,0
191017,contacts,0,0
191018,",",0,0
191019,overall,0,0
191020,costs,0,0
191021,over,0,0
191022,the,0,0
191023,28-day,0,0
191024,follow-up,0,0
191025,were,0,0
191026,similar,0,0
191027,in,0,0
191028,all,0,0
191029,three,0,0
191030,arms,0,0
191031,(,0,0
191032,approximately,0,0
191033,?75,0,1
191034,per,0,1
191035,patient,0,0
191036,),0,0
191037,.,0,0
191038,Triage,0,0
191039,appeared,0,0
191040,safe,0,0
191041,",",0,0
191042,and,0,0
191043,no,0,0
191044,differences,0,0
191045,in,0,0
191046,patient,0,0
191047,health,0,0
191048,status,0,0
191049,were,0,0
191050,observed,0,0
191051,.,0,0
191052,NT,0,1
191053,was,0,0
191054,somewhat,0,0
191055,less,0,0
191056,acceptable,0,0
191057,to,0,0
191058,patients,0,0
191059,than,0,0
191060,GPT,1,0
191061,or,1,1
191062,UC,1,0
191063,.,1,0
191064,The,1,0
191065,process,0,0
191066,evaluation,0,0
191067,identified,0,0
191068,the,0,0
191069,complexity,0,0
191070,associated,0,0
191071,with,0,0
191072,introducing,0,1
191073,triage,0,1
191074,but,0,0
191075,found,0,0
191076,no,0,0
191077,consistency,0,0
191078,across,0,0
191079,practices,0,0
191080,about,0,0
191081,what,0,0
191082,works,0,0
191083,and,0,0
191084,what,0,0
191085,does,0,0
191086,not,0,0
191087,work,0,0
191088,when,0,0
191089,implementing,0,0
191090,it,0,0
191091,.,0,0
191092,CONCLUSIONS,0,0
191093,Introducing,0,0
191094,GPT,0,0
191095,or,0,1
191096,NT,0,1
191097,was,0,0
191098,associated,0,0
191099,with,0,0
191100,a,0,0
191101,redistribution,0,0
191102,of,0,0
191103,primary,0,0
191104,care,0,1
191105,workload,0,0
191106,for,0,0
191107,patients,0,0
191108,requesting,0,0
191109,same-day,0,1
191110,consultations,0,1
191111,",",0,0
191112,and,0,0
191113,at,0,0
191114,similar,0,0
191115,cost,0,0
191116,to,0,0
191117,UC,0,0
191118,.,0,0
191119,Although,0,0
191120,triage,0,0
191121,seemed,0,0
191122,to,0,0
191123,be,0,0
191124,safe,0,0
191125,",",0,0
191126,investigation,0,0
191127,of,0,0
191128,the,0,0
191129,circumstances,0,0
191130,of,0,0
191131,a,0,0
191132,larger,0,0
191133,number,0,0
191134,of,0,0
191135,deaths,0,0
191136,or,0,0
191137,admissions,0,0
191138,after,0,0
191139,triage,0,0
191140,might,0,0
191141,be,0,0
191142,warranted,0,0
191143,",",0,0
191144,and,0,0
191145,monitoring,0,1
191146,of,0,0
191147,these,0,0
191148,events,0,0
191149,is,0,0
191150,necessary,0,0
191151,as,0,0
191152,triage,0,1
191153,is,0,0
191154,implemented,0,0
191155,.,0,0
191156,TRIAL,0,0
191157,REGISTRATION,0,0
191158,Current,0,1
191159,Controlled,0,1
191160,Trials,0,1
191161,ISRCTN20687662,0,1
191162,.,0,0
191163,FUNDING,0,0
191164,This,0,0
191165,project,0,0
191166,was,0,0
191167,funded,0,0
191168,by,0,0
191169,the,0,0
191170,NIHR,0,1
191171,Health,0,1
191172,Technology,0,0
191173,Assessment,0,1
191174,programme,0,1
191175,and,0,0
191176,will,0,0
191177,be,0,0
191178,published,0,0
191179,in,0,0
191180,full,0,0
191181,in,0,0
191182,Health,0,0
191183,Technology,0,0
191184,Assessment,0,1
191185,;,0,0
191186,Vol,0,1
191187,.,0,0
191188,19,0,0
191189,",",0,0
191190,No,0,0
191191,.,0,0
191192,13,0,0
191193,.,0,0
191194,See,0,0
191195,the,0,0
191196,NIHR,0,1
191197,Journals,0,1
191198,Library,0,1
191199,website,0,1
191200,for,0,0
191201,further,0,0
191202,project,0,0
191203,information,0,0
191204,.,0,0
191205,Magnetic,1,1
191206,resonance,1,0
191207,imaging,1,0
191208,in,0,0
191209,the,0,0
191210,evaluation,0,0
191211,of,0,0
191212,clinical,0,0
191213,treatment,0,0
191214,of,0,0
191215,otospongiosis,0,0
191216,:,0,0
191217,a,0,0
191218,pilot,0,0
191219,study,0,0
191220,.,0,0
191221,OBJECTIVES,0,0
191222,To,0,0
191223,evaluate,0,0
191224,the,0,0
191225,applicability,0,0
191226,of,0,0
191227,magnetic,1,1
191228,resonance,1,1
191229,imaging,1,1
191230,(,1,1
191231,MRI,1,1
191232,),1,1
191233,as,0,0
191234,a,0,0
191235,method,0,1
191236,for,0,0
191237,monitoring,0,0
191238,the,0,0
191239,activity,0,0
191240,of,0,0
191241,otospongiotic,0,0
191242,lesions,0,0
191243,before,0,0
191244,and,0,0
191245,after,0,0
191246,clinical,0,0
191247,treatment,0,0
191248,.,0,0
191249,STUDY,0,0
191250,DESIGN,0,0
191251,Prospective,0,0
191252,",",0,0
191253,randomized,0,0
191254,",",0,0
191255,controlled,0,0
191256,",",0,0
191257,double-blind,0,0
191258,study,0,0
191259,.,0,0
191260,SETTING,0,0
191261,One,0,0
191262,single,0,1
191263,tertiary,0,0
191264,care,0,1
191265,institution,0,0
191266,in,0,0
191267,a,0,0
191268,large,0,0
191269,",",0,0
191270,cosmopolitan,0,0
191271,city,0,0
191272,.,0,0
191273,METHODS,0,0
191274,Twenty-six,0,0
191275,patients,0,0
191276,(,0,0
191277,n,0,0
191278,=,0,0
191279,42,0,0
191280,ears,0,0
191281,),0,0
191282,with,0,0
191283,clinical,0,0
191284,",",0,0
191285,audiometric,0,0
191286,",",0,0
191287,and,0,0
191288,tomographic,0,1
191289,diagnosis,0,0
191290,of,0,0
191291,otosclerosis,0,0
191292,were,0,0
191293,enrolled,0,0
191294,.,0,0
191295,If,0,0
191296,computed,1,0
191297,tomography,1,1
191298,(,0,1
191299,CT,0,1
191300,),0,1
191301,demonstrated,0,0
191302,active,0,0
191303,lesions,0,0
191304,",",0,0
191305,these,0,0
191306,patients,0,0
191307,underwent,1,0
191308,MRI,1,0
191309,to,0,0
191310,detect,0,0
191311,otospongiotic,0,1
191312,foci,0,0
191313,",",0,0
191314,seen,0,0
191315,as,0,0
191316,areas,0,0
191317,of,0,0
191318,gadolinium,0,1
191319,enhancement,0,0
191320,.,0,0
191321,Patients,0,0
191322,were,0,0
191323,divided,0,0
191324,into,0,0
191325,3,0,0
191326,groups,0,0
191327,and,0,0
191328,received,0,1
191329,treatment,0,0
191330,with,0,0
191331,placebo,1,1
191332,",",1,0
191333,sodium,1,1
191334,alendronate,1,1
191335,",",1,0
191336,or,1,1
191337,sodium,1,1
191338,fluoride,1,1
191339,for,0,0
191340,6,0,0
191341,months,0,0
191342,.,0,0
191343,After,0,0
191344,this,0,0
191345,period,0,0
191346,",",0,0
191347,clinical,0,0
191348,and,0,0
191349,audiometric,0,1
191350,evaluations,0,1
191351,and,0,0
191352,a,0,0
191353,second,0,0
191354,MRI,1,0
191355,were,0,0
191356,performed,0,0
191357,.,0,0
191358,Each,0,0
191359,MRI,1,0
191360,was,0,0
191361,evaluated,0,0
191362,by,0,0
191363,both,0,0
191364,a,0,0
191365,neuroradiologist,0,1
191366,and,0,0
191367,an,0,0
191368,otolaryngologist,0,1
191369,in,0,0
191370,a,0,0
191371,subjective,0,0
191372,(,0,0
191373,visual,0,1
191374,),0,1
191375,and,0,0
191376,objective,0,0
191377,(,0,1
191378,using,0,0
191379,specific,0,1
191380,eFilm,0,0
191381,Workstation,0,1
191382,software,0,1
191383,),0,0
191384,manner,0,1
191385,.,0,0
191386,RESULTS,0,0
191387,Otospongiosis,0,0
191388,was,0,0
191389,most,0,0
191390,predominantly,0,0
191391,identified,0,0
191392,in,0,0
191393,the,0,0
191394,region,0,0
191395,anterior,0,0
191396,to,0,0
191397,the,0,0
191398,oval,0,0
191399,window,0,0
191400,",",0,0
191401,and,0,0
191402,this,0,0
191403,site,0,0
191404,was,0,0
191405,reliable,0,0
191406,for,0,0
191407,comparing,0,0
191408,pre-,0,1
191409,and,0,0
191410,posttreatment,0,0
191411,scans,0,0
191412,.,0,0
191413,The,0,0
191414,patients,0,0
191415,in,0,0
191416,the,0,0
191417,alendronate,0,1
191418,and,0,0
191419,sodium,0,1
191420,fluoride,0,1
191421,groups,0,0
191422,had,0,0
191423,MRI,1,0
191424,findings,0,0
191425,that,0,0
191426,suggested,0,0
191427,a,0,0
191428,decrease,0,0
191429,in,0,0
191430,activity,0,0
191431,of,0,0
191432,otospongiotic,0,0
191433,lesions,0,0
191434,",",0,0
191435,more,0,0
191436,relevant,0,0
191437,in,0,0
191438,the,0,0
191439,alendronate,0,1
191440,group,0,0
191441,.,0,0
191442,These,0,0
191443,findings,0,0
191444,were,0,0
191445,statistically,0,0
191446,significant,0,0
191447,for,0,0
191448,both,0,0
191449,subjective,0,0
191450,and,0,0
191451,objective,0,0
191452,MRI,1,1
191453,evaluations,0,0
191454,.,0,0
191455,CONCLUSIONS,0,0
191456,MRI,0,0
191457,shows,0,0
191458,higher,0,0
191459,sensitivity,0,0
191460,than,0,0
191461,clinical,0,0
191462,or,0,1
191463,audiometric,0,1
191464,assessment,0,0
191465,for,0,0
191466,detecting,0,0
191467,reduction,0,0
191468,in,0,0
191469,activity,0,0
191470,of,0,0
191471,otospongiosis,0,0
191472,.,0,0
191473,The,0,0
191474,objective,0,0
191475,MRI,1,1
191476,evaluation,0,0
191477,based,0,0
191478,on,0,0
191479,software,0,1
191480,analysis,0,0
191481,was,0,0
191482,the,0,0
191483,most,0,0
191484,accurate,0,0
191485,method,0,1
191486,of,0,0
191487,monitoring,0,1
191488,clinical,0,0
191489,treatment,0,1
191490,response,0,0
191491,in,0,0
191492,otospongiosis,0,0
191493,.,0,0
191494,Safety,0,1
191495,and,0,0
191496,benefit,0,0
191497,of,0,0
191498,discontinuing,0,1
191499,statin,1,1
191500,therapy,1,1
191501,in,0,0
191502,the,0,0
191503,setting,0,0
191504,of,0,0
191505,advanced,0,0
191506,",",0,0
191507,life-limiting,0,0
191508,illness,0,0
191509,:,0,0
191510,a,0,0
191511,randomized,0,0
191512,clinical,0,0
191513,trial,0,0
191514,.,0,0
191515,IMPORTANCE,0,0
191516,For,0,0
191517,patients,0,0
191518,with,0,0
191519,limited,0,0
191520,prognosis,0,0
191521,",",0,0
191522,some,0,0
191523,medication,0,1
191524,risks,0,0
191525,may,0,0
191526,outweigh,0,0
191527,the,0,0
191528,benefits,0,0
191529,",",0,0
191530,particularly,0,0
191531,when,0,0
191532,benefits,0,0
191533,take,0,0
191534,years,0,0
191535,to,0,0
191536,accrue,0,0
191537,;,0,0
191538,statins,0,1
191539,are,0,0
191540,one,0,0
191541,example,0,0
191542,.,0,0
191543,Data,0,0
191544,are,0,0
191545,lacking,0,0
191546,regarding,0,0
191547,the,0,0
191548,risks,0,0
191549,and,0,0
191550,benefits,0,0
191551,of,0,0
191552,discontinuing,0,1
191553,statin,0,1
191554,therapy,0,1
191555,for,0,0
191556,patients,0,0
191557,with,0,0
191558,limited,0,0
191559,life,0,0
191560,expectancy,0,0
191561,.,0,0
191562,OBJECTIVE,0,0
191563,To,0,0
191564,evaluate,0,0
191565,the,0,0
191566,safety,0,0
191567,",",0,0
191568,clinical,0,0
191569,",",0,0
191570,and,0,0
191571,cost,0,0
191572,impact,0,0
191573,of,0,0
191574,discontinuing,0,1
191575,statin,1,1
191576,medications,0,1
191577,for,0,0
191578,patients,0,0
191579,in,0,0
191580,the,0,0
191581,palliative,0,0
191582,care,0,1
191583,setting,0,0
191584,.,0,0
191585,DESIGN,0,0
191586,",",0,0
191587,SETTING,0,0
191588,",",0,0
191589,AND,0,0
191590,PARTICIPANTS,0,0
191591,This,0,0
191592,was,0,0
191593,a,0,0
191594,multicenter,0,0
191595,",",0,0
191596,parallel-group,0,0
191597,",",0,0
191598,unblinded,0,0
191599,",",0,0
191600,pragmatic,0,0
191601,clinical,0,0
191602,trial,0,0
191603,.,0,0
191604,Eligibility,0,0
191605,included,0,0
191606,adults,0,0
191607,with,0,0
191608,an,0,0
191609,estimated,0,0
191610,life,0,0
191611,expectancy,0,0
191612,of,0,0
191613,between,0,0
191614,1,0,0
191615,month,0,0
191616,and,0,0
191617,1,0,0
191618,year,0,0
191619,",",0,0
191620,statin,0,1
191621,therapy,0,1
191622,for,0,0
191623,3,0,0
191624,months,0,0
191625,or,0,0
191626,more,0,0
191627,for,0,0
191628,primary,0,0
191629,or,0,1
191630,secondary,0,0
191631,prevention,0,0
191632,of,0,0
191633,cardiovascular,0,0
191634,disease,0,0
191635,",",0,0
191636,recent,0,0
191637,deterioration,0,0
191638,in,0,0
191639,functional,0,0
191640,status,0,0
191641,",",0,0
191642,and,0,0
191643,no,0,0
191644,recent,0,0
191645,active,0,1
191646,cardiovascular,0,0
191647,disease,0,0
191648,.,0,0
191649,Participants,0,0
191650,were,0,0
191651,randomized,0,0
191652,to,0,0
191653,either,0,1
191654,discontinue,1,0
191655,or,1,1
191656,continue,1,0
191657,statin,1,1
191658,therapy,1,1
191659,and,0,0
191660,were,0,0
191661,monitored,0,0
191662,monthly,0,0
191663,for,0,0
191664,up,0,0
191665,to,0,0
191666,1,0,0
191667,year,0,0
191668,.,0,0
191669,The,0,0
191670,study,0,0
191671,was,0,0
191672,conducted,0,0
191673,from,0,0
191674,June,0,0
191675,3,0,0
191676,",",0,0
191677,2011,0,0
191678,",",0,0
191679,to,0,0
191680,May,0,1
191681,2,0,0
191682,",",0,0
191683,2013,0,0
191684,.,0,0
191685,All,0,0
191686,analyses,0,0
191687,were,0,0
191688,performed,0,0
191689,using,0,0
191690,an,0,0
191691,intent-to-treat,0,0
191692,approach,0,1
191693,.,0,0
191694,INTERVENTIONS,0,0
191695,Statin,1,1
191696,therapy,1,1
191697,was,0,0
191698,withdrawn,0,0
191699,from,0,0
191700,eligible,0,0
191701,patients,0,0
191702,who,0,0
191703,were,0,0
191704,randomized,0,0
191705,to,0,0
191706,the,0,0
191707,discontinuation,0,0
191708,group,0,0
191709,.,0,0
191710,Patients,0,0
191711,in,0,0
191712,the,0,0
191713,continuation,0,0
191714,group,0,0
191715,continued,0,0
191716,to,0,0
191717,receive,1,0
191718,statins,1,1
191719,.,1,0
191720,MAIN,0,0
191721,OUTCOMES,0,0
191722,AND,0,0
191723,MEASURES,0,0
191724,Outcomes,0,0
191725,included,0,0
191726,death,0,0
191727,within,0,0
191728,60,0,0
191729,days,0,0
191730,(,0,0
191731,primary,0,0
191732,outcome,0,0
191733,),0,0
191734,",",0,0
191735,survival,0,0
191736,",",0,0
191737,cardiovascular,0,0
191738,events,0,0
191739,",",0,0
191740,performance,0,0
191741,status,0,0
191742,",",0,0
191743,quality,0,0
191744,of,0,0
191745,life,0,0
191746,(,0,1
191747,QOL,0,1
191748,),0,0
191749,",",0,0
191750,symptoms,0,0
191751,",",0,0
191752,number,0,0
191753,of,0,0
191754,nonstatin,0,1
191755,medications,0,1
191756,",",0,0
191757,and,0,0
191758,cost,0,0
191759,savings,0,0
191760,.,0,0
191761,RESULTS,0,0
191762,A,0,0
191763,total,0,0
191764,of,0,0
191765,381,0,0
191766,patients,0,0
191767,were,0,0
191768,enrolled,0,0
191769,;,0,0
191770,189,0,0
191771,of,0,0
191772,these,0,0
191773,were,0,0
191774,randomized,0,0
191775,to,0,0
191776,discontinue,0,0
191777,statins,1,1
191778,",",0,0
191779,and,0,0
191780,192,0,0
191781,were,0,0
191782,randomized,0,0
191783,to,0,0
191784,continue,0,0
191785,therapy,0,1
191786,.,0,1
191787,Mean,0,0
191788,(,0,0
191789,SD,0,0
191790,),0,1
191791,age,0,0
191792,was,0,0
191793,74.1,0,0
191794,(,0,0
191795,11.6,0,0
191796,),0,0
191797,years,0,0
191798,",",0,0
191799,22.0,0,0
191800,%,0,0
191801,of,0,0
191802,the,0,0
191803,participants,0,0
191804,were,0,0
191805,cognitively,0,0
191806,impaired,0,0
191807,",",0,0
191808,and,0,0
191809,48.8,0,0
191810,%,0,0
191811,had,0,0
191812,cancer,0,0
191813,.,0,0
191814,The,0,0
191815,proportion,0,0
191816,of,0,0
191817,participants,0,0
191818,in,0,0
191819,the,0,0
191820,discontinuation,0,0
191821,vs,0,0
191822,continuation,0,0
191823,groups,0,0
191824,who,0,0
191825,died,0,0
191826,within,0,0
191827,60,0,0
191828,days,0,0
191829,was,0,0
191830,not,0,0
191831,significantly,0,0
191832,different,0,0
191833,(,0,0
191834,23.8,0,0
191835,%,0,0
191836,vs,0,0
191837,20.3,0,0
191838,%,0,0
191839,;,0,0
191840,90,0,0
191841,%,0,0
191842,CI,0,0
191843,",",0,0
191844,-3.5,0,1
191845,%,0,0
191846,to,0,0
191847,10.5,0,0
191848,%,0,0
191849,;,0,0
191850,P=.36,0,0
191851,),0,1
191852,and,0,0
191853,did,0,0
191854,not,0,0
191855,meet,0,0
191856,the,0,0
191857,noninferiority,0,0
191858,end,0,0
191859,point,0,0
191860,.,0,0
191861,Total,0,0
191862,QOL,0,0
191863,was,0,0
191864,better,0,0
191865,for,0,0
191866,the,0,0
191867,group,0,0
191868,discontinuing,0,1
191869,statin,0,1
191870,therapy,0,1
191871,(,0,0
191872,mean,0,0
191873,McGill,0,0
191874,QOL,0,1
191875,score,0,0
191876,",",0,0
191877,7.11,0,0
191878,vs,0,0
191879,6.85,0,0
191880,;,0,0
191881,P=.04,0,0
191882,),0,0
191883,.,0,0
191884,Few,0,0
191885,participants,0,0
191886,experienced,0,0
191887,cardiovascular,0,0
191888,events,0,0
191889,(,0,0
191890,13,0,0
191891,in,0,0
191892,the,0,0
191893,discontinuation,0,0
191894,group,0,0
191895,vs,0,0
191896,11,0,0
191897,in,0,0
191898,the,0,0
191899,continuation,0,0
191900,group,0,0
191901,),0,0
191902,.,0,0
191903,Mean,0,0
191904,cost,0,0
191905,savings,0,0
191906,were,0,0
191907,$,0,0
191908,3.37,0,0
191909,per,0,0
191910,day,0,0
191911,and,0,0
191912,$,0,0
191913,716,0,0
191914,per,0,0
191915,patient,0,0
191916,.,0,0
191917,CONCLUSIONS,0,0
191918,AND,0,0
191919,RELEVANCE,0,0
191920,This,0,0
191921,pragmatic,0,0
191922,trial,0,0
191923,suggests,0,0
191924,that,0,0
191925,stopping,0,0
191926,statin,0,1
191927,medication,0,1
191928,therapy,0,1
191929,is,0,0
191930,safe,0,0
191931,and,0,0
191932,may,0,0
191933,be,0,0
191934,associated,0,0
191935,with,0,0
191936,benefits,0,0
191937,including,0,0
191938,improved,0,0
191939,QOL,0,1
191940,",",0,0
191941,use,0,0
191942,of,0,0
191943,fewer,0,0
191944,nonstatin,0,1
191945,medications,0,0
191946,",",0,0
191947,and,0,0
191948,a,0,0
191949,corresponding,0,0
191950,reduction,0,0
191951,in,0,0
191952,medication,0,0
191953,costs,0,0
191954,.,0,0
191955,Thoughtful,0,0
191956,patient-provider,0,1
191957,discussions,0,1
191958,regarding,0,0
191959,the,0,0
191960,uncertain,0,0
191961,benefit,0,0
191962,and,0,0
191963,potential,0,0
191964,decrement,0,0
191965,in,0,0
191966,QOL,0,0
191967,associated,0,0
191968,with,0,0
191969,statin,0,1
191970,continuation,0,0
191971,in,0,0
191972,this,0,0
191973,setting,0,0
191974,are,0,0
191975,warranted,0,0
191976,.,0,0
191977,TRIAL,0,0
191978,REGISTRATION,0,0
191979,clinicaltrials.gov,0,0
191980,Identifier,0,0
191981,:,0,0
191982,NCT01415934,0,0
191983,.,0,0
191984,Coronary,1,0
191985,artery,1,0
191986,bypass,1,1
191987,graft,1,1
191988,surgery,1,1
191989,provides,0,0
191990,clinically,0,0
191991,important,0,0
191992,quality-of-life,0,0
191993,improvements,0,0
191994,over,0,0
191995,medical,0,0
191996,therapy,0,1
191997,in,0,0
191998,patients,0,0
191999,with,0,0
192000,ischaemic,0,0
192001,left,0,0
192002,ventricular,0,0
192003,dysfunction,0,0
192004,.,0,0
192005,Afatinib,1,1
192006,versus,0,1
192007,methotrexate,1,1
192008,as,0,0
192009,second-line,0,1
192010,treatment,0,0
192011,in,0,0
192012,patients,0,0
192013,with,0,0
192014,recurrent,0,0
192015,or,0,1
192016,metastatic,0,0
192017,squamous-cell,0,0
192018,carcinoma,0,0
192019,of,0,0
192020,the,0,0
192021,head,0,0
192022,and,0,0
192023,neck,0,1
192024,progressing,0,0
192025,on,0,0
192026,or,0,1
192027,after,0,0
192028,platinum-based,0,1
192029,therapy,0,1
192030,(,0,1
192031,LUX-Head,0,1
192032,&,0,1
192033,Neck,0,0
192034,1,0,0
192035,),0,0
192036,:,0,0
192037,an,0,0
192038,open-label,0,0
192039,",",0,0
192040,randomised,0,0
192041,phase,0,0
192042,3,0,0
192043,trial,0,0
192044,.,0,0
192045,BACKGROUND,0,0
192046,Patients,0,0
192047,with,0,0
192048,recurrent,0,0
192049,or,0,1
192050,metastatic,0,0
192051,squamous-cell,0,0
192052,carcinoma,0,0
192053,of,0,0
192054,the,0,0
192055,head,0,0
192056,and,0,1
192057,neck,0,1
192058,(,0,1
192059,HNSCC,0,0
192060,),0,1
192061,progressing,0,0
192062,after,0,0
192063,first-line,0,1
192064,platinum,0,1
192065,regimens,0,1
192066,have,0,0
192067,a,0,0
192068,poor,0,0
192069,prognosis,0,0
192070,and,0,0
192071,few,0,0
192072,treatment,0,0
192073,options,0,0
192074,.,0,0
192075,Afatinib,1,1
192076,",",0,0
192077,an,0,0
192078,irreversible,0,0
192079,ERBB,0,1
192080,family,0,1
192081,blocker,0,1
192082,",",0,0
192083,has,0,0
192084,shown,0,0
192085,efficacy,0,0
192086,in,0,0
192087,a,0,0
192088,phase,0,0
192089,2,0,0
192090,study,0,0
192091,in,0,0
192092,this,0,0
192093,setting,0,0
192094,.,0,0
192095,We,0,0
192096,aimed,0,0
192097,to,0,0
192098,assess,0,0
192099,the,0,0
192100,efficacy,0,0
192101,and,0,0
192102,safety,0,0
192103,of,0,0
192104,afatinib,1,1
192105,compared,0,0
192106,with,0,0
192107,methotrexate,1,1
192108,as,0,0
192109,second-line,0,1
192110,treatment,0,0
192111,in,0,0
192112,patients,0,0
192113,with,0,0
192114,recurrent,0,0
192115,or,0,1
192116,metastatic,0,0
192117,HNSCC,0,0
192118,progressing,0,0
192119,on,0,0
192120,or,0,1
192121,after,0,0
192122,platinum-based,0,1
192123,therapy,0,1
192124,.,0,0
192125,METHODS,0,0
192126,In,0,0
192127,this,0,0
192128,open-label,0,0
192129,",",0,0
192130,phase,0,0
192131,3,0,0
192132,",",0,0
192133,randomised,0,0
192134,controlled,0,0
192135,trial,0,0
192136,conducted,0,0
192137,in,0,0
192138,101,0,0
192139,centres,0,0
192140,in,0,0
192141,19,0,0
192142,countries,0,0
192143,",",0,0
192144,we,0,0
192145,enrolled,0,0
192146,patients,0,0
192147,aged,0,0
192148,18,0,0
192149,years,0,0
192150,or,0,0
192151,older,0,0
192152,with,0,0
192153,histologically,0,0
192154,or,0,0
192155,cytologically,0,1
192156,confirmed,0,0
192157,HNSCC,0,0
192158,that,0,0
192159,was,0,0
192160,recurrent,0,0
192161,",",0,0
192162,metastatic,0,0
192163,",",0,0
192164,or,0,0
192165,both,0,0
192166,who,0,0
192167,had,0,0
192168,progressed,0,0
192169,on,0,0
192170,or,0,1
192171,after,0,0
192172,first-line,0,1
192173,platinum-based,0,1
192174,therapy,0,1
192175,",",0,0
192176,were,0,0
192177,not,0,0
192178,amenable,0,0
192179,for,0,0
192180,salvage,0,1
192181,surgery,0,1
192182,or,0,1
192183,radiotherapy,0,1
192184,",",0,0
192185,and,0,0
192186,who,0,0
192187,had,0,0
192188,an,0,0
192189,Eastern,0,0
192190,Cooperative,0,0
192191,Oncology,0,0
192192,Group,0,0
192193,(,0,1
192194,ECOG,0,1
192195,),0,1
192196,performance,0,0
192197,status,0,0
192198,of,0,0
192199,0,0,0
192200,or,0,0
192201,1,0,0
192202,.,0,0
192203,Previous,0,0
192204,treatment,0,0
192205,with,0,0
192206,more,0,0
192207,than,0,0
192208,one,0,0
192209,systemic,0,0
192210,regimen,0,1
192211,in,0,0
192212,this,0,0
192213,setting,0,0
192214,was,0,0
192215,not,0,0
192216,allowed,0,0
192217,;,0,0
192218,previous,0,0
192219,treatment,0,0
192220,with,0,0
192221,EGFR-targeted,1,1
192222,antibody,1,1
192223,therapy,1,1
192224,(,1,0
192225,but,1,0
192226,not,1,0
192227,EGFR-targeted,1,1
192228,tyrosine-kinase,1,1
192229,inhibitors,1,1
192230,),1,0
192231,was,0,0
192232,allowed,0,0
192233,.,0,0
192234,We,0,0
192235,randomly,0,0
192236,assigned,0,0
192237,eligible,0,0
192238,patients,0,0
192239,in,0,0
192240,a,0,0
192241,2:1,0,0
192242,ratio,0,0
192243,to,0,0
192244,receive,0,1
192245,oral,1,1
192246,afatinib,1,1
192247,(,1,0
192248,40,1,1
192249,mg/day,1,1
192250,),1,0
192251,or,1,1
192252,intravenous,1,1
192253,methotrexate,1,1
192254,(,1,0
192255,40,1,1
192256,mg/m,1,1
192257,(,1,0
192258,2,1,0
192259,),1,0
192260,per,1,1
192261,week,1,0
192262,),1,0
192263,",",0,0
192264,stratified,0,0
192265,by,0,0
192266,ECOG,0,1
192267,performance,0,0
192268,status,0,0
192269,and,0,0
192270,previous,0,0
192271,EGFR-targeted,0,1
192272,antibody,0,0
192273,therapy,0,1
192274,for,0,0
192275,recurrent,0,0
192276,or,0,1
192277,metastatic,0,0
192278,disease,0,0
192279,.,0,0
192280,Randomisation,0,0
192281,was,0,0
192282,done,0,0
192283,centrally,0,0
192284,with,0,0
192285,an,0,0
192286,interactive,0,1
192287,voice,0,0
192288,or,0,1
192289,web-based,0,1
192290,response,0,0
192291,system,0,0
192292,.,0,0
192293,Clinicians,0,0
192294,and,0,0
192295,patients,0,0
192296,were,0,0
192297,not,0,0
192298,masked,0,0
192299,to,0,0
192300,treatment,0,0
192301,allocation,0,0
192302,;,0,0
192303,independent,0,0
192304,review,0,0
192305,of,0,0
192306,tumour,0,0
192307,response,0,0
192308,was,0,0
192309,done,0,0
192310,in,0,0
192311,a,0,0
192312,blinded,0,0
192313,manner,0,0
192314,.,0,0
192315,The,0,0
192316,primary,0,0
192317,endpoint,0,0
192318,was,0,0
192319,progression-free,0,0
192320,survival,0,0
192321,as,0,0
192322,assessed,0,0
192323,by,0,0
192324,an,0,0
192325,independent,0,0
192326,",",0,0
192327,central,0,0
192328,imaging,0,0
192329,review,0,0
192330,committee,0,0
192331,.,0,0
192332,Efficacy,0,0
192333,analyses,0,0
192334,were,0,0
192335,done,0,0
192336,in,0,0
192337,the,0,0
192338,intention-to-treat,0,0
192339,population,0,0
192340,and,0,0
192341,safety,0,0
192342,analyses,0,0
192343,were,0,0
192344,done,0,0
192345,in,0,0
192346,patients,0,0
192347,who,0,0
192348,received,0,0
192349,at,0,0
192350,least,0,0
192351,one,0,0
192352,dose,0,0
192353,of,0,0
192354,study,0,0
192355,drug,0,0
192356,.,0,0
192357,This,0,0
192358,ongoing,0,0
192359,study,0,0
192360,is,0,0
192361,registered,0,0
192362,with,0,0
192363,ClinicalTrials.gov,0,0
192364,",",0,0
192365,number,0,0
192366,NCT01345682,0,0
192367,.,0,0
192368,FINDINGS,0,0
192369,Between,0,0
192370,Jan,0,0
192371,10,0,0
192372,",",0,0
192373,2012,0,0
192374,",",0,0
192375,and,0,0
192376,Dec,0,1
192377,12,0,0
192378,",",0,0
192379,2013,0,0
192380,",",0,0
192381,we,0,0
192382,enrolled,0,0
192383,483,0,0
192384,patients,0,0
192385,and,0,0
192386,randomly,0,0
192387,assigned,0,0
192388,322,0,0
192389,to,0,0
192390,afatinib,1,1
192391,and,0,0
192392,161,0,0
192393,to,0,0
192394,methotrexate,1,1
192395,.,1,0
192396,After,0,0
192397,a,0,0
192398,median,0,0
192399,follow-up,0,0
192400,of,0,0
192401,6?7,0,0
192402,months,0,0
192403,(,0,0
192404,IQR,0,1
192405,3?1-9?0,0,1
192406,),0,0
192407,",",0,0
192408,progression-free,0,0
192409,survival,0,0
192410,was,0,0
192411,longer,0,0
192412,in,0,0
192413,the,0,0
192414,afatinib,1,1
192415,group,1,0
192416,than,0,0
192417,in,0,0
192418,the,0,0
192419,methotrexate,1,1
192420,group,1,0
192421,(,0,0
192422,median,0,0
192423,2?6,0,1
192424,months,0,0
192425,[,0,0
192426,95,0,0
192427,%,0,0
192428,CI,0,0
192429,2?0-2?7,0,0
192430,],0,0
192431,for,0,0
192432,the,0,0
192433,afatinib,0,1
192434,group,0,0
192435,vs,0,0
192436,1?7,0,1
192437,months,0,0
192438,[,0,0
192439,1?5-2?4,0,0
192440,],0,0
192441,for,0,0
192442,the,0,0
192443,methotrexate,0,1
192444,group,0,0
192445,;,0,0
192446,hazard,0,0
192447,ratio,0,0
192448,[,0,0
192449,HR,0,0
192450,],0,0
192451,0?80,0,1
192452,[,0,0
192453,95,0,0
192454,%,0,0
192455,CI,0,0
192456,0?65-0?98,0,1
192457,],0,0
192458,",",0,0
192459,p=0?030,0,0
192460,),0,0
192461,.,0,0
192462,The,0,0
192463,most,0,0
192464,frequent,0,0
192465,grade,0,0
192466,3,0,0
192467,or,0,0
192468,4,0,0
192469,drug-related,0,0
192470,adverse,0,0
192471,events,0,0
192472,were,0,0
192473,rash,0,0
192474,or,0,1
192475,acne,0,0
192476,(,0,0
192477,31,0,0
192478,[,0,0
192479,10,0,0
192480,%,0,0
192481,],0,0
192482,of,0,0
192483,320,0,0
192484,patients,0,0
192485,in,0,0
192486,the,0,0
192487,afatinib,0,1
192488,group,0,0
192489,vs,0,0
192490,none,0,0
192491,of,0,0
192492,160,0,0
192493,patients,0,0
192494,in,0,0
192495,the,0,0
192496,methotrexate,0,1
192497,group,0,0
192498,),0,0
192499,",",0,0
192500,diarrhoea,0,0
192501,(,0,0
192502,30,0,0
192503,[,0,0
192504,9,0,0
192505,%,0,0
192506,],0,0
192507,vs,0,0
192508,three,0,0
192509,[,0,0
192510,2,0,0
192511,%,0,0
192512,],0,0
192513,),0,0
192514,",",0,0
192515,stomatitis,0,1
192516,(,0,0
192517,20,0,0
192518,[,0,0
192519,6,0,0
192520,%,0,0
192521,],0,0
192522,vs,0,0
192523,13,0,0
192524,[,0,0
192525,8,0,0
192526,%,0,0
192527,],0,0
192528,),0,0
192529,",",0,0
192530,fatigue,0,0
192531,(,0,0
192532,18,0,0
192533,[,0,0
192534,6,0,0
192535,%,0,0
192536,],0,0
192537,vs,0,0
192538,five,0,0
192539,[,0,0
192540,3,0,0
192541,%,0,0
192542,],0,0
192543,),0,0
192544,",",0,0
192545,and,0,1
192546,neutropenia,0,0
192547,(,0,0
192548,1,0,0
192549,[,0,0
192550,<,0,0
192551,1,0,0
192552,%,0,0
192553,],0,0
192554,vs,0,0
192555,11,0,0
192556,[,0,0
192557,7,0,0
192558,%,0,0
192559,],0,0
192560,),0,0
192561,;,0,0
192562,serious,0,0
192563,adverse,0,0
192564,events,0,0
192565,occurred,0,0
192566,in,0,0
192567,44,0,0
192568,(,0,0
192569,14,0,1
192570,%,0,0
192571,),0,0
192572,of,1,0
192573,afatinib-treated,1,0
192574,patients,0,0
192575,and,0,0
192576,18,0,0
192577,(,0,0
192578,11,0,0
192579,%,0,0
192580,),0,0
192581,of,1,0
192582,methotrexate-treated,1,1
192583,patients,0,0
192584,.,0,0
192585,INTERPRETATION,1,0
192586,Afatinib,1,1
192587,was,1,0
192588,associated,0,0
192589,with,0,0
192590,significant,0,0
192591,improvements,0,0
192592,in,0,0
192593,progression-free,0,0
192594,survival,0,0
192595,and,0,0
192596,had,0,0
192597,a,0,0
192598,manageable,0,0
192599,safety,0,0
192600,profile,0,0
192601,.,0,0
192602,These,0,0
192603,findings,0,0
192604,provide,0,0
192605,important,0,0
192606,new,0,0
192607,insights,0,0
192608,into,0,0
192609,the,0,0
192610,treatment,0,0
192611,of,0,0
192612,this,0,0
192613,patient,0,0
192614,population,0,0
192615,and,0,0
192616,support,0,0
192617,further,0,0
192618,investigations,0,0
192619,with,0,0
192620,irreversible,0,0
192621,ERBB,0,1
192622,family,0,1
192623,blockers,0,1
192624,in,0,0
192625,HNSCC,0,0
192626,.,0,0
192627,FUNDING,0,0
192628,Boehringer,0,1
192629,Ingelheim,0,0
192630,.,0,0
192631,Icosapent,1,1
192632,Ethyl,1,1
192633,(,1,0
192634,Eicosapentaenoic,1,1
192635,Acid,1,1
192636,Ethyl,1,1
192637,Ester,1,1
192638,),1,0
192639,:,1,0
192640,Effects,0,0
192641,Upon,0,0
192642,High-Sensitivity,0,0
192643,C-Reactive,0,0
192644,Protein,0,1
192645,and,0,0
192646,Lipid,0,0
192647,Parameters,0,0
192648,in,0,0
192649,Patients,0,0
192650,With,0,0
192651,Metabolic,0,0
192652,Syndrome,0,0
192653,.,0,0
192654,BACKGROUND,0,0
192655,The,0,0
192656,aim,0,0
192657,of,0,0
192658,this,0,0
192659,analysis,0,0
192660,was,0,0
192661,to,0,0
192662,examine,0,0
192663,the,0,0
192664,effects,0,0
192665,of,0,0
192666,icosapent,1,1
192667,ethyl,1,1
192668,(,1,1
192669,eicosapentaenoic,1,1
192670,acid,1,1
192671,ethyl,1,1
192672,ester,1,1
192673,",",1,0
192674,IPE,1,0
192675,),1,0
192676,on,0,0
192677,high-sensitivity,0,1
192678,C-reactive,0,1
192679,protein,0,1
192680,(,0,1
192681,hsCRP,0,1
192682,),0,1
192683,and,0,0
192684,lipid,0,0
192685,parameters,0,0
192686,in,0,0
192687,patients,0,0
192688,with,0,0
192689,metabolic,0,0
192690,syndrome,0,0
192691,",",0,0
192692,with,0,0
192693,and,0,0
192694,without,0,1
192695,stable,0,0
192696,statin,0,1
192697,therapy,0,1
192698,.,0,0
192699,METHODS,0,0
192700,This,0,0
192701,post,0,0
192702,hoc,0,0
192703,exploratory,0,1
192704,analysis,0,0
192705,evaluated,0,0
192706,patients,0,0
192707,with,0,0
192708,metabolic,0,0
192709,syndrome,0,0
192710,treated,0,0
192711,with,0,0
192712,IPE,1,0
192713,4,0,0
192714,grams/day,0,0
192715,",",0,0
192716,IPE,0,0
192717,2,0,0
192718,grams/day,0,0
192719,",",0,0
192720,or,0,1
192721,placebo,1,1
192722,in,0,0
192723,phase,0,0
192724,3,0,0
192725,",",0,0
192726,randomized,0,0
192727,",",0,0
192728,placebo-controlled,0,1
192729,studies,0,0
192730,entitled,0,0
192731,:,0,0
192732,MARINE,0,1
192733,[,0,1
192734,triglyceride,0,0
192735,(,0,1
192736,TG,0,1
192737,),0,1
192738,levels,0,0
192739,?500,0,1
192740,and,0,0
192741,?2000,0,1
192742,mg/dL,0,1
192743,],0,0
192744,and,0,0
192745,ANCHOR,0,1
192746,[,0,1
192747,TG,0,1
192748,levels,0,0
192749,?200,0,1
192750,and,0,0
192751,<,0,0
192752,500,0,1
192753,mg/dL,0,0
192754,",",0,0
192755,despite,0,0
192756,low-density,0,0
192757,lipoprotein,0,1
192758,cholesterol,0,1
192759,(,0,1
192760,LDL-C,0,1
192761,),0,1
192762,control,0,1
192763,with,0,0
192764,stable,0,0
192765,statin,0,1
192766,therapy,0,1
192767,],0,0
192768,.,0,0
192769,RESULTS,0,0
192770,Compared,0,0
192771,with,1,0
192772,placebo,1,1
192773,in,1,0
192774,patients,0,0
192775,with,0,0
192776,metabolic,0,0
192777,syndrome,0,0
192778,in,0,0
192779,MARINE,0,1
192780,(,0,1
192781,n=204,0,1
192782,),0,1
192783,and,0,1
192784,ANCHOR,0,1
192785,(,0,1
192786,n=645,0,0
192787,),0,0
192788,",",0,0
192789,at,0,0
192790,the,0,0
192791,approved,0,0
192792,dose,0,0
192793,of,0,0
192794,4,0,0
192795,grams/day,0,0
192796,",",0,0
192797,IPE,0,0
192798,significantly,0,0
192799,lowered,0,0
192800,hsCRP,0,0
192801,levels,0,0
192802,40.0,0,0
192803,%,0,0
192804,(,0,1
192805,P=0.0007,0,0
192806,),0,1
192807,in,0,0
192808,MARINE,0,1
192809,and,0,0
192810,23.0,0,0
192811,%,0,0
192812,(,0,1
192813,P=0.0003,0,0
192814,),0,1
192815,in,0,0
192816,ANCHOR,0,0
192817,.,0,0
192818,Compared,0,0
192819,with,1,0
192820,placebo,1,1
192821,in,1,0
192822,MARINE,0,1
192823,",",0,0
192824,which,0,0
192825,included,0,0
192826,patients,0,0
192827,with,0,0
192828,and,0,0
192829,without,0,1
192830,statin,0,1
192831,therapy,1,1
192832,",",1,0
192833,IPE,1,0
192834,4,1,0
192835,grams/day,1,0
192836,significantly,0,0
192837,reduced,0,0
192838,hsCRP,0,0
192839,levels,0,0
192840,78.0,0,0
192841,%,0,0
192842,in,0,0
192843,statin-treated,0,0
192844,patients,0,0
192845,(,0,0
192846,P=0.0035,0,0
192847,",",0,1
192848,n=16,0,0
192849,),0,0
192850,.,0,0
192851,Compared,0,0
192852,with,1,0
192853,placebo,1,1
192854,in,1,0
192855,MARINE,0,1
192856,",",0,0
192857,IPE,0,0
192858,4,0,0
192859,grams/day,0,0
192860,significantly,0,0
192861,reduced,0,0
192862,TG,0,1
192863,levels,0,0
192864,(,0,0
192865,35.0,0,0
192866,%,0,0
192867,;,0,0
192868,P,0,0
192869,<,0,0
192870,0.0001,0,0
192871,),0,0
192872,",",0,0
192873,non-high-density,0,1
192874,lipoprotein,0,1
192875,cholesterol,0,1
192876,(,0,0
192877,non-HDL-C,0,0
192878,;,0,0
192879,19.9,0,0
192880,%,0,0
192881,;,0,0
192882,P,0,0
192883,<,0,0
192884,0.0001,0,0
192885,),0,0
192886,",",0,0
192887,and,0,0
192888,apolipoprotein,0,0
192889,B,0,1
192890,levels,0,0
192891,(,0,0
192892,ApoB,0,1
192893,),0,1
192894,(,0,0
192895,9.1,0,0
192896,%,0,0
192897,;,0,0
192898,P=0.0015,0,0
192899,),0,0
192900,without,0,0
192901,raising,0,0
192902,LDL-C,0,0
192903,levels,0,0
192904,.,0,0
192905,Compared,0,0
192906,with,0,0
192907,placebo,0,1
192908,in,0,0
192909,ANCHOR,0,0
192910,",",0,0
192911,IPE,1,0
192912,4,1,0
192913,grams/day,1,0
192914,significantly,0,0
192915,reduced,0,0
192916,TG,0,1
192917,(,0,0
192918,21.7,0,0
192919,%,0,0
192920,;,0,0
192921,P,0,0
192922,<,0,0
192923,0.0001,0,0
192924,),0,0
192925,",",0,0
192926,non-HDL-C,0,0
192927,(,0,0
192928,13.5,0,0
192929,%,0,0
192930,;,0,0
192931,P,0,0
192932,<,0,0
192933,0.0001,0,0
192934,),0,0
192935,",",0,0
192936,ApoB,0,1
192937,(,0,0
192938,8.8,0,0
192939,%,0,0
192940,;,0,0
192941,P,0,0
192942,<,0,0
192943,0.0001,0,0
192944,),0,0
192945,",",0,0
192946,LDL-C,0,1
192947,(,0,0
192948,5.2,0,0
192949,%,0,0
192950,;,0,0
192951,P=0.0236,0,0
192952,),0,0
192953,",",0,0
192954,and,0,0
192955,HDL-C,0,1
192956,levels,0,0
192957,(,0,0
192958,4.0,0,0
192959,%,0,0
192960,;,0,0
192961,P=0.0053,0,0
192962,),0,0
192963,.,0,0
192964,CONCLUSIONS,0,0
192965,Compared,0,0
192966,with,0,0
192967,placebo,0,1
192968,",",0,0
192969,IPE,0,0
192970,4,0,0
192971,grams/day,0,0
192972,significantly,0,0
192973,lowered,0,0
192974,hsCRP,0,0
192975,levels,0,0
192976,and,0,0
192977,improved,0,0
192978,lipids,0,0
192979,without,0,0
192980,raising,0,0
192981,LDL-C,0,1
192982,levels,0,0
192983,in,0,0
192984,patients,0,0
192985,with,0,0
192986,metabolic,0,0
192987,syndrome,0,0
192988,and,0,1
192989,high,0,0
192990,(,0,1
192991,?200,0,1
192992,and,0,0
192993,<,0,0
192994,500,0,1
192995,mg/dL,0,0
192996,),0,0
192997,or,0,1
192998,very,0,0
192999,high,0,0
193000,(,0,0
193001,?500,0,1
193002,and,0,0
193003,?2000,0,1
193004,mg/dL,0,1
193005,),0,0
193006,TG,0,0
193007,levels,0,0
193008,",",0,0
193009,with,0,0
193010,or,0,1
193011,without,0,1
193012,stable,0,0
193013,statin,0,1
193014,therapy,0,1
193015,.,0,0
193016,Differential,0,0
193017,effect,0,0
193018,of,0,0
193019,aspirin,1,1
193020,on,0,0
193021,thromboxane,0,1
193022,and,0,0
193023,prostaglandin,0,1
193024,biosynthesis,0,0
193025,in,0,0
193026,man,0,0
193027,.,0,0
193028,1,0,0
193029,.,0,0
193030,Effects,0,0
193031,of,0,0
193032,a,0,0
193033,single,0,0
193034,intravenous,0,1
193035,dose,0,0
193036,of,0,0
193037,aspirin,1,1
193038,(,0,0
193039,600,0,1
193040,mg,0,1
193041,),0,0
193042,on,0,0
193043,bradykinin-stimulated,0,0
193044,prostaglandin,0,1
193045,(,0,1
193046,PG,0,1
193047,),0,1
193048,and,0,0
193049,on,0,0
193050,thromboxane,0,1
193051,(,0,1
193052,TX,0,1
193053,),0,1
193054,biosynthesis,0,0
193055,were,0,0
193056,determined,0,0
193057,in,0,0
193058,nine,0,0
193059,healthy,0,0
193060,male,0,0
193061,volunteers,0,0
193062,.,0,0
193063,Plasma,0,0
193064,concentrations,0,0
193065,of,0,0
193066,6-oxo-PGF1,0,0
193067,alpha,0,1
193068,and,0,0
193069,"13,14-dihydro-15-oxo-PGF2",0,1
193070,alpha,0,1
193071,were,0,0
193072,measured,0,0
193073,in,0,0
193074,samples,0,0
193075,obtained,0,0
193076,during,0,0
193077,repeated,0,0
193078,10,0,0
193079,min,0,0
193080,intravenous,0,1
193081,infusions,0,1
193082,of,0,0
193083,bradykinin,0,1
193084,before,0,0
193085,and,0,0
193086,up,0,0
193087,to,0,0
193088,6,0,0
193089,h,0,0
193090,after,0,0
193091,the,0,0
193092,dose,0,0
193093,of,0,0
193094,aspirin,1,1
193095,.,1,0
193096,TXB2,0,0
193097,was,0,0
193098,measured,0,0
193099,in,0,0
193100,serum,0,0
193101,from,0,0
193102,blood,0,0
193103,allowed,0,0
193104,to,0,0
193105,clot,0,0
193106,at,0,0
193107,37,0,0
193108,degrees,0,0
193109,C.,0,0
193110,2,0,0
193111,.,0,0
193112,Aspirin,1,1
193113,inhibited,0,0
193114,bradykinin,0,1
193115,stimulated,0,0
193116,PG,0,1
193117,and,0,0
193118,platelet,0,0
193119,TX,0,1
193120,biosynthesis,0,0
193121,0.5,0,1
193122,h,0,0
193123,after,0,0
193124,the,0,0
193125,dose,0,0
193126,.,0,0
193127,Serum,0,0
193128,TXB2,0,0
193129,remained,0,0
193130,low,0,0
193131,",",0,0
193132,whereas,0,0
193133,PG,0,1
193134,synthesis,0,0
193135,recovered,0,0
193136,within,0,0
193137,6,0,0
193138,h.,0,0
193139,3,0,0
193140,.,0,0
193141,Effects,0,0
193142,of,0,0
193143,intravenous,1,1
193144,sodium,1,1
193145,salicylate,1,1
193146,(,0,0
193147,600,0,1
193148,mg,0,1
193149,),0,0
193150,were,0,0
193151,studied,0,0
193152,identically,0,0
193153,in,0,0
193154,eight,0,0
193155,subjects,0,0
193156,.,0,0
193157,Prostanoid,0,1
193158,biosynthesis,0,0
193159,was,0,0
193160,not,0,0
193161,inhibited,0,0
193162,.,0,0
193163,4,0,0
193164,.,0,0
193165,Biosynthesis,0,0
193166,of,0,0
193167,prostacyclin,0,1
193168,and,0,0
193169,TXA2,0,1
193170,under,0,0
193171,basal,0,0
193172,conditions,0,0
193173,was,0,0
193174,studied,0,0
193175,in,0,0
193176,eight,0,0
193177,subjects,0,0
193178,by,0,0
193179,measuring,0,0
193180,"2,3-dinor-6-oxo-PGF1",0,0
193181,alpha,0,1
193182,and,0,0
193183,"2,3-dinor-TXB2",0,0
193184,in,0,0
193185,hourly,0,0
193186,urine,0,0
193187,samples,0,0
193188,obtained,0,0
193189,during,0,0
193190,and,0,0
193191,after,0,0
193192,intravenous,0,1
193193,infusion,1,1
193194,of,1,0
193195,aspirin,1,1
193196,and,0,0
193197,",",0,0
193198,on,0,0
193199,a,0,0
193200,separate,0,0
193201,occasion,0,0
193202,",",0,0
193203,of,0,0
193204,vehicle,0,1
193205,.,0,0
193206,5,0,0
193207,.,0,0
193208,Aspirin,1,1
193209,infusion,1,0
193210,reduced,0,0
193211,urinary,0,0
193212,excretion,0,0
193213,of,0,0
193214,both,0,0
193215,metabolites,0,0
193216,greater,0,0
193217,than,0,0
193218,90,0,0
193219,%,0,0
193220,",",0,0
193221,but,0,0
193222,excretion,0,0
193223,of,0,0
193224,"2,3-dinor-6-oxo-PGF1",0,0
193225,alpha,0,0
193226,recovered,0,0
193227,more,0,0
193228,rapidly,0,0
193229,than,0,0
193230,did,0,0
193231,that,0,0
193232,of,0,0
193233,"2,3-dinor-TXB2",0,0
193234,.,0,0
193235,6,0,0
193236,.,0,0
193237,We,0,0
193238,conclude,0,0
193239,that,0,0
193240,cyclo-oxygenase,0,1
193241,is,0,0
193242,rapidly,0,0
193243,synthesised,0,0
193244,in,0,0
193245,bradykinin-responsive,0,1
193246,tissues,0,0
193247,in,0,0
193248,vivo,0,0
193249,and,0,0
193250,that,0,0
193251,this,0,0
193252,reflects,0,0
193253,similarly,0,0
193254,rapid,0,0
193255,enzyme,0,0
193256,biosynthesis,0,0
193257,in,0,0
193258,tissues,0,0
193259,that,0,0
193260,produce,0,0
193261,PGI2,0,1
193262,under,0,0
193263,basal,0,0
193264,conditions,0,0
193265,.,0,0
193266,Effects,0,0
193267,of,0,0
193268,the,0,0
193269,Quest,1,1
193270,to,1,0
193271,Lava,1,0
193272,Mountain,1,0
193273,Computer,1,1
193274,Game,1,1
193275,on,0,0
193276,Dietary,0,1
193277,and,0,0
193278,Physical,0,0
193279,Activity,0,0
193280,Behaviors,0,0
193281,of,0,0
193282,Elementary,0,0
193283,School,0,1
193284,Children,0,0
193285,:,0,0
193286,A,0,0
193287,Pilot,0,0
193288,Group-Randomized,0,1
193289,Controlled,0,1
193290,Trial,0,0
193291,.,0,0
193292,BACKGROUND,0,0
193293,Computer-based,1,1
193294,educational,1,1
193295,games,1,1
193296,present,0,0
193297,an,0,0
193298,opportunity,0,0
193299,for,0,0
193300,health,0,0
193301,education,0,1
193302,in,0,0
193303,school,0,0
193304,;,0,0
193305,however,0,0
193306,",",0,0
193307,their,0,0
193308,feasibility,0,0
193309,in,0,0
193310,school,0,0
193311,settings,0,0
193312,and,0,0
193313,effectiveness,0,0
193314,in,0,0
193315,changing,0,0
193316,behavior,0,0
193317,are,0,0
193318,poorly,0,0
193319,understood,0,0
193320,.,0,0
193321,OBJECTIVE,0,0
193322,To,0,0
193323,evaluate,0,0
193324,the,0,0
193325,feasibility,0,0
193326,",",0,0
193327,acceptability,0,0
193328,",",0,0
193329,and,0,0
193330,effects,0,0
193331,of,0,0
193332,the,0,0
193333,Quest,1,1
193334,to,1,0
193335,Lava,1,0
193336,Mountain,1,0
193337,(,1,1
193338,QTLM,1,0
193339,),1,1
193340,computer,1,1
193341,game,1,1
193342,on,0,0
193343,dietary,0,0
193344,behaviors,0,0
193345,",",0,0
193346,physical,0,1
193347,activity,0,0
193348,behaviors,0,0
193349,",",0,0
193350,and,0,0
193351,psychosocial,0,0
193352,factors,0,0
193353,among,0,0
193354,ethnically,0,0
193355,diverse,0,0
193356,children,0,0
193357,in,0,0
193358,Texas,0,0
193359,.,0,0
193360,DESIGN,0,0
193361,Quasi-experimental,0,0
193362,group-randomized,0,0
193363,controlled,0,0
193364,trial,0,0
193365,conducted,0,0
193366,during,0,0
193367,the,0,0
193368,2012-2013,0,0
193369,school,0,0
193370,year,0,0
193371,.,0,0
193372,PARTICIPANTS/SETTING,0,0
193373,A,0,0
193374,total,0,0
193375,of,0,0
193376,107,0,0
193377,children,0,0
193378,in,0,0
193379,fourth,0,0
193380,and,0,0
193381,fifth,0,0
193382,grade,0,0
193383,consented,0,0
193384,.,0,0
193385,There,0,0
193386,was,0,0
193387,an,0,0
193388,attrition,0,0
193389,rate,0,0
193390,of,0,0
193391,8.8,0,0
193392,%,0,0
193393,with,0,0
193394,a,0,0
193395,final,0,0
193396,sample,0,0
193397,size,0,0
193398,of,0,0
193399,44,0,0
193400,children,0,0
193401,in,0,0
193402,three,0,0
193403,intervention,0,1
193404,schools,0,0
193405,",",0,0
193406,and,0,0
193407,a,0,0
193408,sample,0,0
193409,of,0,0
193410,50,0,0
193411,children,0,0
193412,in,0,0
193413,three,0,0
193414,comparison,0,0
193415,schools,0,0
193416,.,0,0
193417,Dietary,0,1
193418,intake,0,0
193419,was,0,0
193420,measured,0,0
193421,using,0,0
193422,two,0,0
193423,random,0,0
193424,24-hour,0,0
193425,recalls,0,0
193426,",",0,0
193427,whereas,0,0
193428,child,0,0
193429,self-report,0,0
193430,surveys,0,0
193431,measured,0,0
193432,diet,0,1
193433,",",0,0
193434,physical,0,1
193435,activity,0,0
193436,",",0,0
193437,and,0,0
193438,psychosocial,0,0
193439,factors,0,0
193440,before,0,0
193441,and,0,0
193442,after,0,0
193443,the,0,0
193444,intervention,0,1
193445,.,0,0
193446,Process,0,0
193447,data,0,0
193448,on,0,0
193449,QTLM,1,0
193450,usability,0,0
193451,and,0,0
193452,back-end,0,1
193453,server,0,1
193454,data,0,0
193455,on,0,0
193456,QTLM,0,0
193457,exposure,0,1
193458,and,0,0
193459,progress,0,0
193460,achieved,0,0
193461,were,0,0
193462,collected,0,0
193463,.,0,0
193464,INTERVENTION,0,0
193465,QTLM,1,0
193466,was,0,0
193467,implemented,0,0
193468,as,0,0
193469,part,0,0
193470,of,0,0
193471,the,0,0
193472,in-school,0,1
193473,or,0,1
193474,afterschool,0,1
193475,program,0,1
193476,.,0,0
193477,Recommended,0,0
193478,game,0,1
193479,exposure,0,1
193480,duration,0,0
193481,was,0,0
193482,90,0,0
193483,min/wk,0,0
193484,for,0,0
193485,6,0,0
193486,weeks,0,0
193487,.,0,0
193488,STATISTICAL,0,0
193489,ANALYSIS,0,0
193490,Analysis,0,1
193491,of,0,0
193492,covariance,0,0
193493,or,0,1
193494,logistic,0,0
193495,regression,0,0
193496,models,0,0
193497,evaluated,0,0
193498,effects,0,0
193499,of,0,0
193500,QTLM,1,0
193501,on,0,0
193502,diet,0,1
193503,",",0,0
193504,physical,0,1
193505,activity,0,0
193506,",",0,0
193507,and,0,0
193508,psychosocial,0,0
193509,factors,0,0
193510,.,0,0
193511,Post,0,0
193512,hoc,0,0
193513,exploratory,0,1
193514,analysis,0,0
193515,examined,0,0
193516,the,0,0
193517,changes,0,0
193518,before,0,0
193519,and,0,0
193520,after,0,0
193521,the,0,0
193522,intervention,0,1
193523,in,0,0
193524,outcome,0,0
193525,variables,0,0
193526,among,0,0
193527,children,0,0
193528,in,0,0
193529,the,0,0
193530,intervention,0,1
193531,group,0,0
193532,.,0,0
193533,Significance,0,0
193534,was,0,0
193535,set,0,0
193536,at,0,0
193537,P,0,0
193538,<,0,0
193539,0.05,0,0
193540,.,0,0
193541,RESULTS,0,0
193542,Children,0,0
193543,played,0,0
193544,an,0,0
193545,average,0,0
193546,of,0,0
193547,274?110,0,1
193548,minutes,0,0
193549,(,0,0
193550,approximately,0,0
193551,4.6,0,0
193552,hours,0,0
193553,),0,0
193554,of,1,0
193555,QTLM,1,0
193556,during,0,0
193557,the,0,0
193558,6,0,0
193559,weeks,0,0
193560,(,0,0
193561,51,0,0
193562,%,0,0
193563,of,0,0
193564,recommended,0,0
193565,dosage,0,0
193566,),0,0
193567,.,0,0
193568,Compared,0,0
193569,with,0,0
193570,the,0,0
193571,comparison,0,0
193572,group,0,0
193573,",",0,0
193574,children,0,0
193575,in,0,0
193576,the,0,0
193577,intervention,0,1
193578,group,0,0
193579,reported,0,0
193580,decreased,0,0
193581,sugar,0,1
193582,consumption,0,1
193583,(,0,1
193584,P=0.021,0,0
193585,),0,0
193586,and,0,0
193587,higher,0,0
193588,nutrition/physical,0,1
193589,activity,0,0
193590,attitudes,0,0
193591,(,0,0
193592,P=0.041,0,0
193593,),0,1
193594,pre-,0,0
193595,to,0,0
193596,postintervention,0,0
193597,.,0,0
193598,There,0,0
193599,were,0,0
193600,no,0,0
193601,significant,0,0
193602,effects,0,0
193603,of,0,0
193604,QTLM,0,0
193605,on,0,0
193606,physical,0,1
193607,activity,0,0
193608,.,0,0
193609,However,0,0
193610,",",0,0
193611,post,0,0
193612,hoc,0,0
193613,analysis,0,0
193614,showed,0,0
193615,that,0,0
193616,higher,1,0
193617,QTLM,1,0
193618,exposure,0,0
193619,and,0,0
193620,gaming,0,0
193621,progress,0,0
193622,was,0,0
193623,associated,0,0
193624,with,0,0
193625,increased,0,0
193626,frequency,0,0
193627,of,0,0
193628,physical,0,1
193629,activity,0,0
193630,(,0,0
193631,P,0,0
193632,<,0,0
193633,0.05,0,0
193634,),0,0
193635,.,0,0
193636,CONCLUSIONS,1,0
193637,QTLM,1,0
193638,has,0,0
193639,some,0,0
193640,promising,0,0
193641,acceptability,0,0
193642,and,0,0
193643,initial,0,0
193644,effects,0,0
193645,on,0,0
193646,diet,0,1
193647,and,0,0
193648,physical,0,1
193649,activity,0,0
193650,behaviors,0,0
193651,among,0,0
193652,children,0,0
193653,in,0,0
193654,elementary,0,0
193655,school,0,0
193656,.,0,0
193657,The,0,0
193658,impact,0,0
193659,of,0,0
193660,amalgam,1,1
193661,dental,1,0
193662,fillings,1,1
193663,on,0,0
193664,the,0,0
193665,frequency,0,0
193666,of,0,0
193667,Helicobacter,0,0
193668,pylori,0,0
193669,infection,0,0
193670,and,0,0
193671,H.,0,0
193672,pylori,0,0
193673,eradication,0,0
193674,rates,0,0
193675,in,0,0
193676,patients,0,0
193677,treated,0,0
193678,with,0,0
193679,concomitant,1,0
193680,",",1,0
193681,quadruple,1,1
193682,",",1,0
193683,and,1,0
193684,levofloxacin-based,1,1
193685,therapies,1,1
193686,.,1,0
193687,BACKGROUND,0,0
193688,AND,0,0
193689,AIM,0,0
193690,Mercury,0,0
193691,exposure,0,1
193692,is,0,0
193693,encountered,0,0
193694,most,0,0
193695,commonly,0,0
193696,in,0,0
193697,individuals,0,0
193698,with,0,0
193699,amalgam,1,1
193700,fillings,1,1
193701,.,1,0
193702,The,0,0
193703,toxic,0,0
193704,",",0,0
193705,bactericidal,0,0
193706,",",0,0
193707,and,0,0
193708,immunosuppressive,0,1
193709,effects,0,0
193710,of,0,0
193711,mercury,0,0
193712,are,0,0
193713,well,0,0
193714,known,0,0
193715,.,0,0
193716,Furthermore,0,0
193717,",",0,0
193718,multiple,0,0
193719,antibiotic,0,1
193720,resistance,0,0
193721,can,0,0
193722,be,0,0
193723,transferred,0,0
193724,",",0,0
193725,together,0,0
193726,with,0,0
193727,mercury,0,0
193728,resistance,0,0
193729,.,0,0
193730,The,0,0
193731,aim,0,0
193732,of,0,0
193733,this,0,0
193734,study,0,0
193735,was,0,0
193736,to,0,0
193737,investigate,0,0
193738,the,0,0
193739,frequency,0,0
193740,of,0,0
193741,Helicobacter,0,0
193742,pylori,0,0
193743,infection,0,0
193744,in,0,0
193745,dyspeptic,0,0
193746,patients,0,0
193747,with,0,0
193748,amalgam,0,1
193749,fillings,0,1
193750,and,0,0
193751,the,0,0
193752,effect,0,0
193753,of,0,0
193754,the,0,0
193755,amalgam,0,1
193756,fillings,0,1
193757,on,0,0
193758,H.,0,0
193759,pylori,0,0
193760,eradication,0,0
193761,rates,0,0
193762,in,0,0
193763,these,0,0
193764,patients,0,0
193765,.,0,0
193766,PATIENTS,0,0
193767,AND,0,0
193768,METHODS,0,0
193769,Four,0,1
193770,hundred,0,0
193771,and,0,0
193772,seventy-five,0,0
193773,patients,0,0
193774,who,0,0
193775,presented,0,0
193776,with,0,0
193777,dyspeptic,0,0
193778,complaints,0,0
193779,and,0,0
193780,underwent,0,0
193781,upper,0,0
193782,gastrointestinal,0,0
193783,endoscopy,0,1
193784,and,0,0
193785,gastric,0,0
193786,biopsy,0,1
193787,were,0,0
193788,included,0,0
193789,in,0,0
193790,this,0,0
193791,study,0,0
193792,.,0,0
193793,One,0,0
193794,hundred,0,0
193795,and,0,0
193796,sixty-nine,0,0
193797,(,0,0
193798,35.6,0,0
193799,%,0,0
193800,),0,0
193801,patients,0,0
193802,were,0,0
193803,negative,0,0
193804,and,0,0
193805,306,0,0
193806,(,0,0
193807,64.4,0,0
193808,%,0,0
193809,),0,0
193810,patients,0,0
193811,were,0,0
193812,positive,0,0
193813,for,0,0
193814,H.,0,0
193815,pylori,0,0
193816,.,0,0
193817,All,0,0
193818,of,0,0
193819,the,0,0
193820,participants,0,0
193821,underwent,0,0
193822,dental,0,0
193823,examinations,0,0
193824,in,0,0
193825,a,0,0
193826,blinded,0,0
193827,manner,0,0
193828,.,0,0
193829,The,0,0
193830,participants,0,0
193831,were,0,0
193832,divided,0,0
193833,into,0,0
193834,two,0,0
193835,groups,0,0
193836,on,0,0
193837,the,0,0
193838,basis,0,0
193839,of,0,0
193840,the,0,0
193841,presence,0,0
193842,of,0,0
193843,amalgam,0,1
193844,fillings,0,1
193845,.,0,0
193846,The,0,0
193847,H.,0,0
193848,pylori-positive,0,0
193849,patients,0,0
193850,were,0,0
193851,divided,0,0
193852,randomly,0,0
193853,into,0,0
193854,three,0,0
193855,subgroups,0,0
193856,:,0,0
193857,patients,0,0
193858,who,0,0
193859,received,0,0
193860,concomitant,1,0
193861,therapy,1,1
193862,(,1,1
193863,CT,1,1
193864,),1,1
193865,(,1,0
193866,rabeprazole-amoxicillin-clarithromycin-metronidazole,1,1
193867,for,0,0
193868,14,0,0
193869,days,0,0
193870,;,0,0
193871,n=122,0,0
193872,),0,0
193873,;,0,0
193874,patients,0,0
193875,who,0,0
193876,received,0,0
193877,quadruple,1,1
193878,therapy,1,1
193879,(,1,1
193880,QT,1,1
193881,),1,1
193882,(,1,0
193883,rabeprazole-tetracycline-metronidazole-colloidal,1,1
193884,bismuth,1,1
193885,subcitrate,1,1
193886,for,0,0
193887,10,0,0
193888,days,0,0
193889,;,0,0
193890,n=97,0,0
193891,),0,1
193892,;,0,0
193893,and,0,0
193894,patients,0,0
193895,who,0,0
193896,received,0,0
193897,levofloxacin-based,1,1
193898,therapy,1,1
193899,(,1,1
193900,LT,1,1
193901,),1,1
193902,(,1,0
193903,rabeprazole-amoxicillin-levofloxacin,1,1
193904,for,0,0
193905,10,0,0
193906,days,0,0
193907,;,0,0
193908,n=87,0,0
193909,),0,0
193910,.,0,1
193911,Eradication,0,0
193912,success,0,0
193913,was,0,0
193914,detected,0,0
193915,by,0,0
193916,a,0,0
193917,urea,0,1
193918,breath,0,0
193919,test,0,0
193920,6,0,0
193921,weeks,0,0
193922,after,0,0
193923,the,0,0
193924,end,0,0
193925,of,0,0
193926,treatment,0,0
193927,.,0,0
193928,RESULTS,0,0
193929,The,0,0
193930,frequency,0,0
193931,of,0,0
193932,H.,0,0
193933,pylori,0,0
193934,infection,0,0
193935,was,0,0
193936,significantly,0,0
193937,lower,0,0
193938,in,0,0
193939,the,0,0
193940,filling,1,0
193941,group,0,0
193942,compared,0,0
193943,with,0,0
193944,the,0,0
193945,nonfilling,0,1
193946,group,0,0
193947,(,0,1
193948,53.7,0,0
193949,and,0,0
193950,78.8,0,0
193951,%,0,0
193952,",",0,0
193953,respectively,0,0
193954,;,0,0
193955,P,0,0
193956,<,0,0
193957,0.001,0,0
193958,),0,0
193959,.,0,0
193960,The,0,0
193961,eradication,0,0
193962,rates,0,0
193963,in,0,0
193964,the,0,0
193965,CT,1,0
193966,",",1,0
193967,QT,1,0
193968,",",1,0
193969,and,1,0
193970,LT,1,0
193971,groups,0,0
193972,were,0,0
193973,65.5,0,0
193974,",",0,0
193975,67.0,0,0
193976,",",0,0
193977,and,0,0
193978,58.6,0,0
193979,%,0,0
193980,",",0,0
193981,respectively,0,0
193982,",",0,0
193983,in,0,0
193984,the,0,0
193985,intention-to-treat,0,0
193986,(,0,1
193987,ITT,0,1
193988,),0,1
193989,analysis,0,0
193990,and,0,0
193991,69.6,0,0
193992,",",0,0
193993,70.7,0,0
193994,",",0,0
193995,and,0,0
193996,62.2,0,0
193997,%,0,0
193998,",",0,0
193999,respectively,0,0
194000,",",0,0
194001,in,0,0
194002,the,0,0
194003,per-protocol,0,0
194004,(,0,1
194005,PP,0,1
194006,),0,1
194007,analysis,0,0
194008,.,0,0
194009,In,0,0
194010,all,0,0
194011,of,0,0
194012,the,0,0
194013,H.,0,0
194014,pylori-positive,0,0
194015,patients,0,0
194016,and,0,0
194017,separately,0,0
194018,in,0,0
194019,the,0,0
194020,CT,1,0
194021,and,0,0
194022,LT,1,0
194023,groups,0,0
194024,",",0,0
194025,the,0,0
194026,eradication,0,0
194027,rates,0,0
194028,were,0,0
194029,significantly,0,0
194030,lower,0,0
194031,in,0,0
194032,the,0,0
194033,filling,1,0
194034,group,0,0
194035,compared,0,0
194036,with,0,0
194037,the,0,0
194038,nonfilling,1,1
194039,group,0,0
194040,.,0,0
194041,However,0,0
194042,",",0,0
194043,in,0,0
194044,the,0,0
194045,QT,1,0
194046,group,0,0
194047,",",0,0
194048,there,0,0
194049,was,0,0
194050,no,0,0
194051,significant,0,0
194052,difference,0,0
194053,between,0,0
194054,the,0,0
194055,patients,0,0
194056,with,0,0
194057,and,0,0
194058,without,0,1
194059,fillings,0,1
194060,(,0,0
194061,P=0.001,0,0
194062,",",0,0
194063,0.003,0,0
194064,",",0,0
194065,0.012,0,0
194066,",",0,0
194067,0.14,0,0
194068,",",0,0
194069,respectively,0,0
194070,),0,0
194071,.,0,0
194072,Logistic,0,0
194073,regression,0,0
194074,analysis,0,0
194075,showed,0,0
194076,that,0,0
194077,the,0,0
194078,absence,0,0
194079,of,0,0
194080,amalgam,0,1
194081,filling,0,0
194082,exerts,0,0
194083,independent,0,0
194084,effects,0,0
194085,on,0,0
194086,the,0,0
194087,increased,0,0
194088,frequency,0,0
194089,of,0,0
194090,H.,0,0
194091,pylori,0,0
194092,infection,0,0
194093,and,0,0
194094,increased,0,0
194095,rate,0,0
194096,of,0,0
194097,H.,0,0
194098,pylori,0,0
194099,eradication,0,0
194100,.,0,0
194101,CONCLUSION,0,0
194102,This,0,0
194103,is,0,0
194104,the,0,0
194105,first,0,0
194106,study,0,0
194107,to,0,0
194108,show,0,0
194109,a,0,0
194110,lower,0,0
194111,frequency,0,0
194112,of,0,0
194113,H.,0,0
194114,pylori,0,0
194115,colonization,0,0
194116,in,0,0
194117,patients,0,0
194118,with,0,0
194119,amalgam,1,1
194120,fillings,1,1
194121,than,0,0
194122,without,0,0
194123,and,0,0
194124,that,0,0
194125,H.,0,0
194126,pylori,0,0
194127,eradication,0,0
194128,rates,0,0
194129,are,0,0
194130,lower,0,0
194131,in,0,0
194132,patients,0,0
194133,with,0,0
194134,amalgam,1,1
194135,fillings,1,1
194136,compared,0,0
194137,to,0,0
194138,those,0,0
194139,without,0,0
194140,.,0,0
194141,Sensory,1,1
194142,Adapted,1,0
194143,Dental,1,1
194144,Environments,1,1
194145,to,0,0
194146,Enhance,0,0
194147,Oral,0,1
194148,Care,0,0
194149,for,0,0
194150,Children,0,0
194151,with,0,0
194152,Autism,0,0
194153,Spectrum,0,1
194154,Disorders,0,0
194155,:,0,0
194156,A,0,0
194157,Randomized,0,0
194158,Controlled,0,1
194159,Pilot,0,0
194160,Study,0,0
194161,.,0,0
194162,This,0,0
194163,pilot,0,0
194164,and,0,0
194165,feasibility,0,0
194166,study,0,0
194167,examined,0,0
194168,the,0,0
194169,impact,0,0
194170,of,0,0
194171,a,0,0
194172,sensory,1,1
194173,adapted,1,0
194174,dental,1,1
194175,environment,1,0
194176,(,1,1
194177,SADE,1,0
194178,),1,1
194179,to,0,0
194180,reduce,0,0
194181,distress,0,0
194182,",",0,0
194183,sensory,0,1
194184,discomfort,0,0
194185,",",0,0
194186,and,0,0
194187,perception,0,0
194188,of,0,0
194189,pain,0,0
194190,during,0,0
194191,oral,1,1
194192,prophylaxis,1,1
194193,for,0,0
194194,children,0,0
194195,with,0,0
194196,autism,0,0
194197,spectrum,0,0
194198,disorder,0,0
194199,(,0,1
194200,ASD,0,0
194201,),0,0
194202,.,0,0
194203,Participants,0,0
194204,were,0,0
194205,44,0,0
194206,children,0,0
194207,ages,0,0
194208,6-12,0,0
194209,(,0,0
194210,n,0,0
194211,=,0,0
194212,22,0,0
194213,typical,0,0
194214,",",0,0
194215,n,0,0
194216,=,0,0
194217,22,0,0
194218,ASD,0,0
194219,),0,0
194220,.,0,0
194221,In,0,0
194222,an,0,0
194223,experimental,0,0
194224,crossover,0,0
194225,design,0,0
194226,",",0,0
194227,each,0,0
194228,participant,0,0
194229,underwent,0,0
194230,two,0,0
194231,professional,0,0
194232,dental,1,0
194233,cleanings,1,1
194234,",",0,0
194235,one,0,0
194236,in,0,0
194237,a,0,0
194238,regular,1,1
194239,dental,1,1
194240,environment,1,0
194241,(,1,1
194242,RDE,1,1
194243,),1,1
194244,and,0,0
194245,one,0,0
194246,in,0,0
194247,a,0,0
194248,SADE,1,0
194249,",",0,0
194250,administered,0,0
194251,in,0,0
194252,a,0,0
194253,randomized,0,0
194254,and,0,0
194255,counterbalanced,0,1
194256,order,0,0
194257,3-4,0,0
194258,months,0,0
194259,apart,0,0
194260,.,0,0
194261,Outcomes,0,0
194262,included,0,0
194263,measures,0,0
194264,of,0,0
194265,physiological,0,0
194266,anxiety,0,0
194267,",",0,0
194268,behavioral,0,1
194269,distress,0,0
194270,",",0,0
194271,pain,0,0
194272,intensity,0,0
194273,",",0,0
194274,and,0,0
194275,sensory,0,1
194276,discomfort,0,0
194277,.,0,0
194278,Both,0,0
194279,groups,0,0
194280,exhibited,0,0
194281,decreased,0,0
194282,physiological,0,0
194283,anxiety,0,0
194284,and,0,0
194285,reported,0,0
194286,lower,0,0
194287,pain,0,0
194288,and,0,0
194289,sensory,0,1
194290,discomfort,0,0
194291,in,0,0
194292,the,0,0
194293,SADE,1,0
194294,condition,0,0
194295,compared,0,0
194296,to,0,0
194297,RDE,1,0
194298,",",0,0
194299,indicating,0,0
194300,a,0,0
194301,beneficial,0,0
194302,effect,0,0
194303,of,0,0
194304,the,0,0
194305,SADE,1,0
194306,.,1,0
194307,Three-year,0,0
194308,efficacy,0,0
194309,and,0,0
194310,safety,0,0
194311,of,0,0
194312,a,0,0
194313,new,0,0
194314,52-mg,0,0
194315,levonorgestrel-releasing,1,1
194316,intrauterine,0,0
194317,system,0,0
194318,.,0,0
194319,OBJECTIVE,0,0
194320,To,0,0
194321,assess,0,0
194322,3-year,0,0
194323,data,0,0
194324,on,0,0
194325,the,0,0
194326,efficacy,0,0
194327,and,0,0
194328,safety,0,0
194329,of,0,0
194330,a,0,0
194331,new,0,0
194332,52-mg,0,0
194333,levonorgestrel,1,1
194334,intrauterine,1,1
194335,contraceptive,1,1
194336,(,1,1
194337,LNG20,1,1
194338,),1,1
194339,designed,0,0
194340,for,0,0
194341,up,0,0
194342,to,0,0
194343,7,0,0
194344,years,0,0
194345,use,0,0
194346,.,0,0
194347,STUDY,0,0
194348,DESIGN,0,0
194349,Nulliparous,0,0
194350,and,0,0
194351,parous,0,0
194352,women,0,0
194353,aged,0,0
194354,16-45,0,0
194355,years,0,0
194356,at,0,0
194357,enrollment,0,0
194358,with,0,0
194359,regular,0,1
194360,menstrual,0,0
194361,cycles,0,1
194362,and,0,0
194363,requesting,0,0
194364,contraception,0,1
194365,were,0,0
194366,enrolled,0,0
194367,in,0,0
194368,an,0,0
194369,open-label,0,0
194370,",",0,0
194371,partially,0,0
194372,randomized,0,0
194373,trial,0,0
194374,to,0,0
194375,evaluate,0,0
194376,LNG20,1,0
194377,.,1,0
194378,The,0,0
194379,primary,0,0
194380,outcome,0,0
194381,was,0,0
194382,pregnancy,0,0
194383,rate,0,0
194384,for,0,0
194385,women,0,0
194386,aged,0,0
194387,16-35,0,0
194388,years,0,0
194389,calculated,0,0
194390,as,0,0
194391,the,0,0
194392,Pearl,0,0
194393,Index,0,1
194394,.,0,0
194395,Women,0,0
194396,aged,0,0
194397,36-45,0,0
194398,years,0,0
194399,received,0,0
194400,LNG20,1,0
194401,for,0,0
194402,safety,0,0
194403,evaluation,0,0
194404,only,0,0
194405,.,0,0
194406,All,0,0
194407,participants,0,0
194408,had,0,0
194409,in-person,0,1
194410,or,0,1
194411,phone,0,1
194412,follow-up,0,0
194413,approximately,0,0
194414,every,0,0
194415,3,0,0
194416,months,0,0
194417,during,0,0
194418,the,0,0
194419,study,0,0
194420,.,0,0
194421,RESULTS,0,0
194422,A,0,0
194423,total,0,0
194424,of,0,0
194425,1600,0,0
194426,women,0,0
194427,aged,0,0
194428,16-35,0,0
194429,years,0,0
194430,and,0,0
194431,151,0,0
194432,women,0,0
194433,aged,0,0
194434,36-45,0,0
194435,years,0,0
194436,agreed,0,0
194437,to,0,0
194438,LNG20,1,1
194439,placement,0,1
194440,",",0,0
194441,including,0,0
194442,1011,0,0
194443,(,0,0
194444,57.7,0,0
194445,%,0,0
194446,),0,0
194447,nulliparous,0,0
194448,and,0,0
194449,438,0,0
194450,(,0,0
194451,25.1,0,0
194452,%,0,0
194453,),0,0
194454,obese,0,0
194455,women,0,0
194456,.,0,0
194457,Successful,0,0
194458,placement,0,0
194459,occurred,0,0
194460,in,0,0
194461,1714,0,0
194462,(,0,0
194463,97.9,0,0
194464,%,0,0
194465,),0,0
194466,women,0,0
194467,.,0,0
194468,Six,0,0
194469,pregnancies,0,0
194470,occurred,0,0
194471,",",0,0
194472,four,0,0
194473,of,0,0
194474,which,0,0
194475,were,0,0
194476,ectopic,0,0
194477,.,0,0
194478,The,0,0
194479,Pearl,0,0
194480,Index,0,1
194481,for,0,0
194482,LNG20,1,0
194483,was,0,0
194484,0.15,0,1
194485,(,0,0
194486,95,0,0
194487,%,0,0
194488,CI,0,0
194489,0.02-0.55,0,0
194490,),0,0
194491,through,0,0
194492,Year,0,0
194493,1,0,0
194494,",",0,0
194495,0.26,0,0
194496,(,0,0
194497,95,0,0
194498,%,0,0
194499,CI,0,0
194500,0.10-0.57,0,0
194501,),0,0
194502,through,0,0
194503,Year,0,0
194504,2,0,0
194505,",",0,0
194506,and,0,0
194507,0.22,0,0
194508,(,0,0
194509,95,0,0
194510,%,0,0
194511,CI,0,0
194512,0.08-0.49,0,0
194513,),0,0
194514,through,0,0
194515,Year,0,0
194516,3,0,0
194517,.,0,0
194518,The,0,0
194519,cumulative,0,0
194520,life-table,0,0
194521,pregnancy,0,0
194522,rate,0,0
194523,was,0,0
194524,0.55,0,0
194525,(,0,0
194526,95,0,0
194527,%,0,0
194528,CI,0,0
194529,0.24-1.23,0,0
194530,),0,0
194531,through,0,0
194532,3,0,0
194533,years,0,0
194534,.,0,0
194535,Expulsion,0,0
194536,was,0,0
194537,reported,0,0
194538,in,0,0
194539,62,0,0
194540,(,0,0
194541,3.5,0,1
194542,%,0,0
194543,),0,0
194544,participants,0,0
194545,",",0,0
194546,most,0,0
194547,(,0,0
194548,50,0,0
194549,[,0,0
194550,80.6,0,0
194551,%,0,0
194552,],0,0
194553,),0,0
194554,during,0,0
194555,the,0,0
194556,first,0,0
194557,year,0,0
194558,of,0,0
194559,use,0,0
194560,.,0,0
194561,Of,0,0
194562,women,0,0
194563,who,0,0
194564,discontinued,0,0
194565,LNG20,1,0
194566,and,0,0
194567,desired,0,0
194568,pregnancy,0,0
194569,",",0,0
194570,86.8,0,0
194571,%,0,0
194572,conceived,0,0
194573,spontaneously,0,0
194574,within,0,0
194575,12,0,0
194576,months,0,0
194577,.,0,0
194578,Pelvic,0,0
194579,infection,0,0
194580,was,0,0
194581,diagnosed,0,0
194582,in,0,0
194583,10,0,0
194584,(,0,0
194585,0.6,0,1
194586,%,0,0
194587,),0,0
194588,women,0,0
194589,.,0,0
194590,Only,0,0
194591,26,0,0
194592,(,0,0
194593,1.5,0,0
194594,%,0,0
194595,),0,0
194596,LNG20,1,0
194597,users,0,0
194598,discontinued,0,0
194599,due,0,0
194600,to,0,0
194601,bleeding,0,0
194602,complaints,0,0
194603,.,0,0
194604,CONCLUSION,0,0
194605,The,0,0
194606,LNG20,1,1
194607,intrauterine,0,0
194608,system,0,1
194609,is,0,0
194610,highly,0,0
194611,effective,0,0
194612,and,0,0
194613,safe,0,0
194614,over,0,0
194615,3,0,0
194616,years,0,0
194617,of,0,0
194618,use,0,0
194619,in,0,0
194620,nulliparous,0,0
194621,and,0,0
194622,parous,0,0
194623,women,0,0
194624,.,0,0
194625,IMPLICATIONS,0,0
194626,STATEMENT,0,0
194627,A,0,0
194628,new,0,0
194629,52-mg,0,0
194630,levonorgestrel-releasing,1,1
194631,intrauterine,1,0
194632,system,1,1
194633,is,0,0
194634,effective,0,0
194635,and,0,0
194636,safe,0,0
194637,for,0,0
194638,nulliparous,0,0
194639,and,0,0
194640,parous,0,0
194641,women,0,0
194642,for,0,0
194643,at,0,0
194644,least,0,0
194645,3,0,0
194646,years,0,0
194647,.,0,0
194648,Comparison,0,0
194649,of,0,0
194650,4,0,0
194651,supraglotttic,1,1
194652,devices,1,0
194653,used,0,0
194654,by,0,0
194655,paramedics,0,0
194656,during,0,0
194657,simulated,0,1
194658,CPR,0,1
194659,:,0,0
194660,a,0,0
194661,randomized,0,0
194662,controlled,0,0
194663,crossover,0,0
194664,trial,0,0
194665,.,0,0
194666,BACKGROUND,0,0
194667,Ensuring,0,0
194668,an,0,0
194669,open,0,1
194670,airway,0,0
194671,during,0,0
194672,cardiopulmonary,0,0
194673,resuscitation,0,1
194674,is,0,0
194675,fundamental,0,0
194676,.,0,0
194677,The,0,0
194678,aim,0,0
194679,of,0,0
194680,this,0,0
194681,study,0,0
194682,was,0,0
194683,to,0,0
194684,determine,0,0
194685,the,0,0
194686,success,0,0
194687,rate,0,0
194688,of,0,0
194689,blind,0,0
194690,intubation,0,1
194691,during,0,0
194692,simulated,0,1
194693,cardiopulmonary,0,1
194694,resuscitation,0,1
194695,by,0,0
194696,untrained,0,0
194697,personnel,0,0
194698,.,0,0
194699,METHODS,0,0
194700,Four,0,0
194701,devices,0,0
194702,were,0,0
194703,compared,0,0
194704,in,0,0
194705,a,0,0
194706,simulated,0,1
194707,resuscitation,0,1
194708,scenario,0,0
194709,:,0,1
194710,ILMA,1,0
194711,(,0,0
194712,Intavent,0,1
194713,Direct,0,1
194714,Ltd,0,1
194715,",",0,0
194716,Buckinghamshire,0,0
194717,",",0,0
194718,United,0,0
194719,Kingdom,0,0
194720,),0,0
194721,",",0,0
194722,Cobra,1,1
194723,PLA,1,1
194724,(,0,0
194725,Engineered,0,1
194726,Medical,0,1
194727,Systems,0,1
194728,Inc,0,0
194729,",",0,0
194730,Indianapolis,0,0
194731,",",0,0
194732,IN,0,0
194733,),0,0
194734,",",0,0
194735,Supraglottic,1,1
194736,Airway,1,0
194737,Laryngopharyngeal,1,1
194738,Tube,1,0
194739,(,1,1
194740,SALT,1,1
194741,),1,1
194742,(,0,0
194743,ECOLAB,0,0
194744,",",0,0
194745,St.,0,0
194746,Paul,0,0
194747,",",0,0
194748,MN,0,1
194749,),0,0
194750,",",0,0
194751,and,0,0
194752,Air-Q,1,1
194753,(,0,1
194754,Mercury,0,0
194755,Medical,0,1
194756,",",0,0
194757,Clearwater,0,0
194758,",",0,0
194759,FL,0,1
194760,),0,0
194761,.,0,0
194762,A,0,0
194763,group,0,0
194764,of,0,0
194765,210,0,0
194766,paramedics,0,0
194767,intubated,0,0
194768,a,0,0
194769,manikin,0,1
194770,with,0,0
194771,continuous,0,1
194772,chest,0,0
194773,compressions,0,1
194774,.,0,0
194775,RESULTS,0,0
194776,The,0,0
194777,mean,0,0
194778,times,0,0
194779,to,0,0
194780,intubation,0,1
194781,were,0,0
194782,40.46,0,0
194783,?,0,0
194784,4.64,0,0
194785,",",0,0
194786,33.96,0,0
194787,?,0,0
194788,6.23,0,0
194789,",",0,0
194790,17.2,0,0
194791,?,0,0
194792,4.63,0,0
194793,",",0,0
194794,and,0,0
194795,49.23,0,0
194796,?,0,0
194797,13.19,0,0
194798,seconds,0,0
194799,(,0,0
194800,SALT,0,1
194801,vs,0,0
194802,ILMA,0,0
194803,",",0,0
194804,Cobra,0,1
194805,PLA,0,1
194806,",",0,0
194807,and,0,0
194808,Air-Q,0,1
194809,;,0,0
194810,P,0,0
194811,<,0,0
194812,.05,0,0
194813,),0,0
194814,.,0,0
194815,The,0,0
194816,success,0,0
194817,ratios,0,0
194818,of,0,0
194819,blind,0,0
194820,intubation,0,1
194821,for,0,0
194822,the,0,0
194823,devices,0,0
194824,were,0,0
194825,86.7,0,0
194826,%,0,0
194827,",",0,0
194828,85.7,0,0
194829,%,0,0
194830,",",0,0
194831,100,0,0
194832,%,0,0
194833,",",0,0
194834,and,0,0
194835,71.4,0,0
194836,%,0,0
194837,(,0,0
194838,SALT,0,1
194839,vs,0,0
194840,ILMA,0,0
194841,",",0,0
194842,Cobra,0,1
194843,PLA,0,1
194844,",",0,0
194845,and,0,0
194846,Air-Q,0,1
194847,;,0,0
194848,P,0,0
194849,<,0,0
194850,.05,0,0
194851,),0,0
194852,.,0,0
194853,CONCLUSION,0,0
194854,The,0,0
194855,study,0,0
194856,showed,0,0
194857,that,0,0
194858,the,0,0
194859,most,0,0
194860,efficient,0,0
194861,device,0,1
194862,with,0,0
194863,the,0,0
194864,shortest,0,0
194865,blind,0,0
194866,intubation,0,1
194867,time,0,0
194868,was,0,0
194869,the,0,0
194870,SALT,1,0
194871,device,1,1
194872,.,1,0
194873,Erlotinib,1,1
194874,is,0,0
194875,effective,0,0
194876,in,0,0
194877,pancreatic,0,0
194878,cancer,0,0
194879,with,0,0
194880,epidermal,0,1
194881,growth,0,0
194882,factor,0,1
194883,receptor,0,0
194884,mutations,0,0
194885,:,0,0
194886,a,0,0
194887,randomized,0,0
194888,",",0,0
194889,open-label,0,0
194890,",",0,0
194891,prospective,0,0
194892,trial,0,0
194893,.,0,0
194894,OBJECTIVE,0,0
194895,To,0,0
194896,analyze,0,0
194897,the,0,0
194898,efficacy,0,0
194899,of,0,0
194900,gemcitabine,1,1
194901,with,0,0
194902,or,0,1
194903,without,0,1
194904,erlotinib,1,1
194905,for,0,0
194906,pancreatic,0,0
194907,cancer,0,0
194908,",",0,0
194909,and,0,0
194910,to,0,0
194911,determine,0,0
194912,the,0,0
194913,predictive,0,0
194914,role,0,0
194915,of,0,0
194916,epidermal,0,1
194917,growth,0,0
194918,factor,0,1
194919,receptor,0,0
194920,(,0,1
194921,EGFR,0,1
194922,),0,1
194923,and,0,0
194924,KRAS,0,1
194925,mutations,0,0
194926,in,0,0
194927,these,0,0
194928,patients,0,0
194929,.,0,0
194930,METHODS,0,0
194931,This,0,0
194932,was,0,0
194933,a,0,0
194934,single-center,0,0
194935,",",0,0
194936,randomized,0,0
194937,",",0,0
194938,open-label,0,0
194939,",",0,0
194940,prospective,0,0
194941,trial,0,0
194942,.,0,0
194943,Eighty-eight,0,0
194944,chemotherapy-na?ve,0,1
194945,metastatic,0,0
194946,pancreatic,0,0
194947,cancer,0,0
194948,patients,0,0
194949,were,0,0
194950,randomized,0,0
194951,for,0,0
194952,treatment,0,0
194953,with,1,0
194954,gemcitabine,1,1
194955,or,1,1
194956,gemcitabine,1,1
194957,plus,1,1
194958,erlotinib,1,1
194959,.,1,1
194960,EGFR,0,0
194961,and,0,0
194962,KRAS,0,1
194963,mutations,0,0
194964,were,0,0
194965,analyzed,0,0
194966,",",0,0
194967,respectively,0,0
194968,.,0,0
194969,The,0,0
194970,primary,0,0
194971,endpoint,0,0
194972,was,0,0
194973,the,0,0
194974,disease,0,0
194975,control,0,1
194976,rate,0,0
194977,.,0,0
194978,RESULTS,0,0
194979,Disease,0,0
194980,control,0,1
194981,rate,0,0
194982,(,0,0
194983,64,0,0
194984,%,0,0
194985,vs.,0,0
194986,25,0,0
194987,%,0,0
194988,;,0,0
194989,P,0,0
194990,<,0,0
194991,0.001,0,0
194992,),0,0
194993,",",0,0
194994,progression-free,0,0
194995,survival,0,0
194996,(,0,0
194997,median,0,0
194998,3.8,0,0
194999,vs.,0,0
195000,2.4,0,0
195001,months,0,0
195002,;,0,0
195003,P,0,0
195004,<,0,0
195005,0.001,0,0
195006,),0,0
195007,",",0,0
195008,and,0,0
195009,overall,0,0
195010,survival,0,0
195011,(,0,0
195012,median,0,0
195013,7.2,0,0
195014,vs.,0,0
195015,4.4,0,0
195016,months,0,0
195017,;,0,0
195018,P,0,0
195019,<,0,0
195020,0.001,0,0
195021,),0,0
195022,were,0,0
195023,better,0,0
195024,in,0,0
195025,the,1,0
195026,gemcitabine,1,1
195027,plus,1,1
195028,erlotinib,1,1
195029,group,0,0
195030,than,0,0
195031,in,0,0
195032,the,1,0
195033,gemcitabine,1,1
195034,alone,1,1
195035,group,0,0
195036,.,0,0
195037,In,0,0
195038,the,1,0
195039,gemcitabine,1,1
195040,plus,1,1
195041,erlotinib,1,1
195042,group,0,0
195043,",",0,0
195044,disease,0,0
195045,control,0,1
195046,(,0,0
195047,85,0,0
195048,%,0,0
195049,vs.,0,0
195050,33,0,0
195051,%,0,0
195052,;,0,0
195053,P,0,0
195054,=,0,0
195055,0.001,0,0
195056,),0,0
195057,",",0,0
195058,progression-free,0,0
195059,survival,0,0
195060,(,0,0
195061,median,0,0
195062,5.9,0,0
195063,vs.,0,0
195064,2.4,0,0
195065,months,0,0
195066,;,0,0
195067,P,0,0
195068,=,0,0
195069,0.004,0,0
195070,),0,0
195071,",",0,0
195072,and,0,0
195073,overall,0,0
195074,survival,0,0
195075,(,0,0
195076,median,0,0
195077,8.7,0,0
195078,vs.,0,0
195079,6.0,0,0
195080,months,0,0
195081,;,0,0
195082,P,0,0
195083,=,0,0
195084,0.044,0,0
195085,),0,0
195086,were,0,0
195087,better,0,0
195088,in,0,0
195089,patients,0,0
195090,with,0,0
195091,EGFR,0,0
195092,mutations,0,0
195093,than,0,0
195094,in,0,0
195095,those,0,0
195096,without,0,0
195097,EGFR,0,0
195098,mutations,0,0
195099,.,0,0
195100,KRAS,0,1
195101,mutation,0,0
195102,was,0,0
195103,not,0,0
195104,associated,0,0
195105,with,0,0
195106,treatment,0,1
195107,response,0,0
195108,or,0,1
195109,survival,0,0
195110,.,0,0
195111,CONCLUSIONS,1,0
195112,Gemcitabine,1,1
195113,plus,1,1
195114,erlotinib,1,1
195115,is,0,0
195116,more,0,0
195117,effective,0,0
195118,than,1,0
195119,gemcitabine,1,1
195120,alone,1,1
195121,for,0,0
195122,treating,0,0
195123,metastatic,0,0
195124,pancreatic,0,0
195125,cancer,0,0
195126,patients,0,0
195127,",",0,0
195128,especially,0,0
195129,those,0,0
195130,with,0,0
195131,EGFR,0,0
195132,mutations,0,0
195133,.,0,0
195134,ClinicalTrials.gov,0,0
195135,number,0,0
195136,",",0,0
195137,NCT01608841,0,0
195138,.,0,0
195139,Efficacy,0,0
195140,of,0,0
195141,fimasartan/hydrochlorothiazide,1,1
195142,combination,1,1
195143,in,0,0
195144,hypertensive,0,0
195145,patients,0,0
195146,inadequately,0,0
195147,controlled,0,0
195148,by,0,0
195149,fimasartan,1,1
195150,monotherapy,1,1
195151,.,1,0
195152,BACKGROUND,0,0
195153,The,0,0
195154,study,0,0
195155,reported,0,0
195156,here,0,0
195157,compared,0,0
195158,the,0,0
195159,blood,0,0
195160,pressure,0,0
195161,(,0,1
195162,BP,0,0
195163,),0,1
195164,-lowering,0,1
195165,efficacy,0,0
195166,of,0,0
195167,fimasartan,1,1
195168,alone,1,1
195169,with,0,0
195170,that,0,0
195171,of,0,0
195172,fimasartan/hydrochlorothiazide,1,1
195173,(,1,1
195174,HCTZ,1,1
195175,),1,1
195176,combination,1,1
195177,in,0,0
195178,patients,0,0
195179,whose,0,0
195180,BP,0,0
195181,goal,0,0
195182,was,0,0
195183,not,0,0
195184,achieved,0,0
195185,after,0,0
195186,4,0,0
195187,weeks,0,0
195188,of,0,0
195189,treatment,0,0
195190,with,0,0
195191,once-daily,0,1
195192,fimasartan,1,1
195193,60,0,0
195194,mg.,0,1
195195,METHODS,0,0
195196,Patients,0,0
195197,with,0,0
195198,sitting,0,0
195199,diastolic,0,0
195200,blood,0,1
195201,pressure,0,1
195202,(,0,1
195203,siDBP,0,0
195204,),0,1
195205,?90,0,1
195206,mmHg,0,0
195207,with,0,0
195208,4,0,0
195209,weeks,0,0
195210,of,0,0
195211,once-daily,1,1
195212,fimasartan,1,1
195213,60,1,0
195214,mg,0,1
195215,were,0,0
195216,randomly,0,0
195217,assigned,0,0
195218,to,0,0
195219,receive,0,0
195220,either,0,1
195221,once-daily,1,1
195222,fimasartan,1,1
195223,60,1,0
195224,mg/HCTZ,1,0
195225,12.5,1,0
195226,mg,1,1
195227,or,1,1
195228,fimasartan,1,1
195229,60,1,0
195230,mg,0,1
195231,for,0,0
195232,4,0,0
195233,weeks,0,0
195234,.,0,0
195235,After,0,0
195236,4,0,0
195237,weeks,0,0
195238,",",0,0
195239,the,0,0
195240,dose,0,0
195241,was,0,0
195242,increased,0,0
195243,from,1,0
195244,fimasartan,1,1
195245,60,1,0
195246,mg/HCTZ,1,0
195247,12.5,1,0
195248,mg,0,1
195249,to,0,0
195250,fimasartan,1,1
195251,120,1,0
195252,mg/HCTZ,1,0
195253,12.5,1,0
195254,mg,0,1
195255,or,0,1
195256,from,1,0
195257,fimasartan,1,1
195258,60,1,0
195259,mg,0,1
195260,to,0,0
195261,fimasartan,1,1
195262,120,1,0
195263,mg,0,1
195264,if,0,0
195265,siDBP,0,0
195266,was,0,0
195267,?90,0,1
195268,mmHg,0,0
195269,.,0,0
195270,RESULTS,0,0
195271,Of,0,0
195272,the,0,0
195273,263,0,0
195274,randomized,0,0
195275,patients,0,0
195276,",",0,0
195277,256,0,0
195278,patients,0,0
195279,who,0,0
195280,had,0,0
195281,available,0,0
195282,efficacy,0,0
195283,data,0,0
195284,were,0,0
195285,analyzed,0,0
195286,.,0,0
195287,The,0,0
195288,fimasartan/HCTZ,1,1
195289,treatment,1,0
195290,group,0,0
195291,showed,0,0
195292,a,0,0
195293,greater,0,0
195294,reduction,0,0
195295,of,0,0
195296,siDBP,0,0
195297,compared,0,0
195298,to,0,0
195299,the,0,0
195300,fimasartan,1,1
195301,treatment,1,0
195302,group,0,0
195303,at,0,0
195304,Week,0,1
195305,4,0,1
195306,(,0,0
195307,6.88?8.10,0,0
195308,mmHg,0,1
195309,vs,0,0
195310,3.38?7.33,0,0
195311,",",0,0
195312,P=0.0008,0,0
195313,),0,0
195314,",",0,0
195315,and,0,0
195316,the,0,0
195317,effect,0,0
195318,persisted,0,0
195319,at,0,0
195320,Week,0,1
195321,8,0,0
195322,(,0,0
195323,8.67?9.39,0,0
195324,mmHg,0,1
195325,vs,0,0
195326,5.02?8.27,0,0
195327,mmHg,0,0
195328,",",0,0
195329,P=0.0023,0,0
195330,),0,0
195331,.,0,0
195332,Reduction,0,0
195333,of,0,0
195334,sitting,0,0
195335,systolic,0,0
195336,BP,0,0
195337,in,0,0
195338,the,1,0
195339,fimasartan/HCTZ,1,1
195340,treatment,1,0
195341,group,0,0
195342,was,0,0
195343,also,0,0
195344,greater,0,0
195345,than,0,0
195346,that,0,0
195347,in,0,0
195348,the,1,0
195349,fimasartan,1,1
195350,treatment,1,1
195351,group,0,1
195352,(,0,0
195353,at,0,0
195354,Week,0,1
195355,4,0,0
195356,",",0,0
195357,10.50?13.76,0,0
195358,mmHg,0,0
195359,vs,0,0
195360,5.75?12.18,0,0
195361,mmHg,0,0
195362,",",0,0
195363,P=0.0069,0,0
195364,and,0,0
195365,",",0,0
195366,at,0,0
195367,Week,0,1
195368,8,0,0
195369,",",0,0
195370,13.45?15.15,0,0
195371,mmHg,0,0
195372,vs,0,0
195373,6.84?13.57,0,0
195374,mmHg,0,0
195375,",",0,0
195376,P=0.0007,0,0
195377,),0,0
195378,.,0,0
195379,The,0,0
195380,proportion,0,0
195381,of,0,0
195382,patients,0,0
195383,who,0,0
195384,achieved,0,0
195385,a,0,0
195386,reduction,0,0
195387,of,0,0
195388,siDBP,0,0
195389,?10,0,1
195390,mmHg,0,1
195391,from,0,0
195392,baseline,0,0
195393,and/or,0,0
195394,a,0,0
195395,mean,0,0
195396,siDBP,0,0
195397,<,0,0
195398,90,0,0
195399,mmHg,0,0
195400,after,0,0
195401,4,0,0
195402,weeks,0,0
195403,of,0,0
195404,treatment,0,0
195405,was,0,0
195406,higher,0,0
195407,in,0,0
195408,the,0,0
195409,fimasartan/HCTZ,1,1
195410,treatment,1,0
195411,group,1,0
195412,than,0,0
195413,in,0,0
195414,the,1,0
195415,fimasartan,1,1
195416,treatment,1,1
195417,group,0,1
195418,(,0,0
195419,53.6,0,0
195420,%,0,0
195421,vs,0,0
195422,39.8,0,0
195423,%,0,0
195424,",",0,0
195425,P=0.0359,0,0
195426,),0,0
195427,.,0,0
195428,The,0,0
195429,overall,0,0
195430,incidence,0,0
195431,of,0,0
195432,adverse,0,0
195433,drug,0,1
195434,reaction,0,1
195435,was,0,0
195436,11.79,0,0
195437,%,0,0
195438,with,0,0
195439,no,0,0
195440,significant,0,0
195441,difference,0,0
195442,between,0,0
195443,the,0,0
195444,treatment,0,0
195445,groups,0,0
195446,.,0,0
195447,CONCLUSION,0,0
195448,The,0,0
195449,combination,0,1
195450,treatment,1,0
195451,of,1,0
195452,fimasartan,1,1
195453,and,1,0
195454,HCTZ,1,0
195455,achieved,1,0
195456,better,0,0
195457,BP,0,0
195458,control,0,1
195459,than,1,0
195460,fimasartan,1,1
195461,monotherapy,1,1
195462,",",1,0
195463,and,0,0
195464,had,0,0
195465,comparable,0,0
195466,safety,0,0
195467,and,0,0
195468,tolerance,0,0
195469,to,1,0
195470,fimasartan,1,1
195471,monotherapy,1,1
195472,.,1,0
195473,The,0,0
195474,effects,0,0
195475,of,0,0
195476,parental,1,0
195477,components,1,0
195478,in,0,0
195479,a,0,0
195480,trauma-focused,1,1
195481,cognitive,1,0
195482,behavioral,1,1
195483,based,1,0
195484,therapy,1,1
195485,for,0,0
195486,children,0,0
195487,exposed,0,0
195488,to,0,0
195489,interparental,0,0
195490,violence,0,0
195491,:,0,1
195492,study,0,0
195493,protocol,0,1
195494,for,0,0
195495,a,0,0
195496,randomized,0,0
195497,controlled,0,0
195498,trial,0,0
195499,.,0,0
195500,BACKGROUND,0,0
195501,Interparental,0,0
195502,violence,0,0
195503,is,0,0
195504,both,0,0
195505,common,0,0
195506,and,0,0
195507,harmful,0,0
195508,and,0,0
195509,impacts,0,0
195510,children,0,0
195511,'s,0,0
195512,lives,0,0
195513,directly,0,0
195514,and,0,0
195515,indirectly,0,0
195516,.,0,0
195517,Direct,0,0
195518,effects,0,0
195519,refer,0,0
195520,to,0,0
195521,affective,0,0
195522,",",0,0
195523,behavioral,0,1
195524,",",0,0
195525,and,0,0
195526,cognitive,0,0
195527,responses,0,0
195528,to,0,0
195529,interparental,0,0
195530,violence,0,0
195531,and,0,0
195532,psychosocial,0,0
195533,adjustment,0,0
195534,.,0,0
195535,Indirect,0,0
195536,effects,0,0
195537,refer,0,0
195538,to,0,0
195539,deteriorated,0,0
195540,parental,0,1
195541,availability,0,0
195542,and,0,0
195543,parent-child,0,1
195544,interaction,0,0
195545,.,0,0
195546,Standard,0,1
195547,Trauma,1,0
195548,Focused,1,1
195549,Cognitive,1,1
195550,Behavioral,1,1
195551,Therapy,1,1
195552,may,0,0
195553,be,0,0
195554,insufficient,0,0
195555,for,0,0
195556,children,0,0
195557,traumatized,0,0
195558,by,0,0
195559,exposure,0,0
195560,to,0,0
195561,interparental,0,0
195562,violence,0,0
195563,",",0,0
195564,given,0,0
195565,the,0,0
195566,pervasive,0,0
195567,impact,0,0
195568,of,0,0
195569,interparental,0,0
195570,violence,0,0
195571,on,0,0
195572,the,0,0
195573,family,0,1
195574,system,0,0
195575,.,0,0
195576,HORIZON,0,0
195577,is,0,0
195578,a,0,0
195579,trauma,1,0
195580,focused,1,0
195581,cognitive,1,0
195582,behavioral,1,1
195583,therapy,1,1
195584,based,0,0
195585,group,0,0
195586,program,0,1
195587,with,0,0
195588,the,0,0
195589,added,0,0
195590,component,0,0
195591,of,0,0
195592,a,0,0
195593,preparatory,1,1
195594,parenting,1,0
195595,program,1,1
195596,aimed,0,0
195597,at,0,0
195598,improving,0,0
195599,parental,0,1
195600,availability,0,0
195601,;,0,0
195602,and,0,0
195603,the,0,0
195604,added,0,1
195605,component,0,0
195606,of,0,0
195607,parent-child,0,1
195608,sessions,0,1
195609,to,0,0
195610,improve,0,0
195611,parent-child,0,1
195612,interaction,0,0
195613,.,0,0
195614,METHODS/DESIGN,0,0
195615,This,0,0
195616,is,0,0
195617,a,0,0
195618,multicenter,0,0
195619,",",0,0
195620,multi-informant,0,0
195621,and,0,0
195622,multi-method,0,0
195623,randomized,0,0
195624,clinical,0,0
195625,trial,0,0
195626,study,0,0
195627,with,0,0
195628,a,0,0
195629,2,0,0
195630,by,0,0
195631,2,0,0
195632,factorial,0,0
195633,experimental,0,0
195634,design,0,0
195635,.,0,1
195636,Participants,0,0
195637,(,0,0
195638,N,0,0
195639,=,0,0
195640,100,0,0
195641,),0,0
195642,are,0,0
195643,children,0,0
195644,(,0,0
195645,4-12,0,0
195646,years,0,0
195647,),0,0
195648,",",0,0
195649,and,0,0
195650,their,0,0
195651,parents,0,0
195652,",",0,0
195653,who,0,0
195654,have,0,0
195655,been,0,0
195656,exposed,0,0
195657,to,0,0
195658,interparental,0,0
195659,violence,0,0
195660,.,0,0
195661,The,0,0
195662,main,0,0
195663,aim,0,0
195664,of,0,0
195665,the,0,0
195666,study,0,0
195667,is,0,0
195668,to,0,0
195669,test,0,0
195670,the,0,0
195671,effects,0,0
195672,of,0,0
195673,two,0,0
195674,parental,0,0
195675,components,0,0
195676,as,0,0
195677,an,0,0
195678,addition,0,0
195679,to,0,0
195680,a,0,0
195681,trauma,1,0
195682,focused,1,0
195683,cognitive,1,0
195684,behavioral,1,1
195685,based,1,0
195686,group,1,0
195687,therapy,1,1
195688,for,1,0
195689,reducing,0,0
195690,children,0,0
195691,'s,0,0
195692,symptoms,0,0
195693,.,0,0
195694,Primary,0,0
195695,outcome,0,0
195696,measures,0,0
195697,are,0,0
195698,posttraumatic,0,0
195699,stress,0,0
195700,symptoms,0,0
195701,",",0,0
195702,and,0,0
195703,internalizing,0,0
195704,and,0,0
195705,externalizing,0,0
195706,problems,0,0
195707,in,0,0
195708,children,0,0
195709,.,0,0
195710,The,0,0
195711,secondary,0,0
195712,aim,0,0
195713,of,0,0
195714,the,0,0
195715,study,0,0
195716,is,0,0
195717,to,0,0
195718,test,0,0
195719,the,0,0
195720,effect,0,0
195721,of,0,0
195722,the,0,0
195723,two,0,0
195724,added,0,0
195725,components,0,0
195726,on,0,0
195727,adjustment,0,0
195728,problems,0,0
195729,in,0,0
195730,children,0,0
195731,and,0,0
195732,to,0,0
195733,test,0,0
195734,whether,0,0
195735,enhanced,0,0
195736,effects,0,0
195737,can,0,0
195738,be,0,0
195739,explained,0,0
195740,by,0,0
195741,changes,0,0
195742,in,0,0
195743,children,0,0
195744,'s,0,0
195745,responses,0,0
195746,towards,0,0
195747,experienced,0,0
195748,violence,0,0
195749,",",0,0
195750,in,0,0
195751,parental,0,0
195752,availability,0,0
195753,",",0,0
195754,and,0,0
195755,in,0,0
195756,quality,0,0
195757,of,0,0
195758,parent-child,0,1
195759,interaction,0,0
195760,.,0,0
195761,To,0,0
195762,address,0,0
195763,this,0,0
195764,secondary,0,0
195765,aim,0,0
195766,",",0,0
195767,the,0,0
195768,main,0,0
195769,parameters,0,0
195770,are,0,0
195771,observational,0,0
195772,and,0,0
195773,questionnaire,0,0
195774,measures,0,0
195775,of,0,0
195776,parental,0,0
195777,availability,0,0
195778,",",0,0
195779,parent-child,0,1
195780,relationship,0,0
195781,variables,0,0
195782,",",0,0
195783,children,0,0
195784,'s,0,0
195785,adjustment,0,0
195786,problems,0,0
195787,and,0,0
195788,children,0,0
195789,'s,0,0
195790,responses,0,0
195791,to,0,0
195792,interparental,0,0
195793,violence,0,0
195794,.,0,0
195795,Data,0,0
195796,are,0,0
195797,collected,0,0
195798,three,0,0
195799,times,0,0
195800,:,0,0
195801,before,0,0
195802,and,0,0
195803,after,0,0
195804,the,0,0
195805,program,0,1
195806,and,0,0
195807,six,0,0
195808,months,0,0
195809,later,0,0
195810,.,0,0
195811,Both,0,1
195812,intention-to-treat,0,0
195813,and,0,0
195814,completer,0,0
195815,analyses,0,0
195816,will,0,0
195817,be,0,0
195818,done,0,0
195819,.,0,0
195820,DISCUSSION,0,0
195821,The,0,0
195822,current,0,0
195823,study,0,0
195824,will,0,0
195825,enhance,0,0
195826,our,0,0
195827,understanding,0,0
195828,of,0,0
195829,the,0,0
195830,efficacy,1,0
195831,interparental,1,0
195832,violence-related,1,0
195833,parental,1,0
195834,components,1,0
195835,added,1,0
195836,to,1,0
195837,trauma,1,0
195838,focused,1,0
195839,cognitive,1,0
195840,behavioral,1,1
195841,group,1,0
195842,program,1,1
195843,for,1,0
195844,children,0,0
195845,who,0,0
195846,have,0,0
195847,been,0,0
195848,exposed,0,0
195849,to,0,0
195850,IPV,0,0
195851,.,0,0
195852,It,0,0
195853,will,0,0
195854,illuminate,0,0
195855,mechanisms,0,0
195856,underlying,0,0
195857,change,0,0
195858,by,0,0
195859,considering,0,0
195860,multiple,0,0
195861,dimensions,0,0
195862,of,0,0
195863,child,0,0
195864,responses,0,0
195865,",",0,0
195866,parenting,0,0
195867,variables,0,0
195868,and,0,0
195869,identify,0,0
195870,selection,0,0
195871,criteria,0,0
195872,for,0,0
195873,participation,0,0
195874,in,0,0
195875,treatment,0,0
195876,.,0,0
195877,TRIAL,0,0
195878,REGISTRATION,0,0
195879,Netherlands,0,0
195880,Trial,0,1
195881,Register,0,0
195882,NTR4015,0,1
195883,.,0,0
195884,Registered,0,0
195885,4th,0,0
195886,of,0,0
195887,June,0,0
195888,",",0,0
195889,2013,0,0
195890,.,0,0
195891,Disclosure,0,1
195892,of,0,0
195893,HSV-2,0,1
195894,serological,0,1
195895,test,0,0
195896,results,0,0
195897,in,0,0
195898,the,0,0
195899,context,0,0
195900,of,0,0
195901,an,0,0
195902,adolescent,0,0
195903,HIV,0,1
195904,prevention,0,0
195905,trial,0,0
195906,in,0,0
195907,Kenya,0,0
195908,.,0,0
195909,OBJECTIVES,0,0
195910,Herpes,0,0
195911,simplex,0,0
195912,virus,0,1
195913,type,0,0
195914,2,0,0
195915,(,0,0
195916,HSV-2,0,1
195917,),0,1
195918,biomarkers,0,0
195919,are,0,0
195920,often,0,0
195921,used,0,0
195922,in,0,0
195923,adolescent,0,0
195924,sub-Saharan,0,0
195925,HIV,0,1
195926,prevention,0,0
195927,studies,0,0
195928,",",0,0
195929,but,0,0
195930,evaluations,0,0
195931,of,0,0
195932,test,0,0
195933,performance,0,0
195934,and,0,0
195935,disclosure,0,0
195936,outcomes,0,0
195937,are,0,0
195938,rare,0,0
195939,in,0,0
195940,the,0,0
195941,published,0,0
195942,literature,0,0
195943,.,0,0
195944,Therefore,0,0
195945,",",0,0
195946,we,0,0
195947,investigated,0,0
195948,the,0,0
195949,proportion,0,0
195950,of,0,0
195951,ELISA-positive,0,0
195952,and,0,0
195953,indeterminate,0,0
195954,samples,0,0
195955,confirmed,0,0
195956,by,0,0
195957,western,1,1
195958,blot,1,1
195959,(,0,1
195960,WB,0,1
195961,),0,0
195962,",",0,0
195963,the,0,0
195964,psychosocial,0,0
195965,response,0,0
195966,to,0,0
195967,disclosure,0,0
195968,and,0,0
195969,whether,0,0
195970,reports,0,0
195971,of,0,0
195972,sexual,0,0
195973,behaviour,0,0
195974,and,0,0
195975,HSV-2,0,1
195976,symptoms,0,0
195977,are,0,0
195978,consistent,0,0
195979,with,0,0
195980,WB,0,0
195981,confirmatory,0,0
195982,results,0,0
195983,among,0,0
195984,adolescent,0,0
195985,orphans,0,0
195986,in,0,0
195987,Kenya,0,0
195988,.,0,0
195989,METHODS,0,0
195990,In,0,0
195991,2011,0,0
195992,",",0,0
195993,837,0,0
195994,Kenyan,0,0
195995,orphan,0,0
195996,youth,0,0
195997,in,0,0
195998,grades,0,0
195999,7,0,0
196000,and,0,0
196001,8,0,0
196002,enrolled,0,0
196003,in,0,0
196004,an,0,0
196005,HIV,0,1
196006,prevention,0,0
196007,clinical,0,0
196008,trial,0,0
196009,with,0,0
196010,HSV-2,0,1
196011,biomarker,0,0
196012,outcomes,0,0
196013,.,0,0
196014,We,0,0
196015,used,0,0
196016,a,0,0
196017,modified,0,0
196018,algorithm,0,0
196019,for,0,0
196020,the,0,0
196021,Kalon,0,1
196022,HSV-2,0,1
196023,ELISA,0,0
196024,to,0,0
196025,improve,0,0
196026,specificity,0,0
196027,;,0,0
196028,positive,0,0
196029,and,0,0
196030,indeterminate,0,0
196031,results,0,0
196032,were,0,0
196033,WB,0,0
196034,tested,0,0
196035,.,0,0
196036,We,0,0
196037,developed,0,0
196038,culturally,0,1
196039,sensitive,0,0
196040,protocols,0,0
196041,for,0,0
196042,disclosing,0,0
196043,positive,0,0
196044,results,0,0
196045,",",0,0
196046,and,0,0
196047,documented,0,0
196048,psychosocial,0,0
196049,responses,0,0
196050,",",0,0
196051,reports,0,0
196052,of,0,0
196053,sexual,0,0
196054,contact,0,1
196055,and,0,0
196056,HSV-2,0,1
196057,symptoms,0,0
196058,.,0,0
196059,RESULTS,0,0
196060,28,0,0
196061,adolescents,0,0
196062,(,0,0
196063,3.3,0,0
196064,%,0,0
196065,),0,0
196066,were,0,0
196067,identified,0,0
196068,as,0,0
196069,HSV-2,0,1
196070,seropositive,0,0
196071,",",0,0
196072,six,0,0
196073,as,0,0
196074,indeterminate,0,0
196075,.,0,0
196076,Of,0,0
196077,these,0,0
196078,",",0,0
196079,22,0,0
196080,positive,0,0
196081,and,0,0
196082,all,0,0
196083,indeterminates,0,0
196084,were,0,0
196085,WB,0,0
196086,tested,0,0
196087,;,0,0
196088,20,0,0
196089,and,0,0
196090,5,0,0
196091,",",0,0
196092,respectively,0,0
196093,",",0,0
196094,were,0,0
196095,confirmed,0,0
196096,positive,0,0
196097,.,0,0
196098,Most,0,0
196099,youth,0,0
196100,reported,0,0
196101,moderate,0,0
196102,brief,0,1
196103,stress,0,0
196104,after,0,0
196105,disclosure,0,0
196106,;,0,0
196107,22,0,0
196108,%,0,0
196109,reported,0,0
196110,longer,0,0
196111,and,0,0
196112,more,0,0
196113,severe,0,0
196114,distress,0,0
196115,.,0,0
196116,Boys,0,1
196117,were,0,0
196118,more,0,0
196119,likely,0,0
196120,to,0,0
196121,be,0,0
196122,in,0,0
196123,the,0,0
196124,latter,0,0
196125,category,0,0
196126,.,0,0
196127,Self-reported,0,0
196128,virginity,0,0
196129,was,0,0
196130,highly,0,0
196131,inconsistent,0,0
196132,with,0,0
196133,WB-confirmed,0,0
196134,positives,0,0
196135,.,0,0
196136,CONCLUSIONS,0,0
196137,The,0,0
196138,higher,0,0
196139,than,0,0
196140,manufacturer,0,0
196141,'s,0,0
196142,cut-off,0,0
196143,for,0,0
196144,Kalon,0,1
196145,ELISA,0,0
196146,modestly,0,0
196147,reduced,0,0
196148,the,0,0
196149,rate,0,0
196150,of,0,0
196151,false-positive,0,0
196152,test,0,0
196153,results,0,0
196154,",",0,0
196155,but,0,0
196156,also,0,0
196157,increased,0,0
196158,false,0,0
196159,negatives,0,0
196160,.,0,0
196161,Investigators,0,0
196162,should,0,0
196163,consider,0,0
196164,the,0,0
196165,risk,0,0
196166,:,0,0
196167,benefit,0,0
196168,ratio,0,0
196169,in,0,0
196170,deciding,0,0
196171,whether,0,0
196172,or,0,1
196173,not,0,0
196174,to,0,0
196175,disclose,0,0
196176,HSV-2,0,1
196177,results,0,0
196178,to,0,0
196179,adolescent,0,0
196180,participants,0,0
196181,under,0,0
196182,specific,0,0
196183,field,0,0
196184,conditions,0,0
196185,.,0,0
196186,TRIAL,0,0
196187,REGISTRATION,0,0
196188,NUMBER,0,0
196189,NCT01501864,0,0
196190,.,0,0
196191,Physical,1,0
196192,exercise,1,1
196193,at,1,0
196194,the,1,0
196195,workplace,1,0
196196,reduces,0,0
196197,perceived,0,0
196198,physical,0,0
196199,exertion,0,0
196200,during,0,0
196201,healthcare,0,0
196202,work,0,0
196203,:,0,0
196204,cluster,0,0
196205,randomized,0,0
196206,controlled,0,0
196207,trial,0,0
196208,.,0,0
196209,BACKGROUND,0,0
196210,High,1,0
196211,physical,1,1
196212,exertion,1,0
196213,during,0,0
196214,work,0,0
196215,is,0,0
196216,a,0,0
196217,risk,0,0
196218,factor,0,0
196219,for,0,0
196220,musculoskeletal,0,0
196221,pain,0,0
196222,and,0,0
196223,long-term,0,0
196224,sickness,0,0
196225,absence,0,0
196226,.,0,0
196227,Physical,0,0
196228,exertion,0,0
196229,(,0,1
196230,RPE,0,1
196231,),0,1
196232,reflects,0,0
196233,the,0,0
196234,balance,0,0
196235,between,0,0
196236,physical,0,1
196237,work,0,0
196238,demands,0,0
196239,and,0,0
196240,physical,0,1
196241,capacity,0,0
196242,of,0,0
196243,the,0,0
196244,individual,0,0
196245,.,0,0
196246,Thus,0,0
196247,",",0,0
196248,increasing,0,0
196249,the,0,0
196250,physical,0,1
196251,capacity,0,0
196252,through,0,0
196253,physical,0,1
196254,exercise,0,1
196255,may,0,0
196256,decrease,0,0
196257,physical,0,0
196258,exertion,0,0
196259,during,0,0
196260,work,0,0
196261,.,0,0
196262,This,0,0
196263,study,0,0
196264,investigates,0,0
196265,the,0,0
196266,effect,0,0
196267,of,0,0
196268,workplace-based,0,1
196269,versus,0,1
196270,home-based,0,1
196271,physical,0,1
196272,exercise,0,1
196273,on,0,0
196274,physical,0,1
196275,exertion,0,0
196276,during,0,0
196277,work,0,0
196278,(,0,1
196279,WRPE,0,1
196280,),0,1
196281,among,0,0
196282,healthcare,0,0
196283,workers,0,0
196284,.,0,0
196285,METHODS,0,0
196286,200,0,1
196287,female,0,0
196288,healthcare,0,0
196289,workers,0,0
196290,(,0,0
196291,age,0,0
196292,:,0,0
196293,42.0,0,0
196294,",",0,0
196295,body,0,0
196296,mass,0,0
196297,index,0,0
196298,:,0,0
196299,24.1,0,0
196300,",",0,0
196301,average,0,0
196302,pain,0,0
196303,intensity,0,0
196304,:,0,0
196305,3.1,0,0
196306,on,0,0
196307,a,0,0
196308,scale,0,0
196309,of,0,0
196310,0,0,0
196311,to,0,0
196312,10,0,0
196313,",",0,0
196314,average,0,0
196315,WRPE,0,1
196316,:,0,0
196317,3.6,0,0
196318,on,0,0
196319,a,0,0
196320,scale,0,0
196321,of,0,0
196322,0,0,0
196323,to,0,0
196324,10,0,0
196325,),0,0
196326,from,0,0
196327,18,0,0
196328,departments,0,0
196329,at,0,0
196330,three,0,0
196331,participating,0,0
196332,hospitals,0,0
196333,.,0,0
196334,Participants,0,0
196335,were,0,0
196336,randomly,0,0
196337,allocated,0,0
196338,at,0,0
196339,the,0,0
196340,cluster,0,0
196341,level,0,0
196342,to,0,0
196343,10,0,0
196344,weeks,0,0
196345,of,0,0
196346,:,0,0
196347,(,1,0
196348,1,1,0
196349,),1,0
196350,workplace,1,0
196351,physical,1,1
196352,exercise,1,1
196353,(,1,1
196354,WORK,1,1
196355,),1,1
196356,performed,1,0
196357,in,1,0
196358,groups,1,0
196359,during,1,0
196360,working,1,0
196361,hours,1,0
196362,for,1,0
196363,5?10,1,0
196364,minutes,1,0
196365,per,1,0
196366,week,1,0
196367,and,1,0
196368,up,1,0
196369,to,1,0
196370,five,1,0
196371,group-based,1,1
196372,coaching,1,1
196373,sessions,1,1
196374,on,1,0
196375,motivation,1,0
196376,for,1,0
196377,regular,1,1
196378,physical,1,1
196379,exercise,1,1
196380,",",1,0
196381,or,1,1
196382,(,1,0
196383,2,1,1
196384,),1,0
196385,home-based,1,1
196386,physical,1,1
196387,exercise,1,1
196388,(,1,1
196389,HOME,1,1
196390,),1,1
196391,performed,1,0
196392,during,1,0
196393,leisure,1,0
196394,time,1,0
196395,for,1,0
196396,5?10,1,1
196397,minutes,1,0
196398,per,1,0
196399,week,1,0
196400,.,1,0
196401,Physical,0,0
196402,exertion,0,0
196403,was,0,0
196404,assessed,0,0
196405,at,0,0
196406,baseline,0,0
196407,and,0,0
196408,at,0,0
196409,10-week,0,1
196410,follow-up,0,0
196411,.,0,0
196412,RESULTS,0,0
196413,2.2,0,0
196414,(,0,0
196415,SD,0,0
196416,:,0,1
196417,1.1,0,0
196418,),0,0
196419,and,0,0
196420,1.0,0,1
196421,(,0,0
196422,SD,0,0
196423,:,0,1
196424,1.2,0,0
196425,),0,0
196426,training,0,1
196427,sessions,0,1
196428,were,0,0
196429,performed,0,0
196430,per,0,0
196431,week,0,0
196432,in,0,0
196433,WORK,0,0
196434,and,0,0
196435,HOME,0,0
196436,",",0,0
196437,respectively,0,0
196438,.,0,0
196439,Physical,0,0
196440,exertion,0,0
196441,was,0,0
196442,reduced,0,0
196443,more,0,0
196444,in,0,0
196445,WORK,0,0
196446,than,0,0
196447,HOME,0,1
196448,(,0,0
196449,p,0,0
196450,<,0,0
196451,0.01,0,0
196452,),0,0
196453,.,0,0
196454,Between-group,0,0
196455,differences,0,0
196456,in,0,0
196457,physical,0,1
196458,exertion,0,0
196459,at,0,0
196460,follow-up,0,0
196461,(,0,0
196462,WORK,0,1
196463,vs.,0,0
196464,HOME,0,1
196465,),0,0
196466,was,0,0
196467,-0.5,0,0
196468,points,0,0
196469,(,0,0
196470,95,0,0
196471,%,0,0
196472,CI,0,0
196473,-0.8,0,0
196474,to,0,0
196475,-0.2,0,0
196476,),0,0
196477,.,0,0
196478,Within-group,0,1
196479,effect,0,0
196480,size,0,0
196481,(,0,0
196482,Cohen,0,0
196483,'s,0,1
196484,d,0,1
196485,),0,0
196486,in,0,0
196487,WORK,0,1
196488,and,0,0
196489,HOME,0,0
196490,was,0,0
196491,0.43,0,0
196492,and,0,0
196493,0.13,0,0
196494,",",0,0
196495,respectively,0,0
196496,.,0,0
196497,CONCLUSIONS,1,0
196498,Physical,1,0
196499,exercise,1,1
196500,performed,1,0
196501,at,0,0
196502,the,0,0
196503,workplace,0,0
196504,appears,0,0
196505,more,0,0
196506,effective,0,0
196507,than,1,0
196508,home-based,1,1
196509,exercise,1,1
196510,in,1,0
196511,reducing,0,0
196512,physical,0,1
196513,exertion,0,0
196514,during,0,0
196515,daily,0,1
196516,work,0,0
196517,tasks,0,0
196518,in,0,0
196519,healthcare,0,0
196520,workers,0,0
196521,.,0,0
196522,Optimal,1,0
196523,vaccination,1,1
196524,program,1,1
196525,for,0,0
196526,healthy,0,0
196527,adults,0,0
196528,in,0,0
196529,China,0,0
196530,.,0,0
196531,There,0,0
196532,is,0,0
196533,still,0,0
196534,no,0,0
196535,suitable,0,0
196536,routine,0,0
196537,hepatitis,1,1
196538,B,1,1
196539,immunization,1,1
196540,strategy,0,0
196541,for,0,0
196542,adults,0,0
196543,in,0,0
196544,China,0,0
196545,.,0,0
196546,To,0,0
196547,establish,0,0
196548,an,0,0
196549,optimal,1,0
196550,vaccination,1,1
196551,schedule,1,1
196552,for,0,0
196553,healthy,0,0
196554,adults,0,0
196555,",",0,0
196556,we,0,0
196557,investigated,0,0
196558,various,0,0
196559,schedules,0,1
196560,in,0,0
196561,healthy,0,0
196562,adults,0,0
196563,.,0,0
196564,In,0,0
196565,this,0,0
196566,randomized,0,0
196567,5143,0,0
196568,healthy,0,0
196569,adults,0,0
196570,received,0,0
196571,10,0,0
196572,?g,1,1
196573,hepatitis,1,1
196574,B,1,1
196575,vaccine,1,1
196576,at,1,0
196577,0,1,0
196578,",",1,0
196579,1,1,0
196580,and,1,0
196581,3,1,0
196582,months,1,0
196583,(,1,0
196584,group,1,1
196585,A,1,1
196586,),1,0
196587,",",1,0
196588,0,1,0
196589,",",1,0
196590,1,1,0
196591,and,1,0
196592,6,1,0
196593,months,1,0
196594,(,1,0
196595,group,1,1
196596,B,1,1
196597,),1,0
196598,",",1,0
196599,or,1,1
196600,0,1,0
196601,",",1,0
196602,1,1,0
196603,and,1,0
196604,12,1,0
196605,months,1,0
196606,(,1,0
196607,group,1,1
196608,C,1,1
196609,),1,0
196610,.,1,0
196611,Blood,0,0
196612,samples,0,0
196613,were,0,0
196614,collected,0,0
196615,after,0,0
196616,1,0,0
196617,month,0,0
196618,and,0,0
196619,12,0,0
196620,months,0,0
196621,after,0,0
196622,the,0,0
196623,third,0,0
196624,dose,0,0
196625,.,0,0
196626,The,0,0
196627,geometric,0,0
196628,mean,0,0
196629,titer,0,0
196630,(,0,1
196631,GMT,0,0
196632,),0,1
196633,",",0,0
196634,seroconversion,0,0
196635,rate,0,0
196636,(,0,0
196637,levels,0,0
196638,of,0,0
196639,anti-HBs,0,0
196640,?,0,0
196641,10,0,0
196642,mIU/mL,0,0
196643,),0,0
196644,and,0,0
196645,high,0,0
196646,response,0,0
196647,rate,0,0
196648,(,0,0
196649,levels,0,0
196650,of,0,0
196651,anti-HBs,0,0
196652,?,0,0
196653,100,0,0
196654,mIU/mL,0,0
196655,),0,0
196656,were,0,0
196657,assayed,0,0
196658,.,0,0
196659,In,0,0
196660,our,0,0
196661,study,0,0
196662,",",0,0
196663,2438,0,0
196664,healthy,0,0
196665,adults,0,0
196666,finished,0,0
196667,the,0,0
196668,full,0,0
196669,vaccination,0,1
196670,program,0,1
196671,and,0,0
196672,follow-up,0,0
196673,.,0,0
196674,The,0,0
196675,seroconversion/sero-protective,0,0
196676,rate,0,0
196677,of,0,0
196678,groups,0,0
196679,A-C,0,0
196680,at,0,0
196681,one,0,0
196682,and,0,0
196683,12,0,0
196684,month,0,0
196685,after,0,0
196686,administration,0,0
196687,of,0,0
196688,the,0,0
196689,third,0,0
196690,vaccine,0,1
196691,dose,0,0
196692,was,0,0
196693,100,0,0
196694,%,0,0
196695,",",0,0
196696,99.9,0,0
196697,%,0,0
196698,and,0,0
196699,97.9,0,0
196700,%,0,0
196701,verse,0,0
196702,64.9,0,0
196703,%,0,0
196704,",",0,0
196705,75.7,0,0
196706,%,0,0
196707,and,0,0
196708,79.0,0,0
196709,%,0,0
196710,",",0,0
196711,respectively,0,0
196712,.,0,0
196713,GMT,0,0
196714,for,0,0
196715,anti-HBs,0,1
196716,tested,0,0
196717,in,0,0
196718,group,0,0
196719,A,0,0
196720,to,0,0
196721,C,0,0
196722,within,0,0
196723,1,0,0
196724,or,0,0
196725,12,0,0
196726,month,0,0
196727,after,0,0
196728,the,0,0
196729,third,0,0
196730,vaccination,0,1
196731,was,0,0
196732,213.16,0,0
196733,",",0,0
196734,432.58,0,0
196735,and,0,0
196736,451.47,0,0
196737,mIU/ml,0,0
196738,verse,0,0
196739,22.07,0,0
196740,",",0,0
196741,46.70,0,0
196742,and,0,0
196743,56.18,0,0
196744,mIU/ml,0,0
196745,",",0,0
196746,respectively,0,0
196747,.,0,0
196748,There,0,0
196749,were,0,0
196750,significant,0,0
196751,differences,0,0
196752,of,0,0
196753,seroconversion/sero-protective,0,0
196754,rate,0,0
196755,and,0,0
196756,GMT,0,0
196757,among,0,0
196758,the,0,0
196759,3,0,0
196760,groups,0,0
196761,(,0,0
196762,p,0,0
196763,<,0,0
196764,0.01,0,0
196765,),0,0
196766,.,0,0
196767,Given,0,0
196768,the,0,0
196769,high,0,0
196770,anti-HBs,0,1
196771,seroconversion,0,0
196772,rate,0,0
196773,and,0,0
196774,GMT,0,0
196775,in,0,0
196776,all,0,0
196777,3,0,0
196778,groups,1,0
196779,",",1,0
196780,a,1,0
196781,flexible,1,1
196782,schedule,0,1
196783,for,0,0
196784,Hepatitis,0,0
196785,B,0,1
196786,vaccine,0,1
196787,should,0,0
196788,be,0,0
196789,recommended,0,0
196790,to,0,0
196791,adults,0,0
196792,",",0,0
196793,but,0,0
196794,0-1-12,0,1
196795,schedule,0,1
196796,is,0,0
196797,a,0,0
196798,better,0,0
196799,choice,0,0
196800,.,0,0
196801,REVIVE,0,1
196802,Trial,0,0
196803,:,0,0
196804,Retrograde,0,1
196805,Delivery,0,0
196806,of,0,0
196807,Autologous,0,1
196808,Bone,0,1
196809,Marrow,0,0
196810,in,0,0
196811,Patients,0,0
196812,With,0,0
196813,Heart,0,0
196814,Failure,0,0
196815,.,0,0
196816,UNLABELLED,0,0
196817,Cell,1,0
196818,therapy,1,1
196819,is,0,0
196820,an,0,0
196821,evolving,0,0
196822,option,0,0
196823,for,0,0
196824,patients,0,0
196825,with,0,0
196826,end-stage,0,0
196827,heart,0,0
196828,failure,0,0
196829,and,0,0
196830,ongoing,0,0
196831,symptoms,0,0
196832,despite,0,0
196833,optimal,0,0
196834,medical,0,0
196835,therapy,0,1
196836,.,0,0
196837,Our,0,0
196838,goal,0,0
196839,was,0,0
196840,to,0,0
196841,evaluate,0,0
196842,retrograde,0,1
196843,bone,0,0
196844,marrow,0,0
196845,cell,0,0
196846,delivery,0,0
196847,in,0,0
196848,patients,0,0
196849,with,0,0
196850,either,0,0
196851,ischemic,0,0
196852,heart,0,0
196853,failure,0,0
196854,(,0,1
196855,IHF,0,1
196856,),0,1
196857,or,0,1
196858,nonischemic,0,1
196859,heart,0,0
196860,failure,0,0
196861,(,0,1
196862,NIHF,0,1
196863,),0,0
196864,.,0,0
196865,This,0,0
196866,was,0,0
196867,a,0,0
196868,prospective,0,0
196869,randomized,0,0
196870,",",0,0
196871,multicenter,0,0
196872,",",0,0
196873,open-label,0,0
196874,study,0,0
196875,of,0,0
196876,the,0,0
196877,safety,0,0
196878,and,0,0
196879,feasibility,0,0
196880,of,0,0
196881,bone,1,0
196882,marrow,1,0
196883,aspirate,1,1
196884,concentrate,1,1
196885,(,0,1
196886,BMAC,0,1
196887,),0,1
196888,infused,0,0
196889,retrograde,1,1
196890,into,0,0
196891,the,0,0
196892,coronary,0,0
196893,sinus,0,0
196894,.,0,0
196895,Sixty,0,0
196896,patients,0,0
196897,were,0,0
196898,stratified,0,0
196899,by,0,0
196900,IHF,0,0
196901,and,0,0
196902,NIHF,0,1
196903,and,0,0
196904,randomized,0,0
196905,to,0,0
196906,receive,0,0
196907,either,0,1
196908,BMAC,1,1
196909,infusion,1,1
196910,or,0,1
196911,control,1,1
196912,(,0,1
196913,standard,0,1
196914,heart,0,0
196915,failure,0,0
196916,care,0,1
196917,),0,0
196918,in,0,0
196919,a,0,0
196920,4:1,0,0
196921,ratio,0,0
196922,.,0,0
196923,Accordingly,0,0
196924,",",0,0
196925,24,0,0
196926,subjects,0,0
196927,were,0,0
196928,randomized,0,0
196929,to,0,0
196930,the,0,0
196931,ischemic,0,0
196932,BMAC,0,1
196933,group,0,0
196934,and,0,0
196935,6,0,0
196936,to,0,0
196937,the,0,0
196938,ischemic,0,0
196939,control,0,0
196940,group,0,0
196941,.,0,0
196942,Similarly,0,0
196943,",",0,0
196944,24,0,0
196945,subjects,0,0
196946,were,0,0
196947,randomized,0,0
196948,to,0,0
196949,the,0,0
196950,nonischemic,0,1
196951,BMAC,0,1
196952,group,0,0
196953,and,0,0
196954,6,0,0
196955,to,0,0
196956,the,0,0
196957,nonischemic,0,1
196958,control,0,0
196959,group,0,0
196960,.,0,0
196961,All,0,0
196962,60,0,0
196963,patients,0,0
196964,were,0,0
196965,successfully,0,0
196966,enrolled,0,0
196967,in,0,0
196968,the,0,0
196969,study,0,0
196970,.,0,0
196971,The,0,0
196972,treatment,0,0
196973,groups,0,0
196974,received,0,0
196975,BMAC,1,1
196976,infusion,1,1
196977,without,0,0
196978,complications,0,0
196979,.,0,0
196980,The,0,0
196981,left,0,0
196982,ventricular,0,0
196983,ejection,0,0
196984,fraction,0,0
196985,in,0,0
196986,the,0,0
196987,patients,0,0
196988,receiving,0,0
196989,BMAC,0,1
196990,demonstrated,0,0
196991,significant,0,0
196992,improvement,0,0
196993,compared,0,0
196994,with,0,0
196995,baseline,0,0
196996,",",0,0
196997,from,0,0
196998,25.1,0,0
196999,%,0,0
197000,at,0,0
197001,screening,0,0
197002,to,0,0
197003,31.1,0,0
197004,%,0,0
197005,at,0,0
197006,12,0,0
197007,months,0,0
197008,(,0,0
197009,p=.007,0,0
197010,),0,1
197011,in,0,0
197012,the,0,0
197013,NIHF,0,1
197014,group,0,0
197015,and,0,0
197016,from,0,0
197017,26.3,0,0
197018,%,0,0
197019,to,0,0
197020,31.1,0,0
197021,%,0,0
197022,in,0,0
197023,the,0,0
197024,IHF,0,1
197025,group,0,1
197026,(,0,1
197027,p=.035,0,0
197028,),0,0
197029,.,0,0
197030,The,0,0
197031,end-systolic,0,0
197032,diameter,0,0
197033,decreased,0,0
197034,significantly,0,0
197035,in,0,0
197036,the,0,0
197037,nonischemic,0,1
197038,BMAC,1,1
197039,group,0,0
197040,from,0,0
197041,55.6,0,0
197042,to,0,0
197043,50.9,0,0
197044,mm,0,0
197045,(,0,1
197046,p=.020,0,0
197047,),0,0
197048,.,0,0
197049,Retrograde,0,1
197050,BMAC,0,1
197051,delivery,0,1
197052,is,0,0
197053,safe,0,0
197054,.,0,0
197055,All,0,0
197056,patients,0,0
197057,receiving,0,0
197058,BMAC,0,1
197059,experienced,0,0
197060,improvements,0,0
197061,in,0,0
197062,left,0,0
197063,ventricular,0,0
197064,ejection,0,0
197065,fraction,0,0
197066,",",0,0
197067,but,0,0
197068,only,0,0
197069,those,0,0
197070,with,0,0
197071,NIHF,0,1
197072,showed,0,0
197073,improvements,0,0
197074,in,0,0
197075,left,0,0
197076,ventricular,0,0
197077,end-systolic,0,0
197078,diameter,0,0
197079,and,0,0
197080,B-type,0,0
197081,natriuretic,0,0
197082,peptide,0,0
197083,.,0,0
197084,These,0,0
197085,results,0,0
197086,provide,0,0
197087,the,0,0
197088,basis,0,0
197089,for,0,0
197090,a,0,0
197091,larger,0,0
197092,clinical,0,0
197093,trial,0,0
197094,in,0,0
197095,HF,0,0
197096,patients,0,0
197097,.,0,0
197098,SIGNIFICANCE,0,0
197099,This,0,0
197100,work,0,0
197101,is,0,0
197102,the,0,0
197103,first,0,0
197104,prospective,0,0
197105,randomized,0,0
197106,clinical,0,0
197107,trial,0,0
197108,using,0,0
197109,high-dose,0,1
197110,cell,0,0
197111,therapy,0,1
197112,delivered,0,1
197113,via,0,0
197114,a,0,0
197115,retrograde,0,1
197116,coronary,0,0
197117,sinus,0,0
197118,infusion,0,1
197119,in,0,0
197120,patients,0,0
197121,with,0,0
197122,heart,0,0
197123,failure,0,0
197124,.,0,0
197125,This,0,0
197126,was,0,0
197127,a,0,0
197128,multinational,0,0
197129,",",0,0
197130,multicenter,0,0
197131,study,0,0
197132,",",0,0
197133,and,0,0
197134,it,0,0
197135,is,0,0
197136,novel,0,0
197137,",",0,0
197138,translatable,0,0
197139,",",0,0
197140,and,0,0
197141,scalable,0,0
197142,.,0,0
197143,On,0,0
197144,the,0,0
197145,basis,0,0
197146,of,0,0
197147,this,0,0
197148,trial,0,0
197149,and,0,0
197150,the,0,0
197151,safety,0,0
197152,of,0,0
197153,retrograde,0,1
197154,coronary,0,0
197155,sinus,0,0
197156,infusion,0,1
197157,",",0,0
197158,there,0,0
197159,are,0,0
197160,three,0,0
197161,other,0,0
197162,trials,0,0
197163,under,0,0
197164,way,0,0
197165,using,0,0
197166,this,0,0
197167,route,0,1
197168,of,0,0
197169,delivery,0,0
197170,.,0,0
197171,Women,0,0
197172,With,0,0
197173,Gestational,0,0
197174,Diabetes,0,0
197175,Mellitus,0,0
197176,Randomized,0,0
197177,to,0,0
197178,a,0,0
197179,Higher-Complex,0,0
197180,Carbohydrate/Low-Fat,0,1
197181,Diet,0,1
197182,Manifest,0,0
197183,Lower,0,1
197184,Adipose,0,1
197185,Tissue,0,0
197186,Insulin,0,1
197187,Resistance,0,0
197188,",",0,0
197189,Inflammation,0,0
197190,",",0,0
197191,Glucose,0,1
197192,",",0,0
197193,and,0,0
197194,Free,0,1
197195,Fatty,0,1
197196,Acids,0,0
197197,:,0,0
197198,A,0,0
197199,Pilot,0,0
197200,Study,0,0
197201,.,0,0
197202,OBJECTIVE,0,0
197203,Diet,0,1
197204,therapy,0,1
197205,in,0,0
197206,gestational,0,0
197207,diabetes,0,0
197208,mellitus,0,0
197209,(,0,0
197210,GDM,0,1
197211,),0,1
197212,has,0,0
197213,focused,0,0
197214,on,0,0
197215,carbohydrate,0,1
197216,restriction,0,1
197217,but,0,0
197218,is,0,0
197219,poorly,0,0
197220,substantiated,0,0
197221,.,0,0
197222,In,0,0
197223,this,0,0
197224,pilot,0,0
197225,randomized,0,0
197226,clinical,0,0
197227,trial,0,0
197228,",",0,0
197229,we,0,0
197230,challenged,0,0
197231,the,0,0
197232,conventional,1,1
197233,low-carbohydrate/higher-fat,1,1
197234,(,1,1
197235,LC/CONV,1,1
197236,),1,1
197237,diet,1,1
197238,",",0,0
197239,hypothesizing,0,0
197240,that,0,0
197241,a,0,0
197242,higher-complex,1,0
197243,carbohydrate/lower-fat,1,1
197244,(,1,1
197245,CHOICE,1,1
197246,),1,1
197247,diet,1,1
197248,would,0,0
197249,improve,0,0
197250,maternal,0,0
197251,insulin,0,1
197252,resistance,0,0
197253,(,0,1
197254,IR,0,1
197255,),0,1
197256,",",0,0
197257,adipose,0,1
197258,tissue,0,0
197259,(,0,1
197260,AT,0,1
197261,),0,1
197262,lipolysis,0,0
197263,",",0,0
197264,and,0,0
197265,infant,0,0
197266,adiposity,0,0
197267,.,0,0
197268,RESEARCH,0,0
197269,DESIGN,0,0
197270,AND,0,0
197271,METHODS,0,0
197272,At,0,1
197273,31,0,0
197274,weeks,0,0
197275,",",0,0
197276,12,0,0
197277,diet-controlled,0,0
197278,overweight/obese,0,0
197279,women,0,0
197280,with,0,0
197281,GDM,0,1
197282,were,0,0
197283,randomized,0,0
197284,to,0,0
197285,an,0,0
197286,isocaloric,0,1
197287,LC/CONV,0,1
197288,(,0,0
197289,40,0,1
197290,%,0,0
197291,carbohydrate/45,0,1
197292,%,0,0
197293,fat/15,0,1
197294,%,0,0
197295,protein,0,1
197296,;,0,0
197297,n,0,0
197298,=,0,0
197299,6,0,1
197300,),0,0
197301,or,0,1
197302,CHOICE,1,1
197303,(,0,1
197304,60,0,0
197305,%,0,0
197306,/25,0,1
197307,%,0,0
197308,/15,0,1
197309,%,0,0
197310,;,0,0
197311,n,0,0
197312,=,0,0
197313,6,0,0
197314,),0,0
197315,diet,1,1
197316,.,1,0
197317,All,0,0
197318,meals,1,1
197319,were,0,0
197320,provided,0,0
197321,.,0,0
197322,AT,0,0
197323,was,0,0
197324,biopsied,0,0
197325,at,0,0
197326,37,0,0
197327,weeks,0,0
197328,.,0,0
197329,RESULTS,0,0
197330,After,0,0
197331,?7,0,0
197332,weeks,0,0
197333,",",0,0
197334,fasting,0,0
197335,glucose,0,0
197336,(,0,1
197337,P,0,0
197338,=,0,0
197339,0.03,0,0
197340,),0,0
197341,and,0,0
197342,free,0,0
197343,fatty,0,1
197344,acids,0,1
197345,(,0,0
197346,P,0,0
197347,=,0,0
197348,0.06,0,0
197349,),0,0
197350,decreased,0,0
197351,on,0,0
197352,CHOICE,0,1
197353,",",0,0
197354,whereas,0,0
197355,fasting,0,0
197356,glucose,0,0
197357,increased,0,0
197358,on,0,0
197359,LC/CONV,0,1
197360,(,0,0
197361,P,0,0
197362,=,0,0
197363,0.03,0,0
197364,),0,0
197365,.,0,0
197366,Insulin,0,1
197367,suppression,0,0
197368,of,0,0
197369,AT,0,1
197370,lipolysis,0,0
197371,was,0,0
197372,improved,0,0
197373,on,0,0
197374,CHOICE,0,1
197375,versus,0,1
197376,LC/CONV,0,1
197377,(,0,0
197378,56,0,0
197379,vs.,0,0
197380,31,0,0
197381,%,0,0
197382,",",0,0
197383,P,0,0
197384,=,0,0
197385,0.005,0,0
197386,),0,0
197387,",",0,0
197388,consistent,0,0
197389,with,0,0
197390,improved,0,0
197391,IR,0,1
197392,.,0,0
197393,AT,0,0
197394,expression,0,0
197395,of,0,0
197396,multiple,0,0
197397,proinflammatory,0,0
197398,genes,0,0
197399,was,0,0
197400,lower,0,0
197401,on,0,0
197402,CHOICE,0,1
197403,(,0,0
197404,P,0,0
197405,<,0,0
197406,0.01,0,0
197407,),0,0
197408,.,0,0
197409,Infant,0,0
197410,adiposity,0,0
197411,trended,0,0
197412,lower,0,0
197413,with,0,0
197414,CHOICE,0,1
197415,(,0,0
197416,10.1,0,0
197417,?,0,0
197418,1.4,0,0
197419,vs.,0,0
197420,12.6,0,0
197421,?,0,0
197422,2,0,0
197423,%,0,0
197424,",",0,0
197425,respectively,0,0
197426,),0,0
197427,.,0,0
197428,CONCLUSIONS,0,0
197429,A,0,0
197430,CHOICE,0,1
197431,diet,0,1
197432,may,0,0
197433,improve,0,0
197434,maternal,0,0
197435,IR,0,1
197436,and,0,0
197437,infant,0,0
197438,adiposity,0,0
197439,",",0,0
197440,challenging,0,0
197441,recommendations,0,0
197442,for,0,0
197443,a,0,0
197444,LC/CONV,0,1
197445,diet,0,1
197446,.,0,0
197447,A,0,0
197448,Comparison,0,0
197449,of,0,0
197450,Outcomes,0,0
197451,Following,0,1
197452,Laparoscopic,1,1
197453,and,1,0
197454,Open,1,1
197455,Hysterectomy,1,1
197456,With,0,0
197457,or,0,0
197458,Without,0,1
197459,Lymphadenectomy,0,1
197460,for,0,0
197461,Presumed,0,0
197462,Early-Stage,0,0
197463,Endometrial,0,1
197464,Cancer,0,0
197465,:,0,0
197466,Results,0,0
197467,From,0,0
197468,the,0,0
197469,Medical,0,1
197470,Research,0,0
197471,Council,0,1
197472,ASTEC,0,1
197473,Trial,0,0
197474,.,0,0
197475,OBJECTIVES,0,0
197476,Laparoscopic,1,1
197477,hysterectomy,1,1
197478,(,1,1
197479,LH,1,1
197480,),1,1
197481,is,0,0
197482,increasingly,0,0
197483,used,0,0
197484,for,0,0
197485,the,0,0
197486,management,0,1
197487,of,0,0
197488,endometrial,0,0
197489,malignancy,0,0
197490,.,0,0
197491,Its,0,0
197492,benefits,0,0
197493,may,0,0
197494,be,0,0
197495,particularly,0,0
197496,pronounced,0,0
197497,as,0,0
197498,these,0,0
197499,women,0,0
197500,are,0,0
197501,more,0,0
197502,likely,0,0
197503,to,0,0
197504,be,0,0
197505,older,0,0
197506,or,0,0
197507,obese,0,0
197508,.,0,0
197509,The,0,0
197510,aim,0,0
197511,of,0,0
197512,this,0,0
197513,study,0,0
197514,was,0,0
197515,to,0,0
197516,determine,0,0
197517,whether,0,0
197518,outcomes,0,0
197519,for,0,0
197520,LH,0,0
197521,are,0,0
197522,comparable,0,0
197523,to,0,0
197524,the,0,0
197525,open,0,1
197526,hysterectomy,0,1
197527,(,0,1
197528,OH,0,0
197529,),0,1
197530,.,0,0
197531,DESIGN,0,0
197532,This,0,0
197533,was,0,0
197534,a,0,0
197535,prospective,0,0
197536,cohort,0,0
197537,study,0,0
197538,nested,0,1
197539,within,0,0
197540,the,0,0
197541,multicenter,0,0
197542,ASTEC,0,1
197543,(,0,0
197544,A,0,0
197545,Study,0,0
197546,in,0,0
197547,the,0,0
197548,Treatment,0,0
197549,of,0,0
197550,Endometrial,0,1
197551,Cancer,0,1
197552,),0,0
197553,randomized,0,0
197554,controlled,0,0
197555,trial,0,0
197556,(,0,1
197557,1998-2005,0,0
197558,),0,0
197559,.,0,0
197560,POPULATION,0,0
197561,Women,0,0
197562,with,0,0
197563,presumed,0,0
197564,early,0,0
197565,endometrial,0,0
197566,cancer,0,0
197567,were,0,0
197568,included,0,0
197569,.,0,0
197570,METHODS,0,0
197571,Laparoscopic,1,1
197572,hysterectomy,1,1
197573,was,0,0
197574,compared,0,0
197575,with,0,0
197576,OH,1,0
197577,with,1,0
197578,or,1,1
197579,without,1,1
197580,systematic,1,0
197581,lymphadenectomy,1,1
197582,.,1,0
197583,MAIN,0,0
197584,OUTCOME,0,0
197585,MEASURES,0,0
197586,Overall,0,0
197587,survival,0,0
197588,",",0,0
197589,time,0,0
197590,to,0,0
197591,first,0,0
197592,recurrence,0,0
197593,",",0,0
197594,complication,0,0
197595,rates,0,0
197596,",",0,0
197597,and,0,0
197598,surgical,0,1
197599,outcomes,0,0
197600,were,0,0
197601,the,0,0
197602,main,0,0
197603,outcome,0,0
197604,measures,0,0
197605,.,0,0
197606,RESULTS,0,0
197607,Of,0,0
197608,1408,0,0
197609,women,0,0
197610,",",0,0
197611,1309,0,0
197612,(,0,0
197613,93,0,0
197614,%,0,0
197615,),0,0
197616,received,0,1
197617,OH,0,0
197618,",",0,0
197619,and,0,0
197620,99,0,0
197621,(,0,0
197622,7,0,0
197623,%,0,0
197624,),0,0
197625,had,0,0
197626,LH,0,1
197627,.,0,0
197628,LH,0,0
197629,was,0,0
197630,associated,0,0
197631,with,0,0
197632,longer,0,0
197633,operating,0,1
197634,time,0,0
197635,(,0,1
197636,median,0,0
197637,",",0,0
197638,LH,1,1
197639,105,0,0
197640,minutes,0,0
197641,[,0,0
197642,interquartile,0,0
197643,range,0,0
197644,(,0,1
197645,IQR,0,1
197646,),0,1
197647,",",0,0
197648,60-150,0,1
197649,],0,1
197650,vs,0,0
197651,OH,1,0
197652,80,0,0
197653,minutes,0,0
197654,[,0,0
197655,IQR,0,0
197656,",",0,0
197657,60-95,0,0
197658,],0,0
197659,;,0,0
197660,P,0,0
197661,<,0,0
197662,0.001,0,0
197663,),0,0
197664,but,0,0
197665,50,0,0
197666,%,0,0
197667,shorter,0,0
197668,hospital,0,0
197669,stay,0,0
197670,(,0,0
197671,median,0,0
197672,",",0,0
197673,LH,0,1
197674,4,0,0
197675,days,0,0
197676,[,0,0
197677,IQR,0,1
197678,",",0,0
197679,3-5,0,0
197680,],0,1
197681,vs,0,0
197682,OH,1,0
197683,6,0,0
197684,days,0,0
197685,[,0,0
197686,IQR,0,1
197687,",",0,0
197688,5-7,0,1
197689,],0,0
197690,),0,0
197691,.,0,0
197692,The,0,0
197693,number,0,0
197694,of,0,0
197695,harvested,0,0
197696,lymph,0,0
197697,nodes,0,0
197698,was,0,0
197699,similar,0,0
197700,(,0,0
197701,median,0,0
197702,",",0,0
197703,LH,1,1
197704,13,0,0
197705,[,0,0
197706,IQR,0,1
197707,",",0,0
197708,10-16,0,0
197709,],0,1
197710,vs,0,0
197711,OH,1,0
197712,12,0,0
197713,[,0,0
197714,IQR,0,1
197715,",",0,0
197716,11-13,0,0
197717,],0,0
197718,;,0,0
197719,P,0,0
197720,=,0,0
197721,0.67,0,0
197722,),0,0
197723,.,0,0
197724,LH,1,0
197725,had,0,0
197726,fewer,0,0
197727,intraoperative,0,0
197728,and,0,0
197729,postoperative,0,0
197730,adverse,0,0
197731,events,0,0
197732,(,0,0
197733,9,0,0
197734,%,0,0
197735,difference,0,0
197736,",",0,0
197737,LH,0,1
197738,21,0,0
197739,%,0,0
197740,vs,0,0
197741,OH,0,0
197742,30,0,1
197743,%,0,0
197744,;,0,0
197745,borderline,0,0
197746,significance,0,0
197747,;,0,0
197748,P,0,0
197749,=,0,0
197750,0.07,0,0
197751,),0,0
197752,.,0,0
197753,The,0,0
197754,rate,0,0
197755,of,0,0
197756,conversion,0,0
197757,to,0,0
197758,laparotomy,0,1
197759,for,0,0
197760,the,0,0
197761,LH,1,1
197762,group,0,0
197763,was,0,0
197764,high,0,0
197765,(,0,0
197766,27,0,0
197767,%,0,0
197768,),0,0
197769,.,0,0
197770,The,0,0
197771,median,0,0
197772,follow-up,0,0
197773,was,0,0
197774,37,0,0
197775,months,0,0
197776,.,0,0
197777,After,0,0
197778,adjusting,0,0
197779,for,0,0
197780,significant,0,0
197781,prognostic,0,0
197782,factors,0,0
197783,",",0,0
197784,the,0,0
197785,hazard,0,0
197786,ratio,0,0
197787,for,0,0
197788,overall,0,0
197789,survival,0,0
197790,in,0,0
197791,those,0,0
197792,who,0,0
197793,underwent,0,0
197794,LH,1,1
197795,compared,0,0
197796,with,0,0
197797,those,0,0
197798,who,0,0
197799,underwent,0,0
197800,OH,1,0
197801,was,0,0
197802,0.67,0,0
197803,(,0,0
197804,95,0,0
197805,%,0,0
197806,confidence,0,0
197807,interval,0,0
197808,",",0,0
197809,0.31-1.43,0,0
197810,),0,1
197811,(,0,0
197812,P,0,0
197813,=,0,0
197814,0.30,0,0
197815,),0,0
197816,.,0,0
197817,CONCLUSIONS,0,0
197818,Laparoscopic,1,1
197819,hysterectomy,1,1
197820,for,0,0
197821,early,0,0
197822,endometrial,0,0
197823,cancer,0,0
197824,is,0,0
197825,safe,0,0
197826,.,0,0
197827,Although,0,0
197828,it,0,0
197829,requires,0,0
197830,longer,0,0
197831,operating,0,0
197832,time,0,0
197833,it,0,0
197834,is,0,0
197835,associated,0,0
197836,with,0,0
197837,shorter,0,0
197838,hospital,0,0
197839,stay,0,0
197840,and,0,0
197841,favorable,0,0
197842,morbidity,0,0
197843,profile,0,0
197844,.,0,0
197845,Further,0,0
197846,studies,0,0
197847,are,0,0
197848,required,0,0
197849,to,0,0
197850,assess,0,0
197851,the,0,0
197852,long-term,0,0
197853,safety,0,0
197854,.,0,0
197855,The,0,0
197856,VA,1,1
197857,augmentation,1,1
197858,and,1,0
197859,switching,1,0
197860,treatments,1,1
197861,for,0,0
197862,improving,0,0
197863,depression,0,1
197864,outcomes,0,0
197865,(,0,0
197866,VAST-D,0,1
197867,),0,1
197868,study,0,0
197869,:,0,1
197870,Rationale,0,0
197871,and,0,0
197872,design,0,0
197873,considerations,0,0
197874,.,0,0
197875,Because,0,0
197876,two-thirds,0,0
197877,of,0,0
197878,patients,0,0
197879,with,0,0
197880,Major,0,0
197881,Depressive,0,1
197882,Disorder,0,0
197883,do,0,0
197884,not,0,0
197885,achieve,0,0
197886,remission,0,0
197887,with,0,0
197888,their,0,0
197889,first,0,0
197890,antidepressant,0,1
197891,",",0,0
197892,we,0,0
197893,designed,0,0
197894,a,0,0
197895,trial,0,0
197896,of,0,0
197897,three,0,0
197898,next-step,0,0
197899,strategies,0,0
197900,:,0,0
197901,switching,1,0
197902,to,1,0
197903,another,1,1
197904,antidepressant,1,1
197905,(,1,0
197906,bupropion-SR,1,1
197907,),1,1
197908,or,0,1
197909,augmenting,1,0
197910,the,1,0
197911,current,1,0
197912,antidepressant,1,1
197913,with,1,0
197914,either,1,0
197915,another,1,1
197916,antidepressant,1,1
197917,(,1,0
197918,bupropion-SR,1,1
197919,),1,1
197920,or,1,1
197921,with,1,0
197922,an,1,0
197923,atypical,1,1
197924,antipsychotic,1,1
197925,(,1,1
197926,aripiprazole,1,1
197927,),1,0
197928,.,1,0
197929,The,0,0
197930,study,0,0
197931,will,0,0
197932,compare,0,0
197933,12-week,0,0
197934,remission,0,0
197935,rates,0,0
197936,and,0,0
197937,",",0,0
197938,among,0,0
197939,those,0,0
197940,who,0,0
197941,have,0,0
197942,at,0,0
197943,least,0,0
197944,a,0,0
197945,partial,0,0
197946,response,0,0
197947,",",0,0
197948,relapse,0,0
197949,rates,0,0
197950,for,0,0
197951,up,0,0
197952,to,0,0
197953,6,0,0
197954,months,0,0
197955,of,0,0
197956,additional,0,0
197957,treatment,0,0
197958,.,0,0
197959,We,0,0
197960,review,0,0
197961,seven,0,0
197962,key,0,0
197963,efficacy/effectiveness,0,0
197964,design,0,0
197965,decisions,0,0
197966,in,0,0
197967,this,0,0
197968,mixed,0,1
197969,efficacy-effectiveness,0,0
197970,trial,0,0
197971,.,0,0
197972,A,0,0
197973,controlled,0,0
197974,trial,0,0
197975,of,0,0
197976,extended,1,1
197977,radical,1,1
197978,versus,0,1
197979,radical,1,1
197980,mastectomy,1,1
197981,.,1,0
197982,Ten-year,0,0
197983,results,0,0
197984,.,0,0
197985,In,0,0
197986,view,0,0
197987,of,0,0
197988,increasing,0,0
197989,debate,0,0
197990,over,0,0
197991,possible,0,0
197992,benefit,0,0
197993,of,0,0
197994,more,0,0
197995,complete,0,0
197996,surgery,0,0
197997,compared,0,0
197998,to,0,0
197999,conservative,0,1
198000,procedures,0,0
198001,",",0,0
198002,a,0,0
198003,randomized,0,0
198004,controlled,0,0
198005,trial,0,0
198006,contrasting,0,0
198007,the,0,0
198008,then,0,1
198009,standard,1,1
198010,Halsted,1,1
198011,radical,1,1
198012,(,1,1
198013,RDL,1,1
198014,),1,1
198015,operation,1,0
198016,with,0,0
198017,the,0,0
198018,more,0,0
198019,complete,1,0
198020,extended,1,1
198021,radical,1,1
198022,(,1,1
198023,EXT,1,1
198024,),1,1
198025,mastectomy,1,1
198026,was,0,0
198027,initiated,0,0
198028,in,0,0
198029,1973,0,0
198030,.,0,0
198031,Between,0,0
198032,November,0,0
198033,1973,0,0
198034,and,0,0
198035,July,0,0
198036,1982,0,0
198037,",",0,0
198038,123,0,0
198039,women,0,0
198040,younger,0,0
198041,than,0,0
198042,70,0,0
198043,years,0,0
198044,of,0,0
198045,age,0,0
198046,and,0,0
198047,at,0,0
198048,clinical,0,0
198049,Stages,0,0
198050,I,0,0
198051,and,0,0
198052,II,0,0
198053,were,0,0
198054,enrolled,0,0
198055,.,0,0
198056,Of,0,0
198057,the,0,0
198058,total,0,0
198059,series,0,0
198060,",",0,0
198061,112,0,0
198062,were,0,0
198063,treated,0,0
198064,by,0,0
198065,the,0,0
198066,same,0,0
198067,surgeon,0,1
198068,and,0,0
198069,confirmed,0,0
198070,pathologically,0,0
198071,as,0,0
198072,having,0,0
198073,invasive,0,0
198074,mammary,0,0
198075,carcinoma,0,0
198076,.,0,0
198077,In,0,0
198078,this,0,0
198079,more,0,0
198080,homogeneous,0,0
198081,subgroup,0,0
198082,",",0,0
198083,the,0,0
198084,10-year,0,0
198085,survival,0,0
198086,rates,0,0
198087,(,0,0
198088,and,0,0
198089,standard,0,1
198090,errors,0,0
198091,),0,0
198092,were,0,0
198093,for,0,0
198094,RDL,0,1
198095,",",0,0
198096,60,0,0
198097,%,0,0
198098,(,0,0
198099,+/-,0,0
198100,7,0,1
198101,%,0,0
198102,),0,0
198103,and,0,0
198104,for,0,0
198105,EXT,0,1
198106,",",0,0
198107,74,0,0
198108,%,0,0
198109,(,0,0
198110,+/-,0,0
198111,6,0,1
198112,%,0,0
198113,),0,1
198114,(,0,1
198115,P,0,0
198116,value,0,0
198117,for,0,0
198118,comparison,0,0
198119,of,0,0
198120,survival,0,0
198121,curves,0,0
198122,=,0,0
198123,0.13,0,0
198124,),0,0
198125,.,0,0
198126,In,0,0
198127,patients,0,0
198128,from,0,0
198129,this,0,0
198130,subgroup,0,0
198131,with,0,0
198132,central-medial,0,0
198133,tumors,0,0
198134,",",0,0
198135,comprising,0,0
198136,62,0,0
198137,%,0,0
198138,of,0,0
198139,the,0,0
198140,total,0,0
198141,",",0,0
198142,survival,0,0
198143,after,0,0
198144,RDL,0,1
198145,at,0,0
198146,10,0,0
198147,years,0,0
198148,was,0,0
198149,60,0,0
198150,%,0,0
198151,(,0,0
198152,+/-,0,0
198153,8,0,1
198154,%,0,0
198155,),0,0
198156,",",0,0
198157,and,0,0
198158,after,0,0
198159,EXT,0,1
198160,86,0,0
198161,%,0,0
198162,(,0,0
198163,+/-,0,0
198164,6,0,1
198165,%,0,0
198166,),0,1
198167,(,0,0
198168,P,0,0
198169,=,0,0
198170,0.025,0,0
198171,),0,0
198172,.,0,0
198173,In,0,0
198174,the,0,0
198175,remaining,0,0
198176,patients,0,0
198177,with,0,0
198178,lateral,0,0
198179,tumors,0,0
198180,",",0,0
198181,survival,0,0
198182,rates,0,0
198183,were,0,0
198184,unaffected,0,0
198185,by,0,0
198186,treatment,0,0
198187,:,0,0
198188,58,0,0
198189,%,0,0
198190,(,0,0
198191,+/-,0,0
198192,13,0,0
198193,%,0,0
198194,),0,0
198195,and,0,0
198196,56,0,0
198197,%,0,0
198198,(,0,0
198199,+/-,0,0
198200,11,0,0
198201,%,0,0
198202,),0,0
198203,",",0,0
198204,respectively,0,0
198205,(,0,0
198206,P,0,0
198207,=,0,0
198208,0.62,0,0
198209,),0,0
198210,.,0,0
198211,Comparison,0,0
198212,of,0,0
198213,a,0,0
198214,nonrandomized,0,0
198215,series,0,0
198216,of,0,0
198217,266,0,0
198218,RDL,0,1
198219,and,0,0
198220,124,0,0
198221,EXT,0,1
198222,patients,0,0
198223,treated,0,0
198224,between,0,0
198225,1960,0,0
198226,and,0,0
198227,1978,0,0
198228,found,0,0
198229,differences,0,0
198230,consistent,0,0
198231,with,0,0
198232,those,0,0
198233,of,0,0
198234,the,0,0
198235,randomized,0,0
198236,study,0,0
198237,",",0,0
198238,although,0,0
198239,not,0,0
198240,statistically,0,0
198241,significant,0,0
198242,.,0,0
198243,DESFLURANE,0,1
198244,COMPARED,0,1
198245,TO,0,0
198246,SEVOFLURANE,0,1
198247,FOR,0,1
198248,CIRRHOTIC,0,1
198249,PATIENTS,0,1
198250,UNDERGOING,0,1
198251,MAJOR,0,1
198252,LIVER,0,0
198253,RESECTION,0,0
198254,.,0,0
198255,A,0,0
198256,RANDOMIZED,0,0
198257,CONTROL,0,1
198258,STUDY,0,0
198259,.,0,0
198260,BACKGROUND,0,0
198261,Major,0,0
198262,liver,0,0
198263,resection,0,1
198264,is,0,0
198265,associated,0,0
198266,with,0,0
198267,haemodynamic,0,0
198268,",",0,0
198269,hepatic,0,0
198270,and,0,0
198271,renal,0,0
198272,changes,0,0
198273,as,0,0
198274,a,0,0
198275,result,0,0
198276,of,0,0
198277,the,0,0
198278,procedure,0,0
198279,.,0,0
198280,AIM,0,0
198281,To,0,0
198282,compare,0,0
198283,Desflurane,1,1
198284,(,1,1
198285,D,1,1
198286,),1,1
198287,versus,1,1
198288,Sevoflurane,1,1
198289,(,1,1
198290,S,1,1
198291,),1,1
198292,on,0,0
198293,hepatic,0,0
198294,",",0,0
198295,renal,0,0
198296,functions,0,0
198297,",",0,0
198298,haemodynamics,0,0
198299,and,0,0
198300,perioperative,0,1
198301,course,0,0
198302,for,0,0
198303,cirrhotic,0,0
198304,patients,0,0
198305,undergoing,0,0
198306,major,0,0
198307,liver,0,0
198308,resection,0,1
198309,.,0,0
198310,PATIENTS,0,0
198311,AND,0,0
198312,METHODS,0,0
198313,A,0,0
198314,prospective,0,0
198315,randomized,0,0
198316,control,0,1
198317,study,0,0
198318,with,0,0
198319,50,0,1
198320,patients,0,0
198321,(,0,0
198322,Child,0,0
198323,A,0,1
198324,),0,1
198325,(,0,0
198326,D,0,1
198327,",",0,0
198328,n,0,0
198329,=,0,0
198330,25,0,0
198331,and,0,0
198332,S,0,0
198333,",",0,0
198334,n,0,0
198335,=,0,0
198336,25,0,0
198337,),0,0
198338,.,0,0
198339,End,0,1
198340,tidal,0,0
198341,D,0,1
198342,or,0,1
198343,S,0,1
198344,adjusted,0,0
198345,with,0,0
198346,Entropy,0,0
198347,(,0,1
198348,40-60,0,0
198349,),0,0
198350,.,0,0
198351,Haemodynamics,1,0
198352,monitored,1,0
198353,with,1,0
198354,invasive,1,0
198355,blood,1,0
198356,pressure,1,0
198357,and,1,0
198358,trans-oesophageal,1,1
198359,Doppler,1,1
198360,(,1,1
198361,TED,1,1
198362,),1,0
198363,.,1,0
198364,Liver,1,0
198365,and,1,0
198366,kidney,1,1
198367,function,1,0
198368,tests,1,0
198369,",",1,0
198370,blood,1,0
198371,Glutathione-S-transferase,1,1
198372,(,1,1
198373,GST,1,0
198374,),1,1
198375,",",1,0
198376,urinary,1,0
198377,microalbuminuria,1,0
198378,(,1,1
198379,Microalb,1,0
198380,),1,1
198381,were,1,0
198382,assayed,1,0
198383,.,1,0
198384,Extubation,0,0
198385,time,0,0
198386,and,0,0
198387,anaesthetic,0,1
198388,consumption,0,0
198389,were,0,0
198390,recorded,0,0
198391,.,0,0
198392,RESULTS,0,0
198393,Systemic,0,0
198394,vascular,0,0
198395,resistance,0,0
198396,(,0,1
198397,SVR,0,1
198398,),0,1
198399,post-resection,0,0
198400,and,0,1
198401,stroke,0,0
198402,volume,0,0
198403,of,0,0
198404,D,0,0
198405,vs,0,0
198406,S,0,0
198407,were,0,0
198408,835.04,0,0
198409,?,0,0
198410,12.02,0,0
198411,vs,0,0
198412,778.16,0,0
198413,?,0,0
198414,11.97,0,0
198415,dyn.sec.cm,0,0
198416,(,0,1
198417,-5,0,0
198418,),0,0
198419,",",0,0
198420,P,0,0
198421,<,0,0
198422,0.01,0,0
198423,",",0,0
198424,and,0,0
198425,85.72,0,0
198426,?,0,0
198427,2.95,0,0
198428,vs,0,0
198429,76.16,0,0
198430,?,0,0
198431,6.52,0,0
198432,ml,0,0
198433,",",0,0
198434,P,0,0
198435,<,0,0
198436,0.01,0,0
198437,respectively,0,0
198438,.,0,0
198439,Doppler,0,0
198440,corrected,0,0
198441,flow,0,0
198442,time,0,0
198443,(,0,1
198444,FTc,0,1
198445,),0,1
198446,between,0,0
198447,groups,0,0
198448,were,0,0
198449,comparable,0,0
198450,(,0,0
198451,P,0,0
198452,>,0,0
198453,0.05,0,0
198454,),0,0
198455,.,0,0
198456,No,0,0
198457,difference,0,0
198458,post-operatively,0,0
198459,regarding,0,0
198460,hepatic,0,0
198461,and,0,0
198462,renal,0,0
198463,functions,0,0
198464,",",0,0
198465,and,0,0
198466,urine,0,0
198467,Microalb,0,0
198468,(,0,0
198469,14.76,0,0
198470,?,0,0
198471,3.95,0,0
198472,vs,0,0
198473,l4.24,0,0
198474,?,0,0
198475,8.65,0,0
198476,?g/ml,0,0
198477,",",0,0
198478,P,0,0
198479,=,0,0
198480,0.78,0,0
198481,),0,0
198482,",",0,0
198483,but,0,0
198484,a,0,0
198485,statistically,0,0
198486,difference,0,0
198487,was,0,0
198488,found,0,0
198489,with,0,0
198490,GST,0,0
198491,(,0,0
198492,0.046,0,0
198493,?,0,0
198494,[,0,0
198495,symbols,0,1
198496,:,0,0
198497,see,0,0
198498,text,0,1
198499,],0,0
198500,",",0,0
198501,vs,0,0
198502,0.043,0,0
198503,?,0,0
198504,[,0,0
198505,symbols,0,1
198506,:,0,0
198507,see,0,0
198508,text,0,1
198509,],0,0
198510,IU/ml,0,0
198511,",",0,0
198512,P,0,0
198513,<,0,0
198514,0.01,0,0
198515,),0,0
198516,.,0,0
198517,Despite,0,0
198518,a,0,0
198519,higher,0,0
198520,D,0,0
198521,consumption,0,0
198522,(,0,0
198523,73,0,0
198524,?,0,0
198525,17,0,0
198526,vs,0,0
198527,64,0,0
198528,?,0,0
198529,22,0,0
198530,ml,0,0
198531,",",0,0
198532,P,0,0
198533,=,0,0
198534,0.102,0,0
198535,),0,0
198536,",",0,0
198537,cost,0,0
198538,in,0,0
198539,Egyptian,0,0
198540,pounds,0,0
198541,(,0,0
198542,LE,0,1
198543,),0,0
198544,was,0,0
198545,lower,0,0
198546,with,0,0
198547,D,0,0
198548,(,0,0
198549,141.14,0,0
198550,?,0,0
198551,32.90,0,0
198552,vs,0,0
198553,320.60,0,0
198554,?,0,0
198555,114.01,0,0
198556,",",0,0
198557,LE,0,0
198558,",",0,0
198559,P,0,0
198560,<,0,0
198561,0.01,0,0
198562,),0,0
198563,.,0,0
198564,Extubation,0,0
198565,time,0,0
198566,and,0,0
198567,ICU,0,1
198568,stay,0,0
198569,with,0,0
198570,D,0,1
198571,vS,0,0
198572,(,0,0
198573,4.52,0,0
198574,?,0,0
198575,2,0,0
198576,vs,0,0
198577,7.72,0,0
198578,?,0,0
198579,2,0,0
198580,min,0,0
198581,",",0,0
198582,P,0,0
198583,<,0,0
198584,0.01,0,0
198585,),0,0
198586,and,0,0
198587,(,0,0
198588,1.40,0,0
198589,0.50,0,0
198590,vs,0,0
198591,1.64,0,0
198592,?,0,0
198593,0.48,0,0
198594,",",0,0
198595,days,0,0
198596,P,0,0
198597,=,0,0
198598,0.09,0,0
198599,),0,0
198600,respectively,0,0
198601,.,0,0
198602,CONCLUSION,0,0
198603,Neither,0,0
198604,D,0,1
198605,nor,0,0
198606,S,0,1
198607,were,0,0
198608,clinically,0,0
198609,superior,0,0
198610,to,0,0
198611,the,0,0
198612,other,0,0
198613,with,0,0
198614,respect,0,0
198615,to,0,0
198616,liver,0,0
198617,and,0,0
198618,kidneys,0,0
198619,functions,0,0
198620,",",0,0
198621,but,0,0
198622,D,0,1
198623,was,0,0
198624,found,0,0
198625,to,0,0
198626,preserve,0,0
198627,better,0,0
198628,the,0,0
198629,haemodynamic,0,0
198630,parameters,0,0
198631,and,0,0
198632,enhance,0,0
198633,recovery,0,0
198634,at,0,0
198635,a,0,0
198636,lower,0,0
198637,cost,0,0
198638,.,0,0
198639,The,0,0
198640,effectiveness,0,0
198641,of,0,0
198642,single-dose,0,1
198643,metronidazole,1,1
198644,therapy,0,1
198645,for,0,0
198646,patients,0,0
198647,and,0,0
198648,their,0,0
198649,partners,0,0
198650,with,0,0
198651,bacterial,0,0
198652,vaginosis,0,0
198653,.,0,0
198654,A,0,0
198655,randomized,0,0
198656,",",0,0
198657,placebo-controlled,1,1
198658,",",0,0
198659,double-blind,0,0
198660,clinical,0,0
198661,trial,0,0
198662,was,0,0
198663,performed,0,0
198664,to,0,0
198665,test,0,0
198666,the,0,0
198667,hypothesis,0,0
198668,that,0,0
198669,a,0,0
198670,2-g,0,1
198671,single,0,1
198672,dose,0,0
198673,of,0,0
198674,metronidazole,1,1
198675,for,0,0
198676,male,0,0
198677,partners,0,0
198678,of,0,0
198679,women,0,0
198680,with,0,0
198681,bacterial,0,0
198682,vaginosis,0,0
198683,was,0,0
198684,more,0,0
198685,effective,0,0
198686,than,0,0
198687,placebo,0,1
198688,in,0,0
198689,improving,0,0
198690,cure,0,0
198691,rate,0,0
198692,and,0,0
198693,decreasing,0,0
198694,recurrence,0,0
198695,rate,0,0
198696,.,0,0
198697,In,0,0
198698,addition,0,0
198699,",",0,0
198700,the,0,0
198701,effectiveness,0,0
198702,of,0,0
198703,a,0,0
198704,2-g,0,1
198705,single,1,1
198706,dose,1,0
198707,of,1,0
198708,metronidazole,1,1
198709,was,0,0
198710,compared,0,0
198711,with,0,0
198712,a,0,0
198713,seven-day,1,0
198714,course,1,0
198715,of,1,0
198716,500,1,1
198717,mg,1,1
198718,of,1,0
198719,metronidazole,1,1
198720,twice,0,1
198721,a,0,0
198722,day,0,0
198723,in,0,0
198724,patients,0,0
198725,with,0,0
198726,bacterial,0,0
198727,vaginosis,0,0
198728,.,0,0
198729,Statistically,0,0
198730,significant,0,0
198731,benefits,0,0
198732,of,0,0
198733,partner,0,0
198734,treatment,0,0
198735,were,0,0
198736,noted,0,0
198737,in,0,0
198738,the,0,0
198739,initial,0,0
198740,cure,0,0
198741,rate,0,0
198742,by,0,0
198743,Gram-stained,0,0
198744,smear,0,1
198745,criteria,0,0
198746,(,0,0
198747,P,0,0
198748,less,0,0
198749,than,0,0
198750,.01,0,0
198751,),0,1
198752,and,0,0
198753,in,0,0
198754,percentage,0,0
198755,of,0,0
198756,women,0,0
198757,with,0,0
198758,symptoms,0,0
198759,eight,0,0
198760,weeks,0,0
198761,after,0,0
198762,initiating,0,1
198763,therapy,0,1
198764,(,0,0
198765,P,0,0
198766,less,0,0
198767,than,0,0
198768,.05,0,0
198769,),0,0
198770,.,0,0
198771,The,0,0
198772,seven-day,0,0
198773,course,0,0
198774,of,0,0
198775,metronidazole,0,1
198776,was,0,0
198777,superior,0,0
198778,to,0,0
198779,the,0,0
198780,single-dose,0,1
198781,regimen,0,1
198782,in,0,0
198783,the,0,0
198784,percentage,0,0
198785,of,0,0
198786,patients,0,0
198787,with,0,0
198788,clue,0,0
198789,cells,0,0
198790,and,0,0
198791,the,0,0
198792,percentage,0,0
198793,of,0,0
198794,patients,0,0
198795,with,0,0
198796,a,0,0
198797,positive,0,0
198798,sniff,0,0
198799,test,0,0
198800,at,0,0
198801,the,0,0
198802,first,0,0
198803,follow-up,0,0
198804,visit,0,0
198805,;,0,0
198806,however,0,0
198807,",",0,0
198808,differences,0,0
198809,in,0,0
198810,the,0,0
198811,initial,0,0
198812,cure,0,0
198813,rate,0,0
198814,assessed,0,0
198815,by,0,0
198816,clinical,0,0
198817,criteria,0,0
198818,and,0,0
198819,Gram-stained,0,0
198820,smear,0,1
198821,criteria,0,0
198822,were,0,0
198823,not,0,0
198824,statistically,0,0
198825,significant,0,0
198826,between,0,0
198827,the,0,0
198828,two,0,0
198829,patient,0,0
198830,treatment,0,0
198831,regimens,0,1
198832,.,0,0
198833,Recurrence,0,0
198834,rates,0,0
198835,by,0,0
198836,Gram-stained,0,0
198837,smear,0,1
198838,criteria,0,0
198839,between,0,0
198840,patient,0,0
198841,and,0,0
198842,partner,0,1
198843,treatment,0,1
198844,groups,0,0
198845,at,0,0
198846,five,0,0
198847,and,0,0
198848,eight,0,0
198849,weeks,0,0
198850,after,0,0
198851,initiation,0,0
198852,of,0,0
198853,treatment,0,0
198854,were,0,0
198855,also,0,0
198856,not,0,0
198857,significantly,0,0
198858,different,0,0
198859,between,0,0
198860,the,0,0
198861,two,0,0
198862,patient,0,0
198863,regimens,0,1
198864,.,0,0
198865,Single-dose,0,0
198866,metronidazole,1,1
198867,treatment,0,0
198868,of,0,0
198869,the,0,0
198870,sexual,0,0
198871,partner,0,0
198872,of,0,0
198873,women,0,0
198874,with,0,0
198875,bacterial,0,0
198876,vaginosis,0,0
198877,improves,0,0
198878,initial,0,0
198879,bacterial,0,0
198880,vaginosis,0,0
198881,cure,0,0
198882,rates,0,0
198883,.,0,0
198884,The,0,0
198885,seven-day,0,0
198886,course,0,0
198887,of,0,0
198888,metronidazole,0,1
198889,was,0,0
198890,not,0,0
198891,found,0,0
198892,by,0,0
198893,statistical,0,0
198894,analysis,0,0
198895,to,0,0
198896,be,0,0
198897,significantly,0,0
198898,superior,0,0
198899,to,0,0
198900,single-dose,0,1
198901,therapy,0,1
198902,when,0,0
198903,considering,0,0
198904,initial,0,0
198905,cure,0,0
198906,rates,0,0
198907,by,0,0
198908,clinical,0,0
198909,or,0,1
198910,Gram-stained,0,0
198911,smear,0,1
198912,criteria,0,0
198913,or,0,1
198914,recurrence,0,0
198915,rates,0,0
198916,.,0,0
198917,(,0,0
198918,ABSTRACT,0,1
198919,TRUNCATED,0,1
198920,AT,0,1
198921,250,0,1
198922,WORDS,0,1
198923,),0,1
198924,Computer,1,1
198925,Decision,1,0
198926,Support,1,1
198927,Changes,0,1
198928,Physician,0,1
198929,Practice,0,1
198930,But,0,1
198931,Not,0,1
198932,Knowledge,0,1
198933,Regarding,0,0
198934,Autism,0,0
198935,Spectrum,0,1
198936,Disorders,0,0
198937,.,0,0
198938,OBJECTIVE,0,0
198939,To,0,0
198940,examine,0,0
198941,whether,0,0
198942,adding,0,0
198943,an,0,0
198944,autism,0,0
198945,module,0,1
198946,promoting,0,1
198947,adherence,0,0
198948,to,0,0
198949,clinical,0,0
198950,guidelines,0,0
198951,to,0,0
198952,an,0,0
198953,existing,0,1
198954,computer,1,1
198955,decision,1,1
198956,support,1,1
198957,system,1,1
198958,(,0,1
198959,CDSS,0,1
198960,),0,1
198961,changed,0,0
198962,physician,0,1
198963,knowledge,0,0
198964,and,0,0
198965,self-reported,0,0
198966,clinical,0,0
198967,practice,0,0
198968,.,0,0
198969,METHODS,0,0
198970,The,0,0
198971,CHICA,1,1
198972,(,1,0
198973,Child,1,0
198974,Health,1,1
198975,Improvement,1,0
198976,through,1,0
198977,Computer,1,1
198978,Automation,1,1
198979,),1,1
198980,system,1,0
198981,",",0,0
198982,a,0,0
198983,CDSS,1,0
198984,",",0,0
198985,was,0,0
198986,enhanced,0,0
198987,with,0,0
198988,a,0,0
198989,module,0,1
198990,to,0,0
198991,improve,0,0
198992,management,0,1
198993,of,0,0
198994,autism,0,0
198995,in,0,0
198996,2,0,0
198997,of,0,0
198998,the,0,0
198999,4,0,0
199000,community,0,0
199001,pediatric,0,0
199002,clinics,0,0
199003,using,0,0
199004,the,0,0
199005,system,0,0
199006,.,0,0
199007,We,0,0
199008,examined,0,0
199009,the,0,0
199010,knowledge,0,0
199011,and,0,0
199012,beliefs,0,1
199013,of,0,0
199014,pediatric,0,0
199015,users,0,0
199016,using,0,0
199017,cross-sectional,0,0
199018,surveys,0,0
199019,administered,0,0
199020,at,0,0
199021,3,0,0
199022,time,0,0
199023,points,0,0
199024,(,0,0
199025,baseline,0,0
199026,",",0,0
199027,12,0,0
199028,months,0,0
199029,and,0,0
199030,24,0,0
199031,months,0,0
199032,post-implementation,0,0
199033,),0,0
199034,between,0,0
199035,November,0,0
199036,2010,0,0
199037,and,0,0
199038,January,0,0
199039,2013,0,0
199040,.,0,0
199041,Surveys,0,0
199042,measured,0,0
199043,knowledge,0,0
199044,",",0,0
199045,beliefs,0,1
199046,and,0,0
199047,self-reported,0,0
199048,practice,0,0
199049,patterns,0,0
199050,related,0,0
199051,to,0,0
199052,autism,0,0
199053,.,0,0
199054,RESULTS,0,0
199055,A,0,0
199056,total,0,0
199057,of,0,0
199058,45,0,0
199059,",",0,0
199060,39,0,0
199061,",",0,0
199062,and,0,0
199063,42,0,0
199064,pediatricians,0,0
199065,responded,0,0
199066,at,0,0
199067,each,0,0
199068,time,0,0
199069,point,0,0
199070,",",0,0
199071,respectively,0,0
199072,",",0,0
199073,a,0,0
199074,95-100,0,0
199075,%,0,0
199076,response,0,0
199077,rate,0,0
199078,.,0,0
199079,Respondents,0,0
199080,',0,0
199081,knowledge,0,0
199082,of,0,0
199083,autism,0,0
199084,and,0,0
199085,perception,0,0
199086,of,0,0
199087,role,0,0
199088,for,0,0
199089,diagnosis,0,0
199090,did,0,0
199091,not,0,0
199092,vary,0,0
199093,between,0,0
199094,control,0,1
199095,and,0,0
199096,intervention,0,1
199097,groups,0,0
199098,either,0,0
199099,at,0,0
199100,baseline,0,0
199101,or,0,1
199102,any,0,0
199103,of,0,0
199104,the,0,0
199105,two,0,0
199106,post-intervention,0,0
199107,time,0,0
199108,points,0,0
199109,.,0,0
199110,At,0,0
199111,baseline,0,0
199112,",",0,0
199113,there,0,0
199114,was,0,0
199115,no,0,0
199116,difference,0,0
199117,between,0,0
199118,these,0,0
199119,groups,0,0
199120,in,0,0
199121,rates,0,0
199122,in,0,0
199123,the,0,0
199124,routine,0,0
199125,use,0,0
199126,of,0,0
199127,parent-rated,0,0
199128,screening,0,0
199129,instruments,0,1
199130,for,0,0
199131,autism,0,0
199132,.,0,0
199133,However,0,0
199134,",",0,0
199135,by,0,0
199136,12,0,0
199137,and,0,0
199138,24,0,0
199139,months,0,0
199140,post-implementation,0,0
199141,there,0,0
199142,was,0,0
199143,a,0,0
199144,significant,0,0
199145,difference,0,0
199146,between,0,0
199147,intervention,0,1
199148,and,0,0
199149,control,0,1
199150,clinics,0,1
199151,in,0,0
199152,terms,0,0
199153,of,0,0
199154,the,0,0
199155,intervention,0,1
199156,clinics,0,0
199157,consistently,0,0
199158,screening,0,0
199159,eligible,0,0
199160,patients,0,0
199161,with,0,0
199162,a,0,0
199163,validated,0,0
199164,autism,0,0
199165,tool,0,0
199166,.,0,0
199167,Physicians,0,0
199168,at,0,0
199169,all,0,0
199170,clinics,0,0
199171,reported,0,0
199172,ongoing,0,0
199173,challenges,0,0
199174,to,0,0
199175,community,0,0
199176,resources,0,0
199177,for,0,0
199178,further,0,0
199179,work-up,0,1
199180,and,0,0
199181,treatment,0,0
199182,related,0,0
199183,to,0,0
199184,autism,0,0
199185,.,0,0
199186,CONCLUSIONS,0,0
199187,A,0,0
199188,CDSS,1,1
199189,module,0,1
199190,to,0,0
199191,improve,0,0
199192,primary,0,0
199193,care,0,1
199194,management,0,1
199195,of,0,0
199196,ASD,0,0
199197,in,0,0
199198,pediatric,0,0
199199,practice,0,0
199200,led,0,0
199201,to,0,0
199202,significant,0,0
199203,improvements,0,0
199204,in,0,0
199205,physician-reported,0,0
199206,use,0,0
199207,of,0,0
199208,validated,0,0
199209,screening,0,0
199210,tools,0,0
199211,to,0,0
199212,screen,0,0
199213,for,0,0
199214,ASDs,0,0
199215,.,0,0
199216,However,0,0
199217,it,0,0
199218,did,0,0
199219,not,0,0
199220,lead,0,0
199221,to,0,0
199222,corresponding,0,0
199223,changes,0,0
199224,in,0,0
199225,physician,0,1
199226,knowledge,0,0
199227,or,0,1
199228,attitudes,0,0
199229,.,0,0
199230,Preoperative,0,1
199231,Local,0,0
199232,Administration,0,0
199233,of,0,0
199234,Morphine,1,1
199235,as,0,0
199236,an,0,0
199237,Add-on,0,1
199238,Therapy,0,1
199239,in,0,0
199240,Patients,0,0
199241,Undergoing,0,0
199242,Surgical,0,1
199243,Removal,0,0
199244,of,0,0
199245,an,0,0
199246,Odontogenic,0,0
199247,Maxillary,0,0
199248,Cyst,0,1
199249,.,0,0
199250,A,0,0
199251,Randomized,0,0
199252,",",0,0
199253,Double-Blind,0,1
199254,Pilot,0,0
199255,Study,0,0
199256,.,0,0
199257,AIMS,0,0
199258,To,0,0
199259,evaluate,0,0
199260,whether,0,0
199261,a,0,0
199262,combination,0,1
199263,of,0,0
199264,locally,0,1
199265,administered,0,0
199266,morphine,1,1
199267,(,0,0
199268,1,0,1
199269,mg,0,1
199270,),0,1
199271,and,0,0
199272,lidocaine,1,1
199273,as,0,0
199274,part,0,0
199275,of,0,0
199276,a,0,0
199277,multimodal,0,1
199278,analgesic,0,1
199279,approach,0,1
199280,is,0,0
199281,safe,0,0
199282,",",0,0
199283,and,0,0
199284,whether,0,0
199285,it,0,0
199286,improves,0,0
199287,pain,0,0
199288,control,0,0
199289,during,0,0
199290,the,0,0
199291,first,0,0
199292,24,0,0
199293,hours,0,0
199294,after,0,0
199295,odontogenic,0,0
199296,maxillary,0,0
199297,cyst,0,0
199298,removal,0,0
199299,under,0,0
199300,general,0,0
199301,anesthesia,0,1
199302,compared,0,0
199303,to,0,0
199304,local,0,1
199305,lidocaine,0,1
199306,alone,0,1
199307,.,0,0
199308,METHODS,0,0
199309,In,0,0
199310,a,0,0
199311,double-blind,0,0
199312,",",0,0
199313,sham-controlled,0,0
199314,",",0,0
199315,single-center,0,0
199316,trial,0,0
199317,",",0,0
199318,patients,0,0
199319,scheduled,0,0
199320,for,0,0
199321,surgical,0,1
199322,removal,0,0
199323,of,0,0
199324,an,0,0
199325,odontogenic,0,0
199326,maxillary,0,0
199327,cyst,0,0
199328,under,0,0
199329,general,0,0
199330,anesthesia,0,1
199331,were,0,0
199332,randomly,0,0
199333,assigned,0,0
199334,to,0,0
199335,receive,0,0
199336,a,0,0
199337,local,0,1
199338,injection,0,1
199339,of,0,0
199340,lidocaine,1,1
199341,solution,1,1
199342,with,1,0
199343,either,1,0
199344,1,1,0
199345,mg,1,1
199346,of,1,0
199347,morphine,1,1
199348,(,1,1
199349,MLA,1,1
199350,group,0,1
199351,),0,1
199352,or,1,1
199353,with,1,0
199354,no,1,0
199355,morphine,1,1
199356,(,1,0
199357,LA,1,1
199358,group,0,0
199359,),0,0
199360,.,0,0
199361,Pain,0,0
199362,management,0,0
199363,included,0,0
199364,intravenous,0,1
199365,acetaminophen,1,1
199366,(,0,0
199367,1,0,0
199368,g,0,1
199369,every,0,0
199370,6,0,0
199371,hours,0,0
199372,),0,0
199373,in,0,0
199374,all,0,0
199375,patients,0,0
199376,.,0,0
199377,Upon,0,0
199378,request,0,0
199379,",",0,0
199380,the,0,0
199381,patients,0,0
199382,could,0,0
199383,additionally,0,0
199384,receive,0,0
199385,ketoprofen,1,1
199386,(,0,0
199387,first-line,0,1
199388,additional,0,1
199389,analgesia,0,1
199390,),0,1
199391,or,1,1
199392,tramadol,1,1
199393,(,0,0
199394,second-line,0,1
199395,additional,0,1
199396,analgesia,0,0
199397,),0,0
199398,.,0,0
199399,Pain,0,0
199400,intensity,0,0
199401,was,0,0
199402,assessed,0,0
199403,using,0,0
199404,a,0,0
199405,numeric,0,0
199406,rating,0,0
199407,scale,0,0
199408,.,0,0
199409,Primary,0,0
199410,outcome,0,0
199411,measures,0,0
199412,were,0,0
199413,(,0,0
199414,1,0,0
199415,),0,0
199416,no,0,0
199417,need,0,0
199418,for,0,0
199419,any,0,0
199420,additional,0,0
199421,analgesic,0,1
199422,therapy,0,1
199423,and,0,0
199424,(,0,1
199425,2,0,1
199426,),0,0
199427,time,0,0
199428,to,0,0
199429,the,0,0
199430,first,0,0
199431,rescue,0,0
199432,analgesic,0,1
199433,therapy,0,1
199434,during,0,0
199435,the,0,0
199436,first,0,0
199437,24,0,0
199438,hours,0,0
199439,after,0,0
199440,the,0,0
199441,surgery,0,0
199442,.,0,0
199443,RESULTS,0,0
199444,Of,0,1
199445,48,0,0
199446,eligible,0,0
199447,patients,0,0
199448,",",0,0
199449,24,0,0
199450,were,0,0
199451,allocated,0,0
199452,to,0,0
199453,the,0,0
199454,MLA,0,0
199455,group,0,0
199456,and,0,0
199457,24,0,0
199458,to,0,0
199459,the,0,0
199460,LA,0,1
199461,group,0,0
199462,.,0,0
199463,The,0,0
199464,necessity,0,0
199465,of,0,0
199466,additional,0,0
199467,ketoprofen,1,1
199468,therapy,0,1
199469,did,0,0
199470,not,0,0
199471,differ,0,0
199472,significantly,0,0
199473,between,0,0
199474,the,0,0
199475,groups,0,0
199476,(,0,0
199477,25.0,0,0
199478,%,0,0
199479,vs,0,0
199480,50.0,0,0
199481,%,0,0
199482,",",0,0
199483,P=.074,0,0
199484,),0,0
199485,.,0,0
199486,According,0,0
199487,to,0,0
199488,the,0,0
199489,Kaplan-Meier,0,0
199490,analysis,0,0
199491,",",0,0
199492,the,0,0
199493,probability,0,0
199494,of,0,0
199495,remaining,0,0
199496,without,0,0
199497,additional,0,0
199498,analgesic,0,1
199499,intervention,0,1
199500,was,0,0
199501,significantly,0,0
199502,higher,0,0
199503,in,0,0
199504,the,0,0
199505,MLA,0,0
199506,group,0,1
199507,(,0,0
199508,log-rank,0,0
199509,test,0,0
199510,",",0,0
199511,P=.040,0,0
199512,),0,0
199513,",",0,0
199514,but,0,0
199515,there,0,0
199516,were,0,0
199517,no,0,0
199518,significant,0,0
199519,(,0,0
199520,P,0,0
199521,>,0,0
199522,.05,0,0
199523,),0,0
199524,differences,0,0
199525,in,0,0
199526,overall,0,0
199527,and,0,0
199528,maximum,0,0
199529,pain,0,0
199530,severity,0,0
199531,between,0,0
199532,the,0,0
199533,two,0,0
199534,groups,0,0
199535,.,0,0
199536,No,0,0
199537,adverse,0,0
199538,effects,0,0
199539,of,0,0
199540,morphine,0,1
199541,were,0,0
199542,recorded,0,0
199543,.,0,0
199544,CONCLUSION,0,0
199545,Within,0,0
199546,the,0,0
199547,limitations,0,0
199548,of,0,0
199549,this,0,0
199550,study,0,0
199551,",",0,0
199552,local,0,1
199553,administration,0,0
199554,of,0,0
199555,1,0,0
199556,mg,0,1
199557,of,0,0
199558,morphine,1,1
199559,prior,0,0
199560,to,0,0
199561,the,0,0
199562,surgical,0,1
199563,removal,0,0
199564,of,0,0
199565,an,0,0
199566,odontogenic,0,0
199567,maxillary,0,0
199568,cyst,0,0
199569,was,0,0
199570,safe,0,0
199571,",",0,0
199572,but,0,0
199573,it,0,0
199574,did,0,0
199575,not,0,0
199576,prove,0,0
199577,to,0,0
199578,be,0,0
199579,very,0,0
199580,effective,0,0
199581,as,0,0
199582,an,0,0
199583,add-on,0,1
199584,therapy,0,1
199585,for,0,0
199586,postoperative,0,0
199587,pain,0,0
199588,control,0,0
199589,.,0,0
199590,The,0,0
199591,ileal,1,0
199592,bile,1,0
199593,acid,1,1
199594,transporter,1,0
199595,inhibitor,1,1
199596,A4250,1,1
199597,decreases,0,0
199598,serum,0,0
199599,bile,0,0
199600,acids,0,1
199601,by,0,0
199602,interrupting,0,0
199603,the,0,0
199604,enterohepatic,0,0
199605,circulation,0,0
199606,.,0,0
199607,BACKGROUND,0,0
199608,Reabsorption,0,0
199609,of,0,0
199610,bile,0,0
199611,acids,0,1
199612,from,0,0
199613,the,0,0
199614,intestine,0,0
199615,by,0,0
199616,ileal,0,0
199617,bile,0,0
199618,acid,0,1
199619,transporter,0,0
199620,is,0,0
199621,pivotal,0,0
199622,for,0,0
199623,the,0,0
199624,enterohepatic,0,0
199625,circulation,0,0
199626,of,0,0
199627,BAs,0,1
199628,and,0,0
199629,sterol,0,1
199630,homoeostasis,0,0
199631,.,0,0
199632,AIM,0,0
199633,To,0,0
199634,assess,0,0
199635,tolerability,0,0
199636,and,0,0
199637,study,0,0
199638,",",0,0
199639,bile,0,0
199640,acid,0,1
199641,metabolism,0,0
199642,in,0,0
199643,a,0,0
199644,phase,0,0
199645,1,0,0
199646,trial,0,0
199647,with,0,0
199648,the,0,0
199649,selective,0,0
199650,ileal,0,0
199651,bile,0,0
199652,acid,0,1
199653,transporter,0,0
199654,inhibitor,0,1
199655,A4250,0,1
199656,.,0,0
199657,METHODS,0,0
199658,A,0,0
199659,randomised,0,0
199660,double-blind,0,0
199661,",",0,0
199662,single-ascending,0,1
199663,dose,0,1
199664,(,0,1
199665,SAD,0,1
199666,),0,1
199667,and,0,0
199668,multiple-ascending-dose,0,1
199669,study,0,0
199670,consisting,0,0
199671,of,0,0
199672,five,0,0
199673,cohorts,0,0
199674,comprising,0,0
199675,40,0,0
199676,individuals,0,0
199677,with,0,0
199678,a,0,0
199679,single,0,0
199680,administration,0,0
199681,of,0,0
199682,A4250,1,1
199683,(,0,0
199684,0.1,0,0
199685,",",0,0
199686,0.3,0,0
199687,",",0,0
199688,1,0,0
199689,",",0,0
199690,3,0,0
199691,",",0,0
199692,or,0,0
199693,10,0,1
199694,mg,0,1
199695,),0,1
199696,or,1,1
199697,placebo,1,1
199698,and,0,0
199699,three,0,0
199700,cohorts,0,0
199701,comprising,0,0
199702,24,0,0
199703,individuals,0,0
199704,with,0,0
199705,a,0,0
199706,1-week,0,0
199707,administration,0,0
199708,of,1,0
199709,A4250,1,1
199710,(,0,0
199711,1,0,0
199712,or,0,1
199713,3,0,0
199714,mg,0,1
199715,once,0,0
199716,daily,0,1
199717,or,0,1
199718,1.5,0,0
199719,mg,0,1
199720,twice,0,1
199721,daily,0,1
199722,),0,0
199723,or,0,1
199724,placebo,1,1
199725,.,1,0
199726,For,1,0
199727,the,0,0
199728,multiple-ascending-dose,0,1
199729,study,0,0
199730,",",0,0
199731,bile,0,0
199732,acids,0,1
199733,were,0,0
199734,measured,0,0
199735,by,0,0
199736,HPLC-MS,0,1
199737,in,0,0
199738,plasma,0,0
199739,and,0,0
199740,faeces,0,0
199741,",",0,0
199742,and,0,0
199743,fibroblast,0,1
199744,growth,0,1
199745,factor,0,1
199746,19,0,0
199747,(,0,0
199748,FGF19,0,0
199749,),0,1
199750,and,0,0
199751,7?-hydroxy-4-cholesten-3-one,0,1
199752,(,0,0
199753,C4,0,0
199754,),0,1
199755,were,0,0
199756,measured,0,0
199757,in,0,0
199758,plasma,0,0
199759,.,0,0
199760,RESULTS,0,0
199761,No,0,0
199762,serious,0,0
199763,adverse,0,0
199764,events,0,0
199765,occurred,0,0
199766,and,0,0
199767,all,0,0
199768,participants,0,0
199769,finished,0,0
199770,the,0,0
199771,trial,0,0
199772,per,0,0
199773,protocol,0,0
199774,.,0,0
199775,At,0,0
199776,the,0,0
199777,end,0,0
199778,of,0,0
199779,the,0,0
199780,multiple-ascending-dose,0,1
199781,study,0,0
199782,",",0,0
199783,plasma,0,0
199784,total,0,0
199785,bile,0,0
199786,acids,0,1
199787,and,0,0
199788,FGF19,0,0
199789,decreased,0,0
199790,by,0,0
199791,47,0,0
199792,%,0,0
199793,and,0,0
199794,76,0,0
199795,%,0,0
199796,",",0,0
199797,respectively,0,0
199798,",",0,0
199799,at,0,0
199800,3,0,0
199801,mg/day,0,1
199802,(,0,0
199803,P,0,0
199804,<,0,0
199805,0.01,0,0
199806,),0,0
199807,",",0,0
199808,and,0,0
199809,by,0,0
199810,15,0,0
199811,%,0,0
199812,and,0,0
199813,16,0,0
199814,%,0,0
199815,",",0,0
199816,respectively,0,0
199817,",",0,0
199818,at,0,0
199819,1.5,0,0
199820,mg,0,1
199821,twice,0,1
199822,daily,0,1
199823,(,0,0
199824,P,0,0
199825,<,0,0
199826,0.05,0,0
199827,),0,0
199828,.,0,0
199829,Plasma,0,0
199830,C4,0,0
199831,and,0,0
199832,faecal,0,0
199833,bile,0,0
199834,acids,0,1
199835,increased,0,0
199836,at,0,0
199837,all,0,0
199838,dose,0,0
199839,regimens,0,1
199840,",",0,0
199841,by,0,0
199842,555,0,0
199843,%,0,0
199844,",",0,0
199845,664,0,0
199846,%,0,0
199847,",",0,0
199848,292,0,0
199849,%,0,0
199850,and,0,0
199851,338,0,0
199852,%,0,0
199853,",",0,0
199854,421,0,0
199855,%,0,0
199856,",",0,0
199857,420,0,0
199858,%,0,0
199859,",",0,0
199860,respectively,0,0
199861,(,0,0
199862,P,0,0
199863,<,0,0
199864,0.01-0.05,0,0
199865,),0,0
199866,.,0,0
199867,The,0,0
199868,primary,0,0
199869,bile,0,0
199870,acids,0,1
199871,cholic,0,0
199872,and,0,0
199873,chenodeoxycholic,0,1
199874,acids,0,1
199875,constituted,0,0
199876,the,0,0
199877,majority,0,0
199878,of,0,0
199879,faecal,0,0
199880,bile,0,0
199881,acids,0,1
199882,in,0,0
199883,the,0,0
199884,A4250-treated,0,0
199885,groups,0,0
199886,.,0,0
199887,CONCLUSIONS,0,0
199888,A4250,1,1
199889,is,1,0
199890,well,1,0
199891,tolerated,0,0
199892,.,0,0
199893,By,0,0
199894,blocking,0,0
199895,ileal,1,1
199896,bile,1,1
199897,acid,1,1
199898,transporter,1,0
199899,in,0,0
199900,the,0,0
199901,terminal,0,0
199902,ileum,0,0
199903,",",0,0
199904,it,0,0
199905,highly,0,0
199906,efficiently,0,0
199907,interrupts,0,0
199908,the,0,0
199909,enterohepatic,0,0
199910,circulation,0,0
199911,of,0,0
199912,BAs,0,1
199913,",",0,0
199914,and,0,0
199915,should,0,0
199916,be,0,0
199917,of,0,0
199918,benefit,0,0
199919,to,0,0
199920,patients,0,0
199921,with,0,0
199922,cholestatic,0,0
199923,liver,0,0
199924,diseases,0,0
199925,.,0,0
199926,Clinical,0,0
199927,Trial,0,0
199928,registration,0,0
199929,EudraCT,0,1
199930,2013-001175-21,0,0
199931,.,0,0
199932,Reducing,0,0
199933,Sitting,0,0
199934,Time,0,1
199935,After,0,0
199936,Stroke,0,1
199937,:,0,0
199938,A,0,0
199939,Phase,0,0
199940,II,0,1
199941,Safety,0,1
199942,and,0,0
199943,Feasibility,0,0
199944,Randomized,0,0
199945,Controlled,0,1
199946,Trial,0,0
199947,.,0,0
199948,OBJECTIVE,0,0
199949,To,0,0
199950,test,0,0
199951,the,0,0
199952,safety,0,0
199953,",",0,0
199954,feasibility,0,0
199955,",",0,0
199956,and,0,0
199957,effectiveness,0,0
199958,of,0,0
199959,reducing,1,0
199960,sitting,1,1
199961,time,1,0
199962,in,1,0
199963,stroke,1,0
199964,survivors,1,0
199965,.,1,0
199966,DESIGN,0,0
199967,Randomized,0,0
199968,controlled,0,0
199969,trial,0,0
199970,with,0,0
199971,attention-matched,0,0
199972,controls,0,0
199973,and,0,0
199974,blinded,0,0
199975,assessments,0,0
199976,.,0,0
199977,SETTING,0,0
199978,Community,0,0
199979,.,0,0
199980,PARTICIPANTS,0,0
199981,Stroke,0,1
199982,survivors,0,0
199983,(,0,0
199984,N=35,0,0
199985,;,0,0
199986,22,0,0
199987,men,0,0
199988,;,0,0
199989,mean,0,0
199990,age,0,0
199991,",",0,0
199992,66.9?12.7y,0,0
199993,),0,0
199994,.,0,0
199995,INTERVENTIONS,1,0
199996,Four,1,0
199997,counseling,1,1
199998,sessions,1,1
199999,over,0,0
200000,7,0,0
200001,weeks,0,0
200002,with,0,0
200003,a,0,0
200004,message,0,1
200005,of,1,0
200006,sit,1,0
200007,less,1,0
200008,and,1,0
200009,move,1,0
200010,more,1,0
200011,(,1,0
200012,intervention,1,1
200013,group,1,1
200014,),1,1
200015,or,1,1
200016,calcium,1,1
200017,for,1,0
200018,bone,1,0
200019,health,1,0
200020,(,0,1
200021,attention-matched,0,0
200022,control,0,1
200023,group,0,0
200024,),0,0
200025,.,0,0
200026,MAIN,0,0
200027,OUTCOME,0,0
200028,MEASURES,0,0
200029,Measures,0,0
200030,included,0,0
200031,safety,0,0
200032,(,0,0
200033,adverse,0,0
200034,events,0,0
200035,",",0,0
200036,increases,0,0
200037,in,0,0
200038,pain,0,0
200039,",",0,0
200040,spasticity,0,0
200041,",",0,0
200042,or,0,1
200043,fatigue,0,0
200044,),0,1
200045,and,0,1
200046,feasibility,0,0
200047,(,0,1
200048,adherence,0,0
200049,to,0,0
200050,trial,0,0
200051,protocol,0,1
200052,),0,0
200053,.,0,0
200054,Secondary,0,0
200055,measures,0,0
200056,included,0,0
200057,time,0,0
200058,spent,0,0
200059,sitting,0,1
200060,(,0,0
200061,including,0,0
200062,in,0,0
200063,prolonged,0,0
200064,bouts,0,0
200065,?30min,0,0
200066,),0,0
200067,",",0,0
200068,standing,0,0
200069,",",0,0
200070,and,0,0
200071,stepping,0,1
200072,as,0,0
200073,measured,0,0
200074,by,0,0
200075,the,0,0
200076,thigh-worn,0,1
200077,inclinometer,0,0
200078,(,0,0
200079,7d,0,1
200080,",",0,0
200081,24h/d,0,1
200082,protocol,0,1
200083,),0,1
200084,and,0,0
200085,time,0,0
200086,spent,0,0
200087,in,0,0
200088,physical,0,1
200089,activity,0,0
200090,of,0,0
200091,at,0,0
200092,least,0,0
200093,moderate,0,0
200094,intensity,0,0
200095,as,0,0
200096,measured,0,0
200097,by,0,0
200098,a,0,0
200099,triaxial,0,0
200100,accelerometer,0,0
200101,.,0,0
200102,The,0,0
200103,Multimedia,0,1
200104,Activity,0,0
200105,Recall,0,1
200106,for,0,0
200107,Children,0,0
200108,and,0,0
200109,Adults,0,0
200110,was,0,0
200111,used,0,0
200112,to,0,0
200113,describe,0,0
200114,changes,0,0
200115,in,0,0
200116,use,0,0
200117,of,0,0
200118,time,0,0
200119,.,0,0
200120,RESULTS,0,0
200121,Thirty-three,0,0
200122,participants,0,0
200123,completed,0,0
200124,the,0,0
200125,full,0,0
200126,protocol,0,0
200127,.,0,0
200128,Four,0,0
200129,participants,0,0
200130,reported,0,0
200131,falls,0,0
200132,during,0,0
200133,the,0,0
200134,intervention,0,1
200135,period,0,0
200136,with,0,0
200137,no,0,0
200138,other,0,0
200139,adverse,0,0
200140,events,0,0
200141,.,0,0
200142,From,0,0
200143,a,0,0
200144,baseline,0,0
200145,average,0,0
200146,of,0,0
200147,640.7?99.6min/d,1,1
200148,",",1,0
200149,daily,1,1
200150,sitting,1,0
200151,time,1,0
200152,reduced,1,0
200153,on,0,0
200154,average,0,0
200155,by,0,0
200156,30?50.6min/d,0,1
200157,(,0,0
200158,95,0,0
200159,%,0,0
200160,confidence,0,0
200161,interval,0,0
200162,[,0,0
200163,CI,0,0
200164,],0,0
200165,",",0,0
200166,5.8-54.6,0,0
200167,),0,0
200168,in,0,0
200169,the,0,0
200170,intervention,0,1
200171,group,0,0
200172,and,0,0
200173,40.4?92.5min/d,0,0
200174,in,0,0
200175,the,0,0
200176,control,1,1
200177,group,1,0
200178,(,0,0
200179,95,0,0
200180,%,0,0
200181,CI,0,0
200182,",",0,0
200183,13.0-93.8,0,0
200184,),0,0
200185,.,0,0
200186,Participants,0,0
200187,in,0,0
200188,both,0,0
200189,groups,0,0
200190,also,0,0
200191,reduced,0,0
200192,their,0,0
200193,time,0,0
200194,spent,0,0
200195,in,0,0
200196,prolonged,0,0
200197,sitting,0,1
200198,bouts,0,0
200199,(,0,0
200200,?30min,0,1
200201,),0,1
200202,and,0,0
200203,increased,0,0
200204,time,0,0
200205,spent,0,0
200206,standing,0,1
200207,and,0,0
200208,stepping,0,1
200209,.,0,0
200210,CONCLUSIONS,0,0
200211,Our,0,0
200212,protocol,0,0
200213,was,0,0
200214,both,0,0
200215,safe,0,0
200216,and,0,0
200217,feasible,0,0
200218,.,0,0
200219,Participants,0,0
200220,in,0,0
200221,both,0,0
200222,groups,0,0
200223,spent,0,0
200224,less,0,0
200225,time,0,0
200226,sitting,0,0
200227,and,0,0
200228,more,0,0
200229,time,0,0
200230,standing,0,0
200231,and,0,0
200232,stepping,0,1
200233,postintervention,0,0
200234,",",0,0
200235,but,0,0
200236,outcomes,0,0
200237,were,0,0
200238,not,0,0
200239,superior,0,0
200240,for,0,0
200241,intervention,0,1
200242,participants,0,0
200243,.,0,0
200244,Attention,0,0
200245,matching,0,0
200246,is,0,0
200247,desirable,0,0
200248,in,0,0
200249,clinical,0,0
200250,trials,0,0
200251,and,0,0
200252,may,0,0
200253,have,0,0
200254,contributed,0,0
200255,to,0,0
200256,the,0,0
200257,positive,0,0
200258,outcomes,0,0
200259,for,0,0
200260,control,0,0
200261,participants,0,0
200262,.,0,0
200263,Ultrasound,1,1
200264,is,0,0
200265,at,0,0
200266,least,0,0
200267,as,0,0
200268,good,0,0
200269,as,0,0
200270,magnetic,1,1
200271,resonance,1,0
200272,imaging,1,0
200273,in,0,0
200274,predicting,0,0
200275,tumour,0,0
200276,size,0,0
200277,post-neoadjuvant,0,1
200278,chemotherapy,0,1
200279,in,0,0
200280,breast,0,0
200281,cancer,0,0
200282,.,0,0
200283,BACKGROUND,0,0
200284,The,0,0
200285,aim,0,0
200286,of,0,0
200287,this,0,0
200288,study,0,0
200289,was,0,0
200290,to,0,0
200291,evaluate,0,0
200292,the,0,0
200293,accuracy,0,0
200294,of,0,0
200295,clinical,0,0
200296,imaging,0,0
200297,of,0,0
200298,the,0,0
200299,primary,1,0
200300,breast,1,0
200301,tumour,1,0
200302,post-neoadjuvant,1,1
200303,chemotherapy,1,1
200304,(,1,1
200305,NAC,1,1
200306,),1,1
200307,related,0,0
200308,to,0,0
200309,the,0,0
200310,post-neoadjuvant,0,0
200311,histological,0,0
200312,tumour,0,0
200313,size,0,0
200314,(,0,1
200315,gold,0,1
200316,standard,0,1
200317,),0,1
200318,and,0,0
200319,whether,0,0
200320,this,0,0
200321,varies,0,0
200322,with,0,0
200323,breast,0,0
200324,cancer,0,0
200325,subtype,0,0
200326,.,0,0
200327,In,0,0
200328,this,0,0
200329,study,0,0
200330,",",0,0
200331,results,0,0
200332,of,0,0
200333,both,0,0
200334,magnetic,1,1
200335,resonance,1,1
200336,imaging,1,1
200337,(,1,1
200338,MRI,1,1
200339,),1,1
200340,and,1,1
200341,ultrasound,1,1
200342,(,1,1
200343,US,1,1
200344,),1,1
200345,were,0,0
200346,reported,0,0
200347,.,0,0
200348,METHODS,0,0
200349,Patients,0,0
200350,with,0,0
200351,invasive,0,0
200352,breast,0,0
200353,cancer,0,0
200354,were,0,0
200355,enrolled,0,0
200356,in,0,0
200357,the,0,0
200358,INTENS,0,0
200359,study,0,0
200360,between,0,0
200361,2006,0,0
200362,and,0,0
200363,2009,0,0
200364,.,0,0
200365,We,0,0
200366,included,0,0
200367,182,0,0
200368,patients,0,0
200369,",",0,0
200370,of,0,0
200371,whom,0,0
200372,data,0,0
200373,were,0,0
200374,available,0,0
200375,for,0,0
200376,post-NAC,0,1
200377,MRI,1,1
200378,(,0,1
200379,n=155,0,0
200380,),0,0
200381,",",0,0
200382,US,1,1
200383,(,0,1
200384,n=123,0,0
200385,),0,1
200386,",",0,0
200387,and,0,0
200388,histopathological,0,0
200389,tumour,0,0
200390,size,0,0
200391,.,0,0
200392,RESULTS,0,0
200393,MRI,0,0
200394,estimated,0,0
200395,residual,0,0
200396,tumour,0,0
200397,size,0,0
200398,with,0,0
200399,<,0,0
200400,10-mm,0,1
200401,discordance,0,0
200402,in,0,0
200403,54,0,0
200404,%,0,0
200405,of,0,0
200406,patients,0,0
200407,",",0,0
200408,overestimated,0,0
200409,size,0,0
200410,in,0,0
200411,28,0,0
200412,%,0,0
200413,and,0,0
200414,underestimated,0,0
200415,size,0,0
200416,in,0,0
200417,18,0,0
200418,%,0,0
200419,of,0,0
200420,patients,0,0
200421,.,0,0
200422,With,0,0
200423,US,0,1
200424,",",0,0
200425,this,0,0
200426,was,0,0
200427,63,0,0
200428,%,0,0
200429,",",0,0
200430,20,0,0
200431,%,0,0
200432,and,0,0
200433,17,0,0
200434,%,0,0
200435,",",0,0
200436,respectively,0,0
200437,.,0,0
200438,The,0,0
200439,negative,0,0
200440,predictive,0,0
200441,value,0,0
200442,in,0,0
200443,hormone,0,1
200444,receptor-positive,0,1
200445,tumours,0,0
200446,for,0,0
200447,both,0,0
200448,MRI,0,1
200449,and,0,0
200450,US,0,1
200451,was,0,0
200452,low,0,0
200453,",",0,0
200454,26,0,0
200455,%,0,0
200456,and,0,0
200457,33,0,0
200458,%,0,0
200459,",",0,0
200460,respectively,0,0
200461,.,0,0
200462,The,0,0
200463,median,0,0
200464,deviation,0,0
200465,in,0,0
200466,clinical,0,0
200467,tumour,0,0
200468,size,0,0
200469,as,0,0
200470,percentage,0,0
200471,of,0,0
200472,pathological,0,0
200473,tumour,0,0
200474,was,0,0
200475,63,0,0
200476,%,0,0
200477,(,0,0
200478,P25=26,0,1
200479,",",0,0
200480,P75=100,0,1
200481,),0,1
200482,and,0,0
200483,49,0,0
200484,%,0,0
200485,(,0,0
200486,P25=22,0,1
200487,",",0,0
200488,P75=100,0,0
200489,),0,0
200490,for,0,0
200491,MRI,0,1
200492,and,0,0
200493,US,0,1
200494,",",0,0
200495,respectively,0,0
200496,(,0,0
200497,P=0.06,0,0
200498,),0,0
200499,.,0,0
200500,CONCLUSIONS,0,0
200501,In,0,0
200502,this,0,0
200503,study,0,0
200504,",",0,0
200505,US,0,1
200506,was,0,0
200507,at,0,0
200508,least,0,0
200509,as,0,0
200510,good,0,0
200511,as,0,0
200512,breast,0,0
200513,MRI,0,1
200514,in,0,0
200515,providing,0,0
200516,information,0,0
200517,on,0,0
200518,residual,0,0
200519,tumour,0,0
200520,size,0,0
200521,post-neoadjuvant,0,0
200522,chemotherapy,0,1
200523,.,0,0
200524,However,0,0
200525,",",0,0
200526,both,0,0
200527,modalities,0,1
200528,suffered,0,0
200529,from,0,0
200530,a,0,0
200531,substantial,0,0
200532,percentage,0,0
200533,of,0,0
200534,over-,0,0
200535,and,0,0
200536,underestimation,0,0
200537,of,0,0
200538,tumour,0,0
200539,size,0,0
200540,and,0,0
200541,in,0,0
200542,addition,0,0
200543,both,0,0
200544,showed,0,0
200545,a,0,0
200546,low,0,0
200547,negative,0,0
200548,predictive,0,0
200549,value,0,0
200550,of,0,0
200551,pathologic,0,0
200552,complete,0,0
200553,remission,0,0
200554,(,0,1
200555,Gov,0,0
200556,nr,0,1
200557,:,0,1
200558,NCT00314977,0,0
200559,),0,0
200560,.,0,0
200561,Covariance,1,0
200562,analysis,1,0
200563,in,0,0
200564,generalized,0,0
200565,linear,0,0
200566,measurement,0,1
200567,error,0,0
200568,models,0,0
200569,.,0,0
200570,We,0,0
200571,summarize,0,0
200572,some,0,0
200573,of,0,0
200574,the,0,0
200575,recent,0,0
200576,work,0,0
200577,on,0,0
200578,the,0,0
200579,errors-in-variables,0,0
200580,problem,0,0
200581,in,0,0
200582,generalized,0,0
200583,linear,0,0
200584,models,0,0
200585,.,0,0
200586,The,0,0
200587,focus,0,0
200588,is,0,0
200589,on,0,0
200590,covariance,0,0
200591,analysis,0,0
200592,",",0,0
200593,and,0,0
200594,in,0,0
200595,particular,0,0
200596,testing,0,1
200597,for,0,0
200598,and,0,0
200599,estimation,0,0
200600,of,0,0
200601,treatment,0,0
200602,effects,0,0
200603,.,0,0
200604,There,0,0
200605,is,0,0
200606,a,0,0
200607,considerable,0,0
200608,difference,0,0
200609,between,0,0
200610,the,0,0
200611,randomized,0,0
200612,and,0,0
200613,non-randomized,0,0
200614,models,0,0
200615,when,0,0
200616,testing,0,0
200617,for,0,0
200618,an,0,0
200619,effect,0,0
200620,.,0,0
200621,In,0,0
200622,randomized,0,0
200623,studies,0,0
200624,",",0,0
200625,simple,0,0
200626,techniques,0,1
200627,exist,0,0
200628,for,0,0
200629,testing,0,0
200630,for,0,0
200631,a,0,0
200632,treatment,0,0
200633,effect,0,0
200634,.,0,0
200635,In,0,0
200636,some,0,0
200637,instances,0,0
200638,",",0,0
200639,such,0,0
200640,as,0,0
200641,linear,0,0
200642,and,0,0
200643,multiplicative,0,1
200644,regression,0,0
200645,",",0,0
200646,simple,0,0
200647,methods,0,0
200648,exist,0,0
200649,for,0,0
200650,estimating,0,0
200651,the,0,0
200652,treatment,0,0
200653,effect,0,0
200654,.,0,0
200655,In,0,0
200656,other,0,0
200657,examples,0,0
200658,such,0,0
200659,as,0,0
200660,logistic,0,0
200661,regression,0,0
200662,",",0,0
200663,estimating,0,0
200664,a,0,0
200665,treatment,0,0
200666,effect,0,0
200667,requires,0,0
200668,careful,0,0
200669,attention,0,0
200670,to,0,0
200671,measurement,0,0
200672,error,0,0
200673,.,0,0
200674,In,0,0
200675,non-randomized,0,0
200676,studies,0,0
200677,",",0,0
200678,there,0,0
200679,is,0,0
200680,no,0,0
200681,recourse,0,0
200682,to,0,0
200683,understanding,0,0
200684,and,0,0
200685,modelling,0,0
200686,measurement,0,1
200687,error,0,0
200688,.,0,0
200689,In,0,0
200690,particular,0,0
200691,ignoring,0,0
200692,measurement,0,1
200693,error,0,0
200694,can,0,0
200695,lead,0,0
200696,to,0,0
200697,the,0,0
200698,wrong,0,0
200699,conclusions,0,0
200700,",",0,0
200701,for,0,0
200702,example,0,0
200703,the,0,0
200704,true,0,0
200705,but,0,0
200706,unobserved,0,0
200707,data,0,0
200708,may,0,0
200709,indicate,0,0
200710,a,0,0
200711,positive,0,0
200712,effect,0,0
200713,for,0,0
200714,treatment,0,0
200715,",",0,0
200716,while,0,0
200717,the,0,0
200718,observed,0,0
200719,data,0,0
200720,indicate,0,0
200721,the,0,0
200722,opposite,0,0
200723,.,0,0
200724,Some,0,0
200725,of,0,0
200726,the,0,0
200727,possible,0,0
200728,methods,0,0
200729,are,0,0
200730,outlined,0,0
200731,and,0,0
200732,compared,0,0
200733,.,0,0
200734,Propranolol,1,1
200735,in,0,0
200736,acute,0,0
200737,myocardial,0,0
200738,infarction,0,0
200739,:,0,0
200740,the,0,0
200741,MILIS,0,0
200742,experience,0,0
200743,.,0,0
200744,The,0,0
200745,results,0,0
200746,of,0,0
200747,the,0,0
200748,propranolol,1,1
200749,limb,0,0
200750,of,0,0
200751,the,0,0
200752,Multicenter,0,0
200753,Investigation,0,0
200754,of,0,0
200755,the,0,0
200756,Limitation,0,0
200757,of,0,0
200758,Infarct,0,0
200759,Size,0,0
200760,are,0,0
200761,reviewed,0,0
200762,.,0,0
200763,A,0,0
200764,total,0,0
200765,of,0,0
200766,269,0,0
200767,patients,0,0
200768,",",0,0
200769,who,0,0
200770,presented,0,0
200771,with,0,0
200772,symptoms,0,0
200773,and,0,0
200774,electrocardiographic,0,0
200775,signs,0,0
200776,suggesting,0,0
200777,acute,0,0
200778,myocardial,0,0
200779,infarction,0,0
200780,were,0,0
200781,randomized,0,0
200782,to,0,0
200783,acute,0,0
200784,intravenous,0,1
200785,and,0,0
200786,subsequent,0,0
200787,oral,0,1
200788,therapy,0,1
200789,with,0,1
200790,propranolol,1,1
200791,(,0,0
200792,n,0,0
200793,=,0,0
200794,134,0,0
200795,),0,0
200796,or,1,1
200797,placebo,1,1
200798,(,0,1
200799,n,0,0
200800,=,0,0
200801,135,0,0
200802,),0,0
200803,.,0,0
200804,Eligibility,0,0
200805,for,0,0
200806,acute,0,0
200807,beta-blocker,0,1
200808,therapy,0,1
200809,was,0,0
200810,determined,0,0
200811,on,0,0
200812,the,0,0
200813,basis,0,0
200814,of,0,0
200815,readily,0,0
200816,available,0,0
200817,",",0,0
200818,noninvasive,0,0
200819,tests,0,0
200820,.,0,0
200821,Therapy,0,0
200822,was,0,0
200823,started,0,0
200824,at,0,0
200825,an,0,0
200826,average,0,0
200827,time,0,0
200828,of,0,0
200829,8.5,0,0
200830,hours,0,0
200831,after,0,0
200832,onset,0,0
200833,of,0,0
200834,symptoms,0,0
200835,.,0,0
200836,The,0,0
200837,full,0,0
200838,induction,0,0
200839,dose,0,0
200840,of,0,0
200841,intravenous,0,1
200842,propranolol,1,1
200843,(,0,0
200844,0.1,0,1
200845,mg/kg,0,1
200846,),0,0
200847,was,0,0
200848,tolerated,0,0
200849,by,0,0
200850,90,0,0
200851,%,0,0
200852,of,0,0
200853,treated,0,0
200854,patients,0,0
200855,",",0,0
200856,and,0,0
200857,oral,0,1
200858,maintenance,0,0
200859,therapy,0,1
200860,was,0,0
200861,being,0,0
200862,continued,0,0
200863,in,0,0
200864,82,0,0
200865,%,0,0
200866,of,0,0
200867,treated,0,0
200868,patients,0,0
200869,on,0,0
200870,the,0,0
200871,second,0,0
200872,hospital,0,0
200873,day,0,0
200874,.,0,0
200875,There,0,0
200876,was,0,0
200877,a,0,0
200878,significant,0,0
200879,reduction,0,0
200880,in,0,0
200881,heart,0,0
200882,rate,0,0
200883,throughout,0,0
200884,maintenance,0,0
200885,therapy,0,1
200886,with,0,0
200887,propranolol,0,1
200888,",",0,0
200889,which,0,0
200890,continued,0,0
200891,through,0,0
200892,the,0,0
200893,tenth,0,0
200894,hospital,0,0
200895,day,0,0
200896,.,0,0
200897,There,0,0
200898,was,0,0
200899,no,0,0
200900,significant,0,0
200901,difference,0,0
200902,in,0,0
200903,the,0,0
200904,incidence,0,0
200905,of,0,0
200906,congestive,0,0
200907,heart,0,0
200908,failure,0,0
200909,between,0,0
200910,propranolol-,1,1
200911,and,0,0
200912,placebo-treated,1,0
200913,groups,0,0
200914,.,0,0
200915,There,0,0
200916,was,0,0
200917,also,0,0
200918,no,0,0
200919,significant,0,0
200920,difference,0,0
200921,between,0,0
200922,the,0,0
200923,2,0,0
200924,groups,0,0
200925,in,0,0
200926,infarct,0,0
200927,size,0,0
200928,estimated,0,0
200929,by,0,0
200930,measurement,0,0
200931,of,0,0
200932,serum,0,0
200933,CK-MB,0,0
200934,",",0,0
200935,planimetry,0,0
200936,of,0,0
200937,infarct,0,0
200938,area,0,0
200939,on,0,0
200940,technetium,0,1
200941,pyrophosphate,0,1
200942,myocardial,0,0
200943,scintigrams,0,1
200944,or,0,0
200945,R-wave,0,1
200946,measurements,0,0
200947,in,0,0
200948,patients,0,0
200949,with,0,0
200950,transmural,0,0
200951,anterior,0,0
200952,and,0,0
200953,inferior,0,0
200954,infarcts,0,0
200955,.,0,0
200956,There,0,0
200957,was,0,0
200958,no,0,0
200959,significant,0,0
200960,difference,0,0
200961,in,0,0
200962,mortality,0,0
200963,between,0,0
200964,the,0,0
200965,2,0,0
200966,groups,0,0
200967,during,0,0
200968,an,0,0
200969,average,0,0
200970,of,0,0
200971,36,0,0
200972,months,0,0
200973,',0,0
200974,follow-up,0,0
200975,.,0,0
200976,Although,0,0
200977,propranolol,1,1
200978,can,0,0
200979,be,0,0
200980,administered,0,0
200981,safely,0,0
200982,to,0,0
200983,patients,0,0
200984,with,0,0
200985,acute,0,0
200986,myocardial,0,0
200987,infarction,0,0
200988,who,0,0
200989,are,0,0
200990,selected,0,0
200991,on,0,0
200992,the,0,0
200993,basis,0,0
200994,of,0,0
200995,simple,0,0
200996,clinical,0,0
200997,criteria,0,0
200998,",",0,0
200999,there,0,0
201000,is,0,0
201001,no,0,0
201002,evidence,0,0
201003,of,0,0
201004,reduction,0,0
201005,of,0,0
201006,infarct,0,0
201007,size,0,0
201008,when,0,0
201009,beta,0,1
201010,blockade,0,1
201011,is,0,0
201012,begun,0,0
201013,8.5,0,0
201014,hours,0,0
201015,after,0,0
201016,the,0,0
201017,onset,0,0
201018,of,0,0
201019,symptoms,0,0
201020,.,0,0
201021,Comparative,0,0
201022,efficacy,0,0
201023,of,0,0
201024,oral,1,1
201025,erythromycin,1,1
201026,versus,1,1
201027,oral,1,1
201028,tetracycline,1,1
201029,in,0,0
201030,the,0,0
201031,treatment,0,0
201032,of,0,0
201033,acne,0,0
201034,vulgaris,0,0
201035,.,0,0
201036,A,0,0
201037,double-blind,0,0
201038,study,0,0
201039,.,0,0
201040,The,0,0
201041,efficacy,0,0
201042,of,0,0
201043,erythromycin,1,1
201044,base,1,0
201045,(,0,0
201046,E-Mycin,0,1
201047,tablets,0,1
201048,",",0,0
201049,333,0,0
201050,mg,0,1
201051,),0,0
201052,and,0,0
201053,the,0,0
201054,efficacy,0,0
201055,of,0,0
201056,tetracycline,1,1
201057,hydrochloride,1,1
201058,(,0,0
201059,Panmycin,0,1
201060,tablets,0,1
201061,),0,0
201062,were,0,0
201063,compared,0,0
201064,in,0,0
201065,this,0,0
201066,double-blind,0,0
201067,",",0,0
201068,randomized,0,0
201069,study,0,0
201070,.,0,0
201071,Two,0,0
201072,hundred,0,0
201073,patients,0,0
201074,with,0,0
201075,moderate,0,0
201076,to,0,0
201077,moderately,0,0
201078,severe,0,0
201079,acne,0,0
201080,vulgaris,0,0
201081,were,0,0
201082,randomly,0,0
201083,assigned,0,0
201084,to,0,0
201085,the,0,0
201086,study,0,0
201087,.,0,0
201088,One,0,0
201089,hundred,0,0
201090,patients,0,0
201091,received,0,0
201092,1,1,0
201093,gm,1,1
201094,of,1,0
201095,erythromycin,1,1
201096,base,1,0
201097,by,0,0
201098,mouth,0,0
201099,per,0,0
201100,day,0,0
201101,for,0,0
201102,4,0,0
201103,weeks,0,0
201104,",",0,0
201105,followed,0,0
201106,by,0,0
201107,333,0,0
201108,mg/day,0,1
201109,for,0,0
201110,8,0,0
201111,weeks,0,0
201112,",",0,0
201113,plus,0,1
201114,placebo,1,1
201115,for,1,0
201116,tetracycline,1,1
201117,.,1,0
201118,The,0,0
201119,second,0,0
201120,group,0,0
201121,of,0,0
201122,patients,0,0
201123,received,0,0
201124,1,0,0
201125,gm,0,1
201126,of,0,0
201127,tetracycline,1,1
201128,by,0,0
201129,mouth,0,0
201130,per,0,0
201131,day,0,0
201132,for,0,0
201133,4,0,0
201134,weeks,0,0
201135,",",0,0
201136,followed,0,0
201137,by,0,0
201138,500,0,1
201139,mg/day,0,1
201140,for,0,0
201141,8,0,0
201142,weeks,0,0
201143,",",0,0
201144,plus,0,1
201145,placebo,1,1
201146,for,1,0
201147,erythromycin,1,1
201148,.,1,0
201149,Both,0,0
201150,drugs,0,0
201151,reduced,0,0
201152,acne,0,0
201153,severity,0,0
201154,to,0,0
201155,the,0,0
201156,same,0,0
201157,extent,0,0
201158,.,0,0
201159,Pustules,0,0
201160,",",0,0
201161,papules,0,0
201162,",",0,0
201163,and,0,0
201164,open,0,1
201165,comedo,0,0
201166,counts,0,0
201167,decreased,0,0
201168,significantly,0,0
201169,over,0,0
201170,the,0,0
201171,12-week,0,0
201172,period,0,0
201173,.,0,0
201174,Seventy-seven,0,0
201175,percent,0,0
201176,of,0,0
201177,the,0,0
201178,erythromycin-treated,0,1
201179,patients,0,0
201180,and,0,0
201181,89,0,0
201182,%,0,0
201183,of,0,0
201184,the,0,0
201185,tetracycline-treated,0,0
201186,patients,0,0
201187,stated,0,0
201188,that,0,0
201189,their,0,0
201190,acne,0,0
201191,was,0,0
201192,markedly,0,0
201193,improved,0,0
201194,or,0,1
201195,improved,0,0
201196,by,0,0
201197,week,0,0
201198,12,0,0
201199,.,0,0
201200,Most,0,0
201201,of,0,0
201202,the,0,0
201203,side,0,0
201204,effects,0,0
201205,in,0,0
201206,patients,0,0
201207,treated,0,0
201208,with,0,0
201209,erythromycin,0,1
201210,were,0,0
201211,gastrointestinal,0,0
201212,symptoms,0,0
201213,.,0,0
201214,Among,0,0
201215,the,0,0
201216,side,0,0
201217,effects,0,0
201218,in,0,0
201219,patients,0,0
201220,treated,0,0
201221,with,0,0
201222,tetracycline,0,1
201223,were,0,0
201224,Candida,0,0
201225,vaginitis,0,0
201226,in,0,0
201227,one,0,0
201228,patient,0,0
201229,and,0,0
201230,pseudotumor,0,0
201231,cerebri,0,0
201232,in,0,0
201233,one,0,0
201234,patient,0,0
201235,.,0,0
201236,Prevention,0,1
201237,of,0,0
201238,subsequent,0,0
201239,exercise-induced,0,0
201240,periinfarct,0,0
201241,ischemia,0,0
201242,by,0,0
201243,emergency,1,1
201244,coronary,1,0
201245,angioplasty,1,1
201246,in,0,0
201247,acute,0,0
201248,myocardial,0,0
201249,infarction,0,0
201250,:,0,0
201251,comparison,0,0
201252,with,0,0
201253,intracoronary,1,1
201254,streptokinase,1,1
201255,.,1,0
201256,To,0,0
201257,compare,0,0
201258,the,0,0
201259,efficacy,0,0
201260,of,0,0
201261,emergency,1,1
201262,percutaneous,1,1
201263,transluminal,1,1
201264,coronary,1,0
201265,angioplasty,1,1
201266,and,1,0
201267,intracoronary,1,1
201268,streptokinase,1,1
201269,in,0,0
201270,preventing,0,0
201271,exercise-induced,0,0
201272,periinfarct,0,0
201273,ischemia,0,0
201274,",",0,0
201275,28,0,0
201276,patients,0,0
201277,presenting,0,0
201278,within,0,0
201279,12,0,0
201280,hours,0,0
201281,of,0,0
201282,the,0,0
201283,onset,0,0
201284,of,0,0
201285,symptoms,0,0
201286,of,0,0
201287,acute,0,0
201288,myocardial,0,0
201289,infarction,0,0
201290,were,0,0
201291,prospectively,0,0
201292,randomized,0,0
201293,.,0,0
201294,Of,0,0
201295,these,0,0
201296,",",0,0
201297,14,0,0
201298,patients,0,0
201299,were,0,0
201300,treated,0,0
201301,with,0,0
201302,emergency,1,1
201303,angioplasty,1,1
201304,and,0,0
201305,14,0,0
201306,patients,0,0
201307,received,0,0
201308,intracoronary,1,1
201309,streptokinase,1,1
201310,.,1,1
201311,Recatheterization,1,0
201312,and,1,0
201313,submaximal,1,1
201314,exercise,1,1
201315,thallium-201,1,1
201316,single,1,1
201317,photon,1,1
201318,emission,1,0
201319,computed,1,0
201320,tomography,1,1
201321,were,0,0
201322,performed,0,0
201323,before,0,0
201324,hospital,0,0
201325,discharge,0,0
201326,.,0,0
201327,Periinfarct,0,0
201328,ischemia,0,0
201329,was,0,0
201330,defined,0,0
201331,as,0,0
201332,a,0,0
201333,reversible,0,0
201334,thallium,0,1
201335,defect,0,0
201336,adjacent,0,0
201337,to,0,0
201338,a,0,0
201339,fixed,0,1
201340,defect,0,0
201341,assessed,0,0
201342,qualitatively,0,0
201343,.,0,0
201344,Successful,0,0
201345,reperfusion,0,0
201346,was,0,0
201347,achieved,0,0
201348,in,0,0
201349,86,0,0
201350,%,0,0
201351,of,0,0
201352,patients,0,0
201353,treated,0,0
201354,with,0,0
201355,emergency,1,1
201356,angioplasty,1,1
201357,and,0,0
201358,86,0,0
201359,%,0,0
201360,of,0,0
201361,patients,0,0
201362,treated,0,0
201363,with,0,0
201364,intracoronary,0,1
201365,streptokinase,1,1
201366,(,0,0
201367,p,0,0
201368,=,0,0
201369,NS,0,0
201370,),0,0
201371,.,0,0
201372,Residual,0,0
201373,stenosis,0,0
201374,of,0,0
201375,the,0,0
201376,infarct-related,0,0
201377,coronary,0,0
201378,artery,0,0
201379,shown,0,0
201380,at,0,0
201381,predischarge,0,0
201382,angiography,0,1
201383,was,0,0
201384,43.8,0,0
201385,+/-,0,0
201386,31.4,0,0
201387,%,0,0
201388,for,0,0
201389,the,0,0
201390,angioplasty,0,1
201391,group,0,0
201392,and,0,0
201393,75.0,0,0
201394,+/-,0,0
201395,15.6,0,0
201396,%,0,0
201397,for,0,0
201398,the,0,0
201399,streptokinase,0,1
201400,group,0,0
201401,(,0,0
201402,p,0,0
201403,less,0,0
201404,than,0,0
201405,0.05,0,0
201406,),0,0
201407,.,0,0
201408,Of,0,0
201409,the,0,0
201410,angioplasty,0,1
201411,group,0,0
201412,",",0,0
201413,9,0,0
201414,%,0,0
201415,developed,0,0
201416,exercise-induced,0,0
201417,periinfarct,0,0
201418,ischemia,0,0
201419,compared,0,0
201420,with,0,0
201421,60,0,0
201422,%,0,0
201423,of,0,0
201424,the,0,0
201425,streptokinase,0,1
201426,group,0,0
201427,(,0,0
201428,p,0,0
201429,less,0,0
201430,than,0,0
201431,0.05,0,0
201432,),0,0
201433,.,0,0
201434,Thus,0,0
201435,",",0,0
201436,patients,0,0
201437,with,0,0
201438,acute,0,0
201439,myocardial,0,0
201440,infarction,0,0
201441,treated,0,0
201442,with,0,0
201443,emergency,0,1
201444,angioplasty,0,1
201445,had,0,0
201446,significantly,0,0
201447,less,0,0
201448,severe,0,0
201449,residual,0,0
201450,coronary,0,0
201451,stenosis,0,0
201452,and,0,0
201453,exercise-induced,0,0
201454,periinfarct,0,0
201455,ischemia,0,0
201456,than,0,0
201457,did,0,0
201458,those,0,0
201459,treated,0,0
201460,with,0,0
201461,intracoronary,0,1
201462,streptokinase,1,1
201463,.,1,0
201464,These,0,0
201465,results,0,0
201466,suggest,0,0
201467,further,0,0
201468,application,0,1
201469,of,0,0
201470,coronary,1,0
201471,angioplasty,1,1
201472,in,0,0
201473,the,0,0
201474,management,0,1
201475,of,0,0
201476,acute,0,0
201477,myocardial,0,0
201478,infarction,0,0
201479,.,0,0
201480,[,0,1
201481,Therapeutic,0,1
201482,value,0,0
201483,of,0,0
201484,a,0,0
201485,combination,0,1
201486,of,0,0
201487,trimetazidine,1,1
201488,with,0,0
201489,a,0,0
201490,calcium,0,1
201491,inhibitor,0,1
201492,in,0,0
201493,the,0,0
201494,treatment,0,0
201495,of,0,0
201496,chronic,0,0
201497,coronary,0,0
201498,insufficiency,0,0
201499,],0,0
201500,.,0,0
201501,This,0,0
201502,double-blind,0,0
201503,",",0,0
201504,placebo-controlled,0,1
201505,study,0,0
201506,sought,0,0
201507,to,0,0
201508,examine,0,0
201509,the,0,0
201510,short-term,0,0
201511,benefit,0,0
201512,of,0,0
201513,adding,0,0
201514,60,0,0
201515,mg,0,1
201516,of,0,0
201517,trimetazidine,1,1
201518,to,0,0
201519,the,0,0
201520,daily,0,1
201521,therapeutic,0,0
201522,regimen,0,1
201523,of,0,0
201524,29,0,0
201525,male,0,0
201526,patients,0,0
201527,with,0,0
201528,coronary,0,0
201529,insufficiency,0,0
201530,who,0,0
201531,had,0,0
201532,persistent,0,0
201533,ST,0,0
201534,depression,0,0
201535,on,0,0
201536,exercise,0,1
201537,tolerance,0,0
201538,test,0,0
201539,(,0,0
201540,greater,0,0
201541,than,0,0
201542,or,0,0
201543,equal,0,0
201544,to,0,0
201545,1,0,0
201546,mm,0,0
201547,),0,0
201548,",",0,0
201549,despite,0,0
201550,treatment,0,0
201551,with,0,0
201552,nifedipine,1,1
201553,40,0,0
201554,mg,0,1
201555,per,0,0
201556,day,0,0
201557,.,0,0
201558,As,0,0
201559,compared,0,0
201560,with,0,0
201561,the,0,0
201562,placebo,1,1
201563,group,0,0
201564,",",0,0
201565,after,0,0
201566,only,0,0
201567,14,0,0
201568,days,0,0
201569,",",0,0
201570,the,0,0
201571,patients,0,0
201572,treated,0,0
201573,with,0,0
201574,trimetazidine,0,1
201575,showed,0,0
201576,statistically,0,0
201577,significant,0,0
201578,increases,0,0
201579,in,0,0
201580,the,0,0
201581,maximum,0,0
201582,workload,0,0
201583,level,0,0
201584,attained,0,0
201585,before,0,0
201586,ST,0,0
201587,depression,0,1
201588,occurred,0,0
201589,(,0,0
201590,31,0,0
201591,%,0,0
201592,versus,0,0
201593,-,0,0
201594,6,0,0
201595,%,0,0
201596,;,0,0
201597,P,0,0
201598,=,0,0
201599,0.009,0,0
201600,),0,0
201601,",",0,0
201602,the,0,0
201603,total,0,0
201604,work,0,0
201605,performed,0,1
201606,(,0,0
201607,31,0,0
201608,%,0,0
201609,versus,0,1
201610,2,0,0
201611,%,0,0
201612,;,0,0
201613,P,0,0
201614,=,0,0
201615,0.024,0,0
201616,),0,0
201617,and,0,0
201618,a,0,0
201619,significant,0,0
201620,decrease,0,0
201621,in,0,0
201622,the,0,0
201623,systolic,0,0
201624,tension,0,1
201625,time,0,0
201626,(,0,1
201627,double,0,1
201628,product,0,1
201629,),0,1
201630,/workload,0,1
201631,ratio,0,0
201632,(,0,0
201633,-5,0,0
201634,%,0,0
201635,versus,0,1
201636,+11,0,1
201637,%,0,0
201638,;,0,0
201639,P,0,0
201640,=,0,0
201641,0.005,0,0
201642,),0,0
201643,.,0,0
201644,Throughout,0,0
201645,the,0,0
201646,study,0,0
201647,the,0,0
201648,clinical,0,0
201649,acceptability,0,0
201650,was,0,0
201651,excellent,0,0
201652,",",0,0
201653,with,0,0
201654,no,0,0
201655,side,0,0
201656,effects,0,0
201657,attributable,0,0
201658,to,0,0
201659,trimetazidine,0,1
201660,being,0,0
201661,recorded,0,0
201662,.,0,0
201663,This,0,0
201664,study,0,0
201665,shows,0,0
201666,that,0,0
201667,the,0,0
201668,addition,0,0
201669,of,0,0
201670,trimetazidine,0,1
201671,to,0,0
201672,a,0,0
201673,calcium,0,1
201674,antagonist,0,1
201675,brings,0,0
201676,a,0,0
201677,valuable,0,0
201678,improvement,0,0
201679,in,0,0
201680,therapeutic,0,0
201681,results,0,0
201682,.,0,0
201683,No,0,0
201684,effect,0,0
201685,of,0,0
201686,acetylsalicylic,1,1
201687,acid,1,1
201688,on,0,0
201689,B-thromboglobulin,0,1
201690,and,0,0
201691,platelet,0,0
201692,factor,0,0
201693,4,0,0
201694,plasma,0,0
201695,levels,0,0
201696,in,0,0
201697,patients,0,0
201698,with,0,0
201699,transient,0,0
201700,ischaemic,0,0
201701,attacks,0,0
201702,.,0,0
201703,We,0,0
201704,studied,0,0
201705,the,0,0
201706,effect,0,0
201707,of,0,0
201708,acetylsalicylic,1,1
201709,acid,1,1
201710,(,1,1
201711,ASA,1,1
201712,),1,1
201713,versus,1,1
201714,placebo,1,1
201715,on,0,0
201716,B-thromboglobulin,0,1
201717,(,0,1
201718,B-TG,0,1
201719,),0,1
201720,and,0,0
201721,platelet,0,0
201722,factor,0,1
201723,4,0,1
201724,(,0,0
201725,PF4,0,1
201726,),0,1
201727,plasma,0,0
201728,levels,0,0
201729,and,0,0
201730,ADP-induced,0,0
201731,platelet,0,0
201732,aggregation,0,0
201733,in,0,0
201734,25,0,0
201735,male,0,0
201736,patients,0,0
201737,with,0,0
201738,transient,0,0
201739,ischaemic,0,1
201740,attacks,0,0
201741,(,0,0
201742,TIA,0,0
201743,),0,0
201744,.,0,0
201745,The,0,0
201746,patients,0,0
201747,were,0,0
201748,allocated,0,0
201749,randomly,0,0
201750,to,0,0
201751,two,0,0
201752,groups,0,0
201753,:,0,0
201754,14,0,0
201755,patients,0,0
201756,received,0,0
201757,oral,0,1
201758,treatment,0,0
201759,with,0,0
201760,ASA,1,1
201761,500,0,1
201762,mg,0,1
201763,b.i.d,0,1
201764,.,0,0
201765,for,0,0
201766,14,0,0
201767,days,0,0
201768,",",0,0
201769,11,0,0
201770,patients,0,0
201771,placebo,1,1
201772,b.i.d,0,1
201773,.,0,0
201774,for,0,0
201775,the,0,0
201776,same,0,0
201777,period,0,0
201778,.,0,1
201779,B-TG,0,0
201780,and,0,0
201781,PF4,0,1
201782,plasma,0,0
201783,levels,0,0
201784,and,0,0
201785,ADP-induced,0,0
201786,platelet,0,0
201787,aggregation,0,0
201788,were,0,0
201789,determined,0,0
201790,in,0,0
201791,basal,0,0
201792,conditions,0,0
201793,",",0,0
201794,and,0,0
201795,two,0,0
201796,hours,0,0
201797,",",0,0
201798,and,0,0
201799,seven,0,0
201800,and,0,0
201801,fourteen,0,0
201802,days,0,0
201803,after,0,0
201804,starting,0,0
201805,with,0,0
201806,ASA,0,1
201807,or,0,1
201808,placebo,0,1
201809,.,0,0
201810,In,0,0
201811,addition,0,0
201812,",",0,0
201813,the,0,0
201814,same,0,0
201815,parameters,0,0
201816,were,0,0
201817,studied,0,0
201818,in,0,0
201819,a,0,0
201820,group,0,0
201821,of,0,0
201822,20,0,0
201823,healthy,0,0
201824,males,0,0
201825,of,0,0
201826,matched,0,0
201827,age,0,0
201828,.,0,0
201829,Basal,0,0
201830,levels,0,0
201831,of,0,0
201832,plasma,0,0
201833,B-TG,0,1
201834,and,0,0
201835,PF4,0,1
201836,and,0,0
201837,the,0,0
201838,maximal,0,0
201839,amplitude,0,0
201840,of,0,0
201841,ADP-induced,0,0
201842,platelet,0,0
201843,aggregation,0,0
201844,were,0,0
201845,abnormally,0,0
201846,high,0,0
201847,in,0,0
201848,TIA,0,0
201849,patients,0,0
201850,.,0,0
201851,ASA,0,0
201852,caused,0,0
201853,a,0,0
201854,significant,0,0
201855,reduction,0,0
201856,of,0,0
201857,B-TG,0,1
201858,plasma,0,0
201859,levels,0,0
201860,in,0,0
201861,TIA,0,0
201862,patients,0,0
201863,2,0,0
201864,hours,0,0
201865,after,0,0
201866,the,0,0
201867,first,0,0
201868,administration,0,0
201869,",",0,0
201870,but,0,0
201871,no,0,0
201872,effect,0,0
201873,was,0,0
201874,observed,0,0
201875,at,0,0
201876,the,0,0
201877,7th,0,0
201878,and,0,0
201879,14th,0,0
201880,day,0,0
201881,of,0,0
201882,treatment,0,0
201883,.,0,0
201884,PF4,0,1
201885,plasma,0,0
201886,levels,0,0
201887,were,0,0
201888,unaffected,0,0
201889,by,0,0
201890,ASA,0,1
201891,treatment,0,0
201892,.,0,0
201893,It,0,0
201894,is,0,0
201895,concluded,0,0
201896,that,0,0
201897,ASA,0,1
201898,",",0,0
201899,at,0,0
201900,the,0,0
201901,dose,0,0
201902,conventionally,0,0
201903,used,0,0
201904,in,0,0
201905,clinical,0,0
201906,trials,0,0
201907,",",0,0
201908,does,0,0
201909,not,0,0
201910,affect,0,0
201911,the,0,0
201912,release,0,0
201913,of,0,0
201914,two,0,0
201915,alpha-granule,0,0
201916,proteins,0,0
201917,.,0,0
201918,Placebo-controlled,0,0
201919,study,0,0
201920,of,0,0
201921,oral,1,1
201922,enoximone,1,1
201923,in,0,0
201924,congestive,0,0
201925,heart,0,0
201926,failure,0,0
201927,with,0,0
201928,initial,0,0
201929,and,0,0
201930,final,0,0
201931,intravenous,0,1
201932,hemodynamic,0,0
201933,evaluation,0,0
201934,.,0,0
201935,Seventeen,0,0
201936,patients,0,0
201937,with,0,0
201938,stable,0,0
201939,congestive,0,0
201940,heart,0,0
201941,failure,0,0
201942,(,0,1
201943,class,0,0
201944,II,0,1
201945,and,0,0
201946,III,0,0
201947,New,0,1
201948,York,0,1
201949,Heart,0,1
201950,Association,0,0
201951,),0,0
201952,received,0,1
201953,intravenous,0,1
201954,and,0,0
201955,oral,0,1
201956,enoximone,1,1
201957,in,0,0
201958,a,0,0
201959,2-part,0,0
201960,study,0,0
201961,.,0,0
201962,Hemodynamic,0,0
201963,data,0,0
201964,were,0,0
201965,first,0,0
201966,obtained,0,0
201967,after,0,0
201968,intravenous,1,1
201969,administration,1,0
201970,of,1,0
201971,0.75,1,0
201972,mg/kg,1,1
201973,of,1,0
201974,enoximone,1,1
201975,;,1,0
201976,data,1,0
201977,were,1,0
201978,again,1,0
201979,obtained,1,0
201980,after,1,0
201981,12,1,0
201982,weeks,1,0
201983,of,1,0
201984,therapy,1,1
201985,with,1,0
201986,either,1,1
201987,oral,1,1
201988,enoximone,1,1
201989,(,1,0
201990,150,1,0
201991,mg,1,1
201992,3,1,0
201993,times,1,0
201994,daily,1,1
201995,),1,0
201996,or,1,1
201997,placebo,1,1
201998,.,1,0
201999,The,0,0
202000,efficacy,0,0
202001,and,0,0
202002,safety,0,0
202003,of,0,0
202004,oral,1,1
202005,enoximone,1,1
202006,were,0,0
202007,also,0,0
202008,studied,0,0
202009,in,0,0
202010,a,0,0
202011,12-week,0,0
202012,",",0,0
202013,double-blind,0,0
202014,randomized,0,0
202015,format,0,1
202016,.,0,0
202017,In,0,0
202018,the,0,0
202019,intravenous,0,1
202020,study,0,0
202021,",",0,0
202022,enoximone,1,1
202023,was,1,0
202024,delivered,1,0
202025,over,1,0
202026,5,1,0
202027,minutes,1,0
202028,and,1,0
202029,hemodynamic,1,0
202030,data,1,0
202031,were,1,0
202032,measured,1,0
202033,for,1,0
202034,up,1,0
202035,to,1,0
202036,12,1,0
202037,hours,1,0
202038,after,1,0
202039,.,1,0
202040,Cardiac,0,0
202041,index,0,0
202042,increased,0,0
202043,2.76,0,0
202044,+/-,0,0
202045,0.63,0,0
202046,to,0,0
202047,3.42,0,0
202048,+/-,0,0
202049,0.72,0,0
202050,liters/min/m2,0,0
202051,),0,0
202052,",",0,0
202053,pulmonary,0,0
202054,wedge,0,1
202055,pressure,0,1
202056,decreased,0,0
202057,(,0,0
202058,19.5,0,0
202059,+/-,0,0
202060,8.8,0,0
202061,to,0,0
202062,14.6,0,0
202063,+/-,0,0
202064,8.0,0,0
202065,mm,0,0
202066,Hg,0,0
202067,),0,0
202068,as,0,0
202069,did,0,0
202070,mean,0,0
202071,arterial,0,0
202072,blood,0,0
202073,pressure,0,0
202074,(,0,0
202075,101,0,0
202076,+/-,0,0
202077,14.8,0,0
202078,to,0,0
202079,85,0,0
202080,+/-,0,0
202081,13.7,0,0
202082,mm,0,0
202083,Hg,0,0
202084,),0,1
202085,and,0,0
202086,systemic,0,0
202087,vascular,0,0
202088,resistance,0,0
202089,(,0,0
202090,"1,880",0,0
202091,+/-,0,0
202092,573,0,0
202093,to,0,0
202094,"1,254",0,0
202095,+/-,0,0
202096,383,0,0
202097,dynes,0,1
202098,s,0,0
202099,cm-5,0,0
202100,),0,0
202101,.,0,0
202102,Heart,0,0
202103,rate,0,0
202104,increased,0,0
202105,slightly,0,0
202106,(,0,0
202107,82,0,0
202108,+/-,0,0
202109,17,0,0
202110,to,0,0
202111,86,0,0
202112,+/-,0,0
202113,14,0,0
202114,beats/min,0,0
202115,),0,0
202116,.,0,0
202117,All,0,0
202118,these,0,0
202119,changes,0,0
202120,were,0,0
202121,maximal,0,0
202122,1,0,0
202123,to,0,0
202124,2,0,0
202125,hours,0,0
202126,after,0,0
202127,infusion,0,1
202128,and,0,0
202129,lasted,0,0
202130,8,0,0
202131,hours,0,0
202132,at,0,0
202133,least,0,0
202134,.,0,0
202135,Patients,0,0
202136,were,0,0
202137,then,0,0
202138,randomized,0,0
202139,double-blind,0,0
202140,to,0,0
202141,oral,0,1
202142,treatment,0,0
202143,.,0,0
202144,Baseline,0,0
202145,values,0,0
202146,showed,0,0
202147,that,0,0
202148,the,0,0
202149,7,0,0
202150,patients,0,0
202151,who,0,0
202152,received,0,0
202153,placebo,1,1
202154,had,0,0
202155,more,0,0
202156,severe,0,0
202157,CHF,0,0
202158,.,0,0
202159,Therefore,0,0
202160,",",0,0
202161,comparison,0,0
202162,might,0,0
202163,be,0,0
202164,biased,0,0
202165,.,0,0
202166,Patient,0,0
202167,overall,0,0
202168,assessment,0,0
202169,showed,0,0
202170,a,0,0
202171,continuous,0,1
202172,benefit,0,0
202173,in,0,0
202174,both,0,0
202175,groups,0,0
202176,.,0,0
202177,Ejection,0,0
202178,fraction,0,0
202179,improved,0,0
202180,from,0,0
202181,30.1,0,0
202182,+/-,0,0
202183,6.8,0,0
202184,%,0,0
202185,to,0,0
202186,33.9,0,0
202187,+/-,0,0
202188,9.9,0,0
202189,%,0,0
202190,in,0,0
202191,the,0,0
202192,enoximone,0,1
202193,group,0,0
202194,while,0,0
202195,it,0,0
202196,remained,0,0
202197,unchanged,0,0
202198,with,0,0
202199,placebo,0,1
202200,(,0,0
202201,23.4,0,0
202202,+/-,0,0
202203,6.5,0,0
202204,%,0,0
202205,to,0,0
202206,23.4,0,0
202207,+/-,0,0
202208,1.5,0,0
202209,%,0,0
202210,),0,0
202211,.,0,0
202212,(,0,0
202213,ABSTRACT,0,1
202214,TRUNCATED,0,1
202215,AT,0,1
202216,250,0,1
202217,WORDS,0,1
202218,),0,1
202219,[,0,0
202220,Controlled,0,1
202221,study,0,0
202222,of,0,0
202223,the,0,0
202224,quinidine-amiodarone,1,1
202225,combination,1,1
202226,in,0,0
202227,the,0,0
202228,reversal,0,0
202229,of,0,0
202230,auricular,0,0
202231,fibrillation,0,0
202232,],0,0
202233,.,0,0
202234,Comparative,0,0
202235,effects,0,0
202236,of,0,0
202237,pinacidil,1,1
202238,and,1,0
202239,nifedipine,1,1
202240,in,0,0
202241,the,0,0
202242,treatment,0,0
202243,of,0,0
202244,arterial,0,0
202245,hypertension,0,0
202246,.,0,0
202247,Double-blind,0,0
202248,comparison,0,0
202249,of,0,0
202250,doxepin,1,1
202251,versus,1,1
202252,bupropion,1,1
202253,in,0,0
202254,outpatients,0,0
202255,with,0,0
202256,a,0,0
202257,major,0,0
202258,depressive,0,0
202259,disorder,0,0
202260,.,0,0
202261,A,0,0
202262,double-blind,0,0
202263,controlled,0,0
202264,study,0,0
202265,comparing,0,0
202266,the,0,0
202267,effects,0,0
202268,of,0,0
202269,bupropion,1,1
202270,to,1,0
202271,doxepin,1,1
202272,in,0,0
202273,outpatients,0,0
202274,with,0,0
202275,primary,0,0
202276,depression,0,0
202277,was,0,0
202278,conducted,0,0
202279,to,0,0
202280,evaluate,0,0
202281,efficacy,0,0
202282,and,0,0
202283,safety,0,0
202284,differences,0,0
202285,between,0,0
202286,the,0,0
202287,two,0,0
202288,drugs,0,0
202289,.,0,0
202290,Following,0,0
202291,a,0,0
202292,7-day,0,0
202293,placebo,1,1
202294,washout,0,1
202295,period,0,0
202296,",",0,0
202297,patients,0,0
202298,could,0,0
202299,be,0,0
202300,treated,0,0
202301,for,0,0
202302,up,0,0
202303,to,0,0
202304,13,0,0
202305,weeks,0,0
202306,on,0,0
202307,either,0,0
202308,treatment,0,0
202309,.,0,0
202310,Antidepressant,0,1
202311,response,0,0
202312,was,0,0
202313,assessed,0,0
202314,by,0,0
202315,the,0,0
202316,Hamilton,0,0
202317,Depression,0,0
202318,and,0,0
202319,Anxiety,0,0
202320,Scales,0,1
202321,",",0,0
202322,Clinical,0,0
202323,Global,0,0
202324,Severity,0,0
202325,and,0,0
202326,Improvement,0,0
202327,Ratings,0,0
202328,",",0,0
202329,and,0,0
202330,the,0,0
202331,Zung,0,1
202332,Self-Rating,0,1
202333,Depression,0,0
202334,Scale,0,0
202335,.,0,0
202336,Comparable,0,0
202337,efficacy,0,0
202338,between,0,0
202339,the,0,0
202340,compounds,0,1
202341,was,0,0
202342,found,0,0
202343,across,0,0
202344,the,0,0
202345,13-week,0,0
202346,study,0,0
202347,.,0,0
202348,Doxepin,1,1
202349,differed,0,0
202350,from,0,0
202351,bupropion,1,1
202352,mainly,0,0
202353,on,0,0
202354,the,0,0
202355,sleep,0,0
202356,factor,0,0
202357,of,0,0
202358,the,0,0
202359,Hamilton,0,0
202360,Depression,0,0
202361,Scale,0,0
202362,",",0,0
202363,with,0,0
202364,doxepin,1,1
202365,improving,0,0
202366,sleep,0,0
202367,to,0,0
202368,a,0,0
202369,greater,0,0
202370,extent,0,0
202371,than,0,0
202372,bupropion,1,1
202373,.,1,0
202374,Doxepin,1,1
202375,produced,0,0
202376,a,0,0
202377,greater,0,0
202378,incidence,0,0
202379,of,0,0
202380,anticholinergic,0,1
202381,side,0,0
202382,effects,0,0
202383,",",0,0
202384,including,0,0
202385,dry,0,0
202386,mouth,0,0
202387,",",0,0
202388,constipation,0,0
202389,",",0,0
202390,sleepiness,0,0
202391,",",0,0
202392,and,0,0
202393,tiredness,0,0
202394,",",0,0
202395,in,0,0
202396,comparison,0,0
202397,to,0,0
202398,bupropion,1,1
202399,.,1,0
202400,Also,0,0
202401,",",0,0
202402,increased,0,0
202403,appetite,0,0
202404,and,0,0
202405,weight,0,0
202406,gain,0,0
202407,were,0,0
202408,consistent,0,0
202409,side,0,0
202410,effects,0,0
202411,of,0,0
202412,doxepin,1,1
202413,relative,0,0
202414,to,0,0
202415,bupropion,1,1
202416,.,1,0
202417,Comparison,0,0
202418,of,0,0
202419,amiodarone,1,1
202420,and,1,0
202421,disopyramide,1,1
202422,in,0,0
202423,the,0,0
202424,control,0,0
202425,of,0,0
202426,paroxysmal,0,1
202427,atrial,0,0
202428,fibrillation,0,0
202429,and,0,0
202430,atrial,0,0
202431,flutter,0,1
202432,(,0,1
202433,interim,0,0
202434,report,0,0
202435,),0,0
202436,.,0,0
202437,Antibiotic,1,1
202438,prophylaxis,1,1
202439,in,0,0
202440,high-risk,0,0
202441,head,0,1
202442,and,0,0
202443,neck,0,1
202444,surgery,0,1
202445,:,0,0
202446,one-day,1,0
202447,vs.,0,0
202448,five-day,1,0
202449,therapy,1,1
202450,.,1,0
202451,Patients,0,0
202452,who,0,0
202453,undergo,0,0
202454,major,0,0
202455,contaminated,0,0
202456,surgery,0,0
202457,of,0,0
202458,the,0,0
202459,head,0,0
202460,and,0,0
202461,neck,0,1
202462,benefit,0,0
202463,from,0,0
202464,perioperative,0,0
202465,antibiotic,1,1
202466,prophylaxis,1,1
202467,.,1,0
202468,This,0,0
202469,study,0,0
202470,was,0,0
202471,developed,0,0
202472,to,0,0
202473,determine,0,0
202474,if,0,0
202475,5,0,0
202476,days,0,0
202477,of,0,0
202478,antibiotic,1,1
202479,administration,1,0
202480,would,0,0
202481,be,0,0
202482,more,0,0
202483,effective,0,0
202484,than,0,0
202485,1,0,0
202486,day,0,0
202487,.,0,0
202488,A,0,0
202489,multi-institutional,0,0
202490,prospective,0,0
202491,randomized,0,0
202492,double-blind,0,0
202493,study,0,0
202494,was,0,0
202495,designed,0,0
202496,.,0,0
202497,Patients,0,0
202498,who,0,0
202499,were,0,0
202500,identified,0,0
202501,as,0,0
202502,requiring,0,0
202503,pedicled,0,1
202504,flap,0,1
202505,reconstruction,0,1
202506,were,0,0
202507,potential,0,0
202508,candidates,0,0
202509,for,0,0
202510,the,0,0
202511,study,0,0
202512,.,0,0
202513,Later,0,0
202514,",",0,0
202515,patients,0,0
202516,were,0,0
202517,randomly,0,0
202518,assigned,0,0
202519,to,0,0
202520,receive,0,1
202521,cefoperazone,1,1
202522,sodium,1,1
202523,for,0,0
202524,either,0,0
202525,24,1,0
202526,hours,1,0
202527,or,1,0
202528,120,1,0
202529,hours,1,0
202530,.,1,0
202531,In,0,0
202532,each,0,0
202533,case,0,0
202534,",",0,0
202535,the,0,0
202536,drug,0,0
202537,was,0,0
202538,administered,0,0
202539,intravenously,0,1
202540,",",0,0
202541,beginning,0,0
202542,1,0,0
202543,to,0,0
202544,2,0,0
202545,hours,0,0
202546,preoperatively,0,0
202547,and,0,0
202548,continued,0,0
202549,for,0,0
202550,the,0,0
202551,prescribed,0,0
202552,period,0,0
202553,.,0,0
202554,One,0,0
202555,hundred,0,0
202556,nine,0,0
202557,patients,0,0
202558,were,0,0
202559,evaluable,0,0
202560,.,0,0
202561,Fifty-three,0,0
202562,patients,0,0
202563,were,0,0
202564,assigned,0,0
202565,to,0,0
202566,1,0,0
202567,day,0,0
202568,of,0,0
202569,perioperative,0,0
202570,prophylaxis,0,0
202571,.,0,0
202572,Wound,0,0
202573,infection,0,0
202574,developed,0,0
202575,in,0,0
202576,ten,0,0
202577,patients,0,0
202578,(,0,0
202579,18.9,0,0
202580,%,0,0
202581,),0,0
202582,.,0,0
202583,Fifty-six,0,0
202584,patients,0,0
202585,were,0,0
202586,assigned,0,0
202587,to,0,0
202588,5,0,0
202589,days,0,0
202590,of,0,0
202591,perioperative,1,0
202592,antibiotic,1,1
202593,prophylaxis,1,1
202594,.,1,0
202595,Wound,0,0
202596,infection,0,0
202597,developed,0,0
202598,in,0,0
202599,14,0,0
202600,(,0,0
202601,25,0,0
202602,%,0,0
202603,),0,0
202604,of,0,0
202605,these,0,0
202606,patients,0,0
202607,(,0,0
202608,P,0,0
202609,greater,0,0
202610,than,0,0
202611,.05,0,0
202612,),0,0
202613,.,0,0
202614,These,0,0
202615,data,0,0
202616,suggest,0,0
202617,that,0,0
202618,no,0,0
202619,beneficial,0,0
202620,effect,0,0
202621,from,0,0
202622,administration,0,0
202623,of,0,0
202624,antibiotics,1,1
202625,for,0,0
202626,longer,0,0
202627,than,0,0
202628,24,0,0
202629,hours,0,0
202630,postoperatively,0,0
202631,can,0,0
202632,be,0,0
202633,achieved,0,0
202634,in,0,0
202635,patients,0,0
202636,who,0,0
202637,undergo,0,0
202638,myocutaneous,0,1
202639,flap,0,1
202640,reconstruction,0,1
202641,.,0,0
202642,Postoperative,0,1
202643,pain,0,0
202644,control,0,1
202645,for,0,0
202646,outpatient,0,0
202647,oral,0,1
202648,surgery,0,0
202649,.,0,0
202650,16,0,0
202651,healthy,0,0
202652,patients,0,0
202653,requiring,0,0
202654,removal,0,0
202655,of,0,0
202656,bilateral,0,1
202657,symmetrically-impacted,0,1
202658,mandibular,0,0
202659,third,0,0
202660,molars,0,0
202661,participated,0,0
202662,in,0,0
202663,a,0,0
202664,double-blind,0,0
202665,randomised,0,0
202666,crossover,0,0
202667,trial,0,0
202668,to,0,0
202669,test,0,0
202670,the,0,0
202671,effectiveness,0,0
202672,of,0,0
202673,postoperative,0,0
202674,pain,0,0
202675,control,0,1
202676,using,0,0
202677,a,0,0
202678,long-acting,0,1
202679,anti-inflammatory,0,1
202680,agent,0,1
202681,(,1,1
202682,diflunisal,1,1
202683,),1,1
202684,in,0,0
202685,combination,0,1
202686,with,0,0
202687,a,0,0
202688,long-acting,0,1
202689,local,0,1
202690,anaesthetic,0,1
202691,agent,0,1
202692,(,1,1
202693,bupivacaine,1,1
202694,),1,0
202695,.,0,0
202696,Results,0,0
202697,were,0,0
202698,compared,0,0
202699,to,0,0
202700,the,0,0
202701,more,0,0
202702,traditional,0,1
202703,method,0,1
202704,of,0,0
202705,using,0,0
202706,an,0,0
202707,oral,0,1
202708,analgesic,0,0
202709,with,0,0
202710,shorter,0,0
202711,duration,0,0
202712,of,0,0
202713,action,0,0
202714,(,1,0
202715,paracetamol,1,1
202716,with,1,1
202717,codeine,1,1
202718,),1,0
202719,with,0,0
202720,lignocaine,1,1
202721,as,0,0
202722,the,0,0
202723,local,0,1
202724,anaesthetic,0,1
202725,.,0,0
202726,Using,0,0
202727,a,0,0
202728,visual,0,1
202729,analogue,0,0
202730,pain,0,0
202731,scale,0,0
202732,",",0,0
202733,patients,0,0
202734,reported,0,0
202735,that,0,0
202736,significantly,0,0
202737,reduced,0,0
202738,pain,0,0
202739,was,0,0
202740,experienced,0,0
202741,over,0,0
202742,the,0,0
202743,first,0,0
202744,4,0,0
202745,days,0,0
202746,postoperatively,0,0
202747,with,0,0
202748,the,0,0
202749,diflunisal/bupivacaine,1,1
202750,treatment,1,0
202751,and,0,0
202752,patient,0,0
202753,preference,0,0
202754,for,0,0
202755,this,0,0
202756,treatment,0,0
202757,was,0,0
202758,highly,0,0
202759,significant,0,0
202760,.,0,0
202761,This,0,0
202762,report,0,0
202763,represents,0,0
202764,the,0,0
202765,first,0,0
202766,such,0,0
202767,study,0,0
202768,of,0,0
202769,diflunisal,1,1
202770,used,0,0
202771,for,0,0
202772,an,0,0
202773,extended,0,1
202774,course,0,0
202775,in,0,0
202776,oral,0,1
202777,surgery,0,1
202778,with,0,0
202779,pain,0,0
202780,assessment,0,0
202781,over,0,0
202782,the,0,0
202783,same,0,0
202784,period,0,0
202785,.,0,0
202786,No,0,0
202787,significant,0,0
202788,side-effects,0,0
202789,or,0,0
202790,adverse,0,0
202791,reactions,0,0
202792,were,0,0
202793,encountered,0,0
202794,.,0,0
202795,Prospective,0,0
202796,controlled,0,0
202797,study,0,0
202798,of,0,0
202799,androgen,1,1
202800,therapy,1,1
202801,in,0,0
202802,the,0,0
202803,anemia,0,0
202804,of,0,0
202805,chronic,0,0
202806,renal,0,0
202807,disease,0,0
202808,:,0,0
202809,effects,0,0
202810,on,0,0
202811,iron,0,1
202812,kinetics,0,0
202813,.,0,0
202814,Ferrokinetic,0,0
202815,and,0,0
202816,RBC,0,1
202817,mass,0,0
202818,determinations,0,0
202819,were,0,0
202820,made,0,0
202821,at,0,0
202822,3-month,0,0
202823,intervals,0,0
202824,in,0,0
202825,iron-replete,0,1
202826,hemodialysis,0,1
202827,patients,0,0
202828,randomized,0,0
202829,to,0,0
202830,a,0,0
202831,control,1,1
202832,group,1,0
202833,or,1,1
202834,to,1,0
202835,nandrolone,1,1
202836,decanoate,1,1
202837,therapy,1,1
202838,.,1,0
202839,After,0,0
202840,3,0,0
202841,months,0,0
202842,",",0,0
202843,RBC,0,1
202844,mass,0,0
202845,increased,0,0
202846,in,0,0
202847,two,0,0
202848,of,0,0
202849,4,0,0
202850,androgen-treated,0,0
202851,patients,0,0
202852,.,0,0
202853,Erythron,0,0
202854,iron,0,1
202855,turnover,0,0
202856,",",0,0
202857,an,0,0
202858,index,0,0
202859,of,0,0
202860,RBC,0,1
202861,production,0,0
202862,",",0,0
202863,increased,0,0
202864,in,0,0
202865,the,0,0
202866,one,0,0
202867,responder,0,0
202868,studied,0,0
202869,but,0,0
202870,not,0,0
202871,in,0,0
202872,the,0,0
202873,two,0,0
202874,nonresponders,0,0
202875,.,0,0
202876,Similarly,0,0
202877,",",0,0
202878,in,0,0
202879,a,0,0
202880,fifth,0,0
202881,subject,0,0
202882,",",0,0
202883,who,0,0
202884,was,0,0
202885,not,0,0
202886,restudied,0,0
202887,until,0,0
202888,6,0,0
202889,months,0,0
202890,of,0,0
202891,androgen,1,1
202892,therapy,1,1
202893,were,0,0
202894,completed,0,0
202895,",",0,0
202896,an,0,0
202897,increase,0,0
202898,in,0,0
202899,RBC,0,1
202900,mass,0,0
202901,was,0,0
202902,associated,0,0
202903,with,0,0
202904,an,0,0
202905,increase,0,0
202906,in,0,0
202907,erythron,0,1
202908,iron,0,1
202909,turnover,0,0
202910,.,0,0
202911,However,0,0
202912,",",0,0
202913,between,0,0
202914,3,0,0
202915,and,0,0
202916,6,0,0
202917,months,0,0
202918,",",0,0
202919,RBC,0,1
202920,mass,0,0
202921,increased,0,0
202922,in,0,0
202923,all,0,0
202924,4,0,0
202925,androgen-treated,1,0
202926,patients,0,0
202927,studied,0,0
202928,even,0,0
202929,though,0,0
202930,erythron,0,0
202931,iron,0,1
202932,turnovers,0,0
202933,remained,0,0
202934,unchanged,0,0
202935,and,0,0
202936,dialysis-associated,0,0
202937,blood,0,0
202938,losses,0,0
202939,did,0,0
202940,not,0,0
202941,decrease,0,0
202942,.,0,0
202943,Thus,0,0
202944,",",0,0
202945,at,0,0
202946,least,0,0
202947,two,0,0
202948,androgen-treated,1,0
202949,patients,0,0
202950,had,0,0
202951,increases,0,0
202952,in,0,0
202953,RBC,0,1
202954,mass,0,0
202955,without,0,0
202956,ever,0,0
202957,increasing,0,0
202958,their,0,0
202959,erythron,0,1
202960,iron,0,1
202961,turnover,0,0
202962,.,0,0
202963,Two,0,0
202964,of,0,0
202965,three,0,0
202966,control,0,0
202967,subjects,0,0
202968,also,0,0
202969,had,0,0
202970,increased,0,0
202971,erythron,0,0
202972,iron,0,1
202973,turnovers,0,0
202974,",",0,0
202975,which,0,0
202976,in,0,0
202977,one,0,0
202978,case,0,0
202979,was,0,0
202980,related,0,0
202981,to,0,0
202982,increased,0,0
202983,dialysis-associated,0,0
202984,blood,0,0
202985,losses,0,0
202986,.,0,0
202987,Changes,0,0
202988,in,0,0
202989,RBC,0,1
202990,mass,0,0
202991,were,0,0
202992,not,0,0
202993,consistently,0,0
202994,paralleled,0,0
202995,by,0,0
202996,changes,0,0
202997,in,0,0
202998,Hb,0,1
202999,.,0,0
203000,These,0,0
203001,findings,0,0
203002,suggest,0,0
203003,that,0,0
203004,increases,0,0
203005,in,0,0
203006,RBC,0,1
203007,mass,0,0
203008,during,0,0
203009,nandrolone,0,1
203010,decanoate,0,1
203011,therapy,0,1
203012,result,0,0
203013,from,0,0
203014,two,0,0
203015,mechanisms,0,0
203016,:,0,0
203017,increased,0,0
203018,erythropoiesis,0,0
203019,(,0,0
203020,shown,0,0
203021,by,0,0
203022,simultaneous,0,0
203023,increases,0,0
203024,in,0,0
203025,RBC,0,1
203026,mass,0,0
203027,and,0,0
203028,erythron,0,1
203029,iron,0,1
203030,turnover,0,0
203031,),0,1
203032,and,0,0
203033,increased,0,0
203034,RBC,0,1
203035,survival,0,0
203036,(,0,0
203037,indirectly,0,0
203038,shown,0,0
203039,by,0,0
203040,increases,0,0
203041,in,0,0
203042,RBC,0,1
203043,mass,0,0
203044,without,0,0
203045,increases,0,0
203046,in,0,0
203047,erythron,0,0
203048,iron,0,1
203049,turnover,0,0
203050,),0,0
203051,.,0,0
203052,The,0,0
203053,importance,0,0
203054,of,0,0
203055,control,0,0
203056,groups,0,0
203057,",",0,0
203058,RBC,0,1
203059,mass,0,0
203060,determinations,0,0
203061,and,0,0
203062,the,0,0
203063,monitoring,0,1
203064,of,0,0
203065,dialysis-associated,0,0
203066,blood,0,0
203067,losses,0,0
203068,in,0,0
203069,studying,0,0
203070,the,0,0
203071,effects,0,0
203072,of,0,0
203073,androgens,0,0
203074,on,0,0
203075,erythropoiesis,0,0
203076,in,0,0
203077,chronic,0,0
203078,hemodialysis,0,1
203079,patients,0,0
203080,is,0,0
203081,also,0,0
203082,demonstrated,0,0
203083,.,0,0
203084,Psoriasis,0,0
203085,of,0,0
203086,the,0,0
203087,scalp,0,0
203088,treated,0,0
203089,with,0,0
203090,Grenz,1,0
203091,rays,1,1
203092,or,0,1
203093,topical,1,1
203094,corticosteroid,1,1
203095,combined,1,1
203096,with,1,0
203097,Grenz,1,0
203098,rays,1,1
203099,.,1,0
203100,A,0,0
203101,comparative,0,0
203102,randomized,0,0
203103,trial,0,0
203104,.,0,0
203105,To,0,0
203106,investigate,0,0
203107,the,0,0
203108,effect,0,0
203109,of,0,0
203110,Grenz,1,1
203111,ray,1,1
203112,therapy,1,1
203113,alone,0,1
203114,compared,0,0
203115,with,0,0
203116,Grenz,1,0
203117,rays,1,1
203118,combined,1,1
203119,with,1,0
203120,a,1,0
203121,topical,1,1
203122,corticosteroid,1,1
203123,(,1,1
203124,betamethasone,1,1
203125,dipropionate,1,1
203126,),1,1
203127,in,0,0
203128,psoriasis,0,0
203129,of,0,0
203130,the,0,0
203131,scalp,0,0
203132,",",0,0
203133,40,0,0
203134,patients,0,0
203135,were,0,0
203136,randomized,0,0
203137,into,0,0
203138,two,0,0
203139,groups,0,0
203140,.,0,0
203141,One,0,0
203142,group,0,0
203143,received,0,0
203144,4,1,0
203145,Gy,1,1
203146,of,1,0
203147,Grenz,1,0
203148,rays,1,1
203149,administered,0,0
203150,on,0,0
203151,six,0,0
203152,occasions,0,0
203153,at,0,0
203154,intervals,0,0
203155,of,0,0
203156,1,0,0
203157,week,0,0
203158,and,0,0
203159,the,0,0
203160,other,0,0
203161,group,0,0
203162,was,0,0
203163,given,0,0
203164,the,0,0
203165,same,0,0
203166,Grenz,1,1
203167,ray,1,1
203168,treatment,1,1
203169,plus,1,1
203170,topical,1,1
203171,corticosteroid,1,1
203172,.,1,0
203173,The,0,0
203174,patients,0,0
203175,were,0,0
203176,assessed,0,0
203177,before,0,0
203178,and,0,0
203179,after,0,0
203180,Grenz,0,1
203181,ray,0,1
203182,therapy,0,1
203183,and,0,0
203184,were,0,0
203185,followed-up,0,0
203186,for,0,0
203187,6,0,0
203188,months,0,0
203189,.,0,0
203190,Of,0,0
203191,the,0,0
203192,37,0,0
203193,patients,0,0
203194,who,0,0
203195,completed,0,0
203196,the,0,0
203197,trial,0,0
203198,16,0,0
203199,out,0,0
203200,of,0,0
203201,19,0,0
203202,(,0,0
203203,84,0,0
203204,%,0,0
203205,),0,0
203206,of,0,0
203207,the,0,0
203208,patients,0,0
203209,in,0,0
203210,the,0,0
203211,Grenz,1,1
203212,ray,1,1
203213,group,0,0
203214,",",0,0
203215,and,0,0
203216,13,0,0
203217,out,0,0
203218,of,0,0
203219,18,0,0
203220,(,0,0
203221,72,0,0
203222,%,0,0
203223,),0,0
203224,of,0,0
203225,the,0,0
203226,patients,0,0
203227,in,0,0
203228,the,0,0
203229,combination,0,1
203230,group,0,0
203231,healed,0,0
203232,.,0,0
203233,The,0,0
203234,remission,0,0
203235,time,0,0
203236,did,0,0
203237,not,0,0
203238,differ,0,0
203239,significantly,0,0
203240,between,0,0
203241,the,0,0
203242,two,0,0
203243,groups,0,0
203244,.,0,0
203245,Of,0,0
203246,the,0,0
203247,patients,0,0
203248,who,0,0
203249,healed,0,0
203250,",",0,0
203251,5,0,0
203252,of,0,0
203253,16,0,0
203254,patients,0,0
203255,in,0,0
203256,the,0,0
203257,Grenz,1,0
203258,ray,1,1
203259,only,0,0
203260,group,0,0
203261,and,0,0
203262,4,0,0
203263,of,0,0
203264,13,0,0
203265,patients,0,0
203266,in,0,0
203267,the,0,0
203268,combination,0,1
203269,group,0,0
203270,remained,0,0
203271,healed,0,0
203272,at,0,0
203273,6,0,0
203274,months,0,0
203275,.,0,0
203276,We,0,0
203277,conclude,0,0
203278,that,0,0
203279,Grenz,1,1
203280,ray,1,1
203281,therapy,1,1
203282,is,0,0
203283,a,0,0
203284,useful,0,0
203285,treatment,0,0
203286,modality,0,0
203287,for,0,0
203288,scalp,0,1
203289,psoriasis,0,0
203290,",",0,0
203291,but,0,0
203292,that,0,0
203293,the,0,0
203294,addition,0,0
203295,of,0,0
203296,a,0,0
203297,topical,0,1
203298,corticosteroid,1,1
203299,has,0,0
203300,only,0,0
203301,a,0,0
203302,minor,0,0
203303,effect,0,0
203304,.,0,0
203305,[,1,0
203306,Propofol,1,1
203307,infusion,0,1
203308,for,0,0
203309,the,0,0
203310,maintenance,0,0
203311,of,0,0
203312,short-term,0,0
203313,anesthesia,0,1
203314,],0,0
203315,.,0,0
203316,The,0,0
203317,administration,0,0
203318,of,0,0
203319,propofol,1,1
203320,by,0,0
203321,infusion,0,1
203322,for,0,0
203323,maintenance,0,0
203324,of,0,0
203325,anesthesia,0,1
203326,has,0,0
203327,attracted,0,0
203328,much,0,0
203329,attention,0,0
203330,recently,0,0
203331,.,0,0
203332,We,0,0
203333,investigated,0,0
203334,the,0,0
203335,necessary,0,0
203336,infusion,0,1
203337,rate,0,0
203338,of,0,0
203339,propofol,1,1
203340,to,0,0
203341,maintain,0,1
203342,anesthesia,0,1
203343,for,0,0
203344,short,0,0
203345,surgical,0,0
203346,procedures,0,0
203347,without,0,0
203348,loss,0,0
203349,of,0,0
203350,the,0,0
203351,evident,0,0
203352,advantages,0,0
203353,of,0,0
203354,this,0,0
203355,substance,0,0
203356,.,0,0
203357,Forty,0,0
203358,unpremedicated,0,0
203359,female,0,0
203360,patients,0,0
203361,aged,0,0
203362,18-59,0,0
203363,",",0,0
203364,scheduled,0,0
203365,for,0,0
203366,minor,0,0
203367,gynecological,0,0
203368,procedures,0,0
203369,",",0,0
203370,were,0,0
203371,randomly,0,0
203372,assigned,0,0
203373,to,0,0
203374,four,0,0
203375,groups,0,0
203376,.,0,0
203377,Anesthesia,0,0
203378,was,0,0
203379,induced,0,0
203380,with,0,0
203381,2.0,1,0
203382,mg/kg,1,1
203383,propofol,1,1
203384,i.v,1,1
203385,.,1,0
203386,and,0,0
203387,simultaneously,0,0
203388,an,0,0
203389,infusion,0,1
203390,of,0,0
203391,0.05,0,0
203392,",",0,0
203393,0.10,0,0
203394,",",0,0
203395,0.15,0,0
203396,",",0,0
203397,or,0,0
203398,0.20,0,0
203399,mg,0,1
203400,propofol/kg,1,1
203401,per,0,0
203402,minute,0,0
203403,was,0,0
203404,started,0,0
203405,.,0,0
203406,The,0,0
203407,patients,0,0
203408,were,0,0
203409,breathing,0,1
203410,N2O/O2,1,0
203411,with,1,0
203412,FIO2,1,0
203413,33,0,0
203414,%,0,0
203415,.,0,0
203416,Additional,0,0
203417,propofol,1,1
203418,was,0,0
203419,administered,0,0
203420,as,0,0
203421,a,0,0
203422,bolus,0,1
203423,of,0,0
203424,10,0,0
203425,to,0,0
203426,20,0,0
203427,mg,0,1
203428,when,0,0
203429,the,0,0
203430,patients,0,0
203431,moved,0,0
203432,.,0,0
203433,With,0,0
203434,0.05,0,0
203435,mg,0,1
203436,propofol/kg,1,1
203437,per,0,0
203438,minute,0,0
203439,all,0,0
203440,patients,0,0
203441,required,0,0
203442,additional,0,0
203443,bolus,0,1
203444,injections,0,1
203445,of,0,0
203446,propofol,1,1
203447,;,1,0
203448,with,0,0
203449,0.10,0,0
203450,mg,0,0
203451,8,0,0
203452,patients,0,0
203453,",",0,0
203454,with,0,0
203455,0.15,0,0
203456,mg,0,0
203457,5,0,0
203458,patients,0,0
203459,",",0,0
203460,and,0,0
203461,with,0,0
203462,0.20,0,0
203463,mg,0,1
203464,1,0,0
203465,patient,0,0
203466,required,0,0
203467,bolus,0,1
203468,injection,0,1
203469,.,0,0
203470,Therefore,0,0
203471,",",0,0
203472,0.15,0,1
203473,mg/kg,0,1
203474,per,0,0
203475,minute,0,0
203476,can,0,0
203477,be,0,0
203478,considered,0,0
203479,as,0,0
203480,an,0,0
203481,approximate,0,0
203482,ED50,0,0
203483,value,0,0
203484,.,0,0
203485,The,0,0
203486,total,0,0
203487,propofol,1,1
203488,consumption,0,1
203489,(,0,1
203490,infusion,0,1
203491,+,0,1
203492,bolus,0,1
203493,),0,0
203494,increased,0,0
203495,from,0,0
203496,0.102,0,0
203497,+/-,0,0
203498,0.028,0,0
203499,(,0,0
203500,+/-,0,0
203501,SD,0,0
203502,),0,0
203503,with,0,0
203504,the,0,0
203505,lowest,0,0
203506,infusion,0,1
203507,rate,0,0
203508,to,0,0
203509,0.202,0,0
203510,+/-,0,0
203511,0.006,0,0
203512,mg/kg,0,1
203513,per,0,0
203514,minute,0,0
203515,with,0,0
203516,the,0,0
203517,highest,0,0
203518,infusion,0,1
203519,rate,0,0
203520,and,0,0
203521,recovery,0,0
203522,time,0,0
203523,from,0,0
203524,5.2,0,0
203525,+/-,0,0
203526,1.4,0,0
203527,to,0,0
203528,9.9,0,0
203529,+/-,0,0
203530,2.6,0,0
203531,min,0,0
203532,.,0,0
203533,There,0,0
203534,was,0,0
203535,a,0,0
203536,significant,0,0
203537,correlation,0,0
203538,between,0,0
203539,propofol,1,1
203540,consumption,0,0
203541,and,0,0
203542,recovery,0,0
203543,time,0,0
203544,.,0,0
203545,After,0,0
203546,induction,0,0
203547,",",0,0
203548,arterial,0,0
203549,blood,0,0
203550,pressure,0,0
203551,decreased,0,0
203552,by,0,0
203553,systolic/diastolic,0,0
203554,20/10-15,0,0
203555,mmHg,0,0
203556,.,0,0
203557,With,0,0
203558,the,0,0
203559,low,0,0
203560,infusion,0,1
203561,rate,0,0
203562,",",0,0
203563,arterial,0,0
203564,pressure,0,0
203565,increased,0,0
203566,to,0,0
203567,its,0,0
203568,control,0,1
203569,value,0,0
203570,during,0,0
203571,operation,0,0
203572,;,0,0
203573,it,0,0
203574,remained,0,0
203575,at,0,0
203576,the,0,0
203577,postinduction,0,0
203578,value,0,0
203579,with,0,0
203580,high,0,0
203581,infusion,0,1
203582,rates,0,0
203583,.,0,0
203584,Side-effects,0,0
203585,:,0,0
203586,10,0,0
203587,patients,0,0
203588,had,0,0
203589,salivation,0,0
203590,that,0,0
203591,in,0,0
203592,some,0,0
203593,instances,0,0
203594,lead,0,0
203595,to,0,0
203596,coughing,0,0
203597,",",0,0
203598,9,0,0
203599,reported,0,0
203600,pain,0,0
203601,at,0,0
203602,the,0,0
203603,injection,0,1
203604,site,0,0
203605,during,0,0
203606,induction,0,0
203607,",",0,0
203608,and,0,0
203609,9,0,0
203610,reported,0,0
203611,dreams,0,0
203612,of,0,0
203613,a,0,0
203614,pleasant,0,0
203615,nature,0,0
203616,.,0,1
203617,(,0,0
203618,ABSTRACT,0,1
203619,TRUNCATED,0,1
203620,AT,0,1
203621,250,0,1
203622,WORDS,0,1
203623,),0,1
203624,BCG,1,1
203625,(,1,1
203626,RIVM,1,1
203627,),1,1
203628,versus,0,1
203629,mitomycin,1,1
203630,intravesical,1,1
203631,therapy,1,1
203632,in,0,0
203633,superficial,0,1
203634,bladder,0,0
203635,cancer,0,0
203636,.,0,0
203637,First,0,0
203638,results,0,0
203639,of,0,0
203640,randomized,0,0
203641,prospective,0,0
203642,trial,0,0
203643,.,0,0
203644,This,0,0
203645,study,0,0
203646,presents,0,0
203647,the,0,0
203648,preliminary,0,0
203649,results,0,0
203650,of,0,0
203651,a,0,0
203652,randomized,0,0
203653,prospective,0,0
203654,two-arm,0,0
203655,study,0,0
203656,in,0,0
203657,which,0,0
203658,bacillus,1,1
203659,Calmette-Gu?rin,1,1
203660,(,1,1
203661,BCG,1,1
203662,),1,1
203663,RIVM,1,0
203664,",",1,0
203665,a,1,0
203666,Dutch,1,1
203667,BCG,1,1
203668,preparation,0,1
203669,",",0,0
203670,is,0,0
203671,compared,0,0
203672,with,1,0
203673,mitomycin,1,1
203674,C,1,1
203675,(,0,1
203676,MMC,0,1
203677,),0,1
203678,in,0,0
203679,patients,0,0
203680,with,0,0
203681,primary,0,0
203682,or,0,1
203683,recurrent,0,0
203684,superficial,0,1
203685,bladder,0,0
203686,tumors,0,0
203687,",",0,0
203688,including,0,0
203689,carcinoma,0,0
203690,in,0,0
203691,situ,0,1
203692,(,0,1
203693,CIS,0,1
203694,),0,1
203695,.,0,0
203696,Therapeutic,0,0
203697,regimens,0,0
203698,were,0,0
203699,as,0,0
203700,follows,0,0
203701,:,0,0
203702,after,0,0
203703,complete,0,0
203704,transurethral,0,1
203705,resection,0,1
203706,of,0,0
203707,all,0,0
203708,visible,0,0
203709,tumors,0,0
203710,",",0,0
203711,BCG,1,1
203712,RIVM,1,1
203713,(,0,0
203714,1,0,0
203715,x,0,0
203716,10,0,0
203717,(,0,0
203718,9,0,0
203719,),0,0
203720,bacilli,0,1
203721,in,0,0
203722,50,0,0
203723,mL,0,1
203724,saline,0,1
203725,),0,0
203726,was,0,0
203727,instilled,0,1
203728,once,0,0
203729,a,0,0
203730,week,0,0
203731,for,0,0
203732,six,0,0
203733,consecutive,0,0
203734,weeks,0,0
203735,",",0,0
203736,and,1,0
203737,mitomycin,1,1
203738,C,1,1
203739,(,0,0
203740,30,0,1
203741,mg,0,1
203742,in,0,0
203743,50,0,0
203744,mL,0,1
203745,saline,0,1
203746,),0,0
203747,was,0,0
203748,administered,0,0
203749,once,0,0
203750,a,0,0
203751,week,0,0
203752,for,0,0
203753,one,0,0
203754,month,0,0
203755,(,0,0
203756,weeks,0,0
203757,1,0,0
203758,to,0,0
203759,4,0,0
203760,),0,0
203761,and,0,0
203762,thereafter,0,0
203763,once,0,1
203764,a,0,0
203765,month,0,0
203766,for,0,0
203767,a,0,0
203768,total,0,0
203769,of,0,0
203770,six,0,0
203771,months,0,0
203772,.,0,0
203773,Reported,0,0
203774,are,0,0
203775,the,0,0
203776,incidence,0,0
203777,of,0,0
203778,side,0,0
203779,effects,0,0
203780,in,0,0
203781,165,0,0
203782,patients,0,0
203783,and,0,0
203784,the,0,0
203785,recurrence,0,0
203786,rate,0,0
203787,of,0,0
203788,tumors,0,0
203789,in,0,0
203790,308,0,0
203791,patients,0,0
203792,after,0,0
203793,a,0,0
203794,follow-up,0,0
203795,period,0,0
203796,of,0,0
203797,twelve,0,0
203798,months,0,0
203799,.,0,0
203800,Drug-induced,0,0
203801,",",0,0
203802,or,0,1
203803,chemical,0,0
203804,cystitis,0,0
203805,was,0,0
203806,observed,0,0
203807,in,0,0
203808,13,0,0
203809,(,0,0
203810,16.7,0,0
203811,%,0,0
203812,),0,0
203813,of,0,0
203814,78,0,0
203815,BCG-treated,0,0
203816,patients,0,0
203817,and,0,0
203818,in,0,0
203819,12,0,0
203820,(,0,0
203821,13.8,0,0
203822,%,0,0
203823,),0,0
203824,of,0,0
203825,87,0,0
203826,MMC-treated,0,0
203827,patients,0,0
203828,.,0,0
203829,In,0,0
203830,the,0,0
203831,same,0,0
203832,groups,0,0
203833,bacterial,0,0
203834,cystitis,0,0
203835,occurred,0,0
203836,in,0,0
203837,17,0,0
203838,(,0,0
203839,21.8,0,0
203840,%,0,0
203841,),0,0
203842,patients,0,0
203843,and,0,0
203844,in,0,0
203845,16,0,0
203846,(,0,0
203847,18.4,0,0
203848,%,0,0
203849,),0,0
203850,patients,0,0
203851,",",0,0
203852,respectively,0,0
203853,.,0,0
203854,In,0,0
203855,the,0,0
203856,BCG-treated,0,0
203857,group,0,0
203858,(,0,0
203859,N,0,1
203860,=,0,0
203861,148,0,0
203862,),0,0
203863,",",0,0
203864,44,0,0
203865,(,0,0
203866,29.8,0,0
203867,%,0,0
203868,),0,0
203869,had,0,0
203870,recurrent,0,0
203871,tumors,0,0
203872,",",0,0
203873,while,0,0
203874,in,0,0
203875,the,0,0
203876,MMC-treated,0,1
203877,group,0,0
203878,(,0,0
203879,N,0,1
203880,=,0,0
203881,160,0,0
203882,),0,0
203883,",",0,0
203884,40,0,1
203885,(,0,0
203886,25.0,0,0
203887,%,0,0
203888,),0,0
203889,had,0,0
203890,a,0,0
203891,recurrence,0,0
203892,.,0,0
203893,The,0,0
203894,recurrence,0,0
203895,rate,0,0
203896,for,1,0
203897,BCG-treated,1,0
203898,patients,0,0
203899,was,0,0
203900,0.33,0,0
203901,;,0,0
203902,the,0,0
203903,recurrence,0,0
203904,rate,0,0
203905,for,1,0
203906,MMC-treated,1,0
203907,patients,0,0
203908,was,0,0
203909,0.29,0,0
203910,(,0,0
203911,P,0,0
203912,=,0,0
203913,0.560,0,0
203914,",",0,0
203915,not,0,0
203916,significant,0,0
203917,),0,0
203918,.,0,0
203919,These,0,0
203920,preliminary,0,0
203921,data,0,0
203922,demonstrated,0,0
203923,no,0,0
203924,statistically,0,0
203925,significant,0,0
203926,difference,0,0
203927,between,0,0
203928,the,0,0
203929,two,0,0
203930,arms,0,0
203931,with,0,0
203932,regard,0,0
203933,to,0,0
203934,toxicity,0,0
203935,and,0,0
203936,recurrence,0,0
203937,of,0,0
203938,tumors,0,0
203939,.,0,0
203940,Analgesic,0,1
203941,efficacy,0,0
203942,of,0,0
203943,piroxicam,1,1
203944,in,0,0
203945,the,0,0
203946,treatment,0,0
203947,of,0,0
203948,postoperative,0,0
203949,pain,0,0
203950,.,0,0
203951,Two,0,0
203952,randomized,0,0
203953,",",0,0
203954,double-blind,0,0
203955,",",0,0
203956,single-dose,0,1
203957,studies,0,0
203958,were,0,0
203959,conducted,0,0
203960,to,0,0
203961,assess,0,0
203962,the,0,0
203963,analgesic,0,1
203964,efficacy,0,0
203965,and,0,0
203966,safety,0,0
203967,of,0,0
203968,piroxicam,1,1
203969,for,0,0
203970,the,0,0
203971,treatment,0,0
203972,of,0,0
203973,moderate,0,0
203974,or,0,1
203975,severe,0,0
203976,postoperative,0,0
203977,pain,0,0
203978,.,0,0
203979,Study,0,0
203980,1,0,0
203981,evaluated,0,0
203982,the,0,0
203983,analgesic,0,1
203984,efficacy,0,0
203985,of,0,0
203986,piroxicam,1,1
203987,20,0,0
203988,mg,0,1
203989,compared,0,0
203990,with,0,0
203991,that,0,0
203992,of,0,0
203993,codeine,1,1
203994,sulfate,1,1
203995,60,0,0
203996,mg,0,1
203997,and,1,0
203998,placebo,1,1
203999,.,1,0
204000,A,0,0
204001,final,0,0
204002,patient,0,0
204003,population,0,0
204004,of,0,0
204005,149,0,0
204006,subjects,0,0
204007,rated,0,0
204008,pain,0,0
204009,intensity,0,0
204010,and,0,0
204011,pain,0,0
204012,relief,0,0
204013,at,0,0
204014,one,0,0
204015,half,0,1
204016,hour,0,0
204017,and,0,0
204018,one,0,0
204019,hour,0,0
204020,following,0,0
204021,treatment,0,1
204022,and,0,0
204023,then,0,1
204024,hourly,0,0
204025,for,0,0
204026,six,0,0
204027,hours,0,0
204028,",",0,0
204029,with,0,0
204030,a,0,0
204031,global,0,0
204032,assessment,0,0
204033,made,0,0
204034,at,0,0
204035,the,0,0
204036,completion,0,0
204037,of,0,0
204038,24,0,0
204039,hours,0,0
204040,.,0,0
204041,Piroxicam,1,1
204042,20,0,0
204043,mg,0,1
204044,was,0,0
204045,significantly,0,0
204046,more,0,0
204047,efficacious,0,0
204048,than,0,0
204049,placebo,1,1
204050,for,0,0
204051,all,0,0
204052,analgesic,0,0
204053,variables,0,0
204054,",",0,0
204055,including,0,0
204056,the,0,0
204057,sum,0,0
204058,of,0,0
204059,the,0,0
204060,pain,0,0
204061,intensity,0,0
204062,differences,0,0
204063,(,0,0
204064,SPID,0,0
204065,),0,1
204066,",",0,0
204067,total,0,0
204068,pain,0,0
204069,relief,0,0
204070,(,0,1
204071,TOTAL,0,1
204072,),0,1
204073,",",0,0
204074,percent,0,0
204075,SPID,0,0
204076,",",0,0
204077,duration,0,0
204078,of,0,0
204079,effect,0,0
204080,",",0,0
204081,and,0,0
204082,time,0,0
204083,to,0,0
204084,remedication,0,1
204085,.,0,0
204086,Codeine,1,0
204087,60,0,0
204088,mg,0,1
204089,was,0,0
204090,significantly,0,0
204091,superior,0,0
204092,to,0,0
204093,placebo,1,1
204094,for,0,0
204095,percent,0,0
204096,SPID,0,0
204097,and,0,0
204098,some,0,0
204099,hourly,0,0
204100,measures,0,0
204101,.,0,0
204102,Piroxicam,1,1
204103,20,0,0
204104,mg,0,1
204105,was,0,0
204106,significantly,0,0
204107,more,0,0
204108,effective,0,0
204109,than,0,0
204110,codeine,1,1
204111,60,0,0
204112,mg,0,1
204113,for,0,0
204114,percent,0,0
204115,SPID,0,0
204116,and,0,0
204117,a,0,0
204118,few,0,0
204119,hourly,0,0
204120,measures,0,0
204121,including,0,0
204122,time,0,0
204123,to,0,0
204124,remedication,0,1
204125,.,0,0
204126,Study,0,0
204127,2,0,0
204128,assessed,0,0
204129,the,0,0
204130,efficacy,0,0
204131,of,0,0
204132,piroxicam,1,1
204133,20,0,1
204134,mg,0,1
204135,or,0,1
204136,40,0,0
204137,mg,0,1
204138,compared,0,0
204139,with,0,0
204140,aspirin,1,1
204141,648,0,0
204142,mg,0,1
204143,and,0,0
204144,placebo,1,1
204145,.,1,0
204146,Sixty,0,0
204147,patients,0,0
204148,rated,0,0
204149,their,0,0
204150,pain,0,0
204151,intensity,0,0
204152,and,0,0
204153,relief,0,0
204154,hourly,0,0
204155,for,0,0
204156,12,0,0
204157,hours,0,0
204158,and,0,0
204159,at,0,0
204160,24,0,0
204161,hours,0,0
204162,after,0,0
204163,administration,0,0
204164,of,0,0
204165,study,0,0
204166,medication,0,1
204167,.,0,0
204168,Both,0,0
204169,doses,0,0
204170,of,0,0
204171,piroxicam,1,1
204172,were,0,0
204173,significantly,0,0
204174,more,0,0
204175,effective,0,0
204176,than,0,0
204177,placebo,0,1
204178,from,0,0
204179,Hours,0,0
204180,2,0,0
204181,to,0,0
204182,12,0,0
204183,for,0,0
204184,pain,0,0
204185,intensity,0,0
204186,difference,0,0
204187,(,0,1
204188,PID,0,1
204189,),0,1
204190,and,0,0
204191,relief,0,0
204192,scores,0,0
204193,",",0,0
204194,as,0,0
204195,well,0,0
204196,as,0,0
204197,for,0,0
204198,SPID,0,0
204199,and,0,0
204200,TOTAL,0,0
204201,.,0,0
204202,Aspirin,0,1
204203,was,0,0
204204,significantly,0,0
204205,more,0,0
204206,effective,0,0
204207,than,0,0
204208,placebo,1,1
204209,from,0,0
204210,Hours,0,0
204211,2,0,0
204212,to,0,0
204213,8,0,0
204214,for,0,0
204215,relief,0,0
204216,and,0,0
204217,Hours,0,1
204218,2,0,0
204219,to,0,0
204220,10,0,0
204221,for,0,0
204222,PID,0,1
204223,as,0,0
204224,well,0,0
204225,as,0,0
204226,SPID,0,0
204227,and,0,0
204228,TOTAL,0,0
204229,.,0,0
204230,Piroxicam,1,1
204231,40,0,0
204232,mg,0,1
204233,was,0,0
204234,significantly,0,0
204235,more,0,0
204236,effective,0,0
204237,than,0,0
204238,aspirin,1,1
204239,648,0,0
204240,mg,0,1
204241,for,0,0
204242,SPID,0,0
204243,",",0,0
204244,TOTAL,0,0
204245,",",0,0
204246,and,0,0
204247,hourly,0,0
204248,measures,0,0
204249,beginning,0,0
204250,with,0,0
204251,Hour,0,1
204252,6,0,0
204253,through,0,0
204254,Hour,0,0
204255,12,0,0
204256,.,0,0
204257,Piroxicam,1,1
204258,20,0,0
204259,mg,0,1
204260,was,0,0
204261,significantly,0,0
204262,better,0,0
204263,than,0,0
204264,aspirin,1,1
204265,for,0,0
204266,a,0,0
204267,few,0,0
204268,hourly,0,0
204269,measures,0,0
204270,:,0,0
204271,Hours,0,0
204272,7,0,0
204273,to,0,0
204274,9,0,0
204275,for,0,0
204276,relief,0,0
204277,and,0,0
204278,Hour,0,1
204279,7,0,0
204280,for,0,0
204281,PID,0,1
204282,.,0,0
204283,In,0,0
204284,addition,0,0
204285,",",0,0
204286,effects,0,0
204287,of,0,0
204288,piroxicam,0,1
204289,20,0,0
204290,mg,0,1
204291,had,0,0
204292,a,0,0
204293,significantly,0,0
204294,longer,0,0
204295,duration,0,0
204296,than,0,0
204297,aspirin,0,1
204298,.,0,0
204299,Similarly,0,0
204300,",",0,0
204301,piroxicam,1,1
204302,20,0,0
204303,mg,0,1
204304,had,0,0
204305,a,0,0
204306,significantly,0,0
204307,longer,0,0
204308,time,0,0
204309,to,0,0
204310,remedication,0,1
204311,compared,0,0
204312,with,0,0
204313,aspirin,1,1
204314,and,0,0
204315,placebo,1,1
204316,.,0,0
204317,The,0,0
204318,results,0,0
204319,of,0,0
204320,these,0,0
204321,studies,0,0
204322,provide,0,0
204323,evidence,0,0
204324,in,0,0
204325,support,0,0
204326,of,0,0
204327,the,0,0
204328,longer,0,0
204329,duration,0,0
204330,of,0,0
204331,analgesic,0,1
204332,efficacy,0,0
204333,of,0,0
204334,piroxicam,1,1
204335,compared,0,0
204336,with,0,0
204337,codeine,1,1
204338,or,1,1
204339,aspirin,1,1
204340,in,0,0
204341,patients,0,0
204342,with,0,0
204343,postoperative,0,0
204344,pain,0,0
204345,.,0,0
204346,[,1,0
204347,Domperidone,1,1
204348,in,0,0
204349,the,0,0
204350,treatment,0,0
204351,of,0,0
204352,irritable,0,0
204353,colon,0,0
204354,.,0,0
204355,A,0,0
204356,placebo-controlled,1,1
204357,double-blind,0,0
204358,study,0,0
204359,],0,0
204360,.,0,0
204361,Prognostic,0,0
204362,significance,0,0
204363,and,0,0
204364,beneficial,0,0
204365,effect,0,0
204366,of,0,0
204367,diltiazem,1,1
204368,on,0,0
204369,the,0,0
204370,incidence,0,0
204371,of,0,0
204372,early,0,0
204373,recurrent,0,0
204374,ischemia,0,0
204375,after,0,0
204376,non-Q-wave,0,0
204377,myocardial,0,0
204378,infarction,0,0
204379,:,0,0
204380,results,0,0
204381,from,0,0
204382,the,0,0
204383,Multicenter,0,0
204384,Diltiazem,0,1
204385,Reinfarction,0,0
204386,Study,0,0
204387,.,0,0
204388,Of,0,0
204389,576,0,0
204390,patients,0,0
204391,with,0,0
204392,non-Q-wave,0,0
204393,acute,0,0
204394,myocardial,0,0
204395,infarction,0,0
204396,enrolled,0,0
204397,in,0,0
204398,the,0,0
204399,Diltiazem,0,1
204400,Reinfarction,0,0
204401,Study,0,0
204402,",",0,0
204403,246,0,0
204404,(,0,0
204405,43,0,0
204406,%,0,0
204407,),0,0
204408,had,0,0
204409,1,0,0
204410,or,0,0
204411,more,0,0
204412,episodes,0,0
204413,of,0,0
204414,angina,0,0
204415,at,0,0
204416,rest,0,0
204417,or,0,1
204418,with,0,0
204419,minimal,0,0
204420,effort,0,0
204421,during,0,0
204422,10.5,0,0
204423,days,0,0
204424,of,0,0
204425,treatment,0,0
204426,with,0,0
204427,either,0,1
204428,diltiazem,1,1
204429,(,0,0
204430,90,0,0
204431,mg,0,1
204432,every,0,0
204433,6,0,0
204434,hours,0,0
204435,),0,0
204436,or,1,1
204437,placebo,1,1
204438,.,1,1
204439,Reinfarction,0,0
204440,(,0,0
204441,12.2,0,0
204442,%,0,0
204443,vs,0,0
204444,3.6,0,0
204445,%,0,0
204446,",",0,0
204447,p,0,0
204448,less,0,0
204449,than,0,0
204450,0.0001,0,0
204451,),0,0
204452,or,0,1
204453,death,0,0
204454,(,0,1
204455,6.1,0,0
204456,%,0,0
204457,vs,0,0
204458,1.5,0,0
204459,%,0,0
204460,",",0,0
204461,p,0,0
204462,=,0,0
204463,0.003,0,0
204464,),0,0
204465,was,0,0
204466,more,0,0
204467,likely,0,0
204468,to,0,0
204469,occur,0,0
204470,within,0,0
204471,2,0,0
204472,weeks,0,0
204473,of,0,0
204474,randomization,0,0
204475,in,0,0
204476,patients,0,0
204477,with,0,0
204478,postinfarction,0,0
204479,angina,0,0
204480,than,0,0
204481,in,0,0
204482,those,0,0
204483,without,0,0
204484,angina,0,0
204485,.,0,0
204486,Based,0,0
204487,on,0,0
204488,serial,0,0
204489,electrocardiographic,0,0
204490,data,0,0
204491,",",0,0
204492,115,0,0
204493,of,0,0
204494,the,0,0
204495,246,0,0
204496,patients,0,0
204497,with,0,0
204498,angina,0,0
204499,had,0,0
204500,transient,0,0
204501,ST-T,0,0
204502,changes,0,0
204503,and,0,0
204504,131,0,0
204505,did,0,0
204506,not,0,0
204507,.,0,0
204508,Comparison,0,0
204509,of,0,0
204510,the,0,0
204511,14-day,0,0
204512,event,0,0
204513,rates,0,0
204514,in,0,0
204515,these,0,0
204516,2,0,0
204517,groups,0,0
204518,showed,0,0
204519,that,0,0
204520,the,0,0
204521,115,0,0
204522,patients,0,0
204523,with,0,0
204524,electrocardiographic,0,0
204525,evidence,0,0
204526,of,0,0
204527,ischemia,0,0
204528,had,0,0
204529,a,0,0
204530,higher,0,0
204531,frequency,0,0
204532,of,0,0
204533,reinfarction,0,0
204534,(,0,0
204535,20,0,1
204536,%,0,0
204537,vs,0,0
204538,5.3,0,0
204539,%,0,0
204540,",",0,0
204541,p,0,0
204542,less,0,0
204543,than,0,0
204544,0.001,0,0
204545,),0,0
204546,",",0,0
204547,more,0,0
204548,extensive,0,0
204549,damage,0,0
204550,as,0,0
204551,assessed,0,0
204552,by,0,0
204553,peak,0,0
204554,MB-creatine,0,1
204555,kinase,0,1
204556,levels,0,0
204557,(,0,0
204558,91,0,0
204559,+/-,0,0
204560,76,0,0
204561,vs,0,0
204562,37,0,0
204563,+/-,0,0
204564,19,0,0
204565,IU/liter,0,0
204566,",",0,0
204567,p,0,0
204568,=,0,0
204569,0.059,0,0
204570,[,0,0
204571,Wilcoxon,0,1
204572,rank,0,0
204573,sum,0,0
204574,],0,1
204575,),0,1
204576,and,0,0
204577,a,0,0
204578,higher,0,0
204579,mortality,0,0
204580,rate,0,0
204581,(,0,0
204582,11.3,0,0
204583,%,0,0
204584,vs,0,0
204585,1.5,0,0
204586,%,0,0
204587,",",0,0
204588,p,0,0
204589,=,0,0
204590,0.001,0,0
204591,),0,0
204592,.,0,0
204593,Angina,0,0
204594,associated,0,0
204595,with,0,0
204596,transient,0,0
204597,ST-T,0,0
204598,changes,0,0
204599,occurred,0,0
204600,in,0,0
204601,70,0,0
204602,of,0,0
204603,the,0,0
204604,289,0,0
204605,patients,0,0
204606,in,0,0
204607,the,0,0
204608,placebo,1,1
204609,group,0,0
204610,but,0,0
204611,in,0,0
204612,only,0,0
204613,45,0,0
204614,of,0,0
204615,the,0,0
204616,287,0,0
204617,patients,0,0
204618,in,0,0
204619,the,0,0
204620,diltiazem,0,1
204621,group,0,0
204622,--,0,0
204623,a,0,0
204624,28,0,0
204625,%,0,0
204626,reduction,0,0
204627,in,0,0
204628,cumulative,0,0
204629,life-table,0,0
204630,incidence,0,0
204631,(,0,0
204632,p,0,0
204633,=,0,0
204634,0.0103,0,0
204635,[,0,0
204636,2-tail,0,0
204637,",",0,0
204638,log,0,0
204639,rank,0,0
204640,],0,0
204641,;,0,0
204642,95,0,0
204643,%,0,0
204644,confidence,0,0
204645,interval,0,0
204646,",",0,0
204647,9.3,0,0
204648,to,0,0
204649,53.8,0,0
204650,%,0,0
204651,),0,0
204652,.,0,0
204653,It,0,0
204654,is,0,0
204655,concluded,0,0
204656,that,0,0
204657,patients,0,0
204658,with,0,0
204659,early,0,0
204660,postinfarction,0,0
204661,angina,0,0
204662,are,0,0
204663,at,0,0
204664,increased,0,0
204665,risk,0,0
204666,of,0,0
204667,reinfarction,0,0
204668,and,0,0
204669,death,0,0
204670,",",0,0
204671,and,0,0
204672,angina,0,0
204673,associated,0,0
204674,with,0,0
204675,transient,0,0
204676,electrocardiographic,0,0
204677,changes,0,0
204678,identified,0,0
204679,a,0,0
204680,very,0,0
204681,high,0,0
204682,risk,0,0
204683,subset,0,0
204684,.,0,0
204685,This,0,0
204686,subset,0,0
204687,appeared,0,0
204688,to,0,0
204689,have,0,0
204690,a,0,0
204691,larger,0,0
204692,area,0,0
204693,of,0,0
204694,viable,0,0
204695,but,0,0
204696,jeopardized,0,0
204697,myocardium,0,1
204698,and,0,0
204699,benefited,0,0
204700,from,0,0
204701,prophylactic,0,1
204702,therapy,0,1
204703,with,0,0
204704,diltiazem,1,1
204705,.,1,0
204706,Alpha,1,1
204707,interferon,1,1
204708,clinical,0,0
204709,trial,0,0
204710,for,0,0
204711,multiple,0,0
204712,sclerosis,0,1
204713,:,0,0
204714,design,0,0
204715,considerations,0,0
204716,.,0,0
204717,The,0,0
204718,design,0,0
204719,and,0,0
204720,course,0,0
204721,of,0,0
204722,a,0,0
204723,placebo-controlled,1,1
204724,alpha-2,1,1
204725,interferon,1,1
204726,trial,0,0
204727,in,0,0
204728,MS,0,0
204729,patients,0,0
204730,are,0,0
204731,described,0,0
204732,.,0,0
204733,No,0,0
204734,beneficial,0,0
204735,effect,0,0
204736,of,0,0
204737,the,0,0
204738,interferon,1,1
204739,on,0,0
204740,the,0,0
204741,course,0,0
204742,of,0,0
204743,MS,0,0
204744,could,0,0
204745,be,0,0
204746,shown,0,0
204747,.,0,0
204748,[,0,0
204749,Prevention,0,1
204750,of,0,0
204751,migraine,0,0
204752,with,0,0
204753,flunarizine,1,1
204754,and,0,0
204755,acetylsalicylic,1,1
204756,acid,1,1
204757,.,1,0
204758,A,0,0
204759,double-blind,0,0
204760,study,0,0
204761,],0,1
204762,.,0,0
204763,UNLABELLED,0,0
204764,30,0,0
204765,children,0,0
204766,between,0,0
204767,7,0,0
204768,and,0,0
204769,17,0,0
204770,years,0,0
204771,suffering,0,0
204772,from,0,0
204773,at,0,0
204774,least,0,0
204775,2,0,0
204776,attacks/month,0,0
204777,of,0,0
204778,common,0,0
204779,or,0,1
204780,classical,0,1
204781,migraine,0,0
204782,since,0,0
204783,more,0,0
204784,than,0,0
204785,1,0,0
204786,year,0,0
204787,were,0,0
204788,studied,0,0
204789,.,0,0
204790,After,0,0
204791,clinical,0,0
204792,exclusion,0,0
204793,of,0,0
204794,symptomatic,0,0
204795,headache,0,0
204796,4,0,0
204797,weeks,0,0
204798,were,0,0
204799,documented,0,0
204800,by,0,0
204801,means,0,0
204802,of,0,0
204803,a,0,0
204804,migraine,0,0
204805,diary,0,1
204806,.,0,0
204807,Prophylaxis,0,1
204808,with,0,0
204809,Calcium,0,1
204810,entry,0,0
204811,blocker,1,1
204812,Flunarizine,1,1
204813,(,1,1
204814,Sibelium,1,1
204815,),1,1
204816,or,0,1
204817,Thromboxane,0,1
204818,A,0,0
204819,inhibitor,0,1
204820,Acetylsalicylic,1,1
204821,acid,1,1
204822,(,1,1
204823,ASS,1,1
204824,),1,1
204825,was,0,0
204826,carried,0,0
204827,out,0,0
204828,in,0,0
204829,a,0,0
204830,double,0,1
204831,blind,0,0
204832,design,0,0
204833,for,0,0
204834,3,0,0
204835,months,0,0
204836,.,0,0
204837,Medication,0,0
204838,was,0,0
204839,given,0,0
204840,as,0,0
204841,one,0,0
204842,dosage,0,0
204843,in,0,0
204844,the,0,0
204845,evening,0,0
204846,:,0,0
204847,2-5,0,0
204848,mg/kg,0,1
204849,KG,0,1
204850,ASS,1,1
204851,or,0,1
204852,5-10,0,1
204853,mg,0,1
204854,Flunarizine,1,1
204855,.,1,0
204856,Documented,0,0
204857,attack,0,0
204858,frequency,0,0
204859,and,0,0
204860,duration,0,0
204861,were,0,0
204862,controlled,0,0
204863,at,0,0
204864,monthly,0,0
204865,physical,0,1
204866,examinations,0,0
204867,.,0,0
204868,Final,0,0
204869,results,0,0
204870,showed,0,0
204871,no,0,0
204872,differences,0,0
204873,in,0,0
204874,significant,0,0
204875,reduction,0,0
204876,of,0,0
204877,attack,0,0
204878,frequency,0,0
204879,or,0,1
204880,symptoms,0,0
204881,between,0,0
204882,both,0,0
204883,different,0,0
204884,therapeutic,0,0
204885,principals,0,0
204886,.,0,0
204887,72.4,0,0
204888,%,0,0
204889,(,0,0
204890,ASS,0,1
204891,73.3,0,0
204892,%,0,0
204893,;,0,0
204894,Flunarizine,1,1
204895,71.4,0,0
204896,%,0,0
204897,),0,0
204898,of,0,0
204899,patients,0,0
204900,were,0,0
204901,attack-free,0,0
204902,or,0,1
204903,had,0,0
204904,at,0,0
204905,least,0,0
204906,a,0,0
204907,50,0,1
204908,%,0,0
204909,reduction,0,0
204910,.,0,0
204911,Migraine,0,0
204912,frequency,0,0
204913,of,0,0
204914,initially,0,0
204915,7-8,0,0
204916,was,0,0
204917,reduced,0,0
204918,to,0,0
204919,1-2,0,0
204920,attacks/month,0,0
204921,.,0,0
204922,Duration,0,0
204923,remained,0,0
204924,constant,0,0
204925,in,0,0
204926,both,0,0
204927,groups,0,0
204928,(,0,0
204929,1-3,0,1
204930,h,0,1
204931,),0,0
204932,.,0,0
204933,Side,0,0
204934,effects,0,0
204935,were,0,0
204936,slight,0,0
204937,body,0,0
204938,weight,0,0
204939,gain,0,0
204940,or,0,1
204941,abdominal,0,0
204942,pain,0,0
204943,after,0,0
204944,intake,0,0
204945,",",0,0
204946,prophylaxis,0,0
204947,had,0,0
204948,not,0,0
204949,to,0,0
204950,be,0,0
204951,interrupted,0,1
204952,therefore,0,0
204953,.,0,0
204954,Longtime,0,0
204955,prognosis,0,0
204956,is,0,0
204957,not,0,0
204958,yet,0,0
204959,possible,0,0
204960,because,0,0
204961,the,0,0
204962,time,0,0
204963,of,0,0
204964,observation,0,1
204965,is,0,0
204966,too,0,0
204967,short,0,0
204968,so,0,0
204969,far,0,0
204970,.,0,0
204971,CONCLUSION,0,0
204972,Both,0,1
204973,substances,0,0
204974,are,0,0
204975,definitely,0,0
204976,useful,0,0
204977,and,0,0
204978,have,0,0
204979,few,0,0
204980,side,0,0
204981,effects,0,0
204982,in,0,0
204983,childhood,0,0
204984,migraine,0,0
204985,.,0,0
204986,If,0,0
204987,the,0,0
204988,response,0,0
204989,to,0,0
204990,one,0,0
204991,is,0,0
204992,insufficient,0,0
204993,the,0,0
204994,other,0,0
204995,substance,0,0
204996,should,0,0
204997,be,0,0
204998,tried,0,0
204999,.,0,0
205000,Comparison,0,0
205001,of,0,0
205002,nicardipine,1,1
205003,and,0,0
205004,propranolol,1,1
205005,in,0,0
205006,the,0,0
205007,treatment,0,0
205008,of,0,0
205009,mild,0,0
205010,and,0,0
205011,moderate,0,0
205012,hypertension,0,0
205013,.,0,0
205014,In,0,0
205015,a,0,0
205016,double-blind,0,0
205017,controlled,0,0
205018,trial,0,0
205019,22,0,0
205020,patients,0,0
205021,with,0,0
205022,mild,0,0
205023,or,0,1
205024,moderate,0,0
205025,essential,0,0
205026,hypertension,0,0
205027,were,0,0
205028,treated,0,0
205029,with,0,0
205030,nicardipine,1,1
205031,30,0,1
205032,mg,0,1
205033,t.d.s,0,1
205034,.,0,0
205035,and,0,0
205036,19,0,0
205037,patients,0,0
205038,with,0,0
205039,propranolol,1,1
205040,80,0,0
205041,mg,0,1
205042,t.d.s,0,1
205043,.,0,0
205044,as,0,0
205045,monotherapy,0,0
205046,for,0,0
205047,24,0,0
205048,weeks,0,0
205049,.,0,0
205050,Blood,0,0
205051,pressure,0,0
205052,in,0,0
205053,both,0,0
205054,groups,0,0
205055,at,0,0
205056,the,0,0
205057,end,0,0
205058,of,0,0
205059,trial,0,0
205060,was,0,0
205061,equally,0,0
205062,and,0,0
205063,significantly,0,0
205064,reduced,0,0
205065,;,0,0
205066,systolic,0,0
205067,pressure,0,0
205068,22.2,0,0
205069,mmHg,0,0
205070,and,0,0
205071,diastolic,0,0
205072,pressure,0,0
205073,15.5,0,0
205074,mmHg,0,0
205075,in,0,0
205076,the,0,0
205077,supine,0,0
205078,position,0,0
205079,",",0,0
205080,and,0,0
205081,24.4,0,0
205082,mmHg,0,0
205083,and,0,0
205084,18.4,0,0
205085,mmHg,0,0
205086,",",0,0
205087,respectively,0,0
205088,",",0,0
205089,in,0,0
205090,the,0,0
205091,standing,0,0
205092,position,0,0
205093,in,0,0
205094,those,0,0
205095,on,0,0
205096,nicardipine,1,1
205097,",",0,0
205098,and,0,0
205099,by,0,0
205100,23.7,0,0
205101,and,0,0
205102,16.2,0,0
205103,mmHg,0,0
205104,and,0,0
205105,28.0,0,0
205106,and,0,0
205107,19.2,0,0
205108,mmHg,0,0
205109,",",0,0
205110,respectively,0,0
205111,",",0,0
205112,in,0,0
205113,the,0,0
205114,propranolol,1,1
205115,group,0,0
205116,.,0,0
205117,There,0,0
205118,was,0,0
205119,an,0,0
205120,initial,0,0
205121,increase,0,0
205122,in,0,0
205123,heart,0,0
205124,rate,0,0
205125,in,0,0
205126,the,0,0
205127,nicardipine,1,1
205128,group,0,0
205129,",",0,0
205130,but,0,0
205131,the,0,0
205132,rise,0,0
205133,was,0,0
205134,only,0,0
205135,moderate,0,0
205136,(,0,0
205137,3,0,1
205138,beats/min,0,0
205139,supine,0,0
205140,p,0,0
205141,=,0,0
205142,0.3219,0,0
205143,",",0,0
205144,and,0,0
205145,7,0,0
205146,beats/min,0,0
205147,standing,0,0
205148,",",0,0
205149,p,0,0
205150,=,0,0
205151,0.0203,0,0
205152,),0,0
205153,at,0,0
205154,the,0,0
205155,end,0,0
205156,of,0,0
205157,the,0,0
205158,24,0,0
205159,weeks,0,0
205160,.,0,0
205161,In,0,0
205162,the,0,0
205163,propranolol,1,1
205164,group,0,0
205165,heart,0,0
205166,rate,0,0
205167,was,0,0
205168,reduced,0,0
205169,markedly,0,0
205170,.,0,0
205171,Adverse,0,0
205172,effects,0,0
205173,occurred,0,0
205174,in,0,0
205175,77,0,0
205176,%,0,0
205177,of,0,0
205178,patients,0,0
205179,on,0,0
205180,nicardipine,1,1
205181,and,0,0
205182,in,0,0
205183,63,0,0
205184,%,0,0
205185,of,0,0
205186,those,0,0
205187,on,0,0
205188,propranolol,1,1
205189,",",0,0
205190,and,0,0
205191,there,0,0
205192,were,0,0
205193,no,0,0
205194,unexpected,0,0
205195,findings,0,0
205196,.,0,0
205197,The,0,0
205198,effects,0,0
205199,were,0,0
205200,mild,0,0
205201,in,0,0
205202,both,0,0
205203,groups,0,0
205204,and,0,0
205205,did,0,0
205206,not,0,0
205207,lead,0,0
205208,any,0,0
205209,patient,0,0
205210,to,0,0
205211,stop,0,0
205212,medication,0,1
205213,.,0,0
205214,One,0,0
205215,patient,0,0
205216,on,0,0
205217,propranolol,1,1
205218,was,0,0
205219,withdrawn,0,0
205220,from,0,0
205221,the,0,0
205222,trial,0,0
205223,because,0,0
205224,of,0,0
205225,poor,0,0
205226,blood,0,0
205227,pressure,0,1
205228,control,0,1
205229,and,0,0
205230,suspected,0,0
205231,angina,0,0
205232,pectoris,0,0
205233,after,0,0
205234,5,0,0
205235,weeks,0,0
205236,on,0,0
205237,active,0,0
205238,medication,0,1
205239,.,0,0
205240,There,0,0
205241,were,0,0
205242,no,0,0
205243,significant,0,0
205244,changes,0,0
205245,in,0,0
205246,blood,0,0
205247,chemistry,0,0
205248,",",0,0
205249,including,0,0
205250,lipoprotein,0,0
205251,classes,0,0
205252,.,0,0
205253,Overall,0,0
205254,",",0,0
205255,in,0,0
205256,comparison,0,0
205257,with,0,0
205258,propranolol,1,1
205259,",",0,0
205260,nicardipine,0,1
205261,was,0,0
205262,effective,0,0
205263,",",0,0
205264,well-tolerated,0,0
205265,and,0,0
205266,safe,0,0
205267,to,0,0
205268,use,0,0
205269,in,0,0
205270,the,0,0
205271,monotherapy,0,1
205272,of,0,0
205273,mild,0,0
205274,or,0,1
205275,moderate,0,0
205276,essential,0,0
205277,hypertension,0,0
205278,.,0,0
205279,Predictors,0,0
205280,of,0,0
205281,blood,0,0
205282,pressure,0,0
205283,change,0,0
205284,in,0,0
205285,a,0,0
205286,series,0,0
205287,of,0,0
205288,controlled,0,0
205289,dietary,0,1
205290,intervention,0,1
205291,studies,0,0
205292,.,0,0
205293,Three,0,0
205294,controlled,0,0
205295,dietary,1,1
205296,intervention,1,1
205297,studies,0,0
205298,were,0,0
205299,carried,0,0
205300,out,0,0
205301,in,0,0
205302,1981-1983,0,0
205303,in,0,0
205304,North,0,0
205305,Karelia,0,0
205306,",",0,0
205307,Finland,0,0
205308,",",0,0
205309,to,0,0
205310,asses,0,0
205311,the,0,0
205312,impact,0,0
205313,of,0,0
205314,dietary,0,1
205315,fat,0,0
205316,intake,0,0
205317,modification,0,1
205318,on,0,0
205319,blood,0,0
205320,pressure,0,0
205321,(,0,1
205322,BP,0,0
205323,),0,0
205324,.,0,0
205325,All,0,0
205326,these,0,0
205327,studies,0,0
205328,involved,0,0
205329,middle-aged,0,0
205330,men,0,0
205331,and,0,0
205332,women,0,0
205333,in,0,0
205334,rural,0,0
205335,or,0,1
205336,semirural,0,1
205337,areas,0,0
205338,and,0,0
205339,comprised,0,0
205340,a,0,0
205341,baseline,0,0
205342,period,0,0
205343,",",0,0
205344,a,0,0
205345,six,0,0
205346,week,0,0
205347,(,0,0
205348,or,0,1
205349,12,0,0
205350,weeks,0,0
205351,in,0,0
205352,the,0,0
205353,third,0,0
205354,study,0,0
205355,),0,1
205356,intervention,0,1
205357,period,0,0
205358,and,0,0
205359,a,0,0
205360,four,0,0
205361,to,0,0
205362,six,0,0
205363,week,0,0
205364,return,0,0
205365,to,0,0
205366,baseline,0,0
205367,.,0,0
205368,During,0,0
205369,the,0,0
205370,intervention,0,1
205371,period,0,0
205372,the,0,0
205373,total,0,0
205374,fat,1,0
205375,intake,1,0
205376,was,0,0
205377,reduced,0,0
205378,from,0,0
205379,39,0,0
205380,%,0,0
205381,to,0,0
205382,24,0,0
205383,%,0,0
205384,of,0,0
205385,energy,0,0
205386,and,0,0
205387,the,0,0
205388,polyunsaturated/saturated,1,1
205389,(,1,0
205390,P/S,1,0
205391,),1,1
205392,ratio,1,0
205393,increased,0,0
205394,from,0,0
205395,0.2,0,0
205396,to,0,0
205397,0.4-1.2,0,0
205398,.,0,0
205399,In,0,0
205400,all,0,0
205401,groups,0,0
205402,energy,0,0
205403,intake,0,0
205404,was,0,0
205405,kept,0,0
205406,constant,0,0
205407,.,0,0
205408,For,0,0
205409,the,0,0
205410,present,0,0
205411,report,0,0
205412,data,0,0
205413,from,0,0
205414,the,0,0
205415,three,0,0
205416,studies,0,0
205417,were,0,0
205418,pooled,0,0
205419,for,0,0
205420,a,0,0
205421,series,0,0
205422,of,0,0
205423,stepwise,0,0
205424,regression,0,0
205425,analyses,0,0
205426,to,0,0
205427,predict,0,0
205428,changes,0,0
205429,in,0,0
205430,BP,0,0
205431,with,0,0
205432,different,0,0
205433,dietary,0,0
205434,changes,0,0
205435,.,0,0
205436,For,0,0
205437,both,0,0
205438,systolic,0,0
205439,(,0,0
205440,SBP,0,1
205441,),0,1
205442,and,0,0
205443,diastolic,0,0
205444,(,0,1
205445,DBP,0,1
205446,),0,1
205447,blood,0,0
205448,pressure,0,0
205449,",",0,0
205450,change,0,0
205451,in,0,0
205452,polyunsaturated,0,1
205453,fatty,0,1
205454,acid,0,1
205455,intake,0,0
205456,was,0,0
205457,the,0,0
205458,strongest,0,0
205459,dietary,0,1
205460,predictor,0,0
205461,of,0,0
205462,BP,0,0
205463,change,0,0
205464,.,0,0
205465,Changes,0,0
205466,in,0,0
205467,body,0,0
205468,weight,0,0
205469,",",0,0
205470,total,0,0
205471,fat,0,0
205472,intake,0,0
205473,",",0,0
205474,urinary,0,0
205475,sodium,0,1
205476,and,0,0
205477,potassium,0,1
205478,did,0,0
205479,not,0,0
205480,have,0,0
205481,significant,0,0
205482,predictive,0,0
205483,power,0,0
205484,in,0,0
205485,any,0,0
205486,of,0,0
205487,the,0,0
205488,analyses,0,0
205489,.,0,0
205490,The,0,0
205491,findings,0,0
205492,support,0,0
205493,the,0,0
205494,hypothesis,0,0
205495,that,0,0
205496,modification,0,1
205497,of,0,0
205498,dietary,0,1
205499,fat,0,0
205500,intake,0,0
205501,is,0,0
205502,a,0,0
205503,significant,0,0
205504,predictor,0,0
205505,of,0,0
205506,change,0,0
205507,in,0,0
205508,BP,0,0
205509,.,0,0
205510,A,0,0
205511,30-month,0,0
205512,longitudinal,0,0
205513,study,0,0
205514,of,0,0
205515,the,0,0
205516,effects,0,0
205517,of,0,0
205518,some,0,0
205519,oral,1,1
205520,hygiene,1,0
205521,measures,1,0
205522,on,0,0
205523,Streptococcus,0,1
205524,mutans,0,0
205525,and,0,0
205526,approximal,0,0
205527,dental,0,0
205528,caries,0,0
205529,.,0,0
205530,The,0,0
205531,effects,0,0
205532,of,0,0
205533,some,0,0
205534,oral,1,1
205535,hygiene,1,0
205536,measures,1,0
205537,on,0,0
205538,Streptococcus,0,1
205539,mutants,0,0
205540,and,0,0
205541,approximal,0,0
205542,dental,0,0
205543,caries,0,0
205544,were,0,0
205545,evaluated,0,0
205546,.,0,0
205547,One,0,0
205548,hundred,0,0
205549,and,0,0
205550,eighty-seven,0,0
205551,13-year-old,0,0
205552,individuals,0,0
205553,with,0,0
205554,high,0,0
205555,levels,0,0
205556,of,0,0
205557,salivary,0,0
205558,S.,0,1
205559,mutans,0,0
205560,(,0,0
205561,greater,0,0
205562,than,0,0
205563,10,0,0
205564,(,0,0
205565,6,0,0
205566,),0,1
205567,/mL,0,0
205568,),0,0
205569,were,0,0
205570,selected,0,0
205571,.,0,0
205572,They,0,0
205573,were,0,0
205574,randomly,0,0
205575,distributed,0,0
205576,into,0,0
205577,three,0,0
205578,groups,0,0
205579,.,0,0
205580,Group,0,0
205581,I,0,0
205582,initially,0,0
205583,received,0,0
205584,professional,1,0
205585,mechanical,1,0
205586,tooth-cleaning,1,1
205587,",",1,0
205588,tongue-scraping,1,0
205589,",",1,0
205590,chlorhexidine,1,1
205591,treatment,1,0
205592,",",1,0
205593,and,1,0
205594,oral,1,1
205595,hygiene,1,0
205596,instructions,1,1
205597,concentrated,0,0
205598,on,0,0
205599,the,0,0
205600,approximal,0,0
205601,surfaces,0,1
205602,most,0,0
205603,colonized,0,0
205604,by,0,0
205605,S.,0,1
205606,mutans,0,0
205607,.,0,0
205608,The,0,0
205609,treatment,0,0
205610,was,0,0
205611,given,0,0
205612,four,0,0
205613,times,0,0
205614,with,0,0
205615,intervals,0,0
205616,of,0,0
205617,two,0,0
205618,days,0,0
205619,",",0,0
205620,followed,0,0
205621,by,0,0
205622,one,0,0
205623,single,0,0
205624,treatment,0,0
205625,every,0,1
205626,six,0,0
205627,months,0,0
205628,throughout,0,0
205629,the,0,0
205630,experimental,0,0
205631,period,0,0
205632,.,0,0
205633,The,0,0
205634,initial,0,0
205635,treatment,0,0
205636,period,0,0
205637,for,0,0
205638,group,0,0
205639,II,0,0
205640,",",0,0
205641,also,0,0
205642,consisting,0,0
205643,of,0,0
205644,four,0,0
205645,visits,0,0
205646,",",0,0
205647,included,0,0
205648,the,0,0
205649,same,0,0
205650,oral,1,1
205651,hygiene,1,0
205652,instructions,1,1
205653,as,0,0
205654,for,0,0
205655,group,0,0
205656,I,0,0
205657,.,0,0
205658,The,0,0
205659,instructions,0,0
205660,were,0,0
205661,repeated,0,0
205662,every,0,0
205663,six,0,0
205664,months,0,0
205665,.,0,0
205666,Group,0,0
205667,III,0,0
205668,was,0,0
205669,maintained,0,0
205670,in,0,0
205671,the,0,0
205672,preventive,1,0
205673,program,1,1
205674,provided,1,0
205675,by,1,0
205676,the,1,0
205677,local,1,1
205678,Dental,1,0
205679,Health,1,1
205680,Office,1,1
205681,",",0,0
205682,based,0,0
205683,on,0,0
205684,mechanical,1,0
205685,plaque,1,0
205686,control,1,1
205687,and,0,0
205688,topical,1,1
205689,use,1,0
205690,of,1,0
205691,fluorides,1,1
205692,and,1,0
205693,chlorhexidine,1,1
205694,at,0,0
205695,individualized,0,0
205696,intervals,0,0
205697,.,0,0
205698,Group,0,0
205699,I,0,0
205700,showed,0,0
205701,a,0,0
205702,significant,0,0
205703,immediate,0,0
205704,reduction,0,0
205705,of,0,0
205706,S.,0,1
205707,mutans,0,0
205708,in,0,0
205709,saliva,0,0
205710,as,0,0
205711,well,0,0
205712,as,0,0
205713,an,0,0
205714,approximal,0,0
205715,tooth,0,0
205716,surfaces,0,1
205717,.,0,0
205718,After,0,0
205719,six,0,0
205720,months,0,0
205721,",",0,0
205722,there,0,0
205723,were,0,0
205724,no,0,0
205725,differences,0,0
205726,among,0,0
205727,the,0,0
205728,three,0,0
205729,groups,0,0
205730,regarding,0,0
205731,these,0,0
205732,variables,0,0
205733,.,0,0
205734,Compared,0,0
205735,with,0,0
205736,baseline,0,0
205737,",",0,0
205738,there,0,0
205739,was,0,0
205740,a,0,0
205741,significant,0,0
205742,reduction,0,0
205743,of,0,0
205744,S.,0,1
205745,mutans,0,0
205746,in,0,0
205747,all,0,0
205748,groups,0,0
205749,.,0,0
205750,There,0,0
205751,was,0,0
205752,no,0,0
205753,significant,0,0
205754,difference,0,0
205755,in,0,0
205756,caries,0,0
205757,progression,0,0
205758,among,0,0
205759,the,0,0
205760,three,0,0
205761,groups,0,0
205762,.,0,0
205763,However,0,0
205764,",",0,0
205765,the,0,0
205766,selected,0,0
205767,high-risk,0,0
205768,individuals,0,0
205769,in,0,0
205770,group,0,0
205771,I,0,0
205772,developed,0,0
205773,0.25,0,0
205774,new,0,0
205775,manifest,0,0
205776,caries,0,0
205777,lesions,0,0
205778,approximally/year,0,0
205779,",",0,0
205780,compared,0,0
205781,with,0,0
205782,0.27,0,0
205783,for,0,0
205784,all,0,0
205785,children,0,0
205786,of,0,0
205787,the,0,0
205788,same,0,0
205789,age,0,0
205790,group,0,0
205791,in,0,0
205792,the,0,0
205793,area,0,0
205794,.,0,0
205795,Seventeen,0,0
205796,individuals,0,0
205797,had,0,0
205798,approximal,0,0
205799,surfaces,0,1
205800,with,0,0
205801,consistently,0,0
205802,high,0,0
205803,or,0,1
205804,consistently,0,0
205805,low,0,0
205806,S.,0,1
205807,mutans,0,0
205808,levels,0,0
205809,.,0,0
205810,Forty-six,0,0
205811,percent,0,0
205812,of,0,0
205813,the,0,0
205814,surfaces,0,1
205815,with,0,0
205816,high,0,0
205817,values,0,0
205818,developed,0,0
205819,new,0,0
205820,or,0,1
205821,progressive,0,0
205822,caries,0,0
205823,",",0,0
205824,compared,0,0
205825,with,0,0
205826,2,0,0
205827,%,0,0
205828,of,0,0
205829,the,0,0
205830,surfaces,0,1
205831,with,0,0
205832,low,0,0
205833,values,0,0
205834,.,0,0
205835,Nebulized,0,1
205836,racemic,1,1
205837,epinephrine,1,1
205838,by,0,0
205839,IPPB,0,0
205840,for,0,0
205841,the,0,0
205842,treatment,0,0
205843,of,0,0
205844,croup,0,0
205845,:,0,0
205846,a,0,0
205847,double-blind,0,0
205848,study,0,0
205849,.,0,0
205850,Racemic,1,1
205851,epinephrine,1,1
205852,has,0,0
205853,been,0,0
205854,advocated,0,0
205855,for,0,0
205856,the,0,0
205857,treatment,0,0
205858,of,0,0
205859,croup,0,0
205860,",",0,0
205861,but,0,0
205862,controlled,0,0
205863,studies,0,0
205864,have,0,0
205865,not,0,0
205866,proved,0,0
205867,it,0,0
205868,more,0,0
205869,effective,0,0
205870,than,0,0
205871,saline,0,1
205872,.,0,0
205873,Twenty,0,0
205874,patients,0,0
205875,(,0,0
205876,aged,0,0
205877,4,0,0
205878,months,0,0
205879,to,0,0
205880,5,0,0
205881,years,0,0
205882,),0,0
205883,hospitalized,0,0
205884,with,0,0
205885,acute,0,0
205886,croup,0,0
205887,and,0,0
205888,persistent,0,0
205889,inspiratory,0,1
205890,stridor,0,0
205891,at,0,0
205892,rest,0,0
205893,were,0,0
205894,randomly,0,0
205895,assigned,0,0
205896,to,0,0
205897,one,0,0
205898,of,0,0
205899,two,0,0
205900,treatment,0,0
205901,groups,0,0
205902,:,0,0
205903,saline,1,1
205904,or,1,1
205905,racemic,1,1
205906,epinephrine,1,1
205907,",",0,0
205908,both,0,0
205909,nebulized,0,1
205910,and,0,0
205911,delivered,0,1
205912,by,0,0
205913,intermittent,0,0
205914,positive,0,0
205915,pressure,0,0
205916,breathing,0,1
205917,.,0,0
205918,Clinical,0,0
205919,scores,0,0
205920,were,0,0
205921,significantly,0,0
205922,improved,0,0
205923,(,0,0
205924,P,0,0
205925,less,0,0
205926,than,0,0
205927,.01,0,0
205928,),0,0
205929,at,0,0
205930,ten,0,0
205931,and,0,0
205932,30,0,0
205933,minutes,0,0
205934,following,0,0
205935,the,0,0
205936,treatment,0,0
205937,with,0,0
205938,racemic,1,1
205939,epinephrine,1,1
205940,but,0,0
205941,not,0,0
205942,at,0,0
205943,120,0,0
205944,minutes,0,0
205945,.,0,0
205946,Racemic,1,1
205947,epinephrine,1,1
205948,was,0,0
205949,significantly,0,0
205950,more,0,0
205951,effective,0,0
205952,than,0,0
205953,saline,0,1
205954,at,0,0
205955,10,0,0
205956,(,0,0
205957,P,0,0
205958,less,0,0
205959,than,0,0
205960,.01,0,0
205961,),0,1
205962,and,0,0
205963,30,0,1
205964,minutes,0,0
205965,(,0,0
205966,P,0,0
205967,less,0,0
205968,than,0,0
205969,.05,0,0
205970,),0,1
205971,but,0,0
205972,not,0,0
205973,at,0,0
205974,120,0,0
205975,minutes,0,0
205976,after,0,0
205977,the,0,0
205978,treatment,0,0
205979,.,0,0
205980,We,0,0
205981,conclude,0,0
205982,that,0,0
205983,nebulized,0,1
205984,racemic,1,1
205985,epinephrine,1,1
205986,is,0,0
205987,effective,0,0
205988,treatment,0,0
205989,for,0,0
205990,the,0,0
205991,acute,0,0
205992,signs,0,0
205993,of,0,0
205994,croup,0,0
205995,.,0,0
205996,Hemolytic,1,1
205997,streptococcus,1,1
205998,preparation,1,1
205999,OK-432,1,1
206000,;,1,0
206001,beneficial,0,0
206002,adjuvant,0,1
206003,therapy,0,1
206004,in,0,0
206005,recurrent,0,0
206006,gastric,0,0
206007,carcinoma,0,0
206008,.,0,0
206009,The,0,0
206010,administration,0,0
206011,of,0,0
206012,a,0,0
206013,hemolytic,1,0
206014,streptococcus,1,1
206015,preparation,1,1
206016,",",0,0
206017,OK-432,0,1
206018,",",0,0
206019,is,0,0
206020,thought,0,0
206021,to,0,0
206022,be,0,0
206023,of,0,0
206024,therapeutic,0,0
206025,value,0,0
206026,in,0,0
206027,the,0,0
206028,treatment,0,0
206029,of,0,0
206030,cancer,0,0
206031,patients,0,0
206032,through,0,0
206033,a,0,0
206034,stimulatory,0,0
206035,effect,0,0
206036,on,0,0
206037,the,0,0
206038,immune,0,0
206039,system,0,0
206040,.,0,0
206041,In,0,0
206042,order,0,0
206043,to,0,0
206044,evaluate,0,0
206045,any,0,0
206046,beneficial,0,0
206047,effect,0,0
206048,of,0,0
206049,such,0,0
206050,an,0,0
206051,administration,0,0
206052,",",0,0
206053,a,0,0
206054,group,0,0
206055,of,0,0
206056,patients,0,0
206057,with,0,0
206058,recurrent,0,0
206059,gastric,0,0
206060,cancer,0,0
206061,was,0,0
206062,studied,0,0
206063,.,0,0
206064,This,0,0
206065,group,0,0
206066,was,0,0
206067,randomly,0,0
206068,subdivided,0,0
206069,into,0,0
206070,3,1,0
206071,groups,1,0
206072,:,1,0
206073,1,1,0
206074,),1,0
206075,Intradermal,1,1
206076,group,1,1
206077,(,1,0
206078,ID,1,1
206079,Group,1,0
206080,),1,0
206081,",",1,0
206082,42,1,0
206083,patients,1,0
206084,given,1,0
206085,an,1,0
206086,intradermal,1,1
206087,injections,1,1
206088,of,1,0
206089,OK-432,1,1
206090,.,1,0
206091,2,1,0
206092,),1,0
206093,Intramuscular,1,1
206094,group,1,1
206095,(,1,0
206096,IM,1,1
206097,Group,1,0
206098,),1,0
206099,",",1,0
206100,40,1,0
206101,patients,1,0
206102,given,1,0
206103,an,1,0
206104,intramuscular,1,1
206105,injections,1,1
206106,of,1,0
206107,OK-432,1,1
206108,.,1,0
206109,3,1,0
206110,),1,0
206111,Control,1,1
206112,group,1,1
206113,(,1,0
206114,C,1,1
206115,Group,1,0
206116,),1,0
206117,",",1,0
206118,39,1,0
206119,patients,1,0
206120,not,1,0
206121,given,1,0
206122,injections,1,1
206123,.,1,0
206124,Each,0,0
206125,group,0,0
206126,was,0,0
206127,studied,0,0
206128,in,0,0
206129,regards,0,0
206130,to,0,0
206131,the,0,0
206132,length,0,0
206133,of,0,0
206134,survival,0,0
206135,",",0,0
206136,the,0,0
206137,host,0,0
206138,immune,0,0
206139,response,0,0
206140,and,0,0
206141,the,0,0
206142,incidence,0,0
206143,of,0,0
206144,side,0,0
206145,effects,0,0
206146,.,0,0
206147,When,0,0
206148,compared,0,0
206149,to,0,0
206150,the,0,0
206151,IM,0,1
206152,and,0,0
206153,C,0,1
206154,Groups,0,0
206155,",",0,0
206156,the,0,0
206157,ID,0,1
206158,Group,0,0
206159,showed,0,0
206160,improved,0,0
206161,survival,0,0
206162,.,0,0
206163,Accompanying,0,0
206164,this,0,0
206165,improved,0,0
206166,survival,0,0
206167,",",0,0
206168,the,0,0
206169,ID,0,1
206170,Group,0,0
206171,also,0,0
206172,had,0,0
206173,greater,0,0
206174,white,0,0
206175,cell,0,0
206176,and,0,0
206177,lymphocyte,0,0
206178,counts,0,0
206179,",",0,0
206180,a,0,0
206181,greater,0,0
206182,number,0,0
206183,of,0,0
206184,T,0,0
206185,cells,0,0
206186,",",0,0
206187,and,0,0
206188,a,0,0
206189,more,0,0
206190,dramatic,0,0
206191,skin,0,0
206192,reaction,0,1
206193,to,0,0
206194,the,0,0
206195,extracted,0,0
206196,cell,0,0
206197,wall,0,0
206198,polysaccharide,0,1
206199,of,0,0
206200,hemolytic,0,0
206201,streptococcus,0,1
206202,Su-strain,0,1
206203,(,0,1
206204,Su-PS,0,1
206205,),0,0
206206,.,0,0
206207,The,0,0
206208,ID,0,0
206209,Group,0,0
206210,",",0,0
206211,following,0,0
206212,OK-432,0,1
206213,injection,0,1
206214,",",0,0
206215,had,0,0
206216,a,0,0
206217,4.8,0,0
206218,%,0,0
206219,incidence,0,0
206220,of,0,0
206221,fever,0,0
206222,and,0,0
206223,a,0,0
206224,52.4,0,0
206225,%,0,0
206226,incidence,0,0
206227,of,0,0
206228,local,0,1
206229,abscess,0,1
206230,formation,0,0
206231,at,0,0
206232,the,0,0
206233,injection,0,1
206234,site,0,0
206235,.,0,0
206236,90,0,0
206237,%,0,0
206238,of,0,0
206239,the,0,0
206240,IM,0,1
206241,Group,0,0
206242,developed,0,0
206243,fever,0,0
206244,but,0,0
206245,abscess,0,1
206246,formation,0,0
206247,was,0,0
206248,absent,0,0
206249,in,0,0
206250,all,0,0
206251,patients,0,0
206252,.,0,0
206253,From,0,0
206254,these,0,0
206255,results,0,0
206256,",",0,0
206257,it,0,0
206258,was,0,0
206259,concluded,0,0
206260,that,0,0
206261,in,0,0
206262,the,0,0
206263,patients,0,0
206264,tested,0,0
206265,",",0,0
206266,intradermal,0,1
206267,injection,0,1
206268,of,0,0
206269,OK-432,0,1
206270,appears,0,0
206271,to,0,0
206272,be,0,0
206273,clinically,0,0
206274,superior,0,0
206275,to,0,0
206276,intramuscular,0,1
206277,injection,0,1
206278,.,0,0
206279,A,0,0
206280,prospective,0,0
206281,study,0,0
206282,of,0,0
206283,streptokinase,1,1
206284,and,0,0
206285,heparin,1,1
206286,in,0,0
206287,the,0,0
206288,treatment,0,0
206289,of,0,0
206290,deep,0,1
206291,vein,0,0
206292,thrombosis,0,0
206293,.,0,0
206294,In,0,0
206295,a,0,0
206296,prospective,0,0
206297,trial,0,0
206298,",",0,0
206299,42,0,0
206300,medical,0,0
206301,patients,0,0
206302,with,0,0
206303,a,0,0
206304,history,0,0
206305,of,0,0
206306,deep,0,1
206307,vein,0,0
206308,thrombosis,0,0
206309,of,0,0
206310,less,0,0
206311,than,0,0
206312,five,0,0
206313,days,0,0
206314,were,0,0
206315,allocated,0,0
206316,at,0,0
206317,random,0,0
206318,to,0,0
206319,treatment,0,0
206320,with,0,1
206321,streptokinase,1,1
206322,or,0,1
206323,heparin,1,1
206324,.,1,0
206325,Only,0,0
206326,patients,0,0
206327,with,0,0
206328,extensive,0,0
206329,thromboses,0,0
206330,were,0,0
206331,included,0,0
206332,.,0,0
206333,Streptokinase,1,1
206334,was,0,0
206335,given,0,0
206336,in,0,0
206337,a,0,0
206338,loading,0,0
206339,dose,0,0
206340,of,0,0
206341,250,0,0
206342,000,0,0
206343,IU,0,1
206344,and,0,0
206345,a,0,0
206346,maintenance,0,0
206347,dose,0,0
206348,of,0,0
206349,100,0,0
206350,000,0,0
206351,IU/hour,0,0
206352,for,0,0
206353,4,0,0
206354,days,0,0
206355,as,0,0
206356,a,0,0
206357,mean,0,0
206358,.,0,0
206359,Heparin,1,1
206360,was,0,0
206361,given,0,0
206362,in,0,0
206363,a,0,0
206364,loading,0,0
206365,dose,0,0
206366,of,0,0
206367,15,0,0
206368,000,0,0
206369,IU,0,1
206370,and,0,0
206371,a,0,0
206372,maintenance,0,0
206373,dose,0,0
206374,of,0,0
206375,20,0,0
206376,000-50,0,0
206377,000,0,0
206378,IU/day,0,1
206379,.,0,0
206380,The,0,0
206381,therapeutic,0,0
206382,results,0,0
206383,were,0,0
206384,evaluated,0,0
206385,by,0,0
206386,phlebography,0,1
206387,.,0,0
206388,Significant,0,0
206389,thrombolysis,0,0
206390,occurred,0,0
206391,in,0,0
206392,71.4,0,0
206393,%,0,0
206394,of,0,0
206395,21,0,0
206396,patients,0,0
206397,treated,0,0
206398,with,0,0
206399,streptokinase,1,1
206400,and,0,0
206401,in,0,0
206402,23.8,0,0
206403,%,0,0
206404,of,0,0
206405,the,0,0
206406,21,0,0
206407,heparin-treated,1,0
206408,patients,0,0
206409,.,0,0
206410,Using,0,0
206411,the,0,0
206412,chi2-test,0,0
206413,for,0,0
206414,overall,0,0
206415,association,0,0
206416,",",0,0
206417,this,0,0
206418,difference,0,0
206419,was,0,0
206420,statistically,0,0
206421,highly,0,0
206422,significant,0,0
206423,(,0,0
206424,p,0,0
206425,=,0,0
206426,0.002,0,0
206427,),0,0
206428,.,0,0
206429,Three,0,0
206430,patients,0,0
206431,in,0,0
206432,each,0,0
206433,treatment,0,0
206434,group,0,0
206435,experienced,0,0
206436,major,0,0
206437,bleeding,0,0
206438,",",0,0
206439,two,0,0
206440,in,0,0
206441,each,0,0
206442,group,0,0
206443,requiring,0,0
206444,blood,0,0
206445,transfusions,0,0
206446,.,0,0
206447,Minor,0,0
206448,bleeding,0,0
206449,and,0,0
206450,slight,0,0
206451,rise,0,0
206452,in,0,0
206453,temperature,0,0
206454,were,0,0
206455,encountered,0,0
206456,more,0,0
206457,often,0,0
206458,in,0,0
206459,the,0,0
206460,streptokinase,1,1
206461,than,0,0
206462,in,0,0
206463,the,0,0
206464,heparin,1,1
206465,group,0,0
206466,.,0,0
206467,It,0,0
206468,is,0,0
206469,concluded,0,0
206470,that,0,0
206471,patients,0,0
206472,with,0,0
206473,acute,0,0
206474,deep,0,1
206475,vein,0,0
206476,thrombosis,0,0
206477,with,0,0
206478,proximal,0,0
206479,extension,0,0
206480,of,0,0
206481,the,0,0
206482,thrombus,0,0
206483,beyond,0,0
206484,the,0,0
206485,calf,0,1
206486,veins,0,0
206487,should,0,0
206488,be,0,0
206489,offered,0,0
206490,a,0,0
206491,therapeutic,0,0
206492,trial,0,0
206493,with,0,0
206494,streptokinase,1,1
206495,.,1,0
206496,A,0,0
206497,randomized,0,0
206498,comparison,0,0
206499,of,0,0
206500,tamoxifen,1,1
206501,with,0,0
206502,surgical,1,1
206503,oophorectomy,1,1
206504,in,0,0
206505,premenopausal,0,0
206506,patients,0,0
206507,with,0,0
206508,advanced,0,0
206509,breast,0,0
206510,cancer,0,0
206511,.,0,0
206512,We,0,0
206513,randomized,0,0
206514,122,0,0
206515,premenopausal,0,0
206516,women,0,0
206517,to,0,0
206518,receive,0,1
206519,tamoxifen,1,1
206520,or,0,1
206521,to,0,0
206522,undergo,1,0
206523,a,1,0
206524,surgical,1,0
206525,oophorectomy,1,1
206526,.,1,0
206527,Of,0,0
206528,54,0,0
206529,evaluable,0,0
206530,women,0,0
206531,treated,0,0
206532,with,0,0
206533,tamoxifen,1,1
206534,",",0,0
206535,24,0,0
206536,%,0,0
206537,had,0,0
206538,an,0,0
206539,objective,0,0
206540,response,0,0
206541,",",0,0
206542,as,0,0
206543,compared,0,0
206544,with,0,0
206545,21,0,0
206546,%,0,0
206547,of,0,0
206548,53,0,0
206549,women,0,0
206550,having,0,0
206551,an,0,0
206552,oophorectomy,1,1
206553,.,1,0
206554,The,0,0
206555,median,0,0
206556,duration,0,0
206557,of,0,0
206558,response,0,0
206559,for,0,0
206560,tamoxifen,1,1
206561,(,0,0
206562,20,0,1
206563,months,0,0
206564,),0,0
206565,was,0,0
206566,longer,0,0
206567,than,0,0
206568,that,0,0
206569,for,0,0
206570,surgical,1,1
206571,oophorectomy,1,1
206572,(,0,0
206573,7,0,0
206574,months,0,0
206575,),0,0
206576,",",0,0
206577,but,0,0
206578,this,0,0
206579,did,0,0
206580,not,0,0
206581,achieve,0,0
206582,statistical,0,0
206583,significance,0,0
206584,(,0,0
206585,P,0,0
206586,=,0,0
206587,.056,0,0
206588,),0,0
206589,.,0,0
206590,Overall,0,0
206591,median,0,0
206592,survival,0,0
206593,was,0,0
206594,15,0,0
206595,months,0,0
206596,for,0,0
206597,58,0,0
206598,patients,0,0
206599,receiving,0,0
206600,tamoxifen,0,1
206601,and,0,0
206602,25,0,0
206603,months,0,0
206604,for,0,0
206605,53,0,0
206606,patients,0,0
206607,undergoing,0,0
206608,oophorectomy,0,1
206609,(,0,0
206610,P,0,0
206611,=,0,0
206612,.18,0,0
206613,),0,0
206614,.,0,0
206615,Toxicity,0,0
206616,was,0,0
206617,greater,0,0
206618,in,0,0
206619,those,0,0
206620,undergoing,0,0
206621,oophorectomy,0,1
206622,",",0,0
206623,though,0,0
206624,both,0,0
206625,treatments,0,0
206626,were,0,0
206627,well,0,0
206628,tolerated,0,0
206629,.,0,0
206630,In,0,0
206631,those,0,0
206632,premenopausal,0,0
206633,women,0,0
206634,for,0,0
206635,whom,0,0
206636,hormonal,0,0
206637,therapy,0,1
206638,is,0,0
206639,indicated,0,0
206640,",",0,0
206641,tamoxifen,1,1
206642,is,0,0
206643,a,0,0
206644,suitable,0,0
206645,alternative,0,0
206646,to,0,0
206647,surgical,1,0
206648,oophorectomy,1,1
206649,.,1,0
206650,Review,0,1
206651,of,0,0
206652,the,0,0
206653,Multicenter,0,0
206654,Trial,0,1
206655,Committee,0,1
206656,report,0,0
206657,:,0,0
206658,a,0,0
206659,prospective,0,0
206660,",",0,0
206661,randomized,0,0
206662,study,0,0
206663,on,0,0
206664,the,0,0
206665,prophylaxis,0,1
206666,of,0,0
206667,postoperative,0,0
206668,deep,0,1
206669,venous,0,0
206670,thrombosis,0,0
206671,.,0,0
206672,The,0,0
206673,etiology,0,0
206674,of,0,0
206675,postoperative,0,0
206676,deep,0,1
206677,venous,0,1
206678,thrombosis,0,0
206679,(,0,1
206680,DVT,0,1
206681,),0,1
206682,is,0,0
206683,thought,0,0
206684,to,0,0
206685,be,0,0
206686,due,0,0
206687,to,0,0
206688,a,0,0
206689,combination,0,1
206690,of,0,0
206691,factors,0,0
206692,including,0,0
206693,stasis,0,0
206694,",",0,0
206695,a,0,0
206696,hypercoagulable,0,0
206697,state,0,0
206698,and,0,0
206699,venous,0,1
206700,endothelial,0,0
206701,damage,0,0
206702,.,0,0
206703,Methods,0,0
206704,of,0,0
206705,prophylaxis,0,0
206706,are,0,0
206707,directed,0,0
206708,toward,0,0
206709,correcting,0,0
206710,one,0,0
206711,or,0,0
206712,more,0,0
206713,of,0,0
206714,these,0,0
206715,pathologic,0,0
206716,events,0,0
206717,.,0,0
206718,Methods,0,0
206719,counteracting,0,0
206720,more,0,0
206721,than,0,0
206722,one,0,0
206723,of,0,0
206724,these,0,0
206725,factors,0,0
206726,can,0,0
206727,be,0,0
206728,expected,0,0
206729,to,0,0
206730,be,0,0
206731,even,0,0
206732,more,0,0
206733,effective,0,0
206734,.,0,0
206735,The,0,0
206736,combination,0,0
206737,of,0,0
206738,dihydroergotamine,1,1
206739,(,1,1
206740,DHE,1,1
206741,),1,1
206742,and,1,0
206743,heparin,1,1
206744,was,0,0
206745,anticipated,0,0
206746,to,0,0
206747,minimize,0,0
206748,stasis,0,0
206749,and,0,0
206750,the,0,0
206751,hypercoagulable,0,0
206752,state,0,0
206753,respectively,0,0
206754,.,0,0
206755,Based,0,0
206756,upon,0,0
206757,current,0,0
206758,experimental,0,0
206759,evidence,0,0
206760,and,0,0
206761,current,0,1
206762,theory,0,1
206763,",",0,0
206764,an,0,0
206765,additional,0,0
206766,benefit,0,0
206767,might,0,0
206768,include,0,0
206769,minimizing,0,0
206770,venous,0,0
206771,endothelial,0,0
206772,injury,0,0
206773,by,0,0
206774,controlling,0,0
206775,venomotor,0,1
206776,tone,0,1
206777,.,0,0
206778,A,0,0
206779,prospective,0,0
206780,",",0,0
206781,randomized,0,0
206782,",",0,0
206783,double-blind,0,0
206784,",",0,0
206785,multicenter,0,0
206786,trial,0,0
206787,was,0,0
206788,designed,0,0
206789,and,0,0
206790,performed,0,0
206791,in,0,0
206792,the,0,0
206793,United,0,0
206794,States,0,0
206795,evaluating,0,0
206796,the,0,0
206797,prophylactic,0,1
206798,efficacy,0,0
206799,of,0,0
206800,DHE,1,1
206801,0.5,1,1
206802,mg,1,1
206803,plus,1,1
206804,heparin,1,1
206805,5000,1,1
206806,U,1,1
206807,",",1,0
206808,DHE,1,1
206809,0.5,1,1
206810,mg,1,1
206811,plus,1,1
206812,heparin,1,1
206813,2500,1,1
206814,U,1,1
206815,",",1,0
206816,heparin,1,1
206817,5000,1,1
206818,U,1,1
206819,",",0,0
206820,and,0,0
206821,DHE,1,1
206822,0.5,1,1
206823,mg,1,1
206824,versus,0,1
206825,placebo,1,1
206826,.,1,0
206827,General,0,0
206828,surgical,0,0
206829,patients,0,0
206830,including,0,0
206831,those,0,0
206832,undergoing,0,0
206833,noncardiac,0,0
206834,thoracic,0,1
206835,and,0,0
206836,pelvic,0,1
206837,operations,0,0
206838,who,0,0
206839,were,0,0
206840,identified,0,0
206841,at,0,0
206842,moderate,0,0
206843,to,0,0
206844,high,0,0
206845,risk,0,0
206846,for,0,0
206847,postop,0,0
206848,DVT,0,0
206849,were,0,0
206850,included,0,0
206851,.,0,0
206852,Study,0,0
206853,medications,0,0
206854,were,0,0
206855,injected,0,0
206856,subcutaneously,0,1
206857,two,0,0
206858,hours,0,0
206859,preoperatively,0,0
206860,and,0,0
206861,every,0,1
206862,12,0,0
206863,hours,0,0
206864,postoperatively,0,0
206865,for,0,0
206866,5-7,0,0
206867,days,0,0
206868,or,0,0
206869,until,0,0
206870,the,0,0
206871,125I-fibrinogen-uptake,0,1
206872,test,0,0
206873,(,0,1
206874,RFUT,0,1
206875,),0,1
206876,became,0,0
206877,positive,0,0
206878,.,0,0
206879,Eight,0,0
206880,hundred,0,0
206881,and,0,0
206882,eighty,0,0
206883,eight,0,0
206884,patients,0,0
206885,were,0,0
206886,entered,0,0
206887,into,0,0
206888,this,0,0
206889,trial,0,0
206890,and,0,0
206891,744,0,0
206892,(,0,0
206893,85,0,0
206894,%,0,0
206895,),0,0
206896,completed,0,0
206897,the,0,0
206898,study,0,0
206899,.,0,0
206900,Results,0,0
206901,showed,0,0
206902,a,0,0
206903,statistically,0,0
206904,significant,0,0
206905,benefit,0,0
206906,from,0,0
206907,DHE/Hep,1,0
206908,5000,0,1
206909,compared,0,0
206910,to,0,0
206911,placebo,1,1
206912,(,0,0
206913,p,0,0
206914,less,0,0
206915,than,0,0
206916,0.01,0,0
206917,),0,0
206918,and,0,0
206919,compared,0,0
206920,to,0,0
206921,other,0,0
206922,active,0,1
206923,agents,0,1
206924,(,0,0
206925,p,0,0
206926,less,0,0
206927,than,0,0
206928,0.05,0,0
206929,),0,0
206930,.,0,0
206931,None,0,0
206932,of,0,0
206933,the,0,0
206934,other,0,0
206935,active,0,0
206936,agents,0,1
206937,showed,0,0
206938,a,0,0
206939,statistically,0,0
206940,significant,0,0
206941,prophylactic,0,1
206942,benefit,0,0
206943,.,0,1
206944,(,0,0
206945,ABSTRACT,0,1
206946,TRUNCATED,0,1
206947,AT,0,1
206948,250,0,1
206949,WORDS,0,1
206950,),0,1
206951,Untoward,0,0
206952,effects,0,0
206953,of,0,0
206954,fenfluramine,1,1
206955,in,0,0
206956,autistic,0,0
206957,children,0,0
206958,.,0,0
206959,Several,0,0
206960,recent,0,0
206961,studies,0,0
206962,have,0,0
206963,described,0,0
206964,the,0,0
206965,benefits,0,0
206966,of,0,0
206967,fenfluramine,1,1
206968,for,0,0
206969,the,0,0
206970,symptomatic,0,0
206971,treatment,0,0
206972,of,0,0
206973,infantile,0,0
206974,autism,0,0
206975,.,0,0
206976,No,0,0
206977,large,0,0
206978,surveys,0,0
206979,of,0,0
206980,side,0,0
206981,effects,0,0
206982,of,0,0
206983,this,0,0
206984,drug,0,0
206985,have,0,0
206986,been,0,0
206987,reported,0,0
206988,in,0,0
206989,autistic,0,0
206990,children,0,0
206991,.,0,0
206992,To,0,0
206993,evaluate,0,0
206994,the,0,0
206995,untoward,0,0
206996,effects,0,0
206997,of,0,0
206998,fenfluramine,1,1
206999,in,0,0
207000,children,0,0
207001,with,0,0
207002,autism,0,0
207003,",",0,0
207004,12,0,0
207005,subjects,0,0
207006,were,0,0
207007,systematically,0,0
207008,studied,0,0
207009,.,0,0
207010,Medication,0,0
207011,was,0,0
207012,administered,0,0
207013,in,0,0
207014,a,0,0
207015,double-blind,0,0
207016,",",0,0
207017,placebo-controlled,1,1
207018,cross-over,0,0
207019,study,0,0
207020,.,0,0
207021,Parents,0,0
207022,were,0,0
207023,trained,0,1
207024,in,0,0
207025,monitoring,0,0
207026,untoward,0,0
207027,effects,0,0
207028,.,0,0
207029,These,0,0
207030,observations,0,0
207031,were,0,0
207032,compiled,0,0
207033,in,0,0
207034,detailed,0,0
207035,daily,0,0
207036,notes,0,0
207037,.,0,0
207038,In,0,0
207039,addition,0,0
207040,",",0,0
207041,four,0,0
207042,cases,0,0
207043,describing,0,0
207044,unusual,0,0
207045,effects,0,0
207046,found,0,0
207047,in,0,0
207048,a,0,0
207049,sample,0,0
207050,of,0,0
207051,170,0,0
207052,patients,0,0
207053,treated,0,0
207054,with,0,0
207055,fenfluramine,1,1
207056,are,0,0
207057,also,0,0
207058,reported,0,0
207059,.,0,0
207060,In,0,0
207061,the,0,0
207062,initial,0,0
207063,2,0,0
207064,weeks,0,0
207065,of,0,0
207066,active,0,1
207067,drug,0,1
207068,listlessness,0,0
207069,",",0,0
207070,food,0,1
207071,refusal,0,0
207072,",",0,0
207073,and,0,0
207074,stomach,0,0
207075,upset,0,0
207076,were,0,0
207077,frequently,0,0
207078,seen,0,0
207079,.,0,0
207080,A,0,0
207081,different,0,0
207082,pattern,0,0
207083,of,0,0
207084,untoward,0,0
207085,effects,0,0
207086,was,0,0
207087,seen,0,0
207088,in,0,0
207089,the,0,0
207090,final,0,0
207091,14,0,0
207092,weeks,0,0
207093,of,0,0
207094,treatment,0,0
207095,.,0,0
207096,Irritability,0,0
207097,",",0,0
207098,agitation,0,0
207099,",",0,0
207100,and,0,0
207101,crying,0,0
207102,along,0,0
207103,with,0,0
207104,continued,0,0
207105,food,0,0
207106,refusal,0,0
207107,were,0,0
207108,noted,0,0
207109,.,0,0
207110,The,0,0
207111,subjects,0,0
207112,lost,0,0
207113,2.1,0,0
207114,%,0,0
207115,of,0,0
207116,body,0,0
207117,weight,0,0
207118,during,0,0
207119,active,0,1
207120,drug,0,1
207121,phase,0,0
207122,",",0,0
207123,but,0,0
207124,there,0,0
207125,was,0,0
207126,a,0,0
207127,rebound,0,0
207128,weight,0,0
207129,gain,0,0
207130,during,0,0
207131,the,0,0
207132,subsequent,0,0
207133,placebo,1,1
207134,phase,0,0
207135,.,0,0
207136,A,0,0
207137,thorough,0,0
207138,understanding,0,0
207139,of,0,0
207140,fenfluramine,1,1
207141,'s,1,0
207142,side,0,0
207143,effects,0,0
207144,and,0,0
207145,adverse,0,0
207146,reactions,0,0
207147,is,0,0
207148,necessary,0,0
207149,so,0,0
207150,as,0,0
207151,to,0,0
207152,differentiate,0,0
207153,them,0,0
207154,from,0,0
207155,the,0,0
207156,multiple,0,0
207157,symptoms,0,0
207158,inherent,0,0
207159,in,0,0
207160,the,0,0
207161,syndrome,0,0
207162,of,0,0
207163,autism,0,0
207164,.,0,0
207165,Effects,0,0
207166,of,0,0
207167,nifedipine,1,1
207168,on,0,0
207169,gastric,0,0
207170,acid,0,1
207171,secretion,0,0
207172,and,0,0
207173,gastrin,0,1
207174,release,0,1
207175,in,0,0
207176,man,0,0
207177,.,0,0
207178,As,0,0
207179,calcium,0,1
207180,is,0,0
207181,important,0,0
207182,in,0,0
207183,the,0,0
207184,regulation,0,0
207185,of,0,0
207186,gastric,0,0
207187,acid,0,1
207188,secretion,0,0
207189,and,0,0
207190,gastrin,0,1
207191,release,0,0
207192,",",0,0
207193,we,0,0
207194,have,0,0
207195,examined,0,0
207196,the,0,0
207197,effect,0,0
207198,of,0,0
207199,the,0,0
207200,calcium,0,1
207201,antagonist,0,1
207202,nifedipine,1,1
207203,on,0,0
207204,these,0,0
207205,processes,0,0
207206,in,0,0
207207,man,0,0
207208,.,0,0
207209,Nifedipine,1,1
207210,30,0,0
207211,mg,0,1
207212,orally,0,1
207213,inhibited,0,0
207214,basal,0,1
207215,acid,0,1
207216,output,0,0
207217,by,0,0
207218,37,0,0
207219,%,0,0
207220,(,0,0
207221,p,0,0
207222,less,0,0
207223,than,0,0
207224,0.025,0,0
207225,),0,0
207226,and,0,0
207227,that,0,0
207228,stimulated,0,0
207229,by,0,0
207230,low,0,0
207231,infusion,0,1
207232,rates,0,0
207233,of,0,0
207234,pentagastrin,1,1
207235,--,1,0
207236,that,1,0
207237,is,0,0
207238,",",0,0
207239,0.031,0,0
207240,and,0,0
207241,0.062,0,0
207242,microgram/kg/h,0,0
207243,by,0,0
207244,44,0,0
207245,%,0,0
207246,(,0,0
207247,p,0,0
207248,=,0,0
207249,0.05,0,0
207250,),0,0
207251,and,0,0
207252,39,0,0
207253,%,0,0
207254,(,0,0
207255,p,0,0
207256,less,0,0
207257,than,0,0
207258,0.02,0,0
207259,),0,0
207260,respectively,0,0
207261,.,0,0
207262,On,0,0
207263,increasing,0,0
207264,the,0,0
207265,pentagastrin,1,1
207266,infusion,0,1
207267,rate,0,0
207268,the,0,0
207269,inhibition,0,0
207270,was,0,0
207271,surmounted,0,0
207272,suggesting,0,0
207273,it,0,0
207274,was,0,0
207275,competitive,0,0
207276,in,0,0
207277,type,0,0
207278,.,0,0
207279,Nifedipine,1,1
207280,did,0,0
207281,not,0,0
207282,affect,0,0
207283,basal,0,0
207284,or,0,1
207285,Oxo,0,1
207286,meal,0,1
207287,stimulated,0,0
207288,gastrin,0,1
207289,concentrations,0,0
207290,in,0,0
207291,normal,0,0
207292,volunteers,0,0
207293,nor,0,0
207294,did,0,0
207295,it,0,0
207296,affect,0,0
207297,resting,0,0
207298,serum,0,0
207299,gastrin,0,1
207300,or,0,1
207301,calcium,0,1
207302,stimulated,0,0
207303,increase,0,0
207304,in,0,0
207305,gastrin,0,1
207306,in,0,0
207307,a,0,0
207308,single,0,0
207309,patient,0,0
207310,with,0,0
207311,Zollinger-Ellison,0,0
207312,syndrome,0,0
207313,.,0,0
207314,These,0,0
207315,findings,0,0
207316,are,0,0
207317,consistent,0,0
207318,with,0,0
207319,the,0,0
207320,transmembrane,0,0
207321,flux,0,0
207322,of,0,0
207323,calcium,0,1
207324,ions,0,1
207325,being,0,0
207326,involved,0,0
207327,in,0,0
207328,basal,0,1
207329,and,0,0
207330,pentagastrin,0,1
207331,stimulated,0,0
207332,acid,0,1
207333,secretion,0,0
207334,in,0,0
207335,man,0,0
207336,.,0,0
207337,The,0,0
207338,efficacy,0,0
207339,and,0,0
207340,safety,0,0
207341,of,0,0
207342,fenfluramine,1,1
207343,in,0,0
207344,autistic,0,0
207345,children,0,0
207346,:,0,0
207347,preliminary,0,0
207348,analysis,0,0
207349,of,0,0
207350,a,0,0
207351,double-blind,0,0
207352,study,0,0
207353,.,0,0
207354,[,1,0
207355,Intra-arterial,1,1
207356,chemotherapy,1,1
207357,in,0,0
207358,advanced,0,0
207359,ovarian,0,0
207360,cancers,0,0
207361,.,0,0
207362,2,0,0
207363,.,0,0
207364,Therapeutic,0,0
207365,results,0,0
207366,in,0,0
207367,relation,0,0
207368,to,0,0
207369,prognostic,0,0
207370,factors,0,0
207371,],0,0
207372,.,0,0
207373,85,0,0
207374,patients,0,0
207375,with,0,0
207376,advanced,0,0
207377,ovarian,0,0
207378,carcinomas,0,0
207379,were,0,0
207380,treated,0,0
207381,either,0,0
207382,intra-arterially,1,1
207383,with,1,0
207384,MTX,1,1
207385,and,1,0
207386,5-FU,1,1
207387,",",0,0
207388,later,0,0
207389,systemically,1,0
207390,with,1,0
207391,the,1,0
207392,CMFV-combination,1,1
207393,(,0,1
207394,therapy,0,1
207395,arm,0,1
207396,A,0,1
207397,),0,1
207398,or,0,1
207399,only,1,0
207400,systemically,1,0
207401,(,0,0
207402,therapy,0,1
207403,arm,0,1
207404,B,0,1
207405,),0,1
207406,after,0,0
207407,randomization,0,0
207408,.,0,0
207409,The,0,0
207410,achieved,0,0
207411,rates,0,0
207412,of,0,0
207413,remission,0,0
207414,and,0,0
207415,survival,0,0
207416,time,0,0
207417,showed,0,0
207418,an,0,0
207419,obvious,0,0
207420,dependence,0,0
207421,on,0,0
207422,the,0,0
207423,histological,0,0
207424,type,0,0
207425,of,0,0
207426,tumor,0,0
207427,and,0,0
207428,on,0,0
207429,the,0,0
207430,degree,0,0
207431,of,0,0
207432,differentiation,0,0
207433,.,0,0
207434,Whereas,0,0
207435,the,0,0
207436,results,0,0
207437,of,0,0
207438,the,0,0
207439,treatment,0,0
207440,were,0,0
207441,nearly,0,0
207442,identical,0,0
207443,in,0,0
207444,both,0,0
207445,groups,0,0
207446,of,0,0
207447,treatment,0,0
207448,with,0,0
207449,badly,0,0
207450,differentiated,0,0
207451,carcinomas,0,0
207452,",",0,0
207453,a,0,0
207454,significant,0,0
207455,improvement,0,0
207456,could,0,0
207457,be,0,0
207458,achieved,0,0
207459,by,0,0
207460,the,0,0
207461,initial,0,0
207462,local,0,1
207463,treatment,0,0
207464,of,0,0
207465,well,0,0
207466,and,0,0
207467,moderately,0,0
207468,differentiated,0,0
207469,malignancies,0,0
207470,.,0,0
207471,More,0,0
207472,than,0,0
207473,one,0,0
207474,third,0,0
207475,of,0,0
207476,the,0,0
207477,cases,0,0
207478,of,0,0
207479,advanced,0,0
207480,tumors,0,0
207481,were,0,0
207482,operable,0,0
207483,by,0,0
207484,local,0,1
207485,chemotherapy,0,1
207486,.,0,0
207487,Thus,0,0
207488,the,0,0
207489,survival,0,0
207490,time,0,0
207491,could,0,0
207492,be,0,0
207493,extended,0,0
207494,.,0,0
207495,The,0,0
207496,intra-arterial,1,1
207497,chemotherapy,1,1
207498,represents,0,0
207499,an,0,0
207500,expensive,0,0
207501,",",0,0
207502,but,0,0
207503,effective,0,0
207504,method,0,1
207505,of,0,0
207506,treatment,0,0
207507,of,0,0
207508,advanced,0,0
207509,ovarian,0,0
207510,carcinomas,0,0
207511,.,0,0
207512,Therapeutic,0,0
207513,recommendations,0,0
207514,in,0,0
207515,polycythemia,0,0
207516,vera,0,1
207517,based,0,0
207518,on,0,0
207519,Polycythemia,0,0
207520,Vera,0,1
207521,Study,0,0
207522,Group,0,0
207523,protocols,0,0
207524,.,0,0
207525,The,0,0
207526,PVSG,0,0
207527,was,0,0
207528,organized,0,1
207529,in,0,0
207530,1967,0,0
207531,to,0,0
207532,establish,0,0
207533,effective,0,0
207534,diagnostic,0,0
207535,criteria,0,0
207536,for,0,0
207537,polycythemia,0,0
207538,vera,0,1
207539,",",0,0
207540,to,0,0
207541,study,0,0
207542,the,0,0
207543,natural,0,0
207544,history,0,0
207545,of,0,0
207546,the,0,0
207547,disease,0,0
207548,and,0,0
207549,to,0,0
207550,define,0,0
207551,the,0,0
207552,optimal,0,0
207553,treatment,0,0
207554,.,0,0
207555,Although,0,0
207556,polycythemia,0,0
207557,vera,0,1
207558,and,0,0
207559,the,0,0
207560,other,0,0
207561,myeloproliferative,0,0
207562,diseases,0,0
207563,are,0,0
207564,relatively,0,0
207565,uncommon,0,0
207566,",",0,0
207567,the,0,0
207568,PVSG,0,0
207569,was,0,0
207570,able,0,0
207571,to,0,0
207572,accumulate,0,0
207573,well,0,0
207574,over,0,0
207575,"1,000",0,0
207576,patients,0,0
207577,with,0,0
207578,these,0,0
207579,various,0,0
207580,disorders,0,0
207581,and,0,0
207582,to,0,0
207583,study,0,0
207584,them,0,0
207585,according,0,0
207586,to,0,0
207587,a,0,0
207588,total,0,0
207589,of,0,0
207590,15,0,0
207591,different,0,0
207592,protocols,0,0
207593,.,0,0
207594,PVSG-01,0,0
207595,",",0,0
207596,a,0,0
207597,long-term,0,0
207598,randomized,0,0
207599,controlled,0,0
207600,study,0,0
207601,of,0,0
207602,phlebotomy,1,1
207603,alone,1,1
207604,compared,0,0
207605,with,0,0
207606,the,0,0
207607,myelosuppressive,1,1
207608,agents,1,0
207609,",",1,0
207610,32P,1,0
207611,or,1,1
207612,chlorambucil,1,1
207613,supplemented,1,1
207614,by,1,0
207615,phlebotomy,1,1
207616,",",0,0
207617,continues,0,0
207618,to,0,0
207619,receive,0,0
207620,follow-up,0,0
207621,data,0,0
207622,on,0,0
207623,93,0,0
207624,%,0,0
207625,of,0,0
207626,surviving,0,0
207627,patients,0,0
207628,18,0,0
207629,years,0,0
207630,after,0,0
207631,initiation,0,0
207632,of,0,0
207633,the,0,0
207634,study,0,0
207635,.,0,0
207636,During,0,0
207637,its,0,0
207638,lifetime,0,0
207639,",",0,0
207640,PVSG,0,0
207641,has,0,0
207642,developed,0,0
207643,a,0,0
207644,widely,0,0
207645,accepted,0,0
207646,and,0,0
207647,highly,0,0
207648,effective,0,0
207649,set,0,0
207650,of,0,0
207651,criteria,0,0
207652,for,0,0
207653,the,0,0
207654,specific,0,0
207655,diagnosis,0,0
207656,of,0,0
207657,polycythemia,0,0
207658,vera,0,1
207659,as,0,0
207660,well,0,0
207661,as,0,0
207662,useful,0,0
207663,criteria,0,0
207664,for,0,0
207665,the,0,0
207666,diagnosis,0,0
207667,of,0,0
207668,essential,0,0
207669,thrombocythemia,0,0
207670,.,0,0
207671,It,0,0
207672,has,0,0
207673,gathered,0,0
207674,an,0,0
207675,enormous,0,0
207676,volume,0,0
207677,of,0,0
207678,data,0,0
207679,on,0,0
207680,the,0,0
207681,natural,0,0
207682,history,0,0
207683,of,0,0
207684,the,0,0
207685,myeloproliferative,0,0
207686,diseases,0,0
207687,and,0,0
207688,in,0,0
207689,particular,0,0
207690,on,0,0
207691,the,0,0
207692,nature,0,0
207693,of,0,0
207694,the,0,0
207695,prevalent,0,0
207696,complications,0,0
207697,",",0,0
207698,such,0,0
207699,as,0,0
207700,thrombotic,0,0
207701,events,0,0
207702,and,0,0
207703,hematologic,0,0
207704,and,0,0
207705,nonhematologic,0,0
207706,malignancies,0,0
207707,.,0,0
207708,With,0,0
207709,respect,0,0
207710,to,0,0
207711,the,0,0
207712,final,0,0
207713,question,0,0
207714,",",0,0
207715,the,0,0
207716,optimal,0,0
207717,treatment,0,0
207718,for,0,0
207719,polycythemia,0,0
207720,vera,0,1
207721,",",0,0
207722,it,0,0
207723,is,0,0
207724,apparent,0,0
207725,that,0,0
207726,the,0,0
207727,expectation,0,0
207728,of,0,0
207729,a,0,0
207730,single,1,0
207731,optimal,1,0
207732,therapy,1,1
207733,that,0,0
207734,would,0,0
207735,apply,0,0
207736,to,0,0
207737,all,0,0
207738,patients,0,0
207739,at,0,0
207740,all,0,0
207741,ages,0,0
207742,and,0,0
207743,stages,0,0
207744,of,0,0
207745,the,0,0
207746,disease,0,0
207747,was,0,0
207748,naive,0,0
207749,.,0,0
207750,Nevertheless,0,0
207751,considerable,0,0
207752,progress,0,0
207753,has,0,0
207754,been,0,0
207755,made,0,0
207756,.,0,0
207757,Moreover,0,0
207758,",",0,0
207759,the,0,0
207760,group,0,0
207761,has,0,0
207762,defined,0,0
207763,more,0,0
207764,precisely,0,0
207765,than,0,0
207766,ever,0,0
207767,before,0,0
207768,the,0,0
207769,nature,0,0
207770,of,0,0
207771,the,0,0
207772,complications,0,0
207773,of,0,0
207774,the,0,0
207775,disease,0,0
207776,and,0,0
207777,the,0,0
207778,association,0,0
207779,of,0,0
207780,the,0,0
207781,risks,0,0
207782,of,0,0
207783,specific,0,0
207784,complications,0,0
207785,with,0,0
207786,specific,0,0
207787,forms,0,0
207788,of,0,0
207789,therapy,0,1
207790,.,0,0
207791,It,0,0
207792,thus,0,0
207793,has,0,0
207794,made,0,0
207795,it,0,0
207796,possible,0,0
207797,to,0,0
207798,pose,0,0
207799,the,0,0
207800,next,0,0
207801,series,0,0
207802,of,0,0
207803,therapeutic,0,0
207804,questions,0,0
207805,that,0,0
207806,must,0,0
207807,be,0,0
207808,addressed,0,0
207809,in,0,0
207810,this,0,0
207811,disorder,0,0
207812,with,0,0
207813,a,0,0
207814,greater,0,0
207815,degree,0,0
207816,of,0,0
207817,sophistication,0,0
207818,than,0,0
207819,was,0,0
207820,previously,0,0
207821,possible,0,0
207822,.,0,0
207823,Abstinence,1,0
207824,or,1,1
207825,controlled,1,0
207826,drinking,1,0
207827,in,0,0
207828,clinical,0,0
207829,practice,0,0
207830,:,0,0
207831,indications,0,0
207832,at,0,0
207833,initial,0,0
207834,assessment,0,0
207835,.,0,0
207836,Previous,0,0
207837,research,0,0
207838,has,0,0
207839,suggested,0,0
207840,two,0,0
207841,leading,0,0
207842,hypotheses,0,0
207843,concerning,0,0
207844,which,0,0
207845,excessive,0,0
207846,drinkers,0,0
207847,can,0,0
207848,re-establish,0,0
207849,control,0,0
207850,:,0,0
207851,one,0,0
207852,based,0,0
207853,upon,0,0
207854,level,0,0
207855,of,0,0
207856,dependence,0,0
207857,",",0,0
207858,the,0,0
207859,other,0,0
207860,upon,0,0
207861,the,0,0
207862,client,0,0
207863,'s,0,0
207864,personal,0,1
207865,persuasion,0,0
207866,.,0,0
207867,Using,0,0
207868,initial,0,0
207869,assessment,0,0
207870,data,0,0
207871,from,0,0
207872,46,0,0
207873,clients,0,0
207874,of,0,0
207875,a,0,0
207876,clinical,0,0
207877,psychology,0,0
207878,alcohol,0,1
207879,problems,0,0
207880,service,0,1
207881,(,0,0
207882,30,0,0
207883,men,0,0
207884,",",0,0
207885,16,0,0
207886,women,0,0
207887,),0,0
207888,",",0,0
207889,an,0,0
207890,attempt,0,0
207891,was,0,0
207892,made,0,0
207893,to,0,0
207894,operationalize,0,0
207895,the,0,0
207896,concepts,0,0
207897,of,0,0
207898,dependence,1,0
207899,and,0,0
207900,personal,1,1
207901,persuasion,1,1
207902,using,0,0
207903,a,0,0
207904,variety,0,0
207905,of,0,0
207906,indicators,0,0
207907,of,0,0
207908,each,0,0
207909,.,0,0
207910,Although,0,0
207911,SADQ,0,0
207912,scores,0,0
207913,and,0,0
207914,Rand,0,1
207915,definite,0,0
207916,alcoholism,0,0
207917,were,0,0
207918,in,0,0
207919,general,0,0
207920,agreement,0,0
207921,",",0,0
207922,there,0,0
207923,were,0,0
207924,a,0,0
207925,number,0,0
207926,of,0,0
207927,borderline,0,0
207928,instances,0,0
207929,and,0,0
207930,cases,0,0
207931,of,0,0
207932,disagreement,0,0
207933,",",0,0
207934,and,0,0
207935,neither,0,0
207936,was,0,0
207937,in,0,0
207938,good,0,0
207939,agreement,0,0
207940,with,0,0
207941,estimates,0,0
207942,of,0,0
207943,problem,0,0
207944,duration,0,0
207945,",",0,0
207946,nor,0,0
207947,with,0,0
207948,reports,0,0
207949,of,0,0
207950,recent,0,0
207951,or,0,1
207952,earlier,0,0
207953,attainment,0,0
207954,of,0,0
207955,abstinence,1,0
207956,or,0,1
207957,control,1,0
207958,.,1,0
207959,Indicators,0,0
207960,of,0,0
207961,personal,1,1
207962,persuasion,1,0
207963,were,0,0
207964,more,0,0
207965,consistent,0,0
207966,.,0,0
207967,Those,0,0
207968,with,0,0
207969,dependence,1,0
207970,indicators,1,0
207971,for,0,0
207972,abstinence,1,0
207973,tended,0,0
207974,to,0,0
207975,prefer,0,0
207976,abstinence,1,0
207977,as,0,0
207978,a,0,0
207979,goal,0,0
207980,",",0,0
207981,but,0,0
207982,there,0,0
207983,were,0,0
207984,many,0,0
207985,departures,0,0
207986,from,0,0
207987,this,0,0
207988,pattern,0,0
207989,particularly,0,0
207990,for,0,0
207991,women,0,0
207992,.,0,0
207993,It,0,0
207994,is,0,0
207995,concluded,0,0
207996,that,0,0
207997,in,0,0
207998,clinical,0,0
207999,practice,0,0
208000,it,0,0
208001,will,0,0
208002,be,0,0
208003,very,0,0
208004,difficult,0,0
208005,to,0,0
208006,make,0,0
208007,a,0,0
208008,clear,0,1
208009,cut,0,0
208010,recommendation,0,0
208011,about,0,0
208012,treatment,0,0
208013,goal,0,0
208014,at,0,0
208015,initial,0,0
208016,assessment,0,0
208017,except,0,0
208018,in,0,0
208019,a,0,0
208020,few,0,0
208021,cases,0,0
208022,.,0,0
208023,The,0,0
208024,Eastern,0,0
208025,Cooperative,0,0
208026,Oncology,0,0
208027,Group,0,0
208028,experience,0,0
208029,with,0,0
208030,cyclophosphamide,1,1
208031,",",1,0
208032,adriamycin,1,1
208033,",",1,0
208034,and,1,0
208035,5-fluorouracil,1,1
208036,(,1,1
208037,CAF,1,1
208038,),1,1
208039,in,0,0
208040,patients,0,0
208041,with,0,0
208042,metastatic,0,0
208043,breast,0,0
208044,cancer,0,0
208045,.,0,0
208046,Data,0,0
208047,on,0,0
208048,162,0,0
208049,women,0,0
208050,(,0,0
208051,90,0,1
208052,premenopausal,0,1
208053,and,0,0
208054,72,0,0
208055,postmenopausal,0,0
208056,),0,0
208057,with,0,0
208058,metastatic,0,0
208059,breast,0,0
208060,cancer,0,0
208061,randomized,0,0
208062,to,0,0
208063,receive,0,0
208064,cyclophosphamide,1,1
208065,",",1,0
208066,Adriamycin,1,1
208067,(,1,1
208068,doxorubicin,1,1
208069,),1,1
208070,and,1,0
208071,5-fluorouracil,1,1
208072,(,1,1
208073,CAF,1,1
208074,),1,1
208075,on,0,0
208076,two,0,0
208077,Eastern,0,0
208078,Cooperative,0,0
208079,Oncology,0,0
208080,Group,0,0
208081,(,0,1
208082,ECOG,0,1
208083,),0,1
208084,protocols,0,0
208085,were,0,0
208086,analyzed,0,0
208087,.,0,0
208088,Twenty-three,0,0
208089,percent,0,0
208090,had,0,0
208091,complete,0,0
208092,remission,0,0
208093,;,0,0
208094,39,0,0
208095,%,0,0
208096,had,0,0
208097,partial,0,0
208098,remission,0,0
208099,;,0,0
208100,28,0,0
208101,%,0,0
208102,had,0,0
208103,no,0,0
208104,change,0,0
208105,;,0,0
208106,and,0,0
208107,3,0,0
208108,%,0,0
208109,had,0,0
208110,disease,0,0
208111,progression,0,0
208112,.,0,0
208113,Of,0,0
208114,those,0,0
208115,patients,0,0
208116,in,0,0
208117,whom,0,0
208118,receptors,0,0
208119,were,0,0
208120,known,0,0
208121,",",0,0
208122,response,0,0
208123,rates,0,0
208124,were,0,0
208125,65,0,0
208126,%,0,0
208127,for,0,0
208128,estrogen,0,1
208129,(,0,1
208130,ER,0,1
208131,),0,1
208132,-receptor,0,1
208133,positive,0,0
208134,and,0,0
208135,70,0,0
208136,%,0,0
208137,for,0,0
208138,ER-negative,0,0
208139,patients,0,0
208140,.,0,0
208141,The,0,0
208142,median,0,0
208143,duration,0,0
208144,of,0,0
208145,response,0,0
208146,was,0,0
208147,11.4,0,0
208148,months,0,0
208149,.,0,0
208150,The,0,0
208151,median,0,0
208152,survival,0,0
208153,time,0,0
208154,from,0,0
208155,the,0,0
208156,start,0,0
208157,of,0,0
208158,CAF,0,1
208159,was,0,0
208160,20.2,0,0
208161,months,0,0
208162,.,0,0
208163,The,0,0
208164,response,0,0
208165,rate,0,0
208166,",",0,0
208167,time,0,0
208168,to,0,0
208169,treatment,0,1
208170,failure,0,0
208171,(,0,1
208172,TTF,0,1
208173,),0,1
208174,",",0,0
208175,and,0,0
208176,median,0,0
208177,survival,0,0
208178,time,0,0
208179,were,0,0
208180,superior,0,0
208181,in,0,0
208182,the,0,0
208183,premenopausal,0,0
208184,women,0,0
208185,.,0,0
208186,These,0,0
208187,differences,0,0
208188,ceased,0,0
208189,",",0,0
208190,however,0,0
208191,",",0,0
208192,to,0,0
208193,be,0,0
208194,statistically,0,0
208195,significant,0,0
208196,in,0,0
208197,logistic,0,0
208198,models,0,0
208199,.,0,0
208200,Factors,0,0
208201,significantly,0,0
208202,associated,0,0
208203,with,0,0
208204,longer,0,0
208205,TTF,0,0
208206,and,0,0
208207,longer,0,0
208208,survival,0,0
208209,were,0,0
208210,as,0,0
208211,follows,0,0
208212,:,0,0
208213,one,0,0
208214,or,0,0
208215,two,0,0
208216,organs,0,0
208217,with,0,0
208218,metastases,0,0
208219,(,0,0
208220,TTF,0,0
208221,",",0,0
208222,P,0,0
208223,less,0,0
208224,than,0,0
208225,0.0001,0,0
208226,;,0,0
208227,survival,0,0
208228,",",0,0
208229,P,0,0
208230,less,0,0
208231,than,0,0
208232,0.0001,0,0
208233,),0,0
208234,;,0,0
208235,dominant,0,0
208236,site,0,0
208237,other,0,0
208238,than,0,0
208239,soft,0,1
208240,tissue,0,0
208241,(,0,0
208242,TTF,0,1
208243,",",0,0
208244,P,0,0
208245,less,0,0
208246,than,0,0
208247,0.0001,0,0
208248,;,0,0
208249,survival,0,0
208250,",",0,0
208251,P,0,0
208252,=,0,0
208253,0.05,0,0
208254,),0,0
208255,;,0,0
208256,and,0,0
208257,an,0,0
208258,initial,0,0
208259,good,0,0
208260,performance,0,0
208261,status,0,0
208262,(,0,0
208263,TTF,0,1
208264,",",0,0
208265,P,0,0
208266,=,0,0
208267,0.007,0,0
208268,;,0,0
208269,survival,0,0
208270,",",0,0
208271,P,0,0
208272,=,0,0
208273,0.02,0,0
208274,),0,0
208275,.,0,0
208276,Patients,0,0
208277,with,0,0
208278,ER-positive,0,0
208279,disease,0,0
208280,had,0,0
208281,a,0,0
208282,significantly,0,0
208283,longer,0,0
208284,median,0,0
208285,survival,0,0
208286,time,0,0
208287,(,0,0
208288,P,0,0
208289,=,0,0
208290,0.003,0,0
208291,),0,0
208292,.,0,0
208293,The,0,0
208294,treatment,0,0
208295,of,0,0
208296,senile,0,0
208297,dementia,0,0
208298,associated,0,0
208299,with,0,0
208300,cerebrovascular,0,0
208301,insufficiency,0,0
208302,:,0,0
208303,a,0,0
208304,comparative,0,0
208305,study,0,0
208306,of,0,0
208307,buflomedil,1,1
208308,and,1,0
208309,dihydrogenated,1,1
208310,ergot,1,1
208311,alkaloids,1,1
208312,.,1,0
208313,Seventy-six,0,0
208314,patients,0,0
208315,took,0,0
208316,part,0,0
208317,in,0,0
208318,a,0,0
208319,randomized,0,0
208320,",",0,0
208321,comparative,0,0
208322,study,0,0
208323,of,0,0
208324,the,0,0
208325,efficacy,0,0
208326,of,0,0
208327,buflomedil,1,1
208328,hydrochloride,1,1
208329,and,1,0
208330,dihydrogenated,1,1
208331,ergot,1,1
208332,alkaloids,1,1
208333,in,0,0
208334,the,0,0
208335,treatment,0,0
208336,of,0,0
208337,senile,0,0
208338,dementia,0,0
208339,associated,0,0
208340,with,0,0
208341,cerebrovascular,0,0
208342,insufficiency,0,0
208343,.,0,0
208344,Efficacy,0,0
208345,was,0,0
208346,assessed,0,0
208347,by,0,0
208348,the,0,0
208349,patients,0,0
208350,',0,0
208351,performance,0,0
208352,in,0,0
208353,four,0,0
208354,psychometric,0,0
208355,tests,0,0
208356,.,0,0
208357,The,0,0
208358,results,0,0
208359,showed,0,0
208360,that,0,0
208361,a,0,0
208362,trend,0,0
208363,in,0,0
208364,favour,0,0
208365,of,0,0
208366,the,0,0
208367,buflomedil,0,1
208368,group,0,0
208369,in,0,0
208370,three,0,0
208371,of,0,0
208372,the,0,0
208373,tests,0,0
208374,became,0,0
208375,statistically,0,0
208376,significant,0,0
208377,in,0,0
208378,the,0,0
208379,fourth,0,0
208380,.,0,0
208381,Both,0,0
208382,drugs,0,0
208383,appeared,0,0
208384,to,0,0
208385,be,0,0
208386,safe,0,0
208387,",",0,0
208388,causing,0,0
208389,no,0,0
208390,marked,0,0
208391,adverse,0,0
208392,reactions,0,0
208393,.,0,0
208394,In,0,0
208395,conclusion,0,0
208396,",",0,0
208397,buflomedil,0,1
208398,is,0,0
208399,as,0,0
208400,effective,0,0
208401,or,0,1
208402,more,0,0
208403,effective,0,0
208404,than,0,0
208405,dihydrogenated,0,1
208406,ergot,0,1
208407,alkaloids,0,1
208408,in,0,0
208409,the,0,0
208410,treatment,0,0
208411,of,0,0
208412,senile,0,0
208413,dementia,0,0
208414,associated,0,0
208415,with,0,0
208416,cerebrovascular,0,0
208417,insufficiency,0,0
208418,and,0,0
208419,could,0,0
208420,prove,0,0
208421,a,0,0
208422,valuable,0,0
208423,addition,0,0
208424,to,0,0
208425,long-term,0,0
208426,therapy,0,1
208427,if,0,0
208428,further,0,0
208429,studies,0,0
208430,support,0,0
208431,the,0,0
208432,trend,0,0
208433,shown,0,0
208434,in,0,0
208435,this,0,0
208436,study,0,0
208437,.,0,0
208438,A,0,0
208439,randomized,0,0
208440,comparative,0,0
208441,trial,0,0
208442,of,0,0
208443,combined,0,1
208444,versus,0,1
208445,alternating,0,1
208446,therapy,0,1
208447,with,0,0
208448,cytostatic,0,1
208449,drugs,0,1
208450,and,0,0
208451,high-dose,0,1
208452,medroxyprogesteron,0,1
208453,acetate,0,1
208454,in,0,0
208455,advanced,0,0
208456,breast,0,0
208457,cancer,0,0
208458,.,0,0
208459,A,0,0
208460,prospective,0,0
208461,multicenter,0,0
208462,trial,0,0
208463,was,0,0
208464,conducted,0,0
208465,in,0,0
208466,155,0,0
208467,consecutive,0,0
208468,patients,0,0
208469,with,0,0
208470,Stage,0,0
208471,IV,0,0
208472,breast,0,0
208473,cancer,0,0
208474,randomly,0,0
208475,allocated,0,0
208476,to,0,0
208477,receive,0,1
208478,either,0,1
208479,(,0,0
208480,1,0,0
208481,),0,1
208482,vincristin,1,1
208483,(,1,1
208484,V,1,1
208485,),1,1
208486,1.2,0,0
208487,mg/m2,0,1
208488,(,0,0
208489,maximum,0,0
208490,dose,0,0
208491,",",0,0
208492,2,0,0
208493,mg,0,1
208494,),0,0
208495,",",0,0
208496,Adriamycin,1,1
208497,(,1,1
208498,A,1,1
208499,),1,1
208500,(,1,1
208501,doxorubicin,1,1
208502,),1,1
208503,40,0,1
208504,mg/m2,0,1
208505,",",0,0
208506,and,1,0
208507,cyclophosphamide,1,1
208508,(,1,1
208509,C,1,1
208510,),1,1
208511,500,0,1
208512,mg/m2,0,1
208513,",",0,0
208514,all,0,0
208515,intravenously,0,1
208516,on,0,0
208517,day,0,0
208518,1,0,0
208519,",",0,0
208520,every,0,0
208521,4,0,0
208522,weeks,0,0
208523,",",0,0
208524,in,0,0
208525,combination,0,1
208526,with,0,0
208527,medroxyprogesteron,1,1
208528,acetate,1,1
208529,(,1,1
208530,MPA,1,1
208531,),1,1
208532,600,0,1
208533,mg,0,1
208534,orally,0,1
208535,on,0,0
208536,days,0,0
208537,1,0,0
208538,through,0,0
208539,14,0,0
208540,",",0,0
208541,500,0,0
208542,mg,0,0
208543,intramuscularly,0,1
208544,on,0,0
208545,days,0,0
208546,1,0,0
208547,through,0,0
208548,28,0,0
208549,",",0,0
208550,and,0,0
208551,twice,0,1
208552,weekly,0,1
208553,afterwards,0,1
208554,(,0,0
208555,combined,0,1
208556,chemoendocrine,0,1
208557,approach,0,1
208558,),0,1
208559,or,0,1
208560,(,0,1
208561,2,0,0
208562,),0,0
208563,the,0,0
208564,same,0,0
208565,combination,0,1
208566,chemotherapy,0,1
208567,(,0,1
208568,VAC,0,0
208569,),0,1
208570,for,0,0
208571,three,0,0
208572,cycles,0,0
208573,alternating,0,1
208574,with,0,0
208575,MPA,0,1
208576,in,0,0
208577,the,0,0
208578,above-mentioned,0,0
208579,dosage,0,0
208580,during,0,0
208581,8,0,0
208582,weeks,0,0
208583,(,0,0
208584,alternating,0,1
208585,chemoendocrine,0,1
208586,approach,0,1
208587,),0,0
208588,.,0,0
208589,Results,0,0
208590,show,0,0
208591,an,0,0
208592,overall,0,0
208593,response,0,0
208594,rate,0,0
208595,of,0,0
208596,73,0,0
208597,%,0,0
208598,with,0,0
208599,26,0,0
208600,%,0,0
208601,complete,0,0
208602,responses,0,0
208603,in,0,0
208604,the,0,0
208605,combined,0,1
208606,treatment,0,0
208607,arm,0,0
208608,",",0,0
208609,whereas,0,0
208610,in,0,0
208611,the,0,0
208612,alternating,0,1
208613,arm,0,0
208614,",",0,0
208615,an,0,0
208616,overall,0,0
208617,response,0,0
208618,rate,0,0
208619,of,0,0
208620,76,0,0
208621,%,0,0
208622,with,0,0
208623,20,0,0
208624,%,0,0
208625,complete,0,0
208626,responses,0,0
208627,was,0,0
208628,observed,0,0
208629,.,0,0
208630,In,0,0
208631,patients,0,0
208632,with,0,0
208633,more,0,0
208634,than,0,0
208635,one,0,0
208636,metastatic,0,0
208637,site,0,0
208638,",",0,0
208639,response,0,0
208640,rate,0,0
208641,was,0,0
208642,higher,0,0
208643,in,0,0
208644,the,0,0
208645,combination,0,1
208646,treatment,0,0
208647,",",0,0
208648,and,0,0
208649,only,0,0
208650,in,0,0
208651,this,0,0
208652,arm,0,0
208653,were,0,0
208654,complete,0,0
208655,responses,0,0
208656,observed,0,0
208657,in,0,0
208658,these,0,0
208659,patients,0,0
208660,.,0,0
208661,Although,0,0
208662,the,0,0
208663,median,0,0
208664,duration,0,0
208665,of,0,0
208666,response,0,0
208667,was,0,0
208668,long,0,0
208669,in,0,0
208670,both,0,0
208671,treatment,0,0
208672,arms,0,1
208673,(,0,0
208674,combination,0,1
208675,",",0,0
208676,19,0,0
208677,months,0,0
208678,versus,0,0
208679,alternating,0,1
208680,",",0,0
208681,21,0,0
208682,months,0,0
208683,),0,0
208684,",",0,0
208685,the,0,0
208686,median,0,0
208687,overall,0,0
208688,survival,0,0
208689,in,0,0
208690,both,0,0
208691,groups,0,0
208692,was,0,0
208693,not,0,0
208694,definitely,0,0
208695,prolonged,0,0
208696,(,0,0
208697,22,0,0
208698,versus,0,0
208699,24,0,0
208700,months,0,0
208701,",",0,0
208702,respectively,0,0
208703,),0,0
208704,.,0,0
208705,However,0,0
208706,",",0,0
208707,results,0,0
208708,in,0,0
208709,subsets,0,0
208710,of,0,0
208711,patients,0,0
208712,suggest,0,0
208713,that,0,0
208714,the,0,0
208715,alternating,0,1
208716,chemoendocrine,0,1
208717,approach,0,1
208718,may,0,0
208719,be,0,0
208720,better,0,0
208721,for,0,0
208722,estrogen,0,1
208723,receptor,0,0
208724,(,0,1
208725,ER,0,1
208726,),0,1
208727,-negative,0,0
208728,patients,0,0
208729,",",0,0
208730,for,0,0
208731,patients,0,0
208732,younger,0,0
208733,than,0,0
208734,51,0,0
208735,years,0,0
208736,of,0,0
208737,age,0,0
208738,",",0,0
208739,and,0,0
208740,for,0,0
208741,patients,0,0
208742,with,0,0
208743,a,0,0
208744,disease-free,0,0
208745,interval,0,0
208746,of,0,0
208747,1,0,0
208748,year,0,0
208749,or,0,0
208750,less,0,0
208751,.,0,0
208752,Patients,0,0
208753,with,0,0
208754,these,0,0
208755,parameters,0,0
208756,probably,0,0
208757,belong,0,0
208758,to,0,0
208759,the,0,0
208760,same,0,0
208761,population,0,0
208762,.,0,0
208763,It,0,0
208764,is,0,0
208765,concluded,0,0
208766,that,0,0
208767,combination,0,1
208768,of,0,0
208769,chemotherapy,0,1
208770,and,0,0
208771,high-dose,0,1
208772,MPA,0,1
208773,may,0,0
208774,be,0,0
208775,indicated,0,0
208776,in,0,0
208777,ER-positive,0,0
208778,patients,0,0
208779,when,0,0
208780,a,0,0
208781,clinical,0,0
208782,response,0,0
208783,is,0,0
208784,urgently,0,0
208785,needed,0,0
208786,.,0,0
208787,In,0,0
208788,ER-negative,0,0
208789,patients,0,0
208790,",",0,0
208791,the,0,0
208792,alternating,0,1
208793,use,0,0
208794,of,0,0
208795,both,0,0
208796,treatment,0,0
208797,modalities,0,1
208798,deserves,0,0
208799,further,0,0
208800,investigation,0,0
208801,.,0,0
208802,Hodgkin,0,0
208803,'s,0,0
208804,disease,0,0
208805,in,0,0
208806,childhood,0,0
208807,and,0,0
208808,adolescence,0,0
208809,:,0,0
208810,results,0,0
208811,of,0,0
208812,chemotherapy-radiotherapy,0,1
208813,in,0,0
208814,clinical,0,0
208815,stages,0,0
208816,IA-IIB,0,0
208817,.,0,0
208818,From,0,0
208819,April,0,1
208820,1972,0,0
208821,to,0,0
208822,May,0,1
208823,1980,0,0
208824,",",0,0
208825,72,0,0
208826,children,0,0
208827,and,0,0
208828,adolescents,0,0
208829,(,0,0
208830,aged,0,0
208831,5,0,0
208832,to,0,0
208833,19,0,0
208834,years,0,0
208835,old,0,0
208836,",",0,0
208837,median,0,0
208838,16,0,0
208839,),0,0
208840,with,0,0
208841,Hodgkin,0,0
208842,'s,0,0
208843,disease,0,0
208844,",",0,0
208845,clinical,0,0
208846,stages,0,0
208847,IA-IIB,0,0
208848,(,0,0
208849,IA,0,1
208850,",",0,0
208851,18,0,0
208852,;,0,0
208853,II2A,0,1
208854,",",0,0
208855,two,0,0
208856,areas,0,0
208857,involved,0,0
208858,on,0,0
208859,the,0,0
208860,same,0,0
208861,side,0,0
208862,of,0,0
208863,the,0,0
208864,diaphragm,0,1
208865,",",0,0
208866,23,0,0
208867,;,0,0
208868,II3+A,0,0
208869,",",0,0
208870,three,0,0
208871,areas,0,0
208872,or,0,0
208873,more,0,0
208874,",",0,0
208875,16,0,0
208876,;,0,0
208877,IIB,0,1
208878,",",0,0
208879,15,0,0
208880,),0,0
208881,were,0,0
208882,prospectively,0,0
208883,treated,0,0
208884,in,0,0
208885,two,0,0
208886,successive,0,0
208887,clinical,0,0
208888,trials,0,0
208889,(,0,0
208890,H,0,1
208891,72,0,0
208892,and,0,0
208893,H,0,1
208894,77,0,0
208895,),0,0
208896,.,0,0
208897,Clinical,0,0
208898,stages,0,0
208899,IA,0,0
208900,and,0,0
208901,II2A,0,1
208902,received,0,1
208903,three,0,0
208904,courses,0,0
208905,of,0,0
208906,mechlorethamine,1,1
208907,",",1,0
208908,Oncovin,1,1
208909,",",1,0
208910,procarbazine,1,1
208911,",",1,0
208912,and,1,0
208913,prednisone,1,1
208914,(,1,1
208915,MOPP,1,1
208916,),1,1
208917,and,1,0
208918,supradiaphragmatic,1,1
208919,radiotherapy,1,1
208920,(,1,0
208921,40,1,1
208922,Gy,1,1
208923,),1,0
208924,",",1,0
208925,and,1,0
208926,no,1,0
208927,laparotomy,1,1
208928,was,0,0
208929,performed,0,0
208930,.,0,0
208931,Clinical,0,0
208932,stages,0,0
208933,II3+A,0,1
208934,and,0,0
208935,IIB,0,1
208936,received,0,1
208937,either,0,0
208938,six,0,0
208939,cycles,0,0
208940,of,0,0
208941,MOPP,1,1
208942,(,0,0
208943,H,0,1
208944,72,0,0
208945,),0,0
208946,",",0,0
208947,three,0,0
208948,cycles,0,0
208949,of,0,0
208950,MOPP,0,1
208951,",",0,0
208952,or,0,0
208953,three,0,0
208954,cycles,0,0
208955,of,0,0
208956,CCNU,1,0
208957,",",1,0
208958,vinblastine,1,1
208959,",",1,0
208960,procarbazine,1,1
208961,",",0,0
208962,and,0,0
208963,prednisone,1,1
208964,(,0,1
208965,CVPP,0,1
208966,),0,1
208967,(,0,0
208968,H,0,1
208969,77,0,0
208970,),0,0
208971,and,0,0
208972,subsequently,0,0
208973,had,0,0
208974,a,0,0
208975,laparotomy,1,1
208976,followed,0,1
208977,by,0,0
208978,supradiaphragmatic,1,0
208979,radiotherapy,1,1
208980,and,0,0
208981,a,0,0
208982,lumboaortic,0,0
208983,field,0,0
208984,if,0,0
208985,results,0,0
208986,of,0,0
208987,laparotomy,0,1
208988,were,0,0
208989,positive,0,0
208990,.,0,0
208991,Patients,0,0
208992,without,0,0
208993,evidence,0,0
208994,of,0,0
208995,mediastinal,0,0
208996,involvement,0,0
208997,did,0,0
208998,not,0,0
208999,have,0,0
209000,mediastinal,0,0
209001,radiotherapy,0,1
209002,.,0,0
209003,At,0,0
209004,the,0,0
209005,completion,0,0
209006,of,0,0
209007,therapy,0,1
209008,",",0,0
209009,the,0,0
209010,disease,0,0
209011,in,0,0
209012,70,0,0
209013,of,0,0
209014,72,0,0
209015,patients,0,0
209016,was,0,0
209017,in,0,0
209018,complete,0,0
209019,remission,0,0
209020,(,0,0
209021,one,0,0
209022,failure,0,0
209023,",",0,0
209024,one,0,0
209025,death,0,0
209026,during,0,0
209027,treatment,0,0
209028,),0,0
209029,.,0,0
209030,Eight,0,0
209031,patients,0,0
209032,relapsed,0,0
209033,(,0,0
209034,in,0,0
209035,situ,0,1
209036,",",0,0
209037,1,0,0
209038,;,0,0
209039,marginal,0,0
209040,",",0,0
209041,1,0,0
209042,;,0,0
209043,nonirradiated,0,0
209044,subdiaphragmatic,0,1
209045,area,0,0
209046,",",0,0
209047,6,0,0
209048,),0,0
209049,after,0,0
209050,three,0,0
209051,to,0,0
209052,57,0,0
209053,months,0,0
209054,of,0,0
209055,complete,0,0
209056,remission,0,0
209057,(,0,0
209058,median,0,0
209059,20,0,1
209060,months,0,0
209061,),0,0
209062,;,0,0
209063,one,0,0
209064,patient,0,0
209065,died,0,0
209066,after,0,0
209067,relapse,0,0
209068,.,0,0
209069,There,0,0
209070,were,0,0
209071,three,0,0
209072,deaths,0,0
209073,after,0,0
209074,complete,0,0
209075,remission,0,0
209076,of,0,0
209077,the,0,0
209078,disease,0,0
209079,(,0,0
209080,infection,0,0
209081,",",0,0
209082,two,0,0
209083,;,0,0
209084,acute,0,0
209085,nonlymphocytic,0,0
209086,leukemia,0,0
209087,[,0,0
209088,ANLL,0,1
209089,],0,0
209090,",",0,0
209091,one,0,0
209092,),0,0
209093,.,0,0
209094,As,0,0
209095,of,0,0
209096,June,0,0
209097,1984,0,0
209098,the,0,0
209099,median,0,0
209100,follow-up,0,0
209101,was,0,0
209102,82,0,0
209103,months,0,0
209104,(,0,0
209105,range,0,0
209106,",",0,0
209107,49,0,0
209108,to,0,0
209109,145,0,0
209110,months,0,0
209111,),0,0
209112,",",0,0
209113,the,0,0
209114,actuarial,0,0
209115,probabilities,0,0
209116,for,0,0
209117,survival,0,0
209118,and,0,0
209119,freedom,0,0
209120,from,0,0
209121,relapse,0,0
209122,for,0,0
209123,all,0,0
209124,patients,0,0
209125,being,0,0
209126,91.6,0,0
209127,%,0,0
209128,and,0,0
209129,87.6,0,0
209130,%,0,0
209131,",",0,0
209132,respectively,0,0
209133,.,0,0
209134,There,0,0
209135,was,0,0
209136,no,0,0
209137,statistical,0,0
209138,difference,0,0
209139,according,0,0
209140,to,0,0
209141,clinical,0,0
209142,stage,0,0
209143,",",0,0
209144,age,0,0
209145,(,0,0
209146,greater,0,0
209147,than,0,0
209148,15,0,0
209149,or,0,0
209150,less,0,0
209151,than,0,0
209152,15,0,0
209153,years,0,0
209154,),0,0
209155,",",0,0
209156,sex,0,0
209157,",",0,0
209158,or,0,1
209159,number,0,0
209160,of,0,0
209161,cycles,0,0
209162,of,0,0
209163,chemotherapy,0,1
209164,(,0,0
209165,six,0,0
209166,or,0,1
209167,three,0,0
209168,),0,0
209169,.,0,0
209170,Bone,0,1
209171,growth,0,0
209172,defects,0,0
209173,related,0,0
209174,to,0,0
209175,radiotherapy,0,1
209176,were,0,0
209177,reduced,0,0
209178,particularly,0,0
209179,in,0,0
209180,the,0,0
209181,29,0,0
209182,patients,0,0
209183,who,0,0
209184,did,0,0
209185,not,0,0
209186,receive,0,0
209187,mediastinal,0,0
209188,radiotherapy,0,1
209189,.,0,0
209190,None,0,0
209191,of,0,0
209192,these,0,0
209193,patients,0,0
209194,had,0,0
209195,a,0,0
209196,mediastinal,0,0
209197,relapse,0,0
209198,.,0,0
209199,Azoospermia,0,0
209200,was,0,0
209201,the,0,0
209202,rule,0,0
209203,for,0,0
209204,the,0,0
209205,male,0,0
209206,patients,0,0
209207,studied,0,0
209208,",",0,0
209209,but,0,0
209210,young,0,0
209211,girls,0,0
209212,and,0,0
209213,young,0,0
209214,women,0,0
209215,retained,0,0
209216,reproductive,0,0
209217,integrity,0,0
209218,.,0,0
209219,Double-blind,0,0
209220,trial,0,0
209221,comparing,0,0
209222,the,0,0
209223,effectiveness,0,0
209224,of,0,0
209225,the,0,0
209226,homeopathic,1,1
209227,preparation,1,1
209228,Galphimia,1,1
209229,potentiation,1,0
209230,D6,1,1
209231,",",1,0
209232,Galphimia,1,1
209233,dilution,1,1
209234,10,1,1
209235,(,1,0
209236,-6,1,0
209237,),1,1
209238,and,1,0
209239,placebo,1,1
209240,on,0,0
209241,pollinosis,0,0
209242,.,0,0
209243,The,0,0
209244,preparation,0,1
209245,of,0,0
209246,homeopathic,1,1
209247,drugs,1,1
209248,is,0,0
209249,based,0,0
209250,on,0,0
209251,potentiation,0,0
209252,.,0,0
209253,In,0,0
209254,this,0,0
209255,potentiation,0,0
209256,the,0,0
209257,primary,0,0
209258,substance,0,0
209259,is,0,0
209260,specially,0,0
209261,mixed,0,0
209262,with,0,0
209263,a,0,0
209264,carrier,0,1
209265,(,0,0
209266,typically,0,0
209267,90,0,1
209268,%,0,0
209269,ethanol,1,1
209270,),1,0
209271,in,0,0
209272,the,0,0
209273,ratio,0,0
209274,1:10,0,0
209275,.,0,0
209276,Usually,0,0
209277,this,0,0
209278,potentiation,0,0
209279,is,0,0
209280,done,0,0
209281,repeatedly,0,0
209282,and,0,0
209283,the,0,0
209284,final,0,0
209285,drug,0,1
209286,is,0,0
209287,labeled,0,0
209288,",",0,0
209289,e.g.,0,0
209290,",",0,0
209291,D6,1,1
209292,which,0,0
209293,means,0,0
209294,a,0,0
209295,6,0,0
209296,times,0,0
209297,decimal,0,0
209298,potentiation,0,0
209299,.,0,0
209300,In,0,0
209301,a,0,0
209302,controlled,0,0
209303,randomized,0,0
209304,strictly,0,1
209305,double-blind,0,0
209306,trial,0,0
209307,with,0,0
209308,164,0,0
209309,patients,0,0
209310,the,0,0
209311,effectiveness,0,0
209312,of,0,0
209313,homeopathically,0,1
209314,prepared,0,1
209315,Galphimia,1,1
209316,D6,1,1
209317,",",1,0
209318,a,1,0
209319,conventional,1,1
209320,Galphimia,1,1
209321,dilution,1,1
209322,10,0,1
209323,(,0,0
209324,-6,0,0
209325,),0,1
209326,and,0,0
209327,a,0,0
209328,placebo,1,1
209329,was,0,0
209330,investigated,0,0
209331,for,0,0
209332,the,0,0
209333,therapy,0,1
209334,of,0,0
209335,pollinosis,0,0
209336,.,0,0
209337,The,0,0
209338,average,0,0
209339,duration,0,0
209340,of,0,0
209341,treatment,0,0
209342,was,0,0
209343,about,0,0
209344,5,0,0
209345,weeks,0,0
209346,.,0,0
209347,Although,0,0
209348,no,0,0
209349,statistical,0,0
209350,significance,0,0
209351,was,0,0
209352,achieved,0,0
209353,",",0,0
209354,it,0,0
209355,is,0,0
209356,remarkable,0,0
209357,that,0,0
209358,there,0,0
209359,was,0,0
209360,a,0,0
209361,clear,0,1
209362,trend,0,0
209363,for,0,0
209364,the,0,0
209365,superiority,0,0
209366,of,0,0
209367,Galphimia,1,1
209368,D6,1,1
209369,while,0,0
209370,the,0,0
209371,Galphimia,0,1
209372,dilution,0,1
209373,10,0,1
209374,(,0,0
209375,-6,0,0
209376,),0,1
209377,was,0,0
209378,about,0,0
209379,equally,0,0
209380,effective,0,0
209381,compared,0,0
209382,with,0,0
209383,placebo,1,1
209384,.,1,0
209385,The,0,0
209386,study,0,0
209387,itself,0,0
209388,demonstrates,0,0
209389,that,0,0
209390,it,0,0
209391,is,0,0
209392,possible,0,0
209393,to,0,0
209394,do,0,0
209395,strictly,0,1
209396,controlled,0,0
209397,trials,0,0
209398,for,0,0
209399,homeopathic,1,1
209400,drugs,1,1
209401,and,0,0
209402,with,0,0
209403,medical,0,0
209404,practitioners,0,0
209405,.,0,0
209406,Rapid,0,1
209407,tightening,0,0
209408,of,0,0
209409,blood,0,0
209410,glucose,0,0
209411,control,0,1
209412,leads,0,0
209413,to,0,0
209414,transient,0,0
209415,deterioration,0,0
209416,of,0,0
209417,retinopathy,0,0
209418,in,0,0
209419,insulin,0,1
209420,dependent,0,0
209421,diabetes,0,0
209422,mellitus,0,0
209423,:,0,0
209424,the,0,0
209425,Oslo,0,0
209426,study,0,0
209427,.,0,0
209428,In,0,0
209429,a,0,0
209430,study,0,0
209431,of,0,0
209432,retinopathy,0,0
209433,during,0,0
209434,one,0,0
209435,year,0,0
209436,of,0,0
209437,tight,0,0
209438,blood,0,0
209439,glucose,0,0
209440,control,0,1
209441,45,0,0
209442,type,0,0
209443,I,0,0
209444,(,0,0
209445,insulin,0,1
209446,dependent,0,0
209447,),0,0
209448,diabetics,0,0
209449,without,0,0
209450,proliferative,0,0
209451,retinopathy,0,0
209452,were,0,0
209453,randomised,0,0
209454,to,0,0
209455,receive,0,0
209456,either,0,0
209457,continuous,1,1
209458,subcutaneous,1,1
209459,insulin,1,1
209460,infusion,1,1
209461,",",1,0
209462,multiple,1,0
209463,insulin,1,1
209464,injections,1,1
209465,",",1,0
209466,or,1,1
209467,conventional,1,1
209468,insulin,1,1
209469,treatment,1,1
209470,(,0,1
209471,controls,0,0
209472,),0,0
209473,.,0,0
209474,Near,0,0
209475,normoglycaemia,0,0
209476,was,0,0
209477,achieved,0,0
209478,with,0,0
209479,continuous,1,1
209480,infusion,1,1
209481,and,0,0
209482,multiple,1,0
209483,injections,1,1
209484,but,0,0
209485,not,0,0
209486,with,0,0
209487,conventional,0,1
209488,treatment,0,0
209489,.,0,0
209490,Blind,0,0
209491,evaluation,0,0
209492,of,0,0
209493,fluorescein,0,1
209494,angiograms,0,1
209495,performed,0,0
209496,three,0,0
209497,monthly,0,0
209498,showed,0,0
209499,progression,0,0
209500,of,0,0
209501,retinopathy,0,0
209502,in,0,0
209503,the,0,0
209504,control,0,1
209505,group,0,0
209506,",",0,0
209507,transient,0,0
209508,deterioration,0,0
209509,in,0,0
209510,the,0,0
209511,continuous,1,1
209512,infusion,1,1
209513,group,0,0
209514,",",0,0
209515,and,0,0
209516,no,0,0
209517,change,0,0
209518,in,0,0
209519,the,0,0
209520,multiple,1,0
209521,injection,1,1
209522,group,0,0
209523,.,0,0
209524,Half,0,0
209525,the,0,0
209526,patients,0,0
209527,receiving,0,0
209528,continuous,0,1
209529,infusion,0,1
209530,and,0,0
209531,multiple,0,0
209532,injections,0,1
209533,developed,0,0
209534,retinal,0,0
209535,cotton,0,1
209536,wool,0,1
209537,spots,0,0
209538,after,0,0
209539,three,0,0
209540,to,0,0
209541,six,0,0
209542,months,0,0
209543,.,0,0
209544,These,0,0
209545,changes,0,0
209546,regressed,0,0
209547,in,0,0
209548,all,0,0
209549,but,0,0
209550,four,0,0
209551,patients,0,0
209552,after,0,0
209553,12,0,0
209554,months,0,0
209555,.,0,0
209556,Control,0,0
209557,patients,0,0
209558,did,0,0
209559,not,0,0
209560,develop,0,0
209561,cotton,0,1
209562,wool,0,1
209563,spots,0,0
209564,.,0,0
209565,Patients,0,0
209566,who,0,0
209567,developed,0,0
209568,cotton,0,1
209569,wool,0,1
209570,spots,0,0
209571,are,0,0
209572,characterised,0,0
209573,by,0,0
209574,a,0,0
209575,larger,0,0
209576,decrement,0,0
209577,in,0,0
209578,glycosylated,0,0
209579,haemoglobin,0,0
209580,and,0,0
209581,blood,0,0
209582,glucose,0,0
209583,values,0,0
209584,",",0,0
209585,more,0,0
209586,frequent,0,0
209587,episodes,0,0
209588,of,0,0
209589,hypoglycaemia,0,0
209590,",",0,0
209591,a,0,0
209592,longer,0,0
209593,duration,0,0
209594,of,0,0
209595,diabetes,0,0
209596,",",0,0
209597,and,0,0
209598,more,0,0
209599,severe,0,0
209600,retinopathy,0,0
209601,at,0,0
209602,onset,0,0
209603,.,0,0
209604,A,0,0
209605,large,0,0
209606,and,0,0
209607,rapid,0,0
209608,fall,0,0
209609,in,0,0
209610,blood,0,0
209611,glucose,0,0
209612,concentration,0,0
209613,may,0,0
209614,promote,0,1
209615,transient,0,0
209616,deterioration,0,0
209617,of,0,0
209618,diabetic,0,0
209619,retinopathy,0,0
209620,.,0,0
209621,Drug,0,1
209622,preference,0,0
209623,in,0,0
209624,normal,0,0
209625,volunteers,0,0
209626,:,0,0
209627,effects,0,0
209628,of,0,0
209629,age,0,0
209630,and,0,0
209631,time,0,0
209632,of,0,0
209633,day,0,0
209634,.,0,0
209635,These,0,0
209636,experiments,0,0
209637,assessed,0,0
209638,the,0,0
209639,influence,0,0
209640,of,0,0
209641,two,0,0
209642,variables,0,0
209643,",",0,0
209644,age,0,0
209645,of,0,0
209646,subjects,0,0
209647,and,0,0
209648,time,0,0
209649,of,0,0
209650,drug,0,1
209651,administration,0,0
209652,",",0,0
209653,on,0,0
209654,the,0,0
209655,reinforcing,0,0
209656,properties,0,0
209657,of,0,0
209658,amphetamine,1,1
209659,and,0,0
209660,of,0,0
209661,diazepam,1,1
209662,in,0,0
209663,normal,0,0
209664,volunteers,0,0
209665,.,0,0
209666,Three,0,0
209667,groups,0,0
209668,of,0,0
209669,subjects,0,0
209670,were,0,0
209671,tested,0,0
209672,:,0,0
209673,i,0,0
209674,),0,0
209675,a,0,0
209676,group,0,0
209677,of,0,0
209678,40-55-year-old,0,0
209679,subjects,0,0
209680,(,0,0
209681,AGE,0,1
209682,group,0,0
209683,;,0,0
209684,N,0,0
209685,=,0,0
209686,11,0,0
209687,),0,0
209688,who,0,0
209689,were,0,0
209690,tested,0,0
209691,in,0,0
209692,the,0,0
209693,morning,0,0
209694,",",0,0
209695,ii,0,0
209696,),0,0
209697,a,0,0
209698,group,0,0
209699,of,0,0
209700,21-35-year-old,0,0
209701,subjects,0,0
209702,(,0,0
209703,CTL,0,1
209704,group,0,0
209705,;,0,0
209706,N,0,0
209707,=,0,0
209708,12,0,0
209709,),0,0
209710,who,0,0
209711,were,0,0
209712,also,0,0
209713,tested,0,0
209714,in,0,0
209715,the,0,0
209716,morning,0,0
209717,",",0,0
209718,and,0,0
209719,iii,0,0
209720,),0,1
209721,a,0,0
209722,group,0,0
209723,of,0,0
209724,21-35-year-olds,0,0
209725,who,0,0
209726,were,0,0
209727,tested,0,0
209728,in,0,0
209729,the,0,0
209730,late,0,0
209731,afternoon,0,0
209732,(,0,1
209733,AFT,0,1
209734,group,0,0
209735,;,0,0
209736,N,0,0
209737,=,0,0
209738,13,0,0
209739,),0,0
209740,.,0,0
209741,All,0,0
209742,subjects,0,0
209743,participated,0,0
209744,in,0,0
209745,three,0,0
209746,separate,0,0
209747,experiments,0,0
209748,comparing,0,0
209749,one,0,0
209750,drug,0,1
209751,(,0,0
209752,5,0,1
209753,mg,0,1
209754,d,1,1
209755,",",1,0
209756,l-amphetamine,1,1
209757,",",0,0
209758,5,0,1
209759,mg,0,1
209760,diazepam,1,1
209761,or,0,1
209762,10,0,0
209763,mg,0,1
209764,diazepam,1,1
209765,),1,0
209766,to,0,0
209767,placebo,1,1
209768,.,1,0
209769,Each,0,0
209770,experiment,0,0
209771,consisted,0,0
209772,of,0,0
209773,nine,0,0
209774,sessions,0,1
209775,:,0,0
209776,On,0,0
209777,the,0,0
209778,first,0,0
209779,four,0,0
209780,sessions,0,1
209781,subjects,0,0
209782,sampled,0,0
209783,two,0,0
209784,color-coded,0,1
209785,capsules,0,1
209786,on,0,0
209787,alternate,0,1
209788,sessions,0,1
209789,and,0,0
209790,on,0,0
209791,the,0,0
209792,following,0,0
209793,five,0,0
209794,sessions,0,1
209795,they,0,0
209796,chose,0,0
209797,and,0,0
209798,ingested,0,0
209799,the,0,0
209800,capsule,0,1
209801,they,0,0
209802,preferred,0,0
209803,.,0,0
209804,Subjective,0,0
209805,effects,0,0
209806,of,0,0
209807,the,0,0
209808,drugs,0,1
209809,were,0,0
209810,monitored,0,0
209811,using,0,0
209812,the,0,0
209813,Profile,0,1
209814,of,0,0
209815,Mood,0,1
209816,States,0,0
209817,(,0,0
209818,POMS,0,0
209819,),0,1
209820,and,0,0
209821,a,0,0
209822,shortened,0,0
209823,version,0,0
209824,of,0,0
209825,the,0,0
209826,Addiction,0,0
209827,Research,0,0
209828,Center,0,0
209829,Inventory,0,1
209830,(,0,1
209831,ARCI,0,1
209832,),0,0
209833,.,0,0
209834,Subjects,0,0
209835,in,0,0
209836,all,0,0
209837,three,0,0
209838,groups,0,0
209839,chose,0,0
209840,5,0,0
209841,mg,0,1
209842,diazepam,1,1
209843,as,0,0
209844,often,0,0
209845,as,0,0
209846,placebo,0,1
209847,but,0,0
209848,preferred,0,0
209849,placebo,1,1
209850,to,0,0
209851,10,0,0
209852,mg,0,1
209853,diazepam,1,1
209854,.,1,0
209855,In,0,0
209856,contrast,0,0
209857,",",0,0
209858,they,0,0
209859,chose,0,0
209860,amphetamine,1,1
209861,either,0,0
209862,as,0,0
209863,often,0,0
209864,as,0,0
209865,or,0,0
209866,more,0,0
209867,often,0,0
209868,than,0,0
209869,placebo,1,1
209870,.,1,0
209871,The,0,0
209872,subjective,0,0
209873,effects,0,0
209874,of,0,0
209875,diazepam,1,1
209876,(,0,0
209877,i.e,0,1
209878,.,0,1
209879,sedation,0,0
209880,),0,0
209881,were,0,0
209882,similar,0,0
209883,across,0,0
209884,all,0,0
209885,three,0,0
209886,groups,0,0
209887,",",0,0
209888,but,0,0
209889,after,0,0
209890,amphetamine,0,1
209891,the,0,0
209892,AGE,0,1
209893,group,0,0
209894,showed,0,0
209895,greater,0,0
209896,stimulant,0,0
209897,effects,0,0
209898,.,0,0
209899,In,0,0
209900,addition,0,0
209901,",",0,0
209902,the,0,0
209903,AFT,0,1
209904,group,0,0
209905,showed,0,0
209906,fewer,0,0
209907,positive,0,0
209908,mood,0,0
209909,effects,0,0
209910,after,0,0
209911,amphetamine,0,1
209912,than,0,0
209913,the,0,0
209914,CTL,0,1
209915,group,0,0
209916,.,0,0
209917,(,0,0
209918,ABSTRACT,0,1
209919,TRUNCATED,0,1
209920,AT,0,1
209921,250,0,1
209922,WORDS,0,1
209923,),0,1
209924,Mass,0,1
209925,inoculation,0,1
209926,in,0,0
209927,a,0,0
209928,community,0,0
209929,:,0,0
209930,the,0,0
209931,effect,0,0
209932,of,0,0
209933,primary,0,0
209934,prevention,0,0
209935,of,0,0
209936,stress,0,0
209937,reactions,0,0
209938,.,0,0
209939,This,0,0
209940,study,0,0
209941,assessed,0,0
209942,the,0,0
209943,effectiveness,0,0
209944,of,0,0
209945,a,0,0
209946,brief,0,1
209947,",",0,0
209948,situation-specific,0,0
209949,",",0,0
209950,group-administered,0,1
209951,preparatory,0,1
209952,intervention,0,1
209953,in,0,0
209954,a,0,0
209955,nonclient,0,0
209956,school,0,0
209957,population,0,0
209958,undergoing,0,0
209959,mass,1,0
209960,inoculation,1,1
209961,against,1,0
209962,rubella,1,0
209963,.,1,0
209964,Fifty-one,0,0
209965,girls,0,0
209966,were,0,0
209967,randomly,0,0
209968,assigned,0,0
209969,to,0,0
209970,practice,1,0
209971,",",1,0
209972,no-practice,1,1
209973,",",1,0
209974,or,1,1
209975,control,1,0
209976,groups,1,0
209977,.,1,0
209978,Both,0,0
209979,the,0,0
209980,practice,0,1
209981,and,0,0
209982,the,0,0
209983,no-practice,0,1
209984,groups,0,0
209985,received,0,0
209986,information,0,0
209987,that,0,0
209988,described,0,0
209989,the,0,0
209990,inoculation,0,1
209991,procedure,0,1
209992,and,0,0
209993,how,0,0
209994,to,0,0
209995,cope,0,0
209996,with,0,0
209997,it,0,0
209998,by,0,0
209999,using,0,0
210000,cognitive-behavioral,0,1
210001,coping,0,0
210002,skills,0,0
210003,.,0,0
210004,The,0,0
210005,practice,0,0
210006,group,0,0
210007,was,0,0
210008,encouraged,0,0
210009,to,0,0
210010,perform,0,0
210011,coping,0,0
210012,techniques,0,1
210013,of,0,0
210014,this,0,0
210015,type,0,0
210016,",",0,0
210017,whereas,0,0
210018,the,0,0
210019,no-practice,0,1
210020,group,0,0
210021,was,0,0
210022,told,0,0
210023,only,0,0
210024,that,0,0
210025,the,0,0
210026,intervention,0,1
210027,would,0,0
210028,help,0,0
210029,them,0,0
210030,during,0,0
210031,the,0,0
210032,inoculation,0,0
210033,.,0,0
210034,Subjects,0,0
210035,in,0,0
210036,both,0,0
210037,practice,0,0
210038,and,0,0
210039,no-practice,0,1
210040,groups,0,0
210041,reported,0,0
210042,less,0,0
210043,anxiety,0,0
210044,and,0,0
210045,exhibited,0,0
210046,more,0,0
210047,cooperative,0,0
210048,behavior,0,0
210049,during,0,0
210050,inoculation,0,0
210051,than,0,0
210052,subjects,0,0
210053,in,0,0
210054,the,0,0
210055,control,0,1
210056,group,0,0
210057,",",0,0
210058,and,0,0
210059,those,0,0
210060,who,0,0
210061,were,0,0
210062,guided,0,1
210063,and,0,0
210064,prompted,0,0
210065,to,0,0
210066,actively,0,0
210067,practice,0,0
210068,derived,0,0
210069,greater,0,0
210070,benefit,0,0
210071,.,0,0
210072,Fluorouracil,1,1
210073,as,0,0
210074,an,0,0
210075,adjuvant,0,1
210076,to,0,0
210077,surgery,1,1
210078,in,0,0
210079,carcinoma,0,0
210080,of,0,0
210081,the,0,0
210082,colon,0,0
210083,.,0,0
210084,Letter,0,0
210085,:,0,1
210086,Cephaloridine,1,1
210087,and,1,0
210088,gentamicin,1,1
210089,in,0,0
210090,prophylaxis,0,1
210091,of,0,0
210092,surgical,0,1
210093,wound,0,0
210094,infection,0,0
210095,.,0,0
210096,[,0,0
210097,Psychoexperimental,0,1
210098,studies,0,0
210099,on,0,0
210100,the,0,0
210101,effect,0,0
210102,of,0,0
210103,a,0,0
210104,valepotriate,1,1
210105,combination,1,1
210106,as,0,0
210107,well,0,0
210108,as,0,0
210109,the,0,0
210110,combined,0,1
210111,effects,0,0
210112,of,0,0
210113,valtratum,1,1
210114,and,1,0
210115,alcohol,1,1
210116,],1,0
210117,.,0,0
210118,Mebendazole,1,1
210119,in,0,0
210120,enterobiasis,0,0
210121,:,0,0
210122,a,0,0
210123,placebo,1,1
210124,--,1,0
210125,controlled,1,0
210126,trial,0,0
210127,in,0,0
210128,a,0,0
210129,paediatric,0,0
210130,community,0,0
210131,.,0,0
210132,The,0,0
210133,gastric,1,0
210134,emptying,1,0
210135,and,1,0
210136,small,1,0
210137,intestinal,1,0
210138,transit,1,0
210139,after,0,0
210140,highly,0,0
210141,selective,0,0
210142,vagotomy,0,1
210143,without,0,1
210144,drainage,0,1
210145,and,0,0
210146,selective,0,0
210147,vagotomy,0,1
210148,with,0,0
210149,pyloroplasty,0,1
210150,.,0,0
210151,[,0,0
210152,Folic,0,1
210153,acid,0,1
210154,deficiency,0,0
210155,in,0,0
210156,pregnant,0,0
210157,women,0,0
210158,in,0,0
210159,Switzerland,0,0
210160,],0,0
210161,.,0,0
210162,Para-anaesthetic,1,1
210163,headache,1,0
210164,in,0,0
210165,female,0,0
210166,patients,0,0
210167,.,0,0
210168,Response,0,0
210169,latencies,0,0
210170,to,0,0
210171,auditory,1,0
210172,stimuli,1,1
210173,in,0,0
210174,autistic,0,0
210175,children,0,0
210176,engaged,0,0
210177,in,0,0
210178,self-stimulatory,0,0
210179,behavior,0,0
210180,.,0,0
210181,An,0,0
210182,assessment,0,0
210183,of,0,0
210184,beta-adrenoceptor,0,1
210185,blockade,0,1
210186,in,0,0
210187,man,0,0
210188,by,0,0
210189,prizidilol,1,1
210190,hydrochloride,1,1
210191,.,1,0
210192,1,0,0
210193,Prizidilol,1,1
210194,hydrochloride,1,1
210195,(,0,1
210196,SK,0,1
210197,&,0,1
210198,F,0,0
210199,92657,0,1
210200,),0,0
210201,is,0,0
210202,a,0,0
210203,new,0,0
210204,compound,0,1
210205,which,0,0
210206,causes,0,0
210207,both,0,0
210208,arteriolar,0,0
210209,dilatation,0,0
210210,and,0,0
210211,beta-adrenoceptor,0,1
210212,blockade,0,1
210213,.,0,0
210214,The,0,0
210215,effect,0,0
210216,of,0,0
210217,a,0,0
210218,single,0,0
210219,oral,0,1
210220,dose,0,0
210221,on,0,0
210222,the,0,0
210223,responses,0,0
210224,of,0,0
210225,heart,0,0
210226,rate,0,0
210227,and,0,0
210228,blood,0,0
210229,pressure,0,0
210230,to,0,0
210231,isoprenaline,0,1
210232,infusion,0,1
210233,has,0,0
210234,been,0,0
210235,studied,0,0
210236,in,0,0
210237,healthy,0,0
210238,volunteers,0,0
210239,.,0,0
210240,2,0,0
210241,Isoprenaline,1,1
210242,heart,0,0
210243,rate,0,0
210244,dose-response,0,0
210245,curves,0,0
210246,showed,0,0
210247,parallel,0,0
210248,shifts,0,0
210249,to,0,0
210250,the,0,0
210251,right,0,0
210252,after,0,0
210253,oral,0,1
210254,prizidilol,1,1
210255,",",0,0
210256,indicating,0,0
210257,antagonism,0,0
210258,by,0,0
210259,this,0,0
210260,compound,0,1
210261,at,0,0
210262,beta-adrenoceptors,0,1
210263,in,0,0
210264,the,0,0
210265,heart,0,0
210266,.,0,0
210267,3,0,0
210268,Isoprenaline,0,1
210269,dose-response,0,0
210270,curves,0,0
210271,for,0,0
210272,decreases,0,0
210273,in,0,0
210274,diastolic,0,0
210275,blood,0,0
210276,pressure,0,0
210277,also,0,0
210278,showed,0,0
210279,shifts,0,0
210280,to,0,0
210281,the,0,0
210282,right,0,0
210283,after,0,0
210284,oral,0,1
210285,prizidilol,1,1
210286,",",0,0
210287,providing,0,0
210288,evidence,0,0
210289,of,0,0
210290,beta-adrenoceptor,0,1
210291,antagonism,0,0
210292,by,0,0
210293,this,0,0
210294,drug,0,0
210295,in,0,0
210296,peripheral,0,0
210297,resistance,0,0
210298,vessels,0,0
210299,.,0,0
210300,4,0,0
210301,The,0,0
210302,peak,0,0
210303,effect,0,0
210304,of,0,0
210305,a,0,0
210306,40,0,1
210307,mg,0,1
210308,dose,0,0
210309,of,0,0
210310,propranolol,1,1
210311,was,0,0
210312,greater,0,0
210313,than,0,0
210314,that,0,0
210315,of,0,0
210316,a,0,0
210317,200,0,1
210318,mg,0,1
210319,dose,0,0
210320,of,0,0
210321,prizidilol,1,1
210322,but,0,0
210323,both,0,0
210324,drugs,0,1
210325,caused,0,0
210326,persistent,0,0
210327,beta-adrenoceptor,0,1
210328,blockade,0,1
210329,for,0,0
210330,at,0,0
210331,least,0,0
210332,7,0,0
210333,h,0,0
210334,after,0,0
210335,ingestion,0,0
210336,.,0,0
210337,Gradual,0,1
210338,withdrawal,0,1
210339,of,0,0
210340,diazepam,1,1
210341,after,0,0
210342,long-term,0,0
210343,therapy,0,1
210344,.,0,0
210345,41,0,0
210346,outpatients,0,0
210347,who,0,0
210348,were,0,0
210349,long-term,0,0
210350,consumers,0,0
210351,of,0,0
210352,diazepam,1,1
210353,in,0,0
210354,therapeutic,0,0
210355,dosage,0,0
210356,were,0,0
210357,gradually,0,0
210358,withdrawn,0,0
210359,from,0,0
210360,the,0,0
210361,drug,0,0
210362,over,0,0
210363,3,0,0
210364,months,0,0
210365,by,0,0
210366,stepwise,0,0
210367,reduction,0,0
210368,.,0,0
210369,In,0,0
210370,a,0,0
210371,double-blind,0,0
210372,procedure,0,0
210373,half,0,1
210374,the,0,0
210375,patients,0,0
210376,began,0,0
210377,withdrawal,0,0
210378,immediately,0,1
210379,and,0,0
210380,half,0,1
210381,after,0,0
210382,8,0,0
210383,weeks,0,0
210384,.,0,0
210385,Of,0,0
210386,36,0,0
210387,patients,0,0
210388,who,0,0
210389,completed,0,0
210390,treatment,0,0
210391,",",0,0
210392,16,0,0
210393,(,0,0
210394,44.4,0,0
210395,%,0,0
210396,),0,0
210397,experienced,0,0
210398,true,0,0
210399,withdrawal,0,1
210400,phenomena,0,0
210401,on,0,0
210402,reducing,0,0
210403,their,0,0
210404,drugs,0,1
210405,",",0,0
210406,but,0,0
210407,8,0,0
210408,other,0,0
210409,patients,0,0
210410,had,0,0
210411,pseudo-withdrawal,0,0
210412,reactions,0,0
210413,at,0,0
210414,a,0,0
210415,time,0,0
210416,when,0,0
210417,their,0,0
210418,drug,0,1
210419,treatment,0,0
210420,was,0,0
210421,unchanged,0,0
210422,.,0,0
210423,The,0,0
210424,pseudo-withdrawal,0,0
210425,reactions,0,0
210426,consisted,0,0
210427,of,0,0
210428,an,0,0
210429,increase,0,0
210430,in,0,0
210431,anxiety,0,0
210432,symptoms,0,0
210433,only,0,0
210434,",",0,0
210435,whereas,0,0
210436,true,0,0
210437,withdrawal,0,0
210438,symptoms,0,0
210439,also,0,0
210440,included,0,0
210441,perceptual,0,0
210442,changes,0,0
210443,and,0,0
210444,psychotic,0,0
210445,symptoms,0,0
210446,.,0,0
210447,Examination,0,0
210448,of,0,0
210449,pharmacological,0,0
210450,and,0,0
210451,clinical,0,0
210452,predictors,0,0
210453,of,0,0
210454,withdrawal,0,1
210455,phenomena,0,0
210456,and,0,0
210457,later,0,0
210458,relapse,0,0
210459,showed,0,0
210460,that,0,0
210461,personality,0,0
210462,factors,0,0
210463,were,0,0
210464,the,0,0
210465,most,0,0
210466,important,0,0
210467,",",0,0
210468,patients,0,0
210469,with,0,0
210470,passive-dependent,0,0
210471,traits,0,0
210472,having,0,0
210473,a,0,0
210474,significantly,0,0
210475,greater,0,0
210476,prevalence,0,0
210477,of,0,0
210478,withdrawal,0,0
210479,reactions,0,0
210480,.,0,0
210481,Thyroid,1,1
210482,stimulating,1,0
210483,antibodies,1,0
210484,:,1,0
210485,an,0,0
210486,aid,0,0
210487,to,0,0
210488,the,0,0
210489,strategy,0,0
210490,of,0,0
210491,treatment,0,0
210492,of,0,0
210493,Graves,0,0
210494,',0,1
210495,disease,0,0
210496,?,0,0
210497,In,0,0
210498,1976,0,0
210499,we,0,0
210500,initiated,0,0
210501,a,0,0
210502,prospective,0,0
210503,study,0,0
210504,to,0,0
210505,specify,0,0
210506,the,0,0
210507,usefulness,0,0
210508,of,0,0
210509,thyroid,1,0
210510,stimulating,1,1
210511,antibody,1,1
210512,(,1,1
210513,TSAb,1,1
210514,),1,1
210515,determinations,0,0
210516,in,0,0
210517,predicting,0,0
210518,the,0,0
210519,outcome,0,0
210520,of,0,0
210521,post-antithyroid,1,0
210522,drug,1,1
210523,treatment,1,0
210524,for,0,0
210525,Graves,0,0
210526,',0,1
210527,disease,0,0
210528,.,0,0
210529,This,0,0
210530,study,0,0
210531,was,0,0
210532,carried,0,0
210533,out,0,0
210534,on,0,0
210535,55,0,0
210536,patients,0,0
210537,",",0,0
210538,who,0,0
210539,were,0,0
210540,either,0,0
210541,treated,0,0
210542,for,0,0
210543,six,0,0
210544,(,0,0
210545,n,0,0
210546,=,0,0
210547,16,0,0
210548,),0,0
210549,or,0,0
210550,18,0,0
210551,months,0,0
210552,(,0,0
210553,n,0,0
210554,=,0,0
210555,39,0,0
210556,),0,0
210557,and,0,0
210558,followed,0,1
210559,up,0,0
210560,for,0,0
210561,an,0,0
210562,additional,0,0
210563,two-year,0,0
210564,period,0,0
210565,.,0,0
210566,TSAb,1,0
210567,was,0,0
210568,determined,0,0
210569,on,0,0
210570,whole,0,0
210571,serum,0,0
210572,in,0,0
210573,29,0,0
210574,patients,0,0
210575,before,0,0
210576,and,0,0
210577,at,0,0
210578,the,0,0
210579,end,0,0
210580,of,0,0
210581,treatment,0,0
210582,",",0,0
210583,and,0,0
210584,in,0,0
210585,26,0,0
210586,patients,0,0
210587,at,0,0
210588,the,0,0
210589,end,0,0
210590,of,0,0
210591,treatment,0,0
210592,only,0,0
210593,.,0,0
210594,These,0,0
210595,determinations,0,0
210596,were,0,0
210597,carried,0,0
210598,out,0,0
210599,using,0,0
210600,a,0,0
210601,sensitive,0,0
210602,and,0,0
210603,reproducible,0,0
210604,microassay,0,0
210605,based,0,0
210606,on,0,0
210607,cAMP,0,1
210608,accumulation,0,0
210609,in,0,0
210610,human,0,1
210611,thyroid,0,0
210612,cell,0,0
210613,cultures,0,0
210614,.,0,0
210615,Before,0,0
210616,treatment,0,0
210617,",",0,0
210618,TSAb,0,0
210619,ranging,0,0
210620,from,0,0
210621,170,0,0
210622,to,0,0
210623,1529,0,0
210624,%,0,0
210625,was,0,0
210626,present,0,0
210627,in,0,0
210628,28/29,0,0
210629,patients,0,0
210630,and,0,0
210631,reached,0,0
210632,significantly,0,0
210633,low,0,0
210634,levels,0,0
210635,at,0,0
210636,the,0,0
210637,end,0,0
210638,of,0,0
210639,treatment,0,0
210640,whatever,0,0
210641,its,0,0
210642,duration,0,0
210643,.,0,0
210644,TSAb,0,0
210645,was,0,0
210646,undetectable,0,0
210647,in,0,0
210648,24/55,0,0
210649,patients,0,0
210650,at,0,0
210651,the,0,0
210652,end,0,0
210653,of,0,0
210654,treatment,0,0
210655,.,0,0
210656,8/16,0,0
210657,'short-treated,0,0
210658,',0,0
210659,and,0,0
210660,18/39,0,0
210661,'long-treated,0,0
210662,',0,0
210663,patients,0,0
210664,remained,0,0
210665,in,0,0
210666,remission,0,0
210667,.,0,0
210668,As,0,0
210669,expected,0,0
210670,",",0,0
210671,initial,0,0
210672,TSAb,0,0
210673,levels,0,0
210674,had,0,0
210675,no,0,0
210676,predictive,0,0
210677,value,0,0
210678,.,0,0
210679,End-treatment,0,0
210680,TSAb,0,0
210681,values,0,0
210682,",",0,0
210683,when,0,0
210684,low,0,0
210685,(,0,0
210686,less,0,0
210687,than,0,0
210688,350,0,0
210689,%,0,0
210690,),0,0
210691,or,0,1
210692,negative,0,0
210693,did,0,0
210694,not,0,0
210695,correlate,0,0
210696,with,0,0
210697,later,0,0
210698,evolution,0,0
210699,:,0,0
210700,in,0,0
210701,these,0,0
210702,39,0,0
210703,patients,0,0
210704,",",0,0
210705,relapse,0,0
210706,rate,0,0
210707,was,0,0
210708,41,0,0
210709,%,0,0
210710,.,0,0
210711,In,0,0
210712,contrast,0,0
210713,",",0,0
210714,13/16,0,0
210715,patients,0,0
210716,with,0,0
210717,end-treatment,0,0
210718,TSAb,0,0
210719,greater,0,0
210720,than,0,0
210721,350,0,0
210722,%,0,0
210723,relapsed,0,0
210724,.,0,0
210725,Relapses,0,0
210726,tended,0,0
210727,to,0,0
210728,occur,0,0
210729,earlier,0,0
210730,in,0,0
210731,patients,0,0
210732,with,0,0
210733,the,0,0
210734,highest,0,0
210735,TSAb,0,0
210736,levels,0,0
210737,.,0,0
210738,TSAb,0,0
210739,determined,0,0
210740,again,0,0
210741,during,0,0
210742,follow-up,0,0
210743,was,0,0
210744,negative,0,0
210745,in,0,0
210746,each,0,0
210747,of,0,0
210748,the,0,0
210749,18,0,0
210750,patients,0,0
210751,in,0,0
210752,remission,0,0
210753,",",0,0
210754,and,0,0
210755,positive,0,0
210756,in,0,0
210757,8/10,0,0
210758,patients,0,0
210759,at,0,0
210760,the,0,0
210761,time,0,0
210762,of,0,0
210763,relapse,0,0
210764,",",0,0
210765,whatever,0,0
210766,its,0,0
210767,level,0,0
210768,at,0,0
210769,the,0,0
210770,end,0,0
210771,of,0,0
210772,the,0,0
210773,drug,0,1
210774,course,0,0
210775,.,0,0
210776,This,0,0
210777,study,0,0
210778,confirms,0,0
210779,that,0,0
210780,only,0,0
210781,end-treatment,0,1
210782,TSAb,0,0
210783,levels,0,0
210784,are,0,0
210785,predictive,0,0
210786,of,0,0
210787,relapse,0,0
210788,.,0,0
210789,(,0,0
210790,ABSTRACT,0,1
210791,TRUNCATED,0,1
210792,AT,0,1
210793,250,0,1
210794,WORDS,0,1
210795,),0,1
210796,A,0,0
210797,comparison,0,0
210798,of,0,0
210799,propranolol,1,1
210800,and,1,0
210801,nadolol,1,1
210802,pharmacokinetics,1,0
210803,and,0,0
210804,clinical,0,0
210805,effects,0,0
210806,in,0,0
210807,thyrotoxicosis,0,0
210808,.,0,0
210809,For,0,0
210810,a,0,0
210811,comparison,0,0
210812,of,0,0
210813,propranolol,1,1
210814,and,1,0
210815,nadolol,1,1
210816,pharmacokinetics,0,0
210817,and,0,0
210818,clinical,0,0
210819,effects,0,0
210820,",",0,0
210821,20,0,0
210822,newly,0,0
210823,diagnosed,0,0
210824,patients,0,0
210825,with,0,0
210826,thyrotoxicosis,0,0
210827,were,0,0
210828,randomly,0,0
210829,selected,0,0
210830,to,0,0
210831,receive,0,0
210832,as,0,0
210833,sole,0,0
210834,therapy,0,1
210835,",",0,0
210836,either,0,1
210837,propranolol,1,1
210838,",",0,0
210839,40,0,0
210840,mg,0,1
210841,every,0,0
210842,6,0,0
210843,hours,0,0
210844,for,0,0
210845,14,0,0
210846,days,0,0
210847,",",0,0
210848,or,0,0
210849,nadolol,1,1
210850,",",0,0
210851,80,0,0
210852,mg,0,1
210853,each,0,0
210854,morning,0,0
210855,for,0,0
210856,14,0,0
210857,days,0,0
210858,.,0,0
210859,The,0,0
210860,study,0,0
210861,was,0,0
210862,repeated,0,0
210863,when,0,0
210864,the,0,0
210865,patients,0,0
210866,were,0,0
210867,in,0,0
210868,the,0,0
210869,euthyroid,0,0
210870,state,0,0
210871,.,0,0
210872,There,0,0
210873,was,0,0
210874,a,0,0
210875,similar,0,0
210876,and,0,0
210877,highly,0,0
210878,significant,0,0
210879,degree,0,0
210880,of,0,0
210881,beta,0,1
210882,blockade,0,1
210883,and,0,0
210884,amelioration,0,0
210885,of,0,0
210886,symptoms,0,0
210887,of,0,0
210888,thyrotoxicosis,0,0
210889,at,0,0
210890,the,0,0
210891,end,0,0
210892,of,0,0
210893,the,0,0
210894,dosage,0,0
210895,interval,0,0
210896,(,0,1
210897,trough,0,0
210898,),0,0
210899,",",0,0
210900,i.e.,0,0
210901,",",0,0
210902,24,0,0
210903,hours,0,0
210904,after,0,0
210905,nadolol,1,1
210906,or,0,1
210907,6,0,0
210908,to,0,0
210909,8,0,0
210910,hours,0,0
210911,after,0,0
210912,propranolol,1,1
210913,.,1,0
210914,Trough,0,0
210915,and,0,0
210916,peak,0,0
210917,serum,0,0
210918,levels,0,0
210919,of,0,0
210920,propranolol,1,1
210921,were,0,0
210922,significantly,0,0
210923,lower,0,0
210924,when,0,0
210925,the,0,0
210926,patients,0,0
210927,were,0,0
210928,in,0,0
210929,a,0,0
210930,thyrotoxic,0,0
210931,state,0,0
210932,than,0,0
210933,when,0,0
210934,they,0,0
210935,were,0,0
210936,in,0,0
210937,a,0,0
210938,euthyroid,0,0
210939,state,0,0
210940,",",0,0
210941,whereas,0,0
210942,the,0,0
210943,pharmacokinetics,0,0
210944,of,0,0
210945,nadolol,0,1
210946,were,0,0
210947,not,0,0
210948,appreciably,0,0
210949,altered,0,0
210950,by,0,0
210951,thyrotoxicosis,0,0
210952,.,0,0
210953,In,0,0
210954,thyrotoxicosis,0,0
210955,",",0,0
210956,trough,0,0
210957,levels,0,0
210958,of,0,0
210959,propranolol,1,1
210960,and,0,0
210961,nadolol,1,1
210962,were,0,0
210963,significantly,0,0
210964,inversely,0,0
210965,correlated,0,0
210966,with,0,0
210967,derived,0,0
210968,creatinine,0,0
210969,clearance,0,0
210970,values,0,0
210971,.,0,0
210972,In,0,0
210973,the,0,0
210974,symptomatic,0,0
210975,treatment,0,0
210976,of,0,0
210977,thyrotoxicosis,0,0
210978,",",0,0
210979,nadolol,1,1
210980,",",0,0
210981,a,0,0
210982,once-daily,0,1
210983,nonmetabolized,1,1
210984,beta,1,1
210985,blocker,1,1
210986,",",0,0
210987,has,0,0
210988,certain,0,0
210989,advantages,0,0
210990,compared,0,0
210991,with,0,0
210992,propranolol,1,1
210993,.,1,0
210994,It,0,0
210995,is,0,0
210996,preferred,0,0
210997,by,0,0
210998,patients,0,0
210999,",",0,0
211000,is,0,0
211001,more,0,0
211002,convenient,0,0
211003,",",0,0
211004,and,0,0
211005,probably,0,0
211006,aids,0,0
211007,compliance,0,0
211008,.,0,0
211009,[,0,0
211010,The,0,0
211011,somatostatin,1,1
211012,infusion,1,1
211013,test,1,0
211014,for,0,0
211015,the,0,0
211016,evaluation,0,0
211017,of,0,0
211018,glucose,0,0
211019,utilization,0,0
211020,in,0,0
211021,bezafibrate,1,1
211022,medication,1,1
211023,],1,0
211024,.,0,0
211025,The,0,0
211026,utilisation,0,0
211027,of,0,0
211028,blood,1,0
211029,glucose,1,0
211030,may,0,0
211031,be,0,0
211032,used,0,0
211033,for,0,0
211034,definition,0,0
211035,of,0,0
211036,insulin,0,1
211037,resistance,0,0
211038,in,0,0
211039,type,0,0
211040,II,0,1
211041,diabetes,0,0
211042,mellitus,0,0
211043,.,0,0
211044,To,0,0
211045,evaluate,0,0
211046,this,0,0
211047,possibility,0,0
211048,we,0,0
211049,adapted,0,0
211050,an,0,0
211051,infusion,1,1
211052,test,1,0
211053,of,1,0
211054,somatostatin,1,1
211055,in,0,0
211056,10,0,0
211057,normal,0,0
211058,persons,0,0
211059,(,0,0
211060,age,0,0
211061,26,0,0
211062,+/-,0,0
211063,3,0,0
211064,years,0,0
211065,",",0,0
211066,relative,0,0
211067,body,0,0
211068,weight,0,0
211069,26,0,0
211070,+/-,0,0
211071,10,0,0
211072,%,0,0
211073,according,0,0
211074,to,0,0
211075,Broca,0,1
211076,),0,0
211077,in,0,0
211078,a,0,0
211079,randomized,0,0
211080,cross-over,0,0
211081,therapy,0,1
211082,with,0,1
211083,bezafibrate,1,1
211084,(,0,0
211085,3,0,0
211086,X,0,1
211087,200,0,1
211088,mg/die,0,1
211089,),0,0
211090,.,0,0
211091,As,0,0
211092,the,0,0
211093,coefficient,0,0
211094,of,0,0
211095,variation,0,0
211096,(,0,1
211097,VC,0,1
211098,),0,1
211099,of,0,0
211100,measured,0,0
211101,blood,0,0
211102,glucose,0,0
211103,continuously,0,0
211104,increased,0,0
211105,the,0,0
211106,best,0,0
211107,time,0,0
211108,of,0,0
211109,a,0,0
211110,steady,0,0
211111,state,0,0
211112,was,0,0
211113,between,0,0
211114,90,0,0
211115,and,0,0
211116,130,0,0
211117,min,0,0
211118,after,0,0
211119,beginning,0,0
211120,the,0,0
211121,infusion,0,1
211122,(,0,0
211123,mean,0,0
211124,VC,0,1
211125,8.9,0,0
211126,%,0,0
211127,),0,0
211128,.,0,0
211129,While,0,0
211130,insulin,0,0
211131,remained,0,0
211132,nearly,0,0
211133,constant,0,0
211134,(,0,1
211135,41,0,0
211136,(,0,0
211137,45,0,0
211138,;,0,0
211139,38,0,0
211140,),0,0
211141,microU/ml,0,0
211142,),0,1
211143,blood,0,0
211144,glucose,0,0
211145,dropped,0,0
211146,by,0,0
211147,about,0,0
211148,14,0,0
211149,%,0,0
211150,and,0,0
211151,reached,0,0
211152,a,0,0
211153,steady,0,0
211154,state,0,0
211155,of,0,0
211156,89,0,0
211157,(,0,0
211158,134,0,0
211159,;,0,0
211160,45,0,0
211161,),0,0
211162,mg/dl,0,0
211163,.,0,0
211164,During,0,0
211165,the,0,0
211166,therapy,0,1
211167,of,0,0
211168,bezafibrate,1,1
211169,blood,0,0
211170,glucose,0,0
211171,was,0,0
211172,significantly,0,0
211173,decreased,0,0
211174,by,0,0
211175,36,0,0
211176,%,0,0
211177,130,0,0
211178,min,0,0
211179,after,0,0
211180,beginning,0,0
211181,the,0,0
211182,infusion,0,1
211183,.,0,0
211184,Although,0,0
211185,the,0,0
211186,effect,0,0
211187,was,0,0
211188,not,0,0
211189,significant,0,0
211190,during,0,0
211191,the,0,0
211192,whole,0,0
211193,time,0,0
211194,of,0,0
211195,the,0,0
211196,steady,0,0
211197,state,0,0
211198,it,0,0
211199,became,0,0
211200,evident,0,0
211201,by,0,0
211202,a,0,0
211203,negative,0,0
211204,correlation,0,0
211205,with,0,1
211206,lactate,0,0
211207,(,0,0
211208,r,0,0
211209,=,0,0
211210,-0.687,0,0
211211,),0,1
211212,and,0,1
211213,pyruvate,0,1
211214,(,0,1
211215,r,0,0
211216,=,0,0
211217,-0.843,0,0
211218,),0,0
211219,.,0,0
211220,A,0,0
211221,correlation,0,0
211222,with,0,0
211223,a,0,0
211224,concomitant,0,0
211225,decrease,0,0
211226,of,0,0
211227,triglyceride,0,0
211228,and,0,0
211229,cholesterol,0,0
211230,also,0,0
211231,induced,0,0
211232,by,0,0
211233,bezafibrate,1,1
211234,could,0,0
211235,not,0,0
211236,be,0,0
211237,proven,0,0
211238,.,0,0
211239,The,0,0
211240,results,0,0
211241,show,0,0
211242,that,0,0
211243,the,0,0
211244,infusion,1,1
211245,test,1,0
211246,of,1,0
211247,somatostatin,1,1
211248,is,0,0
211249,fitted,0,0
211250,to,0,0
211251,measure,0,0
211252,a,0,0
211253,steady,0,0
211254,state,0,0
211255,of,0,0
211256,blood,0,0
211257,glucose,0,0
211258,and,0,1
211259,insulin,0,1
211260,and,0,0
211261,that,0,0
211262,it,0,0
211263,is,0,0
211264,possible,0,0
211265,by,0,0
211266,this,0,0
211267,technique,0,1
211268,to,0,0
211269,quantify,0,0
211270,a,0,0
211271,changed,0,0
211272,utilisation,0,0
211273,of,0,0
211274,blood,0,0
211275,glucose,0,0
211276,induced,0,0
211277,by,0,0
211278,specific,0,0
211279,therapy,0,1
211280,.,0,0
211281,Metabolic,0,0
211282,and,0,0
211283,circulatory,0,0
211284,effects,0,0
211285,of,0,0
211286,oral,0,1
211287,salbutamol,1,1
211288,in,0,0
211289,the,0,0
211290,third,0,0
211291,trimester,0,0
211292,of,0,0
211293,pregnancy,0,0
211294,in,0,0
211295,diabetic,0,0
211296,and,0,0
211297,non-diabetic,0,0
211298,women,0,0
211299,.,0,0
211300,Metabolic,0,0
211301,and,0,0
211302,cardiovascular,0,0
211303,effects,0,0
211304,of,0,0
211305,4,1,0
211306,mg,1,1
211307,oral,1,1
211308,salbutamol,1,1
211309,were,0,0
211310,studied,0,0
211311,in,0,0
211312,ten,0,0
211313,non-diabetic,0,0
211314,",",0,0
211315,ten,0,0
211316,chemical,0,1
211317,diabetic,0,0
211318,and,0,0
211319,five,0,0
211320,juvenile,0,0
211321,diabetic,0,0
211322,women,0,0
211323,in,0,0
211324,late,0,0
211325,pregnancy,0,0
211326,.,0,0
211327,None,0,0
211328,of,0,0
211329,the,0,0
211330,women,0,0
211331,had,0,0
211332,been,0,0
211333,treated,0,0
211334,with,0,0
211335,beta-sympathomimetic,1,1
211336,drugs,1,1
211337,earlier,0,0
211338,in,0,0
211339,their,0,0
211340,pregnancy,0,0
211341,.,0,0
211342,Heart,0,0
211343,rate,0,0
211344,and,0,0
211345,blood,0,0
211346,pressure,0,0
211347,were,0,0
211348,recorded,0,0
211349,and,0,0
211350,blood,0,0
211351,samples,0,0
211352,for,0,0
211353,measurement,0,0
211354,of,0,0
211355,plasma,0,0
211356,cyclic,0,1
211357,AMP,0,1
211358,",",0,0
211359,insulin,0,0
211360,",",0,0
211361,C-peptide,0,1
211362,",",0,0
211363,glucose,0,0
211364,",",0,0
211365,lactate,0,0
211366,",",0,0
211367,glycerol,0,1
211368,",",0,0
211369,non-esterified,0,0
211370,fatty,0,1
211371,acids,0,1
211372,(,0,0
211373,NEFA,0,1
211374,),0,1
211375,and,0,0
211376,3-hydroxybutyrate,0,1
211377,(,0,1
211378,3-HB,0,0
211379,),0,0
211380,were,0,0
211381,collected,0,0
211382,every,0,0
211383,30,0,0
211384,minutes,0,0
211385,for,0,0
211386,120,0,0
211387,minutes,0,0
211388,after,0,0
211389,salbutamol,1,1
211390,.,1,0
211391,All,0,0
211392,women,0,0
211393,underwent,1,0
211394,the,1,0
211395,same,1,0
211396,procedure,1,0
211397,at,1,0
211398,random,1,0
211399,without,1,0
211400,salbutamol,1,1
211401,.,1,0
211402,There,0,0
211403,were,0,0
211404,significant,0,0
211405,cardiovascular,0,0
211406,effects,0,0
211407,of,0,0
211408,salbutamol,1,1
211409,in,0,0
211410,all,0,0
211411,the,0,0
211412,groups,0,0
211413,but,0,0
211414,no,0,0
211415,differences,0,0
211416,in,0,0
211417,these,0,0
211418,effects,0,0
211419,between,0,0
211420,the,0,0
211421,groups,0,0
211422,.,0,0
211423,Salbutamol,1,1
211424,caused,0,0
211425,significant,0,0
211426,increases,0,0
211427,of,0,0
211428,glycogenolysis,0,0
211429,and,0,0
211430,lipolysis,0,0
211431,in,0,0
211432,all,0,0
211433,the,0,0
211434,groups,0,0
211435,",",0,0
211436,significantly,0,0
211437,larger,0,0
211438,in,0,0
211439,the,0,0
211440,juvenile,0,0
211441,diabetic,0,0
211442,than,0,0
211443,the,0,0
211444,non-diabetic,0,0
211445,and,0,0
211446,chemical,0,0
211447,diabetic,0,0
211448,women,0,0
211449,.,0,0
211450,This,0,0
211451,observation,0,0
211452,could,0,0
211453,be,0,0
211454,explained,0,0
211455,by,0,0
211456,the,0,0
211457,inability,0,0
211458,of,0,0
211459,the,0,0
211460,juvenile,0,0
211461,diabetics,0,0
211462,to,0,0
211463,secrete,0,0
211464,insulin,0,1
211465,",",0,0
211466,shown,0,0
211467,by,0,0
211468,their,0,0
211469,non-measureable,0,0
211470,plasma,0,0
211471,C-peptide,0,0
211472,levels,0,0
211473,.,0,0
211474,The,0,0
211475,metabolic,0,0
211476,responses,0,0
211477,following,0,0
211478,salbutamol,1,1
211479,in,0,0
211480,the,0,0
211481,chemical,0,0
211482,diabetics,0,0
211483,were,0,0
211484,intermediate,0,0
211485,between,0,0
211486,the,0,0
211487,non-diabetic,0,0
211488,and,0,0
211489,juvenile,0,0
211490,diabetic,0,0
211491,groups,0,0
211492,.,0,0
211493,The,0,0
211494,results,0,0
211495,show,0,0
211496,that,0,0
211497,diabetes,0,0
211498,does,0,0
211499,not,0,0
211500,alter,0,0
211501,the,0,0
211502,sensitivity,0,0
211503,of,0,0
211504,beta-receptors,0,1
211505,involved,0,0
211506,in,0,0
211507,cardiovascular,0,0
211508,regulation,0,0
211509,",",0,0
211510,while,0,0
211511,the,0,0
211512,metabolic,0,0
211513,responses,0,0
211514,to,0,0
211515,oral,0,1
211516,salbutamol,1,1
211517,are,0,0
211518,enhanced,0,0
211519,",",0,0
211520,especially,0,0
211521,in,0,0
211522,juvenile,0,0
211523,diabetics,0,0
211524,.,0,0
211525,We,0,0
211526,suggest,0,0
211527,that,0,0
211528,during,0,0
211529,treatment,0,0
211530,with,0,0
211531,beta-sympathomimetic,1,1
211532,drugs,1,1
211533,",",0,0
211534,blood,0,0
211535,glucose,0,0
211536,should,0,0
211537,be,0,0
211538,monitored,0,0
211539,in,0,0
211540,all,0,0
211541,patients,0,0
211542,showing,0,0
211543,criteria,0,0
211544,of,0,0
211545,potential,0,0
211546,diabetes,0,0
211547,.,0,0
211548,Comparison,0,0
211549,of,0,0
211550,hypnotherapy,1,1
211551,with,0,0
211552,systematic,1,0
211553,relaxation,1,1
211554,in,0,0
211555,the,0,0
211556,treatment,0,0
211557,of,0,0
211558,cigarette,0,0
211559,habituation,0,0
211560,.,0,0
211561,Because,0,0
211562,of,0,0
211563,the,0,0
211564,methodological,0,0
211565,deficiencies,0,0
211566,in,0,0
211567,this,0,0
211568,area,0,0
211569,of,0,0
211570,research,0,0
211571,",",0,0
211572,it,0,0
211573,is,0,0
211574,impossible,0,0
211575,to,0,0
211576,make,0,0
211577,any,0,0
211578,valid,0,0
211579,conclusions,0,0
211580,about,0,0
211581,whether,0,0
211582,hypnosis,0,1
211583,itself,0,0
211584,is,0,0
211585,effective,0,0
211586,in,0,0
211587,the,0,0
211588,treatment,0,0
211589,of,0,0
211590,cigarette,0,0
211591,habituation,0,0
211592,.,0,0
211593,In,0,0
211594,this,0,0
211595,study,0,0
211596,",",0,0
211597,87,0,0
211598,volunteers,0,0
211599,who,0,0
211600,wanted,0,0
211601,to,0,0
211602,quit,0,0
211603,cigarette,0,1
211604,smoking,0,0
211605,were,0,0
211606,assigned,0,0
211607,randomly,0,0
211608,to,0,0
211609,the,0,0
211610,experimental,1,0
211611,hypnosis,1,1
211612,group,1,0
211613,",",1,0
211614,the,1,0
211615,comparison,1,0
211616,relaxation,1,1
211617,group,1,0
211618,",",1,0
211619,and,1,0
211620,the,1,0
211621,waiting,1,0
211622,list,1,1
211623,control,1,1
211624,group,1,0
211625,.,1,0
211626,Ss,0,0
211627,in,0,0
211628,the,0,0
211629,treatment,0,0
211630,groups,0,0
211631,had,0,0
211632,four,0,0
211633,weekly,0,1
211634,50-minute,0,1
211635,",",0,0
211636,individual,0,0
211637,sessions,0,1
211638,.,0,0
211639,Four,0,0
211640,months,0,0
211641,after,0,0
211642,the,0,0
211643,completion,0,0
211644,of,0,0
211645,treatment,0,0
211646,",",0,0
211647,Ss,0,0
211648,were,0,0
211649,administered,0,0
211650,a,0,0
211651,questionnaire,0,0
211652,and,0,0
211653,a,0,0
211654,hypnotic,0,1
211655,susceptibility,0,0
211656,scale,0,0
211657,.,0,0
211658,Ss,0,0
211659,in,0,0
211660,the,0,0
211661,hypnosis,1,1
211662,group,0,0
211663,who,0,0
211664,were,0,0
211665,in,0,0
211666,the,0,0
211667,upper,0,0
211668,two-thirds,0,0
211669,of,0,0
211670,the,0,0
211671,group,0,0
211672,in,0,0
211673,terms,0,0
211674,of,0,0
211675,hypnotic,0,1
211676,susceptibility,0,0
211677,reduced,0,0
211678,their,0,0
211679,cigarette,0,1
211680,consumption,0,0
211681,substantially,0,0
211682,more,0,0
211683,than,0,0
211684,Ss,0,0
211685,in,0,0
211686,the,0,0
211687,relaxation,0,1
211688,group,0,0
211689,who,0,0
211690,were,0,0
211691,in,0,0
211692,the,0,0
211693,upper,0,0
211694,two-thirds,0,0
211695,of,0,0
211696,the,0,0
211697,group,0,0
211698,in,0,0
211699,terms,0,0
211700,of,0,0
211701,hypnotic,0,1
211702,susceptibility,0,0
211703,.,0,0
211704,Therefore,0,0
211705,",",0,0
211706,the,0,0
211707,hypnotic,0,1
211708,state,0,0
211709,appears,0,0
211710,to,0,0
211711,be,0,0
211712,therapeutic,0,0
211713,for,0,0
211714,individuals,0,0
211715,who,0,0
211716,can,0,0
211717,enter,0,0
211718,medium,0,0
211719,or,0,1
211720,deep,0,1
211721,states,0,0
211722,of,0,0
211723,hypnosis,0,1
211724,.,0,0
211725,Comparison,0,0
211726,of,0,0
211727,short-term,0,0
211728,efficacy,0,0
211729,of,0,0
211730,diltiazem,1,1
211731,and,1,0
211732,propranolol,1,1
211733,in,0,0
211734,unstable,0,0
211735,angina,0,0
211736,at,0,0
211737,rest,0,0
211738,--,0,0
211739,a,0,0
211740,randomized,0,0
211741,trial,0,0
211742,in,0,0
211743,70,0,0
211744,patients,0,0
211745,.,0,0
211746,The,0,0
211747,short-term,0,0
211748,efficacy,0,0
211749,of,0,0
211750,diltiazem,1,1
211751,(,1,1
211752,D,1,1
211753,),1,1
211754,has,0,0
211755,been,0,0
211756,compared,0,0
211757,to,0,0
211758,that,0,0
211759,of,0,0
211760,propranolol,1,1
211761,(,1,1
211762,P,1,0
211763,),1,0
211764,",",0,0
211765,in,0,0
211766,a,0,0
211767,group,0,0
211768,of,0,0
211769,70,0,0
211770,patients,0,0
211771,hospitalized,0,0
211772,in,0,0
211773,the,0,0
211774,Coronary,0,0
211775,Care,0,0
211776,Unit,0,0
211777,for,0,0
211778,unstable,0,0
211779,angina,0,0
211780,",",0,0
211781,defined,0,0
211782,as,0,0
211783,recent,0,0
211784,(,0,0
211785,less,0,0
211786,than,0,0
211787,one,0,0
211788,month,0,0
211789,),0,1
211790,appearance,0,0
211791,or,0,1
211792,aggravation,0,0
211793,of,0,0
211794,spontaneous,0,0
211795,chest,0,0
211796,pains,0,0
211797,.,0,0
211798,Among,0,0
211799,the,0,0
211800,70,0,0
211801,patients,0,0
211802,",",0,0
211803,24,0,0
211804,had,0,0
211805,angina,0,0
211806,only,0,0
211807,at,0,0
211808,rest,0,0
211809,.,0,0
211810,The,0,0
211811,patients,0,0
211812,have,0,0
211813,been,0,0
211814,divided,0,0
211815,into,0,0
211816,two,0,0
211817,groups,0,0
211818,according,0,0
211819,to,0,0
211820,ST-T,0,0
211821,changes,0,0
211822,during,0,0
211823,chest,0,0
211824,pain,0,0
211825,:,0,0
211826,29,0,0
211827,with,0,0
211828,ST,0,0
211829,elevation,0,0
211830,(,0,0
211831,group,0,1
211832,A,0,1
211833,),0,1
211834,and,0,0
211835,41,0,0
211836,with,0,0
211837,other,0,0
211838,repolarization,0,0
211839,abnormalities,0,0
211840,(,0,0
211841,group,0,1
211842,B,0,1
211843,),0,0
211844,.,0,0
211845,Treatment,0,0
211846,was,0,0
211847,then,0,0
211848,randomized,0,0
211849,in,0,0
211850,each,0,0
211851,group,0,0
211852,.,0,0
211853,Treatment,0,0
211854,Treatment,0,0
211855,was,0,0
211856,considered,0,0
211857,successful,0,0
211858,only,0,0
211859,if,0,0
211860,spontaneous,0,0
211861,chest,0,1
211862,pains,0,0
211863,disappeared,0,0
211864,completely,0,0
211865,.,0,0
211866,Thirty-four,0,0
211867,patients,0,0
211868,were,0,0
211869,treated,0,0
211870,with,0,0
211871,D,1,1
211872,(,0,0
211873,282,0,0
211874,+/-,0,0
211875,102,0,0
211876,mg/day,0,1
211877,),0,0
211878,and,0,0
211879,36,0,0
211880,with,0,0
211881,P,1,0
211882,(,0,0
211883,158,0,0
211884,+/-,0,0
211885,81,0,0
211886,mg/day,0,1
211887,),0,0
211888,.,0,0
211889,In,0,0
211890,the,0,0
211891,whole,0,1
211892,group,0,0
211893,and,0,0
211894,in,0,0
211895,groups,0,0
211896,A,0,0
211897,and,0,0
211898,B,0,0
211899,considered,0,0
211900,individually,0,0
211901,",",0,0
211902,responses,0,0
211903,to,0,0
211904,D,1,1
211905,and,0,0
211906,P,1,0
211907,did,0,0
211908,not,0,0
211909,differ,0,0
211910,.,0,0
211911,Among,0,0
211912,the,0,0
211913,24,0,0
211914,patients,0,0
211915,with,0,0
211916,angina,0,0
211917,exclusively,0,0
211918,at,0,0
211919,rest,0,0
211920,",",0,0
211921,nine,0,0
211922,successes,0,0
211923,and,0,0
211924,four,0,0
211925,failures,0,0
211926,were,0,0
211927,observed,0,0
211928,with,0,0
211929,D.,1,0
211930,There,0,0
211931,was,0,0
211932,no,0,0
211933,symptomatic,0,0
211934,relief,0,0
211935,among,0,0
211936,the,0,0
211937,11,0,0
211938,patients,0,0
211939,treated,0,0
211940,by,0,0
211941,P,1,0
211942,(,0,0
211943,P,0,0
211944,=,0,0
211945,0.001,0,0
211946,),0,0
211947,.,0,0
211948,Moreover,0,0
211949,",",0,0
211950,the,0,0
211951,number,0,0
211952,of,0,0
211953,episodes,0,0
211954,of,0,0
211955,angina,0,0
211956,was,0,0
211957,decreased,0,0
211958,by,0,0
211959,D,1,1
211960,and,0,0
211961,unchanged,0,0
211962,by,0,0
211963,P,1,0
211964,",",0,0
211965,while,0,0
211966,eight,0,0
211967,out,0,0
211968,of,0,0
211969,the,0,0
211970,11,0,0
211971,failures,0,0
211972,with,0,0
211973,P,1,0
211974,were,0,0
211975,immediate,0,0
211976,successes,0,0
211977,when,0,0
211978,treatment,0,0
211979,was,0,0
211980,replaced,0,0
211981,with,0,0
211982,D.,1,0
211983,These,0,0
211984,results,0,0
211985,suggest,0,0
211986,that,0,0
211987,D,1,1
211988,is,0,0
211989,preferable,0,0
211990,to,0,0
211991,P,1,0
211992,for,0,0
211993,management,0,1
211994,of,0,0
211995,unstable,0,0
211996,angina,0,0
211997,in,0,0
211998,patients,0,0
211999,with,0,0
212000,angina,0,0
212001,which,0,0
212002,is,0,0
212003,exclusively,0,0
212004,spontaneous,0,0
212005,.,0,0
212006,A,0,0
212007,controlled,0,0
212008,study,0,0
212009,of,0,0
212010,the,0,0
212011,effect,0,0
212012,of,0,0
212013,indomethacin,1,1
212014,in,0,0
212015,uremic,0,0
212016,pericarditis,0,0
212017,.,0,0
212018,To,0,0
212019,determine,0,0
212020,the,0,0
212021,impact,0,0
212022,of,0,0
212023,indomethacin,1,1
212024,on,0,0
212025,the,0,0
212026,course,0,0
212027,of,0,0
212028,uremic,0,0
212029,pericarditis,0,0
212030,we,0,0
212031,performed,0,0
212032,a,0,0
212033,prospective,0,0
212034,",",0,0
212035,double,0,1
212036,blind,0,0
212037,study,0,0
212038,in,0,0
212039,which,0,0
212040,24,0,0
212041,patients,0,0
212042,with,0,0
212043,endstage,0,0
212044,chronic,0,0
212045,renal,0,0
212046,failure,0,0
212047,and,0,0
212048,pericarditis,0,0
212049,randomly,0,0
212050,received,0,0
212051,indomethacin,1,1
212052,",",0,0
212053,25,0,0
212054,mg,0,1
212055,four,0,0
212056,times,0,0
212057,daily,0,0
212058,",",0,0
212059,(,0,0
212060,11,0,0
212061,patients,0,0
212062,),0,0
212063,or,0,1
212064,a,0,1
212065,placebo,1,1
212066,(,0,0
212067,13,0,0
212068,patients,0,0
212069,),0,0
212070,for,0,0
212071,a,0,0
212072,3-week,0,0
212073,period,0,0
212074,.,0,0
212075,All,0,0
212076,patients,0,0
212077,received,0,0
212078,peritoneal,0,1
212079,or,0,1
212080,hemodialysis,0,1
212081,treatment,0,1
212082,concurrently,0,1
212083,with,0,0
212084,the,0,0
212085,study,0,0
212086,drug,0,0
212087,.,0,0
212088,In,0,0
212089,contrast,0,0
212090,to,0,0
212091,the,0,0
212092,placebo,1,1
212093,",",1,0
212094,indomethacin,1,1
212095,produced,0,0
212096,an,0,0
212097,immediate,0,0
212098,and,0,0
212099,sustained,0,0
212100,reduction,0,0
212101,of,0,0
212102,fever,0,0
212103,in,0,0
212104,all,0,0
212105,but,0,0
212106,one,0,0
212107,patient,0,0
212108,.,0,0
212109,On,0,0
212110,the,0,0
212111,other,0,0
212112,hand,0,0
212113,",",0,0
212114,indomethacin,1,1
212115,had,0,0
212116,no,0,0
212117,effect,0,0
212118,on,0,0
212119,the,0,0
212120,duration,0,0
212121,of,0,0
212122,chest,0,1
212123,pain,0,0
212124,(,0,0
212125,mean,0,0
212126,days,0,0
212127,+/-,0,0
212128,SE,0,1
212129,:,0,0
212130,placebo,1,1
212131,1.4,0,0
212132,+/-,0,0
212133,0.6,0,0
212134,",",0,0
212135,indomethacin,1,1
212136,5.5,0,0
212137,+/-,0,0
212138,3.3,0,0
212139,),0,0
212140,",",0,0
212141,duration,0,0
212142,of,0,0
212143,pericardial,0,0
212144,friction,0,1
212145,rub,0,0
212146,(,0,0
212147,placebo,0,1
212148,10.3,0,0
212149,+/-,0,0
212150,1.7,0,0
212151,",",0,0
212152,indomethacin,1,1
212153,16.0,0,0
212154,+/-,0,0
212155,3.8,0,0
212156,),0,0
212157,",",0,0
212158,or,0,1
212159,on,0,0
212160,the,0,0
212161,amount,0,0
212162,of,0,0
212163,pericardial,0,0
212164,effusion,0,0
212165,.,0,0
212166,Further,0,0
212167,",",0,0
212168,indomethacin,0,1
212169,did,0,0
212170,not,0,0
212171,diminish,0,0
212172,the,0,0
212173,need,0,0
212174,for,0,0
212175,invasive,0,0
212176,surgical,0,0
212177,procedures,0,0
212178,for,0,0
212179,relief,0,0
212180,of,0,0
212181,tamponade,0,0
212182,(,0,0
212183,three,0,0
212184,of,0,0
212185,13,0,0
212186,placebo,0,1
212187,patients,0,0
212188,",",0,0
212189,two,0,0
212190,of,0,0
212191,11,0,0
212192,indomethacin,0,1
212193,patients,0,0
212194,),0,0
212195,or,0,1
212196,result,0,0
212197,in,0,0
212198,decreased,0,0
212199,mortality,0,0
212200,rate,0,0
212201,.,0,1
212202,Death,0,0
212203,(,0,0
212204,not,0,0
212205,due,0,0
212206,to,0,0
212207,pericarditis,0,0
212208,),0,0
212209,occurred,0,0
212210,in,0,0
212211,two,0,0
212212,patients,0,0
212213,treated,0,0
212214,with,0,0
212215,indomethacin,0,1
212216,and,0,0
212217,one,0,0
212218,patient,0,0
212219,who,0,0
212220,received,0,0
212221,the,0,0
212222,placebo,1,1
212223,.,1,0
212224,In,0,0
212225,our,0,0
212226,patients,0,0
212227,pericarditis,0,0
212228,encompassed,0,0
212229,a,0,0
212230,wide,0,0
212231,spectrum,0,0
212232,ranging,0,0
212233,from,0,0
212234,a,0,0
212235,mild,0,0
212236,illness,0,0
212237,of,0,0
212238,several,0,0
212239,days,0,0
212240,duration,0,0
212241,to,0,0
212242,a,0,0
212243,painful,0,0
212244,and,0,0
212245,debilitating,0,0
212246,disease,0,0
212247,lasting,0,0
212248,weeks,0,1
212249,and,0,0
212250,requiring,0,0
212251,surgical,0,1
212252,intervention,0,1
212253,.,0,0
212254,Although,0,0
212255,the,0,0
212256,size,0,0
212257,of,0,0
212258,our,0,0
212259,population,0,0
212260,prohibits,0,0
212261,definitive,0,0
212262,conclusions,0,0
212263,",",0,0
212264,it,0,0
212265,would,0,0
212266,appear,0,0
212267,that,0,0
212268,",",0,0
212269,except,0,0
212270,for,0,0
212271,fever,0,0
212272,",",0,0
212273,the,0,0
212274,manifestations,0,0
212275,and,0,0
212276,natural,0,0
212277,history,0,0
212278,of,0,0
212279,this,0,0
212280,illness,0,0
212281,are,0,0
212282,unaffected,0,0
212283,by,0,0
212284,indomethacin,1,1
212285,.,1,0
212286,Double-blind,0,0
212287,efficacy,0,0
212288,study,0,0
212289,of,0,0
212290,selenium,1,1
212291,sulfide,1,1
212292,in,0,0
212293,tinea,0,0
212294,versicolor,0,1
212295,.,0,0
212296,Selenium,1,1
212297,sulfide,1,1
212298,(,1,0
212299,2.5,1,1
212300,%,1,0
212301,),1,0
212302,lotion,1,1
212303,applied,0,0
212304,daily,0,1
212305,for,0,0
212306,10,0,0
212307,minutes,0,0
212308,for,0,0
212309,7,0,0
212310,consecutive,0,0
212311,days,0,0
212312,was,0,0
212313,found,0,0
212314,to,0,0
212315,be,0,0
212316,an,0,0
212317,effective,0,0
212318,therapeutic,0,0
212319,agent,0,0
212320,",",0,0
212321,significantly,0,0
212322,superior,0,0
212323,to,0,0
212324,the,0,0
212325,vehicle,0,1
212326,",",0,0
212327,in,0,0
212328,a,0,0
212329,double-blind,0,0
212330,study,0,0
212331,in,0,0
212332,the,0,0
212333,treatment,0,0
212334,of,0,0
212335,tinea,0,0
212336,versicolor,0,1
212337,.,0,0
212338,Mild,0,0
212339,transitory,0,0
212340,contact,0,1
212341,dermatitis,0,0
212342,of,0,0
212343,the,0,0
212344,primary,0,0
212345,irritant,0,1
212346,type,0,0
212347,occurred,0,0
212348,in,0,0
212349,all,0,0
212350,the,0,0
212351,treatment,0,0
212352,groups,0,0
212353,and,0,0
212354,was,0,0
212355,apparently,0,0
212356,due,0,0
212357,to,0,0
212358,the,0,0
212359,detergent,0,1
212360,base,0,0
212361,.,0,0
212362,A,0,0
212363,prospective,0,0
212364,randomized,0,0
212365,clinical,0,0
212366,trial,0,0
212367,of,0,0
212368,melphalan,1,1
212369,and,1,0
212370,cis-platinum,1,1
212371,versus,0,1
212372,hexamethylmelamine,1,1
212373,",",1,0
212374,adriamycin,1,1
212375,",",1,0
212376,and,1,0
212377,cyclophosphamide,1,1
212378,in,0,0
212379,advanced,0,0
212380,ovarian,0,0
212381,cancer,0,0
212382,.,0,0
212383,From,0,0
212384,May,0,0
212385,1978,0,0
212386,until,0,0
212387,November,0,0
212388,1980,0,0
212389,",",0,0
212390,169,0,0
212391,previously,0,0
212392,untreated,0,0
212393,patients,0,0
212394,with,0,0
212395,advanced,0,0
212396,epithelial,0,0
212397,ovarian,0,0
212398,cancer,0,0
212399,were,0,0
212400,entered,0,0
212401,into,0,0
212402,a,0,0
212403,prospective,0,0
212404,randomized,0,0
212405,clinical,0,0
212406,trial,0,0
212407,comparing,0,0
212408,the,0,0
212409,combination,0,1
212410,of,0,0
212411,hexamethylmelamine,1,1
212412,",",1,0
212413,Adriamycin,1,1
212414,",",1,0
212415,and,1,0
212416,cyclophosphamide,1,1
212417,(,1,1
212418,HAC,1,1
212419,),1,1
212420,to,1,0
212421,a,1,0
212422,combination,1,1
212423,of,1,0
212424,melphalan,1,1
212425,and,1,0
212426,cis-platinum,1,1
212427,.,1,0
212428,Eleven,0,0
212429,patients,0,0
212430,were,0,0
212431,excluded,0,0
212432,from,0,0
212433,analysis,0,0
212434,and,0,0
212435,another,0,0
212436,5,0,0
212437,patients,0,0
212438,were,0,0
212439,excluded,0,0
212440,from,0,0
212441,response,0,0
212442,analysis,0,0
212443,.,0,0
212444,Of,0,0
212445,153,0,0
212446,patients,0,0
212447,evaluable,0,0
212448,for,0,0
212449,response,0,0
212450,",",0,0
212451,there,0,0
212452,were,0,0
212453,47,0,0
212454,",",0,0
212455,or,0,0
212456,30.7,0,0
212457,%,0,0
212458,",",0,0
212459,complete,0,0
212460,responders,0,0
212461,(,0,0
212462,all,0,0
212463,determined,0,0
212464,surgically,0,0
212465,),0,0
212466,",",0,0
212467,6,0,0
212468,partial,0,0
212469,responders,0,0
212470,",",0,0
212471,and,0,0
212472,100,0,0
212473,nonresponders,0,0
212474,.,0,0
212475,The,0,0
212476,response,0,0
212477,rate,0,0
212478,for,0,0
212479,the,0,0
212480,HAC,1,1
212481,group,0,0
212482,was,0,0
212483,31,0,0
212484,%,0,0
212485,and,0,0
212486,for,0,0
212487,the,0,0
212488,melphalan-platinum,1,1
212489,group,0,0
212490,was,0,0
212491,37.8,0,0
212492,%,0,0
212493,.,0,0
212494,The,0,0
212495,overall,0,0
212496,response,0,0
212497,rate,0,0
212498,was,0,0
212499,34.6,0,0
212500,%,0,0
212501,.,0,0
212502,Residual,0,0
212503,tumor,0,0
212504,diameter,0,0
212505,(,0,0
212506,less,0,0
212507,than,0,0
212508,or,0,0
212509,greater,0,0
212510,than,0,0
212511,2,0,0
212512,cm,0,0
212513,),0,0
212514,exerted,0,0
212515,a,0,0
212516,statistically,0,0
212517,significant,0,0
212518,effect,0,0
212519,on,0,0
212520,response,0,0
212521,--,0,0
212522,47.8,0,0
212523,vs,0,0
212524,24.4,0,0
212525,%,0,0
212526,.,0,0
212527,Of,0,0
212528,the,0,0
212529,47,0,0
212530,complete,0,0
212531,responders,0,0
212532,",",0,0
212533,7,0,0
212534,",",0,0
212535,or,0,0
212536,14.9,0,0
212537,%,0,0
212538,",",0,0
212539,have,0,0
212540,relapsed,0,0
212541,",",0,0
212542,with,0,0
212543,the,0,0
212544,median,0,0
212545,duration,0,0
212546,of,0,0
212547,remission,0,0
212548,of,0,0
212549,44+,0,0
212550,months,0,0
212551,.,0,0
212552,Of,0,0
212553,the,0,0
212554,158,0,0
212555,patients,0,0
212556,evaluable,0,0
212557,for,0,0
212558,survival,0,0
212559,",",0,0
212560,90,0,0
212561,patients,0,0
212562,have,0,0
212563,died,0,0
212564,",",0,0
212565,with,0,0
212566,a,0,0
212567,median,0,0
212568,survival,0,0
212569,time,0,0
212570,of,0,0
212571,27.9,0,0
212572,months,0,0
212573,(,1,0
212574,HAC,1,1
212575,=,0,0
212576,26.4,0,0
212577,months,0,0
212578,",",0,0
212579,melphalan-platinum,1,1
212580,=,0,0
212581,29.6,0,0
212582,months,0,0
212583,),0,0
212584,.,0,0
212585,Age,0,0
212586,",",0,0
212587,FIGO,0,0
212588,stage,0,0
212589,",",0,0
212590,histologic,0,0
212591,grade,0,0
212592,",",0,0
212593,and,0,0
212594,residual,0,0
212595,disease,0,0
212596,all,0,0
212597,exerted,0,0
212598,a,0,0
212599,significant,0,0
212600,effect,0,0
212601,on,0,0
212602,survival,0,0
212603,time,0,0
212604,.,0,0
212605,Second-line,0,1
212606,therapy,0,1
212607,in,0,0
212608,the,0,0
212609,treatment,0,0
212610,failures,0,0
212611,was,0,0
212612,of,0,0
212613,no,0,0
212614,benefit,0,0
212615,.,0,0
212616,Hematologic,0,0
212617,toxicity,0,0
212618,was,0,0
212619,greater,0,0
212620,in,0,0
212621,the,0,0
212622,melphalan-platinum,1,1
212623,group,0,0
212624,.,0,0
212625,Gastrointestinal,0,0
212626,toxicity,0,0
212627,was,0,0
212628,severe,0,0
212629,in,0,0
212630,both,0,0
212631,groups,0,0
212632,.,0,0
212633,Other,0,0
212634,toxicities,0,0
212635,were,0,0
212636,minor,0,0
212637,and,0,0
212638,infrequent,0,0
212639,.,0,0
212640,[,0,0
212641,Randomized,0,0
212642,controlled,0,0
212643,study,0,0
212644,of,0,0
212645,OK-432,1,1
212646,in,0,0
212647,the,0,0
212648,treatment,0,0
212649,of,0,0
212650,cancerous,0,0
212651,pleurisy,0,0
212652,],0,0
212653,.,0,0
212654,A,0,0
212655,randomized,0,0
212656,controlled,0,0
212657,study,0,0
212658,was,0,0
212659,performed,0,0
212660,to,0,0
212661,evaluate,0,0
212662,the,0,0
212663,efficacy,0,0
212664,of,0,0
212665,intrapleural,0,1
212666,and,0,0
212667,systemic,0,0
212668,administration,0,0
212669,of,0,0
212670,OK-432,1,1
212671,",",1,0
212672,streptococcus,1,1
212673,preparation,1,1
212674,",",0,0
212675,in,0,0
212676,patients,0,0
212677,with,0,0
212678,cancerous,0,0
212679,pleurisy,0,0
212680,.,0,0
212681,A,0,0
212682,total,0,0
212683,of,0,0
212684,53,0,0
212685,patients,0,0
212686,were,0,0
212687,accessed,0,0
212688,to,0,0
212689,the,0,0
212690,study,0,0
212691,:,0,0
212692,29,0,0
212693,patients,0,0
212694,for,0,0
212695,the,0,0
212696,OK-432,1,1
212697,group,0,0
212698,and,0,0
212699,24,0,0
212700,patients,0,0
212701,for,0,0
212702,the,0,0
212703,control,1,0
212704,group,1,0
212705,.,1,0
212706,Intrapleural,0,1
212707,instillation,0,0
212708,of,0,0
212709,50,1,0
212710,mg,1,1
212711,of,1,0
212712,adriamycin,1,1
212713,and,1,0
212714,a,1,0
212715,combination,1,1
212716,chemotherapy,1,1
212717,of,1,0
212718,MFC,1,1
212719,(,1,0
212720,mitomycin,1,1
212721,C,0,1
212722,0.08,0,0
212723,mg/kg,0,1
212724,",",0,0
212725,5-FU,0,1
212726,10,0,0
212727,mg/kg,0,1
212728,",",0,0
212729,ara-C,1,1
212730,0.8,0,1
212731,mg/kg,0,1
212732,iv,0,0
212733,",",0,0
212734,weekly,0,1
212735,),0,0
212736,were,0,0
212737,administered,0,0
212738,in,0,0
212739,both,0,0
212740,groups,0,0
212741,.,0,0
212742,In,0,0
212743,the,0,0
212744,OK-432,0,1
212745,group,0,0
212746,intrapleural,0,1
212747,instillation,0,1
212748,of,0,0
212749,2,0,0
212750,units,0,0
212751,of,0,0
212752,OK-432,1,1
212753,was,0,0
212754,administered,0,0
212755,daily,0,1
212756,until,0,0
212757,disappearance,0,0
212758,of,0,0
212759,pleural,0,0
212760,effusion,0,0
212761,;,0,0
212762,thereafter,0,0
212763,",",0,0
212764,2,0,0
212765,to,0,0
212766,5,0,0
212767,units,0,0
212768,of,0,0
212769,OK-432,0,1
212770,were,0,0
212771,administered,0,0
212772,intradermally,0,0
212773,every,0,1
212774,other,0,0
212775,day,0,0
212776,.,0,0
212777,Patients,0,0
212778,with,0,0
212779,stage,0,0
212780,III,0,0
212781,in,0,0
212782,the,0,0
212783,OK-432,0,1
212784,group,0,0
212785,survived,0,0
212786,significantly,0,0
212787,longer,0,0
212788,than,0,0
212789,those,0,0
212790,in,0,0
212791,the,0,0
212792,control,0,1
212793,group,0,0
212794,(,0,0
212795,P,0,0
212796,less,0,0
212797,than,0,0
212798,0.05,0,0
212799,),0,0
212800,",",0,0
212801,but,0,0
212802,there,0,0
212803,was,0,0
212804,no,0,0
212805,significance,0,0
212806,between,0,0
212807,in,0,0
212808,patients,0,0
212809,with,0,0
212810,stage,0,0
212811,IV,0,0
212812,of,0,0
212813,both,0,0
212814,treatment,0,0
212815,groups,0,0
212816,.,0,0
212817,Also,0,0
212818,patients,0,0
212819,with,0,0
212820,PPD,0,1
212821,negative,0,1
212822,skin,0,0
212823,reaction,0,1
212824,at,0,0
212825,the,0,0
212826,time,0,0
212827,of,0,0
212828,beginning,0,0
212829,of,0,0
212830,treatment,0,0
212831,in,0,0
212832,the,0,0
212833,OK-432,0,1
212834,group,0,0
212835,survived,0,0
212836,significantly,0,0
212837,longer,0,0
212838,than,0,0
212839,those,0,0
212840,in,0,0
212841,the,0,0
212842,control,0,1
212843,group,0,0
212844,(,0,0
212845,P,0,0
212846,less,0,0
212847,than,0,0
212848,0.001,0,0
212849,),0,0
212850,",",0,0
212851,but,0,0
212852,there,0,0
212853,was,0,0
212854,no,0,0
212855,significance,0,0
212856,between,0,0
212857,both,0,0
212858,treatment,0,0
212859,groups,0,0
212860,in,0,0
212861,patients,0,0
212862,with,0,0
212863,PPD,0,1
212864,positive,0,0
212865,skin,0,0
212866,reaction,0,1
212867,at,0,0
212868,the,0,0
212869,time,0,0
212870,of,0,0
212871,beginning,0,0
212872,of,0,0
212873,treatment,0,0
212874,.,0,1
212875,Eighteen,0,0
212876,(,0,0
212877,62,0,0
212878,%,0,0
212879,),0,0
212880,of,0,0
212881,29,0,0
212882,patients,0,0
212883,treated,0,0
212884,with,0,0
212885,OK-432,0,1
212886,had,0,0
212887,a,0,0
212888,fever,0,0
212889,",",0,0
212890,but,0,0
212891,well,0,0
212892,tolerated,0,0
212893,.,0,0
212894,The,0,0
212895,effect,0,0
212896,of,0,0
212897,surgical,0,1
212898,trauma,0,1
212899,and,0,0
212900,insulin,1,1
212901,on,0,0
212902,whole-body,0,1
212903,protein,0,1
212904,turnover,0,0
212905,in,0,0
212906,parenterally-fed,0,1
212907,undernourished,0,0
212908,patients,0,0
212909,.,0,0
212910,Ten,0,0
212911,undernourished,0,0
212912,patients,0,0
212913,receiving,0,0
212914,total,0,0
212915,parenteral,0,1
212916,nutrition,0,1
212917,and,0,0
212918,undergoing,0,0
212919,major,0,0
212920,intestinal,0,0
212921,surgery,0,1
212922,were,0,0
212923,restarted,0,0
212924,on,0,0
212925,intravenous,0,1
212926,feeds,0,0
212927,identical,0,0
212928,to,0,0
212929,their,0,0
212930,pre-operative,0,0
212931,regimens,0,1
212932,within,0,0
212933,24,0,0
212934,h,0,0
212935,of,0,0
212936,their,0,0
212937,operation,0,0
212938,.,0,0
212939,Five,0,0
212940,",",0,0
212941,chosen,0,0
212942,at,0,0
212943,random,0,0
212944,",",0,0
212945,received,0,0
212946,post-operatively,0,0
212947,1-2,1,0
212948,units,1,0
212949,insulin/kg,1,1
212950,body,1,0
212951,weight/24,1,1
212952,h,1,0
212953,with,1,0
212954,their,1,0
212955,feed,1,0
212956,",",0,0
212957,while,0,0
212958,the,0,0
212959,other,0,0
212960,five,0,0
212961,received,1,0
212962,the,1,0
212963,feed,1,0
212964,only,1,0
212965,.,1,0
212966,Pre-operatively,0,0
212967,",",0,0
212968,and,0,0
212969,2,0,0
212970,h,0,0
212971,after,0,0
212972,commencing,0,1
212973,their,0,0
212974,post-operative,0,0
212975,feeds,0,0
212976,",",0,0
212977,rates,0,0
212978,of,0,0
212979,whole-body,0,1
212980,protein,0,1
212981,synthesis,0,0
212982,and,0,0
212983,breakdown,0,0
212984,were,0,0
212985,measured,0,0
212986,over,0,0
212987,a,0,0
212988,9-h,0,0
212989,period,0,0
212990,following,0,0
212991,intravenous,0,1
212992,injection,0,1
212993,of,0,0
212994,a,0,0
212995,single,0,1
212996,tracer,0,1
212997,dose,0,0
212998,of,0,0
212999,15N-glycine,1,0
213000,by,0,0
213001,the,0,0
213002,ammonia,0,0
213003,and,0,0
213004,urea,0,1
213005,end-product,0,1
213006,methods,0,0
213007,.,0,0
213008,During,0,0
213009,these,0,0
213010,9-h,0,0
213011,study,0,0
213012,periods,0,0
213013,measurements,0,0
213014,were,0,0
213015,also,0,0
213016,made,0,0
213017,of,0,0
213018,blood,0,0
213019,glucose,0,0
213020,",",0,0
213021,plasma,0,0
213022,insulin,1,1
213023,and,0,0
213024,glucagon,0,1
213025,",",0,0
213026,urinary,0,0
213027,ammonia,0,0
213028,",",0,0
213029,nitrogen,0,0
213030,",",0,0
213031,creatinine,0,0
213032,and,0,0
213033,3-methylhistidine,0,0
213034,.,0,1
213035,Blood,0,0
213036,glucose,0,0
213037,and,0,0
213038,plasma,0,0
213039,insulin,1,1
213040,and,0,0
213041,glucagon,0,1
213042,concentrations,0,0
213043,rose,0,0
213044,post-operatively,0,0
213045,whether,0,0
213046,or,0,1
213047,not,0,0
213048,insulin,1,1
213049,was,0,0
213050,given,0,0
213051,",",0,0
213052,but,0,0
213053,the,0,0
213054,increment,0,0
213055,in,0,0
213056,insulin,1,1
213057,concentration,0,0
213058,was,0,0
213059,significantly,0,0
213060,greater,0,0
213061,when,0,0
213062,insulin,1,0
213063,was,0,0
213064,given,0,0
213065,.,0,0
213066,Apparent,0,0
213067,nitrogen,0,0
213068,balance,0,0
213069,was,0,0
213070,positive,0,0
213071,pre-operatively,0,0
213072,and,0,0
213073,became,0,0
213074,less,0,0
213075,so,0,0
213076,post-operatively,0,0
213077,whether,0,0
213078,insulin,1,1
213079,was,0,0
213080,given,0,0
213081,or,0,0
213082,not,0,0
213083,.,0,0
213084,Similarly,0,0
213085,",",0,0
213086,post-operative,0,0
213087,increments,0,0
213088,in,0,0
213089,urinary,0,0
213090,excretion,0,0
213091,of,0,0
213092,ammonia,0,0
213093,",",0,0
213094,creatinine,0,0
213095,and,0,0
213096,3-methylhistidine,0,0
213097,were,0,0
213098,not,0,0
213099,altered,0,0
213100,by,0,0
213101,addition,0,0
213102,of,0,0
213103,insulin,1,0
213104,.,1,0
213105,Protein,0,0
213106,turnover,0,0
213107,",",0,0
213108,as,0,0
213109,estimated,0,0
213110,by,0,0
213111,the,0,0
213112,ammonia,0,0
213113,end-product,0,1
213114,method,0,1
213115,",",0,0
213116,tended,0,0
213117,to,0,0
213118,rise,0,0
213119,post-operatively,0,0
213120,",",0,0
213121,but,0,0
213122,there,0,0
213123,was,0,0
213124,no,0,0
213125,significant,0,0
213126,difference,0,0
213127,between,0,0
213128,the,0,0
213129,increases,0,0
213130,observed,0,0
213131,with,0,0
213132,or,0,1
213133,without,0,0
213134,insulin,1,1
213135,.,1,0
213136,The,0,0
213137,urea,0,0
213138,end-product,0,1
213139,method,0,1
213140,suggested,0,0
213141,that,0,0
213142,there,0,0
213143,was,0,0
213144,no,0,0
213145,change,0,0
213146,in,0,0
213147,whole-body,0,1
213148,protein,0,1
213149,turnover,0,0
213150,after,0,0
213151,surgery,0,0
213152,",",0,0
213153,whether,0,0
213154,or,0,1
213155,not,0,0
213156,insulin,1,1
213157,was,0,0
213158,given,0,0
213159,.,0,0
213160,This,0,0
213161,study,0,0
213162,does,0,0
213163,not,0,0
213164,support,0,0
213165,the,0,0
213166,clinical,0,0
213167,use,0,0
213168,of,0,0
213169,insulin,1,1
213170,as,0,0
213171,a,0,0
213172,means,0,0
213173,of,0,0
213174,modifying,0,0
213175,protein,0,1
213176,metabolic,0,0
213177,losses,0,0
213178,after,0,0
213179,major,0,0
213180,surgery,0,0
213181,.,0,0
213182,Effects,0,0
213183,of,0,0
213184,mild,1,0
213185,physical,1,1
213186,exercise,1,1
213187,on,0,0
213188,serum,0,0
213189,lipoproteins,0,0
213190,and,0,0
213191,metabolites,0,0
213192,of,0,0
213193,arachidonic,0,1
213194,acid,0,1
213195,:,0,0
213196,a,0,0
213197,controlled,0,0
213198,randomised,0,0
213199,trial,0,0
213200,in,0,0
213201,middle,0,0
213202,aged,0,0
213203,men,0,0
213204,.,0,0
213205,To,0,0
213206,study,0,0
213207,the,0,0
213208,effects,0,0
213209,of,0,0
213210,physical,1,1
213211,exercise,1,1
213212,on,0,0
213213,biochemical,0,0
213214,risk,0,0
213215,factors,0,0
213216,for,0,0
213217,ischaemic,0,0
213218,heart,0,0
213219,disease,0,0
213220,31,0,0
213221,healthy,0,0
213222,middle,0,0
213223,aged,0,0
213224,men,0,0
213225,undertook,0,0
213226,regular,1,0
213227,physical,1,1
213228,exercise,1,1
213229,for,1,0
213230,two,1,0
213231,months,1,0
213232,and,0,0
213233,29,0,0
213234,served,0,0
213235,as,0,0
213236,controls,0,0
213237,in,0,0
213238,a,0,0
213239,randomised,0,0
213240,trial,0,0
213241,.,0,0
213242,In,0,0
213243,the,0,0
213244,men,0,0
213245,taking,0,0
213246,regular,0,1
213247,exercise,0,1
213248,serum,0,0
213249,cholesterol,0,0
213250,concentrations,0,0
213251,increased,0,0
213252,26,0,0
213253,%,0,0
213254,more,0,0
213255,in,0,0
213256,the,0,0
213257,high,0,0
213258,density,0,0
213259,lipoprotein,0,0
213260,subfraction,0,1
213261,two,0,0
213262,(,0,0
213263,HDL2,0,0
213264,),0,1
213265,and,0,0
213266,decreased,0,0
213267,31,0,0
213268,%,0,0
213269,more,0,0
213270,in,0,0
213271,the,0,0
213272,subfraction,0,1
213273,three,0,0
213274,(,0,0
213275,HDL3,0,1
213276,),0,1
213277,and,0,0
213278,9,0,0
213279,%,0,0
213280,more,0,0
213281,in,0,0
213282,the,0,0
213283,low,0,0
213284,density,0,0
213285,lipoprotein,0,0
213286,fraction,0,0
213287,than,0,0
213288,in,0,0
213289,the,0,0
213290,control,0,0
213291,group,0,0
213292,.,0,0
213293,A,0,0
213294,tendency,0,0
213295,towards,0,0
213296,increased,0,0
213297,plasma,0,0
213298,6-keto-prostaglandin,0,0
213299,F1,0,1
213300,alpha,0,1
213301,concentration,0,0
213302,and,0,0
213303,decreased,0,0
213304,serum,0,0
213305,thromboxane,0,1
213306,B2,0,1
213307,concentration,0,0
213308,was,0,0
213309,found,0,0
213310,during,0,0
213311,the,0,0
213312,period,0,0
213313,of,0,0
213314,regular,0,1
213315,exercise,1,1
213316,",",0,0
213317,but,0,0
213318,prostaglandin,0,1
213319,E2,0,0
213320,concentrations,0,0
213321,remained,0,0
213322,unchanged,0,0
213323,.,0,0
213324,The,0,0
213325,increase,0,0
213326,in,0,0
213327,plasma,0,0
213328,6-keto-prostaglandin,0,0
213329,F1,0,1
213330,alpha,0,1
213331,concentration,0,0
213332,was,0,0
213333,associated,0,0
213334,with,0,0
213335,an,0,0
213336,increase,0,0
213337,in,0,0
213338,serum,0,0
213339,HDL2,0,0
213340,cholesterol,0,1
213341,concentration,0,0
213342,in,0,0
213343,the,0,0
213344,group,0,0
213345,taking,0,0
213346,regular,0,1
213347,exercise,1,1
213348,.,1,0
213349,Our,0,0
213350,data,0,0
213351,suggest,0,0
213352,that,0,0
213353,mild,1,0
213354,regular,1,1
213355,physical,1,1
213356,exercise,1,1
213357,favourably,0,1
213358,influences,0,0
213359,cholesterol,0,0
213360,distribution,0,0
213361,in,0,0
213362,serum,0,0
213363,lipoproteins,0,0
213364,in,0,0
213365,healthy,0,0
213366,middle,0,0
213367,aged,0,0
213368,men,0,0
213369,and,0,0
213370,may,0,0
213371,have,0,0
213372,beneficial,0,0
213373,effects,0,0
213374,on,0,0
213375,circulating,0,0
213376,metabolites,0,0
213377,of,0,0
213378,arachidonic,0,1
213379,acid,0,1
213380,.,0,0
213381,Short-term,0,0
213382,pulmonary,0,0
213383,effects,0,0
213384,of,0,0
213385,total,1,0
213386,parenteral,1,1
213387,nutrition,1,1
213388,in,0,0
213389,children,0,0
213390,with,0,0
213391,cystic,0,0
213392,fibrosis,0,0
213393,.,0,0
213394,Indices,0,0
213395,of,0,0
213396,respiratory,0,0
213397,muscle,0,0
213398,strength,0,0
213399,",",0,0
213400,pulmonary,0,0
213401,function,0,0
213402,",",0,0
213403,and,0,0
213404,pulmonary,0,0
213405,diffusing,0,1
213406,capacity,0,0
213407,were,0,0
213408,measured,0,0
213409,in,0,0
213410,11,0,0
213411,malnourished,0,0
213412,children,0,0
213413,(,0,0
213414,age,0,0
213415,10,0,0
213416,to,0,0
213417,17,0,0
213418,years,0,0
213419,),0,0
213420,with,0,0
213421,cystic,0,0
213422,fibrosis,0,0
213423,",",0,0
213424,before,0,0
213425,and,0,0
213426,after,0,0
213427,improvement,0,0
213428,of,0,0
213429,nutritional,0,1
213430,status,0,0
213431,with,0,0
213432,supplemental,1,1
213433,parenteral,1,1
213434,nutrients,1,1
213435,for,0,0
213436,1,0,0
213437,month,0,0
213438,.,0,0
213439,During,0,0
213440,this,0,0
213441,time,0,0
213442,",",0,0
213443,the,0,0
213444,children,0,0
213445,received,0,0
213446,120,0,0
213447,%,0,0
213448,of,0,0
213449,estimated,0,0
213450,energy,0,0
213451,requirements,0,0
213452,(,0,0
213453,either,0,1
213454,3.75,0,1
213455,%,0,0
213456,or,0,1
213457,22.5,0,0
213458,%,0,0
213459,as,0,0
213460,lipid,1,0
213461,),1,1
213462,and,0,0
213463,amino,1,1
213464,acids,1,1
213465,2.5,0,0
213466,gm/120,0,0
213467,kcal,0,1
213468,by,0,0
213469,central,0,0
213470,venous,0,0
213471,catheter,0,1
213472,",",0,0
213473,plus,0,1
213474,as,0,0
213475,much,0,0
213476,of,0,0
213477,their,0,0
213478,usual,0,1
213479,diet,0,1
213480,as,0,0
213481,desired,0,0
213482,.,0,0
213483,With,0,0
213484,nutritional,0,1
213485,supplementation,0,1
213486,",",0,0
213487,body,0,0
213488,weight,0,0
213489,",",0,0
213490,triceps,0,0
213491,skinfold,0,0
213492,thickness,0,0
213493,",",0,0
213494,and,0,0
213495,mid-arm,0,0
213496,muscle,0,1
213497,circumference,0,0
213498,increased,0,0
213499,(,0,0
213500,mean,0,0
213501,15,0,0
213502,%,0,0
213503,",",0,0
213504,62,0,0
213505,%,0,0
213506,",",0,0
213507,and,0,0
213508,95,0,0
213509,%,0,0
213510,",",0,0
213511,respectively,0,0
213512,),0,0
213513,.,0,0
213514,Maximum,0,0
213515,inspiratory,0,0
213516,airway,0,0
213517,pressure,0,0
213518,also,0,0
213519,increased,0,0
213520,(,0,0
213521,mean,0,0
213522,29,0,0
213523,%,0,0
213524,;,0,0
213525,P,0,0
213526,less,0,0
213527,than,0,0
213528,0.01,0,0
213529,),0,0
213530,",",0,0
213531,suggesting,0,0
213532,improvement,0,0
213533,in,0,0
213534,respiratory,0,0
213535,muscle,0,0
213536,strength,0,0
213537,.,0,0
213538,However,0,0
213539,",",0,0
213540,none,0,0
213541,of,0,0
213542,the,0,0
213543,indices,0,0
213544,of,0,0
213545,pulmonary,0,0
213546,function,0,0
213547,improved,0,0
213548,.,0,0
213549,Pulmonary,0,0
213550,diffusing,0,0
213551,capacity,0,0
213552,did,0,0
213553,not,0,0
213554,change,0,0
213555,during,0,0
213556,parenteral,0,1
213557,nutrition,0,1
213558,regardless,0,0
213559,of,0,0
213560,the,0,0
213561,amount,0,0
213562,of,0,0
213563,parenteral,0,1
213564,energy,0,1
213565,intake,0,0
213566,supplied,0,1
213567,by,0,0
213568,lipid,0,0
213569,",",0,0
213570,but,0,0
213571,arterial,0,0
213572,oxygen,0,1
213573,saturation,0,0
213574,decreased,0,0
213575,(,0,0
213576,mean,0,0
213577,of,0,0
213578,93.5,0,0
213579,%,0,0
213580,to,0,0
213581,91.5,0,0
213582,%,0,0
213583,;,0,0
213584,P,0,0
213585,less,0,0
213586,than,0,0
213587,0.005,0,0
213588,),0,0
213589,.,0,0
213590,During,0,0
213591,the,0,0
213592,month,0,0
213593,following,0,0
213594,parenteral,0,1
213595,nutrition,0,1
213596,",",0,0
213597,weight,0,0
213598,",",0,0
213599,skinfold,0,0
213600,thickness,0,0
213601,",",0,0
213602,and,0,0
213603,mid-arm,0,0
213604,muscle,0,1
213605,circumference,0,0
213606,",",0,0
213607,but,0,0
213608,not,0,0
213609,MIP,0,1
213610,",",0,0
213611,decreased,0,0
213612,and,0,0
213613,arterial,0,0
213614,oxygen,0,1
213615,saturation,0,0
213616,returned,0,0
213617,to,0,0
213618,the,0,0
213619,initial,0,0
213620,value,0,0
213621,(,0,0
213622,P,0,0
213623,less,0,0
213624,than,0,0
213625,0.01,0,0
213626,),0,0
213627,.,0,0
213628,Ascorbic,1,1
213629,acid,1,1
213630,and,0,0
213631,performance,0,0
213632,in,0,0
213633,man,0,0
213634,.,0,0
213635,Effects,0,0
213636,on,0,0
213637,performance,0,0
213638,of,0,0
213639,1,0,0
213640,",",0,0
213641,2,0,0
213642,and,0,0
213643,4,0,0
213644,g,0,1
213645,ascorbic,1,1
213646,acid,1,1
213647,were,0,0
213648,studied,0,0
213649,from,0,0
213650,0.5-5.5,0,0
213651,h,0,0
213652,after,0,0
213653,ingestion,0,0
213654,in,0,0
213655,six,0,0
213656,healthy,0,0
213657,females,0,0
213658,.,0,0
213659,Diazepam,1,1
213660,(,1,0
213661,5,1,1
213662,mg,1,1
213663,),1,0
213664,was,1,0
213665,included,1,0
213666,as,1,0
213667,an,1,0
213668,active,1,1
213669,control,1,0
213670,",",0,0
213671,and,0,0
213672,it,0,0
213673,impaired,0,0
213674,digit,0,1
213675,symbol,0,1
213676,substitution,0,1
213677,",",0,0
213678,visuomotor,0,1
213679,coordination,0,1
213680,and,0,0
213681,complex,0,1
213682,reaction,0,1
213683,time,0,0
213684,.,0,0
213685,There,0,0
213686,were,0,0
213687,no,0,0
213688,effects,0,0
213689,of,0,0
213690,any,0,0
213691,dose,0,0
213692,of,0,0
213693,ascorbic,1,1
213694,acid,1,1
213695,on,0,0
213696,performance,0,0
213697,.,0,0
213698,A,0,0
213699,comparison,0,0
213700,of,0,0
213701,the,0,0
213702,serologic,0,0
213703,responses,0,0
213704,to,0,0
213705,oral,0,1
213706,and,0,0
213707,injectable,0,1
213708,trivalent,1,1
213709,poliovirus,1,0
213710,vaccines,1,1
213711,.,1,0
213712,United,0,0
213713,States,0,0
213714,children,0,0
213715,two,0,0
213716,months,0,0
213717,of,0,0
213718,age,0,0
213719,were,0,0
213720,randomly,0,0
213721,assigned,0,0
213722,to,0,0
213723,two,0,0
213724,groups,0,0
213725,that,0,0
213726,received,0,0
213727,either,0,0
213728,the,0,0
213729,commercially,0,0
213730,available,0,0
213731,oral,1,1
213732,trivalent,1,1
213733,poliovirus,1,1
213734,vaccine,1,1
213735,(,1,1
213736,OPV,1,1
213737,),1,1
213738,or,0,1
213739,an,0,0
213740,injectable,1,1
213741,(,1,0
213742,inactivated,1,1
213743,),1,1
213744,trivalent,1,1
213745,poliovirus,1,1
213746,vaccine,1,1
213747,(,1,1
213748,IPV,1,0
213749,),1,1
213750,with,0,0
213751,a,0,0
213752,confirmed,0,0
213753,minimum,0,0
213754,D-antigen,0,1
213755,content,0,0
213756,of,0,0
213757,27,0,0
213758,",",0,0
213759,3.5,0,0
213760,",",0,0
213761,and,0,0
213762,29,0,0
213763,units,0,0
213764,for,0,0
213765,poliovirus,0,0
213766,types,0,0
213767,1,0,0
213768,",",0,0
213769,2,0,0
213770,",",0,0
213771,and,0,0
213772,3,0,0
213773,",",0,0
213774,respectively,0,0
213775,.,0,0
213776,Vaccine,0,0
213777,was,0,0
213778,given,0,0
213779,at,0,0
213780,two,0,0
213781,",",0,0
213782,four,0,0
213783,",",0,0
213784,and,0,0
213785,18,0,0
213786,months,0,0
213787,of,0,0
213788,age,0,0
213789,.,0,0
213790,Sera,0,0
213791,obtained,0,0
213792,from,0,0
213793,439,0,0
213794,children,0,0
213795,at,0,0
213796,two,0,0
213797,",",0,0
213798,four,0,0
213799,",",0,0
213800,and,0,0
213801,six,0,0
213802,months,0,0
213803,of,0,0
213804,age,0,0
213805,and,0,0
213806,from,0,0
213807,85,0,0
213808,children,0,0
213809,at,0,0
213810,18,0,0
213811,and,0,0
213812,20,0,0
213813,months,0,0
213814,of,0,0
213815,age,0,0
213816,were,0,0
213817,examined,0,0
213818,for,0,0
213819,neutralizing,0,0
213820,antibodies,0,0
213821,.,0,0
213822,The,0,0
213823,percentage,0,0
213824,of,0,0
213825,children,0,0
213826,with,0,0
213827,detectable,0,0
213828,antibodies,0,0
213829,and,0,0
213830,the,0,0
213831,reciprocal,0,1
213832,geometric,0,0
213833,mean,0,0
213834,titers,0,0
213835,were,0,0
213836,similar,0,0
213837,for,0,0
213838,both,0,0
213839,groups,0,0
213840,at,0,0
213841,two,0,0
213842,months,0,0
213843,of,0,0
213844,age,0,0
213845,for,0,0
213846,antibodies,0,0
213847,to,0,0
213848,all,0,0
213849,three,0,0
213850,poliovirus,0,0
213851,types,0,0
213852,.,0,0
213853,At,0,0
213854,20,0,0
213855,months,0,0
213856,of,0,0
213857,age,0,0
213858,",",0,0
213859,all,0,0
213860,children,0,0
213861,but,0,0
213862,one,0,0
213863,had,0,0
213864,detectable,0,0
213865,antibodies,0,0
213866,to,0,0
213867,all,0,0
213868,three,0,0
213869,poliovirus,0,0
213870,types,0,0
213871,.,0,0
213872,Significantly,0,0
213873,higher,0,0
213874,geometric,0,0
213875,mean,0,0
213876,titers,0,0
213877,against,0,0
213878,types,0,0
213879,2,0,0
213880,and,0,0
213881,3,0,0
213882,were,0,0
213883,noted,0,0
213884,at,0,0
213885,20,0,0
213886,months,0,0
213887,of,0,0
213888,age,0,0
213889,for,0,0
213890,the,0,0
213891,IPV,1,0
213892,group,0,0
213893,.,0,0
213894,Changes,0,0
213895,in,0,0
213896,heart,0,0
213897,rate,0,0
213898,and,0,0
213899,forearm,0,1
213900,blood,0,1
213901,flow,0,0
213902,following,0,0
213903,intravenous,0,1
213904,boluses,0,1
213905,of,0,0
213906,isoprenaline,1,1
213907,in,0,0
213908,the,0,0
213909,presence,0,0
213910,of,0,0
213911,practolol,0,1
213912,and,0,0
213913,propranolol,0,1
213914,.,0,0
213915,1,0,0
213916,Increases,0,0
213917,in,0,0
213918,heart,0,0
213919,rate,0,0
213920,and,0,0
213921,forearm,0,1
213922,blood,0,1
213923,flow,0,0
213924,following,0,0
213925,graded,0,0
213926,intravenous,0,1
213927,bolus,0,1
213928,injections,0,1
213929,of,0,0
213930,isoprenaline,1,1
213931,sulphate,1,1
213932,",",0,0
213933,were,0,0
213934,measured,0,0
213935,in,0,0
213936,a,0,0
213937,double-blind,0,0
213938,randomised,0,0
213939,study,0,0
213940,of,0,0
213941,six,0,0
213942,subjects,0,0
213943,who,0,0
213944,received,0,0
213945,either,0,0
213946,placebo,1,1
213947,",",1,0
213948,practolol,1,1
213949,50,1,0
213950,mg,1,1
213951,",",1,0
213952,practolol,1,1
213953,200,1,1
213954,mg,1,1
213955,",",1,0
213956,propranolol,1,1
213957,10,1,0
213958,mg,1,1
213959,or,1,1
213960,propranolol,1,1
213961,40,1,1
213962,mg.,1,1
213963,2,0,0
213964,Dose,0,0
213965,related,0,0
213966,increases,0,0
213967,in,0,0
213968,forearm,0,1
213969,blood,0,0
213970,flow,0,0
213971,were,0,0
213972,produced,0,0
213973,by,0,0
213974,the,0,0
213975,graded,0,0
213976,boluses,0,0
213977,of,0,0
213978,isoprenaline,1,1
213979,sulphate,1,1
213980,.,1,0
213981,3,0,0
213982,Practolol,1,1
213983,50,0,1
213984,mg,0,1
213985,attenuated,0,0
213986,the,0,0
213987,heart,0,0
213988,rate,0,0
213989,response,0,0
213990,to,0,0
213991,isoprenaline,0,1
213992,but,0,0
213993,did,0,0
213994,not,0,0
213995,significantly,0,0
213996,affect,0,0
213997,the,0,0
213998,changes,0,0
213999,in,0,0
214000,forearm,0,1
214001,blood,0,0
214002,flow,0,0
214003,.,0,0
214004,Practolol,1,1
214005,200,0,0
214006,mg,0,1
214007,further,0,0
214008,attenuated,0,0
214009,the,0,0
214010,heart,0,0
214011,rate,0,0
214012,responses,0,0
214013,but,0,0
214014,also,0,0
214015,decreased,0,0
214016,the,0,0
214017,forearm,0,1
214018,blood,0,0
214019,flow,0,0
214020,responses,0,0
214021,.,0,0
214022,4,0,0
214023,Propranolol,1,1
214024,10,0,1
214025,mg,0,1
214026,and,0,0
214027,propranolol,0,1
214028,40,0,1
214029,mg,0,1
214030,significantly,0,0
214031,attenuated,0,0
214032,both,0,0
214033,the,0,0
214034,heart,0,0
214035,rate,0,0
214036,and,0,0
214037,forearm,0,1
214038,blood,0,0
214039,flow,0,0
214040,responses,0,0
214041,.,0,0
214042,The,0,0
214043,effect,0,0
214044,on,0,0
214045,forearm,0,1
214046,blood,0,0
214047,flow,0,0
214048,tended,0,0
214049,to,0,0
214050,be,0,0
214051,greater,0,0
214052,than,0,0
214053,the,0,0
214054,effect,0,0
214055,on,0,0
214056,heart,0,0
214057,rate,0,0
214058,.,0,0
214059,5,0,0
214060,Practolol,1,1
214061,200,0,1
214062,mg,0,1
214063,had,0,0
214064,the,0,0
214065,same,0,0
214066,effect,0,0
214067,on,0,0
214068,heart,0,0
214069,rate,0,0
214070,responses,0,0
214071,as,0,0
214072,propranolol,1,1
214073,10,0,1
214074,mg,0,1
214075,but,0,0
214076,a,0,0
214077,significantly,0,0
214078,smaller,0,0
214079,effect,0,0
214080,on,0,0
214081,the,0,0
214082,forearm,0,1
214083,blood,0,0
214084,flow,0,0
214085,responses,0,0
214086,.,0,0
214087,6,0,0
214088,The,0,0
214089,measurement,0,0
214090,of,0,0
214091,forearm,0,1
214092,blood,0,0
214093,flow,0,0
214094,following,0,0
214095,intravenous,0,1
214096,bolus,0,1
214097,injections,0,1
214098,of,0,0
214099,isoprenaline,0,1
214100,provides,0,0
214101,useful,0,0
214102,information,0,0
214103,about,0,0
214104,the,0,0
214105,beta,0,1
214106,2-adrenoceptor,0,1
214107,antagonism,0,0
214108,of,0,0
214109,propranolol,1,1
214110,and,0,0
214111,practolol,1,1
214112,.,0,0
214113,However,0,0
214114,",",0,0
214115,application,0,0
214116,of,0,0
214117,the,0,0
214118,technique,0,1
214119,may,0,0
214120,be,0,0
214121,limited,0,0
214122,by,0,0
214123,the,0,0
214124,magnitude,0,0
214125,of,0,0
214126,the,0,0
214127,heart,0,0
214128,rate,0,0
214129,response,0,0
214130,and,0,0
214131,by,0,0
214132,the,0,0
214133,short-lived,0,0
214134,nature,0,0
214135,of,0,0
214136,the,0,0
214137,increase,0,0
214138,in,0,0
214139,forearm,0,1
214140,blood,0,0
214141,flow,0,0
214142,.,0,0
214143,Delayed,0,1
214144,alloimmunization,0,1
214145,using,0,0
214146,random,1,0
214147,single,1,1
214148,donor,1,0
214149,platelet,1,0
214150,transfusions,1,0
214151,:,1,0
214152,a,0,0
214153,prospective,0,0
214154,study,0,0
214155,in,0,0
214156,thrombocytopenic,0,0
214157,patients,0,0
214158,with,0,0
214159,acute,0,0
214160,leukemia,0,0
214161,.,0,0
214162,A,0,0
214163,randomized,0,0
214164,study,0,0
214165,was,0,0
214166,performed,0,0
214167,in,0,0
214168,54,0,0
214169,thrombocytopenic,0,0
214170,patients,0,0
214171,with,0,0
214172,acute,0,0
214173,leukemia,0,0
214174,.,0,0
214175,Alloimmunization,0,0
214176,of,0,0
214177,recipients,0,0
214178,of,0,0
214179,random,0,0
214180,multiple-donor,1,1
214181,platelet,1,0
214182,concentrates,1,1
214183,(,0,0
214184,MD,0,1
214185,group,0,1
214186,),0,0
214187,was,0,0
214188,compared,0,0
214189,to,0,0
214190,that,0,0
214191,of,0,0
214192,patients,0,0
214193,receiving,0,0
214194,random,1,0
214195,single-donor,1,1
214196,platelets,1,1
214197,(,0,0
214198,SD,0,0
214199,group,0,0
214200,),0,0
214201,.,0,0
214202,In,0,0
214203,the,0,0
214204,SD,0,0
214205,patients,0,0
214206,",",0,0
214207,formation,0,0
214208,of,0,0
214209,alloantibodies,0,0
214210,(,0,0
214211,mostly,0,0
214212,anti-HLA,0,1
214213,),0,0
214214,occurred,0,0
214215,less,0,0
214216,frequently,0,0
214217,(,0,0
214218,p,0,0
214219,less,0,0
214220,than,0,0
214221,0.002,0,0
214222,),0,0
214223,",",0,0
214224,after,0,0
214225,a,0,0
214226,longer,0,0
214227,time,0,0
214228,period,0,0
214229,(,0,0
214230,p,0,0
214231,less,0,0
214232,than,0,0
214233,0.002,0,0
214234,),0,0
214235,",",0,0
214236,and,0,0
214237,after,0,0
214238,a,0,0
214239,higher,0,0
214240,number,0,0
214241,of,0,0
214242,transfusions,0,0
214243,(,0,0
214244,p,0,0
214245,less,0,0
214246,than,0,0
214247,0.005,0,0
214248,),0,0
214249,as,0,0
214250,compared,0,0
214251,to,0,0
214252,MD,0,1
214253,patients,0,0
214254,.,0,0
214255,SD,0,0
214256,patients,0,0
214257,also,0,0
214258,became,0,0
214259,refractory,0,0
214260,to,0,0
214261,random,0,0
214262,platelets,0,0
214263,less,0,0
214264,frequently,0,0
214265,(,0,0
214266,p,0,0
214267,less,0,0
214268,than,0,0
214269,0.005,0,0
214270,),0,0
214271,",",0,0
214272,after,0,0
214273,a,0,0
214274,longer,0,0
214275,time,0,0
214276,period,0,0
214277,",",0,0
214278,and,0,0
214279,after,0,0
214280,a,0,0
214281,higher,0,0
214282,number,0,0
214283,of,0,0
214284,transfusions,0,0
214285,(,0,0
214286,p,0,0
214287,less,0,0
214288,than,0,0
214289,0.02,0,0
214290,),0,0
214291,.,0,0
214292,In,0,0
214293,SD,0,0
214294,patients,0,0
214295,",",0,0
214296,the,0,0
214297,increments,0,0
214298,after,0,0
214299,the,0,0
214300,first,0,0
214301,and,0,0
214302,the,0,0
214303,last,0,0
214304,transfusion,0,1
214305,were,0,0
214306,in,0,0
214307,the,0,0
214308,same,0,0
214309,range,0,0
214310,",",0,0
214311,whereas,0,0
214312,in,0,0
214313,MD,0,1
214314,patients,0,0
214315,",",0,0
214316,the,0,0
214317,1-hr,0,1
214318,(,0,0
214319,p,0,0
214320,less,0,0
214321,than,0,0
214322,0.001,0,0
214323,),0,0
214324,and,0,0
214325,the,0,0
214326,24-hr,0,1
214327,(,0,0
214328,p,0,0
214329,less,0,0
214330,than,0,0
214331,0.025,0,0
214332,),0,0
214333,increments,0,0
214334,decreased,0,0
214335,from,0,0
214336,the,0,0
214337,first,0,0
214338,to,0,0
214339,the,0,0
214340,last,0,0
214341,transfusion,0,0
214342,.,0,0
214343,Thus,0,0
214344,",",0,0
214345,the,0,0
214346,use,0,0
214347,of,0,0
214348,random,1,0
214349,SD,1,0
214350,platelet,1,0
214351,transfusions,1,0
214352,postponed,0,0
214353,alloimmunization,0,0
214354,.,0,0
214355,Budesonide,1,1
214356,and,1,0
214357,beclomethasone,1,1
214358,dipropionate,1,1
214359,in,0,0
214360,hay,0,0
214361,fever,0,0
214362,-,0,0
214363,a,0,0
214364,single,0,1
214365,blind,0,0
214366,comparison,0,0
214367,.,0,0
214368,93,0,0
214369,patients,0,0
214370,with,0,0
214371,seasonal,0,0
214372,allergic,0,0
214373,rhinitis,0,0
214374,took,0,0
214375,part,0,0
214376,in,0,0
214377,a,0,0
214378,single,0,0
214379,blind,0,0
214380,randomized,0,0
214381,clinical,0,0
214382,comparison,0,0
214383,of,0,0
214384,budesonide,1,1
214385,and,1,0
214386,beclomethasone,1,1
214387,dipropionate,1,1
214388,(,1,0
214389,Becotide,1,1
214390,Nasal,1,1
214391,),1,0
214392,.,1,0
214393,All,0,0
214394,patients,0,0
214395,were,0,0
214396,sensitive,0,0
214397,to,0,0
214398,either,0,1
214399,birch,0,1
214400,or,0,1
214401,grass,0,1
214402,pollen,0,1
214403,",",0,0
214404,their,0,0
214405,sensitivity,0,0
214406,being,0,0
214407,confirmed,0,0
214408,by,0,0
214409,a,0,0
214410,skin,0,0
214411,prick,0,0
214412,test,0,0
214413,.,0,0
214414,The,0,0
214415,total,0,0
214416,daily,0,1
214417,dose,0,0
214418,was,0,0
214419,400,0,0
214420,micrograms,0,1
214421,for,0,0
214422,both,0,0
214423,drugs,0,0
214424,.,0,0
214425,Budesonide,1,1
214426,was,0,0
214427,administered,0,0
214428,twice,0,1
214429,a,0,0
214430,day,0,0
214431,and,0,0
214432,Becotide,1,1
214433,Nasal,1,1
214434,four,0,0
214435,times,0,0
214436,a,0,0
214437,day,0,0
214438,.,0,0
214439,Symptoms,0,0
214440,were,0,0
214441,assessed,0,0
214442,over,0,0
214443,a,0,0
214444,four-week,0,1
214445,period,0,0
214446,starting,0,0
214447,with,0,0
214448,a,0,0
214449,run-in,0,0
214450,period,0,0
214451,of,0,0
214452,one,0,0
214453,week,0,0
214454,.,0,0
214455,There,0,0
214456,was,0,0
214457,no,0,0
214458,placebo,0,1
214459,control,0,1
214460,group,0,0
214461,.,0,0
214462,Daily,0,0
214463,pollen,0,0
214464,counts,0,0
214465,were,0,0
214466,measured,0,0
214467,throughout,0,0
214468,the,0,0
214469,trial,0,0
214470,.,0,0
214471,The,0,0
214472,patients,0,0
214473,',0,0
214474,diary,0,1
214475,cards,0,0
214476,revealed,0,0
214477,that,0,0
214478,both,0,0
214479,drugs,0,1
214480,had,0,0
214481,a,0,0
214482,beneficial,0,0
214483,therapeutic,0,0
214484,effect,0,0
214485,",",0,0
214486,and,0,0
214487,that,0,0
214488,budesonide,1,1
214489,was,0,0
214490,significantly,0,0
214491,more,0,0
214492,active,0,0
214493,than,0,0
214494,Becotide,1,1
214495,Nasal,1,1
214496,.,1,0
214497,The,0,0
214498,side,0,0
214499,effects,0,0
214500,of,0,0
214501,both,0,0
214502,drugs,0,1
214503,were,0,0
214504,few,0,0
214505,and,0,0
214506,transient,0,0
214507,.,0,0
214508,Tolfenamic,1,1
214509,acid,1,1
214510,and,1,0
214511,caffeine,1,1
214512,:,1,0
214513,a,0,0
214514,useful,0,0
214515,combination,0,1
214516,in,0,0
214517,migraine,0,0
214518,.,0,0
214519,Tolfenamic,1,1
214520,acid,1,1
214521,is,0,0
214522,a,0,0
214523,potent,0,0
214524,inhibitor,0,1
214525,of,0,0
214526,prostaglandin,0,1
214527,biosynthesis,0,0
214528,",",0,0
214529,which,0,0
214530,has,0,0
214531,been,0,0
214532,proved,0,0
214533,effective,0,0
214534,in,0,0
214535,the,0,0
214536,treatment,0,0
214537,of,0,0
214538,acute,0,0
214539,migraine,0,0
214540,attacks,0,0
214541,.,0,0
214542,The,0,0
214543,usefulness,0,0
214544,of,0,0
214545,caffeine,1,1
214546,",",1,0
214547,metoclopramide,1,1
214548,and,1,0
214549,pyridoxine,1,1
214550,as,0,0
214551,adjuncts,0,1
214552,to,0,0
214553,tolfenamic,1,1
214554,acid,1,1
214555,was,0,0
214556,tested,0,0
214557,in,0,0
214558,acute,0,0
214559,migraine,0,0
214560,attacks,0,0
214561,in,0,0
214562,ten,0,0
214563,patients,0,0
214564,.,0,0
214565,A,0,0
214566,combination,0,0
214567,of,0,0
214568,tolfenamic,1,1
214569,acid,1,1
214570,(,0,0
214571,200,0,1
214572,mg,0,1
214573,),0,0
214574,with,0,0
214575,either,1,1
214576,caffeine,1,1
214577,(,0,0
214578,100,0,1
214579,mg,0,1
214580,),0,0
214581,",",0,0
214582,metoclopramide,1,1
214583,(,0,0
214584,10,0,1
214585,mg,0,1
214586,),0,1
214587,or,1,1
214588,pyridoxine,1,1
214589,(,0,1
214590,300,0,1
214591,mg,0,1
214592,),0,0
214593,was,0,0
214594,given,0,0
214595,twice,0,0
214596,to,0,0
214597,each,0,0
214598,patient,0,0
214599,in,0,0
214600,random,0,0
214601,order,0,0
214602,.,0,0
214603,Thus,0,0
214604,60,0,0
214605,attacks,0,0
214606,were,0,0
214607,treated,0,0
214608,.,0,0
214609,The,0,0
214610,tolfenamic,1,1
214611,acid-caffeine,1,1
214612,combination,1,1
214613,proved,0,0
214614,the,0,0
214615,most,0,0
214616,effective,0,0
214617,as,0,0
214618,judged,0,0
214619,by,0,0
214620,duration,0,0
214621,and,0,0
214622,intensity,0,0
214623,of,0,0
214624,attacks,0,0
214625,",",0,0
214626,working,0,0
214627,ability,0,0
214628,",",0,0
214629,vigilance,0,0
214630,",",0,0
214631,and,0,0
214632,overall,0,0
214633,evaluation,0,0
214634,of,0,0
214635,the,0,0
214636,drugs,0,1
214637,by,0,0
214638,the,0,0
214639,patients,0,0
214640,.,0,0
214641,Metoclopramide,1,1
214642,was,0,0
214643,somewhat,0,0
214644,better,0,0
214645,than,0,0
214646,pyridoxine,1,1
214647,as,0,0
214648,an,0,0
214649,additive,0,1
214650,.,0,0
214651,Comparison,0,0
214652,of,0,0
214653,antihypertensive,0,1
214654,effects,0,0
214655,of,0,0
214656,captopril,1,1
214657,and,1,0
214658,propranolol,1,1
214659,in,0,0
214660,essential,0,0
214661,hypertension,0,0
214662,.,0,0
214663,The,0,0
214664,antihypertensive,0,0
214665,effects,0,0
214666,of,0,0
214667,the,0,0
214668,oral,0,1
214669,converting,0,0
214670,enzyme,0,1
214671,inhibitor,0,1
214672,captopril,1,1
214673,and,1,0
214674,of,1,0
214675,propranolol,1,1
214676,were,0,0
214677,evaluated,0,0
214678,in,0,0
214679,a,0,0
214680,single-blind,0,0
214681,trial,0,0
214682,of,0,0
214683,12,0,0
214684,weeks,0,0
214685,in,0,0
214686,19,0,0
214687,ambulatory,0,0
214688,men,0,0
214689,with,0,0
214690,moderated,0,0
214691,essential,0,0
214692,hypertension,0,0
214693,(,0,1
214694,supine,0,0
214695,diastolic,0,0
214696,blood,0,0
214697,pressure,0,0
214698,[,0,0
214699,DPB,0,1
214700,],0,0
214701,",",0,0
214702,100,0,0
214703,to,0,0
214704,120,0,0
214705,mm,0,0
214706,Hg,0,0
214707,after,0,0
214708,receiving,0,0
214709,placebo,1,1
214710,for,0,0
214711,two,0,0
214712,weeks,0,0
214713,),0,0
214714,whose,0,0
214715,sodium,0,1
214716,intake,0,0
214717,was,0,0
214718,unrestricted,0,0
214719,.,0,0
214720,The,0,0
214721,captopril,1,1
214722,group,0,0
214723,included,0,0
214724,12,0,0
214725,patients,0,0
214726,and,0,0
214727,the,0,0
214728,propranolol,1,1
214729,group,0,0
214730,seven,0,0
214731,.,0,0
214732,After,0,0
214733,the,0,0
214734,initial,0,0
214735,dose-finding,0,0
214736,period,0,0
214737,of,0,0
214738,four,0,0
214739,weeks,0,0
214740,",",0,0
214741,supine,0,0
214742,DBP,0,0
214743,was,0,0
214744,significantly,0,0
214745,reduced,0,0
214746,in,0,0
214747,eight,0,0
214748,patients,0,0
214749,receiving,0,0
214750,captopril,1,1
214751,and,0,0
214752,in,0,0
214753,four,0,0
214754,of,0,0
214755,the,0,0
214756,patients,0,0
214757,receiving,0,0
214758,propranolol,1,1
214759,.,1,0
214760,In,0,0
214761,these,0,0
214762,patients,0,0
214763,DBP,0,0
214764,decreased,0,0
214765,throughout,0,0
214766,the,0,0
214767,following,0,0
214768,eight,0,0
214769,weeks,0,0
214770,.,0,0
214771,In,0,0
214772,the,0,0
214773,remaining,0,0
214774,patients,0,0
214775,from,0,0
214776,each,0,0
214777,group,0,0
214778,",",0,0
214779,DBP,0,0
214780,was,0,0
214781,not,0,0
214782,reduced,0,0
214783,by,0,0
214784,either,0,0
214785,drug,0,1
214786,given,0,0
214787,alone,0,1
214788,at,0,0
214789,maximum,0,0
214790,allowable,0,0
214791,dosages,0,0
214792,during,0,0
214793,dose-finding,0,0
214794,periods,0,0
214795,",",0,0
214796,nor,0,0
214797,by,0,0
214798,combined,0,1
214799,administration,0,0
214800,in,0,0
214801,following,0,0
214802,weeks,0,0
214803,.,0,0
214804,No,0,0
214805,adverse,0,0
214806,side,0,0
214807,effects,0,0
214808,attributable,0,0
214809,to,0,0
214810,captopril,1,1
214811,were,0,0
214812,noted,0,0
214813,",",0,0
214814,except,0,0
214815,in,0,0
214816,one,0,0
214817,patient,0,0
214818,in,0,0
214819,whom,0,0
214820,proteinuria,0,0
214821,developed,0,0
214822,after,0,0
214823,seven,0,0
214824,weeks,0,0
214825,.,0,0
214826,Captopril,1,1
214827,has,0,0
214828,potential,0,0
214829,value,0,0
214830,in,0,0
214831,the,0,0
214832,treatment,0,0
214833,of,0,0
214834,moderate,0,0
214835,essential,0,0
214836,hypertension,0,0
214837,.,0,0
214838,Report,0,0
214839,on,0,0
214840,the,0,0
214841,second,0,0
214842,myelomatosis,0,0
214843,trial,0,0
214844,after,0,0
214845,five,0,0
214846,years,0,0
214847,of,0,0
214848,follow-up,0,0
214849,.,0,0
214850,Medical,0,0
214851,Research,0,0
214852,Council,0,1
214853,'s,0,0
214854,Working,0,1
214855,Party,0,0
214856,on,0,0
214857,Leukaemia,0,0
214858,in,0,0
214859,Adults,0,0
214860,.,0,0
214861,Three,0,0
214862,hundred,0,0
214863,and,0,0
214864,seventy-two,0,0
214865,patients,0,0
214866,were,0,0
214867,randomized,0,0
214868,between,0,0
214869,3,1,0
214870,regimens,1,1
214871,of,1,0
214872,chemotherapy,1,1
214873,:,1,0
214874,cyclophosphamide,1,1
214875,",",1,0
214876,intermittent,1,0
214877,melphalan,1,1
214878,",",1,0
214879,and,1,0
214880,melphalan,1,1
214881,with,1,0
214882,prednisone,1,1
214883,",",1,0
214884,and,1,0
214885,were,1,0
214886,followed,1,1
214887,up,1,0
214888,to,1,0
214889,death,1,0
214890,or,1,1
214891,for,1,0
214892,at,1,0
214893,least,1,0
214894,5,1,0
214895,years,1,0
214896,.,1,0
214897,There,0,0
214898,was,0,0
214899,no,0,0
214900,difference,0,0
214901,in,0,0
214902,survival,0,0
214903,between,0,0
214904,the,0,0
214905,treatments,0,0
214906,",",0,0
214907,either,0,0
214908,overall,0,0
214909,or,0,1
214910,in,0,0
214911,any,0,0
214912,subgroup,0,0
214913,of,0,0
214914,patients,0,0
214915,.,0,0
214916,Therefore,0,0
214917,",",0,0
214918,the,0,0
214919,choice,0,0
214920,among,0,0
214921,these,0,0
214922,3,0,0
214923,treatments,0,0
214924,should,0,0
214925,be,0,0
214926,guided,0,0
214927,by,0,0
214928,the,0,0
214929,patient,0,0
214930,'s,0,0
214931,comfort,0,0
214932,and,0,0
214933,convenience,0,0
214934,.,0,0
214935,The,0,0
214936,most,0,0
214937,important,0,0
214938,prognostic,0,0
214939,feature,0,0
214940,at,0,0
214941,presentation,0,0
214942,was,0,0
214943,the,0,0
214944,quality,0,0
214945,of,0,0
214946,renal,0,0
214947,function,0,0
214948,.,0,0
214949,It,0,0
214950,was,0,0
214951,possible,0,0
214952,to,0,0
214953,define,0,0
214954,good,0,0
214955,",",0,0
214956,intermediate,0,0
214957,and,0,0
214958,poor,0,0
214959,renal-function,0,0
214960,groups,0,0
214961,which,0,0
214962,were,0,0
214963,highly,0,0
214964,correlated,0,0
214965,with,0,0
214966,prognosis,0,0
214967,(,0,0
214968,X2,0,1
214969,for,0,0
214970,trend,0,0
214971,=,0,0
214972,62.6,0,0
214973,),0,0
214974,.,0,0
214975,The,0,0
214976,haemoglobin,0,0
214977,level,0,0
214978,at,0,0
214979,presentation,0,0
214980,was,0,0
214981,strongly,0,0
214982,correlated,0,0
214983,with,0,0
214984,prognosis,0,0
214985,among,0,0
214986,patients,0,0
214987,in,0,0
214988,the,0,0
214989,good,0,0
214990,renal-function,0,0
214991,group,0,0
214992,.,0,0
214993,Among,0,0
214994,107,0,0
214995,patients,0,0
214996,who,0,0
214997,presented,0,0
214998,with,0,0
214999,good,0,0
215000,renal,0,0
215001,function,0,0
215002,and,0,0
215003,with,0,0
215004,haemoglobin,0,0
215005,above,0,0
215006,100,0,0
215007,g/l,0,0
215008,",",0,0
215009,the,0,0
215010,5-year,0,0
215011,survival,0,0
215012,was,0,0
215013,43,0,0
215014,%,0,0
215015,.,0,0
215016,Other,0,0
215017,prognostic,0,0
215018,features,0,0
215019,were,0,0
215020,much,0,0
215021,less,0,0
215022,important,0,0
215023,when,0,0
215024,account,0,0
215025,was,0,0
215026,taken,0,0
215027,of,0,0
215028,renal,0,0
215029,function,0,0
215030,and,0,0
215031,haemoglobin,0,0
215032,level,0,0
215033,.,0,0
215034,Corticosteroid-induced,0,1
215035,osteopenia,0,0
215036,and,0,0
215037,vitamin,0,1
215038,D,0,1
215039,metabolism,0,0
215040,.,0,0
215041,Effect,0,0
215042,of,0,0
215043,vitamin,1,1
215044,D2,1,1
215045,",",1,0
215046,calcium,1,1
215047,phosphate,1,1
215048,and,0,0
215049,sodium,1,1
215050,fluoride,1,1
215051,administration,0,0
215052,.,0,0
215053,Thirty-one,0,0
215054,patients,0,0
215055,scheduled,0,0
215056,for,0,0
215057,long-term,0,0
215058,(,0,0
215059,24,0,0
215060,weeks,0,0
215061,),0,0
215062,treatment,0,0
215063,with,0,0
215064,prednisone,1,1
215065,in,0,0
215066,comparatively,0,0
215067,high,0,0
215068,doses,0,0
215069,were,0,0
215070,randomly,0,0
215071,allocated,0,0
215072,to,0,0
215073,two,0,0
215074,further,0,0
215075,treatment,0,0
215076,groups,0,0
215077,.,0,0
215078,Group,1,0
215079,A,1,0
215080,received,1,1
215081,prednisone,1,1
215082,plus,1,1
215083,'triple-treatment,1,1
215084,',1,1
215085,(,1,0
215086,vitamin,1,1
215087,D2,1,1
215088,45000,1,1
215089,iu,1,1
215090,twice,1,1
215091,weekly,1,1
215092,",",1,0
215093,sodium,1,1
215094,fluoride,1,1
215095,50,1,0
215096,mg,1,1
215097,and,1,0
215098,calcium,1,1
215099,phosphate,1,1
215100,4.5,1,0
215101,g,1,1
215102,daily,1,1
215103,),1,0
215104,",",1,0
215105,group,1,0
215106,B,1,0
215107,received,1,1
215108,only,1,0
215109,prednisone,1,1
215110,.,1,0
215111,The,0,0
215112,study,0,0
215113,was,0,0
215114,undertaken,0,0
215115,in,0,0
215116,order,0,0
215117,to,0,0
215118,evaluate,0,0
215119,the,0,0
215120,effect,0,0
215121,of,0,0
215122,prednisone-,1,1
215123,and,0,0
215124,triple-treatment,1,1
215125,upon,0,0
215126,bone,0,0
215127,mineral,0,0
215128,content,0,1
215129,(,0,1
215130,BMC,0,1
215131,),0,1
215132,and,0,0
215133,vitamin,0,1
215134,D,0,1
215135,metabolism,0,0
215136,.,0,0
215137,The,0,0
215138,groups,0,0
215139,were,0,0
215140,comparable,0,0
215141,with,0,0
215142,regard,0,0
215143,to,0,0
215144,age,0,0
215145,",",0,0
215146,sex,0,0
215147,and,0,0
215148,prednisone,0,1
215149,dose,0,0
215150,.,0,0
215151,BMC,0,0
215152,fell,0,0
215153,rapidly,0,0
215154,and,0,0
215155,similarly,0,0
215156,in,0,0
215157,both,0,0
215158,groups,0,0
215159,",",0,0
215160,demonstrating,0,0
215161,that,0,0
215162,the,0,0
215163,triple-treatment,0,1
215164,has,0,0
215165,no,0,0
215166,preventive,0,0
215167,effect,0,0
215168,on,0,0
215169,corticosteroid,0,1
215170,induced,0,0
215171,osteopenia,0,0
215172,.,0,0
215173,Serum,0,0
215174,concentrations,0,0
215175,of,0,0
215176,25OHD2,0,0
215177,",",0,0
215178,25OHD3,0,0
215179,and,0,0
215180,"1,25",0,1
215181,(,0,0
215182,OH,0,0
215183,),0,1
215184,2D,0,0
215185,were,0,0
215186,unchanged,0,0
215187,in,0,0
215188,group,0,1
215189,B,0,1
215190,(,0,0
215191,without,0,1
215192,triple-treatment,0,1
215193,),0,0
215194,",",0,0
215195,whereas,0,0
215196,in,0,0
215197,group,0,0
215198,A,0,0
215199,25OHD2,0,1
215200,increased,0,0
215201,enormously,0,0
215202,",",0,0
215203,25OHD3,0,0
215204,was,0,0
215205,suppressed,0,0
215206,possibly,0,0
215207,by,0,0
215208,substrate,0,0
215209,competition,0,0
215210,for,0,0
215211,hydroxylation,0,0
215212,in,0,0
215213,the,0,0
215214,liver,0,0
215215,and,0,0
215216,"1,25",0,1
215217,(,0,0
215218,OH,0,0
215219,),0,1
215220,2D,0,0
215221,was,0,0
215222,halved,0,0
215223,.,0,0
215224,The,0,0
215225,suppression,0,0
215226,of,0,0
215227,"1,25",0,1
215228,(,0,0
215229,OH,0,0
215230,),0,1
215231,2D,0,0
215232,may,0,0
215233,be,0,0
215234,an,0,0
215235,effect,0,0
215236,of,0,0
215237,raised,0,0
215238,25OHD2,0,1
215239,alone,0,1
215240,",",0,0
215241,or,0,1
215242,in,0,0
215243,combination,0,1
215244,with,0,0
215245,corticosteroid,0,1
215246,excess,0,0
215247,.,0,0
215248,Non-Hodgkin,0,0
215249,'s,0,0
215250,malignant,0,0
215251,lymphomas,0,0
215252,:,0,0
215253,treatment,0,0
215254,of,0,0
215255,localized,0,0
215256,relapses,0,0
215257,with,0,0
215258,chemo,1,0
215259,+,1,1
215260,radio,1,1
215261,+,1,1
215262,BCG-therapy,1,1
215263,.,1,0
215264,16,0,0
215265,patients,0,0
215266,with,0,0
215267,relapsing,0,0
215268,non-Hodgkin,0,0
215269,'s,0,0
215270,malignant,0,0
215271,lymphomas,0,0
215272,considered,0,0
215273,as,0,0
215274,clinical,0,0
215275,stage,0,0
215276,I,0,0
215277,or,0,1
215278,II,0,0
215279,were,0,0
215280,treated,0,0
215281,by,0,0
215282,an,0,0
215283,association,0,0
215284,of,0,0
215285,chemo,1,1
215286,+,1,1
215287,radiotherapy,1,1
215288,and,1,0
215289,thereafter,1,0
215290,by,1,0
215291,maintenance,1,0
215292,BCG,1,1
215293,therapy,1,1
215294,.,1,0
215295,5,0,0
215296,of,0,0
215297,them,0,0
215298,were,0,0
215299,included,0,0
215300,in,0,0
215301,a,0,0
215302,randomized,0,0
215303,trial,0,0
215304,and,0,0
215305,have,0,0
215306,a,0,0
215307,significantly,0,0
215308,different,0,0
215309,disease-free,0,0
215310,survival,0,0
215311,from,0,0
215312,patients,0,0
215313,receiving,0,0
215314,the,0,0
215315,same,0,0
215316,treatment,0,0
215317,but,0,0
215318,without,0,0
215319,BCG,1,1
215320,.,1,0
215321,11,0,0
215322,were,0,0
215323,systematically,0,0
215324,treated,0,0
215325,by,0,0
215326,BCG,1,1
215327,and,0,0
215328,they,0,0
215329,also,0,0
215330,have,0,0
215331,a,0,0
215332,fairly,0,0
215333,good,0,0
215334,disease-free,0,0
215335,survival,0,0
215336,.,0,0
215337,Such,0,0
215338,a,0,0
215339,treatment,0,0
215340,appears,0,0
215341,to,0,0
215342,be,0,0
215343,of,0,0
215344,value,0,0
215345,in,0,0
215346,treating,0,0
215347,these,0,0
215348,patients,0,0
215349,and,0,0
215350,even,0,0
215351,probably,0,0
215352,of,0,0
215353,curing,0,1
215354,some,0,0
215355,of,0,0
215356,them,0,0
215357,.,0,0
215358,Antibiotic,0,1
215359,therapy,0,1
215360,of,0,0
215361,acute,0,0
215362,exacerbations,0,0
215363,of,0,0
215364,chronic,0,0
215365,bronchitis,0,0
215366,.,0,0
215367,A,0,0
215368,controlled,0,0
215369,study,0,0
215370,using,0,0
215371,tetracycline,1,1
215372,.,1,0
215373,We,0,0
215374,conducted,0,0
215375,a,0,0
215376,double-blind,0,0
215377,",",0,0
215378,randomized,0,0
215379,",",0,0
215380,placebo-controlled,1,1
215381,trial,0,0
215382,in,0,0
215383,40,0,0
215384,patients,0,0
215385,to,0,0
215386,evaluate,0,0
215387,the,0,0
215388,need,0,0
215389,for,0,0
215390,antibiotics,0,1
215391,in,0,0
215392,acute,0,0
215393,exacerbations,0,0
215394,of,0,0
215395,chronic,0,0
215396,bronchitis,0,0
215397,.,0,0
215398,All,0,0
215399,patients,0,0
215400,were,0,0
215401,sufficiently,0,0
215402,ill,0,0
215403,to,0,0
215404,require,0,0
215405,hospitalization,0,0
215406,although,0,0
215407,none,0,0
215408,needed,0,0
215409,ventilatory,0,1
215410,support,0,0
215411,;,0,0
215412,the,0,0
215413,presence,0,0
215414,of,0,0
215415,pneumonia,0,0
215416,was,0,0
215417,excluded,0,0
215418,.,0,0
215419,Treatment,0,0
215420,consisted,0,0
215421,of,0,0
215422,bronchodilators,1,0
215423,",",1,0
215424,corticosteroids,1,1
215425,",",0,0
215426,and,0,0
215427,either,0,1
215428,tetracycline,1,1
215429,",",0,0
215430,500,0,1
215431,mg,0,1
215432,",",0,0
215433,or,1,1
215434,placebo,1,1
215435,by,0,0
215436,mouth,0,0
215437,every,0,1
215438,6,0,0
215439,hours,0,0
215440,for,0,0
215441,1,0,0
215442,week,0,0
215443,.,0,0
215444,Arterial,0,0
215445,blood,0,0
215446,gases,0,0
215447,",",0,0
215448,spirometric,0,0
215449,tests,0,0
215450,",",0,0
215451,bacteriologic,0,0
215452,evaluation,0,0
215453,of,0,0
215454,sputum,0,0
215455,",",0,0
215456,and,0,0
215457,patient,0,0
215458,and,0,0
215459,physician,0,1
215460,evaluation,0,0
215461,of,0,0
215462,the,0,0
215463,severity,0,0
215464,of,0,0
215465,illness,0,0
215466,were,0,0
215467,assessed,0,0
215468,at,0,0
215469,the,0,0
215470,beginning,0,0
215471,and,0,0
215472,end,0,0
215473,of,0,0
215474,the,0,0
215475,study,0,0
215476,.,0,0
215477,All,0,0
215478,patients,0,0
215479,improved,0,0
215480,both,0,0
215481,symptomatically,0,0
215482,and,0,0
215483,by,0,0
215484,objective,0,0
215485,measures,0,0
215486,of,0,0
215487,lung,0,0
215488,function,0,0
215489,.,0,0
215490,At,0,0
215491,the,0,0
215492,end,0,0
215493,of,0,0
215494,the,0,0
215495,study,0,0
215496,period,0,0
215497,there,0,0
215498,were,0,0
215499,no,0,0
215500,differences,0,0
215501,between,0,0
215502,those,0,0
215503,patients,0,0
215504,receiving,0,0
215505,tetracycline,0,1
215506,and,0,0
215507,those,0,0
215508,receiving,0,0
215509,placebo,1,1
215510,.,1,0
215511,We,0,0
215512,conclude,0,0
215513,that,0,0
215514,antibiotic,0,1
215515,therapy,0,1
215516,is,0,0
215517,not,0,0
215518,needed,0,0
215519,in,0,0
215520,moderately,0,0
215521,ill,0,0
215522,patients,0,0
215523,with,0,0
215524,exacerbations,0,0
215525,of,0,0
215526,chronic,0,0
215527,bronchitis,0,0
215528,.,0,0
215529,Treatment,0,1
215530,of,0,0
215531,familial,0,0
215532,hypercholesterolemia,0,0
215533,with,0,0
215534,a,0,0
215535,combination,1,1
215536,of,1,0
215537,bezafibrate,1,1
215538,and,1,0
215539,guar,1,1
215540,.,1,0
215541,The,0,0
215542,effect,0,0
215543,of,0,0
215544,guar,1,1
215545,(,0,0
215546,15.6,0,0
215547,g/day,0,0
215548,),0,0
215549,",",0,0
215550,a,1,0
215551,dietary,1,1
215552,fibre,1,1
215553,",",0,0
215554,and,0,0
215555,simultaneous,0,1
215556,administration,0,0
215557,of,0,0
215558,bezafibrate,1,1
215559,(,0,0
215560,600,0,1
215561,mg/day,0,1
215562,),0,0
215563,during,0,0
215564,dietetic,0,1
215565,treatment,0,0
215566,on,0,0
215567,the,0,0
215568,plasma,0,0
215569,lipoproteins,0,0
215570,and,0,0
215571,apolipoproteins,0,0
215572,was,0,0
215573,investigated,0,0
215574,in,0,0
215575,12,0,0
215576,patients,0,0
215577,with,0,0
215578,familial,0,0
215579,hypercholesterolemia,0,1
215580,(,0,0
215581,corresponding,0,0
215582,to,0,0
215583,the,0,0
215584,HLP,0,1
215585,type,0,0
215586,IIa,0,1
215587,pattern,0,0
215588,),0,0
215589,.,0,0
215590,Either,1,0
215591,bezafibrate,1,1
215592,alone,1,1
215593,or,1,0
215594,bezafibrate,1,1
215595,in,1,0
215596,combination,1,1
215597,with,1,0
215598,guar,1,1
215599,was,1,0
215600,administered,1,0
215601,in,1,0
215602,a,1,0
215603,cross-over,1,0
215604,study,1,0
215605,for,1,0
215606,3,1,0
215607,months,1,0
215608,.,1,0
215609,Guar,1,0
215610,led,0,0
215611,to,0,0
215612,an,0,0
215613,additional,0,0
215614,lowering,0,0
215615,of,0,0
215616,the,0,0
215617,total,0,0
215618,cholesterol,0,0
215619,in,0,0
215620,the,0,0
215621,plasma,0,0
215622,by,0,0
215623,7,0,0
215624,%,0,0
215625,(,0,0
215626,P,0,0
215627,less,0,0
215628,than,0,0
215629,or,0,0
215630,equal,0,0
215631,to,0,0
215632,0.05,0,0
215633,),0,0
215634,associated,0,0
215635,with,0,0
215636,a,0,0
215637,fall,0,0
215638,of,0,0
215639,the,0,0
215640,low,0,0
215641,density,0,0
215642,lipoprotein,0,1
215643,cholesterol,0,1
215644,(,0,1
215645,LDL-cholesterol,0,1
215646,(,0,1
215647,LDL-cholesterol,0,1
215648,),0,1
215649,by,0,0
215650,13,0,0
215651,%,0,0
215652,(,0,0
215653,P,0,0
215654,less,0,0
215655,than,0,0
215656,or,0,0
215657,equal,0,0
215658,to,0,0
215659,0.01,0,0
215660,),0,0
215661,without,0,0
215662,any,0,0
215663,changes,0,0
215664,in,0,0
215665,the,0,0
215666,very,0,0
215667,low,0,0
215668,density,0,0
215669,lipoprotein,0,0
215670,(,0,1
215671,VLDL,0,1
215672,),0,1
215673,and,0,0
215674,high,0,0
215675,density,0,0
215676,lipoprotein,0,0
215677,(,0,1
215678,HDL,0,1
215679,),0,0
215680,cholesterols,0,0
215681,.,0,0
215682,In,0,0
215683,parallel,0,0
215684,with,0,0
215685,the,0,0
215686,decrease,0,0
215687,in,0,0
215688,LDL-cholesterol,0,1
215689,",",0,0
215690,the,0,0
215691,apoprotein,0,0
215692,B,0,0
215693,also,0,0
215694,was,0,0
215695,diminished,0,0
215696,by,0,0
215697,20,0,1
215698,%,0,0
215699,(,0,0
215700,P,0,0
215701,less,0,0
215702,than,0,0
215703,or,0,0
215704,equal,0,0
215705,to,0,0
215706,0.05,0,0
215707,),0,0
215708,.,0,0
215709,The,0,0
215710,plasma,0,0
215711,triglyceride,0,0
215712,level,0,0
215713,and,0,0
215714,the,0,0
215715,triglyceride,0,0
215716,distribution,0,0
215717,within,0,0
215718,the,0,0
215719,individual,0,0
215720,lipoprotein,0,0
215721,fractions,0,1
215722,were,0,0
215723,not,0,0
215724,altered,0,0
215725,in,0,0
215726,any,0,0
215727,consistent,0,0
215728,manner,0,0
215729,by,0,0
215730,the,0,0
215731,addition,0,0
215732,of,0,0
215733,guar,1,1
215734,.,1,0
215735,Neither,0,0
215736,the,0,0
215737,fasting,0,0
215738,plasma,0,0
215739,glucose,0,1
215740,level,0,0
215741,nor,0,0
215742,the,0,0
215743,body,0,0
215744,weight,0,0
215745,were,0,0
215746,affected,0,0
215747,.,0,0
215748,The,0,0
215749,side-effects,0,0
215750,due,0,0
215751,to,0,0
215752,guar,1,1
215753,treatment,1,0
215754,consisted,0,0
215755,of,0,0
215756,slight,0,0
215757,nausea,0,0
215758,",",0,0
215759,meteorism,0,0
215760,and,0,0
215761,constipation,0,0
215762,",",0,0
215763,but,0,0
215764,this,0,0
215765,did,0,0
215766,not,0,0
215767,in,0,0
215768,any,0,0
215769,of,0,0
215770,the,0,0
215771,cases,0,0
215772,lead,0,0
215773,to,0,0
215774,early,0,0
215775,termination,0,0
215776,of,0,0
215777,the,0,0
215778,study,0,0
215779,.,0,0
215780,These,0,0
215781,results,0,0
215782,demonstrate,0,0
215783,that,0,0
215784,guar,1,1
215785,exerts,0,0
215786,its,0,0
215787,cholesterol-lowering,0,1
215788,effect,0,0
215789,in,0,0
215790,addition,0,0
215791,to,0,0
215792,that,0,0
215793,of,0,0
215794,bezafibrate,1,1
215795,.,1,0
215796,Breast,0,0
215797,cancer,0,0
215798,screening,1,0
215799,in,0,0
215800,Sweden,0,0
215801,.,0,0
215802,The,0,0
215803,single,0,0
215804,modality,0,0
215805,approach,0,1
215806,.,0,0
215807,Four,0,0
215808,population-based,0,0
215809,breast,0,0
215810,cancer,0,0
215811,screening,0,0
215812,projects,0,0
215813,are,0,0
215814,in,0,0
215815,progress,0,0
215816,in,0,0
215817,Sweden,0,0
215818,",",0,0
215819,three,0,0
215820,of,0,0
215821,which,0,0
215822,are,0,0
215823,randomized,0,0
215824,studies,0,0
215825,.,0,0
215826,Mammography,1,1
215827,is,0,0
215828,the,0,0
215829,only,0,0
215830,screening,0,0
215831,method,0,1
215832,.,0,0
215833,51,0,0
215834,%,0,0
215835,of,0,0
215836,all,0,0
215837,carcinomas,0,0
215838,detected,0,0
215839,at,0,0
215840,the,0,0
215841,first,0,0
215842,screening,0,0
215843,were,0,0
215844,either,0,0
215845,in,0,0
215846,situ,0,1
215847,or,0,1
215848,invasive,0,0
215849,with,0,0
215850,a,0,0
215851,diameter,0,0
215852,of,0,0
215853,10,0,0
215854,mm,0,0
215855,or,0,0
215856,less,0,0
215857,.,0,0
215858,Axillary,0,0
215859,metastases,0,0
215860,were,0,0
215861,found,0,0
215862,in,0,0
215863,16,0,0
215864,%,0,0
215865,of,0,0
215866,the,0,0
215867,patients,0,0
215868,.,0,0
215869,Sensitivity,0,0
215870,was,0,0
215871,over,0,0
215872,90,0,0
215873,%,0,0
215874,in,0,0
215875,all,0,0
215876,projects,0,0
215877,.,0,0
215878,The,0,0
215879,ultimate,0,0
215880,aim,0,0
215881,of,0,0
215882,the,0,0
215883,randomized,0,0
215884,projects,0,0
215885,is,0,0
215886,to,0,0
215887,demonstrate,0,0
215888,the,0,0
215889,effect,0,0
215890,of,0,0
215891,screening,1,0
215892,on,0,0
215893,breast,0,0
215894,cancer,0,0
215895,mortality,0,0
215896,.,0,0
215897,It,0,0
215898,is,0,0
215899,estimated,0,0
215900,that,0,0
215901,mortality,0,0
215902,statistics,0,0
215903,will,0,0
215904,reach,0,0
215905,significant,0,0
215906,levels,0,0
215907,in,0,0
215908,1983.,0,0
215909,",",0,0
215910,Double-blind,0,0
215911,comparison,0,0
215912,of,0,0
215913,the,0,0
215914,efficacy,0,0
215915,and,0,0
215916,safety,0,0
215917,of,0,0
215918,trandolapril,1,1
215919,2,0,0
215920,mg,0,1
215921,and,0,0
215922,hydrochlorothiazide,1,1
215923,25,0,0
215924,mg,0,0
215925,in,0,0
215926,patients,0,0
215927,with,0,0
215928,mild-to-moderate,0,0
215929,essential,0,0
215930,hypertension,0,0
215931,.,0,0
215932,Investigator,0,0
215933,Study,0,0
215934,Group,0,0
215935,.,0,0
215936,This,0,0
215937,multicenter,0,0
215938,international,0,0
215939,trial,0,0
215940,recruited,0,0
215941,205,0,0
215942,patients,0,0
215943,from,0,0
215944,16,0,0
215945,investigators,0,0
215946,.,0,0
215947,After,0,0
215948,a,0,0
215949,4-week,0,0
215950,",",0,0
215951,single-blind,1,0
215952,placebo,1,1
215953,run-in,0,0
215954,",",0,0
215955,patients,0,0
215956,were,0,0
215957,randomized,0,0
215958,to,0,0
215959,receive,0,0
215960,16,0,0
215961,weeks,0,0
215962,of,0,0
215963,trandolapril,1,1
215964,2,0,1
215965,mg/day,0,1
215966,(,0,0
215967,68,0,0
215968,patients,0,0
215969,),0,0
215970,",",0,0
215971,hydrochlorothiazide,1,1
215972,(,1,0
215973,HCTZ,1,0
215974,),1,1
215975,25,0,1
215976,mg/day,0,1
215977,(,0,0
215978,68,0,0
215979,patients,0,0
215980,),0,0
215981,",",0,0
215982,or,1,1
215983,the,1,0
215984,combination,1,1
215985,(,0,0
215986,69,0,0
215987,patients,0,0
215988,),0,0
215989,.,0,0
215990,Morning,0,0
215991,predosing,0,0
215992,supine,0,0
215993,diastolic,0,0
215994,blood,0,0
215995,pressure,0,0
215996,(,0,1
215997,DBP,0,0
215998,),0,1
215999,was,0,0
216000,the,0,0
216001,primary,0,0
216002,efficacy,0,0
216003,measurement,0,0
216004,.,0,0
216005,Intention-to-treat,0,0
216006,analysis,0,0
216007,showed,0,0
216008,significant,0,0
216009,decreases,0,0
216010,in,0,0
216011,all,0,0
216012,three,0,0
216013,groups,0,0
216014,in,0,0
216015,mean,0,0
216016,(,0,0
216017,+/-,0,0
216018,SEM,0,1
216019,),0,1
216020,supine,0,0
216021,DBP,0,0
216022,throughout,0,0
216023,the,0,0
216024,study,0,0
216025,",",0,0
216026,with,0,0
216027,no,0,0
216028,significant,0,0
216029,differences,0,0
216030,at,0,0
216031,week,0,0
216032,16,0,0
216033,between,0,0
216034,trandolapril,0,1
216035,(,0,0
216036,-10.6,0,0
216037,+/-,0,0
216038,1.3,0,0
216039,mm,0,0
216040,Hg,0,0
216041,),0,1
216042,and,0,0
216043,HCTZ,0,1
216044,(,0,1
216045,-10.9,0,0
216046,+/-,0,0
216047,1.3,0,0
216048,mm,0,0
216049,Hg,0,0
216050,),0,0
216051,.,0,0
216052,The,0,0
216053,combination,0,0
216054,gave,0,0
216055,a,0,0
216056,significantly,0,0
216057,greater,0,0
216058,reduction,0,0
216059,than,0,0
216060,either,0,1
216061,drug,0,1
216062,alone,0,1
216063,(,0,0
216064,-15.1,0,0
216065,+/-,0,0
216066,1.13,0,0
216067,mm,0,0
216068,Hg,0,0
216069,),0,0
216070,.,0,0
216071,Blood,0,0
216072,pressure,0,0
216073,was,0,0
216074,normalized,0,0
216075,in,0,0
216076,the,0,0
216077,combination,0,1
216078,group,0,0
216079,in,0,0
216080,67,0,0
216081,%,0,0
216082,of,0,0
216083,patients,0,0
216084,",",0,0
216085,a,0,0
216086,significantly,0,0
216087,higher,0,0
216088,proportion,0,0
216089,than,0,0
216090,either,0,1
216091,trandolapril,0,1
216092,(,0,0
216093,63,0,0
216094,%,0,0
216095,),0,0
216096,or,0,1
216097,HCTZ,0,1
216098,(,0,1
216099,60,0,0
216100,%,0,0
216101,;,0,0
216102,p,0,0
216103,=,0,0
216104,0.04,0,0
216105,),0,0
216106,.,0,0
216107,Each,0,0
216108,treatment,0,0
216109,was,0,0
216110,well,0,0
216111,tolerated,0,0
216112,.,0,0
216113,The,0,0
216114,incidence,0,0
216115,of,0,0
216116,adverse,0,0
216117,events,0,0
216118,was,0,0
216119,similar,0,0
216120,in,0,0
216121,all,0,0
216122,three,0,0
216123,groups,0,0
216124,.,0,0
216125,Trandolapril,0,1
216126,2,0,0
216127,mg,0,1
216128,once,0,1
216129,daily,0,1
216130,is,0,0
216131,an,0,0
216132,effective,0,0
216133,antihypertensive,0,1
216134,agent,0,0
216135,",",0,0
216136,comparable,0,0
216137,to,0,0
216138,HCTZ,0,0
216139,.,0,0
216140,Furthermore,0,0
216141,",",0,0
216142,the,0,0
216143,combination,0,1
216144,of,0,0
216145,the,0,0
216146,two,0,0
216147,drugs,0,0
216148,was,0,0
216149,shown,0,0
216150,to,0,0
216151,enhance,0,0
216152,the,0,0
216153,antihypertensive,0,1
216154,effect,0,0
216155,of,0,0
216156,the,0,0
216157,two,0,0
216158,compounds,0,0
216159,alone,0,0
216160,.,0,0
216161,Abdominoperineal,1,1
216162,resection,1,1
216163,and,0,0
216164,anterior,1,1
216165,resection,1,1
216166,in,0,0
216167,the,0,0
216168,treatment,0,0
216169,of,0,0
216170,rectal,0,0
216171,cancer,0,0
216172,:,0,0
216173,results,0,0
216174,in,0,0
216175,relation,0,0
216176,to,0,0
216177,adjuvant,1,1
216178,preoperative,1,0
216179,radiotherapy,1,1
216180,.,1,0
216181,The,0,0
216182,outcome,0,0
216183,of,0,0
216184,patients,0,0
216185,with,0,0
216186,rectal,0,0
216187,cancer,0,0
216188,treated,0,0
216189,by,0,0
216190,abdominoperineal,1,1
216191,or,1,1
216192,anterior,1,1
216193,resection,1,1
216194,",",1,0
216195,with,1,0
216196,or,1,1
216197,without,1,1
216198,preoperative,1,1
216199,radiotherapy,1,1
216200,",",0,0
216201,was,0,0
216202,assessed,0,0
216203,to,0,0
216204,detect,0,0
216205,any,0,0
216206,differences,0,0
216207,attributable,0,0
216208,to,0,0
216209,the,0,0
216210,operative,0,0
216211,method,0,1
216212,and,0,0
216213,interactions,0,0
216214,between,0,0
216215,radiotherapy,0,1
216216,and,0,0
216217,type,0,0
216218,of,0,0
216219,surgery,0,0
216220,.,0,0
216221,The,0,0
216222,study,0,0
216223,was,0,0
216224,based,0,0
216225,on,0,0
216226,1292,0,0
216227,patients,0,0
216228,included,0,0
216229,in,0,0
216230,two,0,0
216231,consecutive,0,0
216232,controlled,0,0
216233,randomized,0,0
216234,trials,0,0
216235,of,0,0
216236,preoperative,1,0
216237,radiotherapy,1,1
216238,in,0,0
216239,operable,0,0
216240,rectal,0,0
216241,carcinoma,0,0
216242,.,0,0
216243,The,0,0
216244,outcome,0,0
216245,was,0,0
216246,not,0,0
216247,related,0,0
216248,to,0,0
216249,surgical,0,0
216250,method,0,1
216251,.,0,0
216252,Radiotherapy,0,1
216253,increased,0,0
216254,postoperative,0,0
216255,mortality,0,0
216256,and,0,0
216257,complications,0,0
216258,and,0,0
216259,reduced,0,0
216260,local,0,1
216261,and,0,0
216262,distant,0,0
216263,recurrence,0,0
216264,",",0,0
216265,but,0,0
216266,had,0,0
216267,no,0,0
216268,effect,0,0
216269,on,0,0
216270,overall,0,0
216271,survival,0,0
216272,.,0,0
216273,Effects,0,0
216274,of,0,0
216275,radiotherapy,1,1
216276,were,0,0
216277,similar,0,0
216278,irrespective,0,0
216279,of,0,0
216280,the,0,0
216281,type,0,0
216282,of,0,0
216283,surgery,0,0
216284,",",0,0
216285,except,0,0
216286,that,0,0
216287,the,0,0
216288,increase,0,0
216289,in,0,0
216290,postoperative,0,0
216291,mortality,0,0
216292,in,0,0
216293,irradiated,0,1
216294,patients,0,0
216295,was,0,0
216296,greater,0,0
216297,in,0,0
216298,those,0,0
216299,treated,0,0
216300,with,0,0
216301,abdominoperineal,0,1
216302,resection,0,0
216303,.,0,0
216304,Sphincter-saving,1,0
216305,procedures,1,0
216306,appear,0,0
216307,to,0,0
216308,have,0,0
216309,no,0,0
216310,adverse,0,0
216311,effects,0,0
216312,on,0,0
216313,outcome,0,0
216314,of,0,0
216315,rectal,0,0
216316,cancer,0,0
216317,",",0,0
216318,but,0,0
216319,the,0,0
216320,optimum,0,0
216321,use,0,0
216322,of,0,0
216323,radiotherapy,0,1
216324,is,0,0
216325,still,0,0
216326,to,0,0
216327,be,0,0
216328,defined,0,0
216329,.,0,0
216330,Active,1,1
216331,treatment,1,0
216332,programs,1,1
216333,for,0,0
216334,patients,0,0
216335,with,0,0
216336,chronic,0,0
216337,low,0,0
216338,back,0,0
216339,pain,0,0
216340,:,0,0
216341,a,0,0
216342,prospective,0,0
216343,",",0,0
216344,randomized,0,0
216345,",",0,0
216346,observer-blinded,0,0
216347,study,0,0
216348,.,0,0
216349,Several,0,0
216350,new,0,0
216351,studies,0,0
216352,have,0,0
216353,indicated,0,0
216354,that,0,0
216355,an,0,0
216356,active,0,1
216357,approach,0,1
216358,to,0,0
216359,patients,0,0
216360,with,0,0
216361,chronic,0,0
216362,disabling,0,0
216363,low,0,0
216364,back,0,1
216365,pain,0,0
216366,(,0,1
216367,LBP,0,0
216368,),0,1
216369,seems,0,0
216370,effective,0,0
216371,.,0,0
216372,Some,0,0
216373,of,0,0
216374,these,0,0
216375,studies,0,0
216376,emphasize,0,0
216377,the,0,0
216378,importance,0,0
216379,of,0,0
216380,dealing,0,0
216381,with,0,0
216382,the,0,0
216383,patient,0,0
216384,'s,0,0
216385,total,0,0
216386,situation,0,0
216387,in,0,0
216388,comprehensive,0,0
216389,multidisciplinary,0,0
216390,programs,0,1
216391,--,0,0
216392,the,0,0
216393,bio-psycho-social,0,1
216394,model,0,0
216395,.,0,0
216396,However,0,0
216397,",",0,0
216398,these,0,0
216399,programs,0,1
216400,are,0,0
216401,expensive,0,0
216402,.,0,0
216403,The,0,0
216404,aim,0,0
216405,of,0,0
216406,this,0,0
216407,study,0,0
216408,was,0,0
216409,to,0,0
216410,evaluate,0,0
216411,the,0,0
216412,rehabilitation,0,1
216413,outcome,0,0
216414,from,0,0
216415,three,0,0
216416,different,0,0
216417,active,0,0
216418,programs,0,1
216419,in,0,0
216420,terms,0,0
216421,of,0,0
216422,:,0,0
216423,(,0,0
216424,1,0,0
216425,),0,1
216426,return-to-work,0,1
216427,rate,0,0
216428,",",0,0
216429,(,0,0
216430,2,0,0
216431,),0,0
216432,days,0,0
216433,of,0,0
216434,sick,0,0
216435,leave,0,1
216436,",",0,0
216437,(,0,0
216438,3,0,0
216439,),0,0
216440,health-care,0,0
216441,contacts,0,1
216442,",",0,0
216443,(,0,0
216444,4,0,1
216445,),0,1
216446,pain,0,0
216447,and,0,0
216448,disability,0,0
216449,scores,0,0
216450,",",0,0
216451,and,0,0
216452,(,0,0
216453,5,0,1
216454,),0,0
216455,staying,0,0
216456,physically,0,0
216457,active,0,0
216458,.,0,0
216459,The,0,0
216460,subjects,0,0
216461,included,0,0
216462,132,0,0
216463,patients,0,0
216464,randomized,0,0
216465,to,0,0
216466,the,0,0
216467,study,0,0
216468,",",0,0
216469,of,0,0
216470,whom,0,0
216471,123,0,0
216472,started,0,0
216473,one,0,0
216474,of,0,0
216475,the,0,0
216476,treatment,0,0
216477,programs,0,1
216478,.,0,0
216479,They,0,0
216480,had,0,0
216481,all,0,0
216482,had,0,0
216483,at,0,0
216484,least,0,0
216485,6,0,0
216486,months,0,0
216487,of,0,0
216488,chronic,0,0
216489,LBP,0,0
216490,.,0,0
216491,The,0,0
216492,patients,0,0
216493,were,0,0
216494,randomized,0,0
216495,into,0,0
216496,one,0,0
216497,of,0,0
216498,three,0,0
216499,programs,0,1
216500,:,0,0
216501,group,0,0
216502,1,0,0
216503,--,0,0
216504,a,0,0
216505,full-time,1,1
216506,",",1,0
216507,intensive,1,0
216508,3-week,1,1
216509,multidisciplinary,1,1
216510,program,1,1
216511,",",1,0
216512,including,1,0
216513,active,1,1
216514,physical,1,1
216515,and,1,0
216516,ergonomic,1,1
216517,training,1,1
216518,and,1,0
216519,psychological,1,0
216520,pain,1,0
216521,management,1,1
216522,",",0,0
216523,followed,0,1
216524,by,0,0
216525,1,0,0
216526,day,0,0
216527,weekly,0,1
216528,for,0,0
216529,the,0,0
216530,subsequent,0,0
216531,3,0,0
216532,weeks,0,0
216533,;,0,0
216534,group,0,0
216535,2,1,0
216536,--,1,0
216537,active,1,0
216538,physical,1,1
216539,training,1,1
216540,",",1,0
216541,twice,1,1
216542,a,1,0
216543,week,1,0
216544,for,1,0
216545,6,1,0
216546,weeks,1,0
216547,",",1,0
216548,for,1,0
216549,a,1,0
216550,total,1,0
216551,of,1,0
216552,24h,1,0
216553,;,1,0
216554,group,0,0
216555,3,1,0
216556,--,1,0
216557,psychological,1,0
216558,pain,1,0
216559,management,1,1
216560,combined,1,1
216561,with,1,0
216562,active,1,1
216563,physical,1,1
216564,training,1,1
216565,",",0,0
216566,twice,0,1
216567,a,0,0
216568,week,0,0
216569,for,0,0
216570,6,0,0
216571,weeks,0,0
216572,",",0,0
216573,also,0,0
216574,for,0,0
216575,a,0,0
216576,total,0,0
216577,of,0,0
216578,24h,0,0
216579,.,0,0
216580,The,0,0
216581,results,0,0
216582,presented,0,0
216583,here,0,0
216584,are,0,0
216585,based,0,0
216586,on,0,0
216587,data,0,0
216588,collected,0,0
216589,4,0,0
216590,months,0,0
216591,following,0,0
216592,treatment,0,0
216593,",",0,0
216594,which,0,0
216595,shows,0,0
216596,an,0,0
216597,86,0,0
216598,%,0,0
216599,response,0,0
216600,rate,0,0
216601,.,0,0
216602,The,0,0
216603,initial,0,0
216604,examination,0,0
216605,and,0,0
216606,the,0,0
216607,follow-up,0,0
216608,evaluation,0,0
216609,were,0,0
216610,performed,0,0
216611,by,0,0
216612,a,0,0
216613,blinded,0,0
216614,observer,0,0
216615,.,0,0
216616,The,0,0
216617,results,0,0
216618,show,0,0
216619,that,0,0
216620,4,0,0
216621,months,0,0
216622,after,0,0
216623,treatment,0,0
216624,",",0,0
216625,the,0,0
216626,intensive,0,1
216627,multidisciplinary,0,1
216628,program,0,1
216629,is,0,0
216630,superior,0,0
216631,to,0,0
216632,the,0,0
216633,less,0,0
216634,intensive,0,0
216635,programs,0,1
216636,in,0,0
216637,terms,0,0
216638,of,0,0
216639,return-to-work,0,1
216640,rate,0,0
216641,",",0,0
216642,health-care,0,0
216643,contacts,0,0
216644,",",0,0
216645,pain,0,0
216646,and,0,0
216647,disability,0,0
216648,scores,0,0
216649,",",0,0
216650,and,0,0
216651,staying,0,0
216652,physically,0,0
216653,active,0,1
216654,.,0,0
216655,(,0,0
216656,ABSTRACT,0,1
216657,TRUNCATED,0,1
216658,AT,0,1
216659,250,0,1
216660,WORDS,0,1
216661,),0,1
216662,Reducing,0,0
216663,the,0,0
216664,risk,0,0
216665,of,0,0
216666,coronary,0,0
216667,events,0,0
216668,:,0,0
216669,evidence,0,0
216670,from,0,0
216671,the,0,0
216672,Scandinavian,0,0
216673,Simvastatin,0,1
216674,Survival,0,1
216675,Study,0,0
216676,(,0,1
216677,4S,0,0
216678,),0,0
216679,.,0,0
216680,The,0,0
216681,Scandinavian,0,0
216682,Simvastatin,0,1
216683,Survival,0,1
216684,Study,0,0
216685,(,0,1
216686,4S,0,0
216687,),0,0
216688,was,0,0
216689,designed,0,0
216690,to,0,0
216691,evaluate,0,0
216692,the,0,0
216693,effects,0,0
216694,of,0,0
216695,cholesterol,0,0
216696,reduction,0,0
216697,with,0,0
216698,simvastatin,1,1
216699,on,0,0
216700,mortality,0,0
216701,and,0,0
216702,morbidity,0,0
216703,in,0,0
216704,patients,0,0
216705,with,0,0
216706,coronary,0,0
216707,artery,0,1
216708,disease,0,0
216709,(,0,1
216710,CAD,0,1
216711,),0,0
216712,.,0,0
216713,A,0,0
216714,total,0,0
216715,of,0,0
216716,"4,444",0,0
216717,patients,0,0
216718,with,0,0
216719,angina,0,0
216720,pectoris,0,0
216721,or,0,1
216722,previous,0,0
216723,myocardial,0,0
216724,infarction,0,0
216725,and,0,0
216726,serum,0,0
216727,cholesterol,0,0
216728,levels,0,0
216729,of,0,0
216730,213-310,0,1
216731,mg/dl,0,0
216732,(,0,1
216733,5.5-8.0,0,0
216734,mmol/liter,0,0
216735,),0,0
216736,while,0,0
216737,treated,0,0
216738,with,0,0
216739,a,0,0
216740,lipid-lowering,1,1
216741,diet,1,1
216742,were,0,0
216743,randomly,0,0
216744,assigned,0,0
216745,to,0,0
216746,double-blind,0,0
216747,treatment,0,0
216748,with,0,0
216749,simvastatin,1,1
216750,or,1,1
216751,placebo,1,1
216752,.,1,0
216753,Over,0,0
216754,the,0,0
216755,5.4,0,0
216756,years,0,0
216757,of,0,0
216758,median,0,0
216759,follow-up,0,0
216760,",",0,0
216761,simvastatin,0,1
216762,produced,0,0
216763,changes,0,0
216764,in,0,0
216765,total,0,0
216766,cholesterol,0,0
216767,",",0,0
216768,low,0,0
216769,density,0,0
216770,lipoprotein,0,0
216771,(,0,1
216772,LDL,0,1
216773,),0,1
216774,cholesterol,0,0
216775,",",0,0
216776,and,0,0
216777,high,0,0
216778,density,0,0
216779,lipoprotein,0,0
216780,(,0,1
216781,HDL,0,1
216782,),0,1
216783,cholesterol,0,0
216784,of,0,0
216785,-25,0,1
216786,%,0,0
216787,",",0,0
216788,-35,0,1
216789,%,0,0
216790,",",0,0
216791,and,0,0
216792,+8,0,1
216793,%,0,0
216794,",",0,0
216795,respectively,0,0
216796,",",0,0
216797,with,0,0
216798,minimal,0,0
216799,adverse,0,0
216800,effects,0,0
216801,.,0,0
216802,A,0,0
216803,total,0,0
216804,of,0,0
216805,256,0,0
216806,patients,0,0
216807,(,0,0
216808,12,0,0
216809,%,0,0
216810,),0,0
216811,in,0,0
216812,the,0,0
216813,placebo,0,1
216814,group,0,0
216815,died,0,0
216816,compared,0,0
216817,with,0,0
216818,182,0,0
216819,(,0,0
216820,8,0,0
216821,%,0,0
216822,),0,0
216823,in,0,0
216824,the,0,0
216825,simvastatin,0,1
216826,group,0,0
216827,",",0,0
216828,a,0,0
216829,risk,0,0
216830,reduction,0,0
216831,of,0,0
216832,30,0,1
216833,%,0,0
216834,(,0,0
216835,p,0,0
216836,=,0,0
216837,0.0003,0,0
216838,),0,0
216839,attributable,0,0
216840,to,0,0
216841,a,0,0
216842,42,0,0
216843,%,0,0
216844,reduction,0,0
216845,in,0,0
216846,the,0,0
216847,risk,0,0
216848,of,0,0
216849,coronary,0,0
216850,death,0,0
216851,.,0,0
216852,Noncardiovascular,0,0
216853,causes,0,0
216854,accounted,0,0
216855,for,0,0
216856,49,0,0
216857,and,0,0
216858,46,0,0
216859,deaths,0,0
216860,in,0,0
216861,the,0,0
216862,placebo,0,1
216863,and,0,0
216864,simvastatin,0,1
216865,groups,0,0
216866,",",0,0
216867,respectively,0,0
216868,.,0,0
216869,Major,0,0
216870,coronary,0,0
216871,events,0,0
216872,were,0,0
216873,experienced,0,0
216874,by,0,0
216875,622,0,0
216876,patients,0,0
216877,(,0,0
216878,28,0,0
216879,%,0,0
216880,),0,0
216881,in,0,0
216882,the,0,0
216883,placebo,0,1
216884,group,0,0
216885,and,0,0
216886,431,0,0
216887,patients,0,0
216888,(,0,0
216889,19,0,0
216890,%,0,0
216891,),0,0
216892,in,0,0
216893,the,0,0
216894,simvastatin,0,1
216895,group,0,0
216896,",",0,0
216897,corresponding,0,0
216898,to,0,0
216899,a,0,0
216900,risk,0,0
216901,reduction,0,0
216902,of,0,0
216903,34,0,0
216904,%,0,0
216905,(,0,0
216906,p,0,0
216907,<,0,0
216908,0.00001,0,0
216909,),0,0
216910,.,0,0
216911,This,0,0
216912,risk,0,0
216913,was,0,0
216914,also,0,0
216915,significantly,0,0
216916,reduced,0,0
216917,in,0,0
216918,subgroups,0,0
216919,consisting,0,0
216920,of,0,0
216921,women,0,0
216922,and,0,0
216923,patients,0,0
216924,of,0,0
216925,both,0,0
216926,sexes,0,0
216927,aged,0,0
216928,>,0,0
216929,or,0,0
216930,=,0,0
216931,60,0,0
216932,years,0,0
216933,.,0,0
216934,Other,0,0
216935,benefits,0,0
216936,of,0,0
216937,treatment,0,0
216938,included,0,0
216939,a,0,0
216940,37,0,0
216941,%,0,0
216942,reduction,0,0
216943,(,0,0
216944,p,0,0
216945,<,0,0
216946,0.00001,0,0
216947,),0,0
216948,in,0,0
216949,the,0,0
216950,risk,0,0
216951,of,0,0
216952,undergoing,0,0
216953,myocardial,0,0
216954,revascularization,0,0
216955,procedures,0,0
216956,.,0,0
216957,Simvastatin,0,1
216958,was,0,0
216959,beneficial,0,0
216960,regardless,0,0
216961,of,0,0
216962,whether,0,0
216963,patients,0,0
216964,had,0,0
216965,a,0,0
216966,history,0,0
216967,of,0,0
216968,myocardial,0,0
216969,infarction,0,0
216970,or,0,1
216971,whether,0,0
216972,they,0,0
216973,were,0,0
216974,smokers,0,0
216975,or,0,0
216976,had,0,0
216977,hypertension,0,0
216978,.,0,0
216979,(,0,0
216980,ABSTRACT,0,1
216981,TRUNCATED,0,1
216982,AT,0,1
216983,250,0,1
216984,WORDS,0,1
216985,),0,1
216986,Why,0,0
216987,are,0,0
216988,there,0,0
216989,sometimes,0,0
216990,concreteness,0,0
216991,effects,0,0
216992,in,0,0
216993,memory,0,0
216994,for,0,0
216995,prose,0,1
216996,?,0,0
216997,Four,0,0
216998,experiments,0,0
216999,explored,0,0
217000,on-line,0,1
217001,encoding,0,1
217002,strategies,0,0
217003,and,0,0
217004,memory,0,0
217005,for,0,0
217006,high,0,0
217007,imagery,0,1
217008,and,0,0
217009,low,0,0
217010,imagery,0,1
217011,texts,0,0
217012,.,0,0
217013,Results,0,0
217014,consistently,0,0
217015,indicated,0,0
217016,that,0,0
217017,concreteness,0,0
217018,effects,0,0
217019,in,0,0
217020,memory,0,0
217021,for,0,0
217022,text,0,1
217023,depend,0,0
217024,on,0,0
217025,how,0,0
217026,materials,0,0
217027,are,0,0
217028,presented,0,0
217029,in,0,0
217030,several,0,0
217031,different,0,0
217032,respects,0,0
217033,.,0,0
217034,Most,0,0
217035,importantly,0,0
217036,",",0,0
217037,the,0,0
217038,experiments,0,0
217039,clarified,0,0
217040,apparently,0,0
217041,contradictory,0,0
217042,results,0,0
217043,of,0,0
217044,previous,0,0
217045,studies,0,0
217046,by,0,0
217047,indicating,0,0
217048,that,0,0
217049,concreteness,0,0
217050,effects,0,0
217051,generally,0,0
217052,do,0,0
217053,not,0,0
217054,occur,0,0
217055,in,0,0
217056,memory,0,0
217057,for,0,0
217058,prose,0,1
217059,when,0,0
217060,imageability,0,0
217061,is,0,0
217062,manipulated,0,0
217063,between-subjects,0,0
217064,",",0,0
217065,and,0,0
217066,that,0,0
217067,their,0,0
217068,occurrence,0,0
217069,when,0,0
217070,imageability,0,0
217071,is,0,0
217072,manipulated,0,0
217073,within-subjects,0,0
217074,depends,0,0
217075,on,0,0
217076,the,0,0
217077,order,0,0
217078,occurrence,0,0
217079,when,0,0
217080,imageability,0,0
217081,is,0,0
217082,manipulated,0,0
217083,within-subjects,0,0
217084,depends,0,0
217085,on,0,0
217086,the,0,0
217087,order,0,0
217088,of,0,0
217089,presentation,0,0
217090,.,0,0
217091,In,0,0
217092,addition,0,0
217093,",",0,0
217094,moving,0,0
217095,window,0,0
217096,analyses,0,0
217097,of,0,0
217098,text,1,1
217099,processing,1,0
217100,strategies,1,0
217101,indicated,0,0
217102,that,0,0
217103,differential,0,0
217104,strategies,0,0
217105,observed,0,0
217106,in,0,0
217107,previous,0,0
217108,studies,0,0
217109,when,0,0
217110,subjects,0,0
217111,listened,0,0
217112,to,0,0
217113,high,0,0
217114,vs,0,0
217115,low,0,0
217116,imagery,0,1
217117,text,0,1
217118,do,0,0
217119,not,0,0
217120,generalize,0,0
217121,to,0,0
217122,reading,0,0
217123,of,0,0
217124,the,0,0
217125,same,0,0
217126,materials,0,0
217127,.,0,0
217128,Potential,0,0
217129,explanations,0,0
217130,for,0,0
217131,the,0,0
217132,pattern,0,0
217133,of,0,0
217134,results,0,0
217135,are,0,0
217136,evaluated,0,0
217137,",",0,0
217138,and,0,0
217139,implications,0,0
217140,for,0,0
217141,theories,0,0
217142,of,0,0
217143,mental,0,0
217144,imagery,0,1
217145,and,0,0
217146,memory,0,0
217147,are,0,0
217148,considered,0,0
217149,.,0,0
217150,Quantifying,0,0
217151,the,0,0
217152,extent,0,0
217153,of,0,0
217154,osteonecrosis,0,0
217155,of,0,0
217156,the,0,0
217157,femoral,0,1
217158,head,0,0
217159,.,0,0
217160,A,0,0
217161,new,0,0
217162,method,0,1
217163,using,0,0
217164,MRI,1,0
217165,.,1,0
217166,In,0,0
217167,a,0,0
217168,randomised,0,0
217169,trial,0,0
217170,comparing,0,0
217171,core,0,0
217172,decompression,0,1
217173,with,0,0
217174,conservative,0,1
217175,treatment,0,0
217176,we,0,0
217177,tested,0,0
217178,the,0,0
217179,hypothesis,0,0
217180,that,0,0
217181,the,0,0
217182,extent,0,0
217183,of,0,0
217184,necrosis,0,0
217185,at,0,0
217186,the,0,0
217187,initial,0,0
217188,MRI,1,1
217189,predicts,0,0
217190,the,0,0
217191,subsequent,0,0
217192,risk,0,0
217193,of,0,0
217194,collapse,0,0
217195,of,0,0
217196,the,0,0
217197,femoral,0,1
217198,head,0,0
217199,.,0,0
217200,After,0,0
217201,the,0,0
217202,initial,0,0
217203,clinical,0,0
217204,evaluation,0,0
217205,",",0,0
217206,including,0,0
217207,plain,1,1
217208,radiography,1,1
217209,and,0,0
217210,MRI,1,1
217211,",",0,0
217212,37,0,0
217213,hips,0,0
217214,with,0,0
217215,early-stage,0,0
217216,osteonecrosis,0,0
217217,(,0,1
217218,ON,0,1
217219,),0,1
217220,in,0,0
217221,33,0,0
217222,patients,0,0
217223,were,0,0
217224,randomly,0,0
217225,assigned,0,0
217226,to,0,0
217227,a,0,0
217228,core-decompression,1,1
217229,group,1,0
217230,or,1,1
217231,a,1,0
217232,conservatively-treated,1,0
217233,group,1,0
217234,.,1,0
217235,All,0,0
217236,were,0,0
217237,followed,0,0
217238,regularly,0,0
217239,by,0,0
217240,clinical,0,0
217241,evaluation,0,0
217242,",",0,0
217243,plain,1,1
217244,radiography,1,1
217245,and,0,0
217246,MRI,1,1
217247,at,0,0
217248,intervals,0,0
217249,of,0,0
217250,three,0,0
217251,months,0,0
217252,.,0,0
217253,The,0,0
217254,extent,0,0
217255,of,0,0
217256,ON,0,0
217257,was,0,0
217258,estimated,0,0
217259,on,0,0
217260,the,0,0
217261,basis,0,0
217262,of,0,0
217263,abnormal,0,0
217264,signal,0,0
217265,intensity,0,0
217266,in,0,0
217267,the,0,0
217268,weight-bearing,0,0
217269,portion,0,0
217270,of,0,0
217271,the,0,0
217272,femoral,0,1
217273,head,0,0
217274,as,0,0
217275,determined,0,0
217276,from,0,0
217277,a,0,0
217278,combination,0,1
217279,of,0,0
217280,coronal,0,0
217281,and,0,0
217282,sagittal,0,1
217283,MRIs,0,1
217284,.,0,0
217285,The,0,0
217286,arc,0,0
217287,of,0,0
217288,the,0,0
217289,necrotic,0,0
217290,portion,0,0
217291,in,0,0
217292,the,0,0
217293,mid-coronal,0,1
217294,image,0,1
217295,(,0,1
217296,A,0,0
217297,),0,1
217298,and,0,0
217299,that,0,0
217300,in,0,0
217301,the,0,0
217302,mid-sagittal,0,1
217303,image,0,1
217304,(,0,1
217305,B,0,1
217306,),0,1
217307,were,0,0
217308,used,0,0
217309,to,0,0
217310,quantify,0,0
217311,the,0,0
217312,extent,0,0
217313,of,0,0
217314,necrosis,0,0
217315,by,0,0
217316,the,0,0
217317,formula,0,1
217318,:,0,0
217319,(,0,0
217320,A/180,0,1
217321,),0,1
217322,x,0,0
217323,(,0,1
217324,B/180,0,1
217325,),0,1
217326,x,0,0
217327,100,0,0
217328,.,0,0
217329,There,0,0
217330,was,0,0
217331,a,0,0
217332,strong,0,0
217333,correlation,0,0
217334,between,0,0
217335,this,0,0
217336,index,0,0
217337,and,0,0
217338,the,0,0
217339,risk,0,0
217340,of,0,0
217341,collapse,0,0
217342,before,0,0
217343,and,0,0
217344,after,0,0
217345,adjustment,0,0
217346,for,0,0
217347,age,0,0
217348,",",0,0
217349,gender,0,0
217350,",",0,0
217351,stage,0,0
217352,and,0,0
217353,treatment,0,0
217354,group,0,0
217355,.,0,0
217356,We,0,0
217357,conclude,0,0
217358,that,0,0
217359,the,0,0
217360,extent,0,0
217361,of,0,0
217362,the,0,0
217363,necrotic,0,0
217364,portion,0,0
217365,ascertain,0,0
217366,by,0,0
217367,this,0,0
217368,method,0,1
217369,is,0,0
217370,a,0,0
217371,major,0,0
217372,predictor,0,0
217373,of,0,0
217374,future,0,0
217375,collapse,0,0
217376,.,0,0
217377,We,0,0
217378,propose,0,0
217379,a,0,0
217380,systematic,0,0
217381,method,0,1
217382,of,0,0
217383,determining,0,0
217384,the,0,0
217385,index,0,0
217386,of,0,0
217387,the,0,0
217388,necrotic,0,0
217389,portion,0,0
217390,which,0,0
217391,may,0,0
217392,be,0,0
217393,clinically,0,0
217394,useful,0,0
217395,in,0,0
217396,the,0,0
217397,management,0,1
217398,of,0,0
217399,early-stage,0,0
217400,ON,0,0
217401,of,0,0
217402,the,0,0
217403,femoral,0,1
217404,head,0,0
217405,.,0,0
217406,The,0,0
217407,efficacy,0,0
217408,of,0,0
217409,a,0,0
217410,herbal-based,1,1
217411,toothpaste,1,1
217412,on,0,0
217413,the,0,0
217414,control,0,0
217415,of,0,0
217416,plaque,0,0
217417,and,0,0
217418,gingivitis,0,0
217419,.,0,0
217420,A,0,0
217421,double-blind,0,0
217422,controlled,0,0
217423,clinical,0,0
217424,trial,0,0
217425,with,0,0
217426,parallel,0,0
217427,groups,0,0
217428,was,0,0
217429,designed,0,0
217430,to,0,0
217431,investigate,0,0
217432,the,0,0
217433,effectiveness,0,0
217434,of,0,0
217435,a,0,0
217436,herbal-based,1,1
217437,toothpaste,1,1
217438,in,0,0
217439,the,0,0
217440,control,0,0
217441,of,0,0
217442,plaque,0,0
217443,and,0,0
217444,gingivitis,0,0
217445,as,0,0
217446,compared,0,0
217447,with,0,0
217448,a,0,0
217449,conventional,1,1
217450,dentifrice,1,1
217451,.,1,0
217452,70,0,0
217453,subjects,0,0
217454,with,0,0
217455,gingivitis,0,0
217456,completed,0,0
217457,the,0,0
217458,6-week,0,0
217459,study,0,0
217460,.,0,0
217461,All,0,0
217462,participants,0,0
217463,had,0,0
217464,at,0,0
217465,least,0,0
217466,20,0,0
217467,natural,0,0
217468,teeth,0,0
217469,with,0,0
217470,no,0,0
217471,probing,0,0
217472,depths,0,0
217473,greater,0,0
217474,than,0,0
217475,3,0,0
217476,mm,0,0
217477,and,0,0
217478,a,0,0
217479,plaque,0,0
217480,index,0,0
217481,of,0,0
217482,2,0,0
217483,or,0,0
217484,more,0,0
217485,at,0,0
217486,baseline,0,0
217487,.,0,0
217488,At,0,0
217489,baseline,0,0
217490,",",0,0
217491,both,0,0
217492,groups,0,0
217493,were,0,0
217494,balanced,0,0
217495,for,0,0
217496,the,0,0
217497,parameters,0,0
217498,measured,0,0
217499,:,0,0
217500,plaque,0,0
217501,index,0,0
217502,",",0,0
217503,plaque,0,0
217504,vitality,0,0
217505,",",0,0
217506,gingival,0,0
217507,index,0,0
217508,",",0,0
217509,bleeding,0,0
217510,on,0,0
217511,probing,0,0
217512,and,0,0
217513,gingival,0,1
217514,crevicular,0,0
217515,fluid,0,1
217516,flow,0,0
217517,.,0,0
217518,At,0,0
217519,the,0,0
217520,end,0,0
217521,of,0,0
217522,the,0,0
217523,trial,0,0
217524,",",0,0
217525,there,0,0
217526,were,0,0
217527,reductions,0,0
217528,within,0,0
217529,both,0,0
217530,groups,0,0
217531,",",0,0
217532,however,0,0
217533,",",0,0
217534,there,0,0
217535,were,0,0
217536,no,0,0
217537,significant,0,0
217538,differences,0,0
217539,between,0,0
217540,the,0,0
217541,groups,0,0
217542,.,0,0
217543,It,0,0
217544,was,0,0
217545,concluded,0,0
217546,that,0,0
217547,the,0,0
217548,herbal,1,1
217549,based,1,0
217550,toothpaste,1,1
217551,was,0,0
217552,as,0,0
217553,effective,0,0
217554,as,0,0
217555,the,0,0
217556,conventionally,1,0
217557,formulated,1,0
217558,dentifrice,1,1
217559,in,0,0
217560,the,0,0
217561,control,0,0
217562,of,0,0
217563,plaque,0,0
217564,and,0,0
217565,gingivitis,0,0
217566,.,0,0
217567,Angiotensin-converting,1,1
217568,enzyme,1,1
217569,inhibition,1,0
217570,does,0,0
217571,not,0,0
217572,suppress,0,0
217573,plasma,0,0
217574,angiotensin,0,1
217575,II,0,1
217576,increase,0,0
217577,during,0,0
217578,exercise,0,1
217579,in,0,0
217580,humans,0,0
217581,.,0,0
217582,Physical,0,0
217583,effort,0,0
217584,stimulates,0,0
217585,the,0,0
217586,reninangiotensin,0,1
217587,system,0,1
217588,(,0,1
217589,RAS,0,1
217590,),0,0
217591,.,0,0
217592,We,0,0
217593,studied,0,0
217594,the,0,0
217595,effect,0,0
217596,of,0,0
217597,an,0,0
217598,angiotensin-converting,1,1
217599,enzyme,1,1
217600,inhibitor,1,1
217601,(,1,1
217602,ACE,1,0
217603,inhibitor,1,1
217604,),1,0
217605,in,0,0
217606,a,0,0
217607,double-blind,0,0
217608,placebo-controlled,0,1
217609,study,0,0
217610,",",0,0
217611,on,0,0
217612,eight,0,0
217613,volunteers,0,0
217614,undergoing,0,0
217615,physical,0,1
217616,stress,0,0
217617,on,0,0
217618,an,0,0
217619,ergometric,0,1
217620,bicycle,0,1
217621,.,0,0
217622,The,0,0
217623,effects,0,0
217624,of,0,0
217625,captopril,1,1
217626,(,0,1
217627,C,0,1
217628,),0,1
217629,(,0,0
217630,50,0,1
217631,mg,0,1
217632,",",0,0
217633,three,0,0
217634,times,0,0
217635,daily,0,0
217636,for,0,0
217637,3,0,0
217638,days,0,0
217639,),0,0
217640,on,0,0
217641,arterial,0,1
217642,pressure,0,0
217643,(,0,1
217644,AP,0,1
217645,),0,0
217646,",",0,0
217647,O2,0,1
217648,consumption,0,1
217649,(,0,1
217650,VO2,0,1
217651,),0,0
217652,",",0,0
217653,variations,0,0
217654,in,0,0
217655,auricular,0,0
217656,natriuretic,0,1
217657,factor,0,1
217658,(,0,1
217659,ANF,0,1
217660,),0,1
217661,",",0,0
217662,renin,0,0
217663,",",0,0
217664,angiotensin,0,1
217665,II,0,1
217666,(,0,1
217667,AII,0,1
217668,),0,1
217669,plasma,0,0
217670,levels,0,0
217671,",",0,0
217672,as,0,0
217673,well,0,0
217674,as,0,0
217675,glomerular,0,0
217676,filtration,0,1
217677,rate,0,0
217678,(,0,1
217679,GFR,0,1
217680,),0,1
217681,and,0,0
217682,microalbuminuria,0,0
217683,(,0,1
217684,MA,0,0
217685,),0,1
217686,were,0,0
217687,evaluated,0,0
217688,.,0,0
217689,The,0,0
217690,different,0,0
217691,parameters,0,0
217692,were,0,0
217693,compared,0,0
217694,by,0,0
217695,analysis,0,0
217696,of,0,0
217697,variance,0,0
217698,(,0,1
217699,ANOVA,0,1
217700,),0,0
217701,.,0,0
217702,The,0,0
217703,pressure,0,0
217704,profile,0,0
217705,and,0,0
217706,VO2,0,1
217707,were,0,0
217708,not,0,0
217709,modified,0,0
217710,by,0,0
217711,ACE,1,0
217712,inhibitor,1,1
217713,.,1,0
217714,Exercise,0,1
217715,stimulates,0,0
217716,release,0,0
217717,of,0,0
217718,renin,0,0
217719,;,0,0
217720,this,0,0
217721,action,0,0
217722,was,0,0
217723,greater,0,0
217724,with,0,0
217725,captopril,1,1
217726,administration,0,0
217727,(,0,1
217728,treatment,0,1
217729,effect,0,0
217730,:,0,0
217731,p,0,0
217732,<,0,0
217733,10,0,0
217734,(,0,0
217735,-4,0,0
217736,),0,1
217737,",",0,0
217738,indicating,0,0
217739,blockade,0,1
217740,of,0,0
217741,the,0,0
217742,RAS,0,0
217743,.,0,0
217744,This,0,0
217745,inhibition,0,0
217746,was,0,0
217747,incomplete,0,0
217748,because,0,0
217749,AII,0,1
217750,levels,0,0
217751,increased,0,0
217752,markedly,0,0
217753,when,0,0
217754,captopril,1,1
217755,was,0,0
217756,given,0,0
217757,(,0,0
217758,no,0,0
217759,treatment,0,1
217760,effect,0,0
217761,:,0,0
217762,p,0,0
217763,<,0,0
217764,0.37,0,0
217765,),0,0
217766,.,0,0
217767,Finally,0,0
217768,",",0,0
217769,ACE,1,0
217770,inhibitor,1,1
217771,resulted,0,0
217772,in,0,0
217773,decreased,0,0
217774,GFR,0,1
217775,(,0,0
217776,p,0,0
217777,=,0,0
217778,115,0,0
217779,+/-,0,0
217780,5.8,0,0
217781,ml/mn-1,0,0
217782,",",0,0
217783,C,0,0
217784,=,0,0
217785,91.1,0,0
217786,+/-,0,0
217787,4,0,0
217788,",",0,0
217789,p,0,0
217790,<,0,0
217791,0.05,0,0
217792,),0,0
217793,with,0,0
217794,exercise,0,1
217795,without,0,1
217796,modification,0,1
217797,of,0,0
217798,MA,0,0
217799,.,0,0
217800,ACE,1,0
217801,inhibitor,1,1
217802,administration,1,0
217803,does,0,0
217804,not,0,0
217805,modify,0,0
217806,the,0,0
217807,physical,0,1
217808,performance,0,0
217809,of,0,0
217810,nonathletic,0,0
217811,subjects,0,0
217812,;,0,0
217813,AII,0,1
217814,is,0,0
217815,significantly,0,0
217816,increased,0,0
217817,with,0,0
217818,exercise,0,1
217819,despite,0,0
217820,captopril,0,1
217821,treatment,0,0
217822,;,0,0
217823,ACE,1,0
217824,inhibitor,1,1
217825,decreases,0,0
217826,GFR,0,0
217827,significantly,0,0
217828,but,0,0
217829,does,0,0
217830,not,0,0
217831,influence,0,0
217832,MA,0,0
217833,with,0,0
217834,prolonged,0,0
217835,physical,0,1
217836,effort,0,0
217837,.,0,0
217838,[,0,0
217839,Late,0,0
217840,cardiac,0,0
217841,toxicity,0,0
217842,in,0,0
217843,Hodgkin,0,0
217844,'s,0,0
217845,disease,0,0
217846,.,0,0
217847,A,0,0
217848,study,0,0
217849,with,0,0
217850,pulsed,1,1
217851,Doppler,1,1
217852,echocardiography,1,0
217853,],1,0
217854,.,0,0
217855,49,0,0
217856,patients,0,0
217857,(,0,0
217858,22,0,0
217859,women,0,0
217860,",",0,0
217861,27,0,0
217862,men,0,0
217863,",",0,0
217864,mean,0,0
217865,age,0,0
217866,43.7,0,0
217867,[,0,0
217868,21-65,0,0
217869,],0,1
217870,years,0,0
217871,),0,0
217872,with,0,0
217873,Hodgkin,0,0
217874,'s,0,0
217875,disease,0,0
217876,were,0,0
217877,examined,0,0
217878,by,0,0
217879,Doppler,1,1
217880,echocardiography,1,0
217881,a,0,0
217882,median,0,0
217883,of,0,0
217884,5.37,0,0
217885,(,0,0
217886,2-10,0,0
217887,),0,0
217888,years,0,0
217889,after,0,0
217890,the,0,0
217891,end,0,0
217892,of,0,0
217893,chemotherapy,0,1
217894,(,0,1
217895,given,0,0
217896,according,0,0
217897,to,0,0
217898,the,0,0
217899,COPP/ABVD,0,0
217900,scheme,0,1
217901,",",0,0
217902,with,0,0
217903,or,0,1
217904,without,0,1
217905,mediastinal,1,0
217906,irradiation,1,1
217907,),1,0
217908,for,0,0
217909,possible,0,0
217910,chronic,0,0
217911,changes,0,0
217912,in,0,0
217913,myocardium,0,0
217914,",",0,0
217915,pericardium,0,0
217916,or,0,1
217917,cardiac,0,0
217918,valves,0,0
217919,",",0,0
217920,as,0,0
217921,well,0,0
217922,as,0,0
217923,for,0,0
217924,any,0,0
217925,haemodynamic,0,0
217926,sequelae,0,0
217927,.,0,1
217928,Maximal,0,0
217929,and,0,0
217930,integrated,0,1
217931,early,0,0
217932,(,0,0
217933,E,0,1
217934,",",0,0
217935,Ei,0,1
217936,),0,1
217937,and,0,0
217938,late,0,0
217939,(,0,0
217940,A,0,0
217941,",",0,0
217942,Ai,0,0
217943,),0,1
217944,diastolic,0,0
217945,flow,0,0
217946,velocities,0,0
217947,and,0,0
217948,their,0,0
217949,ratio,0,0
217950,(,0,0
217951,E/A,0,1
217952,",",0,0
217953,Ei/Ai,0,0
217954,),0,0
217955,were,0,0
217956,measured,0,0
217957,by,0,0
217958,pulsed,1,1
217959,Doppler,1,1
217960,over,0,0
217961,the,0,0
217962,mitral,0,0
217963,and,0,0
217964,tricuspid,0,0
217965,valves,0,0
217966,.,0,0
217967,Although,0,0
217968,on,0,0
217969,two-dimensional,0,0
217970,echo,0,1
217971,21,0,0
217972,patients,0,0
217973,(,0,0
217974,42.9,0,0
217975,%,0,0
217976,),0,0
217977,were,0,0
217978,found,0,0
217979,to,0,0
217980,have,0,0
217981,valvar,0,0
217982,thickening,0,0
217983,",",0,0
217984,19,0,0
217985,(,0,0
217986,38.8,0,0
217987,%,0,0
217988,),0,1
217989,pericardial,0,0
217990,thickening,0,0
217991,and,0,0
217992,9,0,0
217993,(,0,0
217994,18.4,0,0
217995,%,0,0
217996,),0,0
217997,a,0,0
217998,reduced,0,0
217999,fibre,0,1
218000,shortening,0,0
218001,fraction,0,0
218002,",",0,0
218003,the,0,0
218004,Doppler,0,1
218005,indices,0,0
218006,were,0,0
218007,statistically,0,0
218008,not,0,0
218009,significantly,0,0
218010,different,0,0
218011,from,0,0
218012,those,0,0
218013,in,0,0
218014,25,0,0
218015,controls,0,0
218016,with,0,0
218017,normal,0,0
218018,hearts,0,0
218019,.,0,0
218020,These,0,0
218021,echocardiographic,0,0
218022,data,0,0
218023,of,0,0
218024,functional,0,0
218025,and,0,0
218026,morphological,0,0
218027,parameters,0,0
218028,indicate,0,0
218029,that,0,0
218030,there,0,0
218031,was,0,0
218032,no,0,0
218033,effect,0,0
218034,on,0,0
218035,various,0,0
218036,measurements,0,0
218037,of,0,0
218038,diastolic,0,0
218039,function,0,0
218040,after,0,0
218041,chemotherapy,0,1
218042,with,0,0
218043,or,0,1
218044,without,0,1
218045,mediastinal,0,0
218046,radiation,0,1
218047,.,0,0
218048,In,0,0
218049,successfully,0,0
218050,treated,0,0
218051,patients,0,0
218052,with,0,0
218053,Hodgkin,0,0
218054,'s,0,0
218055,disease,0,0
218056,the,0,0
218057,described,0,0
218058,changes,0,0
218059,are,0,0
218060,of,0,0
218061,minor,0,0
218062,significance,0,0
218063,.,0,0
218064,Early,1,1
218065,educational,1,1
218066,intervention,1,1
218067,for,0,0
218068,very,0,0
218069,low,0,0
218070,birth,0,0
218071,weight,0,0
218072,infants,0,0
218073,:,0,0
218074,results,0,0
218075,from,0,0
218076,the,0,0
218077,Infant,1,0
218078,Health,1,1
218079,and,1,0
218080,Development,1,0
218081,Program,1,1
218082,.,1,0
218083,OBJECTIVE,0,0
218084,To,0,0
218085,examine,0,0
218086,the,0,0
218087,effect,0,0
218088,of,0,0
218089,early,1,0
218090,educational,1,1
218091,intervention,1,1
218092,after,0,0
218093,discharge,0,0
218094,from,0,0
218095,the,0,0
218096,hospital,0,0
218097,on,0,0
218098,the,0,0
218099,health,0,0
218100,and,0,0
218101,developmental,0,0
218102,status,0,0
218103,of,0,0
218104,very,0,0
218105,low,0,0
218106,birth,0,0
218107,weight,0,0
218108,(,0,0
218109,<,0,0
218110,or,0,1
218111,=,0,0
218112,1500,0,0
218113,gm,0,1
218114,),0,0
218115,infants,0,0
218116,.,0,0
218117,DESIGN,0,0
218118,Randomized,0,0
218119,",",0,0
218120,controlled,0,0
218121,trial,0,0
218122,",",0,0
218123,with,0,0
218124,post,0,0
218125,hoc,0,0
218126,analysis,0,0
218127,.,0,0
218128,SETTING,0,0
218129,Eight,0,0
218130,sites,0,0
218131,",",0,0
218132,heterogeneous,0,0
218133,for,0,0
218134,sociodemographic,0,0
218135,and,0,0
218136,health,0,0
218137,care,0,1
218138,use,0,0
218139,.,0,0
218140,PARTICIPANTS,0,0
218141,Infants,0,0
218142,(,0,0
218143,N,0,0
218144,=,0,0
218145,280,0,0
218146,),0,0
218147,born,0,0
218148,weighing,0,0
218149,<,0,0
218150,or,0,1
218151,=,0,0
218152,1500,0,1
218153,gm,0,1
218154,and,0,0
218155,selected,0,0
218156,for,0,0
218157,the,0,0
218158,Infant,0,0
218159,Health,0,1
218160,and,0,0
218161,Development,0,0
218162,Program,0,1
218163,.,0,0
218164,Eligibility,0,0
218165,was,0,0
218166,limited,0,0
218167,primarily,0,0
218168,by,0,0
218169,geographic,0,0
218170,distance,0,0
218171,from,0,0
218172,the,0,0
218173,day,0,1
218174,care,0,1
218175,center,0,0
218176,.,0,0
218177,One,0,0
218178,third,0,0
218179,were,0,0
218180,randomly,0,0
218181,assigned,0,0
218182,to,0,0
218183,the,0,0
218184,intervention,0,1
218185,(,0,1
218186,INT,0,1
218187,),0,1
218188,group,0,0
218189,and,0,0
218190,two,0,0
218191,thirds,0,0
218192,to,0,0
218193,follow-up,1,0
218194,only,1,0
218195,.,1,0
218196,INTERVENTIONS,0,0
218197,All,0,0
218198,children,0,0
218199,received,0,0
218200,intensive,1,0
218201,pediatric,1,0
218202,and,1,0
218203,developmental,1,0
218204,surveillance,1,0
218205,.,1,0
218206,The,0,0
218207,INT,0,1
218208,group,0,0
218209,received,1,1
218210,home,1,1
218211,visits,1,0
218212,and,1,0
218213,center-based,1,1
218214,educational,1,1
218215,interventions,1,1
218216,until,0,0
218217,36,0,0
218218,months,0,0
218219,of,0,0
218220,age,0,0
218221,(,0,0
218222,corrected,0,0
218223,for,0,0
218224,gestational,0,0
218225,age,0,0
218226,when,0,0
218227,final,0,0
218228,assessments,0,0
218229,were,0,0
218230,completed,0,0
218231,),0,0
218232,.,0,0
218233,OUTCOMES,0,0
218234,Cognitive,0,1
218235,development,0,0
218236,(,0,0
218237,Stanford-Binet,0,1
218238,Intelligence,0,1
218239,Scale,0,1
218240,),0,0
218241,",",0,0
218242,behavioral,0,1
218243,competence,0,0
218244,(,0,0
218245,Achebach,0,1
218246,Child,0,0
218247,Behavior,0,0
218248,Checklist,0,1
218249,),0,0
218250,",",0,0
218251,and,0,0
218252,health,0,1
218253,status,0,0
218254,(,0,0
218255,indexes,0,0
218256,summarizing,0,0
218257,reported,0,0
218258,morbidity,0,0
218259,",",0,0
218260,the,0,0
218261,Functional,0,0
218262,Status,0,1
218263,II,0,1
218264,(,0,1
218265,R,0,1
218266,),0,1
218267,Scale,0,1
218268,",",0,0
218269,and,0,0
218270,General,0,1
218271,Health,0,1
218272,Ratings,0,0
218273,Index,0,1
218274,),0,0
218275,.,0,0
218276,RESULTS,0,0
218277,Cognitive,0,1
218278,development,0,0
218279,scores,0,0
218280,were,0,0
218281,7.2,0,0
218282,points,0,0
218283,higher,0,0
218284,(,0,0
218285,p,0,0
218286,=,0,0
218287,0.002,0,0
218288,),0,0
218289,in,0,0
218290,the,0,0
218291,INT,0,1
218292,group,0,0
218293,",",0,0
218294,after,0,0
218295,adjustment,0,0
218296,for,0,0
218297,baseline,0,0
218298,differences,0,0
218299,in,0,0
218300,site,0,0
218301,",",0,0
218302,sociodemographic,0,0
218303,characteristics,0,0
218304,",",0,0
218305,and,0,0
218306,neonatal,0,0
218307,morbidity,0,0
218308,",",0,0
218309,and,0,0
218310,were,0,0
218311,9.4,0,0
218312,points,0,0
218313,higher,0,0
218314,(,0,0
218315,p,0,0
218316,<,0,0
218317,0.0003,0,0
218318,),0,0
218319,when,0,0
218320,the,0,0
218321,29,0,0
218322,children,0,0
218323,with,0,0
218324,significant,0,0
218325,cerebral,0,0
218326,palsy,0,0
218327,were,0,0
218328,removed,0,0
218329,.,0,0
218330,No,0,0
218331,differences,0,0
218332,in,0,0
218333,behavior,0,0
218334,",",0,0
218335,serious,0,0
218336,morbidity,0,0
218337,",",0,0
218338,functional,0,0
218339,status,0,0
218340,",",0,0
218341,or,0,1
218342,health,0,0
218343,rating,0,0
218344,were,0,0
218345,found,0,0
218346,overall,0,0
218347,.,0,0
218348,The,0,0
218349,infants,0,0
218350,in,0,0
218351,the,0,0
218352,INT,0,1
218353,group,0,0
218354,who,0,0
218355,weighted,0,1
218356,<,0,0
218357,or,0,1
218358,=,0,0
218359,1000,0,0
218360,gm,0,1
218361,at,0,0
218362,birth,0,0
218363,had,0,0
218364,significantly,0,0
218365,lower,0,0
218366,behavior,0,0
218367,problem,0,0
218368,scores,0,0
218369,but,0,0
218370,no,0,0
218371,differences,0,0
218372,on,0,0
218373,other,0,0
218374,outcomes,0,0
218375,.,0,0
218376,All,0,0
218377,children,0,0
218378,in,0,0
218379,the,0,0
218380,INT,0,1
218381,group,0,0
218382,had,0,0
218383,slightly,0,0
218384,higher,0,0
218385,rates,0,0
218386,of,0,0
218387,less,0,0
218388,serious,0,0
218389,morbidity,0,0
218390,.,0,0
218391,CONCLUSION,0,0
218392,The,0,0
218393,advantage,0,0
218394,conferred,0,0
218395,by,0,0
218396,being,0,0
218397,in,0,0
218398,the,0,0
218399,INT,0,1
218400,group,0,0
218401,",",0,0
218402,as,0,0
218403,previously,0,0
218404,reported,0,0
218405,for,0,0
218406,heavier,0,0
218407,infants,0,0
218408,",",0,0
218409,extends,0,0
218410,to,0,0
218411,very,0,0
218412,low,0,0
218413,birth,0,0
218414,weight,0,0
218415,children,0,0
218416,",",0,0
218417,supporting,0,0
218418,the,0,0
218419,use,0,0
218420,of,0,0
218421,early,0,0
218422,intervention,0,1
218423,in,0,0
218424,this,0,0
218425,group,0,0
218426,.,0,0
218427,Prophylactic,1,1
218428,cranial,1,1
218429,irradiation,1,1
218430,for,0,0
218431,patients,0,0
218432,with,0,0
218433,small-cell,0,0
218434,lung,0,0
218435,cancer,0,0
218436,in,0,0
218437,complete,0,0
218438,remission,0,0
218439,.,0,0
218440,BACKGROUND,0,0
218441,Prophylactic,1,1
218442,cranial,1,1
218443,irradiation,1,1
218444,in,0,0
218445,patients,0,0
218446,with,0,0
218447,small-cell,0,0
218448,lung,0,0
218449,cancer,0,0
218450,decreases,0,0
218451,the,0,0
218452,overall,0,0
218453,rate,0,0
218454,of,0,0
218455,brain,0,0
218456,metastases,0,0
218457,without,0,0
218458,an,0,0
218459,effect,0,0
218460,on,0,0
218461,overall,0,0
218462,survival,0,0
218463,.,0,0
218464,It,0,0
218465,has,0,0
218466,been,0,0
218467,suggested,0,0
218468,that,0,0
218469,this,0,0
218470,treatment,0,0
218471,may,0,0
218472,increase,0,0
218473,neuropsychological,0,0
218474,syndromes,0,0
218475,and,0,0
218476,brain,0,0
218477,abnormalities,0,0
218478,indicated,0,0
218479,by,0,0
218480,computed,0,0
218481,tomography,0,1
218482,scans,0,0
218483,.,0,0
218484,However,0,0
218485,",",0,0
218486,other,0,0
218487,retrospective,0,0
218488,data,0,0
218489,suggested,0,0
218490,a,0,0
218491,beneficial,0,0
218492,effect,0,0
218493,on,0,0
218494,overall,0,0
218495,survival,0,0
218496,for,0,0
218497,patients,0,0
218498,in,0,0
218499,complete,0,0
218500,remission,0,0
218501,.,0,0
218502,PURPOSE,0,0
218503,Our,0,0
218504,purpose,0,0
218505,was,0,0
218506,to,0,0
218507,evaluate,0,0
218508,the,0,0
218509,effects,0,0
218510,of,0,0
218511,prophylactic,1,1
218512,cranial,1,1
218513,irradiation,1,1
218514,on,0,0
218515,brain,0,0
218516,metastasis,0,0
218517,",",0,0
218518,overall,0,0
218519,survival,0,0
218520,",",0,0
218521,and,0,0
218522,late-occurring,0,0
218523,toxic,0,0
218524,effects,0,0
218525,in,0,0
218526,patients,0,0
218527,with,0,0
218528,small-cell,0,0
218529,lung,0,0
218530,cancer,0,0
218531,in,0,0
218532,complete,0,0
218533,remission,0,0
218534,.,0,0
218535,METHODS,0,0
218536,We,0,0
218537,conducted,0,0
218538,a,0,0
218539,prospective,0,0
218540,study,0,0
218541,of,0,0
218542,300,0,1
218543,patients,0,0
218544,who,0,0
218545,had,0,0
218546,small-cell,0,0
218547,lung,0,0
218548,cancer,0,0
218549,that,0,0
218550,was,0,0
218551,in,0,0
218552,complete,0,0
218553,remission,0,0
218554,.,0,0
218555,The,0,0
218556,patients,0,0
218557,were,0,0
218558,randomly,0,0
218559,assigned,0,0
218560,to,0,0
218561,receive,0,0
218562,either,0,0
218563,prophylactic,1,1
218564,cranial,1,1
218565,irradiation,1,1
218566,delivering,0,1
218567,24,0,0
218568,Gy,0,1
218569,in,0,0
218570,eight,0,0
218571,fractions,0,1
218572,during,0,0
218573,12,0,0
218574,days,0,0
218575,(,0,0
218576,treatment,0,1
218577,group,0,1
218578,),0,1
218579,or,0,1
218580,no,1,0
218581,prophylactic,1,1
218582,cranial,1,1
218583,irradiation,1,1
218584,(,1,0
218585,control,1,1
218586,group,1,0
218587,),1,0
218588,.,1,0
218589,A,0,0
218590,neuropsychological,0,0
218591,examination,0,0
218592,and,0,0
218593,a,0,0
218594,computed,0,1
218595,tomography,0,1
218596,scan,0,1
218597,of,0,0
218598,the,0,0
218599,brain,0,0
218600,were,0,0
218601,performed,0,0
218602,at,0,0
218603,the,0,0
218604,time,0,0
218605,of,0,0
218606,random,0,0
218607,assignment,0,0
218608,and,0,0
218609,repeatedly,0,0
218610,assessed,0,0
218611,at,0,0
218612,6,0,0
218613,",",0,0
218614,18,0,0
218615,",",0,0
218616,30,0,0
218617,",",0,0
218618,and,0,0
218619,48,0,0
218620,months,0,0
218621,.,0,0
218622,Patterns,0,0
218623,of,0,0
218624,failure,0,0
218625,were,0,0
218626,analyzed,0,0
218627,according,0,0
218628,to,0,0
218629,total,0,0
218630,event,0,0
218631,rates,0,0
218632,and,0,0
218633,also,0,0
218634,according,0,0
218635,to,0,0
218636,an,0,0
218637,isolated,0,0
218638,first,0,0
218639,site,0,0
218640,of,0,0
218641,relapse,0,0
218642,",",0,0
218643,using,0,0
218644,a,0,0
218645,competing-risk,0,0
218646,approach,0,1
218647,.,0,0
218648,RESULTS,0,0
218649,Two,0,0
218650,hundred,0,0
218651,ninety-four,0,0
218652,patients,0,0
218653,who,0,0
218654,did,0,0
218655,not,0,0
218656,have,0,0
218657,brain,0,0
218658,metastases,0,0
218659,at,0,0
218660,the,0,0
218661,time,0,0
218662,of,0,0
218663,random,0,0
218664,assignment,0,0
218665,were,0,0
218666,analyzed,0,0
218667,.,0,0
218668,The,0,0
218669,2-year,0,0
218670,cumulative,0,0
218671,rate,0,0
218672,of,0,0
218673,brain,0,0
218674,metastasis,0,0
218675,as,0,0
218676,an,0,0
218677,isolated,0,0
218678,first,0,0
218679,site,0,0
218680,of,0,0
218681,relapse,0,0
218682,was,0,0
218683,45,0,0
218684,%,0,0
218685,in,0,0
218686,the,0,0
218687,control,0,1
218688,group,0,0
218689,and,0,0
218690,19,0,0
218691,%,0,0
218692,in,0,0
218693,the,0,0
218694,treatment,0,1
218695,group,0,0
218696,(,0,0
218697,P,0,0
218698,<,0,0
218699,10,0,0
218700,(,0,0
218701,-6,0,0
218702,),0,1
218703,),0,0
218704,.,0,0
218705,The,0,0
218706,total,0,0
218707,2-year,0,0
218708,rate,0,0
218709,of,0,0
218710,brain,0,0
218711,metastasis,0,0
218712,was,0,0
218713,67,0,0
218714,%,0,0
218715,and,0,0
218716,40,0,1
218717,%,0,0
218718,",",0,0
218719,respectively,0,0
218720,(,0,0
218721,relative,0,0
218722,risk,0,0
218723,=,0,0
218724,0.35,0,0
218725,;,0,0
218726,P,0,0
218727,<,0,0
218728,10,0,0
218729,(,0,0
218730,-13,0,1
218731,),0,1
218732,),0,0
218733,.,0,0
218734,The,0,0
218735,2-year,0,0
218736,overall,0,0
218737,survival,0,0
218738,rate,0,0
218739,was,0,0
218740,21.5,0,0
218741,%,0,0
218742,in,0,0
218743,the,0,0
218744,control,0,1
218745,group,0,0
218746,and,0,0
218747,29,0,0
218748,%,0,0
218749,in,0,0
218750,the,0,0
218751,treatment,0,1
218752,group,0,0
218753,(,0,1
218754,relative,0,0
218755,risk,0,0
218756,=,0,0
218757,0.83,0,0
218758,;,0,0
218759,P,0,0
218760,=,0,0
218761,.14,0,0
218762,),0,0
218763,.,0,0
218764,There,0,0
218765,were,0,0
218766,no,0,0
218767,significant,0,0
218768,differences,0,0
218769,between,0,0
218770,the,0,0
218771,two,0,0
218772,groups,0,0
218773,in,0,0
218774,terms,0,0
218775,of,0,0
218776,neuropsychological,0,0
218777,function,0,0
218778,or,0,1
218779,abnormalities,0,0
218780,indicated,0,0
218781,by,0,0
218782,computed,0,0
218783,tomography,0,1
218784,brain,0,0
218785,scans,0,0
218786,.,0,0
218787,CONCLUSIONS,0,0
218788,Prophylactic,1,1
218789,cranial,1,1
218790,irradiation,1,1
218791,given,0,0
218792,to,0,0
218793,patients,0,0
218794,with,0,0
218795,small-cell,0,0
218796,lung,0,0
218797,cancer,0,0
218798,in,0,0
218799,complete,0,0
218800,remission,0,0
218801,decreases,0,0
218802,the,0,0
218803,risk,0,0
218804,of,0,0
218805,brain,0,0
218806,metastasis,0,0
218807,threefold,0,0
218808,without,0,0
218809,a,0,0
218810,significant,0,0
218811,increase,0,0
218812,in,0,0
218813,complications,0,0
218814,.,0,0
218815,A,0,0
218816,possible,0,0
218817,beneficial,0,0
218818,effect,0,0
218819,on,0,0
218820,overall,0,0
218821,survival,0,0
218822,should,0,0
218823,be,0,0
218824,tested,0,0
218825,with,0,0
218826,a,0,0
218827,higher,0,0
218828,statistical,0,0
218829,power,0,0
218830,.,0,0
218831,IMPLICATIONS,0,0
218832,The,0,0
218833,results,0,0
218834,of,0,0
218835,the,0,0
218836,trial,0,0
218837,favor,0,0
218838,",",0,0
218839,at,0,0
218840,present,0,0
218841,",",0,0
218842,the,0,0
218843,indication,0,0
218844,of,0,0
218845,prophylactic,0,1
218846,cranial,0,1
218847,irradiation,0,1
218848,for,0,0
218849,patients,0,0
218850,who,0,0
218851,are,0,0
218852,in,0,0
218853,complete,0,0
218854,remission,0,0
218855,.,0,0
218856,A,0,0
218857,longer,0,0
218858,follow-up,0,0
218859,and,0,0
218860,confirmatory,0,0
218861,trials,0,0
218862,are,0,0
218863,needed,0,0
218864,to,0,0
218865,fully,0,0
218866,assess,0,0
218867,late-occurring,0,0
218868,toxic,0,0
218869,effects,0,0
218870,.,0,0
218871,The,0,0
218872,possible,0,0
218873,effect,0,0
218874,on,0,0
218875,overall,0,0
218876,survival,0,0
218877,needs,0,0
218878,to,0,0
218879,be,0,0
218880,evaluated,0,0
218881,with,0,0
218882,a,0,0
218883,larger,0,0
218884,number,0,0
218885,of,0,0
218886,patients,0,0
218887,in,0,0
218888,complete,0,0
218889,remission,0,0
218890,",",0,0
218891,and,0,0
218892,a,0,0
218893,meta-analysis,0,0
218894,of,0,0
218895,similar,0,0
218896,trials,0,0
218897,is,0,0
218898,recommended,0,0
218899,.,0,0
218900,[,0,0
218901,The,0,0
218902,value,0,0
218903,of,0,0
218904,local,1,1
218905,administration,1,0
218906,of,1,0
218907,antibiotics,1,1
218908,in,0,0
218909,treatment,0,0
218910,of,0,0
218911,bone,0,0
218912,infections,0,0
218913,],0,0
218914,.,0,0
218915,An,0,0
218916,open,0,0
218917,",",0,0
218918,controlled,0,0
218919,",",0,0
218920,randomized,0,0
218921,clinical,0,0
218922,investigation,0,0
218923,was,0,0
218924,carried,0,0
218925,out,0,0
218926,in,0,0
218927,33,0,0
218928,patients,0,0
218929,suffering,0,0
218930,from,0,0
218931,osteomyelitis,0,0
218932,.,0,0
218933,In,0,0
218934,the,0,0
218935,first,0,0
218936,group,0,0
218937,",",0,0
218938,17,0,0
218939,patients,0,0
218940,",",0,0
218941,a,0,0
218942,through,0,0
218943,drainage,0,1
218944,with,0,0
218945,sterile,1,1
218946,physiologic,1,0
218947,solution,1,1
218948,was,0,0
218949,applied,0,0
218950,",",0,0
218951,while,0,0
218952,in,0,0
218953,the,0,0
218954,second,0,0
218955,group,0,0
218956,",",0,0
218957,16,0,0
218958,patients,0,0
218959,",",0,0
218960,antibiotic,1,1
218961,was,1,0
218962,added,1,0
218963,to,1,0
218964,the,1,0
218965,sterile,1,1
218966,physiologic,1,0
218967,solution,1,1
218968,.,1,0
218969,In,0,0
218970,all,0,0
218971,patients,0,0
218972,values,0,0
218973,of,0,0
218974,C,0,1
218975,reactive,0,0
218976,protein,0,1
218977,(,0,1
218978,CRP,0,1
218979,),0,1
218980,in,0,0
218981,the,0,0
218982,blood,0,0
218983,were,0,0
218984,examined,0,0
218985,",",0,0
218986,and,0,0
218987,later,0,0
218988,on,0,0
218989,every,0,1
218990,third,0,0
218991,day,0,0
218992,after,0,0
218993,the,0,0
218994,operation,0,0
218995,.,0,0
218996,A,0,0
218997,significant,0,0
218998,difference,0,0
218999,of,0,0
219000,average,0,0
219001,values,0,0
219002,of,0,0
219003,CRP,0,1
219004,between,0,0
219005,the,0,0
219006,3rd,0,0
219007,and,0,0
219008,21st,0,0
219009,day,0,0
219010,in,0,0
219011,both,0,0
219012,groups,0,0
219013,of,0,0
219014,patients,0,0
219015,was,0,0
219016,established,0,0
219017,",",0,0
219018,as,0,0
219019,well,0,0
219020,as,0,0
219021,the,0,0
219022,similarity,0,0
219023,in,0,0
219024,average,0,0
219025,values,0,0
219026,of,0,0
219027,CRP,0,0
219028,",",0,0
219029,which,0,0
219030,points,0,0
219031,to,0,0
219032,the,0,0
219033,fact,0,0
219034,that,0,0
219035,the,0,0
219036,mechanical,0,0
219037,effect,0,0
219038,of,0,0
219039,through,0,0
219040,drainage,0,1
219041,is,0,0
219042,dominant,0,0
219043,",",0,0
219044,speaking,0,0
219045,about,0,0
219046,rinsing,0,1
219047,focus,0,0
219048,of,0,0
219049,infection,0,0
219050,and,0,0
219051,eliminating,0,0
219052,necrotic,0,0
219053,tissues,0,0
219054,and,0,0
219055,small,0,0
219056,sequesters,0,0
219057,.,0,0
219058,[,0,0
219059,Postoperative,0,0
219060,analgesia,0,0
219061,:,0,0
219062,peridural,1,1
219063,morphine,1,1
219064,versus,0,1
219065,sublingual,1,1
219066,buprenorphine,1,1
219067,.,1,0
219068,Comparative,0,0
219069,clinical,0,0
219070,study,0,0
219071,],0,0
219072,.,0,0
219073,The,0,0
219074,authors,0,0
219075,herein,0,0
219076,present,0,0
219077,their,0,0
219078,personal,0,1
219079,series,0,0
219080,on,0,0
219081,the,0,0
219082,clinical,0,0
219083,evaluation,0,0
219084,of,0,0
219085,the,0,0
219086,analgesic,0,1
219087,efficacy,0,0
219088,of,0,0
219089,2,0,0
219090,opiodes,0,0
219091,",",0,0
219092,peridural,1,1
219093,morphine,1,1
219094,hydrochloride,1,1
219095,(,1,0
219096,0.5,1,1
219097,mg/kg,1,1
219098,),1,0
219099,administered,0,0
219100,to,0,0
219101,group,0,0
219102,A,0,0
219103,patients,0,0
219104,",",0,0
219105,and,0,0
219106,sublingual,1,1
219107,buprenorphine,1,1
219108,(,1,0
219109,0.4,1,1
219110,mg,1,1
219111,),1,0
219112,administered,0,0
219113,to,0,0
219114,group,0,0
219115,B,0,1
219116,patients,0,0
219117,in,0,0
219118,the,0,0
219119,management,0,1
219120,of,0,0
219121,post-operative,0,0
219122,pain,0,0
219123,in,0,0
219124,major,0,0
219125,abdominal,0,0
219126,surgery,0,0
219127,.,0,0
219128,The,0,0
219129,study,0,0
219130,was,0,0
219131,conducted,0,0
219132,on,0,0
219133,44,0,0
219134,patients,0,0
219135,",",0,0
219136,both,0,0
219137,male,0,0
219138,and,0,0
219139,female,0,0
219140,",",0,0
219141,classified,0,0
219142,as,0,0
219143,ASA,0,1
219144,II,0,1
219145,and,0,0
219146,III,0,0
219147,.,0,1
219148,Statistical,0,0
219149,analysis,0,0
219150,of,0,0
219151,cardiovascular,0,0
219152,parameters,0,0
219153,(,0,0
219154,BP,0,0
219155,and,0,1
219156,cardiac,0,0
219157,frequency,0,0
219158,),0,0
219159,",",0,0
219160,respiratory,0,0
219161,frequency,0,0
219162,and,0,0
219163,pain,0,0
219164,score,0,0
219165,showed,0,0
219166,an,0,0
219167,overlapping,0,0
219168,progression,0,0
219169,among,0,0
219170,the,0,0
219171,two,0,0
219172,groups,0,0
219173,.,0,0
219174,Spontaneous,0,0
219175,pain,0,0
219176,decreased,0,0
219177,significantly,0,0
219178,to,0,0
219179,zero,0,0
219180,at,0,0
219181,T6,0,1
219182,(,0,0
219183,p,0,0
219184,<,0,0
219185,0.001,0,0
219186,),0,0
219187,.,0,0
219188,However,0,0
219189,",",0,0
219190,the,0,0
219191,necessity,0,0
219192,to,0,0
219193,administer,0,0
219194,buprenorphine,1,1
219195,more,0,0
219196,frequently,0,0
219197,after,0,0
219198,the,0,0
219199,sixth,0,0
219200,hour,0,0
219201,and,0,0
219202,the,0,0
219203,consequent,0,0
219204,increase,0,0
219205,in,0,0
219206,side,0,0
219207,effects,0,0
219208,",",0,0
219209,lead,0,0
219210,us,0,0
219211,to,0,0
219212,believe,0,0
219213,that,0,0
219214,the,0,0
219215,method,0,1
219216,used,0,0
219217,for,0,0
219218,group,0,0
219219,A,0,0
219220,patients,0,0
219221,is,0,0
219222,more,0,0
219223,advantageous,0,0
219224,.,0,0
219225,Randomized,0,0
219226,",",0,0
219227,controlled,0,0
219228,study,0,0
219229,of,0,0
219230,various,0,0
219231,agents,0,1
219232,for,0,0
219233,endoscopic,0,1
219234,injection,0,1
219235,sclerotherapy,0,1
219236,of,0,0
219237,bleeding,0,0
219238,canine,0,0
219239,gastric,0,0
219240,varices,0,0
219241,.,0,0
219242,The,0,0
219243,purpose,0,0
219244,of,0,0
219245,this,0,0
219246,study,0,0
219247,was,0,0
219248,to,0,0
219249,compare,0,0
219250,the,0,0
219251,relative,0,0
219252,efficacy,0,0
219253,and,0,0
219254,technical,0,0
219255,ease,0,0
219256,of,0,0
219257,use,0,0
219258,of,0,0
219259,eight,0,0
219260,different,0,0
219261,agents,0,0
219262,for,0,0
219263,endoscopic,0,1
219264,hemostasis,0,0
219265,and,0,0
219266,obliteration,0,0
219267,of,0,0
219268,bleeding,0,0
219269,gastric,0,0
219270,varices,0,0
219271,in,0,0
219272,a,0,0
219273,canine,0,0
219274,model,0,0
219275,",",0,0
219276,as,0,0
219277,no,0,0
219278,comparative,0,0
219279,data,0,0
219280,are,0,0
219281,available,0,0
219282,on,0,0
219283,gastric,0,0
219284,variceal,0,0
219285,sclerotherapy,0,1
219286,.,0,0
219287,Large,0,0
219288,bleeding,0,0
219289,gastric,0,0
219290,varices,0,0
219291,in,0,0
219292,20,0,0
219293,heparinized,0,1
219294,dogs,0,0
219295,were,0,0
219296,randomized,1,0
219297,to,1,0
219298,endoscopic,1,1
219299,injection,1,1
219300,treatment,1,0
219301,with,1,0
219302,one,1,0
219303,of,1,0
219304,the,1,0
219305,following,1,0
219306,agents,1,0
219307,:,1,0
219308,cyanoacrylate,1,1
219309,;,1,0
219310,a,1,0
219311,1:1:1,1,1
219312,mixture,1,1
219313,of,1,0
219314,sodium,1,1
219315,tetradecyl,1,1
219316,sulfate,1,1
219317,3,1,0
219318,%,1,0
219319,",",1,0
219320,ethanol,1,0
219321,98,1,0
219322,%,1,0
219323,",",1,0
219324,and,1,0
219325,normal,1,0
219326,saline,1,1
219327,solution,1,1
219328,;,1,0
219329,ethanolamine,1,1
219330,oleate,1,1
219331,5,1,0
219332,%,1,0
219333,;,1,0
219334,sodium,1,1
219335,morrhuate,1,1
219336,5,1,0
219337,%,1,0
219338,;,1,0
219339,sodium,1,1
219340,tetradecyl,1,1
219341,sulfate,1,1
219342,1.5,1,0
219343,%,1,0
219344,;,1,0
219345,polidocanol,1,1
219346,1,1,0
219347,%,1,0
219348,;,1,0
219349,normal,1,0
219350,saline,1,1
219351,solution,1,1
219352,with,1,0
219353,epinephrine,1,1
219354,"1:10,000",1,0
219355,;,1,0
219356,or,1,0
219357,normal,1,0
219358,saline,1,1
219359,solution,1,1
219360,(,1,1
219361,control,1,1
219362,),1,0
219363,.,1,0
219364,The,0,0
219365,number,0,0
219366,and,0,0
219367,volume,0,0
219368,of,0,0
219369,injections,0,1
219370,and,0,0
219371,the,0,0
219372,time,0,0
219373,required,0,0
219374,to,0,0
219375,achieve,0,0
219376,complete,0,0
219377,hemostasis,0,0
219378,were,0,0
219379,evaluated,0,0
219380,;,0,0
219381,follow-up,0,0
219382,endoscopy,0,1
219383,was,0,0
219384,performed,0,0
219385,at,0,0
219386,1,0,0
219387,month,0,0
219388,to,0,0
219389,assess,0,0
219390,gastric,0,0
219391,variceal,0,0
219392,obliteration,0,0
219393,.,0,0
219394,Cyanoacrylate,0,1
219395,was,0,0
219396,the,0,0
219397,best,0,0
219398,agent,0,0
219399,overall,0,0
219400,in,0,0
219401,terms,0,0
219402,of,0,0
219403,immediate,0,0
219404,efficacy,0,0
219405,",",0,0
219406,low,0,0
219407,volume,0,0
219408,requirement,0,0
219409,",",0,0
219410,time,0,0
219411,required,0,0
219412,for,0,0
219413,initial,0,0
219414,hemostasis,0,0
219415,",",0,0
219416,and,0,0
219417,reduction,0,0
219418,of,0,0
219419,gastric,0,0
219420,variceal,0,0
219421,size,0,0
219422,.,0,0
219423,Cyanoacrylate,0,1
219424,",",0,0
219425,tetradecyl,0,1
219426,sulfate,0,1
219427,",",0,0
219428,and,0,0
219429,polidocanol,0,1
219430,were,0,0
219431,the,0,0
219432,most,0,0
219433,effective,0,0
219434,agents,0,1
219435,for,0,0
219436,reducing,0,0
219437,gastric,0,0
219438,variceal,0,0
219439,size,0,0
219440,.,0,0
219441,Epinephrine,0,1
219442,was,0,0
219443,effective,0,0
219444,for,0,0
219445,controlling,0,0
219446,induced,0,0
219447,or,0,1
219448,secondary,0,0
219449,bleeding,0,0
219450,caused,0,0
219451,by,0,0
219452,puncture,0,0
219453,of,0,0
219454,the,0,0
219455,gastric,0,0
219456,varices,0,0
219457,with,0,0
219458,the,0,0
219459,sclerotherapy,0,1
219460,needle,0,1
219461,during,0,0
219462,intravariceal,0,0
219463,injections,0,1
219464,.,0,0
219465,Ongoing,0,0
219466,studies,0,0
219467,are,0,0
219468,evaluating,0,0
219469,combinations,0,0
219470,of,0,0
219471,agents,0,0
219472,with,0,0
219473,different,0,0
219474,mechanisms,0,0
219475,of,0,0
219476,action,0,0
219477,",",0,0
219478,such,0,0
219479,as,0,0
219480,epinephrine,0,1
219481,(,0,0
219482,for,0,0
219483,vasoconstriction,0,0
219484,to,0,0
219485,minimize,0,0
219486,secondary,0,0
219487,bleeding,0,0
219488,),0,1
219489,plus,0,1
219490,alcohol,0,1
219491,",",0,0
219492,and/or,0,0
219493,tetradecyl,0,1
219494,sulfate,0,1
219495,(,0,0
219496,for,0,0
219497,variceal,0,0
219498,thrombosis,0,0
219499,and,0,1
219500,sclerosis,0,1
219501,),0,1
219502,.,0,0
219503,(,0,0
219504,ABSTRACT,0,1
219505,TRUNCATED,0,1
219506,AT,0,1
219507,250,0,1
219508,WORDS,0,1
219509,),0,1
219510,Health,0,1
219511,promotion,0,1
219512,and,0,0
219513,disease,0,0
219514,prevention,0,0
219515,for,0,0
219516,older,0,0
219517,adults,0,0
219518,:,0,0
219519,opportunity,0,0
219520,for,0,0
219521,change,0,0
219522,or,0,1
219523,preaching,0,0
219524,to,0,0
219525,the,0,0
219526,converted,0,0
219527,?,0,0
219528,Health,0,0
219529,promotion,0,0
219530,and,0,0
219531,disease,0,0
219532,prevention,0,0
219533,for,0,0
219534,the,0,0
219535,elderly,0,0
219536,offer,0,0
219537,the,0,0
219538,potential,0,0
219539,for,0,0
219540,improving,0,0
219541,the,0,0
219542,quality,0,0
219543,of,0,0
219544,life,0,0
219545,for,0,0
219546,the,0,0
219547,growing,0,0
219548,population,0,0
219549,of,0,0
219550,older,0,0
219551,adults,0,0
219552,",",0,0
219553,while,0,0
219554,reducing,0,0
219555,the,0,0
219556,economic,0,0
219557,burden,0,0
219558,on,0,0
219559,the,0,0
219560,health,0,0
219561,system,0,0
219562,.,0,0
219563,Whether,0,0
219564,this,0,0
219565,potential,0,0
219566,can,0,0
219567,be,0,0
219568,realized,0,0
219569,depends,0,0
219570,",",0,0
219571,in,0,0
219572,part,0,0
219573,",",0,0
219574,on,0,0
219575,whether,0,0
219576,those,0,0
219577,older,0,0
219578,adults,0,0
219579,whose,0,0
219580,health,0,0
219581,behaviors,0,0
219582,put,0,0
219583,them,0,0
219584,at,0,0
219585,risk,0,0
219586,actually,0,0
219587,use,0,0
219588,preventive,1,0
219589,services,1,1
219590,when,0,0
219591,offered,0,0
219592,the,0,0
219593,opportunity,0,0
219594,.,0,0
219595,In,0,0
219596,1988,0,0
219597,the,0,0
219598,Health,0,0
219599,Care,0,0
219600,Financing,0,1
219601,Administration,0,0
219602,began,0,0
219603,a,0,0
219604,series,0,0
219605,of,0,0
219606,health,1,0
219607,promotion,1,0
219608,demonstrations,1,0
219609,to,0,0
219610,address,0,0
219611,health,0,0
219612,issues,0,0
219613,related,0,0
219614,to,0,0
219615,older,0,0
219616,adults,0,0
219617,.,0,0
219618,This,0,0
219619,article,0,0
219620,reports,0,0
219621,on,0,0
219622,program,0,1
219623,participation,0,0
219624,at,0,0
219625,one,0,0
219626,of,0,0
219627,the,0,0
219628,five,0,0
219629,demonstration,0,0
219630,sites,0,0
219631,.,0,0
219632,Over,0,0
219633,"1,900",0,0
219634,community-dwelling,0,0
219635,Medicare,0,1
219636,beneficiaries,0,0
219637,who,0,0
219638,receive,0,0
219639,their,0,0
219640,health,0,0
219641,care,0,1
219642,through,0,0
219643,fee-for-service,0,0
219644,providers,0,0
219645,were,0,0
219646,enrolled,0,0
219647,in,0,0
219648,the,0,0
219649,demonstration,0,0
219650,.,0,0
219651,These,0,0
219652,enrollees,0,0
219653,were,0,0
219654,randomly,0,0
219655,assigned,0,0
219656,to,0,0
219657,control,1,1
219658,and,0,0
219659,experimental,0,0
219660,groups,0,0
219661,",",0,0
219662,with,0,0
219663,the,0,0
219664,latter,0,0
219665,offered,0,0
219666,health,1,0
219667,screening,1,1
219668,and,1,0
219669,promotion,1,0
219670,services,1,1
219671,.,1,0
219672,Nine,0,1
219673,hundred-seventy-three,0,0
219674,of,0,0
219675,the,0,0
219676,experimental,0,0
219677,subjects,0,0
219678,and,0,0
219679,938,0,0
219680,of,0,0
219681,the,0,0
219682,control,0,1
219683,subjects,0,0
219684,completed,0,0
219685,a,0,0
219686,lengthy,0,1
219687,telephone,0,1
219688,interview,0,0
219689,",",0,0
219690,which,0,0
219691,determined,0,0
219692,each,0,0
219693,person,0,0
219694,'s,0,0
219695,use,0,0
219696,of,0,0
219697,preventive,0,0
219698,services,0,1
219699,and,0,0
219700,practices,0,0
219701,.,0,0
219702,Although,0,0
219703,all,0,0
219704,973,0,0
219705,experimental,0,0
219706,subjects,0,0
219707,were,0,0
219708,invited,0,0
219709,by,0,0
219710,letter,0,1
219711,and,0,0
219712,follow-up,0,0
219713,telephone,0,1
219714,calls,0,0
219715,to,0,0
219716,attend,0,0
219717,these,0,0
219718,free-of-charge,0,0
219719,",",0,0
219720,Medicare-provided,0,0
219721,sessions,0,1
219722,",",0,0
219723,not,0,0
219724,everyone,0,0
219725,attended,0,0
219726,.,0,0
219727,We,0,0
219728,analyzed,0,0
219729,17,0,0
219730,health,0,0
219731,behaviors,0,0
219732,of,0,0
219733,those,0,0
219734,who,0,0
219735,attended,0,0
219736,the,0,0
219737,first,0,0
219738,session,0,1
219739,and,0,0
219740,those,0,0
219741,who,0,0
219742,did,0,0
219743,not,0,0
219744,.,0,0
219745,Those,0,0
219746,engaging,0,0
219747,in,0,0
219748,these,0,0
219749,preventive,0,0
219750,behaviors,0,0
219751,were,0,0
219752,neither,0,0
219753,more,0,0
219754,nor,0,0
219755,less,0,0
219756,likely,0,0
219757,to,0,0
219758,attend,0,0
219759,the,0,0
219760,screening,0,0
219761,services,0,1
219762,.,0,0
219763,Thus,0,0
219764,",",0,0
219765,we,0,0
219766,found,0,0
219767,neither,0,0
219768,favorable,0,0
219769,nor,0,0
219770,unfavorable,0,0
219771,selection,0,0
219772,bias,0,0
219773,in,0,0
219774,the,0,0
219775,use,0,0
219776,of,0,0
219777,these,0,0
219778,preventive,0,0
219779,services,0,0
219780,.,0,0
219781,[,0,0
219782,A,0,0
219783,comparison,0,0
219784,of,0,0
219785,2,0,0
219786,methods,0,0
219787,of,0,0
219788,plastic,1,1
219789,cast,1,1
219790,fixation,1,1
219791,in,0,0
219792,treatment,0,0
219793,of,0,0
219794,loco,0,1
219795,classico,0,1
219796,radius,0,0
219797,fracture,0,0
219798,.,0,0
219799,A,0,0
219800,prospective,0,0
219801,",",0,0
219802,randomized,0,0
219803,study,0,0
219804,],0,0
219805,.,0,0
219806,The,0,0
219807,purpose,0,0
219808,of,0,0
219809,this,0,0
219810,study,0,0
219811,was,0,0
219812,to,0,0
219813,compare,0,0
219814,the,0,0
219815,functional,0,0
219816,and,0,0
219817,radiological,0,0
219818,result,0,0
219819,of,0,0
219820,two,0,0
219821,different,0,0
219822,positions,0,0
219823,of,0,0
219824,the,0,0
219825,wrist,0,0
219826,in,0,0
219827,a,0,0
219828,plaster,1,1
219829,cast,1,1
219830,following,0,0
219831,Colles,0,0
219832,',0,1
219833,fracture,0,0
219834,.,0,0
219835,For,0,0
219836,this,0,0
219837,prospective,0,0
219838,study,0,0
219839,",",0,0
219840,each,0,0
219841,of,0,0
219842,50,0,0
219843,patients,0,0
219844,with,0,0
219845,type,0,0
219846,A,0,0
219847,2.2,0,0
219848,",",0,0
219849,A,0,0
219850,3.3,0,0
219851,",",0,0
219852,C,0,0
219853,1.2,0,0
219854,or,0,0
219855,C,0,1
219856,2.2,0,0
219857,(,0,0
219858,AO,0,0
219859,classification,0,0
219860,),0,0
219861,fractures,0,0
219862,of,0,0
219863,the,0,0
219864,radius,0,0
219865,was,0,0
219866,randomly,0,0
219867,assigned,0,0
219868,to,0,0
219869,one,0,0
219870,of,0,0
219871,two,0,0
219872,groups,0,0
219873,.,0,0
219874,Both,0,0
219875,groups,0,0
219876,were,0,0
219877,treated,0,0
219878,in,0,0
219879,the,0,0
219880,same,0,0
219881,way,0,0
219882,as,0,0
219883,far,0,0
219884,as,0,0
219885,anaesthesia,0,1
219886,and,0,0
219887,reduction,0,0
219888,were,0,0
219889,concerned,0,0
219890,.,0,0
219891,The,0,0
219892,only,0,0
219893,difference,0,0
219894,in,0,0
219895,treatment,0,0
219896,lay,0,0
219897,in,0,0
219898,the,0,0
219899,position,0,0
219900,of,0,0
219901,fixation,0,1
219902,in,0,0
219903,plaster,0,1
219904,.,0,0
219905,In,0,0
219906,group,0,0
219907,1,0,0
219908,the,0,0
219909,wrist,1,0
219910,was,1,0
219911,immobilized,1,0
219912,in,1,0
219913,neutral,1,1
219914,flexion-extension,1,0
219915,.,1,0
219916,In,0,0
219917,group,0,0
219918,2,0,0
219919,the,0,0
219920,wrist,0,0
219921,was,0,0
219922,dorsiflexed,1,1
219923,20,1,0
219924,degrees,1,0
219925,",",1,0
219926,while,1,0
219927,the,1,0
219928,carpus,1,1
219929,was,1,0
219930,pushed,1,0
219931,in,1,0
219932,a,1,0
219933,volar,1,1
219934,direction,1,0
219935,by,1,0
219936,an,1,0
219937,impression,1,0
219938,in,1,0
219939,the,1,0
219940,plaster,1,1
219941,cast,1,1
219942,.,1,0
219943,At,0,0
219944,review,0,0
219945,2-7,0,0
219946,years,0,0
219947,after,0,0
219948,the,0,0
219949,accidents,0,0
219950,",",0,0
219951,the,0,0
219952,two,0,0
219953,groups,0,0
219954,were,0,0
219955,compared,0,0
219956,with,0,0
219957,reference,0,0
219958,to,0,0
219959,symptoms,0,0
219960,",",0,0
219961,range,0,0
219962,of,0,0
219963,motion,0,0
219964,at,0,0
219965,the,0,0
219966,wrist,0,1
219967,",",0,0
219968,power,0,0
219969,of,0,0
219970,first,0,0
219971,closure,0,0
219972,and,0,0
219973,radiographic,0,0
219974,appearance,0,0
219975,.,0,0
219976,In,0,0
219977,group,0,0
219978,1,0,0
219979,there,0,0
219980,were,0,0
219981,5,0,0
219982,patients,0,0
219983,with,0,0
219984,significant,0,0
219985,disability,0,0
219986,",",0,0
219987,compared,0,0
219988,with,0,0
219989,only,0,0
219990,1,0,0
219991,in,0,0
219992,group,0,0
219993,2,0,0
219994,.,0,0
219995,A,0,0
219996,significant,0,0
219997,difference,0,0
219998,was,0,0
219999,found,0,0
220000,in,0,0
220001,the,0,0
220002,range,0,0
220003,of,0,0
220004,movement,0,0
220005,between,0,0
220006,the,0,0
220007,two,0,0
220008,groups,0,0
220009,for,0,0
220010,flexion,0,0
220011,and,0,0
220012,ulnar,0,1
220013,abduction,0,1
220014,(,0,0
220015,p,0,0
220016,<,0,0
220017,0.01,0,0
220018,),0,0
220019,.,0,0
220020,The,0,0
220021,loss,0,0
220022,of,0,0
220023,power,0,0
220024,of,0,0
220025,first,0,0
220026,clenching,0,0
220027,(,0,1
220028,difference,0,0
220029,between,0,0
220030,injured,0,0
220031,and,0,0
220032,healthy,0,0
220033,hand,0,1
220034,),0,0
220035,was,0,0
220036,6.2,0,0
220037,mmHg,0,0
220038,for,0,0
220039,group,0,0
220040,1,0,0
220041,and,0,0
220042,3.8,0,0
220043,mmHg,0,0
220044,for,0,0
220045,group,0,0
220046,2,0,0
220047,(,0,0
220048,not,0,0
220049,significant,0,0
220050,),0,0
220051,.,0,0
220052,The,0,0
220053,radiographic,0,0
220054,examination,0,0
220055,showed,0,0
220056,significant,0,0
220057,differences,0,0
220058,both,0,0
220059,in,0,0
220060,sagittal,0,1
220061,inclination,0,0
220062,(,0,0
220063,p,0,0
220064,<,0,0
220065,0.001,0,0
220066,),0,0
220067,and,0,0
220068,in,0,0
220069,radial,0,1
220070,shortening,0,0
220071,(,0,0
220072,p,0,0
220073,<,0,0
220074,0.05,0,0
220075,),0,0
220076,.,0,0
220077,(,0,0
220078,ABSTRACT,0,1
220079,TRUNCATED,0,1
220080,AT,0,1
220081,250,0,1
220082,WORDS,0,1
220083,),0,1
220084,Efficacy,0,0
220085,of,0,0
220086,intramuscular,1,1
220087,oxytetracycline,1,1
220088,as,0,0
220089,a,0,0
220090,dry,0,0
220091,cow,0,1
220092,treatment,0,0
220093,for,0,0
220094,Staphylococcus,0,1
220095,aureus,0,1
220096,mastitis,0,0
220097,.,0,0
220098,To,0,0
220099,determine,0,0
220100,the,0,0
220101,efficacy,0,0
220102,of,0,0
220103,intramuscular,1,1
220104,oxytetracycline,1,1
220105,as,0,0
220106,a,0,0
220107,supplemental,0,1
220108,dry,0,0
220109,cow,0,1
220110,treatment,0,0
220111,for,0,0
220112,Staphylococcus,0,1
220113,aureus,0,1
220114,mastitis,0,0
220115,",",0,0
220116,37,0,0
220117,Holstein,0,0
220118,cows,0,0
220119,were,0,0
220120,randomly,0,0
220121,assigned,0,0
220122,to,0,0
220123,two,0,0
220124,treatment,0,0
220125,groups,0,0
220126,:,0,0
220127,intracisternal,1,1
220128,infusion,1,1
220129,with,1,0
220130,a,1,0
220131,commercial,1,1
220132,preparation,1,1
220133,of,1,0
220134,cephapirin,1,1
220135,benzathine,1,1
220136,at,1,0
220137,drying,1,1
220138,off,1,1
220139,(,1,0
220140,20,1,0
220141,cows,1,1
220142,),1,0
220143,and,1,0
220144,infusion,1,1
220145,with,1,0
220146,cephapirin,1,1
220147,benzathine,1,1
220148,at,1,0
220149,drying,1,1
220150,off,1,1
220151,and,1,0
220152,intramuscular,1,1
220153,oxytetracycline,1,1
220154,at,1,0
220155,11,1,0
220156,mg/kg,1,1
220157,once,1,0
220158,daily,1,0
220159,on,1,0
220160,d,1,1
220161,7,1,0
220162,",",1,0
220163,8,1,0
220164,",",1,0
220165,9,1,0
220166,",",1,0
220167,and,1,0
220168,10,1,0
220169,after,1,0
220170,drying,1,1
220171,off,1,1
220172,(,1,0
220173,17,1,0
220174,cows,1,0
220175,),1,0
220176,.,1,0
220177,Milk,1,1
220178,samples,1,0
220179,collected,1,0
220180,7,1,0
220181,",",1,0
220182,14,1,0
220183,",",1,0
220184,30,1,0
220185,",",1,0
220186,and,1,0
220187,60,1,0
220188,d,1,1
220189,after,1,0
220190,calving,1,0
220191,were,0,0
220192,plated,0,0
220193,for,0,0
220194,bacterial,0,0
220195,isolation,0,0
220196,within,0,0
220197,24,0,0
220198,h,0,0
220199,after,0,0
220200,collection,0,0
220201,and,0,0
220202,after,0,0
220203,24,0,0
220204,to,0,0
220205,72,0,0
220206,h,0,0
220207,of,0,0
220208,storage,0,0
220209,at,0,0
220210,-20,0,0
220211,degrees,0,0
220212,C.,0,0
220213,Quarters,0,0
220214,were,0,0
220215,defined,0,0
220216,as,0,0
220217,infected,0,0
220218,if,0,0
220219,S.,0,1
220220,aureus,0,0
220221,was,0,0
220222,isolated,0,0
220223,from,0,0
220224,the,0,0
220225,fresh,0,0
220226,and,0,0
220227,frozen,0,1
220228,cultures,0,0
220229,from,0,0
220230,any,0,0
220231,one,0,0
220232,sample,0,0
220233,collected,0,0
220234,before,0,0
220235,drying,0,1
220236,off,0,0
220237,.,0,0
220238,An,0,0
220239,infected,0,0
220240,quarter,0,0
220241,was,0,0
220242,defined,0,0
220243,as,0,0
220244,cured,0,0
220245,if,0,0
220246,S.,0,1
220247,aureus,0,0
220248,was,0,0
220249,not,0,0
220250,isolated,0,0
220251,from,0,0
220252,the,0,0
220253,fresh,0,0
220254,or,0,1
220255,frozen,0,1
220256,culture,0,0
220257,from,0,0
220258,milk,0,1
220259,samples,0,0
220260,obtained,0,0
220261,following,0,0
220262,calving,0,0
220263,.,0,0
220264,The,0,0
220265,rate,0,0
220266,of,0,0
220267,cure,0,0
220268,by,0,0
220269,30,0,0
220270,d,0,1
220271,after,0,0
220272,calving,0,0
220273,for,0,0
220274,systemic,0,0
220275,oxytetracycline,1,1
220276,(,0,0
220277,in,0,0
220278,combination,0,1
220279,with,0,0
220280,cephapirin,1,1
220281,treatment,0,0
220282,),0,0
220283,was,0,0
220284,29.4,0,0
220285,%,0,0
220286,for,0,0
220287,infected,0,0
220288,quarters,0,0
220289,and,0,0
220290,29.4,0,0
220291,%,0,0
220292,for,0,0
220293,infected,0,0
220294,cows,0,0
220295,",",0,0
220296,compared,0,0
220297,with,0,0
220298,27.5,0,0
220299,and,0,0
220300,25.0,0,0
220301,%,0,0
220302,",",0,0
220303,respectively,0,0
220304,",",0,0
220305,for,0,0
220306,the,0,0
220307,cephapirin,1,1
220308,treatment,1,0
220309,only,1,0
220310,.,1,0
220311,Results,0,0
220312,including,0,0
220313,the,0,0
220314,culture,0,0
220315,at,0,0
220316,60,0,0
220317,d,0,1
220318,after,0,0
220319,calving,0,0
220320,were,0,0
220321,21.2,0,0
220322,and,0,0
220323,22.5,0,0
220324,%,0,0
220325,",",0,0
220326,respectively,0,0
220327,",",0,0
220328,for,0,0
220329,combination,1,1
220330,therapy,1,1
220331,and,0,0
220332,cephapirin,1,1
220333,therapy,1,1
220334,only,0,0
220335,.,0,0
220336,Systemic,0,0
220337,oxytetracycline,1,1
220338,",",0,0
220339,in,0,0
220340,combination,0,1
220341,with,0,0
220342,intramammary,0,0
220343,dry,0,0
220344,cow,0,1
220345,treatment,0,0
220346,",",0,0
220347,did,0,0
220348,not,0,0
220349,improve,0,0
220350,the,0,0
220351,rate,0,0
220352,of,0,0
220353,cure,0,0
220354,for,0,0
220355,S.,0,1
220356,aureus,0,1
220357,mastitis,0,0
220358,.,0,0
220359,[,0,0
220360,Carbohydrate,0,1
220361,substitutes,0,1
220362,:,0,0
220363,comparative,0,0
220364,study,0,0
220365,of,0,0
220366,intestinal,0,0
220367,absorption,0,0
220368,of,0,0
220369,fructose,1,1
220370,",",1,0
220371,sorbitol,1,1
220372,and,1,0
220373,xylitol,1,1
220374,],1,0
220375,.,0,0
220376,BACKGROUND,0,0
220377,The,0,0
220378,carbohydrate,0,1
220379,substitutes,0,1
220380,fructose,1,1
220381,",",1,0
220382,sorbitol,1,1
220383,and,1,0
220384,xylitol,1,1
220385,are,0,0
220386,gaining,0,0
220387,more,0,0
220388,and,0,0
220389,more,0,0
220390,importance,0,0
220391,in,0,0
220392,the,0,0
220393,production,0,0
220394,of,0,0
220395,dietary,0,1
220396,food,0,0
220397,.,0,0
220398,But,0,0
220399,they,0,0
220400,can,0,0
220401,provoke,0,0
220402,gastrointestinal,0,0
220403,side-effects,0,0
220404,.,0,0
220405,In,0,0
220406,a,0,0
220407,randomized,0,0
220408,double,0,1
220409,blind,0,0
220410,study,0,0
220411,the,0,0
220412,rate,0,0
220413,of,0,0
220414,malabsorption,0,0
220415,of,0,0
220416,these,0,0
220417,sugars,0,1
220418,was,0,0
220419,compared,0,0
220420,and,0,0
220421,the,0,0
220422,concomitant,0,0
220423,symptoms,0,0
220424,were,0,0
220425,recorded,0,0
220426,.,0,0
220427,SUBJECTS,0,0
220428,AND,0,0
220429,METHODS,0,0
220430,25,0,0
220431,healthy,0,0
220432,controls,0,0
220433,received,0,0
220434,25,1,0
220435,g,1,1
220436,of,1,0
220437,each,1,0
220438,sugar,1,1
220439,within,0,0
220440,3,0,0
220441,consecutive,0,0
220442,days,0,0
220443,.,0,0
220444,The,0,0
220445,intestinal,0,0
220446,absorption,0,0
220447,was,0,0
220448,determined,0,0
220449,by,0,0
220450,H2-exhalation,0,0
220451,tests,0,0
220452,and,0,0
220453,the,0,0
220454,clinical,0,0
220455,symptoms,0,0
220456,were,0,0
220457,recorded,0,0
220458,.,0,0
220459,RESULTS,0,0
220460,The,0,0
220461,rate,0,0
220462,of,0,0
220463,malabsorption,0,0
220464,was,0,0
220465,84,0,0
220466,%,0,0
220467,for,0,0
220468,sorbitol,1,1
220469,",",0,0
220470,36,0,0
220471,%,0,0
220472,for,0,0
220473,fructose,1,1
220474,and,0,0
220475,12,0,0
220476,%,0,0
220477,for,0,0
220478,xylitol,1,1
220479,(,0,0
220480,p,0,0
220481,<,0,0
220482,0.01,0,0
220483,for,0,0
220484,sorbitol,1,1
220485,versus,1,1
220486,fructose,1,1
220487,and,1,1
220488,xylitol,1,1
220489,),1,0
220490,.,0,0
220491,57,0,0
220492,%,0,0
220493,of,0,0
220494,the,0,0
220495,participants,0,0
220496,with,0,0
220497,pathological,0,0
220498,H2-test,0,0
220499,after,0,0
220500,sorbitol,1,1
220501,and,0,0
220502,56,0,0
220503,%,0,0
220504,after,0,0
220505,fructose,1,1
220506,reported,0,0
220507,symptoms,0,0
220508,",",0,0
220509,while,0,0
220510,all,0,0
220511,of,0,0
220512,the,0,0
220513,3,0,0
220514,malabsorbers,0,0
220515,of,0,0
220516,xylitol,1,1
220517,were,0,0
220518,symptomatic,0,0
220519,.,0,0
220520,CONCLUSIONS,0,0
220521,There,0,0
220522,is,0,0
220523,an,0,0
220524,advantage,0,0
220525,to,0,0
220526,administering,0,1
220527,xylitol,1,1
220528,and,0,0
220529,fructose,1,1
220530,with,0,0
220531,regard,0,0
220532,to,0,0
220533,the,0,0
220534,intestinal,0,0
220535,absorption,0,0
220536,and,0,0
220537,concomitant,0,0
220538,symptoms,0,0
220539,as,0,0
220540,compared,0,0
220541,with,0,0
220542,sorbitol,1,1
220543,.,1,0
220544,H2-exhalation,0,0
220545,tests,0,0
220546,appear,0,0
220547,to,0,0
220548,be,0,0
220549,a,0,0
220550,reliable,0,0
220551,diagnostic,0,0
220552,tool,0,0
220553,to,0,0
220554,detect,0,0
220555,carbohydrate,0,1
220556,malabsorption,0,0
220557,and,0,0
220558,should,0,0
220559,find,0,0
220560,broader,0,0
220561,application,0,0
220562,in,0,0
220563,patients,0,0
220564,suffering,0,0
220565,from,0,0
220566,non-specific,0,0
220567,abdominal,0,0
220568,complaints,0,0
220569,.,0,0
220570,Epidemiology,0,0
220571,of,0,0
220572,stroke,0,0
220573,.,0,0
220574,Importance,0,0
220575,of,0,0
220576,preventive,1,0
220577,pharmacological,1,0
220578,strategies,1,0
220579,in,0,0
220580,elderly,0,0
220581,patients,0,0
220582,and,0,0
220583,associated,0,0
220584,costs,0,0
220585,.,0,0
220586,Stroke,0,0
220587,is,0,0
220588,a,0,0
220589,major,0,0
220590,cause,0,0
220591,of,0,0
220592,death,0,0
220593,and,0,0
220594,disability,0,0
220595,in,0,0
220596,developed,0,0
220597,countries,0,0
220598,.,0,0
220599,The,0,0
220600,incidence,0,0
220601,of,0,0
220602,stroke,0,0
220603,increases,0,0
220604,exponentially,0,0
220605,with,0,0
220606,age,0,0
220607,",",0,0
220608,yet,0,0
220609,",",0,0
220610,traditionally,0,0
220611,",",0,0
220612,many,0,0
220613,medical,0,0
220614,practitioners,0,0
220615,have,0,0
220616,been,0,0
220617,reluctant,0,0
220618,to,0,0
220619,treat,0,0
220620,hypertension,0,0
220621,in,0,0
220622,older,0,0
220623,patients,0,0
220624,.,0,0
220625,Since,0,0
220626,1991,0,0
220627,",",0,0
220628,the,0,0
220629,results,0,0
220630,of,0,0
220631,3,0,0
220632,major,0,0
220633,trials,0,0
220634,--,0,0
220635,the,0,0
220636,British,0,0
220637,Medical,0,1
220638,Research,0,0
220639,Council,0,1
220640,(,0,1
220641,MRC,0,1
220642,),0,1
220643,trial,0,0
220644,of,0,0
220645,treatment,0,0
220646,in,0,0
220647,older,0,0
220648,adults,0,0
220649,",",0,0
220650,the,0,0
220651,Swedish,0,0
220652,Trial,0,0
220653,in,0,0
220654,Old,0,0
220655,Patients,0,0
220656,with,0,0
220657,Hypertension,0,0
220658,(,0,1
220659,STOP-Hypertension,0,1
220660,),0,1
220661,and,0,0
220662,the,0,0
220663,Systolic,0,0
220664,Hypertension,0,0
220665,in,0,0
220666,the,0,0
220667,Elderly,0,0
220668,Program,0,1
220669,(,0,1
220670,SHEP,0,1
220671,),0,1
220672,--,0,0
220673,have,0,0
220674,conclusively,0,0
220675,established,0,0
220676,the,0,0
220677,benefits,0,0
220678,of,0,0
220679,treating,1,0
220680,older,0,0
220681,patients,0,0
220682,(,0,0
220683,>,0,0
220684,60,0,0
220685,years,0,0
220686,),0,0
220687,with,0,0
220688,both,0,0
220689,diastolic,0,0
220690,and,0,0
220691,isolated,1,0
220692,systolic,1,0
220693,hypertension,1,0
220694,.,1,0
220695,International,0,0
220696,guidelines,0,0
220697,for,0,0
220698,the,0,0
220699,management,0,1
220700,of,0,0
220701,hypertension,0,0
220702,--,0,0
220703,including,0,0
220704,the,0,0
220705,Fifth,0,1
220706,Report,0,0
220707,of,0,0
220708,the,0,0
220709,Joint,0,0
220710,National,0,0
220711,Committee,0,0
220712,",",0,0
220713,the,0,0
220714,1993,0,0
220715,report,0,0
220716,of,0,0
220717,the,0,0
220718,World,0,1
220719,Health,0,1
220720,Organization,0,1
220721,and,0,0
220722,the,0,0
220723,International,0,0
220724,Society,0,0
220725,of,0,0
220726,Hypertension,0,0
220727,and,0,0
220728,the,0,0
220729,second,0,0
220730,report,0,0
220731,of,0,0
220732,the,0,0
220733,British,0,0
220734,Hypertension,0,0
220735,Society,0,0
220736,Working,0,1
220737,Party,0,0
220738,--,0,0
220739,have,0,0
220740,all,0,0
220741,been,0,0
220742,modified,0,0
220743,to,0,0
220744,reflect,0,0
220745,the,0,0
220746,emerging,0,0
220747,evidence,0,0
220748,concerning,0,0
220749,the,0,0
220750,benefits,0,0
220751,of,0,0
220752,treating,1,0
220753,older,0,0
220754,patients,0,0
220755,.,0,0
220756,Cost-effectiveness,0,0
220757,data,0,0
220758,are,0,0
220759,similarly,0,0
220760,in,0,0
220761,accord,0,0
220762,with,0,0
220763,giving,0,0
220764,high,0,0
220765,priority,0,0
220766,to,0,0
220767,the,0,0
220768,treatment,1,0
220769,of,0,0
220770,older,0,0
220771,individuals,0,0
220772,with,0,0
220773,hypertension,0,0
220774,.,0,0
220775,Changes,0,0
220776,in,0,0
220777,beta-carotene,0,1
220778,levels,0,0
220779,by,0,0
220780,long-term,0,0
220781,administration,0,0
220782,of,0,0
220783,natural,1,0
220784,beta-carotene,1,1
220785,derived,0,0
220786,from,0,0
220787,Dunaliella,0,1
220788,bardawil,0,1
220789,in,0,0
220790,humans,0,0
220791,.,0,0
220792,Long-term,0,0
220793,administration,0,0
220794,of,0,0
220795,a,0,0
220796,beta-carotene,1,1
220797,preparation,1,1
220798,derived,0,0
220799,from,0,0
220800,Dunaliella,0,1
220801,bardawil,0,1
220802,",",0,0
220803,a,0,0
220804,beta-carotene-rich,1,1
220805,algae,1,1
220806,",",0,0
220807,was,0,0
220808,studied,0,0
220809,in,0,0
220810,healthy,0,0
220811,young,0,0
220812,male,0,0
220813,volunteers,0,0
220814,.,0,0
220815,The,0,0
220816,daily,0,0
220817,administration,0,0
220818,of,0,0
220819,60,1,0
220820,mg,1,1
220821,of,1,0
220822,the,1,0
220823,beta-carotene,1,1
220824,preparation,1,1
220825,(,0,0
220826,30,0,1
220827,mg,0,1
220828,of,0,0
220829,all-trans,0,1
220830,beta-carotene,0,1
220831,and,0,0
220832,30,0,1
220833,mg,0,1
220834,of,0,0
220835,9-cis,0,1
220836,beta-carotene,0,1
220837,),0,0
220838,was,0,0
220839,performed,0,0
220840,and,0,0
220841,beta-carotene,0,1
220842,concentrations,0,0
220843,were,0,0
220844,determined,0,0
220845,in,0,0
220846,the,0,0
220847,plasma,0,0
220848,",",0,0
220849,red,0,0
220850,blood,0,0
220851,cells,0,0
220852,(,0,0
220853,RBC,0,1
220854,),0,0
220855,",",0,0
220856,platelets,0,1
220857,(,0,0
220858,PLT,0,1
220859,),0,1
220860,",",0,0
220861,and,0,0
220862,mononuclear,0,0
220863,cells,0,0
220864,(,0,0
220865,MN,0,1
220866,),0,0
220867,.,0,0
220868,The,0,0
220869,all-trans,0,1
220870,beta-carotene,0,1
220871,level,0,0
220872,increased,0,0
220873,four-,0,0
220874,",",0,0
220875,two-,0,0
220876,",",0,0
220877,and,0,0
220878,threefold,0,0
220879,the,0,0
220880,baseline,0,0
220881,in,0,0
220882,plasma,0,0
220883,",",0,0
220884,PLT,0,1
220885,",",0,0
220886,and,0,0
220887,MN,0,1
220888,",",0,0
220889,respectively,0,0
220890,.,0,0
220891,Basal,0,0
220892,levels,0,0
220893,of,0,0
220894,9-cis,0,1
220895,beta-carotene,0,1
220896,in,0,0
220897,plasma,0,0
220898,",",0,0
220899,PLT,0,1
220900,",",0,0
220901,and,0,0
220902,MN,0,1
220903,were,0,0
220904,low,0,0
220905,and,0,0
220906,found,0,0
220907,as,0,0
220908,one-tenth,0,0
220909,",",0,0
220910,one-fifth,0,0
220911,",",0,0
220912,and,0,0
220913,one-fifth,0,0
220914,of,0,0
220915,all-trans,0,1
220916,beta-carotene,0,1
220917,",",0,0
220918,which,0,0
220919,increased,0,0
220920,three-,0,0
220921,",",0,0
220922,two-,0,0
220923,",",0,0
220924,and,0,0
220925,1.5-fold,0,0
220926,the,0,0
220927,baseline,0,0
220928,",",0,0
220929,respectively,0,0
220930,.,0,0
220931,Plasma,0,0
220932,and,0,0
220933,RBC,0,1
220934,alpha-tocopherol,0,1
220935,levels,0,0
220936,were,0,0
220937,not,0,0
220938,changed,0,0
220939,by,0,0
220940,the,0,0
220941,intake,0,0
220942,of,0,0
220943,beta-carotene,0,1
220944,.,0,0
220945,No,0,0
220946,side,0,0
220947,effects,0,0
220948,or,0,0
220949,toxicities,0,0
220950,were,0,0
220951,documented,0,0
220952,in,0,0
220953,any,0,0
220954,of,0,0
220955,the,0,0
220956,subjects,0,0
220957,during,0,0
220958,the,0,0
220959,administration,0,0
220960,period,0,0
220961,.,0,0
220962,In,0,0
220963,conclusion,0,0
220964,",",0,0
220965,the,0,0
220966,bioavailability,0,0
220967,of,0,0
220968,beta-carotene,0,1
220969,derived,0,0
220970,from,0,0
220971,Dunaliella,0,1
220972,bardawil,0,1
220973,was,0,0
220974,preferential,0,0
220975,for,0,0
220976,all-trans,0,1
220977,beta-carotene,0,1
220978,",",0,0
220979,although,0,0
220980,a,0,0
220981,small,0,0
220982,amount,0,0
220983,of,0,0
220984,the,0,0
220985,9-cis,0,1
220986,form,0,0
220987,was,0,0
220988,detected,0,0
220989,in,0,0
220990,the,0,0
220991,plasma,0,0
220992,and,0,0
220993,blood,0,0
220994,cells,0,0
220995,.,0,0
220996,Aspirin,1,1
220997,in,0,0
220998,coronary,0,0
220999,heart,0,0
221000,disease,0,0
221001,.,0,0
221002,The,0,0
221003,Coronary,0,0
221004,Drug,0,1
221005,Project,0,1
221006,Research,0,0
221007,Group,0,0
221008,.,0,0
221009,Warfarin,1,1
221010,versus,0,1
221011,aspirin,1,1
221012,for,0,0
221013,prevention,0,0
221014,of,0,0
221015,thromboembolism,0,0
221016,in,0,0
221017,atrial,0,0
221018,fibrillation,0,0
221019,:,0,0
221020,Stroke,0,1
221021,Prevention,0,1
221022,in,0,0
221023,Atrial,0,0
221024,Fibrillation,0,0
221025,II,0,0
221026,Study,0,0
221027,.,0,0
221028,Warfarin,1,1
221029,is,0,0
221030,an,0,0
221031,established,0,0
221032,treatment,0,0
221033,for,0,0
221034,prevention,0,0
221035,of,0,0
221036,ischaemic,0,0
221037,stroke,0,0
221038,in,0,0
221039,patients,0,0
221040,with,0,0
221041,atrial,0,0
221042,fibrillation,0,0
221043,",",0,0
221044,but,0,0
221045,the,0,0
221046,value,0,0
221047,of,0,0
221048,this,0,0
221049,agent,0,0
221050,relative,0,0
221051,to,0,0
221052,aspirin,0,1
221053,in,0,0
221054,unclear,0,0
221055,.,0,0
221056,In,0,0
221057,the,0,0
221058,first,0,0
221059,Stroke,0,1
221060,Prevention,0,1
221061,in,0,0
221062,Atrial,0,0
221063,Fibrillation,0,1
221064,(,0,1
221065,SPAF-I,0,1
221066,),0,1
221067,study,0,0
221068,",",0,0
221069,direct,0,0
221070,comparison,0,0
221071,of,0,0
221072,warfarin,1,1
221073,with,0,0
221074,aspirin,1,1
221075,was,0,0
221076,limited,0,0
221077,by,0,0
221078,the,0,0
221079,small,0,0
221080,number,0,0
221081,of,0,0
221082,thromboembolic,0,0
221083,events,0,0
221084,.,0,0
221085,SPAF-II,0,0
221086,aims,0,0
221087,to,0,0
221088,address,0,0
221089,this,0,0
221090,issue,0,0
221091,and,0,0
221092,also,0,0
221093,to,0,0
221094,assess,0,0
221095,the,0,0
221096,differential,0,0
221097,effects,0,0
221098,of,0,0
221099,the,0,0
221100,two,0,0
221101,treatments,0,0
221102,according,0,0
221103,to,0,0
221104,age,0,0
221105,.,0,0
221106,We,0,0
221107,compared,0,0
221108,warfarin,1,1
221109,(,0,0
221110,prothrombin,0,1
221111,time,0,0
221112,ratio,0,0
221113,1.3-1.8,0,0
221114,",",0,0
221115,international,0,0
221116,normalised,0,0
221117,ratio,0,0
221118,2.0-4.5,0,0
221119,),0,0
221120,with,0,0
221121,aspirin,1,1
221122,325,1,0
221123,mg,1,1
221124,daily,1,1
221125,for,0,0
221126,prevention,0,0
221127,of,0,0
221128,ischaemic,0,1
221129,stroke,0,0
221130,and,0,0
221131,systemic,0,0
221132,embolism,0,0
221133,(,0,0
221134,primary,0,0
221135,events,0,0
221136,),0,0
221137,in,0,0
221138,two,0,0
221139,parallel,0,0
221140,randomised,0,0
221141,trials,0,0
221142,involving,0,0
221143,715,0,0
221144,patients,0,0
221145,aged,0,0
221146,75,0,0
221147,years,0,0
221148,or,0,0
221149,less,0,0
221150,and,0,0
221151,385,0,0
221152,patients,0,0
221153,older,0,0
221154,than,0,0
221155,75,0,0
221156,;,0,0
221157,we,0,0
221158,sought,0,0
221159,reductions,0,0
221160,in,0,0
221161,the,0,0
221162,absolute,0,0
221163,rate,0,0
221164,of,0,0
221165,primary,0,0
221166,events,0,0
221167,by,0,0
221168,warfarin,1,1
221169,compared,0,0
221170,with,0,0
221171,aspirin,1,1
221172,of,0,0
221173,2,0,0
221174,%,0,0
221175,per,0,1
221176,year,0,0
221177,and,0,0
221178,4,0,0
221179,%,0,0
221180,per,0,0
221181,year,0,0
221182,",",0,0
221183,respectively,0,0
221184,.,0,0
221185,In,0,0
221186,the,0,0
221187,younger,0,0
221188,patients,0,0
221189,",",0,0
221190,warfarin,1,1
221191,decreased,0,0
221192,the,0,0
221193,absolute,0,0
221194,rate,0,0
221195,of,0,0
221196,primary,0,0
221197,events,0,0
221198,by,0,0
221199,0.7,0,0
221200,%,0,0
221201,per,0,1
221202,year,0,0
221203,(,0,0
221204,95,0,0
221205,%,0,0
221206,CI-0.4,0,0
221207,to,0,0
221208,1.7,0,0
221209,),0,0
221210,.,0,0
221211,The,0,0
221212,primary,0,0
221213,event,0,0
221214,rate,0,0
221215,per,0,1
221216,year,0,0
221217,was,0,0
221218,1.3,0,0
221219,%,0,0
221220,with,0,0
221221,warfarin,1,1
221222,and,0,0
221223,1.9,0,0
221224,%,0,0
221225,with,0,0
221226,aspirin,1,1
221227,(,0,0
221228,relative,0,0
221229,risk,0,0
221230,[,0,0
221231,RR,0,1
221232,],0,0
221233,0.67,0,0
221234,",",0,0
221235,p,0,0
221236,=,0,0
221237,0.24,0,0
221238,),0,0
221239,.,0,0
221240,The,0,0
221241,absolute,0,0
221242,rate,0,0
221243,of,0,0
221244,primary,0,0
221245,events,0,0
221246,in,0,0
221247,low-risk,0,0
221248,younger,0,0
221249,patients,0,0
221250,(,0,0
221251,without,0,0
221252,hypertension,0,0
221253,",",0,0
221254,recent,0,0
221255,heart,0,0
221256,failure,0,0
221257,",",0,0
221258,or,0,1
221259,previous,0,0
221260,thromboembolism,0,0
221261,),0,1
221262,on,0,0
221263,aspirin,1,1
221264,was,0,0
221265,0.5,0,1
221266,%,0,0
221267,per,0,1
221268,year,0,0
221269,(,0,0
221270,95,0,0
221271,%,0,0
221272,CI,0,0
221273,0.1,0,1
221274,to,0,0
221275,1.9,0,0
221276,),0,0
221277,.,0,0
221278,Among,0,0
221279,older,0,0
221280,patients,0,0
221281,",",0,0
221282,warfarin,1,1
221283,decreased,0,0
221284,the,0,0
221285,absolute,0,0
221286,rate,0,0
221287,of,0,0
221288,primary,0,0
221289,events,0,0
221290,by,0,0
221291,1.2,0,0
221292,%,0,0
221293,per,0,1
221294,year,0,0
221295,(,0,0
221296,95,0,0
221297,%,0,0
221298,CI-1.7,0,0
221299,to,0,0
221300,4.1,0,0
221301,),0,0
221302,.,0,0
221303,The,0,0
221304,primary,0,0
221305,event,0,0
221306,rate,0,0
221307,per,0,1
221308,year,0,0
221309,was,0,0
221310,3.6,0,0
221311,%,0,0
221312,with,0,0
221313,warfarin,1,1
221314,and,0,0
221315,4.8,0,0
221316,%,0,0
221317,with,0,0
221318,aspirin,1,1
221319,(,0,0
221320,RR,0,0
221321,0.73,0,0
221322,",",0,0
221323,p,0,0
221324,=,0,0
221325,0.39,0,0
221326,),0,0
221327,.,0,0
221328,In,0,0
221329,this,0,0
221330,older,0,0
221331,group,0,0
221332,",",0,0
221333,the,0,0
221334,rate,0,0
221335,of,0,0
221336,all,0,0
221337,stroke,0,0
221338,with,0,0
221339,residual,0,0
221340,deficit,0,1
221341,(,0,1
221342,ischaemic,0,1
221343,or,0,1
221344,haemorrhagic,0,0
221345,),0,1
221346,was,0,0
221347,4.3,0,0
221348,%,0,0
221349,per,0,0
221350,year,0,0
221351,with,0,0
221352,aspirin,1,1
221353,and,0,0
221354,4.6,0,0
221355,%,0,0
221356,per,0,0
221357,year,0,0
221358,with,0,1
221359,warfarin,1,1
221360,(,0,0
221361,RR,0,1
221362,1.1,0,0
221363,),0,0
221364,.,0,0
221365,Warfarin,1,1
221366,may,0,0
221367,be,0,0
221368,more,0,0
221369,effective,0,0
221370,than,0,0
221371,aspirin,1,1
221372,for,0,0
221373,prevention,0,0
221374,of,0,0
221375,ischaemic,0,0
221376,stroke,0,0
221377,in,0,0
221378,patients,0,0
221379,with,0,0
221380,atrial,0,0
221381,fibrillation,0,0
221382,",",0,0
221383,but,0,0
221384,the,0,0
221385,absolute,0,0
221386,reduction,0,0
221387,in,0,0
221388,stroke,0,0
221389,rate,0,0
221390,by,0,0
221391,warfarin,1,1
221392,is,0,0
221393,small,0,0
221394,.,0,0
221395,Younger,0,0
221396,patients,0,0
221397,without,0,0
221398,risk,0,0
221399,factors,0,0
221400,had,0,0
221401,a,0,0
221402,low,0,0
221403,rate,0,0
221404,of,0,0
221405,stroke,0,0
221406,when,0,0
221407,treated,0,0
221408,with,0,0
221409,aspirin,1,1
221410,.,1,0
221411,In,0,0
221412,older,0,0
221413,patients,0,0
221414,the,0,0
221415,rate,0,0
221416,of,0,0
221417,stroke,0,0
221418,(,0,1
221419,ischaemic,0,1
221420,and,0,1
221421,haemorrhagic,0,0
221422,),0,1
221423,was,0,0
221424,substantial,0,0
221425,",",0,0
221426,irrespective,0,0
221427,of,0,0
221428,which,0,0
221429,agent,0,0
221430,was,0,0
221431,given,0,0
221432,.,0,0
221433,Patient,0,0
221434,age,0,0
221435,and,0,0
221436,the,0,0
221437,inherent,0,0
221438,risk,0,0
221439,of,0,0
221440,thromboembolism,0,0
221441,should,0,0
221442,be,0,0
221443,considered,0,0
221444,in,0,0
221445,the,0,0
221446,choice,0,0
221447,of,0,0
221448,antithrombotic,0,0
221449,prophylaxis,0,1
221450,for,0,0
221451,patients,0,0
221452,with,0,0
221453,atrial,0,0
221454,fibrillation,0,0
221455,.,0,0
221456,Exposure,0,1
221457,reduced,0,0
221458,agoraphobia,0,0
221459,but,0,0
221460,not,0,0
221461,panic,0,0
221462,",",0,0
221463,and,0,0
221464,cognitive,1,1
221465,therapy,1,1
221466,reduced,0,0
221467,panic,0,0
221468,but,0,0
221469,not,0,0
221470,agoraphobia,0,0
221471,.,0,0
221472,Earlier,0,0
221473,studies,0,0
221474,showed,0,0
221475,that,0,0
221476,cognitive,1,0
221477,therapy,1,1
221478,has,0,0
221479,anti-panic,0,0
221480,effects,0,0
221481,and,0,0
221482,exposure,0,0
221483,has,0,0
221484,anti-agoraphobic,0,0
221485,effects,0,0
221486,while,0,0
221487,other,0,0
221488,studies,0,0
221489,suggest,0,0
221490,that,0,0
221491,agoraphobia,0,0
221492,is,0,0
221493,a,0,0
221494,secondary,0,0
221495,complication,0,0
221496,of,0,0
221497,panic,0,0
221498,disorder,0,0
221499,.,0,0
221500,It,0,0
221501,was,0,0
221502,therefore,0,0
221503,hypothesized,0,0
221504,that,0,0
221505,cognitive,1,0
221506,therapy,1,1
221507,not,0,0
221508,only,0,0
221509,reduces,0,0
221510,panic,0,0
221511,but,0,0
221512,also,0,0
221513,agoraphobia,0,0
221514,and,0,0
221515,that,0,0
221516,it,0,0
221517,potentiates,0,0
221518,the,0,0
221519,effects,0,0
221520,of,0,0
221521,exposure,0,0
221522,in,0,0
221523,vivo,0,0
221524,.,0,0
221525,Two,0,0
221526,groups,0,0
221527,of,0,0
221528,12,0,0
221529,severe,0,0
221530,agoraphobics,0,0
221531,were,0,0
221532,treated,0,0
221533,with,0,0
221534,4,0,0
221535,sessions,0,1
221536,of,0,0
221537,cognitive,1,0
221538,therapy,1,1
221539,followed,1,1
221540,by,1,0
221541,8,1,0
221542,sessions,1,1
221543,of,1,0
221544,cognitive,1,0
221545,therapy,1,1
221546,combined,1,1
221547,with,1,0
221548,in,1,0
221549,vivo,1,0
221550,exposure,1,0
221551,.,1,0
221552,The,0,0
221553,other,0,0
221554,12,0,0
221555,received,0,0
221556,4,1,0
221557,sessions,1,1
221558,of,1,0
221559,'associative,1,0
221560,therapy,1,1
221561,',1,0
221562,",",0,0
221563,a,0,0
221564,presumably,0,0
221565,inert,0,1
221566,treatment,0,0
221567,that,0,0
221568,controls,0,0
221569,for,0,0
221570,therapist,0,1
221571,attention,0,0
221572,",",0,0
221573,followed,0,1
221574,by,0,0
221575,8,0,0
221576,sessions,0,1
221577,of,0,0
221578,in,0,0
221579,vivo,0,0
221580,exposure,0,0
221581,that,0,0
221582,was,0,0
221583,framed,0,0
221584,in,0,0
221585,common,0,0
221586,behavioral,0,1
221587,terms,0,0
221588,.,0,0
221589,The,0,0
221590,initial,0,0
221591,cognitive,0,0
221592,therapy,0,1
221593,produced,0,0
221594,a,0,0
221595,significant,0,0
221596,reduction,0,0
221597,in,0,0
221598,panic,0,0
221599,frequency,0,0
221600,",",0,0
221601,while,0,0
221602,associative,0,0
221603,therapy,0,1
221604,did,0,0
221605,not,0,0
221606,affect,0,0
221607,panic,0,0
221608,.,0,0
221609,Neither,0,0
221610,cognitive,1,0
221611,therapy,1,1
221612,alone,0,1
221613,",",0,0
221614,nor,0,0
221615,associate,1,0
221616,therapy,1,1
221617,alone,0,1
221618,significantly,0,0
221619,reduced,0,0
221620,depression,0,0
221621,",",0,0
221622,state,0,0
221623,or,0,1
221624,trait,0,0
221625,anxiety,0,0
221626,",",0,0
221627,self-rated,0,0
221628,agoraphobia,0,0
221629,or,0,1
221630,behavioral,0,1
221631,avoidance,0,0
221632,.,0,0
221633,After,0,0
221634,adding,0,0
221635,exposure,0,0
221636,however,0,0
221637,",",0,0
221638,these,0,0
221639,parameters,0,0
221640,were,0,0
221641,clearly,0,0
221642,and,0,0
221643,significantly,0,0
221644,reduced,0,0
221645,.,0,0
221646,Cognitive,1,0
221647,therapy,1,1
221648,did,0,0
221649,not,0,0
221650,potentiate,0,0
221651,exposure,0,0
221652,effects,0,0
221653,.,0,0
221654,The,0,0
221655,results,0,0
221656,are,0,0
221657,discussed,0,0
221658,.,0,0
221659,[,0,0
221660,Postlaparoscopic,0,1
221661,pain,0,0
221662,syndrome,0,0
221663,.,0,0
221664,Results,0,0
221665,of,0,0
221666,a,0,0
221667,prospective,0,0
221668,",",0,0
221669,randomized,0,0
221670,study,0,0
221671,],0,0
221672,.,0,0
221673,The,0,0
221674,so-called,0,0
221675,post-laparoscopic,0,1
221676,algesia,0,0
221677,is,0,0
221678,a,0,0
221679,specific,0,0
221680,impairment,0,0
221681,of,0,0
221682,about,0,0
221683,63,0,0
221684,%,0,0
221685,of,0,0
221686,the,0,0
221687,patients,0,0
221688,who,0,0
221689,undergo,0,0
221690,laparoscopic,1,1
221691,surgical,1,0
221692,operations,1,0
221693,.,1,0
221694,This,0,0
221695,impairment,0,0
221696,takes,0,0
221697,the,0,0
221698,form,0,0
221699,of,0,0
221700,mild,0,0
221701,to,0,0
221702,moderate,0,0
221703,shoulder,0,0
221704,pain,0,0
221705,.,0,0
221706,Eliminating,0,0
221707,the,0,0
221708,causes,0,0
221709,of,0,0
221710,pain,0,0
221711,has,0,0
221712,a,0,0
221713,clear,0,0
221714,advantage,0,0
221715,over,0,0
221716,symptomatic,0,0
221717,treatment,0,0
221718,using,0,0
221719,analgetics,0,1
221720,",",0,0
221721,a,0,0
221722,fact,0,0
221723,worth,0,0
221724,a,0,0
221725,good,0,0
221726,consideration,0,0
221727,especially,0,0
221728,with,0,0
221729,the,0,0
221730,post-operative,0,0
221731,sojourn,0,0
221732,at,0,0
221733,the,0,0
221734,hospital,0,0
221735,becoming,0,0
221736,shorter,0,0
221737,and,0,0
221738,shorter,0,0
221739,.,0,0
221740,In,0,0
221741,a,0,0
221742,prospective,0,0
221743,controlled,0,0
221744,study,0,0
221745,",",0,0
221746,involving,0,0
221747,42,0,0
221748,patients,0,0
221749,subdivided,0,0
221750,into,0,0
221751,four,0,0
221752,groups,0,0
221753,namely,0,0
221754,",",0,0
221755,higher,1,0
221756,or,1,0
221757,lower,1,0
221758,insufflation,1,1
221759,pressures,1,0
221760,",",1,0
221761,chemically,1,0
221762,inert,1,1
221763,insufflation,1,1
221764,gas,1,1
221765,and,0,0
221766,control,1,1
221767,groups,0,0
221768,;,0,0
221769,the,0,0
221770,use,0,0
221771,of,0,0
221772,analgetics,0,1
221773,",",0,0
221774,lung,0,0
221775,function,0,0
221776,",",0,0
221777,operation,0,0
221778,duration,0,0
221779,",",0,0
221780,amount,0,0
221781,of,0,0
221782,insufflated,0,1
221783,gas,0,1
221784,",",0,0
221785,intraperitoneal,0,1
221786,pH-values,0,0
221787,and,0,0
221788,post-operative,0,0
221789,complications,0,0
221790,in,0,0
221791,the,0,0
221792,various,0,0
221793,subgroups,0,0
221794,were,0,0
221795,compared,0,0
221796,to,0,0
221797,each,0,0
221798,other,0,0
221799,with,0,0
221800,regard,0,0
221801,to,0,0
221802,post-operative,0,0
221803,pain,0,0
221804,perception,0,0
221805,.,0,0
221806,The,0,0
221807,results,0,0
221808,did,0,0
221809,not,0,0
221810,show,0,0
221811,any,0,0
221812,significant,0,0
221813,differences,0,0
221814,among,0,0
221815,the,0,0
221816,groups,0,0
221817,regarding,0,0
221818,the,0,0
221819,main,0,0
221820,parameters,0,0
221821,like,0,0
221822,pH-value,0,0
221823,or,0,1
221824,different,0,1
221825,insufflation,0,1
221826,pressures,0,0
221827,etc,0,0
221828,.,0,0
221829,These,0,0
221830,results,0,0
221831,led,0,0
221832,to,0,0
221833,the,0,0
221834,termination,0,0
221835,of,0,0
221836,the,0,0
221837,study,0,0
221838,based,0,0
221839,on,0,0
221840,the,0,0
221841,raised,0,0
221842,criteria,0,0
221843,since,0,0
221844,we,0,0
221845,anticipated,0,0
221846,the,0,0
221847,actual,0,0
221848,cause,0,0
221849,of,0,0
221850,the,0,0
221851,shoulder,0,0
221852,pain,0,0
221853,to,0,0
221854,be,0,0
221855,due,0,0
221856,to,0,0
221857,an,0,0
221858,unknown,0,0
221859,factor,0,0
221860,.,0,0
221861,By,0,0
221862,the,0,0
221863,evaluation,0,0
221864,of,0,0
221865,the,0,0
221866,individual,0,0
221867,data,0,0
221868,",",0,0
221869,it,0,0
221870,became,0,0
221871,apparent,0,0
221872,that,0,0
221873,",",0,0
221874,the,0,0
221875,pains,0,0
221876,increase,0,0
221877,with,0,0
221878,increasing,0,0
221879,gas,0,1
221880,consumption,0,0
221881,",",0,0
221882,a,0,0
221883,fact,0,0
221884,which,0,0
221885,led,0,0
221886,to,0,0
221887,assumption,0,0
221888,that,0,0
221889,the,0,0
221890,pains,0,0
221891,are,0,0
221892,caused,0,0
221893,by,0,0
221894,a,0,0
221895,physical,0,1
221896,effect,0,0
221897,such,0,0
221898,as,0,0
221899,the,0,0
221900,cooling,0,1
221901,of,0,0
221902,the,0,0
221903,peritoneum,0,0
221904,.,0,0
221905,Influence,0,0
221906,of,0,0
221907,ball,1,0
221908,weight,1,0
221909,on,0,0
221910,junior,0,0
221911,high,0,0
221912,school,0,0
221913,girls,0,0
221914,',0,0
221915,volleyball,0,1
221916,performance,0,0
221917,.,0,0
221918,This,0,0
221919,study,0,0
221920,was,0,0
221921,designed,0,0
221922,to,0,0
221923,investigate,0,0
221924,the,0,0
221925,influence,1,0
221926,of,1,0
221927,a,1,0
221928,lighter,1,0
221929,ball,1,0
221930,(,1,0
221931,Tachikara,1,1
221932,Volley,1,1
221933,Lite,1,1
221934,),1,0
221935,on,1,0
221936,72,1,0
221937,seventh-grade,1,0
221938,girls,1,0
221939,',1,0
221940,tournament,1,1
221941,game,1,1
221942,play,1,0
221943,and,1,0
221944,pretest-to-posttest,1,1
221945,improvement,1,0
221946,for,1,0
221947,a,1,0
221948,16-day,1,1
221949,volleyball,1,1
221950,practice,1,0
221951,period,1,0
221952,.,1,0
221953,Two,0,0
221954,intact,0,0
221955,classes,0,0
221956,were,0,0
221957,randomly,0,0
221958,assigned,0,0
221959,to,0,0
221960,groups,0,0
221961,",",0,0
221962,one,0,0
221963,of,0,0
221964,whom,0,0
221965,used,0,0
221966,lighter,1,0
221967,balls,1,0
221968,during,0,0
221969,skills,0,0
221970,progressions,0,0
221971,while,0,0
221972,a,0,0
221973,second,0,0
221974,used,0,0
221975,regulation,1,0
221976,balls,1,1
221977,.,1,0
221978,All,0,0
221979,students,0,0
221980,used,0,0
221981,regulation,1,0
221982,balls,1,1
221983,during,0,0
221984,tournament,0,1
221985,game,0,1
221986,play,0,0
221987,and,0,0
221988,skills,0,0
221989,tests,0,0
221990,.,0,0
221991,Both,0,0
221992,groups,0,0
221993,significantly,0,0
221994,improved,0,0
221995,the,0,0
221996,forearm,0,0
221997,pass,0,0
221998,from,0,0
221999,pretest,0,0
222000,to,0,0
222001,posttest,0,0
222002,.,0,0
222003,Analysis,0,0
222004,of,0,0
222005,covariance,0,0
222006,indicated,0,0
222007,no,0,0
222008,significant,0,0
222009,differences,0,0
222010,between,0,0
222011,groups,0,0
222012,on,0,0
222013,posttest,0,0
222014,means,0,0
222015,for,0,0
222016,any,0,0
222017,skill,0,0
222018,.,0,0
222019,A,0,0
222020,2,0,0
222021,x,0,0
222022,6,0,1
222023,(,0,0
222024,treatment,0,0
222025,x,0,0
222026,game,0,1
222027,day,0,1
222028,),0,1
222029,analysis,0,0
222030,of,0,0
222031,variance,0,0
222032,indicated,0,0
222033,that,0,0
222034,the,0,0
222035,group,0,0
222036,practicing,0,0
222037,with,0,0
222038,lighter,1,0
222039,balls,1,0
222040,had,0,0
222041,significantly,0,0
222042,more,0,0
222043,correct,0,0
222044,sets,0,0
222045,and,0,0
222046,a,0,0
222047,higher,0,0
222048,average,0,0
222049,daily,0,1
222050,success,0,0
222051,rate,0,0
222052,for,0,0
222053,the,0,0
222054,set,0,0
222055,and,0,0
222056,underhand,0,0
222057,serve,0,0
222058,on,0,0
222059,game,0,1
222060,days,0,0
222061,than,0,0
222062,the,0,0
222063,group,0,0
222064,using,0,0
222065,a,0,0
222066,regulation,1,0
222067,ball,1,0
222068,.,1,0
222069,Use,0,1
222070,and,0,0
222071,limitations,0,0
222072,of,0,0
222073,Holter,1,0
222074,electrocardiography,1,0
222075,in,0,0
222076,assessing,0,0
222077,drug,0,1
222078,therapy,0,1
222079,of,0,0
222080,myocardial,0,0
222081,ischemia,0,0
222082,during,0,0
222083,the,0,0
222084,peri-PTCA,0,0
222085,period,0,0
222086,.,0,1
222087,Incidence,0,0
222088,and,0,0
222089,pattern,0,0
222090,of,0,0
222091,myocardial,0,0
222092,ischemia,0,0
222093,during,0,0
222094,the,0,0
222095,peri-PTCA,0,0
222096,(,0,0
222097,percutaneous,0,1
222098,transluminal,0,1
222099,coronary,0,0
222100,angioplasty,0,1
222101,),0,1
222102,period,0,0
222103,and,0,0
222104,the,0,0
222105,possible,0,0
222106,role,0,0
222107,of,0,0
222108,continuous,1,1
222109,intravenous,1,1
222110,isosorbide,1,1
222111,dinitrate,1,1
222112,in,0,0
222113,its,0,0
222114,prevention,0,0
222115,were,0,0
222116,examined,0,0
222117,prospectively,0,0
222118,in,0,0
222119,30,0,0
222120,patients,0,0
222121,.,0,0
222122,Holter,1,0
222123,electrocardiographic,1,0
222124,monitoring,1,0
222125,was,0,0
222126,performed,0,0
222127,for,0,0
222128,21,0,0
222129,+/-,0,0
222130,3,0,0
222131,h,0,0
222132,before,0,0
222133,PTCA,0,0
222134,and,0,0
222135,continued,0,0
222136,during,0,0
222137,and,0,0
222138,for,0,0
222139,41,0,0
222140,+/-,0,0
222141,8,0,0
222142,h,0,0
222143,after,0,0
222144,the,0,0
222145,procedure,0,0
222146,.,0,0
222147,Before,0,0
222148,PTCA,0,0
222149,",",0,0
222150,19,0,0
222151,ischemic,0,0
222152,episodes,0,0
222153,were,0,0
222154,present,0,0
222155,in,0,0
222156,10,0,0
222157,(,0,0
222158,33,0,0
222159,%,0,0
222160,),0,0
222161,of,0,0
222162,30,0,0
222163,patients,0,0
222164,.,0,0
222165,PTCA,0,0
222166,produced,0,0
222167,an,0,0
222168,abrupt,0,0
222169,decrease,0,0
222170,in,0,0
222171,number,0,0
222172,(,0,0
222173,p,0,0
222174,=,0,0
222175,0.015,0,0
222176,),0,0
222177,and,0,0
222178,duration,0,0
222179,(,0,1
222180,p,0,0
222181,=,0,0
222182,0.03,0,0
222183,),0,0
222184,of,0,0
222185,spontaneous,0,0
222186,ischemic,0,0
222187,episodes,0,0
222188,.,0,0
222189,The,0,0
222190,rarity,0,0
222191,of,0,0
222192,recurrent,0,0
222193,myocardial,0,0
222194,ischemic,0,0
222195,events,0,0
222196,by,0,0
222197,Holter,1,0
222198,monitoring,1,1
222199,after,0,0
222200,PTCA,0,0
222201,negated,0,0
222202,any,0,0
222203,attempt,0,0
222204,at,0,0
222205,assessing,0,0
222206,the,0,0
222207,efficacy,0,0
222208,of,0,0
222209,intravenous,0,1
222210,isosorbide,1,1
222211,dinitrate,1,1
222212,in,0,0
222213,their,0,0
222214,prevention,0,0
222215,.,0,0
222216,Holter,1,0
222217,monitoring,1,0
222218,could,0,0
222219,not,0,0
222220,be,0,0
222221,used,0,0
222222,as,0,0
222223,an,0,0
222224,early,0,0
222225,predictor,0,0
222226,of,0,0
222227,late,0,0
222228,coronary,0,0
222229,restenosis,0,0
222230,.,0,0
222231,Brief,0,1
222232,report,0,0
222233,:,0,0
222234,a,0,0
222235,controlled,0,0
222236,evaluation,0,0
222237,of,0,0
222238,facilitated,0,0
222239,communication,0,1
222240,using,0,0
222241,open-ended,1,1
222242,and,1,0
222243,fill-in,1,0
222244,questions,1,0
222245,.,1,0
222246,The,0,0
222247,degrees,0,0
222248,of,0,0
222249,UVB-induced,0,0
222250,erythema,0,0
222251,and,0,0
222252,pigmentation,0,0
222253,correlate,0,0
222254,linearly,0,0
222255,and,0,0
222256,are,0,0
222257,reduced,0,0
222258,in,0,0
222259,a,0,0
222260,parallel,0,0
222261,manner,0,0
222262,by,0,0
222263,topical,1,1
222264,anti-inflammatory,1,1
222265,agents,1,0
222266,.,1,0
222267,To,0,0
222268,examine,0,0
222269,whether,0,0
222270,it,0,0
222271,is,0,0
222272,possible,0,0
222273,to,0,0
222274,evaluate,0,0
222275,the,0,0
222276,degree,0,0
222277,of,0,0
222278,ultraviolet,1,1
222279,B,1,1
222280,(,1,1
222281,UVB,1,1
222282,),1,1
222283,-induced,1,1
222284,inflammation,0,0
222285,by,0,0
222286,measuring,0,0
222287,the,0,0
222288,degree,0,0
222289,of,0,0
222290,hyperpigmentation,0,0
222291,",",0,0
222292,we,0,0
222293,investigated,0,0
222294,the,0,0
222295,relationship,0,0
222296,between,0,0
222297,UVB-induced,0,0
222298,erythema,0,0
222299,and,0,0
222300,the,0,0
222301,subsequent,0,0
222302,pigmentation,0,0
222303,quantitatively,0,0
222304,.,0,0
222305,At,0,0
222306,24,0,0
222307,h,0,0
222308,and,0,0
222309,7,0,0
222310,d,0,1
222311,after,0,0
222312,irradiation,0,1
222313,with,0,0
222314,erythemogenic,0,0
222315,doses,0,0
222316,of,0,0
222317,UVB,0,0
222318,to,0,0
222319,the,0,0
222320,backs,0,1
222321,of,0,0
222322,16,0,0
222323,Japanese,0,0
222324,subjects,0,0
222325,",",0,0
222326,the,0,0
222327,degree,0,0
222328,of,0,0
222329,induced,0,0
222330,erythema,0,0
222331,(,0,0
222332,delta,0,0
222333,erythema,0,0
222334,index,0,0
222335,),0,1
222336,and,0,0
222337,that,0,0
222338,of,0,0
222339,pigmentation,0,1
222340,(,0,0
222341,delta,0,1
222342,melanin,0,1
222343,index,0,0
222344,),0,0
222345,were,0,0
222346,examined,0,0
222347,by,0,0
222348,an,0,0
222349,image,1,0
222350,analytic,1,0
222351,method,1,1
222352,using,1,0
222353,a,1,0
222354,videomicroscope,1,1
222355,interfaced,1,1
222356,with,1,0
222357,a,1,0
222358,computer,1,1
222359,.,1,0
222360,The,0,0
222361,relationship,0,0
222362,between,0,0
222363,two,0,0
222364,indices,0,0
222365,was,0,0
222366,linear,0,0
222367,in,0,0
222368,each,0,0
222369,subject,0,0
222370,",",0,0
222371,and,0,0
222372,the,0,0
222373,correlation,0,0
222374,coefficient,0,0
222375,was,0,0
222376,0.83,0,0
222377,when,0,0
222378,evaluated,0,0
222379,using,0,0
222380,whole,0,0
222381,data,0,0
222382,.,0,0
222383,The,0,0
222384,slope,0,0
222385,of,0,0
222386,the,0,0
222387,regression,0,0
222388,line,0,0
222389,for,0,0
222390,the,0,0
222391,delta,0,0
222392,melanin,0,0
222393,index,0,0
222394,against,0,0
222395,delta,0,0
222396,erythema,0,0
222397,index,0,0
222398,tended,0,0
222399,to,0,0
222400,become,0,0
222401,steeper,0,0
222402,as,0,0
222403,non-irradiated,0,1
222404,skin,0,0
222405,color,0,1
222406,became,0,0
222407,darker,0,0
222408,(,0,0
222409,r,0,0
222410,=,0,0
222411,0.63,0,0
222412,),0,0
222413,",",0,0
222414,suggesting,0,0
222415,that,0,0
222416,more,0,0
222417,efficient,0,0
222418,melanogenesis,0,1
222419,takes,0,0
222420,place,0,0
222421,after,0,0
222422,the,0,0
222423,same,0,0
222424,level,0,0
222425,of,0,0
222426,inflammation,0,0
222427,in,0,0
222428,the,0,0
222429,subject,0,0
222430,with,0,0
222431,darker,0,0
222432,skin,0,0
222433,.,0,0
222434,Both,0,1
222435,erythema,0,0
222436,and,0,0
222437,hyperpigmentation,0,0
222438,were,0,0
222439,suppressed,0,0
222440,significantly,0,0
222441,and,0,0
222442,in,0,0
222443,a,0,0
222444,parallel,0,0
222445,manner,0,0
222446,by,0,0
222447,corticosteroids,1,1
222448,and,0,0
222449,indomethacin,1,1
222450,applied,0,1
222451,topically,0,0
222452,immediately,0,0
222453,after,0,0
222454,UVB,0,1
222455,irradiation,0,1
222456,.,0,0
222457,These,0,0
222458,results,0,0
222459,imply,0,0
222460,that,0,0
222461,the,0,0
222462,post-inflammatory,0,0
222463,hyperpigmentation,0,0
222464,correlates,0,0
222465,closely,0,0
222466,with,0,0
222467,the,0,0
222468,severity,0,0
222469,of,0,0
222470,the,0,0
222471,prior,0,0
222472,inflammation,0,0
222473,and,0,0
222474,that,0,0
222475,chemical,0,0
222476,mediators,0,0
222477,released,0,0
222478,in,0,0
222479,the,0,0
222480,inflammatory,0,0
222481,process,0,0
222482,have,0,0
222483,considerable,0,0
222484,influence,0,0
222485,on,0,0
222486,the,0,0
222487,melanogenesis,0,0
222488,.,0,0
222489,We,0,0
222490,conclude,0,0
222491,that,0,0
222492,the,0,0
222493,measurement,0,0
222494,of,0,0
222495,UVB-induced,0,0
222496,hyperpigmentation,0,0
222497,can,0,0
222498,be,0,0
222499,utilized,0,0
222500,for,0,0
222501,the,0,0
222502,assessment,0,0
222503,of,0,0
222504,topical,1,1
222505,anti-inflammatory,1,1
222506,agents,1,0
222507,",",0,0
222508,unless,0,0
222509,these,0,0
222510,have,0,0
222511,direct,0,0
222512,actions,0,0
222513,on,0,0
222514,the,0,0
222515,tyrosinase,0,1
222516,activity,0,0
222517,of,0,0
222518,melanocytes,0,0
222519,.,0,0
222520,Therapy,0,1
222521,for,0,0
222522,progressive,0,0
222523,supranuclear,0,0
222524,palsy,0,0
222525,:,0,1
222526,past,0,0
222527,and,0,0
222528,future,0,0
222529,.,0,1
222530,Dysfunction,0,0
222531,of,0,0
222532,multiple,0,0
222533,brain,0,0
222534,systems,0,0
222535,in,0,0
222536,progressive,0,0
222537,supranuclear,0,0
222538,palsy,0,0
222539,(,0,1
222540,PSP,0,1
222541,),0,1
222542,has,0,0
222543,complicated,0,0
222544,attempts,0,0
222545,to,0,0
222546,treat,0,0
222547,the,0,0
222548,disease,0,0
222549,.,0,0
222550,Neurotransmitter,1,0
222551,replacement,1,1
222552,strategies,1,0
222553,targeting,0,0
222554,the,0,0
222555,dopaminergic,0,0
222556,",",0,0
222557,cholinergic,0,0
222558,",",0,0
222559,and,0,0
222560,serotonergic,0,0
222561,systems,0,0
222562,have,0,0
222563,been,0,0
222564,unsuccessful,0,0
222565,.,0,0
222566,In,0,0
222567,order,0,0
222568,to,0,0
222569,bypass,0,1
222570,the,0,0
222571,degenerated,0,0
222572,cortico-striato-pallidal,0,0
222573,loop,0,0
222574,",",0,0
222575,we,0,0
222576,administered,0,0
222577,the,0,0
222578,adrenergic,1,1
222579,agonist,1,1
222580,idazoxan,1,1
222581,(,1,1
222582,IDA,1,0
222583,),1,1
222584,to,0,0
222585,treat,0,0
222586,PSP,0,0
222587,in,0,0
222588,two,0,0
222589,randomized,0,0
222590,double-blind,0,0
222591,",",0,0
222592,placebo,1,1
222593,controlled,0,0
222594,",",0,0
222595,crossover,0,0
222596,studies,0,0
222597,.,0,0
222598,Approximately,0,0
222599,one,0,0
222600,half,0,0
222601,of,0,0
222602,patients,0,0
222603,enrolled,0,0
222604,in,0,0
222605,these,0,0
222606,studies,0,0
222607,showed,0,0
222608,statistically,0,0
222609,significant,0,0
222610,improvement,0,0
222611,in,0,0
222612,balance,0,0
222613,and,0,0
222614,manual,0,1
222615,dexterity,0,1
222616,while,0,0
222617,taking,0,0
222618,IDA,0,0
222619,compared,0,0
222620,to,0,0
222621,placebo,1,1
222622,.,1,0
222623,These,0,0
222624,results,0,0
222625,suggest,0,0
222626,that,0,0
222627,new,0,0
222628,therapies,1,0
222629,that,0,0
222630,target,0,0
222631,structures,0,0
222632,outside,0,0
222633,of,0,0
222634,the,0,0
222635,basal,0,0
222636,ganglia,0,0
222637,may,0,0
222638,be,0,0
222639,useful,0,0
222640,for,0,0
222641,symptomatic,0,0
222642,treatment,0,0
222643,of,0,0
222644,PSP,0,0
222645,.,0,0
222646,Applying,0,0
222647,this,0,0
222648,strategy,0,0
222649,and,0,0
222650,developing,0,0
222651,treatments,0,1
222652,that,0,0
222653,arrest,0,0
222654,or,0,1
222655,reverse,0,1
222656,clinical,0,0
222657,deterioration,0,0
222658,in,0,0
222659,PSP,0,0
222660,will,0,0
222661,require,0,0
222662,improved,0,0
222663,understanding,0,0
222664,of,0,0
222665,the,0,0
222666,process,0,0
222667,underlying,0,0
222668,the,0,0
222669,illness,0,0
222670,.,0,0
222671,Osteocalcin,1,1
222672,in,0,0
222673,patients,0,0
222674,with,0,0
222675,rheumatoid,0,0
222676,arthritis,0,0
222677,.,0,0
222678,A,0,0
222679,one-year,0,0
222680,followup,0,0
222681,study,0,0
222682,.,0,0
222683,OBJECTIVE,0,0
222684,To,0,0
222685,analyze,0,0
222686,clinical,0,0
222687,",",0,0
222688,radiological,0,0
222689,",",0,0
222690,and,0,0
222691,drug,0,1
222692,(,0,1
222693,disease,0,0
222694,modifying,0,0
222695,antirheumatic,0,1
222696,drug,0,1
222697,",",0,0
222698,DMARD,0,1
222699,),0,1
222700,dependent,0,0
222701,factors,0,0
222702,influencing,0,0
222703,bone,0,0
222704,turnover,0,0
222705,in,0,0
222706,patients,0,0
222707,with,0,0
222708,rheumatoid,0,0
222709,arthritis,0,0
222710,(,0,1
222711,RA,0,0
222712,),0,0
222713,.,0,0
222714,METHODS,0,0
222715,We,0,0
222716,investigated,0,0
222717,in,0,0
222718,a,0,0
222719,one-year,0,0
222720,double,0,1
222721,blind,0,0
222722,randomized,0,0
222723,study,0,0
222724,comparing,0,0
222725,intramuscular,1,1
222726,(,1,1
222727,im,1,1
222728,),1,1
222729,gold,1,1
222730,with,1,0
222731,im,1,1
222732,methotrexate,1,1
222733,(,1,1
222734,MTX,1,1
222735,),1,0
222736,",",0,0
222737,whether,0,0
222738,the,0,0
222739,variation,0,0
222740,of,0,0
222741,inflammatory,0,0
222742,activity,0,0
222743,or,0,1
222744,functional,0,0
222745,capacity,0,0
222746,",",0,0
222747,the,0,0
222748,ascending,0,0
222749,anatomic,0,0
222750,stage,0,0
222751,",",0,0
222752,or,0,1
222753,DMARD,0,1
222754,treatments,0,1
222755,have,0,0
222756,an,0,0
222757,influence,0,0
222758,on,0,0
222759,bone,0,0
222760,formation,0,1
222761,(,0,1
222762,osteocalcin,0,0
222763,),0,1
222764,in,0,0
222765,patients,0,0
222766,with,0,0
222767,RA,0,0
222768,.,0,0
222769,RESULTS,0,0
222770,Patients,0,0
222771,(,0,0
222772,n,0,0
222773,=,0,0
222774,48,0,0
222775,),0,0
222776,enrolled,0,0
222777,at,0,0
222778,the,0,0
222779,beginning,0,0
222780,of,0,0
222781,our,0,0
222782,study,0,0
222783,had,0,0
222784,significantly,0,0
222785,increased,0,0
222786,osteocalcin,0,0
222787,levels,0,0
222788,(,0,0
222789,3.45,0,0
222790,+/-,0,0
222791,0.93,0,0
222792,--,0,0
222793,>,0,0
222794,4.42,0,0
222795,+/-,0,0
222796,1.39,0,0
222797,ng/ml,0,0
222798,p,0,0
222799,<,0,0
222800,0.02,0,0
222801,),0,0
222802,after,0,0
222803,one,0,0
222804,year,0,0
222805,if,0,0
222806,inflammatory,0,0
222807,activity,0,0
222808,decreased,0,0
222809,(,0,0
222810,>,0,0
222811,or,0,1
222812,=,0,0
222813,1,0,0
222814,SD,0,0
222815,:,0,0
222816,erythrocyte,0,0
222817,sedimentation,0,1
222818,rate,0,0
222819,(,0,1
222820,ESR,0,1
222821,),0,1
222822,26.4,0,0
222823,mm/h,0,0
222824,",",0,0
222825,C-reactive,0,1
222826,protein,0,1
222827,(,0,1
222828,CRP,0,1
222829,),0,1
222830,3.8,0,0
222831,mg/dl,0,0
222832,),0,0
222833,.,0,0
222834,We,0,0
222835,found,0,0
222836,a,0,0
222837,significant,0,0
222838,negative,0,0
222839,correlation,0,0
222840,of,0,0
222841,the,0,0
222842,one-year,0,0
222843,CRP-,0,1
222844,(,0,1
222845,r,0,0
222846,=,0,0
222847,-0.44,0,0
222848,",",0,0
222849,p,0,0
222850,<,0,0
222851,0.001,0,0
222852,),0,0
222853,or,0,1
222854,ESR,0,1
222855,differences,0,0
222856,(,0,0
222857,r,0,0
222858,=,0,0
222859,-0.45,0,0
222860,",",0,0
222861,p,0,0
222862,<,0,0
222863,0.001,0,0
222864,),0,0
222865,with,0,0
222866,the,0,0
222867,corresponding,0,0
222868,osteocalcin,0,0
222869,differences,0,0
222870,.,0,0
222871,This,0,0
222872,was,0,0
222873,also,0,0
222874,evident,0,0
222875,if,0,0
222876,these,0,0
222877,patients,0,0
222878,were,0,0
222879,pooled,0,0
222880,with,0,0
222881,15,0,0
222882,patients,0,0
222883,excluded,0,0
222884,from,0,0
222885,the,0,0
222886,double,0,1
222887,blind,0,0
222888,study,0,0
222889,as,0,0
222890,already,0,0
222891,receiving,0,0
222892,DMARD,1,1
222893,treatment,1,1
222894,(,0,0
222895,n,0,0
222896,=,0,0
222897,63,0,0
222898,;,0,0
222899,p,0,0
222900,<,0,0
222901,0.01,0,0
222902,),0,0
222903,.,0,0
222904,Patients,0,0
222905,with,0,0
222906,impaired,0,0
222907,functional,0,0
222908,capacity,0,0
222909,also,0,0
222910,had,0,0
222911,significantly,0,0
222912,reduced,0,0
222913,osteocalcin,0,0
222914,levels,0,0
222915,(,0,0
222916,p,0,0
222917,<,0,0
222918,0.01,0,0
222919,),0,0
222920,.,0,0
222921,In,0,0
222922,both,0,0
222923,cases,0,0
222924,",",0,0
222925,alkaline,0,0
222926,phosphatase,0,0
222927,showed,0,0
222928,no,0,0
222929,significant,0,0
222930,differences,0,0
222931,.,0,0
222932,CONCLUSIONS,0,0
222933,Our,0,0
222934,data,0,0
222935,suggest,0,0
222936,that,0,0
222937,osteocalcin,0,0
222938,",",0,0
222939,a,0,0
222940,useful,0,0
222941,followup,0,0
222942,variable,0,0
222943,of,0,0
222944,bone,0,0
222945,turnover,0,0
222946,",",0,0
222947,is,0,0
222948,changed,0,0
222949,significantly,0,0
222950,(,0,0
222951,p,0,0
222952,<,0,0
222953,0.02,0,0
222954,),0,0
222955,in,0,0
222956,patients,0,0
222957,with,0,0
222958,RA,0,0
222959,regarding,0,0
222960,inflammatory,0,0
222961,activity,0,0
222962,and,0,0
222963,functional,0,0
222964,capacity,0,0
222965,.,0,0
222966,In,0,0
222967,contrast,0,0
222968,to,0,0
222969,alkaline,0,0
222970,phosphatase,0,0
222971,",",0,0
222972,a,0,0
222973,fall,0,0
222974,in,0,0
222975,inflammatory,0,0
222976,activity,0,0
222977,stimulated,0,0
222978,and,0,0
222979,impairment,0,0
222980,of,0,0
222981,functional,0,0
222982,capacity,0,0
222983,significantly,0,0
222984,decreased,0,0
222985,osteocalcin,0,0
222986,levels,0,0
222987,in,0,0
222988,patients,0,0
222989,with,0,0
222990,RA,0,0
222991,.,0,0
222992,Correlation,0,0
222993,between,0,0
222994,in,0,0
222995,vivo,0,0
222996,humoral,0,0
222997,and,0,0
222998,in,0,0
222999,vitro,0,0
223000,cellular,0,0
223001,immune,0,0
223002,responses,0,0
223003,following,0,0
223004,immunization,0,1
223005,with,0,0
223006,hepatitis,1,1
223007,B,1,1
223008,surface,1,1
223009,antigen,1,0
223010,(,1,1
223011,HBsAg,1,1
223012,),1,0
223013,vaccines,1,1
223014,.,1,0
223015,To,0,0
223016,study,0,0
223017,the,0,0
223018,regulation,0,0
223019,of,0,0
223020,the,0,0
223021,human,0,1
223022,immune,0,0
223023,response,0,0
223024,to,0,0
223025,hepatitis,1,1
223026,B,1,1
223027,surface,1,1
223028,antigen,1,0
223029,(,1,1
223030,HBsAg,1,1
223031,),1,1
223032,we,0,0
223033,have,0,0
223034,carefully,0,0
223035,monitored,0,0
223036,the,0,0
223037,in,0,0
223038,vivo,0,0
223039,humoral,0,0
223040,and,0,0
223041,in,0,0
223042,vitro,0,0
223043,cellular,0,0
223044,immune,0,0
223045,responses,0,0
223046,to,0,0
223047,HBsAg,0,1
223048,in,0,0
223049,50,0,0
223050,subjects,0,0
223051,receiving,0,0
223052,four,0,0
223053,doses,0,0
223054,of,0,0
223055,hepatitis,1,0
223056,B,1,1
223057,vaccine,1,1
223058,according,0,0
223059,to,0,0
223060,a,0,0
223061,0,0,0
223062,",",0,0
223063,1,0,0
223064,",",0,0
223065,2,0,0
223066,",",0,0
223067,12,0,0
223068,month,0,0
223069,vaccination,0,1
223070,scheme,0,1
223071,.,0,0
223072,Twenty-three,0,0
223073,subjects,0,0
223074,were,0,0
223075,given,0,0
223076,a,0,0
223077,plasma-derived,1,1
223078,vaccine,1,1
223079,(,1,0
223080,Hevac,1,1
223081,B,1,1
223082,),1,1
223083,and,0,0
223084,27,0,0
223085,received,0,0
223086,a,0,0
223087,recombinant,1,1
223088,HBsAg,1,1
223089,vaccine,1,1
223090,(,1,0
223091,yeast-derived,1,1
223092,;,1,1
223093,Engerix-B,1,1
223094,),1,0
223095,.,1,0
223096,The,0,0
223097,humoral,0,0
223098,and,0,0
223099,cellular,0,0
223100,immune,0,0
223101,responses,0,0
223102,were,0,0
223103,measured,0,0
223104,before,0,0
223105,vaccination,0,1
223106,(,0,0
223107,day,0,1
223108,0,0,0
223109,),0,0
223110,;,0,0
223111,6,0,0
223112,days,0,0
223113,after,0,0
223114,the,0,0
223115,second,0,0
223116,dose,0,1
223117,(,0,1
223118,day,0,1
223119,36,0,0
223120,),0,0
223121,;,0,0
223122,6,0,0
223123,days,0,0
223124,(,0,0
223125,day,0,1
223126,66,0,0
223127,),0,0
223128,",",0,0
223129,2,0,0
223130,months,0,0
223131,(,0,0
223132,day,0,1
223133,120,0,1
223134,),0,0
223135,and,0,0
223136,10,0,1
223137,months,0,0
223138,(,0,0
223139,day,0,1
223140,365,0,0
223141,),0,0
223142,after,0,0
223143,the,0,0
223144,third,0,0
223145,dose,0,0
223146,and,0,0
223147,1,0,0
223148,month,0,0
223149,after,0,0
223150,the,0,0
223151,fourth,0,0
223152,dose,0,1
223153,(,0,1
223154,day,0,1
223155,395,0,0
223156,),0,0
223157,.,0,0
223158,Based,0,0
223159,on,0,0
223160,the,0,0
223161,kinetics,0,0
223162,of,0,0
223163,the,0,0
223164,humoral,0,0
223165,immune,0,0
223166,responses,0,0
223167,",",0,0
223168,the,0,0
223169,vaccinees,0,0
223170,could,0,0
223171,be,0,0
223172,classified,0,0
223173,into,0,0
223174,fast,0,0
223175,",",0,0
223176,intermediate,0,0
223177,and,0,0
223178,slow/non-responders,0,0
223179,.,0,0
223180,Based,0,0
223181,on,0,0
223182,the,0,0
223183,magnitude,0,0
223184,of,0,0
223185,the,0,0
223186,immune,0,0
223187,response,0,0
223188,(,0,1
223189,anti-HBs,0,1
223190,titre,0,0
223191,),0,1
223192,on,0,0
223193,day,0,0
223194,395,0,0
223195,",",0,0
223196,the,0,0
223197,vaccinees,0,0
223198,could,0,0
223199,be,0,0
223200,divided,0,0
223201,into,0,0
223202,high,0,0
223203,(,0,0
223204,>,0,0
223205,or,0,1
223206,=,0,0
223207,2000,0,0
223208,U,0,1
223209,l-1,0,1
223210,),0,1
223211,and,0,0
223212,low,0,0
223213,(,0,1
223214,<,0,0
223215,or,0,1
223216,=,0,0
223217,2000,0,0
223218,U,0,1
223219,l-1,0,1
223220,),0,0
223221,responders,0,0
223222,.,0,0
223223,A,0,0
223224,close,0,0
223225,correlation,0,0
223226,between,0,0
223227,the,0,0
223228,kinetics,0,0
223229,and,0,0
223230,the,0,0
223231,magnitude,0,0
223232,of,0,0
223233,the,0,0
223234,humoral,0,0
223235,immune,0,0
223236,response,0,0
223237,was,0,0
223238,observed,0,0
223239,.,0,0
223240,The,0,0
223241,in,0,0
223242,vivo,0,0
223243,anti-HBs,0,1
223244,response,0,0
223245,was,0,0
223246,measured,0,0
223247,using,0,0
223248,commercially,0,0
223249,available,0,0
223250,immunoradiometric,0,0
223251,assays,0,0
223252,.,0,0
223253,The,0,0
223254,in,0,0
223255,vitro,0,0
223256,cellular,0,0
223257,immune,0,0
223258,response,0,0
223259,was,0,0
223260,measured,0,0
223261,using,0,0
223262,an,0,0
223263,HBsAg-specific,0,0
223264,lymphoproliferation,0,0
223265,assay,0,1
223266,.,0,0
223267,Because,0,0
223268,of,0,0
223269,interassay,0,0
223270,variability,0,0
223271,the,0,0
223272,results,0,0
223273,were,0,0
223274,considered,0,0
223275,as,0,0
223276,dichotomous,0,0
223277,variables,0,0
223278,(,0,0
223279,proliferation,0,0
223280,versus,0,1
223281,non-proliferation,0,0
223282,),0,0
223283,for,0,0
223284,further,0,0
223285,data,0,0
223286,analysis,0,0
223287,.,0,0
223288,A,0,0
223289,statistically,0,0
223290,significant,0,0
223291,correlation,0,0
223292,was,0,0
223293,observed,0,0
223294,between,0,0
223295,the,0,0
223296,kinetics,0,0
223297,and,0,0
223298,magnitude,0,0
223299,of,0,0
223300,the,0,0
223301,humoral,0,0
223302,immune,0,0
223303,response,0,0
223304,on,0,0
223305,the,0,0
223306,one,0,0
223307,hand,0,0
223308,and,0,0
223309,the,0,0
223310,in,0,0
223311,vitro,0,0
223312,anti-HBs,0,1
223313,response,0,0
223314,on,0,0
223315,the,0,0
223316,other,0,0
223317,hand,0,1
223318,.,0,1
223319,(,0,0
223320,ABSTRACT,0,1
223321,TRUNCATED,0,1
223322,AT,0,1
223323,250,0,1
223324,WORDS,0,1
223325,),0,1
223326,Treatment,0,1
223327,of,0,0
223328,multiple,0,0
223329,myeloma,0,1
223330,according,0,0
223331,to,0,0
223332,the,0,0
223333,extension,0,0
223334,of,0,0
223335,the,0,0
223336,disease,0,0
223337,:,0,0
223338,a,0,0
223339,prospective,0,0
223340,",",0,0
223341,randomised,0,0
223342,study,0,0
223343,comparing,0,0
223344,a,0,0
223345,less,0,0
223346,with,0,0
223347,a,0,0
223348,more,0,0
223349,aggressive,1,0
223350,cystostatic,1,1
223351,policy,0,0
223352,.,0,0
223353,Cooperative,0,0
223354,Group,0,0
223355,of,0,0
223356,Study,0,0
223357,and,0,0
223358,Treatment,0,1
223359,of,0,0
223360,Multiple,0,0
223361,Myeloma,0,1
223362,.,0,0
223363,The,0,0
223364,purpose,0,0
223365,of,0,0
223366,the,0,0
223367,study,0,0
223368,was,0,0
223369,to,0,0
223370,ascertain,0,0
223371,whether,0,0
223372,the,0,0
223373,prognostic,0,0
223374,significance,0,0
223375,of,0,0
223376,staging,0,0
223377,in,0,0
223378,multiple,0,1
223379,myeloma,0,1
223380,(,0,1
223381,MM,0,1
223382,),0,1
223383,is,0,0
223384,influenced,0,0
223385,by,0,0
223386,the,0,0
223387,aggressiveness,1,0
223388,of,1,0
223389,effective,1,0
223390,induction,1,1
223391,treatment,1,1
223392,and/or,0,0
223393,by,0,0
223394,continuing,0,0
223395,or,0,1
223396,discontinuing,0,1
223397,maintenance,1,0
223398,chemotherapy,1,1
223399,.,1,0
223400,Patients,0,0
223401,with,0,0
223402,untreated,0,0
223403,stage,0,0
223404,I,0,0
223405,MM,0,1
223406,(,0,1
223407,defined,0,0
223408,according,0,0
223409,to,0,0
223410,Durie,0,0
223411,and,0,1
223412,Salmon,0,1
223413,),0,1
223414,were,0,0
223415,randomised,0,0
223416,between,0,0
223417,being,0,0
223418,followed,1,1
223419,without,1,0
223420,cytostatics,1,1
223421,until,0,0
223422,the,0,0
223423,disease,0,0
223424,progressed,0,0
223425,and,0,0
223426,receiving,1,0
223427,six,1,0
223428,courses,1,1
223429,of,1,0
223430,melphalan,1,1
223431,and,1,1
223432,prednisone,1,1
223433,(,1,1
223434,MP-P,1,1
223435,),1,1
223436,just,0,0
223437,after,0,0
223438,diagnosis,0,0
223439,;,0,0
223440,stage,0,0
223441,II,0,0
223442,patients,0,0
223443,were,0,0
223444,uniformly,0,0
223445,treated,0,0
223446,with,0,0
223447,MPH-P,1,1
223448,and,0,0
223449,stage,0,0
223450,III,0,0
223451,patients,0,0
223452,were,0,0
223453,randomised,0,0
223454,between,0,0
223455,MPH-P,1,0
223456,and,1,0
223457,four,1,0
223458,courses,1,1
223459,of,1,0
223460,combination,1,1
223461,chemotherapy,1,1
223462,with,1,0
223463,Peptichemio,1,1
223464,",",1,0
223465,vincristine,1,1
223466,and,1,1
223467,prednisone,1,1
223468,(,1,1
223469,PTC-VCR-P,1,0
223470,),1,0
223471,.,1,0
223472,Within,0,0
223473,each,0,0
223474,stage,0,0
223475,",",0,0
223476,responsive,0,0
223477,patients,0,0
223478,were,0,0
223479,randomised,0,0
223480,between,0,0
223481,receiving,0,0
223482,additional,0,0
223483,therapy,0,1
223484,only,0,0
223485,until,0,0
223486,maximal,0,0
223487,tumour,0,0
223488,reduction,0,0
223489,was,0,0
223490,reached,0,0
223491,(,0,0
223492,plateau,0,0
223493,phase,0,0
223494,),0,1
223495,and,0,0
223496,continuing,0,1
223497,induction,0,1
223498,therapy,0,1
223499,indefinitely,0,0
223500,until,0,0
223501,relapse,0,0
223502,.,0,0
223503,With,0,0
223504,resistant,0,0
223505,",",0,0
223506,progressive,0,0
223507,or,0,1
223508,relapsing,0,0
223509,disease,0,0
223510,",",0,0
223511,patients,0,0
223512,originally,0,0
223513,treated,0,0
223514,with,0,0
223515,MPH-P,1,0
223516,for,0,0
223517,induction,0,0
223518,received,0,1
223519,combination,0,1
223520,chemotherapy,0,1
223521,and,0,0
223522,vice,0,0
223523,versa,0,0
223524,.,0,0
223525,The,0,0
223526,overall,0,0
223527,first,0,0
223528,response,0,0
223529,rate,0,0
223530,was,0,0
223531,43.8,0,0
223532,%,0,0
223533,(,0,0
223534,42.2,0,0
223535,%,0,0
223536,in,0,0
223537,206,0,0
223538,stage,0,0
223539,I,0,0
223540,",",0,0
223541,II,0,0
223542,and,0,0
223543,III,0,0
223544,patients,0,0
223545,treated,0,0
223546,with,0,0
223547,MPH-P,1,0
223548,and,0,0
223549,48.0,0,0
223550,%,0,0
223551,in,0,0
223552,75,0,0
223553,stage,0,0
223554,III,0,0
223555,patients,0,0
223556,treated,0,0
223557,with,0,0
223558,combination,1,1
223559,chemotherapy,1,1
223560,",",0,0
223561,P,0,0
223562,=,0,0
223563,NS,0,0
223564,),0,0
223565,.,0,0
223566,Combination,1,0
223567,chemotherapy,1,1
223568,was,0,0
223569,more,0,0
223570,myelotoxic,0,0
223571,than,0,0
223572,MPH-P,1,1
223573,and,0,0
223574,",",0,0
223575,in,0,0
223576,particular,0,0
223577,",",0,0
223578,caused,0,0
223579,more,0,0
223580,non-haematological,0,0
223581,side-effects,0,0
223582,.,0,0
223583,Both,0,0
223584,the,0,0
223585,less,0,0
223586,and,0,0
223587,the,0,0
223588,more,0,0
223589,aggressive,0,0
223590,induction,0,0
223591,policies,0,0
223592,gave,0,0
223593,the,0,0
223594,same,0,0
223595,disease,0,0
223596,control,0,1
223597,.,0,0
223598,Progression,0,0
223599,of,0,0
223600,disease,0,0
223601,was,0,0
223602,statistically,0,0
223603,similar,0,0
223604,in,0,0
223605,stage,0,0
223606,I,0,0
223607,patients,0,0
223608,who,0,0
223609,were,0,0
223610,initially,0,0
223611,left,0,0
223612,untreated,0,0
223613,and,0,0
223614,in,0,0
223615,t,0,0
223616,hose,0,1
223617,who,0,0
223618,received,0,0
223619,MPH-P,1,0
223620,just,0,0
223621,after,0,0
223622,diagnosis,0,0
223623,;,0,0
223624,median,0,0
223625,duration,0,0
223626,of,0,0
223627,first,0,0
223628,response,0,0
223629,was,0,0
223630,similar,0,0
223631,in,0,0
223632,stage,0,0
223633,III,0,0
223634,patients,0,0
223635,receiving,0,0
223636,MPH-P,1,1
223637,and,0,0
223638,in,0,0
223639,those,0,0
223640,on,0,0
223641,combination,1,1
223642,chemotherapy,1,1
223643,.,1,0
223644,In,0,0
223645,all,0,0
223646,stages,0,0
223647,",",0,0
223648,discontinuing,0,1
223649,or,0,1
223650,continuing,0,1
223651,maintenance,0,0
223652,did,0,0
223653,not,0,0
223654,alter,0,0
223655,the,0,0
223656,median,0,0
223657,duration,0,0
223658,of,0,0
223659,first,0,0
223660,response,0,0
223661,.,0,0
223662,The,0,0
223663,overall,0,0
223664,second,0,0
223665,response,0,0
223666,rate,0,0
223667,was,0,0
223668,28.5,0,0
223669,%,0,0
223670,(,0,0
223671,34.0,0,0
223672,%,0,0
223673,to,0,0
223674,MPH-P,0,1
223675,and,0,0
223676,25.3,0,0
223677,%,0,0
223678,to,0,0
223679,combination,0,1
223680,chemotherapy,1,1
223681,",",0,0
223682,P,0,0
223683,=,0,0
223684,NS,0,0
223685,),0,0
223686,.,0,0
223687,Median,0,0
223688,survival,0,0
223689,was,0,0
223690,greater,0,0
223691,than,0,0
223692,78,0,0
223693,months,0,0
223694,in,0,0
223695,stage,0,0
223696,I,0,0
223697,",",0,0
223698,was,0,0
223699,46.3,0,0
223700,months,0,0
223701,in,0,0
223702,stage,0,0
223703,II,0,1
223704,and,0,0
223705,was,0,0
223706,24.3,0,0
223707,months,0,0
223708,in,0,0
223709,stage,0,0
223710,III,0,0
223711,patients,0,0
223712,",",0,0
223713,still,0,0
223714,independent,0,0
223715,of,0,0
223716,both,0,0
223717,induction,0,0
223718,and,0,0
223719,post-induction,0,0
223720,policies,0,0
223721,.,0,0
223722,In,0,0
223723,MM,0,1
223724,",",0,0
223725,the,0,0
223726,significance,0,0
223727,of,0,0
223728,staging,0,0
223729,for,0,0
223730,survival,0,0
223731,is,0,0
223732,independent,0,0
223733,of,0,0
223734,both,0,0
223735,the,0,0
223736,aggressiveness,0,0
223737,of,0,0
223738,induction,0,0
223739,and,0,0
223740,of,0,0
223741,continuing,0,1
223742,or,0,1
223743,discontinuing,0,1
223744,maintenance,0,0
223745,chemotherapy,0,1
223746,after,0,0
223747,the,0,0
223748,maximal,0,0
223749,tumor,0,0
223750,reduction,0,0
223751,has,0,0
223752,been,0,0
223753,achieved,0,0
223754,.,0,0
223755,Both,0,1
223756,MPH-P,1,0
223757,and,0,0
223758,and,0,0
223759,the,0,0
223760,association,0,0
223761,of,0,0
223762,PTC,1,1
223763,",",1,0
223764,VCR,1,1
223765,and,1,0
223766,P,1,0
223767,are,0,0
223768,effective,0,0
223769,in,0,0
223770,inducing,0,0
223771,first,0,0
223772,response,0,0
223773,and,0,0
223774,also,0,0
223775,second,0,0
223776,response,0,0
223777,in,0,0
223778,patients,0,0
223779,failing,0,0
223780,on,0,0
223781,the,0,0
223782,alternative,0,0
223783,regimen,0,1
223784,",",0,0
223785,but,0,0
223786,PTC-VCR-P,1,0
223787,causes,0,0
223788,more,0,0
223789,side,0,0
223790,effects,0,0
223791,.,0,0
223792,Thus,0,0
223793,",",0,0
223794,the,0,0
223795,overwhelming,0,0
223796,majority,0,0
223797,of,0,0
223798,patients,0,0
223799,with,0,0
223800,MM,0,1
223801,can,0,0
223802,safely,0,0
223803,be,0,0
223804,given,0,0
223805,MPH-P,1,0
223806,as,0,0
223807,first,0,0
223808,therapy,0,1
223809,",",0,0
223810,and,0,0
223811,this,0,0
223812,treatment,0,0
223813,may,0,0
223814,be,0,0
223815,delayed,0,0
223816,in,0,0
223817,early,0,0
223818,diseases,0,0
223819,.,0,0
223820,Milk,0,1
223821,production,0,0
223822,in,0,0
223823,cows,0,0
223824,with,0,0
223825,endotoxin-induced,1,0
223826,mastitis,1,0
223827,treated,0,0
223828,with,0,0
223829,isotonic,1,1
223830,or,1,1
223831,hypertonic,1,1
223832,sodium,1,1
223833,chloride,1,1
223834,solution,1,1
223835,.,1,0
223836,Milk,0,1
223837,production,0,0
223838,was,0,0
223839,monitored,0,0
223840,in,0,0
223841,16,0,0
223842,cows,0,0
223843,for,0,0
223844,6,0,0
223845,milkings,0,0
223846,after,0,0
223847,intramammary,0,0
223848,infusion,0,1
223849,of,0,0
223850,1,0,0
223851,mg,0,1
223852,of,0,0
223853,endotoxin,1,0
223854,in,0,0
223855,a,0,0
223856,single,0,0
223857,forequarter,0,0
223858,.,0,0
223859,The,0,0
223860,cows,0,0
223861,were,0,0
223862,randomly,0,0
223863,assigned,0,0
223864,to,0,0
223865,1,0,0
223866,of,0,0
223867,2,0,0
223868,treatment,0,0
223869,groups,0,0
223870,;,0,0
223871,8,0,0
223872,cows,0,0
223873,were,0,0
223874,treated,0,0
223875,with,0,0
223876,isotonic,1,1
223877,saline,1,1
223878,solution,1,1
223879,and,0,0
223880,8,0,0
223881,cows,0,0
223882,were,0,0
223883,treated,0,0
223884,with,0,0
223885,hypertonic,1,1
223886,saline,1,1
223887,solution,1,1
223888,.,1,0
223889,Saline,1,0
223890,solutions,0,0
223891,were,0,0
223892,administered,0,0
223893,IV,0,0
223894,(,0,0
223895,5,0,1
223896,ml/kg,0,0
223897,of,0,0
223898,body,0,0
223899,weight,0,0
223900,),0,0
223901,4,0,0
223902,hours,0,0
223903,after,0,0
223904,infusion,0,1
223905,of,0,0
223906,endotoxin,1,0
223907,.,1,0
223908,Mean,0,0
223909,cumulative,0,0
223910,change,0,0
223911,in,0,0
223912,milk,0,1
223913,yield,0,0
223914,and,0,0
223915,interval,0,0
223916,change,0,0
223917,in,0,0
223918,milk,0,1
223919,yield,0,0
223920,were,0,0
223921,greater,0,0
223922,in,0,0
223923,cows,0,0
223924,treated,0,0
223925,with,0,0
223926,isotonic,0,1
223927,saline,0,1
223928,solution,1,1
223929,than,0,0
223930,in,0,0
223931,cows,0,0
223932,treated,0,0
223933,with,0,0
223934,hypertonic,1,1
223935,saline,1,1
223936,solution,1,1
223937,.,1,0
223938,Significant,0,0
223939,differences,0,0
223940,between,0,0
223941,treatment,0,0
223942,groups,0,0
223943,were,0,0
223944,not,0,0
223945,detected,0,0
223946,.,0,0
223947,Once,0,0
223948,versus,0,0
223949,thrice,0,1
223950,daily,1,1
223951,gentamicin,1,1
223952,in,0,0
223953,patients,0,0
223954,with,0,0
223955,serious,0,0
223956,infections,0,0
223957,.,0,0
223958,Aminoglycosides,0,0
223959,are,0,0
223960,usually,0,0
223961,given,0,0
223962,in,0,0
223963,two,0,0
223964,or,0,0
223965,three,0,0
223966,divided,0,0
223967,doses,0,0
223968,.,0,0
223969,A,0,0
223970,once-daily,0,1
223971,regimen,0,1
223972,might,0,0
223973,be,0,0
223974,more,0,0
223975,effective,0,0
223976,and,0,0
223977,less,0,0
223978,toxic,0,0
223979,.,0,0
223980,We,0,0
223981,have,0,0
223982,conducted,0,0
223983,a,0,0
223984,randomised,0,0
223985,trial,0,0
223986,in,0,0
223987,consecutive,0,0
223988,patients,0,0
223989,with,0,0
223990,serious,0,0
223991,infections,0,0
223992,for,0,0
223993,whom,0,0
223994,an,0,0
223995,aminoglycoside,1,1
223996,seemed,0,0
223997,warranted,0,0
223998,.,0,0
223999,Exclusion,0,0
224000,criteria,0,0
224001,were,0,0
224002,neutropenia,0,0
224003,or,0,1
224004,severely,0,0
224005,impaired,0,0
224006,renal,0,0
224007,function,0,0
224008,.,0,0
224009,123,0,0
224010,patients,0,0
224011,were,0,0
224012,enrolled,0,0
224013,.,0,0
224014,For,0,0
224015,efficacy,0,0
224016,analysis,0,0
224017,only,0,0
224018,those,0,0
224019,patients,0,0
224020,were,0,0
224021,considered,0,0
224022,in,0,0
224023,whom,0,0
224024,treatment,0,0
224025,with,0,0
224026,the,0,0
224027,aminoglycoside,0,1
224028,was,0,0
224029,not,0,0
224030,stopped,0,0
224031,within,0,0
224032,72,0,0
224033,h,0,0
224034,(,0,0
224035,n,0,0
224036,=,0,0
224037,67,0,0
224038,),0,0
224039,;,0,0
224040,toxicity,0,0
224041,was,0,0
224042,analysed,0,0
224043,on,0,0
224044,patients,0,0
224045,receiving,0,0
224046,aminoglycosides,1,1
224047,for,0,0
224048,more,0,0
224049,than,0,0
224050,48,0,0
224051,h,0,0
224052,and,0,0
224053,not,0,0
224054,using,0,0
224055,other,0,0
224056,nephrotoxic,0,0
224057,medication,0,1
224058,(,0,0
224059,n,0,0
224060,=,0,0
224061,85,0,0
224062,),0,0
224063,.,0,0
224064,Gentamicin,1,1
224065,4,1,0
224066,mg/kg,1,1
224067,every,1,1
224068,day,1,1
224069,(,1,1
224070,OD,1,1
224071,),1,1
224072,or,1,1
224073,gentamicin,1,1
224074,1.33,1,0
224075,mg/kg,1,1
224076,three,1,0
224077,times,1,0
224078,daily,1,1
224079,(,1,0
224080,MD,1,1
224081,),1,1
224082,(,1,0
224083,with,1,0
224084,dose-reduction,1,1
224085,in,1,0
224086,case,1,0
224087,of,1,0
224088,renal,1,0
224089,dysfunction,1,0
224090,),1,0
224091,were,0,0
224092,given,0,0
224093,intravenously,0,1
224094,.,0,0
224095,In,0,0
224096,almost,0,0
224097,all,0,0
224098,patients,0,0
224099,intravenous,1,1
224100,amoxycillin,1,1
224101,1,1,0
224102,g,1,1
224103,every,1,1
224104,6,1,0
224105,h,1,0
224106,was,0,0
224107,also,0,0
224108,started,0,0
224109,.,0,0
224110,Baseline,0,0
224111,characteristics,0,0
224112,were,0,0
224113,comparable,0,0
224114,in,0,0
224115,both,0,0
224116,arms,0,0
224117,.,0,0
224118,A,0,0
224119,good,0,0
224120,clinical,0,0
224121,response,0,0
224122,was,0,0
224123,observed,0,0
224124,in,0,0
224125,32/35,0,0
224126,(,0,0
224127,91,0,0
224128,%,0,0
224129,),0,0
224130,of,0,0
224131,the,0,0
224132,OD,1,1
224133,and,0,0
224134,in,0,0
224135,25/32,0,0
224136,(,0,0
224137,78,0,0
224138,%,0,0
224139,),0,0
224140,in,0,0
224141,the,0,0
224142,MD,1,1
224143,group,0,1
224144,(,0,0
224145,difference,0,0
224146,13,0,0
224147,%,0,0
224148,",",0,0
224149,95,0,0
224150,%,0,0
224151,confidence,0,0
224152,interval,0,0
224153,-6.4,0,0
224154,%,0,0
224155,to,0,0
224156,+26.9,0,0
224157,%,0,0
224158,),0,0
224159,.,0,0
224160,2,0,0
224161,patients,0,0
224162,in,0,0
224163,each,0,0
224164,group,0,0
224165,died,0,0
224166,with,0,0
224167,uncontrolled,0,0
224168,infection,0,0
224169,.,0,0
224170,An,0,0
224171,insufficient,0,0
224172,bacteriological,0,0
224173,response,0,0
224174,(,0,0
224175,persistent,0,0
224176,positive,0,0
224177,cultures,0,0
224178,",",0,0
224179,resistance,0,0
224180,",",0,0
224181,or,0,1
224182,superinfection,0,0
224183,),0,1
224184,was,0,0
224185,observed,0,0
224186,in,0,0
224187,2,0,0
224188,patients,0,0
224189,with,0,0
224190,OD,0,1
224191,and,0,0
224192,3,0,0
224193,patients,0,0
224194,with,0,0
224195,MD,0,1
224196,.,0,0
224197,In,0,0
224198,patients,0,0
224199,treated,0,0
224200,for,0,0
224201,more,0,0
224202,than,0,0
224203,48,0,0
224204,h,0,0
224205,duration,0,0
224206,of,0,0
224207,therapy,0,1
224208,and,0,0
224209,mean,0,0
224210,doses,0,0
224211,were,0,0
224212,7.0,0,0
224213,days,0,0
224214,(,0,0
224215,1590,0,0
224216,mg,0,1
224217,),0,0
224218,and,0,0
224219,7.4,0,0
224220,days,0,0
224221,(,0,0
224222,1672,0,0
224223,mg,0,1
224224,),0,0
224225,in,0,0
224226,OD,0,1
224227,and,0,0
224228,MD,0,1
224229,respectively,0,0
224230,.,0,0
224231,Mean,0,0
224232,first,0,0
224233,serum,0,0
224234,trough/peak,0,1
224235,levels,0,0
224236,were,0,0
224237,0.6/10.2,0,0
224238,mg/L,0,1
224239,and,0,0
224240,1.4/5.2,0,0
224241,mg/L,0,1
224242,.,0,0
224243,Nephrotoxicity,0,0
224244,(,0,0
224245,a,0,0
224246,rise,0,0
224247,in,0,0
224248,serum,0,0
224249,creatinine,0,0
224250,of,0,0
224251,45,0,0
224252,mumol/L,0,0
224253,or,0,0
224254,more,0,0
224255,),0,0
224256,developed,0,0
224257,in,0,0
224258,2/40,0,0
224259,(,0,0
224260,5,0,1
224261,%,0,0
224262,),0,0
224263,in,0,0
224264,OD,1,1
224265,and,0,0
224266,11/45,0,0
224267,(,0,0
224268,24,0,0
224269,%,0,0
224270,),0,0
224271,in,0,0
224272,MD,1,1
224273,(,0,0
224274,p,0,0
224275,=,0,0
224276,0.016,0,0
224277,),0,0
224278,.,0,0
224279,Risk,0,0
224280,factors,0,0
224281,for,0,0
224282,nephrotoxicity,0,0
224283,were,0,0
224284,duration,0,0
224285,of,0,0
224286,therapy,0,1
224287,and,0,0
224288,baseline,0,0
224289,creatinine,0,0
224290,clearance,0,0
224291,rate,0,0
224292,.,0,0
224293,High-tone,0,1
224294,audiometry,0,0
224295,was,0,0
224296,performed,0,0
224297,when,0,0
224298,possible,0,0
224299,;,0,0
224300,no,0,0
224301,significant,0,0
224302,differences,0,0
224303,were,0,0
224304,found,0,0
224305,in,0,0
224306,hearing,0,0
224307,loss,0,0
224308,(,0,1
224309,3/12,0,1
224310,and,0,0
224311,3/11,0,0
224312,),0,0
224313,or,0,1
224314,prodromal,0,0
224315,signs,0,0
224316,of,0,0
224317,ototoxicity,0,0
224318,(,0,0
224319,5/12,0,0
224320,and,0,0
224321,4/11,0,0
224322,),0,0
224323,.,0,0
224324,A,0,0
224325,once-daily,1,1
224326,dosing,1,0
224327,regimen,1,1
224328,of,1,0
224329,gentamicin,1,1
224330,is,0,0
224331,at,0,0
224332,least,0,0
224333,as,0,0
224334,effective,0,0
224335,as,0,0
224336,and,0,0
224337,is,0,0
224338,less,0,0
224339,nephrotoxic,0,0
224340,than,0,0
224341,more,0,0
224342,frequent,0,0
224343,dosing,0,0
224344,.,0,0
224345,Citalopram,1,1
224346,for,0,0
224347,post-stroke,0,0
224348,pathological,0,0
224349,crying,0,0
224350,.,0,0
224351,Post-stroke,0,1
224352,pathological,0,0
224353,crying,0,0
224354,is,0,0
224355,a,0,0
224356,distressing,0,0
224357,condition,0,0
224358,in,0,0
224359,which,0,0
224360,episodes,0,0
224361,occur,0,0
224362,in,0,0
224363,response,0,0
224364,to,0,0
224365,minor,0,0
224366,stimuli,0,1
224367,without,0,0
224368,associated,0,0
224369,mood,0,0
224370,changes,0,0
224371,.,0,0
224372,There,0,0
224373,is,0,0
224374,preliminary,0,0
224375,evidence,0,0
224376,of,0,0
224377,disturbed,0,0
224378,serotoninergic,0,1
224379,neurotransmission,0,0
224380,in,0,0
224381,such,0,0
224382,cases,0,0
224383,.,0,0
224384,We,0,0
224385,investigated,0,0
224386,the,0,0
224387,effect,0,0
224388,of,0,0
224389,the,0,0
224390,selective,0,0
224391,serotonin,0,1
224392,reuptake,0,1
224393,inhibitor,0,1
224394,citalopram,1,1
224395,on,0,0
224396,uncontrolled,0,0
224397,crying,0,0
224398,in,0,0
224399,stroke,0,0
224400,patients,0,0
224401,in,0,0
224402,a,0,0
224403,double-blind,0,0
224404,placebo-controlled,0,1
224405,crossover,0,0
224406,study,0,0
224407,.,0,0
224408,16,0,0
224409,consecutive,0,0
224410,patients,0,0
224411,(,0,0
224412,median,0,0
224413,age,0,0
224414,58.5,0,0
224415,years,0,0
224416,",",0,0
224417,range,0,0
224418,40-83,0,0
224419,),0,0
224420,entered,0,0
224421,the,0,0
224422,9-week,1,0
224423,study,1,0
224424,a,1,0
224425,median,1,0
224426,of,1,0
224427,168,1,0
224428,days,1,0
224429,(,1,0
224430,range,1,0
224431,6-913,1,0
224432,),1,1
224433,post,1,0
224434,stroke,1,0
224435,and,1,0
224436,were,1,0
224437,treated,1,0
224438,with,1,0
224439,citalopram,1,1
224440,10-20,1,0
224441,mg,1,1
224442,daily,1,0
224443,for,1,0
224444,3,1,0
224445,weeks,1,0
224446,.,1,0
224447,Crying,1,0
224448,history,1,0
224449,was,1,0
224450,determined,1,0
224451,from,1,0
224452,semistructured,1,0
224453,interviews,1,1
224454,and,1,0
224455,from,1,0
224456,diaries,1,1
224457,kept,1,0
224458,by,1,0
224459,the,1,0
224460,patients,1,0
224461,.,1,0
224462,Psychiatric,0,0
224463,assessment,0,0
224464,was,0,0
224465,made,0,0
224466,with,0,0
224467,the,0,0
224468,Hamilton,0,0
224469,depression,0,1
224470,scale,0,0
224471,(,0,1
224472,HDS,0,1
224473,),0,1
224474,",",0,0
224475,and,0,0
224476,unwanted,0,0
224477,effects,0,0
224478,were,0,0
224479,measured,0,0
224480,with,0,0
224481,the,0,0
224482,UKU,0,1
224483,side-effect,0,0
224484,scale,0,0
224485,.,0,0
224486,In,0,0
224487,13,0,0
224488,patients,0,0
224489,in,0,0
224490,whom,0,0
224491,frequency,0,0
224492,of,0,0
224493,crying,0,0
224494,could,0,0
224495,be,0,0
224496,assessed,0,0
224497,",",0,0
224498,the,0,0
224499,number,0,0
224500,of,0,0
224501,daily,0,1
224502,crying,0,0
224503,episodes,0,0
224504,decreased,0,0
224505,by,0,0
224506,at,0,0
224507,least,0,0
224508,50,0,0
224509,%,0,0
224510,in,0,0
224511,all,0,0
224512,cases,0,0
224513,during,0,0
224514,citalopram,0,1
224515,treatment,0,0
224516,vs,0,0
224517,2,0,0
224518,patients,0,0
224519,during,0,0
224520,placebo,0,1
224521,treatment,0,1
224522,(,0,1
224523,p,0,0
224524,<,0,0
224525,0.005,0,0
224526,",",0,0
224527,McNemar,0,1
224528,'s,0,0
224529,test,0,0
224530,),0,0
224531,",",0,0
224532,the,0,0
224533,effect,0,0
224534,being,0,0
224535,rapid,0,0
224536,(,0,0
224537,1-3,0,1
224538,days,0,1
224539,),0,0
224540,and,0,0
224541,pronounced,0,0
224542,in,0,0
224543,11,0,0
224544,(,0,0
224545,73,0,0
224546,%,0,0
224547,),0,0
224548,.,0,0
224549,There,0,0
224550,was,0,0
224551,a,0,0
224552,concomitant,0,0
224553,significant,0,0
224554,decrease,0,0
224555,in,0,0
224556,depression,0,0
224557,rating,0,0
224558,from,0,0
224559,HDS,0,1
224560,8.9,0,0
224561,to,0,0
224562,5.3,0,0
224563,(,0,0
224564,p,0,0
224565,<,0,0
224566,0.005,0,0
224567,",",0,0
224568,Wilcoxon,0,0
224569,'s,0,0
224570,test,0,0
224571,),0,0
224572,.,0,0
224573,Citalopram,0,1
224574,was,0,0
224575,well,0,0
224576,tolerated,0,0
224577,",",0,0
224578,the,0,0
224579,few,0,0
224580,side-effects,0,0
224581,being,0,0
224582,mild,0,0
224583,and,0,0
224584,transient,0,0
224585,.,0,0
224586,We,0,0
224587,conclude,0,0
224588,that,0,0
224589,serotoninergic,0,1
224590,neurotransmission,0,0
224591,plays,0,0
224592,an,0,0
224593,important,0,0
224594,part,0,0
224595,in,0,0
224596,post-stroke,0,0
224597,pathological,0,0
224598,crying,0,0
224599,and,0,0
224600,that,0,0
224601,citalopram,1,1
224602,is,0,0
224603,an,0,0
224604,effective,0,0
224605,and,0,0
224606,well-tolerated,0,0
224607,treatment,0,0
224608,.,0,0
224609,Pain,0,0
224610,relief,0,0
224611,can,0,0
224612,reduce,0,0
224613,hypoxemia,0,0
224614,in,0,0
224615,distressed,0,0
224616,neonates,0,0
224617,during,0,0
224618,routine,0,0
224619,treatment,0,0
224620,procedures,0,0
224621,.,0,0
224622,OBJECTIVE,0,0
224623,To,0,0
224624,determine,0,0
224625,whether,0,0
224626,the,0,0
224627,use,0,0
224628,of,0,0
224629,opioids,1,1
224630,could,0,0
224631,reduce,0,0
224632,the,0,0
224633,hypoxemia,0,0
224634,and,0,0
224635,hemodynamic,0,0
224636,instability,0,0
224637,associated,0,0
224638,with,0,0
224639,routine,0,0
224640,intensive,0,1
224641,care,0,1
224642,procedures,0,0
224643,in,0,0
224644,neonates,0,0
224645,with,0,0
224646,respiratory,0,0
224647,distress,0,0
224648,.,0,0
224649,DESIGN,0,0
224650,Randomized,0,0
224651,and,0,0
224652,placebo-controlled,1,1
224653,study,0,0
224654,.,0,0
224655,METHODS,0,0
224656,Physiological,0,0
224657,",",0,0
224658,plasma,0,0
224659,beta-endorphin,0,0
224660,",",0,0
224661,cortisol,0,0
224662,",",0,0
224663,and,0,0
224664,glucose,0,0
224665,responses,0,0
224666,to,0,0
224667,routine,0,0
224668,treatment,0,0
224669,procedures,0,0
224670,were,0,0
224671,studied,0,0
224672,in,0,0
224673,84,0,0
224674,mechanically,0,1
224675,ventilated,0,1
224676,distressed,0,0
224677,neonates,0,0
224678,randomized,0,0
224679,into,0,0
224680,groups,0,0
224681,receiving,0,0
224682,1,1,0
224683,mg/kg,1,1
224684,meperidine,1,1
224685,or,1,1
224686,0.9,1,1
224687,%,1,0
224688,saline,1,1
224689,15,0,0
224690,minutes,0,0
224691,before,0,0
224692,tracheal,1,1
224693,suction,1,1
224694,or,1,1
224695,routine,1,1
224696,nursing,1,1
224697,care,1,1
224698,.,1,0
224699,RESULTS,0,0
224700,The,0,0
224701,duration,0,0
224702,of,0,0
224703,hypoxemia,0,0
224704,(,0,0
224705,transcutaneous,0,1
224706,partial,0,0
224707,pressure,0,0
224708,of,0,0
224709,O2,0,1
224710,<,0,0
224711,6.6,0,0
224712,kPa,0,1
224713,(,0,0
224714,<,0,0
224715,50,0,1
224716,mm,0,0
224717,Hg,0,0
224718,),0,0
224719,and/or,0,0
224720,arterial,0,0
224721,blood,0,0
224722,oxygen,0,1
224723,saturation,0,0
224724,<,0,0
224725,80,0,0
224726,%,0,0
224727,),0,0
224728,during,0,0
224729,treatment,0,0
224730,procedures,0,0
224731,was,0,0
224732,significantly,0,0
224733,longer,0,0
224734,in,0,0
224735,the,0,0
224736,saline,0,1
224737,group,0,0
224738,(,0,0
224739,mean,0,0
224740,82,0,0
224741,vs,0,0
224742,36,0,0
224743,seconds,0,0
224744,",",0,0
224745,P,0,0
224746,=,0,0
224747,.001,0,0
224748,),0,1
224749,and,0,0
224750,distress,0,0
224751,quantified,0,0
224752,by,0,0
224753,a,0,0
224754,novel,0,0
224755,behavioral,0,1
224756,scoring,0,0
224757,method,0,1
224758,was,0,0
224759,much,0,0
224760,higher,0,0
224761,.,0,0
224762,Changes,0,0
224763,in,0,0
224764,arterial,0,0
224765,blood,0,0
224766,pressure,0,0
224767,",",0,0
224768,heart,0,0
224769,rate,0,0
224770,",",0,0
224771,or,0,1
224772,plasma,0,0
224773,beta-endorphin,0,1
224774,",",0,0
224775,cortisol,0,0
224776,",",0,0
224777,and,0,0
224778,glucose,0,0
224779,concentration,0,0
224780,did,0,0
224781,not,0,0
224782,show,0,0
224783,any,0,0
224784,statistically,0,0
224785,significant,0,0
224786,differences,0,0
224787,between,0,0
224788,the,0,0
224789,groups,0,0
224790,.,0,0
224791,CONCLUSION,0,0
224792,Newborns,0,0
224793,with,0,0
224794,respiratory,0,0
224795,difficulties,0,0
224796,often,0,0
224797,suffer,0,0
224798,from,0,0
224799,hypoxemia,0,0
224800,during,0,0
224801,essential,0,0
224802,treatment,0,0
224803,procedures,0,0
224804,.,0,0
224805,The,0,0
224806,use,0,0
224807,of,0,0
224808,opioid,1,1
224809,analgesia,1,0
224810,may,0,0
224811,reduce,0,0
224812,the,0,0
224813,duration,0,0
224814,of,0,0
224815,hypoxemia,0,0
224816,and,0,0
224817,the,0,0
224818,associated,0,0
224819,distress,0,0
224820,and,0,0
224821,",",0,0
224822,therefore,0,0
224823,",",0,0
224824,may,0,0
224825,improve,0,0
224826,the,0,0
224827,long-term,0,0
224828,results,0,0
224829,of,0,0
224830,neonatal,0,0
224831,intensive,0,1
224832,care,0,1
224833,.,0,0
224834,Treatment,0,1
224835,with,0,0
224836,coumarin,1,1
224837,to,0,0
224838,prevent,0,0
224839,or,0,1
224840,delay,0,0
224841,recurrence,0,0
224842,of,0,0
224843,malignant,0,0
224844,melanoma,0,0
224845,.,0,0
224846,Both,0,1
224847,coumarin,1,1
224848,(,1,0
224849,"1,2-benzopyrone",1,1
224850,),1,0
224851,and,1,0
224852,warfarin,1,1
224853,(,1,1
224854,4-hydroxycoumarin,1,1
224855,),1,0
224856,have,0,0
224857,been,0,0
224858,shown,0,0
224859,to,0,0
224860,prevent,0,0
224861,the,0,0
224862,recurrence,0,0
224863,of,0,0
224864,malignant,0,0
224865,melanoma,0,0
224866,.,0,0
224867,Their,0,0
224868,action,0,0
224869,is,0,0
224870,macrophage-dependent,0,0
224871,and,0,0
224872,the,0,0
224873,dosage,0,0
224874,is,0,0
224875,critical,0,0
224876,.,0,0
224877,In,0,0
224878,1984,0,0
224879,a,0,0
224880,multicentre,0,0
224881,",",0,0
224882,prospective,0,0
224883,",",0,0
224884,randomised,0,0
224885,",",0,0
224886,double-blind,0,0
224887,trial,0,0
224888,of,0,0
224889,coumarin,1,1
224890,",",0,0
224891,given,0,0
224892,as,0,0
224893,a,0,0
224894,daily,0,1
224895,50-mg,0,1
224896,dose,0,0
224897,for,0,0
224898,2,0,0
224899,years,0,0
224900,after,0,0
224901,surgery,0,0
224902,in,0,0
224903,patients,0,0
224904,with,0,0
224905,high-risk,0,0
224906,melanoma,0,0
224907,",",0,0
224908,was,0,0
224909,started,0,0
224910,.,0,0
224911,the,0,0
224912,patients,0,0
224913,had,0,0
224914,lesions,0,0
224915,greater,0,0
224916,than,0,0
224917,1.70,0,0
224918,mm,0,0
224919,thick,0,0
224920,and,0,0
224921,TNM,0,1
224922,stage,0,0
224923,IB,0,1
224924,or,0,1
224925,stage,0,0
224926,II,0,1
224927,disease,0,0
224928,.,0,0
224929,To,0,0
224930,date,0,0
224931,there,0,0
224932,are,0,0
224933,4,0,0
224934,recurrences,0,0
224935,in,0,0
224936,the,0,0
224937,coumarin-treated,0,1
224938,group,0,0
224939,of,0,0
224940,13,0,0
224941,patients,0,0
224942,",",0,0
224943,and,0,0
224944,10,0,0
224945,recurrences,0,0
224946,in,0,0
224947,the,0,0
224948,placebo-treated,0,0
224949,group,0,0
224950,of,0,0
224951,14,0,0
224952,patients,0,0
224953,(,0,0
224954,P,0,0
224955,<,0,0
224956,0.01,0,0
224957,),0,0
224958,.,0,0
224959,There,0,0
224960,were,0,0
224961,no,0,0
224962,toxic,0,0
224963,effects,0,0
224964,.,0,0
224965,[,0,0
224966,A,0,0
224967,controlled,0,0
224968,study,0,0
224969,of,0,0
224970,treating,0,0
224971,haemophilia,0,0
224972,A,0,0
224973,on,0,0
224974,an,0,0
224975,out-patient,0,1
224976,basis,0,0
224977,(,0,1
224978,author,0,0
224979,'s,0,1
224980,transl,0,0
224981,),0,0
224982,],0,0
224983,.,0,0
224984,For,0,0
224985,six,0,0
224986,months,0,0
224987,36,1,0
224988,U,1,1
224989,factor,1,0
224990,VIII,1,1
224991,concentrates,1,1
224992,per,0,0
224993,kg,0,0
224994,bodyweight,0,1
224995,and,0,0
224996,week,0,0
224997,were,0,0
224998,administered,0,0
224999,to,0,0
225000,six,0,0
225001,out-patients,0,0
225002,with,0,0
225003,severe,0,0
225004,haemophilia,0,0
225005,A,0,0
225006,.,0,0
225007,The,0,0
225008,injection,0,0
225009,regimen,0,1
225010,was,0,0
225011,changed,0,0
225012,in,0,0
225013,every,0,1
225014,patient,0,0
225015,every,0,0
225016,two,0,0
225017,months,0,0
225018,",",0,0
225019,from,0,0
225020,36,0,0
225021,U/kg,0,1
225022,once,0,0
225023,to,0,0
225024,18,0,0
225025,U/kg,0,1
225026,twice,0,1
225027,and,0,0
225028,12,0,0
225029,U/kg,0,1
225030,three,0,0
225031,times,0,0
225032,",",0,0
225033,intravenously,0,0
225034,.,0,0
225035,The,0,0
225036,six,0,0
225037,possible,0,0
225038,combinations,0,0
225039,of,0,0
225040,these,0,0
225041,three,0,0
225042,dosage,0,0
225043,schedules,0,1
225044,were,0,0
225045,used,0,0
225046,in,0,0
225047,the,0,0
225048,patients,0,0
225049,in,0,0
225050,a,0,0
225051,strictly,0,1
225052,randomised,0,0
225053,manner,0,1
225054,",",0,0
225055,and,0,0
225056,all,0,0
225057,patients,0,0
225058,were,0,0
225059,treated,0,0
225060,during,0,0
225061,the,0,0
225062,same,0,0
225063,period,0,0
225064,.,0,0
225065,In,0,0
225066,the,0,0
225067,pre-trial,0,0
225068,period,0,0
225069,(,0,1
225070,treatment,0,0
225071,as,0,0
225072,needed,0,0
225073,),0,0
225074,there,0,0
225075,were,0,0
225076,an,0,0
225077,average,0,0
225078,of,0,0
225079,35,0,0
225080,bleedings,0,0
225081,per,0,0
225082,two,0,0
225083,months,0,0
225084,.,0,0
225085,On,0,0
225086,continual,0,0
225087,treatment,0,0
225088,there,0,0
225089,were,0,0
225090,21,0,0
225091,bleedings,0,0
225092,on,0,0
225093,weekly,0,1
225094,injections,0,1
225095,of,0,0
225096,36,0,0
225097,U,1,1
225098,factor,1,0
225099,VIII,1,0
225100,per,0,1
225101,kg,0,0
225102,",",0,0
225103,14,0,0
225104,on,0,0
225105,twice,0,0
225106,weekly,0,1
225107,18,0,0
225108,U/kg,0,1
225109,and,0,0
225110,none,0,0
225111,on,0,0
225112,12,0,0
225113,U/kg,0,1
225114,",",0,0
225115,three,0,0
225116,times,0,0
225117,weekly,0,0
225118,.,0,0
225119,The,0,0
225120,differences,0,0
225121,are,0,0
225122,statistically,0,0
225123,significant,0,0
225124,.,0,0
225125,The,0,0
225126,absence,0,0
225127,of,0,0
225128,bleeding,0,0
225129,on,0,0
225130,the,0,0
225131,last,0,0
225132,dosage,0,0
225133,schedule,0,1
225134,was,0,0
225135,achieved,0,0
225136,during,0,0
225137,normal,0,0
225138,working,0,0
225139,.,0,0
225140,Days,0,0
225141,lost,0,0
225142,from,0,0
225143,work,0,0
225144,per,0,0
225145,patient,0,0
225146,per,0,0
225147,month,0,0
225148,was,0,0
225149,zero,0,0
225150,on,0,0
225151,three,0,0
225152,times,0,0
225153,12,0,0
225154,U/kg,0,1
225155,",",0,0
225156,0.4,0,0
225157,day,0,0
225158,on,0,0
225159,twice,0,0
225160,18,0,0
225161,U/kg,0,1
225162,and,0,0
225163,once,0,1
225164,36,0,0
225165,U/kg,0,1
225166,",",0,0
225167,while,0,0
225168,it,0,0
225169,had,0,0
225170,been,0,0
225171,five,0,0
225172,days,0,0
225173,in,0,0
225174,the,0,0
225175,pre-trial,0,0
225176,period,0,0
225177,.,0,0
225178,In,0,0
225179,addition,0,0
225180,to,0,0
225181,freedom,0,0
225182,from,0,0
225183,bleeding,0,0
225184,and,0,0
225185,no,0,0
225186,lost,0,0
225187,days,0,0
225188,from,0,0
225189,work,0,0
225190,",",0,0
225191,there,0,0
225192,was,0,0
225193,increased,0,0
225194,mobility,0,0
225195,and,0,0
225196,physical,0,1
225197,capacity,0,0
225198,.,0,0
225199,Maternal,0,1
225200,erythropoietin,0,1
225201,in,0,0
225202,singleton,0,0
225203,pregnancies,0,0
225204,:,0,0
225205,a,0,0
225206,randomized,0,0
225207,trial,0,0
225208,on,0,0
225209,the,0,0
225210,effect,0,0
225211,of,0,0
225212,oral,0,1
225213,hematinic,0,1
225214,supplementation,1,1
225215,.,1,0
225216,OBJECTIVE,0,0
225217,Our,0,0
225218,purpose,0,0
225219,was,0,0
225220,to,0,0
225221,study,0,0
225222,the,0,0
225223,effect,0,0
225224,of,0,0
225225,hematinic,0,1
225226,supplementation,0,1
225227,on,0,0
225228,the,0,0
225229,maternal,0,0
225230,erythropoietin,0,1
225231,response,0,0
225232,during,0,0
225233,singleton,0,0
225234,pregnancy,0,0
225235,.,0,0
225236,STUDY,0,0
225237,DESIGN,0,0
225238,In,0,0
225239,a,0,0
225240,randomized,0,0
225241,",",0,0
225242,double-blind,0,0
225243,trial,0,0
225244,97,0,0
225245,patients,0,0
225246,with,0,0
225247,a,0,0
225248,first-trimester,0,1
225249,hemoglobin,0,0
225250,level,0,0
225251,>,0,0
225252,or,0,1
225253,=,0,0
225254,14.0,0,0
225255,gm/dl,0,0
225256,received,0,1
225257,either,0,1
225258,iron,1,1
225259,and,1,0
225260,folic,1,1
225261,acid,1,1
225262,(,0,1
225263,hematinic,0,1
225264,group,0,0
225265,",",0,0
225266,n,0,0
225267,=,0,0
225268,53,0,0
225269,),0,0
225270,or,0,1
225271,a,0,1
225272,placebo,1,1
225273,(,0,0
225274,n,0,0
225275,=,0,0
225276,44,0,0
225277,),0,0
225278,.,0,0
225279,Serial,0,0
225280,hemoglobin,0,0
225281,",",0,0
225282,hematocrit,0,0
225283,",",0,0
225284,and,0,0
225285,serum,0,0
225286,erythropoietin,0,1
225287,were,0,0
225288,recorded,0,0
225289,from,0,0
225290,maternal,0,0
225291,blood,0,0
225292,and,0,0
225293,from,0,0
225294,cord,0,0
225295,blood,0,0
225296,on,0,0
225297,delivery,0,0
225298,.,0,0
225299,Serum,0,0
225300,ferritin,0,1
225301,was,0,0
225302,measured,0,0
225303,in,0,0
225304,the,0,0
225305,first,0,0
225306,trimester,0,0
225307,",",0,0
225308,at,0,0
225309,36,0,0
225310,weeks,0,0
225311,',0,0
225312,gestation,0,0
225313,",",0,0
225314,and,0,0
225315,in,0,0
225316,cord,0,0
225317,blood,0,0
225318,.,0,0
225319,RESULTS,0,0
225320,In,0,0
225321,both,0,0
225322,groups,0,0
225323,(,0,0
225324,1,0,0
225325,),0,0
225326,the,0,0
225327,mean,0,0
225328,hemoglobin,0,0
225329,was,0,0
225330,lower,0,0
225331,(,0,0
225332,p,0,0
225333,<,0,0
225334,0.01,0,0
225335,),0,0
225336,at,0,0
225337,40,0,0
225338,weeks,0,0
225339,',0,0
225340,gestation,0,0
225341,than,0,0
225342,when,0,0
225343,first,0,0
225344,examined,0,0
225345,and,0,0
225346,(,0,0
225347,2,0,0
225348,),0,0
225349,the,0,0
225350,mean,0,0
225351,serum,0,0
225352,erythropoietin,0,1
225353,was,0,0
225354,higher,0,0
225355,(,0,0
225356,p,0,0
225357,<,0,0
225358,0.01,0,0
225359,),0,0
225360,.,0,0
225361,The,0,0
225362,mean,0,0
225363,serum,0,0
225364,ferritin,0,1
225365,was,0,0
225366,lower,0,0
225367,(,0,0
225368,p,0,0
225369,<,0,0
225370,0.001,0,0
225371,),0,0
225372,in,0,0
225373,both,0,0
225374,groups,0,0
225375,at,0,0
225376,36,0,0
225377,weeks,0,0
225378,',0,0
225379,gestation,0,0
225380,than,0,0
225381,at,0,0
225382,presentation,0,0
225383,but,0,0
225384,higher,0,0
225385,(,0,0
225386,p,0,0
225387,=,0,0
225388,0.04,0,0
225389,),0,0
225390,in,0,0
225391,the,0,0
225392,hematinic,0,1
225393,group,0,0
225394,than,0,0
225395,in,0,0
225396,the,0,0
225397,placebo,0,1
225398,group,0,0
225399,.,0,0
225400,The,0,0
225401,mean,0,0
225402,hemoglobin,0,0
225403,and,0,0
225404,hematocrit,0,0
225405,were,0,0
225406,similar,0,0
225407,in,0,0
225408,the,0,0
225409,two,0,0
225410,groups,0,0
225411,until,0,0
225412,the,0,0
225413,third,0,0
225414,trimester,0,0
225415,but,0,0
225416,thereafter,0,0
225417,were,0,0
225418,higher,0,0
225419,(,0,0
225420,p,0,0
225421,<,0,0
225422,0.05,0,0
225423,),0,0
225424,in,0,0
225425,the,0,0
225426,hematinic,0,1
225427,group,0,0
225428,.,0,0
225429,The,0,0
225430,mean,0,0
225431,maternal,0,0
225432,serum,0,0
225433,erythropoietin,0,1
225434,was,0,0
225435,higher,0,0
225436,(,0,0
225437,p,0,0
225438,<,0,0
225439,0.05,0,0
225440,),0,0
225441,in,0,0
225442,the,0,0
225443,placebo,0,1
225444,group,0,0
225445,than,0,0
225446,in,0,0
225447,the,0,0
225448,hematinic,0,1
225449,group,0,0
225450,after,0,0
225451,24,0,0
225452,weeks,0,0
225453,',0,0
225454,gestation,0,0
225455,.,0,0
225456,The,0,0
225457,mean,0,0
225458,cord,0,0
225459,blood,0,0
225460,hematologic,0,0
225461,values,0,0
225462,were,0,0
225463,similar,0,0
225464,in,0,0
225465,the,0,0
225466,two,0,0
225467,groups,0,0
225468,.,0,0
225469,CONCLUSION,0,0
225470,Maternal,0,1
225471,serum,0,0
225472,erythropoietin,0,1
225473,increased,0,0
225474,during,0,0
225475,pregnancy,0,0
225476,",",0,0
225477,but,0,0
225478,this,0,0
225479,response,0,0
225480,was,0,0
225481,reduced,0,0
225482,in,0,0
225483,the,0,0
225484,third,0,0
225485,trimester,0,0
225486,in,0,0
225487,the,0,0
225488,hematinic-supplemented,0,1
225489,group,0,0
225490,.,0,0
225491,Risk,0,0
225492,of,0,0
225493,aspiration,0,0
225494,with,0,0
225495,the,0,0
225496,laryngeal,1,0
225497,mask,0,1
225498,.,0,0
225499,In,0,0
225500,order,0,0
225501,to,0,0
225502,assess,0,0
225503,if,0,0
225504,the,0,0
225505,use,0,0
225506,of,0,0
225507,the,0,0
225508,laryngeal,0,0
225509,mask,0,1
225510,airway,0,0
225511,is,0,0
225512,associated,0,0
225513,with,0,0
225514,an,0,0
225515,increased,0,0
225516,risk,0,0
225517,of,0,0
225518,gastric,0,0
225519,regurgitation,0,0
225520,during,0,0
225521,mechanical,0,0
225522,ventilation,0,1
225523,",",0,0
225524,we,0,0
225525,studied,0,0
225526,50,0,0
225527,patients,0,0
225528,allocated,0,0
225529,randomly,0,0
225530,to,0,0
225531,undergo,0,0
225532,anaesthesia,1,1
225533,with,0,0
225534,either,0,1
225535,artificial,1,1
225536,ventilation,1,1
225537,with,1,0
225538,isoflurane,1,1
225539,and,1,0
225540,nitrous,1,1
225541,oxide,1,1
225542,in,1,0
225543,oxygen,1,1
225544,and,1,1
225545,atracurium,1,1
225546,(,0,1
225547,group,0,1
225548,A,0,1
225549,),0,1
225550,or,0,1
225551,spontaneous,1,0
225552,ventilation,1,1
225553,with,1,0
225554,isoflurane,1,1
225555,and,1,0
225556,nitrous,1,1
225557,oxide,1,1
225558,in,1,0
225559,oxygen,1,1
225560,(,0,0
225561,group,0,1
225562,B,0,1
225563,),0,0
225564,.,0,0
225565,In,0,0
225566,both,0,0
225567,groups,0,0
225568,a,0,0
225569,laryngeal,0,0
225570,mask,0,1
225571,airway,0,0
225572,was,0,0
225573,used,0,0
225574,.,0,0
225575,Regurgitation,0,0
225576,was,0,0
225577,assessed,0,0
225578,by,0,0
225579,the,0,0
225580,patient,0,0
225581,ingesting,0,1
225582,a,0,0
225583,methylene,1,1
225584,blue,1,1
225585,capsule,1,1
225586,10,0,1
225587,min,0,0
225588,before,0,0
225589,induction,0,0
225590,of,0,0
225591,anaesthesia,0,1
225592,and,0,0
225593,examining,0,0
225594,the,0,0
225595,oropharynx,0,0
225596,by,0,0
225597,direct,0,0
225598,laryngoscopy,0,1
225599,at,0,0
225600,the,0,0
225601,end,0,0
225602,of,0,0
225603,surgery,0,0
225604,.,0,0
225605,In,0,0
225606,one,0,0
225607,patient,0,0
225608,in,0,0
225609,each,0,0
225610,group,0,0
225611,",",0,0
225612,there,0,0
225613,was,0,0
225614,staining,0,0
225615,of,0,0
225616,the,0,0
225617,oropharynx,0,0
225618,with,0,0
225619,blue,0,1
225620,dye,0,1
225621,at,0,0
225622,the,0,0
225623,end,0,0
225624,of,0,0
225625,surgery,0,0
225626,.,0,0
225627,In,0,0
225628,the,0,0
225629,patient,0,0
225630,in,0,0
225631,group,0,0
225632,A,0,0
225633,",",0,0
225634,dye,0,1
225635,was,0,0
225636,present,0,0
225637,in,0,0
225638,the,0,0
225639,trachea,0,1
225640,and,0,0
225641,bronchi,0,0
225642,.,0,0
225643,[,0,0
225644,Effects,0,0
225645,of,0,0
225646,an,0,0
225647,intensive,1,1
225648,therapy,1,1
225649,program,1,1
225650,for,0,0
225651,behaviorally,0,0
225652,disordered,0,0
225653,mentally,0,0
225654,handicapped,0,0
225655,patients,0,0
225656,on,0,0
225657,staff,0,0
225658,personnel,0,1
225659,in,0,0
225660,residential,0,1
225661,care,0,1
225662,],0,0
225663,.,0,0
225664,This,0,0
225665,study,0,0
225666,evaluates,0,0
225667,the,0,0
225668,effects,0,0
225669,of,0,0
225670,an,0,0
225671,intensive,1,1
225672,therapy,1,1
225673,program,1,1
225674,designed,0,0
225675,for,0,0
225676,mentally,0,0
225677,handicapped,0,0
225678,persons,0,0
225679,with,0,0
225680,severely,0,0
225681,disturbed,0,0
225682,or,0,1
225683,autistic,0,0
225684,behavior,0,0
225685,on,0,0
225686,their,0,0
225687,staff,0,0
225688,personal,0,1
225689,which,0,0
225690,had,0,0
225691,an,0,0
225692,active,0,1
225693,role,0,0
225694,in,0,0
225695,the,0,0
225696,program,0,1
225697,.,0,0
225698,The,0,0
225699,staff,0,0
225700,members,0,0
225701,rated,0,0
225702,their,0,0
225703,professional,0,0
225704,competence,0,0
225705,",",0,0
225706,quality,0,0
225707,of,0,0
225708,interaction,0,0
225709,with,0,0
225710,the,0,0
225711,client,0,0
225712,",",0,0
225713,team,0,0
225714,culture,0,0
225715,and,0,0
225716,work,0,0
225717,satisfaction,0,0
225718,before,0,0
225719,and,0,0
225720,after,0,0
225721,being,0,0
225722,engaged,0,0
225723,in,0,0
225724,the,0,0
225725,program,0,1
225726,",",0,0
225727,with,0,0
225728,additional,0,0
225729,ratings,0,0
225730,of,0,0
225731,their,0,0
225732,personal,0,0
225733,aims,0,0
225734,at,0,0
225735,the,0,0
225736,beginning,0,0
225737,of,0,0
225738,the,0,0
225739,program,0,1
225740,.,0,0
225741,Three,0,0
225742,sets,0,0
225743,of,0,0
225744,data,0,0
225745,were,0,0
225746,obtained,0,0
225747,with,0,0
225748,the,0,0
225749,program,0,1
225750,being,0,0
225751,conducted,0,0
225752,three,0,0
225753,times,0,0
225754,in,0,0
225755,a,0,0
225756,row,0,0
225757,.,0,0
225758,The,0,0
225759,testings,0,0
225760,of,0,0
225761,the,0,0
225762,related,0,0
225763,as,0,0
225764,well,0,0
225765,as,0,0
225766,the,0,0
225767,independent,0,0
225768,samples,0,0
225769,show,0,0
225770,differentiated,0,0
225771,program,0,1
225772,effects,0,0
225773,.,0,0
225774,The,0,0
225775,main,0,0
225776,effect,0,0
225777,is,0,0
225778,an,0,0
225779,increase,0,0
225780,of,0,0
225781,the,0,0
225782,professional,0,0
225783,competence,0,0
225784,and,0,0
225785,quality,0,0
225786,of,0,0
225787,interaction,0,0
225788,",",0,0
225789,especially,0,0
225790,by,0,0
225791,the,0,0
225792,qualified,0,0
225793,staff,0,0
225794,members,0,0
225795,.,0,0
225796,Trainees,0,0
225797,put,0,0
225798,emphasis,0,0
225799,on,0,0
225800,the,0,0
225801,development,0,0
225802,of,0,0
225803,their,0,0
225804,personal,0,1
225805,relationship,0,0
225806,with,0,0
225807,the,0,0
225808,client,0,0
225809,.,0,0
225810,The,0,0
225811,results,0,0
225812,are,0,0
225813,discussed,0,0
225814,in,0,0
225815,terms,0,0
225816,of,0,0
225817,the,0,0
225818,impact,0,0
225819,of,0,0
225820,learning,0,1
225821,processes,0,0
225822,specific,0,0
225823,to,0,0
225824,the,0,0
225825,roles,0,0
225826,of,0,0
225827,the,0,0
225828,staff,0,0
225829,members,0,0
225830,and,0,0
225831,motivational,0,1
225832,factors,0,0
225833,on,0,0
225834,learning,0,1
225835,and,0,0
225836,therapy,0,1
225837,outcome,0,0
225838,",",0,0
225839,along,0,0
225840,with,0,0
225841,institutional,0,0
225842,conditions,0,0
225843,influencing,0,0
225844,successful,0,0
225845,learning,0,1
225846,.,0,0
225847,Thus,0,0
225848,the,0,0
225849,program,0,1
225850,facilitates,0,0
225851,the,0,0
225852,professional,0,0
225853,and,0,0
225854,interpersonal,0,1
225855,learning,0,1
225856,process,0,0
225857,of,0,0
225858,staff,0,0
225859,members,0,0
225860,in,0,0
225861,a,0,0
225862,specific,0,0
225863,way,0,0
225864,with,0,0
225865,success,0,0
225866,as,0,0
225867,well,0,0
225868,as,0,0
225869,with,0,0
225870,limitations,0,0
225871,.,0,0
225872,Evaluation,0,1
225873,of,0,0
225874,postural,0,0
225875,stability,0,0
225876,by,0,0
225877,computerised,1,1
225878,posturography,1,1
225879,following,0,0
225880,outpatient,0,1
225881,paediatric,1,0
225882,anaesthesia,1,1
225883,.,1,0
225884,Comparison,0,0
225885,of,0,0
225886,propofol/alfentanil/N2O,1,1
225887,anaesthesia,1,1
225888,with,1,0
225889,thiopentone/halothane/N2O,1,1
225890,anaesthesia,1,1
225891,.,1,0
225892,Simple,0,0
225893,clinical,0,0
225894,tests,0,0
225895,",",0,0
225896,like,0,0
225897,Romberg,0,0
225898,'s,0,0
225899,test,0,0
225900,or,0,1
225901,a,0,0
225902,walking,0,1
225903,test,0,0
225904,",",0,0
225905,have,0,0
225906,proved,0,0
225907,to,0,0
225908,be,0,0
225909,inadequate,0,0
225910,guidelines,0,0
225911,for,0,0
225912,safe,0,0
225913,discharge,0,1
225914,after,0,0
225915,outpatient,0,0
225916,anaesthesia,0,1
225917,.,0,0
225918,A,0,0
225919,randomised,0,0
225920,study,0,0
225921,was,0,0
225922,therefore,0,0
225923,planned,0,0
225924,to,0,0
225925,compare,0,0
225926,postural,0,0
225927,stability,0,0
225928,measured,0,0
225929,by,0,0
225930,computerised,0,1
225931,posturography,0,0
225932,in,0,0
225933,31,0,0
225934,oral,1,1
225935,midazolam-atropine,1,1
225936,premedicated,0,1
225937,children,0,0
225938,aged,0,0
225939,6.9,0,0
225940,(,0,0
225941,s.e,0,0
225942,.,0,1
225943,0.4,0,0
225944,),0,0
225945,years,0,0
225946,who,0,0
225947,had,0,0
225948,been,0,0
225949,anaesthetised,1,0
225950,with,0,0
225951,either,0,1
225952,propofol/alfentanil/N2O,1,1
225953,or,1,1
225954,thiopentone/halothane/N2O,1,1
225955,.,1,0
225956,The,0,0
225957,sway,0,0
225958,velocity,0,0
225959,of,0,0
225960,the,0,0
225961,children,0,0
225962,was,0,0
225963,measured,0,0
225964,before,0,0
225965,premedication,0,0
225966,and,0,0
225967,1,0,0
225968,",",0,0
225969,2,0,0
225970,and,0,0
225971,3,0,0
225972,h,0,0
225973,after,0,0
225974,the,0,0
225975,end,0,0
225976,of,0,0
225977,anaesthesia,0,1
225978,.,0,0
225979,Results,0,0
225980,show,0,0
225981,that,0,0
225982,sway,0,0
225983,velocity,0,0
225984,had,0,0
225985,returned,0,0
225986,to,0,0
225987,baseline,0,0
225988,values,0,0
225989,3,0,0
225990,h,0,0
225991,after,0,0
225992,the,0,0
225993,end,0,0
225994,of,0,0
225995,anaesthesia,0,1
225996,in,0,0
225997,all,0,0
225998,children,0,0
225999,who,0,0
226000,had,0,0
226001,received,0,0
226002,propofol/alfentanil/N2O,1,1
226003,and,0,0
226004,in,0,0
226005,12,0,0
226006,of,0,0
226007,the,0,0
226008,15,0,0
226009,children,0,0
226010,who,0,0
226011,had,0,0
226012,received,0,0
226013,thiopentone/halothane/N2O,1,1
226014,.,1,0
226015,The,0,0
226016,quantified,0,0
226017,version,0,0
226018,of,0,0
226019,the,0,0
226020,Romberg,0,0
226021,test,0,0
226022,performed,0,0
226023,with,0,0
226024,eyes,0,0
226025,open,0,1
226026,or,0,0
226027,closed,0,1
226028,was,0,0
226029,not,0,0
226030,impaired,0,0
226031,after,0,0
226032,anaesthesia,0,1
226033,",",0,0
226034,compared,0,0
226035,with,0,0
226036,the,0,0
226037,control,0,1
226038,values,0,0
226039,",",0,0
226040,indicating,0,0
226041,that,0,0
226042,in,0,0
226043,children,0,0
226044,poor,0,0
226045,equilibrium,0,0
226046,is,0,0
226047,not,0,0
226048,compensated,0,0
226049,by,0,0
226050,vision,0,0
226051,.,0,0
226052,The,0,0
226053,clinical,0,0
226054,recovery,0,0
226055,with,0,0
226056,respect,0,0
226057,to,0,0
226058,the,0,0
226059,times,0,0
226060,to,0,0
226061,eye,0,0
226062,opening,0,0
226063,",",0,0
226064,to,0,0
226065,responding,0,0
226066,to,0,0
226067,command,0,0
226068,or,0,1
226069,to,0,0
226070,being,0,0
226071,fully,0,0
226072,awake,0,1
226073,did,0,0
226074,not,0,0
226075,differ,0,0
226076,between,0,0
226077,the,0,0
226078,two,0,0
226079,anaesthesia,0,1
226080,methods,0,0
226081,.,0,0
226082,On,0,0
226083,the,0,0
226084,basis,0,0
226085,of,0,0
226086,recovery,0,0
226087,assessed,0,0
226088,by,0,0
226089,postural,0,0
226090,stability,0,0
226091,",",0,0
226092,propofol/alfentanil/N2O,1,1
226093,anaesthesia,1,1
226094,was,0,0
226095,not,0,0
226096,preferable,0,0
226097,to,0,0
226098,thiopentone/halothane/N2O,1,1
226099,anaesthesia,1,1
226100,after,0,0
226101,minor,0,0
226102,paediatric,0,0
226103,otolaryngological,1,0
226104,surgery,1,0
226105,.,1,0
226106,Cefprozil,1,1
226107,versus,1,1
226108,penicillin,1,1
226109,V,1,1
226110,in,0,0
226111,treatment,0,0
226112,of,0,0
226113,streptococcal,0,1
226114,tonsillopharyngitis,0,0
226115,.,0,0
226116,In,0,0
226117,a,0,0
226118,randomized,0,0
226119,multicenter,0,0
226120,study,0,0
226121,",",0,0
226122,the,0,0
226123,efficacy,0,0
226124,and,0,0
226125,safety,0,0
226126,of,0,0
226127,cefprozil,1,1
226128,were,0,0
226129,compared,0,0
226130,with,0,0
226131,those,0,0
226132,of,0,0
226133,penicillin,1,1
226134,in,0,0
226135,the,0,0
226136,treatment,0,0
226137,of,0,0
226138,group,0,0
226139,A,0,0
226140,streptococcal,0,1
226141,tonsillopharyngitis,0,0
226142,in,0,0
226143,children,0,0
226144,.,0,0
226145,Of,0,0
226146,the,0,0
226147,409,0,0
226148,patients,0,0
226149,enrolled,0,0
226150,",",0,0
226151,323,0,0
226152,were,0,0
226153,evaluable,0,0
226154,for,0,0
226155,their,0,0
226156,clinical,0,0
226157,and,0,0
226158,bacteriological,0,0
226159,responses,0,0
226160,;,0,0
226161,of,0,0
226162,these,0,0
226163,323,0,0
226164,children,0,0
226165,",",0,0
226166,172,0,0
226167,received,0,0
226168,cefprozil,1,1
226169,and,0,0
226170,151,0,0
226171,received,0,0
226172,penicillin,1,1
226173,V.,1,1
226174,The,0,0
226175,clinical,0,0
226176,responses,0,0
226177,in,0,0
226178,patients,0,0
226179,treated,0,0
226180,with,0,0
226181,cefprozil,1,1
226182,were,0,0
226183,significantly,0,0
226184,better,0,0
226185,than,0,0
226186,those,0,0
226187,in,0,0
226188,patients,0,0
226189,who,0,0
226190,received,0,1
226191,penicillin,1,1
226192,(,0,0
226193,95.3,0,0
226194,versus,0,1
226195,88.1,0,0
226196,%,0,0
226197,;,0,0
226198,P,0,0
226199,=,0,0
226200,0.023,0,0
226201,),0,0
226202,.,0,0
226203,Eradication,0,0
226204,of,0,0
226205,the,0,0
226206,original,0,0
226207,serotype,0,0
226208,of,0,0
226209,group,0,0
226210,A,0,0
226211,streptococci,0,1
226212,was,0,0
226213,achieved,0,0
226214,in,0,0
226215,91.3,0,0
226216,%,0,0
226217,of,0,0
226218,patients,0,0
226219,treated,0,0
226220,with,0,0
226221,cefprozil,1,1
226222,and,0,0
226223,87.4,0,0
226224,%,0,0
226225,of,0,0
226226,patients,0,0
226227,treated,0,0
226228,with,0,0
226229,penicillin,1,1
226230,",",0,0
226231,the,0,0
226232,difference,0,0
226233,not,0,0
226234,being,0,0
226235,statistically,0,0
226236,significant,0,0
226237,(,0,0
226238,P,0,0
226239,=,0,0
226240,0.125,0,1
226241,),0,0
226242,.,0,0
226243,However,0,0
226244,",",0,0
226245,there,0,0
226246,were,0,0
226247,significantly,0,0
226248,more,0,0
226249,symptomatic,0,0
226250,patients,0,0
226251,among,0,0
226252,the,0,0
226253,bacteriological,0,0
226254,failures,0,0
226255,in,0,0
226256,the,0,0
226257,penicillin,1,1
226258,group,0,0
226259,(,0,0
226260,68.4,0,0
226261,%,0,0
226262,),0,0
226263,than,0,0
226264,in,0,0
226265,the,0,0
226266,cefprozil,1,1
226267,group,0,0
226268,(,0,0
226269,26.7,0,0
226270,%,0,0
226271,),0,0
226272,.,0,0
226273,beta-Lactamase-producing,0,0
226274,Staphylococcus,0,1
226275,aureus,0,1
226276,was,0,0
226277,more,0,0
226278,frequently,0,0
226279,isolated,0,0
226280,from,0,0
226281,the,0,0
226282,throat,0,0
226283,flora,0,0
226284,during,0,0
226285,penicillin,1,1
226286,therapy,1,1
226287,than,0,0
226288,during,0,0
226289,cefprozil,1,1
226290,treatment,0,0
226291,.,0,0
226292,No,0,0
226293,difference,0,0
226294,in,0,0
226295,the,0,0
226296,incidence,0,0
226297,of,0,0
226298,adverse,0,0
226299,events,0,0
226300,probably,0,0
226301,related,0,0
226302,or,0,1
226303,of,0,0
226304,unknown,0,0
226305,relationship,0,0
226306,to,0,0
226307,the,0,0
226308,study,0,0
226309,drugs,0,1
226310,was,0,0
226311,observed,0,0
226312,in,0,0
226313,the,0,0
226314,two,0,0
226315,treatment,0,0
226316,groups,0,0
226317,(,0,0
226318,5.2,0,0
226319,%,0,0
226320,of,0,0
226321,those,0,0
226322,treated,0,0
226323,with,0,0
226324,cefprozil,1,1
226325,and,0,0
226326,6.0,0,0
226327,%,0,0
226328,of,0,0
226329,those,0,0
226330,treated,0,0
226331,with,0,0
226332,penicillin,1,1
226333,),1,0
226334,.,0,0
226335,Cefprozil,1,1
226336,can,0,0
226337,be,0,0
226338,considered,0,0
226339,a,0,0
226340,safe,0,0
226341,and,0,0
226342,reliable,0,0
226343,drug,0,1
226344,for,0,0
226345,the,0,0
226346,treatment,0,0
226347,of,0,0
226348,streptococcal,0,1
226349,pharyngitis,0,0
226350,in,0,0
226351,children,0,0
226352,.,0,0
226353,A,0,0
226354,workplace,1,0
226355,intervention,1,1
226356,for,0,0
226357,increasing,0,0
226358,outdoor,0,1
226359,workers,0,0
226360,',0,0
226361,use,0,0
226362,of,0,0
226363,solar,0,1
226364,protection,0,0
226365,.,0,0
226366,OBJECTIVES,0,0
226367,Outdoor,0,1
226368,workers,0,0
226369,are,0,0
226370,at,0,0
226371,high,0,0
226372,risk,0,0
226373,of,0,0
226374,developing,0,0
226375,skin,0,0
226376,cancer,0,0
226377,.,0,0
226378,Primary,0,0
226379,prevention,0,0
226380,in,0,0
226381,this,0,0
226382,group,0,0
226383,can,0,0
226384,potentially,0,0
226385,reduce,0,0
226386,the,0,0
226387,incidence,0,0
226388,of,0,0
226389,skin,0,0
226390,cancer,0,0
226391,",",0,0
226392,and,0,0
226393,also,0,0
226394,potentiates,0,0
226395,the,0,0
226396,spontaneous,0,0
226397,remission,0,0
226398,of,0,0
226399,existing,0,0
226400,solar,0,1
226401,keratoses,0,0
226402,.,0,0
226403,A,0,0
226404,randomized,0,0
226405,controlled,0,0
226406,trial,0,0
226407,was,0,0
226408,conducted,0,0
226409,to,0,0
226410,evaluate,0,0
226411,a,0,0
226412,solar,1,1
226413,protection,1,0
226414,intervention,1,1
226415,targeting,0,0
226416,outdoor,0,0
226417,workers,0,0
226418,.,0,0
226419,METHODS,0,0
226420,Outdoor,0,1
226421,workers,0,0
226422,were,0,0
226423,randomly,0,0
226424,allocated,0,0
226425,to,0,0
226426,an,0,0
226427,intervention,1,1
226428,(,0,0
226429,n,0,0
226430,=,0,0
226431,65,0,0
226432,),0,0
226433,or,1,1
226434,control,1,1
226435,group,1,1
226436,(,0,0
226437,n,0,0
226438,=,0,0
226439,77,0,0
226440,),0,0
226441,.,0,0
226442,The,0,0
226443,intervention,0,1
226444,group,0,0
226445,received,0,1
226446,individual,1,0
226447,skin,1,0
226448,screening,1,0
226449,by,1,0
226450,a,1,0
226451,dermatologist,1,0
226452,and,1,0
226453,participated,1,0
226454,in,1,0
226455,an,1,0
226456,education,1,1
226457,session,1,1
226458,.,1,0
226459,Pre-,0,0
226460,and,0,0
226461,posttest,0,0
226462,outcome,0,0
226463,measures,0,0
226464,included,0,0
226465,solar,0,1
226466,protection,0,1
226467,behavior,0,1
226468,(,0,1
226469,assessed,0,0
226470,using,0,0
226471,a,0,0
226472,validated,0,0
226473,diary,0,1
226474,),0,0
226475,",",0,0
226476,knowledge,0,0
226477,",",0,0
226478,and,0,0
226479,attitudes,0,0
226480,.,0,0
226481,RESULTS,0,0
226482,There,0,0
226483,was,0,0
226484,a,0,0
226485,significant,0,0
226486,increase,0,0
226487,(,0,0
226488,16,0,0
226489,%,0,0
226490,),0,0
226491,in,0,0
226492,the,0,0
226493,percentage,0,0
226494,of,0,0
226495,outdoor,0,0
226496,workers,0,0
226497,who,0,0
226498,were,0,0
226499,using,0,0
226500,a,0,0
226501,high,0,0
226502,level,0,0
226503,of,0,0
226504,solar,0,1
226505,protection,0,0
226506,at,0,0
226507,posttest,0,0
226508,compared,0,0
226509,to,0,0
226510,pretest,0,0
226511,in,0,0
226512,the,0,0
226513,intervention,0,1
226514,group,0,0
226515,",",0,0
226516,but,0,0
226517,there,0,0
226518,was,0,0
226519,no,0,0
226520,change,0,0
226521,in,0,0
226522,the,0,0
226523,control,0,0
226524,group,0,0
226525,.,0,0
226526,Although,0,0
226527,both,0,0
226528,groups,0,0
226529,improved,0,0
226530,in,0,0
226531,their,0,0
226532,knowledge,0,0
226533,score,0,0
226534,",",0,0
226535,the,0,0
226536,intervention,0,1
226537,group,0,0
226538,showed,0,0
226539,a,0,0
226540,significantly,0,0
226541,greater,0,0
226542,improvement,0,0
226543,at,0,0
226544,posttest,0,0
226545,.,0,0
226546,No,0,0
226547,changes,0,0
226548,in,0,0
226549,attitudes,0,0
226550,were,0,0
226551,detected,0,0
226552,.,0,0
226553,CONCLUSIONS,0,0
226554,The,0,0
226555,findings,0,0
226556,suggest,0,0
226557,that,0,0
226558,changes,0,0
226559,in,0,0
226560,solar,0,1
226561,protection,0,0
226562,are,0,0
226563,achievable,0,0
226564,with,0,0
226565,outdoor,0,0
226566,workers,0,0
226567,.,0,0
226568,MR,0,1
226569,imaging,0,0
226570,of,0,0
226571,pituitary,0,0
226572,region,0,0
226573,lesions,0,0
226574,with,0,0
226575,gadodiamide,1,1
226576,injection,0,1
226577,.,0,0
226578,Twelve,0,0
226579,patients,0,0
226580,with,0,0
226581,known,0,0
226582,or,0,1
226583,suspected,0,0
226584,pituitary,0,0
226585,lesions,0,0
226586,underwent,0,0
226587,MR,1,1
226588,imaging,1,0
226589,with,0,0
226590,gadodiamide,1,1
226591,injection,1,1
226592,at,0,0
226593,a,0,0
226594,dose,0,0
226595,of,0,0
226596,0.1,0,1
226597,(,0,0
226598,n,0,0
226599,=,0,0
226600,5,0,1
226601,),0,0
226602,or,0,1
226603,0.3,0,1
226604,(,0,0
226605,n,0,0
226606,=,0,0
226607,7,0,0
226608,),0,0
226609,mM/kg,0,1
226610,.,0,0
226611,Six,0,0
226612,of,0,0
226613,the,0,0
226614,patients,0,0
226615,were,0,0
226616,also,0,0
226617,studied,0,0
226618,with,0,0
226619,0.1,1,0
226620,mM/kg,1,1
226621,gadopentetate,1,1
226622,dimeglumine,1,1
226623,.,1,0
226624,Consistent,0,0
226625,with,0,0
226626,previous,0,0
226627,reports,0,0
226628,gadodiamide,1,1
226629,injection,0,1
226630,was,0,0
226631,found,0,0
226632,to,0,0
226633,be,0,0
226634,a,0,0
226635,safe,0,0
226636,and,0,0
226637,effective,0,0
226638,contrast,0,1
226639,medium,0,1
226640,for,0,0
226641,MR,0,1
226642,imaging,0,0
226643,of,0,0
226644,the,0,0
226645,pituitary,0,0
226646,region,0,0
226647,.,0,0
226648,No,0,0
226649,additional,0,0
226650,diagnostic,0,0
226651,information,0,0
226652,was,0,0
226653,obtained,0,0
226654,using,0,0
226655,0.3,0,0
226656,mM/kg,0,1
226657,gadodiamide,1,1
226658,injection,0,1
226659,compared,0,0
226660,to,0,0
226661,0.1,0,0
226662,mM/kg,0,1
226663,gadopentate,0,1
226664,dimeglumine,0,1
226665,in,0,0
226666,the,0,0
226667,same,0,0
226668,patients,0,0
226669,.,0,0
226670,The,0,0
226671,high,0,0
226672,dose,0,0
226673,(,0,0
226674,0.3,0,1
226675,mM/kg,0,1
226676,),0,1
226677,gadodiamide,1,1
226678,injection,0,1
226679,in,0,0
226680,7,0,0
226681,patients,0,0
226682,did,0,0
226683,not,0,0
226684,shorten,0,0
226685,the,0,0
226686,T2,0,0
226687,value,0,0
226688,sufficiently,0,0
226689,to,0,0
226690,overwhelm,0,0
226691,the,0,0
226692,T1,0,1
226693,shortening,0,0
226694,and,0,0
226695,leave,0,1
226696,pathologic,0,0
226697,lesions,0,0
226698,hypointense,0,0
226699,compared,0,0
226700,to,0,0
226701,precontrast,0,0
226702,studies,0,0
226703,.,0,0
226704,With,0,0
226705,the,0,0
226706,comparable,0,0
226707,relaxivities,0,0
226708,of,0,0
226709,gadodiamide,1,1
226710,injection,0,1
226711,and,0,0
226712,gadopentetate,1,1
226713,dimeglumine,1,1
226714,",",0,0
226715,similarities,0,0
226716,in,0,0
226717,results,0,0
226718,have,0,0
226719,to,0,0
226720,be,0,0
226721,expected,0,0
226722,when,0,0
226723,using,0,0
226724,these,0,0
226725,media,0,1
226726,for,0,0
226727,MR,0,1
226728,image,0,1
226729,enhancement,0,0
226730,.,0,0
226731,Does,0,0
226732,wavelength,0,0
226733,matter,0,0
226734,when,0,0
226735,photocoagulating,0,0
226736,eyes,0,0
226737,with,0,0
226738,macular,0,0
226739,degeneration,0,0
226740,or,0,1
226741,diabetic,0,0
226742,retinopathy,0,0
226743,?,0,0
226744,A,0,0
226745,program,0,1
226746,of,0,0
226747,screening,0,1
226748,and,0,0
226749,prompting,0,0
226750,improves,0,0
226751,short-term,0,0
226752,physician,0,1
226753,counseling,0,1
226754,of,0,0
226755,dependent,0,0
226756,and,0,0
226757,nondependent,0,0
226758,harmful,0,0
226759,drinkers,0,0
226760,.,0,0
226761,BACKGROUND,0,0
226762,Physicians,0,0
226763,in,0,0
226764,the,0,0
226765,general,0,0
226766,medical,0,0
226767,setting,0,0
226768,commonly,0,0
226769,encounter,0,0
226770,but,0,0
226771,rarely,0,0
226772,counsel,0,0
226773,patients,0,0
226774,with,0,0
226775,dependent,0,0
226776,or,0,1
226777,harmful,0,0
226778,drinking,0,0
226779,behaviors,0,0
226780,.,0,0
226781,We,0,0
226782,tested,0,0
226783,whether,0,0
226784,providing,0,0
226785,physicians,0,1
226786,with,0,0
226787,their,0,0
226788,patients,0,0
226789,',0,0
226790,results,0,0
226791,on,0,0
226792,the,0,0
226793,alcohol,0,1
226794,module,0,1
226795,of,0,0
226796,the,0,0
226797,Diagnostic,0,0
226798,Interview,0,1
226799,Schedule,0,1
226800,and,0,0
226801,counseling,0,1
226802,directives,0,1
226803,would,0,0
226804,prompt,0,0
226805,them,0,0
226806,to,0,0
226807,counsel,0,0
226808,these,0,0
226809,patients,0,0
226810,.,0,0
226811,METHODS,0,0
226812,We,0,0
226813,randomly,0,0
226814,assigned,0,0
226815,83,0,0
226816,first-,0,0
226817,",",0,0
226818,second-,0,0
226819,",",0,0
226820,and,0,0
226821,third-year,0,1
226822,medical,0,0
226823,residents,0,0
226824,to,0,0
226825,receive,1,0
226826,or,1,1
226827,not,1,0
226828,to,1,0
226829,receive,1,0
226830,diagnostic,1,0
226831,information,1,0
226832,and,1,0
226833,counseling,1,1
226834,directives,1,1
226835,on,1,0
226836,214,0,0
226837,patients,0,0
226838,who,0,0
226839,reported,0,0
226840,at,0,0
226841,least,0,0
226842,one,0,0
226843,symptom,0,0
226844,of,0,0
226845,alcohol,0,1
226846,impairment,0,0
226847,as,0,0
226848,defined,0,0
226849,in,0,0
226850,the,0,0
226851,Diagnostic,0,0
226852,and,0,0
226853,Statistical,0,0
226854,Manual,0,1
226855,of,0,0
226856,Mental,0,0
226857,Disorders,0,0
226858,",",0,0
226859,Third,0,0
226860,Edition,0,0
226861,.,0,0
226862,Using,0,0
226863,binary,1,0
226864,logistic,1,0
226865,regression,1,0
226866,",",0,0
226867,we,0,0
226868,examined,0,0
226869,the,0,0
226870,effect,0,0
226871,of,0,0
226872,specific,0,0
226873,covariables,0,0
226874,on,0,0
226875,rates,0,0
226876,of,0,0
226877,physician,0,1
226878,counseling,0,1
226879,.,0,0
226880,These,0,0
226881,variables,0,0
226882,included,0,0
226883,physician,0,1
226884,information,0,0
226885,status,0,0
226886,",",0,0
226887,patient,0,0
226888,gender,0,0
226889,",",0,0
226890,and,0,0
226891,drinking,0,0
226892,disorder,0,0
226893,severity,0,0
226894,and,0,0
226895,recency,0,0
226896,.,0,0
226897,We,0,0
226898,also,0,0
226899,examined,0,0
226900,the,0,0
226901,effect,0,0
226902,of,0,0
226903,physician,0,1
226904,prompting,0,0
226905,on,0,0
226906,counseling,0,1
226907,of,0,0
226908,female,0,0
226909,patients,0,0
226910,",",0,0
226911,patients,0,0
226912,with,0,0
226913,inactive,0,0
226914,disorders,0,0
226915,",",0,0
226916,and,0,0
226917,nondependent,0,0
226918,but,0,0
226919,harmful,0,0
226920,drinkers,0,0
226921,.,0,0
226922,We,0,0
226923,determined,0,0
226924,counseling,0,1
226925,by,0,0
226926,post-visit,0,0
226927,patient,0,0
226928,interviews,0,0
226929,.,0,0
226930,RESULTS,0,0
226931,Physician,0,0
226932,prompting,0,0
226933,",",0,0
226934,dependent,0,0
226935,drinking,0,0
226936,",",0,0
226937,and,0,0
226938,recent,0,0
226939,disorder,0,0
226940,activity,0,0
226941,were,0,0
226942,significant,0,0
226943,correlates,0,0
226944,of,0,0
226945,physician,0,1
226946,counseling,0,1
226947,(,0,0
226948,P,0,0
226949,<,0,0
226950,.05,0,0
226951,),0,0
226952,",",0,0
226953,while,0,0
226954,male,0,0
226955,gender,0,0
226956,was,0,0
226957,a,0,0
226958,marginally,0,0
226959,significant,0,0
226960,correlate,0,0
226961,(,0,0
226962,P,0,0
226963,=,0,0
226964,.08,0,0
226965,),0,0
226966,.,0,0
226967,Informed,0,0
226968,physicians,0,0
226969,counseled,0,0
226970,female,0,0
226971,patients,0,0
226972,",",0,0
226973,harmful,0,0
226974,but,0,0
226975,nondependent,0,0
226976,drinkers,0,0
226977,",",0,0
226978,and,0,0
226979,patients,0,0
226980,with,0,0
226981,inactive,0,0
226982,disorders,0,0
226983,more,0,0
226984,often,0,0
226985,than,0,0
226986,their,0,0
226987,uninformed,0,0
226988,colleagues,0,0
226989,",",0,0
226990,although,0,0
226991,only,0,0
226992,the,0,0
226993,last,0,0
226994,variable,0,0
226995,achieved,0,0
226996,statistical,0,0
226997,significance,0,0
226998,.,0,0
226999,CONCLUSIONS,0,0
227000,Providing,0,0
227001,physicians,0,1
227002,with,0,0
227003,the,0,0
227004,results,0,0
227005,of,0,0
227006,the,0,0
227007,Diagnostic,0,0
227008,Interview,0,1
227009,Schedule,0,1
227010,and,0,0
227011,counseling,0,1
227012,directives,0,1
227013,resulted,0,0
227014,in,0,0
227015,short-term,0,0
227016,improvement,0,0
227017,in,0,0
227018,their,0,0
227019,rates,0,0
227020,of,0,0
227021,counseling,0,1
227022,patients,0,0
227023,with,0,0
227024,a,0,0
227025,history,0,0
227026,of,0,0
227027,dependent,0,0
227028,or,0,1
227029,nondependent,0,0
227030,but,0,0
227031,harmful,0,0
227032,drinking,0,0
227033,.,0,0
227034,Further,0,0
227035,research,0,0
227036,is,0,0
227037,necessary,0,0
227038,to,0,0
227039,determine,0,0
227040,long-term,0,0
227041,gains,0,0
227042,in,0,0
227043,rates,0,0
227044,of,0,0
227045,physician,1,1
227046,counseling,1,1
227047,and,1,0
227048,improvements,1,0
227049,in,0,0
227050,the,0,0
227051,course,0,0
227052,of,0,0
227053,these,0,0
227054,patients,0,0
227055,.,0,0
227056,Effect,0,0
227057,of,0,0
227058,extradural,1,1
227059,analgesia,1,0
227060,on,0,0
227061,stress,0,0
227062,responses,0,0
227063,to,0,0
227064,abdominal,0,0
227065,surgery,0,1
227066,in,0,0
227067,infants,0,0
227068,.,0,0
227069,We,0,0
227070,studied,0,0
227071,40,0,0
227072,children,0,0
227073,younger,0,0
227074,than,0,0
227075,4,0,0
227076,yr,0,0
227077,having,0,0
227078,elective,0,1
227079,abdominal,0,0
227080,surgery,0,1
227081,under,0,0
227082,general,1,0
227083,anaesthesia,1,1
227084,supplemented,0,1
227085,with,0,0
227086,either,0,0
227087,systemic,1,0
227088,opioids,1,1
227089,or,1,1
227090,extradural,1,1
227091,bupivacaine,1,1
227092,.,1,0
227093,Venous,1,0
227094,blood,1,0
227095,samples,1,0
227096,were,0,0
227097,obtained,0,0
227098,before,0,0
227099,tracheal,0,1
227100,intubation,0,1
227101,to,0,0
227102,measure,0,0
227103,baseline,0,0
227104,concentrations,0,0
227105,of,0,0
227106,adrenaline,0,1
227107,",",0,0
227108,noradrenaline,0,1
227109,",",0,0
227110,glucose,0,0
227111,",",0,0
227112,ACTH,0,0
227113,and,0,0
227114,cortisol,0,0
227115,.,0,0
227116,Additional,0,0
227117,samples,0,0
227118,were,0,0
227119,obtained,0,0
227120,45,0,0
227121,min,0,0
227122,after,0,0
227123,the,0,0
227124,start,0,0
227125,of,0,0
227126,surgery,0,0
227127,",",0,0
227128,at,0,0
227129,the,0,0
227130,end,0,0
227131,of,0,0
227132,surgery,0,0
227133,",",0,0
227134,1,0,0
227135,h,0,0
227136,and,0,0
227137,24,0,0
227138,h,0,0
227139,after,0,0
227140,the,0,0
227141,end,0,0
227142,of,0,0
227143,surgery,0,0
227144,.,0,0
227145,Plasma,0,0
227146,concentrations,0,0
227147,of,0,0
227148,bupivacaine,1,1
227149,were,0,0
227150,measured,0,0
227151,also,0,0
227152,in,0,0
227153,the,0,0
227154,extradural,0,1
227155,group,0,0
227156,at,0,0
227157,each,0,0
227158,sampling,0,0
227159,time,0,0
227160,.,0,0
227161,Both,0,0
227162,techniques,0,1
227163,provided,0,0
227164,acceptable,0,0
227165,analgesia,0,0
227166,",",0,0
227167,but,0,0
227168,the,0,0
227169,perioperative,0,0
227170,increases,0,0
227171,in,0,0
227172,adrenaline,0,1
227173,",",0,0
227174,glucose,0,0
227175,and,0,0
227176,ACTH,0,0
227177,were,0,0
227178,significantly,0,0
227179,greater,0,0
227180,in,0,0
227181,the,0,0
227182,opioid,0,1
227183,group,0,0
227184,.,0,0
227185,Noradrenaline,0,0
227186,concentrations,0,0
227187,decreased,0,0
227188,to,0,0
227189,less,0,0
227190,than,0,0
227191,baseline,0,0
227192,values,0,0
227193,in,0,0
227194,the,0,0
227195,extradural,0,1
227196,group,0,0
227197,and,0,0
227198,were,0,0
227199,significantly,0,0
227200,less,0,0
227201,than,0,0
227202,in,0,0
227203,the,0,0
227204,opioid,0,1
227205,group,0,0
227206,.,0,0
227207,The,0,0
227208,perioperative,0,0
227209,increase,0,0
227210,in,0,0
227211,cortisol,0,0
227212,was,0,0
227213,similar,0,0
227214,in,0,0
227215,the,0,0
227216,two,0,0
227217,groups,0,0
227218,",",0,0
227219,despite,0,0
227220,the,0,0
227221,differences,0,0
227222,in,0,0
227223,ACTH,0,0
227224,responses,0,0
227225,.,0,0
227226,Most,0,0
227227,responses,0,0
227228,returned,0,0
227229,to,0,0
227230,the,0,0
227231,baseline,0,0
227232,values,0,0
227233,within,0,0
227234,24,0,0
227235,h.,0,0
227236,Plasma,0,0
227237,bupivacaine,1,1
227238,concentrations,0,0
227239,remained,0,0
227240,within,0,0
227241,safe,0,0
227242,limits,0,0
227243,during,0,0
227244,the,0,0
227245,study,0,0
227246,",",0,0
227247,but,0,0
227248,systemic,0,0
227249,concentrations,0,0
227250,increased,0,0
227251,in,0,0
227252,some,0,0
227253,of,0,0
227254,the,0,0
227255,patients,0,0
227256,during,0,0
227257,postoperative,0,0
227258,infusion,0,1
227259,with,0,0
227260,0.125,0,1
227261,%,0,0
227262,bupivacaine,0,1
227263,.,0,0
227264,Timing,0,0
227265,of,0,0
227266,antibiotic,1,1
227267,administration,1,0
227268,in,0,0
227269,knee,0,0
227270,replacement,0,1
227271,under,0,0
227272,tourniquet,0,1
227273,.,0,0
227274,Cephamandole,1,1
227275,levels,0,0
227276,in,0,0
227277,serum,0,0
227278,and,0,0
227279,drain,0,1
227280,fluid,0,1
227281,were,0,0
227282,measured,0,0
227283,in,0,0
227284,32,0,0
227285,knee,0,0
227286,replacement,0,1
227287,operations,0,0
227288,to,0,0
227289,determine,0,0
227290,the,0,0
227291,benefit,0,0
227292,of,0,0
227293,an,0,0
227294,intravenous,0,1
227295,dose,0,0
227296,of,0,0
227297,antibiotic,0,1
227298,at,0,0
227299,the,0,0
227300,time,0,0
227301,of,0,0
227302,tourniquet,0,1
227303,deflation,0,1
227304,.,0,0
227305,Concentrations,0,0
227306,of,0,0
227307,cephamandole,1,1
227308,in,0,0
227309,drain,0,1
227310,fluid,0,1
227311,were,0,0
227312,directly,0,0
227313,proportional,0,0
227314,to,0,0
227315,the,0,0
227316,serum,0,0
227317,concentration,0,0
227318,at,0,0
227319,the,0,0
227320,time,0,0
227321,of,0,0
227322,tourniquet,0,1
227323,release,0,0
227324,.,0,0
227325,A,0,0
227326,'tourniquet-release,1,1
227327,',1,0
227328,dose,1,0
227329,of,1,0
227330,antibiotic,1,1
227331,increased,0,0
227332,drain,0,1
227333,fluid,0,1
227334,concentration,0,0
227335,threefold,0,0
227336,.,0,0
227337,Torasemide,1,1
227338,in,0,0
227339,the,0,0
227340,treatment,0,0
227341,of,0,0
227342,patients,0,0
227343,with,0,0
227344,cirrhosis,0,0
227345,and,0,0
227346,ascites,0,0
227347,.,0,0
227348,The,0,0
227349,effects,0,0
227350,of,0,0
227351,torasemide,1,1
227352,(,1,0
227353,20,1,1
227354,mg/day,1,1
227355,),1,0
227356,and,0,0
227357,furosemide,1,1
227358,(,1,0
227359,50,1,1
227360,mg/day,1,1
227361,),1,0
227362,",",0,0
227363,each,0,0
227364,given,0,0
227365,over,0,0
227366,4,0,0
227367,days,0,0
227368,",",0,0
227369,were,0,0
227370,compared,0,0
227371,in,0,0
227372,a,0,0
227373,randomized,0,0
227374,and,0,0
227375,crossover,0,0
227376,study,0,0
227377,carried,0,0
227378,out,0,0
227379,in,0,0
227380,seven,0,0
227381,patients,0,0
227382,with,0,0
227383,cirrhosis,0,0
227384,and,0,0
227385,tense,0,1
227386,ascites,0,0
227387,.,0,0
227388,Patients,0,0
227389,also,0,0
227390,received,0,0
227391,a,0,0
227392,low-sodium,1,1
227393,(,1,0
227394,40,1,1
227395,mmol/day,1,1
227396,),1,1
227397,diet,1,1
227398,and,1,0
227399,the,1,0
227400,aldosterone,1,0
227401,antagonist,1,1
227402,",",1,0
227403,potassium,1,1
227404,canrenoate,1,1
227405,(,0,0
227406,100,0,0
227407,mg,0,1
227408,b.i.d.,0,1
227409,),0,0
227410,.,0,0
227411,Torasemide,1,1
227412,induced,0,0
227413,a,0,0
227414,remarkably,0,0
227415,higher,0,0
227416,natriuretic,0,0
227417,(,0,0
227418,120,0,0
227419,+/-,0,0
227420,15,0,0
227421,vs.,0,0
227422,33,0,0
227423,+/-,0,0
227424,6,0,0
227425,mmol/day,0,0
227426,",",0,0
227427,p,0,0
227428,<,0,0
227429,0.02,0,0
227430,),0,0
227431,and,0,0
227432,diuretic,0,1
227433,(,0,0
227434,1450,0,1
227435,+/-,0,0
227436,63,0,0
227437,vs.,0,0
227438,900,0,1
227439,+/-,0,0
227440,58,0,0
227441,ml,0,0
227442,",",0,0
227443,p,0,0
227444,<,0,0
227445,0.005,0,0
227446,),0,0
227447,effect,0,0
227448,than,0,0
227449,furosemide,1,1
227450,.,1,0
227451,Body,0,1
227452,weight,0,0
227453,loss,0,0
227454,was,0,0
227455,also,0,0
227456,significantly,0,0
227457,higher,0,0
227458,(,0,0
227459,2.5,0,0
227460,+/-,0,0
227461,1.6,0,0
227462,vs.,0,0
227463,0.2,0,0
227464,+/-,0,0
227465,1.3,0,0
227466,kg,0,0
227467,",",0,0
227468,p,0,0
227469,<,0,0
227470,0.01,0,0
227471,),0,0
227472,during,0,0
227473,the,0,0
227474,torasemide,1,1
227475,period,0,0
227476,.,0,0
227477,Kaliuresis,0,0
227478,was,0,0
227479,similar,0,0
227480,during,0,0
227481,the,0,0
227482,two,0,0
227483,treatment,0,0
227484,periods,0,0
227485,",",0,0
227486,despite,0,0
227487,the,0,0
227488,striking,0,0
227489,differences,0,0
227490,observed,0,0
227491,in,0,0
227492,natriuresis,0,0
227493,.,0,0
227494,Neither,0,0
227495,torasemide,1,1
227496,nor,0,0
227497,furosemide,1,1
227498,induced,0,0
227499,any,0,0
227500,significant,0,0
227501,change,0,0
227502,in,0,0
227503,serum,0,0
227504,electrolyte,0,1
227505,or,0,1
227506,creatinine,0,0
227507,concentrations,0,0
227508,",",0,0
227509,or,0,0
227510,in,0,0
227511,ammonia,0,0
227512,levels,0,0
227513,.,0,0
227514,The,0,0
227515,results,0,0
227516,of,0,0
227517,this,0,0
227518,study,0,0
227519,indicate,0,0
227520,that,0,0
227521,torasemide,1,1
227522,is,0,0
227523,suitable,0,0
227524,for,0,0
227525,the,0,0
227526,treatment,0,0
227527,of,0,0
227528,sodium,0,1
227529,retention,0,0
227530,in,0,0
227531,patients,0,0
227532,with,0,0
227533,cirrhosis,0,0
227534,and,0,0
227535,ascites,0,0
227536,.,0,0
227537,Metronidazole,1,1
227538,in,0,0
227539,periodontitis,1,0
227540,(,0,1
227541,IV,0,0
227542,),0,0
227543,.,0,0
227544,The,0,0
227545,effect,0,0
227546,of,0,0
227547,patient,0,0
227548,compliance,0,0
227549,on,0,0
227550,treatment,0,0
227551,parameters,0,0
227552,.,0,0
227553,Patient,0,0
227554,compliance,0,0
227555,with,0,0
227556,the,0,0
227557,unsupervised,0,1
227558,usage,0,0
227559,of,0,0
227560,prescription,0,1
227561,medication,0,1
227562,can,0,0
227563,be,0,0
227564,poor,0,0
227565,.,0,0
227566,In,0,0
227567,the,0,0
227568,treatment,0,0
227569,of,0,0
227570,periodontal,0,0
227571,infections,0,0
227572,with,0,0
227573,systemic,0,0
227574,antimicrobial,0,1
227575,agents,0,0
227576,",",0,0
227577,in,0,0
227578,situations,0,0
227579,where,0,0
227580,the,0,0
227581,efficacy,0,0
227582,of,0,0
227583,the,0,0
227584,antimicrobial,0,1
227585,agent,0,0
227586,is,0,0
227587,being,0,0
227588,evaluated,0,0
227589,",",0,0
227590,non-compliance,0,0
227591,could,0,0
227592,underestimate,0,0
227593,the,0,0
227594,true,0,0
227595,efficacy,0,0
227596,of,0,0
227597,the,0,0
227598,agent,0,0
227599,.,0,0
227600,Metronidazole,1,1
227601,is,0,0
227602,an,0,0
227603,agent,0,0
227604,with,0,0
227605,reported,0,0
227606,success,0,0
227607,in,0,0
227608,the,0,0
227609,treatment,0,0
227610,of,0,0
227611,anaerobic,0,0
227612,periodontal,0,0
227613,infections,0,0
227614,.,0,0
227615,Metronidazole,1,1
227616,is,0,0
227617,particularly,0,0
227618,effective,0,0
227619,in,0,0
227620,vitro,0,0
227621,against,0,0
227622,spirochetes,0,1
227623,",",0,0
227624,and,0,0
227625,this,0,0
227626,efficacy,0,0
227627,was,0,0
227628,investigated,0,0
227629,as,0,0
227630,a,0,0
227631,means,0,0
227632,of,0,0
227633,measuring,0,0
227634,patient,0,0
227635,compliance,0,0
227636,with,0,0
227637,metronidazole,1,1
227638,usage,0,0
227639,.,0,0
227640,Patients,0,0
227641,who,0,0
227642,had,0,0
227643,high,0,0
227644,proportions,0,0
227645,of,0,0
227646,spirochetes,0,0
227647,",",0,0
227648,i.e.,0,0
227649,",",0,0
227650,>,0,0
227651,20,0,0
227652,%,0,0
227653,",",0,0
227654,in,0,0
227655,plaques,0,0
227656,removed,0,0
227657,from,0,0
227658,diseased,0,0
227659,periodontal,0,0
227660,sites,0,0
227661,",",0,0
227662,were,0,0
227663,given,0,0
227664,metronidazole,1,1
227665,(,0,0
227666,500,0,1
227667,mg,0,1
227668,bid,0,1
227669,),0,0
227670,under,0,0
227671,supervision,0,1
227672,.,0,0
227673,In,0,0
227674,all,0,0
227675,individuals,0,0
227676,who,0,0
227677,received,0,0
227678,the,0,0
227679,metronidazole,1,1
227680,",",0,0
227681,there,0,0
227682,was,0,0
227683,a,0,0
227684,significant,0,0
227685,and,0,0
227686,rapid,0,0
227687,decline,0,0
227688,and/or,0,0
227689,disappearance,0,0
227690,of,0,0
227691,spirochetes,0,0
227692,from,0,0
227693,the,0,0
227694,plaque,0,0
227695,during,0,0
227696,the,0,0
227697,time,0,0
227698,interval,0,0
227699,that,0,0
227700,metronidazole,1,1
227701,was,0,0
227702,detectable,0,0
227703,in,0,0
227704,the,0,0
227705,saliva,0,0
227706,.,0,0
227707,This,0,0
227708,observed,0,0
227709,decline,0,0
227710,in,0,0
227711,spirochetes,0,0
227712,was,0,0
227713,then,0,0
227714,used,0,0
227715,to,0,0
227716,determine,0,0
227717,which,0,0
227718,patients,0,0
227719,had,0,0
227720,been,0,0
227721,compliant,0,0
227722,in,0,0
227723,a,0,0
227724,double-blind,0,0
227725,clinical,0,0
227726,trial,0,0
227727,involving,0,0
227728,the,0,0
227729,unsupervised,0,1
227730,usage,0,0
227731,of,0,0
227732,metronidazole,1,1
227733,.,1,0
227734,Only,0,0
227735,10,0,0
227736,of,0,0
227737,18,0,0
227738,patients,0,0
227739,(,0,0
227740,56,0,0
227741,%,0,0
227742,),0,0
227743,were,0,0
227744,considered,0,0
227745,compliant,0,0
227746,in,0,0
227747,their,0,0
227748,usage,0,0
227749,of,0,0
227750,metronidazole,1,1
227751,.,1,0
227752,These,0,0
227753,10,0,0
227754,patients,0,0
227755,experienced,0,0
227756,a,0,0
227757,significantly,0,0
227758,greater,0,0
227759,benefit,0,0
227760,from,0,0
227761,the,0,0
227762,metronidazole,1,1
227763,than,0,0
227764,did,0,0
227765,the,0,0
227766,8,0,0
227767,patients,0,0
227768,who,0,0
227769,were,0,0
227770,considered,0,0
227771,noncompliant,0,0
227772,",",0,0
227773,i.e.,0,0
227774,",",0,0
227775,a,0,0
227776,reduction,0,0
227777,of,0,0
227778,surgical,0,0
227779,needs,0,0
227780,of,0,0
227781,8.3,0,0
227782,teeth,0,0
227783,per,0,0
227784,compliant,0,0
227785,patient,0,0
227786,versus,0,1
227787,3.6,0,0
227788,teeth,0,0
227789,per,0,0
227790,non-compliant,0,0
227791,patient,0,0
227792,.,0,0
227793,A,0,0
227794,test,0,0
227795,for,0,0
227796,the,0,0
227797,hydrolysis,0,0
227798,of,0,0
227799,the,0,0
227800,synthetic,0,1
227801,peptide,0,0
227802,(,0,1
227803,BANA,0,1
227804,),0,1
227805,was,0,0
227806,also,0,0
227807,able,0,0
227808,to,0,0
227809,identify,0,0
227810,most,0,0
227811,non-compliant,0,0
227812,patients,0,0
227813,.,0,0
227814,Clinical,0,0
227815,trials,0,0
227816,involving,0,0
227817,the,0,0
227818,unsupervised,0,1
227819,usage,0,0
227820,of,0,0
227821,systemic,0,0
227822,medication,0,1
227823,need,0,0
227824,to,0,0
227825,take,0,0
227826,into,0,0
227827,account,0,0
227828,patient,0,0
227829,non-compliance,0,0
227830,.,0,0
227831,Hypotensive,0,0
227832,effects,0,0
227833,and,0,0
227834,influence,0,0
227835,on,0,0
227836,serum,0,0
227837,lipids,0,0
227838,of,0,0
227839,"SQ29,852",1,0
227840,",",1,0
227841,a,1,0
227842,new,1,0
227843,angiotensin,1,1
227844,converting,1,0
227845,enzyme,1,1
227846,inhibitor,1,1
227847,",",0,0
227848,in,0,0
227849,patients,0,0
227850,with,0,0
227851,essential,0,0
227852,hypertension,0,0
227853,:,0,0
227854,a,0,0
227855,comparison,0,0
227856,with,0,0
227857,atenolol,1,1
227858,.,1,0
227859,The,0,0
227860,effects,0,0
227861,of,0,0
227862,"SQ29,852",1,0
227863,(,0,0
227864,n,0,0
227865,=,0,0
227866,24,0,0
227867,),0,0
227868,",",0,0
227869,a,0,0
227870,new,0,0
227871,angiotensin,1,1
227872,converting,1,0
227873,enzyme,1,1
227874,inhibitor,1,1
227875,",",0,0
227876,and,0,0
227877,atenolol,1,1
227878,(,0,1
227879,n,0,0
227880,=,0,0
227881,22,0,0
227882,),0,0
227883,",",0,0
227884,monotherapies,0,0
227885,were,0,0
227886,compared,0,0
227887,in,0,0
227888,46,0,0
227889,patients,0,0
227890,with,0,0
227891,mild,0,0
227892,to,0,0
227893,moderate,0,0
227894,essential,0,0
227895,hypertension,0,0
227896,.,0,0
227897,Both,0,1
227898,"SQ29,852",1,0
227899,(,0,0
227900,mean,0,0
227901,dose,0,0
227902,15.0,0,0
227903,+/-,0,0
227904,5.1,0,0
227905,mg/day,0,1
227906,),0,0
227907,and,0,0
227908,atenolol,1,1
227909,(,0,0
227910,mean,0,0
227911,dose,0,0
227912,37.5,0,0
227913,+/-,0,0
227914,18.5,0,0
227915,mg/day,0,1
227916,),0,0
227917,significantly,0,0
227918,decreased,0,0
227919,both,0,0
227920,systolic,0,0
227921,and,0,0
227922,diastolic,0,0
227923,blood,0,0
227924,pressures,0,0
227925,.,0,0
227926,There,0,0
227927,were,0,0
227928,no,0,0
227929,significant,0,0
227930,changes,0,0
227931,in,0,0
227932,serum,0,0
227933,lipids,0,0
227934,",",0,0
227935,apolipoproteins,0,0
227936,",",0,0
227937,lipoproteins,0,0
227938,or,0,0
227939,atherosclerotic,0,0
227940,indices,0,0
227941,after,0,0
227942,both,0,0
227943,"SQ29,852",1,0
227944,and,0,0
227945,atenolol,1,1
227946,.,1,0
227947,There,0,0
227948,were,0,0
227949,also,0,0
227950,no,0,0
227951,significant,0,0
227952,inter-group,0,0
227953,differences,0,0
227954,.,0,0
227955,There,0,0
227956,were,0,0
227957,no,0,0
227958,serious,0,0
227959,side,0,0
227960,effects,0,0
227961,or,0,1
227962,abnormal,0,0
227963,laboratory,0,0
227964,tests,0,0
227965,in,0,0
227966,both,0,0
227967,treatment,0,0
227968,groups,0,0
227969,.,0,0
227970,It,0,0
227971,is,0,0
227972,concluded,0,0
227973,that,0,0
227974,"SQ29,852",1,0
227975,is,0,0
227976,an,0,0
227977,effective,0,0
227978,antihypertensive,0,1
227979,drug,0,1
227980,without,0,1
227981,adverse,0,0
227982,effect,0,0
227983,on,0,0
227984,lipid,0,0
227985,metabolism,0,0
227986,.,0,0
227987,Lack,0,1
227988,of,0,0
227989,interaction,0,0
227990,between,0,0
227991,pantoprazole,1,1
227992,and,1,0
227993,digoxin,1,1
227994,at,0,0
227995,therapeutic,0,0
227996,doses,0,0
227997,in,0,0
227998,man,0,0
227999,.,0,0
228000,Substituted,1,0
228001,benzimidazole,1,1
228002,inhibitors,1,1
228003,of,0,0
228004,the,0,0
228005,gastric,0,0
228006,H+/K+ATPase,0,0
228007,may,0,0
228008,interact,0,0
228009,with,0,0
228010,the,0,0
228011,cytochrome,0,1
228012,P450,0,0
228013,enzyme,0,1
228014,system,0,1
228015,and,0,0
228016,alter,0,0
228017,the,0,0
228018,pharmacokinetics,0,0
228019,of,0,0
228020,coadministered,0,0
228021,drugs,0,1
228022,.,0,0
228023,On,0,0
228024,the,0,0
228025,other,0,0
228026,hand,0,0
228027,",",0,0
228028,changes,0,0
228029,in,0,0
228030,intragastric,0,0
228031,pH,0,1
228032,might,0,0
228033,alter,0,0
228034,the,0,0
228035,absorption,0,0
228036,of,0,0
228037,other,0,0
228038,drugs,0,1
228039,.,0,0
228040,The,0,0
228041,primary,0,0
228042,aim,0,0
228043,of,0,0
228044,the,0,0
228045,present,0,0
228046,study,0,0
228047,was,0,0
228048,to,0,0
228049,determine,0,0
228050,whether,0,0
228051,pantoprazole,1,1
228052,modifies,0,0
228053,the,0,0
228054,steady-state,0,0
228055,serum,0,0
228056,concentrations,0,0
228057,of,0,0
228058,orally,0,1
228059,administered,0,0
228060,digoxin,1,1
228061,.,1,0
228062,Secondary,0,0
228063,aims,0,0
228064,were,0,0
228065,the,0,0
228066,influence,0,0
228067,of,0,0
228068,digoxin,1,1
228069,on,0,0
228070,the,0,0
228071,pharmacokinetics,0,0
228072,of,0,0
228073,pantoprazole,1,1
228074,as,0,0
228075,well,0,0
228076,as,0,0
228077,safety,0,0
228078,and,0,0
228079,tolerability,0,0
228080,.,0,1
228081,Eighteen,0,0
228082,healthy,0,0
228083,volunteers,0,0
228084,received,0,0
228085,a,0,0
228086,single,0,0
228087,oral,1,1
228088,dose,1,0
228089,of,1,0
228090,pantoprazole,1,1
228091,(,1,0
228092,40,1,1
228093,mg,1,1
228094,),1,0
228095,and,1,0
228096,serum,1,0
228097,concentrations,1,0
228098,were,0,0
228099,determined,0,0
228100,.,0,0
228101,Three,0,0
228102,to,0,0
228103,10,0,0
228104,days,0,0
228105,later,0,0
228106,",",0,0
228107,subjects,0,0
228108,received,0,0
228109,in,0,0
228110,a,0,0
228111,single-blind,0,0
228112,",",0,0
228113,randomized,0,0
228114,",",0,0
228115,crossover,0,0
228116,fashion,0,1
228117,oral,0,1
228118,beta-acetyldigoxin,1,1
228119,(,0,0
228120,0.2,0,1
228121,mg,0,1
228122,),0,0
228123,twice,0,1
228124,daily,0,1
228125,and,0,0
228126,concomitant,1,0
228127,oral,1,1
228128,pantoprazole,1,1
228129,(,0,0
228130,40,0,1
228131,mg,0,1
228132,),0,0
228133,or,0,1
228134,placebo,1,1
228135,once,0,1
228136,daily,0,1
228137,for,0,0
228138,5,0,0
228139,days,0,0
228140,.,0,0
228141,Serum,0,0
228142,concentrations,0,0
228143,of,0,0
228144,pantoprazole,1,1
228145,and,1,0
228146,digoxin,1,1
228147,were,0,0
228148,determined,0,0
228149,on,0,0
228150,day,0,0
228151,5,0,0
228152,.,0,0
228153,Primary,0,0
228154,characteristics,0,0
228155,for,0,0
228156,confirmative,0,0
228157,assessment,0,0
228158,of,0,0
228159,no,0,0
228160,interaction,0,0
228161,were,0,0
228162,AUC,0,0
228163,and,0,0
228164,Cmax,0,0
228165,of,0,0
228166,digoxin,1,1
228167,.,1,0
228168,Lack,0,0
228169,of,0,0
228170,interaction,0,0
228171,in,0,0
228172,the,0,0
228173,sense,0,0
228174,of,0,0
228175,equivalence,0,0
228176,was,0,0
228177,concluded,0,0
228178,for,0,0
228179,both,0,0
228180,digoxin,0,1
228181,(,0,0
228182,with,0,0
228183,and,0,0
228184,without,0,1
228185,pantoprazole,1,1
228186,),1,1
228187,and,0,0
228188,pantoprazole,1,1
228189,(,1,1
228190,with,1,0
228191,and,1,0
228192,without,1,1
228193,digoxin,1,1
228194,),1,0
228195,as,0,0
228196,the,0,0
228197,90,0,0
228198,%,0,0
228199,-confidence,0,0
228200,intervals,0,0
228201,of,0,0
228202,the,0,0
228203,respective,0,0
228204,AUC-,0,0
228205,and,0,0
228206,Cmax-ratios,0,0
228207,were,0,0
228208,within,0,0
228209,the,0,0
228210,equivalence,0,0
228211,range,0,0
228212,of,0,0
228213,0.8-1.25,0,0
228214,.,0,0
228215,Pantoprazole,1,1
228216,did,0,0
228217,not,0,0
228218,influence,0,0
228219,the,0,0
228220,characteristic,0,0
228221,ECG,0,1
228222,modifications,0,1
228223,(,0,0
228224,T-wave,0,1
228225,),0,1
228226,caused,0,0
228227,by,0,0
228228,digoxin,0,1
228229,.,0,0
228230,Both,0,0
228231,drugs,0,0
228232,were,0,0
228233,well,0,0
228234,tolerated,0,0
228235,and,0,0
228236,no,0,0
228237,adverse,0,0
228238,events,0,0
228239,or,0,0
228240,clinically,0,0
228241,relevant,0,0
228242,alterations,0,0
228243,in,0,0
228244,vital,0,0
228245,signs,0,0
228246,or,0,1
228247,clinical,0,0
228248,laboratory,0,0
228249,parameters,0,0
228250,were,0,0
228251,observed,0,0
228252,during,0,0
228253,treatment,0,0
228254,.,0,0
228255,In,0,0
228256,conclusion,0,0
228257,",",0,0
228258,pantoprazole,1,1
228259,and,1,0
228260,digoxin,1,1
228261,may,0,0
228262,be,0,0
228263,administered,0,0
228264,concomitantly,0,0
228265,without,0,0
228266,the,0,0
228267,need,0,0
228268,for,0,0
228269,dose,0,0
228270,adjustment,0,0
228271,.,0,0
228272,Effect,0,0
228273,of,0,0
228274,dietary,0,1
228275,supplementation,0,1
228276,with,0,0
228277,n-3,0,1
228278,fatty,0,1
228279,acids,0,1
228280,on,0,0
228281,coronary,0,0
228282,artery,0,0
228283,bypass,0,1
228284,graft,0,1
228285,patency,0,0
228286,.,0,0
228287,Epidemiologic,0,0
228288,and,0,0
228289,experimental,0,0
228290,data,0,0
228291,suggest,0,0
228292,that,0,0
228293,a,0,0
228294,high,0,0
228295,dietary,0,1
228296,intake,0,0
228297,of,0,0
228298,long-chain,0,1
228299,polyunsaturated,0,1
228300,n-3,1,1
228301,fatty,1,1
228302,acids,1,1
228303,may,0,0
228304,reduce,0,0
228305,the,0,0
228306,risk,0,0
228307,of,0,0
228308,atherothrombotic,0,0
228309,disease,0,0
228310,.,0,0
228311,In,0,0
228312,a,0,0
228313,randomized,0,0
228314,",",0,0
228315,controlled,0,0
228316,study,0,0
228317,",",0,0
228318,610,0,0
228319,patients,0,0
228320,undergoing,0,0
228321,coronary,0,0
228322,artery,0,0
228323,bypass,0,1
228324,grafting,0,1
228325,were,0,0
228326,assigned,0,0
228327,either,0,0
228328,to,0,0
228329,a,0,0
228330,fish,1,1
228331,oil,1,1
228332,group,1,0
228333,",",1,0
228334,receiving,1,0
228335,4,1,0
228336,g/day,1,0
228337,of,1,0
228338,fish,1,1
228339,oil,1,1
228340,concentrate,1,1
228341,",",1,0
228342,or,1,0
228343,to,1,0
228344,a,1,0
228345,control,1,1
228346,group,1,0
228347,.,1,0
228348,All,0,0
228349,patients,0,0
228350,received,0,0
228351,antithrombotic,1,0
228352,treatment,1,0
228353,",",1,0
228354,either,1,1
228355,aspirin,1,1
228356,or,1,1
228357,warfarin,1,1
228358,.,1,0
228359,Their,0,0
228360,diet,0,1
228361,and,0,0
228362,serum,0,0
228363,phospholipid,0,1
228364,fatty,0,1
228365,acid,0,1
228366,profiles,0,0
228367,were,0,0
228368,monitored,0,0
228369,.,0,0
228370,The,0,0
228371,primary,0,0
228372,end,0,0
228373,point,0,0
228374,was,0,0
228375,1-year,0,0
228376,graft,0,1
228377,patency,0,0
228378,",",0,0
228379,which,0,0
228380,was,0,0
228381,assessed,0,0
228382,by,0,0
228383,angiography,0,1
228384,in,0,0
228385,95,0,0
228386,%,0,0
228387,of,0,0
228388,patients,0,0
228389,.,0,0
228390,Vein,0,0
228391,graft,0,0
228392,occlusion,0,0
228393,rates,0,0
228394,per,0,0
228395,distal,0,0
228396,anastomoses,0,1
228397,were,0,0
228398,27,0,0
228399,%,0,0
228400,in,0,0
228401,the,0,0
228402,fish,1,1
228403,oil,1,1
228404,group,0,0
228405,and,0,0
228406,33,0,0
228407,%,0,0
228408,in,0,0
228409,the,0,0
228410,control,0,1
228411,group,0,0
228412,(,0,0
228413,odds,0,0
228414,ratio,0,0
228415,0.77,0,0
228416,",",0,0
228417,95,0,0
228418,%,0,0
228419,confidence,0,0
228420,interval,0,0
228421,",",0,0
228422,0.60,0,0
228423,to,0,0
228424,0.99,0,0
228425,",",0,0
228426,p,0,0
228427,=,0,0
228428,0.034,0,0
228429,),0,0
228430,.,0,0
228431,In,0,0
228432,the,0,0
228433,fish,1,1
228434,oil,1,1
228435,group,0,0
228436,",",0,0
228437,43,0,0
228438,%,0,0
228439,of,0,0
228440,the,0,0
228441,patients,0,0
228442,had,0,0
228443,>,0,0
228444,or,0,0
228445,=,0,0
228446,1,0,0
228447,occluded,0,1
228448,vein,0,1
228449,graft,0,1
228450,(,0,1
228451,s,0,1
228452,),0,0
228453,compared,0,0
228454,with,0,0
228455,51,0,0
228456,%,0,0
228457,in,0,0
228458,the,0,0
228459,control,0,1
228460,group,0,0
228461,(,0,0
228462,odds,0,0
228463,ratio,0,0
228464,0.72,0,0
228465,",",0,0
228466,95,0,0
228467,%,0,0
228468,confidence,0,0
228469,interval,0,0
228470,",",0,0
228471,0.51,0,0
228472,to,0,0
228473,1.01,0,0
228474,",",0,0
228475,p,0,0
228476,=,0,0
228477,0.05,0,0
228478,),0,0
228479,.,0,0
228480,Moreover,0,0
228481,",",0,0
228482,in,0,0
228483,the,0,0
228484,entire,0,0
228485,patient,0,0
228486,group,0,0
228487,",",0,0
228488,there,0,0
228489,was,0,0
228490,a,0,0
228491,significant,0,0
228492,trend,0,0
228493,to,0,0
228494,fewer,0,0
228495,patients,0,0
228496,with,0,0
228497,vein,0,0
228498,graft,0,0
228499,occlusions,0,0
228500,with,0,0
228501,increasing,0,0
228502,relative,0,0
228503,change,0,0
228504,in,0,0
228505,serum,0,0
228506,phospholipid,0,0
228507,n-3,0,1
228508,fatty,0,1
228509,acids,0,1
228510,during,0,0
228511,the,0,0
228512,study,0,0
228513,period,0,0
228514,(,0,1
228515,p,0,0
228516,for,0,0
228517,linear,0,0
228518,trend,0,0
228519,=,0,0
228520,0.0037,0,0
228521,),0,0
228522,.,0,0
228523,Thus,0,0
228524,",",0,0
228525,in,0,0
228526,patients,0,0
228527,undergoing,0,0
228528,coronary,0,0
228529,artery,0,1
228530,bypass,0,1
228531,grafting,0,1
228532,",",0,0
228533,dietary,0,1
228534,supplementation,0,1
228535,with,0,0
228536,n-3,1,1
228537,fatty,1,1
228538,acids,1,1
228539,reduced,0,0
228540,the,0,0
228541,incidence,0,0
228542,of,0,0
228543,vein,0,0
228544,graft,0,1
228545,occlusion,0,0
228546,",",0,0
228547,and,0,0
228548,an,0,0
228549,inverse,0,0
228550,relation,0,0
228551,between,0,0
228552,relative,0,0
228553,change,0,0
228554,in,0,0
228555,serum,0,0
228556,phospholipid,0,0
228557,n-3,0,1
228558,fatty,0,1
228559,acids,0,1
228560,and,0,0
228561,vein,0,0
228562,graft,0,1
228563,occlusions,0,0
228564,was,0,0
228565,observed,0,0
228566,.,0,0
228567,The,0,0
228568,effect,0,0
228569,of,0,0
228570,liquid,1,1
228571,fibre,1,1
228572,on,0,0
228573,feeding,0,1
228574,behaviour,0,0
228575,.,0,0
228576,Placebo-controlled,1,0
228577,acute,0,0
228578,dosage,0,0
228579,naltrexone,1,1
228580,study,0,0
228581,in,0,0
228582,young,0,0
228583,autistic,0,0
228584,children,0,0
228585,.,0,0
228586,In,0,0
228587,a,0,0
228588,double-blind,0,0
228589,",",0,0
228590,placebo-controlled,1,1
228591,crossover,0,0
228592,trial,0,0
228593,23,0,0
228594,autistic,0,0
228595,children,0,0
228596,were,0,0
228597,treated,0,0
228598,with,0,0
228599,a,0,0
228600,single,0,0
228601,40-mg,0,1
228602,dose,0,0
228603,of,0,0
228604,the,0,0
228605,opiate,0,1
228606,antagonist,0,1
228607,naltrexone,1,1
228608,.,1,0
228609,Drug,0,0
228610,effects,0,0
228611,were,0,0
228612,monitored,0,0
228613,by,0,0
228614,detailed,0,0
228615,playroom,0,1
228616,observations,0,0
228617,",",0,0
228618,actometers,0,1
228619,",",0,0
228620,and,0,0
228621,parents,0,0
228622,',0,0
228623,checklist,0,0
228624,ratings,0,0
228625,(,0,0
228626,Aberrant,0,0
228627,Behavior,0,0
228628,Checklist,0,0
228629,",",0,0
228630,social,0,0
228631,items,0,1
228632,and,0,0
228633,target,0,0
228634,behaviors,0,0
228635,),0,0
228636,.,0,0
228637,Naltrexone,1,1
228638,treatment,0,0
228639,failed,0,0
228640,to,0,0
228641,produce,0,0
228642,significant,0,0
228643,changes,0,0
228644,in,0,0
228645,social,0,0
228646,behavior,0,0
228647,",",0,0
228648,but,0,0
228649,it,0,0
228650,did,0,0
228651,reduce,0,0
228652,irritability,0,0
228653,and,0,0
228654,target,0,0
228655,scores,0,0
228656,on,0,0
228657,behavior,0,0
228658,checklists,0,1
228659,.,0,0
228660,The,0,0
228661,playroom,0,1
228662,data,0,0
228663,indicated,0,0
228664,that,0,0
228665,naltrexone,1,1
228666,significantly,0,0
228667,affected,0,0
228668,indices,0,0
228669,of,0,0
228670,activity,0,0
228671,and,0,0
228672,attention,0,0
228673,.,0,0
228674,Effect,0,0
228675,of,0,0
228676,marine,1,0
228677,oils,1,1
228678,supplementation,1,1
228679,on,0,0
228680,coagulation,0,1
228681,and,0,0
228682,cellular,0,0
228683,activation,0,0
228684,in,0,0
228685,whole,0,0
228686,blood,0,0
228687,.,0,0
228688,A,0,0
228689,study,0,0
228690,was,0,0
228691,performed,0,0
228692,to,0,0
228693,explore,0,0
228694,the,0,0
228695,effects,0,0
228696,of,0,0
228697,supplemental,0,1
228698,intake,0,0
228699,of,0,0
228700,various,0,0
228701,marine,0,0
228702,oils,0,1
228703,known,0,0
228704,to,0,0
228705,be,0,0
228706,part,0,0
228707,of,0,0
228708,the,0,0
228709,Eskimo,0,1
228710,diet,0,1
228711,.,0,0
228712,Healthy,0,0
228713,men,0,0
228714,and,0,0
228715,women,0,0
228716,(,0,0
228717,134,0,0
228718,),0,0
228719,were,0,0
228720,randomly,0,0
228721,selected,0,0
228722,to,0,0
228723,consume,0,0
228724,15,0,0
228725,mL/d,0,1
228726,of,0,0
228727,oil,1,1
228728,from,1,0
228729,blubber,1,0
228730,of,1,0
228731,seal,1,1
228732,",",1,0
228733,cod,1,1
228734,liver,1,0
228735,",",1,0
228736,seal/cod,1,0
228737,liver,1,0
228738,",",1,0
228739,blubber,1,0
228740,of,1,0
228741,Minke,1,1
228742,whale,1,0
228743,",",1,0
228744,or,1,1
228745,no,1,0
228746,oil,1,1
228747,for,0,0
228748,ten,0,0
228749,weeks,0,0
228750,.,0,0
228751,Total,0,0
228752,cholesterol,0,0
228753,was,0,0
228754,unchanged,0,0
228755,in,0,0
228756,the,0,0
228757,oil,0,1
228758,groups,0,0
228759,",",0,0
228760,whereas,0,0
228761,high,0,0
228762,density,0,0
228763,lipoprotein,0,0
228764,cholesterol,0,0
228765,increased,0,0
228766,7,0,0
228767,%,0,0
228768,in,0,0
228769,the,0,0
228770,seal/cod,1,0
228771,liver,1,0
228772,oil,1,1
228773,(,0,1
228774,CLO,0,1
228775,),0,1
228776,group,0,0
228777,(,0,1
228778,P,0,0
228779,<,0,0
228780,0.05,0,0
228781,),0,0
228782,and,0,0
228783,11,0,0
228784,%,0,0
228785,in,0,0
228786,the,0,0
228787,whale,1,0
228788,oil,1,1
228789,group,0,1
228790,(,0,0
228791,P,0,0
228792,<,0,0
228793,0.005,0,0
228794,),0,0
228795,.,0,0
228796,Triacylglycerol,0,0
228797,was,0,0
228798,significantly,0,0
228799,reduced,0,0
228800,in,0,0
228801,the,0,0
228802,CLO,0,1
228803,group,0,0
228804,only,0,0
228805,.,0,0
228806,The,0,0
228807,concentration,0,0
228808,of,0,0
228809,prothrombin,0,0
228810,fragment,0,0
228811,1,0,0
228812,+,0,0
228813,2,0,0
228814,was,0,0
228815,reduced,0,0
228816,25,0,0
228817,%,0,0
228818,(,0,0
228819,P,0,0
228820,<,0,0
228821,0.05,0,0
228822,),0,0
228823,after,0,0
228824,whale,0,0
228825,oil,0,1
228826,supplementation,0,1
228827,.,0,0
228828,No,0,0
228829,change,0,0
228830,in,0,0
228831,fibrinogen,0,0
228832,or,0,1
228833,factor,0,0
228834,VIIc,0,1
228835,was,0,0
228836,detected,0,0
228837,.,0,0
228838,Tumor,0,0
228839,necrosis,0,0
228840,factor,0,1
228841,generation,0,0
228842,in,0,0
228843,lipopolysaccharide,0,1
228844,(,0,1
228845,LPS,0,1
228846,),0,1
228847,-stimulated,0,0
228848,blood,0,0
228849,was,0,0
228850,30,0,0
228851,%,0,0
228852,reduced,0,0
228853,after,0,0
228854,whale,0,0
228855,oil,0,1
228856,(,0,0
228857,P,0,0
228858,<,0,0
228859,0.05,0,0
228860,),0,0
228861,",",0,0
228862,but,0,0
228863,was,0,0
228864,unaffected,0,0
228865,by,0,0
228866,intake,0,0
228867,of,0,0
228868,seal,0,1
228869,or,0,1
228870,CLO,0,1
228871,.,0,0
228872,The,0,0
228873,LPS-induced,0,0
228874,tissue,0,0
228875,factor,0,1
228876,activity,0,0
228877,in,0,0
228878,monocytes,0,0
228879,was,0,0
228880,reduced,0,0
228881,to,0,0
228882,a,0,0
228883,significant,0,0
228884,degree,0,0
228885,only,0,0
228886,in,0,0
228887,the,0,0
228888,seal/CLO,0,1
228889,group,0,0
228890,(,0,0
228891,34,0,0
228892,%,0,0
228893,),0,0
228894,and,0,0
228895,whale,0,0
228896,oil,0,1
228897,group,0,1
228898,(,0,0
228899,35,0,0
228900,%,0,0
228901,),0,1
228902,(,0,0
228903,P,0,0
228904,<,0,0
228905,0.05,0,0
228906,),0,0
228907,.,0,0
228908,The,0,0
228909,most,0,0
228910,dramatic,0,0
228911,change,0,0
228912,in,0,0
228913,thromboxane,0,0
228914,B2,0,0
228915,in,0,0
228916,LPS-stimulated,0,0
228917,blood,0,0
228918,was,0,0
228919,seen,0,0
228920,after,0,0
228921,whale,0,0
228922,oil,0,1
228923,intake,0,0
228924,with,0,0
228925,44,0,0
228926,%,0,0
228927,reduction,0,0
228928,(,0,0
228929,P,0,0
228930,<,0,0
228931,0.01,0,0
228932,),0,0
228933,.,0,0
228934,Supplementation,0,1
228935,of,0,0
228936,a,0,0
228937,regular,0,1
228938,diet,0,1
228939,with,0,0
228940,a,0,0
228941,combination,0,1
228942,of,0,0
228943,seal,0,1
228944,oil,0,1
228945,and,0,0
228946,CLO,0,1
228947,and,0,0
228948,especially,0,0
228949,with,0,0
228950,whale,0,0
228951,oil,0,1
228952,seems,0,0
228953,to,0,0
228954,have,0,0
228955,beneficial,0,0
228956,effects,0,0
228957,on,0,0
228958,several,0,0
228959,products,0,0
228960,thought,0,0
228961,to,0,0
228962,be,0,0
228963,associated,0,0
228964,with,0,0
228965,cardiovascular,0,0
228966,and,0,0
228967,thrombotic,0,0
228968,diseases,0,0
228969,.,0,0
228970,Processing,0,1
228971,familiar,0,1
228972,and,0,0
228973,unfamiliar,0,1
228974,auditory,0,1
228975,stimuli,0,1
228976,during,0,0
228977,general,0,0
228978,anesthesia,0,1
228979,.,0,0
228980,We,0,0
228981,tested,0,0
228982,memory,0,0
228983,priming,0,1
228984,for,0,0
228985,auditory,1,1
228986,stimuli,1,1
228987,presented,0,0
228988,during,0,0
228989,general,1,0
228990,propofol-sufentanil,1,1
228991,anesthesia,1,1
228992,in,0,0
228993,58,0,0
228994,patients,0,0
228995,undergoing,0,0
228996,day-case,1,1
228997,arthroscopic,1,1
228998,surgery,1,1
228999,.,1,0
229000,Stimuli,1,1
229001,were,1,0
229002,presented,1,0
229003,via,1,0
229004,headphones,1,1
229005,and,1,0
229006,consisted,1,0
229007,of,1,0
229008,common,1,0
229009,facts,1,0
229010,(,0,0
229011,Group,0,0
229012,A,0,0
229013,",",0,0
229014,29,0,0
229015,patients,0,0
229016,),0,0
229017,",",0,0
229018,or,1,1
229019,familiar,1,1
229020,or,1,1
229021,unfamiliar,1,1
229022,full,1,0
229023,names,1,0
229024,of,1,0
229025,fictitious,1,0
229026,people,1,0
229027,(,0,0
229028,GRoup,0,0
229029,B,0,1
229030,",",0,0
229031,29,0,0
229032,patients,0,0
229033,),0,0
229034,.,0,0
229035,Group,0,0
229036,A,0,0
229037,was,0,0
229038,expected,0,0
229039,to,0,0
229040,give,0,0
229041,more,0,0
229042,correct,0,0
229043,answers,0,0
229044,to,0,0
229045,questions,0,0
229046,about,0,0
229047,the,0,0
229048,common,0,0
229049,facts,0,0
229050,than,0,0
229051,Group,0,0
229052,B,0,0
229053,",",0,0
229054,when,0,0
229055,tested,0,0
229056,postoperatively,0,0
229057,",",0,0
229058,and,0,0
229059,Group,0,0
229060,B,0,1
229061,to,0,0
229062,attribute,0,0
229063,more,0,0
229064,fame,0,0
229065,to,0,0
229066,presented,0,0
229067,names,0,0
229068,than,0,0
229069,Group,0,0
229070,A,0,1
229071,(,0,0
229072,famous,0,0
229073,names,0,1
229074,test,0,0
229075,),0,0
229076,.,0,0
229077,Because,0,0
229078,the,0,0
229079,process,0,0
229080,for,0,0
229081,learning,0,1
229082,new,0,0
229083,or,0,1
229084,unfamiliar,0,1
229085,stimuli,0,1
229086,(,0,0
229087,elaboration,0,0
229088,),0,1
229089,in,0,0
229090,particular,0,0
229091,may,0,0
229092,be,0,0
229093,impaired,0,0
229094,under,0,0
229095,general,0,0
229096,anesthesia,0,1
229097,",",0,0
229098,more,0,0
229099,memory,0,0
229100,priming,0,0
229101,was,0,0
229102,expected,0,0
229103,for,0,0
229104,familiar,0,0
229105,than,0,0
229106,for,0,0
229107,unfamiliar,0,0
229108,material,0,0
229109,.,0,0
229110,No,0,0
229111,significant,0,0
229112,differences,0,0
229113,were,0,0
229114,demonstrated,0,0
229115,between,0,0
229116,the,0,0
229117,two,0,0
229118,groups,0,0
229119,in,0,0
229120,performance,0,0
229121,on,0,0
229122,common,0,0
229123,facts,0,0
229124,or,0,0
229125,in,0,0
229126,fame,0,0
229127,attributed,0,0
229128,to,0,0
229129,the,0,0
229130,names,0,0
229131,.,0,0
229132,The,0,0
229133,amount,0,0
229134,of,0,0
229135,memory,0,0
229136,priming,0,0
229137,",",0,0
229138,however,0,0
229139,",",0,0
229140,was,0,0
229141,positively,0,0
229142,related,0,0
229143,to,0,0
229144,one,0,0
229145,of,0,0
229146,two,0,0
229147,measures,0,0
229148,of,0,0
229149,preoperative,0,0
229150,anxiety,0,0
229151,.,0,0
229152,Antibiotic,1,1
229153,strategy,1,0
229154,after,0,0
229155,the,0,0
229156,empiric,0,0
229157,phase,0,0
229158,in,0,0
229159,patients,0,0
229160,treated,0,0
229161,for,0,0
229162,a,0,0
229163,hematological,0,0
229164,malignancy,0,0
229165,.,0,0
229166,Empiric,1,0
229167,broad-spectrum,1,1
229168,antibiotic,1,1
229169,therapy,1,1
229170,has,0,0
229171,become,0,0
229172,a,0,0
229173,generally,0,0
229174,accepted,0,0
229175,strategy,0,0
229176,in,0,0
229177,the,0,0
229178,treatment,0,0
229179,of,0,0
229180,febrile,0,0
229181,neutropenic,0,0
229182,patients,0,0
229183,.,0,0
229184,Particularly,0,0
229185,in,0,0
229186,patients,0,0
229187,with,0,0
229188,prolonged,0,0
229189,neutropenia,0,0
229190,",",0,0
229191,subsequent,0,0
229192,adaptation,0,0
229193,of,0,0
229194,such,0,0
229195,a,0,0
229196,regimen,0,1
229197,will,0,0
229198,be,0,0
229199,the,0,0
229200,rule,0,0
229201,rather,0,0
229202,than,0,0
229203,exception,0,0
229204,.,0,0
229205,Since,0,0
229206,there,0,0
229207,are,0,0
229208,no,0,0
229209,uniformly,0,0
229210,accepted,0,0
229211,guidelines,0,0
229212,for,0,0
229213,the,0,0
229214,modification,0,1
229215,of,0,0
229216,antibiotic,1,1
229217,therapy,1,1
229218,during,0,0
229219,the,0,0
229220,post-empiric,0,1
229221,phase,0,0
229222,",",0,0
229223,we,0,0
229224,assessed,0,0
229225,the,0,0
229226,impact,1,0
229227,of,1,0
229228,a,1,0
229229,set,1,0
229230,of,1,0
229231,rules,1,0
229232,that,1,0
229233,evolved,1,0
229234,during,1,0
229235,the,1,0
229236,first,1,0
229237,randomized,1,0
229238,trials,1,0
229239,.,1,0
229240,Evaluation,1,0
229241,of,1,0
229242,the,1,0
229243,clinician,1,0
229244,'s,1,0
229245,compliance,1,0
229246,with,1,0
229247,these,1,0
229248,rules,1,0
229249,in,1,0
229250,1951,1,0
229251,febrile,1,0
229252,neutropenic,1,0
229253,episodes,1,0
229254,was,1,0
229255,the,1,0
229256,subject,1,0
229257,of,1,0
229258,the,1,0
229259,present,1,0
229260,analysis,1,0
229261,.,1,0
229262,Treatment,1,0
229263,was,1,0
229264,modified,1,0
229265,in,0,0
229266,761,0,1
229267,(,0,0
229268,39,0,0
229269,%,0,0
229270,),0,0
229271,cases,0,0
229272,",",0,0
229273,and,0,0
229274,these,0,0
229275,changes,0,0
229276,were,0,0
229277,made,0,0
229278,according,0,0
229279,to,0,0
229280,the,0,0
229281,rules,0,0
229282,in,0,0
229283,76,0,0
229284,%,0,0
229285,.,0,0
229286,For,0,0
229287,75,0,0
229288,%,0,0
229289,of,0,0
229290,the,0,0
229291,alterations,0,0
229292,in,0,0
229293,treatment,0,0
229294,during,0,0
229295,the,0,0
229296,evening,0,0
229297,and,0,0
229298,night,0,0
229299,shifts,0,0
229300,",",0,0
229301,no,0,0
229302,reasonable,0,0
229303,explanation,0,0
229304,was,0,0
229305,established,0,0
229306,",",0,0
229307,while,0,0
229308,93,0,0
229309,%,0,0
229310,of,0,0
229311,the,0,0
229312,modifications,0,0
229313,during,0,0
229314,the,0,0
229315,normal,0,0
229316,working,0,0
229317,hours,0,0
229318,were,0,0
229319,made,0,0
229320,for,0,0
229321,objective,0,0
229322,reasons,0,0
229323,.,0,0
229324,The,0,0
229325,empiric,0,0
229326,regimen,0,1
229327,was,0,0
229328,more,0,0
229329,frequently,0,0
229330,changed,0,0
229331,in,0,0
229332,patients,0,0
229333,with,0,0
229334,a,0,0
229335,clinical,0,0
229336,focus,0,0
229337,of,0,0
229338,infection,0,0
229339,at,0,0
229340,the,0,0
229341,onset,0,0
229342,of,0,0
229343,fever,0,0
229344,than,0,0
229345,in,0,0
229346,patients,0,0
229347,who,0,0
229348,showed,0,0
229349,fever,0,0
229350,as,0,0
229351,the,0,0
229352,only,0,0
229353,symptom,0,0
229354,of,0,0
229355,a,0,0
229356,possible,0,0
229357,infection,0,0
229358,.,0,0
229359,The,0,0
229360,perceived,0,0
229361,need,0,0
229362,for,0,0
229363,modification,0,1
229364,amounted,0,0
229365,to,0,0
229366,69,0,0
229367,%,0,0
229368,in,0,0
229369,pulmonary,0,0
229370,infections,0,0
229371,",",0,0
229372,to,0,0
229373,51,0,0
229374,%,0,0
229375,in,0,0
229376,skin,0,0
229377,and,0,0
229378,soft-tissue,0,0
229379,infections,0,0
229380,",",0,0
229381,to,0,0
229382,44,0,0
229383,%,0,0
229384,in,0,0
229385,patients,0,0
229386,with,0,0
229387,abdominal,0,0
229388,complaints,0,0
229389,",",0,0
229390,and,0,0
229391,to,0,0
229392,37,0,0
229393,%,0,0
229394,in,0,0
229395,upper,0,0
229396,respiratory,0,0
229397,tract,0,0
229398,infections,0,0
229399,.,0,0
229400,Glycopeptides,0,1
229401,constituted,0,0
229402,22,0,0
229403,%,0,0
229404,of,0,0
229405,modifications,0,0
229406,",",0,0
229407,particularly,0,0
229408,in,0,0
229409,patients,0,0
229410,with,0,0
229411,a,0,0
229412,central,0,0
229413,venous,0,0
229414,catheter,0,1
229415,",",0,0
229416,and,0,0
229417,systemically,0,0
229418,active,0,1
229419,antifungals,0,1
229420,were,0,0
229421,administered,0,0
229422,in,0,0
229423,16,0,0
229424,%,0,0
229425,of,0,0
229426,cases,0,0
229427,.,0,0
229428,Especially,0,0
229429,inexperienced,0,0
229430,clinicians,0,0
229431,tend,0,0
229432,to,0,0
229433,adjust,0,0
229434,antibiotic,1,1
229435,therapy,1,1
229436,",",0,0
229437,in,0,0
229438,spite,0,0
229439,of,0,0
229440,the,0,0
229441,fact,0,0
229442,that,0,0
229443,persistence,0,0
229444,of,0,0
229445,fever,0,0
229446,alone,0,1
229447,seldom,0,0
229448,reflects,0,0
229449,inadequate,0,0
229450,treatment,0,0
229451,when,0,0
229452,the,0,0
229453,clinical,0,0
229454,condition,0,0
229455,of,0,0
229456,the,0,0
229457,patient,0,0
229458,is,0,0
229459,stable,0,0
229460,or,0,0
229461,improving,0,0
229462,.,0,0
229463,On,0,0
229464,the,0,0
229465,other,0,0
229466,hand,0,0
229467,",",0,0
229468,the,0,0
229469,development,0,0
229470,of,0,0
229471,subsequent,0,0
229472,infectious,0,0
229473,events,0,0
229474,emphasizes,0,0
229475,that,0,0
229476,a,0,0
229477,genuine,0,0
229478,need,0,0
229479,for,0,0
229480,modification,0,1
229481,does,0,0
229482,frequently,0,0
229483,exist,0,0
229484,.,0,0
229485,Relaxation,1,1
229486,and,1,1
229487,imagery,1,1
229488,and,1,0
229489,cognitive-behavioral,1,1
229490,training,1,1
229491,reduce,0,0
229492,pain,0,0
229493,during,0,0
229494,cancer,0,0
229495,treatment,0,0
229496,:,0,0
229497,a,0,0
229498,controlled,0,0
229499,clinical,0,0
229500,trial,0,0
229501,.,0,0
229502,Few,0,0
229503,controlled,0,0
229504,clinical,0,0
229505,trials,0,0
229506,of,0,0
229507,psychological,0,0
229508,interventions,0,1
229509,for,0,0
229510,cancer,0,0
229511,pain,0,0
229512,relief,0,0
229513,exist,0,0
229514,in,0,0
229515,spite,0,0
229516,of,0,0
229517,frequent,0,0
229518,support,0,0
229519,for,0,0
229520,their,0,0
229521,importance,0,0
229522,as,0,0
229523,adjuncts,0,1
229524,to,0,0
229525,medical,0,0
229526,treatment,0,0
229527,.,0,0
229528,This,0,0
229529,study,0,0
229530,compared,0,0
229531,oral,0,1
229532,mucositis,0,0
229533,pain,0,0
229534,levels,0,0
229535,in,0,0
229536,4,0,0
229537,groups,0,0
229538,of,0,0
229539,cancer,0,0
229540,patients,0,0
229541,receiving,0,0
229542,bone,0,0
229543,marrow,0,1
229544,transplants,0,1
229545,(,0,0
229546,BMT,0,0
229547,),0,1
229548,:,0,0
229549,(,0,0
229550,1,0,0
229551,),0,0
229552,treatment,1,0
229553,as,1,0
229554,usual,1,1
229555,control,1,1
229556,",",1,0
229557,(,1,0
229558,2,1,0
229559,),1,1
229560,therapist,1,1
229561,support,1,1
229562,",",1,0
229563,(,1,0
229564,3,1,0
229565,),1,1
229566,relaxation,1,1
229567,and,1,1
229568,imagery,1,1
229569,training,1,1
229570,",",1,0
229571,and,1,0
229572,(,1,0
229573,4,1,1
229574,),1,0
229575,training,1,1
229576,in,1,0
229577,a,1,0
229578,package,1,1
229579,of,1,0
229580,cognitive-behavioral,1,1
229581,coping,1,0
229582,skills,1,0
229583,which,1,0
229584,included,1,0
229585,relaxation,1,1
229586,and,1,0
229587,imagery,1,1
229588,.,1,0
229589,A,0,0
229590,total,0,0
229591,of,0,0
229592,94,0,0
229593,patients,0,0
229594,completed,0,0
229595,the,0,0
229596,study,0,0
229597,which,0,0
229598,involved,0,0
229599,two,0,0
229600,training,0,1
229601,sessions,0,1
229602,prior,0,0
229603,to,0,0
229604,treatment,0,0
229605,and,0,0
229606,twice,0,1
229607,a,0,0
229608,week,0,0
229609,'booster,0,1
229610,',0,0
229611,sessions,0,1
229612,during,0,0
229613,the,0,0
229614,first,0,0
229615,5,0,0
229616,weeks,0,0
229617,of,0,0
229618,treatment,0,0
229619,.,0,0
229620,Results,0,0
229621,confirmed,0,0
229622,our,0,0
229623,hypothesis,0,0
229624,that,0,0
229625,patients,0,0
229626,who,0,0
229627,received,0,0
229628,either,0,1
229629,relaxation,0,1
229630,and,0,0
229631,imagery,0,1
229632,alone,0,1
229633,or,0,0
229634,patients,0,0
229635,who,0,0
229636,received,0,0
229637,the,0,0
229638,package,0,1
229639,of,0,0
229640,cognitive-behavioral,0,1
229641,coping,0,0
229642,skills,0,0
229643,would,0,0
229644,report,0,0
229645,less,0,0
229646,pain,0,0
229647,than,0,0
229648,patients,0,0
229649,in,0,0
229650,the,0,0
229651,other,0,0
229652,2,0,0
229653,groups,0,0
229654,.,0,0
229655,The,0,0
229656,hypothesis,0,0
229657,that,0,0
229658,the,0,0
229659,cognitive-behavioral,0,1
229660,skills,0,0
229661,package,0,1
229662,would,0,0
229663,have,0,0
229664,an,0,0
229665,additive,0,1
229666,effect,0,0
229667,beyond,0,0
229668,relaxation,0,1
229669,and,0,0
229670,imagery,0,1
229671,alone,0,1
229672,was,0,0
229673,not,0,0
229674,confirmed,0,0
229675,.,0,0
229676,Average,0,0
229677,visual,0,0
229678,analogue,0,1
229679,scale,0,0
229680,(,0,1
229681,VAS,0,1
229682,),0,1
229683,report,0,0
229684,of,0,0
229685,pain,0,0
229686,within,0,0
229687,the,0,0
229688,therapist,0,1
229689,support,0,0
229690,group,0,0
229691,was,0,0
229692,not,0,0
229693,significantly,0,0
229694,lower,0,0
229695,than,0,0
229696,the,0,0
229697,control,0,1
229698,group,0,0
229699,(,0,0
229700,P,0,0
229701,=,0,0
229702,0.103,0,0
229703,),0,0
229704,nor,0,0
229705,significantly,0,0
229706,higher,0,0
229707,than,0,0
229708,the,0,0
229709,training,0,1
229710,groups,0,0
229711,.,0,0
229712,Patient,0,0
229713,reports,0,0
229714,of,0,0
229715,relative,0,0
229716,helpfulness,0,0
229717,of,0,0
229718,the,0,0
229719,interventions,0,0
229720,for,0,0
229721,managing,0,0
229722,pain,0,0
229723,and,0,0
229724,nausea,0,0
229725,matched,0,0
229726,the,0,0
229727,results,0,0
229728,of,0,0
229729,VAS,0,0
229730,reports,0,0
229731,.,0,0
229732,From,0,0
229733,these,0,0
229734,results,0,0
229735,",",0,0
229736,we,0,0
229737,conclude,0,0
229738,that,0,0
229739,relaxation,0,1
229740,and,0,0
229741,imagery,0,1
229742,training,0,1
229743,reduces,0,0
229744,cancer,0,0
229745,treatment-related,0,0
229746,pain,0,0
229747,;,0,0
229748,adding,0,0
229749,cognitive-behavioral,0,1
229750,skills,0,1
229751,to,0,0
229752,the,0,0
229753,relaxation,0,1
229754,with,0,0
229755,imagery,0,1
229756,does,0,0
229757,not,0,0
229758,",",0,0
229759,on,0,0
229760,average,0,0
229761,",",0,0
229762,further,0,0
229763,improve,0,0
229764,pain,0,0
229765,relief,0,0
229766,.,0,0
229767,The,0,0
229768,individual,0,0
229769,responsiveness,0,0
229770,to,0,0
229771,growth,1,1
229772,hormone,1,1
229773,(,1,1
229774,GH,1,1
229775,),1,1
229776,treatment,1,0
229777,in,0,0
229778,GH-deficient,0,1
229779,adults,0,0
229780,is,0,0
229781,dependent,0,0
229782,on,0,0
229783,the,0,0
229784,level,0,0
229785,of,0,0
229786,GH-binding,0,0
229787,protein,0,1
229788,",",0,0
229789,body,0,0
229790,mass,0,0
229791,index,0,0
229792,",",0,0
229793,age,0,0
229794,",",0,0
229795,and,0,0
229796,gender,0,0
229797,.,0,0
229798,The,0,0
229799,aim,0,0
229800,of,0,0
229801,the,0,0
229802,present,0,0
229803,trial,0,0
229804,was,0,0
229805,to,0,0
229806,study,0,0
229807,the,0,0
229808,individual,0,0
229809,responsiveness,0,0
229810,to,0,0
229811,GH,1,1
229812,treatment,1,0
229813,in,0,0
229814,terms,0,0
229815,of,0,0
229816,body,0,0
229817,composition,0,0
229818,and,0,0
229819,to,0,0
229820,search,0,0
229821,for,0,0
229822,possible,0,0
229823,predictors,0,0
229824,of,0,0
229825,the,0,0
229826,response,0,0
229827,in,0,0
229828,GH-deficient,0,1
229829,adults,0,0
229830,.,0,0
229831,Sixty-eight,0,0
229832,patients,0,0
229833,(,0,0
229834,44,0,0
229835,men,0,0
229836,and,0,0
229837,24,0,0
229838,women,0,0
229839,),0,0
229840,with,0,0
229841,a,0,0
229842,mean,0,0
229843,age,0,0
229844,of,0,0
229845,44.3,0,0
229846,(,0,0
229847,1.2,0,0
229848,),0,1
229849,yr,0,0
229850,and,0,0
229851,verified,0,0
229852,GH,0,1
229853,deficiency,0,0
229854,participated,0,0
229855,in,0,0
229856,a,0,0
229857,2-phase,0,0
229858,treatment,0,0
229859,trial,0,0
229860,with,0,0
229861,an,0,0
229862,initial,0,0
229863,randomized,0,0
229864,",",0,0
229865,double,0,1
229866,blind,0,0
229867,",",0,0
229868,placebo-controlled,1,1
229869,",",0,0
229870,6-month,0,0
229871,period,0,0
229872,",",0,0
229873,followed,0,1
229874,by,0,0
229875,an,0,0
229876,open,0,1
229877,treatment,0,0
229878,period,0,0
229879,",",0,0
229880,thereby,0,0
229881,ensuring,0,0
229882,all,0,0
229883,patients,0,0
229884,12,0,0
229885,months,0,0
229886,of,0,0
229887,GH,0,1
229888,treatment,0,0
229889,.,0,0
229890,Recombinant,1,0
229891,human,1,0
229892,GH,1,1
229893,was,0,0
229894,administered,0,0
229895,sc,0,0
229896,daily,0,1
229897,at,0,0
229898,bedtime,0,1
229899,",",0,0
229900,with,0,0
229901,a,0,0
229902,target,0,0
229903,dose,0,0
229904,of,0,0
229905,12,0,0
229906,micrograms/kg,0,0
229907,x,0,0
229908,day,0,0
229909,.,0,0
229910,GHBP,0,0
229911,was,0,0
229912,measured,0,0
229913,by,0,0
229914,ligand-mediated,0,0
229915,immunofunctional,0,1
229916,assay,0,1
229917,",",0,0
229918,and,0,0
229919,serum,0,0
229920,insulin-like,0,1
229921,growth,0,0
229922,factor,0,1
229923,I,0,0
229924,(,0,0
229925,IGF-I,0,1
229926,),0,1
229927,was,0,0
229928,determined,0,0
229929,by,0,0
229930,RIA,0,1
229931,after,0,0
229932,acid-ethanol,0,1
229933,extraction,0,0
229934,",",0,0
229935,using,0,0
229936,a,0,0
229937,truncated,0,0
229938,IGF-I,0,1
229939,analog,0,1
229940,as,0,0
229941,the,0,0
229942,radioligand,0,1
229943,.,0,0
229944,Lean,0,0
229945,body,0,0
229946,mass,0,0
229947,(,0,1
229948,LBM,0,1
229949,),0,1
229950,and,0,0
229951,body,0,0
229952,fat,0,1
229953,(,0,1
229954,BF,0,1
229955,),0,1
229956,were,0,0
229957,determined,0,0
229958,by,0,0
229959,dual,0,0
229960,energy,0,1
229961,x-ray,0,1
229962,absorptiometry,0,0
229963,",",0,0
229964,and,0,0
229965,total,0,0
229966,body,0,0
229967,water,0,1
229968,(,0,1
229969,TBW,0,0
229970,),0,1
229971,was,0,0
229972,determined,0,0
229973,by,0,0
229974,bioelectrical,0,0
229975,impedance,0,0
229976,.,0,0
229977,During,0,0
229978,the,0,0
229979,placebo,0,1
229980,control,0,1
229981,period,0,0
229982,",",0,0
229983,serum,0,0
229984,IGF-I,0,1
229985,",",0,0
229986,LBM,0,0
229987,",",0,0
229988,and,0,0
229989,TBW,0,0
229990,increased,0,0
229991,(,0,0
229992,P,0,0
229993,<,0,0
229994,0.001,0,0
229995,),0,0
229996,",",0,0
229997,whereas,0,0
229998,BF,0,1
229999,decreased,0,0
230000,(,0,0
230001,P,0,0
230002,<,0,0
230003,0.001,0,0
230004,),0,0
230005,and,0,0
230006,serum,0,0
230007,GHBP,0,0
230008,was,0,0
230009,unchanged,0,0
230010,in,0,0
230011,the,0,0
230012,group,0,0
230013,treated,0,0
230014,with,0,0
230015,GH,0,1
230016,compared,0,0
230017,with,0,0
230018,the,0,0
230019,patients,0,0
230020,treated,0,0
230021,with,0,0
230022,placebo,0,1
230023,.,0,0
230024,After,0,0
230025,12,0,0
230026,months,0,0
230027,of,0,0
230028,GH,0,1
230029,treatment,0,0
230030,",",0,0
230031,the,0,0
230032,individual,0,0
230033,changes,0,0
230034,in,0,0
230035,BF,0,1
230036,ranged,0,0
230037,from,0,0
230038,-12.5,0,0
230039,to,0,0
230040,4.3,0,0
230041,kg,0,0
230042,and,0,0
230043,from,0,0
230044,-4.5,0,1
230045,to,0,0
230046,10.1,0,0
230047,kg,0,0
230048,in,0,0
230049,LBM,0,0
230050,.,0,1
230051,Age,0,1
230052,(,0,0
230053,P,0,0
230054,<,0,0
230055,0.05,0,0
230056,),0,0
230057,and,0,0
230058,baseline,0,0
230059,GHBP,0,1
230060,level,0,0
230061,(,0,0
230062,P,0,0
230063,<,0,0
230064,0.01,0,0
230065,),0,0
230066,were,0,0
230067,inversely,0,0
230068,correlated,0,0
230069,with,0,0
230070,the,0,0
230071,increase,0,0
230072,in,0,0
230073,LBM,0,0
230074,.,0,0
230075,The,0,0
230076,GH-induced,0,0
230077,increment,0,0
230078,in,0,0
230079,IGF-I,0,1
230080,and,0,0
230081,TBW,0,0
230082,was,0,0
230083,greater,0,0
230084,in,0,0
230085,men,0,0
230086,than,0,0
230087,in,0,0
230088,women,0,0
230089,(,0,0
230090,P,0,0
230091,<,0,0
230092,0.01,0,0
230093,),0,0
230094,",",0,0
230095,whereas,0,0
230096,the,0,0
230097,decreases,0,0
230098,in,0,0
230099,BF,0,1
230100,were,0,0
230101,similar,0,0
230102,in,0,0
230103,men,0,0
230104,and,0,0
230105,women,0,0
230106,.,0,0
230107,This,0,0
230108,trial,0,0
230109,demonstrates,0,0
230110,the,0,0
230111,variability,0,0
230112,in,0,0
230113,responsiveness,0,0
230114,to,0,0
230115,GH,1,1
230116,administration,0,0
230117,in,0,0
230118,GH-deficient,0,1
230119,adults,0,0
230120,.,0,0
230121,The,0,0
230122,best,0,0
230123,response,0,0
230124,to,0,0
230125,GH,0,1
230126,was,0,0
230127,obtained,0,0
230128,in,0,0
230129,younger,0,0
230130,patients,0,0
230131,with,0,0
230132,low,0,0
230133,GHBP,0,0
230134,levels,0,0
230135,.,0,0
230136,Furthermore,0,0
230137,",",0,0
230138,men,0,0
230139,responded,0,0
230140,better,0,0
230141,than,0,0
230142,women,0,0
230143,.,0,0
230144,The,0,0
230145,effects,0,0
230146,of,0,0
230147,amantadine,1,1
230148,and,0,0
230149,pemoline,1,1
230150,on,0,0
230151,cognitive,0,0
230152,functioning,0,0
230153,in,0,0
230154,multiple,0,0
230155,sclerosis,0,1
230156,.,0,0
230157,BACKGROUND,0,0
230158,Amantadine,1,1
230159,hydrochloride,1,1
230160,and,0,0
230161,pemoline,1,1
230162,",",0,0
230163,both,0,0
230164,frequently,0,0
230165,used,0,0
230166,to,0,0
230167,treat,0,0
230168,the,0,0
230169,fatigue,0,0
230170,of,0,0
230171,multiple,0,1
230172,sclerosis,0,1
230173,(,0,1
230174,MS,0,0
230175,),0,0
230176,",",0,0
230177,may,0,0
230178,also,0,0
230179,improve,0,0
230180,attention,0,0
230181,and,0,0
230182,other,0,0
230183,cognitive,0,0
230184,functions,0,0
230185,in,0,0
230186,MS.,0,0
230187,To,0,0
230188,our,0,0
230189,knowledge,0,0
230190,",",0,0
230191,these,0,0
230192,agents,0,0
230193,have,0,0
230194,never,0,0
230195,been,0,0
230196,compared,0,0
230197,in,0,0
230198,a,0,0
230199,placebo-controlled,0,1
230200,trial,0,0
230201,of,0,0
230202,patients,0,0
230203,with,0,0
230204,MS,0,0
230205,.,0,0
230206,OBJECTIVE,0,0
230207,To,0,0
230208,evaluate,0,0
230209,the,0,0
230210,effects,0,0
230211,of,0,0
230212,amantadine,1,1
230213,and,1,0
230214,pemoline,1,1
230215,on,0,0
230216,cognitive,0,0
230217,functioning,0,0
230218,in,0,0
230219,MS.,0,1
230220,METHODS,0,0
230221,A,0,0
230222,total,0,0
230223,of,0,0
230224,45,0,0
230225,ambulatory,0,0
230226,patients,0,0
230227,with,0,0
230228,MS,0,0
230229,and,0,0
230230,severe,0,0
230231,fatigue,0,0
230232,were,0,0
230233,treated,0,0
230234,for,0,0
230235,6,0,0
230236,weeks,0,0
230237,with,0,0
230238,amantadine,1,1
230239,",",1,0
230240,pemoline,1,1
230241,",",1,0
230242,or,1,1
230243,placebo,1,1
230244,using,0,0
230245,a,0,0
230246,parallel,0,0
230247,group,0,0
230248,design,0,0
230249,.,0,0
230250,They,0,0
230251,underwent,0,0
230252,comprehensive,0,0
230253,neuropsychological,0,0
230254,testing,0,0
230255,to,0,0
230256,determine,0,0
230257,treatment,0,0
230258,effects,0,0
230259,on,0,0
230260,cognitive,0,0
230261,functioning,0,0
230262,.,0,0
230263,Primary,0,0
230264,outcome,0,0
230265,measures,0,0
230266,were,0,0
230267,tests,0,0
230268,of,0,0
230269,attention,0,0
230270,(,0,0
230271,Digit,0,0
230272,Span,0,1
230273,",",0,0
230274,Trail,0,1
230275,Making,0,0
230276,Test,0,0
230277,",",0,0
230278,and,0,0
230279,Symbol,0,1
230280,Digit,0,0
230281,Modalities,0,1
230282,Test,0,0
230283,),0,0
230284,",",0,0
230285,verbal,0,1
230286,memory,0,0
230287,(,0,0
230288,Selective,0,1
230289,Reminding,0,1
230290,Test,0,0
230291,),0,0
230292,",",0,0
230293,nonverbal,0,1
230294,memory,0,0
230295,(,0,0
230296,Benton,0,1
230297,Visual,0,1
230298,Retention,0,0
230299,Test,0,0
230300,),0,0
230301,",",0,0
230302,and,0,0
230303,motor,0,1
230304,speed,0,0
230305,(,0,0
230306,Finger,0,1
230307,Tapping,0,0
230308,Test,0,0
230309,),0,0
230310,.,0,0
230311,RESULTS,0,0
230312,Fatigue,0,0
230313,did,0,0
230314,not,0,0
230315,significantly,0,0
230316,correlate,0,0
230317,with,0,0
230318,any,0,0
230319,of,0,0
230320,the,0,0
230321,neuropsychological,0,0
230322,outcome,0,0
230323,measures,0,0
230324,at,0,0
230325,baseline,0,0
230326,or,0,1
230327,after,0,0
230328,treatment,0,0
230329,.,0,0
230330,All,0,0
230331,three,0,0
230332,treatment,0,0
230333,groups,0,0
230334,improved,0,0
230335,on,0,0
230336,tests,0,0
230337,of,0,0
230338,attention,0,0
230339,(,0,0
230340,P,0,0
230341,<,0,0
230342,.003,0,0
230343,),0,0
230344,",",0,0
230345,verbal,0,1
230346,memory,0,0
230347,(,0,0
230348,P,0,0
230349,<,0,0
230350,.001,0,0
230351,),0,0
230352,",",0,0
230353,and,0,0
230354,motor,0,1
230355,speed,0,0
230356,(,0,0
230357,P,0,0
230358,<,0,0
230359,.002,0,0
230360,),0,0
230361,.,0,0
230362,There,0,0
230363,were,0,0
230364,no,0,0
230365,significant,0,0
230366,differences,0,0
230367,between,0,0
230368,amantadine,0,1
230369,",",0,0
230370,pemoline,0,1
230371,",",0,0
230372,and,0,0
230373,placebo,0,1
230374,.,0,0
230375,CONCLUSIONS,0,0
230376,Cognitive,0,1
230377,functioning,0,0
230378,in,0,0
230379,MS,0,0
230380,is,0,0
230381,independent,0,0
230382,of,0,0
230383,fatigue,0,0
230384,.,0,0
230385,Neither,0,0
230386,amantadine,1,1
230387,nor,0,0
230388,pemoline,1,1
230389,enhances,0,0
230390,cognitive,0,0
230391,performance,0,0
230392,in,0,0
230393,MS,0,0
230394,compared,0,0
230395,with,0,0
230396,placebo,1,1
230397,.,1,0
230398,Tight-fitting,1,1
230399,underwear,1,1
230400,and,0,0
230401,sperm,0,1
230402,quality,0,0
230403,.,0,0
230404,[,0,0
230405,Clinical,0,0
230406,early,0,0
230407,phase,0,0
230408,II,0,1
230409,study,0,0
230410,of,0,0
230411,bicalutamide,1,1
230412,(,1,1
230413,Casodex,1,1
230414,),1,1
230415,in,0,0
230416,patients,0,0
230417,with,0,0
230418,prostatic,0,0
230419,cancer,0,0
230420,],0,0
230421,.,0,0
230422,To,0,0
230423,investigate,0,0
230424,the,0,0
230425,efficacy,0,0
230426,and,0,0
230427,safety,0,0
230428,of,0,0
230429,bicalutamide,1,1
230430,(,0,1
230431,Casodex,0,1
230432,),0,1
230433,with,0,0
230434,its,0,0
230435,clinically,0,0
230436,recommended,0,0
230437,dose,0,0
230438,",",0,0
230439,the,0,0
230440,randomized,0,0
230441,early,0,0
230442,phase,0,0
230443,II,0,1
230444,study,0,0
230445,was,0,0
230446,performed,0,0
230447,in,0,0
230448,124,0,0
230449,patients,0,0
230450,with,0,0
230451,prostatic,0,0
230452,cancer,0,0
230453,(,0,1
230454,stage,0,0
230455,C,0,1
230456,",",0,0
230457,D,0,0
230458,),0,0
230459,.,0,0
230460,The,0,0
230461,patients,0,0
230462,were,0,0
230463,given,0,0
230464,50,1,0
230465,",",1,0
230466,80,1,0
230467,or,1,0
230468,100,1,0
230469,mg,1,1
230470,of,1,0
230471,bicalutamide,1,1
230472,orally,0,1
230473,once,0,0
230474,a,0,0
230475,day,0,0
230476,in,0,0
230477,fixed,0,0
230478,doses,0,0
230479,for,0,0
230480,12,0,0
230481,weeks,0,0
230482,;,0,0
230483,122,0,0
230484,patients,0,0
230485,were,0,0
230486,eligible,0,0
230487,for,0,0
230488,evaluation,0,0
230489,.,0,0
230490,The,0,0
230491,overall,0,0
230492,response,0,0
230493,rate,0,0
230494,was,0,0
230495,50.0,0,0
230496,%,0,0
230497,(,0,0
230498,20/40,0,0
230499,),0,0
230500,",",0,0
230501,61.0,0,0
230502,%,0,0
230503,(,0,0
230504,25/41,0,0
230505,),0,0
230506,and,0,0
230507,53.7,0,0
230508,%,0,0
230509,(,0,0
230510,22/41,0,0
230511,),0,0
230512,in,0,0
230513,the,0,0
230514,50,0,0
230515,mg,0,0
230516,",",0,0
230517,80,0,0
230518,mg,0,1
230519,and,0,0
230520,100,0,1
230521,mg,0,1
230522,groups,0,0
230523,",",0,0
230524,respectively,0,0
230525,.,0,0
230526,The,0,0
230527,response,0,0
230528,rate,0,0
230529,in,0,0
230530,prostate,0,0
230531,lesion,0,0
230532,",",0,0
230533,bone,0,0
230534,and,0,0
230535,lymph,0,0
230536,node,0,0
230537,metastases,0,0
230538,was,0,0
230539,slightly,0,0
230540,higher,0,0
230541,in,0,0
230542,the,0,0
230543,80,0,0
230544,mg,0,1
230545,group,0,0
230546,than,0,0
230547,in,0,0
230548,the,0,0
230549,50,0,1
230550,mg,0,1
230551,and,0,0
230552,100,0,1
230553,mg,0,1
230554,groups,0,0
230555,.,0,0
230556,The,0,0
230557,proportion,0,0
230558,of,0,0
230559,patients,0,0
230560,showing,0,0
230561,a,0,0
230562,response,0,0
230563,with,0,0
230564,regard,0,0
230565,to,0,0
230566,serum,0,0
230567,PSA,0,0
230568,(,0,1
230569,CR,0,1
230570,and,0,1
230571,PR,0,1
230572,),0,1
230573,was,0,0
230574,84.2,0,0
230575,",",0,0
230576,92.7,0,0
230577,and,0,0
230578,97.6,0,0
230579,%,0,0
230580,in,0,0
230581,the,0,0
230582,50,0,0
230583,",",0,0
230584,80,0,0
230585,and,0,0
230586,100,0,0
230587,mg,0,1
230588,groups,0,0
230589,",",0,0
230590,respectively,0,0
230591,.,0,0
230592,The,0,0
230593,incidence,0,0
230594,of,0,0
230595,adverse,0,0
230596,reactions,0,0
230597,was,0,0
230598,65.0,0,0
230599,",",0,0
230600,61.0,0,0
230601,and,0,0
230602,61.0,0,0
230603,%,0,0
230604,in,0,0
230605,the,0,0
230606,50,0,0
230607,",",0,0
230608,80,0,0
230609,and,0,0
230610,100,0,0
230611,mg,0,1
230612,groups,0,0
230613,",",0,0
230614,respectively,0,0
230615,",",0,0
230616,and,0,0
230617,there,0,0
230618,was,0,0
230619,no,0,0
230620,significant,0,0
230621,difference,0,0
230622,in,0,0
230623,overall,0,0
230624,safety,0,0
230625,rating,0,0
230626,in,0,0
230627,the,0,0
230628,three,0,0
230629,groups,0,0
230630,.,0,0
230631,Frequent,0,0
230632,adverse,0,0
230633,reactions,0,0
230634,were,0,0
230635,gynecomastia,0,0
230636,and,0,0
230637,breast,0,0
230638,pain,0,0
230639,.,0,0
230640,Only,0,0
230641,one,0,0
230642,patient,0,0
230643,in,0,0
230644,the,0,0
230645,80,0,0
230646,mg,0,1
230647,group,0,0
230648,was,0,0
230649,withdrawn,0,0
230650,due,0,0
230651,to,0,0
230652,shortness,0,0
230653,of,0,0
230654,breath,0,0
230655,.,0,0
230656,Serum,0,0
230657,concentrations,0,0
230658,of,0,0
230659,LH,0,0
230660,",",0,0
230661,testosterone,0,1
230662,and,0,0
230663,estradiol,0,1
230664,increased,0,0
230665,significantly,0,0
230666,after,0,0
230667,treatment,0,0
230668,.,0,0
230669,Bicalutamide,1,1
230670,was,0,0
230671,concluded,0,0
230672,to,0,0
230673,be,0,0
230674,effective,0,0
230675,and,0,0
230676,well,0,0
230677,tolerated,0,0
230678,in,0,0
230679,patients,0,0
230680,with,0,0
230681,prostatic,0,0
230682,cancer,0,0
230683,",",0,0
230684,and,0,0
230685,its,0,0
230686,recommended,0,0
230687,dose,0,0
230688,was,0,0
230689,80,0,0
230690,mg,0,1
230691,once,0,0
230692,daily,0,0
230693,.,0,0
230694,MRI,1,1
230695,signal,1,0
230696,hyperintensities,0,0
230697,in,0,0
230698,geriatric,0,0
230699,depression,0,0
230700,.,0,0
230701,OBJECTIVE,0,0
230702,The,0,0
230703,authors,0,0
230704,rated,0,0
230705,periventricular,0,0
230706,and,0,0
230707,subcortical,0,0
230708,signal,0,0
230709,hyperintensities,0,0
230710,on,0,0
230711,magnetic,1,1
230712,resonance,1,1
230713,imaging,1,1
230714,(,1,1
230715,MRI,1,1
230716,),1,1
230717,scans,0,0
230718,in,0,0
230719,elderly,0,0
230720,patients,0,0
230721,with,0,0
230722,depression,0,0
230723,and,0,0
230724,in,0,0
230725,normal,1,0
230726,subjects,0,0
230727,with,0,0
230728,similar,0,0
230729,demographic,0,0
230730,features,0,0
230731,to,0,0
230732,examine,0,0
230733,whether,0,0
230734,such,0,0
230735,changes,0,0
230736,discriminate,0,0
230737,patients,0,0
230738,with,0,0
230739,depression,0,0
230740,from,0,0
230741,normal,1,0
230742,subjects,0,0
230743,and,0,0
230744,whether,0,0
230745,they,0,0
230746,are,0,0
230747,associated,0,0
230748,with,0,0
230749,any,0,0
230750,clinical,0,0
230751,variables,0,0
230752,.,0,0
230753,METHOD,0,0
230754,Two,0,0
230755,established,0,0
230756,hyperintensity,0,0
230757,rating,0,0
230758,systems,0,0
230759,were,0,0
230760,used,0,0
230761,to,0,0
230762,compare,0,0
230763,the,0,0
230764,MRI,1,1
230765,brain,1,0
230766,scans,1,0
230767,of,0,0
230768,48,0,0
230769,elderly,0,0
230770,patients,0,0
230771,with,0,0
230772,depression,0,0
230773,diagnosed,0,0
230774,according,0,0
230775,to,0,0
230776,DSM-III-R,0,0
230777,with,0,0
230778,the,0,0
230779,scans,0,0
230780,of,0,0
230781,39,0,0
230782,normal,0,0
230783,elderly,0,0
230784,subjects,0,0
230785,.,0,0
230786,RESULTS,0,0
230787,Elderly,0,0
230788,depressed,0,0
230789,patients,0,0
230790,manifested,0,0
230791,significantly,0,0
230792,more,0,0
230793,severe,0,0
230794,hyperintensity,0,0
230795,ratings,0,0
230796,in,0,0
230797,the,0,0
230798,subcortical,0,0
230799,gray,0,1
230800,matter,0,0
230801,than,0,0
230802,age-matched,0,0
230803,comparison,0,0
230804,subjects,0,0
230805,.,0,0
230806,Significant,0,0
230807,differences,0,0
230808,were,0,0
230809,not,0,0
230810,identified,0,0
230811,between,0,0
230812,patients,0,0
230813,with,0,0
230814,similar,0,0
230815,current,0,0
230816,ages,0,0
230817,and,0,0
230818,cerebrovascular,0,0
230819,disease,0,0
230820,risk,0,0
230821,who,0,0
230822,had,0,0
230823,early-onset,0,0
230824,or,0,1
230825,late-onset,0,0
230826,depression,0,0
230827,.,0,0
230828,CONCLUSIONS,0,0
230829,These,0,0
230830,findings,0,0
230831,support,0,0
230832,those,0,0
230833,of,0,0
230834,neuroimaging,0,0
230835,studies,0,0
230836,implicating,0,0
230837,the,0,0
230838,basal,0,1
230839,ganglia,0,0
230840,in,0,0
230841,depression,0,0
230842,and,0,0
230843,geriatric,0,0
230844,depression,0,0
230845,.,0,0
230846,The,0,0
230847,data,0,0
230848,suggest,0,0
230849,that,0,0
230850,the,0,0
230851,relationship,0,0
230852,observed,0,0
230853,in,0,0
230854,some,0,0
230855,reports,0,0
230856,between,0,0
230857,late-onset,0,0
230858,depression,0,0
230859,and,0,0
230860,MRI,1,1
230861,hyperintensities,0,0
230862,is,0,0
230863,most,0,0
230864,likely,0,0
230865,a,0,0
230866,function,0,0
230867,of,0,0
230868,cerebrovascular,0,0
230869,disease,0,0
230870,risk,0,0
230871,and,0,0
230872,age,0,0
230873,.,0,0
230874,Randomized,0,0
230875,controlled,0,0
230876,trial,0,0
230877,of,0,0
230878,acellular,1,1
230879,diphtheria,1,1
230880,",",1,0
230881,pertussis,1,1
230882,and,1,0
230883,tetanus,1,1
230884,vaccines,1,1
230885,in,0,0
230886,southern,0,0
230887,Ghana,0,1
230888,.,0,0
230889,A,0,0
230890,randomized,0,0
230891,controlled,0,0
230892,trial,0,0
230893,of,0,0
230894,acellular,1,1
230895,diphtheria/pertussis/tetanus,1,1
230896,(,1,1
230897,ADPT,1,1
230898,),1,1
230899,freeze-dried,1,1
230900,and,1,0
230901,liquid,1,1
230902,vaccines,1,1
230903,in,0,0
230904,infants,0,0
230905,was,0,0
230906,conducted,0,0
230907,in,0,0
230908,a,0,0
230909,peri-urban,0,0
230910,community,0,1
230911,(,0,1
230912,Ashaiman,0,0
230913,),0,1
230914,in,0,0
230915,southern,0,0
230916,Ghana,0,1
230917,.,0,0
230918,Immunogenicity,0,0
230919,of,0,0
230920,the,0,0
230921,acellular,0,1
230922,vaccines,0,1
230923,",",0,0
230924,persistence,0,0
230925,of,0,0
230926,antibodies,0,0
230927,and,0,0
230928,adverse,0,0
230929,reactions,0,0
230930,were,0,0
230931,compared,0,0
230932,with,0,0
230933,those,0,0
230934,achieved,0,0
230935,with,0,0
230936,a,0,0
230937,whole-cell,1,1
230938,diphtheria-pertussis-tetanus,1,1
230939,(,1,1
230940,DPT,1,1
230941,),1,1
230942,vaccine,1,1
230943,.,1,0
230944,The,0,0
230945,incidence,0,0
230946,of,0,0
230947,pertussis,0,0
230948,in,0,0
230949,the,0,0
230950,vaccine,0,1
230951,groups,0,0
230952,and,0,0
230953,prevalence,0,0
230954,of,0,0
230955,pertussis,0,0
230956,in,0,0
230957,children,0,0
230958,under,0,0
230959,5,0,0
230960,years,0,0
230961,of,0,0
230962,age,0,0
230963,in,0,0
230964,the,0,0
230965,study,0,0
230966,area,0,0
230967,were,0,0
230968,also,0,0
230969,determined,0,0
230970,.,0,0
230971,The,0,0
230972,acellular,0,1
230973,vaccines,0,1
230974,produced,0,0
230975,significantly,0,0
230976,fewer,0,0
230977,local,0,0
230978,and,0,0
230979,systemic,0,0
230980,reactions,0,0
230981,.,0,0
230982,Local,0,0
230983,reactions,0,0
230984,such,0,0
230985,as,0,0
230986,swelling,0,0
230987,and,0,0
230988,redness,0,0
230989,were,0,0
230990,observed,0,0
230991,in,0,0
230992,2,0,0
230993,%,0,0
230994,(,0,0
230995,8/399,0,0
230996,),0,0
230997,to,0,0
230998,2.3,0,0
230999,%,0,0
231000,(,0,0
231001,9/385,0,0
231002,),0,0
231003,of,0,0
231004,the,0,0
231005,acellular,1,1
231006,vaccine,1,1
231007,recipients,0,0
231008,as,0,0
231009,against,0,0
231010,31,0,0
231011,%,0,0
231012,(,0,0
231013,122/394,0,0
231014,),0,0
231015,in,0,0
231016,the,0,0
231017,whole-cell,0,1
231018,vaccine,0,1
231019,group,0,0
231020,.,0,1
231021,Fever,0,0
231022,(,0,0
231023,>,0,0
231024,or,0,1
231025,=,0,0
231026,37.5,0,0
231027,degrees,0,0
231028,C,0,0
231029,),0,0
231030,occurred,0,0
231031,in,0,0
231032,7.27,0,0
231033,%,0,0
231034,(,0,0
231035,29/399,0,0
231036,),0,0
231037,to,0,0
231038,9.8,0,0
231039,%,0,0
231040,(,0,0
231041,38/385,0,0
231042,),0,0
231043,in,0,0
231044,the,0,0
231045,acellular,1,1
231046,vaccine,1,1
231047,groups,0,0
231048,compared,0,0
231049,with,0,0
231050,36.6,0,0
231051,%,0,0
231052,(,0,0
231053,145/394,0,0
231054,),0,0
231055,in,0,0
231056,the,0,0
231057,whole-cell,0,1
231058,vaccine,0,1
231059,group,0,0
231060,.,0,0
231061,Geometric,0,0
231062,mean,0,0
231063,titres,0,0
231064,(,0,0
231065,GMTs,0,0
231066,),0,0
231067,",",0,0
231068,measured,0,0
231069,by,0,0
231070,ELISA,0,0
231071,",",0,0
231072,to,0,0
231073,pertussis,0,1
231074,toxin,0,1
231075,(,0,1
231076,PT,0,1
231077,),0,1
231078,and,0,0
231079,filamentous,0,1
231080,haemagglutinin,0,1
231081,(,0,1
231082,FHA,0,1
231083,),0,1
231084,were,0,0
231085,significantly,0,0
231086,higher,0,0
231087,in,0,0
231088,the,0,0
231089,acellular,1,1
231090,vaccine,1,1
231091,groups,0,0
231092,than,0,0
231093,in,0,0
231094,the,0,0
231095,whole-cell,1,1
231096,DPT,1,1
231097,(,1,1
231098,WCDPT,1,0
231099,),1,1
231100,group,0,0
231101,.,0,0
231102,There,0,0
231103,were,0,0
231104,no,0,0
231105,significant,0,0
231106,differences,0,0
231107,in,0,0
231108,the,0,0
231109,GMTs,0,0
231110,of,0,0
231111,tetanus,0,1
231112,and,0,0
231113,diphtheria,0,1
231114,antitoxins,0,1
231115,between,0,0
231116,the,0,0
231117,two,0,0
231118,groups,0,0
231119,after,0,0
231120,each,0,0
231121,vaccination,0,1
231122,.,0,0
231123,Twelve,0,0
231124,months,0,0
231125,after,0,0
231126,primary,0,0
231127,vaccination,0,1
231128,",",0,0
231129,GMTs,0,0
231130,to,0,0
231131,PT,0,1
231132,in,0,0
231133,the,0,0
231134,freeze-dried,0,1
231135,",",0,0
231136,liquid,0,1
231137,ADPT,0,1
231138,groups,0,0
231139,and,0,0
231140,the,0,0
231141,WCDPT,0,0
231142,group,0,0
231143,have,0,0
231144,fallen,0,0
231145,from,0,0
231146,56.23,0,0
231147,",",0,0
231148,62.63,0,0
231149,and,0,0
231150,44.97,0,0
231151,ELISA,0,0
231152,U/ml,0,0
231153,to,0,0
231154,6.08,0,0
231155,",",0,0
231156,6.18,0,0
231157,and,0,0
231158,11.30,0,0
231159,ELISA,0,0
231160,U/ml,0,0
231161,",",0,0
231162,respectively,0,0
231163,.,0,0
231164,GMTs,0,0
231165,to,0,0
231166,FHA,0,0
231167,in,0,0
231168,all,0,0
231169,the,0,0
231170,vaccine,0,1
231171,groups,0,0
231172,also,0,0
231173,dropped,0,0
231174,during,0,0
231175,the,0,0
231176,same,0,0
231177,period,0,0
231178,from,0,0
231179,49.94,0,0
231180,",",0,0
231181,41.73,0,0
231182,and,0,0
231183,20.74,0,0
231184,ELISA,0,0
231185,U/ml,0,0
231186,to,0,0
231187,7.26,0,0
231188,",",0,0
231189,7.72,0,0
231190,and,0,0
231191,5.91,0,0
231192,ELISA,0,0
231193,U/ml,0,0
231194,",",0,0
231195,respectively,0,0
231196,.,0,0
231197,In,0,0
231198,this,0,0
231199,comparative,0,0
231200,controlled,0,0
231201,trial,0,0
231202,",",0,0
231203,the,0,0
231204,ADPT,1,1
231205,vaccines,1,0
231206,were,0,0
231207,more,0,0
231208,immunogenic,0,0
231209,",",0,0
231210,with,0,0
231211,less,0,0
231212,local,0,0
231213,and,0,0
231214,systemic,0,0
231215,reactions,0,0
231216,",",0,0
231217,than,0,0
231218,the,0,0
231219,WCDPT,1,0
231220,vaccine,1,1
231221,but,0,0
231222,there,0,0
231223,was,0,0
231224,a,0,0
231225,considerable,0,0
231226,drop,0,0
231227,in,0,0
231228,antibody,0,0
231229,titres,0,0
231230,in,0,0
231231,all,0,0
231232,the,0,0
231233,vaccine,0,1
231234,groups,0,0
231235,12,0,0
231236,months,0,0
231237,after,0,0
231238,primary,0,0
231239,vaccination,0,1
231240,.,0,0
231241,However,0,0
231242,",",0,0
231243,the,0,0
231244,levels,0,0
231245,of,0,0
231246,titres,0,0
231247,of,0,0
231248,anti-PT,0,0
231249,and,0,0
231250,anti-FHA,0,1
231251,antibodies,0,0
231252,in,0,0
231253,all,0,0
231254,the,0,0
231255,three,0,0
231256,vaccines,0,0
231257,that,0,0
231258,confer,0,0
231259,protection,0,0
231260,are,0,0
231261,not,0,0
231262,known,0,0
231263,.,0,0
231264,Further,0,0
231265,studies,0,0
231266,are,0,0
231267,necessary,0,0
231268,to,0,0
231269,provide,0,0
231270,this,0,0
231271,information,0,0
231272,in,0,0
231273,order,0,0
231274,to,0,0
231275,assess,0,0
231276,the,0,0
231277,need,0,0
231278,for,0,0
231279,subsequent,0,0
231280,booster,0,1
231281,doses,0,0
231282,after,0,0
231283,primary,0,0
231284,immunization,0,1
231285,with,0,0
231286,both,0,0
231287,ADPT,1,1
231288,and,0,0
231289,WCDPT,1,0
231290,vaccines,0,1
231291,.,0,0
231292,Serum,0,0
231293,bactericidal,0,1
231294,activities,0,0
231295,and,0,0
231296,comparative,0,0
231297,pharmacokinetics,0,0
231298,of,0,0
231299,meropenem,0,1
231300,and,0,0
231301,imipenem-cilastatin,0,1
231302,.,0,0
231303,The,0,0
231304,pharmacokinetics,0,0
231305,and,0,0
231306,serum,0,0
231307,bactericidal,0,1
231308,activities,0,0
231309,(,0,0
231310,SBAs,0,0
231311,),0,1
231312,of,0,0
231313,imipenem,1,1
231314,and,0,0
231315,meropenem,1,1
231316,were,0,0
231317,investigated,0,0
231318,in,0,0
231319,a,0,0
231320,randomized,0,0
231321,crossover,0,0
231322,study,0,0
231323,.,0,0
231324,Twelve,0,0
231325,healthy,0,0
231326,male,0,0
231327,volunteers,0,0
231328,received,0,0
231329,a,0,0
231330,constant,1,0
231331,30-min,1,1
231332,infusion,1,1
231333,of,1,0
231334,either,1,0
231335,1,1,0
231336,g,1,1
231337,of,1,0
231338,imipenem,1,1
231339,plus,1,1
231340,1,1,0
231341,g,1,1
231342,of,1,0
231343,cilastatin,1,1
231344,or,1,1
231345,1,1,0
231346,g,1,1
231347,of,1,0
231348,meropenem,1,1
231349,.,1,0
231350,The,0,0
231351,concentrations,0,0
231352,of,0,0
231353,the,0,0
231354,drugs,0,1
231355,in,0,0
231356,serum,0,0
231357,and,0,0
231358,urine,0,0
231359,were,0,0
231360,determined,1,0
231361,by,1,0
231362,bioassay,1,1
231363,and,1,0
231364,high-pressure,1,1
231365,liquid,1,1
231366,chromatography,1,1
231367,.,1,0
231368,Pharmacokinetic,0,0
231369,parameters,0,0
231370,were,0,0
231371,based,0,0
231372,on,0,0
231373,an,0,0
231374,open,0,1
231375,two-compartment,1,1
231376,model,1,0
231377,and,1,0
231378,a,1,0
231379,noncompartmental,1,0
231380,technique,1,1
231381,.,1,0
231382,At,0,0
231383,the,0,0
231384,end,0,0
231385,of,0,0
231386,infusion,0,0
231387,",",0,0
231388,the,0,0
231389,mean,0,0
231390,concentrations,0,0
231391,of,0,0
231392,imipenem,0,1
231393,and,0,0
231394,meropenem,0,1
231395,measured,0,0
231396,in,0,0
231397,serum,0,0
231398,were,0,0
231399,61.2,0,0
231400,+/-,0,0
231401,9.8,0,0
231402,and,0,0
231403,51.6,0,0
231404,+/-,0,0
231405,6.5,0,0
231406,mg/liter,0,0
231407,",",0,0
231408,respectively,0,0
231409,;,0,0
231410,urinary,0,0
231411,recoveries,0,0
231412,were,0,0
231413,48.6,0,0
231414,%,0,0
231415,+/-,0,0
231416,8.2,0,0
231417,%,0,0
231418,and,0,0
231419,60.0,0,0
231420,%,0,0
231421,+/-,0,0
231422,6.5,0,0
231423,%,0,0
231424,of,0,0
231425,the,0,0
231426,dose,0,0
231427,in,0,0
231428,12,0,0
231429,h,0,0
231430,",",0,0
231431,respectively,0,0
231432,;,0,0
231433,and,0,0
231434,the,0,0
231435,areas,0,0
231436,under,0,0
231437,the,0,0
231438,concentration-time,0,0
231439,curve,0,0
231440,from,0,0
231441,time,0,0
231442,zero,0,0
231443,to,0,0
231444,infinity,0,0
231445,were,0,0
231446,96.1,0,0
231447,+/-,0,0
231448,14.4,0,0
231449,and,0,0
231450,70.5,0,0
231451,+/-,0,0
231452,10.3,0,0
231453,mg.h/liter,0,0
231454,",",0,0
231455,respectively,0,0
231456,(,0,0
231457,P,0,0
231458,<,0,0
231459,or,0,1
231460,=,0,0
231461,0.02,0,0
231462,),0,0
231463,.,0,0
231464,Imipenem,0,1
231465,had,0,0
231466,a,0,0
231467,mean,0,0
231468,half-life,0,0
231469,of,0,0
231470,66.7,0,0
231471,+/-,0,0
231472,10.4,0,0
231473,min,0,0
231474,;,0,0
231475,that,0,0
231476,of,0,0
231477,meropenem,0,1
231478,was,0,0
231479,64.4,0,0
231480,+/-,0,0
231481,6.9,0,0
231482,min,0,0
231483,.,0,0
231484,The,0,0
231485,volumes,0,0
231486,of,0,0
231487,distribution,0,0
231488,at,0,0
231489,steady,0,0
231490,state,0,0
231491,of,0,0
231492,imipenem,0,1
231493,and,0,0
231494,meropenem,0,1
231495,were,0,0
231496,15.3,0,0
231497,+/-,0,0
231498,3.3,0,0
231499,and,0,0
231500,18.6,0,0
231501,+/-,0,0
231502,3.0,0,0
231503,liters/70,0,0
231504,kg,0,0
231505,",",0,0
231506,respectively,0,0
231507,",",0,0
231508,and,0,0
231509,the,0,0
231510,mean,0,0
231511,renal,0,0
231512,clearances,0,0
231513,per,0,0
231514,1.73,0,0
231515,m2,0,0
231516,were,0,0
231517,85.6,0,0
231518,+/-,0,0
231519,17.6,0,0
231520,and,0,0
231521,144.6,0,0
231522,+/-,0,0
231523,26.0,0,0
231524,ml/min,0,0
231525,",",0,0
231526,respectively,0,0
231527,.,0,0
231528,Both,0,0
231529,antibiotics,0,1
231530,were,0,0
231531,well,0,0
231532,tolerated,0,0
231533,in,0,0
231534,this,0,0
231535,single-dose,0,1
231536,administration,0,0
231537,study,0,0
231538,.,0,0
231539,The,0,0
231540,SBAs,0,0
231541,were,0,0
231542,measured,0,0
231543,by,0,0
231544,the,0,0
231545,microdilution,0,1
231546,method,0,1
231547,of,0,0
231548,Reller,0,0
231549,and,0,1
231550,Stratton,0,1
231551,(,0,1
231552,L.,0,1
231553,B.,0,1
231554,Reller,0,0
231555,and,0,0
231556,C.,0,1
231557,W.,0,1
231558,Stratton,0,1
231559,",",0,0
231560,J.,0,1
231561,Infect,0,1
231562,.,0,0
231563,Dis,0,0
231564,.,0,0
231565,136:196-204,0,0
231566,",",0,0
231567,1977,0,0
231568,),0,0
231569,against,0,0
231570,40,0,0
231571,clinically,0,0
231572,isolated,0,0
231573,strains,0,0
231574,.,0,0
231575,Mean,0,0
231576,reciprocal,0,0
231577,bactericidal,0,0
231578,titers,0,0
231579,were,0,0
231580,measured,0,0
231581,1,0,0
231582,and,0,0
231583,6,0,0
231584,h,0,0
231585,after,0,0
231586,administration,0,0
231587,.,0,0
231588,After,0,0
231589,1,0,0
231590,and,0,0
231591,6,0,0
231592,h,0,0
231593,the,0,0
231594,median,0,0
231595,SBAs,0,0
231596,for,0,0
231597,imipenem,0,1
231598,and,0,0
231599,meropenem,0,1
231600,",",0,0
231601,were,0,0
231602,409,0,0
231603,and,0,0
231604,34.9,0,0
231605,and,0,0
231606,97.9,0,0
231607,and,0,0
231608,5.8,0,0
231609,",",0,0
231610,respectively,0,0
231611,",",0,0
231612,against,0,0
231613,Staphylococcus,0,1
231614,aureus,0,0
231615,",",0,0
231616,19.9,0,0
231617,and,0,0
231618,4.4,0,0
231619,and,0,0
231620,19.4,0,0
231621,and,0,0
231622,4.8,0,0
231623,",",0,0
231624,respectively,0,0
231625,",",0,0
231626,against,0,0
231627,Pseudomonas,0,0
231628,aeruginosa,0,0
231629,",",0,0
231630,34.3,0,0
231631,and,0,0
231632,2.2,0,0
231633,and,0,0
231634,232,0,0
231635,and,0,0
231636,15.5,0,0
231637,",",0,0
231638,respectively,0,0
231639,",",0,0
231640,against,0,0
231641,Enterobacter,0,0
231642,cloacae,0,0
231643,",",0,0
231644,and,0,0
231645,13.4,0,0
231646,and,0,0
231647,2.25,0,0
231648,and,0,0
231649,90.7,0,0
231650,and,0,0
231651,7.9,0,0
231652,",",0,0
231653,respectively,0,0
231654,",",0,0
231655,against,0,0
231656,Proteus,0,1
231657,mirabilis,0,1
231658,.,0,0
231659,Both,0,0
231660,drugs,0,0
231661,had,0,0
231662,rather,0,0
231663,short,0,0
231664,biological,0,0
231665,elimination,0,0
231666,half-lives,0,0
231667,and,0,0
231668,a,0,0
231669,predominantly,0,0
231670,renal,0,0
231671,route,0,1
231672,of,0,0
231673,elimination,0,0
231674,.,0,0
231675,Both,0,0
231676,carbapenems,0,0
231677,revealed,0,0
231678,high,0,0
231679,SBAs,0,0
231680,against,0,0
231681,clinically,0,0
231682,important,0,0
231683,pathogens,0,0
231684,at,0,0
231685,1,0,0
231686,h,0,0
231687,;,0,0
231688,meropenem,0,1
231689,had,0,0
231690,a,0,0
231691,higher,0,0
231692,SBA,0,0
231693,against,0,0
231694,E.,0,1
231695,cloacae,0,0
231696,and,0,0
231697,P.,0,1
231698,mirabilis,0,1
231699,",",0,0
231700,and,0,0
231701,the,0,0
231702,SBA,0,1
231703,of,0,0
231704,imipenem,0,1
231705,against,0,0
231706,S.,0,1
231707,aureus,0,0
231708,was,0,0
231709,greater,0,0
231710,than,0,0
231711,the,0,0
231712,SBA,0,1
231713,of,0,0
231714,meropenem,0,1
231715,.,0,0
231716,Prospective,0,0
231717,evaluation,0,0
231718,of,0,0
231719,the,0,0
231720,macrolide,1,1
231721,antibiotic,1,1
231722,dirithromycin,1,1
231723,for,0,0
231724,the,0,0
231725,treatment,0,0
231726,of,0,0
231727,Helicobacter,0,0
231728,pylori,0,0
231729,.,0,0
231730,BACKGROUND,0,0
231731,Macrolide,1,1
231732,antibiotics,1,1
231733,are,0,0
231734,active,0,0
231735,in,0,0
231736,vitro,0,0
231737,and,0,0
231738,in,0,0
231739,vivo,0,0
231740,against,0,0
231741,Helicobacter,0,0
231742,pylori,0,0
231743,.,0,0
231744,We,0,0
231745,assessed,0,0
231746,a,0,0
231747,newer,0,0
231748,macrolide,1,1
231749,",",1,0
231750,dirithromycin,1,1
231751,",",0,0
231752,for,0,0
231753,the,0,0
231754,treatment,0,0
231755,of,0,0
231756,H.,0,0
231757,pylori,0,0
231758,in,0,0
231759,two,0,0
231760,separate,0,0
231761,studies,0,0
231762,.,0,0
231763,METHODS,0,0
231764,Volunteers,0,0
231765,with,0,0
231766,H.,0,0
231767,pylori,0,0
231768,infection,0,0
231769,(,0,0
231770,by,0,0
231771,13C-urea,0,1
231772,breath,0,0
231773,test,0,0
231774,),0,0
231775,were,0,0
231776,randomly,0,0
231777,assigned,0,0
231778,to,0,0
231779,2-week,0,0
231780,treatment,0,0
231781,regimens,0,1
231782,.,0,0
231783,Study,0,0
231784,1,0,0
231785,:,0,0
231786,dirithromycin,1,1
231787,500,1,1
231788,mg,1,1
231789,q.d.s.,1,1
231790,",",0,0
231791,dirithromycin,1,1
231792,500,1,0
231793,mg,1,0
231794,q.d.s,1,1
231795,.,1,0
231796,plus,1,1
231797,omeprazole,1,1
231798,40,1,1
231799,mg,1,1
231800,q.d.s.,1,1
231801,",",0,0
231802,or,1,0
231803,dirithromycin,1,1
231804,500,1,1
231805,mg,1,1
231806,q.d.s,1,1
231807,.,1,0
231808,plus,1,1
231809,metronidazole,1,1
231810,500,1,1
231811,mg,1,1
231812,t.d.s,1,1
231813,.,1,0
231814,Study,0,0
231815,2,0,0
231816,:,0,0
231817,dirithromycin,1,1
231818,500,1,1
231819,mg,1,1
231820,q.d.s,1,1
231821,.,1,0
231822,plus,1,1
231823,omeprazole,1,1
231824,20,1,1
231825,mg,1,1
231826,b.d.,1,1
231827,",",0,0
231828,dirithromycin,1,1
231829,1000,1,0
231830,mg,1,1
231831,q.d.s,1,1
231832,.,1,0
231833,plus,1,1
231834,omeprazole,1,1
231835,20,1,1
231836,mg,1,1
231837,b.d.,1,1
231838,",",0,0
231839,or,1,0
231840,amoxycillin,1,1
231841,500,1,1
231842,mg,1,1
231843,q.d.s,1,1
231844,.,1,0
231845,plus,1,1
231846,omepirazole,1,1
231847,20,1,1
231848,mg,1,1
231849,b.d,1,1
231850,.,1,0
231851,Four,0,0
231852,weeks,0,0
231853,after,0,0
231854,the,0,0
231855,completion,0,0
231856,of,0,0
231857,therapy,0,1
231858,a,0,0
231859,repeat,0,0
231860,13C-urea,0,1
231861,breath,0,0
231862,test,0,0
231863,was,0,0
231864,done,0,0
231865,to,0,0
231866,assess,0,0
231867,for,0,0
231868,cure,0,0
231869,.,0,0
231870,RESULTS,0,0
231871,No,0,0
231872,patient,0,0
231873,taking,0,0
231874,dirithromycin,1,1
231875,alone,0,1
231876,(,0,0
231877,n,0,0
231878,=,0,0
231879,6,0,1
231880,),0,0
231881,or,0,1
231882,in,0,0
231883,combination,0,1
231884,with,0,0
231885,omeprazole,1,1
231886,(,0,0
231887,n,0,0
231888,=,0,0
231889,26,0,0
231890,),0,0
231891,achieved,0,0
231892,cure,0,0
231893,of,0,0
231894,their,0,0
231895,infection,0,0
231896,.,0,0
231897,Eradication,0,0
231898,of,0,0
231899,H.,0,0
231900,pylori,0,0
231901,was,0,0
231902,seen,0,0
231903,in,0,0
231904,one,0,0
231905,of,0,0
231906,seven,0,0
231907,patients,0,0
231908,taking,0,0
231909,dirithromycin,1,1
231910,plus,0,1
231911,metronidazole,1,1
231912,.,1,0
231913,Five,0,0
231914,of,0,0
231915,10,0,0
231916,patients,0,0
231917,taking,0,0
231918,omeprazole-amoxycillin,1,1
231919,dual,0,0
231920,therapy,0,1
231921,had,0,0
231922,their,0,0
231923,H.,0,0
231924,pylori,0,0
231925,infection,0,0
231926,cured,0,0
231927,(,0,0
231928,P,0,0
231929,=,0,0
231930,0.0007,0,0
231931,vs.,0,0
231932,patients,0,0
231933,taking,0,0
231934,dirithromycin,1,1
231935,plus,0,1
231936,omeprazole,1,1
231937,),1,0
231938,.,0,1
231939,Eleven,0,1
231940,(,0,0
231941,47,0,0
231942,%,0,0
231943,),0,0
231944,of,0,0
231945,32,0,0
231946,patients,0,0
231947,taking,0,0
231948,dirithromycin,1,1
231949,alone,0,1
231950,or,0,1
231951,combined,0,1
231952,with,0,0
231953,omeprazole,1,1
231954,reported,0,0
231955,side-effects,0,0
231956,",",0,0
231957,but,0,0
231958,only,0,0
231959,two,0,0
231960,(,0,0
231961,6,0,1
231962,%,0,0
231963,),0,0
231964,stopped,0,0
231965,therapy,0,1
231966,prematurely,0,0
231967,as,0,0
231968,a,0,0
231969,result,0,0
231970,of,0,0
231971,side-effects,0,0
231972,.,0,0
231973,CONCLUSION,0,0
231974,No,0,0
231975,subject,0,0
231976,taking,0,0
231977,dirithromycin,1,1
231978,alone,0,1
231979,or,0,1
231980,in,0,0
231981,combination,0,1
231982,with,0,0
231983,omeprazole,1,1
231984,had,0,0
231985,their,0,0
231986,H.,0,0
231987,pylori,0,0
231988,infection,0,0
231989,cured,0,0
231990,.,0,0
231991,Dirithromycin,1,1
231992,",",0,0
231993,in,0,0
231994,the,0,0
231995,regimen,0,1
231996,used,0,0
231997,",",0,0
231998,shows,0,0
231999,little,0,0
232000,promise,0,0
232001,in,0,0
232002,the,0,0
232003,treatment,0,0
232004,of,0,0
232005,patients,0,0
232006,with,0,0
232007,H.,0,0
232008,pylori,0,0
232009,infection,0,0
232010,.,0,0
232011,The,0,0
232012,long-term,0,0
232013,effects,0,0
232014,of,0,0
232015,auditory,1,1
232016,training,1,1
232017,on,0,0
232018,children,0,0
232019,with,0,0
232020,autism,0,0
232021,.,0,0
232022,Eighty,0,0
232023,children,0,0
232024,",",0,0
232025,3-17,0,0
232026,years,0,0
232027,of,0,0
232028,age,0,0
232029,",",0,0
232030,with,0,0
232031,autism,0,0
232032,or,0,1
232033,Asperger,0,0
232034,syndrome,0,1
232035,and,0,0
232036,mild,0,0
232037,to,0,0
232038,severe,0,0
232039,distress,0,0
232040,in,0,0
232041,the,0,0
232042,presence,0,0
232043,of,0,0
232044,some,0,0
232045,sounds,0,0
232046,",",0,0
232047,were,0,0
232048,randomly,0,0
232049,allocated,0,0
232050,to,0,0
232051,two,0,0
232052,groups,0,0
232053,.,0,0
232054,The,0,0
232055,experimental,0,0
232056,group,0,0
232057,received,0,1
232058,auditory,1,1
232059,training,1,1
232060,and,1,0
232061,the,1,0
232062,control,1,1
232063,group,1,0
232064,listened,1,0
232065,to,1,0
232066,the,1,0
232067,same,1,0
232068,unmodified,1,1
232069,music,1,1
232070,under,1,0
232071,the,1,0
232072,same,1,0
232073,conditions,1,0
232074,.,1,0
232075,Significant,0,0
232076,improvements,0,0
232077,in,0,0
232078,behavior,0,0
232079,and,0,0
232080,severity,0,0
232081,of,0,0
232082,autism,0,0
232083,were,0,0
232084,maintained,0,0
232085,for,0,0
232086,12,0,0
232087,months,0,0
232088,by,0,0
232089,both,0,0
232090,groups,0,0
232091,.,0,0
232092,Informal,0,0
232093,data,0,0
232094,suggested,0,0
232095,that,0,0
232096,a,0,0
232097,range,0,0
232098,of,0,0
232099,abnormal,0,0
232100,responses,0,0
232101,to,0,0
232102,sound,0,0
232103,and,0,0
232104,other,0,0
232105,sensory,0,1
232106,abnormalities,0,0
232107,may,0,0
232108,also,0,0
232109,have,0,0
232110,improved,0,0
232111,.,0,0
232112,Verbal,0,1
232113,and,0,0
232114,performance,0,0
232115,IQ,0,0
232116,increased,0,0
232117,significantly,0,0
232118,3,0,0
232119,to,0,0
232120,12,0,0
232121,months,0,0
232122,after,0,0
232123,interventions,0,0
232124,.,0,0
232125,Findings,0,0
232126,suggest,0,0
232127,that,0,0
232128,some,0,0
232129,aspect,0,0
232130,of,0,0
232131,both,0,0
232132,auditory,1,1
232133,training,1,1
232134,and,1,0
232135,listening,1,1
232136,to,0,0
232137,selected,0,0
232138,unmodified,0,1
232139,music,0,1
232140,may,0,0
232141,have,0,0
232142,a,0,0
232143,beneficial,0,0
232144,effect,0,0
232145,on,0,0
232146,children,0,0
232147,with,0,0
232148,autism,0,0
232149,and,0,0
232150,sound,0,1
232151,sensitivity,0,0
232152,",",0,0
232153,and,0,0
232154,indicate,0,0
232155,a,0,0
232156,need,0,0
232157,for,0,0
232158,further,0,0
232159,research,0,0
232160,into,0,0
232161,the,0,0
232162,effects,0,0
232163,that,0,0
232164,led,0,0
232165,to,0,0
232166,these,0,0
232167,changes,0,0
232168,and,0,0
232169,the,0,0
232170,mechanisms,0,0
232171,involved,0,0
232172,in,0,0
232173,the,0,0
232174,sensory,0,0
232175,abnormalities,0,0
232176,commonly,0,0
232177,associated,0,0
232178,with,0,0
232179,autism,0,0
232180,.,0,0
232181,Relation,0,1
232182,of,0,0
232183,total,0,0
232184,homocysteine,1,0
232185,and,0,0
232186,lipid,1,0
232187,levels,1,0
232188,in,0,0
232189,children,0,0
232190,to,0,0
232191,premature,0,0
232192,cardiovascular,0,0
232193,death,0,0
232194,in,0,0
232195,male,0,0
232196,relatives,0,0
232197,.,0,0
232198,We,0,0
232199,assessed,0,0
232200,the,0,0
232201,relative,0,0
232202,importance,0,0
232203,of,0,0
232204,lipid,1,0
232205,",",0,0
232206,apo,0,0
232207,B,0,0
232208,",",0,0
232209,lipoprotein,0,0
232210,(,0,1
232211,a,0,0
232212,),0,1
232213,[,0,0
232214,Lp,0,1
232215,(,0,1
232216,a,0,0
232217,),0,1
232218,],0,0
232219,",",0,0
232220,and,0,0
232221,total,0,0
232222,homocysteine,1,1
232223,(,0,1
232224,tHcy,0,1
232225,),0,1
232226,levels,0,0
232227,in,0,0
232228,children,0,0
232229,in,0,0
232230,relation,0,0
232231,to,0,0
232232,premature,0,0
232233,cardiovascular,0,0
232234,disease,0,0
232235,in,0,0
232236,family,0,0
232237,members,0,0
232238,.,0,0
232239,Parents,0,0
232240,of,0,0
232241,381,0,0
232242,girls,0,0
232243,and,0,0
232244,375,0,0
232245,boys,0,0
232246,age,0,0
232247,8-12,0,1
232248,y,0,0
232249,completed,0,0
232250,family,1,1
232251,history,1,0
232252,questionnaires,1,0
232253,.,1,0
232254,Nonfasting,0,0
232255,serum,1,0
232256,lipid,1,1
232257,and,1,0
232258,lipoproteins,1,1
232259,and,1,0
232260,plasma,1,0
232261,tHcy,1,1
232262,and,1,0
232263,cysteine,1,1
232264,levels,0,0
232265,were,0,0
232266,measured,0,0
232267,in,0,0
232268,the,0,0
232269,children,0,0
232270,.,0,0
232271,Serum,0,0
232272,folate,0,1
232273,and,0,0
232274,vitamin,0,1
232275,B12,0,1
232276,levels,0,0
232277,were,0,0
232278,determined,0,0
232279,in,0,0
232280,a,0,0
232281,random,0,0
232282,subsample,0,0
232283,of,0,0
232284,23,0,0
232285,%,0,0
232286,of,0,0
232287,the,0,0
232288,children,0,0
232289,",",0,0
232290,who,0,0
232291,participated,0,0
232292,in,0,0
232293,a,0,0
232294,food,0,1
232295,frequency,0,0
232296,interview,0,0
232297,.,0,0
232298,Children,0,0
232299,whose,0,0
232300,parents,0,0
232301,reported,0,0
232302,hypercholesterolemia,0,0
232303,had,0,0
232304,higher,0,0
232305,total,0,0
232306,and,0,0
232307,non-HDL,0,1
232308,cholesterol,0,1
232309,and,0,0
232310,apo,0,0
232311,B,0,1
232312,levels,0,0
232313,than,0,0
232314,the,0,0
232315,rest,0,0
232316,",",0,0
232317,but,0,0
232318,these,0,0
232319,levels,0,0
232320,were,0,0
232321,not,0,0
232322,associated,0,0
232323,with,0,0
232324,cardiovascular,0,0
232325,disease,0,0
232326,.,0,0
232327,tHcy,1,0
232328,levels,0,0
232329,were,0,0
232330,similar,0,0
232331,in,0,0
232332,girls,0,0
232333,and,0,0
232334,boys,0,0
232335,.,0,0
232336,tHcy,1,0
232337,was,0,0
232338,higher,0,0
232339,in,0,0
232340,children,0,0
232341,whose,0,0
232342,father,0,0
232343,",",0,0
232344,grandfather,0,0
232345,",",0,0
232346,or,0,1
232347,uncle,0,0
232348,died,0,0
232349,at,0,0
232350,age,0,0
232351,<,0,0
232352,or,0,1
232353,=,0,0
232354,55,0,0
232355,y,0,0
232356,of,0,0
232357,myocardial,0,0
232358,infarction,0,0
232359,or,0,1
232360,sudden,0,0
232361,cardiac,0,1
232362,arrest,0,0
232363,(,0,0
232364,n,0,0
232365,=,0,0
232366,42,0,0
232367,),0,0
232368,than,0,0
232369,in,0,0
232370,control,0,0
232371,children,0,0
232372,[,0,0
232373,5.92,0,0
232374,mumol/L,0,0
232375,(,0,0
232376,95,0,0
232377,%,0,0
232378,confidence,0,0
232379,interval,0,0
232380,[,0,0
232381,CI,0,0
232382,],0,0
232383,of,0,0
232384,5.47-6.36,0,0
232385,),0,1
232386,versus,0,1
232387,5.25,0,1
232388,mumol/L,0,0
232389,(,0,0
232390,95,0,0
232391,%,0,0
232392,CI,0,0
232393,",",0,0
232394,5.16-5.34,0,0
232395,),0,0
232396,],0,0
232397,",",0,0
232398,also,0,0
232399,after,0,0
232400,adjustment,0,0
232401,for,0,0
232402,socioeconomic,0,0
232403,group,0,0
232404,.,0,1
232405,Intake,0,0
232406,and,0,0
232407,serum,0,0
232408,levels,0,0
232409,of,0,0
232410,vitamin,0,1
232411,B12,0,1
232412,and,0,0
232413,folate,0,1
232414,were,0,0
232415,within,0,0
232416,recommended,0,0
232417,or,0,1
232418,reference,0,0
232419,ranges,0,0
232420,.,0,0
232421,In,0,0
232422,a,0,0
232423,stepwise,0,0
232424,multiple,0,0
232425,regression,0,0
232426,analysis,0,0
232427,",",0,0
232428,serum,0,0
232429,folate,0,1
232430,(,0,1
232431,negative,0,1
232432,correlation,0,0
232433,),0,0
232434,",",0,0
232435,plasma,0,0
232436,creatinine,0,0
232437,",",0,0
232438,and,0,0
232439,sugar,0,1
232440,intake,0,0
232441,as,0,0
232442,percent,0,0
232443,of,0,0
232444,dietary,0,1
232445,energy,0,1
232446,(,0,0
232447,positive,0,0
232448,correlations,0,0
232449,),0,0
232450,were,0,0
232451,significantly,0,0
232452,associated,0,0
232453,with,0,0
232454,tHcy,0,0
232455,(,0,0
232456,multiple,0,1
232457,r,0,0
232458,=,0,0
232459,0.44,0,0
232460,",",0,0
232461,adjusted,0,0
232462,r2,0,0
232463,=,0,0
232464,18,0,0
232465,%,0,0
232466,;,0,0
232467,95,0,0
232468,%,0,0
232469,CI,0,0
232470,",",0,0
232471,5-30,0,0
232472,%,0,0
232473,),0,0
232474,.,0,0
232475,Our,0,0
232476,data,0,0
232477,show,0,0
232478,that,0,0
232479,a,0,0
232480,modest,0,0
232481,elevation,0,0
232482,in,0,0
232483,tHcy,0,0
232484,in,0,0
232485,children,0,0
232486,was,0,0
232487,related,0,0
232488,to,0,0
232489,premature,0,0
232490,cardiovascular,0,0
232491,death,0,0
232492,in,0,0
232493,their,0,0
232494,male,0,0
232495,relatives,0,0
232496,and,0,0
232497,may,0,0
232498,partly,0,0
232499,account,0,0
232500,for,0,0
232501,the,0,0
232502,contribution,0,0
232503,of,0,0
232504,family,0,1
232505,history,0,0
232506,to,0,0
232507,risk,0,0
232508,of,0,0
232509,cardiovascular,0,0
232510,disease,0,0
232511,.,0,0
232512,tHcy,1,0
232513,may,0,0
232514,be,0,0
232515,modifiable,0,0
232516,through,0,0
232517,the,0,0
232518,diet,0,1
232519,",",0,0
232520,even,0,0
232521,in,0,0
232522,children,0,0
232523,with,0,0
232524,apparently,0,0
232525,adequate,0,0
232526,vitamin,0,1
232527,nutriture,0,0
232528,.,0,0
232529,Intraumbilical,0,1
232530,vein,0,0
232531,injection,0,1
232532,of,0,0
232533,prostaglandin,1,1
232534,F2,1,0
232535,alpha,1,1
232536,in,0,0
232537,retained,0,0
232538,placenta,0,0
232539,.,0,0
232540,A,0,0
232541,randomized,0,0
232542,protocol,0,0
232543,was,0,0
232544,used,0,0
232545,to,0,0
232546,study,0,0
232547,the,0,0
232548,effect,0,0
232549,of,0,0
232550,intraumbilical,1,0
232551,prostaglandin,1,1
232552,F2,1,1
232553,alpha,1,1
232554,(,1,0
232555,Hembate,1,1
232556,",",1,0
232557,Upjohn,1,0
232558,),1,1
232559,and,0,0
232560,oxytocin,1,1
232561,injection,1,1
232562,in,0,0
232563,women,0,0
232564,with,0,0
232565,retained,0,0
232566,placenta,0,0
232567,.,0,0
232568,Prostaglandin,1,1
232569,F2,1,0
232570,alpha,1,0
232571,",",1,0
232572,20,1,0
232573,mg,1,1
232574,",",1,0
232575,diluted,1,0
232576,to,1,0
232577,20,1,0
232578,ml,1,0
232579,in,1,0
232580,normal,1,0
232581,saline,1,1
232582,solution,1,1
232583,(,0,0
232584,10,0,0
232585,women,0,0
232586,",",0,0
232587,group,0,0
232588,1,0,0
232589,),0,0
232590,",",0,0
232591,30,1,0
232592,IU,1,1
232593,of,1,0
232594,oxytocin,1,1
232595,",",1,0
232596,diluted,1,0
232597,to,1,0
232598,20,1,0
232599,ml,1,0
232600,in,1,0
232601,normal,1,0
232602,saline,1,1
232603,solution,1,1
232604,(,0,0
232605,11,0,0
232606,women,0,0
232607,",",0,0
232608,group,0,0
232609,2,0,0
232610,),0,0
232611,",",0,0
232612,or,0,1
232613,20,1,0
232614,ml,1,0
232615,of,1,0
232616,normal,1,0
232617,saline,1,1
232618,solution,1,1
232619,alone,1,1
232620,(,0,0
232621,7,0,0
232622,women,0,0
232623,",",0,0
232624,group,0,0
232625,3,0,0
232626,),0,0
232627,",",0,0
232628,were,0,0
232629,injected,0,0
232630,into,0,0
232631,the,0,0
232632,umbilical,0,0
232633,vein,0,0
232634,1,0,0
232635,h,0,0
232636,after,0,0
232637,delivery,0,0
232638,.,0,0
232639,Nine,0,1
232640,women,0,0
232641,(,0,0
232642,group,0,0
232643,4,0,0
232644,",",0,0
232645,controls,0,0
232646,),0,0
232647,underwent,0,0
232648,manual,0,1
232649,removal,0,0
232650,of,0,0
232651,the,0,0
232652,retained,0,0
232653,placenta,0,0
232654,.,0,0
232655,In,0,0
232656,group,0,0
232657,1,0,0
232658,",",0,0
232659,placental,0,0
232660,expulsion,0,0
232661,occurred,0,0
232662,in,0,0
232663,all,0,0
232664,patients,0,0
232665,and,0,0
232666,the,0,0
232667,duration,0,0
232668,of,0,0
232669,the,0,0
232670,placental,0,0
232671,expulsion,0,0
232672,after,0,0
232673,prostaglandin,1,1
232674,F2,1,0
232675,alpha,1,1
232676,injection,0,1
232677,was,0,0
232678,6.8,0,0
232679,+/-,0,0
232680,1.36,0,0
232681,(,0,0
232682,mean,0,0
232683,+/-,0,0
232684,SE,0,1
232685,),0,1
232686,min,0,0
232687,:,0,0
232688,in,0,0
232689,group,0,0
232690,2,0,0
232691,",",0,0
232692,six,0,0
232693,placental,0,0
232694,expulsions,0,0
232695,occurred,0,0
232696,after,0,0
232697,13.3,0,0
232698,+/-,0,0
232699,1.97,0,0
232700,min,0,0
232701,(,0,0
232702,mean,0,0
232703,+/-,0,0
232704,SE,0,1
232705,),0,1
232706,;,0,0
232707,and,0,0
232708,in,0,0
232709,group,0,0
232710,3,0,0
232711,",",0,0
232712,no,0,0
232713,effect,0,0
232714,was,0,0
232715,recorded,0,0
232716,after,0,0
232717,intraumbilical,0,1
232718,saline,0,1
232719,injection,0,1
232720,.,0,0
232721,We,0,0
232722,suggest,0,0
232723,that,0,0
232724,intraumbilical,0,1
232725,vein,0,0
232726,injection,0,1
232727,of,0,0
232728,prostaglandin,1,1
232729,F2,1,0
232730,alpha,1,0
232731,might,0,0
232732,be,0,0
232733,a,0,0
232734,beneficial,0,0
232735,",",0,0
232736,non-surgical,0,1
232737,method,0,1
232738,for,0,0
232739,treating,0,0
232740,retained,0,0
232741,placenta,0,0
232742,.,0,0
232743,Oxytocin,1,1
232744,might,0,0
232745,reduce,0,0
232746,the,0,0
232747,incidence,0,0
232748,of,0,0
232749,manual,0,1
232750,lysis,0,0
232751,of,0,0
232752,the,0,0
232753,placenta,0,0
232754,and,0,0
232755,achieve,0,0
232756,partial,0,0
232757,success,0,0
232758,.,0,0
232759,Regular,0,1
232760,replacement,0,1
232761,of,0,0
232762,extended,1,1
232763,wear,1,1
232764,rigid,1,1
232765,gas,1,1
232766,permeable,1,1
232767,contact,1,1
232768,lenses,1,1
232769,.,1,0
232770,PURPOSE,0,0
232771,While,0,0
232772,the,0,0
232773,benefits,0,0
232774,of,0,0
232775,planned,0,0
232776,replacement,0,1
232777,of,0,0
232778,soft,1,1
232779,contact,1,1
232780,lenses,1,1
232781,have,0,0
232782,been,0,0
232783,investigated,0,0
232784,",",0,0
232785,the,0,0
232786,question,0,0
232787,of,0,0
232788,whether,0,0
232789,there,0,0
232790,are,0,0
232791,any,0,0
232792,clinical,0,0
232793,benefits,0,0
232794,to,0,0
232795,planned,0,0
232796,replacement,0,1
232797,of,0,0
232798,rigid,1,1
232799,gas,1,1
232800,permeable,1,1
232801,(,1,1
232802,RGP,1,1
232803,),1,1
232804,lenses,1,1
232805,does,0,0
232806,not,0,0
232807,appear,0,0
232808,to,0,0
232809,have,0,0
232810,been,0,0
232811,addressed,0,0
232812,experimentally,0,0
232813,.,0,0
232814,We,0,0
232815,aimed,0,0
232816,to,0,0
232817,determine,0,0
232818,the,0,0
232819,benefits,0,0
232820,of,0,0
232821,regular,1,1
232822,replacement,1,1
232823,of,0,0
232824,extended,1,1
232825,wear,1,1
232826,RGP,1,1
232827,contact,1,1
232828,lenses,1,1
232829,.,1,0
232830,METHODS,0,0
232831,We,0,0
232832,conducted,0,0
232833,a,0,0
232834,prospective,0,0
232835,",",0,0
232836,single-center,0,0
232837,",",0,0
232838,controlled,0,0
232839,",",0,0
232840,double-masked,0,0
232841,study,0,0
232842,of,0,0
232843,39,0,0
232844,RGP,0,0
232845,lens,0,1
232846,wearers,0,0
232847,.,0,0
232848,The,0,0
232849,subjects,0,0
232850,were,0,0
232851,divided,0,0
232852,into,0,0
232853,two,0,0
232854,groups,0,0
232855,and,0,0
232856,wore,1,0
232857,extended,1,1
232858,wear,1,1
232859,Quantum,1,1
232860,2,1,0
232861,lenses,1,1
232862,(,0,0
232863,Dk,0,1
232864,=,0,0
232865,120,0,0
232866,),0,0
232867,for,0,0
232868,12,0,0
232869,months,0,0
232870,.,0,0
232871,Subjects,0,0
232872,in,0,0
232873,Group,0,0
232874,I,0,0
232875,replaced,1,0
232876,lenses,1,1
232877,every,1,0
232878,3,1,0
232879,months,1,0
232880,",",0,0
232881,whereas,0,0
232882,those,0,0
232883,in,0,0
232884,Group,0,0
232885,II,0,0
232886,were,0,0
232887,not,1,0
232888,scheduled,1,0
232889,to,1,0
232890,replace,1,0
232891,their,1,0
232892,lenses,1,1
232893,.,1,0
232894,The,0,0
232895,integrity,0,0
232896,of,0,0
232897,the,0,0
232898,lenses,0,1
232899,and,0,0
232900,the,0,0
232901,ocular,0,0
232902,responses,0,0
232903,to,0,0
232904,lens,0,1
232905,wear,0,0
232906,were,0,0
232907,monitored,0,0
232908,in,0,0
232909,both,0,0
232910,groups,0,0
232911,every,0,0
232912,three,0,0
232913,months,0,0
232914,.,0,0
232915,RESULTS,0,0
232916,Compared,0,0
232917,to,0,0
232918,lenses,0,1
232919,worn,0,0
232920,by,0,0
232921,subjects,0,0
232922,in,0,0
232923,Group,0,0
232924,I,0,0
232925,",",0,0
232926,lenses,0,1
232927,worn,0,0
232928,by,0,0
232929,Group,0,0
232930,II,0,1
232931,subjects,0,0
232932,showed,0,0
232933,significantly,0,0
232934,more,0,0
232935,mucous,0,1
232936,coating,0,1
232937,",",0,0
232938,lens,0,1
232939,binding,0,0
232940,",",0,0
232941,and,0,0
232942,corneal,0,0
232943,staining,0,0
232944,over,0,0
232945,time,0,0
232946,(,0,0
232947,P,0,0
232948,<,0,0
232949,0.05,0,0
232950,;,0,0
232951,ANCOVA,0,0
232952,),0,0
232953,.,0,0
232954,There,0,0
232955,was,0,0
232956,no,0,0
232957,difference,0,0
232958,in,0,0
232959,microcystic,0,1
232960,or,0,1
232961,tarsal,0,0
232962,conjunctiva,0,1
232963,response,0,0
232964,",",0,0
232965,lens,0,1
232966,comfort,0,0
232967,",",0,0
232968,refractive,0,0
232969,change,0,0
232970,",",0,0
232971,or,0,1
232972,visual,0,0
232973,acuity,0,0
232974,between,0,0
232975,the,0,0
232976,two,0,0
232977,groups,0,0
232978,.,0,0
232979,CONCLUSIONS,0,0
232980,We,0,0
232981,advocate,0,0
232982,that,0,0
232983,to,0,0
232984,maintain,0,0
232985,optimal,0,0
232986,lens,0,1
232987,integrity,0,0
232988,and,0,0
232989,ocular,0,0
232990,health,0,0
232991,",",0,0
232992,RGP,0,1
232993,lenses,0,1
232994,used,0,0
232995,for,0,0
232996,extended,0,1
232997,wear,0,0
232998,should,0,0
232999,be,0,0
233000,replaced,0,0
233001,every,0,0
233002,3,0,0
233003,to,0,0
233004,6,0,0
233005,months,0,0
233006,.,0,0
233007,The,0,0
233008,comparative,0,0
233009,safety,0,0
233010,and,0,0
233011,diagnostic,0,0
233012,accuracy,0,0
233013,of,0,0
233014,adenosine,1,1
233015,myocardial,1,0
233016,perfusion,1,1
233017,imaging,1,0
233018,in,0,0
233019,women,0,0
233020,versus,0,0
233021,men,0,0
233022,.,0,0
233023,STUDY,0,0
233024,OBJECTIVE,0,0
233025,To,0,0
233026,determine,0,0
233027,if,0,0
233028,the,0,0
233029,diagnostic,0,0
233030,accuracy,0,0
233031,and,0,0
233032,safety,0,0
233033,of,0,0
233034,intravenous,0,1
233035,adenosine,1,1
233036,myocardial,1,0
233037,perfusion,1,1
233038,imaging,1,0
233039,is,0,0
233040,significantly,0,0
233041,different,0,0
233042,in,0,0
233043,men,0,0
233044,compared,0,0
233045,with,0,0
233046,women,0,0
233047,.,0,0
233048,DESIGN,0,0
233049,Prospective,0,0
233050,",",0,0
233051,comparative,0,0
233052,",",0,0
233053,open-label,0,0
233054,clinical,0,0
233055,trial,0,0
233056,.,0,0
233057,SETTING,0,0
233058,Nuclear,0,0
233059,medicine,0,1
233060,laboratory,0,0
233061,in,0,0
233062,a,0,0
233063,university-affiliated,0,0
233064,hospital,0,0
233065,.,0,0
233066,PATIENTS,0,0
233067,Consecutive,0,0
233068,patients,0,0
233069,who,0,0
233070,were,0,0
233071,referred,0,0
233072,for,0,0
233073,evaluation,0,0
233074,of,0,0
233075,known,0,0
233076,or,0,1
233077,suspected,0,0
233078,coronary,0,0
233079,artery,0,0
233080,disease,0,0
233081,.,0,0
233082,Patients,0,0
233083,were,0,0
233084,judged,0,0
233085,not,0,0
233086,to,0,0
233087,be,0,0
233088,able,0,0
233089,to,0,0
233090,exercise,0,1
233091,adequately,0,0
233092,.,0,0
233093,INTERVENTIONS,0,0
233094,Coronary,1,0
233095,angiography,1,1
233096,was,1,0
233097,conducted,1,0
233098,within,1,0
233099,6,1,0
233100,weeks,1,0
233101,of,1,0
233102,an,1,0
233103,adenosine,1,1
233104,thallium-201,1,1
233105,myocardial,1,0
233106,perfusion,1,1
233107,imaging,1,0
233108,study,1,0
233109,.,1,1
233110,MEASUREMENTS,0,0
233111,AND,0,0
233112,MAIN,0,1
233113,RESULTS,0,0
233114,Diagnostic,0,0
233115,accuracy,0,0
233116,is,0,0
233117,shown,0,0
233118,in,0,0
233119,the,0,0
233120,table,0,0
233121,.,0,0
233122,[,0,0
233123,table,0,0
233124,:,0,0
233125,see,0,0
233126,text,0,1
233127,],0,0
233128,Overall,0,0
233129,",",0,0
233130,side,0,0
233131,effects,0,0
233132,from,0,0
233133,adenosine,0,0
233134,were,0,0
233135,not,0,0
233136,different,0,0
233137,between,0,0
233138,men,0,0
233139,and,0,0
233140,women,0,0
233141,.,0,0
233142,The,0,0
233143,frequencies,0,0
233144,of,0,0
233145,ST,0,0
233146,depression,0,1
233147,and,0,0
233148,chest,0,1
233149,pain,0,0
233150,were,0,0
233151,significantly,0,0
233152,greater,0,0
233153,in,0,0
233154,women,0,0
233155,than,0,0
233156,men,0,0
233157,",",0,0
233158,although,0,0
233159,their,0,0
233160,etiologies,0,0
233161,are,0,0
233162,unknown,0,0
233163,.,0,0
233164,The,0,0
233165,frequency,0,0
233166,of,0,0
233167,severe,0,0
233168,side,0,0
233169,effects,0,0
233170,such,0,0
233171,as,0,0
233172,heart,0,0
233173,block,0,1
233174,and,0,0
233175,hypotension,0,0
233176,was,0,0
233177,not,0,0
233178,different,0,0
233179,between,0,0
233180,men,0,0
233181,and,0,0
233182,women,0,0
233183,.,0,0
233184,CONCLUSIONS,0,0
233185,The,0,0
233186,diagnostic,0,0
233187,accuracy,0,0
233188,and,0,0
233189,safety,0,0
233190,of,0,0
233191,adenosine,1,1
233192,thallium-201,1,1
233193,myocardial,1,0
233194,perfusion,1,1
233195,imaging,1,0
233196,are,0,0
233197,generally,0,0
233198,similar,0,0
233199,in,0,0
233200,women,0,0
233201,and,0,0
233202,men,0,0
233203,.,0,0
233204,An,0,0
233205,occupation,1,0
233206,based,1,0
233207,physical,1,1
233208,activity,1,0
233209,intervention,1,1
233210,program,1,1
233211,:,1,1
233212,improving,0,0
233213,fitness,0,0
233214,and,0,0
233215,decreasing,0,0
233216,obesity,0,0
233217,.,0,0
233218,The,0,0
233219,purpose,0,0
233220,of,0,0
233221,this,0,0
233222,quasi-experimental,0,1
233223,study,0,0
233224,was,0,0
233225,to,0,0
233226,determine,0,0
233227,the,0,0
233228,effectiveness,0,0
233229,of,0,0
233230,an,0,0
233231,occupation,1,0
233232,based,1,0
233233,health,1,0
233234,and,1,0
233235,fitness,1,0
233236,program,1,1
233237,.,1,0
233238,Subjects,0,0
233239,were,0,0
233240,"1,504",0,0
233241,police,0,0
233242,trainees,0,0
233243,(,0,0
233244,85,0,0
233245,%,0,0
233246,male,0,0
233247,",",0,0
233248,15,0,0
233249,%,0,0
233250,female,0,0
233251,),0,0
233252,with,0,0
233253,an,0,0
233254,ethnic,0,0
233255,distribution,0,0
233256,of,0,0
233257,82,0,0
233258,%,0,0
233259,white,0,0
233260,",",0,0
233261,16,0,0
233262,%,0,0
233263,African,0,0
233264,American,0,0
233265,",",0,0
233266,and,0,0
233267,2,0,0
233268,%,0,0
233269,other,0,0
233270,.,0,0
233271,Data,0,0
233272,were,0,0
233273,collected,0,0
233274,at,0,0
233275,25,0,0
233276,sites,0,0
233277,across,0,0
233278,the,0,0
233279,state,0,0
233280,of,0,0
233281,North,0,0
233282,Carolina,0,0
233283,.,0,0
233284,The,0,0
233285,sites,0,0
233286,were,0,0
233287,randomly,0,0
233288,assigned,0,0
233289,to,0,0
233290,either,0,0
233291,the,0,0
233292,experimental,0,0
233293,group,0,0
233294,(,1,0
233295,implemented,1,0
233296,the,1,0
233297,intervention,1,1
233298,),1,0
233299,or,0,1
233300,the,0,0
233301,control,0,1
233302,group,0,0
233303,(,1,0
233304,continued,1,0
233305,usual,1,1
233306,training,1,1
233307,),1,0
233308,.,0,0
233309,As,0,0
233310,compared,0,0
233311,with,0,0
233312,controls,0,0
233313,",",0,0
233314,subjects,0,0
233315,at,0,0
233316,the,0,0
233317,experimental,0,0
233318,sites,0,0
233319,improved,0,0
233320,significantly,0,0
233321,in,0,0
233322,cardiovascular,0,0
233323,fitness,0,0
233324,(,0,1
233325,aerobic,0,1
233326,power,0,0
233327,),0,0
233328,",",0,0
233329,general,0,0
233330,muscular,0,0
233331,strength,0,0
233332,(,0,1
233333,number,0,0
233334,of,0,0
233335,sit,0,0
233336,ups,0,0
233337,per,0,0
233338,minute,0,0
233339,),0,0
233340,",",0,0
233341,and,0,0
233342,flexibility,0,0
233343,",",0,0
233344,and,0,0
233345,lowered,0,0
233346,their,0,0
233347,body,0,0
233348,fat,0,0
233349,.,0,0
233350,The,0,0
233351,intervention,0,1
233352,required,0,0
233353,minimal,0,0
233354,equipment,0,1
233355,and,0,0
233356,was,0,0
233357,taught,0,0
233358,primarily,0,0
233359,by,0,0
233360,peers,0,0
233361,who,0,0
233362,received,0,0
233363,a,0,0
233364,1,0,0
233365,week,0,0
233366,training,0,1
233367,program,0,1
233368,.,0,0
233369,This,0,0
233370,occupational,1,1
233371,approach,1,1
233372,to,0,0
233373,improving,0,0
233374,health,0,0
233375,could,0,0
233376,be,0,0
233377,particularly,0,0
233378,useful,0,0
233379,in,0,0
233380,occupations,0,0
233381,with,0,0
233382,many,0,0
233383,workers,0,0
233384,who,0,0
233385,seldom,0,0
233386,engage,0,0
233387,in,0,0
233388,leisure,0,1
233389,time,0,0
233390,physical,0,1
233391,activity,0,0
233392,.,0,0
233393,Secondary,0,0
233394,caries,0,0
233395,formation,0,0
233396,in,0,0
233397,vitro,0,0
233398,around,0,0
233399,glass,0,1
233400,ionomer-lined,0,1
233401,amalgam,0,1
233402,and,0,0
233403,composite,0,1
233404,restorations,0,1
233405,.,0,0
233406,The,0,0
233407,aim,0,0
233408,of,0,0
233409,this,0,0
233410,in,0,0
233411,vitro,0,0
233412,secondary,0,0
233413,caries,0,0
233414,study,0,0
233415,was,0,0
233416,to,0,0
233417,examine,0,0
233418,the,0,0
233419,glass-ionomer,1,1
233420,liner,1,1
233421,'s,1,0
233422,effect,0,0
233423,on,0,0
233424,wall-lesion,0,1
233425,inhibition,0,0
233426,when,0,0
233427,a,0,0
233428,conventional,0,1
233429,and,0,0
233430,a,0,0
233431,light-cured,0,1
233432,glass,1,1
233433,ionomer,1,1
233434,liner,1,1
233435,was,0,0
233436,placed,0,0
233437,under,0,0
233438,amalgam,1,1
233439,and,0,0
233440,composite,1,1
233441,resin,1,1
233442,restorations,0,1
233443,.,0,0
233444,Class,0,0
233445,V,0,1
233446,preparations,0,1
233447,in,0,0
233448,extracted,0,0
233449,upper,0,0
233450,premolars,0,0
233451,were,0,0
233452,used,0,0
233453,and,0,0
233454,ten,0,0
233455,restorations,0,1
233456,were,0,0
233457,used,0,0
233458,for,0,0
233459,each,0,0
233460,of,0,0
233461,the,0,0
233462,following,0,0
233463,groups,0,0
233464,:,0,0
233465,(,1,0
233466,i,1,0
233467,),1,1
233468,two,1,0
233469,layers,1,0
233470,of,1,0
233471,copal,1,1
233472,varnish,1,1
233473,and,1,0
233474,amalgam,1,1
233475,;,1,1
233476,(,1,1
233477,ii,1,0
233478,),1,1
233479,conventional,1,1
233480,glass-ionomer,1,1
233481,and,1,0
233482,amalgam,1,1
233483,;,1,1
233484,(,1,1
233485,iii,1,0
233486,),1,1
233487,light-cured,1,1
233488,glass-ionomer,1,1
233489,and,1,0
233490,amalgam,1,1
233491,;,1,1
233492,(,1,1
233493,iv,1,0
233494,),1,1
233495,bonding,1,1
233496,agent,1,1
233497,and,1,0
233498,light-cured,1,1
233499,composite,1,1
233500,resin,1,1
233501,;,1,1
233502,(,1,1
233503,v,1,1
233504,),1,1
233505,conventional,1,1
233506,glass-ionomer,1,1
233507,",",1,0
233508,bonding,1,1
233509,agent,1,0
233510,and,1,0
233511,light-cured,1,1
233512,composite,1,1
233513,resin,1,1
233514,;,1,1
233515,(,1,1
233516,vi,1,0
233517,),1,1
233518,light-cured,1,1
233519,glass-ionomer,1,1
233520,",",1,0
233521,extended,1,0
233522,0.3,1,0
233523,mm,1,0
233524,short,1,0
233525,of,1,0
233526,the,1,0
233527,enamel,1,0
233528,margin,1,0
233529,bonding,1,1
233530,agent,1,1
233531,and,1,0
233532,light-cured,1,1
233533,composite,1,1
233534,resin,1,1
233535,;,1,1
233536,and,1,0
233537,(,1,1
233538,vii,1,1
233539,),1,1
233540,light-cured,1,1
233541,glass-ionomer,1,1
233542,",",1,0
233543,extended,1,0
233544,1,1,0
233545,mm,1,0
233546,short,1,0
233547,of,1,0
233548,the,1,0
233549,enamel,1,0
233550,margin,1,0
233551,",",1,0
233552,bonding,1,1
233553,agent,1,0
233554,and,1,0
233555,light-cured,1,1
233556,composite,1,1
233557,resin,1,1
233558,.,1,0
233559,The,0,0
233560,teeth,0,0
233561,were,0,0
233562,thermocycled,0,1
233563,and,0,0
233564,artificial,1,1
233565,caries,1,0
233566,were,0,0
233567,created,0,0
233568,using,0,0
233569,an,0,0
233570,acid-gel,0,1
233571,.,0,0
233572,The,0,0
233573,results,0,0
233574,of,0,0
233575,this,0,0
233576,study,0,0
233577,showed,0,0
233578,that,0,0
233579,artificial,0,1
233580,recurrent,0,0
233581,caries,0,0
233582,can,0,0
233583,be,0,0
233584,reduced,0,0
233585,significantly,0,0
233586,(,0,0
233587,P,0,0
233588,<,0,0
233589,0.05,0,0
233590,),0,0
233591,with,0,0
233592,a,0,0
233593,glass-ionomer,1,1
233594,liner,1,1
233595,under,1,0
233596,amalgam,1,1
233597,restorations,1,1
233598,.,1,0
233599,The,0,0
233600,results,0,0
233601,also,0,0
233602,showed,0,0
233603,that,0,0
233604,when,0,0
233605,the,0,0
233606,light-cured,0,1
233607,glass-ionomer,1,1
233608,liner,0,1
233609,was,0,0
233610,placed,0,0
233611,0.3,0,0
233612,mm,0,0
233613,from,0,0
233614,the,0,0
233615,cavosurface,0,0
233616,margin,0,0
233617,under,0,0
233618,composite,0,1
233619,resin,0,1
233620,restoration,0,0
233621,",",0,0
233622,the,0,0
233623,artificial,0,1
233624,recurrent,0,0
233625,caries,0,0
233626,reduced,0,0
233627,significantly,0,0
233628,(,0,0
233629,P,0,0
233630,<,0,0
233631,0.05,0,0
233632,),0,0
233633,.,0,0
233634,Relationship,0,0
233635,of,0,0
233636,the,0,0
233637,dose,0,0
233638,of,0,0
233639,intravenous,0,1
233640,gammaglobulin,1,1
233641,to,0,0
233642,the,0,0
233643,prevention,0,0
233644,of,0,0
233645,infections,0,0
233646,in,0,0
233647,adults,0,0
233648,with,0,0
233649,common,0,0
233650,variable,0,0
233651,immunodeficiency,0,0
233652,.,0,0
233653,The,0,0
233654,objective,0,0
233655,was,0,0
233656,to,0,0
233657,assess,0,0
233658,clinical,0,0
233659,efficacy,0,0
233660,of,0,0
233661,3,0,0
233662,dosages,0,0
233663,of,0,0
233664,intravenous,1,1
233665,gammaglobulins,1,1
233666,to,0,0
233667,prevent,0,0
233668,infectious,0,0
233669,episodes,0,0
233670,in,0,0
233671,adult,0,0
233672,common,0,0
233673,variable,0,0
233674,immunodeficiency,0,0
233675,.,0,0
233676,We,0,0
233677,designed,0,0
233678,a,0,0
233679,randomized,0,0
233680,",",0,0
233681,double,0,1
233682,blind,0,0
233683,",",0,0
233684,dose-assessing,0,0
233685,study,0,0
233686,.,0,0
233687,The,0,0
233688,setting,0,0
233689,was,0,0
233690,at,0,0
233691,University,0,0
233692,Hospital,0,0
233693,",",0,0
233694,Out-patient,0,0
233695,Clinic,0,1
233696,.,0,0
233697,Our,0,0
233698,patients,0,0
233699,were,0,0
233700,twenty-one,0,0
233701,adult,0,0
233702,patients,0,0
233703,with,0,0
233704,common,0,0
233705,variable,0,0
233706,immunodeficiency,0,0
233707,.,0,0
233708,The,0,0
233709,measurements,0,0
233710,were,0,0
233711,comparative,0,0
233712,study,0,0
233713,of,0,0
233714,the,0,0
233715,number,0,0
233716,and,0,0
233717,severity,0,0
233718,of,0,0
233719,infections,0,0
233720,using,0,0
233721,3,0,0
233722,various,0,0
233723,dosages,0,0
233724,of,0,0
233725,intravenous,0,1
233726,gammaglobulins,1,1
233727,",",0,0
233728,each,0,0
233729,given,0,0
233730,monthly,0,0
233731,for,0,0
233732,M,0,0
233733,least,0,0
233734,6,0,0
233735,months,0,0
233736,.,0,0
233737,Results,0,0
233738,indicated,0,0
233739,four,0,0
233740,hundred,0,0
233741,and,0,0
233742,eighty-four,0,0
233743,infectious,0,0
233744,episodes,0,0
233745,occurred,0,0
233746,while,0,0
233747,giving,0,0
233748,305,1,0
233749,infusions,1,1
233750,of,1,0
233751,IVIG,1,0
233752,200,1,1
233753,mg/kg,1,1
233754,;,1,0
233755,205,0,0
233756,infectious,0,0
233757,episodes,0,0
233758,while,0,0
233759,giving,0,0
233760,170,1,0
233761,infusions,1,1
233762,of,1,0
233763,400,1,0
233764,mg/kg,1,1
233765,and,0,0
233766,436,0,0
233767,infectious,0,0
233768,episodes,0,0
233769,while,0,0
233770,giving,0,0
233771,247,1,0
233772,infusions,1,1
233773,of,1,0
233774,600,1,0
233775,mg/kg,1,1
233776,.,1,0
233777,The,0,0
233778,morbidity,0,0
233779,scores,0,0
233780,(,0,0
233781,infection/infusion,0,0
233782,),0,1
233783,were,0,0
233784,1.59,0,0
233785,",",0,0
233786,1.21,0,0
233787,and,0,0
233788,1.77,0,0
233789,respectively,0,0
233790,(,0,0
233791,p,0,0
233792,-,0,1
233793,N/S,0,1
233794,),0,0
233795,.,0,0
233796,There,0,0
233797,was,0,0
233798,no,0,0
233799,significant,0,0
233800,difference,0,0
233801,in,0,0
233802,the,0,0
233803,severity,0,0
233804,of,0,0
233805,infections,0,0
233806,on,0,0
233807,the,0,0
233808,above,0,0
233809,3,0,0
233810,dosages,0,0
233811,",",0,0
233812,and,0,0
233813,no,0,0
233814,difference,0,0
233815,in,0,0
233816,the,0,0
233817,duration,0,0
233818,of,0,0
233819,infection-free,0,0
233820,intervals,0,0
233821,.,0,0
233822,The,0,0
233823,conclusions,0,0
233824,resulted,0,0
233825,in,0,0
233826,no,0,0
233827,significant,0,0
233828,differences,0,0
233829,in,0,0
233830,morbidity,0,0
233831,in,0,0
233832,adult,0,0
233833,patients,0,0
233834,with,0,0
233835,common,0,0
233836,variable,0,0
233837,immunodeficiency,0,0
233838,treated,0,0
233839,in,0,0
233840,cross-over,0,0
233841,pattern,0,0
233842,with,0,0
233843,IVIG,0,0
233844,200,0,1
233845,mg/kg,0,1
233846,",",0,0
233847,400,0,1
233848,mg/kg,0,1
233849,and,0,0
233850,600,0,1
233851,mg/kg,0,1
233852,.,0,0
233853,Thus,0,0
233854,",",0,0
233855,high,0,0
233856,dosages,0,0
233857,of,0,0
233858,IVIG,0,0
233859,are,0,0
233860,not,0,0
233861,conferring,0,0
233862,better,0,0
233863,protection,0,0
233864,against,0,0
233865,infections,0,0
233866,in,0,0
233867,such,0,0
233868,patients,0,0
233869,.,0,0
233870,Baseline,0,1
233871,characteristics,0,0
233872,of,0,0
233873,participants,0,0
233874,in,0,0
233875,the,0,0
233876,Appropriate,0,1
233877,Blood,0,0
233878,Pressure,0,1
233879,Control,0,1
233880,in,0,0
233881,Diabetes,0,0
233882,trial,0,0
233883,.,0,0
233884,The,0,0
233885,ABCD,0,0
233886,(,0,0
233887,Appropriate,0,1
233888,Blood,0,0
233889,Pressure,0,1
233890,Control,0,1
233891,in,0,0
233892,Diabetes,0,0
233893,),0,1
233894,trial,0,0
233895,is,0,0
233896,a,0,0
233897,large,0,0
233898,",",0,0
233899,prospective,0,0
233900,",",0,0
233901,randomized,0,0
233902,clinical,0,0
233903,trial,0,0
233904,designed,0,0
233905,to,0,0
233906,compare,0,0
233907,the,0,0
233908,effects,0,0
233909,of,0,0
233910,intensive,1,0
233911,with,0,0
233912,moderate,1,0
233913,blood,1,0
233914,pressure,1,0
233915,control,1,1
233916,on,0,0
233917,the,0,0
233918,prevention,0,0
233919,and,0,0
233920,progression,0,0
233921,of,0,0
233922,diabetic,0,0
233923,nephropathy,0,0
233924,",",0,0
233925,retinopathy,0,0
233926,",",0,0
233927,cardiovascular,0,0
233928,disease,0,0
233929,",",0,0
233930,and,0,0
233931,neuropathy,0,0
233932,in,0,0
233933,non-insulin-dependent,0,0
233934,diabetes,0,0
233935,(,0,0
233936,NIDDM,0,1
233937,),0,0
233938,.,0,0
233939,The,0,0
233940,secondary,0,0
233941,objective,0,0
233942,is,0,0
233943,to,0,0
233944,determine,0,0
233945,equivalency,0,0
233946,of,0,0
233947,the,0,0
233948,effects,0,0
233949,of,0,0
233950,a,0,0
233951,calcium,1,1
233952,channel,1,1
233953,blocker,1,1
233954,(,1,1
233955,nisoldipine,1,1
233956,),1,1
233957,and,0,0
233958,of,0,0
233959,an,0,0
233960,angiotensin-converting,1,1
233961,enzyme,1,1
233962,inhibitor,1,1
233963,(,1,1
233964,enalapril,1,1
233965,),1,1
233966,as,0,0
233967,a,0,0
233968,first-line,0,1
233969,antihypertensive,0,1
233970,agent,0,0
233971,in,0,0
233972,the,0,0
233973,prevention,0,0
233974,and/or,0,0
233975,progression,0,0
233976,of,0,0
233977,these,0,0
233978,diabetic,0,0
233979,vascular,0,0
233980,complications,0,0
233981,.,0,0
233982,The,0,0
233983,study,0,0
233984,consists,0,0
233985,of,0,0
233986,two,0,0
233987,study,0,0
233988,populations,0,0
233989,:,0,0
233990,a,0,0
233991,hypertensive,0,0
233992,one,0,0
233993,(,0,1
233994,diastolic,0,0
233995,blood,0,0
233996,pressure,0,0
233997,of,0,0
233998,>,0,0
233999,or,0,1
234000,=,0,0
234001,90.0,0,0
234002,mm,0,0
234003,Hg,0,0
234004,at,0,0
234005,the,0,0
234006,time,0,0
234007,of,0,0
234008,randomization,0,0
234009,),0,1
234010,and,0,0
234011,a,0,0
234012,normotensive,0,0
234013,one,0,0
234014,(,0,1
234015,diastolic,0,0
234016,blood,0,0
234017,pressure,0,0
234018,of,0,0
234019,80.0-89.0,0,0
234020,mm,0,0
234021,Hg,0,0
234022,at,0,0
234023,the,0,0
234024,time,0,0
234025,of,0,0
234026,randomization,0,0
234027,),0,0
234028,.,0,0
234029,A,0,0
234030,total,0,0
234031,of,0,0
234032,950,0,0
234033,men,0,0
234034,and,0,0
234035,women,0,0
234036,aged,0,0
234037,40-74,0,0
234038,years,0,0
234039,were,0,0
234040,randomized,0,0
234041,and,0,0
234042,are,0,0
234043,being,0,0
234044,followed,0,1
234045,for,0,0
234046,5,0,0
234047,years,0,0
234048,at,0,0
234049,a,0,0
234050,single,0,0
234051,center,0,0
234052,.,0,0
234053,There,0,0
234054,were,0,0
234055,470,0,0
234056,randomized,0,0
234057,participants,0,0
234058,in,0,0
234059,the,0,0
234060,hypertensive,0,0
234061,population,0,0
234062,and,0,0
234063,480,0,0
234064,randomized,0,0
234065,participants,0,0
234066,in,0,0
234067,the,0,0
234068,normotensive,0,0
234069,population,0,0
234070,.,0,0
234071,This,0,0
234072,report,0,0
234073,summarizes,0,0
234074,the,0,0
234075,demographic,0,0
234076,",",0,0
234077,biochemical,0,0
234078,",",0,0
234079,and,0,0
234080,clinical,0,0
234081,characteristics,0,0
234082,of,0,0
234083,the,0,0
234084,randomized,0,0
234085,patients,0,0
234086,at,0,0
234087,the,0,0
234088,time,0,0
234089,of,0,0
234090,entry,0,0
234091,into,0,0
234092,the,0,0
234093,trial,0,0
234094,and,0,0
234095,evaluates,0,0
234096,the,0,0
234097,balance,0,0
234098,between,0,0
234099,the,0,0
234100,treatment,0,0
234101,groups,0,0
234102,within,0,0
234103,each,0,0
234104,population,0,0
234105,.,0,0
234106,Using,0,0
234107,a,0,0
234108,choice,1,0
234109,assessment,1,0
234110,to,0,0
234111,predict,0,0
234112,reinforcer,0,1
234113,effectiveness,0,0
234114,.,0,0
234115,A,1,0
234116,choice,1,0
234117,assessment,1,0
234118,has,0,0
234119,been,0,0
234120,found,0,0
234121,to,0,0
234122,be,0,0
234123,a,0,0
234124,more,0,0
234125,accurate,0,0
234126,method,0,1
234127,of,0,0
234128,identifying,0,0
234129,preferences,0,0
234130,than,0,0
234131,is,0,0
234132,single-item,0,0
234133,presentation,0,0
234134,.,0,0
234135,However,0,0
234136,",",0,0
234137,it,0,0
234138,is,0,0
234139,not,0,0
234140,clear,0,0
234141,whether,0,0
234142,the,0,0
234143,effectiveness,0,0
234144,of,0,0
234145,reinforcement,0,1
234146,varies,0,0
234147,positively,0,0
234148,with,0,0
234149,the,0,0
234150,degree,0,0
234151,of,0,0
234152,preference,0,0
234153,(,0,0
234154,i.e.,0,0
234155,",",0,0
234156,whether,0,0
234157,the,0,0
234158,relative,0,0
234159,preference,0,0
234160,based,0,0
234161,on,0,0
234162,the,0,0
234163,results,0,0
234164,of,0,0
234165,a,0,0
234166,choice,0,0
234167,assessment,0,0
234168,predicts,0,0
234169,relative,0,0
234170,reinforcer,0,1
234171,effectiveness,0,0
234172,),0,0
234173,.,0,0
234174,In,0,0
234175,the,0,0
234176,current,0,0
234177,study,0,0
234178,",",0,0
234179,we,0,0
234180,attempted,0,0
234181,to,0,0
234182,address,0,0
234183,this,0,0
234184,question,0,0
234185,by,0,0
234186,categorizing,0,0
234187,stimuli,0,1
234188,as,0,0
234189,high,0,0
234190,",",0,0
234191,middle,0,0
234192,",",0,0
234193,and,0,0
234194,low,0,0
234195,preference,0,0
234196,based,0,0
234197,on,0,0
234198,the,0,0
234199,results,0,0
234200,of,0,0
234201,a,0,0
234202,choice,1,0
234203,assessment,1,0
234204,",",0,0
234205,and,0,0
234206,then,0,1
234207,comparing,0,0
234208,the,0,0
234209,reinforcing,0,1
234210,effectiveness,0,0
234211,of,0,0
234212,these,0,0
234213,stimuli,0,1
234214,using,0,0
234215,a,0,0
234216,concurrent,1,1
234217,operants,1,1
234218,paradigm,1,0
234219,.,1,0
234220,High-preference,0,0
234221,stimuli,0,0
234222,consistently,0,0
234223,functioned,0,0
234224,as,0,0
234225,reinforcers,0,1
234226,for,0,0
234227,all,0,0
234228,4,0,0
234229,clients,0,0
234230,.,0,0
234231,Middle-preference,0,0
234232,stimuli,0,0
234233,functioned,0,0
234234,as,0,0
234235,reinforcers,0,1
234236,for,0,0
234237,2,0,0
234238,clients,0,0
234239,",",0,0
234240,but,0,0
234241,only,0,0
234242,when,0,0
234243,compared,0,0
234244,with,0,0
234245,low-preference,0,1
234246,stimuli,0,1
234247,.,0,0
234248,Low-preference,0,0
234249,stimuli,0,0
234250,did,0,0
234251,not,0,0
234252,function,0,0
234253,as,0,0
234254,reinforcers,0,1
234255,when,0,0
234256,compared,0,0
234257,to,0,0
234258,high-,0,1
234259,and,0,0
234260,middle-preference,0,1
234261,stimuli,0,1
234262,.,0,0
234263,These,0,0
234264,results,0,0
234265,suggest,0,0
234266,that,0,0
234267,a,0,0
234268,choice,1,0
234269,assessment,1,0
234270,can,0,0
234271,be,0,0
234272,used,0,0
234273,to,0,0
234274,predict,0,0
234275,the,0,0
234276,relative,0,0
234277,reinforcing,0,1
234278,value,0,0
234279,of,0,0
234280,various,0,0
234281,stimuli,0,1
234282,",",0,0
234283,which,0,0
234284,",",0,0
234285,in,0,0
234286,turn,0,0
234287,",",0,0
234288,may,0,0
234289,help,0,0
234290,to,0,0
234291,improve,0,0
234292,programs,0,1
234293,for,0,0
234294,clients,0,0
234295,with,0,0
234296,severe,0,0
234297,to,0,0
234298,profound,0,0
234299,disabilities,0,0
234300,.,0,0
234301,Effects,0,0
234302,of,0,0
234303,perioperative,0,0
234304,indomethacin,1,1
234305,on,0,0
234306,intracranial,0,0
234307,pressure,0,0
234308,",",0,0
234309,cerebral,0,0
234310,blood,0,0
234311,flow,0,0
234312,",",0,0
234313,and,0,0
234314,cerebral,0,0
234315,metabolism,0,0
234316,in,0,0
234317,patients,0,0
234318,subjected,0,0
234319,to,0,0
234320,craniotomy,0,1
234321,for,0,0
234322,cerebral,0,0
234323,tumors,0,0
234324,.,0,0
234325,This,0,0
234326,study,0,0
234327,was,0,0
234328,carried,0,0
234329,out,0,0
234330,to,0,0
234331,evaluate,0,0
234332,the,0,0
234333,effects,0,0
234334,of,0,0
234335,perioperative,0,0
234336,indomethacin,0,1
234337,on,0,0
234338,intracranial,0,0
234339,pressure,0,0
234340,(,0,1
234341,ICP,0,1
234342,),0,1
234343,",",0,0
234344,cerebral,0,0
234345,blood,0,0
234346,flow,0,0
234347,(,0,1
234348,CBF,0,1
234349,),0,1
234350,",",0,0
234351,and,0,0
234352,cerebral,0,0
234353,metabolism,0,0
234354,.,0,0
234355,Twenty,0,0
234356,patients,0,0
234357,subjected,0,0
234358,to,0,0
234359,craniotomy,0,1
234360,for,0,0
234361,supratentorial,0,0
234362,cerebral,0,0
234363,tumors,0,0
234364,were,0,0
234365,anesthetized,1,0
234366,with,1,0
234367,thiopental,1,1
234368,",",1,0
234369,fentanyl,1,1
234370,",",1,0
234371,nitrous,1,1
234372,oxide,1,1
234373,",",1,0
234374,and,1,0
234375,isoflurane,1,1
234376,.,1,0
234377,A,0,0
234378,PaCO2,0,1
234379,level,0,0
234380,averaging,0,0
234381,4.8,0,0
234382,kPa,0,1
234383,(,0,0
234384,median,0,0
234385,),0,0
234386,was,0,0
234387,achieved,0,0
234388,.,0,0
234389,The,0,0
234390,patients,0,0
234391,were,0,0
234392,randomized,0,0
234393,to,0,0
234394,intravenous,1,1
234395,indomethacin,1,1
234396,50,1,1
234397,mg,1,1
234398,or,1,1
234399,placebo,1,1
234400,administrated,1,1
234401,after,1,0
234402,exposure,1,0
234403,of,1,0
234404,the,1,0
234405,dura,1,0
234406,.,1,0
234407,ICP,1,0
234408,was,1,0
234409,measured,1,0
234410,continuously,1,0
234411,subdurally,1,1
234412,with,1,0
234413,a,1,0
234414,22-gauge,1,1
234415,canula,1,1
234416,connected,1,1
234417,to,1,0
234418,a,1,0
234419,transducer,1,1
234420,.,1,0
234421,CBF,0,0
234422,and,0,0
234423,the,0,0
234424,arteriovenous,0,0
234425,difference,0,0
234426,of,0,0
234427,oxygen,0,1
234428,(,0,1
234429,AVDO2,0,1
234430,),0,1
234431,were,0,0
234432,measured,0,0
234433,twice,0,0
234434,",",0,0
234435,before,0,0
234436,and,0,0
234437,after,0,0
234438,indomethacin/placebo,1,1
234439,administration,0,0
234440,.,0,0
234441,A,0,0
234442,significant,0,0
234443,decrease,0,0
234444,in,0,0
234445,ICP,0,0
234446,from,0,0
234447,6.5,0,0
234448,to,0,0
234449,1.5,0,0
234450,mm,0,0
234451,Hg,0,0
234452,(,0,0
234453,median,0,0
234454,),0,0
234455,was,0,0
234456,found,0,0
234457,after,0,0
234458,indomethacin,0,1
234459,administration,0,0
234460,.,0,0
234461,This,0,0
234462,decrease,0,0
234463,was,0,0
234464,caused,0,0
234465,by,0,0
234466,a,0,0
234467,significant,0,0
234468,decrease,0,0
234469,in,0,0
234470,CBF,0,0
234471,associated,0,0
234472,with,0,0
234473,a,0,0
234474,significant,0,0
234475,increase,0,0
234476,in,0,0
234477,AVDO2,0,1
234478,.,0,0
234479,Indomethacin,0,1
234480,did,0,0
234481,not,0,0
234482,affect,0,0
234483,the,0,0
234484,cerebral,0,0
234485,metabolic,0,0
234486,rate,0,0
234487,of,0,0
234488,oxygen,0,0
234489,",",0,0
234490,the,0,0
234491,arteriovenous,0,0
234492,difference,0,0
234493,of,0,0
234494,lactate,0,0
234495,",",0,0
234496,or,0,1
234497,the,0,0
234498,lactate/oxygen,0,1
234499,index,0,0
234500,",",0,0
234501,suggesting,0,0
234502,that,0,0
234503,indomethacin,0,1
234504,did,0,0
234505,not,0,0
234506,provoke,0,0
234507,global,0,0
234508,cerebral,0,0
234509,ischemia,0,0
234510,.,0,0
234511,In,0,0
234512,the,0,0
234513,indomethacin,0,1
234514,group,0,0
234515,",",0,0
234516,dura,0,1
234517,was,0,0
234518,sufficiently,0,0
234519,relaxed,0,1
234520,in,0,0
234521,eight,0,0
234522,of,0,0
234523,nine,0,0
234524,patients,0,0
234525,and,0,0
234526,dura,0,1
234527,was,0,0
234528,opened,0,1
234529,without,0,0
234530,the,0,0
234531,occurrence,0,0
234532,of,0,0
234533,cerebral,0,0
234534,swelling,0,0
234535,.,0,0
234536,In,0,0
234537,one,0,0
234538,patient,0,0
234539,",",0,0
234540,mannitol,0,1
234541,treatment,0,0
234542,was,0,0
234543,necessary,0,0
234544,to,0,0
234545,prevent,0,0
234546,dural,0,1
234547,tightness,0,0
234548,.,0,0
234549,In,0,0
234550,the,0,0
234551,placebo,0,1
234552,group,0,0
234553,",",0,0
234554,mannitol,0,1
234555,supplemented,0,1
234556,with,0,0
234557,hypocapnia,0,0
234558,was,0,0
234559,applied,0,0
234560,in,0,0
234561,five,0,0
234562,patients,0,0
234563,.,0,0
234564,These,0,0
234565,findings,0,0
234566,suggest,0,0
234567,that,0,0
234568,perioperative,0,0
234569,treatment,0,0
234570,with,0,0
234571,indomethacin,1,1
234572,is,0,0
234573,an,0,0
234574,excellent,0,0
234575,treatment,0,0
234576,of,0,0
234577,intracranial,0,0
234578,hypertension,0,0
234579,during,0,0
234580,normocapnic,0,1
234581,isoflurane,0,1
234582,anesthesia,0,1
234583,for,0,0
234584,craniotomy,0,1
234585,.,0,0
234586,Ganciclovir,1,1
234587,use,0,0
234588,during,0,0
234589,mild,0,0
234590,renal,0,0
234591,failure,0,0
234592,in,0,0
234593,heart,1,0
234594,transplantation,1,0
234595,.,1,0
234596,A,0,0
234597,double-blind,0,0
234598,",",0,0
234599,placebo-controlled,1,1
234600,study,0,0
234601,of,0,0
234602,fluvoxamine,1,1
234603,in,0,0
234604,adults,0,0
234605,with,0,0
234606,autistic,0,0
234607,disorder,0,0
234608,.,0,0
234609,BACKGROUND,0,0
234610,Autistic,0,0
234611,disorder,0,0
234612,is,0,0
234613,characterized,0,0
234614,by,0,0
234615,a,0,0
234616,fundamental,0,0
234617,disturbance,0,0
234618,in,0,0
234619,social,0,0
234620,interaction,0,0
234621,",",0,0
234622,impairments,0,0
234623,in,0,0
234624,communication,0,0
234625,",",0,0
234626,and,0,0
234627,a,0,0
234628,markedly,0,0
234629,restricted,0,0
234630,repertoire,0,0
234631,of,0,0
234632,activities,0,0
234633,and,0,0
234634,interests,0,0
234635,.,0,0
234636,Abnormalities,0,0
234637,in,0,0
234638,the,0,0
234639,serotonin,0,1
234640,neurotransmitter,0,0
234641,system,0,0
234642,have,0,0
234643,been,0,0
234644,identified,0,0
234645,in,0,0
234646,some,0,0
234647,persons,0,0
234648,with,0,0
234649,autism,0,0
234650,.,0,0
234651,No,0,0
234652,consistently,0,0
234653,effective,0,0
234654,and,0,0
234655,safe,0,0
234656,drugs,0,1
234657,have,0,0
234658,been,0,0
234659,developed,0,0
234660,for,0,0
234661,treating,0,0
234662,the,0,0
234663,symptoms,0,0
234664,of,0,0
234665,autism,0,0
234666,.,0,0
234667,METHODS,0,0
234668,Thirty,0,0
234669,adults,0,0
234670,with,0,0
234671,autistic,0,0
234672,disorder,0,0
234673,completed,0,0
234674,a,0,0
234675,12-week,0,0
234676,double-blind,0,0
234677,",",0,0
234678,placebo-controlled,1,1
234679,trial,0,0
234680,of,0,0
234681,the,0,0
234682,potent,0,0
234683,and,0,0
234684,selective,1,1
234685,serotonin,1,1
234686,uptake,1,0
234687,inhibitor,1,1
234688,fluvoxamine,1,1
234689,maleate,1,1
234690,.,1,0
234691,Behavioral,0,0
234692,ratings,0,0
234693,were,0,0
234694,obtained,0,0
234695,at,0,0
234696,baseline,0,0
234697,and,0,0
234698,after,0,0
234699,4,0,0
234700,",",0,0
234701,8,0,0
234702,",",0,0
234703,and,0,0
234704,12,0,0
234705,weeks,0,0
234706,of,0,0
234707,treatment,0,0
234708,.,0,0
234709,RESULTS,0,0
234710,Eight,0,0
234711,(,0,0
234712,53,0,0
234713,%,0,0
234714,),0,0
234715,of,0,0
234716,15,0,0
234717,patients,0,0
234718,in,0,0
234719,the,0,0
234720,fluvoxamine-treated,1,1
234721,group,0,0
234722,were,0,0
234723,categorized,0,0
234724,as,0,0
234725,responders,0,0
234726,compared,0,0
234727,with,0,0
234728,none,0,0
234729,of,0,0
234730,15,0,0
234731,in,0,0
234732,the,0,0
234733,placebo,1,1
234734,group,0,0
234735,(,0,0
234736,P,0,0
234737,=,0,0
234738,.001,0,0
234739,),0,0
234740,.,0,0
234741,Fluvoxamine,1,1
234742,was,0,0
234743,superior,0,0
234744,to,0,0
234745,placebo,1,1
234746,in,0,0
234747,reducing,0,0
234748,repetitive,0,1
234749,thoughts,0,0
234750,and,0,0
234751,behavior,0,0
234752,(,0,1
234753,P,0,0
234754,<,0,0
234755,.001,0,0
234756,),0,0
234757,",",0,0
234758,maladaptive,0,0
234759,behavior,0,0
234760,(,0,0
234761,P,0,0
234762,<,0,0
234763,.001,0,0
234764,),0,0
234765,",",0,0
234766,and,0,1
234767,aggression,0,0
234768,(,0,1
234769,P,0,0
234770,<,0,0
234771,.03,0,0
234772,),0,0
234773,",",0,0
234774,and,0,0
234775,in,0,0
234776,improving,0,0
234777,some,0,0
234778,aspects,0,0
234779,of,0,0
234780,social,0,1
234781,relatedness,0,0
234782,(,0,0
234783,P,0,0
234784,<,0,0
234785,.04,0,0
234786,),0,0
234787,",",0,0
234788,especially,0,0
234789,language,0,1
234790,usage,0,0
234791,(,0,0
234792,P,0,0
234793,<,0,0
234794,.008,0,0
234795,),0,0
234796,.,0,0
234797,Treatment,0,0
234798,response,0,0
234799,was,0,0
234800,not,0,0
234801,correlated,0,0
234802,with,0,0
234803,age,0,0
234804,level,0,0
234805,of,0,0
234806,autistic,0,0
234807,behavior,0,0
234808,",",0,0
234809,or,0,1
234810,full-scale,0,0
234811,IQ,0,0
234812,.,0,0
234813,Other,0,0
234814,than,0,0
234815,mild,0,0
234816,sedation,0,0
234817,and,0,0
234818,nausea,0,0
234819,in,0,0
234820,a,0,0
234821,few,0,0
234822,patients,0,0
234823,",",0,0
234824,fluvoxamine,1,1
234825,was,0,0
234826,well,0,0
234827,tolerated,0,0
234828,.,0,0
234829,No,0,0
234830,dyskinesias,0,0
234831,",",0,0
234832,adverse,0,0
234833,cardiovascular,0,0
234834,events,0,0
234835,",",0,0
234836,or,0,0
234837,seizures,0,0
234838,occurred,0,0
234839,.,0,0
234840,CONCLUSIONS,0,0
234841,Fluvoxamine,1,1
234842,is,0,0
234843,more,0,0
234844,effective,0,0
234845,than,0,0
234846,placebo,1,1
234847,in,0,0
234848,the,0,0
234849,short-term,0,0
234850,treatment,0,0
234851,of,0,0
234852,the,0,0
234853,symptoms,0,0
234854,of,0,0
234855,autistic,0,0
234856,disorder,0,0
234857,in,0,0
234858,adults,0,0
234859,.,0,0
234860,Controlled,0,0
234861,studies,0,0
234862,of,0,0
234863,fluvoxamine,1,1
234864,and,0,0
234865,other,0,0
234866,potent,0,0
234867,and,0,0
234868,selective,0,1
234869,serotonin,0,1
234870,uptake,0,0
234871,inhibitors,0,1
234872,seem,0,0
234873,warranted,0,0
234874,in,0,0
234875,children,0,0
234876,and,0,0
234877,adolescents,0,0
234878,with,0,0
234879,autism,0,0
234880,.,0,0
234881,Ranitidine,0,1
234882,improves,0,0
234883,lymphocyte,0,0
234884,function,0,0
234885,after,0,0
234886,severe,0,0
234887,head,0,0
234888,injury,0,0
234889,:,0,0
234890,results,0,0
234891,of,0,0
234892,a,0,0
234893,randomized,0,0
234894,",",0,0
234895,double-blind,0,0
234896,study,0,0
234897,.,0,0
234898,OBJECTIVE,0,0
234899,To,0,0
234900,study,0,0
234901,the,0,0
234902,immunomodulatory,0,1
234903,effect,0,0
234904,of,0,0
234905,the,0,0
234906,histamine,0,1
234907,receptor,0,0
234908,antagonist,0,1
234909,",",0,0
234910,ranitidine,0,1
234911,",",0,0
234912,in,0,0
234913,patients,0,0
234914,admitted,0,0
234915,to,0,0
234916,the,0,0
234917,intensive,0,1
234918,care,0,1
234919,unit,0,0
234920,after,0,0
234921,severe,0,0
234922,head,0,0
234923,injury,0,0
234924,.,0,0
234925,DESIGN,0,0
234926,Randomized,0,0
234927,",",0,0
234928,prospective,0,0
234929,",",0,0
234930,double-blind,0,0
234931,study,0,0
234932,.,0,0
234933,SETTING,0,0
234934,Surgical,0,1
234935,intensive,0,1
234936,care,0,1
234937,unit,0,0
234938,of,0,0
234939,a,0,0
234940,university,0,0
234941,Level,0,0
234942,I,0,0
234943,trauma,0,0
234944,center,0,0
234945,.,0,0
234946,PATIENTS,0,0
234947,Twenty,0,0
234948,patients,0,0
234949,admitted,0,0
234950,with,0,0
234951,a,0,0
234952,Glasgow,0,0
234953,Coma,0,0
234954,Scale,0,1
234955,score,0,0
234956,of,0,0
234957,<,0,0
234958,10,0,0
234959,who,0,0
234960,were,0,0
234961,enrolled,0,0
234962,as,0,0
234963,part,0,0
234964,of,0,0
234965,a,0,0
234966,prospective,0,0
234967,",",0,0
234968,multicenter,0,0
234969,trial,0,0
234970,to,0,0
234971,assess,0,0
234972,the,0,0
234973,impact,0,0
234974,of,0,0
234975,multiple,0,0
234976,risk,0,0
234977,factors,0,0
234978,and,0,0
234979,ranitidine,0,1
234980,prophylaxis,0,1
234981,on,0,0
234982,the,0,0
234983,development,0,0
234984,of,0,0
234985,stress-related,0,0
234986,upper,0,0
234987,gastrointestinal,0,0
234988,bleeding,0,0
234989,.,0,0
234990,INTERVENTIONS,0,0
234991,Continuous,1,1
234992,infusion,1,1
234993,of,1,0
234994,ranitidine,1,1
234995,at,1,0
234996,6.25,1,0
234997,mg/hr,1,1
234998,(,1,0
234999,n,1,0
235000,=,1,0
235001,9,1,0
235002,),1,0
235003,or,1,1
235004,placebo,1,1
235005,(,1,1
235006,n,1,0
235007,=,1,0
235008,11,1,0
235009,),1,0
235010,for,1,0
235011,a,1,0
235012,maximum,1,0
235013,of,1,0
235014,5,1,0
235015,days,1,0
235016,.,1,0
235017,MEASUREMENTS,0,0
235018,AND,0,0
235019,MAIN,0,1
235020,RESULTS,0,0
235021,Before,0,0
235022,the,0,0
235023,patients,0,0
235024,were,0,0
235025,enrolled,0,0
235026,in,0,0
235027,the,0,0
235028,study,0,0
235029,and,0,0
235030,on,0,0
235031,completion,0,0
235032,of,0,0
235033,treatment,0,0
235034,",",0,0
235035,lymphocyte,0,0
235036,cell-surface,0,0
235037,antigen,0,0
235038,expression,0,0
235039,was,0,0
235040,determined,0,0
235041,by,0,0
235042,flow,0,0
235043,cytometry,0,1
235044,(,0,0
235045,n,0,0
235046,=,0,0
235047,14,0,0
235048,patients,0,0
235049,),0,0
235050,;,0,0
235051,mitogen-stimulated,0,0
235052,interferon-gamma,0,1
235053,and,0,0
235054,interleukin-2,0,1
235055,production,0,0
235056,were,0,0
235057,measured,0,0
235058,by,0,0
235059,enzyme-linked,0,0
235060,immunosorbent,0,1
235061,assay,0,1
235062,(,0,0
235063,n,0,0
235064,=,0,0
235065,19,0,0
235066,patients,0,0
235067,),0,0
235068,.,0,0
235069,Treatment,0,0
235070,with,0,0
235071,ranitidine,1,1
235072,",",0,0
235073,but,0,0
235074,not,0,0
235075,placebo,1,1
235076,",",0,0
235077,was,0,0
235078,associated,0,0
235079,with,0,0
235080,a,0,0
235081,significant,0,0
235082,increase,0,0
235083,in,0,0
235084,CD4+,0,0
235085,lymphocytes,0,0
235086,(,0,0
235087,33,0,0
235088,%,0,0
235089,to,0,0
235090,49,0,0
235091,%,0,0
235092,;,0,0
235093,p,0,0
235094,<,0,0
235095,.05,0,0
235096,),0,1
235097,and,0,0
235098,a,0,0
235099,significant,0,0
235100,decrease,0,0
235101,in,0,0
235102,CD8+,0,0
235103,lymphocytes,0,0
235104,(,0,0
235105,41,0,0
235106,%,0,0
235107,to,0,0
235108,27,0,0
235109,%,0,0
235110,;,0,0
235111,p,0,0
235112,<,0,0
235113,.05,0,0
235114,),0,0
235115,.,0,0
235116,Also,0,0
235117,",",0,0
235118,the,0,0
235119,mitogen-stimulated,0,0
235120,interferon-gamma,0,1
235121,production,0,0
235122,increased,0,0
235123,from,0,0
235124,121,0,0
235125,to,0,0
235126,269,0,0
235127,pg/mL,0,0
235128,(,0,0
235129,p,0,0
235130,<,0,0
235131,.05,0,0
235132,),0,0
235133,in,0,0
235134,patients,0,0
235135,treated,0,0
235136,with,0,0
235137,ranitidine,1,1
235138,",",0,0
235139,but,0,0
235140,not,0,0
235141,in,0,0
235142,patients,0,0
235143,treated,0,0
235144,with,0,0
235145,placebo,1,1
235146,.,1,0
235147,There,0,0
235148,were,0,0
235149,no,0,0
235150,significant,0,0
235151,differences,0,0
235152,in,0,0
235153,interleukin-2,0,1
235154,production,0,0
235155,or,0,1
235156,circulating,0,0
235157,B-cell,0,0
235158,concentrations,0,0
235159,between,0,0
235160,both,0,0
235161,groups,0,0
235162,.,0,0
235163,CONCLUSION,0,0
235164,This,0,0
235165,study,0,0
235166,demonstrates,0,0
235167,an,0,0
235168,immunostimulatory,0,1
235169,effect,0,0
235170,of,0,0
235171,the,0,0
235172,histamine-2-receptor,0,1
235173,antagonist,0,1
235174,",",0,0
235175,ranitidine,0,1
235176,",",0,0
235177,both,0,0
235178,at,0,0
235179,the,0,0
235180,cellular,0,0
235181,and,0,0
235182,mediator,0,0
235183,levels,0,0
235184,in,0,0
235185,patients,0,0
235186,after,0,0
235187,head,0,0
235188,injury,0,0
235189,.,0,0
235190,Age,0,1
235191,and,0,0
235192,autonomic,0,0
235193,effects,0,0
235194,on,0,0
235195,interrelationships,0,0
235196,between,0,0
235197,lung,0,0
235198,volume,0,0
235199,and,0,0
235200,heart,0,0
235201,rate,0,0
235202,.,0,0
235203,To,0,0
235204,determine,0,0
235205,effects,0,0
235206,of,0,0
235207,aging,0,0
235208,and,0,0
235209,autonomic,0,0
235210,input,0,1
235211,on,0,0
235212,interrelationships,0,0
235213,between,0,0
235214,respiratory,0,0
235215,and,0,0
235216,heart,0,0
235217,rate,0,0
235218,variability,0,0
235219,",",0,0
235220,we,0,0
235221,collected,0,0
235222,5,0,0
235223,min,0,0
235224,of,0,0
235225,lung,0,0
235226,volume,0,0
235227,of,0,0
235228,R-R,0,0
235229,interval,0,0
235230,data,0,0
235231,from,0,0
235232,7,0,0
235233,young,0,0
235234,[,0,0
235235,27,0,0
235236,+/-,0,0
235237,3,0,0
235238,(,0,0
235239,SD,0,0
235240,),0,1
235241,yr,0,0
235242,],0,1
235243,and,0,0
235244,10,0,0
235245,older,0,0
235246,(,0,0
235247,69,0,0
235248,+/-,0,0
235249,6,0,0
235250,yr,0,0
235251,),0,0
235252,healthy,0,0
235253,supine,0,0
235254,humans,0,0
235255,before,0,0
235256,and,0,0
235257,after,0,0
235258,double,0,1
235259,pharmacological,0,0
235260,autonomic,0,0
235261,blockade,0,1
235262,with,0,1
235263,propranolol,1,1
235264,(,0,0
235265,0.2,0,1
235266,mg/kg,0,1
235267,iv,0,0
235268,),0,1
235269,and,0,1
235270,atropine,1,1
235271,(,0,0
235272,0.04,0,0
235273,mg/kg,0,1
235274,iv,0,0
235275,),0,0
235276,.,0,0
235277,Estimates,0,0
235278,of,0,0
235279,respiratory,0,0
235280,and,0,0
235281,heart,0,0
235282,rate,0,0
235283,power,0,0
235284,spectra,0,0
235285,and,0,0
235286,linear,0,0
235287,transfer,0,0
235288,functions,0,0
235289,between,0,0
235290,the,0,0
235291,two,0,0
235292,groups,0,0
235293,were,0,0
235294,generated,0,0
235295,by,0,0
235296,Fourier,0,1
235297,analysis,0,0
235298,.,0,0
235299,Age,0,0
235300,",",0,0
235301,double,0,1
235302,blockade,0,0
235303,effects,0,0
235304,",",0,0
235305,the,0,0
235306,age-drug,0,1
235307,interactions,0,0
235308,were,0,0
235309,determined,0,0
235310,by,0,0
235311,analysis,0,0
235312,of,0,0
235313,variance,0,0
235314,for,0,0
235315,repeated,0,0
235316,measures,0,0
235317,.,0,0
235318,Basal,0,0
235319,R-R,0,0
235320,intervals,0,0
235321,were,0,0
235322,unaffected,0,0
235323,by,0,0
235324,age,0,0
235325,.,0,0
235326,Double,0,0
235327,blockade,0,0
235328,decreased,0,0
235329,R-R,0,0
235330,intervals,0,0
235331,and,0,0
235332,variability,0,0
235333,in,0,0
235334,both,0,0
235335,age,0,0
235336,groups,0,0
235337,(,0,0
235338,P,0,0
235339,<,0,0
235340,0.0001,0,0
235341,),0,0
235342,",",0,0
235343,but,0,0
235344,R-R,0,0
235345,intervals,0,0
235346,decreased,0,0
235347,less,0,0
235348,in,0,0
235349,older,0,0
235350,than,0,0
235351,in,0,0
235352,young,0,0
235353,subjects,0,0
235354,(,0,0
235355,P,0,0
235356,<,0,0
235357,0.0001,0,0
235358,),0,0
235359,.,0,0
235360,In,0,0
235361,contrast,0,0
235362,",",0,0
235363,basal,0,0
235364,respiratory,0,0
235365,intervals,0,0
235366,and,0,0
235367,standard,0,1
235368,deviation,0,0
235369,were,0,0
235370,greater,0,0
235371,in,0,0
235372,older,0,0
235373,subjects,0,0
235374,(,0,0
235375,P,0,0
235376,=,0,0
235377,0.05,0,0
235378,),0,0
235379,and,0,0
235380,were,0,0
235381,unaffected,0,0
235382,by,0,0
235383,double,0,1
235384,blockade,0,0
235385,in,0,0
235386,young,0,0
235387,and,0,0
235388,older,0,0
235389,subjects,0,0
235390,.,0,0
235391,Lung,0,0
235392,volume-to-heart,0,0
235393,rate,0,0
235394,spectral,0,0
235395,coherence,0,0
235396,was,0,0
235397,highest,0,0
235398,at,0,0
235399,frequencies,0,0
235400,associated,0,0
235401,with,0,0
235402,respiration,0,0
235403,and,0,0
235404,greater,0,0
235405,in,0,0
235406,young,0,0
235407,than,0,0
235408,in,0,0
235409,older,0,0
235410,subjects,0,0
235411,(,0,0
235412,P,0,0
235413,<,0,0
235414,0.07,0,0
235415,),0,0
235416,.,0,0
235417,Double,0,0
235418,blockade,0,0
235419,decreased,0,0
235420,lung,0,0
235421,volume-to-heart,0,0
235422,rate,0,0
235423,variability,0,0
235424,transfer,0,1
235425,function,0,0
235426,magnitude,0,0
235427,(,0,0
235428,P,0,0
235429,<,0,0
235430,0.007,0,0
235431,),0,0
235432,and,0,0
235433,increased,0,0
235434,phase,0,1
235435,angle,0,0
235436,(,0,0
235437,P,0,0
235438,<,0,0
235439,0.02,0,0
235440,),0,0
235441,without,0,0
235442,age,0,0
235443,effects,0,0
235444,or,0,0
235445,age-drug,0,1
235446,interactions,0,0
235447,.,0,0
235448,In,0,0
235449,conclusion,0,0
235450,",",0,0
235451,heart,0,0
235452,rate,0,0
235453,",",0,0
235454,respiration,0,1
235455,",",0,0
235456,and,0,0
235457,respiration-heart,0,1
235458,rate,0,0
235459,interrelations,0,0
235460,are,0,0
235461,altered,0,0
235462,by,0,0
235463,aging,0,0
235464,",",0,0
235465,and,0,0
235466,double,0,1
235467,autonomic,0,0
235468,pharmacological,0,0
235469,blockade,0,1
235470,does,0,0
235471,not,0,0
235472,eliminate,0,0
235473,all,0,0
235474,age-related,0,0
235475,differences,0,0
235476,.,0,0
235477,A,0,0
235478,randomised,0,0
235479,open,0,1
235480,multicentre,0,0
235481,comparative,0,0
235482,trial,0,0
235483,of,0,0
235484,lamotrigine,1,1
235485,and,1,0
235486,carbamazepine,1,1
235487,as,0,0
235488,monotherapy,0,1
235489,in,0,0
235490,patients,0,0
235491,with,0,0
235492,newly,0,0
235493,diagnosed,0,0
235494,or,0,1
235495,recurrent,0,0
235496,epilepsy,0,0
235497,.,0,0
235498,The,0,0
235499,efficacy,0,0
235500,and,0,0
235501,safety,0,0
235502,of,0,0
235503,lamotrigine,1,1
235504,and,1,0
235505,carbamazepine,1,1
235506,as,0,0
235507,monotherapy,0,1
235508,in,0,0
235509,patients,0,0
235510,with,0,0
235511,untreated,0,0
235512,",",0,0
235513,newly,0,0
235514,diagnosed,0,0
235515,or,0,1
235516,recurrent,0,0
235517,partial,0,0
235518,and/or,0,0
235519,generalised,0,0
235520,tonic-clonic,0,0
235521,seizures,0,0
235522,",",0,0
235523,were,0,0
235524,compared,0,0
235525,in,0,0
235526,a,0,0
235527,randomised,0,0
235528,",",0,0
235529,open,0,1
235530,",",0,0
235531,multicentre,0,0
235532,study,0,0
235533,.,0,0
235534,Patients,0,0
235535,received,0,0
235536,24,0,0
235537,weeks,0,0
235538,',0,0
235539,treatment,0,0
235540,with,0,0
235541,oral,1,1
235542,lamotrigine,1,1
235543,100,1,1
235544,mg,1,1
235545,(,1,0
235546,LTG,1,1
235547,100,1,0
235548,",",1,0
235549,n,1,0
235550,=,1,0
235551,115,1,0
235552,),1,0
235553,or,1,1
235554,200,1,1
235555,mg,1,1
235556,(,1,0
235557,LTG,1,1
235558,200,1,1
235559,",",1,0
235560,n,1,0
235561,=,1,0
235562,111,1,0
235563,),1,0
235564,or,1,0
235565,carbamazepine,1,1
235566,600,1,1
235567,mg,1,1
235568,(,1,0
235569,CBZ,1,1
235570,600,0,1
235571,",",0,0
235572,n,0,0
235573,=,0,0
235574,117,0,0
235575,),0,0
235576,.,0,0
235577,Efficacy,0,0
235578,measurements,0,0
235579,were,0,0
235580,comparable,0,0
235581,between,0,0
235582,the,0,0
235583,three,0,0
235584,treatment,0,0
235585,groups,0,0
235586,",",0,0
235587,although,0,0
235588,the,0,0
235589,higher,0,0
235590,lamotrigine,1,1
235591,dose,0,0
235592,was,0,0
235593,possibly,0,0
235594,most,0,0
235595,effective,0,0
235596,",",0,0
235597,with,0,0
235598,60.4,0,0
235599,%,0,0
235600,completing,0,0
235601,seizure,0,0
235602,free,0,0
235603,compared,0,0
235604,with,0,0
235605,51.3,0,0
235606,%,0,0
235607,(,0,0
235608,LTG,0,1
235609,100,0,1
235610,),0,0
235611,and,0,0
235612,54.7,0,0
235613,%,0,0
235614,(,0,0
235615,CBZ,0,1
235616,600,0,1
235617,),0,0
235618,.,0,0
235619,Both,0,1
235620,dosage,0,0
235621,regimens,0,1
235622,of,0,0
235623,lamotrigine,1,1
235624,were,0,0
235625,well,0,0
235626,tolerated,0,0
235627,.,0,0
235628,More,0,0
235629,patients,0,0
235630,on,0,0
235631,CBZ,1,1
235632,600,0,0
235633,reported,0,0
235634,adverse,0,0
235635,experiences,0,0
235636,",",0,0
235637,66,0,0
235638,%,0,0
235639,versus,0,1
235640,53,0,0
235641,%,0,0
235642,(,1,0
235643,LTG,1,1
235644,100,0,1
235645,),0,0
235646,and,0,0
235647,58,0,0
235648,%,0,0
235649,(,1,0
235650,LTG,1,1
235651,200,0,1
235652,),0,0
235653,",",0,0
235654,and,0,0
235655,of,0,0
235656,these,0,0
235657,a,0,0
235658,greater,0,0
235659,proportion,0,0
235660,were,0,0
235661,attributed,0,0
235662,to,0,0
235663,CBZ,1,1
235664,600,0,1
235665,treatment,0,0
235666,",",0,0
235667,53,0,0
235668,%,0,0
235669,versus,0,1
235670,23,0,0
235671,%,0,0
235672,(,0,0
235673,LTG,0,1
235674,100,0,1
235675,),0,0
235676,and,0,0
235677,28,0,1
235678,%,0,0
235679,(,0,0
235680,LTG,0,1
235681,200,0,1
235682,),0,0
235683,.,0,0
235684,Similarly,0,0
235685,",",0,0
235686,a,0,0
235687,greater,0,0
235688,proportion,0,0
235689,of,0,0
235690,the,0,0
235691,CBZ,1,1
235692,600,0,1
235693,group,0,0
235694,required,0,0
235695,a,0,0
235696,change,0,0
235697,in,0,0
235698,dose,0,0
235699,",",0,0
235700,47,0,0
235701,%,0,0
235702,versus,0,1
235703,20,0,1
235704,%,0,0
235705,(,1,0
235706,LTG,1,1
235707,100,0,1
235708,),0,0
235709,and,0,0
235710,17,0,0
235711,%,0,0
235712,(,1,0
235713,LTG,1,1
235714,200,0,1
235715,),0,0
235716,or,0,0
235717,withdrew,0,0
235718,completely,0,0
235719,due,0,0
235720,to,0,0
235721,adverse,0,0
235722,experiences,0,0
235723,",",0,0
235724,10.3,0,0
235725,%,0,0
235726,versus,0,1
235727,4.3,0,0
235728,%,0,0
235729,(,1,0
235730,LTG,1,1
235731,100,0,1
235732,),0,0
235733,and,0,0
235734,4.5,0,1
235735,%,0,0
235736,(,1,0
235737,LTG,1,1
235738,200,0,1
235739,),0,0
235740,.,0,0
235741,The,0,0
235742,most,0,0
235743,common,0,0
235744,adverse,0,0
235745,experience,0,0
235746,leading,0,0
235747,to,0,0
235748,withdrawal,0,0
235749,was,0,0
235750,rash,0,0
235751,",",0,0
235752,with,0,0
235753,approximately,0,0
235754,double,0,1
235755,the,0,0
235756,proportion,0,0
235757,of,0,0
235758,reports,0,0
235759,occurring,0,0
235760,in,0,0
235761,patients,0,0
235762,on,0,0
235763,CBZ,1,1
235764,600,0,1
235765,(,0,0
235766,5.1,0,0
235767,%,0,0
235768,),0,0
235769,compared,0,0
235770,with,0,0
235771,lamotrigine,1,1
235772,(,0,0
235773,1.7,0,0
235774,%,0,0
235775,on,0,0
235776,LTG,1,0
235777,100,0,0
235778,and,0,0
235779,2.7,0,0
235780,%,0,0
235781,on,0,0
235782,LTG,1,1
235783,200,0,1
235784,),0,0
235785,.,0,0
235786,Overall,0,0
235787,lamotrigine,1,1
235788,appeared,0,0
235789,equally,0,0
235790,effective,0,0
235791,but,0,0
235792,better,0,0
235793,tolerated,0,0
235794,compared,0,0
235795,with,0,0
235796,carbamazepine,1,1
235797,.,1,0
235798,Effects,0,0
235799,of,0,0
235800,fenoterol,1,1
235801,on,0,0
235802,inspiratory,0,1
235803,effort,0,0
235804,sensation,0,0
235805,and,0,0
235806,fatigue,0,0
235807,during,0,0
235808,inspiratory,0,0
235809,threshold,0,0
235810,loading,0,0
235811,.,0,0
235812,We,0,0
235813,studied,0,0
235814,the,0,0
235815,effects,0,0
235816,of,0,0
235817,a,0,0
235818,single,0,0
235819,dose,0,0
235820,of,0,0
235821,fenoterol,1,1
235822,on,0,0
235823,the,0,0
235824,relationship,0,0
235825,between,0,0
235826,inspiratory,0,1
235827,effort,0,0
235828,sensation,0,0
235829,(,0,1
235830,IES,0,0
235831,),0,1
235832,and,0,0
235833,inspiratory,0,1
235834,muscle,0,1
235835,fatigue,0,0
235836,induced,0,0
235837,by,0,0
235838,inspiratory,0,1
235839,threshold,0,0
235840,loading,0,1
235841,in,0,0
235842,healthy,0,0
235843,subjects,0,0
235844,.,0,0
235845,The,0,0
235846,magnitude,0,0
235847,of,0,0
235848,the,0,0
235849,threshold,0,0
235850,was,0,0
235851,60,0,0
235852,%,0,0
235853,of,0,0
235854,maximal,0,0
235855,static,0,1
235856,inspiratory,0,1
235857,mouth,0,1
235858,pressure,0,0
235859,(,0,0
235860,PI,0,1
235861,",",0,1
235862,mmax,0,0
235863,),0,0
235864,at,0,0
235865,functional,0,0
235866,residual,0,0
235867,capacity,0,0
235868,",",0,0
235869,and,0,0
235870,the,0,0
235871,duty,0,1
235872,cycle,0,0
235873,was,0,0
235874,0.5,0,0
235875,.,0,0
235876,Subjects,0,0
235877,continued,0,0
235878,the,0,0
235879,threshold,0,0
235880,loaded,0,0
235881,breathing,0,1
235882,until,0,0
235883,the,0,0
235884,target,0,0
235885,mouth,0,0
235886,pressure,0,0
235887,could,0,0
235888,no,0,0
235889,longer,0,0
235890,be,0,0
235891,maintained,0,0
235892,(,0,0
235893,endurance,0,1
235894,time,0,0
235895,),0,0
235896,.,0,0
235897,The,0,0
235898,intensity,0,0
235899,of,0,0
235900,the,0,0
235901,IES,0,0
235902,was,0,0
235903,scored,0,0
235904,with,0,0
235905,a,0,0
235906,modified,0,0
235907,Borg,0,1
235908,scale,0,0
235909,.,0,0
235910,Either,0,0
235911,fenoterol,1,1
235912,(,1,1
235913,5,1,1
235914,mg,1,1
235915,),1,0
235916,or,1,1
235917,a,1,0
235918,placebo,1,1
235919,was,0,0
235920,given,0,0
235921,orally,0,1
235922,2,0,0
235923,h,0,0
235924,before,0,0
235925,loading,0,0
235926,in,0,0
235927,a,0,0
235928,randomized,0,0
235929,double-blind,0,0
235930,crossover,0,0
235931,protocol,0,0
235932,.,0,0
235933,The,0,0
235934,endurance,0,0
235935,time,0,0
235936,with,0,1
235937,fenoterol,0,1
235938,(,0,0
235939,34.4,0,0
235940,+/-,0,0
235941,8.6,0,0
235942,min,0,0
235943,),0,0
235944,was,0,0
235945,longer,0,0
235946,than,0,0
235947,that,0,0
235948,with,0,0
235949,the,0,0
235950,placebo,0,1
235951,(,0,0
235952,22.2,0,0
235953,+/-,0,0
235954,7.1,0,0
235955,min,0,0
235956,;,0,0
235957,P,0,0
235958,<,0,0
235959,0.05,0,0
235960,),0,0
235961,.,0,0
235962,The,0,0
235963,ratio,0,0
235964,of,0,0
235965,high-,0,0
235966,to,0,0
235967,low-frequency,0,1
235968,power,0,0
235969,of,0,0
235970,the,0,0
235971,diaphragmatic,0,1
235972,electromyogram,0,0
235973,(,0,1
235974,EMGdi,0,1
235975,),0,1
235976,decreased,0,0
235977,during,0,0
235978,loading,0,0
235979,;,0,0
235980,the,0,0
235981,decrease,0,0
235982,was,0,0
235983,less,0,0
235984,with,0,0
235985,fenoterol,1,1
235986,(,0,0
235987,P,0,0
235988,<,0,0
235989,0.05,0,0
235990,),0,0
235991,.,0,0
235992,The,0,0
235993,EMGdi,0,0
235994,also,0,0
235995,decreased,0,0
235996,with,0,0
235997,loading,0,0
235998,;,0,0
235999,the,0,0
236000,decrease,0,0
236001,was,0,0
236002,greater,0,0
236003,on,0,0
236004,fenoterol,0,1
236005,treatment,0,1
236006,(,0,0
236007,P,0,0
236008,<,0,0
236009,0.01,0,0
236010,),0,0
236011,.,0,0
236012,The,0,0
236013,PI,0,1
236014,",",0,0
236015,mmax,0,0
236016,and,0,0
236017,maximal,0,0
236018,transdiaphragmatic,0,1
236019,pressure,0,0
236020,(,0,1
236021,Pdi,0,0
236022,),0,1
236023,were,0,0
236024,similarly,0,0
236025,decreased,0,0
236026,after,0,0
236027,loading,0,0
236028,on,0,0
236029,either,0,1
236030,treatment,0,0
236031,.,0,0
236032,The,0,0
236033,intensity,0,0
236034,of,0,0
236035,the,0,0
236036,IES,0,0
236037,rose,0,0
236038,with,0,0
236039,time,0,0
236040,during,0,0
236041,loading,0,0
236042,in,0,0
236043,both,0,0
236044,groups,0,0
236045,but,0,0
236046,was,0,0
236047,lower,0,0
236048,with,0,0
236049,fenoterol,1,1
236050,than,0,0
236051,with,0,0
236052,the,0,0
236053,placebo,0,1
236054,(,0,0
236055,P,0,0
236056,<,0,0
236057,0.05,0,0
236058,),0,0
236059,.,0,0
236060,The,0,0
236061,ratio,0,0
236062,of,0,0
236063,Pdi,0,0
236064,to,0,0
236065,integrated,0,1
236066,activity,0,0
236067,of,0,0
236068,the,0,0
236069,EMGdi,0,1
236070,increased,0,0
236071,with,0,0
236072,fenoterol,0,1
236073,(,0,0
236074,P,0,0
236075,<,0,0
236076,0.05,0,0
236077,),0,0
236078,.,0,0
236079,Fenoterol,0,1
236080,treatment,0,0
236081,increased,0,0
236082,both,0,0
236083,superimposed,0,0
236084,Pdi,0,0
236085,twitch,0,1
236086,and,0,0
236087,Pdi,0,0
236088,twitch,0,1
236089,of,0,0
236090,relaxed,0,1
236091,diaphragm,0,1
236092,and,0,0
236093,decreased,0,0
236094,the,0,0
236095,value,0,0
236096,of,0,0
236097,(,0,0
236098,1-superimposed,0,0
236099,Pdi,0,1
236100,twitch/Pdi,0,1
236101,twitch,0,1
236102,of,0,0
236103,relaxed,0,1
236104,diaphragm,0,1
236105,),0,0
236106,.,0,0
236107,Thus,0,0
236108,we,0,0
236109,conclude,0,0
236110,that,0,0
236111,in,0,0
236112,normal,0,0
236113,subjects,0,0
236114,fenoterol,0,1
236115,reduces,0,0
236116,diaphragmatic,0,1
236117,fatigue,0,0
236118,and,0,0
236119,decreases,0,0
236120,the,0,0
236121,motor,0,0
236122,command,0,0
236123,to,0,0
236124,the,0,0
236125,diaphragm,0,1
236126,",",0,0
236127,resulting,0,0
236128,in,0,0
236129,a,0,0
236130,decrease,0,0
236131,in,0,0
236132,IES,0,0
236133,during,0,0
236134,inspiratory,0,0
236135,threshold,0,0
236136,loading,0,1
236137,and,0,0
236138,a,0,0
236139,prolongation,0,0
236140,of,0,0
236141,endurance,0,0
236142,.,0,0
236143,Pedantic,1,1
236144,speaking,1,0
236145,style,0,1
236146,differentiates,0,0
236147,Asperger,0,0
236148,syndrome,0,0
236149,from,0,0
236150,high-functioning,0,0
236151,autism,0,0
236152,.,0,0
236153,Asperger,0,0
236154,syndrome,0,0
236155,(,0,1
236156,AS,0,1
236157,),0,1
236158,is,0,0
236159,a,0,0
236160,pervasive,0,0
236161,developmental,0,0
236162,disorder,0,0
236163,recently,0,0
236164,introduced,0,0
236165,as,0,0
236166,a,0,0
236167,new,0,0
236168,diagnostic,0,0
236169,category,0,0
236170,in,0,0
236171,the,0,0
236172,ICD-10,0,1
236173,and,0,0
236174,the,0,0
236175,DSM-IV,0,0
236176,.,0,0
236177,Along,0,0
236178,with,0,0
236179,motor,0,0
236180,clumsiness,0,0
236181,",",0,0
236182,pedantic,1,1
236183,speech,1,1
236184,has,0,0
236185,been,0,0
236186,proposed,0,0
236187,as,0,0
236188,a,0,0
236189,clinical,0,0
236190,feature,0,0
236191,of,0,0
236192,AS,0,0
236193,.,0,0
236194,However,0,0
236195,",",0,0
236196,few,0,0
236197,attempts,0,0
236198,have,0,0
236199,been,0,0
236200,made,0,0
236201,to,0,0
236202,define,0,0
236203,and,0,0
236204,measure,0,0
236205,this,0,0
236206,symptom,0,0
236207,.,0,0
236208,We,0,0
236209,studied,0,0
236210,17,0,0
236211,patients,0,0
236212,with,0,0
236213,AS,0,0
236214,(,0,0
236215,ICD-10,0,1
236216,;,0,0
236217,14,0,0
236218,male,0,0
236219,",",0,0
236220,3,0,0
236221,female,0,0
236222,;,0,0
236223,mean,0,0
236224,age,0,0
236225,16.4,0,0
236226,years,0,0
236227,",",0,0
236228,mean,0,0
236229,full-scale,0,0
236230,IQ,0,0
236231,97,0,0
236232,),0,0
236233,and,0,0
236234,compared,0,0
236235,them,0,0
236236,with,0,0
236237,a,0,0
236238,control,0,1
236239,group,0,0
236240,of,0,0
236241,13,0,0
236242,patients,0,0
236243,with,0,0
236244,normal-intelligence,0,1
236245,autism,0,0
236246,or,0,1
236247,high-functioning,0,1
236248,autism,0,0
236249,(,0,1
236250,HFA,0,1
236251,),0,1
236252,(,0,0
236253,ICD-10/DSM-III-R,0,1
236254,;,0,0
236255,12,0,0
236256,male,0,0
236257,",",0,0
236258,1,0,0
236259,female,0,0
236260,;,0,0
236261,mean,0,0
236262,age,0,0
236263,15.5,0,0
236264,years,0,0
236265,",",0,0
236266,mean,0,0
236267,full-scale,0,0
236268,IQ,0,0
236269,81.2,0,0
236270,),0,0
236271,.,0,0
236272,An,0,0
236273,operational,0,0
236274,definition,0,0
236275,of,0,0
236276,pedantic,0,1
236277,speech,0,1
236278,was,0,0
236279,formulated,0,0
236280,and,0,0
236281,a,0,0
236282,rating,0,0
236283,scale,0,0
236284,devised,0,0
236285,.,0,0
236286,13,0,0
236287,(,0,0
236288,76,0,0
236289,%,0,0
236290,),0,0
236291,of,0,0
236292,the,0,0
236293,AS,0,0
236294,patients,0,0
236295,were,0,0
236296,rated,0,0
236297,as,0,0
236298,pedantic,1,1
236299,compared,0,0
236300,to,0,0
236301,4,0,0
236302,(,0,0
236303,31,0,0
236304,%,0,0
236305,),0,0
236306,of,0,0
236307,the,0,0
236308,HFA,0,1
236309,group,0,1
236310,(,0,0
236311,chi,0,0
236312,2,0,0
236313,=,0,0
236314,6.3,0,0
236315,;,0,0
236316,p,0,0
236317,=,0,0
236318,.01,0,0
236319,),0,0
236320,.,0,0
236321,Results,0,0
236322,suggest,0,0
236323,that,0,0
236324,pedantic,1,1
236325,speech,1,1
236326,is,0,0
236327,common,0,0
236328,in,0,0
236329,AS,0,0
236330,and,0,0
236331,may,0,0
236332,help,0,0
236333,differentiate,0,0
236334,AS,0,0
236335,from,0,0
236336,high-functioning,0,0
236337,autism,0,0
236338,.,0,0
236339,Feasibility,0,0
236340,and,0,0
236341,effects,0,0
236342,of,0,0
236343,nurse,1,1
236344,run,1,0
236345,clinics,1,0
236346,for,0,0
236347,patients,0,0
236348,with,0,0
236349,epilepsy,0,0
236350,in,0,0
236351,general,0,0
236352,practice,0,0
236353,:,0,0
236354,randomised,0,0
236355,controlled,0,0
236356,trial,0,0
236357,.,0,0
236358,Epilepsy,0,0
236359,Care,0,0
236360,Evaluation,0,1
236361,Group,0,0
236362,.,0,0
236363,OBJECTIVE,0,0
236364,To,0,0
236365,test,0,0
236366,the,0,0
236367,feasibility,0,0
236368,and,0,0
236369,effect,0,0
236370,of,0,0
236371,nurse,1,1
236372,run,1,1
236373,epilepsy,1,0
236374,clinics,1,0
236375,in,0,0
236376,primary,0,0
236377,care,0,1
236378,.,0,0
236379,DESIGN,0,0
236380,A,0,0
236381,randomised,0,0
236382,controlled,0,0
236383,trial,0,0
236384,of,0,0
236385,nurse,1,1
236386,run,1,0
236387,clinics,1,0
236388,versus,0,0
236389,usual,1,1
236390,care,1,1
236391,.,1,0
236392,SETTING,0,0
236393,Six,0,0
236394,general,0,0
236395,practices,0,0
236396,in,0,0
236397,the,0,0
236398,South,0,0
236399,Thames,0,0
236400,region,0,0
236401,.,0,0
236402,SUBJECTS,0,0
236403,251,0,0
236404,patients,0,0
236405,aged,0,0
236406,over,0,0
236407,15,0,0
236408,years,0,0
236409,who,0,0
236410,were,0,0
236411,taking,0,0
236412,anti-epileptic,0,1
236413,drugs,0,1
236414,or,0,0
236415,had,0,0
236416,a,0,0
236417,diagnosis,0,0
236418,of,0,0
236419,epilepsy,0,0
236420,and,0,0
236421,an,0,0
236422,attack,0,0
236423,in,0,0
236424,the,0,0
236425,past,0,0
236426,two,0,0
236427,years,0,0
236428,who,0,0
236429,met,0,0
236430,specified,0,0
236431,inclusion,0,0
236432,criteria,0,0
236433,and,0,0
236434,had,0,0
236435,responded,0,0
236436,to,0,0
236437,a,0,0
236438,questionnaire,0,0
236439,.,0,0
236440,MAIN,0,0
236441,OUTCOME,0,0
236442,MEASURES,0,0
236443,Questionnaire,1,1
236444,responses,1,0
236445,and,0,0
236446,recording,0,0
236447,of,0,0
236448,key,0,0
236449,variables,0,0
236450,extracted,0,0
236451,from,0,0
236452,the,0,0
236453,clinical,0,0
236454,records,0,0
236455,before,0,0
236456,and,0,0
236457,after,0,0
236458,the,0,0
236459,intervention,0,1
236460,.,0,0
236461,RESULTS,0,0
236462,127,0,0
236463,patients,0,0
236464,were,0,0
236465,randomised,0,0
236466,to,0,0
236467,a,0,0
236468,nurse,0,1
236469,run,0,0
236470,clinic,0,0
236471,",",0,0
236472,of,0,0
236473,whom,0,0
236474,106,0,0
236475,(,0,0
236476,83,0,0
236477,%,0,0
236478,),0,0
236479,attended,0,0
236480,.,0,0
236481,The,0,0
236482,nurse,0,0
236483,wrote,0,0
236484,28,0,0
236485,letters,0,0
236486,to,0,0
236487,the,0,0
236488,general,0,0
236489,practitioners,0,0
236490,suggesting,0,0
236491,changes,1,0
236492,in,1,0
236493,epilepsy,1,0
236494,management,1,1
236495,.,1,0
236496,For,0,0
236497,this,0,0
236498,intervention,0,1
236499,group,0,0
236500,compared,0,0
236501,with,0,0
236502,the,0,0
236503,usual,1,1
236504,care,1,1
236505,group,0,0
236506,there,0,0
236507,was,0,0
236508,a,0,0
236509,highly,0,0
236510,significant,0,0
236511,improvement,0,0
236512,in,0,0
236513,the,0,0
236514,level,0,0
236515,of,0,0
236516,advice,0,1
236517,recorded,0,0
236518,as,0,0
236519,having,0,0
236520,been,0,0
236521,given,0,0
236522,on,0,0
236523,drug,0,1
236524,compliance,0,0
236525,",",0,0
236526,adverse,0,0
236527,drug,0,1
236528,effects,0,0
236529,",",0,0
236530,driving,0,0
236531,",",0,0
236532,alcohol,0,1
236533,intake,0,0
236534,",",0,0
236535,and,0,0
236536,self,0,1
236537,help,0,0
236538,groups,0,0
236539,.,0,0
236540,CONCLUSIONS,0,0
236541,Nurse,1,0
236542,run,1,0
236543,clinics,1,0
236544,for,0,0
236545,patients,0,0
236546,with,0,0
236547,epilepsy,0,0
236548,were,0,0
236549,feasible,0,0
236550,and,0,0
236551,well,0,0
236552,attended,0,0
236553,.,0,0
236554,Such,0,0
236555,clinics,0,0
236556,can,0,0
236557,significantly,0,0
236558,improve,0,0
236559,the,0,0
236560,level,0,0
236561,of,0,0
236562,advice,0,1
236563,and,0,0
236564,drug,0,1
236565,management,0,1
236566,recorded,0,0
236567,.,0,0
236568,Vitrectomy,0,1
236569,with,0,0
236570,silicone,1,1
236571,oil,1,1
236572,or,0,1
236573,long-acting,1,1
236574,gas,1,1
236575,in,0,0
236576,eyes,0,0
236577,with,0,0
236578,severe,0,0
236579,proliferative,0,0
236580,vitreoretinopathy,0,0
236581,:,0,0
236582,results,0,0
236583,of,0,0
236584,additional,0,0
236585,and,0,0
236586,long-term,0,0
236587,follow-up,0,0
236588,.,0,0
236589,Silicone,0,1
236590,Study,0,0
236591,report,0,0
236592,11,0,0
236593,.,0,0
236594,BACKGROUND,0,0
236595,The,0,0
236596,Silicone,0,1
236597,Study,0,0
236598,evaluated,0,0
236599,the,0,0
236600,outcomes,0,0
236601,of,0,0
236602,vitreoretinal,0,0
236603,surgery,0,1
236604,for,0,0
236605,retinal,0,0
236606,detachment,0,0
236607,with,0,0
236608,proliferative,0,0
236609,vitreoretinopathy,0,1
236610,(,0,1
236611,PVR,0,1
236612,),0,0
236613,.,0,0
236614,OBJECTIVE,0,0
236615,To,0,0
236616,evaluate,0,0
236617,short-term,0,0
236618,(,0,0
236619,up,0,0
236620,to,0,0
236621,36,0,0
236622,months,0,0
236623,),0,0
236624,outcomes,0,0
236625,in,0,0
236626,eyes,0,0
236627,randomized,0,0
236628,to,0,0
236629,silicone,1,1
236630,oil,1,1
236631,or,0,1
236632,perfluoropropane,1,1
236633,gas,1,1
236634,and,0,1
236635,long-term,0,0
236636,(,0,0
236637,up,0,0
236638,to,0,0
236639,72,0,0
236640,months,0,0
236641,),0,0
236642,outcomes,0,0
236643,in,0,0
236644,eyes,0,0
236645,with,0,0
236646,attached,0,0
236647,maculas,0,0
236648,at,0,0
236649,36,0,0
236650,months,0,0
236651,.,0,0
236652,DESIGN,0,0
236653,Prospective,0,0
236654,",",0,0
236655,randomized,0,0
236656,",",0,0
236657,multicentered,0,0
236658,surgical,0,0
236659,trial,0,0
236660,.,0,0
236661,SETTING,0,0
236662,Community-,0,0
236663,and,0,0
236664,university-based,0,0
236665,vitreoretinal,0,0
236666,practices,0,0
236667,.,0,0
236668,PATIENTS,0,0
236669,Two-hundred,0,0
236670,sixty-five,0,0
236671,eyes,0,0
236672,with,0,0
236673,PVR,0,0
236674,randomized,0,0
236675,to,0,0
236676,perfluoropropane,1,1
236677,gas,1,1
236678,and,0,0
236679,silicone,1,1
236680,oil,1,1
236681,with,0,0
236682,follow-up,0,0
236683,through,0,0
236684,3,0,0
236685,years,0,0
236686,(,0,0
236687,cohort,0,0
236688,1,0,0
236689,),0,0
236690,and,0,0
236691,249,0,0
236692,eyes,0,0
236693,with,0,0
236694,attached,0,0
236695,maculas,0,0
236696,at,0,0
236697,36,0,0
236698,months,0,0
236699,(,1,0
236700,121,1,0
236701,eyes,1,0
236702,randomized,1,0
236703,to,1,0
236704,long-acting,1,1
236705,gas,1,1
236706,[,1,0
236707,either,1,1
236708,sulfur,1,1
236709,hexafluoride,1,1
236710,or,1,1
236711,perfluoropropane,1,1
236712,],1,0
236713,and,1,0
236714,128,1,0
236715,eyes,1,0
236716,randomized,1,0
236717,to,1,0
236718,silicone,1,1
236719,oil,1,1
236720,),1,0
236721,with,1,0
236722,follow-up,1,0
236723,up,1,0
236724,to,1,0
236725,6,1,0
236726,years,1,0
236727,(,1,0
236728,cohort,1,0
236729,2,1,0
236730,),1,0
236731,.,1,0
236732,Both,0,1
236733,cohorts,0,0
236734,consisted,0,0
236735,of,0,0
236736,eyes,0,0
236737,that,0,0
236738,had,0,0
236739,and,0,0
236740,had,0,0
236741,not,0,0
236742,undergone,0,0
236743,vitrectomy,0,1
236744,for,0,0
236745,PVR,0,1
236746,(,0,0
236747,groups,0,0
236748,1,0,0
236749,and,0,0
236750,2,0,0
236751,",",0,0
236752,respectively,0,0
236753,),0,0
236754,before,0,0
236755,randomization,0,0
236756,.,0,0
236757,Of,0,0
236758,the,0,0
236759,265,0,0
236760,eyes,0,0
236761,in,0,0
236762,cohort,0,0
236763,1,0,0
236764,",",0,0
236765,24-month,0,0
236766,follow-up,0,0
236767,data,0,0
236768,were,0,0
236769,available,0,0
236770,for,0,0
236771,218,0,0
236772,eyes,0,0
236773,(,0,0
236774,82,0,0
236775,%,0,0
236776,),0,0
236777,and,0,0
236778,36-month,0,0
236779,follow-up,0,0
236780,data,0,0
236781,were,0,0
236782,available,0,0
236783,for,0,0
236784,196,0,0
236785,eyes,0,0
236786,(,0,0
236787,74,0,0
236788,%,0,0
236789,),0,0
236790,.,0,0
236791,Of,0,0
236792,208,0,0
236793,eyes,0,0
236794,in,0,0
236795,cohort,0,0
236796,2,0,0
236797,",",0,0
236798,48-month,0,0
236799,follow-up,0,0
236800,data,0,0
236801,were,0,0
236802,available,0,0
236803,for,0,0
236804,146,0,0
236805,eyes,0,0
236806,(,0,0
236807,70,0,0
236808,%,0,0
236809,),0,0
236810,",",0,0
236811,60-month,0,0
236812,follow-up,0,0
236813,data,0,0
236814,for,0,0
236815,119,0,0
236816,eyes,0,0
236817,(,0,0
236818,57,0,0
236819,%,0,0
236820,),0,0
236821,",",0,0
236822,and,0,0
236823,72-month,0,0
236824,follow-up,0,0
236825,data,0,0
236826,for,0,0
236827,73,0,0
236828,eyes,0,0
236829,(,0,0
236830,35,0,0
236831,%,0,0
236832,),0,0
236833,.,0,0
236834,INTERVENTIONS,0,1
236835,Vitrectomy,0,1
236836,surgery,0,1
236837,for,0,0
236838,PVR,0,0
236839,with,0,0
236840,a,0,0
236841,long-acting,1,1
236842,gas,1,1
236843,or,0,1
236844,silicone,1,1
236845,oil,1,1
236846,as,0,0
236847,the,0,0
236848,intraocular,0,1
236849,tamponade,0,0
236850,.,0,0
236851,MAIN,0,0
236852,OUTCOME,0,0
236853,MEASURES,0,0
236854,Changes,0,1
236855,in,0,0
236856,visual,0,0
236857,acuity,0,0
236858,",",0,0
236859,recurrent,0,0
236860,retinal,0,0
236861,detachment,0,0
236862,",",0,0
236863,and,0,0
236864,incidence,0,0
236865,of,0,0
236866,complications,0,0
236867,.,0,0
236868,RESULTS,0,0
236869,In,0,0
236870,group,0,0
236871,1,0,0
236872,of,0,0
236873,cohort,0,0
236874,1,0,0
236875,",",0,0
236876,compared,0,0
236877,with,0,0
236878,oil-treated,0,0
236879,eyes,0,0
236880,",",0,0
236881,gas-treated,0,0
236882,eyes,0,0
236883,had,0,0
236884,a,0,0
236885,higher,0,0
236886,rate,0,0
236887,of,0,0
236888,complete,0,0
236889,retinal,0,0
236890,reattachment,0,0
236891,from,0,0
236892,18,0,0
236893,to,0,0
236894,36,0,0
236895,months,0,0
236896,(,0,0
236897,P,0,0
236898,<,0,0
236899,.05,0,0
236900,),0,0
236901,.,0,0
236902,No,0,0
236903,other,0,0
236904,differences,0,0
236905,were,0,0
236906,found,0,0
236907,.,0,0
236908,In,0,0
236909,group,0,0
236910,2,0,0
236911,of,0,0
236912,cohort,0,0
236913,1,0,0
236914,",",0,0
236915,no,0,0
236916,notable,0,0
236917,differences,0,0
236918,were,0,0
236919,found,0,0
236920,between,0,0
236921,treatment,0,0
236922,arms,0,0
236923,.,0,0
236924,In,0,0
236925,cohort,0,0
236926,2,0,0
236927,",",0,0
236928,during,0,0
236929,6,0,0
236930,years,0,0
236931,of,0,0
236932,follow-up,0,0
236933,",",0,0
236934,attachment,0,0
236935,of,0,0
236936,the,0,0
236937,macula,0,0
236938,was,0,0
236939,maintained,0,0
236940,for,0,0
236941,all,0,0
236942,eyes,0,0
236943,.,0,0
236944,No,0,0
236945,notable,0,0
236946,differences,0,0
236947,in,0,0
236948,the,0,0
236949,rates,0,0
236950,of,0,0
236951,complete,0,0
236952,retinal,0,0
236953,attachment,0,0
236954,",",0,0
236955,visual,0,0
236956,acuity,0,0
236957,of,0,0
236958,5/200,0,0
236959,or,0,0
236960,better,0,0
236961,",",0,0
236962,or,0,0
236963,glaucoma,0,1
236964,were,0,0
236965,found,0,0
236966,between,0,0
236967,treatment,0,0
236968,groups,0,0
236969,.,0,0
236970,In,0,0
236971,contrast,0,0
236972,",",0,0
236973,gas-treated,0,0
236974,eyes,0,0
236975,had,0,0
236976,more,0,0
236977,hypotony,0,0
236978,(,0,0
236979,P,0,0
236980,<,0,0
236981,.001,0,0
236982,),0,0
236983,.,0,0
236984,Silicone,1,1
236985,oil-treated,1,0
236986,eyes,0,0
236987,that,0,0
236988,underwent,0,0
236989,subsequent,0,0
236990,surgery,0,1
236991,were,0,0
236992,more,0,0
236993,likely,0,0
236994,to,0,0
236995,have,0,0
236996,the,0,0
236997,oil,0,1
236998,retained,0,0
236999,(,0,0
237000,P,0,0
237001,=,0,0
237002,.02,0,0
237003,),0,0
237004,.,0,0
237005,Compared,0,0
237006,with,0,0
237007,oil-retained,0,0
237008,eyes,0,0
237009,",",0,0
237010,oil-removed,0,0
237011,eyes,0,0
237012,had,0,0
237013,higher,0,0
237014,rates,0,0
237015,of,0,0
237016,complete,0,0
237017,posterior,0,1
237018,attachment,0,0
237019,(,0,0
237020,P,0,0
237021,=,0,0
237022,.01,0,0
237023,),0,1
237024,and,0,0
237025,of,0,0
237026,a,0,0
237027,visual,0,0
237028,acuity,0,0
237029,of,0,0
237030,5/200,0,0
237031,or,0,0
237032,better,0,0
237033,(,0,0
237034,P,0,0
237035,<,0,0
237036,.001,0,0
237037,),0,1
237038,and,0,0
237039,less,0,0
237040,keratopathy,0,0
237041,(,0,0
237042,P,0,0
237043,<,0,0
237044,.05,0,0
237045,),0,0
237046,.,0,0
237047,Compared,0,0
237048,with,0,0
237049,oil-removed,0,0
237050,eyes,0,0
237051,",",0,0
237052,gas-treated,0,0
237053,eyes,0,0
237054,had,0,0
237055,a,0,0
237056,worse,0,0
237057,visual,0,0
237058,acuity,0,0
237059,outcome,0,0
237060,(,0,0
237061,P,0,0
237062,<,0,0
237063,.05,0,0
237064,),0,0
237065,and,0,0
237066,more,0,0
237067,hypotony,0,0
237068,(,0,0
237069,P,0,0
237070,<,0,0
237071,.01,0,0
237072,),0,0
237073,.,0,0
237074,CONCLUSION,0,0
237075,The,0,0
237076,Silicone,0,1
237077,Study,0,0
237078,showed,0,0
237079,that,0,0
237080,silicone,0,1
237081,oil,0,1
237082,and,0,0
237083,perfluoropropane,0,1
237084,gas,0,1
237085,were,0,0
237086,equal,0,0
237087,in,0,0
237088,most,0,0
237089,respects,0,0
237090,for,0,0
237091,the,0,0
237092,management,0,1
237093,of,0,0
237094,retinal,0,0
237095,detachments,0,0
237096,with,0,0
237097,PVR,0,0
237098,.,0,0
237099,Success,0,0
237100,in,0,0
237101,the,0,0
237102,first,0,0
237103,surgery,0,0
237104,for,0,0
237105,PVR,0,1
237106,is,0,0
237107,paramount,0,0
237108,for,0,0
237109,obtaining,0,0
237110,better,0,0
237111,visual,0,0
237112,results,0,0
237113,.,0,0
237114,Overall,0,0
237115,",",0,0
237116,surgery,0,0
237117,for,0,0
237118,PVR,0,0
237119,had,0,0
237120,a,0,0
237121,high,0,0
237122,likelihood,0,0
237123,of,0,0
237124,retinal,0,0
237125,reattachment,0,0
237126,",",0,0
237127,and,0,0
237128,if,0,0
237129,anatomically,0,0
237130,and,0,0
237131,visually,0,0
237132,successful,0,0
237133,at,0,0
237134,3,0,0
237135,years,0,0
237136,",",0,0
237137,there,0,0
237138,is,0,0
237139,an,0,0
237140,excellent,0,0
237141,chance,0,0
237142,that,0,0
237143,the,0,0
237144,results,0,0
237145,will,0,0
237146,be,0,0
237147,maintained,0,0
237148,over,0,0
237149,the,0,0
237150,long-term,0,0
237151,.,0,0
237152,Confounding,0,0
237153,by,0,0
237154,indication,0,0
237155,?,0,0
237156,Clinical,0,0
237157,evaluation,0,0
237158,of,0,0
237159,the,0,0
237160,speed,0,0
237161,and,0,0
237162,effectiveness,0,0
237163,of,0,0
237164,subgingival,0,1
237165,calculus,0,0
237166,removal,0,0
237167,on,0,0
237168,single-rooted,0,0
237169,teeth,0,0
237170,with,0,0
237171,diamond-coated,1,1
237172,ultrasonic,1,1
237173,tips,1,1
237174,.,1,0
237175,Several,0,0
237176,studies,0,0
237177,have,0,0
237178,found,0,0
237179,incomplete,0,0
237180,calculus,0,0
237181,removal,0,0
237182,during,0,0
237183,periodontal,0,0
237184,treatment,0,0
237185,with,0,0
237186,traditional,0,1
237187,hand,0,1
237188,curets,0,1
237189,",",0,0
237190,sonic,0,0
237191,",",0,0
237192,and,0,0
237193,ultrasonic,0,1
237194,instruments,0,0
237195,.,0,0
237196,This,0,0
237197,study,0,0
237198,evaluated,0,0
237199,the,0,0
237200,speed,0,0
237201,and,0,0
237202,effectiveness,0,0
237203,of,0,0
237204,subgingival,1,1
237205,calculus,1,0
237206,removal,1,0
237207,with,0,0
237208,new,1,0
237209,diamond-coated,1,1
237210,ultrasonic,1,1
237211,tips,1,1
237212,on,0,0
237213,single-rooted,0,0
237214,teeth,0,0
237215,.,0,0
237216,Single,0,1
237217,session,0,1
237218,subgingival,0,1
237219,scaling,0,0
237220,and,0,0
237221,root,0,1
237222,planing,0,1
237223,was,0,0
237224,performed,0,0
237225,on,0,0
237226,80,0,0
237227,teeth,0,0
237228,with,0,0
237229,5,0,0
237230,to,0,0
237231,12,0,0
237232,mm,0,0
237233,probing,0,0
237234,depths,0,0
237235,in,0,0
237236,15,0,0
237237,patients,0,0
237238,.,0,0
237239,Each,0,0
237240,patient,0,0
237241,provided,0,0
237242,groups,0,0
237243,of,0,0
237244,4,0,0
237245,teeth,0,0
237246,that,0,0
237247,were,0,0
237248,randomly,0,0
237249,treated,0,0
237250,with,0,0
237251,either,0,0
237252,hand,1,1
237253,curets,1,1
237254,(,1,0
237255,HAND,1,0
237256,),1,1
237257,;,1,0
237258,standard,1,1
237259,smooth,1,0
237260,ultrasonic,1,1
237261,tip,1,1
237262,(,1,1
237263,US,1,1
237264,),1,1
237265,;,1,0
237266,or,1,1
237267,fine,1,1
237268,grit,1,1
237269,(,1,1
237270,FINDIAM,1,1
237271,),1,1
237272,or,1,1
237273,medium,1,1
237274,grit,1,1
237275,(,1,1
237276,MEDDIAM,1,1
237277,),1,1
237278,diamond-coated,1,1
237279,ultrasonic,1,1
237280,tips,1,1
237281,.,1,0
237282,The,0,0
237283,time,0,0
237284,taken,0,0
237285,to,0,0
237286,reach,0,0
237287,the,0,0
237288,therapeutic,0,0
237289,endpoint,0,0
237290,of,0,0
237291,a,0,0
237292,clean,0,1
237293,",",0,0
237294,smooth,0,0
237295,root,0,1
237296,surface,0,1
237297,in,0,0
237298,a,0,0
237299,defined,0,0
237300,region,0,0
237301,on,0,0
237302,each,0,0
237303,tooth,0,0
237304,with,0,0
237305,each,0,0
237306,instrument,0,0
237307,by,0,0
237308,the,0,0
237309,3,0,0
237310,therapists,0,0
237311,with,0,0
237312,differing,0,0
237313,experience,0,0
237314,levels,0,0
237315,was,0,0
237316,recorded,0,0
237317,.,0,0
237318,The,0,0
237319,teeth,0,0
237320,were,0,0
237321,then,0,0
237322,atraumatically,0,0
237323,extracted,0,0
237324,",",0,0
237325,stored,0,0
237326,in,0,0
237327,a,0,0
237328,surfactant,0,1
237329,",",0,0
237330,photographed,0,0
237331,at,0,0
237332,10X,0,0
237333,",",0,0
237334,and,0,0
237335,the,0,0
237336,percent,0,0
237337,of,0,0
237338,calculus,0,0
237339,present,0,0
237340,in,0,0
237341,the,0,0
237342,area,0,0
237343,of,0,0
237344,the,0,0
237345,pocket,0,0
237346,or,0,1
237347,on,0,0
237348,a,0,0
237349,comparable,0,0
237350,control,0,1
237351,surface,0,1
237352,calculated,0,0
237353,by,0,0
237354,histometric,0,0
237355,point,0,0
237356,counting,0,1
237357,.,0,0
237358,ANOVA,0,1
237359,and,0,0
237360,paired,0,1
237361,t,0,0
237362,tests,0,0
237363,showed,0,0
237364,that,0,0
237365,mean,0,0
237366,percent,0,0
237367,remaining,0,0
237368,calculus,0,0
237369,on,0,0
237370,treated,0,0
237371,versus,0,1
237372,control,0,1
237373,surfaces,0,1
237374,was,0,0
237375,HAND,0,0
237376,4.6,0,0
237377,+/-,0,0
237378,5.3,0,0
237379,versus,0,0
237380,57.5,0,0
237381,+/-,0,0
237382,28.2,0,0
237383,",",0,0
237384,US,0,1
237385,4.7,0,0
237386,+/-,0,0
237387,6.4,0,0
237388,versus,0,0
237389,54.4,0,0
237390,+/-,0,0
237391,25.9,0,0
237392,",",0,0
237393,FINDIAM,0,0
237394,4.3,0,0
237395,+/-,0,0
237396,5.2,0,0
237397,versus,0,0
237398,37.5,0,0
237399,+/-,0,0
237400,22.1,0,0
237401,",",0,0
237402,and,0,0
237403,MEDDIAM,0,1
237404,3.4,0,0
237405,+/-,0,0
237406,4.2,0,0
237407,versus,0,0
237408,50.7,0,0
237409,+/-,0,0
237410,20.1,0,0
237411,",",0,0
237412,respectively,0,0
237413,(,0,0
237414,all,0,0
237415,P,0,0
237416,<,0,0
237417,0.01,0,0
237418,),0,0
237419,.,0,0
237420,The,0,0
237421,mean,0,0
237422,time,0,0
237423,in,0,0
237424,seconds,0,0
237425,to,0,0
237426,reach,0,0
237427,the,0,0
237428,clinical,0,0
237429,endpoint,0,0
237430,ranged,0,0
237431,from,0,0
237432,HAND,0,0
237433,289,0,0
237434,+/-,0,0
237435,193,0,0
237436,",",0,0
237437,US,0,1
237438,194,0,0
237439,+/-,0,0
237440,67,0,0
237441,",",0,0
237442,FINDIAM,0,0
237443,167,0,0
237444,+/-,0,0
237445,71,0,0
237446,",",0,0
237447,to,0,0
237448,MEDDIAM,0,0
237449,147,0,0
237450,+/-,0,0
237451,92,0,0
237452,.,0,0
237453,All,0,0
237454,powered,0,0
237455,instruments,0,0
237456,were,0,0
237457,significantly,0,0
237458,faster,0,0
237459,than,0,0
237460,HAND,0,0
237461,(,0,0
237462,P,0,0
237463,<,0,0
237464,0.05,0,0
237465,),0,0
237466,",",0,0
237467,but,0,0
237468,did,0,0
237469,not,0,0
237470,differ,0,0
237471,from,0,0
237472,each,0,0
237473,other,0,0
237474,.,0,0
237475,On,0,0
237476,a,0,0
237477,0,0,0
237478,=,0,0
237479,smooth,0,0
237480,to,0,0
237481,3,0,0
237482,=,0,0
237483,rough,0,0
237484,scale,0,0
237485,",",0,0
237486,most,0,0
237487,often,0,0
237488,HAND,0,0
237489,resulted,0,0
237490,in,0,0
237491,smooth,0,0
237492,surfaces,0,1
237493,(,0,0
237494,10/20,0,1
237495,),0,0
237496,",",0,0
237497,the,0,0
237498,powered,0,0
237499,tips,0,1
237500,of,0,0
237501,all,0,0
237502,types,0,0
237503,slight,0,0
237504,surface,0,1
237505,roughness,0,0
237506,(,0,0
237507,10/20,0,1
237508,each,0,0
237509,),0,0
237510,",",0,0
237511,and,0,0
237512,US,0,1
237513,the,0,0
237514,most,0,0
237515,moderate,0,0
237516,roughness,0,0
237517,(,0,1
237518,7/20,0,0
237519,),0,0
237520,.,0,0
237521,There,0,0
237522,were,0,0
237523,no,0,0
237524,differences,0,0
237525,in,0,0
237526,percent,0,0
237527,calculus,0,0
237528,remaining,0,0
237529,",",0,0
237530,surface,0,1
237531,roughness,0,0
237532,",",0,0
237533,or,0,1
237534,time,0,0
237535,spent,0,0
237536,among,0,0
237537,the,0,0
237538,3,0,0
237539,treating,0,0
237540,clinicians,0,0
237541,despite,0,0
237542,their,0,0
237543,varying,0,0
237544,experience,0,0
237545,levels,0,0
237546,.,0,0
237547,The,0,0
237548,results,0,0
237549,of,0,0
237550,this,0,0
237551,study,0,0
237552,showed,0,0
237553,that,0,0
237554,percent,0,0
237555,calculus,0,0
237556,remaining,0,0
237557,was,0,0
237558,<,0,0
237559,5,0,0
237560,%,0,0
237561,with,0,0
237562,all,0,0
237563,the,0,0
237564,instruments,0,0
237565,given,0,0
237566,time,0,0
237567,ad,0,0
237568,libitum,0,1
237569,on,0,0
237570,a,0,0
237571,given,0,0
237572,root,0,0
237573,surface,0,1
237574,.,0,0
237575,Root,0,0
237576,roughness,0,0
237577,was,0,0
237578,generally,0,0
237579,slightly,0,0
237580,greater,0,0
237581,with,0,0
237582,all,0,0
237583,3,0,0
237584,powered,0,0
237585,tips,0,1
237586,.,0,0
237587,All,0,0
237588,of,0,0
237589,the,0,0
237590,powered,0,0
237591,instruments,0,0
237592,took,0,0
237593,significantly,0,0
237594,less,0,0
237595,time,0,0
237596,than,0,0
237597,the,0,0
237598,HAND,0,0
237599,.,0,0
237600,Both,0,1
237601,DIAM,0,0
237602,tips,0,1
237603,took,0,0
237604,less,0,0
237605,time,0,0
237606,than,0,0
237607,US,1,1
237608,.,1,0
237609,Diamond-coated,1,1
237610,ultrasonic,1,0
237611,tips,1,1
237612,appeared,0,0
237613,to,0,0
237614,be,0,0
237615,much,0,0
237616,more,0,0
237617,efficient,0,0
237618,than,0,0
237619,HAND,0,0
237620,or,0,1
237621,US,0,1
237622,in,0,0
237623,removing,0,0
237624,calculus,0,0
237625,in,0,0
237626,moderate-deep,0,1
237627,probing,0,0
237628,depths,0,1
237629,on,0,0
237630,single-rooted,0,0
237631,teeth,0,0
237632,in,0,0
237633,vivo,0,0
237634,.,0,0
237635,Comparison,0,0
237636,of,0,0
237637,the,0,0
237638,efficacy,0,0
237639,and,0,0
237640,safety,0,0
237641,of,0,0
237642,ebrotidine,0,1
237643,in,0,0
237644,the,0,0
237645,treatment,0,0
237646,of,0,0
237647,duodenal,0,0
237648,ulcer,0,0
237649,.,0,0
237650,A,0,0
237651,multicentre,0,0
237652,",",0,0
237653,double-blind,0,0
237654,",",0,0
237655,placebo-controlled,0,1
237656,phase,0,0
237657,II,0,0
237658,study,0,0
237659,.,0,1
237660,Ebrotidine,0,1
237661,(,0,0
237662,N-,0,1
237663,[,0,1
237664,(,0,1
237665,E,0,1
237666,),0,1
237667,-,0,0
237668,[,0,0
237669,[,0,0
237670,2-,0,0
237671,[,0,0
237672,[,0,1
237673,[,0,0
237674,2-,0,0
237675,[,0,1
237676,(,0,1
237677,diaminomethylene,0,1
237678,),0,1
237679,amino,0,1
237680,],0,0
237681,-4,0,0
237682,-thiazoly,0,1
237683,],0,1
237684,methyl,0,1
237685,],0,1
237686,thio,0,1
237687,],0,1
237688,ethyl,0,1
237689,],0,0
237690,amino,0,1
237691,],0,1
237692,methylene,0,1
237693,],0,1
237694,-4-bromo-benzenesulfon,0,1
237695,amide,0,0
237696,",",0,0
237697,CAS,0,1
237698,100981-43-9,0,0
237699,",",0,0
237700,FI-3542,0,0
237701,),0,1
237702,is,0,0
237703,a,0,0
237704,new,0,0
237705,H2-receptor,0,1
237706,antagonist,0,1
237707,characterized,0,0
237708,by,0,0
237709,its,0,0
237710,high,0,0
237711,receptor,0,0
237712,affinity,0,0
237713,and,0,0
237714,gastroprotective,0,1
237715,effect,0,0
237716,.,0,0
237717,This,0,0
237718,Phase,0,0
237719,II,0,0
237720,study,0,0
237721,has,0,0
237722,been,0,0
237723,undertaken,0,0
237724,to,0,0
237725,establish,0,0
237726,the,0,0
237727,efficacy,0,0
237728,and,0,0
237729,safety,0,0
237730,of,0,0
237731,ebrotidine,1,1
237732,",",0,0
237733,administered,0,0
237734,in,0,0
237735,four,0,0
237736,dosages,0,0
237737,as,0,0
237738,a,0,0
237739,single,0,1
237740,evening,0,0
237741,dose,0,1
237742,versus,0,1
237743,placebo,1,1
237744,in,0,0
237745,the,0,0
237746,treatment,0,0
237747,of,0,0
237748,duodenal,0,0
237749,ulcer,0,0
237750,.,0,0
237751,A,0,0
237752,total,0,0
237753,of,0,0
237754,110,0,0
237755,duodenal,0,0
237756,ulcer,0,0
237757,patients,0,0
237758,were,0,0
237759,studied,0,0
237760,in,0,0
237761,a,0,0
237762,randomized,0,0
237763,",",0,0
237764,double-blind,0,0
237765,",",0,0
237766,placebo-controlled,0,1
237767,",",0,0
237768,multicentre,0,0
237769,clinical,0,0
237770,trial,0,0
237771,.,0,0
237772,The,1,0
237773,patients,1,0
237774,were,1,0
237775,assigned,1,0
237776,to,1,0
237777,5,1,0
237778,groups,1,0
237779,:,1,0
237780,placebo,1,1
237781,",",1,0
237782,200,1,1
237783,mg,1,1
237784,",",1,0
237785,400,1,1
237786,mg,1,1
237787,",",1,0
237788,600,1,1
237789,mg,1,1
237790,and,1,0
237791,800,1,1
237792,mg,1,1
237793,of,1,0
237794,ebrotidine,1,1
237795,once,1,0
237796,daily,1,0
237797,.,1,0
237798,Controls,1,0
237799,were,1,0
237800,performed,1,0
237801,at,1,0
237802,baseline,1,0
237803,and,1,0
237804,every,1,1
237805,two,1,0
237806,weeks,1,0
237807,at,1,0
237808,four,1,0
237809,follow-up,1,0
237810,visits,1,0
237811,unless,1,0
237812,ulcer,1,0
237813,healed,1,0
237814,before,1,0
237815,.,1,0
237816,Endoscopic,0,1
237817,examination,0,0
237818,was,0,0
237819,the,0,0
237820,main,0,0
237821,parameter,0,0
237822,for,0,0
237823,the,0,0
237824,assessment,0,0
237825,of,0,0
237826,treatment,0,1
237827,efficacy,0,0
237828,and,0,0
237829,ulcer,0,0
237830,healing,0,0
237831,rate,0,0
237832,.,0,0
237833,Vital,1,0
237834,signs,1,0
237835,and,1,0
237836,blood/,1,0
237837,urine,1,0
237838,analysis,1,0
237839,were,1,0
237840,used,1,0
237841,to,1,0
237842,establish,1,0
237843,safety,1,0
237844,.,1,0
237845,The,0,0
237846,three,0,0
237847,groups,0,0
237848,treated,0,0
237849,with,0,0
237850,higher,0,0
237851,dosages,0,0
237852,(,0,0
237853,400,0,1
237854,to,0,0
237855,800,0,1
237856,mg,0,1
237857,of,0,0
237858,ebrotidine,0,1
237859,daily,0,1
237860,),0,0
237861,showed,0,0
237862,an,0,0
237863,endoscopic,0,1
237864,ulcer,0,0
237865,healing,0,0
237866,rate,0,0
237867,of,0,0
237868,90-95,0,0
237869,%,0,0
237870,",",0,0
237871,significantly,0,0
237872,higher,0,0
237873,than,0,0
237874,55,0,0
237875,%,0,0
237876,achieved,0,0
237877,with,0,0
237878,placebo,0,1
237879,(,0,0
237880,p,0,0
237881,<,0,0
237882,0.05,0,0
237883,),0,0
237884,",",0,0
237885,whilst,0,0
237886,the,0,0
237887,differences,0,0
237888,between,0,0
237889,these,0,0
237890,three,0,0
237891,dosages,0,0
237892,of,0,0
237893,ebrotidine,0,1
237894,were,0,0
237895,not,0,0
237896,statistically,0,0
237897,significant,0,0
237898,.,0,0
237899,Healing,0,0
237900,rate,0,0
237901,in,0,0
237902,the,0,0
237903,group,0,0
237904,treated,0,0
237905,with,0,0
237906,200,0,0
237907,mg,0,1
237908,of,0,0
237909,ebrotidine,0,1
237910,daily,0,1
237911,was,0,0
237912,not,0,0
237913,significantly,0,0
237914,different,0,0
237915,from,0,0
237916,that,0,0
237917,in,0,0
237918,the,0,0
237919,placebo,0,1
237920,group,0,0
237921,.,0,0
237922,The,0,0
237923,development,0,0
237924,of,0,0
237925,symptoms,0,0
237926,",",0,0
237927,number,0,0
237928,of,0,0
237929,episodes,0,0
237930,of,0,0
237931,ulcer-related,0,0
237932,pain,0,0
237933,",",0,0
237934,total,0,0
237935,ulcerated,0,0
237936,surface,0,1
237937,area,0,0
237938,or,0,1
237939,subjective,0,0
237940,ratings,0,0
237941,by,0,0
237942,the,0,0
237943,patients,0,0
237944,and,0,0
237945,investigators,0,0
237946,also,0,0
237947,differed,0,0
237948,significantly,0,0
237949,between,0,0
237950,ebrotidine,0,1
237951,(,0,0
237952,400,0,1
237953,",",0,0
237954,600,0,0
237955,and,0,0
237956,800,0,0
237957,mg,0,1
237958,daily,0,1
237959,),0,0
237960,and,0,0
237961,placebo,0,1
237962,",",0,0
237963,and,0,0
237964,again,0,0
237965,",",0,0
237966,no,0,0
237967,marked,0,0
237968,differences,0,0
237969,were,0,0
237970,found,0,0
237971,between,0,0
237972,these,0,0
237973,three,0,0
237974,doses,0,0
237975,of,0,0
237976,ebrotidine,0,1
237977,.,0,0
237978,As,0,0
237979,far,0,0
237980,as,0,0
237981,tolerance,0,0
237982,is,0,0
237983,concerned,0,0
237984,",",0,0
237985,no,0,0
237986,clinically,0,0
237987,or,0,0
237988,statistically,0,0
237989,significant,0,0
237990,changes,0,0
237991,were,0,0
237992,observed,0,0
237993,in,0,0
237994,vital,0,0
237995,signs,0,0
237996,and,0,0
237997,analytical,0,0
237998,parameters,0,0
237999,.,0,0
238000,The,0,0
238001,incidence,0,0
238002,of,0,0
238003,side,0,0
238004,effects,0,0
238005,was,0,0
238006,less,0,0
238007,than,0,0
238008,that,0,0
238009,presented,0,0
238010,by,0,0
238011,the,0,0
238012,placebo,0,1
238013,group,0,0
238014,",",0,0
238015,possibly,0,0
238016,due,0,0
238017,to,0,0
238018,a,0,0
238019,greater,0,0
238020,consumption,0,0
238021,of,0,0
238022,antacids,0,1
238023,in,0,0
238024,this,0,0
238025,group,0,0
238026,.,0,0
238027,Results,0,0
238028,showed,0,0
238029,that,0,0
238030,a,0,0
238031,daily,0,1
238032,dose,0,0
238033,of,0,0
238034,400,0,1
238035,mg,0,1
238036,ebrotidine,0,1
238037,is,0,0
238038,effective,0,0
238039,and,0,0
238040,safe,0,0
238041,in,0,0
238042,the,0,0
238043,treatment,0,0
238044,of,0,0
238045,duodenal,0,0
238046,ulcers,0,0
238047,.,0,0
238048,The,0,0
238049,benefit,0,0
238050,of,0,0
238051,low-dose,0,1
238052,dopamine,1,1
238053,during,0,0
238054,vigorous,0,0
238055,diuresis,0,0
238056,for,0,0
238057,congestive,0,0
238058,heart,0,0
238059,failure,0,0
238060,associated,0,0
238061,with,0,0
238062,renal,0,0
238063,insufficiency,0,0
238064,:,0,0
238065,does,0,0
238066,it,0,0
238067,protect,0,0
238068,renal,0,0
238069,function,0,0
238070,?,0,0
238071,BACKGROUND,0,0
238072,Low-dose,0,1
238073,dopamine,1,1
238074,",",0,0
238075,a,0,0
238076,renal,0,0
238077,vasodilator,0,1
238078,",",0,0
238079,has,0,0
238080,been,0,0
238081,used,0,0
238082,empirically,0,0
238083,to,0,0
238084,improve,0,0
238085,renal,0,0
238086,function,0,0
238087,or,0,1
238088,outcome,0,0
238089,in,0,0
238090,critically,0,0
238091,ill,0,0
238092,patients,0,0
238093,with,0,0
238094,oliguria,0,0
238095,or,0,0
238096,acute,0,0
238097,renal,0,0
238098,failure,0,0
238099,.,0,0
238100,HYPOTHESIS,0,0
238101,This,0,0
238102,study,0,0
238103,was,0,0
238104,designed,0,0
238105,to,0,0
238106,investigate,0,0
238107,the,0,0
238108,efficacy,0,0
238109,of,0,0
238110,low-dose,0,1
238111,dopamine,1,1
238112,(,0,0
238113,2,0,1
238114,micrograms/kg/min,0,1
238115,),0,0
238116,as,0,0
238117,a,0,0
238118,renal-protective,0,0
238119,agent,0,0
238120,during,0,0
238121,vigorous,0,0
238122,diuresis,0,0
238123,for,0,0
238124,congestive,0,0
238125,heart,0,0
238126,failure,0,0
238127,(,0,1
238128,CHF,0,0
238129,),0,1
238130,associated,0,0
238131,with,0,0
238132,mild,0,0
238133,or,0,1
238134,moderate,0,0
238135,renal,0,0
238136,insufficiency,0,0
238137,.,0,0
238138,METHODS,0,0
238139,Of,0,1
238140,20,0,0
238141,study,0,0
238142,patients,0,0
238143,(,0,0
238144,mean,0,0
238145,age,0,0
238146,74.3,0,0
238147,+/-,0,0
238148,15,0,0
238149,years,0,0
238150,),0,0
238151,with,0,0
238152,severe,0,0
238153,CHF,0,0
238154,",",0,0
238155,10,0,0
238156,(,0,0
238157,Group,0,0
238158,A,0,1
238159,),0,0
238160,were,0,0
238161,randomized,0,0
238162,to,0,0
238163,a,0,0
238164,treatment,0,0
238165,strategy,0,0
238166,of,0,0
238167,intravenous,0,1
238168,bumetanide,1,1
238169,(,0,0
238170,1,0,1
238171,mg,0,1
238172,b.i.d,0,1
238173,.,0,0
238174,),0,0
238175,alone,0,1
238176,and,0,0
238177,another,0,1
238178,10,0,1
238179,(,0,0
238180,Group,0,0
238181,B,0,1
238182,),0,0
238183,to,0,0
238184,low-dose,0,1
238185,dopamine,1,1
238186,and,0,0
238187,a,0,0
238188,similar,0,0
238189,diuretic,0,1
238190,regimen,0,1
238191,for,0,0
238192,a,0,0
238193,duration,0,0
238194,of,0,0
238195,5,0,0
238196,days,0,0
238197,or,0,0
238198,less,0,0
238199,if,0,0
238200,clinical,0,0
238201,edema,0,0
238202,remitted,0,0
238203,.,0,0
238204,RESULTS,0,0
238205,Group,0,0
238206,B,0,0
238207,patients,0,0
238208,showed,0,0
238209,a,0,0
238210,significant,0,0
238211,improvement,0,0
238212,in,0,0
238213,renal,0,0
238214,function,0,0
238215,and,0,0
238216,urinary,0,0
238217,output,0,0
238218,:,0,1
238219,serum,0,0
238220,blood,0,0
238221,urea,0,1
238222,nitrogen,0,0
238223,48.9,0,0
238224,+/-,0,0
238225,10.3,0,0
238226,to,0,0
238227,32.1,0,0
238228,+/-,0,0
238229,14.4,0,0
238230,mg/dl,0,0
238231,(,0,0
238232,p,0,0
238233,<,0,0
238234,0.05,0,0
238235,),0,0
238236,;,0,0
238237,serum,0,0
238238,creatinine,0,0
238239,1.97,0,0
238240,+/-,0,0
238241,0.24,0,0
238242,to,0,0
238243,1.49,0,0
238244,+/-,0,0
238245,0.39,0,0
238246,mg/dl,0,0
238247,(,0,0
238248,p,0,0
238249,<,0,0
238250,0.05,0,0
238251,),0,0
238252,;,0,0
238253,creatinine,0,0
238254,clearance,0,0
238255,35.6,0,0
238256,+/-,0,0
238257,11.6,0,0
238258,to,0,0
238259,48.8,0,0
238260,+/-,0,0
238261,12.3,0,0
238262,ml/min,0,0
238263,(,0,0
238264,p,0,0
238265,<,0,0
238266,0.05,0,0
238267,),0,0
238268,;,0,0
238269,and,0,0
238270,indexed,0,0
238271,urinary,0,0
238272,output,0,0
238273,0.56,0,0
238274,+/-,0,0
238275,0.16,0,0
238276,to,0,0
238277,2.02,0,0
238278,+/-,0,0
238279,0.72,0,0
238280,ml/kg/h,0,1
238281,(,0,0
238282,p,0,0
238283,<,0,0
238284,0.05,0,0
238285,),0,0
238286,.,0,0
238287,Group,0,0
238288,A,0,0
238289,patients,0,0
238290,showed,0,0
238291,a,0,0
238292,significant,0,0
238293,increase,0,0
238294,in,0,0
238295,urinary,0,0
238296,output,0,0
238297,but,0,0
238298,nonsignificant,0,0
238299,renal,0,0
238300,functional,0,0
238301,deterioration,0,0
238302,.,0,0
238303,CONCLUSION,0,0
238304,The,0,0
238305,renal-protective,0,0
238306,effect,0,0
238307,of,0,0
238308,low-dose,0,1
238309,dopamine,1,1
238310,in,0,0
238311,the,0,0
238312,setting,0,0
238313,of,0,0
238314,CHF,0,0
238315,and,0,0
238316,vigorous,0,0
238317,diuresis,0,1
238318,is,0,0
238319,supported,0,0
238320,by,0,0
238321,this,0,0
238322,study,0,0
238323,.,0,0
238324,Mortality,0,0
238325,in,0,0
238326,patients,0,0
238327,with,0,0
238328,small,0,0
238329,choroidal,0,0
238330,melanoma,0,0
238331,.,0,0
238332,COMS,0,0
238333,report,0,0
238334,no,0,0
238335,.,0,0
238336,4,0,0
238337,.,0,0
238338,The,0,0
238339,Collaborative,0,0
238340,Ocular,0,0
238341,Melanoma,0,0
238342,Study,0,0
238343,Group,0,0
238344,.,0,0
238345,OBJECTIVE,0,0
238346,To,0,0
238347,describe,0,0
238348,the,0,0
238349,clinical,0,0
238350,characteristics,0,0
238351,and,0,0
238352,survival,0,0
238353,experience,0,0
238354,of,0,0
238355,a,0,0
238356,prospectively,0,0
238357,followed,0,1
238358,up,0,0
238359,group,0,0
238360,of,0,0
238361,patients,0,0
238362,with,0,0
238363,small,0,0
238364,choroidal,0,0
238365,melanoma,0,0
238366,.,0,0
238367,METHODS,0,0
238368,The,0,0
238369,Collaborative,0,0
238370,Ocular,0,0
238371,Melanoma,0,1
238372,Study,0,0
238373,(,0,1
238374,COMS,0,1
238375,),0,1
238376,is,0,0
238377,a,0,0
238378,set,0,0
238379,of,0,0
238380,clinical,0,0
238381,trials,0,0
238382,designed,0,0
238383,to,0,0
238384,compare,0,0
238385,the,0,0
238386,role,0,0
238387,of,0,0
238388,radiotherapy,1,1
238389,and,0,0
238390,enucleation,1,1
238391,in,0,0
238392,the,0,0
238393,treatment,0,0
238394,of,0,0
238395,medium,0,1
238396,and,0,0
238397,large-size,0,1
238398,choroidal,0,0
238399,melanoma,0,0
238400,.,0,0
238401,From,0,0
238402,December,0,0
238403,1986,0,0
238404,to,0,0
238405,August,0,0
238406,1989,0,0
238407,",",0,0
238408,patients,0,0
238409,with,0,0
238410,small,0,0
238411,choroidal,0,0
238412,melanoma,0,0
238413,",",0,0
238414,not,0,0
238415,large,0,0
238416,enough,0,0
238417,to,0,0
238418,be,0,0
238419,eligible,0,0
238420,for,0,0
238421,the,0,0
238422,COMS,0,0
238423,clinical,0,0
238424,trials,0,0
238425,",",0,0
238426,were,0,0
238427,offered,0,0
238428,participation,0,0
238429,in,0,0
238430,a,0,0
238431,nonrandomized,0,0
238432,prospective,0,0
238433,follow-up,0,0
238434,study,0,0
238435,.,0,0
238436,Small,0,0
238437,choroidal,0,0
238438,melanomas,0,0
238439,were,0,0
238440,defined,0,0
238441,as,0,0
238442,1.0,0,0
238443,to,0,0
238444,3.0,0,0
238445,mm,0,0
238446,in,0,0
238447,apical,0,0
238448,height,0,0
238449,and,0,0
238450,at,0,0
238451,least,0,0
238452,5.0,0,0
238453,mm,0,0
238454,in,0,0
238455,basal,0,0
238456,diameter,0,0
238457,.,0,0
238458,A,0,0
238459,total,0,0
238460,of,0,0
238461,204,0,0
238462,patients,0,0
238463,were,0,0
238464,enrolled,0,0
238465,in,0,0
238466,the,0,0
238467,study,0,0
238468,.,0,0
238469,Patients,0,0
238470,were,0,0
238471,followed,0,0
238472,up,0,0
238473,annually,0,0
238474,through,0,0
238475,August,0,0
238476,1989,0,0
238477,.,0,0
238478,Two,0,0
238479,additional,0,0
238480,assessments,0,0
238481,of,0,0
238482,treatment,0,0
238483,status,0,0
238484,and,0,0
238485,mortality,0,0
238486,were,0,0
238487,conducted,0,0
238488,in,0,0
238489,1993-1994,0,0
238490,and,0,0
238491,1995-1996,0,0
238492,.,0,0
238493,The,0,0
238494,median,0,0
238495,length,0,0
238496,of,0,0
238497,follow-up,0,0
238498,was,0,0
238499,92,0,0
238500,months,0,0
238501,.,0,0
238502,Eight,0,0
238503,percent,0,0
238504,of,0,0
238505,patients,0,0
238506,were,0,0
238507,treated,0,0
238508,at,0,0
238509,the,0,0
238510,time,0,0
238511,of,0,0
238512,study,0,0
238513,enrollment,0,0
238514,and,0,0
238515,an,0,0
238516,additional,0,0
238517,33,0,0
238518,%,0,0
238519,were,0,0
238520,treated,0,0
238521,during,0,0
238522,follow-up,0,0
238523,.,0,0
238524,RESULTS,0,0
238525,Twenty-seven,0,0
238526,patients,0,0
238527,have,0,0
238528,died,0,0
238529,;,0,0
238530,6,0,0
238531,deaths,0,0
238532,were,0,0
238533,reported,0,0
238534,by,0,0
238535,the,0,0
238536,clinical,0,0
238537,center,0,0
238538,as,0,0
238539,due,0,0
238540,to,0,0
238541,metastatic,0,0
238542,melanoma,0,0
238543,.,0,0
238544,The,0,0
238545,Kaplan-Meier,0,0
238546,estimate,0,0
238547,of,0,0
238548,5-year,0,0
238549,all-cause,0,0
238550,mortality,0,0
238551,was,0,0
238552,6.0,0,0
238553,%,0,0
238554,(,0,0
238555,95,0,0
238556,%,0,0
238557,confidence,0,0
238558,interval,0,0
238559,",",0,0
238560,2.7,0,0
238561,%,0,0
238562,-9.3,0,0
238563,%,0,0
238564,),0,1
238565,and,0,0
238566,8-year,0,0
238567,all-cause,0,0
238568,mortality,0,0
238569,was,0,0
238570,14.9,0,0
238571,%,0,0
238572,(,0,0
238573,95,0,0
238574,%,0,0
238575,confidence,0,0
238576,interval,0,0
238577,",",0,0
238578,9.6,0,0
238579,%,0,0
238580,-20.2,0,0
238581,%,0,0
238582,),0,0
238583,.,0,0
238584,CONCLUSIONS,0,0
238585,Otherwise,0,0
238586,healthy,0,0
238587,patients,0,0
238588,",",0,0
238589,average,0,0
238590,age,0,0
238591,of,0,0
238592,60,0,0
238593,years,0,0
238594,",",0,0
238595,without,0,0
238596,a,0,0
238597,previous,0,0
238598,diagnosis,0,0
238599,of,0,0
238600,malignant,0,0
238601,disease,0,0
238602,who,0,0
238603,have,0,0
238604,small,0,0
238605,choroidal,0,0
238606,lesions,0,0
238607,judged,0,0
238608,to,0,0
238609,be,0,0
238610,melanoma,0,0
238611,have,0,0
238612,a,0,0
238613,low,0,0
238614,risk,0,0
238615,of,0,0
238616,dying,0,0
238617,within,0,0
238618,5,0,0
238619,years,0,0
238620,.,0,0
238621,Active,1,1
238622,warming,1,0
238623,",",0,0
238624,not,0,0
238625,passive,0,1
238626,heat,0,0
238627,retention,0,0
238628,",",0,0
238629,maintains,0,0
238630,normothermia,0,1
238631,during,0,0
238632,combined,0,1
238633,epidural-general,0,1
238634,anesthesia,0,1
238635,for,0,0
238636,hip,0,0
238637,and,0,0
238638,knee,0,1
238639,arthroplasty,0,1
238640,.,0,0
238641,STUDY,0,0
238642,OBJECTIVE,0,0
238643,to,0,0
238644,compare,0,0
238645,passive,0,1
238646,heat,0,0
238647,retention,0,0
238648,by,0,0
238649,low-flow,0,1
238650,anesthesia,0,1
238651,",",0,0
238652,alone,0,1
238653,and,0,0
238654,with,0,0
238655,additional,0,0
238656,thermal,0,0
238657,insulation,0,1
238658,by,0,0
238659,reflective,0,1
238660,blankets,0,1
238661,",",0,0
238662,with,0,0
238663,forced-air,0,1
238664,warming,0,0
238665,preventing,0,0
238666,intraoperative,0,1
238667,hypothermia,0,1
238668,during,0,0
238669,combined,0,1
238670,epidural-general,0,1
238671,anesthesia,0,1
238672,.,0,0
238673,DESIGN,0,0
238674,Randomized,0,0
238675,",",0,0
238676,controlled,0,0
238677,study,0,0
238678,.,0,0
238679,SETTING,0,0
238680,Inpatient,0,0
238681,anesthesia,0,1
238682,at,0,0
238683,a,0,0
238684,university,0,0
238685,department,0,0
238686,of,0,0
238687,orthopedic,0,0
238688,surgery,0,1
238689,.,0,0
238690,PATIENTS,0,0
238691,30,0,0
238692,ASA,0,1
238693,physical,0,1
238694,status,0,0
238695,I,0,0
238696,and,0,0
238697,II,0,0
238698,patients,0,0
238699,",",0,0
238700,who,0,0
238701,were,0,0
238702,scheduled,0,0
238703,for,0,0
238704,elective,0,1
238705,hip,0,0
238706,or,0,1
238707,knee,0,1
238708,arthroplasty,0,1
238709,and,0,0
238710,were,0,0
238711,free,0,0
238712,from,0,0
238713,systemic,0,0
238714,disease,0,0
238715,.,0,0
238716,INTERVENTIONS,0,0
238717,Patients,0,0
238718,received,0,0
238719,epidural,0,1
238720,block,0,0
238721,up,0,0
238722,to,0,0
238723,T10,0,1
238724,by,0,0
238725,alkalinized,1,1
238726,lidocaine,1,1
238727,2,1,0
238728,%,1,0
238729,",",0,0
238730,and,0,0
238731,then,0,1
238732,were,0,0
238733,administered,0,0
238734,standard,1,1
238735,general,1,0
238736,anesthesia,1,1
238737,by,1,0
238738,means,1,0
238739,of,1,0
238740,low-flow,1,1
238741,rebreathing,1,1
238742,system,1,1
238743,(,0,1
238744,fresh,0,1
238745,gas,0,1
238746,flow,0,0
238747,=,0,0
238748,1,0,0
238749,L/min,0,0
238750,),0,0
238751,.,0,0
238752,All,0,0
238753,procedures,0,0
238754,started,0,0
238755,between,0,0
238756,8,0,0
238757,and,0,0
238758,10,0,0
238759,AM,0,1
238760,",",0,0
238761,and,0,0
238762,operating,0,1
238763,room,0,1
238764,(,0,1
238765,OR,0,0
238766,),0,1
238767,temperature,0,0
238768,was,0,0
238769,maintained,0,0
238770,between,0,0
238771,21,0,0
238772,degrees,0,0
238773,and,0,0
238774,23,0,0
238775,degrees,0,0
238776,C,0,0
238777,",",0,0
238778,with,0,0
238779,relative,0,0
238780,humidity,0,1
238781,ranging,0,0
238782,between,0,0
238783,40,0,1
238784,%,0,0
238785,and,0,0
238786,45,0,0
238787,%,0,0
238788,.,0,0
238789,For,0,0
238790,heat,0,0
238791,retention,0,0
238792,or,0,1
238793,warming,0,1
238794,therapy,0,1
238795,",",0,0
238796,patients,0,0
238797,received,0,0
238798,either,0,0
238799,low-flow,1,1
238800,anesthesia,1,1
238801,only,1,0
238802,(,0,0
238803,control,0,1
238804,",",0,0
238805,n,0,0
238806,=,0,0
238807,10,0,0
238808,),0,0
238809,",",0,0
238810,low-flow,1,1
238811,anesthesia,1,1
238812,with,1,0
238813,additional,1,0
238814,reflective,1,1
238815,blankets,1,1
238816,(,0,0
238817,blanket,0,1
238818,",",0,0
238819,n,0,0
238820,=,0,0
238821,10,0,0
238822,),0,0
238823,",",0,0
238824,or,0,1
238825,low-flow,1,1
238826,anesthesia,1,1
238827,with,1,0
238828,active,1,1
238829,forced-air,1,1
238830,warming,1,1
238831,(,0,0
238832,forced-air,0,1
238833,",",0,0
238834,n,0,0
238835,=,0,0
238836,10,0,0
238837,),0,0
238838,.,0,0
238839,Tympanic,0,0
238840,temperature,0,0
238841,was,0,0
238842,measured,0,0
238843,at,0,0
238844,OR,0,0
238845,arrival,0,0
238846,(,0,1
238847,baseline,0,0
238848,),0,1
238849,;,0,0
238850,immediately,0,0
238851,following,0,0
238852,general,0,0
238853,anesthesia,0,1
238854,induction,0,0
238855,;,0,0
238856,30,0,0
238857,",",0,0
238858,60,0,0
238859,",",0,0
238860,90,0,0
238861,",",0,0
238862,and,0,0
238863,120,0,0
238864,minutes,0,0
238865,from,0,0
238866,general,0,0
238867,anesthesia,0,1
238868,induction,0,1
238869,;,0,0
238870,and,0,0
238871,at,0,0
238872,the,0,0
238873,end,0,0
238874,of,0,0
238875,surgery,0,0
238876,.,0,0
238877,MEASUREMENTS,0,0
238878,AND,0,0
238879,MAIN,0,1
238880,RESULTS,0,0
238881,Duration,0,0
238882,of,0,0
238883,anesthesia,0,1
238884,",",0,0
238885,invasiveness,0,0
238886,of,0,0
238887,surgery,0,1
238888,",",0,0
238889,and,0,0
238890,baseline,0,0
238891,core,0,1
238892,temperature,0,0
238893,were,0,0
238894,similar,0,0
238895,in,0,0
238896,the,0,0
238897,three,0,0
238898,groups,0,0
238899,.,0,0
238900,Core,0,0
238901,temperature,0,0
238902,decreased,0,0
238903,in,0,0
238904,all,0,0
238905,the,0,0
238906,three,0,0
238907,groups,0,0
238908,30,0,0
238909,minutes,0,0
238910,after,0,0
238911,general,0,0
238912,anesthesia,0,1
238913,induction,0,1
238914,compared,0,0
238915,with,0,0
238916,baseline,0,0
238917,(,0,0
238918,p,0,0
238919,<,0,0
238920,0.01,0,0
238921,),0,0
238922,;,0,0
238923,afterwards,0,0
238924,",",0,0
238925,it,0,0
238926,progressively,0,0
238927,decreased,0,0
238928,in,0,0
238929,the,0,0
238930,control,0,1
238931,and,0,0
238932,blankets,0,1
238933,groups,0,0
238934,(,0,0
238935,p,0,0
238936,=,0,0
238937,0.004,0,0
238938,),0,0
238939,",",0,0
238940,with,0,0
238941,a,0,0
238942,reduction,0,0
238943,from,0,0
238944,baseline,0,0
238945,values,0,0
238946,measured,0,0
238947,at,0,0
238948,the,0,0
238949,end,0,0
238950,of,0,0
238951,surgery,0,0
238952,of,0,0
238953,2.0,0,0
238954,degrees,0,0
238955,C,0,0
238956,and,0,0
238957,1.6,0,0
238958,degrees,0,0
238959,C,0,0
238960,",",0,0
238961,respectively,0,0
238962,.,0,0
238963,In,0,0
238964,the,0,0
238965,forced-air,0,1
238966,group,0,0
238967,",",0,0
238968,after,0,0
238969,the,0,0
238970,initial,0,0
238971,significant,0,0
238972,decrease,0,0
238973,(,0,0
238974,p,0,0
238975,=,0,0
238976,0.01,0,0
238977,vs.,0,0
238978,baseline,0,0
238979,),0,0
238980,",",0,0
238981,core,0,0
238982,temperature,0,0
238983,progressively,0,0
238984,increased,0,0
238985,to,0,0
238986,35.8,0,0
238987,+/-,0,0
238988,0.6,0,0
238989,degrees,0,0
238990,C,0,0
238991,",",0,0
238992,which,0,0
238993,was,0,0
238994,similar,0,0
238995,to,0,0
238996,preoperative,0,0
238997,values,0,0
238998,and,0,0
238999,significantly,0,0
239000,higher,0,0
239001,than,0,0
239002,either,0,0
239003,the,0,0
239004,control,0,1
239005,or,0,1
239006,blankets,0,1
239007,groups,0,0
239008,(,0,0
239009,p,0,0
239010,=,0,0
239011,0.004,0,0
239012,),0,0
239013,.,0,0
239014,CONCLUSIONS,0,0
239015,During,0,0
239016,combined,0,1
239017,epidural-general,0,1
239018,anesthesia,0,1
239019,for,0,0
239020,elective,0,1
239021,hip,0,0
239022,and,0,0
239023,knee,0,1
239024,arthroplasty,0,1
239025,",",0,0
239026,passive,0,1
239027,heat,0,0
239028,retention,0,0
239029,by,0,0
239030,means,0,0
239031,of,0,0
239032,low-flow,1,1
239033,anesthesia,1,1
239034,alone,1,1
239035,and,1,0
239036,in,1,0
239037,combination,1,1
239038,with,1,0
239039,reflective,1,1
239040,blankets,1,1
239041,is,0,0
239042,ineffective,0,0
239043,in,0,0
239044,maintaining,0,0
239045,intraoperative,0,1
239046,normothermia,0,1
239047,and,0,0
239048,definitely,0,0
239049,inferior,0,0
239050,to,0,0
239051,active,0,1
239052,forced-air,0,1
239053,warning,0,0
239054,.,0,0
239055,Postoperative,0,0
239056,analgesia,0,0
239057,with,0,0
239058,preoperative,0,1
239059,oral,0,1
239060,ibuprofen,1,1
239061,or,0,1
239062,acetaminophen,1,1
239063,in,0,0
239064,children,0,0
239065,undergoing,0,0
239066,myringotomy,0,1
239067,.,0,0
239068,Previous,0,0
239069,studies,0,0
239070,have,0,0
239071,shown,0,0
239072,over,0,0
239073,70,0,0
239074,%,0,0
239075,of,0,0
239076,children,0,0
239077,require,0,0
239078,analgesics,1,0
239079,following,0,0
239080,bilateral,0,1
239081,myringotomy,0,1
239082,and,0,0
239083,tube,0,1
239084,placement,0,1
239085,(,0,1
239086,BM,0,1
239087,&,0,1
239088,T,0,0
239089,),0,0
239090,.,0,0
239091,This,0,0
239092,double-blind,0,0
239093,",",0,0
239094,placebo-controlled,0,1
239095,study,0,0
239096,compared,0,0
239097,the,0,0
239098,postoperative,0,0
239099,analgesic,0,0
239100,effects,0,0
239101,of,0,0
239102,preoperatively,0,0
239103,administered,0,0
239104,oral,0,1
239105,acetaminophen,1,1
239106,or,1,1
239107,ibuprofen,1,1
239108,.,1,0
239109,Forty,0,0
239110,three,0,0
239111,ASA,0,1
239112,I,0,0
239113,or,0,1
239114,II,0,0
239115,children,0,0
239116,age,0,0
239117,six,0,0
239118,months,0,0
239119,or,0,0
239120,older,0,0
239121,scheduled,0,0
239122,for,0,0
239123,elective,0,1
239124,BM,0,0
239125,&,0,1
239126,T,0,0
239127,were,0,0
239128,randomized,0,0
239129,to,0,0
239130,receive,0,1
239131,acetaminophen,1,1
239132,(,1,1
239133,paracetamol,1,1
239134,),1,1
239135,15,1,0
239136,mg.kg-1,1,1
239137,",",1,0
239138,ibuprofen,1,1
239139,10,1,0
239140,mg.kg-1,1,1
239141,",",1,0
239142,or,1,1
239143,placebo,1,1
239144,.,1,1
239145,Postoperative,0,0
239146,pain,0,0
239147,was,0,0
239148,assessed,0,0
239149,using,0,0
239150,the,0,0
239151,Children,0,0
239152,'s,0,0
239153,Hospital,0,0
239154,of,0,0
239155,Eastern,0,0
239156,Ontario,0,1
239157,Pain,0,1
239158,Scale,0,1
239159,(,0,1
239160,CHEOPS,0,1
239161,),0,1
239162,upon,0,0
239163,arrival,0,0
239164,to,0,0
239165,the,0,0
239166,PACU,0,1
239167,and,0,0
239168,at,0,0
239169,5,0,0
239170,",",0,0
239171,10,0,0
239172,",",0,0
239173,15,0,0
239174,",",0,0
239175,30,0,0
239176,",",0,0
239177,45,0,0
239178,",",0,0
239179,and,0,0
239180,60,0,0
239181,min,0,0
239182,.,0,0
239183,CHEOP,0,1
239184,scores,0,0
239185,did,0,0
239186,not,0,0
239187,differ,0,0
239188,between,0,0
239189,the,0,0
239190,groups,0,0
239191,at,0,0
239192,any,0,0
239193,time,0,0
239194,.,0,0
239195,There,0,0
239196,was,0,0
239197,no,0,0
239198,difference,0,0
239199,in,0,0
239200,the,0,0
239201,number,0,0
239202,of,0,0
239203,children,0,0
239204,receiving,0,0
239205,rescue,0,0
239206,analgesia,0,0
239207,.,0,0
239208,This,0,0
239209,study,0,0
239210,showed,0,0
239211,no,0,0
239212,benefit,0,0
239213,of,0,0
239214,preoperatively,0,0
239215,administered,0,0
239216,oral,0,1
239217,ibuprofen,1,1
239218,10,0,1
239219,mg.kg-1,0,1
239220,or,0,1
239221,acetaminophen,1,1
239222,15,0,0
239223,mg.kg-1,0,1
239224,over,0,0
239225,placebo,0,1
239226,for,0,0
239227,the,0,0
239228,relief,0,0
239229,of,0,0
239230,postoperative,0,0
239231,pain,0,0
239232,in,0,0
239233,children,0,0
239234,undergoing,0,0
239235,BM,0,0
239236,&,0,1
239237,T,0,0
239238,.,0,0
239239,A,0,0
239240,comparison,0,0
239241,of,0,0
239242,intermittent,1,0
239243,vaginal,1,1
239244,administration,1,0
239245,of,1,0
239246,misoprostol,1,1
239247,with,0,0
239248,continuous,1,1
239249,dinoprostone,1,1
239250,for,0,0
239251,cervical,0,1
239252,ripening,0,1
239253,and,0,0
239254,labor,0,0
239255,induction,0,1
239256,.,0,0
239257,OBJECTIVE,0,0
239258,Our,0,0
239259,purpose,0,0
239260,was,0,0
239261,to,0,0
239262,compare,0,0
239263,the,0,0
239264,effect,0,0
239265,of,0,0
239266,vaginal,1,1
239267,administration,1,0
239268,of,1,0
239269,misoprostol,1,1
239270,(,1,1
239271,Cytotec,1,1
239272,),1,1
239273,with,0,0
239274,that,0,0
239275,of,0,0
239276,dinoprostone,1,1
239277,(,1,1
239278,Cervidil,1,1
239279,),1,1
239280,on,0,0
239281,cervical,0,1
239282,ripening,0,1
239283,and,0,0
239284,labor,0,0
239285,induction,0,0
239286,.,0,0
239287,STUDY,0,0
239288,DESIGN,0,0
239289,Two,0,0
239290,hundred,0,0
239291,patients,0,0
239292,with,0,0
239293,indications,0,0
239294,for,0,0
239295,induction,0,0
239296,of,0,0
239297,labor,0,0
239298,and,0,0
239299,unfavorable,0,0
239300,cervical,0,1
239301,examinations,0,0
239302,were,0,0
239303,randomly,0,0
239304,assigned,0,0
239305,to,0,0
239306,receive,0,0
239307,vaginally,0,1
239308,administered,0,0
239309,misoprostol,1,1
239310,(,1,0
239311,prostaglandin,1,1
239312,E1,1,1
239313,),1,1
239314,or,0,1
239315,the,0,0
239316,dinoprostone,1,1
239317,(,1,0
239318,prostaglandin,1,1
239319,E2,1,1
239320,),1,1
239321,vaginal,0,1
239322,insert,0,1
239323,.,0,0
239324,Twenty-five,0,0
239325,microgram,0,1
239326,tablets,0,1
239327,of,0,0
239328,misoprostol,1,1
239329,were,0,0
239330,placed,0,0
239331,in,0,0
239332,the,0,0
239333,posterior,0,0
239334,vaginal,0,1
239335,fornix,0,1
239336,every,0,1
239337,4,0,0
239338,hours,0,0
239339,for,0,0
239340,a,0,0
239341,maximum,0,0
239342,of,0,0
239343,six,0,0
239344,doses,0,0
239345,.,0,0
239346,Additional,0,0
239347,misoprostol,1,1
239348,was,0,0
239349,not,0,0
239350,given,0,0
239351,after,0,0
239352,either,0,0
239353,spontaneous,0,0
239354,rupture,0,0
239355,of,0,0
239356,membranes,0,0
239357,",",0,0
239358,adequate,0,0
239359,cervical,0,1
239360,ripening,0,1
239361,(,0,1
239362,Bishop,0,0
239363,score,0,0
239364,of,0,0
239365,>,0,0
239366,or,0,1
239367,=,0,0
239368,8,0,0
239369,or,0,1
239370,cervical,0,1
239371,dilatation,0,0
239372,of,0,0
239373,>,0,0
239374,or,0,1
239375,=,0,0
239376,3,0,1
239377,cm,0,0
239378,),0,0
239379,",",0,0
239380,or,0,1
239381,beginning,0,0
239382,of,0,0
239383,active,0,0
239384,labor,0,0
239385,.,0,0
239386,The,0,0
239387,vaginal,0,0
239388,insert,0,0
239389,",",0,0
239390,Cervidil,1,1
239391,",",0,0
239392,containing,0,1
239393,10,0,0
239394,mg,0,1
239395,of,0,0
239396,dinoprostone,1,1
239397,in,0,0
239398,a,0,0
239399,timed-release,0,1
239400,preparation,0,1
239401,was,0,0
239402,placed,0,0
239403,in,0,0
239404,the,0,0
239405,posterior,0,0
239406,vaginal,0,1
239407,formix,0,1
239408,for,0,0
239409,a,0,0
239410,maximum,0,0
239411,period,0,0
239412,of,0,0
239413,24,0,0
239414,hours,0,0
239415,.,0,0
239416,The,0,0
239417,vaginal,0,0
239418,insert,0,0
239419,was,0,0
239420,removed,0,0
239421,for,0,0
239422,spontaneous,0,0
239423,rupture,0,0
239424,of,0,0
239425,membranes,0,0
239426,",",0,0
239427,entry,0,0
239428,into,0,0
239429,active,0,1
239430,labor,0,0
239431,",",0,0
239432,adequate,0,0
239433,cervical,0,1
239434,ripening,0,1
239435,",",0,0
239436,or,0,1
239437,abnormality,0,0
239438,of,0,0
239439,uterine,0,0
239440,contractile,0,0
239441,pattern,0,1
239442,or,0,1
239443,fetal,0,0
239444,cardiac,0,0
239445,activity,0,0
239446,.,0,0
239447,RESULTS,0,0
239448,Of,0,0
239449,the,0,0
239450,200,0,0
239451,patients,0,0
239452,enrolled,0,0
239453,",",0,0
239454,99,0,0
239455,were,0,0
239456,randomized,0,0
239457,to,0,0
239458,misoprostol,1,1
239459,and,0,0
239460,101,0,0
239461,to,0,0
239462,dinoprostone,1,1
239463,.,1,0
239464,The,0,0
239465,average,0,0
239466,interval,0,0
239467,from,0,0
239468,start,0,0
239469,of,0,0
239470,induction,0,0
239471,to,0,0
239472,vaginal,0,1
239473,delivery,0,0
239474,was,0,0
239475,1,0,0
239476,hour,0,0
239477,shorter,0,0
239478,in,0,0
239479,the,0,0
239480,misoprostol,1,1
239481,group,0,0
239482,(,0,0
239483,1296.7,0,0
239484,+/-,0,0
239485,722.1,0,0
239486,minutes,0,0
239487,),0,0
239488,than,0,0
239489,in,0,0
239490,the,0,0
239491,dinoprostone,1,1
239492,group,0,0
239493,(,0,0
239494,1360.0,0,0
239495,+/-,0,0
239496,792.0,0,0
239497,minutes,0,0
239498,),0,0
239499,",",0,0
239500,but,0,0
239501,this,0,0
239502,difference,0,0
239503,was,0,0
239504,not,0,0
239505,statistically,0,0
239506,significant,0,0
239507,(,0,0
239508,p,0,0
239509,=,0,0
239510,0.97,0,0
239511,),0,0
239512,.,0,0
239513,Oxytocin,1,1
239514,augmentation,0,0
239515,of,0,0
239516,labor,0,0
239517,was,0,0
239518,used,0,0
239519,in,0,0
239520,50,0,0
239521,(,0,0
239522,50.5,0,0
239523,%,0,0
239524,),0,0
239525,misoprostol-treated,1,1
239526,patients,0,0
239527,and,0,0
239528,43,0,0
239529,(,0,0
239530,43.5,0,0
239531,%,0,0
239532,),0,0
239533,dinoprostone-treated,1,1
239534,patients,0,0
239535,(,0,0
239536,relative,0,0
239537,risk,0,0
239538,1.14,0,0
239539,",",0,0
239540,95,0,0
239541,%,0,0
239542,confidence,0,0
239543,interval,0,0
239544,0.86,0,0
239545,to,0,0
239546,1.51,0,0
239547,",",0,0
239548,p,0,0
239549,=,0,0
239550,0.35,0,0
239551,),0,0
239552,.,0,0
239553,There,0,0
239554,were,0,0
239555,no,0,0
239556,significant,0,0
239557,differences,0,0
239558,between,0,0
239559,routes,0,0
239560,of,0,0
239561,delivery,0,0
239562,with,0,0
239563,misoprostol,1,1
239564,or,0,1
239565,dinoprostone,1,1
239566,.,1,0
239567,Overall,0,0
239568,",",0,0
239569,38,0,0
239570,patients,0,0
239571,(,0,0
239572,19.3,0,0
239573,%,0,0
239574,),0,0
239575,had,0,0
239576,cesarean,0,0
239577,deliveries,0,0
239578,.,0,0
239579,There,0,0
239580,was,0,0
239581,a,0,0
239582,significantly,0,0
239583,lower,0,0
239584,prevalence,0,0
239585,of,0,0
239586,tachysystole,0,0
239587,(,0,0
239588,six,0,0
239589,or,0,0
239590,more,0,0
239591,uterine,0,0
239592,contractions,0,0
239593,in,0,0
239594,a,0,0
239595,10-minute,0,1
239596,window,0,0
239597,for,0,0
239598,two,0,0
239599,consecutive,0,0
239600,10-minute,0,1
239601,periods,0,0
239602,),0,0
239603,in,0,0
239604,the,0,0
239605,misoprostol,1,1
239606,group,0,0
239607,(,0,0
239608,7.1,0,0
239609,%,0,0
239610,),0,0
239611,than,0,0
239612,in,0,0
239613,the,0,0
239614,dinoprostone,1,1
239615,group,0,0
239616,(,0,0
239617,18.4,0,0
239618,%,0,0
239619,),0,1
239620,(,0,0
239621,relative,0,0
239622,risk,0,0
239623,0.52,0,0
239624,",",0,0
239625,95,0,0
239626,%,0,0
239627,confidence,0,0
239628,interval,0,0
239629,0.31,0,0
239630,to,0,0
239631,0.89,0,0
239632,",",0,0
239633,p,0,0
239634,=,0,0
239635,0.02,0,0
239636,),0,0
239637,.,0,0
239638,There,0,0
239639,were,0,0
239640,no,0,0
239641,significant,0,0
239642,differences,0,0
239643,in,0,0
239644,frequency,0,0
239645,of,0,0
239646,uterine,0,0
239647,hyperstimulation,0,0
239648,or,0,1
239649,hypertonus,0,0
239650,.,0,1
239651,Abnormal,0,0
239652,fetal,0,0
239653,heart,0,0
239654,rate,0,0
239655,tracings,0,0
239656,were,0,0
239657,found,0,0
239658,in,0,0
239659,23,0,0
239660,(,0,0
239661,23.2,0,0
239662,%,0,0
239663,),0,0
239664,of,0,0
239665,misoprostol-treated,1,1
239666,patients,0,0
239667,and,0,0
239668,35,0,0
239669,(,0,0
239670,35.7,0,0
239671,%,0,0
239672,),0,0
239673,of,0,0
239674,dinoprostone-treated,1,1
239675,patients,0,0
239676,(,0,0
239677,relative,0,0
239678,risk,0,0
239679,0.73,0,0
239680,",",0,0
239681,95,0,0
239682,%,0,0
239683,confidence,0,0
239684,interval,0,0
239685,0.52,0,0
239686,to,0,0
239687,1.01,0,0
239688,",",0,0
239689,p,0,0
239690,=,0,0
239691,0.0546,0,0
239692,),0,0
239693,.,0,0
239694,No,0,0
239695,significant,0,0
239696,differences,0,0
239697,were,0,0
239698,found,0,0
239699,in,0,0
239700,meconium,0,0
239701,passage,0,0
239702,",",0,0
239703,1-,0,1
239704,or,0,1
239705,5-minute,0,1
239706,Apgar,0,0
239707,scores,0,0
239708,<,0,0
239709,7,0,0
239710,",",0,0
239711,neonatal,0,0
239712,resuscitations,0,1
239713,",",0,0
239714,or,0,0
239715,admissions,0,0
239716,to,0,0
239717,the,0,0
239718,neonatal,0,0
239719,intensive,0,1
239720,care,0,1
239721,unit,0,0
239722,between,0,0
239723,the,0,0
239724,two,0,0
239725,groups,0,0
239726,.,0,0
239727,CONCLUSIONS,0,0
239728,Vaginally,0,0
239729,administered,0,0
239730,misoprostol,1,1
239731,is,0,0
239732,as,0,0
239733,effective,0,0
239734,as,0,0
239735,dinoprostone,0,1
239736,for,0,0
239737,cervical,0,1
239738,ripening,0,1
239739,and,0,0
239740,the,0,0
239741,induction,0,0
239742,of,0,0
239743,labor,0,0
239744,.,0,0
239745,Mean,0,0
239746,time,0,0
239747,intervals,0,0
239748,to,0,0
239749,delivery,0,0
239750,",",0,0
239751,need,0,0
239752,for,0,0
239753,oxytocin,1,1
239754,augmentation,0,0
239755,",",0,0
239756,and,0,0
239757,routes,0,0
239758,of,0,0
239759,delivery,0,0
239760,were,0,0
239761,similar,0,0
239762,between,0,0
239763,the,0,0
239764,two,0,0
239765,groups,0,0
239766,.,0,0
239767,Incidence,0,0
239768,of,0,0
239769,uterine,0,0
239770,tachysystole,0,0
239771,with,0,0
239772,misoprostol,1,1
239773,every,0,1
239774,4,0,0
239775,hours,0,0
239776,was,0,0
239777,significantly,0,0
239778,less,0,0
239779,than,0,0
239780,with,0,0
239781,dinoprostone,1,1
239782,.,1,0
239783,Lack,0,1
239784,of,0,0
239785,effect,0,0
239786,of,0,0
239787,food,1,0
239788,on,0,0
239789,the,0,0
239790,steady,0,0
239791,state,0,0
239792,pharmacokinetics,0,0
239793,of,0,0
239794,BMS-181101,0,0
239795,",",0,0
239796,an,0,0
239797,antidepressant,0,1
239798,",",0,0
239799,in,0,0
239800,healthy,0,0
239801,subjects,0,0
239802,.,0,0
239803,The,0,0
239804,effect,0,0
239805,of,0,0
239806,food,0,0
239807,on,0,0
239808,the,0,0
239809,pharmacokinetics,0,0
239810,of,0,0
239811,BMS-181101,1,0
239812,",",0,0
239813,a,0,0
239814,new,0,0
239815,anti-depressant,0,1
239816,under,0,0
239817,development,0,0
239818,",",0,0
239819,was,0,0
239820,investigated,0,0
239821,in,0,0
239822,12,0,0
239823,healthy,0,0
239824,male,0,0
239825,volunteers,0,0
239826,at,0,0
239827,steady,0,0
239828,state,0,0
239829,.,0,0
239830,Each,0,0
239831,subject,0,0
239832,received,0,0
239833,a,0,0
239834,15,1,0
239835,mg,1,1
239836,oral,1,1
239837,dose,1,0
239838,of,1,0
239839,BMS-181101,1,1
239840,twice,1,1
239841,a,1,0
239842,day,1,1
239843,(,0,0
239844,q,0,1
239845,12,0,1
239846,h,0,0
239847,),0,0
239848,for,0,0
239849,11,0,0
239850,days,0,0
239851,and,0,0
239852,a,0,0
239853,morning,1,0
239854,dose,1,0
239855,of,1,0
239856,BMS-181101,1,1
239857,on,1,0
239858,day,1,0
239859,12,1,0
239860,.,1,0
239861,Six,0,0
239862,subjects,0,0
239863,were,0,0
239864,randomly,0,0
239865,assigned,0,0
239866,to,0,0
239867,receive,0,0
239868,BMS-181101,1,1
239869,under,0,0
239870,fasted,0,0
239871,conditions,0,0
239872,from,0,0
239873,days,0,0
239874,1,0,0
239875,to,0,0
239876,6,0,0
239877,and,0,0
239878,then,0,0
239879,crossed,0,1
239880,over,0,0
239881,to,0,0
239882,fed,0,0
239883,conditions,0,0
239884,from,0,0
239885,days,0,0
239886,7,0,0
239887,to,0,0
239888,12,0,0
239889,.,0,0
239890,The,0,0
239891,other,0,0
239892,six,0,0
239893,subjects,0,0
239894,received,0,0
239895,the,0,0
239896,reverse,0,0
239897,conditions,0,0
239898,",",0,0
239899,fed,0,0
239900,for,0,0
239901,days,0,0
239902,1-6,0,0
239903,and,0,0
239904,fasted,0,1
239905,for,0,0
239906,days,0,0
239907,7-12,0,0
239908,.,0,0
239909,Serial,0,0
239910,blood,0,0
239911,samples,0,0
239912,were,0,0
239913,collected,0,0
239914,up,0,0
239915,to,0,0
239916,12,0,0
239917,h,0,0
239918,on,0,0
239919,days,0,0
239920,6,0,0
239921,and,0,0
239922,12,0,0
239923,following,0,0
239924,the,0,0
239925,administration,0,0
239926,of,0,0
239927,the,0,0
239928,morning,0,0
239929,dose,0,0
239930,.,0,0
239931,In,0,0
239932,addition,0,0
239933,",",0,0
239934,trough,0,0
239935,blood,0,0
239936,samples,0,0
239937,were,0,0
239938,collected,0,0
239939,on,0,0
239940,days,0,0
239941,4,0,0
239942,",",0,0
239943,5,0,0
239944,",",0,0
239945,10,0,0
239946,",",0,0
239947,and,0,0
239948,11,0,0
239949,prior,0,0
239950,to,0,0
239951,the,0,0
239952,morning,0,0
239953,dose,0,0
239954,.,0,0
239955,Plasma,0,0
239956,samples,0,0
239957,were,0,0
239958,analyzed,0,0
239959,for,0,0
239960,intact,0,0
239961,BMS-181101,1,1
239962,using,0,0
239963,a,0,0
239964,validated,0,0
239965,high-performance,0,0
239966,liquid,0,1
239967,chromatography,0,1
239968,method,0,1
239969,with,0,0
239970,an,0,0
239971,electrochemical,0,0
239972,detector,0,1
239973,.,0,0
239974,BMS-181101,0,0
239975,was,0,0
239976,well,0,0
239977,tolerated,0,0
239978,both,0,0
239979,with,0,0
239980,and,0,0
239981,without,0,1
239982,ingestion,0,0
239983,of,0,0
239984,food,0,0
239985,.,0,0
239986,The,0,0
239987,statistical,0,0
239988,evaluation,0,0
239989,of,0,0
239990,the,0,0
239991,Cmin,0,0
239992,values,0,0
239993,indicated,0,0
239994,that,0,0
239995,steady,0,0
239996,state,0,0
239997,of,0,0
239998,BMS-181101,1,1
239999,was,0,0
240000,achieved,0,0
240001,by,0,0
240002,the,0,0
240003,fourth,0,0
240004,day,0,0
240005,of,0,0
240006,dosing,0,0
240007,regardless,0,0
240008,of,0,0
240009,whether,0,0
240010,the,0,0
240011,subject,0,0
240012,was,0,0
240013,fasted,0,1
240014,or,0,0
240015,fed,0,1
240016,.,0,0
240017,When,0,0
240018,BMS-181101,0,0
240019,was,0,0
240020,administered,0,0
240021,with,0,0
240022,food,0,0
240023,",",0,0
240024,Cmax,0,0
240025,was,0,0
240026,reduced,0,0
240027,by,0,0
240028,about,0,0
240029,25,0,0
240030,%,0,0
240031,and,0,0
240032,tmax,0,0
240033,was,0,0
240034,prolonged,0,0
240035,by,0,0
240036,1,0,0
240037,h.,0,0
240038,However,0,0
240039,",",0,0
240040,AUCtau,0,0
240041,",",0,0
240042,t1/2,0,0
240043,",",0,0
240044,and,0,0
240045,time,0,0
240046,to,0,0
240047,attain,0,0
240048,steady,0,0
240049,state,0,0
240050,of,0,0
240051,BMS-181101,0,1
240052,were,0,0
240053,not,0,0
240054,altered,0,0
240055,by,0,0
240056,ingestion,0,0
240057,of,0,0
240058,food,0,0
240059,.,0,0
240060,In,0,0
240061,summary,0,0
240062,",",0,0
240063,BMS-181101,1,1
240064,can,0,0
240065,be,0,0
240066,given,0,0
240067,with,0,0
240068,food,0,0
240069,without,0,0
240070,adversely,0,0
240071,impacting,0,0
240072,the,0,0
240073,safety,0,0
240074,or,0,1
240075,pharmacokinetic,0,0
240076,profiles,0,0
240077,of,0,0
240078,the,0,0
240079,drug,0,0
240080,.,0,0
240081,Intravenous,1,1
240082,magnesium,1,1
240083,sulfate,1,1
240084,in,0,0
240085,acute,0,0
240086,severe,0,0
240087,asthma,0,0
240088,not,0,0
240089,responding,0,0
240090,to,0,0
240091,conventional,1,1
240092,therapy,1,1
240093,.,1,0
240094,OBJECTIVE,0,0
240095,To,0,0
240096,evaluate,0,0
240097,the,0,0
240098,effectiveness,0,0
240099,of,0,0
240100,early,0,0
240101,administration,0,0
240102,of,0,0
240103,intravenous,1,1
240104,Magnesium,1,1
240105,sulfate,1,1
240106,(,1,0
240107,i.v,1,1
240108,.,1,1
240109,MgSO4,1,0
240110,),1,0
240111,in,0,0
240112,children,0,0
240113,with,0,0
240114,acute,0,0
240115,severe,0,0
240116,asthma,0,0
240117,not,0,0
240118,responding,0,0
240119,to,0,0
240120,conventional,1,1
240121,therapy,1,1
240122,.,1,0
240123,DESIGN,0,0
240124,Randomized,0,0
240125,double-blind,0,0
240126,",",0,0
240127,placebo-controlled,1,1
240128,trial,0,0
240129,.,0,0
240130,SETTING,0,0
240131,Pediatric,0,0
240132,emergency,0,1
240133,service,0,1
240134,of,0,0
240135,a,0,0
240136,large,0,0
240137,teaching,0,1
240138,hospital,0,0
240139,.,0,0
240140,SUBJECTS,0,0
240141,47,0,0
240142,children,0,0
240143,aged,0,0
240144,between,0,0
240145,1-12,0,0
240146,years,0,0
240147,with,0,0
240148,acute,0,0
240149,severe,0,0
240150,asthma,0,0
240151,showing,0,0
240152,inadequate,0,0
240153,or,0,1
240154,poor,0,0
240155,response,0,0
240156,to,0,0
240157,3,0,0
240158,doses,0,0
240159,of,0,0
240160,nebulized,1,1
240161,salbutamol,1,1
240162,given,0,0
240163,at,0,0
240164,an,0,0
240165,interval,0,0
240166,of,0,0
240167,20,0,0
240168,min,0,0
240169,each,0,0
240170,.,0,0
240171,INTERVENTION,0,0
240172,The,0,0
240173,MgSO4,1,0
240174,group,0,0
240175,received,1,1
240176,0.2,1,1
240177,ml/kg,1,0
240178,of,1,0
240179,50,1,0
240180,%,1,0
240181,MgSO4,1,0
240182,as,1,0
240183,intravenous,1,1
240184,(,1,0
240185,i.v,1,1
240186,.,1,1
240187,),1,0
240188,infusion,1,0
240189,over,0,0
240190,35,0,0
240191,minutes,0,0
240192,and,0,0
240193,the,0,0
240194,placebo,1,1
240195,group,0,0
240196,received,0,1
240197,normal,1,0
240198,saline,1,1
240199,infusion,1,1
240200,in,0,0
240201,the,0,0
240202,same,0,0
240203,dose,0,0
240204,and,0,0
240205,at,0,0
240206,the,0,0
240207,same,0,0
240208,rate,0,0
240209,.,0,0
240210,MgSO4,1,0
240211,solution,1,1
240212,and,0,0
240213,normal,1,0
240214,saline,1,1
240215,were,0,0
240216,coded,0,0
240217,and,0,0
240218,dispensed,0,1
240219,in,0,0
240220,identical,0,0
240221,containers,0,1
240222,.,0,0
240223,Decoding,0,0
240224,was,0,0
240225,done,0,0
240226,at,0,0
240227,the,0,0
240228,completion,0,0
240229,of,0,0
240230,the,0,0
240231,study,0,0
240232,.,0,0
240233,All,0,0
240234,the,0,0
240235,patients,0,0
240236,received,0,0
240237,oxygen,1,0
240238,",",1,0
240239,nebulized,1,1
240240,salbutamol,1,1
240241,",",1,0
240242,i.v,1,1
240243,.,1,1
240244,aminophylline,1,1
240245,and,0,0
240246,corticosteroids,1,1
240247,.,1,0
240248,RESULTS,0,0
240249,MgSO4,1,0
240250,group,0,0
240251,showed,0,0
240252,early,0,0
240253,and,0,0
240254,significant,0,0
240255,improvement,0,0
240256,as,0,0
240257,compared,0,0
240258,to,0,0
240259,placebo,1,1
240260,group,0,0
240261,in,0,0
240262,PEFR,0,1
240263,and,0,0
240264,SaO2,0,1
240265,at,0,0
240266,30,0,0
240267,min,0,0
240268,and,0,0
240269,1,0,0
240270,",",0,0
240271,2,0,0
240272,",",0,0
240273,3,0,0
240274,and,0,0
240275,7,0,0
240276,hours,0,0
240277,after,0,0
240278,stopping,0,0
240279,the,0,0
240280,infusion,0,1
240281,(,0,0
240282,p,0,0
240283,ranging,0,0
240284,from,0,0
240285,<,0,0
240286,0.05,0,0
240287,to,0,0
240288,<,0,0
240289,0.01,0,0
240290,),0,0
240291,.,0,0
240292,The,0,0
240293,clinical,0,0
240294,asthma,0,0
240295,score,0,0
240296,also,0,0
240297,showed,0,0
240298,significant,0,0
240299,improvement,0,0
240300,in,0,0
240301,the,0,0
240302,MgSO4,1,0
240303,group,0,0
240304,1,0,0
240305,",",0,0
240306,2,0,0
240307,",",0,0
240308,3,0,0
240309,and,0,0
240310,11,0,0
240311,hours,0,0
240312,after,0,0
240313,stopping,0,0
240314,the,0,0
240315,infusion,0,1
240316,(,0,0
240317,p,0,0
240318,<,0,0
240319,0.01,0,0
240320,),0,0
240321,.,0,0
240322,CONCLUSION,0,0
240323,Addition,0,0
240324,of,0,0
240325,MgSO4,1,0
240326,to,0,0
240327,conventional,1,1
240328,therapy,1,1
240329,helps,0,0
240330,in,0,0
240331,achieving,0,0
240332,earlier,0,0
240333,improvement,0,0
240334,in,0,0
240335,clinical,0,0
240336,signs,0,0
240337,and,0,0
240338,symptoms,0,0
240339,of,0,0
240340,asthma,0,0
240341,and,0,0
240342,PEFR,0,1
240343,in,0,0
240344,patients,0,0
240345,not,0,0
240346,responding,0,0
240347,to,0,0
240348,conventional,0,1
240349,therapy,0,1
240350,alone,0,1
240351,.,0,0
240352,The,0,0
240353,influence,0,0
240354,of,0,0
240355,preoperative,0,0
240356,antibiotics,1,1
240357,on,0,0
240358,success,0,0
240359,of,0,0
240360,endosseous,1,1
240361,implants,1,1
240362,up,0,0
240363,to,0,0
240364,and,0,0
240365,including,0,0
240366,stage,0,0
240367,II,0,1
240368,surgery,0,1
240369,:,0,0
240370,a,0,0
240371,study,0,0
240372,of,0,0
240373,"2,641",0,0
240374,implants,0,1
240375,.,0,0
240376,According,0,0
240377,to,0,0
240378,the,0,0
240379,American,0,0
240380,College,0,0
240381,of,0,0
240382,Surgeons,0,0
240383,",",0,0
240384,complex,0,0
240385,oral,0,1
240386,surgical,0,1
240387,procedures,0,0
240388,",",0,0
240389,including,0,0
240390,the,0,0
240391,transoral,0,1
240392,placement,0,1
240393,of,0,0
240394,endosseous,0,1
240395,implants,0,1
240396,",",0,0
240397,are,0,0
240398,of,0,0
240399,the,0,0
240400,type,0,0
240401,that,0,0
240402,may,0,0
240403,require,0,0
240404,prophylactic,1,1
240405,antibiotics,1,1
240406,.,1,0
240407,However,0,0
240408,",",0,0
240409,the,0,0
240410,routine,0,0
240411,use,0,0
240412,of,0,0
240413,prophylactic,1,1
240414,antibiotics,1,1
240415,in,0,0
240416,the,0,0
240417,field,0,0
240418,of,0,0
240419,dental,0,0
240420,implantology,0,1
240421,continues,0,0
240422,to,0,0
240423,be,0,0
240424,controversial,0,0
240425,",",0,0
240426,and,0,0
240427,their,0,0
240428,utilization,0,0
240429,varies,0,0
240430,widely,0,0
240431,.,0,0
240432,No,0,0
240433,data,0,0
240434,from,0,0
240435,a,0,0
240436,randomized,0,0
240437,prospective,0,0
240438,clinical,0,0
240439,study,0,0
240440,of,0,0
240441,the,0,0
240442,prophylactic,0,1
240443,use,0,0
240444,of,0,0
240445,antibiotics,1,1
240446,in,0,0
240447,implant,0,1
240448,surgery,0,1
240449,have,0,0
240450,been,0,0
240451,previously,0,0
240452,published,0,0
240453,.,0,0
240454,As,0,0
240455,part,0,0
240456,of,0,0
240457,the,0,0
240458,comprehensive,0,0
240459,Dental,0,0
240460,Implant,0,1
240461,Clinical,0,0
240462,Research,0,0
240463,Group,0,0
240464,clinical,0,0
240465,implant,0,1
240466,study,0,0
240467,",",0,0
240468,the,0,0
240469,preoperative,0,0
240470,or,0,1
240471,postoperative,0,0
240472,use,0,0
240473,of,0,0
240474,antibiotics,1,1
240475,",",0,0
240476,the,0,0
240477,type,0,0
240478,used,0,0
240479,",",0,0
240480,and,0,0
240481,the,0,0
240482,duration,0,0
240483,of,0,0
240484,coverage,0,0
240485,was,0,0
240486,left,0,0
240487,to,0,0
240488,the,0,0
240489,discretion,0,0
240490,of,0,0
240491,the,0,0
240492,surgeon,0,0
240493,.,0,0
240494,These,0,0
240495,data,0,0
240496,were,0,0
240497,recorded,0,0
240498,and,0,0
240499,correlated,0,0
240500,with,0,0
240501,failure,0,0
240502,of,0,0
240503,osseointegration,0,0
240504,during,0,0
240505,healing,0,0
240506,(,0,0
240507,stage,0,0
240508,I,0,0
240509,),0,0
240510,and,0,0
240511,at,0,0
240512,stage,0,0
240513,II,0,1
240514,surgery,0,1
240515,(,0,1
240516,uncovering,0,0
240517,),0,0
240518,.,0,0
240519,The,0,0
240520,results,0,0
240521,showed,0,0
240522,that,0,0
240523,significantly,0,0
240524,fewer,0,0
240525,failures,0,0
240526,occurred,0,0
240527,when,0,0
240528,preoperative,0,0
240529,antibiotics,1,1
240530,were,0,0
240531,used,0,0
240532,.,0,0
240533,Long-term,0,0
240534,follow-up,0,0
240535,of,0,0
240536,three,0,0
240537,randomized,0,0
240538,trials,0,0
240539,comparing,0,0
240540,idarubicin,1,1
240541,and,1,0
240542,daunorubicin,1,1
240543,as,0,0
240544,induction,0,0
240545,therapies,0,1
240546,for,0,0
240547,patients,0,0
240548,with,0,0
240549,untreated,0,0
240550,acute,0,0
240551,myeloid,0,0
240552,leukemia,0,0
240553,.,0,0
240554,BACKGROUND,0,0
240555,Most,0,0
240556,clinical,0,0
240557,trials,0,0
240558,for,0,0
240559,acute,0,0
240560,leukemia,0,0
240561,have,0,0
240562,reported,0,0
240563,results,0,0
240564,after,0,0
240565,2-3,0,0
240566,years,0,0
240567,of,0,0
240568,follow-up,0,0
240569,.,0,0
240570,Comparisons,0,0
240571,between,0,0
240572,the,0,0
240573,original,0,0
240574,data,0,0
240575,and,0,0
240576,longer-term,0,0
240577,follow-up,0,0
240578,data,0,0
240579,may,0,0
240580,be,0,0
240581,of,0,0
240582,interest,0,0
240583,",",0,0
240584,particularly,0,0
240585,with,0,0
240586,regard,0,0
240587,to,0,0
240588,promising,0,0
240589,new,0,0
240590,therapies,0,1
240591,.,0,0
240592,METHODS,0,0
240593,In,0,0
240594,1996,0,0
240595,",",0,0
240596,survival,0,0
240597,data,0,0
240598,were,0,0
240599,updated,0,0
240600,from,0,0
240601,three,0,0
240602,prospective,0,0
240603,",",0,0
240604,randomized,0,0
240605,comparisons,0,0
240606,of,0,0
240607,idarubicin,1,1
240608,and,1,0
240609,daunorubicin,1,1
240610,that,0,0
240611,began,0,0
240612,in,0,0
240613,1984,0,0
240614,and,0,0
240615,1985,0,0
240616,.,0,0
240617,These,0,0
240618,were,0,0
240619,trials,0,0
240620,of,0,0
240621,the,0,0
240622,Memorial,0,0
240623,Sloan-Kettering,0,0
240624,Cancer,0,1
240625,Center,0,0
240626,(,0,1
240627,MSKCC,0,1
240628,),0,0
240629,",",0,0
240630,the,0,0
240631,U.S.,0,1
240632,Multicenter,0,0
240633,Study,0,0
240634,Group,0,0
240635,",",0,0
240636,and,0,0
240637,the,0,0
240638,Southeastern,0,0
240639,Cancer,0,0
240640,Study,0,0
240641,Group,0,0
240642,(,0,1
240643,SEG,0,1
240644,),0,0
240645,.,0,0
240646,The,0,0
240647,original,0,0
240648,results,0,0
240649,of,0,0
240650,these,0,0
240651,trials,0,0
240652,were,0,0
240653,reported,0,0
240654,in,0,0
240655,1991,0,0
240656,and,0,0
240657,1992,0,0
240658,.,0,0
240659,RESULTS,0,0
240660,The,0,0
240661,original,0,0
240662,results,0,0
240663,of,0,0
240664,the,0,0
240665,SEG,0,1
240666,trial,0,0
240667,demonstrated,0,0
240668,no,0,0
240669,significant,0,0
240670,difference,0,0
240671,between,0,0
240672,idarubicin,0,1
240673,and,0,0
240674,daunorubicin,0,1
240675,.,0,0
240676,The,0,0
240677,updated,0,0
240678,survival,0,0
240679,analysis,0,0
240680,showed,0,0
240681,similar,0,0
240682,results,0,0
240683,.,0,0
240684,The,0,0
240685,MSKCC,0,0
240686,trial,0,0
240687,revealed,0,0
240688,a,0,0
240689,significant,0,0
240690,advantage,0,0
240691,of,0,0
240692,idarubicin,0,1
240693,compared,0,0
240694,with,0,0
240695,daunorubicin,0,1
240696,in,0,0
240697,both,0,0
240698,the,0,0
240699,original,0,0
240700,and,0,0
240701,the,0,0
240702,updated,0,0
240703,analyses,0,0
240704,.,0,0
240705,The,0,0
240706,U.S.,0,1
240707,Multicenter,0,0
240708,trial,0,0
240709,found,0,0
240710,a,0,0
240711,significant,0,0
240712,difference,0,0
240713,favoring,0,0
240714,idarubicin,0,1
240715,in,0,0
240716,the,0,0
240717,original,0,0
240718,analysis,0,0
240719,",",0,0
240720,but,0,0
240721,the,0,0
240722,difference,0,0
240723,was,0,0
240724,not,0,0
240725,significant,0,0
240726,in,0,0
240727,the,0,0
240728,updated,0,0
240729,analysis,0,0
240730,.,0,0
240731,CONCLUSIONS,0,0
240732,It,0,0
240733,is,0,0
240734,essential,0,0
240735,that,0,0
240736,the,0,0
240737,median,0,0
240738,length,0,0
240739,of,0,0
240740,follow-up,0,0
240741,be,0,0
240742,clearly,0,0
240743,stated,0,0
240744,in,0,0
240745,any,0,0
240746,clinical,0,0
240747,trial,0,0
240748,.,0,0
240749,When,0,0
240750,the,0,0
240751,results,0,0
240752,obtained,0,0
240753,with,0,0
240754,a,0,0
240755,particularly,0,0
240756,promising,0,0
240757,new,0,0
240758,drug,0,1
240759,or,0,1
240760,procedure,0,0
240761,are,0,0
240762,presented,0,0
240763,early,0,0
240764,in,0,0
240765,the,0,0
240766,course,0,0
240767,of,0,0
240768,study,0,0
240769,(,0,0
240770,within,0,0
240771,1-2,0,0
240772,years,0,0
240773,),0,0
240774,",",0,0
240775,the,0,0
240776,investigators,0,0
240777,should,0,0
240778,strongly,0,0
240779,consider,0,0
240780,a,0,0
240781,repeat,0,0
240782,evaluation,0,0
240783,after,0,0
240784,an,0,0
240785,additional,0,0
240786,3-5,0,0
240787,years,0,0
240788,of,0,0
240789,follow-up,0,0
240790,.,0,0
240791,Lower,0,0
240792,extremity,0,0
240793,deep,0,1
240794,vein,0,0
240795,thrombosis,0,0
240796,:,0,0
240797,a,0,0
240798,prospective,0,0
240799,",",0,0
240800,randomized,0,0
240801,",",0,0
240802,controlled,0,0
240803,trial,0,0
240804,in,0,0
240805,comatose,0,0
240806,or,0,1
240807,sedated,0,1
240808,patients,0,0
240809,undergoing,0,0
240810,femoral,1,1
240811,vein,1,0
240812,catheterization,1,1
240813,.,1,0
240814,OBJECTIVES,0,0
240815,To,0,0
240816,determine,0,0
240817,the,0,0
240818,rate,0,0
240819,of,0,0
240820,lower,0,0
240821,extremity,0,0
240822,deep,0,1
240823,vein,0,0
240824,thrombosis,0,0
240825,after,0,0
240826,the,0,0
240827,use,0,0
240828,of,0,0
240829,femoral,1,0
240830,catheters,1,1
240831,in,0,0
240832,intensive,0,1
240833,care,0,1
240834,unit,0,1
240835,(,0,1
240836,ICU,0,1
240837,),0,1
240838,comatose,0,0
240839,or,0,1
240840,sedated,0,1
240841,adults,0,0
240842,.,0,0
240843,Results,0,0
240844,were,0,0
240845,then,0,0
240846,compared,0,0
240847,with,0,0
240848,results,0,0
240849,of,0,0
240850,patients,0,0
240851,undergoing,0,0
240852,superior,1,0
240853,vena,1,0
240854,cava,1,0
240855,catheterization,1,1
240856,.,1,0
240857,DESIGN,0,0
240858,Prospective,0,0
240859,",",0,0
240860,randomized,0,0
240861,",",0,0
240862,controlled,0,0
240863,",",0,0
240864,unblinded,0,0
240865,study,0,0
240866,.,0,0
240867,SETTING,0,0
240868,A,0,0
240869,mixed,0,1
240870,medical/surgical,0,0
240871,ICU,0,1
240872,in,0,0
240873,a,0,0
240874,university,0,0
240875,hospital,0,0
240876,.,0,0
240877,PATIENTS,0,0
240878,Sixty-one,0,0
240879,comatose,0,0
240880,or,0,1
240881,sedated,0,1
240882,patients,0,0
240883,admitted,0,0
240884,to,0,0
240885,the,0,0
240886,ICU,0,1
240887,who,0,0
240888,underwent,0,0
240889,central,1,0
240890,venous,1,0
240891,catheterization,1,1
240892,.,1,0
240893,INTERVENTIONS,0,0
240894,Patients,0,0
240895,were,0,0
240896,monitored,0,0
240897,for,0,0
240898,signs,0,0
240899,of,0,0
240900,thrombotic,0,0
240901,complications,0,0
240902,.,0,0
240903,On,0,0
240904,catheter,0,1
240905,removal,0,0
240906,",",0,0
240907,a,0,0
240908,lower-extremity,0,0
240909,bilateral,0,1
240910,phlebographic,0,0
240911,examination,0,0
240912,was,0,0
240913,performed,0,0
240914,in,0,0
240915,each,0,0
240916,patient,0,0
240917,.,0,0
240918,MEASUREMENTS,0,0
240919,AND,0,0
240920,MAIN,0,1
240921,RESULTS,0,0
240922,After,0,0
240923,randomization,0,0
240924,",",0,0
240925,31,0,0
240926,patients,0,0
240927,underwent,0,0
240928,femoral,1,1
240929,vein,1,1
240930,catheterization,1,1
240931,and,0,0
240932,30,0,0
240933,patients,0,0
240934,underwent,0,0
240935,superior,1,0
240936,vena,1,0
240937,cava,1,0
240938,catheterization,1,1
240939,",",0,0
240940,either,0,0
240941,by,0,0
240942,axillary,0,0
240943,(,0,0
240944,21,0,0
240945,patients,0,0
240946,),0,0
240947,or,0,1
240948,internal,0,1
240949,jugular,0,0
240950,vein,0,1
240951,(,0,0
240952,10,0,1
240953,patients,0,0
240954,),0,0
240955,cannulation,0,0
240956,.,0,0
240957,Single,1,1
240958,lumen,1,0
240959,polyurethane,1,1
240960,catheters,1,1
240961,were,0,0
240962,inserted,0,0
240963,for,0,0
240964,a,0,0
240965,mean,0,0
240966,duration,0,0
240967,of,0,0
240968,7.1,0,0
240969,+/-,0,0
240970,4.6,0,0
240971,(,0,0
240972,SD,0,0
240973,),0,1
240974,days,0,0
240975,in,0,0
240976,the,0,0
240977,femoral,1,1
240978,vein,1,1
240979,group,1,0
240980,and,0,0
240981,9.9,0,0
240982,+/-,0,0
240983,5.5,0,0
240984,days,0,0
240985,in,0,0
240986,the,0,0
240987,superior,1,0
240988,vena,1,0
240989,cava,1,0
240990,group,1,1
240991,(,0,0
240992,p,0,0
240993,=,0,0
240994,NS,0,0
240995,),0,0
240996,.,0,0
240997,No,0,0
240998,patient,0,0
240999,had,0,0
241000,clinical,0,0
241001,signs,0,0
241002,of,0,0
241003,leg,0,0
241004,venous,0,1
241005,thrombosis,0,0
241006,or,0,1
241007,pulmonary,0,0
241008,embolism,0,0
241009,during,0,0
241010,the,0,0
241011,study,0,0
241012,period,0,0
241013,.,0,0
241014,In,0,0
241015,each,0,0
241016,patient,0,0
241017,",",0,0
241018,lower,1,0
241019,extremity,1,0
241020,bilateral,1,1
241021,phlebography,1,1
241022,was,0,0
241023,performed,0,0
241024,at,0,0
241025,the,0,0
241026,time,0,0
241027,of,0,0
241028,catheter,0,1
241029,removal,0,0
241030,.,0,0
241031,Leg,0,0
241032,phlebographies,0,1
241033,were,0,0
241034,normal,0,0
241035,in,0,0
241036,18,0,0
241037,(,0,0
241038,60,0,0
241039,%,0,0
241040,),0,0
241041,patients,0,0
241042,in,0,0
241043,the,0,0
241044,femoral,0,1
241045,vein,0,1
241046,group,0,0
241047,and,0,0
241048,26,0,0
241049,(,0,0
241050,84,0,0
241051,%,0,0
241052,),0,0
241053,patients,0,0
241054,in,0,0
241055,the,0,0
241056,superior,0,0
241057,vena,0,0
241058,cava,0,0
241059,group,0,0
241060,.,0,0
241061,Fibrin,0,1
241062,sleeves,0,0
241063,which,0,0
241064,developed,0,0
241065,around,0,0
241066,the,0,0
241067,femoral,0,0
241068,catheters,0,1
241069,were,0,0
241070,seen,0,0
241071,in,0,0
241072,seven,0,0
241073,(,0,0
241074,23.3,0,0
241075,%,0,0
241076,),0,0
241077,patients,0,0
241078,in,0,0
241079,the,0,0
241080,femoral,1,1
241081,vein,1,1
241082,group,1,0
241083,and,0,0
241084,in,0,0
241085,no,0,0
241086,patients,0,0
241087,in,0,0
241088,the,0,0
241089,superior,1,0
241090,vena,1,0
241091,cava,1,0
241092,cannulation,1,1
241093,group,1,0
241094,.,1,0
241095,Three,0,0
241096,patients,0,0
241097,had,0,0
241098,femoral,0,1
241099,vein,0,0
241100,thrombosis,0,0
241101,",",0,0
241102,two,0,0
241103,(,0,0
241104,6.6,0,0
241105,%,0,0
241106,),0,0
241107,patients,0,0
241108,in,0,0
241109,the,0,0
241110,femoral,1,1
241111,vein,1,1
241112,group,1,1
241113,(,0,0
241114,two,0,0
241115,nonobstructive,0,0
241116,thromboses,0,0
241117,",",0,0
241118,adherent,0,0
241119,to,0,0
241120,the,0,0
241121,common,0,0
241122,femoral,0,1
241123,vein,0,1
241124,wall,0,0
241125,),0,1
241126,and,0,0
241127,one,0,1
241128,(,0,0
241129,3.0,0,0
241130,%,0,0
241131,),0,0
241132,patient,0,0
241133,in,0,0
241134,the,0,0
241135,superior,1,0
241136,vena,1,0
241137,cava,1,0
241138,group,1,1
241139,(,0,1
241140,nonobstructive,0,1
241141,thrombosis,0,0
241142,which,0,0
241143,developed,0,0
241144,in,0,0
241145,the,0,0
241146,superficial,0,0
241147,femoral,0,1
241148,vein,0,1
241149,),0,1
241150,(,0,0
241151,p,0,0
241152,=,0,0
241153,NS,0,0
241154,),0,0
241155,.,0,0
241156,Lower,0,0
241157,deep,0,0
241158,extremities,0,0
241159,thrombosis,0,0
241160,developed,0,0
241161,in,0,0
241162,five,0,0
241163,(,0,0
241164,16.7,0,0
241165,%,0,0
241166,),0,0
241167,patients,0,0
241168,in,0,0
241169,the,0,0
241170,femoral,0,1
241171,vein,0,1
241172,group,0,0
241173,and,0,0
241174,in,0,0
241175,five,0,0
241176,(,0,0
241177,16,0,0
241178,%,0,0
241179,),0,0
241180,patients,0,0
241181,in,0,0
241182,the,0,0
241183,superior,0,0
241184,vena,0,0
241185,cava,0,0
241186,group,0,1
241187,(,0,0
241188,p,0,0
241189,=,0,0
241190,NS,0,0
241191,),0,0
241192,.,0,0
241193,CONCLUSIONS,0,0
241194,Femoral,1,0
241195,vein,1,1
241196,catheterization,1,1
241197,with,0,0
241198,a,0,0
241199,polyurethane,0,1
241200,catheter,1,1
241201,is,0,0
241202,associated,0,0
241203,with,0,0
241204,a,0,0
241205,lower,0,0
241206,rate,0,0
241207,of,0,0
241208,extremity,0,0
241209,deep,0,1
241210,vein,0,0
241211,thrombosis,0,0
241212,which,0,0
241213,is,0,0
241214,similar,0,0
241215,to,0,0
241216,the,0,0
241217,rate,0,0
241218,observed,0,0
241219,after,0,0
241220,superior,0,0
241221,vena,0,0
241222,cannulation,0,1
241223,in,0,0
241224,comatose,0,0
241225,or,0,1
241226,sedated,0,1
241227,patients,0,0
241228,.,0,0
241229,Femoral,0,0
241230,vein,0,0
241231,thrombosis,0,0
241232,was,0,0
241233,observed,0,0
241234,at,0,0
241235,a,0,0
241236,rate,0,0
241237,of,0,0
241238,6.6,0,0
241239,%,0,0
241240,after,0,0
241241,femoral,1,1
241242,vein,1,1
241243,cannulation,1,1
241244,and,0,0
241245,a,0,0
241246,rate,0,0
241247,of,0,0
241248,3,0,0
241249,%,0,0
241250,after,0,0
241251,superior,1,0
241252,vena,1,0
241253,cava,1,0
241254,cannulation,1,0
241255,.,1,0
241256,Given,0,0
241257,the,0,0
241258,acceptable,0,0
241259,rate,0,0
241260,of,0,0
241261,this,0,0
241262,clinically,0,0
241263,important,0,0
241264,complication,0,0
241265,",",0,0
241266,femoral,1,1
241267,vein,1,0
241268,cannulation,1,1
241269,offers,0,0
241270,an,0,0
241271,attractive,0,0
241272,alternative,0,0
241273,to,0,0
241274,insertion,0,1
241275,via,0,1
241276,the,0,0
241277,vena,1,0
241278,cava,1,0
241279,in,0,0
241280,the,0,0
241281,critically,0,0
241282,ill,0,0
241283,.,0,0
241284,Twice-a-day,0,1
241285,versus,0,1
241286,four-times-a-day,0,1
241287,ofloxacin,0,1
241288,treatment,0,0
241289,of,0,0
241290,external,0,1
241291,ocular,0,0
241292,infection,0,0
241293,.,0,0
241294,PURPOSE,0,0
241295,The,0,0
241296,purpose,0,0
241297,of,0,0
241298,this,0,0
241299,study,0,0
241300,was,0,0
241301,to,0,0
241302,compare,0,0
241303,the,0,0
241304,efficacies,0,0
241305,of,0,0
241306,0.3,0,0
241307,%,0,0
241308,ofloxacin,0,1
241309,eyedrops,0,1
241310,",",0,0
241311,when,0,0
241312,given,0,0
241313,twice-a-day,0,1
241314,(,0,1
241315,BID,0,1
241316,),0,1
241317,versus,0,1
241318,four-times-a-day,0,1
241319,(,0,1
241320,QID,0,1
241321,),0,0
241322,",",0,0
241323,for,0,0
241324,the,0,0
241325,treatment,0,0
241326,of,0,0
241327,external,0,1
241328,ocular,0,0
241329,disease,0,0
241330,.,0,0
241331,METHOD,0,0
241332,Fifty,0,0
241333,patients,0,0
241334,with,0,0
241335,blepharitis,0,0
241336,",",0,0
241337,conjuctivitis,0,0
241338,",",0,0
241339,or,0,1
241340,blepharoconjunctivitis,0,1
241341,were,0,0
241342,randomly,0,0
241343,assigned,0,0
241344,to,0,0
241345,treatment,1,0
241346,with,1,0
241347,0.3,1,0
241348,%,1,0
241349,ofloxacin,1,1
241350,eyedrops,1,1
241351,",",1,0
241352,BID,1,1
241353,or,1,1
241354,QID,1,1
241355,",",1,0
241356,for,1,0
241357,10,1,0
241358,days,1,0
241359,.,1,0
241360,Signs,0,0
241361,",",0,0
241362,symptoms,0,0
241363,",",0,0
241364,and,0,0
241365,cultures,0,0
241366,were,0,0
241367,evaluated,0,0
241368,at,0,0
241369,the,0,0
241370,beginning,0,0
241371,and,0,0
241372,at,0,0
241373,the,0,0
241374,end,0,0
241375,of,0,0
241376,the,0,0
241377,study,0,0
241378,.,0,0
241379,RESULTS,0,0
241380,The,0,0
241381,clinical,0,0
241382,outcome,0,0
241383,was,0,0
241384,virtually,0,0
241385,identical,0,0
241386,in,0,0
241387,the,0,0
241388,two,0,0
241389,groups,0,0
241390,.,0,0
241391,There,0,0
241392,was,0,0
241393,a,0,0
241394,significant,0,0
241395,decrease,0,0
241396,in,0,0
241397,clinical,0,0
241398,scores,0,0
241399,in,0,0
241400,the,0,0
241401,BID,0,1
241402,and,0,0
241403,QID,0,1
241404,groups,0,0
241405,by,0,0
241406,days,0,0
241407,3,0,0
241408,to,0,0
241409,5,0,0
241410,(,0,0
241411,2.6-3.0,0,0
241412,points,0,0
241413,),0,0
241414,and,0,0
241415,a,0,0
241416,further,0,0
241417,decrease,0,0
241418,by,0,0
241419,day,0,1
241420,11,0,0
241421,(,0,0
241422,4.3-5.0,0,0
241423,points,0,0
241424,),0,0
241425,.,0,0
241426,There,0,0
241427,was,0,0
241428,no,0,0
241429,significant,0,0
241430,difference,0,0
241431,between,0,0
241432,the,0,0
241433,two,0,0
241434,groups,0,0
241435,at,0,0
241436,any,0,0
241437,time,0,0
241438,interval,0,0
241439,.,0,0
241440,Microbiologic,0,0
241441,studies,0,0
241442,showed,0,0
241443,a,0,0
241444,reduction,0,0
241445,in,0,0
241446,colony-forming,0,0
241447,units,0,0
241448,in,0,0
241449,87,0,0
241450,%,0,0
241451,of,0,0
241452,the,0,0
241453,BID,0,1
241454,group,0,0
241455,and,0,0
241456,in,0,0
241457,80,0,0
241458,%,0,0
241459,of,0,0
241460,the,0,0
241461,QID,0,1
241462,group,0,0
241463,.,0,0
241464,CONCLUSION,0,0
241465,The,0,0
241466,treatment,0,0
241467,of,0,0
241468,external,0,1
241469,ocular,0,0
241470,disease,0,0
241471,with,0,0
241472,0.3,0,0
241473,%,0,0
241474,ofloxacin,0,1
241475,eyedrops,0,1
241476,was,0,0
241477,equally,0,0
241478,effective,0,0
241479,when,0,0
241480,given,0,0
241481,BID,0,1
241482,or,0,1
241483,QID,0,1
241484,.,0,0
241485,Randomized,0,0
241486,controlled,0,0
241487,study,0,0
241488,of,0,0
241489,customized,0,1
241490,preventive,0,1
241491,medicine,0,1
241492,reminder,0,1
241493,letters,0,1
241494,in,0,0
241495,a,0,0
241496,community,0,0
241497,practice,0,0
241498,.,0,0
241499,OBJECTIVE,0,0
241500,To,0,0
241501,test,0,0
241502,the,0,0
241503,effectiveness,0,0
241504,of,0,0
241505,customized,0,1
241506,",",0,0
241507,family-oriented,0,1
241508,reminder,0,1
241509,letters,0,1
241510,in,0,0
241511,activating,0,0
241512,patients,0,0
241513,to,0,0
241514,seek,0,0
241515,appropriate,0,0
241516,preventive,0,0
241517,services,0,1
241518,.,0,0
241519,DESIGN,0,0
241520,Randomized,0,0
241521,clinical,0,0
241522,trial,0,0
241523,.,0,0
241524,One,1,0
241525,group,1,0
241526,received,1,0
241527,computer-generated,1,0
241528,",",1,0
241529,customized,1,1
241530,letters,1,1
241531,explaining,1,0
241532,recommended,1,0
241533,preventive,1,0
241534,procedures,1,0
241535,for,1,0
241536,each,1,0
241537,family,1,1
241538,member,1,0
241539,.,1,0
241540,A,1,0
241541,second,1,0
241542,group,1,0
241543,received,1,1
241544,a,1,0
241545,form,1,0
241546,letter,1,1
241547,listing,1,1
241548,recommendations,1,0
241549,for,1,0
241550,all,1,0
241551,preventive,1,0
241552,procedures,1,0
241553,for,1,0
241554,all,1,0
241555,age,1,0
241556,and,1,0
241557,sex,1,0
241558,groups,1,0
241559,.,1,0
241560,A,1,0
241561,third,1,0
241562,group,1,0
241563,(,1,0
241564,control,1,1
241565,group,1,0
241566,),1,0
241567,received,1,0
241568,no,1,0
241569,letters,1,1
241570,.,1,0
241571,SETTING,0,0
241572,A,0,0
241573,private,0,0
241574,medical,0,0
241575,centre,0,0
241576,",",0,0
241577,without,0,0
241578,university,0,0
241579,affiliation,0,0
241580,",",0,0
241581,in,0,0
241582,rural,0,0
241583,Quebec,0,0
241584,.,0,0
241585,PARTICIPANTS,0,0
241586,From,0,0
241587,8770,0,0
241588,patients,0,0
241589,who,0,0
241590,met,0,0
241591,study,0,0
241592,criteria,0,0
241593,",",0,0
241594,719,0,0
241595,families,0,0
241596,were,0,0
241597,randomly,0,0
241598,selected,0,0
241599,.,0,0
241600,Data,0,0
241601,were,0,0
241602,available,0,0
241603,for,0,0
241604,1971,0,0
241605,of,0,0
241606,1998,0,0
241607,patients,0,0
241608,in,0,0
241609,these,0,0
241610,families,0,0
241611,.,0,0
241612,MAIN,0,0
241613,OUTCOME,0,0
241614,MEASURES,0,0
241615,The,0,0
241616,Family,0,1
241617,Received,0,0
241618,Index,0,1
241619,is,0,0
241620,the,0,0
241621,proportion,0,0
241622,of,0,0
241623,all,0,0
241624,procedures,0,0
241625,for,0,0
241626,which,0,0
241627,a,0,0
241628,family,0,0
241629,was,0,0
241630,overdue,0,0
241631,that,0,0
241632,they,0,0
241633,received,0,0
241634,.,0,0
241635,The,0,0
241636,Family,0,0
241637,End-of-study,0,0
241638,Up-to-date,0,1
241639,Index,0,1
241640,is,0,0
241641,the,0,0
241642,proportion,0,0
241643,of,0,0
241644,procedures,0,0
241645,for,0,0
241646,which,0,0
241647,the,0,0
241648,family,0,0
241649,was,0,0
241650,eligible,0,0
241651,and,0,0
241652,for,0,0
241653,which,0,0
241654,they,0,0
241655,were,0,0
241656,up-to-date,0,0
241657,at,0,0
241658,the,0,0
241659,end,0,0
241660,of,0,0
241661,the,0,0
241662,study,0,0
241663,.,0,0
241664,RESULTS,0,0
241665,The,0,0
241666,Family,0,1
241667,Received,0,0
241668,Index,0,1
241669,for,0,0
241670,families,0,1
241671,mailed,0,0
241672,customized,1,0
241673,letters,1,1
241674,was,0,0
241675,more,0,0
241676,than,0,0
241677,double,0,1
241678,the,0,0
241679,index,0,0
241680,for,0,0
241681,patients,0,0
241682,not,0,0
241683,mailed,0,0
241684,letters,0,1
241685,(,0,0
241686,Kruskal-Wallis,0,0
241687,P,0,0
241688,=,0,0
241689,.0139,0,0
241690,),0,0
241691,.,0,0
241692,Comparison,0,0
241693,of,0,0
241694,the,0,0
241695,Family,0,1
241696,End-of-study,0,0
241697,Up-to-date,0,0
241698,indices,0,0
241699,also,0,0
241700,demonstrated,0,0
241701,that,0,0
241702,families,0,0
241703,of,0,0
241704,patients,0,0
241705,sent,0,0
241706,customized,1,1
241707,letters,1,1
241708,were,0,0
241709,more,0,0
241710,likely,0,0
241711,to,0,0
241712,be,0,0
241713,up-to-date,0,0
241714,than,0,0
241715,families,0,0
241716,not,0,0
241717,sent,0,0
241718,letters,0,1
241719,(,0,0
241720,Kruskal-Wallis,0,0
241721,P,0,0
241722,=,0,0
241723,.0054,0,0
241724,),0,0
241725,.,0,0
241726,No,0,0
241727,statistically,0,0
241728,significant,0,0
241729,difference,0,0
241730,appeared,0,0
241731,between,0,0
241732,the,0,0
241733,number,0,0
241734,of,0,0
241735,preventive,0,0
241736,measures,0,0
241737,received,0,0
241738,by,0,0
241739,the,0,0
241740,control,1,1
241741,group,0,0
241742,and,0,0
241743,the,0,0
241744,form-letter,1,1
241745,group,0,0
241746,.,0,0
241747,CONCLUSIONS,0,0
241748,This,0,0
241749,study,0,0
241750,demonstrates,0,0
241751,a,0,0
241752,clinically,0,0
241753,small,0,0
241754,but,0,0
241755,statistically,0,0
241756,significant,0,0
241757,value,0,0
241758,to,0,0
241759,customizing,1,1
241760,reminder,1,1
241761,letters,1,1
241762,.,1,0
241763,Effect,0,0
241764,of,0,0
241765,indomethacin,1,1
241766,phonophoresis,1,1
241767,on,0,0
241768,the,0,0
241769,relief,0,0
241770,of,0,0
241771,temporomandibular,0,0
241772,joint,0,0
241773,pain,0,0
241774,.,0,0
241775,The,0,0
241776,pain-relieving,0,0
241777,effect,0,0
241778,of,0,0
241779,indomethacin,1,1
241780,phonophoresis,1,1
241781,on,0,0
241782,temporomandibular,0,0
241783,(,0,1
241784,TMJ,0,1
241785,),0,1
241786,joint,0,0
241787,pain,0,0
241788,was,0,0
241789,evaluated,0,0
241790,in,0,0
241791,a,0,0
241792,double-blind,0,0
241793,",",0,0
241794,placebo-controlled,1,1
241795,clinical,0,0
241796,trial,0,0
241797,.,0,0
241798,Twenty,0,0
241799,subjects,0,0
241800,",",0,0
241801,who,0,0
241802,have,0,0
241803,TMJ,0,1
241804,pain,0,0
241805,",",0,0
241806,were,0,0
241807,included,0,0
241808,for,0,0
241809,this,0,0
241810,study,0,0
241811,and,0,0
241812,randomly,0,0
241813,assigned,0,0
241814,to,0,0
241815,either,0,0
241816,the,0,0
241817,experimental,0,0
241818,group,0,0
241819,(,0,0
241820,n,0,0
241821,=,0,0
241822,10,0,1
241823,),0,0
241824,or,0,1
241825,the,0,0
241826,control,1,1
241827,group,1,0
241828,(,0,0
241829,n,0,0
241830,=,0,0
241831,10,0,0
241832,),0,0
241833,.,0,0
241834,Each,0,0
241835,treatment,0,0
241836,consisted,0,0
241837,of,0,0
241838,the,0,0
241839,application,0,0
241840,of,0,0
241841,ultrasound,1,1
241842,massage,1,1
241843,(,0,0
241844,1.0,0,0
241845,MHz,0,1
241846,",",0,0
241847,0.8,0,0
241848,to,0,0
241849,1.5,0,0
241850,W/cm2,0,0
241851,continuous,0,1
241852,output,0,0
241853,),0,0
241854,for,0,0
241855,15,0,0
241856,minutes,0,0
241857,to,0,0
241858,the,0,0
241859,painful,0,0
241860,temporomandibular,0,0
241861,joint,0,0
241862,.,0,0
241863,As,0,0
241864,a,0,0
241865,conducting,0,1
241866,medium,0,0
241867,",",0,0
241868,1,1,0
241869,%,1,0
241870,indomethacin,1,1
241871,cream,1,1
241872,was,0,0
241873,used,0,0
241874,for,0,0
241875,the,0,0
241876,experimental,0,0
241877,group,0,0
241878,and,0,0
241879,placebo,1,1
241880,cream,1,1
241881,for,0,0
241882,the,0,0
241883,control,0,1
241884,group,0,0
241885,respectively,0,0
241886,.,0,0
241887,Pre-,0,0
241888,and,0,0
241889,post-treatment,0,0
241890,pain,0,0
241891,levels,0,0
241892,and,0,0
241893,pain,0,0
241894,sensitivity,0,0
241895,were,0,0
241896,assessed,0,0
241897,with,0,0
241898,visual,0,0
241899,analogue,0,0
241900,scales,0,0
241901,(,0,0
241902,VAS,0,1
241903,),0,1
241904,and,0,0
241905,pressure,0,1
241906,pain,0,0
241907,threshold,0,0
241908,(,0,1
241909,PPT,0,0
241910,),0,0
241911,.,0,0
241912,Mean,0,0
241913,data,0,0
241914,indicated,0,0
241915,that,0,0
241916,post-treatment,0,0
241917,VAS,0,1
241918,was,0,0
241919,significantly,0,0
241920,decreased,0,0
241921,and,0,0
241922,post-treatment,0,0
241923,PPT,0,0
241924,was,0,0
241925,significantly,0,0
241926,increased,0,0
241927,in,0,0
241928,the,0,0
241929,experimental,0,0
241930,group,0,0
241931,",",0,0
241932,not,0,0
241933,in,0,0
241934,the,0,0
241935,control,0,0
241936,group,0,0
241937,.,0,0
241938,The,0,0
241939,results,0,0
241940,of,0,0
241941,this,0,0
241942,study,0,0
241943,suggest,0,0
241944,that,0,0
241945,indomethacin,1,1
241946,phonophoresis,1,1
241947,provides,0,0
241948,significant,0,0
241949,pain,0,0
241950,relieving,0,0
241951,effect,0,0
241952,over,0,0
241953,the,0,0
241954,TMJ,0,1
241955,pain,0,0
241956,.,0,0
241957,The,0,0
241958,importance,0,0
241959,of,0,0
241960,the,0,0
241961,dual-switch,1,1
241962,valve,1,0
241963,for,0,0
241964,the,0,0
241965,treatment,0,0
241966,of,0,0
241967,adult,0,0
241968,normotensive,0,0
241969,or,0,1
241970,hypertensive,0,0
241971,hydrocephalus,0,0
241972,.,0,0
241973,Since,0,0
241974,the,0,0
241975,beginning,0,0
241976,of,0,0
241977,1995,0,0
241978,the,0,0
241979,new,0,0
241980,hydrostatic,1,1
241981,dual-switch,1,1
241982,valve,1,1
241983,(,1,1
241984,DSV,1,0
241985,),1,1
241986,was,0,0
241987,implanted,0,1
241988,in,0,0
241989,35,0,0
241990,adult,0,0
241991,patients,0,0
241992,with,0,0
241993,hydrocephalus,0,0
241994,of,0,0
241995,different,0,0
241996,etiology,0,0
241997,.,0,0
241998,26,0,0
241999,patients,0,0
242000,suffered,0,0
242001,from,0,0
242002,normotensive,0,0
242003,hydrocephalus,0,0
242004,(,0,0
242005,10,0,1
242006,idiopathic,0,0
242007,and,0,0
242008,16,0,0
242009,symptomatic,0,0
242010,),0,0
242011,",",0,0
242012,and,0,0
242013,9,0,0
242014,patients,0,0
242015,from,0,0
242016,hypertensive,0,0
242017,hydrocephalus,0,0
242018,of,0,0
242019,various,0,0
242020,origin,0,0
242021,.,0,0
242022,The,0,0
242023,first,0,0
242024,21,0,0
242025,cases,0,0
242026,of,0,0
242027,this,0,0
242028,cohort,0,0
242029,were,0,0
242030,compared,0,0
242031,in,0,0
242032,a,0,0
242033,randomized,0,0
242034,study,0,0
242035,with,0,0
242036,a,0,0
242037,comparable,0,0
242038,group,0,0
242039,of,0,0
242040,21,0,0
242041,hydrocephalic,0,0
242042,patients,0,0
242043,who,0,0
242044,received,0,0
242045,a,0,0
242046,conventional,1,1
242047,differential-pressure,1,1
242048,(,1,1
242049,DP-,1,1
242050,),1,1
242051,valve,1,0
242052,.,1,0
242053,The,0,0
242054,clinical,0,0
242055,status,0,0
242056,and,0,0
242057,CT,0,1
242058,were,0,0
242059,assessed,0,0
242060,prior,0,0
242061,to,0,0
242062,shunting,0,1
242063,",",0,0
242064,14,0,0
242065,days,0,0
242066,and,0,0
242067,3,0,0
242068,and,0,0
242069,6,0,0
242070,months,0,0
242071,after,0,0
242072,the,0,0
242073,operation,0,0
242074,.,0,0
242075,The,0,0
242076,reduction,0,0
242077,of,0,0
242078,ventricular,0,0
242079,size,0,0
242080,was,0,0
242081,evaluated,0,0
242082,by,0,0
242083,the,0,0
242084,measurement,0,0
242085,of,0,0
242086,the,0,0
242087,Evans,0,0
242088,Index,0,1
242089,.,0,0
242090,The,0,0
242091,CT,0,0
242092,follow-up,0,0
242093,in,0,0
242094,the,0,0
242095,DSV,1,0
242096,group,0,0
242097,was,0,0
242098,characterized,0,0
242099,by,0,0
242100,an,0,0
242101,only,0,0
242102,minimal,0,0
242103,(,0,1
242104,14,0,1
242105,),0,0
242106,or,0,1
242107,only,0,0
242108,slight,0,0
242109,(,0,0
242110,16,0,0
242111,),0,0
242112,reduction,0,0
242113,of,0,0
242114,ventricular,0,0
242115,size,0,0
242116,in,0,0
242117,the,0,0
242118,vast,0,0
242119,majority,0,0
242120,of,0,0
242121,cases,0,0
242122,.,0,0
242123,A,0,0
242124,comparison,0,0
242125,of,0,0
242126,21,0,0
242127,patients,0,0
242128,with,0,0
242129,a,0,0
242130,DSV,1,0
242131,and,0,0
242132,the,0,0
242133,patients,0,0
242134,with,0,0
242135,DP,1,0
242136,valves,1,0
242137,",",0,0
242138,evaluated,0,0
242139,by,0,0
242140,measuring,0,0
242141,the,0,0
242142,reduction,0,0
242143,of,0,0
242144,the,0,0
242145,Evans,0,0
242146,Index,0,1
242147,",",0,0
242148,revealed,0,0
242149,a,0,0
242150,distinctly,0,0
242151,higher,0,0
242152,percentage,0,0
242153,of,0,0
242154,significant,0,0
242155,regressions,0,0
242156,in,0,0
242157,the,0,0
242158,DP,1,1
242159,valve,1,0
242160,collective,0,0
242161,",",0,0
242162,without,0,0
242163,doubt,0,0
242164,due,0,0
242165,to,0,0
242166,chronic,0,0
242167,overdrainage,0,1
242168,.,0,0
242169,The,0,0
242170,overall,0,0
242171,clinical,0,0
242172,result,0,0
242173,of,0,0
242174,our,0,0
242175,35,0,0
242176,patients,0,0
242177,with,0,0
242178,a,0,0
242179,DSV,1,0
242180,was,0,0
242181,excellent,0,0
242182,and,0,0
242183,good,0,0
242184,in,0,0
242185,31,0,0
242186,patients,0,0
242187,",",0,0
242188,but,0,0
242189,the,0,0
242190,outcome,0,0
242191,seems,0,0
242192,to,0,0
242193,be,0,0
242194,more,0,0
242195,dependent,0,0
242196,on,0,0
242197,the,0,0
242198,preshunt,0,0
242199,damage,0,0
242200,of,0,0
242201,the,0,0
242202,brain,0,0
242203,than,0,0
242204,on,0,0
242205,hydrocephalic,0,0
242206,aspects,0,0
242207,.,0,0
242208,A,0,0
242209,neglegible,0,0
242210,incidence,0,0
242211,of,0,0
242212,subdural,0,0
242213,effusions,0,0
242214,in,0,0
242215,the,0,0
242216,DSV,1,0
242217,group,0,0
242218,compared,0,0
242219,to,0,0
242220,11,0,0
242221,cases,0,0
242222,in,0,0
242223,the,0,0
242224,DP,1,0
242225,valve,1,0
242226,collective,0,0
242227,reflects,0,0
242228,the,0,0
242229,ability,0,0
242230,of,0,0
242231,the,0,0
242232,DSV,1,0
242233,to,0,0
242234,prevent,0,0
242235,overdrainage,0,1
242236,.,0,0
242237,The,0,0
242238,capability,0,0
242239,of,0,0
242240,the,0,0
242241,DSV,1,0
242242,to,0,0
242243,maintain,0,0
242244,the,0,0
242245,IVP,0,0
242246,within,0,0
242247,physiological,0,0
242248,limits,0,0
242249,after,0,0
242250,shunting,0,0
242251,",",0,0
242252,especially,0,0
242253,in,0,0
242254,the,0,0
242255,upright,0,0
242256,position,0,0
242257,",",0,0
242258,is,0,0
242259,documented,0,0
242260,by,0,0
242261,a,0,0
242262,comparison,0,0
242263,with,0,0
242264,possible,0,0
242265,unphysiological,0,0
242266,IVP,0,0
242267,variations,0,0
242268,in,0,0
242269,other,0,0
242270,valve,0,0
242271,constructions,0,0
242272,",",0,0
242273,which,0,0
242274,depend,0,0
242275,on,0,0
242276,the,0,0
242277,level,0,0
242278,of,0,0
242279,implantation,0,0
242280,",",0,0
242281,subcutaneous,0,1
242282,pressure,0,0
242283,or,0,1
242284,CSF,0,0
242285,flow,0,0
242286,through,0,0
242287,the,0,0
242288,valve,0,0
242289,.,0,0
242290,Pruritus,0,0
242291,in,0,0
242292,HIV-1,0,0
242293,disease,0,0
242294,:,0,0
242295,therapy,0,1
242296,with,0,0
242297,drugs,0,1
242298,which,0,0
242299,may,0,0
242300,modulate,0,0
242301,the,0,0
242302,pattern,0,0
242303,of,0,0
242304,immune,0,0
242305,dysregulation,0,0
242306,.,0,0
242307,BACKGROUND,0,0
242308,Pruritus,0,0
242309,in,0,0
242310,HIV-1+,0,0
242311,patients,0,0
242312,is,0,0
242313,common,0,0
242314,and,0,0
242315,increases,0,0
242316,with,0,0
242317,disease,0,0
242318,progression,0,0
242319,.,0,0
242320,The,0,0
242321,causes,0,0
242322,of,0,0
242323,pruritus,0,0
242324,are,0,0
242325,numerous,0,0
242326,including,0,0
242327,xerosis,0,0
242328,",",0,0
242329,drug,0,1
242330,and,0,0
242331,photoeruptions,0,0
242332,",",0,0
242333,follicular,0,0
242334,and,0,0
242335,papular,0,0
242336,eruptions,0,0
242337,as,0,0
242338,well,0,0
242339,as,0,0
242340,infestations,0,0
242341,and,0,0
242342,infections,0,0
242343,by,0,0
242344,a,0,0
242345,wide,0,0
242346,range,0,0
242347,of,0,0
242348,organisms,0,0
242349,.,0,0
242350,One,0,0
242351,other,0,0
242352,possible,0,0
242353,factor,0,0
242354,contributing,0,0
242355,to,0,0
242356,pruritus,0,0
242357,is,0,0
242358,the,0,0
242359,pattern,0,0
242360,of,0,0
242361,immune,0,0
242362,dysregulation,0,0
242363,.,0,0
242364,With,0,0
242365,advancing,0,0
242366,HIV-1,0,0
242367,disease,0,0
242368,there,0,0
242369,is,0,0
242370,Th1,0,0
242371,to,0,0
242372,Th2,0,1
242373,cytokine,0,0
242374,switching,0,0
242375,.,0,0
242376,METHODS,0,0
242377,After,0,0
242378,some,0,0
242379,positive,0,0
242380,results,0,0
242381,with,0,0
242382,prostaglandin,0,1
242383,inhibitors,0,1
242384,",",0,0
242385,we,0,0
242386,undertook,0,0
242387,a,0,0
242388,study,0,0
242389,in,0,0
242390,which,0,0
242391,we,0,0
242392,randomly,0,0
242393,placed,0,0
242394,patients,0,0
242395,on,0,0
242396,four,0,0
242397,different,0,0
242398,forms,0,0
242399,of,0,0
242400,therapy,0,1
242401,for,0,0
242402,their,0,0
242403,pruritus,0,0
242404,.,0,0
242405,The,0,0
242406,therapies,0,0
242407,included,0,0
242408,hydroxyzine,1,1
242409,with,1,0
242410,or,1,1
242411,without,1,1
242412,doxepin,1,1
242413,at,1,0
242414,night,1,0
242415,",",1,0
242416,pentoxifylline,1,1
242417,",",1,0
242418,indomethacin,1,1
242419,and,1,0
242420,topical,1,1
242421,moisturization,1,1
242422,with,1,0
242423,medium-strength,1,1
242424,topical,1,1
242425,steroids,1,1
242426,.,1,0
242427,All,0,0
242428,patients,0,0
242429,were,0,0
242430,evaluated,0,0
242431,for,0,0
242432,both,0,0
242433,subjective,0,0
242434,relief,0,0
242435,as,0,0
242436,well,0,0
242437,as,0,0
242438,side,0,0
242439,effects,0,0
242440,.,0,0
242441,RESULTS,0,0
242442,Patients,0,0
242443,placed,0,0
242444,on,0,0
242445,indomethacin,0,1
242446,obtained,0,0
242447,relief,0,0
242448,more,0,0
242449,consistently,0,0
242450,and,0,0
242451,more,0,0
242452,completely,0,0
242453,.,0,0
242454,Patients,0,0
242455,on,0,0
242456,pentoxifylline,0,1
242457,had,0,0
242458,the,0,0
242459,fewest,0,0
242460,side,0,0
242461,effects,0,0
242462,of,0,0
242463,all,0,0
242464,oral,0,1
242465,therapies,0,0
242466,.,0,0
242467,Patients,0,0
242468,on,0,0
242469,antihistamines,0,1
242470,with,0,0
242471,or,0,0
242472,without,0,1
242473,doxepin,0,1
242474,had,0,0
242475,the,0,0
242476,highest,0,0
242477,incidence,0,0
242478,of,0,0
242479,side,0,0
242480,effects,0,0
242481,",",0,0
242482,although,0,0
242483,more,0,0
242484,of,0,0
242485,these,0,0
242486,patients,0,0
242487,reported,0,0
242488,a,0,0
242489,greater,0,0
242490,degree,0,0
242491,of,0,0
242492,relief,0,0
242493,than,0,0
242494,patients,0,0
242495,on,0,0
242496,pentoxifylline,0,1
242497,.,0,0
242498,All,0,0
242499,patients,0,0
242500,on,0,0
242501,oral,0,1
242502,therapy,0,1
242503,overall,0,0
242504,had,0,0
242505,greater,0,0
242506,relief,0,0
242507,than,0,0
242508,patients,0,0
242509,using,0,0
242510,topical,0,1
242511,steroids,0,1
242512,.,0,0
242513,CONCLUSION,0,0
242514,The,0,0
242515,systemic,0,0
242516,therapies,0,0
242517,which,0,0
242518,may,0,0
242519,modulate,0,0
242520,the,0,0
242521,pattern,0,0
242522,of,0,0
242523,immune,0,0
242524,dysregulation,0,0
242525,seen,0,0
242526,in,0,0
242527,HIV-1,0,0
242528,disease,0,0
242529,may,0,0
242530,be,0,0
242531,beneficial,0,0
242532,in,0,0
242533,the,0,0
242534,pruritus,0,0
242535,seen,0,0
242536,in,0,0
242537,late-stage,0,0
242538,patients,0,0
242539,.,0,0
242540,The,0,0
242541,reliability,0,0
242542,of,0,0
242543,catheter-tip,1,1
242544,transducers,1,1
242545,for,0,0
242546,the,0,0
242547,measurement,0,0
242548,of,0,0
242549,intrauterine,0,0
242550,pressure,0,0
242551,in,0,0
242552,the,0,0
242553,third,0,0
242554,stage,0,0
242555,of,0,0
242556,labour,0,0
242557,.,0,0
242558,In,0,0
242559,order,0,0
242560,to,0,0
242561,assess,0,0
242562,the,0,0
242563,reliability,0,0
242564,of,0,0
242565,intrauterine,0,0
242566,pressure,0,0
242567,measurements,0,0
242568,in,0,0
242569,the,0,0
242570,third,0,0
242571,stage,0,0
242572,of,0,0
242573,labour,0,0
242574,",",0,0
242575,catheter-tip,1,1
242576,transducers,1,1
242577,were,0,0
242578,used,0,0
242579,in,0,0
242580,20,0,0
242581,women,0,0
242582,randomly,0,0
242583,allocated,0,0
242584,into,0,0
242585,two,0,0
242586,groups,0,0
242587,of,0,0
242588,10,0,0
242589,.,0,0
242590,In,0,0
242591,each,0,0
242592,case,0,0
242593,in,0,0
242594,the,0,0
242595,first,0,0
242596,group,0,0
242597,two,0,0
242598,catheters,1,1
242599,were,0,0
242600,tied,0,0
242601,together,0,0
242602,and,0,0
242603,introduced,0,0
242604,transcervically,0,1
242605,into,0,0
242606,the,0,0
242607,uterine,0,0
242608,cavity,0,1
242609,after,0,0
242610,delivery,0,0
242611,of,0,0
242612,the,0,0
242613,placenta,0,0
242614,.,0,0
242615,In,0,0
242616,each,0,0
242617,case,0,0
242618,in,0,0
242619,the,0,0
242620,second,0,0
242621,group,0,0
242622,two,0,0
242623,catheters,0,1
242624,were,0,0
242625,inserted,0,0
242626,independently,0,0
242627,into,0,0
242628,the,0,0
242629,same,0,0
242630,uterine,0,0
242631,cavity,0,1
242632,.,0,0
242633,The,0,0
242634,active,0,0
242635,and,0,0
242636,cumulative,0,0
242637,active,0,1
242638,pressures,0,0
242639,recorded,0,0
242640,from,0,0
242641,the,0,0
242642,pairs,0,0
242643,of,0,0
242644,catheters,1,1
242645,within,0,0
242646,each,0,0
242647,uterine,0,0
242648,cavity,0,1
242649,were,0,0
242650,compared,0,0
242651,.,0,0
242652,Comparison,0,0
242653,of,0,0
242654,individual,0,0
242655,active,0,1
242656,pressure,0,0
242657,readings,0,0
242658,from,0,0
242659,separate,0,0
242660,transducers,0,1
242661,revealed,0,0
242662,good,0,0
242663,agreement,0,0
242664,whether,0,0
242665,the,0,0
242666,catheters,1,1
242667,were,0,0
242668,tied,0,0
242669,together,0,0
242670,or,0,1
242671,were,0,0
242672,separate,0,0
242673,.,0,0
242674,Cumulative,0,0
242675,active,0,0
242676,pressure,0,0
242677,was,0,0
242678,very,0,0
242679,similar,0,0
242680,when,0,0
242681,assessed,0,0
242682,by,0,0
242683,each,0,0
242684,catheter,1,1
242685,in,0,0
242686,the,0,0
242687,same,0,0
242688,uterus,0,0
242689,.,0,0
242690,Intrauterine,1,0
242691,catheter-tip,1,1
242692,transducers,1,1
242693,can,0,0
242694,be,0,0
242695,used,0,0
242696,reliably,0,0
242697,to,0,0
242698,measure,0,0
242699,uterine,0,0
242700,activity,0,0
242701,in,0,0
242702,the,0,0
242703,third,0,0
242704,stage,0,0
242705,of,0,0
242706,labour,0,0
242707,although,0,0
242708,there,0,0
242709,may,0,0
242710,be,0,0
242711,minor,0,0
242712,contraction,0,0
242713,by,0,0
242714,contraction,0,0
242715,differences,0,0
242716,in,0,0
242717,recordings,0,1
242718,of,0,0
242719,individual,0,0
242720,active,0,0
242721,pressures,0,0
242722,.,0,0
242723,Amoxicillin/metronidazole/omeprazole/clarithromycin,0,1
242724,:,0,0
242725,a,0,0
242726,new,0,0
242727,",",0,0
242728,short,0,1
242729,quadruple,0,1
242730,therapy,0,1
242731,for,0,0
242732,Helicobacter,0,0
242733,pylori,0,0
242734,eradication,0,0
242735,.,0,0
242736,BACKGROUND,0,0
242737,Triple,0,1
242738,therapy,0,1
242739,regimens,0,1
242740,including,0,0
242741,two,0,0
242742,antibiotics,0,1
242743,plus,0,1
242744,acid,0,1
242745,suppression,0,0
242746,have,0,0
242747,become,0,0
242748,the,0,0
242749,new,0,0
242750,standard,0,1
242751,therapy,0,1
242752,in,0,0
242753,Helicobacter,0,0
242754,pylori,0,0
242755,eradication,0,0
242756,because,0,0
242757,of,0,0
242758,success,0,0
242759,rates,0,0
242760,of,0,0
242761,about,0,0
242762,90,0,0
242763,%,0,0
242764,.,0,0
242765,However,0,0
242766,",",0,0
242767,these,0,0
242768,regimens,0,1
242769,are,0,0
242770,still,0,0
242771,costly,0,0
242772,",",0,0
242773,duration,0,0
242774,is,0,0
242775,about,0,0
242776,one,0,0
242777,week,0,0
242778,or,0,0
242779,less,0,0
242780,",",0,0
242781,and,0,0
242782,side-effects,0,0
242783,are,0,0
242784,not,0,0
242785,negligible,0,0
242786,.,0,0
242787,We,0,0
242788,therefore,0,0
242789,evaluated,0,0
242790,a,0,0
242791,new,0,0
242792,quadruple,0,1
242793,therapy,0,1
242794,",",0,0
242795,because,0,0
242796,theoretically,0,0
242797,a,0,0
242798,shorter,0,0
242799,duration,0,0
242800,of,0,0
242801,treatment,0,0
242802,may,0,0
242803,result,0,0
242804,in,0,0
242805,reduced,0,0
242806,costs,0,0
242807,",",0,0
242808,fewer,0,0
242809,side-effects,0,0
242810,",",0,0
242811,and,0,0
242812,possibly,0,0
242813,in,0,0
242814,a,0,0
242815,lower,0,0
242816,potential,0,0
242817,for,0,0
242818,antibiotic,0,1
242819,resistances,0,0
242820,.,0,0
242821,METHODS,0,0
242822,Controlled,0,0
242823,",",0,0
242824,prospective,0,0
242825,pilot,0,0
242826,study,0,0
242827,including,0,0
242828,H.,0,0
242829,pylori-positive,0,0
242830,patients,0,0
242831,with,0,0
242832,gastric,0,0
242833,or,0,1
242834,duodenal,0,0
242835,ulcers,0,0
242836,or,0,1
242837,erosive,0,1
242838,gastritis,0,0
242839,",",0,0
242840,treated,0,0
242841,after,0,0
242842,failure,0,0
242843,of,0,0
242844,dual,0,0
242845,therapy,0,1
242846,(,0,0
242847,proton-pump-inhibitors,0,1
242848,or,0,1
242849,ranitidine,0,1
242850,plus,0,1
242851,amoxicillin,0,1
242852,),0,0
242853,or,0,1
242854,for,0,0
242855,the,0,0
242856,first,0,0
242857,time,0,0
242858,.,0,0
242859,They,0,0
242860,were,0,0
242861,assigned,0,0
242862,to,0,0
242863,a,0,0
242864,one,1,0
242865,week,1,0
242866,triple,1,1
242867,standard,1,1
242868,therapy,1,1
242869,",",1,0
242870,consisting,1,0
242871,of,1,0
242872,metronidazole,1,1
242873,400,1,1
242874,mg,1,1
242875,bid,1,1
242876,+,1,1
242877,omeprazole,1,1
242878,20,1,0
242879,mg,1,0
242880,bid,1,1
242881,+,1,1
242882,clarithromycin,1,1
242883,250,1,0
242884,mg,1,0
242885,bid,1,1
242886,",",1,0
242887,or,1,0
242888,a,1,0
242889,newly,1,0
242890,created,1,0
242891,quadruple-regimen,1,1
242892,",",1,0
242893,which,1,0
242894,adds,1,0
242895,amoxicillin,1,1
242896,(,1,0
242897,1,1,0
242898,g,1,1
242899,bid,1,1
242900,),1,0
242901,to,1,0
242902,the,1,0
242903,above,1,0
242904,triple,1,0
242905,regimen,1,1
242906,.,1,0
242907,Each,0,0
242908,of,0,0
242909,the,0,0
242910,four,0,0
242911,drugs,0,0
242912,was,0,0
242913,given,0,0
242914,for,0,0
242915,5,0,0
242916,days,0,0
242917,.,0,0
242918,H.,0,0
242919,pylori,0,0
242920,status,0,0
242921,was,0,0
242922,checked,0,0
242923,by,0,0
242924,13C,0,0
242925,urea,0,1
242926,breath,0,0
242927,test,0,0
242928,before,0,0
242929,and,0,0
242930,after,0,0
242931,four,0,0
242932,weeks,0,0
242933,of,0,0
242934,therapy,0,1
242935,.,0,0
242936,RESULTS,0,0
242937,A,0,0
242938,total,0,0
242939,of,0,0
242940,71,0,0
242941,patients,0,0
242942,were,0,0
242943,treated,0,0
242944,by,0,0
242945,quadruple,0,1
242946,therapy,0,1
242947,",",0,0
242948,and,0,0
242949,42,0,0
242950,patients,0,0
242951,were,0,0
242952,treated,0,0
242953,by,0,0
242954,triple,0,1
242955,therapy,0,1
242956,.,0,0
242957,The,0,0
242958,eradication,0,0
242959,rate,0,0
242960,of,0,0
242961,H.,0,0
242962,pylori,0,0
242963,for,0,0
242964,patients,0,0
242965,under,0,0
242966,quadruple,0,1
242967,treatment,0,0
242968,",",0,0
242969,without,0,0
242970,vs.,0,0
242971,with,0,0
242972,previous,0,0
242973,dual,0,0
242974,therapy,0,1
242975,",",0,0
242976,were,0,0
242977,96,0,0
242978,%,0,0
242979,vs.,0,0
242980,92,0,0
242981,%,0,0
242982,(,0,0
242983,42/44,0,1
242984,vs.,0,0
242985,22/24,0,0
242986,),0,0
242987,by,0,0
242988,per,0,1
242989,protocol,0,1
242990,and,0,0
242991,91,0,0
242992,%,0,0
242993,vs.,0,0
242994,88,0,0
242995,%,0,0
242996,(,0,0
242997,42/46,0,0
242998,vs.,0,0
242999,22/25,0,0
243000,),0,0
243001,by,0,0
243002,intention,0,0
243003,to,0,0
243004,treat,0,0
243005,analysis,0,0
243006,(,0,0
243007,comparisons,0,0
243008,not,0,0
243009,significant,0,0
243010,),0,0
243011,.,0,0
243012,No,0,0
243013,major,0,0
243014,side-effects,0,0
243015,were,0,0
243016,reported,0,0
243017,.,0,0
243018,CONCLUSIONS,0,0
243019,Five-day,0,1
243020,quadruple,0,1
243021,therapy,0,1
243022,(,0,0
243023,with,0,0
243024,omeprazole,0,1
243025,",",0,0
243026,metronidazole,0,1
243027,",",0,0
243028,clarithromycin,0,1
243029,and,0,1
243030,amoxicillin,0,1
243031,),0,1
243032,represents,0,0
243033,an,0,0
243034,effective,0,0
243035,and,0,0
243036,safe,0,0
243037,new,0,0
243038,regimen,0,1
243039,for,0,0
243040,H.,0,0
243041,pylori,0,0
243042,eradication,0,0
243043,.,0,0
243044,[,0,0
243045,Prevention,0,1
243046,of,0,0
243047,vascular,0,0
243048,complications,0,0
243049,following,0,0
243050,cerebral,0,0
243051,ischemia,0,0
243052,of,0,0
243053,arterial,0,0
243054,origin,0,0
243055,;,0,0
243056,the,0,0
243057,ESPRIT,0,0
243058,trial,0,0
243059,:,0,0
243060,mild,1,0
243061,anticoagulant,1,1
243062,therapy,1,1
243063,",",0,0
243064,combination,0,1
243065,treatment,0,0
243066,with,0,0
243067,acetylsalicylic,1,1
243068,acid,1,1
243069,plus,1,1
243070,dipyridamole,1,1
243071,or,1,1
243072,treatment,1,0
243073,with,1,0
243074,acetylsalicylic,1,1
243075,acid,1,1
243076,alone,1,1
243077,?,0,0
243078,],0,0
243079,.,0,0
243080,The,0,0
243081,European,0,0
243082,and,0,0
243083,Australian,0,0
243084,Stroke,0,1
243085,Prevention,0,1
243086,in,0,0
243087,Reversible,0,0
243088,Ischaemia,0,0
243089,Trial,0,1
243090,(,0,1
243091,ESPRIT,0,0
243092,),0,1
243093,is,0,0
243094,a,0,0
243095,randomised,0,0
243096,clinical,0,0
243097,trial,0,0
243098,in,0,0
243099,which,0,0
243100,patients,0,0
243101,with,0,0
243102,cerebral,0,0
243103,ischaemia,0,1
243104,of,0,0
243105,arterial,0,0
243106,origin,0,0
243107,will,0,0
243108,be,0,0
243109,randomised,0,0
243110,between,0,0
243111,oral,1,1
243112,anticoagulation,1,1
243113,(,0,0
243114,international,0,0
243115,normalized,0,0
243116,ratio,0,0
243117,(,0,1
243118,INR,0,1
243119,),0,1
243120,:,0,0
243121,2.0-3.0,0,1
243122,),0,0
243123,",",0,0
243124,the,0,0
243125,combination,0,1
243126,of,0,0
243127,acetylsalicylic,1,1
243128,acid,1,1
243129,(,0,0
243130,in,0,0
243131,any,0,0
243132,dose,0,0
243133,between,0,0
243134,30,0,0
243135,and,0,0
243136,325,0,0
243137,mg,0,1
243138,per,0,0
243139,day,0,0
243140,),0,1
243141,plus,0,1
243142,dipyridamole,1,1
243143,(,0,0
243144,400,0,1
243145,mg,0,1
243146,daily,0,1
243147,),0,0
243148,and,0,0
243149,acetylsalicylic,1,1
243150,acid,1,1
243151,only,0,0
243152,(,0,0
243153,in,0,0
243154,any,0,0
243155,dose,0,0
243156,between,0,0
243157,30,0,0
243158,and,0,0
243159,325,0,0
243160,mg,0,1
243161,per,0,0
243162,day,0,0
243163,),0,0
243164,.,0,0
243165,It,0,0
243166,is,0,0
243167,planned,0,0
243168,to,0,0
243169,enroll,0,0
243170,4500,0,0
243171,patients,0,0
243172,with,0,0
243173,a,0,0
243174,mean,0,0
243175,follow-up,0,0
243176,of,0,0
243177,three,0,0
243178,years,0,0
243179,.,0,0
243180,Primary,0,0
243181,outcome,0,0
243182,is,0,0
243183,the,0,0
243184,composite,0,1
243185,event,0,0
243186,of,0,0
243187,vascular,0,0
243188,death,0,0
243189,",",0,0
243190,stroke,0,0
243191,",",0,0
243192,myocardial,0,0
243193,infarction,0,0
243194,",",0,0
243195,or,0,1
243196,major,0,0
243197,bleeding,0,0
243198,complication,0,0
243199,;,0,0
243200,outcome,0,0
243201,assessment,0,0
243202,will,0,0
243203,be,0,0
243204,blinded,0,0
243205,.,0,0
243206,ESPRIT,0,0
243207,is,0,0
243208,an,0,0
243209,international,0,0
243210,",",0,0
243211,multicentre,0,0
243212,study,0,0
243213,in,0,0
243214,which,0,0
243215,60-80,0,0
243216,hospitals,0,0
243217,in,0,0
243218,the,0,0
243219,Netherlands,0,0
243220,and,0,0
243221,other,0,0
243222,countries,0,0
243223,in,0,0
243224,Europe,0,1
243225,and,0,0
243226,Australia,0,0
243227,will,0,0
243228,participate,0,0
243229,.,0,0
243230,Quantifying,0,0
243231,oral,1,1
243232,analgesic,1,1
243233,consumption,0,0
243234,using,0,0
243235,a,0,0
243236,novel,0,0
243237,method,0,1
243238,and,0,0
243239,comparison,0,0
243240,with,0,0
243241,patient-controlled,0,1
243242,intravenous,0,1
243243,analgesic,1,1
243244,consumption,0,0
243245,.,0,0
243246,Humoral,0,0
243247,immune,0,0
243248,response,0,0
243249,to,0,0
243250,tetanus-diphtheria,1,1
243251,vaccine,1,1
243252,given,0,0
243253,during,0,0
243254,extended,0,1
243255,use,0,0
243256,of,0,0
243257,chloroquine,1,1
243258,or,1,1
243259,primaquine,1,1
243260,malaria,1,1
243261,chemoprophylaxis,1,1
243262,.,1,0
243263,Immune,0,0
243264,suppression,0,0
243265,resulting,0,0
243266,from,0,0
243267,prolonged,0,0
243268,chemoprophylaxis,0,1
243269,and,0,0
243270,potential,0,0
243271,drug-vaccine,0,1
243272,interaction,0,0
243273,were,0,0
243274,investigated,0,0
243275,within,0,0
243276,the,0,0
243277,context,0,0
243278,of,0,0
243279,a,0,0
243280,randomized,0,0
243281,placebo-controlled,1,1
243282,trial,0,0
243283,that,0,0
243284,compared,0,0
243285,daily,0,1
243286,primaquine,1,1
243287,or,0,1
243288,weekly,0,1
243289,chloroquine,1,1
243290,administration,0,0
243291,for,0,0
243292,malaria,0,0
243293,prevention,0,0
243294,.,0,0
243295,After,0,0
243296,11,0,0
243297,months,0,0
243298,of,0,0
243299,prophylaxis,0,0
243300,",",0,0
243301,adult,0,0
243302,male,0,0
243303,subjects,0,0
243304,received,0,0
243305,a,0,0
243306,tetanus-diphtheria,1,1
243307,(,1,1
243308,Td,1,1
243309,),1,1
243310,vaccination,1,1
243311,.,1,0
243312,Prophylaxis,0,1
243313,continued,0,0
243314,4,0,0
243315,weeks,0,0
243316,longer,0,0
243317,.,0,0
243318,Anti-tetanus,0,1
243319,and,0,0
243320,anti-diphtheria,0,1
243321,antibody,0,0
243322,levels,0,0
243323,were,0,0
243324,measured,0,0
243325,by,0,0
243326,ELISA,1,0
243327,at,0,0
243328,baseline,0,0
243329,and,0,0
243330,at,0,0
243331,1,0,0
243332,",",0,0
243333,3,0,0
243334,",",0,0
243335,7,0,0
243336,",",0,0
243337,and,0,0
243338,14,0,0
243339,months,0,0
243340,after,0,0
243341,Td,0,1
243342,vaccination,0,1
243343,.,0,0
243344,All,0,0
243345,groups,0,0
243346,were,0,0
243347,comparable,0,0
243348,at,0,0
243349,baseline,0,0
243350,.,0,0
243351,Immunization,0,1
243352,triggered,0,0
243353,significant,0,0
243354,increases,0,0
243355,in,0,0
243356,anti-tetanus,0,1
243357,and,0,0
243358,anti-diphtheria,0,1
243359,IgG,0,1
243360,levels,0,0
243361,over,0,0
243362,each,0,0
243363,group,0,0
243364,'s,0,0
243365,pre-Td,0,1
243366,baseline,0,0
243367,levels,0,0
243368,and,0,0
243369,those,0,0
243370,of,0,0
243371,an,0,0
243372,unvaccinated,0,0
243373,control,0,0
243374,group,0,0
243375,.,0,0
243376,Geometric,0,0
243377,mean,0,0
243378,anti-tetanus,0,1
243379,titers,0,0
243380,(,0,0
243381,GMTs,0,0
243382,),0,1
243383,in,0,0
243384,the,0,0
243385,primaquine,0,1
243386,group,0,0
243387,were,0,0
243388,significantly,0,0
243389,higher,0,0
243390,than,0,0
243391,those,0,0
243392,of,0,0
243393,the,0,0
243394,placebo,1,1
243395,group,0,0
243396,at,0,0
243397,1,0,0
243398,",",0,0
243399,3,0,0
243400,",",0,0
243401,and,0,0
243402,14,0,0
243403,months,0,0
243404,.,0,0
243405,Anti-tetanus,0,1
243406,GMTs,0,0
243407,in,0,0
243408,placebo,1,1
243409,and,0,0
243410,chloroquine,1,1
243411,groups,0,0
243412,declined,0,0
243413,over,0,0
243414,14,0,0
243415,months,0,0
243416,to,0,0
243417,levels,0,0
243418,comparable,0,0
243419,to,0,0
243420,those,0,0
243421,of,0,0
243422,unvaccinated,0,0
243423,controls,0,0
243424,",",0,0
243425,but,0,0
243426,levels,0,0
243427,in,0,0
243428,the,0,0
243429,primaquine,0,1
243430,group,0,0
243431,remained,0,0
243432,significantly,0,0
243433,higher,0,0
243434,than,0,0
243435,in,0,0
243436,controls,0,0
243437,.,0,0
243438,Effects,0,0
243439,of,0,0
243440,formoterol,1,1
243441,",",1,0
243442,salmeterol,1,1
243443,or,1,1
243444,oxitropium,1,1
243445,bromide,1,1
243446,on,0,0
243447,airway,0,0
243448,responses,0,0
243449,to,0,0
243450,salbutamol,1,1
243451,in,0,0
243452,COPD,0,0
243453,.,0,0
243454,We,0,0
243455,examined,0,0
243456,whether,0,0
243457,a,0,0
243458,pretreatment,0,0
243459,with,0,0
243460,formoterol,1,1
243461,",",1,0
243462,oxitropium,1,1
243463,bromide,1,1
243464,",",1,0
243465,or,1,1
243466,salmeterol,1,1
243467,might,0,0
243468,modify,0,0
243469,the,0,0
243470,dose-response,0,0
243471,curves,0,0
243472,to,0,0
243473,inhaled,0,1
243474,salbutamol,1,1
243475,in,0,0
243476,patients,0,0
243477,with,0,0
243478,stable,0,0
243479,and,0,0
243480,partially,0,0
243481,reversible,0,0
243482,chronic,0,0
243483,obstructive,0,0
243484,pulmonary,0,0
243485,disease,0,0
243486,(,0,1
243487,COPD,0,0
243488,),0,1
243489,.,0,0
243490,Sixteen,0,0
243491,outpatients,0,0
243492,with,0,0
243493,partially,0,0
243494,reversible,0,0
243495,",",0,0
243496,stable,0,0
243497,COPD,0,0
243498,received,1,0
243499,24,1,0
243500,microg,1,0
243501,formoterol,1,1
243502,",",1,0
243503,50,1,1
243504,microg,1,0
243505,salmeterol,1,1
243506,",",1,0
243507,200,1,1
243508,microg,1,1
243509,oxitropium,1,1
243510,bromide,1,1
243511,",",1,0
243512,or,1,0
243513,placebo,1,1
243514,on,1,0
243515,four,1,0
243516,non-consecutive,1,0
243517,days,1,0
243518,.,1,0
243519,Spirometric,1,0
243520,testing,1,0
243521,was,0,0
243522,performed,0,0
243523,immediately,0,0
243524,before,0,0
243525,inhalation,0,1
243526,of,0,0
243527,treatment,0,0
243528,and,0,0
243529,after,0,0
243530,2,0,0
243531,h.,0,0
243532,A,0,0
243533,dose-response,0,0
243534,curve,0,0
243535,to,0,0
243536,inhaled,0,1
243537,salbutamol,1,1
243538,was,0,0
243539,then,0,1
243540,constructed,1,0
243541,using,1,0
243542,doses,1,0
243543,of,1,0
243544,100,1,0
243545,",",1,0
243546,100,1,0
243547,",",1,0
243548,200,1,1
243549,microg,1,0
243550,and,1,0
243551,400,1,1
243552,microg,1,0
243553,--,1,0
243554,that,1,0
243555,is,1,0
243556,",",1,0
243557,a,1,0
243558,total,1,0
243559,cumulative,1,0
243560,dose,1,0
243561,of,1,0
243562,800,1,1
243563,microg,1,0
243564,.,1,0
243565,Dose,0,0
243566,increments,0,0
243567,were,0,0
243568,given,0,0
243569,at,0,0
243570,20,0,0
243571,min,0,0
243572,intervals,0,0
243573,with,0,0
243574,measurements,0,0
243575,being,0,0
243576,made,0,0
243577,15,0,0
243578,min,0,0
243579,after,0,0
243580,each,0,0
243581,dose,0,0
243582,.,0,0
243583,Formoterol,1,1
243584,",",1,0
243585,salmeterol,1,1
243586,",",0,0
243587,or,0,1
243588,oxitropium,1,1
243589,bromide,1,1
243590,elicited,0,0
243591,a,0,0
243592,significant,0,0
243593,increase,0,0
243594,in,0,0
243595,forced,0,1
243596,expiratory,0,0
243597,volume,0,0
243598,in,0,0
243599,one,0,0
243600,second,0,0
243601,(,0,1
243602,FEV1,0,0
243603,),0,1
243604,compared,0,0
243605,with,0,0
243606,placebo,1,1
243607,(,0,0
243608,mean,0,0
243609,differences,0,0
243610,(,0,0
243611,L,0,1
243612,),0,1
243613,=,0,0
243614,placebo,1,1
243615,0.05,0,0
243616,;,0,0
243617,formoterol,1,1
243618,0.34,0,0
243619,;,0,0
243620,salmeterol,1,1
243621,0.27,0,0
243622,;,0,0
243623,oxitropium,1,1
243624,bromide,1,1
243625,0.23,0,0
243626,),0,0
243627,.,0,0
243628,Dose-dependent,0,0
243629,increases,0,0
243630,in,0,0
243631,FEV1,0,0
243632,were,0,0
243633,seen,0,0
243634,(,0,0
243635,mean,0,0
243636,values,0,0
243637,(,0,0
243638,L,0,1
243639,),0,1
243640,before,0,0
243641,salbutamol,0,1
243642,and,0,0
243643,after,0,0
243644,a,0,0
243645,cumulative,0,0
243646,dose,0,0
243647,of,0,0
243648,100,0,0
243649,",",0,0
243650,200,0,0
243651,",",0,0
243652,400,0,0
243653,",",0,0
243654,and,0,0
243655,800,0,1
243656,microg,0,1
243657,=,0,0
243658,placebo,1,1
243659,:,1,0
243660,1.06,0,0
243661,",",0,0
243662,1.28,0,0
243663,",",0,0
243664,1.35,0,0
243665,",",0,0
243666,1.39,0,0
243667,",",0,0
243668,1.41,0,0
243669,;,0,0
243670,formoterol,1,1
243671,:,1,0
243672,1.33,0,0
243673,",",0,0
243674,1.37,0,0
243675,",",0,0
243676,1.41,0,0
243677,",",0,0
243678,1.44,0,0
243679,",",0,0
243680,1.44,0,0
243681,;,0,0
243682,salmeterol,1,1
243683,:,1,0
243684,1.30,0,0
243685,",",0,0
243686,1.33,0,0
243687,",",0,0
243688,1.36,0,0
243689,",",0,0
243690,1.39,0,0
243691,",",0,0
243692,1.42,0,0
243693,;,0,0
243694,oxitropium,1,1
243695,bromide,1,1
243696,:,1,0
243697,1.27,0,0
243698,",",0,0
243699,1.34,0,0
243700,",",0,0
243701,1.37,0,0
243702,",",0,0
243703,1.41,0,0
243704,",",0,0
243705,1.40,0,0
243706,),0,0
243707,.,0,0
243708,Statistical,0,0
243709,analysis,0,0
243710,revealed,0,0
243711,no,0,0
243712,significant,0,0
243713,differences,0,0
243714,in,0,0
243715,FEV1,0,0
243716,and,0,0
243717,forced,0,1
243718,vital,0,0
243719,capacity,0,0
243720,(,0,1
243721,FVC,0,1
243722,),0,1
243723,responses,0,0
243724,to,0,0
243725,salbutamol,0,1
243726,after,0,0
243727,therapy,0,1
243728,with,0,0
243729,formoterol,1,1
243730,",",1,0
243731,salmeterol,1,1
243732,",",1,0
243733,or,1,1
243734,oxitropium,1,1
243735,bromide,1,1
243736,compared,0,0
243737,with,0,0
243738,placebo,1,1
243739,.,1,0
243740,This,0,0
243741,study,0,0
243742,clearly,0,0
243743,shows,0,0
243744,that,0,0
243745,a,0,0
243746,pretreatment,0,0
243747,with,0,0
243748,a,0,0
243749,conventional,0,1
243750,dose,0,0
243751,of,0,0
243752,formoterol,1,1
243753,",",1,0
243754,salmeterol,1,1
243755,",",1,0
243756,or,1,1
243757,oxitropium,1,1
243758,bromide,1,1
243759,does,0,0
243760,not,0,0
243761,preclude,0,0
243762,the,0,0
243763,possibility,0,0
243764,of,0,0
243765,inducing,0,0
243766,a,0,0
243767,further,0,0
243768,bronchodilation,0,0
243769,with,0,0
243770,salbutamol,1,1
243771,in,0,0
243772,patients,0,0
243773,suffering,0,0
243774,from,0,0
243775,partially,0,0
243776,reversible,0,0
243777,chronic,0,0
243778,obstructive,0,0
243779,pulmonary,0,0
243780,disease,0,0
243781,.,0,0
243782,Diet,0,1
243783,design,0,0
243784,for,0,0
243785,a,0,0
243786,multicenter,0,0
243787,controlled,0,0
243788,feeding,0,1
243789,trial,0,0
243790,:,0,0
243791,the,0,0
243792,DELTA,0,1
243793,program,0,1
243794,.,0,0
243795,Delta,0,1
243796,Research,0,0
243797,Group,0,0
243798,.,0,0
243799,OBJECTIVE,0,0
243800,To,0,0
243801,describe,0,0
243802,the,0,0
243803,process,0,0
243804,and,0,0
243805,results,0,0
243806,of,0,0
243807,diet,0,1
243808,standardization,0,0
243809,",",0,0
243810,diet,0,1
243811,validation,0,0
243812,",",0,0
243813,and,0,0
243814,monitoring,0,1
243815,of,0,0
243816,diet,0,1
243817,composition,0,0
243818,",",0,0
243819,which,0,0
243820,were,0,0
243821,key,0,0
243822,components,0,0
243823,of,0,0
243824,protocol,0,0
243825,1,0,0
243826,of,0,0
243827,Dietary,0,1
243828,Effects,0,0
243829,on,0,0
243830,Lipoproteins,0,1
243831,and,0,0
243832,Thrombogenic,0,1
243833,Activity,0,0
243834,(,0,1
243835,DELTA-1,0,1
243836,),0,0
243837,",",0,0
243838,the,0,0
243839,initial,0,0
243840,protocol,0,0
243841,in,0,0
243842,a,0,0
243843,program,0,1
243844,of,0,0
243845,multicenter,0,0
243846,human,0,1
243847,feeding,0,1
243848,studies,0,0
243849,designed,0,0
243850,to,0,0
243851,evaluate,0,0
243852,the,0,0
243853,effects,0,0
243854,of,0,0
243855,amount,0,0
243856,and,0,0
243857,type,0,0
243858,of,0,0
243859,fat,0,0
243860,on,0,0
243861,lipoproteins,0,0
243862,and,0,0
243863,hemostasis,0,0
243864,parameters,0,0
243865,in,0,0
243866,various,0,0
243867,demographic,0,0
243868,groups,0,0
243869,.,0,0
243870,DESIGN,0,0
243871,DELTA-1,0,1
243872,was,0,0
243873,based,0,0
243874,on,0,0
243875,a,0,0
243876,randomized,0,0
243877,",",0,0
243878,blinded,0,0
243879,",",0,0
243880,crossover,0,0
243881,experimental,0,0
243882,design,0,0
243883,.,0,0
243884,Three,1,0
243885,diets,1,1
243886,were,0,0
243887,fed,0,0
243888,for,0,0
243889,8,0,0
243890,weeks,0,0
243891,to,0,0
243892,103,0,0
243893,healthy,0,0
243894,men,0,0
243895,and,0,0
243896,women,0,0
243897,aged,0,0
243898,22,0,0
243899,to,0,0
243900,67,0,0
243901,years,0,0
243902,at,0,0
243903,4,0,0
243904,field,0,0
243905,centers,0,0
243906,.,0,0
243907,Diet,1,1
243908,A,1,0
243909,",",1,0
243910,an,1,0
243911,average,1,0
243912,American,1,0
243913,diet,1,1
243914,",",1,0
243915,was,1,0
243916,designed,1,0
243917,to,1,0
243918,provide,1,0
243919,37,1,0
243920,%,1,0
243921,of,1,0
243922,energy,1,0
243923,from,1,0
243924,fat,1,0
243925,",",1,0
243926,16,1,0
243927,%,1,0
243928,of,1,0
243929,energy,1,0
243930,from,1,0
243931,saturated,1,1
243932,fatty,1,1
243933,acids,1,1
243934,(,1,0
243935,SFAs,1,1
243936,),1,1
243937,;,1,0
243938,diet,1,1
243939,B,1,1
243940,(,1,1
243941,step,1,0
243942,1,1,1
243943,diet,1,1
243944,),1,0
243945,was,1,0
243946,designed,1,0
243947,to,1,0
243948,provide,1,0
243949,30,1,0
243950,%,1,0
243951,of,1,0
243952,energy,1,0
243953,from,1,0
243954,fat,1,0
243955,",",1,0
243956,9,1,0
243957,%,1,0
243958,of,1,0
243959,energy,1,0
243960,from,1,0
243961,SFA,1,1
243962,;,1,0
243963,and,0,0
243964,diet,1,1
243965,C,1,1
243966,(,1,0
243967,low,1,0
243968,SFA,1,1
243969,diet,1,1
243970,),1,0
243971,was,1,0
243972,designed,1,0
243973,to,1,0
243974,provide,1,0
243975,26,1,0
243976,%,1,0
243977,of,1,0
243978,energy,1,0
243979,from,1,0
243980,fat,1,0
243981,",",1,0
243982,5,1,0
243983,%,1,0
243984,of,1,0
243985,energy,1,0
243986,from,0,0
243987,SFA,0,1
243988,.,0,0
243989,Key,0,0
243990,features,0,0
243991,of,0,0
243992,diet,0,1
243993,standardization,0,0
243994,included,0,0
243995,central,0,0
243996,procurement,0,0
243997,of,0,0
243998,fat-containing,0,1
243999,foods,0,1
244000,",",0,0
244001,inclusion,0,0
244002,of,0,0
244003,standard,0,1
244004,ingredients,0,1
244005,",",0,0
244006,precision,0,0
244007,weighing,0,0
244008,of,0,0
244009,foods,0,1
244010,--,0,0
244011,especially,0,0
244012,sources,0,0
244013,of,0,0
244014,fat,0,0
244015,and,0,0
244016,cholesterol,0,0
244017,--,0,1
244018,and,0,0
244019,use,0,0
244020,of,0,0
244021,standardized,0,0
244022,written,0,1
244023,procedures,0,0
244024,.,0,0
244025,SETTING,0,0
244026,For,0,0
244027,menu,0,1
244028,validation,0,0
244029,",",0,0
244030,a,0,0
244031,set,0,0
244032,of,0,0
244033,12,0,0
244034,menus,0,1
244035,for,0,0
244036,each,0,0
244037,diet,0,1
244038,was,0,0
244039,prepared,0,1
244040,in,0,0
244041,duplicate,0,0
244042,and,0,0
244043,chemically,0,0
244044,assayed,0,0
244045,.,0,0
244046,For,0,0
244047,monitoring,0,0
244048,of,0,0
244049,diet,0,1
244050,composition,0,0
244051,during,0,0
244052,the,0,0
244053,study,0,0
244054,",",0,0
244055,an,0,0
244056,8-day,0,0
244057,diet,0,1
244058,cycle,0,0
244059,(,0,0
244060,6,0,1
244061,weekday,0,0
244062,and,0,0
244063,2,0,0
244064,weekend,0,0
244065,menus,0,1
244066,),0,0
244067,was,0,0
244068,sampled,0,0
244069,by,0,0
244070,every,0,1
244071,field,0,0
244072,center,0,0
244073,twice,0,1
244074,during,0,0
244075,each,0,0
244076,of,0,0
244077,3,0,0
244078,feeding,0,0
244079,periods,0,0
244080,.,0,0
244081,STATISTICAL,0,0
244082,ANALYSES,0,1
244083,Means,0,1
244084,(,0,0
244085,+/-,0,0
244086,standard,0,1
244087,error,0,0
244088,),0,0
244089,were,0,0
244090,calculated,0,0
244091,and,0,0
244092,compared,0,0
244093,with,0,0
244094,target,0,0
244095,nutrient,0,1
244096,specifications,0,0
244097,.,0,0
244098,RESULTS,0,0
244099,DELTA-1,0,1
244100,was,0,0
244101,able,0,0
244102,to,0,0
244103,provide,0,0
244104,a,0,0
244105,standardized,0,0
244106,diet,0,1
244107,that,0,0
244108,met,0,0
244109,nutrient,0,1
244110,specifications,0,0
244111,across,0,0
244112,4,0,0
244113,field,0,0
244114,centers,0,0
244115,over,0,0
244116,24,0,0
244117,weeks,0,0
244118,of,0,0
244119,participant,0,1
244120,feeding,0,1
244121,spanning,0,0
244122,a,0,0
244123,total,0,0
244124,of,0,0
244125,8,0,0
244126,months,0,0
244127,.,0,0
244128,APPLICATIONS,0,0
244129,Prestudy,0,0
244130,chemical,0,0
244131,validation,0,0
244132,of,0,0
244133,menus,0,1
244134,and,0,0
244135,continuous,0,1
244136,sampling,0,0
244137,and,0,0
244138,assay,0,1
244139,of,0,0
244140,diets,0,1
244141,throughout,0,0
244142,the,0,0
244143,study,0,0
244144,are,0,0
244145,essential,0,0
244146,to,0,0
244147,standardize,0,0
244148,experimental,0,0
244149,diets,0,1
244150,and,0,0
244151,to,0,0
244152,ensure,0,0
244153,that,0,0
244154,nutrient,0,1
244155,target,0,0
244156,goals,0,0
244157,are,0,0
244158,met,0,0
244159,and,0,0
244160,maintained,0,0
244161,throughout,0,0
244162,a,0,0
244163,controlled,0,0
244164,multicenter,0,0
244165,feeding,0,1
244166,study,0,0
244167,.,0,0
244168,A,0,0
244169,prospective,0,0
244170,randomized,0,0
244171,study,0,0
244172,of,0,0
244173,transurethral,1,1
244174,resection,1,1
244175,of,1,0
244176,the,1,0
244177,prostate,1,0
244178,and,1,0
244179,transurethral,1,1
244180,vaporization,1,1
244181,of,1,0
244182,the,1,0
244183,prostate,1,0
244184,as,0,0
244185,a,0,0
244186,therapeutic,0,0
244187,alternative,0,0
244188,in,0,0
244189,the,0,0
244190,management,0,0
244191,of,0,0
244192,men,0,0
244193,with,0,0
244194,BPH,0,0
244195,.,0,0
244196,OBJECTIVE,0,0
244197,The,0,0
244198,common,0,0
244199,goals,0,0
244200,of,0,0
244201,new,0,0
244202,surgical,0,1
244203,treatment,0,0
244204,for,0,0
244205,benign,0,0
244206,prostatic,0,1
244207,hyperplasia,0,0
244208,(,0,1
244209,BPH,0,1
244210,),0,1
244211,are,0,0
244212,to,0,0
244213,improve,0,0
244214,subjective,0,0
244215,and,0,0
244216,objective,0,0
244217,symptoms,0,0
244218,",",0,0
244219,to,0,0
244220,decrease,0,0
244221,the,0,0
244222,risk,0,0
244223,of,0,0
244224,postoperative,0,0
244225,complications,0,0
244226,and,0,0
244227,short,0,0
244228,hospitalization,0,0
244229,.,0,0
244230,Transurethral,1,1
244231,electrovaporization,1,0
244232,of,1,0
244233,the,1,0
244234,prostate,1,0
244235,(,1,1
244236,TUVP,1,1
244237,),1,1
244238,is,0,0
244239,a,0,0
244240,new,0,0
244241,",",0,0
244242,minimally,0,1
244243,invasive,0,0
244244,and,0,0
244245,a,0,0
244246,promising,0,0
244247,alternative,0,0
244248,to,0,0
244249,standard,1,1
244250,transurethral,1,1
244251,resection,1,1
244252,of,1,0
244253,the,1,0
244254,prostate,1,0
244255,(,1,1
244256,TURP,1,0
244257,),1,1
244258,in,0,0
244259,the,0,0
244260,treatment,0,0
244261,of,0,0
244262,BPH,0,0
244263,.,0,0
244264,The,0,0
244265,aim,0,0
244266,of,0,0
244267,this,0,0
244268,study,0,0
244269,is,0,0
244270,to,0,0
244271,compare,0,0
244272,the,0,0
244273,efficacy,0,0
244274,and,0,0
244275,safety,0,0
244276,of,0,0
244277,these,0,0
244278,two,0,0
244279,treatment,0,0
244280,alternatives,0,0
244281,.,0,0
244282,METHODS,0,0
244283,A,0,0
244284,prospective,0,0
244285,randomized,0,0
244286,trial,0,0
244287,of,0,0
244288,60,0,0
244289,patients,0,0
244290,with,0,0
244291,symptomatic,0,0
244292,BPH,0,1
244293,was,0,0
244294,performed,0,0
244295,.,0,0
244296,Preoperative,0,0
244297,and,0,0
244298,postoperative,0,0
244299,International,0,1
244300,Prostate,0,1
244301,Symptom,0,1
244302,Score,0,1
244303,(,0,1
244304,IPSS,0,1
244305,),0,1
244306,",",0,0
244307,maximum,0,0
244308,flow,0,0
244309,rates,0,0
244310,(,0,0
244311,Qmax,0,1
244312,),0,1
244313,and,0,0
244314,complications,0,0
244315,were,0,0
244316,recorded,0,0
244317,in,0,0
244318,each,0,0
244319,patient,0,0
244320,.,0,0
244321,The,0,0
244322,volume,0,0
244323,of,0,0
244324,the,0,0
244325,prostate,0,0
244326,was,0,0
244327,measured,0,0
244328,preoperatively,0,0
244329,and,0,0
244330,postoperatively,0,0
244331,using,0,0
244332,transrectal,0,1
244333,ultrasound,0,1
244334,.,0,0
244335,RESULTS,0,0
244336,Of,0,0
244337,the,0,0
244338,30,0,0
244339,patients,0,0
244340,who,0,0
244341,underwent,0,0
244342,TURP,0,0
244343,",",0,0
244344,mean,0,0
244345,hospital,0,0
244346,stay,0,0
244347,was,0,0
244348,4.5,0,0
244349,days,0,0
244350,.,0,0
244351,The,0,0
244352,Foley,0,1
244353,catheter,0,1
244354,was,0,0
244355,removed,0,0
244356,on,0,0
244357,postoperative,0,0
244358,day,0,1
244359,4,0,1
244360,following,0,0
244361,surgery,0,0
244362,.,0,0
244363,IPSS,0,0
244364,decreased,0,0
244365,from,0,0
244366,21.6,0,0
244367,to,0,0
244368,5.2,0,0
244369,",",0,0
244370,Qmax,0,0
244371,increased,0,0
244372,from,0,0
244373,9.2,0,0
244374,to,0,0
244375,19.2,0,0
244376,ml/s,0,0
244377,at,0,0
244378,3,0,0
244379,months,0,0
244380,.,0,0
244381,Mean,0,0
244382,prostatic,0,0
244383,volume,0,0
244384,at,0,0
244385,3,0,0
244386,months,0,0
244387,decreased,0,0
244388,from,0,0
244389,51.7,0,0
244390,to,0,0
244391,26.2,0,0
244392,g,0,1
244393,",",0,0
244394,a,0,0
244395,49.3,0,0
244396,%,0,0
244397,reduction,0,0
244398,.,0,0
244399,Of,0,0
244400,30,0,0
244401,patients,0,0
244402,undergoing,0,0
244403,TUVP,0,0
244404,",",0,0
244405,mean,0,0
244406,hospital,0,0
244407,stay,0,0
244408,was,0,0
244409,2.5,0,0
244410,days,0,0
244411,and,0,0
244412,the,0,0
244413,catheter,0,1
244414,was,0,0
244415,removed,0,0
244416,within,0,0
244417,2,0,0
244418,days,0,0
244419,following,0,0
244420,surgery,0,0
244421,.,0,0
244422,Postoperative,0,0
244423,urinary,0,0
244424,retention,0,0
244425,did,0,0
244426,not,0,0
244427,occur,0,0
244428,in,0,0
244429,any,0,0
244430,patient,0,0
244431,.,0,0
244432,IPSS,0,0
244433,decreased,0,0
244434,from,0,0
244435,19.4,0,0
244436,to,0,0
244437,4.1,0,0
244438,and,0,0
244439,Qmax,0,0
244440,increased,0,0
244441,from,0,0
244442,7.9,0,0
244443,to,0,0
244444,17.7,0,0
244445,ml/s,0,0
244446,at,0,0
244447,3,0,0
244448,months,0,0
244449,.,0,0
244450,Mean,0,0
244451,prostatic,0,0
244452,volume,0,0
244453,decreased,0,0
244454,from,0,0
244455,48.9,0,0
244456,to,0,0
244457,27.8,0,0
244458,g,0,1
244459,",",0,0
244460,a,0,0
244461,43.1,0,0
244462,%,0,0
244463,reduction,0,0
244464,at,0,0
244465,3,0,0
244466,months,0,0
244467,.,0,0
244468,In,0,0
244469,the,0,0
244470,TUVP,0,1
244471,group,0,0
244472,",",0,0
244473,none,0,0
244474,of,0,0
244475,the,0,0
244476,patients,0,0
244477,required,0,0
244478,blood,0,0
244479,transfusions,0,0
244480,or,0,0
244481,developed,0,0
244482,clinical,0,0
244483,transurethral,0,1
244484,resection,0,1
244485,syndrome,0,0
244486,.,0,0
244487,There,0,0
244488,were,0,0
244489,no,0,0
244490,major,0,0
244491,complications,0,0
244492,.,0,0
244493,Sphincteric,0,0
244494,incontinence,0,0
244495,",",0,0
244496,urethral,0,0
244497,strictures,0,0
244498,or,0,1
244499,bladder,0,0
244500,neck,0,1
244501,contractures,0,0
244502,were,0,0
244503,not,0,0
244504,recorded,0,0
244505,.,0,0
244506,At,0,0
244507,3,0,0
244508,months,0,0
244509,postoperatively,0,0
244510,",",0,0
244511,13,0,0
244512,patients,0,0
244513,in,0,0
244514,the,0,0
244515,TURP,0,0
244516,group,0,0
244517,and,0,0
244518,7,0,0
244519,patients,0,0
244520,in,0,0
244521,the,0,0
244522,TUVP,0,1
244523,group,0,0
244524,had,0,0
244525,retrograde,0,1
244526,ejaculation,0,0
244527,.,0,0
244528,CONCLUSION,0,0
244529,Our,0,0
244530,initial,0,0
244531,experience,0,0
244532,of,0,0
244533,TUVP,0,1
244534,suggests,0,0
244535,advantages,0,0
244536,over,0,0
244537,conventional,0,1
244538,TURP,0,0
244539,through,0,0
244540,reduced,0,0
244541,blood,0,0
244542,loss,0,0
244543,and,0,0
244544,shorter,0,0
244545,hospital,0,0
244546,stay,0,0
244547,.,0,0
244548,It,0,0
244549,appears,0,0
244550,to,0,0
244551,be,0,0
244552,an,0,0
244553,effective,0,0
244554,treatment,0,0
244555,for,0,0
244556,BPH,0,0
244557,;,0,0
244558,however,0,0
244559,",",0,0
244560,long-term,0,0
244561,results,0,0
244562,should,0,0
244563,be,0,0
244564,evaluated,0,0
244565,.,0,0
244566,Salbutamol,1,1
244567,or,0,1
244568,mist,1,0
244569,in,0,0
244570,acute,0,0
244571,bronchiolitis,0,0
244572,.,0,0
244573,BACKGROUND,0,0
244574,The,0,0
244575,role,0,0
244576,of,0,0
244577,bronchodilators,0,0
244578,in,0,0
244579,the,0,0
244580,treatment,0,0
244581,of,0,0
244582,bronchiolitis,0,0
244583,remains,0,0
244584,controversial,0,0
244585,.,0,0
244586,METHODS,0,0
244587,A,0,0
244588,double-blind,0,0
244589,",",0,0
244590,placebo,0,1
244591,controlled,0,0
244592,trial,0,0
244593,was,0,0
244594,performed,0,0
244595,to,0,0
244596,evaluate,0,0
244597,the,0,0
244598,clinical,0,0
244599,response,0,0
244600,to,0,0
244601,nebulized,0,1
244602,salbutamol,1,1
244603,.,1,0
244604,One,0,0
244605,hundred,0,0
244606,and,0,0
244607,fifty-six,0,0
244608,infants,0,0
244609,aged,0,0
244610,between,0,0
244611,7,0,0
244612,weeks,0,0
244613,and,0,0
244614,24,0,0
244615,months,0,0
244616,who,0,0
244617,had,0,0
244618,had,0,0
244619,an,0,0
244620,episode,0,0
244621,of,0,0
244622,wheezing,0,0
244623,and,0,0
244624,other,0,0
244625,signs,0,0
244626,and,0,0
244627,symptoms,0,0
244628,of,0,0
244629,bronchiolitis,0,0
244630,were,0,0
244631,randomized,0,0
244632,to,0,0
244633,three,0,0
244634,groups,0,0
244635,as,0,0
244636,follows,0,0
244637,:,0,0
244638,(,0,0
244639,i,0,0
244640,),0,1
244641,nebulized,1,1
244642,salbutamol,1,1
244643,was,0,0
244644,administered,0,0
244645,to,0,0
244646,52,0,0
244647,patients,0,0
244648,in,0,0
244649,group,0,0
244650,I,0,0
244651,at,0,0
244652,a,0,0
244653,dose,0,0
244654,of,0,0
244655,0.15,0,0
244656,mg/kg,0,1
244657,in,0,0
244658,2,0,0
244659,mL,0,1
244660,saline,1,1
244661,;,1,1
244662,(,0,1
244663,ii,0,1
244664,),0,1
244665,saline,1,1
244666,was,1,0
244667,nebulized,1,1
244668,to,0,0
244669,52,0,0
244670,patients,0,0
244671,in,0,0
244672,group,0,0
244673,II,0,1
244674,and,0,1
244675,(,0,1
244676,iii,0,0
244677,),0,1
244678,in,0,0
244679,group,0,0
244680,III,0,0
244681,52,0,0
244682,patients,0,0
244683,received,0,0
244684,mist,1,0
244685,in,0,0
244686,a,0,0
244687,tent,0,1
244688,.,0,0
244689,All,0,0
244690,three,0,0
244691,groups,0,0
244692,were,0,0
244693,administered,0,0
244694,oxygen,1,0
244695,during,0,0
244696,the,0,0
244697,procedures,0,0
244698,.,0,0
244699,Treatment,0,0
244700,was,0,0
244701,repeated,0,0
244702,with,0,0
244703,the,0,0
244704,same,0,0
244705,agent,0,0
244706,after,0,0
244707,30,0,0
244708,min,0,0
244709,if,0,0
244710,the,0,0
244711,respiratory,0,0
244712,score,0,0
244713,was,0,0
244714,5,0,0
244715,or,0,0
244716,more,0,0
244717,.,0,0
244718,Respiratory,0,0
244719,rate,0,0
244720,",",0,0
244721,heart,0,0
244722,rate,0,0
244723,",",0,0
244724,oxygen,0,1
244725,saturation,0,0
244726,and,0,0
244727,presence,0,0
244728,of,0,0
244729,cyanosis,0,0
244730,",",0,0
244731,wheezing,0,0
244732,",",0,0
244733,retractions,0,0
244734,were,0,0
244735,recorded,0,0
244736,before,0,0
244737,and,0,0
244738,after,0,0
244739,each,0,0
244740,treatment,0,0
244741,.,0,0
244742,RESULTS,0,0
244743,The,0,0
244744,decrease,0,0
244745,in,0,0
244746,the,0,0
244747,respiratory,0,0
244748,score,0,0
244749,was,0,0
244750,5.2,0,0
244751,+/-,0,0
244752,1.8,0,0
244753,",",0,0
244754,0.82,0,0
244755,+/-,0,0
244756,2.4,0,0
244757,and,0,0
244758,1.7,0,0
244759,+/-,0,0
244760,1.3,0,0
244761,in,0,0
244762,group,0,0
244763,I,0,0
244764,",",0,0
244765,II,0,0
244766,and,0,0
244767,III,0,0
244768,",",0,0
244769,respectively,0,0
244770,.,0,0
244771,The,0,0
244772,decrease,0,0
244773,in,0,0
244774,group,0,0
244775,I,0,0
244776,was,0,0
244777,significantly,0,0
244778,higher,0,0
244779,than,0,0
244780,in,0,0
244781,the,0,0
244782,other,0,0
244783,groups,0,0
244784,.,0,0
244785,Heart,0,0
244786,rate,0,0
244787,was,0,0
244788,similar,0,0
244789,between,0,0
244790,groups,0,0
244791,.,0,0
244792,Oxygen,0,0
244793,saturation,0,0
244794,decreased,0,0
244795,in,0,0
244796,group,0,0
244797,I,0,0
244798,without,0,0
244799,reaching,0,0
244800,statistical,0,0
244801,significance,0,0
244802,.,0,0
244803,CONCLUSIONS,0,0
244804,Salbutamol,1,1
244805,was,0,0
244806,shown,0,0
244807,to,0,0
244808,be,0,0
244809,effective,0,0
244810,and,0,0
244811,safe,0,0
244812,in,0,0
244813,the,0,0
244814,treatment,0,0
244815,of,0,0
244816,acute,0,0
244817,bronchiolitis,0,0
244818,.,0,0
244819,Laser,1,1
244820,therapy,1,1
244821,combined,1,1
244822,with,1,0
244823,brachytherapy,1,1
244824,for,0,0
244825,the,0,0
244826,palliation,0,0
244827,of,0,0
244828,malignant,0,0
244829,dysphagia,0,0
244830,.,0,0
244831,BACKGROUND/AIM,0,0
244832,OF,0,1
244833,STUDY,0,0
244834,Laser,1,1
244835,therapy,1,1
244836,is,0,0
244837,effective,0,0
244838,in,0,0
244839,relieving,0,0
244840,malignant,0,0
244841,dysphagia,0,1
244842,",",0,0
244843,but,0,0
244844,repeated,0,0
244845,treatments,0,0
244846,at,0,0
244847,4,0,0
244848,to,0,0
244849,6,0,0
244850,week,0,0
244851,intervals,0,0
244852,are,0,0
244853,usually,0,0
244854,required,0,0
244855,.,0,0
244856,This,0,0
244857,prospective,0,0
244858,randomised,0,0
244859,trial,0,0
244860,is,0,0
244861,designed,0,0
244862,to,0,0
244863,determine,0,0
244864,if,0,0
244865,addition,0,0
244866,of,0,0
244867,brachytherapy,0,1
244868,offers,0,0
244869,any,0,0
244870,advantages,0,0
244871,over,0,0
244872,laser,1,1
244873,therapy,1,0
244874,alone,0,1
244875,.,0,0
244876,METHODS,0,0
244877,Patients,0,0
244878,with,0,0
244879,inoperable,0,0
244880,carcinoma,0,0
244881,of,0,0
244882,the,0,0
244883,oesophagus,0,0
244884,were,0,0
244885,randomised,0,0
244886,to,0,0
244887,receive,0,0
244888,either,0,1
244889,endoscopic,1,1
244890,Nd,1,1
244891,:,1,0
244892,YAG,1,1
244893,laser,1,1
244894,therapy,1,1
244895,alone,0,1
244896,",",0,0
244897,or,0,1
244898,laser,1,1
244899,followed,0,1
244900,by,0,0
244901,brachytherapy,1,1
244902,.,1,0
244903,Patients,0,0
244904,who,0,0
244905,developed,0,0
244906,worsening,0,0
244907,dysphagia,0,0
244908,during,0,0
244909,follow-up,0,0
244910,were,0,0
244911,offered,0,0
244912,further,0,0
244913,treatment,0,0
244914,as,0,0
244915,appropriate,0,0
244916,.,0,0
244917,RESULTS,0,0
244918,Fourteen,0,0
244919,patients,0,0
244920,were,0,0
244921,randomised,0,0
244922,to,0,0
244923,receive,0,0
244924,laser,1,1
244925,only,1,0
244926,",",0,0
244927,and,0,0
244928,12,0,0
244929,to,0,0
244930,receive,0,0
244931,laser,0,1
244932,followed,0,1
244933,by,0,0
244934,brachytherapy,1,1
244935,.,1,0
244936,Of,0,0
244937,these,0,0
244938,12,0,0
244939,",",0,0
244940,one,0,0
244941,was,0,0
244942,lost,0,0
244943,to,0,0
244944,follow-up,0,0
244945,and,0,0
244946,four,0,0
244947,did,0,0
244948,not,0,0
244949,receive,0,0
244950,brachytherapy,1,1
244951,because,0,0
244952,they,0,0
244953,were,0,0
244954,unfit,0,0
244955,",",0,0
244956,had,0,0
244957,extension,0,0
244958,into,0,0
244959,the,0,0
244960,cardia,0,0
244961,or,0,1
244962,had,0,0
244963,mainly,0,0
244964,extrinsic,0,0
244965,compression,0,1
244966,.,0,0
244967,These,0,0
244968,4,0,0
244969,are,0,0
244970,included,0,0
244971,on,0,0
244972,an,0,0
244973,'intention-to-treat,0,1
244974,',0,0
244975,basis,0,0
244976,.,0,0
244977,The,0,0
244978,mean,0,0
244979,therapeutic,0,0
244980,interval,0,0
244981,for,0,0
244982,the,0,0
244983,brachytherapy,0,1
244984,group,0,0
244985,was,0,0
244986,significantly,0,0
244987,longer,0,0
244988,",",0,0
244989,83,0,0
244990,days,0,0
244991,compared,0,0
244992,to,0,0
244993,36,0,0
244994,days,0,0
244995,for,0,0
244996,the,0,0
244997,laser,0,1
244998,group,0,0
244999,(,0,0
245000,p,0,0
245001,=,0,0
245002,0.026,0,0
245003,),0,0
245004,.,0,0
245005,There,0,0
245006,were,0,0
245007,no,0,0
245008,differences,0,0
245009,in,0,0
245010,the,0,0
245011,degree,0,0
245012,of,0,0
245013,dysphagia,0,0
245014,relief,0,0
245015,",",0,0
245016,number,0,0
245017,of,0,0
245018,endoscopic,0,1
245019,procedures,0,0
245020,or,0,0
245021,survival,0,0
245022,times,0,0
245023,.,0,0
245024,CONCLUSION,0,0
245025,The,0,0
245026,preliminary,0,0
245027,results,0,0
245028,of,0,0
245029,this,0,0
245030,trial,0,0
245031,suggest,0,0
245032,that,0,0
245033,brachytherapy,1,1
245034,in,0,0
245035,addition,0,0
245036,to,0,0
245037,laser,0,1
245038,therapy,0,1
245039,prolongs,0,1
245040,the,0,0
245041,first,0,0
245042,therapeutic,0,0
245043,interval,0,0
245044,.,0,0
245045,However,0,0
245046,",",0,0
245047,no,0,0
245048,long-term,0,0
245049,advantages,0,0
245050,have,0,0
245051,been,0,0
245052,shown,0,0
245053,.,0,0
245054,Epileptogenic,0,0
245055,activity,0,0
245056,of,0,0
245057,folic,0,1
245058,acid,0,1
245059,after,0,0
245060,drug,0,0
245061,induces,0,0
245062,SLE,0,1
245063,(,0,0
245064,folic,0,1
245065,acid,0,1
245066,and,0,1
245067,epilepsy,0,0
245068,),0,1
245069,OBJECTIVE,0,0
245070,To,0,0
245071,study,0,0
245072,the,0,0
245073,effect,0,0
245074,of,0,0
245075,folic,1,1
245076,acid-containing,1,1
245077,multivitamin,1,1
245078,supplementation,1,1
245079,in,0,0
245080,epileptic,0,0
245081,women,0,0
245082,before,0,0
245083,and,0,0
245084,during,0,0
245085,pregnancy,0,0
245086,in,0,0
245087,order,0,0
245088,to,0,0
245089,determine,0,0
245090,the,0,0
245091,rate,0,0
245092,of,0,0
245093,structural,0,0
245094,birth,0,0
245095,defects,0,0
245096,and,0,0
245097,epilepsy-related,0,0
245098,side,0,0
245099,effects,0,0
245100,.,0,0
245101,STUDY,0,0
245102,DESIGN,0,0
245103,First,0,1
245104,a,0,0
245105,randomised,0,0
245106,trial,0,0
245107,",",0,0
245108,later,0,0
245109,periconception,0,1
245110,care,0,1
245111,including,0,0
245112,in,0,0
245113,total,0,0
245114,12225,0,0
245115,females,0,0
245116,.,0,0
245117,RESULTS,0,0
245118,Of,0,1
245119,60,0,0
245120,epileptic,0,0
245121,women,0,0
245122,with,0,0
245123,periconceptional,1,1
245124,folic,1,1
245125,acid,1,1
245126,(,0,0
245127,0.8,0,1
245128,mg,1,1
245129,),1,0
245130,-containing,1,1
245131,multivitamin,1,1
245132,supplementation,1,1
245133,",",0,0
245134,no,0,0
245135,one,0,0
245136,developed,0,0
245137,epilepsy-related,0,0
245138,side,0,0
245139,effects,0,0
245140,during,0,0
245141,the,0,0
245142,periconception,0,0
245143,period,0,0
245144,.,0,0
245145,One,0,0
245146,epileptic,0,0
245147,woman,0,0
245148,delivered,0,1
245149,a,0,0
245150,newborn,0,0
245151,with,0,0
245152,cleft,0,0
245153,lip,0,1
245154,and,0,0
245155,palate,0,0
245156,.,0,0
245157,Another,0,0
245158,patient,0,0
245159,exhibited,0,0
245160,with,0,0
245161,a,0,0
245162,cluster,0,0
245163,of,0,0
245164,seizures,0,0
245165,after,0,0
245166,the,0,0
245167,periconception,0,1
245168,period,0,0
245169,using,0,0
245170,another,0,0
245171,multivitamin,0,1
245172,.,0,0
245173,This,0,0
245174,22-year-old,0,0
245175,epileptic,0,0
245176,woman,0,0
245177,was,0,0
245178,treated,0,0
245179,continuously,0,0
245180,by,0,0
245181,carbamazepine,1,1
245182,and,1,0
245183,a,1,0
245184,folic,1,1
245185,acid,1,1
245186,(,0,0
245187,1,0,1
245188,mg,1,1
245189,),1,1
245190,-containing,1,1
245191,multivitamin,1,1
245192,from,0,0
245193,the,0,0
245194,20th,0,0
245195,week,0,0
245196,of,0,0
245197,gestation,0,0
245198,.,0,0
245199,She,0,0
245200,developed,0,0
245201,status,0,0
245202,epilepticus,0,1
245203,and,0,0
245204,later,0,0
245205,symptoms,0,0
245206,of,0,0
245207,systemic,0,0
245208,lupus,0,0
245209,erythematodes,0,0
245210,.,0,0
245211,Her,0,0
245212,pregnancy,0,0
245213,ended,0,0
245214,with,0,0
245215,stillbirth,0,0
245216,.,0,0
245217,CONCLUSIONS,0,0
245218,The,0,0
245219,epileptic,0,0
245220,pregnant,0,0
245221,patient,0,0
245222,'s,0,0
245223,autoimmune,0,0
245224,disease,0,0
245225,(,0,0
245226,probably,0,0
245227,drug-induced,0,0
245228,lupus,0,0
245229,),0,0
245230,could,0,0
245231,damage,0,0
245232,the,0,0
245233,blood-brain,0,0
245234,barrier,0,0
245235,",",0,0
245236,therefore,0,0
245237,the,0,0
245238,therapeutic,0,1
245239,dose,0,0
245240,(,0,0
245241,>,0,0
245242,or,0,1
245243,=1,0,0
245244,mg,0,1
245245,),0,0
245246,of,0,0
245247,folic,0,1
245248,acid,0,1
245249,triggered,0,0
245250,a,0,0
245251,cluster,0,0
245252,of,0,0
245253,seizures,0,0
245254,.,0,0
245255,Physiological,0,0
245256,dose,0,0
245257,(,0,0
245258,<,0,0
245259,1,0,1
245260,mg,0,1
245261,),0,0
245262,of,0,0
245263,folic,0,1
245264,acid,0,1
245265,both,0,0
245266,in,0,0
245267,healthy,0,0
245268,and,0,0
245269,60,0,0
245270,epileptic,0,0
245271,women,0,0
245272,",",0,0
245273,all,0,0
245274,without,0,0
245275,any,0,0
245276,autoimmune,0,0
245277,disease,0,0
245278,",",0,0
245279,did,0,0
245280,not,0,0
245281,increase,0,0
245282,the,0,0
245283,risk,0,0
245284,for,0,0
245285,epileptic,0,0
245286,seizures,0,0
245287,.,0,0
245288,Oxidative,0,0
245289,DNA,0,0
245290,damage,0,0
245291,measured,0,0
245292,in,0,0
245293,human,0,0
245294,lymphocytes,0,0
245295,:,0,0
245296,large,0,0
245297,differences,0,0
245298,between,0,0
245299,sexes,0,0
245300,and,0,0
245301,between,0,0
245302,countries,0,0
245303,",",0,0
245304,and,0,0
245305,correlations,0,0
245306,with,0,0
245307,heart,0,0
245308,disease,0,0
245309,mortality,0,0
245310,rates,0,0
245311,.,0,0
245312,The,0,0
245313,'antioxidant,0,1
245314,hypothesis,0,0
245315,',0,0
245316,proposes,0,0
245317,that,0,0
245318,vitamin,1,1
245319,C,1,1
245320,",",1,0
245321,vitamin,1,1
245322,E,1,1
245323,",",1,0
245324,carotenoids,1,1
245325,",",0,0
245326,and,0,0
245327,other,0,0
245328,antioxidants,1,1
245329,occurring,0,0
245330,in,0,0
245331,fruit,0,1
245332,and,0,0
245333,vegetables,0,1
245334,afford,0,0
245335,protection,0,0
245336,against,0,0
245337,heart,0,0
245338,disease,0,0
245339,and,0,0
245340,cancer,0,0
245341,by,0,0
245342,preventing,0,0
245343,oxidative,0,0
245344,damage,0,0
245345,to,0,0
245346,lipids,0,0
245347,and,0,0
245348,to,0,0
245349,DNA,0,0
245350,",",0,0
245351,respectively,0,0
245352,.,0,0
245353,To,0,0
245354,test,0,0
245355,elements,0,0
245356,of,0,0
245357,this,0,0
245358,hypothesis,0,0
245359,",",0,0
245360,we,0,0
245361,have,0,0
245362,measured,1,0
245363,blood,1,0
245364,levels,1,0
245365,of,0,0
245366,dietary,0,0
245367,antioxidants,0,1
245368,",",0,0
245369,and,0,0
245370,8-oxodeoxyguanosine,1,1
245371,(,0,1
245372,8-oxo-dG,0,0
245373,),0,0
245374,concentrations,0,0
245375,in,0,0
245376,lymphocyte,1,0
245377,DNA,1,0
245378,",",0,0
245379,in,0,0
245380,healthy,0,0
245381,men,0,0
245382,and,0,0
245383,women,0,0
245384,from,0,0
245385,five,0,0
245386,European,0,0
245387,countries,0,0
245388,:,0,0
245389,France,0,0
245390,",",0,0
245391,Ireland,0,0
245392,",",0,0
245393,The,0,0
245394,Netherlands,0,0
245395,",",0,0
245396,Spain,0,0
245397,",",0,0
245398,and,0,0
245399,the,0,0
245400,U.K,0,1
245401,.,0,0
245402,Volunteers,0,0
245403,",",0,0
245404,aged,0,0
245405,25,0,0
245406,45,0,0
245407,",",0,0
245408,all,0,0
245409,nonsmokers,0,0
245410,",",0,0
245411,gave,0,0
245412,blood,0,0
245413,samples,0,0
245414,before,0,0
245415,and,0,0
245416,after,0,0
245417,a,0,0
245418,12-wk,1,0
245419,carotenoid,1,1
245420,supplementation,1,1
245421,regime,1,1
245422,.,1,0
245423,Vitamin,0,1
245424,C,0,0
245425,was,0,0
245426,measured,0,0
245427,in,0,0
245428,plasma,0,0
245429,and,0,0
245430,vitamin,0,1
245431,E,0,1
245432,and,0,0
245433,carotenoids,0,1
245434,were,0,0
245435,measured,0,0
245436,in,0,0
245437,serum,0,0
245438,by,0,0
245439,high-performance,0,0
245440,liquid,1,1
245441,chromatography,1,1
245442,(,0,1
245443,HPLC,0,0
245444,),0,0
245445,.,0,0
245446,8-oxo-dG,0,0
245447,was,0,0
245448,assayed,0,0
245449,by,0,0
245450,HPLC,0,0
245451,(,0,0
245452,with,0,0
245453,coulometric,0,1
245454,detection,0,1
245455,),0,0
245456,in,0,0
245457,DNA,0,0
245458,isolated,0,0
245459,from,0,0
245460,lymphocytes,0,0
245461,from,0,0
245462,the,0,0
245463,same,0,0
245464,blood,0,0
245465,samples,0,0
245466,.,0,0
245467,Mean,0,0
245468,values,0,0
245469,were,0,0
245470,calculated,0,0
245471,for,0,0
245472,groups,0,0
245473,of,0,0
245474,volunteers,0,0
245475,at,0,0
245476,each,0,0
245477,sampling,0,0
245478,time,0,0
245479,according,0,0
245480,to,0,0
245481,country,0,0
245482,",",0,0
245483,sex,0,0
245484,",",0,0
245485,and,0,0
245486,supplementation,0,1
245487,(,0,0
245488,between,0,0
245489,9,0,0
245490,and,0,0
245491,24,0,0
245492,individual,0,0
245493,samples,0,0
245494,contributing,0,0
245495,to,0,0
245496,each,0,0
245497,mean,0,0
245498,),0,0
245499,.,0,0
245500,We,0,0
245501,found,0,0
245502,that,0,0
245503,8-oxo-dG,0,0
245504,levels,0,0
245505,in,0,0
245506,lymphocyte,0,0
245507,DNA,0,0
245508,vary,0,0
245509,significantly,0,0
245510,according,0,0
245511,to,0,0
245512,sex,0,0
245513,and,0,0
245514,country,0,0
245515,.,0,0
245516,A,0,0
245517,low,0,0
245518,mean,0,0
245519,8-oxo-dG,0,0
245520,concentration,0,0
245521,is,0,0
245522,seen,0,0
245523,in,0,0
245524,DNA,0,0
245525,of,0,0
245526,women,0,0
245527,from,0,0
245528,all,0,0
245529,five,0,0
245530,countries,0,0
245531,",",0,0
245532,and,0,0
245533,of,0,0
245534,men,0,0
245535,from,0,0
245536,France,0,0
245537,and,0,0
245538,Spain,0,0
245539,.,0,1
245540,8-oxo-dG,0,0
245541,is,0,0
245542,significantly,0,0
245543,higher,0,0
245544,(,0,0
245545,up,0,0
245546,to,0,0
245547,about,0,0
245548,threefold,0,0
245549,),0,0
245550,in,0,0
245551,lymphocyte,0,0
245552,DNA,0,0
245553,from,0,0
245554,men,0,0
245555,in,0,0
245556,Ireland,0,0
245557,and,0,0
245558,the,0,0
245559,U.K.,0,1
245560,Oxidative,0,0
245561,DNA,0,0
245562,damage,0,0
245563,is,0,0
245564,not,0,0
245565,significantly,0,0
245566,affected,0,0
245567,by,0,0
245568,carotenoid,0,1
245569,supplementation,0,1
245570,;,0,0
245571,nor,0,0
245572,is,0,0
245573,there,0,0
245574,any,0,0
245575,association,0,0
245576,with,0,0
245577,mean,0,0
245578,baseline,0,0
245579,levels,0,0
245580,of,0,0
245581,antioxidants,0,1
245582,",",0,0
245583,which,0,0
245584,are,0,0
245585,generally,0,0
245586,similar,0,0
245587,in,0,0
245588,the,0,0
245589,five,0,0
245590,countries,0,0
245591,.,0,0
245592,The,0,0
245593,five,0,0
245594,countries,0,0
245595,sampled,0,0
245596,lie,0,0
245597,on,0,0
245598,an,0,0
245599,axis,0,0
245600,from,0,0
245601,northern,0,0
245602,to,0,0
245603,southern,0,0
245604,Europe,0,1
245605,with,0,0
245606,a,0,0
245607,steep,0,0
245608,gradient,0,1
245609,in,0,0
245610,terms,0,0
245611,of,0,0
245612,premature,0,0
245613,heart,0,0
245614,disease,0,0
245615,.,0,0
245616,There,0,0
245617,is,0,0
245618,a,0,0
245619,strong,0,0
245620,association,0,0
245621,between,0,0
245622,premature,0,0
245623,coronary,0,0
245624,heart,0,0
245625,disease,0,0
245626,mortality,0,0
245627,in,0,0
245628,men,0,0
245629,and,0,0
245630,the,0,0
245631,mean,0,0
245632,levels,0,0
245633,of,0,0
245634,8-oxo-dG,0,0
245635,for,0,0
245636,the,0,0
245637,five,0,0
245638,countries,0,0
245639,(,0,0
245640,r,0,0
245641,=,0,0
245642,0.95,0,0
245643,",",0,0
245644,P,0,0
245645,<,0,0
245646,0.01,0,0
245647,),0,0
245648,.,0,0
245649,Women,0,0
245650,have,0,0
245651,low,0,0
245652,coronary,0,0
245653,heart,0,0
245654,disease,0,0
245655,mortality,0,0
245656,rates,0,0
245657,",",0,0
245658,which,0,0
245659,do,0,0
245660,not,0,0
245661,correlate,0,0
245662,with,0,0
245663,8-oxo-dG,0,0
245664,.,0,0
245665,In,0,0
245666,terms,0,0
245667,of,0,0
245668,cancer,0,0
245669,deaths,0,0
245670,",",0,0
245671,only,0,0
245672,colorectal,0,0
245673,cancer,0,0
245674,in,0,0
245675,men,0,0
245676,shows,0,0
245677,a,0,0
245678,significant,0,0
245679,positive,0,0
245680,correlation,0,0
245681,(,0,1
245682,r,0,0
245683,=,0,0
245684,0.91,0,0
245685,",",0,0
245686,P,0,0
245687,<,0,0
245688,0.05,0,0
245689,),0,0
245690,",",0,0
245691,and,0,0
245692,stomach,0,0
245693,cancer,0,0
245694,in,0,0
245695,women,0,0
245696,is,0,0
245697,negatively,0,0
245698,correlated,0,0
245699,with,0,0
245700,DNA,0,1
245701,oxidation,0,1
245702,(,0,0
245703,r,0,0
245704,=,0,0
245705,-0.92,0,0
245706,",",0,0
245707,P,0,0
245708,=,0,0
245709,0.01,0,0
245710,),0,0
245711,.,0,0
245712,Functional,0,1
245713,modification,0,1
245714,of,0,0
245715,agonist-antagonist,0,1
245716,electromyographic,0,0
245717,activity,0,0
245718,for,0,0
245719,rapid,0,0
245720,movement,0,0
245721,inhibition,0,0
245722,.,0,0
245723,Subjects,0,0
245724,made,0,0
245725,a,0,0
245726,fast,0,1
245727,elbow,0,1
245728,extension,0,0
245729,movement,0,0
245730,to,0,0
245731,designated,0,0
245732,target,0,0
245733,in,0,0
245734,response,0,0
245735,to,0,0
245736,a,0,0
245737,go,1,0
245738,signal,1,0
245739,.,1,0
245740,In,0,0
245741,45,0,0
245742,%,0,0
245743,of,0,0
245744,trials,0,0
245745,a,0,0
245746,stop,0,0
245747,signal,0,0
245748,was,0,0
245749,presented,0,0
245750,after,0,0
245751,the,0,0
245752,go,0,0
245753,signal,0,0
245754,",",0,0
245755,to,0,0
245756,which,0,0
245757,subjects,0,0
245758,were,0,0
245759,asked,0,0
245760,to,0,0
245761,stop,0,0
245762,the,0,0
245763,movement,0,0
245764,as,0,0
245765,rapidly,0,0
245766,as,0,0
245767,possible,0,0
245768,.,0,0
245769,The,1,0
245770,interstimulus,1,1
245771,interval,1,0
245772,(,1,1
245773,ISI,1,1
245774,),1,1
245775,",",1,0
245776,or,1,1
245777,time,1,0
245778,interval,1,0
245779,between,1,0
245780,the,1,0
245781,go,1,0
245782,and,1,0
245783,stop,1,0
245784,signals,1,0
245785,",",0,0
245786,was,0,0
245787,randomly,0,0
245788,varied,0,0
245789,between,0,0
245790,0,0,0
245791,and,0,0
245792,200,0,1
245793,ms.,0,0
245794,Electromyographic,1,1
245795,(,1,1
245796,EMG,1,1
245797,),1,1
245798,activity,1,0
245799,was,1,0
245800,recorded,1,0
245801,from,1,0
245802,biceps,1,1
245803,brachii,1,1
245804,and,1,0
245805,triceps,1,0
245806,brachii,1,1
245807,.,1,0
245808,Subjects,0,0
245809,could,0,0
245810,sometimes,0,0
245811,completely,0,0
245812,inhibit,0,0
245813,initiation,0,0
245814,of,0,0
245815,the,0,0
245816,movements,0,0
245817,when,0,0
245818,the,0,0
245819,ISI,0,1
245820,was,0,0
245821,0,0,0
245822,ms,0,0
245823,",",0,0
245824,but,0,0
245825,could,0,0
245826,rarely,0,0
245827,do,0,0
245828,so,0,0
245829,when,0,0
245830,the,0,0
245831,ISI,0,1
245832,exceeded,0,0
245833,100,0,0
245834,ms.,0,0
245835,For,0,0
245836,responses,0,0
245837,that,0,0
245838,were,0,0
245839,initiated,0,0
245840,but,0,0
245841,stopped,0,0
245842,on,0,0
245843,the,0,0
245844,way,0,0
245845,",",0,0
245846,the,0,0
245847,amplitude,0,0
245848,of,0,0
245849,the,0,0
245850,movement,0,0
245851,decreased,0,0
245852,linearly,0,0
245853,as,0,0
245854,the,0,0
245855,time,0,0
245856,interval,0,0
245857,(,0,1
245858,=modification,0,1
245859,time,0,0
245860,),0,0
245861,from,0,0
245862,the,0,0
245863,stop,0,0
245864,signal,0,0
245865,to,0,0
245866,EMG,0,0
245867,onset,0,0
245868,increased,0,0
245869,.,0,0
245870,The,0,0
245871,peak,0,0
245872,velocity,0,0
245873,increased,0,0
245874,linearly,0,0
245875,as,0,0
245876,the,0,0
245877,movement,0,0
245878,amplitude,0,0
245879,increased,0,0
245880,.,0,0
245881,This,0,0
245882,tendency,0,0
245883,was,0,0
245884,similar,0,0
245885,to,0,0
245886,those,0,0
245887,previously,0,0
245888,reported,0,0
245889,in,0,0
245890,step-tracking,0,1
245891,movements,0,0
245892,with,0,0
245893,various,0,0
245894,amplitudes,0,0
245895,.,0,0
245896,In,0,0
245897,spite,0,0
245898,of,0,0
245899,the,0,0
245900,similarity,0,0
245901,in,0,0
245902,the,0,0
245903,kinematics,0,0
245904,of,0,0
245905,the,0,0
245906,movement,0,0
245907,",",0,0
245908,the,0,0
245909,EMG,0,0
245910,pattern,0,0
245911,was,0,0
245912,different,0,0
245913,from,0,0
245914,that,0,0
245915,of,0,0
245916,step-tracking,0,1
245917,movement,0,0
245918,.,0,0
245919,While,0,0
245920,the,0,0
245921,initial,0,0
245922,agonist,0,1
245923,burst,0,0
245924,(,0,1
245925,AG1,0,0
245926,),0,1
245927,decreased,0,0
245928,linearly,0,0
245929,after,0,0
245930,the,0,0
245931,modification,0,1
245932,time,0,0
245933,exceeded,0,0
245934,100,0,0
245935,ms,0,0
245936,",",0,0
245937,the,0,0
245938,antagonist,0,1
245939,burst,0,0
245940,(,0,1
245941,ANT,0,0
245942,),0,1
245943,increased,0,0
245944,compared,0,0
245945,with,0,0
245946,the,0,0
245947,go,0,0
245948,trial,0,0
245949,for,0,0
245950,the,0,0
245951,modification,0,1
245952,time,0,0
245953,from,0,0
245954,0,0,0
245955,to,0,0
245956,200,0,0
245957,ms,0,0
245958,and,0,0
245959,decreased,0,0
245960,after,0,0
245961,the,0,0
245962,modification,0,1
245963,time,0,0
245964,exceeded,0,0
245965,300,0,1
245966,ms,0,0
245967,.,0,0
245968,This,0,0
245969,change,0,0
245970,of,0,0
245971,activation,0,0
245972,is,0,0
245973,analogous,0,0
245974,to,0,0
245975,functional,0,0
245976,modification,0,1
245977,of,0,0
245978,middle-latency,0,1
245979,reflex,0,0
245980,EMG,0,0
245981,response,0,0
245982,to,0,0
245983,load,0,0
245984,",",0,0
245985,or,0,1
245986,cutaneous,0,0
245987,perturbation,0,0
245988,.,0,0
245989,In,0,0
245990,conclusion,0,0
245991,",",0,0
245992,it,0,0
245993,is,0,0
245994,suggested,0,0
245995,that,0,0
245996,adaptive,0,0
245997,mechanisms,0,0
245998,",",0,0
245999,which,0,0
246000,would,0,0
246001,functionally,0,0
246002,modify,0,0
246003,the,0,0
246004,reflex,0,0
246005,responses,0,0
246006,",",0,0
246007,are,0,0
246008,also,0,0
246009,continuously,0,0
246010,working,0,0
246011,during,0,0
246012,voluntary,0,1
246013,movements,0,0
246014,in,0,0
246015,response,0,0
246016,to,0,0
246017,sudden,0,0
246018,changes,0,0
246019,in,0,0
246020,environmental,0,0
246021,information,0,0
246022,.,0,0
246023,Pharmacokinetics,0,0
246024,of,0,0
246025,cefuroxime,1,1
246026,in,0,0
246027,healthy,0,0
246028,volunteers,0,0
246029,:,0,0
246030,an,0,0
246031,update,0,0
246032,.,0,0
246033,Efficacy,0,0
246034,and,0,0
246035,safety,0,0
246036,relative,0,0
246037,to,0,0
246038,placebo,1,1
246039,of,0,0
246040,an,0,0
246041,oral,0,1
246042,formulation,0,1
246043,of,0,0
246044,cetirizine,1,1
246045,and,0,0
246046,sustained-release,0,1
246047,pseudoephedrine,1,1
246048,in,0,0
246049,the,0,0
246050,management,0,1
246051,of,0,0
246052,nasal,0,0
246053,congestion,0,0
246054,.,0,0
246055,BACKGROUND,0,0
246056,The,0,0
246057,aim,0,0
246058,of,0,0
246059,this,0,0
246060,study,0,0
246061,was,0,0
246062,to,0,0
246063,assess,0,0
246064,the,0,0
246065,clinical,0,0
246066,efficacy,0,0
246067,of,0,0
246068,an,0,0
246069,oral,0,1
246070,formulation,0,1
246071,of,0,0
246072,cetirizine,1,1
246073,5,0,1
246074,mg,0,1
246075,with,0,0
246076,sustained-release,0,1
246077,pseudoephedrine,1,1
246078,(,0,1
246079,PSE,0,0
246080,),0,1
246081,120,0,0
246082,mg,0,1
246083,relative,0,0
246084,to,0,0
246085,placebo,1,1
246086,in,0,0
246087,patients,0,0
246088,with,0,0
246089,nasal,0,0
246090,congestion,0,0
246091,.,0,0
246092,METHODS,0,0
246093,Twenty-four,0,0
246094,patients,0,0
246095,with,0,0
246096,perennial,0,0
246097,rhinitis,0,0
246098,due,0,0
246099,to,0,0
246100,house-dust-mite,0,1
246101,(,0,1
246102,HDM,0,1
246103,),0,1
246104,allergy,0,0
246105,were,0,0
246106,recruited,0,0
246107,in,0,0
246108,this,0,0
246109,crossover,0,0
246110,study,0,0
246111,.,0,0
246112,A,0,0
246113,treatment,0,0
246114,period,0,0
246115,of,0,0
246116,1,0,0
246117,week,0,0
246118,",",0,0
246119,in,0,0
246120,which,0,0
246121,cetirizine/PSE,1,1
246122,was,0,0
246123,administered,0,0
246124,twice,0,0
246125,daily,0,0
246126,",",0,0
246127,was,0,0
246128,followed,0,0
246129,by,0,0
246130,a,0,0
246131,washout,0,1
246132,period,0,0
246133,of,0,0
246134,at,0,0
246135,least,0,0
246136,2,0,0
246137,weeks,0,0
246138,and,0,0
246139,a,0,0
246140,further,0,0
246141,period,0,0
246142,of,0,0
246143,1,0,0
246144,week,0,0
246145,in,0,0
246146,which,0,0
246147,the,0,0
246148,alternative,0,1
246149,treatment,0,0
246150,was,0,0
246151,given,0,0
246152,to,0,0
246153,each,0,0
246154,patient,0,0
246155,.,0,0
246156,Immediately,0,0
246157,after,0,0
246158,the,0,0
246159,first,0,0
246160,dose,0,0
246161,of,0,0
246162,each,0,0
246163,medication,0,1
246164,(,0,0
246165,day,0,1
246166,1,0,0
246167,),0,0
246168,",",0,0
246169,nasal,0,1
246170,congestion,0,0
246171,and,0,0
246172,related,0,0
246173,symptoms,0,0
246174,were,0,0
246175,assessed,0,0
246176,during,0,0
246177,a,0,0
246178,7-h,0,1
246179,challenge,0,0
246180,with,0,0
246181,HDM,0,1
246182,feces,0,0
246183,",",0,0
246184,with,0,0
246185,the,0,0
246186,Vienna,0,0
246187,Challenge,0,1
246188,Chamber,0,1
246189,(,0,1
246190,VCC,0,1
246191,),0,0
246192,",",0,0
246193,to,0,0
246194,investigate,0,0
246195,onset,0,0
246196,of,0,0
246197,action,0,0
246198,of,0,0
246199,the,0,0
246200,preparation,0,1
246201,.,0,0
246202,A,0,0
246203,second,0,0
246204,challenge,0,0
246205,of,0,0
246206,3-h,0,0
246207,duration,0,0
246208,",",0,0
246209,carried,0,0
246210,out,0,0
246211,at,0,0
246212,least,0,0
246213,12,0,0
246214,h,0,0
246215,after,0,0
246216,the,0,0
246217,final,0,0
246218,dose,0,0
246219,",",0,0
246220,was,0,0
246221,undertaken,0,0
246222,after,0,0
246223,1,0,0
246224,week,0,0
246225,(,0,0
246226,mean,0,0
246227,),0,1
246228,of,0,0
246229,twice-daily,0,1
246230,treatment,0,0
246231,to,0,0
246232,assess,0,0
246233,residual,0,0
246234,effects,0,0
246235,of,0,0
246236,the,0,0
246237,formulation,0,1
246238,after,0,0
246239,achievement,0,0
246240,of,0,0
246241,steady,0,0
246242,state,0,0
246243,.,0,0
246244,RESULTS,0,0
246245,The,0,0
246246,oral,0,1
246247,formulation,0,1
246248,of,0,0
246249,cetirizine/PSE,1,1
246250,was,0,0
246251,significantly,0,0
246252,(,0,0
246253,P,0,0
246254,<,0,0
246255,0.001,0,0
246256,),0,0
246257,superior,0,0
246258,to,0,0
246259,placebo,1,1
246260,in,0,0
246261,improving,0,0
246262,nasal,0,1
246263,obstruction,0,0
246264,during,0,0
246265,both,0,0
246266,challenges,0,0
246267,.,0,0
246268,The,0,0
246269,improvement,0,0
246270,in,0,0
246271,nasal,0,1
246272,airflow,0,0
246273,and,0,0
246274,nasal,0,1
246275,patency,0,0
246276,was,0,0
246277,significantly,0,0
246278,greater,0,0
246279,with,0,0
246280,cetirizine/PSE,1,1
246281,than,0,0
246282,with,0,0
246283,placebo,1,1
246284,(,0,0
246285,P,0,0
246286,<,0,0
246287,0.02,0,0
246288,),0,0
246289,.,0,0
246290,In,0,0
246291,addition,0,0
246292,",",0,0
246293,subjective,0,0
246294,assessment,0,0
246295,of,0,0
246296,nasal,0,0
246297,symptoms,0,0
246298,showed,0,0
246299,that,0,0
246300,cetirizine/PSE,0,1
246301,was,0,0
246302,significantly,0,0
246303,superior,0,0
246304,to,0,0
246305,placebo,1,1
246306,in,0,0
246307,both,0,0
246308,challenges,0,0
246309,for,0,0
246310,the,0,0
246311,sum,0,0
246312,of,0,0
246313,nasal,0,0
246314,obstruction,0,0
246315,scores,0,0
246316,(,0,0
246317,P,0,0
246318,<,0,0
246319,0.01,0,0
246320,),0,0
246321,.,0,0
246322,Both,0,1
246323,medications,0,0
246324,were,0,0
246325,well,0,0
246326,tolerated,0,0
246327,",",0,0
246328,and,0,0
246329,no,0,0
246330,serious,0,0
246331,adverse,0,0
246332,events,0,0
246333,occurred,0,0
246334,during,0,0
246335,the,0,0
246336,study,0,0
246337,.,0,0
246338,CONCLUSIONS,0,0
246339,In,0,0
246340,this,0,0
246341,study,0,0
246342,",",0,0
246343,cetirizine/PSE,1,1
246344,relieved,0,0
246345,nasal,0,1
246346,congestion,0,0
246347,and,0,0
246348,other,0,0
246349,objective,0,0
246350,and,0,0
246351,subjective,0,0
246352,symptoms,0,0
246353,to,0,0
246354,a,0,0
246355,significantly,0,0
246356,greater,0,0
246357,extent,0,0
246358,than,0,0
246359,placebo,0,1
246360,.,0,0
246361,No,0,0
246362,serious,0,0
246363,adverse,0,0
246364,events,0,0
246365,occurred,0,0
246366,",",0,0
246367,and,0,0
246368,both,0,0
246369,regimens,0,1
246370,were,0,0
246371,equally,0,0
246372,well,0,0
246373,tolerated,0,0
246374,.,0,0
246375,Treatment,0,1
246376,of,0,0
246377,children,0,0
246378,with,0,0
246379,autism,0,0
246380,:,0,0
246381,a,0,0
246382,randomized,0,0
246383,controlled,0,0
246384,trial,0,0
246385,to,0,0
246386,evaluate,0,0
246387,a,0,0
246388,caregiver-based,1,1
246389,intervention,1,1
246390,program,1,1
246391,in,0,0
246392,community,0,1
246393,day-care,0,0
246394,centers,0,0
246395,.,0,0
246396,This,0,0
246397,study,0,0
246398,reports,0,0
246399,on,0,0
246400,the,0,0
246401,results,0,0
246402,of,0,0
246403,a,0,0
246404,randomized,0,0
246405,controlled,0,0
246406,trial,0,0
246407,that,0,0
246408,evaluated,0,0
246409,a,0,0
246410,caregiver-based,1,1
246411,intervention,1,1
246412,program,1,1
246413,for,0,0
246414,children,0,0
246415,with,0,0
246416,autism,0,0
246417,in,0,0
246418,community,0,1
246419,day-care,0,0
246420,centers,0,0
246421,.,0,0
246422,Thirty-five,0,0
246423,preschool,0,0
246424,children,0,0
246425,with,0,0
246426,a,0,0
246427,DSM,0,0
246428,III-R,0,1
246429,diagnosis,0,0
246430,of,0,0
246431,autism,0,0
246432,or,0,1
246433,pervasive,0,0
246434,developmental,0,0
246435,disorder,0,0
246436,were,0,0
246437,randomized,0,0
246438,to,0,0
246439,an,0,0
246440,experimental,0,0
246441,or,0,1
246442,control,0,1
246443,group,0,0
246444,.,0,0
246445,Children,0,0
246446,in,0,0
246447,the,0,0
246448,experimental,0,0
246449,group,0,0
246450,were,0,0
246451,enrolled,0,0
246452,in,0,0
246453,day,0,1
246454,care,0,1
246455,and,0,0
246456,their,0,0
246457,parents,1,0
246458,and,1,0
246459,child,1,0
246460,care,1,1
246461,workers,1,0
246462,received,1,0
246463,a,1,0
246464,12-week,1,0
246465,intervention,1,1
246466,consisting,1,0
246467,of,1,0
246468,lectures,1,1
246469,and,1,0
246470,on-site,1,1
246471,consultations,1,1
246472,to,1,0
246473,day-care,1,0
246474,centers,1,0
246475,.,1,0
246476,In,0,0
246477,addition,0,0
246478,",",0,0
246479,supportive,0,1
246480,work,0,0
246481,was,0,0
246482,undertaken,0,0
246483,with,0,0
246484,families,0,0
246485,.,0,0
246486,Control,0,0
246487,subjects,0,0
246488,received,0,0
246489,day,1,0
246490,care,1,1
246491,alone,1,1
246492,.,1,0
246493,In,0,0
246494,the,0,0
246495,experimental,0,0
246496,group,0,0
246497,",",0,0
246498,there,0,0
246499,were,0,0
246500,greater,0,0
246501,gains,0,0
246502,in,0,0
246503,language,0,0
246504,abilities,0,0
246505,",",0,0
246506,significant,0,0
246507,increases,0,0
246508,in,0,0
246509,caregivers,0,0
246510,',0,0
246511,knowledge,0,0
246512,about,0,0
246513,autism,0,0
246514,",",0,0
246515,greater,0,0
246516,perception,0,0
246517,of,0,0
246518,control,0,0
246519,on,0,0
246520,the,0,0
246521,part,0,0
246522,of,0,0
246523,mothers,0,0
246524,",",0,0
246525,and,0,0
246526,greater,0,0
246527,parent,0,1
246528,satisfaction,0,0
246529,.,0,0
246530,We,0,0
246531,conclude,0,0
246532,that,0,0
246533,this,0,0
246534,research,0,0
246535,design,0,0
246536,demonstrated,0,0
246537,that,0,0
246538,the,0,0
246539,intervention,0,1
246540,was,0,0
246541,significantly,0,0
246542,superior,0,0
246543,to,0,0
246544,day,0,0
246545,care,0,1
246546,alone,0,1
246547,.,0,0
246548,BEACOPP,0,1
246549,",",0,0
246550,a,0,0
246551,new,0,0
246552,dose-escalated,1,0
246553,and,1,0
246554,accelerated,1,0
246555,regimen,1,1
246556,",",0,0
246557,is,0,0
246558,at,0,0
246559,least,0,0
246560,as,0,0
246561,effective,0,0
246562,as,0,0
246563,COPP/ABVD,1,0
246564,in,0,0
246565,patients,0,0
246566,with,0,0
246567,advanced-stage,0,0
246568,Hodgkin,0,0
246569,'s,0,0
246570,lymphoma,0,0
246571,:,0,0
246572,interim,0,0
246573,report,0,0
246574,from,0,0
246575,a,0,0
246576,trial,0,0
246577,of,0,0
246578,the,0,0
246579,German,0,0
246580,Hodgkin,0,0
246581,'s,0,0
246582,Lymphoma,0,0
246583,Study,0,0
246584,Group,0,0
246585,.,0,0
246586,PURPOSE,0,0
246587,The,0,0
246588,HD9,0,0
246589,trial,0,0
246590,aims,0,0
246591,to,0,0
246592,evaluate,0,0
246593,whether,0,0
246594,moderate,0,0
246595,dose,0,0
246596,escalation,0,0
246597,and/or,0,0
246598,acceleration,0,0
246599,of,0,0
246600,standard,1,1
246601,polychemotherapy,1,1
246602,is,0,0
246603,beneficial,0,0
246604,for,0,0
246605,advanced-stage,0,0
246606,Hodgkin,0,0
246607,'s,0,0
246608,disease,0,0
246609,(,0,1
246610,HD,0,1
246611,),0,0
246612,.,0,0
246613,Two,0,0
246614,variants,0,0
246615,of,0,0
246616,a,0,0
246617,novel,1,0
246618,bleomycin,1,1
246619,",",1,0
246620,etoposide,1,1
246621,",",1,0
246622,doxorubicin,1,1
246623,",",1,0
246624,cyclophosphamide,1,1
246625,",",1,0
246626,vincristine,1,1
246627,",",1,0
246628,procarbazine,1,1
246629,",",1,0
246630,and,1,0
246631,prednisone,1,1
246632,(,1,1
246633,BEACOPP,1,1
246634,),1,1
246635,scheme,1,1
246636,(,1,1
246637,standard,1,1
246638,and,1,0
246639,escalated,1,0
246640,dose,1,0
246641,),1,0
246642,are,0,0
246643,compared,0,0
246644,with,0,0
246645,cyclophosphamide,1,1
246646,",",1,0
246647,vincristine,1,1
246648,",",1,0
246649,procarbazine,1,1
246650,",",1,0
246651,and,1,0
246652,prednisone,1,1
246653,(,1,1
246654,COPP,1,1
246655,),1,1
246656,/doxorubicin,1,1
246657,",",1,0
246658,bleomycin,1,1
246659,",",1,0
246660,vinblastine,1,1
246661,",",1,0
246662,and,1,0
246663,dacarbazine,1,1
246664,(,1,1
246665,ABVD,1,0
246666,),1,0
246667,.,1,0
246668,PATIENTS,0,0
246669,AND,0,0
246670,METHODS,0,0
246671,The,0,0
246672,randomized,0,0
246673,",",0,0
246674,three-arm,0,0
246675,trial,0,0
246676,recruited,0,0
246677,patients,0,0
246678,in,0,0
246679,stages,0,0
246680,IIB,0,1
246681,and,0,0
246682,IIIA,0,1
246683,with,0,0
246684,risk,0,0
246685,factors,0,0
246686,and,0,0
246687,stages,0,0
246688,IIIB,0,0
246689,and,0,0
246690,IV,0,0
246691,.,0,0
246692,BEACOPP,0,0
246693,in,0,0
246694,baseline,0,0
246695,dose,0,1
246696,contains,0,0
246697,all,0,0
246698,drug,0,0
246699,dosages,0,0
246700,of,0,0
246701,COPP/ABVD,1,0
246702,(,0,0
246703,except,0,0
246704,vincristine,0,1
246705,and,0,1
246706,procarbazine,0,1
246707,),0,1
246708,rearranged,0,0
246709,in,0,0
246710,a,0,0
246711,shorter,0,0
246712,",",0,0
246713,3-week,0,0
246714,cycle,0,0
246715,.,0,0
246716,Escalated,0,0
246717,BEACOPP,0,0
246718,uses,0,0
246719,higher,0,0
246720,doses,0,0
246721,of,0,0
246722,cyclophosphamide,1,1
246723,",",1,0
246724,doxorubicin,1,1
246725,",",1,0
246726,and,1,0
246727,etoposide,1,1
246728,with,1,0
246729,granulocyte,1,1
246730,colony-stimulating,1,1
246731,factor,1,1
246732,(,1,1
246733,G-CSF,1,1
246734,),1,1
246735,support,0,0
246736,.,0,0
246737,After,0,0
246738,eight,0,0
246739,chemotherapy,1,1
246740,cycles,0,0
246741,",",0,0
246742,initial,0,0
246743,bulky,0,0
246744,and,0,0
246745,residual,0,0
246746,disease,0,0
246747,is,0,0
246748,irradiated,0,0
246749,.,0,0
246750,The,0,0
246751,trial,0,0
246752,is,0,0
246753,monitored,0,0
246754,and,0,0
246755,analyzed,0,0
246756,by,0,0
246757,means,0,0
246758,of,0,0
246759,a,0,0
246760,sequential,0,0
246761,strategy,0,0
246762,.,0,0
246763,RESULTS,0,0
246764,An,0,0
246765,interim,0,0
246766,analysis,0,0
246767,with,0,0
246768,505,0,0
246769,assessable,0,0
246770,patients,0,0
246771,and,0,0
246772,a,0,0
246773,median,0,0
246774,follow-up,0,0
246775,of,0,0
246776,23,0,0
246777,months,0,0
246778,showed,0,0
246779,a,0,0
246780,significant,0,0
246781,inferiority,0,0
246782,(,0,0
246783,according,0,0
246784,to,0,0
246785,sequential,0,1
246786,monitoring,0,1
246787,strategy,0,0
246788,),0,0
246789,of,0,0
246790,the,0,0
246791,COPP/ABVD,1,0
246792,regimen,0,1
246793,in,0,0
246794,progression,0,0
246795,rate,0,0
246796,and,0,0
246797,freedom,0,0
246798,from,0,0
246799,treatment,0,1
246800,failure,0,0
246801,(,0,1
246802,FFTF,0,1
246803,),0,1
246804,compared,0,0
246805,with,0,0
246806,the,0,0
246807,pooled,0,0
246808,results,0,0
246809,of,0,0
246810,both,0,0
246811,BEACOPP,1,0
246812,variants,0,0
246813,.,0,0
246814,The,0,0
246815,24-month,0,0
246816,FFTF,0,1
246817,rate,0,0
246818,was,0,0
246819,75,0,0
246820,%,0,0
246821,for,0,0
246822,COPP/ABVD,0,0
246823,and,0,0
246824,84,0,0
246825,%,0,0
246826,for,0,0
246827,BEACOPP,1,1
246828,pooled,0,0
246829,(,0,0
246830,P,0,0
246831,=,0,0
246832,.034,0,0
246833,),0,0
246834,.,0,0
246835,There,0,0
246836,was,0,0
246837,12,0,0
246838,%,0,0
246839,progressive,0,0
246840,disease,0,0
246841,with,0,0
246842,COPP/ABVD,0,0
246843,and,0,0
246844,6,0,0
246845,%,0,0
246846,with,0,0
246847,BEACOPP,1,0
246848,pooled,0,0
246849,.,0,0
246850,Differences,0,0
246851,in,0,0
246852,survival,0,0
246853,were,0,0
246854,not,0,0
246855,significant,0,0
246856,in,0,0
246857,sequential,0,0
246858,analysis,0,0
246859,.,0,0
246860,The,0,0
246861,acute,0,0
246862,toxicity,0,0
246863,of,0,0
246864,baseline,0,0
246865,BEACOPP,1,1
246866,resembled,0,0
246867,that,0,0
246868,of,0,0
246869,COPP/ABVD,1,0
246870,;,1,0
246871,escalated,0,0
246872,BEACOPP,1,0
246873,showed,0,0
246874,increased,0,0
246875,but,0,0
246876,manageable,0,0
246877,hematologic,0,0
246878,toxicity,0,0
246879,.,0,0
246880,CONCLUSION,0,0
246881,Combined,0,0
246882,with,0,0
246883,local,0,1
246884,irradiation,0,1
246885,",",0,0
246886,BEACOPP,1,0
246887,in,0,0
246888,one,0,0
246889,or,0,0
246890,both,0,0
246891,variants,0,0
246892,shows,0,0
246893,superior,0,0
246894,disease,0,0
246895,control,0,1
246896,compared,0,0
246897,with,0,0
246898,COPP/ABVD,1,0
246899,",",0,0
246900,with,0,0
246901,acceptable,0,0
246902,acute,0,0
246903,toxicity,0,0
246904,.,0,0
246905,Further,0,0
246906,follow-up,0,0
246907,is,0,0
246908,required,0,0
246909,to,0,0
246910,assess,0,0
246911,the,0,0
246912,effect,0,0
246913,of,0,0
246914,dosage,0,0
246915,and,0,0
246916,the,0,0
246917,effect,0,0
246918,on,0,0
246919,survival,0,0
246920,and,0,0
246921,late,0,0
246922,toxicities,0,0
246923,.,0,0
246924,Herpes,1,0
246925,simplex,1,0
246926,virus,1,1
246927,vaccine,1,1
246928,in,0,0
246929,recurrent,0,0
246930,herpetic,0,0
246931,ocular,0,0
246932,infection,0,0
246933,.,0,0
246934,PURPOSE,0,0
246935,To,0,0
246936,evaluate,0,0
246937,the,0,0
246938,efficacy,0,0
246939,of,0,0
246940,an,0,0
246941,antiherpetic,1,1
246942,vaccine,1,1
246943,in,0,0
246944,recurrent,0,0
246945,herpetic,0,0
246946,ocular,0,0
246947,infections,0,0
246948,.,0,0
246949,METHODS,0,0
246950,Twenty,0,0
246951,patients,0,0
246952,with,0,0
246953,herpes,0,0
246954,simplex,0,0
246955,virus,0,0
246956,1-related,0,0
246957,recurrent,0,0
246958,keratitis/keratouveitis,0,0
246959,were,0,0
246960,prospectively,0,0
246961,enrolled,0,0
246962,and,0,0
246963,randomly,0,0
246964,assigned,0,0
246965,to,0,0
246966,receive,0,0
246967,either,0,0
246968,a,0,0
246969,specific,1,0
246970,vaccination,1,1
246971,with,1,0
246972,heat,1,0
246973,shock-inactivated,1,1
246974,herpes,1,0
246975,simplex,1,0
246976,virus,1,0
246977,type,1,0
246978,1,1,0
246979,(,0,0
246980,10,0,0
246981,patients,0,0
246982,),0,0
246983,or,0,1
246984,to,0,0
246985,be,0,0
246986,observed,1,0
246987,as,1,0
246988,controls,1,0
246989,(,0,0
246990,10,0,0
246991,patients,0,0
246992,),0,0
246993,.,0,0
246994,The,0,0
246995,number,0,0
246996,",",0,0
246997,duration,0,0
246998,",",0,0
246999,and,0,0
247000,anatomic,0,0
247001,localization,0,0
247002,of,0,0
247003,relapses,0,0
247004,were,0,0
247005,recorded,0,0
247006,in,0,0
247007,all,0,0
247008,the,0,0
247009,patients,0,0
247010,for,0,0
247011,12,0,0
247012,months,0,0
247013,before,0,0
247014,inclusion,0,0
247015,in,0,0
247016,the,0,0
247017,study,0,0
247018,and,0,0
247019,for,0,0
247020,a,0,0
247021,similar,0,0
247022,period,0,0
247023,after,0,0
247024,the,0,0
247025,assignment,0,0
247026,of,0,0
247027,each,0,0
247028,subject,0,0
247029,to,0,0
247030,vaccine,0,1
247031,or,0,1
247032,control,0,1
247033,group,0,0
247034,.,0,0
247035,RESULTS,0,0
247036,In,0,0
247037,the,0,0
247038,vaccine,0,1
247039,group,0,0
247040,",",0,0
247041,we,0,0
247042,observed,0,0
247043,a,0,0
247044,reduction,0,0
247045,both,0,0
247046,in,0,0
247047,the,0,0
247048,number,0,0
247049,(,0,0
247050,p,0,0
247051,=,0,0
247052,0.016,0,0
247053,),0,0
247054,and,0,0
247055,average,0,0
247056,duration,0,0
247057,(,0,0
247058,p,0,0
247059,=,0,0
247060,0.050,0,0
247061,),0,0
247062,of,0,0
247063,recurrences,0,0
247064,",",0,0
247065,whereas,0,0
247066,in,0,0
247067,the,0,0
247068,control,0,1
247069,group,0,0
247070,",",0,0
247071,no,0,0
247072,significant,0,0
247073,change,0,0
247074,was,0,0
247075,found,0,0
247076,comparing,0,0
247077,a,0,0
247078,12-month,0,0
247079,period,0,0
247080,before,0,0
247081,and,0,0
247082,after,0,0
247083,inclusion,0,0
247084,in,0,0
247085,the,0,0
247086,study,0,0
247087,.,0,0
247088,The,0,0
247089,comparison,0,0
247090,between,0,0
247091,the,0,0
247092,two,0,0
247093,groups,0,0
247094,highlighted,0,0
247095,a,0,0
247096,significant,0,0
247097,reduction,0,0
247098,in,0,0
247099,the,0,0
247100,number,0,0
247101,(,0,0
247102,p,0,0
247103,=,0,0
247104,0.013,0,0
247105,),0,0
247106,and,0,0
247107,average,0,0
247108,duration,0,0
247109,(,0,0
247110,p,0,0
247111,=,0,0
247112,0.051,0,0
247113,),0,0
247114,of,0,0
247115,relapses,0,0
247116,in,0,0
247117,treated,0,0
247118,subjects,0,0
247119,",",0,0
247120,who,0,0
247121,did,0,0
247122,not,0,0
247123,show,0,0
247124,any,0,0
247125,significant,0,0
247126,vaccine-induced,0,0
247127,side,0,0
247128,effects,0,0
247129,.,0,0
247130,CONCLUSION,0,0
247131,The,0,0
247132,use,0,0
247133,of,0,0
247134,a,0,0
247135,vaccination,1,1
247136,with,0,0
247137,heat,0,0
247138,shock-inactivated,0,1
247139,herpes,0,0
247140,simplex,0,0
247141,virus,0,0
247142,1,0,0
247143,seems,0,0
247144,to,0,0
247145,be,0,0
247146,able,0,0
247147,to,0,0
247148,reduce,0,0
247149,the,0,0
247150,number,0,0
247151,and,0,0
247152,duration,0,0
247153,of,0,0
247154,relapses,0,0
247155,in,0,0
247156,herpes,0,0
247157,simplex,0,0
247158,virus,0,0
247159,1-related,0,0
247160,keratitis/keratouveitis,0,0
247161,.,0,0
247162,Total,1,0
247163,parenteral,1,1
247164,nutrition,1,1
247165,with,1,0
247166,glutamine,1,1
247167,dipeptide,1,0
247168,shortened,0,0
247169,hospital,0,0
247170,stays,0,0
247171,and,0,0
247172,improved,0,0
247173,immune,0,0
247174,status,0,0
247175,and,0,0
247176,nitrogen,0,0
247177,economy,0,0
247178,after,0,0
247179,major,0,0
247180,abdominal,0,0
247181,surgery,0,0
247182,.,0,0
247183,[,1,1
247184,Plasma,1,1
247185,separation,1,0
247186,combined,0,1
247187,with,0,0
247188,CVVHF,1,0
247189,in,0,0
247190,septic,0,0
247191,and,0,0
247192,SIRS,0,1
247193,patients,0,0
247194,],0,0
247195,.,0,0
247196,In,0,0
247197,a,0,0
247198,prospective,0,0
247199,non-randomized,0,0
247200,trial,0,0
247201,",",0,0
247202,59,0,0
247203,patients,0,0
247204,with,0,0
247205,sepsis,0,0
247206,(,0,0
247207,n,0,0
247208,=,0,0
247209,43,0,0
247210,),0,0
247211,and,0,0
247212,SIRS,0,1
247213,(,0,1
247214,n,0,0
247215,=,0,0
247216,16,0,0
247217,),0,0
247218,were,0,0
247219,treated,0,0
247220,on,0,0
247221,a,0,0
247222,surgical,0,1
247223,intensive,0,1
247224,care,0,1
247225,unit,0,0
247226,.,0,0
247227,In,0,0
247228,22,0,0
247229,patients,0,0
247230,plasmapheresis,1,1
247231,in,1,0
247232,combination,1,1
247233,with,1,0
247234,continuous,1,1
247235,venovenous,1,1
247236,hemofiltration,1,1
247237,(,1,1
247238,CVVHF,1,0
247239,),1,1
247240,was,0,0
247241,administered,0,0
247242,.,0,0
247243,Lethality,0,0
247244,was,0,0
247245,56,0,0
247246,%,0,0
247247,in,0,0
247248,the,0,0
247249,sepsis,0,0
247250,group,0,0
247251,;,0,0
247252,in,0,0
247253,the,0,0
247254,therapy,0,1
247255,group,0,0
247256,lethality,0,0
247257,was,0,0
247258,significantly,0,0
247259,lower,0,0
247260,in,0,0
247261,patients,0,0
247262,with,0,0
247263,plasmapheresis,0,1
247264,",",0,0
247265,even,0,0
247266,though,0,0
247267,in,0,0
247268,this,0,0
247269,population,0,0
247270,the,0,0
247271,organic,0,1
247272,failure,0,0
247273,rate,0,0
247274,was,0,0
247275,higher,0,0
247276,.,0,0
247277,Finally,0,0
247278,the,0,0
247279,dependency,0,0
247280,of,0,0
247281,lethality,0,0
247282,and,0,0
247283,age,0,0
247284,was,0,0
247285,similar,0,0
247286,in,0,0
247287,both,0,0
247288,groups,0,0
247289,.,0,0
247290,Lethality,0,0
247291,at,0,0
247292,22,0,0
247293,%,0,0
247294,in,0,0
247295,the,0,0
247296,plasmapheresis,1,1
247297,group,0,0
247298,with,0,0
247299,double,0,1
247300,organ,0,0
247301,failure,0,0
247302,was,0,0
247303,significantly,0,0
247304,lower,0,0
247305,(,0,0
247306,P,0,0
247307,>,0,0
247308,0.01,0,0
247309,),0,0
247310,than,0,0
247311,in,0,0
247312,controls,0,0
247313,.,0,0
247314,Reduction,0,0
247315,of,0,0
247316,lethality,0,0
247317,seemed,0,0
247318,to,0,0
247319,be,0,0
247320,as,0,0
247321,high,0,0
247322,as,0,0
247323,18,0,0
247324,%,0,0
247325,in,0,0
247326,patients,0,0
247327,with,0,0
247328,sepsis,0,0
247329,",",0,0
247330,while,0,0
247331,patients,0,0
247332,with,0,0
247333,SIRS,0,0
247334,did,0,0
247335,not,0,0
247336,profit,0,0
247337,from,0,0
247338,the,0,0
247339,additional,0,0
247340,therapy,0,1
247341,.,0,0
247342,A,0,0
247343,prospective,0,0
247344,randomized,0,0
247345,trial,0,0
247346,in,0,0
247347,sepsis,0,0
247348,and,0,0
247349,double,0,1
247350,organic,0,1
247351,failure,0,0
247352,should,0,0
247353,be,0,0
247354,projected,0,0
247355,.,0,0
247356,Morphological,0,0
247357,onset,0,0
247358,and,0,0
247359,early,0,0
247360,diagnosis,0,0
247361,in,0,0
247362,apical,0,0
247363,hypertrophic,0,0
247364,cardiomyopathy,0,0
247365,:,0,0
247366,a,0,0
247367,long,0,0
247368,term,0,0
247369,analysis,0,0
247370,with,0,0
247371,nuclear,1,0
247372,magnetic,1,1
247373,resonance,1,0
247374,imaging,1,0
247375,.,1,0
247376,OBJECTIVES,0,0
247377,A,0,0
247378,long-term,0,0
247379,follow-up,0,0
247380,study,0,0
247381,with,0,0
247382,nuclear,1,0
247383,magnetic,1,1
247384,resonance,1,1
247385,(,1,1
247386,NMR,1,1
247387,),1,1
247388,imaging,1,0
247389,was,0,0
247390,undertaken,0,0
247391,to,0,0
247392,detect,0,0
247393,the,0,0
247394,morphological,0,0
247395,onset,0,0
247396,and,0,0
247397,to,0,0
247398,establish,0,0
247399,the,0,0
247400,early,0,0
247401,diagnosis,0,0
247402,in,0,0
247403,apical,0,0
247404,hypertrophic,0,1
247405,cardiomyopathy,0,0
247406,(,0,1
247407,HCM,0,0
247408,),0,0
247409,.,0,0
247410,BACKGROUND,0,0
247411,A,0,0
247412,spadelike,0,0
247413,configuration,0,0
247414,on,0,0
247415,left,0,0
247416,ventriculogram,0,0
247417,(,0,1
247418,LVG,0,1
247419,),0,1
247420,is,0,0
247421,regarded,0,0
247422,as,0,0
247423,a,0,0
247424,diagnostic,0,0
247425,criterion,0,0
247426,for,0,0
247427,the,0,0
247428,classical,0,1
247429,apical,0,0
247430,HCM,0,0
247431,.,0,0
247432,There,0,0
247433,also,0,0
247434,exists,0,0
247435,a,0,0
247436,segmented,0,1
247437,hypertrophy,0,0
247438,at,0,0
247439,the,0,0
247440,apical,0,0
247441,level,0,0
247442,without,0,1
247443,indicating,0,0
247444,the,0,0
247445,spadelike,0,1
247446,features,0,0
247447,(,0,0
247448,a,0,0
247449,nonspade,0,1
247450,configuration,0,0
247451,),0,0
247452,.,0,0
247453,To,0,0
247454,detect,0,0
247455,the,0,0
247456,hypertrophied,0,0
247457,myocardium,0,0
247458,of,0,0
247459,the,0,0
247460,nonspade,0,1
247461,configuration,0,0
247462,",",0,0
247463,circumferential,0,0
247464,scrutiny,0,0
247465,of,0,0
247466,the,0,0
247467,apex,0,0
247468,is,0,0
247469,required,0,0
247470,.,0,0
247471,Although,0,0
247472,both,0,0
247473,configurations,0,0
247474,can,0,0
247475,be,0,0
247476,underlying,0,0
247477,causes,0,0
247478,of,0,0
247479,giant,0,1
247480,negative,0,0
247481,T,0,0
247482,waves,0,0
247483,",",0,0
247484,etiological,0,0
247485,relationship,0,0
247486,between,0,0
247487,the,0,0
247488,two,0,0
247489,is,0,0
247490,not,0,0
247491,clarified,0,0
247492,.,0,0
247493,METHODS,0,0
247494,The,0,0
247495,criteria,0,0
247496,for,0,0
247497,the,0,0
247498,spadelike,0,0
247499,configuration,0,0
247500,defined,0,0
247501,on,0,0
247502,left,0,0
247503,ventricular,0,0
247504,short-axis,0,1
247505,NMR,1,0
247506,images,1,1
247507,were,0,0
247508,as,0,0
247509,follows,0,0
247510,:,0,0
247511,(,0,0
247512,apical,0,0
247513,maximal,0,0
247514,thickness,0,0
247515,>,0,0
247516,or,0,1
247517,=,0,0
247518,15,0,1
247519,mm,0,0
247520,),0,0
247521,",",0,0
247522,(,0,0
247523,apical,0,0
247524,anterior,0,1
247525,thickness,0,0
247526,over,0,0
247527,basal,0,0
247528,anterior,0,1
247529,thickness,0,0
247530,>,0,0
247531,or,0,1
247532,=,0,0
247533,1.3,0,0
247534,),0,0
247535,and,0,0
247536,(,0,1
247537,apical,0,1
247538,posterior,0,1
247539,thickness,0,0
247540,over,0,0
247541,basal,0,0
247542,posterior,0,1
247543,thickness,0,0
247544,>,0,0
247545,or,0,1
247546,=1.3,0,0
247547,),0,0
247548,.,0,0
247549,Thirteen,0,0
247550,patients,0,0
247551,who,0,0
247552,had,0,0
247553,predominant,0,0
247554,hypertrophy,0,0
247555,(,0,0
247556,>,0,0
247557,or,0,1
247558,=,0,0
247559,15,0,1
247560,mm,0,0
247561,),0,0
247562,at,0,0
247563,the,0,0
247564,apical,0,0
247565,level,0,0
247566,without,0,0
247567,the,0,0
247568,spadelike,0,0
247569,configuration,0,0
247570,underwent,0,0
247571,NMR,1,1
247572,imaging,1,0
247573,twice,1,1
247574,before,1,0
247575,and,1,0
247576,after,1,0
247577,54+/-10,1,0
247578,months,1,0
247579,',1,0
247580,follow-up,1,0
247581,.,1,0
247582,RESULTS,0,0
247583,Apical,0,0
247584,hypertrophy,0,0
247585,that,0,0
247586,had,0,0
247587,been,0,0
247588,confined,0,0
247589,to,0,0
247590,the,0,0
247591,lateral,0,1
247592,wall,0,0
247593,in,0,0
247594,four,0,0
247595,",",0,0
247596,the,0,0
247597,anterior-lateral,0,1
247598,wall,0,0
247599,in,0,0
247600,two,0,0
247601,",",0,0
247602,and,0,0
247603,the,0,0
247604,septal-anterior,0,1
247605,wall,0,0
247606,in,0,0
247607,one,0,0
247608,developed,0,0
247609,to,0,0
247610,become,0,0
247611,circumferential,0,0
247612,hypertrophy,0,0
247613,that,0,0
247614,fulfilled,0,0
247615,the,0,0
247616,criteria,0,0
247617,for,0,0
247618,the,0,0
247619,spadelike,0,0
247620,configuration,0,0
247621,after,0,0
247622,the,0,0
247623,follow-up,0,0
247624,period,0,0
247625,.,0,0
247626,CONCLUSIONS,0,0
247627,The,0,0
247628,spadelike,0,0
247629,configuration,0,0
247630,can,0,0
247631,begin,0,0
247632,with,0,0
247633,the,0,0
247634,nonspade,0,1
247635,configuration,0,0
247636,and,0,0
247637,therefore,0,0
247638,",",0,0
247639,both,0,0
247640,can,0,0
247641,constitute,0,0
247642,a,0,0
247643,single,0,1
247644,disease,0,0
247645,entity,0,0
247646,of,0,0
247647,apical,0,0
247648,HCM,0,0
247649,.,0,0
247650,The,0,0
247651,early,0,0
247652,diagnosis,0,0
247653,of,0,0
247654,apical,0,0
247655,HCM,0,0
247656,can,0,0
247657,be,0,0
247658,achieved,0,0
247659,by,0,0
247660,identifying,0,0
247661,the,0,0
247662,hypertrophy,0,0
247663,frequently,0,0
247664,confined,0,0
247665,to,0,0
247666,the,0,0
247667,lateral,0,1
247668,wall,0,0
247669,at,0,0
247670,the,0,0
247671,apical,0,0
247672,level,0,0
247673,.,0,0
247674,Active,1,1
247675,specific,1,1
247676,immunotherapy,1,1
247677,for,0,0
247678,stage,0,0
247679,II,0,1
247680,and,0,0
247681,stage,0,0
247682,III,0,1
247683,human,0,1
247684,colon,0,0
247685,cancer,0,0
247686,:,0,0
247687,a,0,0
247688,randomised,0,0
247689,trial,0,0
247690,.,0,0
247691,BACKGROUND,0,0
247692,Colon,0,1
247693,cancer,0,0
247694,is,0,0
247695,curable,0,0
247696,by,0,0
247697,surgery,0,1
247698,",",0,0
247699,but,0,0
247700,cure,0,0
247701,rate,0,0
247702,depends,0,0
247703,on,0,0
247704,the,0,0
247705,extent,0,0
247706,of,0,0
247707,disease,0,0
247708,.,0,0
247709,We,0,0
247710,investigated,0,0
247711,whether,0,0
247712,adjuvant,0,1
247713,active,1,1
247714,specific,1,1
247715,immunotherapy,1,1
247716,(,0,1
247717,ASI,0,1
247718,),0,1
247719,with,0,0
247720,an,0,0
247721,autologous,0,1
247722,tumour,0,0
247723,cell-BCG,0,0
247724,vaccine,0,1
247725,with,0,0
247726,surgical,0,1
247727,resection,0,1
247728,was,0,0
247729,more,0,0
247730,beneficial,0,0
247731,than,0,0
247732,resection,0,0
247733,alone,0,1
247734,in,0,0
247735,stage,0,0
247736,II,0,1
247737,and,0,0
247738,III,0,1
247739,colon,0,0
247740,cancer,0,0
247741,.,0,0
247742,METHODS,0,0
247743,In,0,0
247744,a,0,0
247745,prospective,0,0
247746,randomised,0,0
247747,trial,0,0
247748,",",0,0
247749,254,0,0
247750,patients,0,0
247751,with,0,0
247752,colon,0,0
247753,cancer,0,0
247754,were,0,0
247755,randomly,0,0
247756,assigned,0,0
247757,postoperative,1,0
247758,ASI,1,1
247759,or,1,1
247760,no,1,0
247761,adjuvant,1,1
247762,treatment,1,0
247763,.,1,0
247764,ASI,0,0
247765,was,0,0
247766,three,0,0
247767,weekly,0,1
247768,vaccinations,0,1
247769,starting,0,0
247770,4,0,0
247771,weeks,0,0
247772,after,0,0
247773,surgery,0,0
247774,",",0,0
247775,with,0,0
247776,a,0,0
247777,booster,0,1
247778,vaccination,0,1
247779,at,0,0
247780,6,0,0
247781,months,0,0
247782,with,0,0
247783,10,0,0
247784,(,0,0
247785,7,0,0
247786,),0,0
247787,irradiated,0,1
247788,autologous,1,1
247789,tumour,1,0
247790,cells,1,0
247791,.,1,0
247792,The,0,0
247793,first,0,0
247794,vaccinations,0,1
247795,contained,0,0
247796,10,0,0
247797,(,0,0
247798,7,0,0
247799,),0,0
247800,BCG,0,1
247801,organisms,0,0
247802,.,0,0
247803,We,0,0
247804,followed,0,0
247805,up,0,0
247806,patients,0,0
247807,for,0,0
247808,time,0,0
247809,to,0,0
247810,recurrence,0,0
247811,",",0,0
247812,and,0,0
247813,recurrence-free,0,0
247814,and,0,0
247815,overall,0,0
247816,survival,0,0
247817,.,0,0
247818,Analysis,0,0
247819,was,0,0
247820,by,0,0
247821,intention,0,0
247822,to,0,0
247823,treat,0,0
247824,.,0,0
247825,FINDINGS,0,0
247826,The,0,0
247827,5.3,0,0
247828,year,0,0
247829,median,0,0
247830,follow-up,0,0
247831,(,0,0
247832,range,0,0
247833,8,0,0
247834,months,0,0
247835,to,0,0
247836,8,0,0
247837,years,0,0
247838,11,0,0
247839,months,0,0
247840,),0,0
247841,showed,0,0
247842,44,0,0
247843,%,0,0
247844,(,0,0
247845,95,0,0
247846,%,0,0
247847,CI,0,0
247848,7-66,0,0
247849,),0,0
247850,risk,0,0
247851,reduction,0,0
247852,for,0,0
247853,recurrence,0,0
247854,in,0,0
247855,the,0,0
247856,recurrence-free,0,0
247857,period,0,0
247858,in,0,0
247859,all,0,0
247860,patients,0,0
247861,receiving,0,0
247862,ASI,1,1
247863,(,0,1
247864,p=0.023,0,0
247865,),0,1
247866,.,0,0
247867,Overall,0,0
247868,",",0,0
247869,there,0,0
247870,were,0,0
247871,40,0,0
247872,recurrences,0,0
247873,in,0,0
247874,the,0,0
247875,control,0,1
247876,group,0,0
247877,and,0,0
247878,25,0,0
247879,in,0,0
247880,the,0,0
247881,ASI,0,0
247882,group,0,0
247883,.,0,0
247884,Analysis,0,0
247885,by,0,0
247886,stage,0,0
247887,showed,0,0
247888,no,0,0
247889,significant,0,0
247890,benefit,0,0
247891,of,0,0
247892,ASI,0,1
247893,in,0,0
247894,stage,0,0
247895,III,0,0
247896,disease,0,0
247897,.,0,0
247898,The,0,0
247899,major,0,0
247900,impact,0,0
247901,of,0,0
247902,ASI,0,0
247903,was,0,0
247904,seen,0,0
247905,in,0,0
247906,patients,0,0
247907,with,0,0
247908,stage,0,0
247909,II,0,1
247910,disease,0,0
247911,",",0,0
247912,with,0,0
247913,a,0,0
247914,significantly,0,0
247915,longer,0,0
247916,recurrence-free,0,0
247917,period,0,0
247918,(,0,1
247919,p=0.011,0,0
247920,),0,1
247921,and,0,0
247922,61,0,0
247923,%,0,0
247924,(,0,0
247925,18-81,0,0
247926,),0,1
247927,risk,0,0
247928,reduction,0,0
247929,for,0,0
247930,recurrences,0,0
247931,.,0,0
247932,Recurrence-free,0,0
247933,survival,0,0
247934,was,0,0
247935,significantly,0,0
247936,longer,0,0
247937,with,0,0
247938,ASI,0,1
247939,(,0,0
247940,42,0,0
247941,%,0,0
247942,risk,0,0
247943,reduction,0,0
247944,for,0,0
247945,recurrence,0,0
247946,or,0,1
247947,death,0,0
247948,[,0,1
247949,0-68,0,0
247950,],0,0
247951,",",0,0
247952,p=0.032,0,0
247953,),0,1
247954,and,0,0
247955,there,0,0
247956,was,0,0
247957,a,0,0
247958,trend,0,0
247959,towards,0,0
247960,improved,0,0
247961,overall,0,0
247962,survival,0,0
247963,.,0,0
247964,INTERPRETATION,0,0
247965,ASI,0,0
247966,gave,0,0
247967,significant,0,0
247968,clinical,0,0
247969,benefit,0,0
247970,in,0,0
247971,surgically,0,0
247972,resected,0,0
247973,patients,0,0
247974,with,0,0
247975,stage,0,0
247976,II,0,1
247977,colon,0,0
247978,cancer,0,0
247979,.,0,0
247980,ASI,0,0
247981,has,0,0
247982,minimal,0,0
247983,adverse,0,0
247984,reactions,0,0
247985,and,0,0
247986,should,0,0
247987,be,0,0
247988,considered,0,0
247989,in,0,0
247990,the,0,0
247991,management,0,1
247992,of,0,0
247993,stage,0,0
247994,II,0,1
247995,colon,0,0
247996,cancer,0,0
247997,.,0,0
